id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
161207129|NCT01211613|582139520|FG000|Overall Study|Lost to Follow-up|2|||
161207130|NCT01211613|582139521|FG001|Overall Study|Lost to Follow-up|2|||
161207131|NCT01211613|582139522|FG002|Overall Study|Lost to Follow-up|2|||
161207132|NCT01211613|582139520|FG000|Overall Study|Withdrawal by Subject|1|||
161207133|NCT01211613|582139521|FG001|Overall Study|Withdrawal by Subject|0|||
161207134|NCT01211613|582139522|FG002|Overall Study|Withdrawal by Subject|0|||
161207135|NCT03853213|582139523|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
161207136|NCT03853213|582139524|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
161207137|NCT03853213|582139523|FG000|Overall Study|Other (e.g., too busy)|0|||
161207138|NCT03853213|582139524|FG001|Overall Study|Other (e.g., too busy)|2|||
161207139|NCT02239692|582139525|FG000|Overall Study|Incomplete colonoscopy|1|||
161207140|NCT02239692|582139526|FG001|Overall Study|Incomplete colonoscopy|2|||
161207141|NCT02239692|582139525|FG000|Overall Study|Adverse Event|0|||
161207142|NCT02239692|582139526|FG001|Overall Study|Adverse Event|1|||
161207143|NCT02239692|582139525|FG000|Overall Study|Physician Decision|0|||
161207144|NCT02239692|582139526|FG001|Overall Study|Physician Decision|1|||
161207145|NCT02239692|582139525|FG000|Overall Study|Lost to Follow-up|1|||
161207146|NCT02239692|582139526|FG001|Overall Study|Lost to Follow-up|4|||
161207147|NCT02239692|582139525|FG000|Overall Study|Withdrawal by Subject|3|||
161207148|NCT02239692|582139526|FG001|Overall Study|Withdrawal by Subject|5|||
161207149|NCT02239692|582139525|FG000|Overall Study|Other reason|1|||
161207150|NCT02239692|582139526|FG001|Overall Study|Other reason|0|||
161207151|NCT01901146|582139527|FG000|Neoadjuvant Phase|Death|1|||
161092390|NCT03440320|581729832|FG000|Overall Study|Withdrawal by Subject|0|||
161207152|NCT01901146|582139528|FG001|Neoadjuvant Phase|Death|2|||
161207153|NCT01901146|582139529|FG002|Neoadjuvant Phase|Death|0|||
161207154|NCT01901146|582139530|FG003|Neoadjuvant Phase|Death|0|||
161207155|NCT01901146|582139531|FG004|Neoadjuvant Phase|Death|0|||
161207156|NCT01901146|582139527|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
161207157|NCT01901146|582139528|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
161207158|NCT01901146|582139529|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161207159|NCT01901146|582139530|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161207160|NCT01901146|582139531|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
161207161|NCT01901146|582139527|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
161207162|NCT01901146|582139528|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161207163|NCT01901146|582139529|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
161207164|NCT01901146|582139530|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161207165|NCT01901146|582139531|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161207166|NCT01901146|582139527|FG000|Neoadjuvant Phase|Physician Decision|1|||
161207167|NCT01901146|582139528|FG001|Neoadjuvant Phase|Physician Decision|2|||
161207168|NCT01901146|582139529|FG002|Neoadjuvant Phase|Physician Decision|0|||
161207169|NCT01901146|582139530|FG003|Neoadjuvant Phase|Physician Decision|0|||
161207170|NCT01901146|582139531|FG004|Neoadjuvant Phase|Physician Decision|0|||
161207171|NCT01901146|582139527|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
161207172|NCT01901146|582139528|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
161207173|NCT01901146|582139529|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161207174|NCT01901146|582139530|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161207175|NCT01901146|582139531|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161207176|NCT01901146|582139527|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161207177|NCT01901146|582139528|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
161207178|NCT01901146|582139529|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161207179|NCT01901146|582139530|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161207180|NCT01901146|582139531|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
161207181|NCT01901146|582139527|FG000|Adjuvant Phase|Other|0|||
161207182|NCT01901146|582139528|FG001|Adjuvant Phase|Other|0|||
161207183|NCT01901146|582139529|FG002|Adjuvant Phase|Other|1|||
161207184|NCT01901146|582139530|FG003|Adjuvant Phase|Other|0|||
161207185|NCT01901146|582139531|FG004|Adjuvant Phase|Other|0|||
161207186|NCT01901146|582139527|FG000|Adjuvant Phase|Death|0|||
161207187|NCT01901146|582139528|FG001|Adjuvant Phase|Death|0|||
161207188|NCT01901146|582139529|FG002|Adjuvant Phase|Death|0|||
161207189|NCT01901146|582139530|FG003|Adjuvant Phase|Death|0|||
161207190|NCT01901146|582139531|FG004|Adjuvant Phase|Death|3|||
161207191|NCT01901146|582139527|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
161207192|NCT01901146|582139528|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
161207193|NCT01901146|582139529|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
161207194|NCT01901146|582139530|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
161207195|NCT01901146|582139531|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
161207196|NCT01901146|582139527|FG000|Adjuvant Phase|Physician Decision|0|||
161207197|NCT01901146|582139528|FG001|Adjuvant Phase|Physician Decision|0|||
161207198|NCT01901146|582139529|FG002|Adjuvant Phase|Physician Decision|9|||
161207199|NCT01901146|582139530|FG003|Adjuvant Phase|Physician Decision|2|||
161207200|NCT01901146|582139531|FG004|Adjuvant Phase|Physician Decision|4|||
161321372|NCT00401193|582562924|FG000|Overall Study|Adverse Event|1|||
161207201|NCT01901146|582139527|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
161207202|NCT01901146|582139528|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
161207203|NCT01901146|582139529|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
161207204|NCT01901146|582139530|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
161207205|NCT01901146|582139531|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
161207206|NCT00297492|582139532|FG000|Set Quit Date|Lost to Follow-up|7|||
161207207|NCT00297492|582139533|FG001|Set Quit Date|Lost to Follow-up|13|||
161207208|NCT00297492|582139534|FG002|Set Quit Date|Lost to Follow-up|5|||
161207209|NCT00297492|582139532|FG000|6 Month Follow-up|Lost to Follow-up|63|||
161207210|NCT00297492|582139533|FG001|6 Month Follow-up|Lost to Follow-up|49|||
161207211|NCT00297492|582139534|FG002|6 Month Follow-up|Lost to Follow-up|27|||
161207212|NCT01296152|582139539|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161207213|NCT01268683|582139540|FG000|Overall Study|Lost to Follow-up|1|||
161207214|NCT01268683|582139540|FG000|Overall Study|Death|1|||
161207215|NCT04256759|582139541|FG000|Overall Study|Physician Decision|1|||
161207216|NCT04256759|582139541|FG000|Overall Study|Lack of Efficacy|1|||
161207217|NCT03981614|582139546|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
161207218|NCT03981614|582139547|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
161207219|NCT03981614|582139548|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
161207220|NCT04971226|582139549|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
161207221|NCT04971226|582139550|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161207222|NCT04971226|582139551|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
161207223|NCT04971226|582139552|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
161207224|NCT04971226|582139549|FG000|Overall Study|Adverse Event|6|||
161207225|NCT04971226|582139550|FG001|Overall Study|Adverse Event|5|||
161207226|NCT04971226|582139551|FG002|Overall Study|Adverse Event|11|||
161207227|NCT04971226|582139552|FG003|Overall Study|Adverse Event|10|||
161207228|NCT04971226|582139549|FG000|Overall Study|Progressive disease|2|||
161207229|NCT04971226|582139550|FG001|Overall Study|Progressive disease|0|||
161207230|NCT04971226|582139551|FG002|Overall Study|Progressive disease|3|||
161207231|NCT04971226|582139552|FG003|Overall Study|Progressive disease|1|||
161207232|NCT04971226|582139549|FG000|Overall Study|Protocol Deviation|1|||
161207233|NCT04971226|582139550|FG001|Overall Study|Protocol Deviation|0|||
161207234|NCT04971226|582139551|FG002|Overall Study|Protocol Deviation|1|||
161207235|NCT04971226|582139552|FG003|Overall Study|Protocol Deviation|1|||
161207236|NCT04971226|582139549|FG000|Overall Study|Subject Decision|0|||
161207237|NCT04971226|582139550|FG001|Overall Study|Subject Decision|1|||
161207238|NCT04971226|582139551|FG002|Overall Study|Subject Decision|1|||
161207239|NCT04971226|582139552|FG003|Overall Study|Subject Decision|1|||
161207240|NCT04971226|582139549|FG000|Overall Study|Pregnancy|0|||
161207241|NCT04971226|582139550|FG001|Overall Study|Pregnancy|0|||
161207242|NCT04971226|582139551|FG002|Overall Study|Pregnancy|0|||
161207243|NCT04971226|582139552|FG003|Overall Study|Pregnancy|1|||
161207244|NCT04971226|582139549|FG000|Overall Study|Participants not treated|1|||
161207245|NCT04971226|582139550|FG001|Overall Study|Participants not treated|0|||
161207246|NCT04971226|582139551|FG002|Overall Study|Participants not treated|2|||
161207247|NCT04971226|582139552|FG003|Overall Study|Participants not treated|1|||
161207248|NCT04439149|582139555|FG000|Overall Study|Ineligible|1|||
161207249|NCT04439149|582139555|FG000|Overall Study|Never start protocol therapy|1|||
161207250|NCT04439149|582139555|FG000|Overall Study|Adverse Event|4|||
161207251|NCT04439149|582139555|FG000|Overall Study|Disease Progression|14|||
161207252|NCT04439149|582139555|FG000|Overall Study|Complicating disease|1|||
161207253|NCT04439149|582139555|FG000|Overall Study|Withdrawal by Subject|3|||
161207254|NCT05264506|582139558|FG000|Overall Study|Adverse Event|59|||
161207255|NCT05264506|582139558|FG000|Overall Study|Lost to Follow-up|204|||
161207256|NCT05264506|582139558|FG000|Overall Study|Protocol Violation|185|||
161207257|NCT05264506|582139558|FG000|Overall Study|Pregnancy|60|||
161207258|NCT05264506|582139558|FG000|Overall Study|Physician Decision|6|||
161207259|NCT05264506|582139558|FG000|Overall Study|Non-compliance with Study Drug|29|||
161207260|NCT05264506|582139558|FG000|Overall Study|Study termination|677|||
161207261|NCT05264506|582139558|FG000|Overall Study|Withdrawal by Subject|208|||
160863404|NCT03312634|580894724|FG000|Overall Study|Adverse Event|11|||
160863405|NCT03312634|580894725|FG001|Overall Study|Adverse Event|0|||
160863406|NCT03312634|580894724|FG000|Overall Study|Sponsor request|2|||
160863407|NCT03312634|580894725|FG001|Overall Study|Sponsor request|0|||
160863408|NCT03312634|580894724|FG000|Overall Study|Withdrawal by Subject|31|||
161092391|NCT03440320|581729833|FG001|Overall Study|Withdrawal by Subject|1|||
161092392|NCT00001962|581729834|FG000|Overall Study|Lack of Efficacy|18|||
161092393|NCT00001962|581729834|FG000|Overall Study|Lack of Accrual|6|||
161092394|NCT00001962|581729834|FG000|Overall Study|Death|1|||
161092395|NCT00001962|581729834|FG000|Overall Study|Lost to Follow-up|2|||
161092396|NCT00001962|581729834|FG000|Overall Study|Adverse Event|1|||
161092397|NCT00604279|581729838|FG000|Overall Study|Lack of Efficacy|22|||
161092398|NCT00604279|581729839|FG001|Overall Study|Lack of Efficacy|9|||
161092399|NCT00604279|581729838|FG000|Overall Study|Lost to Follow-up|9|||
161092400|NCT00604279|581729839|FG001|Overall Study|Lost to Follow-up|14|||
161092401|NCT00604279|581729838|FG000|Overall Study|Pregnancy|2|||
161092402|NCT00604279|581729839|FG001|Overall Study|Pregnancy|0|||
161092403|NCT00604279|581729838|FG000|Overall Study|Protocol Violation|3|||
161207262|NCT05264506|582139558|FG000|Overall Study|Discontinued prior treatment|89|||
161207263|NCT02032823|582139560|FG000|Overall Study|Death|75|||
161207264|NCT02032823|582139561|FG001|Overall Study|Death|109|||
161207265|NCT02032823|582139560|FG000|Overall Study|Lost to Follow-up|18|||
161207266|NCT02032823|582139561|FG001|Overall Study|Lost to Follow-up|17|||
161207267|NCT02032823|582139560|FG000|Overall Study|Withdrawal by Subject|70|||
161207268|NCT02032823|582139561|FG001|Overall Study|Withdrawal by Subject|53|||
161207269|NCT02032823|582139560|FG000|Overall Study|Ongoing study at data cut-off|755|||
161207270|NCT02032823|582139561|FG001|Overall Study|Ongoing study at data cut-off|731|||
161207271|NCT02032823|582139560|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
161092404|NCT00604279|581729839|FG001|Overall Study|Protocol Violation|1|||
161092405|NCT00604279|581729838|FG000|Overall Study|Withdrawal by Subject|16|||
161092406|NCT00604279|581729839|FG001|Overall Study|Withdrawal by Subject|5|||
161092407|NCT00604279|581729838|FG000|Overall Study|Adverse Event|4|||
161092408|NCT00604279|581729839|FG001|Overall Study|Adverse Event|5|||
161092409|NCT00604279|581729838|FG000|Overall Study|Other|8|||
161207272|NCT02032823|582139561|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
161207273|NCT06065176|582139562|FG000|Overall Study|Lost to Follow-up|11|||
161207274|NCT06065176|582139563|FG001|Overall Study|Lost to Follow-up|11|||
161092410|NCT00604279|581729839|FG001|Overall Study|Other|4|||
161092411|NCT03938545|581729840|FG000|Overall Study|Lost to Follow-up|0|||
161092412|NCT03938545|581729841|FG001|Overall Study|Lost to Follow-up|0|||
161092413|NCT03938545|581729842|FG002|Overall Study|Lost to Follow-up|0|||
161092414|NCT03938545|581729843|FG003|Overall Study|Lost to Follow-up|1|||
161092415|NCT03938545|581729840|FG000|Overall Study|Non-compliance with study drug|0|||
161092416|NCT03938545|581729841|FG001|Overall Study|Non-compliance with study drug|0|||
161092417|NCT03938545|581729842|FG002|Overall Study|Non-compliance with study drug|1|||
161092418|NCT03938545|581729843|FG003|Overall Study|Non-compliance with study drug|0|||
161092419|NCT03938545|581729840|FG000|Overall Study|Pregnancy|1|||
161092420|NCT03938545|581729841|FG001|Overall Study|Pregnancy|0|||
161092421|NCT03938545|581729842|FG002|Overall Study|Pregnancy|0|||
161092422|NCT03938545|581729843|FG003|Overall Study|Pregnancy|0|||
161092423|NCT03938545|581729840|FG000|Overall Study|Study terminated by sponsor|6|||
161092424|NCT03938545|581729841|FG001|Overall Study|Study terminated by sponsor|4|||
161092425|NCT03938545|581729842|FG002|Overall Study|Study terminated by sponsor|2|||
161092426|NCT03938545|581729843|FG003|Overall Study|Study terminated by sponsor|4|||
161092427|NCT03938545|581729840|FG000|Overall Study|Withdrawal by Subject|0|||
161092428|NCT03938545|581729841|FG001|Overall Study|Withdrawal by Subject|1|||
161092429|NCT03938545|581729842|FG002|Overall Study|Withdrawal by Subject|0|||
161092430|NCT03938545|581729843|FG003|Overall Study|Withdrawal by Subject|0|||
161092431|NCT03938545|581729840|FG000|Overall Study|Adverse Event|1|||
161092432|NCT03938545|581729841|FG001|Overall Study|Adverse Event|0|||
161092433|NCT03938545|581729842|FG002|Overall Study|Adverse Event|0|||
161207275|NCT06065176|582139564|FG002|Overall Study|Lost to Follow-up|10|||
161207276|NCT06065176|582139562|FG000|Overall Study|Withdrawal by Subject|1|||
161207277|NCT06065176|582139563|FG001|Overall Study|Withdrawal by Subject|1|||
161092434|NCT03938545|581729843|FG003|Overall Study|Adverse Event|0|||
161092435|NCT00355056|581729844|FG000|Randomization Period|Early Termination|4|||
161092436|NCT00355056|581729845|FG001|Randomization Period|Early Termination|6|||
161092437|NCT01060540|581729846|FG000|Overall Study|Withdrawal by Subject|10|||
161092438|NCT01060540|581729847|FG001|Overall Study|Withdrawal by Subject|20|||
161092439|NCT01060540|581729846|FG000|Overall Study|Lost to Follow-up|52|||
161092440|NCT01060540|581729847|FG001|Overall Study|Lost to Follow-up|43|||
161092441|NCT01060540|581729846|FG000|Overall Study|Death|2|||
161092442|NCT01060540|581729847|FG001|Overall Study|Death|1|||
161092443|NCT01060540|581729846|FG000|Overall Study|Physician Decision|0|||
161092444|NCT01060540|581729847|FG001|Overall Study|Physician Decision|1|||
161092445|NCT00816400|581729851|FG000|Overall Study|Death|2|||
161092446|NCT00816400|581729852|FG001|Overall Study|Death|3|||
161092447|NCT00816400|581729853|FG002|Overall Study|Death|3|||
161092448|NCT00816400|581729854|FG003|Overall Study|Death|3|||
161092449|NCT00816400|581729855|FG004|Overall Study|Death|2|||
161092450|NCT00816400|581729856|FG005|Overall Study|Death|3|||
161092451|NCT00816400|581729857|FG006|Overall Study|Death|2|||
161207278|NCT06065176|582139564|FG002|Overall Study|Withdrawal by Subject|2|||
161207279|NCT06065176|582139562|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
161207280|NCT06065176|582139563|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
161092452|NCT00816400|581729858|FG007|Overall Study|Death|5|||
161092453|NCT00816400|581729859|FG008|Overall Study|Death|6|||
161092454|NCT00816400|581729851|FG000|Overall Study|In hospice care at the end of the study|0|||
161092455|NCT00816400|581729852|FG001|Overall Study|In hospice care at the end of the study|0|||
161207281|NCT06065176|582139564|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
161207282|NCT04521608|582139565|FG000|Overall Study|Death|8|||
160863409|NCT03312634|580894725|FG001|Overall Study|Withdrawal by Subject|9|||
161207283|NCT04521608|582139566|FG001|Overall Study|Death|9|||
161207284|NCT04521608|582139565|FG000|Overall Study|Withdrawal by Subject|25|||
161207285|NCT04521608|582139566|FG001|Overall Study|Withdrawal by Subject|18|||
161207286|NCT04521608|582139565|FG000|Overall Study|Disease Progression|3|||
161092456|NCT00816400|581729853|FG002|Overall Study|In hospice care at the end of the study|2|||
161207287|NCT04521608|582139566|FG001|Overall Study|Disease Progression|10|||
161207288|NCT04521608|582139565|FG000|Overall Study|Complicating Disease|6|||
161207289|NCT04521608|582139566|FG001|Overall Study|Complicating Disease|3|||
161207290|NCT04521608|582139565|FG000|Overall Study|Lost Contact|25|||
161207291|NCT04521608|582139566|FG001|Overall Study|Lost Contact|27|||
161207292|NCT04521608|582139565|FG000|Overall Study|Ineligible|1|||
161207293|NCT04521608|582139566|FG001|Overall Study|Ineligible|0|||
161207294|NCT04521608|582139565|FG000|Overall Study|Refused Further Study Participation|13|||
161207295|NCT04521608|582139566|FG001|Overall Study|Refused Further Study Participation|7|||
161207296|NCT04083378|582139569|FG000|Overall Study|Death|18|||
161207297|NCT04083378|582139570|FG001|Overall Study|Death|4|||
161207298|NCT04083378|582139569|FG000|Overall Study|Lost to Follow-up|4|||
161207299|NCT04083378|582139570|FG001|Overall Study|Lost to Follow-up|0|||
161207300|NCT05824273|582139571|FG000|Overall Study|Lost to Follow-up|16|||
161207301|NCT05824273|582139572|FG001|Overall Study|Lost to Follow-up|13|||
161207302|NCT04223193|582139583|FG000|Overall Study|Adverse Event|6|||
161207303|NCT04223193|582139584|FG001|Overall Study|Adverse Event|36|||
161207304|NCT04223193|582139583|FG000|Overall Study|Lack of Efficacy|2|||
161207305|NCT04223193|582139584|FG001|Overall Study|Lack of Efficacy|2|||
161207306|NCT04223193|582139583|FG000|Overall Study|Lost to Follow-up|1|||
161207307|NCT04223193|582139584|FG001|Overall Study|Lost to Follow-up|1|||
161207308|NCT04223193|582139583|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
161207309|NCT04223193|582139584|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161207310|NCT04223193|582139583|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
161207311|NCT04223193|582139584|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161207312|NCT04223193|582139583|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161207313|NCT04223193|582139584|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161207314|NCT04223193|582139583|FG000|Overall Study|Physician Decision|0|||
161207315|NCT04223193|582139584|FG001|Overall Study|Physician Decision|1|||
161207316|NCT04223193|582139583|FG000|Overall Study|Protocol Violation|1|||
161207317|NCT04223193|582139584|FG001|Overall Study|Protocol Violation|1|||
161207318|NCT04223193|582139583|FG000|Overall Study|Site Terminated by Sponsor|1|||
161207319|NCT04223193|582139584|FG001|Overall Study|Site Terminated by Sponsor|3|||
161207320|NCT04223193|582139583|FG000|Overall Study|Withdrawal by Subject|5|||
161207321|NCT04223193|582139584|FG001|Overall Study|Withdrawal by Subject|6|||
161207322|NCT04223193|582139583|FG000|Overall Study|Other|3|||
161207323|NCT04223193|582139584|FG001|Overall Study|Other|6|||
161207324|NCT03732677|582139585|FG000|Overall Study|Terminated the study|154|||
161207325|NCT03732677|582139586|FG001|Overall Study|Terminated the study|197|||
161207326|NCT03732677|582139585|FG000|Overall Study|Continuing study off treatment|379|||
161207327|NCT03732677|582139586|FG001|Overall Study|Continuing study off treatment|333|||
161207328|NCT03131817|582139587|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
161207329|NCT02061293|582139589|FG000|Overall Study|Elevated Blood Pressure|1|||
161207330|NCT02061293|582139590|FG001|Overall Study|Elevated Blood Pressure|1|||
161207331|NCT04066894|582139592|FG000|Overall Study|Lack of Efficacy|1|||
161207332|NCT04066894|582139592|FG000|Overall Study|Screen Failure|1|||
161207333|NCT03494816|582139593|FG000|Overall Study|Protocol Violation|2|||
161207334|NCT03494816|582139593|FG000|Overall Study|Physician Decision|2|||
161207335|NCT03494816|582139593|FG000|Overall Study|Did not start trial treatment|1|||
161207336|NCT03494816|582139593|FG000|Overall Study|Adverse Event|1|||
161207337|NCT00633217|582139599|FG000|Overall Study|Adverse Event|5|||
161207338|NCT00633217|582139600|FG001|Overall Study|Adverse Event|9|||
161207339|NCT00633217|582139599|FG000|Overall Study|Lack of Efficacy|0|||
161207340|NCT00633217|582139600|FG001|Overall Study|Lack of Efficacy|2|||
161207341|NCT00633217|582139599|FG000|Overall Study|Protocol Violation|3|||
161207342|NCT00633217|582139600|FG001|Overall Study|Protocol Violation|7|||
161207343|NCT00633217|582139599|FG000|Overall Study|Lost to Follow-up|2|||
161207344|NCT00633217|582139600|FG001|Overall Study|Lost to Follow-up|2|||
161207345|NCT00633217|582139599|FG000|Overall Study|Investigator Discretion|2|||
161207346|NCT00633217|582139600|FG001|Overall Study|Investigator Discretion|0|||
161207347|NCT00633217|582139599|FG000|Overall Study|Withdrew Consent|3|||
161207348|NCT00633217|582139600|FG001|Overall Study|Withdrew Consent|3|||
161207349|NCT05838755|582139601|FG000|Overall Study|Adverse Event|1|||
161207350|NCT05838755|582139602|FG001|Overall Study|Adverse Event|0|||
161207351|NCT05838755|582139603|FG002|Overall Study|Adverse Event|0|||
161207352|NCT05838755|582139601|FG000|Overall Study|Lack of Efficacy|1|||
161207353|NCT05838755|582139602|FG001|Overall Study|Lack of Efficacy|0|||
161207354|NCT05838755|582139603|FG002|Overall Study|Lack of Efficacy|1|||
161207355|NCT05838755|582139601|FG000|Overall Study|Lost to Follow-up|0|||
161207356|NCT05838755|582139602|FG001|Overall Study|Lost to Follow-up|1|||
161207357|NCT05838755|582139603|FG002|Overall Study|Lost to Follow-up|4|||
161207358|NCT05838755|582139601|FG000|Overall Study|Withdrawal by Subject|0|||
161207359|NCT05838755|582139602|FG001|Overall Study|Withdrawal by Subject|2|||
161207360|NCT05838755|582139603|FG002|Overall Study|Withdrawal by Subject|0|||
161207361|NCT05838755|582139601|FG000|Overall Study|Study terminated by sponsor|26|||
161207362|NCT05838755|582139602|FG001|Overall Study|Study terminated by sponsor|27|||
161207363|NCT05838755|582139603|FG002|Overall Study|Study terminated by sponsor|26|||
161207364|NCT05838755|582139601|FG000|Overall Study|Randomized, not treated|2|||
161207365|NCT05838755|582139602|FG001|Overall Study|Randomized, not treated|0|||
161207366|NCT05838755|582139603|FG002|Overall Study|Randomized, not treated|1|||
161207367|NCT05838755|582139601|FG000|Overall Study|Pregnancy|0|||
161207368|NCT05838755|582139602|FG001|Overall Study|Pregnancy|1|||
161207369|NCT05838755|582139603|FG002|Overall Study|Pregnancy|0|||
161207370|NCT01283282|582139604|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
161207371|NCT01283282|582139605|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
161207372|NCT01283282|582139604|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
161207373|NCT01283282|582139605|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
161207374|NCT01283282|582139604|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
161207375|NCT01283282|582139605|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
161207376|NCT00096031|582139606|FG000|Overall Study|Adverse Event|3|||
161207377|NCT00096031|582139606|FG000|Overall Study|Lack of Efficacy|42|||
161207378|NCT00096031|582139606|FG000|Overall Study|Death|4|||
161207379|NCT00096031|582139606|FG000|Overall Study|Withdrawal by Subject|1|||
161207380|NCT00096031|582139606|FG000|Overall Study|Ineligible|8|||
161207381|NCT00096031|582139606|FG000|Overall Study|Not protocol specified|5|||
161207382|NCT00483717|582139607|FG000|Overall Study|Protocol Violation|5|||
161207383|NCT00483717|582139608|FG001|Overall Study|Protocol Violation|7|||
161207384|NCT00483717|582139607|FG000|Overall Study|Time of dosing missing|1|||
161207385|NCT00483717|582139608|FG001|Overall Study|Time of dosing missing|1|||
161207386|NCT00483717|582139607|FG000|Overall Study|No treatment for migraine|16|||
161207387|NCT00483717|582139608|FG001|Overall Study|No treatment for migraine|13|||
161207388|NCT00483717|582139607|FG000|Overall Study|Lost to Follow-up|1|||
161207389|NCT00483717|582139608|FG001|Overall Study|Lost to Follow-up|0|||
161207390|NCT00483717|582139607|FG000|Overall Study|Withdrawal by Subject|1|||
161207391|NCT00483717|582139608|FG001|Overall Study|Withdrawal by Subject|0|||
161207392|NCT00083226|582139609|FG000|Overall Study|Lack of Efficacy|19|||
161207393|NCT00083226|582139609|FG000|Overall Study|Adverse Event|9|||
161207394|NCT00083226|582139609|FG000|Overall Study|Death|4|||
161207395|NCT00083226|582139609|FG000|Overall Study|Withdrawal by Subject|4|||
161207396|NCT00083226|582139609|FG000|Overall Study|Other|2|||
161207397|NCT00083226|582139609|FG000|Overall Study|ineligible or not receiving treatment|4|||
161207398|NCT00909857|582139610|FG000|Overall Study|Withdrawal by Subject|6|||
161207399|NCT00909857|582139611|FG001|Overall Study|Withdrawal by Subject|10|||
161207400|NCT00909857|582139610|FG000|Overall Study|Adverse Event|5|||
161207401|NCT00909857|582139611|FG001|Overall Study|Adverse Event|5|||
161207402|NCT00909857|582139610|FG000|Overall Study|Lost to Follow-up|2|||
161207403|NCT00909857|582139611|FG001|Overall Study|Lost to Follow-up|5|||
161207404|NCT00909857|582139610|FG000|Overall Study|Protocol Violation|2|||
161207405|NCT00909857|582139611|FG001|Overall Study|Protocol Violation|1|||
161207406|NCT00909857|582139610|FG000|Overall Study|Pregnancy|1|||
161207407|NCT00909857|582139611|FG001|Overall Study|Pregnancy|0|||
161207408|NCT00909857|582139610|FG000|Overall Study|Other|1|||
161207409|NCT00909857|582139611|FG001|Overall Study|Other|0|||
161207410|NCT00909857|582139610|FG000|Overall Study|Did not receive study medication|19|||
161207411|NCT00909857|582139611|FG001|Overall Study|Did not receive study medication|24|||
161207412|NCT03878108|582139612|FG000|Overall Study|Adverse Event|1|||
161207413|NCT03878108|582139613|FG001|Overall Study|Adverse Event|0|||
161207414|NCT00604175|582139614|FG000|Entry Through Week 28|Death|2|||
161207415|NCT00604175|582139615|FG001|Entry Through Week 28|Death|0|||
161207416|NCT00604175|582139616|FG002|Entry Through Week 28|Death|0|||
161207417|NCT00604175|582139614|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
161207418|NCT00604175|582139615|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
161207419|NCT00604175|582139616|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
161207420|NCT00604175|582139614|FG000|Entry Through Week 28|Lost to Follow-up|4|||
161207421|NCT00604175|582139615|FG001|Entry Through Week 28|Lost to Follow-up|3|||
161207422|NCT00604175|582139616|FG002|Entry Through Week 28|Lost to Follow-up|0|||
161207423|NCT00604175|582139614|FG000|Entry Through Week 28|Ineligible|1|||
161207424|NCT00604175|582139615|FG001|Entry Through Week 28|Ineligible|0|||
161207425|NCT00604175|582139616|FG002|Entry Through Week 28|Ineligible|0|||
161207426|NCT00604175|582139614|FG000|Entry Through Week 28|Did not start intervention|2|||
161207427|NCT00604175|582139615|FG001|Entry Through Week 28|Did not start intervention|0|||
161207428|NCT00604175|582139616|FG002|Entry Through Week 28|Did not start intervention|1|||
161207429|NCT00604175|582139614|FG000|Week 29 Through Week 72|Death|0|||
161207430|NCT00604175|582139615|FG001|Week 29 Through Week 72|Death|0|||
161207431|NCT00604175|582139616|FG002|Week 29 Through Week 72|Death|1|||
161207432|NCT00604175|582139614|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
161207433|NCT00604175|582139615|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
161207434|NCT00604175|582139616|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
160863410|NCT03312634|580894724|FG000|Overall Study|Enrolled in an interventional study|0|||
160977803|NCT03864926|581310077|FG000|Overall Study|Death|0|||
161207435|NCT00604175|582139614|FG000|Week 29 Through Week 72|Site closure|0|||
161207436|NCT00604175|582139615|FG001|Week 29 Through Week 72|Site closure|1|||
161207437|NCT00604175|582139616|FG002|Week 29 Through Week 72|Site closure|0|||
161207438|NCT00604175|582139614|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
161207439|NCT00604175|582139615|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
161207440|NCT00604175|582139616|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
161207441|NCT01682681|582139617|FG000|Overall Study|Lack of Efficacy|62|||
161207442|NCT01682681|582139617|FG000|Overall Study|Withdrawal by Subject|1|||
161207443|NCT01682681|582139617|FG000|Overall Study|Moved to other hospital|10|||
161207444|NCT01682681|582139617|FG000|Overall Study|Lost to Follow-up|174|||
161207445|NCT01682681|582139617|FG000|Overall Study|Adverse Event|46|||
161207446|NCT01682681|582139617|FG000|Overall Study|tapering of topiramate|5|||
161207447|NCT01682681|582139617|FG000|Overall Study|Other|21|||
161207448|NCT01682681|582139617|FG000|Overall Study|Low compliance|13|||
161207449|NCT03353415|582139620|FG000|Masked CGM Wear|Lost to Follow-up|2|||
161207450|NCT03353415|582139620|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
161207451|NCT03205163|582139621|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
161207452|NCT03205163|582139622|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
161207453|NCT00005879|582139623|FG000|Overall Study|Withdrawal by Subject|8|||
161207454|NCT00005879|582139624|FG001|Overall Study|Withdrawal by Subject|10|||
161207455|NCT01238172|582139625|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
161207456|NCT01238172|582139626|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
161207457|NCT01238172|582139625|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
161207458|NCT01238172|582139626|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
161207459|NCT05022121|582139627|FG000|Overall Study|Lack of Efficacy|1|||
161207460|NCT05022121|582139628|FG001|Overall Study|Lack of Efficacy|0|||
161207461|NCT05022121|582139627|FG000|Overall Study|Lost to Follow-up|0|||
161207462|NCT05022121|582139628|FG001|Overall Study|Lost to Follow-up|2|||
161207463|NCT00131937|582139629|FG000|Overall Study|Adverse Event|3|||
161207464|NCT00131937|582139629|FG000|Overall Study|Withdrawal by Subject|2|||
161207465|NCT00131937|582139629|FG000|Overall Study|Physician Decision|1|||
161207466|NCT00131937|582139629|FG000|Overall Study|Disease Progression|7|||
161207467|NCT00131937|582139629|FG000|Overall Study|Alternative therapy|1|||
161207468|NCT04647253|582139636|FG000|Overall Study|Death ≤ 365 Days|16|||
161207469|NCT04647253|582139637|FG001|Overall Study|Death ≤ 365 Days|7|||
161207470|NCT04647253|582139636|FG000|Overall Study|Physician Decision|0|||
161207471|NCT04647253|582139637|FG001|Overall Study|Physician Decision|1|||
161207472|NCT04647253|582139636|FG000|Overall Study|Withdrawal by Subject|7|||
161207473|NCT04647253|582139637|FG001|Overall Study|Withdrawal by Subject|2|||
161207474|NCT04647253|582139636|FG000|Overall Study|Missed 12-Month Visit|9|||
161207475|NCT04647253|582139637|FG001|Overall Study|Missed 12-Month Visit|7|||
161207476|NCT04647253|582139636|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
161207477|NCT04647253|582139637|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
161257831|NCT02093923|582322489|FG004|Overall Study|Lost to Follow-up|0|||
161257832|NCT02093923|582322485|FG000|Overall Study|Screen failure after randomization|0|||
161257833|NCT02093923|582322486|FG001|Overall Study|Screen failure after randomization|0|||
161257834|NCT02093923|582322487|FG002|Overall Study|Screen failure after randomization|0|||
161257835|NCT02093923|582322488|FG003|Overall Study|Screen failure after randomization|1|||
161257836|NCT02093923|582322489|FG004|Overall Study|Screen failure after randomization|0|||
161257837|NCT03438006|582322490|FG000|Overall Study|Adverse Event|1|||
161257838|NCT03438006|582322490|FG000|Overall Study|Lost to Follow-up|67|||
161257839|NCT03438006|582322490|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
161257840|NCT03438006|582322490|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
161257841|NCT02737592|582322491|FG000|Overall Study|Withdrawal by Subject|1|||
161257842|NCT04678817|582323492|FG000|Overall Study|Lost to Follow-up|28|||
161257843|NCT04678817|582323493|FG001|Overall Study|Lost to Follow-up|0|||
161257844|NCT04678817|582323494|FG002|Overall Study|Lost to Follow-up|0|||
161257845|NCT01961687|582323497|FG000|Overall Study|Lost to Follow-up|19|||
161257846|NCT01961687|582323497|FG000|Overall Study|Re-operation|17|||
161257847|NCT01961687|582323497|FG000|Overall Study|Death|7|||
161257848|NCT01961687|582323497|FG000|Overall Study|Withdrawal by Subject|6|||
161092457|NCT00816400|581729854|FG003|Overall Study|In hospice care at the end of the study|0|||
161092458|NCT00816400|581729855|FG004|Overall Study|In hospice care at the end of the study|0|||
161092459|NCT00816400|581729856|FG005|Overall Study|In hospice care at the end of the study|0|||
161092460|NCT00816400|581729857|FG006|Overall Study|In hospice care at the end of the study|0|||
161092461|NCT00816400|581729858|FG007|Overall Study|In hospice care at the end of the study|0|||
161092462|NCT00816400|581729859|FG008|Overall Study|In hospice care at the end of the study|0|||
161092463|NCT00596427|581729860|FG000|Overall Study|Withdrawal by Subject|2|||
161092464|NCT00596427|581729861|FG001|Overall Study|Withdrawal by Subject|2|||
161257849|NCT01961687|582323497|FG000|Overall Study|Adverse Event|6|||
161257850|NCT01961687|582323497|FG000|Overall Study|Moved to area without study site|2|||
161092465|NCT00596427|581729860|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
161092466|NCT00596427|581729861|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
161092467|NCT00596427|581729860|FG000|Overall Study|Protocol Violation|1|||
161092468|NCT00596427|581729861|FG001|Overall Study|Protocol Violation|0|||
161092469|NCT02401867|581729862|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
161092470|NCT02401867|581729862|FG000|Analysis|Cervical assay could not be conducted|9|||
161207478|NCT01020773|582141625|FG000|Overall Study|Withdrawal by Subject|4|||
161207479|NCT01020773|582141626|FG001|Overall Study|Withdrawal by Subject|3|||
161207480|NCT03302299|582141627|FG000|Overall Study|Protocol Violation|1|||
161207481|NCT01458132|582141628|FG000|Overall Study|Other|15|||
161207482|NCT01458132|582141629|FG001|Overall Study|Other|3|||
161207483|NCT02038959|582141634|FG000|Overall Study|Withdrawal by Subject|6|||
161207484|NCT02038959|582141635|FG001|Overall Study|Withdrawal by Subject|8|||
161207485|NCT00819091|582141641|FG000|Overall Study|Adverse Event|3|||
161207486|NCT00819091|582141642|FG001|Overall Study|Adverse Event|5|||
161207487|NCT00819091|582141641|FG000|Overall Study|Protocol Violation|0|||
161207488|NCT00819091|582141642|FG001|Overall Study|Protocol Violation|1|||
161207489|NCT00819091|582141641|FG000|Overall Study|Lost to Follow-up|2|||
161207490|NCT00819091|582141642|FG001|Overall Study|Lost to Follow-up|0|||
161207491|NCT00819091|582141641|FG000|Overall Study|Withdrawal by Subject|1|||
161207492|NCT00819091|582141642|FG001|Overall Study|Withdrawal by Subject|2|||
161207493|NCT00819091|582141641|FG000|Overall Study|Other|1|||
161207494|NCT00819091|582141642|FG001|Overall Study|Other|2|||
161207495|NCT01788163|582141644|FG000|Overall Study|Other|53|||
161207496|NCT01788163|582141645|FG001|Overall Study|Other|0|||
161207497|NCT01788163|582141646|FG002|Overall Study|Other|0|||
161207498|NCT01788163|582141647|FG003|Overall Study|Other|0|||
161207499|NCT01788163|582141648|FG004|Overall Study|Other|0|||
161207500|NCT01788163|582141649|FG005|Overall Study|Other|7|||
161207501|NCT01788163|582141650|FG006|Overall Study|Other|1|||
161092471|NCT01650246|581729863|FG000|Overall Study|Adverse Event|23|||
161092472|NCT01650246|581729863|FG000|Overall Study|Protocol Violation|5|||
161207502|NCT01788163|582141651|FG007|Overall Study|Other|48|||
161207503|NCT01788163|582141652|FG008|Overall Study|Other|15|||
161207504|NCT01788163|582141644|FG000|Overall Study|Withdrawal by Subject|2|||
161207505|NCT01788163|582141645|FG001|Overall Study|Withdrawal by Subject|0|||
161207506|NCT01788163|582141646|FG002|Overall Study|Withdrawal by Subject|0|||
161207507|NCT01788163|582141647|FG003|Overall Study|Withdrawal by Subject|0|||
161207508|NCT01788163|582141648|FG004|Overall Study|Withdrawal by Subject|0|||
161207509|NCT01788163|582141649|FG005|Overall Study|Withdrawal by Subject|0|||
161207510|NCT01788163|582141650|FG006|Overall Study|Withdrawal by Subject|0|||
161207511|NCT01788163|582141651|FG007|Overall Study|Withdrawal by Subject|0|||
161207512|NCT01788163|582141652|FG008|Overall Study|Withdrawal by Subject|1|||
161092473|NCT01650246|581729863|FG000|Overall Study|Sponsor terminated study|53|||
161092474|NCT01650246|581729863|FG000|Overall Study|Lost to Follow-up|5|||
161092475|NCT01650246|581729863|FG000|Overall Study|Withdrawal by Subject|26|||
161092476|NCT01650246|581729863|FG000|Overall Study|Death|1|||
161092477|NCT01650246|581729863|FG000|Overall Study|Lack of Efficacy|30|||
161092478|NCT03435497|581729865|FG000|Overall Study|Lost to Follow-up|1|||
161207513|NCT00545441|582141653|FG000|Overall Study|Fistula draining at 6 months|2|||
161207514|NCT00545441|582141654|FG001|Overall Study|Fistula draining at 6 months|4|||
161207515|NCT00545441|582141653|FG000|Overall Study|Lost to Follow-up|9|||
161207516|NCT00545441|582141654|FG001|Overall Study|Lost to Follow-up|5|||
161207517|NCT00545441|582141653|FG000|Overall Study|Technical failure|0|||
161207518|NCT00545441|582141654|FG001|Overall Study|Technical failure|1|||
161207519|NCT00545441|582141653|FG000|Overall Study|Withdrawal by Subject|1|||
161207520|NCT00545441|582141654|FG001|Overall Study|Withdrawal by Subject|1|||
161207521|NCT00545441|582141653|FG000|Overall Study|Persistence or recurrence of fistula|5|||
161207522|NCT00545441|582141654|FG001|Overall Study|Persistence or recurrence of fistula|2|||
161207523|NCT00545441|582141653|FG000|Overall Study|Patients were not treated|1|||
161207524|NCT00545441|582141654|FG001|Overall Study|Patients were not treated|3|||
161207525|NCT03911960|582141655|FG000|Overall Study|Lost to Follow-up|5|||
161207526|NCT03911960|582141656|FG001|Overall Study|Lost to Follow-up|3|||
161207527|NCT00265239|582141657|FG000|Overall Study|Adverse Event|2|||
161207528|NCT00265239|582141658|FG001|Overall Study|Adverse Event|1|||
161207529|NCT02803138|582141661|FG000|Overall Study|Failure to return|38|||
161207530|NCT02803138|582141661|FG000|Overall Study|Insufficient virological response|2|||
161207531|NCT02803138|582141661|FG000|Overall Study|Withdrawn consent|1|||
161207532|NCT02803138|582141661|FG000|Overall Study|Death|1|||
161207533|NCT02803138|582141661|FG000|Overall Study|Other, not specified|28|||
161207534|NCT00424515|582141662|FG000|Overall Study|Progressive Disease|10|||
161207535|NCT00424515|582141663|FG001|Overall Study|Progressive Disease|11|||
161207536|NCT00424515|582141662|FG000|Overall Study|Adverse Event|0|||
161207537|NCT00424515|582141663|FG001|Overall Study|Adverse Event|1|||
161207538|NCT00424515|582141662|FG000|Overall Study|Intercurrent Illness|0|||
161207539|NCT00424515|582141663|FG001|Overall Study|Intercurrent Illness|1|||
161207540|NCT00424515|582141662|FG000|Overall Study|Withdrawal by Subject|1|||
161207541|NCT00424515|582141663|FG001|Overall Study|Withdrawal by Subject|0|||
161207542|NCT04071366|582141664|FG000|Part 1: Open-label (29 Days)|Death|4|||
161207543|NCT04071366|582141665|FG001|Part 1: Open-label (29 Days)|Death|2|||
161207544|NCT04071366|582141666|FG002|Part 1: Open-label (29 Days)|Death|8|||
161207545|NCT04071366|582141667|FG003|Part 1: Open-label (29 Days)|Death|0|||
161092479|NCT03435497|581729866|FG001|Overall Study|Lost to Follow-up|0|||
161207546|NCT04071366|582141668|FG004|Part 1: Open-label (29 Days)|Death|0|||
161207547|NCT04071366|582141664|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161207548|NCT04071366|582141665|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161207549|NCT04071366|582141666|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
161207550|NCT04071366|582141667|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161207551|NCT04071366|582141668|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
161207552|NCT04071366|582141664|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
161207553|NCT04071366|582141665|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161207554|NCT04071366|582141666|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
161207555|NCT04071366|582141667|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161207556|NCT04071366|582141668|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
161207557|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Death|0|||
161207558|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Death|0|||
161207559|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Death|0|||
161207560|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Death|2|||
161207561|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Death|2|||
161207562|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161207563|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161207564|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161207565|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
161207566|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
161207567|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
161207568|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
161207569|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
161207570|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
161207571|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
161207572|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161207573|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161207574|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
161207575|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
161207576|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
161207577|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161207578|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161207579|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161207580|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
161207581|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
161207582|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161207583|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161207584|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161207585|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
161207586|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
161207587|NCT04071366|582141664|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161207588|NCT04071366|582141665|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161207589|NCT04071366|582141666|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161207590|NCT04071366|582141667|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
161207591|NCT04071366|582141668|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
161207592|NCT04318535|582141669|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
160863411|NCT03312634|580894725|FG001|Overall Study|Enrolled in an interventional study|52|||
160863412|NCT03312634|580894724|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
160863413|NCT03312634|580894725|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
160863414|NCT03312634|580894724|FG000|Overall Study|Death|0|||
160863415|NCT03312634|580894725|FG001|Overall Study|Death|1|||
160863416|NCT03312634|580894724|FG000|Overall Study|Non-compliance|0|||
160863417|NCT03312634|580894725|FG001|Overall Study|Non-compliance|2|||
160863418|NCT03312634|580894724|FG000|Overall Study|Lost to Follow-up|0|||
160863419|NCT03312634|580894725|FG001|Overall Study|Lost to Follow-up|1|||
160863420|NCT03312634|580894724|FG000|Overall Study|Enrolled into non-interventional study|0|||
160863421|NCT03312634|580894725|FG001|Overall Study|Enrolled into non-interventional study|5|||
160863422|NCT03312634|580894724|FG000|Overall Study|Worsening clinical condition|0|||
160863423|NCT03312634|580894725|FG001|Overall Study|Worsening clinical condition|1|||
160863424|NCT03312634|580894724|FG000|Overall Study|Participant did not want to travel|0|||
160863425|NCT03312634|580894725|FG001|Overall Study|Participant did not want to travel|1|||
160863426|NCT03312634|580894724|FG000|Overall Study|Physician Decision|1|||
160863427|NCT03312634|580894725|FG001|Overall Study|Physician Decision|0|||
160863428|NCT03312634|580894724|FG000|Overall Study|Other|13|||
160863429|NCT03312634|580894725|FG001|Overall Study|Other|0|||
160863430|NCT01148979|580894734|FG000|Overall Study|Lost to Follow-up|0|||
160863431|NCT01148979|580894735|FG001|Overall Study|Lost to Follow-up|1|||
161207593|NCT04318535|582141670|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
161207594|NCT04318535|582141671|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
161207595|NCT00021229|582141676|FG000|Overall Study|Adverse Event|10|||
161207596|NCT00021229|582141677|FG001|Overall Study|Adverse Event|5|||
160863432|NCT00777153|580894736|FG000|Overall Study|Lost to Follow-up|1|||
160863433|NCT00777153|580894737|FG001|Overall Study|Lost to Follow-up|1|||
160863434|NCT00777153|580894738|FG002|Overall Study|Lost to Follow-up|0|||
160863435|NCT00777153|580894736|FG000|Overall Study|Death|85|||
160863436|NCT00777153|580894737|FG001|Overall Study|Death|73|||
160863437|NCT00777153|580894738|FG002|Overall Study|Death|33|||
160863438|NCT00777153|580894736|FG000|Overall Study|Withdrawal by Subject|3|||
160863439|NCT00777153|580894737|FG001|Overall Study|Withdrawal by Subject|4|||
160863440|NCT00777153|580894738|FG002|Overall Study|Withdrawal by Subject|3|||
160863441|NCT00777153|580894736|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
160863442|NCT00777153|580894737|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
160863443|NCT00777153|580894738|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
160863444|NCT02079246|580894739|FG000|OLEX|Withdrawal before treatment|1|||
160863445|NCT02079246|580894740|FG001|OLEX|Withdrawal before treatment|0|||
160863446|NCT02079246|580894739|FG000|OLEX|Death|11|||
160863447|NCT02079246|580894740|FG001|OLEX|Death|0|||
160863448|NCT02079246|580894739|FG000|OLEX|Adverse Event|66|||
160863449|NCT02079246|580894740|FG001|OLEX|Adverse Event|0|||
160863450|NCT02079246|580894739|FG000|OLEX|Withdrawal by Subject|60|||
160863451|NCT02079246|580894740|FG001|OLEX|Withdrawal by Subject|0|||
160863452|NCT02079246|580894739|FG000|OLEX|Lost to Follow-up|6|||
160863453|NCT02079246|580894740|FG001|OLEX|Lost to Follow-up|0|||
160863454|NCT02079246|580894739|FG000|OLEX|Protocol Violation|6|||
160863455|NCT02079246|580894740|FG001|OLEX|Protocol Violation|0|||
160863456|NCT02079246|580894739|FG000|OLEX|Lack of Efficacy|3|||
160863457|NCT02079246|580894740|FG001|OLEX|Lack of Efficacy|0|||
160863458|NCT02079246|580894739|FG000|OLEX|Results of the lead-in studies|58|||
160863459|NCT02079246|580894740|FG001|OLEX|Results of the lead-in studies|0|||
160863460|NCT02079246|580894739|FG000|OLEX|Other: Disallowed medication|8|||
161207597|NCT00021229|582141678|FG002|Overall Study|Adverse Event|2|||
161207598|NCT00021229|582141676|FG000|Overall Study|Death|0|||
161207599|NCT00021229|582141677|FG001|Overall Study|Death|1|||
161207600|NCT00021229|582141678|FG002|Overall Study|Death|0|||
161207601|NCT00021229|582141676|FG000|Overall Study|Withdrawal by Subject|7|||
161207602|NCT00021229|582141677|FG001|Overall Study|Withdrawal by Subject|7|||
161207603|NCT00021229|582141678|FG002|Overall Study|Withdrawal by Subject|1|||
161207604|NCT00021229|582141676|FG000|Overall Study|Progressive Disease|15|||
161207605|NCT00021229|582141677|FG001|Overall Study|Progressive Disease|19|||
161207606|NCT00021229|582141678|FG002|Overall Study|Progressive Disease|12|||
161207607|NCT00021229|582141676|FG000|Overall Study|Protocol Violation|1|||
161207608|NCT00021229|582141677|FG001|Overall Study|Protocol Violation|1|||
161207609|NCT00021229|582141678|FG002|Overall Study|Protocol Violation|0|||
161207610|NCT00021229|582141676|FG000|Overall Study|Physician Decision|0|||
161321373|NCT00401193|582562925|FG001|Overall Study|Adverse Event|3|||
161321374|NCT00401193|582562926|FG002|Overall Study|Adverse Event|1|||
161207611|NCT00021229|582141677|FG001|Overall Study|Physician Decision|0|||
161207612|NCT00021229|582141678|FG002|Overall Study|Physician Decision|1|||
161207613|NCT00021229|582141676|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
161207614|NCT00021229|582141677|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
161321375|NCT00401193|582562924|FG000|Overall Study|Protocol Violation|3|||
161321376|NCT00401193|582562925|FG001|Overall Study|Protocol Violation|1|||
161321377|NCT00401193|582562926|FG002|Overall Study|Protocol Violation|1|||
161321378|NCT00401193|582562924|FG000|Overall Study|Lost to Follow-up|6|||
161321379|NCT00401193|582562925|FG001|Overall Study|Lost to Follow-up|5|||
161321380|NCT00401193|582562926|FG002|Overall Study|Lost to Follow-up|1|||
161321381|NCT00401193|582562924|FG000|Overall Study|Withdrawal by Subject|2|||
161321382|NCT00401193|582562925|FG001|Overall Study|Withdrawal by Subject|0|||
161321383|NCT00401193|582562926|FG002|Overall Study|Withdrawal by Subject|1|||
161321384|NCT00401193|582562924|FG000|Overall Study|Other Event|3|||
161321385|NCT00401193|582562925|FG001|Overall Study|Other Event|2|||
161321386|NCT00401193|582562926|FG002|Overall Study|Other Event|2|||
161321387|NCT04378569|582562930|FG000|Overall Study|Adverse Event|0|||
161321388|NCT04378569|582562931|FG001|Overall Study|Adverse Event|0|||
161321389|NCT04378569|582562932|FG002|Overall Study|Adverse Event|2|||
161321390|NCT04378569|582562933|FG003|Overall Study|Adverse Event|0|||
161321391|NCT04378569|582562934|FG004|Overall Study|Adverse Event|3|||
161321392|NCT04378569|582562935|FG005|Overall Study|Adverse Event|3|||
161321393|NCT04378569|582562930|FG000|Overall Study|Lost to Follow-up|0|||
160863461|NCT02079246|580894740|FG001|OLEX|Other: Disallowed medication|0|||
160863462|NCT02079246|580894739|FG000|OLEX|Other: Insufficient compliance|2|||
161321394|NCT04378569|582562931|FG001|Overall Study|Lost to Follow-up|3|||
161321395|NCT04378569|582562932|FG002|Overall Study|Lost to Follow-up|1|||
160863463|NCT02079246|580894740|FG001|OLEX|Other: Insufficient compliance|0|||
161321396|NCT04378569|582562933|FG003|Overall Study|Lost to Follow-up|0|||
161321397|NCT04378569|582562934|FG004|Overall Study|Lost to Follow-up|1|||
161321398|NCT04378569|582562935|FG005|Overall Study|Lost to Follow-up|1|||
161321399|NCT04378569|582562930|FG000|Overall Study|Protocol Violation|0|||
161321400|NCT04378569|582562931|FG001|Overall Study|Protocol Violation|0|||
160863464|NCT02079246|580894739|FG000|OLEX|Other: Caregiver unavailable|3|||
161207615|NCT00021229|582141678|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
161207616|NCT02156466|582141682|FG000|Overall Study|Adverse Event|0|||
161321401|NCT04378569|582562932|FG002|Overall Study|Protocol Violation|0|||
161321402|NCT04378569|582562933|FG003|Overall Study|Protocol Violation|0|||
161321403|NCT04378569|582562934|FG004|Overall Study|Protocol Violation|0|||
161321404|NCT04378569|582562935|FG005|Overall Study|Protocol Violation|1|||
161321405|NCT04378569|582562930|FG000|Overall Study|Withdrawal by Subject|0|||
161321406|NCT04378569|582562931|FG001|Overall Study|Withdrawal by Subject|6|||
161321407|NCT04378569|582562932|FG002|Overall Study|Withdrawal by Subject|7|||
161321408|NCT04378569|582562933|FG003|Overall Study|Withdrawal by Subject|4|||
161321409|NCT04378569|582562934|FG004|Overall Study|Withdrawal by Subject|5|||
161321410|NCT04378569|582562935|FG005|Overall Study|Withdrawal by Subject|4|||
160863465|NCT02079246|580894740|FG001|OLEX|Other: Caregiver unavailable|0|||
160863466|NCT02079246|580894739|FG000|OLEX|Other: Coordinator decision|1|||
160863467|NCT02079246|580894740|FG001|OLEX|Other: Coordinator decision|0|||
160863468|NCT02079246|580894739|FG000|OLEX|Other: Worsening of condition|1|||
160863469|NCT02079246|580894740|FG001|OLEX|Other: Worsening of condition|0|||
160863470|NCT02079246|580894739|FG000|OLEX|Other: Moved to nursing home|1|||
160863471|NCT02079246|580894740|FG001|OLEX|Other: Moved to nursing home|0|||
160863472|NCT02079246|580894739|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
160863473|NCT02079246|580894740|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
160863474|NCT02079246|580894739|FG000|OLEX-MEM|Adverse Event|0|||
160863475|NCT02079246|580894740|FG001|OLEX-MEM|Adverse Event|6|||
160863476|NCT02079246|580894739|FG000|OLEX-MEM|Withdrawal by Subject|0|||
160863477|NCT02079246|580894740|FG001|OLEX-MEM|Withdrawal by Subject|7|||
160863478|NCT02079246|580894739|FG000|OLEX-MEM|Protocol Violation|0|||
160863479|NCT02079246|580894740|FG001|OLEX-MEM|Protocol Violation|2|||
160863480|NCT02079246|580894739|FG000|OLEX-MEM|Lost to Follow-up|0|||
160863481|NCT02079246|580894740|FG001|OLEX-MEM|Lost to Follow-up|1|||
160863482|NCT02079246|580894739|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
160863483|NCT02079246|580894740|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
160863484|NCT03591406|580894745|FG000|Overall Study|Adverse Event|5|||
160863485|NCT03591406|580894746|FG001|Overall Study|Adverse Event|3|||
160863486|NCT03591406|580894745|FG000|Overall Study|Protocol Violation|2|||
160863487|NCT03591406|580894746|FG001|Overall Study|Protocol Violation|1|||
160863488|NCT03591406|580894745|FG000|Overall Study|Withdrawal by Subject|0|||
160863489|NCT03591406|580894746|FG001|Overall Study|Withdrawal by Subject|5|||
160863490|NCT01389596|580894747|FG000|Overall Study|Protocol Violation|3|||
160863491|NCT01389596|580894748|FG001|Overall Study|Protocol Violation|4|||
160863492|NCT01389596|580894749|FG002|Overall Study|Protocol Violation|3|||
160863493|NCT01389596|580894747|FG000|Overall Study|Withdrawal by Subject|1|||
160863494|NCT01389596|580894748|FG001|Overall Study|Withdrawal by Subject|2|||
160863495|NCT01389596|580894749|FG002|Overall Study|Withdrawal by Subject|2|||
160863496|NCT01389596|580894747|FG000|Overall Study|Insufficient Clinical Response|3|||
160863497|NCT01389596|580894748|FG001|Overall Study|Insufficient Clinical Response|4|||
160863498|NCT01389596|580894749|FG002|Overall Study|Insufficient Clinical Response|5|||
160863499|NCT01389596|580894747|FG000|Overall Study|Adverse Event|1|||
160863500|NCT01389596|580894748|FG001|Overall Study|Adverse Event|4|||
160863501|NCT01389596|580894749|FG002|Overall Study|Adverse Event|0|||
160863502|NCT01389596|580894747|FG000|Overall Study|Death|0|||
160863503|NCT01389596|580894748|FG001|Overall Study|Death|1|||
160863504|NCT01389596|580894749|FG002|Overall Study|Death|0|||
161321411|NCT04378569|582562930|FG000|Overall Study|Lack of response|0|||
160863505|NCT01389596|580894747|FG000|Overall Study|Other Unspecified|2|||
160863506|NCT01389596|580894748|FG001|Overall Study|Other Unspecified|1|||
160863507|NCT01389596|580894749|FG002|Overall Study|Other Unspecified|0|||
160863508|NCT01709084|580894750|FG000|Overall Study|Lost to Follow-up|4|||
160863509|NCT01709084|580894751|FG001|Overall Study|Lost to Follow-up|7|||
160863510|NCT01709084|580894750|FG000|Overall Study|Withdrawal by Subject|2|||
160863511|NCT01709084|580894751|FG001|Overall Study|Withdrawal by Subject|2|||
160863512|NCT01709084|580894750|FG000|Overall Study|Adverse Event|5|||
160863513|NCT01709084|580894751|FG001|Overall Study|Adverse Event|0|||
160863514|NCT01709084|580894750|FG000|Overall Study|Other|5|||
160863515|NCT01709084|580894751|FG001|Overall Study|Other|3|||
160863516|NCT01709084|580894750|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
160863517|NCT01709084|580894751|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
160863518|NCT01709084|580894750|FG000|Overall Study|Not Treated|0|||
160863519|NCT01709084|580894751|FG001|Overall Study|Not Treated|2|||
160863520|NCT00214201|580894752|FG000|Overall Study|Withdrawal by Subject|2|||
160863521|NCT00214201|580894753|FG001|Overall Study|Withdrawal by Subject|0|||
160863522|NCT00214201|580894752|FG000|Overall Study|Death|0|||
160863523|NCT00214201|580894753|FG001|Overall Study|Death|2|||
160863524|NCT01357850|580894759|FG000|Overall Study|Lost to Follow-up|1|||
160863525|NCT01357850|580894760|FG001|Overall Study|Lost to Follow-up|0|||
160863526|NCT01357850|580894761|FG002|Overall Study|Lost to Follow-up|0|||
160863527|NCT01357850|580894762|FG003|Overall Study|Lost to Follow-up|0|||
160863528|NCT04610281|580894763|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
160863529|NCT04610281|580894764|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
160863530|NCT01942837|580894765|FG000|Overall Study|Death|1|||
160977804|NCT03864926|581310078|FG001|Overall Study|Death|2|||
160863531|NCT01942837|580894765|FG000|Overall Study|Symptomatic or radiographic progression|49|||
160863532|NCT01942837|580894765|FG000|Overall Study|Adverse Event|6|||
160863533|NCT01942837|580894765|FG000|Overall Study|Physician Decision|3|||
160863534|NCT01942837|580894765|FG000|Overall Study|Withdrawal by Subject|2|||
160863535|NCT01942837|580894765|FG000|Overall Study|Intercurrent Illness|1|||
160863536|NCT01942837|580894765|FG000|Overall Study|On treatment|3|||
160863537|NCT01942837|580894765|FG000|Overall Study|Never initiate the treatment|2|||
161321412|NCT04378569|582562931|FG001|Overall Study|Lack of response|0|||
161321413|NCT04378569|582562932|FG002|Overall Study|Lack of response|1|||
161321414|NCT04378569|582562933|FG003|Overall Study|Lack of response|0|||
161321415|NCT04378569|582562934|FG004|Overall Study|Lack of response|1|||
160863538|NCT01298648|580894766|FG000|Overall Study|Withdrawal by Subject|2|||
160863539|NCT01298648|580894766|FG000|Overall Study|Lost to Follow-up|21|||
160863540|NCT02351856|580894772|FG000|Overall Study|Adverse Event|2|||
160863541|NCT02351856|580894772|FG000|Overall Study|Physician Decision|5|||
160863542|NCT02351856|580894772|FG000|Overall Study|Study terminated by sponsor|1|||
160863543|NCT01458392|580894777|FG000|Overall Study|Death|2|||
160863544|NCT01458392|580894778|FG001|Overall Study|Death|11|||
160863545|NCT01458392|580894779|FG002|Overall Study|Death|22|||
160863546|NCT01458392|580894777|FG000|Overall Study|At the discretion of the sponsor|0|||
160863547|NCT01458392|580894778|FG001|Overall Study|At the discretion of the sponsor|2|||
160863548|NCT01458392|580894779|FG002|Overall Study|At the discretion of the sponsor|7|||
160863549|NCT01458392|580894777|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
160863550|NCT01458392|580894778|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
160863551|NCT01458392|580894779|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
160863552|NCT03038100|580894788|FG000|Overall Study|Death|289|||
160863553|NCT03038100|580894789|FG001|Overall Study|Death|272|||
160863554|NCT03038100|580894788|FG000|Overall Study|Lost to Follow-up|9|||
160863555|NCT03038100|580894789|FG001|Overall Study|Lost to Follow-up|10|||
160863556|NCT03038100|580894788|FG000|Overall Study|Protocol Deviation|1|||
160863557|NCT03038100|580894789|FG001|Overall Study|Protocol Deviation|4|||
160863558|NCT03038100|580894788|FG000|Overall Study|Withdrawal by Subject|45|||
160863559|NCT03038100|580894789|FG001|Overall Study|Withdrawal by Subject|51|||
160863560|NCT03038100|580894788|FG000|Overall Study|Study Terminated By Sponsor|305|||
160863561|NCT03038100|580894789|FG001|Overall Study|Study Terminated By Sponsor|311|||
160863562|NCT03038100|580894788|FG000|Overall Study|Physician Decision|1|||
160863563|NCT03038100|580894789|FG001|Overall Study|Physician Decision|3|||
160863564|NCT00918255|580894790|FG000|Overall Study|Adverse Event|1|||
160863565|NCT00918255|580894791|FG001|Overall Study|Adverse Event|0|||
160863566|NCT00918255|580894792|FG002|Overall Study|Adverse Event|0|||
160863567|NCT00918255|580894790|FG000|Overall Study|Withdrawal by Subject|1|||
160863568|NCT00918255|580894791|FG001|Overall Study|Withdrawal by Subject|0|||
160863569|NCT00918255|580894792|FG002|Overall Study|Withdrawal by Subject|2|||
160863570|NCT00918255|580894790|FG000|Overall Study|Lack of Efficacy|1|||
160863571|NCT00918255|580894791|FG001|Overall Study|Lack of Efficacy|0|||
160863572|NCT00918255|580894792|FG002|Overall Study|Lack of Efficacy|0|||
160863573|NCT00918255|580894790|FG000|Overall Study|Lost to Follow-up|1|||
160863574|NCT00918255|580894791|FG001|Overall Study|Lost to Follow-up|0|||
160863575|NCT00918255|580894792|FG002|Overall Study|Lost to Follow-up|2|||
160863576|NCT00918255|580894790|FG000|Overall Study|Exceeded allowed number of interventions|0|||
160863577|NCT00918255|580894791|FG001|Overall Study|Exceeded allowed number of interventions|0|||
160863578|NCT00918255|580894792|FG002|Overall Study|Exceeded allowed number of interventions|1|||
160863579|NCT00918255|580894790|FG000|Overall Study|Non-compliance|1|||
160863580|NCT00918255|580894791|FG001|Overall Study|Non-compliance|0|||
160863581|NCT00918255|580894792|FG002|Overall Study|Non-compliance|0|||
160863582|NCT00918255|580894790|FG000|Overall Study|Investigator discretion|1|||
160863583|NCT00918255|580894791|FG001|Overall Study|Investigator discretion|0|||
160863584|NCT00918255|580894792|FG002|Overall Study|Investigator discretion|0|||
160863585|NCT02038933|580894793|FG000|Overall Study|Disease progression|104|||
160863586|NCT02038933|580894793|FG000|Overall Study|Study drug toxicity|6|||
160863587|NCT02038933|580894793|FG000|Overall Study|Adverse event unrelated to study drug|6|||
160863588|NCT02038933|580894793|FG000|Overall Study|Participant request to discontinue treatment|2|||
160863589|NCT02038933|580894793|FG000|Overall Study|Lost to Follow-up|1|||
160863590|NCT02038933|580894793|FG000|Overall Study|Other reasons|2|||
160863591|NCT03250273|580894826|FG000|Overall Study|Disease Progression|2|||
160863592|NCT03250273|580894827|FG001|Overall Study|Disease Progression|11|||
160863593|NCT03250273|580894826|FG000|Overall Study|Death|0|||
160863594|NCT03250273|580894827|FG001|Overall Study|Death|1|||
160863595|NCT04154904|580894828|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
160863596|NCT04154904|580894829|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
160863597|NCT04154904|580894830|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
160863598|NCT02392624|580894831|FG000|Overall Study|Withdrawal by Subject|15|||
161321416|NCT04378569|582562935|FG005|Overall Study|Lack of response|1|||
160863599|NCT02392624|580894832|FG001|Overall Study|Withdrawal by Subject|12|||
160863600|NCT02392624|580894833|FG002|Overall Study|Withdrawal by Subject|9|||
160863601|NCT02392624|580894831|FG000|Overall Study|Adverse Event|4|||
161321417|NCT01844817|582562936|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
161321418|NCT01844817|582562937|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
161321419|NCT01844817|582562936|FG000|Treatment|Progressive Disease|27|||
161321420|NCT01844817|582562937|FG001|Treatment|Progressive Disease|36|||
161321421|NCT01844817|582562936|FG000|Treatment|Adverse Event|17|||
161321422|NCT01844817|582562937|FG001|Treatment|Adverse Event|9|||
161321423|NCT01844817|582562936|FG000|Treatment|Withdrawal by Subject|10|||
161321424|NCT01844817|582562937|FG001|Treatment|Withdrawal by Subject|6|||
161321425|NCT01844817|582562936|FG000|Treatment|Death|10|||
161321426|NCT01844817|582562937|FG001|Treatment|Death|8|||
161321427|NCT01844817|582562936|FG000|Treatment|Lost to Follow-up|0|||
161321428|NCT01844817|582562937|FG001|Treatment|Lost to Follow-up|1|||
161321429|NCT01844817|582562936|FG000|Treatment|Other|0|||
161321430|NCT01844817|582562937|FG001|Treatment|Other|3|||
161321431|NCT03638466|582562939|FG000|Overall Study|Early Termination|0|||
161321432|NCT03638466|582562940|FG001|Overall Study|Early Termination|1|||
161321433|NCT02576977|582562941|FG000|Overall Study|Adverse Event|13|||
161321434|NCT02576977|582562942|FG001|Overall Study|Adverse Event|2|||
161321435|NCT02576977|582562941|FG000|Overall Study|Death|73|||
161321436|NCT02576977|582562942|FG001|Overall Study|Death|60|||
161321437|NCT02576977|582562941|FG000|Overall Study|Screen failure|1|||
161321438|NCT02576977|582562942|FG001|Overall Study|Screen failure|0|||
161321439|NCT02576977|582562941|FG000|Overall Study|Study Terminated at Selected Sites|27|||
161321440|NCT02576977|582562942|FG001|Overall Study|Study Terminated at Selected Sites|50|||
161321441|NCT02576977|582562941|FG000|Overall Study|Withdrawal by Subject|11|||
161321442|NCT02576977|582562942|FG001|Overall Study|Withdrawal by Subject|11|||
161321443|NCT02576977|582562941|FG000|Overall Study|Final Disposition Unknown|0|||
161321444|NCT02576977|582562942|FG001|Overall Study|Final Disposition Unknown|1|||
161321445|NCT02576977|582562941|FG000|Overall Study|Lost to Follow-up|1|||
161321446|NCT02576977|582562942|FG001|Overall Study|Lost to Follow-up|0|||
161321447|NCT02576977|582562941|FG000|Overall Study|Progressive Disease|0|||
161321448|NCT02576977|582562942|FG001|Overall Study|Progressive Disease|1|||
161321449|NCT02447328|582562947|FG000|Overall Study|Withdrawal by Subject|1|||
161321450|NCT02906579|582562958|FG000|Overall Study|Adverse Event|1|||
161321451|NCT02906579|582562958|FG000|Overall Study|Physician Decision|1|||
161321452|NCT00759655|582562959|FG000|Overall Study|Termination of the study by sponsor|1|||
161321453|NCT02753816|582562960|FG000|Overall Study|Protocol Violation|0|||
161321454|NCT02753816|582562961|FG001|Overall Study|Protocol Violation|1|||
161321455|NCT02753816|582562962|FG002|Overall Study|Protocol Violation|0|||
161321456|NCT01473940|582562963|FG000|Induction Therapy|Death|0|||
161321457|NCT01473940|582562964|FG001|Induction Therapy|Death|0|||
161321458|NCT01473940|582562965|FG002|Induction Therapy|Death|1|||
161321459|NCT01473940|582562966|FG003|Induction Therapy|Death|1|||
161321460|NCT01473940|582562963|FG000|Induction Therapy|Progressive Disease|0|||
161321461|NCT01473940|582562964|FG001|Induction Therapy|Progressive Disease|1|||
161321462|NCT01473940|582562965|FG002|Induction Therapy|Progressive Disease|1|||
161321463|NCT01473940|582562966|FG003|Induction Therapy|Progressive Disease|0|||
161321464|NCT01473940|582562963|FG000|Maintenance Therapy|Progressive Disease|1|||
161321465|NCT01473940|582562964|FG001|Maintenance Therapy|Progressive Disease|2|||
161321466|NCT01473940|582562965|FG002|Maintenance Therapy|Progressive Disease|1|||
161321467|NCT01473940|582562966|FG003|Maintenance Therapy|Progressive Disease|4|||
161321468|NCT00534248|582562967|FG000|Overall Study|Adverse Event|19|||
161321469|NCT00534248|582562968|FG001|Overall Study|Adverse Event|29|||
161321470|NCT00534248|582562967|FG000|Overall Study|Lost to Follow-up|353|||
161321471|NCT00534248|582562968|FG001|Overall Study|Lost to Follow-up|375|||
161321472|NCT00534248|582562967|FG000|Overall Study|Other protocol specified criteria|13|||
161321473|NCT00534248|582562968|FG001|Overall Study|Other protocol specified criteria|3|||
161321474|NCT00534248|582562967|FG000|Overall Study|Physician Decision|10|||
161321475|NCT00534248|582562968|FG001|Overall Study|Physician Decision|7|||
161321476|NCT00534248|582562967|FG000|Overall Study|Protocol Violation|3|||
161207617|NCT02156466|582141683|FG001|Overall Study|Adverse Event|0|||
161207618|NCT02156466|582141684|FG002|Overall Study|Adverse Event|1|||
161207619|NCT02156466|582141685|FG003|Overall Study|Adverse Event|1|||
161207620|NCT02156466|582141686|FG004|Overall Study|Adverse Event|0|||
161207621|NCT02156466|582141682|FG000|Overall Study|Quantiferon Positivity|0|||
161207622|NCT02156466|582141683|FG001|Overall Study|Quantiferon Positivity|0|||
161207623|NCT02156466|582141684|FG002|Overall Study|Quantiferon Positivity|0|||
161207624|NCT02156466|582141685|FG003|Overall Study|Quantiferon Positivity|1|||
161207625|NCT02156466|582141686|FG004|Overall Study|Quantiferon Positivity|0|||
161207626|NCT03724968|582141687|FG000|Overall Study|Insurance issues|0|||
161207627|NCT03724968|582141688|FG001|Overall Study|Insurance issues|1|||
161207628|NCT03724968|582141687|FG000|Overall Study|Study closed|0|||
161321477|NCT00534248|582562968|FG001|Overall Study|Protocol Violation|4|||
161321478|NCT00534248|582562967|FG000|Overall Study|Withdrawal by Subject|263|||
161321479|NCT00534248|582562968|FG001|Overall Study|Withdrawal by Subject|255|||
161321480|NCT02849171|582562969|FG000|Overall Study|Withdrawal by Subject|1|||
161321481|NCT02849171|582562969|FG000|Overall Study|Not treated|1|||
161321482|NCT03084302|582562976|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
161321483|NCT03084302|582562976|FG000|Overall Study|No valid objective monitor data|6|||
161321484|NCT00929994|582562977|FG000|Overall Study|Withdrawal by Subject|1|||
160863602|NCT02392624|580894832|FG001|Overall Study|Adverse Event|1|||
160863603|NCT02392624|580894833|FG002|Overall Study|Adverse Event|2|||
160863604|NCT02392624|580894831|FG000|Overall Study|Pregnancy|1|||
160863605|NCT02392624|580894832|FG001|Overall Study|Pregnancy|0|||
160863606|NCT02392624|580894833|FG002|Overall Study|Pregnancy|0|||
160863607|NCT02392624|580894831|FG000|Overall Study|Protocol Violation|0|||
160863608|NCT02392624|580894832|FG001|Overall Study|Protocol Violation|0|||
160863609|NCT02392624|580894833|FG002|Overall Study|Protocol Violation|1|||
160863610|NCT02392624|580894831|FG000|Overall Study|Sponsor/Investigator Decision|2|||
160863611|NCT02392624|580894832|FG001|Overall Study|Sponsor/Investigator Decision|1|||
160863612|NCT02392624|580894833|FG002|Overall Study|Sponsor/Investigator Decision|0|||
160863613|NCT02392624|580894831|FG000|Overall Study|Other|49|||
160863614|NCT02392624|580894832|FG001|Overall Study|Other|1|||
160863615|NCT02392624|580894833|FG002|Overall Study|Other|1|||
160863616|NCT00936715|580894834|FG000|Overall Study|Investigators Discretion|1|||
160863617|NCT00936715|580894834|FG000|Overall Study|Protocol Violation|1|||
160863618|NCT00936715|580894834|FG000|Overall Study|Safety or Tolerability Reasons|4|||
160863619|NCT03841604|580894837|FG000|Overall Study|Withdrawal by Subject|3|||
160863620|NCT03841604|580894838|FG001|Overall Study|Withdrawal by Subject|1|||
160863621|NCT03841604|580894837|FG000|Overall Study|Adverse Event|4|||
160863622|NCT03841604|580894838|FG001|Overall Study|Adverse Event|2|||
160863623|NCT03841604|580894837|FG000|Overall Study|Physician Decision|1|||
160863624|NCT03841604|580894838|FG001|Overall Study|Physician Decision|0|||
160863625|NCT01337960|580894839|FG000|Overall Study|Lost to Follow-up|1|||
160863626|NCT01337960|580894840|FG001|Overall Study|Lost to Follow-up|0|||
160863627|NCT01337960|580894841|FG002|Overall Study|Lost to Follow-up|0|||
160863628|NCT01337960|580894839|FG000|Overall Study|Withdrawal by Subject|1|||
160863629|NCT01337960|580894840|FG001|Overall Study|Withdrawal by Subject|0|||
160863630|NCT01337960|580894841|FG002|Overall Study|Withdrawal by Subject|0|||
160863631|NCT03763877|580894843|FG000|Overall Study|Withdrawal by Subject|3|||
160863632|NCT03763877|580894844|FG001|Overall Study|Withdrawal by Subject|1|||
160863633|NCT03763877|580894845|FG002|Overall Study|Withdrawal by Subject|3|||
160863634|NCT03763877|580894846|FG003|Overall Study|Withdrawal by Subject|4|||
160863635|NCT03763877|580894843|FG000|Overall Study|Adverse Event|1|||
160863636|NCT03763877|580894844|FG001|Overall Study|Adverse Event|1|||
160863637|NCT03763877|580894845|FG002|Overall Study|Adverse Event|3|||
160863638|NCT03763877|580894846|FG003|Overall Study|Adverse Event|1|||
160863639|NCT03763877|580894843|FG000|Overall Study|Protocol Violation|1|||
160863640|NCT03763877|580894844|FG001|Overall Study|Protocol Violation|1|||
160863641|NCT03763877|580894845|FG002|Overall Study|Protocol Violation|0|||
160863642|NCT03763877|580894846|FG003|Overall Study|Protocol Violation|0|||
160863643|NCT03763877|580894843|FG000|Overall Study|Lost to Follow-up|0|||
160863644|NCT03763877|580894844|FG001|Overall Study|Lost to Follow-up|1|||
160863645|NCT03763877|580894845|FG002|Overall Study|Lost to Follow-up|1|||
160863646|NCT03763877|580894846|FG003|Overall Study|Lost to Follow-up|0|||
160863647|NCT01774721|580894850|FG000|Overall Study|Death|133|||
160863648|NCT01774721|580894851|FG001|Overall Study|Death|152|||
160863649|NCT01774721|580894850|FG000|Overall Study|Withdrawal by Subject|20|||
160863650|NCT01774721|580894851|FG001|Overall Study|Withdrawal by Subject|14|||
160863651|NCT01774721|580894850|FG000|Overall Study|Lost to Follow-up|6|||
160863652|NCT01774721|580894851|FG001|Overall Study|Lost to Follow-up|7|||
160863653|NCT01774721|580894850|FG000|Overall Study|Did not meet eligibility criteria|0|||
160863654|NCT01774721|580894851|FG001|Overall Study|Did not meet eligibility criteria|3|||
160863655|NCT01774721|580894850|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
160863656|NCT01774721|580894851|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
160863657|NCT01774721|580894850|FG000|Overall Study|Study terminated by sponsor|5|||
160863658|NCT01774721|580894851|FG001|Overall Study|Study terminated by sponsor|0|||
160863659|NCT01774721|580894850|FG000|Overall Study|Disease progression|5|||
160863660|NCT01774721|580894851|FG001|Overall Study|Disease progression|0|||
160863661|NCT00084136|580894861|FG000|PI Comparison|Death|10|||
160863662|NCT00084136|580894862|FG001|PI Comparison|Death|9|||
160863663|NCT00084136|580894863|FG002|PI Comparison|Death|0|||
160863664|NCT00084136|580894861|FG000|PI Comparison|Lost to Follow-up|11|||
160863665|NCT00084136|580894862|FG001|PI Comparison|Lost to Follow-up|8|||
160863666|NCT00084136|580894863|FG002|PI Comparison|Lost to Follow-up|0|||
160863667|NCT00084136|580894861|FG000|PI Comparison|Withdrawal by Subject|33|||
160863668|NCT00084136|580894862|FG001|PI Comparison|Withdrawal by Subject|30|||
160863669|NCT00084136|580894863|FG002|PI Comparison|Withdrawal by Subject|0|||
160863670|NCT00084136|580894861|FG000|PI Comparison|Clinic site closed|1|||
160863671|NCT00084136|580894862|FG001|PI Comparison|Clinic site closed|0|||
160863672|NCT00084136|580894863|FG002|PI Comparison|Clinic site closed|0|||
160863673|NCT00084136|580894861|FG000|NRTI Comparison|Death|20|||
160863674|NCT00084136|580894862|FG001|NRTI Comparison|Death|0|||
160863675|NCT00084136|580894863|FG002|NRTI Comparison|Death|18|||
160863676|NCT00084136|580894861|FG000|NRTI Comparison|Lost to Follow-up|14|||
160863677|NCT00084136|580894862|FG001|NRTI Comparison|Lost to Follow-up|0|||
160863678|NCT00084136|580894863|FG002|NRTI Comparison|Lost to Follow-up|12|||
160863679|NCT00084136|580894861|FG000|NRTI Comparison|Withdrawal by Subject|54|||
160863680|NCT00084136|580894862|FG001|NRTI Comparison|Withdrawal by Subject|0|||
160863681|NCT00084136|580894863|FG002|NRTI Comparison|Withdrawal by Subject|38|||
160863682|NCT00084136|580894861|FG000|NRTI Comparison|Clinic site closed|12|||
160863683|NCT00084136|580894862|FG001|NRTI Comparison|Clinic site closed|0|||
160863684|NCT00084136|580894863|FG002|NRTI Comparison|Clinic site closed|14|||
160863685|NCT00084136|580894861|FG000|NRTI Comparison|Not reason above|1|||
160863686|NCT00084136|580894862|FG001|NRTI Comparison|Not reason above|0|||
160863687|NCT00084136|580894863|FG002|NRTI Comparison|Not reason above|0|||
160863688|NCT03938259|580894867|FG000|Overall Study|unable to establish baseline for ventilation|1|||
160863689|NCT03938259|580894868|FG001|Overall Study|unable to establish baseline for ventilation|1|||
160863690|NCT01213472|580894869|FG000|Overall Study|Recurrence/Progressive disease|25|||
160863691|NCT01213472|580894869|FG000|Overall Study|Withdrawal by Subject|1|||
160863692|NCT01213472|580894869|FG000|Overall Study|Physician Decision|1|||
160863693|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
160863694|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
160863695|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
160863696|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
160863697|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
160863698|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
160863699|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
160863700|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
160863701|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
160863702|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
160863703|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
160863704|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
160863705|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
160863706|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
160863707|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
160863708|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
160863709|NCT03773978|580894880|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
160863710|NCT03773978|580894881|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
160863711|NCT03773978|580894880|FG000|DBW Period|Adverse Event|2|||
160863712|NCT03773978|580894881|FG001|DBW Period|Adverse Event|2|||
160863713|NCT03773978|580894880|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
160863714|NCT03773978|580894881|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
160863715|NCT03773978|580894880|FG000|DBW Period|Withdrawal by Subject|2|||
160863716|NCT03773978|580894881|FG001|DBW Period|Withdrawal by Subject|1|||
160863717|NCT03773978|580894880|FG000|DBW Period|Due to epidemic or pandemic|5|||
160863718|NCT03773978|580894881|FG001|DBW Period|Due to epidemic or pandemic|6|||
160863719|NCT03773978|580894880|FG000|DBW Period|Study team decision|1|||
160863720|NCT03773978|580894881|FG001|DBW Period|Study team decision|0|||
160863721|NCT03777982|580894882|FG000|Overall Study|Physician Decision|0|||
160863722|NCT03777982|580894883|FG001|Overall Study|Physician Decision|1|||
160863723|NCT00198822|580894884|FG000|Overall Study|Lost to Follow-up|14|||
160863724|NCT00198822|580894885|FG001|Overall Study|Lost to Follow-up|20|||
160863725|NCT00198822|580894886|FG002|Overall Study|Lost to Follow-up|21|||
160863726|NCT00453206|580894888|FG000|Overall Study|Death|1|||
160863727|NCT03866577|580894891|FG000|Overall Study|Protocol Violation|0|||
160863728|NCT03866577|580894892|FG001|Overall Study|Protocol Violation|0|||
160863729|NCT03866577|580894893|FG002|Overall Study|Protocol Violation|0|||
160863730|NCT03866577|580894894|FG003|Overall Study|Protocol Violation|0|||
160863731|NCT03866577|580894895|FG004|Overall Study|Protocol Violation|0|||
160863732|NCT03866577|580894896|FG005|Overall Study|Protocol Violation|0|||
160863733|NCT03866577|580894897|FG006|Overall Study|Protocol Violation|0|||
160863734|NCT03866577|580894898|FG007|Overall Study|Protocol Violation|0|||
160863735|NCT03866577|580894899|FG008|Overall Study|Protocol Violation|0|||
160863736|NCT03866577|580894900|FG009|Overall Study|Protocol Violation|0|||
160863737|NCT03866577|580894901|FG010|Overall Study|Protocol Violation|0|||
160863738|NCT03866577|580894902|FG011|Overall Study|Protocol Violation|1|||
160863739|NCT03866577|580894903|FG012|Overall Study|Protocol Violation|0|||
160863740|NCT03866577|580894891|FG000|Overall Study|Withdrawal by Subject|0|||
160863741|NCT03866577|580894892|FG001|Overall Study|Withdrawal by Subject|0|||
160863742|NCT03866577|580894893|FG002|Overall Study|Withdrawal by Subject|0|||
160863743|NCT03866577|580894894|FG003|Overall Study|Withdrawal by Subject|0|||
160863744|NCT03866577|580894895|FG004|Overall Study|Withdrawal by Subject|0|||
160863745|NCT03866577|580894896|FG005|Overall Study|Withdrawal by Subject|0|||
160863746|NCT03866577|580894897|FG006|Overall Study|Withdrawal by Subject|0|||
160863747|NCT03866577|580894898|FG007|Overall Study|Withdrawal by Subject|0|||
160863748|NCT03866577|580894899|FG008|Overall Study|Withdrawal by Subject|1|||
160863749|NCT03866577|580894900|FG009|Overall Study|Withdrawal by Subject|1|||
161207629|NCT03724968|582141688|FG001|Overall Study|Study closed|1|||
161207630|NCT00399490|582141691|FG000|Overall Study|Adverse Event|19|||
160863750|NCT03866577|580894901|FG010|Overall Study|Withdrawal by Subject|0|||
160863751|NCT03866577|580894902|FG011|Overall Study|Withdrawal by Subject|0|||
160863752|NCT03866577|580894903|FG012|Overall Study|Withdrawal by Subject|0|||
160863753|NCT03866577|580894891|FG000|Overall Study|Not qualified for IVIg infusion|0|||
160863754|NCT03866577|580894892|FG001|Overall Study|Not qualified for IVIg infusion|0|||
160863755|NCT03866577|580894893|FG002|Overall Study|Not qualified for IVIg infusion|0|||
160863756|NCT03866577|580894894|FG003|Overall Study|Not qualified for IVIg infusion|0|||
160863757|NCT03866577|580894895|FG004|Overall Study|Not qualified for IVIg infusion|0|||
160863758|NCT03866577|580894896|FG005|Overall Study|Not qualified for IVIg infusion|0|||
160863759|NCT03866577|580894897|FG006|Overall Study|Not qualified for IVIg infusion|0|||
160863760|NCT03866577|580894898|FG007|Overall Study|Not qualified for IVIg infusion|0|||
160863761|NCT03866577|580894899|FG008|Overall Study|Not qualified for IVIg infusion|0|||
160863762|NCT03866577|580894900|FG009|Overall Study|Not qualified for IVIg infusion|1|||
160863763|NCT03866577|580894901|FG010|Overall Study|Not qualified for IVIg infusion|0|||
160863764|NCT03866577|580894902|FG011|Overall Study|Not qualified for IVIg infusion|0|||
160863765|NCT03866577|580894903|FG012|Overall Study|Not qualified for IVIg infusion|0|||
160863766|NCT03818256|580894904|FG000|Overall Study|Withdrawal by Subject|2|||
160863767|NCT03818256|580894905|FG001|Overall Study|Withdrawal by Subject|2|||
160863768|NCT03818256|580894904|FG000|Overall Study|Adverse Event|3|||
160863769|NCT03818256|580894905|FG001|Overall Study|Adverse Event|1|||
160863770|NCT03818256|580894904|FG000|Overall Study|Lost to Follow-up|0|||
160863771|NCT03818256|580894905|FG001|Overall Study|Lost to Follow-up|5|||
160863772|NCT03818256|580894904|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
160863773|NCT03818256|580894905|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
160863774|NCT03818256|580894904|FG000|Overall Study|Not reporting for scheduled visits|1|||
160863775|NCT03818256|580894905|FG001|Overall Study|Not reporting for scheduled visits|0|||
160863776|NCT03818256|580894904|FG000|Overall Study|Non-compliant with investigational product|1|||
160863777|NCT03818256|580894905|FG001|Overall Study|Non-compliant with investigational product|0|||
160863778|NCT01342211|580894906|FG000|Overall Study|Lost to Follow-up|0|||
160863779|NCT01342211|580894907|FG001|Overall Study|Lost to Follow-up|0|||
160863780|NCT01342211|580894908|FG002|Overall Study|Lost to Follow-up|0|||
160863781|NCT01342211|580894909|FG003|Overall Study|Lost to Follow-up|1|||
160863782|NCT01342211|580894910|FG004|Overall Study|Lost to Follow-up|0|||
160863783|NCT01342211|580894906|FG000|Overall Study|Adverse Event|0|||
160863784|NCT01342211|580894907|FG001|Overall Study|Adverse Event|0|||
160863785|NCT01342211|580894908|FG002|Overall Study|Adverse Event|0|||
160863786|NCT01342211|580894909|FG003|Overall Study|Adverse Event|0|||
160863787|NCT01342211|580894910|FG004|Overall Study|Adverse Event|1|||
160863788|NCT01342211|580894906|FG000|Overall Study|Withdrawal by Subject|0|||
160863789|NCT01342211|580894907|FG001|Overall Study|Withdrawal by Subject|0|||
160863790|NCT01342211|580894908|FG002|Overall Study|Withdrawal by Subject|0|||
160863791|NCT01342211|580894909|FG003|Overall Study|Withdrawal by Subject|1|||
160863792|NCT01342211|580894910|FG004|Overall Study|Withdrawal by Subject|0|||
160863793|NCT01342211|580894906|FG000|Overall Study|Randomized, but not Treated|0|||
160863794|NCT01342211|580894907|FG001|Overall Study|Randomized, but not Treated|2|||
160863795|NCT01342211|580894908|FG002|Overall Study|Randomized, but not Treated|0|||
160863796|NCT01342211|580894909|FG003|Overall Study|Randomized, but not Treated|0|||
160863797|NCT01342211|580894910|FG004|Overall Study|Randomized, but not Treated|1|||
160863798|NCT02749422|580894913|FG000|Overall Study|Lost to Follow-up|0|||
160863799|NCT02749422|580894914|FG001|Overall Study|Lost to Follow-up|2|||
160863800|NCT02749422|580894913|FG000|Overall Study|Ineligible|0|||
160863801|NCT02749422|580894914|FG001|Overall Study|Ineligible|1|||
160863802|NCT01824836|580894915|FG000|Overall Study|Adverse Event|48|||
160863803|NCT01824836|580894915|FG000|Overall Study|Withdrawal by Subject|63|||
160863804|NCT01824836|580894915|FG000|Overall Study|Other complicating disease|116|||
160863805|NCT01824836|580894915|FG000|Overall Study|Disease progression|5|||
160863806|NCT01824836|580894915|FG000|Overall Study|Alternative therapy|2|||
160863807|NCT01824836|580894915|FG000|Overall Study|Depression|1|||
160863808|NCT01824836|580894915|FG000|Overall Study|Non-compliance|3|||
160863809|NCT01824836|580894915|FG000|Overall Study|Patient regained ovarian function|3|||
160863810|NCT01824836|580894915|FG000|Overall Study|Lost to Follow-up|8|||
160863811|NCT01824836|580894915|FG000|Overall Study|Physician Decision|2|||
160863812|NCT01824836|580894915|FG000|Overall Study|Research office was closed|3|||
160863813|NCT01824836|580894915|FG000|Overall Study|Relocation|3|||
160863814|NCT01824836|580894915|FG000|Overall Study|Insurance-related issue|1|||
160863815|NCT01824836|580894915|FG000|Overall Study|Transportation issue|1|||
160863816|NCT01824836|580894915|FG000|Overall Study|Patient transferred care|1|||
160863817|NCT01824836|580894915|FG000|Overall Study|Unknown reasons|4|||
160863818|NCT01824836|580894915|FG000|Overall Study|Never started treatment|16|||
160863819|NCT05530252|580894916|FG000|Overall Study|Lost to Follow-up|1|||
161207631|NCT00399490|582141691|FG000|Overall Study|Lack of Efficacy|31|||
161207632|NCT00399490|582141691|FG000|Overall Study|Lost to Follow-up|5|||
161207633|NCT00399490|582141691|FG000|Overall Study|Withdrawal by Subject|18|||
161207634|NCT00399490|582141691|FG000|Overall Study|Other|25|||
160863820|NCT05530252|580894917|FG001|Overall Study|Lost to Follow-up|1|||
160863821|NCT05530252|580894918|FG002|Overall Study|Lost to Follow-up|1|||
160863822|NCT01350999|580894919|FG000|Overall Study|Adverse Event|4|||
160863823|NCT01350999|580894920|FG001|Overall Study|Adverse Event|9|||
160863824|NCT01350999|580894921|FG002|Overall Study|Adverse Event|10|||
160863825|NCT01350999|580894919|FG000|Overall Study|Voluntary withdrawal|3|||
160863826|NCT01350999|580894920|FG001|Overall Study|Voluntary withdrawal|4|||
160863827|NCT01350999|580894921|FG002|Overall Study|Voluntary withdrawal|6|||
160863828|NCT01350999|580894919|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
160863829|NCT01350999|580894920|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
160863830|NCT01350999|580894921|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
160917859|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
160917860|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
160917861|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
160917862|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
160917863|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
160917864|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
160917865|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
160917866|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
160917867|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
160917868|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
160917869|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
160917870|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
160917871|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
160917872|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
160917873|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
160917874|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
160917875|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
160917876|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
160917877|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
160917878|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
160917879|NCT03510884|581094127|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
160917880|NCT03510884|581094128|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
160917881|NCT03510884|581094129|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
160917882|NCT03510884|581094130|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
160917883|NCT00715078|581094131|FG000|Overall Study|Death|29|||
160917884|NCT00715078|581094132|FG001|Overall Study|Death|36|||
160917885|NCT00715078|581094133|FG002|Overall Study|Death|36|||
160917886|NCT00715078|581094131|FG000|Overall Study|Withdrawal by Subject|1|||
160917887|NCT00715078|581094132|FG001|Overall Study|Withdrawal by Subject|0|||
160917888|NCT00715078|581094133|FG002|Overall Study|Withdrawal by Subject|1|||
160917889|NCT00715078|581094131|FG000|Overall Study|Unable to start due to disease prog.|0|||
160917890|NCT00715078|581094132|FG001|Overall Study|Unable to start due to disease prog.|0|||
160917891|NCT00715078|581094133|FG002|Overall Study|Unable to start due to disease prog.|1|||
160917892|NCT00157950|581094134|FG000|Overall Study|Death|1|||
160917893|NCT00157950|581094135|FG001|Overall Study|Death|0|||
160917894|NCT02892760|581094139|FG000|Overall Study|Withdrawal by Subject|3|||
160917895|NCT01500629|581094140|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
160917896|NCT01500629|581094141|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
160917897|NCT00588848|581094142|FG000|Overall Study|Physician Decision|0|||
160917898|NCT00588848|581094143|FG001|Overall Study|Physician Decision|3|||
160917899|NCT01499667|581094144|FG000|Overall Study|administrative problems|4|||
160917900|NCT01499667|581094145|FG001|Overall Study|administrative problems|5|||
160917901|NCT01499667|581094146|FG002|Overall Study|administrative problems|5|||
160917902|NCT01499667|581094144|FG000|Overall Study|Protocol Violation|1|||
160917903|NCT01499667|581094145|FG001|Overall Study|Protocol Violation|3|||
160917904|NCT01499667|581094146|FG002|Overall Study|Protocol Violation|2|||
160917905|NCT01499667|581094144|FG000|Overall Study|Adverse Event|0|||
160917906|NCT01499667|581094145|FG001|Overall Study|Adverse Event|2|||
160917907|NCT01499667|581094146|FG002|Overall Study|Adverse Event|2|||
160917908|NCT01499667|581094144|FG000|Overall Study|Withdrawal by Subject|2|||
160917909|NCT01499667|581094145|FG001|Overall Study|Withdrawal by Subject|1|||
160917910|NCT01499667|581094146|FG002|Overall Study|Withdrawal by Subject|1|||
160917911|NCT01499667|581094144|FG000|Overall Study|Lack of Efficacy|2|||
160917912|NCT01499667|581094145|FG001|Overall Study|Lack of Efficacy|0|||
160917913|NCT01499667|581094146|FG002|Overall Study|Lack of Efficacy|0|||
161207635|NCT02437890|582141692|FG000|Overall Study|Non-compliance to study drug|0|||
160917914|NCT02902965|581094147|FG000|Overall Study|Withdrawal by Subject|10|||
160917915|NCT02673489|581094148|FG000|Treatment Period|Lost to Follow-up|3|||
160917916|NCT02673489|581094149|FG001|Treatment Period|Lost to Follow-up|0|||
160917917|NCT02673489|581094148|FG000|Treatment Period|Participant request to discontinue|1|||
160917918|NCT02673489|581094149|FG001|Treatment Period|Participant request to discontinue|1|||
160917919|NCT02673489|581094148|FG000|Treatment Period|Participant moved to another province|1|||
160917920|NCT02673489|581094149|FG001|Treatment Period|Participant moved to another province|0|||
161257851|NCT01961687|582323497|FG000|Overall Study|Sponsor decision|2|||
160917921|NCT02673489|581094148|FG000|Treatment Period|Participant was incarcerated|0|||
160863831|NCT02144610|580896656|FG000|Overall Study|Physician Decision|1|||
160863832|NCT02144610|580896657|FG001|Overall Study|Physician Decision|0|||
160863833|NCT02144610|580896656|FG000|Overall Study|Withdrawal by Subject|1|||
160863834|NCT02144610|580896657|FG001|Overall Study|Withdrawal by Subject|5|||
160863835|NCT02144610|580896656|FG000|Overall Study|Death|2|||
160863836|NCT02144610|580896657|FG001|Overall Study|Death|2|||
160863837|NCT02144610|580896656|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
160863838|NCT02144610|580896657|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
160863839|NCT02144610|580896656|FG000|Overall Study|Other|0|||
160863840|NCT02144610|580896657|FG001|Overall Study|Other|1|||
160863841|NCT01354899|580896658|FG000|Overall Study|discharge from the hospital|2|||
160863842|NCT01354899|580896658|FG000|Overall Study|Protocol Violation|1|||
160863843|NCT00463567|580896661|FG000|Overall Study|Adverse Event|29|||
160863844|NCT00463567|580896662|FG001|Overall Study|Adverse Event|26|||
160863845|NCT00463567|580896663|FG002|Overall Study|Adverse Event|17|||
160863846|NCT00463567|580896664|FG003|Overall Study|Adverse Event|46|||
160863847|NCT00463567|580896665|FG004|Overall Study|Adverse Event|10|||
160863848|NCT00463567|580896666|FG005|Overall Study|Adverse Event|10|||
160863849|NCT00463567|580896667|FG006|Overall Study|Adverse Event|4|||
160863850|NCT00463567|580896661|FG000|Overall Study|Withdrawal by Subject|29|||
160863851|NCT00463567|580896662|FG001|Overall Study|Withdrawal by Subject|22|||
160863852|NCT00463567|580896663|FG002|Overall Study|Withdrawal by Subject|20|||
160863853|NCT00463567|580896664|FG003|Overall Study|Withdrawal by Subject|37|||
160863854|NCT00463567|580896665|FG004|Overall Study|Withdrawal by Subject|6|||
160863855|NCT00463567|580896666|FG005|Overall Study|Withdrawal by Subject|5|||
160863856|NCT00463567|580896667|FG006|Overall Study|Withdrawal by Subject|1|||
160863857|NCT00463567|580896661|FG000|Overall Study|Protocol Deviation|13|||
160863858|NCT00463567|580896662|FG001|Overall Study|Protocol Deviation|9|||
160863859|NCT00463567|580896663|FG002|Overall Study|Protocol Deviation|14|||
160863860|NCT00463567|580896664|FG003|Overall Study|Protocol Deviation|11|||
160863861|NCT00463567|580896665|FG004|Overall Study|Protocol Deviation|1|||
160863862|NCT00463567|580896666|FG005|Overall Study|Protocol Deviation|1|||
160863863|NCT00463567|580896667|FG006|Overall Study|Protocol Deviation|2|||
160863864|NCT00463567|580896661|FG000|Overall Study|Lost to Follow-up|12|||
160863865|NCT00463567|580896662|FG001|Overall Study|Lost to Follow-up|6|||
160863866|NCT00463567|580896663|FG002|Overall Study|Lost to Follow-up|13|||
160863867|NCT00463567|580896664|FG003|Overall Study|Lost to Follow-up|8|||
160863868|NCT00463567|580896665|FG004|Overall Study|Lost to Follow-up|1|||
160863869|NCT00463567|580896666|FG005|Overall Study|Lost to Follow-up|1|||
160863870|NCT00463567|580896667|FG006|Overall Study|Lost to Follow-up|1|||
160977805|NCT00445601|581310079|FG000|Overall Study|Withdrawal by Subject|11|||
160977806|NCT00445601|581310080|FG001|Overall Study|Withdrawal by Subject|11|||
160977807|NCT00445601|581310079|FG000|Overall Study|TURBT Complication|12|||
160977808|NCT00445601|581310080|FG001|Overall Study|TURBT Complication|8|||
160977809|NCT00445601|581310079|FG000|Overall Study|Incorrect Disease Status|6|||
160977810|NCT00445601|581310080|FG001|Overall Study|Incorrect Disease Status|6|||
160977811|NCT00445601|581310079|FG000|Overall Study|Drug Delivery Issue|2|||
160977812|NCT00445601|581310080|FG001|Overall Study|Drug Delivery Issue|2|||
160977813|NCT00445601|581310079|FG000|Overall Study|Adverse Event|2|||
160977814|NCT00445601|581310080|FG001|Overall Study|Adverse Event|0|||
160977815|NCT00445601|581310079|FG000|Overall Study|Death prior to TURBT|0|||
160977816|NCT00445601|581310080|FG001|Overall Study|Death prior to TURBT|1|||
160977817|NCT00619476|581310081|FG000|Overall Study|Adverse Event|12|||
160977818|NCT00619476|581310082|FG001|Overall Study|Adverse Event|6|||
161207636|NCT02437890|582141693|FG001|Overall Study|Non-compliance to study drug|1|||
161207637|NCT02437890|582141694|FG002|Overall Study|Non-compliance to study drug|0|||
160863871|NCT00463567|580896661|FG000|Overall Study|Administrative problems|5|||
160863872|NCT00463567|580896662|FG001|Overall Study|Administrative problems|3|||
160863873|NCT00463567|580896663|FG002|Overall Study|Administrative problems|6|||
160863874|NCT00463567|580896664|FG003|Overall Study|Administrative problems|9|||
160977819|NCT00619476|581310083|FG002|Overall Study|Adverse Event|12|||
160977820|NCT00619476|581310084|FG003|Overall Study|Adverse Event|16|||
160977821|NCT00619476|581310081|FG000|Overall Study|Lack of Efficacy|6|||
160977822|NCT00619476|581310082|FG001|Overall Study|Lack of Efficacy|1|||
160977823|NCT00619476|581310083|FG002|Overall Study|Lack of Efficacy|1|||
160977824|NCT00619476|581310084|FG003|Overall Study|Lack of Efficacy|4|||
160977825|NCT00619476|581310081|FG000|Overall Study|Protocol Violation|5|||
160977826|NCT00619476|581310082|FG001|Overall Study|Protocol Violation|4|||
161207638|NCT02437890|582141695|FG003|Overall Study|Non-compliance to study drug|0|||
160863875|NCT00463567|580896665|FG004|Overall Study|Administrative problems|3|||
160863876|NCT00463567|580896666|FG005|Overall Study|Administrative problems|2|||
160977827|NCT00619476|581310083|FG002|Overall Study|Protocol Violation|4|||
160977828|NCT00619476|581310084|FG003|Overall Study|Protocol Violation|9|||
160863877|NCT00463567|580896667|FG006|Overall Study|Administrative problems|2|||
160863878|NCT00463567|580896661|FG000|Overall Study|Lack of Efficacy|4|||
160863879|NCT00463567|580896662|FG001|Overall Study|Lack of Efficacy|9|||
160863880|NCT00463567|580896663|FG002|Overall Study|Lack of Efficacy|9|||
160863881|NCT00463567|580896664|FG003|Overall Study|Lack of Efficacy|17|||
160977829|NCT00619476|581310081|FG000|Overall Study|Lost to Follow-up|1|||
161207639|NCT02437890|582141696|FG004|Overall Study|Non-compliance to study drug|1|||
161207640|NCT02437890|582141692|FG000|Overall Study|Sponsor's decision|1|||
161207641|NCT02437890|582141693|FG001|Overall Study|Sponsor's decision|1|||
161207642|NCT02437890|582141694|FG002|Overall Study|Sponsor's decision|4|||
161207643|NCT02437890|582141695|FG003|Overall Study|Sponsor's decision|0|||
161207644|NCT02437890|582141696|FG004|Overall Study|Sponsor's decision|2|||
161207645|NCT02437890|582141692|FG000|Overall Study|Physician Decision|0|||
161207646|NCT02437890|582141693|FG001|Overall Study|Physician Decision|0|||
161207647|NCT02437890|582141694|FG002|Overall Study|Physician Decision|0|||
161207648|NCT02437890|582141695|FG003|Overall Study|Physician Decision|1|||
161207649|NCT02437890|582141696|FG004|Overall Study|Physician Decision|0|||
161207650|NCT02437890|582141692|FG000|Overall Study|Unable to attend visit(s)|1|||
161207651|NCT02437890|582141693|FG001|Overall Study|Unable to attend visit(s)|0|||
161207652|NCT02437890|582141694|FG002|Overall Study|Unable to attend visit(s)|0|||
161207653|NCT02437890|582141695|FG003|Overall Study|Unable to attend visit(s)|0|||
161207654|NCT02437890|582141696|FG004|Overall Study|Unable to attend visit(s)|0|||
161207655|NCT02437890|582141692|FG000|Overall Study|Lack of Efficacy|1|||
161207656|NCT02437890|582141693|FG001|Overall Study|Lack of Efficacy|3|||
161207657|NCT02437890|582141694|FG002|Overall Study|Lack of Efficacy|0|||
161207658|NCT02437890|582141695|FG003|Overall Study|Lack of Efficacy|3|||
161207659|NCT02437890|582141696|FG004|Overall Study|Lack of Efficacy|1|||
161207660|NCT02437890|582141692|FG000|Overall Study|Adverse Event|4|||
161207661|NCT02437890|582141693|FG001|Overall Study|Adverse Event|9|||
161207662|NCT02437890|582141694|FG002|Overall Study|Adverse Event|5|||
161207663|NCT02437890|582141695|FG003|Overall Study|Adverse Event|11|||
161207664|NCT02437890|582141696|FG004|Overall Study|Adverse Event|7|||
161207665|NCT02437890|582141692|FG000|Overall Study|Withdrawal by Subject|1|||
160977830|NCT00619476|581310082|FG001|Overall Study|Lost to Follow-up|2|||
160977831|NCT00619476|581310083|FG002|Overall Study|Lost to Follow-up|0|||
160977832|NCT00619476|581310084|FG003|Overall Study|Lost to Follow-up|1|||
160977833|NCT00619476|581310081|FG000|Overall Study|Investigator Discretion|2|||
160977834|NCT00619476|581310082|FG001|Overall Study|Investigator Discretion|2|||
160977835|NCT00619476|581310083|FG002|Overall Study|Investigator Discretion|2|||
160977836|NCT00619476|581310084|FG003|Overall Study|Investigator Discretion|0|||
160977837|NCT00619476|581310081|FG000|Overall Study|Withdrawal by Subject|5|||
160977838|NCT00619476|581310082|FG001|Overall Study|Withdrawal by Subject|7|||
160977839|NCT00619476|581310083|FG002|Overall Study|Withdrawal by Subject|5|||
160977840|NCT00619476|581310084|FG003|Overall Study|Withdrawal by Subject|4|||
160977841|NCT01091428|581310085|FG000|Phase 1|Progressive Disease|24|||
160977842|NCT01091428|581310086|FG001|Phase 1|Progressive Disease|8|||
160977843|NCT01091428|581310087|FG002|Phase 1|Progressive Disease|0|||
160977844|NCT01091428|581310088|FG003|Phase 1|Progressive Disease|0|||
160977845|NCT01091428|581310085|FG000|Phase 1|Symptomatic Deterioration|3|||
160977846|NCT01091428|581310086|FG001|Phase 1|Symptomatic Deterioration|2|||
160977847|NCT01091428|581310087|FG002|Phase 1|Symptomatic Deterioration|0|||
160977848|NCT01091428|581310088|FG003|Phase 1|Symptomatic Deterioration|0|||
160977849|NCT01091428|581310085|FG000|Phase 1|Adverse Event|2|||
160977850|NCT01091428|581310086|FG001|Phase 1|Adverse Event|0|||
160977851|NCT01091428|581310087|FG002|Phase 1|Adverse Event|0|||
160977852|NCT01091428|581310088|FG003|Phase 1|Adverse Event|0|||
160977853|NCT01091428|581310085|FG000|Phase 1|Withdrawal by Subject|7|||
160977854|NCT01091428|581310086|FG001|Phase 1|Withdrawal by Subject|0|||
160977855|NCT01091428|581310087|FG002|Phase 1|Withdrawal by Subject|0|||
160977856|NCT01091428|581310088|FG003|Phase 1|Withdrawal by Subject|0|||
160977857|NCT01091428|581310085|FG000|Phase 1|Reason not specified|0|||
160977858|NCT01091428|581310086|FG001|Phase 1|Reason not specified|1|||
160977859|NCT01091428|581310087|FG002|Phase 1|Reason not specified|0|||
160977860|NCT01091428|581310088|FG003|Phase 1|Reason not specified|0|||
160977861|NCT01091428|581310085|FG000|Phase 1|Single-Patient IND|2|||
160863882|NCT00463567|580896665|FG004|Overall Study|Lack of Efficacy|1|||
160863883|NCT00463567|580896666|FG005|Overall Study|Lack of Efficacy|0|||
160863884|NCT00463567|580896667|FG006|Overall Study|Lack of Efficacy|1|||
160863885|NCT00463567|580896661|FG000|Overall Study|Abnormal lab value(s)|1|||
160863886|NCT00463567|580896662|FG001|Overall Study|Abnormal lab value(s)|1|||
160977862|NCT01091428|581310086|FG001|Phase 1|Single-Patient IND|0|||
160977863|NCT01091428|581310087|FG002|Phase 1|Single-Patient IND|0|||
160977864|NCT01091428|581310088|FG003|Phase 1|Single-Patient IND|0|||
161207666|NCT02437890|582141693|FG001|Overall Study|Withdrawal by Subject|2|||
161207667|NCT02437890|582141694|FG002|Overall Study|Withdrawal by Subject|6|||
161207668|NCT02437890|582141695|FG003|Overall Study|Withdrawal by Subject|5|||
161207669|NCT02437890|582141696|FG004|Overall Study|Withdrawal by Subject|5|||
160977865|NCT01091428|581310085|FG000|Phase 2|Progressive Disease|0|||
161207670|NCT02437890|582141692|FG000|Overall Study|Death|0|||
161207671|NCT02437890|582141693|FG001|Overall Study|Death|0|||
161207672|NCT02437890|582141694|FG002|Overall Study|Death|0|||
161207673|NCT02437890|582141695|FG003|Overall Study|Death|2|||
161207674|NCT02437890|582141696|FG004|Overall Study|Death|0|||
161092480|NCT03435497|581729865|FG000|Overall Study|Death|1|||
160977866|NCT01091428|581310086|FG001|Phase 2|Progressive Disease|0|||
160977867|NCT01091428|581310087|FG002|Phase 2|Progressive Disease|44|||
160977868|NCT01091428|581310088|FG003|Phase 2|Progressive Disease|46|||
160977869|NCT01091428|581310085|FG000|Phase 2|Symptomatic Deterioration|0|||
160977870|NCT01091428|581310086|FG001|Phase 2|Symptomatic Deterioration|0|||
160977871|NCT01091428|581310087|FG002|Phase 2|Symptomatic Deterioration|1|||
160977872|NCT01091428|581310088|FG003|Phase 2|Symptomatic Deterioration|6|||
160977873|NCT01091428|581310085|FG000|Phase 2|Adverse Event|0|||
160977874|NCT01091428|581310086|FG001|Phase 2|Adverse Event|0|||
160977875|NCT01091428|581310087|FG002|Phase 2|Adverse Event|12|||
160977876|NCT01091428|581310088|FG003|Phase 2|Adverse Event|5|||
160977877|NCT01091428|581310085|FG000|Phase 2|Withdrawal by Subject|0|||
160977878|NCT01091428|581310086|FG001|Phase 2|Withdrawal by Subject|0|||
160977879|NCT01091428|581310087|FG002|Phase 2|Withdrawal by Subject|9|||
160977880|NCT01091428|581310088|FG003|Phase 2|Withdrawal by Subject|8|||
160977881|NCT01091428|581310085|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
160977882|NCT01091428|581310086|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
160977883|NCT01091428|581310087|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
160977884|NCT01091428|581310088|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
160863887|NCT00463567|580896663|FG002|Overall Study|Abnormal lab value(s)|2|||
160863888|NCT00463567|580896664|FG003|Overall Study|Abnormal lab value(s)|1|||
160863889|NCT00463567|580896665|FG004|Overall Study|Abnormal lab value(s)|1|||
160863890|NCT00463567|580896666|FG005|Overall Study|Abnormal lab value(s)|0|||
160863891|NCT00463567|580896667|FG006|Overall Study|Abnormal lab value(s)|0|||
160863892|NCT00463567|580896661|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160977885|NCT01091428|581310085|FG000|Phase 2|Reason not specified|0|||
160977886|NCT01091428|581310086|FG001|Phase 2|Reason not specified|0|||
160977887|NCT01091428|581310087|FG002|Phase 2|Reason not specified|4|||
160977888|NCT01091428|581310088|FG003|Phase 2|Reason not specified|3|||
160977889|NCT01091428|581310085|FG000|Phase 2|Physician Decision|0|||
160977890|NCT01091428|581310086|FG001|Phase 2|Physician Decision|0|||
160977891|NCT01091428|581310087|FG002|Phase 2|Physician Decision|2|||
160977892|NCT01091428|581310088|FG003|Phase 2|Physician Decision|0|||
160977893|NCT01625910|581310093|FG000|Overall Study|Lost to Follow-up|3|||
160977894|NCT01625910|581310094|FG001|Overall Study|Lost to Follow-up|4|||
160977895|NCT02959138|581310095|FG000|Overall Study|Enrolled but Never Treated|0|||
160977896|NCT02959138|581310096|FG001|Overall Study|Enrolled but Never Treated|1|||
160977897|NCT02959138|581310097|FG002|Overall Study|Enrolled but Never Treated|0|||
160977898|NCT02391038|581310098|FG000|Overall Study|Progressive disease|3|||
160977899|NCT02391038|581310099|FG001|Overall Study|Progressive disease|3|||
160977900|NCT02391038|581310100|FG002|Overall Study|Progressive disease|6|||
160863893|NCT00463567|580896662|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160863894|NCT00463567|580896663|FG002|Overall Study|Abnormal test procedure result(s)|6|||
160863895|NCT00463567|580896664|FG003|Overall Study|Abnormal test procedure result(s)|2|||
160863896|NCT00463567|580896665|FG004|Overall Study|Abnormal test procedure result(s)|0|||
160863897|NCT00463567|580896666|FG005|Overall Study|Abnormal test procedure result(s)|2|||
160863898|NCT00463567|580896667|FG006|Overall Study|Abnormal test procedure result(s)|0|||
160863899|NCT00463567|580896661|FG000|Overall Study|Death|1|||
160863900|NCT00463567|580896662|FG001|Overall Study|Death|0|||
160863901|NCT00463567|580896663|FG002|Overall Study|Death|2|||
160863902|NCT00463567|580896664|FG003|Overall Study|Death|0|||
161092481|NCT03435497|581729866|FG001|Overall Study|Death|0|||
161092482|NCT03435497|581729865|FG000|Overall Study|Withdrawal by Subject|0|||
160863903|NCT00463567|580896665|FG004|Overall Study|Death|0|||
160863904|NCT00463567|580896666|FG005|Overall Study|Death|0|||
160863905|NCT00463567|580896667|FG006|Overall Study|Death|0|||
160863906|NCT00641667|580896670|FG000|Overall Study|Withdrawal by Subject|1|||
161092483|NCT03435497|581729866|FG001|Overall Study|Withdrawal by Subject|4|||
161092484|NCT03435497|581729865|FG000|Overall Study|Wrong survey administered|0|||
160863907|NCT00641667|580896670|FG000|Overall Study|Adverse Event|1|||
160863908|NCT00641667|580896670|FG000|Overall Study|Physician Decision|1|||
160863909|NCT00641667|580896670|FG000|Overall Study|Worsening of underlying disease|3|||
160863910|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
160863911|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
160863912|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
160863913|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
160863914|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
160863915|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
160863916|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
160863917|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
160863918|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
161092485|NCT03435497|581729866|FG001|Overall Study|Wrong survey administered|2|||
161092486|NCT04281004|581729869|FG000|Overall Study|Physician Decision|1|||
161092487|NCT04281004|581729870|FG001|Overall Study|Physician Decision|0|||
160863919|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
160977901|NCT04213989|581310106|FG000|Overall Study|Withdrawal by Subject|3|||
160977902|NCT04213989|581310107|FG001|Overall Study|Withdrawal by Subject|2|||
160977903|NCT04213989|581310106|FG000|Overall Study|Physician Decision|1|||
160863920|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
160863921|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
160863922|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
160863923|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
160863924|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
160863925|NCT01235741|580896671|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
160863926|NCT01235741|580896672|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
160863927|NCT01235741|580896673|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
160863928|NCT01235741|580896671|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
160863929|NCT01235741|580896672|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
160863930|NCT01235741|580896673|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
160863931|NCT01235741|580896671|FG000|Randomized to Treatment|Adverse Event|0|||
160863932|NCT01235741|580896672|FG001|Randomized to Treatment|Adverse Event|1|||
160863933|NCT01235741|580896673|FG002|Randomized to Treatment|Adverse Event|1|||
160863934|NCT01235741|580896671|FG000|Randomized to Treatment|Sponsor terminated study|0|||
160863935|NCT01235741|580896672|FG001|Randomized to Treatment|Sponsor terminated study|35|||
160977904|NCT04213989|581310107|FG001|Overall Study|Physician Decision|0|||
160977905|NCT04213989|581310106|FG000|Overall Study|Lost to Follow-up|0|||
160977906|NCT04213989|581310107|FG001|Overall Study|Lost to Follow-up|4|||
160863936|NCT01235741|580896673|FG002|Randomized to Treatment|Sponsor terminated study|34|||
160977907|NCT01327547|581310108|FG000|Overall Study|Adverse Event|4|||
160977908|NCT01327547|581310109|FG001|Overall Study|Adverse Event|1|||
160977909|NCT01327547|581310108|FG000|Overall Study|Death|1|||
160977910|NCT01327547|581310109|FG001|Overall Study|Death|2|||
160977911|NCT01327547|581310108|FG000|Overall Study|Lost to Follow-up|6|||
160977912|NCT01327547|581310109|FG001|Overall Study|Lost to Follow-up|6|||
160977913|NCT01327547|581310108|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
160977914|NCT01327547|581310109|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
160977915|NCT01327547|581310108|FG000|Overall Study|Withdrawal by Subject|3|||
160977916|NCT01327547|581310109|FG001|Overall Study|Withdrawal by Subject|7|||
160977917|NCT01327547|581310108|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
160977918|NCT01327547|581310109|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
160977919|NCT01327547|581310108|FG000|Overall Study|Protocol Violation|1|||
160977920|NCT01327547|581310109|FG001|Overall Study|Protocol Violation|0|||
160977921|NCT01327547|581310108|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
160977922|NCT01327547|581310109|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
160977923|NCT01327547|581310108|FG000|Overall Study|Required prohibited medication|2|||
160977924|NCT01327547|581310109|FG001|Overall Study|Required prohibited medication|0|||
160977925|NCT01327547|581310108|FG000|Overall Study|Non-compliance with study procedures|1|||
160977926|NCT01327547|581310109|FG001|Overall Study|Non-compliance with study procedures|0|||
160977927|NCT01327547|581310108|FG000|Overall Study|By investigator in subject's interest|0|||
160977928|NCT01327547|581310109|FG001|Overall Study|By investigator in subject's interest|1|||
160977929|NCT03918239|581310112|FG000|Overall Study|Lost to Follow-up|3|||
160977930|NCT03918239|581310113|FG001|Overall Study|Lost to Follow-up|1|||
160977931|NCT03918239|581310112|FG000|Overall Study|Pregnancy|0|||
160977932|NCT03918239|581310113|FG001|Overall Study|Pregnancy|2|||
160977933|NCT03918239|581310112|FG000|Overall Study|Withdrawal by Subject|3|||
160977934|NCT03918239|581310113|FG001|Overall Study|Withdrawal by Subject|3|||
160977935|NCT03918239|581310112|FG000|Overall Study|positive urine drug screening results|4|||
160977936|NCT03918239|581310113|FG001|Overall Study|positive urine drug screening results|1|||
160977937|NCT01984424|581310118|FG000|Overall Study|Withdrawal by Subject|3|||
160977938|NCT01984424|581310119|FG001|Overall Study|Withdrawal by Subject|5|||
160977939|NCT01984424|581310118|FG000|Overall Study|Sponsor Decision|0|||
160977940|NCT01984424|581310119|FG001|Overall Study|Sponsor Decision|1|||
160977941|NCT01984424|581310118|FG000|Overall Study|Lost to Follow-up|0|||
160977942|NCT01984424|581310119|FG001|Overall Study|Lost to Follow-up|1|||
160977943|NCT01807221|581310122|FG000|Overall Study|Progressive disease|1|||
160977944|NCT01807221|581310123|FG001|Overall Study|Progressive disease|0|||
160977945|NCT01807221|581310124|FG002|Overall Study|Progressive disease|1|||
160977946|NCT01807221|581310125|FG003|Overall Study|Progressive disease|0|||
160977947|NCT01807221|581310126|FG004|Overall Study|Progressive disease|0|||
160977948|NCT01807221|581310127|FG005|Overall Study|Progressive disease|0|||
160977949|NCT01807221|581310122|FG000|Overall Study|Death|7|||
161207675|NCT02328547|582141697|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
160977950|NCT01807221|581310123|FG001|Overall Study|Death|9|||
160977951|NCT01807221|581310124|FG002|Overall Study|Death|4|||
160977952|NCT01807221|581310125|FG003|Overall Study|Death|2|||
160977953|NCT01807221|581310126|FG004|Overall Study|Death|1|||
160977954|NCT01807221|581310127|FG005|Overall Study|Death|6|||
160977955|NCT01807221|581310122|FG000|Overall Study|Physician Decision|2|||
160977956|NCT01807221|581310123|FG001|Overall Study|Physician Decision|1|||
160977957|NCT01807221|581310124|FG002|Overall Study|Physician Decision|0|||
160977958|NCT01807221|581310125|FG003|Overall Study|Physician Decision|0|||
160977959|NCT01807221|581310126|FG004|Overall Study|Physician Decision|0|||
160977960|NCT01807221|581310127|FG005|Overall Study|Physician Decision|0|||
160977961|NCT01807221|581310122|FG000|Overall Study|Adverse Event|33|||
160977962|NCT01807221|581310123|FG001|Overall Study|Adverse Event|22|||
160977963|NCT01807221|581310124|FG002|Overall Study|Adverse Event|26|||
160977964|NCT01807221|581310125|FG003|Overall Study|Adverse Event|25|||
160977965|NCT01807221|581310126|FG004|Overall Study|Adverse Event|18|||
160977966|NCT01807221|581310127|FG005|Overall Study|Adverse Event|21|||
160977967|NCT01807221|581310122|FG000|Overall Study|Protocol Violation|0|||
160977968|NCT01807221|581310123|FG001|Overall Study|Protocol Violation|2|||
160977969|NCT01807221|581310124|FG002|Overall Study|Protocol Violation|1|||
160977970|NCT01807221|581310125|FG003|Overall Study|Protocol Violation|2|||
160977971|NCT01807221|581310126|FG004|Overall Study|Protocol Violation|0|||
160977972|NCT01807221|581310127|FG005|Overall Study|Protocol Violation|1|||
160977973|NCT01807221|581310122|FG000|Overall Study|Non-compliance|1|||
160977974|NCT01807221|581310123|FG001|Overall Study|Non-compliance|2|||
160977975|NCT01807221|581310124|FG002|Overall Study|Non-compliance|0|||
160977976|NCT01807221|581310125|FG003|Overall Study|Non-compliance|1|||
160977977|NCT01807221|581310126|FG004|Overall Study|Non-compliance|0|||
160977978|NCT01807221|581310127|FG005|Overall Study|Non-compliance|0|||
160977979|NCT01807221|581310122|FG000|Overall Study|Logistical difficulties|0|||
160977980|NCT01807221|581310123|FG001|Overall Study|Logistical difficulties|1|||
160977981|NCT01807221|581310124|FG002|Overall Study|Logistical difficulties|0|||
160977982|NCT01807221|581310125|FG003|Overall Study|Logistical difficulties|0|||
160977983|NCT01807221|581310126|FG004|Overall Study|Logistical difficulties|1|||
160977984|NCT01807221|581310127|FG005|Overall Study|Logistical difficulties|0|||
160977985|NCT01807221|581310122|FG000|Overall Study|Withdrawal by Subject|33|||
160977986|NCT01807221|581310123|FG001|Overall Study|Withdrawal by Subject|15|||
160977987|NCT01807221|581310124|FG002|Overall Study|Withdrawal by Subject|8|||
160977988|NCT01807221|581310125|FG003|Overall Study|Withdrawal by Subject|14|||
160977989|NCT01807221|581310126|FG004|Overall Study|Withdrawal by Subject|16|||
160977990|NCT01807221|581310127|FG005|Overall Study|Withdrawal by Subject|13|||
160977991|NCT01807221|581310122|FG000|Overall Study|Sponsor decision|2|||
160977992|NCT01807221|581310123|FG001|Overall Study|Sponsor decision|0|||
160977993|NCT01807221|581310124|FG002|Overall Study|Sponsor decision|1|||
160977994|NCT01807221|581310125|FG003|Overall Study|Sponsor decision|1|||
160977995|NCT01807221|581310126|FG004|Overall Study|Sponsor decision|0|||
160977996|NCT01807221|581310127|FG005|Overall Study|Sponsor decision|0|||
160977997|NCT01807221|581310122|FG000|Overall Study|Lost to Follow-up|1|||
160977998|NCT01807221|581310123|FG001|Overall Study|Lost to Follow-up|0|||
160977999|NCT01807221|581310124|FG002|Overall Study|Lost to Follow-up|2|||
160978000|NCT01807221|581310125|FG003|Overall Study|Lost to Follow-up|1|||
160978001|NCT01807221|581310126|FG004|Overall Study|Lost to Follow-up|0|||
160978002|NCT01807221|581310127|FG005|Overall Study|Lost to Follow-up|0|||
160978003|NCT00594906|581310130|FG000|Overall Study|Physician Decision|1|||
160978004|NCT00594906|581310131|FG001|Overall Study|Physician Decision|0|||
160978005|NCT00594906|581310130|FG000|Overall Study|Physician Decision|0|||
160978006|NCT00594906|581310131|FG001|Overall Study|Physician Decision|1|||
160978007|NCT00594906|581310130|FG000|Overall Study|Death|0|||
160978008|NCT00594906|581310131|FG001|Overall Study|Death|1|||
160978009|NCT03772314|581310139|FG000|Overall Study|Adverse Event|7|||
160978010|NCT03772314|581310140|FG001|Overall Study|Adverse Event|2|||
160978011|NCT01613027|581310141|FG000|Overall Study|Lost to Follow-up|5|||
160978012|NCT01613027|581310141|FG000|Overall Study|Switched Physician|1|||
160978013|NCT01613027|581310141|FG000|Overall Study|Lack of Efficacy|1|||
160978014|NCT01613027|581310141|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
160978015|NCT04267614|581310144|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
160978016|NCT04267614|581310144|FG000|Overall Study|Lost to Follow-up|115|||
160978017|NCT03881059|581310150|FG000|Treatment Period - Part A|Adverse Event|1|||
160978018|NCT03881059|581310151|FG001|Treatment Period - Part A|Adverse Event|3|||
160978019|NCT03881059|581310152|FG002|Treatment Period - Part A|Adverse Event|4|||
160978020|NCT03881059|581310150|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
160978021|NCT03881059|581310151|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
160978022|NCT03881059|581310152|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
160978023|NCT03881059|581310150|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
160978024|NCT03881059|581310151|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
160978025|NCT03881059|581310152|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
160978026|NCT03881059|581310150|FG000|Treatment Period - Part A|Other reasons|2|||
160978027|NCT03881059|581310151|FG001|Treatment Period - Part A|Other reasons|1|||
160978028|NCT03881059|581310152|FG002|Treatment Period - Part A|Other reasons|0|||
160978029|NCT03881059|581310150|FG000|Treatment Period - Part B|Adverse Event|0|||
160978030|NCT03881059|581310151|FG001|Treatment Period - Part B|Adverse Event|0|||
160978031|NCT03881059|581310152|FG002|Treatment Period - Part B|Adverse Event|3|||
160978032|NCT03881059|581310150|FG000|Treatment Period - Part B|Death|0|||
160978033|NCT03881059|581310151|FG001|Treatment Period - Part B|Death|1|||
160978034|NCT03881059|581310152|FG002|Treatment Period - Part B|Death|1|||
160978035|NCT03881059|581310150|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
161092488|NCT00701779|581729871|FG000|Overall Study|Adverse Event|6|||
160978036|NCT03881059|581310151|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
160978037|NCT03881059|581310152|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
160978038|NCT03881059|581310150|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
160978039|NCT03881059|581310151|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
160978040|NCT03881059|581310152|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
160978041|NCT03881059|581310150|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
160978042|NCT03881059|581310151|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
160978043|NCT03881059|581310152|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
160978044|NCT03881059|581310150|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
160978045|NCT03881059|581310151|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
160978046|NCT03881059|581310152|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
160978047|NCT03881059|581310150|FG000|Treatment Period - Part B|Other reasons|4|||
160978048|NCT03881059|581310151|FG001|Treatment Period - Part B|Other reasons|3|||
160978049|NCT03881059|581310152|FG002|Treatment Period - Part B|Other reasons|3|||
160978050|NCT02065570|581310153|FG000|Induction Study|Adverse Event|5|||
160978051|NCT02065570|581310154|FG001|Induction Study|Adverse Event|12|||
160978052|NCT02065570|581310155|FG002|Induction Study|Adverse Event|0|||
160978053|NCT02065570|581310156|FG003|Induction Study|Adverse Event|0|||
161092489|NCT00701779|581729871|FG000|Overall Study|Lost to Follow-up|1|||
161092490|NCT00701779|581729871|FG000|Overall Study|Withdrawal by Subject|2|||
161092491|NCT02245672|581729872|FG000|Overall Study|Adverse Event|4|||
161092492|NCT02245672|581729873|FG001|Overall Study|Adverse Event|4|||
161092493|NCT02245672|581729874|FG002|Overall Study|Adverse Event|4|||
161092494|NCT02245672|581729872|FG000|Overall Study|Lost to Follow-up|3|||
161092495|NCT02245672|581729873|FG001|Overall Study|Lost to Follow-up|5|||
160978054|NCT02065570|581310153|FG000|Induction Study|Withdrawal by Subject|2|||
160978055|NCT02065570|581310154|FG001|Induction Study|Withdrawal by Subject|3|||
160978056|NCT02065570|581310155|FG002|Induction Study|Withdrawal by Subject|0|||
160978057|NCT02065570|581310156|FG003|Induction Study|Withdrawal by Subject|0|||
160978058|NCT02065570|581310153|FG000|Induction Study|Lost to Follow-up|1|||
160978059|NCT02065570|581310154|FG001|Induction Study|Lost to Follow-up|1|||
160978060|NCT02065570|581310155|FG002|Induction Study|Lost to Follow-up|0|||
160978061|NCT02065570|581310156|FG003|Induction Study|Lost to Follow-up|0|||
160978062|NCT02065570|581310153|FG000|Induction Study|Other, Not Specified|6|||
160978063|NCT02065570|581310154|FG001|Induction Study|Other, Not Specified|5|||
160978064|NCT02065570|581310155|FG002|Induction Study|Other, Not Specified|0|||
160978065|NCT02065570|581310156|FG003|Induction Study|Other, Not Specified|0|||
160978066|NCT02065570|581310153|FG000|Maintenance Study|Adverse Event|0|||
160978067|NCT02065570|581310154|FG001|Maintenance Study|Adverse Event|0|||
160978068|NCT02065570|581310155|FG002|Maintenance Study|Adverse Event|8|||
160978069|NCT02065570|581310156|FG003|Maintenance Study|Adverse Event|8|||
160978070|NCT02065570|581310153|FG000|Maintenance Study|Withdrawal by Subject|0|||
160978071|NCT02065570|581310154|FG001|Maintenance Study|Withdrawal by Subject|0|||
160978072|NCT02065570|581310155|FG002|Maintenance Study|Withdrawal by Subject|1|||
160978073|NCT02065570|581310156|FG003|Maintenance Study|Withdrawal by Subject|4|||
160978074|NCT02065570|581310153|FG000|Maintenance Study|Lost to Follow-up|0|||
160978075|NCT02065570|581310154|FG001|Maintenance Study|Lost to Follow-up|0|||
160978076|NCT02065570|581310155|FG002|Maintenance Study|Lost to Follow-up|2|||
161207676|NCT02328547|582141698|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
161207677|NCT02328547|582141697|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161207678|NCT02328547|582141698|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161207679|NCT00344305|582141699|FG000|Overall Study|Lost to Follow-up|2|||
161207680|NCT00344305|582141700|FG001|Overall Study|Lost to Follow-up|0|||
161207681|NCT00344305|582141699|FG000|Overall Study|Participant was not contacted in window|0|||
161207682|NCT00344305|582141700|FG001|Overall Study|Participant was not contacted in window|1|||
161207683|NCT00306852|582141707|FG000|Overall Study|Death|14|||
160978077|NCT02065570|581310156|FG003|Maintenance Study|Lost to Follow-up|2|||
160978078|NCT02065570|581310153|FG000|Maintenance Study|Other, Not Specified|0|||
161207684|NCT00306852|582141708|FG001|Overall Study|Death|14|||
161207685|NCT00306852|582141707|FG000|Overall Study|Lost to Follow-up|15|||
161207686|NCT00306852|582141708|FG001|Overall Study|Lost to Follow-up|24|||
160978079|NCT02065570|581310154|FG001|Maintenance Study|Other, Not Specified|0|||
160978080|NCT02065570|581310155|FG002|Maintenance Study|Other, Not Specified|11|||
160978081|NCT02065570|581310156|FG003|Maintenance Study|Other, Not Specified|5|||
160978082|NCT02743793|581310157|FG000|Overall Study|Death|1|||
160978083|NCT02743793|581310158|FG001|Overall Study|Death|1|||
160978084|NCT02743793|581310157|FG000|Overall Study|Withdrawal by Subject|0|||
160978085|NCT02743793|581310158|FG001|Overall Study|Withdrawal by Subject|1|||
160978086|NCT02743793|581310157|FG000|Overall Study|Screen Failure|4|||
160978087|NCT02743793|581310158|FG001|Overall Study|Screen Failure|0|||
160978088|NCT02743793|581310157|FG000|Overall Study|No Primary Care Physician|0|||
161092496|NCT02245672|581729874|FG002|Overall Study|Lost to Follow-up|1|||
161207687|NCT00817778|582141709|FG000|Overall Study|Adverse Event|1|||
161207688|NCT00817778|582141710|FG001|Overall Study|Adverse Event|0|||
161207689|NCT00817778|582141709|FG000|Overall Study|Withdrawal by Subject|1|||
161207690|NCT00817778|582141710|FG001|Overall Study|Withdrawal by Subject|1|||
160978089|NCT02743793|581310158|FG001|Overall Study|No Primary Care Physician|1|||
160978090|NCT02743793|581310157|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
161207691|NCT00817778|582141709|FG000|Overall Study|Protocol Violation|0|||
161207692|NCT00817778|582141710|FG001|Overall Study|Protocol Violation|1|||
161207693|NCT00817778|582141709|FG000|Overall Study|Study-specific discontinuation criteria|0|||
161207694|NCT00817778|582141710|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161207695|NCT00817778|582141709|FG000|Overall Study|Poor venous access|1|||
161207696|NCT00817778|582141710|FG001|Overall Study|Poor venous access|0|||
161207697|NCT01286207|582141711|FG000|Overall Study|Adverse Event|27|||
161207698|NCT01286207|582141712|FG001|Overall Study|Adverse Event|41|||
161207699|NCT01286207|582141713|FG002|Overall Study|Adverse Event|8|||
161207700|NCT01286207|582141711|FG000|Overall Study|Lost to Follow-up|49|||
161207701|NCT01286207|582141712|FG001|Overall Study|Lost to Follow-up|43|||
161207702|NCT01286207|582141713|FG002|Overall Study|Lost to Follow-up|20|||
161207703|NCT01286207|582141711|FG000|Overall Study|Withdrawal by Subject|93|||
161207704|NCT01286207|582141712|FG001|Overall Study|Withdrawal by Subject|79|||
161207705|NCT01286207|582141713|FG002|Overall Study|Withdrawal by Subject|41|||
161207706|NCT01286207|582141711|FG000|Overall Study|Lack of Response|92|||
161207707|NCT01286207|582141712|FG001|Overall Study|Lack of Response|38|||
161207708|NCT01286207|582141713|FG002|Overall Study|Lack of Response|8|||
161207709|NCT01286207|582141711|FG000|Overall Study|Other|37|||
161207710|NCT01286207|582141712|FG001|Overall Study|Other|47|||
161207711|NCT01286207|582141713|FG002|Overall Study|Other|13|||
161207712|NCT02923115|582141714|FG000|Overall Study|Lost to Follow-up|0|||
161207713|NCT02923115|582141715|FG001|Overall Study|Lost to Follow-up|0|||
161207714|NCT02923115|582141716|FG002|Overall Study|Lost to Follow-up|0|||
161207715|NCT02923115|582141717|FG003|Overall Study|Lost to Follow-up|1|||
161207716|NCT02923115|582141718|FG004|Overall Study|Lost to Follow-up|0|||
161207717|NCT02923115|582141719|FG005|Overall Study|Lost to Follow-up|0|||
161207718|NCT02923115|582141714|FG000|Overall Study|Withdrawal by Subject|0|||
161207719|NCT02923115|582141715|FG001|Overall Study|Withdrawal by Subject|1|||
161207720|NCT02923115|582141716|FG002|Overall Study|Withdrawal by Subject|0|||
161207721|NCT02923115|582141717|FG003|Overall Study|Withdrawal by Subject|0|||
161207722|NCT02923115|582141718|FG004|Overall Study|Withdrawal by Subject|0|||
161207723|NCT02923115|582141719|FG005|Overall Study|Withdrawal by Subject|0|||
161207724|NCT02923115|582141714|FG000|Overall Study|Randomized, but not dosed|0|||
161207725|NCT02923115|582141715|FG001|Overall Study|Randomized, but not dosed|0|||
161207726|NCT02923115|582141716|FG002|Overall Study|Randomized, but not dosed|3|||
161207727|NCT02923115|582141717|FG003|Overall Study|Randomized, but not dosed|1|||
161207728|NCT02923115|582141718|FG004|Overall Study|Randomized, but not dosed|5|||
161207729|NCT02923115|582141719|FG005|Overall Study|Randomized, but not dosed|0|||
161207730|NCT01875991|582141722|FG000|Overall Study|Withdrawal by Subject|6|||
161207731|NCT01875991|582141723|FG001|Overall Study|Withdrawal by Subject|6|||
161207732|NCT01875991|582141722|FG000|Overall Study|Sponsor Decision|1|||
161207733|NCT01875991|582141723|FG001|Overall Study|Sponsor Decision|0|||
161207734|NCT03151707|582141724|FG000|Overall Study|Lost to Follow-up|6|||
161207735|NCT02617446|582141726|FG000|Overall Study|Withdrawal by Subject|0|||
161207736|NCT02617446|582141727|FG001|Overall Study|Withdrawal by Subject|2|||
161207737|NCT02617446|582141728|FG002|Overall Study|Withdrawal by Subject|0|||
161207738|NCT02617446|582141726|FG000|Overall Study|Adverse Event|1|||
161207739|NCT02617446|582141727|FG001|Overall Study|Adverse Event|0|||
161207740|NCT02617446|582141728|FG002|Overall Study|Adverse Event|5|||
161207741|NCT02617446|582141726|FG000|Overall Study|Lost to Follow-up|3|||
161207742|NCT02617446|582141727|FG001|Overall Study|Lost to Follow-up|0|||
161207743|NCT02617446|582141728|FG002|Overall Study|Lost to Follow-up|0|||
161207744|NCT02617446|582141726|FG000|Overall Study|Death|0|||
161207745|NCT02617446|582141727|FG001|Overall Study|Death|0|||
161207746|NCT02617446|582141728|FG002|Overall Study|Death|2|||
161207747|NCT00285012|582141737|FG000|Assigned to Study Treatment (Tx)|Other|2|||
161207748|NCT00285012|582141738|FG001|Assigned to Study Treatment (Tx)|Other|3|||
161207749|NCT00285012|582141737|FG000|Received Study Tx|Death|2|||
160978091|NCT02743793|581310158|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
161092497|NCT02245672|581729872|FG000|Overall Study|Withdrawal by Subject|6|||
161092498|NCT02245672|581729873|FG001|Overall Study|Withdrawal by Subject|3|||
161092499|NCT02245672|581729874|FG002|Overall Study|Withdrawal by Subject|0|||
161092500|NCT02245672|581729872|FG000|Overall Study|Randomized in error (not treated)|0|||
161092501|NCT02245672|581729873|FG001|Overall Study|Randomized in error (not treated)|1|||
161092502|NCT02245672|581729874|FG002|Overall Study|Randomized in error (not treated)|0|||
161092503|NCT04363801|581729880|FG000|Overall Study|Death|18|||
161092504|NCT04363801|581729881|FG001|Overall Study|Death|14|||
161092505|NCT04363801|581729882|FG002|Overall Study|Death|16|||
161092506|NCT04363801|581729883|FG003|Overall Study|Death|48|||
161092507|NCT04363801|581729884|FG004|Overall Study|Death|38|||
161092508|NCT04363801|581729880|FG000|Overall Study|Withdrawal by Subject|1|||
161207750|NCT00285012|582141738|FG001|Received Study Tx|Death|1|||
161321485|NCT00929994|582562977|FG000|Overall Study|medical issue unrelated to intervention|4|||
161207751|NCT00285012|582141737|FG000|Received Study Tx|Adverse Event|5|||
161207752|NCT00285012|582141738|FG001|Received Study Tx|Adverse Event|11|||
161092509|NCT04363801|581729881|FG001|Overall Study|Withdrawal by Subject|6|||
161092510|NCT04363801|581729882|FG002|Overall Study|Withdrawal by Subject|1|||
161092511|NCT04363801|581729883|FG003|Overall Study|Withdrawal by Subject|4|||
161092512|NCT04363801|581729884|FG004|Overall Study|Withdrawal by Subject|14|||
161092513|NCT04363801|581729880|FG000|Overall Study|Sponsor Decision|6|||
161092514|NCT04363801|581729881|FG001|Overall Study|Sponsor Decision|4|||
161092515|NCT04363801|581729882|FG002|Overall Study|Sponsor Decision|10|||
161092516|NCT04363801|581729883|FG003|Overall Study|Sponsor Decision|33|||
161092517|NCT04363801|581729884|FG004|Overall Study|Sponsor Decision|32|||
161092518|NCT04363801|581729880|FG000|Overall Study|Lost to Follow-up|0|||
161092519|NCT04363801|581729881|FG001|Overall Study|Lost to Follow-up|0|||
161092520|NCT04363801|581729882|FG002|Overall Study|Lost to Follow-up|1|||
161092521|NCT04363801|581729883|FG003|Overall Study|Lost to Follow-up|0|||
161092522|NCT04363801|581729884|FG004|Overall Study|Lost to Follow-up|1|||
161092523|NCT01146054|581729885|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
161092524|NCT01146054|581729885|FG000|Overall Study|Rapid tumor progression|2|||
161092525|NCT01146054|581729885|FG000|Overall Study|Other illness precluded treatment|2|||
161092526|NCT01146054|581729885|FG000|Overall Study|Lost to Follow-up|1|||
161092527|NCT00762970|581729886|FG000|Overall Study|Withdrawal by Subject|7|||
161092528|NCT00762970|581729887|FG001|Overall Study|Withdrawal by Subject|4|||
161092529|NCT00762970|581729888|FG002|Overall Study|Withdrawal by Subject|0|||
161092530|NCT00762970|581729886|FG000|Overall Study|Protocol Violation|3|||
161207753|NCT00285012|582141737|FG000|Received Study Tx|Lack of Efficacy|0|||
161207754|NCT00285012|582141738|FG001|Received Study Tx|Lack of Efficacy|3|||
161207755|NCT00285012|582141737|FG000|Received Study Tx|Lost to Follow-up|29|||
161207756|NCT00285012|582141738|FG001|Received Study Tx|Lost to Follow-up|31|||
161207757|NCT00285012|582141737|FG000|Received Study Tx|Withdrawal by Subject|31|||
161207758|NCT00285012|582141738|FG001|Received Study Tx|Withdrawal by Subject|43|||
161207759|NCT00285012|582141737|FG000|Received Study Tx|Other|5|||
161207760|NCT00285012|582141738|FG001|Received Study Tx|Other|5|||
161207761|NCT05631093|582141741|FG000|Overall Study|Death|0|||
161207762|NCT05631093|582141742|FG001|Overall Study|Death|1|||
161207763|NCT05631093|582141741|FG000|Overall Study|Lost to Follow-up|1|||
161207764|NCT05631093|582141742|FG001|Overall Study|Lost to Follow-up|2|||
161207765|NCT05631093|582141741|FG000|Overall Study|Physician Decision|1|||
161207766|NCT05631093|582141742|FG001|Overall Study|Physician Decision|0|||
161207767|NCT05631093|582141741|FG000|Overall Study|Withdrawal by Subject|4|||
161207768|NCT05631093|582141742|FG001|Overall Study|Withdrawal by Subject|1|||
161207769|NCT05631093|582141741|FG000|Overall Study|Ongoing|353|||
161207770|NCT05631093|582141742|FG001|Overall Study|Ongoing|177|||
161207771|NCT05631093|582141741|FG000|Overall Study|Adverse Event|0|||
161207772|NCT05631093|582141742|FG001|Overall Study|Adverse Event|1|||
161207773|NCT02873195|582141743|FG000|Overall Study|Ineligible|5|||
161207774|NCT02873195|582141744|FG001|Overall Study|Ineligible|0|||
161207775|NCT03107715|582141746|FG000|Overall Study|did not deliver at the home hospital|4|||
161207776|NCT03107715|582141747|FG001|Overall Study|did not deliver at the home hospital|6|||
161092531|NCT00762970|581729887|FG001|Overall Study|Protocol Violation|1|||
161092532|NCT00762970|581729888|FG002|Overall Study|Protocol Violation|1|||
161092533|NCT00762970|581729886|FG000|Overall Study|Lost to Follow-up|1|||
161092534|NCT00762970|581729887|FG001|Overall Study|Lost to Follow-up|2|||
161092535|NCT00762970|581729888|FG002|Overall Study|Lost to Follow-up|0|||
161092536|NCT00762970|581729886|FG000|Overall Study|Difficulty of handling lens|1|||
161092537|NCT00762970|581729887|FG001|Overall Study|Difficulty of handling lens|2|||
161092538|NCT00762970|581729888|FG002|Overall Study|Difficulty of handling lens|0|||
161092539|NCT02901041|581729889|FG000|Overall Study|Withdrawal by PI|4|||
161092540|NCT02901041|581729890|FG001|Overall Study|Withdrawal by PI|8|||
161092541|NCT02901041|581729889|FG000|Overall Study|Withdrawal by Subject|7|||
161092542|NCT02901041|581729890|FG001|Overall Study|Withdrawal by Subject|3|||
161092543|NCT01480674|581729891|FG000|Overall Study|Death|23|||
161092544|NCT01480674|581729891|FG000|Overall Study|Lost to Follow-up|2|||
161092545|NCT01480674|581729891|FG000|Overall Study|visit not done|10|||
161092546|NCT03818204|581729892|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092547|NCT03818204|581729893|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092548|NCT03818204|581729894|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160863937|NCT01235741|580896671|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
161092549|NCT03818204|581729895|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092550|NCT03818204|581729896|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
161092551|NCT03818204|581729897|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092552|NCT03818204|581729898|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
160863938|NCT01235741|580896672|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
161092553|NCT03818204|581729899|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092554|NCT03818204|581729900|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161207777|NCT03107715|582141746|FG000|Overall Study|infant stillborn|0|||
160863939|NCT01235741|580896673|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
161092555|NCT03818204|581729901|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161207778|NCT03107715|582141747|FG001|Overall Study|infant stillborn|1|||
161207779|NCT03252756|582141748|FG000|Overall Study|Protocol Violation|2|||
161207780|NCT03252756|582141749|FG001|Overall Study|Protocol Violation|4|||
160978092|NCT02743793|581310157|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
160978093|NCT02743793|581310158|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
161207781|NCT03252756|582141748|FG000|Overall Study|COVID-19 Pandemic|1|||
161207782|NCT03252756|582141749|FG001|Overall Study|COVID-19 Pandemic|1|||
161207783|NCT03252756|582141748|FG000|Overall Study|Study Drug Expiration|0|||
161207784|NCT03252756|582141749|FG001|Overall Study|Study Drug Expiration|1|||
161207785|NCT03594175|582141750|FG000|Overall Study|Not treated|8|||
161207786|NCT03594175|582141751|FG001|Overall Study|Not treated|1|||
161207787|NCT03594175|582141752|FG002|Overall Study|Not treated|5|||
161207788|NCT03594175|582141750|FG000|Overall Study|Adverse Event|3|||
161207789|NCT03594175|582141751|FG001|Overall Study|Adverse Event|0|||
161207790|NCT03594175|582141752|FG002|Overall Study|Adverse Event|0|||
161207791|NCT03594175|582141750|FG000|Overall Study|Withdrawal by Subject|3|||
161207792|NCT03594175|582141751|FG001|Overall Study|Withdrawal by Subject|0|||
161207793|NCT03594175|582141752|FG002|Overall Study|Withdrawal by Subject|0|||
161207794|NCT03594175|582141750|FG000|Overall Study|Protocol Violation|2|||
161207795|NCT03594175|582141751|FG001|Overall Study|Protocol Violation|2|||
161207796|NCT03594175|582141752|FG002|Overall Study|Protocol Violation|2|||
161207797|NCT04644237|582141753|FG000|Overall Study|Death|4|||
161207798|NCT04644237|582141754|FG001|Overall Study|Death|2|||
161207799|NCT04644237|582141753|FG000|Overall Study|Adverse Event|18|||
161207800|NCT04644237|582141754|FG001|Overall Study|Adverse Event|19|||
161207801|NCT04644237|582141753|FG000|Overall Study|Progressive Disease|61|||
161207802|NCT04644237|582141754|FG001|Overall Study|Progressive Disease|23|||
161207803|NCT04644237|582141753|FG000|Overall Study|Clinical Progression|4|||
161207804|NCT04644237|582141754|FG001|Overall Study|Clinical Progression|1|||
161207805|NCT04644237|582141753|FG000|Overall Study|Withdrawal by Subject|4|||
161207806|NCT04644237|582141754|FG001|Overall Study|Withdrawal by Subject|2|||
161207807|NCT04644237|582141753|FG000|Overall Study|Physician Decision|4|||
161207808|NCT04644237|582141754|FG001|Overall Study|Physician Decision|0|||
161207809|NCT04644237|582141753|FG000|Overall Study|Other|6|||
161207810|NCT04644237|582141754|FG001|Overall Study|Other|3|||
161207811|NCT04644237|582141753|FG000|Overall Study|Randomized but not Treated|1|||
161207812|NCT04644237|582141754|FG001|Overall Study|Randomized but not Treated|0|||
161207813|NCT01500434|582141755|FG000|Overall Study|Death|1|||
161207814|NCT01500434|582141755|FG000|Overall Study|Withdrawal by Subject|1|||
161207815|NCT01500434|582141755|FG000|Overall Study|Missed 12-month follow-up|5|||
161207816|NCT04822701|582141756|FG000|Overall Study|Not treated|2|||
161207817|NCT04822701|582141757|FG001|Overall Study|Not treated|0|||
161207818|NCT04822701|582141756|FG000|Overall Study|Lost to Follow-up|1|||
161207819|NCT04822701|582141757|FG001|Overall Study|Lost to Follow-up|0|||
161207820|NCT04822701|582141756|FG000|Overall Study|Withdrawal by Subject|1|||
161207821|NCT04822701|582141757|FG001|Overall Study|Withdrawal by Subject|0|||
161207822|NCT04502862|582141758|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
161207823|NCT04502862|582141759|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
161207824|NCT04502862|582141758|FG000|Overall Study|Withdrawal by Subject|1|||
161207825|NCT04502862|582141759|FG001|Overall Study|Withdrawal by Subject|0|||
161207826|NCT04502862|582141758|FG000|Overall Study|Adverse Event|1|||
161207827|NCT04502862|582141759|FG001|Overall Study|Adverse Event|1|||
161207828|NCT03560466|582141760|FG000|Overall Study|Adverse Event|1|||
161207829|NCT03560466|582141761|FG001|Overall Study|Adverse Event|2|||
161207830|NCT03560466|582141762|FG002|Overall Study|Adverse Event|0|||
161207831|NCT03560466|582141760|FG000|Overall Study|Poor Compliance to Protocol|0|||
161207832|NCT03560466|582141761|FG001|Overall Study|Poor Compliance to Protocol|2|||
161207833|NCT03560466|582141762|FG002|Overall Study|Poor Compliance to Protocol|0|||
161207834|NCT03560466|582141760|FG000|Overall Study|Other|6|||
161207835|NCT03560466|582141761|FG001|Overall Study|Other|8|||
161207836|NCT03560466|582141762|FG002|Overall Study|Other|1|||
161207837|NCT01858558|582142841|FG000|Overall Study|Death|1|||
161207838|NCT01858558|582142842|FG001|Overall Study|Death|1|||
161207839|NCT01858558|582142841|FG000|Overall Study|Lost to Follow-up|1|||
161207840|NCT01858558|582142842|FG001|Overall Study|Lost to Follow-up|0|||
161207841|NCT01858558|582142841|FG000|Overall Study|Disease progression|3|||
161207842|NCT01858558|582142842|FG001|Overall Study|Disease progression|1|||
161207843|NCT01858558|582142841|FG000|Overall Study|Product contamination|2|||
161207844|NCT01858558|582142842|FG001|Overall Study|Product contamination|0|||
160978094|NCT00786474|581310161|FG000|Overall Study|Death|5|||
161207845|NCT01858558|582142841|FG000|Overall Study|Failed expansion of cell product|2|||
161207846|NCT01858558|582142842|FG001|Overall Study|Failed expansion of cell product|0|||
161207847|NCT01336608|582142843|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
161207848|NCT01336608|582142844|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161207849|NCT01336608|582142845|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161207850|NCT01336608|582142846|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
161207851|NCT01336608|582142843|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
161207852|NCT01336608|582142844|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161207853|NCT01336608|582142845|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161207854|NCT01336608|582142846|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161321486|NCT00929994|582562977|FG000|Overall Study|employment|1|||
161321487|NCT02061813|582562979|FG000|Overall Study|Withdrawal by Subject|1|||
161321488|NCT02061813|582562979|FG000|Overall Study|Protocol Violation|2|||
161321489|NCT01705080|582562980|FG000|Overall Study|Missed visit|10|||
161207855|NCT01336608|582142843|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
161207856|NCT01336608|582142844|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
161207857|NCT01336608|582142845|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
161207858|NCT01336608|582142846|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161207859|NCT01336608|582142843|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
161207860|NCT01336608|582142844|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
161207861|NCT01336608|582142845|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
161207862|NCT01336608|582142846|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
161207863|NCT01336608|582142843|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
161207864|NCT01336608|582142844|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161207865|NCT01336608|582142845|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161207866|NCT01336608|582142846|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
161207867|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161207868|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
161207869|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
161207870|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
161207871|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161207872|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
161207873|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161207874|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
161207875|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
161207876|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161207877|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
161207878|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
161207879|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161207880|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
161207881|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161207882|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
161207883|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
161207884|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
161207885|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
161207886|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
161207887|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161207888|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
161207889|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161207890|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161207891|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161207892|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
161207893|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161207894|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
161207895|NCT01336608|582142843|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161207896|NCT01336608|582142844|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
161207897|NCT01336608|582142845|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
161207898|NCT01336608|582142846|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
161207899|NCT01190098|582142851|FG000|Overall Study|Adverse Event|2|||
161207900|NCT01190098|582142852|FG001|Overall Study|Adverse Event|0|||
161207901|NCT01190098|582142851|FG000|Overall Study|Patient coomorbidity|0|||
161207902|NCT01190098|582142852|FG001|Overall Study|Patient coomorbidity|1|||
161207903|NCT01190098|582142851|FG000|Overall Study|Lack of transportation|1|||
161207904|NCT01190098|582142852|FG001|Overall Study|Lack of transportation|0|||
161207905|NCT01190098|582142851|FG000|Overall Study|Other|0|||
161207906|NCT01190098|582142852|FG001|Overall Study|Other|1|||
161207907|NCT04723173|582142857|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
161207908|NCT02996448|582142858|FG000|Overall Study|Study terminated due to adverse effects|3|||
161207909|NCT01422720|582142859|FG000|Overall Study|Adverse Event|16|||
161207910|NCT01422720|582142859|FG000|Overall Study|Lack of Efficacy|1|||
161207911|NCT01422720|582142859|FG000|Overall Study|Withdrawal by Subject|4|||
161207912|NCT01422720|582142859|FG000|Overall Study|Ineligibility|1|||
161207913|NCT00606801|582142860|FG000|Intervention|Protocol Violation|3|||
161207914|NCT00606801|582142861|FG001|Intervention|Protocol Violation|3|||
161207915|NCT02082262|582142862|FG000|Overall Study|Withdrawal by Subject|3|||
161207916|NCT02082262|582142862|FG000|Overall Study|Adverse Event|48|||
161207917|NCT01726335|582142867|FG000|Overall Study|Lost to Follow-up|2|||
161207918|NCT01726335|582142867|FG000|Overall Study|Withdrawal by Subject|15|||
161207919|NCT01726335|582142867|FG000|Overall Study|Adverse Event|4|||
161207920|NCT01726335|582142867|FG000|Overall Study|Lost to Follow-up|2|||
161207921|NCT01726335|582142867|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
161207922|NCT01586624|582142868|FG000|Overall Study|Adverse Event|3|||
161207923|NCT01586624|582142869|FG001|Overall Study|Adverse Event|0|||
161207924|NCT01586624|582142870|FG002|Overall Study|Adverse Event|2|||
161207925|NCT01586624|582142871|FG003|Overall Study|Adverse Event|1|||
161207926|NCT01586624|582142872|FG004|Overall Study|Adverse Event|3|||
161207927|NCT01586624|582142873|FG005|Overall Study|Adverse Event|3|||
161207928|NCT01586624|582142874|FG006|Overall Study|Adverse Event|2|||
161207929|NCT01586624|582142875|FG007|Overall Study|Adverse Event|3|||
161207930|NCT01586624|582142868|FG000|Overall Study|Physician Decision|0|||
161207931|NCT01586624|582142869|FG001|Overall Study|Physician Decision|1|||
161207932|NCT01586624|582142870|FG002|Overall Study|Physician Decision|1|||
161207933|NCT01586624|582142871|FG003|Overall Study|Physician Decision|0|||
161207934|NCT01586624|582142872|FG004|Overall Study|Physician Decision|2|||
161207935|NCT01586624|582142873|FG005|Overall Study|Physician Decision|0|||
161207936|NCT01586624|582142874|FG006|Overall Study|Physician Decision|1|||
161207937|NCT01586624|582142875|FG007|Overall Study|Physician Decision|1|||
161207938|NCT01586624|582142868|FG000|Overall Study|Withdrawal by Subject|0|||
161207939|NCT01586624|582142869|FG001|Overall Study|Withdrawal by Subject|0|||
161207940|NCT01586624|582142870|FG002|Overall Study|Withdrawal by Subject|0|||
161207941|NCT01586624|582142871|FG003|Overall Study|Withdrawal by Subject|1|||
161207942|NCT01586624|582142872|FG004|Overall Study|Withdrawal by Subject|0|||
161207943|NCT01586624|582142873|FG005|Overall Study|Withdrawal by Subject|0|||
161207944|NCT01586624|582142874|FG006|Overall Study|Withdrawal by Subject|0|||
161207945|NCT01586624|582142875|FG007|Overall Study|Withdrawal by Subject|0|||
161207946|NCT01586624|582142868|FG000|Overall Study|Evidence of disease progression|1|||
161207947|NCT01586624|582142869|FG001|Overall Study|Evidence of disease progression|3|||
161207948|NCT01586624|582142870|FG002|Overall Study|Evidence of disease progression|2|||
161207949|NCT01586624|582142871|FG003|Overall Study|Evidence of disease progression|5|||
161207950|NCT01586624|582142872|FG004|Overall Study|Evidence of disease progression|3|||
161207951|NCT01586624|582142873|FG005|Overall Study|Evidence of disease progression|5|||
161207952|NCT01586624|582142874|FG006|Overall Study|Evidence of disease progression|4|||
161207953|NCT01586624|582142875|FG007|Overall Study|Evidence of disease progression|6|||
161207954|NCT01586624|582142868|FG000|Overall Study|Screen failure (no treatment received)|0|||
160863940|NCT01235741|580896671|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
161207955|NCT01586624|582142869|FG001|Overall Study|Screen failure (no treatment received)|0|||
161207956|NCT01586624|582142870|FG002|Overall Study|Screen failure (no treatment received)|0|||
161207957|NCT01586624|582142871|FG003|Overall Study|Screen failure (no treatment received)|0|||
161207958|NCT01586624|582142872|FG004|Overall Study|Screen failure (no treatment received)|0|||
161207959|NCT01586624|582142873|FG005|Overall Study|Screen failure (no treatment received)|0|||
161207960|NCT01586624|582142874|FG006|Overall Study|Screen failure (no treatment received)|1|||
161207961|NCT01586624|582142875|FG007|Overall Study|Screen failure (no treatment received)|0|||
161207962|NCT01796860|582142881|FG000|Overall Study|Withdrawal by Subject|3|||
161207963|NCT01537549|582142883|FG000|Overall Study|Lost to Follow-up|1|||
161207964|NCT01537549|582142883|FG000|Overall Study|Withdrawal by Subject|2|||
161207965|NCT00883740|582142884|FG000|First Intervention|Lost to Follow-up|1|||
161207966|NCT00883740|582142885|FG001|First Intervention|Lost to Follow-up|0|||
161207967|NCT00883740|582142884|FG000|First Intervention|No longer willing to participate|2|||
161207968|NCT00883740|582142885|FG001|First Intervention|No longer willing to participate|0|||
161207969|NCT00883740|582142884|FG000|First Intervention|Protocol Violation|3|||
161207970|NCT00883740|582142885|FG001|First Intervention|Protocol Violation|6|||
161207971|NCT00883740|582142884|FG000|First Intervention|Adverse Event|1|||
161207972|NCT00883740|582142885|FG001|First Intervention|Adverse Event|2|||
161207973|NCT00883740|582142884|FG000|Second Intervention|Protocol Violation|1|||
161207974|NCT00883740|582142885|FG001|Second Intervention|Protocol Violation|0|||
161207975|NCT00883740|582142884|FG000|Second Intervention|No longer willing to participate|0|||
161207976|NCT00883740|582142885|FG001|Second Intervention|No longer willing to participate|1|||
161207977|NCT04840901|582142888|FG000|Overall Study|Lost to Follow-up|3|||
161207978|NCT04840901|582142889|FG001|Overall Study|Lost to Follow-up|1|||
161207979|NCT04840901|582142888|FG000|Overall Study|Moved|1|||
160863941|NCT01235741|580896672|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
161207980|NCT04840901|582142889|FG001|Overall Study|Moved|0|||
161207981|NCT04840901|582142888|FG000|Overall Study|Unable to comply with study schedule|0|||
161207982|NCT04840901|582142889|FG001|Overall Study|Unable to comply with study schedule|1|||
161207983|NCT04840901|582142888|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
161207984|NCT04840901|582142889|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
161207985|NCT00103259|582142890|FG000|Overall Study|Death|3|||
161207986|NCT00103259|582142891|FG001|Overall Study|Death|2|||
161207987|NCT00103259|582142890|FG000|Overall Study|Withdrawal by Subject|2|||
161207988|NCT00103259|582142891|FG001|Overall Study|Withdrawal by Subject|3|||
161207989|NCT00103259|582142890|FG000|Overall Study|alternative therapy|1|||
161207990|NCT00103259|582142891|FG001|Overall Study|alternative therapy|0|||
161207991|NCT00103259|582142890|FG000|Overall Study|other (reasons were not specified)|2|||
161207992|NCT00103259|582142891|FG001|Overall Study|other (reasons were not specified)|1|||
161207993|NCT00103259|582142890|FG000|Overall Study|ineligible/no protocol therapy|4|||
161207994|NCT00103259|582142891|FG001|Overall Study|ineligible/no protocol therapy|6|||
161207995|NCT03224234|582142892|FG000|Main Study|Lost to Follow-up|5|||
161207996|NCT03224234|582142893|FG001|Main Study|Lost to Follow-up|5|||
161207997|NCT02610842|582142894|FG000|Overall Study|Lost to Follow-up|5|||
161207998|NCT02494583|582142897|FG000|Overall Study|Death|224|||
161207999|NCT02494583|582142898|FG001|Overall Study|Death|214|||
161208000|NCT02494583|582142899|FG002|Overall Study|Death|225|||
161208001|NCT02494583|582142897|FG000|Overall Study|Lost to Follow-up|1|||
161208002|NCT02494583|582142898|FG001|Overall Study|Lost to Follow-up|0|||
161208003|NCT02494583|582142899|FG002|Overall Study|Lost to Follow-up|0|||
161208004|NCT02494583|582142897|FG000|Overall Study|Protocol Violation|1|||
161208005|NCT02494583|582142898|FG001|Overall Study|Protocol Violation|2|||
161208006|NCT02494583|582142899|FG002|Overall Study|Protocol Violation|0|||
161208007|NCT02494583|582142897|FG000|Overall Study|Screen Failure|0|||
161208008|NCT02494583|582142898|FG001|Overall Study|Screen Failure|1|||
161208009|NCT02494583|582142899|FG002|Overall Study|Screen Failure|0|||
161208010|NCT02494583|582142897|FG000|Overall Study|Transferred to Extension Study|15|||
161208011|NCT02494583|582142898|FG001|Overall Study|Transferred to Extension Study|15|||
161208012|NCT02494583|582142899|FG002|Overall Study|Transferred to Extension Study|6|||
161208013|NCT02494583|582142897|FG000|Overall Study|Did Not Continue on Extension Study|8|||
161208014|NCT02494583|582142898|FG001|Overall Study|Did Not Continue on Extension Study|10|||
161208015|NCT02494583|582142899|FG002|Overall Study|Did Not Continue on Extension Study|4|||
161208016|NCT02494583|582142897|FG000|Overall Study|Withdrawal by Subject|7|||
161208017|NCT02494583|582142898|FG001|Overall Study|Withdrawal by Subject|15|||
161208018|NCT02494583|582142899|FG002|Overall Study|Withdrawal by Subject|15|||
161208019|NCT00627458|582142902|FG000|Overall Study|Migrated from study area|1|||
161208020|NCT00627458|582142903|FG001|Overall Study|Migrated from study area|0|||
161208021|NCT00627458|582142904|FG002|Overall Study|Migrated from study area|1|||
161208022|NCT00627458|582142902|FG000|Overall Study|Withdrawal by Subject|2|||
161208023|NCT00627458|582142903|FG001|Overall Study|Withdrawal by Subject|6|||
161208024|NCT00627458|582142904|FG002|Overall Study|Withdrawal by Subject|5|||
161208025|NCT00627458|582142902|FG000|Overall Study|Lost to Follow-up|1|||
161208026|NCT00627458|582142903|FG001|Overall Study|Lost to Follow-up|1|||
161208027|NCT00627458|582142904|FG002|Overall Study|Lost to Follow-up|0|||
161208028|NCT03891875|582142905|FG000|Overall Study|Withdrawal by Subject|20|||
161208029|NCT03891875|582142906|FG001|Overall Study|Withdrawal by Subject|3|||
161208030|NCT03891875|582142905|FG000|Overall Study|Adverse Event|10|||
161208031|NCT03891875|582142906|FG001|Overall Study|Adverse Event|4|||
161208032|NCT03891875|582142905|FG000|Overall Study|Physician Decision|1|||
161208033|NCT03891875|582142906|FG001|Overall Study|Physician Decision|1|||
161208034|NCT03891875|582142905|FG000|Overall Study|Protocol Violation|1|||
161208035|NCT03891875|582142906|FG001|Overall Study|Protocol Violation|0|||
161208036|NCT03891875|582142905|FG000|Overall Study|Lost to Follow-up|1|||
161208037|NCT03891875|582142906|FG001|Overall Study|Lost to Follow-up|0|||
161208038|NCT03891875|582142905|FG000|Overall Study|COVID-19 infection|1|||
161208039|NCT03891875|582142906|FG001|Overall Study|COVID-19 infection|0|||
161208040|NCT01783483|582142911|FG000|Overall Study|Death|3|||
161208041|NCT01783483|582142912|FG001|Overall Study|Death|3|||
161208042|NCT01783483|582142911|FG000|Overall Study|Lost to Follow-up|14|||
161208043|NCT01783483|582142912|FG001|Overall Study|Lost to Follow-up|10|||
161208044|NCT01783483|582142911|FG000|Overall Study|Withdrawal by Subject|2|||
161208045|NCT01783483|582142912|FG001|Overall Study|Withdrawal by Subject|1|||
161208046|NCT01783483|582142911|FG000|Overall Study|Physician Decision|1|||
161208047|NCT01783483|582142912|FG001|Overall Study|Physician Decision|1|||
161208048|NCT02268045|582142913|FG000|Overall Study|Death|4|||
161208049|NCT02268045|582142914|FG001|Overall Study|Death|4|||
161208050|NCT02268045|582142913|FG000|Overall Study|Disease Progression|2|||
161208051|NCT02268045|582142914|FG001|Overall Study|Disease Progression|1|||
161208052|NCT02268045|582142913|FG000|Overall Study|Adverse Event|7|||
161208053|NCT02268045|582142914|FG001|Overall Study|Adverse Event|7|||
161208054|NCT02268045|582142913|FG000|Overall Study|Withdrawal by Subject|2|||
161208055|NCT02268045|582142914|FG001|Overall Study|Withdrawal by Subject|6|||
161208056|NCT02268045|582142913|FG000|Overall Study|Physician Decision|0|||
161208057|NCT02268045|582142914|FG001|Overall Study|Physician Decision|1|||
161208058|NCT02268045|582142913|FG000|Overall Study|Protocol Violation|1|||
161208059|NCT02268045|582142914|FG001|Overall Study|Protocol Violation|1|||
161208060|NCT00835068|582142915|FG000|Overall Study|Death|1|||
161208061|NCT00835068|582142916|FG001|Overall Study|Death|0|||
161208062|NCT00835068|582142915|FG000|Overall Study|Adverse Event|0|||
161208063|NCT00835068|582142916|FG001|Overall Study|Adverse Event|1|||
161208064|NCT00835068|582142915|FG000|Overall Study|Other|8|||
161208065|NCT00835068|582142916|FG001|Overall Study|Other|0|||
161208066|NCT00835068|582142915|FG000|Overall Study|Withdrawal by Subject|1|||
161208067|NCT00835068|582142916|FG001|Overall Study|Withdrawal by Subject|0|||
161208068|NCT01308762|582142917|FG000|Overall Study|Protocol Violation|0|||
161208069|NCT01308762|582142918|FG001|Overall Study|Protocol Violation|1|||
161208070|NCT01308762|582142919|FG002|Overall Study|Protocol Violation|0|||
161208071|NCT00646282|582142920|FG000|Overall Study|Protocol terminated|4|||
161208072|NCT00646282|582142921|FG001|Overall Study|Protocol terminated|4|||
161208073|NCT01556490|582142922|FG000|Randomized Patients Summary|Protocol Violation|22|||
161208074|NCT01556490|582142923|FG001|Randomized Patients Summary|Protocol Violation|23|||
161208075|NCT01556490|582142922|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
161208076|NCT01556490|582142923|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
161208077|NCT00530088|582142924|FG000|Overall Study|Disease Progression|4|||
161208078|NCT00530088|582142924|FG000|Overall Study|Physician Decision|4|||
161208079|NCT00530088|582142924|FG000|Overall Study|Other Not Specified|2|||
161208080|NCT02058368|582142929|FG000|Overall Study|Adverse Event|15|||
161208081|NCT02058368|582142930|FG001|Overall Study|Adverse Event|20|||
161208082|NCT02058368|582142929|FG000|Overall Study|Lack of Efficacy|0|||
161208083|NCT02058368|582142930|FG001|Overall Study|Lack of Efficacy|1|||
161208084|NCT02058368|582142929|FG000|Overall Study|Protocol Violation|0|||
161208085|NCT02058368|582142930|FG001|Overall Study|Protocol Violation|4|||
161208086|NCT02058368|582142929|FG000|Overall Study|Lost to Follow-up|2|||
161208087|NCT02058368|582142930|FG001|Overall Study|Lost to Follow-up|0|||
161208088|NCT02058368|582142929|FG000|Overall Study|Physician Decision|2|||
161208089|NCT02058368|582142930|FG001|Overall Study|Physician Decision|3|||
161208090|NCT02058368|582142929|FG000|Overall Study|Withdrawal by Subject|22|||
161208091|NCT02058368|582142930|FG001|Overall Study|Withdrawal by Subject|26|||
161208092|NCT02181842|582142931|FG000|Overall Study|Case Report Forms Uncollected|2|||
161208093|NCT01652872|582142932|FG000|Overall Study|Death|36|||
161208094|NCT01652872|582142933|FG001|Overall Study|Death|39|||
161208095|NCT01652872|582142932|FG000|Overall Study|Lost to Follow-up|28|||
161208096|NCT01652872|582142933|FG001|Overall Study|Lost to Follow-up|23|||
161208097|NCT01652872|582142932|FG000|Overall Study|Decision by sponsor|5|||
161208098|NCT01652872|582142933|FG001|Overall Study|Decision by sponsor|7|||
161208099|NCT01652872|582142932|FG000|Overall Study|Withdrawal by Subject|76|||
161208100|NCT01652872|582142933|FG001|Overall Study|Withdrawal by Subject|84|||
161208101|NCT00758706|582142934|FG000|Overall Study|Adverse Event|4|||
161208102|NCT00758706|582142935|FG001|Overall Study|Adverse Event|4|||
161208103|NCT02706353|582142949|FG000|Dose Level 1|Disease Progression|1|||
161208104|NCT02706353|582142950|FG001|Dose Level 1|Disease Progression|0|||
161208105|NCT02706353|582142951|FG002|Dose Level 1|Disease Progression|0|||
161208106|NCT02706353|582142952|FG003|Dose Level 1|Disease Progression|0|||
161208107|NCT02706353|582142953|FG004|Dose Level 1|Disease Progression|0|||
161208108|NCT02706353|582142954|FG005|Dose Level 1|Disease Progression|0|||
161208109|NCT02706353|582142949|FG000|Dose Level 3|Disease Progression|0|||
161208110|NCT02706353|582142950|FG001|Dose Level 3|Disease Progression|0|||
161208111|NCT02706353|582142951|FG002|Dose Level 3|Disease Progression|2|||
161208112|NCT02706353|582142952|FG003|Dose Level 3|Disease Progression|0|||
161208113|NCT02706353|582142953|FG004|Dose Level 3|Disease Progression|0|||
161208114|NCT02706353|582142954|FG005|Dose Level 3|Disease Progression|0|||
161208115|NCT02706353|582142949|FG000|Dose Level 4|Disease Progression|0|||
161208116|NCT02706353|582142950|FG001|Dose Level 4|Disease Progression|0|||
161208117|NCT02706353|582142951|FG002|Dose Level 4|Disease Progression|0|||
161208118|NCT02706353|582142952|FG003|Dose Level 4|Disease Progression|1|||
161208119|NCT02706353|582142953|FG004|Dose Level 4|Disease Progression|0|||
161208120|NCT02706353|582142954|FG005|Dose Level 4|Disease Progression|0|||
161208121|NCT02706353|582142949|FG000|Dose Level 4|Toxicity|0|||
161208122|NCT02706353|582142950|FG001|Dose Level 4|Toxicity|0|||
161208123|NCT02706353|582142951|FG002|Dose Level 4|Toxicity|0|||
161208124|NCT02706353|582142952|FG003|Dose Level 4|Toxicity|1|||
161208125|NCT02706353|582142953|FG004|Dose Level 4|Toxicity|0|||
161208126|NCT02706353|582142954|FG005|Dose Level 4|Toxicity|0|||
161208127|NCT02706353|582142949|FG000|Dose Level 4|Death|0|||
161208128|NCT02706353|582142950|FG001|Dose Level 4|Death|0|||
161208129|NCT02706353|582142951|FG002|Dose Level 4|Death|0|||
161208130|NCT02706353|582142952|FG003|Dose Level 4|Death|1|||
161208131|NCT02706353|582142953|FG004|Dose Level 4|Death|0|||
161208132|NCT02706353|582142954|FG005|Dose Level 4|Death|0|||
161208133|NCT02706353|582142949|FG000|Dose Level 5|Toxicity|0|||
161208134|NCT02706353|582142950|FG001|Dose Level 5|Toxicity|0|||
161208135|NCT02706353|582142951|FG002|Dose Level 5|Toxicity|0|||
161208136|NCT02706353|582142952|FG003|Dose Level 5|Toxicity|0|||
161208137|NCT02706353|582142953|FG004|Dose Level 5|Toxicity|1|||
161208138|NCT02706353|582142954|FG005|Dose Level 5|Toxicity|0|||
161208139|NCT02706353|582142949|FG000|Dose Level 5|Disease Progression|0|||
161208140|NCT02706353|582142950|FG001|Dose Level 5|Disease Progression|0|||
161208141|NCT02706353|582142951|FG002|Dose Level 5|Disease Progression|0|||
161208142|NCT02706353|582142952|FG003|Dose Level 5|Disease Progression|0|||
161208143|NCT02706353|582142953|FG004|Dose Level 5|Disease Progression|3|||
161208144|NCT02706353|582142954|FG005|Dose Level 5|Disease Progression|2|||
161208145|NCT02706353|582142949|FG000|Dose Level 5|Death|0|||
161208146|NCT02706353|582142950|FG001|Dose Level 5|Death|0|||
161208147|NCT02706353|582142951|FG002|Dose Level 5|Death|0|||
161208148|NCT02706353|582142952|FG003|Dose Level 5|Death|0|||
161208149|NCT02706353|582142953|FG004|Dose Level 5|Death|1|||
161208150|NCT02706353|582142954|FG005|Dose Level 5|Death|6|||
161208151|NCT02706353|582142949|FG000|Dose Level 5|Withdrawal by Subject|0|||
161208152|NCT02706353|582142950|FG001|Dose Level 5|Withdrawal by Subject|0|||
161208153|NCT02706353|582142951|FG002|Dose Level 5|Withdrawal by Subject|0|||
161208154|NCT02706353|582142952|FG003|Dose Level 5|Withdrawal by Subject|0|||
161208155|NCT02706353|582142953|FG004|Dose Level 5|Withdrawal by Subject|0|||
161208156|NCT02706353|582142954|FG005|Dose Level 5|Withdrawal by Subject|2|||
161208157|NCT01408576|582144395|FG000|Overall Study|Lack of Efficacy|17|||
161208158|NCT01408576|582144396|FG001|Overall Study|Lack of Efficacy|30|||
161208159|NCT01408576|582144397|FG002|Overall Study|Lack of Efficacy|48|||
161208160|NCT01408576|582144395|FG000|Overall Study|Protocol Violation|1|||
161208161|NCT01408576|582144396|FG001|Overall Study|Protocol Violation|2|||
161208162|NCT01408576|582144397|FG002|Overall Study|Protocol Violation|2|||
161208163|NCT01408576|582144395|FG000|Overall Study|Lost to Follow-up|10|||
161208164|NCT01408576|582144396|FG001|Overall Study|Lost to Follow-up|9|||
161208165|NCT01408576|582144397|FG002|Overall Study|Lost to Follow-up|17|||
161208166|NCT01408576|582144395|FG000|Overall Study|Withdrawal by Subject|34|||
161208167|NCT01408576|582144396|FG001|Overall Study|Withdrawal by Subject|60|||
161208168|NCT01408576|582144397|FG002|Overall Study|Withdrawal by Subject|66|||
161208169|NCT01408576|582144395|FG000|Overall Study|Sponsor terminated study|89|||
161208170|NCT01408576|582144396|FG001|Overall Study|Sponsor terminated study|333|||
161208171|NCT01408576|582144397|FG002|Overall Study|Sponsor terminated study|330|||
161208172|NCT01408576|582144395|FG000|Overall Study|AE, serious fatal|4|||
161208173|NCT01408576|582144396|FG001|Overall Study|AE, serious fatal|4|||
161208174|NCT01408576|582144397|FG002|Overall Study|AE, serious fatal|1|||
161208175|NCT01408576|582144395|FG000|Overall Study|SAE, non-fatal|11|||
161208176|NCT01408576|582144396|FG001|Overall Study|SAE, non-fatal|23|||
161208177|NCT01408576|582144397|FG002|Overall Study|SAE, non-fatal|14|||
161208178|NCT01408576|582144395|FG000|Overall Study|AE, non-serious non-fatal|12|||
161208179|NCT01408576|582144396|FG001|Overall Study|AE, non-serious non-fatal|19|||
161208180|NCT01408576|582144397|FG002|Overall Study|AE, non-serious non-fatal|11|||
161321490|NCT01705080|582562981|FG001|Overall Study|Missed visit|4|||
161321491|NCT01705080|582562982|FG002|Overall Study|Missed visit|1|||
161321492|NCT01705080|582562980|FG000|Overall Study|Death|4|||
161321493|NCT01705080|582562981|FG001|Overall Study|Death|4|||
161321494|NCT01705080|582562982|FG002|Overall Study|Death|6|||
161321495|NCT01705080|582562980|FG000|Overall Study|Withdrawal by Subject|61|||
161321496|NCT01705080|582562981|FG001|Overall Study|Withdrawal by Subject|44|||
161321497|NCT01705080|582562982|FG002|Overall Study|Withdrawal by Subject|9|||
161321498|NCT01704755|582562987|FG000|Overall Study|Adverse Event|4|||
161321499|NCT01704755|582562988|FG001|Overall Study|Adverse Event|1|||
161321500|NCT01704755|582562987|FG000|Overall Study|Lost to Follow-up|3|||
161321501|NCT01704755|582562988|FG001|Overall Study|Lost to Follow-up|4|||
161321502|NCT01704755|582562987|FG000|Overall Study|Withdrew consent|1|||
161321503|NCT01704755|582562988|FG001|Overall Study|Withdrew consent|1|||
161208181|NCT01408576|582144395|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161208182|NCT01408576|582144396|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161208183|NCT01408576|582144397|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161208184|NCT01408576|582144395|FG000|Overall Study|AE, unknown type|0|||
161208185|NCT01408576|582144396|FG001|Overall Study|AE, unknown type|1|||
161208186|NCT01408576|582144397|FG002|Overall Study|AE, unknown type|0|||
161208187|NCT01408576|582144395|FG000|Overall Study|Other|10|||
161208188|NCT01408576|582144396|FG001|Overall Study|Other|16|||
161208189|NCT01408576|582144397|FG002|Overall Study|Other|18|||
161208190|NCT02016755|582144398|FG000|Overall Study|Major amputation of index limb|2|||
161208191|NCT02016755|582144398|FG000|Overall Study|Adverse Event|2|||
161208192|NCT02016755|582144398|FG000|Overall Study|Physician Decision|1|||
161208193|NCT02016755|582144398|FG000|Overall Study|Death|2|||
161208194|NCT02476851|582144399|FG000|Overall Study|Protocol Violation|1|||
161208195|NCT02476851|582144400|FG001|Overall Study|Protocol Violation|1|||
161208196|NCT00647426|582144410|FG000|Overall Study|Withdrawal by Subject|2|||
161208197|NCT02360397|582144416|FG000|Overall Study|Incomplete screening|3|||
161208198|NCT02360397|582144416|FG000|Overall Study|Adverse Event|1|||
161208199|NCT03543046|582144423|FG000|Overall Study|Adverse Event|1|||
161208200|NCT03543046|582144424|FG001|Overall Study|Adverse Event|1|||
161208201|NCT03543046|582144423|FG000|Overall Study|Physician Decision|1|||
161208202|NCT03543046|582144424|FG001|Overall Study|Physician Decision|1|||
161208203|NCT03543046|582144423|FG000|Overall Study|Protocol Violation|1|||
161208204|NCT03543046|582144424|FG001|Overall Study|Protocol Violation|0|||
161208205|NCT02748616|582144432|FG000|Overall Study|Lost to Follow-up|1|||
161208206|NCT02748616|582144432|FG000|Overall Study|Withdrawal by Subject|2|||
161208207|NCT02748616|582144432|FG000|Overall Study|Physician Decision|2|||
161208208|NCT02748616|582144432|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
161208209|NCT00068406|582144435|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
161208210|NCT00068406|582144435|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
161208211|NCT02018042|582144439|FG000|Overall Study|Withdrawal by Subject|1|||
161208212|NCT00589693|582144440|FG000|Overall Study|randomized in error|12|||
161208213|NCT00589693|582144441|FG001|Overall Study|randomized in error|6|||
161208214|NCT00589693|582144440|FG000|Overall Study|Adverse Event|4|||
161208215|NCT00589693|582144441|FG001|Overall Study|Adverse Event|4|||
161208216|NCT00589693|582144440|FG000|Overall Study|Death|26|||
161208217|NCT00589693|582144441|FG001|Overall Study|Death|16|||
161208218|NCT00589693|582144440|FG000|Overall Study|Lack of Efficacy|0|||
161208219|NCT00589693|582144441|FG001|Overall Study|Lack of Efficacy|1|||
161208220|NCT00589693|582144440|FG000|Overall Study|Lost to Follow-up|1|||
161208221|NCT00589693|582144441|FG001|Overall Study|Lost to Follow-up|0|||
161208222|NCT00589693|582144440|FG000|Overall Study|Physician Decision|0|||
161208223|NCT00589693|582144441|FG001|Overall Study|Physician Decision|1|||
161208224|NCT00589693|582144440|FG000|Overall Study|Protocol Violation|1|||
161208225|NCT00589693|582144441|FG001|Overall Study|Protocol Violation|1|||
161208226|NCT03231709|582144442|FG000|Treatment Period 1|Reason not Specified|0|||
161208227|NCT03231709|582144443|FG001|Treatment Period 1|Reason not Specified|1|||
161208228|NCT03231709|582144442|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
161208229|NCT03231709|582144443|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
161208230|NCT02609178|582144444|FG000|First Crown|Withdrawal by Subject|0|||
161208231|NCT02609178|582144445|FG001|First Crown|Withdrawal by Subject|0|||
161208232|NCT02609178|582144446|FG002|First Crown|Withdrawal by Subject|1|||
161208233|NCT02609178|582144447|FG003|First Crown|Withdrawal by Subject|1|||
161208234|NCT02609178|582144448|FG004|First Crown|Withdrawal by Subject|0|||
161208235|NCT02609178|582144449|FG005|First Crown|Withdrawal by Subject|0|||
161208236|NCT02419469|582144450|FG000|Overall Study|Withdrawal by Subject|1|||
161208237|NCT01377233|582144451|FG000|Open-label|Adverse Event|1|||
161208238|NCT01377233|582144452|FG001|Open-label|Adverse Event|0|||
161208239|NCT01377233|582144453|FG002|Open-label|Adverse Event|0|||
161208240|NCT01377233|582144454|FG003|Open-label|Adverse Event|0|||
161208241|NCT01377233|582144455|FG004|Open-label|Adverse Event|0|||
161208242|NCT01377233|582144451|FG000|Open-label|Withdrawal by Subject|3|||
161208243|NCT01377233|582144452|FG001|Open-label|Withdrawal by Subject|0|||
161208244|NCT01377233|582144453|FG002|Open-label|Withdrawal by Subject|0|||
161208245|NCT01377233|582144454|FG003|Open-label|Withdrawal by Subject|0|||
161208246|NCT01377233|582144455|FG004|Open-label|Withdrawal by Subject|0|||
161208247|NCT01377233|582144451|FG000|Double-blind|Adverse Event|0|||
161208248|NCT01377233|582144452|FG001|Double-blind|Adverse Event|1|||
161208249|NCT01377233|582144453|FG002|Double-blind|Adverse Event|2|||
161208250|NCT01377233|582144454|FG003|Double-blind|Adverse Event|2|||
161208251|NCT01377233|582144455|FG004|Double-blind|Adverse Event|0|||
161208252|NCT01377233|582144451|FG000|Double-blind|Protocol Violation|0|||
161208253|NCT01377233|582144452|FG001|Double-blind|Protocol Violation|0|||
161208254|NCT01377233|582144453|FG002|Double-blind|Protocol Violation|0|||
161208255|NCT01377233|582144454|FG003|Double-blind|Protocol Violation|0|||
161208256|NCT01377233|582144455|FG004|Double-blind|Protocol Violation|1|||
161208257|NCT01377233|582144451|FG000|Double-blind|Withdrawal by Subject|0|||
161208258|NCT01377233|582144452|FG001|Double-blind|Withdrawal by Subject|0|||
161208259|NCT01377233|582144453|FG002|Double-blind|Withdrawal by Subject|0|||
161208260|NCT01377233|582144454|FG003|Double-blind|Withdrawal by Subject|1|||
161208261|NCT01377233|582144455|FG004|Double-blind|Withdrawal by Subject|0|||
161208262|NCT01377233|582144451|FG000|Double-blind|Administrative or other|0|||
161208263|NCT01377233|582144452|FG001|Double-blind|Administrative or other|0|||
161208264|NCT01377233|582144453|FG002|Double-blind|Administrative or other|0|||
161208265|NCT01377233|582144454|FG003|Double-blind|Administrative or other|1|||
161208266|NCT01377233|582144455|FG004|Double-blind|Administrative or other|1|||
161208267|NCT01785875|582144456|FG000|Overall Study|Withdrawal by Subject|41|||
161208268|NCT01785875|582144457|FG001|Overall Study|Withdrawal by Subject|34|||
161208269|NCT01785875|582144458|FG002|Overall Study|Withdrawal by Subject|36|||
161208270|NCT01785875|582144456|FG000|Overall Study|Lost to Follow-up|19|||
161208271|NCT01785875|582144457|FG001|Overall Study|Lost to Follow-up|22|||
161208272|NCT01785875|582144458|FG002|Overall Study|Lost to Follow-up|6|||
161208273|NCT01785875|582144456|FG000|Overall Study|Death|27|||
161208274|NCT01785875|582144457|FG001|Overall Study|Death|16|||
161208275|NCT01785875|582144458|FG002|Overall Study|Death|7|||
161321504|NCT01704755|582562987|FG000|Overall Study|Other (not specified)|3|||
161321505|NCT01704755|582562988|FG001|Overall Study|Other (not specified)|1|||
161321506|NCT01704755|582562987|FG000|Overall Study|Withdrew consent and personal issues|1|||
161321507|NCT01704755|582562988|FG001|Overall Study|Withdrew consent and personal issues|0|||
161321508|NCT02075008|582562995|FG000|Overall Study|Technical problems|1|||
161321509|NCT02075008|582562995|FG000|Overall Study|Pregnancy|1|||
161321510|NCT02075008|582562995|FG000|Overall Study|Physician Decision|1|||
161208276|NCT01785875|582144456|FG000|Overall Study|Sponsor Decision|0|||
161208277|NCT01785875|582144457|FG001|Overall Study|Sponsor Decision|2|||
161208278|NCT01785875|582144458|FG002|Overall Study|Sponsor Decision|0|||
161208279|NCT01785875|582144456|FG000|Overall Study|Protocol Specified Criteria|207|||
161208280|NCT01785875|582144457|FG001|Overall Study|Protocol Specified Criteria|214|||
161208281|NCT01785875|582144458|FG002|Overall Study|Protocol Specified Criteria|55|||
161208282|NCT01785875|582144456|FG000|Overall Study|Missing|0|||
161321511|NCT02075008|582562995|FG000|Overall Study|Lost to Follow-up|1|||
161321512|NCT02075008|582562995|FG000|Overall Study|Lack of Efficacy|1|||
161321513|NCT02075008|582562995|FG000|Overall Study|Death|1|||
161321514|NCT02075008|582562995|FG000|Overall Study|Adverse Event|5|||
161321515|NCT02075008|582562995|FG000|Overall Study|Withdrawal by Subject|6|||
161321516|NCT02075008|582562995|FG000|Overall Study|Study terminated by Sponsor|159|||
161321517|NCT03130959|582562996|FG000|Overall Study|Disease progression|19|||
161321518|NCT03130959|582562997|FG001|Overall Study|Disease progression|7|||
161208283|NCT01785875|582144457|FG001|Overall Study|Missing|1|||
161208284|NCT01785875|582144458|FG002|Overall Study|Missing|3|||
161208285|NCT01414062|582144461|FG000|Overall Study|Lost to Follow-up|3|||
161208286|NCT01414062|582144462|FG001|Overall Study|Lost to Follow-up|2|||
161208287|NCT01414062|582144461|FG000|Overall Study|Left Country|1|||
161208288|NCT01414062|582144462|FG001|Overall Study|Left Country|1|||
161208289|NCT01414062|582144461|FG000|Overall Study|Family Disapproval|1|||
161208290|NCT01414062|582144462|FG001|Overall Study|Family Disapproval|0|||
161208291|NCT01414062|582144461|FG000|Overall Study|Withdrawal by Subject|0|||
161321519|NCT03130959|582562998|FG002|Overall Study|Disease progression|12|||
161321520|NCT03130959|582562999|FG003|Overall Study|Disease progression|7|||
161321521|NCT03130959|582563000|FG004|Overall Study|Disease progression|12|||
161208292|NCT01414062|582144462|FG001|Overall Study|Withdrawal by Subject|1|||
161208293|NCT04075292|582144463|FG000|Overall Study|Withdrawal by Subject|1|||
161208294|NCT04075292|582144464|FG001|Overall Study|Withdrawal by Subject|9|||
161208295|NCT04075292|582144463|FG000|Overall Study|Death|2|||
161208296|NCT04075292|582144464|FG001|Overall Study|Death|5|||
161208297|NCT04075292|582144463|FG000|Overall Study|Remained on study at time of DCO|74|||
161208298|NCT04075292|582144464|FG001|Overall Study|Remained on study at time of DCO|64|||
161208299|NCT00902265|582144467|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
161208300|NCT00902265|582144467|FG000|Overall Study|Adverse Event|2|||
161208301|NCT00902265|582144467|FG000|Overall Study|Lack of Efficacy|2|||
161208302|NCT00902265|582144467|FG000|Overall Study|Protocol Violation|1|||
161208303|NCT02866695|582144469|FG000|Overall Study|Adverse Event|1|||
161321522|NCT03130959|582563001|FG005|Overall Study|Disease progression|3|||
161321523|NCT03130959|582563002|FG006|Overall Study|Disease progression|6|||
161321524|NCT03130959|582563003|FG007|Overall Study|Disease progression|3|||
161321525|NCT03130959|582563004|FG008|Overall Study|Disease progression|15|||
161321526|NCT03130959|582563005|FG009|Overall Study|Disease progression|8|||
161321527|NCT03130959|582562996|FG000|Overall Study|Study drug toxicity|2|||
161321528|NCT03130959|582562997|FG001|Overall Study|Study drug toxicity|2|||
161321529|NCT03130959|582562998|FG002|Overall Study|Study drug toxicity|1|||
161321530|NCT03130959|582562999|FG003|Overall Study|Study drug toxicity|2|||
161321531|NCT03130959|582563000|FG004|Overall Study|Study drug toxicity|1|||
161321532|NCT03130959|582563001|FG005|Overall Study|Study drug toxicity|1|||
161321533|NCT03130959|582563002|FG006|Overall Study|Study drug toxicity|3|||
161321534|NCT03130959|582563003|FG007|Overall Study|Study drug toxicity|0|||
161321535|NCT03130959|582563004|FG008|Overall Study|Study drug toxicity|3|||
161321536|NCT03130959|582563005|FG009|Overall Study|Study drug toxicity|3|||
161321537|NCT03130959|582562996|FG000|Overall Study|Other reasons|0|||
161321538|NCT03130959|582562997|FG001|Overall Study|Other reasons|0|||
161321539|NCT03130959|582562998|FG002|Overall Study|Other reasons|0|||
161321540|NCT03130959|582562999|FG003|Overall Study|Other reasons|0|||
161321541|NCT03130959|582563000|FG004|Overall Study|Other reasons|0|||
161321542|NCT03130959|582563001|FG005|Overall Study|Other reasons|1|||
161321543|NCT03130959|582563002|FG006|Overall Study|Other reasons|1|||
161321544|NCT03130959|582563003|FG007|Overall Study|Other reasons|0|||
161321545|NCT03130959|582563004|FG008|Overall Study|Other reasons|0|||
161321546|NCT03130959|582563005|FG009|Overall Study|Other reasons|0|||
161321547|NCT03130959|582562996|FG000|Overall Study|Subject request to discontinue therapy|0|||
161321548|NCT03130959|582562997|FG001|Overall Study|Subject request to discontinue therapy|0|||
160863942|NCT01235741|580896673|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
160863943|NCT01235741|580896671|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
160863944|NCT01235741|580896672|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
160863945|NCT01235741|580896673|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
160863946|NCT01124006|580896674|FG000|Overall Study|Withdrawal by Subject|2|||
160863947|NCT01124006|580896675|FG001|Overall Study|Withdrawal by Subject|2|||
160863948|NCT01124006|580896676|FG002|Overall Study|Withdrawal by Subject|0|||
161321549|NCT03130959|582562998|FG002|Overall Study|Subject request to discontinue therapy|1|||
160863949|NCT01124006|580896674|FG000|Overall Study|Lost to Follow-up|1|||
161321550|NCT03130959|582562999|FG003|Overall Study|Subject request to discontinue therapy|1|||
161321551|NCT03130959|582563000|FG004|Overall Study|Subject request to discontinue therapy|0|||
161321552|NCT03130959|582563001|FG005|Overall Study|Subject request to discontinue therapy|0|||
161321553|NCT03130959|582563002|FG006|Overall Study|Subject request to discontinue therapy|1|||
161321554|NCT03130959|582563003|FG007|Overall Study|Subject request to discontinue therapy|1|||
160863950|NCT01124006|580896675|FG001|Overall Study|Lost to Follow-up|0|||
161208304|NCT02866695|582144469|FG000|Overall Study|Lost to Follow-up|1|||
161321555|NCT03130959|582563004|FG008|Overall Study|Subject request to discontinue therapy|0|||
161321556|NCT03130959|582563005|FG009|Overall Study|Subject request to discontinue therapy|0|||
161321557|NCT03130959|582562996|FG000|Overall Study|Not reported|0|||
161321558|NCT03130959|582562997|FG001|Overall Study|Not reported|0|||
161321559|NCT03130959|582562998|FG002|Overall Study|Not reported|0|||
161321560|NCT03130959|582562999|FG003|Overall Study|Not reported|1|||
161321561|NCT03130959|582563000|FG004|Overall Study|Not reported|0|||
161321562|NCT03130959|582563001|FG005|Overall Study|Not reported|1|||
161321563|NCT03130959|582563002|FG006|Overall Study|Not reported|0|||
161321564|NCT03130959|582563003|FG007|Overall Study|Not reported|0|||
161321565|NCT03130959|582563004|FG008|Overall Study|Not reported|0|||
161321566|NCT03130959|582563005|FG009|Overall Study|Not reported|1|||
161321567|NCT03130959|582562996|FG000|Overall Study|Adverse Event unrelated to drug|0|||
161321568|NCT03130959|582562997|FG001|Overall Study|Adverse Event unrelated to drug|0|||
161321569|NCT03130959|582562998|FG002|Overall Study|Adverse Event unrelated to drug|1|||
161321570|NCT03130959|582562999|FG003|Overall Study|Adverse Event unrelated to drug|1|||
161321571|NCT03130959|582563000|FG004|Overall Study|Adverse Event unrelated to drug|1|||
161321572|NCT03130959|582563001|FG005|Overall Study|Adverse Event unrelated to drug|0|||
161321573|NCT03130959|582563002|FG006|Overall Study|Adverse Event unrelated to drug|1|||
161321574|NCT03130959|582563003|FG007|Overall Study|Adverse Event unrelated to drug|0|||
161321575|NCT03130959|582563004|FG008|Overall Study|Adverse Event unrelated to drug|1|||
161321576|NCT03130959|582563005|FG009|Overall Study|Adverse Event unrelated to drug|1|||
161321577|NCT03130959|582562996|FG000|Overall Study|Participant withdrew consent|0|||
161321578|NCT03130959|582562997|FG001|Overall Study|Participant withdrew consent|1|||
161321579|NCT03130959|582562998|FG002|Overall Study|Participant withdrew consent|0|||
161321580|NCT03130959|582562999|FG003|Overall Study|Participant withdrew consent|2|||
161321581|NCT03130959|582563000|FG004|Overall Study|Participant withdrew consent|1|||
161321582|NCT03130959|582563001|FG005|Overall Study|Participant withdrew consent|0|||
161321583|NCT03130959|582563002|FG006|Overall Study|Participant withdrew consent|0|||
161321584|NCT03130959|582563003|FG007|Overall Study|Participant withdrew consent|0|||
161321585|NCT03130959|582563004|FG008|Overall Study|Participant withdrew consent|0|||
161321586|NCT03130959|582563005|FG009|Overall Study|Participant withdrew consent|2|||
161321587|NCT03130959|582562996|FG000|Overall Study|Administrative reason by sponsor|1|||
161321588|NCT03130959|582562997|FG001|Overall Study|Administrative reason by sponsor|0|||
161321589|NCT03130959|582562998|FG002|Overall Study|Administrative reason by sponsor|1|||
161321590|NCT03130959|582562999|FG003|Overall Study|Administrative reason by sponsor|0|||
160863951|NCT01124006|580896676|FG002|Overall Study|Lost to Follow-up|1|||
161321591|NCT03130959|582563000|FG004|Overall Study|Administrative reason by sponsor|0|||
161321592|NCT03130959|582563001|FG005|Overall Study|Administrative reason by sponsor|0|||
161321593|NCT03130959|582563002|FG006|Overall Study|Administrative reason by sponsor|0|||
161321594|NCT03130959|582563003|FG007|Overall Study|Administrative reason by sponsor|0|||
161321595|NCT03130959|582563004|FG008|Overall Study|Administrative reason by sponsor|0|||
161321596|NCT03130959|582563005|FG009|Overall Study|Administrative reason by sponsor|0|||
161321597|NCT03130959|582562996|FG000|Overall Study|Lost to Follow-up|1|||
161321598|NCT03130959|582562997|FG001|Overall Study|Lost to Follow-up|0|||
161321599|NCT03130959|582562998|FG002|Overall Study|Lost to Follow-up|0|||
161321600|NCT03130959|582562999|FG003|Overall Study|Lost to Follow-up|0|||
161321601|NCT03130959|582563000|FG004|Overall Study|Lost to Follow-up|0|||
161321602|NCT03130959|582563001|FG005|Overall Study|Lost to Follow-up|0|||
161321603|NCT03130959|582563002|FG006|Overall Study|Lost to Follow-up|0|||
161321604|NCT03130959|582563003|FG007|Overall Study|Lost to Follow-up|0|||
161321605|NCT03130959|582563004|FG008|Overall Study|Lost to Follow-up|0|||
161321606|NCT03130959|582563005|FG009|Overall Study|Lost to Follow-up|0|||
161321607|NCT02821416|582563006|FG000|Overall Study|Adverse Event|0|||
161321608|NCT02821416|582563007|FG001|Overall Study|Adverse Event|1|||
161321609|NCT02821416|582563006|FG000|Overall Study|Withdrawal by Subject|2|||
161321610|NCT02821416|582563007|FG001|Overall Study|Withdrawal by Subject|0|||
161321611|NCT02821416|582563006|FG000|Overall Study|Lost to Follow-up|1|||
161321612|NCT02821416|582563007|FG001|Overall Study|Lost to Follow-up|0|||
161321613|NCT01763203|582563014|FG000|Overall Study|Death|4|||
161321614|NCT01763203|582563015|FG001|Overall Study|Death|7|||
161321615|NCT01763203|582563014|FG000|Overall Study|Lost to Follow-up|12|||
161321616|NCT01763203|582563015|FG001|Overall Study|Lost to Follow-up|12|||
161321617|NCT01763203|582563014|FG000|Overall Study|Withdrawal by Subject|8|||
161321618|NCT01763203|582563015|FG001|Overall Study|Withdrawal by Subject|12|||
161321619|NCT01763203|582563014|FG000|Overall Study|Moved out of study region|7|||
161321620|NCT01763203|582563015|FG001|Overall Study|Moved out of study region|10|||
161321621|NCT01763203|582563014|FG000|Overall Study|Physician Decision|2|||
161321622|NCT01763203|582563015|FG001|Overall Study|Physician Decision|1|||
161321623|NCT02256917|582563016|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
161321624|NCT02256917|582563016|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
161321625|NCT02256917|582563016|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
160863952|NCT01124006|580896674|FG000|Overall Study|Other|0|||
160978095|NCT00786474|581310162|FG001|Overall Study|Death|4|||
160863953|NCT01124006|580896675|FG001|Overall Study|Other|0|||
160863954|NCT01124006|580896676|FG002|Overall Study|Other|1|||
160863955|NCT01712399|580896679|FG000|Overall Study|Lost to Follow-up|1|||
161321626|NCT02256917|582563016|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
161321627|NCT02256917|582563016|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
161321628|NCT02933528|582563017|FG000|Overall Study|Lost to Follow-up|2|||
161321629|NCT01639703|582563018|FG000|Overall Study|Withdrawal by Subject|5|||
161321630|NCT01639703|582563018|FG000|Overall Study|Other reason|7|||
161321631|NCT03076996|582563019|FG000|Overall Study|Withdrawal by Subject|2|||
161321632|NCT03076996|582563019|FG000|Overall Study|Lost to Follow-up|3|||
161321633|NCT03076996|582563019|FG000|Overall Study|Literacy precluded participation|1|||
161321634|NCT02438280|582563021|FG000|Overall Study|Physician Decision|1|||
161321635|NCT02438280|582563022|FG001|Overall Study|Physician Decision|0|||
161321636|NCT01753115|582563023|FG000|Overall Study|Lost to Follow-up|3|||
161321637|NCT01753115|582563024|FG001|Overall Study|Lost to Follow-up|6|||
161321638|NCT01753115|582563025|FG002|Overall Study|Lost to Follow-up|8|||
161321639|NCT01753115|582563023|FG000|Overall Study|Withdrawal by Subject|6|||
161321640|NCT01753115|582563024|FG001|Overall Study|Withdrawal by Subject|5|||
161321641|NCT01753115|582563025|FG002|Overall Study|Withdrawal by Subject|6|||
161321642|NCT01753115|582563023|FG000|Overall Study|Subject non-compliant|3|||
161321643|NCT01753115|582563024|FG001|Overall Study|Subject non-compliant|3|||
161321644|NCT01753115|582563025|FG002|Overall Study|Subject non-compliant|0|||
161321645|NCT01753115|582563023|FG000|Overall Study|Used excluded drug|0|||
161321646|NCT01753115|582563024|FG001|Overall Study|Used excluded drug|1|||
161321647|NCT01753115|582563025|FG002|Overall Study|Used excluded drug|0|||
161321648|NCT02782377|582563033|FG000|Overall Study|Physician Decision|5|||
161321649|NCT02521792|582563034|FG000|Overall Study|Study Terminated|6|||
161321650|NCT01188668|582563035|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
161321651|NCT01188668|582563035|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
161321652|NCT01188668|582563035|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
161321653|NCT00902746|582563036|FG000|Overall Study|Protocol Violation|7|||
161321654|NCT00902746|582563036|FG000|Overall Study|Withdrawal by Subject|16|||
161321655|NCT00902746|582563036|FG000|Overall Study|Adverse Event|8|||
161321656|NCT00902746|582563036|FG000|Overall Study|Lost to Follow-up|3|||
161321657|NCT00902746|582563036|FG000|Overall Study|Physician Decision|2|||
161321658|NCT02081001|582563038|FG000|Overall Study|Adverse Event|0|||
161321659|NCT02081001|582563039|FG001|Overall Study|Adverse Event|0|||
161321660|NCT02081001|582563040|FG002|Overall Study|Adverse Event|0|||
161321661|NCT02081001|582563041|FG003|Overall Study|Adverse Event|0|||
161321662|NCT02081001|582563042|FG004|Overall Study|Adverse Event|1|||
161321663|NCT02081001|582563043|FG005|Overall Study|Adverse Event|0|||
161321664|NCT02081001|582563044|FG006|Overall Study|Adverse Event|0|||
161321665|NCT02081001|582563045|FG007|Overall Study|Adverse Event|0|||
161321666|NCT02081001|582563046|FG008|Overall Study|Adverse Event|0|||
161321667|NCT02081001|582563047|FG009|Overall Study|Adverse Event|0|||
161321668|NCT02081001|582563048|FG010|Overall Study|Adverse Event|0|||
161321669|NCT02081001|582563049|FG011|Overall Study|Adverse Event|0|||
161321670|NCT02937636|582563054|FG000|Overall Study|Other (Not specified)|3|||
161321671|NCT02937636|582563055|FG001|Overall Study|Other (Not specified)|2|||
161321672|NCT00359294|582563056|FG000|Overall Study|Progressive disease|1|||
161321673|NCT00359294|582563057|FG001|Overall Study|Progressive disease|1|||
161321674|NCT00359294|582563058|FG002|Overall Study|Progressive disease|2|||
161321675|NCT00359294|582563059|FG003|Overall Study|Progressive disease|3|||
161321676|NCT00359294|582563060|FG004|Overall Study|Progressive disease|2|||
161321677|NCT00359294|582563056|FG000|Overall Study|Withdrawal by Subject|0|||
161321678|NCT00359294|582563057|FG001|Overall Study|Withdrawal by Subject|0|||
161321679|NCT00359294|582563058|FG002|Overall Study|Withdrawal by Subject|0|||
161321680|NCT00359294|582563059|FG003|Overall Study|Withdrawal by Subject|0|||
161321681|NCT00359294|582563060|FG004|Overall Study|Withdrawal by Subject|1|||
161321682|NCT00359294|582563056|FG000|Overall Study|Not treated|0|||
161321683|NCT00359294|582563057|FG001|Overall Study|Not treated|0|||
161321684|NCT00359294|582563058|FG002|Overall Study|Not treated|0|||
161321685|NCT00359294|582563059|FG003|Overall Study|Not treated|1|||
161321686|NCT00359294|582563060|FG004|Overall Study|Not treated|0|||
161321687|NCT00359294|582563056|FG000|Overall Study|Physician Decision|0|||
161321688|NCT00359294|582563057|FG001|Overall Study|Physician Decision|0|||
161321689|NCT00359294|582563058|FG002|Overall Study|Physician Decision|1|||
161321690|NCT00359294|582563059|FG003|Overall Study|Physician Decision|0|||
161321691|NCT00359294|582563060|FG004|Overall Study|Physician Decision|0|||
161321692|NCT04208412|582563063|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
161321693|NCT04208412|582563064|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
161321694|NCT04208412|582563063|FG000|Overall Study|Withdrawal by Subject|1|||
161321695|NCT04208412|582563064|FG001|Overall Study|Withdrawal by Subject|0|||
161321696|NCT04208412|582563063|FG000|Overall Study|Lost to Follow-up|0|||
161321697|NCT04208412|582563064|FG001|Overall Study|Lost to Follow-up|1|||
161321698|NCT03882957|582563065|FG000|Overall Study|Did not complete all three arms|1|||
161321699|NCT03762681|582563069|FG000|Part 1|Withdrawal by Subject|0|||
161321700|NCT03762681|582563070|FG001|Part 1|Withdrawal by Subject|0|||
161321701|NCT03762681|582563071|FG002|Part 1|Withdrawal by Subject|0|||
161321702|NCT03762681|582563072|FG003|Part 1|Withdrawal by Subject|1|||
161321703|NCT03762681|582563073|FG004|Part 1|Withdrawal by Subject|0|||
161321704|NCT03762681|582563074|FG005|Part 1|Withdrawal by Subject|0|||
161321705|NCT03762681|582563075|FG006|Part 1|Withdrawal by Subject|0|||
161321706|NCT03762681|582563076|FG007|Part 1|Withdrawal by Subject|0|||
161321707|NCT03762681|582563069|FG000|Part 2a|Pandemic Travel Restrictions|0|||
161321708|NCT03762681|582563070|FG001|Part 2a|Pandemic Travel Restrictions|0|||
161321709|NCT03762681|582563071|FG002|Part 2a|Pandemic Travel Restrictions|0|||
161321710|NCT03762681|582563072|FG003|Part 2a|Pandemic Travel Restrictions|0|||
161321711|NCT03762681|582563073|FG004|Part 2a|Pandemic Travel Restrictions|0|||
161321712|NCT03762681|582563074|FG005|Part 2a|Pandemic Travel Restrictions|0|||
161321713|NCT03762681|582563075|FG006|Part 2a|Pandemic Travel Restrictions|0|||
161321714|NCT03762681|582563076|FG007|Part 2a|Pandemic Travel Restrictions|1|||
161321715|NCT03148067|582563077|FG000|Overall Study|Lost to Follow-up|3|||
161321716|NCT03148067|582563077|FG000|Overall Study|Death|1|||
161321717|NCT00435188|582563082|FG000|Overall Study|Death|1|||
161321718|NCT00435188|582563083|FG001|Overall Study|Death|6|||
161321719|NCT00435188|582563082|FG000|Overall Study|Withdrawal by Subject|16|||
161321720|NCT00435188|582563083|FG001|Overall Study|Withdrawal by Subject|11|||
161321721|NCT00435188|582563082|FG000|Overall Study|Lost to Follow-up|5|||
161321722|NCT00435188|582563083|FG001|Overall Study|Lost to Follow-up|6|||
161321723|NCT01915771|582563084|FG000|Day 1|Withdrawal by Subject|1|||
161321724|NCT01915771|582563084|FG000|Day 15|Withdrawal by Subject|1|||
161321725|NCT02912455|582563085|FG000|Overall Study|Withdrawal by Subject|0|||
161321726|NCT02912455|582563086|FG001|Overall Study|Withdrawal by Subject|1|||
161321727|NCT02912455|582563085|FG000|Overall Study|Lack of Efficacy|0|||
161321728|NCT02912455|582563086|FG001|Overall Study|Lack of Efficacy|1|||
161321729|NCT02912455|582563085|FG000|Overall Study|Lost to Follow-up|2|||
161321730|NCT02912455|582563086|FG001|Overall Study|Lost to Follow-up|1|||
161321731|NCT02501161|582566346|FG000|Overall Study|Adverse Event|2|||
161321732|NCT02501161|582566347|FG001|Overall Study|Adverse Event|6|||
161321733|NCT02501161|582566346|FG000|Overall Study|Lost to Follow-up|7|||
161321734|NCT02501161|582566347|FG001|Overall Study|Lost to Follow-up|4|||
161321735|NCT02501161|582566346|FG000|Overall Study|Withdrawal by Subject|10|||
161321736|NCT02501161|582566347|FG001|Overall Study|Withdrawal by Subject|15|||
161321737|NCT02501161|582566346|FG000|Overall Study|Other|3|||
161321738|NCT02501161|582566347|FG001|Overall Study|Other|0|||
161321739|NCT04336475|582566348|FG000|Overall Study|pain|1|||
161321740|NCT04336475|582566349|FG001|Overall Study|pain|0|||
161321741|NCT04336475|582566348|FG000|Overall Study|upper respiratory infection|1|||
161321742|NCT04336475|582566349|FG001|Overall Study|upper respiratory infection|0|||
161321743|NCT04336475|582566348|FG000|Overall Study|Lost to Follow-up|0|||
161321744|NCT04336475|582566349|FG001|Overall Study|Lost to Follow-up|2|||
161321745|NCT02030119|582566352|FG000|Overall Study|Withdrawal by Subject|3|||
161321746|NCT02030119|582566353|FG001|Overall Study|Withdrawal by Subject|1|||
161321747|NCT02030119|582566354|FG002|Overall Study|Withdrawal by Subject|5|||
161321748|NCT02030119|582566355|FG003|Overall Study|Withdrawal by Subject|3|||
161321749|NCT02030119|582566352|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
161321750|NCT02030119|582566353|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
161321751|NCT02030119|582566354|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
161321752|NCT02030119|582566355|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
161321753|NCT02213380|582566361|FG000|Underwent Randomization|Withdrawal by Subject|2|||
161321754|NCT02213380|582566362|FG001|Underwent Randomization|Withdrawal by Subject|0|||
161321755|NCT02213380|582566361|FG000|Underwent Randomization|Not treated|3|||
161321756|NCT02213380|582566362|FG001|Underwent Randomization|Not treated|3|||
161321757|NCT02213380|582566361|FG000|Per-protocol Analysis|Protocol Violation|32|||
161321758|NCT02213380|582566362|FG001|Per-protocol Analysis|Protocol Violation|36|||
161321759|NCT01465230|582566370|FG000|Overall Study|Withdrawal by Subject|2|||
161321760|NCT00905567|582566371|FG000|Washout|Withdrawal by Subject|0|||
161321761|NCT00905567|582566372|FG001|Washout|Withdrawal by Subject|1|||
161321762|NCT01738919|582566374|FG000|Overall Study|Lost to Follow-up|1|||
161321763|NCT01738919|582566375|FG001|Overall Study|Lost to Follow-up|0|||
161321764|NCT01738919|582566374|FG000|Overall Study|Immigrated|0|||
160863956|NCT01712399|580896679|FG000|Overall Study|Withdrawal by Subject|39|||
161321765|NCT01738919|582566375|FG001|Overall Study|Immigrated|1|||
161321766|NCT01738919|582566374|FG000|Overall Study|Withdrawal by Subject|0|||
161321767|NCT01738919|582566375|FG001|Overall Study|Withdrawal by Subject|1|||
161321768|NCT01738919|582566374|FG000|Overall Study|Not treated in accordance to guidelines|0|||
161321769|NCT01738919|582566375|FG001|Overall Study|Not treated in accordance to guidelines|1|||
161321770|NCT02532257|582566376|FG000|Overall Study|Adverse Event|2|||
161321771|NCT02532257|582566376|FG000|Overall Study|Physician Decision|4|||
161321772|NCT02532257|582566376|FG000|Overall Study|Withdrawal by Subject|3|||
161321773|NCT02532257|582566376|FG000|Overall Study|Progressive Disease|10|||
161321774|NCT02259400|582566377|FG000|Overall Study|Death|0|||
161321775|NCT02259400|582566378|FG001|Overall Study|Death|2|||
161321776|NCT03498313|582566382|FG000|Experimental Period 1|Adverse Event|1|||
161321777|NCT03498313|582566383|FG001|Experimental Period 1|Adverse Event|0|||
160863957|NCT01712399|580896679|FG000|Overall Study|Death|1|||
160863958|NCT01712399|580896679|FG000|Overall Study|Adverse Event|11|||
161321778|NCT03498313|582566384|FG002|Experimental Period 1|Adverse Event|0|||
161321779|NCT03498313|582566385|FG003|Experimental Period 1|Adverse Event|1|||
161321780|NCT03498313|582566386|FG004|Experimental Period 1|Adverse Event|0|||
161321781|NCT03498313|582566387|FG005|Experimental Period 1|Adverse Event|0|||
161321782|NCT03498313|582566382|FG000|Experimental Period 1|Withdrawal by Subject|0|||
161321783|NCT03498313|582566383|FG001|Experimental Period 1|Withdrawal by Subject|1|||
161321784|NCT03498313|582566384|FG002|Experimental Period 1|Withdrawal by Subject|0|||
160863959|NCT01712399|580896679|FG000|Overall Study|Study closure|345|||
160978096|NCT00786474|581310161|FG000|Overall Study|Withdrawal by Subject|23|||
161321785|NCT03498313|582566385|FG003|Experimental Period 1|Withdrawal by Subject|0|||
161321786|NCT03498313|582566386|FG004|Experimental Period 1|Withdrawal by Subject|0|||
161321787|NCT03498313|582566387|FG005|Experimental Period 1|Withdrawal by Subject|0|||
161321788|NCT03498313|582566382|FG000|Washout Period 1|Anovulation|1|||
161321789|NCT03498313|582566383|FG001|Washout Period 1|Anovulation|0|||
161321790|NCT03498313|582566384|FG002|Washout Period 1|Anovulation|0|||
161321791|NCT03498313|582566385|FG003|Washout Period 1|Anovulation|0|||
161321792|NCT03498313|582566386|FG004|Washout Period 1|Anovulation|0|||
161321793|NCT03498313|582566387|FG005|Washout Period 1|Anovulation|0|||
161321794|NCT03498313|582566382|FG000|Washout Period 1|Withdrawal by Subject|0|||
161321795|NCT03498313|582566383|FG001|Washout Period 1|Withdrawal by Subject|3|||
161321796|NCT03498313|582566384|FG002|Washout Period 1|Withdrawal by Subject|0|||
161321797|NCT03498313|582566385|FG003|Washout Period 1|Withdrawal by Subject|1|||
161321798|NCT03498313|582566386|FG004|Washout Period 1|Withdrawal by Subject|0|||
161321799|NCT03498313|582566387|FG005|Washout Period 1|Withdrawal by Subject|1|||
161321800|NCT03498313|582566382|FG000|Experimental Period 2|Adverse Event|0|||
161321801|NCT03498313|582566383|FG001|Experimental Period 2|Adverse Event|0|||
161321802|NCT03498313|582566384|FG002|Experimental Period 2|Adverse Event|0|||
161321803|NCT03498313|582566385|FG003|Experimental Period 2|Adverse Event|0|||
161321804|NCT03498313|582566386|FG004|Experimental Period 2|Adverse Event|1|||
161321805|NCT03498313|582566387|FG005|Experimental Period 2|Adverse Event|2|||
161321806|NCT03498313|582566382|FG000|Washout Period 2|Physician Decision|1|||
161321807|NCT03498313|582566383|FG001|Washout Period 2|Physician Decision|0|||
161321808|NCT03498313|582566384|FG002|Washout Period 2|Physician Decision|0|||
161321809|NCT03498313|582566385|FG003|Washout Period 2|Physician Decision|1|||
161321810|NCT03498313|582566386|FG004|Washout Period 2|Physician Decision|0|||
161321811|NCT03498313|582566387|FG005|Washout Period 2|Physician Decision|1|||
161321812|NCT03498313|582566382|FG000|Washout Period 2|Withdrawal by Subject|3|||
161321813|NCT03498313|582566383|FG001|Washout Period 2|Withdrawal by Subject|2|||
161321814|NCT03498313|582566384|FG002|Washout Period 2|Withdrawal by Subject|0|||
161321815|NCT03498313|582566385|FG003|Washout Period 2|Withdrawal by Subject|0|||
161321816|NCT03498313|582566386|FG004|Washout Period 2|Withdrawal by Subject|2|||
161321817|NCT03498313|582566387|FG005|Washout Period 2|Withdrawal by Subject|0|||
161321818|NCT03498313|582566382|FG000|Washout Period 2|Anovulation|0|||
161321819|NCT03498313|582566383|FG001|Washout Period 2|Anovulation|0|||
161321820|NCT03498313|582566384|FG002|Washout Period 2|Anovulation|0|||
161321821|NCT03498313|582566385|FG003|Washout Period 2|Anovulation|0|||
161321822|NCT03498313|582566386|FG004|Washout Period 2|Anovulation|0|||
161321823|NCT03498313|582566387|FG005|Washout Period 2|Anovulation|1|||
161321824|NCT02372383|582566391|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
161321825|NCT02372383|582566392|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
161321826|NCT02372383|582566393|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
161321827|NCT00621257|582566394|FG000|Overall Study|Lost to Follow-up|4|||
161321828|NCT00621257|582566395|FG001|Overall Study|Lost to Follow-up|0|||
161321829|NCT00621257|582566396|FG002|Overall Study|Lost to Follow-up|2|||
161321830|NCT00621257|582566397|FG003|Overall Study|Lost to Follow-up|4|||
161321831|NCT00621257|582566398|FG004|Overall Study|Lost to Follow-up|7|||
161321832|NCT00621257|582566394|FG000|Overall Study|Adverse Event|0|||
161321833|NCT00621257|582566395|FG001|Overall Study|Adverse Event|1|||
161321834|NCT00621257|582566396|FG002|Overall Study|Adverse Event|1|||
161321835|NCT00621257|582566397|FG003|Overall Study|Adverse Event|0|||
161321836|NCT00621257|582566398|FG004|Overall Study|Adverse Event|0|||
161321837|NCT00621257|582566394|FG000|Overall Study|Physician Decision|0|||
161321838|NCT00621257|582566395|FG001|Overall Study|Physician Decision|2|||
160978097|NCT00786474|581310162|FG001|Overall Study|Withdrawal by Subject|31|||
160978098|NCT00786474|581310161|FG000|Overall Study|Lost to Follow-up|3|||
161321839|NCT00621257|582566396|FG002|Overall Study|Physician Decision|0|||
161321840|NCT00621257|582566397|FG003|Overall Study|Physician Decision|1|||
161321841|NCT00621257|582566398|FG004|Overall Study|Physician Decision|1|||
161321842|NCT00621257|582566394|FG000|Overall Study|Withdrawal by Subject|0|||
161321843|NCT00621257|582566395|FG001|Overall Study|Withdrawal by Subject|0|||
161321844|NCT00621257|582566396|FG002|Overall Study|Withdrawal by Subject|0|||
161321845|NCT00621257|582566397|FG003|Overall Study|Withdrawal by Subject|1|||
161321846|NCT00621257|582566398|FG004|Overall Study|Withdrawal by Subject|1|||
161321847|NCT01255904|582566399|FG000|Overall Study|Physician Decision|1|||
161321848|NCT01255904|582566400|FG001|Overall Study|Physician Decision|4|||
161321849|NCT02756819|582566401|FG000|Overall Study|Lost for observation|23|||
161321850|NCT02756819|582566401|FG000|Overall Study|Patient's unwillingness|16|||
161321851|NCT02756819|582566401|FG000|Overall Study|Insufficient efficacy|2|||
161321852|NCT02756819|582566401|FG000|Overall Study|Adverse Event|2|||
161321853|NCT02756819|582566401|FG000|Overall Study|Reason not Specified|9|||
161321854|NCT00741598|582566402|FG000|Overall Study|Lost to Follow-up|3|||
161321855|NCT00741598|582566403|FG001|Overall Study|Lost to Follow-up|4|||
161321856|NCT00741598|582566402|FG000|Overall Study|Lack of Efficacy|1|||
161321857|NCT00741598|582566403|FG001|Overall Study|Lack of Efficacy|2|||
161321858|NCT00741598|582566402|FG000|Overall Study|Physician Decision|1|||
161321859|NCT00741598|582566403|FG001|Overall Study|Physician Decision|1|||
161321860|NCT00741598|582566402|FG000|Overall Study|Pregnancy|1|||
161321861|NCT00741598|582566403|FG001|Overall Study|Pregnancy|0|||
161321862|NCT00741598|582566402|FG000|Overall Study|Withdrawal by Subject|3|||
161321863|NCT00741598|582566403|FG001|Overall Study|Withdrawal by Subject|2|||
161321864|NCT01247350|582566404|FG000|Overall Study|Adverse Event|0|||
161321865|NCT01247350|582566405|FG001|Overall Study|Adverse Event|0|||
161321866|NCT01247350|582566406|FG002|Overall Study|Adverse Event|1|||
161321867|NCT01247350|582566407|FG003|Overall Study|Adverse Event|0|||
161321868|NCT01247350|582566408|FG004|Overall Study|Adverse Event|0|||
161321869|NCT01247350|582566404|FG000|Overall Study|Withdrawal by Subject|0|||
161321870|NCT01247350|582566405|FG001|Overall Study|Withdrawal by Subject|0|||
161321871|NCT01247350|582566406|FG002|Overall Study|Withdrawal by Subject|0|||
161321872|NCT01247350|582566407|FG003|Overall Study|Withdrawal by Subject|1|||
161321873|NCT01247350|582566408|FG004|Overall Study|Withdrawal by Subject|0|||
161321874|NCT01247350|582566404|FG000|Overall Study|Entry criteria not met|0|||
161321875|NCT01247350|582566405|FG001|Overall Study|Entry criteria not met|0|||
161321876|NCT01247350|582566406|FG002|Overall Study|Entry criteria not met|0|||
161321877|NCT01247350|582566407|FG003|Overall Study|Entry criteria not met|0|||
161321878|NCT01247350|582566408|FG004|Overall Study|Entry criteria not met|1|||
161321879|NCT00169104|582566409|FG000|Overall Study|Withdrawal by Subject|2|||
161321880|NCT00169104|582566410|FG001|Overall Study|Withdrawal by Subject|0|||
161321881|NCT00169104|582566409|FG000|Overall Study|Protocol Violation|0|||
161321882|NCT00169104|582566410|FG001|Overall Study|Protocol Violation|1|||
161321883|NCT00169104|582566409|FG000|Overall Study|Physician Decision|0|||
161321884|NCT00169104|582566410|FG001|Overall Study|Physician Decision|1|||
161321885|NCT01540981|582566411|FG000|Overall Study|Withdrawal by Subject|1|||
161321886|NCT01540981|582566412|FG001|Overall Study|Withdrawal by Subject|0|||
161321887|NCT02328937|582566415|FG000|Period 1|Lost to Follow-up|0|||
161321888|NCT02328937|582566416|FG001|Period 1|Lost to Follow-up|0|||
161321889|NCT02328937|582566417|FG002|Period 1|Lost to Follow-up|0|||
161321890|NCT02328937|582566418|FG003|Period 1|Lost to Follow-up|1|||
161321891|NCT02328937|582566419|FG004|Period 1|Lost to Follow-up|0|||
161321892|NCT02328937|582566420|FG005|Period 1|Lost to Follow-up|0|||
161321893|NCT02328937|582566415|FG000|Period 2|Adverse Event|0|||
161321894|NCT02328937|582566416|FG001|Period 2|Adverse Event|0|||
161321895|NCT02328937|582566417|FG002|Period 2|Adverse Event|1|||
161321896|NCT02328937|582566418|FG003|Period 2|Adverse Event|0|||
161321897|NCT02328937|582566419|FG004|Period 2|Adverse Event|0|||
161321898|NCT02328937|582566420|FG005|Period 2|Adverse Event|0|||
161321899|NCT00435461|582566425|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
161321900|NCT00435461|582566426|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
161321901|NCT00435461|582566427|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
161321902|NCT00435461|582566425|FG000|Overall Study|Protocol Violation|6|||
161321903|NCT00435461|582566426|FG001|Overall Study|Protocol Violation|9|||
161321904|NCT00435461|582566427|FG002|Overall Study|Protocol Violation|10|||
161321905|NCT00435461|582566425|FG000|Overall Study|Participant randomized(inadequate score)|1|||
161321906|NCT00435461|582566426|FG001|Overall Study|Participant randomized(inadequate score)|0|||
161321907|NCT00435461|582566427|FG002|Overall Study|Participant randomized(inadequate score)|0|||
161321908|NCT00435461|582566425|FG000|Overall Study|Compliance less than 80 percent|1|||
161321909|NCT00435461|582566426|FG001|Overall Study|Compliance less than 80 percent|0|||
161321910|NCT00435461|582566427|FG002|Overall Study|Compliance less than 80 percent|0|||
161321911|NCT00435461|582566425|FG000|Overall Study|In error, two study medications switched|1|||
161321912|NCT00435461|582566426|FG001|Overall Study|In error, two study medications switched|0|||
161321913|NCT00435461|582566427|FG002|Overall Study|In error, two study medications switched|0|||
161321914|NCT00435461|582566425|FG000|Overall Study|Lack of Efficacy|2|||
161321915|NCT00435461|582566426|FG001|Overall Study|Lack of Efficacy|1|||
161321916|NCT00435461|582566427|FG002|Overall Study|Lack of Efficacy|0|||
161321917|NCT00435461|582566425|FG000|Overall Study|Withdrawal by Subject|1|||
161321918|NCT00435461|582566426|FG001|Overall Study|Withdrawal by Subject|0|||
161321919|NCT00435461|582566427|FG002|Overall Study|Withdrawal by Subject|2|||
161321920|NCT00435461|582566425|FG000|Overall Study|Randomized in error|1|||
161321921|NCT00435461|582566426|FG001|Overall Study|Randomized in error|0|||
161321922|NCT00435461|582566427|FG002|Overall Study|Randomized in error|0|||
161321923|NCT00435461|582566425|FG000|Overall Study|Participant could not tolerate symptoms|0|||
161321924|NCT00435461|582566426|FG001|Overall Study|Participant could not tolerate symptoms|0|||
161321925|NCT00435461|582566427|FG002|Overall Study|Participant could not tolerate symptoms|1|||
161321926|NCT00435461|582566425|FG000|Overall Study|Participant could not swallow capsule|0|||
161208305|NCT05016765|582144470|FG000|Overall Study|Lost to Follow-up|4|||
161208306|NCT01988493|582144473|FG000|Overall Study|Randomized but not treated|0|||
161208307|NCT01988493|582144474|FG001|Overall Study|Randomized but not treated|0|||
161208308|NCT01988493|582144475|FG002|Overall Study|Randomized but not treated|0|||
161208309|NCT01988493|582144476|FG003|Overall Study|Randomized but not treated|0|||
161208310|NCT01988493|582144477|FG004|Overall Study|Randomized but not treated|1|||
161208311|NCT00185731|582144482|FG000|Overall Study|Withdrawal by Subject|1|||
161208312|NCT00185731|582144482|FG000|Overall Study|Not Eligible|1|||
161208313|NCT03087773|582144483|FG000|Overall Study|Withdrawal by Subject|8|||
161208314|NCT03087773|582144484|FG001|Overall Study|Withdrawal by Subject|4|||
161208315|NCT03087773|582144483|FG000|Overall Study|Lost to Follow-up|12|||
161208316|NCT03087773|582144484|FG001|Overall Study|Lost to Follow-up|8|||
161208317|NCT05144477|582144487|FG000|Overall Study|Withdrawal by Subject|1|||
161208318|NCT05144477|582144488|FG001|Overall Study|Withdrawal by Subject|1|||
161208319|NCT01787188|582144491|FG000|Overall Study|Adverse Event|2|||
161208320|NCT01787188|582144492|FG001|Overall Study|Adverse Event|4|||
161208321|NCT01787188|582144493|FG002|Overall Study|Adverse Event|6|||
161208322|NCT01787188|582144491|FG000|Overall Study|Lack of Efficacy|7|||
161208323|NCT01787188|582144492|FG001|Overall Study|Lack of Efficacy|3|||
161208324|NCT01787188|582144493|FG002|Overall Study|Lack of Efficacy|5|||
161208325|NCT01787188|582144491|FG000|Overall Study|Non-compliance with Study Drug|0|||
161208326|NCT01787188|582144492|FG001|Overall Study|Non-compliance with Study Drug|1|||
161208327|NCT01787188|582144493|FG002|Overall Study|Non-compliance with Study Drug|0|||
161208328|NCT01787188|582144491|FG000|Overall Study|Withdrawal by Subject|4|||
161208329|NCT01787188|582144492|FG001|Overall Study|Withdrawal by Subject|3|||
161208330|NCT01787188|582144493|FG002|Overall Study|Withdrawal by Subject|2|||
161208331|NCT01787188|582144491|FG000|Overall Study|Protocol Violation|3|||
161208332|NCT01787188|582144492|FG001|Overall Study|Protocol Violation|2|||
161208333|NCT01787188|582144493|FG002|Overall Study|Protocol Violation|3|||
161208334|NCT01787188|582144491|FG000|Overall Study|Lost to Follow-up|1|||
161208335|NCT01787188|582144492|FG001|Overall Study|Lost to Follow-up|2|||
161208336|NCT01787188|582144493|FG002|Overall Study|Lost to Follow-up|2|||
161208337|NCT01787188|582144491|FG000|Overall Study|Other, including patient moved|0|||
161208338|NCT01787188|582144492|FG001|Overall Study|Other, including patient moved|3|||
161208339|NCT01787188|582144493|FG002|Overall Study|Other, including patient moved|0|||
161208340|NCT00854607|582144494|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
161208341|NCT00965263|582144500|FG000|Overall Study|Physician Decision|2|||
161208342|NCT00965263|582144501|FG001|Overall Study|Physician Decision|0|||
161208343|NCT00965263|582144500|FG000|Overall Study|Family emergency|0|||
161208344|NCT00965263|582144501|FG001|Overall Study|Family emergency|1|||
161208345|NCT00965263|582144500|FG000|Overall Study|Protocol Violation|0|||
161208346|NCT00965263|582144501|FG001|Overall Study|Protocol Violation|2|||
161208347|NCT03959137|582144502|FG000|Overall Study|Protocol Violation|6|||
161208348|NCT02756078|582144503|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
161208349|NCT02756078|582144504|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
161208350|NCT02756078|582144503|FG000|Period 1|Lost to Follow-up|0|||
161208351|NCT02756078|582144504|FG001|Period 1|Lost to Follow-up|2|||
161208352|NCT02756078|582144503|FG000|Period 1|Protocol Violation|0|||
161208353|NCT02756078|582144504|FG001|Period 1|Protocol Violation|1|||
161208354|NCT02756078|582144503|FG000|Period 1|Adverse Event|1|||
161208355|NCT02756078|582144504|FG001|Period 1|Adverse Event|10|||
161208356|NCT02756078|582144503|FG000|Period 1|Withdrawal by Subject|6|||
161208357|NCT02756078|582144504|FG001|Period 1|Withdrawal by Subject|6|||
161208358|NCT02756078|582144503|FG000|Period 1|Lens Discomfort|2|||
161208359|NCT02756078|582144504|FG001|Period 1|Lens Discomfort|2|||
161208360|NCT02756078|582144503|FG000|Period 2|Adverse Event|3|||
161208361|NCT02756078|582144504|FG001|Period 2|Adverse Event|5|||
161208362|NCT02756078|582144503|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
161208363|NCT02756078|582144504|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
161208364|NCT02756078|582144503|FG000|Period 2|Withdrawal by Subject|3|||
161208365|NCT02756078|582144504|FG001|Period 2|Withdrawal by Subject|1|||
161208366|NCT03985293|582144508|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
161208367|NCT03985293|582144509|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
161208368|NCT03985293|582144510|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
161208369|NCT03985293|582144511|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
161208370|NCT03985293|582144512|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
161208371|NCT03985293|582144513|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
161208372|NCT03985293|582144508|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
161208373|NCT03985293|582144509|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161208374|NCT03985293|582144510|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
161208375|NCT03985293|582144511|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161208376|NCT03985293|582144512|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
161208377|NCT03985293|582144513|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
161208378|NCT03985293|582144508|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161208379|NCT03985293|582144509|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161208380|NCT03985293|582144510|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161208381|NCT03985293|582144511|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
161321927|NCT00435461|582566426|FG001|Overall Study|Participant could not swallow capsule|0|||
161321928|NCT00435461|582566427|FG002|Overall Study|Participant could not swallow capsule|1|||
161321929|NCT00435461|582566425|FG000|Overall Study|Pregnancy|2|||
161321930|NCT00435461|582566426|FG001|Overall Study|Pregnancy|0|||
161321931|NCT00435461|582566427|FG002|Overall Study|Pregnancy|0|||
161321932|NCT00435461|582566425|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
161321933|NCT00435461|582566426|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
161321934|NCT00435461|582566427|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
161321935|NCT00435461|582566425|FG000|Overall Study|Participant ended study one day early|1|||
161321936|NCT00435461|582566426|FG001|Overall Study|Participant ended study one day early|0|||
161321937|NCT00435461|582566427|FG002|Overall Study|Participant ended study one day early|0|||
161321938|NCT00435461|582566425|FG000|Overall Study|Noncompliance with study requirements|1|||
161321939|NCT00435461|582566426|FG001|Overall Study|Noncompliance with study requirements|1|||
161321940|NCT00435461|582566427|FG002|Overall Study|Noncompliance with study requirements|1|||
161321941|NCT00435461|582566425|FG000|Overall Study|Adverse Event|1|||
161321942|NCT00435461|582566426|FG001|Overall Study|Adverse Event|2|||
161321943|NCT00435461|582566427|FG002|Overall Study|Adverse Event|6|||
161321944|NCT00435461|582566425|FG000|Overall Study|Non-Compliance of diary|2|||
161321945|NCT00435461|582566426|FG001|Overall Study|Non-Compliance of diary|0|||
161321946|NCT00435461|582566427|FG002|Overall Study|Non-Compliance of diary|1|||
161321947|NCT00435461|582566425|FG000|Overall Study|Lost to Follow-up|1|||
161321948|NCT00435461|582566426|FG001|Overall Study|Lost to Follow-up|1|||
161321949|NCT00435461|582566427|FG002|Overall Study|Lost to Follow-up|2|||
161321950|NCT04676724|582566428|FG000|Overall Study|Adverse Event|2|||
161321951|NCT04676724|582566429|FG001|Overall Study|Adverse Event|0|||
161321952|NCT04676724|582566428|FG000|Overall Study|Lost to Follow-up|1|||
161321953|NCT04676724|582566429|FG001|Overall Study|Lost to Follow-up|0|||
161321954|NCT04676724|582566428|FG000|Overall Study|Physician Decision|0|||
161321955|NCT04676724|582566429|FG001|Overall Study|Physician Decision|1|||
161321956|NCT04676724|582566428|FG000|Overall Study|Withdrawal by Subject|3|||
161321957|NCT04676724|582566429|FG001|Overall Study|Withdrawal by Subject|2|||
161321958|NCT00398047|582566435|FG000|Overall Study|all patient progressed before completion|3|||
161321959|NCT02588092|582566442|FG000|Overall Study|Death|4|||
161321960|NCT02588092|582566443|FG001|Overall Study|Death|3|||
161321961|NCT02588092|582566444|FG002|Overall Study|Death|3|||
160863960|NCT01705509|580896685|FG000|Inclusion CPET|Screen Failure|5|||
160863961|NCT01705509|580896685|FG000|Inclusion CPET|Withdrawal by Subject|2|||
160863962|NCT01705509|580896685|FG000|CPET w/ Ranexa|Screen Failure|2|||
160863963|NCT00904033|580896686|FG000|Overall Study|Withdrawal by Subject|1|||
160863964|NCT00904033|580896687|FG001|Overall Study|Withdrawal by Subject|1|||
160863965|NCT00904033|580896688|FG002|Overall Study|Withdrawal by Subject|0|||
160863966|NCT00904033|580896689|FG003|Overall Study|Withdrawal by Subject|0|||
160863967|NCT00904033|580896686|FG000|Overall Study|Physician Decision|0|||
160863968|NCT00904033|580896687|FG001|Overall Study|Physician Decision|0|||
160863969|NCT00904033|580896688|FG002|Overall Study|Physician Decision|1|||
160863970|NCT00904033|580896689|FG003|Overall Study|Physician Decision|0|||
160863971|NCT00904033|580896686|FG000|Overall Study|Unable to obtain final blood draw|0|||
160863972|NCT00904033|580896687|FG001|Overall Study|Unable to obtain final blood draw|0|||
160863973|NCT00904033|580896688|FG002|Overall Study|Unable to obtain final blood draw|0|||
160863974|NCT00904033|580896689|FG003|Overall Study|Unable to obtain final blood draw|2|||
160863975|NCT02736890|580896690|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
160863976|NCT02736890|580896691|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
160863977|NCT02736890|580896690|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
160863978|NCT02736890|580896691|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
160863979|NCT01803607|580896693|FG000|Overall Study|Adverse Event|5|||
160863980|NCT01803607|580896694|FG001|Overall Study|Adverse Event|3|||
160863981|NCT01803607|580896693|FG000|Overall Study|Lack of Efficacy|0|||
160863982|NCT01803607|580896694|FG001|Overall Study|Lack of Efficacy|1|||
160863983|NCT01803607|580896693|FG000|Overall Study|Protocol Violation|3|||
160863984|NCT01803607|580896694|FG001|Overall Study|Protocol Violation|2|||
160863985|NCT01803607|580896693|FG000|Overall Study|Study terminated by sponsor|54|||
160863986|NCT01803607|580896694|FG001|Overall Study|Study terminated by sponsor|56|||
160863987|NCT01803607|580896693|FG000|Overall Study|Withdrawal by Subject|6|||
160863988|NCT01803607|580896694|FG001|Overall Study|Withdrawal by Subject|5|||
160863989|NCT03077412|580896695|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
160863990|NCT03077412|580896696|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
160863991|NCT03077412|580896697|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
161321962|NCT02588092|582566445|FG003|Overall Study|Death|3|||
160863992|NCT03077412|580896695|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
160863993|NCT03077412|580896696|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
160863994|NCT03077412|580896697|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
161321963|NCT02588092|582566446|FG004|Overall Study|Death|2|||
161321964|NCT02588092|582566447|FG005|Overall Study|Death|2|||
161321965|NCT02588092|582566448|FG006|Overall Study|Death|2|||
160863995|NCT03077412|580896695|FG000|Overall Study|Adverse Event|1|||
160863996|NCT03077412|580896696|FG001|Overall Study|Adverse Event|2|||
160863997|NCT03077412|580896697|FG002|Overall Study|Adverse Event|2|||
160863998|NCT03077412|580896695|FG000|Overall Study|Investigator's Discretion|0|||
160863999|NCT03077412|580896696|FG001|Overall Study|Investigator's Discretion|1|||
160864000|NCT03077412|580896697|FG002|Overall Study|Investigator's Discretion|1|||
160864001|NCT03077412|580896695|FG000|Overall Study|Withdrew Consent|0|||
160864002|NCT03077412|580896696|FG001|Overall Study|Withdrew Consent|2|||
160864003|NCT03077412|580896697|FG002|Overall Study|Withdrew Consent|0|||
160864004|NCT01936870|580896698|FG000|Overall Study|No Visit After Treatment|176|||
160864005|NCT01936870|580896698|FG000|Overall Study|Protocol Violation|12|||
160864006|NCT01936870|580896698|FG000|Overall Study|No Drug Administration|1|||
160864007|NCT00248040|580896699|FG000|Overall Study|transplantectomy|2|||
160864008|NCT00248040|580896700|FG001|Overall Study|transplantectomy|1|||
160864009|NCT00248040|580896701|FG002|Overall Study|transplantectomy|3|||
160864010|NCT00248040|580896699|FG000|Overall Study|transplant cancelled post treat start|1|||
160864011|NCT00248040|580896700|FG001|Overall Study|transplant cancelled post treat start|0|||
160864012|NCT00248040|580896701|FG002|Overall Study|transplant cancelled post treat start|0|||
160864013|NCT00248040|580896699|FG000|Overall Study|Death|0|||
160864014|NCT00248040|580896700|FG001|Overall Study|Death|0|||
160864015|NCT00248040|580896701|FG002|Overall Study|Death|1|||
160864016|NCT00118417|580896702|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
160864017|NCT00118417|580896703|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
160864018|NCT00118417|580896702|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
160864019|NCT00118417|580896703|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
160864020|NCT00118417|580896702|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
160864021|NCT00118417|580896703|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
160864022|NCT00118417|580896702|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
160864023|NCT00118417|580896703|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
160864024|NCT00118417|580896702|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
160864025|NCT00118417|580896703|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
160864026|NCT02978781|580896704|FG000|Part A|Adverse Event|1|||
160864027|NCT02978781|580896705|FG001|Part A|Adverse Event|1|||
160864028|NCT02978781|580896706|FG002|Part A|Adverse Event|0|||
160864029|NCT02978781|580896707|FG003|Part A|Adverse Event|0|||
160864030|NCT02978781|580896708|FG004|Part A|Adverse Event|0|||
160864031|NCT02978781|580896704|FG000|Part A|Withdrawal by Subject|0|||
160864032|NCT02978781|580896705|FG001|Part A|Withdrawal by Subject|1|||
160864033|NCT02978781|580896706|FG002|Part A|Withdrawal by Subject|0|||
160864034|NCT02978781|580896707|FG003|Part A|Withdrawal by Subject|0|||
160864035|NCT02978781|580896708|FG004|Part A|Withdrawal by Subject|0|||
160864036|NCT02978781|580896704|FG000|Part B|Withdrawal by Subject|0|||
160864037|NCT02978781|580896705|FG001|Part B|Withdrawal by Subject|0|||
160864038|NCT02978781|580896706|FG002|Part B|Withdrawal by Subject|0|||
160864039|NCT02978781|580896707|FG003|Part B|Withdrawal by Subject|1|||
160864040|NCT02978781|580896708|FG004|Part B|Withdrawal by Subject|0|||
160864041|NCT02978781|580896704|FG000|Part C|Adverse Event|0|||
160864042|NCT02978781|580896705|FG001|Part C|Adverse Event|0|||
160864043|NCT02978781|580896706|FG002|Part C|Adverse Event|0|||
160864044|NCT02978781|580896707|FG003|Part C|Adverse Event|0|||
161321966|NCT02588092|582566449|FG007|Overall Study|Death|1|||
161321967|NCT02588092|582566450|FG008|Overall Study|Death|5|||
161321968|NCT02588092|582566451|FG009|Overall Study|Death|2|||
161321969|NCT02588092|582566442|FG000|Overall Study|Withdrawal by Subject|0|||
161321970|NCT02588092|582566443|FG001|Overall Study|Withdrawal by Subject|0|||
161321971|NCT02588092|582566444|FG002|Overall Study|Withdrawal by Subject|0|||
161321972|NCT02588092|582566445|FG003|Overall Study|Withdrawal by Subject|0|||
161321973|NCT02588092|582566446|FG004|Overall Study|Withdrawal by Subject|0|||
161321974|NCT02588092|582566447|FG005|Overall Study|Withdrawal by Subject|1|||
161321975|NCT02588092|582566448|FG006|Overall Study|Withdrawal by Subject|1|||
161321976|NCT02588092|582566449|FG007|Overall Study|Withdrawal by Subject|2|||
161321977|NCT02588092|582566450|FG008|Overall Study|Withdrawal by Subject|0|||
161321978|NCT02588092|582566451|FG009|Overall Study|Withdrawal by Subject|0|||
161321979|NCT02588092|582566442|FG000|Overall Study|Started Another Treatment|0|||
161321980|NCT02588092|582566443|FG001|Overall Study|Started Another Treatment|0|||
161321981|NCT02588092|582566444|FG002|Overall Study|Started Another Treatment|0|||
160864045|NCT02978781|580896708|FG004|Part C|Adverse Event|2|||
160864046|NCT02978781|580896704|FG000|Part C|Withdrawal by Subject|0|||
160864047|NCT02978781|580896705|FG001|Part C|Withdrawal by Subject|0|||
160864048|NCT02978781|580896706|FG002|Part C|Withdrawal by Subject|0|||
160864049|NCT02978781|580896707|FG003|Part C|Withdrawal by Subject|0|||
160864050|NCT02978781|580896708|FG004|Part C|Withdrawal by Subject|1|||
160864051|NCT02978781|580896704|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864052|NCT02978781|580896705|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864053|NCT02978781|580896706|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864054|NCT02978781|580896707|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
160864055|NCT02978781|580896708|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
160864056|NCT01383356|580896709|FG000|Period 1|Adverse Event|5|||
161321982|NCT02588092|582566445|FG003|Overall Study|Started Another Treatment|0|||
161321983|NCT02588092|582566446|FG004|Overall Study|Started Another Treatment|1|||
161321984|NCT02588092|582566447|FG005|Overall Study|Started Another Treatment|0|||
161321985|NCT02588092|582566448|FG006|Overall Study|Started Another Treatment|0|||
161321986|NCT02588092|582566449|FG007|Overall Study|Started Another Treatment|1|||
161321987|NCT02588092|582566450|FG008|Overall Study|Started Another Treatment|0|||
161321988|NCT02588092|582566451|FG009|Overall Study|Started Another Treatment|0|||
161321989|NCT02588092|582566442|FG000|Overall Study|Sponsor Decision|0|||
161321990|NCT02588092|582566443|FG001|Overall Study|Sponsor Decision|0|||
161321991|NCT02588092|582566444|FG002|Overall Study|Sponsor Decision|0|||
161321992|NCT02588092|582566445|FG003|Overall Study|Sponsor Decision|0|||
161321993|NCT02588092|582566446|FG004|Overall Study|Sponsor Decision|0|||
161321994|NCT02588092|582566447|FG005|Overall Study|Sponsor Decision|0|||
161321995|NCT02588092|582566448|FG006|Overall Study|Sponsor Decision|0|||
161321996|NCT02588092|582566449|FG007|Overall Study|Sponsor Decision|0|||
161321997|NCT02588092|582566450|FG008|Overall Study|Sponsor Decision|1|||
161321998|NCT02588092|582566451|FG009|Overall Study|Sponsor Decision|1|||
161321999|NCT01348100|582566452|FG000|Overall Study|Subject Withdrew Consent|0|||
161322000|NCT01348100|582566453|FG001|Overall Study|Subject Withdrew Consent|0|||
161322001|NCT01348100|582566454|FG002|Overall Study|Subject Withdrew Consent|2|||
161322002|NCT01348100|582566455|FG003|Overall Study|Subject Withdrew Consent|0|||
161322003|NCT01348100|582566456|FG004|Overall Study|Subject Withdrew Consent|1|||
161322004|NCT01348100|582566457|FG005|Overall Study|Subject Withdrew Consent|0|||
161322005|NCT01348100|582566458|FG006|Overall Study|Subject Withdrew Consent|1|||
161322006|NCT01348100|582566452|FG000|Overall Study|Protocol Deviation|0|||
161322007|NCT01348100|582566453|FG001|Overall Study|Protocol Deviation|0|||
161322008|NCT01348100|582566454|FG002|Overall Study|Protocol Deviation|0|||
161322009|NCT01348100|582566455|FG003|Overall Study|Protocol Deviation|1|||
161322010|NCT01348100|582566456|FG004|Overall Study|Protocol Deviation|0|||
161322011|NCT01348100|582566457|FG005|Overall Study|Protocol Deviation|0|||
161322012|NCT01348100|582566458|FG006|Overall Study|Protocol Deviation|0|||
161322013|NCT01348100|582566452|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161322014|NCT01348100|582566453|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161322015|NCT01348100|582566454|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161322016|NCT01348100|582566455|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161322017|NCT01348100|582566456|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161322018|NCT01348100|582566457|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161322019|NCT01348100|582566458|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161322020|NCT01348100|582566452|FG000|Overall Study|Lost to Follow-up|0|||
161322021|NCT01348100|582566453|FG001|Overall Study|Lost to Follow-up|0|||
161322022|NCT01348100|582566454|FG002|Overall Study|Lost to Follow-up|0|||
161322023|NCT01348100|582566455|FG003|Overall Study|Lost to Follow-up|0|||
161322024|NCT01348100|582566456|FG004|Overall Study|Lost to Follow-up|0|||
161322025|NCT01348100|582566457|FG005|Overall Study|Lost to Follow-up|0|||
161322026|NCT01348100|582566458|FG006|Overall Study|Lost to Follow-up|1|||
161322027|NCT01348100|582566452|FG000|Overall Study|Administrative Problems|0|||
161322028|NCT01348100|582566453|FG001|Overall Study|Administrative Problems|0|||
161322029|NCT01348100|582566454|FG002|Overall Study|Administrative Problems|0|||
161322030|NCT01348100|582566455|FG003|Overall Study|Administrative Problems|0|||
161322031|NCT01348100|582566456|FG004|Overall Study|Administrative Problems|0|||
161322032|NCT01348100|582566457|FG005|Overall Study|Administrative Problems|1|||
161322033|NCT01348100|582566458|FG006|Overall Study|Administrative Problems|1|||
161322034|NCT00531947|582566461|FG000|Overall Study|Adverse Event|5|||
161322035|NCT00531947|582566462|FG001|Overall Study|Adverse Event|10|||
161322036|NCT00531947|582566461|FG000|Overall Study|Lost to Follow-up|12|||
161322037|NCT00531947|582566462|FG001|Overall Study|Lost to Follow-up|9|||
161322038|NCT00531947|582566461|FG000|Overall Study|Withdrawal by Subject|14|||
161322039|NCT00531947|582566462|FG001|Overall Study|Withdrawal by Subject|19|||
161322040|NCT00531947|582566461|FG000|Overall Study|Protocol Violation|2|||
161322041|NCT00531947|582566462|FG001|Overall Study|Protocol Violation|1|||
161322042|NCT00531947|582566461|FG000|Overall Study|Non-Compliance|4|||
161322043|NCT00531947|582566462|FG001|Overall Study|Non-Compliance|7|||
161322044|NCT00531947|582566461|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
161322045|NCT00531947|582566462|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
161322046|NCT02383355|582566465|FG000|Overall Study|Adverse Event|2|||
161322047|NCT02383355|582566466|FG001|Overall Study|Adverse Event|0|||
161322048|NCT00524680|582566467|FG000|Overall Study|progression|0|||
161322049|NCT00524680|582566468|FG001|Overall Study|progression|0|||
161322050|NCT00524680|582566469|FG002|Overall Study|progression|0|||
161322051|NCT00524680|582566470|FG003|Overall Study|progression|1|||
161322052|NCT00524680|582566467|FG000|Overall Study|Adverse Event|2|||
161322053|NCT00524680|582566468|FG001|Overall Study|Adverse Event|0|||
161322054|NCT00524680|582566469|FG002|Overall Study|Adverse Event|0|||
161322055|NCT00524680|582566470|FG003|Overall Study|Adverse Event|1|||
161322056|NCT00524680|582566467|FG000|Overall Study|Other|0|||
161322057|NCT00524680|582566468|FG001|Overall Study|Other|1|||
161322058|NCT00524680|582566469|FG002|Overall Study|Other|2|||
161322059|NCT00524680|582566470|FG003|Overall Study|Other|3|||
161322060|NCT00524680|582566467|FG000|Overall Study|Withdrawal by Subject|1|||
161322061|NCT00524680|582566468|FG001|Overall Study|Withdrawal by Subject|0|||
161322062|NCT00524680|582566469|FG002|Overall Study|Withdrawal by Subject|1|||
161322063|NCT00524680|582566470|FG003|Overall Study|Withdrawal by Subject|1|||
161322064|NCT01146561|582566471|FG000|Overall Study|Withdrawal by Subject|1|||
161322065|NCT01146561|582566471|FG000|Overall Study|Lost to Follow-up|1|||
161322066|NCT00334295|582566480|FG000|Overall Study|Patients received fewer than 3 injection|5|||
161208382|NCT03985293|582144512|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161322067|NCT00893971|582566481|FG000|Overall Study|Physician Decision|3|||
161322068|NCT01416155|582566482|FG000|Overall Study|Adverse Event|8|||
161322069|NCT01416155|582566482|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
161322070|NCT01416155|582566482|FG000|Overall Study|Withdrawal by Subject|33|||
161322071|NCT01416155|582566482|FG000|Overall Study|Investigator decision|8|||
161322072|NCT01416155|582566482|FG000|Overall Study|Other|7|||
161322073|NCT00829829|582566486|FG000|Overall Study|Protocol Violation|0|||
161322074|NCT00829829|582566487|FG001|Overall Study|Protocol Violation|3|||
161322075|NCT00829829|582566488|FG002|Overall Study|Protocol Violation|0|||
161322076|NCT00829829|582566486|FG000|Overall Study|Adverse Event|4|||
161322077|NCT00829829|582566487|FG001|Overall Study|Adverse Event|4|||
161322078|NCT00829829|582566488|FG002|Overall Study|Adverse Event|3|||
161322079|NCT00829829|582566486|FG000|Overall Study|Withdrawal by Subject|8|||
161322080|NCT00829829|582566487|FG001|Overall Study|Withdrawal by Subject|4|||
161322081|NCT00829829|582566488|FG002|Overall Study|Withdrawal by Subject|2|||
161322082|NCT00829829|582566486|FG000|Overall Study|Decision by the Sponsor|1|||
161322083|NCT00829829|582566487|FG001|Overall Study|Decision by the Sponsor|0|||
161322084|NCT00829829|582566488|FG002|Overall Study|Decision by the Sponsor|2|||
161322085|NCT00829829|582566486|FG000|Overall Study|Lost to Follow-up|7|||
161322086|NCT00829829|582566487|FG001|Overall Study|Lost to Follow-up|3|||
161322087|NCT00829829|582566488|FG002|Overall Study|Lost to Follow-up|3|||
161322088|NCT00829829|582566486|FG000|Overall Study|Other than specified above|2|||
161322089|NCT00829829|582566487|FG001|Overall Study|Other than specified above|2|||
161322090|NCT00829829|582566488|FG002|Overall Study|Other than specified above|1|||
161322091|NCT04811664|582566489|FG000|Overall Study|Lost to Follow-up|78|||
161322092|NCT04811664|582566490|FG001|Overall Study|Lost to Follow-up|125|||
161322093|NCT04811664|582566491|FG002|Overall Study|Lost to Follow-up|46|||
161322094|NCT04811664|582566489|FG000|Overall Study|Withdrawal by Subject|39|||
161322095|NCT04811664|582566490|FG001|Overall Study|Withdrawal by Subject|76|||
161322096|NCT04811664|582566491|FG002|Overall Study|Withdrawal by Subject|12|||
161322097|NCT04811664|582566489|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161322098|NCT04811664|582566490|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
161322099|NCT04811664|582566491|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
161208383|NCT03985293|582144513|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
161208384|NCT03985293|582144508|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
161322100|NCT04811664|582566489|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
161322101|NCT04811664|582566490|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
161322102|NCT04811664|582566491|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
161322103|NCT04811664|582566489|FG000|Overall Study|Protocol Violation|0|||
161322104|NCT04811664|582566490|FG001|Overall Study|Protocol Violation|5|||
161322105|NCT04811664|582566491|FG002|Overall Study|Protocol Violation|11|||
161322106|NCT04811664|582566489|FG000|Overall Study|Study Terminated by Sponsor|4|||
161322107|NCT04811664|582566490|FG001|Overall Study|Study Terminated by Sponsor|3|||
161322108|NCT04811664|582566491|FG002|Overall Study|Study Terminated by Sponsor|34|||
161322109|NCT04811664|582566489|FG000|Overall Study|Early Study Closure|3|||
161322110|NCT04811664|582566490|FG001|Overall Study|Early Study Closure|7|||
161322111|NCT04811664|582566491|FG002|Overall Study|Early Study Closure|79|||
161322112|NCT04811664|582566489|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
161322113|NCT04811664|582566490|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
161322114|NCT04811664|582566491|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
161322115|NCT00382109|582566492|FG000|Overall Study|Adverse Event|3|||
161322116|NCT00382109|582566493|FG001|Overall Study|Adverse Event|0|||
161322117|NCT00382109|582566492|FG000|Overall Study|Physician Decision|6|||
161322118|NCT00382109|582566493|FG001|Overall Study|Physician Decision|1|||
161322119|NCT00382109|582566492|FG000|Overall Study|Withdrawal by Subject|1|||
161322120|NCT00382109|582566493|FG001|Overall Study|Withdrawal by Subject|0|||
161322121|NCT00382109|582566492|FG000|Overall Study|ineligible|2|||
161322122|NCT00382109|582566493|FG001|Overall Study|ineligible|0|||
161322123|NCT00382109|582566492|FG000|Overall Study|Other|0|||
161322124|NCT00382109|582566493|FG001|Overall Study|Other|2|||
161322125|NCT00382109|582566492|FG000|Overall Study|consent withdrawal|0|||
161322126|NCT00382109|582566493|FG001|Overall Study|consent withdrawal|1|||
161322127|NCT02717442|582566494|FG000|Overall Study|Study Terminated by Sponsor|31|||
161322128|NCT02717442|582566495|FG001|Overall Study|Study Terminated by Sponsor|29|||
161322129|NCT02717442|582566494|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
161322130|NCT02717442|582566495|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
161322131|NCT02717442|582566494|FG000|Overall Study|Other - Not Specified|2|||
161322132|NCT02717442|582566495|FG001|Overall Study|Other - Not Specified|0|||
161322133|NCT01249833|582566496|FG000|Overall Study|Lost to Follow-up|0|||
161322134|NCT01249833|582566497|FG001|Overall Study|Lost to Follow-up|1|||
161322135|NCT05052697|582566498|FG000|Substudy A|Lost to Follow-up|0|||
161322136|NCT05052697|582566499|FG001|Substudy A|Lost to Follow-up|0|||
161322137|NCT05052697|582566500|FG002|Substudy A|Lost to Follow-up|0|||
161322138|NCT05052697|582566501|FG003|Substudy A|Lost to Follow-up|0|||
161322139|NCT05052697|582566502|FG004|Substudy A|Lost to Follow-up|0|||
161322140|NCT05052697|582566503|FG005|Substudy A|Lost to Follow-up|1|||
161322141|NCT05052697|582566504|FG006|Substudy A|Lost to Follow-up|0|||
161322142|NCT05052697|582566505|FG007|Substudy A|Lost to Follow-up|0|||
161322143|NCT05052697|582566506|FG008|Substudy A|Lost to Follow-up|0|||
161322144|NCT05052697|582566507|FG009|Substudy A|Lost to Follow-up|0|||
161322145|NCT05052697|582566508|FG010|Substudy A|Lost to Follow-up|0|||
161322146|NCT05052697|582566509|FG011|Substudy A|Lost to Follow-up|0|||
161322147|NCT05052697|582566510|FG012|Substudy A|Lost to Follow-up|0|||
161322148|NCT05052697|582566511|FG013|Substudy A|Lost to Follow-up|0|||
160864057|NCT01383356|580896710|FG001|Period 1|Adverse Event|3|||
160864058|NCT01383356|580896709|FG000|Period 1|Non-compliance|3|||
160864059|NCT01383356|580896710|FG001|Period 1|Non-compliance|0|||
160864060|NCT01383356|580896709|FG000|Period 1|Out of Range Mid-study-Test|0|||
160864061|NCT01383356|580896710|FG001|Period 1|Out of Range Mid-study-Test|1|||
160864062|NCT01383356|580896709|FG000|Period 1|Personal|0|||
160864063|NCT01383356|580896710|FG001|Period 1|Personal|2|||
160864064|NCT02054104|580896712|FG000|Overall Study|Did not want to continue due to college classes|1|||
160864065|NCT02054104|580896713|FG001|Overall Study|Did not want to continue due to college classes|0|||
160864066|NCT02054104|580896712|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
160864067|NCT02054104|580896713|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
160864068|NCT02054104|580896712|FG000|Overall Study|No evidence of immunologic response|2|||
160864069|NCT02054104|580896713|FG001|Overall Study|No evidence of immunologic response|2|||
160864070|NCT02054104|580896712|FG000|Overall Study|Disease Progression On Study|4|||
160864071|NCT02054104|580896713|FG001|Overall Study|Disease Progression On Study|5|||
160864072|NCT02054104|580896712|FG000|Overall Study|Diagnosis of lymphoma|0|||
160864073|NCT02054104|580896713|FG001|Overall Study|Diagnosis of lymphoma|1|||
160864074|NCT02054104|580896712|FG000|Overall Study|Inconclusive response|0|||
160864075|NCT02054104|580896713|FG001|Overall Study|Inconclusive response|1|||
160864076|NCT00836693|580896718|FG000|Overall Study|Adverse Event|4|||
160864077|NCT00836693|580896719|FG001|Overall Study|Adverse Event|1|||
160864078|NCT00836693|580896718|FG000|Overall Study|Sponsor Decision|0|||
160864079|NCT00836693|580896719|FG001|Overall Study|Sponsor Decision|1|||
160864080|NCT00836693|580896718|FG000|Overall Study|Physician Decision|2|||
160864081|NCT00836693|580896719|FG001|Overall Study|Physician Decision|0|||
160864082|NCT00836693|580896718|FG000|Overall Study|Withdrawal by Subject|9|||
160864083|NCT00836693|580896719|FG001|Overall Study|Withdrawal by Subject|4|||
160864084|NCT00836693|580896718|FG000|Overall Study|Protocol Violation|1|||
160864085|NCT00836693|580896719|FG001|Overall Study|Protocol Violation|0|||
160864086|NCT00836693|580896718|FG000|Overall Study|Lost to Follow-up|1|||
160864087|NCT00836693|580896719|FG001|Overall Study|Lost to Follow-up|0|||
160864088|NCT02612779|580896720|FG000|Overall Study|Administrative reason by sponsor|4|||
160864089|NCT02612779|580896721|FG001|Overall Study|Administrative reason by sponsor|1|||
160864090|NCT02612779|580896720|FG000|Overall Study|No longer meet study criteria|0|||
160864091|NCT02612779|580896721|FG001|Overall Study|No longer meet study criteria|1|||
160864092|NCT02612779|580896720|FG000|Overall Study|Disease progression|29|||
160864093|NCT02612779|580896721|FG001|Overall Study|Disease progression|2|||
161322149|NCT05052697|582566512|FG014|Substudy A|Lost to Follow-up|0|||
161322150|NCT05052697|582566513|FG015|Substudy A|Lost to Follow-up|2|||
160864094|NCT02612779|580896720|FG000|Overall Study|Study drug toxicity|10|||
160864095|NCT02612779|580896721|FG001|Overall Study|Study drug toxicity|1|||
160864096|NCT02612779|580896720|FG000|Overall Study|Death|1|||
160864097|NCT02612779|580896721|FG001|Overall Study|Death|0|||
160864098|NCT02612779|580896720|FG000|Overall Study|Adverse event unrelated to study drug|5|||
160864099|NCT02612779|580896721|FG001|Overall Study|Adverse event unrelated to study drug|0|||
160864100|NCT02612779|580896720|FG000|Overall Study|Participant withdrew consent|4|||
160864101|NCT02612779|580896721|FG001|Overall Study|Participant withdrew consent|0|||
160864102|NCT02612779|580896720|FG000|Overall Study|Lost to Follow-up|1|||
160864103|NCT02612779|580896721|FG001|Overall Study|Lost to Follow-up|0|||
160864104|NCT02612779|580896720|FG000|Overall Study|Maximum clinical benefit|10|||
160864105|NCT02612779|580896721|FG001|Overall Study|Maximum clinical benefit|1|||
160864106|NCT02612779|580896720|FG000|Overall Study|Other reasons|4|||
160864107|NCT02612779|580896721|FG001|Overall Study|Other reasons|0|||
160864108|NCT02633306|580896724|FG000|Overall Study|Withdrawal by Subject|3|||
160864109|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864110|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
161322151|NCT05052697|582566514|FG016|Substudy A|Lost to Follow-up|0|||
161322152|NCT05052697|582566515|FG017|Substudy A|Lost to Follow-up|0|||
161322153|NCT05052697|582566516|FG018|Substudy A|Lost to Follow-up|0|||
160864111|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
160864112|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864113|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864114|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
160864115|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
160864116|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864117|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864118|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864119|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864120|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864121|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
160864122|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
160864123|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864124|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864125|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864126|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
160864127|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864128|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864129|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
160864130|NCT00129402|580896741|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864131|NCT00129402|580896742|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864132|NCT00129402|580896743|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
160864133|NCT00129402|580896744|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864134|NCT00129402|580896745|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
160864135|NCT00129402|580896746|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864136|NCT00129402|580896747|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
160864137|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864138|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864139|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
160864140|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864141|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864142|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864143|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
160864144|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864145|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864146|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
160864147|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864148|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864149|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
160864150|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
160864151|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864152|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864153|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
160864154|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864155|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864156|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864157|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
160864158|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864159|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864160|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
160864161|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864162|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864163|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
160864164|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
160864165|NCT00129402|580896741|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864166|NCT00129402|580896742|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864167|NCT00129402|580896743|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
160864168|NCT00129402|580896744|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864169|NCT00129402|580896745|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864170|NCT00129402|580896746|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
160864171|NCT00129402|580896747|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
160864172|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864173|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864174|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864175|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864176|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864177|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
160864178|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
160864179|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864180|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864181|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864182|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864183|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864184|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
160864185|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
160864186|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864187|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864188|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864189|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864190|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864191|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
160864192|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
160864193|NCT00129402|580896741|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864194|NCT00129402|580896742|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864195|NCT00129402|580896743|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864196|NCT00129402|580896744|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864197|NCT00129402|580896745|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864198|NCT00129402|580896746|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
160864199|NCT00129402|580896747|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
160864200|NCT00763035|580896748|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
160864201|NCT00763035|580896749|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
160864202|NCT00763035|580896748|FG000|First Intervention|Adverse Event|0|||
160864203|NCT00763035|580896749|FG001|First Intervention|Adverse Event|1|||
160864204|NCT00763035|580896748|FG000|Second Intervention|Adverse Event|1|||
160864205|NCT00763035|580896749|FG001|Second Intervention|Adverse Event|0|||
160864206|NCT00763035|580896748|FG000|Second Intervention|Physician Decision|2|||
160864207|NCT00763035|580896749|FG001|Second Intervention|Physician Decision|0|||
160864208|NCT02131259|580896750|FG000|Overall Study|Progressive disease|751|||
160864209|NCT02131259|580896750|FG000|Overall Study|Adverse Event|341|||
160864210|NCT02131259|580896750|FG000|Overall Study|Lost to Follow-up|7|||
160864211|NCT02131259|580896750|FG000|Overall Study|Relocation|32|||
160864212|NCT02131259|580896750|FG000|Overall Study|Other|63|||
160864213|NCT02131259|580896750|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
160864214|NCT02131259|580896750|FG000|Overall Study|Progressive disease/relocation|1|||
160864215|NCT02131259|580896750|FG000|Overall Study|Progressive disease/other|2|||
160864216|NCT02131259|580896750|FG000|Overall Study|AE/lost to follow-up|1|||
160864217|NCT02131259|580896750|FG000|Overall Study|AE/other|1|||
160864218|NCT02131259|580896750|FG000|Overall Study|Progressive disease/AE/other|1|||
160864219|NCT02131259|580896750|FG000|Overall Study|Missing|3|||
160864220|NCT01472289|580896757|FG000|Overall Study|Death|2|||
160864221|NCT00907335|580896758|FG000|Overall Study|Withdrawal by Subject|2|||
160864222|NCT00907335|580896759|FG001|Overall Study|Withdrawal by Subject|0|||
160864223|NCT00907335|580896758|FG000|Overall Study|Adverse Event|4|||
160864224|NCT00907335|580896759|FG001|Overall Study|Adverse Event|1|||
160864225|NCT00907335|580896758|FG000|Overall Study|Lost to Follow-up|2|||
160864226|NCT00907335|580896759|FG001|Overall Study|Lost to Follow-up|0|||
160864227|NCT03879772|580896760|FG000|Overall Study|Adverse Event|2|||
160864228|NCT03879772|580896761|FG001|Overall Study|Adverse Event|2|||
160864229|NCT03879772|580896762|FG002|Overall Study|Adverse Event|3|||
160864230|NCT03879772|580896763|FG003|Overall Study|Adverse Event|4|||
160864231|NCT03879772|580896764|FG004|Overall Study|Adverse Event|3|||
160864232|NCT03879772|580896760|FG000|Overall Study|Treatment Failure|1|||
160864233|NCT03879772|580896761|FG001|Overall Study|Treatment Failure|0|||
160864234|NCT03879772|580896762|FG002|Overall Study|Treatment Failure|0|||
160864235|NCT03879772|580896763|FG003|Overall Study|Treatment Failure|2|||
160864236|NCT03879772|580896764|FG004|Overall Study|Treatment Failure|1|||
160864237|NCT03879772|580896760|FG000|Overall Study|Lost to Follow-up|0|||
161208385|NCT03985293|582144509|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
160864238|NCT03879772|580896761|FG001|Overall Study|Lost to Follow-up|0|||
160864239|NCT03879772|580896762|FG002|Overall Study|Lost to Follow-up|0|||
160864240|NCT03879772|580896763|FG003|Overall Study|Lost to Follow-up|0|||
160864241|NCT03879772|580896764|FG004|Overall Study|Lost to Follow-up|1|||
160864242|NCT03879772|580896760|FG000|Overall Study|Withdrawal by Subject|0|||
160864243|NCT03879772|580896761|FG001|Overall Study|Withdrawal by Subject|1|||
160864244|NCT03879772|580896762|FG002|Overall Study|Withdrawal by Subject|3|||
160864245|NCT03879772|580896763|FG003|Overall Study|Withdrawal by Subject|1|||
160864246|NCT03879772|580896764|FG004|Overall Study|Withdrawal by Subject|1|||
160864247|NCT03879772|580896760|FG000|Overall Study|Protocol Violation|0|||
160864248|NCT03879772|580896761|FG001|Overall Study|Protocol Violation|0|||
160864249|NCT03879772|580896762|FG002|Overall Study|Protocol Violation|3|||
160864250|NCT03879772|580896763|FG003|Overall Study|Protocol Violation|1|||
160864251|NCT03879772|580896764|FG004|Overall Study|Protocol Violation|2|||
160864252|NCT03879772|580896760|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
160864253|NCT03879772|580896761|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
160864254|NCT03879772|580896762|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
160864255|NCT03879772|580896763|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
160864256|NCT03879772|580896764|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
160864257|NCT00389610|580896776|FG000|Overall Study|Disease Progression|0|||
160864258|NCT00389610|580896777|FG001|Overall Study|Disease Progression|19|||
160864259|NCT00389610|580896776|FG000|Overall Study|Death|0|||
160864260|NCT00389610|580896777|FG001|Overall Study|Death|1|||
160864261|NCT00389610|580896776|FG000|Overall Study|Physician Decision|0|||
160864262|NCT00389610|580896777|FG001|Overall Study|Physician Decision|1|||
160864263|NCT00389610|580896776|FG000|Overall Study|Withdrawal by Subject|0|||
160864264|NCT00389610|580896777|FG001|Overall Study|Withdrawal by Subject|1|||
160864265|NCT00887809|580896778|FG000|Overall Study|Patient Not Treated|3|||
160864266|NCT00887809|580896779|FG001|Overall Study|Patient Not Treated|0|||
160864267|NCT00887809|580896778|FG000|Overall Study|Death|1|||
160864268|NCT00887809|580896779|FG001|Overall Study|Death|0|||
160864269|NCT03131570|580896780|FG000|Overall Study|Adverse Event|1|||
160864270|NCT03131570|580896781|FG001|Overall Study|Adverse Event|0|||
160864271|NCT04596267|580896782|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
160864272|NCT04596267|580896783|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
160864273|NCT04596267|580896782|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
160864274|NCT04596267|580896783|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
160864275|NCT00071058|580896784|FG000|Overall Study|brain tumor-removed from study|1|||
160864276|NCT04189952|580896792|FG000|Follow-up Period|Death|1|||
160864277|NCT04189952|580896792|FG000|Follow-up Period|Withdrawal by Subject|1|||
160864278|NCT00870740|580896793|FG000|Overall Study|Adverse Event|2|||
160864279|NCT00870740|580896794|FG001|Overall Study|Adverse Event|1|||
160864280|NCT00870740|580896795|FG002|Overall Study|Adverse Event|3|||
160864281|NCT00870740|580896796|FG003|Overall Study|Adverse Event|2|||
160864282|NCT00870740|580896797|FG004|Overall Study|Adverse Event|1|||
160864283|NCT00870740|580896798|FG005|Overall Study|Adverse Event|6|||
160864284|NCT00870740|580896793|FG000|Overall Study|Consent Withdrawn|6|||
160864285|NCT00870740|580896794|FG001|Overall Study|Consent Withdrawn|3|||
160864286|NCT00870740|580896795|FG002|Overall Study|Consent Withdrawn|4|||
160864287|NCT00870740|580896796|FG003|Overall Study|Consent Withdrawn|6|||
160864288|NCT00870740|580896797|FG004|Overall Study|Consent Withdrawn|6|||
160864289|NCT00870740|580896798|FG005|Overall Study|Consent Withdrawn|5|||
160864290|NCT00870740|580896793|FG000|Overall Study|Investigator Decision|2|||
160864291|NCT00870740|580896794|FG001|Overall Study|Investigator Decision|0|||
160864292|NCT00870740|580896795|FG002|Overall Study|Investigator Decision|1|||
160864293|NCT00870740|580896796|FG003|Overall Study|Investigator Decision|0|||
160864294|NCT00870740|580896797|FG004|Overall Study|Investigator Decision|0|||
160864295|NCT00870740|580896798|FG005|Overall Study|Investigator Decision|0|||
160864296|NCT00870740|580896793|FG000|Overall Study|Subject Non-compliance|0|||
160864297|NCT00870740|580896794|FG001|Overall Study|Subject Non-compliance|0|||
160864298|NCT00870740|580896795|FG002|Overall Study|Subject Non-compliance|0|||
160864299|NCT00870740|580896796|FG003|Overall Study|Subject Non-compliance|0|||
160864300|NCT00870740|580896797|FG004|Overall Study|Subject Non-compliance|0|||
160864301|NCT00870740|580896798|FG005|Overall Study|Subject Non-compliance|1|||
160864302|NCT00870740|580896793|FG000|Overall Study|Death|0|||
160864303|NCT00870740|580896794|FG001|Overall Study|Death|0|||
160864304|NCT00870740|580896795|FG002|Overall Study|Death|0|||
160864305|NCT00870740|580896796|FG003|Overall Study|Death|0|||
160864306|NCT00870740|580896797|FG004|Overall Study|Death|1|||
160864307|NCT00870740|580896798|FG005|Overall Study|Death|0|||
160864308|NCT00870740|580896793|FG000|Overall Study|Other|2|||
160864309|NCT00870740|580896794|FG001|Overall Study|Other|5|||
160864310|NCT00870740|580896795|FG002|Overall Study|Other|2|||
160864311|NCT00870740|580896796|FG003|Overall Study|Other|4|||
160864312|NCT00870740|580896797|FG004|Overall Study|Other|3|||
160864313|NCT00870740|580896798|FG005|Overall Study|Other|5|||
160864314|NCT04298697|580896806|FG000|Overall Study|Lost to Follow-up|5|||
160864315|NCT04298697|580896807|FG001|Overall Study|Lost to Follow-up|5|||
160864316|NCT04298697|580896808|FG002|Overall Study|Lost to Follow-up|1|||
160864317|NCT04298697|580896809|FG003|Overall Study|Lost to Follow-up|0|||
160864318|NCT04298697|580896806|FG000|Overall Study|Withdrawal by Subject|0|||
160864319|NCT04298697|580896807|FG001|Overall Study|Withdrawal by Subject|3|||
160864320|NCT04298697|580896808|FG002|Overall Study|Withdrawal by Subject|2|||
160864321|NCT04298697|580896809|FG003|Overall Study|Withdrawal by Subject|3|||
160864322|NCT03995368|580896810|FG000|Overall Study|Lost to Follow-up|1|||
160864323|NCT03995368|580896811|FG001|Overall Study|Lost to Follow-up|4|||
160864324|NCT03995368|580896812|FG002|Overall Study|Lost to Follow-up|1|||
160864325|NCT03995368|580896810|FG000|Overall Study|Did not meet inclusion criteria|1|||
160864326|NCT03995368|580896811|FG001|Overall Study|Did not meet inclusion criteria|6|||
160864327|NCT03995368|580896812|FG002|Overall Study|Did not meet inclusion criteria|3|||
160864328|NCT03995368|580896810|FG000|Overall Study|Withdrawal by Subject|0|||
160864329|NCT03995368|580896811|FG001|Overall Study|Withdrawal by Subject|1|||
160864330|NCT03995368|580896812|FG002|Overall Study|Withdrawal by Subject|1|||
160864331|NCT04322526|580896813|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
160864332|NCT04322526|580896814|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
160864333|NCT04322526|580896813|FG000|Washout (1 Week)|Lost to Follow-up|1|||
160864334|NCT04322526|580896814|FG001|Washout (1 Week)|Lost to Follow-up|2|||
160864335|NCT03205423|580896815|FG000|Overall Study|Personal|1|||
160864336|NCT03205423|580896816|FG001|Overall Study|Personal|1|||
160864337|NCT03205423|580896815|FG000|Overall Study|Physician Decision|0|||
160864338|NCT03205423|580896816|FG001|Overall Study|Physician Decision|2|||
160864339|NCT02594124|580896817|FG000|Overall Study|Adverse Event|0|||
160864340|NCT02594124|580896818|FG001|Overall Study|Adverse Event|5|||
160864341|NCT02594124|580896819|FG002|Overall Study|Adverse Event|8|||
160864342|NCT02594124|580896820|FG003|Overall Study|Adverse Event|1|||
160864343|NCT02594124|580896821|FG004|Overall Study|Adverse Event|0|||
160864344|NCT02594124|580896822|FG005|Overall Study|Adverse Event|0|||
160864345|NCT02594124|580896823|FG006|Overall Study|Adverse Event|2|||
160864346|NCT02594124|580896824|FG007|Overall Study|Adverse Event|2|||
160864347|NCT02594124|580896825|FG008|Overall Study|Adverse Event|0|||
160864348|NCT02594124|580896817|FG000|Overall Study|Withdrawal by Subject|2|||
160864349|NCT02594124|580896818|FG001|Overall Study|Withdrawal by Subject|3|||
160864350|NCT02594124|580896819|FG002|Overall Study|Withdrawal by Subject|5|||
160864351|NCT02594124|580896820|FG003|Overall Study|Withdrawal by Subject|1|||
160864352|NCT02594124|580896821|FG004|Overall Study|Withdrawal by Subject|8|||
160864353|NCT02594124|580896822|FG005|Overall Study|Withdrawal by Subject|4|||
160864354|NCT02594124|580896823|FG006|Overall Study|Withdrawal by Subject|13|||
160864355|NCT02594124|580896824|FG007|Overall Study|Withdrawal by Subject|19|||
160864356|NCT02594124|580896825|FG008|Overall Study|Withdrawal by Subject|0|||
160864357|NCT02594124|580896817|FG000|Overall Study|Physician Decision|0|||
160864358|NCT02594124|580896818|FG001|Overall Study|Physician Decision|2|||
160864359|NCT02594124|580896819|FG002|Overall Study|Physician Decision|0|||
160864360|NCT02594124|580896820|FG003|Overall Study|Physician Decision|0|||
160864361|NCT02594124|580896821|FG004|Overall Study|Physician Decision|0|||
160864362|NCT02594124|580896822|FG005|Overall Study|Physician Decision|0|||
160864363|NCT02594124|580896823|FG006|Overall Study|Physician Decision|0|||
160864364|NCT02594124|580896824|FG007|Overall Study|Physician Decision|1|||
160864365|NCT02594124|580896825|FG008|Overall Study|Physician Decision|0|||
160864366|NCT02594124|580896817|FG000|Overall Study|Commercial drug|0|||
160864367|NCT02594124|580896818|FG001|Overall Study|Commercial drug|1|||
160864368|NCT02594124|580896819|FG002|Overall Study|Commercial drug|6|||
160864369|NCT02594124|580896820|FG003|Overall Study|Commercial drug|3|||
160864370|NCT02594124|580896821|FG004|Overall Study|Commercial drug|0|||
160978099|NCT00786474|581310162|FG001|Overall Study|Lost to Follow-up|3|||
160978100|NCT00786474|581310161|FG000|Overall Study|Physician Decision|2|||
160978101|NCT00786474|581310162|FG001|Overall Study|Physician Decision|1|||
160978102|NCT00786474|581310161|FG000|Overall Study|Other|4|||
160978103|NCT00786474|581310162|FG001|Overall Study|Other|4|||
160978104|NCT04276090|581310163|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
160978105|NCT04276090|581310164|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
160978106|NCT04642469|581310166|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
160978107|NCT04642469|581310167|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
160978108|NCT04642469|581310166|FG000|Overall Study|Death|1|||
160978109|NCT04642469|581310167|FG001|Overall Study|Death|2|||
160978110|NCT04642469|581310166|FG000|Overall Study|Study/site closed following amendment 1|11|||
160978111|NCT04642469|581310167|FG001|Overall Study|Study/site closed following amendment 1|11|||
160978112|NCT04642469|581310166|FG000|Overall Study|Other|1|||
160978113|NCT04642469|581310167|FG001|Overall Study|Other|1|||
160978114|NCT04642469|581310166|FG000|Overall Study|Withdrawal by Subject|1|||
160978115|NCT04642469|581310167|FG001|Overall Study|Withdrawal by Subject|0|||
160978116|NCT01088529|581310169|FG000|Overall Study|Did not receive study treatment|0|||
160978117|NCT01088529|581310170|FG001|Overall Study|Did not receive study treatment|1|||
160978118|NCT02838628|581310172|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
160864371|NCT02594124|580896822|FG005|Overall Study|Commercial drug|0|||
160864372|NCT02594124|580896823|FG006|Overall Study|Commercial drug|7|||
160864373|NCT02594124|580896824|FG007|Overall Study|Commercial drug|11|||
160864374|NCT02594124|580896825|FG008|Overall Study|Commercial drug|2|||
160864375|NCT02594124|580896817|FG000|Overall Study|Reason Not Specified|1|||
160864376|NCT02594124|580896818|FG001|Overall Study|Reason Not Specified|3|||
160864377|NCT02594124|580896819|FG002|Overall Study|Reason Not Specified|4|||
160864378|NCT02594124|580896820|FG003|Overall Study|Reason Not Specified|0|||
160864379|NCT02594124|580896821|FG004|Overall Study|Reason Not Specified|0|||
160864380|NCT02594124|580896822|FG005|Overall Study|Reason Not Specified|1|||
160864381|NCT02594124|580896823|FG006|Overall Study|Reason Not Specified|1|||
160864382|NCT02594124|580896824|FG007|Overall Study|Reason Not Specified|6|||
160864383|NCT02594124|580896825|FG008|Overall Study|Reason Not Specified|1|||
160864384|NCT05523089|580896826|FG000|Overall Study|Withdrawal by Subject|1|||
160864385|NCT05523089|580896827|FG001|Overall Study|Withdrawal by Subject|0|||
160864386|NCT05523089|580896828|FG002|Overall Study|Withdrawal by Subject|0|||
160864387|NCT05523089|580896826|FG000|Overall Study|Lost to Follow-up|1|||
160864388|NCT05523089|580896827|FG001|Overall Study|Lost to Follow-up|0|||
160864389|NCT05523089|580896828|FG002|Overall Study|Lost to Follow-up|0|||
160864390|NCT00554216|580898835|FG000|Overall Study|Lost to Follow-up|92|||
160864391|NCT00554216|580898836|FG001|Overall Study|Lost to Follow-up|31|||
160864392|NCT00554216|580898837|FG002|Overall Study|Lost to Follow-up|63|||
160864393|NCT00554216|580898835|FG000|Overall Study|Adverse Event|16|||
160864394|NCT00554216|580898836|FG001|Overall Study|Adverse Event|16|||
160864395|NCT00554216|580898837|FG002|Overall Study|Adverse Event|36|||
160864396|NCT00554216|580898835|FG000|Overall Study|Withdrawal by Subject|92|||
160864397|NCT00554216|580898836|FG001|Overall Study|Withdrawal by Subject|31|||
160864398|NCT00554216|580898837|FG002|Overall Study|Withdrawal by Subject|43|||
160864399|NCT00554216|580898835|FG000|Overall Study|Non compliance|10|||
160864400|NCT00554216|580898836|FG001|Overall Study|Non compliance|4|||
160864401|NCT00554216|580898837|FG002|Overall Study|Non compliance|5|||
160864402|NCT00554216|580898835|FG000|Overall Study|Pregnancy|2|||
160864403|NCT00554216|580898836|FG001|Overall Study|Pregnancy|1|||
160864404|NCT00554216|580898837|FG002|Overall Study|Pregnancy|14|||
160864405|NCT00554216|580898835|FG000|Overall Study|Restricted med|3|||
160864406|NCT00554216|580898836|FG001|Overall Study|Restricted med|1|||
160864407|NCT00554216|580898837|FG002|Overall Study|Restricted med|1|||
160864408|NCT00554216|580898835|FG000|Overall Study|Other|12|||
160864409|NCT00554216|580898836|FG001|Overall Study|Other|7|||
160864410|NCT00554216|580898837|FG002|Overall Study|Other|10|||
160864411|NCT00554216|580898835|FG000|Overall Study|Lack of Efficacy|15|||
160864412|NCT00554216|580898836|FG001|Overall Study|Lack of Efficacy|3|||
160864413|NCT00554216|580898837|FG002|Overall Study|Lack of Efficacy|0|||
160978119|NCT02838628|581310173|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
160978120|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Adverse Event|1|||
160978121|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Adverse Event|0|||
160978122|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Non-compliance|0|||
160978123|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Non-compliance|1|||
160978124|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
160978125|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
160978126|NCT02838628|581310172|FG000|Recurrence Follow-up Period|Other un-specified|1|||
160978127|NCT02838628|581310173|FG001|Recurrence Follow-up Period|Other un-specified|1|||
160978128|NCT02303626|581310175|FG000|Overall Study|Lack of Efficacy|1|||
160978129|NCT02303626|581310176|FG001|Overall Study|Lack of Efficacy|0|||
160978130|NCT02303626|581310177|FG002|Overall Study|Lack of Efficacy|1|||
160978131|NCT02303626|581310175|FG000|Overall Study|Adverse Event|0|||
160978132|NCT02303626|581310176|FG001|Overall Study|Adverse Event|2|||
160978133|NCT02303626|581310177|FG002|Overall Study|Adverse Event|0|||
160978134|NCT02303626|581310175|FG000|Overall Study|Protocol Violation|0|||
160978135|NCT02303626|581310176|FG001|Overall Study|Protocol Violation|1|||
160978136|NCT02303626|581310177|FG002|Overall Study|Protocol Violation|0|||
160978137|NCT02303626|581310175|FG000|Overall Study|Pregnancy|0|||
160978138|NCT02303626|581310176|FG001|Overall Study|Pregnancy|0|||
160978139|NCT02303626|581310177|FG002|Overall Study|Pregnancy|1|||
160978140|NCT02303626|581310175|FG000|Overall Study|Subject Non-Compliance|0|||
160978141|NCT02303626|581310176|FG001|Overall Study|Subject Non-Compliance|0|||
160978142|NCT02303626|581310177|FG002|Overall Study|Subject Non-Compliance|1|||
160978143|NCT05832437|581310178|FG000|Overall Study|time off work|1|||
160978144|NCT05832437|581310179|FG001|Overall Study|time off work|0|||
160978145|NCT05832437|581310180|FG002|Overall Study|time off work|0|||
160978146|NCT05832437|581310181|FG003|Overall Study|time off work|0|||
160978147|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978148|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978149|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978150|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160864414|NCT05291520|580898838|FG000|Overall Study|Lost to Follow-up|0|||
160864415|NCT05291520|580898839|FG001|Overall Study|Lost to Follow-up|0|||
160864416|NCT05291520|580898840|FG002|Overall Study|Lost to Follow-up|1|||
160864417|NCT01347112|580898841|FG000|Overall Study|Withdrawal by Subject|1|||
160864418|NCT01347112|580898842|FG001|Overall Study|Withdrawal by Subject|7|||
160864419|NCT01347112|580898841|FG000|Overall Study|Lost to Follow-up|3|||
160864420|NCT01347112|580898842|FG001|Overall Study|Lost to Follow-up|5|||
160864421|NCT05462756|580898859|FG000|Treatment Period|Adverse Event|3|||
160864422|NCT05462756|580898860|FG001|Treatment Period|Adverse Event|0|||
160864423|NCT05462756|580898859|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
160864424|NCT05462756|580898860|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
160864425|NCT05462756|580898859|FG000|Treatment Period|Death|0|||
160864426|NCT05462756|580898860|FG001|Treatment Period|Death|1|||
160864427|NCT05462756|580898859|FG000|Treatment Period|Lost to Follow-up|2|||
160864428|NCT05462756|580898860|FG001|Treatment Period|Lost to Follow-up|1|||
160864429|NCT05462756|580898859|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
160864430|NCT05462756|580898860|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
160864431|NCT05462756|580898859|FG000|Treatment Period|Physician Decision|2|||
160864432|NCT05462756|580898860|FG001|Treatment Period|Physician Decision|0|||
160864433|NCT05462756|580898859|FG000|Treatment Period|Protocol Violation|0|||
160864434|NCT05462756|580898860|FG001|Treatment Period|Protocol Violation|1|||
160864435|NCT05462756|580898859|FG000|Treatment Period|Withdrawal by Subject|5|||
160864436|NCT05462756|580898860|FG001|Treatment Period|Withdrawal by Subject|12|||
160864437|NCT05462756|580898859|FG000|Follow-Up Period|Adverse Event|1|||
160864438|NCT05462756|580898860|FG001|Follow-Up Period|Adverse Event|0|||
160864439|NCT05462756|580898859|FG000|Follow-Up Period|Death|1|||
160864440|NCT05462756|580898860|FG001|Follow-Up Period|Death|0|||
160864441|NCT05462756|580898859|FG000|Follow-Up Period|Lost to Follow-up|3|||
160864442|NCT05462756|580898860|FG001|Follow-Up Period|Lost to Follow-up|1|||
160864443|NCT05462756|580898859|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160864444|NCT05462756|580898860|FG001|Follow-Up Period|Withdrawal by Subject|4|||
160864445|NCT01432730|580898865|FG000|Period 1|Adverse Event|2|||
160864446|NCT01432730|580898866|FG001|Period 1|Adverse Event|0|||
160864447|NCT01432730|580898865|FG000|Period 2|Adverse Event|0|||
160864448|NCT01432730|580898866|FG001|Period 2|Adverse Event|4|||
160864449|NCT01421719|580898867|FG000|Overall Study|Withdrawal by Subject|4|||
160864450|NCT01281124|580898872|FG000|Overall Study|Death|1|||
160864451|NCT01198795|580898873|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
160864452|NCT01198795|580898873|FG000|Overall Study|Withdrawal by Subject|17|||
160864453|NCT01198795|580898873|FG000|Overall Study|Lost to Follow-up|15|||
160864454|NCT01198795|580898873|FG000|Overall Study|Adverse Event|9|||
160864455|NCT01198795|580898873|FG000|Overall Study|Lack of Efficacy|5|||
160864456|NCT01198795|580898873|FG000|Overall Study|Protocol Violation|2|||
160864457|NCT01198795|580898873|FG000|Overall Study|Other Reason|4|||
160864458|NCT00706238|580898874|FG000|Overall Study|Disease progression|4|||
160864459|NCT00706238|580898874|FG000|Overall Study|Other|1|||
160864460|NCT04226742|580898875|FG000|Overall Study|Lost to Follow-up|16|||
160864461|NCT04226742|580898876|FG001|Overall Study|Lost to Follow-up|13|||
160864462|NCT04226742|580898875|FG000|Overall Study|Withdrawal by Subject|5|||
160864463|NCT04226742|580898876|FG001|Overall Study|Withdrawal by Subject|3|||
160864464|NCT05097963|580898879|FG000|Overall Study|Protocol Violation|13|||
160864465|NCT05097963|580898879|FG000|Overall Study|Withdrawal by Subject|21|||
160864466|NCT02492763|580898880|FG000|Overall Study|Withdrawal by Subject|0|||
160864467|NCT02492763|580898881|FG001|Overall Study|Withdrawal by Subject|2|||
160864468|NCT02492763|580898882|FG002|Overall Study|Withdrawal by Subject|1|||
160864469|NCT02492763|580898883|FG003|Overall Study|Withdrawal by Subject|0|||
160864470|NCT02492763|580898880|FG000|Overall Study|Adverse Event|3|||
160864471|NCT02492763|580898881|FG001|Overall Study|Adverse Event|1|||
160864472|NCT02492763|580898882|FG002|Overall Study|Adverse Event|1|||
160864473|NCT02492763|580898883|FG003|Overall Study|Adverse Event|2|||
160864474|NCT02492763|580898880|FG000|Overall Study|Death|0|||
160864475|NCT02492763|580898881|FG001|Overall Study|Death|0|||
160864476|NCT02492763|580898882|FG002|Overall Study|Death|1|||
160864477|NCT02492763|580898883|FG003|Overall Study|Death|0|||
160864478|NCT02492763|580898880|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
160864479|NCT02492763|580898881|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
160864480|NCT02492763|580898882|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
160864481|NCT02492763|580898883|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
160864482|NCT02492763|580898880|FG000|Overall Study|Lost to Follow-up|0|||
160864483|NCT02492763|580898881|FG001|Overall Study|Lost to Follow-up|0|||
160864484|NCT02492763|580898882|FG002|Overall Study|Lost to Follow-up|1|||
160864485|NCT02492763|580898883|FG003|Overall Study|Lost to Follow-up|0|||
160864486|NCT02492763|580898880|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160864487|NCT02492763|580898881|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160864488|NCT02492763|580898882|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160864489|NCT02492763|580898883|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160864490|NCT02492763|580898880|FG000|Overall Study|Screen Failure|0|||
160864491|NCT02492763|580898881|FG001|Overall Study|Screen Failure|0|||
160864492|NCT02492763|580898882|FG002|Overall Study|Screen Failure|0|||
161322154|NCT05052697|582566517|FG019|Substudy A|Lost to Follow-up|0|||
160864493|NCT02492763|580898883|FG003|Overall Study|Screen Failure|1|||
160864494|NCT02492763|580898880|FG000|Overall Study|Study Terminated by Sponsor|13|||
160996802|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160864495|NCT02492763|580898881|FG001|Overall Study|Study Terminated by Sponsor|10|||
160864496|NCT02492763|580898882|FG002|Overall Study|Study Terminated by Sponsor|6|||
160864497|NCT02492763|580898883|FG003|Overall Study|Study Terminated by Sponsor|10|||
160864498|NCT01193244|580898884|FG000|Overall Study|Withdrawal by Subject|79|||
160864499|NCT01193244|580898885|FG001|Overall Study|Withdrawal by Subject|97|||
160864500|NCT01193244|580898884|FG000|Overall Study|Other|303|||
160864501|NCT01193244|580898885|FG001|Overall Study|Other|278|||
160864502|NCT01193244|580898884|FG000|Overall Study|Lost to Follow-up|6|||
160864503|NCT01193244|580898885|FG001|Overall Study|Lost to Follow-up|15|||
160864504|NCT02395471|580898895|FG000|Overall Study|Lost to Follow-up|2|||
160864505|NCT02395471|580898896|FG001|Overall Study|Lost to Follow-up|0|||
160864506|NCT02395471|580898895|FG000|Overall Study|Withdrawal by Subject|2|||
160864507|NCT02395471|580898896|FG001|Overall Study|Withdrawal by Subject|1|||
160864508|NCT02395471|580898895|FG000|Overall Study|Physician Decision|1|||
160864509|NCT02395471|580898896|FG001|Overall Study|Physician Decision|0|||
160864510|NCT02395471|580898895|FG000|Overall Study|Protocol Violation|0|||
160864511|NCT02395471|580898896|FG001|Overall Study|Protocol Violation|1|||
160864512|NCT02395471|580898895|FG000|Overall Study|Failure to swollow sponge twice|1|||
160864513|NCT02395471|580898896|FG001|Overall Study|Failure to swollow sponge twice|0|||
160864514|NCT02395471|580898895|FG000|Overall Study|Patient did not return for procedure|0|||
160864515|NCT02395471|580898896|FG001|Overall Study|Patient did not return for procedure|1|||
160864516|NCT02395471|580898895|FG000|Overall Study|Subject not eligible|1|||
160864517|NCT02395471|580898896|FG001|Overall Study|Subject not eligible|0|||
160864518|NCT03847896|580898897|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864519|NCT03847896|580898898|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864520|NCT03847896|580898899|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
160864521|NCT03847896|580898900|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864522|NCT03847896|580898901|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
160864523|NCT03847896|580898897|FG000|Overall Study|Withdrawal by Subject|2|||
160864524|NCT03847896|580898898|FG001|Overall Study|Withdrawal by Subject|10|||
160864525|NCT03847896|580898899|FG002|Overall Study|Withdrawal by Subject|5|||
160864526|NCT03847896|580898900|FG003|Overall Study|Withdrawal by Subject|9|||
160864527|NCT03847896|580898901|FG004|Overall Study|Withdrawal by Subject|8|||
160864528|NCT03847896|580898897|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160864529|NCT03847896|580898898|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160864530|NCT03847896|580898899|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160864531|NCT03847896|580898900|FG003|Overall Study|Withdrawal by parent/guardian|0|||
160864532|NCT03847896|580898901|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160864533|NCT03847896|580898897|FG000|Overall Study|Adverse Event|2|||
160864534|NCT03847896|580898898|FG001|Overall Study|Adverse Event|1|||
160864535|NCT03847896|580898899|FG002|Overall Study|Adverse Event|3|||
160864536|NCT03847896|580898900|FG003|Overall Study|Adverse Event|2|||
160864537|NCT03847896|580898901|FG004|Overall Study|Adverse Event|4|||
160864538|NCT03847896|580898897|FG000|Overall Study|A severe exacerbation event|0|||
160864539|NCT03847896|580898898|FG001|Overall Study|A severe exacerbation event|0|||
160864540|NCT03847896|580898899|FG002|Overall Study|A severe exacerbation event|0|||
160864541|NCT03847896|580898900|FG003|Overall Study|A severe exacerbation event|0|||
160864542|NCT03847896|580898901|FG004|Overall Study|A severe exacerbation event|3|||
160864543|NCT03847896|580898897|FG000|Overall Study|Protocol Violation|0|||
160864544|NCT03847896|580898898|FG001|Overall Study|Protocol Violation|2|||
160864545|NCT03847896|580898899|FG002|Overall Study|Protocol Violation|1|||
160864546|NCT03847896|580898900|FG003|Overall Study|Protocol Violation|0|||
160864547|NCT03847896|580898901|FG004|Overall Study|Protocol Violation|2|||
160864548|NCT03847896|580898897|FG000|Overall Study|Lost to Follow-up|0|||
160864549|NCT03847896|580898898|FG001|Overall Study|Lost to Follow-up|0|||
160864550|NCT03847896|580898899|FG002|Overall Study|Lost to Follow-up|0|||
160864551|NCT03847896|580898900|FG003|Overall Study|Lost to Follow-up|1|||
160864552|NCT03847896|580898901|FG004|Overall Study|Lost to Follow-up|0|||
160864553|NCT03847896|580898897|FG000|Overall Study|Condition under investigation worsened|0|||
160864554|NCT03847896|580898898|FG001|Overall Study|Condition under investigation worsened|0|||
160864555|NCT03847896|580898899|FG002|Overall Study|Condition under investigation worsened|0|||
160864556|NCT03847896|580898900|FG003|Overall Study|Condition under investigation worsened|1|||
160864557|NCT03847896|580898901|FG004|Overall Study|Condition under investigation worsened|1|||
160864558|NCT03847896|580898897|FG000|Overall Study|Lack of Efficacy|0|||
160864559|NCT03847896|580898898|FG001|Overall Study|Lack of Efficacy|0|||
160864560|NCT03847896|580898899|FG002|Overall Study|Lack of Efficacy|0|||
160864561|NCT03847896|580898900|FG003|Overall Study|Lack of Efficacy|2|||
160864562|NCT03847896|580898901|FG004|Overall Study|Lack of Efficacy|2|||
160864563|NCT03847896|580898897|FG000|Overall Study|Other reasons|3|||
160864564|NCT03847896|580898898|FG001|Overall Study|Other reasons|3|||
160864565|NCT03847896|580898899|FG002|Overall Study|Other reasons|1|||
160978151|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160864566|NCT03847896|580898900|FG003|Overall Study|Other reasons|2|||
160864567|NCT03847896|580898901|FG004|Overall Study|Other reasons|1|||
160864568|NCT01039376|580898902|FG000|Overall Study|Lost to Follow-up|5|||
160864569|NCT01039376|580898903|FG001|Overall Study|Lost to Follow-up|12|||
160864570|NCT01039376|580898902|FG000|Overall Study|Physician Decision|15|||
160864571|NCT01039376|580898903|FG001|Overall Study|Physician Decision|10|||
160864572|NCT01039376|580898902|FG000|Overall Study|Withdrawal by Subject|20|||
160864573|NCT01039376|580898903|FG001|Overall Study|Withdrawal by Subject|32|||
160864574|NCT01039376|580898902|FG000|Overall Study|Study terminated by Sponsor|90|||
160864575|NCT01039376|580898903|FG001|Overall Study|Study terminated by Sponsor|72|||
160864576|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
160864577|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
160864578|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Adverse Event|31|||
160864579|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Adverse Event|21|||
160864580|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
160864581|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
160864582|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
160864583|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
160864584|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
160864585|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
160864586|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
160864587|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
160864588|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Administrative problems|3|||
160864589|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Administrative problems|3|||
160864590|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Death|5|||
160864591|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Death|8|||
160864592|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Disease progression|139|||
160864593|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Disease progression|119|||
160864594|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
160864595|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
160864596|NCT00785785|580898904|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
160864597|NCT00785785|580898905|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
160864598|NCT00785785|580898904|FG000|Optional Extension Phase|Adverse Event|4|||
160864599|NCT00785785|580898905|FG001|Optional Extension Phase|Adverse Event|5|||
160864600|NCT00785785|580898904|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
160864601|NCT00785785|580898905|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
160864602|NCT00785785|580898904|FG000|Optional Extension Phase|Lost to Follow-up|1|||
160864603|NCT00785785|580898905|FG001|Optional Extension Phase|Lost to Follow-up|0|||
160864604|NCT00785785|580898904|FG000|Optional Extension Phase|Administrative problems|2|||
160864605|NCT00785785|580898905|FG001|Optional Extension Phase|Administrative problems|0|||
160864606|NCT00785785|580898904|FG000|Optional Extension Phase|Death|1|||
160864607|NCT00785785|580898905|FG001|Optional Extension Phase|Death|5|||
160864608|NCT00785785|580898904|FG000|Optional Extension Phase|Disease progression|22|||
160864609|NCT00785785|580898905|FG001|Optional Extension Phase|Disease progression|70|||
160864610|NCT00785785|580898904|FG000|Optional Extension Phase|Protocol deviation|0|||
160864611|NCT00785785|580898905|FG001|Optional Extension Phase|Protocol deviation|2|||
160864612|NCT00785785|580898904|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
160864613|NCT00785785|580898905|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
160864614|NCT03252925|580898906|FG000|Overall Study|Withdrawal by Subject|1|||
160864615|NCT03252925|580898907|FG001|Overall Study|Withdrawal by Subject|0|||
160864616|NCT03252925|580898906|FG000|Overall Study|Protocol Violation|6|||
160864617|NCT03252925|580898907|FG001|Overall Study|Protocol Violation|0|||
160864618|NCT03252925|580898906|FG000|Overall Study|Adverse Event|1|||
160864619|NCT03252925|580898907|FG001|Overall Study|Adverse Event|0|||
160864620|NCT03252925|580898906|FG000|Overall Study|Lost to Follow-up|6|||
160864621|NCT03252925|580898907|FG001|Overall Study|Lost to Follow-up|6|||
160864622|NCT01244893|580898908|FG000|Baseline|Protocol Violation|0|||
160864623|NCT01244893|580898909|FG001|Baseline|Protocol Violation|1|||
160864624|NCT01244893|580898908|FG000|1-Week Follow Up|Lost to Follow-up|1|||
160864625|NCT01244893|580898909|FG001|1-Week Follow Up|Lost to Follow-up|0|||
160864626|NCT00357552|580898910|FG000|Screening|Did not meet eligibility criteria|84|||
160864627|NCT00357552|580898910|FG000|Weeks 0 to 24|Death|1|||
160864628|NCT00357552|580898910|FG000|Weeks 24 to 104|Death|3|||
160864629|NCT00357552|580898910|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
160864630|NCT00521404|580898913|FG000|Overall Study|Adverse Event|13|||
160864631|NCT00521404|580898913|FG000|Overall Study|Disease Progression|33|||
160864632|NCT00521404|580898913|FG000|Overall Study|Investigator decision|5|||
160864633|NCT00521404|580898913|FG000|Overall Study|Withdrawal of consent|3|||
160978152|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978153|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
160978154|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
160978155|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978156|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
160978157|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978158|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978159|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978160|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160864634|NCT00521404|580898913|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
160864635|NCT00521404|580898913|FG000|Overall Study|Other|7|||
160864636|NCT04555616|580898916|FG000|Overall Study|Death|1|||
160864637|NCT04555616|580898917|FG001|Overall Study|Death|0|||
160864638|NCT04555616|580898918|FG002|Overall Study|Death|1|||
160864639|NCT04555616|580898916|FG000|Overall Study|Withdrawal by Subject|2|||
160864640|NCT04555616|580898917|FG001|Overall Study|Withdrawal by Subject|1|||
160864641|NCT04555616|580898918|FG002|Overall Study|Withdrawal by Subject|0|||
160864642|NCT00882557|580898919|FG000|Overall Study|Withdrawal by Subject|1|||
160864643|NCT00882557|580898920|FG001|Overall Study|Withdrawal by Subject|0|||
160864644|NCT00882557|580898919|FG000|Overall Study|Trouble with Vein Access|1|||
160864645|NCT00882557|580898920|FG001|Overall Study|Trouble with Vein Access|0|||
160864646|NCT00882557|580898919|FG000|Overall Study|Randomized Not Treated|0|||
160864647|NCT00882557|580898920|FG001|Overall Study|Randomized Not Treated|1|||
160864648|NCT02282605|580898921|FG000|Overall Study|negative SA result on Day -1|3|||
160864649|NCT02282605|580898922|FG001|Overall Study|negative SA result on Day -1|0|||
160864650|NCT02282605|580898923|FG002|Overall Study|negative SA result on Day -1|0|||
160864651|NCT00711191|580898924|FG000|Overall Study|Adverse Event|1|||
160864652|NCT00711191|580898925|FG001|Overall Study|Adverse Event|1|||
160864653|NCT00711191|580898926|FG002|Overall Study|Adverse Event|2|||
160864654|NCT00711191|580898924|FG000|Overall Study|Objective progression or relapse|2|||
160864655|NCT00711191|580898925|FG001|Overall Study|Objective progression or relapse|3|||
160864656|NCT00711191|580898926|FG002|Overall Study|Objective progression or relapse|7|||
160864657|NCT00711191|580898924|FG000|Overall Study|Withdrawal by Subject|0|||
160864658|NCT00711191|580898925|FG001|Overall Study|Withdrawal by Subject|1|||
160864659|NCT00711191|580898926|FG002|Overall Study|Withdrawal by Subject|3|||
160864660|NCT02035267|580898927|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
160864661|NCT02035267|580898928|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
160864662|NCT02035267|580898929|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
160864663|NCT02035267|580898930|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
160864664|NCT02035267|580898927|FG000|Overall Study|Adverse Event|0|||
160864665|NCT02035267|580898928|FG001|Overall Study|Adverse Event|0|||
160864666|NCT02035267|580898929|FG002|Overall Study|Adverse Event|1|||
160864667|NCT02035267|580898930|FG003|Overall Study|Adverse Event|0|||
160864668|NCT02035267|580898927|FG000|Overall Study|Lost to Follow-up|0|||
160864669|NCT02035267|580898928|FG001|Overall Study|Lost to Follow-up|0|||
160864670|NCT02035267|580898929|FG002|Overall Study|Lost to Follow-up|0|||
160864671|NCT02035267|580898930|FG003|Overall Study|Lost to Follow-up|1|||
160864672|NCT02035267|580898927|FG000|Overall Study|Other unspecified|0|||
160864673|NCT02035267|580898928|FG001|Overall Study|Other unspecified|1|||
160864674|NCT02035267|580898929|FG002|Overall Study|Other unspecified|0|||
160864675|NCT02035267|580898930|FG003|Overall Study|Other unspecified|0|||
160864676|NCT03038880|580898936|FG000|Overall Study|Death|1|||
160864677|NCT03038880|580898937|FG001|Overall Study|Death|2|||
160864678|NCT03038880|580898938|FG002|Overall Study|Death|0|||
160864679|NCT03038880|580898936|FG000|Overall Study|Physician Decision|2|||
160864680|NCT03038880|580898937|FG001|Overall Study|Physician Decision|1|||
160864681|NCT03038880|580898938|FG002|Overall Study|Physician Decision|0|||
160864682|NCT03926611|580898943|FG000|Overall Study|Adverse Event|0|||
160864683|NCT03926611|580898944|FG001|Overall Study|Adverse Event|0|||
160864684|NCT03926611|580898945|FG002|Overall Study|Adverse Event|0|||
160864685|NCT03926611|580898946|FG003|Overall Study|Adverse Event|3|||
160864686|NCT03926611|580898947|FG004|Overall Study|Adverse Event|1|||
160864687|NCT03926611|580898948|FG005|Overall Study|Adverse Event|3|||
160864688|NCT03926611|580898949|FG006|Overall Study|Adverse Event|0|||
160864689|NCT03926611|580898943|FG000|Overall Study|Lack of Efficacy|1|||
160864690|NCT03926611|580898944|FG001|Overall Study|Lack of Efficacy|2|||
160864691|NCT03926611|580898945|FG002|Overall Study|Lack of Efficacy|0|||
160864692|NCT03926611|580898946|FG003|Overall Study|Lack of Efficacy|0|||
160864693|NCT03926611|580898947|FG004|Overall Study|Lack of Efficacy|1|||
160864694|NCT03926611|580898948|FG005|Overall Study|Lack of Efficacy|0|||
160864695|NCT03926611|580898949|FG006|Overall Study|Lack of Efficacy|1|||
160864696|NCT03926611|580898943|FG000|Overall Study|Physician Decision|0|||
160864697|NCT03926611|580898944|FG001|Overall Study|Physician Decision|0|||
160864698|NCT03926611|580898945|FG002|Overall Study|Physician Decision|0|||
160864699|NCT03926611|580898946|FG003|Overall Study|Physician Decision|0|||
160864700|NCT03926611|580898947|FG004|Overall Study|Physician Decision|0|||
160864701|NCT03926611|580898948|FG005|Overall Study|Physician Decision|1|||
160864702|NCT03926611|580898949|FG006|Overall Study|Physician Decision|0|||
160864703|NCT03926611|580898943|FG000|Overall Study|Protocol Violation|1|||
160864704|NCT03926611|580898944|FG001|Overall Study|Protocol Violation|0|||
160864705|NCT03926611|580898945|FG002|Overall Study|Protocol Violation|0|||
160864706|NCT03926611|580898946|FG003|Overall Study|Protocol Violation|1|||
160864707|NCT03926611|580898947|FG004|Overall Study|Protocol Violation|1|||
160864708|NCT03926611|580898948|FG005|Overall Study|Protocol Violation|1|||
160864709|NCT03926611|580898949|FG006|Overall Study|Protocol Violation|1|||
160864710|NCT03926611|580898943|FG000|Overall Study|Technical problems|0|||
160864711|NCT03926611|580898944|FG001|Overall Study|Technical problems|0|||
160864712|NCT03926611|580898945|FG002|Overall Study|Technical problems|0|||
160864713|NCT03926611|580898946|FG003|Overall Study|Technical problems|0|||
160864714|NCT03926611|580898947|FG004|Overall Study|Technical problems|0|||
160864715|NCT03926611|580898948|FG005|Overall Study|Technical problems|1|||
160864716|NCT03926611|580898949|FG006|Overall Study|Technical problems|0|||
160864717|NCT03926611|580898943|FG000|Overall Study|Withdrawal by Subject|1|||
160864718|NCT03926611|580898944|FG001|Overall Study|Withdrawal by Subject|1|||
160864719|NCT03926611|580898945|FG002|Overall Study|Withdrawal by Subject|1|||
160864720|NCT03926611|580898946|FG003|Overall Study|Withdrawal by Subject|0|||
160864721|NCT03926611|580898947|FG004|Overall Study|Withdrawal by Subject|0|||
160864722|NCT03926611|580898948|FG005|Overall Study|Withdrawal by Subject|1|||
160864723|NCT03926611|580898949|FG006|Overall Study|Withdrawal by Subject|3|||
160864724|NCT03926611|580898943|FG000|Overall Study|Covid-19 pandemic|0|||
160864725|NCT03926611|580898944|FG001|Overall Study|Covid-19 pandemic|0|||
160864726|NCT03926611|580898945|FG002|Overall Study|Covid-19 pandemic|1|||
160864727|NCT03926611|580898946|FG003|Overall Study|Covid-19 pandemic|0|||
160864728|NCT03926611|580898947|FG004|Overall Study|Covid-19 pandemic|1|||
160864729|NCT03926611|580898948|FG005|Overall Study|Covid-19 pandemic|2|||
160864730|NCT03926611|580898949|FG006|Overall Study|Covid-19 pandemic|0|||
160864731|NCT01657019|580898950|FG000|Overall Study|Withdrawal by Subject|65|||
160864732|NCT01657019|580898950|FG000|Overall Study|Adverse Event|55|||
160864733|NCT01657019|580898950|FG000|Overall Study|Lost to Follow-up|48|||
160864734|NCT01657019|580898950|FG000|Overall Study|Protocol Violation|6|||
160864735|NCT01657019|580898950|FG000|Overall Study|Lack of Efficacy|3|||
160864736|NCT01657019|580898950|FG000|Overall Study|Other|58|||
160864737|NCT01744977|580898951|FG000|Overall Study|Withdrawal by Subject|1|||
160864738|NCT01744977|580898952|FG001|Overall Study|Withdrawal by Subject|2|||
160864739|NCT01744977|580898951|FG000|Overall Study|Death|2|||
160864740|NCT01744977|580898952|FG001|Overall Study|Death|3|||
160864741|NCT01744977|580898951|FG000|Overall Study|Lost to Follow-up|2|||
160864742|NCT01744977|580898952|FG001|Overall Study|Lost to Follow-up|0|||
160864743|NCT01744977|580898951|FG000|Overall Study|No longer meets inclusion|6|||
160864744|NCT01744977|580898952|FG001|Overall Study|No longer meets inclusion|0|||
160864745|NCT01750229|580898955|FG000|Randomized Crossover Phase|Adverse Event|1|||
160864746|NCT01750229|580898955|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
160864747|NCT01750229|580898955|FG000|Long-term Follow-up Phase|Adverse Event|2|||
160864748|NCT01750229|580898955|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
160864749|NCT03774576|580898956|FG000|Period 2|Adverse Event|1|||
160864750|NCT02796170|580898957|FG000|Overall Study|Lost to Follow-up|3|||
160864751|NCT02796170|580898958|FG001|Overall Study|Lost to Follow-up|0|||
160864752|NCT01527370|580898959|FG000|Overall Study|Withdrawal by Subject|4|||
160864753|NCT01527370|580898959|FG000|Overall Study|Physician Decision|1|||
160864754|NCT01527370|580898959|FG000|Overall Study|Death|1|||
160864755|NCT00912808|580898960|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
160864756|NCT00912808|580898961|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160864757|NCT00912808|580898960|FG000|Washout|Withdrawal by Subject|0|||
160864758|NCT00912808|580898961|FG001|Washout|Withdrawal by Subject|1|||
160864759|NCT00912808|580898960|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160864760|NCT00912808|580898961|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
160864761|NCT00912808|580898960|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
160864762|NCT00912808|580898961|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
160864763|NCT00702221|580898962|FG000|Overall Study|Adverse Event|4|||
160864764|NCT00702221|580898963|FG001|Overall Study|Adverse Event|3|||
160864765|NCT02900378|580898964|FG000|Randomization (Visit 2)|Adverse Event|14|||
160864766|NCT02900378|580898965|FG001|Randomization (Visit 2)|Adverse Event|11|||
160864767|NCT02900378|580898964|FG000|Randomization (Visit 2)|Death|1|||
160864768|NCT02900378|580898965|FG001|Randomization (Visit 2)|Death|4|||
160864769|NCT02900378|580898964|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
160864770|NCT02900378|580898965|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
160864771|NCT02900378|580898964|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
160864772|NCT02900378|580898965|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
160864773|NCT02900378|580898964|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
160864774|NCT02900378|580898965|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
160864775|NCT02900378|580898964|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
160864776|NCT02900378|580898965|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
160864777|NCT02900378|580898964|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
160978161|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978162|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160864778|NCT02900378|580898965|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
160864779|NCT01134055|580898968|FG000|Overall Study|Adverse Event|5|||
160864780|NCT01134055|580898969|FG001|Overall Study|Adverse Event|2|||
160864781|NCT01134055|580898970|FG002|Overall Study|Adverse Event|2|||
160864782|NCT01134055|580898971|FG003|Overall Study|Adverse Event|2|||
160864783|NCT01134055|580898972|FG004|Overall Study|Adverse Event|5|||
160864784|NCT01134055|580898973|FG005|Overall Study|Adverse Event|7|||
160864785|NCT01134055|580898974|FG006|Overall Study|Adverse Event|2|||
160864786|NCT01134055|580898968|FG000|Overall Study|Lost to Follow-up|0|||
160978163|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978164|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
160978165|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978166|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
160978167|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978168|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978169|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978170|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978171|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978172|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978173|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978174|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
160978175|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978176|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
160978177|NCT04159415|581310182|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978178|NCT04159415|581310183|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978179|NCT04159415|581310184|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978180|NCT04159415|581310185|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978181|NCT04159415|581310186|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978182|NCT04159415|581310187|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978183|NCT04159415|581310188|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978184|NCT04159415|581310189|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978185|NCT04159415|581310190|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
160978186|NCT04159415|581310191|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
160978187|NCT05407311|581310192|FG000|Overall Study|Withdrawal by Subject|5|||
160978188|NCT05407311|581310192|FG000|Overall Study|Protocol Violation|3|||
160978189|NCT05407311|581310192|FG000|Overall Study|Physician Decision|1|||
160978190|NCT05407311|581310192|FG000|Overall Study|Non-compliance|1|||
160978191|NCT00337662|581310193|FG000|Study Period II|Lost to Follow-up|0|||
160978192|NCT00337662|581310194|FG001|Study Period II|Lost to Follow-up|0|||
160978193|NCT00337662|581310195|FG002|Study Period II|Lost to Follow-up|0|||
160978194|NCT00337662|581310196|FG003|Study Period II|Lost to Follow-up|35|||
160978195|NCT00337662|581310193|FG000|Study Period II|Withdrawal by Subject|0|||
160978196|NCT00337662|581310194|FG001|Study Period II|Withdrawal by Subject|0|||
160978197|NCT00337662|581310195|FG002|Study Period II|Withdrawal by Subject|0|||
160978198|NCT00337662|581310196|FG003|Study Period II|Withdrawal by Subject|20|||
160978199|NCT00337662|581310193|FG000|Study Period II|Adverse Event|0|||
160978200|NCT00337662|581310194|FG001|Study Period II|Adverse Event|0|||
160978201|NCT00337662|581310195|FG002|Study Period II|Adverse Event|0|||
160978202|NCT00337662|581310196|FG003|Study Period II|Adverse Event|16|||
160978203|NCT00337662|581310193|FG000|Study Period II|Physician Decision|0|||
160978204|NCT00337662|581310194|FG001|Study Period II|Physician Decision|0|||
160978205|NCT00337662|581310195|FG002|Study Period II|Physician Decision|0|||
160978206|NCT00337662|581310196|FG003|Study Period II|Physician Decision|13|||
160978207|NCT00337662|581310193|FG000|Study Period II|Entry Criteria Not Met|0|||
160978208|NCT00337662|581310194|FG001|Study Period II|Entry Criteria Not Met|0|||
160978209|NCT00337662|581310195|FG002|Study Period II|Entry Criteria Not Met|0|||
160978210|NCT00337662|581310196|FG003|Study Period II|Entry Criteria Not Met|6|||
160978211|NCT00337662|581310193|FG000|Study Period II|Protocol Violation|0|||
160978212|NCT00337662|581310194|FG001|Study Period II|Protocol Violation|0|||
161092556|NCT03818204|581729902|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092557|NCT03818204|581729903|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092558|NCT03818204|581729904|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092559|NCT03818204|581729905|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
161092560|NCT03818204|581729906|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092561|NCT03818204|581729907|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092562|NCT03818204|581729908|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092563|NCT03818204|581729909|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092564|NCT03818204|581729910|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
161092565|NCT03818204|581729892|FG000|Overall Study|Physician Decision|0|||
161092566|NCT03818204|581729893|FG001|Overall Study|Physician Decision|0|||
161092567|NCT03818204|581729894|FG002|Overall Study|Physician Decision|0|||
161092568|NCT03818204|581729895|FG003|Overall Study|Physician Decision|0|||
161092569|NCT03818204|581729896|FG004|Overall Study|Physician Decision|0|||
160978213|NCT00337662|581310195|FG002|Study Period II|Protocol Violation|0|||
160978214|NCT00337662|581310196|FG003|Study Period II|Protocol Violation|6|||
160978215|NCT00337662|581310193|FG000|Study Period II|Lack of Efficacy|0|||
160978216|NCT00337662|581310194|FG001|Study Period II|Lack of Efficacy|0|||
160978217|NCT00337662|581310195|FG002|Study Period II|Lack of Efficacy|0|||
160978218|NCT00337662|581310196|FG003|Study Period II|Lack of Efficacy|7|||
160978219|NCT00337662|581310193|FG000|Study Period II|Sponsor Decision|0|||
160978220|NCT00337662|581310194|FG001|Study Period II|Sponsor Decision|0|||
160978221|NCT00337662|581310195|FG002|Study Period II|Sponsor Decision|0|||
160978222|NCT00337662|581310196|FG003|Study Period II|Sponsor Decision|2|||
160978223|NCT00337662|581310193|FG000|Study Period II|Parent/Caregiver Decision|0|||
160978224|NCT00337662|581310194|FG001|Study Period II|Parent/Caregiver Decision|0|||
160978225|NCT00337662|581310195|FG002|Study Period II|Parent/Caregiver Decision|0|||
160978226|NCT00337662|581310196|FG003|Study Period II|Parent/Caregiver Decision|1|||
160978227|NCT00337662|581310193|FG000|Study Period III|Lost to Follow-up|14|||
160978228|NCT00337662|581310194|FG001|Study Period III|Lost to Follow-up|16|||
160978229|NCT00337662|581310195|FG002|Study Period III|Lost to Follow-up|14|||
160978230|NCT00337662|581310196|FG003|Study Period III|Lost to Follow-up|0|||
160978231|NCT00337662|581310193|FG000|Study Period III|Withdrawal by Subject|18|||
160978232|NCT00337662|581310194|FG001|Study Period III|Withdrawal by Subject|14|||
160978233|NCT00337662|581310195|FG002|Study Period III|Withdrawal by Subject|12|||
160978234|NCT00337662|581310196|FG003|Study Period III|Withdrawal by Subject|0|||
160978235|NCT00337662|581310193|FG000|Study Period III|Adverse Event|9|||
160978236|NCT00337662|581310194|FG001|Study Period III|Adverse Event|10|||
160978237|NCT00337662|581310195|FG002|Study Period III|Adverse Event|8|||
160978238|NCT00337662|581310196|FG003|Study Period III|Adverse Event|0|||
160978239|NCT00337662|581310193|FG000|Study Period III|Protocol Violation|3|||
160978240|NCT00337662|581310194|FG001|Study Period III|Protocol Violation|8|||
160978241|NCT00337662|581310195|FG002|Study Period III|Protocol Violation|2|||
160978242|NCT00337662|581310196|FG003|Study Period III|Protocol Violation|0|||
160978243|NCT00337662|581310193|FG000|Study Period III|Physician Decision|6|||
160978244|NCT00337662|581310194|FG001|Study Period III|Physician Decision|5|||
160978245|NCT00337662|581310195|FG002|Study Period III|Physician Decision|0|||
160978246|NCT00337662|581310196|FG003|Study Period III|Physician Decision|0|||
160978247|NCT00337662|581310193|FG000|Study Period III|Entry Criteria Not Met|4|||
160978248|NCT00337662|581310194|FG001|Study Period III|Entry Criteria Not Met|1|||
160978249|NCT00337662|581310195|FG002|Study Period III|Entry Criteria Not Met|3|||
160978250|NCT00337662|581310196|FG003|Study Period III|Entry Criteria Not Met|0|||
160978251|NCT00337662|581310193|FG000|Study Period III|Lack of Efficacy|4|||
160978252|NCT00337662|581310194|FG001|Study Period III|Lack of Efficacy|4|||
160978253|NCT00337662|581310195|FG002|Study Period III|Lack of Efficacy|2|||
161322155|NCT05052697|582566518|FG020|Substudy A|Lost to Follow-up|0|||
160978254|NCT00337662|581310196|FG003|Study Period III|Lack of Efficacy|0|||
160978255|NCT00337662|581310193|FG000|Study Period III|Parent/Caregiver Decision|0|||
160978256|NCT00337662|581310194|FG001|Study Period III|Parent/Caregiver Decision|0|||
160978257|NCT00337662|581310195|FG002|Study Period III|Parent/Caregiver Decision|2|||
160978258|NCT00337662|581310196|FG003|Study Period III|Parent/Caregiver Decision|0|||
160978259|NCT00337662|581310193|FG000|Study Period III|Sponsor Decision|1|||
160978260|NCT00337662|581310194|FG001|Study Period III|Sponsor Decision|0|||
160978261|NCT00337662|581310195|FG002|Study Period III|Sponsor Decision|1|||
160978262|NCT00337662|581310196|FG003|Study Period III|Sponsor Decision|0|||
160978263|NCT00337662|581310193|FG000|Study Period III|Clinical Relapse|1|||
160978264|NCT00337662|581310194|FG001|Study Period III|Clinical Relapse|0|||
160978265|NCT00337662|581310195|FG002|Study Period III|Clinical Relapse|0|||
160978266|NCT00337662|581310196|FG003|Study Period III|Clinical Relapse|0|||
160978267|NCT01265823|581310197|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
160978268|NCT01265823|581310197|FG000|Overall Study|Failure to Return|4|||
160978269|NCT01265823|581310197|FG000|Overall Study|Protocol Violation|1|||
160978270|NCT01265823|581310197|FG000|Overall Study|Participant Request|1|||
160978271|NCT01263106|581310198|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
160978272|NCT01263106|581310199|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
160978273|NCT00882921|581310200|FG000|Overall Study|Death|2|||
160978274|NCT00882921|581310200|FG000|Overall Study|Other|3|||
160978275|NCT00882921|581310200|FG000|Overall Study|Lost to Follow-up|2|||
160978276|NCT00882921|581310200|FG000|Overall Study|Termination By Investigator|3|||
160978277|NCT00882921|581310200|FG000|Overall Study|Withdrawal Of Consent|1|||
160978278|NCT05027074|581310218|FG000|Overall Study|Death|47|||
160978279|NCT05027074|581310219|FG001|Overall Study|Death|42|||
160978280|NCT05027074|581310220|FG002|Overall Study|Death|39|||
160978281|NCT05027074|581310218|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160978282|NCT05027074|581310219|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160978283|NCT05027074|581310220|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160978284|NCT05027074|581310218|FG000|Overall Study|Site Terminated By Sponsor|3|||
160978285|NCT05027074|581310219|FG001|Overall Study|Site Terminated By Sponsor|0|||
160978286|NCT05027074|581310220|FG002|Overall Study|Site Terminated By Sponsor|2|||
160978287|NCT05027074|581310218|FG000|Overall Study|Withdrawal by Subject|13|||
160978288|NCT05027074|581310219|FG001|Overall Study|Withdrawal by Subject|8|||
160978289|NCT05027074|581310220|FG002|Overall Study|Withdrawal by Subject|10|||
160978290|NCT05027074|581310218|FG000|Overall Study|Lost to Follow-up|2|||
160978291|NCT05027074|581310219|FG001|Overall Study|Lost to Follow-up|4|||
160978292|NCT05027074|581310220|FG002|Overall Study|Lost to Follow-up|3|||
160978293|NCT05027074|581310218|FG000|Overall Study|Status Not Recorded|0|||
160978294|NCT05027074|581310219|FG001|Overall Study|Status Not Recorded|0|||
160978295|NCT05027074|581310220|FG002|Overall Study|Status Not Recorded|1|||
160978296|NCT02180438|581310226|FG000|Overall Study|Lost to Follow-up|1|||
160978297|NCT00785707|581310227|FG000|Overall Study|Lost to Follow-up|7|||
160978298|NCT05569954|581310232|FG000|Overall Study|Lost to Follow-up|3|||
160978299|NCT05569954|581310233|FG001|Overall Study|Lost to Follow-up|4|||
160978300|NCT05569954|581310232|FG000|Overall Study|Protocol Violation|1|||
160978301|NCT05569954|581310233|FG001|Overall Study|Protocol Violation|2|||
160978302|NCT05569954|581310232|FG000|Overall Study|Withdrawal by Subject|4|||
160978303|NCT05569954|581310233|FG001|Overall Study|Withdrawal by Subject|2|||
160978304|NCT03857841|581310243|FG000|Overall Study|Death|1|||
160978305|NCT03857841|581310244|FG001|Overall Study|Death|0|||
160978306|NCT03857841|581310245|FG002|Overall Study|Death|0|||
160978307|NCT03857841|581310246|FG003|Overall Study|Death|0|||
160978308|NCT03857841|581310243|FG000|Overall Study|Study Terminated by Sponsor|1|||
160978309|NCT03857841|581310244|FG001|Overall Study|Study Terminated by Sponsor|0|||
160978310|NCT03857841|581310245|FG002|Overall Study|Study Terminated by Sponsor|0|||
160978311|NCT03857841|581310246|FG003|Overall Study|Study Terminated by Sponsor|0|||
160978312|NCT00384059|581310247|FG000|Infant Series|Not consented|2|||
160978313|NCT00384059|581310248|FG001|Infant Series|Not consented|6|||
160978314|NCT00384059|581310247|FG000|Infant Series|Withdrawal by Subject|2|||
160978315|NCT00384059|581310248|FG001|Infant Series|Withdrawal by Subject|2|||
160978316|NCT00384059|581310247|FG000|Infant Series|Adverse Event|1|||
160978317|NCT00384059|581310248|FG001|Infant Series|Adverse Event|2|||
160978318|NCT00384059|581310247|FG000|Infant Series|Protocol Violation|1|||
160978319|NCT00384059|581310248|FG001|Infant Series|Protocol Violation|2|||
160978320|NCT00384059|581310247|FG000|Infant Series|Lost to Follow-up|0|||
160978321|NCT00384059|581310248|FG001|Infant Series|Lost to Follow-up|1|||
160978322|NCT00384059|581310247|FG000|After Infant Series|Protocol Violation|2|||
160978323|NCT00384059|581310248|FG001|After Infant Series|Protocol Violation|3|||
160978324|NCT00384059|581310247|FG000|After Infant Series|Withdrawal by Subject|2|||
160978325|NCT00384059|581310248|FG001|After Infant Series|Withdrawal by Subject|2|||
160978326|NCT00384059|581310247|FG000|After Infant Series|Failed to Return|0|||
160978327|NCT00384059|581310248|FG001|After Infant Series|Failed to Return|2|||
160978328|NCT00384059|581310247|FG000|After Infant Series|Adverse Event|0|||
160978329|NCT00384059|581310248|FG001|After Infant Series|Adverse Event|1|||
160978330|NCT00384059|581310247|FG000|After Infant Series|Physician Decision|0|||
160978331|NCT00384059|581310248|FG001|After Infant Series|Physician Decision|1|||
160978332|NCT00384059|581310247|FG000|After Infant Series|Lost to Follow-up|0|||
160978333|NCT00384059|581310248|FG001|After Infant Series|Lost to Follow-up|1|||
160978334|NCT00384059|581310247|FG000|Toddler Dose|Lost to Follow-up|1|||
160978335|NCT00384059|581310248|FG001|Toddler Dose|Lost to Follow-up|1|||
160978336|NCT00384059|581310247|FG000|Toddler Dose|Failed to return|0|||
160978337|NCT00384059|581310248|FG001|Toddler Dose|Failed to return|1|||
160978338|NCT00381641|581310251|FG000|Overall Study|Withdrawal by Subject|0|||
160978339|NCT00381641|581310252|FG001|Overall Study|Withdrawal by Subject|2|||
160996803|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996804|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996805|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996806|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
160996807|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
160996808|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
160996809|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996810|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996811|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996812|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996813|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996814|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996815|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
160996816|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996817|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996818|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
160996819|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
160996820|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
160996821|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996822|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996823|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996824|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160996825|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160978340|NCT00802737|581311850|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
160978341|NCT00802737|581311851|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
160978342|NCT00802737|581311852|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
160978343|NCT00802737|581311850|FG000|Overall Study|Death|6|||
160978344|NCT00802737|581311851|FG001|Overall Study|Death|5|||
160978345|NCT00802737|581311852|FG002|Overall Study|Death|1|||
160978346|NCT00802737|581311850|FG000|Overall Study|Adverse Event|1|||
160978347|NCT00802737|581311851|FG001|Overall Study|Adverse Event|0|||
160978348|NCT00802737|581311852|FG002|Overall Study|Adverse Event|0|||
160978349|NCT00802737|581311850|FG000|Overall Study|Received Prohibited Therapy|1|||
160978350|NCT00802737|581311851|FG001|Overall Study|Received Prohibited Therapy|0|||
160978351|NCT00802737|581311852|FG002|Overall Study|Received Prohibited Therapy|0|||
160978352|NCT00802737|581311850|FG000|Overall Study|Ongoing CLL-Treatment|0|||
160978353|NCT00802737|581311851|FG001|Overall Study|Ongoing CLL-Treatment|1|||
160978354|NCT00802737|581311852|FG002|Overall Study|Ongoing CLL-Treatment|0|||
160978355|NCT00802737|581311850|FG000|Overall Study|Participant too Unwell|0|||
160978356|NCT00802737|581311851|FG001|Overall Study|Participant too Unwell|2|||
160978357|NCT00802737|581311852|FG002|Overall Study|Participant too Unwell|0|||
160978358|NCT03390036|581311853|FG000|Overall Study|Lost to Follow-up|1|||
160978359|NCT03390036|581311854|FG001|Overall Study|Lost to Follow-up|0|||
160978360|NCT03390036|581311855|FG002|Overall Study|Lost to Follow-up|0|||
160978361|NCT03390036|581311853|FG000|Overall Study|Lack of Efficacy|1|||
160978362|NCT03390036|581311854|FG001|Overall Study|Lack of Efficacy|0|||
160978363|NCT03390036|581311855|FG002|Overall Study|Lack of Efficacy|0|||
160978364|NCT01681368|581311858|FG000|Overall Study|Refused further treatment|1|||
160978365|NCT01681368|581311858|FG000|Overall Study|Refused further follow up|1|||
160978366|NCT06017999|581311861|FG000|Overall Study|Withdrawal by Subject|0|||
160978367|NCT06017999|581311862|FG001|Overall Study|Withdrawal by Subject|4|||
160978368|NCT06017999|581311863|FG002|Overall Study|Withdrawal by Subject|3|||
160978369|NCT06017999|581311861|FG000|Overall Study|Adverse Event|2|||
160978370|NCT06017999|581311862|FG001|Overall Study|Adverse Event|1|||
160978371|NCT06017999|581311863|FG002|Overall Study|Adverse Event|1|||
160978372|NCT06017999|581311861|FG000|Overall Study|Lost to Follow-up|0|||
160978373|NCT06017999|581311862|FG001|Overall Study|Lost to Follow-up|0|||
160978374|NCT06017999|581311863|FG002|Overall Study|Lost to Follow-up|1|||
160978375|NCT06017999|581311861|FG000|Overall Study|Physician Decision|1|||
161208386|NCT03985293|582144510|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
161208387|NCT03985293|582144511|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
161208388|NCT03985293|582144512|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
161208389|NCT03985293|582144513|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
161208390|NCT03985293|582144508|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
161208391|NCT03985293|582144509|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
161208392|NCT03985293|582144510|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161208393|NCT03985293|582144511|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161208394|NCT03985293|582144512|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
161208395|NCT03985293|582144513|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
161208396|NCT03985293|582144508|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
161208397|NCT03985293|582144509|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
161208398|NCT03985293|582144510|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
161208399|NCT03985293|582144511|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
161208400|NCT03985293|582144512|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
161208401|NCT03985293|582144513|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
160978376|NCT06017999|581311862|FG001|Overall Study|Physician Decision|1|||
160978377|NCT06017999|581311863|FG002|Overall Study|Physician Decision|0|||
160978378|NCT06017999|581311861|FG000|Overall Study|Non-Compliance|0|||
160978379|NCT06017999|581311862|FG001|Overall Study|Non-Compliance|0|||
160978380|NCT06017999|581311863|FG002|Overall Study|Non-Compliance|1|||
160978381|NCT06017999|581311861|FG000|Overall Study|Lack of Efficacy|1|||
160978382|NCT06017999|581311862|FG001|Overall Study|Lack of Efficacy|0|||
160978383|NCT06017999|581311863|FG002|Overall Study|Lack of Efficacy|7|||
160978384|NCT06017999|581311861|FG000|Overall Study|COVID Positive|0|||
160978385|NCT06017999|581311862|FG001|Overall Study|COVID Positive|1|||
160978386|NCT06017999|581311863|FG002|Overall Study|COVID Positive|0|||
160978387|NCT06017999|581311861|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
161208402|NCT03985293|582144508|FG000|FOLLOW-UP|Lost to Follow-up|0|||
161208403|NCT03985293|582144509|FG001|FOLLOW-UP|Lost to Follow-up|0|||
160978388|NCT06017999|581311862|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
160978389|NCT06017999|581311863|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
160978390|NCT01155388|581311864|FG000|Overall Study|Adverse Event|1|||
160978391|NCT01155388|581311865|FG001|Overall Study|Adverse Event|0|||
160978392|NCT03943589|581311866|FG000|Overall Study|Death|1|||
160978393|NCT03943589|581311866|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
160978394|NCT04329104|581311867|FG000|Efficacy Study|Withdrawal by Subject|0|||
161208404|NCT03985293|582144510|FG002|FOLLOW-UP|Lost to Follow-up|1|||
161208405|NCT03985293|582144511|FG003|FOLLOW-UP|Lost to Follow-up|0|||
161208406|NCT03985293|582144512|FG004|FOLLOW-UP|Lost to Follow-up|0|||
161208407|NCT03985293|582144513|FG005|FOLLOW-UP|Lost to Follow-up|0|||
160978395|NCT04329104|581311868|FG001|Efficacy Study|Withdrawal by Subject|0|||
160978396|NCT04329104|581311869|FG002|Efficacy Study|Withdrawal by Subject|0|||
160978397|NCT04329104|581311870|FG003|Efficacy Study|Withdrawal by Subject|5|||
160978398|NCT04329104|581311871|FG004|Efficacy Study|Withdrawal by Subject|6|||
160978399|NCT04329104|581311872|FG005|Efficacy Study|Withdrawal by Subject|8|||
160978400|NCT03884231|581311873|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
160978401|NCT03884231|581311873|FG000|Overall Study|Subject Withdrew Consent|1|||
160978402|NCT03884231|581311873|FG000|Overall Study|MRI Scan Not Performed|1|||
160978403|NCT00900627|581311874|FG000|Overall Study|Condition under investigation worsened|4|||
160978404|NCT00900627|581311875|FG001|Overall Study|Condition under investigation worsened|0|||
160978405|NCT00900627|581311876|FG002|Overall Study|Condition under investigation worsened|5|||
160978406|NCT00900627|581311877|FG003|Overall Study|Condition under investigation worsened|3|||
160978407|NCT00900627|581311878|FG004|Overall Study|Condition under investigation worsened|0|||
160978408|NCT00900627|581311879|FG005|Overall Study|Condition under investigation worsened|0|||
160978409|NCT00900627|581311874|FG000|Overall Study|Withdrawal by Subject|1|||
160978410|NCT00900627|581311875|FG001|Overall Study|Withdrawal by Subject|0|||
160978411|NCT00900627|581311876|FG002|Overall Study|Withdrawal by Subject|1|||
160978412|NCT00900627|581311877|FG003|Overall Study|Withdrawal by Subject|0|||
160978413|NCT00900627|581311878|FG004|Overall Study|Withdrawal by Subject|1|||
160978414|NCT00900627|581311879|FG005|Overall Study|Withdrawal by Subject|2|||
160978415|NCT00900627|581311874|FG000|Overall Study|Adverse Event|1|||
160978416|NCT00900627|581311875|FG001|Overall Study|Adverse Event|2|||
160978417|NCT00900627|581311876|FG002|Overall Study|Adverse Event|0|||
160978418|NCT00900627|581311877|FG003|Overall Study|Adverse Event|3|||
160978419|NCT00900627|581311878|FG004|Overall Study|Adverse Event|0|||
160978420|NCT00900627|581311879|FG005|Overall Study|Adverse Event|0|||
160978421|NCT00900627|581311874|FG000|Overall Study|Death|0|||
160978422|NCT00900627|581311875|FG001|Overall Study|Death|0|||
160978423|NCT00900627|581311876|FG002|Overall Study|Death|0|||
160978424|NCT00900627|581311877|FG003|Overall Study|Death|0|||
160978425|NCT00900627|581311878|FG004|Overall Study|Death|28|||
160978426|NCT00900627|581311879|FG005|Overall Study|Death|24|||
160978427|NCT00373295|581311880|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978428|NCT00373295|581311881|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
161208408|NCT02588651|582144514|FG000|Overall Study|Adverse Event|1|||
161208409|NCT02588651|582144514|FG000|Overall Study|Withdrawal by Subject|2|||
160978429|NCT00373295|581311882|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978430|NCT00373295|581311883|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978431|NCT00373295|581311884|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
160978432|NCT00373295|581311885|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
160978433|NCT00830947|581311886|FG000|Overall Study|Lost to Follow-up|4|||
160978434|NCT00830947|581311887|FG001|Overall Study|Lost to Follow-up|4|||
160978435|NCT01474512|581311899|FG000|Induction Period|Adverse Event|6|||
160978436|NCT01474512|581311900|FG001|Induction Period|Adverse Event|10|||
160978437|NCT01474512|581311901|FG002|Induction Period|Adverse Event|10|||
160978438|NCT01474512|581311902|FG003|Induction Period|Adverse Event|0|||
160978439|NCT01474512|581311903|FG004|Induction Period|Adverse Event|0|||
160978440|NCT01474512|581311904|FG005|Induction Period|Adverse Event|0|||
160978441|NCT01474512|581311905|FG006|Induction Period|Adverse Event|0|||
160978442|NCT01474512|581311906|FG007|Induction Period|Adverse Event|0|||
160978443|NCT01474512|581311907|FG008|Induction Period|Adverse Event|0|||
160978444|NCT01474512|581311908|FG009|Induction Period|Adverse Event|0|||
160978445|NCT01474512|581311909|FG010|Induction Period|Adverse Event|0|||
160978446|NCT01474512|581311910|FG011|Induction Period|Adverse Event|0|||
160978447|NCT01474512|581311911|FG012|Induction Period|Adverse Event|0|||
160978448|NCT01474512|581311912|FG013|Induction Period|Adverse Event|0|||
160978449|NCT01474512|581311913|FG014|Induction Period|Adverse Event|0|||
160978450|NCT01474512|581311914|FG015|Induction Period|Adverse Event|0|||
160978451|NCT01474512|581311915|FG016|Induction Period|Adverse Event|0|||
160978452|NCT01474512|581311916|FG017|Induction Period|Adverse Event|0|||
160978453|NCT01474512|581311899|FG000|Induction Period|Lack of Efficacy|7|||
160978454|NCT01474512|581311900|FG001|Induction Period|Lack of Efficacy|1|||
160978455|NCT01474512|581311901|FG002|Induction Period|Lack of Efficacy|0|||
160978456|NCT01474512|581311902|FG003|Induction Period|Lack of Efficacy|0|||
160978457|NCT01474512|581311903|FG004|Induction Period|Lack of Efficacy|0|||
160978458|NCT01474512|581311904|FG005|Induction Period|Lack of Efficacy|0|||
160978459|NCT01474512|581311905|FG006|Induction Period|Lack of Efficacy|0|||
160978460|NCT01474512|581311906|FG007|Induction Period|Lack of Efficacy|0|||
160978461|NCT01474512|581311907|FG008|Induction Period|Lack of Efficacy|0|||
160978462|NCT01474512|581311908|FG009|Induction Period|Lack of Efficacy|0|||
160978463|NCT01474512|581311909|FG010|Induction Period|Lack of Efficacy|0|||
160978464|NCT01474512|581311910|FG011|Induction Period|Lack of Efficacy|0|||
160978465|NCT01474512|581311911|FG012|Induction Period|Lack of Efficacy|0|||
160978466|NCT01474512|581311912|FG013|Induction Period|Lack of Efficacy|0|||
160978467|NCT01474512|581311913|FG014|Induction Period|Lack of Efficacy|0|||
160978468|NCT01474512|581311914|FG015|Induction Period|Lack of Efficacy|0|||
160978469|NCT01474512|581311915|FG016|Induction Period|Lack of Efficacy|0|||
161208410|NCT02588651|582144514|FG000|Overall Study|Death|1|||
160978470|NCT01474512|581311916|FG017|Induction Period|Lack of Efficacy|0|||
161208411|NCT02588651|582144514|FG000|Overall Study|Lack of Efficacy|13|||
161208412|NCT02588651|582144514|FG000|Overall Study|Lost to Follow-up|1|||
161208413|NCT02588651|582144514|FG000|Overall Study|Physician Decision|1|||
161208414|NCT02588651|582144514|FG000|Overall Study|Disease progression|2|||
161208415|NCT05899218|582144515|FG000|Overall Study|Lost to Follow-up|2|||
161208416|NCT05899218|582144516|FG001|Overall Study|Lost to Follow-up|2|||
161208417|NCT05899218|582144515|FG000|Overall Study|deemed ineligible out of country|1|||
161208418|NCT05899218|582144516|FG001|Overall Study|deemed ineligible out of country|0|||
160978471|NCT01474512|581311899|FG000|Induction Period|Withdrawal by Subject|6|||
160978472|NCT01474512|581311900|FG001|Induction Period|Withdrawal by Subject|6|||
160978473|NCT01474512|581311901|FG002|Induction Period|Withdrawal by Subject|5|||
160978474|NCT01474512|581311902|FG003|Induction Period|Withdrawal by Subject|0|||
160978475|NCT01474512|581311903|FG004|Induction Period|Withdrawal by Subject|0|||
160978476|NCT01474512|581311904|FG005|Induction Period|Withdrawal by Subject|0|||
160978477|NCT01474512|581311905|FG006|Induction Period|Withdrawal by Subject|0|||
160978478|NCT01474512|581311906|FG007|Induction Period|Withdrawal by Subject|0|||
160978479|NCT01474512|581311907|FG008|Induction Period|Withdrawal by Subject|0|||
160978480|NCT01474512|581311908|FG009|Induction Period|Withdrawal by Subject|0|||
160978481|NCT01474512|581311909|FG010|Induction Period|Withdrawal by Subject|0|||
160978482|NCT01474512|581311910|FG011|Induction Period|Withdrawal by Subject|0|||
160978483|NCT01474512|581311911|FG012|Induction Period|Withdrawal by Subject|0|||
160978484|NCT01474512|581311912|FG013|Induction Period|Withdrawal by Subject|0|||
160978485|NCT01474512|581311913|FG014|Induction Period|Withdrawal by Subject|0|||
160978486|NCT01474512|581311914|FG015|Induction Period|Withdrawal by Subject|0|||
160978487|NCT01474512|581311915|FG016|Induction Period|Withdrawal by Subject|0|||
160978488|NCT01474512|581311916|FG017|Induction Period|Withdrawal by Subject|0|||
161208419|NCT02587325|582144521|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
161208420|NCT02587325|582144522|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
161208421|NCT02587325|582144523|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
161208422|NCT02587325|582144524|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
161208423|NCT02587325|582144525|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
161208424|NCT02587325|582144521|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161208425|NCT02587325|582144522|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161208426|NCT02587325|582144523|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161208427|NCT02587325|582144524|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
161208428|NCT02587325|582144525|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
161208429|NCT02587325|582144521|FG000|32-Week Optional Extension Part|Adverse Event|0|||
161208430|NCT02587325|582144522|FG001|32-Week Optional Extension Part|Adverse Event|0|||
161208431|NCT02587325|582144523|FG002|32-Week Optional Extension Part|Adverse Event|1|||
161208432|NCT02587325|582144524|FG003|32-Week Optional Extension Part|Adverse Event|0|||
161208433|NCT02587325|582144525|FG004|32-Week Optional Extension Part|Adverse Event|0|||
161208434|NCT02587325|582144521|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
161208435|NCT02587325|582144522|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
160978489|NCT01474512|581311899|FG000|Induction Period|Protocol Violation|3|||
161208436|NCT02587325|582144523|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
161208437|NCT02587325|582144524|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
161208438|NCT02587325|582144525|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
161208439|NCT00390572|582144526|FG000|Overall Study|Lost to Follow-up|8|||
161208440|NCT00390572|582144527|FG001|Overall Study|Lost to Follow-up|4|||
161208441|NCT00390572|582144526|FG000|Overall Study|health condition|0|||
161208442|NCT00390572|582144527|FG001|Overall Study|health condition|1|||
161208443|NCT03078192|582144558|FG000|Overall Study|Withdrawal by Subject|2|||
161208444|NCT03078192|582144559|FG001|Overall Study|Withdrawal by Subject|1|||
160978490|NCT01474512|581311900|FG001|Induction Period|Protocol Violation|6|||
160978491|NCT01474512|581311901|FG002|Induction Period|Protocol Violation|0|||
160978492|NCT01474512|581311902|FG003|Induction Period|Protocol Violation|0|||
160978493|NCT01474512|581311903|FG004|Induction Period|Protocol Violation|0|||
160978494|NCT01474512|581311904|FG005|Induction Period|Protocol Violation|0|||
160978495|NCT01474512|581311905|FG006|Induction Period|Protocol Violation|0|||
160978496|NCT01474512|581311906|FG007|Induction Period|Protocol Violation|0|||
160978497|NCT01474512|581311907|FG008|Induction Period|Protocol Violation|0|||
160978498|NCT01474512|581311908|FG009|Induction Period|Protocol Violation|0|||
160978499|NCT01474512|581311909|FG010|Induction Period|Protocol Violation|0|||
161208445|NCT03078192|582144558|FG000|Overall Study|screen failure|0|||
161208446|NCT03078192|582144559|FG001|Overall Study|screen failure|3|||
161208447|NCT01142466|582146800|FG000|Overall Study|Adverse Event|2|||
161208448|NCT01142466|582146801|FG001|Overall Study|Adverse Event|1|||
161208449|NCT01142466|582146800|FG000|Overall Study|Withdrawal by Subject|1|||
160978500|NCT01474512|581311910|FG011|Induction Period|Protocol Violation|0|||
160978501|NCT01474512|581311911|FG012|Induction Period|Protocol Violation|0|||
160978502|NCT01474512|581311912|FG013|Induction Period|Protocol Violation|0|||
160978503|NCT01474512|581311913|FG014|Induction Period|Protocol Violation|0|||
160978504|NCT01474512|581311914|FG015|Induction Period|Protocol Violation|0|||
160978505|NCT01474512|581311915|FG016|Induction Period|Protocol Violation|0|||
160978506|NCT01474512|581311916|FG017|Induction Period|Protocol Violation|0|||
160978507|NCT01474512|581311899|FG000|Induction Period|Sponsor Decision|1|||
160978508|NCT01474512|581311900|FG001|Induction Period|Sponsor Decision|1|||
160978509|NCT01474512|581311901|FG002|Induction Period|Sponsor Decision|1|||
160978510|NCT01474512|581311902|FG003|Induction Period|Sponsor Decision|0|||
160978511|NCT01474512|581311903|FG004|Induction Period|Sponsor Decision|0|||
160978512|NCT01474512|581311904|FG005|Induction Period|Sponsor Decision|0|||
160978513|NCT01474512|581311905|FG006|Induction Period|Sponsor Decision|0|||
160978514|NCT01474512|581311906|FG007|Induction Period|Sponsor Decision|0|||
160978515|NCT01474512|581311907|FG008|Induction Period|Sponsor Decision|0|||
160978516|NCT01474512|581311908|FG009|Induction Period|Sponsor Decision|0|||
160978517|NCT01474512|581311909|FG010|Induction Period|Sponsor Decision|0|||
160978518|NCT01474512|581311910|FG011|Induction Period|Sponsor Decision|0|||
160978519|NCT01474512|581311911|FG012|Induction Period|Sponsor Decision|0|||
160978520|NCT01474512|581311912|FG013|Induction Period|Sponsor Decision|0|||
160978521|NCT01474512|581311913|FG014|Induction Period|Sponsor Decision|0|||
160978522|NCT01474512|581311914|FG015|Induction Period|Sponsor Decision|0|||
160978523|NCT01474512|581311915|FG016|Induction Period|Sponsor Decision|0|||
160978524|NCT01474512|581311916|FG017|Induction Period|Sponsor Decision|0|||
160978525|NCT01474512|581311899|FG000|Induction Period|Lost to Follow-up|1|||
160978526|NCT01474512|581311900|FG001|Induction Period|Lost to Follow-up|0|||
160978527|NCT01474512|581311901|FG002|Induction Period|Lost to Follow-up|2|||
160978528|NCT01474512|581311902|FG003|Induction Period|Lost to Follow-up|0|||
160978529|NCT01474512|581311903|FG004|Induction Period|Lost to Follow-up|0|||
160978530|NCT01474512|581311904|FG005|Induction Period|Lost to Follow-up|0|||
160978531|NCT01474512|581311905|FG006|Induction Period|Lost to Follow-up|0|||
160978532|NCT01474512|581311906|FG007|Induction Period|Lost to Follow-up|0|||
160978533|NCT01474512|581311907|FG008|Induction Period|Lost to Follow-up|0|||
160978534|NCT01474512|581311908|FG009|Induction Period|Lost to Follow-up|0|||
160978535|NCT01474512|581311909|FG010|Induction Period|Lost to Follow-up|0|||
160978536|NCT01474512|581311910|FG011|Induction Period|Lost to Follow-up|0|||
160978537|NCT01474512|581311911|FG012|Induction Period|Lost to Follow-up|0|||
160978538|NCT01474512|581311912|FG013|Induction Period|Lost to Follow-up|0|||
160978539|NCT01474512|581311913|FG014|Induction Period|Lost to Follow-up|0|||
160978540|NCT01474512|581311914|FG015|Induction Period|Lost to Follow-up|0|||
160978541|NCT01474512|581311915|FG016|Induction Period|Lost to Follow-up|0|||
160978542|NCT01474512|581311916|FG017|Induction Period|Lost to Follow-up|0|||
160978543|NCT01474512|581311899|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978544|NCT01474512|581311900|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978545|NCT01474512|581311901|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978546|NCT01474512|581311902|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
160978547|NCT01474512|581311903|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
160978548|NCT01474512|581311904|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
160978549|NCT01474512|581311905|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
160978550|NCT01474512|581311906|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978551|NCT01474512|581311907|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978552|NCT01474512|581311908|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978553|NCT01474512|581311909|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978554|NCT01474512|581311910|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978555|NCT01474512|581311911|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978556|NCT01474512|581311912|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978557|NCT01474512|581311913|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978558|NCT01474512|581311914|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978559|NCT01474512|581311915|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978560|NCT01474512|581311916|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
160978561|NCT01474512|581311899|FG000|Maintenance Period|Adverse Event|0|||
160978562|NCT01474512|581311900|FG001|Maintenance Period|Adverse Event|0|||
160978563|NCT01474512|581311901|FG002|Maintenance Period|Adverse Event|0|||
160978564|NCT01474512|581311902|FG003|Maintenance Period|Adverse Event|4|||
160978565|NCT01474512|581311903|FG004|Maintenance Period|Adverse Event|2|||
160978566|NCT01474512|581311904|FG005|Maintenance Period|Adverse Event|7|||
161208450|NCT01142466|582146801|FG001|Overall Study|Withdrawal by Subject|1|||
161208451|NCT02414854|582146802|FG000|Overall Study|Adverse Event|9|||
160978567|NCT01474512|581311905|FG006|Maintenance Period|Adverse Event|0|||
160978568|NCT01474512|581311906|FG007|Maintenance Period|Adverse Event|19|||
160978569|NCT01474512|581311907|FG008|Maintenance Period|Adverse Event|1|||
160978570|NCT01474512|581311908|FG009|Maintenance Period|Adverse Event|3|||
160978571|NCT01474512|581311909|FG010|Maintenance Period|Adverse Event|0|||
160978572|NCT01474512|581311910|FG011|Maintenance Period|Adverse Event|0|||
160978573|NCT01474512|581311911|FG012|Maintenance Period|Adverse Event|0|||
160978574|NCT01474512|581311912|FG013|Maintenance Period|Adverse Event|0|||
160978575|NCT01474512|581311913|FG014|Maintenance Period|Adverse Event|0|||
160978576|NCT01474512|581311914|FG015|Maintenance Period|Adverse Event|0|||
160978577|NCT01474512|581311915|FG016|Maintenance Period|Adverse Event|0|||
160978578|NCT01474512|581311916|FG017|Maintenance Period|Adverse Event|0|||
160978579|NCT01474512|581311899|FG000|Maintenance Period|Withdrawal by Subject|0|||
160978580|NCT01474512|581311900|FG001|Maintenance Period|Withdrawal by Subject|0|||
160978581|NCT01474512|581311901|FG002|Maintenance Period|Withdrawal by Subject|0|||
160978582|NCT01474512|581311902|FG003|Maintenance Period|Withdrawal by Subject|6|||
160978583|NCT01474512|581311903|FG004|Maintenance Period|Withdrawal by Subject|2|||
160978584|NCT01474512|581311904|FG005|Maintenance Period|Withdrawal by Subject|3|||
160978585|NCT01474512|581311905|FG006|Maintenance Period|Withdrawal by Subject|1|||
160978586|NCT01474512|581311906|FG007|Maintenance Period|Withdrawal by Subject|6|||
160978587|NCT01474512|581311907|FG008|Maintenance Period|Withdrawal by Subject|3|||
160978588|NCT01474512|581311908|FG009|Maintenance Period|Withdrawal by Subject|1|||
160978589|NCT01474512|581311909|FG010|Maintenance Period|Withdrawal by Subject|0|||
160978590|NCT01474512|581311910|FG011|Maintenance Period|Withdrawal by Subject|0|||
160978591|NCT01474512|581311911|FG012|Maintenance Period|Withdrawal by Subject|0|||
160978592|NCT01474512|581311912|FG013|Maintenance Period|Withdrawal by Subject|0|||
160978593|NCT01474512|581311913|FG014|Maintenance Period|Withdrawal by Subject|0|||
160978594|NCT01474512|581311914|FG015|Maintenance Period|Withdrawal by Subject|0|||
160978595|NCT01474512|581311915|FG016|Maintenance Period|Withdrawal by Subject|0|||
160978596|NCT01474512|581311916|FG017|Maintenance Period|Withdrawal by Subject|0|||
160978597|NCT01474512|581311899|FG000|Maintenance Period|Lost to Follow-up|0|||
160978598|NCT01474512|581311900|FG001|Maintenance Period|Lost to Follow-up|0|||
161208452|NCT02414854|582146803|FG001|Overall Study|Adverse Event|7|||
161208453|NCT02414854|582146804|FG002|Overall Study|Adverse Event|1|||
161208454|NCT02414854|582146805|FG003|Overall Study|Adverse Event|12|||
161208455|NCT02414854|582146802|FG000|Overall Study|Poor compliance to protocol|1|||
161208456|NCT02414854|582146803|FG001|Overall Study|Poor compliance to protocol|1|||
161208457|NCT02414854|582146804|FG002|Overall Study|Poor compliance to protocol|2|||
161208458|NCT02414854|582146805|FG003|Overall Study|Poor compliance to protocol|2|||
161208459|NCT02414854|582146802|FG000|Overall Study|Other than specified above|12|||
161208460|NCT02414854|582146803|FG001|Overall Study|Other than specified above|37|||
161208461|NCT02414854|582146804|FG002|Overall Study|Other than specified above|17|||
161208462|NCT02414854|582146805|FG003|Overall Study|Other than specified above|37|||
161208463|NCT01355523|582146806|FG000|Overall Study|Withdrawal by Subject|1|||
161208464|NCT01355523|582146807|FG001|Overall Study|Withdrawal by Subject|4|||
161208465|NCT01355523|582146806|FG000|Overall Study|Lost to Follow-up|0|||
161208466|NCT01355523|582146807|FG001|Overall Study|Lost to Follow-up|2|||
161208467|NCT01355523|582146806|FG000|Overall Study|Protocol Violation|0|||
161208468|NCT01355523|582146807|FG001|Overall Study|Protocol Violation|2|||
161208469|NCT01355523|582146806|FG000|Overall Study|Adverse Event|0|||
161208470|NCT01355523|582146807|FG001|Overall Study|Adverse Event|2|||
161208471|NCT00303316|582146808|FG000|Overall Study|Protocol Violation|1|||
161208472|NCT00303316|582146809|FG001|Overall Study|Protocol Violation|0|||
161208473|NCT00303316|582146808|FG000|Overall Study|Lost to Follow-up|0|||
161208474|NCT00303316|582146809|FG001|Overall Study|Lost to Follow-up|1|||
161208475|NCT00303316|582146808|FG000|Overall Study|Withdrawal by Subject|1|||
161208476|NCT00303316|582146809|FG001|Overall Study|Withdrawal by Subject|2|||
161208477|NCT01074307|582146810|FG000|Overall Study|No primary endpoint evaluation|14|||
161208478|NCT01074307|582146811|FG001|Overall Study|No primary endpoint evaluation|6|||
161208479|NCT01074307|582146810|FG000|Overall Study|Exclusion criterion|0|||
161208480|NCT01074307|582146811|FG001|Overall Study|Exclusion criterion|1|||
161208481|NCT01074307|582146810|FG000|Overall Study|Protocol Violation|8|||
161208482|NCT01074307|582146811|FG001|Overall Study|Protocol Violation|5|||
161208483|NCT02703454|582146819|FG000|Overall Study|Not treated|1|||
161208484|NCT02703454|582146820|FG001|Overall Study|Not treated|3|||
161208485|NCT02703454|582146819|FG000|Overall Study|Withdrawal by Subject|4|||
161208486|NCT02703454|582146820|FG001|Overall Study|Withdrawal by Subject|3|||
161208487|NCT02703454|582146819|FG000|Overall Study|Lost to Follow-up|1|||
161208488|NCT02703454|582146820|FG001|Overall Study|Lost to Follow-up|2|||
161208489|NCT02703454|582146819|FG000|Overall Study|Study discontinuation|5|||
161208490|NCT02703454|582146820|FG001|Overall Study|Study discontinuation|8|||
161208491|NCT02284373|582146821|FG000|Overall Study|Withdrawal by Subject|0|||
161208492|NCT02284373|582146822|FG001|Overall Study|Withdrawal by Subject|1|||
161208493|NCT02284373|582146823|FG002|Overall Study|Withdrawal by Subject|0|||
161208494|NCT02284373|582146821|FG000|Overall Study|Other|0|||
161208495|NCT02284373|582146822|FG001|Overall Study|Other|1|||
161208496|NCT02284373|582146823|FG002|Overall Study|Other|0|||
161208497|NCT02284373|582146821|FG000|Overall Study|Lost to Follow-up|0|||
161208498|NCT02284373|582146822|FG001|Overall Study|Lost to Follow-up|1|||
161208499|NCT02284373|582146823|FG002|Overall Study|Lost to Follow-up|0|||
161322156|NCT05052697|582566519|FG021|Substudy A|Lost to Follow-up|0|||
160978599|NCT01474512|581311901|FG002|Maintenance Period|Lost to Follow-up|0|||
160978600|NCT01474512|581311902|FG003|Maintenance Period|Lost to Follow-up|3|||
160978601|NCT01474512|581311903|FG004|Maintenance Period|Lost to Follow-up|3|||
160978602|NCT01474512|581311904|FG005|Maintenance Period|Lost to Follow-up|0|||
160978603|NCT01474512|581311905|FG006|Maintenance Period|Lost to Follow-up|0|||
160978604|NCT01474512|581311906|FG007|Maintenance Period|Lost to Follow-up|2|||
161208500|NCT01902134|582146824|FG000|Overall Study|Adverse Event|3|||
161322157|NCT05052697|582566520|FG022|Substudy A|Lost to Follow-up|0|||
160978605|NCT01474512|581311907|FG008|Maintenance Period|Lost to Follow-up|1|||
161208501|NCT01902134|582146825|FG001|Overall Study|Adverse Event|1|||
161208502|NCT01902134|582146826|FG002|Overall Study|Adverse Event|2|||
161208503|NCT01902134|582146827|FG003|Overall Study|Adverse Event|1|||
160978606|NCT01474512|581311908|FG009|Maintenance Period|Lost to Follow-up|1|||
160978607|NCT01474512|581311909|FG010|Maintenance Period|Lost to Follow-up|0|||
160978608|NCT01474512|581311910|FG011|Maintenance Period|Lost to Follow-up|0|||
160978609|NCT01474512|581311911|FG012|Maintenance Period|Lost to Follow-up|0|||
160978610|NCT01474512|581311912|FG013|Maintenance Period|Lost to Follow-up|0|||
160978611|NCT01474512|581311913|FG014|Maintenance Period|Lost to Follow-up|0|||
160978612|NCT01474512|581311914|FG015|Maintenance Period|Lost to Follow-up|0|||
160978613|NCT01474512|581311915|FG016|Maintenance Period|Lost to Follow-up|0|||
160978614|NCT01474512|581311916|FG017|Maintenance Period|Lost to Follow-up|0|||
160978615|NCT01474512|581311899|FG000|Maintenance Period|Death|0|||
161208504|NCT01902134|582146828|FG004|Overall Study|Adverse Event|1|||
161208505|NCT01902134|582146829|FG005|Overall Study|Adverse Event|3|||
161208506|NCT01902134|582146824|FG000|Overall Study|Lack of Efficacy|0|||
161208507|NCT01902134|582146825|FG001|Overall Study|Lack of Efficacy|0|||
161208508|NCT01902134|582146826|FG002|Overall Study|Lack of Efficacy|2|||
161208509|NCT01902134|582146827|FG003|Overall Study|Lack of Efficacy|0|||
161208510|NCT01902134|582146828|FG004|Overall Study|Lack of Efficacy|0|||
161208511|NCT01902134|582146829|FG005|Overall Study|Lack of Efficacy|1|||
161208512|NCT01902134|582146824|FG000|Overall Study|Physician Decision|0|||
161208513|NCT01902134|582146825|FG001|Overall Study|Physician Decision|1|||
161208514|NCT01902134|582146826|FG002|Overall Study|Physician Decision|0|||
161208515|NCT01902134|582146827|FG003|Overall Study|Physician Decision|0|||
161208516|NCT01902134|582146828|FG004|Overall Study|Physician Decision|0|||
161208517|NCT01902134|582146829|FG005|Overall Study|Physician Decision|0|||
161208518|NCT01902134|582146824|FG000|Overall Study|Protocol Violation|0|||
161208519|NCT01902134|582146825|FG001|Overall Study|Protocol Violation|0|||
161208520|NCT01902134|582146826|FG002|Overall Study|Protocol Violation|0|||
161208521|NCT01902134|582146827|FG003|Overall Study|Protocol Violation|0|||
161208522|NCT01902134|582146828|FG004|Overall Study|Protocol Violation|0|||
161208523|NCT01902134|582146829|FG005|Overall Study|Protocol Violation|1|||
161208524|NCT01902134|582146824|FG000|Overall Study|Withdrawal by Subject|4|||
161208525|NCT01902134|582146825|FG001|Overall Study|Withdrawal by Subject|8|||
161208526|NCT01902134|582146826|FG002|Overall Study|Withdrawal by Subject|9|||
161208527|NCT01902134|582146827|FG003|Overall Study|Withdrawal by Subject|1|||
161208528|NCT01902134|582146828|FG004|Overall Study|Withdrawal by Subject|5|||
161208529|NCT01902134|582146829|FG005|Overall Study|Withdrawal by Subject|4|||
161208530|NCT01902134|582146824|FG000|Overall Study|no compliance|1|||
161208531|NCT01902134|582146825|FG001|Overall Study|no compliance|0|||
161208532|NCT01902134|582146826|FG002|Overall Study|no compliance|0|||
161208533|NCT01902134|582146827|FG003|Overall Study|no compliance|0|||
161208534|NCT01902134|582146828|FG004|Overall Study|no compliance|0|||
161208535|NCT01902134|582146829|FG005|Overall Study|no compliance|0|||
161208536|NCT01902134|582146824|FG000|Overall Study|Other|0|||
161208537|NCT01902134|582146825|FG001|Overall Study|Other|1|||
161208538|NCT01902134|582146826|FG002|Overall Study|Other|2|||
161208539|NCT01902134|582146827|FG003|Overall Study|Other|0|||
161208540|NCT01902134|582146828|FG004|Overall Study|Other|1|||
161208541|NCT01902134|582146829|FG005|Overall Study|Other|0|||
161208542|NCT00305110|582146830|FG000|Overall Study|Missing data|29|||
161208543|NCT00337129|582146831|FG000|Overall Study|Adverse Event|4|||
161208544|NCT00337129|582146831|FG000|Overall Study|Withdrawal by Subject|1|||
161208545|NCT00337129|582146831|FG000|Overall Study|Lack of Efficacy|32|||
161208546|NCT00337129|582146831|FG000|Overall Study|Death|2|||
161208547|NCT00337129|582146831|FG000|Overall Study|not protocol specified|1|||
161322158|NCT05052697|582566521|FG023|Substudy A|Lost to Follow-up|0|||
161322159|NCT05052697|582566522|FG024|Substudy A|Lost to Follow-up|0|||
161322160|NCT05052697|582566523|FG025|Substudy A|Lost to Follow-up|0|||
161322161|NCT05052697|582566524|FG026|Substudy A|Lost to Follow-up|0|||
161322162|NCT05052697|582566525|FG027|Substudy A|Lost to Follow-up|0|||
161322163|NCT05052697|582566526|FG028|Substudy A|Lost to Follow-up|0|||
161322164|NCT05052697|582566527|FG029|Substudy A|Lost to Follow-up|0|||
161322165|NCT05052697|582566528|FG030|Substudy A|Lost to Follow-up|0|||
161322166|NCT05052697|582566529|FG031|Substudy A|Lost to Follow-up|0|||
161322167|NCT05052697|582566530|FG032|Substudy A|Lost to Follow-up|0|||
161322168|NCT05052697|582566531|FG033|Substudy A|Lost to Follow-up|0|||
161322169|NCT05052697|582566498|FG000|Substudy A|No longer met eligibility criteria|0|||
161322170|NCT05052697|582566499|FG001|Substudy A|No longer met eligibility criteria|0|||
161322171|NCT05052697|582566500|FG002|Substudy A|No longer met eligibility criteria|0|||
161322172|NCT05052697|582566501|FG003|Substudy A|No longer met eligibility criteria|0|||
161322173|NCT05052697|582566502|FG004|Substudy A|No longer met eligibility criteria|0|||
161322174|NCT05052697|582566503|FG005|Substudy A|No longer met eligibility criteria|0|||
161322175|NCT05052697|582566504|FG006|Substudy A|No longer met eligibility criteria|0|||
161322176|NCT05052697|582566505|FG007|Substudy A|No longer met eligibility criteria|0|||
160978616|NCT01474512|581311900|FG001|Maintenance Period|Death|0|||
160978617|NCT01474512|581311901|FG002|Maintenance Period|Death|0|||
161322177|NCT05052697|582566506|FG008|Substudy A|No longer met eligibility criteria|0|||
161322178|NCT05052697|582566507|FG009|Substudy A|No longer met eligibility criteria|0|||
161208548|NCT01084603|582146834|FG000|Baseline|Withdrawal by Subject|2|||
161257852|NCT01961687|582323497|FG000|Overall Study|Physician Decision|1|||
161208549|NCT01084603|582146834|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
161208550|NCT01084603|582146834|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
161208551|NCT01084603|582146834|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
161208552|NCT01084603|582146834|FG000|Washout Period 4|Adverse Event|1|||
161208553|NCT01392170|582146840|FG000|Overall Study|Withdrawal by Subject|1|||
161208554|NCT01392170|582146840|FG000|Overall Study|Ineligible|1|||
161208555|NCT03174925|582146844|FG000|Overall Study|Elastographic images not retrievable|2|||
161208556|NCT03174925|582146844|FG000|Overall Study|Elastography image not interpretable|1|||
161208557|NCT04247594|582146847|FG000|Overall Study|Withdrawal by Subject|4|||
161208558|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
161208559|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
161208560|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
161208561|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
161208562|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
161208563|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
161208564|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
161208565|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
161208566|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161208567|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161208568|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161208569|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
161208570|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
161208571|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161208572|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161208573|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
161208574|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
161208575|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
161208576|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
161208577|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
161208578|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
161208579|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
161208580|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
161208581|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
161208582|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
161208583|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161208584|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
161208585|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161208586|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
161208587|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161208588|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161208589|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
161208590|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
161208591|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161208592|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
161208593|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
161208594|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161208595|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161208596|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
161208597|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
161208598|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
161208599|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
161208600|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
161208601|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
161208602|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
160978618|NCT01474512|581311902|FG003|Maintenance Period|Death|0|||
160978619|NCT01474512|581311903|FG004|Maintenance Period|Death|0|||
160978620|NCT01474512|581311904|FG005|Maintenance Period|Death|2|||
160978621|NCT01474512|581311905|FG006|Maintenance Period|Death|0|||
160978622|NCT01474512|581311906|FG007|Maintenance Period|Death|0|||
160978623|NCT01474512|581311907|FG008|Maintenance Period|Death|0|||
160978624|NCT01474512|581311908|FG009|Maintenance Period|Death|0|||
160978625|NCT01474512|581311909|FG010|Maintenance Period|Death|0|||
160978626|NCT01474512|581311910|FG011|Maintenance Period|Death|0|||
160978627|NCT01474512|581311911|FG012|Maintenance Period|Death|0|||
160978628|NCT01474512|581311912|FG013|Maintenance Period|Death|0|||
160978629|NCT01474512|581311913|FG014|Maintenance Period|Death|0|||
160978630|NCT01474512|581311914|FG015|Maintenance Period|Death|0|||
160978631|NCT01474512|581311915|FG016|Maintenance Period|Death|0|||
160978632|NCT01474512|581311916|FG017|Maintenance Period|Death|0|||
160978633|NCT01474512|581311899|FG000|Maintenance Period|Physician Decision|0|||
160978634|NCT01474512|581311900|FG001|Maintenance Period|Physician Decision|0|||
160978635|NCT01474512|581311901|FG002|Maintenance Period|Physician Decision|0|||
161208603|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
161208604|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
161208605|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
161208606|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
161208607|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
161208608|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161208609|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
161208610|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161208611|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161208612|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161208613|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
161208614|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
161208615|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
161208616|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
161208617|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
161208618|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
161208619|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
161208620|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
161208621|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
161208622|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
161208623|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
161208624|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
161208625|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
161208626|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
161208627|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
161208628|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
161208629|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
161208630|NCT04440163|582146849|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
161208631|NCT04440163|582146850|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
161208632|NCT04440163|582146851|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
161208633|NCT04440163|582146852|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
161208634|NCT04440163|582146853|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
161208635|NCT04440163|582146854|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
161208636|NCT04440163|582146855|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
161208637|NCT04440163|582146856|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
161208638|NCT04440163|582146849|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
161208639|NCT04440163|582146850|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
161208640|NCT04440163|582146851|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161208641|NCT04440163|582146852|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161208642|NCT04440163|582146853|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
161208643|NCT04440163|582146854|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
161208644|NCT04440163|582146855|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
161208645|NCT04440163|582146856|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
161322179|NCT05052697|582566508|FG010|Substudy A|No longer met eligibility criteria|0|||
160978636|NCT01474512|581311902|FG003|Maintenance Period|Physician Decision|0|||
160978637|NCT01474512|581311903|FG004|Maintenance Period|Physician Decision|0|||
160978638|NCT01474512|581311904|FG005|Maintenance Period|Physician Decision|1|||
160978639|NCT01474512|581311905|FG006|Maintenance Period|Physician Decision|0|||
160978640|NCT01474512|581311906|FG007|Maintenance Period|Physician Decision|2|||
160978641|NCT01474512|581311907|FG008|Maintenance Period|Physician Decision|0|||
160978642|NCT01474512|581311908|FG009|Maintenance Period|Physician Decision|0|||
160978643|NCT01474512|581311909|FG010|Maintenance Period|Physician Decision|0|||
160978644|NCT01474512|581311910|FG011|Maintenance Period|Physician Decision|0|||
160978645|NCT01474512|581311911|FG012|Maintenance Period|Physician Decision|0|||
160978646|NCT01474512|581311912|FG013|Maintenance Period|Physician Decision|0|||
160978647|NCT01474512|581311913|FG014|Maintenance Period|Physician Decision|0|||
160978648|NCT01474512|581311914|FG015|Maintenance Period|Physician Decision|0|||
160978649|NCT01474512|581311915|FG016|Maintenance Period|Physician Decision|0|||
160978650|NCT01474512|581311916|FG017|Maintenance Period|Physician Decision|0|||
160978651|NCT01474512|581311899|FG000|Maintenance Period|Clinical Relapse|0|||
160978652|NCT01474512|581311900|FG001|Maintenance Period|Clinical Relapse|0|||
160978653|NCT01474512|581311901|FG002|Maintenance Period|Clinical Relapse|0|||
160978654|NCT01474512|581311902|FG003|Maintenance Period|Clinical Relapse|1|||
160978655|NCT01474512|581311903|FG004|Maintenance Period|Clinical Relapse|0|||
160978656|NCT01474512|581311904|FG005|Maintenance Period|Clinical Relapse|0|||
160978657|NCT01474512|581311905|FG006|Maintenance Period|Clinical Relapse|0|||
160978658|NCT01474512|581311906|FG007|Maintenance Period|Clinical Relapse|0|||
160978659|NCT01474512|581311907|FG008|Maintenance Period|Clinical Relapse|0|||
160978660|NCT01474512|581311908|FG009|Maintenance Period|Clinical Relapse|0|||
160978661|NCT01474512|581311909|FG010|Maintenance Period|Clinical Relapse|0|||
160978662|NCT01474512|581311910|FG011|Maintenance Period|Clinical Relapse|0|||
160978663|NCT01474512|581311911|FG012|Maintenance Period|Clinical Relapse|0|||
160978664|NCT01474512|581311912|FG013|Maintenance Period|Clinical Relapse|0|||
160978665|NCT01474512|581311913|FG014|Maintenance Period|Clinical Relapse|0|||
160978666|NCT01474512|581311914|FG015|Maintenance Period|Clinical Relapse|0|||
160978667|NCT01474512|581311915|FG016|Maintenance Period|Clinical Relapse|0|||
160978668|NCT01474512|581311916|FG017|Maintenance Period|Clinical Relapse|0|||
160978669|NCT01474512|581311899|FG000|Maintenance Period|Lack of Efficacy|0|||
161208646|NCT04440163|582146849|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208647|NCT04440163|582146850|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208648|NCT04440163|582146851|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208649|NCT04440163|582146852|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
161208650|NCT04440163|582146853|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208651|NCT04440163|582146854|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208652|NCT04440163|582146855|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208653|NCT04440163|582146856|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
161208654|NCT01128153|582146857|FG000|Overall Study|Adverse Event|1|||
161208655|NCT01128153|582146858|FG001|Overall Study|Adverse Event|3|||
161208656|NCT01128153|582146857|FG000|Overall Study|Condition under investigation worsened|8|||
161208657|NCT01128153|582146858|FG001|Overall Study|Condition under investigation worsened|7|||
161208658|NCT01128153|582146857|FG000|Overall Study|Withdrawal by Subject|2|||
161208659|NCT01128153|582146858|FG001|Overall Study|Withdrawal by Subject|3|||
161208660|NCT01128153|582146857|FG000|Overall Study|Incorrect enrolment to study|2|||
161208661|NCT01128153|582146858|FG001|Overall Study|Incorrect enrolment to study|1|||
161208662|NCT01128153|582146857|FG000|Overall Study|Protocol Violation|2|||
161208663|NCT01128153|582146858|FG001|Overall Study|Protocol Violation|0|||
161208664|NCT01128153|582146857|FG000|Overall Study|Developed discontinuation criteria|1|||
161208665|NCT01128153|582146858|FG001|Overall Study|Developed discontinuation criteria|1|||
161208666|NCT01954082|582146859|FG000|Overall Study|Study Suspension|42|||
161208667|NCT01954082|582146860|FG001|Overall Study|Study Suspension|36|||
161208668|NCT01954082|582146859|FG000|Overall Study|Adverse Event|10|||
161208669|NCT01954082|582146860|FG001|Overall Study|Adverse Event|4|||
161208670|NCT01954082|582146859|FG000|Overall Study|Intolerance|0|||
161208671|NCT01954082|582146860|FG001|Overall Study|Intolerance|1|||
161208672|NCT01954082|582146859|FG000|Overall Study|Non-compliance|6|||
161208673|NCT01954082|582146860|FG001|Overall Study|Non-compliance|4|||
161208674|NCT01954082|582146859|FG000|Overall Study|Physician Decision|2|||
161208675|NCT01954082|582146860|FG001|Overall Study|Physician Decision|0|||
161208676|NCT01954082|582146859|FG000|Overall Study|Parent Decision|1|||
161208677|NCT01954082|582146860|FG001|Overall Study|Parent Decision|0|||
161208678|NCT01954082|582146859|FG000|Overall Study|Withdrawal by Subject|0|||
161208679|NCT01954082|582146860|FG001|Overall Study|Withdrawal by Subject|1|||
161208680|NCT01954082|582146859|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
161208681|NCT01954082|582146860|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
161208682|NCT01954082|582146859|FG000|Overall Study|Redirection of Care|0|||
161208683|NCT01954082|582146860|FG001|Overall Study|Redirection of Care|2|||
161208684|NCT01954082|582146859|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
161208685|NCT01954082|582146860|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
161208686|NCT01954082|582146859|FG000|Overall Study|Comfort Care|0|||
161208687|NCT01954082|582146860|FG001|Overall Study|Comfort Care|1|||
161208688|NCT01954082|582146859|FG000|Overall Study|Infant Moved|0|||
161208689|NCT01954082|582146860|FG001|Overall Study|Infant Moved|1|||
161208690|NCT01954082|582146859|FG000|Overall Study|Randomized not Treated|4|||
161208691|NCT01954082|582146860|FG001|Overall Study|Randomized not Treated|2|||
160978670|NCT01474512|581311900|FG001|Maintenance Period|Lack of Efficacy|0|||
160978671|NCT01474512|581311901|FG002|Maintenance Period|Lack of Efficacy|0|||
161208692|NCT01682512|582146861|FG000|Overall Study|Adverse Event|6|||
161208693|NCT01682512|582146862|FG001|Overall Study|Adverse Event|5|||
161208694|NCT01682512|582146863|FG002|Overall Study|Adverse Event|2|||
161208695|NCT01682512|582146861|FG000|Overall Study|Withdrawal by Subject|2|||
161208696|NCT01682512|582146862|FG001|Overall Study|Withdrawal by Subject|6|||
161208697|NCT01682512|582146863|FG002|Overall Study|Withdrawal by Subject|3|||
161208698|NCT01682512|582146861|FG000|Overall Study|Physician Decision|0|||
161322180|NCT05052697|582566509|FG011|Substudy A|No longer met eligibility criteria|0|||
160978672|NCT01474512|581311902|FG003|Maintenance Period|Lack of Efficacy|1|||
160978673|NCT01474512|581311903|FG004|Maintenance Period|Lack of Efficacy|0|||
161092570|NCT03818204|581729897|FG005|Overall Study|Physician Decision|0|||
160978674|NCT01474512|581311904|FG005|Maintenance Period|Lack of Efficacy|0|||
160978675|NCT01474512|581311905|FG006|Maintenance Period|Lack of Efficacy|0|||
160978676|NCT01474512|581311906|FG007|Maintenance Period|Lack of Efficacy|11|||
160978677|NCT01474512|581311907|FG008|Maintenance Period|Lack of Efficacy|11|||
160978678|NCT01474512|581311908|FG009|Maintenance Period|Lack of Efficacy|12|||
160978679|NCT01474512|581311909|FG010|Maintenance Period|Lack of Efficacy|0|||
160978680|NCT01474512|581311910|FG011|Maintenance Period|Lack of Efficacy|0|||
160978681|NCT01474512|581311911|FG012|Maintenance Period|Lack of Efficacy|0|||
160978682|NCT01474512|581311912|FG013|Maintenance Period|Lack of Efficacy|0|||
160978683|NCT01474512|581311913|FG014|Maintenance Period|Lack of Efficacy|0|||
160978684|NCT01474512|581311914|FG015|Maintenance Period|Lack of Efficacy|0|||
160978685|NCT01474512|581311915|FG016|Maintenance Period|Lack of Efficacy|0|||
160978686|NCT01474512|581311916|FG017|Maintenance Period|Lack of Efficacy|0|||
160978687|NCT01474512|581311899|FG000|Maintenance Period|Protocol Violation|0|||
160978688|NCT01474512|581311900|FG001|Maintenance Period|Protocol Violation|0|||
160978689|NCT01474512|581311901|FG002|Maintenance Period|Protocol Violation|0|||
160978690|NCT01474512|581311902|FG003|Maintenance Period|Protocol Violation|1|||
160978691|NCT01474512|581311903|FG004|Maintenance Period|Protocol Violation|0|||
160978692|NCT01474512|581311904|FG005|Maintenance Period|Protocol Violation|0|||
160978693|NCT01474512|581311905|FG006|Maintenance Period|Protocol Violation|0|||
160978694|NCT01474512|581311906|FG007|Maintenance Period|Protocol Violation|1|||
160978695|NCT01474512|581311907|FG008|Maintenance Period|Protocol Violation|0|||
160978696|NCT01474512|581311908|FG009|Maintenance Period|Protocol Violation|1|||
160978697|NCT01474512|581311909|FG010|Maintenance Period|Protocol Violation|0|||
160978698|NCT01474512|581311910|FG011|Maintenance Period|Protocol Violation|0|||
160978699|NCT01474512|581311911|FG012|Maintenance Period|Protocol Violation|0|||
160978700|NCT01474512|581311912|FG013|Maintenance Period|Protocol Violation|0|||
160978701|NCT01474512|581311913|FG014|Maintenance Period|Protocol Violation|0|||
160978702|NCT01474512|581311914|FG015|Maintenance Period|Protocol Violation|0|||
160978703|NCT01474512|581311915|FG016|Maintenance Period|Protocol Violation|0|||
160978704|NCT01474512|581311916|FG017|Maintenance Period|Protocol Violation|0|||
160978705|NCT01474512|581311899|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
160978706|NCT01474512|581311900|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
160978707|NCT01474512|581311901|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
160978708|NCT01474512|581311902|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
160978709|NCT01474512|581311903|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
160978710|NCT01474512|581311904|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
160978711|NCT01474512|581311905|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
160978712|NCT01474512|581311906|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
160978713|NCT01474512|581311907|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
160978714|NCT01474512|581311908|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
160978715|NCT01474512|581311909|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
160978716|NCT01474512|581311910|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
160978717|NCT01474512|581311911|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
160978718|NCT01474512|581311912|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
160978719|NCT01474512|581311913|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
160978720|NCT01474512|581311914|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
160978721|NCT01474512|581311915|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
160978722|NCT01474512|581311916|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
160978723|NCT01474512|581311899|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
160978724|NCT01474512|581311900|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
160978725|NCT01474512|581311901|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
160978726|NCT01474512|581311902|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
160978727|NCT01474512|581311903|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
160978728|NCT01474512|581311904|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
160978729|NCT01474512|581311905|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
160978730|NCT01474512|581311906|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
160978731|NCT01474512|581311907|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
160978732|NCT01474512|581311908|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
160978733|NCT01474512|581311909|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
160978734|NCT01474512|581311910|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
160978735|NCT01474512|581311911|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
160978736|NCT01474512|581311912|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
160978737|NCT01474512|581311913|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
160978738|NCT01474512|581311914|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
160978739|NCT01474512|581311915|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
160978740|NCT01474512|581311916|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
160978741|NCT01474512|581311899|FG000|Long-Term Extension Period|Adverse Event|0|||
160978742|NCT01474512|581311900|FG001|Long-Term Extension Period|Adverse Event|0|||
160978743|NCT01474512|581311901|FG002|Long-Term Extension Period|Adverse Event|0|||
160978744|NCT01474512|581311902|FG003|Long-Term Extension Period|Adverse Event|0|||
160978745|NCT01474512|581311903|FG004|Long-Term Extension Period|Adverse Event|0|||
160978746|NCT01474512|581311904|FG005|Long-Term Extension Period|Adverse Event|0|||
160978747|NCT01474512|581311905|FG006|Long-Term Extension Period|Adverse Event|0|||
160978748|NCT01474512|581311906|FG007|Long-Term Extension Period|Adverse Event|0|||
160978749|NCT01474512|581311907|FG008|Long-Term Extension Period|Adverse Event|0|||
160978750|NCT01474512|581311908|FG009|Long-Term Extension Period|Adverse Event|0|||
160978751|NCT01474512|581311909|FG010|Long-Term Extension Period|Adverse Event|0|||
160978752|NCT01474512|581311910|FG011|Long-Term Extension Period|Adverse Event|1|||
160978753|NCT01474512|581311911|FG012|Long-Term Extension Period|Adverse Event|57|||
160978754|NCT01474512|581311912|FG013|Long-Term Extension Period|Adverse Event|58|||
160978755|NCT01474512|581311913|FG014|Long-Term Extension Period|Adverse Event|0|||
160978756|NCT01474512|581311914|FG015|Long-Term Extension Period|Adverse Event|0|||
160978757|NCT01474512|581311915|FG016|Long-Term Extension Period|Adverse Event|0|||
160978758|NCT01474512|581311916|FG017|Long-Term Extension Period|Adverse Event|0|||
160978759|NCT01474512|581311899|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
160978760|NCT01474512|581311900|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
160978761|NCT01474512|581311901|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
160978762|NCT01474512|581311902|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
160978763|NCT01474512|581311903|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
160978764|NCT01474512|581311904|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
160978765|NCT01474512|581311905|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
160978766|NCT01474512|581311906|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
160978767|NCT01474512|581311907|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
160978768|NCT01474512|581311908|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
160978769|NCT01474512|581311909|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
160978770|NCT01474512|581311910|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
160978771|NCT01474512|581311911|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
160978772|NCT01474512|581311912|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
160978773|NCT01474512|581311913|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
160978774|NCT01474512|581311914|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
160978775|NCT01474512|581311915|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
160978776|NCT01474512|581311916|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
160978777|NCT01474512|581311899|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
160978778|NCT01474512|581311900|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
160978779|NCT01474512|581311901|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
160978780|NCT01474512|581311902|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
160978781|NCT01474512|581311903|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
160978782|NCT01474512|581311904|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
160978783|NCT01474512|581311905|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
160978784|NCT01474512|581311906|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
160978785|NCT01474512|581311907|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
160978786|NCT01474512|581311908|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
160978787|NCT01474512|581311909|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
160978788|NCT01474512|581311910|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
160978789|NCT01474512|581311911|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
160978790|NCT01474512|581311912|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
160978791|NCT01474512|581311913|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
160978792|NCT01474512|581311914|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
160978793|NCT01474512|581311915|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
160978794|NCT01474512|581311916|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
160978795|NCT01474512|581311899|FG000|Long-Term Extension Period|Physician Decision|0|||
160978796|NCT01474512|581311900|FG001|Long-Term Extension Period|Physician Decision|0|||
160978797|NCT01474512|581311901|FG002|Long-Term Extension Period|Physician Decision|0|||
160978798|NCT01474512|581311902|FG003|Long-Term Extension Period|Physician Decision|0|||
160978799|NCT01474512|581311903|FG004|Long-Term Extension Period|Physician Decision|0|||
160978800|NCT01474512|581311904|FG005|Long-Term Extension Period|Physician Decision|0|||
160978801|NCT01474512|581311905|FG006|Long-Term Extension Period|Physician Decision|0|||
160978802|NCT01474512|581311906|FG007|Long-Term Extension Period|Physician Decision|0|||
160978803|NCT01474512|581311907|FG008|Long-Term Extension Period|Physician Decision|0|||
160978804|NCT01474512|581311908|FG009|Long-Term Extension Period|Physician Decision|0|||
160978805|NCT01474512|581311909|FG010|Long-Term Extension Period|Physician Decision|0|||
160978806|NCT01474512|581311910|FG011|Long-Term Extension Period|Physician Decision|0|||
160978807|NCT01474512|581311911|FG012|Long-Term Extension Period|Physician Decision|21|||
160978808|NCT01474512|581311912|FG013|Long-Term Extension Period|Physician Decision|21|||
160978809|NCT01474512|581311913|FG014|Long-Term Extension Period|Physician Decision|0|||
160978810|NCT01474512|581311914|FG015|Long-Term Extension Period|Physician Decision|0|||
160978811|NCT01474512|581311915|FG016|Long-Term Extension Period|Physician Decision|0|||
160978812|NCT01474512|581311916|FG017|Long-Term Extension Period|Physician Decision|0|||
160978813|NCT01474512|581311899|FG000|Long-Term Extension Period|Clinical Relapse|0|||
160978814|NCT01474512|581311900|FG001|Long-Term Extension Period|Clinical Relapse|0|||
160978815|NCT01474512|581311901|FG002|Long-Term Extension Period|Clinical Relapse|0|||
160978816|NCT01474512|581311902|FG003|Long-Term Extension Period|Clinical Relapse|0|||
160978817|NCT01474512|581311903|FG004|Long-Term Extension Period|Clinical Relapse|0|||
160978818|NCT01474512|581311904|FG005|Long-Term Extension Period|Clinical Relapse|0|||
160978819|NCT01474512|581311905|FG006|Long-Term Extension Period|Clinical Relapse|0|||
160978820|NCT01474512|581311906|FG007|Long-Term Extension Period|Clinical Relapse|0|||
160978821|NCT01474512|581311907|FG008|Long-Term Extension Period|Clinical Relapse|0|||
160978822|NCT01474512|581311908|FG009|Long-Term Extension Period|Clinical Relapse|0|||
160978823|NCT01474512|581311909|FG010|Long-Term Extension Period|Clinical Relapse|0|||
160978824|NCT01474512|581311910|FG011|Long-Term Extension Period|Clinical Relapse|0|||
160978825|NCT01474512|581311911|FG012|Long-Term Extension Period|Clinical Relapse|9|||
160978826|NCT01474512|581311912|FG013|Long-Term Extension Period|Clinical Relapse|9|||
160978827|NCT01474512|581311913|FG014|Long-Term Extension Period|Clinical Relapse|0|||
160978828|NCT01474512|581311914|FG015|Long-Term Extension Period|Clinical Relapse|0|||
160978829|NCT01474512|581311915|FG016|Long-Term Extension Period|Clinical Relapse|0|||
160978830|NCT01474512|581311916|FG017|Long-Term Extension Period|Clinical Relapse|0|||
160978831|NCT01474512|581311899|FG000|Long-Term Extension Period|Death|0|||
160978832|NCT01474512|581311900|FG001|Long-Term Extension Period|Death|0|||
160978833|NCT01474512|581311901|FG002|Long-Term Extension Period|Death|0|||
160978834|NCT01474512|581311902|FG003|Long-Term Extension Period|Death|0|||
160978835|NCT01474512|581311903|FG004|Long-Term Extension Period|Death|0|||
160978836|NCT01474512|581311904|FG005|Long-Term Extension Period|Death|0|||
160978837|NCT01474512|581311905|FG006|Long-Term Extension Period|Death|0|||
160978838|NCT01474512|581311906|FG007|Long-Term Extension Period|Death|0|||
160978839|NCT01474512|581311907|FG008|Long-Term Extension Period|Death|0|||
160978840|NCT01474512|581311908|FG009|Long-Term Extension Period|Death|0|||
160978841|NCT01474512|581311909|FG010|Long-Term Extension Period|Death|0|||
160978842|NCT01474512|581311910|FG011|Long-Term Extension Period|Death|0|||
160978843|NCT01474512|581311911|FG012|Long-Term Extension Period|Death|9|||
160978844|NCT01474512|581311912|FG013|Long-Term Extension Period|Death|9|||
160978845|NCT01474512|581311913|FG014|Long-Term Extension Period|Death|0|||
160978846|NCT01474512|581311914|FG015|Long-Term Extension Period|Death|0|||
160978847|NCT01474512|581311915|FG016|Long-Term Extension Period|Death|0|||
160978848|NCT01474512|581311916|FG017|Long-Term Extension Period|Death|0|||
160978849|NCT01474512|581311899|FG000|Long-Term Extension Period|Sponsor Decision|0|||
160978850|NCT01474512|581311900|FG001|Long-Term Extension Period|Sponsor Decision|0|||
160978851|NCT01474512|581311901|FG002|Long-Term Extension Period|Sponsor Decision|0|||
160978852|NCT01474512|581311902|FG003|Long-Term Extension Period|Sponsor Decision|0|||
160978853|NCT01474512|581311903|FG004|Long-Term Extension Period|Sponsor Decision|0|||
160978854|NCT01474512|581311904|FG005|Long-Term Extension Period|Sponsor Decision|0|||
160978855|NCT01474512|581311905|FG006|Long-Term Extension Period|Sponsor Decision|0|||
160978856|NCT01474512|581311906|FG007|Long-Term Extension Period|Sponsor Decision|0|||
160978857|NCT01474512|581311907|FG008|Long-Term Extension Period|Sponsor Decision|0|||
160978858|NCT01474512|581311908|FG009|Long-Term Extension Period|Sponsor Decision|0|||
160978859|NCT01474512|581311909|FG010|Long-Term Extension Period|Sponsor Decision|0|||
160978860|NCT01474512|581311910|FG011|Long-Term Extension Period|Sponsor Decision|0|||
160978861|NCT01474512|581311911|FG012|Long-Term Extension Period|Sponsor Decision|6|||
160978862|NCT01474512|581311912|FG013|Long-Term Extension Period|Sponsor Decision|6|||
160978863|NCT01474512|581311913|FG014|Long-Term Extension Period|Sponsor Decision|0|||
160978864|NCT01474512|581311914|FG015|Long-Term Extension Period|Sponsor Decision|0|||
160978865|NCT01474512|581311915|FG016|Long-Term Extension Period|Sponsor Decision|0|||
160978866|NCT01474512|581311916|FG017|Long-Term Extension Period|Sponsor Decision|0|||
160978867|NCT01474512|581311899|FG000|Long-Term Extension Period|Protocol Violation|0|||
160978868|NCT01474512|581311900|FG001|Long-Term Extension Period|Protocol Violation|0|||
160978869|NCT01474512|581311901|FG002|Long-Term Extension Period|Protocol Violation|0|||
160978870|NCT01474512|581311902|FG003|Long-Term Extension Period|Protocol Violation|0|||
160978871|NCT01474512|581311903|FG004|Long-Term Extension Period|Protocol Violation|0|||
160978872|NCT01474512|581311904|FG005|Long-Term Extension Period|Protocol Violation|0|||
160978873|NCT01474512|581311905|FG006|Long-Term Extension Period|Protocol Violation|0|||
160978874|NCT01474512|581311906|FG007|Long-Term Extension Period|Protocol Violation|0|||
160978875|NCT01474512|581311907|FG008|Long-Term Extension Period|Protocol Violation|0|||
160978876|NCT01474512|581311908|FG009|Long-Term Extension Period|Protocol Violation|0|||
160978877|NCT01474512|581311909|FG010|Long-Term Extension Period|Protocol Violation|0|||
160978878|NCT01474512|581311910|FG011|Long-Term Extension Period|Protocol Violation|0|||
160978879|NCT01474512|581311911|FG012|Long-Term Extension Period|Protocol Violation|5|||
160978880|NCT01474512|581311912|FG013|Long-Term Extension Period|Protocol Violation|5|||
160978881|NCT01474512|581311913|FG014|Long-Term Extension Period|Protocol Violation|0|||
160978882|NCT01474512|581311914|FG015|Long-Term Extension Period|Protocol Violation|0|||
160978883|NCT01474512|581311915|FG016|Long-Term Extension Period|Protocol Violation|0|||
160978884|NCT01474512|581311916|FG017|Long-Term Extension Period|Protocol Violation|0|||
160978885|NCT01474512|581311899|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978886|NCT01474512|581311900|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978887|NCT01474512|581311901|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161208699|NCT01682512|582146862|FG001|Overall Study|Physician Decision|2|||
161208700|NCT01682512|582146863|FG002|Overall Study|Physician Decision|0|||
161208701|NCT01682512|582146861|FG000|Overall Study|Study terminated by sponsor|46|||
161208702|NCT01682512|582146862|FG001|Overall Study|Study terminated by sponsor|43|||
161208703|NCT01682512|582146863|FG002|Overall Study|Study terminated by sponsor|0|||
161208704|NCT01682512|582146861|FG000|Overall Study|Lost to Follow-up|3|||
161208705|NCT01682512|582146862|FG001|Overall Study|Lost to Follow-up|0|||
161208706|NCT01682512|582146863|FG002|Overall Study|Lost to Follow-up|2|||
161208707|NCT01682512|582146861|FG000|Overall Study|Protocol Violation|2|||
161208708|NCT01682512|582146862|FG001|Overall Study|Protocol Violation|3|||
161208709|NCT01682512|582146863|FG002|Overall Study|Protocol Violation|2|||
161208710|NCT01682512|582146861|FG000|Overall Study|Primary lack of efficacy|10|||
161208711|NCT01682512|582146862|FG001|Overall Study|Primary lack of efficacy|7|||
161208712|NCT01682512|582146863|FG002|Overall Study|Primary lack of efficacy|7|||
161208713|NCT01682512|582146861|FG000|Overall Study|Secondary lack of efficacy|1|||
161208714|NCT01682512|582146862|FG001|Overall Study|Secondary lack of efficacy|1|||
161208715|NCT01682512|582146863|FG002|Overall Study|Secondary lack of efficacy|0|||
161208716|NCT01682512|582146861|FG000|Overall Study|Other than stated above|2|||
161208717|NCT01682512|582146862|FG001|Overall Study|Other than stated above|4|||
161208718|NCT01682512|582146863|FG002|Overall Study|Other than stated above|2|||
161208719|NCT00417027|582146864|FG000|Overall Study|Protocol Violation|0|||
161208720|NCT00417027|582146865|FG001|Overall Study|Protocol Violation|5|||
161208721|NCT00417027|582146866|FG002|Overall Study|Protocol Violation|5|||
161208722|NCT03137082|582146867|FG000|Overall Study|Withdrawal by Subject|1|||
161208723|NCT03137082|582146868|FG001|Overall Study|Withdrawal by Subject|1|||
161208724|NCT03137082|582146867|FG000|Overall Study|Lost to Follow-up|1|||
161208725|NCT03137082|582146868|FG001|Overall Study|Lost to Follow-up|0|||
161208726|NCT04285983|582146869|FG000|Overall Study|Protocol Violation|6|||
161208727|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161208728|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
161208729|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161208730|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
161208731|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
161208732|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
161208733|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
161208734|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
161208735|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161208736|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
161208737|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161208738|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
161208739|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
161208740|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
161208741|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
161208742|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
161208743|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
161208744|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
161208745|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
161208746|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
161208747|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161208748|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
161208749|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161208750|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
161208751|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
161208752|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161208753|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161208754|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
161208755|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
161208756|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
161208757|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
161208758|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
161208759|NCT03747939|582146870|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161208760|NCT03747939|582146871|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
161208761|NCT03747939|582146872|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161208762|NCT03747939|582146873|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
161208763|NCT03747939|582146870|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
161208764|NCT03747939|582146871|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
161208765|NCT03747939|582146872|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
161208766|NCT03747939|582146873|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
161208767|NCT03747939|582146870|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
161208768|NCT03747939|582146871|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
161208769|NCT03747939|582146872|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
161208770|NCT03747939|582146873|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
161208771|NCT03747939|582146870|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
161208772|NCT03747939|582146871|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
161208773|NCT03747939|582146872|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
161208774|NCT03747939|582146873|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
161208775|NCT03747939|582146870|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
161208776|NCT03747939|582146871|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
161208777|NCT03747939|582146872|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
161208778|NCT03747939|582146873|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
161208779|NCT03747939|582146870|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161208780|NCT03747939|582146871|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161208781|NCT03747939|582146872|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
161208782|NCT03747939|582146873|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
161208783|NCT01447628|582146874|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161208784|NCT01447628|582146875|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161208785|NCT01447628|582146876|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
161208786|NCT01447628|582146877|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
161208787|NCT00810615|582146882|FG000|Overall Study|Withdrawal by Subject|1|||
161208788|NCT00810615|582146883|FG001|Overall Study|Withdrawal by Subject|1|||
161208789|NCT01766310|582146885|FG000|Overall Study|Lost to Follow-up|1|||
161208790|NCT01766310|582146886|FG001|Overall Study|Lost to Follow-up|3|||
161092571|NCT03818204|581729898|FG006|Overall Study|Physician Decision|0|||
161092572|NCT03818204|581729899|FG007|Overall Study|Physician Decision|0|||
161092573|NCT03818204|581729900|FG008|Overall Study|Physician Decision|0|||
161092574|NCT03818204|581729901|FG009|Overall Study|Physician Decision|0|||
161092575|NCT03818204|581729902|FG010|Overall Study|Physician Decision|0|||
161092576|NCT03818204|581729903|FG011|Overall Study|Physician Decision|0|||
161092577|NCT03818204|581729904|FG012|Overall Study|Physician Decision|0|||
161092578|NCT03818204|581729905|FG013|Overall Study|Physician Decision|0|||
161092579|NCT03818204|581729906|FG014|Overall Study|Physician Decision|1|||
161092580|NCT03818204|581729907|FG015|Overall Study|Physician Decision|0|||
161092581|NCT03818204|581729908|FG016|Overall Study|Physician Decision|0|||
161092582|NCT03818204|581729909|FG017|Overall Study|Physician Decision|0|||
161092583|NCT03818204|581729910|FG018|Overall Study|Physician Decision|0|||
161092584|NCT00887250|581729911|FG000|Overall Study|Adverse Event|3|||
161092585|NCT00887250|581729912|FG001|Overall Study|Adverse Event|0|||
161092586|NCT00887250|581729913|FG002|Overall Study|Adverse Event|7|||
161092587|NCT00887250|581729911|FG000|Overall Study|Lack of Efficacy|9|||
161092588|NCT00887250|581729912|FG001|Overall Study|Lack of Efficacy|6|||
160978888|NCT01474512|581311902|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978889|NCT01474512|581311903|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978890|NCT01474512|581311904|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978891|NCT01474512|581311905|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978892|NCT01474512|581311906|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978893|NCT01474512|581311907|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978894|NCT01474512|581311908|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978895|NCT01474512|581311909|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978896|NCT01474512|581311910|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978897|NCT01474512|581311911|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
160978898|NCT01474512|581311912|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
160978899|NCT01474512|581311913|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978900|NCT01474512|581311914|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978901|NCT01474512|581311915|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
160978902|NCT01474512|581311916|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
161208791|NCT01591499|582146887|FG000|Baseline Visit|Withdrawal by Subject|0|||
161208792|NCT01591499|582146888|FG001|Baseline Visit|Withdrawal by Subject|2|||
161208793|NCT01591499|582146889|FG002|Baseline Visit|Withdrawal by Subject|0|||
161208794|NCT01591499|582146890|FG003|Baseline Visit|Withdrawal by Subject|2|||
161208795|NCT01591499|582146887|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
161208796|NCT01591499|582146888|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
161208797|NCT01591499|582146889|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
161208798|NCT01591499|582146890|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
161208799|NCT01591499|582146887|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
161208800|NCT01591499|582146888|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
160978903|NCT01474512|581311899|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978904|NCT01474512|581311900|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978905|NCT01474512|581311901|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161092589|NCT00887250|581729913|FG002|Overall Study|Lack of Efficacy|1|||
161208801|NCT01591499|582146889|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
161208802|NCT01591499|582146890|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
161208803|NCT02125734|582146891|FG000|Period 2|Adverse Event|0|||
161208804|NCT02125734|582146892|FG001|Period 2|Adverse Event|1|||
161208805|NCT00902278|582146893|FG000|Overall Study|Physician Decision|1|||
161208806|NCT00902278|582146894|FG001|Overall Study|Physician Decision|0|||
161208807|NCT00902278|582146895|FG002|Overall Study|Physician Decision|2|||
161208808|NCT00902278|582146896|FG003|Overall Study|Physician Decision|0|||
161208809|NCT00902278|582146897|FG004|Overall Study|Physician Decision|1|||
161208810|NCT00902278|582146893|FG000|Overall Study|Lost to Follow-up|3|||
161208811|NCT00902278|582146894|FG001|Overall Study|Lost to Follow-up|2|||
161208812|NCT00902278|582146895|FG002|Overall Study|Lost to Follow-up|3|||
161208813|NCT00902278|582146896|FG003|Overall Study|Lost to Follow-up|0|||
161208814|NCT00902278|582146897|FG004|Overall Study|Lost to Follow-up|1|||
161208815|NCT01289990|582146900|FG000|Overall Study|Death|0|||
161208816|NCT01289990|582146901|FG001|Overall Study|Death|0|||
161208817|NCT01289990|582146902|FG002|Overall Study|Death|0|||
161208818|NCT01289990|582146903|FG003|Overall Study|Death|1|||
161208819|NCT01289990|582146904|FG004|Overall Study|Death|2|||
161208820|NCT01289990|582146905|FG005|Overall Study|Death|1|||
161208821|NCT01289990|582146906|FG006|Overall Study|Death|0|||
161208822|NCT01289990|582146907|FG007|Overall Study|Death|0|||
161208823|NCT01289990|582146908|FG008|Overall Study|Death|0|||
161208824|NCT01289990|582146909|FG009|Overall Study|Death|0|||
161208825|NCT01289990|582146910|FG010|Overall Study|Death|0|||
161208826|NCT01289990|582146911|FG011|Overall Study|Death|1|||
161208827|NCT01289990|582146912|FG012|Overall Study|Death|0|||
161208828|NCT01289990|582146900|FG000|Overall Study|Lost to Follow-up|3|||
161208829|NCT01289990|582146901|FG001|Overall Study|Lost to Follow-up|2|||
161208830|NCT01289990|582146902|FG002|Overall Study|Lost to Follow-up|5|||
161208831|NCT01289990|582146903|FG003|Overall Study|Lost to Follow-up|5|||
161208832|NCT01289990|582146904|FG004|Overall Study|Lost to Follow-up|3|||
161208833|NCT01289990|582146905|FG005|Overall Study|Lost to Follow-up|4|||
161208834|NCT01289990|582146906|FG006|Overall Study|Lost to Follow-up|2|||
161208835|NCT01289990|582146907|FG007|Overall Study|Lost to Follow-up|2|||
161208836|NCT01289990|582146908|FG008|Overall Study|Lost to Follow-up|1|||
161208837|NCT01289990|582146909|FG009|Overall Study|Lost to Follow-up|4|||
161208838|NCT01289990|582146910|FG010|Overall Study|Lost to Follow-up|2|||
161208839|NCT01289990|582146911|FG011|Overall Study|Lost to Follow-up|1|||
161208840|NCT01289990|582146912|FG012|Overall Study|Lost to Follow-up|2|||
161208841|NCT01289990|582146900|FG000|Overall Study|Withdrawal by Subject|15|||
161208842|NCT01289990|582146901|FG001|Overall Study|Withdrawal by Subject|14|||
161208843|NCT01289990|582146902|FG002|Overall Study|Withdrawal by Subject|12|||
161208844|NCT01289990|582146903|FG003|Overall Study|Withdrawal by Subject|13|||
161208845|NCT01289990|582146904|FG004|Overall Study|Withdrawal by Subject|8|||
161208846|NCT01289990|582146905|FG005|Overall Study|Withdrawal by Subject|7|||
161208847|NCT01289990|582146906|FG006|Overall Study|Withdrawal by Subject|13|||
161208848|NCT01289990|582146907|FG007|Overall Study|Withdrawal by Subject|9|||
161208849|NCT01289990|582146908|FG008|Overall Study|Withdrawal by Subject|12|||
161208850|NCT01289990|582146909|FG009|Overall Study|Withdrawal by Subject|13|||
161208851|NCT01289990|582146910|FG010|Overall Study|Withdrawal by Subject|11|||
161208852|NCT01289990|582146911|FG011|Overall Study|Withdrawal by Subject|13|||
161208853|NCT01289990|582146912|FG012|Overall Study|Withdrawal by Subject|16|||
161208854|NCT01289990|582146900|FG000|Overall Study|discontinued in preceding trial|18|||
161208855|NCT01289990|582146901|FG001|Overall Study|discontinued in preceding trial|20|||
161208856|NCT01289990|582146902|FG002|Overall Study|discontinued in preceding trial|41|||
161208857|NCT01289990|582146903|FG003|Overall Study|discontinued in preceding trial|17|||
161208858|NCT01289990|582146904|FG004|Overall Study|discontinued in preceding trial|11|||
161208859|NCT01289990|582146905|FG005|Overall Study|discontinued in preceding trial|12|||
161208860|NCT01289990|582146906|FG006|Overall Study|discontinued in preceding trial|18|||
161208861|NCT01289990|582146907|FG007|Overall Study|discontinued in preceding trial|8|||
161208862|NCT01289990|582146908|FG008|Overall Study|discontinued in preceding trial|17|||
161208863|NCT01289990|582146909|FG009|Overall Study|discontinued in preceding trial|21|||
161208864|NCT01289990|582146910|FG010|Overall Study|discontinued in preceding trial|17|||
161208865|NCT01289990|582146911|FG011|Overall Study|discontinued in preceding trial|17|||
161208866|NCT01289990|582146912|FG012|Overall Study|discontinued in preceding trial|24|||
161208867|NCT01289990|582146900|FG000|Overall Study|did not continue in extension|41|||
161208868|NCT01289990|582146901|FG001|Overall Study|did not continue in extension|45|||
161322181|NCT05052697|582566510|FG012|Substudy A|No longer met eligibility criteria|0|||
161322182|NCT05052697|582566511|FG013|Substudy A|No longer met eligibility criteria|1|||
161208869|NCT01289990|582146902|FG002|Overall Study|did not continue in extension|51|||
161208870|NCT01289990|582146903|FG003|Overall Study|did not continue in extension|51|||
161208871|NCT01289990|582146904|FG004|Overall Study|did not continue in extension|48|||
161208872|NCT01289990|582146905|FG005|Overall Study|did not continue in extension|50|||
161208873|NCT01289990|582146906|FG006|Overall Study|did not continue in extension|54|||
161208874|NCT01289990|582146907|FG007|Overall Study|did not continue in extension|36|||
161208875|NCT01289990|582146908|FG008|Overall Study|did not continue in extension|44|||
161208876|NCT01289990|582146909|FG009|Overall Study|did not continue in extension|48|||
161208877|NCT01289990|582146910|FG010|Overall Study|did not continue in extension|45|||
161208878|NCT01289990|582146911|FG011|Overall Study|did not continue in extension|34|||
161208879|NCT01289990|582146912|FG012|Overall Study|did not continue in extension|56|||
161208880|NCT01289990|582146900|FG000|Overall Study|Not treated|0|||
161208881|NCT01289990|582146901|FG001|Overall Study|Not treated|0|||
161208882|NCT01289990|582146902|FG002|Overall Study|Not treated|0|||
161208883|NCT01289990|582146903|FG003|Overall Study|Not treated|0|||
161208884|NCT01289990|582146904|FG004|Overall Study|Not treated|0|||
161208885|NCT01289990|582146905|FG005|Overall Study|Not treated|0|||
161208886|NCT01289990|582146906|FG006|Overall Study|Not treated|1|||
161208887|NCT01289990|582146907|FG007|Overall Study|Not treated|0|||
161208888|NCT01289990|582146908|FG008|Overall Study|Not treated|1|||
161208889|NCT01289990|582146909|FG009|Overall Study|Not treated|0|||
161208890|NCT01289990|582146910|FG010|Overall Study|Not treated|1|||
161208891|NCT01289990|582146911|FG011|Overall Study|Not treated|2|||
161208892|NCT01289990|582146912|FG012|Overall Study|Not treated|0|||
161208893|NCT02441179|582146913|FG000|Overall Study|Withdrawal by Subject|1|||
161208894|NCT02441179|582146914|FG001|Overall Study|Withdrawal by Subject|1|||
161208895|NCT03454672|582146915|FG000|Overall Study|Adverse Event|1|||
161208896|NCT03454672|582146916|FG001|Overall Study|Adverse Event|1|||
161208897|NCT03454672|582146915|FG000|Overall Study|Lost to Follow-up|1|||
161208898|NCT03454672|582146916|FG001|Overall Study|Lost to Follow-up|3|||
161208899|NCT03454672|582146915|FG000|Overall Study|painful|1|||
161208900|NCT03454672|582146916|FG001|Overall Study|painful|2|||
161208901|NCT03454672|582146915|FG000|Overall Study|Non-compliance|2|||
161208902|NCT03454672|582146916|FG001|Overall Study|Non-compliance|4|||
161208903|NCT03454672|582146915|FG000|Overall Study|personal reasons|3|||
161208904|NCT03454672|582146916|FG001|Overall Study|personal reasons|2|||
161208905|NCT03454672|582146915|FG000|Overall Study|Withdrawal by Subject|1|||
161208906|NCT03454672|582146916|FG001|Overall Study|Withdrawal by Subject|0|||
161208907|NCT05166512|582146917|FG000|Randomized|Lost to Follow-up|2|||
161208908|NCT05166512|582146918|FG001|Randomized|Lost to Follow-up|0|||
161208909|NCT05166512|582146917|FG000|Randomized|Withdrawal by Subject|1|||
161208910|NCT05166512|582146918|FG001|Randomized|Withdrawal by Subject|0|||
161208911|NCT05166512|582146917|FG000|Baseline Data Collection|Lost to Follow-up|0|||
161208912|NCT05166512|582146918|FG001|Baseline Data Collection|Lost to Follow-up|3|||
161208913|NCT05166512|582146917|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
161208914|NCT05166512|582146918|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
161208915|NCT05166512|582146917|FG000|Baseline Data Collection|Protocol Violation|2|||
161208916|NCT05166512|582146918|FG001|Baseline Data Collection|Protocol Violation|0|||
161208917|NCT05166512|582146917|FG000|4 Month Data Collection|Lost to Follow-up|1|||
161208918|NCT05166512|582146918|FG001|4 Month Data Collection|Lost to Follow-up|0|||
161208919|NCT05166512|582146917|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
161208920|NCT05166512|582146918|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
161208921|NCT05166512|582146917|FG000|12 Month Data Collection|Lost to Follow-up|3|||
161208922|NCT05166512|582146918|FG001|12 Month Data Collection|Lost to Follow-up|1|||
161208923|NCT05166512|582146917|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
161208924|NCT05166512|582146918|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
161208925|NCT00420849|582146919|FG000|Overall Study|Lack of Efficacy|154|||
161208926|NCT00420849|582146919|FG000|Overall Study|Adverse Event|107|||
161208927|NCT00420849|582146919|FG000|Overall Study|Withdrawal by Subject|28|||
161208928|NCT00420849|582146919|FG000|Overall Study|Death|18|||
161208929|NCT00420849|582146919|FG000|Overall Study|Other|14|||
161208930|NCT00420849|582146919|FG000|Overall Study|Transplant|8|||
161208931|NCT00420849|582146919|FG000|Overall Study|Protocol Violation|1|||
161208932|NCT00420849|582146919|FG000|Overall Study|Lost to Follow-up|1|||
161208933|NCT01488071|582146920|FG000|Overall Study|Adverse Event|15|||
161208934|NCT01488071|582146921|FG001|Overall Study|Adverse Event|23|||
161208935|NCT01488071|582146920|FG000|Overall Study|Lack of Efficacy|11|||
161208936|NCT01488071|582146921|FG001|Overall Study|Lack of Efficacy|17|||
161208937|NCT01488071|582146920|FG000|Overall Study|Non-compliance with study drug|2|||
161208938|NCT01488071|582146921|FG001|Overall Study|Non-compliance with study drug|0|||
161208939|NCT01488071|582146920|FG000|Overall Study|Protocol Violation|5|||
161208940|NCT01488071|582146921|FG001|Overall Study|Protocol Violation|7|||
161208941|NCT01488071|582146920|FG000|Overall Study|Withdrawal of Consent|14|||
161208942|NCT01488071|582146921|FG001|Overall Study|Withdrawal of Consent|12|||
161208943|NCT01488071|582146920|FG000|Overall Study|Lost to Follow-up|1|||
161208944|NCT01488071|582146921|FG001|Overall Study|Lost to Follow-up|0|||
161208945|NCT01488071|582146920|FG000|Overall Study|Administrative or Other Reason(s)|5|||
161208946|NCT01488071|582146921|FG001|Overall Study|Administrative or Other Reason(s)|4|||
161208947|NCT02139306|582146922|FG000|Overall Study|Withdrawal by Subject|4|||
161208948|NCT02139306|582146923|FG001|Overall Study|Withdrawal by Subject|6|||
161208949|NCT02139306|582146922|FG000|Overall Study|Adverse Event|3|||
161208950|NCT02139306|582146923|FG001|Overall Study|Adverse Event|4|||
161208951|NCT02139306|582146922|FG000|Overall Study|Physician Decision|0|||
161208952|NCT02139306|582146923|FG001|Overall Study|Physician Decision|1|||
161208953|NCT02139306|582146922|FG000|Overall Study|Other Unspecified|2|||
161208954|NCT02139306|582146923|FG001|Overall Study|Other Unspecified|3|||
161208955|NCT02139306|582146922|FG000|Overall Study|Protocol Violation|4|||
161208956|NCT02139306|582146923|FG001|Overall Study|Protocol Violation|0|||
161208957|NCT04449354|582146924|FG000|Overall Study|Withdrawal by Subject|1|||
161208958|NCT05789420|582146925|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
161208959|NCT05789420|582146925|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
161208960|NCT02278952|582146926|FG000|Overall Study|Insufficient Sample|6|||
161208961|NCT01220128|582146927|FG000|Overall Study|Progressive disease|0|||
161208962|NCT01220128|582146928|FG001|Overall Study|Progressive disease|0|||
161208963|NCT01220128|582146929|FG002|Overall Study|Progressive disease|2|||
161208964|NCT01220128|582146930|FG003|Overall Study|Progressive disease|0|||
161208965|NCT01220128|582146931|FG004|Overall Study|Progressive disease|0|||
161208966|NCT01220128|582146932|FG005|Overall Study|Progressive disease|0|||
161208967|NCT01220128|582146933|FG006|Overall Study|Progressive disease|0|||
161208968|NCT01220128|582146927|FG000|Overall Study|Sponsor study termination|0|||
161208969|NCT01220128|582146928|FG001|Overall Study|Sponsor study termination|1|||
161208970|NCT01220128|582146929|FG002|Overall Study|Sponsor study termination|0|||
161208971|NCT01220128|582146930|FG003|Overall Study|Sponsor study termination|0|||
161208972|NCT01220128|582146931|FG004|Overall Study|Sponsor study termination|0|||
161208973|NCT01220128|582146932|FG005|Overall Study|Sponsor study termination|0|||
161208974|NCT01220128|582146933|FG006|Overall Study|Sponsor study termination|1|||
161208975|NCT01220128|582146927|FG000|Overall Study|Adverse event, serious fatal|2|||
160978906|NCT01474512|581311902|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978907|NCT01474512|581311903|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978908|NCT01474512|581311904|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978909|NCT01474512|581311905|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978910|NCT01474512|581311906|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978911|NCT01474512|581311907|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978912|NCT01474512|581311908|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978913|NCT01474512|581311909|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978914|NCT01474512|581311910|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
160978915|NCT01474512|581311911|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978916|NCT01474512|581311912|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978917|NCT01474512|581311913|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978918|NCT01474512|581311914|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978919|NCT01474512|581311915|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
160978920|NCT01474512|581311916|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
161208976|NCT01220128|582146928|FG001|Overall Study|Adverse event, serious fatal|0|||
160978921|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
160978922|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
160978923|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
160978924|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
160978925|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
160978926|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
160978927|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
160978928|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
160978929|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
160978930|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
160978931|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
160978932|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
160978933|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
160978934|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
160978935|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
160978936|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
160978937|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
160978938|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
160978939|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978940|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978941|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978942|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978943|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978944|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978945|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161208977|NCT01220128|582146929|FG002|Overall Study|Adverse event, serious fatal|0|||
161208978|NCT01220128|582146930|FG003|Overall Study|Adverse event, serious fatal|0|||
161208979|NCT01220128|582146931|FG004|Overall Study|Adverse event, serious fatal|0|||
161208980|NCT01220128|582146932|FG005|Overall Study|Adverse event, serious fatal|0|||
161208981|NCT01220128|582146933|FG006|Overall Study|Adverse event, serious fatal|1|||
160978946|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978947|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978948|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
161208982|NCT01220128|582146927|FG000|Overall Study|Adverse event, non-fatal|1|||
161208983|NCT01220128|582146928|FG001|Overall Study|Adverse event, non-fatal|0|||
161208984|NCT01220128|582146929|FG002|Overall Study|Adverse event, non-fatal|0|||
161208985|NCT01220128|582146930|FG003|Overall Study|Adverse event, non-fatal|0|||
161208986|NCT01220128|582146931|FG004|Overall Study|Adverse event, non-fatal|0|||
161208987|NCT01220128|582146932|FG005|Overall Study|Adverse event, non-fatal|0|||
161208988|NCT01220128|582146933|FG006|Overall Study|Adverse event, non-fatal|3|||
161208989|NCT01220128|582146927|FG000|Overall Study|Other|0|||
161208990|NCT01220128|582146928|FG001|Overall Study|Other|0|||
161208991|NCT01220128|582146929|FG002|Overall Study|Other|1|||
161208992|NCT01220128|582146930|FG003|Overall Study|Other|0|||
161208993|NCT01220128|582146931|FG004|Overall Study|Other|0|||
161208994|NCT01220128|582146932|FG005|Overall Study|Other|0|||
161208995|NCT01220128|582146933|FG006|Overall Study|Other|0|||
161208996|NCT01220128|582146927|FG000|Overall Study|Consent withdrawn by subject|1|||
161208997|NCT01220128|582146928|FG001|Overall Study|Consent withdrawn by subject|0|||
161208998|NCT01220128|582146929|FG002|Overall Study|Consent withdrawn by subject|0|||
161208999|NCT01220128|582146930|FG003|Overall Study|Consent withdrawn by subject|0|||
161209000|NCT01220128|582146931|FG004|Overall Study|Consent withdrawn by subject|0|||
161209001|NCT01220128|582146932|FG005|Overall Study|Consent withdrawn by subject|0|||
161322183|NCT05052697|582566512|FG014|Substudy A|No longer met eligibility criteria|0|||
161322184|NCT05052697|582566513|FG015|Substudy A|No longer met eligibility criteria|0|||
161322185|NCT05052697|582566514|FG016|Substudy A|No longer met eligibility criteria|0|||
161322186|NCT05052697|582566515|FG017|Substudy A|No longer met eligibility criteria|0|||
160978949|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978950|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978951|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978952|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
160978953|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
160978954|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
160978955|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
160978956|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
160978957|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978958|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978959|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978960|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978961|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978962|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978963|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978964|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978965|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978966|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978967|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978968|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978969|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978970|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
160978971|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
160978972|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
160978973|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
160978974|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
160978975|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978976|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978977|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978978|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978979|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978980|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978981|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978982|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978983|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978984|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978985|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978986|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978987|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978988|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978989|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978990|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
160978991|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
161322187|NCT05052697|582566516|FG018|Substudy A|No longer met eligibility criteria|0|||
161322188|NCT05052697|582566517|FG019|Substudy A|No longer met eligibility criteria|0|||
161322189|NCT05052697|582566518|FG020|Substudy A|No longer met eligibility criteria|0|||
161322190|NCT05052697|582566519|FG021|Substudy A|No longer met eligibility criteria|0|||
161322191|NCT05052697|582566520|FG022|Substudy A|No longer met eligibility criteria|0|||
161322192|NCT05052697|582566521|FG023|Substudy A|No longer met eligibility criteria|0|||
161322193|NCT05052697|582566522|FG024|Substudy A|No longer met eligibility criteria|0|||
161322194|NCT05052697|582566523|FG025|Substudy A|No longer met eligibility criteria|0|||
160978992|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
160978993|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
160978994|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
160978995|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
160978996|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
160978997|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
160978998|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
160978999|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
160979000|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
160979001|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
160979002|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
160979003|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
160979004|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
160979005|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
160979006|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
160979007|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
160979008|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
160979009|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
160979010|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
161092590|NCT00887250|581729911|FG000|Overall Study|Lost to Follow-up|2|||
161092591|NCT00887250|581729912|FG001|Overall Study|Lost to Follow-up|3|||
161092592|NCT00887250|581729913|FG002|Overall Study|Lost to Follow-up|1|||
161092593|NCT00887250|581729911|FG000|Overall Study|Protocol Violation|2|||
161092594|NCT00887250|581729912|FG001|Overall Study|Protocol Violation|2|||
161092595|NCT00887250|581729913|FG002|Overall Study|Protocol Violation|1|||
161092596|NCT00887250|581729911|FG000|Overall Study|Withdrawal by Subject|2|||
161092597|NCT00887250|581729912|FG001|Overall Study|Withdrawal by Subject|1|||
161092598|NCT00887250|581729913|FG002|Overall Study|Withdrawal by Subject|2|||
161092599|NCT00887250|581729911|FG000|Overall Study|Patient uncooperative|0|||
161092600|NCT00887250|581729912|FG001|Overall Study|Patient uncooperative|0|||
161092601|NCT00887250|581729913|FG002|Overall Study|Patient uncooperative|1|||
161092602|NCT05754333|581729914|FG000|Overall Study|Miscellaneous|3|||
161092603|NCT05754333|581729915|FG001|Overall Study|Miscellaneous|0|||
161092604|NCT05754333|581729916|FG002|Overall Study|Miscellaneous|0|||
161092605|NCT05754333|581729917|FG003|Overall Study|Miscellaneous|0|||
161092606|NCT05754333|581729914|FG000|Overall Study|Lost to Follow-up|2|||
161092607|NCT05754333|581729915|FG001|Overall Study|Lost to Follow-up|1|||
161092608|NCT05754333|581729916|FG002|Overall Study|Lost to Follow-up|0|||
161092609|NCT05754333|581729917|FG003|Overall Study|Lost to Follow-up|1|||
161092610|NCT03401229|581729923|FG000|Overall Study|Lost to Follow-up|2|||
161092611|NCT03401229|581729924|FG001|Overall Study|Lost to Follow-up|1|||
161209002|NCT01220128|582146933|FG006|Overall Study|Consent withdrawn by subject|0|||
161209003|NCT02913261|582146934|FG000|Overall Study|Technical problems|0|||
161209004|NCT02913261|582146935|FG001|Overall Study|Technical problems|1|||
161209005|NCT02913261|582146934|FG000|Overall Study|Lack of Efficacy|32|||
161209006|NCT02913261|582146935|FG001|Overall Study|Lack of Efficacy|69|||
161209007|NCT02913261|582146934|FG000|Overall Study|Adverse Event|27|||
161209008|NCT02913261|582146935|FG001|Overall Study|Adverse Event|5|||
161209009|NCT02913261|582146934|FG000|Overall Study|Death|25|||
161209010|NCT02913261|582146935|FG001|Overall Study|Death|22|||
161209011|NCT02913261|582146934|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
161209012|NCT02913261|582146935|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
161209013|NCT02913261|582146934|FG000|Overall Study|Disease relapse|8|||
161209014|NCT02913261|582146935|FG001|Overall Study|Disease relapse|13|||
161209015|NCT02913261|582146934|FG000|Overall Study|Physician Decision|8|||
161209016|NCT02913261|582146935|FG001|Overall Study|Physician Decision|9|||
161209017|NCT02913261|582146934|FG000|Overall Study|Subject/guardian decision|4|||
161209018|NCT02913261|582146935|FG001|Overall Study|Subject/guardian decision|6|||
161209019|NCT02913261|582146934|FG000|Overall Study|Graft loss|2|||
161209020|NCT02913261|582146935|FG001|Overall Study|Graft loss|0|||
161209021|NCT02304302|582146938|FG000|Overall Study|Adverse Event|2|||
161209022|NCT02304302|582146939|FG001|Overall Study|Adverse Event|3|||
161209023|NCT02304302|582146938|FG000|Overall Study|Lost to Follow-up|1|||
161209024|NCT02304302|582146939|FG001|Overall Study|Lost to Follow-up|4|||
161209025|NCT02304302|582146938|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
161209026|NCT02304302|582146939|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
161209027|NCT00391118|582146940|FG000|Overall Study|Adverse Event|3|||
161209028|NCT00391118|582146941|FG001|Overall Study|Adverse Event|10|||
161209029|NCT00391118|582146942|FG002|Overall Study|Adverse Event|7|||
161209030|NCT00391118|582146940|FG000|Overall Study|Lost to Follow-up|0|||
161209031|NCT00391118|582146941|FG001|Overall Study|Lost to Follow-up|2|||
161209032|NCT00391118|582146942|FG002|Overall Study|Lost to Follow-up|3|||
161322195|NCT05052697|582566524|FG026|Substudy A|No longer met eligibility criteria|0|||
161322196|NCT05052697|582566525|FG027|Substudy A|No longer met eligibility criteria|0|||
161092612|NCT03401229|581729923|FG000|Overall Study|Other|1|||
161092613|NCT03401229|581729924|FG001|Overall Study|Other|3|||
161322197|NCT05052697|582566526|FG028|Substudy A|No longer met eligibility criteria|0|||
161322198|NCT05052697|582566527|FG029|Substudy A|No longer met eligibility criteria|0|||
161322199|NCT05052697|582566528|FG030|Substudy A|No longer met eligibility criteria|0|||
161322200|NCT05052697|582566529|FG031|Substudy A|No longer met eligibility criteria|0|||
161322201|NCT05052697|582566530|FG032|Substudy A|No longer met eligibility criteria|0|||
161322202|NCT05052697|582566531|FG033|Substudy A|No longer met eligibility criteria|0|||
161322203|NCT05052697|582566498|FG000|Substudy A|Not vaccinated|0|||
161322204|NCT05052697|582566499|FG001|Substudy A|Not vaccinated|0|||
161092614|NCT03401229|581729923|FG000|Overall Study|Adverse Event|8|||
161209033|NCT00391118|582146940|FG000|Overall Study|Withdrawal by Subject|0|||
161209034|NCT00391118|582146941|FG001|Overall Study|Withdrawal by Subject|9|||
161209035|NCT00391118|582146942|FG002|Overall Study|Withdrawal by Subject|1|||
161209036|NCT00391118|582146940|FG000|Overall Study|Death|0|||
161209037|NCT00391118|582146941|FG001|Overall Study|Death|1|||
161209038|NCT00391118|582146942|FG002|Overall Study|Death|0|||
161209039|NCT00391118|582146940|FG000|Overall Study|Physician Decision|0|||
161209040|NCT00391118|582146941|FG001|Overall Study|Physician Decision|3|||
161209041|NCT00391118|582146942|FG002|Overall Study|Physician Decision|0|||
161209042|NCT00391118|582146940|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
161209043|NCT00391118|582146941|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
161209044|NCT00391118|582146942|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
161209045|NCT00391118|582146940|FG000|Overall Study|Progressive Disease|7|||
161209046|NCT00391118|582146941|FG001|Overall Study|Progressive Disease|26|||
161209047|NCT00391118|582146942|FG002|Overall Study|Progressive Disease|43|||
161209048|NCT00391118|582146940|FG000|Overall Study|Sponsor Decision|0|||
161209049|NCT00391118|582146941|FG001|Overall Study|Sponsor Decision|1|||
161209050|NCT00391118|582146942|FG002|Overall Study|Sponsor Decision|3|||
161209051|NCT00391118|582146940|FG000|Overall Study|Protocol Violation|1|||
161209052|NCT00391118|582146941|FG001|Overall Study|Protocol Violation|0|||
161209053|NCT00391118|582146942|FG002|Overall Study|Protocol Violation|0|||
161322205|NCT05052697|582566500|FG002|Substudy A|Not vaccinated|0|||
161092615|NCT03401229|581729924|FG001|Overall Study|Adverse Event|6|||
161092616|NCT03401229|581729923|FG000|Overall Study|Withdrawal by Subject|29|||
161092617|NCT03401229|581729924|FG001|Overall Study|Withdrawal by Subject|26|||
161092618|NCT03401229|581729923|FG000|Overall Study|COVID-19|0|||
161092619|NCT03401229|581729924|FG001|Overall Study|COVID-19|1|||
161092620|NCT05333224|581729925|FG000|Overall Study - Infants|Lost to Follow-up|1|||
161092621|NCT05333224|581729926|FG001|Overall Study - Infants|Lost to Follow-up|1|||
161092622|NCT00819390|581729931|FG000|Overall Study|Lost to Follow-up|1|||
161092623|NCT00819390|581729932|FG001|Overall Study|Lost to Follow-up|1|||
161092624|NCT00819390|581729933|FG002|Overall Study|Lost to Follow-up|0|||
161092625|NCT00819390|581729934|FG003|Overall Study|Lost to Follow-up|0|||
161092626|NCT00819390|581729931|FG000|Overall Study|Withdrawal by Subject|2|||
161092627|NCT00819390|581729932|FG001|Overall Study|Withdrawal by Subject|0|||
161092628|NCT00819390|581729933|FG002|Overall Study|Withdrawal by Subject|0|||
161092629|NCT00819390|581729934|FG003|Overall Study|Withdrawal by Subject|0|||
161092630|NCT00819390|581729931|FG000|Overall Study|Adverse Event|0|||
161092631|NCT00819390|581729932|FG001|Overall Study|Adverse Event|0|||
161092632|NCT00819390|581729933|FG002|Overall Study|Adverse Event|1|||
161092633|NCT00819390|581729934|FG003|Overall Study|Adverse Event|0|||
161092634|NCT02709096|581729939|FG000|Overall Study|non-compliance|1|||
161092635|NCT02709096|581729940|FG001|Overall Study|non-compliance|1|||
161092636|NCT00818649|581729941|FG000|Overall Study|Declining performance status|2|||
161092637|NCT00818649|581729941|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
161092638|NCT00818649|581729941|FG000|Overall Study|Adverse Event|1|||
161092639|NCT00505284|581729942|FG000|Overall Study|Adverse Event|3|||
161092640|NCT00505284|581729943|FG001|Overall Study|Adverse Event|7|||
161092641|NCT00505284|581729944|FG002|Overall Study|Adverse Event|9|||
161092642|NCT00505284|581729945|FG003|Overall Study|Adverse Event|14|||
161092643|NCT00505284|581729946|FG004|Overall Study|Adverse Event|22|||
161092644|NCT00505284|581729942|FG000|Overall Study|Protocol Violation|0|||
161092645|NCT00505284|581729943|FG001|Overall Study|Protocol Violation|1|||
161092646|NCT00505284|581729944|FG002|Overall Study|Protocol Violation|1|||
161092647|NCT00505284|581729945|FG003|Overall Study|Protocol Violation|0|||
161092648|NCT00505284|581729946|FG004|Overall Study|Protocol Violation|0|||
161092649|NCT00505284|581729942|FG000|Overall Study|Withdrawal by Subject|2|||
161092650|NCT00505284|581729943|FG001|Overall Study|Withdrawal by Subject|6|||
161092651|NCT00505284|581729944|FG002|Overall Study|Withdrawal by Subject|1|||
161092652|NCT00505284|581729945|FG003|Overall Study|Withdrawal by Subject|0|||
161092653|NCT00505284|581729946|FG004|Overall Study|Withdrawal by Subject|6|||
161092654|NCT00505284|581729942|FG000|Overall Study|Lack of Efficacy|0|||
161092655|NCT00505284|581729943|FG001|Overall Study|Lack of Efficacy|1|||
161092656|NCT00505284|581729944|FG002|Overall Study|Lack of Efficacy|1|||
161092657|NCT00505284|581729945|FG003|Overall Study|Lack of Efficacy|1|||
161092658|NCT00505284|581729946|FG004|Overall Study|Lack of Efficacy|1|||
161092659|NCT00505284|581729942|FG000|Overall Study|Physician Decision|0|||
161092660|NCT00505284|581729943|FG001|Overall Study|Physician Decision|1|||
161322206|NCT05052697|582566501|FG003|Substudy A|Not vaccinated|1|||
161322207|NCT05052697|582566502|FG004|Substudy A|Not vaccinated|0|||
161092661|NCT00505284|581729944|FG002|Overall Study|Physician Decision|0|||
161092662|NCT00505284|581729945|FG003|Overall Study|Physician Decision|0|||
161092663|NCT00505284|581729946|FG004|Overall Study|Physician Decision|0|||
161092664|NCT00505284|581729942|FG000|Overall Study|Other|5|||
161092665|NCT00505284|581729943|FG001|Overall Study|Other|0|||
161092666|NCT00505284|581729944|FG002|Overall Study|Other|0|||
161092667|NCT00505284|581729945|FG003|Overall Study|Other|4|||
161092668|NCT00505284|581729946|FG004|Overall Study|Other|4|||
161092669|NCT03513588|581729947|FG000|Overall Study|Lost to Follow-up|0|||
161092670|NCT03513588|581729948|FG001|Overall Study|Lost to Follow-up|1|||
161092671|NCT03513588|581729949|FG002|Overall Study|Lost to Follow-up|1|||
161092672|NCT03513588|581729947|FG000|Overall Study|Study dosing paused by sponsor|1|||
161092673|NCT03513588|581729948|FG001|Overall Study|Study dosing paused by sponsor|1|||
161092674|NCT03513588|581729949|FG002|Overall Study|Study dosing paused by sponsor|0|||
161092675|NCT03513588|581729947|FG000|Overall Study|Death|0|||
161092676|NCT03513588|581729948|FG001|Overall Study|Death|0|||
161092677|NCT03513588|581729949|FG002|Overall Study|Death|1|||
161092678|NCT01275131|581729950|FG000|Period 1|Withdrawal by Subject|1|||
161092679|NCT01275131|581729951|FG001|Period 1|Withdrawal by Subject|0|||
161092680|NCT01275131|581729952|FG002|Period 1|Withdrawal by Subject|3|||
161092681|NCT01275131|581729953|FG003|Period 1|Withdrawal by Subject|2|||
161092682|NCT01275131|581729950|FG000|Period 1|Physician Decision|1|||
161092683|NCT01275131|581729951|FG001|Period 1|Physician Decision|0|||
161092684|NCT01275131|581729952|FG002|Period 1|Physician Decision|0|||
161092685|NCT01275131|581729953|FG003|Period 1|Physician Decision|0|||
161092686|NCT01275131|581729950|FG000|Period 2 (Crossover)|Adverse Event|0|||
161092687|NCT01275131|581729951|FG001|Period 2 (Crossover)|Adverse Event|1|||
161092688|NCT01275131|581729952|FG002|Period 2 (Crossover)|Adverse Event|0|||
161092689|NCT01275131|581729953|FG003|Period 2 (Crossover)|Adverse Event|0|||
161092690|NCT01275131|581729950|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
161092691|NCT01275131|581729951|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
161092692|NCT01275131|581729952|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
161092693|NCT01275131|581729953|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
161092694|NCT01740323|581729954|FG000|Overall Study|Adverse Event|1|||
161092695|NCT01740323|581729955|FG001|Overall Study|Adverse Event|0|||
161092696|NCT01740323|581729954|FG000|Overall Study|Randomized but did not take study drug|1|||
161092697|NCT01740323|581729955|FG001|Overall Study|Randomized but did not take study drug|0|||
161092698|NCT06338462|581729956|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
161092699|NCT02112708|581729962|FG000|Baseline|Physician Decision|16|||
161092700|NCT02112708|581729963|FG001|Baseline|Physician Decision|11|||
161092701|NCT02112708|581729962|FG000|Baseline|Lost to Follow-up|12|||
161092702|NCT02112708|581729963|FG001|Baseline|Lost to Follow-up|0|||
161092703|NCT02112708|581729962|FG000|4 Month|Death|0|||
161092704|NCT02112708|581729963|FG001|4 Month|Death|1|||
161092705|NCT02112708|581729962|FG000|4 Month|Withdrawal by Subject|12|||
161092706|NCT02112708|581729963|FG001|4 Month|Withdrawal by Subject|0|||
161092707|NCT00953745|581729964|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
161092708|NCT00953745|581729965|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
161092709|NCT00953745|581729964|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
161092710|NCT00953745|581729965|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
161092711|NCT00953745|581729964|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
161092712|NCT00953745|581729965|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
161092713|NCT00953745|581729964|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
161092714|NCT00953745|581729965|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
161092715|NCT00953745|581729964|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
161092716|NCT00953745|581729965|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
161092717|NCT00953745|581729964|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
161092718|NCT00953745|581729965|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
161092719|NCT00903682|581729967|FG000|Overall Study|Adverse Event|6|||
161092720|NCT00903682|581729968|FG001|Overall Study|Adverse Event|13|||
161092721|NCT00903682|581729967|FG000|Overall Study|Lost to Follow-up|1|||
161092722|NCT00903682|581729968|FG001|Overall Study|Lost to Follow-up|0|||
161092723|NCT00903682|581729967|FG000|Overall Study|Withdrawal by Subject|5|||
161092724|NCT00903682|581729968|FG001|Overall Study|Withdrawal by Subject|0|||
161092725|NCT00903682|581729967|FG000|Overall Study|Pregnancy|0|||
161092726|NCT00903682|581729968|FG001|Overall Study|Pregnancy|1|||
161092727|NCT00903682|581729967|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
161092728|NCT00903682|581729968|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
161092729|NCT00903682|581729967|FG000|Overall Study|Subject Non-Compliant|1|||
161092730|NCT00903682|581729968|FG001|Overall Study|Subject Non-Compliant|0|||
161092731|NCT00903682|581729967|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
161092732|NCT00903682|581729968|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
161092733|NCT00903682|581729967|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
161209054|NCT05473247|582146943|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
161322208|NCT05052697|582566503|FG005|Substudy A|Not vaccinated|0|||
161209055|NCT01311505|582146944|FG000|First Intervention Period|Protocol Violation|0|||
161209056|NCT01311505|582146945|FG001|First Intervention Period|Protocol Violation|1|||
161209057|NCT00314262|582146949|FG000|Overall Study|Adverse Event|2|||
161209058|NCT00314262|582146949|FG000|Overall Study|Withdrawal by Subject|2|||
161209059|NCT00314262|582146949|FG000|Overall Study|Physician Decision|1|||
161209060|NCT00532779|582146950|FG000|Overall Study|Adverse Event|122|||
161209061|NCT00532779|582146951|FG001|Overall Study|Adverse Event|112|||
161209062|NCT00532779|582146952|FG002|Overall Study|Adverse Event|56|||
161209063|NCT00532779|582146950|FG000|Overall Study|Lost to Follow-up|76|||
161209064|NCT00532779|582146951|FG001|Overall Study|Lost to Follow-up|65|||
161209065|NCT00532779|582146952|FG002|Overall Study|Lost to Follow-up|66|||
161209066|NCT00532779|582146950|FG000|Overall Study|Withdrawal by Subject|63|||
161209067|NCT00532779|582146951|FG001|Overall Study|Withdrawal by Subject|60|||
161209068|NCT00532779|582146952|FG002|Overall Study|Withdrawal by Subject|90|||
161209069|NCT00532779|582146950|FG000|Overall Study|Lack of Efficacy|12|||
161209070|NCT00532779|582146951|FG001|Overall Study|Lack of Efficacy|12|||
161209071|NCT00532779|582146952|FG002|Overall Study|Lack of Efficacy|40|||
161209072|NCT00532779|582146950|FG000|Overall Study|Protocol Violation|5|||
161209073|NCT00532779|582146951|FG001|Overall Study|Protocol Violation|9|||
161209074|NCT00532779|582146952|FG002|Overall Study|Protocol Violation|7|||
161209075|NCT00532779|582146950|FG000|Overall Study|Pregnancy|2|||
161209076|NCT00532779|582146951|FG001|Overall Study|Pregnancy|5|||
161209077|NCT00532779|582146952|FG002|Overall Study|Pregnancy|3|||
161209078|NCT00532779|582146950|FG000|Overall Study|Death|0|||
161209079|NCT00532779|582146951|FG001|Overall Study|Death|1|||
161209080|NCT00532779|582146952|FG002|Overall Study|Death|0|||
161209081|NCT00532779|582146950|FG000|Overall Study|Drug noncompliance, moved, other|14|||
161209082|NCT00532779|582146951|FG001|Overall Study|Drug noncompliance, moved, other|23|||
161209083|NCT00532779|582146952|FG002|Overall Study|Drug noncompliance, moved, other|29|||
161209084|NCT02662556|582146953|FG000|Overall Study|Adverse Event|4|||
161209085|NCT02662556|582146953|FG000|Overall Study|Lack of Efficacy|4|||
161209086|NCT00828516|582146962|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
161209087|NCT00689273|582146963|FG000|Overall Study|Adverse Event|3|||
161209088|NCT00689273|582146964|FG001|Overall Study|Adverse Event|1|||
161209089|NCT00689273|582146963|FG000|Overall Study|Lack of Efficacy|3|||
161209090|NCT00689273|582146964|FG001|Overall Study|Lack of Efficacy|0|||
161209091|NCT00689273|582146963|FG000|Overall Study|Lost to Follow-up|0|||
161209092|NCT00689273|582146964|FG001|Overall Study|Lost to Follow-up|2|||
161209093|NCT00689273|582146963|FG000|Overall Study|Other|6|||
161209094|NCT00689273|582146964|FG001|Overall Study|Other|2|||
161209095|NCT00689273|582146963|FG000|Overall Study|Randomized but not Treated|1|||
161209096|NCT00689273|582146964|FG001|Overall Study|Randomized but not Treated|0|||
161209097|NCT02787746|582146967|FG000|Overall Study|Adverse Event|42|||
161209098|NCT02787746|582146967|FG000|Overall Study|Withdrawal by Subject|65|||
161209099|NCT02787746|582146967|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
161209100|NCT03703297|582146970|FG000|Overall Study|Death|115|||
161209101|NCT03703297|582146971|FG001|Overall Study|Death|0|||
161209102|NCT03703297|582146972|FG002|Overall Study|Death|144|||
161209103|NCT03703297|582146970|FG000|Overall Study|Withdrawal by Subject|9|||
161209104|NCT03703297|582146971|FG001|Overall Study|Withdrawal by Subject|0|||
161209105|NCT03703297|582146972|FG002|Overall Study|Withdrawal by Subject|11|||
161209106|NCT03703297|582146970|FG000|Overall Study|Ongoing at the time of DCO|140|||
161209107|NCT03703297|582146971|FG001|Overall Study|Ongoing at the time of DCO|200|||
161209108|NCT03703297|582146972|FG002|Overall Study|Ongoing at the time of DCO|111|||
161209109|NCT00700310|582148984|FG000|Overall Study|Adverse Event|6|||
161209110|NCT00700310|582148985|FG001|Overall Study|Adverse Event|10|||
161322209|NCT05052697|582566504|FG006|Substudy A|Not vaccinated|0|||
161209111|NCT00700310|582148986|FG002|Overall Study|Adverse Event|5|||
161209112|NCT00700310|582148987|FG003|Overall Study|Adverse Event|11|||
161209113|NCT00700310|582148984|FG000|Overall Study|Lost to Follow-up|4|||
161209114|NCT00700310|582148985|FG001|Overall Study|Lost to Follow-up|1|||
161209115|NCT00700310|582148986|FG002|Overall Study|Lost to Follow-up|0|||
161209116|NCT00700310|582148987|FG003|Overall Study|Lost to Follow-up|1|||
161209117|NCT00700310|582148984|FG000|Overall Study|Withdrawal by Subject|8|||
161209118|NCT00700310|582148985|FG001|Overall Study|Withdrawal by Subject|9|||
161209119|NCT00700310|582148986|FG002|Overall Study|Withdrawal by Subject|8|||
161209120|NCT00700310|582148987|FG003|Overall Study|Withdrawal by Subject|8|||
161209121|NCT00700310|582148984|FG000|Overall Study|Lack of Efficacy|0|||
161209122|NCT00700310|582148985|FG001|Overall Study|Lack of Efficacy|3|||
161209123|NCT00700310|582148986|FG002|Overall Study|Lack of Efficacy|0|||
161209124|NCT00700310|582148987|FG003|Overall Study|Lack of Efficacy|1|||
161209125|NCT00700310|582148984|FG000|Overall Study|Administrative/Other|1|||
161209126|NCT00700310|582148985|FG001|Overall Study|Administrative/Other|3|||
161322210|NCT05052697|582566505|FG007|Substudy A|Not vaccinated|0|||
161209127|NCT00700310|582148986|FG002|Overall Study|Administrative/Other|1|||
161322211|NCT05052697|582566506|FG008|Substudy A|Not vaccinated|1|||
161209128|NCT00700310|582148987|FG003|Overall Study|Administrative/Other|3|||
161209129|NCT00700310|582148984|FG000|Overall Study|Randomized, Not Treated|2|||
161322212|NCT05052697|582566507|FG009|Substudy A|Not vaccinated|0|||
161209130|NCT00700310|582148985|FG001|Overall Study|Randomized, Not Treated|0|||
161209131|NCT00700310|582148986|FG002|Overall Study|Randomized, Not Treated|2|||
161209132|NCT00700310|582148987|FG003|Overall Study|Randomized, Not Treated|2|||
161209133|NCT02162511|582148989|FG000|Overall Study|Lack of Efficacy|0|||
161209134|NCT02162511|582148990|FG001|Overall Study|Lack of Efficacy|0|||
161209135|NCT02162511|582148991|FG002|Overall Study|Lack of Efficacy|2|||
161209136|NCT01160198|582148992|FG000|Overall Study|Withdrawal by Subject|2|||
161209137|NCT01160198|582148993|FG001|Overall Study|Withdrawal by Subject|1|||
161209138|NCT01160198|582148994|FG002|Overall Study|Withdrawal by Subject|0|||
161209139|NCT01160198|582148992|FG000|Overall Study|Adverse Event|0|||
161209140|NCT01160198|582148993|FG001|Overall Study|Adverse Event|1|||
161209141|NCT01160198|582148994|FG002|Overall Study|Adverse Event|0|||
161209142|NCT01160198|582148992|FG000|Overall Study|Lost to Follow-up|0|||
161209143|NCT01160198|582148993|FG001|Overall Study|Lost to Follow-up|1|||
161209144|NCT01160198|582148994|FG002|Overall Study|Lost to Follow-up|0|||
161209145|NCT01160198|582148992|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
161209146|NCT01160198|582148993|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
161209147|NCT01160198|582148994|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
161209148|NCT00802529|582148995|FG000|Overall Study|Lost to Follow-up|0|||
161209149|NCT00802529|582148996|FG001|Overall Study|Lost to Follow-up|1|||
161209150|NCT00552617|582148998|FG000|Overall Study|Not Treated|0|||
161209151|NCT00552617|582148999|FG001|Overall Study|Not Treated|0|||
161322213|NCT05052697|582566508|FG010|Substudy A|Not vaccinated|0|||
161322214|NCT05052697|582566509|FG011|Substudy A|Not vaccinated|0|||
161322215|NCT05052697|582566510|FG012|Substudy A|Not vaccinated|0|||
161322216|NCT05052697|582566511|FG013|Substudy A|Not vaccinated|0|||
161322217|NCT05052697|582566512|FG014|Substudy A|Not vaccinated|0|||
161322218|NCT05052697|582566513|FG015|Substudy A|Not vaccinated|0|||
161322219|NCT05052697|582566514|FG016|Substudy A|Not vaccinated|0|||
161322220|NCT05052697|582566515|FG017|Substudy A|Not vaccinated|0|||
161322221|NCT05052697|582566516|FG018|Substudy A|Not vaccinated|0|||
161322222|NCT05052697|582566517|FG019|Substudy A|Not vaccinated|0|||
161322223|NCT05052697|582566518|FG020|Substudy A|Not vaccinated|0|||
161322224|NCT05052697|582566519|FG021|Substudy A|Not vaccinated|0|||
161322225|NCT05052697|582566520|FG022|Substudy A|Not vaccinated|0|||
161322226|NCT05052697|582566521|FG023|Substudy A|Not vaccinated|0|||
161322227|NCT05052697|582566522|FG024|Substudy A|Not vaccinated|0|||
161322228|NCT05052697|582566523|FG025|Substudy A|Not vaccinated|0|||
161322229|NCT05052697|582566524|FG026|Substudy A|Not vaccinated|0|||
161322230|NCT05052697|582566525|FG027|Substudy A|Not vaccinated|0|||
161322231|NCT05052697|582566526|FG028|Substudy A|Not vaccinated|0|||
161322232|NCT05052697|582566527|FG029|Substudy A|Not vaccinated|0|||
161322233|NCT05052697|582566528|FG030|Substudy A|Not vaccinated|0|||
161322234|NCT05052697|582566529|FG031|Substudy A|Not vaccinated|0|||
161322235|NCT05052697|582566530|FG032|Substudy A|Not vaccinated|0|||
161322236|NCT05052697|582566531|FG033|Substudy A|Not vaccinated|0|||
161322237|NCT05052697|582566498|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322238|NCT05052697|582566499|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322239|NCT05052697|582566500|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322240|NCT05052697|582566501|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322241|NCT05052697|582566502|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322242|NCT05052697|582566503|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322243|NCT05052697|582566504|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322244|NCT05052697|582566505|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322245|NCT05052697|582566506|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322246|NCT05052697|582566507|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322247|NCT05052697|582566508|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322248|NCT05052697|582566509|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322249|NCT05052697|582566510|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322250|NCT05052697|582566511|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322251|NCT05052697|582566512|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322252|NCT05052697|582566513|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322253|NCT05052697|582566514|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322254|NCT05052697|582566515|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322255|NCT05052697|582566516|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
160864787|NCT01134055|580898969|FG001|Overall Study|Lost to Follow-up|1|||
161209152|NCT00552617|582149000|FG002|Overall Study|Not Treated|1|||
161209153|NCT00552617|582149001|FG003|Overall Study|Not Treated|0|||
161209154|NCT00552617|582149002|FG004|Overall Study|Not Treated|0|||
161209155|NCT00552617|582149003|FG005|Overall Study|Not Treated|0|||
161322256|NCT05052697|582566517|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161322257|NCT05052697|582566518|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322258|NCT05052697|582566519|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
161322259|NCT05052697|582566520|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
161322260|NCT05052697|582566521|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322261|NCT05052697|582566522|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161092734|NCT00903682|581729968|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
161092735|NCT03110185|581729969|FG000|Overall Study|Death|0|||
161092736|NCT03110185|581729970|FG001|Overall Study|Death|1|||
161092737|NCT03110185|581729969|FG000|Overall Study|Withdrawal by Subject|2|||
161092738|NCT03110185|581729970|FG001|Overall Study|Withdrawal by Subject|7|||
161092739|NCT03110185|581729969|FG000|Overall Study|Time Constraints|0|||
161092740|NCT03110185|581729970|FG001|Overall Study|Time Constraints|6|||
161092741|NCT03110185|581729969|FG000|Overall Study|Conflict with care|5|||
161092742|NCT03110185|581729970|FG001|Overall Study|Conflict with care|12|||
161092743|NCT03110185|581729969|FG000|Overall Study|Protocol Violation|1|||
161092744|NCT03110185|581729970|FG001|Overall Study|Protocol Violation|4|||
161092745|NCT03110185|581729969|FG000|Overall Study|MRI Incompatible|2|||
161092746|NCT03110185|581729970|FG001|Overall Study|MRI Incompatible|0|||
161092747|NCT03110185|581729969|FG000|Overall Study|Patient Refusal|0|||
161092748|NCT03110185|581729970|FG001|Overall Study|Patient Refusal|1|||
161092749|NCT03075410|581729971|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
161092750|NCT03075410|581729972|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
161092751|NCT03075410|581729973|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
161092752|NCT03075410|581729974|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
161092753|NCT03075410|581729975|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
161092754|NCT03075410|581729976|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
161092755|NCT03075410|581729977|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
161092756|NCT03075410|581729978|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
161209156|NCT00552617|582149004|FG006|Overall Study|Not Treated|0|||
161209157|NCT00552617|582149005|FG007|Overall Study|Not Treated|0|||
161209158|NCT00552617|582149006|FG008|Overall Study|Not Treated|0|||
161209159|NCT00552617|582149007|FG009|Overall Study|Not Treated|1|||
161209160|NCT00552617|582148998|FG000|Overall Study|Lost to Follow-up|0|||
161209161|NCT00552617|582148999|FG001|Overall Study|Lost to Follow-up|0|||
161209162|NCT00552617|582149000|FG002|Overall Study|Lost to Follow-up|0|||
161209163|NCT00552617|582149001|FG003|Overall Study|Lost to Follow-up|1|||
161209164|NCT00552617|582149002|FG004|Overall Study|Lost to Follow-up|0|||
161209165|NCT00552617|582149003|FG005|Overall Study|Lost to Follow-up|2|||
161209166|NCT00552617|582149004|FG006|Overall Study|Lost to Follow-up|0|||
161209167|NCT00552617|582149005|FG007|Overall Study|Lost to Follow-up|0|||
161209168|NCT00552617|582149006|FG008|Overall Study|Lost to Follow-up|2|||
161209169|NCT00552617|582149007|FG009|Overall Study|Lost to Follow-up|0|||
161209170|NCT04651218|582149008|FG000|Overall Study|Withdrawal by Subject|0|||
161209171|NCT04651218|582149009|FG001|Overall Study|Withdrawal by Subject|2|||
161209172|NCT01399125|582149012|FG000|Overall Study|Adverse Event|32|||
161209173|NCT01399125|582149013|FG001|Overall Study|Adverse Event|30|||
161209174|NCT01399125|582149012|FG000|Overall Study|Abnormal Lab values|0|||
161209175|NCT01399125|582149013|FG001|Overall Study|Abnormal Lab values|1|||
161209176|NCT01399125|582149012|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161209177|NCT01399125|582149013|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161209178|NCT01399125|582149012|FG000|Overall Study|Withdrawal by Subject|5|||
161209179|NCT01399125|582149013|FG001|Overall Study|Withdrawal by Subject|8|||
161209180|NCT01399125|582149012|FG000|Overall Study|Lost to Follow-up|2|||
161209181|NCT01399125|582149013|FG001|Overall Study|Lost to Follow-up|3|||
161209182|NCT01399125|582149012|FG000|Overall Study|Administrative Problems|7|||
161209183|NCT01399125|582149013|FG001|Overall Study|Administrative Problems|11|||
161209184|NCT01399125|582149012|FG000|Overall Study|Death|0|||
161209185|NCT01399125|582149013|FG001|Overall Study|Death|1|||
161209186|NCT01399125|582149012|FG000|Overall Study|Protocol Deviation|5|||
161209187|NCT01399125|582149013|FG001|Overall Study|Protocol Deviation|2|||
161209188|NCT00563524|582149018|FG000|Overall Study|Adverse Event|0|||
161209189|NCT00563524|582149019|FG001|Overall Study|Adverse Event|1|||
161209190|NCT00563524|582149020|FG002|Overall Study|Adverse Event|0|||
161209191|NCT00563524|582149021|FG003|Overall Study|Adverse Event|0|||
161209192|NCT00563524|582149022|FG004|Overall Study|Adverse Event|2|||
161209193|NCT00563524|582149023|FG005|Overall Study|Adverse Event|0|||
161209194|NCT00563524|582149018|FG000|Overall Study|Lost to Follow-up|1|||
161209195|NCT00563524|582149019|FG001|Overall Study|Lost to Follow-up|0|||
161209196|NCT00563524|582149020|FG002|Overall Study|Lost to Follow-up|0|||
161209197|NCT00563524|582149021|FG003|Overall Study|Lost to Follow-up|0|||
161209198|NCT00563524|582149022|FG004|Overall Study|Lost to Follow-up|0|||
161209199|NCT00563524|582149023|FG005|Overall Study|Lost to Follow-up|0|||
161209200|NCT00563524|582149018|FG000|Overall Study|Protocol Violation|0|||
161209201|NCT00563524|582149019|FG001|Overall Study|Protocol Violation|1|||
161209202|NCT00563524|582149020|FG002|Overall Study|Protocol Violation|0|||
161322262|NCT05052697|582566523|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322263|NCT05052697|582566524|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322264|NCT05052697|582566525|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161209203|NCT00563524|582149021|FG003|Overall Study|Protocol Violation|0|||
161209204|NCT00563524|582149022|FG004|Overall Study|Protocol Violation|0|||
161209205|NCT00563524|582149023|FG005|Overall Study|Protocol Violation|0|||
161209206|NCT00563524|582149018|FG000|Overall Study|Withdrawal by Subject|1|||
161209207|NCT00563524|582149019|FG001|Overall Study|Withdrawal by Subject|1|||
161322265|NCT05052697|582566526|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322266|NCT05052697|582566527|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322267|NCT05052697|582566528|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322268|NCT05052697|582566529|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322269|NCT05052697|582566530|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322270|NCT05052697|582566531|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
161322271|NCT05052697|582566498|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322272|NCT05052697|582566499|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322273|NCT05052697|582566500|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322274|NCT05052697|582566501|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322275|NCT05052697|582566502|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322276|NCT05052697|582566503|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322277|NCT05052697|582566504|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322278|NCT05052697|582566505|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322279|NCT05052697|582566506|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322280|NCT05052697|582566507|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322281|NCT05052697|582566508|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322282|NCT05052697|582566509|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322283|NCT05052697|582566510|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322284|NCT05052697|582566511|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322285|NCT05052697|582566512|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322286|NCT05052697|582566513|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322287|NCT05052697|582566514|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322288|NCT05052697|582566515|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
161322289|NCT05052697|582566516|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322290|NCT05052697|582566517|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322291|NCT05052697|582566518|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322292|NCT05052697|582566519|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322293|NCT05052697|582566520|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322294|NCT05052697|582566521|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322295|NCT05052697|582566522|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322296|NCT05052697|582566523|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322297|NCT05052697|582566524|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322298|NCT05052697|582566525|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322299|NCT05052697|582566526|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322300|NCT05052697|582566527|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322301|NCT05052697|582566528|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322302|NCT05052697|582566529|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322303|NCT05052697|582566530|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322304|NCT05052697|582566531|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
161322305|NCT05052697|582566498|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322306|NCT05052697|582566499|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322307|NCT05052697|582566500|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322308|NCT05052697|582566501|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322309|NCT05052697|582566502|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322310|NCT05052697|582566503|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322311|NCT05052697|582566504|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322312|NCT05052697|582566505|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322313|NCT05052697|582566506|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322314|NCT05052697|582566507|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322315|NCT05052697|582566508|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322316|NCT05052697|582566509|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322317|NCT05052697|582566510|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322318|NCT05052697|582566511|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322319|NCT05052697|582566512|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322320|NCT05052697|582566513|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322321|NCT05052697|582566514|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322322|NCT05052697|582566515|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322323|NCT05052697|582566516|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322324|NCT05052697|582566517|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
161322325|NCT05052697|582566518|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322326|NCT05052697|582566519|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322327|NCT05052697|582566520|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322328|NCT05052697|582566521|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322329|NCT05052697|582566522|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322330|NCT05052697|582566523|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322331|NCT05052697|582566524|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322332|NCT05052697|582566525|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322333|NCT05052697|582566526|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322334|NCT05052697|582566527|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322335|NCT05052697|582566528|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322336|NCT05052697|582566529|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322337|NCT05052697|582566530|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322338|NCT05052697|582566531|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
161322339|NCT05052697|582566498|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322340|NCT05052697|582566499|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322341|NCT05052697|582566500|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322342|NCT05052697|582566501|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322343|NCT05052697|582566502|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322344|NCT05052697|582566503|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322345|NCT05052697|582566504|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322346|NCT05052697|582566505|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161209208|NCT00563524|582149020|FG002|Overall Study|Withdrawal by Subject|3|||
161209209|NCT00563524|582149021|FG003|Overall Study|Withdrawal by Subject|0|||
161209210|NCT00563524|582149022|FG004|Overall Study|Withdrawal by Subject|0|||
161209211|NCT00563524|582149023|FG005|Overall Study|Withdrawal by Subject|1|||
161209212|NCT01272193|582149025|FG000|Overall Study|Adverse Event|1|||
161209213|NCT01272193|582149026|FG001|Overall Study|Adverse Event|1|||
161322347|NCT05052697|582566506|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322348|NCT05052697|582566507|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322349|NCT05052697|582566508|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322350|NCT05052697|582566509|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322351|NCT05052697|582566510|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322352|NCT05052697|582566511|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161209214|NCT01272193|582149025|FG000|Overall Study|Lack of Efficacy|0|||
161209215|NCT01272193|582149026|FG001|Overall Study|Lack of Efficacy|3|||
161209216|NCT01272193|582149025|FG000|Overall Study|Withdrawal Criteria|1|||
161209217|NCT01272193|582149026|FG001|Overall Study|Withdrawal Criteria|1|||
161209218|NCT01272193|582149025|FG000|Overall Study|Unclassified|8|||
161209219|NCT01272193|582149026|FG001|Overall Study|Unclassified|7|||
161209220|NCT03578276|582149027|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
161209221|NCT03578276|582149028|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
161209222|NCT02626182|582149029|FG000|Overall Study|Adverse Event|2|||
161209223|NCT02626182|582149030|FG001|Overall Study|Adverse Event|0|||
161209224|NCT01508325|582149036|FG000|Overall Study|Withdrawal by Subject|8|||
161322353|NCT05052697|582566512|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322354|NCT05052697|582566513|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322355|NCT05052697|582566514|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322356|NCT05052697|582566515|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161322357|NCT05052697|582566516|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322358|NCT05052697|582566517|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322359|NCT05052697|582566518|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322360|NCT05052697|582566519|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322361|NCT05052697|582566520|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322362|NCT05052697|582566521|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322363|NCT05052697|582566522|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322364|NCT05052697|582566523|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161322365|NCT05052697|582566524|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322366|NCT05052697|582566525|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
161322367|NCT05052697|582566526|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322368|NCT05052697|582566527|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322369|NCT05052697|582566528|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322370|NCT05052697|582566529|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322371|NCT05052697|582566530|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322372|NCT05052697|582566531|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
161322373|NCT05052697|582566498|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322374|NCT05052697|582566499|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322375|NCT05052697|582566500|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322376|NCT05052697|582566501|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322377|NCT05052697|582566502|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322378|NCT05052697|582566503|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322379|NCT05052697|582566504|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322380|NCT05052697|582566505|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161209225|NCT01508325|582149037|FG001|Overall Study|Withdrawal by Subject|9|||
161209226|NCT01508325|582149036|FG000|Overall Study|Protocol Violation|0|||
161209227|NCT01508325|582149037|FG001|Overall Study|Protocol Violation|3|||
161209228|NCT01508325|582149036|FG000|Overall Study|Physician Decision|2|||
161209229|NCT01508325|582149037|FG001|Overall Study|Physician Decision|1|||
161209230|NCT01508325|582149036|FG000|Overall Study|Adverse Event|1|||
161209231|NCT01508325|582149037|FG001|Overall Study|Adverse Event|0|||
161209232|NCT01508325|582149036|FG000|Overall Study|Lost to Follow-up|5|||
161322381|NCT05052697|582566506|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322382|NCT05052697|582566507|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322383|NCT05052697|582566508|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322384|NCT05052697|582566509|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322385|NCT05052697|582566510|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322386|NCT05052697|582566511|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322387|NCT05052697|582566512|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322388|NCT05052697|582566513|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322389|NCT05052697|582566514|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322390|NCT05052697|582566515|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322391|NCT05052697|582566516|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322392|NCT05052697|582566517|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322393|NCT05052697|582566518|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322394|NCT05052697|582566519|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322395|NCT05052697|582566520|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322396|NCT05052697|582566521|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322397|NCT05052697|582566522|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322398|NCT05052697|582566523|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322399|NCT05052697|582566524|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322400|NCT05052697|582566525|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322401|NCT05052697|582566526|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
161322402|NCT05052697|582566527|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322403|NCT05052697|582566528|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161322404|NCT05052697|582566529|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161322405|NCT05052697|582566530|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
161322406|NCT05052697|582566531|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
161322407|NCT05052697|582566498|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322408|NCT05052697|582566499|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322409|NCT05052697|582566500|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322410|NCT05052697|582566501|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322411|NCT05052697|582566502|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322412|NCT05052697|582566503|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322413|NCT05052697|582566504|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322414|NCT05052697|582566505|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322415|NCT05052697|582566506|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322416|NCT05052697|582566507|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322417|NCT05052697|582566508|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322418|NCT05052697|582566509|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322419|NCT05052697|582566510|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322420|NCT05052697|582566511|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322421|NCT05052697|582566512|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322422|NCT05052697|582566513|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322423|NCT05052697|582566514|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322424|NCT05052697|582566515|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322425|NCT05052697|582566516|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322426|NCT05052697|582566517|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322427|NCT05052697|582566518|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322428|NCT05052697|582566519|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322429|NCT05052697|582566520|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322430|NCT05052697|582566521|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322431|NCT05052697|582566522|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322432|NCT05052697|582566523|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322433|NCT05052697|582566524|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322434|NCT05052697|582566525|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161322435|NCT05052697|582566526|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
161322436|NCT05052697|582566527|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
161322437|NCT05052697|582566528|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
161322438|NCT05052697|582566529|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
161322439|NCT05052697|582566530|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
161322440|NCT05052697|582566531|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
161092757|NCT03075410|581729979|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
161092758|NCT03075410|581729971|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
161092759|NCT03075410|581729972|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092760|NCT03075410|581729973|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161209233|NCT01508325|582149037|FG001|Overall Study|Lost to Follow-up|6|||
161322441|NCT05052697|582566498|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322442|NCT05052697|582566499|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322443|NCT05052697|582566500|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322444|NCT05052697|582566501|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322445|NCT05052697|582566502|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322446|NCT05052697|582566503|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322447|NCT05052697|582566504|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322448|NCT05052697|582566505|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322449|NCT05052697|582566506|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322450|NCT05052697|582566507|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322451|NCT05052697|582566508|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322452|NCT05052697|582566509|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322453|NCT05052697|582566510|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322454|NCT05052697|582566511|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322455|NCT05052697|582566512|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322456|NCT05052697|582566513|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322457|NCT05052697|582566514|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322458|NCT05052697|582566515|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322459|NCT05052697|582566516|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322460|NCT05052697|582566517|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322461|NCT05052697|582566518|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322462|NCT05052697|582566519|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322463|NCT05052697|582566520|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322464|NCT05052697|582566521|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322465|NCT05052697|582566522|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322466|NCT05052697|582566523|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322467|NCT05052697|582566524|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322468|NCT05052697|582566525|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322469|NCT05052697|582566526|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322470|NCT05052697|582566527|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322471|NCT05052697|582566528|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322472|NCT05052697|582566529|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322473|NCT05052697|582566530|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
161322474|NCT05052697|582566531|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
161322475|NCT05052697|582566498|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322476|NCT05052697|582566499|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322477|NCT05052697|582566500|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322478|NCT05052697|582566501|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322479|NCT05052697|582566502|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322480|NCT05052697|582566503|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322481|NCT05052697|582566504|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322482|NCT05052697|582566505|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322483|NCT05052697|582566506|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322484|NCT05052697|582566507|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322485|NCT05052697|582566508|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322486|NCT05052697|582566509|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322487|NCT05052697|582566510|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322488|NCT05052697|582566511|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322489|NCT05052697|582566512|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322490|NCT05052697|582566513|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322491|NCT05052697|582566514|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322492|NCT05052697|582566515|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322493|NCT05052697|582566516|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322494|NCT05052697|582566517|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322495|NCT05052697|582566518|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322496|NCT05052697|582566519|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322497|NCT05052697|582566520|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322498|NCT05052697|582566521|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322499|NCT05052697|582566522|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322500|NCT05052697|582566523|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322501|NCT05052697|582566524|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322502|NCT05052697|582566525|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322503|NCT05052697|582566526|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
161322504|NCT05052697|582566527|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
161322505|NCT05052697|582566528|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
161322506|NCT05052697|582566529|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
160861850|NCT02531802|580887846|FG001|Received Vaccination 2|Adverse Event|0|||
161322507|NCT05052697|582566530|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322508|NCT05052697|582566531|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
161322509|NCT03796676|582566532|FG000|Overall Study|Adverse Event|2|||
161322510|NCT03796676|582566533|FG001|Overall Study|Adverse Event|1|||
161322511|NCT03796676|582566534|FG002|Overall Study|Adverse Event|2|||
161322512|NCT03796676|582566532|FG000|Overall Study|Lost to Follow-up|2|||
161322513|NCT03796676|582566533|FG001|Overall Study|Lost to Follow-up|1|||
161322514|NCT03796676|582566534|FG002|Overall Study|Lost to Follow-up|0|||
161322515|NCT03796676|582566532|FG000|Overall Study|Protocol Violation|0|||
161322516|NCT03796676|582566533|FG001|Overall Study|Protocol Violation|0|||
161322517|NCT03796676|582566534|FG002|Overall Study|Protocol Violation|1|||
161322518|NCT03796676|582566532|FG000|Overall Study|Withdrawal by Subject|1|||
161322519|NCT03796676|582566533|FG001|Overall Study|Withdrawal by Subject|1|||
161322520|NCT03796676|582566534|FG002|Overall Study|Withdrawal by Subject|0|||
161322521|NCT03796676|582566532|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
161322522|NCT03796676|582566533|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
161322523|NCT03796676|582566534|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
161322524|NCT01900899|582566538|FG000|Overall Study|Withdrawal by Subject|7|||
161322525|NCT01900899|582566539|FG001|Overall Study|Withdrawal by Subject|1|||
161322526|NCT01900899|582566538|FG000|Overall Study|Migrated from study area|2|||
161322527|NCT01900899|582566539|FG001|Overall Study|Migrated from study area|0|||
161322528|NCT02772809|582566540|FG000|Overall Study|not completed some tasks|6|||
161322529|NCT00534105|582566543|FG000|Overall Study|Lost to Follow-up|23|||
161322530|NCT00534105|582566544|FG001|Overall Study|Lost to Follow-up|39|||
161322531|NCT02774005|582566545|FG000|Overall Study|Adverse Event|8|||
161322532|NCT02774005|582566545|FG000|Overall Study|Withdrawal by Subject|23|||
161322533|NCT02774005|582566545|FG000|Overall Study|Lost to Follow-up|7|||
161322534|NCT02774005|582566545|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
161322535|NCT02774005|582566545|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
161322536|NCT02774005|582566545|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
161322537|NCT02774005|582566545|FG000|Overall Study|Death|1|||
161322538|NCT02774005|582566545|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
161322539|NCT02774005|582566545|FG000|Overall Study|Lack of compliance with study medication|4|||
161322540|NCT02774005|582566545|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
161322541|NCT02774005|582566545|FG000|Overall Study|another study|1|||
161322542|NCT02774005|582566545|FG000|Overall Study|cardiologist imposed travel restriction|1|||
161322543|NCT00723697|582566546|FG000|Overall Study|Physician questionnaires not received|2|||
161322544|NCT00723697|582566546|FG000|Overall Study|Missing Informed Consent Form|10|||
161322545|NCT00723697|582566546|FG000|Overall Study|Other exclusion criteria applied|6|||
161322546|NCT03275389|582566551|FG000|Overall Study|Lost to Follow-up|10|||
161322547|NCT03275389|582566552|FG001|Overall Study|Lost to Follow-up|10|||
161322548|NCT03275389|582566553|FG002|Overall Study|Lost to Follow-up|19|||
161322549|NCT03275389|582566554|FG003|Overall Study|Lost to Follow-up|12|||
161322550|NCT03275389|582566555|FG004|Overall Study|Lost to Follow-up|11|||
161322551|NCT03275389|582566556|FG005|Overall Study|Lost to Follow-up|12|||
161322552|NCT03275389|582566557|FG006|Overall Study|Lost to Follow-up|21|||
161322553|NCT03275389|582566558|FG007|Overall Study|Lost to Follow-up|15|||
161322554|NCT03275389|582566559|FG008|Overall Study|Lost to Follow-up|12|||
161322555|NCT03275389|582566560|FG009|Overall Study|Lost to Follow-up|14|||
161322556|NCT03275389|582566551|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322557|NCT03275389|582566552|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322558|NCT03275389|582566553|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322559|NCT03275389|582566554|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322560|NCT03275389|582566555|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322561|NCT03275389|582566556|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
161322562|NCT03275389|582566557|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322563|NCT03275389|582566558|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322564|NCT03275389|582566559|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
161322565|NCT03275389|582566560|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
161322566|NCT03275389|582566551|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161322567|NCT03275389|582566552|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161322568|NCT03275389|582566553|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161322569|NCT03275389|582566554|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
161322570|NCT03275389|582566555|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161322571|NCT03275389|582566556|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161322572|NCT03275389|582566557|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161322573|NCT03275389|582566558|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
161322574|NCT03275389|582566559|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161322575|NCT03275389|582566560|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161322576|NCT03275389|582566551|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322577|NCT03275389|582566552|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161322578|NCT03275389|582566553|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322579|NCT03275389|582566554|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
161322580|NCT03275389|582566555|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322581|NCT03275389|582566556|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322582|NCT03275389|582566557|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161322583|NCT03275389|582566558|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322584|NCT03275389|582566559|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322585|NCT03275389|582566560|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161322586|NCT03275389|582566551|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322587|NCT03275389|582566552|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322588|NCT03275389|582566553|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161322589|NCT03275389|582566554|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322590|NCT03275389|582566555|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322591|NCT03275389|582566556|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322592|NCT03275389|582566557|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322593|NCT03275389|582566558|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322594|NCT03275389|582566559|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161322595|NCT03275389|582566560|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161322596|NCT03275389|582566551|FG000|Overall Study|Other|0|||
161322597|NCT03275389|582566552|FG001|Overall Study|Other|4|||
161322598|NCT03275389|582566553|FG002|Overall Study|Other|3|||
161322599|NCT03275389|582566554|FG003|Overall Study|Other|2|||
161322600|NCT03275389|582566555|FG004|Overall Study|Other|2|||
161322601|NCT03275389|582566556|FG005|Overall Study|Other|2|||
161322602|NCT03275389|582566557|FG006|Overall Study|Other|0|||
161322603|NCT03275389|582566558|FG007|Overall Study|Other|0|||
161322604|NCT03275389|582566559|FG008|Overall Study|Other|1|||
161322605|NCT03275389|582566560|FG009|Overall Study|Other|0|||
161322606|NCT00978341|582566561|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
161322607|NCT00978341|582566562|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
161322608|NCT03035916|582566563|FG000|Overall Study|Puncture failed|0|||
161322609|NCT03035916|582566564|FG001|Overall Study|Puncture failed|2|||
161322610|NCT03035916|582566565|FG002|Overall Study|Puncture failed|0|||
161322611|NCT03885999|582566566|FG000|Overall Study|Adverse Event|1|||
161322612|NCT02452554|582566567|FG000|Overall Study|Death|2|||
161322613|NCT02452554|582566568|FG001|Overall Study|Death|1|||
161322614|NCT02452554|582566569|FG002|Overall Study|Death|0|||
161322615|NCT02452554|582566570|FG003|Overall Study|Death|0|||
161322616|NCT02452554|582566571|FG004|Overall Study|Death|0|||
161322617|NCT02452554|582566572|FG005|Overall Study|Death|0|||
161322618|NCT02452554|582566567|FG000|Overall Study|Lack of Efficacy|13|||
161322619|NCT02452554|582566568|FG001|Overall Study|Lack of Efficacy|14|||
161322620|NCT02452554|582566569|FG002|Overall Study|Lack of Efficacy|9|||
161322621|NCT02452554|582566570|FG003|Overall Study|Lack of Efficacy|1|||
161322622|NCT02452554|582566571|FG004|Overall Study|Lack of Efficacy|5|||
161322623|NCT02452554|582566572|FG005|Overall Study|Lack of Efficacy|8|||
161322624|NCT02452554|582566567|FG000|Overall Study|Physician Decision|0|||
161322625|NCT02452554|582566568|FG001|Overall Study|Physician Decision|1|||
161322626|NCT02452554|582566569|FG002|Overall Study|Physician Decision|0|||
161322627|NCT02452554|582566570|FG003|Overall Study|Physician Decision|0|||
161322628|NCT02452554|582566571|FG004|Overall Study|Physician Decision|0|||
161322629|NCT02452554|582566572|FG005|Overall Study|Physician Decision|0|||
161322630|NCT02452554|582566567|FG000|Overall Study|Withdrawal by Subject|1|||
161322631|NCT02452554|582566568|FG001|Overall Study|Withdrawal by Subject|0|||
161322632|NCT02452554|582566569|FG002|Overall Study|Withdrawal by Subject|2|||
161322633|NCT02452554|582566570|FG003|Overall Study|Withdrawal by Subject|0|||
161322634|NCT02452554|582566571|FG004|Overall Study|Withdrawal by Subject|0|||
161322635|NCT02452554|582566572|FG005|Overall Study|Withdrawal by Subject|1|||
161322636|NCT02452554|582566567|FG000|Overall Study|Ineligible|0|||
161322637|NCT02452554|582566568|FG001|Overall Study|Ineligible|1|||
161322638|NCT02452554|582566569|FG002|Overall Study|Ineligible|0|||
161322639|NCT02452554|582566570|FG003|Overall Study|Ineligible|0|||
161322640|NCT02452554|582566571|FG004|Overall Study|Ineligible|0|||
161322641|NCT02452554|582566572|FG005|Overall Study|Ineligible|0|||
161322642|NCT02452554|582566567|FG000|Overall Study|Never Received Treatment|1|||
161322643|NCT02452554|582566568|FG001|Overall Study|Never Received Treatment|0|||
161322644|NCT02452554|582566569|FG002|Overall Study|Never Received Treatment|0|||
161322645|NCT02452554|582566570|FG003|Overall Study|Never Received Treatment|0|||
161209234|NCT01508325|582149036|FG000|Overall Study|Other|2|||
161322646|NCT02452554|582566571|FG004|Overall Study|Never Received Treatment|0|||
161322647|NCT02452554|582566572|FG005|Overall Study|Never Received Treatment|0|||
161322648|NCT01790516|582566573|FG000|Overall Study|Physician Decision|1|||
161322649|NCT01790516|582566574|FG001|Overall Study|Physician Decision|0|||
161322650|NCT01402986|582566575|FG000|Overall Study|Withdrawal by Subject|7|||
161322651|NCT01402986|582566576|FG001|Overall Study|Withdrawal by Subject|10|||
161322652|NCT01402986|582566577|FG002|Overall Study|Withdrawal by Subject|7|||
160864788|NCT01134055|580898970|FG002|Overall Study|Lost to Follow-up|0|||
161322653|NCT01402986|582566578|FG003|Overall Study|Withdrawal by Subject|13|||
161322654|NCT01402986|582566575|FG000|Overall Study|Death|0|||
161322655|NCT01402986|582566576|FG001|Overall Study|Death|0|||
161322656|NCT01402986|582566577|FG002|Overall Study|Death|0|||
161322657|NCT01402986|582566578|FG003|Overall Study|Death|2|||
161322658|NCT01402986|582566575|FG000|Overall Study|Lost to Follow-up|0|||
161322659|NCT01402986|582566576|FG001|Overall Study|Lost to Follow-up|0|||
161322660|NCT01402986|582566577|FG002|Overall Study|Lost to Follow-up|0|||
161322661|NCT01402986|582566578|FG003|Overall Study|Lost to Follow-up|1|||
161322662|NCT01402986|582566575|FG000|Overall Study|Other|2|||
161322663|NCT01402986|582566576|FG001|Overall Study|Other|5|||
161322664|NCT01402986|582566577|FG002|Overall Study|Other|1|||
161322665|NCT01402986|582566578|FG003|Overall Study|Other|6|||
161322666|NCT01085084|582566579|FG000|Overall Study|Withdrawal by Subject|1|||
161322667|NCT01085084|582566580|FG001|Overall Study|Withdrawal by Subject|0|||
161322668|NCT01085084|582566581|FG002|Overall Study|Withdrawal by Subject|0|||
161322669|NCT01085084|582566579|FG000|Overall Study|Lost to Follow-up|2|||
161322670|NCT01085084|582566580|FG001|Overall Study|Lost to Follow-up|1|||
161322671|NCT01085084|582566581|FG002|Overall Study|Lost to Follow-up|1|||
161322672|NCT01085084|582566579|FG000|Overall Study|Adverse Event|4|||
161322673|NCT01085084|582566580|FG001|Overall Study|Adverse Event|3|||
161322674|NCT01085084|582566581|FG002|Overall Study|Adverse Event|6|||
161322675|NCT01085084|582566579|FG000|Overall Study|Treatment Failure|0|||
161322676|NCT01085084|582566580|FG001|Overall Study|Treatment Failure|1|||
161322677|NCT01085084|582566581|FG002|Overall Study|Treatment Failure|2|||
161322678|NCT03749109|582566582|FG000|Overall Study|Adverse Event|2|||
161322679|NCT03749109|582566583|FG001|Overall Study|Adverse Event|0|||
161322680|NCT03178851|582566584|FG000|Overall Study|Death|48|||
161322681|NCT03178851|582566585|FG001|Overall Study|Death|2|||
161322682|NCT03178851|582566586|FG002|Overall Study|Death|25|||
161322683|NCT03178851|582566584|FG000|Overall Study|Withdrawal by Subject|8|||
161322684|NCT03178851|582566585|FG001|Overall Study|Withdrawal by Subject|0|||
161322685|NCT03178851|582566586|FG002|Overall Study|Withdrawal by Subject|0|||
161322686|NCT03178851|582566584|FG000|Overall Study|Lost to Follow-up|5|||
161322687|NCT03178851|582566585|FG001|Overall Study|Lost to Follow-up|2|||
161322688|NCT03178851|582566586|FG002|Overall Study|Lost to Follow-up|0|||
161322689|NCT03178851|582566584|FG000|Overall Study|Adverse Event|0|||
161322690|NCT03178851|582566585|FG001|Overall Study|Adverse Event|0|||
161322691|NCT03178851|582566586|FG002|Overall Study|Adverse Event|1|||
161322692|NCT03178851|582566584|FG000|Overall Study|Study Termination by Sponsor|31|||
161322693|NCT03178851|582566585|FG001|Overall Study|Study Termination by Sponsor|7|||
161322694|NCT03178851|582566586|FG002|Overall Study|Study Termination by Sponsor|26|||
161322695|NCT03034135|582566587|FG000|Overall Study|Withdrawal by Subject|2|||
161322696|NCT00520767|582566593|FG000|Overall Study|Death|2|||
160864789|NCT01134055|580898971|FG003|Overall Study|Lost to Follow-up|1|||
160864790|NCT01134055|580898972|FG004|Overall Study|Lost to Follow-up|0|||
160864791|NCT01134055|580898973|FG005|Overall Study|Lost to Follow-up|0|||
160864792|NCT01134055|580898974|FG006|Overall Study|Lost to Follow-up|0|||
160864793|NCT01134055|580898968|FG000|Overall Study|Withdrawal by Subject|3|||
160864794|NCT01134055|580898969|FG001|Overall Study|Withdrawal by Subject|3|||
160864795|NCT01134055|580898970|FG002|Overall Study|Withdrawal by Subject|1|||
160864796|NCT01134055|580898971|FG003|Overall Study|Withdrawal by Subject|2|||
160864797|NCT01134055|580898972|FG004|Overall Study|Withdrawal by Subject|0|||
160864798|NCT01134055|580898973|FG005|Overall Study|Withdrawal by Subject|0|||
160864799|NCT01134055|580898974|FG006|Overall Study|Withdrawal by Subject|8|||
160864800|NCT01134055|580898968|FG000|Overall Study|Protocol Violation|0|||
160864801|NCT01134055|580898969|FG001|Overall Study|Protocol Violation|0|||
160864802|NCT01134055|580898970|FG002|Overall Study|Protocol Violation|0|||
160864803|NCT01134055|580898971|FG003|Overall Study|Protocol Violation|1|||
160864804|NCT01134055|580898972|FG004|Overall Study|Protocol Violation|1|||
160864805|NCT01134055|580898973|FG005|Overall Study|Protocol Violation|0|||
160864806|NCT01134055|580898974|FG006|Overall Study|Protocol Violation|0|||
160864807|NCT01134055|580898968|FG000|Overall Study|Physician Decision|0|||
161209235|NCT01508325|582149037|FG001|Overall Study|Other|2|||
160864808|NCT01134055|580898969|FG001|Overall Study|Physician Decision|0|||
160864809|NCT01134055|580898970|FG002|Overall Study|Physician Decision|0|||
160864810|NCT01134055|580898971|FG003|Overall Study|Physician Decision|0|||
160864811|NCT01134055|580898972|FG004|Overall Study|Physician Decision|0|||
161209236|NCT00520494|582149040|FG000|Overall Study|Withdrawal by Subject|1|||
161092761|NCT03075410|581729974|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092762|NCT03075410|581729975|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092763|NCT03075410|581729976|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092764|NCT03075410|581729977|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092765|NCT03075410|581729978|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092766|NCT03075410|581729979|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
161092767|NCT01427751|581729980|FG000|Overall Study|Adverse Event|18|||
161092768|NCT01427751|581729981|FG001|Overall Study|Adverse Event|2|||
161209237|NCT01830920|582149042|FG000|Overall Study|Adverse Event|1|||
161092769|NCT01427751|581729980|FG000|Overall Study|No further treatment benefit expected|5|||
161092770|NCT01427751|581729981|FG001|Overall Study|No further treatment benefit expected|1|||
161092771|NCT01427751|581729980|FG000|Overall Study|Lost to Follow-up|3|||
161092772|NCT01427751|581729981|FG001|Overall Study|Lost to Follow-up|1|||
161092773|NCT01427751|581729980|FG000|Overall Study|Withdrawal of consent|2|||
161092774|NCT01427751|581729981|FG001|Overall Study|Withdrawal of consent|2|||
161092775|NCT01427751|581729980|FG000|Overall Study|Protocol Violation|6|||
161209238|NCT01830920|582149043|FG001|Overall Study|Adverse Event|0|||
161209239|NCT01830920|582149044|FG002|Overall Study|Adverse Event|1|||
161209240|NCT01830920|582149045|FG003|Overall Study|Adverse Event|0|||
161209241|NCT01830920|582149046|FG004|Overall Study|Adverse Event|0|||
161209242|NCT01830920|582149042|FG000|Overall Study|Withdrawal by Subject|2|||
161209243|NCT01830920|582149043|FG001|Overall Study|Withdrawal by Subject|2|||
161209244|NCT01830920|582149044|FG002|Overall Study|Withdrawal by Subject|1|||
161209245|NCT01830920|582149045|FG003|Overall Study|Withdrawal by Subject|7|||
161209246|NCT01830920|582149046|FG004|Overall Study|Withdrawal by Subject|1|||
161209247|NCT01830920|582149042|FG000|Overall Study|Death|3|||
161209248|NCT01830920|582149043|FG001|Overall Study|Death|3|||
161209249|NCT01830920|582149044|FG002|Overall Study|Death|5|||
161209250|NCT01830920|582149045|FG003|Overall Study|Death|4|||
161209251|NCT01830920|582149046|FG004|Overall Study|Death|4|||
161209252|NCT01830920|582149042|FG000|Overall Study|Other|15|||
161209253|NCT01830920|582149043|FG001|Overall Study|Other|1|||
161209254|NCT01830920|582149044|FG002|Overall Study|Other|1|||
161209255|NCT01830920|582149045|FG003|Overall Study|Other|5|||
161209256|NCT01830920|582149046|FG004|Overall Study|Other|3|||
161209257|NCT02216214|582149047|FG000|Overall Study|Randomized Never Received Study Drug|1|||
161209258|NCT02216214|582149048|FG001|Overall Study|Randomized Never Received Study Drug|0|||
161209259|NCT02216214|582149047|FG000|Overall Study|Adverse Event|10|||
161209260|NCT02216214|582149048|FG001|Overall Study|Adverse Event|8|||
161209261|NCT02216214|582149047|FG000|Overall Study|Lack of Efficacy|2|||
161209262|NCT02216214|582149048|FG001|Overall Study|Lack of Efficacy|2|||
161209263|NCT02216214|582149047|FG000|Overall Study|Lost to Follow-up|3|||
161209264|NCT02216214|582149048|FG001|Overall Study|Lost to Follow-up|2|||
161209265|NCT02216214|582149047|FG000|Overall Study|Protocol Violation|4|||
161209266|NCT02216214|582149048|FG001|Overall Study|Protocol Violation|2|||
161209267|NCT02216214|582149047|FG000|Overall Study|Withdrawal by Subject|22|||
161209268|NCT02216214|582149048|FG001|Overall Study|Withdrawal by Subject|20|||
161209269|NCT02216214|582149047|FG000|Overall Study|Study Terminated By Sponsor|0|||
161209270|NCT02216214|582149048|FG001|Overall Study|Study Terminated By Sponsor|1|||
161209271|NCT02216214|582149047|FG000|Overall Study|Miscellaneous|1|||
161209272|NCT02216214|582149048|FG001|Overall Study|Miscellaneous|1|||
161209273|NCT05354206|582149049|FG000|Overall Study|Withdrawal by Subject|1|||
161209274|NCT05354206|582149050|FG001|Overall Study|Withdrawal by Subject|0|||
161209275|NCT04936334|582149051|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
161209276|NCT00713830|582149052|FG000|Overall Study|Adverse Event|23|||
161209277|NCT00713830|582149053|FG001|Overall Study|Adverse Event|71|||
161209278|NCT00713830|582149052|FG000|Overall Study|Lack of Efficacy|24|||
161209279|NCT00713830|582149053|FG001|Overall Study|Lack of Efficacy|16|||
161209280|NCT00713830|582149052|FG000|Overall Study|Lost to Follow-up|2|||
161209281|NCT00713830|582149053|FG001|Overall Study|Lost to Follow-up|9|||
161209282|NCT00713830|582149052|FG000|Overall Study|Withdrawal by Subject|13|||
161209283|NCT00713830|582149053|FG001|Overall Study|Withdrawal by Subject|23|||
161209284|NCT00713830|582149052|FG000|Overall Study|Poor Compliance to Protocol|7|||
161209285|NCT00713830|582149053|FG001|Overall Study|Poor Compliance to Protocol|14|||
161209286|NCT00713830|582149052|FG000|Overall Study|Familial and Personal Reasons|9|||
161209287|NCT00713830|582149053|FG001|Overall Study|Familial and Personal Reasons|34|||
161209288|NCT00713830|582149052|FG000|Overall Study|Sponsor Decision|4|||
161209289|NCT00713830|582149053|FG001|Overall Study|Sponsor Decision|10|||
161209290|NCT02787785|582149056|FG000|Overall Study|Death|3|||
161209291|NCT02787785|582149057|FG001|Overall Study|Death|4|||
161209292|NCT02787785|582149056|FG000|Overall Study|Lost to Follow-up|1|||
161209293|NCT02787785|582149057|FG001|Overall Study|Lost to Follow-up|1|||
161209294|NCT02787785|582149056|FG000|Overall Study|Withdrawal by Subject|0|||
161209295|NCT02787785|582149057|FG001|Overall Study|Withdrawal by Subject|5|||
161209296|NCT01440595|582149068|FG000|Overall Study|Lost to Follow-up|0|||
161322697|NCT03251482|582568545|FG000|Overall Study|Withdrawal by Subject|0|||
161209297|NCT01440595|582149069|FG001|Overall Study|Lost to Follow-up|1|||
161322698|NCT03251482|582568546|FG001|Overall Study|Withdrawal by Subject|1|||
161322699|NCT03251482|582568547|FG002|Overall Study|Withdrawal by Subject|0|||
161322700|NCT03251482|582568548|FG003|Overall Study|Withdrawal by Subject|0|||
161322701|NCT03251482|582568549|FG004|Overall Study|Withdrawal by Subject|0|||
161322702|NCT04530838|582568550|FG000|Overall Study|Other|2|||
161322703|NCT04530838|582568551|FG001|Overall Study|Other|1|||
161322704|NCT04530838|582568552|FG002|Overall Study|Other|0|||
161322705|NCT04530838|582568550|FG000|Overall Study|Physician Decision|0|||
161322706|NCT04530838|582568551|FG001|Overall Study|Physician Decision|0|||
161322707|NCT04530838|582568552|FG002|Overall Study|Physician Decision|1|||
161322708|NCT04530838|582568550|FG000|Overall Study|Death|0|||
161322709|NCT04530838|582568551|FG001|Overall Study|Death|0|||
161322710|NCT04530838|582568552|FG002|Overall Study|Death|1|||
160864812|NCT01134055|580898973|FG005|Overall Study|Physician Decision|0|||
160864813|NCT01134055|580898974|FG006|Overall Study|Physician Decision|1|||
160864814|NCT03345784|580898977|FG000|Overall Study|Withdrawal by Subject|2|||
160864815|NCT03345784|580898978|FG001|Overall Study|Withdrawal by Subject|1|||
160864816|NCT04798196|580898980|FG000|Overall Study|Lost to Follow-up|3|||
160864817|NCT04798196|580898981|FG001|Overall Study|Lost to Follow-up|1|||
160864818|NCT04798196|580898982|FG002|Overall Study|Lost to Follow-up|3|||
160864819|NCT00001959|580898990|FG000|Overall Study|newly diagnosed colon cancer|1|||
160864820|NCT00001959|580898990|FG000|Overall Study|disabling sedation|1|||
160864821|NCT00001959|580898990|FG000|Overall Study|non-compliance|1|||
161322711|NCT04530838|582568550|FG000|Overall Study|Adverse Event|0|||
161322712|NCT04530838|582568551|FG001|Overall Study|Adverse Event|1|||
161322713|NCT04530838|582568552|FG002|Overall Study|Adverse Event|0|||
160864822|NCT03592186|580898991|FG000|Overall Study|Withdrawal by Subject|1|||
160864823|NCT03592186|580898992|FG001|Overall Study|Withdrawal by Subject|0|||
160864824|NCT03592186|580898991|FG000|Overall Study|Lost to Follow-up|16|||
160864825|NCT03592186|580898992|FG001|Overall Study|Lost to Follow-up|11|||
160864826|NCT03755934|580898993|FG000|Overall Study|Adverse Event|4|||
160864827|NCT03755934|580898994|FG001|Overall Study|Adverse Event|1|||
160864828|NCT03755934|580898995|FG002|Overall Study|Adverse Event|1|||
160864829|NCT03755934|580898996|FG003|Overall Study|Adverse Event|3|||
160864830|NCT03755934|580898993|FG000|Overall Study|Physician Decision|2|||
160864831|NCT03755934|580898994|FG001|Overall Study|Physician Decision|0|||
160864832|NCT03755934|580898995|FG002|Overall Study|Physician Decision|0|||
160864833|NCT03755934|580898996|FG003|Overall Study|Physician Decision|1|||
160864834|NCT03755934|580898993|FG000|Overall Study|Withdrawal by Subject|5|||
160864835|NCT03755934|580898994|FG001|Overall Study|Withdrawal by Subject|0|||
160864836|NCT03755934|580898995|FG002|Overall Study|Withdrawal by Subject|0|||
160864837|NCT03755934|580898996|FG003|Overall Study|Withdrawal by Subject|1|||
160864838|NCT03755934|580898993|FG000|Overall Study|Other|3|||
160864839|NCT03755934|580898994|FG001|Overall Study|Other|1|||
160864840|NCT03755934|580898995|FG002|Overall Study|Other|3|||
160864841|NCT03755934|580898996|FG003|Overall Study|Other|1|||
160864842|NCT01498068|580898997|FG000|Overall Study|Withdrawal by Subject|1|||
160864843|NCT01498068|580898998|FG001|Overall Study|Withdrawal by Subject|1|||
160864844|NCT00361296|580899001|FG000|Overall Study|Physician Decision|1|||
160864845|NCT00361296|580899001|FG000|Overall Study|Lack of Efficacy|2|||
160864846|NCT00904982|580899003|FG000|Overall Study|Withdrawal by Subject|2|||
160864847|NCT00904982|580899004|FG001|Overall Study|Withdrawal by Subject|0|||
160864848|NCT00904982|580899005|FG002|Overall Study|Withdrawal by Subject|0|||
160864849|NCT00904982|580899006|FG003|Overall Study|Withdrawal by Subject|0|||
160864850|NCT01353898|580899009|FG000|Overall Study|Study site terminated|0|||
160864851|NCT01353898|580899010|FG001|Overall Study|Study site terminated|0|||
160864852|NCT01353898|580899011|FG002|Overall Study|Study site terminated|0|||
160864853|NCT01353898|580899012|FG003|Overall Study|Study site terminated|0|||
160864854|NCT01353898|580899013|FG004|Overall Study|Study site terminated|0|||
160864855|NCT01353898|580899014|FG005|Overall Study|Study site terminated|1|||
160864856|NCT02072668|580899015|FG000|Second Intervention|Lost to Follow-up|1|||
160864857|NCT02072668|580899016|FG001|Second Intervention|Lost to Follow-up|0|||
160864858|NCT02668653|580899017|FG000|Overall Study|Refractory disease|41|||
160864859|NCT02668653|580899018|FG001|Overall Study|Refractory disease|70|||
160864860|NCT02668653|580899017|FG000|Overall Study|Relapse|44|||
160864861|NCT02668653|580899018|FG001|Overall Study|Relapse|65|||
160864862|NCT02668653|580899017|FG000|Overall Study|Adverse Event|58|||
160864863|NCT02668653|580899018|FG001|Overall Study|Adverse Event|23|||
161209298|NCT01440595|582149070|FG002|Overall Study|Lost to Follow-up|0|||
160864864|NCT02668653|580899017|FG000|Overall Study|Subject decision to stop study drug|25|||
160864865|NCT02668653|580899018|FG001|Overall Study|Subject decision to stop study drug|23|||
160864866|NCT02668653|580899017|FG000|Overall Study|Other reasons not specified|16|||
160864867|NCT02668653|580899018|FG001|Overall Study|Other reasons not specified|11|||
160864868|NCT02668653|580899017|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
160864869|NCT02668653|580899018|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
161322714|NCT04530838|582568550|FG000|Overall Study|No longer meets eligibility criteria|1|||
161322715|NCT04530838|582568551|FG001|Overall Study|No longer meets eligibility criteria|0|||
161322716|NCT04530838|582568552|FG002|Overall Study|No longer meets eligibility criteria|2|||
160864870|NCT02668653|580899017|FG000|Overall Study|Investigator decision|10|||
160864871|NCT02668653|580899018|FG001|Overall Study|Investigator decision|7|||
160864872|NCT02668653|580899017|FG000|Overall Study|Failure to meet continuation criteria|5|||
160864873|NCT02668653|580899018|FG001|Overall Study|Failure to meet continuation criteria|12|||
160864874|NCT02668653|580899017|FG000|Overall Study|Lost to Follow-up|1|||
160864875|NCT02668653|580899018|FG001|Overall Study|Lost to Follow-up|0|||
160864876|NCT02668653|580899017|FG000|Overall Study|Pregnancy|0|||
160864877|NCT02668653|580899018|FG001|Overall Study|Pregnancy|1|||
160864878|NCT02668653|580899017|FG000|Overall Study|Death|0|||
160864879|NCT02668653|580899018|FG001|Overall Study|Death|1|||
160864880|NCT01352793|580899024|FG000|Overall Study|Lost to Follow-up|289|||
160864881|NCT01352793|580899025|FG001|Overall Study|Lost to Follow-up|125|||
160864882|NCT01352793|580899024|FG000|Overall Study|Withdrawal by Subject|120|||
160864883|NCT01352793|580899025|FG001|Overall Study|Withdrawal by Subject|55|||
160864884|NCT01352793|580899024|FG000|Overall Study|Protocol Violation|44|||
160864885|NCT01352793|580899025|FG001|Overall Study|Protocol Violation|23|||
160864886|NCT01352793|580899024|FG000|Overall Study|Adverse Event|44|||
160864887|NCT01352793|580899025|FG001|Overall Study|Adverse Event|10|||
161322717|NCT04530838|582568550|FG000|Overall Study|Withdrawal by parent/guardian|5|||
161322718|NCT04530838|582568551|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161322719|NCT04530838|582568552|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161322720|NCT00803712|582568553|FG000|Overall Study|Noncompliance|3|||
161322721|NCT00803712|582568554|FG001|Overall Study|Noncompliance|0|||
161322722|NCT00803712|582568553|FG000|Overall Study|Adverse Event|5|||
161322723|NCT00803712|582568554|FG001|Overall Study|Adverse Event|0|||
161322724|NCT00803712|582568553|FG000|Overall Study|Death|8|||
161322725|NCT00803712|582568554|FG001|Overall Study|Death|7|||
161322726|NCT00803712|582568553|FG000|Overall Study|Lost to Follow-up|3|||
161322727|NCT00803712|582568554|FG001|Overall Study|Lost to Follow-up|1|||
160864888|NCT01352793|580899024|FG000|Overall Study|Physician Decision|1|||
160864889|NCT01352793|580899025|FG001|Overall Study|Physician Decision|0|||
160864890|NCT01352793|580899024|FG000|Overall Study|Pregnancy|26|||
160864891|NCT01352793|580899025|FG001|Overall Study|Pregnancy|8|||
160864892|NCT01352793|580899024|FG000|Overall Study|Other|25|||
160864893|NCT01352793|580899025|FG001|Overall Study|Other|7|||
160864894|NCT01352793|580899024|FG000|Overall Study|Medication error|2|||
160864895|NCT01352793|580899025|FG001|Overall Study|Medication error|2|||
160864896|NCT01352793|580899024|FG000|Overall Study|Death|1|||
160864897|NCT01352793|580899025|FG001|Overall Study|Death|0|||
161322728|NCT00803712|582568553|FG000|Overall Study|Withdrawal by Subject|2|||
161322729|NCT00803712|582568554|FG001|Overall Study|Withdrawal by Subject|4|||
161322730|NCT00803712|582568553|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
161322731|NCT00803712|582568554|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
161322732|NCT00803712|582568553|FG000|Overall Study|Protocol criteria (other)|0|||
161322733|NCT00803712|582568554|FG001|Overall Study|Protocol criteria (other)|2|||
161322734|NCT00803712|582568553|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
161322735|NCT00803712|582568554|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
161322736|NCT00803712|582568553|FG000|Overall Study|Administrative decision|2|||
161322737|NCT00803712|582568554|FG001|Overall Study|Administrative decision|3|||
161322738|NCT00803712|582568553|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
161322739|NCT00803712|582568554|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
161322740|NCT02823470|582568559|FG000|Overall Study|Adverse Event|1|||
161322741|NCT02823470|582568560|FG001|Overall Study|Adverse Event|0|||
161322742|NCT02823470|582568559|FG000|Overall Study|Study terminated by sponsor|8|||
161322743|NCT02823470|582568560|FG001|Overall Study|Study terminated by sponsor|15|||
161322744|NCT02155309|582568562|FG000|Overall Study|Protocol Violation|0|||
161322745|NCT02155309|582568563|FG001|Overall Study|Protocol Violation|0|||
161322746|NCT02155309|582568564|FG002|Overall Study|Protocol Violation|1|||
160864898|NCT01352793|580899024|FG000|Overall Study|Randomized but not vaccinated|8|||
160864899|NCT01352793|580899025|FG001|Overall Study|Randomized but not vaccinated|0|||
160864900|NCT01352793|580899024|FG000|Overall Study|No longer meets eligibility criteria|25|||
160864901|NCT01352793|580899025|FG001|Overall Study|No longer meets eligibility criteria|15|||
160864902|NCT02083354|580901179|FG000|Overall Study|Withdrawal by Subject|9|||
160864903|NCT02083354|580901179|FG000|Overall Study|Lost to Follow-up|1|||
161209299|NCT01440595|582149068|FG000|Overall Study|Study terminated by sponsor.|1|||
160864904|NCT02083354|580901179|FG000|Overall Study|Adverse Event|3|||
160864905|NCT02083354|580901179|FG000|Overall Study|Disease progression|46|||
160864906|NCT02083354|580901179|FG000|Overall Study|Study closed/terminated|5|||
160864907|NCT01987453|580901180|FG000|Overall Study|Death|0|||
160864908|NCT01987453|580901181|FG001|Overall Study|Death|0|||
160864909|NCT01987453|580901182|FG002|Overall Study|Death|1|||
161322747|NCT01310127|582568565|FG000|Overall Study|Protocol Violation|1|||
161322748|NCT01310127|582568566|FG001|Overall Study|Protocol Violation|1|||
161322749|NCT01310127|582568565|FG000|Overall Study|advanced psc cataract outlier|1|||
161322750|NCT01310127|582568566|FG001|Overall Study|advanced psc cataract outlier|0|||
161322751|NCT01490840|582568567|FG000|Phase 1|Lost to Follow-up|1|||
161322752|NCT01490840|582568568|FG001|Phase 1|Lost to Follow-up|0|||
161322753|NCT01490840|582568567|FG000|Phase 1|Adverse Event|2|||
160864910|NCT01987453|580901180|FG000|Overall Study|Lack of Efficacy|1|||
160864911|NCT01987453|580901181|FG001|Overall Study|Lack of Efficacy|12|||
160864912|NCT01987453|580901182|FG002|Overall Study|Lack of Efficacy|0|||
160864913|NCT04040933|580901186|FG000|Overall Study|Protocol Violation|1|||
160864914|NCT04040933|580901186|FG000|Overall Study|Withdrawal by Subject|2|||
160864915|NCT02066181|580901187|FG000|Overall Study|Withdrawal by Subject|1|||
160864916|NCT02066181|580901188|FG001|Overall Study|Withdrawal by Subject|1|||
160864917|NCT00775190|580901193|FG000|Overall Study|Lost to Follow-up|2|||
160864918|NCT00775190|580901194|FG001|Overall Study|Lost to Follow-up|3|||
160864919|NCT00775190|580901193|FG000|Overall Study|Withdrawal by Subject|1|||
160864920|NCT00775190|580901194|FG001|Overall Study|Withdrawal by Subject|2|||
160864921|NCT00775190|580901193|FG000|Overall Study|Protocol Violation|1|||
160864922|NCT00775190|580901194|FG001|Overall Study|Protocol Violation|0|||
160864923|NCT02141295|580901195|FG000|Overall Study|Adverse Event|1|||
160864924|NCT02141295|580901196|FG001|Overall Study|Adverse Event|18|||
160864925|NCT02141295|580901197|FG002|Overall Study|Adverse Event|11|||
160864926|NCT02141295|580901195|FG000|Overall Study|Physician Decision|2|||
160864927|NCT02141295|580901196|FG001|Overall Study|Physician Decision|19|||
160864928|NCT02141295|580901197|FG002|Overall Study|Physician Decision|14|||
160864929|NCT02141295|580901195|FG000|Overall Study|Study terminated by sponsor|0|||
160864930|NCT02141295|580901196|FG001|Overall Study|Study terminated by sponsor|6|||
160864931|NCT02141295|580901197|FG002|Overall Study|Study terminated by sponsor|6|||
160864932|NCT02141295|580901195|FG000|Overall Study|Non-compliance|0|||
160864933|NCT02141295|580901196|FG001|Overall Study|Non-compliance|1|||
160864934|NCT02141295|580901197|FG002|Overall Study|Non-compliance|0|||
160864935|NCT02141295|580901195|FG000|Overall Study|Progressive disease|3|||
160864936|NCT02141295|580901196|FG001|Overall Study|Progressive disease|32|||
160864937|NCT02141295|580901197|FG002|Overall Study|Progressive disease|50|||
160864938|NCT02141295|580901195|FG000|Overall Study|Reason not specified|0|||
160864939|NCT02141295|580901196|FG001|Overall Study|Reason not specified|9|||
160864940|NCT02141295|580901197|FG002|Overall Study|Reason not specified|10|||
160864941|NCT02141295|580901195|FG000|Overall Study|Withdrawal by Subject|0|||
160864942|NCT02141295|580901196|FG001|Overall Study|Withdrawal by Subject|9|||
160864943|NCT02141295|580901197|FG002|Overall Study|Withdrawal by Subject|4|||
160864944|NCT01710501|580901198|FG000|Overall Study|Lost to Follow-up|2|||
160864945|NCT01710501|580901199|FG001|Overall Study|Lost to Follow-up|0|||
160864946|NCT01710501|580901200|FG002|Overall Study|Lost to Follow-up|0|||
160864947|NCT02536976|580901201|FG000|Overall Study|Physician Decision|0|||
160864948|NCT02536976|580901202|FG001|Overall Study|Physician Decision|1|||
160864949|NCT01671319|580901205|FG000|Overall Study|Withdrawal by Subject|1|||
160864950|NCT01376804|580901206|FG000|Treatment Period|Withdrawal by Subject|1|||
160864951|NCT01376804|580901206|FG000|Treatment Period|Adverse Event|6|||
160864952|NCT01376804|580901206|FG000|Treatment Period|Patient did not receive study drug|1|||
160864953|NCT02904954|580901211|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
160864954|NCT02904954|580901212|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
160864955|NCT02904954|580901211|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
160864956|NCT02904954|580901212|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
160864957|NCT02904954|580901211|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
160864958|NCT02904954|580901212|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
160864959|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Recurrence|2|||
160864960|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Recurrence|0|||
160864961|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Adverse Event|2|||
160864962|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Adverse Event|6|||
160864963|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Participant wishes|12|||
160864964|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Participant wishes|7|||
160864965|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Physician Decision|2|||
160864966|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Physician Decision|1|||
160864967|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
160864968|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
160864969|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Death|0|||
160864970|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Death|1|||
160864971|NCT02904954|580901211|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
160864972|NCT02904954|580901212|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
160864973|NCT00753506|580901213|FG000|Overall Study|Withdrawal by Subject|4|||
160864974|NCT00753506|580901214|FG001|Overall Study|Withdrawal by Subject|1|||
160864975|NCT00753506|580901213|FG000|Overall Study|Lost to Follow-up|2|||
160864976|NCT00753506|580901214|FG001|Overall Study|Lost to Follow-up|0|||
160864977|NCT00753506|580901213|FG000|Overall Study|Other reason|1|||
161092776|NCT01427751|581729981|FG001|Overall Study|Protocol Violation|4|||
160864978|NCT00753506|580901214|FG001|Overall Study|Other reason|1|||
160864979|NCT03819114|580901215|FG000|Overall Study|Protocol Violation|0|||
160864980|NCT03819114|580901216|FG001|Overall Study|Protocol Violation|1|||
160864981|NCT03819114|580901217|FG002|Overall Study|Protocol Violation|1|||
161092777|NCT01427751|581729980|FG000|Overall Study|Death|2|||
160864982|NCT03819114|580901218|FG003|Overall Study|Protocol Violation|0|||
160864983|NCT03819114|580901215|FG000|Overall Study|Lost to Follow-up|0|||
160864984|NCT03819114|580901216|FG001|Overall Study|Lost to Follow-up|0|||
160864985|NCT03819114|580901217|FG002|Overall Study|Lost to Follow-up|1|||
160864986|NCT03819114|580901218|FG003|Overall Study|Lost to Follow-up|0|||
160864987|NCT00628108|580901219|FG000|Overall Study|Adverse Event|0|||
160864988|NCT00628108|580901220|FG001|Overall Study|Adverse Event|3|||
160864989|NCT00628108|580901219|FG000|Overall Study|Withdrawal by Subject|1|||
160864990|NCT00628108|580901220|FG001|Overall Study|Withdrawal by Subject|0|||
160864991|NCT03848832|580901221|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
160864992|NCT03848832|580901222|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
160864993|NCT03848832|580901223|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
160864994|NCT03848832|580901221|FG000|Overall Study|Withdrawal by Subject|0|||
160864995|NCT03848832|580901222|FG001|Overall Study|Withdrawal by Subject|0|||
160864996|NCT03848832|580901223|FG002|Overall Study|Withdrawal by Subject|1|||
160864997|NCT03848832|580901221|FG000|Overall Study|Withdrawal (Covid-19)|0|||
160864998|NCT03848832|580901222|FG001|Overall Study|Withdrawal (Covid-19)|2|||
160864999|NCT03848832|580901223|FG002|Overall Study|Withdrawal (Covid-19)|0|||
160865000|NCT03848832|580901221|FG000|Overall Study|Physician Decision|2|||
160865001|NCT03848832|580901222|FG001|Overall Study|Physician Decision|1|||
160865002|NCT03848832|580901223|FG002|Overall Study|Physician Decision|3|||
160865003|NCT03848832|580901221|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
160865004|NCT03848832|580901222|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
160865005|NCT03848832|580901223|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
160865006|NCT03848832|580901221|FG000|Overall Study|Adverse Event|1|||
160865007|NCT03848832|580901222|FG001|Overall Study|Adverse Event|0|||
160865008|NCT03848832|580901223|FG002|Overall Study|Adverse Event|0|||
160865009|NCT00865566|580901224|FG000|Overall Study|Death|1|||
160865010|NCT00865566|580901225|FG001|Overall Study|Death|11|||
160865011|NCT00865566|580901224|FG000|Overall Study|Lost to Follow-up|314|||
160865012|NCT00865566|580901225|FG001|Overall Study|Lost to Follow-up|315|||
160865013|NCT00865566|580901224|FG000|Overall Study|Withdrawal by Subject|45|||
160865014|NCT00865566|580901225|FG001|Overall Study|Withdrawal by Subject|65|||
160865015|NCT00865566|580901224|FG000|Overall Study|Physician Decision|0|||
160865016|NCT00865566|580901225|FG001|Overall Study|Physician Decision|1|||
160865017|NCT00865566|580901224|FG000|Overall Study|Participant relocated|78|||
160865018|NCT00865566|580901225|FG001|Overall Study|Participant relocated|107|||
160865019|NCT00865566|580901224|FG000|Overall Study|Participant unable to adhere|27|||
160865020|NCT00865566|580901225|FG001|Overall Study|Participant unable to adhere|42|||
160865021|NCT00865566|580901224|FG000|Overall Study|Other; N=245 due to early study closure|154|||
160865022|NCT00865566|580901225|FG001|Overall Study|Other; N=245 due to early study closure|139|||
160865023|NCT00865566|580901224|FG000|Overall Study|HIV infection|5|||
160865024|NCT00865566|580901225|FG001|Overall Study|HIV infection|7|||
160865025|NCT02453321|580901226|FG000|Overall Study|Weakness|1|||
160865026|NCT02453321|580901227|FG001|Overall Study|Weakness|1|||
160865027|NCT02453321|580901228|FG002|Overall Study|Weakness|2|||
160865028|NCT02453321|580901226|FG000|Overall Study|Deep Venous Thrombosis|0|||
160865029|NCT02453321|580901227|FG001|Overall Study|Deep Venous Thrombosis|1|||
160865030|NCT02453321|580901228|FG002|Overall Study|Deep Venous Thrombosis|0|||
160865031|NCT02404025|580901229|FG000|Overall Study|Adverse Event|1|||
160865032|NCT02404025|580901229|FG000|Overall Study|Lack of Efficacy|3|||
160865033|NCT00098813|580901230|FG000|Overall Study|Death|8|||
160865034|NCT00098813|580901230|FG000|Overall Study|Protocol Violation|1|||
160865035|NCT00098813|580901230|FG000|Overall Study|Withdrawal by Subject|7|||
160865036|NCT00098813|580901230|FG000|Overall Study|Progression of Disease|1|||
160865037|NCT00098813|580901230|FG000|Overall Study|Other complicating disease|1|||
160865038|NCT00098813|580901230|FG000|Overall Study|Reversal of RAI resistance|1|||
160865039|NCT02230670|580901232|FG000|Overall Study|Adverse Event|1|||
160865040|NCT02230670|580901233|FG001|Overall Study|Adverse Event|2|||
160865041|NCT02230670|580901232|FG000|Overall Study|Withdrawal by Subject|2|||
160865042|NCT02230670|580901233|FG001|Overall Study|Withdrawal by Subject|2|||
160865043|NCT02230670|580901232|FG000|Overall Study|Physician Decision|0|||
160865044|NCT02230670|580901233|FG001|Overall Study|Physician Decision|1|||
160865045|NCT02230670|580901232|FG000|Overall Study|Protocol Violation|0|||
160865046|NCT02230670|580901233|FG001|Overall Study|Protocol Violation|1|||
160865047|NCT02230670|580901232|FG000|Overall Study|Progression to Child-Pugh C|1|||
160865048|NCT02230670|580901233|FG001|Overall Study|Progression to Child-Pugh C|2|||
160865049|NCT01907854|580901238|FG000|Overall Study|Protocol Violation|1|||
160865050|NCT01907854|580901239|FG001|Overall Study|Protocol Violation|1|||
160865051|NCT01907854|580901238|FG000|Overall Study|Withdrawal by Subject|9|||
160865052|NCT01907854|580901239|FG001|Overall Study|Withdrawal by Subject|7|||
160865053|NCT01907854|580901238|FG000|Overall Study|Lost to Follow-up|2|||
160865054|NCT01907854|580901239|FG001|Overall Study|Lost to Follow-up|2|||
160865055|NCT01907854|580901238|FG000|Overall Study|Unclassified|4|||
160865056|NCT01907854|580901239|FG001|Overall Study|Unclassified|3|||
160865057|NCT02215252|580901240|FG000|Overall Study|Adverse Event|1|||
160865058|NCT02215252|580901241|FG001|Overall Study|Adverse Event|5|||
160865059|NCT02215252|580901242|FG002|Overall Study|Adverse Event|2|||
160865060|NCT02215252|580901240|FG000|Overall Study|Lost to Follow-up|0|||
160865061|NCT02215252|580901241|FG001|Overall Study|Lost to Follow-up|0|||
160865062|NCT02215252|580901242|FG002|Overall Study|Lost to Follow-up|1|||
160865063|NCT02215252|580901240|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
160865064|NCT02215252|580901241|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
160865065|NCT02215252|580901242|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
160865066|NCT02215252|580901240|FG000|Overall Study|Protocol Violation|0|||
160865067|NCT02215252|580901241|FG001|Overall Study|Protocol Violation|1|||
160865068|NCT02215252|580901242|FG002|Overall Study|Protocol Violation|0|||
160865069|NCT02215252|580901240|FG000|Overall Study|Withdrawal by Subject|1|||
160865070|NCT02215252|580901241|FG001|Overall Study|Withdrawal by Subject|0|||
160865071|NCT02215252|580901242|FG002|Overall Study|Withdrawal by Subject|0|||
160865072|NCT02215252|580901240|FG000|Overall Study|Other|0|||
160865073|NCT02215252|580901241|FG001|Overall Study|Other|1|||
160865074|NCT02215252|580901242|FG002|Overall Study|Other|1|||
160865075|NCT00892099|580901244|FG000|Overall Study|Death|1|||
160865076|NCT00892099|580901245|FG001|Overall Study|Death|0|||
160865077|NCT00892099|580901246|FG002|Overall Study|Death|1|||
160865078|NCT00892099|580901244|FG000|Overall Study|Adverse Event|1|||
160865079|NCT00892099|580901245|FG001|Overall Study|Adverse Event|0|||
160865080|NCT00892099|580901246|FG002|Overall Study|Adverse Event|0|||
160865081|NCT00892099|580901244|FG000|Overall Study|replocated|1|||
160865082|NCT00892099|580901245|FG001|Overall Study|replocated|0|||
160865083|NCT00892099|580901246|FG002|Overall Study|replocated|2|||
160865084|NCT00892099|580901244|FG000|Overall Study|Prolonged hospitalization|1|||
160865085|NCT00892099|580901245|FG001|Overall Study|Prolonged hospitalization|0|||
160865086|NCT00892099|580901246|FG002|Overall Study|Prolonged hospitalization|1|||
160865087|NCT00892099|580901244|FG000|Overall Study|no further details|1|||
160865088|NCT00892099|580901245|FG001|Overall Study|no further details|0|||
160865089|NCT00892099|580901246|FG002|Overall Study|no further details|1|||
160865090|NCT00892099|580901244|FG000|Overall Study|kidney function recovered|0|||
160865091|NCT00892099|580901245|FG001|Overall Study|kidney function recovered|1|||
160865092|NCT00892099|580901246|FG002|Overall Study|kidney function recovered|0|||
160865093|NCT00892099|580901244|FG000|Overall Study|investigator decision|0|||
160865094|NCT00892099|580901245|FG001|Overall Study|investigator decision|0|||
160865095|NCT00892099|580901246|FG002|Overall Study|investigator decision|1|||
160865096|NCT00892099|580901244|FG000|Overall Study|Lost to Follow-up|0|||
160865097|NCT00892099|580901245|FG001|Overall Study|Lost to Follow-up|0|||
160865098|NCT00892099|580901246|FG002|Overall Study|Lost to Follow-up|1|||
160865099|NCT01746901|580901247|FG000|Naloxone Challenge Phase|Adverse Event|2|||
160865100|NCT01746901|580901248|FG001|Naloxone Challenge Phase|Adverse Event|0|||
160865101|NCT01746901|580901249|FG002|Naloxone Challenge Phase|Adverse Event|0|||
160865102|NCT01746901|580901250|FG003|Naloxone Challenge Phase|Adverse Event|0|||
160865103|NCT01746901|580901251|FG004|Naloxone Challenge Phase|Adverse Event|0|||
160865104|NCT01746901|580901252|FG005|Naloxone Challenge Phase|Adverse Event|0|||
160865105|NCT01746901|580901253|FG006|Naloxone Challenge Phase|Adverse Event|0|||
160865106|NCT01746901|580901254|FG007|Naloxone Challenge Phase|Adverse Event|0|||
160865107|NCT01746901|580901255|FG008|Naloxone Challenge Phase|Adverse Event|0|||
160865108|NCT01746901|580901247|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
160865109|NCT01746901|580901248|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865110|NCT01746901|580901249|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865111|NCT01746901|580901250|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865112|NCT01746901|580901251|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865113|NCT01746901|580901252|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865114|NCT01746901|580901253|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865115|NCT01746901|580901254|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865116|NCT01746901|580901255|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
160865117|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865118|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
160865119|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865120|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865121|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865122|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865123|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865124|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865125|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
160865126|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865127|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
160865128|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
160865129|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865130|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865131|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865132|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865133|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865134|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
160865135|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865136|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
160865137|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
160865138|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865139|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865140|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865141|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865142|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865143|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
160865144|NCT01746901|580901247|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865145|NCT01746901|580901248|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
160865146|NCT01746901|580901249|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
160865147|NCT01746901|580901250|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865148|NCT01746901|580901251|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161092778|NCT01427751|581729981|FG001|Overall Study|Death|0|||
161092779|NCT01427751|581729980|FG000|Overall Study|Other miscellaneous reasons|6|||
161092780|NCT01427751|581729981|FG001|Overall Study|Other miscellaneous reasons|4|||
161322754|NCT01490840|582568568|FG001|Phase 1|Adverse Event|1|||
161322755|NCT01490840|582568567|FG000|Phase 1|Withdrawal by Subject|6|||
161322756|NCT01490840|582568568|FG001|Phase 1|Withdrawal by Subject|5|||
161322757|NCT01490840|582568567|FG000|Phase 1|Visit 6a omitted|1|||
161322758|NCT01490840|582568568|FG001|Phase 1|Visit 6a omitted|0|||
161322759|NCT01490840|582568567|FG000|Phase 2|Withdrawal by Subject|4|||
161322760|NCT01490840|582568568|FG001|Phase 2|Withdrawal by Subject|3|||
161322761|NCT01490840|582568567|FG000|Phase 2|Permanent interruption of fingolimod|0|||
161322762|NCT01490840|582568568|FG001|Phase 2|Permanent interruption of fingolimod|1|||
161322763|NCT01490840|582568567|FG000|Phase 2|Lost to Follow-up|1|||
161322764|NCT01490840|582568568|FG001|Phase 2|Lost to Follow-up|1|||
161322765|NCT01490840|582568567|FG000|Phase 2|Adverse Event|1|||
161322766|NCT01490840|582568568|FG001|Phase 2|Adverse Event|1|||
161322767|NCT00184002|582568573|FG000|Overall Study|Adverse Event|9|||
161322768|NCT00184002|582568573|FG000|Overall Study|Death|3|||
161322769|NCT00184002|582568573|FG000|Overall Study|Physician Decision|1|||
161322770|NCT00184002|582568573|FG000|Overall Study|Withdrawal by Subject|4|||
161322771|NCT00694356|582568580|FG000|Overall Study|Adverse Event|1|||
161322772|NCT00694356|582568581|FG001|Overall Study|Adverse Event|0|||
161322773|NCT00694356|582568582|FG002|Overall Study|Adverse Event|0|||
161322774|NCT00694356|582568580|FG000|Overall Study|Progressive Disease|2|||
161322775|NCT00694356|582568581|FG001|Overall Study|Progressive Disease|6|||
161322776|NCT00694356|582568582|FG002|Overall Study|Progressive Disease|6|||
161322777|NCT02087670|582568585|FG000|Overall Study|Withdrawal by Subject|3|||
161322778|NCT02087670|582568586|FG001|Overall Study|Withdrawal by Subject|2|||
161322779|NCT03117361|582568588|FG000|Overall Study|Progressive disease|5|||
161322780|NCT03117361|582568588|FG000|Overall Study|Death|1|||
161322781|NCT03117361|582568588|FG000|Overall Study|Physician Decision|2|||
161322782|NCT03117361|582568588|FG000|Overall Study|On study treatment at the end of study|1|||
161322783|NCT03117361|582568588|FG000|Overall Study|Treatment-related adverse event|1|||
161322784|NCT00878800|582568589|FG000|Overall Study|Adverse Event|0|||
161322785|NCT00878800|582568590|FG001|Overall Study|Adverse Event|0|||
161322786|NCT00878800|582568591|FG002|Overall Study|Adverse Event|2|||
161322787|NCT00878800|582568592|FG003|Overall Study|Adverse Event|0|||
160865149|NCT01746901|580901252|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865150|NCT01746901|580901253|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865151|NCT01746901|580901254|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865152|NCT01746901|580901255|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
160865153|NCT01746901|580901247|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
160865154|NCT01746901|580901248|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
161322788|NCT00878800|582568593|FG004|Overall Study|Adverse Event|1|||
161322789|NCT00878800|582568589|FG000|Overall Study|Progressive disease|1|||
161322790|NCT00878800|582568590|FG001|Overall Study|Progressive disease|5|||
161322791|NCT00878800|582568591|FG002|Overall Study|Progressive disease|6|||
161322792|NCT00878800|582568592|FG003|Overall Study|Progressive disease|5|||
161322793|NCT00878800|582568593|FG004|Overall Study|Progressive disease|13|||
161322794|NCT00878800|582568589|FG000|Overall Study|Withdrew consent|1|||
161322795|NCT00878800|582568590|FG001|Overall Study|Withdrew consent|1|||
161322796|NCT00878800|582568591|FG002|Overall Study|Withdrew consent|0|||
160861851|NCT02531802|580887847|FG002|Received Vaccination 2|Adverse Event|0|||
161092781|NCT00368992|581729990|FG000|Overall Study|Ineligible|5|||
161092782|NCT00368992|581729990|FG000|Overall Study|Refused treatment|3|||
161322797|NCT00878800|582568592|FG003|Overall Study|Withdrew consent|1|||
161322798|NCT00878800|582568593|FG004|Overall Study|Withdrew consent|1|||
161322799|NCT00878800|582568589|FG000|Overall Study|Death|0|||
161322800|NCT00878800|582568590|FG001|Overall Study|Death|0|||
161322801|NCT00878800|582568591|FG002|Overall Study|Death|1|||
161322802|NCT00878800|582568592|FG003|Overall Study|Death|0|||
161322803|NCT00878800|582568593|FG004|Overall Study|Death|0|||
161322804|NCT00878800|582568589|FG000|Overall Study|Other|1|||
160865155|NCT01746901|580901249|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
160865156|NCT01746901|580901250|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
160865157|NCT01746901|580901251|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
160979011|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979012|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979013|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979014|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979015|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979016|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979017|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979018|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979019|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979020|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979021|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979022|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979023|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979024|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979025|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979026|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
160979027|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
160979028|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
160979029|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
160979030|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
160979031|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
160979032|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
160979033|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
160979034|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
160979035|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
160979036|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
160979037|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
160979038|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
160979039|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
160979040|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
160979041|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
160979042|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
160979043|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
160979044|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
160979045|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
160979046|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
160979047|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979048|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979049|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979050|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979051|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979052|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979053|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979054|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979055|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979056|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979057|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979058|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979059|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979060|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979061|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
160979062|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
160865158|NCT01746901|580901252|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
160865159|NCT01746901|580901253|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
160865160|NCT01746901|580901254|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
160865161|NCT01746901|580901255|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
160865162|NCT01746901|580901247|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865163|NCT01746901|580901248|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865164|NCT01746901|580901249|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865165|NCT01746901|580901250|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865166|NCT01746901|580901251|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865167|NCT01746901|580901252|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865168|NCT01746901|580901253|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865169|NCT01746901|580901254|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
160865170|NCT01746901|580901255|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
160865171|NCT01746901|580901247|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865172|NCT01746901|580901248|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
161092783|NCT00368992|581729990|FG000|Overall Study|Lack of Efficacy|63|||
160865173|NCT01746901|580901249|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865174|NCT01746901|580901250|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865175|NCT01746901|580901251|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865176|NCT01746901|580901252|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
160865177|NCT01746901|580901253|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
160865178|NCT01746901|580901254|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865179|NCT01746901|580901255|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
160865180|NCT01746901|580901247|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865181|NCT01746901|580901248|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865182|NCT01746901|580901249|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865183|NCT01746901|580901250|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
160865184|NCT01746901|580901251|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865185|NCT01746901|580901252|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865186|NCT01746901|580901253|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865187|NCT01746901|580901254|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865188|NCT01746901|580901255|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
160865189|NCT01746901|580901247|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865190|NCT01746901|580901248|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865191|NCT01746901|580901249|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865192|NCT01746901|580901250|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865193|NCT01746901|580901251|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865194|NCT01746901|580901252|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
160865195|NCT01746901|580901253|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865196|NCT01746901|580901254|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
160865197|NCT01746901|580901255|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
160865198|NCT01746901|580901247|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865199|NCT01746901|580901248|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865200|NCT01746901|580901249|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865201|NCT01746901|580901250|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865202|NCT01746901|580901251|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865203|NCT01746901|580901252|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865204|NCT01746901|580901253|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
160865205|NCT01746901|580901254|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
160865206|NCT01746901|580901255|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
160865207|NCT04455815|580901256|FG000|Randomisation Phase|Adverse Event|1|||
160865208|NCT04455815|580901257|FG001|Randomisation Phase|Adverse Event|0|||
160865209|NCT04455815|580901256|FG000|Treatment Phase|Adverse Event|0|||
160865210|NCT04455815|580901257|FG001|Treatment Phase|Adverse Event|1|||
160865211|NCT04455815|580901256|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
160865212|NCT04455815|580901257|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
160865213|NCT04455815|580901256|FG000|Treatment Phase|Withdrawal by Subject|1|||
160865214|NCT04455815|580901257|FG001|Treatment Phase|Withdrawal by Subject|1|||
160865215|NCT02106390|580901258|FG000|Overall Study|Withdrawal by Subject|15|||
160865216|NCT02106390|580901259|FG001|Overall Study|Withdrawal by Subject|16|||
160865217|NCT02106390|580901260|FG002|Overall Study|Withdrawal by Subject|15|||
160865218|NCT02106390|580901258|FG000|Overall Study|Lost to Follow-up|25|||
160865219|NCT02106390|580901259|FG001|Overall Study|Lost to Follow-up|20|||
160865220|NCT02106390|580901260|FG002|Overall Study|Lost to Follow-up|13|||
160865221|NCT02106390|580901258|FG000|Overall Study|Other: Administrative Reason|8|||
160865222|NCT02106390|580901259|FG001|Overall Study|Other: Administrative Reason|5|||
160865223|NCT02106390|580901260|FG002|Overall Study|Other: Administrative Reason|12|||
160865224|NCT02106390|580901258|FG000|Overall Study|Other: Unspecified|1|||
160865225|NCT02106390|580901259|FG001|Overall Study|Other: Unspecified|4|||
160865226|NCT02106390|580901260|FG002|Overall Study|Other: Unspecified|2|||
160865227|NCT02106390|580901258|FG000|Overall Study|Adverse Event|0|||
160865228|NCT02106390|580901259|FG001|Overall Study|Adverse Event|2|||
160865229|NCT02106390|580901260|FG002|Overall Study|Adverse Event|1|||
160865230|NCT02106390|580901258|FG000|Overall Study|Protocol Violation|0|||
160865231|NCT02106390|580901259|FG001|Overall Study|Protocol Violation|1|||
160865232|NCT02106390|580901260|FG002|Overall Study|Protocol Violation|0|||
160865233|NCT03594110|580901261|FG000|Interventional Part|Participant concerned about study treatment|23|||
160865234|NCT03594110|580901262|FG001|Interventional Part|Participant concerned about study treatment|28|||
160865235|NCT03594110|580901261|FG000|Interventional Part|Doctor advice|38|||
160865236|NCT03594110|580901262|FG001|Interventional Part|Doctor advice|40|||
160865237|NCT03594110|580901261|FG000|Interventional Part|Participants' wish|89|||
160865238|NCT03594110|580901262|FG001|Interventional Part|Participants' wish|68|||
160865239|NCT03594110|580901261|FG000|Interventional Part|Adverse event-non-fatal events|119|||
160865240|NCT03594110|580901262|FG001|Interventional Part|Adverse event-non-fatal events|116|||
160865241|NCT03594110|580901261|FG000|Interventional Part|Study drug stopped, reason missing|336|||
160865242|NCT03594110|580901262|FG001|Interventional Part|Study drug stopped, reason missing|294|||
160865243|NCT03594110|580901261|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
160865244|NCT03594110|580901262|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
160865245|NCT03594110|580901261|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
160865246|NCT03594110|580901262|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
160865247|NCT03594110|580901261|FG000|Interventional Part|Contraindicated drug started|32|||
160865248|NCT03594110|580901262|FG001|Interventional Part|Contraindicated drug started|18|||
160865249|NCT03594110|580901261|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
160865250|NCT03594110|580901262|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
160865251|NCT03594110|580901261|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
160865252|NCT03594110|580901262|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
160865253|NCT03594110|580901261|FG000|Non-interventional Part|Withdrawal by Subject|3|||
160865254|NCT03594110|580901262|FG001|Non-interventional Part|Withdrawal by Subject|4|||
160865255|NCT03594110|580901261|FG000|Non-interventional Part|Lost to Follow-up|45|||
160865256|NCT03594110|580901262|FG001|Non-interventional Part|Lost to Follow-up|41|||
160865257|NCT03041038|580901263|FG000|Overall Study|Withdrawal by Subject|4|||
160865258|NCT03041038|580901264|FG001|Overall Study|Withdrawal by Subject|0|||
160865259|NCT03041038|580901263|FG000|Overall Study|Lost to Follow-up|1|||
160865260|NCT03041038|580901264|FG001|Overall Study|Lost to Follow-up|1|||
160865261|NCT03041038|580901263|FG000|Overall Study|Protocol Violation|1|||
160865262|NCT03041038|580901264|FG001|Overall Study|Protocol Violation|1|||
160865263|NCT00803569|580901265|FG000|Overall Study|Progressive Disease|3|||
160865264|NCT00803569|580901265|FG000|Overall Study|Noncompliance|1|||
160865265|NCT02177032|580901266|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
160865266|NCT02177032|580901267|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
160865267|NCT02177032|580901268|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
160865268|NCT02177032|580901269|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
160865269|NCT02177032|580901266|FG000|Overall Study|Lost to Follow-up|0|||
160865270|NCT02177032|580901267|FG001|Overall Study|Lost to Follow-up|2|||
160865271|NCT02177032|580901268|FG002|Overall Study|Lost to Follow-up|0|||
160865272|NCT02177032|580901269|FG003|Overall Study|Lost to Follow-up|0|||
160865273|NCT02177032|580901266|FG000|Overall Study|OTHER|2|||
160865274|NCT02177032|580901267|FG001|Overall Study|OTHER|0|||
160865275|NCT02177032|580901268|FG002|Overall Study|OTHER|1|||
160865276|NCT02177032|580901269|FG003|Overall Study|OTHER|0|||
160865277|NCT02177032|580901266|FG000|Overall Study|Withdrawal by Subject|1|||
160865278|NCT02177032|580901267|FG001|Overall Study|Withdrawal by Subject|0|||
160865279|NCT02177032|580901268|FG002|Overall Study|Withdrawal by Subject|1|||
160865280|NCT02177032|580901269|FG003|Overall Study|Withdrawal by Subject|0|||
160865281|NCT00930046|580901270|FG000|Overall Study|Wound catheter malfunctioned|1|||
160865282|NCT00930046|580901271|FG001|Overall Study|Wound catheter malfunctioned|2|||
160865283|NCT01598532|580901272|FG000|Overall Study|Lost to Follow-up|3|||
160865284|NCT01598532|580901272|FG000|Overall Study|Did not meet inclusion criteria|8|||
160865285|NCT01249261|580901273|FG000|Overall Study|Withdrawal by Subject|1|||
160865286|NCT01249261|580901274|FG001|Overall Study|Withdrawal by Subject|0|||
160865287|NCT01967940|580901279|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
160865288|NCT01967940|580901280|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
160865289|NCT01967940|580901281|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
160865290|NCT01967940|580901282|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
160865291|NCT01967940|580901279|FG000|Part 2|Adverse Event|0|||
160865292|NCT01967940|580901280|FG001|Part 2|Adverse Event|0|||
160865293|NCT01967940|580901281|FG002|Part 2|Adverse Event|0|||
160865294|NCT01967940|580901282|FG003|Part 2|Adverse Event|1|||
160865295|NCT01967940|580901279|FG000|Part 2|Unknown Reason|0|||
160865296|NCT01967940|580901280|FG001|Part 2|Unknown Reason|0|||
160865297|NCT01967940|580901281|FG002|Part 2|Unknown Reason|0|||
160865298|NCT01967940|580901282|FG003|Part 2|Unknown Reason|1|||
160865299|NCT04109547|580901283|FG000|Overall Study|Withdrawal by Subject|3|||
160865300|NCT04109547|580901284|FG001|Overall Study|Withdrawal by Subject|2|||
160865301|NCT04109547|580901285|FG002|Overall Study|Withdrawal by Subject|6|||
160865302|NCT04109547|580901286|FG003|Overall Study|Withdrawal by Subject|6|||
160865303|NCT04109547|580901283|FG000|Overall Study|Lost to Follow-up|0|||
160865304|NCT04109547|580901284|FG001|Overall Study|Lost to Follow-up|0|||
160865305|NCT04109547|580901285|FG002|Overall Study|Lost to Follow-up|0|||
160865306|NCT04109547|580901286|FG003|Overall Study|Lost to Follow-up|1|||
160865307|NCT04109547|580901283|FG000|Overall Study|Physician Decision|1|||
160865308|NCT04109547|580901284|FG001|Overall Study|Physician Decision|2|||
160865309|NCT04109547|580901285|FG002|Overall Study|Physician Decision|0|||
160865310|NCT04109547|580901286|FG003|Overall Study|Physician Decision|0|||
160865311|NCT01550003|580901287|FG000|Overall Study|Adverse Event|0|||
160865312|NCT01550003|580901288|FG001|Overall Study|Adverse Event|9|||
160865313|NCT01550003|580901289|FG002|Overall Study|Adverse Event|15|||
160865314|NCT01550003|580901287|FG000|Overall Study|Lack of Efficacy|4|||
160865315|NCT01550003|580901288|FG001|Overall Study|Lack of Efficacy|11|||
160865316|NCT01550003|580901289|FG002|Overall Study|Lack of Efficacy|15|||
160865317|NCT01550003|580901287|FG000|Overall Study|Protocol Violation|0|||
160865318|NCT01550003|580901288|FG001|Overall Study|Protocol Violation|3|||
160865319|NCT01550003|580901289|FG002|Overall Study|Protocol Violation|2|||
160865320|NCT01550003|580901287|FG000|Overall Study|Lost to Follow-up|1|||
160865321|NCT01550003|580901288|FG001|Overall Study|Lost to Follow-up|4|||
160865322|NCT01550003|580901289|FG002|Overall Study|Lost to Follow-up|8|||
160865323|NCT01550003|580901287|FG000|Overall Study|Consent withdrawn|2|||
160865324|NCT01550003|580901288|FG001|Overall Study|Consent withdrawn|11|||
160865325|NCT01550003|580901289|FG002|Overall Study|Consent withdrawn|23|||
160865326|NCT01550003|580901287|FG000|Overall Study|Missing|1|||
160865327|NCT01550003|580901288|FG001|Overall Study|Missing|0|||
160865328|NCT01550003|580901289|FG002|Overall Study|Missing|2|||
160865329|NCT01550003|580901287|FG000|Overall Study|Study closure as announced by sponsor|7|||
160865330|NCT01550003|580901288|FG001|Overall Study|Study closure as announced by sponsor|6|||
160865331|NCT01550003|580901289|FG002|Overall Study|Study closure as announced by sponsor|24|||
160865332|NCT01550003|580901287|FG000|Overall Study|Protocol Noncompliance|1|||
160865333|NCT01550003|580901288|FG001|Overall Study|Protocol Noncompliance|0|||
160865334|NCT01550003|580901289|FG002|Overall Study|Protocol Noncompliance|0|||
160865335|NCT01550003|580901287|FG000|Overall Study|Study closure|0|||
160865336|NCT01550003|580901288|FG001|Overall Study|Study closure|1|||
160865337|NCT01550003|580901289|FG002|Overall Study|Study closure|1|||
160865338|NCT01550003|580901287|FG000|Overall Study|Patient reached adulthood|0|||
160865339|NCT01550003|580901288|FG001|Overall Study|Patient reached adulthood|1|||
160865340|NCT01550003|580901289|FG002|Overall Study|Patient reached adulthood|0|||
160865341|NCT01550003|580901287|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
160865342|NCT01550003|580901288|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
160865343|NCT01550003|580901289|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
160865344|NCT01550003|580901287|FG000|Overall Study|Sponsor's order|0|||
160865345|NCT01550003|580901288|FG001|Overall Study|Sponsor's order|3|||
160865346|NCT01550003|580901289|FG002|Overall Study|Sponsor's order|3|||
160865347|NCT01550003|580901287|FG000|Overall Study|Sponsor's decision|1|||
160865348|NCT01550003|580901288|FG001|Overall Study|Sponsor's decision|5|||
160865349|NCT01550003|580901289|FG002|Overall Study|Sponsor's decision|4|||
160865350|NCT01550003|580901287|FG000|Overall Study|Subject mother passed away|0|||
160865351|NCT01550003|580901288|FG001|Overall Study|Subject mother passed away|1|||
160865352|NCT01550003|580901289|FG002|Overall Study|Subject mother passed away|0|||
160865353|NCT01550003|580901287|FG000|Overall Study|Discontinuation|0|||
160865354|NCT01550003|580901288|FG001|Overall Study|Discontinuation|1|||
160865355|NCT01550003|580901289|FG002|Overall Study|Discontinuation|0|||
160865356|NCT01550003|580901287|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
160865357|NCT01550003|580901288|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
160865358|NCT01550003|580901289|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
160865359|NCT01550003|580901287|FG000|Overall Study|Site closure|0|||
160865360|NCT01550003|580901288|FG001|Overall Study|Site closure|2|||
160865361|NCT01550003|580901289|FG002|Overall Study|Site closure|0|||
160865362|NCT01550003|580901287|FG000|Overall Study|Pregnancy|0|||
160865363|NCT01550003|580901288|FG001|Overall Study|Pregnancy|1|||
160865364|NCT01550003|580901289|FG002|Overall Study|Pregnancy|0|||
160865365|NCT01550003|580901287|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
160865366|NCT01550003|580901288|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
160865367|NCT01550003|580901289|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
160865368|NCT01550003|580901287|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
160865369|NCT01550003|580901288|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
160865370|NCT01550003|580901289|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
160865371|NCT01550003|580901287|FG000|Overall Study|Switching to adult rheumatologist|0|||
160865372|NCT01550003|580901288|FG001|Overall Study|Switching to adult rheumatologist|0|||
160865373|NCT01550003|580901289|FG002|Overall Study|Switching to adult rheumatologist|1|||
160865374|NCT01550003|580901287|FG000|Overall Study|Patient transition to adult care|0|||
160865375|NCT01550003|580901288|FG001|Overall Study|Patient transition to adult care|0|||
160865376|NCT01550003|580901289|FG002|Overall Study|Patient transition to adult care|1|||
160865377|NCT01550003|580901287|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
160865378|NCT01550003|580901288|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
160865379|NCT01550003|580901289|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
160865380|NCT01550003|580901287|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
160865381|NCT01550003|580901288|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
160865382|NCT01550003|580901289|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
160865383|NCT01550003|580901287|FG000|Overall Study|Per Sponsor request|1|||
160865384|NCT01550003|580901288|FG001|Overall Study|Per Sponsor request|0|||
160865385|NCT01550003|580901289|FG002|Overall Study|Per Sponsor request|1|||
160865386|NCT01550003|580901287|FG000|Overall Study|Patient not compliance|0|||
160865387|NCT01550003|580901288|FG001|Overall Study|Patient not compliance|0|||
160865388|NCT01550003|580901289|FG002|Overall Study|Patient not compliance|1|||
160865389|NCT01550003|580901287|FG000|Overall Study|Non-compliance|0|||
160865390|NCT01550003|580901288|FG001|Overall Study|Non-compliance|0|||
160865391|NCT01550003|580901289|FG002|Overall Study|Non-compliance|1|||
160865392|NCT01550003|580901287|FG000|Overall Study|Study closed|0|||
160865393|NCT01550003|580901288|FG001|Overall Study|Study closed|1|||
160865394|NCT01550003|580901289|FG002|Overall Study|Study closed|0|||
160865395|NCT01550003|580901287|FG000|Overall Study|Transitioned to adult rheumatology|0|||
160865396|NCT01550003|580901288|FG001|Overall Study|Transitioned to adult rheumatology|0|||
160865397|NCT01550003|580901289|FG002|Overall Study|Transitioned to adult rheumatology|1|||
160865398|NCT05567783|580901290|FG000|Overall Study|Death|2|||
160865399|NCT05567783|580901291|FG001|Overall Study|Death|3|||
160865400|NCT05567783|580901292|FG002|Overall Study|Death|0|||
160865401|NCT05567783|580901290|FG000|Overall Study|Lost to Follow-up|25|||
160865402|NCT05567783|580901291|FG001|Overall Study|Lost to Follow-up|19|||
160865403|NCT05567783|580901292|FG002|Overall Study|Lost to Follow-up|17|||
160865404|NCT05567783|580901290|FG000|Overall Study|Physician Decision|10|||
160865405|NCT05567783|580901291|FG001|Overall Study|Physician Decision|7|||
160865406|NCT05567783|580901292|FG002|Overall Study|Physician Decision|9|||
160865407|NCT05567783|580901290|FG000|Overall Study|Study Terminated by Sponsor|924|||
160865408|NCT05567783|580901291|FG001|Overall Study|Study Terminated by Sponsor|937|||
160865409|NCT05567783|580901292|FG002|Overall Study|Study Terminated by Sponsor|941|||
160865410|NCT05567783|580901290|FG000|Overall Study|Withdrawal by Subject|23|||
160865411|NCT05567783|580901291|FG001|Overall Study|Withdrawal by Subject|27|||
160865412|NCT05567783|580901292|FG002|Overall Study|Withdrawal by Subject|24|||
160865413|NCT05567783|580901290|FG000|Overall Study|Incarcerated|1|||
160865414|NCT05567783|580901291|FG001|Overall Study|Incarcerated|0|||
160865415|NCT05567783|580901292|FG002|Overall Study|Incarcerated|0|||
160865416|NCT05567783|580901290|FG000|Overall Study|Participant randomized in error|4|||
160865417|NCT05567783|580901291|FG001|Overall Study|Participant randomized in error|2|||
160865418|NCT05567783|580901292|FG002|Overall Study|Participant randomized in error|2|||
160865419|NCT03675126|580901295|FG000|Overall Study|Study Terminated by Sponsor|9|||
160865420|NCT03675126|580901295|FG000|Overall Study|Death|2|||
160865421|NCT03675126|580901295|FG000|Overall Study|Withdrawal by Subject|4|||
160865422|NCT01929317|580901299|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
160865423|NCT01929317|580901300|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
160865424|NCT01929317|580901299|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
160865425|NCT01929317|580901300|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
160865426|NCT01929317|580901299|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
160865427|NCT01929317|580901300|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
160865428|NCT01929317|580901299|FG000|Long-term Phase|Adverse Event|5|||
160865429|NCT01929317|580901300|FG001|Long-term Phase|Adverse Event|1|||
160865430|NCT01929317|580901299|FG000|Long-term Phase|Physician Decision|3|||
160865431|NCT01929317|580901300|FG001|Long-term Phase|Physician Decision|0|||
160865432|NCT01929317|580901299|FG000|Long-term Phase|Withdrawal by Subject|4|||
160865433|NCT01929317|580901300|FG001|Long-term Phase|Withdrawal by Subject|0|||
160865434|NCT01929317|580901299|FG000|Long-term Phase|Protocol Violation|1|||
160865435|NCT01929317|580901300|FG001|Long-term Phase|Protocol Violation|0|||
160865436|NCT01929317|580901299|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
160865437|NCT01929317|580901300|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
160865438|NCT01929317|580901299|FG000|Long-term Phase|Study Closed/Terminated|5|||
160865439|NCT01929317|580901300|FG001|Long-term Phase|Study Closed/Terminated|3|||
160865440|NCT00993967|580901306|FG000|Overall Study|Adverse Event|8|||
160865441|NCT00993967|580901306|FG000|Overall Study|Death|1|||
160865442|NCT00993967|580901306|FG000|Overall Study|Lost to Follow-up|14|||
160865443|NCT00993967|580901306|FG000|Overall Study|Withdrawal by Subject|36|||
160865444|NCT00993967|580901306|FG000|Overall Study|Protocol Violation|2|||
160865445|NCT03815929|580901307|FG000|Overall Study|Lost to Follow-up|2|||
160865446|NCT03815929|580901308|FG001|Overall Study|Lost to Follow-up|1|||
160865447|NCT03815929|580901309|FG002|Overall Study|Lost to Follow-up|0|||
160865448|NCT03815929|580901307|FG000|Overall Study|Physician Decision|2|||
160865449|NCT03815929|580901308|FG001|Overall Study|Physician Decision|2|||
160865450|NCT03815929|580901309|FG002|Overall Study|Physician Decision|0|||
160865451|NCT03815929|580901307|FG000|Overall Study|Withdrawal by Subject|0|||
160865452|NCT03815929|580901308|FG001|Overall Study|Withdrawal by Subject|0|||
160865453|NCT03815929|580901309|FG002|Overall Study|Withdrawal by Subject|1|||
160865454|NCT02205736|580901310|FG000|Overall Study|Lost to Follow-up|106|||
160865455|NCT02638220|580901318|FG000|Overall Study|Lost to Follow-up|6|||
160865456|NCT02638220|580901318|FG000|Overall Study|Withdrawal by Subject|3|||
160865457|NCT02638220|580901318|FG000|Overall Study|Physician Decision|1|||
160865458|NCT02638220|580901318|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
160865459|NCT04323124|580901319|FG000|Overall Study|Adverse Event|0|||
160865460|NCT04323124|580901320|FG001|Overall Study|Adverse Event|0|||
160865461|NCT04323124|580901321|FG002|Overall Study|Adverse Event|0|||
160865462|NCT04323124|580901322|FG003|Overall Study|Adverse Event|0|||
160865463|NCT04323124|580901323|FG004|Overall Study|Adverse Event|0|||
161092784|NCT00368992|581729990|FG000|Overall Study|Adverse Event|26|||
161092785|NCT00368992|581729990|FG000|Overall Study|Death|4|||
161092786|NCT00368992|581729990|FG000|Overall Study|Other|9|||
160865464|NCT04323124|580901324|FG005|Overall Study|Adverse Event|1|||
160865465|NCT04323124|580901325|FG006|Overall Study|Adverse Event|0|||
160865466|NCT04323124|580901326|FG007|Overall Study|Adverse Event|1|||
160865467|NCT04323124|580901327|FG008|Overall Study|Adverse Event|1|||
160865468|NCT04323124|580901328|FG009|Overall Study|Adverse Event|0|||
160865469|NCT04323124|580901329|FG010|Overall Study|Adverse Event|0|||
160865470|NCT04323124|580901330|FG011|Overall Study|Adverse Event|0|||
160865471|NCT04323124|580901331|FG012|Overall Study|Adverse Event|0|||
160865472|NCT04323124|580901332|FG013|Overall Study|Adverse Event|0|||
160865473|NCT04323124|580901333|FG014|Overall Study|Adverse Event|0|||
160865474|NCT04323124|580901319|FG000|Overall Study|Other|0|||
160865475|NCT04323124|580901320|FG001|Overall Study|Other|0|||
160865476|NCT04323124|580901321|FG002|Overall Study|Other|0|||
160865477|NCT04323124|580901322|FG003|Overall Study|Other|0|||
160865478|NCT04323124|580901323|FG004|Overall Study|Other|1|||
160865479|NCT04323124|580901324|FG005|Overall Study|Other|0|||
160865480|NCT04323124|580901325|FG006|Overall Study|Other|0|||
160865481|NCT04323124|580901326|FG007|Overall Study|Other|0|||
160865482|NCT04323124|580901327|FG008|Overall Study|Other|1|||
160865483|NCT04323124|580901328|FG009|Overall Study|Other|0|||
160865484|NCT04323124|580901329|FG010|Overall Study|Other|0|||
160865485|NCT04323124|580901330|FG011|Overall Study|Other|0|||
160865486|NCT04323124|580901331|FG012|Overall Study|Other|0|||
160865487|NCT04323124|580901332|FG013|Overall Study|Other|0|||
160865488|NCT04323124|580901333|FG014|Overall Study|Other|0|||
160865489|NCT04323124|580901319|FG000|Overall Study|Coming from a red zone (COVID)|0|||
160865490|NCT04323124|580901320|FG001|Overall Study|Coming from a red zone (COVID)|0|||
160865491|NCT04323124|580901321|FG002|Overall Study|Coming from a red zone (COVID)|0|||
160865492|NCT04323124|580901322|FG003|Overall Study|Coming from a red zone (COVID)|0|||
160865493|NCT04323124|580901323|FG004|Overall Study|Coming from a red zone (COVID)|1|||
160865494|NCT04323124|580901324|FG005|Overall Study|Coming from a red zone (COVID)|1|||
160865495|NCT04323124|580901325|FG006|Overall Study|Coming from a red zone (COVID)|0|||
160865496|NCT04323124|580901326|FG007|Overall Study|Coming from a red zone (COVID)|0|||
160865497|NCT04323124|580901327|FG008|Overall Study|Coming from a red zone (COVID)|0|||
160865498|NCT04323124|580901328|FG009|Overall Study|Coming from a red zone (COVID)|0|||
160865499|NCT04323124|580901329|FG010|Overall Study|Coming from a red zone (COVID)|0|||
160865500|NCT04323124|580901330|FG011|Overall Study|Coming from a red zone (COVID)|0|||
160865501|NCT04323124|580901331|FG012|Overall Study|Coming from a red zone (COVID)|0|||
160865502|NCT04323124|580901332|FG013|Overall Study|Coming from a red zone (COVID)|0|||
160865503|NCT04323124|580901333|FG014|Overall Study|Coming from a red zone (COVID)|0|||
160865504|NCT04323124|580901319|FG000|Overall Study|No longer meets eligibility criteria|0|||
160865505|NCT04323124|580901320|FG001|Overall Study|No longer meets eligibility criteria|0|||
160865506|NCT04323124|580901321|FG002|Overall Study|No longer meets eligibility criteria|0|||
160865507|NCT04323124|580901322|FG003|Overall Study|No longer meets eligibility criteria|0|||
160865508|NCT04323124|580901323|FG004|Overall Study|No longer meets eligibility criteria|0|||
160865509|NCT04323124|580901324|FG005|Overall Study|No longer meets eligibility criteria|0|||
160865510|NCT04323124|580901325|FG006|Overall Study|No longer meets eligibility criteria|0|||
160865511|NCT04323124|580901326|FG007|Overall Study|No longer meets eligibility criteria|1|||
160865512|NCT04323124|580901327|FG008|Overall Study|No longer meets eligibility criteria|0|||
160865513|NCT04323124|580901328|FG009|Overall Study|No longer meets eligibility criteria|0|||
160865514|NCT04323124|580901329|FG010|Overall Study|No longer meets eligibility criteria|0|||
160865515|NCT04323124|580901330|FG011|Overall Study|No longer meets eligibility criteria|0|||
160865516|NCT04323124|580901331|FG012|Overall Study|No longer meets eligibility criteria|0|||
160865517|NCT04323124|580901332|FG013|Overall Study|No longer meets eligibility criteria|1|||
160865518|NCT04323124|580901333|FG014|Overall Study|No longer meets eligibility criteria|1|||
160865519|NCT04323124|580901319|FG000|Overall Study|Study terminated by sponsor|0|||
160865520|NCT04323124|580901320|FG001|Overall Study|Study terminated by sponsor|0|||
160865521|NCT04323124|580901321|FG002|Overall Study|Study terminated by sponsor|0|||
160865522|NCT04323124|580901322|FG003|Overall Study|Study terminated by sponsor|0|||
160865523|NCT04323124|580901323|FG004|Overall Study|Study terminated by sponsor|0|||
160865524|NCT04323124|580901324|FG005|Overall Study|Study terminated by sponsor|0|||
160865525|NCT04323124|580901325|FG006|Overall Study|Study terminated by sponsor|0|||
160865526|NCT04323124|580901326|FG007|Overall Study|Study terminated by sponsor|0|||
160865527|NCT04323124|580901327|FG008|Overall Study|Study terminated by sponsor|0|||
160865528|NCT04323124|580901328|FG009|Overall Study|Study terminated by sponsor|0|||
160865529|NCT04323124|580901329|FG010|Overall Study|Study terminated by sponsor|0|||
160865530|NCT04323124|580901330|FG011|Overall Study|Study terminated by sponsor|2|||
160865531|NCT04323124|580901331|FG012|Overall Study|Study terminated by sponsor|1|||
160865532|NCT04323124|580901332|FG013|Overall Study|Study terminated by sponsor|0|||
160865533|NCT04323124|580901333|FG014|Overall Study|Study terminated by sponsor|0|||
160865534|NCT02968004|580902896|FG000|Main Study Phase|Adverse Event|1|||
160865535|NCT02968004|580902897|FG001|Main Study Phase|Adverse Event|0|||
160865536|NCT02968004|580902896|FG000|Main Study Phase|Withdrawal by Subject|0|||
160865537|NCT02968004|580902897|FG001|Main Study Phase|Withdrawal by Subject|1|||
160865538|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
160865539|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
161092787|NCT00790751|581729997|FG000|Overall Study|Protocol non-compliance|16|||
161092788|NCT00790751|581729998|FG001|Overall Study|Protocol non-compliance|16|||
160865540|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
160865541|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
160865542|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
160865543|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
160865544|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
160865545|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
160865546|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
160865547|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
160865548|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
160865549|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
160865550|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
160865551|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
160865552|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
160865553|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
160865554|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
160865555|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
160865556|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
160865557|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
160865558|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
160865559|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
160865560|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
160865561|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
160865562|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
160865563|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
160865564|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
160865565|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
160865566|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
160865567|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
160865568|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
160865569|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
160865570|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
160865571|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
160865572|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
160865573|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
160865574|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
160865575|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
160865576|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
160865577|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
160865578|NCT02968004|580902896|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
160865579|NCT02968004|580902897|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
160865580|NCT03722238|580902902|FG000|Overall Study|Protocol Violation|1|||
160865581|NCT03722238|580902903|FG001|Overall Study|Protocol Violation|0|||
160865582|NCT03722238|580902902|FG000|Overall Study|Physician Decision|1|||
160979063|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
160979064|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
160979065|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979066|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979067|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979068|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979069|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979070|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979071|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979072|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160865583|NCT03722238|580902903|FG001|Overall Study|Physician Decision|0|||
160865584|NCT03722238|580902902|FG000|Overall Study|Death|1|||
160865585|NCT03722238|580902903|FG001|Overall Study|Death|0|||
160865586|NCT03722238|580902902|FG000|Overall Study|Lost to Follow-up|6|||
160979073|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979074|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979075|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979076|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979077|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160865587|NCT03722238|580902903|FG001|Overall Study|Lost to Follow-up|0|||
160865588|NCT03722238|580902902|FG000|Overall Study|Partial missing data|44|||
160865589|NCT03722238|580902903|FG001|Overall Study|Partial missing data|1|||
160865590|NCT03722238|580902902|FG000|Overall Study|Withdrawal by Subject|2|||
160865591|NCT03722238|580902903|FG001|Overall Study|Withdrawal by Subject|0|||
160979078|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979079|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
160979080|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979081|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
160979082|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
160979083|NCT01474512|581311899|FG000|Post-Treatment Follow-Up|Death|0|||
160979084|NCT01474512|581311900|FG001|Post-Treatment Follow-Up|Death|0|||
160865592|NCT03722238|580902902|FG000|Overall Study|Other|4|||
160865593|NCT03722238|580902903|FG001|Overall Study|Other|0|||
160865594|NCT03722238|580902902|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
160865595|NCT03722238|580902903|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
160865596|NCT03722238|580902902|FG000|Overall Study|Did not meet risk classification group criteria|90|||
160865597|NCT03722238|580902903|FG001|Overall Study|Did not meet risk classification group criteria|0|||
160865598|NCT03722238|580902902|FG000|Overall Study|Did not sign consent|17|||
160865599|NCT03722238|580902903|FG001|Overall Study|Did not sign consent|0|||
160865600|NCT03722238|580902902|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
160865601|NCT03722238|580902903|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
160865602|NCT03722238|580902902|FG000|Overall Study|Not willing to purchase study medication|142|||
160865603|NCT03722238|580902903|FG001|Overall Study|Not willing to purchase study medication|0|||
160865604|NCT03722238|580902902|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
160865605|NCT03722238|580902903|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
160865606|NCT02085460|580902904|FG000|Overall Study|Adverse Event|2|||
160865607|NCT02085460|580902905|FG001|Overall Study|Adverse Event|2|||
160865608|NCT02085460|580902906|FG002|Overall Study|Adverse Event|1|||
160865609|NCT02085460|580902904|FG000|Overall Study|Physician Decision|1|||
160865610|NCT02085460|580902905|FG001|Overall Study|Physician Decision|1|||
160865611|NCT02085460|580902906|FG002|Overall Study|Physician Decision|2|||
160865612|NCT02085460|580902904|FG000|Overall Study|Withdrawal by Subject|11|||
160865613|NCT02085460|580902905|FG001|Overall Study|Withdrawal by Subject|5|||
160865614|NCT02085460|580902906|FG002|Overall Study|Withdrawal by Subject|7|||
160865615|NCT02606643|580902907|FG000|Overall Study|did not meet inclusion criteria|1|||
160979085|NCT01474512|581311901|FG002|Post-Treatment Follow-Up|Death|0|||
160979086|NCT01474512|581311902|FG003|Post-Treatment Follow-Up|Death|0|||
160979087|NCT01474512|581311903|FG004|Post-Treatment Follow-Up|Death|0|||
160979088|NCT01474512|581311904|FG005|Post-Treatment Follow-Up|Death|0|||
160979089|NCT01474512|581311905|FG006|Post-Treatment Follow-Up|Death|0|||
160979090|NCT01474512|581311906|FG007|Post-Treatment Follow-Up|Death|0|||
160979091|NCT01474512|581311907|FG008|Post-Treatment Follow-Up|Death|0|||
160979092|NCT01474512|581311908|FG009|Post-Treatment Follow-Up|Death|0|||
160979093|NCT01474512|581311909|FG010|Post-Treatment Follow-Up|Death|0|||
160979094|NCT01474512|581311910|FG011|Post-Treatment Follow-Up|Death|0|||
160979095|NCT01474512|581311911|FG012|Post-Treatment Follow-Up|Death|0|||
160979096|NCT01474512|581311912|FG013|Post-Treatment Follow-Up|Death|0|||
160979097|NCT01474512|581311913|FG014|Post-Treatment Follow-Up|Death|0|||
160979098|NCT01474512|581311914|FG015|Post-Treatment Follow-Up|Death|0|||
160979099|NCT01474512|581311915|FG016|Post-Treatment Follow-Up|Death|1|||
160979100|NCT01474512|581311916|FG017|Post-Treatment Follow-Up|Death|0|||
160979101|NCT01118962|581311919|FG000|Overall Study|Adverse Event|2|||
160979102|NCT01118962|581311919|FG000|Overall Study|Lack of Efficacy|1|||
160979103|NCT01118962|581311919|FG000|Overall Study|Protocol Violation|1|||
160979104|NCT01118962|581311919|FG000|Overall Study|Withdrawal by Subject|4|||
160979105|NCT01118962|581311919|FG000|Overall Study|Pregnancy|1|||
160979106|NCT01118962|581311919|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
160979107|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
160979108|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
160979109|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979110|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979111|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979112|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
160979113|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
160979114|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
160979115|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979116|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979117|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979118|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
160979119|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
160979120|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
160979121|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979122|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979123|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979124|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
160979125|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979126|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
160979127|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979128|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979129|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979130|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
160979131|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
160979132|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979133|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979134|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979135|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979136|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
160979137|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
160979138|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
160979139|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979140|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979141|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979142|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
160979143|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
160979144|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
160979145|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979146|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979147|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979148|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
160979149|NCT01089556|581311922|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
160979150|NCT01089556|581311923|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
160979151|NCT01089556|581311924|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979152|NCT01089556|581311925|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979153|NCT01089556|581311926|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979154|NCT01089556|581311927|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
160979155|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
160979156|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
160979157|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
160979158|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
160979159|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
160979160|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
160979161|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
160979162|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
160979163|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979164|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979165|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979166|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
160979167|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979168|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979169|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979170|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
160979171|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
160979172|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
160979173|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979174|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979175|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
160979176|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979177|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979178|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
160979179|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
160979180|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
160979181|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
160979182|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
160979183|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
160979184|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
160979185|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
160979186|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
160979187|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
160979188|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
160979189|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
160979190|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
160979191|NCT01089556|581311922|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
160979192|NCT01089556|581311923|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
161092789|NCT00790751|581729999|FG002|Overall Study|Protocol non-compliance|10|||
160979193|NCT01089556|581311924|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
161092790|NCT00790751|581730000|FG003|Overall Study|Protocol non-compliance|11|||
160979194|NCT01089556|581311925|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
160979195|NCT01089556|581311926|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
160979196|NCT01089556|581311927|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
160979197|NCT01702428|581311928|FG000|Overall Study|Adverse Event|2|||
160979198|NCT01702428|581311929|FG001|Overall Study|Adverse Event|0|||
160979199|NCT01702428|581311930|FG002|Overall Study|Adverse Event|0|||
160979200|NCT01702428|581311931|FG003|Overall Study|Adverse Event|0|||
160979201|NCT01702428|581311928|FG000|Overall Study|Lost to Follow-up|33|||
160979202|NCT01702428|581311929|FG001|Overall Study|Lost to Follow-up|41|||
160979203|NCT01702428|581311930|FG002|Overall Study|Lost to Follow-up|37|||
160979204|NCT01702428|581311931|FG003|Overall Study|Lost to Follow-up|44|||
160979205|NCT01702428|581311928|FG000|Overall Study|Parents cannot assist to site|1|||
160979206|NCT01702428|581311929|FG001|Overall Study|Parents cannot assist to site|0|||
160979207|NCT01702428|581311930|FG002|Overall Study|Parents cannot assist to site|1|||
160979208|NCT01702428|581311931|FG003|Overall Study|Parents cannot assist to site|0|||
160979209|NCT01702428|581311928|FG000|Overall Study|Lost Coverage|0|||
160979210|NCT01702428|581311929|FG001|Overall Study|Lost Coverage|0|||
160979211|NCT01702428|581311930|FG002|Overall Study|Lost Coverage|0|||
160979212|NCT01702428|581311931|FG003|Overall Study|Lost Coverage|1|||
160979213|NCT01702428|581311928|FG000|Overall Study|Lost Health Plan|3|||
160979214|NCT01702428|581311929|FG001|Overall Study|Lost Health Plan|5|||
160979215|NCT01702428|581311930|FG002|Overall Study|Lost Health Plan|0|||
160979216|NCT01702428|581311931|FG003|Overall Study|Lost Health Plan|2|||
160979217|NCT01702428|581311928|FG000|Overall Study|Mother transferred care|0|||
160979218|NCT01702428|581311929|FG001|Overall Study|Mother transferred care|1|||
160979219|NCT01702428|581311930|FG002|Overall Study|Mother transferred care|0|||
160979220|NCT01702428|581311931|FG003|Overall Study|Mother transferred care|0|||
160979221|NCT01702428|581311928|FG000|Overall Study|Parents too busy|1|||
160979222|NCT01702428|581311929|FG001|Overall Study|Parents too busy|0|||
160979223|NCT01702428|581311930|FG002|Overall Study|Parents too busy|0|||
160979224|NCT01702428|581311931|FG003|Overall Study|Parents too busy|0|||
160979225|NCT01702428|581311928|FG000|Overall Study|Protocol Violation|3|||
160979226|NCT01702428|581311929|FG001|Overall Study|Protocol Violation|0|||
160979227|NCT01702428|581311930|FG002|Overall Study|Protocol Violation|1|||
160979228|NCT01702428|581311931|FG003|Overall Study|Protocol Violation|0|||
160979229|NCT01702428|581311928|FG000|Overall Study|Withdrawal by Subject|21|||
160979230|NCT01702428|581311929|FG001|Overall Study|Withdrawal by Subject|23|||
160979231|NCT01702428|581311930|FG002|Overall Study|Withdrawal by Subject|14|||
160979232|NCT01702428|581311931|FG003|Overall Study|Withdrawal by Subject|10|||
160979233|NCT02091869|581311932|FG000|Overall Study|Withdrawal by Subject|0|||
160979234|NCT02091869|581311933|FG001|Overall Study|Withdrawal by Subject|3|||
160979235|NCT03685708|581311937|FG000|Overall Study|Withdrawal by Subject|0|||
160979236|NCT03685708|581311938|FG001|Overall Study|Withdrawal by Subject|0|||
160979237|NCT03685708|581311939|FG002|Overall Study|Withdrawal by Subject|1|||
160979238|NCT03685708|581311937|FG000|Overall Study|Screen Fail|0|||
160979239|NCT03685708|581311938|FG001|Overall Study|Screen Fail|1|||
160979240|NCT03685708|581311939|FG002|Overall Study|Screen Fail|1|||
160979241|NCT03685708|581311937|FG000|Overall Study|COVID 19 Pandemic|1|||
160979242|NCT03685708|581311938|FG001|Overall Study|COVID 19 Pandemic|1|||
160979243|NCT03685708|581311939|FG002|Overall Study|COVID 19 Pandemic|6|||
160979244|NCT03685708|581311937|FG000|Overall Study|Disease Progression|0|||
160979245|NCT03685708|581311938|FG001|Overall Study|Disease Progression|0|||
160979246|NCT03685708|581311939|FG002|Overall Study|Disease Progression|1|||
160979247|NCT02771210|581311941|FG000|Period 1|Adverse Event|5|||
160979248|NCT02771210|581311942|FG001|Period 1|Adverse Event|3|||
160979249|NCT02771210|581311941|FG000|Period 1|Lack of Efficacy|3|||
160979250|NCT02771210|581311942|FG001|Period 1|Lack of Efficacy|6|||
160979251|NCT02771210|581311941|FG000|Period 1|Lost to Follow-up|2|||
160979252|NCT02771210|581311942|FG001|Period 1|Lost to Follow-up|0|||
160979253|NCT02771210|581311941|FG000|Period 1|Physician Decision|0|||
160979254|NCT02771210|581311942|FG001|Period 1|Physician Decision|1|||
160979255|NCT02771210|581311941|FG000|Period 1|Withdrawal by Subject|0|||
160979256|NCT02771210|581311942|FG001|Period 1|Withdrawal by Subject|3|||
160979257|NCT02771210|581311941|FG000|Period 1|Withdrawal of informed consent|1|||
160979258|NCT02771210|581311942|FG001|Period 1|Withdrawal of informed consent|5|||
160979259|NCT02771210|581311941|FG000|Period 2|Adverse Event|1|||
160979260|NCT02771210|581311942|FG001|Period 2|Adverse Event|0|||
160979261|NCT02771210|581311941|FG000|Period 2|Lack of Efficacy|0|||
160979262|NCT02771210|581311942|FG001|Period 2|Lack of Efficacy|1|||
160979263|NCT02771210|581311941|FG000|Period 2|Withdrawal by Subject|1|||
160979264|NCT02771210|581311942|FG001|Period 2|Withdrawal by Subject|0|||
160979265|NCT02771210|581311941|FG000|Period 2|Withdrawal of informed consent|0|||
160979266|NCT02771210|581311942|FG001|Period 2|Withdrawal of informed consent|2|||
160979267|NCT04397523|581311943|FG000|Overall Study|Lost to Follow-up|3|||
160979268|NCT04397523|581311943|FG000|Overall Study|Transfer from/to other hospital|8|||
160979269|NCT01275196|581311944|FG000|Overall Study|Adverse Event|3|||
160979270|NCT01275196|581311945|FG001|Overall Study|Adverse Event|5|||
160979271|NCT01275196|581311944|FG000|Overall Study|Withdrawal by Subject|4|||
160979272|NCT01275196|581311945|FG001|Overall Study|Withdrawal by Subject|5|||
160979273|NCT01275196|581311944|FG000|Overall Study|Lost to Follow-up|1|||
160979274|NCT01275196|581311945|FG001|Overall Study|Lost to Follow-up|0|||
160979275|NCT01275196|581311944|FG000|Overall Study|Disease Progression|6|||
160979276|NCT01275196|581311945|FG001|Overall Study|Disease Progression|5|||
160979277|NCT01275196|581311944|FG000|Overall Study|Protocol Violation|1|||
160979278|NCT01275196|581311945|FG001|Overall Study|Protocol Violation|0|||
160979279|NCT01275196|581311944|FG000|Overall Study|Suboptimal response/treatment failure|5|||
160979280|NCT01275196|581311945|FG001|Overall Study|Suboptimal response/treatment failure|6|||
160979281|NCT02222896|581311948|FG000|Abdomen|Did not qualify|34|||
160979282|NCT02222896|581311949|FG001|Abdomen|Did not qualify|10|||
160979283|NCT02222896|581311950|FG002|Abdomen|Did not qualify|32|||
160979284|NCT02222896|581311948|FG000|Groin|Did not qualify|43|||
160979285|NCT02222896|581311949|FG001|Groin|Did not qualify|9|||
160979286|NCT02222896|581311950|FG002|Groin|Did not qualify|40|||
160979287|NCT01744496|581311951|FG000|Titration Period|Adverse Event|2|||
160979288|NCT01744496|581311952|FG001|Titration Period|Adverse Event|1|||
160979289|NCT01744496|581311951|FG000|Titration Period|Personal reasons|0|||
160979290|NCT01744496|581311952|FG001|Titration Period|Personal reasons|1|||
160979291|NCT01744496|581311951|FG000|Maintenance Period|Adverse Event|1|||
160979292|NCT01744496|581311952|FG001|Maintenance Period|Adverse Event|3|||
160979293|NCT01744496|581311951|FG000|Maintenance Period|Protocol Violation|1|||
160979294|NCT01744496|581311952|FG001|Maintenance Period|Protocol Violation|0|||
160979295|NCT01744496|581311951|FG000|Maintenance Period|Withdrawal by Subject|1|||
160979296|NCT01744496|581311952|FG001|Maintenance Period|Withdrawal by Subject|1|||
160979297|NCT01744496|581311951|FG000|Maintenance Period|Subject left town|1|||
160979298|NCT01744496|581311952|FG001|Maintenance Period|Subject left town|0|||
160979299|NCT01865617|581311956|FG000|Overall Study|Death|27|||
160979300|NCT01865617|581311957|FG001|Overall Study|Death|3|||
160979301|NCT01865617|581311958|FG002|Overall Study|Death|1|||
160979302|NCT01865617|581311959|FG003|Overall Study|Death|1|||
160979303|NCT01865617|581311960|FG004|Overall Study|Death|5|||
160979304|NCT01865617|581311961|FG005|Overall Study|Death|1|||
160979305|NCT01865617|581311962|FG006|Overall Study|Death|11|||
160979306|NCT01865617|581311963|FG007|Overall Study|Death|1|||
160979307|NCT01865617|581311964|FG008|Overall Study|Death|11|||
160979308|NCT01865617|581311965|FG009|Overall Study|Death|3|||
160979309|NCT01865617|581311966|FG010|Overall Study|Death|32|||
160979310|NCT01865617|581311967|FG011|Overall Study|Death|6|||
160979311|NCT01865617|581311968|FG012|Overall Study|Death|13|||
160979312|NCT01865617|581311956|FG000|Overall Study|Lost to Follow-up|2|||
160979313|NCT01865617|581311957|FG001|Overall Study|Lost to Follow-up|0|||
160979314|NCT01865617|581311958|FG002|Overall Study|Lost to Follow-up|0|||
160979315|NCT01865617|581311959|FG003|Overall Study|Lost to Follow-up|0|||
160979316|NCT01865617|581311960|FG004|Overall Study|Lost to Follow-up|0|||
160979317|NCT01865617|581311961|FG005|Overall Study|Lost to Follow-up|0|||
160979318|NCT01865617|581311962|FG006|Overall Study|Lost to Follow-up|0|||
160979319|NCT01865617|581311963|FG007|Overall Study|Lost to Follow-up|0|||
160979320|NCT01865617|581311964|FG008|Overall Study|Lost to Follow-up|0|||
160979321|NCT01865617|581311965|FG009|Overall Study|Lost to Follow-up|0|||
160979322|NCT01865617|581311966|FG010|Overall Study|Lost to Follow-up|0|||
160979323|NCT01865617|581311967|FG011|Overall Study|Lost to Follow-up|0|||
160979324|NCT01865617|581311968|FG012|Overall Study|Lost to Follow-up|0|||
160979325|NCT01865617|581311956|FG000|Overall Study|Withdrawal by Subject|1|||
160979326|NCT01865617|581311957|FG001|Overall Study|Withdrawal by Subject|0|||
160979327|NCT01865617|581311958|FG002|Overall Study|Withdrawal by Subject|0|||
160979328|NCT01865617|581311959|FG003|Overall Study|Withdrawal by Subject|0|||
160979329|NCT01865617|581311960|FG004|Overall Study|Withdrawal by Subject|0|||
160979330|NCT01865617|581311961|FG005|Overall Study|Withdrawal by Subject|0|||
160979331|NCT01865617|581311962|FG006|Overall Study|Withdrawal by Subject|0|||
160979332|NCT01865617|581311963|FG007|Overall Study|Withdrawal by Subject|0|||
160979333|NCT01865617|581311964|FG008|Overall Study|Withdrawal by Subject|0|||
160979334|NCT01865617|581311965|FG009|Overall Study|Withdrawal by Subject|0|||
160979335|NCT01865617|581311966|FG010|Overall Study|Withdrawal by Subject|0|||
160979336|NCT01865617|581311967|FG011|Overall Study|Withdrawal by Subject|0|||
160979337|NCT01865617|581311968|FG012|Overall Study|Withdrawal by Subject|0|||
160979338|NCT01865617|581311956|FG000|Overall Study|Patient proceeded to new therapy|0|||
160979339|NCT01865617|581311957|FG001|Overall Study|Patient proceeded to new therapy|0|||
160979340|NCT01865617|581311958|FG002|Overall Study|Patient proceeded to new therapy|0|||
160979341|NCT01865617|581311959|FG003|Overall Study|Patient proceeded to new therapy|0|||
160979342|NCT01865617|581311960|FG004|Overall Study|Patient proceeded to new therapy|2|||
160979343|NCT01865617|581311961|FG005|Overall Study|Patient proceeded to new therapy|0|||
160979344|NCT01865617|581311962|FG006|Overall Study|Patient proceeded to new therapy|0|||
160979345|NCT01865617|581311963|FG007|Overall Study|Patient proceeded to new therapy|0|||
160979346|NCT01865617|581311964|FG008|Overall Study|Patient proceeded to new therapy|0|||
160979347|NCT01865617|581311965|FG009|Overall Study|Patient proceeded to new therapy|0|||
160979348|NCT01865617|581311966|FG010|Overall Study|Patient proceeded to new therapy|0|||
160979349|NCT01865617|581311967|FG011|Overall Study|Patient proceeded to new therapy|0|||
160979350|NCT01865617|581311968|FG012|Overall Study|Patient proceeded to new therapy|0|||
160979351|NCT01865617|581311956|FG000|Overall Study|Other|0|||
160979352|NCT01865617|581311957|FG001|Overall Study|Other|0|||
160979353|NCT01865617|581311958|FG002|Overall Study|Other|0|||
160979354|NCT01865617|581311959|FG003|Overall Study|Other|0|||
160979355|NCT01865617|581311960|FG004|Overall Study|Other|0|||
160979356|NCT01865617|581311961|FG005|Overall Study|Other|0|||
160979357|NCT01865617|581311962|FG006|Overall Study|Other|1|||
160979358|NCT01865617|581311963|FG007|Overall Study|Other|0|||
160979359|NCT01865617|581311964|FG008|Overall Study|Other|0|||
160979360|NCT01865617|581311965|FG009|Overall Study|Other|0|||
160979361|NCT01865617|581311966|FG010|Overall Study|Other|0|||
160979362|NCT01865617|581311967|FG011|Overall Study|Other|0|||
160979363|NCT01865617|581311968|FG012|Overall Study|Other|0|||
160979364|NCT02500979|581311969|FG000|Period 1|Hyperglycemia|1|||
160979365|NCT02500979|581311970|FG001|Period 1|Hyperglycemia|0|||
160979366|NCT02500979|581311969|FG000|Period 1|Severe non-compliance to protocol|0|||
160979367|NCT02500979|581311970|FG001|Period 1|Severe non-compliance to protocol|1|||
160979368|NCT02500979|581311969|FG000|Period 1|Adverse Event|1|||
160979369|NCT02500979|581311970|FG001|Period 1|Adverse Event|0|||
160979370|NCT02500979|581311969|FG000|Period 1|Subject decision|2|||
160979371|NCT02500979|581311970|FG001|Period 1|Subject decision|0|||
160979372|NCT02500979|581311969|FG000|Period 2|Change in risk|1|||
160979373|NCT02500979|581311970|FG001|Period 2|Change in risk|0|||
160979374|NCT02796963|581311971|FG000|Overall Study|Lost to Follow-up|89|||
160979375|NCT02796963|581311972|FG001|Overall Study|Lost to Follow-up|76|||
160979376|NCT02796963|581311973|FG002|Overall Study|Lost to Follow-up|69|||
160979377|NCT02796963|581311974|FG003|Overall Study|Lost to Follow-up|72|||
160979378|NCT03192215|581311975|FG000|Overall Study|Death|28|||
160979379|NCT03192215|581311976|FG001|Overall Study|Death|23|||
160979380|NCT03192215|581311975|FG000|Overall Study|Lost to Follow-up|10|||
160979381|NCT03192215|581311976|FG001|Overall Study|Lost to Follow-up|15|||
160979382|NCT03192215|581311975|FG000|Overall Study|Withdrawal by Subject|49|||
160979383|NCT03192215|581311976|FG001|Overall Study|Withdrawal by Subject|48|||
160979384|NCT03192215|581311975|FG000|Overall Study|Other as reported in analysis|4|||
160979385|NCT03192215|581311976|FG001|Overall Study|Other as reported in analysis|1|||
160865616|NCT02606643|580902908|FG001|Overall Study|did not meet inclusion criteria|3|||
160865617|NCT02158546|580902916|FG000|Overall Study|Physician Decision|0|||
160865618|NCT02158546|580902917|FG001|Overall Study|Physician Decision|1|||
160865619|NCT02158546|580902918|FG002|Overall Study|Physician Decision|0|||
160865620|NCT02158546|580902919|FG003|Overall Study|Physician Decision|0|||
160865621|NCT02158546|580902916|FG000|Overall Study|Non-compliance|0|||
160865622|NCT02158546|580902917|FG001|Overall Study|Non-compliance|1|||
160865623|NCT02158546|580902918|FG002|Overall Study|Non-compliance|0|||
160865624|NCT02158546|580902919|FG003|Overall Study|Non-compliance|1|||
160865625|NCT02158546|580902916|FG000|Overall Study|Failure to meet eligibility criteria|0|||
160865626|NCT02158546|580902917|FG001|Overall Study|Failure to meet eligibility criteria|1|||
160865627|NCT02158546|580902918|FG002|Overall Study|Failure to meet eligibility criteria|0|||
160865628|NCT02158546|580902919|FG003|Overall Study|Failure to meet eligibility criteria|0|||
160865629|NCT02158546|580902916|FG000|Overall Study|Lack of Efficacy|1|||
160865630|NCT02158546|580902917|FG001|Overall Study|Lack of Efficacy|1|||
160865631|NCT02158546|580902918|FG002|Overall Study|Lack of Efficacy|0|||
160865632|NCT02158546|580902919|FG003|Overall Study|Lack of Efficacy|0|||
160865633|NCT02158546|580902916|FG000|Overall Study|Adverse Event|2|||
160865634|NCT02158546|580902917|FG001|Overall Study|Adverse Event|2|||
160865635|NCT02158546|580902918|FG002|Overall Study|Adverse Event|0|||
160865636|NCT02158546|580902919|FG003|Overall Study|Adverse Event|0|||
160865637|NCT02158546|580902916|FG000|Overall Study|Withdrawal by Subject|6|||
160865638|NCT02158546|580902917|FG001|Overall Study|Withdrawal by Subject|2|||
160865639|NCT02158546|580902918|FG002|Overall Study|Withdrawal by Subject|1|||
160865640|NCT02158546|580902919|FG003|Overall Study|Withdrawal by Subject|0|||
160865641|NCT02158546|580902916|FG000|Overall Study|Lost to Follow-up|5|||
160865642|NCT02158546|580902917|FG001|Overall Study|Lost to Follow-up|4|||
160865643|NCT02158546|580902918|FG002|Overall Study|Lost to Follow-up|0|||
160865644|NCT02158546|580902919|FG003|Overall Study|Lost to Follow-up|1|||
160865645|NCT02158546|580902916|FG000|Overall Study|Site Excluded|5|||
160865646|NCT02158546|580902917|FG001|Overall Study|Site Excluded|5|||
160865647|NCT02158546|580902918|FG002|Overall Study|Site Excluded|3|||
160865648|NCT02158546|580902919|FG003|Overall Study|Site Excluded|4|||
160865649|NCT00891904|580902924|FG000|Overall Study|Death|1|||
160865650|NCT00891904|580902924|FG000|Overall Study|Adverse Event|1|||
160865651|NCT01046396|580902925|FG000|Overall Study|Withdrawal by Subject|5|||
160865652|NCT01605799|580902936|FG000|Overall Study|Withdrawal by Subject|2|||
160865653|NCT01605799|580902937|FG001|Overall Study|Withdrawal by Subject|1|||
160865654|NCT01055197|580902942|FG000|Overall Study|Protocol Violation|7|||
160865655|NCT01055197|580902943|FG001|Overall Study|Protocol Violation|2|||
160979386|NCT00119262|581311977|FG000|Overall Study|Lack of Efficacy|0|||
161209300|NCT01440595|582149069|FG001|Overall Study|Study terminated by sponsor.|2|||
160979387|NCT00119262|581311978|FG001|Overall Study|Lack of Efficacy|3|||
160979388|NCT00119262|581311977|FG000|Overall Study|Withdrawal by Subject|12|||
160979389|NCT00119262|581311978|FG001|Overall Study|Withdrawal by Subject|11|||
161209301|NCT01440595|582149070|FG002|Overall Study|Study terminated by sponsor.|1|||
160979390|NCT00119262|581311977|FG000|Overall Study|Adverse Event|33|||
160979391|NCT00119262|581311978|FG001|Overall Study|Adverse Event|35|||
160979392|NCT00119262|581311977|FG000|Overall Study|other disease|0|||
160979393|NCT00119262|581311978|FG001|Overall Study|other disease|2|||
160979394|NCT00119262|581311977|FG000|Overall Study|ineligble|1|||
160979395|NCT00119262|581311978|FG001|Overall Study|ineligble|2|||
160979396|NCT00119262|581311977|FG000|Overall Study|others|0|||
160979397|NCT00119262|581311978|FG001|Overall Study|others|5|||
160979398|NCT03853317|581311979|FG000|Overall Study|Progressive Disease|5|||
160979399|NCT03853317|581311979|FG000|Overall Study|Adverse Event|1|||
160979400|NCT03853317|581311979|FG000|Overall Study|Death|1|||
160979401|NCT03853317|581311979|FG000|Overall Study|other event|2|||
160979402|NCT01551303|581311988|FG000|Overall Study|failed awareness check on vision test|4|||
160979403|NCT01551303|581311989|FG001|Overall Study|failed awareness check on vision test|7|||
160979404|NCT01927731|581311995|FG000|Overall Study|Graft Failure|1|||
160979405|NCT01927731|581311996|FG001|Overall Study|Graft Failure|2|||
160979406|NCT01927731|581311995|FG000|Overall Study|Physician Decision|2|||
160979407|NCT01927731|581311996|FG001|Overall Study|Physician Decision|3|||
160979408|NCT01927731|581311995|FG000|Overall Study|Withdrawal by Subject|0|||
160979409|NCT01927731|581311996|FG001|Overall Study|Withdrawal by Subject|2|||
160979410|NCT01927731|581311995|FG000|Overall Study|Death|0|||
160979411|NCT01927731|581311996|FG001|Overall Study|Death|3|||
160979412|NCT02589392|581312001|FG000|Overall Study|Adverse Event|1|||
160979413|NCT02589392|581312002|FG001|Overall Study|Adverse Event|1|||
160979414|NCT02589392|581312001|FG000|Overall Study|Withdrawal by Subject|1|||
160979415|NCT02589392|581312002|FG001|Overall Study|Withdrawal by Subject|2|||
160979416|NCT02589392|581312001|FG000|Overall Study|Protocol Violation|1|||
160979417|NCT02589392|581312002|FG001|Overall Study|Protocol Violation|1|||
160979418|NCT02589392|581312001|FG000|Overall Study|Lost to Follow-up|2|||
160979419|NCT02589392|581312002|FG001|Overall Study|Lost to Follow-up|2|||
160979420|NCT02589392|581312001|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
160979421|NCT02589392|581312002|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
160979422|NCT00322374|581312004|FG000|Starting Dose|Physician Decision|2|||
160979423|NCT00322374|581312005|FG001|Starting Dose|Physician Decision|0|||
160979424|NCT00322374|581312006|FG002|Starting Dose|Physician Decision|0|||
160979425|NCT00322374|581312007|FG003|Starting Dose|Physician Decision|0|||
160979426|NCT00322374|581312004|FG000|Starting Dose|Study Drug Toxicity|4|||
160979427|NCT00322374|581312005|FG001|Starting Dose|Study Drug Toxicity|0|||
160979428|NCT00322374|581312006|FG002|Starting Dose|Study Drug Toxicity|0|||
160979429|NCT00322374|581312007|FG003|Starting Dose|Study Drug Toxicity|0|||
160979430|NCT00322374|581312004|FG000|First Escalation|Documented Disease Progression|0|||
160979431|NCT00322374|581312005|FG001|First Escalation|Documented Disease Progression|6|||
160979432|NCT00322374|581312006|FG002|First Escalation|Documented Disease Progression|0|||
160979433|NCT00322374|581312007|FG003|First Escalation|Documented Disease Progression|0|||
160979434|NCT00322374|581312004|FG000|First Escalation|Physician Decision|0|||
160979435|NCT00322374|581312005|FG001|First Escalation|Physician Decision|12|||
160979436|NCT00322374|581312006|FG002|First Escalation|Physician Decision|0|||
160979437|NCT00322374|581312007|FG003|First Escalation|Physician Decision|0|||
160979438|NCT00322374|581312004|FG000|First Escalation|Study Drug Toxicity|0|||
160979439|NCT00322374|581312005|FG001|First Escalation|Study Drug Toxicity|11|||
160979440|NCT00322374|581312006|FG002|First Escalation|Study Drug Toxicity|0|||
160979441|NCT00322374|581312007|FG003|First Escalation|Study Drug Toxicity|0|||
160979442|NCT00322374|581312004|FG000|First Escalation|Participant Request|0|||
160979443|NCT00322374|581312005|FG001|First Escalation|Participant Request|1|||
160979444|NCT00322374|581312006|FG002|First Escalation|Participant Request|0|||
160979445|NCT00322374|581312007|FG003|First Escalation|Participant Request|0|||
160979446|NCT00322374|581312004|FG000|Second Escalation|Physician Decision|0|||
160979447|NCT00322374|581312005|FG001|Second Escalation|Physician Decision|0|||
160979448|NCT00322374|581312006|FG002|Second Escalation|Physician Decision|5|||
160979449|NCT00322374|581312007|FG003|Second Escalation|Physician Decision|0|||
160979450|NCT00322374|581312004|FG000|Second Escalation|Study Drug Toxicity|0|||
160979451|NCT00322374|581312005|FG001|Second Escalation|Study Drug Toxicity|0|||
160979452|NCT00322374|581312006|FG002|Second Escalation|Study Drug Toxicity|1|||
160979453|NCT00322374|581312007|FG003|Second Escalation|Study Drug Toxicity|0|||
160979454|NCT03382600|581312008|FG000|Overall Study|Adverse Event|3|||
160979455|NCT03382600|581312009|FG001|Overall Study|Adverse Event|3|||
160979456|NCT03382600|581312008|FG000|Overall Study|Clinical Disease Progression|2|||
160979457|NCT03382600|581312009|FG001|Overall Study|Clinical Disease Progression|4|||
160979458|NCT03382600|581312008|FG000|Overall Study|Radiological Progression|40|||
160979459|NCT03382600|581312009|FG001|Overall Study|Radiological Progression|31|||
160979460|NCT03382600|581312008|FG000|Overall Study|Withdrawal by Subject|0|||
160979461|NCT03382600|581312009|FG001|Overall Study|Withdrawal by Subject|1|||
160979462|NCT03382600|581312008|FG000|Overall Study|Other|9|||
160979463|NCT03382600|581312009|FG001|Overall Study|Other|7|||
160979464|NCT02269943|581312010|FG000|Treatment Period|Death|0|||
160979465|NCT02269943|581312011|FG001|Treatment Period|Death|1|||
160979466|NCT02269943|581312010|FG000|Treatment Period|Adverse Event|1|||
160979467|NCT02269943|581312011|FG001|Treatment Period|Adverse Event|10|||
160979468|NCT02269943|581312010|FG000|Treatment Period|Progressive Disease|5|||
160979469|NCT02269943|581312011|FG001|Treatment Period|Progressive Disease|17|||
160979470|NCT02269943|581312010|FG000|Treatment Period|Symptomatic Deterioration|0|||
160979471|NCT02269943|581312011|FG001|Treatment Period|Symptomatic Deterioration|2|||
160979472|NCT02269943|581312010|FG000|Follow-Up Survival Period|Death|3|||
160979473|NCT02269943|581312011|FG001|Follow-Up Survival Period|Death|16|||
160979474|NCT02269943|581312010|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
160979475|NCT02269943|581312011|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
160979476|NCT02269943|581312010|FG000|Follow-Up Survival Period|Alive|2|||
160979477|NCT02269943|581312011|FG001|Follow-Up Survival Period|Alive|8|||
160979478|NCT02733042|581312012|FG000|Overall Study|Adverse Event|1|||
160979479|NCT02733042|581312013|FG001|Overall Study|Adverse Event|0|||
160979480|NCT02733042|581312014|FG002|Overall Study|Adverse Event|1|||
160979481|NCT02733042|581312015|FG003|Overall Study|Adverse Event|1|||
160979482|NCT02733042|581312016|FG004|Overall Study|Adverse Event|0|||
160979483|NCT02733042|581312017|FG005|Overall Study|Adverse Event|0|||
160979484|NCT02733042|581312018|FG006|Overall Study|Adverse Event|0|||
160979485|NCT02733042|581312019|FG007|Overall Study|Adverse Event|0|||
160979486|NCT02733042|581312020|FG008|Overall Study|Adverse Event|0|||
160979487|NCT02733042|581312021|FG009|Overall Study|Adverse Event|0|||
160979488|NCT02733042|581312022|FG010|Overall Study|Adverse Event|2|||
160979489|NCT02733042|581312023|FG011|Overall Study|Adverse Event|2|||
160979490|NCT02733042|581312024|FG012|Overall Study|Adverse Event|0|||
160979491|NCT02733042|581312025|FG013|Overall Study|Adverse Event|2|||
160979492|NCT02733042|581312026|FG014|Overall Study|Adverse Event|0|||
160979493|NCT02733042|581312027|FG015|Overall Study|Adverse Event|0|||
160979494|NCT02733042|581312028|FG016|Overall Study|Adverse Event|0|||
160979495|NCT02733042|581312029|FG017|Overall Study|Adverse Event|1|||
160979496|NCT02733042|581312030|FG018|Overall Study|Adverse Event|0|||
160979497|NCT02733042|581312012|FG000|Overall Study|Progressive Disease|2|||
160979498|NCT02733042|581312013|FG001|Overall Study|Progressive Disease|1|||
160979499|NCT02733042|581312014|FG002|Overall Study|Progressive Disease|3|||
160979500|NCT02733042|581312015|FG003|Overall Study|Progressive Disease|1|||
160979501|NCT02733042|581312016|FG004|Overall Study|Progressive Disease|2|||
160979502|NCT02733042|581312017|FG005|Overall Study|Progressive Disease|3|||
160979503|NCT02733042|581312018|FG006|Overall Study|Progressive Disease|0|||
160979504|NCT02733042|581312019|FG007|Overall Study|Progressive Disease|3|||
160979505|NCT02733042|581312020|FG008|Overall Study|Progressive Disease|3|||
160979506|NCT02733042|581312021|FG009|Overall Study|Progressive Disease|2|||
160979507|NCT02733042|581312022|FG010|Overall Study|Progressive Disease|2|||
160979508|NCT02733042|581312023|FG011|Overall Study|Progressive Disease|2|||
160979509|NCT02733042|581312024|FG012|Overall Study|Progressive Disease|8|||
160979510|NCT02733042|581312025|FG013|Overall Study|Progressive Disease|1|||
160979511|NCT02733042|581312026|FG014|Overall Study|Progressive Disease|4|||
160979512|NCT02733042|581312027|FG015|Overall Study|Progressive Disease|7|||
160979513|NCT02733042|581312028|FG016|Overall Study|Progressive Disease|2|||
160979514|NCT02733042|581312029|FG017|Overall Study|Progressive Disease|3|||
160979515|NCT02733042|581312030|FG018|Overall Study|Progressive Disease|4|||
160979516|NCT02733042|581312012|FG000|Overall Study|Withdrawal by Subject|0|||
160979517|NCT02733042|581312013|FG001|Overall Study|Withdrawal by Subject|1|||
160979518|NCT02733042|581312014|FG002|Overall Study|Withdrawal by Subject|2|||
160979519|NCT02733042|581312015|FG003|Overall Study|Withdrawal by Subject|1|||
160979520|NCT02733042|581312016|FG004|Overall Study|Withdrawal by Subject|1|||
160979521|NCT02733042|581312017|FG005|Overall Study|Withdrawal by Subject|0|||
160979522|NCT02733042|581312018|FG006|Overall Study|Withdrawal by Subject|0|||
160979523|NCT02733042|581312019|FG007|Overall Study|Withdrawal by Subject|0|||
160979524|NCT02733042|581312020|FG008|Overall Study|Withdrawal by Subject|1|||
160979525|NCT02733042|581312021|FG009|Overall Study|Withdrawal by Subject|1|||
160979526|NCT02733042|581312022|FG010|Overall Study|Withdrawal by Subject|0|||
160979527|NCT02733042|581312023|FG011|Overall Study|Withdrawal by Subject|2|||
160979528|NCT02733042|581312024|FG012|Overall Study|Withdrawal by Subject|1|||
160979529|NCT02733042|581312025|FG013|Overall Study|Withdrawal by Subject|1|||
160979530|NCT02733042|581312026|FG014|Overall Study|Withdrawal by Subject|0|||
160979531|NCT02733042|581312027|FG015|Overall Study|Withdrawal by Subject|0|||
160979532|NCT02733042|581312028|FG016|Overall Study|Withdrawal by Subject|0|||
160979533|NCT02733042|581312029|FG017|Overall Study|Withdrawal by Subject|0|||
160979534|NCT02733042|581312030|FG018|Overall Study|Withdrawal by Subject|0|||
160979535|NCT02733042|581312012|FG000|Overall Study|Other Reasons|0|||
160979536|NCT02733042|581312013|FG001|Overall Study|Other Reasons|0|||
160979537|NCT02733042|581312014|FG002|Overall Study|Other Reasons|1|||
160979538|NCT02733042|581312015|FG003|Overall Study|Other Reasons|0|||
160979539|NCT02733042|581312016|FG004|Overall Study|Other Reasons|0|||
160979540|NCT02733042|581312017|FG005|Overall Study|Other Reasons|0|||
160979541|NCT02733042|581312018|FG006|Overall Study|Other Reasons|0|||
160979542|NCT02733042|581312019|FG007|Overall Study|Other Reasons|0|||
160979543|NCT02733042|581312020|FG008|Overall Study|Other Reasons|0|||
160979544|NCT02733042|581312021|FG009|Overall Study|Other Reasons|1|||
160979545|NCT02733042|581312022|FG010|Overall Study|Other Reasons|1|||
160979546|NCT02733042|581312023|FG011|Overall Study|Other Reasons|0|||
160979547|NCT02733042|581312024|FG012|Overall Study|Other Reasons|0|||
160979548|NCT02733042|581312025|FG013|Overall Study|Other Reasons|0|||
161209302|NCT01347879|582149071|FG000|Overall Study|Adverse Event|0|||
160979549|NCT02733042|581312026|FG014|Overall Study|Other Reasons|0|||
160979550|NCT02733042|581312027|FG015|Overall Study|Other Reasons|1|||
160979551|NCT02733042|581312028|FG016|Overall Study|Other Reasons|0|||
160979552|NCT02733042|581312029|FG017|Overall Study|Other Reasons|1|||
160979553|NCT02733042|581312030|FG018|Overall Study|Other Reasons|0|||
160979554|NCT02733042|581312012|FG000|Overall Study|Death|0|||
160979555|NCT02733042|581312013|FG001|Overall Study|Death|0|||
160979556|NCT02733042|581312014|FG002|Overall Study|Death|0|||
160979557|NCT02733042|581312015|FG003|Overall Study|Death|0|||
160979558|NCT02733042|581312016|FG004|Overall Study|Death|0|||
160979559|NCT02733042|581312017|FG005|Overall Study|Death|0|||
160979560|NCT02733042|581312018|FG006|Overall Study|Death|1|||
160979561|NCT02733042|581312019|FG007|Overall Study|Death|0|||
160979562|NCT02733042|581312020|FG008|Overall Study|Death|1|||
160979563|NCT02733042|581312021|FG009|Overall Study|Death|0|||
160979564|NCT02733042|581312022|FG010|Overall Study|Death|1|||
160979565|NCT02733042|581312023|FG011|Overall Study|Death|0|||
160979566|NCT02733042|581312024|FG012|Overall Study|Death|0|||
160979567|NCT02733042|581312025|FG013|Overall Study|Death|0|||
160979568|NCT02733042|581312026|FG014|Overall Study|Death|1|||
160979569|NCT02733042|581312027|FG015|Overall Study|Death|2|||
160979570|NCT02733042|581312028|FG016|Overall Study|Death|0|||
160979571|NCT02733042|581312029|FG017|Overall Study|Death|0|||
160979572|NCT02733042|581312030|FG018|Overall Study|Death|0|||
160979573|NCT02066532|581312035|FG000|Phase II|Withdrawal by Subject|1|||
160979574|NCT02066532|581312036|FG001|Phase II|Withdrawal by Subject|0|||
160979575|NCT02066532|581312037|FG002|Phase II|Withdrawal by Subject|0|||
160979576|NCT02066532|581312038|FG003|Phase II|Withdrawal by Subject|0|||
160979577|NCT05033080|581312039|FG000|Overall Study|Adverse Event|4|||
160979578|NCT05033080|581312040|FG001|Overall Study|Adverse Event|4|||
160979579|NCT05033080|581312039|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
160979580|NCT05033080|581312040|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
160979581|NCT05033080|581312039|FG000|Overall Study|Lost to Follow-up|1|||
160979582|NCT05033080|581312040|FG001|Overall Study|Lost to Follow-up|0|||
160979583|NCT05033080|581312039|FG000|Overall Study|Other non-compliance|0|||
160979584|NCT05033080|581312040|FG001|Overall Study|Other non-compliance|1|||
160979585|NCT05033080|581312039|FG000|Overall Study|Physician Decision|0|||
160979586|NCT05033080|581312040|FG001|Overall Study|Physician Decision|1|||
160979587|NCT05033080|581312039|FG000|Overall Study|Other|1|||
160979588|NCT05033080|581312040|FG001|Overall Study|Other|1|||
160979589|NCT01233609|581312041|FG000|Overall Study|Death|1|||
160979590|NCT01233609|581312042|FG001|Overall Study|Death|0|||
160979591|NCT01233609|581312041|FG000|Overall Study|Lost to Follow-up|3|||
160979592|NCT01233609|581312042|FG001|Overall Study|Lost to Follow-up|1|||
160979593|NCT01233609|581312041|FG000|Overall Study|Adverse Event|2|||
160979594|NCT01233609|581312042|FG001|Overall Study|Adverse Event|1|||
160979595|NCT01233609|581312041|FG000|Overall Study|Withdrawal by Subject|3|||
160979596|NCT01233609|581312042|FG001|Overall Study|Withdrawal by Subject|0|||
160979597|NCT03391960|581312043|FG000|Overall Study|Protocol Violation|0|||
160979598|NCT03391960|581312044|FG001|Overall Study|Protocol Violation|0|||
160979599|NCT04076020|581313313|FG000|Overall Study|Death|4|||
160979600|NCT04076020|581313314|FG001|Overall Study|Death|6|||
160979601|NCT04076020|581313313|FG000|Overall Study|Withdrawal by Subject|12|||
160979602|NCT04076020|581313314|FG001|Overall Study|Withdrawal by Subject|8|||
160979603|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
160979604|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
160979605|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
160979606|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
160979607|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160979608|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
160979609|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160979610|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
160979611|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
160979612|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
160979613|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160979614|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
160979615|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
160979616|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
160979617|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160979618|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
160979619|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
160979620|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
160979621|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
160996826|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160979622|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
160979623|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
160979624|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
160979625|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
160979626|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
160979627|NCT03230864|581313316|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
160979628|NCT03230864|581313317|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
160979629|NCT03230864|581313318|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
160979630|NCT03230864|581313319|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
160979631|NCT03230864|581313316|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
160979632|NCT03230864|581313317|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
160979633|NCT03230864|581313318|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
160979634|NCT03230864|581313319|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
160979635|NCT03230864|581313316|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160979636|NCT03230864|581313317|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
160979637|NCT03230864|581313318|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
160979638|NCT03230864|581313319|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
160979639|NCT03230864|581313316|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
160979640|NCT03230864|581313317|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
160979641|NCT03230864|581313318|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
160979642|NCT03230864|581313319|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
160979643|NCT03537261|581313329|FG000|Overall Study|Lost to Follow-up|4|||
160979644|NCT03537261|581313330|FG001|Overall Study|Lost to Follow-up|5|||
160979645|NCT03537261|581313329|FG000|Overall Study|Withdrawal by Subject|4|||
160979646|NCT03537261|581313330|FG001|Overall Study|Withdrawal by Subject|6|||
160979647|NCT03537261|581313329|FG000|Overall Study|Did not return study questionnaires|0|||
160979648|NCT03537261|581313330|FG001|Overall Study|Did not return study questionnaires|1|||
160979649|NCT00502996|581313333|FG000|Overall Study|Lost to Follow-up|9|||
160979650|NCT00502996|581313333|FG000|Overall Study|Protocol Violation|2|||
160979651|NCT00502996|581313333|FG000|Overall Study|Treatment failure|25|||
160979652|NCT00502996|581313333|FG000|Overall Study|Withdrawal Informed Consent|6|||
160979653|NCT00502996|581313333|FG000|Overall Study|Adverse Event|2|||
160979654|NCT01729728|581313334|FG000|Overall Study|Adverse Event|0|||
160979655|NCT01729728|581313335|FG001|Overall Study|Adverse Event|6|||
160979656|NCT01729728|581313336|FG002|Overall Study|Adverse Event|0|||
160979657|NCT01729728|581313334|FG000|Overall Study|Protocol Violation|1|||
160979658|NCT01729728|581313335|FG001|Overall Study|Protocol Violation|0|||
160979659|NCT01729728|581313336|FG002|Overall Study|Protocol Violation|1|||
160979660|NCT01316692|581313337|FG000|Overall Study|Adverse Event|5|||
160979661|NCT01316692|581313337|FG000|Overall Study|Disease Progression|7|||
160979662|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
160979663|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
160979664|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
160979665|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
160979666|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
160979667|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
160979668|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
160979669|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
160979670|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
160979671|NCT02001974|581313350|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
160979672|NCT02001974|581313351|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
160979673|NCT02001974|581313352|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
160979674|NCT00993317|581313353|FG000|Overall Study|Adverse Event|2|||
160979675|NCT00993317|581313354|FG001|Overall Study|Adverse Event|4|||
160979676|NCT00993317|581313353|FG000|Overall Study|Lack of Efficacy|18|||
160979677|NCT00993317|581313354|FG001|Overall Study|Lack of Efficacy|18|||
160979678|NCT00993317|581313353|FG000|Overall Study|Withdrawal by Subject|0|||
160979679|NCT00993317|581313354|FG001|Overall Study|Withdrawal by Subject|2|||
160979680|NCT00993317|581313353|FG000|Overall Study|Investigator's opinion|0|||
160979681|NCT00993317|581313354|FG001|Overall Study|Investigator's opinion|1|||
160979682|NCT00993317|581313353|FG000|Overall Study|Early study termination at the site|1|||
160979683|NCT00993317|581313354|FG001|Overall Study|Early study termination at the site|0|||
160979684|NCT01380990|581313355|FG000|Overall Study|Treatment Failure|1|||
160979685|NCT01380990|581313356|FG001|Overall Study|Treatment Failure|0|||
160979686|NCT01380990|581313355|FG000|Overall Study|Death|0|||
160979687|NCT01380990|581313356|FG001|Overall Study|Death|1|||
160979688|NCT00672958|581313357|FG000|Overall Study|Adverse Event|11|||
160979689|NCT00672958|581313358|FG001|Overall Study|Adverse Event|9|||
160979690|NCT00672958|581313357|FG000|Overall Study|Lack of Efficacy|6|||
160979691|NCT00672958|581313358|FG001|Overall Study|Lack of Efficacy|11|||
160979692|NCT00672958|581313357|FG000|Overall Study|Non-compliance with study drug|2|||
160979693|NCT00672958|581313358|FG001|Overall Study|Non-compliance with study drug|3|||
160979694|NCT00672958|581313357|FG000|Overall Study|Protocol deviations|11|||
160979695|NCT00672958|581313358|FG001|Overall Study|Protocol deviations|5|||
160979696|NCT00672958|581313357|FG000|Overall Study|Voluntary withdrawal|12|||
160979697|NCT00672958|581313358|FG001|Overall Study|Voluntary withdrawal|8|||
160979698|NCT00672958|581313357|FG000|Overall Study|Lost to Follow-up|22|||
160979699|NCT00672958|581313358|FG001|Overall Study|Lost to Follow-up|17|||
160979700|NCT00672958|581313357|FG000|Overall Study|Reason not specified|0|||
160979701|NCT00672958|581313358|FG001|Overall Study|Reason not specified|3|||
160979702|NCT04422639|581313359|FG000|Overall Study|Death|1|||
160979703|NCT04422639|581313360|FG001|Overall Study|Death|0|||
160979704|NCT04422639|581313359|FG000|Overall Study|study closed prior to completion of FU visits|0|||
160979705|NCT04422639|581313360|FG001|Overall Study|study closed prior to completion of FU visits|2|||
160979706|NCT01964521|581313361|FG000|Overall Study|Lost to Follow-up|4|||
160979707|NCT02374593|581313362|FG000|Overall Study|non-compliant|2|||
160979708|NCT02374593|581313363|FG001|Overall Study|non-compliant|0|||
160979709|NCT01463293|581313365|FG000|Overall Study|Lost to Follow-up|1|||
160979710|NCT01463293|581313366|FG001|Overall Study|Lost to Follow-up|4|||
160979711|NCT01463293|581313367|FG002|Overall Study|Lost to Follow-up|5|||
160979712|NCT01463293|581313365|FG000|Overall Study|Adverse Event|1|||
160979713|NCT01463293|581313366|FG001|Overall Study|Adverse Event|2|||
160979714|NCT01463293|581313367|FG002|Overall Study|Adverse Event|0|||
160979715|NCT01463293|581313365|FG000|Overall Study|Withdrawal by Subject|4|||
160979716|NCT01463293|581313366|FG001|Overall Study|Withdrawal by Subject|10|||
160979717|NCT01463293|581313367|FG002|Overall Study|Withdrawal by Subject|5|||
160979718|NCT01463293|581313365|FG000|Overall Study|Other|0|||
160979719|NCT01463293|581313366|FG001|Overall Study|Other|0|||
160979720|NCT01463293|581313367|FG002|Overall Study|Other|2|||
160979721|NCT01284140|581313368|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
160979722|NCT01284140|581313369|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
160979723|NCT01284140|581313368|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
160979724|NCT01284140|581313369|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
160979725|NCT05376371|581313375|FG000|Overall Study|change in release date|10|||
160979726|NCT03560245|581313377|FG000|Overall Study|Withdrawal by Subject|3|||
160979727|NCT03560245|581313378|FG001|Overall Study|Withdrawal by Subject|2|||
160979728|NCT03560245|581313377|FG000|Overall Study|Adverse Event|1|||
160979729|NCT03560245|581313378|FG001|Overall Study|Adverse Event|1|||
160979730|NCT03560245|581313377|FG000|Overall Study|Protocol Violation|1|||
160979731|NCT03560245|581313378|FG001|Overall Study|Protocol Violation|0|||
160979732|NCT03560245|581313377|FG000|Overall Study|Death|0|||
160979733|NCT03560245|581313378|FG001|Overall Study|Death|1|||
160979734|NCT03560245|581313377|FG000|Overall Study|Lost to Follow-up|0|||
160979735|NCT03560245|581313378|FG001|Overall Study|Lost to Follow-up|1|||
160979736|NCT03560245|581313377|FG000|Overall Study|Physician Decision|0|||
160979737|NCT03560245|581313378|FG001|Overall Study|Physician Decision|1|||
160979738|NCT03560245|581313377|FG000|Overall Study|Other|0|||
160979739|NCT03560245|581313378|FG001|Overall Study|Other|1|||
160979740|NCT00960752|581313385|FG000|Overall Study|Adverse Event|0|||
160979741|NCT00960752|581313386|FG001|Overall Study|Adverse Event|0|||
160979742|NCT00960752|581313387|FG002|Overall Study|Adverse Event|1|||
160979743|NCT00960752|581313385|FG000|Overall Study|Progression|0|||
160979744|NCT00960752|581313386|FG001|Overall Study|Progression|0|||
160979745|NCT00960752|581313387|FG002|Overall Study|Progression|1|||
160979746|NCT02058290|581313391|FG000|Overall Study|Protocol Violation|2|||
160979747|NCT02058290|581313392|FG001|Overall Study|Protocol Violation|1|||
160979748|NCT02058290|581313391|FG000|Overall Study|Physician Decision|1|||
160979749|NCT02058290|581313392|FG001|Overall Study|Physician Decision|0|||
160979750|NCT02058290|581313391|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
160979751|NCT02058290|581313392|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
160979752|NCT02058290|581313391|FG000|Overall Study|Withdrawal by Subject|0|||
160979753|NCT02058290|581313392|FG001|Overall Study|Withdrawal by Subject|1|||
160979754|NCT00105586|581313396|FG000|Overall Study|Adverse Event|4|||
160979755|NCT00105586|581313397|FG001|Overall Study|Adverse Event|3|||
160979756|NCT00105586|581313396|FG000|Overall Study|Physician Decision|13|||
160979757|NCT00105586|581313397|FG001|Overall Study|Physician Decision|13|||
160979758|NCT02262260|581313400|FG000|Overall Study|Adverse Event|4|||
160979759|NCT02262260|581313401|FG001|Overall Study|Adverse Event|1|||
160979760|NCT02262260|581313400|FG000|Overall Study|Withdrawal of consent|4|||
160979761|NCT02262260|581313401|FG001|Overall Study|Withdrawal of consent|2|||
160979762|NCT02262260|581313400|FG000|Overall Study|Lost to Follow-up|1|||
160979763|NCT02262260|581313401|FG001|Overall Study|Lost to Follow-up|2|||
160979764|NCT02262260|581313400|FG000|Overall Study|Protocol deviation|2|||
160979765|NCT02262260|581313401|FG001|Overall Study|Protocol deviation|5|||
160979766|NCT01794117|581313402|FG000|Overall Study|Adverse Event|1|||
160979767|NCT01794117|581313403|FG001|Overall Study|Adverse Event|0|||
160979768|NCT01794117|581313404|FG002|Overall Study|Adverse Event|0|||
160979769|NCT01794117|581313405|FG003|Overall Study|Adverse Event|0|||
160979770|NCT01794117|581313402|FG000|Overall Study|Participant noncompliance|0|||
160979771|NCT01794117|581313403|FG001|Overall Study|Participant noncompliance|1|||
160979772|NCT01794117|581313404|FG002|Overall Study|Participant noncompliance|0|||
160979773|NCT01794117|581313405|FG003|Overall Study|Participant noncompliance|0|||
160979774|NCT01794117|581313402|FG000|Overall Study|Refused further treatment|0|||
160979775|NCT01794117|581313403|FG001|Overall Study|Refused further treatment|2|||
160979776|NCT01794117|581313404|FG002|Overall Study|Refused further treatment|0|||
160979777|NCT01794117|581313405|FG003|Overall Study|Refused further treatment|0|||
161092791|NCT00790751|581729997|FG000|Overall Study|Lost to Follow-up|4|||
161092792|NCT00790751|581729998|FG001|Overall Study|Lost to Follow-up|9|||
161092793|NCT00790751|581729999|FG002|Overall Study|Lost to Follow-up|4|||
161092794|NCT00790751|581730000|FG003|Overall Study|Lost to Follow-up|5|||
161092795|NCT00790751|581729997|FG000|Overall Study|Adverse Event|5|||
161092796|NCT00790751|581729998|FG001|Overall Study|Adverse Event|3|||
161092797|NCT00790751|581729999|FG002|Overall Study|Adverse Event|5|||
161092798|NCT00790751|581730000|FG003|Overall Study|Adverse Event|4|||
161092799|NCT00790751|581729997|FG000|Overall Study|Requirement for restricted medication|0|||
161092800|NCT00790751|581729998|FG001|Overall Study|Requirement for restricted medication|2|||
161092801|NCT00790751|581729999|FG002|Overall Study|Requirement for restricted medication|0|||
161092802|NCT00790751|581730000|FG003|Overall Study|Requirement for restricted medication|0|||
161092803|NCT00790751|581729997|FG000|Overall Study|Death|0|||
161092804|NCT00790751|581729998|FG001|Overall Study|Death|0|||
161092805|NCT00790751|581729999|FG002|Overall Study|Death|1|||
161092806|NCT00790751|581730000|FG003|Overall Study|Death|0|||
160979794|NCT03406702|581313408|FG000|Overall Study|Missed Day 27 Dosing|1|||
160979795|NCT00735644|581313411|FG000|Overall Study|Did not receive study vaccine|0|||
160979796|NCT00735644|581313412|FG001|Overall Study|Did not receive study vaccine|1|||
160979797|NCT00735644|581313413|FG002|Overall Study|Did not receive study vaccine|0|||
160979798|NCT00735644|581313414|FG003|Overall Study|Did not receive study vaccine|0|||
160979799|NCT00735644|581313415|FG004|Overall Study|Did not receive study vaccine|0|||
160979800|NCT00735644|581313411|FG000|Overall Study|Withdrawal by Subject|0|||
160979801|NCT00735644|581313412|FG001|Overall Study|Withdrawal by Subject|1|||
160979802|NCT00735644|581313413|FG002|Overall Study|Withdrawal by Subject|1|||
160979803|NCT00735644|581313414|FG003|Overall Study|Withdrawal by Subject|1|||
160979804|NCT00735644|581313415|FG004|Overall Study|Withdrawal by Subject|0|||
160979805|NCT01040780|581315022|FG000|Overall Study|Protocol Violation|1|||
160979806|NCT01040780|581315023|FG001|Overall Study|Protocol Violation|3|||
160979807|NCT03681639|581315024|FG000|Overall Study|Death|4|||
160979808|NCT03681639|581315024|FG000|Overall Study|Lost to Follow-up|2|||
160979809|NCT03681639|581315024|FG000|Overall Study|Withdrawal by Subject|1|||
160979810|NCT03681639|581315024|FG000|Overall Study|Adverse Event|2|||
160979811|NCT00654940|581315025|FG000|Period 1|Adverse Event|0|||
160979812|NCT00654940|581315026|FG001|Period 1|Adverse Event|1|||
160979813|NCT00654940|581315025|FG000|Period 1|Intolerable Pain Level|1|||
160979814|NCT00654940|581315026|FG001|Period 1|Intolerable Pain Level|0|||
160979815|NCT00581113|581315032|FG000|Overall Study|Withdrawal by Subject|0|||
160979816|NCT00581113|581315033|FG001|Overall Study|Withdrawal by Subject|1|||
160979817|NCT01818141|581315034|FG000|Overall Study|Withdrawal by Subject|2|||
160979818|NCT01818141|581315035|FG001|Overall Study|Withdrawal by Subject|0|||
160979819|NCT01818141|581315034|FG000|Overall Study|No baseline C.diff colonies|1|||
160979820|NCT01818141|581315035|FG001|Overall Study|No baseline C.diff colonies|1|||
160979821|NCT01818141|581315034|FG000|Overall Study|Lost to Follow-up|0|||
160979822|NCT01818141|581315035|FG001|Overall Study|Lost to Follow-up|2|||
160979823|NCT04834362|581315038|FG000|Overall Study|Death|1|||
160979824|NCT04834362|581315039|FG001|Overall Study|Death|2|||
160979825|NCT00329719|581315042|FG000|Overall Study|Lost to Follow-up|0|||
160979826|NCT00329719|581315043|FG001|Overall Study|Lost to Follow-up|0|||
160979827|NCT00329719|581315044|FG002|Overall Study|Lost to Follow-up|0|||
160979828|NCT00329719|581315045|FG003|Overall Study|Lost to Follow-up|1|||
160979829|NCT01809210|581315048|FG000|Overall Study|Withdrawal by Subject|0|||
160979830|NCT01809210|581315049|FG001|Overall Study|Withdrawal by Subject|0|||
160979831|NCT01809210|581315050|FG002|Overall Study|Withdrawal by Subject|1|||
160979832|NCT01809210|581315051|FG003|Overall Study|Withdrawal by Subject|1|||
160979833|NCT01809210|581315052|FG004|Overall Study|Withdrawal by Subject|1|||
160979834|NCT01809210|581315053|FG005|Overall Study|Withdrawal by Subject|0|||
160979835|NCT01809210|581315054|FG006|Overall Study|Withdrawal by Subject|4|||
160979836|NCT01809210|581315048|FG000|Overall Study|Death|1|||
160979837|NCT01809210|581315049|FG001|Overall Study|Death|1|||
160979838|NCT01809210|581315050|FG002|Overall Study|Death|2|||
160979839|NCT01809210|581315051|FG003|Overall Study|Death|0|||
160979840|NCT01809210|581315052|FG004|Overall Study|Death|1|||
160979841|NCT01809210|581315053|FG005|Overall Study|Death|3|||
160979842|NCT01809210|581315054|FG006|Overall Study|Death|1|||
160979843|NCT01668147|581315055|FG000|Overall Study|Withdrawal by Subject|6|||
160979844|NCT01115998|581315058|FG000|Overall Study|Lost to Follow-up|6|||
160979845|NCT01115998|581315059|FG001|Overall Study|Lost to Follow-up|6|||
160979846|NCT00224133|581315060|FG000|Overall Study|Adverse Event|93|||
160979847|NCT00224133|581315060|FG000|Overall Study|Protocol Violation|6|||
160979848|NCT00224133|581315060|FG000|Overall Study|Withdrawal by Subject|33|||
160979849|NCT00224133|581315060|FG000|Overall Study|Lack of Efficacy|58|||
160979850|NCT00224133|581315060|FG000|Overall Study|Lost to Follow-up|21|||
160979851|NCT00224133|581315060|FG000|Overall Study|Physician Decision|1|||
160979852|NCT00224133|581315060|FG000|Overall Study|Other|14|||
160979853|NCT01238575|581315064|FG000|Overall Study|Lack of Efficacy|2|||
160979854|NCT01238575|581315065|FG001|Overall Study|Lack of Efficacy|4|||
160979855|NCT01238575|581315064|FG000|Overall Study|Adverse Event|2|||
160979856|NCT01238575|581315065|FG001|Overall Study|Adverse Event|0|||
160979857|NCT00593554|581315067|FG000|Overall Study|Death|1|||
160979858|NCT00593554|581315068|FG001|Overall Study|Death|2|||
160979859|NCT00593554|581315067|FG000|Overall Study|Physician Decision|0|||
160979860|NCT00593554|581315068|FG001|Overall Study|Physician Decision|1|||
160979861|NCT00593554|581315067|FG000|Overall Study|Withdrawal by Subject|1|||
160979862|NCT00593554|581315068|FG001|Overall Study|Withdrawal by Subject|0|||
160979863|NCT00593554|581315067|FG000|Overall Study|Disease Progression|1|||
160979864|NCT00593554|581315068|FG001|Overall Study|Disease Progression|2|||
160979865|NCT00795132|581315071|FG000|Overall Study|Death|1|||
160979866|NCT00795132|581315071|FG000|Overall Study|Relapse|2|||
160979867|NCT00358150|581315076|FG000|Overall Study|Adverse Event|3|||
160979868|NCT00358150|581315076|FG000|Overall Study|Withdrawal by Subject|1|||
160979869|NCT00358150|581315076|FG000|Overall Study|Undefined|3|||
160979870|NCT04747275|581315077|FG000|Overall Study|Study terminated|0|||
160979871|NCT04747275|581315078|FG001|Overall Study|Study terminated|1|||
160979872|NCT03268590|581315081|FG000|Overall Study|Previously unknown exclusion criteria|1|||
160979873|NCT00531011|581315082|FG000|Overall Study|Withdrawal by Subject|2|||
160979874|NCT00531011|581315083|FG001|Overall Study|Withdrawal by Subject|4|||
160979875|NCT00531011|581315082|FG000|Overall Study|Death|1|||
160979876|NCT00531011|581315083|FG001|Overall Study|Death|0|||
160979877|NCT00531011|581315082|FG000|Overall Study|Lost to Follow-up|1|||
160979878|NCT00531011|581315083|FG001|Overall Study|Lost to Follow-up|0|||
160979879|NCT00531011|581315082|FG000|Overall Study|Physician Decision|0|||
160979880|NCT00531011|581315083|FG001|Overall Study|Physician Decision|3|||
160979881|NCT04254679|581315108|FG000|Overall Study|Protocol Violation|1|||
160979882|NCT04254679|581315109|FG001|Overall Study|Protocol Violation|1|||
160979883|NCT04254679|581315108|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
160979884|NCT04254679|581315109|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
160979885|NCT02823964|581315110|FG000|Overall Study|Adverse Event|2|||
160979886|NCT02823964|581315110|FG000|Overall Study|Physician Decision|1|||
160979887|NCT02823964|581315110|FG000|Overall Study|Lack of Efficacy|1|||
160979888|NCT02823964|581315110|FG000|Overall Study|Withdrawal by Subject|1|||
160979889|NCT00610675|581315113|FG000|Overall Study|Untreated|4|||
160979890|NCT00610675|581315113|FG000|Overall Study|Adverse Event|67|||
160979891|NCT00610675|581315113|FG000|Overall Study|Insufficient Effect|31|||
160979892|NCT00610675|581315113|FG000|Overall Study|Withdrawal by Subject|28|||
160979893|NCT00610675|581315113|FG000|Overall Study|Reasons unrelated to trial|27|||
160979894|NCT00610675|581315113|FG000|Overall Study|Lack of Compliance|7|||
160979895|NCT00610675|581315113|FG000|Overall Study|Lost to Follow-up|31|||
160979896|NCT00610675|581315113|FG000|Overall Study|Other reason (not specified)|25|||
160979897|NCT04844918|581315118|FG000|Overall Study|Adverse Event|7|||
160979898|NCT04844918|581315119|FG001|Overall Study|Adverse Event|8|||
160979899|NCT04844918|581315120|FG002|Overall Study|Adverse Event|5|||
160979900|NCT04844918|581315118|FG000|Overall Study|Physician Decision|0|||
160979901|NCT04844918|581315119|FG001|Overall Study|Physician Decision|1|||
160979902|NCT04844918|581315120|FG002|Overall Study|Physician Decision|0|||
160979903|NCT04844918|581315118|FG000|Overall Study|Withdrawal by Subject|6|||
160979904|NCT04844918|581315119|FG001|Overall Study|Withdrawal by Subject|3|||
160979905|NCT04844918|581315120|FG002|Overall Study|Withdrawal by Subject|3|||
160979906|NCT04844918|581315118|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
160979907|NCT04844918|581315119|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
160979908|NCT04844918|581315120|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
160979909|NCT01009047|581315121|FG000|Overall Study|Adverse Event|5|||
160979910|NCT01009047|581315122|FG001|Overall Study|Adverse Event|0|||
160979911|NCT01009047|581315121|FG000|Overall Study|Lost to Follow-up|0|||
160979912|NCT01009047|581315122|FG001|Overall Study|Lost to Follow-up|2|||
160979913|NCT01009047|581315121|FG000|Overall Study|Lack of Efficacy|4|||
160979914|NCT01009047|581315122|FG001|Overall Study|Lack of Efficacy|11|||
160979915|NCT01009047|581315121|FG000|Overall Study|Withdrawal by consent|16|||
160979916|NCT01009047|581315122|FG001|Overall Study|Withdrawal by consent|11|||
160979917|NCT01009047|581315121|FG000|Overall Study|Other|3|||
160979918|NCT01009047|581315122|FG001|Overall Study|Other|2|||
160979919|NCT01630590|581315126|FG000|Overall Study|Adverse Event|9|||
160979920|NCT01630590|581315126|FG000|Overall Study|Lack of Efficacy|37|||
160979921|NCT01630590|581315126|FG000|Overall Study|Withdrawal by Subject|4|||
160979922|NCT01630590|581315126|FG000|Overall Study|2nd primary tumor|2|||
160979923|NCT01630590|581315126|FG000|Overall Study|Automobile accident|1|||
160979924|NCT01630590|581315126|FG000|Overall Study|Maximum benefit|4|||
160979925|NCT02366936|581315127|FG000|Overall Study|Withdrawal by Subject|2|||
160979926|NCT02366936|581315127|FG000|Overall Study|Lost to Follow-up|4|||
160979927|NCT02366936|581315127|FG000|Overall Study|Physician Decision|2|||
160979928|NCT01751113|581315128|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979929|NCT01751113|581315129|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979930|NCT01751113|581315130|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979931|NCT01751113|581315131|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
160979932|NCT01751113|581315132|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
160979933|NCT01751113|581315133|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
160979934|NCT01751113|581315128|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979935|NCT01751113|581315129|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979936|NCT01751113|581315130|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979937|NCT01751113|581315131|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979938|NCT01751113|581315132|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
160979939|NCT01751113|581315133|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
160979940|NCT02878213|581315134|FG000|Overall Study|Withdrawal by Subject|2|||
160979941|NCT02878213|581315134|FG000|Overall Study|Adverse Event|1|||
160979942|NCT00363896|581315135|FG000|Overall Study|Withdrawal by Subject|29|||
160979943|NCT00363896|581315136|FG001|Overall Study|Withdrawal by Subject|16|||
160979944|NCT00363896|581315135|FG000|Overall Study|Adverse Event|24|||
160979945|NCT00363896|581315136|FG001|Overall Study|Adverse Event|13|||
160979946|NCT00363896|581315135|FG000|Overall Study|COPD exacerbation|13|||
160979947|NCT00363896|581315136|FG001|Overall Study|COPD exacerbation|7|||
160979948|NCT00363896|581315135|FG000|Overall Study|Lack of Efficacy|12|||
160979949|NCT00363896|581315136|FG001|Overall Study|Lack of Efficacy|8|||
160979950|NCT00363896|581315135|FG000|Overall Study|Protocol Violation|6|||
160979951|NCT00363896|581315136|FG001|Overall Study|Protocol Violation|1|||
160979952|NCT00363896|581315135|FG000|Overall Study|Lost to Follow-up|3|||
160979953|NCT00363896|581315136|FG001|Overall Study|Lost to Follow-up|0|||
160979954|NCT00363896|581315135|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
160979955|NCT00363896|581315136|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
160979956|NCT00363896|581315135|FG000|Overall Study|Other|1|||
160979957|NCT00363896|581315136|FG001|Overall Study|Other|2|||
160979958|NCT01558674|581315137|FG000|Part 1|Study Terminated by Sponsor|10|||
160979959|NCT01558674|581315138|FG001|Part 1|Study Terminated by Sponsor|0|||
160979960|NCT01558674|581315137|FG000|Part 1|Withdrawal by Subject|1|||
160979961|NCT01558674|581315138|FG001|Part 1|Withdrawal by Subject|0|||
160979962|NCT01555021|581315143|FG000|Overall Study|Lost to Follow-up|1|||
160979963|NCT01555021|581315144|FG001|Overall Study|Lost to Follow-up|2|||
160979964|NCT02471404|581315148|FG000|Overall Study|Adverse Event|7|||
160979965|NCT02471404|581315149|FG001|Overall Study|Adverse Event|1|||
160979966|NCT02471404|581315150|FG002|Overall Study|Adverse Event|2|||
160979967|NCT02471404|581315148|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
160979968|NCT02471404|581315149|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
160979969|NCT02471404|581315150|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
160979970|NCT02471404|581315148|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
160979971|NCT02471404|581315149|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160979972|NCT02471404|581315150|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
160979973|NCT02471404|581315148|FG000|Overall Study|Lost to Follow-up|1|||
160979974|NCT02471404|581315149|FG001|Overall Study|Lost to Follow-up|1|||
160979975|NCT02471404|581315150|FG002|Overall Study|Lost to Follow-up|3|||
160979976|NCT02471404|581315148|FG000|Overall Study|Protocol Violation|1|||
160979977|NCT02471404|581315149|FG001|Overall Study|Protocol Violation|0|||
160979978|NCT02471404|581315150|FG002|Overall Study|Protocol Violation|0|||
160979979|NCT02471404|581315148|FG000|Overall Study|Withdrawal by Subject|8|||
160979980|NCT02471404|581315149|FG001|Overall Study|Withdrawal by Subject|4|||
160979981|NCT02471404|581315150|FG002|Overall Study|Withdrawal by Subject|5|||
160979982|NCT02471404|581315148|FG000|Overall Study|Other reasons not specified|10|||
160979983|NCT02471404|581315149|FG001|Overall Study|Other reasons not specified|7|||
160979984|NCT02471404|581315150|FG002|Overall Study|Other reasons not specified|12|||
160979985|NCT01388530|581315151|FG000|Overall Study|Lost to Follow-up|5|||
160979986|NCT02204293|581315152|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
160979987|NCT02204293|581315153|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
160979988|NCT02204293|581315154|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
160979989|NCT02204293|581315155|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
160979990|NCT02204293|581315156|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
160979991|NCT02204293|581315157|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
160979992|NCT02204293|581315152|FG000|Core Study Part I|Adverse Event|1|||
160979993|NCT02204293|581315153|FG001|Core Study Part I|Adverse Event|0|||
160979994|NCT02204293|581315154|FG002|Core Study Part I|Adverse Event|0|||
160979995|NCT02204293|581315155|FG003|Core Study Part I|Adverse Event|0|||
160979996|NCT02204293|581315156|FG004|Core Study Part I|Adverse Event|0|||
160979997|NCT02204293|581315157|FG005|Core Study Part I|Adverse Event|0|||
160979998|NCT02204293|581315152|FG000|Core Study Part I|Physician Decision|0|||
160979999|NCT02204293|581315153|FG001|Core Study Part I|Physician Decision|3|||
160980000|NCT02204293|581315154|FG002|Core Study Part I|Physician Decision|0|||
160980001|NCT02204293|581315155|FG003|Core Study Part I|Physician Decision|0|||
161092807|NCT00790751|581729997|FG000|Overall Study|Physician Decision|0|||
161092808|NCT00790751|581729998|FG001|Overall Study|Physician Decision|0|||
161092809|NCT00790751|581729999|FG002|Overall Study|Physician Decision|0|||
161092810|NCT00790751|581730000|FG003|Overall Study|Physician Decision|1|||
161092811|NCT02427464|581730003|FG000|Overall Study|Adverse Event|6|||
161209303|NCT01347879|582149072|FG001|Overall Study|Adverse Event|12|||
160980002|NCT02204293|581315156|FG004|Core Study Part I|Physician Decision|0|||
160980003|NCT02204293|581315157|FG005|Core Study Part I|Physician Decision|0|||
160980004|NCT02204293|581315152|FG000|LTE Phase|Study Suspended|0|||
160980005|NCT02204293|581315153|FG001|LTE Phase|Study Suspended|0|||
160980006|NCT02204293|581315154|FG002|LTE Phase|Study Suspended|0|||
160980007|NCT02204293|581315155|FG003|LTE Phase|Study Suspended|0|||
160980008|NCT02204293|581315156|FG004|LTE Phase|Study Suspended|0|||
160980009|NCT02204293|581315157|FG005|LTE Phase|Study Suspended|7|||
160980010|NCT02420327|581315158|FG000|Overall Study|Adverse Event|7|||
160980011|NCT02420327|581315158|FG000|Overall Study|Pregnancy|1|||
160980012|NCT02420327|581315158|FG000|Overall Study|Withdrawal by Subject|6|||
160980013|NCT02420327|581315158|FG000|Overall Study|Lost to Follow-up|1|||
160980014|NCT02420327|581315158|FG000|Overall Study|Protocol Violation|1|||
160980015|NCT01225835|581315161|FG000|Overall Study|Completed protocol|2|||
160980016|NCT01225835|581315162|FG001|Overall Study|Completed protocol|1|||
160980017|NCT01225835|581315161|FG000|Overall Study|Did not meet hCG criterion|2|||
160980018|NCT01225835|581315162|FG001|Overall Study|Did not meet hCG criterion|0|||
160980019|NCT01225835|581315161|FG000|Overall Study|Adverse Event|2|||
160980020|NCT01225835|581315162|FG001|Overall Study|Adverse Event|1|||
160980021|NCT01225835|581315161|FG000|Overall Study|Other|1|||
160980022|NCT01225835|581315162|FG001|Overall Study|Other|1|||
160980023|NCT01146574|581315163|FG000|Overall Study|Death|0|||
160980024|NCT01146574|581315164|FG001|Overall Study|Death|1|||
160980025|NCT01146574|581315165|FG002|Overall Study|Death|1|||
160980026|NCT01146574|581315166|FG003|Overall Study|Death|0|||
160980027|NCT01146574|581315167|FG004|Overall Study|Death|0|||
160980028|NCT01146574|581315168|FG005|Overall Study|Death|0|||
160980029|NCT01146574|581315169|FG006|Overall Study|Death|0|||
160980030|NCT01146574|581315163|FG000|Overall Study|Other reasons|0|||
160980031|NCT01146574|581315164|FG001|Overall Study|Other reasons|0|||
160980032|NCT01146574|581315165|FG002|Overall Study|Other reasons|3|||
160980033|NCT01146574|581315166|FG003|Overall Study|Other reasons|0|||
160980034|NCT01146574|581315167|FG004|Overall Study|Other reasons|0|||
160980035|NCT01146574|581315168|FG005|Overall Study|Other reasons|0|||
160980036|NCT01146574|581315169|FG006|Overall Study|Other reasons|0|||
160980037|NCT01146574|581315163|FG000|Overall Study|Kidney transplant|0|||
160980038|NCT01146574|581315164|FG001|Overall Study|Kidney transplant|0|||
160980039|NCT01146574|581315165|FG002|Overall Study|Kidney transplant|1|||
160980040|NCT01146574|581315166|FG003|Overall Study|Kidney transplant|1|||
160980041|NCT01146574|581315167|FG004|Overall Study|Kidney transplant|0|||
160980042|NCT01146574|581315168|FG005|Overall Study|Kidney transplant|0|||
160980043|NCT01146574|581315169|FG006|Overall Study|Kidney transplant|0|||
160980044|NCT01146574|581315163|FG000|Overall Study|Withdrew consent|0|||
160980045|NCT01146574|581315164|FG001|Overall Study|Withdrew consent|0|||
160980046|NCT01146574|581315165|FG002|Overall Study|Withdrew consent|1|||
160980047|NCT01146574|581315166|FG003|Overall Study|Withdrew consent|1|||
160980048|NCT01146574|581315167|FG004|Overall Study|Withdrew consent|2|||
160980049|NCT01146574|581315168|FG005|Overall Study|Withdrew consent|1|||
160980050|NCT01146574|581315169|FG006|Overall Study|Withdrew consent|1|||
160980051|NCT03051659|581315170|FG000|Treatment Period|Withdrawal by Subject|0|||
160980052|NCT03051659|581315171|FG001|Treatment Period|Withdrawal by Subject|2|||
160980053|NCT03051659|581315170|FG000|Survival Follow-up|Lost to Follow-up|23|||
160980054|NCT03051659|581315171|FG001|Survival Follow-up|Lost to Follow-up|22|||
160980055|NCT01266993|581315172|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
160980056|NCT01266993|581315173|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
160980057|NCT01266993|581315172|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
160980058|NCT01266993|581315173|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
160980059|NCT04779242|581315174|FG000|Overall Study|Adverse Event|1|||
160980060|NCT04779242|581315175|FG001|Overall Study|Adverse Event|1|||
160980061|NCT04779242|581315174|FG000|Overall Study|Lost to Follow-up|2|||
160980062|NCT04779242|581315175|FG001|Overall Study|Lost to Follow-up|4|||
160980063|NCT04779242|581315174|FG000|Overall Study|Withdrawal by Subject|7|||
160980064|NCT04779242|581315175|FG001|Overall Study|Withdrawal by Subject|9|||
160980065|NCT04779242|581315174|FG000|Overall Study|Death|6|||
160980066|NCT04779242|581315175|FG001|Overall Study|Death|6|||
160980067|NCT04779242|581315174|FG000|Overall Study|COVID-19 related reasons|2|||
160980068|NCT04779242|581315175|FG001|Overall Study|COVID-19 related reasons|1|||
160980069|NCT04779242|581315174|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
160980070|NCT04779242|581315175|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
160980071|NCT04779242|581315174|FG000|Overall Study|Martial Law in Ukraine|2|||
160980072|NCT04779242|581315175|FG001|Overall Study|Martial Law in Ukraine|3|||
160980073|NCT00849680|581315180|FG000|Overall Study|Adverse Event|0|||
160980074|NCT00849680|581315181|FG001|Overall Study|Adverse Event|0|||
160980075|NCT00849680|581315182|FG002|Overall Study|Adverse Event|0|||
160980076|NCT00849680|581315183|FG003|Overall Study|Adverse Event|0|||
160980077|NCT00849680|581315184|FG004|Overall Study|Adverse Event|0|||
160980078|NCT00849680|581315185|FG005|Overall Study|Adverse Event|0|||
160980079|NCT00849680|581315186|FG006|Overall Study|Adverse Event|2|||
160980080|NCT00849680|581315187|FG007|Overall Study|Adverse Event|0|||
160980081|NCT00849680|581315180|FG000|Overall Study|Lost to Follow-up|7|||
160980082|NCT00849680|581315181|FG001|Overall Study|Lost to Follow-up|3|||
160980083|NCT00849680|581315182|FG002|Overall Study|Lost to Follow-up|12|||
160980084|NCT00849680|581315183|FG003|Overall Study|Lost to Follow-up|11|||
160980085|NCT00849680|581315184|FG004|Overall Study|Lost to Follow-up|8|||
160980086|NCT00849680|581315185|FG005|Overall Study|Lost to Follow-up|11|||
160980087|NCT00849680|581315186|FG006|Overall Study|Lost to Follow-up|12|||
160980088|NCT00849680|581315187|FG007|Overall Study|Lost to Follow-up|5|||
160980089|NCT00849680|581315180|FG000|Overall Study|Subject moved|1|||
160980090|NCT00849680|581315181|FG001|Overall Study|Subject moved|0|||
160980091|NCT00849680|581315182|FG002|Overall Study|Subject moved|3|||
160980092|NCT00849680|581315183|FG003|Overall Study|Subject moved|1|||
160980093|NCT00849680|581315184|FG004|Overall Study|Subject moved|0|||
160980094|NCT00849680|581315185|FG005|Overall Study|Subject moved|2|||
160980095|NCT00849680|581315186|FG006|Overall Study|Subject moved|2|||
160980096|NCT00849680|581315187|FG007|Overall Study|Subject moved|2|||
160980097|NCT00849680|581315180|FG000|Overall Study|Withdrawal by Subject|2|||
160980098|NCT00849680|581315181|FG001|Overall Study|Withdrawal by Subject|0|||
160980099|NCT00849680|581315182|FG002|Overall Study|Withdrawal by Subject|0|||
160980100|NCT00849680|581315183|FG003|Overall Study|Withdrawal by Subject|2|||
160980101|NCT00849680|581315184|FG004|Overall Study|Withdrawal by Subject|2|||
160980102|NCT00849680|581315185|FG005|Overall Study|Withdrawal by Subject|2|||
160980103|NCT00849680|581315186|FG006|Overall Study|Withdrawal by Subject|1|||
160980104|NCT00849680|581315187|FG007|Overall Study|Withdrawal by Subject|1|||
160980105|NCT00849680|581315180|FG000|Overall Study|Subject unable to comply with protocol|1|||
160980106|NCT00849680|581315181|FG001|Overall Study|Subject unable to comply with protocol|0|||
160980107|NCT00849680|581315182|FG002|Overall Study|Subject unable to comply with protocol|0|||
160980108|NCT00849680|581315183|FG003|Overall Study|Subject unable to comply with protocol|0|||
160980109|NCT00849680|581315184|FG004|Overall Study|Subject unable to comply with protocol|0|||
160980110|NCT00849680|581315185|FG005|Overall Study|Subject unable to comply with protocol|0|||
160980111|NCT00849680|581315186|FG006|Overall Study|Subject unable to comply with protocol|0|||
160980112|NCT00849680|581315187|FG007|Overall Study|Subject unable to comply with protocol|0|||
160980113|NCT04285229|581315188|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160980114|NCT04285229|581315189|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980115|NCT04285229|581315190|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980116|NCT04285229|581315191|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980117|NCT04285229|581315192|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980118|NCT04285229|581315193|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160980119|NCT04285229|581315188|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
160980120|NCT04285229|581315189|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
160980121|NCT04285229|581315190|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
160980122|NCT04285229|581315191|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
160980123|NCT04285229|581315192|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
160980124|NCT04285229|581315193|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
160980125|NCT04285229|581315188|FG000|Extended Treatment Period|Adverse Event|0|||
160980126|NCT04285229|581315189|FG001|Extended Treatment Period|Adverse Event|0|||
160980127|NCT04285229|581315190|FG002|Extended Treatment Period|Adverse Event|0|||
160980128|NCT04285229|581315191|FG003|Extended Treatment Period|Adverse Event|1|||
160980129|NCT04285229|581315192|FG004|Extended Treatment Period|Adverse Event|0|||
160980130|NCT04285229|581315193|FG005|Extended Treatment Period|Adverse Event|0|||
160980131|NCT04285229|581315188|FG000|Extended Treatment Period|Physician Decision|0|||
160980132|NCT04285229|581315189|FG001|Extended Treatment Period|Physician Decision|0|||
160980133|NCT04285229|581315190|FG002|Extended Treatment Period|Physician Decision|1|||
160980134|NCT04285229|581315191|FG003|Extended Treatment Period|Physician Decision|0|||
160980135|NCT04285229|581315192|FG004|Extended Treatment Period|Physician Decision|0|||
160980136|NCT04285229|581315193|FG005|Extended Treatment Period|Physician Decision|0|||
160980137|NCT04285229|581315188|FG000|Follow-up Period|Adverse Event|0|||
160980138|NCT04285229|581315189|FG001|Follow-up Period|Adverse Event|0|||
160980139|NCT04285229|581315190|FG002|Follow-up Period|Adverse Event|0|||
160980140|NCT04285229|581315191|FG003|Follow-up Period|Adverse Event|0|||
160980141|NCT04285229|581315192|FG004|Follow-up Period|Adverse Event|1|||
160980142|NCT04285229|581315193|FG005|Follow-up Period|Adverse Event|4|||
160980143|NCT04285229|581315188|FG000|Follow-up Period|Withdrawal by Subject|0|||
160980144|NCT04285229|581315189|FG001|Follow-up Period|Withdrawal by Subject|0|||
160980145|NCT04285229|581315190|FG002|Follow-up Period|Withdrawal by Subject|0|||
160980146|NCT04285229|581315191|FG003|Follow-up Period|Withdrawal by Subject|0|||
160980147|NCT04285229|581315192|FG004|Follow-up Period|Withdrawal by Subject|0|||
160980148|NCT04285229|581315193|FG005|Follow-up Period|Withdrawal by Subject|5|||
160980149|NCT04285229|581315188|FG000|Follow-up Period|Covid-19|0|||
160980150|NCT04285229|581315189|FG001|Follow-up Period|Covid-19|0|||
160980151|NCT04285229|581315190|FG002|Follow-up Period|Covid-19|0|||
160980152|NCT04285229|581315191|FG003|Follow-up Period|Covid-19|0|||
160980153|NCT04285229|581315192|FG004|Follow-up Period|Covid-19|0|||
160980154|NCT04285229|581315193|FG005|Follow-up Period|Covid-19|2|||
160980155|NCT04285229|581315188|FG000|Follow-up Period|Physician Decision|0|||
160980156|NCT04285229|581315189|FG001|Follow-up Period|Physician Decision|0|||
160980157|NCT04285229|581315190|FG002|Follow-up Period|Physician Decision|0|||
160980158|NCT04285229|581315191|FG003|Follow-up Period|Physician Decision|0|||
160980159|NCT04285229|581315192|FG004|Follow-up Period|Physician Decision|0|||
160980160|NCT04285229|581315193|FG005|Follow-up Period|Physician Decision|1|||
160980161|NCT00655551|581315194|FG000|All Periods Combined|Adverse Event|0|||
160980162|NCT00655551|581315195|FG001|All Periods Combined|Adverse Event|3|||
160980163|NCT00655551|581315196|FG002|All Periods Combined|Adverse Event|4|||
160980164|NCT00655551|581315194|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
160980165|NCT00655551|581315195|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
160980166|NCT00655551|581315196|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
160980167|NCT00655551|581315194|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
160980168|NCT00655551|581315195|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
160980169|NCT00655551|581315196|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
160980170|NCT00655551|581315194|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
160980171|NCT00655551|581315195|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
160980172|NCT00655551|581315196|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
161092812|NCT02427464|581730004|FG001|Overall Study|Adverse Event|1|||
161092813|NCT02427464|581730003|FG000|Overall Study|Lost to Follow-up|16|||
161092814|NCT02427464|581730004|FG001|Overall Study|Lost to Follow-up|5|||
161092815|NCT02427464|581730003|FG000|Overall Study|Physician Decision|2|||
161092816|NCT02427464|581730004|FG001|Overall Study|Physician Decision|0|||
161092817|NCT02427464|581730003|FG000|Overall Study|Withdrawal by Subject|10|||
161092818|NCT02427464|581730004|FG001|Overall Study|Withdrawal by Subject|8|||
161092819|NCT02427464|581730003|FG000|Overall Study|Noncompliance|16|||
161092820|NCT02427464|581730004|FG001|Overall Study|Noncompliance|10|||
161092821|NCT02572843|581730008|FG000|Accrual|Brain metastasis retrospectively detected|1|||
160980173|NCT02049710|581315202|FG000|Overall Study|Lost to Follow-up|319|||
160980174|NCT02049710|581315203|FG001|Overall Study|Lost to Follow-up|324|||
160980175|NCT00003458|581315204|FG000|Overall Study|Not evaluable|4|||
160980176|NCT06385483|581315208|FG000|Overall Study|Withdrawal by Subject|2|||
160980177|NCT06385483|581315208|FG000|Overall Study|Never start protocol therapy|2|||
160980178|NCT06385483|581315208|FG000|Overall Study|Disease progression|15|||
160980179|NCT01216293|581315209|FG000|Main Study|Adverse Event|1|||
160980180|NCT01216293|581315210|FG001|Main Study|Adverse Event|4|||
160980181|NCT01216293|581315211|FG002|Main Study|Adverse Event|2|||
160980182|NCT01216293|581315209|FG000|Main Study|Major Protocol Deviation|1|||
160980183|NCT01216293|581315210|FG001|Main Study|Major Protocol Deviation|0|||
160980184|NCT01216293|581315211|FG002|Main Study|Major Protocol Deviation|1|||
160980185|NCT01216293|581315209|FG000|Main Study|Lost to Follow-up|3|||
160980186|NCT01216293|581315210|FG001|Main Study|Lost to Follow-up|1|||
160980187|NCT01216293|581315211|FG002|Main Study|Lost to Follow-up|0|||
160980188|NCT01216293|581315209|FG000|Main Study|Voluntary Withdrawal|2|||
160980189|NCT01216293|581315210|FG001|Main Study|Voluntary Withdrawal|2|||
160980190|NCT01216293|581315211|FG002|Main Study|Voluntary Withdrawal|2|||
160980191|NCT01216293|581315209|FG000|Main Study|Other Reason Not Specified|0|||
160980192|NCT01216293|581315210|FG001|Main Study|Other Reason Not Specified|1|||
160980193|NCT01216293|581315211|FG002|Main Study|Other Reason Not Specified|1|||
160980194|NCT01216293|581315209|FG000|Main Study|Randomized, Not Treated|1|||
161092822|NCT02572843|581730008|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
161092823|NCT02572843|581730008|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
161092824|NCT02572843|581730008|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
161092825|NCT02572843|581730008|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
161092826|NCT02572843|581730008|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
161092827|NCT02572843|581730008|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
161092828|NCT02572843|581730008|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
161092829|NCT02572843|581730008|FG000|Surgery|lost to follow up|7|||
161092830|NCT02572843|581730008|FG000|Surgery|Death|1|||
161092831|NCT01078454|581730011|FG000|Overall Study|Adverse Event|1|||
161092832|NCT01078454|581730012|FG001|Overall Study|Adverse Event|1|||
161092833|NCT01078454|581730011|FG000|Overall Study|Death|0|||
161092834|NCT01078454|581730012|FG001|Overall Study|Death|1|||
161092835|NCT04737187|581730013|FG000|Overall Study|Switched to marketed drug|32|||
161092836|NCT04737187|581730014|FG001|Overall Study|Switched to marketed drug|4|||
161092837|NCT04737187|581730013|FG000|Overall Study|Radiological Progressive Disease|145|||
161092838|NCT04737187|581730014|FG001|Overall Study|Radiological Progressive Disease|146|||
161092839|NCT04737187|581730013|FG000|Overall Study|Clinical Progressive Disease|20|||
161092840|NCT04737187|581730014|FG001|Overall Study|Clinical Progressive Disease|20|||
160980195|NCT01216293|581315210|FG001|Main Study|Randomized, Not Treated|0|||
160980196|NCT01216293|581315211|FG002|Main Study|Randomized, Not Treated|0|||
160980197|NCT01216293|581315209|FG000|Calcium Absorption Substudy|Adverse Event|0|||
161092841|NCT04737187|581730013|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
161092842|NCT04737187|581730014|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
161092843|NCT04737187|581730013|FG000|Overall Study|Adverse Event|16|||
161092844|NCT04737187|581730014|FG001|Overall Study|Adverse Event|16|||
161092845|NCT04737187|581730013|FG000|Overall Study|Physician Decision|2|||
161092846|NCT04737187|581730014|FG001|Overall Study|Physician Decision|0|||
161092847|NCT04737187|581730013|FG000|Overall Study|Withdrawal by Subject|5|||
161092848|NCT04737187|581730014|FG001|Overall Study|Withdrawal by Subject|8|||
161092849|NCT03464097|581730019|FG000|Overall Study|Withdrawal by Subject|15|||
161092850|NCT03464097|581730020|FG001|Overall Study|Withdrawal by Subject|13|||
161092851|NCT03464097|581730021|FG002|Overall Study|Withdrawal by Subject|11|||
161092852|NCT03464097|581730019|FG000|Overall Study|Study terminated by sponsor|47|||
161092853|NCT03464097|581730020|FG001|Overall Study|Study terminated by sponsor|44|||
161092854|NCT03464097|581730021|FG002|Overall Study|Study terminated by sponsor|40|||
161092855|NCT03464097|581730019|FG000|Overall Study|Pregnancy|0|||
161092856|NCT03464097|581730020|FG001|Overall Study|Pregnancy|1|||
161092857|NCT03464097|581730021|FG002|Overall Study|Pregnancy|0|||
161092858|NCT03464097|581730019|FG000|Overall Study|Other reasons|5|||
161092859|NCT03464097|581730020|FG001|Overall Study|Other reasons|12|||
161092860|NCT03464097|581730021|FG002|Overall Study|Other reasons|14|||
161092861|NCT03464097|581730019|FG000|Overall Study|Lost to Follow-up|0|||
161092862|NCT03464097|581730020|FG001|Overall Study|Lost to Follow-up|1|||
161092863|NCT03464097|581730021|FG002|Overall Study|Lost to Follow-up|1|||
161092864|NCT03464097|581730019|FG000|Overall Study|Lack of Efficacy|11|||
161092865|NCT03464097|581730020|FG001|Overall Study|Lack of Efficacy|18|||
161092866|NCT03464097|581730021|FG002|Overall Study|Lack of Efficacy|30|||
161092867|NCT03464097|581730019|FG000|Overall Study|Death|1|||
161092868|NCT03464097|581730020|FG001|Overall Study|Death|0|||
161092869|NCT03464097|581730021|FG002|Overall Study|Death|0|||
161092870|NCT03464097|581730019|FG000|Overall Study|Adverse Event|13|||
161092871|NCT03464097|581730020|FG001|Overall Study|Adverse Event|6|||
161092872|NCT03464097|581730021|FG002|Overall Study|Adverse Event|8|||
161142525|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Adverse Event|0|||
161142526|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Adverse Event|0|||
161142527|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Adverse Event|0|||
161142528|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Adverse Event|0|||
161142529|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Adverse Event|0|||
161142530|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Adverse Event|0|||
161142531|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Adverse Event|1|||
161142532|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Adverse Event|0|||
161142533|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Death|0|||
161142534|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Death|0|||
161142535|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Death|0|||
161142536|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Death|0|||
161142537|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Death|0|||
160980198|NCT01216293|581315210|FG001|Calcium Absorption Substudy|Adverse Event|2|||
160980199|NCT01216293|581315211|FG002|Calcium Absorption Substudy|Adverse Event|0|||
160980200|NCT01216293|581315209|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
160980201|NCT01216293|581315210|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
160980202|NCT01216293|581315211|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
160980203|NCT01216293|581315209|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
160980204|NCT01216293|581315210|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
160980205|NCT01216293|581315211|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
160980206|NCT02169830|581317384|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
160980207|NCT02169830|581317385|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
160980208|NCT02169830|581317386|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
160980209|NCT02169830|581317384|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
160980210|NCT02169830|581317385|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
160980211|NCT02169830|581317386|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
160980212|NCT02169830|581317384|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
160980213|NCT02169830|581317385|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
160980214|NCT02169830|581317386|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160980215|NCT02169830|581317384|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
160980216|NCT02169830|581317385|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
160980217|NCT02169830|581317386|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
160980218|NCT02169830|581317384|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
160980219|NCT02169830|581317385|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
160980220|NCT02169830|581317386|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
160980221|NCT03204695|581317387|FG000|Overall Study|Death|1|||
160980222|NCT03204695|581317387|FG000|Overall Study|Participant was treated with another device|1|||
161142538|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Death|0|||
161142539|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Death|0|||
160980223|NCT03204695|581317387|FG000|Overall Study|Physician Decision|2|||
161142540|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Death|0|||
161142541|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Death|0|||
160980224|NCT04781647|581317391|FG000|Overall Study|Study terminated by Sponsor|11|||
160980225|NCT04781647|581317392|FG001|Overall Study|Study terminated by Sponsor|9|||
160980226|NCT04781647|581317393|FG002|Overall Study|Study terminated by Sponsor|9|||
160980227|NCT04781647|581317391|FG000|Overall Study|Withdrawal by Subject|1|||
160980228|NCT04781647|581317392|FG001|Overall Study|Withdrawal by Subject|2|||
160980229|NCT04781647|581317393|FG002|Overall Study|Withdrawal by Subject|0|||
160980230|NCT04781647|581317391|FG000|Overall Study|Adverse Event|0|||
160980231|NCT04781647|581317392|FG001|Overall Study|Adverse Event|1|||
160980232|NCT04781647|581317393|FG002|Overall Study|Adverse Event|1|||
160980233|NCT04781647|581317391|FG000|Overall Study|Protocol Violation|1|||
160980234|NCT04781647|581317392|FG001|Overall Study|Protocol Violation|0|||
160980235|NCT04781647|581317393|FG002|Overall Study|Protocol Violation|0|||
160980236|NCT04781647|581317391|FG000|Overall Study|Pregnancy|0|||
160980237|NCT04781647|581317392|FG001|Overall Study|Pregnancy|0|||
160980238|NCT04781647|581317393|FG002|Overall Study|Pregnancy|1|||
160980239|NCT04781647|581317391|FG000|Overall Study|Virology rebounded|1|||
160980240|NCT04781647|581317392|FG001|Overall Study|Virology rebounded|0|||
160980241|NCT04781647|581317393|FG002|Overall Study|Virology rebounded|0|||
160980242|NCT00777803|581317394|FG000|Overall Study|Lost to Follow-up|12|||
160980243|NCT00777803|581317395|FG001|Overall Study|Lost to Follow-up|5|||
160980244|NCT00777803|581317394|FG000|Overall Study|Adverse Event|1|||
160980245|NCT00777803|581317395|FG001|Overall Study|Adverse Event|0|||
160980246|NCT00777803|581317394|FG000|Overall Study|Non-compliance|2|||
160980247|NCT00777803|581317395|FG001|Overall Study|Non-compliance|2|||
160980248|NCT01755689|581317396|FG000|Overall Study|Withdrawal by Subject|1|||
160980249|NCT01755689|581317397|FG001|Overall Study|Withdrawal by Subject|3|||
160980250|NCT01755689|581317398|FG002|Overall Study|Withdrawal by Subject|2|||
160980251|NCT01755689|581317399|FG003|Overall Study|Withdrawal by Subject|1|||
160980252|NCT01755689|581317400|FG004|Overall Study|Withdrawal by Subject|1|||
160980253|NCT01755689|581317396|FG000|Overall Study|Migrated/moved from study area|0|||
160980254|NCT01755689|581317397|FG001|Overall Study|Migrated/moved from study area|1|||
160980255|NCT01755689|581317398|FG002|Overall Study|Migrated/moved from study area|1|||
160980256|NCT01755689|581317399|FG003|Overall Study|Migrated/moved from study area|1|||
160980257|NCT01755689|581317400|FG004|Overall Study|Migrated/moved from study area|1|||
160980258|NCT01755689|581317396|FG000|Overall Study|Lost to Follow-up|1|||
160980259|NCT01755689|581317397|FG001|Overall Study|Lost to Follow-up|0|||
160980260|NCT01755689|581317398|FG002|Overall Study|Lost to Follow-up|1|||
160980261|NCT01755689|581317399|FG003|Overall Study|Lost to Follow-up|0|||
160980262|NCT01755689|581317400|FG004|Overall Study|Lost to Follow-up|2|||
160980263|NCT01755689|581317396|FG000|Overall Study|Pregnancy|1|||
160980264|NCT01755689|581317397|FG001|Overall Study|Pregnancy|1|||
160980265|NCT01755689|581317398|FG002|Overall Study|Pregnancy|2|||
160980266|NCT01755689|581317399|FG003|Overall Study|Pregnancy|4|||
160980267|NCT01755689|581317400|FG004|Overall Study|Pregnancy|2|||
160980268|NCT02930122|581317403|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
160980269|NCT02930122|581317404|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
160980270|NCT01995357|581317405|FG000|Period 5|Lack of Efficacy|1|||
160980271|NCT01995357|581317406|FG001|Period 5|Lack of Efficacy|0|||
160980272|NCT01995357|581317407|FG002|Period 5|Lack of Efficacy|0|||
160980273|NCT01995357|581317408|FG003|Period 5|Lack of Efficacy|0|||
160980274|NCT01995357|581317409|FG004|Period 5|Lack of Efficacy|0|||
160980275|NCT01995357|581317410|FG005|Period 5|Lack of Efficacy|0|||
160980276|NCT01995357|581317405|FG000|Period 5|Adverse Event|1|||
160980277|NCT01995357|581317406|FG001|Period 5|Adverse Event|0|||
160980278|NCT01995357|581317407|FG002|Period 5|Adverse Event|1|||
160980279|NCT01995357|581317408|FG003|Period 5|Adverse Event|0|||
160980280|NCT01995357|581317409|FG004|Period 5|Adverse Event|0|||
160980281|NCT01995357|581317410|FG005|Period 5|Adverse Event|0|||
160980282|NCT02609659|581317411|FG000|Overall Study|Adverse Event|1|||
160980283|NCT02609659|581317411|FG000|Overall Study|Lost to Follow-up|6|||
160980284|NCT02609659|581317411|FG000|Overall Study|Other|1|||
160980285|NCT01004250|581317414|FG000|Induction Therapy Period|Adverse Event|10|||
160980286|NCT01004250|581317414|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
160980287|NCT01004250|581317414|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
160980288|NCT01004250|581317414|FG000|Induction Therapy Period|Physician Decision|2|||
160980289|NCT01004250|581317414|FG000|Maintenance Therapy Period|Adverse Event|15|||
160980290|NCT01004250|581317414|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
160980291|NCT01004250|581317414|FG000|Maintenance Therapy Period|Protocol Violation|1|||
160980292|NCT01004250|581317414|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
160980293|NCT01004250|581317414|FG000|Maintenance Therapy Period|Physician Decision|4|||
160980294|NCT01004250|581317414|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
160980295|NCT01853254|581317415|FG000|Overall Study|Abnormal Laboratory Test|1|||
160980296|NCT01853254|581317415|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
160980297|NCT01853254|581317415|FG000|Overall Study|Death|1|||
160980298|NCT01853254|581317415|FG000|Overall Study|Failure to Return|43|||
160980299|NCT01853254|581317415|FG000|Overall Study|Insufficient Therapeutic Response|22|||
160980300|NCT01853254|581317415|FG000|Overall Study|Refusal of Treatment|1|||
160980301|NCT01853254|581317415|FG000|Overall Study|Other Protocol Violation|1|||
161092873|NCT02647320|581731696|FG000|Overall Study|Adverse Event|0|||
161092874|NCT02647320|581731697|FG001|Overall Study|Adverse Event|1|||
161092875|NCT02647320|581731698|FG002|Overall Study|Adverse Event|3|||
161092876|NCT02647320|581731699|FG003|Overall Study|Adverse Event|2|||
161092877|NCT02647320|581731700|FG004|Overall Study|Adverse Event|1|||
161092878|NCT02647320|581731696|FG000|Overall Study|Protocol Violation|0|||
161092879|NCT02647320|581731697|FG001|Overall Study|Protocol Violation|0|||
161092880|NCT02647320|581731698|FG002|Overall Study|Protocol Violation|3|||
161092881|NCT02647320|581731699|FG003|Overall Study|Protocol Violation|0|||
161092882|NCT02647320|581731700|FG004|Overall Study|Protocol Violation|0|||
161092883|NCT02647320|581731696|FG000|Overall Study|Withdrawal by Subject|7|||
161092884|NCT02647320|581731697|FG001|Overall Study|Withdrawal by Subject|4|||
161092885|NCT02647320|581731698|FG002|Overall Study|Withdrawal by Subject|2|||
161092886|NCT02647320|581731699|FG003|Overall Study|Withdrawal by Subject|2|||
161092887|NCT02647320|581731700|FG004|Overall Study|Withdrawal by Subject|7|||
161092888|NCT02647320|581731696|FG000|Overall Study|Persistent hyperglycemia|0|||
161092889|NCT02647320|581731697|FG001|Overall Study|Persistent hyperglycemia|1|||
161092890|NCT02647320|581731698|FG002|Overall Study|Persistent hyperglycemia|1|||
161092891|NCT02647320|581731699|FG003|Overall Study|Persistent hyperglycemia|1|||
161092892|NCT02647320|581731700|FG004|Overall Study|Persistent hyperglycemia|1|||
161092893|NCT02647320|581731696|FG000|Overall Study|Study terminated by sponsor|1|||
161092894|NCT02647320|581731697|FG001|Overall Study|Study terminated by sponsor|1|||
161142542|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Death|1|||
161142543|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Death|0|||
160980302|NCT01853254|581317415|FG000|Overall Study|Withdrawal of Consent|16|||
160980303|NCT01853254|581317415|FG000|Overall Study|Administrative/Other|16|||
160980304|NCT02462083|581317416|FG000|Overall Study|Sponsor request|39|||
160980305|NCT02462083|581317416|FG000|Overall Study|Withdrawal by Subject|87|||
160980306|NCT02462083|581317416|FG000|Overall Study|Lost to Follow-up|41|||
160980307|NCT02462083|581317416|FG000|Overall Study|Lack of Efficacy|151|||
160980308|NCT02462083|581317416|FG000|Overall Study|Pregnancy|1|||
160980309|NCT02462083|581317416|FG000|Overall Study|Protocol Violation|6|||
160980310|NCT02462083|581317416|FG000|Overall Study|Adverse Event|33|||
160980311|NCT02462083|581317416|FG000|Overall Study|Worsening condition|16|||
160980312|NCT02462083|581317416|FG000|Overall Study|Other than specified|45|||
160980313|NCT02711995|581317419|FG000|Washout (90 Days)|Conflicting medication|1|||
160980314|NCT01383993|581317425|FG000|Overall Study|Adverse Event|1|||
160980315|NCT01383993|581317426|FG001|Overall Study|Adverse Event|1|||
160980316|NCT01383993|581317427|FG002|Overall Study|Adverse Event|0|||
160980317|NCT01383993|581317425|FG000|Overall Study|Withdrawal by Subject|0|||
160980318|NCT01383993|581317426|FG001|Overall Study|Withdrawal by Subject|0|||
160980319|NCT01383993|581317427|FG002|Overall Study|Withdrawal by Subject|1|||
160980320|NCT01383993|581317425|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
160980321|NCT01383993|581317426|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
160980322|NCT01383993|581317427|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
160980323|NCT01489020|581317432|FG000|Overall Study|Withdrawal by Subject|1|||
160980324|NCT01489020|581317433|FG001|Overall Study|Withdrawal by Subject|0|||
160980325|NCT01489020|581317434|FG002|Overall Study|Withdrawal by Subject|0|||
160980326|NCT01489020|581317435|FG003|Overall Study|Withdrawal by Subject|0|||
160980327|NCT01489020|581317436|FG004|Overall Study|Withdrawal by Subject|0|||
160980328|NCT01489020|581317437|FG005|Overall Study|Withdrawal by Subject|0|||
160980329|NCT01489020|581317432|FG000|Overall Study|Adverse Event|0|||
160980330|NCT01489020|581317433|FG001|Overall Study|Adverse Event|0|||
160980331|NCT01489020|581317434|FG002|Overall Study|Adverse Event|3|||
160980332|NCT01489020|581317435|FG003|Overall Study|Adverse Event|0|||
160980333|NCT01489020|581317436|FG004|Overall Study|Adverse Event|3|||
160980334|NCT01489020|581317437|FG005|Overall Study|Adverse Event|0|||
160980335|NCT01489020|581317432|FG000|Overall Study|Concomitant disease|0|||
160980336|NCT01489020|581317433|FG001|Overall Study|Concomitant disease|0|||
160980337|NCT01489020|581317434|FG002|Overall Study|Concomitant disease|0|||
160980338|NCT01489020|581317435|FG003|Overall Study|Concomitant disease|0|||
160980339|NCT01489020|581317436|FG004|Overall Study|Concomitant disease|3|||
160980340|NCT01489020|581317437|FG005|Overall Study|Concomitant disease|0|||
160980341|NCT02451930|581317439|FG000|Overall Study|Death|0|||
160980342|NCT02451930|581317440|FG001|Overall Study|Death|15|||
160980343|NCT02451930|581317439|FG000|Overall Study|Lost to Follow-up|0|||
160980344|NCT02451930|581317440|FG001|Overall Study|Lost to Follow-up|3|||
160980345|NCT02451930|581317439|FG000|Overall Study|Sponsor Decision|2|||
160980346|NCT02451930|581317440|FG001|Overall Study|Sponsor Decision|10|||
160980347|NCT02451930|581317439|FG000|Overall Study|Withdrawal by Subject|0|||
160980348|NCT02451930|581317440|FG001|Overall Study|Withdrawal by Subject|1|||
160980349|NCT02451930|581317439|FG000|Overall Study|Other|0|||
160980350|NCT02451930|581317440|FG001|Overall Study|Other|1|||
160980351|NCT00962585|581317441|FG000|Overall Study|Adverse Event|0|||
160980352|NCT00962585|581317442|FG001|Overall Study|Adverse Event|2|||
160980353|NCT00962585|581317443|FG002|Overall Study|Adverse Event|1|||
160980354|NCT00962585|581317444|FG003|Overall Study|Adverse Event|0|||
160980355|NCT00962585|581317441|FG000|Overall Study|Lost to Follow-up|3|||
160980356|NCT00962585|581317442|FG001|Overall Study|Lost to Follow-up|0|||
160980357|NCT00962585|581317443|FG002|Overall Study|Lost to Follow-up|1|||
160980358|NCT00962585|581317444|FG003|Overall Study|Lost to Follow-up|0|||
160980359|NCT00962585|581317441|FG000|Overall Study|Protocol Violation|0|||
160980360|NCT00962585|581317442|FG001|Overall Study|Protocol Violation|0|||
160980361|NCT00962585|581317443|FG002|Overall Study|Protocol Violation|1|||
160980362|NCT00962585|581317444|FG003|Overall Study|Protocol Violation|0|||
160980363|NCT00962585|581317441|FG000|Overall Study|Withdrawal by Subject|1|||
160980364|NCT00962585|581317442|FG001|Overall Study|Withdrawal by Subject|0|||
160980365|NCT00962585|581317443|FG002|Overall Study|Withdrawal by Subject|0|||
160980366|NCT00962585|581317444|FG003|Overall Study|Withdrawal by Subject|0|||
160980367|NCT00962585|581317441|FG000|Overall Study|Withdrew Consent|2|||
160980368|NCT00962585|581317442|FG001|Overall Study|Withdrew Consent|0|||
160980369|NCT00962585|581317443|FG002|Overall Study|Withdrew Consent|0|||
160980370|NCT00962585|581317444|FG003|Overall Study|Withdrew Consent|0|||
160980371|NCT00262743|581317445|FG000|Overall Study|Adverse Event|0|||
160980372|NCT00262743|581317446|FG001|Overall Study|Adverse Event|9|||
161322805|NCT00878800|582568590|FG001|Overall Study|Other|1|||
161322806|NCT00878800|582568591|FG002|Overall Study|Other|0|||
161322807|NCT00878800|582568592|FG003|Overall Study|Other|0|||
161322808|NCT00878800|582568593|FG004|Overall Study|Other|1|||
161322809|NCT02072941|582568594|FG000|Overall Study|Withdrawal by Subject|29|||
161322810|NCT02072941|582568595|FG001|Overall Study|Withdrawal by Subject|21|||
161322811|NCT02072941|582568594|FG000|Overall Study|Lost to Follow-up|4|||
161322812|NCT02072941|582568595|FG001|Overall Study|Lost to Follow-up|4|||
161322813|NCT02072941|582568594|FG000|Overall Study|Death|3|||
161322814|NCT02072941|582568595|FG001|Overall Study|Death|2|||
161322815|NCT02072941|582568594|FG000|Overall Study|Removed by Study Staff|2|||
161322816|NCT02072941|582568595|FG001|Overall Study|Removed by Study Staff|2|||
161322817|NCT00715299|582568603|FG000|Overall Study|Withdrawal by Subject|1|||
161322818|NCT00715299|582568603|FG000|Overall Study|Adverse Event|3|||
161322819|NCT00715299|582568603|FG000|Overall Study|failed the pre-screen exercise test|2|||
161322820|NCT02020889|582568604|FG000|Overall Study|Adverse Event|0|||
161322821|NCT02020889|582568605|FG001|Overall Study|Adverse Event|1|||
161322822|NCT02020889|582568604|FG000|Overall Study|Lack of Efficacy|1|||
161322823|NCT02020889|582568605|FG001|Overall Study|Lack of Efficacy|0|||
161322824|NCT02020889|582568604|FG000|Overall Study|Lost to Follow-up|1|||
161322825|NCT02020889|582568605|FG001|Overall Study|Lost to Follow-up|0|||
161322826|NCT02020889|582568604|FG000|Overall Study|Physician Decision|2|||
161322827|NCT02020889|582568605|FG001|Overall Study|Physician Decision|0|||
161322828|NCT02020889|582568604|FG000|Overall Study|Withdrawal by Subject|3|||
161322829|NCT02020889|582568605|FG001|Overall Study|Withdrawal by Subject|2|||
161322830|NCT00809094|582568606|FG000|Overall Study|Lost to Follow-up|0|||
161322831|NCT00809094|582568607|FG001|Overall Study|Lost to Follow-up|1|||
161322832|NCT00232557|582568608|FG000|Overall Study|Lost to Follow-up|3|||
161322833|NCT00232557|582568609|FG001|Overall Study|Lost to Follow-up|5|||
161322834|NCT02457195|582568614|FG000|Overall Study|Adverse Event|3|||
161322835|NCT02457195|582568614|FG000|Overall Study|Protocol Violation|2|||
161322836|NCT02457195|582568614|FG000|Overall Study|Withdrawal by Subject|4|||
161322837|NCT04819438|582568616|FG000|Overall Study|Withdrawal by Subject|1|||
161322838|NCT04819438|582568617|FG001|Overall Study|Withdrawal by Subject|0|||
161322839|NCT04819438|582568616|FG000|Overall Study|Adverse Event|0|||
161322840|NCT04819438|582568617|FG001|Overall Study|Adverse Event|1|||
161322841|NCT04819438|582568616|FG000|Overall Study|Protocol Violation|0|||
161322842|NCT04819438|582568617|FG001|Overall Study|Protocol Violation|1|||
161322843|NCT03836209|582568618|FG000|Overall Study|Adverse Event|5|||
161322844|NCT03836209|582568619|FG001|Overall Study|Adverse Event|2|||
161322845|NCT03836209|582568618|FG000|Overall Study|Death|4|||
161322846|NCT03836209|582568619|FG001|Overall Study|Death|1|||
161322847|NCT03836209|582568618|FG000|Overall Study|Lack of Efficacy|7|||
161322848|NCT03836209|582568619|FG001|Overall Study|Lack of Efficacy|10|||
161322849|NCT03836209|582568618|FG000|Overall Study|Physician Decision|7|||
161322850|NCT03836209|582568619|FG001|Overall Study|Physician Decision|11|||
161322851|NCT03836209|582568618|FG000|Overall Study|Protocol Violation|0|||
161322852|NCT03836209|582568619|FG001|Overall Study|Protocol Violation|3|||
161322853|NCT03836209|582568618|FG000|Overall Study|Withdrawal by Subject|2|||
161322854|NCT03836209|582568619|FG001|Overall Study|Withdrawal by Subject|10|||
161322855|NCT03836209|582568618|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
160980373|NCT00262743|581317445|FG000|Overall Study|Disease progression|0|||
160980374|NCT00262743|581317446|FG001|Overall Study|Disease progression|3|||
160980375|NCT02485353|581317447|FG000|Overall Study|Death|1|||
160980376|NCT02485353|581317447|FG000|Overall Study|Disease Progression|1|||
160980377|NCT04430335|581317456|FG000|Overall Study|Withdrawal by Subject|1|||
160980378|NCT00179010|581317459|FG000|Overall Study|Muscle probe defective|1|||
160980379|NCT00179010|581317460|FG001|Overall Study|Muscle probe defective|1|||
161322856|NCT03836209|582568619|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
161322857|NCT05980013|582568620|FG000|Overall Study|Withdrawal by Subject|0|||
161322858|NCT05980013|582568621|FG001|Overall Study|Withdrawal by Subject|1|||
161322859|NCT05980013|582568620|FG000|Overall Study|Device Error|0|||
160980380|NCT00179010|581317459|FG000|Overall Study|Failure to place arterial line|0|||
160980381|NCT00179010|581317460|FG001|Overall Study|Failure to place arterial line|1|||
160980382|NCT03249376|581317478|FG000|Overall Study|Adverse Event|11|||
160980383|NCT03249376|581317479|FG001|Overall Study|Adverse Event|5|||
160980384|NCT03249376|581317478|FG000|Overall Study|Lack of Efficacy|2|||
160980385|NCT03249376|581317479|FG001|Overall Study|Lack of Efficacy|4|||
160980386|NCT03249376|581317478|FG000|Overall Study|Protocol Violation|3|||
160980387|NCT03249376|581317479|FG001|Overall Study|Protocol Violation|2|||
160980388|NCT03249376|581317478|FG000|Overall Study|Physician Decision|0|||
160980389|NCT03249376|581317479|FG001|Overall Study|Physician Decision|2|||
160980390|NCT03249376|581317478|FG000|Overall Study|Withdrawal by Subject|3|||
160980391|NCT03249376|581317479|FG001|Overall Study|Withdrawal by Subject|9|||
160980392|NCT03249376|581317478|FG000|Overall Study|LTFU|2|||
160980393|NCT03249376|581317479|FG001|Overall Study|LTFU|1|||
160980394|NCT00627042|581317480|FG000|Overall Study|Withdrawal by Subject|2|||
160980395|NCT00794820|581317488|FG000|Overall Study|Adverse Event|11|||
160980396|NCT00794820|581317488|FG000|Overall Study|Secondary Malignancies|2|||
160980397|NCT00794820|581317488|FG000|Overall Study|Resistant Disease|2|||
160980398|NCT00794820|581317488|FG000|Overall Study|Ineligible/Screen Failure|1|||
160980399|NCT00432679|581317492|FG000|Overall Study|Adverse Event|2|||
160980400|NCT00432679|581317493|FG001|Overall Study|Adverse Event|1|||
160980401|NCT00432679|581317492|FG000|Overall Study|Withdrawal by Subject|3|||
160980402|NCT00432679|581317493|FG001|Overall Study|Withdrawal by Subject|2|||
160980403|NCT00280293|581317495|FG000|Overall Study|Protocol Violation|3|||
160980404|NCT00280293|581317496|FG001|Overall Study|Protocol Violation|0|||
160980405|NCT00280293|581317495|FG000|Overall Study|Physician Decision|5|||
160980406|NCT00280293|581317496|FG001|Overall Study|Physician Decision|4|||
160980407|NCT00280293|581317495|FG000|Overall Study|Lost to Follow-up|14|||
160980408|NCT00280293|581317496|FG001|Overall Study|Lost to Follow-up|12|||
161092895|NCT02647320|581731698|FG002|Overall Study|Study terminated by sponsor|1|||
161092896|NCT02647320|581731699|FG003|Overall Study|Study terminated by sponsor|1|||
161092897|NCT02647320|581731700|FG004|Overall Study|Study terminated by sponsor|2|||
161092898|NCT02647320|581731696|FG000|Overall Study|Reason not provided|0|||
161092899|NCT02647320|581731697|FG001|Overall Study|Reason not provided|0|||
161092900|NCT02647320|581731698|FG002|Overall Study|Reason not provided|1|||
161092901|NCT02647320|581731699|FG003|Overall Study|Reason not provided|0|||
161092902|NCT02647320|581731700|FG004|Overall Study|Reason not provided|2|||
161092903|NCT02647320|581731696|FG000|Overall Study|Lost to Follow-up|1|||
161092904|NCT02647320|581731697|FG001|Overall Study|Lost to Follow-up|1|||
161092905|NCT02647320|581731698|FG002|Overall Study|Lost to Follow-up|0|||
161092906|NCT02647320|581731699|FG003|Overall Study|Lost to Follow-up|0|||
161092907|NCT02647320|581731700|FG004|Overall Study|Lost to Follow-up|0|||
161092908|NCT02647320|581731696|FG000|Overall Study|Develop anemia|1|||
161092909|NCT02647320|581731697|FG001|Overall Study|Develop anemia|0|||
161092910|NCT02647320|581731698|FG002|Overall Study|Develop anemia|0|||
161092911|NCT02647320|581731699|FG003|Overall Study|Develop anemia|0|||
161092912|NCT02647320|581731700|FG004|Overall Study|Develop anemia|0|||
161092913|NCT02647320|581731696|FG000|Overall Study|Lack of Efficacy|0|||
161092914|NCT02647320|581731697|FG001|Overall Study|Lack of Efficacy|0|||
161092915|NCT02647320|581731698|FG002|Overall Study|Lack of Efficacy|0|||
161092916|NCT02647320|581731699|FG003|Overall Study|Lack of Efficacy|1|||
161092917|NCT02647320|581731700|FG004|Overall Study|Lack of Efficacy|0|||
161092918|NCT02647320|581731696|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
161092919|NCT02647320|581731697|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
161092920|NCT02647320|581731698|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
161092921|NCT02647320|581731699|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
161092922|NCT02647320|581731700|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
161092923|NCT00081770|581731701|FG000|Overall Study|Adverse Event|130|||
161092924|NCT00081770|581731702|FG001|Overall Study|Adverse Event|98|||
161092925|NCT00081770|581731703|FG002|Overall Study|Adverse Event|136|||
161092926|NCT00081770|581731701|FG000|Overall Study|Lack of Efficacy|262|||
161092927|NCT00081770|581731702|FG001|Overall Study|Lack of Efficacy|357|||
161092928|NCT00081770|581731703|FG002|Overall Study|Lack of Efficacy|211|||
161092929|NCT00081770|581731701|FG000|Overall Study|Lost to Follow-up|45|||
161092930|NCT00081770|581731702|FG001|Overall Study|Lost to Follow-up|34|||
161209304|NCT01347879|582149071|FG000|Overall Study|Lost to Follow-up|2|||
160980409|NCT00280293|581317495|FG000|Overall Study|Withdrawal by Subject|3|||
160980410|NCT00280293|581317496|FG001|Overall Study|Withdrawal by Subject|5|||
160980411|NCT00280293|581317495|FG000|Overall Study|Incarceration/Legal Reasons|1|||
160980412|NCT00280293|581317496|FG001|Overall Study|Incarceration/Legal Reasons|1|||
160980413|NCT00280293|581317495|FG000|Overall Study|Adverse Event|0|||
160980414|NCT00280293|581317496|FG001|Overall Study|Adverse Event|1|||
160980415|NCT01177813|581317497|FG000|Overall Study|Adverse Event|8|||
160980416|NCT01177813|581317498|FG001|Overall Study|Adverse Event|2|||
160980417|NCT01177813|581317499|FG002|Overall Study|Adverse Event|4|||
160980418|NCT01177813|581317500|FG003|Overall Study|Adverse Event|6|||
160980419|NCT01177813|581317501|FG004|Overall Study|Adverse Event|3|||
160980420|NCT01177813|581317497|FG000|Overall Study|Lack of Efficacy|1|||
161092931|NCT00081770|581731703|FG002|Overall Study|Lost to Follow-up|45|||
161092932|NCT00081770|581731701|FG000|Overall Study|Protocol Violation|15|||
161092933|NCT00081770|581731702|FG001|Overall Study|Protocol Violation|10|||
161092934|NCT00081770|581731703|FG002|Overall Study|Protocol Violation|10|||
161092935|NCT00081770|581731701|FG000|Overall Study|Withdrawal by Subject|45|||
161092936|NCT00081770|581731702|FG001|Overall Study|Withdrawal by Subject|40|||
161092937|NCT00081770|581731703|FG002|Overall Study|Withdrawal by Subject|42|||
161092938|NCT00081770|581731701|FG000|Overall Study|Did not meet protocol eligibility|2|||
161092939|NCT00081770|581731702|FG001|Overall Study|Did not meet protocol eligibility|0|||
161092940|NCT00081770|581731703|FG002|Overall Study|Did not meet protocol eligibility|3|||
161092941|NCT00081770|581731701|FG000|Overall Study|Administrative|1|||
161092942|NCT00081770|581731702|FG001|Overall Study|Administrative|0|||
161092943|NCT00081770|581731703|FG002|Overall Study|Administrative|1|||
161092944|NCT00081770|581731701|FG000|Overall Study|Other|2|||
161092945|NCT00081770|581731702|FG001|Overall Study|Other|7|||
161092946|NCT00081770|581731703|FG002|Overall Study|Other|8|||
161092947|NCT01072877|581731704|FG000|Overall Study|Lost to Follow-up|1|||
161092948|NCT01072877|581731705|FG001|Overall Study|Lost to Follow-up|1|||
161092949|NCT01072877|581731706|FG002|Overall Study|Lost to Follow-up|0|||
161092950|NCT01072877|581731707|FG003|Overall Study|Lost to Follow-up|2|||
161092951|NCT01072877|581731708|FG004|Overall Study|Lost to Follow-up|0|||
161092952|NCT00601419|581731709|FG000|Overall Study|Lost to Follow-up|3|||
161092953|NCT00601419|581731709|FG000|Overall Study|Missed Visits|1|||
161092954|NCT01217957|581731720|FG000|Phase 1|Withdrawal by Patient|1|||
161092955|NCT01217957|581731721|FG001|Phase 1|Withdrawal by Patient|0|||
161092956|NCT01217957|581731722|FG002|Phase 1|Withdrawal by Patient|1|||
161092957|NCT01217957|581731723|FG003|Phase 1|Withdrawal by Patient|1|||
161092958|NCT01217957|581731724|FG004|Phase 1|Withdrawal by Patient|0|||
161092959|NCT01217957|581731720|FG000|Phase 2|Withdrawal by Patient|0|||
161092960|NCT01217957|581731721|FG001|Phase 2|Withdrawal by Patient|0|||
161092961|NCT01217957|581731722|FG002|Phase 2|Withdrawal by Patient|0|||
161092962|NCT01217957|581731723|FG003|Phase 2|Withdrawal by Patient|0|||
161092963|NCT01217957|581731724|FG004|Phase 2|Withdrawal by Patient|1|||
161092964|NCT00971932|581731725|FG000|Overall Study|Withdrawal by Subject|1|||
161092965|NCT00971932|581731725|FG000|Overall Study|Investigator's decision|2|||
161092966|NCT00971932|581731725|FG000|Overall Study|Ongoing|4|||
161092967|NCT01640054|581731726|FG000|Overall Study|Study-specific disc criteria|1|||
161092968|NCT01640054|581731726|FG000|Overall Study|Lack of Efficacy|3|||
161092969|NCT01640054|581731726|FG000|Overall Study|Adverse Event|2|||
161092970|NCT01206777|581731728|FG000|Overall Study|Death|1|||
161092971|NCT01206777|581731728|FG000|Overall Study|Adverse Event|1|||
161092972|NCT02382016|581731729|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
161092973|NCT02382016|581731730|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
161092974|NCT02382016|581731729|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
161092975|NCT02382016|581731730|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
161092976|NCT02382016|581731729|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
161092977|NCT02382016|581731730|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
161092978|NCT02382016|581731729|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
161092979|NCT02382016|581731730|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
161092980|NCT02382016|581731729|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
161092981|NCT02382016|581731730|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
161092982|NCT02382016|581731729|FG000|Open-label (OL) Treatment Period|Death|4|||
161092983|NCT02382016|581731730|FG001|Open-label (OL) Treatment Period|Death|0|||
161092984|NCT02382016|581731729|FG000|OL Extension Period|Physician Decision|3|||
161092985|NCT02382016|581731730|FG001|OL Extension Period|Physician Decision|0|||
161092986|NCT02382016|581731729|FG000|OL Extension Period|Death|2|||
161092987|NCT02382016|581731730|FG001|OL Extension Period|Death|0|||
161092988|NCT02382016|581731729|FG000|OL Extension Period|Withdrawal by Subject|1|||
161092989|NCT02382016|581731730|FG001|OL Extension Period|Withdrawal by Subject|0|||
161092990|NCT00730171|581731735|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
161092991|NCT00730171|581731735|FG000|Overall Study|Adverse Event|193|||
161092992|NCT00730171|581731735|FG000|Overall Study|Protocol Violation|48|||
161092993|NCT00730171|581731735|FG000|Overall Study|Withdrawal by Subject|202|||
161092994|NCT00730171|581731735|FG000|Overall Study|Lost to Follow-up|121|||
161092995|NCT00730171|581731735|FG000|Overall Study|Insufficient Therapeutic Response|141|||
161092996|NCT00730171|581731735|FG000|Overall Study|Other|61|||
161092997|NCT01729156|581731736|FG000|Overall Study|Withdrawal by Subject|1|||
161092998|NCT01729156|581731737|FG001|Overall Study|Withdrawal by Subject|0|||
161092999|NCT01729156|581731738|FG002|Overall Study|Withdrawal by Subject|0|||
161093000|NCT01256658|581731741|FG000|Period 1|Lost to Follow-up|837|||
161093001|NCT01256658|581731742|FG001|Period 1|Lost to Follow-up|661|||
161093002|NCT01256658|581731741|FG000|Period 1|Withdrawal by Subject|35|||
161093003|NCT01256658|581731742|FG001|Period 1|Withdrawal by Subject|43|||
161093004|NCT01256658|581731741|FG000|Period 1|Death|48|||
161093005|NCT01256658|581731742|FG001|Period 1|Death|44|||
161093006|NCT00719563|581731743|FG000|Overall Study|Adverse Event|16|||
161093007|NCT00719563|581731744|FG001|Overall Study|Adverse Event|13|||
161093008|NCT00719563|581731743|FG000|Overall Study|Medical condition changed|3|||
161093009|NCT00719563|581731744|FG001|Overall Study|Medical condition changed|5|||
161093010|NCT00719563|581731743|FG000|Overall Study|Lack of Efficacy|3|||
161093011|NCT00719563|581731744|FG001|Overall Study|Lack of Efficacy|7|||
161093012|NCT00719563|581731743|FG000|Overall Study|Personal reasons|6|||
161093013|NCT00719563|581731744|FG001|Overall Study|Personal reasons|7|||
161093014|NCT00719563|581731743|FG000|Overall Study|Unknown reasons|4|||
161093015|NCT00719563|581731744|FG001|Overall Study|Unknown reasons|6|||
161093016|NCT00719563|581731743|FG000|Overall Study|Noncompliant|1|||
161093017|NCT00719563|581731744|FG001|Overall Study|Noncompliant|1|||
161093018|NCT00719563|581731743|FG000|Overall Study|Lost to Follow-up|5|||
161093019|NCT00719563|581731744|FG001|Overall Study|Lost to Follow-up|3|||
161093020|NCT01386788|581731747|FG000|Overall Study|Lost to Follow-up|2|||
161093021|NCT00462865|581731750|FG000|Overall Study|Adverse Event|1|||
161093022|NCT02120625|581731751|FG000|Overall Study|Physician Decision|2|||
161093023|NCT04142450|581731752|FG000|Overall Study|Screen Failure|1|||
161093024|NCT04142450|581731752|FG000|Overall Study|Lost to Follow-up|1|||
161093025|NCT00120406|581731753|FG000|Overall Study|Death|9|||
161093026|NCT00120406|581731754|FG001|Overall Study|Death|4|||
161093027|NCT00120406|581731753|FG000|Overall Study|Withdrawal by Subject|5|||
161093028|NCT00120406|581731754|FG001|Overall Study|Withdrawal by Subject|7|||
161093029|NCT00120406|581731753|FG000|Overall Study|Lost to Follow-up|5|||
161093030|NCT00120406|581731754|FG001|Overall Study|Lost to Follow-up|2|||
161093031|NCT00120406|581731753|FG000|Overall Study|received non-study stent|0|||
161093032|NCT00120406|581731754|FG001|Overall Study|received non-study stent|2|||
161093033|NCT00120406|581731753|FG000|Overall Study|patient moved but has not withdrawn|0|||
161093034|NCT00120406|581731754|FG001|Overall Study|patient moved but has not withdrawn|1|||
161093035|NCT06336603|581731755|FG000|Overall Study|Withdrawal by Subject|1|||
161093036|NCT06336603|581731755|FG000|Overall Study|Lost to Follow-up|2|||
161093037|NCT00975507|581731763|FG000|Overall Study|Adverse Event|1|||
161093038|NCT00975507|581731764|FG001|Overall Study|Adverse Event|0|||
161093039|NCT00975507|581731763|FG000|Overall Study|Lost to Follow-up|7|||
161093040|NCT00975507|581731764|FG001|Overall Study|Lost to Follow-up|1|||
161093041|NCT00975507|581731763|FG000|Overall Study|Protocol Violation|2|||
161093042|NCT00975507|581731764|FG001|Overall Study|Protocol Violation|0|||
161093043|NCT00975507|581731763|FG000|Overall Study|Withdrawal by Subject|10|||
161093044|NCT00975507|581731764|FG001|Overall Study|Withdrawal by Subject|3|||
161093045|NCT01295034|581731765|FG000|Overall Study|Lost to Follow-up|5|||
161093046|NCT01295034|581731766|FG001|Overall Study|Lost to Follow-up|5|||
161093047|NCT03249714|581731767|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
161093048|NCT03249714|581731768|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
161093049|NCT03249714|581731767|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
161093050|NCT03249714|581731768|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
161093051|NCT03249714|581731767|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
161093052|NCT03249714|581731768|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
161093053|NCT03249714|581731767|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
161093054|NCT03249714|581731768|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
161093055|NCT00824161|581731771|FG000|Overall Study|Withdrawal by Subject|1|||
161093056|NCT00824161|581731771|FG000|Overall Study|Screen Failure|1|||
161093057|NCT00879762|581731772|FG000|Overall Study|Lost to Follow-up|3|||
161093058|NCT00879762|581731773|FG001|Overall Study|Lost to Follow-up|1|||
161093059|NCT04754477|581731776|FG000|Overall Study|Withdrawal by Subject|1|||
161093060|NCT02699983|581731778|FG000|Overall Study|Withdrawal by Subject|1|||
161093061|NCT02699983|581731779|FG001|Overall Study|Withdrawal by Subject|0|||
161093062|NCT03575143|581731780|FG000|Overall Study|Lost to Follow-up|0|||
161093063|NCT03575143|581731781|FG001|Overall Study|Lost to Follow-up|0|||
161093064|NCT03575143|581731782|FG002|Overall Study|Lost to Follow-up|4|||
161093065|NCT03575143|581731780|FG000|Overall Study|Withdrawal by Subject|0|||
161093066|NCT03575143|581731781|FG001|Overall Study|Withdrawal by Subject|0|||
161093067|NCT03575143|581731782|FG002|Overall Study|Withdrawal by Subject|5|||
161093068|NCT03575143|581731780|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
161093069|NCT03575143|581731781|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
161093070|NCT03575143|581731782|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
161093071|NCT01211197|581731786|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161093072|NCT01211197|581731787|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161093073|NCT01211197|581731788|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161093074|NCT01211197|581731789|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161093075|NCT01211197|581731790|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161093076|NCT01211197|581731791|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161093077|NCT01211197|581731786|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
161093078|NCT01211197|581731787|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
161093079|NCT01211197|581731788|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
161093080|NCT01211197|581731789|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
161093081|NCT01211197|581731790|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
161093082|NCT01211197|581731791|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
161142544|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Death|0|||
161093083|NCT01776424|581731792|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
161093084|NCT01776424|581731793|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
161093085|NCT01776424|581731794|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
161093086|NCT01776424|581731792|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
161093087|NCT01776424|581731793|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
161093088|NCT01776424|581731794|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
161093089|NCT01776424|581731792|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
161093090|NCT01776424|581731793|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
161093091|NCT01776424|581731794|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
161093092|NCT01776424|581731792|FG000|LTOLE Part (Open Label)|Refused|5|||
161093093|NCT01776424|581731793|FG001|LTOLE Part (Open Label)|Refused|2|||
161093094|NCT01776424|581731794|FG002|LTOLE Part (Open Label)|Refused|11|||
161093095|NCT01776424|581731792|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
161093096|NCT01776424|581731793|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
161093097|NCT01776424|581731794|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
161093098|NCT02294227|581731795|FG000|Overall Study|Death|0|||
161093099|NCT02294227|581731796|FG001|Overall Study|Death|0|||
161093100|NCT02294227|581731797|FG002|Overall Study|Death|1|||
161093101|NCT02294227|581731795|FG000|Overall Study|Subject/Guardian Decision|6|||
161093102|NCT02294227|581731796|FG001|Overall Study|Subject/Guardian Decision|3|||
161093103|NCT02294227|581731797|FG002|Overall Study|Subject/Guardian Decision|7|||
161093104|NCT02294227|581731795|FG000|Overall Study|Physician Decision|1|||
161093105|NCT02294227|581731796|FG001|Overall Study|Physician Decision|2|||
161093106|NCT02294227|581731797|FG002|Overall Study|Physician Decision|1|||
161093107|NCT02294227|581731795|FG000|Overall Study|Lost to Follow-up|1|||
161093108|NCT02294227|581731796|FG001|Overall Study|Lost to Follow-up|0|||
161093109|NCT02294227|581731797|FG002|Overall Study|Lost to Follow-up|0|||
161093110|NCT02294227|581731795|FG000|Overall Study|Lack of Efficacy|11|||
161093111|NCT02294227|581731796|FG001|Overall Study|Lack of Efficacy|12|||
161093112|NCT02294227|581731797|FG002|Overall Study|Lack of Efficacy|8|||
161093113|NCT02294227|581731795|FG000|Overall Study|Adverse Event|6|||
161093114|NCT02294227|581731796|FG001|Overall Study|Adverse Event|8|||
161093115|NCT02294227|581731797|FG002|Overall Study|Adverse Event|2|||
161093116|NCT00887432|581731798|FG000|Overall Study|Start Excluded Therapy|3|||
161093117|NCT00887432|581731799|FG001|Overall Study|Start Excluded Therapy|0|||
161093118|NCT00887432|581731798|FG000|Overall Study|Did not complete treatment|6|||
161093119|NCT00887432|581731799|FG001|Overall Study|Did not complete treatment|8|||
161093120|NCT00887432|581731798|FG000|Overall Study|Protocol Violation|2|||
161093121|NCT00887432|581731799|FG001|Overall Study|Protocol Violation|3|||
161093122|NCT00887432|581731798|FG000|Overall Study|Withdrawal by Subject|3|||
161093123|NCT00887432|581731799|FG001|Overall Study|Withdrawal by Subject|2|||
161093124|NCT00887432|581731798|FG000|Overall Study|Lost to Follow-up|1|||
161093125|NCT00887432|581731799|FG001|Overall Study|Lost to Follow-up|0|||
161093126|NCT00887432|581731798|FG000|Overall Study|No reason provided|0|||
161093127|NCT00887432|581731799|FG001|Overall Study|No reason provided|1|||
161093128|NCT00899548|581731800|FG000|Overall Study|Physician Decision|3|||
161093129|NCT00551460|581731801|FG000|Overall Study|Adverse Event|1|||
161093130|NCT00551460|581731801|FG000|Overall Study|Withdrawal by Subject|1|||
161093131|NCT00551460|581731801|FG000|Overall Study|Physician Decision|1|||
161093132|NCT00551460|581731801|FG000|Overall Study|Death|7|||
161093133|NCT00551460|581731801|FG000|Overall Study|Ineligible|4|||
161093134|NCT00551460|581731801|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
161093135|NCT04781387|581731802|FG000|Overall Study|Withdrawal by Subject|1|||
161093136|NCT04781387|581731803|FG001|Overall Study|Withdrawal by Subject|0|||
161093137|NCT04781387|581731804|FG002|Overall Study|Withdrawal by Subject|1|||
161093138|NCT04781387|581731802|FG000|Overall Study|Lost to Follow-up|1|||
161093139|NCT04781387|581731803|FG001|Overall Study|Lost to Follow-up|0|||
161093140|NCT04781387|581731804|FG002|Overall Study|Lost to Follow-up|0|||
161093141|NCT01636960|581731805|FG000|Induction Phase|Adverse Event|2|||
161093142|NCT01636960|581731805|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
161093143|NCT01636960|581731805|FG000|Maintenance Phase|Adverse Event|3|||
161093144|NCT01636960|581731805|FG000|Maintenance Phase|Progressive disease|1|||
161093145|NCT01209780|581731806|FG000|Overall Study|Adverse Event|0|||
161093146|NCT01209780|581731807|FG001|Overall Study|Adverse Event|1|||
161093147|NCT01209780|581731808|FG002|Overall Study|Adverse Event|0|||
161093148|NCT01209780|581731809|FG003|Overall Study|Adverse Event|0|||
161093149|NCT01209780|581731810|FG004|Overall Study|Adverse Event|0|||
161093150|NCT01209780|581731806|FG000|Overall Study|Withdrawal by Subject|9|||
161093151|NCT01209780|581731807|FG001|Overall Study|Withdrawal by Subject|2|||
161093152|NCT01209780|581731808|FG002|Overall Study|Withdrawal by Subject|1|||
161093153|NCT01209780|581731809|FG003|Overall Study|Withdrawal by Subject|1|||
161093154|NCT01209780|581731810|FG004|Overall Study|Withdrawal by Subject|0|||
161093155|NCT01209780|581731806|FG000|Overall Study|Lost to Follow-up|17|||
161093156|NCT01209780|581731807|FG001|Overall Study|Lost to Follow-up|12|||
161093157|NCT01209780|581731808|FG002|Overall Study|Lost to Follow-up|3|||
161093158|NCT01209780|581731809|FG003|Overall Study|Lost to Follow-up|9|||
161093159|NCT01209780|581731810|FG004|Overall Study|Lost to Follow-up|4|||
161093160|NCT01209780|581731806|FG000|Overall Study|Protocol Violation|0|||
161093161|NCT01209780|581731807|FG001|Overall Study|Protocol Violation|1|||
161093162|NCT01209780|581731808|FG002|Overall Study|Protocol Violation|0|||
161093163|NCT01209780|581731809|FG003|Overall Study|Protocol Violation|0|||
161093164|NCT01209780|581731810|FG004|Overall Study|Protocol Violation|0|||
161093165|NCT01209780|581731806|FG000|Overall Study|Inappropriate enrollment|0|||
161093166|NCT01209780|581731807|FG001|Overall Study|Inappropriate enrollment|2|||
161093167|NCT01209780|581731808|FG002|Overall Study|Inappropriate enrollment|0|||
161093168|NCT01209780|581731809|FG003|Overall Study|Inappropriate enrollment|0|||
161093169|NCT01209780|581731810|FG004|Overall Study|Inappropriate enrollment|1|||
161093170|NCT00448123|581731812|FG000|Overall Study|Lost to Follow-up|9|||
161093171|NCT00448123|581731813|FG001|Overall Study|Lost to Follow-up|6|||
161093172|NCT00448123|581731812|FG000|Overall Study|Physician Decision|6|||
161093173|NCT00448123|581731813|FG001|Overall Study|Physician Decision|6|||
161093174|NCT02318797|581731814|FG000|Overall Study|Death|3|||
161093175|NCT02318797|581731815|FG001|Overall Study|Death|6|||
161093176|NCT02318797|581731814|FG000|Overall Study|Lost to Follow-up|85|||
161093177|NCT02318797|581731815|FG001|Overall Study|Lost to Follow-up|96|||
161093178|NCT00940108|581731818|FG000|Overall Study|Adverse Event|2|||
161093179|NCT00940108|581731819|FG001|Overall Study|Adverse Event|4|||
161093180|NCT00940108|581731820|FG002|Overall Study|Adverse Event|0|||
161093181|NCT00940108|581731821|FG003|Overall Study|Adverse Event|2|||
161093182|NCT00940108|581731818|FG000|Overall Study|Withdrew Consent|2|||
161093183|NCT00940108|581731819|FG001|Overall Study|Withdrew Consent|1|||
161093184|NCT00940108|581731820|FG002|Overall Study|Withdrew Consent|0|||
161093185|NCT00940108|581731821|FG003|Overall Study|Withdrew Consent|1|||
161093186|NCT00940108|581731818|FG000|Overall Study|Dose 2 contraindicated|1|||
161093187|NCT00940108|581731819|FG001|Overall Study|Dose 2 contraindicated|1|||
161093188|NCT00940108|581731820|FG002|Overall Study|Dose 2 contraindicated|0|||
161093189|NCT00940108|581731821|FG003|Overall Study|Dose 2 contraindicated|1|||
161093190|NCT00940108|581731818|FG000|Overall Study|Declined further vaccination|0|||
161093191|NCT00940108|581731819|FG001|Overall Study|Declined further vaccination|1|||
161093192|NCT00940108|581731820|FG002|Overall Study|Declined further vaccination|3|||
161093193|NCT00940108|581731821|FG003|Overall Study|Declined further vaccination|0|||
161093194|NCT00940108|581731818|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
161093195|NCT00940108|581731819|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
161093196|NCT00940108|581731820|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
161093197|NCT00940108|581731821|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
161093198|NCT00940108|581731818|FG000|Overall Study|Viral illness after Dose 1|0|||
161093199|NCT00940108|581731819|FG001|Overall Study|Viral illness after Dose 1|1|||
161093200|NCT00940108|581731820|FG002|Overall Study|Viral illness after Dose 1|0|||
161093201|NCT00940108|581731821|FG003|Overall Study|Viral illness after Dose 1|0|||
161093202|NCT00940108|581731818|FG000|Overall Study|Diagnosed with H1N1|0|||
161093203|NCT00940108|581731819|FG001|Overall Study|Diagnosed with H1N1|0|||
161093204|NCT00940108|581731820|FG002|Overall Study|Diagnosed with H1N1|0|||
161093205|NCT00940108|581731821|FG003|Overall Study|Diagnosed with H1N1|1|||
161093206|NCT00928447|581731822|FG000|Overall Study|Withdrawal by Subject|1|||
161093207|NCT00928447|581731822|FG000|Overall Study|Investigator's decision|1|||
161093208|NCT03756129|581731825|FG000|Overall Study|Adverse Event|1|||
161093209|NCT03756129|581731826|FG001|Overall Study|Adverse Event|1|||
161093210|NCT03756129|581731827|FG002|Overall Study|Adverse Event|0|||
161093211|NCT03756129|581731828|FG003|Overall Study|Adverse Event|2|||
161093212|NCT03756129|581731829|FG004|Overall Study|Adverse Event|0|||
161093213|NCT03756129|581731830|FG005|Overall Study|Adverse Event|0|||
161093214|NCT03756129|581731825|FG000|Overall Study|Withdrawal by Subject|2|||
161093215|NCT03756129|581731826|FG001|Overall Study|Withdrawal by Subject|1|||
161093216|NCT03756129|581731827|FG002|Overall Study|Withdrawal by Subject|3|||
161093217|NCT03756129|581731828|FG003|Overall Study|Withdrawal by Subject|1|||
161093218|NCT03756129|581731829|FG004|Overall Study|Withdrawal by Subject|1|||
161093219|NCT03756129|581731830|FG005|Overall Study|Withdrawal by Subject|3|||
161093220|NCT03756129|581731825|FG000|Overall Study|Lost to Follow-up|0|||
161093221|NCT03756129|581731826|FG001|Overall Study|Lost to Follow-up|0|||
161093222|NCT03756129|581731827|FG002|Overall Study|Lost to Follow-up|0|||
161093223|NCT03756129|581731828|FG003|Overall Study|Lost to Follow-up|0|||
161093224|NCT03756129|581731829|FG004|Overall Study|Lost to Follow-up|0|||
161093225|NCT03756129|581731830|FG005|Overall Study|Lost to Follow-up|1|||
161093226|NCT03756129|581731825|FG000|Overall Study|Physician Decision|0|||
161093227|NCT03756129|581731826|FG001|Overall Study|Physician Decision|0|||
161093228|NCT03756129|581731827|FG002|Overall Study|Physician Decision|0|||
161093229|NCT03756129|581731828|FG003|Overall Study|Physician Decision|0|||
161093230|NCT03756129|581731829|FG004|Overall Study|Physician Decision|0|||
161209305|NCT01347879|582149072|FG001|Overall Study|Lost to Follow-up|0|||
161093231|NCT03756129|581731830|FG005|Overall Study|Physician Decision|1|||
161093232|NCT03432260|581731831|FG000|Overall Study|Lost to Follow-up|1|||
161093233|NCT03432260|581731832|FG001|Overall Study|Lost to Follow-up|1|||
161093234|NCT03432260|581731833|FG002|Overall Study|Lost to Follow-up|0|||
161093235|NCT03432260|581731834|FG003|Overall Study|Lost to Follow-up|0|||
161093236|NCT03432260|581731835|FG004|Overall Study|Lost to Follow-up|1|||
161093237|NCT02186847|581731836|FG000|Overall Study|Protocol Violation|3|||
161093238|NCT02186847|581731837|FG001|Overall Study|Protocol Violation|0|||
161093239|NCT03319849|581731838|FG000|Overall Study|Adverse Event|1|||
161093240|NCT03319849|581731839|FG001|Overall Study|Adverse Event|0|||
161093241|NCT03319849|581731838|FG000|Overall Study|Physician Decision|0|||
161093242|NCT03319849|581731839|FG001|Overall Study|Physician Decision|1|||
161093243|NCT03319849|581731838|FG000|Overall Study|Withdrawal by Subject|0|||
161093244|NCT03319849|581731839|FG001|Overall Study|Withdrawal by Subject|1|||
161093245|NCT03319849|581731838|FG000|Overall Study|COVID-19|0|||
161093246|NCT03319849|581731839|FG001|Overall Study|COVID-19|1|||
161093247|NCT03319849|581731838|FG000|Overall Study|Other|1|||
161093248|NCT03319849|581731839|FG001|Overall Study|Other|2|||
161093249|NCT03319849|581731838|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
161093250|NCT03319849|581731839|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
161093251|NCT03319849|581731838|FG000|Overall Study|Lost to Follow-up|0|||
161093252|NCT03319849|581731839|FG001|Overall Study|Lost to Follow-up|2|||
161093253|NCT00112047|581731840|FG000|Randomized Phase|Lost to Follow-up|26|||
161093254|NCT00112047|581731841|FG001|Randomized Phase|Lost to Follow-up|33|||
161093255|NCT00112047|581731840|FG000|Randomized Phase|Adverse Event|10|||
161093256|NCT00112047|581731841|FG001|Randomized Phase|Adverse Event|10|||
161093257|NCT00112047|581731840|FG000|Randomized Phase|Withrawal of consent|10|||
161093258|NCT00112047|581731841|FG001|Randomized Phase|Withrawal of consent|18|||
161093259|NCT00112047|581731840|FG000|Randomized Phase|Sub-optimal virological response|3|||
161093260|NCT00112047|581731841|FG001|Randomized Phase|Sub-optimal virological response|13|||
161093261|NCT00112047|581731840|FG000|Randomized Phase|Noncompliance|8|||
161093262|NCT00112047|581731841|FG001|Randomized Phase|Noncompliance|4|||
161093263|NCT00112047|581731840|FG000|Randomized Phase|Protocol Violation|2|||
161093264|NCT00112047|581731841|FG001|Randomized Phase|Protocol Violation|0|||
161093265|NCT00112047|581731840|FG000|Randomized Phase|Pregnancy|3|||
161093266|NCT00112047|581731841|FG001|Randomized Phase|Pregnancy|1|||
161093267|NCT00112047|581731840|FG000|Randomized Phase|Death|1|||
161093268|NCT00112047|581731841|FG001|Randomized Phase|Death|3|||
161093269|NCT00112047|581731840|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
161093270|NCT00112047|581731841|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
161093271|NCT00112047|581731840|FG000|Randomized Phase|Inability to swallow pills|0|||
161093272|NCT00112047|581731841|FG001|Randomized Phase|Inability to swallow pills|1|||
161093273|NCT00112047|581731840|FG000|Randomized Phase|Incarceration|3|||
161093274|NCT00112047|581731841|FG001|Randomized Phase|Incarceration|2|||
161093275|NCT00112047|581731840|FG000|Randomized Phase|Moved out of State|0|||
161093276|NCT00112047|581731841|FG001|Randomized Phase|Moved out of State|1|||
161093277|NCT00112047|581731840|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
161093278|NCT00112047|581731841|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
161093279|NCT00112047|581731840|FG000|Randomized Phase|High Hepatitis B DNA|0|||
161093280|NCT00112047|581731841|FG001|Randomized Phase|High Hepatitis B DNA|1|||
161093281|NCT00112047|581731840|FG000|Atripla Phase|Adverse Event|2|||
161093282|NCT00112047|581731841|FG001|Atripla Phase|Adverse Event|1|||
161093283|NCT00112047|581731840|FG000|Atripla Phase|Lost to Follow-up|5|||
161093284|NCT00112047|581731841|FG001|Atripla Phase|Lost to Follow-up|7|||
161093285|NCT00112047|581731840|FG000|Atripla Phase|Pregnancy|0|||
161093286|NCT00112047|581731841|FG001|Atripla Phase|Pregnancy|1|||
161093287|NCT00112047|581731840|FG000|Atripla Phase|Death|0|||
161093288|NCT00112047|581731841|FG001|Atripla Phase|Death|2|||
161093289|NCT00112047|581731840|FG000|Atripla Phase|Withdrew consent|7|||
161093290|NCT00112047|581731841|FG001|Atripla Phase|Withdrew consent|7|||
161093291|NCT00112047|581731840|FG000|Atripla Phase|Sub-optimal virological response|0|||
161093292|NCT00112047|581731841|FG001|Atripla Phase|Sub-optimal virological response|1|||
161093293|NCT00112047|581731840|FG000|Atripla Phase|Non-compliance|1|||
161093294|NCT00112047|581731841|FG001|Atripla Phase|Non-compliance|0|||
161093295|NCT00112047|581731840|FG000|Atripla Phase|Other|3|||
161093296|NCT00112047|581731841|FG001|Atripla Phase|Other|1|||
161093297|NCT01307579|581731842|FG000|Overall Study|Death|3|||
161093298|NCT01307579|581731843|FG001|Overall Study|Death|6|||
161093299|NCT01307579|581731842|FG000|Overall Study|Physician Decision|26|||
161093300|NCT01307579|581731843|FG001|Overall Study|Physician Decision|29|||
161093301|NCT01307579|581731842|FG000|Overall Study|Withdrawal by Subject|7|||
161093302|NCT01307579|581731843|FG001|Overall Study|Withdrawal by Subject|3|||
161093303|NCT01307579|581731842|FG000|Overall Study|Institutional diagnosis of IFD|21|||
161093304|NCT01307579|581731843|FG001|Overall Study|Institutional diagnosis of IFD|36|||
161093305|NCT01307579|581731842|FG000|Overall Study|Begin conditioning for HSCT|42|||
161093306|NCT01307579|581731843|FG001|Overall Study|Begin conditioning for HSCT|44|||
161093307|NCT01307579|581731842|FG000|Overall Study|Refractory or relapsed AML|38|||
161093308|NCT01307579|581731843|FG001|Overall Study|Refractory or relapsed AML|23|||
161093309|NCT01307579|581731842|FG000|Overall Study|Ineligible|3|||
161093310|NCT01307579|581731843|FG001|Overall Study|Ineligible|4|||
161093311|NCT05677893|581733683|FG000|Overall Study|Withdrawal by Subject|0|||
161093312|NCT05677893|581733684|FG001|Overall Study|Withdrawal by Subject|0|||
161093313|NCT05677893|581733685|FG002|Overall Study|Withdrawal by Subject|0|||
161093314|NCT05677893|581733686|FG003|Overall Study|Withdrawal by Subject|0|||
161093315|NCT05677893|581733687|FG004|Overall Study|Withdrawal by Subject|1|||
161093316|NCT05677893|581733688|FG005|Overall Study|Withdrawal by Subject|1|||
161093317|NCT05677893|581733689|FG006|Overall Study|Withdrawal by Subject|0|||
161093318|NCT05677893|581733683|FG000|Overall Study|Others|1|||
161093319|NCT05677893|581733684|FG001|Overall Study|Others|0|||
161093320|NCT05677893|581733685|FG002|Overall Study|Others|0|||
161093321|NCT05677893|581733686|FG003|Overall Study|Others|0|||
161093322|NCT05677893|581733687|FG004|Overall Study|Others|0|||
161093323|NCT05677893|581733688|FG005|Overall Study|Others|0|||
161093324|NCT05677893|581733689|FG006|Overall Study|Others|0|||
161093325|NCT03217266|581733690|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
161093326|NCT03217266|581733691|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161093327|NCT03217266|581733692|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161093328|NCT03217266|581733693|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
161093329|NCT03217266|581733690|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
161093330|NCT03217266|581733691|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
161093331|NCT03217266|581733692|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
161093332|NCT03217266|581733693|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
161093333|NCT03217266|581733690|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
161093334|NCT03217266|581733691|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
161093335|NCT03217266|581733692|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
161093336|NCT03217266|581733693|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
161093337|NCT02101034|581733694|FG000|Overall Study|Enrolled but did not start treatment|0|||
161093338|NCT02101034|581733695|FG001|Overall Study|Enrolled but did not start treatment|0|||
161093339|NCT02101034|581733696|FG002|Overall Study|Enrolled but did not start treatment|1|||
161093340|NCT02101034|581733697|FG003|Overall Study|Enrolled but did not start treatment|0|||
161093341|NCT02101034|581733698|FG004|Overall Study|Enrolled but did not start treatment|0|||
161093342|NCT01101477|581733700|FG000|Overall Study|Protocol Violation|5|||
161093343|NCT01101477|581733701|FG001|Overall Study|Protocol Violation|3|||
161093344|NCT01101477|581733702|FG002|Overall Study|Protocol Violation|1|||
161093345|NCT01222507|581733703|FG000|Overall Study|Physician Decision|1|||
161093346|NCT01222507|581733703|FG000|Overall Study|Withdrawal by Subject|1|||
161093347|NCT01786174|581733708|FG000|Overall Study|Discontinued Study Drug|2|||
161093348|NCT01786174|581733709|FG001|Overall Study|Discontinued Study Drug|0|||
161093349|NCT00995020|581733710|FG000|Overall Study|margin analysis not performed|2|||
161093350|NCT00995020|581733711|FG001|Overall Study|margin analysis not performed|5|||
161093351|NCT00995020|581733710|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
161093352|NCT00995020|581733711|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
161093353|NCT01614197|581733712|FG000|Overall Study|Withdrawal by Subject|0|||
161093354|NCT01614197|581733713|FG001|Overall Study|Withdrawal by Subject|1|||
161093355|NCT01614197|581733714|FG002|Overall Study|Withdrawal by Subject|0|||
161093356|NCT01614197|581733715|FG003|Overall Study|Withdrawal by Subject|0|||
161093357|NCT03442985|581733716|FG000|Overall Study|Sponsor Request|55|||
161093358|NCT03442985|581733717|FG001|Overall Study|Sponsor Request|60|||
161093359|NCT03442985|581733718|FG002|Overall Study|Sponsor Request|54|||
161093360|NCT03442985|581733716|FG000|Overall Study|Lost to Follow-up|5|||
161093361|NCT03442985|581733717|FG001|Overall Study|Lost to Follow-up|2|||
161093362|NCT03442985|581733718|FG002|Overall Study|Lost to Follow-up|7|||
161093363|NCT03442985|581733716|FG000|Overall Study|Withdrawal by Subject|2|||
161093364|NCT03442985|581733717|FG001|Overall Study|Withdrawal by Subject|3|||
161093365|NCT03442985|581733718|FG002|Overall Study|Withdrawal by Subject|4|||
161093366|NCT03442985|581733716|FG000|Overall Study|Adverse Event|0|||
161093367|NCT03442985|581733717|FG001|Overall Study|Adverse Event|1|||
161093368|NCT03442985|581733718|FG002|Overall Study|Adverse Event|0|||
161093369|NCT00876694|581733720|FG000|Overall Study|Adverse Event|10|||
161093370|NCT00876694|581733721|FG001|Overall Study|Adverse Event|7|||
161093371|NCT00876694|581733720|FG000|Overall Study|Subject withdrew consent|6|||
161093372|NCT00876694|581733721|FG001|Overall Study|Subject withdrew consent|4|||
161093373|NCT00876694|581733720|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161093374|NCT00876694|581733721|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161093375|NCT00876694|581733720|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161093376|NCT00876694|581733721|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161093377|NCT00876694|581733720|FG000|Overall Study|Administrative problems|1|||
161093378|NCT00876694|581733721|FG001|Overall Study|Administrative problems|1|||
161093379|NCT00876694|581733720|FG000|Overall Study|Death|1|||
161093380|NCT00876694|581733721|FG001|Overall Study|Death|0|||
161093381|NCT00288509|581733722|FG000|Treatment Cycle 1|Adverse Event|1|||
161093382|NCT00288509|581733722|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
161093383|NCT00288509|581733722|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
161093384|NCT00288509|581733722|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
161093385|NCT00288509|581733722|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
161093386|NCT00288509|581733722|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
161322860|NCT05980013|582568621|FG001|Overall Study|Device Error|1|||
161093387|NCT00288509|581733722|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
161093388|NCT00288509|581733722|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
161093389|NCT00288509|581733722|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
161093390|NCT00288509|581733722|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
161093391|NCT00288509|581733722|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
161093392|NCT00288509|581733722|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
161093393|NCT00288509|581733722|FG000|Treatment Cycle 4|Physician Decision|4|||
161093394|NCT00288509|581733722|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
161322861|NCT04892446|582568622|FG000|Overall Study|Death|4|||
161093395|NCT00084266|581733723|FG000|Overall Study|Death|42|||
161093396|NCT00084266|581733724|FG001|Overall Study|Death|39|||
161093397|NCT00084266|581733723|FG000|Overall Study|Adverse Event|8|||
161093398|NCT00084266|581733724|FG001|Overall Study|Adverse Event|5|||
161093399|NCT00084266|581733723|FG000|Overall Study|Lack of Efficacy|2|||
161093400|NCT00084266|581733724|FG001|Overall Study|Lack of Efficacy|4|||
161093401|NCT00084266|581733723|FG000|Overall Study|Lost to Follow-up|5|||
161093402|NCT00084266|581733724|FG001|Overall Study|Lost to Follow-up|3|||
161093403|NCT00084266|581733723|FG000|Overall Study|Participant not willing to participate|3|||
161093404|NCT00084266|581733724|FG001|Overall Study|Participant not willing to participate|8|||
161093405|NCT00084266|581733723|FG000|Overall Study|Other|360|||
161093406|NCT00084266|581733724|FG001|Overall Study|Other|344|||
161093407|NCT00084266|581733723|FG000|Overall Study|Randomized not treated|21|||
161093408|NCT00084266|581733724|FG001|Overall Study|Randomized not treated|20|||
161093409|NCT01215422|581733725|FG000|Overall Study|Relocation|1|||
161093410|NCT01215422|581733726|FG001|Overall Study|Relocation|0|||
161093411|NCT01215422|581733727|FG002|Overall Study|Relocation|0|||
161093412|NCT01215422|581733728|FG003|Overall Study|Relocation|0|||
161093413|NCT01215422|581733725|FG000|Overall Study|Failed intubations|0|||
161093414|NCT01215422|581733726|FG001|Overall Study|Failed intubations|0|||
161093415|NCT01215422|581733727|FG002|Overall Study|Failed intubations|3|||
161093416|NCT01215422|581733728|FG003|Overall Study|Failed intubations|8|||
161093417|NCT01215422|581733725|FG000|Overall Study|Did not complete all intubations|7|||
161093418|NCT01215422|581733726|FG001|Overall Study|Did not complete all intubations|0|||
161093419|NCT01215422|581733727|FG002|Overall Study|Did not complete all intubations|0|||
161093420|NCT01215422|581733728|FG003|Overall Study|Did not complete all intubations|0|||
161093421|NCT01313637|581733738|FG000|Overall Study|Adverse Event|17|||
161093422|NCT01313637|581733739|FG001|Overall Study|Adverse Event|24|||
161093423|NCT01313637|581733740|FG002|Overall Study|Adverse Event|25|||
161093424|NCT01313637|581733741|FG003|Overall Study|Adverse Event|18|||
161093425|NCT01313637|581733738|FG000|Overall Study|Lack of Efficacy|44|||
161093426|NCT01313637|581733739|FG001|Overall Study|Lack of Efficacy|38|||
161093427|NCT01313637|581733740|FG002|Overall Study|Lack of Efficacy|37|||
161093428|NCT01313637|581733741|FG003|Overall Study|Lack of Efficacy|24|||
161093429|NCT01313637|581733738|FG000|Overall Study|Protocol Violation|4|||
161093430|NCT01313637|581733739|FG001|Overall Study|Protocol Violation|3|||
161093431|NCT01313637|581733740|FG002|Overall Study|Protocol Violation|11|||
161093432|NCT01313637|581733741|FG003|Overall Study|Protocol Violation|5|||
161093433|NCT01313637|581733738|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
161093434|NCT01313637|581733739|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
161093435|NCT01313637|581733740|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
161093436|NCT01313637|581733741|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
161093437|NCT01313637|581733738|FG000|Overall Study|Lost to Follow-up|0|||
161093438|NCT01313637|581733739|FG001|Overall Study|Lost to Follow-up|2|||
161093439|NCT01313637|581733740|FG002|Overall Study|Lost to Follow-up|1|||
161093440|NCT01313637|581733741|FG003|Overall Study|Lost to Follow-up|3|||
161093441|NCT01313637|581733738|FG000|Overall Study|Withdrawal by Subject|11|||
161093442|NCT01313637|581733739|FG001|Overall Study|Withdrawal by Subject|13|||
161093443|NCT01313637|581733740|FG002|Overall Study|Withdrawal by Subject|18|||
161093444|NCT01313637|581733741|FG003|Overall Study|Withdrawal by Subject|15|||
161093445|NCT00795951|581733744|FG000|Overall Study|Lost to Follow-up|1|||
161093446|NCT00795951|581733744|FG000|Overall Study|Withdrawal by Subject|1|||
161093447|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
161093448|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
161093449|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
161093450|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
161093451|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
161093452|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
161093453|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
161093454|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
161093455|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
161093456|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
161093457|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
161093458|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
161093459|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
161093460|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
161093461|NCT03548987|581733746|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
161093462|NCT03548987|581733747|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
160980421|NCT01177813|581317498|FG001|Overall Study|Lack of Efficacy|0|||
160980422|NCT01177813|581317499|FG002|Overall Study|Lack of Efficacy|0|||
160980423|NCT01177813|581317500|FG003|Overall Study|Lack of Efficacy|0|||
160980424|NCT01177813|581317501|FG004|Overall Study|Lack of Efficacy|0|||
160980425|NCT01177813|581317497|FG000|Overall Study|Protocol Violation|3|||
160980426|NCT01177813|581317498|FG001|Overall Study|Protocol Violation|2|||
160980427|NCT01177813|581317499|FG002|Overall Study|Protocol Violation|2|||
160980428|NCT01177813|581317500|FG003|Overall Study|Protocol Violation|0|||
160980429|NCT01177813|581317501|FG004|Overall Study|Protocol Violation|1|||
160980430|NCT01177813|581317497|FG000|Overall Study|Lost to Follow-up|12|||
160980431|NCT01177813|581317498|FG001|Overall Study|Lost to Follow-up|5|||
160980432|NCT01177813|581317499|FG002|Overall Study|Lost to Follow-up|6|||
160980433|NCT01177813|581317500|FG003|Overall Study|Lost to Follow-up|3|||
160980434|NCT01177813|581317501|FG004|Overall Study|Lost to Follow-up|0|||
161093463|NCT03548987|581733746|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
161093464|NCT03548987|581733747|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
161093465|NCT03548987|581733746|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
161093466|NCT03548987|581733747|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
161093467|NCT03548987|581733746|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
161093468|NCT03548987|581733747|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
161093469|NCT03548987|581733746|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
161093470|NCT03548987|581733747|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
161093471|NCT03548987|581733746|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
161093472|NCT03548987|581733747|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
161093473|NCT03548987|581733746|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
161093474|NCT03548987|581733747|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
161093475|NCT04572841|581733748|FG000|Overall Study|Adverse Event|1|||
161093476|NCT04572841|581733749|FG001|Overall Study|Adverse Event|1|||
161093477|NCT04572841|581733748|FG000|Overall Study|Withdrawal by Subject|2|||
161093478|NCT04572841|581733749|FG001|Overall Study|Withdrawal by Subject|1|||
161093479|NCT01323647|581733754|FG000|Overall Study|Migrated/moved from study area|2|||
161093480|NCT01323647|581733755|FG001|Overall Study|Migrated/moved from study area|0|||
161093481|NCT01323647|581733754|FG000|Overall Study|Withdrawal by Subject|5|||
161093482|NCT01323647|581733755|FG001|Overall Study|Withdrawal by Subject|0|||
161093483|NCT01323647|581733754|FG000|Overall Study|Lost to Follow-up|2|||
161093484|NCT01323647|581733755|FG001|Overall Study|Lost to Follow-up|0|||
161093485|NCT00712673|581733756|FG000|Overall Study|Adverse Event|3|||
161093486|NCT00712673|581733757|FG001|Overall Study|Adverse Event|3|||
161093487|NCT00712673|581733758|FG002|Overall Study|Adverse Event|21|||
161093488|NCT00712673|581733759|FG003|Overall Study|Adverse Event|26|||
161093489|NCT00712673|581733756|FG000|Overall Study|Lack of Efficacy|2|||
161093490|NCT00712673|581733757|FG001|Overall Study|Lack of Efficacy|8|||
161093491|NCT00712673|581733758|FG002|Overall Study|Lack of Efficacy|8|||
161093492|NCT00712673|581733759|FG003|Overall Study|Lack of Efficacy|6|||
161093493|NCT00712673|581733756|FG000|Overall Study|Poor Compliance to Protocol|3|||
161093494|NCT00712673|581733757|FG001|Overall Study|Poor Compliance to Protocol|3|||
161093495|NCT00712673|581733758|FG002|Overall Study|Poor Compliance to Protocol|4|||
161093496|NCT00712673|581733759|FG003|Overall Study|Poor Compliance to Protocol|16|||
161093497|NCT00712673|581733756|FG000|Overall Study|Lost to Follow-up|1|||
161093498|NCT00712673|581733757|FG001|Overall Study|Lost to Follow-up|0|||
161093499|NCT00712673|581733758|FG002|Overall Study|Lost to Follow-up|2|||
161093500|NCT00712673|581733759|FG003|Overall Study|Lost to Follow-up|0|||
161093501|NCT00712673|581733756|FG000|Overall Study|Withdrawal by Subject|6|||
161093502|NCT00712673|581733757|FG001|Overall Study|Withdrawal by Subject|7|||
161093503|NCT00712673|581733758|FG002|Overall Study|Withdrawal by Subject|15|||
161093504|NCT00712673|581733759|FG003|Overall Study|Withdrawal by Subject|20|||
161093505|NCT00712673|581733756|FG000|Overall Study|Familial and Personal Reasons|5|||
161093506|NCT00712673|581733757|FG001|Overall Study|Familial and Personal Reasons|0|||
161093507|NCT00712673|581733758|FG002|Overall Study|Familial and Personal Reasons|5|||
161093508|NCT00712673|581733759|FG003|Overall Study|Familial and Personal Reasons|2|||
161093509|NCT00712673|581733756|FG000|Overall Study|Investigator's Decision|1|||
161093510|NCT00712673|581733757|FG001|Overall Study|Investigator's Decision|0|||
161093511|NCT00712673|581733758|FG002|Overall Study|Investigator's Decision|0|||
161093512|NCT00712673|581733759|FG003|Overall Study|Investigator's Decision|0|||
161093513|NCT00712673|581733756|FG000|Overall Study|Protocol Violation|0|||
161322862|NCT04892446|582568623|FG001|Overall Study|Death|4|||
160980435|NCT01177813|581317497|FG000|Overall Study|Withdrawal by Subject|12|||
160980436|NCT01177813|581317498|FG001|Overall Study|Withdrawal by Subject|7|||
161093514|NCT00712673|581733757|FG001|Overall Study|Protocol Violation|0|||
161093515|NCT00712673|581733758|FG002|Overall Study|Protocol Violation|2|||
161093516|NCT00712673|581733759|FG003|Overall Study|Protocol Violation|0|||
160980437|NCT01177813|581317499|FG002|Overall Study|Withdrawal by Subject|6|||
160980438|NCT01177813|581317500|FG003|Overall Study|Withdrawal by Subject|5|||
160980439|NCT01177813|581317501|FG004|Overall Study|Withdrawal by Subject|3|||
161093517|NCT02768870|581733762|FG000|Overall Study|Death|1|||
161093518|NCT02768870|581733762|FG000|Overall Study|Reoperation|6|||
160980440|NCT01177813|581317497|FG000|Overall Study|Other reason not defined above|5|||
160980441|NCT01177813|581317498|FG001|Overall Study|Other reason not defined above|2|||
160980442|NCT01177813|581317499|FG002|Overall Study|Other reason not defined above|2|||
160980443|NCT01177813|581317500|FG003|Overall Study|Other reason not defined above|3|||
160980444|NCT01177813|581317501|FG004|Overall Study|Other reason not defined above|2|||
160980445|NCT02056119|581317506|FG000|Overall Study|Death|1|||
160980446|NCT02056119|581317507|FG001|Overall Study|Death|2|||
160980447|NCT02056119|581317506|FG000|Overall Study|Intubated for less than 24 hrs|2|||
160980448|NCT02056119|581317507|FG001|Overall Study|Intubated for less than 24 hrs|7|||
160980449|NCT02056119|581317506|FG000|Overall Study|No aerosol treatments were given.|3|||
160980450|NCT02056119|581317507|FG001|Overall Study|No aerosol treatments were given.|2|||
160980451|NCT02056119|581317506|FG000|Overall Study|Received Metaneb treatment|0|||
160980452|NCT02056119|581317507|FG001|Overall Study|Received Metaneb treatment|2|||
160980453|NCT02056119|581317506|FG000|Overall Study|Protocol Violation|4|||
160980454|NCT02056119|581317507|FG001|Overall Study|Protocol Violation|7|||
160980455|NCT00983619|581317508|FG000|Overall Study|Lost to Follow-up|0|||
160980456|NCT00983619|581317509|FG001|Overall Study|Lost to Follow-up|1|||
160980457|NCT00983619|581317510|FG002|Overall Study|Lost to Follow-up|0|||
160980458|NCT00983619|581317511|FG003|Overall Study|Lost to Follow-up|0|||
160980459|NCT00983619|581317512|FG004|Overall Study|Lost to Follow-up|0|||
160980460|NCT00983619|581317513|FG005|Overall Study|Lost to Follow-up|2|||
160980461|NCT00983619|581317514|FG006|Overall Study|Lost to Follow-up|0|||
160980462|NCT00983619|581317515|FG007|Overall Study|Lost to Follow-up|0|||
160980463|NCT00983619|581317516|FG008|Overall Study|Lost to Follow-up|0|||
160980464|NCT00983619|581317517|FG009|Overall Study|Lost to Follow-up|0|||
160980465|NCT00983619|581317518|FG010|Overall Study|Lost to Follow-up|0|||
160980466|NCT00983619|581317519|FG011|Overall Study|Lost to Follow-up|2|||
160980467|NCT00983619|581317508|FG000|Overall Study|Withdrawal by Subject|2|||
160980468|NCT00983619|581317509|FG001|Overall Study|Withdrawal by Subject|1|||
160980469|NCT00983619|581317510|FG002|Overall Study|Withdrawal by Subject|1|||
160980470|NCT00983619|581317511|FG003|Overall Study|Withdrawal by Subject|3|||
160980471|NCT00983619|581317512|FG004|Overall Study|Withdrawal by Subject|1|||
160980472|NCT00983619|581317513|FG005|Overall Study|Withdrawal by Subject|23|||
160980473|NCT00983619|581317514|FG006|Overall Study|Withdrawal by Subject|0|||
160980474|NCT00983619|581317515|FG007|Overall Study|Withdrawal by Subject|0|||
160980475|NCT00983619|581317516|FG008|Overall Study|Withdrawal by Subject|0|||
160980476|NCT00983619|581317517|FG009|Overall Study|Withdrawal by Subject|0|||
160980477|NCT00983619|581317518|FG010|Overall Study|Withdrawal by Subject|1|||
160980478|NCT00983619|581317519|FG011|Overall Study|Withdrawal by Subject|1|||
160980479|NCT00983619|581317508|FG000|Overall Study|Death|0|||
160980480|NCT00983619|581317509|FG001|Overall Study|Death|2|||
160980481|NCT00983619|581317510|FG002|Overall Study|Death|2|||
160980482|NCT00983619|581317511|FG003|Overall Study|Death|1|||
160980483|NCT00983619|581317512|FG004|Overall Study|Death|2|||
160980484|NCT00983619|581317513|FG005|Overall Study|Death|30|||
160980485|NCT00983619|581317514|FG006|Overall Study|Death|1|||
160980486|NCT00983619|581317515|FG007|Overall Study|Death|0|||
160980487|NCT00983619|581317516|FG008|Overall Study|Death|1|||
160980488|NCT00983619|581317517|FG009|Overall Study|Death|2|||
160980489|NCT00983619|581317518|FG010|Overall Study|Death|9|||
160980490|NCT00983619|581317519|FG011|Overall Study|Death|8|||
160980491|NCT00983619|581317508|FG000|Overall Study|Other|1|||
160980492|NCT00983619|581317509|FG001|Overall Study|Other|0|||
160980493|NCT00983619|581317510|FG002|Overall Study|Other|0|||
160980494|NCT00983619|581317511|FG003|Overall Study|Other|1|||
160980495|NCT00983619|581317512|FG004|Overall Study|Other|0|||
160980496|NCT00983619|581317513|FG005|Overall Study|Other|12|||
160980497|NCT00983619|581317514|FG006|Overall Study|Other|2|||
160980498|NCT00983619|581317515|FG007|Overall Study|Other|2|||
160980499|NCT00983619|581317516|FG008|Overall Study|Other|0|||
160980500|NCT00983619|581317517|FG009|Overall Study|Other|1|||
160980501|NCT00983619|581317518|FG010|Overall Study|Other|1|||
160980502|NCT00983619|581317519|FG011|Overall Study|Other|0|||
160980503|NCT04716881|581317520|FG000|Overall Study|Adverse Event|1|||
160980504|NCT04716881|581317520|FG000|Overall Study|Lost to Follow-up|1|||
160980505|NCT02443103|581317521|FG000|Overall Study|Adverse Event|2|||
160980506|NCT02443103|581317521|FG000|Overall Study|Noncompliance|1|||
160980507|NCT04147260|581317522|FG000|Overall Study|Adverse Event|1|||
160980508|NCT04147260|581317523|FG001|Overall Study|Adverse Event|0|||
160980509|NCT04147260|581317524|FG002|Overall Study|Adverse Event|1|||
160980510|NCT04147260|581317525|FG003|Overall Study|Adverse Event|2|||
160980511|NCT04147260|581317526|FG004|Overall Study|Adverse Event|0|||
160980512|NCT04147260|581317522|FG000|Overall Study|Withdrawal by Subject|0|||
160980513|NCT04147260|581317523|FG001|Overall Study|Withdrawal by Subject|0|||
160980514|NCT04147260|581317524|FG002|Overall Study|Withdrawal by Subject|1|||
160980515|NCT04147260|581317525|FG003|Overall Study|Withdrawal by Subject|1|||
160980516|NCT04147260|581317526|FG004|Overall Study|Withdrawal by Subject|0|||
160980517|NCT01313923|581317529|FG000|Overall Study|Physician Decision|3|||
160980518|NCT00785538|581317532|FG000|Treatment Period|Adverse Event|1|||
160980519|NCT00785538|581317533|FG001|Treatment Period|Adverse Event|2|||
161093519|NCT02768870|581733762|FG000|Overall Study|Lost to Follow-up|1|||
161093520|NCT02768870|581733762|FG000|Overall Study|Exit|4|||
161093521|NCT02963610|581733763|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
161093522|NCT01774110|581733764|FG000|Overall Study|Lost to Follow-up|7|||
161093523|NCT00063154|581733765|FG000|Overall Study|Disease progression|27|||
161093524|NCT00063154|581733765|FG000|Overall Study|Adverse Event|2|||
161093525|NCT00063154|581733765|FG000|Overall Study|Physician Decision|10|||
161093526|NCT00063154|581733765|FG000|Overall Study|Death|3|||
161093527|NCT00063154|581733765|FG000|Overall Study|Reason unspecified|1|||
161093528|NCT00063154|581733765|FG000|Overall Study|Did not receive treatment|8|||
161093529|NCT02203695|581733766|FG000|Overall Study|Patient withdrew consent|1|||
161093530|NCT02203695|581733767|FG001|Overall Study|Patient withdrew consent|1|||
161093531|NCT02203695|581733766|FG000|Overall Study|Started non-study treatment|1|||
161093532|NCT02203695|581733767|FG001|Overall Study|Started non-study treatment|0|||
161093533|NCT01259726|581733768|FG000|Overall Study|Death|1|||
161093534|NCT01259726|581733769|FG001|Overall Study|Death|0|||
161093535|NCT01259726|581733770|FG002|Overall Study|Death|0|||
161093536|NCT01259726|581733771|FG003|Overall Study|Death|0|||
161093537|NCT01259726|581733768|FG000|Overall Study|Physician Decision|2|||
161093538|NCT01259726|581733769|FG001|Overall Study|Physician Decision|0|||
161093539|NCT01259726|581733770|FG002|Overall Study|Physician Decision|1|||
161093540|NCT01259726|581733771|FG003|Overall Study|Physician Decision|1|||
161093541|NCT01259726|581733768|FG000|Overall Study|Withdrawal by Subject|1|||
161093542|NCT01259726|581733769|FG001|Overall Study|Withdrawal by Subject|3|||
161093543|NCT01259726|581733770|FG002|Overall Study|Withdrawal by Subject|2|||
161093544|NCT01259726|581733771|FG003|Overall Study|Withdrawal by Subject|1|||
161093545|NCT01259726|581733768|FG000|Overall Study|Lost to Follow-up|1|||
161093546|NCT01259726|581733769|FG001|Overall Study|Lost to Follow-up|1|||
161093547|NCT01259726|581733770|FG002|Overall Study|Lost to Follow-up|1|||
161093548|NCT01259726|581733771|FG003|Overall Study|Lost to Follow-up|3|||
161093549|NCT00261846|581733772|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
161093550|NCT00261846|581733773|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
161093551|NCT00261846|581733774|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
161093552|NCT00261846|581733775|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093553|NCT00261846|581733776|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093554|NCT00261846|581733777|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093555|NCT00261846|581733778|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093556|NCT00261846|581733779|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093557|NCT00261846|581733780|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093558|NCT00261846|581733781|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093559|NCT00261846|581733782|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093560|NCT00261846|581733783|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
161093561|NCT00261846|581733772|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093562|NCT00261846|581733773|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093563|NCT00261846|581733774|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093564|NCT00261846|581733775|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
161093565|NCT00261846|581733776|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093566|NCT00261846|581733777|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093567|NCT00261846|581733778|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093568|NCT00261846|581733779|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093569|NCT00261846|581733780|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
161093570|NCT00261846|581733781|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093571|NCT00261846|581733782|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093572|NCT00261846|581733783|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
161093573|NCT00261846|581733772|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161093574|NCT00261846|581733773|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161093575|NCT00261846|581733774|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161093576|NCT00261846|581733775|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
161093577|NCT00261846|581733776|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
161093578|NCT00261846|581733777|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
161209306|NCT01347879|582149071|FG000|Overall Study|Withdrawal by Subject|3|||
161093579|NCT00261846|581733778|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
161093580|NCT00261846|581733779|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
161093581|NCT00261846|581733780|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161093582|NCT00261846|581733781|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
161093583|NCT00261846|581733782|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161093584|NCT00261846|581733783|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
161093585|NCT00261846|581733772|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161093586|NCT00261846|581733773|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161093587|NCT00261846|581733774|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161209307|NCT01347879|582149072|FG001|Overall Study|Withdrawal by Subject|2|||
160980520|NCT00785538|581317534|FG002|Treatment Period|Adverse Event|2|||
160980521|NCT00785538|581317535|FG003|Treatment Period|Adverse Event|0|||
160980522|NCT00785538|581317532|FG000|Treatment Period|Withdrawal by Subject|0|||
160980523|NCT00785538|581317533|FG001|Treatment Period|Withdrawal by Subject|0|||
160980524|NCT00785538|581317534|FG002|Treatment Period|Withdrawal by Subject|0|||
160980525|NCT00785538|581317535|FG003|Treatment Period|Withdrawal by Subject|1|||
160980526|NCT01680458|581317540|FG000|Overall Study|Protocol Violation|3|||
160980527|NCT02138747|581317541|FG000|Treatment Period 1|Adverse Event|10|||
160980528|NCT02138747|581317542|FG001|Treatment Period 1|Adverse Event|14|||
160980529|NCT02138747|581317543|FG002|Treatment Period 1|Adverse Event|2|||
160980530|NCT02138747|581317544|FG003|Treatment Period 1|Adverse Event|1|||
160980531|NCT02138747|581317541|FG000|Treatment Period 1|Lost to Follow-up|0|||
160980532|NCT02138747|581317542|FG001|Treatment Period 1|Lost to Follow-up|1|||
160980533|NCT02138747|581317543|FG002|Treatment Period 1|Lost to Follow-up|1|||
160980534|NCT02138747|581317544|FG003|Treatment Period 1|Lost to Follow-up|0|||
160980535|NCT02138747|581317541|FG000|Treatment Period 1|Protocol Violation|0|||
160980536|NCT02138747|581317542|FG001|Treatment Period 1|Protocol Violation|2|||
160980537|NCT02138747|581317543|FG002|Treatment Period 1|Protocol Violation|0|||
160980538|NCT02138747|581317544|FG003|Treatment Period 1|Protocol Violation|0|||
160980539|NCT02138747|581317541|FG000|Treatment Period 1|Withdrawal by Subject|8|||
160980540|NCT02138747|581317542|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160980541|NCT02138747|581317543|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160980542|NCT02138747|581317544|FG003|Treatment Period 1|Withdrawal by Subject|3|||
160980543|NCT02138747|581317541|FG000|Treatment Period 1|Other - Miscellaneous|2|||
160980544|NCT02138747|581317542|FG001|Treatment Period 1|Other - Miscellaneous|4|||
160980545|NCT02138747|581317543|FG002|Treatment Period 1|Other - Miscellaneous|0|||
160980546|NCT02138747|581317544|FG003|Treatment Period 1|Other - Miscellaneous|0|||
160980547|NCT02138747|581317541|FG000|Treatment Period 2|Adverse Event|6|||
160980548|NCT02138747|581317542|FG001|Treatment Period 2|Adverse Event|3|||
160980549|NCT02138747|581317543|FG002|Treatment Period 2|Adverse Event|1|||
160980550|NCT02138747|581317544|FG003|Treatment Period 2|Adverse Event|1|||
160980551|NCT02138747|581317541|FG000|Treatment Period 2|Lost to Follow-up|2|||
160980552|NCT02138747|581317542|FG001|Treatment Period 2|Lost to Follow-up|0|||
160980553|NCT02138747|581317543|FG002|Treatment Period 2|Lost to Follow-up|0|||
160980554|NCT02138747|581317544|FG003|Treatment Period 2|Lost to Follow-up|0|||
160980555|NCT02138747|581317541|FG000|Treatment Period 2|Protocol Violation|1|||
160980556|NCT02138747|581317542|FG001|Treatment Period 2|Protocol Violation|0|||
160980557|NCT02138747|581317543|FG002|Treatment Period 2|Protocol Violation|0|||
160980558|NCT02138747|581317544|FG003|Treatment Period 2|Protocol Violation|0|||
160980559|NCT02138747|581317541|FG000|Treatment Period 2|Withdrawal by Subject|5|||
160980560|NCT02138747|581317542|FG001|Treatment Period 2|Withdrawal by Subject|4|||
160980561|NCT02138747|581317543|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160980562|NCT02138747|581317544|FG003|Treatment Period 2|Withdrawal by Subject|2|||
160980563|NCT02138747|581317541|FG000|Treatment Period 2|Other - Miscellaneous|3|||
160980564|NCT02138747|581317542|FG001|Treatment Period 2|Other - Miscellaneous|0|||
160980565|NCT02138747|581317543|FG002|Treatment Period 2|Other - Miscellaneous|0|||
160980566|NCT02138747|581317544|FG003|Treatment Period 2|Other - Miscellaneous|0|||
160980567|NCT02302066|581317548|FG000|Overall Study|Adverse Event|1|||
160980568|NCT02302066|581317549|FG001|Overall Study|Adverse Event|1|||
160980569|NCT02302066|581317550|FG002|Overall Study|Adverse Event|3|||
160980570|NCT02302066|581317551|FG003|Overall Study|Adverse Event|0|||
160980571|NCT02302066|581317548|FG000|Overall Study|Lost to Follow-up|4|||
160980572|NCT02302066|581317549|FG001|Overall Study|Lost to Follow-up|5|||
160980573|NCT02302066|581317550|FG002|Overall Study|Lost to Follow-up|24|||
160980574|NCT02302066|581317551|FG003|Overall Study|Lost to Follow-up|7|||
160980575|NCT02302066|581317548|FG000|Overall Study|Withdrawal by Subject|25|||
160980576|NCT02302066|581317549|FG001|Overall Study|Withdrawal by Subject|58|||
160980577|NCT02302066|581317550|FG002|Overall Study|Withdrawal by Subject|124|||
160980578|NCT02302066|581317551|FG003|Overall Study|Withdrawal by Subject|33|||
160980579|NCT02302066|581317548|FG000|Overall Study|Pregnancy|2|||
160980580|NCT02302066|581317549|FG001|Overall Study|Pregnancy|10|||
161093588|NCT00261846|581733775|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
160980581|NCT02302066|581317550|FG002|Overall Study|Pregnancy|12|||
160980582|NCT02302066|581317551|FG003|Overall Study|Pregnancy|0|||
161093589|NCT00261846|581733776|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
160980583|NCT02302066|581317548|FG000|Overall Study|Reason Not Specified|1|||
160980584|NCT02302066|581317549|FG001|Overall Study|Reason Not Specified|1|||
160980585|NCT02302066|581317550|FG002|Overall Study|Reason Not Specified|9|||
160980586|NCT02302066|581317551|FG003|Overall Study|Reason Not Specified|1|||
160980587|NCT02696902|581317556|FG000|Overall Study|Lost to Follow-up|0|||
160980588|NCT02696902|581317557|FG001|Overall Study|Lost to Follow-up|1|||
160980589|NCT02696902|581317558|FG002|Overall Study|Lost to Follow-up|1|||
160980590|NCT02696902|581317556|FG000|Overall Study|Withdrawal by Subject|0|||
160980591|NCT02696902|581317557|FG001|Overall Study|Withdrawal by Subject|0|||
160980592|NCT02696902|581317558|FG002|Overall Study|Withdrawal by Subject|1|||
160980593|NCT02696902|581317556|FG000|Overall Study|Death|19|||
160980594|NCT02696902|581317557|FG001|Overall Study|Death|3|||
160980595|NCT02696902|581317558|FG002|Overall Study|Death|24|||
161093590|NCT00261846|581733777|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161093591|NCT00261846|581733778|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161093592|NCT00261846|581733779|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161093593|NCT00261846|581733780|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
161093594|NCT00261846|581733781|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161093595|NCT00261846|581733782|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
161093596|NCT00261846|581733783|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
161093597|NCT00261846|581733772|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
161093598|NCT00261846|581733773|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
161093599|NCT00261846|581733774|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
161093600|NCT00261846|581733775|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
161093601|NCT00261846|581733776|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
161093602|NCT00261846|581733777|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
161093603|NCT00261846|581733778|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
161093604|NCT00261846|581733779|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
161093605|NCT00261846|581733780|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
161093606|NCT00261846|581733781|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
161093607|NCT00261846|581733782|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
161093608|NCT00261846|581733783|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
161093609|NCT00261846|581733772|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
161093610|NCT00261846|581733773|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
161093611|NCT00261846|581733774|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
161093612|NCT00261846|581733775|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
161209308|NCT01347879|582149071|FG000|Overall Study|Other|2|||
161209309|NCT01347879|582149072|FG001|Overall Study|Other|3|||
161209310|NCT01850108|582149073|FG000|Overall Study|Lost to Follow-up|4|||
161209311|NCT01850108|582149073|FG000|Overall Study|Not eligible|1|||
161209312|NCT01850108|582149073|FG000|Overall Study|Failed engraftment|2|||
161209313|NCT01850108|582149073|FG000|Overall Study|Physician Decision|1|||
161209314|NCT03273712|582149082|FG000|Overall Study|Death|5|||
161209315|NCT03273712|582149082|FG000|Overall Study|Adverse Event|1|||
161209316|NCT03273712|582149082|FG000|Overall Study|Disease Progression|1|||
161209317|NCT03496207|582149083|FG000|Base Study|Adverse Event|0|||
161209318|NCT03496207|582149084|FG001|Base Study|Adverse Event|0|||
161209319|NCT03496207|582149085|FG002|Base Study|Adverse Event|1|||
161209320|NCT03496207|582149086|FG003|Base Study|Adverse Event|1|||
161209321|NCT03496207|582149087|FG004|Base Study|Adverse Event|4|||
161209322|NCT03496207|582149083|FG000|Base Study|Death|0|||
161209323|NCT03496207|582149084|FG001|Base Study|Death|0|||
161209324|NCT03496207|582149085|FG002|Base Study|Death|0|||
161209325|NCT03496207|582149086|FG003|Base Study|Death|0|||
161209326|NCT03496207|582149087|FG004|Base Study|Death|1|||
161209327|NCT03496207|582149083|FG000|Base Study|Withdrawal by Subject|0|||
161209328|NCT03496207|582149084|FG001|Base Study|Withdrawal by Subject|0|||
161209329|NCT03496207|582149085|FG002|Base Study|Withdrawal by Subject|1|||
161209330|NCT03496207|582149086|FG003|Base Study|Withdrawal by Subject|0|||
161209331|NCT03496207|582149087|FG004|Base Study|Withdrawal by Subject|1|||
161209332|NCT03496207|582149083|FG000|Extension Period|Adverse Event|0|||
161209333|NCT03496207|582149084|FG001|Extension Period|Adverse Event|0|||
161209334|NCT03496207|582149085|FG002|Extension Period|Adverse Event|0|||
161209335|NCT03496207|582149086|FG003|Extension Period|Adverse Event|1|||
161209336|NCT03496207|582149087|FG004|Extension Period|Adverse Event|1|||
161209337|NCT03496207|582149083|FG000|Extension Period|Death|1|||
161209338|NCT03496207|582149084|FG001|Extension Period|Death|0|||
161209339|NCT03496207|582149085|FG002|Extension Period|Death|0|||
161209340|NCT03496207|582149086|FG003|Extension Period|Death|1|||
161209341|NCT03496207|582149087|FG004|Extension Period|Death|2|||
161209342|NCT03496207|582149083|FG000|Extension Period|Withdrawal by Subject|1|||
161209343|NCT03496207|582149084|FG001|Extension Period|Withdrawal by Subject|0|||
161209344|NCT03496207|582149085|FG002|Extension Period|Withdrawal by Subject|0|||
161209345|NCT03496207|582149086|FG003|Extension Period|Withdrawal by Subject|1|||
161209346|NCT03496207|582149087|FG004|Extension Period|Withdrawal by Subject|1|||
161209347|NCT03496207|582149083|FG000|Extension Period|Elevated hemoglobin levels|0|||
161209348|NCT03496207|582149084|FG001|Extension Period|Elevated hemoglobin levels|0|||
161209349|NCT03496207|582149085|FG002|Extension Period|Elevated hemoglobin levels|0|||
161209350|NCT03496207|582149086|FG003|Extension Period|Elevated hemoglobin levels|0|||
161209351|NCT03496207|582149087|FG004|Extension Period|Elevated hemoglobin levels|1|||
161209352|NCT01542736|582149088|FG000|Overall Study|Death|1|||
161209353|NCT03674827|582149089|FG000|Treatment Phase|Adverse Event|0|||
161209354|NCT03674827|582149090|FG001|Treatment Phase|Adverse Event|0|||
161209355|NCT03674827|582149091|FG002|Treatment Phase|Adverse Event|0|||
161209356|NCT03674827|582149092|FG003|Treatment Phase|Adverse Event|0|||
161093613|NCT00261846|581733776|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
161209357|NCT03674827|582149093|FG004|Treatment Phase|Adverse Event|0|||
161209358|NCT03674827|582149094|FG005|Treatment Phase|Adverse Event|2|||
161209359|NCT03674827|582149089|FG000|Treatment Phase|Death|2|||
161093614|NCT00261846|581733777|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
161093615|NCT00261846|581733778|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
161093616|NCT00261846|581733779|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
161209360|NCT03674827|582149090|FG001|Treatment Phase|Death|0|||
161209361|NCT03674827|582149091|FG002|Treatment Phase|Death|0|||
160980596|NCT02696902|581317556|FG000|Overall Study|Participant not fit post-randomization|0|||
160980597|NCT02696902|581317557|FG001|Overall Study|Participant not fit post-randomization|0|||
160980598|NCT02696902|581317558|FG002|Overall Study|Participant not fit post-randomization|1|||
160980599|NCT02696902|581317556|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
160980600|NCT02696902|581317557|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
160980601|NCT02696902|581317558|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
160980602|NCT02696902|581317556|FG000|Overall Study|Principal investigator's decision|1|||
160980603|NCT02696902|581317557|FG001|Overall Study|Principal investigator's decision|0|||
160980604|NCT02696902|581317558|FG002|Overall Study|Principal investigator's decision|0|||
160980605|NCT02696902|581317556|FG000|Overall Study|Sponsor's decision|1|||
160980606|NCT02696902|581317557|FG001|Overall Study|Sponsor's decision|0|||
160980607|NCT02696902|581317558|FG002|Overall Study|Sponsor's decision|0|||
160980608|NCT02696902|581317556|FG000|Overall Study|Transferred to other hospital|1|||
160980609|NCT02696902|581317557|FG001|Overall Study|Transferred to other hospital|0|||
160980610|NCT02696902|581317558|FG002|Overall Study|Transferred to other hospital|0|||
160980611|NCT01857622|581317560|FG000|Overall Study|Adverse Event|5|||
160980612|NCT01857622|581317561|FG001|Overall Study|Adverse Event|0|||
160980613|NCT01857622|581317562|FG002|Overall Study|Adverse Event|2|||
160980614|NCT01857622|581317560|FG000|Overall Study|Physician Decision|1|||
160980615|NCT01857622|581317561|FG001|Overall Study|Physician Decision|0|||
160980616|NCT01857622|581317562|FG002|Overall Study|Physician Decision|0|||
160980617|NCT01857622|581317560|FG000|Overall Study|Protocol Violation|4|||
160980618|NCT01857622|581317561|FG001|Overall Study|Protocol Violation|1|||
160980619|NCT01857622|581317562|FG002|Overall Study|Protocol Violation|0|||
160980620|NCT01857622|581317560|FG000|Overall Study|Withdrawal by Subject|1|||
160980621|NCT01857622|581317561|FG001|Overall Study|Withdrawal by Subject|0|||
160980622|NCT01857622|581317562|FG002|Overall Study|Withdrawal by Subject|0|||
160980623|NCT00514046|581317571|FG000|Overall Study|transferred to another protocol|2|||
160980624|NCT00514046|581317572|FG001|Overall Study|transferred to another protocol|1|||
160980625|NCT00514046|581317573|FG002|Overall Study|transferred to another protocol|3|||
160980626|NCT00514046|581317574|FG003|Overall Study|transferred to another protocol|0|||
160980627|NCT00514046|581317575|FG004|Overall Study|transferred to another protocol|1|||
160980628|NCT00514046|581317576|FG005|Overall Study|transferred to another protocol|0|||
160980629|NCT00514046|581317577|FG006|Overall Study|transferred to another protocol|0|||
160980630|NCT00514046|581317578|FG007|Overall Study|transferred to another protocol|0|||
160980631|NCT00514046|581317579|FG008|Overall Study|transferred to another protocol|0|||
160980632|NCT00514046|581317571|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
160980633|NCT00514046|581317572|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
160980634|NCT00514046|581317573|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
160980635|NCT00514046|581317574|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
160980636|NCT00514046|581317575|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
160980637|NCT00514046|581317576|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
160980638|NCT00514046|581317577|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
160980639|NCT00514046|581317578|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
160980640|NCT00514046|581317579|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
160980641|NCT00514046|581317571|FG000|Overall Study|Disease progression on study|0|||
161093617|NCT00261846|581733780|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
160980642|NCT00514046|581317572|FG001|Overall Study|Disease progression on study|0|||
160980643|NCT00514046|581317573|FG002|Overall Study|Disease progression on study|2|||
160980644|NCT00514046|581317574|FG003|Overall Study|Disease progression on study|0|||
160980645|NCT00514046|581317575|FG004|Overall Study|Disease progression on study|0|||
160980646|NCT00514046|581317576|FG005|Overall Study|Disease progression on study|1|||
160980647|NCT00514046|581317577|FG006|Overall Study|Disease progression on study|0|||
160980648|NCT00514046|581317578|FG007|Overall Study|Disease progression on study|0|||
160980649|NCT00514046|581317579|FG008|Overall Study|Disease progression on study|0|||
160980650|NCT02855164|581317580|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980651|NCT02855164|581317581|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980652|NCT02855164|581317582|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
160980653|NCT02855164|581317583|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
160980654|NCT02855164|581317584|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
160980655|NCT02855164|581317585|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980656|NCT02855164|581317586|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980657|NCT02855164|581317587|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
160980658|NCT02855164|581317580|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
160980659|NCT02855164|581317581|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
160980660|NCT02855164|581317582|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
160980661|NCT02855164|581317583|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
160980662|NCT02855164|581317584|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
160980663|NCT02855164|581317585|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
160980664|NCT02855164|581317586|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
161093618|NCT00261846|581733781|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
161093619|NCT00261846|581733782|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
161093620|NCT00261846|581733783|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
161093621|NCT00261846|581733772|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
161093622|NCT00261846|581733773|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
161093623|NCT00261846|581733774|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
161093624|NCT00261846|581733775|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
161093625|NCT00261846|581733776|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
161093626|NCT00261846|581733777|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
161093627|NCT00261846|581733778|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
161093628|NCT00261846|581733779|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
161093629|NCT00261846|581733780|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
161093630|NCT00261846|581733781|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
161093631|NCT00261846|581733782|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
161093632|NCT00261846|581733783|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
161093633|NCT01745848|581733788|FG000|Overall Study|Adverse Event|6|||
161093634|NCT03581825|581733791|FG000|Period 1|Lens Discomfort|1|||
161093635|NCT03581825|581733792|FG001|Period 1|Lens Discomfort|0|||
161093636|NCT03581825|581733791|FG000|Period 2|Unsatisfactory Vision to Test|0|||
161093637|NCT03581825|581733792|FG001|Period 2|Unsatisfactory Vision to Test|1|||
161093638|NCT00585195|581733794|FG000|Overall Study|Adverse Event|0|||
161093639|NCT00585195|581733795|FG001|Overall Study|Adverse Event|0|||
161093640|NCT00585195|581733796|FG002|Overall Study|Adverse Event|0|||
161093641|NCT00585195|581733797|FG003|Overall Study|Adverse Event|0|||
161093642|NCT00585195|581733798|FG004|Overall Study|Adverse Event|2|||
161093643|NCT00585195|581733799|FG005|Overall Study|Adverse Event|1|||
161093644|NCT00585195|581733800|FG006|Overall Study|Adverse Event|0|||
161093645|NCT00585195|581733801|FG007|Overall Study|Adverse Event|1|||
161093646|NCT00585195|581733802|FG008|Overall Study|Adverse Event|0|||
161093647|NCT00585195|581733803|FG009|Overall Study|Adverse Event|0|||
161093648|NCT00585195|581733804|FG010|Overall Study|Adverse Event|3|||
161093649|NCT00585195|581733805|FG011|Overall Study|Adverse Event|0|||
161093650|NCT00585195|581733806|FG012|Overall Study|Adverse Event|8|||
161093651|NCT00585195|581733807|FG013|Overall Study|Adverse Event|6|||
161093652|NCT00585195|581733808|FG014|Overall Study|Adverse Event|4|||
161093653|NCT00585195|581733809|FG015|Overall Study|Adverse Event|1|||
161093654|NCT00585195|581733810|FG016|Overall Study|Adverse Event|14|||
161093655|NCT00585195|581733811|FG017|Overall Study|Adverse Event|9|||
161093656|NCT00585195|581733812|FG018|Overall Study|Adverse Event|2|||
161093657|NCT00585195|581733813|FG019|Overall Study|Adverse Event|3|||
161093658|NCT00585195|581733814|FG020|Overall Study|Adverse Event|1|||
161093659|NCT00585195|581733794|FG000|Overall Study|Progressive Disease|2|||
161093660|NCT00585195|581733795|FG001|Overall Study|Progressive Disease|2|||
161093661|NCT00585195|581733796|FG002|Overall Study|Progressive Disease|5|||
161093662|NCT00585195|581733797|FG003|Overall Study|Progressive Disease|4|||
161093663|NCT00585195|581733798|FG004|Overall Study|Progressive Disease|6|||
161093664|NCT00585195|581733799|FG005|Overall Study|Progressive Disease|4|||
161093665|NCT00585195|581733800|FG006|Overall Study|Progressive Disease|6|||
161093666|NCT00585195|581733801|FG007|Overall Study|Progressive Disease|3|||
161093667|NCT00585195|581733802|FG008|Overall Study|Progressive Disease|0|||
161093668|NCT00585195|581733803|FG009|Overall Study|Progressive Disease|5|||
161093669|NCT00585195|581733804|FG010|Overall Study|Progressive Disease|2|||
161093670|NCT00585195|581733805|FG011|Overall Study|Progressive Disease|25|||
161093671|NCT00585195|581733806|FG012|Overall Study|Progressive Disease|29|||
161093672|NCT00585195|581733807|FG013|Overall Study|Progressive Disease|26|||
161093673|NCT00585195|581733808|FG014|Overall Study|Progressive Disease|21|||
161093674|NCT00585195|581733809|FG015|Overall Study|Progressive Disease|12|||
161093675|NCT00585195|581733810|FG016|Overall Study|Progressive Disease|94|||
161093676|NCT00585195|581733811|FG017|Overall Study|Progressive Disease|42|||
161093677|NCT00585195|581733812|FG018|Overall Study|Progressive Disease|4|||
161093678|NCT00585195|581733813|FG019|Overall Study|Progressive Disease|9|||
161093679|NCT00585195|581733814|FG020|Overall Study|Progressive Disease|8|||
161093680|NCT00585195|581733794|FG000|Overall Study|Withdrawal by Subject|1|||
161093681|NCT00585195|581733795|FG001|Overall Study|Withdrawal by Subject|1|||
161093682|NCT00585195|581733796|FG002|Overall Study|Withdrawal by Subject|2|||
161093683|NCT00585195|581733797|FG003|Overall Study|Withdrawal by Subject|2|||
161093684|NCT00585195|581733798|FG004|Overall Study|Withdrawal by Subject|0|||
161093685|NCT00585195|581733799|FG005|Overall Study|Withdrawal by Subject|0|||
161093686|NCT00585195|581733800|FG006|Overall Study|Withdrawal by Subject|0|||
161209362|NCT03674827|582149092|FG003|Treatment Phase|Death|0|||
161093687|NCT00585195|581733801|FG007|Overall Study|Withdrawal by Subject|1|||
161093688|NCT00585195|581733802|FG008|Overall Study|Withdrawal by Subject|0|||
161093689|NCT00585195|581733803|FG009|Overall Study|Withdrawal by Subject|0|||
161093690|NCT00585195|581733804|FG010|Overall Study|Withdrawal by Subject|3|||
161093691|NCT00585195|581733805|FG011|Overall Study|Withdrawal by Subject|8|||
161093692|NCT00585195|581733806|FG012|Overall Study|Withdrawal by Subject|15|||
161093693|NCT00585195|581733807|FG013|Overall Study|Withdrawal by Subject|0|||
161093694|NCT00585195|581733808|FG014|Overall Study|Withdrawal by Subject|3|||
161093695|NCT00585195|581733809|FG015|Overall Study|Withdrawal by Subject|0|||
161093696|NCT00585195|581733810|FG016|Overall Study|Withdrawal by Subject|7|||
161093697|NCT00585195|581733811|FG017|Overall Study|Withdrawal by Subject|1|||
161093698|NCT00585195|581733812|FG018|Overall Study|Withdrawal by Subject|2|||
161093699|NCT00585195|581733813|FG019|Overall Study|Withdrawal by Subject|2|||
161093700|NCT00585195|581733814|FG020|Overall Study|Withdrawal by Subject|0|||
161093701|NCT00585195|581733794|FG000|Overall Study|Other|0|||
161093702|NCT00585195|581733795|FG001|Overall Study|Other|1|||
161093703|NCT00585195|581733796|FG002|Overall Study|Other|1|||
161093704|NCT00585195|581733797|FG003|Overall Study|Other|1|||
161093705|NCT00585195|581733798|FG004|Overall Study|Other|0|||
161093706|NCT00585195|581733799|FG005|Overall Study|Other|1|||
161093707|NCT00585195|581733800|FG006|Overall Study|Other|0|||
161093708|NCT00585195|581733801|FG007|Overall Study|Other|0|||
161093709|NCT00585195|581733802|FG008|Overall Study|Other|2|||
161093710|NCT00585195|581733803|FG009|Overall Study|Other|1|||
161093711|NCT00585195|581733804|FG010|Overall Study|Other|0|||
161093712|NCT00585195|581733805|FG011|Overall Study|Other|19|||
161093713|NCT00585195|581733806|FG012|Overall Study|Other|24|||
161093714|NCT00585195|581733807|FG013|Overall Study|Other|7|||
161093715|NCT00585195|581733808|FG014|Overall Study|Other|11|||
161093716|NCT00585195|581733809|FG015|Overall Study|Other|3|||
161093717|NCT00585195|581733810|FG016|Overall Study|Other|28|||
161093718|NCT00585195|581733811|FG017|Overall Study|Other|12|||
161093719|NCT00585195|581733812|FG018|Overall Study|Other|10|||
161093720|NCT00585195|581733813|FG019|Overall Study|Other|4|||
161093721|NCT00585195|581733814|FG020|Overall Study|Other|2|||
161093722|NCT00585195|581733794|FG000|Overall Study|Randomized not treated|0|||
161093723|NCT00585195|581733795|FG001|Overall Study|Randomized not treated|0|||
161093724|NCT00585195|581733796|FG002|Overall Study|Randomized not treated|1|||
161093725|NCT00585195|581733797|FG003|Overall Study|Randomized not treated|0|||
161093726|NCT00585195|581733798|FG004|Overall Study|Randomized not treated|1|||
161093727|NCT00585195|581733799|FG005|Overall Study|Randomized not treated|0|||
161093728|NCT00585195|581733800|FG006|Overall Study|Randomized not treated|1|||
161093729|NCT00585195|581733801|FG007|Overall Study|Randomized not treated|0|||
161093730|NCT00585195|581733802|FG008|Overall Study|Randomized not treated|0|||
161093731|NCT00585195|581733803|FG009|Overall Study|Randomized not treated|0|||
161093732|NCT00585195|581733804|FG010|Overall Study|Randomized not treated|2|||
161093733|NCT00585195|581733805|FG011|Overall Study|Randomized not treated|0|||
161093734|NCT00585195|581733806|FG012|Overall Study|Randomized not treated|0|||
161093735|NCT00585195|581733807|FG013|Overall Study|Randomized not treated|0|||
161093736|NCT00585195|581733808|FG014|Overall Study|Randomized not treated|0|||
161093737|NCT00585195|581733809|FG015|Overall Study|Randomized not treated|1|||
161093738|NCT00585195|581733810|FG016|Overall Study|Randomized not treated|0|||
161093739|NCT00585195|581733811|FG017|Overall Study|Randomized not treated|1|||
161093740|NCT00585195|581733812|FG018|Overall Study|Randomized not treated|3|||
161093741|NCT00585195|581733813|FG019|Overall Study|Randomized not treated|0|||
161093742|NCT00585195|581733814|FG020|Overall Study|Randomized not treated|2|||
161093743|NCT00585195|581733794|FG000|Overall Study|Death|0|||
161093744|NCT00585195|581733795|FG001|Overall Study|Death|0|||
161093745|NCT00585195|581733796|FG002|Overall Study|Death|0|||
161093746|NCT00585195|581733797|FG003|Overall Study|Death|0|||
161093747|NCT00585195|581733798|FG004|Overall Study|Death|0|||
161093748|NCT00585195|581733799|FG005|Overall Study|Death|0|||
161093749|NCT00585195|581733800|FG006|Overall Study|Death|0|||
161093750|NCT00585195|581733801|FG007|Overall Study|Death|0|||
161093751|NCT00585195|581733802|FG008|Overall Study|Death|1|||
161093752|NCT00585195|581733803|FG009|Overall Study|Death|0|||
161093753|NCT00585195|581733804|FG010|Overall Study|Death|1|||
161093754|NCT00585195|581733805|FG011|Overall Study|Death|1|||
161093755|NCT00585195|581733806|FG012|Overall Study|Death|7|||
161093756|NCT00585195|581733807|FG013|Overall Study|Death|2|||
161093757|NCT00585195|581733808|FG014|Overall Study|Death|8|||
161093758|NCT00585195|581733809|FG015|Overall Study|Death|2|||
161093759|NCT00585195|581733810|FG016|Overall Study|Death|11|||
161093760|NCT00585195|581733811|FG017|Overall Study|Death|0|||
161093761|NCT00585195|581733812|FG018|Overall Study|Death|0|||
161093762|NCT00585195|581733813|FG019|Overall Study|Death|0|||
161093763|NCT00585195|581733814|FG020|Overall Study|Death|1|||
161093764|NCT00585195|581733794|FG000|Overall Study|Lost to Follow-up|0|||
161093765|NCT00585195|581733795|FG001|Overall Study|Lost to Follow-up|0|||
161093766|NCT00585195|581733796|FG002|Overall Study|Lost to Follow-up|0|||
161093767|NCT00585195|581733797|FG003|Overall Study|Lost to Follow-up|0|||
161093768|NCT00585195|581733798|FG004|Overall Study|Lost to Follow-up|0|||
161093769|NCT00585195|581733799|FG005|Overall Study|Lost to Follow-up|0|||
161093770|NCT00585195|581733800|FG006|Overall Study|Lost to Follow-up|0|||
161093771|NCT00585195|581733801|FG007|Overall Study|Lost to Follow-up|0|||
161093772|NCT00585195|581733802|FG008|Overall Study|Lost to Follow-up|0|||
161093773|NCT00585195|581733803|FG009|Overall Study|Lost to Follow-up|0|||
161093774|NCT00585195|581733804|FG010|Overall Study|Lost to Follow-up|0|||
161093775|NCT00585195|581733805|FG011|Overall Study|Lost to Follow-up|0|||
161093776|NCT00585195|581733806|FG012|Overall Study|Lost to Follow-up|1|||
161093777|NCT00585195|581733807|FG013|Overall Study|Lost to Follow-up|0|||
161093778|NCT00585195|581733808|FG014|Overall Study|Lost to Follow-up|0|||
161093779|NCT00585195|581733809|FG015|Overall Study|Lost to Follow-up|0|||
161093780|NCT00585195|581733810|FG016|Overall Study|Lost to Follow-up|0|||
161093781|NCT00585195|581733811|FG017|Overall Study|Lost to Follow-up|2|||
161093782|NCT00585195|581733812|FG018|Overall Study|Lost to Follow-up|0|||
161093783|NCT00585195|581733813|FG019|Overall Study|Lost to Follow-up|0|||
161093784|NCT00585195|581733814|FG020|Overall Study|Lost to Follow-up|0|||
161093785|NCT00585195|581733794|FG000|Overall Study|Site Terminated by Sponsor|0|||
160980665|NCT02855164|581317587|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
160980666|NCT02855164|581317580|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
160980667|NCT02855164|581317581|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
160980668|NCT02855164|581317582|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
160980669|NCT02855164|581317583|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
160980670|NCT02855164|581317584|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
160980671|NCT02855164|581317585|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
161093786|NCT00585195|581733795|FG001|Overall Study|Site Terminated by Sponsor|0|||
161093787|NCT00585195|581733796|FG002|Overall Study|Site Terminated by Sponsor|0|||
161093788|NCT00585195|581733797|FG003|Overall Study|Site Terminated by Sponsor|0|||
161093789|NCT00585195|581733798|FG004|Overall Study|Site Terminated by Sponsor|0|||
161093790|NCT00585195|581733799|FG005|Overall Study|Site Terminated by Sponsor|0|||
161093791|NCT00585195|581733800|FG006|Overall Study|Site Terminated by Sponsor|0|||
161093792|NCT00585195|581733801|FG007|Overall Study|Site Terminated by Sponsor|0|||
161093793|NCT00585195|581733802|FG008|Overall Study|Site Terminated by Sponsor|0|||
161093794|NCT00585195|581733803|FG009|Overall Study|Site Terminated by Sponsor|0|||
161093795|NCT00585195|581733804|FG010|Overall Study|Site Terminated by Sponsor|0|||
161093796|NCT00585195|581733805|FG011|Overall Study|Site Terminated by Sponsor|0|||
161093797|NCT00585195|581733806|FG012|Overall Study|Site Terminated by Sponsor|1|||
161093798|NCT00585195|581733807|FG013|Overall Study|Site Terminated by Sponsor|0|||
161093799|NCT00585195|581733808|FG014|Overall Study|Site Terminated by Sponsor|0|||
161093800|NCT00585195|581733809|FG015|Overall Study|Site Terminated by Sponsor|0|||
161093801|NCT00585195|581733810|FG016|Overall Study|Site Terminated by Sponsor|0|||
161093802|NCT00585195|581733811|FG017|Overall Study|Site Terminated by Sponsor|0|||
161093803|NCT00585195|581733812|FG018|Overall Study|Site Terminated by Sponsor|0|||
161093804|NCT00585195|581733813|FG019|Overall Study|Site Terminated by Sponsor|0|||
161093805|NCT00585195|581733814|FG020|Overall Study|Site Terminated by Sponsor|0|||
161093806|NCT00585195|581733794|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
161093807|NCT00585195|581733795|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
161093808|NCT00585195|581733796|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
161093809|NCT00585195|581733797|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
161093810|NCT00585195|581733798|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
161093811|NCT00585195|581733799|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
161093812|NCT00585195|581733800|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
161093813|NCT00585195|581733801|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
161093814|NCT00585195|581733802|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
161093815|NCT00585195|581733803|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
161093816|NCT00585195|581733804|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
161093817|NCT00585195|581733805|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
161093818|NCT00585195|581733806|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
161093819|NCT00585195|581733807|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
161093820|NCT00585195|581733808|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
161093821|NCT00585195|581733809|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
161093822|NCT00585195|581733810|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
161093823|NCT00585195|581733811|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
161093824|NCT00585195|581733812|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
161093825|NCT00585195|581733813|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
161093826|NCT00585195|581733814|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
161093827|NCT00770341|581733815|FG000|Overall Study|Did not meet eligibility criteria|1|||
161093828|NCT00770341|581733816|FG001|Overall Study|Did not meet eligibility criteria|0|||
161093829|NCT00770341|581733817|FG002|Overall Study|Did not meet eligibility criteria|0|||
161093830|NCT00770341|581733815|FG000|Overall Study|Withdrawal by Subject|0|||
161093831|NCT00770341|581733816|FG001|Overall Study|Withdrawal by Subject|1|||
161093832|NCT00770341|581733817|FG002|Overall Study|Withdrawal by Subject|0|||
161093833|NCT00770341|581733815|FG000|Overall Study|Clinical Adverse Event|3|||
161093834|NCT00770341|581733816|FG001|Overall Study|Clinical Adverse Event|1|||
161093835|NCT00770341|581733817|FG002|Overall Study|Clinical Adverse Event|2|||
161093836|NCT00770341|581733815|FG000|Overall Study|Laboratory adverse event|3|||
161093837|NCT00770341|581733816|FG001|Overall Study|Laboratory adverse event|3|||
161093838|NCT00770341|581733817|FG002|Overall Study|Laboratory adverse event|0|||
161209363|NCT03674827|582149093|FG004|Treatment Phase|Death|1|||
161093839|NCT00770341|581733815|FG000|Overall Study|Lack of Efficacy|3|||
161093840|NCT00770341|581733816|FG001|Overall Study|Lack of Efficacy|0|||
161093841|NCT00770341|581733817|FG002|Overall Study|Lack of Efficacy|1|||
161093842|NCT00770341|581733815|FG000|Overall Study|Other|1|||
161093843|NCT00770341|581733816|FG001|Overall Study|Other|0|||
161093844|NCT00770341|581733817|FG002|Overall Study|Other|0|||
161093845|NCT00770341|581733815|FG000|Overall Study|Not treated|1|||
161093846|NCT00770341|581733816|FG001|Overall Study|Not treated|0|||
161093847|NCT00770341|581733817|FG002|Overall Study|Not treated|0|||
161093848|NCT02739360|581733818|FG000|Overall Study|Adverse Event|1|||
161093849|NCT02739360|581733818|FG000|Overall Study|Study terminated by Sponsor|2|||
161093850|NCT02533570|581733820|FG000|Overall Study|Adverse Event|0|||
161093851|NCT02533570|581733821|FG001|Overall Study|Adverse Event|1|||
161093852|NCT02533570|581733822|FG002|Overall Study|Adverse Event|1|||
161093853|NCT01163916|581733823|FG000|Overall Study|Withdrawal by Subject|2|||
161093854|NCT01163916|581733824|FG001|Overall Study|Withdrawal by Subject|0|||
161093855|NCT01163916|581733825|FG002|Overall Study|Withdrawal by Subject|2|||
161093856|NCT01163916|581733823|FG000|Overall Study|Adverse Event|2|||
161093857|NCT01163916|581733824|FG001|Overall Study|Adverse Event|0|||
161093858|NCT01163916|581733825|FG002|Overall Study|Adverse Event|1|||
161093859|NCT01163916|581733823|FG000|Overall Study|Lack of Efficacy|2|||
161093860|NCT01163916|581733824|FG001|Overall Study|Lack of Efficacy|0|||
161093861|NCT01163916|581733825|FG002|Overall Study|Lack of Efficacy|1|||
161093862|NCT01163916|581733823|FG000|Overall Study|Other|24|||
161093863|NCT01163916|581733824|FG001|Overall Study|Other|4|||
161093864|NCT01163916|581733825|FG002|Overall Study|Other|16|||
161093865|NCT00529958|581733826|FG000|2-Year Follow-up|Lost to Follow-up|1|||
161093866|NCT00529958|581733827|FG001|2-Year Follow-up|Lost to Follow-up|2|||
161093867|NCT00529958|581733828|FG002|2-Year Follow-up|Lost to Follow-up|2|||
161093868|NCT00529958|581733826|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
161093869|NCT00529958|581733827|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
161093870|NCT00529958|581733828|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
161093871|NCT00529958|581733826|FG000|5-Year Follow-up|Lost to Follow-up|2|||
161093872|NCT00529958|581733827|FG001|5-Year Follow-up|Lost to Follow-up|3|||
161093873|NCT00529958|581733828|FG002|5-Year Follow-up|Lost to Follow-up|1|||
161093874|NCT00529958|581733826|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
161093875|NCT00529958|581733827|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
161093876|NCT00529958|581733828|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
161093877|NCT02337751|581733829|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
161093878|NCT02337751|581733830|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161093879|NCT02337751|581733829|FG000|Overall Study|Voluntary Withdrawal|6|||
161093880|NCT02337751|581733830|FG001|Overall Study|Voluntary Withdrawal|8|||
161093881|NCT02337751|581733829|FG000|Overall Study|Lack of Efficacy|2|||
161093882|NCT02337751|581733830|FG001|Overall Study|Lack of Efficacy|5|||
161093883|NCT02337751|581733829|FG000|Overall Study|Investigator's Judgement|1|||
161093884|NCT02337751|581733830|FG001|Overall Study|Investigator's Judgement|0|||
161093885|NCT01340651|581733831|FG000|Overall Study|Adverse Event|3|||
160980672|NCT02855164|581317586|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
160980673|NCT02855164|581317587|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
160980674|NCT02855164|581317580|FG000|Part C (Randomized Set)|Adverse Event|0|||
160980675|NCT02855164|581317581|FG001|Part C (Randomized Set)|Adverse Event|0|||
160980676|NCT02855164|581317582|FG002|Part C (Randomized Set)|Adverse Event|0|||
160980677|NCT02855164|581317583|FG003|Part C (Randomized Set)|Adverse Event|0|||
160980678|NCT02855164|581317584|FG004|Part C (Randomized Set)|Adverse Event|0|||
160980679|NCT02855164|581317585|FG005|Part C (Randomized Set)|Adverse Event|5|||
160980680|NCT02855164|581317586|FG006|Part C (Randomized Set)|Adverse Event|9|||
160980681|NCT02855164|581317587|FG007|Part C (Randomized Set)|Adverse Event|2|||
160980682|NCT02855164|581317580|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
160980683|NCT02855164|581317581|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
160980684|NCT02855164|581317582|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
160980685|NCT02855164|581317583|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
160980686|NCT02855164|581317584|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
160980687|NCT02855164|581317585|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
160980688|NCT02855164|581317586|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
160980689|NCT02855164|581317587|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
160980690|NCT02855164|581317580|FG000|Part C (Randomized Set)|Physician Decision|0|||
160980691|NCT02855164|581317581|FG001|Part C (Randomized Set)|Physician Decision|0|||
160980692|NCT02855164|581317582|FG002|Part C (Randomized Set)|Physician Decision|0|||
161093886|NCT01340651|581733831|FG000|Overall Study|Consent Withdrawn|2|||
161093887|NCT01340651|581733831|FG000|Overall Study|Commercial Supply per Sponsor|12|||
160980693|NCT02855164|581317583|FG003|Part C (Randomized Set)|Physician Decision|0|||
161093888|NCT01315353|581733832|FG000|Overall Study|Death|2|||
160980694|NCT02855164|581317584|FG004|Part C (Randomized Set)|Physician Decision|0|||
160980695|NCT02855164|581317585|FG005|Part C (Randomized Set)|Physician Decision|1|||
160980696|NCT02855164|581317586|FG006|Part C (Randomized Set)|Physician Decision|0|||
161093889|NCT01315353|581733833|FG001|Overall Study|Death|1|||
161093890|NCT01315353|581733834|FG002|Overall Study|Death|0|||
161093891|NCT01315353|581733832|FG000|Overall Study|Withdrawal by Subject|2|||
161093892|NCT01315353|581733833|FG001|Overall Study|Withdrawal by Subject|6|||
161093893|NCT01315353|581733834|FG002|Overall Study|Withdrawal by Subject|1|||
161093894|NCT01315353|581733832|FG000|Overall Study|Lost to Follow-up|13|||
161093895|NCT01315353|581733833|FG001|Overall Study|Lost to Follow-up|6|||
161093896|NCT01315353|581733834|FG002|Overall Study|Lost to Follow-up|6|||
160980697|NCT02855164|581317587|FG007|Part C (Randomized Set)|Physician Decision|1|||
160980698|NCT02855164|581317580|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980699|NCT02855164|581317581|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980700|NCT02855164|581317582|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980701|NCT02855164|581317583|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980702|NCT02855164|581317584|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
160980703|NCT02855164|581317585|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
160980704|NCT02855164|581317586|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
160980705|NCT02855164|581317587|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
160980706|NCT00876460|581317588|FG000|Combination Therapy Phase|Progressive disease|2|||
160980707|NCT00876460|581317589|FG001|Combination Therapy Phase|Progressive disease|3|||
160980708|NCT00876460|581317590|FG002|Combination Therapy Phase|Progressive disease|3|||
160980709|NCT00876460|581317591|FG003|Combination Therapy Phase|Progressive disease|3|||
160980710|NCT00876460|581317592|FG004|Combination Therapy Phase|Progressive disease|3|||
160980711|NCT00876460|581317593|FG005|Combination Therapy Phase|Progressive disease|1|||
160980712|NCT00876460|581317594|FG006|Combination Therapy Phase|Progressive disease|1|||
160980713|NCT00876460|581317595|FG007|Combination Therapy Phase|Progressive disease|1|||
160980714|NCT00876460|581317588|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
160980715|NCT00876460|581317589|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
160980716|NCT00876460|581317590|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
160980717|NCT00876460|581317591|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
160980718|NCT00876460|581317592|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
160980719|NCT00876460|581317593|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
160980720|NCT00876460|581317594|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
160980721|NCT00876460|581317595|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
160980722|NCT00876460|581317588|FG000|Combination Therapy Phase|Adverse Event|0|||
160980723|NCT00876460|581317589|FG001|Combination Therapy Phase|Adverse Event|2|||
160980724|NCT00876460|581317590|FG002|Combination Therapy Phase|Adverse Event|0|||
160980725|NCT00876460|581317591|FG003|Combination Therapy Phase|Adverse Event|2|||
160980726|NCT00876460|581317592|FG004|Combination Therapy Phase|Adverse Event|2|||
160980727|NCT00876460|581317593|FG005|Combination Therapy Phase|Adverse Event|0|||
160980728|NCT00876460|581317594|FG006|Combination Therapy Phase|Adverse Event|3|||
160980729|NCT00876460|581317595|FG007|Combination Therapy Phase|Adverse Event|2|||
160980730|NCT00876460|581317588|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
160980731|NCT00876460|581317589|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
160980732|NCT00876460|581317590|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
160980733|NCT00876460|581317591|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
160980734|NCT00876460|581317592|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
160980735|NCT00876460|581317593|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
160980736|NCT00876460|581317594|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
160980737|NCT00876460|581317595|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
160980738|NCT00876460|581317588|FG000|Combination Therapy Phase|Other reason not defined above|0|||
160980739|NCT00876460|581317589|FG001|Combination Therapy Phase|Other reason not defined above|0|||
160980740|NCT00876460|581317590|FG002|Combination Therapy Phase|Other reason not defined above|0|||
160980741|NCT00876460|581317591|FG003|Combination Therapy Phase|Other reason not defined above|0|||
160980742|NCT00876460|581317592|FG004|Combination Therapy Phase|Other reason not defined above|0|||
160980743|NCT00876460|581317593|FG005|Combination Therapy Phase|Other reason not defined above|0|||
160980744|NCT00876460|581317594|FG006|Combination Therapy Phase|Other reason not defined above|1|||
160980745|NCT00876460|581317595|FG007|Combination Therapy Phase|Other reason not defined above|2|||
160980746|NCT00876460|581317588|FG000|Combination Therapy Phase|Not treated|0|||
160980747|NCT00876460|581317589|FG001|Combination Therapy Phase|Not treated|0|||
160980748|NCT00876460|581317590|FG002|Combination Therapy Phase|Not treated|0|||
160980749|NCT00876460|581317591|FG003|Combination Therapy Phase|Not treated|0|||
160980750|NCT00876460|581317592|FG004|Combination Therapy Phase|Not treated|0|||
160980751|NCT00876460|581317593|FG005|Combination Therapy Phase|Not treated|0|||
160980752|NCT00876460|581317594|FG006|Combination Therapy Phase|Not treated|1|||
160980753|NCT00876460|581317595|FG007|Combination Therapy Phase|Not treated|0|||
160980754|NCT00876460|581317588|FG000|Mono Therapy Phase|Progressive disease|0|||
160980755|NCT00876460|581317589|FG001|Mono Therapy Phase|Progressive disease|0|||
160980756|NCT00876460|581317590|FG002|Mono Therapy Phase|Progressive disease|0|||
160980757|NCT00876460|581317591|FG003|Mono Therapy Phase|Progressive disease|0|||
160980758|NCT00876460|581317592|FG004|Mono Therapy Phase|Progressive disease|2|||
160980759|NCT00876460|581317593|FG005|Mono Therapy Phase|Progressive disease|0|||
160980760|NCT00876460|581317594|FG006|Mono Therapy Phase|Progressive disease|1|||
160980761|NCT00876460|581317595|FG007|Mono Therapy Phase|Progressive disease|3|||
160980762|NCT00876460|581317588|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
160980763|NCT00876460|581317589|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
160980764|NCT00876460|581317590|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
160980765|NCT00876460|581317591|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
160980766|NCT00876460|581317592|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
160980767|NCT00876460|581317593|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
160980768|NCT00876460|581317594|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
160980769|NCT00876460|581317595|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
160980770|NCT00876460|581317588|FG000|Mono Therapy Phase|Adverse Event|0|||
160980771|NCT00876460|581317589|FG001|Mono Therapy Phase|Adverse Event|0|||
160980772|NCT00876460|581317590|FG002|Mono Therapy Phase|Adverse Event|0|||
160980773|NCT00876460|581317591|FG003|Mono Therapy Phase|Adverse Event|1|||
160980774|NCT00876460|581317592|FG004|Mono Therapy Phase|Adverse Event|0|||
160980775|NCT00876460|581317593|FG005|Mono Therapy Phase|Adverse Event|0|||
160980776|NCT00876460|581317594|FG006|Mono Therapy Phase|Adverse Event|0|||
160980777|NCT00876460|581317595|FG007|Mono Therapy Phase|Adverse Event|0|||
160980778|NCT00383240|581317596|FG000|Overall Study|Adverse Event|4|||
160980779|NCT00383240|581317597|FG001|Overall Study|Adverse Event|6|||
160980780|NCT00383240|581317598|FG002|Overall Study|Adverse Event|9|||
160980781|NCT00383240|581317599|FG003|Overall Study|Adverse Event|7|||
160980782|NCT00383240|581317596|FG000|Overall Study|Treatment Failure|8|||
160980783|NCT00383240|581317597|FG001|Overall Study|Treatment Failure|13|||
160980784|NCT00383240|581317598|FG002|Overall Study|Treatment Failure|47|||
160980785|NCT00383240|581317599|FG003|Overall Study|Treatment Failure|46|||
160980786|NCT00383240|581317596|FG000|Overall Study|Lost to Follow-up|3|||
160980787|NCT00383240|581317597|FG001|Overall Study|Lost to Follow-up|0|||
160980788|NCT00383240|581317598|FG002|Overall Study|Lost to Follow-up|0|||
160980789|NCT00383240|581317599|FG003|Overall Study|Lost to Follow-up|2|||
160980790|NCT00383240|581317596|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
160980791|NCT00383240|581317597|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
160980792|NCT00383240|581317598|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
160980793|NCT00383240|581317599|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
160980794|NCT00383240|581317596|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
160980795|NCT00383240|581317597|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
160980796|NCT00383240|581317598|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
160980797|NCT00383240|581317599|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
160980798|NCT00383240|581317596|FG000|Overall Study|Protocol Violation|4|||
160980799|NCT00383240|581317597|FG001|Overall Study|Protocol Violation|5|||
160980800|NCT00383240|581317598|FG002|Overall Study|Protocol Violation|9|||
160980801|NCT00383240|581317599|FG003|Overall Study|Protocol Violation|6|||
160980802|NCT00383240|581317596|FG000|Overall Study|Did not meet protocol eligibility|9|||
160980803|NCT00383240|581317597|FG001|Overall Study|Did not meet protocol eligibility|4|||
160980804|NCT00383240|581317598|FG002|Overall Study|Did not meet protocol eligibility|9|||
160980805|NCT00383240|581317599|FG003|Overall Study|Did not meet protocol eligibility|3|||
160980806|NCT00383240|581317596|FG000|Overall Study|Administrative|1|||
160980807|NCT00383240|581317597|FG001|Overall Study|Administrative|1|||
160980808|NCT00383240|581317598|FG002|Overall Study|Administrative|0|||
160980809|NCT00383240|581317599|FG003|Overall Study|Administrative|0|||
160980810|NCT01349829|581319789|FG000|Overall Study|Lost to Follow-up|4|||
160980811|NCT01349829|581319790|FG001|Overall Study|Lost to Follow-up|8|||
160980812|NCT01349829|581319789|FG000|Overall Study|Consent withdrawal|3|||
160980813|NCT01349829|581319790|FG001|Overall Study|Consent withdrawal|8|||
160980814|NCT01349829|581319789|FG000|Overall Study|Migrated/moved|2|||
160980815|NCT01349829|581319790|FG001|Overall Study|Migrated/moved|7|||
160980816|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
160980817|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980818|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980819|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980820|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
160980821|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
160980822|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980823|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980824|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980825|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
160980826|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
160980827|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980828|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980829|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980830|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
160980831|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
160980832|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980833|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980834|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980835|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
160980836|NCT02555371|581319791|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
160980837|NCT02555371|581319792|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980838|NCT02555371|581319793|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980839|NCT02555371|581319794|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
160980840|NCT02555371|581319795|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
161142545|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Death|0|||
161093897|NCT01315353|581733832|FG000|Overall Study|Unwilling to adhere to requirements|5|||
161093898|NCT01315353|581733833|FG001|Overall Study|Unwilling to adhere to requirements|5|||
161093899|NCT01315353|581733834|FG002|Overall Study|Unwilling to adhere to requirements|4|||
161093900|NCT01315353|581733832|FG000|Overall Study|Site closing|7|||
161093901|NCT01315353|581733833|FG001|Overall Study|Site closing|4|||
161093902|NCT01315353|581733834|FG002|Overall Study|Site closing|0|||
161093903|NCT01315353|581733832|FG000|Overall Study|Taken off study by site in error|0|||
161093904|NCT01315353|581733833|FG001|Overall Study|Taken off study by site in error|1|||
161093905|NCT01315353|581733834|FG002|Overall Study|Taken off study by site in error|0|||
161093906|NCT01315353|581733832|FG000|Overall Study|Inadvertent randomization/assignment|0|||
161093907|NCT01315353|581733833|FG001|Overall Study|Inadvertent randomization/assignment|0|||
161093908|NCT01315353|581733834|FG002|Overall Study|Inadvertent randomization/assignment|2|||
161093909|NCT01009580|581733835|FG000|Overall Study|Adverse Event|4|||
161093910|NCT01009580|581733836|FG001|Overall Study|Adverse Event|4|||
161093911|NCT01009580|581733835|FG000|Overall Study|Lack of Efficacy|0|||
161093912|NCT01009580|581733836|FG001|Overall Study|Lack of Efficacy|1|||
161093913|NCT01009580|581733835|FG000|Overall Study|Protocol Violation|2|||
161093914|NCT01009580|581733836|FG001|Overall Study|Protocol Violation|3|||
161093915|NCT01009580|581733835|FG000|Overall Study|Withdrawal Criteria|4|||
161093916|NCT01009580|581733836|FG001|Overall Study|Withdrawal Criteria|6|||
161093917|NCT01009580|581733835|FG000|Overall Study|Unclassified|17|||
161093918|NCT01009580|581733836|FG001|Overall Study|Unclassified|21|||
161093919|NCT04469270|581733837|FG000|Overall Study|Adverse Event|2|||
161093920|NCT04469270|581733838|FG001|Overall Study|Adverse Event|0|||
161093921|NCT04469270|581733837|FG000|Overall Study|Lost to Follow-up|4|||
161093922|NCT04469270|581733838|FG001|Overall Study|Lost to Follow-up|3|||
161093923|NCT04469270|581733837|FG000|Overall Study|Withdrawal by Subject|7|||
160980841|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
160980842|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
160980843|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
160980844|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
160980845|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
160980846|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
160980847|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
160980848|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
160980849|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
160980850|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
160980851|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980852|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
160980853|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980854|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980855|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
160980856|NCT02555371|581319791|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
160980857|NCT02555371|581319792|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
160980858|NCT02555371|581319793|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
160980859|NCT02555371|581319794|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
160980860|NCT02555371|581319795|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
160980861|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980862|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980863|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980864|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
160980865|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
160980866|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980867|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980868|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980869|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
160980870|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
160980871|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
161093924|NCT04469270|581733838|FG001|Overall Study|Withdrawal by Subject|3|||
161093925|NCT04469270|581733837|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
161093926|NCT04469270|581733838|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
161093927|NCT04469270|581733837|FG000|Overall Study|missing|1|||
161093928|NCT04469270|581733838|FG001|Overall Study|missing|0|||
161093929|NCT05572021|581733841|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
160980872|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
160980873|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
161093930|NCT05572021|581733842|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
161093931|NCT04576455|581733843|FG000|Overall Study|Ongoing in the Study|48|||
161093932|NCT04576455|581733844|FG001|Overall Study|Ongoing in the Study|58|||
161093933|NCT04576455|581733843|FG000|Overall Study|Death|83|||
161093934|NCT04576455|581733844|FG001|Overall Study|Death|77|||
161093935|NCT04576455|581733843|FG000|Overall Study|Lost to Follow-up|4|||
161093936|NCT04576455|581733844|FG001|Overall Study|Lost to Follow-up|5|||
161093937|NCT04576455|581733843|FG000|Overall Study|Withdrawal by Subject|16|||
161093938|NCT04576455|581733844|FG001|Overall Study|Withdrawal by Subject|12|||
161093939|NCT00345293|581733845|FG000|Overall Study|Unable to access line for sample|1|||
161093940|NCT00345293|581733846|FG001|Overall Study|Unable to access line for sample|0|||
161093941|NCT00345293|581733845|FG000|Overall Study|Withdrawal by Subject|1|||
161093942|NCT00345293|581733846|FG001|Overall Study|Withdrawal by Subject|0|||
161093943|NCT04873232|581733854|FG000|Overall Study|Lost to Follow-up|1|||
161093944|NCT04873232|581733855|FG001|Overall Study|Lost to Follow-up|4|||
161093945|NCT04873232|581733854|FG000|Overall Study|Withdrawal by Subject|1|||
161093946|NCT04873232|581733855|FG001|Overall Study|Withdrawal by Subject|0|||
161093947|NCT01390181|581735412|FG000|Overall Study|Lost to Follow-up|1|||
161093948|NCT01390181|581735412|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
161093949|NCT00720941|581735417|FG000|Overall Study|Protocol Violation|1|||
161093950|NCT00720941|581735418|FG001|Overall Study|Protocol Violation|2|||
161093951|NCT00720941|581735417|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
161093952|NCT00720941|581735418|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
161093953|NCT00720941|581735417|FG000|Overall Study|Lost to Follow-up|20|||
161093954|NCT00720941|581735418|FG001|Overall Study|Lost to Follow-up|15|||
161093955|NCT00720941|581735417|FG000|Overall Study|Physician Decision|14|||
161093956|NCT00720941|581735418|FG001|Overall Study|Physician Decision|12|||
161093957|NCT00720941|581735417|FG000|Overall Study|Withdrawal by Subject|29|||
161093958|NCT00720941|581735418|FG001|Overall Study|Withdrawal by Subject|36|||
161093959|NCT03628898|581735420|FG000|Overall Study|Device deficiency|1|||
161093960|NCT02598557|581735423|FG000|Overall Study|Withdrawal by Subject|1|||
161093961|NCT02598557|581735424|FG001|Overall Study|Withdrawal by Subject|0|||
161093962|NCT02598557|581735425|FG002|Overall Study|Withdrawal by Subject|1|||
161093963|NCT02598557|581735423|FG000|Overall Study|Participant did not start treatment|2|||
161093964|NCT02598557|581735424|FG001|Overall Study|Participant did not start treatment|1|||
161093965|NCT02598557|581735425|FG002|Overall Study|Participant did not start treatment|1|||
161093966|NCT02598557|581735423|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
161093967|NCT02598557|581735424|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
161093968|NCT02598557|581735425|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
161093969|NCT02598557|581735423|FG000|Overall Study|Adverse Event|1|||
161093970|NCT02598557|581735424|FG001|Overall Study|Adverse Event|1|||
161093971|NCT02598557|581735425|FG002|Overall Study|Adverse Event|0|||
161093972|NCT02864381|581735426|FG000|Overall Study|Death|58|||
161093973|NCT02864381|581735427|FG001|Overall Study|Death|61|||
161093974|NCT02864381|581735426|FG000|Overall Study|Withdrew Consent|5|||
161093975|NCT02864381|581735427|FG001|Overall Study|Withdrew Consent|6|||
161093976|NCT02864381|581735426|FG000|Overall Study|Reason Unknown|7|||
161093977|NCT02864381|581735427|FG001|Overall Study|Reason Unknown|3|||
161093978|NCT02864381|581735426|FG000|Overall Study|Lost to Follow-up|1|||
161093979|NCT02864381|581735427|FG001|Overall Study|Lost to Follow-up|1|||
161093980|NCT02864381|581735426|FG000|Overall Study|Investigator's Discretion|1|||
161093981|NCT02864381|581735427|FG001|Overall Study|Investigator's Discretion|0|||
161093982|NCT02864381|581735426|FG000|Overall Study|Protocol Violation|0|||
161093983|NCT02864381|581735427|FG001|Overall Study|Protocol Violation|1|||
161093984|NCT02986334|581735428|FG000|Overall Study|Withdrawal by Subject|0|||
161093985|NCT02986334|581735429|FG001|Overall Study|Withdrawal by Subject|1|||
161093986|NCT02986334|581735430|FG002|Overall Study|Withdrawal by Subject|2|||
161093987|NCT02986334|581735428|FG000|Overall Study|Lost to Follow-up|1|||
161093988|NCT02986334|581735429|FG001|Overall Study|Lost to Follow-up|2|||
161093989|NCT02986334|581735430|FG002|Overall Study|Lost to Follow-up|1|||
161093990|NCT02986334|581735428|FG000|Overall Study|Adverse Event|0|||
161093991|NCT02986334|581735429|FG001|Overall Study|Adverse Event|2|||
161093992|NCT02986334|581735430|FG002|Overall Study|Adverse Event|1|||
161093993|NCT02986334|581735428|FG000|Overall Study|non compliance in phone ratings|2|||
161093994|NCT02986334|581735429|FG001|Overall Study|non compliance in phone ratings|1|||
161093995|NCT02986334|581735430|FG002|Overall Study|non compliance in phone ratings|2|||
161093996|NCT02986334|581735428|FG000|Overall Study|undisclosed comorbidities|0|||
161093997|NCT02986334|581735429|FG001|Overall Study|undisclosed comorbidities|1|||
161093998|NCT02986334|581735430|FG002|Overall Study|undisclosed comorbidities|1|||
161093999|NCT00667355|581735432|FG000|Overall Study|Adverse Event|5|||
161094000|NCT00667355|581735432|FG000|Overall Study|Lost to Follow-up|1|||
161094001|NCT00667355|581735432|FG000|Overall Study|Other reason was not specified|5|||
161094002|NCT00655863|581735433|FG000|Overall Study|Lost to Follow-up|0|||
161094003|NCT00655863|581735434|FG001|Overall Study|Lost to Follow-up|0|||
161094004|NCT00655863|581735435|FG002|Overall Study|Lost to Follow-up|1|||
161094005|NCT01138007|581735436|FG000|Overall Study|Adverse Event|4|||
161094006|NCT01138007|581735437|FG001|Overall Study|Adverse Event|12|||
161209364|NCT03674827|582149094|FG005|Treatment Phase|Death|0|||
161094007|NCT01138007|581735438|FG002|Overall Study|Adverse Event|9|||
161094008|NCT01138007|581735436|FG000|Overall Study|Lack of Efficacy|2|||
161094009|NCT01138007|581735437|FG001|Overall Study|Lack of Efficacy|0|||
161094010|NCT01138007|581735438|FG002|Overall Study|Lack of Efficacy|6|||
161094011|NCT01138007|581735436|FG000|Overall Study|Protocol Violation|2|||
161094012|NCT01138007|581735437|FG001|Overall Study|Protocol Violation|3|||
161094013|NCT01138007|581735438|FG002|Overall Study|Protocol Violation|2|||
161094014|NCT01138007|581735436|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
161094015|NCT01138007|581735437|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
161094016|NCT01138007|581735438|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
161094017|NCT01138007|581735436|FG000|Overall Study|Lost to Follow-up|3|||
161094018|NCT01138007|581735437|FG001|Overall Study|Lost to Follow-up|3|||
161094019|NCT01138007|581735438|FG002|Overall Study|Lost to Follow-up|5|||
161094020|NCT01138007|581735436|FG000|Overall Study|Physician Decision|0|||
161094021|NCT01138007|581735437|FG001|Overall Study|Physician Decision|5|||
161094022|NCT01138007|581735438|FG002|Overall Study|Physician Decision|3|||
161094023|NCT01138007|581735436|FG000|Overall Study|Withdrawal by Subject|5|||
161094024|NCT01138007|581735437|FG001|Overall Study|Withdrawal by Subject|6|||
161094025|NCT01138007|581735438|FG002|Overall Study|Withdrawal by Subject|15|||
161094026|NCT04661878|581735439|FG000|Overall Study|Lost to Follow-up|6|||
161094027|NCT04661878|581735440|FG001|Overall Study|Lost to Follow-up|5|||
161094028|NCT03603028|581735441|FG000|Overall Study|Withdrawal by Subject|1|||
161094029|NCT00640016|581735444|FG000|Overall Study|Withdrawal by Subject|0|||
161094030|NCT00640016|581735445|FG001|Overall Study|Withdrawal by Subject|1|||
161094031|NCT00640016|581735446|FG002|Overall Study|Withdrawal by Subject|0|||
161094032|NCT00640016|581735447|FG003|Overall Study|Withdrawal by Subject|0|||
161094033|NCT00640016|581735444|FG000|Overall Study|Study termination|2|||
161094034|NCT00640016|581735445|FG001|Overall Study|Study termination|1|||
161094035|NCT00640016|581735446|FG002|Overall Study|Study termination|3|||
161094036|NCT00640016|581735447|FG003|Overall Study|Study termination|2|||
161094037|NCT00640016|581735444|FG000|Overall Study|Adverse Event|0|||
161094038|NCT00640016|581735445|FG001|Overall Study|Adverse Event|0|||
161094039|NCT00640016|581735446|FG002|Overall Study|Adverse Event|0|||
161094040|NCT00640016|581735447|FG003|Overall Study|Adverse Event|1|||
161094041|NCT00846391|581735448|FG000|Overall Study|Physician Decision|0|||
161094042|NCT00846391|581735449|FG001|Overall Study|Physician Decision|0|||
161094043|NCT00846391|581735450|FG002|Overall Study|Physician Decision|1|||
161094044|NCT00846391|581735448|FG000|Overall Study|Study Terminated by Sponsor|1|||
161094045|NCT00846391|581735449|FG001|Overall Study|Study Terminated by Sponsor|2|||
161094046|NCT00846391|581735450|FG002|Overall Study|Study Terminated by Sponsor|2|||
161094047|NCT01287065|581735451|FG000|Treatment Period 1|Adverse Event|0|||
161094048|NCT01287065|581735452|FG001|Treatment Period 1|Adverse Event|0|||
161094049|NCT01287065|581735453|FG002|Treatment Period 1|Adverse Event|0|||
161094050|NCT01287065|581735454|FG003|Treatment Period 1|Adverse Event|0|||
161094051|NCT01287065|581735455|FG004|Treatment Period 1|Adverse Event|1|||
161094052|NCT01287065|581735456|FG005|Treatment Period 1|Adverse Event|0|||
161094053|NCT01287065|581735451|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161094054|NCT01287065|581735452|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161094055|NCT01287065|581735453|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161094056|NCT01287065|581735454|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161094057|NCT01287065|581735455|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161094058|NCT01287065|581735456|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161094059|NCT01580969|581735461|FG000|Overall Study|Physician Decision|3|||
161094060|NCT01580969|581735462|FG001|Overall Study|Physician Decision|0|||
161094061|NCT01580969|581735463|FG002|Overall Study|Physician Decision|0|||
161094062|NCT00511472|581735467|FG000|Overall Study|Clinical Adverse Event|1|||
161094063|NCT00511472|581735468|FG001|Overall Study|Clinical Adverse Event|2|||
161094064|NCT00511472|581735467|FG000|Overall Study|Laboratory Adverse Event|0|||
161094065|NCT00511472|581735468|FG001|Overall Study|Laboratory Adverse Event|2|||
161094066|NCT00511472|581735467|FG000|Overall Study|Not reported|2|||
161094067|NCT00511472|581735468|FG001|Overall Study|Not reported|2|||
161094068|NCT02019927|581735469|FG000|Overall Study|Lost to Follow-up|2|||
161094069|NCT02019927|581735470|FG001|Overall Study|Lost to Follow-up|4|||
161322863|NCT04892446|582568624|FG002|Overall Study|Death|0|||
161094070|NCT02019927|581735471|FG002|Overall Study|Lost to Follow-up|1|||
161094071|NCT02019927|581735472|FG003|Overall Study|Lost to Follow-up|2|||
161094072|NCT02019927|581735473|FG004|Overall Study|Lost to Follow-up|3|||
161094073|NCT02019927|581735474|FG005|Overall Study|Lost to Follow-up|1|||
161322864|NCT04892446|582568622|FG000|Overall Study|Withdrew consent|3|||
161094074|NCT03181451|581735481|FG000|Overall Study|Adverse Event|0|||
161094075|NCT03181451|581735482|FG001|Overall Study|Adverse Event|1|||
161094076|NCT03181451|581735483|FG002|Overall Study|Adverse Event|0|||
161094077|NCT03181451|581735481|FG000|Overall Study|Withdrawal by Subject|0|||
161094078|NCT03181451|581735482|FG001|Overall Study|Withdrawal by Subject|1|||
161094079|NCT03181451|581735483|FG002|Overall Study|Withdrawal by Subject|0|||
161094080|NCT01259284|581735490|FG000|Overall Study|Study Termination|2|||
161094081|NCT01259284|581735491|FG001|Overall Study|Study Termination|0|||
161094082|NCT01259284|581735492|FG002|Overall Study|Study Termination|0|||
161322865|NCT04892446|582568623|FG001|Overall Study|Withdrew consent|0|||
161094083|NCT00069238|581735493|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
161094084|NCT00069238|581735494|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
161094085|NCT00069238|581735495|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
161094086|NCT00069238|581735493|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
161094087|NCT00069238|581735494|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
161094088|NCT00069238|581735495|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
161094089|NCT00069238|581735493|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
161094090|NCT00069238|581735494|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
161094091|NCT00069238|581735495|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
161094092|NCT01001832|581735497|FG000|Short-term Period|Adverse Event|2|||
161094093|NCT01001832|581735498|FG001|Short-term Period|Adverse Event|3|||
161094094|NCT01001832|581735497|FG000|Long-term Period|Adverse Event|2|||
161094095|NCT01001832|581735498|FG001|Long-term Period|Adverse Event|1|||
161094096|NCT01001832|581735497|FG000|Long-term Period|Withdrawal by Subject|1|||
161094097|NCT01001832|581735498|FG001|Long-term Period|Withdrawal by Subject|0|||
161094098|NCT01001832|581735497|FG000|Long-term Period|Lack of Efficacy|0|||
161094099|NCT01001832|581735498|FG001|Long-term Period|Lack of Efficacy|2|||
161094100|NCT01001832|581735497|FG000|Long-term Period|Other|1|||
161094101|NCT01001832|581735498|FG001|Long-term Period|Other|2|||
161094102|NCT01001832|581735497|FG000|Follow-up Period|Withdrawal by Subject|1|||
161094103|NCT01001832|581735498|FG001|Follow-up Period|Withdrawal by Subject|0|||
161094104|NCT01001832|581735497|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
161094105|NCT01001832|581735498|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
161094106|NCT01001832|581735497|FG000|Follow-up Period|Other|2|||
161094107|NCT01001832|581735498|FG001|Follow-up Period|Other|1|||
161094108|NCT00926211|581735502|FG000|Overall Study|Lost to Follow-up|1|||
161094109|NCT01242800|581735503|FG000|Overall Study|Patient refusal|0|||
161094110|NCT01242800|581735504|FG001|Overall Study|Patient refusal|10|||
161094111|NCT01242800|581735503|FG000|Overall Study|Physician Decision|0|||
161094112|NCT01242800|581735504|FG001|Overall Study|Physician Decision|1|||
161094113|NCT01242800|581735503|FG000|Overall Study|Disease progression|0|||
161094114|NCT01242800|581735504|FG001|Overall Study|Disease progression|3|||
161094115|NCT01242800|581735503|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
161094116|NCT01242800|581735504|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
161094117|NCT01242800|581735503|FG000|Overall Study|Reasons not reported|0|||
161094118|NCT01242800|581735504|FG001|Overall Study|Reasons not reported|4|||
161094119|NCT04508023|581735508|FG000|Overall Study|Withdrawal by Subject|1|||
161094120|NCT04508023|581735509|FG001|Overall Study|Withdrawal by Subject|2|||
161094121|NCT00511901|581735510|FG000|Overall Study|Withdrawal by Subject|1|||
161094122|NCT00511901|581735511|FG001|Overall Study|Withdrawal by Subject|3|||
161094123|NCT03562247|581735515|FG000|Overall Study|Lost to Follow-up|3|||
161094124|NCT03562247|581735516|FG001|Overall Study|Lost to Follow-up|1|||
161094125|NCT03562247|581735517|FG002|Overall Study|Lost to Follow-up|1|||
161094126|NCT00983931|581735518|FG000|14 Day Washout Period|Physician Decision|1|||
161094127|NCT01281969|581735519|FG000|Overall Study|not randomized didn't meet criteria|0|||
161094128|NCT01281969|581735520|FG001|Overall Study|not randomized didn't meet criteria|0|||
161094129|NCT01281969|581735521|FG002|Overall Study|not randomized didn't meet criteria|7|||
161094130|NCT01281969|581735519|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
161094131|NCT01281969|581735520|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
161094132|NCT01281969|581735521|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
161094133|NCT01281969|581735519|FG000|Overall Study|not randomized, child consent not given|0|||
161094134|NCT01281969|581735520|FG001|Overall Study|not randomized, child consent not given|0|||
161094135|NCT01281969|581735521|FG002|Overall Study|not randomized, child consent not given|2|||
161094136|NCT02409368|581735526|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
161094137|NCT02409368|581735527|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
161094138|NCT02409368|581735528|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
161094139|NCT02409368|581735529|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
161094140|NCT02409368|581735526|FG000|ECOG Reclassification|Death|1|||
161094141|NCT02409368|581735527|FG001|ECOG Reclassification|Death|5|||
161094142|NCT02409368|581735528|FG002|ECOG Reclassification|Death|0|||
161094143|NCT02409368|581735529|FG003|ECOG Reclassification|Death|0|||
161094144|NCT02409368|581735526|FG000|ECOG Reclassification|Disease Progression|113|||
161094145|NCT02409368|581735527|FG001|ECOG Reclassification|Disease Progression|382|||
161094146|NCT02409368|581735528|FG002|ECOG Reclassification|Disease Progression|70|||
161094147|NCT02409368|581735529|FG003|ECOG Reclassification|Disease Progression|1|||
161094148|NCT02409368|581735526|FG000|ECOG Reclassification|Lost to Follow-up|1|||
161094149|NCT02409368|581735527|FG001|ECOG Reclassification|Lost to Follow-up|5|||
161094150|NCT02409368|581735528|FG002|ECOG Reclassification|Lost to Follow-up|0|||
161094151|NCT02409368|581735529|FG003|ECOG Reclassification|Lost to Follow-up|0|||
161094152|NCT02409368|581735526|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
161094153|NCT02409368|581735527|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
161094154|NCT02409368|581735528|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
161094155|NCT02409368|581735529|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
161094156|NCT02409368|581735526|FG000|ECOG Reclassification|Poor/non-compliance|0|||
161094157|NCT02409368|581735527|FG001|ECOG Reclassification|Poor/non-compliance|3|||
161094158|NCT02409368|581735528|FG002|ECOG Reclassification|Poor/non-compliance|2|||
161094159|NCT02409368|581735529|FG003|ECOG Reclassification|Poor/non-compliance|0|||
161094160|NCT02409368|581735526|FG000|ECOG Reclassification|Study drug toxicity|17|||
161094161|NCT02409368|581735527|FG001|ECOG Reclassification|Study drug toxicity|42|||
161094162|NCT02409368|581735528|FG002|ECOG Reclassification|Study drug toxicity|7|||
161094163|NCT02409368|581735529|FG003|ECOG Reclassification|Study drug toxicity|0|||
161094164|NCT02409368|581735526|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
161094165|NCT02409368|581735527|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
161094166|NCT02409368|581735528|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
161094167|NCT02409368|581735529|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
161094168|NCT02409368|581735526|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
161094169|NCT02409368|581735527|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
161094170|NCT02409368|581735528|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
161094171|NCT02409368|581735529|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
161094172|NCT02409368|581735526|FG000|ECOG Reclassification|Participant withdrew consent|2|||
161094173|NCT02409368|581735527|FG001|ECOG Reclassification|Participant withdrew consent|3|||
161094174|NCT02409368|581735528|FG002|ECOG Reclassification|Participant withdrew consent|4|||
161094175|NCT02409368|581735529|FG003|ECOG Reclassification|Participant withdrew consent|0|||
161094176|NCT02409368|581735526|FG000|ECOG Reclassification|Other Reasons|5|||
161094177|NCT02409368|581735527|FG001|ECOG Reclassification|Other Reasons|26|||
161094178|NCT02409368|581735528|FG002|ECOG Reclassification|Other Reasons|2|||
161094179|NCT02409368|581735529|FG003|ECOG Reclassification|Other Reasons|0|||
161094180|NCT02409368|581735526|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
161094181|NCT02409368|581735527|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
161094182|NCT02409368|581735528|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
161094183|NCT02409368|581735529|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
161094184|NCT01296347|581735530|FG000|Allocation|Withdrawal by Subject|1|||
161094185|NCT01296347|581735531|FG001|Allocation|Withdrawal by Subject|2|||
161094186|NCT01296347|581735530|FG000|Allocation|Lack of Efficacy|1|||
161094187|NCT01296347|581735531|FG001|Allocation|Lack of Efficacy|2|||
161094188|NCT01296347|581735530|FG000|Allocation|not received infusion|1|||
161094189|NCT01296347|581735531|FG001|Allocation|not received infusion|0|||
161094190|NCT01296347|581735530|FG000|6 Week Follow up|Death|0|||
161094191|NCT01296347|581735531|FG001|6 Week Follow up|Death|1|||
161094192|NCT01296347|581735530|FG000|3 Month Follow up|Death|1|||
161094193|NCT01296347|581735531|FG001|3 Month Follow up|Death|0|||
161094194|NCT01296347|581735530|FG000|3 Month Follow up|Lost to Follow-up|0|||
161094195|NCT01296347|581735531|FG001|3 Month Follow up|Lost to Follow-up|1|||
161094196|NCT01296347|581735530|FG000|6 Month Follow up|Death|2|||
161094197|NCT01296347|581735531|FG001|6 Month Follow up|Death|1|||
161094198|NCT01296347|581735530|FG000|6 Month Follow up|Lost to Follow-up|0|||
161094199|NCT01296347|581735531|FG001|6 Month Follow up|Lost to Follow-up|1|||
161094200|NCT01296347|581735530|FG000|12 Month Follow up|Lost to Follow-up|3|||
161094201|NCT01296347|581735531|FG001|12 Month Follow up|Lost to Follow-up|1|||
161094202|NCT01296347|581735530|FG000|12 Month Follow up|Death|1|||
161094203|NCT01296347|581735531|FG001|12 Month Follow up|Death|1|||
161094204|NCT01296347|581735530|FG000|12 Month Follow up|Withdrawal by Subject|0|||
161094205|NCT01296347|581735531|FG001|12 Month Follow up|Withdrawal by Subject|1|||
161094206|NCT02240693|581735532|FG000|Overall Study|Adverse Event|0|||
161094207|NCT02240693|581735533|FG001|Overall Study|Adverse Event|0|||
161094208|NCT02240693|581735534|FG002|Overall Study|Adverse Event|0|||
161094209|NCT02240693|581735535|FG003|Overall Study|Adverse Event|0|||
161094210|NCT02240693|581735536|FG004|Overall Study|Adverse Event|1|||
161094211|NCT02240693|581735532|FG000|Overall Study|Withdrawal by Subject|0|||
161094212|NCT02240693|581735533|FG001|Overall Study|Withdrawal by Subject|0|||
161094213|NCT02240693|581735534|FG002|Overall Study|Withdrawal by Subject|2|||
161094214|NCT02240693|581735535|FG003|Overall Study|Withdrawal by Subject|1|||
161094215|NCT02240693|581735536|FG004|Overall Study|Withdrawal by Subject|0|||
161094216|NCT02240693|581735532|FG000|Overall Study|Other than specified|0|||
161094217|NCT02240693|581735533|FG001|Overall Study|Other than specified|0|||
161094218|NCT02240693|581735534|FG002|Overall Study|Other than specified|2|||
161094219|NCT02240693|581735535|FG003|Overall Study|Other than specified|0|||
161094220|NCT02240693|581735536|FG004|Overall Study|Other than specified|0|||
161094221|NCT03343301|581735537|FG000|Overall Study|Withdrawal by Subject|1|||
161094222|NCT03343301|581735538|FG001|Overall Study|Withdrawal by Subject|1|||
161094223|NCT03343301|581735537|FG000|Overall Study|Death|0|||
161094224|NCT03343301|581735538|FG001|Overall Study|Death|2|||
161094225|NCT03343301|581735537|FG000|Overall Study|Other|0|||
161094226|NCT03343301|581735538|FG001|Overall Study|Other|6|||
161094227|NCT03343301|581735537|FG000|Overall Study|Missing|2|||
161094228|NCT03343301|581735538|FG001|Overall Study|Missing|0|||
161094229|NCT02668185|581735541|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
161094230|NCT02668185|581735542|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
161094231|NCT02668185|581735541|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
161094232|NCT02668185|581735542|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
161094233|NCT02668185|581735541|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
161094234|NCT02668185|581735542|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
161094235|NCT02668185|581735541|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
161094236|NCT02668185|581735542|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
161094237|NCT01013597|581735543|FG000|Overall Study|Withdrawal by Subject|1|||
161094238|NCT00427895|581735544|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094239|NCT00427895|581735545|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094240|NCT00427895|581735546|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094241|NCT00427895|581735547|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
161094242|NCT00427895|581735548|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094243|NCT00427895|581735549|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094244|NCT00427895|581735550|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094245|NCT00427895|581735551|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
161094246|NCT00427895|581735544|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094247|NCT00427895|581735545|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094248|NCT00427895|581735546|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094249|NCT00427895|581735547|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094250|NCT00427895|581735548|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094251|NCT00427895|581735549|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094252|NCT00427895|581735550|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
161094253|NCT00427895|581735551|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
161094254|NCT00427895|581735544|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094255|NCT00427895|581735545|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094256|NCT00427895|581735546|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094257|NCT00427895|581735547|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094258|NCT00427895|581735548|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094259|NCT00427895|581735549|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094260|NCT00427895|581735550|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
161094261|NCT00427895|581735551|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
161094262|NCT00427895|581735544|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
161094263|NCT00427895|581735545|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
161094264|NCT00427895|581735546|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
161094265|NCT00427895|581735547|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
161094266|NCT00427895|581735548|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
161094267|NCT00427895|581735549|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
161094268|NCT00427895|581735550|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
161094269|NCT00427895|581735551|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
161094270|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161094271|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
161094272|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
161094273|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
161094274|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161094275|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161094276|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161094277|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
161094278|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
161094279|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161094280|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
161094281|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
161094282|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161094283|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161094284|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161094285|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
161094286|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
161094287|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
161094288|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161094289|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161094290|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161094291|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161094292|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161094293|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
161094294|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
161094295|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
161094296|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
161094297|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
161094298|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161322866|NCT04892446|582568624|FG002|Overall Study|Withdrew consent|1|||
160980874|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
160980875|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
160980876|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980877|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980878|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980879|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
160980880|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
160980881|NCT02555371|581319791|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980882|NCT02555371|581319792|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980883|NCT02555371|581319793|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980884|NCT02555371|581319794|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
160980885|NCT02555371|581319795|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
160980886|NCT03095599|581319796|FG000|Overall Study|Withdrawal by Subject|1|||
160980887|NCT03095599|581319797|FG001|Overall Study|Withdrawal by Subject|0|||
160980888|NCT03095599|581319796|FG000|Overall Study|Lost to Follow-up|1|||
160980889|NCT03095599|581319797|FG001|Overall Study|Lost to Follow-up|0|||
160980890|NCT03095599|581319796|FG000|Overall Study|Withdrawal prior to vaccination|1|||
160980891|NCT03095599|581319797|FG001|Overall Study|Withdrawal prior to vaccination|0|||
160980892|NCT00742885|581319799|FG000|Overall Study|Lost to Follow-up|1|||
160980893|NCT00742885|581319800|FG001|Overall Study|Lost to Follow-up|0|||
160980894|NCT03615482|581319803|FG000|Overall Study|Death|1|||
160980895|NCT03615482|581319804|FG001|Overall Study|Death|0|||
160980896|NCT03615482|581319803|FG000|Overall Study|Lost to Follow-up|7|||
160980897|NCT03615482|581319804|FG001|Overall Study|Lost to Follow-up|7|||
160980898|NCT03615482|581319803|FG000|Overall Study|Physician Decision|2|||
160980899|NCT03615482|581319804|FG001|Overall Study|Physician Decision|3|||
160980900|NCT03615482|581319803|FG000|Overall Study|Withdrawal by Subject|7|||
160980901|NCT03615482|581319804|FG001|Overall Study|Withdrawal by Subject|7|||
160980902|NCT00322868|581319805|FG000|Overall Study|disease progression|1|||
160980903|NCT01642186|581319810|FG000|Overall Study|Death|0|||
160980904|NCT01642186|581319811|FG001|Overall Study|Death|2|||
160980905|NCT01642186|581319812|FG002|Overall Study|Death|2|||
160980906|NCT01642186|581319810|FG000|Overall Study|Lost to Follow-up|0|||
160980907|NCT01642186|581319811|FG001|Overall Study|Lost to Follow-up|0|||
160980908|NCT01642186|581319812|FG002|Overall Study|Lost to Follow-up|1|||
160980909|NCT00163215|581319813|FG000|Overall Study|Lack of Efficacy|3|||
160980910|NCT00163215|581319813|FG000|Overall Study|Withdrawal by Subject|5|||
160980911|NCT00163215|581319813|FG000|Overall Study|Other|7|||
160980912|NCT01023308|581319814|FG000|Overall Study|Abnormal test proceedure results|3|||
160980913|NCT01023308|581319815|FG001|Overall Study|Abnormal test proceedure results|8|||
160980914|NCT01023308|581319814|FG000|Overall Study|Administrative problems|2|||
160980915|NCT01023308|581319815|FG001|Overall Study|Administrative problems|1|||
160980916|NCT01023308|581319814|FG000|Overall Study|Adverse Event|130|||
160980917|NCT01023308|581319815|FG001|Overall Study|Adverse Event|66|||
160980918|NCT01023308|581319814|FG000|Overall Study|Death|21|||
160980919|NCT01023308|581319815|FG001|Overall Study|Death|17|||
160980920|NCT01023308|581319814|FG000|Overall Study|Disease progression|82|||
160980921|NCT01023308|581319815|FG001|Overall Study|Disease progression|153|||
160980922|NCT01023308|581319814|FG000|Overall Study|New Cancer therapy|4|||
160980923|NCT01023308|581319815|FG001|Overall Study|New Cancer therapy|7|||
160980924|NCT01023308|581319814|FG000|Overall Study|Protocol Violation|3|||
160980925|NCT01023308|581319815|FG001|Overall Study|Protocol Violation|4|||
160980926|NCT01023308|581319814|FG000|Overall Study|Untreated|5|||
160980927|NCT01023308|581319815|FG001|Overall Study|Untreated|5|||
160980928|NCT01023308|581319814|FG000|Overall Study|Lost to Follow-up|1|||
160980929|NCT01023308|581319815|FG001|Overall Study|Lost to Follow-up|0|||
160980930|NCT01023308|581319814|FG000|Overall Study|Withdrawal by Subject|34|||
160980931|NCT01023308|581319815|FG001|Overall Study|Withdrawal by Subject|18|||
160980932|NCT02254421|581319824|FG000|Overall Study|Randomized but Not Treated|1|||
160980933|NCT02254421|581319825|FG001|Overall Study|Randomized but Not Treated|0|||
160980934|NCT02254421|581319824|FG000|Overall Study|Death|0|||
160980935|NCT02254421|581319825|FG001|Overall Study|Death|2|||
160980936|NCT02254421|581319824|FG000|Overall Study|Withdrew Consent|1|||
160980937|NCT02254421|581319825|FG001|Overall Study|Withdrew Consent|1|||
160980938|NCT00867490|581319828|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
160980939|NCT00867490|581319828|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
160980940|NCT00867490|581319828|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
160980941|NCT00867490|581319828|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
160980942|NCT00867490|581319828|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
160980943|NCT01950273|581319829|FG000|Overall Study|Protocol Violation|1|||
160980944|NCT01950273|581319830|FG001|Overall Study|Protocol Violation|0|||
160980945|NCT01950273|581319829|FG000|Overall Study|Withdrawal by Subject|2|||
160980946|NCT01950273|581319830|FG001|Overall Study|Withdrawal by Subject|0|||
160980947|NCT01950273|581319829|FG000|Overall Study|Other not defined above|1|||
160980948|NCT01950273|581319830|FG001|Overall Study|Other not defined above|0|||
160980949|NCT01154036|581319839|FG000|Phase I|Physician Decision|0|||
160980950|NCT01154036|581319840|FG001|Phase I|Physician Decision|1|||
161094299|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161094300|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161094301|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
161094302|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094303|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094304|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094305|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
161094306|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094307|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094308|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094309|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
161094310|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
161094311|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
161094312|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
161094313|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
161094314|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161094315|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161094316|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161094317|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
161094318|NCT00427895|581735544|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161094319|NCT00427895|581735545|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161094320|NCT00427895|581735546|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
161094321|NCT00427895|581735547|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
161094322|NCT00427895|581735548|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161094323|NCT00427895|581735549|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161094324|NCT00427895|581735550|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161094325|NCT00427895|581735551|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
161094326|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161094327|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
161094328|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
161094329|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
161094330|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161094331|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161094332|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161094333|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
161094334|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
161094335|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
161094336|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161094337|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
161094338|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161094339|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161094340|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161094341|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
161094342|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
161094343|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
161094344|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
161094345|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
161094346|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161094347|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161094348|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161094349|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
161094350|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094351|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
161094352|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094353|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094354|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094355|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094356|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094357|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
161094358|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Death|1|||
161094359|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Death|0|||
161094360|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Death|0|||
161094361|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Death|0|||
161094362|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Death|0|||
161094363|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Death|0|||
161094364|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Death|0|||
161094365|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Death|0|||
161094366|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161094367|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161094368|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
161094369|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
161094370|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161094371|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161094372|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161094373|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
161094374|NCT00427895|581735544|FG000|Vax 1/Year 1 Follow-up|Other|0|||
161094375|NCT00427895|581735545|FG001|Vax 1/Year 1 Follow-up|Other|0|||
161094376|NCT00427895|581735546|FG002|Vax 1/Year 1 Follow-up|Other|0|||
161094377|NCT00427895|581735547|FG003|Vax 1/Year 1 Follow-up|Other|2|||
161094378|NCT00427895|581735548|FG004|Vax 1/Year 1 Follow-up|Other|0|||
161094379|NCT00427895|581735549|FG005|Vax 1/Year 1 Follow-up|Other|0|||
161094380|NCT00427895|581735550|FG006|Vax 1/Year 1 Follow-up|Other|0|||
161094381|NCT00427895|581735551|FG007|Vax 1/Year 1 Follow-up|Other|0|||
161094382|NCT00427895|581735544|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
161094383|NCT00427895|581735545|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
161094384|NCT00427895|581735546|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
161094385|NCT00427895|581735547|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
161094386|NCT00427895|581735548|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161094387|NCT00427895|581735549|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161094388|NCT00427895|581735550|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161094389|NCT00427895|581735551|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
161094390|NCT02678247|581735552|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
161094391|NCT02678247|581735553|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
161094392|NCT02678247|581735552|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
161094393|NCT02678247|581735553|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
161094394|NCT02678247|581735552|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
161094395|NCT02678247|581735553|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
161094396|NCT02678247|581735552|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
161094397|NCT02678247|581735553|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
161094398|NCT02678247|581735552|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
161094399|NCT02678247|581735553|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
161094400|NCT02678247|581735552|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
161094401|NCT02678247|581735553|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
161094402|NCT02796560|581735559|FG000|Overall Study|Adverse Event|2|||
161094403|NCT02796560|581735560|FG001|Overall Study|Adverse Event|0|||
161094404|NCT02796560|581735559|FG000|Overall Study|Withdrawal by Subject|2|||
161094405|NCT02796560|581735560|FG001|Overall Study|Withdrawal by Subject|2|||
161094406|NCT03816332|581735562|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
161094407|NCT03816332|581735562|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
161094408|NCT05330312|581735563|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
161094409|NCT05330312|581735564|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
161094410|NCT05330312|581735565|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
161094411|NCT05330312|581735563|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
161094412|NCT05330312|581735564|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
161094413|NCT05330312|581735565|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
161094414|NCT05330312|581735563|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
161094415|NCT05330312|581735564|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
161094416|NCT05330312|581735565|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
161094417|NCT05330312|581735563|FG000|Pivotal Investigation - Part 2|Death|1|||
161094418|NCT05330312|581735564|FG001|Pivotal Investigation - Part 2|Death|4|||
161094419|NCT05330312|581735565|FG002|Pivotal Investigation - Part 2|Death|0|||
161094420|NCT03534284|581735566|FG000|Overall Study|Death|2|||
161094421|NCT03534284|581735567|FG001|Overall Study|Death|3|||
161094422|NCT03534284|581735568|FG002|Overall Study|Death|3|||
161094423|NCT03534284|581735566|FG000|Overall Study|Withdrawal by Subject|5|||
161094424|NCT03534284|581735567|FG001|Overall Study|Withdrawal by Subject|0|||
161094425|NCT03534284|581735568|FG002|Overall Study|Withdrawal by Subject|0|||
161094426|NCT03316300|581735569|FG000|Overall Study|Withdrawal by Subject|3|||
161094427|NCT03316300|581735570|FG001|Overall Study|Withdrawal by Subject|2|||
161094428|NCT03316300|581735569|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
161094429|NCT03316300|581735570|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
161094430|NCT03316300|581735569|FG000|Overall Study|Adverse Event|1|||
161094431|NCT03316300|581735570|FG001|Overall Study|Adverse Event|0|||
161094432|NCT03316300|581735569|FG000|Overall Study|COVID-19|0|||
161094433|NCT03316300|581735570|FG001|Overall Study|COVID-19|1|||
161094434|NCT00423930|581735571|FG000|Overall Study|Withdrawal by Subject|2|||
161094435|NCT04002401|581735572|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
161094436|NCT04002401|581735572|FG000|Overall Study|Death|10|||
161094437|NCT04002401|581735572|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
161094438|NCT04002401|581735572|FG000|Overall Study|Enrolled but Never Treated|1|||
161094439|NCT04002401|581735572|FG000|Overall Study|Lost to Follow-up|1|||
161094440|NCT03511053|581737116|FG000|Overall Study|Withdrawal by Subject|1|||
161094441|NCT02425644|581737117|FG000|Overall Study|Lost to Follow-up|2|||
160980951|NCT01154036|581319841|FG002|Phase I|Physician Decision|0|||
160980952|NCT01154036|581319842|FG003|Phase I|Physician Decision|0|||
160980953|NCT01154036|581319843|FG004|Phase I|Physician Decision|0|||
160980954|NCT01154036|581319844|FG005|Phase I|Physician Decision|0|||
160980955|NCT01154036|581319845|FG006|Phase I|Physician Decision|0|||
160980956|NCT01154036|581319846|FG007|Phase I|Physician Decision|0|||
160980957|NCT01154036|581319839|FG000|Phase I|Lost to Follow-up|0|||
160980958|NCT01154036|581319840|FG001|Phase I|Lost to Follow-up|3|||
160980959|NCT01154036|581319841|FG002|Phase I|Lost to Follow-up|6|||
161094442|NCT02425644|581737118|FG001|Overall Study|Lost to Follow-up|3|||
160980960|NCT01154036|581319842|FG003|Phase I|Lost to Follow-up|0|||
160980961|NCT01154036|581319843|FG004|Phase I|Lost to Follow-up|0|||
160980962|NCT01154036|581319844|FG005|Phase I|Lost to Follow-up|0|||
160980963|NCT01154036|581319845|FG006|Phase I|Lost to Follow-up|0|||
160980964|NCT01154036|581319846|FG007|Phase I|Lost to Follow-up|0|||
160980965|NCT01154036|581319839|FG000|Phase I|Protocol Violation|0|||
160980966|NCT01154036|581319840|FG001|Phase I|Protocol Violation|3|||
160980967|NCT01154036|581319841|FG002|Phase I|Protocol Violation|9|||
160980968|NCT01154036|581319842|FG003|Phase I|Protocol Violation|0|||
160980969|NCT01154036|581319843|FG004|Phase I|Protocol Violation|0|||
160980970|NCT01154036|581319844|FG005|Phase I|Protocol Violation|0|||
160980971|NCT01154036|581319845|FG006|Phase I|Protocol Violation|0|||
160980972|NCT01154036|581319846|FG007|Phase I|Protocol Violation|0|||
160980973|NCT01154036|581319839|FG000|Phase I|Withdrawal by Subject|2|||
160980974|NCT01154036|581319840|FG001|Phase I|Withdrawal by Subject|10|||
161094443|NCT02425644|581737117|FG000|Overall Study|Withdrawal by Subject|41|||
161094444|NCT02425644|581737118|FG001|Overall Study|Withdrawal by Subject|36|||
161094445|NCT02425644|581737117|FG000|Overall Study|Lack of Efficacy|3|||
161094446|NCT02425644|581737118|FG001|Overall Study|Lack of Efficacy|10|||
161094447|NCT02425644|581737117|FG000|Overall Study|Adverse Event|13|||
161094448|NCT02425644|581737118|FG001|Overall Study|Adverse Event|3|||
161094449|NCT02425644|581737117|FG000|Overall Study|Death|0|||
161094450|NCT02425644|581737118|FG001|Overall Study|Death|2|||
161094451|NCT02425644|581737117|FG000|Overall Study|Other|18|||
161094452|NCT02425644|581737118|FG001|Overall Study|Other|17|||
161094453|NCT02720536|581737119|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
161094454|NCT02720536|581737119|FG000|Overall Study|PR - pregnancy|2|||
161094455|NCT02720536|581737119|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
160980975|NCT01154036|581319841|FG002|Phase I|Withdrawal by Subject|29|||
160980976|NCT01154036|581319842|FG003|Phase I|Withdrawal by Subject|0|||
160980977|NCT01154036|581319843|FG004|Phase I|Withdrawal by Subject|0|||
161094456|NCT02720536|581737119|FG000|Overall Study|PR - death|1|||
161094457|NCT02720536|581737119|FG000|Overall Study|PR - adverse event|1|||
161094458|NCT02720536|581737119|FG000|Overall Study|PR - abnormal lab value(s)|1|||
161094459|NCT02720536|581737119|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
161094460|NCT00294554|581737120|FG000|Overall Study|Lack of Efficacy|0|||
161094461|NCT00294554|581737121|FG001|Overall Study|Lack of Efficacy|1|||
161094462|NCT00294554|581737120|FG000|Overall Study|Physician Decision|0|||
161094463|NCT00294554|581737121|FG001|Overall Study|Physician Decision|1|||
161094464|NCT01717989|581737122|FG000|Overall Study|Ineligibility determined|6|||
161094465|NCT01717989|581737122|FG000|Overall Study|Protocol deviation|6|||
161094466|NCT01717989|581737122|FG000|Overall Study|Withdrawal by Subject|11|||
161094467|NCT01717989|581737122|FG000|Overall Study|Physician Decision|2|||
161094468|NCT01717989|581737122|FG000|Overall Study|Lost to Follow-up|11|||
161094469|NCT01717989|581737122|FG000|Overall Study|Death|439|||
161094470|NCT01717989|581737122|FG000|Overall Study|Protocol-specified criteria|551|||
161094471|NCT01717989|581737122|FG000|Overall Study|Other|40|||
161094472|NCT03224325|581737123|FG000|Overall Study|Adverse Event|1|||
161094473|NCT03224325|581737124|FG001|Overall Study|Adverse Event|0|||
161094474|NCT03224325|581737125|FG002|Overall Study|Adverse Event|0|||
161094475|NCT03224325|581737126|FG003|Overall Study|Adverse Event|0|||
161094476|NCT03224325|581737127|FG004|Overall Study|Adverse Event|0|||
161094477|NCT03224325|581737128|FG005|Overall Study|Adverse Event|0|||
161094478|NCT03224325|581737129|FG006|Overall Study|Adverse Event|1|||
160980978|NCT01154036|581319844|FG005|Phase I|Withdrawal by Subject|0|||
160980979|NCT01154036|581319845|FG006|Phase I|Withdrawal by Subject|0|||
160980980|NCT01154036|581319846|FG007|Phase I|Withdrawal by Subject|0|||
161094479|NCT03224325|581737123|FG000|Overall Study|Withdrawal by Subject|0|||
160980981|NCT01154036|581319839|FG000|Phase I|Adverse Event|1|||
160980982|NCT01154036|581319840|FG001|Phase I|Adverse Event|11|||
160980983|NCT01154036|581319841|FG002|Phase I|Adverse Event|12|||
160980984|NCT01154036|581319842|FG003|Phase I|Adverse Event|0|||
160980985|NCT01154036|581319843|FG004|Phase I|Adverse Event|0|||
160980986|NCT01154036|581319844|FG005|Phase I|Adverse Event|0|||
160980987|NCT01154036|581319845|FG006|Phase I|Adverse Event|0|||
160980988|NCT01154036|581319846|FG007|Phase I|Adverse Event|0|||
160980989|NCT01154036|581319839|FG000|Phase II|Adverse Event|0|||
161094480|NCT03224325|581737124|FG001|Overall Study|Withdrawal by Subject|0|||
161094481|NCT03224325|581737125|FG002|Overall Study|Withdrawal by Subject|0|||
161094482|NCT03224325|581737126|FG003|Overall Study|Withdrawal by Subject|1|||
161094483|NCT03224325|581737127|FG004|Overall Study|Withdrawal by Subject|0|||
161142546|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Death|0|||
161094484|NCT03224325|581737128|FG005|Overall Study|Withdrawal by Subject|0|||
161094485|NCT03224325|581737129|FG006|Overall Study|Withdrawal by Subject|0|||
161094486|NCT01607554|581737134|FG000|Overall Study|Disease progression|2|||
161094487|NCT03952806|581737138|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
161094488|NCT03952806|581737139|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
161094489|NCT03952806|581737138|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
161094490|NCT03952806|581737139|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
161094491|NCT03952806|581737138|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
161094492|NCT03952806|581737139|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
161094493|NCT03952806|581737138|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
161094494|NCT03952806|581737139|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
161094495|NCT03952806|581737138|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
161094496|NCT03952806|581737139|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
161094497|NCT03952806|581737138|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
161094498|NCT03952806|581737139|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
161094499|NCT03952806|581737138|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
161094500|NCT03952806|581737139|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
161094501|NCT03952806|581737138|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
161094502|NCT03952806|581737139|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
161094503|NCT03952806|581737138|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
161094504|NCT03952806|581737139|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
161094505|NCT03952806|581737138|FG000|OLE Phase (48 Weeks)|Other|16|||
161094506|NCT03952806|581737139|FG001|OLE Phase (48 Weeks)|Other|13|||
161094507|NCT05580588|581737140|FG000|Overall Study|Lack of Efficacy|12|||
161094508|NCT00756470|581737145|FG000|Overall Study|Withdrawal by Subject|1|||
161094509|NCT00756470|581737145|FG000|Overall Study|Adverse Event|4|||
161094510|NCT02875977|581737146|FG000|Overall Study|Lost to Follow-up|42|||
161094511|NCT02875977|581737147|FG001|Overall Study|Lost to Follow-up|29|||
161094512|NCT01079741|581737148|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161094513|NCT01079741|581737149|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
161094514|NCT01079741|581737150|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161094515|NCT01079741|581737151|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161094516|NCT01079741|581737152|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
161094517|NCT01079741|581737148|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161094518|NCT01079741|581737149|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161094519|NCT01079741|581737150|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161094520|NCT01079741|581737151|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
161094521|NCT01079741|581737152|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
161094522|NCT00406653|581737153|FG000|Induction Period|Adverse Event|1|||
161094523|NCT00406653|581737154|FG001|Induction Period|Adverse Event|10|||
161094524|NCT00406653|581737155|FG002|Induction Period|Adverse Event|4|||
161094525|NCT00406653|581737156|FG003|Induction Period|Adverse Event|11|||
161094526|NCT00406653|581737157|FG004|Induction Period|Adverse Event|0|||
161094527|NCT00406653|581737158|FG005|Induction Period|Adverse Event|0|||
161094528|NCT00406653|581737159|FG006|Induction Period|Adverse Event|0|||
161094529|NCT00406653|581737153|FG000|Induction Period|Lack of Efficacy|11|||
161094530|NCT00406653|581737154|FG001|Induction Period|Lack of Efficacy|14|||
161094531|NCT00406653|581737155|FG002|Induction Period|Lack of Efficacy|8|||
161094532|NCT00406653|581737156|FG003|Induction Period|Lack of Efficacy|10|||
161094533|NCT00406653|581737157|FG004|Induction Period|Lack of Efficacy|0|||
161094534|NCT00406653|581737158|FG005|Induction Period|Lack of Efficacy|0|||
161094535|NCT00406653|581737159|FG006|Induction Period|Lack of Efficacy|0|||
161094536|NCT00406653|581737153|FG000|Induction Period|Lost to Follow-up|0|||
161094537|NCT00406653|581737154|FG001|Induction Period|Lost to Follow-up|2|||
161094538|NCT00406653|581737155|FG002|Induction Period|Lost to Follow-up|0|||
161094539|NCT00406653|581737156|FG003|Induction Period|Lost to Follow-up|0|||
161094540|NCT00406653|581737157|FG004|Induction Period|Lost to Follow-up|0|||
161094541|NCT00406653|581737158|FG005|Induction Period|Lost to Follow-up|0|||
161094542|NCT00406653|581737159|FG006|Induction Period|Lost to Follow-up|0|||
161094543|NCT00406653|581737153|FG000|Induction Period|Withdrawal of Consent|2|||
161094544|NCT00406653|581737154|FG001|Induction Period|Withdrawal of Consent|5|||
161094545|NCT00406653|581737155|FG002|Induction Period|Withdrawal of Consent|1|||
161094546|NCT00406653|581737156|FG003|Induction Period|Withdrawal of Consent|2|||
161094547|NCT00406653|581737157|FG004|Induction Period|Withdrawal of Consent|0|||
161094548|NCT00406653|581737158|FG005|Induction Period|Withdrawal of Consent|0|||
161094549|NCT00406653|581737159|FG006|Induction Period|Withdrawal of Consent|0|||
161094550|NCT00406653|581737153|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
161094551|NCT00406653|581737154|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
161094552|NCT00406653|581737155|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
161094553|NCT00406653|581737156|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
161094554|NCT00406653|581737157|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
161094555|NCT00406653|581737158|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
161142547|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Death|1|||
160980990|NCT01154036|581319840|FG001|Phase II|Adverse Event|0|||
160980991|NCT01154036|581319841|FG002|Phase II|Adverse Event|0|||
160980992|NCT01154036|581319842|FG003|Phase II|Adverse Event|0|||
160980993|NCT01154036|581319843|FG004|Phase II|Adverse Event|1|||
160980994|NCT01154036|581319844|FG005|Phase II|Adverse Event|1|||
160980995|NCT01154036|581319845|FG006|Phase II|Adverse Event|1|||
160980996|NCT01154036|581319846|FG007|Phase II|Adverse Event|1|||
160980997|NCT01154036|581319839|FG000|Phase II|Physician Decision|0|||
160980998|NCT01154036|581319840|FG001|Phase II|Physician Decision|0|||
160980999|NCT01154036|581319841|FG002|Phase II|Physician Decision|0|||
160981000|NCT01154036|581319842|FG003|Phase II|Physician Decision|0|||
160981001|NCT01154036|581319843|FG004|Phase II|Physician Decision|0|||
160981002|NCT01154036|581319844|FG005|Phase II|Physician Decision|0|||
160981003|NCT01154036|581319845|FG006|Phase II|Physician Decision|1|||
160981004|NCT01154036|581319846|FG007|Phase II|Physician Decision|0|||
160981005|NCT01154036|581319839|FG000|Phase II|Lost to Follow-up|0|||
160981006|NCT01154036|581319840|FG001|Phase II|Lost to Follow-up|0|||
160981007|NCT01154036|581319841|FG002|Phase II|Lost to Follow-up|0|||
160981008|NCT01154036|581319842|FG003|Phase II|Lost to Follow-up|1|||
160981009|NCT01154036|581319843|FG004|Phase II|Lost to Follow-up|2|||
160981010|NCT01154036|581319844|FG005|Phase II|Lost to Follow-up|0|||
160981011|NCT01154036|581319845|FG006|Phase II|Lost to Follow-up|2|||
160981012|NCT01154036|581319846|FG007|Phase II|Lost to Follow-up|1|||
160981013|NCT01154036|581319839|FG000|Phase II|Protocol Violation|0|||
160981014|NCT01154036|581319840|FG001|Phase II|Protocol Violation|0|||
160981015|NCT01154036|581319841|FG002|Phase II|Protocol Violation|0|||
160981016|NCT01154036|581319842|FG003|Phase II|Protocol Violation|0|||
160981017|NCT01154036|581319843|FG004|Phase II|Protocol Violation|1|||
160981018|NCT01154036|581319844|FG005|Phase II|Protocol Violation|2|||
160981019|NCT01154036|581319845|FG006|Phase II|Protocol Violation|0|||
160981020|NCT01154036|581319846|FG007|Phase II|Protocol Violation|0|||
160981021|NCT01154036|581319839|FG000|Phase II|Withdrawal by Subject|0|||
160981022|NCT01154036|581319840|FG001|Phase II|Withdrawal by Subject|0|||
160981023|NCT01154036|581319841|FG002|Phase II|Withdrawal by Subject|0|||
160981024|NCT01154036|581319842|FG003|Phase II|Withdrawal by Subject|0|||
160981025|NCT01154036|581319843|FG004|Phase II|Withdrawal by Subject|4|||
160981026|NCT01154036|581319844|FG005|Phase II|Withdrawal by Subject|2|||
160981027|NCT01154036|581319845|FG006|Phase II|Withdrawal by Subject|5|||
160981028|NCT01154036|581319846|FG007|Phase II|Withdrawal by Subject|4|||
160981029|NCT02264574|581319847|FG000|Overall Study|Death|21|||
160981030|NCT02264574|581319848|FG001|Overall Study|Death|21|||
160981031|NCT02264574|581319847|FG000|Overall Study|Withdrawal by Subject|8|||
160981032|NCT02264574|581319848|FG001|Overall Study|Withdrawal by Subject|6|||
160981033|NCT02264574|581319847|FG000|Overall Study|Other, Not Specified|0|||
160981034|NCT02264574|581319848|FG001|Overall Study|Other, Not Specified|3|||
160981035|NCT02080520|581319849|FG000|Overall Study|Self-reported symptoms|5|||
160981036|NCT02080520|581319850|FG001|Overall Study|Self-reported symptoms|6|||
160981037|NCT02080520|581319849|FG000|Overall Study|Unable to contact|2|||
160981038|NCT02080520|581319850|FG001|Overall Study|Unable to contact|1|||
160981039|NCT02080520|581319849|FG000|Overall Study|Initiated aspirin|2|||
160981040|NCT02080520|581319850|FG001|Overall Study|Initiated aspirin|0|||
160981041|NCT02080520|581319849|FG000|Overall Study|Atrial fibrillation|1|||
160981042|NCT02080520|581319850|FG001|Overall Study|Atrial fibrillation|1|||
161094556|NCT00406653|581737159|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
160981043|NCT02080520|581319849|FG000|Overall Study|Cancer|1|||
160981044|NCT02080520|581319850|FG001|Overall Study|Cancer|2|||
161094557|NCT00406653|581737153|FG000|Induction Period|Pregnancy|1|||
161094558|NCT00406653|581737154|FG001|Induction Period|Pregnancy|0|||
161094559|NCT00406653|581737155|FG002|Induction Period|Pregnancy|0|||
161094560|NCT00406653|581737156|FG003|Induction Period|Pregnancy|0|||
161094561|NCT00406653|581737157|FG004|Induction Period|Pregnancy|0|||
161094562|NCT00406653|581737158|FG005|Induction Period|Pregnancy|0|||
161094563|NCT00406653|581737159|FG006|Induction Period|Pregnancy|0|||
161094564|NCT00406653|581737153|FG000|Induction Period|Declined participation but followup done|0|||
161094565|NCT00406653|581737154|FG001|Induction Period|Declined participation but followup done|2|||
161094566|NCT00406653|581737155|FG002|Induction Period|Declined participation but followup done|1|||
161094567|NCT00406653|581737156|FG003|Induction Period|Declined participation but followup done|1|||
161094568|NCT00406653|581737157|FG004|Induction Period|Declined participation but followup done|0|||
161094569|NCT00406653|581737158|FG005|Induction Period|Declined participation but followup done|0|||
161094570|NCT00406653|581737159|FG006|Induction Period|Declined participation but followup done|0|||
161094571|NCT00406653|581737153|FG000|Induction Period|Given prohibited drug|0|||
161094572|NCT00406653|581737154|FG001|Induction Period|Given prohibited drug|1|||
161094573|NCT00406653|581737155|FG002|Induction Period|Given prohibited drug|2|||
160981045|NCT02080520|581319849|FG000|Overall Study|Not interested in study|1|||
160981046|NCT02080520|581319850|FG001|Overall Study|Not interested in study|3|||
160981047|NCT02080520|581319849|FG000|Overall Study|Too busy|1|||
160981048|NCT02080520|581319850|FG001|Overall Study|Too busy|1|||
160981049|NCT02080520|581319849|FG000|Overall Study|Work-related injury|1|||
160981050|NCT02080520|581319850|FG001|Overall Study|Work-related injury|0|||
161209365|NCT03674827|582149089|FG000|Treatment Phase|Progressive Disease|0|||
161209366|NCT03674827|582149090|FG001|Treatment Phase|Progressive Disease|4|||
161209367|NCT03674827|582149091|FG002|Treatment Phase|Progressive Disease|3|||
161209368|NCT03674827|582149092|FG003|Treatment Phase|Progressive Disease|4|||
161209369|NCT03674827|582149093|FG004|Treatment Phase|Progressive Disease|4|||
161209370|NCT03674827|582149094|FG005|Treatment Phase|Progressive Disease|9|||
161209371|NCT03674827|582149089|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
161209372|NCT03674827|582149090|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
161209373|NCT03674827|582149091|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
161209374|NCT03674827|582149092|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
161209375|NCT03674827|582149093|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
161209376|NCT03674827|582149094|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
161209377|NCT03674827|582149089|FG000|Treatment Phase|Withdrawal by Subject|0|||
161209378|NCT03674827|582149090|FG001|Treatment Phase|Withdrawal by Subject|0|||
161209379|NCT03674827|582149091|FG002|Treatment Phase|Withdrawal by Subject|0|||
161209380|NCT03674827|582149092|FG003|Treatment Phase|Withdrawal by Subject|0|||
161209381|NCT03674827|582149093|FG004|Treatment Phase|Withdrawal by Subject|0|||
161209382|NCT03674827|582149094|FG005|Treatment Phase|Withdrawal by Subject|1|||
161209383|NCT03674827|582149089|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
161209384|NCT03674827|582149090|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
161209385|NCT03674827|582149091|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
161209386|NCT03674827|582149092|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
161209387|NCT03674827|582149093|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
161209388|NCT03674827|582149094|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
161209389|NCT03674827|582149089|FG000|Treatment Phase|Other|0|||
161209390|NCT03674827|582149090|FG001|Treatment Phase|Other|1|||
161209391|NCT03674827|582149091|FG002|Treatment Phase|Other|0|||
161209392|NCT03674827|582149092|FG003|Treatment Phase|Other|0|||
161209393|NCT03674827|582149093|FG004|Treatment Phase|Other|0|||
161209394|NCT03674827|582149094|FG005|Treatment Phase|Other|1|||
161209395|NCT03674827|582149089|FG000|Long-Term Follow-up Phase|Death|2|||
161209396|NCT03674827|582149090|FG001|Long-Term Follow-up Phase|Death|4|||
161209397|NCT03674827|582149091|FG002|Long-Term Follow-up Phase|Death|2|||
161209398|NCT03674827|582149092|FG003|Long-Term Follow-up Phase|Death|3|||
161209399|NCT03674827|582149093|FG004|Long-Term Follow-up Phase|Death|2|||
161209400|NCT03674827|582149094|FG005|Long-Term Follow-up Phase|Death|6|||
161209401|NCT03674827|582149089|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
161209402|NCT03674827|582149090|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
161209403|NCT03674827|582149091|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
161209404|NCT03674827|582149092|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
161209405|NCT03674827|582149093|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
161209406|NCT03674827|582149094|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
161209407|NCT03674827|582149089|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161209408|NCT03674827|582149090|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161209409|NCT03674827|582149091|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
161209410|NCT03674827|582149092|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
161209411|NCT03674827|582149093|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
161209412|NCT03674827|582149094|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
161209413|NCT00363129|582149099|FG000|Overall Study|Withdrawal by Subject|11|||
161209414|NCT00363129|582149100|FG001|Overall Study|Withdrawal by Subject|18|||
161209415|NCT00363129|582149099|FG000|Overall Study|Adverse Event|8|||
161209416|NCT00363129|582149100|FG001|Overall Study|Adverse Event|3|||
161209417|NCT00363129|582149099|FG000|Overall Study|Alternate Treatment|2|||
161209418|NCT00363129|582149100|FG001|Overall Study|Alternate Treatment|4|||
161209419|NCT00363129|582149099|FG000|Overall Study|Other Medical Problems|2|||
161209420|NCT00363129|582149100|FG001|Overall Study|Other Medical Problems|4|||
161209421|NCT00363129|582149099|FG000|Overall Study|Death|0|||
161209422|NCT00363129|582149100|FG001|Overall Study|Death|1|||
161209423|NCT00363129|582149099|FG000|Overall Study|Other Reasons|6|||
161209424|NCT00363129|582149100|FG001|Overall Study|Other Reasons|3|||
161209425|NCT00659581|582149101|FG000|Overall Study|Adverse Event|1006|||
161209426|NCT00659581|582149101|FG000|Overall Study|Lack of Efficacy|1183|||
161209427|NCT00659581|582149101|FG000|Overall Study|Other|6393|||
161209428|NCT01892020|582149103|FG000|Period 1|Adverse Event|1|||
161209429|NCT01892020|582149104|FG001|Period 1|Adverse Event|1|||
161209430|NCT01892020|582149103|FG000|Period 1|Protocol Violation|2|||
161209431|NCT01892020|582149104|FG001|Period 1|Protocol Violation|4|||
161209432|NCT01892020|582149103|FG000|Period 1|Unclassified|0|||
161209433|NCT01892020|582149104|FG001|Period 1|Unclassified|1|||
161209434|NCT01892020|582149103|FG000|Period 2|Protocol Violation|1|||
161209435|NCT01892020|582149104|FG001|Period 2|Protocol Violation|0|||
161322867|NCT04892446|582568622|FG000|Overall Study|Investigator's discretion|1|||
161209436|NCT01831596|582149106|FG000|Overall Study|Other|8|||
161209437|NCT02508649|582149107|FG000|Overall Study|Withdrawal by Subject|4|||
161209438|NCT02508649|582149108|FG001|Overall Study|Withdrawal by Subject|6|||
161209439|NCT02508649|582149109|FG002|Overall Study|Withdrawal by Subject|5|||
161209440|NCT02508649|582149110|FG003|Overall Study|Withdrawal by Subject|6|||
161209441|NCT02508649|582149107|FG000|Overall Study|Investigator withdrew the subject|1|||
161209442|NCT02508649|582149108|FG001|Overall Study|Investigator withdrew the subject|2|||
161209443|NCT02508649|582149109|FG002|Overall Study|Investigator withdrew the subject|1|||
161209444|NCT02508649|582149110|FG003|Overall Study|Investigator withdrew the subject|0|||
161209445|NCT02508649|582149107|FG000|Overall Study|Post randomization screening failure|12|||
161209446|NCT02508649|582149108|FG001|Overall Study|Post randomization screening failure|4|||
161209447|NCT02508649|582149109|FG002|Overall Study|Post randomization screening failure|9|||
161209448|NCT02508649|582149110|FG003|Overall Study|Post randomization screening failure|3|||
161209449|NCT02508649|582149107|FG000|Overall Study|Lost to Follow-up|1|||
161209450|NCT02508649|582149108|FG001|Overall Study|Lost to Follow-up|1|||
161209451|NCT02508649|582149109|FG002|Overall Study|Lost to Follow-up|0|||
161209452|NCT02508649|582149110|FG003|Overall Study|Lost to Follow-up|1|||
161209453|NCT00446134|582149111|FG000|Overall Study|Adverse Event|7|||
161209454|NCT00446134|582149112|FG001|Overall Study|Adverse Event|17|||
161209455|NCT00446134|582149113|FG002|Overall Study|Adverse Event|13|||
161209456|NCT00446134|582149114|FG003|Overall Study|Adverse Event|18|||
161209457|NCT00446134|582149111|FG000|Overall Study|Lack of Efficacy|19|||
161209458|NCT00446134|582149112|FG001|Overall Study|Lack of Efficacy|19|||
161209459|NCT00446134|582149113|FG002|Overall Study|Lack of Efficacy|24|||
161209460|NCT00446134|582149114|FG003|Overall Study|Lack of Efficacy|19|||
161209461|NCT00446134|582149111|FG000|Overall Study|Protocol Violation|0|||
161209462|NCT00446134|582149112|FG001|Overall Study|Protocol Violation|2|||
161209463|NCT00446134|582149113|FG002|Overall Study|Protocol Violation|1|||
161209464|NCT00446134|582149114|FG003|Overall Study|Protocol Violation|0|||
161209465|NCT00446134|582149111|FG000|Overall Study|Lost to Follow-up|1|||
161209466|NCT00446134|582149112|FG001|Overall Study|Lost to Follow-up|3|||
161209467|NCT00446134|582149113|FG002|Overall Study|Lost to Follow-up|1|||
161209468|NCT00446134|582149114|FG003|Overall Study|Lost to Follow-up|1|||
161209469|NCT00446134|582149111|FG000|Overall Study|Withdrawal by Subject|3|||
161209470|NCT00446134|582149112|FG001|Overall Study|Withdrawal by Subject|3|||
161209471|NCT00446134|582149113|FG002|Overall Study|Withdrawal by Subject|1|||
161209472|NCT00446134|582149114|FG003|Overall Study|Withdrawal by Subject|3|||
161209473|NCT00446134|582149111|FG000|Overall Study|Physician Decision|0|||
161209474|NCT00446134|582149112|FG001|Overall Study|Physician Decision|0|||
161209475|NCT00446134|582149113|FG002|Overall Study|Physician Decision|0|||
161209476|NCT00446134|582149114|FG003|Overall Study|Physician Decision|2|||
160981051|NCT02080520|581319849|FG000|Overall Study|Personal reasons|0|||
160981052|NCT02080520|581319850|FG001|Overall Study|Personal reasons|3|||
160981053|NCT00390455|581319851|FG000|Overall Study|Adverse Event|17|||
160981054|NCT00390455|581319852|FG001|Overall Study|Adverse Event|3|||
160981055|NCT00390455|581319851|FG000|Overall Study|Withdrawal by Subject|8|||
160981056|NCT00390455|581319852|FG001|Overall Study|Withdrawal by Subject|8|||
160981057|NCT00390455|581319851|FG000|Overall Study|Alternate Treatment|0|||
160981058|NCT00390455|581319852|FG001|Overall Study|Alternate Treatment|1|||
160981059|NCT00390455|581319851|FG000|Overall Study|Other Medical Reasons|7|||
160981060|NCT00390455|581319852|FG001|Overall Study|Other Medical Reasons|11|||
160981061|NCT01591460|581319855|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
160981062|NCT01591460|581319855|FG000|Overall Study|Futility Rule (Week 12)|7|||
160981063|NCT01591460|581319855|FG000|Overall Study|Futility Rule (Week 24)|3|||
160981064|NCT01591460|581319855|FG000|Overall Study|Rebound or Breakthrough|3|||
160981065|NCT01591460|581319855|FG000|Overall Study|Treatment Discontinued by Error|1|||
160981066|NCT01591460|581319855|FG000|Overall Study|Lost to Follow-up|1|||
160981067|NCT01591460|581319855|FG000|Overall Study|Noncompliance|1|||
161209477|NCT00446134|582149111|FG000|Overall Study|Adverse Event-Diarrhea|1|||
161209478|NCT00446134|582149112|FG001|Overall Study|Adverse Event-Diarrhea|1|||
161209479|NCT00446134|582149113|FG002|Overall Study|Adverse Event-Diarrhea|2|||
161209480|NCT00446134|582149114|FG003|Overall Study|Adverse Event-Diarrhea|0|||
161209481|NCT00446134|582149111|FG000|Overall Study|Reason Not Completed|3|||
161209482|NCT00446134|582149112|FG001|Overall Study|Reason Not Completed|0|||
161209483|NCT00446134|582149113|FG002|Overall Study|Reason Not Completed|1|||
161209484|NCT00446134|582149114|FG003|Overall Study|Reason Not Completed|2|||
161209485|NCT00567996|582149121|FG000|Overall Study|Adverse Event|18|||
160981068|NCT01591460|581319855|FG000|Overall Study|Participant Refusal|3|||
160981069|NCT01591460|581319855|FG000|Overall Study|Withdrawal by Subject|1|||
160981070|NCT01591460|581319855|FG000|Overall Study|Protocol Violation|1|||
160981071|NCT04102540|581319860|FG000|Overall Study|Withdrawn by PI|2|||
160981072|NCT04102540|581319860|FG000|Overall Study|Lost to Follow-up|6|||
160981073|NCT03405662|581319861|FG000|Overall Study|COVID-19 restriction|1|||
160981074|NCT03405662|581319862|FG001|Overall Study|COVID-19 restriction|0|||
160981075|NCT03405662|581319861|FG000|Overall Study|unblinding|0|||
161209486|NCT00567996|582149122|FG001|Overall Study|Adverse Event|16|||
161209487|NCT00567996|582149123|FG002|Overall Study|Adverse Event|13|||
161209488|NCT00567996|582149121|FG000|Overall Study|Protocol Deviation|9|||
161209489|NCT00567996|582149122|FG001|Overall Study|Protocol Deviation|11|||
160981076|NCT03405662|581319862|FG001|Overall Study|unblinding|1|||
161209490|NCT00567996|582149123|FG002|Overall Study|Protocol Deviation|13|||
161209491|NCT00567996|582149121|FG000|Overall Study|Withdrawal by Subject|8|||
161209492|NCT00567996|582149122|FG001|Overall Study|Withdrawal by Subject|12|||
161209493|NCT00567996|582149123|FG002|Overall Study|Withdrawal by Subject|22|||
161209494|NCT00567996|582149121|FG000|Overall Study|Abnormal Lab value(s)|2|||
161209495|NCT00567996|582149122|FG001|Overall Study|Abnormal Lab value(s)|1|||
161209496|NCT00567996|582149123|FG002|Overall Study|Abnormal Lab value(s)|2|||
161209497|NCT00567996|582149121|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161209498|NCT00567996|582149122|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161209499|NCT00567996|582149123|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161209500|NCT00567996|582149121|FG000|Overall Study|Lost to Follow-up|2|||
161209501|NCT00567996|582149122|FG001|Overall Study|Lost to Follow-up|5|||
161209502|NCT00567996|582149123|FG002|Overall Study|Lost to Follow-up|2|||
161209503|NCT00567996|582149121|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161209504|NCT00567996|582149122|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161209505|NCT00567996|582149123|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
161209506|NCT00567996|582149121|FG000|Overall Study|Administrative problems|1|||
161209507|NCT00567996|582149122|FG001|Overall Study|Administrative problems|1|||
161209508|NCT00567996|582149123|FG002|Overall Study|Administrative problems|0|||
161209509|NCT00567996|582149121|FG000|Overall Study|Death|1|||
161209510|NCT00567996|582149122|FG001|Overall Study|Death|0|||
161209511|NCT00567996|582149123|FG002|Overall Study|Death|2|||
161209512|NCT00567996|582149121|FG000|Overall Study|Patient's inability to use the device|0|||
161209513|NCT00567996|582149122|FG001|Overall Study|Patient's inability to use the device|1|||
161209514|NCT00567996|582149123|FG002|Overall Study|Patient's inability to use the device|0|||
161209515|NCT02149199|582149125|FG000|Overall Study|Study specific withdrawal criteria|4|||
161209516|NCT02149199|582149126|FG001|Overall Study|Study specific withdrawal criteria|21|||
161209517|NCT02149199|582149127|FG002|Overall Study|Study specific withdrawal criteria|6|||
161209518|NCT02149199|582149125|FG000|Overall Study|Other|20|||
161209519|NCT02149199|582149126|FG001|Overall Study|Other|25|||
161209520|NCT02149199|582149127|FG002|Overall Study|Other|20|||
160981077|NCT03405662|581319861|FG000|Overall Study|placement in memory care facility|0|||
160981078|NCT03405662|581319862|FG001|Overall Study|placement in memory care facility|2|||
161209521|NCT02149199|582149125|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
161209522|NCT02149199|582149126|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
161209523|NCT02149199|582149127|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
160981079|NCT01458249|581319863|FG000|Overall Study|Not treated|1|||
160981080|NCT01458249|581319863|FG000|Overall Study|Adverse Event|4|||
160981081|NCT01458249|581319863|FG000|Overall Study|Other|2|||
160981082|NCT01458249|581319863|FG000|Overall Study|Ongoing|1|||
160981083|NCT01348854|581319864|FG000|Overall Study|Lost to Follow-up|2|||
160981084|NCT01348854|581319865|FG001|Overall Study|Lost to Follow-up|1|||
160981085|NCT01348854|581319864|FG000|Overall Study|Withdrawal by Subject|1|||
160981086|NCT01348854|581319865|FG001|Overall Study|Withdrawal by Subject|0|||
160981087|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
160981088|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
160981089|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
160981090|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
160981091|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
160981092|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
160981093|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
160981094|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
160981095|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
160981096|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
160981097|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
160981098|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
160981099|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
160981100|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
160981101|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
160981102|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
160981103|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
160981104|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
160981105|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
160981106|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
160981107|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
160981108|NCT03220737|581319866|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981109|NCT03220737|581319867|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161209524|NCT02149199|582149125|FG000|Overall Study|Withdrawal by Subject|75|||
161209525|NCT02149199|582149126|FG001|Overall Study|Withdrawal by Subject|93|||
161209526|NCT02149199|582149127|FG002|Overall Study|Withdrawal by Subject|77|||
161209527|NCT02149199|582149125|FG000|Overall Study|Protocol Violation|16|||
160981110|NCT03220737|581319868|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
160981111|NCT03220737|581319869|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
161209528|NCT02149199|582149126|FG001|Overall Study|Protocol Violation|13|||
160981112|NCT03220737|581319870|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981113|NCT03220737|581319871|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981114|NCT03220737|581319872|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
160981115|NCT03220737|581319866|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981116|NCT03220737|581319867|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981117|NCT03220737|581319868|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981118|NCT03220737|581319869|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981119|NCT03220737|581319870|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
160981120|NCT03220737|581319871|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981121|NCT03220737|581319872|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
160981122|NCT03220737|581319866|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
160981123|NCT03220737|581319867|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981124|NCT03220737|581319868|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981125|NCT03220737|581319869|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981126|NCT03220737|581319870|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981127|NCT03220737|581319871|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981128|NCT03220737|581319872|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
160981129|NCT03220737|581319866|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
160981130|NCT03220737|581319867|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981131|NCT03220737|581319868|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981132|NCT03220737|581319869|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981133|NCT03220737|581319870|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981134|NCT03220737|581319871|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981135|NCT03220737|581319872|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
160981136|NCT03220737|581319866|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
160981137|NCT03220737|581319867|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981138|NCT03220737|581319868|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981139|NCT03220737|581319869|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981140|NCT03220737|581319870|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981141|NCT03220737|581319871|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981142|NCT03220737|581319872|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
160981143|NCT04011384|581319880|FG000|Overall Study|Withdrawal by Subject|2|||
160981144|NCT04011384|581319881|FG001|Overall Study|Withdrawal by Subject|0|||
160981145|NCT01686932|581319882|FG000|Period 1|Adverse Event|1|||
160981146|NCT01686932|581319883|FG001|Period 1|Adverse Event|1|||
160981147|NCT04827134|581319886|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
160981148|NCT04827134|581319887|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
160981149|NCT04827134|581319888|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
160981150|NCT04827134|581319889|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
160981151|NCT00924469|581319899|FG000|Overall Study|Adverse Event|2|||
160981152|NCT00924469|581319900|FG001|Overall Study|Adverse Event|0|||
160981153|NCT00924469|581319899|FG000|Overall Study|Withdrawal by Subject|0|||
161094574|NCT00406653|581737156|FG003|Induction Period|Given prohibited drug|0|||
161209529|NCT02149199|582149127|FG002|Overall Study|Protocol Violation|15|||
161094575|NCT00406653|581737157|FG004|Induction Period|Given prohibited drug|0|||
161094576|NCT00406653|581737158|FG005|Induction Period|Given prohibited drug|0|||
161094577|NCT00406653|581737159|FG006|Induction Period|Given prohibited drug|0|||
161094578|NCT00406653|581737153|FG000|Induction Period|Incarcerated|0|||
161094579|NCT00406653|581737154|FG001|Induction Period|Incarcerated|0|||
161094580|NCT00406653|581737155|FG002|Induction Period|Incarcerated|1|||
161094581|NCT00406653|581737156|FG003|Induction Period|Incarcerated|0|||
161094582|NCT00406653|581737157|FG004|Induction Period|Incarcerated|0|||
161094583|NCT00406653|581737158|FG005|Induction Period|Incarcerated|0|||
161094584|NCT00406653|581737159|FG006|Induction Period|Incarcerated|0|||
161094585|NCT00406653|581737153|FG000|Induction Period|Patient relocated|0|||
161094586|NCT00406653|581737154|FG001|Induction Period|Patient relocated|0|||
161094587|NCT00406653|581737155|FG002|Induction Period|Patient relocated|1|||
161094588|NCT00406653|581737156|FG003|Induction Period|Patient relocated|0|||
161094589|NCT00406653|581737157|FG004|Induction Period|Patient relocated|0|||
161094590|NCT00406653|581737158|FG005|Induction Period|Patient relocated|0|||
161094591|NCT00406653|581737159|FG006|Induction Period|Patient relocated|0|||
161094592|NCT00406653|581737153|FG000|Maintenance Period|Adverse Event|0|||
161094593|NCT00406653|581737154|FG001|Maintenance Period|Adverse Event|0|||
161094594|NCT00406653|581737155|FG002|Maintenance Period|Adverse Event|0|||
161094595|NCT00406653|581737156|FG003|Maintenance Period|Adverse Event|0|||
161094596|NCT00406653|581737157|FG004|Maintenance Period|Adverse Event|1|||
161094597|NCT00406653|581737158|FG005|Maintenance Period|Adverse Event|1|||
161094598|NCT00406653|581737159|FG006|Maintenance Period|Adverse Event|0|||
161094599|NCT00406653|581737153|FG000|Maintenance Period|Lack of Efficacy|0|||
161094600|NCT00406653|581737154|FG001|Maintenance Period|Lack of Efficacy|0|||
161094601|NCT00406653|581737155|FG002|Maintenance Period|Lack of Efficacy|0|||
161094602|NCT00406653|581737156|FG003|Maintenance Period|Lack of Efficacy|0|||
161209530|NCT02149199|582149125|FG000|Overall Study|Lost to Follow-up|3|||
161209531|NCT02149199|582149126|FG001|Overall Study|Lost to Follow-up|12|||
161209532|NCT02149199|582149127|FG002|Overall Study|Lost to Follow-up|11|||
161209533|NCT02149199|582149125|FG000|Overall Study|Death|0|||
161209534|NCT02149199|582149126|FG001|Overall Study|Death|0|||
161209535|NCT02149199|582149127|FG002|Overall Study|Death|1|||
161209536|NCT02149199|582149125|FG000|Overall Study|Adverse Event|6|||
161209537|NCT02149199|582149126|FG001|Overall Study|Adverse Event|15|||
161209538|NCT02149199|582149127|FG002|Overall Study|Adverse Event|9|||
161209539|NCT02956005|582149128|FG000|Overall Study|Not eligible|1|||
161209540|NCT02956005|582149128|FG000|Overall Study|Withdrawal by Subject|3|||
161209541|NCT02956005|582149128|FG000|Overall Study|Physician Decision|12|||
161209542|NCT03125629|582149129|FG000|Overall Study|Withdrawal by Subject|2|||
161209543|NCT03125629|582149129|FG000|Overall Study|Equipment malfunction|1|||
161094603|NCT00406653|581737157|FG004|Maintenance Period|Lack of Efficacy|20|||
161094604|NCT00406653|581737158|FG005|Maintenance Period|Lack of Efficacy|26|||
161094605|NCT00406653|581737159|FG006|Maintenance Period|Lack of Efficacy|0|||
161094606|NCT00406653|581737153|FG000|Maintenance Period|Lost to Follow-up|0|||
161209544|NCT00743119|582149130|FG000|Overall Study|unreliable|3|||
161209545|NCT00743119|582149130|FG000|Overall Study|Withdrawal by Subject|1|||
161209546|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209547|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209548|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209549|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161209550|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161209551|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209552|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209553|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209554|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209555|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161209556|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209557|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209558|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161209559|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
161209560|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
161209561|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
161209562|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
161209563|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
161209564|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
161209565|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
160981154|NCT00924469|581319900|FG001|Overall Study|Withdrawal by Subject|1|||
160981155|NCT00924469|581319899|FG000|Overall Study|Lost to Follow-up|0|||
160981156|NCT00924469|581319900|FG001|Overall Study|Lost to Follow-up|1|||
160981157|NCT01651936|581319901|FG000|Base Study|Adverse Event|3|||
160981158|NCT01651936|581319902|FG001|Base Study|Adverse Event|0|||
160981159|NCT01651936|581319903|FG002|Base Study|Adverse Event|0|||
160981160|NCT01651936|581319901|FG000|Base Study|Withdrawal by Subject|1|||
160981161|NCT01651936|581319902|FG001|Base Study|Withdrawal by Subject|1|||
160981162|NCT01651936|581319903|FG002|Base Study|Withdrawal by Subject|0|||
160981163|NCT01651936|581319901|FG000|Base Study|Early Escape|2|||
160981164|NCT01651936|581319902|FG001|Base Study|Early Escape|8|||
160981165|NCT01651936|581319903|FG002|Base Study|Early Escape|0|||
160981166|NCT01651936|581319901|FG000|Base Study|Study terminated by sponsor|21|||
160981167|NCT01651936|581319902|FG001|Base Study|Study terminated by sponsor|16|||
160981168|NCT01651936|581319903|FG002|Base Study|Study terminated by sponsor|0|||
160981169|NCT01651936|581319901|FG000|Extension Study|Lack of Efficacy|0|||
160981170|NCT01651936|581319902|FG001|Extension Study|Lack of Efficacy|0|||
160981171|NCT01651936|581319903|FG002|Extension Study|Lack of Efficacy|1|||
160981172|NCT01651936|581319901|FG000|Extension Study|Study terminated by sponsor|0|||
160981173|NCT01651936|581319902|FG001|Extension Study|Study terminated by sponsor|0|||
160981174|NCT01651936|581319903|FG002|Extension Study|Study terminated by sponsor|13|||
160981175|NCT03044353|581319904|FG000|Overall Study|Adverse Event|0|||
160981176|NCT03044353|581319905|FG001|Overall Study|Adverse Event|1|||
161094607|NCT00406653|581737154|FG001|Maintenance Period|Lost to Follow-up|0|||
161094608|NCT00406653|581737155|FG002|Maintenance Period|Lost to Follow-up|0|||
161094609|NCT00406653|581737156|FG003|Maintenance Period|Lost to Follow-up|0|||
161094610|NCT00406653|581737157|FG004|Maintenance Period|Lost to Follow-up|2|||
161094611|NCT00406653|581737158|FG005|Maintenance Period|Lost to Follow-up|1|||
161094612|NCT00406653|581737159|FG006|Maintenance Period|Lost to Follow-up|0|||
161094613|NCT00406653|581737153|FG000|Maintenance Period|Withdrawal of Consent|0|||
161094614|NCT00406653|581737154|FG001|Maintenance Period|Withdrawal of Consent|0|||
161094615|NCT00406653|581737155|FG002|Maintenance Period|Withdrawal of Consent|0|||
161094616|NCT00406653|581737156|FG003|Maintenance Period|Withdrawal of Consent|0|||
160981177|NCT03044353|581319906|FG002|Overall Study|Adverse Event|0|||
160981178|NCT03358329|581319907|FG000|Overall Study|Lost to Follow-up|2|||
160981179|NCT03358329|581319907|FG000|Overall Study|Withdrawal by Subject|2|||
160981180|NCT03875911|581319908|FG000|Overall Study|Lost to Follow-up|3|||
160981181|NCT03875911|581319909|FG001|Overall Study|Lost to Follow-up|6|||
160981182|NCT03875911|581319910|FG002|Overall Study|Lost to Follow-up|2|||
160981183|NCT03875911|581319908|FG000|Overall Study|Surgery cancelled|1|||
160981184|NCT03875911|581319909|FG001|Overall Study|Surgery cancelled|0|||
160981185|NCT03875911|581319910|FG002|Overall Study|Surgery cancelled|1|||
160981186|NCT03875911|581319908|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
160981187|NCT03875911|581319909|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
160981188|NCT03875911|581319910|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
160981189|NCT05284019|581319911|FG000|Overall Study|Study terminated|2|||
160981190|NCT05284019|581319912|FG001|Overall Study|Study terminated|2|||
160981191|NCT05284019|581319913|FG002|Overall Study|Study terminated|2|||
161094617|NCT00406653|581737157|FG004|Maintenance Period|Withdrawal of Consent|2|||
161209566|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209567|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209568|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209569|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209570|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161209571|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209572|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209573|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209574|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161209575|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209576|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209577|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209578|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161209579|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161209580|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
161209581|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161209582|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
161094618|NCT00406653|581737158|FG005|Maintenance Period|Withdrawal of Consent|0|||
161094619|NCT00406653|581737159|FG006|Maintenance Period|Withdrawal of Consent|0|||
161094620|NCT00406653|581737153|FG000|Maintenance Period|Pregnancy|0|||
161094621|NCT00406653|581737154|FG001|Maintenance Period|Pregnancy|0|||
161209583|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
161209584|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161209585|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209586|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209587|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209588|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209589|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161209590|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209591|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209592|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209593|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209594|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209595|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209596|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209597|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209598|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
161209599|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209600|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209601|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
161209602|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
161209603|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209604|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209605|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209606|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
160981192|NCT05284019|581319914|FG003|Overall Study|Study terminated|5|||
160981193|NCT05284019|581319915|FG004|Overall Study|Study terminated|15|||
161094622|NCT00406653|581737155|FG002|Maintenance Period|Pregnancy|0|||
161094623|NCT00406653|581737156|FG003|Maintenance Period|Pregnancy|0|||
161094624|NCT00406653|581737157|FG004|Maintenance Period|Pregnancy|0|||
160981194|NCT05284019|581319911|FG000|Overall Study|Withdrawal by Subject|0|||
161094625|NCT00406653|581737158|FG005|Maintenance Period|Pregnancy|1|||
161094626|NCT00406653|581737159|FG006|Maintenance Period|Pregnancy|0|||
161094627|NCT00406653|581737153|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
161094628|NCT00406653|581737154|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
161094629|NCT00406653|581737155|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
161094630|NCT00406653|581737156|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
161094631|NCT00406653|581737157|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
161094632|NCT00406653|581737158|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
161094633|NCT00406653|581737159|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
161094634|NCT00406653|581737153|FG000|Maintenance Period|Error in disease score evaluation|0|||
161094635|NCT00406653|581737154|FG001|Maintenance Period|Error in disease score evaluation|0|||
161094636|NCT00406653|581737155|FG002|Maintenance Period|Error in disease score evaluation|0|||
161094637|NCT00406653|581737156|FG003|Maintenance Period|Error in disease score evaluation|0|||
161094638|NCT00406653|581737157|FG004|Maintenance Period|Error in disease score evaluation|1|||
161094639|NCT00406653|581737158|FG005|Maintenance Period|Error in disease score evaluation|0|||
161094640|NCT00406653|581737159|FG006|Maintenance Period|Error in disease score evaluation|0|||
161209607|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209608|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209609|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209610|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209611|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209612|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209613|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161209614|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209615|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209616|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161209617|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209618|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209619|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161209620|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
161209621|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
161209622|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161209623|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161209624|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209625|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161209626|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209627|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209628|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161209629|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209630|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209631|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209632|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161209633|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209634|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
161209635|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
161209636|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
161209637|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161209638|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
161209639|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
161209640|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
161209641|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209642|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161209643|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
161209644|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209645|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209646|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209647|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209648|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161209649|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161209650|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161209651|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
160981195|NCT05284019|581319912|FG001|Overall Study|Withdrawal by Subject|0|||
160981196|NCT05284019|581319913|FG002|Overall Study|Withdrawal by Subject|0|||
160981197|NCT05284019|581319914|FG003|Overall Study|Withdrawal by Subject|1|||
160981198|NCT05284019|581319915|FG004|Overall Study|Withdrawal by Subject|1|||
160981199|NCT05284019|581319911|FG000|Overall Study|Lost to Follow-up|1|||
160981200|NCT05284019|581319912|FG001|Overall Study|Lost to Follow-up|0|||
160981201|NCT05284019|581319913|FG002|Overall Study|Lost to Follow-up|0|||
160981202|NCT05284019|581319914|FG003|Overall Study|Lost to Follow-up|2|||
160981203|NCT05284019|581319915|FG004|Overall Study|Lost to Follow-up|1|||
160981204|NCT01990300|581319916|FG000|Overall Study|Case Report Forms Uncollected|89|||
160981205|NCT01990300|581319916|FG000|Overall Study|Protocol Deviation|53|||
160981206|NCT01231503|581319917|FG000|Overall Study|Adverse Event|0|||
160981207|NCT01231503|581319918|FG001|Overall Study|Adverse Event|0|||
160981208|NCT01231503|581319919|FG002|Overall Study|Adverse Event|0|||
160981209|NCT01231503|581319920|FG003|Overall Study|Adverse Event|0|||
160981210|NCT01231503|581319921|FG004|Overall Study|Adverse Event|0|||
160981211|NCT01231503|581319922|FG005|Overall Study|Adverse Event|1|||
160981212|NCT01231503|581319923|FG006|Overall Study|Adverse Event|0|||
160981213|NCT01231503|581319924|FG007|Overall Study|Adverse Event|0|||
160981214|NCT01231503|581319917|FG000|Overall Study|Adverse event, serious fatal|0|||
160981215|NCT01231503|581319918|FG001|Overall Study|Adverse event, serious fatal|0|||
160981216|NCT01231503|581319919|FG002|Overall Study|Adverse event, serious fatal|1|||
160981217|NCT01231503|581319920|FG003|Overall Study|Adverse event, serious fatal|1|||
160981218|NCT01231503|581319921|FG004|Overall Study|Adverse event, serious fatal|0|||
160981219|NCT01231503|581319922|FG005|Overall Study|Adverse event, serious fatal|1|||
160981220|NCT01231503|581319923|FG006|Overall Study|Adverse event, serious fatal|0|||
160981221|NCT01231503|581319924|FG007|Overall Study|Adverse event, serious fatal|0|||
160981222|NCT01231503|581319917|FG000|Overall Study|Withdrawal by Subject|6|||
160981223|NCT01231503|581319918|FG001|Overall Study|Withdrawal by Subject|3|||
160981224|NCT01231503|581319919|FG002|Overall Study|Withdrawal by Subject|3|||
160981225|NCT01231503|581319920|FG003|Overall Study|Withdrawal by Subject|1|||
160981226|NCT01231503|581319921|FG004|Overall Study|Withdrawal by Subject|3|||
160981227|NCT01231503|581319922|FG005|Overall Study|Withdrawal by Subject|5|||
160981228|NCT01231503|581319923|FG006|Overall Study|Withdrawal by Subject|1|||
160981229|NCT01231503|581319924|FG007|Overall Study|Withdrawal by Subject|2|||
160981230|NCT01231503|581319917|FG000|Overall Study|Lost to Follow-up|8|||
160981231|NCT01231503|581319918|FG001|Overall Study|Lost to Follow-up|10|||
160981232|NCT01231503|581319919|FG002|Overall Study|Lost to Follow-up|8|||
160981233|NCT01231503|581319920|FG003|Overall Study|Lost to Follow-up|5|||
160981234|NCT01231503|581319921|FG004|Overall Study|Lost to Follow-up|7|||
160981235|NCT01231503|581319922|FG005|Overall Study|Lost to Follow-up|9|||
160981236|NCT01231503|581319923|FG006|Overall Study|Lost to Follow-up|6|||
160981237|NCT01231503|581319924|FG007|Overall Study|Lost to Follow-up|6|||
160981238|NCT01231503|581319917|FG000|Overall Study|Protocol Violation|0|||
160981239|NCT01231503|581319918|FG001|Overall Study|Protocol Violation|0|||
160981240|NCT01231503|581319919|FG002|Overall Study|Protocol Violation|0|||
160981241|NCT01231503|581319920|FG003|Overall Study|Protocol Violation|1|||
160981242|NCT01231503|581319921|FG004|Overall Study|Protocol Violation|0|||
160981243|NCT01231503|581319922|FG005|Overall Study|Protocol Violation|0|||
160981244|NCT01231503|581319923|FG006|Overall Study|Protocol Violation|0|||
160981245|NCT01231503|581319924|FG007|Overall Study|Protocol Violation|0|||
160981246|NCT02293837|581319925|FG000|Overall Study|Lost to Follow-up|0|||
160981247|NCT02293837|581319926|FG001|Overall Study|Lost to Follow-up|2|||
160981248|NCT02293837|581319927|FG002|Overall Study|Lost to Follow-up|1|||
160981249|NCT02293837|581319928|FG003|Overall Study|Lost to Follow-up|0|||
160981250|NCT02293837|581319925|FG000|Overall Study|Withdrawal by Subject|2|||
160981251|NCT02293837|581319926|FG001|Overall Study|Withdrawal by Subject|1|||
160981252|NCT02293837|581319927|FG002|Overall Study|Withdrawal by Subject|2|||
160981253|NCT02293837|581319928|FG003|Overall Study|Withdrawal by Subject|1|||
160981254|NCT02293837|581319925|FG000|Overall Study|COVID-19 Related|1|||
160981255|NCT02293837|581319926|FG001|Overall Study|COVID-19 Related|1|||
160981256|NCT02293837|581319927|FG002|Overall Study|COVID-19 Related|0|||
160981257|NCT02293837|581319928|FG003|Overall Study|COVID-19 Related|0|||
160981258|NCT02293837|581319925|FG000|Overall Study|Participant ill and could not be infused|0|||
160981259|NCT02293837|581319926|FG001|Overall Study|Participant ill and could not be infused|0|||
160981260|NCT02293837|581319927|FG002|Overall Study|Participant ill and could not be infused|1|||
160981261|NCT02293837|581319928|FG003|Overall Study|Participant ill and could not be infused|0|||
160981262|NCT03285113|581319929|FG000|Overall Study|Unable to implant leads|2|||
161209652|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
160981263|NCT01076088|581319930|FG000|Overall Study|Adverse Event|1|||
160981264|NCT01076088|581319931|FG001|Overall Study|Adverse Event|6|||
160981265|NCT01076088|581319932|FG002|Overall Study|Adverse Event|3|||
160981266|NCT01076088|581319933|FG003|Overall Study|Adverse Event|2|||
160981267|NCT01076088|581319934|FG004|Overall Study|Adverse Event|3|||
160981268|NCT01076088|581319935|FG005|Overall Study|Adverse Event|3|||
160981269|NCT01076088|581319930|FG000|Overall Study|Lost to Follow-up|1|||
160981270|NCT01076088|581319931|FG001|Overall Study|Lost to Follow-up|1|||
160981271|NCT01076088|581319932|FG002|Overall Study|Lost to Follow-up|0|||
160981272|NCT01076088|581319933|FG003|Overall Study|Lost to Follow-up|1|||
160981273|NCT01076088|581319934|FG004|Overall Study|Lost to Follow-up|1|||
160981274|NCT01076088|581319935|FG005|Overall Study|Lost to Follow-up|2|||
160981275|NCT01076088|581319930|FG000|Overall Study|Non-compliance with study drug|0|||
160981276|NCT01076088|581319931|FG001|Overall Study|Non-compliance with study drug|0|||
160981277|NCT01076088|581319932|FG002|Overall Study|Non-compliance with study drug|0|||
160981278|NCT01076088|581319933|FG003|Overall Study|Non-compliance with study drug|1|||
160981279|NCT01076088|581319934|FG004|Overall Study|Non-compliance with study drug|0|||
160981280|NCT01076088|581319935|FG005|Overall Study|Non-compliance with study drug|0|||
160981281|NCT01076088|581319930|FG000|Overall Study|Physician Decision|1|||
160981282|NCT01076088|581319931|FG001|Overall Study|Physician Decision|3|||
160981283|NCT01076088|581319932|FG002|Overall Study|Physician Decision|0|||
160981284|NCT01076088|581319933|FG003|Overall Study|Physician Decision|1|||
160981285|NCT01076088|581319934|FG004|Overall Study|Physician Decision|1|||
160981286|NCT01076088|581319935|FG005|Overall Study|Physician Decision|0|||
160981287|NCT01076088|581319930|FG000|Overall Study|Withdrawal by Subject|8|||
160981288|NCT01076088|581319931|FG001|Overall Study|Withdrawal by Subject|8|||
160981289|NCT01076088|581319932|FG002|Overall Study|Withdrawal by Subject|14|||
160981290|NCT01076088|581319933|FG003|Overall Study|Withdrawal by Subject|10|||
160981291|NCT01076088|581319934|FG004|Overall Study|Withdrawal by Subject|11|||
160981292|NCT01076088|581319935|FG005|Overall Study|Withdrawal by Subject|17|||
160981293|NCT01076088|581319930|FG000|Overall Study|Other protocol specified criteria|0|||
160981294|NCT01076088|581319931|FG001|Overall Study|Other protocol specified criteria|0|||
160981295|NCT01076088|581319932|FG002|Overall Study|Other protocol specified criteria|0|||
160981296|NCT01076088|581319933|FG003|Overall Study|Other protocol specified criteria|0|||
160981297|NCT01076088|581319934|FG004|Overall Study|Other protocol specified criteria|0|||
160981298|NCT01076088|581319935|FG005|Overall Study|Other protocol specified criteria|1|||
160981299|NCT03053492|581319936|FG000|Overall Study|Adverse Event|1|||
160981300|NCT03053492|581319937|FG001|Overall Study|Adverse Event|1|||
160981301|NCT03053492|581319936|FG000|Overall Study|Withdrawal by Subject|7|||
160981302|NCT03053492|581319937|FG001|Overall Study|Withdrawal by Subject|5|||
160981303|NCT02207374|581319942|FG000|Overall Study|Withdrawal by Subject|5|||
160981304|NCT02207374|581319943|FG001|Overall Study|Withdrawal by Subject|9|||
160981305|NCT02207374|581319944|FG002|Overall Study|Withdrawal by Subject|4|||
160981306|NCT02207374|581319942|FG000|Overall Study|Death|1|||
160981307|NCT02207374|581319943|FG001|Overall Study|Death|0|||
160981308|NCT02207374|581319944|FG002|Overall Study|Death|1|||
160981309|NCT02207374|581319942|FG000|Overall Study|Missing follow-up information|0|||
160981310|NCT02207374|581319943|FG001|Overall Study|Missing follow-up information|1|||
160981311|NCT02207374|581319944|FG002|Overall Study|Missing follow-up information|1|||
160981312|NCT02087150|581319945|FG000|Overall Study|Death|0|||
160981313|NCT02087150|581319946|FG001|Overall Study|Death|1|||
160981314|NCT02087150|581319947|FG002|Overall Study|Death|0|||
160981315|NCT02087150|581319945|FG000|Overall Study|Lost to Follow-up|6|||
160981316|NCT02087150|581319946|FG001|Overall Study|Lost to Follow-up|13|||
160981317|NCT02087150|581319947|FG002|Overall Study|Lost to Follow-up|7|||
160981318|NCT02087150|581319945|FG000|Overall Study|Withdrawal by Subject|2|||
160981319|NCT02087150|581319946|FG001|Overall Study|Withdrawal by Subject|5|||
160981320|NCT02087150|581319947|FG002|Overall Study|Withdrawal by Subject|3|||
160981321|NCT02087150|581319945|FG000|Overall Study|Physician Decision|0|||
160981322|NCT02087150|581319946|FG001|Overall Study|Physician Decision|1|||
160981323|NCT02087150|581319947|FG002|Overall Study|Physician Decision|0|||
160981324|NCT02087150|581319945|FG000|Overall Study|Procedure not done|1|||
160981325|NCT02087150|581319946|FG001|Overall Study|Procedure not done|13|||
160981326|NCT02087150|581319947|FG002|Overall Study|Procedure not done|0|||
160981327|NCT02087150|581319945|FG000|Overall Study|F/U not completed w/in study window|0|||
160981328|NCT02087150|581319946|FG001|Overall Study|F/U not completed w/in study window|0|||
160981329|NCT02087150|581319947|FG002|Overall Study|F/U not completed w/in study window|1|||
160981330|NCT02087150|581319945|FG000|Overall Study|Other|1|||
160981331|NCT02087150|581319946|FG001|Overall Study|Other|0|||
160981332|NCT02087150|581319947|FG002|Overall Study|Other|0|||
160981333|NCT02087150|581319945|FG000|Overall Study|Pt moved out of town|0|||
160981334|NCT02087150|581319946|FG001|Overall Study|Pt moved out of town|1|||
160981335|NCT02087150|581319947|FG002|Overall Study|Pt moved out of town|0|||
160981336|NCT00683449|581319948|FG000|Overall Study|Lost to Follow-up|0|||
160981337|NCT00683449|581319949|FG001|Overall Study|Lost to Follow-up|1|||
160981338|NCT00683449|581319950|FG002|Overall Study|Lost to Follow-up|0|||
160981339|NCT00683449|581319951|FG003|Overall Study|Lost to Follow-up|0|||
160981340|NCT00683449|581319952|FG004|Overall Study|Lost to Follow-up|0|||
160981341|NCT01000376|581319957|FG000|Cycle 1 Day 1|Adverse Event|1|||
160981342|NCT01000376|581319958|FG001|Cycle 1 Day 1|Adverse Event|0|||
160981343|NCT01000376|581319957|FG000|Cycle 1 Day 1|Progressive Disease|1|||
160981344|NCT01000376|581319958|FG001|Cycle 1 Day 1|Progressive Disease|0|||
160981345|NCT00507026|581319959|FG000|Overall Study|Lack of Efficacy|6|||
160981346|NCT00507026|581319960|FG001|Overall Study|Lack of Efficacy|4|||
160981347|NCT00507026|581319961|FG002|Overall Study|Lack of Efficacy|21|||
160981348|NCT00507026|581319959|FG000|Overall Study|Withdrawal by Subject|2|||
161209653|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209654|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161209655|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209656|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
161209657|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
161209658|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
161209659|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
161209660|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209661|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209662|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209663|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209664|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
161209665|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209666|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209667|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209668|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209669|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
161209670|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209671|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209672|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209673|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209674|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209675|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209676|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209677|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209678|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
161209679|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161209680|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161209681|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161209682|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161209683|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161209684|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161209685|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161209686|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161209687|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161209688|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161209689|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
161209690|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
160981349|NCT00507026|581319960|FG001|Overall Study|Withdrawal by Subject|0|||
160981350|NCT00507026|581319961|FG002|Overall Study|Withdrawal by Subject|0|||
160981351|NCT00507026|581319959|FG000|Overall Study|Investigator Decision|1|||
160981352|NCT00507026|581319960|FG001|Overall Study|Investigator Decision|0|||
160981353|NCT00507026|581319961|FG002|Overall Study|Investigator Decision|0|||
160981354|NCT00507026|581319959|FG000|Overall Study|Adverse Event|2|||
160981355|NCT00507026|581319960|FG001|Overall Study|Adverse Event|0|||
160981356|NCT00507026|581319961|FG002|Overall Study|Adverse Event|0|||
160981357|NCT00507026|581319959|FG000|Overall Study|Protocol Violation|1|||
160981358|NCT00507026|581319960|FG001|Overall Study|Protocol Violation|0|||
160981359|NCT00507026|581319961|FG002|Overall Study|Protocol Violation|0|||
160981360|NCT00507026|581319959|FG000|Overall Study|Other|1|||
160981361|NCT00507026|581319960|FG001|Overall Study|Other|0|||
160981362|NCT00507026|581319961|FG002|Overall Study|Other|0|||
160981363|NCT04230980|581319962|FG000|Overall Study|Lost to Follow-up|1|||
160981364|NCT04230980|581319963|FG001|Overall Study|Lost to Follow-up|2|||
160981365|NCT04230980|581319962|FG000|Overall Study|Adverse Event|0|||
161094641|NCT00406653|581737153|FG000|Open-Label Period|Death|0|||
161094642|NCT00406653|581737154|FG001|Open-Label Period|Death|0|||
161094643|NCT00406653|581737155|FG002|Open-Label Period|Death|0|||
161094644|NCT00406653|581737156|FG003|Open-Label Period|Death|0|||
161094645|NCT00406653|581737157|FG004|Open-Label Period|Death|0|||
161094646|NCT00406653|581737158|FG005|Open-Label Period|Death|0|||
161094647|NCT00406653|581737159|FG006|Open-Label Period|Death|1|||
161094648|NCT00406653|581737153|FG000|Open-Label Period|Adverse Event|0|||
161094649|NCT00406653|581737154|FG001|Open-Label Period|Adverse Event|0|||
161094650|NCT00406653|581737155|FG002|Open-Label Period|Adverse Event|0|||
161094651|NCT00406653|581737156|FG003|Open-Label Period|Adverse Event|0|||
161209691|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161209692|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
160981366|NCT04230980|581319963|FG001|Overall Study|Adverse Event|1|||
160981367|NCT04793464|581319965|FG000|Overall Study|Lost to Follow-up|458|||
161094652|NCT00406653|581737157|FG004|Open-Label Period|Adverse Event|0|||
161094653|NCT00406653|581737158|FG005|Open-Label Period|Adverse Event|0|||
161094654|NCT00406653|581737159|FG006|Open-Label Period|Adverse Event|18|||
160981368|NCT04793464|581319966|FG001|Overall Study|Lost to Follow-up|168|||
160981369|NCT04793464|581319967|FG002|Overall Study|Lost to Follow-up|5|||
160981370|NCT04793464|581319965|FG000|Overall Study|Withdrawal by Subject|43|||
160981371|NCT04793464|581319966|FG001|Overall Study|Withdrawal by Subject|15|||
160981372|NCT04793464|581319967|FG002|Overall Study|Withdrawal by Subject|0|||
160981373|NCT00845871|581319973|FG000|Assessment Period|Adverse Event|2|||
160981374|NCT00845871|581319973|FG000|Assessment Period|Abnormal laboratory values|1|||
160981375|NCT00845871|581319973|FG000|Assessment Period|Abnormal test procedure results|1|||
160981376|NCT00845871|581319973|FG000|Assessment Period|Patient withdrew consent|3|||
160981377|NCT01291225|581319975|FG000|Overall Study|Lost to Follow-up|85|||
160981378|NCT01291225|581319976|FG001|Overall Study|Lost to Follow-up|39|||
160981379|NCT04318093|581319977|FG000|Overall Study|Adverse Event|2|||
160981380|NCT04318093|581319978|FG001|Overall Study|Adverse Event|2|||
160981381|NCT04318093|581319977|FG000|Overall Study|Participant withdrew consent|1|||
160981382|NCT04318093|581319978|FG001|Overall Study|Participant withdrew consent|0|||
160981383|NCT04318093|581319977|FG000|Overall Study|Other reasons|0|||
160981384|NCT04318093|581319978|FG001|Overall Study|Other reasons|1|||
160981385|NCT01734434|581319979|FG000|Overall Study|Death Infant|3|||
160981386|NCT01734434|581319980|FG001|Overall Study|Death Infant|1|||
160981387|NCT01734434|581319981|FG002|Overall Study|Death Infant|17|||
160981388|NCT01734434|581319982|FG003|Overall Study|Death Infant|5|||
160981389|NCT01734434|581319979|FG000|Overall Study|Lost to Follow-up|2|||
160981390|NCT01734434|581319980|FG001|Overall Study|Lost to Follow-up|9|||
160981391|NCT01734434|581319981|FG002|Overall Study|Lost to Follow-up|67|||
160981392|NCT01734434|581319982|FG003|Overall Study|Lost to Follow-up|11|||
160981393|NCT01734434|581319979|FG000|Overall Study|No Live Birth|1|||
160981394|NCT01734434|581319980|FG001|Overall Study|No Live Birth|2|||
160981395|NCT01734434|581319981|FG002|Overall Study|No Live Birth|32|||
160981396|NCT01734434|581319982|FG003|Overall Study|No Live Birth|6|||
160981397|NCT01734434|581319979|FG000|Overall Study|Withdrawal by Subject|4|||
160981398|NCT01734434|581319980|FG001|Overall Study|Withdrawal by Subject|0|||
160981399|NCT01734434|581319981|FG002|Overall Study|Withdrawal by Subject|8|||
160981400|NCT01734434|581319982|FG003|Overall Study|Withdrawal by Subject|1|||
160981401|NCT01734434|581319979|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
160981402|NCT01734434|581319980|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
160981403|NCT01734434|581319981|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
161322868|NCT04892446|582568623|FG001|Overall Study|Investigator's discretion|1|||
161322869|NCT04892446|582568624|FG002|Overall Study|Investigator's discretion|0|||
161322870|NCT04892446|582568622|FG000|Overall Study|Study terminated by sponsor|0|||
161322871|NCT04892446|582568623|FG001|Overall Study|Study terminated by sponsor|0|||
161322872|NCT04892446|582568624|FG002|Overall Study|Study terminated by sponsor|2|||
161322873|NCT01768559|582568626|FG000|Overall Study|Randomized but not treated|0|||
161322874|NCT01768559|582568627|FG001|Overall Study|Randomized but not treated|0|||
161322875|NCT01768559|582568628|FG002|Overall Study|Randomized but not treated|1|||
161322876|NCT01768559|582568626|FG000|Overall Study|Adverse Event|15|||
161322877|NCT01768559|582568627|FG001|Overall Study|Adverse Event|2|||
161322878|NCT01768559|582568628|FG002|Overall Study|Adverse Event|5|||
161322879|NCT01768559|582568626|FG000|Overall Study|Lack of Efficacy|6|||
161322880|NCT01768559|582568627|FG001|Overall Study|Lack of Efficacy|4|||
160981404|NCT01734434|581319982|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
160981405|NCT01734434|581319979|FG000|Overall Study|Subject Not Reachable|0|||
160981406|NCT01734434|581319980|FG001|Overall Study|Subject Not Reachable|0|||
160981407|NCT01734434|581319981|FG002|Overall Study|Subject Not Reachable|1|||
160981408|NCT01734434|581319982|FG003|Overall Study|Subject Not Reachable|0|||
160981409|NCT01734434|581319979|FG000|Overall Study|Treatment Defaulter|0|||
160981410|NCT01734434|581319980|FG001|Overall Study|Treatment Defaulter|0|||
160981411|NCT01734434|581319981|FG002|Overall Study|Treatment Defaulter|1|||
160981412|NCT01734434|581319982|FG003|Overall Study|Treatment Defaulter|0|||
160981413|NCT01734434|581319979|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
160981414|NCT01734434|581319980|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
160981415|NCT01734434|581319981|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
160981416|NCT01734434|581319982|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
160981417|NCT01734434|581319979|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
160981418|NCT01734434|581319980|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
160981419|NCT01734434|581319981|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
160981420|NCT01734434|581319982|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
160981421|NCT01370603|581319983|FG000|Period 1|Adverse Event|5|||
160981422|NCT01370603|581319984|FG001|Period 1|Adverse Event|3|||
160981423|NCT01370603|581319983|FG000|Period 1|Lost to Follow-up|2|||
160981424|NCT01370603|581319984|FG001|Period 1|Lost to Follow-up|0|||
160981425|NCT01370603|581319983|FG000|Period 1|Protocol Violation|2|||
160981426|NCT01370603|581319984|FG001|Period 1|Protocol Violation|2|||
160981427|NCT01370603|581319983|FG000|Period 1|Withdrawal by Subject|5|||
160981428|NCT01370603|581319984|FG001|Period 1|Withdrawal by Subject|5|||
161322881|NCT01768559|582568628|FG002|Overall Study|Lack of Efficacy|0|||
161322882|NCT01768559|582568626|FG000|Overall Study|Poor compliance to protocol|0|||
161209693|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
161209694|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
161209695|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
161209696|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
161209697|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
161209698|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209699|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209700|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209701|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209702|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209703|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209704|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209705|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209706|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
160981429|NCT01370603|581319983|FG000|Crossover Washout|Adverse Event|2|||
161209707|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209708|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
161209709|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209710|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209711|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209712|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209713|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209714|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209715|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209716|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
161209717|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161209718|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161209719|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161209720|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161209721|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161209722|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161209723|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161209724|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161209725|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161209726|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161209727|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
160981430|NCT01370603|581319984|FG001|Crossover Washout|Adverse Event|1|||
160981431|NCT01370603|581319983|FG000|Crossover Washout|Lost to Follow-up|2|||
160981432|NCT01370603|581319984|FG001|Crossover Washout|Lost to Follow-up|0|||
160981433|NCT01370603|581319983|FG000|Crossover Washout|Protocol Violation|1|||
160981434|NCT01370603|581319984|FG001|Crossover Washout|Protocol Violation|0|||
160981435|NCT01370603|581319983|FG000|Crossover Washout|Withdrawal by Subject|4|||
160981436|NCT01370603|581319984|FG001|Crossover Washout|Withdrawal by Subject|1|||
160981437|NCT01370603|581319983|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
160981438|NCT01370603|581319984|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
160981439|NCT01370603|581319983|FG000|Period 2|Adverse Event|1|||
160981440|NCT01370603|581319984|FG001|Period 2|Adverse Event|4|||
160981441|NCT01370603|581319983|FG000|Period 2|Lost to Follow-up|1|||
160981442|NCT01370603|581319984|FG001|Period 2|Lost to Follow-up|0|||
160981443|NCT01370603|581319983|FG000|Period 2|Withdrawal by Subject|1|||
160981444|NCT01370603|581319984|FG001|Period 2|Withdrawal by Subject|0|||
160981445|NCT04714216|581321674|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
160981446|NCT04714216|581321674|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
160981447|NCT00513019|581321675|FG000|Overall Study|Adverse Event|1|||
160981448|NCT00513019|581321676|FG001|Overall Study|Adverse Event|0|||
160981449|NCT00513019|581321675|FG000|Overall Study|Withdrawal by Subject|4|||
160981450|NCT00513019|581321676|FG001|Overall Study|Withdrawal by Subject|5|||
160981451|NCT04129580|581321677|FG000|Overall Study|Lost to Follow-up|14|||
160981452|NCT04129580|581321678|FG001|Overall Study|Lost to Follow-up|25|||
160981453|NCT01852162|581321679|FG000|Overall Study|Adverse Event|1|||
160981454|NCT01852162|581321680|FG001|Overall Study|Adverse Event|0|||
160981455|NCT01852162|581321679|FG000|Overall Study|Withdrawal by Subject|3|||
160981456|NCT01852162|581321680|FG001|Overall Study|Withdrawal by Subject|1|||
160981457|NCT01500226|581321683|FG000|Overall Study|Adverse Event|31|||
160981458|NCT01500226|581321684|FG001|Overall Study|Adverse Event|38|||
160981459|NCT01500226|581321683|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
160981460|NCT01500226|581321684|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
160981461|NCT01500226|581321683|FG000|Overall Study|Withdrawal by Subject|93|||
160981462|NCT01500226|581321684|FG001|Overall Study|Withdrawal by Subject|96|||
160981463|NCT01500226|581321683|FG000|Overall Study|Death|12|||
160981464|NCT01500226|581321684|FG001|Overall Study|Death|4|||
161209728|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161209729|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161209730|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161209731|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
161209732|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
161209733|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
161209734|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
161209735|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
161209736|NCT01915498|582149133|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
161209737|NCT01915498|582149134|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161209738|NCT01915498|582149135|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161209739|NCT01915498|582149136|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
161094655|NCT00406653|581737153|FG000|Open-Label Period|Lack of Efficacy|0|||
161094656|NCT00406653|581737154|FG001|Open-Label Period|Lack of Efficacy|0|||
161094657|NCT00406653|581737155|FG002|Open-Label Period|Lack of Efficacy|0|||
161094658|NCT00406653|581737156|FG003|Open-Label Period|Lack of Efficacy|0|||
161094659|NCT00406653|581737157|FG004|Open-Label Period|Lack of Efficacy|0|||
161094660|NCT00406653|581737158|FG005|Open-Label Period|Lack of Efficacy|0|||
161094661|NCT00406653|581737159|FG006|Open-Label Period|Lack of Efficacy|160|||
161094662|NCT00406653|581737153|FG000|Open-Label Period|Lost to Follow-up|0|||
161094663|NCT00406653|581737154|FG001|Open-Label Period|Lost to Follow-up|0|||
161094664|NCT00406653|581737155|FG002|Open-Label Period|Lost to Follow-up|0|||
161094665|NCT00406653|581737156|FG003|Open-Label Period|Lost to Follow-up|0|||
161094666|NCT00406653|581737157|FG004|Open-Label Period|Lost to Follow-up|0|||
161094667|NCT00406653|581737158|FG005|Open-Label Period|Lost to Follow-up|0|||
161094668|NCT00406653|581737159|FG006|Open-Label Period|Lost to Follow-up|6|||
161094669|NCT00406653|581737153|FG000|Open-Label Period|Withdrawal of Consent|0|||
161094670|NCT00406653|581737154|FG001|Open-Label Period|Withdrawal of Consent|0|||
161094671|NCT00406653|581737155|FG002|Open-Label Period|Withdrawal of Consent|0|||
161094672|NCT00406653|581737156|FG003|Open-Label Period|Withdrawal of Consent|0|||
161094673|NCT00406653|581737157|FG004|Open-Label Period|Withdrawal of Consent|0|||
161094674|NCT00406653|581737158|FG005|Open-Label Period|Withdrawal of Consent|0|||
161094675|NCT00406653|581737159|FG006|Open-Label Period|Withdrawal of Consent|11|||
161094676|NCT00406653|581737153|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161094677|NCT00406653|581737154|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161094678|NCT00406653|581737155|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161094679|NCT00406653|581737156|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161094680|NCT00406653|581737157|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161094681|NCT00406653|581737158|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
161094682|NCT00406653|581737159|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
161094683|NCT00406653|581737153|FG000|Open-Label Period|Pregnancy|0|||
161094684|NCT00406653|581737154|FG001|Open-Label Period|Pregnancy|0|||
161094685|NCT00406653|581737155|FG002|Open-Label Period|Pregnancy|0|||
161094686|NCT00406653|581737156|FG003|Open-Label Period|Pregnancy|0|||
161094687|NCT00406653|581737157|FG004|Open-Label Period|Pregnancy|0|||
161094688|NCT00406653|581737158|FG005|Open-Label Period|Pregnancy|0|||
161094689|NCT00406653|581737159|FG006|Open-Label Period|Pregnancy|2|||
161094690|NCT00406653|581737153|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
161094691|NCT00406653|581737154|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
161094692|NCT00406653|581737155|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
161094693|NCT00406653|581737156|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
161094694|NCT00406653|581737157|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
161094695|NCT00406653|581737158|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
161094696|NCT00406653|581737159|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
161209740|NCT01915498|582149137|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
160981465|NCT01500226|581321683|FG000|Overall Study|Disease Progression|16|||
160981466|NCT01500226|581321684|FG001|Overall Study|Disease Progression|14|||
160981467|NCT01500226|581321683|FG000|Overall Study|Protocol Violation|53|||
160981468|NCT01500226|581321684|FG001|Overall Study|Protocol Violation|39|||
160981469|NCT01500226|581321683|FG000|Overall Study|Physician Decision|17|||
160981470|NCT01500226|581321684|FG001|Overall Study|Physician Decision|15|||
160981471|NCT01500226|581321683|FG000|Overall Study|Lack of Efficacy|14|||
160981472|NCT01500226|581321684|FG001|Overall Study|Lack of Efficacy|30|||
160981473|NCT01500226|581321683|FG000|Overall Study|Lost to Follow-up|9|||
160981474|NCT01500226|581321684|FG001|Overall Study|Lost to Follow-up|5|||
160981475|NCT01500226|581321683|FG000|Overall Study|Other Reasons|19|||
161094697|NCT00406653|581737153|FG000|Open-Label Period|Declined participation but followup done|0|||
161094698|NCT00406653|581737154|FG001|Open-Label Period|Declined participation but followup done|0|||
161094699|NCT00406653|581737155|FG002|Open-Label Period|Declined participation but followup done|0|||
161094700|NCT00406653|581737156|FG003|Open-Label Period|Declined participation but followup done|0|||
160981476|NCT01500226|581321684|FG001|Overall Study|Other Reasons|16|||
161209741|NCT01915498|582149138|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
161209742|NCT01915498|582149139|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
161209743|NCT01915498|582149140|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
161209744|NCT01915498|582149141|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
161209745|NCT01915498|582149142|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
161209746|NCT01915498|582149143|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
161209747|NCT01915498|582149144|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
161209748|NCT01915498|582149145|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
160981477|NCT02955277|581321685|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
160981478|NCT02955277|581321686|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
160981479|NCT02955277|581321685|FG000|Post to Follow-up|Lost to Follow-up|8|||
160981480|NCT02955277|581321686|FG001|Post to Follow-up|Lost to Follow-up|11|||
161209749|NCT01915498|582149146|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
161209750|NCT01915498|582149147|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
161209751|NCT01915498|582149148|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
161209752|NCT01915498|582149149|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
161209753|NCT01915498|582149150|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
161209754|NCT01915498|582149151|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
161209755|NCT01915498|582149133|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209756|NCT01915498|582149134|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209757|NCT01915498|582149135|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209758|NCT01915498|582149136|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209759|NCT01915498|582149137|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209760|NCT01915498|582149138|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209761|NCT01915498|582149139|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209762|NCT01915498|582149140|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209763|NCT01915498|582149141|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209764|NCT01915498|582149142|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209765|NCT01915498|582149143|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209766|NCT01915498|582149144|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209767|NCT01915498|582149145|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209768|NCT01915498|582149146|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209769|NCT01915498|582149147|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
160981481|NCT04212169|581321689|FG000|Overall Study|Adverse Event|0|||
160981482|NCT04212169|581321690|FG001|Overall Study|Adverse Event|0|||
161209770|NCT01915498|582149148|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209771|NCT01915498|582149149|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209772|NCT01915498|582149150|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
161209773|NCT01915498|582149151|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
161209774|NCT01915498|582149133|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209775|NCT01915498|582149134|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209776|NCT01915498|582149135|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209777|NCT01915498|582149136|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209778|NCT01915498|582149137|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209779|NCT01915498|582149138|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209780|NCT01915498|582149139|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209781|NCT01915498|582149140|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209782|NCT01915498|582149141|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209783|NCT01915498|582149142|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209784|NCT01915498|582149143|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209785|NCT01915498|582149144|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209786|NCT01915498|582149145|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209787|NCT01915498|582149146|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209788|NCT01915498|582149147|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209789|NCT01915498|582149148|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209790|NCT01915498|582149149|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209791|NCT01915498|582149150|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
161209792|NCT01915498|582149151|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
161209793|NCT01915498|582149133|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209794|NCT01915498|582149134|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209795|NCT01915498|582149135|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209796|NCT01915498|582149136|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
160981483|NCT04212169|581321691|FG002|Overall Study|Adverse Event|0|||
160981484|NCT04212169|581321692|FG003|Overall Study|Adverse Event|2|||
160981485|NCT04212169|581321689|FG000|Overall Study|Lost to Follow-up|1|||
160981486|NCT04212169|581321690|FG001|Overall Study|Lost to Follow-up|0|||
160981487|NCT04212169|581321691|FG002|Overall Study|Lost to Follow-up|0|||
160981488|NCT04212169|581321692|FG003|Overall Study|Lost to Follow-up|2|||
160981489|NCT04212169|581321689|FG000|Overall Study|Withdrawal by Subject|10|||
160981490|NCT04212169|581321690|FG001|Overall Study|Withdrawal by Subject|2|||
160981491|NCT04212169|581321691|FG002|Overall Study|Withdrawal by Subject|5|||
160981492|NCT04212169|581321692|FG003|Overall Study|Withdrawal by Subject|7|||
160981493|NCT04212169|581321689|FG000|Overall Study|Other reason, unspecified|3|||
160981494|NCT04212169|581321690|FG001|Overall Study|Other reason, unspecified|1|||
160981495|NCT04212169|581321691|FG002|Overall Study|Other reason, unspecified|0|||
160981496|NCT04212169|581321692|FG003|Overall Study|Other reason, unspecified|2|||
160981497|NCT02176928|581321693|FG000|Overall Study|Lost to Follow-up|2|||
161094701|NCT00406653|581737157|FG004|Open-Label Period|Declined participation but followup done|0|||
161094702|NCT00406653|581737158|FG005|Open-Label Period|Declined participation but followup done|0|||
161094703|NCT00406653|581737159|FG006|Open-Label Period|Declined participation but followup done|8|||
161094704|NCT00406653|581737153|FG000|Open-Label Period|Discontinued by Sponsor|0|||
161094705|NCT00406653|581737154|FG001|Open-Label Period|Discontinued by Sponsor|0|||
161094706|NCT00406653|581737155|FG002|Open-Label Period|Discontinued by Sponsor|0|||
161094707|NCT00406653|581737156|FG003|Open-Label Period|Discontinued by Sponsor|0|||
161094708|NCT00406653|581737157|FG004|Open-Label Period|Discontinued by Sponsor|0|||
161094709|NCT00406653|581737158|FG005|Open-Label Period|Discontinued by Sponsor|0|||
161094710|NCT00406653|581737159|FG006|Open-Label Period|Discontinued by Sponsor|1|||
161094711|NCT00406653|581737153|FG000|Open-Label Period|Refused followup|0|||
161094712|NCT00406653|581737154|FG001|Open-Label Period|Refused followup|0|||
161094713|NCT00406653|581737155|FG002|Open-Label Period|Refused followup|0|||
161094714|NCT00406653|581737156|FG003|Open-Label Period|Refused followup|0|||
161094715|NCT00406653|581737157|FG004|Open-Label Period|Refused followup|0|||
161094716|NCT00406653|581737158|FG005|Open-Label Period|Refused followup|0|||
161094717|NCT00406653|581737159|FG006|Open-Label Period|Refused followup|1|||
161094718|NCT00446992|581737160|FG000|Overall Study|Adverse Event|11|||
161094719|NCT00446992|581737160|FG000|Overall Study|Lost to Follow-up|5|||
161094720|NCT00731120|581737161|FG000|Overall Study|Adverse Event|7|||
161094721|NCT00731120|581737162|FG001|Overall Study|Adverse Event|6|||
161094722|NCT00731120|581737163|FG002|Overall Study|Adverse Event|8|||
161094723|NCT00731120|581737161|FG000|Overall Study|Lack of Efficacy|4|||
161094724|NCT00731120|581737162|FG001|Overall Study|Lack of Efficacy|5|||
161094725|NCT00731120|581737163|FG002|Overall Study|Lack of Efficacy|4|||
161094726|NCT00731120|581737161|FG000|Overall Study|Noncompliance with Study Drug|3|||
161094727|NCT00731120|581737162|FG001|Overall Study|Noncompliance with Study Drug|3|||
161094728|NCT00731120|581737163|FG002|Overall Study|Noncompliance with Study Drug|1|||
161094729|NCT00731120|581737161|FG000|Overall Study|Protocol Deviations|1|||
161094730|NCT00731120|581737162|FG001|Overall Study|Protocol Deviations|6|||
161094731|NCT00731120|581737163|FG002|Overall Study|Protocol Deviations|1|||
161094732|NCT00731120|581737161|FG000|Overall Study|Withdrawal of Consent|13|||
161094733|NCT00731120|581737162|FG001|Overall Study|Withdrawal of Consent|8|||
161094734|NCT00731120|581737163|FG002|Overall Study|Withdrawal of Consent|4|||
161094735|NCT00731120|581737161|FG000|Overall Study|Lost to Follow-up|10|||
161094736|NCT00731120|581737162|FG001|Overall Study|Lost to Follow-up|15|||
161094737|NCT00731120|581737163|FG002|Overall Study|Lost to Follow-up|17|||
161209797|NCT01915498|582149137|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209798|NCT01915498|582149138|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209799|NCT01915498|582149139|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209800|NCT01915498|582149140|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209801|NCT01915498|582149141|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209802|NCT01915498|582149142|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209803|NCT01915498|582149143|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209804|NCT01915498|582149144|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209805|NCT01915498|582149145|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161094738|NCT00731120|581737161|FG000|Overall Study|Other|4|||
161094739|NCT00731120|581737162|FG001|Overall Study|Other|0|||
161094740|NCT00731120|581737163|FG002|Overall Study|Other|1|||
161094741|NCT02434939|581737166|FG000|Overall Study|Lack of Efficacy|34|||
161094742|NCT02434939|581737167|FG001|Overall Study|Lack of Efficacy|48|||
161094743|NCT02434939|581737166|FG000|Overall Study|Withdrawal by Subject|3|||
161094744|NCT02434939|581737167|FG001|Overall Study|Withdrawal by Subject|0|||
161209806|NCT01915498|582149146|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209807|NCT01915498|582149147|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161094745|NCT02434939|581737166|FG000|Overall Study|Adverse Event|0|||
161094746|NCT02434939|581737167|FG001|Overall Study|Adverse Event|1|||
160981498|NCT02176928|581321694|FG001|Overall Study|Lost to Follow-up|4|||
161094747|NCT01326533|581737168|FG000|Overall Study|Lost to Follow-up|2|||
161094748|NCT01326533|581737169|FG001|Overall Study|Lost to Follow-up|0|||
161094749|NCT01326533|581737168|FG000|Overall Study|Withdrawal by Subject|1|||
161094750|NCT01326533|581737169|FG001|Overall Study|Withdrawal by Subject|0|||
161209808|NCT01915498|582149148|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209809|NCT01915498|582149149|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209810|NCT01915498|582149150|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
161209811|NCT01915498|582149151|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
161209812|NCT02524665|582149154|FG000|Overall Study|Lost to Follow-up|1|||
161209813|NCT01185639|582149155|FG000|Overall Study|Progressed and didn't receive therapy|2|||
161209814|NCT02499406|582151032|FG000|Overall Study|missed 3 treatment sessions|4|||
161209815|NCT01467570|582151033|FG000|Overall Study|Lost to Follow-up|8|||
161209816|NCT01467570|582151034|FG001|Overall Study|Lost to Follow-up|9|||
161209817|NCT02766088|582151045|FG000|Overall Study|Sponsor study termination|498|||
161209818|NCT02766088|582151045|FG000|Overall Study|Migrated/moved from the study area|1|||
161209819|NCT02766088|582151045|FG000|Overall Study|Lost to Follow-up|5|||
161209820|NCT02766088|582151045|FG000|Overall Study|Other|1|||
161209821|NCT02766088|582151045|FG000|Overall Study|Death|1|||
161209822|NCT01222715|582151046|FG000|Overall Study|Adverse Event|0|||
161209823|NCT01222715|582151047|FG001|Overall Study|Adverse Event|4|||
161209824|NCT01222715|582151046|FG000|Overall Study|Death|0|||
161209825|NCT01222715|582151047|FG001|Overall Study|Death|1|||
161209826|NCT01222715|582151046|FG000|Overall Study|Lack of Efficacy|22|||
161209827|NCT01222715|582151047|FG001|Overall Study|Lack of Efficacy|14|||
161209828|NCT01222715|582151046|FG000|Overall Study|Physician Decision|12|||
161209829|NCT01222715|582151047|FG001|Overall Study|Physician Decision|2|||
161209830|NCT01222715|582151046|FG000|Overall Study|Refusal of further protocol therapy|0|||
161209831|NCT01222715|582151047|FG001|Overall Study|Refusal of further protocol therapy|4|||
161209832|NCT01222715|582151046|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
161209833|NCT01222715|582151047|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
161209834|NCT01222715|582151046|FG000|Overall Study|Ineligible|0|||
161209835|NCT01222715|582151047|FG001|Overall Study|Ineligible|1|||
161209836|NCT01222715|582151046|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
161209837|NCT01222715|582151047|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
161209838|NCT03836729|582151048|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
161209839|NCT00763269|582151054|FG000|Overall Study|Lost to Follow-up|12|||
161209840|NCT00763269|582151055|FG001|Overall Study|Lost to Follow-up|13|||
161209841|NCT01791127|582151056|FG000|Overall Study|Death|356|||
161209842|NCT01791127|582151056|FG000|Overall Study|Patient has withdrawn from study|293|||
161209843|NCT01791127|582151056|FG000|Overall Study|Lost to Follow-up|42|||
161209844|NCT01791127|582151056|FG000|Overall Study|All Siello leads are explanted|31|||
161209845|NCT01791127|582151056|FG000|Overall Study|Completion of 30 day safety registry|1|||
161209846|NCT01791127|582151056|FG000|Overall Study|Study terminated for EP Passion|749|||
161209847|NCT00544557|582151063|FG000|Overall Study|Adverse Event|140|||
161209848|NCT00544557|582151063|FG000|Overall Study|Lack of Efficacy|196|||
161209849|NCT00544557|582151063|FG000|Overall Study|Other|98|||
161322883|NCT01768559|582568627|FG001|Overall Study|Poor compliance to protocol|3|||
161094751|NCT01326533|581737168|FG000|Overall Study|Adverse Event|1|||
161094752|NCT01326533|581737169|FG001|Overall Study|Adverse Event|0|||
161094753|NCT04079803|581737170|FG000|Overall Study|Withdrawal by Subject|0|||
161094754|NCT04079803|581737171|FG001|Overall Study|Withdrawal by Subject|0|||
161094755|NCT04079803|581737172|FG002|Overall Study|Withdrawal by Subject|1|||
161094756|NCT01032382|581737174|FG000|Overall Study|Disease dissemination|1|||
161094757|NCT01032382|581737175|FG001|Overall Study|Disease dissemination|1|||
161094758|NCT01032382|581737174|FG000|Overall Study|Treatment failure|3|||
161094759|NCT01032382|581737175|FG001|Overall Study|Treatment failure|1|||
161094760|NCT01032382|581737174|FG000|Overall Study|Index lesion relapse|1|||
161094761|NCT01032382|581737175|FG001|Overall Study|Index lesion relapse|3|||
161094762|NCT01012713|581737176|FG000|Overall Study|Lack of Efficacy|3|||
161094763|NCT01668667|581737184|FG000|Overall Study|Adverse Event|3|||
161094764|NCT01668667|581737185|FG001|Overall Study|Adverse Event|6|||
161094765|NCT01668667|581737186|FG002|Overall Study|Adverse Event|4|||
161094766|NCT01668667|581737187|FG003|Overall Study|Adverse Event|4|||
161094767|NCT01668667|581737184|FG000|Overall Study|Lack of Efficacy|3|||
161094768|NCT01668667|581737185|FG001|Overall Study|Lack of Efficacy|2|||
161094769|NCT01668667|581737186|FG002|Overall Study|Lack of Efficacy|2|||
161094770|NCT01668667|581737187|FG003|Overall Study|Lack of Efficacy|3|||
161094771|NCT01668667|581737184|FG000|Overall Study|Protocol Violation|6|||
161094772|NCT01668667|581737185|FG001|Overall Study|Protocol Violation|10|||
161094773|NCT01668667|581737186|FG002|Overall Study|Protocol Violation|12|||
161094774|NCT01668667|581737187|FG003|Overall Study|Protocol Violation|5|||
161094775|NCT01668667|581737184|FG000|Overall Study|Lost to Follow-up|9|||
161209850|NCT00467818|582151064|FG000|Overall Study|Adverse Event|1|||
161209851|NCT00467818|582151065|FG001|Overall Study|Adverse Event|0|||
161209852|NCT00467818|582151064|FG000|Overall Study|Lost to Follow-up|2|||
161209853|NCT00467818|582151065|FG001|Overall Study|Lost to Follow-up|2|||
161209854|NCT01017029|582151066|FG000|Overall Study|Lost to Follow-up|1|||
161209855|NCT01017029|582151067|FG001|Overall Study|Lost to Follow-up|0|||
161209856|NCT01017029|582151066|FG000|Overall Study|Administrative problem|0|||
161209857|NCT01017029|582151067|FG001|Overall Study|Administrative problem|1|||
161209858|NCT01017029|582151066|FG000|Overall Study|Death|3|||
161094776|NCT01668667|581737185|FG001|Overall Study|Lost to Follow-up|4|||
161094777|NCT01668667|581737186|FG002|Overall Study|Lost to Follow-up|7|||
161094778|NCT01668667|581737187|FG003|Overall Study|Lost to Follow-up|6|||
161094779|NCT01668667|581737184|FG000|Overall Study|Physician Decision|3|||
161094780|NCT01668667|581737185|FG001|Overall Study|Physician Decision|0|||
161094781|NCT01668667|581737186|FG002|Overall Study|Physician Decision|1|||
161094782|NCT01668667|581737187|FG003|Overall Study|Physician Decision|0|||
161094783|NCT01668667|581737184|FG000|Overall Study|Withdrawal by Subject|7|||
161094784|NCT01668667|581737185|FG001|Overall Study|Withdrawal by Subject|4|||
161094785|NCT01668667|581737186|FG002|Overall Study|Withdrawal by Subject|5|||
161094786|NCT01668667|581737187|FG003|Overall Study|Withdrawal by Subject|5|||
161094787|NCT02988622|581737188|FG000|Overall Study|Lost to Follow-up|17|||
161094788|NCT02447172|581737189|FG000|Overall Study|Adverse Event|11|||
161094789|NCT02447172|581737190|FG001|Overall Study|Adverse Event|8|||
161094790|NCT02447172|581737191|FG002|Overall Study|Adverse Event|7|||
161094791|NCT02447172|581737189|FG000|Overall Study|Death|3|||
161094792|NCT02447172|581737190|FG001|Overall Study|Death|1|||
161094793|NCT02447172|581737191|FG002|Overall Study|Death|0|||
161094794|NCT02447172|581737189|FG000|Overall Study|Protocol Violation|2|||
161094795|NCT02447172|581737190|FG001|Overall Study|Protocol Violation|1|||
161094796|NCT02447172|581737191|FG002|Overall Study|Protocol Violation|2|||
161094797|NCT02447172|581737189|FG000|Overall Study|Lost to Follow-up|7|||
161094798|NCT02447172|581737190|FG001|Overall Study|Lost to Follow-up|4|||
161094799|NCT02447172|581737191|FG002|Overall Study|Lost to Follow-up|4|||
161094800|NCT02447172|581737189|FG000|Overall Study|Withdrawal by Subject|5|||
161094801|NCT02447172|581737190|FG001|Overall Study|Withdrawal by Subject|1|||
161094802|NCT02447172|581737191|FG002|Overall Study|Withdrawal by Subject|3|||
161094803|NCT02447172|581737189|FG000|Overall Study|protocol specific treatment unrelated|3|||
161094804|NCT02447172|581737190|FG001|Overall Study|protocol specific treatment unrelated|0|||
161094805|NCT02447172|581737191|FG002|Overall Study|protocol specific treatment unrelated|2|||
161094806|NCT03261700|581737192|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
161094807|NCT03261700|581737193|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
161094808|NCT01204398|581737194|FG000|Overall Study|Adverse Event|1|||
161094809|NCT03164564|581737205|FG000|Overall Study|Death|3|||
161094810|NCT03164564|581737206|FG001|Overall Study|Death|0|||
161094811|NCT03164564|581737205|FG000|Overall Study|Withdrawal by Subject|20|||
161094812|NCT03164564|581737206|FG001|Overall Study|Withdrawal by Subject|15|||
161094813|NCT03164564|581737205|FG000|Overall Study|Lost to Follow-up|2|||
161094814|NCT03164564|581737206|FG001|Overall Study|Lost to Follow-up|0|||
161094815|NCT03164564|581737205|FG000|Overall Study|Physician Decision|0|||
161094816|NCT03164564|581737206|FG001|Overall Study|Physician Decision|1|||
161094817|NCT03164564|581737205|FG000|Overall Study|Adverse Event|0|||
161094818|NCT03164564|581737206|FG001|Overall Study|Adverse Event|1|||
161094819|NCT03164564|581737205|FG000|Overall Study|Ongoing|1586|||
161094820|NCT03164564|581737206|FG001|Overall Study|Ongoing|1586|||
161094821|NCT01910181|581737211|FG000|Overall Study|Death|37|||
161094822|NCT01910181|581737211|FG000|Overall Study|Lost to Follow-up|3|||
161094823|NCT01910181|581737211|FG000|Overall Study|Study Terminated by Sponsor|6|||
161094824|NCT02656823|581737212|FG000|Overall Study|Adverse Event|3|||
161094825|NCT02656823|581737212|FG000|Overall Study|Lost to Follow-up|2|||
161094826|NCT03567434|581737216|FG000|Overall Study|Lost to Follow-up|1|||
161094827|NCT03567434|581737217|FG001|Overall Study|Lost to Follow-up|3|||
161094828|NCT02881957|581737223|FG000|Overall Study|Comfort care|0|||
161094829|NCT02881957|581737224|FG001|Overall Study|Comfort care|1|||
161094830|NCT02881957|581737223|FG000|Overall Study|Concurrent trial enrollment|0|||
161094831|NCT02881957|581737224|FG001|Overall Study|Concurrent trial enrollment|1|||
161094832|NCT02881957|581737223|FG000|Overall Study|Discharged within 48 hours|0|||
161094833|NCT02881957|581737224|FG001|Overall Study|Discharged within 48 hours|1|||
161094834|NCT02881957|581737223|FG000|Overall Study|Withdrawal by Subject|2|||
161094835|NCT02881957|581737224|FG001|Overall Study|Withdrawal by Subject|1|||
161094836|NCT02881957|581737223|FG000|Overall Study|Protocol Violation|1|||
161094837|NCT02881957|581737224|FG001|Overall Study|Protocol Violation|0|||
161094838|NCT05269355|581737230|FG000|Overall Study|Progressive Disease|104|||
161094839|NCT05269355|581737231|FG001|Overall Study|Progressive Disease|68|||
161094840|NCT05269355|581737230|FG000|Overall Study|Study Terminated by Sponsor|87|||
161094841|NCT05269355|581737231|FG001|Overall Study|Study Terminated by Sponsor|29|||
161094842|NCT05269355|581737230|FG000|Overall Study|Adverse Event|15|||
161094843|NCT05269355|581737231|FG001|Overall Study|Adverse Event|8|||
161094844|NCT05269355|581737230|FG000|Overall Study|Withdrawal by Subject|18|||
161209859|NCT01017029|582151067|FG001|Overall Study|Death|1|||
161094845|NCT05269355|581737231|FG001|Overall Study|Withdrawal by Subject|5|||
161094846|NCT05269355|581737230|FG000|Overall Study|Physician Decision|6|||
161094847|NCT05269355|581737231|FG001|Overall Study|Physician Decision|4|||
161094848|NCT05269355|581737230|FG000|Overall Study|Death|3|||
161094849|NCT05269355|581737231|FG001|Overall Study|Death|5|||
161094850|NCT05269355|581737230|FG000|Overall Study|Other Than Specified|5|||
161094851|NCT05269355|581737231|FG001|Overall Study|Other Than Specified|1|||
161094852|NCT05269355|581737230|FG000|Overall Study|Randomized But Not Treated|1|||
161209860|NCT01313728|582151068|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
161209861|NCT04529499|582151071|FG000|Overall Study|Withdrawal by Subject|9|||
161209862|NCT04529499|582151072|FG001|Overall Study|Withdrawal by Subject|11|||
161209863|NCT04529499|582151071|FG000|Overall Study|Physician Decision|1|||
161209864|NCT04529499|582151072|FG001|Overall Study|Physician Decision|2|||
161209865|NCT04529499|582151071|FG000|Overall Study|Adverse Event|4|||
161209866|NCT04529499|582151072|FG001|Overall Study|Adverse Event|4|||
161209867|NCT04529499|582151071|FG000|Overall Study|Death|14|||
161209868|NCT04529499|582151072|FG001|Overall Study|Death|11|||
161209869|NCT04529499|582151071|FG000|Overall Study|Lost to Follow-up|1|||
161209870|NCT04529499|582151072|FG001|Overall Study|Lost to Follow-up|1|||
161209871|NCT04529499|582151071|FG000|Overall Study|Others|7|||
161209872|NCT04529499|582151072|FG001|Overall Study|Others|11|||
161209873|NCT00683904|582151073|FG000|Dose Level 1|Disease progression|2|||
161209874|NCT00683904|582151074|FG001|Dose Level 1|Disease progression|0|||
161209875|NCT00683904|582151073|FG000|Dose Level 1|Adverse Event|1|||
161209876|NCT00683904|582151074|FG001|Dose Level 1|Adverse Event|0|||
161209877|NCT00683904|582151073|FG000|Dose Level 2|Adverse Event|0|||
161209878|NCT00683904|582151074|FG001|Dose Level 2|Adverse Event|2|||
161209879|NCT02702271|582151075|FG000|Overall Study|Death|36|||
161209880|NCT02702271|582151076|FG001|Overall Study|Death|7|||
161209881|NCT02702271|582151075|FG000|Overall Study|Lost to Follow-up|12|||
161209882|NCT02702271|582151076|FG001|Overall Study|Lost to Follow-up|0|||
161209883|NCT02702271|582151075|FG000|Overall Study|Withdrawal by Subject|8|||
161209884|NCT02702271|582151076|FG001|Overall Study|Withdrawal by Subject|1|||
161209885|NCT02702271|582151075|FG000|Overall Study|Physician Decision|2|||
161209886|NCT02702271|582151076|FG001|Overall Study|Physician Decision|0|||
161209887|NCT02702271|582151075|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
161209888|NCT02702271|582151076|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
161209889|NCT01494649|582151077|FG000|Overall Study|Lost to Follow-up|0|||
161209890|NCT01494649|582151078|FG001|Overall Study|Lost to Follow-up|1|||
161209891|NCT01345058|582151082|FG000|Overall Study|Withdrawal by Subject|1|||
161209892|NCT01345058|582151083|FG001|Overall Study|Withdrawal by Subject|0|||
161209893|NCT01345058|582151082|FG000|Overall Study|Participant Reported Increase in Events|1|||
161209894|NCT01345058|582151083|FG001|Overall Study|Participant Reported Increase in Events|0|||
161209895|NCT01345058|582151082|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
161209896|NCT01345058|582151083|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
161209897|NCT01345058|582151082|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
161209898|NCT01345058|582151083|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
161209899|NCT01345058|582151082|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
161209900|NCT01345058|582151083|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
161209901|NCT00000135|582151084|FG000|Overall Study|Death|27|||
161209902|NCT00000135|582151085|FG001|Overall Study|Death|14|||
161209903|NCT02989610|582151088|FG000|Overall Study|Withdrawal by Subject|20|||
161209904|NCT02989610|582151088|FG000|Overall Study|Departure of PI from Site|8|||
161209905|NCT02989610|582151088|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
161209906|NCT02989610|582151088|FG000|Overall Study|Lost to Follow-up|3|||
161209907|NCT02989610|582151088|FG000|Overall Study|Death|3|||
161209908|NCT02989610|582151088|FG000|Overall Study|System Explant|3|||
161209909|NCT02989610|582151088|FG000|Overall Study|Subject Non-Compliance|2|||
161209910|NCT02989610|582151088|FG000|Overall Study|System Revision|2|||
161209911|NCT02989610|582151088|FG000|Overall Study|PI Left, Study Closing|1|||
161209912|NCT02989610|582151088|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
161209913|NCT02989610|582151088|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
161209914|NCT02602080|582151091|FG000|Overall Study|Protocol Violation|6|||
161209915|NCT02602080|582151092|FG001|Overall Study|Protocol Violation|1|||
161209916|NCT02602080|582151093|FG002|Overall Study|Protocol Violation|3|||
161209917|NCT01066039|582151101|FG000|Overall Study|Adverse Event|6|||
161209918|NCT01066039|582151101|FG000|Overall Study|Withdrawal by Subject|17|||
161209919|NCT01066039|582151101|FG000|Overall Study|Protocol Violation|2|||
161209920|NCT01066039|582151101|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
161209921|NCT01066039|582151101|FG000|Overall Study|Investigator's Request|1|||
161209922|NCT01066039|582151101|FG000|Overall Study|Dropout due to Insulin Administration|1|||
161209923|NCT01066039|582151101|FG000|Overall Study|Additional Antihypertensive Required|4|||
161209924|NCT01066039|582151101|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
161209925|NCT01066039|582151101|FG000|Overall Study|Failure to Control Blood Pressure|1|||
161209926|NCT01066039|582151101|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
161209927|NCT04508621|582151102|FG000|Overall Study|Adverse Event|39|||
161209928|NCT04508621|582151103|FG001|Overall Study|Adverse Event|16|||
161209929|NCT04508621|582151102|FG000|Overall Study|Lack of Efficacy|2|||
161209930|NCT04508621|582151103|FG001|Overall Study|Lack of Efficacy|8|||
161209931|NCT04508621|582151102|FG000|Overall Study|Physician Decision|0|||
161209932|NCT04508621|582151103|FG001|Overall Study|Physician Decision|1|||
161209933|NCT04508621|582151102|FG000|Overall Study|Withdrawal by Subject|10|||
161209934|NCT04508621|582151103|FG001|Overall Study|Withdrawal by Subject|14|||
161209935|NCT04508621|582151102|FG000|Overall Study|Lost to Follow-up|12|||
161094853|NCT05269355|581737231|FG001|Overall Study|Randomized But Not Treated|0|||
161094854|NCT03705832|581737232|FG000|Overall Study|Physician Decision|0|||
161094855|NCT03705832|581737233|FG001|Overall Study|Physician Decision|1|||
161094856|NCT03705832|581737232|FG000|Overall Study|Withdrawal by Subject|1|||
161094857|NCT03705832|581737233|FG001|Overall Study|Withdrawal by Subject|0|||
161094858|NCT01050790|581737234|FG000|Overall Study|Adverse Event|1|||
161094859|NCT01880528|581737235|FG000|Overall Study|Other|1|||
161094860|NCT01880528|581737236|FG001|Overall Study|Other|1|||
161094861|NCT00081497|581737237|FG000|Overall Study|Adverse Event|2|||
161094862|NCT00081497|581737238|FG001|Overall Study|Adverse Event|0|||
161094863|NCT00081497|581737237|FG000|Overall Study|Death|0|||
161094864|NCT00081497|581737238|FG001|Overall Study|Death|1|||
161094865|NCT00081497|581737237|FG000|Overall Study|Withdrawal by Subject|1|||
161094866|NCT00081497|581737238|FG001|Overall Study|Withdrawal by Subject|0|||
161094867|NCT00081497|581737237|FG000|Overall Study|Non-compliance|0|||
161094868|NCT00081497|581737238|FG001|Overall Study|Non-compliance|1|||
161094869|NCT01439360|581737239|FG000|Overall Study|Adverse Event|4|||
161094870|NCT01439360|581737240|FG001|Overall Study|Adverse Event|16|||
161094871|NCT01439360|581737239|FG000|Overall Study|Lost to Follow-up|43|||
161094872|NCT01439360|581737240|FG001|Overall Study|Lost to Follow-up|58|||
161094873|NCT01439360|581737239|FG000|Overall Study|Others|10|||
161094874|NCT01439360|581737240|FG001|Overall Study|Others|5|||
161094875|NCT01439360|581737239|FG000|Overall Study|Protocol Violation|1|||
161094876|NCT01439360|581737240|FG001|Overall Study|Protocol Violation|0|||
161094877|NCT01439360|581737239|FG000|Overall Study|Withdrawal by Subject|140|||
161094878|NCT01439360|581737240|FG001|Overall Study|Withdrawal by Subject|129|||
161094879|NCT02390245|581737242|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
161094880|NCT02390245|581737243|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
161094881|NCT02390245|581737244|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
161094882|NCT02390245|581737242|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
161094883|NCT02390245|581737243|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
161094884|NCT02390245|581737244|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
161094900|NCT00985166|581739567|FG000|Overall Study|Lost to Follow-up|3|||
161094901|NCT00985166|581739568|FG001|Overall Study|Lost to Follow-up|2|||
161094902|NCT00985166|581739569|FG002|Overall Study|Lost to Follow-up|2|||
161094903|NCT00985166|581739567|FG000|Overall Study|Withdrawal by Subject|3|||
161094904|NCT00985166|581739568|FG001|Overall Study|Withdrawal by Subject|2|||
161094905|NCT00985166|581739569|FG002|Overall Study|Withdrawal by Subject|0|||
161094906|NCT00985166|581739567|FG000|Overall Study|Test not done|2|||
161094907|NCT00985166|581739568|FG001|Overall Study|Test not done|0|||
161094908|NCT00985166|581739569|FG002|Overall Study|Test not done|4|||
161094909|NCT00985166|581739567|FG000|Overall Study|Other|1|||
161094910|NCT00985166|581739568|FG001|Overall Study|Other|0|||
161094911|NCT00985166|581739569|FG002|Overall Study|Other|1|||
161094912|NCT01028222|581739570|FG000|Overall Study|Protocol deviation|1|||
161094913|NCT01028222|581739571|FG001|Overall Study|Protocol deviation|0|||
161094914|NCT01028222|581739570|FG000|Overall Study|Disease progression|33|||
161094915|NCT01028222|581739571|FG001|Overall Study|Disease progression|9|||
161094916|NCT01028222|581739570|FG000|Overall Study|Administrative problems|1|||
161094917|NCT01028222|581739571|FG001|Overall Study|Administrative problems|1|||
161094918|NCT01028222|581739570|FG000|Overall Study|Lost to Follow-up|0|||
161094919|NCT01028222|581739571|FG001|Overall Study|Lost to Follow-up|1|||
161094920|NCT01028222|581739570|FG000|Overall Study|Withdrawal by Subject|1|||
161094921|NCT01028222|581739571|FG001|Overall Study|Withdrawal by Subject|0|||
161094922|NCT01028222|581739570|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
161094923|NCT01028222|581739571|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
161094924|NCT01028222|581739570|FG000|Overall Study|Adverse Event|2|||
161094925|NCT01028222|581739571|FG001|Overall Study|Adverse Event|0|||
161094926|NCT00146328|581739572|FG000|Overall Study|Adverse Event|39|||
161094927|NCT00146328|581739573|FG001|Overall Study|Adverse Event|48|||
161094928|NCT00146328|581739574|FG002|Overall Study|Adverse Event|79|||
161094929|NCT00146328|581739572|FG000|Overall Study|Protocol Violation|11|||
161094930|NCT00146328|581739573|FG001|Overall Study|Protocol Violation|6|||
161094931|NCT00146328|581739574|FG002|Overall Study|Protocol Violation|12|||
161094932|NCT00146328|581739572|FG000|Overall Study|Lost to Follow-up|7|||
161094933|NCT00146328|581739573|FG001|Overall Study|Lost to Follow-up|4|||
161094934|NCT00146328|581739574|FG002|Overall Study|Lost to Follow-up|7|||
161094935|NCT00146328|581739572|FG000|Overall Study|Withdrawal by Subject|16|||
161094936|NCT00146328|581739573|FG001|Overall Study|Withdrawal by Subject|16|||
161094937|NCT00146328|581739574|FG002|Overall Study|Withdrawal by Subject|22|||
161094938|NCT00146328|581739572|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
161094939|NCT00146328|581739573|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
161094940|NCT00146328|581739574|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
161094941|NCT00146328|581739572|FG000|Overall Study|Trial ended/site closed|8|||
161094942|NCT00146328|581739573|FG001|Overall Study|Trial ended/site closed|2|||
161094943|NCT00146328|581739574|FG002|Overall Study|Trial ended/site closed|19|||
161094944|NCT00146328|581739572|FG000|Overall Study|Patient decision to end|0|||
161094945|NCT00146328|581739573|FG001|Overall Study|Patient decision to end|1|||
161094946|NCT00146328|581739574|FG002|Overall Study|Patient decision to end|6|||
161094947|NCT00146328|581739572|FG000|Overall Study|Enroll into other trial|2|||
161094948|NCT00146328|581739573|FG001|Overall Study|Enroll into other trial|4|||
161094949|NCT00146328|581739574|FG002|Overall Study|Enroll into other trial|2|||
161094950|NCT00146328|581739572|FG000|Overall Study|Death|0|||
161094951|NCT00146328|581739573|FG001|Overall Study|Death|1|||
161094952|NCT00146328|581739574|FG002|Overall Study|Death|1|||
161094953|NCT00146328|581739572|FG000|Overall Study|Moved|2|||
161094954|NCT00146328|581739573|FG001|Overall Study|Moved|0|||
161094955|NCT00146328|581739574|FG002|Overall Study|Moved|0|||
161094956|NCT00146328|581739572|FG000|Overall Study|Interaction with other medication|2|||
161094957|NCT00146328|581739573|FG001|Overall Study|Interaction with other medication|0|||
161094958|NCT00146328|581739574|FG002|Overall Study|Interaction with other medication|1|||
161094959|NCT00300781|581739575|FG000|Overall Study|Disease Progression|55|||
161094960|NCT00300781|581739576|FG001|Overall Study|Disease Progression|52|||
161094961|NCT00300781|581739575|FG000|Overall Study|Adverse Event|5|||
161094962|NCT00300781|581739576|FG001|Overall Study|Adverse Event|6|||
161094963|NCT00300781|581739575|FG000|Overall Study|Withdrawal by Subject|1|||
161094964|NCT00300781|581739576|FG001|Overall Study|Withdrawal by Subject|2|||
161094965|NCT00300781|581739575|FG000|Overall Study|Physician Decision|1|||
161094966|NCT00300781|581739576|FG001|Overall Study|Physician Decision|0|||
161094967|NCT00300781|581739575|FG000|Overall Study|Not Recorded|0|||
161094968|NCT00300781|581739576|FG001|Overall Study|Not Recorded|1|||
161094969|NCT00300781|581739575|FG000|Overall Study|Symptomatic Deterioration|1|||
161094970|NCT00300781|581739576|FG001|Overall Study|Symptomatic Deterioration|0|||
161094971|NCT00300781|581739575|FG000|Overall Study|Lost to Follow-up|0|||
161094972|NCT00300781|581739576|FG001|Overall Study|Lost to Follow-up|1|||
161094973|NCT00567268|581739577|FG000|Overall Study|Protocol Violation|7|||
161094974|NCT00567268|581739577|FG000|Overall Study|Lost to Follow-up|36|||
161094975|NCT00567268|581739577|FG000|Overall Study|No Visit After First Day of Treatment|2|||
161094976|NCT00567268|581739577|FG000|Overall Study|No Drug Administration|4|||
161094977|NCT00567268|581739577|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
161094978|NCT02525861|581739580|FG000|Overall Study|Adverse Event|1|||
161094979|NCT02525861|581739581|FG001|Overall Study|Adverse Event|0|||
161094980|NCT02525861|581739580|FG000|Overall Study|Withdrawal by Subject|0|||
161094981|NCT02525861|581739581|FG001|Overall Study|Withdrawal by Subject|1|||
161094982|NCT02525861|581739580|FG000|Overall Study|Physician Decision|0|||
161094983|NCT02525861|581739581|FG001|Overall Study|Physician Decision|1|||
161094984|NCT01117454|581739584|FG000|Overall Study|Pregnancy|0|||
161094985|NCT01117454|581739585|FG001|Overall Study|Pregnancy|1|||
161094986|NCT00888433|581739586|FG000|Overall Study|Withdrawal by Subject|1|||
161094987|NCT00888433|581739587|FG001|Overall Study|Withdrawal by Subject|2|||
161094988|NCT00888433|581739586|FG000|Overall Study|Missed Visit|2|||
161094989|NCT00888433|581739587|FG001|Overall Study|Missed Visit|1|||
161094990|NCT02544217|581739590|FG000|Overall Study|Withdrawal by Subject|1|||
161209936|NCT04508621|582151103|FG001|Overall Study|Lost to Follow-up|9|||
161209937|NCT04508621|582151102|FG000|Overall Study|COVID-19 related crisis|3|||
161209938|NCT04508621|582151103|FG001|Overall Study|COVID-19 related crisis|0|||
161094991|NCT02544217|581739591|FG001|Overall Study|Withdrawal by Subject|1|||
161094992|NCT02544217|581739592|FG002|Overall Study|Withdrawal by Subject|0|||
161094993|NCT02544217|581739593|FG003|Overall Study|Withdrawal by Subject|0|||
161094994|NCT02544217|581739594|FG004|Overall Study|Withdrawal by Subject|0|||
161094995|NCT02544217|581739595|FG005|Overall Study|Withdrawal by Subject|0|||
161094996|NCT02027701|581739597|FG000|Overall Study|Adverse Event|3|||
161094997|NCT02027701|581739597|FG000|Overall Study|Lack of Efficacy|8|||
161094998|NCT02027701|581739597|FG000|Overall Study|Physician Decision|2|||
161094999|NCT02027701|581739597|FG000|Overall Study|Withdrawal by Subject|3|||
161095000|NCT00820027|581739598|FG000|Overall Study|Adverse Event|15|||
161095001|NCT00820027|581739599|FG001|Overall Study|Adverse Event|8|||
161095002|NCT00820027|581739600|FG002|Overall Study|Adverse Event|10|||
161209939|NCT04508621|582151102|FG000|Overall Study|Subject non-compliance|1|||
161209940|NCT04508621|582151103|FG001|Overall Study|Subject non-compliance|0|||
161095003|NCT00820027|581739601|FG003|Overall Study|Adverse Event|5|||
161095004|NCT00820027|581739598|FG000|Overall Study|Lack of Efficacy|2|||
161322884|NCT01768559|582568628|FG002|Overall Study|Poor compliance to protocol|2|||
161095005|NCT00820027|581739599|FG001|Overall Study|Lack of Efficacy|1|||
161095006|NCT00820027|581739600|FG002|Overall Study|Lack of Efficacy|2|||
161095007|NCT00820027|581739601|FG003|Overall Study|Lack of Efficacy|2|||
161095008|NCT00820027|581739598|FG000|Overall Study|Physician Decision|0|||
161095009|NCT00820027|581739599|FG001|Overall Study|Physician Decision|1|||
161095010|NCT00820027|581739600|FG002|Overall Study|Physician Decision|1|||
161095011|NCT00820027|581739601|FG003|Overall Study|Physician Decision|0|||
161095012|NCT00820027|581739598|FG000|Overall Study|Protocol Violation|3|||
161095013|NCT00820027|581739599|FG001|Overall Study|Protocol Violation|0|||
161095014|NCT00820027|581739600|FG002|Overall Study|Protocol Violation|4|||
161095015|NCT00820027|581739601|FG003|Overall Study|Protocol Violation|0|||
161095016|NCT00820027|581739598|FG000|Overall Study|Withdrawal by Subject|6|||
161095017|NCT00820027|581739599|FG001|Overall Study|Withdrawal by Subject|4|||
161095018|NCT00820027|581739600|FG002|Overall Study|Withdrawal by Subject|4|||
161095019|NCT00820027|581739601|FG003|Overall Study|Withdrawal by Subject|6|||
161095020|NCT02604433|581739602|FG000|Overall Study|Withdrawal by Subject|37|||
161095021|NCT02604433|581739603|FG001|Overall Study|Withdrawal by Subject|16|||
161095022|NCT02604433|581739602|FG000|Overall Study|Adverse Event|4|||
161095023|NCT02604433|581739603|FG001|Overall Study|Adverse Event|0|||
161095024|NCT02604433|581739602|FG000|Overall Study|Other reasons|3|||
161095025|NCT02604433|581739603|FG001|Overall Study|Other reasons|5|||
161095026|NCT02604433|581739602|FG000|Overall Study|Death|4|||
161095027|NCT02604433|581739603|FG001|Overall Study|Death|1|||
161095028|NCT02604433|581739602|FG000|Overall Study|Transition to Rollover Protocol|169|||
161095029|NCT02604433|581739603|FG001|Overall Study|Transition to Rollover Protocol|82|||
161095030|NCT02604433|581739602|FG000|Overall Study|Physician Decision|1|||
161095031|NCT02604433|581739603|FG001|Overall Study|Physician Decision|1|||
161095032|NCT02604433|581739602|FG000|Overall Study|Lack of Efficacy|0|||
161095033|NCT02604433|581739603|FG001|Overall Study|Lack of Efficacy|1|||
161095034|NCT00887679|581739604|FG000|Overall Study|Withdrawal by Subject|1|||
161095035|NCT00887679|581739604|FG000|Overall Study|Lost to Follow-up|4|||
161095036|NCT00887679|581739604|FG000|Overall Study|Physician Decision|5|||
161095037|NCT02683941|581739605|FG000|Double-blind Phase|Adverse Event|0|||
161095038|NCT02683941|581739606|FG001|Double-blind Phase|Adverse Event|1|||
161095039|NCT02683941|581739605|FG000|Double-blind Phase|Withdrawal by Subject|4|||
161095040|NCT02683941|581739606|FG001|Double-blind Phase|Withdrawal by Subject|2|||
161095041|NCT02683941|581739605|FG000|Double-blind Phase|Lost to Follow-up|1|||
161095042|NCT02683941|581739606|FG001|Double-blind Phase|Lost to Follow-up|0|||
161095043|NCT02683941|581739605|FG000|Double-blind Phase|Disease Progression|5|||
161095044|NCT02683941|581739606|FG001|Double-blind Phase|Disease Progression|2|||
161095045|NCT02683941|581739605|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
161095046|NCT02683941|581739606|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
161095047|NCT02683941|581739605|FG000|Open-label Treatment Phase|Disease Progression|1|||
161095048|NCT02683941|581739606|FG001|Open-label Treatment Phase|Disease Progression|2|||
161095049|NCT02683941|581739605|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
161095050|NCT02683941|581739606|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
161095051|NCT02683941|581739605|FG000|Open-label Treatment Phase|Other|1|||
161095052|NCT02683941|581739606|FG001|Open-label Treatment Phase|Other|0|||
161095053|NCT02683941|581739605|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
161095054|NCT02683941|581739606|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
161095055|NCT02683941|581739605|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
161095056|NCT02683941|581739606|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
161095057|NCT02683941|581739605|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
161095058|NCT02683941|581739606|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
161095059|NCT02683941|581739605|FG000|Open-label Follow-up Phase|Other|8|||
161095060|NCT02683941|581739606|FG001|Open-label Follow-up Phase|Other|1|||
161095061|NCT00325039|581739607|FG000|Overall Study|Lost to Follow-up|18|||
161095062|NCT00325039|581739608|FG001|Overall Study|Lost to Follow-up|14|||
161095063|NCT01009203|581739610|FG000|Overall Study|Withdrawal by Subject|1|||
161095064|NCT01009203|581739610|FG000|Overall Study|Adverse Event|5|||
161095065|NCT01009203|581739610|FG000|Overall Study|Treatment-unrelated death|1|||
161095066|NCT00892723|581739614|FG000|Overall Study|Lost to Follow-up|1|||
161095067|NCT00892723|581739615|FG001|Overall Study|Lost to Follow-up|3|||
161095068|NCT00892723|581739616|FG002|Overall Study|Lost to Follow-up|1|||
161095069|NCT00892723|581739614|FG000|Overall Study|Withdrawal by Subject|1|||
161095070|NCT00892723|581739615|FG001|Overall Study|Withdrawal by Subject|1|||
161095071|NCT00892723|581739616|FG002|Overall Study|Withdrawal by Subject|1|||
161095072|NCT02974088|581739617|FG000|Overall Study|Lost to Follow-up|0|||
161095073|NCT02974088|581739618|FG001|Overall Study|Lost to Follow-up|2|||
161095074|NCT02974088|581739617|FG000|Overall Study|Adverse Event|0|||
161095075|NCT02974088|581739618|FG001|Overall Study|Adverse Event|1|||
161095076|NCT00150969|581739621|FG000|24 Month Main Study|Adverse Event|3|||
161095077|NCT00150969|581739622|FG001|24 Month Main Study|Adverse Event|4|||
161095078|NCT00150969|581739621|FG000|24 Month Main Study|Death|1|||
161095079|NCT00150969|581739622|FG001|24 Month Main Study|Death|1|||
161095080|NCT00150969|581739621|FG000|24 Month Main Study|Lack of Efficacy|1|||
161095081|NCT00150969|581739622|FG001|24 Month Main Study|Lack of Efficacy|8|||
161095082|NCT00150969|581739621|FG000|24 Month Main Study|Lost to Follow-up|3|||
161095083|NCT00150969|581739622|FG001|24 Month Main Study|Lost to Follow-up|2|||
161095084|NCT00150969|581739621|FG000|24 Month Main Study|Protocol Violation|4|||
161095085|NCT00150969|581739622|FG001|24 Month Main Study|Protocol Violation|2|||
161095086|NCT00150969|581739621|FG000|24 Month Main Study|Withdrawal by Subject|7|||
161095087|NCT00150969|581739622|FG001|24 Month Main Study|Withdrawal by Subject|4|||
161095088|NCT00150969|581739621|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
161095089|NCT00150969|581739622|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
161095090|NCT00150969|581739621|FG000|24-48 Month Extension|Lack of Efficacy|0|||
161095091|NCT00150969|581739622|FG001|24-48 Month Extension|Lack of Efficacy|1|||
161095092|NCT00150969|581739621|FG000|24-48 Month Extension|Adverse Event|1|||
161095093|NCT00150969|581739622|FG001|24-48 Month Extension|Adverse Event|3|||
161095094|NCT00150969|581739621|FG000|24-48 Month Extension|Other Reason|81|||
161095095|NCT00150969|581739622|FG001|24-48 Month Extension|Other Reason|91|||
161095096|NCT00146757|581739623|FG000|Overall Study|Death|1|||
161095097|NCT00146757|581739624|FG001|Overall Study|Death|0|||
161095098|NCT00146757|581739623|FG000|Overall Study|Adverse Event|1|||
161095099|NCT00146757|581739624|FG001|Overall Study|Adverse Event|0|||
161095100|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
161095101|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
161095102|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
161095103|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
161095104|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
161095105|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
161095106|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
161095107|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
161095108|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
161095109|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
161095110|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
161095111|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
161095112|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
161095113|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
161095114|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
161095115|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
161095116|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
161095117|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
161095118|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
161095119|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
161095120|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
161095121|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
161095122|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
161095123|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
161095124|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
161095125|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
161095126|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
161095127|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
161095128|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
161095129|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
161095130|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Other|10|||
161095131|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Other|7|||
161095132|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Other|8|||
161095133|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Other|8|||
161095134|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Other|0|||
161095135|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
161095136|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
161095137|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
161095138|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
161095139|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
161095140|NCT00615836|581739625|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
161095141|NCT00615836|581739626|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161095142|NCT00615836|581739627|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161095143|NCT00615836|581739628|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161095144|NCT00615836|581739629|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
161095145|NCT01630434|581739630|FG000|Overall Study|Donor lungs turned down|1|||
161095146|NCT01630434|581739631|FG001|Overall Study|Donor lungs turned down|0|||
161322885|NCT01768559|582568626|FG000|Overall Study|Other than specified|9|||
161322886|NCT01768559|582568627|FG001|Overall Study|Other than specified|8|||
161095147|NCT01630434|581739630|FG000|Overall Study|Protocol Violation|9|||
161095148|NCT01630434|581739631|FG001|Overall Study|Protocol Violation|4|||
161095149|NCT01630434|581739630|FG000|Overall Study|Death|20|||
161095150|NCT01630434|581739631|FG001|Overall Study|Death|26|||
161095151|NCT00687973|581739632|FG000|Overall Study|Adverse Event|18|||
161095152|NCT00687973|581739633|FG001|Overall Study|Adverse Event|28|||
161095153|NCT00687973|581739632|FG000|Overall Study|Lack of Efficacy|2|||
161095154|NCT00687973|581739633|FG001|Overall Study|Lack of Efficacy|3|||
161095155|NCT00687973|581739632|FG000|Overall Study|Protocol Violation|1|||
161095156|NCT00687973|581739633|FG001|Overall Study|Protocol Violation|2|||
161095157|NCT00687973|581739632|FG000|Overall Study|Administrative Reasons|0|||
161095158|NCT00687973|581739633|FG001|Overall Study|Administrative Reasons|2|||
161095159|NCT00687973|581739632|FG000|Overall Study|Withdrawal by Subject|3|||
161095160|NCT00687973|581739633|FG001|Overall Study|Withdrawal by Subject|3|||
161095161|NCT02075541|581739635|FG000|Overall Study|Serious Adverse Event|1|||
161095162|NCT02075541|581739636|FG001|Overall Study|Serious Adverse Event|4|||
161095163|NCT02075541|581739635|FG000|Overall Study|Protocol Violation|1|||
161095164|NCT02075541|581739636|FG001|Overall Study|Protocol Violation|0|||
161095165|NCT02075541|581739635|FG000|Overall Study|Withdrawal by Subject|1|||
161095166|NCT02075541|581739636|FG001|Overall Study|Withdrawal by Subject|3|||
161095167|NCT02075541|581739635|FG000|Overall Study|Sponsor study termination|0|||
161095168|NCT02075541|581739636|FG001|Overall Study|Sponsor study termination|1|||
161095169|NCT02075541|581739635|FG000|Overall Study|Other- unable to perform study procedure|1|||
161095170|NCT02075541|581739636|FG001|Overall Study|Other- unable to perform study procedure|0|||
161095171|NCT02349360|581739637|FG000|Overall Study|Withdrawal by Subject|0|||
161095172|NCT02349360|581739638|FG001|Overall Study|Withdrawal by Subject|1|||
161095173|NCT00394953|581739639|FG000|First Treatment Period|Adverse Event|1|||
161095174|NCT00394953|581739640|FG001|First Treatment Period|Adverse Event|2|||
161095175|NCT00394953|581739639|FG000|First Treatment Period|Death|6|||
161095176|NCT00394953|581739640|FG001|First Treatment Period|Death|7|||
161095177|NCT00394953|581739639|FG000|First Treatment Period|Lack of Efficacy|1|||
161095178|NCT00394953|581739640|FG001|First Treatment Period|Lack of Efficacy|1|||
161095179|NCT00394953|581739639|FG000|First Treatment Period|Withdrawal by Subject|6|||
161095180|NCT00394953|581739640|FG001|First Treatment Period|Withdrawal by Subject|3|||
161095181|NCT00394953|581739639|FG000|First Treatment Period|Lost to Follow-up|0|||
161095182|NCT00394953|581739640|FG001|First Treatment Period|Lost to Follow-up|1|||
161095183|NCT00394953|581739639|FG000|First Treatment Period|Renal transplant|11|||
161095184|NCT00394953|581739640|FG001|First Treatment Period|Renal transplant|7|||
161095185|NCT00394953|581739639|FG000|First Treatment Period|Not defined|4|||
161095186|NCT00394953|581739640|FG001|First Treatment Period|Not defined|1|||
161095187|NCT00394953|581739639|FG000|Second Treatment Period|Adverse Event|2|||
161095188|NCT00394953|581739640|FG001|Second Treatment Period|Adverse Event|5|||
161095189|NCT00394953|581739639|FG000|Second Treatment Period|Death|8|||
161095190|NCT00394953|581739640|FG001|Second Treatment Period|Death|4|||
161095191|NCT00394953|581739639|FG000|Second Treatment Period|Lack of Efficacy|9|||
161095192|NCT00394953|581739640|FG001|Second Treatment Period|Lack of Efficacy|47|||
161095193|NCT00394953|581739639|FG000|Second Treatment Period|Withdrawal by Subject|3|||
161095194|NCT00394953|581739640|FG001|Second Treatment Period|Withdrawal by Subject|3|||
161095195|NCT00394953|581739639|FG000|Second Treatment Period|Lost to Follow-up|0|||
161095196|NCT00394953|581739640|FG001|Second Treatment Period|Lost to Follow-up|1|||
161095197|NCT00394953|581739639|FG000|Second Treatment Period|Renal transplant|4|||
161095198|NCT00394953|581739640|FG001|Second Treatment Period|Renal transplant|6|||
161095199|NCT00394953|581739639|FG000|Second Treatment Period|Not defined|3|||
161095200|NCT00394953|581739640|FG001|Second Treatment Period|Not defined|8|||
161095201|NCT03021954|581739647|FG000|Overall Study|Lost to Follow-up|10|||
161095202|NCT03021954|581739648|FG001|Overall Study|Lost to Follow-up|43|||
161095203|NCT03021954|581739647|FG000|Overall Study|Subjects had avulsion trauma|4|||
161095204|NCT03021954|581739648|FG001|Overall Study|Subjects had avulsion trauma|1|||
161095205|NCT02196714|581739651|FG000|Overall Study|Protocol Violation|0|||
161095206|NCT02196714|581739652|FG001|Overall Study|Protocol Violation|0|||
161095207|NCT02196714|581739653|FG002|Overall Study|Protocol Violation|1|||
161095208|NCT02196714|581739654|FG003|Overall Study|Protocol Violation|0|||
161095209|NCT03353350|581739658|FG000|30-week Core Treatment Period|Protocol Violation|1|||
161095210|NCT03353350|581739659|FG001|30-week Core Treatment Period|Protocol Violation|1|||
161095211|NCT03353350|581739660|FG002|30-week Core Treatment Period|Protocol Violation|1|||
161095212|NCT03353350|581739661|FG003|30-week Core Treatment Period|Protocol Violation|0|||
161209941|NCT02574260|582151104|FG000|Overall Study|Disease Progression|1|||
161095213|NCT03353350|581739658|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
161095214|NCT03353350|581739659|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
161095215|NCT03353350|581739660|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
161095216|NCT03353350|581739661|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
161095217|NCT03353350|581739658|FG000|30-week Core Treatment Period|Adverse Event|0|||
161095218|NCT03353350|581739659|FG001|30-week Core Treatment Period|Adverse Event|4|||
161095219|NCT03353350|581739660|FG002|30-week Core Treatment Period|Adverse Event|2|||
161095220|NCT03353350|581739661|FG003|30-week Core Treatment Period|Adverse Event|3|||
161095221|NCT03353350|581739658|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
161095222|NCT03353350|581739659|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
161095223|NCT03353350|581739660|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
161095224|NCT03353350|581739661|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
161095225|NCT03353350|581739658|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
161095226|NCT03353350|581739659|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
161095227|NCT03353350|581739660|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
161095228|NCT03353350|581739661|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
161095229|NCT03353350|581739658|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
161095230|NCT03353350|581739659|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
161095231|NCT03353350|581739660|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
161095232|NCT03353350|581739661|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
161095233|NCT03353350|581739658|FG000|26-week Treatment Extension Period|Adverse Event|1|||
161095234|NCT03353350|581739659|FG001|26-week Treatment Extension Period|Adverse Event|0|||
161095235|NCT03353350|581739660|FG002|26-week Treatment Extension Period|Adverse Event|0|||
161095236|NCT03353350|581739661|FG003|26-week Treatment Extension Period|Adverse Event|1|||
161095237|NCT03353350|581739658|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
161095238|NCT03353350|581739659|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
161095239|NCT03353350|581739660|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
161095240|NCT03353350|581739661|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
161095241|NCT00807235|581739666|FG000|Overall Study|Adverse Event|1|||
161095242|NCT00807235|581739667|FG001|Overall Study|Adverse Event|0|||
161095243|NCT00985153|581739670|FG000|Overall Study|Lost to Follow-up|16|||
161095244|NCT00985153|581739671|FG001|Overall Study|Lost to Follow-up|19|||
161095245|NCT00985153|581739672|FG002|Overall Study|Lost to Follow-up|17|||
161095246|NCT00985153|581739673|FG003|Overall Study|Lost to Follow-up|20|||
161095247|NCT00985153|581739670|FG000|Overall Study|Protocol Violation|3|||
161095248|NCT00985153|581739671|FG001|Overall Study|Protocol Violation|2|||
161095249|NCT00985153|581739672|FG002|Overall Study|Protocol Violation|4|||
161095250|NCT00985153|581739673|FG003|Overall Study|Protocol Violation|3|||
161095251|NCT00985153|581739670|FG000|Overall Study|Withdrawal by Subject|6|||
161095252|NCT00985153|581739671|FG001|Overall Study|Withdrawal by Subject|11|||
161095253|NCT00985153|581739672|FG002|Overall Study|Withdrawal by Subject|11|||
161095254|NCT00985153|581739673|FG003|Overall Study|Withdrawal by Subject|10|||
161095255|NCT00985153|581739670|FG000|Overall Study|Missed One or More Bleeds|7|||
161095256|NCT00985153|581739671|FG001|Overall Study|Missed One or More Bleeds|7|||
161095257|NCT00985153|581739672|FG002|Overall Study|Missed One or More Bleeds|8|||
161095258|NCT00985153|581739673|FG003|Overall Study|Missed One or More Bleeds|10|||
161095259|NCT00985153|581739670|FG000|Overall Study|Incomplete Safety Follow-up|3|||
161095260|NCT00985153|581739671|FG001|Overall Study|Incomplete Safety Follow-up|5|||
161095261|NCT00985153|581739672|FG002|Overall Study|Incomplete Safety Follow-up|4|||
161095262|NCT00985153|581739673|FG003|Overall Study|Incomplete Safety Follow-up|4|||
161095263|NCT01679405|581739674|FG000|Overall Study|Death|2|||
161095264|NCT01679405|581739675|FG001|Overall Study|Death|5|||
161095265|NCT04677179|581739676|FG000|Induction Treatment Period|Adverse Event|1|||
161095266|NCT04677179|581739677|FG001|Induction Treatment Period|Adverse Event|0|||
161095267|NCT04677179|581739678|FG002|Induction Treatment Period|Adverse Event|0|||
161095268|NCT04677179|581739679|FG003|Induction Treatment Period|Adverse Event|0|||
161209942|NCT00752895|582151105|FG000|Overall Study|Withdrawal by Subject|8|||
161209943|NCT00752895|582151106|FG001|Overall Study|Withdrawal by Subject|3|||
161209944|NCT03022799|582151107|FG000|Overall Study|Adverse Event|0|||
161209945|NCT03022799|582151108|FG001|Overall Study|Adverse Event|0|||
161209946|NCT03022799|582151109|FG002|Overall Study|Adverse Event|0|||
161209947|NCT03022799|582151110|FG003|Overall Study|Adverse Event|0|||
161209948|NCT03022799|582151111|FG004|Overall Study|Adverse Event|0|||
161209949|NCT03022799|582151112|FG005|Overall Study|Adverse Event|0|||
161209950|NCT03022799|582151113|FG006|Overall Study|Adverse Event|0|||
161209951|NCT03022799|582151114|FG007|Overall Study|Adverse Event|0|||
161209952|NCT03022799|582151115|FG008|Overall Study|Adverse Event|0|||
161209953|NCT03022799|582151116|FG009|Overall Study|Adverse Event|1|||
161209954|NCT03022799|582151117|FG010|Overall Study|Adverse Event|1|||
161209955|NCT03022799|582151118|FG011|Overall Study|Adverse Event|0|||
161209956|NCT03022799|582151119|FG012|Overall Study|Adverse Event|0|||
161209957|NCT04881448|582151122|FG000|Overall Study|Study cancelled by sponsor|220|||
161209958|NCT04881448|582151122|FG000|Overall Study|Withdrawal by Subject|2|||
161095269|NCT04677179|581739680|FG004|Induction Treatment Period|Adverse Event|0|||
161095270|NCT04677179|581739681|FG005|Induction Treatment Period|Adverse Event|0|||
161095271|NCT04677179|581739682|FG006|Induction Treatment Period|Adverse Event|0|||
161095272|NCT04677179|581739683|FG007|Induction Treatment Period|Adverse Event|0|||
161095273|NCT04677179|581739684|FG008|Induction Treatment Period|Adverse Event|0|||
161095274|NCT04677179|581739685|FG009|Induction Treatment Period|Adverse Event|0|||
161095275|NCT04677179|581739676|FG000|Induction Treatment Period|Physician Decision|1|||
161209959|NCT04881448|582151122|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
161209960|NCT00883129|582151124|FG000|Overall Study|Adverse Event|7|||
161095276|NCT04677179|581739677|FG001|Induction Treatment Period|Physician Decision|0|||
161095277|NCT04677179|581739678|FG002|Induction Treatment Period|Physician Decision|1|||
161095278|NCT04677179|581739679|FG003|Induction Treatment Period|Physician Decision|0|||
161095279|NCT04677179|581739680|FG004|Induction Treatment Period|Physician Decision|0|||
161095280|NCT04677179|581739681|FG005|Induction Treatment Period|Physician Decision|0|||
161209961|NCT00883129|582151125|FG001|Overall Study|Adverse Event|15|||
161209962|NCT00883129|582151124|FG000|Overall Study|Withdrawal by Subject|8|||
161209963|NCT00883129|582151125|FG001|Overall Study|Withdrawal by Subject|9|||
161209964|NCT00883129|582151124|FG000|Overall Study|Non-compliance|3|||
161209965|NCT00883129|582151125|FG001|Overall Study|Non-compliance|6|||
161209966|NCT00883129|582151124|FG000|Overall Study|Lost to Follow-up|1|||
161209967|NCT00883129|582151125|FG001|Overall Study|Lost to Follow-up|2|||
161209968|NCT00883129|582151124|FG000|Overall Study|Death|1|||
161209969|NCT00883129|582151125|FG001|Overall Study|Death|2|||
161209970|NCT00883129|582151124|FG000|Overall Study|Defined Treatment Failure|0|||
161209971|NCT00883129|582151125|FG001|Overall Study|Defined Treatment Failure|2|||
161209972|NCT03273257|582151126|FG000|Overall Study|Death|0|||
161209973|NCT03273257|582151127|FG001|Overall Study|Death|1|||
161209974|NCT03273257|582151126|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
161209975|NCT03273257|582151127|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
161209976|NCT03273257|582151126|FG000|Overall Study|Study terminated|3|||
161209977|NCT03273257|582151127|FG001|Overall Study|Study terminated|2|||
161209978|NCT01966107|582151129|FG000|Overall Study|excluded from FAS|21|||
161209979|NCT01966107|582151130|FG001|Overall Study|excluded from FAS|20|||
161209980|NCT01966107|582151129|FG000|Overall Study|discontinued treatment|345|||
161209981|NCT01966107|582151130|FG001|Overall Study|discontinued treatment|372|||
161209982|NCT01966107|582151129|FG000|Overall Study|due to study closure|164|||
161209983|NCT01966107|582151130|FG001|Overall Study|due to study closure|186|||
161209984|NCT01966107|582151129|FG000|Overall Study|withdrew from the study|272|||
161209985|NCT01966107|582151130|FG001|Overall Study|withdrew from the study|303|||
161209986|NCT02200614|582151131|FG000|Double Blind Treatment|Adverse Event|86|||
161209987|NCT02200614|582151132|FG001|Double Blind Treatment|Adverse Event|48|||
161209988|NCT02200614|582151131|FG000|Double Blind Treatment|Confirmed metastasis|120|||
161209989|NCT02200614|582151132|FG001|Double Blind Treatment|Confirmed metastasis|140|||
161095281|NCT04677179|581739682|FG006|Induction Treatment Period|Physician Decision|0|||
161095282|NCT04677179|581739683|FG007|Induction Treatment Period|Physician Decision|0|||
161095283|NCT04677179|581739684|FG008|Induction Treatment Period|Physician Decision|0|||
161095284|NCT04677179|581739685|FG009|Induction Treatment Period|Physician Decision|0|||
161095285|NCT04677179|581739676|FG000|Induction Treatment Period|Protocol Violation|0|||
161095286|NCT04677179|581739677|FG001|Induction Treatment Period|Protocol Violation|1|||
161095287|NCT04677179|581739678|FG002|Induction Treatment Period|Protocol Violation|0|||
161095288|NCT04677179|581739679|FG003|Induction Treatment Period|Protocol Violation|0|||
161095289|NCT04677179|581739680|FG004|Induction Treatment Period|Protocol Violation|0|||
161095290|NCT04677179|581739681|FG005|Induction Treatment Period|Protocol Violation|0|||
161095291|NCT04677179|581739682|FG006|Induction Treatment Period|Protocol Violation|0|||
161095292|NCT04677179|581739683|FG007|Induction Treatment Period|Protocol Violation|0|||
161095293|NCT04677179|581739684|FG008|Induction Treatment Period|Protocol Violation|0|||
161095294|NCT04677179|581739685|FG009|Induction Treatment Period|Protocol Violation|0|||
161095295|NCT04677179|581739676|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
161095296|NCT04677179|581739677|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
161095297|NCT04677179|581739678|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
161095298|NCT04677179|581739679|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
161095299|NCT04677179|581739680|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
161095300|NCT04677179|581739681|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
161095301|NCT04677179|581739682|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
161095302|NCT04677179|581739683|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
161095303|NCT04677179|581739684|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
161095304|NCT04677179|581739685|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
161095305|NCT04677179|581739676|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
161095306|NCT04677179|581739677|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
161095307|NCT04677179|581739678|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
161095308|NCT04677179|581739679|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
161095309|NCT04677179|581739680|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
161095310|NCT04677179|581739681|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
161095311|NCT04677179|581739682|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
161209990|NCT02200614|582151131|FG000|Double Blind Treatment|Judgment of the investigator|59|||
161209991|NCT02200614|582151132|FG001|Double Blind Treatment|Judgment of the investigator|99|||
161209992|NCT02200614|582151131|FG000|Double Blind Treatment|Metastasis by local reading|1|||
161209993|NCT02200614|582151132|FG001|Double Blind Treatment|Metastasis by local reading|3|||
161209994|NCT02200614|582151131|FG000|Double Blind Treatment|Other reason|6|||
161209995|NCT02200614|582151132|FG001|Double Blind Treatment|Other reason|2|||
161209996|NCT02200614|582151131|FG000|Double Blind Treatment|Personal reason|77|||
161209997|NCT02200614|582151132|FG001|Double Blind Treatment|Personal reason|85|||
161209998|NCT02200614|582151131|FG000|Double Blind Treatment|Protocol deviation|14|||
161209999|NCT02200614|582151132|FG001|Double Blind Treatment|Protocol deviation|7|||
161210000|NCT02200614|582151131|FG000|Double Blind Treatment|Not treated|1|||
161210001|NCT02200614|582151132|FG001|Double Blind Treatment|Not treated|0|||
161210002|NCT02200614|582151131|FG000|Open Label|Adverse Event|41|||
161210003|NCT02200614|582151132|FG001|Open Label|Adverse Event|11|||
161210004|NCT02200614|582151131|FG000|Open Label|Confirmed metastasis|1|||
161210005|NCT02200614|582151132|FG001|Open Label|Confirmed metastasis|0|||
161210006|NCT02200614|582151131|FG000|Open Label|Judgment of the investigator|29|||
161210007|NCT02200614|582151132|FG001|Open Label|Judgment of the investigator|2|||
161210008|NCT02200614|582151131|FG000|Open Label|Metastasis by local reading|138|||
161210009|NCT02200614|582151132|FG001|Open Label|Metastasis by local reading|27|||
161210010|NCT02200614|582151131|FG000|Open Label|Other reason|22|||
161210011|NCT02200614|582151132|FG001|Open Label|Other reason|4|||
161210012|NCT02200614|582151131|FG000|Open Label|Personal reason|60|||
161210013|NCT02200614|582151132|FG001|Open Label|Personal reason|8|||
161210014|NCT02200614|582151131|FG000|Open Label|Protocol deviation|3|||
161210015|NCT02200614|582151132|FG001|Open Label|Protocol deviation|2|||
161210016|NCT02200614|582151131|FG000|Open Label|Missing|2|||
161210017|NCT02200614|582151132|FG001|Open Label|Missing|2|||
161210018|NCT01898884|582151133|FG000|Multiple Dose Period|Adverse Event|0|||
161210019|NCT01898884|582151134|FG001|Multiple Dose Period|Adverse Event|0|||
161210020|NCT01898884|582151135|FG002|Multiple Dose Period|Adverse Event|0|||
161210021|NCT01898884|582151136|FG003|Multiple Dose Period|Adverse Event|0|||
161210022|NCT01898884|582151137|FG004|Multiple Dose Period|Adverse Event|0|||
161210023|NCT01898884|582151138|FG005|Multiple Dose Period|Adverse Event|0|||
161210024|NCT01898884|582151139|FG006|Multiple Dose Period|Adverse Event|1|||
161210025|NCT01898884|582151140|FG007|Multiple Dose Period|Adverse Event|0|||
161210026|NCT01898884|582151141|FG008|Multiple Dose Period|Adverse Event|0|||
161210027|NCT01898884|582151133|FG000|Multiple Dose Period|Randomized Not Treated|0|||
161210028|NCT01898884|582151134|FG001|Multiple Dose Period|Randomized Not Treated|0|||
161095312|NCT04677179|581739683|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
161210029|NCT01898884|582151135|FG002|Multiple Dose Period|Randomized Not Treated|0|||
161210030|NCT01898884|582151136|FG003|Multiple Dose Period|Randomized Not Treated|0|||
161210031|NCT01898884|582151137|FG004|Multiple Dose Period|Randomized Not Treated|0|||
161210032|NCT01898884|582151138|FG005|Multiple Dose Period|Randomized Not Treated|0|||
161210033|NCT01898884|582151139|FG006|Multiple Dose Period|Randomized Not Treated|0|||
161210034|NCT01898884|582151140|FG007|Multiple Dose Period|Randomized Not Treated|0|||
161210035|NCT01898884|582151141|FG008|Multiple Dose Period|Randomized Not Treated|1|||
161210036|NCT00759759|582151142|FG000|Overall Study|didn't return for period 2|1|||
161210037|NCT00759759|582151143|FG001|Overall Study|didn't return for period 2|0|||
161210038|NCT00759759|582151142|FG000|Overall Study|Didn't receive drug in period 2|1|||
161210039|NCT00759759|582151143|FG001|Overall Study|Didn't receive drug in period 2|0|||
161210040|NCT00759759|582151142|FG000|Overall Study|Withdrawal by Subject|2|||
161095313|NCT04677179|581739684|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
161095314|NCT04677179|581739685|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
161095315|NCT04677179|581739676|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
161095316|NCT04677179|581739677|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
161095317|NCT04677179|581739678|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
161095318|NCT04677179|581739679|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
161095319|NCT04677179|581739680|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
161095320|NCT04677179|581739681|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
161095321|NCT04677179|581739682|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
161095322|NCT04677179|581739683|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
161095323|NCT04677179|581739684|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
161095324|NCT04677179|581739685|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
161095325|NCT04677179|581739676|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095326|NCT04677179|581739677|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095327|NCT04677179|581739678|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095328|NCT04677179|581739679|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
161095329|NCT04677179|581739680|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095330|NCT04677179|581739681|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095331|NCT04677179|581739682|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095332|NCT04677179|581739683|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095333|NCT04677179|581739684|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
161095334|NCT04677179|581739685|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
161210041|NCT00759759|582151143|FG001|Overall Study|Withdrawal by Subject|1|||
161210042|NCT00434148|582151144|FG000|Overall Study|Adverse Event|18|||
161210043|NCT00434148|582151145|FG001|Overall Study|Adverse Event|18|||
161210044|NCT00434148|582151144|FG000|Overall Study|Lack of Efficacy|25|||
161210045|NCT00434148|582151145|FG001|Overall Study|Lack of Efficacy|28|||
161095335|NCT04677179|581739676|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095336|NCT04677179|581739677|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095337|NCT04677179|581739678|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095338|NCT04677179|581739679|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
161095339|NCT04677179|581739680|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
161095340|NCT04677179|581739681|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
161095341|NCT04677179|581739682|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095342|NCT04677179|581739683|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095343|NCT04677179|581739684|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095344|NCT04677179|581739685|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
161095345|NCT04677179|581739676|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161095346|NCT04677179|581739677|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161095347|NCT04677179|581739678|FG002|Extension Treatment Period|Lack of Efficacy|0|||
161095348|NCT04677179|581739679|FG003|Extension Treatment Period|Lack of Efficacy|0|||
161095349|NCT04677179|581739680|FG004|Extension Treatment Period|Lack of Efficacy|0|||
161095350|NCT04677179|581739681|FG005|Extension Treatment Period|Lack of Efficacy|0|||
161095351|NCT04677179|581739682|FG006|Extension Treatment Period|Lack of Efficacy|6|||
161095352|NCT04677179|581739683|FG007|Extension Treatment Period|Lack of Efficacy|0|||
161095353|NCT04677179|581739684|FG008|Extension Treatment Period|Lack of Efficacy|0|||
161095354|NCT04677179|581739685|FG009|Extension Treatment Period|Lack of Efficacy|0|||
161095355|NCT04677179|581739676|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
161095356|NCT04677179|581739677|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161095357|NCT04677179|581739678|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161095358|NCT04677179|581739679|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
161095359|NCT04677179|581739680|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
161095360|NCT04677179|581739681|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
161095361|NCT04677179|581739682|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
161095362|NCT04677179|581739683|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
161095363|NCT04677179|581739684|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
161095364|NCT04677179|581739685|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
161095365|NCT04677179|581739676|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
161095366|NCT04677179|581739677|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
161095367|NCT04677179|581739678|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
161095368|NCT04677179|581739679|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
161095369|NCT04677179|581739680|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
161095370|NCT04677179|581739681|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
161095371|NCT04677179|581739682|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
161095372|NCT04677179|581739683|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
161095373|NCT04677179|581739684|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
161095374|NCT04677179|581739685|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
161095375|NCT04677179|581739676|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
161095376|NCT04677179|581739677|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
161095377|NCT04677179|581739678|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
161095378|NCT04677179|581739679|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
161095379|NCT04677179|581739680|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
161095380|NCT04677179|581739681|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
161095381|NCT04677179|581739682|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
161095382|NCT04677179|581739683|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
161095383|NCT04677179|581739684|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
161095384|NCT04677179|581739685|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
161095385|NCT04677179|581739676|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095386|NCT04677179|581739677|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095387|NCT04677179|581739678|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095388|NCT04677179|581739679|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095389|NCT04677179|581739680|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095390|NCT04677179|581739681|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095391|NCT04677179|581739682|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095392|NCT04677179|581739683|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
161095393|NCT04677179|581739684|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
161095394|NCT04677179|581739685|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
161095395|NCT04677179|581739676|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095396|NCT04677179|581739677|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095397|NCT04677179|581739678|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095398|NCT04677179|581739679|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095399|NCT04677179|581739680|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095400|NCT04677179|581739681|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095401|NCT04677179|581739682|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095402|NCT04677179|581739683|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
161095403|NCT04677179|581739684|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095404|NCT04677179|581739685|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161095405|NCT04677179|581739676|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095406|NCT04677179|581739677|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095407|NCT04677179|581739678|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095408|NCT04677179|581739679|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095409|NCT04677179|581739680|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095410|NCT04677179|581739681|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095411|NCT04677179|581739682|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095412|NCT04677179|581739683|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
161095413|NCT04677179|581739684|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
161095414|NCT04677179|581739685|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161095415|NCT04677179|581739676|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095416|NCT04677179|581739677|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095417|NCT04677179|581739678|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095418|NCT04677179|581739679|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095419|NCT04677179|581739680|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095420|NCT04677179|581739681|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095421|NCT04677179|581739682|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
161095422|NCT04677179|581739683|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
161095423|NCT04677179|581739684|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
161095424|NCT04677179|581739685|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
161095425|NCT01536015|581739686|FG000|Overall Study|Adverse Event|1|||
161095426|NCT01536015|581739687|FG001|Overall Study|Adverse Event|4|||
161095427|NCT01536015|581739686|FG000|Overall Study|Lost to Follow-up|0|||
161095428|NCT01536015|581739687|FG001|Overall Study|Lost to Follow-up|1|||
161095429|NCT01536015|581739686|FG000|Overall Study|Inclusion Criterion not met|2|||
161095430|NCT01536015|581739687|FG001|Overall Study|Inclusion Criterion not met|0|||
161095431|NCT01536015|581739686|FG000|Overall Study|Study closure|5|||
161095432|NCT01536015|581739687|FG001|Overall Study|Study closure|5|||
161095433|NCT01723254|581739690|FG000|Overall Study|Conflict with work schedule|0|||
161095434|NCT01723254|581739691|FG001|Overall Study|Conflict with work schedule|0|||
161095435|NCT01723254|581739692|FG002|Overall Study|Conflict with work schedule|0|||
161095436|NCT01723254|581739693|FG003|Overall Study|Conflict with work schedule|0|||
161095437|NCT01723254|581739694|FG004|Overall Study|Conflict with work schedule|0|||
161095438|NCT01723254|581739695|FG005|Overall Study|Conflict with work schedule|0|||
161095439|NCT01723254|581739696|FG006|Overall Study|Conflict with work schedule|0|||
161095440|NCT01723254|581739697|FG007|Overall Study|Conflict with work schedule|1|||
161095441|NCT01723254|581739690|FG000|Overall Study|Personal issues|0|||
161095442|NCT01723254|581739691|FG001|Overall Study|Personal issues|0|||
161095443|NCT01723254|581739692|FG002|Overall Study|Personal issues|0|||
161095444|NCT01723254|581739693|FG003|Overall Study|Personal issues|0|||
161095445|NCT01723254|581739694|FG004|Overall Study|Personal issues|0|||
161095446|NCT01723254|581739695|FG005|Overall Study|Personal issues|1|||
161095447|NCT01723254|581739696|FG006|Overall Study|Personal issues|0|||
161095448|NCT01723254|581739697|FG007|Overall Study|Personal issues|0|||
161095449|NCT01723254|581739690|FG000|Overall Study|No longer have time to participate|0|||
161095450|NCT01723254|581739691|FG001|Overall Study|No longer have time to participate|0|||
161095451|NCT01723254|581739692|FG002|Overall Study|No longer have time to participate|0|||
161095452|NCT01723254|581739693|FG003|Overall Study|No longer have time to participate|1|||
161095453|NCT01723254|581739694|FG004|Overall Study|No longer have time to participate|0|||
161095454|NCT01723254|581739695|FG005|Overall Study|No longer have time to participate|0|||
161095455|NCT01723254|581739696|FG006|Overall Study|No longer have time to participate|0|||
161095456|NCT01723254|581739697|FG007|Overall Study|No longer have time to participate|0|||
161095457|NCT01723254|581739690|FG000|Overall Study|Move/Left to another country/city|0|||
161095458|NCT01723254|581739691|FG001|Overall Study|Move/Left to another country/city|0|||
161095459|NCT01723254|581739692|FG002|Overall Study|Move/Left to another country/city|2|||
161095460|NCT01723254|581739693|FG003|Overall Study|Move/Left to another country/city|1|||
161095461|NCT01723254|581739694|FG004|Overall Study|Move/Left to another country/city|1|||
161095462|NCT01723254|581739695|FG005|Overall Study|Move/Left to another country/city|0|||
161095463|NCT01723254|581739696|FG006|Overall Study|Move/Left to another country/city|0|||
161095464|NCT01723254|581739697|FG007|Overall Study|Move/Left to another country/city|0|||
161095465|NCT01723254|581739690|FG000|Overall Study|Protocol Violation|0|||
161095466|NCT01723254|581739691|FG001|Overall Study|Protocol Violation|1|||
161095467|NCT01723254|581739692|FG002|Overall Study|Protocol Violation|0|||
161095468|NCT01723254|581739693|FG003|Overall Study|Protocol Violation|0|||
161095469|NCT01723254|581739694|FG004|Overall Study|Protocol Violation|0|||
161095470|NCT01723254|581739695|FG005|Overall Study|Protocol Violation|0|||
161095471|NCT01723254|581739696|FG006|Overall Study|Protocol Violation|0|||
161095472|NCT01723254|581739697|FG007|Overall Study|Protocol Violation|0|||
161095473|NCT01723254|581739690|FG000|Overall Study|Withdrawal by Subject|1|||
161095474|NCT01723254|581739691|FG001|Overall Study|Withdrawal by Subject|2|||
161095475|NCT01723254|581739692|FG002|Overall Study|Withdrawal by Subject|1|||
161095476|NCT01723254|581739693|FG003|Overall Study|Withdrawal by Subject|0|||
161095477|NCT01723254|581739694|FG004|Overall Study|Withdrawal by Subject|1|||
161095478|NCT01723254|581739695|FG005|Overall Study|Withdrawal by Subject|1|||
161095479|NCT01723254|581739696|FG006|Overall Study|Withdrawal by Subject|1|||
161095480|NCT01723254|581739697|FG007|Overall Study|Withdrawal by Subject|2|||
161095481|NCT01201265|581739698|FG000|Overall Study|Death|14|||
161095482|NCT01201265|581739698|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161095483|NCT01201265|581739698|FG000|Overall Study|Lost to Follow-up|10|||
161095484|NCT01201265|581739698|FG000|Overall Study|Withdrawal by Subject|7|||
161095485|NCT01201265|581739698|FG000|Overall Study|Disease Progression|4|||
161095486|NCT04640077|581739699|FG000|Period 1|Withdrawal by Subject|4|||
161095487|NCT04640077|581739700|FG001|Period 1|Withdrawal by Subject|5|||
161095488|NCT04640077|581739701|FG002|Period 1|Withdrawal by Subject|0|||
161095489|NCT04640077|581739699|FG000|Period 1|Adverse Event|1|||
161095490|NCT04640077|581739700|FG001|Period 1|Adverse Event|1|||
161095491|NCT04640077|581739701|FG002|Period 1|Adverse Event|0|||
161095492|NCT04640077|581739699|FG000|Period 1|Screen Failure|2|||
161095493|NCT04640077|581739700|FG001|Period 1|Screen Failure|0|||
161095494|NCT04640077|581739701|FG002|Period 1|Screen Failure|0|||
161095495|NCT04640077|581739699|FG000|Period 2|Withdrawal by Subject|0|||
161095496|NCT04640077|581739700|FG001|Period 2|Withdrawal by Subject|0|||
161095497|NCT04640077|581739701|FG002|Period 2|Withdrawal by Subject|18|||
161095498|NCT04640077|581739699|FG000|Period 2|Adverse Event|0|||
161095499|NCT04640077|581739700|FG001|Period 2|Adverse Event|0|||
161095500|NCT04640077|581739701|FG002|Period 2|Adverse Event|6|||
161095501|NCT04640077|581739699|FG000|Period 2|Lost to Follow-up|0|||
161095502|NCT04640077|581739700|FG001|Period 2|Lost to Follow-up|0|||
161095503|NCT04640077|581739701|FG002|Period 2|Lost to Follow-up|2|||
161095504|NCT04640077|581739699|FG000|Period 2|Death|0|||
161210046|NCT00434148|582151144|FG000|Overall Study|Withdrawal by Subject|15|||
161210047|NCT00434148|582151145|FG001|Overall Study|Withdrawal by Subject|15|||
161210048|NCT00434148|582151144|FG000|Overall Study|Protocol Violation|4|||
161210049|NCT00434148|582151145|FG001|Overall Study|Protocol Violation|0|||
161210050|NCT00434148|582151144|FG000|Overall Study|Administrative problems|6|||
161210051|NCT00434148|582151145|FG001|Overall Study|Administrative problems|10|||
161210052|NCT00434148|582151144|FG000|Overall Study|Lost to Follow-up|0|||
161210053|NCT00434148|582151145|FG001|Overall Study|Lost to Follow-up|1|||
161210054|NCT00434148|582151144|FG000|Overall Study|Condition no longer requires study drug|1|||
161210055|NCT00434148|582151145|FG001|Overall Study|Condition no longer requires study drug|0|||
161210056|NCT00434148|582151144|FG000|Overall Study|Abnormal test procedure result|0|||
161210057|NCT00434148|582151145|FG001|Overall Study|Abnormal test procedure result|1|||
161210058|NCT01556165|582151149|FG000|Overall Study|Adverse Event|5|||
161210059|NCT01556165|582151150|FG001|Overall Study|Adverse Event|3|||
161210060|NCT01556165|582151149|FG000|Overall Study|Protocol Violation|0|||
161210061|NCT01556165|582151150|FG001|Overall Study|Protocol Violation|3|||
161210062|NCT01556165|582151149|FG000|Overall Study|Withdrawal of Consent|7|||
161210063|NCT01556165|582151150|FG001|Overall Study|Withdrawal of Consent|1|||
161210064|NCT02531698|582151153|FG000|Overall Study|Adverse Event|2|||
161210065|NCT02531698|582151154|FG001|Overall Study|Adverse Event|1|||
161210066|NCT02531698|582151153|FG000|Overall Study|Withdrawal by Subject|6|||
161210067|NCT02531698|582151154|FG001|Overall Study|Withdrawal by Subject|1|||
161210068|NCT02531698|582151153|FG000|Overall Study|Protocol Violation|2|||
161210069|NCT02531698|582151154|FG001|Overall Study|Protocol Violation|0|||
161210070|NCT02531698|582151153|FG000|Overall Study|Lost to Follow-up|1|||
161210071|NCT02531698|582151154|FG001|Overall Study|Lost to Follow-up|0|||
161210072|NCT01861717|582151155|FG000|Overall Study|Lost to Follow-up|1|||
161210073|NCT01861717|582151155|FG000|Overall Study|Withdrawal by Subject|1|||
161210074|NCT02395536|582151161|FG000|Overall Study|Lost to Follow-up|4|||
161210075|NCT02395536|582151162|FG001|Overall Study|Lost to Follow-up|4|||
161210076|NCT02395536|582151161|FG000|Overall Study|Death|2|||
161210077|NCT02395536|582151162|FG001|Overall Study|Death|0|||
161210078|NCT02395536|582151161|FG000|Overall Study|Physician Decision|4|||
161210079|NCT02395536|582151162|FG001|Overall Study|Physician Decision|6|||
161210080|NCT02395536|582151161|FG000|Overall Study|Withdrawal by Subject|9|||
161210081|NCT02395536|582151162|FG001|Overall Study|Withdrawal by Subject|17|||
161095505|NCT04640077|581739700|FG001|Period 2|Death|0|||
161095506|NCT04640077|581739701|FG002|Period 2|Death|2|||
161095507|NCT04640077|581739699|FG000|Period 2|Progressive Disease|0|||
161095508|NCT04640077|581739700|FG001|Period 2|Progressive Disease|0|||
161095509|NCT04640077|581739701|FG002|Period 2|Progressive Disease|1|||
161095510|NCT04640077|581739699|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
161095511|NCT04640077|581739700|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
161095512|NCT04640077|581739701|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
161095513|NCT01257425|581739702|FG000|Overall Study|Lack of Efficacy|3|||
161095514|NCT01257425|581739703|FG001|Overall Study|Lack of Efficacy|3|||
161210082|NCT02395536|582151161|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
161210083|NCT02395536|582151162|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
161210084|NCT02395536|582151161|FG000|Overall Study|Insurance issue|0|||
161210085|NCT02395536|582151162|FG001|Overall Study|Insurance issue|1|||
161095515|NCT01257425|581739702|FG000|Overall Study|Adverse Event|1|||
161095516|NCT01257425|581739703|FG001|Overall Study|Adverse Event|1|||
161095517|NCT01257425|581739702|FG000|Overall Study|Protocol Violation|1|||
161095518|NCT01257425|581739703|FG001|Overall Study|Protocol Violation|1|||
161095519|NCT01257425|581739702|FG000|Overall Study|Withdrawal by Subject|0|||
161095520|NCT01257425|581739703|FG001|Overall Study|Withdrawal by Subject|1|||
161095521|NCT01257425|581739702|FG000|Overall Study|Death|1|||
161095522|NCT01257425|581739703|FG001|Overall Study|Death|0|||
161095523|NCT02041520|581739705|FG000|Overall Study|Adverse Event|2|||
161095524|NCT02041520|581739706|FG001|Overall Study|Adverse Event|1|||
161095525|NCT02041520|581739705|FG000|Overall Study|Withdrawal by Subject|3|||
161095526|NCT02041520|581739706|FG001|Overall Study|Withdrawal by Subject|4|||
161095527|NCT02041520|581739705|FG000|Overall Study|Protocol Violation|1|||
161095528|NCT02041520|581739706|FG001|Overall Study|Protocol Violation|0|||
161095529|NCT02041520|581739705|FG000|Overall Study|Lost to Follow-up|0|||
161095530|NCT02041520|581739706|FG001|Overall Study|Lost to Follow-up|1|||
161095531|NCT02041520|581739705|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
161095532|NCT02041520|581739706|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
161095533|NCT00413972|581739707|FG000|Overall Study|Adverse Event|2|||
161095534|NCT00413972|581739708|FG001|Overall Study|Adverse Event|1|||
161095535|NCT00413972|581739709|FG002|Overall Study|Adverse Event|0|||
161095536|NCT00413972|581739710|FG003|Overall Study|Adverse Event|0|||
161095537|NCT00413972|581739707|FG000|Overall Study|Lost to Follow-up|1|||
161095538|NCT00413972|581739708|FG001|Overall Study|Lost to Follow-up|2|||
161095539|NCT00413972|581739709|FG002|Overall Study|Lost to Follow-up|1|||
161095540|NCT00413972|581739710|FG003|Overall Study|Lost to Follow-up|0|||
161095541|NCT00413972|581739707|FG000|Overall Study|Withdrawal by Subject|4|||
161095542|NCT00413972|581739708|FG001|Overall Study|Withdrawal by Subject|5|||
161095543|NCT00413972|581739709|FG002|Overall Study|Withdrawal by Subject|7|||
161095544|NCT00413972|581739710|FG003|Overall Study|Withdrawal by Subject|2|||
161095545|NCT00413972|581739707|FG000|Overall Study|Protocol Violation|0|||
161095546|NCT00413972|581739708|FG001|Overall Study|Protocol Violation|0|||
161095547|NCT00413972|581739709|FG002|Overall Study|Protocol Violation|2|||
161095548|NCT00413972|581739710|FG003|Overall Study|Protocol Violation|0|||
161095549|NCT00413972|581739707|FG000|Overall Study|Other|0|||
161095550|NCT00413972|581739708|FG001|Overall Study|Other|0|||
161095551|NCT00413972|581739709|FG002|Overall Study|Other|0|||
161095552|NCT00413972|581739710|FG003|Overall Study|Other|1|||
161095553|NCT02254278|581739711|FG000|Overall Study|Protocol Violation|1|||
161095554|NCT02254278|581739712|FG001|Overall Study|Protocol Violation|1|||
161095555|NCT05437510|581739716|FG000|Overall Study|Adverse Event|2|||
161095556|NCT05437510|581739717|FG001|Overall Study|Adverse Event|1|||
161095557|NCT05437510|581739716|FG000|Overall Study|Protocol Deviation|1|||
161095558|NCT05437510|581739717|FG001|Overall Study|Protocol Deviation|6|||
161095559|NCT05437510|581739716|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
161095560|NCT05437510|581739717|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
161095561|NCT05437510|581739716|FG000|Overall Study|Lost to Follow-up|265|||
161095562|NCT05437510|581739717|FG001|Overall Study|Lost to Follow-up|358|||
161095563|NCT03769181|581741331|FG000|Overall Study|Adverse Event|1|||
161095564|NCT03769181|581741332|FG001|Overall Study|Adverse Event|0|||
161095565|NCT03769181|581741333|FG002|Overall Study|Adverse Event|2|||
161095566|NCT03769181|581741334|FG003|Overall Study|Adverse Event|4|||
161095567|NCT03769181|581741331|FG000|Overall Study|Withdrawal by Subject|1|||
161095568|NCT03769181|581741332|FG001|Overall Study|Withdrawal by Subject|0|||
161095569|NCT03769181|581741333|FG002|Overall Study|Withdrawal by Subject|2|||
161095570|NCT03769181|581741334|FG003|Overall Study|Withdrawal by Subject|1|||
161095571|NCT03769181|581741331|FG000|Overall Study|Progressive disease|9|||
161095572|NCT03769181|581741332|FG001|Overall Study|Progressive disease|7|||
161095573|NCT03769181|581741333|FG002|Overall Study|Progressive disease|13|||
161095574|NCT03769181|581741334|FG003|Overall Study|Progressive disease|6|||
161095575|NCT03769181|581741331|FG000|Overall Study|Other - Unspecified|2|||
161095576|NCT03769181|581741332|FG001|Overall Study|Other - Unspecified|1|||
161210086|NCT00701558|582151163|FG000|Overall Study|Death|7|||
161210087|NCT00701558|582151163|FG000|Overall Study|Lost to Follow-up|8|||
161095577|NCT03769181|581741333|FG002|Overall Study|Other - Unspecified|0|||
161095578|NCT03769181|581741334|FG003|Overall Study|Other - Unspecified|0|||
161095579|NCT00826111|581741341|FG000|Overall Study|Lost to Follow-up|0|||
161095580|NCT00826111|581741342|FG001|Overall Study|Lost to Follow-up|1|||
161095581|NCT00826111|581741341|FG000|Overall Study|Protocol Violation|1|||
161095582|NCT00826111|581741342|FG001|Overall Study|Protocol Violation|0|||
161095583|NCT00826111|581741341|FG000|Overall Study|Withdrawal by Subject|5|||
161210088|NCT01640964|582151166|FG000|Overall Study|Lost to Follow-up|0|||
161095584|NCT00826111|581741342|FG001|Overall Study|Withdrawal by Subject|0|||
161095585|NCT00826111|581741341|FG000|Overall Study|Physician Decision|1|||
161095586|NCT00826111|581741342|FG001|Overall Study|Physician Decision|1|||
161095587|NCT01195545|581741343|FG000|Overall Study|Protocol Violation|4|||
161095588|NCT00792805|581741344|FG000|Overall Study|Adverse Event|12|||
161095589|NCT00792805|581741345|FG001|Overall Study|Adverse Event|10|||
161095590|NCT00792805|581741346|FG002|Overall Study|Adverse Event|10|||
161210089|NCT01640964|582151167|FG001|Overall Study|Lost to Follow-up|0|||
161095591|NCT00792805|581741344|FG000|Overall Study|Subject withdrew consent|5|||
161095592|NCT00792805|581741345|FG001|Overall Study|Subject withdrew consent|6|||
161095593|NCT00792805|581741346|FG002|Overall Study|Subject withdrew consent|5|||
161095594|NCT00792805|581741344|FG000|Overall Study|Administrative problems|2|||
161095595|NCT00792805|581741345|FG001|Overall Study|Administrative problems|0|||
161095596|NCT00792805|581741346|FG002|Overall Study|Administrative problems|4|||
161095597|NCT00792805|581741344|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161095598|NCT00792805|581741345|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161095599|NCT00792805|581741346|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161095600|NCT00792805|581741344|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161095601|NCT00792805|581741345|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
161095602|NCT00792805|581741346|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
161095603|NCT00792805|581741344|FG000|Overall Study|Lost to Follow-up|1|||
161095604|NCT00792805|581741345|FG001|Overall Study|Lost to Follow-up|1|||
161095605|NCT00792805|581741346|FG002|Overall Study|Lost to Follow-up|6|||
161095606|NCT00792805|581741344|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161095607|NCT00792805|581741345|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161095608|NCT00792805|581741346|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161095609|NCT00792805|581741344|FG000|Overall Study|Protocol deviation|0|||
161095610|NCT00792805|581741345|FG001|Overall Study|Protocol deviation|1|||
161095611|NCT00792805|581741346|FG002|Overall Study|Protocol deviation|1|||
161095612|NCT02072434|581741347|FG000|Overall Study|Protocol Violation|10|||
161095613|NCT02072434|581741348|FG001|Overall Study|Protocol Violation|9|||
161095614|NCT02072434|581741347|FG000|Overall Study|Physician Decision|5|||
161095615|NCT02072434|581741348|FG001|Overall Study|Physician Decision|10|||
161095616|NCT02072434|581741347|FG000|Overall Study|Adverse event, serious fatal|1|||
161095617|NCT02072434|581741348|FG001|Overall Study|Adverse event, serious fatal|6|||
161095618|NCT02072434|581741347|FG000|Overall Study|Adverse Event|7|||
161095619|NCT02072434|581741348|FG001|Overall Study|Adverse Event|6|||
161095620|NCT02072434|581741347|FG000|Overall Study|Withdrawal by Subject|17|||
161095621|NCT02072434|581741348|FG001|Overall Study|Withdrawal by Subject|29|||
161095622|NCT02072434|581741347|FG000|Overall Study|Other|14|||
161210090|NCT01640964|582151168|FG002|Overall Study|Lost to Follow-up|1|||
161210091|NCT01640964|582151166|FG000|Overall Study|Protocol Deviation|1|||
161210092|NCT01640964|582151167|FG001|Overall Study|Protocol Deviation|1|||
161210093|NCT01640964|582151168|FG002|Overall Study|Protocol Deviation|2|||
161210094|NCT03591107|582153365|FG000|Overall Study|Same patient in both arms|1|||
161210095|NCT03591107|582153366|FG001|Overall Study|Same patient in both arms|1|||
161210096|NCT03591107|582153365|FG000|Overall Study|Sought care at other clinics|0|||
161210097|NCT03591107|582153366|FG001|Overall Study|Sought care at other clinics|2|||
161210098|NCT03591107|582153365|FG000|Overall Study|Discharged from clinic|0|||
161210099|NCT03591107|582153366|FG001|Overall Study|Discharged from clinic|1|||
161210100|NCT03591107|582153365|FG000|Overall Study|Withdrawal by Subject|0|||
161210101|NCT03591107|582153366|FG001|Overall Study|Withdrawal by Subject|1|||
161210102|NCT00304954|582153369|FG000|Overall Study|Withdrawal by Subject|0|||
161210103|NCT00304954|582153370|FG001|Overall Study|Withdrawal by Subject|0|||
161210104|NCT00304954|582153371|FG002|Overall Study|Withdrawal by Subject|1|||
161210105|NCT00304954|582153372|FG003|Overall Study|Withdrawal by Subject|0|||
161210106|NCT00304954|582153369|FG000|Overall Study|Adverse Event|1|||
161210107|NCT00304954|582153370|FG001|Overall Study|Adverse Event|0|||
161210108|NCT00304954|582153371|FG002|Overall Study|Adverse Event|0|||
161210109|NCT00304954|582153372|FG003|Overall Study|Adverse Event|0|||
161210110|NCT00350519|582153373|FG000|Overall Study|Death|0|||
161210111|NCT00350519|582153374|FG001|Overall Study|Death|1|||
161210112|NCT00350519|582153373|FG000|Overall Study|Physician Decision|0|||
161210113|NCT00350519|582153374|FG001|Overall Study|Physician Decision|1|||
161210114|NCT00350519|582153373|FG000|Overall Study|Protocol Violation|1|||
161210115|NCT00350519|582153374|FG001|Overall Study|Protocol Violation|2|||
161210116|NCT00350519|582153373|FG000|Overall Study|Withdrawal by Subject|3|||
161210117|NCT00350519|582153374|FG001|Overall Study|Withdrawal by Subject|2|||
161210118|NCT00736099|582153376|FG000|Overall Study|Adverse Event|61|||
161210119|NCT00736099|582153377|FG001|Overall Study|Adverse Event|18|||
161210120|NCT00736099|582153376|FG000|Overall Study|Protocol Violation|10|||
161095623|NCT02072434|581741348|FG001|Overall Study|Other|29|||
161095624|NCT02072434|581741347|FG000|Overall Study|Lost to Follow-up|0|||
161095625|NCT02072434|581741348|FG001|Overall Study|Lost to Follow-up|1|||
161095626|NCT02276872|581741349|FG000|Overall Study|Adverse Event|1|||
161095627|NCT02276872|581741350|FG001|Overall Study|Adverse Event|0|||
161210121|NCT00736099|582153377|FG001|Overall Study|Protocol Violation|4|||
161095628|NCT02276872|581741351|FG002|Overall Study|Adverse Event|0|||
161095629|NCT04175808|581741352|FG000|Part A|Miscellaneous|2|||
161095630|NCT04175808|581741353|FG001|Part A|Miscellaneous|0|||
161095631|NCT04175808|581741354|FG002|Part A|Miscellaneous|0|||
161210122|NCT00736099|582153376|FG000|Overall Study|Lost to Follow-up|12|||
161210123|NCT00736099|582153377|FG001|Overall Study|Lost to Follow-up|5|||
161210124|NCT00736099|582153376|FG000|Overall Study|Withdrawal by Subject|42|||
161210125|NCT00736099|582153377|FG001|Overall Study|Withdrawal by Subject|13|||
161210126|NCT00736099|582153376|FG000|Overall Study|Lack of Efficacy|15|||
161095632|NCT04175808|581741355|FG003|Part A|Miscellaneous|0|||
161095633|NCT04175808|581741356|FG004|Part A|Miscellaneous|0|||
161095634|NCT04175808|581741357|FG005|Part A|Miscellaneous|0|||
161095635|NCT04175808|581741358|FG006|Part A|Miscellaneous|0|||
161095636|NCT00402363|581741360|FG000|Overall Study|Adverse Event|9|||
161095637|NCT00402363|581741361|FG001|Overall Study|Adverse Event|14|||
161095638|NCT00402363|581741362|FG002|Overall Study|Adverse Event|2|||
161095639|NCT00402363|581741363|FG003|Overall Study|Adverse Event|2|||
161095640|NCT00402363|581741360|FG000|Overall Study|Withdrew Consent|10|||
161095641|NCT00402363|581741361|FG001|Overall Study|Withdrew Consent|5|||
161095642|NCT00402363|581741362|FG002|Overall Study|Withdrew Consent|2|||
161095643|NCT00402363|581741363|FG003|Overall Study|Withdrew Consent|1|||
161095644|NCT00402363|581741360|FG000|Overall Study|Protocol Violation|3|||
161095645|NCT00402363|581741361|FG001|Overall Study|Protocol Violation|5|||
161095646|NCT00402363|581741362|FG002|Overall Study|Protocol Violation|0|||
161095647|NCT00402363|581741363|FG003|Overall Study|Protocol Violation|3|||
161095648|NCT00402363|581741360|FG000|Overall Study|Lost to Follow-up|5|||
161095649|NCT00402363|581741361|FG001|Overall Study|Lost to Follow-up|4|||
161095650|NCT00402363|581741362|FG002|Overall Study|Lost to Follow-up|0|||
161095651|NCT00402363|581741363|FG003|Overall Study|Lost to Follow-up|2|||
161095652|NCT00402363|581741360|FG000|Overall Study|"Captured as Other"|6|||
161095653|NCT00402363|581741361|FG001|Overall Study|"Captured as Other"|2|||
161095654|NCT00402363|581741362|FG002|Overall Study|"Captured as Other"|2|||
161095655|NCT00402363|581741363|FG003|Overall Study|"Captured as Other"|2|||
161095656|NCT00937833|581741372|FG000|Overall Study|Protocol Violation|1|||
161095657|NCT00937833|581741373|FG001|Overall Study|Protocol Violation|2|||
161095658|NCT00937833|581741372|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
161095659|NCT00937833|581741373|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
161095660|NCT00937833|581741372|FG000|Overall Study|Lost to Follow-up|10|||
161095661|NCT00937833|581741373|FG001|Overall Study|Lost to Follow-up|8|||
161095662|NCT00937833|581741372|FG000|Overall Study|Withdrawal by Subject|4|||
161095663|NCT00937833|581741373|FG001|Overall Study|Withdrawal by Subject|6|||
161095664|NCT03278106|581741375|FG000|Overall Study|No protocol treatment|1|||
161095665|NCT02175004|581741376|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
161095666|NCT02175004|581741377|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
161095667|NCT02175004|581741376|FG000|Overall Study|Investigator Judgment|1|||
161095668|NCT02175004|581741377|FG001|Overall Study|Investigator Judgment|4|||
161095669|NCT02175004|581741376|FG000|Overall Study|Voluntary Withdrawal|6|||
161095670|NCT02175004|581741377|FG001|Overall Study|Voluntary Withdrawal|19|||
161095671|NCT02175004|581741376|FG000|Overall Study|Liver Transplant|1|||
161095672|NCT02175004|581741377|FG001|Overall Study|Liver Transplant|0|||
161095673|NCT02175004|581741376|FG000|Overall Study|Disease Progression|1|||
161095674|NCT02175004|581741377|FG001|Overall Study|Disease Progression|0|||
161095675|NCT02175004|581741376|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
161095676|NCT02175004|581741377|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
161095677|NCT00162032|581741378|FG000|Overall Study|Lost to Follow-up|4|||
161095678|NCT00162032|581741379|FG001|Overall Study|Lost to Follow-up|2|||
161095679|NCT00162032|581741378|FG000|Overall Study|Reason not specified|1|||
161095680|NCT00162032|581741379|FG001|Overall Study|Reason not specified|0|||
161095681|NCT01137955|581741380|FG000|Overall Study|Withdrawal by Subject|5|||
161095682|NCT01137955|581741381|FG001|Overall Study|Withdrawal by Subject|4|||
161095683|NCT04263909|581741382|FG000|Overall Study|Physician Decision|1|||
161095684|NCT04263909|581741383|FG001|Overall Study|Physician Decision|0|||
161095685|NCT04263909|581741384|FG002|Overall Study|Physician Decision|0|||
161095686|NCT04263909|581741382|FG000|Overall Study|Adverse Event|3|||
161095687|NCT04263909|581741383|FG001|Overall Study|Adverse Event|0|||
161095688|NCT04263909|581741384|FG002|Overall Study|Adverse Event|0|||
161095689|NCT04263909|581741382|FG000|Overall Study|Protocol Violation|5|||
161095690|NCT04263909|581741383|FG001|Overall Study|Protocol Violation|0|||
161095691|NCT04263909|581741384|FG002|Overall Study|Protocol Violation|0|||
161095692|NCT00068588|581741385|FG000|Overall Study|Adverse Event|0|||
161095693|NCT00068588|581741386|FG001|Overall Study|Adverse Event|0|||
161095694|NCT00068588|581741387|FG002|Overall Study|Adverse Event|2|||
161095695|NCT00068588|581741385|FG000|Overall Study|Withdrawal by Subject|0|||
161095696|NCT00068588|581741386|FG001|Overall Study|Withdrawal by Subject|0|||
161095697|NCT00068588|581741387|FG002|Overall Study|Withdrawal by Subject|1|||
161095698|NCT00068588|581741385|FG000|Overall Study|Poor KPS|0|||
161095699|NCT00068588|581741386|FG001|Overall Study|Poor KPS|0|||
161095700|NCT00068588|581741387|FG002|Overall Study|Poor KPS|1|||
161095701|NCT03840486|581741388|FG000|Overall Study|Withdrawal by Subject|0|||
161095702|NCT03840486|581741389|FG001|Overall Study|Withdrawal by Subject|1|||
161095703|NCT03840486|581741390|FG002|Overall Study|Withdrawal by Subject|0|||
161095704|NCT03840486|581741391|FG003|Overall Study|Withdrawal by Subject|0|||
161095705|NCT03840486|581741392|FG004|Overall Study|Withdrawal by Subject|0|||
161095706|NCT03840486|581741393|FG005|Overall Study|Withdrawal by Subject|0|||
161095707|NCT03840486|581741394|FG006|Overall Study|Withdrawal by Subject|0|||
161095708|NCT03840486|581741395|FG007|Overall Study|Withdrawal by Subject|0|||
161095709|NCT03840486|581741396|FG008|Overall Study|Withdrawal by Subject|0|||
161210127|NCT00736099|582153377|FG001|Overall Study|Lack of Efficacy|8|||
161210128|NCT00736099|582153376|FG000|Overall Study|Other reason|43|||
161210129|NCT00736099|582153377|FG001|Overall Study|Other reason|10|||
161210130|NCT00948025|582153378|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
161210131|NCT00948025|582153379|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
161210132|NCT00948025|582153378|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
161210133|NCT00948025|582153379|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
161210134|NCT00948025|582153378|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
161210135|NCT00948025|582153379|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
161210136|NCT04006847|582153382|FG000|Overall Study|Product issue|1|||
161210137|NCT03555890|582153390|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161210138|NCT03555890|582153391|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161210139|NCT03555890|582153392|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161210140|NCT03555890|582153393|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161210141|NCT03372369|582153394|FG000|Qualification Period|Withdrawal by Subject|16|||
161210142|NCT03372369|582153395|FG001|Qualification Period|Withdrawal by Subject|13|||
161210143|NCT03372369|582153394|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
161210144|NCT03372369|582153395|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
161210145|NCT03372369|582153394|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
161210146|NCT03372369|582153395|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
161095710|NCT03840486|581741397|FG009|Overall Study|Withdrawal by Subject|0|||
161095711|NCT03840486|581741398|FG010|Overall Study|Withdrawal by Subject|0|||
161095712|NCT03840486|581741399|FG011|Overall Study|Withdrawal by Subject|0|||
161095713|NCT03285178|581741400|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
161095714|NCT03285178|581741401|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161095715|NCT03285178|581741402|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161095716|NCT03285178|581741403|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161095717|NCT03285178|581741404|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161095718|NCT03285178|581741405|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161095719|NCT03285178|581741406|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
161095720|NCT03285178|581741400|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
161095721|NCT03285178|581741401|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161095722|NCT03285178|581741402|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161095723|NCT03285178|581741403|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161095724|NCT03285178|581741404|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161095725|NCT03285178|581741405|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161095726|NCT03285178|581741406|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
161095727|NCT03285178|581741400|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
161095728|NCT03285178|581741401|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
161095729|NCT03285178|581741402|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
161095730|NCT03285178|581741403|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
161095731|NCT03285178|581741404|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
161095732|NCT03285178|581741405|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
161095733|NCT03285178|581741406|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
161095734|NCT03285178|581741400|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
161095735|NCT03285178|581741401|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161095736|NCT03285178|581741402|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161095737|NCT03285178|581741403|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161095738|NCT03285178|581741404|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161095739|NCT03285178|581741405|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161095740|NCT03285178|581741406|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
161095741|NCT03285178|581741400|FG000|Single-Blind Run-In Period|Physician Decision|2|||
161095742|NCT03285178|581741401|FG001|Single-Blind Run-In Period|Physician Decision|0|||
161095743|NCT03285178|581741402|FG002|Single-Blind Run-In Period|Physician Decision|0|||
161095744|NCT03285178|581741403|FG003|Single-Blind Run-In Period|Physician Decision|0|||
161095745|NCT03285178|581741404|FG004|Single-Blind Run-In Period|Physician Decision|0|||
161095746|NCT03285178|581741405|FG005|Single-Blind Run-In Period|Physician Decision|0|||
161095747|NCT03285178|581741406|FG006|Single-Blind Run-In Period|Physician Decision|0|||
161095748|NCT03285178|581741400|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161095749|NCT03285178|581741401|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
161210147|NCT02239601|582153396|FG000|Overall Study|Withdrawal by Subject|3|||
161210148|NCT02239601|582153397|FG001|Overall Study|Withdrawal by Subject|4|||
161210149|NCT02239601|582153396|FG000|Overall Study|Protocol Violation|4|||
161095750|NCT03285178|581741402|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
161095751|NCT03285178|581741403|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161095752|NCT03285178|581741404|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161095753|NCT03285178|581741405|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161095754|NCT03285178|581741406|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
161095755|NCT03285178|581741400|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161095756|NCT03285178|581741401|FG001|Double-Blind Treatment Period|Adverse Event|0|||
161095757|NCT03285178|581741402|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161095758|NCT03285178|581741403|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161095759|NCT03285178|581741404|FG004|Double-Blind Treatment Period|Adverse Event|0|||
161095760|NCT03285178|581741405|FG005|Double-Blind Treatment Period|Adverse Event|0|||
161095761|NCT03285178|581741406|FG006|Double-Blind Treatment Period|Adverse Event|2|||
161095762|NCT03285178|581741400|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161095763|NCT03285178|581741401|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161095764|NCT03285178|581741402|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161095765|NCT03285178|581741403|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
161095766|NCT03285178|581741404|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
161095767|NCT03285178|581741405|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
161095768|NCT03285178|581741406|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
161095769|NCT03285178|581741400|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161095770|NCT03285178|581741401|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161095771|NCT03285178|581741402|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161095772|NCT03285178|581741403|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161095773|NCT03285178|581741404|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161095774|NCT03285178|581741405|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161095775|NCT03285178|581741406|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161095776|NCT03285178|581741400|FG000|Double-Blind Treatment Period|COVID-19|0|||
161095777|NCT03285178|581741401|FG001|Double-Blind Treatment Period|COVID-19|0|||
161095778|NCT03285178|581741402|FG002|Double-Blind Treatment Period|COVID-19|1|||
161095779|NCT03285178|581741403|FG003|Double-Blind Treatment Period|COVID-19|0|||
161095780|NCT03285178|581741404|FG004|Double-Blind Treatment Period|COVID-19|0|||
161095781|NCT03285178|581741405|FG005|Double-Blind Treatment Period|COVID-19|0|||
161095782|NCT03285178|581741406|FG006|Double-Blind Treatment Period|COVID-19|0|||
161095783|NCT01128894|581741407|FG000|Overall Study|Adverse Event|31|||
161095784|NCT01128894|581741408|FG001|Overall Study|Adverse Event|41|||
161095785|NCT01128894|581741407|FG000|Overall Study|Protocol Violation|2|||
161095786|NCT01128894|581741408|FG001|Overall Study|Protocol Violation|1|||
161095787|NCT01128894|581741407|FG000|Overall Study|Noncompliance|4|||
161095788|NCT01128894|581741408|FG001|Overall Study|Noncompliance|5|||
161095789|NCT01128894|581741407|FG000|Overall Study|Lost to Follow-up|8|||
161095790|NCT01128894|581741408|FG001|Overall Study|Lost to Follow-up|8|||
161095791|NCT01128894|581741407|FG000|Overall Study|Withdrawal by Subject|10|||
161095792|NCT01128894|581741408|FG001|Overall Study|Withdrawal by Subject|12|||
161095793|NCT01128894|581741407|FG000|Overall Study|Physician Decision|2|||
161095794|NCT01128894|581741408|FG001|Overall Study|Physician Decision|1|||
161095795|NCT01128894|581741407|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
161095796|NCT01128894|581741408|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
161095797|NCT01128738|581741409|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
161095798|NCT01128738|581741410|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
161095799|NCT01128738|581741409|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
161095800|NCT01128738|581741410|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
161095801|NCT01128738|581741409|FG000|Second TP|Lost to Follow-up|0|||
161095802|NCT01128738|581741410|FG001|Second TP|Lost to Follow-up|1|||
161095803|NCT01128738|581741409|FG000|Second TP|Withdrawal by Subject|0|||
161095804|NCT01128738|581741410|FG001|Second TP|Withdrawal by Subject|2|||
161095805|NCT00973362|581741411|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
161095806|NCT00973362|581741412|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
161095807|NCT00973362|581741411|FG000|Baseline Evaluation|No colposcopy visit|62|||
161095808|NCT00973362|581741412|FG001|Baseline Evaluation|No colposcopy visit|0|||
161095809|NCT00973362|581741411|FG000|Baseline Evaluation|Inevaluable|686|||
161095810|NCT00973362|581741412|FG001|Baseline Evaluation|Inevaluable|223|||
161095811|NCT00973362|581741411|FG000|3-Year Follow-up|Lost to Follow-up|17|||
161095812|NCT00973362|581741412|FG001|3-Year Follow-up|Lost to Follow-up|0|||
161095813|NCT05116046|581741417|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161095814|NCT05116046|581741418|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161095815|NCT05116046|581741419|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161095816|NCT05116046|581741417|FG000|Overall Study|Study terminated by sponsor|14|||
161210150|NCT02239601|582153397|FG001|Overall Study|Protocol Violation|2|||
161095817|NCT05116046|581741418|FG001|Overall Study|Study terminated by sponsor|16|||
161095818|NCT05116046|581741419|FG002|Overall Study|Study terminated by sponsor|1|||
161095819|NCT01054846|581741421|FG000|Overall Study|Lost to Follow-up|76|||
161095820|NCT01054846|581741422|FG001|Overall Study|Lost to Follow-up|17|||
161095821|NCT02446886|581741426|FG000|Overall Study|Adverse Event|1|||
161095822|NCT02446886|581741427|FG001|Overall Study|Adverse Event|3|||
161095823|NCT02446886|581741426|FG000|Overall Study|Withdrawal by Subject|1|||
161095824|NCT02446886|581741427|FG001|Overall Study|Withdrawal by Subject|1|||
161095825|NCT01592864|581741432|FG000|Overall Study|Withdrawal by Subject|0|||
161095826|NCT01592864|581741433|FG001|Overall Study|Withdrawal by Subject|1|||
161095827|NCT01971203|581741440|FG000|Overall Study|Protocol Violation|3|||
161095828|NCT01971203|581741441|FG001|Overall Study|Protocol Violation|2|||
161095829|NCT01971203|581741440|FG000|Overall Study|Withdrawal by Subject|5|||
161095830|NCT01971203|581741441|FG001|Overall Study|Withdrawal by Subject|6|||
161095831|NCT01971203|581741440|FG000|Overall Study|Adverse Event|1|||
161095832|NCT01971203|581741441|FG001|Overall Study|Adverse Event|0|||
161095833|NCT03037619|581741442|FG000|Overall Study|Lost to Follow-up|0|||
161095834|NCT03037619|581741443|FG001|Overall Study|Lost to Follow-up|1|||
161095835|NCT00307125|581741448|FG000|Screening Phase|Adverse Event|1|||
161095836|NCT00307125|581741449|FG001|Screening Phase|Adverse Event|0|||
161095837|NCT00307125|581741450|FG002|Screening Phase|Adverse Event|0|||
161095838|NCT00307125|581741448|FG000|Screening Phase|Protocol Violation|27|||
161095839|NCT00307125|581741449|FG001|Screening Phase|Protocol Violation|0|||
161095840|NCT00307125|581741450|FG002|Screening Phase|Protocol Violation|0|||
161095841|NCT00307125|581741448|FG000|Screening Phase|Lost to Follow-up|87|||
161095842|NCT00307125|581741449|FG001|Screening Phase|Lost to Follow-up|0|||
161095843|NCT00307125|581741450|FG002|Screening Phase|Lost to Follow-up|0|||
161095844|NCT00307125|581741448|FG000|Screening Phase|Death|10|||
161095845|NCT00307125|581741449|FG001|Screening Phase|Death|0|||
161210151|NCT01383954|582153398|FG000|Overall Study|Lack of Efficacy|2|||
161210152|NCT01383954|582153398|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
161210153|NCT01383954|582153398|FG000|Overall Study|Adverse Event|1|||
161210154|NCT01383954|582153398|FG000|Overall Study|Reason Not Specified|9|||
161210155|NCT04023994|582153406|FG000|Overall Study|Lost to Follow-up|0|||
161210156|NCT04023994|582153407|FG001|Overall Study|Lost to Follow-up|1|||
161210157|NCT04023994|582153408|FG002|Overall Study|Lost to Follow-up|2|||
161210158|NCT04023994|582153409|FG003|Overall Study|Lost to Follow-up|0|||
161210159|NCT04023994|582153410|FG004|Overall Study|Lost to Follow-up|0|||
161210160|NCT04023994|582153411|FG005|Overall Study|Lost to Follow-up|0|||
161210161|NCT04023994|582153406|FG000|Overall Study|Withdrawal by Subject|0|||
161210162|NCT04023994|582153407|FG001|Overall Study|Withdrawal by Subject|0|||
161210163|NCT04023994|582153408|FG002|Overall Study|Withdrawal by Subject|0|||
161210164|NCT04023994|582153409|FG003|Overall Study|Withdrawal by Subject|1|||
161210165|NCT04023994|582153410|FG004|Overall Study|Withdrawal by Subject|0|||
161210166|NCT04023994|582153411|FG005|Overall Study|Withdrawal by Subject|0|||
161210167|NCT00707174|582153412|FG000|Overall Study|Adverse Event|1|||
161210168|NCT00707174|582153413|FG001|Overall Study|Adverse Event|6|||
161210169|NCT00707174|582153412|FG000|Overall Study|Withdrawal by Subject|4|||
161210170|NCT00707174|582153413|FG001|Overall Study|Withdrawal by Subject|1|||
161210171|NCT02143947|582153415|FG000|Overall Study|Lost to Follow-up|4|||
161210172|NCT02143947|582153416|FG001|Overall Study|Lost to Follow-up|2|||
161210173|NCT00697112|582153421|FG000|Overall Study|Adverse Event|8|||
161210174|NCT00697112|582153421|FG000|Overall Study|Lost to Follow-up|1|||
161210175|NCT00697112|582153421|FG000|Overall Study|Did not meet inclusion criteria|1|||
161210176|NCT00422058|582153426|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
161210177|NCT00422058|582153427|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
161210178|NCT00422058|582153428|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
161210179|NCT00422058|582153429|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
161210180|NCT00422058|582153430|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
161210181|NCT00422058|582153431|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
161210182|NCT00422058|582153426|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
161210183|NCT00422058|582153427|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
161210184|NCT00422058|582153428|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
161210185|NCT00422058|582153429|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
161210186|NCT00422058|582153430|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
161210187|NCT00422058|582153431|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
161210188|NCT00422058|582153426|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
161210189|NCT00422058|582153427|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161210190|NCT00422058|582153428|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161095846|NCT00307125|581741450|FG002|Screening Phase|Death|0|||
161095847|NCT00307125|581741448|FG000|Screening Phase|Withdrawal by Subject|77|||
161095848|NCT00307125|581741449|FG001|Screening Phase|Withdrawal by Subject|0|||
161095849|NCT00307125|581741450|FG002|Screening Phase|Withdrawal by Subject|0|||
161210191|NCT00422058|582153429|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
161095850|NCT00307125|581741448|FG000|Screening Phase|Physician Decision|26|||
161210192|NCT00422058|582153430|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
161210193|NCT00422058|582153431|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
161210194|NCT00422058|582153426|FG000|Double-Blind, Week 0-20|Other|11|||
161095851|NCT00307125|581741449|FG001|Screening Phase|Physician Decision|0|||
161210195|NCT00422058|582153427|FG001|Double-Blind, Week 0-20|Other|3|||
161210196|NCT00422058|582153428|FG002|Double-Blind, Week 0-20|Other|8|||
161210197|NCT00422058|582153429|FG003|Double-Blind, Week 0-20|Other|8|||
161210198|NCT00422058|582153430|FG004|Double-Blind, Week 0-20|Other|4|||
161210199|NCT00422058|582153431|FG005|Double-Blind, Week 0-20|Other|10|||
161210200|NCT00422058|582153426|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
161210201|NCT00422058|582153427|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
161210202|NCT00422058|582153428|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
161210203|NCT00422058|582153429|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
161210204|NCT00422058|582153430|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
161210205|NCT00422058|582153431|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
161210206|NCT00422058|582153426|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
161210207|NCT00422058|582153427|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
161210208|NCT00422058|582153428|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
161210209|NCT00422058|582153429|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
161210210|NCT00422058|582153430|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
161210211|NCT00422058|582153431|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
161210212|NCT00422058|582153426|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
161210213|NCT00422058|582153427|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
161210214|NCT00422058|582153428|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
161210215|NCT00422058|582153429|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
161210216|NCT00422058|582153430|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
161210217|NCT00422058|582153431|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
161210218|NCT00422058|582153426|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
161210219|NCT00422058|582153427|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
161210220|NCT00422058|582153428|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
161210221|NCT00422058|582153429|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
161210222|NCT00422058|582153430|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
161210223|NCT00422058|582153431|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
161210224|NCT00422058|582153426|FG000|Open-Label Extension, Week 20-104|Other|13|||
161210225|NCT00422058|582153427|FG001|Open-Label Extension, Week 20-104|Other|14|||
161210226|NCT00422058|582153428|FG002|Open-Label Extension, Week 20-104|Other|6|||
161210227|NCT00422058|582153429|FG003|Open-Label Extension, Week 20-104|Other|13|||
161210228|NCT00422058|582153430|FG004|Open-Label Extension, Week 20-104|Other|16|||
161210229|NCT00422058|582153431|FG005|Open-Label Extension, Week 20-104|Other|18|||
161210230|NCT04057118|582153432|FG000|Overall Study|Adverse Event|1|||
161210231|NCT04057118|582153433|FG001|Overall Study|Adverse Event|0|||
161210232|NCT04057118|582153434|FG002|Overall Study|Adverse Event|1|||
161210233|NCT04057118|582153435|FG003|Overall Study|Adverse Event|1|||
161210234|NCT04057118|582153432|FG000|Overall Study|Physician Decision|0|||
161210235|NCT04057118|582153433|FG001|Overall Study|Physician Decision|0|||
161210236|NCT04057118|582153434|FG002|Overall Study|Physician Decision|1|||
161210237|NCT04057118|582153435|FG003|Overall Study|Physician Decision|1|||
161210238|NCT04057118|582153432|FG000|Overall Study|Withdrawal by Subject|2|||
161210239|NCT04057118|582153433|FG001|Overall Study|Withdrawal by Subject|2|||
161210240|NCT04057118|582153434|FG002|Overall Study|Withdrawal by Subject|0|||
161210241|NCT04057118|582153435|FG003|Overall Study|Withdrawal by Subject|2|||
161210242|NCT04057118|582153432|FG000|Overall Study|Not Specific|0|||
161210243|NCT04057118|582153433|FG001|Overall Study|Not Specific|0|||
161210244|NCT04057118|582153434|FG002|Overall Study|Not Specific|1|||
161210245|NCT04057118|582153435|FG003|Overall Study|Not Specific|1|||
161210246|NCT03402126|582153438|FG000|Overall Study|Lost to Follow-up|6|||
161210247|NCT03402126|582153438|FG000|Overall Study|Protocol Violation|10|||
161210248|NCT03402126|582153438|FG000|Overall Study|Sponsor request/Study termination|29|||
161210249|NCT03402126|582153438|FG000|Overall Study|Study product no longer in use|1|||
161210250|NCT03402126|582153438|FG000|Overall Study|Technical problems|1|||
161210251|NCT03402126|582153438|FG000|Overall Study|Withdrawal by Subject|6|||
161210252|NCT03402126|582153438|FG000|Overall Study|Physician Decision|2|||
161210253|NCT03402126|582153438|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
161210254|NCT03402126|582153438|FG000|Overall Study|Death|4|||
161210255|NCT00572156|582153439|FG000|Overall Study|Adverse Event|3|||
161210256|NCT00572156|582153440|FG001|Overall Study|Adverse Event|1|||
161210257|NCT00572156|582153441|FG002|Overall Study|Adverse Event|5|||
161210258|NCT00572156|582153442|FG003|Overall Study|Adverse Event|1|||
161210259|NCT00572156|582153439|FG000|Overall Study|Lost to Follow-up|1|||
161210260|NCT00572156|582153440|FG001|Overall Study|Lost to Follow-up|1|||
161210261|NCT00572156|582153441|FG002|Overall Study|Lost to Follow-up|1|||
161210262|NCT00572156|582153442|FG003|Overall Study|Lost to Follow-up|0|||
161210263|NCT00572156|582153439|FG000|Overall Study|Protocol Violation|1|||
161210264|NCT00572156|582153440|FG001|Overall Study|Protocol Violation|2|||
161210265|NCT00572156|582153441|FG002|Overall Study|Protocol Violation|0|||
161210266|NCT00572156|582153442|FG003|Overall Study|Protocol Violation|2|||
161210267|NCT00572156|582153439|FG000|Overall Study|Patient/Parent Decision|1|||
161095852|NCT00307125|581741450|FG002|Screening Phase|Physician Decision|0|||
161095853|NCT00307125|581741448|FG000|Screening Phase|Sponsor Decision|4|||
161095854|NCT00307125|581741449|FG001|Screening Phase|Sponsor Decision|0|||
161095855|NCT00307125|581741450|FG002|Screening Phase|Sponsor Decision|0|||
161095856|NCT00307125|581741448|FG000|Screening Phase|Study Terminated|17|||
161095857|NCT00307125|581741449|FG001|Screening Phase|Study Terminated|0|||
161095858|NCT00307125|581741450|FG002|Screening Phase|Study Terminated|0|||
161095859|NCT00307125|581741448|FG000|Screening Phase|Graft Loss|3|||
161095860|NCT00307125|581741449|FG001|Screening Phase|Graft Loss|0|||
161095861|NCT00307125|581741450|FG002|Screening Phase|Graft Loss|0|||
161095862|NCT00307125|581741448|FG000|Screening Phase|Graft Failure|8|||
161095863|NCT00307125|581741449|FG001|Screening Phase|Graft Failure|0|||
161095864|NCT00307125|581741450|FG002|Screening Phase|Graft Failure|0|||
161095865|NCT00307125|581741448|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
161095866|NCT00307125|581741449|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
161095867|NCT00307125|581741450|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
161095868|NCT00307125|581741448|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
161095869|NCT00307125|581741449|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
161095870|NCT00307125|581741450|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
161095871|NCT00307125|581741448|FG000|Screening Phase|Moved or transferred facilities|34|||
161095872|NCT00307125|581741449|FG001|Screening Phase|Moved or transferred facilities|0|||
161095873|NCT00307125|581741450|FG002|Screening Phase|Moved or transferred facilities|0|||
161095874|NCT00307125|581741448|FG000|Screening Phase|Received Pancreas Transplant|8|||
161095875|NCT00307125|581741449|FG001|Screening Phase|Received Pancreas Transplant|0|||
161095876|NCT00307125|581741450|FG002|Screening Phase|Received Pancreas Transplant|0|||
161095877|NCT00307125|581741448|FG000|Screening Phase|Ineligible for pilot|4|||
161095878|NCT00307125|581741449|FG001|Screening Phase|Ineligible for pilot|0|||
161095879|NCT00307125|581741450|FG002|Screening Phase|Ineligible for pilot|0|||
161095880|NCT00307125|581741448|FG000|Screening Phase|Try to get pregnant|1|||
161095881|NCT00307125|581741449|FG001|Screening Phase|Try to get pregnant|0|||
161095882|NCT00307125|581741450|FG002|Screening Phase|Try to get pregnant|0|||
161095883|NCT00307125|581741448|FG000|Screening Phase|Developed acute leukemia|1|||
161095884|NCT00307125|581741449|FG001|Screening Phase|Developed acute leukemia|0|||
161095885|NCT00307125|581741450|FG002|Screening Phase|Developed acute leukemia|0|||
161095886|NCT00307125|581741448|FG000|Screening Phase|Metastatic colon cancer|1|||
161095887|NCT00307125|581741449|FG001|Screening Phase|Metastatic colon cancer|0|||
161095888|NCT00307125|581741450|FG002|Screening Phase|Metastatic colon cancer|0|||
161095889|NCT00307125|581741448|FG000|Screening Phase|Malignancy|1|||
161095890|NCT00307125|581741449|FG001|Screening Phase|Malignancy|0|||
161095891|NCT00307125|581741450|FG002|Screening Phase|Malignancy|0|||
161095892|NCT00307125|581741448|FG000|Screening Phase|PAK|1|||
161095893|NCT00307125|581741449|FG001|Screening Phase|PAK|0|||
161095894|NCT00307125|581741450|FG002|Screening Phase|PAK|0|||
161095895|NCT00307125|581741448|FG000|Screening Phase|Ineligible|1|||
161095896|NCT00307125|581741449|FG001|Screening Phase|Ineligible|0|||
161095897|NCT00307125|581741450|FG002|Screening Phase|Ineligible|0|||
161095898|NCT00307125|581741448|FG000|Screening Phase|Screen Error|1|||
161095899|NCT00307125|581741449|FG001|Screening Phase|Screen Error|0|||
161095900|NCT00307125|581741450|FG002|Screening Phase|Screen Error|0|||
161095901|NCT00307125|581741448|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
161095902|NCT00307125|581741449|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
161095903|NCT00307125|581741450|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
161095904|NCT00307125|581741448|FG000|Screening Phase|AMR and treated with rituximab|1|||
161095905|NCT00307125|581741449|FG001|Screening Phase|AMR and treated with rituximab|0|||
161095906|NCT00307125|581741450|FG002|Screening Phase|AMR and treated with rituximab|0|||
161095907|NCT00307125|581741448|FG000|Screening Phase|Coronary artery bypass|1|||
161095908|NCT00307125|581741449|FG001|Screening Phase|Coronary artery bypass|0|||
161095909|NCT00307125|581741450|FG002|Screening Phase|Coronary artery bypass|0|||
161095910|NCT00307125|581741448|FG000|Pilot Phase|Lost to Follow-up|0|||
161095911|NCT00307125|581741449|FG001|Pilot Phase|Lost to Follow-up|1|||
161095912|NCT00307125|581741450|FG002|Pilot Phase|Lost to Follow-up|0|||
161095913|NCT00307125|581741448|FG000|Pilot Phase|Withdrawal by Subject|0|||
161095914|NCT00307125|581741449|FG001|Pilot Phase|Withdrawal by Subject|1|||
161095915|NCT00307125|581741450|FG002|Pilot Phase|Withdrawal by Subject|1|||
161095916|NCT02571049|581741451|FG000|Screening|Did not meet entry criteria|2|||
161095917|NCT02571049|581741452|FG001|Screening|Did not meet entry criteria|2|||
161095918|NCT02571049|581741451|FG000|Randomization|No migraine attack|0|||
161095919|NCT02571049|581741452|FG001|Randomization|No migraine attack|1|||
161095920|NCT02571049|581741451|FG000|Randomization|Adverse Event|0|||
161095921|NCT02571049|581741452|FG001|Randomization|Adverse Event|1|||
161095922|NCT01055262|581741455|FG000|Overall Study|Adverse Event|5|||
161095923|NCT01055262|581741455|FG000|Overall Study|Protocol Violation|3|||
161095924|NCT01055262|581741455|FG000|Overall Study|Uncooperativeness|1|||
161095925|NCT03370471|581741456|FG000|Overall Study|Withdrawal by Subject|6|||
161095926|NCT03370471|581741457|FG001|Overall Study|Withdrawal by Subject|1|||
161095927|NCT03370471|581741456|FG000|Overall Study|Unable to access veins for blood draw|0|||
161095928|NCT03370471|581741457|FG001|Overall Study|Unable to access veins for blood draw|1|||
161095929|NCT03370471|581741456|FG000|Overall Study|Screen fail|1|||
161095930|NCT03370471|581741457|FG001|Overall Study|Screen fail|0|||
161095931|NCT00561951|581741460|FG000|Overall Study|Adverse Event|11|||
161095932|NCT00561951|581741461|FG001|Overall Study|Adverse Event|14|||
161095933|NCT00561951|581741462|FG002|Overall Study|Adverse Event|14|||
161095934|NCT00561951|581741460|FG000|Overall Study|Lack of Efficacy|5|||
161095935|NCT00561951|581741461|FG001|Overall Study|Lack of Efficacy|3|||
161095936|NCT00561951|581741462|FG002|Overall Study|Lack of Efficacy|2|||
161210268|NCT00572156|582153440|FG001|Overall Study|Patient/Parent Decision|6|||
161210269|NCT00572156|582153441|FG002|Overall Study|Patient/Parent Decision|4|||
161210270|NCT00572156|582153442|FG003|Overall Study|Patient/Parent Decision|3|||
161210271|NCT00572156|582153439|FG000|Overall Study|Sponsor Decision|20|||
161210272|NCT00572156|582153440|FG001|Overall Study|Sponsor Decision|16|||
161210273|NCT00572156|582153441|FG002|Overall Study|Sponsor Decision|17|||
161210274|NCT00572156|582153442|FG003|Overall Study|Sponsor Decision|19|||
161210275|NCT02261974|582153443|FG000|Overall Study|Withdrawal by Subject|3|||
161210276|NCT02261974|582153444|FG001|Overall Study|Withdrawal by Subject|2|||
161210277|NCT02261974|582153443|FG000|Overall Study|Pregnancy|0|||
161210278|NCT02261974|582153444|FG001|Overall Study|Pregnancy|1|||
161210279|NCT02261974|582153443|FG000|Overall Study|Missed treatment cut-off date|6|||
161210280|NCT02261974|582153444|FG001|Overall Study|Missed treatment cut-off date|3|||
161210281|NCT02261974|582153443|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
161210282|NCT02261974|582153444|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
161210283|NCT02261974|582153443|FG000|Overall Study|Lost to Follow-up|2|||
161210284|NCT02261974|582153444|FG001|Overall Study|Lost to Follow-up|0|||
161210285|NCT02261974|582153443|FG000|Overall Study|Adverse Event|1|||
161210286|NCT02261974|582153444|FG001|Overall Study|Adverse Event|0|||
161210287|NCT02030834|582153445|FG000|Overall Study|Death|4|||
161210288|NCT02030834|582153446|FG001|Overall Study|Death|0|||
161210289|NCT02030834|582153447|FG002|Overall Study|Death|0|||
161210290|NCT02030834|582153445|FG000|Overall Study|Manufacturing failure|2|||
161210291|NCT02030834|582153446|FG001|Overall Study|Manufacturing failure|0|||
161210292|NCT02030834|582153447|FG002|Overall Study|Manufacturing failure|1|||
161210293|NCT02030834|582153445|FG000|Overall Study|Disease progression|2|||
161210294|NCT02030834|582153446|FG001|Overall Study|Disease progression|0|||
161210295|NCT02030834|582153447|FG002|Overall Study|Disease progression|2|||
161210296|NCT02030834|582153445|FG000|Overall Study|Lost to Follow-up|1|||
161210297|NCT02030834|582153446|FG001|Overall Study|Lost to Follow-up|0|||
161210298|NCT02030834|582153447|FG002|Overall Study|Lost to Follow-up|0|||
161210299|NCT02030834|582153445|FG000|Overall Study|Withdrawal by Subject|1|||
161210300|NCT02030834|582153446|FG001|Overall Study|Withdrawal by Subject|0|||
161210301|NCT02030834|582153447|FG002|Overall Study|Withdrawal by Subject|0|||
161210302|NCT02030834|582153445|FG000|Overall Study|Lack of funding|1|||
161210303|NCT02030834|582153446|FG001|Overall Study|Lack of funding|0|||
161210304|NCT02030834|582153447|FG002|Overall Study|Lack of funding|0|||
161210305|NCT03216954|582153450|FG000|Overall Study|Adverse Event|0|||
161210306|NCT03216954|582153451|FG001|Overall Study|Adverse Event|0|||
161210307|NCT03216954|582153452|FG002|Overall Study|Adverse Event|1|||
161210308|NCT03216954|582153453|FG003|Overall Study|Adverse Event|0|||
161210309|NCT03216954|582153454|FG004|Overall Study|Adverse Event|1|||
161210310|NCT03216954|582153450|FG000|Overall Study|Withdrawal by Subject|2|||
161210311|NCT03216954|582153451|FG001|Overall Study|Withdrawal by Subject|0|||
161210312|NCT03216954|582153452|FG002|Overall Study|Withdrawal by Subject|0|||
161210313|NCT03216954|582153453|FG003|Overall Study|Withdrawal by Subject|0|||
161210314|NCT03216954|582153454|FG004|Overall Study|Withdrawal by Subject|0|||
161210315|NCT03216954|582153450|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161210316|NCT03216954|582153451|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
161095937|NCT00561951|581741460|FG000|Overall Study|Lost to Follow-up|1|||
161210317|NCT03216954|582153452|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161210318|NCT03216954|582153453|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161210319|NCT03216954|582153454|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
161210320|NCT04736576|582153457|FG000|Overall Study|Progressive disease|3|||
161210321|NCT04736576|582153458|FG001|Overall Study|Progressive disease|1|||
161210322|NCT04736576|582153457|FG000|Overall Study|Death|1|||
161210323|NCT04736576|582153458|FG001|Overall Study|Death|0|||
161210324|NCT00720304|582153459|FG000|Overall Study|Withdrawal by Subject|14|||
161210325|NCT00720304|582153460|FG001|Overall Study|Withdrawal by Subject|1|||
161210326|NCT00720304|582153459|FG000|Overall Study|Death|1|||
161210327|NCT00720304|582153460|FG001|Overall Study|Death|0|||
161095938|NCT00561951|581741461|FG001|Overall Study|Lost to Follow-up|1|||
161210328|NCT00720304|582153459|FG000|Overall Study|Physician Decision|5|||
161210329|NCT00720304|582153460|FG001|Overall Study|Physician Decision|2|||
161210330|NCT00720304|582153459|FG000|Overall Study|Adverse Event|3|||
161210331|NCT00720304|582153460|FG001|Overall Study|Adverse Event|1|||
161095939|NCT00561951|581741462|FG002|Overall Study|Lost to Follow-up|0|||
161095940|NCT00561951|581741460|FG000|Overall Study|Withdrawal by Subject|10|||
161210332|NCT00720304|582153459|FG000|Overall Study|Disease progression|6|||
161210333|NCT00720304|582153460|FG001|Overall Study|Disease progression|1|||
161210334|NCT04330482|582153463|FG000|Overall Study|Lost to Follow-up|2|||
161210335|NCT04330482|582153464|FG001|Overall Study|Lost to Follow-up|1|||
161210336|NCT04330482|582153463|FG000|Overall Study|Withdrawal by Subject|0|||
161210337|NCT04330482|582153464|FG001|Overall Study|Withdrawal by Subject|3|||
161210338|NCT05180630|582153465|FG000|First Intervention|Physician Decision|0|||
161210339|NCT05180630|582153466|FG001|First Intervention|Physician Decision|0|||
161210340|NCT05180630|582153467|FG002|First Intervention|Physician Decision|3|||
161210341|NCT04333199|582153470|FG000|Evaluated Patients|Lost to Follow-up|0|||
161210342|NCT04333199|582153471|FG001|Evaluated Patients|Lost to Follow-up|1|||
161210343|NCT04333199|582153472|FG002|Evaluated Patients|Lost to Follow-up|2|||
161210344|NCT00709735|582153474|FG000|Overall Study|Lost to Follow-up|1|||
161210345|NCT00709735|582153475|FG001|Overall Study|Lost to Follow-up|1|||
161210346|NCT00709735|582153474|FG000|Overall Study|Relapse into Opioid Abuse|0|||
161210347|NCT00709735|582153475|FG001|Overall Study|Relapse into Opioid Abuse|1|||
161210348|NCT00709735|582153474|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
161210349|NCT00709735|582153475|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
161210350|NCT01333475|582153476|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
161210351|NCT01333475|582153477|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
161210352|NCT01333475|582153476|FG000|Overall Study|Toxicity|1|||
161210353|NCT01333475|582153477|FG001|Overall Study|Toxicity|3|||
161210354|NCT04440007|582153478|FG000|Overall Study|Adverse Event|0|||
161210355|NCT04440007|582153479|FG001|Overall Study|Adverse Event|1|||
161210356|NCT04440007|582153478|FG000|Overall Study|Lost to Follow-up|1|||
161210357|NCT04440007|582153479|FG001|Overall Study|Lost to Follow-up|3|||
161210358|NCT04440007|582153478|FG000|Overall Study|Death|7|||
161210359|NCT04440007|582153479|FG001|Overall Study|Death|2|||
161210360|NCT04440007|582153478|FG000|Overall Study|Physician Decision|1|||
161210361|NCT04440007|582153479|FG001|Overall Study|Physician Decision|1|||
161210362|NCT04440007|582153478|FG000|Overall Study|Withdrawal by Subject|2|||
161210363|NCT04440007|582153479|FG001|Overall Study|Withdrawal by Subject|1|||
161210364|NCT04440007|582153478|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
161210365|NCT04440007|582153479|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
161210366|NCT04440007|582153478|FG000|Overall Study|Discontinued prior to dosing|0|||
161210367|NCT04440007|582153479|FG001|Overall Study|Discontinued prior to dosing|2|||
161210368|NCT01466673|582153480|FG000|Overall Study|Non-compliance with study treatment|2|||
161210369|NCT01466673|582153481|FG001|Overall Study|Non-compliance with study treatment|0|||
161210370|NCT01466673|582153480|FG000|Overall Study|Lost to Follow-up|3|||
161210371|NCT01466673|582153481|FG001|Overall Study|Lost to Follow-up|5|||
161210372|NCT01466673|582153480|FG000|Overall Study|Adverse Event|2|||
161210373|NCT01466673|582153481|FG001|Overall Study|Adverse Event|1|||
161210374|NCT02981602|582153482|FG000|Overall Study|Adverse Event|0|||
161210375|NCT02981602|582153483|FG001|Overall Study|Adverse Event|0|||
161210376|NCT02981602|582153484|FG002|Overall Study|Adverse Event|0|||
161210377|NCT02981602|582153485|FG003|Overall Study|Adverse Event|1|||
161210378|NCT02981602|582153486|FG004|Overall Study|Adverse Event|0|||
161210379|NCT00666718|582153487|FG000|Overall Study|Adverse Event|0|||
161210380|NCT00666718|582153488|FG001|Overall Study|Adverse Event|1|||
161210381|NCT00666718|582153487|FG000|Overall Study|Death|1|||
161210382|NCT00666718|582153488|FG001|Overall Study|Death|0|||
161210383|NCT00666718|582153487|FG000|Overall Study|Lost to Follow-up|1|||
161210384|NCT00666718|582153488|FG001|Overall Study|Lost to Follow-up|0|||
161210385|NCT00666718|582153487|FG000|Overall Study|Entry Criteria Not Met|2|||
161210386|NCT00666718|582153488|FG001|Overall Study|Entry Criteria Not Met|0|||
161210387|NCT00666718|582153487|FG000|Overall Study|Protocol Violation|1|||
161210388|NCT00666718|582153488|FG001|Overall Study|Protocol Violation|3|||
161210389|NCT00666718|582153487|FG000|Overall Study|Withdrawal by Subject|7|||
161210390|NCT00666718|582153488|FG001|Overall Study|Withdrawal by Subject|12|||
161210391|NCT00666718|582153487|FG000|Overall Study|Physician Decision|0|||
161210392|NCT00666718|582153488|FG001|Overall Study|Physician Decision|2|||
161210393|NCT02567266|582153500|FG000|Overall Study|Withdrawal by Subject|10|||
161210394|NCT02567266|582153501|FG001|Overall Study|Withdrawal by Subject|7|||
161210395|NCT02567266|582153502|FG002|Overall Study|Withdrawal by Subject|6|||
161210396|NCT02567266|582153500|FG000|Overall Study|Lost to Follow-up|13|||
161210397|NCT02567266|582153501|FG001|Overall Study|Lost to Follow-up|8|||
161210398|NCT02567266|582153502|FG002|Overall Study|Lost to Follow-up|10|||
161210399|NCT02983227|582153503|FG000|Overall Study|Adverse Event|21|||
161210400|NCT02983227|582153504|FG001|Overall Study|Adverse Event|3|||
161210401|NCT02983227|582153503|FG000|Overall Study|Death|3|||
161210402|NCT02983227|582153504|FG001|Overall Study|Death|0|||
161210403|NCT02983227|582153503|FG000|Overall Study|Lack of Efficacy|8|||
161210404|NCT02983227|582153504|FG001|Overall Study|Lack of Efficacy|1|||
161210405|NCT02983227|582153503|FG000|Overall Study|Lost to Follow-up|3|||
161210406|NCT02983227|582153504|FG001|Overall Study|Lost to Follow-up|0|||
161210407|NCT02983227|582153503|FG000|Overall Study|Multiple Reasons|2|||
161210408|NCT02983227|582153504|FG001|Overall Study|Multiple Reasons|1|||
161095941|NCT00561951|581741461|FG001|Overall Study|Withdrawal by Subject|9|||
161095942|NCT00561951|581741462|FG002|Overall Study|Withdrawal by Subject|10|||
161095943|NCT00561951|581741460|FG000|Overall Study|Protocol Violation|4|||
161095944|NCT00561951|581741461|FG001|Overall Study|Protocol Violation|3|||
161095945|NCT00561951|581741462|FG002|Overall Study|Protocol Violation|4|||
161095946|NCT00561951|581741460|FG000|Overall Study|Physician Decision|1|||
161095947|NCT00561951|581741461|FG001|Overall Study|Physician Decision|0|||
161095948|NCT00561951|581741462|FG002|Overall Study|Physician Decision|0|||
161095949|NCT00561951|581741460|FG000|Overall Study|Pregnancy|0|||
161095950|NCT00561951|581741461|FG001|Overall Study|Pregnancy|1|||
161095951|NCT00561951|581741462|FG002|Overall Study|Pregnancy|0|||
161095952|NCT00561951|581741460|FG000|Overall Study|Meet Withdrawal Criterion|0|||
161095953|NCT00561951|581741461|FG001|Overall Study|Meet Withdrawal Criterion|1|||
161095954|NCT00561951|581741462|FG002|Overall Study|Meet Withdrawal Criterion|1|||
161095955|NCT00561951|581741460|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
161095956|NCT00561951|581741461|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
161095957|NCT00561951|581741462|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
161095958|NCT01765179|581741463|FG000|Overall Study|Adverse Event|3|||
161095959|NCT01765179|581741463|FG000|Overall Study|Lost to Follow-up|5|||
161095960|NCT01765179|581741463|FG000|Overall Study|Non-compliance with study drug|2|||
161095961|NCT01765179|581741463|FG000|Overall Study|Protocol Violation|1|||
161095962|NCT01765179|581741463|FG000|Overall Study|Withdrawal by Subject|8|||
161095963|NCT01765179|581741463|FG000|Overall Study|Hematocrit >54%|3|||
161095964|NCT01765179|581741463|FG000|Overall Study|prohibited med|1|||
161095965|NCT01765179|581741463|FG000|Overall Study|Out of country unable to finish study|1|||
161095966|NCT01765179|581741463|FG000|Overall Study|lack of venous access|1|||
161095967|NCT01765179|581741463|FG000|Overall Study|work conflict|1|||
161095968|NCT01765179|581741463|FG000|Overall Study|Ca elevated 10.6|1|||
161095969|NCT02640157|581741464|FG000|Overall Study|Adverse Event|2|||
161095970|NCT02640157|581741465|FG001|Overall Study|Adverse Event|2|||
161095971|NCT02640157|581741466|FG002|Overall Study|Adverse Event|1|||
161095972|NCT02640157|581741464|FG000|Overall Study|Withdrew consent|2|||
161095973|NCT02640157|581741465|FG001|Overall Study|Withdrew consent|0|||
161095974|NCT02640157|581741466|FG002|Overall Study|Withdrew consent|2|||
161095975|NCT02640157|581741464|FG000|Overall Study|Lost to Follow-up|9|||
161095976|NCT02640157|581741465|FG001|Overall Study|Lost to Follow-up|2|||
161095977|NCT02640157|581741466|FG002|Overall Study|Lost to Follow-up|7|||
161095978|NCT02640157|581741464|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
161095979|NCT02640157|581741465|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
161095980|NCT02640157|581741466|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
161095981|NCT01596621|581741467|FG000|Overall Study|Death|4|||
161095982|NCT01596621|581741467|FG000|Overall Study|Withdrawal by Subject|9|||
161095983|NCT01596621|581741467|FG000|Overall Study|Disease Progression|49|||
161095984|NCT01596621|581741467|FG000|Overall Study|Lost to Follow-up|3|||
161095985|NCT01596621|581741467|FG000|Overall Study|Other than specified|13|||
161095986|NCT00710021|581741468|FG000|Overall Study|Lost to Follow-up|1|||
161095987|NCT00710021|581741469|FG001|Overall Study|Lost to Follow-up|0|||
161095988|NCT00710021|581741470|FG002|Overall Study|Lost to Follow-up|0|||
161095989|NCT00710021|581741468|FG000|Overall Study|Subject's Decision|0|||
161095990|NCT00710021|581741469|FG001|Overall Study|Subject's Decision|1|||
161095991|NCT00710021|581741470|FG002|Overall Study|Subject's Decision|0|||
161095992|NCT00710021|581741468|FG000|Overall Study|Subject misrandomized|0|||
161095993|NCT00710021|581741469|FG001|Overall Study|Subject misrandomized|1|||
161095994|NCT00710021|581741470|FG002|Overall Study|Subject misrandomized|1|||
161095995|NCT00710021|581741468|FG000|Overall Study|Physician Decision|0|||
161095996|NCT00710021|581741469|FG001|Overall Study|Physician Decision|1|||
161095997|NCT00710021|581741470|FG002|Overall Study|Physician Decision|0|||
161095998|NCT00421707|581741471|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
161095999|NCT00421707|581741472|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
161096000|NCT00421707|581741471|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
161096001|NCT00421707|581741472|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
161096002|NCT00421707|581741471|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
161096003|NCT00421707|581741472|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
161096004|NCT00421707|581741471|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
161096005|NCT00421707|581741472|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
161096006|NCT00421707|581741471|FG000|Period 2: Washout|Adverse Event|1|||
161096007|NCT00421707|581741472|FG001|Period 2: Washout|Adverse Event|1|||
161096008|NCT00421707|581741471|FG000|Period 2: Washout|Withdrawal by Subject|0|||
161096009|NCT00421707|581741472|FG001|Period 2: Washout|Withdrawal by Subject|1|||
161096010|NCT00421707|581741471|FG000|Period 2: Washout|Lost to Follow-up|0|||
161096011|NCT00421707|581741472|FG001|Period 2: Washout|Lost to Follow-up|1|||
161096012|NCT00421707|581741471|FG000|Period 2: Washout|Other: Pregnancy|0|||
161096013|NCT00421707|581741472|FG001|Period 2: Washout|Other: Pregnancy|1|||
161096014|NCT00421707|581741471|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
161096015|NCT00421707|581741472|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
161210409|NCT02983227|582153503|FG000|Overall Study|Physician Decision|3|||
161096016|NCT00421707|581741471|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
161096017|NCT00421707|581741472|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
161096018|NCT00421707|581741471|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
161096019|NCT00421707|581741472|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
161096020|NCT01898923|581741475|FG000|Overall Study|Lack of Efficacy|5|||
161096021|NCT01898923|581741476|FG001|Overall Study|Lack of Efficacy|6|||
161096022|NCT01898923|581741475|FG000|Overall Study|Adverse Event|3|||
161096023|NCT01898923|581741476|FG001|Overall Study|Adverse Event|1|||
161096024|NCT01898923|581741475|FG000|Overall Study|Lost to Follow-up|0|||
161096025|NCT01898923|581741476|FG001|Overall Study|Lost to Follow-up|1|||
161096026|NCT01898923|581741475|FG000|Overall Study|Withdrawal by Subject|4|||
161096027|NCT01898923|581741476|FG001|Overall Study|Withdrawal by Subject|7|||
161096028|NCT01898923|581741475|FG000|Overall Study|Physician Decision|3|||
161096029|NCT01898923|581741476|FG001|Overall Study|Physician Decision|4|||
161096030|NCT01898923|581741475|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
161096031|NCT01898923|581741476|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
161096032|NCT00723021|581741477|FG000|Intervention Period 4|Adverse Event|0|||
161096033|NCT00723021|581741478|FG001|Intervention Period 4|Adverse Event|0|||
161096034|NCT00723021|581741479|FG002|Intervention Period 4|Adverse Event|0|||
161096035|NCT00723021|581741480|FG003|Intervention Period 4|Adverse Event|0|||
161096036|NCT00723021|581741481|FG004|Intervention Period 4|Adverse Event|1|||
161096037|NCT02903368|581741485|FG000|Part 1|Adverse Event|3|||
161096038|NCT02903368|581741486|FG001|Part 1|Adverse Event|0|||
161096039|NCT02903368|581741487|FG002|Part 1|Adverse Event|0|||
161096040|NCT02903368|581741488|FG003|Part 1|Adverse Event|0|||
161096041|NCT02903368|581741485|FG000|Part 1|Withdrawal by Subject|1|||
161096042|NCT02903368|581741486|FG001|Part 1|Withdrawal by Subject|0|||
161096043|NCT02903368|581741487|FG002|Part 1|Withdrawal by Subject|0|||
161096044|NCT02903368|581741488|FG003|Part 1|Withdrawal by Subject|0|||
161096045|NCT02903368|581741485|FG000|Part 2|Adverse Event|0|||
161096046|NCT02903368|581741486|FG001|Part 2|Adverse Event|0|||
161096047|NCT02903368|581741487|FG002|Part 2|Adverse Event|5|||
161096048|NCT02903368|581741488|FG003|Part 2|Adverse Event|0|||
161096049|NCT02903368|581741485|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
161096050|NCT02903368|581741486|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
161096051|NCT02903368|581741487|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
161096052|NCT02903368|581741488|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
161096053|NCT02903368|581741485|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
161096054|NCT02903368|581741486|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
161096055|NCT02903368|581741487|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
161096056|NCT02903368|581741488|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
161096057|NCT02903368|581741485|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
161096058|NCT02903368|581741486|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
161096059|NCT02903368|581741487|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
161096060|NCT02903368|581741488|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
161096069|NCT00147823|581741493|FG000|Overall Study|Lost to Follow-up|6|||
161096070|NCT00147823|581741494|FG001|Overall Study|Lost to Follow-up|12|||
161096071|NCT00147823|581741493|FG000|Overall Study|Physician Decision|1|||
161096072|NCT00147823|581741494|FG001|Overall Study|Physician Decision|0|||
161096073|NCT00147823|581741493|FG000|Overall Study|Withdrawal by Subject|0|||
161096074|NCT00147823|581741494|FG001|Overall Study|Withdrawal by Subject|1|||
161096075|NCT00147823|581741493|FG000|Overall Study|Did not receive vitoss due to infection|6|||
161096076|NCT00147823|581741494|FG001|Overall Study|Did not receive vitoss due to infection|2|||
161096077|NCT04751656|581742707|FG000|Overall Study|Lost to Follow-up|1|||
161096078|NCT01485354|581742713|FG000|Overall Study|Withdrawal by Subject|5|||
161096079|NCT03566810|581742714|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161096080|NCT03566810|581742715|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
161096081|NCT03566810|581742716|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161096082|NCT03566810|581742717|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
161096083|NCT01444651|581742720|FG000|Overall Study|Adverse Event|3|||
161096084|NCT01444651|581742721|FG001|Overall Study|Adverse Event|2|||
161096085|NCT01444651|581742720|FG000|Overall Study|Lost to Follow-up|5|||
161096086|NCT01444651|581742721|FG001|Overall Study|Lost to Follow-up|5|||
161096087|NCT01444651|581742720|FG000|Overall Study|Non-fasting|2|||
161096088|NCT01444651|581742721|FG001|Overall Study|Non-fasting|1|||
161096089|NCT01444651|581742720|FG000|Overall Study|Missing data|1|||
161096090|NCT01444651|581742721|FG001|Overall Study|Missing data|1|||
161096091|NCT03338192|581742722|FG000|Year One to Year Two|High Blood Pressure|7|||
161096092|NCT03338192|581742723|FG001|Year One to Year Two|High Blood Pressure|1|||
161096093|NCT03338192|581742722|FG000|Year One to Year Two|HIV +|1|||
161096094|NCT03338192|581742723|FG001|Year One to Year Two|HIV +|0|||
161096095|NCT03338192|581742722|FG000|Year Two to Year Four|High Blood Pressure|1|||
161096096|NCT03338192|581742723|FG001|Year Two to Year Four|High Blood Pressure|0|||
161096097|NCT03338192|581742722|FG000|Year Two to Year Four|HIV +|2|||
161096098|NCT03338192|581742723|FG001|Year Two to Year Four|HIV +|0|||
161096099|NCT03338192|581742722|FG000|Year Four to Year Six|High Blood Pressure|2|||
161096100|NCT03338192|581742723|FG001|Year Four to Year Six|High Blood Pressure|1|||
161096101|NCT01929980|581742728|FG000|Overall Study|Physician Decision|1|||
161096102|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
161096103|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
161096104|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
161096105|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
161096106|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
161096107|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
161096108|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
161096109|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
161096110|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
161096111|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
161096112|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
161096113|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
161096114|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Death|3|||
161096115|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Death|1|||
161096116|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
161096117|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
161096118|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Adverse Event|7|||
161096119|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Adverse Event|8|||
161096120|NCT03236246|581742729|FG000|24-Week Dose Titration Period|Captured as Other|1|||
161096121|NCT03236246|581742730|FG001|24-Week Dose Titration Period|Captured as Other|2|||
161096122|NCT03236246|581742729|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
161096123|NCT03236246|581742730|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
161096124|NCT03236246|581742729|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
161096125|NCT03236246|581742730|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
161096126|NCT03236246|581742729|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
161096127|NCT03236246|581742730|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
161096128|NCT03236246|581742729|FG000|24-Week Dose Maintenance Period|Death|0|||
161096129|NCT03236246|581742730|FG001|24-Week Dose Maintenance Period|Death|1|||
161096130|NCT03236246|581742729|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
161096131|NCT03236246|581742730|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
161096132|NCT02952001|581742731|FG000|Overall Study|Adverse Event|3|||
161096133|NCT02952001|581742732|FG001|Overall Study|Adverse Event|0|||
161096134|NCT02952001|581742731|FG000|Overall Study|Prohibited therapy|10|||
161096135|NCT02952001|581742732|FG001|Overall Study|Prohibited therapy|3|||
161096136|NCT02952001|581742731|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
161096137|NCT02952001|581742732|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
161096138|NCT01681628|581742735|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
161096139|NCT01681628|581742736|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
161096140|NCT01681628|581742735|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
161096141|NCT01681628|581742736|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
161096142|NCT01681628|581742735|FG000|19 Months Follow-up|Death|1|||
161096143|NCT01681628|581742736|FG001|19 Months Follow-up|Death|0|||
161096144|NCT01681628|581742735|FG000|19 Months Follow-up|Lost to Follow-up|61|||
161096145|NCT01681628|581742736|FG001|19 Months Follow-up|Lost to Follow-up|43|||
161210410|NCT02983227|582153504|FG001|Overall Study|Physician Decision|1|||
161210411|NCT02983227|582153503|FG000|Overall Study|Withdrawal by Subject|19|||
161096146|NCT01794520|581742737|FG000|Overall Study|Adverse events- related to progression|0|||
161096147|NCT01794520|581742738|FG001|Overall Study|Adverse events- related to progression|0|||
161096148|NCT01794520|581742739|FG002|Overall Study|Adverse events- related to progression|1|||
161096149|NCT01794520|581742740|FG003|Overall Study|Adverse events- related to progression|2|||
161096150|NCT01794520|581742741|FG004|Overall Study|Adverse events- related to progression|0|||
161096151|NCT01794520|581742742|FG005|Overall Study|Adverse events- related to progression|1|||
161096152|NCT01794520|581742743|FG006|Overall Study|Adverse events- related to progression|0|||
161210412|NCT02983227|582153504|FG001|Overall Study|Withdrawal by Subject|8|||
161210413|NCT02164539|582153507|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
161096153|NCT01794520|581742737|FG000|Overall Study|Adverse event- not related to progression|1|||
161096154|NCT01794520|581742738|FG001|Overall Study|Adverse event- not related to progression|1|||
161096155|NCT01794520|581742739|FG002|Overall Study|Adverse event- not related to progression|0|||
161096156|NCT01794520|581742740|FG003|Overall Study|Adverse event- not related to progression|0|||
161096157|NCT01794520|581742741|FG004|Overall Study|Adverse event- not related to progression|2|||
161096158|NCT01794520|581742742|FG005|Overall Study|Adverse event- not related to progression|0|||
161096159|NCT01794520|581742743|FG006|Overall Study|Adverse event- not related to progression|0|||
161096160|NCT01794520|581742737|FG000|Overall Study|Progressive disease|5|||
161096161|NCT01794520|581742738|FG001|Overall Study|Progressive disease|6|||
161096162|NCT01794520|581742739|FG002|Overall Study|Progressive disease|2|||
161096163|NCT01794520|581742740|FG003|Overall Study|Progressive disease|5|||
161096164|NCT01794520|581742741|FG004|Overall Study|Progressive disease|27|||
161096165|NCT01794520|581742742|FG005|Overall Study|Progressive disease|18|||
161096166|NCT01794520|581742743|FG006|Overall Study|Progressive disease|0|||
161096167|NCT01794520|581742737|FG000|Overall Study|Withdrew consent|0|||
161096168|NCT01794520|581742738|FG001|Overall Study|Withdrew consent|0|||
161096169|NCT01794520|581742739|FG002|Overall Study|Withdrew consent|1|||
161096170|NCT01794520|581742740|FG003|Overall Study|Withdrew consent|1|||
161096171|NCT01794520|581742741|FG004|Overall Study|Withdrew consent|0|||
161096172|NCT01794520|581742742|FG005|Overall Study|Withdrew consent|0|||
161096173|NCT01794520|581742743|FG006|Overall Study|Withdrew consent|0|||
161096174|NCT01794520|581742737|FG000|Overall Study|Lost to Follow-up|0|||
161096175|NCT01794520|581742738|FG001|Overall Study|Lost to Follow-up|0|||
161096176|NCT01794520|581742739|FG002|Overall Study|Lost to Follow-up|0|||
161096177|NCT01794520|581742740|FG003|Overall Study|Lost to Follow-up|0|||
161096178|NCT01794520|581742741|FG004|Overall Study|Lost to Follow-up|1|||
161096179|NCT01794520|581742742|FG005|Overall Study|Lost to Follow-up|0|||
161096180|NCT01794520|581742743|FG006|Overall Study|Lost to Follow-up|0|||
161096181|NCT01794520|581742737|FG000|Overall Study|Toxicity|0|||
161096182|NCT01794520|581742738|FG001|Overall Study|Toxicity|2|||
161096183|NCT01794520|581742739|FG002|Overall Study|Toxicity|0|||
161096184|NCT01794520|581742740|FG003|Overall Study|Toxicity|0|||
161096185|NCT01794520|581742741|FG004|Overall Study|Toxicity|0|||
161096186|NCT01794520|581742742|FG005|Overall Study|Toxicity|0|||
161096187|NCT01794520|581742743|FG006|Overall Study|Toxicity|0|||
161096188|NCT01794520|581742737|FG000|Overall Study|Study terminated by sponsor|0|||
161096189|NCT01794520|581742738|FG001|Overall Study|Study terminated by sponsor|0|||
161096190|NCT01794520|581742739|FG002|Overall Study|Study terminated by sponsor|1|||
161096191|NCT01794520|581742740|FG003|Overall Study|Study terminated by sponsor|0|||
161096192|NCT01794520|581742741|FG004|Overall Study|Study terminated by sponsor|1|||
161096193|NCT01794520|581742742|FG005|Overall Study|Study terminated by sponsor|0|||
161096194|NCT01794520|581742743|FG006|Overall Study|Study terminated by sponsor|7|||
161096195|NCT01794520|581742737|FG000|Overall Study|Death|0|||
161096196|NCT01794520|581742738|FG001|Overall Study|Death|0|||
161096197|NCT01794520|581742739|FG002|Overall Study|Death|0|||
161096198|NCT01794520|581742740|FG003|Overall Study|Death|0|||
161096199|NCT01794520|581742741|FG004|Overall Study|Death|1|||
161096200|NCT01794520|581742742|FG005|Overall Study|Death|0|||
161096201|NCT01794520|581742743|FG006|Overall Study|Death|22|||
161096202|NCT01794520|581742737|FG000|Overall Study|Other, not specified|0|||
161096203|NCT01794520|581742738|FG001|Overall Study|Other, not specified|0|||
161096204|NCT01794520|581742739|FG002|Overall Study|Other, not specified|1|||
161096205|NCT01794520|581742740|FG003|Overall Study|Other, not specified|1|||
161096206|NCT01794520|581742741|FG004|Overall Study|Other, not specified|4|||
161096207|NCT01794520|581742742|FG005|Overall Study|Other, not specified|1|||
161096208|NCT01794520|581742743|FG006|Overall Study|Other, not specified|2|||
161096209|NCT01376349|581742745|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
161096210|NCT01376349|581742746|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
161096211|NCT01376349|581742747|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
161096212|NCT01376349|581742745|FG000|Raondomized Treatment|Adverse Event|13|||
161096213|NCT01376349|581742746|FG001|Raondomized Treatment|Adverse Event|17|||
161096214|NCT01376349|581742747|FG002|Raondomized Treatment|Adverse Event|14|||
161096215|NCT01376349|581742745|FG000|Raondomized Treatment|Unkown|1|||
161096216|NCT01376349|581742746|FG001|Raondomized Treatment|Unkown|2|||
161096217|NCT01376349|581742747|FG002|Raondomized Treatment|Unkown|1|||
161096218|NCT01376349|581742745|FG000|Raondomized Treatment|Alternative Treatment|0|||
161096219|NCT01376349|581742746|FG001|Raondomized Treatment|Alternative Treatment|0|||
161096220|NCT01376349|581742747|FG002|Raondomized Treatment|Alternative Treatment|1|||
161096221|NCT00718640|581742748|FG000|Overall Study|Adverse Event|4|||
161096222|NCT00718640|581742748|FG000|Overall Study|Death|1|||
161096223|NCT00718640|581742748|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
161096224|NCT05193500|581742749|FG000|Overall Study|Withdrawal by Subject|7|||
161096225|NCT05193500|581742750|FG001|Overall Study|Withdrawal by Subject|4|||
161096226|NCT05193500|581742751|FG002|Overall Study|Withdrawal by Subject|3|||
161096227|NCT05193500|581742752|FG003|Overall Study|Withdrawal by Subject|5|||
161096228|NCT01978262|581742753|FG000|Overall Study|Withdrawal by Subject|9|||
161096229|NCT01978262|581742753|FG000|Overall Study|Lost to Follow-up|2|||
161096230|NCT02202551|581742754|FG000|Overall Study|Adverse Event|8|||
161096231|NCT02202551|581742755|FG001|Overall Study|Adverse Event|19|||
161096232|NCT02202551|581742756|FG002|Overall Study|Adverse Event|5|||
161096233|NCT02202551|581742757|FG003|Overall Study|Adverse Event|9|||
161096234|NCT02202551|581742754|FG000|Overall Study|Death|3|||
161096235|NCT02202551|581742755|FG001|Overall Study|Death|2|||
161096236|NCT02202551|581742756|FG002|Overall Study|Death|1|||
161096237|NCT02202551|581742757|FG003|Overall Study|Death|1|||
161096238|NCT02202551|581742754|FG000|Overall Study|Lost to Follow-up|0|||
161096239|NCT02202551|581742755|FG001|Overall Study|Lost to Follow-up|1|||
161096240|NCT02202551|581742756|FG002|Overall Study|Lost to Follow-up|0|||
161096241|NCT02202551|581742757|FG003|Overall Study|Lost to Follow-up|1|||
161096242|NCT02202551|581742754|FG000|Overall Study|Needed to take excluded medication|0|||
161096243|NCT02202551|581742755|FG001|Overall Study|Needed to take excluded medication|2|||
161096244|NCT02202551|581742756|FG002|Overall Study|Needed to take excluded medication|0|||
161096245|NCT02202551|581742757|FG003|Overall Study|Needed to take excluded medication|1|||
161096246|NCT02202551|581742754|FG000|Overall Study|Subject moved away|0|||
161096247|NCT02202551|581742755|FG001|Overall Study|Subject moved away|1|||
161096248|NCT02202551|581742756|FG002|Overall Study|Subject moved away|0|||
161096249|NCT02202551|581742757|FG003|Overall Study|Subject moved away|0|||
161096250|NCT02202551|581742754|FG000|Overall Study|DBS surgery|3|||
161096251|NCT02202551|581742755|FG001|Overall Study|DBS surgery|0|||
161096252|NCT02202551|581742756|FG002|Overall Study|DBS surgery|0|||
161096253|NCT02202551|581742757|FG003|Overall Study|DBS surgery|0|||
161096254|NCT02202551|581742754|FG000|Overall Study|Dyskinesia upon taper|1|||
161096255|NCT02202551|581742755|FG001|Overall Study|Dyskinesia upon taper|0|||
161096256|NCT02202551|581742756|FG002|Overall Study|Dyskinesia upon taper|0|||
161096257|NCT02202551|581742757|FG003|Overall Study|Dyskinesia upon taper|0|||
161096258|NCT02202551|581742754|FG000|Overall Study|Lack of Efficacy|0|||
161096259|NCT02202551|581742755|FG001|Overall Study|Lack of Efficacy|1|||
161096260|NCT02202551|581742756|FG002|Overall Study|Lack of Efficacy|0|||
161096261|NCT02202551|581742757|FG003|Overall Study|Lack of Efficacy|0|||
161096262|NCT02202551|581742754|FG000|Overall Study|Physician Decision|1|||
161096263|NCT02202551|581742755|FG001|Overall Study|Physician Decision|0|||
161096264|NCT02202551|581742756|FG002|Overall Study|Physician Decision|0|||
161096265|NCT02202551|581742757|FG003|Overall Study|Physician Decision|0|||
161096266|NCT02202551|581742754|FG000|Overall Study|Site closure|3|||
161096267|NCT02202551|581742755|FG001|Overall Study|Site closure|0|||
161096268|NCT02202551|581742756|FG002|Overall Study|Site closure|0|||
161096269|NCT02202551|581742757|FG003|Overall Study|Site closure|1|||
161096270|NCT02202551|581742754|FG000|Overall Study|Unable to complete visits per protocol|1|||
161096271|NCT02202551|581742755|FG001|Overall Study|Unable to complete visits per protocol|0|||
161096272|NCT02202551|581742756|FG002|Overall Study|Unable to complete visits per protocol|0|||
161096273|NCT02202551|581742757|FG003|Overall Study|Unable to complete visits per protocol|0|||
161096274|NCT02202551|581742754|FG000|Overall Study|Worsening Dyskinesia|0|||
161096275|NCT02202551|581742755|FG001|Overall Study|Worsening Dyskinesia|0|||
161096276|NCT02202551|581742756|FG002|Overall Study|Worsening Dyskinesia|0|||
161096277|NCT02202551|581742757|FG003|Overall Study|Worsening Dyskinesia|1|||
161096278|NCT02202551|581742754|FG000|Overall Study|Protocol Violation|0|||
161096279|NCT02202551|581742755|FG001|Overall Study|Protocol Violation|1|||
161096280|NCT02202551|581742756|FG002|Overall Study|Protocol Violation|0|||
161096281|NCT02202551|581742757|FG003|Overall Study|Protocol Violation|0|||
161096282|NCT02202551|581742754|FG000|Overall Study|Sponsor's decision|2|||
161096283|NCT02202551|581742755|FG001|Overall Study|Sponsor's decision|0|||
161096284|NCT02202551|581742756|FG002|Overall Study|Sponsor's decision|0|||
161096285|NCT02202551|581742757|FG003|Overall Study|Sponsor's decision|0|||
161096286|NCT02202551|581742754|FG000|Overall Study|Subject unwilling to proceed|1|||
161096287|NCT02202551|581742755|FG001|Overall Study|Subject unwilling to proceed|5|||
161096288|NCT02202551|581742756|FG002|Overall Study|Subject unwilling to proceed|3|||
161096289|NCT02202551|581742757|FG003|Overall Study|Subject unwilling to proceed|5|||
161096290|NCT02202551|581742754|FG000|Overall Study|Subject consent withdrawn|0|||
161096291|NCT02202551|581742755|FG001|Overall Study|Subject consent withdrawn|3|||
161096292|NCT02202551|581742756|FG002|Overall Study|Subject consent withdrawn|1|||
161096293|NCT02202551|581742757|FG003|Overall Study|Subject consent withdrawn|2|||
161096294|NCT02202551|581742754|FG000|Overall Study|eGFR<50mL/min/m2|2|||
161096295|NCT02202551|581742755|FG001|Overall Study|eGFR<50mL/min/m2|2|||
161096296|NCT02202551|581742756|FG002|Overall Study|eGFR<50mL/min/m2|0|||
161096297|NCT02202551|581742757|FG003|Overall Study|eGFR<50mL/min/m2|1|||
161096298|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
161096299|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
161096300|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Death|0|||
161096301|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Death|2|||
161096302|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161096303|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
161096304|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
161096305|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
161096306|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
161096307|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
161096308|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
161096309|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
161096310|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
161096311|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
161096312|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
161096313|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
161096314|NCT00343252|581742771|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
161096315|NCT00343252|581742772|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
161096316|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
161096317|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
161096318|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Death|3|||
161096319|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Death|3|||
161096320|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161096321|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161096322|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
161096323|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
161096324|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
161096325|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
161096326|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
161096327|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
161096328|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
161096329|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
161096330|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
161096331|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
161096332|NCT00343252|581742771|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
161096333|NCT00343252|581742772|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
161096334|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
161096335|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
161096336|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Death|4|||
161096337|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Death|5|||
161096338|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
161096339|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
161096340|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
161096341|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
161096342|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
161096343|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
161096344|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
161096345|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
161096346|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
161096347|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
161096348|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
161096349|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
161096350|NCT00343252|581742771|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
161096351|NCT00343252|581742772|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
161096352|NCT02076178|581742773|FG000|Oral Phase|Adverse Event|0|||
161096353|NCT02076178|581742774|FG001|Oral Phase|Adverse Event|7|||
161096354|NCT02076178|581742773|FG000|Oral Phase|Withdrawal by Subject|0|||
161096355|NCT02076178|581742774|FG001|Oral Phase|Withdrawal by Subject|4|||
161096356|NCT02076178|581742773|FG000|Oral Phase|Physician Decision|0|||
161096357|NCT02076178|581742774|FG001|Oral Phase|Physician Decision|1|||
161096358|NCT02076178|581742773|FG000|Injection Phase|Protocol defined stopping criteria|1|||
161096359|NCT02076178|581742774|FG001|Injection Phase|Protocol defined stopping criteria|0|||
161096360|NCT02076178|581742773|FG000|Injection Phase|Withdrawal by Subject|0|||
161096361|NCT02076178|581742774|FG001|Injection Phase|Withdrawal by Subject|3|||
161096362|NCT02076178|581742773|FG000|Injection Phase|Physician Decision|0|||
161096363|NCT02076178|581742774|FG001|Injection Phase|Physician Decision|3|||
161096364|NCT02076178|581742773|FG000|Injection Phase|Lost to Follow-up|0|||
161096365|NCT02076178|581742774|FG001|Injection Phase|Lost to Follow-up|1|||
161096366|NCT01026454|581742775|FG000|Second Intervention|Pregnancy|1|||
161096367|NCT01026454|581742776|FG001|Second Intervention|Pregnancy|1|||
161096368|NCT02893930|581742777|FG000|Overall Study|Adverse Event|3|||
161096369|NCT02893930|581742777|FG000|Overall Study|Death|1|||
161096370|NCT02893930|581742777|FG000|Overall Study|Disease progression|5|||
161096371|NCT02893930|581742777|FG000|Overall Study|Withdrawal by Subject|2|||
161096372|NCT02893930|581742777|FG000|Overall Study|Physician Decision|1|||
161096373|NCT02893930|581742777|FG000|Overall Study|Ineligible|1|||
161096374|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
161096375|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
161096376|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
161096377|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
161096378|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
161096379|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
161096380|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
161096381|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
161096382|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
161096383|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
161096384|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
161096385|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
161096386|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
161096387|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
161096388|NCT01294683|581742784|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
161096389|NCT01294683|581742785|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
161096390|NCT01294683|581742784|FG000|Post Crossover (Period III)|Adverse Event|6|||
161096391|NCT01294683|581742785|FG001|Post Crossover (Period III)|Adverse Event|6|||
161096392|NCT01294683|581742784|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
161096393|NCT01294683|581742785|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
161096394|NCT01294683|581742784|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
161096395|NCT01294683|581742785|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
161096396|NCT01294683|581742784|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
161096397|NCT01294683|581742785|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
161096398|NCT01794923|581742786|FG000|Overall Study|Adverse Event|0|||
161096399|NCT01794923|581742787|FG001|Overall Study|Adverse Event|0|||
161096400|NCT01794923|581742788|FG002|Overall Study|Adverse Event|1|||
161096401|NCT01881750|581742789|FG000|Overall Study|Changes in concomitant therapies|2|||
161096402|NCT01881750|581742790|FG001|Overall Study|Changes in concomitant therapies|3|||
161096403|NCT01881750|581742789|FG000|Overall Study|Lost to Follow-up|0|||
161096404|NCT01881750|581742790|FG001|Overall Study|Lost to Follow-up|1|||
161096405|NCT00051363|581742791|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
161096406|NCT00051363|581742792|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
161096407|NCT00051363|581742791|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
161096408|NCT00051363|581742792|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
161096409|NCT00051363|581742791|FG000|Overall Study|Death|2|||
161096410|NCT00051363|581742792|FG001|Overall Study|Death|2|||
161096411|NCT00051363|581742791|FG000|Overall Study|Excluded Pre-Randomization|2|||
161096412|NCT00051363|581742792|FG001|Overall Study|Excluded Pre-Randomization|5|||
161096413|NCT00026208|581742797|FG000|Overall Study|Complications of auto accident|1|||
161096414|NCT00026208|581742798|FG001|Overall Study|Complications of auto accident|0|||
161096415|NCT03282240|581742799|FG000|Overall Study|Adverse Event|2|||
161096416|NCT03282240|581742800|FG001|Overall Study|Adverse Event|2|||
161096417|NCT03282240|581742801|FG002|Overall Study|Adverse Event|0|||
161096418|NCT03282240|581742799|FG000|Overall Study|Lost to Follow-up|3|||
161096419|NCT03282240|581742800|FG001|Overall Study|Lost to Follow-up|0|||
161096420|NCT03282240|581742801|FG002|Overall Study|Lost to Follow-up|0|||
161096421|NCT03282240|581742799|FG000|Overall Study|Protocol Deviation|4|||
161096422|NCT03282240|581742800|FG001|Overall Study|Protocol Deviation|1|||
161096423|NCT03282240|581742801|FG002|Overall Study|Protocol Deviation|2|||
161096424|NCT03282240|581742799|FG000|Overall Study|Withdrawal by Subject|1|||
161096425|NCT03282240|581742800|FG001|Overall Study|Withdrawal by Subject|0|||
161096426|NCT03282240|581742801|FG002|Overall Study|Withdrawal by Subject|1|||
161096427|NCT01675479|581742802|FG000|Overall Study|Lost to Follow-up|11|||
161096428|NCT02910739|581742803|FG000|Overall Study|Adverse Event|1|||
161096429|NCT02910739|581742804|FG001|Overall Study|Adverse Event|0|||
161096430|NCT02910739|581742805|FG002|Overall Study|Adverse Event|0|||
161096431|NCT02910739|581742806|FG003|Overall Study|Adverse Event|0|||
161096432|NCT01572922|581742809|FG000|Overall Study|Adverse Event|1|||
161096433|NCT01572922|581742809|FG000|Overall Study|Protocol Violation|1|||
161096434|NCT01572922|581742809|FG000|Overall Study|Death|1|||
161096435|NCT01103245|581744977|FG000|Overall Study|Withdrawal by Subject|1|||
161096436|NCT01103245|581744978|FG001|Overall Study|Withdrawal by Subject|0|||
161096437|NCT01103245|581744979|FG002|Overall Study|Withdrawal by Subject|3|||
161096438|NCT01103245|581744980|FG003|Overall Study|Withdrawal by Subject|0|||
161096439|NCT01103245|581744977|FG000|Overall Study|Inadequate IV access|1|||
161210414|NCT02164539|582153508|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
161096440|NCT01103245|581744978|FG001|Overall Study|Inadequate IV access|0|||
161096441|NCT01103245|581744979|FG002|Overall Study|Inadequate IV access|0|||
161096442|NCT01103245|581744980|FG003|Overall Study|Inadequate IV access|0|||
161096443|NCT01103245|581744977|FG000|Overall Study|Adverse Event|0|||
161096444|NCT01103245|581744978|FG001|Overall Study|Adverse Event|2|||
161096445|NCT01103245|581744979|FG002|Overall Study|Adverse Event|1|||
161096446|NCT01103245|581744980|FG003|Overall Study|Adverse Event|0|||
161096447|NCT01103245|581744977|FG000|Overall Study|Physician Decision|1|||
161096448|NCT01103245|581744978|FG001|Overall Study|Physician Decision|0|||
161096449|NCT01103245|581744979|FG002|Overall Study|Physician Decision|0|||
161096450|NCT01103245|581744980|FG003|Overall Study|Physician Decision|0|||
161096451|NCT03078907|581744981|FG000|Overall Study|Adverse Event|2|||
161096452|NCT03078907|581744982|FG001|Overall Study|Adverse Event|0|||
161096453|NCT03078907|581744981|FG000|Overall Study|Other|1|||
161096454|NCT03078907|581744982|FG001|Overall Study|Other|0|||
161096455|NCT03078907|581744981|FG000|Overall Study|Protocol Violation|0|||
161096456|NCT03078907|581744982|FG001|Overall Study|Protocol Violation|1|||
161096457|NCT01955122|581744983|FG000|Overall Study|Physician Decision|5|||
161096458|NCT01955122|581744984|FG001|Overall Study|Physician Decision|5|||
161096459|NCT01672788|581744985|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
161096460|NCT01672788|581744986|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
161096461|NCT01672788|581744987|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
161096462|NCT01672788|581744988|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
161096463|NCT02464228|581744991|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
161096464|NCT02464228|581744992|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
161096465|NCT02464228|581744993|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
161096466|NCT02464228|581744994|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
161096467|NCT02464228|581744991|FG000|Overall Study|Physician Decision|2|||
161096468|NCT02464228|581744992|FG001|Overall Study|Physician Decision|0|||
161096469|NCT02464228|581744993|FG002|Overall Study|Physician Decision|1|||
161096470|NCT02464228|581744994|FG003|Overall Study|Physician Decision|0|||
161096471|NCT02464228|581744991|FG000|Overall Study|Miscellaneous|1|||
161096472|NCT02464228|581744992|FG001|Overall Study|Miscellaneous|0|||
161096473|NCT02464228|581744993|FG002|Overall Study|Miscellaneous|1|||
161096474|NCT02464228|581744994|FG003|Overall Study|Miscellaneous|0|||
161096475|NCT02464228|581744991|FG000|Overall Study|Adverse Event|9|||
161096476|NCT02464228|581744992|FG001|Overall Study|Adverse Event|0|||
161096477|NCT02464228|581744993|FG002|Overall Study|Adverse Event|3|||
161096478|NCT02464228|581744994|FG003|Overall Study|Adverse Event|0|||
161096479|NCT02464228|581744991|FG000|Overall Study|Withdrawal by Subject|1|||
161096480|NCT02464228|581744992|FG001|Overall Study|Withdrawal by Subject|1|||
161096481|NCT02464228|581744993|FG002|Overall Study|Withdrawal by Subject|1|||
161096482|NCT02464228|581744994|FG003|Overall Study|Withdrawal by Subject|0|||
161096483|NCT02464228|581744991|FG000|Overall Study|Disease Progression|22|||
161096484|NCT02464228|581744992|FG001|Overall Study|Disease Progression|12|||
161096485|NCT02464228|581744993|FG002|Overall Study|Disease Progression|5|||
161096486|NCT02464228|581744994|FG003|Overall Study|Disease Progression|2|||
161096487|NCT04796896|581744998|FG000|Overall Study|Adverse Event|1|||
161096488|NCT04796896|581744999|FG001|Overall Study|Adverse Event|0|||
161096489|NCT04796896|581745000|FG002|Overall Study|Adverse Event|0|||
161096490|NCT04796896|581745001|FG003|Overall Study|Adverse Event|0|||
161096491|NCT04796896|581745002|FG004|Overall Study|Adverse Event|0|||
161096492|NCT04796896|581745003|FG005|Overall Study|Adverse Event|1|||
161096493|NCT04796896|581745004|FG006|Overall Study|Adverse Event|1|||
161096494|NCT04796896|581745005|FG007|Overall Study|Adverse Event|0|||
161096495|NCT04796896|581745006|FG008|Overall Study|Adverse Event|1|||
161096496|NCT04796896|581745007|FG009|Overall Study|Adverse Event|1|||
161096497|NCT04796896|581745008|FG010|Overall Study|Adverse Event|1|||
161096498|NCT04796896|581745009|FG011|Overall Study|Adverse Event|0|||
161096499|NCT04796896|581744998|FG000|Overall Study|Lost to Follow-up|24|||
161096500|NCT04796896|581744999|FG001|Overall Study|Lost to Follow-up|15|||
161096501|NCT04796896|581745000|FG002|Overall Study|Lost to Follow-up|6|||
161096502|NCT04796896|581745001|FG003|Overall Study|Lost to Follow-up|4|||
161096503|NCT04796896|581745002|FG004|Overall Study|Lost to Follow-up|21|||
161096504|NCT04796896|581745003|FG005|Overall Study|Lost to Follow-up|55|||
161096505|NCT04796896|581745004|FG006|Overall Study|Lost to Follow-up|237|||
161096506|NCT04796896|581745005|FG007|Overall Study|Lost to Follow-up|52|||
161096507|NCT04796896|581745006|FG008|Overall Study|Lost to Follow-up|221|||
161096508|NCT04796896|581745007|FG009|Overall Study|Lost to Follow-up|43|||
161096509|NCT04796896|581745008|FG010|Overall Study|Lost to Follow-up|142|||
161096510|NCT04796896|581745009|FG011|Overall Study|Lost to Follow-up|18|||
161096511|NCT04796896|581744998|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
161096512|NCT04796896|581744999|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
161096513|NCT04796896|581745000|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
161096514|NCT04796896|581745001|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
161096515|NCT04796896|581745002|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
161096516|NCT04796896|581745003|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
161096517|NCT04796896|581745004|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
161096518|NCT04796896|581745005|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
161096519|NCT04796896|581745006|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
161096520|NCT04796896|581745007|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
161096521|NCT04796896|581745008|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
161096522|NCT04796896|581745009|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
161096523|NCT04796896|581744998|FG000|Overall Study|Physician Decision|1|||
161096524|NCT04796896|581744999|FG001|Overall Study|Physician Decision|0|||
161096525|NCT04796896|581745000|FG002|Overall Study|Physician Decision|0|||
161096526|NCT04796896|581745001|FG003|Overall Study|Physician Decision|0|||
161096527|NCT04796896|581745002|FG004|Overall Study|Physician Decision|0|||
161096528|NCT04796896|581745003|FG005|Overall Study|Physician Decision|3|||
161096529|NCT04796896|581745004|FG006|Overall Study|Physician Decision|18|||
161096530|NCT04796896|581745005|FG007|Overall Study|Physician Decision|1|||
161096531|NCT04796896|581745006|FG008|Overall Study|Physician Decision|7|||
161096532|NCT04796896|581745007|FG009|Overall Study|Physician Decision|0|||
161096533|NCT04796896|581745008|FG010|Overall Study|Physician Decision|5|||
161096534|NCT04796896|581745009|FG011|Overall Study|Physician Decision|0|||
161096535|NCT04796896|581744998|FG000|Overall Study|Withdrawal by Subject|36|||
161096536|NCT04796896|581744999|FG001|Overall Study|Withdrawal by Subject|31|||
161096537|NCT04796896|581745000|FG002|Overall Study|Withdrawal by Subject|11|||
161096538|NCT04796896|581745001|FG003|Overall Study|Withdrawal by Subject|8|||
161096539|NCT04796896|581745002|FG004|Overall Study|Withdrawal by Subject|16|||
161096540|NCT04796896|581745003|FG005|Overall Study|Withdrawal by Subject|162|||
161096541|NCT04796896|581745004|FG006|Overall Study|Withdrawal by Subject|299|||
161096542|NCT04796896|581745005|FG007|Overall Study|Withdrawal by Subject|149|||
161096543|NCT04796896|581745006|FG008|Overall Study|Withdrawal by Subject|303|||
161096544|NCT04796896|581745007|FG009|Overall Study|Withdrawal by Subject|94|||
161096545|NCT04796896|581745008|FG010|Overall Study|Withdrawal by Subject|192|||
161096546|NCT04796896|581745009|FG011|Overall Study|Withdrawal by Subject|16|||
161096547|NCT04796896|581744998|FG000|Overall Study|Other Than Specified|6|||
161096548|NCT04796896|581744999|FG001|Overall Study|Other Than Specified|5|||
161096549|NCT04796896|581745000|FG002|Overall Study|Other Than Specified|3|||
161096550|NCT04796896|581745001|FG003|Overall Study|Other Than Specified|2|||
161096551|NCT04796896|581745002|FG004|Overall Study|Other Than Specified|6|||
161096552|NCT04796896|581745003|FG005|Overall Study|Other Than Specified|31|||
161096553|NCT04796896|581745004|FG006|Overall Study|Other Than Specified|86|||
161096554|NCT04796896|581745005|FG007|Overall Study|Other Than Specified|66|||
161096555|NCT04796896|581745006|FG008|Overall Study|Other Than Specified|388|||
161096556|NCT04796896|581745007|FG009|Overall Study|Other Than Specified|48|||
161096557|NCT04796896|581745008|FG010|Overall Study|Other Than Specified|258|||
161096558|NCT04796896|581745009|FG011|Overall Study|Other Than Specified|4|||
161096559|NCT04796896|581744998|FG000|Overall Study|Protocol Deviation|0|||
161096560|NCT04796896|581744999|FG001|Overall Study|Protocol Deviation|0|||
161096561|NCT04796896|581745000|FG002|Overall Study|Protocol Deviation|0|||
161096562|NCT04796896|581745001|FG003|Overall Study|Protocol Deviation|1|||
161096563|NCT04796896|581745002|FG004|Overall Study|Protocol Deviation|1|||
161096564|NCT04796896|581745003|FG005|Overall Study|Protocol Deviation|2|||
161096565|NCT04796896|581745004|FG006|Overall Study|Protocol Deviation|2|||
161096566|NCT04796896|581745005|FG007|Overall Study|Protocol Deviation|2|||
161096567|NCT04796896|581745006|FG008|Overall Study|Protocol Deviation|2|||
161096568|NCT04796896|581745007|FG009|Overall Study|Protocol Deviation|1|||
161096569|NCT04796896|581745008|FG010|Overall Study|Protocol Deviation|0|||
161096570|NCT04796896|581745009|FG011|Overall Study|Protocol Deviation|0|||
161096571|NCT04796896|581744998|FG000|Overall Study|Missing|0|||
161096572|NCT04796896|581744999|FG001|Overall Study|Missing|0|||
161096573|NCT04796896|581745000|FG002|Overall Study|Missing|0|||
161096574|NCT04796896|581745001|FG003|Overall Study|Missing|0|||
161096575|NCT04796896|581745002|FG004|Overall Study|Missing|0|||
161096576|NCT04796896|581745003|FG005|Overall Study|Missing|0|||
161096577|NCT04796896|581745004|FG006|Overall Study|Missing|2|||
161096578|NCT04796896|581745005|FG007|Overall Study|Missing|1|||
161096579|NCT04796896|581745006|FG008|Overall Study|Missing|2|||
161096580|NCT04796896|581745007|FG009|Overall Study|Missing|1|||
161096581|NCT04796896|581745008|FG010|Overall Study|Missing|1|||
161096582|NCT04796896|581745009|FG011|Overall Study|Missing|0|||
161096583|NCT04796896|581744998|FG000|Overall Study|Death|0|||
161096584|NCT04796896|581744999|FG001|Overall Study|Death|0|||
161096585|NCT04796896|581745000|FG002|Overall Study|Death|0|||
161322887|NCT01768559|582568628|FG002|Overall Study|Other than specified|5|||
161322888|NCT00237692|582568631|FG000|Overall Study|Lost to Follow-up|9|||
161322889|NCT00237692|582568632|FG001|Overall Study|Lost to Follow-up|3|||
161322890|NCT00237692|582568633|FG002|Overall Study|Lost to Follow-up|5|||
161322891|NCT00237692|582568634|FG003|Overall Study|Lost to Follow-up|3|||
161322892|NCT00237692|582568631|FG000|Overall Study|Death|1|||
161322893|NCT00237692|582568632|FG001|Overall Study|Death|2|||
161322894|NCT00237692|582568633|FG002|Overall Study|Death|2|||
161322895|NCT00237692|582568634|FG003|Overall Study|Death|3|||
161322896|NCT00237692|582568631|FG000|Overall Study|Excluded - did not meet criteria|4|||
161322897|NCT00237692|582568632|FG001|Overall Study|Excluded - did not meet criteria|3|||
161322898|NCT00237692|582568633|FG002|Overall Study|Excluded - did not meet criteria|5|||
161322899|NCT00237692|582568634|FG003|Overall Study|Excluded - did not meet criteria|9|||
161322900|NCT00237692|582568631|FG000|Overall Study|Withdrawal by Subject|4|||
161322901|NCT00237692|582568632|FG001|Overall Study|Withdrawal by Subject|6|||
161322902|NCT00237692|582568633|FG002|Overall Study|Withdrawal by Subject|10|||
161322903|NCT00237692|582568634|FG003|Overall Study|Withdrawal by Subject|4|||
161096586|NCT04796896|581745001|FG003|Overall Study|Death|0|||
161096587|NCT04796896|581745002|FG004|Overall Study|Death|0|||
161096588|NCT04796896|581745003|FG005|Overall Study|Death|0|||
161096589|NCT04796896|581745004|FG006|Overall Study|Death|0|||
161322904|NCT00685360|582568635|FG000|Overall Study|Lost to Follow-up|0|||
161322905|NCT00685360|582568636|FG001|Overall Study|Lost to Follow-up|1|||
161322906|NCT00685360|582568637|FG002|Overall Study|Lost to Follow-up|2|||
161096590|NCT04796896|581745005|FG007|Overall Study|Death|0|||
161096591|NCT04796896|581745006|FG008|Overall Study|Death|1|||
161096592|NCT04796896|581745007|FG009|Overall Study|Death|0|||
161096593|NCT04796896|581745008|FG010|Overall Study|Death|0|||
161096594|NCT04796896|581745009|FG011|Overall Study|Death|0|||
161096595|NCT02021292|581745010|FG000|Overall Study|Physician Decision|0|||
161096596|NCT02021292|581745011|FG001|Overall Study|Physician Decision|1|||
161096597|NCT02021292|581745010|FG000|Overall Study|Lost to Follow-up|0|||
161096598|NCT02021292|581745011|FG001|Overall Study|Lost to Follow-up|1|||
161096599|NCT02021292|581745010|FG000|Overall Study|Death|0|||
161096600|NCT02021292|581745011|FG001|Overall Study|Death|1|||
161096601|NCT04356183|581745012|FG000|Overall Study|Lost to Follow-up|1|||
161096602|NCT04356183|581745013|FG001|Overall Study|Lost to Follow-up|0|||
161096603|NCT04356183|581745012|FG000|Overall Study|Withdrawal by Subject|1|||
161096604|NCT04356183|581745013|FG001|Overall Study|Withdrawal by Subject|1|||
161096605|NCT05972733|581745016|FG000|Overall Study|Lost to Follow-up|2|||
161096606|NCT05972733|581745016|FG000|Overall Study|Withdrawal by Subject|1|||
161096607|NCT01177787|581745017|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
161096608|NCT01177787|581745017|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
161096609|NCT01177787|581745017|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
161096610|NCT01637623|581745018|FG000|Overall Study|Lost to Follow-up|0|||
161096611|NCT01637623|581745019|FG001|Overall Study|Lost to Follow-up|0|||
161096612|NCT01637623|581745020|FG002|Overall Study|Lost to Follow-up|2|||
161096613|NCT01637623|581745018|FG000|Overall Study|Physician Decision|1|||
161096614|NCT01637623|581745019|FG001|Overall Study|Physician Decision|0|||
161096615|NCT01637623|581745020|FG002|Overall Study|Physician Decision|1|||
161096616|NCT02824263|581745025|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
161096617|NCT02824263|581745026|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
161096618|NCT02824263|581745025|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
161096619|NCT02824263|581745026|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
161096620|NCT00568321|581745027|FG000|Overall Study|Adverse Event|1|||
161096621|NCT00568321|581745028|FG001|Overall Study|Adverse Event|0|||
161096622|NCT00568321|581745029|FG002|Overall Study|Adverse Event|0|||
161096623|NCT00568321|581745027|FG000|Overall Study|Lack of Efficacy|8|||
161096624|NCT00568321|581745028|FG001|Overall Study|Lack of Efficacy|5|||
161096625|NCT00568321|581745029|FG002|Overall Study|Lack of Efficacy|6|||
161096626|NCT00568321|581745027|FG000|Overall Study|Lost to Follow-up|0|||
161096627|NCT00568321|581745028|FG001|Overall Study|Lost to Follow-up|0|||
161096628|NCT00568321|581745029|FG002|Overall Study|Lost to Follow-up|1|||
161096629|NCT00568321|581745027|FG000|Overall Study|Withdrawal by Subject|2|||
161096630|NCT00568321|581745028|FG001|Overall Study|Withdrawal by Subject|0|||
161096631|NCT00568321|581745029|FG002|Overall Study|Withdrawal by Subject|0|||
161096632|NCT00568321|581745027|FG000|Overall Study|Protocol Violation|0|||
161096633|NCT00568321|581745028|FG001|Overall Study|Protocol Violation|0|||
161096634|NCT00568321|581745029|FG002|Overall Study|Protocol Violation|1|||
161096635|NCT00568321|581745027|FG000|Overall Study|Randomized, not treated|2|||
161096636|NCT00568321|581745028|FG001|Overall Study|Randomized, not treated|0|||
161096637|NCT00568321|581745029|FG002|Overall Study|Randomized, not treated|1|||
161096638|NCT01676909|581745031|FG000|Overall Study|Withdrawal by Subject|3|||
161096639|NCT01676909|581745032|FG001|Overall Study|Withdrawal by Subject|5|||
161096640|NCT01676909|581745031|FG000|Overall Study|Lost to Follow-up|15|||
161096641|NCT01676909|581745032|FG001|Overall Study|Lost to Follow-up|9|||
161096642|NCT04615247|581745033|FG000|Overall Study|Adverse Event|0|||
161096643|NCT04615247|581745034|FG001|Overall Study|Adverse Event|2|||
161096644|NCT04615247|581745033|FG000|Overall Study|Withdrawal by Subject|1|||
161096645|NCT04615247|581745034|FG001|Overall Study|Withdrawal by Subject|1|||
161096646|NCT00823901|581745037|FG000|Overall Study|Adverse Event|1|||
161096647|NCT00823901|581745038|FG001|Overall Study|Adverse Event|1|||
161096648|NCT00823901|581745037|FG000|Overall Study|Lack of Efficacy|1|||
161096649|NCT00823901|581745038|FG001|Overall Study|Lack of Efficacy|0|||
161096650|NCT00823901|581745037|FG000|Overall Study|Lost to Follow-up|2|||
161096651|NCT00823901|581745038|FG001|Overall Study|Lost to Follow-up|1|||
161096652|NCT01369511|581745039|FG000|Overall Study|Adverse Event|1|||
161096653|NCT01369511|581745040|FG001|Overall Study|Adverse Event|1|||
161096654|NCT01369511|581745041|FG002|Overall Study|Adverse Event|5|||
161096655|NCT01369511|581745042|FG003|Overall Study|Adverse Event|0|||
161096656|NCT01369511|581745039|FG000|Overall Study|Entry criteria not met|2|||
161096657|NCT01369511|581745040|FG001|Overall Study|Entry criteria not met|0|||
161096658|NCT01369511|581745041|FG002|Overall Study|Entry criteria not met|0|||
161096659|NCT01369511|581745042|FG003|Overall Study|Entry criteria not met|1|||
161096660|NCT01369511|581745039|FG000|Overall Study|Lost to Follow-up|0|||
161096661|NCT01369511|581745040|FG001|Overall Study|Lost to Follow-up|1|||
161096662|NCT01369511|581745041|FG002|Overall Study|Lost to Follow-up|1|||
161096663|NCT01369511|581745042|FG003|Overall Study|Lost to Follow-up|2|||
161096664|NCT01369511|581745039|FG000|Overall Study|Protocol Violation|0|||
161096665|NCT01369511|581745040|FG001|Overall Study|Protocol Violation|1|||
161322907|NCT00685360|582568635|FG000|Overall Study|Adverse Event|4|||
161322908|NCT00685360|582568636|FG001|Overall Study|Adverse Event|6|||
161322909|NCT00685360|582568637|FG002|Overall Study|Adverse Event|4|||
161322910|NCT00685360|582568635|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
161322911|NCT00685360|582568636|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
161322912|NCT00685360|582568637|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
161322913|NCT00685360|582568635|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
161322914|NCT00685360|582568636|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
161322915|NCT00685360|582568637|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
161322916|NCT00685360|582568635|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
161322917|NCT00685360|582568636|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
161322918|NCT00685360|582568637|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
161322919|NCT00685360|582568635|FG000|Overall Study|Protocol Deviation|0|||
161322920|NCT00685360|582568636|FG001|Overall Study|Protocol Deviation|1|||
161322921|NCT00685360|582568637|FG002|Overall Study|Protocol Deviation|1|||
161322922|NCT01386944|582568644|FG000|Overall Study|Adverse Event|26|||
161322923|NCT01386944|582568644|FG000|Overall Study|Lack of Efficacy|14|||
161322924|NCT01386944|582568644|FG000|Overall Study|Lost to Follow-up|8|||
161322925|NCT01386944|582568644|FG000|Overall Study|Unspecified reason|8|||
161322926|NCT03883477|582568645|FG000|Overall Study|Death|1|||
161322927|NCT03883477|582568646|FG001|Overall Study|Death|0|||
161322928|NCT03883477|582568645|FG000|Overall Study|Protocol Violation|0|||
161322929|NCT03883477|582568646|FG001|Overall Study|Protocol Violation|1|||
161322930|NCT04186221|582568647|FG000|Overall Study|Death|1|||
161322931|NCT00972283|582568653|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
161322932|NCT00972283|582568654|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
161322933|NCT00972283|582568653|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
161322934|NCT00972283|582568654|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
161322935|NCT00972283|582568653|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
161322936|NCT00972283|582568654|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
161322937|NCT00972283|582568653|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
161322938|NCT00972283|582568654|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
161322939|NCT00972283|582568653|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
161322940|NCT00972283|582568654|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
161322941|NCT00972283|582568653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
161322942|NCT00972283|582568654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
161322943|NCT00972283|582568653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
161322944|NCT00972283|582568654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
161322945|NCT00972283|582568653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
161322946|NCT00972283|582568654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
161322947|NCT00972283|582568653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
161322948|NCT00972283|582568654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
161322949|NCT00972283|582568653|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
161322950|NCT00972283|582568654|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
161322951|NCT03124537|582568655|FG000|Overall Study|Lost to Follow-up|3|||
161322952|NCT03124537|582568656|FG001|Overall Study|Lost to Follow-up|5|||
161322953|NCT03124537|582568655|FG000|Overall Study|App Crash, Incomplete Data|7|||
161322954|NCT03124537|582568656|FG001|Overall Study|App Crash, Incomplete Data|8|||
161322955|NCT00830518|582568659|FG000|Overall Study|Progressive Disease|18|||
161322956|NCT00830518|582568660|FG001|Overall Study|Progressive Disease|8|||
161322957|NCT00830518|582568659|FG000|Overall Study|Symptomatic Deterioration|4|||
161322958|NCT00830518|582568660|FG001|Overall Study|Symptomatic Deterioration|1|||
161322959|NCT00830518|582568659|FG000|Overall Study|Adverse Event|14|||
161322960|NCT00830518|582568660|FG001|Overall Study|Adverse Event|1|||
161322961|NCT00830518|582568659|FG000|Overall Study|Withdrawal by Patient|2|||
161322962|NCT00830518|582568660|FG001|Overall Study|Withdrawal by Patient|0|||
161322963|NCT00830518|582568659|FG000|Overall Study|Reason not Specified|8|||
161322964|NCT00830518|582568660|FG001|Overall Study|Reason not Specified|1|||
161322965|NCT03092791|582568661|FG000|Overall Study|Lost to Follow-up|0|||
161322966|NCT03092791|582568662|FG001|Overall Study|Lost to Follow-up|0|||
161322967|NCT03092791|582568663|FG002|Overall Study|Lost to Follow-up|0|||
161322968|NCT03092791|582568664|FG003|Overall Study|Lost to Follow-up|0|||
161322969|NCT03092791|582568665|FG004|Overall Study|Lost to Follow-up|0|||
161322970|NCT03092791|582568666|FG005|Overall Study|Lost to Follow-up|0|||
161322971|NCT03092791|582568667|FG006|Overall Study|Lost to Follow-up|1|||
161322972|NCT03092791|582568668|FG007|Overall Study|Lost to Follow-up|0|||
161322973|NCT03092791|582568661|FG000|Overall Study|Withdrawal of Consent|0|||
161322974|NCT03092791|582568662|FG001|Overall Study|Withdrawal of Consent|0|||
161322975|NCT03092791|582568663|FG002|Overall Study|Withdrawal of Consent|0|||
161322976|NCT03092791|582568664|FG003|Overall Study|Withdrawal of Consent|0|||
161322977|NCT03092791|582568665|FG004|Overall Study|Withdrawal of Consent|4|||
161322978|NCT03092791|582568666|FG005|Overall Study|Withdrawal of Consent|12|||
161096666|NCT01369511|581745041|FG002|Overall Study|Protocol Violation|0|||
161096667|NCT01369511|581745042|FG003|Overall Study|Protocol Violation|2|||
161096668|NCT01369511|581745039|FG000|Overall Study|Physician Decision|3|||
161096669|NCT01369511|581745040|FG001|Overall Study|Physician Decision|4|||
161096670|NCT01369511|581745041|FG002|Overall Study|Physician Decision|0|||
161096671|NCT01369511|581745042|FG003|Overall Study|Physician Decision|0|||
161096672|NCT01369511|581745039|FG000|Overall Study|Sponsor decision|2|||
161096673|NCT01369511|581745040|FG001|Overall Study|Sponsor decision|0|||
161096674|NCT01369511|581745041|FG002|Overall Study|Sponsor decision|1|||
161096675|NCT01369511|581745042|FG003|Overall Study|Sponsor decision|0|||
161096676|NCT01369511|581745039|FG000|Overall Study|Withdrawal by Subject|5|||
161096677|NCT01369511|581745040|FG001|Overall Study|Withdrawal by Subject|6|||
161096678|NCT01369511|581745041|FG002|Overall Study|Withdrawal by Subject|4|||
161096679|NCT01369511|581745042|FG003|Overall Study|Withdrawal by Subject|6|||
161096680|NCT00818389|581745043|FG000|Overall Study|Death|1|||
161096681|NCT00818389|581745044|FG001|Overall Study|Death|3|||
161096682|NCT00818389|581745043|FG000|Overall Study|ALS Disease Progression|1|||
161096683|NCT00818389|581745044|FG001|Overall Study|ALS Disease Progression|0|||
161096684|NCT00818389|581745043|FG000|Overall Study|Withdrawal by Subject|2|||
161096685|NCT00818389|581745044|FG001|Overall Study|Withdrawal by Subject|2|||
161096686|NCT00818389|581745043|FG000|Overall Study|Adverse Event|0|||
161096687|NCT00818389|581745044|FG001|Overall Study|Adverse Event|1|||
161096688|NCT04658186|581745047|FG000|Overall Study|Adverse Event|4|||
161096689|NCT04658186|581745048|FG001|Overall Study|Adverse Event|18|||
161096690|NCT04658186|581745049|FG002|Overall Study|Adverse Event|15|||
161096691|NCT04658186|581745047|FG000|Overall Study|Lack of Efficacy|1|||
161096692|NCT04658186|581745048|FG001|Overall Study|Lack of Efficacy|1|||
161096693|NCT04658186|581745049|FG002|Overall Study|Lack of Efficacy|0|||
161096694|NCT04658186|581745047|FG000|Overall Study|Protocol Violation|0|||
161096695|NCT04658186|581745048|FG001|Overall Study|Protocol Violation|0|||
161096696|NCT04658186|581745049|FG002|Overall Study|Protocol Violation|1|||
161096697|NCT04658186|581745047|FG000|Overall Study|Lost to Follow-up|0|||
161096698|NCT04658186|581745048|FG001|Overall Study|Lost to Follow-up|0|||
161096699|NCT04658186|581745049|FG002|Overall Study|Lost to Follow-up|2|||
161096700|NCT04658186|581745047|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
161096701|NCT04658186|581745048|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
161096702|NCT04658186|581745049|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
161096703|NCT04658186|581745047|FG000|Overall Study|Participant is Moving in Another Province|0|||
161096704|NCT04658186|581745048|FG001|Overall Study|Participant is Moving in Another Province|1|||
161096705|NCT04658186|581745049|FG002|Overall Study|Participant is Moving in Another Province|0|||
161096706|NCT04658186|581745047|FG000|Overall Study|Non-Compliance|0|||
161096707|NCT04658186|581745048|FG001|Overall Study|Non-Compliance|1|||
161096708|NCT04658186|581745049|FG002|Overall Study|Non-Compliance|1|||
161096709|NCT04658186|581745047|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
161096710|NCT04658186|581745048|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
161096711|NCT04658186|581745049|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
161096712|NCT04658186|581745047|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
161096713|NCT04658186|581745048|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
161096714|NCT04658186|581745049|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
161096715|NCT04658186|581745047|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
161096716|NCT04658186|581745048|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
161096717|NCT04658186|581745049|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
161096718|NCT04658186|581745047|FG000|Overall Study|PI Decision due to Participant Safety|0|||
161096719|NCT04658186|581745048|FG001|Overall Study|PI Decision due to Participant Safety|0|||
161096720|NCT04658186|581745049|FG002|Overall Study|PI Decision due to Participant Safety|1|||
161096721|NCT04658186|581745047|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
161096722|NCT04658186|581745048|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
161096723|NCT04658186|581745049|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
161096724|NCT04098068|581745050|FG000|Overall Study|Disease Progression|7|||
161096725|NCT04098068|581745050|FG000|Overall Study|Withdrawal by Subject|2|||
161096726|NCT04098068|581745050|FG000|Overall Study|New Cancer Diagnosis|1|||
161096727|NCT03871829|581745051|FG000|Overall Study|Lost to Follow-up|0|||
161096728|NCT03871829|581745052|FG001|Overall Study|Lost to Follow-up|1|||
161096729|NCT03871829|581745051|FG000|Overall Study|Withdrawal by Subject|1|||
161096730|NCT03871829|581745052|FG001|Overall Study|Withdrawal by Subject|1|||
161096731|NCT03871829|581745051|FG000|Overall Study|Death|12|||
161096732|NCT03871829|581745052|FG001|Overall Study|Death|8|||
161096733|NCT03871829|581745051|FG000|Overall Study|Study terminated by sponsor|31|||
161210415|NCT02164539|582153509|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
161210416|NCT02164539|582153510|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
161096734|NCT03871829|581745052|FG001|Overall Study|Study terminated by sponsor|34|||
161096735|NCT02993523|581745053|FG000|Overall Study|Withdrew Consent|0|||
161096736|NCT02993523|581745054|FG001|Overall Study|Withdrew Consent|0|||
161096737|NCT02993523|581745055|FG002|Overall Study|Withdrew Consent|2|||
161096738|NCT02993523|581745056|FG003|Overall Study|Withdrew Consent|9|||
161096739|NCT02993523|581745057|FG004|Overall Study|Withdrew Consent|0|||
161096740|NCT02993523|581745053|FG000|Overall Study|Lost to Follow-up|0|||
161096741|NCT02993523|581745054|FG001|Overall Study|Lost to Follow-up|0|||
161096742|NCT02993523|581745055|FG002|Overall Study|Lost to Follow-up|3|||
161096743|NCT02993523|581745056|FG003|Overall Study|Lost to Follow-up|6|||
161096744|NCT02993523|581745057|FG004|Overall Study|Lost to Follow-up|0|||
161096745|NCT02993523|581745053|FG000|Overall Study|Death|1|||
161096746|NCT02993523|581745054|FG001|Overall Study|Death|1|||
161096747|NCT02993523|581745055|FG002|Overall Study|Death|138|||
161096748|NCT02993523|581745056|FG003|Overall Study|Death|222|||
161096749|NCT02993523|581745057|FG004|Overall Study|Death|6|||
161096750|NCT02993523|581745053|FG000|Overall Study|Reason not Specified|0|||
161096751|NCT02993523|581745054|FG001|Overall Study|Reason not Specified|0|||
161096752|NCT02993523|581745055|FG002|Overall Study|Reason not Specified|1|||
161096753|NCT02993523|581745056|FG003|Overall Study|Reason not Specified|1|||
161096754|NCT02993523|581745057|FG004|Overall Study|Reason not Specified|0|||
161096755|NCT03694418|581745058|FG000|Overall Study|Lost to Follow-up|115|||
161096756|NCT03694418|581745059|FG001|Overall Study|Lost to Follow-up|23|||
161096757|NCT03694418|581745060|FG002|Overall Study|Lost to Follow-up|12|||
161096758|NCT03694418|581745061|FG003|Overall Study|Lost to Follow-up|12|||
161096759|NCT03694418|581745062|FG004|Overall Study|Lost to Follow-up|13|||
161096760|NCT04288778|581745065|FG000|Overall Study|Withdrawal by Subject|2|||
161096761|NCT04288778|581745065|FG000|Overall Study|Adverse Event|5|||
161096762|NCT04288778|581745065|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161096763|NCT04288778|581745065|FG000|Overall Study|Other|1|||
161096764|NCT04288778|581745065|FG000|Overall Study|Started but not treated|2|||
161096765|NCT04442737|581745066|FG000|Overall Study|Lost to Follow-up|1|||
161096766|NCT04442737|581745067|FG001|Overall Study|Lost to Follow-up|3|||
161096767|NCT04442737|581745066|FG000|Overall Study|Withdrawal by Subject|3|||
161096768|NCT04442737|581745067|FG001|Overall Study|Withdrawal by Subject|2|||
161096769|NCT04442737|581745066|FG000|Overall Study|Adverse Event|3|||
161096770|NCT04442737|581745067|FG001|Overall Study|Adverse Event|2|||
161096771|NCT04442737|581745066|FG000|Overall Study|Death|0|||
161096772|NCT04442737|581745067|FG001|Overall Study|Death|1|||
161096773|NCT04442737|581745066|FG000|Overall Study|Protocol Violation|0|||
161096774|NCT04442737|581745067|FG001|Overall Study|Protocol Violation|2|||
161096775|NCT04442737|581745066|FG000|Overall Study|Other|1|||
161096776|NCT04442737|581745067|FG001|Overall Study|Other|1|||
161096777|NCT01139021|581745068|FG000|Overall Study|Adverse Event|0|||
161096778|NCT01139021|581745069|FG001|Overall Study|Adverse Event|0|||
161096779|NCT01139021|581745070|FG002|Overall Study|Adverse Event|0|||
161096780|NCT01139021|581745071|FG003|Overall Study|Adverse Event|0|||
161096781|NCT01139021|581745072|FG004|Overall Study|Adverse Event|1|||
161096782|NCT01139021|581745073|FG005|Overall Study|Adverse Event|0|||
161096783|NCT01139021|581745068|FG000|Overall Study|Lost to Follow-up|0|||
161096784|NCT01139021|581745069|FG001|Overall Study|Lost to Follow-up|0|||
161096785|NCT01139021|581745070|FG002|Overall Study|Lost to Follow-up|0|||
161096786|NCT01139021|581745071|FG003|Overall Study|Lost to Follow-up|0|||
161096787|NCT01139021|581745072|FG004|Overall Study|Lost to Follow-up|2|||
161096788|NCT01139021|581745073|FG005|Overall Study|Lost to Follow-up|0|||
161096789|NCT01139021|581745068|FG000|Overall Study|Protocol Violation|1|||
161096790|NCT01139021|581745069|FG001|Overall Study|Protocol Violation|0|||
161096791|NCT01139021|581745070|FG002|Overall Study|Protocol Violation|0|||
161096792|NCT01139021|581745071|FG003|Overall Study|Protocol Violation|0|||
161096793|NCT01139021|581745072|FG004|Overall Study|Protocol Violation|2|||
161096794|NCT01139021|581745073|FG005|Overall Study|Protocol Violation|0|||
161096795|NCT01139021|581745068|FG000|Overall Study|Withdrawal by Subject|0|||
161096796|NCT01139021|581745069|FG001|Overall Study|Withdrawal by Subject|0|||
161096797|NCT01139021|581745070|FG002|Overall Study|Withdrawal by Subject|0|||
161096798|NCT01139021|581745071|FG003|Overall Study|Withdrawal by Subject|1|||
161096799|NCT01139021|581745072|FG004|Overall Study|Withdrawal by Subject|4|||
161096800|NCT01139021|581745073|FG005|Overall Study|Withdrawal by Subject|0|||
161096801|NCT05458479|581745078|FG000|Overall Study|Lost to Follow-up|1|||
161096802|NCT00784693|581745079|FG000|Overall Study|Lost to Follow-up|0|||
161096803|NCT00784693|581745080|FG001|Overall Study|Lost to Follow-up|1|||
161096804|NCT00784693|581745079|FG000|Overall Study|Lack of Efficacy|1|||
161096805|NCT00784693|581745080|FG001|Overall Study|Lack of Efficacy|1|||
161096806|NCT00784693|581745079|FG000|Overall Study|Withdrawal by Subject|0|||
161096807|NCT00784693|581745080|FG001|Overall Study|Withdrawal by Subject|4|||
161096808|NCT00784693|581745079|FG000|Overall Study|Randomized but not Treated|1|||
161096809|NCT00784693|581745080|FG001|Overall Study|Randomized but not Treated|0|||
161096810|NCT00784693|581745079|FG000|Overall Study|Other|1|||
161096811|NCT00784693|581745080|FG001|Overall Study|Other|0|||
161096812|NCT02982187|581745081|FG000|Overall Study|Withdrawal by Subject|0|||
161096813|NCT02982187|581745082|FG001|Overall Study|Withdrawal by Subject|0|||
161096814|NCT02982187|581745083|FG002|Overall Study|Withdrawal by Subject|0|||
161096815|NCT02982187|581745084|FG003|Overall Study|Withdrawal by Subject|0|||
161096816|NCT02982187|581745085|FG004|Overall Study|Withdrawal by Subject|0|||
161096817|NCT02982187|581745086|FG005|Overall Study|Withdrawal by Subject|0|||
161096818|NCT02982187|581745087|FG006|Overall Study|Withdrawal by Subject|1|||
161096819|NCT02982187|581745088|FG007|Overall Study|Withdrawal by Subject|0|||
161096820|NCT02349451|581745092|FG000|Overall Study|Withdrawal by Subject|0|||
161096821|NCT02349451|581745093|FG001|Overall Study|Withdrawal by Subject|1|||
161096822|NCT02349451|581745094|FG002|Overall Study|Withdrawal by Subject|2|||
161096823|NCT02349451|581745095|FG003|Overall Study|Withdrawal by Subject|1|||
161096824|NCT02168842|581745096|FG000|Overall Study|Withdrawal by Subject|5|||
161096825|NCT02168842|581745097|FG001|Overall Study|Withdrawal by Subject|3|||
161096826|NCT02168842|581745096|FG000|Overall Study|Lost to Follow-up|0|||
161096827|NCT02168842|581745097|FG001|Overall Study|Lost to Follow-up|2|||
161096828|NCT02168842|581745096|FG000|Overall Study|Death|2|||
161096829|NCT02168842|581745097|FG001|Overall Study|Death|1|||
161096830|NCT02168842|581745096|FG000|Overall Study|Physician Decision|1|||
161096831|NCT02168842|581745097|FG001|Overall Study|Physician Decision|2|||
161096832|NCT02147353|581745098|FG000|Overall Study|Lost to Follow-up|2|||
161096833|NCT02147353|581745099|FG001|Overall Study|Lost to Follow-up|0|||
161096834|NCT02147353|581745098|FG000|Overall Study|unable to make visits|4|||
161096835|NCT02147353|581745099|FG001|Overall Study|unable to make visits|0|||
161096836|NCT02147353|581745098|FG000|Overall Study|medication noncompliance|3|||
161096837|NCT02147353|581745099|FG001|Overall Study|medication noncompliance|0|||
161096838|NCT02121834|581745107|FG000|Overall Study|Protocol Violation|0|||
161096839|NCT02121834|581745108|FG001|Overall Study|Protocol Violation|1|||
161096840|NCT02121834|581745109|FG002|Overall Study|Protocol Violation|0|||
161096841|NCT02121834|581745110|FG003|Overall Study|Protocol Violation|0|||
161096842|NCT02121834|581745111|FG004|Overall Study|Protocol Violation|0|||
161096843|NCT02121834|581745112|FG005|Overall Study|Protocol Violation|0|||
161096844|NCT02121834|581745113|FG006|Overall Study|Protocol Violation|0|||
161096845|NCT02121834|581745107|FG000|Overall Study|Withdrawal by Subject|0|||
161096846|NCT02121834|581745108|FG001|Overall Study|Withdrawal by Subject|1|||
161096847|NCT02121834|581745109|FG002|Overall Study|Withdrawal by Subject|1|||
161096848|NCT02121834|581745110|FG003|Overall Study|Withdrawal by Subject|0|||
161096849|NCT02121834|581745111|FG004|Overall Study|Withdrawal by Subject|0|||
161096850|NCT02121834|581745112|FG005|Overall Study|Withdrawal by Subject|0|||
161096851|NCT02121834|581745113|FG006|Overall Study|Withdrawal by Subject|0|||
161096852|NCT02121834|581745107|FG000|Overall Study|Lost to Follow-up|0|||
161096853|NCT02121834|581745108|FG001|Overall Study|Lost to Follow-up|0|||
161096854|NCT02121834|581745109|FG002|Overall Study|Lost to Follow-up|1|||
161096855|NCT02121834|581745110|FG003|Overall Study|Lost to Follow-up|0|||
161096856|NCT02121834|581745111|FG004|Overall Study|Lost to Follow-up|0|||
161096857|NCT02121834|581745112|FG005|Overall Study|Lost to Follow-up|0|||
161096858|NCT02121834|581745113|FG006|Overall Study|Lost to Follow-up|0|||
161096859|NCT02578862|581745114|FG000|Overall Study|Withdrawal by Subject|0|||
161096860|NCT02578862|581745115|FG001|Overall Study|Withdrawal by Subject|1|||
161096861|NCT02578862|581745114|FG000|Overall Study|Unplanned unilateral procedure|0|||
161096862|NCT02578862|581745115|FG001|Overall Study|Unplanned unilateral procedure|1|||
161096863|NCT01230788|581745124|FG000|Overall Study|Prescribed exclusion drug|1|||
161096864|NCT01142596|581745125|FG000|Overall Study|Withdrawal by Subject|9|||
161096865|NCT01142596|581745126|FG001|Overall Study|Withdrawal by Subject|35|||
161096866|NCT01142596|581745125|FG000|Overall Study|Adverse Event|8|||
161096867|NCT01142596|581745126|FG001|Overall Study|Adverse Event|35|||
161096868|NCT01142596|581745125|FG000|Overall Study|Lack of Efficacy|5|||
161096869|NCT01142596|581745126|FG001|Overall Study|Lack of Efficacy|9|||
161096870|NCT01142596|581745125|FG000|Overall Study|Lost to Follow-up|2|||
161096871|NCT01142596|581745126|FG001|Overall Study|Lost to Follow-up|3|||
161096872|NCT01142596|581745125|FG000|Overall Study|Other reason (not specified)|5|||
161096873|NCT01142596|581745126|FG001|Overall Study|Other reason (not specified)|4|||
161096874|NCT01290601|581745127|FG000|Overall Study|Adverse Event|0|||
161096875|NCT01290601|581745128|FG001|Overall Study|Adverse Event|2|||
161096876|NCT01290601|581745129|FG002|Overall Study|Adverse Event|0|||
161096877|NCT01290601|581745130|FG003|Overall Study|Adverse Event|0|||
161096878|NCT01290601|581745127|FG000|Overall Study|Lack of Efficacy|2|||
161096879|NCT01290601|581745128|FG001|Overall Study|Lack of Efficacy|1|||
161096880|NCT01290601|581745129|FG002|Overall Study|Lack of Efficacy|0|||
161096881|NCT01290601|581745130|FG003|Overall Study|Lack of Efficacy|0|||
161096882|NCT01290601|581745127|FG000|Overall Study|Lost to Follow-up|7|||
161096883|NCT01290601|581745128|FG001|Overall Study|Lost to Follow-up|2|||
161096884|NCT01290601|581745129|FG002|Overall Study|Lost to Follow-up|0|||
161096885|NCT01290601|581745130|FG003|Overall Study|Lost to Follow-up|0|||
161096886|NCT01290601|581745127|FG000|Overall Study|Other|1|||
161096887|NCT01290601|581745128|FG001|Overall Study|Other|0|||
161096888|NCT01290601|581745129|FG002|Overall Study|Other|0|||
161096889|NCT01290601|581745130|FG003|Overall Study|Other|0|||
161096890|NCT01290601|581745127|FG000|Overall Study|Protocol Violation|1|||
161096891|NCT01290601|581745128|FG001|Overall Study|Protocol Violation|0|||
161096892|NCT01290601|581745129|FG002|Overall Study|Protocol Violation|0|||
161096893|NCT01290601|581745130|FG003|Overall Study|Protocol Violation|0|||
161096894|NCT00775450|581745131|FG000|Overall Study|Serious Adverse Event|2|||
161096895|NCT00775450|581745132|FG001|Overall Study|Serious Adverse Event|0|||
161096896|NCT00775450|581745133|FG002|Overall Study|Serious Adverse Event|0|||
161096897|NCT00775450|581745134|FG003|Overall Study|Serious Adverse Event|0|||
161096898|NCT00775450|581745135|FG004|Overall Study|Serious Adverse Event|0|||
161096899|NCT00775450|581745131|FG000|Overall Study|Protocol Violation|0|||
161096900|NCT00775450|581745132|FG001|Overall Study|Protocol Violation|0|||
161096901|NCT00775450|581745133|FG002|Overall Study|Protocol Violation|0|||
161096902|NCT00775450|581745134|FG003|Overall Study|Protocol Violation|0|||
161096903|NCT00775450|581745135|FG004|Overall Study|Protocol Violation|1|||
161096904|NCT00775450|581745131|FG000|Overall Study|Withdrawal by Subject|1|||
161096905|NCT00775450|581745132|FG001|Overall Study|Withdrawal by Subject|0|||
161096906|NCT00775450|581745133|FG002|Overall Study|Withdrawal by Subject|0|||
161096907|NCT00775450|581745134|FG003|Overall Study|Withdrawal by Subject|0|||
161096908|NCT00775450|581745135|FG004|Overall Study|Withdrawal by Subject|1|||
161096909|NCT01749540|581745143|FG000|Overall Study|Protocol Violation|0|||
161096910|NCT01749540|581745144|FG001|Overall Study|Protocol Violation|0|||
161096911|NCT01749540|581745145|FG002|Overall Study|Protocol Violation|0|||
161096912|NCT01749540|581745146|FG003|Overall Study|Protocol Violation|0|||
161096913|NCT01749540|581745147|FG004|Overall Study|Protocol Violation|0|||
161096914|NCT01749540|581745148|FG005|Overall Study|Protocol Violation|1|||
161096915|NCT01749540|581745149|FG006|Overall Study|Protocol Violation|1|||
161096916|NCT01749540|581745143|FG000|Overall Study|Withdrawal by Subject|0|||
161096917|NCT01749540|581745144|FG001|Overall Study|Withdrawal by Subject|0|||
161096918|NCT01749540|581745145|FG002|Overall Study|Withdrawal by Subject|0|||
161096919|NCT01749540|581745146|FG003|Overall Study|Withdrawal by Subject|1|||
161096920|NCT01749540|581745147|FG004|Overall Study|Withdrawal by Subject|0|||
161096921|NCT01749540|581745148|FG005|Overall Study|Withdrawal by Subject|0|||
161096922|NCT01749540|581745149|FG006|Overall Study|Withdrawal by Subject|0|||
161096923|NCT01749540|581745143|FG000|Overall Study|Initiated into extension study A536-06|0|||
161096924|NCT01749540|581745144|FG001|Overall Study|Initiated into extension study A536-06|0|||
161096925|NCT01749540|581745145|FG002|Overall Study|Initiated into extension study A536-06|0|||
161096926|NCT01749540|581745146|FG003|Overall Study|Initiated into extension study A536-06|0|||
161096927|NCT01749540|581745147|FG004|Overall Study|Initiated into extension study A536-06|0|||
161096928|NCT01749540|581745148|FG005|Overall Study|Initiated into extension study A536-06|2|||
161096929|NCT01749540|581745149|FG006|Overall Study|Initiated into extension study A536-06|24|||
161096930|NCT05056987|581745150|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
161096931|NCT05056987|581745151|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
161096932|NCT05056987|581745150|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
161096933|NCT05056987|581745151|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
161096934|NCT01182194|581745152|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
161096935|NCT01182194|581745153|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
161096936|NCT01948908|581745154|FG000|Overall Study|Protocol Violation|1|||
161096937|NCT01948908|581745155|FG001|Overall Study|Protocol Violation|0|||
161096938|NCT01948908|581745156|FG002|Overall Study|Protocol Violation|2|||
161096939|NCT01585987|581745157|FG000|Randomized|Withdrawal by Subject|0|||
161096940|NCT01585987|581745158|FG001|Randomized|Withdrawal by Subject|4|||
161096941|NCT01585987|581745157|FG000|Randomized|No longer met criteria|0|||
161096942|NCT01585987|581745158|FG001|Randomized|No longer met criteria|2|||
161096943|NCT01585987|581745157|FG000|Treated|Disease Progression|39|||
161096944|NCT01585987|581745158|FG001|Treated|Disease Progression|36|||
161096945|NCT01585987|581745157|FG000|Treated|Study Drug Toxicity|9|||
161096946|NCT01585987|581745158|FG001|Treated|Study Drug Toxicity|5|||
161096947|NCT01585987|581745157|FG000|Treated|Adverse Event|3|||
161096948|NCT01585987|581745158|FG001|Treated|Adverse Event|0|||
161096949|NCT01585987|581745157|FG000|Treated|Withdrawal by Subject|1|||
161096950|NCT01585987|581745158|FG001|Treated|Withdrawal by Subject|2|||
161096951|NCT01585987|581745157|FG000|Treated|Death|1|||
161096952|NCT01585987|581745158|FG001|Treated|Death|0|||
161096953|NCT01585987|581745157|FG000|Treated|Lost to Follow-up|0|||
161096954|NCT01585987|581745158|FG001|Treated|Lost to Follow-up|1|||
161096955|NCT01585987|581745157|FG000|Treated|Maximum Clinical Benefit|0|||
161096956|NCT01585987|581745158|FG001|Treated|Maximum Clinical Benefit|1|||
161096957|NCT01585987|581745157|FG000|Treated|Non-Specified|1|||
161096958|NCT01585987|581745158|FG001|Treated|Non-Specified|2|||
161096959|NCT01585987|581745157|FG000|Treated|Subject Request|0|||
161096960|NCT01585987|581745158|FG001|Treated|Subject Request|1|||
161096961|NCT01585987|581745157|FG000|Treated|Poor/Non-Compliance|0|||
161096962|NCT01585987|581745158|FG001|Treated|Poor/Non-Compliance|1|||
161096963|NCT03291587|581745159|FG000|Overall Study|Lost to Follow-up|62|||
161210417|NCT02164539|582153511|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
161210418|NCT02164539|582153512|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
161096964|NCT03291587|581745160|FG001|Overall Study|Lost to Follow-up|43|||
161096965|NCT03291587|581745159|FG000|Overall Study|Refused to Answer|5|||
161096966|NCT03291587|581745160|FG001|Overall Study|Refused to Answer|2|||
161096967|NCT03291587|581745159|FG000|Overall Study|Death|2|||
161096968|NCT03291587|581745160|FG001|Overall Study|Death|4|||
161096969|NCT03291587|581745159|FG000|Overall Study|Not interested in participating|8|||
161096970|NCT03291587|581745160|FG001|Overall Study|Not interested in participating|6|||
161210419|NCT02164539|582153513|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
161096971|NCT03291587|581745159|FG000|Overall Study|Too busy to participate|4|||
161096972|NCT03291587|581745160|FG001|Overall Study|Too busy to participate|2|||
161096973|NCT00796120|581745162|FG000|Overall Study|Death|3|||
161096974|NCT00796120|581745163|FG001|Overall Study|Death|0|||
161096975|NCT00796120|581745162|FG000|Overall Study|Adverse Event|11|||
161096976|NCT00796120|581745163|FG001|Overall Study|Adverse Event|6|||
161096977|NCT00796120|581745162|FG000|Overall Study|Progressive disease|22|||
161096978|NCT00796120|581745163|FG001|Overall Study|Progressive disease|13|||
161096979|NCT00796120|581745162|FG000|Overall Study|Participant refusal|3|||
161096980|NCT00796120|581745163|FG001|Overall Study|Participant refusal|4|||
161096981|NCT00796120|581745162|FG000|Overall Study|Other|6|||
161096982|NCT00796120|581745163|FG001|Overall Study|Other|17|||
161096983|NCT00796120|581745162|FG000|Overall Study|Physician Decision|16|||
161096984|NCT00796120|581745163|FG001|Overall Study|Physician Decision|17|||
161096985|NCT00796120|581745162|FG000|Overall Study|Randomized but not treated|0|||
161096986|NCT00796120|581745163|FG001|Overall Study|Randomized but not treated|3|||
161096987|NCT01411839|581745167|FG000|Overall Study|Lost to Follow-up|4|||
161096988|NCT01411839|581745168|FG001|Overall Study|Lost to Follow-up|3|||
161096989|NCT01128361|581746631|FG000|Overall Study|Lost to Follow-up|0|||
161096990|NCT01128361|581746632|FG001|Overall Study|Lost to Follow-up|1|||
161096991|NCT01128361|581746631|FG000|Overall Study|Withdrawal by Subject|5|||
161096992|NCT01128361|581746632|FG001|Overall Study|Withdrawal by Subject|2|||
161096993|NCT05736211|581746649|FG000|Overall Study|Lost to Follow-up|6|||
161096994|NCT05736211|581746650|FG001|Overall Study|Lost to Follow-up|0|||
161096995|NCT00323297|581746651|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
161096996|NCT00323297|581746652|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
161096997|NCT00323297|581746651|FG000|Part A (Double Blind Randomized)|Death|0|||
161096998|NCT00323297|581746652|FG001|Part A (Double Blind Randomized)|Death|1|||
161096999|NCT00323297|581746651|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
161097000|NCT00323297|581746652|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
161097001|NCT00323297|581746651|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
161097002|NCT00323297|581746652|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
161097003|NCT00323297|581746651|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
161097004|NCT00323297|581746652|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
161097005|NCT00323297|581746651|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
161097006|NCT00323297|581746652|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
161097007|NCT00323297|581746651|FG000|Part B (Open-label)|Death|0|||
161097008|NCT00323297|581746652|FG001|Part B (Open-label)|Death|1|||
161097009|NCT00323297|581746651|FG000|Part B (Open-label)|Reason unspecified|0|||
161097010|NCT00323297|581746652|FG001|Part B (Open-label)|Reason unspecified|1|||
161097011|NCT00323297|581746651|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
161097012|NCT00323297|581746652|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
161097013|NCT00323297|581746651|FG000|Part B (Open-label)|Lack of Efficacy|3|||
161097014|NCT00323297|581746652|FG001|Part B (Open-label)|Lack of Efficacy|1|||
161097015|NCT00323297|581746651|FG000|Part B (Open-label)|Adverse Event|5|||
161097016|NCT00323297|581746652|FG001|Part B (Open-label)|Adverse Event|5|||
161097017|NCT00323297|581746651|FG000|Part B (Open-label)|Protocol Violation|0|||
161097018|NCT00323297|581746652|FG001|Part B (Open-label)|Protocol Violation|1|||
161097019|NCT01176773|581746653|FG000|Overall Study|Screen Failure|2|||
161097020|NCT01176773|581746653|FG000|Overall Study|Withdrew consent|1|||
161097021|NCT01498289|581746658|FG000|Overall Study|Adverse Event|16|||
161097022|NCT01498289|581746659|FG001|Overall Study|Adverse Event|18|||
161097023|NCT01498289|581746658|FG000|Overall Study|Death|6|||
161097024|NCT01498289|581746659|FG001|Overall Study|Death|8|||
161097025|NCT01498289|581746658|FG000|Overall Study|Withdrawal unrelated to AE|16|||
161097026|NCT01498289|581746659|FG001|Overall Study|Withdrawal unrelated to AE|16|||
161097027|NCT01498289|581746658|FG000|Overall Study|Progression/relapse|53|||
161097028|NCT01498289|581746659|FG001|Overall Study|Progression/relapse|59|||
161097029|NCT01498289|581746658|FG000|Overall Study|Not protocol specified|7|||
161097030|NCT01498289|581746659|FG001|Overall Study|Not protocol specified|2|||
161097031|NCT01498289|581746658|FG000|Overall Study|Reason under review|0|||
161097032|NCT01498289|581746659|FG001|Overall Study|Reason under review|1|||
161097033|NCT01423253|581746660|FG000|Overall Study|Adverse Event|2|||
161097034|NCT01423253|581746660|FG000|Overall Study|Lack of Efficacy|2|||
161097035|NCT01423253|581746660|FG000|Overall Study|Lost to Follow-up|1|||
161097036|NCT01423253|581746660|FG000|Overall Study|Protocol Violation|2|||
161097037|NCT01423253|581746660|FG000|Overall Study|Withdrawal by Subject|2|||
161097038|NCT00752622|581746674|FG000|Induction Phase|Adverse Event|3|||
161097039|NCT00752622|581746674|FG000|Induction Phase|Other|3|||
161097040|NCT00752622|581746674|FG000|Induction Phase|Non-responder|14|||
161097041|NCT00752622|581746674|FG000|Induction Phase|Withdrawal by Subject|1|||
161097042|NCT00752622|581746674|FG000|Induction Phase|Premature study termination|14|||
161097043|NCT00752622|581746674|FG000|Observational Phase|Premature Study Termination|36|||
161097044|NCT00752622|581746674|FG000|Observational Phase|Non-responder|2|||
161210420|NCT02164539|582153507|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
161097045|NCT00752622|581746674|FG000|Observational Phase|Withdrawal by Subject|2|||
161097046|NCT00752622|581746674|FG000|Observational Phase|Adverse Event|1|||
161097047|NCT00752622|581746674|FG000|Observational Phase|Other|2|||
161097048|NCT00752622|581746674|FG000|Interventional Phase|Non-responder|2|||
161097049|NCT00752622|581746674|FG000|Interventional Phase|Physician Decision|1|||
161097050|NCT00752622|581746674|FG000|Interventional Phase|Premature Study Termination|5|||
161097051|NCT00576836|581746675|FG000|Overall Study|Death|0|||
161097052|NCT00576836|581746676|FG001|Overall Study|Death|1|||
161097053|NCT00576836|581746675|FG000|Overall Study|Physician Decision|0|||
161097054|NCT00576836|581746676|FG001|Overall Study|Physician Decision|1|||
161097055|NCT00392327|581746679|FG000|Overall Study|Death|1|||
161097056|NCT00392327|581746680|FG001|Overall Study|Death|0|||
161097057|NCT00392327|581746681|FG002|Overall Study|Death|1|||
161097058|NCT00392327|581746682|FG003|Overall Study|Death|0|||
161097059|NCT00392327|581746683|FG004|Overall Study|Death|0|||
161097060|NCT00392327|581746684|FG005|Overall Study|Death|0|||
161097061|NCT00392327|581746685|FG006|Overall Study|Death|0|||
161097062|NCT00392327|581746686|FG007|Overall Study|Death|0|||
161097063|NCT00392327|581746679|FG000|Overall Study|Lack of Efficacy|8|||
161097064|NCT00392327|581746680|FG001|Overall Study|Lack of Efficacy|8|||
161097065|NCT00392327|581746681|FG002|Overall Study|Lack of Efficacy|9|||
161097066|NCT00392327|581746682|FG003|Overall Study|Lack of Efficacy|6|||
161097067|NCT00392327|581746683|FG004|Overall Study|Lack of Efficacy|3|||
161097068|NCT00392327|581746684|FG005|Overall Study|Lack of Efficacy|3|||
161097069|NCT00392327|581746685|FG006|Overall Study|Lack of Efficacy|3|||
161097070|NCT00392327|581746686|FG007|Overall Study|Lack of Efficacy|3|||
161097071|NCT00392327|581746679|FG000|Overall Study|Physician Decision|3|||
161097072|NCT00392327|581746680|FG001|Overall Study|Physician Decision|5|||
161097073|NCT00392327|581746681|FG002|Overall Study|Physician Decision|2|||
161097074|NCT00392327|581746682|FG003|Overall Study|Physician Decision|2|||
161097075|NCT00392327|581746683|FG004|Overall Study|Physician Decision|0|||
161097076|NCT00392327|581746684|FG005|Overall Study|Physician Decision|1|||
161097077|NCT00392327|581746685|FG006|Overall Study|Physician Decision|5|||
161097078|NCT00392327|581746686|FG007|Overall Study|Physician Decision|3|||
161097079|NCT00392327|581746679|FG000|Overall Study|Protocol Violation|0|||
161097080|NCT00392327|581746680|FG001|Overall Study|Protocol Violation|0|||
161097081|NCT00392327|581746681|FG002|Overall Study|Protocol Violation|1|||
161097082|NCT00392327|581746682|FG003|Overall Study|Protocol Violation|0|||
161097083|NCT00392327|581746683|FG004|Overall Study|Protocol Violation|0|||
161097084|NCT00392327|581746684|FG005|Overall Study|Protocol Violation|0|||
161097085|NCT00392327|581746685|FG006|Overall Study|Protocol Violation|0|||
161097086|NCT00392327|581746686|FG007|Overall Study|Protocol Violation|0|||
161097087|NCT00392327|581746679|FG000|Overall Study|Withdrawal by Subject|3|||
161097088|NCT00392327|581746680|FG001|Overall Study|Withdrawal by Subject|2|||
161097089|NCT00392327|581746681|FG002|Overall Study|Withdrawal by Subject|4|||
161097090|NCT00392327|581746682|FG003|Overall Study|Withdrawal by Subject|6|||
161097091|NCT00392327|581746683|FG004|Overall Study|Withdrawal by Subject|0|||
161210421|NCT02164539|582153508|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
161210422|NCT02164539|582153509|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
161097092|NCT00392327|581746684|FG005|Overall Study|Withdrawal by Subject|1|||
161097093|NCT00392327|581746685|FG006|Overall Study|Withdrawal by Subject|1|||
161097094|NCT00392327|581746686|FG007|Overall Study|Withdrawal by Subject|5|||
161097095|NCT00392327|581746679|FG000|Overall Study|Ineligible|0|||
161097096|NCT00392327|581746680|FG001|Overall Study|Ineligible|4|||
161097097|NCT00392327|581746681|FG002|Overall Study|Ineligible|3|||
161097098|NCT00392327|581746682|FG003|Overall Study|Ineligible|2|||
161097099|NCT00392327|581746683|FG004|Overall Study|Ineligible|0|||
161097100|NCT00392327|581746684|FG005|Overall Study|Ineligible|0|||
161097101|NCT00392327|581746685|FG006|Overall Study|Ineligible|0|||
161097102|NCT00392327|581746686|FG007|Overall Study|Ineligible|0|||
161097103|NCT00894686|581746687|FG000|Overall Study|Withdrawal by Subject|50|||
161097104|NCT00894686|581746687|FG000|Overall Study|Physician Decision|1|||
161097105|NCT00894686|581746687|FG000|Overall Study|Other|5|||
161097106|NCT03267940|581746688|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
161097107|NCT03267940|581746689|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
161097108|NCT03267940|581746690|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161097109|NCT03267940|581746691|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161097110|NCT03267940|581746692|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161097111|NCT03267940|581746693|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
161097112|NCT03267940|581746688|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161097113|NCT03267940|581746689|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
161210423|NCT02164539|582153510|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
161097114|NCT03267940|581746690|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161097115|NCT03267940|581746691|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161097116|NCT03267940|581746692|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161097117|NCT03267940|581746693|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
161097118|NCT03267940|581746688|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161210424|NCT02164539|582153511|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
161210425|NCT02164539|582153512|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
161097119|NCT03267940|581746689|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
161097120|NCT03267940|581746690|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161097121|NCT03267940|581746691|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161097122|NCT03267940|581746692|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161097123|NCT03267940|581746693|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
161097124|NCT03267940|581746688|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
161097125|NCT03267940|581746689|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
161097126|NCT03267940|581746690|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161097127|NCT03267940|581746691|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161097128|NCT03267940|581746692|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161210426|NCT02164539|582153513|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
161210427|NCT02164539|582153507|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
161210428|NCT02164539|582153508|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
161210429|NCT02164539|582153509|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
161210430|NCT02164539|582153510|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
161210431|NCT02164539|582153511|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
161210432|NCT02164539|582153512|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
161210433|NCT02164539|582153513|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
161210434|NCT02164539|582153507|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
161210435|NCT02164539|582153508|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161210436|NCT02164539|582153509|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161210437|NCT02164539|582153510|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161210438|NCT02164539|582153511|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161210439|NCT02164539|582153512|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161210440|NCT02164539|582153513|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
161210441|NCT02164539|582153507|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
161210442|NCT02164539|582153508|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
161210443|NCT02164539|582153509|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
161210444|NCT02164539|582153510|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
161210445|NCT02164539|582153511|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
161210446|NCT02164539|582153512|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
161210447|NCT02164539|582153513|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
161210448|NCT02164539|582153507|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
161210449|NCT02164539|582153508|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
161210450|NCT02164539|582153509|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
161210451|NCT02164539|582153510|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
161210452|NCT02164539|582153511|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
161210453|NCT02164539|582153512|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
161210454|NCT02164539|582153513|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
161210455|NCT01255722|582153514|FG000|Overall Study|Adverse Event|0|||
161210456|NCT01255722|582153515|FG001|Overall Study|Adverse Event|1|||
161210457|NCT01255722|582153516|FG002|Overall Study|Adverse Event|1|||
161210458|NCT01255722|582153514|FG000|Overall Study|asymptomatic patient|1|||
161210459|NCT01255722|582153515|FG001|Overall Study|asymptomatic patient|0|||
161210460|NCT01255722|582153516|FG002|Overall Study|asymptomatic patient|0|||
161210461|NCT01255722|582153514|FG000|Overall Study|beta-blocker contraindicated|2|||
161210462|NCT01255722|582153515|FG001|Overall Study|beta-blocker contraindicated|0|||
161210463|NCT01255722|582153516|FG002|Overall Study|beta-blocker contraindicated|0|||
161210464|NCT00527397|582153519|FG000|Overall Study|Adverse Event|3|||
161210465|NCT00527397|582153519|FG000|Overall Study|Lack of Efficacy|1|||
161210466|NCT00527397|582153519|FG000|Overall Study|Protocol Violation|1|||
161210467|NCT00527397|582153519|FG000|Overall Study|Withdrawal by Subject|6|||
161210468|NCT00527397|582153519|FG000|Overall Study|Study terminated by sponsor|13|||
161210469|NCT02065791|582153523|FG000|Overall Study|Closed Site|1|||
161210470|NCT02065791|582153524|FG001|Overall Study|Closed Site|1|||
161210471|NCT02065791|582153523|FG000|Overall Study|Withdrawal by Subject|11|||
161210472|NCT02065791|582153524|FG001|Overall Study|Withdrawal by Subject|5|||
161210473|NCT02065791|582153523|FG000|Overall Study|Lost to Follow-up|13|||
161210474|NCT02065791|582153524|FG001|Overall Study|Lost to Follow-up|9|||
161210475|NCT04529096|582153525|FG000|Overall Study|Adverse Event|6|||
161210476|NCT04529096|582153526|FG001|Overall Study|Adverse Event|1|||
161210477|NCT04529096|582153525|FG000|Overall Study|Lack of Efficacy|1|||
161210478|NCT04529096|582153526|FG001|Overall Study|Lack of Efficacy|0|||
161210479|NCT04529096|582153525|FG000|Overall Study|Lost to Follow-up|1|||
161210480|NCT04529096|582153526|FG001|Overall Study|Lost to Follow-up|1|||
161097129|NCT03267940|581746693|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
161210481|NCT04529096|582153525|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161210482|NCT04529096|582153526|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161210483|NCT04529096|582153525|FG000|Overall Study|Physician Decision|1|||
161210484|NCT04529096|582153526|FG001|Overall Study|Physician Decision|3|||
161210485|NCT04529096|582153525|FG000|Overall Study|Withdrawal by Subject|5|||
161210486|NCT04529096|582153526|FG001|Overall Study|Withdrawal by Subject|0|||
161210487|NCT03091400|582153527|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
161210488|NCT03091400|582153528|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
161210489|NCT03467971|582153529|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161210490|NCT03467971|582153530|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161210491|NCT00975884|582153531|FG000|Overall Study|Adverse Event|1|||
161210492|NCT00975884|582153532|FG001|Overall Study|Adverse Event|0|||
161210493|NCT00975884|582153531|FG000|Overall Study|Lost to Follow-up|5|||
161322979|NCT03092791|582568667|FG006|Overall Study|Withdrawal of Consent|6|||
161097130|NCT03267940|581746688|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161097131|NCT03267940|581746689|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161097132|NCT03267940|581746690|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161097133|NCT03267940|581746691|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
161097134|NCT03267940|581746692|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
161097135|NCT03267940|581746693|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
161097136|NCT03267940|581746688|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161097137|NCT03267940|581746689|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161097138|NCT03267940|581746690|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
161097139|NCT03267940|581746691|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
161097140|NCT03267940|581746692|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
161097141|NCT03267940|581746693|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
161097142|NCT03267940|581746688|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
161097143|NCT03267940|581746689|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
161097144|NCT03267940|581746690|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
161097145|NCT03267940|581746691|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161097146|NCT03267940|581746692|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161097147|NCT03267940|581746693|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
161097148|NCT03267940|581746688|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
161097149|NCT03267940|581746689|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
161097150|NCT03267940|581746690|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
161097151|NCT03267940|581746691|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
161097152|NCT03267940|581746692|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
161097153|NCT03267940|581746693|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
161097154|NCT03267940|581746688|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161097155|NCT03267940|581746689|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161097156|NCT03267940|581746690|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
161097157|NCT03267940|581746691|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
161097158|NCT03267940|581746692|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
161097159|NCT03267940|581746693|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
161097160|NCT00178126|581746700|FG000|Overall Study|Lost to Follow-up|21|||
161097161|NCT00178126|581746701|FG001|Overall Study|Lost to Follow-up|21|||
161097162|NCT00178126|581746700|FG000|Overall Study|did not receive intervention|4|||
161097163|NCT00178126|581746701|FG001|Overall Study|did not receive intervention|6|||
161097164|NCT01074216|581746702|FG000|Overall Study|Physician Decision|1|||
161097165|NCT01074216|581746702|FG000|Overall Study|Not Treated|12|||
161097166|NCT01323634|581746703|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
161097167|NCT01323634|581746704|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
161097168|NCT01323634|581746705|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
161097169|NCT01323634|581746703|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
161097170|NCT01323634|581746704|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
161097171|NCT01323634|581746705|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
161097172|NCT01323634|581746703|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
161097173|NCT01323634|581746704|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161097174|NCT01323634|581746705|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161097175|NCT01323634|581746703|FG000|2-week Run-in Period|Physician Decision|5|||
161097176|NCT01323634|581746704|FG001|2-week Run-in Period|Physician Decision|0|||
161097177|NCT01323634|581746705|FG002|2-week Run-in Period|Physician Decision|0|||
161097178|NCT01323634|581746703|FG000|2-week Run-in Period|Protocol Violation|1|||
161097179|NCT01323634|581746704|FG001|2-week Run-in Period|Protocol Violation|0|||
161097180|NCT01323634|581746705|FG002|2-week Run-in Period|Protocol Violation|0|||
161097181|NCT01323634|581746703|FG000|2-week Run-in Period|Adverse Event|1|||
161097182|NCT01323634|581746704|FG001|2-week Run-in Period|Adverse Event|0|||
161097183|NCT01323634|581746705|FG002|2-week Run-in Period|Adverse Event|0|||
161097184|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161097185|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
161097186|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
161097187|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161210494|NCT00975884|582153532|FG001|Overall Study|Lost to Follow-up|3|||
161210495|NCT00975884|582153531|FG000|Overall Study|Withdrawal by Subject|9|||
161210496|NCT00975884|582153532|FG001|Overall Study|Withdrawal by Subject|9|||
161210497|NCT00975884|582153531|FG000|Overall Study|Other|1|||
161097188|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161097189|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
161097190|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161097191|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
161097192|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
161097193|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161097194|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161097195|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161097196|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
161097197|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
161097198|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
161097199|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161097200|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
161097201|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
161097202|NCT01323634|581746703|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
161097203|NCT01323634|581746704|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
161097204|NCT01323634|581746705|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
161097205|NCT01575028|581746706|FG000|Overall Study|Physician Decision|0|||
161097206|NCT01575028|581746707|FG001|Overall Study|Physician Decision|1|||
161097207|NCT01759407|581746710|FG000|Overall Study|Protocol Violation|0|||
161097208|NCT01759407|581746711|FG001|Overall Study|Protocol Violation|2|||
161097209|NCT02520284|581746712|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
161097210|NCT02520284|581746713|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
161097211|NCT02520284|581746714|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
161097212|NCT02520284|581746712|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161097213|NCT02520284|581746713|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161097214|NCT02520284|581746714|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
161097215|NCT02520284|581746712|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
161097216|NCT02520284|581746713|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
161097217|NCT02520284|581746714|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
161097218|NCT02520284|581746712|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
161097219|NCT02520284|581746713|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
161097220|NCT02520284|581746714|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
161097221|NCT02520284|581746712|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
161097222|NCT02520284|581746713|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
161097223|NCT02520284|581746714|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
161097224|NCT02520284|581746712|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
161097225|NCT02520284|581746713|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
161097226|NCT02520284|581746714|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
161097227|NCT02520284|581746712|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
161097228|NCT02520284|581746713|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
161097229|NCT02520284|581746714|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
161097230|NCT02520284|581746712|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
161097231|NCT02520284|581746713|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
161097232|NCT02520284|581746714|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
161097233|NCT02520284|581746712|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
161097234|NCT02520284|581746713|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
161097235|NCT02520284|581746714|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
161097236|NCT02520284|581746712|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
161097237|NCT02520284|581746713|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
161097238|NCT02520284|581746714|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
161097239|NCT02520284|581746712|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
161097240|NCT02520284|581746713|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
161097241|NCT02520284|581746714|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
161097242|NCT03737474|581746715|FG000|Overall Study|Adverse Event|18|||
161097243|NCT03737474|581746716|FG001|Overall Study|Adverse Event|48|||
161097244|NCT03737474|581746715|FG000|Overall Study|Lack of Efficacy|1|||
161097245|NCT03737474|581746716|FG001|Overall Study|Lack of Efficacy|3|||
161210498|NCT00975884|582153532|FG001|Overall Study|Other|3|||
161210499|NCT03707522|582153533|FG000|Overall Study|Lost to Follow-up|24|||
161210500|NCT03707522|582153534|FG001|Overall Study|Lost to Follow-up|27|||
161210501|NCT03707522|582153535|FG002|Overall Study|Lost to Follow-up|41|||
161210502|NCT03707522|582153536|FG003|Overall Study|Lost to Follow-up|36|||
161097246|NCT03737474|581746715|FG000|Overall Study|Protocol Violation|0|||
161097247|NCT03737474|581746716|FG001|Overall Study|Protocol Violation|8|||
161210503|NCT00383019|582153537|FG000|Overall Study|Adverse Event|5|||
161210504|NCT00383019|582153538|FG001|Overall Study|Adverse Event|1|||
161097248|NCT03737474|581746715|FG000|Overall Study|Withdrawal by Subject|5|||
161097249|NCT03737474|581746716|FG001|Overall Study|Withdrawal by Subject|20|||
161097250|NCT03737474|581746715|FG000|Overall Study|Non-compliance With Study Drug|0|||
161097251|NCT03737474|581746716|FG001|Overall Study|Non-compliance With Study Drug|1|||
161097252|NCT03737474|581746715|FG000|Overall Study|Physician Decision|1|||
161097253|NCT03737474|581746716|FG001|Overall Study|Physician Decision|4|||
161097254|NCT02513745|581746719|FG000|Overall Study|Criteria at time of surgery not met.|3|||
161097255|NCT02513745|581746720|FG001|Overall Study|Criteria at time of surgery not met.|3|||
161097256|NCT01139658|581746723|FG000|Overall Study|Adverse Event|10|||
161097257|NCT01139658|581746724|FG001|Overall Study|Adverse Event|27|||
161097258|NCT01139658|581746723|FG000|Overall Study|Lack of Efficacy|15|||
161097259|NCT01139658|581746724|FG001|Overall Study|Lack of Efficacy|7|||
161097260|NCT01139658|581746723|FG000|Overall Study|Withdrawal by Subject|2|||
161097261|NCT01139658|581746724|FG001|Overall Study|Withdrawal by Subject|4|||
161097262|NCT01139658|581746723|FG000|Overall Study|No documentation of treatment|1|||
161097263|NCT01139658|581746724|FG001|Overall Study|No documentation of treatment|0|||
161097264|NCT01139658|581746723|FG000|Overall Study|Other|28|||
161097265|NCT01139658|581746724|FG001|Overall Study|Other|75|||
161097266|NCT00753272|581746727|FG000|Overall Study|Adverse Event|878|||
161097267|NCT00753272|581746728|FG001|Overall Study|Adverse Event|869|||
161097268|NCT00753272|581746727|FG000|Overall Study|Protocol Violation|28|||
161097269|NCT00753272|581746728|FG001|Overall Study|Protocol Violation|46|||
161097270|NCT00753272|581746727|FG000|Overall Study|Withdrawal by Subject|2481|||
161097271|NCT00753272|581746728|FG001|Overall Study|Withdrawal by Subject|2407|||
161097272|NCT00753272|581746727|FG000|Overall Study|Lost to Follow-up|491|||
161097273|NCT00753272|581746728|FG001|Overall Study|Lost to Follow-up|497|||
161097274|NCT00753272|581746727|FG000|Overall Study|Other|1104|||
161097275|NCT00753272|581746728|FG001|Overall Study|Other|1088|||
161097276|NCT00803270|581746729|FG000|Overall Study|Lost to Follow-up|1|||
161097277|NCT00803270|581746730|FG001|Overall Study|Lost to Follow-up|2|||
161097278|NCT01966471|581746731|FG000|Overall Study|Death|44|||
161097279|NCT01966471|581746732|FG001|Overall Study|Death|56|||
161097280|NCT01966471|581746731|FG000|Overall Study|Lost to Follow-up|46|||
161097281|NCT01966471|581746732|FG001|Overall Study|Lost to Follow-up|39|||
161097282|NCT01966471|581746731|FG000|Overall Study|Various reasons|4|||
161097283|NCT01966471|581746732|FG001|Overall Study|Various reasons|4|||
161097284|NCT01966471|581746731|FG000|Overall Study|Physician Decision|7|||
161097285|NCT01966471|581746732|FG001|Overall Study|Physician Decision|5|||
161097286|NCT01966471|581746731|FG000|Overall Study|Study Terminated By Sponsor|758|||
161097287|NCT01966471|581746732|FG001|Overall Study|Study Terminated By Sponsor|773|||
161097288|NCT01966471|581746731|FG000|Overall Study|Withdrawal by Subject|59|||
161097289|NCT01966471|581746732|FG001|Overall Study|Withdrawal by Subject|51|||
161097290|NCT02092220|581746736|FG000|Period 1|Unrelated Illness|0|||
161097291|NCT02092220|581746737|FG001|Period 1|Unrelated Illness|2|||
161097292|NCT02092220|581746736|FG000|Period 2|Severe Hypoglycaemia|1|||
161097293|NCT02092220|581746737|FG001|Period 2|Severe Hypoglycaemia|0|||
161097294|NCT02092220|581746736|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
161097295|NCT02092220|581746737|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
161097296|NCT00960531|581746738|FG000|Overall Study|Lack of Efficacy|1|||
161097297|NCT00960531|581746739|FG001|Overall Study|Lack of Efficacy|0|||
161097298|NCT00960531|581746740|FG002|Overall Study|Lack of Efficacy|0|||
161097299|NCT00960531|581746741|FG003|Overall Study|Lack of Efficacy|0|||
161097300|NCT00960531|581746742|FG004|Overall Study|Lack of Efficacy|0|||
161210505|NCT00383019|582153537|FG000|Overall Study|Withdrawal by Subject|0|||
161097301|NCT00960531|581746743|FG005|Overall Study|Lack of Efficacy|0|||
161097302|NCT00960531|581746744|FG006|Overall Study|Lack of Efficacy|0|||
161210506|NCT00383019|582153538|FG001|Overall Study|Withdrawal by Subject|1|||
161210507|NCT01619085|582153539|FG000|Overall Study|Adverse Event|231|||
161210508|NCT01619085|582153539|FG000|Overall Study|Protocol Violation|4|||
161210509|NCT01619085|582153539|FG000|Overall Study|Lost to Follow-up|3|||
161210510|NCT01619085|582153539|FG000|Overall Study|Withdrawal by Subject|45|||
161210511|NCT01619085|582153539|FG000|Overall Study|Other than specified|96|||
161210512|NCT01619085|582153539|FG000|Overall Study|Not treated|1|||
161210513|NCT01619085|582153539|FG000|Overall Study|Death|145|||
161322980|NCT03092791|582568668|FG007|Overall Study|Withdrawal of Consent|4|||
161097303|NCT00960531|581746745|FG007|Overall Study|Lack of Efficacy|0|||
161097304|NCT00960531|581746746|FG008|Overall Study|Lack of Efficacy|0|||
161097305|NCT00960531|581746747|FG009|Overall Study|Lack of Efficacy|0|||
161097306|NCT00960531|581746738|FG000|Overall Study|Withdrawal by Subject|1|||
161322981|NCT03092791|582568661|FG000|Overall Study|Study Termination|0|||
161097307|NCT00960531|581746739|FG001|Overall Study|Withdrawal by Subject|0|||
161097308|NCT00960531|581746740|FG002|Overall Study|Withdrawal by Subject|5|||
161097309|NCT00960531|581746741|FG003|Overall Study|Withdrawal by Subject|2|||
161097310|NCT00960531|581746742|FG004|Overall Study|Withdrawal by Subject|0|||
161097311|NCT00960531|581746743|FG005|Overall Study|Withdrawal by Subject|0|||
161097312|NCT00960531|581746744|FG006|Overall Study|Withdrawal by Subject|2|||
161097313|NCT00960531|581746745|FG007|Overall Study|Withdrawal by Subject|0|||
161210514|NCT00833976|582154874|FG000|Overall Study|Withdrawal by Subject|5|||
161322982|NCT03092791|582568662|FG001|Overall Study|Study Termination|0|||
161210515|NCT00833976|582154874|FG000|Overall Study|Lost to Follow-up|4|||
161210516|NCT00833976|582154874|FG000|Overall Study|Did not meet eligibility criteria|41|||
161210517|NCT00833976|582154874|FG000|Overall Study|Physician Decision|1|||
161210518|NCT01246973|582154877|FG000|Overall Study|Other|38|||
161210519|NCT01246973|582154878|FG001|Overall Study|Other|25|||
161210520|NCT01246973|582154877|FG000|Overall Study|Adverse Event|16|||
161097314|NCT00960531|581746746|FG008|Overall Study|Withdrawal by Subject|1|||
161097315|NCT00960531|581746747|FG009|Overall Study|Withdrawal by Subject|0|||
161097316|NCT00960531|581746738|FG000|Overall Study|Caregiver Request|2|||
161097317|NCT00960531|581746739|FG001|Overall Study|Caregiver Request|0|||
161097318|NCT00960531|581746740|FG002|Overall Study|Caregiver Request|6|||
161097319|NCT00960531|581746741|FG003|Overall Study|Caregiver Request|5|||
161097320|NCT00960531|581746742|FG004|Overall Study|Caregiver Request|0|||
161097321|NCT00960531|581746743|FG005|Overall Study|Caregiver Request|2|||
161097322|NCT00960531|581746744|FG006|Overall Study|Caregiver Request|3|||
161097323|NCT00960531|581746745|FG007|Overall Study|Caregiver Request|1|||
161097324|NCT00960531|581746746|FG008|Overall Study|Caregiver Request|3|||
161097325|NCT00960531|581746747|FG009|Overall Study|Caregiver Request|0|||
161097326|NCT00960531|581746738|FG000|Overall Study|Investigator Request|0|||
161097327|NCT00960531|581746739|FG001|Overall Study|Investigator Request|0|||
161097328|NCT00960531|581746740|FG002|Overall Study|Investigator Request|1|||
161097329|NCT00960531|581746741|FG003|Overall Study|Investigator Request|0|||
161097330|NCT00960531|581746742|FG004|Overall Study|Investigator Request|0|||
161097331|NCT00960531|581746743|FG005|Overall Study|Investigator Request|0|||
161097332|NCT00960531|581746744|FG006|Overall Study|Investigator Request|0|||
161097333|NCT00960531|581746745|FG007|Overall Study|Investigator Request|0|||
161097334|NCT00960531|581746746|FG008|Overall Study|Investigator Request|0|||
161097335|NCT00960531|581746747|FG009|Overall Study|Investigator Request|0|||
161097336|NCT00960531|581746738|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161097337|NCT00960531|581746739|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161097338|NCT00960531|581746740|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161097339|NCT00960531|581746741|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161097340|NCT00960531|581746742|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161097341|NCT00960531|581746743|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161097342|NCT00960531|581746744|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
161097343|NCT00960531|581746745|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
161097344|NCT00960531|581746746|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
161097345|NCT00960531|581746747|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
161097346|NCT00960531|581746738|FG000|Overall Study|Lost to Follow-up|0|||
161097347|NCT00960531|581746739|FG001|Overall Study|Lost to Follow-up|0|||
161097348|NCT00960531|581746740|FG002|Overall Study|Lost to Follow-up|1|||
161097349|NCT00960531|581746741|FG003|Overall Study|Lost to Follow-up|0|||
161097350|NCT00960531|581746742|FG004|Overall Study|Lost to Follow-up|0|||
161097351|NCT00960531|581746743|FG005|Overall Study|Lost to Follow-up|0|||
161097352|NCT00960531|581746744|FG006|Overall Study|Lost to Follow-up|1|||
161097353|NCT00960531|581746745|FG007|Overall Study|Lost to Follow-up|0|||
161097354|NCT00960531|581746746|FG008|Overall Study|Lost to Follow-up|0|||
161097355|NCT00960531|581746747|FG009|Overall Study|Lost to Follow-up|0|||
161097356|NCT00960531|581746738|FG000|Overall Study|Failed to Return|2|||
161097357|NCT00960531|581746739|FG001|Overall Study|Failed to Return|0|||
161097358|NCT00960531|581746740|FG002|Overall Study|Failed to Return|0|||
161097359|NCT00960531|581746741|FG003|Overall Study|Failed to Return|0|||
161097360|NCT00960531|581746742|FG004|Overall Study|Failed to Return|0|||
161097361|NCT00960531|581746743|FG005|Overall Study|Failed to Return|0|||
161097362|NCT00960531|581746744|FG006|Overall Study|Failed to Return|0|||
161097363|NCT00960531|581746745|FG007|Overall Study|Failed to Return|2|||
161097364|NCT00960531|581746746|FG008|Overall Study|Failed to Return|0|||
161097365|NCT00960531|581746747|FG009|Overall Study|Failed to Return|0|||
161097366|NCT00960531|581746738|FG000|Overall Study|Adverse Event (AE)|2|||
161097367|NCT00960531|581746739|FG001|Overall Study|Adverse Event (AE)|0|||
161097368|NCT00960531|581746740|FG002|Overall Study|Adverse Event (AE)|0|||
161097369|NCT00960531|581746741|FG003|Overall Study|Adverse Event (AE)|0|||
161097370|NCT00960531|581746742|FG004|Overall Study|Adverse Event (AE)|0|||
161097371|NCT00960531|581746743|FG005|Overall Study|Adverse Event (AE)|1|||
161097372|NCT00960531|581746744|FG006|Overall Study|Adverse Event (AE)|2|||
161097373|NCT00960531|581746745|FG007|Overall Study|Adverse Event (AE)|0|||
161210521|NCT01246973|582154878|FG001|Overall Study|Adverse Event|9|||
161210522|NCT01246973|582154877|FG000|Overall Study|Withdrawal by Subject|7|||
161097374|NCT00960531|581746746|FG008|Overall Study|Adverse Event (AE)|2|||
161097375|NCT00960531|581746747|FG009|Overall Study|Adverse Event (AE)|0|||
161097376|NCT00960531|581746738|FG000|Overall Study|Reason not Specified|2|||
161097377|NCT00960531|581746739|FG001|Overall Study|Reason not Specified|1|||
161097378|NCT00960531|581746740|FG002|Overall Study|Reason not Specified|13|||
161097379|NCT00960531|581746741|FG003|Overall Study|Reason not Specified|1|||
161097380|NCT00960531|581746742|FG004|Overall Study|Reason not Specified|2|||
161097381|NCT00960531|581746743|FG005|Overall Study|Reason not Specified|0|||
161210523|NCT01246973|582154878|FG001|Overall Study|Withdrawal by Subject|13|||
161210524|NCT01416142|582154879|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
161097382|NCT00960531|581746744|FG006|Overall Study|Reason not Specified|16|||
161097383|NCT00960531|581746745|FG007|Overall Study|Reason not Specified|0|||
161097384|NCT00960531|581746746|FG008|Overall Study|Reason not Specified|8|||
161097385|NCT00960531|581746747|FG009|Overall Study|Reason not Specified|1|||
161097386|NCT00593957|581746748|FG000|Overall Study|Physician Decision|0|||
161097387|NCT00593957|581746749|FG001|Overall Study|Physician Decision|1|||
161097388|NCT00593957|581746750|FG002|Overall Study|Physician Decision|2|||
161097389|NCT02411578|581746753|FG000|Crossover Trial Phase|Pregnancy|0|||
161097390|NCT02411578|581746754|FG001|Crossover Trial Phase|Pregnancy|1|||
161097391|NCT00494481|581746755|FG000|Overall Study|Condition under investigation worsened|11|||
161097392|NCT00494481|581746756|FG001|Overall Study|Condition under investigation worsened|13|||
161097393|NCT00494481|581746755|FG000|Overall Study|Adverse Event|15|||
161097394|NCT00494481|581746756|FG001|Overall Study|Adverse Event|11|||
161097395|NCT00494481|581746755|FG000|Overall Study|Other|1|||
161097396|NCT00494481|581746756|FG001|Overall Study|Other|0|||
161097397|NCT00494481|581746755|FG000|Overall Study|Never received IP|2|||
161097398|NCT00494481|581746756|FG001|Overall Study|Never received IP|0|||
161097399|NCT00332189|581746757|FG000|Overall Study|Adverse Event|3|||
161097400|NCT00332189|581746757|FG000|Overall Study|Uncooperative/Noncompliant|3|||
161097401|NCT00332189|581746757|FG000|Overall Study|Withdrawal by Subject|9|||
161097402|NCT00332189|581746757|FG000|Overall Study|Lack of Efficacy|4|||
161097403|NCT00332189|581746757|FG000|Overall Study|Moved out of country|2|||
161097404|NCT02225353|581746760|FG000|Overall Study|Lost to Follow-up|0|||
161097405|NCT02225353|581746761|FG001|Overall Study|Lost to Follow-up|1|||
161097406|NCT02225353|581746762|FG002|Overall Study|Lost to Follow-up|3|||
161097407|NCT02225353|581746760|FG000|Overall Study|Protocol Violation|4|||
161097408|NCT02225353|581746761|FG001|Overall Study|Protocol Violation|5|||
161097409|NCT02225353|581746762|FG002|Overall Study|Protocol Violation|12|||
161097410|NCT03707925|581746763|FG000|Overall Study|Inevaluable|1|||
161097411|NCT01193920|581746764|FG000|Overall Study|Withdrawal by Subject|1|||
161097412|NCT01193920|581746765|FG001|Overall Study|Withdrawal by Subject|0|||
161097413|NCT01193920|581746766|FG002|Overall Study|Withdrawal by Subject|5|||
161097414|NCT01193920|581746767|FG003|Overall Study|Withdrawal by Subject|1|||
161097415|NCT01193920|581746768|FG004|Overall Study|Withdrawal by Subject|3|||
161097416|NCT01193920|581746769|FG005|Overall Study|Withdrawal by Subject|1|||
161097417|NCT01193920|581746770|FG006|Overall Study|Withdrawal by Subject|3|||
161097418|NCT01193920|581746771|FG007|Overall Study|Withdrawal by Subject|0|||
161097419|NCT01193920|581746772|FG008|Overall Study|Withdrawal by Subject|1|||
161097420|NCT01193920|581746773|FG009|Overall Study|Withdrawal by Subject|0|||
161210525|NCT01416142|582154880|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
161210526|NCT01416142|582154881|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
161210527|NCT02464059|582154882|FG000|Overall Study|Lost to Follow-up|6|||
161210528|NCT00678379|582154883|FG000|Overall Study|Injection performed after tonsillectomy|2|||
161210529|NCT00678379|582154884|FG001|Overall Study|Injection performed after tonsillectomy|0|||
161210530|NCT00678379|582154885|FG002|Overall Study|Injection performed after tonsillectomy|1|||
161097421|NCT01193920|581746764|FG000|Overall Study|Lost to Follow-up|1|||
161097422|NCT01193920|581746765|FG001|Overall Study|Lost to Follow-up|0|||
161097423|NCT01193920|581746766|FG002|Overall Study|Lost to Follow-up|1|||
161097424|NCT01193920|581746767|FG003|Overall Study|Lost to Follow-up|1|||
161097425|NCT01193920|581746768|FG004|Overall Study|Lost to Follow-up|3|||
161097426|NCT01193920|581746769|FG005|Overall Study|Lost to Follow-up|3|||
161097427|NCT01193920|581746770|FG006|Overall Study|Lost to Follow-up|1|||
161097428|NCT01193920|581746771|FG007|Overall Study|Lost to Follow-up|0|||
161097429|NCT01193920|581746772|FG008|Overall Study|Lost to Follow-up|2|||
161097430|NCT01193920|581746773|FG009|Overall Study|Lost to Follow-up|3|||
161097431|NCT01193920|581746764|FG000|Overall Study|Protocol Violation|1|||
161097432|NCT01193920|581746765|FG001|Overall Study|Protocol Violation|0|||
161097433|NCT01193920|581746766|FG002|Overall Study|Protocol Violation|0|||
161097434|NCT01193920|581746767|FG003|Overall Study|Protocol Violation|0|||
161097435|NCT01193920|581746768|FG004|Overall Study|Protocol Violation|0|||
161097436|NCT01193920|581746769|FG005|Overall Study|Protocol Violation|0|||
161097437|NCT01193920|581746770|FG006|Overall Study|Protocol Violation|0|||
161097438|NCT01193920|581746771|FG007|Overall Study|Protocol Violation|0|||
161097439|NCT01193920|581746772|FG008|Overall Study|Protocol Violation|0|||
161097440|NCT01193920|581746773|FG009|Overall Study|Protocol Violation|0|||
161097441|NCT01193920|581746764|FG000|Overall Study|Death|0|||
161097442|NCT01193920|581746765|FG001|Overall Study|Death|0|||
161097443|NCT01193920|581746766|FG002|Overall Study|Death|0|||
161097444|NCT01193920|581746767|FG003|Overall Study|Death|1|||
161097445|NCT01193920|581746768|FG004|Overall Study|Death|0|||
161210531|NCT00678379|582154883|FG000|Overall Study|Incomplete Data|4|||
161210532|NCT00678379|582154884|FG001|Overall Study|Incomplete Data|3|||
161097446|NCT01193920|581746769|FG005|Overall Study|Death|0|||
161097447|NCT01193920|581746770|FG006|Overall Study|Death|2|||
161097448|NCT01193920|581746771|FG007|Overall Study|Death|3|||
161097449|NCT01193920|581746772|FG008|Overall Study|Death|2|||
161097450|NCT01193920|581746773|FG009|Overall Study|Death|4|||
161097451|NCT01193920|581746764|FG000|Overall Study|Unable to classify|0|||
161097452|NCT01193920|581746765|FG001|Overall Study|Unable to classify|0|||
161322983|NCT03092791|582568663|FG002|Overall Study|Study Termination|0|||
161097453|NCT01193920|581746766|FG002|Overall Study|Unable to classify|0|||
161097454|NCT01193920|581746767|FG003|Overall Study|Unable to classify|1|||
161097455|NCT01193920|581746768|FG004|Overall Study|Unable to classify|0|||
161097456|NCT01193920|581746769|FG005|Overall Study|Unable to classify|0|||
161097457|NCT01193920|581746770|FG006|Overall Study|Unable to classify|0|||
161097458|NCT01193920|581746771|FG007|Overall Study|Unable to classify|1|||
161097459|NCT01193920|581746772|FG008|Overall Study|Unable to classify|0|||
161097460|NCT01193920|581746773|FG009|Overall Study|Unable to classify|0|||
161097461|NCT00954421|581746774|FG000|Screening|screen failures|3|||
161097462|NCT00954421|581746774|FG000|6 Months of DBS|Withdrawal by Subject|1|||
161097463|NCT00954421|581746774|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
161097464|NCT04683731|581746777|FG000|Overall Study|Withdrawal by Subject|1|||
161097465|NCT04683731|581746778|FG001|Overall Study|Withdrawal by Subject|0|||
161097466|NCT04683731|581746779|FG002|Overall Study|Withdrawal by Subject|3|||
161097467|NCT04683731|581746780|FG003|Overall Study|Withdrawal by Subject|2|||
161097468|NCT04683731|581746777|FG000|Overall Study|Determined patient was not eligible|3|||
161097469|NCT04683731|581746778|FG001|Overall Study|Determined patient was not eligible|3|||
161097470|NCT04683731|581746779|FG002|Overall Study|Determined patient was not eligible|12|||
161097471|NCT04683731|581746780|FG003|Overall Study|Determined patient was not eligible|3|||
161097472|NCT00883051|581746781|FG000|Overall Study|Lost to Follow-up|0|||
161097473|NCT00883051|581746782|FG001|Overall Study|Lost to Follow-up|0|||
161097474|NCT00883051|581746783|FG002|Overall Study|Lost to Follow-up|0|||
161097475|NCT00883051|581746784|FG003|Overall Study|Lost to Follow-up|0|||
161097476|NCT00883051|581746785|FG004|Overall Study|Lost to Follow-up|1|||
161097477|NCT00883051|581746781|FG000|Overall Study|Did not use study medication|24|||
161097478|NCT00883051|581746782|FG001|Overall Study|Did not use study medication|22|||
161097479|NCT00883051|581746783|FG002|Overall Study|Did not use study medication|29|||
161097480|NCT00883051|581746784|FG003|Overall Study|Did not use study medication|29|||
161097481|NCT00883051|581746785|FG004|Overall Study|Did not use study medication|17|||
161097482|NCT03144804|581746786|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
161097483|NCT00959647|581746787|FG000|Overall Study|Adverse Event|2|||
161097484|NCT00959647|581746787|FG000|Overall Study|Progressive disease|6|||
161097485|NCT00959647|581746787|FG000|Overall Study|Study terminated by sponsor|4|||
161097486|NCT00959647|581746787|FG000|Overall Study|Withdrawal by Subject|7|||
161097487|NCT04223856|581746788|FG000|Overall Study|Progressive disease|153|||
161097488|NCT04223856|581746789|FG001|Overall Study|Progressive disease|73|||
161097489|NCT04223856|581746788|FG000|Overall Study|Adverse Event|97|||
161097490|NCT04223856|581746789|FG001|Overall Study|Adverse Event|62|||
161097491|NCT04223856|581746788|FG000|Overall Study|Physician Decision|9|||
161097492|NCT04223856|581746789|FG001|Overall Study|Physician Decision|28|||
161097493|NCT04223856|581746788|FG000|Overall Study|Withdrawal by Subject|22|||
161097494|NCT04223856|581746789|FG001|Overall Study|Withdrawal by Subject|24|||
161097495|NCT04223856|581746788|FG000|Overall Study|Other|7|||
161097496|NCT04223856|581746789|FG001|Overall Study|Other|2|||
161097497|NCT04223856|581746788|FG000|Overall Study|Randomized but not treated|2|||
161322984|NCT03092791|582568664|FG003|Overall Study|Study Termination|0|||
161322985|NCT03092791|582568665|FG004|Overall Study|Study Termination|55|||
161322986|NCT03092791|582568666|FG005|Overall Study|Study Termination|46|||
161322987|NCT03092791|582568667|FG006|Overall Study|Study Termination|53|||
161322988|NCT03092791|582568668|FG007|Overall Study|Study Termination|55|||
161322989|NCT03092791|582568661|FG000|Overall Study|Death|0|||
161322990|NCT03092791|582568662|FG001|Overall Study|Death|0|||
161322991|NCT03092791|582568663|FG002|Overall Study|Death|0|||
161322992|NCT03092791|582568664|FG003|Overall Study|Death|0|||
161322993|NCT03092791|582568665|FG004|Overall Study|Death|0|||
161322994|NCT03092791|582568666|FG005|Overall Study|Death|1|||
161322995|NCT03092791|582568667|FG006|Overall Study|Death|0|||
161322996|NCT03092791|582568668|FG007|Overall Study|Death|1|||
161322997|NCT03092791|582568661|FG000|Overall Study|Reason Not Specified|0|||
161322998|NCT03092791|582568662|FG001|Overall Study|Reason Not Specified|0|||
161322999|NCT03092791|582568663|FG002|Overall Study|Reason Not Specified|0|||
161323000|NCT03092791|582568664|FG003|Overall Study|Reason Not Specified|0|||
161323001|NCT03092791|582568665|FG004|Overall Study|Reason Not Specified|1|||
161097498|NCT04223856|581746789|FG001|Overall Study|Randomized but not treated|11|||
161097499|NCT04223856|581746788|FG000|Overall Study|On-treatment|144|||
161097500|NCT04223856|581746789|FG001|Overall Study|On-treatment|0|||
161097501|NCT06515483|581746790|FG000|Overall Study|Subject withdraw due to family issues|1|||
161097502|NCT06515483|581746791|FG001|Overall Study|Subject withdraw due to family issues|0|||
161097503|NCT04641299|581748648|FG000|Overall Study|Adverse Event|0|||
161097504|NCT04641299|581748649|FG001|Overall Study|Adverse Event|0|||
161097505|NCT04641299|581748650|FG002|Overall Study|Adverse Event|2|||
161097506|NCT04641299|581748651|FG003|Overall Study|Adverse Event|0|||
161097507|NCT04641299|581748648|FG000|Overall Study|Lost to Follow-up|0|||
161097508|NCT04641299|581748649|FG001|Overall Study|Lost to Follow-up|1|||
161097509|NCT04641299|581748650|FG002|Overall Study|Lost to Follow-up|0|||
161097510|NCT04641299|581748651|FG003|Overall Study|Lost to Follow-up|0|||
161097511|NCT04641299|581748648|FG000|Overall Study|Withdrawal by Subject|1|||
161097512|NCT04641299|581748649|FG001|Overall Study|Withdrawal by Subject|0|||
161097513|NCT04641299|581748650|FG002|Overall Study|Withdrawal by Subject|0|||
161097514|NCT04641299|581748651|FG003|Overall Study|Withdrawal by Subject|0|||
161097515|NCT04641299|581748648|FG000|Overall Study|Reason not given|1|||
161097516|NCT04641299|581748649|FG001|Overall Study|Reason not given|0|||
161097517|NCT04641299|581748650|FG002|Overall Study|Reason not given|0|||
161097518|NCT04641299|581748651|FG003|Overall Study|Reason not given|0|||
161097519|NCT01890148|581748655|FG000|Overall Study|Adverse Event|1|||
161097520|NCT05104476|581748658|FG000|Overall Study|Randomized But Not Treated|1|||
161097521|NCT05104476|581748659|FG001|Overall Study|Randomized But Not Treated|2|||
161097522|NCT05104476|581748658|FG000|Overall Study|Adverse Event|2|||
161097523|NCT05104476|581748659|FG001|Overall Study|Adverse Event|2|||
161097524|NCT05104476|581748658|FG000|Overall Study|Withdrawal by Subject|3|||
161097525|NCT05104476|581748659|FG001|Overall Study|Withdrawal by Subject|3|||
161097526|NCT05104476|581748658|FG000|Overall Study|Other Than Specified|0|||
161097527|NCT05104476|581748659|FG001|Overall Study|Other Than Specified|3|||
161097528|NCT00992511|581748663|FG000|Overall Study|Migrated/moved from study area|1|||
161097529|NCT00992511|581748664|FG001|Overall Study|Migrated/moved from study area|0|||
161097530|NCT00992511|581748665|FG002|Overall Study|Migrated/moved from study area|1|||
161097531|NCT00992511|581748666|FG003|Overall Study|Migrated/moved from study area|2|||
161097532|NCT00992511|581748663|FG000|Overall Study|Lost to Follow-up|1|||
161097533|NCT00992511|581748664|FG001|Overall Study|Lost to Follow-up|0|||
161097534|NCT00992511|581748665|FG002|Overall Study|Lost to Follow-up|0|||
161210533|NCT00678379|582154885|FG002|Overall Study|Incomplete Data|3|||
161210534|NCT01835470|582154886|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
161210535|NCT01835470|582154886|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
161210536|NCT01011907|582154887|FG000|Overall Study|Withdrawal by Subject|13|||
161210537|NCT01011907|582154888|FG001|Overall Study|Withdrawal by Subject|11|||
161097535|NCT00992511|581748666|FG003|Overall Study|Lost to Follow-up|2|||
161097536|NCT00992511|581748663|FG000|Overall Study|Withdrawal by Subject|0|||
161097537|NCT00992511|581748664|FG001|Overall Study|Withdrawal by Subject|0|||
161097538|NCT00992511|581748665|FG002|Overall Study|Withdrawal by Subject|1|||
161097539|NCT00992511|581748666|FG003|Overall Study|Withdrawal by Subject|1|||
161097540|NCT01180998|581748667|FG000|Overall Study|Poor Vision|0|||
161097541|NCT01180998|581748668|FG001|Overall Study|Poor Vision|2|||
161097542|NCT01180998|581748669|FG002|Overall Study|Poor Vision|2|||
161097543|NCT01180998|581748667|FG000|Overall Study|Lost to Follow-up|0|||
161210538|NCT01011907|582154887|FG000|Overall Study|Adverse Event|1|||
161210539|NCT01011907|582154888|FG001|Overall Study|Adverse Event|4|||
161210540|NCT01637961|582154893|FG000|Overall Study|Ineligible: wrong primary|1|||
161210541|NCT01637961|582154893|FG000|Overall Study|Ineligible: inadequate pathology|1|||
161210542|NCT03101293|582154894|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
161210543|NCT03101293|582154895|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
161210544|NCT04682639|582154897|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
161210545|NCT04682639|582154898|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161210546|NCT04682639|582154899|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
161210547|NCT04682639|582154900|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161210548|NCT04682639|582154901|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
161210549|NCT04682639|582154897|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161210550|NCT04682639|582154898|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161210551|NCT04682639|582154899|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161210552|NCT04682639|582154900|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161210553|NCT04682639|582154901|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161210554|NCT04682639|582154897|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
161210555|NCT04682639|582154898|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161210556|NCT04682639|582154899|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161210557|NCT04682639|582154900|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161210558|NCT04682639|582154901|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161210559|NCT04682639|582154897|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161210560|NCT04682639|582154898|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
161210561|NCT04682639|582154899|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161097544|NCT01180998|581748668|FG001|Overall Study|Lost to Follow-up|0|||
161097545|NCT01180998|581748669|FG002|Overall Study|Lost to Follow-up|1|||
161210562|NCT04682639|582154900|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161210563|NCT04682639|582154901|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
161210564|NCT04682639|582154897|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
161210565|NCT04682639|582154898|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161097546|NCT01180998|581748667|FG000|Overall Study|Protocol Violation|1|||
161097547|NCT01180998|581748668|FG001|Overall Study|Protocol Violation|2|||
161097548|NCT01180998|581748669|FG002|Overall Study|Protocol Violation|0|||
161097549|NCT01180998|581748667|FG000|Overall Study|Withdrawal by Subject|0|||
161097550|NCT01180998|581748668|FG001|Overall Study|Withdrawal by Subject|0|||
161210566|NCT04682639|582154899|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161210567|NCT04682639|582154900|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161210568|NCT04682639|582154901|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
161210569|NCT04682639|582154897|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161210570|NCT04682639|582154898|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161210571|NCT04682639|582154899|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
161210572|NCT04682639|582154900|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161210573|NCT04682639|582154901|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161210574|NCT04682639|582154897|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
161210575|NCT04682639|582154898|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
161210576|NCT04682639|582154899|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
161210577|NCT04682639|582154900|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
161210578|NCT04682639|582154901|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
161210579|NCT04682639|582154897|FG000|OLE Period (28 Weeks)|Other|1|||
161210580|NCT04682639|582154898|FG001|OLE Period (28 Weeks)|Other|2|||
161210581|NCT04682639|582154899|FG002|OLE Period (28 Weeks)|Other|0|||
161210582|NCT04682639|582154900|FG003|OLE Period (28 Weeks)|Other|0|||
161210583|NCT04682639|582154901|FG004|OLE Period (28 Weeks)|Other|1|||
161210584|NCT04682639|582154897|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
161210585|NCT04682639|582154898|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
161210586|NCT04682639|582154899|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161210587|NCT04682639|582154900|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161210588|NCT04682639|582154901|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
161210589|NCT04682639|582154897|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
161210590|NCT04682639|582154898|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
161210591|NCT04682639|582154899|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161210592|NCT04682639|582154900|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161210593|NCT04682639|582154901|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161210594|NCT04682639|582154897|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161210595|NCT04682639|582154898|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
161210596|NCT04682639|582154899|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161210597|NCT04682639|582154900|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161210598|NCT04682639|582154901|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161210599|NCT04682639|582154897|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
161210600|NCT04682639|582154898|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
161210601|NCT04682639|582154899|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
161210602|NCT04682639|582154900|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
161210603|NCT04682639|582154901|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
161210604|NCT02773446|582154902|FG000|First Admission|Withdrawal by Subject|0|||
161210605|NCT02773446|582154903|FG001|First Admission|Withdrawal by Subject|0|||
161210606|NCT02773446|582154904|FG002|First Admission|Withdrawal by Subject|0|||
161210607|NCT02773446|582154905|FG003|First Admission|Withdrawal by Subject|1|||
161210608|NCT02773446|582154906|FG004|First Admission|Withdrawal by Subject|0|||
161210609|NCT02773446|582154907|FG005|First Admission|Withdrawal by Subject|0|||
161210610|NCT02773446|582154902|FG000|First Admission|Lost to Follow-up|1|||
161210611|NCT02773446|582154903|FG001|First Admission|Lost to Follow-up|0|||
161210612|NCT02773446|582154904|FG002|First Admission|Lost to Follow-up|0|||
161210613|NCT02773446|582154905|FG003|First Admission|Lost to Follow-up|0|||
161210614|NCT02773446|582154906|FG004|First Admission|Lost to Follow-up|0|||
161210615|NCT02773446|582154907|FG005|First Admission|Lost to Follow-up|0|||
161210616|NCT01613131|582154908|FG000|Overall Study|Withdrawal by Subject|3|||
161210617|NCT01613131|582154909|FG001|Overall Study|Withdrawal by Subject|5|||
161210618|NCT02454972|582154910|FG000|Overall Study|Progressive disease|17|||
161210619|NCT02454972|582154911|FG001|Overall Study|Progressive disease|16|||
161210620|NCT02454972|582154912|FG002|Overall Study|Progressive disease|59|||
161210621|NCT02454972|582154913|FG003|Overall Study|Progressive disease|23|||
161210622|NCT02454972|582154914|FG004|Overall Study|Progressive disease|16|||
161210623|NCT02454972|582154915|FG005|Overall Study|Progressive disease|12|||
161210624|NCT02454972|582154916|FG006|Overall Study|Progressive disease|19|||
161210625|NCT02454972|582154917|FG007|Overall Study|Progressive disease|27|||
161210626|NCT02454972|582154918|FG008|Overall Study|Progressive disease|0|||
161210627|NCT02454972|582154910|FG000|Overall Study|Death|0|||
161210628|NCT02454972|582154911|FG001|Overall Study|Death|0|||
161210629|NCT02454972|582154912|FG002|Overall Study|Death|5|||
161210630|NCT02454972|582154913|FG003|Overall Study|Death|1|||
161210631|NCT02454972|582154914|FG004|Overall Study|Death|0|||
161210632|NCT02454972|582154915|FG005|Overall Study|Death|0|||
161210633|NCT02454972|582154916|FG006|Overall Study|Death|0|||
161210634|NCT02454972|582154917|FG007|Overall Study|Death|0|||
160865656|NCT01055197|580902942|FG000|Overall Study|Withdrawal by Subject|2|||
161210635|NCT02454972|582154918|FG008|Overall Study|Death|95|||
161210636|NCT02454972|582154910|FG000|Overall Study|Physician Decision|0|||
161210637|NCT02454972|582154911|FG001|Overall Study|Physician Decision|1|||
161210638|NCT02454972|582154912|FG002|Overall Study|Physician Decision|2|||
161210639|NCT02454972|582154913|FG003|Overall Study|Physician Decision|1|||
161210640|NCT02454972|582154914|FG004|Overall Study|Physician Decision|2|||
161210641|NCT02454972|582154915|FG005|Overall Study|Physician Decision|0|||
161210642|NCT02454972|582154916|FG006|Overall Study|Physician Decision|0|||
161210643|NCT02454972|582154917|FG007|Overall Study|Physician Decision|1|||
161210644|NCT02454972|582154918|FG008|Overall Study|Physician Decision|0|||
161210645|NCT02454972|582154910|FG000|Overall Study|Non treatment-related adverse event|2|||
161210646|NCT02454972|582154911|FG001|Overall Study|Non treatment-related adverse event|0|||
161210647|NCT02454972|582154912|FG002|Overall Study|Non treatment-related adverse event|1|||
161210648|NCT02454972|582154913|FG003|Overall Study|Non treatment-related adverse event|0|||
161210649|NCT02454972|582154914|FG004|Overall Study|Non treatment-related adverse event|0|||
161210650|NCT02454972|582154915|FG005|Overall Study|Non treatment-related adverse event|1|||
161210651|NCT02454972|582154916|FG006|Overall Study|Non treatment-related adverse event|0|||
161210652|NCT02454972|582154917|FG007|Overall Study|Non treatment-related adverse event|1|||
161210653|NCT02454972|582154918|FG008|Overall Study|Non treatment-related adverse event|0|||
161210654|NCT02454972|582154910|FG000|Overall Study|Treatment-related adverse events|0|||
161210655|NCT02454972|582154911|FG001|Overall Study|Treatment-related adverse events|1|||
161210656|NCT02454972|582154912|FG002|Overall Study|Treatment-related adverse events|1|||
161210657|NCT02454972|582154913|FG003|Overall Study|Treatment-related adverse events|0|||
161210658|NCT02454972|582154914|FG004|Overall Study|Treatment-related adverse events|2|||
161210659|NCT02454972|582154915|FG005|Overall Study|Treatment-related adverse events|0|||
161210660|NCT02454972|582154916|FG006|Overall Study|Treatment-related adverse events|0|||
161210661|NCT02454972|582154917|FG007|Overall Study|Treatment-related adverse events|2|||
161210662|NCT02454972|582154918|FG008|Overall Study|Treatment-related adverse events|0|||
161210663|NCT02454972|582154910|FG000|Overall Study|Patient moves to compassionate use|0|||
161210664|NCT02454972|582154911|FG001|Overall Study|Patient moves to compassionate use|0|||
161210665|NCT02454972|582154912|FG002|Overall Study|Patient moves to compassionate use|0|||
161210666|NCT02454972|582154913|FG003|Overall Study|Patient moves to compassionate use|0|||
161210667|NCT02454972|582154914|FG004|Overall Study|Patient moves to compassionate use|0|||
161210668|NCT02454972|582154915|FG005|Overall Study|Patient moves to compassionate use|0|||
161210669|NCT02454972|582154916|FG006|Overall Study|Patient moves to compassionate use|2|||
161210670|NCT02454972|582154917|FG007|Overall Study|Patient moves to compassionate use|0|||
161210671|NCT02454972|582154918|FG008|Overall Study|Patient moves to compassionate use|0|||
161210672|NCT02454972|582154910|FG000|Overall Study|Withdrawal by Subject|0|||
161210673|NCT02454972|582154911|FG001|Overall Study|Withdrawal by Subject|1|||
161210674|NCT02454972|582154912|FG002|Overall Study|Withdrawal by Subject|5|||
161210675|NCT02454972|582154913|FG003|Overall Study|Withdrawal by Subject|2|||
161210676|NCT02454972|582154914|FG004|Overall Study|Withdrawal by Subject|3|||
161210677|NCT02454972|582154915|FG005|Overall Study|Withdrawal by Subject|2|||
161210678|NCT02454972|582154916|FG006|Overall Study|Withdrawal by Subject|0|||
161210679|NCT02454972|582154917|FG007|Overall Study|Withdrawal by Subject|1|||
161210680|NCT02454972|582154918|FG008|Overall Study|Withdrawal by Subject|2|||
161210681|NCT02454972|582154910|FG000|Overall Study|Multiple delay/holds on treatment|0|||
161210682|NCT02454972|582154911|FG001|Overall Study|Multiple delay/holds on treatment|0|||
161210683|NCT02454972|582154912|FG002|Overall Study|Multiple delay/holds on treatment|0|||
161210684|NCT02454972|582154913|FG003|Overall Study|Multiple delay/holds on treatment|1|||
161210685|NCT02454972|582154914|FG004|Overall Study|Multiple delay/holds on treatment|0|||
161210686|NCT02454972|582154915|FG005|Overall Study|Multiple delay/holds on treatment|0|||
161210687|NCT02454972|582154916|FG006|Overall Study|Multiple delay/holds on treatment|0|||
161210688|NCT02454972|582154917|FG007|Overall Study|Multiple delay/holds on treatment|0|||
161210689|NCT02454972|582154918|FG008|Overall Study|Multiple delay/holds on treatment|0|||
161210690|NCT02454972|582154910|FG000|Overall Study|Never treated|0|||
161210691|NCT02454972|582154911|FG001|Overall Study|Never treated|0|||
161210692|NCT02454972|582154912|FG002|Overall Study|Never treated|3|||
161210693|NCT02454972|582154913|FG003|Overall Study|Never treated|1|||
161210694|NCT02454972|582154914|FG004|Overall Study|Never treated|1|||
161210695|NCT02454972|582154915|FG005|Overall Study|Never treated|0|||
161210696|NCT02454972|582154916|FG006|Overall Study|Never treated|0|||
161210697|NCT02454972|582154917|FG007|Overall Study|Never treated|0|||
161210698|NCT02454972|582154918|FG008|Overall Study|Never treated|5|||
161210699|NCT02454972|582154910|FG000|Overall Study|Lost to Follow-up|0|||
161210700|NCT02454972|582154911|FG001|Overall Study|Lost to Follow-up|0|||
161210701|NCT02454972|582154912|FG002|Overall Study|Lost to Follow-up|0|||
161210702|NCT02454972|582154913|FG003|Overall Study|Lost to Follow-up|0|||
161210703|NCT02454972|582154914|FG004|Overall Study|Lost to Follow-up|0|||
161210704|NCT02454972|582154915|FG005|Overall Study|Lost to Follow-up|0|||
161210705|NCT02454972|582154916|FG006|Overall Study|Lost to Follow-up|0|||
161210706|NCT02454972|582154917|FG007|Overall Study|Lost to Follow-up|0|||
161210707|NCT02454972|582154918|FG008|Overall Study|Lost to Follow-up|2|||
161210708|NCT02454972|582154910|FG000|Overall Study|Study termination|0|||
161210709|NCT02454972|582154911|FG001|Overall Study|Study termination|0|||
161210710|NCT02454972|582154912|FG002|Overall Study|Study termination|0|||
161210711|NCT02454972|582154913|FG003|Overall Study|Study termination|0|||
161210712|NCT02454972|582154914|FG004|Overall Study|Study termination|0|||
161210713|NCT02454972|582154915|FG005|Overall Study|Study termination|0|||
161210714|NCT02454972|582154916|FG006|Overall Study|Study termination|0|||
161210715|NCT02454972|582154917|FG007|Overall Study|Study termination|0|||
161210716|NCT02454972|582154918|FG008|Overall Study|Study termination|6|||
161210717|NCT01020305|582154925|FG000|Overall Study|Adverse Event|2|||
161210718|NCT01070966|582154928|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
161210719|NCT01070966|582154928|FG000|Participants for Safety Evaluation|Off-label use|9|||
161210720|NCT01070966|582154928|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
161210721|NCT01070966|582154928|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
161210722|NCT01070966|582154928|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
161210723|NCT01070966|582154928|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
161210724|NCT01070966|582154928|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
161210725|NCT01070966|582154928|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
161210726|NCT01725113|582154929|FG000|Overall Study|Kidney Transplant|1|||
161210727|NCT01725113|582154930|FG001|Overall Study|Kidney Transplant|1|||
161210728|NCT01725113|582154929|FG000|Overall Study|Withdrawal by Subject|0|||
161210729|NCT01725113|582154930|FG001|Overall Study|Withdrawal by Subject|1|||
161210730|NCT02753400|582154931|FG000|Overall Study|Adverse Event|3|||
161210731|NCT02753400|582154932|FG001|Overall Study|Adverse Event|0|||
161210732|NCT02753400|582154931|FG000|Overall Study|Withdrawal by Subject|2|||
161210733|NCT02753400|582154932|FG001|Overall Study|Withdrawal by Subject|1|||
161210734|NCT03989115|582154933|FG000|Overall Study|Withdrawal by Subject|2|||
161210735|NCT03989115|582154934|FG001|Overall Study|Withdrawal by Subject|1|||
161210736|NCT03989115|582154935|FG002|Overall Study|Withdrawal by Subject|3|||
161210737|NCT03989115|582154936|FG003|Overall Study|Withdrawal by Subject|0|||
161210738|NCT03989115|582154937|FG004|Overall Study|Withdrawal by Subject|17|||
161210739|NCT03989115|582154938|FG005|Overall Study|Withdrawal by Subject|1|||
161210740|NCT03989115|582154939|FG006|Overall Study|Withdrawal by Subject|0|||
161210741|NCT03989115|582154940|FG007|Overall Study|Withdrawal by Subject|0|||
161210742|NCT03989115|582154933|FG000|Overall Study|Sponsor decision to terminate the study|1|||
161210743|NCT03989115|582154934|FG001|Overall Study|Sponsor decision to terminate the study|1|||
161210744|NCT03989115|582154935|FG002|Overall Study|Sponsor decision to terminate the study|0|||
161210745|NCT03989115|582154936|FG003|Overall Study|Sponsor decision to terminate the study|1|||
161210746|NCT03989115|582154937|FG004|Overall Study|Sponsor decision to terminate the study|11|||
161210747|NCT03989115|582154938|FG005|Overall Study|Sponsor decision to terminate the study|0|||
161210748|NCT03989115|582154939|FG006|Overall Study|Sponsor decision to terminate the study|2|||
161210749|NCT03989115|582154940|FG007|Overall Study|Sponsor decision to terminate the study|1|||
161210750|NCT03989115|582154933|FG000|Overall Study|Lost to Follow-up|2|||
161210751|NCT03989115|582154934|FG001|Overall Study|Lost to Follow-up|0|||
161210752|NCT03989115|582154935|FG002|Overall Study|Lost to Follow-up|0|||
161210753|NCT03989115|582154936|FG003|Overall Study|Lost to Follow-up|0|||
161210754|NCT03989115|582154937|FG004|Overall Study|Lost to Follow-up|1|||
161210755|NCT03989115|582154938|FG005|Overall Study|Lost to Follow-up|0|||
161210756|NCT03989115|582154939|FG006|Overall Study|Lost to Follow-up|0|||
161210757|NCT03989115|582154940|FG007|Overall Study|Lost to Follow-up|0|||
161210758|NCT03989115|582154933|FG000|Overall Study|Death|2|||
161210759|NCT03989115|582154934|FG001|Overall Study|Death|2|||
161210760|NCT03989115|582154935|FG002|Overall Study|Death|9|||
161210761|NCT03989115|582154936|FG003|Overall Study|Death|6|||
161210762|NCT03989115|582154937|FG004|Overall Study|Death|31|||
161210763|NCT03989115|582154938|FG005|Overall Study|Death|6|||
161210764|NCT03989115|582154939|FG006|Overall Study|Death|2|||
161210765|NCT03989115|582154940|FG007|Overall Study|Death|3|||
161210766|NCT03989115|582154933|FG000|Overall Study|Other|1|||
161210767|NCT03989115|582154934|FG001|Overall Study|Other|2|||
161210768|NCT03989115|582154935|FG002|Overall Study|Other|0|||
161210769|NCT03989115|582154936|FG003|Overall Study|Other|0|||
161210770|NCT03989115|582154937|FG004|Overall Study|Other|5|||
161210771|NCT03989115|582154938|FG005|Overall Study|Other|0|||
161210772|NCT03989115|582154939|FG006|Overall Study|Other|0|||
161210773|NCT03989115|582154940|FG007|Overall Study|Other|0|||
161210774|NCT01415921|582154941|FG000|Overall Study|Adverse Event|0|||
161210775|NCT01415921|582154942|FG001|Overall Study|Adverse Event|1|||
161210776|NCT01415921|582154941|FG000|Overall Study|Physician Decision|1|||
161210777|NCT01415921|582154942|FG001|Overall Study|Physician Decision|1|||
161210778|NCT01415921|582154941|FG000|Overall Study|Withdrawal by Subject|0|||
161210779|NCT01415921|582154942|FG001|Overall Study|Withdrawal by Subject|1|||
161210780|NCT01415921|582154941|FG000|Overall Study|Other|2|||
161210781|NCT01415921|582154942|FG001|Overall Study|Other|0|||
161210782|NCT02725671|582154944|FG000|Overall Study|Lost to Follow-up|1|||
161210783|NCT00963599|582154945|FG000|Overall Study|Adverse Event|2|||
161210784|NCT00963599|582154946|FG001|Overall Study|Adverse Event|0|||
161210785|NCT00963599|582154947|FG002|Overall Study|Adverse Event|1|||
161210786|NCT00963599|582154948|FG003|Overall Study|Adverse Event|2|||
161210787|NCT00963599|582154945|FG000|Overall Study|Lack of Efficacy|0|||
161210788|NCT00963599|582154946|FG001|Overall Study|Lack of Efficacy|2|||
161210789|NCT00963599|582154947|FG002|Overall Study|Lack of Efficacy|1|||
161210790|NCT00963599|582154948|FG003|Overall Study|Lack of Efficacy|4|||
161210791|NCT00963599|582154945|FG000|Overall Study|Lost to Follow-up|0|||
161210792|NCT00963599|582154946|FG001|Overall Study|Lost to Follow-up|1|||
161210793|NCT00963599|582154947|FG002|Overall Study|Lost to Follow-up|1|||
161210794|NCT00963599|582154948|FG003|Overall Study|Lost to Follow-up|1|||
161210795|NCT00963599|582154945|FG000|Overall Study|Protocol Violation|2|||
161210796|NCT00963599|582154946|FG001|Overall Study|Protocol Violation|2|||
161210797|NCT00963599|582154947|FG002|Overall Study|Protocol Violation|3|||
161210798|NCT00963599|582154948|FG003|Overall Study|Protocol Violation|4|||
161210799|NCT00963599|582154945|FG000|Overall Study|Withdrawal by Subject|2|||
161210800|NCT00963599|582154946|FG001|Overall Study|Withdrawal by Subject|1|||
161210801|NCT00963599|582154947|FG002|Overall Study|Withdrawal by Subject|3|||
161210802|NCT00963599|582154948|FG003|Overall Study|Withdrawal by Subject|3|||
161210803|NCT00190684|582154951|FG000|Overall Study|Adverse Event|86|||
161210804|NCT00190684|582154951|FG000|Overall Study|Satisfactory response|80|||
161210805|NCT00190684|582154951|FG000|Overall Study|Lack of efficacy|204|||
161210806|NCT00190684|582154951|FG000|Overall Study|Lost to Follow-up|232|||
161210807|NCT00190684|582154951|FG000|Overall Study|Patient moved|60|||
161210808|NCT00190684|582154951|FG000|Overall Study|Patient Decision|432|||
161210809|NCT00190684|582154951|FG000|Overall Study|Clinical relapse|67|||
161210810|NCT00190684|582154951|FG000|Overall Study|Sponsor's decision|17|||
161210811|NCT00190684|582154951|FG000|Overall Study|Physician Decision|84|||
161210812|NCT00190684|582154951|FG000|Overall Study|Protocol Violation|123|||
161210813|NCT00190684|582154951|FG000|Overall Study|Study Period III Completed|103|||
161210814|NCT00190684|582154951|FG000|Overall Study|Study Period V Completed|1|||
161210815|NCT02354976|582154955|FG000|Overall Study|Other - reason not specified|1|||
161210816|NCT02354976|582154956|FG001|Overall Study|Other - reason not specified|0|||
161210817|NCT02354976|582154957|FG002|Overall Study|Other - reason not specified|1|||
161210818|NCT02354976|582154955|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
161210819|NCT02354976|582154956|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
161210820|NCT02354976|582154957|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
161210821|NCT02354976|582154955|FG000|Overall Study|Adverse Event|1|||
161210822|NCT02354976|582154956|FG001|Overall Study|Adverse Event|0|||
161210823|NCT02354976|582154957|FG002|Overall Study|Adverse Event|2|||
161210824|NCT01706770|582154958|FG000|Overall Study|Lost to Follow-up|1|||
161210825|NCT01706770|582154959|FG001|Overall Study|Lost to Follow-up|0|||
161210826|NCT01706770|582154958|FG000|Overall Study|Physician Decision|1|||
161210827|NCT01706770|582154959|FG001|Overall Study|Physician Decision|0|||
161210828|NCT00068445|582154960|FG000|Randomization|Cancel|1|||
161210829|NCT00068445|582154961|FG001|Randomization|Cancel|3|||
161210830|NCT00068445|582154960|FG000|Randomization|Ineligible|1|||
161210831|NCT00068445|582154961|FG001|Randomization|Ineligible|1|||
161210832|NCT00068445|582154960|FG000|Treatment|Refused Further Treatment|13|||
161210833|NCT00068445|582154961|FG001|Treatment|Refused Further Treatment|10|||
161210834|NCT00068445|582154960|FG000|Treatment|Adverse Event|7|||
161210835|NCT00068445|582154961|FG001|Treatment|Adverse Event|1|||
161210836|NCT00068445|582154960|FG000|Treatment|Other (Specifics not available)|9|||
161210837|NCT00068445|582154961|FG001|Treatment|Other (Specifics not available)|5|||
161210838|NCT01155284|582154962|FG000|Overall Study|Withdrawal by Subject|4|||
161210839|NCT01155284|582154963|FG001|Overall Study|Withdrawal by Subject|3|||
161210840|NCT01155284|582154962|FG000|Overall Study|Lost to Follow-up|1|||
161210841|NCT01155284|582154963|FG001|Overall Study|Lost to Follow-up|2|||
161210842|NCT01155284|582154962|FG000|Overall Study|Physician Decision|1|||
161210843|NCT01155284|582154963|FG001|Overall Study|Physician Decision|0|||
161210844|NCT01155284|582154962|FG000|Overall Study|Adverse Event|1|||
161210845|NCT01155284|582154963|FG001|Overall Study|Adverse Event|0|||
161210846|NCT01896700|582154964|FG000|Overall Study|Adverse Event|4|||
161210847|NCT01896700|582154965|FG001|Overall Study|Adverse Event|5|||
161210848|NCT01896700|582154964|FG000|Overall Study|Withdrawal by Subject|0|||
161210849|NCT01896700|582154965|FG001|Overall Study|Withdrawal by Subject|1|||
161210850|NCT00123487|582154966|FG000|Randomized|Death prior to starting treatment|0|||
161210851|NCT00123487|582154967|FG001|Randomized|Death prior to starting treatment|1|||
161210852|NCT00123487|582154966|FG000|Randomized|SAE prior to starting treatment|1|||
161210853|NCT00123487|582154967|FG001|Randomized|SAE prior to starting treatment|0|||
161210854|NCT00123487|582154966|FG000|Treated With Study Drug|Adverse Event|23|||
161210855|NCT00123487|582154967|FG001|Treated With Study Drug|Adverse Event|22|||
161210856|NCT00123487|582154966|FG000|Treated With Study Drug|Disease Progression|141|||
161210857|NCT00123487|582154967|FG001|Treated With Study Drug|Disease Progression|122|||
161210858|NCT00123487|582154966|FG000|Treated With Study Drug|Physician Decision|8|||
161210859|NCT00123487|582154967|FG001|Treated With Study Drug|Physician Decision|9|||
161210860|NCT00123487|582154966|FG000|Treated With Study Drug|Other|59|||
161210861|NCT00123487|582154967|FG001|Treated With Study Drug|Other|58|||
161210862|NCT00123487|582154966|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
161210863|NCT00123487|582154967|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
161210864|NCT00123487|582154966|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
161210865|NCT00123487|582154967|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
161210866|NCT00123487|582154966|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
161210867|NCT00123487|582154967|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
161210868|NCT00423488|582154968|FG000|Overall Study|No evidence of study drug intake|2|||
161210869|NCT00423488|582154969|FG001|Overall Study|No evidence of study drug intake|1|||
161210870|NCT00423488|582154968|FG000|Overall Study|No post baseline data|3|||
161210871|NCT00423488|582154969|FG001|Overall Study|No post baseline data|0|||
161210872|NCT03118765|582154970|FG000|Overall Study|Withdrawal by Subject|0|||
161210873|NCT03118765|582154971|FG001|Overall Study|Withdrawal by Subject|0|||
161210874|NCT03118765|582154972|FG002|Overall Study|Withdrawal by Subject|1|||
161210875|NCT03118765|582154973|FG003|Overall Study|Withdrawal by Subject|0|||
161210876|NCT03118765|582154974|FG004|Overall Study|Withdrawal by Subject|0|||
161210877|NCT03118765|582154970|FG000|Overall Study|Adverse Event|1|||
161210878|NCT03118765|582154971|FG001|Overall Study|Adverse Event|1|||
161210879|NCT03118765|582154972|FG002|Overall Study|Adverse Event|1|||
161210880|NCT03118765|582154973|FG003|Overall Study|Adverse Event|1|||
161210881|NCT03118765|582154974|FG004|Overall Study|Adverse Event|1|||
161210882|NCT03118765|582154970|FG000|Overall Study|Non compliance with Study Procedures|0|||
161210883|NCT03118765|582154971|FG001|Overall Study|Non compliance with Study Procedures|0|||
161210884|NCT03118765|582154972|FG002|Overall Study|Non compliance with Study Procedures|0|||
161210885|NCT03118765|582154973|FG003|Overall Study|Non compliance with Study Procedures|1|||
161210886|NCT03118765|582154974|FG004|Overall Study|Non compliance with Study Procedures|0|||
161210887|NCT03118765|582154970|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161210888|NCT03118765|582154971|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
161210889|NCT03118765|582154972|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
161210890|NCT03118765|582154973|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161210891|NCT03118765|582154974|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
161210892|NCT03118765|582154970|FG000|Overall Study|COPD Exacerbation|1|||
161210893|NCT03118765|582154971|FG001|Overall Study|COPD Exacerbation|0|||
161210894|NCT03118765|582154972|FG002|Overall Study|COPD Exacerbation|0|||
161210895|NCT03118765|582154973|FG003|Overall Study|COPD Exacerbation|1|||
161210896|NCT03118765|582154974|FG004|Overall Study|COPD Exacerbation|0|||
161210897|NCT03118765|582154970|FG000|Overall Study|Lost to Follow-up|1|||
161210898|NCT03118765|582154971|FG001|Overall Study|Lost to Follow-up|0|||
161210899|NCT03118765|582154972|FG002|Overall Study|Lost to Follow-up|1|||
161210900|NCT03118765|582154973|FG003|Overall Study|Lost to Follow-up|0|||
161210901|NCT03118765|582154974|FG004|Overall Study|Lost to Follow-up|0|||
161210902|NCT03118765|582154970|FG000|Overall Study|Sponsor Decision|1|||
161210903|NCT03118765|582154971|FG001|Overall Study|Sponsor Decision|0|||
161210904|NCT03118765|582154972|FG002|Overall Study|Sponsor Decision|1|||
161210905|NCT03118765|582154973|FG003|Overall Study|Sponsor Decision|0|||
161210906|NCT03118765|582154974|FG004|Overall Study|Sponsor Decision|1|||
161210907|NCT02643966|582154977|FG000|First Screening Round|ineligible|1|||
161210908|NCT02643966|582154977|FG000|First Screening Round|excluded from analysis|2|||
161210909|NCT02643966|582154977|FG000|First Screening Round|Lost to Follow-up|56|||
161210910|NCT02643966|582154977|FG000|First Screening Round|Withdrawal by Subject|28|||
161210911|NCT02643966|582154977|FG000|First Screening Round|Death|1|||
161210912|NCT02643966|582154977|FG000|Between First and Second Screening|Lost to Follow-up|65|||
161210913|NCT02643966|582154977|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
161210914|NCT02643966|582154977|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
161210915|NCT02643966|582154977|FG000|Second Screening Round|Withdrawal by Subject|20|||
161210916|NCT02643966|582154977|FG000|Second Screening Round|Lost to Follow-up|57|||
161210917|NCT02643966|582154977|FG000|Second Screening Round|Physician Decision|2|||
161210918|NCT02643966|582154977|FG000|Second Screening Round|Death|4|||
161210919|NCT02643966|582154977|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
161210920|NCT02643966|582154977|FG000|Between Second and Third Screening|Death|1|||
161210921|NCT02643966|582154977|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
161210922|NCT02643966|582154977|FG000|Third Screening Round|PI excluded|2|||
161210923|NCT02643966|582154977|FG000|Third Screening Round|Lost to Follow-up|241|||
161210924|NCT01493531|582154978|FG000|Overall Study|Adverse Event|4|||
161210925|NCT01493531|582154979|FG001|Overall Study|Adverse Event|12|||
161210926|NCT01493531|582154980|FG002|Overall Study|Adverse Event|9|||
161210927|NCT01493531|582154978|FG000|Overall Study|Gout flare|3|||
161210928|NCT01493531|582154979|FG001|Overall Study|Gout flare|0|||
161210929|NCT01493531|582154980|FG002|Overall Study|Gout flare|2|||
161210930|NCT01493531|582154978|FG000|Overall Study|Protocol Violation|8|||
161210931|NCT01493531|582154979|FG001|Overall Study|Protocol Violation|15|||
161210932|NCT01493531|582154980|FG002|Overall Study|Protocol Violation|12|||
161210933|NCT01493531|582154978|FG000|Overall Study|Sponsor terminated study|5|||
161210934|NCT01493531|582154979|FG001|Overall Study|Sponsor terminated study|2|||
161323002|NCT03092791|582568666|FG005|Overall Study|Reason Not Specified|1|||
161323003|NCT03092791|582568667|FG006|Overall Study|Reason Not Specified|0|||
161210935|NCT01493531|582154980|FG002|Overall Study|Sponsor terminated study|3|||
161210936|NCT01493531|582154978|FG000|Overall Study|Lost to Follow-up|5|||
161210937|NCT01493531|582154979|FG001|Overall Study|Lost to Follow-up|7|||
161210938|NCT01493531|582154980|FG002|Overall Study|Lost to Follow-up|11|||
161210939|NCT01493531|582154978|FG000|Overall Study|Withdrawal by Subject|16|||
161210940|NCT01493531|582154979|FG001|Overall Study|Withdrawal by Subject|13|||
161210941|NCT01493531|582154980|FG002|Overall Study|Withdrawal by Subject|11|||
161210942|NCT01493531|582154978|FG000|Overall Study|Death|0|||
161210943|NCT01493531|582154979|FG001|Overall Study|Death|1|||
161323004|NCT03092791|582568668|FG007|Overall Study|Reason Not Specified|0|||
161210944|NCT01493531|582154980|FG002|Overall Study|Death|0|||
161210945|NCT03835975|582154985|FG000|Overall Study|Lost to Follow-up|1|||
161210946|NCT03835975|582154986|FG001|Overall Study|Lost to Follow-up|1|||
161210947|NCT03835975|582154987|FG002|Overall Study|Lost to Follow-up|0|||
161210948|NCT03835975|582154988|FG003|Overall Study|Lost to Follow-up|0|||
161210949|NCT03835975|582154989|FG004|Overall Study|Lost to Follow-up|0|||
161210950|NCT03835975|582154985|FG000|Overall Study|No longer met eligibility criteria|0|||
161210951|NCT03835975|582154986|FG001|Overall Study|No longer met eligibility criteria|1|||
161210952|NCT03835975|582154987|FG002|Overall Study|No longer met eligibility criteria|0|||
161210953|NCT03835975|582154988|FG003|Overall Study|No longer met eligibility criteria|0|||
161210954|NCT03835975|582154989|FG004|Overall Study|No longer met eligibility criteria|0|||
161210955|NCT03835975|582154985|FG000|Overall Study|Protocol Violation|1|||
161210956|NCT03835975|582154986|FG001|Overall Study|Protocol Violation|1|||
161210957|NCT03835975|582154987|FG002|Overall Study|Protocol Violation|2|||
161210958|NCT03835975|582154988|FG003|Overall Study|Protocol Violation|0|||
161210959|NCT03835975|582154989|FG004|Overall Study|Protocol Violation|0|||
161210960|NCT03835975|582154985|FG000|Overall Study|Withdrawal by Subject|1|||
161210961|NCT03835975|582154986|FG001|Overall Study|Withdrawal by Subject|0|||
161210962|NCT03835975|582154987|FG002|Overall Study|Withdrawal by Subject|1|||
161210963|NCT03835975|582154988|FG003|Overall Study|Withdrawal by Subject|1|||
161210964|NCT03835975|582154989|FG004|Overall Study|Withdrawal by Subject|0|||
161210965|NCT03031431|582154990|FG000|Overall Study|Infant removed by maternal request|1|||
161210966|NCT01612702|582154991|FG000|Overall Study|Protocol Violation|11|||
161210967|NCT01612702|582154992|FG001|Overall Study|Protocol Violation|11|||
161210968|NCT03070431|582154993|FG000|Overall Study|Withdrawal by Subject|2|||
161210969|NCT03070431|582154993|FG000|Overall Study|Lost to Follow-up|2|||
161210970|NCT00370396|582154996|FG000|Overall Study|Withdrawal by Subject|0|||
161210971|NCT00370396|582154997|FG001|Overall Study|Withdrawal by Subject|0|||
161210972|NCT00370396|582154998|FG002|Overall Study|Withdrawal by Subject|1|||
161210973|NCT00370396|582154996|FG000|Overall Study|Lost to Follow-up|11|||
161210974|NCT00370396|582154997|FG001|Overall Study|Lost to Follow-up|1|||
161210975|NCT00370396|582154998|FG002|Overall Study|Lost to Follow-up|0|||
161210976|NCT00995488|582155002|FG000|Overall Study|Withdrawal by Subject|1|||
161210977|NCT01656967|582155003|FG000|Overall Study|faulty monitor|1|||
161210978|NCT01656967|582155004|FG001|Overall Study|faulty monitor|0|||
161210979|NCT01656967|582155003|FG000|Overall Study|unsuccessful ETT insertion|3|||
161210980|NCT01656967|582155004|FG001|Overall Study|unsuccessful ETT insertion|2|||
161210981|NCT02598622|582156093|FG000|Overall Study|Withdrawal by Subject|3|||
161210982|NCT02598622|582156094|FG001|Overall Study|Withdrawal by Subject|0|||
161210983|NCT02598622|582156093|FG000|Overall Study|Physician Decision|3|||
161210984|NCT02598622|582156094|FG001|Overall Study|Physician Decision|0|||
161210985|NCT00681824|582156098|FG000|Overall Study|withdrawn by investigator|0|||
161210986|NCT00681824|582156099|FG001|Overall Study|withdrawn by investigator|0|||
161210987|NCT00681824|582156100|FG002|Overall Study|withdrawn by investigator|1|||
161210988|NCT00681824|582156098|FG000|Overall Study|scheduling conflict|1|||
161210989|NCT00681824|582156099|FG001|Overall Study|scheduling conflict|0|||
161210990|NCT00681824|582156100|FG002|Overall Study|scheduling conflict|0|||
161210991|NCT00681824|582156098|FG000|Overall Study|Death|0|||
161210992|NCT00681824|582156099|FG001|Overall Study|Death|1|||
161210993|NCT00681824|582156100|FG002|Overall Study|Death|0|||
161210994|NCT03724916|582156101|FG000|Overall Study|Withdrawal by Subject|0|||
161210995|NCT03724916|582156102|FG001|Overall Study|Withdrawal by Subject|1|||
161210996|NCT03724916|582156103|FG002|Overall Study|Withdrawal by Subject|1|||
161210997|NCT03724916|582156104|FG003|Overall Study|Withdrawal by Subject|2|||
161210998|NCT03724916|582156101|FG000|Overall Study|Randomized but not Treated|1|||
161210999|NCT03724916|582156102|FG001|Overall Study|Randomized but not Treated|0|||
161211000|NCT03724916|582156103|FG002|Overall Study|Randomized but not Treated|0|||
161211001|NCT03724916|582156104|FG003|Overall Study|Randomized but not Treated|0|||
161211002|NCT04575038|582156105|FG000|Overall Study|Withdrawal by Subject|1|||
161211003|NCT04575038|582156106|FG001|Overall Study|Withdrawal by Subject|1|||
161211004|NCT04335110|582156113|FG000|Overall Study|Withdrawal by Subject|1|||
161211005|NCT04335110|582156114|FG001|Overall Study|Withdrawal by Subject|1|||
161211006|NCT04335110|582156113|FG000|Overall Study|Death|0|||
161211007|NCT04335110|582156114|FG001|Overall Study|Death|1|||
161211008|NCT04388527|582156117|FG000|Overall Study|Death|14|||
161211009|NCT04388527|582156117|FG000|Overall Study|Withdrawal by Subject|2|||
161323005|NCT02182830|582568672|FG000|Overall Study|Not Treated|1|||
161211010|NCT04388527|582156117|FG000|Overall Study|Lost to Follow-up|1|||
161211011|NCT03333382|582156118|FG000|Overall Study|Lost to Follow-up|1|||
161211012|NCT03333382|582156119|FG001|Overall Study|Lost to Follow-up|0|||
161211013|NCT03471182|582156120|FG000|Overall Study|Withdrawal by Subject|1|||
161323006|NCT02182830|582568673|FG001|Overall Study|Not Treated|1|||
161211014|NCT03471182|582156121|FG001|Overall Study|Withdrawal by Subject|1|||
161211015|NCT03471182|582156122|FG002|Overall Study|Withdrawal by Subject|0|||
161211016|NCT03471182|582156120|FG000|Overall Study|Technical failure|2|||
161211017|NCT03471182|582156121|FG001|Overall Study|Technical failure|0|||
161211018|NCT03471182|582156122|FG002|Overall Study|Technical failure|0|||
161211019|NCT00331773|582156126|FG000|Overall Study|Withdrawal by Subject|6|||
161211020|NCT00331773|582156127|FG001|Overall Study|Withdrawal by Subject|4|||
161211021|NCT00331773|582156126|FG000|Overall Study|Protocol Violation|10|||
161211022|NCT00331773|582156127|FG001|Overall Study|Protocol Violation|3|||
161211023|NCT03451331|582156128|FG000|Overall Study|Withdrawal by Subject|1|||
161211024|NCT03451331|582156129|FG001|Overall Study|Withdrawal by Subject|0|||
161211025|NCT03451331|582156128|FG000|Overall Study|Unable to start treatment.|1|||
161211026|NCT03451331|582156129|FG001|Overall Study|Unable to start treatment.|1|||
161211027|NCT00289731|582156130|FG000|Overall Study|Adverse Event|1|||
161211028|NCT00289731|582156131|FG001|Overall Study|Adverse Event|2|||
161211029|NCT00289731|582156132|FG002|Overall Study|Adverse Event|2|||
161211030|NCT00289731|582156130|FG000|Overall Study|Other|1|||
161211031|NCT00289731|582156131|FG001|Overall Study|Other|0|||
161211032|NCT00289731|582156132|FG002|Overall Study|Other|0|||
161211033|NCT02513459|582156133|FG000|Overall Study|Adverse Event|7|||
161211034|NCT02513459|582156133|FG000|Overall Study|Withdrew consent|5|||
161211035|NCT02513459|582156133|FG000|Overall Study|Loss of efficacy|2|||
161211036|NCT02513459|582156133|FG000|Overall Study|Pregnancy|2|||
161211037|NCT02513459|582156133|FG000|Overall Study|Subject decision|2|||
161211038|NCT02513459|582156133|FG000|Overall Study|Lack of response|1|||
161211039|NCT02513459|582156133|FG000|Overall Study|Reproductive plans|1|||
161211040|NCT02513459|582156133|FG000|Overall Study|Surgery planned-- not done|1|||
161211041|NCT00923195|582156134|FG000|Overall Study|Death|0|||
161211042|NCT00923195|582156135|FG001|Overall Study|Death|1|||
161211043|NCT00525031|582156136|FG000|Overall Study|Disease Progression|1|||
161211044|NCT00525031|582156137|FG001|Overall Study|Disease Progression|1|||
161211045|NCT00787566|582156142|FG000|Overall Study|AE related to chemotherapy|0|||
161211046|NCT00787566|582156143|FG001|Overall Study|AE related to chemotherapy|1|||
161211047|NCT00787566|582156144|FG002|Overall Study|AE related to chemotherapy|0|||
161211048|NCT02140164|582156145|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
161211049|NCT01814761|582156146|FG000|Overall Study|Other Reasons|1|||
161211050|NCT01814761|582156147|FG001|Overall Study|Other Reasons|10|||
161211051|NCT01814761|582156146|FG000|Overall Study|Ocular Adverse Event|6|||
161211052|NCT01814761|582156147|FG001|Overall Study|Ocular Adverse Event|15|||
161211053|NCT01814761|582156146|FG000|Overall Study|Lost to Follow-up|1|||
161211054|NCT01814761|582156147|FG001|Overall Study|Lost to Follow-up|5|||
161211055|NCT00775983|582156148|FG000|Overall Study|Protocol Violation|1|||
161211056|NCT00775983|582156149|FG001|Overall Study|Protocol Violation|2|||
161211057|NCT00660790|582156158|FG000|Baseline to 3 Months|Death|1|||
161211058|NCT00660790|582156158|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
161211059|NCT00660790|582156158|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
161211060|NCT00686374|582156163|FG000|Overall Study|Lack of Efficacy|10|||
161211061|NCT00686374|582156163|FG000|Overall Study|Adverse Event|8|||
161211062|NCT00686374|582156163|FG000|Overall Study|Withdrew consent|5|||
161211063|NCT00686374|582156163|FG000|Overall Study|Lost to Follow-up|1|||
161211064|NCT00686374|582156163|FG000|Overall Study|Missing reason|33|||
161211065|NCT00686374|582156163|FG000|Overall Study|Other, not specified|4|||
161211066|NCT00618774|582156164|FG000|Overall Study|Adverse Event|5|||
161211067|NCT00618774|582156165|FG001|Overall Study|Adverse Event|3|||
161211068|NCT00618774|582156164|FG000|Overall Study|Withdrawal by Subject|1|||
161211069|NCT00618774|582156165|FG001|Overall Study|Withdrawal by Subject|0|||
161211070|NCT00829439|582156169|FG000|Overall Study|Adverse Event|0|||
161211071|NCT00829439|582156170|FG001|Overall Study|Adverse Event|0|||
161211072|NCT00829439|582156171|FG002|Overall Study|Adverse Event|1|||
161211073|NCT00829439|582156172|FG003|Overall Study|Adverse Event|0|||
161211074|NCT02525562|582156173|FG000|Overall Study|Death|9|||
161211075|NCT02525562|582156174|FG001|Overall Study|Death|0|||
161211076|NCT02525562|582156175|FG002|Overall Study|Death|0|||
161211077|NCT02525562|582156173|FG000|Overall Study|Lost to Follow-up|19|||
161211078|NCT02525562|582156174|FG001|Overall Study|Lost to Follow-up|0|||
161211079|NCT02525562|582156175|FG002|Overall Study|Lost to Follow-up|0|||
161211080|NCT02525562|582156173|FG000|Overall Study|Withdrawal by Subject|37|||
161211081|NCT02525562|582156174|FG001|Overall Study|Withdrawal by Subject|0|||
161211082|NCT02525562|582156175|FG002|Overall Study|Withdrawal by Subject|0|||
161211083|NCT02525562|582156173|FG000|Overall Study|Revision/Removal of Study Device|4|||
161211084|NCT02525562|582156174|FG001|Overall Study|Revision/Removal of Study Device|0|||
161211085|NCT02525562|582156175|FG002|Overall Study|Revision/Removal of Study Device|0|||
161211086|NCT02525562|582156173|FG000|Overall Study|Study Closed by Sponsor|154|||
161211087|NCT02525562|582156174|FG001|Overall Study|Study Closed by Sponsor|0|||
161211088|NCT02525562|582156175|FG002|Overall Study|Study Closed by Sponsor|0|||
161211089|NCT01946282|582156176|FG000|Year 1|Did not return FIT kit|4186|||
160865657|NCT01055197|580902943|FG001|Overall Study|Withdrawal by Subject|0|||
161211090|NCT01946282|582156177|FG001|Year 1|Did not return FIT kit|608|||
161211091|NCT01946282|582156178|FG002|Year 1|Did not return FIT kit|654|||
161211092|NCT01946282|582156176|FG000|Year 2|Did not return FIT kit|803|||
161211093|NCT01946282|582156177|FG001|Year 2|Did not return FIT kit|131|||
161211094|NCT01946282|582156178|FG002|Year 2|Did not return FIT kit|115|||
161211095|NCT01946282|582156176|FG000|Year 3|Did not return FIT kit|288|||
161211096|NCT01946282|582156177|FG001|Year 3|Did not return FIT kit|43|||
161211097|NCT01946282|582156178|FG002|Year 3|Did not return FIT kit|30|||
161211098|NCT01462695|582156179|FG000|Overall Study|Adverse Event|1|||
161211099|NCT01462695|582156180|FG001|Overall Study|Adverse Event|1|||
161211100|NCT01462695|582156179|FG000|Overall Study|Death|2|||
161211101|NCT01462695|582156180|FG001|Overall Study|Death|0|||
161211102|NCT01462695|582156179|FG000|Overall Study|Lack of Efficacy|6|||
161211103|NCT01462695|582156180|FG001|Overall Study|Lack of Efficacy|12|||
161211104|NCT01462695|582156179|FG000|Overall Study|Physician Decision|5|||
161211105|NCT01462695|582156180|FG001|Overall Study|Physician Decision|0|||
161211106|NCT01462695|582156179|FG000|Overall Study|Withdrawal by Subject|2|||
161211107|NCT01462695|582156180|FG001|Overall Study|Withdrawal by Subject|0|||
161211108|NCT01462695|582156179|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
161211109|NCT01462695|582156180|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
161211110|NCT03196791|582156183|FG000|Overall Study|Protocol Violation|7|||
161211111|NCT03196791|582156184|FG001|Overall Study|Protocol Violation|3|||
161211112|NCT03196791|582156183|FG000|Overall Study|Withdrawal by Subject|3|||
161211113|NCT03196791|582156184|FG001|Overall Study|Withdrawal by Subject|2|||
161211114|NCT00051636|582156186|FG000|Period 1 - Core|Adverse Event|2|||
161211115|NCT00051636|582156187|FG001|Period 1 - Core|Adverse Event|2|||
161211116|NCT00051636|582156186|FG000|Period 1 - Core|Protocol Violation|1|||
161211117|NCT00051636|582156187|FG001|Period 1 - Core|Protocol Violation|0|||
161211118|NCT00051636|582156186|FG000|Period 1 - Core|Withdrawal by Subject|1|||
161211119|NCT00051636|582156187|FG001|Period 1 - Core|Withdrawal by Subject|2|||
161211120|NCT00051636|582156186|FG000|Period 1 - Core|Lost to Follow-up|0|||
161211121|NCT00051636|582156187|FG001|Period 1 - Core|Lost to Follow-up|2|||
161211122|NCT00051636|582156186|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
161211123|NCT00051636|582156187|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
161211124|NCT00051636|582156186|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
161211125|NCT00051636|582156187|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
161211126|NCT00051636|582156186|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
161211127|NCT00051636|582156187|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
161211128|NCT00051636|582156186|FG000|Period 2- Extended Observation Period|Death|4|||
161211129|NCT00051636|582156187|FG001|Period 2- Extended Observation Period|Death|5|||
161211130|NCT00051636|582156186|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
161211131|NCT00051636|582156187|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
161211132|NCT01174368|582156188|FG000|Overall Study|Withdrawal by Subject|1|||
161211133|NCT00479765|582156189|FG000|Overall Study|study terminated|4|||
161211134|NCT02392559|582156193|FG000|Overall Study|Withdrawal by Subject|0|||
161211135|NCT02392559|582156194|FG001|Overall Study|Withdrawal by Subject|1|||
161211136|NCT02340078|582156200|FG000|Overall Study|Protocol Violation|1|||
161211137|NCT00944125|582156203|FG000|3 to 6 Months|Withdrawal by Subject|0|||
161211138|NCT00944125|582156204|FG001|3 to 6 Months|Withdrawal by Subject|2|||
161211139|NCT00944125|582156203|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
161211140|NCT00944125|582156204|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
161211141|NCT04816877|582156207|FG000|Overall Study|Withdrawal by Subject|1|||
161211142|NCT04816877|582156208|FG001|Overall Study|Withdrawal by Subject|0|||
161211143|NCT02176642|582156209|FG000|Overall Study|Withdrawal by Subject|0|||
161211144|NCT02176642|582156210|FG001|Overall Study|Withdrawal by Subject|1|||
161211145|NCT03338673|582156212|FG000|Overall Study|Lost to Follow-up|1|||
161211146|NCT03338673|582156213|FG001|Overall Study|Lost to Follow-up|1|||
161323007|NCT02182830|582568672|FG000|Overall Study|Trial stopped, reason missing|3|||
161097551|NCT01180998|581748669|FG002|Overall Study|Withdrawal by Subject|1|||
161097552|NCT01180998|581748667|FG000|Overall Study|Poor comfort|3|||
161097553|NCT01180998|581748668|FG001|Overall Study|Poor comfort|0|||
161097554|NCT01180998|581748669|FG002|Overall Study|Poor comfort|4|||
161097555|NCT01180998|581748667|FG000|Overall Study|Poor lens handling|0|||
161097556|NCT01180998|581748668|FG001|Overall Study|Poor lens handling|0|||
161097557|NCT01180998|581748669|FG002|Overall Study|Poor lens handling|2|||
161097558|NCT01176968|581748670|FG000|Overall Study|Adverse Event|10|||
161097559|NCT01176968|581748671|FG001|Overall Study|Adverse Event|11|||
161097560|NCT01176968|581748670|FG000|Overall Study|Death|2|||
161097561|NCT01176968|581748671|FG001|Overall Study|Death|3|||
161097562|NCT01176968|581748670|FG000|Overall Study|Lack of Efficacy|0|||
161097563|NCT01176968|581748671|FG001|Overall Study|Lack of Efficacy|1|||
161097564|NCT01176968|581748670|FG000|Overall Study|Lost to Follow-up|16|||
161097565|NCT01176968|581748671|FG001|Overall Study|Lost to Follow-up|14|||
161097566|NCT01176968|581748670|FG000|Overall Study|Withdrawal by Subject|48|||
161097567|NCT01176968|581748671|FG001|Overall Study|Withdrawal by Subject|48|||
161097568|NCT01176968|581748670|FG000|Overall Study|Protocol Violation|2|||
161097569|NCT01176968|581748671|FG001|Overall Study|Protocol Violation|1|||
161097570|NCT01176968|581748670|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161097571|NCT01176968|581748671|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161097572|NCT01176968|581748670|FG000|Overall Study|Study terminated by sponsor|0|||
161097573|NCT01176968|581748671|FG001|Overall Study|Study terminated by sponsor|1|||
161097574|NCT01176968|581748670|FG000|Overall Study|Reason not defined|5|||
161211147|NCT00995930|582156219|FG000|Overall Study|Protocol deviation|2|||
161211148|NCT00995930|582156220|FG001|Overall Study|Protocol deviation|5|||
161211149|NCT00995930|582156219|FG000|Overall Study|Death|0|||
161211150|NCT00995930|582156220|FG001|Overall Study|Death|1|||
161211151|NCT00995930|582156219|FG000|Overall Study|Administrative problems|4|||
161211152|NCT00995930|582156220|FG001|Overall Study|Administrative problems|2|||
161211153|NCT00995930|582156219|FG000|Overall Study|Lost to Follow-up|1|||
161211154|NCT00995930|582156220|FG001|Overall Study|Lost to Follow-up|2|||
161211155|NCT00995930|582156219|FG000|Overall Study|Withdrawal by Subject|3|||
161211156|NCT00995930|582156220|FG001|Overall Study|Withdrawal by Subject|4|||
161211157|NCT00995930|582156219|FG000|Overall Study|Adverse Event|11|||
161211158|NCT00995930|582156220|FG001|Overall Study|Adverse Event|14|||
161211159|NCT05788237|582156223|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161211160|NCT05788237|582156224|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
161211161|NCT05788237|582156225|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161211162|NCT05788237|582156226|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
161211163|NCT05788237|582156223|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161211164|NCT05788237|582156224|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
161211165|NCT05788237|582156225|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161211166|NCT05788237|582156226|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
161211167|NCT05788237|582156223|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
161211168|NCT05788237|582156224|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
161211169|NCT05788237|582156225|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
161211170|NCT05788237|582156226|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
161211171|NCT05788237|582156223|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
161211172|NCT05788237|582156224|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
161211173|NCT05788237|582156225|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
161211174|NCT05788237|582156226|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
161211175|NCT05788237|582156223|FG000|SSA (Approximately 2 Months)|Death|0|||
161211176|NCT05788237|582156224|FG001|SSA (Approximately 2 Months)|Death|1|||
161211177|NCT05788237|582156225|FG002|SSA (Approximately 2 Months)|Death|0|||
161211178|NCT05788237|582156226|FG003|SSA (Approximately 2 Months)|Death|0|||
161211179|NCT05788237|582156223|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161211180|NCT05788237|582156224|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161211181|NCT05788237|582156225|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
161211182|NCT05788237|582156226|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
161211183|NCT05788237|582156223|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161211184|NCT05788237|582156224|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161211185|NCT05788237|582156225|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
161211186|NCT05788237|582156226|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
161211187|NCT05788237|582156223|FG000|SSB (Approximately 1 Month)|Other|0|||
161211188|NCT05788237|582156224|FG001|SSB (Approximately 1 Month)|Other|0|||
161211189|NCT05788237|582156225|FG002|SSB (Approximately 1 Month)|Other|0|||
161211190|NCT05788237|582156226|FG003|SSB (Approximately 1 Month)|Other|1|||
161211191|NCT02424565|582158320|FG000|Period 1 (D0)|Protocol Violation|0|||
161211192|NCT02424565|582158321|FG001|Period 1 (D0)|Protocol Violation|1|||
161211193|NCT01808209|582158322|FG000|Overall Study|Lost to Follow-up|0|||
161211194|NCT01808209|582158323|FG001|Overall Study|Lost to Follow-up|1|||
161211195|NCT00685919|582158330|FG000|Overall Study|Withdrawal by Subject|0|||
161211196|NCT00685919|582158331|FG001|Overall Study|Withdrawal by Subject|0|||
161211197|NCT00685919|582158332|FG002|Overall Study|Withdrawal by Subject|1|||
161211198|NCT00685919|582158333|FG003|Overall Study|Withdrawal by Subject|0|||
161211199|NCT00685919|582158330|FG000|Overall Study|Physician Decision|1|||
161211200|NCT00685919|582158331|FG001|Overall Study|Physician Decision|0|||
161211201|NCT00685919|582158332|FG002|Overall Study|Physician Decision|0|||
161211202|NCT00685919|582158333|FG003|Overall Study|Physician Decision|0|||
161211203|NCT04228302|582158334|FG000|Overall Study|Adverse Event|0|||
161211204|NCT04228302|582158335|FG001|Overall Study|Adverse Event|0|||
161211205|NCT04228302|582158336|FG002|Overall Study|Adverse Event|0|||
161211206|NCT04228302|582158337|FG003|Overall Study|Adverse Event|0|||
161211207|NCT04228302|582158338|FG004|Overall Study|Adverse Event|1|||
161211208|NCT04228302|582158339|FG005|Overall Study|Adverse Event|0|||
161211209|NCT03066440|582158340|FG000|Overall Study|Physician Decision|1|||
161211210|NCT03066440|582158341|FG001|Overall Study|Physician Decision|1|||
161211211|NCT03066440|582158340|FG000|Overall Study|Protocol Violation|0|||
161211212|NCT03066440|582158341|FG001|Overall Study|Protocol Violation|2|||
161211213|NCT00736333|582158342|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
161211214|NCT00736333|582158342|FG000|Overall Study|Data Missing|2|||
161211215|NCT00736333|582158342|FG000|Overall Study|Tumor Progression|75|||
161211216|NCT00736333|582158342|FG000|Overall Study|Toxicity|6|||
161211217|NCT00736333|582158342|FG000|Overall Study|Withdrawal by Subject|10|||
161211218|NCT00736333|582158342|FG000|Overall Study|Death|7|||
161211219|NCT00736333|582158342|FG000|Overall Study|Other|4|||
161211220|NCT04991311|582158344|FG000|Overall Study|Adverse Event|1|||
161211221|NCT00054275|582158346|FG000|Overall Study|Withdrawal by Subject|4|||
161211222|NCT00054275|582158346|FG000|Overall Study|Adverse Event|5|||
161211223|NCT00054275|582158346|FG000|Overall Study|Progressive disease in cycle 1|1|||
161211224|NCT00054275|582158346|FG000|Overall Study|Physician Decision|1|||
161211225|NCT03876873|582158347|FG000|Overall Study|Physician Decision|0|||
161211226|NCT03876873|582158348|FG001|Overall Study|Physician Decision|1|||
161211227|NCT01106352|582158349|FG000|Overall Study|Subjects untreated|0|||
161211228|NCT01106352|582158350|FG001|Overall Study|Subjects untreated|0|||
161211229|NCT01106352|582158351|FG002|Overall Study|Subjects untreated|0|||
161211230|NCT01106352|582158352|FG003|Overall Study|Subjects untreated|3|||
161211231|NCT01106352|582158353|FG004|Overall Study|Subjects untreated|4|||
161211232|NCT01106352|582158349|FG000|Overall Study|Sponsor Decision|1|||
161211233|NCT01106352|582158350|FG001|Overall Study|Sponsor Decision|0|||
161211234|NCT01106352|582158351|FG002|Overall Study|Sponsor Decision|0|||
161211235|NCT01106352|582158352|FG003|Overall Study|Sponsor Decision|0|||
161211236|NCT01106352|582158353|FG004|Overall Study|Sponsor Decision|0|||
161211237|NCT01106352|582158349|FG000|Overall Study|Too ill to come in for the visit|0|||
161211238|NCT01106352|582158350|FG001|Overall Study|Too ill to come in for the visit|0|||
161211239|NCT01106352|582158351|FG002|Overall Study|Too ill to come in for the visit|1|||
161211240|NCT01106352|582158352|FG003|Overall Study|Too ill to come in for the visit|0|||
161211241|NCT01106352|582158353|FG004|Overall Study|Too ill to come in for the visit|0|||
161211242|NCT01106352|582158349|FG000|Overall Study|Lost to Follow-up|0|||
161211243|NCT01106352|582158350|FG001|Overall Study|Lost to Follow-up|0|||
161211244|NCT01106352|582158351|FG002|Overall Study|Lost to Follow-up|0|||
161211245|NCT01106352|582158352|FG003|Overall Study|Lost to Follow-up|0|||
161211246|NCT01106352|582158353|FG004|Overall Study|Lost to Follow-up|1|||
161211247|NCT01106352|582158349|FG000|Overall Study|Death|0|||
161211248|NCT01106352|582158350|FG001|Overall Study|Death|0|||
161211249|NCT01106352|582158351|FG002|Overall Study|Death|1|||
161211250|NCT01106352|582158352|FG003|Overall Study|Death|3|||
161211251|NCT01106352|582158353|FG004|Overall Study|Death|1|||
161211252|NCT01106352|582158349|FG000|Overall Study|Disease progression|0|||
161211253|NCT01106352|582158350|FG001|Overall Study|Disease progression|0|||
161211254|NCT01106352|582158351|FG002|Overall Study|Disease progression|0|||
161211255|NCT01106352|582158352|FG003|Overall Study|Disease progression|1|||
161211256|NCT01106352|582158353|FG004|Overall Study|Disease progression|0|||
161211257|NCT01106352|582158349|FG000|Overall Study|Withdrawal by Subject|0|||
161211258|NCT01106352|582158350|FG001|Overall Study|Withdrawal by Subject|0|||
161211259|NCT01106352|582158351|FG002|Overall Study|Withdrawal by Subject|0|||
161211260|NCT01106352|582158352|FG003|Overall Study|Withdrawal by Subject|3|||
161211261|NCT01106352|582158353|FG004|Overall Study|Withdrawal by Subject|2|||
161211262|NCT01106352|582158349|FG000|Overall Study|Went on hospice|0|||
161211263|NCT01106352|582158350|FG001|Overall Study|Went on hospice|0|||
161211264|NCT01106352|582158351|FG002|Overall Study|Went on hospice|0|||
161211265|NCT01106352|582158352|FG003|Overall Study|Went on hospice|1|||
161211266|NCT01106352|582158353|FG004|Overall Study|Went on hospice|0|||
161211267|NCT01106352|582158349|FG000|Overall Study|Subject entered hospice|0|||
161211268|NCT01106352|582158350|FG001|Overall Study|Subject entered hospice|0|||
161211269|NCT01106352|582158351|FG002|Overall Study|Subject entered hospice|0|||
161211270|NCT01106352|582158352|FG003|Overall Study|Subject entered hospice|1|||
161211271|NCT01106352|582158353|FG004|Overall Study|Subject entered hospice|0|||
161211272|NCT01106352|582158349|FG000|Overall Study|Home hospice since July 2013|0|||
161211273|NCT01106352|582158350|FG001|Overall Study|Home hospice since July 2013|0|||
161211274|NCT01106352|582158351|FG002|Overall Study|Home hospice since July 2013|0|||
161211275|NCT01106352|582158352|FG003|Overall Study|Home hospice since July 2013|1|||
161211276|NCT01106352|582158353|FG004|Overall Study|Home hospice since July 2013|0|||
161211277|NCT03547531|582158354|FG000|Overall Study|not coming in data collection : sick|2|||
161211278|NCT03547531|582158355|FG001|Overall Study|not coming in data collection : sick|2|||
161211279|NCT03547531|582158354|FG000|Overall Study|having family occasion|0|||
161211280|NCT03547531|582158355|FG001|Overall Study|having family occasion|2|||
161211281|NCT03944707|582158356|FG000|Overall Study|Adverse Event|0|||
161211282|NCT03944707|582158357|FG001|Overall Study|Adverse Event|2|||
161211283|NCT03944707|582158356|FG000|Overall Study|Study terminated by sponsor|12|||
161211284|NCT03944707|582158357|FG001|Overall Study|Study terminated by sponsor|7|||
161211285|NCT03944707|582158356|FG000|Overall Study|Subject decision|0|||
161211286|NCT03944707|582158357|FG001|Overall Study|Subject decision|1|||
161211287|NCT02444182|582158366|FG000|Overall Study|non-compliance|2|||
161211288|NCT02444182|582158367|FG001|Overall Study|non-compliance|1|||
161211289|NCT02444182|582158366|FG000|Overall Study|Lost to Follow-up|0|||
161211290|NCT02444182|582158367|FG001|Overall Study|Lost to Follow-up|4|||
161211291|NCT01959230|582158368|FG000|Overall Study|Failure to follow study procedures|0|||
161211292|NCT01959230|582158369|FG001|Overall Study|Failure to follow study procedures|1|||
161211293|NCT01959230|582158368|FG000|Overall Study|Administrative reasons|2|||
161211294|NCT01959230|582158369|FG001|Overall Study|Administrative reasons|0|||
161211295|NCT01959230|582158368|FG000|Overall Study|Withdrawal by Subject|2|||
161211296|NCT01959230|582158369|FG001|Overall Study|Withdrawal by Subject|0|||
161211297|NCT01453374|582158370|FG000|Overall Study|Adverse Event|7|||
161211298|NCT01453374|582158370|FG000|Overall Study|Lack of Efficacy|1|||
161211299|NCT01453374|582158370|FG000|Overall Study|Lost to Follow-up|3|||
161211300|NCT01453374|582158370|FG000|Overall Study|Withdrawal by Subject|5|||
161211301|NCT01453374|582158370|FG000|Overall Study|Incarcerated|2|||
161211302|NCT00996918|582158376|FG000|Overall Study|Lack of Efficacy|1|||
161211303|NCT00996918|582158377|FG001|Overall Study|Lack of Efficacy|1|||
161211304|NCT00996918|582158378|FG002|Overall Study|Lack of Efficacy|2|||
161211305|NCT00996918|582158379|FG003|Overall Study|Lack of Efficacy|2|||
161211306|NCT00996918|582158380|FG004|Overall Study|Lack of Efficacy|0|||
161211307|NCT00996918|582158376|FG000|Overall Study|Adverse Event|2|||
161211308|NCT00996918|582158377|FG001|Overall Study|Adverse Event|5|||
161211309|NCT00996918|582158378|FG002|Overall Study|Adverse Event|2|||
161211310|NCT00996918|582158379|FG003|Overall Study|Adverse Event|6|||
161211311|NCT00996918|582158380|FG004|Overall Study|Adverse Event|0|||
161211312|NCT00996918|582158376|FG000|Overall Study|Withdrawal by Subject|1|||
161211313|NCT00996918|582158377|FG001|Overall Study|Withdrawal by Subject|4|||
161211314|NCT00996918|582158378|FG002|Overall Study|Withdrawal by Subject|3|||
161211315|NCT00996918|582158379|FG003|Overall Study|Withdrawal by Subject|3|||
161211316|NCT00996918|582158380|FG004|Overall Study|Withdrawal by Subject|2|||
161211317|NCT00996918|582158376|FG000|Overall Study|Physician Decision|1|||
161211318|NCT00996918|582158377|FG001|Overall Study|Physician Decision|0|||
161211319|NCT00996918|582158378|FG002|Overall Study|Physician Decision|0|||
161211320|NCT00996918|582158379|FG003|Overall Study|Physician Decision|0|||
161211321|NCT00996918|582158380|FG004|Overall Study|Physician Decision|0|||
161211322|NCT00996918|582158376|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
161211323|NCT00996918|582158377|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
161211324|NCT00996918|582158378|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
161211325|NCT00996918|582158379|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
161211326|NCT00996918|582158380|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
161211327|NCT00996918|582158376|FG000|Overall Study|Loss of Caregiver|0|||
161211328|NCT00996918|582158377|FG001|Overall Study|Loss of Caregiver|1|||
161211329|NCT00996918|582158378|FG002|Overall Study|Loss of Caregiver|0|||
161211330|NCT00996918|582158379|FG003|Overall Study|Loss of Caregiver|0|||
161211331|NCT00996918|582158380|FG004|Overall Study|Loss of Caregiver|0|||
161211332|NCT00996918|582158376|FG000|Overall Study|Other|3|||
161211333|NCT00996918|582158377|FG001|Overall Study|Other|1|||
161211334|NCT00996918|582158378|FG002|Overall Study|Other|0|||
161211335|NCT00996918|582158379|FG003|Overall Study|Other|0|||
161211336|NCT00996918|582158380|FG004|Overall Study|Other|0|||
161211337|NCT00447694|582158381|FG000|Overall Study|Adverse Event|2|||
161211338|NCT00447694|582158381|FG000|Overall Study|Abnormal laboratory value|1|||
161211339|NCT00447694|582158381|FG000|Overall Study|Abnormal test procedure result|1|||
161211340|NCT00447694|582158381|FG000|Overall Study|Withdrawal by Subject|2|||
161211341|NCT01965535|582158382|FG000|Overall Study|Lack of Efficacy|2|||
161211342|NCT01965535|582158383|FG001|Overall Study|Lack of Efficacy|1|||
161211343|NCT01169987|582158385|FG000|Overall Study|Withdrawal by Subject|3|||
161211344|NCT01169987|582158385|FG000|Overall Study|Lost to Follow-up|24|||
161211345|NCT01169987|582158385|FG000|Overall Study|Other|4|||
161211346|NCT00386100|582158387|FG000|Overall Study|Did not receive study medication|6|||
161211347|NCT00386100|582158388|FG001|Overall Study|Did not receive study medication|4|||
161211348|NCT00386100|582158387|FG000|Overall Study|Adverse Event|15|||
161211349|NCT00386100|582158388|FG001|Overall Study|Adverse Event|25|||
161211350|NCT00386100|582158387|FG000|Overall Study|Death|0|||
161211351|NCT00386100|582158388|FG001|Overall Study|Death|1|||
161211352|NCT00386100|582158387|FG000|Overall Study|Insufficient therapeutic effect|30|||
161211353|NCT00386100|582158388|FG001|Overall Study|Insufficient therapeutic effect|6|||
161211354|NCT00386100|582158387|FG000|Overall Study|Lost to Follow-up|29|||
161211355|NCT00386100|582158388|FG001|Overall Study|Lost to Follow-up|29|||
161211356|NCT00386100|582158387|FG000|Overall Study|Non-compliance|18|||
161211357|NCT00386100|582158388|FG001|Overall Study|Non-compliance|19|||
161211358|NCT00386100|582158387|FG000|Overall Study|Protocol Violation|5|||
161211359|NCT00386100|582158388|FG001|Overall Study|Protocol Violation|3|||
161211360|NCT00386100|582158387|FG000|Overall Study|Withdrawal by Subject|32|||
161211361|NCT00386100|582158388|FG001|Overall Study|Withdrawal by Subject|31|||
161211362|NCT00386100|582158387|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
161211363|NCT00386100|582158388|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
161211364|NCT00386100|582158387|FG000|Overall Study|BMD <2.5|1|||
161211365|NCT00386100|582158388|FG001|Overall Study|BMD <2.5|0|||
161211366|NCT00386100|582158387|FG000|Overall Study|Consecutive elevated Hba1C|1|||
161211367|NCT00386100|582158388|FG001|Overall Study|Consecutive elevated Hba1C|0|||
161211368|NCT00386100|582158387|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
161211369|NCT00386100|582158388|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
161211370|NCT00386100|582158387|FG000|Overall Study|Laboratory findings|1|||
161211371|NCT00386100|582158388|FG001|Overall Study|Laboratory findings|0|||
161211372|NCT00386100|582158387|FG000|Overall Study|Participant's concern due to CPK levels|1|||
161211373|NCT00386100|582158388|FG001|Overall Study|Participant's concern due to CPK levels|0|||
161211374|NCT00386100|582158387|FG000|Overall Study|Participant moving out of state|2|||
161211375|NCT00386100|582158388|FG001|Overall Study|Participant moving out of state|0|||
161211376|NCT00386100|582158387|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
161211377|NCT00386100|582158388|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
161211378|NCT00386100|582158387|FG000|Overall Study|Didn't meet entry criteria|1|||
161211379|NCT00386100|582158388|FG001|Overall Study|Didn't meet entry criteria|1|||
161211380|NCT00386100|582158387|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
161211381|NCT00386100|582158388|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
161211382|NCT00386100|582158387|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
161211383|NCT00386100|582158388|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
161211384|NCT00386100|582158387|FG000|Overall Study|Bad metabolic control & patient security|1|||
161211385|NCT00386100|582158388|FG001|Overall Study|Bad metabolic control & patient security|0|||
161211386|NCT00386100|582158387|FG000|Overall Study|Bone loss by DXA bone scan|1|||
161211387|NCT00386100|582158388|FG001|Overall Study|Bone loss by DXA bone scan|0|||
161211388|NCT00386100|582158387|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
161211389|NCT00386100|582158388|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
161211390|NCT00386100|582158387|FG000|Overall Study|7.6% bone loss|1|||
161211391|NCT00386100|582158388|FG001|Overall Study|7.6% bone loss|0|||
161211392|NCT00386100|582158387|FG000|Overall Study|Osteoporosis|0|||
161211393|NCT00386100|582158388|FG001|Overall Study|Osteoporosis|1|||
161211394|NCT00386100|582158387|FG000|Overall Study|Positive pregnancy test|1|||
161211395|NCT00386100|582158388|FG001|Overall Study|Positive pregnancy test|3|||
161211396|NCT00386100|582158387|FG000|Overall Study|Out of country for 5 months|1|||
161211397|NCT00386100|582158388|FG001|Overall Study|Out of country for 5 months|0|||
161211398|NCT00386100|582158387|FG000|Overall Study|Hb1Ac >8%|0|||
161211399|NCT00386100|582158388|FG001|Overall Study|Hb1Ac >8%|1|||
161211400|NCT00386100|582158387|FG000|Overall Study|Participant randomized in error|1|||
161211401|NCT00386100|582158388|FG001|Overall Study|Participant randomized in error|0|||
161211402|NCT00886782|582158392|FG000|Overall Study|Disease progression|3|||
161211403|NCT00886782|582158393|FG001|Overall Study|Disease progression|3|||
161211404|NCT00886782|582158394|FG002|Overall Study|Disease progression|3|||
161211405|NCT00886782|582158392|FG000|Overall Study|Study drug toxicity|0|||
161211406|NCT00886782|582158393|FG001|Overall Study|Study drug toxicity|0|||
161211407|NCT00886782|582158394|FG002|Overall Study|Study drug toxicity|1|||
161211408|NCT00886782|582158392|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
161211409|NCT00886782|582158393|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
161211410|NCT00886782|582158394|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
161211411|NCT00078819|582158395|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161211412|NCT00078819|582158396|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
161211413|NCT00078819|582158397|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161211414|NCT00078819|582158398|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
161211415|NCT00078819|582158395|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
161211416|NCT00078819|582158396|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161211417|NCT00078819|582158397|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161211418|NCT00078819|582158398|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
161211419|NCT00078819|582158395|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
161211420|NCT00078819|582158396|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
161211421|NCT00078819|582158397|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
161211422|NCT00078819|582158398|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
161211423|NCT00078819|582158395|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
161211424|NCT00078819|582158396|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
161211425|NCT00078819|582158397|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
161211426|NCT00078819|582158398|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
161211427|NCT00078819|582158395|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
161211428|NCT00078819|582158396|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
161211429|NCT00078819|582158397|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
161211430|NCT00078819|582158398|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
161211431|NCT00078819|582158395|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
161211432|NCT00078819|582158396|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
161211433|NCT00078819|582158397|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
161211434|NCT00078819|582158398|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
161211435|NCT00078819|582158395|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
161211436|NCT00078819|582158396|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
161211437|NCT00078819|582158397|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
161211438|NCT00078819|582158398|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
161211439|NCT00078819|582158395|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161211440|NCT00078819|582158396|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161211441|NCT00078819|582158397|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
161211442|NCT00078819|582158398|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
161211443|NCT04130919|582158399|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
161211444|NCT04130919|582158400|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
161211445|NCT04130919|582158401|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
161211446|NCT04130919|582158402|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
161211447|NCT04130919|582158403|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
161211448|NCT04130919|582158404|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
161211449|NCT04130919|582158399|FG000|Blinded Treatment Phase|Adverse Event|0|||
161211450|NCT04130919|582158400|FG001|Blinded Treatment Phase|Adverse Event|0|||
161211451|NCT04130919|582158401|FG002|Blinded Treatment Phase|Adverse Event|1|||
161211452|NCT04130919|582158402|FG003|Blinded Treatment Phase|Adverse Event|0|||
161211453|NCT04130919|582158403|FG004|Blinded Treatment Phase|Adverse Event|0|||
161211454|NCT04130919|582158404|FG005|Blinded Treatment Phase|Adverse Event|0|||
161211455|NCT04130919|582158399|FG000|Blinded Treatment Phase|Disease worsening|0|||
161211456|NCT04130919|582158400|FG001|Blinded Treatment Phase|Disease worsening|0|||
161211457|NCT04130919|582158401|FG002|Blinded Treatment Phase|Disease worsening|1|||
161211458|NCT04130919|582158402|FG003|Blinded Treatment Phase|Disease worsening|0|||
161211459|NCT04130919|582158403|FG004|Blinded Treatment Phase|Disease worsening|0|||
161211460|NCT04130919|582158404|FG005|Blinded Treatment Phase|Disease worsening|0|||
161211461|NCT04130919|582158399|FG000|Blinded Treatment Phase|Investigator's decision|0|||
161211462|NCT04130919|582158400|FG001|Blinded Treatment Phase|Investigator's decision|1|||
161211463|NCT04130919|582158401|FG002|Blinded Treatment Phase|Investigator's decision|0|||
161211464|NCT04130919|582158402|FG003|Blinded Treatment Phase|Investigator's decision|0|||
161211465|NCT04130919|582158403|FG004|Blinded Treatment Phase|Investigator's decision|0|||
161211466|NCT04130919|582158404|FG005|Blinded Treatment Phase|Investigator's decision|0|||
161211467|NCT04130919|582158399|FG000|Blinded Treatment Phase|Withdrew consent|1|||
161211468|NCT04130919|582158400|FG001|Blinded Treatment Phase|Withdrew consent|0|||
161211469|NCT04130919|582158401|FG002|Blinded Treatment Phase|Withdrew consent|0|||
161211470|NCT04130919|582158402|FG003|Blinded Treatment Phase|Withdrew consent|0|||
161211471|NCT04130919|582158403|FG004|Blinded Treatment Phase|Withdrew consent|0|||
161211472|NCT04130919|582158404|FG005|Blinded Treatment Phase|Withdrew consent|0|||
161211473|NCT04130919|582158399|FG000|Open-label Treatment Phase|Withdrew consent|0|||
161211474|NCT04130919|582158400|FG001|Open-label Treatment Phase|Withdrew consent|0|||
161211475|NCT04130919|582158401|FG002|Open-label Treatment Phase|Withdrew consent|0|||
161211476|NCT04130919|582158402|FG003|Open-label Treatment Phase|Withdrew consent|1|||
161211477|NCT04130919|582158403|FG004|Open-label Treatment Phase|Withdrew consent|1|||
161211478|NCT04130919|582158404|FG005|Open-label Treatment Phase|Withdrew consent|1|||
161211479|NCT04130919|582158399|FG000|Open-label Treatment Phase|Disease worsening|0|||
161211480|NCT04130919|582158400|FG001|Open-label Treatment Phase|Disease worsening|0|||
161211481|NCT04130919|582158401|FG002|Open-label Treatment Phase|Disease worsening|0|||
161211482|NCT04130919|582158402|FG003|Open-label Treatment Phase|Disease worsening|1|||
161211483|NCT04130919|582158403|FG004|Open-label Treatment Phase|Disease worsening|0|||
161211484|NCT04130919|582158404|FG005|Open-label Treatment Phase|Disease worsening|1|||
161211485|NCT04130919|582158399|FG000|Open-label Treatment Phase|Investigator's decision|0|||
161211486|NCT04130919|582158400|FG001|Open-label Treatment Phase|Investigator's decision|0|||
161211487|NCT04130919|582158401|FG002|Open-label Treatment Phase|Investigator's decision|0|||
161211488|NCT04130919|582158402|FG003|Open-label Treatment Phase|Investigator's decision|1|||
161211489|NCT04130919|582158403|FG004|Open-label Treatment Phase|Investigator's decision|0|||
161211490|NCT04130919|582158404|FG005|Open-label Treatment Phase|Investigator's decision|0|||
161211491|NCT04130919|582158399|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161211492|NCT04130919|582158400|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161211493|NCT04130919|582158401|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
161211494|NCT04130919|582158402|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
161211495|NCT04130919|582158403|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
161211496|NCT04130919|582158404|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
161211497|NCT04130919|582158399|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161211498|NCT04130919|582158400|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161211499|NCT04130919|582158401|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161211500|NCT04130919|582158402|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161211501|NCT04130919|582158403|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
161211502|NCT04130919|582158404|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
161211503|NCT03012815|582158405|FG000|Overall Study|Lost to Follow-up|1|||
161211504|NCT03012815|582158406|FG001|Overall Study|Lost to Follow-up|0|||
161211505|NCT03012815|582158405|FG000|Overall Study|Physician Decision|3|||
161211506|NCT03012815|582158406|FG001|Overall Study|Physician Decision|2|||
161211507|NCT03012815|582158405|FG000|Overall Study|Adverse Event|1|||
161211508|NCT03012815|582158406|FG001|Overall Study|Adverse Event|0|||
161211509|NCT02400905|582158408|FG000|Overall Study|Death|24|||
161211510|NCT02400905|582158408|FG000|Overall Study|Lost to Follow-up|18|||
161211511|NCT02400905|582158408|FG000|Overall Study|Withdrawal by Subject|16|||
161211512|NCT02400905|582158408|FG000|Overall Study|Physician Decision|4|||
161211513|NCT02400905|582158408|FG000|Overall Study|Other|1|||
161211514|NCT00879970|582158409|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
161211515|NCT00879970|582158410|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
161097575|NCT01176968|581748671|FG001|Overall Study|Reason not defined|3|||
161097576|NCT04485104|581748686|FG000|Overall Study|Physician Decision|2|||
161097577|NCT04485104|581748687|FG001|Overall Study|Physician Decision|0|||
161097578|NCT04485104|581748686|FG000|Overall Study|Decision by sponsor|0|||
161097579|NCT04485104|581748687|FG001|Overall Study|Decision by sponsor|1|||
161097580|NCT00744523|581748688|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
161097581|NCT00744523|581748689|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
161097582|NCT05057247|581748690|FG000|Overall Study|Death|4|||
161097583|NCT05057247|581748690|FG000|Overall Study|Physician Decision|3|||
161097584|NCT05057247|581748690|FG000|Overall Study|Progressive Disease|7|||
161097585|NCT05057247|581748690|FG000|Overall Study|Withdrawal by Subject|3|||
161097586|NCT05057247|581748690|FG000|Overall Study|Adverse Event|6|||
161097587|NCT05057247|581748690|FG000|Overall Study|Subject Non-Compliance|1|||
161097588|NCT05057247|581748690|FG000|Overall Study|On treatment|2|||
161097589|NCT03588728|581748694|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
161097590|NCT03588728|581748695|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
161097591|NCT03588728|581748696|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
161097592|NCT03588728|581748697|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
161097593|NCT03588728|581748694|FG000|Overall Study|Lab shut down due to COVID-19|0|||
161097594|NCT03588728|581748695|FG001|Overall Study|Lab shut down due to COVID-19|0|||
161097595|NCT03588728|581748696|FG002|Overall Study|Lab shut down due to COVID-19|0|||
161097596|NCT03588728|581748697|FG003|Overall Study|Lab shut down due to COVID-19|1|||
161097597|NCT03588728|581748694|FG000|Overall Study|multiple technical issues|1|||
161097598|NCT03588728|581748695|FG001|Overall Study|multiple technical issues|0|||
161097599|NCT03588728|581748696|FG002|Overall Study|multiple technical issues|0|||
161097600|NCT03588728|581748697|FG003|Overall Study|multiple technical issues|0|||
161097601|NCT03588728|581748694|FG000|Overall Study|Hospitalized for COVID|1|||
161097602|NCT03588728|581748695|FG001|Overall Study|Hospitalized for COVID|0|||
161097603|NCT03588728|581748696|FG002|Overall Study|Hospitalized for COVID|0|||
161097604|NCT03588728|581748697|FG003|Overall Study|Hospitalized for COVID|0|||
161097605|NCT03588728|581748694|FG000|Overall Study|Schedule change unable to attend sessions|1|||
161097606|NCT03588728|581748695|FG001|Overall Study|Schedule change unable to attend sessions|0|||
161097607|NCT03588728|581748696|FG002|Overall Study|Schedule change unable to attend sessions|0|||
161097608|NCT03588728|581748697|FG003|Overall Study|Schedule change unable to attend sessions|0|||
161097609|NCT01388790|581748698|FG000|Overall Study|Ongoing at data cut-off date|8|||
161097610|NCT03153137|581748699|FG000|Overall Study|Lost to Follow-up|1|||
161097611|NCT03153137|581748700|FG001|Overall Study|Lost to Follow-up|0|||
161097612|NCT03153137|581748699|FG000|Overall Study|Withdrawal by Subject|2|||
161097613|NCT03153137|581748700|FG001|Overall Study|Withdrawal by Subject|1|||
161097614|NCT03153137|581748699|FG000|Overall Study|Physician Decision|0|||
161097615|NCT03153137|581748700|FG001|Overall Study|Physician Decision|3|||
161097616|NCT00195507|581748701|FG000|Overall Study|Adverse Event|24|||
161097617|NCT00195507|581748702|FG001|Overall Study|Adverse Event|13|||
161097618|NCT00195507|581748701|FG000|Overall Study|Death|0|||
161097619|NCT00195507|581748702|FG001|Overall Study|Death|1|||
161097620|NCT00195507|581748701|FG000|Overall Study|Failed to Return|4|||
161097621|NCT00195507|581748702|FG001|Overall Study|Failed to Return|3|||
161097622|NCT00195507|581748701|FG000|Overall Study|Physician Decision|1|||
161097623|NCT00195507|581748702|FG001|Overall Study|Physician Decision|2|||
161097624|NCT00195507|581748701|FG000|Overall Study|Lost to Follow-up|3|||
161097625|NCT00195507|581748702|FG001|Overall Study|Lost to Follow-up|2|||
161097626|NCT00195507|581748701|FG000|Overall Study|Protocol Violation|5|||
161097627|NCT00195507|581748702|FG001|Overall Study|Protocol Violation|4|||
161097628|NCT00195507|581748701|FG000|Overall Study|Lack of Efficacy|40|||
161097629|NCT00195507|581748702|FG001|Overall Study|Lack of Efficacy|67|||
161097630|NCT00195507|581748701|FG000|Overall Study|Withdrawal by Subject|16|||
161097631|NCT00195507|581748702|FG001|Overall Study|Withdrawal by Subject|23|||
161097632|NCT00195507|581748701|FG000|Overall Study|Protocol Deviation|6|||
161097633|NCT00195507|581748702|FG001|Overall Study|Protocol Deviation|3|||
161097634|NCT00528866|581748703|FG000|Overall Study|Protocol Violation|6|||
161097635|NCT00993915|581748704|FG000|Overall Study|Insufficient clinical response|3|||
161097636|NCT00993915|581748704|FG000|Overall Study|Withdrawal by Subject|2|||
161097637|NCT00993915|581748704|FG000|Overall Study|Other|1|||
161097638|NCT00993915|581748704|FG000|Overall Study|Ongoing|3|||
161097639|NCT01386658|581748705|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
161097640|NCT01386658|581748706|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
161097641|NCT01386658|581748705|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
161097642|NCT01386658|581748706|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
161097643|NCT02465463|581748707|FG000|Overall Study|Lost to Follow-up|2|||
161097644|NCT02465463|581748708|FG001|Overall Study|Lost to Follow-up|1|||
161097645|NCT02465463|581748707|FG000|Overall Study|Death|1|||
161097646|NCT02465463|581748708|FG001|Overall Study|Death|0|||
161097647|NCT02465463|581748707|FG000|Overall Study|Protocol Violation|1|||
161097648|NCT02465463|581748708|FG001|Overall Study|Protocol Violation|0|||
161097649|NCT01067326|581748713|FG000|Overall Study|Adverse Event|0|||
161097650|NCT01067326|581748714|FG001|Overall Study|Adverse Event|2|||
161211516|NCT00879970|582158411|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
161211517|NCT00879970|582158412|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
161211518|NCT00879970|582158413|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
161211519|NCT00879970|582158409|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
161211520|NCT00879970|582158410|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
161211521|NCT00879970|582158411|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
161211522|NCT00879970|582158412|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
161211523|NCT00879970|582158413|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
161211524|NCT00879970|582158409|FG000|Period 1 TZD Randomization|Death|2|||
161211525|NCT00879970|582158410|FG001|Period 1 TZD Randomization|Death|1|||
161211526|NCT00879970|582158411|FG002|Period 1 TZD Randomization|Death|0|||
161211527|NCT00879970|582158412|FG003|Period 1 TZD Randomization|Death|0|||
161211528|NCT00879970|582158413|FG004|Period 1 TZD Randomization|Death|0|||
161211529|NCT00879970|582158409|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
161211530|NCT00879970|582158410|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161211531|NCT00879970|582158411|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
161211532|NCT00879970|582158412|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161211533|NCT00879970|582158413|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
161211534|NCT00879970|582158409|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161211535|NCT00879970|582158410|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161211536|NCT00879970|582158411|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
161211537|NCT00879970|582158412|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
161211538|NCT00879970|582158413|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
161211539|NCT00879970|582158409|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161211540|NCT00879970|582158410|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161211541|NCT00879970|582158411|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161211542|NCT00879970|582158412|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
161211543|NCT00879970|582158413|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
161211544|NCT00879970|582158409|FG000|Period 2 Vitamin D Randomization|Death|0|||
161211545|NCT00879970|582158410|FG001|Period 2 Vitamin D Randomization|Death|0|||
161211546|NCT00879970|582158411|FG002|Period 2 Vitamin D Randomization|Death|0|||
161211547|NCT00879970|582158412|FG003|Period 2 Vitamin D Randomization|Death|2|||
161211548|NCT00879970|582158413|FG004|Period 2 Vitamin D Randomization|Death|0|||
161211549|NCT01749033|582158417|FG000|Overall Study|Did not receive allocated intervention|3|||
161211550|NCT01749033|582158418|FG001|Overall Study|Did not receive allocated intervention|3|||
161211551|NCT01749033|582158419|FG002|Overall Study|Did not receive allocated intervention|0|||
161211552|NCT01749033|582158417|FG000|Overall Study|Lost to Follow-up|0|||
161211553|NCT01749033|582158418|FG001|Overall Study|Lost to Follow-up|2|||
161211554|NCT01749033|582158419|FG002|Overall Study|Lost to Follow-up|1|||
161211555|NCT01256398|582158420|FG000|Overall Study|Withdrawal by Subject|1|||
161211556|NCT00061945|582158421|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
161211557|NCT00061945|582158422|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
161211558|NCT00061945|582158421|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
161211559|NCT00061945|582158422|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
161211560|NCT00061945|582158421|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
161211561|NCT00061945|582158422|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
161211562|NCT00061945|582158421|FG000|Course IV: Alemtuzumab|Early exits|6|||
161211563|NCT00061945|582158422|FG001|Course IV: Alemtuzumab|Early exits|15|||
161211564|NCT01039584|582158423|FG000|Overall Study|Withdrawal by Subject|4|||
161211565|NCT01039584|582158424|FG001|Overall Study|Withdrawal by Subject|2|||
161211566|NCT01039584|582158425|FG002|Overall Study|Withdrawal by Subject|1|||
161211567|NCT01039584|582158423|FG000|Overall Study|Protocol Violation|10|||
161211568|NCT01039584|582158424|FG001|Overall Study|Protocol Violation|4|||
161211569|NCT01039584|582158425|FG002|Overall Study|Protocol Violation|6|||
161211570|NCT01039584|582158423|FG000|Overall Study|Lost to Follow-up|5|||
161211571|NCT01039584|582158424|FG001|Overall Study|Lost to Follow-up|3|||
161211572|NCT01039584|582158425|FG002|Overall Study|Lost to Follow-up|4|||
161211573|NCT01039584|582158423|FG000|Overall Study|Negative Baseline culture for Candida|59|||
161211574|NCT01039584|582158424|FG001|Overall Study|Negative Baseline culture for Candida|59|||
161211575|NCT01039584|582158425|FG002|Overall Study|Negative Baseline culture for Candida|24|||
161211576|NCT01039584|582158423|FG000|Overall Study|Lack of Efficacy|7|||
161211577|NCT01039584|582158424|FG001|Overall Study|Lack of Efficacy|6|||
161211578|NCT01039584|582158425|FG002|Overall Study|Lack of Efficacy|10|||
161211579|NCT01039584|582158423|FG000|Overall Study|other|1|||
161211580|NCT01039584|582158424|FG001|Overall Study|other|3|||
161211581|NCT01039584|582158425|FG002|Overall Study|other|1|||
161211582|NCT01039584|582158423|FG000|Overall Study|Pap smear with significant pathology|10|||
161211583|NCT01039584|582158424|FG001|Overall Study|Pap smear with significant pathology|10|||
161211584|NCT01039584|582158425|FG002|Overall Study|Pap smear with significant pathology|3|||
161211585|NCT01039584|582158423|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
161097651|NCT01067326|581748713|FG000|Overall Study|Withdrawal by Subject|1|||
161097652|NCT01067326|581748714|FG001|Overall Study|Withdrawal by Subject|0|||
161097653|NCT01067326|581748713|FG000|Overall Study|Early Study Termination|1|||
161097654|NCT01067326|581748714|FG001|Overall Study|Early Study Termination|1|||
161097655|NCT03026127|581748723|FG000|CRISP R61|Adverse Event|5|||
161097656|NCT03026127|581748724|FG001|CRISP R61|Adverse Event|0|||
161097657|NCT03026127|581748725|FG002|CRISP R61|Adverse Event|0|||
161097658|NCT03026127|581748723|FG000|CRISP R61|Lost to Follow-up|2|||
161097659|NCT03026127|581748724|FG001|CRISP R61|Lost to Follow-up|0|||
161097660|NCT03026127|581748725|FG002|CRISP R61|Lost to Follow-up|0|||
161097661|NCT03026127|581748723|FG000|CRISP R61|Dropped before therapy|5|||
161097662|NCT03026127|581748724|FG001|CRISP R61|Dropped before therapy|0|||
161097663|NCT03026127|581748725|FG002|CRISP R61|Dropped before therapy|0|||
161097664|NCT03026127|581748723|FG000|CRISP R33|Lost to Follow-up|0|||
161097665|NCT03026127|581748724|FG001|CRISP R33|Lost to Follow-up|5|||
161097666|NCT03026127|581748725|FG002|CRISP R33|Lost to Follow-up|4|||
161097667|NCT03026127|581748723|FG000|CRISP R33|Adverse Event|0|||
161097668|NCT03026127|581748724|FG001|CRISP R33|Adverse Event|9|||
161097669|NCT03026127|581748725|FG002|CRISP R33|Adverse Event|5|||
161097670|NCT03026127|581748723|FG000|CRISP R33|Withdrawal by Subject|0|||
161097671|NCT03026127|581748724|FG001|CRISP R33|Withdrawal by Subject|9|||
161097672|NCT03026127|581748725|FG002|CRISP R33|Withdrawal by Subject|1|||
161097673|NCT03026127|581748723|FG000|CRISP R33|Lack of Efficacy|0|||
161097674|NCT03026127|581748724|FG001|CRISP R33|Lack of Efficacy|3|||
161097675|NCT03026127|581748725|FG002|CRISP R33|Lack of Efficacy|2|||
161097676|NCT03026127|581748723|FG000|CRISP R33|Physician Decision|0|||
161097677|NCT03026127|581748724|FG001|CRISP R33|Physician Decision|3|||
161097678|NCT03026127|581748725|FG002|CRISP R33|Physician Decision|1|||
161097679|NCT03026127|581748723|FG000|CRISP R33|Transportation|0|||
161097680|NCT03026127|581748724|FG001|CRISP R33|Transportation|2|||
161097681|NCT03026127|581748725|FG002|CRISP R33|Transportation|1|||
161097682|NCT00564018|581748727|FG000|Overall Study|Withdrawal by Subject|2|||
161097683|NCT00564018|581748728|FG001|Overall Study|Withdrawal by Subject|3|||
161097684|NCT00564018|581748729|FG002|Overall Study|Withdrawal by Subject|1|||
161097685|NCT04526197|581748735|FG000|Period 1|Adverse Event|0|||
161097686|NCT04526197|581748736|FG001|Period 1|Adverse Event|1|||
161097687|NCT04526197|581748735|FG000|Period 1|Withdrawal by Subject|1|||
161097688|NCT04526197|581748736|FG001|Period 1|Withdrawal by Subject|0|||
161097689|NCT04526197|581748735|FG000|Period 2|Adverse Event|0|||
161097690|NCT04526197|581748736|FG001|Period 2|Adverse Event|1|||
161097691|NCT04526197|581748735|FG000|Period 2|Withdrawal by Subject|0|||
161097692|NCT04526197|581748736|FG001|Period 2|Withdrawal by Subject|1|||
161097693|NCT01209143|581748737|FG000|Overall Study|Adverse Event|2|||
161097694|NCT01209143|581748738|FG001|Overall Study|Adverse Event|1|||
161097695|NCT01209143|581748737|FG000|Overall Study|Death|0|||
161097696|NCT01209143|581748738|FG001|Overall Study|Death|1|||
161097697|NCT01209143|581748737|FG000|Overall Study|Physician Decision|3|||
161097698|NCT01209143|581748738|FG001|Overall Study|Physician Decision|1|||
161097699|NCT01209143|581748737|FG000|Overall Study|Lost to Follow-up|1|||
161097700|NCT01209143|581748738|FG001|Overall Study|Lost to Follow-up|0|||
161097701|NCT01209143|581748737|FG000|Overall Study|Withdrawal by Subject|2|||
161097702|NCT01209143|581748738|FG001|Overall Study|Withdrawal by Subject|1|||
161097703|NCT01209143|581748737|FG000|Overall Study|Disease progression|11|||
161097704|NCT01209143|581748738|FG001|Overall Study|Disease progression|16|||
161097705|NCT00381303|581748739|FG000|Overall Study|Lost to Follow-up|25|||
161097706|NCT00381303|581748740|FG001|Overall Study|Lost to Follow-up|9|||
161097707|NCT00381303|581748739|FG000|Overall Study|AE/HIV-related event|22|||
161097708|NCT00381303|581748740|FG001|Overall Study|AE/HIV-related event|6|||
161097709|NCT00381303|581748739|FG000|Overall Study|Non-Adherence|13|||
161097710|NCT00381303|581748740|FG001|Overall Study|Non-Adherence|6|||
161097711|NCT00381303|581748739|FG000|Overall Study|Withdrawal by Subject|13|||
161097712|NCT00381303|581748740|FG001|Overall Study|Withdrawal by Subject|6|||
161097713|NCT00381303|581748739|FG000|Overall Study|Virologic failure|6|||
161097714|NCT00381303|581748740|FG001|Overall Study|Virologic failure|4|||
161097715|NCT00381303|581748739|FG000|Overall Study|Ineligible to continue the trial|2|||
161097716|NCT00381303|581748740|FG001|Overall Study|Ineligible to continue the trial|1|||
161097717|NCT00381303|581748739|FG000|Overall Study|Pregnancy|2|||
161097718|NCT00381303|581748740|FG001|Overall Study|Pregnancy|0|||
161097719|NCT00381303|581748739|FG000|Overall Study|Physician Decision|1|||
161097720|NCT00381303|581748740|FG001|Overall Study|Physician Decision|0|||
161097721|NCT00381303|581748739|FG000|Overall Study|Physician's decision to close the site|3|||
161097722|NCT00381303|581748740|FG001|Overall Study|Physician's decision to close the site|1|||
161097723|NCT00381303|581748739|FG000|Overall Study|Subject moved out of state|2|||
161097724|NCT00381303|581748740|FG001|Overall Study|Subject moved out of state|0|||
161097725|NCT00381303|581748739|FG000|Overall Study|Subject taking too many different meds|1|||
161097726|NCT00381303|581748740|FG001|Overall Study|Subject taking too many different meds|0|||
161097727|NCT00381303|581748739|FG000|Overall Study|No virologic response by week 12|1|||
161097728|NCT00381303|581748740|FG001|Overall Study|No virologic response by week 12|0|||
161097729|NCT00381303|581748739|FG000|Overall Study|Subject was too busy for appointments|1|||
161211586|NCT01039584|582158424|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
161211587|NCT01039584|582158425|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
161211588|NCT03672396|582158428|FG000|Overall Study|Withdrawal by Subject|4|||
161211589|NCT03672396|582158428|FG000|Overall Study|Physician Decision|1|||
161211590|NCT03672396|582158428|FG000|Overall Study|Adverse Event|1|||
161211591|NCT04380701|582158435|FG000|Overall Study|Pregnancy|0|||
161211592|NCT04380701|582158436|FG001|Overall Study|Pregnancy|0|||
161211593|NCT04380701|582158437|FG002|Overall Study|Pregnancy|0|||
161211594|NCT04380701|582158438|FG003|Overall Study|Pregnancy|0|||
161211595|NCT04380701|582158439|FG004|Overall Study|Pregnancy|0|||
161211596|NCT04380701|582158440|FG005|Overall Study|Pregnancy|0|||
161211597|NCT04380701|582158441|FG006|Overall Study|Pregnancy|0|||
161211598|NCT04380701|582158442|FG007|Overall Study|Pregnancy|0|||
161211599|NCT04380701|582158443|FG008|Overall Study|Pregnancy|0|||
161211600|NCT04380701|582158444|FG009|Overall Study|Pregnancy|0|||
161211601|NCT04380701|582158445|FG010|Overall Study|Pregnancy|0|||
161211602|NCT04380701|582158446|FG011|Overall Study|Pregnancy|0|||
161211603|NCT04380701|582158447|FG012|Overall Study|Pregnancy|0|||
161211604|NCT04380701|582158448|FG013|Overall Study|Pregnancy|0|||
161211605|NCT04380701|582158449|FG014|Overall Study|Pregnancy|0|||
161211606|NCT04380701|582158450|FG015|Overall Study|Pregnancy|0|||
161211607|NCT04380701|582158451|FG016|Overall Study|Pregnancy|0|||
161211608|NCT04380701|582158452|FG017|Overall Study|Pregnancy|0|||
161211609|NCT04380701|582158453|FG018|Overall Study|Pregnancy|0|||
161211610|NCT04380701|582158454|FG019|Overall Study|Pregnancy|0|||
161211611|NCT04380701|582158455|FG020|Overall Study|Pregnancy|0|||
161211612|NCT04380701|582158456|FG021|Overall Study|Pregnancy|0|||
161211613|NCT04380701|582158457|FG022|Overall Study|Pregnancy|0|||
161211614|NCT04380701|582158458|FG023|Overall Study|Pregnancy|0|||
161211615|NCT04380701|582158459|FG024|Overall Study|Pregnancy|0|||
161211616|NCT04380701|582158460|FG025|Overall Study|Pregnancy|0|||
161211617|NCT04380701|582158461|FG026|Overall Study|Pregnancy|0|||
161211618|NCT04380701|582158462|FG027|Overall Study|Pregnancy|0|||
161211619|NCT04380701|582158463|FG028|Overall Study|Pregnancy|0|||
161211620|NCT04380701|582158464|FG029|Overall Study|Pregnancy|0|||
161211621|NCT04380701|582158465|FG030|Overall Study|Pregnancy|0|||
161211622|NCT04380701|582158466|FG031|Overall Study|Pregnancy|0|||
161211623|NCT04380701|582158467|FG032|Overall Study|Pregnancy|1|||
161211624|NCT04380701|582158468|FG033|Overall Study|Pregnancy|0|||
161211625|NCT04380701|582158435|FG000|Overall Study|Lost to Follow-up|0|||
161211626|NCT04380701|582158436|FG001|Overall Study|Lost to Follow-up|0|||
161211627|NCT04380701|582158437|FG002|Overall Study|Lost to Follow-up|0|||
161211628|NCT04380701|582158438|FG003|Overall Study|Lost to Follow-up|0|||
161211629|NCT04380701|582158439|FG004|Overall Study|Lost to Follow-up|0|||
161211630|NCT04380701|582158440|FG005|Overall Study|Lost to Follow-up|0|||
161211631|NCT04380701|582158441|FG006|Overall Study|Lost to Follow-up|0|||
161211632|NCT04380701|582158442|FG007|Overall Study|Lost to Follow-up|0|||
161211633|NCT04380701|582158443|FG008|Overall Study|Lost to Follow-up|0|||
161211634|NCT04380701|582158444|FG009|Overall Study|Lost to Follow-up|0|||
161211635|NCT04380701|582158445|FG010|Overall Study|Lost to Follow-up|0|||
161211636|NCT04380701|582158446|FG011|Overall Study|Lost to Follow-up|0|||
161211637|NCT04380701|582158447|FG012|Overall Study|Lost to Follow-up|0|||
161211638|NCT04380701|582158448|FG013|Overall Study|Lost to Follow-up|0|||
161211639|NCT04380701|582158449|FG014|Overall Study|Lost to Follow-up|0|||
161211640|NCT04380701|582158450|FG015|Overall Study|Lost to Follow-up|0|||
161211641|NCT04380701|582158451|FG016|Overall Study|Lost to Follow-up|0|||
161211642|NCT04380701|582158452|FG017|Overall Study|Lost to Follow-up|0|||
161211643|NCT04380701|582158453|FG018|Overall Study|Lost to Follow-up|0|||
161211644|NCT04380701|582158454|FG019|Overall Study|Lost to Follow-up|0|||
161211645|NCT04380701|582158455|FG020|Overall Study|Lost to Follow-up|1|||
161211646|NCT04380701|582158456|FG021|Overall Study|Lost to Follow-up|0|||
161211647|NCT04380701|582158457|FG022|Overall Study|Lost to Follow-up|0|||
161211648|NCT04380701|582158458|FG023|Overall Study|Lost to Follow-up|1|||
161211649|NCT04380701|582158459|FG024|Overall Study|Lost to Follow-up|0|||
161211650|NCT04380701|582158460|FG025|Overall Study|Lost to Follow-up|0|||
161211651|NCT04380701|582158461|FG026|Overall Study|Lost to Follow-up|0|||
161211652|NCT04380701|582158462|FG027|Overall Study|Lost to Follow-up|0|||
161211653|NCT04380701|582158463|FG028|Overall Study|Lost to Follow-up|0|||
161211654|NCT04380701|582158464|FG029|Overall Study|Lost to Follow-up|1|||
161211655|NCT04380701|582158465|FG030|Overall Study|Lost to Follow-up|0|||
161211656|NCT04380701|582158466|FG031|Overall Study|Lost to Follow-up|0|||
161211657|NCT04380701|582158467|FG032|Overall Study|Lost to Follow-up|0|||
161211658|NCT04380701|582158468|FG033|Overall Study|Lost to Follow-up|1|||
161211659|NCT04380701|582158435|FG000|Overall Study|Private reason(s)|0|||
161211660|NCT04380701|582158436|FG001|Overall Study|Private reason(s)|0|||
161211661|NCT04380701|582158437|FG002|Overall Study|Private reason(s)|0|||
161211662|NCT04380701|582158438|FG003|Overall Study|Private reason(s)|0|||
161211663|NCT04380701|582158439|FG004|Overall Study|Private reason(s)|0|||
161211664|NCT04380701|582158440|FG005|Overall Study|Private reason(s)|0|||
161211665|NCT04380701|582158441|FG006|Overall Study|Private reason(s)|1|||
161211666|NCT04380701|582158442|FG007|Overall Study|Private reason(s)|0|||
161211667|NCT04380701|582158443|FG008|Overall Study|Private reason(s)|1|||
161211668|NCT04380701|582158444|FG009|Overall Study|Private reason(s)|1|||
161211669|NCT04380701|582158445|FG010|Overall Study|Private reason(s)|0|||
161211670|NCT04380701|582158446|FG011|Overall Study|Private reason(s)|0|||
161211671|NCT04380701|582158447|FG012|Overall Study|Private reason(s)|0|||
161211672|NCT04380701|582158448|FG013|Overall Study|Private reason(s)|0|||
161211673|NCT04380701|582158449|FG014|Overall Study|Private reason(s)|0|||
161211674|NCT04380701|582158450|FG015|Overall Study|Private reason(s)|0|||
161211675|NCT04380701|582158451|FG016|Overall Study|Private reason(s)|0|||
161211676|NCT04380701|582158452|FG017|Overall Study|Private reason(s)|0|||
161211677|NCT04380701|582158453|FG018|Overall Study|Private reason(s)|0|||
161211678|NCT04380701|582158454|FG019|Overall Study|Private reason(s)|0|||
161211679|NCT04380701|582158455|FG020|Overall Study|Private reason(s)|0|||
161211680|NCT04380701|582158456|FG021|Overall Study|Private reason(s)|0|||
161211681|NCT04380701|582158457|FG022|Overall Study|Private reason(s)|0|||
161211682|NCT04380701|582158458|FG023|Overall Study|Private reason(s)|1|||
161211683|NCT04380701|582158459|FG024|Overall Study|Private reason(s)|0|||
161211684|NCT04380701|582158460|FG025|Overall Study|Private reason(s)|0|||
161211685|NCT04380701|582158461|FG026|Overall Study|Private reason(s)|0|||
161211686|NCT04380701|582158462|FG027|Overall Study|Private reason(s)|0|||
161211687|NCT04380701|582158463|FG028|Overall Study|Private reason(s)|0|||
161211688|NCT04380701|582158464|FG029|Overall Study|Private reason(s)|1|||
161211689|NCT04380701|582158465|FG030|Overall Study|Private reason(s)|0|||
161211690|NCT04380701|582158466|FG031|Overall Study|Private reason(s)|0|||
161211691|NCT04380701|582158467|FG032|Overall Study|Private reason(s)|0|||
161211692|NCT04380701|582158468|FG033|Overall Study|Private reason(s)|0|||
161211693|NCT04380701|582158435|FG000|Overall Study|Withdrawal by Subject|0|||
161211694|NCT04380701|582158436|FG001|Overall Study|Withdrawal by Subject|0|||
161211695|NCT04380701|582158437|FG002|Overall Study|Withdrawal by Subject|0|||
161211696|NCT04380701|582158438|FG003|Overall Study|Withdrawal by Subject|0|||
161211697|NCT04380701|582158439|FG004|Overall Study|Withdrawal by Subject|0|||
161211698|NCT04380701|582158440|FG005|Overall Study|Withdrawal by Subject|0|||
161211699|NCT04380701|582158441|FG006|Overall Study|Withdrawal by Subject|1|||
161211700|NCT04380701|582158442|FG007|Overall Study|Withdrawal by Subject|1|||
161211701|NCT04380701|582158443|FG008|Overall Study|Withdrawal by Subject|0|||
161211702|NCT04380701|582158444|FG009|Overall Study|Withdrawal by Subject|0|||
161211703|NCT04380701|582158445|FG010|Overall Study|Withdrawal by Subject|0|||
161211704|NCT04380701|582158446|FG011|Overall Study|Withdrawal by Subject|1|||
161211705|NCT04380701|582158447|FG012|Overall Study|Withdrawal by Subject|0|||
161211706|NCT04380701|582158448|FG013|Overall Study|Withdrawal by Subject|1|||
161211707|NCT04380701|582158449|FG014|Overall Study|Withdrawal by Subject|0|||
161211708|NCT04380701|582158450|FG015|Overall Study|Withdrawal by Subject|0|||
161211709|NCT04380701|582158451|FG016|Overall Study|Withdrawal by Subject|1|||
161211710|NCT04380701|582158452|FG017|Overall Study|Withdrawal by Subject|0|||
161211711|NCT04380701|582158453|FG018|Overall Study|Withdrawal by Subject|0|||
161211712|NCT04380701|582158454|FG019|Overall Study|Withdrawal by Subject|0|||
161211713|NCT04380701|582158455|FG020|Overall Study|Withdrawal by Subject|0|||
161211714|NCT04380701|582158456|FG021|Overall Study|Withdrawal by Subject|0|||
161211715|NCT04380701|582158457|FG022|Overall Study|Withdrawal by Subject|2|||
161211716|NCT04380701|582158458|FG023|Overall Study|Withdrawal by Subject|2|||
161211717|NCT04380701|582158459|FG024|Overall Study|Withdrawal by Subject|1|||
161211718|NCT04380701|582158460|FG025|Overall Study|Withdrawal by Subject|1|||
161211719|NCT04380701|582158461|FG026|Overall Study|Withdrawal by Subject|0|||
161211720|NCT04380701|582158462|FG027|Overall Study|Withdrawal by Subject|0|||
161211721|NCT04380701|582158463|FG028|Overall Study|Withdrawal by Subject|0|||
161211722|NCT04380701|582158464|FG029|Overall Study|Withdrawal by Subject|0|||
161211723|NCT04380701|582158465|FG030|Overall Study|Withdrawal by Subject|0|||
161211724|NCT04380701|582158466|FG031|Overall Study|Withdrawal by Subject|0|||
161211725|NCT04380701|582158467|FG032|Overall Study|Withdrawal by Subject|0|||
161211726|NCT04380701|582158468|FG033|Overall Study|Withdrawal by Subject|0|||
161211727|NCT04380701|582158435|FG000|Overall Study|Adverse Event|0|||
161211728|NCT04380701|582158436|FG001|Overall Study|Adverse Event|0|||
161211729|NCT04380701|582158437|FG002|Overall Study|Adverse Event|0|||
161211730|NCT04380701|582158438|FG003|Overall Study|Adverse Event|0|||
161211731|NCT04380701|582158439|FG004|Overall Study|Adverse Event|0|||
161211732|NCT04380701|582158440|FG005|Overall Study|Adverse Event|1|||
161211733|NCT04380701|582158441|FG006|Overall Study|Adverse Event|0|||
161211734|NCT04380701|582158442|FG007|Overall Study|Adverse Event|0|||
161211735|NCT04380701|582158443|FG008|Overall Study|Adverse Event|0|||
161211736|NCT04380701|582158444|FG009|Overall Study|Adverse Event|0|||
161211737|NCT04380701|582158445|FG010|Overall Study|Adverse Event|0|||
161211738|NCT04380701|582158446|FG011|Overall Study|Adverse Event|0|||
161211739|NCT04380701|582158447|FG012|Overall Study|Adverse Event|0|||
161211740|NCT04380701|582158448|FG013|Overall Study|Adverse Event|0|||
161211741|NCT04380701|582158449|FG014|Overall Study|Adverse Event|0|||
161211742|NCT04380701|582158450|FG015|Overall Study|Adverse Event|1|||
161211743|NCT04380701|582158451|FG016|Overall Study|Adverse Event|0|||
161211744|NCT04380701|582158452|FG017|Overall Study|Adverse Event|0|||
161211745|NCT04380701|582158453|FG018|Overall Study|Adverse Event|0|||
161211746|NCT04380701|582158454|FG019|Overall Study|Adverse Event|1|||
161211747|NCT04380701|582158455|FG020|Overall Study|Adverse Event|0|||
161211748|NCT04380701|582158456|FG021|Overall Study|Adverse Event|0|||
161211749|NCT04380701|582158457|FG022|Overall Study|Adverse Event|0|||
161211750|NCT04380701|582158458|FG023|Overall Study|Adverse Event|0|||
161211751|NCT04380701|582158459|FG024|Overall Study|Adverse Event|0|||
161211752|NCT04380701|582158460|FG025|Overall Study|Adverse Event|0|||
161211753|NCT04380701|582158461|FG026|Overall Study|Adverse Event|0|||
161211754|NCT04380701|582158462|FG027|Overall Study|Adverse Event|0|||
161211755|NCT04380701|582158463|FG028|Overall Study|Adverse Event|0|||
161211756|NCT04380701|582158464|FG029|Overall Study|Adverse Event|0|||
161211757|NCT04380701|582158465|FG030|Overall Study|Adverse Event|0|||
161211758|NCT04380701|582158466|FG031|Overall Study|Adverse Event|0|||
161211759|NCT04380701|582158467|FG032|Overall Study|Adverse Event|0|||
161211760|NCT04380701|582158468|FG033|Overall Study|Adverse Event|0|||
161211761|NCT04380701|582158435|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
161211762|NCT04380701|582158436|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
161211763|NCT04380701|582158437|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
161211764|NCT04380701|582158438|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
161211765|NCT04380701|582158439|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
161211766|NCT04380701|582158440|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
161211767|NCT04380701|582158441|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
161211768|NCT04380701|582158442|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
161211769|NCT04380701|582158443|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
161211770|NCT04380701|582158444|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
161211771|NCT04380701|582158445|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
161211772|NCT04380701|582158446|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
161211773|NCT04380701|582158447|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
161211774|NCT04380701|582158448|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
161211775|NCT04380701|582158449|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
161211776|NCT04380701|582158450|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
161211777|NCT04380701|582158451|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
161211778|NCT04380701|582158452|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
161211779|NCT04380701|582158453|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
161211780|NCT04380701|582158454|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
161211781|NCT04380701|582158455|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
161211782|NCT04380701|582158456|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
161211783|NCT04380701|582158457|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
161211784|NCT04380701|582158458|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
161211785|NCT04380701|582158459|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
161211786|NCT04380701|582158460|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
161211787|NCT04380701|582158461|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
161211788|NCT04380701|582158462|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
161211789|NCT04380701|582158463|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
161211790|NCT04380701|582158464|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
161211791|NCT04380701|582158465|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
161211792|NCT04380701|582158466|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
161211793|NCT04380701|582158467|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
161211794|NCT04380701|582158468|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
161211795|NCT04380701|582158435|FG000|Overall Study|Physician Decision|0|||
161211796|NCT04380701|582158436|FG001|Overall Study|Physician Decision|0|||
161211797|NCT04380701|582158437|FG002|Overall Study|Physician Decision|0|||
161211798|NCT04380701|582158438|FG003|Overall Study|Physician Decision|0|||
161211799|NCT04380701|582158439|FG004|Overall Study|Physician Decision|0|||
161211800|NCT04380701|582158440|FG005|Overall Study|Physician Decision|0|||
161211801|NCT04380701|582158441|FG006|Overall Study|Physician Decision|0|||
161211802|NCT04380701|582158442|FG007|Overall Study|Physician Decision|0|||
161211803|NCT04380701|582158443|FG008|Overall Study|Physician Decision|0|||
161211804|NCT04380701|582158444|FG009|Overall Study|Physician Decision|0|||
161211805|NCT04380701|582158445|FG010|Overall Study|Physician Decision|0|||
161211806|NCT04380701|582158446|FG011|Overall Study|Physician Decision|0|||
161211807|NCT04380701|582158447|FG012|Overall Study|Physician Decision|0|||
161211808|NCT04380701|582158448|FG013|Overall Study|Physician Decision|0|||
161211809|NCT04380701|582158449|FG014|Overall Study|Physician Decision|0|||
161211810|NCT04380701|582158450|FG015|Overall Study|Physician Decision|0|||
161211811|NCT04380701|582158451|FG016|Overall Study|Physician Decision|0|||
161211812|NCT04380701|582158452|FG017|Overall Study|Physician Decision|0|||
161211813|NCT04380701|582158453|FG018|Overall Study|Physician Decision|0|||
161211814|NCT04380701|582158454|FG019|Overall Study|Physician Decision|0|||
161211815|NCT04380701|582158455|FG020|Overall Study|Physician Decision|0|||
161211816|NCT04380701|582158456|FG021|Overall Study|Physician Decision|0|||
161211817|NCT04380701|582158457|FG022|Overall Study|Physician Decision|0|||
161211818|NCT04380701|582158458|FG023|Overall Study|Physician Decision|0|||
161211819|NCT04380701|582158459|FG024|Overall Study|Physician Decision|2|||
161211820|NCT04380701|582158460|FG025|Overall Study|Physician Decision|0|||
161211821|NCT04380701|582158461|FG026|Overall Study|Physician Decision|0|||
161211822|NCT04380701|582158462|FG027|Overall Study|Physician Decision|0|||
161211823|NCT04380701|582158463|FG028|Overall Study|Physician Decision|0|||
161211824|NCT04380701|582158464|FG029|Overall Study|Physician Decision|0|||
161211825|NCT04380701|582158465|FG030|Overall Study|Physician Decision|0|||
161323008|NCT02182830|582568673|FG001|Overall Study|Trial stopped, reason missing|3|||
161323009|NCT02182830|582568672|FG000|Overall Study|Consent withdrawn|8|||
161323010|NCT02182830|582568673|FG001|Overall Study|Consent withdrawn|8|||
161323011|NCT02182830|582568672|FG000|Overall Study|Lost to Follow-up|3|||
161323012|NCT02182830|582568673|FG001|Overall Study|Lost to Follow-up|3|||
161323013|NCT04399538|582568674|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
161323014|NCT04399538|582568675|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
161323015|NCT04399538|582568676|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
161323016|NCT04399538|582568677|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
161323017|NCT04399538|582568678|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
161323018|NCT04399538|582568674|FG000|Double-Blind Treatment|Adverse Event|0|||
161323019|NCT04399538|582568675|FG001|Double-Blind Treatment|Adverse Event|0|||
161323020|NCT04399538|582568676|FG002|Double-Blind Treatment|Adverse Event|0|||
161323021|NCT04399538|582568677|FG003|Double-Blind Treatment|Adverse Event|0|||
161323022|NCT04399538|582568678|FG004|Double-Blind Treatment|Adverse Event|1|||
161323023|NCT04399538|582568674|FG000|Follow-Up|Adverse Event|0|||
161323024|NCT04399538|582568675|FG001|Follow-Up|Adverse Event|0|||
161323025|NCT04399538|582568676|FG002|Follow-Up|Adverse Event|0|||
161323026|NCT04399538|582568677|FG003|Follow-Up|Adverse Event|0|||
161323027|NCT04399538|582568678|FG004|Follow-Up|Adverse Event|1|||
161323028|NCT04399538|582568674|FG000|Follow-Up|Withdrawal by Subject|0|||
161323029|NCT04399538|582568675|FG001|Follow-Up|Withdrawal by Subject|0|||
161323030|NCT04399538|582568676|FG002|Follow-Up|Withdrawal by Subject|0|||
161323031|NCT04399538|582568677|FG003|Follow-Up|Withdrawal by Subject|2|||
161323032|NCT04399538|582568678|FG004|Follow-Up|Withdrawal by Subject|0|||
161323033|NCT00586898|582568683|FG000|Overall Study|Adverse Event|1|||
161323034|NCT00586898|582568683|FG000|Overall Study|Patiemt Non-compliance|1|||
161323035|NCT00586898|582568683|FG000|Overall Study|Evaluable for Toxicity Only|5|||
161323036|NCT01588405|582568684|FG000|Overall Study|Adverse Event|1|||
161323037|NCT01588405|582568684|FG000|Overall Study|Clinical Worsening|1|||
161323038|NCT03268005|582568685|FG000|Overall Study|Death|2|||
161323039|NCT03268005|582568686|FG001|Overall Study|Death|1|||
161323040|NCT03268005|582568685|FG000|Overall Study|Lost to Follow-up|2|||
161323041|NCT03268005|582568686|FG001|Overall Study|Lost to Follow-up|2|||
160865658|NCT00734539|580902944|FG000|Main Study|Death|33|||
161211826|NCT04380701|582158466|FG031|Overall Study|Physician Decision|0|||
161211827|NCT04380701|582158467|FG032|Overall Study|Physician Decision|0|||
161211828|NCT04380701|582158468|FG033|Overall Study|Physician Decision|0|||
161211829|NCT04380701|582158435|FG000|Overall Study|Death|0|||
161211830|NCT04380701|582158436|FG001|Overall Study|Death|0|||
161211831|NCT04380701|582158437|FG002|Overall Study|Death|0|||
161211832|NCT04380701|582158438|FG003|Overall Study|Death|0|||
161211833|NCT04380701|582158439|FG004|Overall Study|Death|0|||
161211834|NCT04380701|582158440|FG005|Overall Study|Death|0|||
161211835|NCT04380701|582158441|FG006|Overall Study|Death|0|||
161211836|NCT04380701|582158442|FG007|Overall Study|Death|0|||
161211837|NCT04380701|582158443|FG008|Overall Study|Death|0|||
161211838|NCT04380701|582158444|FG009|Overall Study|Death|0|||
161211839|NCT04380701|582158445|FG010|Overall Study|Death|0|||
161211840|NCT04380701|582158446|FG011|Overall Study|Death|0|||
161211841|NCT04380701|582158447|FG012|Overall Study|Death|0|||
161211842|NCT04380701|582158448|FG013|Overall Study|Death|0|||
161211843|NCT04380701|582158449|FG014|Overall Study|Death|0|||
161211844|NCT04380701|582158450|FG015|Overall Study|Death|0|||
161211845|NCT04380701|582158451|FG016|Overall Study|Death|0|||
161211846|NCT04380701|582158452|FG017|Overall Study|Death|0|||
161211847|NCT04380701|582158453|FG018|Overall Study|Death|0|||
161211848|NCT04380701|582158454|FG019|Overall Study|Death|0|||
161211849|NCT04380701|582158455|FG020|Overall Study|Death|0|||
161211850|NCT04380701|582158456|FG021|Overall Study|Death|0|||
161211851|NCT04380701|582158457|FG022|Overall Study|Death|0|||
161211852|NCT04380701|582158458|FG023|Overall Study|Death|0|||
161211853|NCT04380701|582158459|FG024|Overall Study|Death|1|||
161211854|NCT04380701|582158460|FG025|Overall Study|Death|0|||
161211855|NCT04380701|582158461|FG026|Overall Study|Death|0|||
161211856|NCT04380701|582158462|FG027|Overall Study|Death|0|||
161211857|NCT04380701|582158463|FG028|Overall Study|Death|0|||
161211858|NCT04380701|582158464|FG029|Overall Study|Death|0|||
161211859|NCT04380701|582158465|FG030|Overall Study|Death|0|||
161211860|NCT04380701|582158466|FG031|Overall Study|Death|0|||
161211861|NCT04380701|582158467|FG032|Overall Study|Death|0|||
161211862|NCT04380701|582158468|FG033|Overall Study|Death|0|||
161211863|NCT04380701|582158435|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161323042|NCT03268005|582568685|FG000|Overall Study|Withdrawal by Subject|11|||
161323043|NCT03268005|582568686|FG001|Overall Study|Withdrawal by Subject|11|||
161323044|NCT01926197|582568688|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
161323045|NCT01926197|582568689|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
161323046|NCT01926197|582568688|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
161323047|NCT01926197|582568689|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
161323048|NCT00492232|582568690|FG000|Placebo Run-in|Adverse Event|0|||
161211864|NCT04380701|582158436|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161097730|NCT00381303|581748740|FG001|Overall Study|Subject was too busy for appointments|0|||
161097731|NCT00381303|581748739|FG000|Overall Study|Subject did not continue visits|1|||
161097732|NCT00381303|581748740|FG001|Overall Study|Subject did not continue visits|0|||
161097733|NCT00381303|581748739|FG000|Overall Study|Subject primary physician's decision|1|||
161097734|NCT00381303|581748740|FG001|Overall Study|Subject primary physician's decision|0|||
161097735|NCT01136811|581748741|FG000|Overall Study|Physician Decision|11|||
161097736|NCT01211522|581748743|FG000|Overall Study|Withdrawal by Subject|3|||
161097737|NCT01211522|581748744|FG001|Overall Study|Withdrawal by Subject|7|||
161097738|NCT01211522|581748745|FG002|Overall Study|Withdrawal by Subject|5|||
161097739|NCT01116882|581748751|FG000|30-day|Lost to Follow-up|50|||
161097740|NCT01116882|581748752|FG001|30-day|Lost to Follow-up|21|||
161097741|NCT01116882|581748751|FG000|30-day|Withdrawal by Subject|2|||
161097742|NCT01116882|581748752|FG001|30-day|Withdrawal by Subject|4|||
161097743|NCT01116882|581748751|FG000|30-day|Other Reasons|16|||
161097744|NCT01116882|581748752|FG001|30-day|Other Reasons|6|||
161097745|NCT01116882|581748751|FG000|12-month|Lost to Follow-up|111|||
161097746|NCT01116882|581748752|FG001|12-month|Lost to Follow-up|42|||
161097747|NCT01116882|581748751|FG000|12-month|Other Reasons|151|||
161097748|NCT01116882|581748752|FG001|12-month|Other Reasons|49|||
161097749|NCT01116882|581748751|FG000|12-month|Withdrawal by Subject|5|||
161097750|NCT01116882|581748752|FG001|12-month|Withdrawal by Subject|8|||
161097751|NCT00547365|581748753|FG000|Overall Study|Physician Decision|1|||
161097752|NCT00547365|581748753|FG000|Overall Study|Lost to Follow-up|1|||
161097753|NCT00547365|581748753|FG000|Overall Study|Protocol Violation|2|||
161097754|NCT00547365|581748753|FG000|Overall Study|death (not related to study)|4|||
161097755|NCT00504881|581748754|FG000|Overall Study|Lack of Efficacy|1|||
161097756|NCT00504881|581748755|FG001|Overall Study|Lack of Efficacy|5|||
161097757|NCT00504881|581748754|FG000|Overall Study|Lost to Follow-up|0|||
161097758|NCT00504881|581748755|FG001|Overall Study|Lost to Follow-up|2|||
161097759|NCT00504881|581748754|FG000|Overall Study|Withdrawal by Subject|1|||
161097760|NCT00504881|581748755|FG001|Overall Study|Withdrawal by Subject|4|||
161097761|NCT00504881|581748754|FG000|Overall Study|Non-Compliance|1|||
161097762|NCT00504881|581748755|FG001|Overall Study|Non-Compliance|0|||
161097763|NCT00504881|581748754|FG000|Overall Study|No Birth Control|0|||
161097764|NCT00504881|581748755|FG001|Overall Study|No Birth Control|1|||
161097765|NCT00504881|581748754|FG000|Overall Study|Safety Visit not performed|0|||
161097766|NCT00504881|581748755|FG001|Overall Study|Safety Visit not performed|1|||
161097767|NCT00504881|581748754|FG000|Overall Study|AE, serious fatal|0|||
161211865|NCT04380701|582158437|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211866|NCT04380701|582158438|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211867|NCT04380701|582158439|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211868|NCT04380701|582158440|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211869|NCT04380701|582158441|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211870|NCT04380701|582158442|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211871|NCT04380701|582158443|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211872|NCT04380701|582158444|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211873|NCT04380701|582158445|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211874|NCT04380701|582158446|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211875|NCT04380701|582158447|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211876|NCT04380701|582158448|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211877|NCT04380701|582158449|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211878|NCT04380701|582158450|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211879|NCT04380701|582158451|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211880|NCT04380701|582158452|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211881|NCT04380701|582158453|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211882|NCT04380701|582158454|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211883|NCT04380701|582158455|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211884|NCT04380701|582158456|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
161211885|NCT04380701|582158457|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
161211886|NCT04380701|582158458|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
161211887|NCT04380701|582158459|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
161211888|NCT04380701|582158460|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211889|NCT04380701|582158461|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211890|NCT04380701|582158462|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211891|NCT04380701|582158463|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211892|NCT04380701|582158464|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211893|NCT04380701|582158465|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211894|NCT04380701|582158466|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211895|NCT04380701|582158467|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211896|NCT04380701|582158468|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
161211897|NCT03550794|582158469|FG000|Overall Study|No longer met inclusion criteria|1|||
161211898|NCT03550794|582158470|FG001|Overall Study|No longer met inclusion criteria|2|||
161211899|NCT03550794|582158469|FG000|Overall Study|Goals of care changed|1|||
161211900|NCT03550794|582158470|FG001|Overall Study|Goals of care changed|0|||
161211901|NCT03550794|582158469|FG000|Overall Study|Withdrawal by Subject|2|||
161211902|NCT03550794|582158470|FG001|Overall Study|Withdrawal by Subject|0|||
161211903|NCT03550794|582158469|FG000|Overall Study|Death|0|||
161211904|NCT03550794|582158470|FG001|Overall Study|Death|1|||
161211905|NCT01864525|582158471|FG000|Overall Study|Adverse Event|1|||
161211906|NCT01864525|582158472|FG001|Overall Study|Adverse Event|0|||
161211907|NCT01890785|582158473|FG000|Third Intervention|Withdrawal by Subject|0|||
161211908|NCT01890785|582158474|FG001|Third Intervention|Withdrawal by Subject|1|||
161211909|NCT01890785|582158475|FG002|Third Intervention|Withdrawal by Subject|0|||
161211910|NCT01890785|582158476|FG003|Third Intervention|Withdrawal by Subject|0|||
161211911|NCT01890785|582158477|FG004|Third Intervention|Withdrawal by Subject|0|||
161211912|NCT01890785|582158478|FG005|Third Intervention|Withdrawal by Subject|0|||
161211913|NCT03296553|582158479|FG000|Overall Study|Withdrawal by Subject|1|||
161211914|NCT03296553|582158480|FG001|Overall Study|Withdrawal by Subject|1|||
161211915|NCT03296553|582158479|FG000|Overall Study|Death|1|||
161211916|NCT03296553|582158480|FG001|Overall Study|Death|0|||
161211917|NCT00558519|582158481|FG000|Overall Study|Ph+|20|||
161211918|NCT00558519|582158481|FG000|Overall Study|Ineligible|1|||
161211919|NCT00558519|582158481|FG000|Overall Study|Insufficient data|1|||
161211920|NCT00558519|582158481|FG000|Overall Study|Never received treatment|1|||
161211921|NCT03001011|582158482|FG000|Overall Study|Adverse Event|9|||
161211922|NCT03001011|582158483|FG001|Overall Study|Adverse Event|3|||
161211923|NCT03001011|582158482|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
161211924|NCT03001011|582158483|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
161211925|NCT03001011|582158482|FG000|Overall Study|Other than specified above|3|||
161211926|NCT03001011|582158483|FG001|Overall Study|Other than specified above|8|||
161211927|NCT00065065|582158484|FG000|Overall Study|Adverse Event|3|||
161211928|NCT00065065|582158485|FG001|Overall Study|Adverse Event|2|||
161211929|NCT00065065|582158484|FG000|Overall Study|Withdrawal by Subject|1|||
161211930|NCT00065065|582158485|FG001|Overall Study|Withdrawal by Subject|5|||
161211931|NCT00065065|582158484|FG000|Overall Study|Lack of Efficacy|4|||
161211932|NCT00065065|582158485|FG001|Overall Study|Lack of Efficacy|11|||
161211933|NCT00065065|582158484|FG000|Overall Study|Other|2|||
161211934|NCT00065065|582158485|FG001|Overall Study|Other|2|||
161211935|NCT04363736|582158486|FG000|Overall Study|Withdrawal by Subject|1|||
161211936|NCT04363736|582158487|FG001|Overall Study|Withdrawal by Subject|0|||
161211937|NCT04363736|582158486|FG000|Overall Study|Lost to Follow-up|10|||
161211938|NCT04363736|582158487|FG001|Overall Study|Lost to Follow-up|7|||
161211939|NCT04363736|582158486|FG000|Overall Study|Death|8|||
161211940|NCT04363736|582158487|FG001|Overall Study|Death|6|||
161211941|NCT01050673|582158488|FG000|Overall Study|Physician Decision|4|||
161211942|NCT01050673|582158489|FG001|Overall Study|Physician Decision|5|||
161211943|NCT03797222|582158490|FG000|Overall Study|Withdrawal by Subject|1|||
161211944|NCT01021137|582158492|FG000|Overall Study|Lost to Follow-up|9|||
161211945|NCT01021137|582158493|FG001|Overall Study|Lost to Follow-up|4|||
161211946|NCT01021137|582158494|FG002|Overall Study|Lost to Follow-up|2|||
161211947|NCT01021137|582158495|FG003|Overall Study|Lost to Follow-up|6|||
161211948|NCT01021137|582158492|FG000|Overall Study|Withdrawal by Subject|1|||
161211949|NCT01021137|582158493|FG001|Overall Study|Withdrawal by Subject|0|||
161211950|NCT01021137|582158494|FG002|Overall Study|Withdrawal by Subject|0|||
161211951|NCT01021137|582158495|FG003|Overall Study|Withdrawal by Subject|3|||
161211952|NCT00725725|582158496|FG000|Overall Study|Adverse Event|1|||
161211953|NCT00725725|582158497|FG001|Overall Study|Adverse Event|3|||
161211954|NCT00725725|582158498|FG002|Overall Study|Adverse Event|2|||
161211955|NCT00725725|582158496|FG000|Overall Study|Lost to Follow-up|2|||
161211956|NCT00725725|582158497|FG001|Overall Study|Lost to Follow-up|0|||
161211957|NCT00725725|582158498|FG002|Overall Study|Lost to Follow-up|2|||
161211958|NCT00725725|582158496|FG000|Overall Study|Withdrawal by Subject|1|||
161211959|NCT00725725|582158497|FG001|Overall Study|Withdrawal by Subject|0|||
161211960|NCT00725725|582158498|FG002|Overall Study|Withdrawal by Subject|1|||
161211961|NCT00725725|582158496|FG000|Overall Study|Protocol Violation|0|||
161211962|NCT00725725|582158497|FG001|Overall Study|Protocol Violation|1|||
161211963|NCT00725725|582158498|FG002|Overall Study|Protocol Violation|0|||
161211964|NCT03077828|582158499|FG000|Treatment Cycles|Death|1|||
161211965|NCT03077828|582158499|FG000|Treatment Cycles|Withdrawal by Subject|1|||
161211966|NCT03077828|582158499|FG000|Treatment Cycles|Screen Fail|2|||
161211967|NCT03077828|582158499|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
161211968|NCT03077828|582158499|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
161211969|NCT03077828|582158499|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
161211970|NCT03077828|582158499|FG000|Follow-up|Patients still in follow-up|15|||
161211971|NCT00729365|582158500|FG000|Overall Study|Physician Decision|33|||
161211972|NCT00729365|582158501|FG001|Overall Study|Physician Decision|6|||
161211973|NCT00729365|582158502|FG002|Overall Study|Physician Decision|7|||
161323049|NCT00492232|582568691|FG001|Placebo Run-in|Adverse Event|2|||
161323050|NCT00492232|582568690|FG000|Placebo Run-in|Protocol Violation|0|||
161323051|NCT00492232|582568691|FG001|Placebo Run-in|Protocol Violation|3|||
161323052|NCT00492232|582568690|FG000|Placebo Run-in|Lost to Follow-up|0|||
161323053|NCT00492232|582568691|FG001|Placebo Run-in|Lost to Follow-up|3|||
161323054|NCT00492232|582568690|FG000|Placebo Run-in|Withdrawal by Subject|0|||
161323055|NCT00492232|582568691|FG001|Placebo Run-in|Withdrawal by Subject|8|||
161323056|NCT00492232|582568690|FG000|Placebo Run-in|Pregnancy|0|||
161323057|NCT00492232|582568691|FG001|Placebo Run-in|Pregnancy|1|||
161323058|NCT00492232|582568690|FG000|Placebo Run-in|Entrance criteria not met|0|||
161323059|NCT00492232|582568691|FG001|Placebo Run-in|Entrance criteria not met|45|||
161323060|NCT00492232|582568690|FG000|Placebo Run-in|Other|0|||
161323061|NCT00492232|582568691|FG001|Placebo Run-in|Other|6|||
161323062|NCT00492232|582568690|FG000|Placebo Run-in|Missing|0|||
161323063|NCT00492232|582568691|FG001|Placebo Run-in|Missing|2|||
161323064|NCT00492232|582568690|FG000|Double-Blind Treatment|Adverse Event|1|||
161323065|NCT00492232|582568691|FG001|Double-Blind Treatment|Adverse Event|2|||
161323066|NCT00492232|582568690|FG000|Double-Blind Treatment|Protocol Violation|3|||
161323067|NCT00492232|582568691|FG001|Double-Blind Treatment|Protocol Violation|7|||
161323068|NCT00492232|582568690|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
161323069|NCT00492232|582568691|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
161323070|NCT00492232|582568690|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
161323071|NCT00492232|582568691|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
161323072|NCT00492232|582568690|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
161323073|NCT00492232|582568691|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
161323074|NCT00492232|582568690|FG000|Double-Blind Treatment|Other|6|||
161323075|NCT00492232|582568691|FG001|Double-Blind Treatment|Other|5|||
161323076|NCT00492232|582568690|FG000|Double-Blind Treatment|Randomized not treated|1|||
161323077|NCT00492232|582568691|FG001|Double-Blind Treatment|Randomized not treated|0|||
161323078|NCT00492232|582568690|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
161323079|NCT00492232|582568691|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161323080|NCT00980655|582568692|FG000|Overall Study|Adverse Event|13|||
161323081|NCT00980655|582568693|FG001|Overall Study|Adverse Event|31|||
161323082|NCT00980655|582568692|FG000|Overall Study|Death|0|||
161323083|NCT00980655|582568693|FG001|Overall Study|Death|7|||
161323084|NCT00980655|582568692|FG000|Overall Study|Protocol Violation|2|||
161323085|NCT00980655|582568693|FG001|Overall Study|Protocol Violation|7|||
161323086|NCT00980655|582568692|FG000|Overall Study|Withdrawal by Subject|0|||
161323087|NCT00980655|582568693|FG001|Overall Study|Withdrawal by Subject|4|||
161323088|NCT00980655|582568692|FG000|Overall Study|Lost to Follow-up|0|||
161323089|NCT00980655|582568693|FG001|Overall Study|Lost to Follow-up|1|||
161323090|NCT00980655|582568692|FG000|Overall Study|Parent/legal guardian request|1|||
161323091|NCT00980655|582568693|FG001|Overall Study|Parent/legal guardian request|0|||
161323092|NCT00980655|582568692|FG000|Overall Study|Other|0|||
161323093|NCT00980655|582568693|FG001|Overall Study|Other|1|||
161323094|NCT04162795|582568694|FG000|Overall Study|Other|16|||
161323095|NCT04162795|582568694|FG000|Overall Study|Screen failures|10|||
161323096|NCT02029274|582568698|FG000|Overall Study|Adverse Event|1|||
161323097|NCT02029274|582568699|FG001|Overall Study|Adverse Event|0|||
161323098|NCT02029274|582568700|FG002|Overall Study|Adverse Event|2|||
161323099|NCT02029274|582568701|FG003|Overall Study|Adverse Event|2|||
161323100|NCT00802672|582569921|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
161323101|NCT00802672|582569922|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
161323102|NCT00802672|582569923|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
161323103|NCT00802672|582569921|FG000|Overall Study|Adverse Event|1|||
161323104|NCT00802672|582569922|FG001|Overall Study|Adverse Event|1|||
161323105|NCT00802672|582569923|FG002|Overall Study|Adverse Event|1|||
161323106|NCT00802672|582569921|FG000|Overall Study|Protocol Violation|2|||
161323107|NCT00802672|582569922|FG001|Overall Study|Protocol Violation|1|||
161323108|NCT00802672|582569923|FG002|Overall Study|Protocol Violation|1|||
161323109|NCT00802672|582569921|FG000|Overall Study|Lost to Follow-up|5|||
161097768|NCT00504881|581748755|FG001|Overall Study|AE, serious fatal|1|||
161097769|NCT00504881|581748754|FG000|Overall Study|SAE, non-fatal|2|||
161097770|NCT00504881|581748755|FG001|Overall Study|SAE, non-fatal|6|||
161323110|NCT00802672|582569922|FG001|Overall Study|Lost to Follow-up|5|||
161323111|NCT00802672|582569923|FG002|Overall Study|Lost to Follow-up|3|||
161323112|NCT00802672|582569921|FG000|Overall Study|Withdrawal by Subject|1|||
161323113|NCT00802672|582569922|FG001|Overall Study|Withdrawal by Subject|1|||
161323114|NCT00802672|582569923|FG002|Overall Study|Withdrawal by Subject|2|||
161323115|NCT00802672|582569921|FG000|Overall Study|other|3|||
161323116|NCT00802672|582569922|FG001|Overall Study|other|1|||
161323117|NCT00802672|582569923|FG002|Overall Study|other|2|||
161323118|NCT00305227|582569932|FG000|Overall Study|Lost to Follow-up|7|||
161323119|NCT00305227|582569933|FG001|Overall Study|Lost to Follow-up|6|||
161323120|NCT05133323|582569934|FG000|Overall Study|Lack of Efficacy|0|||
161323121|NCT05133323|582569935|FG001|Overall Study|Lack of Efficacy|0|||
161323122|NCT05133323|582569936|FG002|Overall Study|Lack of Efficacy|1|||
161323123|NCT05133323|582569934|FG000|Overall Study|Withdrawal by Subject|2|||
161323124|NCT05133323|582569935|FG001|Overall Study|Withdrawal by Subject|1|||
161323125|NCT05133323|582569936|FG002|Overall Study|Withdrawal by Subject|0|||
161323126|NCT04152083|582569948|FG000|Overall Study|Lost to Follow-up|2|||
161323127|NCT04152083|582569949|FG001|Overall Study|Lost to Follow-up|1|||
161323128|NCT04152083|582569948|FG000|Overall Study|Adverse Event|1|||
161323129|NCT04152083|582569949|FG001|Overall Study|Adverse Event|0|||
161323130|NCT04152083|582569948|FG000|Overall Study|Randomized but not treated|3|||
161323131|NCT04152083|582569949|FG001|Overall Study|Randomized but not treated|2|||
161323132|NCT01042392|582569950|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
161323133|NCT01042392|582569951|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
161323134|NCT01042392|582569952|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
161323135|NCT01042392|582569953|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
161323136|NCT01042392|582569950|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
161323137|NCT01042392|582569951|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161323138|NCT01042392|582569952|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161323139|NCT01042392|582569953|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
161323140|NCT01042392|582569950|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
161211974|NCT03125915|582158504|FG000|1 Month Follow up|Lost to Follow-up|3|||
161211975|NCT03125915|582158505|FG001|1 Month Follow up|Lost to Follow-up|3|||
161211976|NCT03125915|582158506|FG002|1 Month Follow up|Lost to Follow-up|2|||
161211977|NCT03125915|582158507|FG003|1 Month Follow up|Lost to Follow-up|3|||
161211978|NCT03125915|582158504|FG000|3 Month Follow-up|Lost to Follow-up|6|||
161211979|NCT03125915|582158505|FG001|3 Month Follow-up|Lost to Follow-up|4|||
161211980|NCT03125915|582158506|FG002|3 Month Follow-up|Lost to Follow-up|4|||
161211981|NCT03125915|582158507|FG003|3 Month Follow-up|Lost to Follow-up|2|||
161211982|NCT03125915|582158504|FG000|6 Month Follow-up|Lost to Follow-up|7|||
161211983|NCT03125915|582158505|FG001|6 Month Follow-up|Lost to Follow-up|3|||
161211984|NCT03125915|582158506|FG002|6 Month Follow-up|Lost to Follow-up|6|||
161211985|NCT03125915|582158507|FG003|6 Month Follow-up|Lost to Follow-up|3|||
161211986|NCT00295620|582158510|FG000|Overall Study|Lost to Follow-up|9|||
161211987|NCT00295620|582158511|FG001|Overall Study|Lost to Follow-up|5|||
161211988|NCT00295620|582158510|FG000|Overall Study|Withdrawal by Subject|37|||
161211989|NCT00295620|582158511|FG001|Overall Study|Withdrawal by Subject|50|||
161211990|NCT00295620|582158510|FG000|Overall Study|Death|206|||
161211991|NCT00295620|582158511|FG001|Overall Study|Death|207|||
161211992|NCT00295620|582158510|FG000|Overall Study|Other reasons|10|||
161211993|NCT00295620|582158511|FG001|Overall Study|Other reasons|9|||
161211994|NCT00295620|582158510|FG000|Overall Study|Discontinuation by sponsor|580|||
161211995|NCT00295620|582158511|FG001|Overall Study|Discontinuation by sponsor|593|||
161211996|NCT00295620|582158510|FG000|Overall Study|Protocol Violation|30|||
161211997|NCT00295620|582158511|FG001|Overall Study|Protocol Violation|32|||
161211998|NCT01309828|582158512|FG000|Overall Study|Adverse Event|10|||
161211999|NCT01309828|582158513|FG001|Overall Study|Adverse Event|11|||
161212000|NCT01309828|582158512|FG000|Overall Study|Voluntary Withdrawal|5|||
161212001|NCT01309828|582158513|FG001|Overall Study|Voluntary Withdrawal|4|||
161212002|NCT01309828|582158512|FG000|Overall Study|Major Protocol Deviation|0|||
161212003|NCT01309828|582158513|FG001|Overall Study|Major Protocol Deviation|1|||
161212004|NCT01309828|582158512|FG000|Overall Study|Other|1|||
161212005|NCT01309828|582158513|FG001|Overall Study|Other|0|||
161212006|NCT00217971|582158514|FG000|Overall Study|Adverse Event|1|||
161212007|NCT00217971|582158515|FG001|Overall Study|Adverse Event|1|||
161212008|NCT00217971|582158514|FG000|Overall Study|Lost to Follow-up|15|||
161212009|NCT00217971|582158515|FG001|Overall Study|Lost to Follow-up|19|||
161212010|NCT00217971|582158514|FG000|Overall Study|Physician Decision|0|||
161212011|NCT00217971|582158515|FG001|Overall Study|Physician Decision|1|||
161212012|NCT00217971|582158514|FG000|Overall Study|Withdrawal by Subject|7|||
161212013|NCT00217971|582158515|FG001|Overall Study|Withdrawal by Subject|12|||
161212014|NCT00217971|582158514|FG000|Overall Study|non compliant|1|||
161212015|NCT00217971|582158515|FG001|Overall Study|non compliant|0|||
161212016|NCT02556632|582158516|FG000|Overall Study|Lost to Follow-up|1|||
161212017|NCT02556632|582158517|FG001|Overall Study|Lost to Follow-up|0|||
161212018|NCT02556632|582158518|FG002|Overall Study|Lost to Follow-up|0|||
161323141|NCT01042392|582569951|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
161323142|NCT01042392|582569952|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
161212019|NCT02556632|582158516|FG000|Overall Study|Disliked Intervention|1|||
161212020|NCT02556632|582158517|FG001|Overall Study|Disliked Intervention|1|||
161212021|NCT02556632|582158518|FG002|Overall Study|Disliked Intervention|1|||
161212022|NCT02556632|582158516|FG000|Overall Study|No Reason|1|||
161212023|NCT02556632|582158517|FG001|Overall Study|No Reason|0|||
161212024|NCT02556632|582158518|FG002|Overall Study|No Reason|1|||
161212025|NCT02556632|582158516|FG000|Overall Study|Personal Issues|0|||
161212026|NCT02556632|582158517|FG001|Overall Study|Personal Issues|1|||
161212027|NCT02556632|582158518|FG002|Overall Study|Personal Issues|1|||
161212028|NCT02556632|582158516|FG000|Overall Study|Changed Mind|0|||
161212029|NCT02556632|582158517|FG001|Overall Study|Changed Mind|1|||
161212030|NCT02556632|582158518|FG002|Overall Study|Changed Mind|0|||
161323143|NCT01042392|582569953|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
161323144|NCT01042392|582569950|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161323145|NCT01042392|582569951|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161323146|NCT01042392|582569952|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
161323147|NCT01042392|582569953|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
161323148|NCT01042392|582569950|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
161323149|NCT01042392|582569951|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161323150|NCT01042392|582569952|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161323151|NCT01042392|582569953|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
161323152|NCT01042392|582569950|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161323153|NCT01042392|582569951|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161323154|NCT01042392|582569952|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
161323155|NCT01042392|582569953|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
161323156|NCT01042392|582569950|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
161323157|NCT01042392|582569951|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161323158|NCT01042392|582569952|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161323159|NCT01042392|582569953|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
161323160|NCT01042392|582569950|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161323161|NCT01042392|582569951|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161323162|NCT01042392|582569952|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
161323163|NCT01042392|582569953|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
161323164|NCT01042392|582569950|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
161323165|NCT01042392|582569951|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161323166|NCT01042392|582569952|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161323167|NCT01042392|582569953|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
161323168|NCT03318003|582569954|FG000|Overall Study|Withdrawal by Subject|1|||
161323169|NCT03318003|582569955|FG001|Overall Study|Withdrawal by Subject|1|||
161323170|NCT03318003|582569954|FG000|Overall Study|fetal loss|0|||
161323171|NCT03318003|582569955|FG001|Overall Study|fetal loss|1|||
161323172|NCT00614874|582569959|FG000|Overall Study|Protocol Violation|1|||
161323173|NCT00614874|582569959|FG000|Overall Study|Withdrawal by Subject|1|||
161323174|NCT00807612|582569961|FG000|Overall Study|Death|8|||
161323175|NCT00807612|582569961|FG000|Overall Study|Study early termination|5|||
161323176|NCT00807612|582569961|FG000|Overall Study|Withdrawal by Subject|1|||
161323177|NCT02768792|582569962|FG000|Overall Study|Adverse Event|1|||
161323178|NCT04607135|582569964|FG000|Overall Study|Physician Decision|1|||
161323179|NCT04607135|582569964|FG000|Overall Study|Withdrawal by Subject|1|||
161323180|NCT04607135|582569964|FG000|Overall Study|Equipment not working|3|||
161323181|NCT03465709|582569965|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
161323182|NCT03465709|582569965|FG000|Overall Study|Withdrawal by Subject|3|||
161323183|NCT05359952|582569966|FG000|Overall Study|Lost to Follow-up|1|||
161323184|NCT05359952|582569967|FG001|Overall Study|Lost to Follow-up|0|||
161323185|NCT00705341|582569968|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
161323186|NCT00705341|582569969|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
161323187|NCT00705341|582569970|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
161323188|NCT00705341|582569971|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
161323189|NCT00705341|582569968|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161323190|NCT00705341|582569969|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161323191|NCT00705341|582569970|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
161323192|NCT00705341|582569971|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
161323193|NCT03173456|582569974|FG000|Baseline|Medication dispensing system malfunction'|0|||
161323194|NCT03173456|582569975|FG001|Baseline|Medication dispensing system malfunction'|1|||
161323195|NCT03173456|582569976|FG002|Baseline|Medication dispensing system malfunction'|0|||
161323196|NCT03173456|582569977|FG003|Baseline|Medication dispensing system malfunction'|0|||
161323197|NCT03173456|582569978|FG004|Baseline|Medication dispensing system malfunction'|2|||
161323198|NCT03173456|582569974|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
161323199|NCT03173456|582569975|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
161323200|NCT03173456|582569976|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
161323201|NCT03173456|582569977|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
161323202|NCT03173456|582569978|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
161323203|NCT01733121|582569979|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
161323204|NCT01733121|582569980|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
161323205|NCT01733121|582569979|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
161323206|NCT01733121|582569980|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
161323207|NCT01733121|582569979|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
161323208|NCT01733121|582569980|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
161323209|NCT01733121|582569979|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161323210|NCT01733121|582569980|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
161323211|NCT01737879|582569983|FG000|Overall Study|Death|1|||
161323212|NCT01737879|582569983|FG000|Overall Study|Sponsor decision|40|||
161323213|NCT04978337|582569986|FG000|Overall Study|Withdrawal by Subject|0|||
161323214|NCT04978337|582569987|FG001|Overall Study|Withdrawal by Subject|1|||
161323215|NCT01436227|582569991|FG000|Overall Study|Adverse Event|7|||
161323216|NCT01436227|582569991|FG000|Overall Study|Death|1|||
161323217|NCT01436227|582569991|FG000|Overall Study|Lack of Efficacy|1|||
161323218|NCT01436227|582569991|FG000|Overall Study|Lost to Follow-up|3|||
161323219|NCT01436227|582569991|FG000|Overall Study|Physician Decision|1|||
161323220|NCT01436227|582569991|FG000|Overall Study|Withdrawal by Subject|7|||
161323221|NCT01436227|582569991|FG000|Overall Study|Disease progression, relapse|6|||
161323222|NCT04865419|582569994|FG000|Overall Study|Other|1|||
161323223|NCT04865419|582569995|FG001|Overall Study|Other|2|||
161323224|NCT04865419|582569996|FG002|Overall Study|Other|2|||
161323225|NCT04865419|582569997|FG003|Overall Study|Other|1|||
161323226|NCT04865419|582569998|FG004|Overall Study|Other|3|||
161323227|NCT04865419|582569999|FG005|Overall Study|Other|0|||
161323228|NCT04865419|582570000|FG006|Overall Study|Other|0|||
161323229|NCT04865419|582570001|FG007|Overall Study|Other|1|||
161323230|NCT04865419|582570002|FG008|Overall Study|Other|0|||
161323231|NCT04865419|582570003|FG009|Overall Study|Other|0|||
161323232|NCT04865419|582570004|FG010|Overall Study|Other|0|||
161323233|NCT04865419|582569994|FG000|Overall Study|Withdrawal by Subject|0|||
161323234|NCT04865419|582569995|FG001|Overall Study|Withdrawal by Subject|1|||
161323235|NCT04865419|582569996|FG002|Overall Study|Withdrawal by Subject|1|||
161323236|NCT04865419|582569997|FG003|Overall Study|Withdrawal by Subject|0|||
161323237|NCT04865419|582569998|FG004|Overall Study|Withdrawal by Subject|0|||
161323238|NCT04865419|582569999|FG005|Overall Study|Withdrawal by Subject|0|||
161323239|NCT04865419|582570000|FG006|Overall Study|Withdrawal by Subject|0|||
161323240|NCT04865419|582570001|FG007|Overall Study|Withdrawal by Subject|1|||
161323241|NCT04865419|582570002|FG008|Overall Study|Withdrawal by Subject|2|||
161323242|NCT04865419|582570003|FG009|Overall Study|Withdrawal by Subject|1|||
161323243|NCT04865419|582570004|FG010|Overall Study|Withdrawal by Subject|0|||
161323244|NCT04865419|582569994|FG000|Overall Study|Study terminated by Sponsor|0|||
161323245|NCT04865419|582569995|FG001|Overall Study|Study terminated by Sponsor|0|||
161323246|NCT04865419|582569996|FG002|Overall Study|Study terminated by Sponsor|0|||
161323247|NCT04865419|582569997|FG003|Overall Study|Study terminated by Sponsor|2|||
161323248|NCT04865419|582569998|FG004|Overall Study|Study terminated by Sponsor|2|||
161323249|NCT04865419|582569999|FG005|Overall Study|Study terminated by Sponsor|0|||
161323250|NCT04865419|582570000|FG006|Overall Study|Study terminated by Sponsor|0|||
161323251|NCT04865419|582570001|FG007|Overall Study|Study terminated by Sponsor|0|||
161323252|NCT04865419|582570002|FG008|Overall Study|Study terminated by Sponsor|0|||
161323253|NCT04865419|582570003|FG009|Overall Study|Study terminated by Sponsor|0|||
161323254|NCT04865419|582570004|FG010|Overall Study|Study terminated by Sponsor|1|||
161323255|NCT04865419|582569994|FG000|Overall Study|Death|3|||
161323256|NCT04865419|582569995|FG001|Overall Study|Death|1|||
161323257|NCT04865419|582569996|FG002|Overall Study|Death|4|||
161323258|NCT04865419|582569997|FG003|Overall Study|Death|2|||
161323259|NCT04865419|582569998|FG004|Overall Study|Death|5|||
161323260|NCT04865419|582569999|FG005|Overall Study|Death|2|||
161323261|NCT04865419|582570000|FG006|Overall Study|Death|1|||
161323262|NCT04865419|582570001|FG007|Overall Study|Death|1|||
161323263|NCT04865419|582570002|FG008|Overall Study|Death|2|||
161323264|NCT04865419|582570003|FG009|Overall Study|Death|2|||
161323265|NCT04865419|582570004|FG010|Overall Study|Death|1|||
161323266|NCT04865419|582569994|FG000|Overall Study|Lost to Follow-up|0|||
161323267|NCT04865419|582569995|FG001|Overall Study|Lost to Follow-up|0|||
161323268|NCT04865419|582569996|FG002|Overall Study|Lost to Follow-up|0|||
161323269|NCT04865419|582569997|FG003|Overall Study|Lost to Follow-up|0|||
161323270|NCT04865419|582569998|FG004|Overall Study|Lost to Follow-up|0|||
161323271|NCT04865419|582569999|FG005|Overall Study|Lost to Follow-up|0|||
161323272|NCT04865419|582570000|FG006|Overall Study|Lost to Follow-up|0|||
161323273|NCT04865419|582570001|FG007|Overall Study|Lost to Follow-up|0|||
161323274|NCT04865419|582570002|FG008|Overall Study|Lost to Follow-up|0|||
161323275|NCT04865419|582570003|FG009|Overall Study|Lost to Follow-up|1|||
161323276|NCT04865419|582570004|FG010|Overall Study|Lost to Follow-up|0|||
161323277|NCT05446142|582570005|FG000|Period 2|Adverse Event|1|||
161323278|NCT05446142|582570006|FG001|Period 2|Adverse Event|0|||
161323279|NCT05446142|582570007|FG002|Period 2|Adverse Event|0|||
161323280|NCT05446142|582570008|FG003|Period 2|Adverse Event|0|||
161323281|NCT05446142|582570009|FG004|Period 2|Adverse Event|0|||
161323282|NCT05446142|582570010|FG005|Period 2|Adverse Event|0|||
161323283|NCT00547157|582570015|FG000|Overall Study|Other|1|||
161323284|NCT00547157|582570016|FG001|Overall Study|Other|0|||
161323285|NCT00547157|582570015|FG000|Overall Study|Death|38|||
161323286|NCT00547157|582570016|FG001|Overall Study|Death|18|||
161323287|NCT00547157|582570015|FG000|Overall Study|Withdrawal by Subject|3|||
161323288|NCT00547157|582570016|FG001|Overall Study|Withdrawal by Subject|1|||
161323289|NCT00547157|582570015|FG000|Overall Study|Administrative decision|3|||
161323290|NCT00547157|582570016|FG001|Overall Study|Administrative decision|2|||
161323291|NCT00547157|582570015|FG000|Overall Study|Lost to Follow-up|4|||
161323292|NCT00547157|582570016|FG001|Overall Study|Lost to Follow-up|2|||
161323293|NCT03853291|582570017|FG000|Overall Study|Lost to Follow-up|1|||
161323294|NCT03853291|582570018|FG001|Overall Study|Lost to Follow-up|2|||
161323295|NCT03853291|582570019|FG002|Overall Study|Lost to Follow-up|0|||
161323296|NCT03853291|582570020|FG003|Overall Study|Lost to Follow-up|0|||
161323297|NCT03853291|582570021|FG004|Overall Study|Lost to Follow-up|0|||
161323298|NCT03853291|582570022|FG005|Overall Study|Lost to Follow-up|0|||
161323299|NCT03853291|582570017|FG000|Overall Study|Determined to be ineligible|1|||
161323300|NCT03853291|582570018|FG001|Overall Study|Determined to be ineligible|1|||
161323301|NCT03853291|582570019|FG002|Overall Study|Determined to be ineligible|0|||
161323302|NCT03853291|582570020|FG003|Overall Study|Determined to be ineligible|0|||
161323303|NCT03853291|582570021|FG004|Overall Study|Determined to be ineligible|0|||
161323304|NCT03853291|582570022|FG005|Overall Study|Determined to be ineligible|0|||
161323305|NCT01990768|582570023|FG000|Intervention Started|Found to be ineligible|14|||
161323306|NCT01990768|582570024|FG001|Intervention Started|Found to be ineligible|13|||
161323307|NCT01990768|582570025|FG002|Intervention Started|Found to be ineligible|11|||
161323308|NCT01990768|582570023|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
161323309|NCT01990768|582570024|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
161323310|NCT01990768|582570025|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
161323311|NCT01990768|582570023|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
161323312|NCT01990768|582570024|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
161323313|NCT01990768|582570025|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
161323314|NCT01990768|582570023|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
161323315|NCT01990768|582570024|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
161323316|NCT01990768|582570025|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
161323317|NCT01990768|582570023|FG000|Intervention Started|Patient care priority|1|||
161323318|NCT01990768|582570024|FG001|Intervention Started|Patient care priority|2|||
161323319|NCT01990768|582570025|FG002|Intervention Started|Patient care priority|3|||
161323320|NCT01990768|582570023|FG000|Intervention Started|IV lost|2|||
161323321|NCT01990768|582570024|FG001|Intervention Started|IV lost|2|||
161323322|NCT01990768|582570025|FG002|Intervention Started|IV lost|2|||
161323323|NCT01990768|582570023|FG000|Intervention Started|Required CPR|1|||
161323324|NCT01990768|582570024|FG001|Intervention Started|Required CPR|1|||
161323325|NCT01990768|582570025|FG002|Intervention Started|Required CPR|0|||
161323326|NCT01990768|582570023|FG000|Intervention Started|Seizure or hx of seizure|0|||
161323327|NCT01990768|582570024|FG001|Intervention Started|Seizure or hx of seizure|0|||
161323328|NCT01990768|582570025|FG002|Intervention Started|Seizure or hx of seizure|2|||
161323329|NCT01990768|582570023|FG000|Intervention Started|Discovered to be pregnant|0|||
161323330|NCT01990768|582570024|FG001|Intervention Started|Discovered to be pregnant|1|||
161323331|NCT01990768|582570025|FG002|Intervention Started|Discovered to be pregnant|0|||
161323332|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
161323333|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
161323334|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
161212031|NCT02556632|582158516|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
161323335|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
161323336|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
161323337|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
161323338|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
161323339|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
161323340|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
161323341|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
161323342|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
161323343|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
161323344|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Death|3|||
161323345|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Death|1|||
161323346|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Death|1|||
161323347|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Discharged|2|||
161323348|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Discharged|1|||
161323349|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Discharged|0|||
161323350|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
161323351|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
161323352|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
161323353|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
161323354|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
161323355|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
161323356|NCT01990768|582570023|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
161323357|NCT01990768|582570024|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
161323358|NCT01990768|582570025|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
161323359|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
161323360|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
161323361|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
161323362|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
161323363|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
161323364|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
161323365|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
161323366|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
161323367|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
161323368|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
161323369|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
161323370|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
161323371|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
161323372|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
161323373|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
161323374|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
161323375|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
161323376|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
161323377|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
161323378|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
161323379|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
161323380|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
161323381|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
161323382|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
161323383|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
161323384|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
161323385|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
161323386|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
161323387|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
161323388|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
161323389|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161323390|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161323391|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
161323392|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
161323393|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
161323394|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
161323395|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
161323396|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
161323397|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
161323398|NCT01990768|582570023|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
161323399|NCT01990768|582570024|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
161323400|NCT01990768|582570025|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
161323401|NCT01990768|582570023|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
161323402|NCT01990768|582570024|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
161323403|NCT01990768|582570025|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
161323404|NCT01990768|582570023|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
161323405|NCT01990768|582570024|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
161323406|NCT01990768|582570025|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
161323407|NCT01990768|582570023|FG000|6-Month Follow-up|No contact information|5|||
161323408|NCT01990768|582570024|FG001|6-Month Follow-up|No contact information|6|||
161323409|NCT01990768|582570025|FG002|6-Month Follow-up|No contact information|5|||
161323410|NCT01990768|582570023|FG000|6-Month Follow-up|Homeless|4|||
161323411|NCT01990768|582570024|FG001|6-Month Follow-up|Homeless|3|||
161323412|NCT01990768|582570025|FG002|6-Month Follow-up|Homeless|6|||
161323413|NCT01990768|582570023|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
161323414|NCT01990768|582570024|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
161323415|NCT01990768|582570025|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
161323416|NCT01990768|582570023|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
161323417|NCT01990768|582570024|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
161323418|NCT01990768|582570025|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
161323419|NCT01990768|582570023|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
161323420|NCT01990768|582570024|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
161323421|NCT01990768|582570025|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
161323422|NCT02348008|582570026|FG000|Overall Study|Adverse Event|2|||
161323423|NCT02348008|582570027|FG001|Overall Study|Adverse Event|3|||
161323424|NCT02348008|582570028|FG002|Overall Study|Adverse Event|3|||
161323425|NCT02348008|582570026|FG000|Overall Study|Disease Progression|1|||
161323426|NCT02348008|582570027|FG001|Overall Study|Disease Progression|5|||
161323427|NCT02348008|582570028|FG002|Overall Study|Disease Progression|16|||
161323428|NCT02348008|582570026|FG000|Overall Study|Withdrawal by Subject|0|||
160865659|NCT00734539|580902945|FG001|Main Study|Death|32|||
161323429|NCT02348008|582570027|FG001|Overall Study|Withdrawal by Subject|1|||
161323430|NCT02348008|582570028|FG002|Overall Study|Withdrawal by Subject|0|||
161323431|NCT02348008|582570026|FG000|Overall Study|Symptomatic Deterioration|0|||
161323432|NCT02348008|582570027|FG001|Overall Study|Symptomatic Deterioration|1|||
161323433|NCT02348008|582570028|FG002|Overall Study|Symptomatic Deterioration|0|||
161323434|NCT00845676|582570032|FG000|Overall Study|Virologic breakthrough at week 20|1|||
161323435|NCT00845676|582570032|FG000|Overall Study|Adverse Event|1|||
161323436|NCT02756364|582570033|FG000|Overall Study|Site Terminated by Sponsor|24|||
161323437|NCT02756364|582570034|FG001|Overall Study|Site Terminated by Sponsor|30|||
161323438|NCT02756364|582570035|FG002|Overall Study|Site Terminated by Sponsor|21|||
161323439|NCT02756364|582570033|FG000|Overall Study|Death|20|||
161323440|NCT02756364|582570034|FG001|Overall Study|Death|15|||
161323441|NCT02756364|582570035|FG002|Overall Study|Death|18|||
161323442|NCT02756364|582570033|FG000|Overall Study|Withdrawal by Patient|2|||
161323443|NCT02756364|582570034|FG001|Overall Study|Withdrawal by Patient|1|||
161323444|NCT02756364|582570035|FG002|Overall Study|Withdrawal by Patient|8|||
161323445|NCT02756364|582570033|FG000|Overall Study|Lost to Follow-up|0|||
161323446|NCT02756364|582570034|FG001|Overall Study|Lost to Follow-up|1|||
161323447|NCT02756364|582570035|FG002|Overall Study|Lost to Follow-up|1|||
161323448|NCT02223364|582570036|FG000|Overall Study|Protocol Violation|3|||
161323449|NCT02223364|582570037|FG001|Overall Study|Protocol Violation|0|||
161323450|NCT02223364|582570038|FG002|Overall Study|Protocol Violation|3|||
161323451|NCT02223364|582570036|FG000|Overall Study|subject expired before surgery|1|||
161323452|NCT02223364|582570037|FG001|Overall Study|subject expired before surgery|0|||
161323453|NCT02223364|582570038|FG002|Overall Study|subject expired before surgery|0|||
161323454|NCT02223364|582570036|FG000|Overall Study|Physician Decision|1|||
161323455|NCT02223364|582570037|FG001|Overall Study|Physician Decision|0|||
161323456|NCT02223364|582570038|FG002|Overall Study|Physician Decision|0|||
161323457|NCT02984267|582570039|FG000|Overall Study|Protocol Violation|1|||
161323458|NCT02984267|582570040|FG001|Overall Study|Protocol Violation|0|||
161323459|NCT02984267|582570039|FG000|Overall Study|Withdrawal by Subject|0|||
161323460|NCT02984267|582570040|FG001|Overall Study|Withdrawal by Subject|1|||
161323461|NCT02685072|582570041|FG000|Treatment Period|Lost to Follow-up|12|||
161323462|NCT02685072|582570042|FG001|Treatment Period|Lost to Follow-up|6|||
161323463|NCT02685072|582570041|FG000|Treatment Period|Withdrawal by Subject|1|||
161323464|NCT02685072|582570042|FG001|Treatment Period|Withdrawal by Subject|3|||
161323465|NCT02685072|582570041|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
161323466|NCT02685072|582570042|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
161323467|NCT01994902|582570043|FG000|Test Period 1|Withdrawal by Subject|3|||
161323468|NCT01994902|582570044|FG001|Test Period 1|Withdrawal by Subject|0|||
161323469|NCT01994902|582570043|FG000|Test Period 1|device deficiency with adverse event|0|||
161323470|NCT01994902|582570044|FG001|Test Period 1|device deficiency with adverse event|1|||
161323471|NCT01994902|582570043|FG000|Test Period 1|Adverse Event|2|||
161323472|NCT01994902|582570044|FG001|Test Period 1|Adverse Event|1|||
161323473|NCT01994902|582570043|FG000|Test Period 1|Lack of Efficacy|0|||
161323474|NCT01994902|582570044|FG001|Test Period 1|Lack of Efficacy|1|||
161323475|NCT01994902|582570043|FG000|Test Period 1|bag too small|1|||
161323476|NCT01994902|582570044|FG001|Test Period 1|bag too small|0|||
161323477|NCT01994902|582570043|FG000|Test Period 2|Withdrawal by Subject|0|||
161323478|NCT01994902|582570044|FG001|Test Period 2|Withdrawal by Subject|2|||
161323479|NCT01994902|582570043|FG000|Test Period 2|Lack of Efficacy|0|||
161323480|NCT01994902|582570044|FG001|Test Period 2|Lack of Efficacy|1|||
161323481|NCT01994902|582570043|FG000|Test Period 2|Other|0|||
161323482|NCT01994902|582570044|FG001|Test Period 2|Other|3|||
161323483|NCT03597139|582570046|FG000|Overall Study|Adverse Event|3|||
161323484|NCT03597139|582570047|FG001|Overall Study|Adverse Event|0|||
161323485|NCT03597139|582570046|FG000|Overall Study|Protocol Non-compliance|1|||
161323486|NCT03597139|582570047|FG001|Overall Study|Protocol Non-compliance|0|||
161323487|NCT00248833|582570050|FG000|Overall Study|Adverse Event|2|||
161323488|NCT00248833|582570051|FG001|Overall Study|Adverse Event|0|||
161323489|NCT00248833|582570052|FG002|Overall Study|Adverse Event|0|||
161323490|NCT00248833|582570050|FG000|Overall Study|Withdrawal by Subject|0|||
161323491|NCT00248833|582570051|FG001|Overall Study|Withdrawal by Subject|1|||
161323492|NCT00248833|582570052|FG002|Overall Study|Withdrawal by Subject|1|||
161323493|NCT00248833|582570050|FG000|Overall Study|Lost to Follow-up|1|||
161323494|NCT00248833|582570051|FG001|Overall Study|Lost to Follow-up|1|||
161323495|NCT00248833|582570052|FG002|Overall Study|Lost to Follow-up|1|||
161323496|NCT00248833|582570050|FG000|Overall Study|Other|0|||
161323497|NCT00248833|582570051|FG001|Overall Study|Other|1|||
161323498|NCT00248833|582570052|FG002|Overall Study|Other|0|||
161323499|NCT02427802|582570053|FG000|Overall Study|Adverse Event|11|||
161323500|NCT02427802|582570054|FG001|Overall Study|Adverse Event|3|||
161323501|NCT02427802|582570055|FG002|Overall Study|Adverse Event|7|||
161323502|NCT02427802|582570053|FG000|Overall Study|Death|0|||
161323503|NCT02427802|582570054|FG001|Overall Study|Death|4|||
161323504|NCT02427802|582570055|FG002|Overall Study|Death|1|||
161323505|NCT02427802|582570053|FG000|Overall Study|Lost to Follow-up|13|||
161323506|NCT02427802|582570054|FG001|Overall Study|Lost to Follow-up|8|||
161323507|NCT02427802|582570055|FG002|Overall Study|Lost to Follow-up|8|||
161323508|NCT02427802|582570053|FG000|Overall Study|Physician Decision|4|||
161323509|NCT02427802|582570054|FG001|Overall Study|Physician Decision|2|||
161323510|NCT02427802|582570055|FG002|Overall Study|Physician Decision|4|||
161323511|NCT02427802|582570053|FG000|Overall Study|Withdrawal by Subject|10|||
161323512|NCT02427802|582570054|FG001|Overall Study|Withdrawal by Subject|5|||
161323513|NCT02427802|582570055|FG002|Overall Study|Withdrawal by Subject|11|||
161323514|NCT02427802|582570053|FG000|Overall Study|Protocol Violation|3|||
161323515|NCT02427802|582570054|FG001|Overall Study|Protocol Violation|1|||
161323516|NCT02427802|582570055|FG002|Overall Study|Protocol Violation|1|||
161323517|NCT02427802|582570053|FG000|Overall Study|protocol specific treatment unrelated|18|||
161323518|NCT02427802|582570054|FG001|Overall Study|protocol specific treatment unrelated|11|||
161323519|NCT02427802|582570055|FG002|Overall Study|protocol specific treatment unrelated|11|||
161323520|NCT02226120|582570056|FG000|Overall Study|Adverse Event|60|||
161323521|NCT02226120|582570056|FG000|Overall Study|Death|172|||
161323522|NCT02226120|582570056|FG000|Overall Study|Study terminated by sponsor|1|||
161323523|NCT02226120|582570056|FG000|Overall Study|Technical problems|4|||
161323524|NCT02226120|582570056|FG000|Overall Study|Lost to Follow-up|13|||
161323525|NCT02226120|582570056|FG000|Overall Study|Physician Decision|21|||
161323526|NCT02226120|582570056|FG000|Overall Study|Withdrawal by parent/guardian|36|||
161323527|NCT02226120|582570056|FG000|Overall Study|Non-compliance with study drug|10|||
161323528|NCT02226120|582570056|FG000|Overall Study|Protocol deviation|1|||
161323529|NCT02226120|582570056|FG000|Overall Study|missing treatment disposition pages|2|||
161323530|NCT00467558|582570058|FG000|Overall Study|Lost to Follow-up|2|||
161323531|NCT00467558|582570059|FG001|Overall Study|Lost to Follow-up|0|||
161323532|NCT02636439|582570060|FG000|Overall Study|Adverse Event|2|||
161323533|NCT02636439|582570061|FG001|Overall Study|Adverse Event|2|||
161323534|NCT02636439|582570060|FG000|Overall Study|Lost to Follow-up|1|||
161323535|NCT02636439|582570061|FG001|Overall Study|Lost to Follow-up|0|||
161323536|NCT02636439|582570060|FG000|Overall Study|Non-compliance|1|||
161323537|NCT02636439|582570061|FG001|Overall Study|Non-compliance|1|||
161323538|NCT02636439|582570060|FG000|Overall Study|Personal reasons|2|||
161323539|NCT02636439|582570061|FG001|Overall Study|Personal reasons|0|||
161323540|NCT02494401|582570063|FG000|Overall Study|Lost to Follow-up|22|||
161323541|NCT02494401|582570064|FG001|Overall Study|Lost to Follow-up|25|||
161323542|NCT02494401|582570063|FG000|Overall Study|Withdrawal by Subject|3|||
161323543|NCT02494401|582570064|FG001|Overall Study|Withdrawal by Subject|2|||
161323544|NCT05188729|582570065|FG000|Overall Study|Withdrawal by Subject|0|||
161323545|NCT05188729|582570066|FG001|Overall Study|Withdrawal by Subject|0|||
161323546|NCT05188729|582570067|FG002|Overall Study|Withdrawal by Subject|0|||
161323547|NCT05188729|582570068|FG003|Overall Study|Withdrawal by Subject|0|||
161323548|NCT05188729|582570069|FG004|Overall Study|Withdrawal by Subject|0|||
161323549|NCT05188729|582570070|FG005|Overall Study|Withdrawal by Subject|0|||
161323550|NCT05188729|582570071|FG006|Overall Study|Withdrawal by Subject|0|||
161323551|NCT05188729|582570072|FG007|Overall Study|Withdrawal by Subject|0|||
161323552|NCT05188729|582570073|FG008|Overall Study|Withdrawal by Subject|0|||
161323553|NCT05188729|582570074|FG009|Overall Study|Withdrawal by Subject|1|||
161323554|NCT05188729|582570075|FG010|Overall Study|Withdrawal by Subject|0|||
161323555|NCT05188729|582570076|FG011|Overall Study|Withdrawal by Subject|0|||
161323556|NCT05188729|582570077|FG012|Overall Study|Withdrawal by Subject|0|||
161323557|NCT05188729|582570065|FG000|Overall Study|Lost to Follow-up|0|||
161323558|NCT05188729|582570066|FG001|Overall Study|Lost to Follow-up|0|||
161323559|NCT05188729|582570067|FG002|Overall Study|Lost to Follow-up|0|||
161323560|NCT05188729|582570068|FG003|Overall Study|Lost to Follow-up|0|||
161323561|NCT05188729|582570069|FG004|Overall Study|Lost to Follow-up|0|||
161323562|NCT05188729|582570070|FG005|Overall Study|Lost to Follow-up|0|||
161323563|NCT05188729|582570071|FG006|Overall Study|Lost to Follow-up|0|||
161323564|NCT05188729|582570072|FG007|Overall Study|Lost to Follow-up|0|||
161323565|NCT05188729|582570073|FG008|Overall Study|Lost to Follow-up|0|||
161323566|NCT05188729|582570074|FG009|Overall Study|Lost to Follow-up|0|||
161323567|NCT05188729|582570075|FG010|Overall Study|Lost to Follow-up|1|||
161323568|NCT05188729|582570076|FG011|Overall Study|Lost to Follow-up|1|||
161323569|NCT05188729|582570077|FG012|Overall Study|Lost to Follow-up|0|||
161323570|NCT01073163|582571830|FG000|Overall Study|Adverse Event|1|||
161323571|NCT01073163|582571830|FG000|Overall Study|Disease Progression|1|||
161323572|NCT01073163|582571830|FG000|Overall Study|Early termination|1|||
161323573|NCT00703677|582571831|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
161323574|NCT03859648|582571834|FG000|Overall Study|Lost to Follow-up|1|||
161323575|NCT03859648|582571834|FG000|Overall Study|Adverse Event|1|||
161323576|NCT02748057|582571837|FG000|Overall Study|Adverse Event|1|||
161323577|NCT02748057|582571838|FG001|Overall Study|Adverse Event|0|||
161323578|NCT02748057|582571837|FG000|Overall Study|Physician Decision|0|||
161323579|NCT02748057|582571838|FG001|Overall Study|Physician Decision|1|||
161323580|NCT02748057|582571837|FG000|Overall Study|Protocol Violation|2|||
161323581|NCT02748057|582571838|FG001|Overall Study|Protocol Violation|1|||
161323582|NCT02748057|582571837|FG000|Overall Study|Participant Moved|1|||
161323583|NCT02748057|582571838|FG001|Overall Study|Participant Moved|0|||
161323584|NCT02748057|582571837|FG000|Overall Study|Withdrawal by Subject|1|||
161323585|NCT02748057|582571838|FG001|Overall Study|Withdrawal by Subject|0|||
161323586|NCT01990573|582571842|FG000|Overall Study|Physician Decision|0|||
161323587|NCT01990573|582571843|FG001|Overall Study|Physician Decision|0|||
161323588|NCT01990573|582571844|FG002|Overall Study|Physician Decision|1|||
161323589|NCT02793947|582571853|FG000|Overall Study|Death|1|||
161323590|NCT02793947|582571854|FG001|Overall Study|Death|0|||
161323591|NCT02793947|582571853|FG000|Overall Study|Physician Decision|1|||
161323592|NCT02793947|582571854|FG001|Overall Study|Physician Decision|5|||
161323593|NCT01025284|582571858|FG000|Overall Study|Investigator Decision|0|||
161323594|NCT01025284|582571859|FG001|Overall Study|Investigator Decision|1|||
161323595|NCT01025284|582571860|FG002|Overall Study|Investigator Decision|0|||
161323596|NCT01025284|582571858|FG000|Overall Study|Withdrawal by Subject|0|||
161323597|NCT01025284|582571859|FG001|Overall Study|Withdrawal by Subject|1|||
161323598|NCT01025284|582571860|FG002|Overall Study|Withdrawal by Subject|0|||
161323599|NCT02542397|582571861|FG000|Overall Study|Death|2|||
161323600|NCT02542397|582571861|FG000|Overall Study|Physician Decision|6|||
161323601|NCT02542397|582571861|FG000|Overall Study|Withdrawal by Subject|6|||
161323602|NCT02542397|582571861|FG000|Overall Study|Lost to Follow-up|2|||
161323603|NCT00547248|582571866|FG000|Overall Study|Protocol Violation|0|||
161323604|NCT00547248|582571867|FG001|Overall Study|Protocol Violation|0|||
161323605|NCT00547248|582571868|FG002|Overall Study|Protocol Violation|1|||
161323606|NCT00547248|582571869|FG003|Overall Study|Protocol Violation|1|||
161323607|NCT00547248|582571866|FG000|Overall Study|Migrated/moved from study area|0|||
161323608|NCT00547248|582571867|FG001|Overall Study|Migrated/moved from study area|0|||
161323609|NCT00547248|582571868|FG002|Overall Study|Migrated/moved from study area|2|||
161323610|NCT00547248|582571869|FG003|Overall Study|Migrated/moved from study area|0|||
161323611|NCT00547248|582571866|FG000|Overall Study|Withdrawal by Subject|0|||
161323612|NCT00547248|582571867|FG001|Overall Study|Withdrawal by Subject|0|||
161323613|NCT00547248|582571868|FG002|Overall Study|Withdrawal by Subject|7|||
161323614|NCT00547248|582571869|FG003|Overall Study|Withdrawal by Subject|1|||
161323615|NCT02090283|582571873|FG000|Overall Study|Withdrawal by Subject|6|||
161323616|NCT02090283|582571874|FG001|Overall Study|Withdrawal by Subject|6|||
161323617|NCT02090283|582571875|FG002|Overall Study|Withdrawal by Subject|6|||
161323618|NCT02090283|582571873|FG000|Overall Study|Sponsor Terminated Study|6|||
161323619|NCT02090283|582571874|FG001|Overall Study|Sponsor Terminated Study|6|||
161323620|NCT02090283|582571875|FG002|Overall Study|Sponsor Terminated Study|1|||
161323621|NCT02090283|582571873|FG000|Overall Study|Lost to Follow-up|2|||
161323622|NCT02090283|582571874|FG001|Overall Study|Lost to Follow-up|2|||
161323623|NCT02090283|582571875|FG002|Overall Study|Lost to Follow-up|3|||
161323624|NCT02090283|582571873|FG000|Overall Study|Adverse Event|1|||
161323625|NCT02090283|582571874|FG001|Overall Study|Adverse Event|1|||
161323626|NCT02090283|582571875|FG002|Overall Study|Adverse Event|0|||
161323627|NCT02090283|582571873|FG000|Overall Study|Protocol Violation|2|||
161323628|NCT02090283|582571874|FG001|Overall Study|Protocol Violation|0|||
161323629|NCT02090283|582571875|FG002|Overall Study|Protocol Violation|0|||
161323630|NCT00697593|582571877|FG000|Overall Study|Adverse Event|3|||
161323631|NCT00697593|582571877|FG000|Overall Study|Protocol Violation|1|||
161323632|NCT00697593|582571877|FG000|Overall Study|Lack of Efficacy|3|||
161323633|NCT00697593|582571877|FG000|Overall Study|Suspension of the study by sponsor|12|||
161323634|NCT00632125|582571883|FG000|Overall Study|Death|82|||
161323635|NCT00632125|582571883|FG000|Overall Study|Withdrawal by Subject|44|||
161323636|NCT00632125|582571883|FG000|Overall Study|Adverse Event|36|||
161323637|NCT00632125|582571883|FG000|Overall Study|Renal transplantation|17|||
161323638|NCT00632125|582571883|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
161323639|NCT00632125|582571883|FG000|Overall Study|Non-compliance|8|||
161323640|NCT00632125|582571883|FG000|Overall Study|Development of uncontrolled hypertension|5|||
161323641|NCT00632125|582571883|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
161323642|NCT00577772|582571886|FG000|Overall Study|Lost to Follow-up|0|||
161323643|NCT00577772|582571887|FG001|Overall Study|Lost to Follow-up|1|||
161323644|NCT00540644|582571889|FG000|Overall Study|Adverse Event|3|||
161323645|NCT00540644|582571890|FG001|Overall Study|Adverse Event|1|||
161323646|NCT00540644|582571889|FG000|Overall Study|Disease Progression|3|||
161323647|NCT00540644|582571890|FG001|Overall Study|Disease Progression|1|||
161323648|NCT00540644|582571889|FG000|Overall Study|Physician Decision|0|||
161323649|NCT00540644|582571890|FG001|Overall Study|Physician Decision|5|||
161323650|NCT00540644|582571889|FG000|Overall Study|Withdrawal by Subject|2|||
161323651|NCT00540644|582571890|FG001|Overall Study|Withdrawal by Subject|2|||
161323652|NCT00540644|582571889|FG000|Overall Study|Noncomplilance|1|||
161323653|NCT00540644|582571890|FG001|Overall Study|Noncomplilance|0|||
161323654|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
161323655|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
160861852|NCT02531802|580887848|FG003|Received Vaccination 2|Adverse Event|0|||
160861853|NCT02531802|580887849|FG004|Received Vaccination 2|Adverse Event|0|||
161323656|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
161323657|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
160861854|NCT02531802|580887850|FG005|Received Vaccination 2|Adverse Event|2|||
160861855|NCT02531802|580887851|FG006|Received Vaccination 2|Adverse Event|0|||
160861856|NCT02531802|580887852|FG007|Received Vaccination 2|Adverse Event|0|||
161323658|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
161323659|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
161323660|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
161323661|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
161323662|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
161323663|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
161323664|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
161323665|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
161323666|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
161323667|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
161323668|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Death|1|||
161323669|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Death|0|||
161323670|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
161323671|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
161323672|NCT00105989|582571891|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
161323673|NCT00105989|582571892|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
161323674|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
161323675|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
161323676|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
161323677|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
161323678|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
161323679|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
161323680|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
161323681|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
161323682|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
161323683|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
161323684|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
161323685|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
161323686|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
161323687|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
161323688|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Death|0|||
161323689|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Death|0|||
161323690|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
161323691|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
161323692|NCT00105989|582571891|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
161323693|NCT00105989|582571892|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
161323694|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
161323695|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
161323696|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
161323697|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
161323698|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
161323699|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
161323700|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
161323701|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
161323702|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
161323703|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
161323704|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
161323705|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
161323706|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
161323707|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
161323708|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
161323709|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
161323710|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
161323711|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
161323712|NCT00105989|582571891|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
161323713|NCT00105989|582571892|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
161323714|NCT01716663|582571893|FG000|Overall Study|Withdrawn prior to procedure|4|||
161323715|NCT01716663|582571893|FG000|Overall Study|Treated with non-study catheter|2|||
161323716|NCT01806168|582571896|FG000|Overall Study|Adverse Event|1|||
161323717|NCT01806168|582571897|FG001|Overall Study|Adverse Event|0|||
161323718|NCT01806168|582571898|FG002|Overall Study|Adverse Event|0|||
161323719|NCT01806168|582571896|FG000|Overall Study|Withdrawal by Subject|0|||
161323720|NCT01806168|582571897|FG001|Overall Study|Withdrawal by Subject|1|||
161323721|NCT01806168|582571898|FG002|Overall Study|Withdrawal by Subject|2|||
161323722|NCT01806168|582571896|FG000|Overall Study|Protocol Violation|0|||
161323723|NCT01806168|582571897|FG001|Overall Study|Protocol Violation|0|||
161097771|NCT00504881|581748754|FG000|Overall Study|AE, non-serious non-fatal|4|||
161097772|NCT00504881|581748755|FG001|Overall Study|AE, non-serious non-fatal|14|||
161097773|NCT00504881|581748754|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161097774|NCT00504881|581748755|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
161097775|NCT00504881|581748754|FG000|Overall Study|AE of unknown type|1|||
161097776|NCT00504881|581748755|FG001|Overall Study|AE of unknown type|0|||
161097777|NCT01777269|581748756|FG000|Overall Study|Adverse Event|24|||
161097778|NCT01777269|581748757|FG001|Overall Study|Adverse Event|33|||
161097779|NCT01777269|581748756|FG000|Overall Study|Lack of Efficacy|8|||
161097780|NCT01777269|581748757|FG001|Overall Study|Lack of Efficacy|10|||
161097781|NCT01777269|581748756|FG000|Overall Study|Protocol Violation|4|||
161097782|NCT01777269|581748757|FG001|Overall Study|Protocol Violation|4|||
161097783|NCT01777269|581748756|FG000|Overall Study|Participants reached stopping criteria|1|||
161097784|NCT01777269|581748757|FG001|Overall Study|Participants reached stopping criteria|1|||
161097785|NCT01777269|581748756|FG000|Overall Study|Lost to Follow-up|4|||
161097786|NCT01777269|581748757|FG001|Overall Study|Lost to Follow-up|0|||
161097787|NCT01777269|581748756|FG000|Overall Study|Physician Decision|5|||
161097788|NCT01777269|581748757|FG001|Overall Study|Physician Decision|2|||
161097789|NCT01777269|581748756|FG000|Overall Study|Withdrawal by Subject|9|||
161097790|NCT01777269|581748757|FG001|Overall Study|Withdrawal by Subject|9|||
161097791|NCT01030198|581748764|FG000|Overall Study|Could not measure efficacy accurately|0|||
161097792|NCT01030198|581748765|FG001|Overall Study|Could not measure efficacy accurately|7|||
161097793|NCT02370043|581748766|FG000|Overall Study|Withdrawal by Subject|0|||
161097794|NCT02370043|581748767|FG001|Overall Study|Withdrawal by Subject|0|||
161097795|NCT02370043|581748768|FG002|Overall Study|Withdrawal by Subject|0|||
161097796|NCT02370043|581748769|FG003|Overall Study|Withdrawal by Subject|0|||
161097797|NCT02370043|581748770|FG004|Overall Study|Withdrawal by Subject|1|||
161097798|NCT02370043|581748771|FG005|Overall Study|Withdrawal by Subject|1|||
161097799|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
161097800|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
161097801|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
161097802|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
161097803|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
161097804|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
161097805|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
161097806|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
161097807|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
161097808|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
161097809|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
161097810|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
161097811|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
161097812|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
161097813|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
161097814|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
161097815|NCT01231516|581748772|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
161097816|NCT01231516|581748773|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
161097817|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
161097818|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
161097819|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
161097820|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
161097821|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
161097822|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
161097823|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
161097824|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
161097825|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
161097826|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
161097827|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
161097828|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
161097829|NCT01231516|581748772|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
161097830|NCT01231516|581748773|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
161097831|NCT05266586|581748774|FG000|Overall Study|Adverse Event|2|||
161097832|NCT05266586|581748775|FG001|Overall Study|Adverse Event|2|||
161097833|NCT05266586|581748776|FG002|Overall Study|Adverse Event|1|||
161097834|NCT05266586|581748774|FG000|Overall Study|Withdrawal by Subject|1|||
161097835|NCT05266586|581748775|FG001|Overall Study|Withdrawal by Subject|0|||
161097836|NCT05266586|581748776|FG002|Overall Study|Withdrawal by Subject|1|||
161212032|NCT02556632|582158517|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
160865660|NCT00734539|580902944|FG000|Main Study|Physician Decision|2|||
161323724|NCT01806168|582571898|FG002|Overall Study|Protocol Violation|1|||
161323725|NCT04435808|582571899|FG000|Overall Study|Study stopped by DSMB|0|||
161323726|NCT04435808|582571900|FG001|Overall Study|Study stopped by DSMB|1|||
161323727|NCT01151345|582571903|FG000|First Intervention Period|Protocol Violation|0|||
161323728|NCT01151345|582571904|FG001|First Intervention Period|Protocol Violation|1|||
161323729|NCT01765569|582571905|FG000|Period B|Withdrawal by Subject|1|||
161323730|NCT01765569|582571905|FG000|Period C|Death|1|||
161323731|NCT05415462|582571906|FG000|Overall Study|Death|18|||
161323732|NCT05415462|582571907|FG001|Overall Study|Death|10|||
161323733|NCT05415462|582571906|FG000|Overall Study|Lost to Follow-up|72|||
161323734|NCT05415462|582571907|FG001|Overall Study|Lost to Follow-up|64|||
161323735|NCT05415462|582571906|FG000|Overall Study|Physician Decision|5|||
161323736|NCT05415462|582571907|FG001|Overall Study|Physician Decision|5|||
161323737|NCT05415462|582571906|FG000|Overall Study|Protocol Deviation|1|||
161323738|NCT05415462|582571907|FG001|Overall Study|Protocol Deviation|0|||
161323739|NCT05415462|582571906|FG000|Overall Study|Withdrawal by Subject|129|||
161323740|NCT05415462|582571907|FG001|Overall Study|Withdrawal by Subject|101|||
161323741|NCT05415462|582571906|FG000|Overall Study|Other Than Specified|8|||
161323742|NCT05415462|582571907|FG001|Overall Study|Other Than Specified|8|||
161323743|NCT01030718|582571908|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
161323744|NCT01030718|582571909|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
161323745|NCT01030718|582571910|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
161323746|NCT01030718|582571908|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
161323747|NCT01030718|582571909|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
161323748|NCT01030718|582571910|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
161323749|NCT01030718|582571908|FG000|Studies CA180-031 and -036 Combined|Death|0|||
161323750|NCT01030718|582571909|FG001|Studies CA180-031 and -036 Combined|Death|1|||
161323751|NCT01030718|582571910|FG002|Studies CA180-031 and -036 Combined|Death|0|||
161323752|NCT01030718|582571908|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
161323753|NCT01030718|582571909|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
161323754|NCT01030718|582571910|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
161323755|NCT01030718|582571908|FG000|Study CA180-036 Only|insufficient effect|1|||
161323756|NCT01030718|582571909|FG001|Study CA180-036 Only|insufficient effect|1|||
161323757|NCT01030718|582571910|FG002|Study CA180-036 Only|insufficient effect|5|||
161323758|NCT01030718|582571908|FG000|Study CA180-036 Only|Adverse Event|2|||
161323759|NCT01030718|582571909|FG001|Study CA180-036 Only|Adverse Event|3|||
161323760|NCT01030718|582571910|FG002|Study CA180-036 Only|Adverse Event|0|||
161323761|NCT01030718|582571908|FG000|Study CA180-036 Only|Death|0|||
161323762|NCT01030718|582571909|FG001|Study CA180-036 Only|Death|1|||
161323763|NCT01030718|582571910|FG002|Study CA180-036 Only|Death|0|||
161323764|NCT01030718|582571908|FG000|Study CA180-036 Only|Other Reasons|0|||
161323765|NCT01030718|582571909|FG001|Study CA180-036 Only|Other Reasons|2|||
161323766|NCT01030718|582571910|FG002|Study CA180-036 Only|Other Reasons|0|||
161323767|NCT00423813|582571911|FG000|Overall Study|Adverse Event|11|||
161323768|NCT00423813|582571912|FG001|Overall Study|Adverse Event|30|||
161323769|NCT00423813|582571913|FG002|Overall Study|Adverse Event|40|||
161323770|NCT00423813|582571911|FG000|Overall Study|Withdrawal by Subject|6|||
161323771|NCT00423813|582571912|FG001|Overall Study|Withdrawal by Subject|8|||
161323772|NCT00423813|582571913|FG002|Overall Study|Withdrawal by Subject|5|||
161323773|NCT00423813|582571911|FG000|Overall Study|Lost to Follow-up|5|||
161323774|NCT00423813|582571912|FG001|Overall Study|Lost to Follow-up|4|||
161097837|NCT05266586|581748774|FG000|Overall Study|Non-compliance with study drug|0|||
161097838|NCT05266586|581748775|FG001|Overall Study|Non-compliance with study drug|1|||
161097839|NCT05266586|581748776|FG002|Overall Study|Non-compliance with study drug|0|||
161097840|NCT05266586|581748774|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
161097841|NCT05266586|581748775|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
161097842|NCT05266586|581748776|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
161097843|NCT03431857|581748778|FG000|Overall Study|Death|6|||
161097844|NCT03431857|581748778|FG000|Overall Study|Lost to Follow-up|41|||
161097845|NCT03431857|581748778|FG000|Overall Study|Adverse Event|6|||
161097846|NCT03431857|581748778|FG000|Overall Study|Withdrawal by Subject|1|||
161097847|NCT01323621|581748780|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
161212033|NCT02556632|582158518|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
161212034|NCT02556632|582158516|FG000|Overall Study|Unrelated Adverse Event|1|||
161323775|NCT00423813|582571913|FG002|Overall Study|Lost to Follow-up|4|||
161323776|NCT00423813|582571911|FG000|Overall Study|Lack of Efficacy|23|||
161323777|NCT00423813|582571912|FG001|Overall Study|Lack of Efficacy|18|||
161323778|NCT00423813|582571913|FG002|Overall Study|Lack of Efficacy|19|||
161323779|NCT00423813|582571911|FG000|Overall Study|Physician Decision|2|||
161323780|NCT00423813|582571912|FG001|Overall Study|Physician Decision|0|||
161323781|NCT00423813|582571913|FG002|Overall Study|Physician Decision|0|||
161323782|NCT00423813|582571911|FG000|Overall Study|Sponsor Decision|0|||
161323783|NCT00423813|582571912|FG001|Overall Study|Sponsor Decision|1|||
160865661|NCT00734539|580902945|FG001|Main Study|Physician Decision|0|||
161212035|NCT02556632|582158517|FG001|Overall Study|Unrelated Adverse Event|0|||
161323784|NCT00423813|582571913|FG002|Overall Study|Sponsor Decision|0|||
161323785|NCT00423813|582571911|FG000|Overall Study|Protocol Violation|9|||
161323786|NCT00423813|582571912|FG001|Overall Study|Protocol Violation|4|||
161323787|NCT00423813|582571913|FG002|Overall Study|Protocol Violation|4|||
161323788|NCT00423813|582571911|FG000|Overall Study|Pregnancy|0|||
161323789|NCT00423813|582571912|FG001|Overall Study|Pregnancy|0|||
161323790|NCT00423813|582571913|FG002|Overall Study|Pregnancy|1|||
161323791|NCT00423813|582571911|FG000|Overall Study|Subject started night shift work|1|||
161323792|NCT00423813|582571912|FG001|Overall Study|Subject started night shift work|0|||
161323793|NCT00423813|582571913|FG002|Overall Study|Subject started night shift work|0|||
161323794|NCT00423813|582571911|FG000|Overall Study|Will start exclusionary medications|0|||
161323795|NCT00423813|582571912|FG001|Overall Study|Will start exclusionary medications|1|||
161323796|NCT00423813|582571913|FG002|Overall Study|Will start exclusionary medications|0|||
161323797|NCT00423813|582571911|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
161323798|NCT00423813|582571912|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
161323799|NCT00423813|582571913|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
161323800|NCT01904032|582571921|FG000|Overall Study|Adverse Event|3|||
161323801|NCT01904032|582571922|FG001|Overall Study|Adverse Event|1|||
161323802|NCT01904032|582571921|FG000|Overall Study|Lost to Follow-up|4|||
161323803|NCT01904032|582571922|FG001|Overall Study|Lost to Follow-up|2|||
161323804|NCT01658904|582571923|FG000|Overall Study|Principal Investigator discretion|2|||
161323805|NCT01658904|582571924|FG001|Overall Study|Principal Investigator discretion|0|||
161323806|NCT01658904|582571925|FG002|Overall Study|Principal Investigator discretion|0|||
161323807|NCT02998996|582571928|FG000|Overall Study|Lost to Follow-up|0|||
161323808|NCT02998996|582571929|FG001|Overall Study|Lost to Follow-up|0|||
161323809|NCT02998996|582571930|FG002|Overall Study|Lost to Follow-up|1|||
161323810|NCT02998996|582571931|FG003|Overall Study|Lost to Follow-up|0|||
161323811|NCT02998996|582571932|FG004|Overall Study|Lost to Follow-up|0|||
161323812|NCT02998996|582571933|FG005|Overall Study|Lost to Follow-up|0|||
161323813|NCT02998996|582571928|FG000|Overall Study|Pregnancy|0|||
161323814|NCT02998996|582571929|FG001|Overall Study|Pregnancy|1|||
161323815|NCT02998996|582571930|FG002|Overall Study|Pregnancy|0|||
161323816|NCT02998996|582571931|FG003|Overall Study|Pregnancy|0|||
161323817|NCT02998996|582571932|FG004|Overall Study|Pregnancy|0|||
161323818|NCT02998996|582571933|FG005|Overall Study|Pregnancy|0|||
161323819|NCT02998996|582571928|FG000|Overall Study|Family reasons|0|||
161323820|NCT02998996|582571929|FG001|Overall Study|Family reasons|0|||
161323821|NCT02998996|582571930|FG002|Overall Study|Family reasons|0|||
161323822|NCT02998996|582571931|FG003|Overall Study|Family reasons|0|||
161323823|NCT02998996|582571932|FG004|Overall Study|Family reasons|1|||
161323824|NCT02998996|582571933|FG005|Overall Study|Family reasons|0|||
161323825|NCT01087203|582571934|FG000|Overall Study|Lost to Follow-up|2|||
161323826|NCT01087203|582571935|FG001|Overall Study|Lost to Follow-up|0|||
161323827|NCT01087203|582571934|FG000|Overall Study|Withdrawal by Subject|2|||
161323828|NCT01087203|582571935|FG001|Overall Study|Withdrawal by Subject|6|||
161323829|NCT01087203|582571934|FG000|Overall Study|Lack of Efficacy|1|||
161323830|NCT01087203|582571935|FG001|Overall Study|Lack of Efficacy|2|||
161323831|NCT01087203|582571934|FG000|Overall Study|Study terminated by sponsor|27|||
161323832|NCT01087203|582571935|FG001|Overall Study|Study terminated by sponsor|27|||
161323833|NCT04074330|582571939|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
161323834|NCT04074330|582571940|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
161323835|NCT04074330|582571941|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
161323836|NCT04074330|582571942|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
161323837|NCT04074330|582571943|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
161323838|NCT04074330|582571944|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
161323839|NCT04074330|582571945|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
161323840|NCT04074330|582571946|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
161323841|NCT04074330|582571947|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
161323842|NCT04074330|582571948|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
161323843|NCT04074330|582571939|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161323844|NCT04074330|582571940|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161323845|NCT04074330|582571941|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161323846|NCT04074330|582571942|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
161323847|NCT04074330|582571943|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161323848|NCT04074330|582571944|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161323849|NCT04074330|582571945|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
161323850|NCT04074330|582571946|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
161323851|NCT04074330|582571947|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161323852|NCT04074330|582571948|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
161323853|NCT04074330|582571939|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323854|NCT04074330|582571940|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323855|NCT04074330|582571941|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
161323856|NCT04074330|582571942|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323857|NCT04074330|582571943|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323858|NCT04074330|582571944|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323859|NCT04074330|582571945|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323860|NCT04074330|582571946|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323861|NCT04074330|582571947|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323862|NCT04074330|582571948|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
161323863|NCT04074330|582571939|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323864|NCT04074330|582571940|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323865|NCT04074330|582571941|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323866|NCT04074330|582571942|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323867|NCT04074330|582571943|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323868|NCT04074330|582571944|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
161323869|NCT04074330|582571945|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323870|NCT04074330|582571946|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
161323871|NCT04074330|582571947|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323872|NCT04074330|582571948|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
161323873|NCT04074330|582571939|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161323874|NCT04074330|582571940|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161323875|NCT04074330|582571941|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161323876|NCT04074330|582571942|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161097848|NCT01323621|581748781|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
161097849|NCT01323621|581748782|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
161097850|NCT01323621|581748780|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
161097851|NCT01323621|581748781|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
161323877|NCT04074330|582571943|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
161323878|NCT04074330|582571944|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
161323879|NCT04074330|582571945|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161323880|NCT04074330|582571946|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161323881|NCT04074330|582571947|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161323882|NCT04074330|582571948|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
161323883|NCT04074330|582571939|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161323884|NCT04074330|582571940|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161323885|NCT04074330|582571941|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161323886|NCT04074330|582571942|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161323887|NCT04074330|582571943|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161323888|NCT04074330|582571944|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
161323889|NCT04074330|582571945|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161097852|NCT01323621|581748782|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
161323890|NCT04074330|582571946|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161323891|NCT04074330|582571947|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161323892|NCT04074330|582571948|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
161097853|NCT01323621|581748780|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
161097854|NCT01323621|581748781|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
161097855|NCT01323621|581748782|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
161097856|NCT01323621|581748780|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
161097857|NCT01323621|581748781|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
161097858|NCT01323621|581748782|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
161097859|NCT01323621|581748780|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
160865662|NCT00734539|580902944|FG000|Main Study|Withdrawal by Subject|1|||
161097860|NCT01323621|581748781|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
161097861|NCT01323621|581748782|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
161097862|NCT01323621|581748780|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
161097863|NCT01323621|581748781|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
161097864|NCT01323621|581748782|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
161097865|NCT01323621|581748780|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
161097866|NCT01323621|581748781|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
161097867|NCT01323621|581748782|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
161097868|NCT01323621|581748780|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161097869|NCT01323621|581748781|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
161097870|NCT01323621|581748782|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
161097871|NCT01323621|581748780|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
161097872|NCT01323621|581748781|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
161097873|NCT01323621|581748782|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
161097874|NCT01323621|581748780|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161097875|NCT01323621|581748781|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161097876|NCT01323621|581748782|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161097877|NCT01323621|581748780|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
161097878|NCT01323621|581748781|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
161097879|NCT01323621|581748782|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
161097880|NCT01323621|581748780|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161097881|NCT01323621|581748781|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
161097882|NCT01323621|581748782|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
161097883|NCT02876835|581748784|FG000|Treatment Period (51.1 Month)|Other|1|||
161097884|NCT02876835|581748785|FG001|Treatment Period (51.1 Month)|Other|0|||
161097885|NCT02876835|581748784|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
161097886|NCT02876835|581748785|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
161097887|NCT02876835|581748784|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
161097888|NCT02876835|581748785|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
161097889|NCT02876835|581748784|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
161097890|NCT02876835|581748785|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
161097891|NCT01117857|581748786|FG000|Overall Study|Lost to Follow-up|4|||
161097892|NCT01117857|581748786|FG000|Overall Study|Withdrawal by Subject|4|||
161097893|NCT01117857|581748786|FG000|Overall Study|Physician Decision|1|||
161097894|NCT01119001|581748787|FG000|Overall Study|Withdrawal by Subject|2|||
161097895|NCT05245097|581748788|FG000|Overall Study|Adverse Event|13|||
161097896|NCT05245097|581748789|FG001|Overall Study|Adverse Event|2|||
161097897|NCT05245097|581748788|FG000|Overall Study|Protocol Violation|8|||
161097898|NCT05245097|581748789|FG001|Overall Study|Protocol Violation|6|||
161097899|NCT05245097|581748788|FG000|Overall Study|Withdrawal by Subject|18|||
161097900|NCT05245097|581748789|FG001|Overall Study|Withdrawal by Subject|0|||
161097901|NCT05245097|581748788|FG000|Overall Study|Death|6|||
161097902|NCT05245097|581748789|FG001|Overall Study|Death|7|||
161097903|NCT05245097|581748788|FG000|Overall Study|Physician Decision|6|||
161097904|NCT05245097|581748789|FG001|Overall Study|Physician Decision|0|||
161097905|NCT05245097|581748788|FG000|Overall Study|Relocation|4|||
161097906|NCT05245097|581748789|FG001|Overall Study|Relocation|3|||
161097907|NCT03604523|581748794|FG000|Overall Study|Physician Decision|1|||
161097908|NCT03604523|581748795|FG001|Overall Study|Physician Decision|0|||
161097909|NCT00458341|581748796|FG000|Cycle 1|Adverse Event|1|||
161097910|NCT00458341|581748797|FG001|Cycle 1|Adverse Event|0|||
161097911|NCT05461794|581748798|FG000|Overall Study|Withdrawal by Subject|1|||
161097912|NCT05461794|581748799|FG001|Overall Study|Withdrawal by Subject|1|||
161097913|NCT05461794|581748800|FG002|Overall Study|Withdrawal by Subject|3|||
161097914|NCT05461794|581748798|FG000|Overall Study|Study Terminated By Sponsor|18|||
161097915|NCT05461794|581748799|FG001|Overall Study|Study Terminated By Sponsor|13|||
161097916|NCT05461794|581748800|FG002|Overall Study|Study Terminated By Sponsor|16|||
161212036|NCT02556632|582158518|FG002|Overall Study|Unrelated Adverse Event|3|||
161212037|NCT02556632|582158516|FG000|Overall Study|Related Adverse Event|0|||
161097917|NCT05461794|581748798|FG000|Overall Study|Death|20|||
161097918|NCT05461794|581748799|FG001|Overall Study|Death|5|||
161097919|NCT05461794|581748800|FG002|Overall Study|Death|19|||
161097920|NCT01335009|581748803|FG000|Overall Study|Too ill to travel to study sites|1|||
161097921|NCT01335009|581748804|FG001|Overall Study|Too ill to travel to study sites|0|||
161097922|NCT01335009|581748803|FG000|Overall Study|Death|28|||
161097923|NCT01335009|581748804|FG001|Overall Study|Death|32|||
161097924|NCT01335009|581748803|FG000|Overall Study|Withdrawal by Subject|1|||
161212038|NCT02556632|582158517|FG001|Overall Study|Related Adverse Event|1|||
160865663|NCT00734539|580902945|FG001|Main Study|Withdrawal by Subject|3|||
161097925|NCT01335009|581748804|FG001|Overall Study|Withdrawal by Subject|1|||
161212039|NCT02556632|582158518|FG002|Overall Study|Related Adverse Event|0|||
161212040|NCT02556632|582158516|FG000|Overall Study|Possibly Related Adverse Event|0|||
161097926|NCT01335009|581748803|FG000|Overall Study|Lost to Follow-up|1|||
161097927|NCT01335009|581748804|FG001|Overall Study|Lost to Follow-up|0|||
161097928|NCT04824521|581748805|FG000|Overall Study|Lost to Follow-up|1|||
161097929|NCT01598311|581748806|FG000|Overall Study|Physician Decision|4|||
161097930|NCT01598311|581748807|FG001|Overall Study|Physician Decision|5|||
161097931|NCT01598311|581748806|FG000|Overall Study|Adverse Event|9|||
161097932|NCT01598311|581748807|FG001|Overall Study|Adverse Event|13|||
161097933|NCT01598311|581748806|FG000|Overall Study|Lost to Follow-up|7|||
161097934|NCT01598311|581748807|FG001|Overall Study|Lost to Follow-up|12|||
161097935|NCT01598311|581748806|FG000|Overall Study|Withdrawal by Subject|9|||
161097936|NCT01598311|581748807|FG001|Overall Study|Withdrawal by Subject|13|||
161097937|NCT01598311|581748806|FG000|Overall Study|No reason provided.|0|||
161097938|NCT01598311|581748807|FG001|Overall Study|No reason provided.|5|||
161097939|NCT01598311|581748806|FG000|Overall Study|Randomized but never treated|8|||
161097940|NCT01598311|581748807|FG001|Overall Study|Randomized but never treated|5|||
161097941|NCT01598311|581748806|FG000|Overall Study|Treated but no confirmed CDAD|9|||
161097942|NCT01598311|581748807|FG001|Overall Study|Treated but no confirmed CDAD|8|||
161097943|NCT01598311|581748806|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
161097944|NCT01598311|581748807|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
161097945|NCT00523718|581751104|FG000|Overall Study|Withdrawal by Subject|1|||
161097946|NCT00523718|581751105|FG001|Overall Study|Withdrawal by Subject|0|||
161097947|NCT00523718|581751104|FG000|Overall Study|Protocol Violation|2|||
161097948|NCT00523718|581751105|FG001|Overall Study|Protocol Violation|0|||
161097949|NCT01306890|581751106|FG000|Overall Study|Adverse Event|2|||
161097950|NCT01306890|581751106|FG000|Overall Study|Death|1223|||
161097951|NCT01306890|581751106|FG000|Overall Study|Lost to Follow-up|58|||
161097952|NCT01306890|581751106|FG000|Overall Study|Withdrawal by Subject|88|||
161097953|NCT01306890|581751106|FG000|Overall Study|Unspecified reasons|104|||
161097954|NCT01306890|581751106|FG000|Overall Study|Study Termination|3|||
161097955|NCT01306890|581751106|FG000|Overall Study|No discontinuation documentation|41|||
160865664|NCT00734539|580902944|FG000|Main Study|Enrolled in error; ineligible|1|||
160865665|NCT00734539|580902945|FG001|Main Study|Enrolled in error; ineligible|0|||
161097956|NCT02217436|581751107|FG000|Overall Study|Protocol Violation|1|||
161097957|NCT02217436|581751108|FG001|Overall Study|Protocol Violation|1|||
161097958|NCT02217436|581751107|FG000|Overall Study|Incomplete data|0|||
161097959|NCT02217436|581751108|FG001|Overall Study|Incomplete data|1|||
160865666|NCT02504151|580902946|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
161212041|NCT02556632|582158517|FG001|Overall Study|Possibly Related Adverse Event|0|||
161212042|NCT02556632|582158518|FG002|Overall Study|Possibly Related Adverse Event|1|||
161212043|NCT02556632|582158516|FG000|Overall Study|Did Not Start RT|0|||
161212044|NCT02556632|582158517|FG001|Overall Study|Did Not Start RT|1|||
161097960|NCT00234494|581751113|FG000|Overall Study|Protocol Violation|2|||
161097961|NCT02634346|581751117|FG000|Overall Study|Withdrawal by Subject|8|||
161097962|NCT02634346|581751118|FG001|Overall Study|Withdrawal by Subject|9|||
161097963|NCT02634346|581751119|FG002|Overall Study|Withdrawal by Subject|8|||
161097964|NCT02634346|581751117|FG000|Overall Study|Adverse Event|2|||
161097965|NCT02634346|581751118|FG001|Overall Study|Adverse Event|2|||
161097966|NCT02634346|581751119|FG002|Overall Study|Adverse Event|7|||
161097967|NCT02634346|581751117|FG000|Overall Study|Lack of Efficacy|1|||
161097968|NCT02634346|581751118|FG001|Overall Study|Lack of Efficacy|2|||
161097969|NCT02634346|581751119|FG002|Overall Study|Lack of Efficacy|8|||
161097970|NCT02634346|581751117|FG000|Overall Study|Lost to Follow-up|1|||
161097971|NCT02634346|581751118|FG001|Overall Study|Lost to Follow-up|0|||
161097972|NCT02634346|581751119|FG002|Overall Study|Lost to Follow-up|0|||
161097973|NCT02634346|581751117|FG000|Overall Study|Protocol Violation|0|||
161097974|NCT02634346|581751118|FG001|Overall Study|Protocol Violation|1|||
161097975|NCT02634346|581751119|FG002|Overall Study|Protocol Violation|0|||
161097976|NCT02170389|581751120|FG000|Overall Study|Study terminated prior to start of treat|1|||
161097977|NCT00908232|581751126|FG000|Cycle 1 to 4|Death|5|||
161097978|NCT00908232|581751127|FG001|Cycle 1 to 4|Death|0|||
161097979|NCT00908232|581751128|FG002|Cycle 1 to 4|Death|0|||
161097980|NCT00908232|581751129|FG003|Cycle 1 to 4|Death|0|||
161097981|NCT00908232|581751126|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
161097982|NCT00908232|581751127|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
161097983|NCT00908232|581751128|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
161097984|NCT00908232|581751129|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
161097985|NCT00908232|581751126|FG000|Cycle 1 to 4|Progressive Disease|6|||
161097986|NCT00908232|581751127|FG001|Cycle 1 to 4|Progressive Disease|0|||
161097987|NCT00908232|581751128|FG002|Cycle 1 to 4|Progressive Disease|0|||
161097988|NCT00908232|581751129|FG003|Cycle 1 to 4|Progressive Disease|0|||
161097989|NCT00908232|581751126|FG000|Cycle 1 to 4|Adverse Event|12|||
161097990|NCT00908232|581751127|FG001|Cycle 1 to 4|Adverse Event|0|||
161097991|NCT00908232|581751128|FG002|Cycle 1 to 4|Adverse Event|0|||
161097992|NCT00908232|581751129|FG003|Cycle 1 to 4|Adverse Event|0|||
161097993|NCT00908232|581751126|FG000|Cycle 1 to 4|Other|1|||
161097994|NCT00908232|581751127|FG001|Cycle 1 to 4|Other|0|||
161097995|NCT00908232|581751128|FG002|Cycle 1 to 4|Other|0|||
161097996|NCT00908232|581751129|FG003|Cycle 1 to 4|Other|0|||
161097997|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
161097998|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161097999|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161098000|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
161098001|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
161098002|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161098003|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161098004|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
161098005|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
161098006|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
161098007|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
161098008|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
161098009|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
161098010|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
161098011|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
161098012|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
161098013|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
161098014|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
161098015|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
161098016|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
161098017|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
161098018|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161098019|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161098020|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
161098021|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
161098022|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
161098023|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
161098024|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
161098025|NCT00908232|581751126|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
161098026|NCT00908232|581751127|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161098027|NCT00908232|581751128|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161098028|NCT00908232|581751129|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
161098029|NCT00769860|581751138|FG000|Overall Study|Withdrawal by Subject|2|||
161098030|NCT00769860|581751139|FG001|Overall Study|Withdrawal by Subject|0|||
161098031|NCT00448435|581751142|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
161098032|NCT00448435|581751143|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
161098033|NCT02804178|581751148|FG000|Overall Study|Adverse Event|1|||
161098034|NCT00412971|581751149|FG000|Overall Study|Lost to Follow-up|17|||
161098035|NCT00412971|581751150|FG001|Overall Study|Lost to Follow-up|9|||
161098036|NCT00412971|581751149|FG000|Overall Study|Protocol Violation|13|||
161098037|NCT00412971|581751150|FG001|Overall Study|Protocol Violation|1|||
161098038|NCT01774084|581751151|FG000|Overall Study|Personal reasons|1|||
161098039|NCT01774084|581751152|FG001|Overall Study|Personal reasons|0|||
161098040|NCT01106404|581751153|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
161098041|NCT01106404|581751154|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
161098042|NCT01106404|581751153|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
161098043|NCT01106404|581751154|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
161098044|NCT01106404|581751153|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
161098045|NCT01106404|581751154|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
161098046|NCT01106404|581751153|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
161212045|NCT02556632|582158518|FG002|Overall Study|Did Not Start RT|0|||
161098047|NCT01106404|581751154|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
161098048|NCT01387230|581751155|FG000|Overall Study|Adverse Event|0|||
161098049|NCT01387230|581751156|FG001|Overall Study|Adverse Event|1|||
161098050|NCT01387230|581751157|FG002|Overall Study|Adverse Event|3|||
161098051|NCT01387230|581751155|FG000|Overall Study|Lack of Efficacy|8|||
161098052|NCT01387230|581751156|FG001|Overall Study|Lack of Efficacy|5|||
161098053|NCT01387230|581751157|FG002|Overall Study|Lack of Efficacy|4|||
161212046|NCT02556632|582158516|FG000|Overall Study|Ineligible|0|||
161098054|NCT01387230|581751155|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
161098055|NCT01387230|581751156|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161098056|NCT01387230|581751157|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
161098057|NCT01387230|581751155|FG000|Overall Study|Lost to Follow-up|0|||
161098058|NCT01387230|581751156|FG001|Overall Study|Lost to Follow-up|0|||
161098059|NCT01387230|581751157|FG002|Overall Study|Lost to Follow-up|1|||
161098060|NCT01387230|581751155|FG000|Overall Study|Withdrawal by Subject|4|||
161098061|NCT01387230|581751156|FG001|Overall Study|Withdrawal by Subject|1|||
161098062|NCT01387230|581751157|FG002|Overall Study|Withdrawal by Subject|0|||
161098063|NCT03027557|581751161|FG000|Overall Study|Adverse Event|1|||
161098064|NCT03027557|581751162|FG001|Overall Study|Adverse Event|0|||
161098065|NCT03027557|581751163|FG002|Overall Study|Adverse Event|0|||
161098066|NCT02430051|581751166|FG000|Overall Study|Withdrawal by Subject|6|||
161098067|NCT02430051|581751167|FG001|Overall Study|Withdrawal by Subject|3|||
161098068|NCT02430051|581751166|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
161098069|NCT02430051|581751167|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
161098070|NCT02430051|581751166|FG000|Overall Study|Protocol Violation|1|||
161098071|NCT02430051|581751167|FG001|Overall Study|Protocol Violation|0|||
161098072|NCT02030405|581751172|FG000|Overall Study|Withdrawal by Subject|1|||
161098073|NCT02030405|581751172|FG000|Overall Study|Lost to Follow-up|1|||
161098074|NCT00132496|581751173|FG000|Overall Study|Withdrawal by Subject|1|||
161098075|NCT00132496|581751174|FG001|Overall Study|Withdrawal by Subject|2|||
161098076|NCT00132496|581751173|FG000|Overall Study|Physician Decision|1|||
161098077|NCT00132496|581751174|FG001|Overall Study|Physician Decision|0|||
161098078|NCT00986440|581751177|FG000|Overall Study|Progressive disease|27|||
161098079|NCT00986440|581751178|FG001|Overall Study|Progressive disease|37|||
161098080|NCT00986440|581751177|FG000|Overall Study|Serious adverse event or adverse event|9|||
161098081|NCT00986440|581751178|FG001|Overall Study|Serious adverse event or adverse event|2|||
161098082|NCT00986440|581751177|FG000|Overall Study|Withdrawal by Subject|1|||
161098083|NCT00986440|581751178|FG001|Overall Study|Withdrawal by Subject|2|||
161098084|NCT00986440|581751177|FG000|Overall Study|Screen failure (not dosed)|4|||
161098085|NCT00986440|581751178|FG001|Overall Study|Screen failure (not dosed)|2|||
161098086|NCT00388154|581751179|FG000|Overall Study|Withdrawal by Subject|1|||
161098087|NCT01145755|581751184|FG000|Overall Study|Adverse Event|2|||
161098088|NCT01145755|581751185|FG001|Overall Study|Adverse Event|4|||
161098089|NCT01145755|581751186|FG002|Overall Study|Adverse Event|2|||
161098090|NCT01145755|581751184|FG000|Overall Study|Withdrawal by Subject|2|||
161098091|NCT01145755|581751185|FG001|Overall Study|Withdrawal by Subject|2|||
161098092|NCT01145755|581751186|FG002|Overall Study|Withdrawal by Subject|2|||
161098093|NCT01145755|581751184|FG000|Overall Study|Lost to Follow-up|2|||
161098094|NCT01145755|581751185|FG001|Overall Study|Lost to Follow-up|3|||
161098095|NCT01145755|581751186|FG002|Overall Study|Lost to Follow-up|1|||
161098096|NCT01145755|581751184|FG000|Overall Study|Protocol Violation|0|||
161098097|NCT01145755|581751185|FG001|Overall Study|Protocol Violation|3|||
161098098|NCT01145755|581751186|FG002|Overall Study|Protocol Violation|1|||
161098099|NCT01145755|581751184|FG000|Overall Study|Study Closure|14|||
161098100|NCT01145755|581751185|FG001|Overall Study|Study Closure|14|||
161098101|NCT01145755|581751186|FG002|Overall Study|Study Closure|17|||
161098102|NCT01145755|581751184|FG000|Overall Study|Lack of Efficacy|0|||
161098103|NCT01145755|581751185|FG001|Overall Study|Lack of Efficacy|1|||
161098104|NCT01145755|581751186|FG002|Overall Study|Lack of Efficacy|0|||
161098105|NCT01145755|581751184|FG000|Overall Study|Patient could not swollow medication|0|||
161098106|NCT01145755|581751185|FG001|Overall Study|Patient could not swollow medication|0|||
161098107|NCT01145755|581751186|FG002|Overall Study|Patient could not swollow medication|1|||
161098108|NCT01145755|581751184|FG000|Overall Study|Withdrawal by Subject|0|||
161098109|NCT01145755|581751185|FG001|Overall Study|Withdrawal by Subject|0|||
161098110|NCT01145755|581751186|FG002|Overall Study|Withdrawal by Subject|1|||
161098111|NCT01145755|581751184|FG000|Overall Study|Positive urine ethanol|0|||
161098112|NCT01145755|581751185|FG001|Overall Study|Positive urine ethanol|1|||
161098113|NCT01145755|581751186|FG002|Overall Study|Positive urine ethanol|0|||
161098114|NCT01009554|581751187|FG000|Overall Study|Adverse Event|1|||
161098115|NCT01009554|581751188|FG001|Overall Study|Adverse Event|1|||
161098116|NCT01009554|581751187|FG000|Overall Study|Withdrawal by Subject|1|||
161098117|NCT01009554|581751188|FG001|Overall Study|Withdrawal by Subject|3|||
161098118|NCT01009554|581751187|FG000|Overall Study|Noncompliant with Study Product|0|||
161098119|NCT01009554|581751188|FG001|Overall Study|Noncompliant with Study Product|3|||
161212047|NCT02556632|582158517|FG001|Overall Study|Ineligible|1|||
161098120|NCT02973048|581751189|FG000|Overall Study|Epidural catheter insertion failure|1|||
161098121|NCT02973048|581751190|FG001|Overall Study|Epidural catheter insertion failure|0|||
161098122|NCT02973048|581751189|FG000|Overall Study|Withdrawal by Subject|0|||
161098123|NCT02973048|581751190|FG001|Overall Study|Withdrawal by Subject|3|||
161098124|NCT00403754|581751191|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
161098125|NCT00403754|581751192|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
161098126|NCT00403754|581751193|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
161098127|NCT00403754|581751194|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
161212048|NCT02556632|582158518|FG002|Overall Study|Ineligible|0|||
161098128|NCT00403754|581751191|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
161098129|NCT00403754|581751192|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
161098130|NCT00403754|581751193|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
161098131|NCT00403754|581751194|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
161098132|NCT04343248|581751195|FG000|Overall Study|Withdrawal by Subject|5|||
161098133|NCT04343248|581751196|FG001|Overall Study|Withdrawal by Subject|6|||
161098134|NCT04343248|581751195|FG000|Overall Study|Death|1|||
161098135|NCT04343248|581751196|FG001|Overall Study|Death|2|||
161098136|NCT04343248|581751195|FG000|Overall Study|Lost to Follow-up|9|||
161098137|NCT04343248|581751196|FG001|Overall Study|Lost to Follow-up|6|||
161098138|NCT04343248|581751195|FG000|Overall Study|Physician Decision|0|||
161098139|NCT04343248|581751196|FG001|Overall Study|Physician Decision|1|||
161098140|NCT04343248|581751195|FG000|Overall Study|Adverse Event|1|||
161098141|NCT04343248|581751196|FG001|Overall Study|Adverse Event|0|||
161098142|NCT03951220|581751201|FG000|Overall Study|Withdrawal by Subject|9|||
161098143|NCT03951220|581751202|FG001|Overall Study|Withdrawal by Subject|2|||
161098144|NCT03951220|581751203|FG002|Overall Study|Withdrawal by Subject|0|||
161098145|NCT02730598|581751210|FG000|Overall Study|Withdrawal by Subject|3|||
161098146|NCT02730598|581751211|FG001|Overall Study|Withdrawal by Subject|3|||
161098147|NCT02730598|581751210|FG000|Overall Study|Protocol Violation|0|||
161098148|NCT02730598|581751211|FG001|Overall Study|Protocol Violation|1|||
161098149|NCT02730598|581751210|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
161098150|NCT02730598|581751211|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
161098151|NCT00810394|581751212|FG000|Overall Study|Withdrawal by Subject|3|||
161098152|NCT00467285|581751215|FG000|Overall Study|Lost to Follow-up|4|||
161098153|NCT00467285|581751216|FG001|Overall Study|Lost to Follow-up|4|||
161098154|NCT03891524|581751217|FG000|Overall Study|Death|0|||
161098155|NCT03891524|581751218|FG001|Overall Study|Death|0|||
161098156|NCT03891524|581751219|FG002|Overall Study|Death|0|||
161098157|NCT03891524|581751220|FG003|Overall Study|Death|0|||
161098158|NCT03891524|581751221|FG004|Overall Study|Death|0|||
161098159|NCT03891524|581751222|FG005|Overall Study|Death|0|||
161098160|NCT03891524|581751223|FG006|Overall Study|Death|0|||
161098161|NCT03891524|581751224|FG007|Overall Study|Death|1|||
161098162|NCT03891524|581751217|FG000|Overall Study|Withdrawal by Subject|0|||
161098163|NCT03891524|581751218|FG001|Overall Study|Withdrawal by Subject|1|||
161098164|NCT03891524|581751219|FG002|Overall Study|Withdrawal by Subject|2|||
161098165|NCT03891524|581751220|FG003|Overall Study|Withdrawal by Subject|1|||
161098166|NCT03891524|581751221|FG004|Overall Study|Withdrawal by Subject|2|||
161098167|NCT03891524|581751222|FG005|Overall Study|Withdrawal by Subject|2|||
161098168|NCT03891524|581751223|FG006|Overall Study|Withdrawal by Subject|2|||
161098169|NCT03891524|581751224|FG007|Overall Study|Withdrawal by Subject|1|||
161098170|NCT02958267|581751226|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
161098171|NCT02958267|581751227|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
161098172|NCT02958267|581751226|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
161098173|NCT02958267|581751227|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
161098174|NCT02958267|581751226|FG000|Follow-up Visits|Additional treatment pursued|2|||
161098175|NCT02958267|581751227|FG001|Follow-up Visits|Additional treatment pursued|1|||
161098176|NCT01210118|581751228|FG000|Overall Study|Lost to Follow-up|1|||
161098177|NCT01210118|581751229|FG001|Overall Study|Lost to Follow-up|1|||
161098178|NCT01210118|581751228|FG000|Overall Study|Protocol Violation|1|||
161098179|NCT01210118|581751229|FG001|Overall Study|Protocol Violation|1|||
161098180|NCT01210118|581751228|FG000|Overall Study|Spontaneous abortion|1|||
161098181|NCT01210118|581751229|FG001|Overall Study|Spontaneous abortion|3|||
161098182|NCT01079130|581751230|FG000|Overall Study|Adverse Event|1|||
161098183|NCT01079130|581751231|FG001|Overall Study|Adverse Event|1|||
161098184|NCT01079130|581751232|FG002|Overall Study|Adverse Event|0|||
161098185|NCT01079130|581751233|FG003|Overall Study|Adverse Event|1|||
161098186|NCT01079130|581751234|FG004|Overall Study|Adverse Event|5|||
161098187|NCT01079130|581751235|FG005|Overall Study|Adverse Event|1|||
161098188|NCT01079130|581751230|FG000|Overall Study|Administrative problems|1|||
161098189|NCT01079130|581751231|FG001|Overall Study|Administrative problems|3|||
161098190|NCT01079130|581751232|FG002|Overall Study|Administrative problems|0|||
161098191|NCT01079130|581751233|FG003|Overall Study|Administrative problems|0|||
161098192|NCT01079130|581751234|FG004|Overall Study|Administrative problems|0|||
161098193|NCT01079130|581751235|FG005|Overall Study|Administrative problems|1|||
161098194|NCT01079130|581751230|FG000|Overall Study|Withdrawal by Subject|0|||
161098195|NCT01079130|581751231|FG001|Overall Study|Withdrawal by Subject|1|||
161098196|NCT01079130|581751232|FG002|Overall Study|Withdrawal by Subject|0|||
161098197|NCT01079130|581751233|FG003|Overall Study|Withdrawal by Subject|0|||
161098198|NCT01079130|581751234|FG004|Overall Study|Withdrawal by Subject|1|||
161098199|NCT01079130|581751235|FG005|Overall Study|Withdrawal by Subject|3|||
161098200|NCT01079130|581751230|FG000|Overall Study|Protocol deviation|0|||
161098201|NCT01079130|581751231|FG001|Overall Study|Protocol deviation|2|||
161098202|NCT01079130|581751232|FG002|Overall Study|Protocol deviation|1|||
161098203|NCT01079130|581751233|FG003|Overall Study|Protocol deviation|2|||
161098204|NCT01079130|581751234|FG004|Overall Study|Protocol deviation|0|||
161098205|NCT01079130|581751235|FG005|Overall Study|Protocol deviation|0|||
161098206|NCT01079130|581751230|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161098207|NCT01079130|581751231|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161098208|NCT01079130|581751232|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161098209|NCT01079130|581751233|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161098210|NCT01079130|581751234|FG004|Overall Study|Abnormal test procedure result(s)|1|||
161098211|NCT01079130|581751235|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161098212|NCT01079130|581751230|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161098213|NCT01079130|581751231|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161098214|NCT01079130|581751232|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161098215|NCT01079130|581751233|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161098216|NCT01079130|581751234|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161098217|NCT01079130|581751235|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161098218|NCT01079130|581751230|FG000|Overall Study|Lost to Follow-up|0|||
161098219|NCT01079130|581751231|FG001|Overall Study|Lost to Follow-up|0|||
161098220|NCT01079130|581751232|FG002|Overall Study|Lost to Follow-up|0|||
161098221|NCT01079130|581751233|FG003|Overall Study|Lost to Follow-up|0|||
161098222|NCT01079130|581751234|FG004|Overall Study|Lost to Follow-up|1|||
161098223|NCT01079130|581751235|FG005|Overall Study|Lost to Follow-up|0|||
161098224|NCT00475033|581751242|FG000|Infant Series|Failed to return|3|||
161098225|NCT00475033|581751243|FG001|Infant Series|Failed to return|4|||
161098226|NCT00475033|581751242|FG000|Infant Series|Parent or legal guardian request|1|||
161098227|NCT00475033|581751243|FG001|Infant Series|Parent or legal guardian request|5|||
161098228|NCT00475033|581751242|FG000|Infant Series|Protocol Violation|1|||
161098229|NCT00475033|581751243|FG001|Infant Series|Protocol Violation|2|||
161098230|NCT00475033|581751242|FG000|Infant Series|Lost to Follow-up|2|||
161098231|NCT00475033|581751243|FG001|Infant Series|Lost to Follow-up|0|||
161098232|NCT00475033|581751242|FG000|Infant Series|Adverse Event|0|||
161098233|NCT00475033|581751243|FG001|Infant Series|Adverse Event|2|||
161098234|NCT00475033|581751242|FG000|After the Infant Series|Adverse Event|0|||
161098235|NCT00475033|581751243|FG001|After the Infant Series|Adverse Event|4|||
161098236|NCT00475033|581751242|FG000|After the Infant Series|Parent or legal guardian request|2|||
161098237|NCT00475033|581751243|FG001|After the Infant Series|Parent or legal guardian request|2|||
161098238|NCT00475033|581751242|FG000|After the Infant Series|Failed to return|2|||
161098239|NCT00475033|581751243|FG001|After the Infant Series|Failed to return|1|||
161098240|NCT00475033|581751242|FG000|After the Infant Series|Protocol Violation|1|||
161098241|NCT00475033|581751243|FG001|After the Infant Series|Protocol Violation|0|||
161098242|NCT00475033|581751242|FG000|After the Infant Series|Lost to Follow-up|1|||
161098243|NCT00475033|581751243|FG001|After the Infant Series|Lost to Follow-up|0|||
161098244|NCT00475033|581751242|FG000|After the Infant Series|Other|0|||
161098245|NCT00475033|581751243|FG001|After the Infant Series|Other|1|||
161098246|NCT00475033|581751242|FG000|Toddler Dose|Parent or legal guardian request|2|||
161098247|NCT00475033|581751243|FG001|Toddler Dose|Parent or legal guardian request|0|||
161098248|NCT00475033|581751242|FG000|Toddler Dose|Failed to return|1|||
161098249|NCT00475033|581751243|FG001|Toddler Dose|Failed to return|0|||
161098250|NCT00475033|581751242|FG000|Toddler Dose|Lost to Follow-up|1|||
161098251|NCT00475033|581751243|FG001|Toddler Dose|Lost to Follow-up|0|||
161098252|NCT01696942|581751246|FG000|Overall Study|Withdrawal by Subject|1|||
161098253|NCT01696942|581751247|FG001|Overall Study|Withdrawal by Subject|0|||
161098254|NCT01696942|581751246|FG000|Overall Study|Protocol Violation|1|||
161098255|NCT01696942|581751247|FG001|Overall Study|Protocol Violation|2|||
161098256|NCT01696942|581751246|FG000|Overall Study|screen failure|0|||
161098257|NCT01696942|581751247|FG001|Overall Study|screen failure|1|||
161098258|NCT04484831|581751248|FG000|Overall Study|Withdrawal by Subject|1|||
161098259|NCT04484831|581751249|FG001|Overall Study|Withdrawal by Subject|0|||
161098260|NCT00174265|581751250|FG000|Overall Study|Adverse Event|7|||
161098261|NCT00174265|581751251|FG001|Overall Study|Adverse Event|4|||
161098262|NCT00174265|581751250|FG000|Overall Study|Lack of Efficacy|2|||
161098263|NCT00174265|581751251|FG001|Overall Study|Lack of Efficacy|2|||
161098264|NCT00174265|581751250|FG000|Overall Study|Withdrawal by Subject|3|||
161098265|NCT00174265|581751251|FG001|Overall Study|Withdrawal by Subject|5|||
161098266|NCT00174265|581751250|FG000|Overall Study|Lost to Follow-up|1|||
161098267|NCT00174265|581751251|FG001|Overall Study|Lost to Follow-up|0|||
161098268|NCT00174265|581751250|FG000|Overall Study|Other (Not specified)|16|||
161098269|NCT00174265|581751251|FG001|Overall Study|Other (Not specified)|10|||
161098270|NCT03231943|581751252|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098271|NCT03231943|581751253|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
161098272|NCT03231943|581751254|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
161098273|NCT03231943|581751255|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098274|NCT03231943|581751256|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098275|NCT03231943|581751257|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098276|NCT03231943|581751258|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098277|NCT03231943|581751259|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098278|NCT03231943|581751260|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098279|NCT03231943|581751261|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098280|NCT03231943|581751262|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098281|NCT03231943|581751263|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098282|NCT03231943|581751264|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
161098283|NCT03231943|581751252|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098284|NCT03231943|581751253|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
161098285|NCT03231943|581751254|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098286|NCT03231943|581751255|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098287|NCT03231943|581751256|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098288|NCT03231943|581751257|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098289|NCT03231943|581751258|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098290|NCT03231943|581751259|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098291|NCT03231943|581751260|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098292|NCT03231943|581751261|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098293|NCT03231943|581751262|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098294|NCT03231943|581751263|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098295|NCT03231943|581751264|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
161098296|NCT03231943|581751252|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
161098297|NCT03231943|581751253|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098298|NCT03231943|581751254|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098299|NCT03231943|581751255|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098300|NCT03231943|581751256|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098301|NCT03231943|581751257|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098302|NCT03231943|581751258|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098303|NCT03231943|581751259|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098304|NCT03231943|581751260|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098305|NCT03231943|581751261|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098306|NCT03231943|581751262|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098307|NCT03231943|581751263|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098308|NCT03231943|581751264|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
161098309|NCT03231943|581751252|FG000|Part 2|Adverse Event|0|||
161098310|NCT03231943|581751253|FG001|Part 2|Adverse Event|0|||
161098311|NCT03231943|581751254|FG002|Part 2|Adverse Event|0|||
161098312|NCT03231943|581751255|FG003|Part 2|Adverse Event|0|||
161098313|NCT03231943|581751256|FG004|Part 2|Adverse Event|0|||
161098314|NCT03231943|581751257|FG005|Part 2|Adverse Event|0|||
161098315|NCT03231943|581751258|FG006|Part 2|Adverse Event|0|||
161098316|NCT03231943|581751259|FG007|Part 2|Adverse Event|0|||
161098317|NCT03231943|581751260|FG008|Part 2|Adverse Event|0|||
161098318|NCT03231943|581751261|FG009|Part 2|Adverse Event|0|||
161098319|NCT03231943|581751262|FG010|Part 2|Adverse Event|1|||
161098320|NCT03231943|581751263|FG011|Part 2|Adverse Event|0|||
161098321|NCT03231943|581751264|FG012|Part 2|Adverse Event|0|||
161098322|NCT03231943|581751252|FG000|Part 2|Withdrawal by Subject|0|||
161098323|NCT03231943|581751253|FG001|Part 2|Withdrawal by Subject|0|||
161098324|NCT03231943|581751254|FG002|Part 2|Withdrawal by Subject|0|||
161098325|NCT03231943|581751255|FG003|Part 2|Withdrawal by Subject|0|||
161098326|NCT03231943|581751256|FG004|Part 2|Withdrawal by Subject|0|||
161098327|NCT03231943|581751257|FG005|Part 2|Withdrawal by Subject|0|||
161098328|NCT03231943|581751258|FG006|Part 2|Withdrawal by Subject|0|||
161098329|NCT03231943|581751259|FG007|Part 2|Withdrawal by Subject|0|||
161098330|NCT03231943|581751260|FG008|Part 2|Withdrawal by Subject|0|||
161098331|NCT03231943|581751261|FG009|Part 2|Withdrawal by Subject|0|||
161098332|NCT03231943|581751262|FG010|Part 2|Withdrawal by Subject|0|||
161098333|NCT03231943|581751263|FG011|Part 2|Withdrawal by Subject|1|||
161098334|NCT03231943|581751264|FG012|Part 2|Withdrawal by Subject|0|||
161098335|NCT03471871|581751265|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161098336|NCT03471871|581751266|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161098337|NCT03471871|581751267|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
161098338|NCT03471871|581751268|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161098339|NCT03471871|581751269|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
161098340|NCT03471871|581751265|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161098341|NCT03471871|581751266|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161098342|NCT03471871|581751267|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
161098343|NCT03471871|581751268|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
161098344|NCT03471871|581751269|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
161098345|NCT03471871|581751265|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161098346|NCT03471871|581751266|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161098347|NCT03471871|581751267|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161098348|NCT03471871|581751268|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
161098349|NCT03471871|581751269|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
161098350|NCT03471871|581751265|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161098351|NCT03471871|581751266|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161098352|NCT03471871|581751267|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161098353|NCT03471871|581751268|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
161098354|NCT03471871|581751269|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
161098355|NCT03471871|581751265|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161098356|NCT03471871|581751266|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161098357|NCT03471871|581751267|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161098358|NCT03471871|581751268|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
161098359|NCT03471871|581751269|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
161098360|NCT00047320|581751270|FG000|Overall Study|Lack of Efficacy|8|||
161098361|NCT00047320|581751270|FG000|Overall Study|Lost to Follow-up|1|||
161098362|NCT00047320|581751270|FG000|Overall Study|Physician Decision|8|||
161098363|NCT00047320|581751270|FG000|Overall Study|Withdrawal by Subject|9|||
161098364|NCT00047320|581751270|FG000|Overall Study|Ineligible|2|||
161098365|NCT02818920|581751271|FG000|Overall Study|Unresectable|4|||
161098366|NCT02818920|581751271|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
161098367|NCT02818920|581751271|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
161098368|NCT02818920|581751271|FG000|Overall Study|Adverse Event|3|||
161098369|NCT02818920|581751271|FG000|Overall Study|Developed Other Disease|1|||
161098370|NCT02818920|581751271|FG000|Overall Study|Refused Further Treatment|1|||
161098371|NCT00445068|581751272|FG000|Overall Study|Disease progression|26|||
161098372|NCT00445068|581751272|FG000|Overall Study|Adverse Event|5|||
161098373|NCT00445068|581751272|FG000|Overall Study|Abnormal laboratory value|2|||
161098374|NCT00445068|581751272|FG000|Overall Study|Withdrawal by Subject|2|||
161098375|NCT00445068|581751272|FG000|Overall Study|Death|1|||
161098376|NCT02673619|581751273|FG000|Overall Study|Lost to Follow-up|1|||
161098377|NCT02673619|581751274|FG001|Overall Study|Lost to Follow-up|0|||
161098378|NCT02673619|581751275|FG002|Overall Study|Lost to Follow-up|0|||
161098379|NCT02673619|581751276|FG003|Overall Study|Lost to Follow-up|0|||
161098380|NCT02673619|581751273|FG000|Overall Study|Withdrawal by Subject|1|||
161098381|NCT02673619|581751274|FG001|Overall Study|Withdrawal by Subject|1|||
161098382|NCT02673619|581751275|FG002|Overall Study|Withdrawal by Subject|1|||
161098383|NCT02673619|581751276|FG003|Overall Study|Withdrawal by Subject|0|||
161098384|NCT02673619|581751273|FG000|Overall Study|Adverse Event|0|||
161098385|NCT02673619|581751274|FG001|Overall Study|Adverse Event|0|||
161098386|NCT02673619|581751275|FG002|Overall Study|Adverse Event|1|||
161098387|NCT02673619|581751276|FG003|Overall Study|Adverse Event|0|||
161098388|NCT02673619|581751273|FG000|Overall Study|Lack of Efficacy|0|||
161098389|NCT02673619|581751274|FG001|Overall Study|Lack of Efficacy|0|||
161098390|NCT02673619|581751275|FG002|Overall Study|Lack of Efficacy|1|||
161098391|NCT02673619|581751276|FG003|Overall Study|Lack of Efficacy|0|||
161098392|NCT03444324|581751277|FG000|Overall Study|Withdrawal by Subject|0|||
161098393|NCT03444324|581751278|FG001|Overall Study|Withdrawal by Subject|1|||
161098394|NCT03444324|581751277|FG000|Overall Study|Lost to Follow-up|4|||
161098395|NCT03444324|581751278|FG001|Overall Study|Lost to Follow-up|2|||
161098396|NCT03444324|581751277|FG000|Overall Study|Protocol Violation|0|||
161098397|NCT03444324|581751278|FG001|Overall Study|Protocol Violation|1|||
161098398|NCT03444324|581751277|FG000|Overall Study|Lack of Trial Compliance|1|||
161098399|NCT03444324|581751278|FG001|Overall Study|Lack of Trial Compliance|1|||
161098400|NCT03444324|581751277|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
161098401|NCT03444324|581751278|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
161098402|NCT00658684|581751279|FG000|Overall Study|Adverse Event|10|||
161098403|NCT00658684|581751280|FG001|Overall Study|Adverse Event|8|||
161098404|NCT00658684|581751281|FG002|Overall Study|Adverse Event|2|||
161098405|NCT00658684|581751282|FG003|Overall Study|Adverse Event|0|||
161098406|NCT00658684|581751279|FG000|Overall Study|Withdrawal by Subject|6|||
161098407|NCT00658684|581751280|FG001|Overall Study|Withdrawal by Subject|4|||
161098408|NCT00658684|581751281|FG002|Overall Study|Withdrawal by Subject|1|||
161098409|NCT00658684|581751282|FG003|Overall Study|Withdrawal by Subject|1|||
161098410|NCT00658684|581751279|FG000|Overall Study|Lack of Efficacy|1|||
161098411|NCT00658684|581751280|FG001|Overall Study|Lack of Efficacy|1|||
161098412|NCT00658684|581751281|FG002|Overall Study|Lack of Efficacy|0|||
161098413|NCT00658684|581751282|FG003|Overall Study|Lack of Efficacy|0|||
161098414|NCT00658684|581751279|FG000|Overall Study|Protocol Violation|1|||
161098415|NCT00658684|581751280|FG001|Overall Study|Protocol Violation|1|||
161098416|NCT00658684|581751281|FG002|Overall Study|Protocol Violation|0|||
161098417|NCT00658684|581751282|FG003|Overall Study|Protocol Violation|0|||
161098418|NCT00658684|581751279|FG000|Overall Study|Pregnancy|1|||
161098419|NCT00658684|581751280|FG001|Overall Study|Pregnancy|1|||
161098420|NCT00658684|581751281|FG002|Overall Study|Pregnancy|0|||
161098421|NCT00658684|581751282|FG003|Overall Study|Pregnancy|0|||
161098422|NCT00688103|581751283|FG000|Overall Study|Adverse Event|4|||
161098423|NCT00688103|581751284|FG001|Overall Study|Adverse Event|1|||
161098424|NCT00688103|581751283|FG000|Overall Study|Lack of Efficacy|11|||
161098425|NCT00688103|581751284|FG001|Overall Study|Lack of Efficacy|1|||
161098426|NCT00688103|581751283|FG000|Overall Study|Withdrawal by Subject|4|||
161098427|NCT00688103|581751284|FG001|Overall Study|Withdrawal by Subject|2|||
161098428|NCT00688103|581751283|FG000|Overall Study|complex reasons|11|||
161098429|NCT00688103|581751284|FG001|Overall Study|complex reasons|9|||
161098430|NCT05959629|581751288|FG000|Overall Study|partially necrotic/technical issues|2|||
161098431|NCT05959629|581751289|FG001|Overall Study|partially necrotic/technical issues|2|||
161098432|NCT02076113|581752551|FG000|Overall Study|Lost to Follow-up|4|||
161098433|NCT02076113|581752552|FG001|Overall Study|Lost to Follow-up|1|||
161098434|NCT02076113|581752551|FG000|Overall Study|Withdrawal by Subject|2|||
161098435|NCT02076113|581752552|FG001|Overall Study|Withdrawal by Subject|3|||
161098436|NCT02076113|581752551|FG000|Overall Study|Death|1|||
161098437|NCT02076113|581752552|FG001|Overall Study|Death|3|||
161098438|NCT04209621|581752555|FG000|Overall Study|Death|1|||
161098439|NCT04209621|581752555|FG000|Overall Study|Study Terminated Early|2|||
161098440|NCT02249767|581752556|FG000|Overall Study|Did not use medication|8|||
161098441|NCT02249767|581752557|FG001|Overall Study|Did not use medication|9|||
161098442|NCT02249767|581752558|FG002|Overall Study|Did not use medication|8|||
161098443|NCT01372410|581752559|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161098444|NCT01372410|581752560|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161212049|NCT02556632|582158516|FG000|Overall Study|Disliked Study Procedures|0|||
161212050|NCT02556632|582158517|FG001|Overall Study|Disliked Study Procedures|0|||
161098445|NCT01372410|581752561|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161098446|NCT01372410|581752562|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161098447|NCT01372410|581752563|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
161098448|NCT01372410|581752564|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161098449|NCT01372410|581752565|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161098450|NCT01372410|581752566|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
161098451|NCT01372410|581752559|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
161098452|NCT01372410|581752560|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
161098453|NCT01372410|581752561|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
161098454|NCT01372410|581752562|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
161098455|NCT01372410|581752563|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
161098456|NCT01372410|581752564|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
161098457|NCT01372410|581752565|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
161098458|NCT01372410|581752566|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
161098459|NCT01372410|581752559|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098460|NCT01372410|581752560|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098461|NCT01372410|581752561|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098462|NCT01372410|581752562|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098463|NCT01372410|581752563|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
161098464|NCT01372410|581752564|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098465|NCT01372410|581752565|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098466|NCT01372410|581752566|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161098467|NCT01372410|581752559|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098468|NCT01372410|581752560|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098469|NCT01372410|581752561|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098470|NCT01372410|581752562|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098471|NCT01372410|581752563|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098472|NCT01372410|581752564|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098473|NCT01372410|581752565|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
161323893|NCT04074330|582571939|FG000|Dose Expansion (up to 42 Months)|Death|0|||
161323894|NCT04074330|582571940|FG001|Dose Expansion (up to 42 Months)|Death|0|||
161323895|NCT04074330|582571941|FG002|Dose Expansion (up to 42 Months)|Death|0|||
161323896|NCT04074330|582571942|FG003|Dose Expansion (up to 42 Months)|Death|0|||
161323897|NCT04074330|582571943|FG004|Dose Expansion (up to 42 Months)|Death|0|||
161323898|NCT04074330|582571944|FG005|Dose Expansion (up to 42 Months)|Death|0|||
161323899|NCT04074330|582571945|FG006|Dose Expansion (up to 42 Months)|Death|0|||
161323900|NCT04074330|582571946|FG007|Dose Expansion (up to 42 Months)|Death|0|||
161323901|NCT04074330|582571947|FG008|Dose Expansion (up to 42 Months)|Death|1|||
161323902|NCT04074330|582571948|FG009|Dose Expansion (up to 42 Months)|Death|0|||
161323903|NCT04074330|582571939|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323904|NCT04074330|582571940|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323905|NCT04074330|582571941|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323906|NCT04074330|582571942|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323907|NCT04074330|582571943|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323908|NCT04074330|582571944|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323909|NCT04074330|582571945|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323910|NCT04074330|582571946|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
161323911|NCT04074330|582571947|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
161323912|NCT04074330|582571948|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
161323913|NCT01429298|582571953|FG000|Overall Study|Protocol Violation|4|||
161323914|NCT01429298|582571954|FG001|Overall Study|Protocol Violation|6|||
161323915|NCT02903420|582571955|FG000|Overall Study|Death|3|||
161323916|NCT00181883|582571958|FG000|Overall Study|Lack of Efficacy|2|||
161323917|NCT00181883|582571958|FG000|Overall Study|Treatment Limiting AEs|3|||
161323918|NCT00181883|582571958|FG000|Overall Study|Withdrawal by Subject|4|||
161323919|NCT00181883|582571958|FG000|Overall Study|Lost to Follow-up|1|||
161323920|NCT05305989|582571959|FG000|Overall Study|Other|3|||
161323921|NCT05305989|582571960|FG001|Overall Study|Other|2|||
161323922|NCT05305989|582571961|FG002|Overall Study|Other|0|||
161323923|NCT05305989|582571959|FG000|Overall Study|Sponsor decision|2|||
161323924|NCT05305989|582571960|FG001|Overall Study|Sponsor decision|1|||
161323925|NCT05305989|582571961|FG002|Overall Study|Sponsor decision|0|||
161323926|NCT05305989|582571959|FG000|Overall Study|Protocol Violation|0|||
161323927|NCT05305989|582571960|FG001|Overall Study|Protocol Violation|1|||
161323928|NCT05305989|582571961|FG002|Overall Study|Protocol Violation|0|||
161323929|NCT05305989|582571959|FG000|Overall Study|Investigator decision|1|||
161323930|NCT05305989|582571960|FG001|Overall Study|Investigator decision|2|||
161323931|NCT05305989|582571961|FG002|Overall Study|Investigator decision|0|||
161323932|NCT05305989|582571959|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
161323933|NCT05305989|582571960|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
161098474|NCT01372410|581752566|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
161098475|NCT01372410|581752559|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
161098476|NCT01372410|581752560|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161098477|NCT01372410|581752561|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161098478|NCT01372410|581752562|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161098479|NCT01372410|581752563|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161098480|NCT01372410|581752564|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161212051|NCT02556632|582158518|FG002|Overall Study|Disliked Study Procedures|1|||
161212052|NCT02556632|582158516|FG000|Overall Study|Treatment or Change Delay|0|||
161212053|NCT02556632|582158517|FG001|Overall Study|Treatment or Change Delay|0|||
161212054|NCT02556632|582158518|FG002|Overall Study|Treatment or Change Delay|1|||
161212055|NCT00808015|582158521|FG000|Overall Study|Death|1|||
161212056|NCT00808015|582158521|FG000|Overall Study|Lack of Efficacy|58|||
161212057|NCT00808015|582158521|FG000|Overall Study|Lost to Follow-up|76|||
161212058|NCT00808015|582158521|FG000|Overall Study|Participants not willing to participate|158|||
161212059|NCT00808015|582158521|FG000|Overall Study|Adverse Event|22|||
161212060|NCT00808015|582158521|FG000|Overall Study|Other|25|||
161212061|NCT00808015|582158521|FG000|Overall Study|Enrolled but not treated|4|||
161212062|NCT00084617|582158531|FG000|Overall Study|Withdrawal by Subject|7|||
161212063|NCT00084617|582158531|FG000|Overall Study|Lack of Efficacy|1|||
161212064|NCT00084617|582158531|FG000|Overall Study|Protocol Violation|1|||
161212065|NCT01625286|582158532|FG000|Overall Study|Adverse Event|0|||
161212066|NCT01625286|582158533|FG001|Overall Study|Adverse Event|0|||
161212067|NCT01625286|582158534|FG002|Overall Study|Adverse Event|0|||
161212068|NCT01625286|582158535|FG003|Overall Study|Adverse Event|0|||
161212069|NCT01625286|582158536|FG004|Overall Study|Adverse Event|1|||
161212070|NCT01625286|582158537|FG005|Overall Study|Adverse Event|2|||
161212071|NCT01625286|582158538|FG006|Overall Study|Adverse Event|1|||
161212072|NCT01625286|582158532|FG000|Overall Study|Death|0|||
161212073|NCT01625286|582158533|FG001|Overall Study|Death|0|||
161212074|NCT01625286|582158534|FG002|Overall Study|Death|1|||
161212075|NCT01625286|582158535|FG003|Overall Study|Death|1|||
161212076|NCT01625286|582158536|FG004|Overall Study|Death|0|||
161212077|NCT01625286|582158537|FG005|Overall Study|Death|11|||
161212078|NCT01625286|582158538|FG006|Overall Study|Death|16|||
161212079|NCT01625286|582158532|FG000|Overall Study|Withdrawal by Subject|0|||
161212080|NCT01625286|582158533|FG001|Overall Study|Withdrawal by Subject|1|||
161212081|NCT01625286|582158534|FG002|Overall Study|Withdrawal by Subject|0|||
161212082|NCT01625286|582158535|FG003|Overall Study|Withdrawal by Subject|1|||
161212083|NCT01625286|582158536|FG004|Overall Study|Withdrawal by Subject|0|||
161212084|NCT01625286|582158537|FG005|Overall Study|Withdrawal by Subject|0|||
161212085|NCT01625286|582158538|FG006|Overall Study|Withdrawal by Subject|1|||
161212086|NCT01625286|582158532|FG000|Overall Study|Any reason not specifically recorded|0|||
161212087|NCT01625286|582158533|FG001|Overall Study|Any reason not specifically recorded|0|||
161212088|NCT01625286|582158534|FG002|Overall Study|Any reason not specifically recorded|0|||
161212089|NCT01625286|582158535|FG003|Overall Study|Any reason not specifically recorded|0|||
161212090|NCT01625286|582158536|FG004|Overall Study|Any reason not specifically recorded|0|||
161212091|NCT01625286|582158537|FG005|Overall Study|Any reason not specifically recorded|1|||
161212092|NCT01625286|582158538|FG006|Overall Study|Any reason not specifically recorded|0|||
161212093|NCT01625286|582158532|FG000|Overall Study|Progressive disease|6|||
161212094|NCT01625286|582158533|FG001|Overall Study|Progressive disease|3|||
161212095|NCT01625286|582158534|FG002|Overall Study|Progressive disease|4|||
161212096|NCT01625286|582158535|FG003|Overall Study|Progressive disease|5|||
161212097|NCT01625286|582158536|FG004|Overall Study|Progressive disease|5|||
161212098|NCT01625286|582158537|FG005|Overall Study|Progressive disease|0|||
161212099|NCT01625286|582158538|FG006|Overall Study|Progressive disease|0|||
161212100|NCT01625286|582158532|FG000|Overall Study|Lost to Follow-up|0|||
161212101|NCT01625286|582158533|FG001|Overall Study|Lost to Follow-up|0|||
161212102|NCT01625286|582158534|FG002|Overall Study|Lost to Follow-up|0|||
161212103|NCT01625286|582158535|FG003|Overall Study|Lost to Follow-up|0|||
161212104|NCT01625286|582158536|FG004|Overall Study|Lost to Follow-up|0|||
161212105|NCT01625286|582158537|FG005|Overall Study|Lost to Follow-up|0|||
161212106|NCT01625286|582158538|FG006|Overall Study|Lost to Follow-up|1|||
161212107|NCT04355767|582158539|FG000|Overall Study|Withdrawal by Subject|2|||
161212108|NCT04355767|582158540|FG001|Overall Study|Withdrawal by Subject|2|||
161212109|NCT04355767|582158539|FG000|Overall Study|Death|5|||
161212110|NCT04355767|582158540|FG001|Overall Study|Death|1|||
161212111|NCT04523831|582158542|FG000|Overall Study|Lost to Follow-up|15|||
161212112|NCT04523831|582158543|FG001|Overall Study|Lost to Follow-up|17|||
161212113|NCT04523831|582158542|FG000|Overall Study|Death|0|||
161212114|NCT04523831|582158543|FG001|Overall Study|Death|3|||
161212115|NCT04523831|582158542|FG000|Overall Study|Adverse Event|2|||
161212116|NCT04523831|582158543|FG001|Overall Study|Adverse Event|0|||
161212117|NCT00686790|582160027|FG000|Overall Study|Adverse Event|2|||
161212118|NCT00686790|582160027|FG000|Overall Study|Withdrawal by Subject|1|||
161212119|NCT00686790|582160027|FG000|Overall Study|Death|1|||
161212120|NCT00686790|582160027|FG000|Overall Study|Lost to Follow-up|12|||
161098481|NCT01372410|581752565|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
161098482|NCT01372410|581752566|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
161098483|NCT01372410|581752559|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098484|NCT01372410|581752560|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098485|NCT01372410|581752561|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098486|NCT01372410|581752562|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098487|NCT01372410|581752563|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
161098488|NCT01372410|581752564|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098489|NCT01372410|581752565|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098490|NCT01372410|581752566|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
161098491|NCT01372410|581752559|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161098492|NCT01372410|581752560|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161098493|NCT01372410|581752561|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161098494|NCT01372410|581752562|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161098495|NCT01372410|581752563|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161098496|NCT01372410|581752564|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
161098497|NCT01372410|581752565|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161098498|NCT01372410|581752566|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
161212121|NCT00096382|582160028|FG000|Overall Study|Not treated|1|||
161098499|NCT01372410|581752559|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098500|NCT01372410|581752560|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098501|NCT01372410|581752561|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098502|NCT01372410|581752562|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098503|NCT01372410|581752563|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098504|NCT01372410|581752564|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098505|NCT01372410|581752565|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
161098506|NCT01372410|581752566|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
161098507|NCT01372410|581752559|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098508|NCT01372410|581752560|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098509|NCT01372410|581752561|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
161098510|NCT01372410|581752562|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098511|NCT01372410|581752563|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098512|NCT01372410|581752564|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098513|NCT01372410|581752565|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098514|NCT01372410|581752566|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
161098515|NCT01372410|581752559|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098516|NCT01372410|581752560|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098517|NCT01372410|581752561|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098518|NCT01372410|581752562|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098519|NCT01372410|581752563|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098520|NCT01372410|581752564|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
161098521|NCT01372410|581752565|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098522|NCT01372410|581752566|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
161098523|NCT04585646|581752567|FG000|First Intervention|Physician Decision|1|||
161098524|NCT04585646|581752568|FG001|First Intervention|Physician Decision|0|||
161098525|NCT04585646|581752567|FG000|First Intervention|Lost to Follow-up|0|||
161098526|NCT04585646|581752568|FG001|First Intervention|Lost to Follow-up|3|||
161098527|NCT04585646|581752567|FG000|First Intervention|Withdrawal by Subject|0|||
161098528|NCT04585646|581752568|FG001|First Intervention|Withdrawal by Subject|1|||
160861857|NCT02531802|580887853|FG008|Received Vaccination 2|Adverse Event|0|||
161098529|NCT04614662|581752571|FG000|Overall Study|Withdrawal by Subject|0|||
161098530|NCT04614662|581752572|FG001|Overall Study|Withdrawal by Subject|1|||
161098531|NCT01862640|581752580|FG000|Overall Study|Adverse Event|4|||
161212122|NCT00096382|582160029|FG001|Overall Study|Not treated|0|||
161098532|NCT01862640|581752581|FG001|Overall Study|Adverse Event|10|||
161098533|NCT01862640|581752582|FG002|Overall Study|Adverse Event|6|||
161098534|NCT01862640|581752583|FG003|Overall Study|Adverse Event|8|||
161098535|NCT01862640|581752580|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161098536|NCT01862640|581752581|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161098537|NCT01862640|581752582|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
161098538|NCT01862640|581752583|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161098539|NCT01862640|581752580|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
161098540|NCT01862640|581752581|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
161098541|NCT01862640|581752582|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
161098542|NCT01862640|581752583|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
161098543|NCT01862640|581752580|FG000|Overall Study|Withdrawal by Subject|2|||
161098544|NCT01862640|581752581|FG001|Overall Study|Withdrawal by Subject|4|||
161098545|NCT01862640|581752582|FG002|Overall Study|Withdrawal by Subject|8|||
161098546|NCT01862640|581752583|FG003|Overall Study|Withdrawal by Subject|5|||
161098547|NCT01862640|581752580|FG000|Overall Study|Protocol Deviation|0|||
161098548|NCT01862640|581752581|FG001|Overall Study|Protocol Deviation|0|||
161098549|NCT01862640|581752582|FG002|Overall Study|Protocol Deviation|1|||
161098550|NCT01862640|581752583|FG003|Overall Study|Protocol Deviation|0|||
161098551|NCT02178553|581752586|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
161098552|NCT02178553|581752587|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
161098553|NCT02178553|581752586|FG000|Overall Study|Physician Decision|0|||
161098554|NCT02178553|581752587|FG001|Overall Study|Physician Decision|4|||
161098555|NCT02178553|581752586|FG000|Overall Study|Technical problem with injection|1|||
161098556|NCT02178553|581752587|FG001|Overall Study|Technical problem with injection|3|||
161098557|NCT05085665|581752588|FG000|Overall Study|Physician Decision|2|||
161098558|NCT03294109|581752589|FG000|Overall Study|Withdrawal by Subject|6|||
161098559|NCT03294109|581752590|FG001|Overall Study|Withdrawal by Subject|5|||
161098560|NCT01717768|581752591|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098561|NCT01717768|581752592|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
161098562|NCT01717768|581752593|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098563|NCT01717768|581752594|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098564|NCT01717768|581752595|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161339853|NCT05507437|582633392|FG000|Overall Study|Withdrawal by Subject|1|||
161339854|NCT05507437|582633393|FG001|Overall Study|Withdrawal by Subject|1|||
161339855|NCT05507437|582633392|FG000|Overall Study|Death|3|||
161339856|NCT05507437|582633393|FG001|Overall Study|Death|0|||
161339857|NCT06583096|582633394|FG000|Overall Study|Lost to Follow-up|4|||
161339858|NCT06583096|582633395|FG001|Overall Study|Lost to Follow-up|10|||
161339859|NCT06583096|582633394|FG000|Overall Study|Withdrawal by Subject|0|||
161339860|NCT06583096|582633395|FG001|Overall Study|Withdrawal by Subject|2|||
161339861|NCT05172609|582633396|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
161339862|NCT05172609|582633397|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
161339863|NCT05172609|582633396|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
161339864|NCT05172609|582633397|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
161339865|NCT05172609|582633396|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
161339866|NCT05172609|582633397|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
161339867|NCT05610605|582633400|FG000|6-month Assessment|Death|1|||
161339868|NCT05610605|582633401|FG001|6-month Assessment|Death|1|||
161339869|NCT05610605|582633400|FG000|6-month Assessment|Lost to Follow-up|20|||
161339870|NCT05610605|582633401|FG001|6-month Assessment|Lost to Follow-up|0|||
161339871|NCT05610605|582633400|FG000|6-month Assessment|Institutionalized|1|||
161339872|NCT05610605|582633401|FG001|6-month Assessment|Institutionalized|2|||
161339873|NCT05610605|582633400|FG000|12-month Assessment|Death|2|||
161339874|NCT05610605|582633401|FG001|12-month Assessment|Death|1|||
161339875|NCT05610605|582633400|FG000|12-month Assessment|Lost to Follow-up|1|||
161339876|NCT05610605|582633401|FG001|12-month Assessment|Lost to Follow-up|4|||
161339877|NCT05610605|582633400|FG000|12-month Assessment|Institutionalized|2|||
161339878|NCT05610605|582633401|FG001|12-month Assessment|Institutionalized|1|||
161339879|NCT00753519|582633402|FG000|Overall Study|Withdrawal by Subject|0|||
161339880|NCT00753519|582633403|FG001|Overall Study|Withdrawal by Subject|2|||
161339881|NCT00042289|582633404|FG000|Overall Study|Lost to Follow-up|3|||
161339882|NCT00042289|582633405|FG001|Overall Study|Lost to Follow-up|0|||
161339883|NCT00042289|582633406|FG002|Overall Study|Lost to Follow-up|0|||
161339884|NCT00042289|582633407|FG003|Overall Study|Lost to Follow-up|1|||
161339885|NCT00042289|582633408|FG004|Overall Study|Lost to Follow-up|3|||
161339886|NCT00042289|582633409|FG005|Overall Study|Lost to Follow-up|3|||
161339887|NCT00042289|582633410|FG006|Overall Study|Lost to Follow-up|6|||
161339888|NCT00042289|582633411|FG007|Overall Study|Lost to Follow-up|1|||
161339889|NCT00042289|582633412|FG008|Overall Study|Lost to Follow-up|1|||
161339890|NCT00042289|582633413|FG009|Overall Study|Lost to Follow-up|0|||
161339891|NCT00042289|582633414|FG010|Overall Study|Lost to Follow-up|0|||
161098565|NCT01717768|581752596|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098566|NCT01717768|581752597|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098567|NCT01717768|581752598|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098568|NCT01717768|581752599|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098569|NCT01717768|581752600|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098570|NCT01717768|581752601|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161212123|NCT00096382|582160028|FG000|Overall Study|Death during treatment|1|||
161212124|NCT00096382|582160029|FG001|Overall Study|Death during treatment|0|||
161212125|NCT03862625|582160030|FG000|Overall Study|Lost to Follow-up|0|||
161212126|NCT03862625|582160031|FG001|Overall Study|Lost to Follow-up|1|||
161212127|NCT01835132|582160032|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
161212128|NCT01681771|582160033|FG000|Overall Study|Lost to Follow-up|4|||
161212129|NCT01681771|582160034|FG001|Overall Study|Lost to Follow-up|2|||
161212130|NCT04242186|582160042|FG000|Overall Study|Death|5|||
161212131|NCT00550420|582160045|FG000|Overall Study|Adverse Event|28|||
161212132|NCT00550420|582160045|FG000|Overall Study|Lost to Follow-up|8|||
161212133|NCT00550420|582160045|FG000|Overall Study|Protocol Violation|11|||
161212134|NCT00550420|582160045|FG000|Overall Study|Withdrawal by Subject|30|||
161212135|NCT00550420|582160045|FG000|Overall Study|Still in study at termination|206|||
161212136|NCT00550420|582160045|FG000|Overall Study|Missing|2|||
161212137|NCT00550420|582160045|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
161212138|NCT00550420|582160045|FG000|Overall Study|Investigators opinion|1|||
161212139|NCT00550420|582160045|FG000|Overall Study|Lack of curative effect|1|||
161212140|NCT00550420|582160045|FG000|Overall Study|Unethical stop of enrollment|2|||
161212141|NCT00550420|582160045|FG000|Overall Study|Caregiver's decision to withdraw|1|||
161212142|NCT00550420|582160045|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
161212143|NCT00550420|582160045|FG000|Overall Study|Exclusion criteria|1|||
161212144|NCT00550420|582160045|FG000|Overall Study|Prohibited medicine|1|||
161212145|NCT00782275|582160046|FG000|Overall Study|Adverse Event|11|||
161212146|NCT00782275|582160046|FG000|Overall Study|Withdrawal by Subject|1|||
161212147|NCT00782275|582160046|FG000|Overall Study|Progressive Disease|21|||
161212148|NCT00782275|582160046|FG000|Overall Study|Physician Decision|4|||
161212149|NCT00782275|582160046|FG000|Overall Study|Not started treatment|1|||
161212150|NCT00782275|582160046|FG000|Overall Study|Other|3|||
161212151|NCT04378010|582160047|FG000|Overall Study|Adverse Event|8|||
161212152|NCT04378010|582160048|FG001|Overall Study|Adverse Event|14|||
161212153|NCT04378010|582160049|FG002|Overall Study|Adverse Event|4|||
161212154|NCT04378010|582160047|FG000|Overall Study|Withdrawal by Subject|0|||
161212155|NCT04378010|582160048|FG001|Overall Study|Withdrawal by Subject|2|||
161212156|NCT04378010|582160049|FG002|Overall Study|Withdrawal by Subject|1|||
161212157|NCT04378010|582160047|FG000|Overall Study|Protocol Violation|2|||
161212158|NCT04378010|582160048|FG001|Overall Study|Protocol Violation|1|||
161212159|NCT04378010|582160049|FG002|Overall Study|Protocol Violation|4|||
161212160|NCT04378010|582160047|FG000|Overall Study|Study terminated by Sponsor|22|||
161212161|NCT04378010|582160048|FG001|Overall Study|Study terminated by Sponsor|16|||
161212162|NCT04378010|582160049|FG002|Overall Study|Study terminated by Sponsor|22|||
161212163|NCT04378010|582160047|FG000|Overall Study|Subject inability to complete study visit|0|||
161212164|NCT04378010|582160048|FG001|Overall Study|Subject inability to complete study visit|0|||
161212165|NCT04378010|582160049|FG002|Overall Study|Subject inability to complete study visit|1|||
161212166|NCT04378010|582160047|FG000|Overall Study|Subject never dosed|0|||
161212167|NCT04378010|582160048|FG001|Overall Study|Subject never dosed|1|||
161212168|NCT04378010|582160049|FG002|Overall Study|Subject never dosed|0|||
161212169|NCT01792284|582160050|FG000|Lead-in Period|Adverse Event|15|||
161212170|NCT01792284|582160051|FG001|Lead-in Period|Adverse Event|0|||
161212171|NCT01792284|582160052|FG002|Lead-in Period|Adverse Event|0|||
161212172|NCT01792284|582160050|FG000|Lead-in Period|Lost to Follow-up|2|||
161212173|NCT01792284|582160051|FG001|Lead-in Period|Lost to Follow-up|0|||
161212174|NCT01792284|582160052|FG002|Lead-in Period|Lost to Follow-up|0|||
161212175|NCT01792284|582160050|FG000|Lead-in Period|Protocol Violation|1|||
161212176|NCT01792284|582160051|FG001|Lead-in Period|Protocol Violation|0|||
161212177|NCT01792284|582160052|FG002|Lead-in Period|Protocol Violation|0|||
161212178|NCT01792284|582160050|FG000|Lead-in Period|Withdrawal by Subject|10|||
161212179|NCT01792284|582160051|FG001|Lead-in Period|Withdrawal by Subject|0|||
161212180|NCT01792284|582160052|FG002|Lead-in Period|Withdrawal by Subject|0|||
161212181|NCT01792284|582160050|FG000|Lead-in Period|Physician Decision|1|||
161212182|NCT01792284|582160051|FG001|Lead-in Period|Physician Decision|0|||
161212183|NCT01792284|582160052|FG002|Lead-in Period|Physician Decision|0|||
161212184|NCT01792284|582160050|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
161212185|NCT01792284|582160051|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
161212186|NCT01792284|582160052|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
161212187|NCT01792284|582160050|FG000|Randomization Period 1|Withdrawal by Subject|0|||
161212188|NCT01792284|582160051|FG001|Randomization Period 1|Withdrawal by Subject|1|||
161212189|NCT01792284|582160052|FG002|Randomization Period 1|Withdrawal by Subject|1|||
161212190|NCT01792284|582160050|FG000|Randomization Period 1|Physician Decision|0|||
161212191|NCT01792284|582160051|FG001|Randomization Period 1|Physician Decision|1|||
161212192|NCT01792284|582160052|FG002|Randomization Period 1|Physician Decision|1|||
161212193|NCT01792284|582160050|FG000|Randomization Period 1|Adverse Event|0|||
161212194|NCT01792284|582160051|FG001|Randomization Period 1|Adverse Event|0|||
161212195|NCT01792284|582160052|FG002|Randomization Period 1|Adverse Event|2|||
161212196|NCT01792284|582160050|FG000|Randomization Period 1|Lost to Follow-up|0|||
161212197|NCT01792284|582160051|FG001|Randomization Period 1|Lost to Follow-up|0|||
161212198|NCT01792284|582160052|FG002|Randomization Period 1|Lost to Follow-up|1|||
161212199|NCT01792284|582160050|FG000|Randomization Period 2|Protocol Violation|0|||
161098571|NCT01717768|581752602|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
161098572|NCT01717768|581752591|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098573|NCT01717768|581752592|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098574|NCT01717768|581752593|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098575|NCT01717768|581752594|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098576|NCT01717768|581752595|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098577|NCT01717768|581752596|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098578|NCT01717768|581752597|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098579|NCT01717768|581752598|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098580|NCT01717768|581752599|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098581|NCT01717768|581752600|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098582|NCT01717768|581752601|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
161098583|NCT01717768|581752602|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
161098584|NCT01717768|581752591|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098585|NCT01717768|581752592|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098586|NCT01717768|581752593|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161212200|NCT01792284|582160051|FG001|Randomization Period 2|Protocol Violation|1|||
161212201|NCT01792284|582160052|FG002|Randomization Period 2|Protocol Violation|0|||
161212202|NCT01792284|582160050|FG000|Randomization Period 2|Withdrawal by Subject|0|||
161212203|NCT01792284|582160051|FG001|Randomization Period 2|Withdrawal by Subject|2|||
161212204|NCT01792284|582160052|FG002|Randomization Period 2|Withdrawal by Subject|0|||
161212205|NCT02019979|582160053|FG000|Overall Study|study terminated|14|||
161212206|NCT00379587|582160059|FG000|Overall Study|Lost to Follow-up|2|||
161212207|NCT03237611|582160060|FG000|Overall Study|Withdrawal by Subject|1|||
161212208|NCT03237611|582160060|FG000|Overall Study|Ineligible|1|||
161212209|NCT01169649|582160064|FG000|Overall Study|Patient Not Treated|3|||
161212210|NCT00534092|582160065|FG000|Overall Study|Lost to Follow-up|1|||
161212211|NCT00534092|582160066|FG001|Overall Study|Lost to Follow-up|0|||
161212212|NCT00534092|582160065|FG000|Overall Study|personal reasons/family concerns|1|||
161212213|NCT00534092|582160066|FG001|Overall Study|personal reasons/family concerns|0|||
161212214|NCT02919475|582160067|FG000|Overall Study|Adverse Event|3|||
161212215|NCT02919475|582160068|FG001|Overall Study|Adverse Event|3|||
161212216|NCT02919475|582160069|FG002|Overall Study|Adverse Event|3|||
161212217|NCT02919475|582160070|FG003|Overall Study|Adverse Event|9|||
161212218|NCT02919475|582160071|FG004|Overall Study|Adverse Event|2|||
161212219|NCT02919475|582160067|FG000|Overall Study|Death|0|||
161212220|NCT02919475|582160068|FG001|Overall Study|Death|1|||
161212221|NCT02919475|582160069|FG002|Overall Study|Death|0|||
161212222|NCT02919475|582160070|FG003|Overall Study|Death|0|||
161212223|NCT02919475|582160071|FG004|Overall Study|Death|0|||
161212224|NCT02919475|582160067|FG000|Overall Study|Lost to Follow-up|0|||
161212225|NCT02919475|582160068|FG001|Overall Study|Lost to Follow-up|0|||
161212226|NCT02919475|582160069|FG002|Overall Study|Lost to Follow-up|0|||
161212227|NCT02919475|582160070|FG003|Overall Study|Lost to Follow-up|1|||
161212228|NCT02919475|582160071|FG004|Overall Study|Lost to Follow-up|0|||
161212229|NCT02919475|582160067|FG000|Overall Study|Withdrawal by Subject|2|||
161212230|NCT02919475|582160068|FG001|Overall Study|Withdrawal by Subject|3|||
161212231|NCT02919475|582160069|FG002|Overall Study|Withdrawal by Subject|1|||
161212232|NCT02919475|582160070|FG003|Overall Study|Withdrawal by Subject|2|||
161212233|NCT02919475|582160071|FG004|Overall Study|Withdrawal by Subject|2|||
161212234|NCT02919475|582160067|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161212235|NCT02919475|582160068|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161212236|NCT02919475|582160069|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161212237|NCT02919475|582160070|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
161212238|NCT02919475|582160071|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161212239|NCT02323295|582160072|FG000|Overall Study|Adverse Event|0|||
161212240|NCT02323295|582160073|FG001|Overall Study|Adverse Event|1|||
161212241|NCT02323295|582160072|FG000|Overall Study|Withdrawal by Subject|0|||
161212242|NCT02323295|582160073|FG001|Overall Study|Withdrawal by Subject|1|||
161212243|NCT02323295|582160072|FG000|Overall Study|Patient did not have surgery as planned.|0|||
161212244|NCT02323295|582160073|FG001|Overall Study|Patient did not have surgery as planned.|1|||
161212245|NCT02370784|582160074|FG000|Overall Study|Patient started prohibited medication|0|||
161212246|NCT02370784|582160075|FG001|Overall Study|Patient started prohibited medication|1|||
161212247|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161212248|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
161212249|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161212250|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
161212251|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
161212252|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
161212253|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
161212254|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
161212255|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
161212256|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
161212257|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
161212258|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
161212259|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
161212260|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
161212261|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
161212262|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
161212263|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
161212264|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
161212265|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
161212266|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
161212267|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
161212268|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
161212269|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
161212270|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
161212271|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
161098587|NCT01717768|581752594|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098588|NCT01717768|581752595|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098589|NCT01717768|581752596|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098590|NCT01717768|581752597|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098591|NCT01717768|581752598|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
161098592|NCT01717768|581752599|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098593|NCT01717768|581752600|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098594|NCT01717768|581752601|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098595|NCT01717768|581752602|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
161098596|NCT01717768|581752591|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098597|NCT01717768|581752592|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098598|NCT01717768|581752593|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098599|NCT01717768|581752594|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098600|NCT01717768|581752595|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098601|NCT01717768|581752596|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098602|NCT01717768|581752597|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098603|NCT01717768|581752598|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098604|NCT01717768|581752599|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098605|NCT01717768|581752600|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
161098606|NCT01717768|581752601|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098607|NCT01717768|581752602|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
161098608|NCT01182766|581752603|FG000|Overall Study|Lost to Follow-up|32|||
161098609|NCT01182766|581752604|FG001|Overall Study|Lost to Follow-up|36|||
161098610|NCT01182766|581752605|FG002|Overall Study|Lost to Follow-up|29|||
161098611|NCT01182766|581752603|FG000|Overall Study|Withdrawal by Subject|14|||
161098612|NCT01182766|581752604|FG001|Overall Study|Withdrawal by Subject|3|||
161098613|NCT01182766|581752605|FG002|Overall Study|Withdrawal by Subject|6|||
161212272|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
161212273|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
161339892|NCT00042289|582633415|FG011|Overall Study|Lost to Follow-up|0|||
161339893|NCT00042289|582633416|FG012|Overall Study|Lost to Follow-up|0|||
161339894|NCT00042289|582633417|FG013|Overall Study|Lost to Follow-up|0|||
161339895|NCT00042289|582633418|FG014|Overall Study|Lost to Follow-up|0|||
161339896|NCT00042289|582633419|FG015|Overall Study|Lost to Follow-up|1|||
161339897|NCT00042289|582633420|FG016|Overall Study|Lost to Follow-up|1|||
161339898|NCT00042289|582633421|FG017|Overall Study|Lost to Follow-up|0|||
161339899|NCT00042289|582633422|FG018|Overall Study|Lost to Follow-up|3|||
161339900|NCT00042289|582633423|FG019|Overall Study|Lost to Follow-up|2|||
161339901|NCT00042289|582633424|FG020|Overall Study|Lost to Follow-up|0|||
161339902|NCT00042289|582633425|FG021|Overall Study|Lost to Follow-up|0|||
161339903|NCT00042289|582633426|FG022|Overall Study|Lost to Follow-up|0|||
161339904|NCT00042289|582633427|FG023|Overall Study|Lost to Follow-up|0|||
161339905|NCT00042289|582633428|FG024|Overall Study|Lost to Follow-up|0|||
161339906|NCT00042289|582633429|FG025|Overall Study|Lost to Follow-up|0|||
161339907|NCT00042289|582633430|FG026|Overall Study|Lost to Follow-up|2|||
161339908|NCT00042289|582633431|FG027|Overall Study|Lost to Follow-up|2|||
161339909|NCT00042289|582633432|FG028|Overall Study|Lost to Follow-up|2|||
161339910|NCT00042289|582633433|FG029|Overall Study|Lost to Follow-up|0|||
161339911|NCT00042289|582633434|FG030|Overall Study|Lost to Follow-up|0|||
161339912|NCT00042289|582633435|FG031|Overall Study|Lost to Follow-up|2|||
161339913|NCT00042289|582633436|FG032|Overall Study|Lost to Follow-up|1|||
161339914|NCT00042289|582633437|FG033|Overall Study|Lost to Follow-up|1|||
161339915|NCT00042289|582633438|FG034|Overall Study|Lost to Follow-up|1|||
161339916|NCT00042289|582633439|FG035|Overall Study|Lost to Follow-up|2|||
161339917|NCT00042289|582633440|FG036|Overall Study|Lost to Follow-up|1|||
161339918|NCT00042289|582633441|FG037|Overall Study|Lost to Follow-up|1|||
161339919|NCT00042289|582633442|FG038|Overall Study|Lost to Follow-up|0|||
161339920|NCT00042289|582633443|FG039|Overall Study|Lost to Follow-up|5|||
161339921|NCT00042289|582633444|FG040|Overall Study|Lost to Follow-up|0|||
161339922|NCT00042289|582633445|FG041|Overall Study|Lost to Follow-up|2|||
161339923|NCT00042289|582633446|FG042|Overall Study|Lost to Follow-up|2|||
161339924|NCT00042289|582633447|FG043|Overall Study|Lost to Follow-up|0|||
161339925|NCT00042289|582633448|FG044|Overall Study|Lost to Follow-up|0|||
161339926|NCT00042289|582633449|FG045|Overall Study|Lost to Follow-up|1|||
161339927|NCT00042289|582633450|FG046|Overall Study|Lost to Follow-up|0|||
161339928|NCT00042289|582633404|FG000|Overall Study|Other reason|0|||
161339929|NCT00042289|582633405|FG001|Overall Study|Other reason|0|||
161339930|NCT00042289|582633406|FG002|Overall Study|Other reason|0|||
161339931|NCT00042289|582633407|FG003|Overall Study|Other reason|2|||
161339932|NCT00042289|582633408|FG004|Overall Study|Other reason|0|||
161339933|NCT00042289|582633409|FG005|Overall Study|Other reason|0|||
161339934|NCT00042289|582633410|FG006|Overall Study|Other reason|0|||
161098614|NCT01182766|581752603|FG000|Overall Study|Physician Decision|1|||
161098615|NCT01182766|581752604|FG001|Overall Study|Physician Decision|0|||
161098616|NCT01182766|581752605|FG002|Overall Study|Physician Decision|0|||
161098617|NCT01182766|581752603|FG000|Overall Study|Non-compliance|1|||
161098618|NCT01182766|581752604|FG001|Overall Study|Non-compliance|1|||
161098619|NCT01182766|581752605|FG002|Overall Study|Non-compliance|1|||
161098620|NCT00372385|581752606|FG000|Overall Study|Adverse Event|6|||
161098621|NCT00372385|581752607|FG001|Overall Study|Adverse Event|11|||
161098622|NCT00372385|581752608|FG002|Overall Study|Adverse Event|9|||
161098623|NCT00372385|581752609|FG003|Overall Study|Adverse Event|7|||
161098624|NCT00372385|581752606|FG000|Overall Study|Noncompliance|0|||
161098625|NCT00372385|581752607|FG001|Overall Study|Noncompliance|1|||
161098626|NCT00372385|581752608|FG002|Overall Study|Noncompliance|1|||
161098627|NCT00372385|581752609|FG003|Overall Study|Noncompliance|1|||
161098628|NCT00372385|581752606|FG000|Overall Study|Physician Decision|1|||
161098629|NCT00372385|581752607|FG001|Overall Study|Physician Decision|0|||
161098630|NCT00372385|581752608|FG002|Overall Study|Physician Decision|0|||
161098631|NCT00372385|581752609|FG003|Overall Study|Physician Decision|0|||
161098632|NCT00372385|581752606|FG000|Overall Study|Lost to Follow-up|2|||
161098633|NCT00372385|581752607|FG001|Overall Study|Lost to Follow-up|0|||
161098634|NCT00372385|581752608|FG002|Overall Study|Lost to Follow-up|0|||
161098635|NCT00372385|581752609|FG003|Overall Study|Lost to Follow-up|0|||
161098636|NCT00372385|581752606|FG000|Overall Study|Withdrawal by Subject|2|||
161098637|NCT00372385|581752607|FG001|Overall Study|Withdrawal by Subject|1|||
161098638|NCT00372385|581752608|FG002|Overall Study|Withdrawal by Subject|0|||
161098639|NCT00372385|581752609|FG003|Overall Study|Withdrawal by Subject|0|||
161098640|NCT00372385|581752606|FG000|Overall Study|Refusal of Treatment|3|||
161098641|NCT00372385|581752607|FG001|Overall Study|Refusal of Treatment|6|||
161098642|NCT00372385|581752608|FG002|Overall Study|Refusal of Treatment|0|||
161212274|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
161098643|NCT00372385|581752609|FG003|Overall Study|Refusal of Treatment|0|||
161098644|NCT00372385|581752606|FG000|Overall Study|No Response|1|||
161098645|NCT00372385|581752607|FG001|Overall Study|No Response|1|||
161212275|NCT01872689|582160080|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
161098646|NCT00372385|581752608|FG002|Overall Study|No Response|0|||
161098647|NCT00372385|581752609|FG003|Overall Study|No Response|0|||
161098648|NCT00372385|581752606|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
161098649|NCT00372385|581752607|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161098650|NCT00372385|581752608|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161212276|NCT01872689|582160081|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
161212277|NCT01872689|582160082|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
161212278|NCT01872689|582160083|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
161212279|NCT01872689|582160080|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
161212280|NCT01872689|582160081|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
161212281|NCT01872689|582160082|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
161212282|NCT01872689|582160083|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
161212283|NCT01872689|582160080|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
161212284|NCT01872689|582160081|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
161212285|NCT01872689|582160082|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
161212286|NCT01872689|582160083|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
161212287|NCT01872689|582160080|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161212288|NCT01872689|582160081|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
161212289|NCT01872689|582160082|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161212290|NCT01872689|582160083|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
161212291|NCT01872689|582160080|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
161212292|NCT01872689|582160081|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
161212293|NCT01872689|582160082|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
161212294|NCT01872689|582160083|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
161212295|NCT01872689|582160080|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
161212296|NCT01872689|582160081|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
161212297|NCT01872689|582160082|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
161212298|NCT01872689|582160083|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
161212299|NCT01872689|582160080|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
161212300|NCT01872689|582160081|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
161212301|NCT01872689|582160082|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
161212302|NCT01872689|582160083|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
161212303|NCT01456052|582160084|FG000|Overall Study|Adverse Event|1|||
161212304|NCT01456052|582160085|FG001|Overall Study|Adverse Event|1|||
161212305|NCT01456052|582160086|FG002|Overall Study|Adverse Event|2|||
161212306|NCT01456052|582160084|FG000|Overall Study|Consent withdrawn|0|||
161212307|NCT01456052|582160085|FG001|Overall Study|Consent withdrawn|2|||
161212308|NCT01456052|582160086|FG002|Overall Study|Consent withdrawn|1|||
161212309|NCT01456052|582160084|FG000|Overall Study|Protocol Violation|0|||
161212310|NCT01456052|582160085|FG001|Overall Study|Protocol Violation|1|||
161212311|NCT01456052|582160086|FG002|Overall Study|Protocol Violation|0|||
161212312|NCT01456052|582160084|FG000|Overall Study|Physician Decision|1|||
161212313|NCT01456052|582160085|FG001|Overall Study|Physician Decision|0|||
161212314|NCT01456052|582160086|FG002|Overall Study|Physician Decision|1|||
161212315|NCT01456052|582160084|FG000|Overall Study|Treatment Failure|0|||
161212316|NCT01456052|582160085|FG001|Overall Study|Treatment Failure|1|||
161212317|NCT01456052|582160086|FG002|Overall Study|Treatment Failure|1|||
161212318|NCT02762565|582160089|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
161212319|NCT01113710|582160090|FG000|Overall Study|Adverse Event|64|||
161212320|NCT01113710|582160090|FG000|Overall Study|Lack of Efficacy|41|||
161212321|NCT01113710|582160090|FG000|Overall Study|No Information Available|40|||
161212322|NCT01113710|582160090|FG000|Overall Study|Withdrawal by Subject|28|||
161212323|NCT01113710|582160090|FG000|Overall Study|Lost to Follow-up|20|||
161212324|NCT01113710|582160090|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
161212325|NCT01113710|582160090|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
161212326|NCT01113710|582160090|FG000|Overall Study|Lack of Patient's Compliance|8|||
161212327|NCT01113710|582160090|FG000|Overall Study|Other|7|||
161212328|NCT01113710|582160090|FG000|Overall Study|Adverse Event/Other|5|||
161212329|NCT01113710|582160090|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
161212330|NCT01113710|582160090|FG000|Overall Study|Lack of Efficacy/Other|4|||
161098651|NCT00372385|581752609|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
161098652|NCT00372385|581752606|FG000|Overall Study|Virologic Stopping Rule|17|||
161098653|NCT00372385|581752607|FG001|Overall Study|Virologic Stopping Rule|0|||
161098654|NCT00372385|581752608|FG002|Overall Study|Virologic Stopping Rule|0|||
161098655|NCT00372385|581752609|FG003|Overall Study|Virologic Stopping Rule|0|||
161098656|NCT01605253|581752612|FG000|Overall Study|Physician Decision|3|||
161098657|NCT01605253|581752613|FG001|Overall Study|Physician Decision|2|||
161098658|NCT01605253|581752612|FG000|Overall Study|Lost to Follow-up|3|||
161098659|NCT01605253|581752613|FG001|Overall Study|Lost to Follow-up|1|||
161098660|NCT02554903|581752614|FG000|Overall Study|Death|1|||
161098661|NCT02554903|581752615|FG001|Overall Study|Death|1|||
161098662|NCT02554903|581752614|FG000|Overall Study|Physician Decision|2|||
161098663|NCT02554903|581752615|FG001|Overall Study|Physician Decision|2|||
161098664|NCT02554903|581752614|FG000|Overall Study|Heart Transplant|1|||
161098665|NCT02554903|581752615|FG001|Overall Study|Heart Transplant|2|||
161098666|NCT04427501|581752622|FG000|Overall Study|Death|0|||
161098667|NCT04427501|581752623|FG001|Overall Study|Death|0|||
161098668|NCT04427501|581752624|FG002|Overall Study|Death|0|||
161098669|NCT04427501|581752625|FG003|Overall Study|Death|0|||
161098670|NCT04427501|581752626|FG004|Overall Study|Death|0|||
161098671|NCT04427501|581752627|FG005|Overall Study|Death|15|||
161098672|NCT04427501|581752628|FG006|Overall Study|Death|0|||
161098673|NCT04427501|581752629|FG007|Overall Study|Death|0|||
161098674|NCT04427501|581752630|FG008|Overall Study|Death|0|||
161098675|NCT04427501|581752631|FG009|Overall Study|Death|0|||
161098676|NCT04427501|581752632|FG010|Overall Study|Death|0|||
161098677|NCT04427501|581752633|FG011|Overall Study|Death|0|||
161098678|NCT04427501|581752622|FG000|Overall Study|Lost to Follow-up|5|||
161098679|NCT04427501|581752623|FG001|Overall Study|Lost to Follow-up|1|||
161098680|NCT04427501|581752624|FG002|Overall Study|Lost to Follow-up|2|||
161098681|NCT04427501|581752625|FG003|Overall Study|Lost to Follow-up|0|||
161098682|NCT04427501|581752626|FG004|Overall Study|Lost to Follow-up|2|||
161098683|NCT04427501|581752627|FG005|Overall Study|Lost to Follow-up|11|||
161098684|NCT04427501|581752628|FG006|Overall Study|Lost to Follow-up|10|||
161098685|NCT04427501|581752629|FG007|Overall Study|Lost to Follow-up|10|||
161098686|NCT04427501|581752630|FG008|Overall Study|Lost to Follow-up|2|||
161098687|NCT04427501|581752631|FG009|Overall Study|Lost to Follow-up|5|||
161098688|NCT04427501|581752632|FG010|Overall Study|Lost to Follow-up|2|||
161098689|NCT04427501|581752633|FG011|Overall Study|Lost to Follow-up|0|||
161098690|NCT04427501|581752622|FG000|Overall Study|Physician Decision|0|||
161098691|NCT04427501|581752623|FG001|Overall Study|Physician Decision|3|||
161098692|NCT04427501|581752624|FG002|Overall Study|Physician Decision|0|||
161098693|NCT04427501|581752625|FG003|Overall Study|Physician Decision|0|||
161098694|NCT04427501|581752626|FG004|Overall Study|Physician Decision|0|||
161098695|NCT04427501|581752627|FG005|Overall Study|Physician Decision|0|||
161098696|NCT04427501|581752628|FG006|Overall Study|Physician Decision|2|||
161098697|NCT04427501|581752629|FG007|Overall Study|Physician Decision|0|||
161098698|NCT04427501|581752630|FG008|Overall Study|Physician Decision|0|||
161098699|NCT04427501|581752631|FG009|Overall Study|Physician Decision|0|||
161098700|NCT04427501|581752632|FG010|Overall Study|Physician Decision|0|||
161098701|NCT04427501|581752633|FG011|Overall Study|Physician Decision|0|||
161098702|NCT04427501|581752622|FG000|Overall Study|Withdrawal by Subject|9|||
161098703|NCT04427501|581752623|FG001|Overall Study|Withdrawal by Subject|2|||
161098704|NCT04427501|581752624|FG002|Overall Study|Withdrawal by Subject|2|||
161098705|NCT04427501|581752625|FG003|Overall Study|Withdrawal by Subject|3|||
161098706|NCT04427501|581752626|FG004|Overall Study|Withdrawal by Subject|7|||
161098707|NCT04427501|581752627|FG005|Overall Study|Withdrawal by Subject|25|||
161098708|NCT04427501|581752628|FG006|Overall Study|Withdrawal by Subject|15|||
161098709|NCT04427501|581752629|FG007|Overall Study|Withdrawal by Subject|7|||
161098710|NCT04427501|581752630|FG008|Overall Study|Withdrawal by Subject|4|||
161098711|NCT04427501|581752631|FG009|Overall Study|Withdrawal by Subject|1|||
161098712|NCT04427501|581752632|FG010|Overall Study|Withdrawal by Subject|4|||
161098713|NCT04427501|581752633|FG011|Overall Study|Withdrawal by Subject|0|||
161098714|NCT04427501|581752622|FG000|Overall Study|Other - as reported by the investigator|1|||
161098715|NCT04427501|581752623|FG001|Overall Study|Other - as reported by the investigator|0|||
161212331|NCT01113710|582160090|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
161212332|NCT01113710|582160090|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
161212333|NCT01113710|582160090|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
161212334|NCT01113710|582160090|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
161098716|NCT04427501|581752624|FG002|Overall Study|Other - as reported by the investigator|0|||
161098717|NCT04427501|581752625|FG003|Overall Study|Other - as reported by the investigator|0|||
161098718|NCT04427501|581752626|FG004|Overall Study|Other - as reported by the investigator|0|||
161098719|NCT04427501|581752627|FG005|Overall Study|Other - as reported by the investigator|6|||
161098720|NCT04427501|581752628|FG006|Overall Study|Other - as reported by the investigator|6|||
161339935|NCT00042289|582633411|FG007|Overall Study|Other reason|0|||
161098721|NCT04427501|581752629|FG007|Overall Study|Other - as reported by the investigator|0|||
161098722|NCT04427501|581752630|FG008|Overall Study|Other - as reported by the investigator|0|||
161098723|NCT04427501|581752631|FG009|Overall Study|Other - as reported by the investigator|0|||
161098724|NCT04427501|581752632|FG010|Overall Study|Other - as reported by the investigator|0|||
161098725|NCT04427501|581752633|FG011|Overall Study|Other - as reported by the investigator|0|||
161098726|NCT04427501|581752622|FG000|Overall Study|Other|0|||
161098727|NCT04427501|581752623|FG001|Overall Study|Other|0|||
161098728|NCT04427501|581752624|FG002|Overall Study|Other|0|||
161098729|NCT04427501|581752625|FG003|Overall Study|Other|0|||
161098730|NCT04427501|581752626|FG004|Overall Study|Other|0|||
161098731|NCT04427501|581752627|FG005|Overall Study|Other|0|||
161098732|NCT04427501|581752628|FG006|Overall Study|Other|0|||
161098733|NCT04427501|581752629|FG007|Overall Study|Other|0|||
161098734|NCT04427501|581752630|FG008|Overall Study|Other|0|||
161098735|NCT04427501|581752631|FG009|Overall Study|Other|0|||
161098736|NCT04427501|581752632|FG010|Overall Study|Other|0|||
161098737|NCT04427501|581752633|FG011|Overall Study|Other|1|||
161098738|NCT03170154|581752634|FG000|Overall Study|Lost to Follow-up|4|||
161098739|NCT03170154|581752634|FG000|Overall Study|Death|2|||
161098740|NCT03170154|581752634|FG000|Overall Study|Withdrawal by Subject|2|||
161098741|NCT01906346|581752635|FG000|Overall Study|AEs|1|||
161098742|NCT04936841|581752638|FG000|Overall Study|Death|1|||
161098743|NCT02279862|581752639|FG000|Overall Study|Study drug toxicity|3|||
161098744|NCT02279862|581752640|FG001|Overall Study|Study drug toxicity|6|||
161098745|NCT02279862|581752639|FG000|Overall Study|No longer meets criteria|0|||
161098746|NCT02279862|581752640|FG001|Overall Study|No longer meets criteria|1|||
161098747|NCT02279862|581752639|FG000|Overall Study|Administrative reason by sponsor|0|||
161098748|NCT02279862|581752640|FG001|Overall Study|Administrative reason by sponsor|1|||
161098749|NCT02279862|581752639|FG000|Overall Study|Disease progression|5|||
161098750|NCT02279862|581752640|FG001|Overall Study|Disease progression|2|||
161098751|NCT02279862|581752639|FG000|Overall Study|Study closed by sponsor|16|||
161098752|NCT02279862|581752640|FG001|Overall Study|Study closed by sponsor|13|||
161098753|NCT02279862|581752639|FG000|Overall Study|Other|1|||
161098754|NCT02279862|581752640|FG001|Overall Study|Other|2|||
161098755|NCT02279862|581752639|FG000|Overall Study|Withdrawal by Subject|1|||
161098756|NCT02279862|581752640|FG001|Overall Study|Withdrawal by Subject|0|||
161098757|NCT04226833|581752643|FG000|Overall Study|Death|0|||
161098758|NCT04226833|581752644|FG001|Overall Study|Death|0|||
161098759|NCT04226833|581752645|FG002|Overall Study|Death|1|||
161098760|NCT04226833|581752646|FG003|Overall Study|Death|0|||
161098761|NCT01163721|581752649|FG000|Overall Study|Adverse Event|5|||
161098762|NCT01163721|581752650|FG001|Overall Study|Adverse Event|6|||
161098763|NCT01163721|581752649|FG000|Overall Study|Withdrawal by Subject|3|||
161098764|NCT01163721|581752650|FG001|Overall Study|Withdrawal by Subject|4|||
161098765|NCT01163721|581752649|FG000|Overall Study|Lost to Follow-up|0|||
161098766|NCT01163721|581752650|FG001|Overall Study|Lost to Follow-up|1|||
161098767|NCT01163721|581752649|FG000|Overall Study|Physician Decision|0|||
161098768|NCT01163721|581752650|FG001|Overall Study|Physician Decision|1|||
161098769|NCT01050205|581752656|FG000|Overall Study|Lost to Follow-up|7|||
161098770|NCT01050205|581752657|FG001|Overall Study|Lost to Follow-up|1|||
161098771|NCT01050205|581752656|FG000|Overall Study|Withdrawal by Subject|1|||
161098772|NCT01050205|581752657|FG001|Overall Study|Withdrawal by Subject|1|||
161098773|NCT01050205|581752656|FG000|Overall Study|Relocated from area|1|||
161098774|NCT01050205|581752657|FG001|Overall Study|Relocated from area|2|||
161098775|NCT01050205|581752656|FG000|Overall Study|Discontinued Intervention|2|||
161098776|NCT01050205|581752657|FG001|Overall Study|Discontinued Intervention|0|||
161098777|NCT00364156|581752658|FG000|Overall Study|Withdrawal by Subject|73|||
161098778|NCT00364156|581752659|FG001|Overall Study|Withdrawal by Subject|80|||
161098779|NCT00364156|581752658|FG000|Overall Study|Protocol Violation|6|||
161098780|NCT00364156|581752659|FG001|Overall Study|Protocol Violation|1|||
161098781|NCT01472380|581752660|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
161098782|NCT01472380|581752660|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
161098783|NCT02708095|581752661|FG000|Overall Study|Adverse Event|4|||
161098784|NCT02708095|581752662|FG001|Overall Study|Adverse Event|10|||
161098785|NCT02708095|581752663|FG002|Overall Study|Adverse Event|11|||
161098786|NCT02708095|581752661|FG000|Overall Study|Lack of Efficacy|9|||
161098787|NCT02708095|581752662|FG001|Overall Study|Lack of Efficacy|3|||
161098788|NCT02708095|581752663|FG002|Overall Study|Lack of Efficacy|0|||
161098789|NCT02708095|581752661|FG000|Overall Study|Lost to Follow-up|2|||
161098790|NCT02708095|581752662|FG001|Overall Study|Lost to Follow-up|0|||
161098791|NCT02708095|581752663|FG002|Overall Study|Lost to Follow-up|0|||
161098792|NCT02708095|581752661|FG000|Overall Study|Physician Decision|2|||
161098793|NCT02708095|581752662|FG001|Overall Study|Physician Decision|3|||
161098794|NCT02708095|581752663|FG002|Overall Study|Physician Decision|2|||
161098795|NCT02708095|581752661|FG000|Overall Study|Protocol Violation|0|||
161098796|NCT02708095|581752662|FG001|Overall Study|Protocol Violation|0|||
161339936|NCT00042289|582633412|FG008|Overall Study|Other reason|0|||
161098797|NCT02708095|581752663|FG002|Overall Study|Protocol Violation|1|||
161339937|NCT00042289|582633413|FG009|Overall Study|Other reason|0|||
161339938|NCT00042289|582633414|FG010|Overall Study|Other reason|0|||
161339939|NCT00042289|582633415|FG011|Overall Study|Other reason|0|||
161339940|NCT00042289|582633416|FG012|Overall Study|Other reason|0|||
161339941|NCT00042289|582633417|FG013|Overall Study|Other reason|0|||
161339942|NCT00042289|582633418|FG014|Overall Study|Other reason|0|||
161339943|NCT00042289|582633419|FG015|Overall Study|Other reason|0|||
161339944|NCT00042289|582633420|FG016|Overall Study|Other reason|0|||
161339945|NCT00042289|582633421|FG017|Overall Study|Other reason|0|||
161339946|NCT00042289|582633422|FG018|Overall Study|Other reason|1|||
161339947|NCT00042289|582633423|FG019|Overall Study|Other reason|0|||
161339948|NCT00042289|582633424|FG020|Overall Study|Other reason|0|||
161339949|NCT00042289|582633425|FG021|Overall Study|Other reason|0|||
161339950|NCT00042289|582633426|FG022|Overall Study|Other reason|0|||
161339951|NCT00042289|582633427|FG023|Overall Study|Other reason|1|||
161339952|NCT00042289|582633428|FG024|Overall Study|Other reason|0|||
161339953|NCT00042289|582633429|FG025|Overall Study|Other reason|0|||
161339954|NCT00042289|582633430|FG026|Overall Study|Other reason|1|||
161339955|NCT00042289|582633431|FG027|Overall Study|Other reason|0|||
161339956|NCT00042289|582633432|FG028|Overall Study|Other reason|3|||
161339957|NCT00042289|582633433|FG029|Overall Study|Other reason|0|||
161339958|NCT00042289|582633434|FG030|Overall Study|Other reason|0|||
161339959|NCT00042289|582633435|FG031|Overall Study|Other reason|1|||
161339960|NCT00042289|582633436|FG032|Overall Study|Other reason|0|||
161339961|NCT00042289|582633437|FG033|Overall Study|Other reason|1|||
161339962|NCT00042289|582633438|FG034|Overall Study|Other reason|0|||
161339963|NCT00042289|582633439|FG035|Overall Study|Other reason|2|||
161339964|NCT00042289|582633440|FG036|Overall Study|Other reason|0|||
161339965|NCT00042289|582633441|FG037|Overall Study|Other reason|0|||
161339966|NCT00042289|582633442|FG038|Overall Study|Other reason|0|||
161339967|NCT00042289|582633443|FG039|Overall Study|Other reason|0|||
161339968|NCT00042289|582633444|FG040|Overall Study|Other reason|0|||
161339969|NCT00042289|582633445|FG041|Overall Study|Other reason|0|||
161098798|NCT02708095|581752661|FG000|Overall Study|Withdrawal by Subject|5|||
161098799|NCT02708095|581752662|FG001|Overall Study|Withdrawal by Subject|3|||
161098800|NCT02708095|581752663|FG002|Overall Study|Withdrawal by Subject|4|||
161098801|NCT03254485|581752676|FG000|Overall Study|Adverse Event|3|||
161098802|NCT03254485|581752677|FG001|Overall Study|Adverse Event|0|||
161098803|NCT03254485|581752678|FG002|Overall Study|Adverse Event|0|||
161098804|NCT03254485|581752679|FG003|Overall Study|Adverse Event|6|||
161098805|NCT03254485|581752676|FG000|Overall Study|Protocol Violation|6|||
161098806|NCT03254485|581752677|FG001|Overall Study|Protocol Violation|0|||
161098807|NCT03254485|581752678|FG002|Overall Study|Protocol Violation|0|||
161098808|NCT03254485|581752679|FG003|Overall Study|Protocol Violation|2|||
161098809|NCT03254485|581752676|FG000|Overall Study|Withdrawal by Subject|1|||
161098810|NCT03254485|581752677|FG001|Overall Study|Withdrawal by Subject|0|||
161098811|NCT03254485|581752678|FG002|Overall Study|Withdrawal by Subject|0|||
161098812|NCT03254485|581752679|FG003|Overall Study|Withdrawal by Subject|4|||
161098813|NCT03254485|581752676|FG000|Overall Study|Death|0|||
161098814|NCT03254485|581752677|FG001|Overall Study|Death|0|||
161098815|NCT03254485|581752678|FG002|Overall Study|Death|0|||
161098816|NCT03254485|581752679|FG003|Overall Study|Death|1|||
161098817|NCT03254485|581752676|FG000|Overall Study|Lost to Follow-up|1|||
161098818|NCT03254485|581752677|FG001|Overall Study|Lost to Follow-up|0|||
161098819|NCT03254485|581752678|FG002|Overall Study|Lost to Follow-up|0|||
161098820|NCT03254485|581752679|FG003|Overall Study|Lost to Follow-up|0|||
161098821|NCT03254485|581752676|FG000|Overall Study|Other|1|||
161098822|NCT03254485|581752677|FG001|Overall Study|Other|0|||
161098823|NCT03254485|581752678|FG002|Overall Study|Other|0|||
161098824|NCT03254485|581752679|FG003|Overall Study|Other|2|||
161098825|NCT03153111|581752680|FG000|Overall Study|Death|2|||
161098826|NCT03153111|581752681|FG001|Overall Study|Death|5|||
161098827|NCT03153111|581752680|FG000|Overall Study|Lost to Follow-up|1|||
161098828|NCT03153111|581752681|FG001|Overall Study|Lost to Follow-up|0|||
161098829|NCT03153111|581752680|FG000|Overall Study|Physician Decision|5|||
161098830|NCT03153111|581752681|FG001|Overall Study|Physician Decision|1|||
161098831|NCT03153111|581752680|FG000|Overall Study|Withdrawal by Subject|3|||
161098832|NCT03153111|581752681|FG001|Overall Study|Withdrawal by Subject|3|||
161098833|NCT01422850|581752683|FG000|Overall Study|Physician Decision|3|||
161098834|NCT02244996|581752685|FG000|Overall Study|Lack of Efficacy|2|||
161098835|NCT02244996|581752686|FG001|Overall Study|Lack of Efficacy|6|||
161098836|NCT03040622|581752688|FG000|Overall Study|unable to implant device|3|||
161098837|NCT06071754|581752691|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
161098838|NCT03226275|581752692|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161098839|NCT03226275|581752693|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161098840|NCT03226275|581752694|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
161098841|NCT03226275|581752695|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
161098842|NCT03226275|581752692|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161098843|NCT03226275|581752693|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161098844|NCT03226275|581752694|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
161098845|NCT03226275|581752695|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
161098846|NCT01436071|581754206|FG000|Overall Study|Adverse Event|1|||
161098847|NCT01436071|581754207|FG001|Overall Study|Adverse Event|0|||
161098848|NCT01436071|581754206|FG000|Overall Study|Lack of Efficacy|16|||
161098849|NCT01436071|581754207|FG001|Overall Study|Lack of Efficacy|7|||
161098850|NCT01436071|581754206|FG000|Overall Study|Protocol Violation|0|||
161098851|NCT01436071|581754207|FG001|Overall Study|Protocol Violation|1|||
161098852|NCT01436071|581754206|FG000|Overall Study|Lost to Follow-up|3|||
161098853|NCT01436071|581754207|FG001|Overall Study|Lost to Follow-up|1|||
161098854|NCT01436071|581754206|FG000|Overall Study|Physician Decision|1|||
161098855|NCT01436071|581754207|FG001|Overall Study|Physician Decision|0|||
161098856|NCT01436071|581754206|FG000|Overall Study|Withdrawal by Subject|2|||
161098857|NCT01436071|581754207|FG001|Overall Study|Withdrawal by Subject|2|||
161098858|NCT01436071|581754206|FG000|Overall Study|Did Not Receive Trial Medication|3|||
161098859|NCT01436071|581754207|FG001|Overall Study|Did Not Receive Trial Medication|3|||
161098860|NCT00352885|581754210|FG000|Overall Study|Withdrawal by Subject|0|||
161098861|NCT00352885|581754211|FG001|Overall Study|Withdrawal by Subject|3|||
161098862|NCT00352885|581754210|FG000|Overall Study|Development of major depression|0|||
161098863|NCT00352885|581754211|FG001|Overall Study|Development of major depression|1|||
161098864|NCT00352885|581754210|FG000|Overall Study|Progression of metastatic melanoma|5|||
161098865|NCT00352885|581754211|FG001|Overall Study|Progression of metastatic melanoma|3|||
161098866|NCT00352885|581754210|FG000|Overall Study|Side effects of IL-2 administration|1|||
161098867|NCT00352885|581754211|FG001|Overall Study|Side effects of IL-2 administration|0|||
161098868|NCT01920594|581754212|FG000|Overall Study|Adverse Event|4|||
161098869|NCT01920594|581754213|FG001|Overall Study|Adverse Event|2|||
161098870|NCT01920594|581754212|FG000|Overall Study|Lost to Follow-up|1|||
161098871|NCT01920594|581754213|FG001|Overall Study|Lost to Follow-up|0|||
161098872|NCT01920594|581754212|FG000|Overall Study|Recovery|2|||
161098873|NCT01920594|581754213|FG001|Overall Study|Recovery|0|||
161098874|NCT01920594|581754212|FG000|Overall Study|Investigator discretion|0|||
161098875|NCT01920594|581754213|FG001|Overall Study|Investigator discretion|1|||
161098876|NCT01754857|581754214|FG000|Overall Study|Adverse Event|7|||
161098877|NCT01754857|581754214|FG000|Overall Study|Disease progression|3|||
161098878|NCT01754857|581754214|FG000|Overall Study|Physician Decision|2|||
161098879|NCT01754857|581754214|FG000|Overall Study|Withdrawal by Subject|3|||
161098880|NCT01754857|581754214|FG000|Overall Study|other complicating disease|1|||
161098881|NCT01754857|581754214|FG000|Overall Study|ineligible to continue onto maintenance|1|||
161098882|NCT01754857|581754214|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
161098883|NCT01754857|581754214|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
161098884|NCT00833911|581754218|FG000|Titration|Adverse Event|18|||
161098885|NCT00833911|581754218|FG000|Titration|Withdrawal by Subject|3|||
161098886|NCT00833911|581754218|FG000|Maintenance Phase I|Adverse Event|73|||
161098887|NCT00833911|581754218|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
161098888|NCT00833911|581754218|FG000|Maintenance Phase I|Physician Decision|10|||
161098889|NCT00833911|581754218|FG000|Maintenance Phase I|Lack of Efficacy|4|||
161098890|NCT00833911|581754218|FG000|Maintenance Phase II|Adverse Event|6|||
161098891|NCT00833911|581754218|FG000|Maintenance Phase II|Physician Decision|2|||
161098892|NCT00833911|581754218|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
161098893|NCT00833911|581754218|FG000|Maintenance Phase II|Lack of Efficacy|1|||
161098894|NCT03942406|581754219|FG000|Overall Study|Lost to Follow-up|4|||
161098895|NCT03942406|581754220|FG001|Overall Study|Lost to Follow-up|5|||
161098896|NCT03942406|581754221|FG002|Overall Study|Lost to Follow-up|3|||
161098897|NCT03942406|581754222|FG003|Overall Study|Lost to Follow-up|7|||
161098898|NCT03942406|581754223|FG004|Overall Study|Lost to Follow-up|1|||
161098899|NCT03942406|581754224|FG005|Overall Study|Lost to Follow-up|0|||
161098900|NCT03942406|581754225|FG006|Overall Study|Lost to Follow-up|0|||
161098901|NCT03942406|581754219|FG000|Overall Study|Withdrawal by Subject|3|||
161098902|NCT03942406|581754220|FG001|Overall Study|Withdrawal by Subject|1|||
161098903|NCT03942406|581754221|FG002|Overall Study|Withdrawal by Subject|1|||
161098904|NCT03942406|581754222|FG003|Overall Study|Withdrawal by Subject|3|||
161098905|NCT03942406|581754223|FG004|Overall Study|Withdrawal by Subject|0|||
161098906|NCT03942406|581754224|FG005|Overall Study|Withdrawal by Subject|0|||
161098907|NCT03942406|581754225|FG006|Overall Study|Withdrawal by Subject|0|||
161098908|NCT03942406|581754219|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
161098909|NCT03942406|581754220|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
161098910|NCT03942406|581754221|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
161098911|NCT03942406|581754222|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
161098912|NCT03942406|581754223|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
161098913|NCT03942406|581754224|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
161098914|NCT03942406|581754225|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
161098915|NCT02616614|581754226|FG000|Overall Study|Withdrawal by Subject|10|||
161098916|NCT02616614|581754227|FG001|Overall Study|Withdrawal by Subject|5|||
161098917|NCT02616614|581754228|FG002|Overall Study|Withdrawal by Subject|6|||
161098918|NCT02616614|581754226|FG000|Overall Study|Physician Decision|2|||
161098919|NCT02616614|581754227|FG001|Overall Study|Physician Decision|1|||
161098920|NCT02616614|581754228|FG002|Overall Study|Physician Decision|0|||
161098921|NCT02616614|581754226|FG000|Overall Study|Adverse Event|1|||
161098922|NCT02616614|581754227|FG001|Overall Study|Adverse Event|4|||
161098923|NCT02616614|581754228|FG002|Overall Study|Adverse Event|1|||
161098924|NCT02616614|581754226|FG000|Overall Study|Protocol Violation|0|||
161098925|NCT02616614|581754227|FG001|Overall Study|Protocol Violation|3|||
161098926|NCT02616614|581754228|FG002|Overall Study|Protocol Violation|1|||
161098927|NCT02616614|581754226|FG000|Overall Study|Prohibited Medication|12|||
161098928|NCT02616614|581754227|FG001|Overall Study|Prohibited Medication|9|||
161098929|NCT02616614|581754228|FG002|Overall Study|Prohibited Medication|5|||
161098930|NCT02616614|581754226|FG000|Overall Study|More than 3 applications missed|6|||
161098931|NCT02616614|581754227|FG001|Overall Study|More than 3 applications missed|8|||
161098932|NCT02616614|581754228|FG002|Overall Study|More than 3 applications missed|1|||
161098933|NCT02616614|581754226|FG000|Overall Study|Lost to Follow-up|31|||
161098934|NCT02616614|581754227|FG001|Overall Study|Lost to Follow-up|28|||
161339970|NCT00042289|582633446|FG042|Overall Study|Other reason|0|||
161098935|NCT02616614|581754228|FG002|Overall Study|Lost to Follow-up|13|||
161098936|NCT02616614|581754226|FG000|Overall Study|Pregnancy|2|||
161098937|NCT02616614|581754227|FG001|Overall Study|Pregnancy|0|||
161098938|NCT02616614|581754228|FG002|Overall Study|Pregnancy|1|||
161098939|NCT02616614|581754226|FG000|Overall Study|Other|1|||
161098940|NCT02616614|581754227|FG001|Overall Study|Other|2|||
161098941|NCT02616614|581754228|FG002|Overall Study|Other|1|||
161098942|NCT02748018|581754229|FG000|Study Period|Adverse Event|1|||
161098943|NCT02748018|581754230|FG001|Study Period|Adverse Event|3|||
161098944|NCT02748018|581754231|FG002|Study Period|Adverse Event|4|||
161098945|NCT02748018|581754232|FG003|Study Period|Adverse Event|0|||
161098946|NCT02748018|581754233|FG004|Study Period|Adverse Event|3|||
161098947|NCT02748018|581754234|FG005|Study Period|Adverse Event|3|||
161339971|NCT00042289|582633447|FG043|Overall Study|Other reason|1|||
161098948|NCT02748018|581754229|FG000|Study Period|Withdrawal by Subject|7|||
161098949|NCT02748018|581754230|FG001|Study Period|Withdrawal by Subject|4|||
161098950|NCT02748018|581754231|FG002|Study Period|Withdrawal by Subject|4|||
161098951|NCT02748018|581754232|FG003|Study Period|Withdrawal by Subject|11|||
161098952|NCT02748018|581754233|FG004|Study Period|Withdrawal by Subject|12|||
161098953|NCT02748018|581754234|FG005|Study Period|Withdrawal by Subject|10|||
161098954|NCT02748018|581754229|FG000|Study Period|Pregnancy|0|||
161098955|NCT02748018|581754230|FG001|Study Period|Pregnancy|1|||
161098956|NCT02748018|581754231|FG002|Study Period|Pregnancy|0|||
161098957|NCT02748018|581754232|FG003|Study Period|Pregnancy|0|||
161098958|NCT02748018|581754233|FG004|Study Period|Pregnancy|1|||
161098959|NCT02748018|581754234|FG005|Study Period|Pregnancy|0|||
161098960|NCT02748018|581754229|FG000|Study Period|Physician Decision|2|||
161098961|NCT02748018|581754230|FG001|Study Period|Physician Decision|2|||
161098962|NCT02748018|581754231|FG002|Study Period|Physician Decision|1|||
161098963|NCT02748018|581754232|FG003|Study Period|Physician Decision|0|||
161098964|NCT02748018|581754233|FG004|Study Period|Physician Decision|2|||
161098965|NCT02748018|581754234|FG005|Study Period|Physician Decision|0|||
161098966|NCT02748018|581754229|FG000|Study Period|Lost to Follow-up|0|||
161098967|NCT02748018|581754230|FG001|Study Period|Lost to Follow-up|0|||
161098968|NCT02748018|581754231|FG002|Study Period|Lost to Follow-up|0|||
161098969|NCT02748018|581754232|FG003|Study Period|Lost to Follow-up|2|||
161098970|NCT02748018|581754233|FG004|Study Period|Lost to Follow-up|0|||
161098971|NCT02748018|581754234|FG005|Study Period|Lost to Follow-up|1|||
161098972|NCT02748018|581754229|FG000|Continuation Period|Adverse Event|2|||
161098973|NCT02748018|581754230|FG001|Continuation Period|Adverse Event|0|||
161098974|NCT02748018|581754231|FG002|Continuation Period|Adverse Event|1|||
161098975|NCT02748018|581754232|FG003|Continuation Period|Adverse Event|1|||
161098976|NCT02748018|581754233|FG004|Continuation Period|Adverse Event|1|||
161098977|NCT02748018|581754234|FG005|Continuation Period|Adverse Event|4|||
161098978|NCT02748018|581754229|FG000|Continuation Period|Withdrawal by Subject|3|||
161098979|NCT02748018|581754230|FG001|Continuation Period|Withdrawal by Subject|5|||
161098980|NCT02748018|581754231|FG002|Continuation Period|Withdrawal by Subject|3|||
161098981|NCT02748018|581754232|FG003|Continuation Period|Withdrawal by Subject|9|||
161098982|NCT02748018|581754233|FG004|Continuation Period|Withdrawal by Subject|11|||
161098983|NCT02748018|581754234|FG005|Continuation Period|Withdrawal by Subject|1|||
161098984|NCT02748018|581754229|FG000|Continuation Period|Lost to Follow-up|0|||
161098985|NCT02748018|581754230|FG001|Continuation Period|Lost to Follow-up|2|||
161098986|NCT02748018|581754231|FG002|Continuation Period|Lost to Follow-up|1|||
161098987|NCT02748018|581754232|FG003|Continuation Period|Lost to Follow-up|0|||
161098988|NCT02748018|581754233|FG004|Continuation Period|Lost to Follow-up|1|||
161098989|NCT02748018|581754234|FG005|Continuation Period|Lost to Follow-up|0|||
161098990|NCT02748018|581754229|FG000|Continuation Period|Pregnancy|1|||
161098991|NCT02748018|581754230|FG001|Continuation Period|Pregnancy|2|||
161098992|NCT02748018|581754231|FG002|Continuation Period|Pregnancy|0|||
161098993|NCT02748018|581754232|FG003|Continuation Period|Pregnancy|0|||
161098994|NCT02748018|581754233|FG004|Continuation Period|Pregnancy|0|||
161098995|NCT02748018|581754234|FG005|Continuation Period|Pregnancy|0|||
161098996|NCT02748018|581754229|FG000|Continuation Period|Physician Decision|0|||
161098997|NCT02748018|581754230|FG001|Continuation Period|Physician Decision|1|||
161098998|NCT02748018|581754231|FG002|Continuation Period|Physician Decision|2|||
161098999|NCT02748018|581754232|FG003|Continuation Period|Physician Decision|0|||
161099000|NCT02748018|581754233|FG004|Continuation Period|Physician Decision|2|||
161099001|NCT02748018|581754234|FG005|Continuation Period|Physician Decision|1|||
161099002|NCT02748018|581754229|FG000|Continuation Period|Protocol Violation|0|||
161099003|NCT02748018|581754230|FG001|Continuation Period|Protocol Violation|1|||
161099004|NCT02748018|581754231|FG002|Continuation Period|Protocol Violation|0|||
161099005|NCT02748018|581754232|FG003|Continuation Period|Protocol Violation|0|||
161099006|NCT02748018|581754233|FG004|Continuation Period|Protocol Violation|0|||
161099007|NCT02748018|581754234|FG005|Continuation Period|Protocol Violation|0|||
161099008|NCT06069778|581754235|FG000|Overall Study|Withdrawal by Subject|1|||
161099009|NCT03801902|581754236|FG000|Overall Study|Did not receive protocol treatment.|1|||
161099010|NCT03801902|581754237|FG001|Overall Study|Did not receive protocol treatment.|0|||
161099011|NCT03801902|581754238|FG002|Overall Study|Did not receive protocol treatment.|0|||
161099012|NCT03801902|581754239|FG003|Overall Study|Did not receive protocol treatment.|0|||
161099013|NCT04704336|581754245|FG000|Overall Study|Death|2|||
161099014|NCT04704336|581754246|FG001|Overall Study|Death|2|||
161099015|NCT04704336|581754245|FG000|Overall Study|Lost to Follow-up|33|||
161099016|NCT04704336|581754246|FG001|Overall Study|Lost to Follow-up|40|||
161099017|NCT02260882|581754247|FG000|Overall Study|Protocol Violation|0|||
161099018|NCT02260882|581754248|FG001|Overall Study|Protocol Violation|1|||
161099019|NCT02119325|581754249|FG000|Washout Period 1|Adverse Event|0|||
161099020|NCT02119325|581754250|FG001|Washout Period 1|Adverse Event|1|||
161099021|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
161099022|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
161099023|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
161099024|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
161099025|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
161099026|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
161099027|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
161099028|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
161099029|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Death|1|||
161099030|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Death|1|||
161099031|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
161099032|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
161099033|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
161099034|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
161099035|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
161099036|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
161099037|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
161099038|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
161099039|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
161099040|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
161099041|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
161099042|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
161099043|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
161099044|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
161099045|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
161099046|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
161099047|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
161099048|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
161099049|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
161099050|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
161099051|NCT00559585|581754253|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
161099052|NCT00559585|581754254|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
161099053|NCT00559585|581754253|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
161099054|NCT00559585|581754254|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
161099055|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
161099056|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
161099057|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
161099058|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
161099059|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
161099060|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
161099061|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
161099062|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
161099063|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
161099064|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
161099065|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
161099066|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
161099067|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
161099068|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
161099069|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
161099070|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
161099071|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
161099072|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
161099073|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
161099074|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
161099075|NCT00559585|581754253|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
161099076|NCT00559585|581754254|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
161099077|NCT00639223|581754256|FG000|Overall Study|Lost to Follow-up|0|||
161099078|NCT00639223|581754257|FG001|Overall Study|Lost to Follow-up|2|||
161099079|NCT02511678|581754258|FG000|Overall Study|Withdrawal by Subject|2|||
161099080|NCT02511678|581754258|FG000|Overall Study|Lost to Follow-up|4|||
161099081|NCT02511678|581754258|FG000|Overall Study|Death|19|||
161099082|NCT02511678|581754258|FG000|Overall Study|Adverse Event|1|||
161099083|NCT02511678|581754258|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
161099084|NCT02511678|581754258|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
161099085|NCT02511678|581754258|FG000|Overall Study|Required Radiofrequency Ablation|1|||
161099086|NCT02511678|581754258|FG000|Overall Study|Biopsy was Negative|1|||
161099087|NCT02511678|581754258|FG000|Overall Study|Protocol Violation|1|||
161099088|NCT02511678|581754258|FG000|Overall Study|Received Radiation Treatment|1|||
161099089|NCT01295281|581754261|FG000|First Intervention (7 Days)|Death|0|||
161099090|NCT01295281|581754262|FG001|First Intervention (7 Days)|Death|1|||
161099091|NCT00292461|581754263|FG000|Overall Study|Adverse Event|4|||
161099092|NCT00292461|581754264|FG001|Overall Study|Adverse Event|2|||
161099093|NCT00292461|581754263|FG000|Overall Study|Lack of Efficacy|1|||
161099094|NCT00292461|581754264|FG001|Overall Study|Lack of Efficacy|0|||
161099095|NCT00292461|581754263|FG000|Overall Study|Withdrawal by Subject|0|||
161099096|NCT00292461|581754264|FG001|Overall Study|Withdrawal by Subject|1|||
161099097|NCT00292461|581754263|FG000|Overall Study|Protocol Violation|4|||
161099098|NCT00292461|581754264|FG001|Overall Study|Protocol Violation|3|||
161099099|NCT00292461|581754263|FG000|Overall Study|Lost to Follow-up|1|||
161099100|NCT00292461|581754264|FG001|Overall Study|Lost to Follow-up|0|||
161099101|NCT00633061|581754272|FG000|Overall Study|Study closed|86|||
161099102|NCT00633061|581754273|FG001|Overall Study|Study closed|0|||
161099103|NCT02000427|581754274|FG000|Overall Study|Death|22|||
161099104|NCT05125679|581754277|FG000|Overall Study|Study Terminated by Sponsor|2|||
161099105|NCT05125679|581754278|FG001|Overall Study|Study Terminated by Sponsor|5|||
161099106|NCT06268288|581754283|FG000|Overall Study|Withdrawal by Subject|1|||
161099107|NCT06268288|581754284|FG001|Overall Study|Withdrawal by Subject|2|||
161099108|NCT03049735|581754287|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
161099109|NCT03049735|581754288|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
161099110|NCT03049735|581754289|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
161099111|NCT03049735|581754287|FG000|Overall Study|Other|5|||
161099112|NCT03049735|581754288|FG001|Overall Study|Other|3|||
161099113|NCT03049735|581754289|FG002|Overall Study|Other|1|||
161099114|NCT03049735|581754287|FG000|Overall Study|Lack of Efficacy|4|||
161099115|NCT03049735|581754288|FG001|Overall Study|Lack of Efficacy|0|||
161099116|NCT03049735|581754289|FG002|Overall Study|Lack of Efficacy|3|||
161099117|NCT03049735|581754287|FG000|Overall Study|Protocol deviation|1|||
161099118|NCT03049735|581754288|FG001|Overall Study|Protocol deviation|0|||
161099119|NCT03049735|581754289|FG002|Overall Study|Protocol deviation|0|||
161099120|NCT03049735|581754287|FG000|Overall Study|Pregnancy|0|||
161099121|NCT03049735|581754288|FG001|Overall Study|Pregnancy|0|||
161099122|NCT03049735|581754289|FG002|Overall Study|Pregnancy|1|||
161099123|NCT03049735|581754287|FG000|Overall Study|Adverse Event|7|||
161099124|NCT03049735|581754288|FG001|Overall Study|Adverse Event|18|||
161099125|NCT03049735|581754289|FG002|Overall Study|Adverse Event|5|||
161099126|NCT03049735|581754287|FG000|Overall Study|Withdrawal by Subject|10|||
161099127|NCT03049735|581754288|FG001|Overall Study|Withdrawal by Subject|3|||
161099128|NCT03049735|581754289|FG002|Overall Study|Withdrawal by Subject|7|||
161099129|NCT03049735|581754287|FG000|Overall Study|Lost to Follow-up|1|||
161099130|NCT03049735|581754288|FG001|Overall Study|Lost to Follow-up|5|||
161099131|NCT03049735|581754289|FG002|Overall Study|Lost to Follow-up|5|||
161099132|NCT02146326|581754290|FG000|Overall Study|Lost to Follow-up|3|||
161099133|NCT02146326|581754291|FG001|Overall Study|Lost to Follow-up|3|||
161099134|NCT02146326|581754292|FG002|Overall Study|Lost to Follow-up|11|||
161099135|NCT02146326|581754293|FG003|Overall Study|Lost to Follow-up|19|||
161099136|NCT02146326|581754290|FG000|Overall Study|Withdrawal by Subject|2|||
161099137|NCT02146326|581754291|FG001|Overall Study|Withdrawal by Subject|1|||
161099138|NCT02146326|581754292|FG002|Overall Study|Withdrawal by Subject|15|||
161099139|NCT02146326|581754293|FG003|Overall Study|Withdrawal by Subject|11|||
161099140|NCT02146326|581754290|FG000|Overall Study|Separated from mental health center|23|||
161099141|NCT02146326|581754291|FG001|Overall Study|Separated from mental health center|33|||
161099142|NCT02146326|581754292|FG002|Overall Study|Separated from mental health center|0|||
161099143|NCT02146326|581754293|FG003|Overall Study|Separated from mental health center|0|||
161099144|NCT02146326|581754290|FG000|Overall Study|Incarcerated|0|||
161099145|NCT02146326|581754291|FG001|Overall Study|Incarcerated|0|||
161099146|NCT02146326|581754292|FG002|Overall Study|Incarcerated|3|||
161099147|NCT02146326|581754293|FG003|Overall Study|Incarcerated|8|||
161099148|NCT02146326|581754290|FG000|Overall Study|Death|0|||
161099149|NCT02146326|581754291|FG001|Overall Study|Death|0|||
161099150|NCT02146326|581754292|FG002|Overall Study|Death|4|||
161099151|NCT02146326|581754293|FG003|Overall Study|Death|4|||
161099152|NCT02146326|581754290|FG000|Overall Study|Unable to complete interview|0|||
161099153|NCT02146326|581754291|FG001|Overall Study|Unable to complete interview|0|||
161099154|NCT02146326|581754292|FG002|Overall Study|Unable to complete interview|10|||
161099155|NCT02146326|581754293|FG003|Overall Study|Unable to complete interview|6|||
161099156|NCT00777946|581754296|FG000|Overall Study|Adverse Event|11|||
161099157|NCT00777946|581754297|FG001|Overall Study|Adverse Event|1|||
161099158|NCT00777946|581754298|FG002|Overall Study|Adverse Event|3|||
161099159|NCT00777946|581754296|FG000|Overall Study|Lack of Efficacy|0|||
161099160|NCT00777946|581754297|FG001|Overall Study|Lack of Efficacy|0|||
161099161|NCT00777946|581754298|FG002|Overall Study|Lack of Efficacy|9|||
161099162|NCT00777946|581754296|FG000|Overall Study|Condition no longer required study drug|1|||
161099163|NCT00777946|581754297|FG001|Overall Study|Condition no longer required study drug|0|||
161099164|NCT00777946|581754298|FG002|Overall Study|Condition no longer required study drug|0|||
161099165|NCT00777946|581754296|FG000|Overall Study|Patient withdrew consent|3|||
161099166|NCT00777946|581754297|FG001|Overall Study|Patient withdrew consent|2|||
161099167|NCT00777946|581754298|FG002|Overall Study|Patient withdrew consent|3|||
161099168|NCT00777946|581754296|FG000|Overall Study|Lost to Follow-up|3|||
161099169|NCT00777946|581754297|FG001|Overall Study|Lost to Follow-up|1|||
161099170|NCT00777946|581754298|FG002|Overall Study|Lost to Follow-up|0|||
161099171|NCT00777946|581754296|FG000|Overall Study|Protocol deviation|2|||
161099172|NCT00777946|581754297|FG001|Overall Study|Protocol deviation|1|||
161099173|NCT00777946|581754298|FG002|Overall Study|Protocol deviation|1|||
161099174|NCT00777946|581754296|FG000|Overall Study|Randomized in error|1|||
161099175|NCT00777946|581754297|FG001|Overall Study|Randomized in error|1|||
161099176|NCT00777946|581754298|FG002|Overall Study|Randomized in error|0|||
161099177|NCT02684357|581754299|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
161099178|NCT02684357|581754300|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
161099179|NCT02684357|581754301|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
161099180|NCT02684357|581754302|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
161099181|NCT02684357|581754303|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
161099182|NCT02684357|581754304|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
161099183|NCT02684357|581754299|FG000|Part A|Lost to Follow-up|0|||
161099184|NCT02684357|581754300|FG001|Part A|Lost to Follow-up|2|||
161099185|NCT02684357|581754301|FG002|Part A|Lost to Follow-up|2|||
161099186|NCT02684357|581754302|FG003|Part A|Lost to Follow-up|0|||
161099187|NCT02684357|581754303|FG004|Part A|Lost to Follow-up|0|||
161099188|NCT02684357|581754304|FG005|Part A|Lost to Follow-up|0|||
161099189|NCT02684357|581754299|FG000|Part A|Withdrawal by Subject|3|||
161099190|NCT02684357|581754300|FG001|Part A|Withdrawal by Subject|0|||
161099191|NCT02684357|581754301|FG002|Part A|Withdrawal by Subject|0|||
161099192|NCT02684357|581754302|FG003|Part A|Withdrawal by Subject|0|||
161099193|NCT02684357|581754303|FG004|Part A|Withdrawal by Subject|0|||
161099194|NCT02684357|581754304|FG005|Part A|Withdrawal by Subject|0|||
161099195|NCT02684357|581754299|FG000|Part A|Other|0|||
161099196|NCT02684357|581754300|FG001|Part A|Other|1|||
161099197|NCT02684357|581754301|FG002|Part A|Other|0|||
161099198|NCT02684357|581754302|FG003|Part A|Other|0|||
161099199|NCT02684357|581754303|FG004|Part A|Other|0|||
161099200|NCT02684357|581754304|FG005|Part A|Other|0|||
161099201|NCT02684357|581754299|FG000|Part B|Adverse Event (Other)|0|||
161099202|NCT02684357|581754300|FG001|Part B|Adverse Event (Other)|0|||
161099203|NCT02684357|581754301|FG002|Part B|Adverse Event (Other)|0|||
161099204|NCT02684357|581754302|FG003|Part B|Adverse Event (Other)|1|||
161099205|NCT02684357|581754303|FG004|Part B|Adverse Event (Other)|1|||
161099206|NCT02684357|581754304|FG005|Part B|Adverse Event (Other)|1|||
161099207|NCT02684357|581754299|FG000|Part B|Lost to Follow-up|0|||
161099208|NCT02684357|581754300|FG001|Part B|Lost to Follow-up|0|||
161099209|NCT02684357|581754301|FG002|Part B|Lost to Follow-up|0|||
161099210|NCT02684357|581754302|FG003|Part B|Lost to Follow-up|1|||
161099211|NCT02684357|581754303|FG004|Part B|Lost to Follow-up|1|||
161099212|NCT02684357|581754304|FG005|Part B|Lost to Follow-up|7|||
161099213|NCT02684357|581754299|FG000|Part B|Withdrawal by Subject|0|||
161099214|NCT02684357|581754300|FG001|Part B|Withdrawal by Subject|0|||
161099215|NCT02684357|581754301|FG002|Part B|Withdrawal by Subject|0|||
161099216|NCT02684357|581754302|FG003|Part B|Withdrawal by Subject|0|||
161099217|NCT02684357|581754303|FG004|Part B|Withdrawal by Subject|2|||
161099218|NCT02684357|581754304|FG005|Part B|Withdrawal by Subject|4|||
161099219|NCT02684357|581754299|FG000|Part B|Other|0|||
161099220|NCT02684357|581754300|FG001|Part B|Other|0|||
161099221|NCT02684357|581754301|FG002|Part B|Other|0|||
161099222|NCT02684357|581754302|FG003|Part B|Other|1|||
161099223|NCT02684357|581754303|FG004|Part B|Other|0|||
161099224|NCT02684357|581754304|FG005|Part B|Other|1|||
161099225|NCT01853982|581754305|FG000|Overall Study|Withdrawal by Subject|1|||
161099226|NCT01853982|581754306|FG001|Overall Study|Withdrawal by Subject|0|||
161099227|NCT01853982|581754305|FG000|Overall Study|Death|1|||
161099228|NCT01853982|581754306|FG001|Overall Study|Death|0|||
161099229|NCT01853982|581754305|FG000|Overall Study|Lost to Follow-up|0|||
161099230|NCT01853982|581754306|FG001|Overall Study|Lost to Follow-up|1|||
161099231|NCT00390910|581754307|FG000|Overall Study|Adverse Event|1|||
161099232|NCT00390910|581754308|FG001|Overall Study|Adverse Event|0|||
161099233|NCT00390910|581754309|FG002|Overall Study|Adverse Event|0|||
161099234|NCT00390910|581754307|FG000|Overall Study|Lost to Follow-up|0|||
161099235|NCT00390910|581754308|FG001|Overall Study|Lost to Follow-up|1|||
161099236|NCT00390910|581754309|FG002|Overall Study|Lost to Follow-up|5|||
161099237|NCT00390910|581754307|FG000|Overall Study|Withdrawal by Subject|1|||
161099238|NCT00390910|581754308|FG001|Overall Study|Withdrawal by Subject|3|||
161099239|NCT00390910|581754309|FG002|Overall Study|Withdrawal by Subject|2|||
161099240|NCT00390910|581754307|FG000|Overall Study|Migrated/moved from study area|0|||
161099241|NCT00390910|581754308|FG001|Overall Study|Migrated/moved from study area|0|||
161099242|NCT00390910|581754309|FG002|Overall Study|Migrated/moved from study area|3|||
161099243|NCT05066724|581754310|FG000|Overall Study|Adverse Event|1|||
161099244|NCT05066724|581754310|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161099245|NCT05066724|581754310|FG000|Overall Study|Withdrawal by Subject|6|||
161099246|NCT05066724|581754310|FG000|Overall Study|Physician Decision|2|||
161099247|NCT04821869|581754322|FG000|Overall Study|Adverse Event|4|||
161099248|NCT04821869|581754322|FG000|Overall Study|Withdrawal by Subject|2|||
161099249|NCT04821869|581754322|FG000|Overall Study|Did not meet FEV1 criteria|1|||
161099250|NCT01313117|581754325|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
161099251|NCT01313117|581754325|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
161099252|NCT03602261|581754330|FG000|Overall Study|Adverse Event|5|||
161099253|NCT03602261|581754331|FG001|Overall Study|Adverse Event|1|||
161099254|NCT03602261|581754330|FG000|Overall Study|Physician Decision|1|||
161099255|NCT03602261|581754331|FG001|Overall Study|Physician Decision|0|||
161099256|NCT03602261|581754330|FG000|Overall Study|Withdrawal by Subject|1|||
161099257|NCT03602261|581754331|FG001|Overall Study|Withdrawal by Subject|1|||
161099258|NCT03602261|581754330|FG000|Overall Study|Lack of Efficacy|0|||
161099259|NCT03602261|581754331|FG001|Overall Study|Lack of Efficacy|1|||
161099260|NCT03602261|581754330|FG000|Overall Study|Subject moving out of state|1|||
161099261|NCT03602261|581754331|FG001|Overall Study|Subject moving out of state|0|||
161099262|NCT03442114|581754332|FG000|Overall Study|Lost to Follow-up|13|||
161099263|NCT03442114|581754333|FG001|Overall Study|Lost to Follow-up|13|||
161099264|NCT03442114|581754332|FG000|Overall Study|Physician Decision|2|||
161099265|NCT03442114|581754333|FG001|Overall Study|Physician Decision|2|||
161099266|NCT03442114|581754332|FG000|Overall Study|Protocol Violation|0|||
161099267|NCT03442114|581754333|FG001|Overall Study|Protocol Violation|2|||
161099268|NCT03442114|581754332|FG000|Overall Study|Withdrawal by Subject|1|||
161099269|NCT03442114|581754333|FG001|Overall Study|Withdrawal by Subject|3|||
161099270|NCT03442114|581754332|FG000|Overall Study|Guardianship Change|0|||
161099271|NCT03442114|581754333|FG001|Overall Study|Guardianship Change|1|||
161099272|NCT03808688|581755938|FG000|Overall Study|Adverse Event|13|||
161099273|NCT03808688|581755939|FG001|Overall Study|Adverse Event|17|||
161099274|NCT03808688|581755938|FG000|Overall Study|Lack of Efficacy|2|||
161099275|NCT03808688|581755939|FG001|Overall Study|Lack of Efficacy|0|||
161099276|NCT03808688|581755938|FG000|Overall Study|Lost to Follow-up|0|||
161099277|NCT03808688|581755939|FG001|Overall Study|Lost to Follow-up|2|||
161099278|NCT03808688|581755938|FG000|Overall Study|Withdrawal by Subject|1|||
161099279|NCT03808688|581755939|FG001|Overall Study|Withdrawal by Subject|0|||
161099280|NCT03808688|581755938|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
161099281|NCT03808688|581755939|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
161099282|NCT03808688|581755938|FG000|Overall Study|IOP Too High|1|||
161099283|NCT03808688|581755939|FG001|Overall Study|IOP Too High|1|||
161099284|NCT03808688|581755938|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
161099285|NCT03808688|581755939|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
161099286|NCT03808688|581755938|FG000|Overall Study|Visit Out of Window|0|||
161099287|NCT03808688|581755939|FG001|Overall Study|Visit Out of Window|1|||
161099288|NCT03808688|581755938|FG000|Overall Study|Medication Non-Compliance|0|||
161099289|NCT03808688|581755939|FG001|Overall Study|Medication Non-Compliance|1|||
161099290|NCT01215175|581755943|FG000|Overall Study|Lost to Follow-up|0|||
161099291|NCT01215175|581755944|FG001|Overall Study|Lost to Follow-up|1|||
161099292|NCT01215175|581755945|FG002|Overall Study|Lost to Follow-up|0|||
161099293|NCT01215175|581755946|FG003|Overall Study|Lost to Follow-up|1|||
161099294|NCT01215175|581755947|FG004|Overall Study|Lost to Follow-up|0|||
161099295|NCT01016964|581755948|FG000|Overall Study|Lost to Follow-up|3|||
161099296|NCT01016964|581755949|FG001|Overall Study|Lost to Follow-up|3|||
161099297|NCT03872453|581755950|FG000|Overall Study|Adverse Event|1|||
161099298|NCT03872453|581755951|FG001|Overall Study|Adverse Event|1|||
161099299|NCT03872453|581755952|FG002|Overall Study|Adverse Event|0|||
161099300|NCT03872453|581755953|FG003|Overall Study|Adverse Event|0|||
161099301|NCT03872453|581755950|FG000|Overall Study|Lost to Follow-up|8|||
161323934|NCT05305989|582571961|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
161323935|NCT05305989|582571959|FG000|Overall Study|Adverse Event|1|||
161323936|NCT05305989|582571960|FG001|Overall Study|Adverse Event|1|||
161323937|NCT05305989|582571961|FG002|Overall Study|Adverse Event|0|||
161323938|NCT05305989|582571959|FG000|Overall Study|Enrolled but never dosed|3|||
161323939|NCT05305989|582571960|FG001|Overall Study|Enrolled but never dosed|2|||
161323940|NCT05305989|582571961|FG002|Overall Study|Enrolled but never dosed|1|||
161323941|NCT03162328|582571962|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
161323942|NCT03162328|582571963|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
161323943|NCT03162328|582571964|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
161323944|NCT03162328|582571962|FG000|Screening Period|Withdrawal by Subject|1|||
161323945|NCT03162328|582571963|FG001|Screening Period|Withdrawal by Subject|0|||
161323946|NCT03162328|582571964|FG002|Screening Period|Withdrawal by Subject|0|||
161323947|NCT03162328|582571962|FG000|Study Period|Withdrawal by Subject|0|||
161323948|NCT03162328|582571963|FG001|Study Period|Withdrawal by Subject|0|||
161323949|NCT03162328|582571964|FG002|Study Period|Withdrawal by Subject|1|||
161099302|NCT03872453|581755951|FG001|Overall Study|Lost to Follow-up|7|||
161099303|NCT03872453|581755952|FG002|Overall Study|Lost to Follow-up|4|||
161099304|NCT03872453|581755953|FG003|Overall Study|Lost to Follow-up|4|||
161099305|NCT03872453|581755950|FG000|Overall Study|Never Treated Migraine|19|||
161099306|NCT03872453|581755951|FG001|Overall Study|Never Treated Migraine|17|||
161323950|NCT00913770|582571965|FG000|Overall Study|Unable to contact|24|||
161323951|NCT00913770|582571966|FG001|Overall Study|Unable to contact|19|||
161323952|NCT00913770|582571967|FG002|Overall Study|Unable to contact|13|||
161099307|NCT03872453|581755952|FG002|Overall Study|Never Treated Migraine|13|||
161099308|NCT03872453|581755953|FG003|Overall Study|Never Treated Migraine|12|||
161099309|NCT03872453|581755950|FG000|Overall Study|Pregnancy|1|||
161099310|NCT03872453|581755951|FG001|Overall Study|Pregnancy|0|||
161099311|NCT03872453|581755952|FG002|Overall Study|Pregnancy|0|||
161099312|NCT03872453|581755953|FG003|Overall Study|Pregnancy|0|||
161099313|NCT03872453|581755950|FG000|Overall Study|Protocol Deviation|2|||
161099314|NCT03872453|581755951|FG001|Overall Study|Protocol Deviation|0|||
161099315|NCT03872453|581755952|FG002|Overall Study|Protocol Deviation|0|||
161099316|NCT03872453|581755953|FG003|Overall Study|Protocol Deviation|2|||
161099317|NCT03872453|581755950|FG000|Overall Study|Withdrawal by Subject|0|||
161099318|NCT03872453|581755951|FG001|Overall Study|Withdrawal by Subject|1|||
161099319|NCT03872453|581755952|FG002|Overall Study|Withdrawal by Subject|2|||
161099320|NCT03872453|581755953|FG003|Overall Study|Withdrawal by Subject|0|||
161099321|NCT03872453|581755950|FG000|Overall Study|Other Than Specified|1|||
161099322|NCT03872453|581755951|FG001|Overall Study|Other Than Specified|0|||
161099323|NCT03872453|581755952|FG002|Overall Study|Other Than Specified|0|||
161099324|NCT03872453|581755953|FG003|Overall Study|Other Than Specified|0|||
161099325|NCT01678209|581755954|FG000|Overall Study|could not scan twice|1|||
161099326|NCT01678209|581755955|FG001|Overall Study|could not scan twice|1|||
161099327|NCT01678209|581755956|FG002|Overall Study|could not scan twice|1|||
161099328|NCT01678209|581755954|FG000|Overall Study|scheduling conflicts|0|||
161099329|NCT01678209|581755955|FG001|Overall Study|scheduling conflicts|0|||
161099330|NCT01678209|581755956|FG002|Overall Study|scheduling conflicts|1|||
161099331|NCT01678209|581755954|FG000|Overall Study|screen fail|16|||
161099332|NCT01678209|581755955|FG001|Overall Study|screen fail|17|||
161099333|NCT01678209|581755956|FG002|Overall Study|screen fail|16|||
161212335|NCT01113710|582160090|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
161212336|NCT01113710|582160090|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
161212337|NCT01113710|582160090|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
161212338|NCT01113710|582160090|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
161212339|NCT01113710|582160090|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
161212340|NCT01113710|582160090|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
161212341|NCT01113710|582160090|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
161212342|NCT01113710|582160090|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
161212343|NCT01113710|582160090|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
161212344|NCT02770716|582160092|FG000|Overall Study|Death|101|||
161212345|NCT02770716|582160093|FG001|Overall Study|Death|45|||
161212346|NCT02770716|582160092|FG000|Overall Study|Withdrawal by Subject|4|||
161099334|NCT03756350|581755961|FG000|Overall Study|Lost to Follow-up|1|||
161099335|NCT00702845|581755965|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
161099336|NCT00702845|581755966|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
161099337|NCT00702845|581755965|FG000|Overall Study|Too high ovarian response|5|||
161099338|NCT00702845|581755966|FG001|Overall Study|Too high ovarian response|1|||
161099339|NCT00702845|581755965|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
161099340|NCT00702845|581755966|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
161099341|NCT00702845|581755965|FG000|Overall Study|Insufficient ovarian response|1|||
161099342|NCT00702845|581755966|FG001|Overall Study|Insufficient ovarian response|0|||
161099343|NCT00702845|581755965|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
161099344|NCT00702845|581755966|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
161099345|NCT00702845|581755965|FG000|Overall Study|No or abnormal fertilization|4|||
161099346|NCT00702845|581755966|FG001|Overall Study|No or abnormal fertilization|2|||
161099347|NCT00702845|581755965|FG000|Overall Study|Patient's decision|2|||
161099348|NCT00702845|581755966|FG001|Overall Study|Patient's decision|1|||
161099349|NCT00702845|581755965|FG000|Overall Study|Not randomized|0|||
161099350|NCT00702845|581755966|FG001|Overall Study|Not randomized|1|||
161099351|NCT00440700|581755967|FG000|Overall Study|Withdrawal by Subject|8|||
161099352|NCT00440700|581755968|FG001|Overall Study|Withdrawal by Subject|8|||
161099353|NCT00440700|581755969|FG002|Overall Study|Withdrawal by Subject|4|||
161099354|NCT00928564|581755970|FG000|Overall Study|Lost to Follow-up|6|||
161099355|NCT00928564|581755971|FG001|Overall Study|Lost to Follow-up|0|||
161099356|NCT01096342|581755974|FG000|Overall Study|Protocol Violation|1|||
161099357|NCT04906616|581755975|FG000|Overall Study|Divorce|3|||
161099358|NCT04906616|581755976|FG001|Overall Study|Divorce|2|||
161099359|NCT01521897|581755977|FG000|Overall Study|Protocol Violation|18|||
161099360|NCT01521897|581755977|FG000|Overall Study|Lost to Follow-up|5|||
161099361|NCT00385203|581755978|FG000|Overall Study|Adverse Event|5|||
161212347|NCT02770716|582160093|FG001|Overall Study|Withdrawal by Subject|2|||
161212348|NCT02770716|582160092|FG000|Overall Study|Lost to Follow-up|1|||
161099362|NCT00385203|581755979|FG001|Overall Study|Adverse Event|4|||
161099363|NCT00385203|581755978|FG000|Overall Study|Death|1|||
161099364|NCT00385203|581755979|FG001|Overall Study|Death|0|||
161099365|NCT00385203|581755978|FG000|Overall Study|Condition under investigation worsened|18|||
161099366|NCT00385203|581755979|FG001|Overall Study|Condition under investigation worsened|3|||
161099367|NCT00385203|581755978|FG000|Overall Study|Incorrect enrollment|2|||
161212349|NCT02770716|582160093|FG001|Overall Study|Lost to Follow-up|0|||
161212350|NCT02770716|582160092|FG000|Overall Study|Various reasons|6|||
161099368|NCT00385203|581755979|FG001|Overall Study|Incorrect enrollment|0|||
161099369|NCT02194062|581755980|FG000|Overall Study|Lost to Follow-up|2|||
161099370|NCT02194062|581755981|FG001|Overall Study|Lost to Follow-up|2|||
161099371|NCT02194062|581755982|FG002|Overall Study|Lost to Follow-up|5|||
161099372|NCT03422172|581755983|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
161099373|NCT03422172|581755983|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
161099374|NCT03422172|581755983|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
161099375|NCT04147234|581755984|FG000|Overall Study|Clinical deterioration|0|||
161099376|NCT04147234|581755985|FG001|Overall Study|Clinical deterioration|0|||
161099377|NCT04147234|581755986|FG002|Overall Study|Clinical deterioration|1|||
161099378|NCT04147234|581755987|FG003|Overall Study|Clinical deterioration|0|||
161099379|NCT04147234|581755988|FG004|Overall Study|Clinical deterioration|0|||
161099380|NCT04147234|581755989|FG005|Overall Study|Clinical deterioration|0|||
161099381|NCT04147234|581755990|FG006|Overall Study|Clinical deterioration|0|||
161099382|NCT04147234|581755984|FG000|Overall Study|Withdrawal by Subject|0|||
161099383|NCT04147234|581755985|FG001|Overall Study|Withdrawal by Subject|1|||
161099384|NCT04147234|581755986|FG002|Overall Study|Withdrawal by Subject|1|||
161099385|NCT04147234|581755987|FG003|Overall Study|Withdrawal by Subject|0|||
161099386|NCT04147234|581755988|FG004|Overall Study|Withdrawal by Subject|0|||
161099387|NCT04147234|581755989|FG005|Overall Study|Withdrawal by Subject|0|||
161099388|NCT04147234|581755990|FG006|Overall Study|Withdrawal by Subject|0|||
161099389|NCT04147234|581755984|FG000|Overall Study|Clinical disease progression|1|||
161099390|NCT04147234|581755985|FG001|Overall Study|Clinical disease progression|3|||
161099391|NCT04147234|581755986|FG002|Overall Study|Clinical disease progression|1|||
161099392|NCT04147234|581755987|FG003|Overall Study|Clinical disease progression|1|||
161099393|NCT04147234|581755988|FG004|Overall Study|Clinical disease progression|0|||
161099394|NCT04147234|581755989|FG005|Overall Study|Clinical disease progression|1|||
161099395|NCT04147234|581755990|FG006|Overall Study|Clinical disease progression|0|||
161099396|NCT04147234|581755984|FG000|Overall Study|Objective disease progression|6|||
161099397|NCT04147234|581755985|FG001|Overall Study|Objective disease progression|4|||
161099398|NCT04147234|581755986|FG002|Overall Study|Objective disease progression|3|||
161099399|NCT04147234|581755987|FG003|Overall Study|Objective disease progression|3|||
161099400|NCT04147234|581755988|FG004|Overall Study|Objective disease progression|5|||
161099401|NCT04147234|581755989|FG005|Overall Study|Objective disease progression|2|||
161099402|NCT04147234|581755990|FG006|Overall Study|Objective disease progression|3|||
161099403|NCT04147234|581755984|FG000|Overall Study|Adverse Event|0|||
161099404|NCT04147234|581755985|FG001|Overall Study|Adverse Event|0|||
161099405|NCT04147234|581755986|FG002|Overall Study|Adverse Event|0|||
161099406|NCT04147234|581755987|FG003|Overall Study|Adverse Event|0|||
161099407|NCT04147234|581755988|FG004|Overall Study|Adverse Event|1|||
161099408|NCT04147234|581755989|FG005|Overall Study|Adverse Event|0|||
161099409|NCT04147234|581755990|FG006|Overall Study|Adverse Event|0|||
161099410|NCT00293722|581755999|FG000|Overall Study|Other|427|||
161099411|NCT04498169|581756002|FG000|Study Completion|Adverse Event|1|||
161099412|NCT04498169|581756003|FG001|Study Completion|Adverse Event|1|||
161099413|NCT04964960|581756004|FG000|Overall Study|Withdrawal by Subject|1|||
161099414|NCT04964960|581756004|FG000|Overall Study|Did not complete cycles|1|||
161099415|NCT02960854|581756005|FG000|Overall Study|Not Disclosed|2|||
161099416|NCT02960854|581756006|FG001|Overall Study|Not Disclosed|2|||
161099417|NCT02960854|581756005|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
161099418|NCT02960854|581756006|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
161099419|NCT02960854|581756005|FG000|Overall Study|Subject Withdrew Consent|0|||
161099420|NCT02960854|581756006|FG001|Overall Study|Subject Withdrew Consent|1|||
161099421|NCT02960854|581756005|FG000|Overall Study|Death|4|||
161099422|NCT02960854|581756006|FG001|Overall Study|Death|6|||
161099423|NCT00221195|581756007|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
161099424|NCT00221195|581756008|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
161099425|NCT00221195|581756007|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
161099426|NCT00221195|581756008|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
161099427|NCT00221195|581756007|FG000|Washout Period (Months 7-9)|Death|0|||
161099428|NCT00221195|581756008|FG001|Washout Period (Months 7-9)|Death|1|||
161099429|NCT00221195|581756007|FG000|Therapy 2 (Months 10-15)|Death|1|||
161099430|NCT00221195|581756008|FG001|Therapy 2 (Months 10-15)|Death|0|||
161099431|NCT00221195|581756007|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
161099432|NCT00221195|581756008|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
161099433|NCT01383161|581756009|FG000|Overall Study|Adverse Event|5|||
161099434|NCT01383161|581756010|FG001|Overall Study|Adverse Event|1|||
161099435|NCT01383161|581756009|FG000|Overall Study|Withdrawal by Subject|0|||
161099436|NCT01383161|581756010|FG001|Overall Study|Withdrawal by Subject|2|||
161099437|NCT01383161|581756009|FG000|Overall Study|Lack of Efficacy|0|||
161099438|NCT01383161|581756010|FG001|Overall Study|Lack of Efficacy|1|||
161099439|NCT01423812|581756017|FG000|Overall Study|Lost to Follow-up|2|||
161099440|NCT01423812|581756018|FG001|Overall Study|Lost to Follow-up|2|||
161099441|NCT01423812|581756017|FG000|Overall Study|Withdrawal by Subject|1|||
161099442|NCT01423812|581756018|FG001|Overall Study|Withdrawal by Subject|2|||
161099443|NCT01207596|581756019|FG000|Overall Study|Physician Decision|4|||
161099444|NCT01207596|581756019|FG000|Overall Study|Lack of Efficacy|1|||
161099445|NCT01207596|581756019|FG000|Overall Study|Adverse Event|3|||
161099446|NCT01207596|581756019|FG000|Overall Study|Withdrawal by Subject|1|||
161099447|NCT03083847|581756020|FG000|Main|Physician Decision|0|||
161099448|NCT03083847|581756021|FG001|Main|Physician Decision|0|||
161099449|NCT03083847|581756022|FG002|Main|Physician Decision|0|||
161099450|NCT03083847|581756023|FG003|Main|Physician Decision|0|||
161099451|NCT03083847|581756024|FG004|Main|Physician Decision|0|||
161099452|NCT03083847|581756025|FG005|Main|Physician Decision|1|||
161099453|NCT03083847|581756026|FG006|Main|Physician Decision|0|||
161099454|NCT03083847|581756027|FG007|Main|Physician Decision|0|||
161099455|NCT03083847|581756028|FG008|Main|Physician Decision|0|||
161099456|NCT03083847|581756029|FG009|Main|Physician Decision|0|||
161099457|NCT03083847|581756020|FG000|Main|Pregnancy|0|||
161099458|NCT03083847|581756021|FG001|Main|Pregnancy|0|||
161099459|NCT03083847|581756022|FG002|Main|Pregnancy|0|||
161099460|NCT03083847|581756023|FG003|Main|Pregnancy|0|||
161099461|NCT03083847|581756024|FG004|Main|Pregnancy|0|||
161099462|NCT03083847|581756025|FG005|Main|Pregnancy|0|||
161099463|NCT03083847|581756026|FG006|Main|Pregnancy|0|||
161099464|NCT03083847|581756027|FG007|Main|Pregnancy|1|||
161099465|NCT03083847|581756028|FG008|Main|Pregnancy|0|||
161099466|NCT03083847|581756029|FG009|Main|Pregnancy|0|||
161099467|NCT03083847|581756020|FG000|Main|Adverse Event|0|||
161099468|NCT03083847|581756021|FG001|Main|Adverse Event|0|||
161099469|NCT03083847|581756022|FG002|Main|Adverse Event|0|||
161099470|NCT03083847|581756023|FG003|Main|Adverse Event|0|||
161099471|NCT03083847|581756024|FG004|Main|Adverse Event|0|||
161099472|NCT03083847|581756025|FG005|Main|Adverse Event|0|||
161099473|NCT03083847|581756026|FG006|Main|Adverse Event|0|||
161099474|NCT03083847|581756027|FG007|Main|Adverse Event|2|||
161099475|NCT03083847|581756028|FG008|Main|Adverse Event|0|||
161099476|NCT03083847|581756029|FG009|Main|Adverse Event|0|||
161099477|NCT03083847|581756020|FG000|Main|Withdrawal by Subject|0|||
161099478|NCT03083847|581756021|FG001|Main|Withdrawal by Subject|0|||
161099479|NCT03083847|581756022|FG002|Main|Withdrawal by Subject|0|||
161099480|NCT03083847|581756023|FG003|Main|Withdrawal by Subject|0|||
161099481|NCT03083847|581756024|FG004|Main|Withdrawal by Subject|0|||
161099482|NCT03083847|581756025|FG005|Main|Withdrawal by Subject|0|||
161099483|NCT03083847|581756026|FG006|Main|Withdrawal by Subject|1|||
161099484|NCT03083847|581756027|FG007|Main|Withdrawal by Subject|1|||
161099485|NCT03083847|581756028|FG008|Main|Withdrawal by Subject|0|||
161099486|NCT03083847|581756029|FG009|Main|Withdrawal by Subject|0|||
161099487|NCT00216203|581756030|FG000|Overall Study|Withdrawal by Subject|2|||
161099488|NCT02596620|581756033|FG000|Overall Study|Lost to Follow-up|1|||
161099489|NCT02596620|581756034|FG001|Overall Study|Lost to Follow-up|1|||
161099490|NCT03155373|581756044|FG000|Overall Study|No longer required surgery|1|||
161099491|NCT03155373|581756044|FG000|Overall Study|Protocol Violation|1|||
161099492|NCT03155373|581756044|FG000|Overall Study|Death|2|||
161099493|NCT03155373|581756044|FG000|Overall Study|Withdrawal by Subject|3|||
161099494|NCT01054144|581756045|FG000|Overall Study|Death|2|||
161099495|NCT03118674|581756046|FG000|Overall Study|Lost to Follow-up|2|||
161099496|NCT03118674|581756046|FG000|Overall Study|Screen Faliure|8|||
161099497|NCT03118674|581756046|FG000|Overall Study|Withdrawal by Subject|5|||
161099498|NCT00954174|581756053|FG000|Overall Study|Adverse Event|28|||
161099499|NCT00954174|581756054|FG001|Overall Study|Adverse Event|23|||
161099500|NCT00954174|581756055|FG002|Overall Study|Adverse Event|4|||
161099501|NCT00954174|581756056|FG003|Overall Study|Adverse Event|9|||
161099502|NCT00954174|581756053|FG000|Overall Study|Death|4|||
161099503|NCT00954174|581756054|FG001|Overall Study|Death|2|||
161099504|NCT00954174|581756055|FG002|Overall Study|Death|0|||
161099505|NCT00954174|581756056|FG003|Overall Study|Death|0|||
161099506|NCT00954174|581756053|FG000|Overall Study|Lack of Efficacy|32|||
161099507|NCT00954174|581756054|FG001|Overall Study|Lack of Efficacy|22|||
161099508|NCT00954174|581756055|FG002|Overall Study|Lack of Efficacy|8|||
161099509|NCT00954174|581756056|FG003|Overall Study|Lack of Efficacy|6|||
161099510|NCT00954174|581756053|FG000|Overall Study|Withdrawal by Subject|14|||
161099511|NCT00954174|581756054|FG001|Overall Study|Withdrawal by Subject|10|||
161099512|NCT00954174|581756055|FG002|Overall Study|Withdrawal by Subject|4|||
161099513|NCT00954174|581756056|FG003|Overall Study|Withdrawal by Subject|3|||
161099514|NCT00954174|581756053|FG000|Overall Study|Medical Reason|4|||
161099515|NCT00954174|581756054|FG001|Overall Study|Medical Reason|2|||
161099516|NCT00954174|581756055|FG002|Overall Study|Medical Reason|1|||
161099517|NCT00954174|581756056|FG003|Overall Study|Medical Reason|0|||
161099518|NCT00954174|581756053|FG000|Overall Study|Ineligible|40|||
161099519|NCT00954174|581756054|FG001|Overall Study|Ineligible|47|||
161099520|NCT00954174|581756055|FG002|Overall Study|Ineligible|7|||
161099521|NCT00954174|581756056|FG003|Overall Study|Ineligible|4|||
161099522|NCT00954174|581756053|FG000|Overall Study|Never Treated|4|||
161099523|NCT00954174|581756054|FG001|Overall Study|Never Treated|17|||
161099524|NCT00954174|581756055|FG002|Overall Study|Never Treated|0|||
161099525|NCT00954174|581756056|FG003|Overall Study|Never Treated|3|||
161099526|NCT02234323|581756057|FG000|All Enrolled|Not Treated: Completed study in database|2|||
161099527|NCT02234323|581756057|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
161099528|NCT02234323|581756057|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
161099529|NCT02234323|581756057|FG000|All Treated|Death|1|||
161099530|NCT02234323|581756057|FG000|All Treated|Physician Decision|5|||
161099531|NCT02234323|581756057|FG000|All Treated|Lack of Efficacy|3|||
161099532|NCT02234323|581756057|FG000|All Treated|Exceeded lab value limit|2|||
161099533|NCT02234323|581756057|FG000|All Treated|Other|7|||
161099534|NCT02644941|581756058|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
161099535|NCT02644941|581756059|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
161099536|NCT00867113|581756060|FG000|Treatment Period|Adverse Event|15|||
161099537|NCT00867113|581756060|FG000|Treatment Period|Death|2|||
161099538|NCT00867113|581756060|FG000|Treatment Period|Withdrawal by Subject|19|||
161099539|NCT00867113|581756060|FG000|Treatment Period|Lost to Follow-up|3|||
161099540|NCT00867113|581756060|FG000|Treatment Period|Administrative problems|1|||
161099541|NCT00867113|581756060|FG000|Treatment Period|Disease progression/relapse|1|||
161099542|NCT00867113|581756060|FG000|Treatment Period|Protocol Violation|4|||
161099543|NCT00867113|581756060|FG000|Post Treatment After Survival Follow-up|Death|1|||
161099544|NCT00867113|581756060|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
161099545|NCT00867113|581756060|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
161099546|NCT00867113|581756060|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
161099547|NCT01145495|581756061|FG000|Overall Study|Adverse Event|6|||
161099548|NCT01145495|581756061|FG000|Overall Study|Withdrawal by Subject|6|||
161099549|NCT01145495|581756061|FG000|Overall Study|Disease progression after respone|2|||
161099550|NCT01886313|581756064|FG000|Overall Study|Adverse Event|1|||
161099551|NCT01886313|581756065|FG001|Overall Study|Adverse Event|1|||
161099552|NCT01603082|581756070|FG000|Overall Study|Adverse Event|0|||
161099553|NCT01603082|581756071|FG001|Overall Study|Adverse Event|1|||
161099554|NCT01603082|581756070|FG000|Overall Study|Withdrawal by Subject|1|||
161099555|NCT01603082|581756071|FG001|Overall Study|Withdrawal by Subject|0|||
161099556|NCT01603082|581756070|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
161099557|NCT01603082|581756071|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
161099558|NCT01641809|581756075|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161099559|NCT01641809|581756076|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161099560|NCT01641809|581756077|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
161099561|NCT01641809|581756078|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
161099562|NCT01641809|581756075|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
161099563|NCT01641809|581756076|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
161099564|NCT01641809|581756077|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
161099565|NCT01641809|581756078|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
161099566|NCT01641809|581756075|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
161099567|NCT01641809|581756076|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
161099568|NCT01641809|581756077|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
161099569|NCT01641809|581756078|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
161099570|NCT01641809|581756075|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
161099571|NCT01641809|581756076|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
161099572|NCT01641809|581756077|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
161099573|NCT01641809|581756078|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
161099574|NCT01641809|581756075|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
161099575|NCT01641809|581756076|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
161099576|NCT01641809|581756077|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
161099577|NCT01641809|581756078|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
161099578|NCT01641809|581756075|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
161099579|NCT01641809|581756076|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
161099580|NCT01641809|581756077|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
161099581|NCT01641809|581756078|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
161099582|NCT01641809|581756075|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
161099583|NCT01641809|581756076|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
161099584|NCT01641809|581756077|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
161099585|NCT01641809|581756078|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
161099586|NCT01641809|581756075|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161099587|NCT01641809|581756076|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
161099588|NCT01641809|581756077|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161099589|NCT01641809|581756078|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
161099590|NCT01641809|581756075|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
161099591|NCT01641809|581756076|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
161099592|NCT01641809|581756077|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
161099593|NCT01641809|581756078|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
161099594|NCT01641809|581756075|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
161099595|NCT01641809|581756076|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
161099596|NCT01641809|581756077|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
161099597|NCT01641809|581756078|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
161099598|NCT01641809|581756075|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
161099599|NCT01641809|581756076|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
161099600|NCT01641809|581756077|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
161099601|NCT01641809|581756078|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
161099602|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
161099603|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
161099604|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
161099605|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
161099606|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
161099607|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
161099608|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
161099609|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
161099610|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
161099611|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
161099612|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
161099613|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
161099614|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
161099615|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
161099616|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
161099617|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
161099618|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
161099619|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
161099620|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
161099621|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
161099622|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
161099623|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
161099624|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
161099625|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
161099626|NCT01641809|581756075|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
161099627|NCT01641809|581756076|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
161099628|NCT01641809|581756077|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
161099629|NCT01641809|581756078|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
161099630|NCT04195581|581756079|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
161099631|NCT04195581|581756079|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
161099632|NCT04195581|581756079|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
161099633|NCT04195581|581756079|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
161099634|NCT04195581|581756079|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
161099635|NCT04195581|581756079|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
161099636|NCT00821431|581756080|FG000|Overall Study|Adverse Event|6|||
161099637|NCT00821431|581756081|FG001|Overall Study|Adverse Event|3|||
161099638|NCT00821431|581756080|FG000|Overall Study|Withdrawal by Subject|5|||
161099639|NCT00821431|581756081|FG001|Overall Study|Withdrawal by Subject|0|||
161099640|NCT00821431|581756080|FG000|Overall Study|Lost to Follow-up|1|||
161099641|NCT00821431|581756081|FG001|Overall Study|Lost to Follow-up|0|||
161099642|NCT00821431|581756080|FG000|Overall Study|Protocol Violation|3|||
161099643|NCT00821431|581756081|FG001|Overall Study|Protocol Violation|1|||
161099644|NCT00821431|581756080|FG000|Overall Study|Physician Decision|0|||
161212351|NCT02770716|582160093|FG001|Overall Study|Various reasons|2|||
161099645|NCT00821431|581756081|FG001|Overall Study|Physician Decision|1|||
161099646|NCT01699789|581756085|FG000|Overall Study|Withdrawal by Subject|18|||
161099647|NCT01699789|581756086|FG001|Overall Study|Withdrawal by Subject|23|||
161099648|NCT01699789|581756085|FG000|Overall Study|Death|1|||
161099649|NCT01699789|581756086|FG001|Overall Study|Death|2|||
161099650|NCT01699789|581756085|FG000|Overall Study|Lost to Follow-up|83|||
161099651|NCT01699789|581756086|FG001|Overall Study|Lost to Follow-up|101|||
161099652|NCT03335163|581757579|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
161099653|NCT03335163|581757579|FG000|Overall Study|Withdrawal by Subject|18|||
161099654|NCT03434353|581757585|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
161099655|NCT03434353|581757586|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
161099656|NCT03434353|581757587|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
161099657|NCT03434353|581757588|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
161099658|NCT03434353|581757589|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
161099659|NCT03434353|581757585|FG000|Overall Study|Withdrew consent|1|||
161099660|NCT03434353|581757586|FG001|Overall Study|Withdrew consent|0|||
161099661|NCT03434353|581757587|FG002|Overall Study|Withdrew consent|3|||
161099662|NCT03434353|581757588|FG003|Overall Study|Withdrew consent|0|||
161099663|NCT03434353|581757589|FG004|Overall Study|Withdrew consent|0|||
161099664|NCT03434353|581757585|FG000|Overall Study|Adverse Event|1|||
161099665|NCT03434353|581757586|FG001|Overall Study|Adverse Event|0|||
161099666|NCT03434353|581757587|FG002|Overall Study|Adverse Event|0|||
161099667|NCT03434353|581757588|FG003|Overall Study|Adverse Event|0|||
161099668|NCT03434353|581757589|FG004|Overall Study|Adverse Event|1|||
161099669|NCT03434353|581757585|FG000|Overall Study|Lost to Follow-up|2|||
161099670|NCT03434353|581757586|FG001|Overall Study|Lost to Follow-up|0|||
161099671|NCT03434353|581757587|FG002|Overall Study|Lost to Follow-up|0|||
161099672|NCT03434353|581757588|FG003|Overall Study|Lost to Follow-up|0|||
161099673|NCT03434353|581757589|FG004|Overall Study|Lost to Follow-up|0|||
161099674|NCT03739762|581757590|FG000|Overall Study|Lost to Follow-up|1|||
161099675|NCT03739762|581757591|FG001|Overall Study|Lost to Follow-up|1|||
161099676|NCT03739762|581757590|FG000|Overall Study|Withdrawal by Subject|2|||
161099677|NCT03739762|581757591|FG001|Overall Study|Withdrawal by Subject|6|||
161099678|NCT00929656|581757592|FG000|Overall Study|Lost to Follow-up|0|||
161099679|NCT00929656|581757593|FG001|Overall Study|Lost to Follow-up|1|||
161099680|NCT00607880|581757594|FG000|Overall Study|Unable to place port due to occlusion|1|||
161099681|NCT00607880|581757595|FG001|Overall Study|Unable to place port due to occlusion|0|||
161099682|NCT01990534|581757596|FG000|Overall Study|Death|22|||
161099683|NCT01990534|581757596|FG000|Overall Study|Progressive disease|3|||
161099684|NCT01990534|581757596|FG000|Overall Study|Protocol Violation|1|||
161099685|NCT01990534|581757596|FG000|Overall Study|Withdrawal of Informed Consent|2|||
161099686|NCT01990534|581757596|FG000|Overall Study|Symptomatic Deterioration|1|||
161099687|NCT01990534|581757596|FG000|Overall Study|Withdrawal by Subject|3|||
161099688|NCT01990534|581757596|FG000|Overall Study|Reason not Specified|2|||
161099689|NCT01990534|581757596|FG000|Overall Study|Lost to Follow-up|1|||
161099690|NCT01831544|581757597|FG000|Overall Study|Death|1|||
161099691|NCT01831544|581757597|FG000|Overall Study|Still on original MVAD device|2|||
161099692|NCT03308942|581757600|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
161099693|NCT03308942|581757601|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
161099694|NCT03308942|581757602|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
161099695|NCT03308942|581757603|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
161099696|NCT03308942|581757604|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
161099697|NCT03308942|581757600|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
161099698|NCT03308942|581757601|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
161099699|NCT03308942|581757602|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
161099700|NCT03308942|581757603|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
161099701|NCT03308942|581757604|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
161099702|NCT03308942|581757600|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161099703|NCT03308942|581757601|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
161099704|NCT03308942|581757602|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161099705|NCT03308942|581757603|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161099706|NCT03308942|581757604|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
161099707|NCT03308942|581757600|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
161099708|NCT03308942|581757601|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
161099709|NCT03308942|581757602|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161099710|NCT03308942|581757603|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161099711|NCT03308942|581757604|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
161099712|NCT03308942|581757600|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161099713|NCT03308942|581757601|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161099714|NCT03308942|581757602|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161099715|NCT03308942|581757603|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
161099716|NCT03308942|581757604|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
161099717|NCT03308942|581757600|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161099718|NCT03308942|581757601|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161099719|NCT03308942|581757602|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161099720|NCT03308942|581757603|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
161099721|NCT03308942|581757604|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
161099722|NCT03308942|581757600|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161099723|NCT03308942|581757601|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161099724|NCT03308942|581757602|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161099725|NCT03308942|581757603|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
161099726|NCT03308942|581757604|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
161099727|NCT01131351|581757605|FG000|Overall Study|Adverse Event|0|||
161099728|NCT01131351|581757606|FG001|Overall Study|Adverse Event|2|||
161099729|NCT01131351|581757605|FG000|Overall Study|Protocol Deviation|0|||
161099730|NCT01131351|581757606|FG001|Overall Study|Protocol Deviation|1|||
161099731|NCT04606771|581757613|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
161099732|NCT04606771|581757614|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
161099733|NCT04606771|581757613|FG000|Overall Study|Death|5|||
161099734|NCT04606771|581757614|FG001|Overall Study|Death|6|||
161099735|NCT04606771|581757613|FG000|Overall Study|Wrong randomisation|0|||
161099736|NCT04606771|581757614|FG001|Overall Study|Wrong randomisation|1|||
161099737|NCT01008696|581757616|FG000|Overall Study|Participant's evasion of hospital visit|5|||
161099738|NCT01008696|581757617|FG001|Overall Study|Participant's evasion of hospital visit|4|||
161099739|NCT01008696|581757616|FG000|Overall Study|Withdrawal by Subject|2|||
161099740|NCT01008696|581757617|FG001|Overall Study|Withdrawal by Subject|4|||
161099741|NCT01008696|581757616|FG000|Overall Study|Physician Decision|5|||
161099742|NCT01008696|581757617|FG001|Overall Study|Physician Decision|1|||
161099743|NCT01008696|581757616|FG000|Overall Study|Adverse Event|1|||
161099744|NCT01008696|581757617|FG001|Overall Study|Adverse Event|0|||
161099745|NCT01008696|581757616|FG000|Overall Study|Participants' non-cooperation|2|||
161099746|NCT01008696|581757617|FG001|Overall Study|Participants' non-cooperation|3|||
161099747|NCT01008696|581757616|FG000|Overall Study|Other|2|||
161099748|NCT01008696|581757617|FG001|Overall Study|Other|3|||
161099749|NCT01008696|581757616|FG000|Overall Study|Other|0|||
161099750|NCT01008696|581757617|FG001|Overall Study|Other|2|||
161099751|NCT02856893|581757618|FG000|Overall Study|Lack of Efficacy|27|||
161099752|NCT02856893|581757619|FG001|Overall Study|Lack of Efficacy|15|||
161099753|NCT02856893|581757620|FG002|Overall Study|Lack of Efficacy|19|||
161099754|NCT02856893|581757618|FG000|Overall Study|Death|1|||
161099755|NCT02856893|581757619|FG001|Overall Study|Death|0|||
161099756|NCT02856893|581757620|FG002|Overall Study|Death|0|||
161099757|NCT02856893|581757618|FG000|Overall Study|Adverse Event|2|||
161099758|NCT02856893|581757619|FG001|Overall Study|Adverse Event|0|||
161099759|NCT02856893|581757620|FG002|Overall Study|Adverse Event|0|||
161099760|NCT02856893|581757618|FG000|Overall Study|Physician Decision|0|||
161099761|NCT02856893|581757619|FG001|Overall Study|Physician Decision|2|||
161099762|NCT02856893|581757620|FG002|Overall Study|Physician Decision|3|||
161099763|NCT02856893|581757618|FG000|Overall Study|Withdrawal by Subject|1|||
161099764|NCT02856893|581757619|FG001|Overall Study|Withdrawal by Subject|1|||
161099765|NCT02856893|581757620|FG002|Overall Study|Withdrawal by Subject|0|||
161099766|NCT02856893|581757618|FG000|Overall Study|Other reasons|2|||
161099767|NCT02856893|581757619|FG001|Overall Study|Other reasons|1|||
161099768|NCT02856893|581757620|FG002|Overall Study|Other reasons|2|||
161099769|NCT02310672|581757621|FG000|Overall Study|Death|1|||
161099770|NCT02310672|581757621|FG000|Overall Study|Lost to Follow-up|1|||
161099771|NCT02310672|581757621|FG000|Overall Study|Withdrawal by Subject|1|||
161099772|NCT02310672|581757621|FG000|Overall Study|Sponsor's decision|12|||
161099773|NCT01214187|581757625|FG000|Overall Study|Adverse Event|6|||
161099774|NCT01214187|581757626|FG001|Overall Study|Adverse Event|2|||
161099775|NCT01214187|581757625|FG000|Overall Study|Death|1|||
161099776|NCT01214187|581757626|FG001|Overall Study|Death|1|||
161099777|NCT01214187|581757625|FG000|Overall Study|Withdrawal by Subject|0|||
161099778|NCT01214187|581757626|FG001|Overall Study|Withdrawal by Subject|3|||
161099779|NCT02308007|581757635|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
161099780|NCT02308007|581757636|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
161099781|NCT02308007|581757637|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
161099782|NCT02308007|581757635|FG000|Overall Study|Positive for STD at Baseline|7|||
161099783|NCT02308007|581757636|FG001|Overall Study|Positive for STD at Baseline|11|||
161099784|NCT02308007|581757637|FG002|Overall Study|Positive for STD at Baseline|7|||
161099785|NCT02308007|581757635|FG000|Overall Study|Lost to Follow-up|3|||
161099786|NCT02308007|581757636|FG001|Overall Study|Lost to Follow-up|0|||
161099787|NCT02308007|581757637|FG002|Overall Study|Lost to Follow-up|1|||
161099788|NCT01233869|581757638|FG000|Initial Treatment Period (24 Months)|Death|1|||
161099789|NCT01233869|581757639|FG001|Initial Treatment Period (24 Months)|Death|0|||
161099790|NCT01233869|581757640|FG002|Initial Treatment Period (24 Months)|Death|0|||
161099791|NCT01233869|581757641|FG003|Initial Treatment Period (24 Months)|Death|0|||
161099792|NCT01233869|581757638|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
161099793|NCT01233869|581757639|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
161099794|NCT01233869|581757640|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
161099795|NCT01233869|581757641|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
161099796|NCT01233869|581757638|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
161099797|NCT01233869|581757639|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
161099798|NCT01233869|581757640|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
161099799|NCT01233869|581757641|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
161099800|NCT01233869|581757638|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161099801|NCT01233869|581757639|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161099802|NCT01233869|581757640|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
161099803|NCT01233869|581757641|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
161099804|NCT01233869|581757638|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
161099805|NCT01233869|581757639|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
161099806|NCT01233869|581757640|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
161099807|NCT01233869|581757641|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
161099808|NCT01233869|581757638|FG000|Extended Treatment Period (46 Months)|Other|3|||
161099809|NCT01233869|581757639|FG001|Extended Treatment Period (46 Months)|Other|0|||
161099810|NCT01233869|581757640|FG002|Extended Treatment Period (46 Months)|Other|0|||
161099811|NCT01233869|581757641|FG003|Extended Treatment Period (46 Months)|Other|3|||
161099812|NCT01233869|581757638|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
161099813|NCT01233869|581757639|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
161099814|NCT01233869|581757640|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
161099815|NCT01233869|581757641|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
161099816|NCT01324323|581757642|FG000|Overall Study|Withdrawal by Subject|1|||
161099817|NCT00537485|581757643|FG000|Overall Study|Adverse Event|10|||
161099818|NCT00537485|581757644|FG001|Overall Study|Adverse Event|5|||
161099819|NCT00537485|581757643|FG000|Overall Study|Withdrawal by Subject|3|||
161099820|NCT00537485|581757644|FG001|Overall Study|Withdrawal by Subject|2|||
161099821|NCT00537485|581757643|FG000|Overall Study|Withdrawal by Subject|1|||
161099822|NCT00537485|581757644|FG001|Overall Study|Withdrawal by Subject|3|||
161099823|NCT00537485|581757643|FG000|Overall Study|Physician Decision|1|||
161099824|NCT00537485|581757644|FG001|Overall Study|Physician Decision|0|||
161099825|NCT01601847|581757653|FG000|Overall Study|Death|1|||
161099826|NCT01601847|581757654|FG001|Overall Study|Death|0|||
161099827|NCT01601847|581757653|FG000|Overall Study|Withdrawal by Subject|11|||
161099828|NCT01601847|581757654|FG001|Overall Study|Withdrawal by Subject|7|||
161099829|NCT01601847|581757653|FG000|Overall Study|Lost to Follow-up|1|||
161099830|NCT01601847|581757654|FG001|Overall Study|Lost to Follow-up|3|||
161099831|NCT00631189|581757655|FG000|Initial Phase|Protocol Violation|347|||
161099832|NCT00631189|581757656|FG001|Initial Phase|Protocol Violation|0|||
161099833|NCT00631189|581757657|FG002|Initial Phase|Protocol Violation|0|||
161099834|NCT00631189|581757658|FG003|Initial Phase|Protocol Violation|0|||
161099835|NCT00631189|581757655|FG000|Initial Phase|Withdrawal by Subject|4|||
161099836|NCT00631189|581757656|FG001|Initial Phase|Withdrawal by Subject|0|||
161099837|NCT00631189|581757657|FG002|Initial Phase|Withdrawal by Subject|0|||
161099838|NCT00631189|581757658|FG003|Initial Phase|Withdrawal by Subject|0|||
161099839|NCT00631189|581757655|FG000|Treatment Phase|Withdrawal by Subject|0|||
161099840|NCT00631189|581757656|FG001|Treatment Phase|Withdrawal by Subject|2|||
161099841|NCT00631189|581757657|FG002|Treatment Phase|Withdrawal by Subject|1|||
161099842|NCT00631189|581757658|FG003|Treatment Phase|Withdrawal by Subject|1|||
161099843|NCT00631189|581757655|FG000|Treatment Phase|Protocol Violation|0|||
161099844|NCT00631189|581757656|FG001|Treatment Phase|Protocol Violation|1|||
161099845|NCT00631189|581757657|FG002|Treatment Phase|Protocol Violation|6|||
161099846|NCT00631189|581757658|FG003|Treatment Phase|Protocol Violation|2|||
161099847|NCT00631189|581757655|FG000|Treatment Phase|Adverse Event|0|||
161099848|NCT00631189|581757656|FG001|Treatment Phase|Adverse Event|3|||
161099849|NCT00631189|581757657|FG002|Treatment Phase|Adverse Event|2|||
161099850|NCT00631189|581757658|FG003|Treatment Phase|Adverse Event|4|||
161099851|NCT00631189|581757655|FG000|Treatment Phase|Lost to Follow-up|0|||
161099852|NCT00631189|581757656|FG001|Treatment Phase|Lost to Follow-up|1|||
161099853|NCT00631189|581757657|FG002|Treatment Phase|Lost to Follow-up|0|||
161099854|NCT00631189|581757658|FG003|Treatment Phase|Lost to Follow-up|0|||
161099855|NCT00631189|581757655|FG000|Treatment Phase|Pregnancy|0|||
161099856|NCT00631189|581757656|FG001|Treatment Phase|Pregnancy|0|||
161099857|NCT00631189|581757657|FG002|Treatment Phase|Pregnancy|1|||
161099858|NCT00631189|581757658|FG003|Treatment Phase|Pregnancy|0|||
161099859|NCT00631189|581757655|FG000|Treatment Phase|patient did not take pravastatin|0|||
161099860|NCT00631189|581757656|FG001|Treatment Phase|patient did not take pravastatin|0|||
161099861|NCT00631189|581757657|FG002|Treatment Phase|patient did not take pravastatin|1|||
161099862|NCT00631189|581757658|FG003|Treatment Phase|patient did not take pravastatin|0|||
161099863|NCT04464265|581757659|FG000|Overall Study|Physician Decision|2|||
161099864|NCT01284062|581757660|FG000|Overall Study|Adverse Event|4|||
161099865|NCT01284062|581757661|FG001|Overall Study|Adverse Event|5|||
161099866|NCT01284062|581757662|FG002|Overall Study|Adverse Event|0|||
161099867|NCT01284062|581757663|FG003|Overall Study|Adverse Event|5|||
161099868|NCT01284062|581757660|FG000|Overall Study|Lack of Efficacy|3|||
161099869|NCT01284062|581757661|FG001|Overall Study|Lack of Efficacy|2|||
161099870|NCT01284062|581757662|FG002|Overall Study|Lack of Efficacy|2|||
161099871|NCT01284062|581757663|FG003|Overall Study|Lack of Efficacy|1|||
161099872|NCT01284062|581757660|FG000|Overall Study|Medication error without adverse event|0|||
161099873|NCT01284062|581757661|FG001|Overall Study|Medication error without adverse event|0|||
161099874|NCT01284062|581757662|FG002|Overall Study|Medication error without adverse event|1|||
161099875|NCT01284062|581757663|FG003|Overall Study|Medication error without adverse event|0|||
161099876|NCT01284062|581757660|FG000|Overall Study|Protocol Violation|1|||
161099877|NCT01284062|581757661|FG001|Overall Study|Protocol Violation|0|||
161099878|NCT01284062|581757662|FG002|Overall Study|Protocol Violation|0|||
161099879|NCT01284062|581757663|FG003|Overall Study|Protocol Violation|2|||
161099880|NCT01284062|581757660|FG000|Overall Study|Withdrawal by Subject|3|||
161099881|NCT01284062|581757661|FG001|Overall Study|Withdrawal by Subject|1|||
161099882|NCT01284062|581757662|FG002|Overall Study|Withdrawal by Subject|2|||
161099883|NCT01284062|581757663|FG003|Overall Study|Withdrawal by Subject|5|||
161099884|NCT01284062|581757660|FG000|Overall Study|Other|0|||
161099885|NCT01284062|581757661|FG001|Overall Study|Other|0|||
161099886|NCT01284062|581757662|FG002|Overall Study|Other|0|||
161099887|NCT01284062|581757663|FG003|Overall Study|Other|1|||
161099888|NCT01284062|581757660|FG000|Overall Study|Site Closed|0|||
161099889|NCT01284062|581757661|FG001|Overall Study|Site Closed|0|||
161099890|NCT01284062|581757662|FG002|Overall Study|Site Closed|1|||
161099891|NCT01284062|581757663|FG003|Overall Study|Site Closed|0|||
161099892|NCT03189862|581757664|FG000|Overall Study|Withdrawal by Subject|1|||
161099893|NCT03189862|581757665|FG001|Overall Study|Withdrawal by Subject|0|||
161099894|NCT03189862|581757664|FG000|Overall Study|Lost to Follow-up|54|||
161099895|NCT03189862|581757665|FG001|Overall Study|Lost to Follow-up|62|||
161099896|NCT00931944|581757667|FG000|Overall Study|Adverse Event|4|||
161099897|NCT00931944|581757667|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
161099898|NCT00931944|581757667|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
161099899|NCT00931944|581757667|FG000|Overall Study|Death|28|||
161099900|NCT00931944|581757667|FG000|Overall Study|Other|2|||
161099901|NCT00634010|581757672|FG000|Overall Study|Adverse Event|2|||
161099902|NCT00634010|581757673|FG001|Overall Study|Adverse Event|5|||
161099903|NCT00634010|581757672|FG000|Overall Study|Withdrawal by Subject|5|||
161099904|NCT00634010|581757673|FG001|Overall Study|Withdrawal by Subject|6|||
161099905|NCT00634010|581757672|FG000|Overall Study|Physician Decision|1|||
161099906|NCT00634010|581757673|FG001|Overall Study|Physician Decision|1|||
161099907|NCT00634010|581757672|FG000|Overall Study|Disease Progression|1|||
161099908|NCT00634010|581757673|FG001|Overall Study|Disease Progression|1|||
161099909|NCT00634010|581757672|FG000|Overall Study|Non-Compliant|1|||
161099910|NCT00634010|581757673|FG001|Overall Study|Non-Compliant|1|||
161099911|NCT01026142|581757674|FG000|Overall Study|Death|136|||
161099912|NCT01026142|581757675|FG001|Overall Study|Death|134|||
161099913|NCT01026142|581757674|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
161099914|NCT01026142|581757675|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
161099915|NCT00882310|581757676|FG000|Overall Study|Screen Failure|10|||
161099916|NCT00882310|581757676|FG000|Overall Study|Never received treatment|1|||
161099917|NCT00882310|581757676|FG000|Overall Study|Death|6|||
161099918|NCT00882310|581757676|FG000|Overall Study|Progression of disease|4|||
161099919|NCT00882310|581757676|FG000|Overall Study|Adverse Event|1|||
161099920|NCT04233164|581757681|FG000|Overall Study|Unable to obtain specimen|0|||
161099921|NCT04233164|581757682|FG001|Overall Study|Unable to obtain specimen|1|||
161099922|NCT04201821|581757685|FG000|Overall Study|Withdrawal by Subject|2|||
161099923|NCT00651157|581757686|FG000|Overall Study|Death|1|||
161099924|NCT00651157|581757686|FG000|Overall Study|Protocol Violation|1|||
161099925|NCT00688181|581757688|FG000|Overall Study|Lost to Follow-up|17|||
161099926|NCT00688181|581757688|FG000|Overall Study|Unknown Reason|4|||
161099927|NCT00688181|581757688|FG000|Overall Study|Non-clinical Reason|2|||
161099928|NCT01891721|581757689|FG000|Overall Study|Lost to Follow-up|10|||
161099929|NCT01891721|581757690|FG001|Overall Study|Lost to Follow-up|5|||
161099930|NCT01891721|581757691|FG002|Overall Study|Lost to Follow-up|1|||
161099931|NCT03829319|581757692|FG000|Overall Study|Sponsor's Decision|4|||
161099932|NCT03829319|581757693|FG001|Overall Study|Sponsor's Decision|90|||
161099933|NCT03829319|581757694|FG002|Overall Study|Sponsor's Decision|102|||
161099934|NCT03829319|581757692|FG000|Overall Study|Withdrawal by Subject|1|||
161099935|NCT03829319|581757693|FG001|Overall Study|Withdrawal by Subject|5|||
161099936|NCT03829319|581757694|FG002|Overall Study|Withdrawal by Subject|4|||
161099937|NCT03829319|581757692|FG000|Overall Study|Physician Decision|0|||
161099938|NCT03829319|581757693|FG001|Overall Study|Physician Decision|3|||
161099939|NCT03829319|581757694|FG002|Overall Study|Physician Decision|0|||
161099940|NCT03829319|581757692|FG000|Overall Study|Lost to Follow-up|0|||
161099941|NCT03829319|581757693|FG001|Overall Study|Lost to Follow-up|0|||
161099942|NCT03829319|581757694|FG002|Overall Study|Lost to Follow-up|1|||
161099943|NCT03829319|581757692|FG000|Overall Study|Death|8|||
161099944|NCT03829319|581757693|FG001|Overall Study|Death|277|||
161099945|NCT03829319|581757694|FG002|Overall Study|Death|266|||
161099946|NCT04484259|581757695|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161099947|NCT04484259|581757696|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161099948|NCT04484259|581757697|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161099949|NCT04484259|581757698|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
161099950|NCT04484259|581757699|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
161099951|NCT04484259|581757695|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161099952|NCT04484259|581757696|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161099953|NCT04484259|581757697|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161099954|NCT04484259|581757698|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
161099955|NCT04484259|581757699|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
161099956|NCT04484259|581757695|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161099957|NCT04484259|581757696|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161099958|NCT04484259|581757697|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161099959|NCT04484259|581757698|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
161099960|NCT04484259|581757699|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
161099961|NCT04484259|581757695|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161099962|NCT04484259|581757696|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161099963|NCT04484259|581757697|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161099964|NCT04484259|581757698|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
161099965|NCT04484259|581757699|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
161099966|NCT04484259|581757695|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161099967|NCT04484259|581757696|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161099968|NCT04484259|581757697|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161099969|NCT04484259|581757698|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
161099970|NCT04484259|581757699|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
161099971|NCT04484259|581757695|FG000|Randomized Treatment|Withdrawal by Subject|1|||
161099972|NCT04484259|581757696|FG001|Randomized Treatment|Withdrawal by Subject|0|||
161099973|NCT04484259|581757697|FG002|Randomized Treatment|Withdrawal by Subject|0|||
161099974|NCT04484259|581757698|FG003|Randomized Treatment|Withdrawal by Subject|0|||
161099975|NCT04484259|581757699|FG004|Randomized Treatment|Withdrawal by Subject|0|||
161099976|NCT04498832|581757700|FG000|Overall Study|Adverse Event|1|||
161099977|NCT04498832|581757701|FG001|Overall Study|Adverse Event|3|||
161099978|NCT04498832|581757700|FG000|Overall Study|Withdrawal by Subject|0|||
161099979|NCT04498832|581757701|FG001|Overall Study|Withdrawal by Subject|1|||
161099980|NCT01313650|581757703|FG000|Overall Study|Adverse Event|9|||
161099981|NCT01313650|581757704|FG001|Overall Study|Adverse Event|34|||
161099982|NCT01313650|581757705|FG002|Overall Study|Adverse Event|24|||
161099983|NCT01313650|581757706|FG003|Overall Study|Adverse Event|23|||
161099984|NCT01313650|581757703|FG000|Overall Study|Lack of Efficacy|37|||
161099985|NCT01313650|581757704|FG001|Overall Study|Lack of Efficacy|20|||
161099986|NCT01313650|581757705|FG002|Overall Study|Lack of Efficacy|32|||
161099987|NCT01313650|581757706|FG003|Overall Study|Lack of Efficacy|20|||
161099988|NCT01313650|581757703|FG000|Overall Study|Lost to Follow-up|1|||
161099989|NCT01313650|581757704|FG001|Overall Study|Lost to Follow-up|0|||
161099990|NCT01313650|581757705|FG002|Overall Study|Lost to Follow-up|3|||
161099991|NCT01313650|581757706|FG003|Overall Study|Lost to Follow-up|2|||
161212352|NCT01042977|582160094|FG000|Overall Study|Adverse Event|4|||
161099992|NCT01313650|581757703|FG000|Overall Study|Withdrawal by Subject|16|||
161099993|NCT01313650|581757704|FG001|Overall Study|Withdrawal by Subject|20|||
161099994|NCT01313650|581757705|FG002|Overall Study|Withdrawal by Subject|15|||
161099995|NCT01313650|581757706|FG003|Overall Study|Withdrawal by Subject|15|||
161099996|NCT01313650|581757703|FG000|Overall Study|Protocol Violation|4|||
161099997|NCT01313650|581757704|FG001|Overall Study|Protocol Violation|7|||
161099998|NCT01313650|581757705|FG002|Overall Study|Protocol Violation|5|||
161099999|NCT01313650|581757706|FG003|Overall Study|Protocol Violation|6|||
161212353|NCT01042977|582160095|FG001|Overall Study|Adverse Event|12|||
161212354|NCT01042977|582160094|FG000|Overall Study|Death|2|||
161212355|NCT01042977|582160095|FG001|Overall Study|Death|1|||
161100000|NCT01313650|581757703|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
161100001|NCT01313650|581757704|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
161100002|NCT01313650|581757705|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
161100003|NCT01313650|581757706|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
161100004|NCT04029480|581757707|FG000|Overall Study|Physician Decision|0|||
161100005|NCT04029480|581757708|FG001|Overall Study|Physician Decision|0|||
161100006|NCT04029480|581757709|FG002|Overall Study|Physician Decision|2|||
161100007|NCT04029480|581757710|FG003|Overall Study|Physician Decision|1|||
161100008|NCT04029480|581757707|FG000|Overall Study|Withdrawal by Subject|2|||
161100009|NCT04029480|581757708|FG001|Overall Study|Withdrawal by Subject|0|||
161100010|NCT04029480|581757709|FG002|Overall Study|Withdrawal by Subject|1|||
161100011|NCT04029480|581757710|FG003|Overall Study|Withdrawal by Subject|1|||
161100012|NCT01839487|581757711|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
161100013|NCT01839487|581757712|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161100014|NCT01839487|581757713|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161100015|NCT01839487|581757714|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161100016|NCT01839487|581757715|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161100017|NCT01839487|581757716|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
161100018|NCT01839487|581757711|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
161100019|NCT01839487|581757712|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
161100020|NCT01839487|581757713|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161100021|NCT01839487|581757714|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161100022|NCT01839487|581757715|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161100023|NCT01839487|581757716|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
161100024|NCT01839487|581757711|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161100025|NCT01839487|581757712|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
161100026|NCT01839487|581757713|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161100027|NCT01839487|581757714|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161100028|NCT01839487|581757715|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161100029|NCT01839487|581757716|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
161100030|NCT01839487|581757711|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
161100031|NCT01839487|581757712|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161100032|NCT01839487|581757713|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161100033|NCT01839487|581757714|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161100034|NCT01839487|581757715|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161100035|NCT01839487|581757716|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
161100036|NCT01839487|581757711|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
161100037|NCT01839487|581757712|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
161100038|NCT01839487|581757713|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
161100039|NCT01839487|581757714|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
161100040|NCT01839487|581757715|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
161100041|NCT01839487|581757716|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
161100042|NCT01839487|581757711|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
161100043|NCT01839487|581757712|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
161100044|NCT01839487|581757713|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
161100045|NCT01839487|581757714|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
161100046|NCT01839487|581757715|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
161100047|NCT01839487|581757716|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
161100048|NCT01839487|581757711|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161100049|NCT01839487|581757712|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161100050|NCT01839487|581757713|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
161212356|NCT01042977|582160094|FG000|Overall Study|Withdrawal by Subject|8|||
161100051|NCT01839487|581757714|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161212357|NCT01042977|582160095|FG001|Overall Study|Withdrawal by Subject|16|||
161212358|NCT01042977|582160094|FG000|Overall Study|Lost to Follow-up|0|||
161212359|NCT01042977|582160095|FG001|Overall Study|Lost to Follow-up|2|||
161100052|NCT01839487|581757715|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
161100053|NCT01839487|581757716|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
161100054|NCT01839487|581757711|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161100055|NCT01839487|581757712|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161100056|NCT01839487|581757713|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
161100057|NCT01839487|581757714|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
161100058|NCT01839487|581757715|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
161100059|NCT01839487|581757716|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
161100060|NCT01839487|581757711|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
161100061|NCT01839487|581757712|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
161100062|NCT01839487|581757713|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
161100063|NCT01839487|581757714|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
161100064|NCT01839487|581757715|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
161100065|NCT01839487|581757716|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
161100066|NCT00447382|581757722|FG000|Overall Study|Adverse Event|1|||
161100067|NCT00447382|581757723|FG001|Overall Study|Adverse Event|1|||
161100068|NCT00447382|581757722|FG000|Overall Study|Lack of Efficacy|1|||
161100069|NCT00447382|581757723|FG001|Overall Study|Lack of Efficacy|0|||
161100070|NCT00447382|581757722|FG000|Overall Study|Protocol Violation|2|||
161100071|NCT00447382|581757723|FG001|Overall Study|Protocol Violation|0|||
161100072|NCT00447382|581757722|FG000|Overall Study|Unclassified|2|||
161100073|NCT00447382|581757723|FG001|Overall Study|Unclassified|5|||
161100074|NCT02408861|581757724|FG000|Overall Study|Death|0|||
161100075|NCT02408861|581757725|FG001|Overall Study|Death|3|||
161100076|NCT02408861|581757726|FG002|Overall Study|Death|1|||
161100077|NCT02408861|581757727|FG003|Overall Study|Death|2|||
161100078|NCT02408861|581757728|FG004|Overall Study|Death|4|||
161100079|NCT02408861|581757729|FG005|Overall Study|Death|1|||
161100080|NCT02408861|581757730|FG006|Overall Study|Death|0|||
161100081|NCT02408861|581757724|FG000|Overall Study|Lost to Follow-up|0|||
161100082|NCT02408861|581757725|FG001|Overall Study|Lost to Follow-up|0|||
161100083|NCT02408861|581757726|FG002|Overall Study|Lost to Follow-up|1|||
161100084|NCT02408861|581757727|FG003|Overall Study|Lost to Follow-up|1|||
161100085|NCT02408861|581757728|FG004|Overall Study|Lost to Follow-up|4|||
161100086|NCT02408861|581757729|FG005|Overall Study|Lost to Follow-up|2|||
161100087|NCT02408861|581757730|FG006|Overall Study|Lost to Follow-up|1|||
161100088|NCT02408861|581757724|FG000|Overall Study|Disease Progression|0|||
161100089|NCT02408861|581757725|FG001|Overall Study|Disease Progression|0|||
161100090|NCT02408861|581757726|FG002|Overall Study|Disease Progression|1|||
161100091|NCT02408861|581757727|FG003|Overall Study|Disease Progression|0|||
161100092|NCT02408861|581757728|FG004|Overall Study|Disease Progression|3|||
161100093|NCT02408861|581757729|FG005|Overall Study|Disease Progression|1|||
161100094|NCT02408861|581757730|FG006|Overall Study|Disease Progression|1|||
161100095|NCT02408861|581757724|FG000|Overall Study|Adverse Event|1|||
161100096|NCT02408861|581757725|FG001|Overall Study|Adverse Event|0|||
161212360|NCT01042977|582160094|FG000|Overall Study|Poor/non-compliance|3|||
161100097|NCT02408861|581757726|FG002|Overall Study|Adverse Event|1|||
161100098|NCT02408861|581757727|FG003|Overall Study|Adverse Event|0|||
161100099|NCT02408861|581757728|FG004|Overall Study|Adverse Event|2|||
161100100|NCT02408861|581757729|FG005|Overall Study|Adverse Event|0|||
161100101|NCT02408861|581757730|FG006|Overall Study|Adverse Event|0|||
161100102|NCT02408861|581757724|FG000|Overall Study|Physician Decision|1|||
161100103|NCT02408861|581757725|FG001|Overall Study|Physician Decision|1|||
161100104|NCT02408861|581757726|FG002|Overall Study|Physician Decision|1|||
161100105|NCT02408861|581757727|FG003|Overall Study|Physician Decision|0|||
161100106|NCT02408861|581757728|FG004|Overall Study|Physician Decision|0|||
161100107|NCT02408861|581757729|FG005|Overall Study|Physician Decision|1|||
161100108|NCT02408861|581757730|FG006|Overall Study|Physician Decision|0|||
161100109|NCT02408861|581757724|FG000|Overall Study|Protocol Violation|1|||
161100110|NCT02408861|581757725|FG001|Overall Study|Protocol Violation|0|||
161100111|NCT02408861|581757726|FG002|Overall Study|Protocol Violation|0|||
161100112|NCT02408861|581757727|FG003|Overall Study|Protocol Violation|0|||
161100113|NCT02408861|581757728|FG004|Overall Study|Protocol Violation|0|||
161100114|NCT02408861|581757729|FG005|Overall Study|Protocol Violation|0|||
161100115|NCT02408861|581757730|FG006|Overall Study|Protocol Violation|0|||
161100116|NCT02408861|581757724|FG000|Overall Study|Withdrawal by Subject|0|||
161100117|NCT02408861|581757725|FG001|Overall Study|Withdrawal by Subject|0|||
161100118|NCT02408861|581757726|FG002|Overall Study|Withdrawal by Subject|0|||
161100119|NCT02408861|581757727|FG003|Overall Study|Withdrawal by Subject|0|||
161100120|NCT02408861|581757728|FG004|Overall Study|Withdrawal by Subject|1|||
161100121|NCT02408861|581757729|FG005|Overall Study|Withdrawal by Subject|1|||
161100122|NCT02408861|581757730|FG006|Overall Study|Withdrawal by Subject|0|||
161100123|NCT02408861|581757724|FG000|Overall Study|Other Treatment|0|||
161100124|NCT02408861|581757725|FG001|Overall Study|Other Treatment|0|||
161100125|NCT02408861|581757726|FG002|Overall Study|Other Treatment|0|||
161100126|NCT02408861|581757727|FG003|Overall Study|Other Treatment|0|||
161100127|NCT02408861|581757728|FG004|Overall Study|Other Treatment|0|||
161100128|NCT02408861|581757729|FG005|Overall Study|Other Treatment|1|||
161100129|NCT02408861|581757730|FG006|Overall Study|Other Treatment|1|||
161100130|NCT04890054|581759704|FG000|Overall Study|Lost to Follow-up|202|||
161100131|NCT04890054|581759705|FG001|Overall Study|Lost to Follow-up|219|||
161100132|NCT04313153|581759706|FG000|Overall Study|Adverse Event (includes Death)|14|||
161100133|NCT04313153|581759707|FG001|Overall Study|Adverse Event (includes Death)|19|||
161100134|NCT04313153|581759708|FG002|Overall Study|Adverse Event (includes Death)|10|||
161100135|NCT04313153|581759706|FG000|Overall Study|Physician Decision|4|||
161100136|NCT04313153|581759707|FG001|Overall Study|Physician Decision|2|||
161100137|NCT04313153|581759708|FG002|Overall Study|Physician Decision|1|||
161100138|NCT04313153|581759706|FG000|Overall Study|Withdrawal by Subject|7|||
161100139|NCT04313153|581759707|FG001|Overall Study|Withdrawal by Subject|6|||
161100140|NCT04313153|581759708|FG002|Overall Study|Withdrawal by Subject|2|||
161100141|NCT04313153|581759706|FG000|Overall Study|Lack of Efficacy|3|||
161100142|NCT04313153|581759707|FG001|Overall Study|Lack of Efficacy|3|||
161100143|NCT04313153|581759708|FG002|Overall Study|Lack of Efficacy|0|||
161100144|NCT04313153|581759706|FG000|Overall Study|Lost to Follow-up|1|||
161100145|NCT04313153|581759707|FG001|Overall Study|Lost to Follow-up|0|||
161100146|NCT04313153|581759708|FG002|Overall Study|Lost to Follow-up|2|||
161100147|NCT04313153|581759706|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
161100148|NCT04313153|581759707|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
161100149|NCT04313153|581759708|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
161100150|NCT04313153|581759706|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
161100151|NCT04313153|581759707|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
161100152|NCT04313153|581759708|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
161100153|NCT04313153|581759706|FG000|Overall Study|Change in Dialysis Modality|0|||
161100154|NCT04313153|581759707|FG001|Overall Study|Change in Dialysis Modality|1|||
161100155|NCT04313153|581759708|FG002|Overall Study|Change in Dialysis Modality|2|||
161100156|NCT04313153|581759706|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
161100157|NCT04313153|581759707|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
161100158|NCT04313153|581759708|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
161100159|NCT04313153|581759706|FG000|Overall Study|Other|5|||
161100160|NCT04313153|581759707|FG001|Overall Study|Other|3|||
161100161|NCT04313153|581759708|FG002|Overall Study|Other|2|||
161100162|NCT05586269|581759709|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
161100163|NCT05586269|581759710|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
161100164|NCT05586269|581759711|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
161100165|NCT05586269|581759712|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
161100166|NCT05586269|581759709|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
161100167|NCT05586269|581759710|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
161100168|NCT05586269|581759711|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
161100169|NCT05586269|581759712|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
161100170|NCT04752475|581759713|FG000|Overall Study|Withdrawal by Subject|1|||
161100171|NCT04752475|581759714|FG001|Overall Study|Withdrawal by Subject|1|||
161100172|NCT01448213|581759718|FG000|Overall Study|Lost to Follow-up|12|||
161100173|NCT01448213|581759719|FG001|Overall Study|Lost to Follow-up|10|||
161100174|NCT01448213|581759718|FG000|Overall Study|Adverse Event|4|||
161100175|NCT01448213|581759719|FG001|Overall Study|Adverse Event|10|||
161100176|NCT01448213|581759718|FG000|Overall Study|Protocol Violation|1|||
161100177|NCT01448213|581759719|FG001|Overall Study|Protocol Violation|2|||
161100178|NCT00733304|581759723|FG000|Overall Study|Adverse Event|3|||
161100179|NCT00733304|581759724|FG001|Overall Study|Adverse Event|0|||
161100180|NCT00733304|581759725|FG002|Overall Study|Adverse Event|0|||
161100181|NCT00733304|581759723|FG000|Overall Study|Lack of Efficacy|0|||
161100182|NCT00733304|581759724|FG001|Overall Study|Lack of Efficacy|0|||
161100183|NCT00733304|581759725|FG002|Overall Study|Lack of Efficacy|2|||
161100184|NCT00733304|581759723|FG000|Overall Study|Lost to Follow-up|0|||
161100185|NCT00733304|581759724|FG001|Overall Study|Lost to Follow-up|1|||
161100186|NCT00733304|581759725|FG002|Overall Study|Lost to Follow-up|0|||
161100187|NCT00733304|581759723|FG000|Overall Study|Physician Decision|3|||
161100188|NCT00733304|581759724|FG001|Overall Study|Physician Decision|1|||
161100189|NCT00733304|581759725|FG002|Overall Study|Physician Decision|3|||
161100190|NCT00733304|581759723|FG000|Overall Study|Withdrawal by Subject|1|||
161100191|NCT00733304|581759724|FG001|Overall Study|Withdrawal by Subject|1|||
161100192|NCT00733304|581759725|FG002|Overall Study|Withdrawal by Subject|0|||
161100193|NCT00528567|581759726|FG000|Overall Study|Death|4|||
161100194|NCT00528567|581759727|FG001|Overall Study|Death|5|||
161100195|NCT00528567|581759726|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
161100196|NCT00528567|581759727|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
161100197|NCT00528567|581759726|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
161100198|NCT00528567|581759727|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
161100199|NCT00528567|581759726|FG000|Overall Study|Violation Criteria at Entry|3|||
161100200|NCT00528567|581759727|FG001|Overall Study|Violation Criteria at Entry|17|||
161100201|NCT00528567|581759726|FG000|Overall Study|Withdrew Consent|59|||
161100202|NCT00528567|581759727|FG001|Overall Study|Withdrew Consent|55|||
161100203|NCT00528567|581759726|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
161100204|NCT00528567|581759727|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
161100205|NCT00528567|581759726|FG000|Overall Study|Failure to Return|1|||
161100206|NCT00528567|581759727|FG001|Overall Study|Failure to Return|4|||
161100207|NCT00528567|581759726|FG000|Overall Study|Other Protocol Violation|5|||
161100208|NCT00528567|581759727|FG001|Overall Study|Other Protocol Violation|21|||
161100209|NCT00528567|581759726|FG000|Overall Study|Administrative/Other|22|||
161100210|NCT00528567|581759727|FG001|Overall Study|Administrative/Other|75|||
161100211|NCT01122576|581759730|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
161100212|NCT01122576|581759731|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
161100213|NCT01122576|581759732|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
161100214|NCT01122576|581759730|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
161100215|NCT01122576|581759731|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
161100216|NCT01122576|581759732|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
161100217|NCT01122576|581759730|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
161100218|NCT01122576|581759731|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
161100219|NCT01122576|581759732|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
161100220|NCT05696236|581759733|FG000|Overall Study|Lost to Follow-up|1|||
161100221|NCT05696236|581759734|FG001|Overall Study|Lost to Follow-up|0|||
161100222|NCT05696236|581759733|FG000|Overall Study|Later determined to not be eligible for participation|0|||
161100223|NCT05696236|581759734|FG001|Overall Study|Later determined to not be eligible for participation|1|||
161100224|NCT05696236|581759733|FG000|Overall Study|Withdrawal by Subject|2|||
161100225|NCT05696236|581759734|FG001|Overall Study|Withdrawal by Subject|2|||
161100226|NCT01829360|581759737|FG000|Overall Study|Protocol Violation|0|||
161100227|NCT01829360|581759738|FG001|Overall Study|Protocol Violation|0|||
161100228|NCT01829360|581759739|FG002|Overall Study|Protocol Violation|1|||
161100229|NCT01829360|581759740|FG003|Overall Study|Protocol Violation|0|||
161100230|NCT00041067|581759741|FG000|Overall Study|Adverse Event|20|||
161100231|NCT00041067|581759741|FG000|Overall Study|Progression|19|||
161100232|NCT00041067|581759741|FG000|Overall Study|Patient refusal|12|||
161100233|NCT00041067|581759741|FG000|Overall Study|Other reasons|23|||
161100234|NCT00041067|581759741|FG000|Overall Study|Ineligible|2|||
161100235|NCT00778622|581759742|FG000|Overall Study|Adverse Event|5|||
161100236|NCT00778622|581759743|FG001|Overall Study|Adverse Event|4|||
161100237|NCT00778622|581759744|FG002|Overall Study|Adverse Event|7|||
161100238|NCT00778622|581759742|FG000|Overall Study|Withdrawal by Subject|4|||
161100239|NCT00778622|581759743|FG001|Overall Study|Withdrawal by Subject|5|||
161100240|NCT00778622|581759744|FG002|Overall Study|Withdrawal by Subject|5|||
161100241|NCT00778622|581759742|FG000|Overall Study|Lost to Follow-up|3|||
161100242|NCT00778622|581759743|FG001|Overall Study|Lost to Follow-up|3|||
161100243|NCT00778622|581759744|FG002|Overall Study|Lost to Follow-up|2|||
161100244|NCT00778622|581759742|FG000|Overall Study|Protocol Violation|0|||
161100245|NCT00778622|581759743|FG001|Overall Study|Protocol Violation|3|||
161100246|NCT00778622|581759744|FG002|Overall Study|Protocol Violation|0|||
161100247|NCT00778622|581759742|FG000|Overall Study|Lack of Efficacy|2|||
161100248|NCT00778622|581759743|FG001|Overall Study|Lack of Efficacy|0|||
161100249|NCT00778622|581759744|FG002|Overall Study|Lack of Efficacy|0|||
161100250|NCT00778622|581759742|FG000|Overall Study|immigration|1|||
161100251|NCT00778622|581759743|FG001|Overall Study|immigration|0|||
161100252|NCT00778622|581759744|FG002|Overall Study|immigration|0|||
161100253|NCT00778622|581759742|FG000|Overall Study|Other|1|||
161100254|NCT00778622|581759743|FG001|Overall Study|Other|0|||
161100255|NCT00778622|581759744|FG002|Overall Study|Other|1|||
161100256|NCT01251120|581759746|FG000|Overall Study|Lack of Efficacy|0|||
161100257|NCT01251120|581759747|FG001|Overall Study|Lack of Efficacy|1|||
161100258|NCT01968070|581759748|FG000|Period 1|Withdrawal by Subject|0|||
161100259|NCT01968070|581759749|FG001|Period 1|Withdrawal by Subject|1|||
161100260|NCT01968070|581759750|FG002|Period 1|Withdrawal by Subject|0|||
161100261|NCT01968070|581759751|FG003|Period 1|Withdrawal by Subject|0|||
161100262|NCT01968070|581759752|FG004|Period 1|Withdrawal by Subject|0|||
161100263|NCT01968070|581759753|FG005|Period 1|Withdrawal by Subject|0|||
161100264|NCT01968070|581759754|FG006|Period 1|Withdrawal by Subject|1|||
161100265|NCT01968070|581759755|FG007|Period 1|Withdrawal by Subject|0|||
161100266|NCT01968070|581759756|FG008|Period 1|Withdrawal by Subject|0|||
161100267|NCT01968070|581759757|FG009|Period 1|Withdrawal by Subject|0|||
161100268|NCT01968070|581759758|FG010|Period 1|Withdrawal by Subject|0|||
161100269|NCT01968070|581759759|FG011|Period 1|Withdrawal by Subject|0|||
161100270|NCT01968070|581759760|FG012|Period 1|Withdrawal by Subject|0|||
161100271|NCT01968070|581759761|FG013|Period 1|Withdrawal by Subject|0|||
161100272|NCT01968070|581759762|FG014|Period 1|Withdrawal by Subject|0|||
161100273|NCT01968070|581759763|FG015|Period 1|Withdrawal by Subject|1|||
161100274|NCT01968070|581759764|FG016|Period 1|Withdrawal by Subject|0|||
161100275|NCT01968070|581759765|FG017|Period 1|Withdrawal by Subject|0|||
161100276|NCT01968070|581759748|FG000|Period 1|Protocol Violation|0|||
161100277|NCT01968070|581759749|FG001|Period 1|Protocol Violation|0|||
161100278|NCT01968070|581759750|FG002|Period 1|Protocol Violation|0|||
161100279|NCT01968070|581759751|FG003|Period 1|Protocol Violation|1|||
161100280|NCT01968070|581759752|FG004|Period 1|Protocol Violation|1|||
161100281|NCT01968070|581759753|FG005|Period 1|Protocol Violation|0|||
161100282|NCT01968070|581759754|FG006|Period 1|Protocol Violation|0|||
161100283|NCT01968070|581759755|FG007|Period 1|Protocol Violation|0|||
161100284|NCT01968070|581759756|FG008|Period 1|Protocol Violation|0|||
161100285|NCT01968070|581759757|FG009|Period 1|Protocol Violation|0|||
161100286|NCT01968070|581759758|FG010|Period 1|Protocol Violation|0|||
161100287|NCT01968070|581759759|FG011|Period 1|Protocol Violation|0|||
161100288|NCT01968070|581759760|FG012|Period 1|Protocol Violation|0|||
161100289|NCT01968070|581759761|FG013|Period 1|Protocol Violation|0|||
161100290|NCT01968070|581759762|FG014|Period 1|Protocol Violation|0|||
161100291|NCT01968070|581759763|FG015|Period 1|Protocol Violation|0|||
161100292|NCT01968070|581759764|FG016|Period 1|Protocol Violation|0|||
161100293|NCT01968070|581759765|FG017|Period 1|Protocol Violation|0|||
161100294|NCT01968070|581759748|FG000|Period 1|Lost to Follow-up|0|||
161100295|NCT01968070|581759749|FG001|Period 1|Lost to Follow-up|0|||
161100296|NCT01968070|581759750|FG002|Period 1|Lost to Follow-up|0|||
161100297|NCT01968070|581759751|FG003|Period 1|Lost to Follow-up|1|||
161100298|NCT01968070|581759752|FG004|Period 1|Lost to Follow-up|0|||
161100299|NCT01968070|581759753|FG005|Period 1|Lost to Follow-up|0|||
161100300|NCT01968070|581759754|FG006|Period 1|Lost to Follow-up|0|||
161100301|NCT01968070|581759755|FG007|Period 1|Lost to Follow-up|0|||
161100302|NCT01968070|581759756|FG008|Period 1|Lost to Follow-up|0|||
161100303|NCT01968070|581759757|FG009|Period 1|Lost to Follow-up|0|||
161100304|NCT01968070|581759758|FG010|Period 1|Lost to Follow-up|0|||
161100305|NCT01968070|581759759|FG011|Period 1|Lost to Follow-up|0|||
161100306|NCT01968070|581759760|FG012|Period 1|Lost to Follow-up|0|||
161100307|NCT01968070|581759761|FG013|Period 1|Lost to Follow-up|0|||
161100308|NCT01968070|581759762|FG014|Period 1|Lost to Follow-up|0|||
161100309|NCT01968070|581759763|FG015|Period 1|Lost to Follow-up|0|||
161100310|NCT01968070|581759764|FG016|Period 1|Lost to Follow-up|0|||
161100311|NCT01968070|581759765|FG017|Period 1|Lost to Follow-up|0|||
161100312|NCT01968070|581759748|FG000|Period 1|Adverse Event|0|||
161100313|NCT01968070|581759749|FG001|Period 1|Adverse Event|0|||
161100314|NCT01968070|581759750|FG002|Period 1|Adverse Event|0|||
161100315|NCT01968070|581759751|FG003|Period 1|Adverse Event|0|||
161100316|NCT01968070|581759752|FG004|Period 1|Adverse Event|0|||
161100317|NCT01968070|581759753|FG005|Period 1|Adverse Event|0|||
161100318|NCT01968070|581759754|FG006|Period 1|Adverse Event|1|||
161100319|NCT01968070|581759755|FG007|Period 1|Adverse Event|0|||
161100320|NCT01968070|581759756|FG008|Period 1|Adverse Event|0|||
161100321|NCT01968070|581759757|FG009|Period 1|Adverse Event|0|||
161100322|NCT01968070|581759758|FG010|Period 1|Adverse Event|0|||
161212361|NCT01042977|582160095|FG001|Overall Study|Poor/non-compliance|4|||
161100323|NCT01968070|581759759|FG011|Period 1|Adverse Event|0|||
161100324|NCT01968070|581759760|FG012|Period 1|Adverse Event|0|||
161100325|NCT01968070|581759761|FG013|Period 1|Adverse Event|0|||
161100326|NCT01968070|581759762|FG014|Period 1|Adverse Event|0|||
161100327|NCT01968070|581759763|FG015|Period 1|Adverse Event|0|||
161100328|NCT01968070|581759764|FG016|Period 1|Adverse Event|0|||
161100329|NCT01968070|581759765|FG017|Period 1|Adverse Event|0|||
161100330|NCT01968070|581759748|FG000|Period 1|Physician Decision|0|||
161100331|NCT01968070|581759749|FG001|Period 1|Physician Decision|0|||
161100332|NCT01968070|581759750|FG002|Period 1|Physician Decision|0|||
161100333|NCT01968070|581759751|FG003|Period 1|Physician Decision|0|||
161100334|NCT01968070|581759752|FG004|Period 1|Physician Decision|0|||
161100335|NCT01968070|581759753|FG005|Period 1|Physician Decision|0|||
161100336|NCT01968070|581759754|FG006|Period 1|Physician Decision|0|||
161100337|NCT01968070|581759755|FG007|Period 1|Physician Decision|0|||
161100338|NCT01968070|581759756|FG008|Period 1|Physician Decision|0|||
161100339|NCT01968070|581759757|FG009|Period 1|Physician Decision|0|||
161100340|NCT01968070|581759758|FG010|Period 1|Physician Decision|0|||
161100341|NCT01968070|581759759|FG011|Period 1|Physician Decision|1|||
161100342|NCT01968070|581759760|FG012|Period 1|Physician Decision|0|||
161100343|NCT01968070|581759761|FG013|Period 1|Physician Decision|0|||
161100344|NCT01968070|581759762|FG014|Period 1|Physician Decision|0|||
161100345|NCT01968070|581759763|FG015|Period 1|Physician Decision|0|||
161100346|NCT01968070|581759764|FG016|Period 1|Physician Decision|0|||
161100347|NCT01968070|581759765|FG017|Period 1|Physician Decision|0|||
161100348|NCT01968070|581759748|FG000|Period 2|Withdrawal by Subject|0|||
161100349|NCT01968070|581759749|FG001|Period 2|Withdrawal by Subject|0|||
161100350|NCT01968070|581759750|FG002|Period 2|Withdrawal by Subject|0|||
161100351|NCT01968070|581759751|FG003|Period 2|Withdrawal by Subject|0|||
161100352|NCT01968070|581759752|FG004|Period 2|Withdrawal by Subject|1|||
161100353|NCT01968070|581759753|FG005|Period 2|Withdrawal by Subject|0|||
161100354|NCT01968070|581759754|FG006|Period 2|Withdrawal by Subject|0|||
161100355|NCT01968070|581759755|FG007|Period 2|Withdrawal by Subject|0|||
161100356|NCT01968070|581759756|FG008|Period 2|Withdrawal by Subject|0|||
161100357|NCT01968070|581759757|FG009|Period 2|Withdrawal by Subject|0|||
161100358|NCT01968070|581759758|FG010|Period 2|Withdrawal by Subject|0|||
161100359|NCT01968070|581759759|FG011|Period 2|Withdrawal by Subject|0|||
161100360|NCT01968070|581759760|FG012|Period 2|Withdrawal by Subject|0|||
161100361|NCT01968070|581759761|FG013|Period 2|Withdrawal by Subject|0|||
161100362|NCT01968070|581759762|FG014|Period 2|Withdrawal by Subject|0|||
161100363|NCT01968070|581759763|FG015|Period 2|Withdrawal by Subject|0|||
161100364|NCT01968070|581759764|FG016|Period 2|Withdrawal by Subject|0|||
161100365|NCT01968070|581759765|FG017|Period 2|Withdrawal by Subject|0|||
161100366|NCT01822522|581759768|FG000|Overall Study|Adverse Event|1|||
161100367|NCT01822522|581759769|FG001|Overall Study|Adverse Event|1|||
161100368|NCT01822522|581759770|FG002|Overall Study|Adverse Event|1|||
161100369|NCT01822522|581759771|FG003|Overall Study|Adverse Event|0|||
161100370|NCT01822522|581759772|FG004|Overall Study|Adverse Event|0|||
161100371|NCT01822522|581759773|FG005|Overall Study|Adverse Event|1|||
161100372|NCT01822522|581759768|FG000|Overall Study|Death|3|||
161100373|NCT01822522|581759769|FG001|Overall Study|Death|0|||
161100374|NCT01822522|581759770|FG002|Overall Study|Death|2|||
161100375|NCT01822522|581759771|FG003|Overall Study|Death|0|||
161100376|NCT01822522|581759772|FG004|Overall Study|Death|0|||
161100377|NCT01822522|581759773|FG005|Overall Study|Death|0|||
161100378|NCT01822522|581759768|FG000|Overall Study|Lost to Follow-up|0|||
161100379|NCT01822522|581759769|FG001|Overall Study|Lost to Follow-up|0|||
161100380|NCT01822522|581759770|FG002|Overall Study|Lost to Follow-up|1|||
161100381|NCT01822522|581759771|FG003|Overall Study|Lost to Follow-up|1|||
161100382|NCT01822522|581759772|FG004|Overall Study|Lost to Follow-up|0|||
161100383|NCT01822522|581759773|FG005|Overall Study|Lost to Follow-up|1|||
161100384|NCT01822522|581759768|FG000|Overall Study|Withdrawal by Subject|0|||
161100385|NCT01822522|581759769|FG001|Overall Study|Withdrawal by Subject|0|||
161100386|NCT01822522|581759770|FG002|Overall Study|Withdrawal by Subject|0|||
161100387|NCT01822522|581759771|FG003|Overall Study|Withdrawal by Subject|1|||
161100388|NCT01822522|581759772|FG004|Overall Study|Withdrawal by Subject|0|||
161100389|NCT01822522|581759773|FG005|Overall Study|Withdrawal by Subject|0|||
161100390|NCT01822522|581759768|FG000|Overall Study|Lack of Efficacy|0|||
161100391|NCT01822522|581759769|FG001|Overall Study|Lack of Efficacy|0|||
161100392|NCT01822522|581759770|FG002|Overall Study|Lack of Efficacy|0|||
161100393|NCT01822522|581759771|FG003|Overall Study|Lack of Efficacy|0|||
161100394|NCT01822522|581759772|FG004|Overall Study|Lack of Efficacy|0|||
161100395|NCT01822522|581759773|FG005|Overall Study|Lack of Efficacy|2|||
161100396|NCT00890929|581759774|FG000|Overall Study|Death before treatment|2|||
161100397|NCT00890929|581759774|FG000|Overall Study|Withdrawal by Subject|3|||
161100398|NCT00890929|581759774|FG000|Overall Study|Physician Decision|1|||
161100399|NCT00108069|581759775|FG000|Overall Study|Never rec'd study drug|0|||
161100400|NCT00108069|581759776|FG001|Overall Study|Never rec'd study drug|1|||
161100401|NCT00108069|581759775|FG000|Overall Study|Adverse Event|1|||
161100402|NCT00108069|581759776|FG001|Overall Study|Adverse Event|1|||
161100403|NCT00108069|581759775|FG000|Overall Study|Withdrawal by Subject|1|||
161100404|NCT00108069|581759776|FG001|Overall Study|Withdrawal by Subject|0|||
161100405|NCT00108069|581759775|FG000|Overall Study|Death|1|||
161100406|NCT00108069|581759776|FG001|Overall Study|Death|0|||
161100407|NCT00108069|581759775|FG000|Overall Study|Progessive disease|27|||
161100408|NCT00108069|581759776|FG001|Overall Study|Progessive disease|11|||
161100409|NCT04029116|581759777|FG000|Overall Study|Adverse Event|0|||
161100410|NCT04029116|581759778|FG001|Overall Study|Adverse Event|2|||
161100411|NCT04029116|581759777|FG000|Overall Study|Lost to Follow-up|3|||
161100412|NCT04029116|581759778|FG001|Overall Study|Lost to Follow-up|5|||
161100413|NCT04029116|581759777|FG000|Overall Study|Physician Decision|2|||
161100414|NCT04029116|581759778|FG001|Overall Study|Physician Decision|0|||
161100415|NCT04029116|581759777|FG000|Overall Study|Pregnancy|1|||
161100416|NCT04029116|581759778|FG001|Overall Study|Pregnancy|2|||
161100417|NCT04029116|581759777|FG000|Overall Study|Withdrawal by Subject|4|||
161100418|NCT04029116|581759778|FG001|Overall Study|Withdrawal by Subject|6|||
161100419|NCT04029116|581759777|FG000|Overall Study|Other|2|||
161100420|NCT04029116|581759778|FG001|Overall Study|Other|1|||
161100421|NCT02469896|581759779|FG000|Overall Study|Withdrawal by Subject|2|||
161100422|NCT02469896|581759780|FG001|Overall Study|Withdrawal by Subject|0|||
161100423|NCT02510560|581759781|FG000|Overall Study|Discontinued from Treatment|27|||
161100424|NCT02510560|581759782|FG001|Overall Study|Discontinued from Treatment|18|||
161100425|NCT02510560|581759783|FG002|Overall Study|Discontinued from Treatment|19|||
161100426|NCT02510560|581759781|FG000|Overall Study|Other|4|||
161100427|NCT02510560|581759782|FG001|Overall Study|Other|4|||
161100428|NCT02510560|581759783|FG002|Overall Study|Other|3|||
161100429|NCT02401412|581759784|FG000|Overall Study|Lost to Follow-up|1|||
161100430|NCT02401412|581759785|FG001|Overall Study|Lost to Follow-up|0|||
161100431|NCT02401412|581759784|FG000|Overall Study|Discontinued Intervention|15|||
161100432|NCT02401412|581759785|FG001|Overall Study|Discontinued Intervention|21|||
161100433|NCT02401412|581759784|FG000|Overall Study|Withdrawal by Subject|4|||
161100434|NCT02401412|581759785|FG001|Overall Study|Withdrawal by Subject|4|||
161100435|NCT02401412|581759784|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
161100436|NCT02401412|581759785|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
161100437|NCT02401412|581759784|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
161100438|NCT02401412|581759785|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
161100439|NCT03684642|581759792|FG000|Overall Study|Adverse Event|6|||
161100440|NCT03684642|581759793|FG001|Overall Study|Adverse Event|15|||
161100441|NCT03684642|581759794|FG002|Overall Study|Adverse Event|11|||
161100442|NCT03684642|581759792|FG000|Overall Study|Withdrawal by Subject|35|||
161100443|NCT03684642|581759793|FG001|Overall Study|Withdrawal by Subject|53|||
161100444|NCT03684642|581759794|FG002|Overall Study|Withdrawal by Subject|23|||
161100445|NCT03684642|581759792|FG000|Overall Study|Lack of Efficacy|0|||
161100446|NCT03684642|581759793|FG001|Overall Study|Lack of Efficacy|0|||
161100447|NCT03684642|581759794|FG002|Overall Study|Lack of Efficacy|1|||
161100448|NCT03684642|581759792|FG000|Overall Study|Poor compliance to protocol|0|||
161100449|NCT03684642|581759793|FG001|Overall Study|Poor compliance to protocol|4|||
161100450|NCT03684642|581759794|FG002|Overall Study|Poor compliance to protocol|1|||
161100451|NCT03684642|581759792|FG000|Overall Study|Other than specified|62|||
161100452|NCT03684642|581759793|FG001|Overall Study|Other than specified|60|||
161100453|NCT03684642|581759794|FG002|Overall Study|Other than specified|67|||
161100454|NCT03684642|581759792|FG000|Overall Study|Randomized and not treated|0|||
161100455|NCT03684642|581759793|FG001|Overall Study|Randomized and not treated|0|||
161100456|NCT03684642|581759794|FG002|Overall Study|Randomized and not treated|1|||
161100457|NCT03684642|581759792|FG000|Overall Study|Missing completion status but alive at last contact|0|||
161100458|NCT03684642|581759793|FG001|Overall Study|Missing completion status but alive at last contact|1|||
161100459|NCT03684642|581759794|FG002|Overall Study|Missing completion status but alive at last contact|2|||
161100460|NCT01843218|581759797|FG000|Overall Study|Withdrawal by Subject|5|||
161100461|NCT01431534|581759798|FG000|Treatment Phase|Adverse Event|0|||
161100462|NCT01431534|581759799|FG001|Treatment Phase|Adverse Event|0|||
161100463|NCT01431534|581759800|FG002|Treatment Phase|Adverse Event|1|||
161100464|NCT01431534|581759798|FG000|Treatment Phase|Progressive Disease|4|||
161100465|NCT01431534|581759799|FG001|Treatment Phase|Progressive Disease|3|||
161100466|NCT01431534|581759800|FG002|Treatment Phase|Progressive Disease|10|||
161100467|NCT02742766|581759804|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100468|NCT02742766|581759805|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100469|NCT02742766|581759806|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100470|NCT02742766|581759807|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100471|NCT02742766|581759808|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100472|NCT02742766|581759809|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100473|NCT02742766|581759810|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100474|NCT02742766|581759811|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100475|NCT02742766|581759812|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100476|NCT02742766|581759813|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100477|NCT02742766|581759814|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100478|NCT02742766|581759815|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100479|NCT02742766|581759816|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100480|NCT02742766|581759817|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
161100481|NCT02742766|581759818|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100482|NCT02742766|581759819|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100483|NCT02742766|581759820|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100484|NCT02742766|581759821|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100485|NCT02742766|581759822|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
161100486|NCT02742766|581759804|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100487|NCT02742766|581759805|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100488|NCT02742766|581759806|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100489|NCT02742766|581759807|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100490|NCT02742766|581759808|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100491|NCT02742766|581759809|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100492|NCT02742766|581759810|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100493|NCT02742766|581759811|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100494|NCT02742766|581759812|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100495|NCT02742766|581759813|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100496|NCT02742766|581759814|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100497|NCT02742766|581759815|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100498|NCT02742766|581759816|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
161100499|NCT02742766|581759817|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
161100500|NCT02742766|581759818|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100501|NCT02742766|581759819|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
161100502|NCT02742766|581759820|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100503|NCT02742766|581759821|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100504|NCT02742766|581759822|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
161100505|NCT03739437|581759823|FG000|Overall Study|Lost to Follow-up|2|||
161100506|NCT03739437|581759824|FG001|Overall Study|Lost to Follow-up|5|||
161100507|NCT01395316|581759826|FG000|Overall Study|Lost to Follow-up|2|||
161100508|NCT01395316|581759826|FG000|Overall Study|poor MRI quality|1|||
161100509|NCT03359590|581759827|FG000|First Intervention|Withdrawal by Subject|1|||
161100510|NCT03359590|581759828|FG001|First Intervention|Withdrawal by Subject|1|||
161100511|NCT03359590|581759827|FG000|First Intervention|Protocol Violation|0|||
161100512|NCT03359590|581759828|FG001|First Intervention|Protocol Violation|1|||
161100513|NCT02540538|581759829|FG000|Overall Study|Pregnancy|0|||
161100514|NCT02540538|581759830|FG001|Overall Study|Pregnancy|1|||
161100515|NCT02540538|581759831|FG002|Overall Study|Pregnancy|0|||
161100516|NCT02846532|581759832|FG000|Overall Study|Lost to Follow-up|0|||
161100517|NCT02846532|581759833|FG001|Overall Study|Lost to Follow-up|1|||
161100518|NCT02846532|581759834|FG002|Overall Study|Lost to Follow-up|1|||
161100519|NCT02846532|581759832|FG000|Overall Study|Withdrawal by Subject|1|||
161100520|NCT02846532|581759833|FG001|Overall Study|Withdrawal by Subject|2|||
161100521|NCT02846532|581759834|FG002|Overall Study|Withdrawal by Subject|0|||
161100522|NCT04908189|581759836|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
161100523|NCT04908189|581759837|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
161100524|NCT04908189|581759838|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
161100525|NCT04908189|581759836|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
161100526|NCT04908189|581759837|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
161100527|NCT04908189|581759838|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
161100528|NCT04908189|581759836|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
161100529|NCT04908189|581759837|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
161100530|NCT04908189|581759838|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
161100531|NCT04908189|581759836|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
161100532|NCT04908189|581759837|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
161100533|NCT04908189|581759838|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
161100534|NCT04908189|581759836|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
161100535|NCT04908189|581759837|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
161100536|NCT04908189|581759838|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
161100537|NCT04908189|581759836|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
161100538|NCT04908189|581759837|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
161100539|NCT04908189|581759838|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
161100540|NCT04908189|581759836|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
161100541|NCT04908189|581759837|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
161100542|NCT04908189|581759838|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
161100543|NCT04908189|581759836|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
161100544|NCT04908189|581759837|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
161100545|NCT04908189|581759838|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
161100546|NCT04908189|581759836|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
161100547|NCT04908189|581759837|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
161100548|NCT04908189|581759838|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
161100549|NCT04908189|581759836|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
161100550|NCT04908189|581759837|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
161100551|NCT04908189|581759838|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
161100552|NCT04908189|581759836|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
161100553|NCT04908189|581759837|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
161100554|NCT04908189|581759838|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
161100555|NCT04908189|581759836|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161100556|NCT04908189|581759837|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161100557|NCT04908189|581759838|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
161100558|NCT04598477|581759839|FG000|Overall Study|Adverse Event|2|||
161100559|NCT04598477|581759840|FG001|Overall Study|Adverse Event|0|||
161100560|NCT04598477|581759839|FG000|Overall Study|Death|0|||
161100561|NCT04598477|581759840|FG001|Overall Study|Death|1|||
161100562|NCT04598477|581759839|FG000|Overall Study|Lost to Follow-up|1|||
161100563|NCT04598477|581759840|FG001|Overall Study|Lost to Follow-up|0|||
161100564|NCT04598477|581759839|FG000|Overall Study|Physician Decision|7|||
161100565|NCT04598477|581759840|FG001|Overall Study|Physician Decision|2|||
161100566|NCT04598477|581759839|FG000|Overall Study|Pregnancy|0|||
161100567|NCT04598477|581759840|FG001|Overall Study|Pregnancy|1|||
161100568|NCT04598477|581759839|FG000|Overall Study|Requires Prohibited Medication|0|||
161100569|NCT04598477|581759840|FG001|Overall Study|Requires Prohibited Medication|1|||
161100570|NCT04598477|581759839|FG000|Overall Study|Study Terminated by Sponsor|18|||
161100571|NCT04598477|581759840|FG001|Overall Study|Study Terminated by Sponsor|12|||
161100572|NCT04598477|581759839|FG000|Overall Study|Withdrawal by Subject|16|||
161100573|NCT04598477|581759840|FG001|Overall Study|Withdrawal by Subject|12|||
161100574|NCT04598477|581759839|FG000|Overall Study|Other|15|||
161100575|NCT04598477|581759840|FG001|Overall Study|Other|8|||
161100576|NCT05579990|581759848|FG000|Overall Study|Lost to Follow-up|3|||
161100577|NCT00607022|581759849|FG000|Overall Study|Withdrawal by Subject|1|||
161100578|NCT00607022|581759850|FG001|Overall Study|Withdrawal by Subject|0|||
161100579|NCT00607022|581759851|FG002|Overall Study|Withdrawal by Subject|0|||
161100580|NCT04786119|581759852|FG000|Overall Study|Withdrawal by Subject|4|||
161100581|NCT04786119|581759853|FG001|Overall Study|Withdrawal by Subject|5|||
161100582|NCT04786119|581759852|FG000|Overall Study|Lost to Follow-up|5|||
161100583|NCT04786119|581759853|FG001|Overall Study|Lost to Follow-up|5|||
161100584|NCT04786119|581759852|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
161100585|NCT04786119|581759853|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
161100586|NCT02593786|581759858|FG000|Overall Study|Disease progression|12|||
161100587|NCT02593786|581759859|FG001|Overall Study|Disease progression|16|||
161100588|NCT02593786|581759860|FG002|Overall Study|Disease progression|10|||
161100589|NCT02593786|581759861|FG003|Overall Study|Disease progression|7|||
161212362|NCT01042977|582160094|FG000|Overall Study|Subject no longer meets study criteria|15|||
161212363|NCT01042977|582160095|FG001|Overall Study|Subject no longer meets study criteria|13|||
161212364|NCT01042977|582160094|FG000|Overall Study|Incorrect enrollment|6|||
161212365|NCT01042977|582160095|FG001|Overall Study|Incorrect enrollment|4|||
161100590|NCT02593786|581759858|FG000|Overall Study|Study drug toxicity|1|||
161100591|NCT02593786|581759859|FG001|Overall Study|Study drug toxicity|0|||
161100592|NCT02593786|581759860|FG002|Overall Study|Study drug toxicity|0|||
161100593|NCT02593786|581759861|FG003|Overall Study|Study drug toxicity|0|||
161100594|NCT02593786|581759858|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161100595|NCT02593786|581759859|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161100596|NCT02593786|581759860|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161100597|NCT02593786|581759861|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161100598|NCT02593786|581759858|FG000|Overall Study|Participant request to discontinue study therapy|0|||
161100599|NCT02593786|581759859|FG001|Overall Study|Participant request to discontinue study therapy|2|||
161100600|NCT02593786|581759860|FG002|Overall Study|Participant request to discontinue study therapy|0|||
161100601|NCT02593786|581759861|FG003|Overall Study|Participant request to discontinue study therapy|0|||
161100602|NCT02593786|581759858|FG000|Overall Study|Other reasons|1|||
161100603|NCT02593786|581759859|FG001|Overall Study|Other reasons|1|||
161100604|NCT02593786|581759860|FG002|Overall Study|Other reasons|0|||
161100605|NCT02593786|581759861|FG003|Overall Study|Other reasons|5|||
161100606|NCT01130051|581759862|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
161100607|NCT01130051|581759863|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
161100608|NCT01130051|581759862|FG000|Washout Period of 14 Days|Protocol Violation|1|||
161100609|NCT01130051|581759863|FG001|Washout Period of 14 Days|Protocol Violation|1|||
161100610|NCT00835120|581759867|FG000|Overall Study|Lack of Efficacy|1|||
161100611|NCT00835120|581759867|FG000|Overall Study|Lost to Follow-up|3|||
161100612|NCT00835120|581759867|FG000|Overall Study|Adverse Event|2|||
161100613|NCT00835120|581759867|FG000|Overall Study|Withdrawal by Subject|2|||
161100614|NCT01658826|581759868|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
161100615|NCT01658826|581759869|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
161100616|NCT01658826|581759868|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
161100617|NCT01658826|581759869|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
161100618|NCT01658826|581759868|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
161100619|NCT01658826|581759869|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
161212366|NCT01042977|582160094|FG000|Overall Study|Safety|0|||
161100620|NCT01658826|581759868|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
161100621|NCT01658826|581759869|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
161100622|NCT01658826|581759868|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
161212367|NCT01042977|582160095|FG001|Overall Study|Safety|2|||
161100623|NCT01658826|581759869|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
161100624|NCT01658826|581759868|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
161100625|NCT01658826|581759869|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
161100626|NCT01658826|581759868|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
161100627|NCT01658826|581759869|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
161100628|NCT01658826|581759868|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
161100629|NCT01658826|581759869|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
161100630|NCT01658826|581759868|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
161100631|NCT01658826|581759869|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
161100632|NCT01019980|581759871|FG000|Overall Study|Drug not available.|2|||
161100633|NCT01019980|581759872|FG001|Overall Study|Drug not available.|0|||
161100634|NCT03610165|581759873|FG000|Overall Study|Device didn't work|0|||
161100635|NCT03610165|581759874|FG001|Overall Study|Device didn't work|1|||
161100636|NCT02038920|581759886|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
161100637|NCT02038920|581759887|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
161100638|NCT02038920|581759888|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161100639|NCT02038920|581759889|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161100640|NCT02038920|581759890|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161100641|NCT02038920|581759891|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
161100642|NCT02038920|581759886|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
161100643|NCT02038920|581759887|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161100644|NCT02038920|581759888|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161100645|NCT02038920|581759889|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161100646|NCT02038920|581759890|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161100647|NCT02038920|581759891|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
161100648|NCT02038920|581759886|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
161100649|NCT02038920|581759887|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
161100650|NCT02038920|581759888|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161100651|NCT02038920|581759889|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161100652|NCT02038920|581759890|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161100653|NCT02038920|581759891|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
161100654|NCT02038920|581759886|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161100655|NCT02038920|581759887|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161100656|NCT02038920|581759888|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
161100657|NCT02038920|581759889|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
161100658|NCT02038920|581759890|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
161100659|NCT02038920|581759891|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
161100660|NCT02038920|581759886|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161100661|NCT02038920|581759887|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161100662|NCT02038920|581759888|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
161100663|NCT02038920|581759889|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161100664|NCT02038920|581759890|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161100665|NCT02038920|581759891|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
161100666|NCT02038920|581759886|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161100667|NCT02038920|581759887|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161100668|NCT02038920|581759888|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
161100669|NCT02038920|581759889|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
161100670|NCT02038920|581759890|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
161100671|NCT02038920|581759891|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
161100672|NCT02038920|581759886|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161100673|NCT02038920|581759887|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161100674|NCT02038920|581759888|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161100675|NCT02038920|581759889|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161100676|NCT02038920|581759890|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
161100677|NCT02038920|581759891|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
161100678|NCT02038920|581759886|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161100679|NCT02038920|581759887|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161100680|NCT02038920|581759888|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161100681|NCT02038920|581759889|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161323953|NCT00913770|582571965|FG000|Overall Study|Refused|11|||
161323954|NCT00913770|582571966|FG001|Overall Study|Refused|10|||
161323955|NCT00913770|582571967|FG002|Overall Study|Refused|8|||
161323956|NCT01066871|582571969|FG000|Overall Study|Lost to Follow-up|0|||
161323957|NCT01066871|582571970|FG001|Overall Study|Lost to Follow-up|2|||
161100682|NCT02038920|581759890|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
161100683|NCT02038920|581759891|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
161100684|NCT02038920|581759886|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161100685|NCT02038920|581759887|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161100686|NCT02038920|581759888|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161100687|NCT02038920|581759889|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161100688|NCT02038920|581759890|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
161100689|NCT02038920|581759891|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
161100690|NCT02038920|581759886|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161100691|NCT02038920|581759887|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161100692|NCT02038920|581759888|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161100693|NCT02038920|581759889|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161100694|NCT02038920|581759890|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
161100695|NCT02038920|581759891|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
161100696|NCT02038920|581759886|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161100697|NCT02038920|581759887|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161100698|NCT02038920|581759888|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161100699|NCT02038920|581759889|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161100700|NCT02038920|581759890|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
161100701|NCT02038920|581759891|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
161100702|NCT02038920|581759886|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161100703|NCT02038920|581759887|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161100704|NCT02038920|581759888|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161100705|NCT02038920|581759889|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161100706|NCT02038920|581759890|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
161100707|NCT02038920|581759891|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
161100708|NCT02383589|581759893|FG000|Treatment Period|Adverse Event|1|||
161100709|NCT02383589|581759894|FG001|Treatment Period|Adverse Event|3|||
161100710|NCT02383589|581759893|FG000|Treatment Period|Lost to Follow-up|0|||
161100711|NCT02383589|581759894|FG001|Treatment Period|Lost to Follow-up|1|||
161100712|NCT02383589|581759893|FG000|Treatment Period|Withdrawal by Subject|0|||
161100713|NCT02383589|581759894|FG001|Treatment Period|Withdrawal by Subject|5|||
161100714|NCT02383589|581759893|FG000|Treatment Period|Non-compliance with study drug|0|||
161100715|NCT02383589|581759894|FG001|Treatment Period|Non-compliance with study drug|1|||
161100716|NCT02383589|581759893|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
161100717|NCT02383589|581759894|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
161100718|NCT02383589|581759893|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
161100719|NCT02383589|581759894|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
161100720|NCT02383589|581759893|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
161100721|NCT02383589|581759894|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
161100722|NCT00866697|581759895|FG000|Overall Study|Study closed/terminated|156|||
161100723|NCT00866697|581759896|FG001|Overall Study|Study closed/terminated|138|||
161100724|NCT00866697|581759895|FG000|Overall Study|Lost to Follow-up|22|||
161100725|NCT00866697|581759896|FG001|Overall Study|Lost to Follow-up|28|||
161100726|NCT00866697|581759895|FG000|Overall Study|Physician Decision|3|||
161100727|NCT00866697|581759896|FG001|Overall Study|Physician Decision|5|||
161100728|NCT00866697|581759895|FG000|Overall Study|Withdrawal by Subject|33|||
161100729|NCT00866697|581759896|FG001|Overall Study|Withdrawal by Subject|57|||
161100730|NCT02906787|581759899|FG000|Overall Study|Withdrawal by Subject|12|||
161100731|NCT02906787|581759900|FG001|Overall Study|Withdrawal by Subject|10|||
161100732|NCT02906787|581759899|FG000|Overall Study|Missed|24|||
161100733|NCT02906787|581759900|FG001|Overall Study|Missed|22|||
161100734|NCT03901053|581759905|FG000|Overall Study|Lost to Follow-up|6|||
161100735|NCT03901053|581759906|FG001|Overall Study|Lost to Follow-up|2|||
161100736|NCT03901053|581759905|FG000|Overall Study|Withdrawal by Subject|4|||
161100737|NCT03901053|581759906|FG001|Overall Study|Withdrawal by Subject|3|||
161100738|NCT03901053|581759905|FG000|Overall Study|Unsatisfactory Device|1|||
161100739|NCT03901053|581759906|FG001|Overall Study|Unsatisfactory Device|2|||
161100740|NCT03901053|581759905|FG000|Overall Study|No longer meets study criteria|1|||
161100741|NCT03901053|581759906|FG001|Overall Study|No longer meets study criteria|3|||
161100742|NCT03901053|581759905|FG000|Overall Study|Subject's Medical Status|0|||
161100743|NCT03901053|581759906|FG001|Overall Study|Subject's Medical Status|1|||
161100744|NCT03901053|581759905|FG000|Overall Study|Screening Failure|1|||
161100745|NCT03901053|581759906|FG001|Overall Study|Screening Failure|0|||
161100746|NCT01310803|581761631|FG000|Overall Study|Subject terminated by Sponsor|1|||
161100747|NCT01310803|581761632|FG001|Overall Study|Subject terminated by Sponsor|0|||
161100748|NCT02113579|581761635|FG000|Overall Study|Adverse Event|1|||
161100749|NCT02113579|581761636|FG001|Overall Study|Adverse Event|0|||
161100750|NCT02113579|581761635|FG000|Overall Study|Withdrawal by Subject|3|||
161100751|NCT02113579|581761636|FG001|Overall Study|Withdrawal by Subject|2|||
161100752|NCT02113579|581761635|FG000|Overall Study|Lost to Follow-up|6|||
161100753|NCT02113579|581761636|FG001|Overall Study|Lost to Follow-up|2|||
161100754|NCT03047551|581761637|FG000|Overall Study|Did not receive TAS|1|||
161100755|NCT03047551|581761638|FG001|Overall Study|Did not receive TAS|0|||
161100756|NCT03047551|581761637|FG000|Overall Study|Physician Decision|1|||
161100757|NCT03047551|581761638|FG001|Overall Study|Physician Decision|0|||
161100758|NCT03047551|581761637|FG000|Overall Study|Withdrawal by Subject|0|||
161100759|NCT03047551|581761638|FG001|Overall Study|Withdrawal by Subject|1|||
161100760|NCT03047551|581761637|FG000|Overall Study|Probe malfunction|0|||
161100761|NCT03047551|581761638|FG001|Overall Study|Probe malfunction|1|||
161100762|NCT03047551|581761637|FG000|Overall Study|Ineligible|0|||
161100763|NCT03047551|581761638|FG001|Overall Study|Ineligible|1|||
161100764|NCT00726622|581761639|FG000|Overall Study|Withdrawal by Subject|16|||
161100765|NCT00726622|581761640|FG001|Overall Study|Withdrawal by Subject|2|||
161100766|NCT00726622|581761639|FG000|Overall Study|Physician Decision|0|||
161100767|NCT00726622|581761640|FG001|Overall Study|Physician Decision|1|||
161100768|NCT00726622|581761639|FG000|Overall Study|Metastasis|2|||
161100769|NCT00726622|581761640|FG001|Overall Study|Metastasis|0|||
161100770|NCT02462928|581761642|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161100771|NCT02462928|581761643|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161100772|NCT02462928|581761644|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
161100773|NCT02462928|581761642|FG000|Overall Study|Adverse Event|47|||
161100774|NCT02462928|581761643|FG001|Overall Study|Adverse Event|51|||
161100775|NCT02462928|581761644|FG002|Overall Study|Adverse Event|25|||
161100776|NCT02462928|581761642|FG000|Overall Study|Lack of Efficacy|3|||
161100777|NCT02462928|581761643|FG001|Overall Study|Lack of Efficacy|8|||
161100778|NCT02462928|581761644|FG002|Overall Study|Lack of Efficacy|3|||
161100779|NCT02462928|581761642|FG000|Overall Study|Lost to Follow-up|4|||
161100780|NCT02462928|581761643|FG001|Overall Study|Lost to Follow-up|4|||
161100781|NCT02462928|581761644|FG002|Overall Study|Lost to Follow-up|1|||
161100782|NCT02462928|581761642|FG000|Overall Study|Withdrawal by Patient|31|||
161100783|NCT02462928|581761643|FG001|Overall Study|Withdrawal by Patient|21|||
161100784|NCT02462928|581761644|FG002|Overall Study|Withdrawal by Patient|21|||
161100785|NCT02462928|581761642|FG000|Overall Study|Protocol Violation|0|||
161100786|NCT02462928|581761643|FG001|Overall Study|Protocol Violation|1|||
161100787|NCT02462928|581761644|FG002|Overall Study|Protocol Violation|0|||
161100788|NCT02462928|581761642|FG000|Overall Study|Reason not Specified|4|||
161100789|NCT02462928|581761643|FG001|Overall Study|Reason not Specified|6|||
161100790|NCT02462928|581761644|FG002|Overall Study|Reason not Specified|5|||
161100791|NCT00395863|581761645|FG000|Overall Study|Patients did not complete both exams|2|||
161100792|NCT00395863|581761646|FG001|Overall Study|Patients did not complete both exams|3|||
161100793|NCT01940354|581761647|FG000|Overall Study|Withdrawal by Subject|4|||
161100794|NCT01940354|581761648|FG001|Overall Study|Withdrawal by Subject|2|||
161100795|NCT02020863|581761649|FG000|Overall Study|Discovery of Metastatic disease|4|||
161100796|NCT02020863|581761649|FG000|Overall Study|Team chose not to place an a line|1|||
161100797|NCT03873493|581761650|FG000|Overall Study|Withdrawal by Subject|1|||
161100798|NCT03873493|581761650|FG000|Overall Study|Death|9|||
161100799|NCT03873493|581761650|FG000|Overall Study|Lost to Follow-up|1|||
161100800|NCT03873493|581761650|FG000|Overall Study|Study Terminated by Sponsor|1|||
161100801|NCT03873493|581761650|FG000|Overall Study|Other|2|||
161100802|NCT00909792|581761657|FG000|Period 1|Did not meet inclusion criteria|0|||
161100803|NCT00909792|581761658|FG001|Period 1|Did not meet inclusion criteria|1|||
161100804|NCT00909792|581761657|FG000|Period 2|Biomicroscopy|1|||
161100805|NCT00909792|581761658|FG001|Period 2|Biomicroscopy|0|||
161100806|NCT00909792|581761657|FG000|Period 2|Lost to Follow-up|0|||
161100807|NCT00909792|581761658|FG001|Period 2|Lost to Follow-up|1|||
161100808|NCT03503513|581761659|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
161100809|NCT03503513|581761659|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
161100810|NCT03503513|581761659|FG000|Overall Study|Physician Decision|3|||
161100811|NCT03503513|581761659|FG000|Overall Study|Withdrawal by Subject|2|||
161100812|NCT03503513|581761659|FG000|Overall Study|Lost to Follow-up|1|||
161100813|NCT01170039|581761664|FG000|Overall Study|Withdrawal by Subject|5|||
161100814|NCT01170039|581761665|FG001|Overall Study|Withdrawal by Subject|3|||
161100815|NCT01170039|581761664|FG000|Overall Study|Lack of funding, drug not available|3|||
161100816|NCT01170039|581761665|FG001|Overall Study|Lack of funding, drug not available|3|||
161100817|NCT01205438|581761666|FG000|Overall Study|Adverse Event|19|||
161100818|NCT01205438|581761667|FG001|Overall Study|Adverse Event|17|||
161100819|NCT01205438|581761668|FG002|Overall Study|Adverse Event|24|||
161100820|NCT01205438|581761666|FG000|Overall Study|Death|1|||
161100821|NCT01205438|581761667|FG001|Overall Study|Death|1|||
161100822|NCT01205438|581761668|FG002|Overall Study|Death|3|||
161100823|NCT01205438|581761666|FG000|Overall Study|Entry Criteria Not Met|16|||
161100824|NCT01205438|581761667|FG001|Overall Study|Entry Criteria Not Met|15|||
161100825|NCT01205438|581761668|FG002|Overall Study|Entry Criteria Not Met|13|||
161100826|NCT01205438|581761666|FG000|Overall Study|Lack of Efficacy|14|||
161100827|NCT01205438|581761667|FG001|Overall Study|Lack of Efficacy|11|||
161100828|NCT01205438|581761668|FG002|Overall Study|Lack of Efficacy|14|||
161100829|NCT01205438|581761666|FG000|Overall Study|Lost to Follow-up|6|||
161100830|NCT01205438|581761667|FG001|Overall Study|Lost to Follow-up|7|||
161100831|NCT01205438|581761668|FG002|Overall Study|Lost to Follow-up|8|||
161100832|NCT01205438|581761666|FG000|Overall Study|Withdrawal by Subject|19|||
161100833|NCT01205438|581761667|FG001|Overall Study|Withdrawal by Subject|25|||
161100834|NCT01205438|581761668|FG002|Overall Study|Withdrawal by Subject|19|||
161100835|NCT01205438|581761666|FG000|Overall Study|Physician Decision|0|||
161100836|NCT01205438|581761667|FG001|Overall Study|Physician Decision|3|||
161100837|NCT01205438|581761668|FG002|Overall Study|Physician Decision|2|||
161100838|NCT01205438|581761666|FG000|Overall Study|Protocol Violation|2|||
161100839|NCT01205438|581761667|FG001|Overall Study|Protocol Violation|7|||
161100840|NCT01205438|581761668|FG002|Overall Study|Protocol Violation|4|||
161100841|NCT01205438|581761666|FG000|Overall Study|Sponsor Decision|0|||
161100842|NCT01205438|581761667|FG001|Overall Study|Sponsor Decision|1|||
161100843|NCT01205438|581761668|FG002|Overall Study|Sponsor Decision|1|||
161100844|NCT01524133|581761669|FG000|Treatment Phase|Withdrawal by Subject|13|||
161100845|NCT01524133|581761670|FG001|Treatment Phase|Withdrawal by Subject|28|||
161100846|NCT01524133|581761671|FG002|Treatment Phase|Withdrawal by Subject|31|||
161100847|NCT01524133|581761669|FG000|Treatment Phase|Physician Decision|6|||
161100848|NCT01524133|581761670|FG001|Treatment Phase|Physician Decision|3|||
161100849|NCT01524133|581761671|FG002|Treatment Phase|Physician Decision|3|||
161100850|NCT01524133|581761669|FG000|Treatment Phase|Lost to Follow-up|0|||
161100851|NCT01524133|581761670|FG001|Treatment Phase|Lost to Follow-up|1|||
161100852|NCT01524133|581761671|FG002|Treatment Phase|Lost to Follow-up|2|||
161100853|NCT01524133|581761669|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
161100854|NCT01524133|581761670|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
161100855|NCT01524133|581761671|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
161100856|NCT01524133|581761669|FG000|Overall Study 52 Weeks|Physician Decision|1|||
161100857|NCT01524133|581761670|FG001|Overall Study 52 Weeks|Physician Decision|0|||
161100858|NCT01524133|581761671|FG002|Overall Study 52 Weeks|Physician Decision|2|||
161100859|NCT01524133|581761669|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
161100860|NCT01524133|581761670|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
161100861|NCT01524133|581761671|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
161100862|NCT02366728|581761672|FG000|Overall Study|Death|0|||
161100863|NCT02366728|581761673|FG001|Overall Study|Death|0|||
161100864|NCT02366728|581761674|FG002|Overall Study|Death|1|||
161100865|NCT02366728|581761672|FG000|Overall Study|Adverse Event|1|||
161100866|NCT02366728|581761673|FG001|Overall Study|Adverse Event|0|||
161100867|NCT02366728|581761674|FG002|Overall Study|Adverse Event|0|||
161100868|NCT02366728|581761672|FG000|Overall Study|Screen Failure|2|||
161100869|NCT02366728|581761673|FG001|Overall Study|Screen Failure|1|||
161100870|NCT02366728|581761674|FG002|Overall Study|Screen Failure|0|||
161100871|NCT02366728|581761672|FG000|Overall Study|Only yielded 2 vaccines|1|||
161100872|NCT02366728|581761673|FG001|Overall Study|Only yielded 2 vaccines|0|||
161100873|NCT02366728|581761674|FG002|Overall Study|Only yielded 2 vaccines|0|||
161100874|NCT00059839|581761676|FG000|Overall Study|Death|1|||
161100875|NCT00059839|581761677|FG001|Overall Study|Death|1|||
161100876|NCT00059839|581761676|FG000|Overall Study|Lack of Efficacy|6|||
161100877|NCT00059839|581761677|FG001|Overall Study|Lack of Efficacy|5|||
161100878|NCT00059839|581761676|FG000|Overall Study|Lost to Follow-up|2|||
161100879|NCT00059839|581761677|FG001|Overall Study|Lost to Follow-up|0|||
161100880|NCT00059839|581761676|FG000|Overall Study|Physician Decision|1|||
161100881|NCT00059839|581761677|FG001|Overall Study|Physician Decision|2|||
161100882|NCT00059839|581761676|FG000|Overall Study|Withdrawal by Subject|1|||
161100883|NCT00059839|581761677|FG001|Overall Study|Withdrawal by Subject|6|||
161100884|NCT00059839|581761676|FG000|Overall Study|Ineligible|1|||
161100885|NCT00059839|581761677|FG001|Overall Study|Ineligible|3|||
161100886|NCT03842163|581761678|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
161100887|NCT03842163|581761678|FG000|Overall Study|Scintigraphy was not performed|44|||
161100888|NCT03829241|581761682|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
161100889|NCT03829241|581761683|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
161100890|NCT03829241|581761682|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
161100891|NCT03829241|581761683|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
161100892|NCT03829241|581761682|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
161100893|NCT03829241|581761683|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
161100894|NCT03829241|581761682|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
161100895|NCT03829241|581761683|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
161323958|NCT01066871|582571971|FG002|Overall Study|Lost to Follow-up|2|||
161100896|NCT03829241|581761682|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
161323959|NCT01066871|582571972|FG003|Overall Study|Lost to Follow-up|0|||
161100897|NCT03829241|581761683|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
161100898|NCT03829241|581761682|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
161100899|NCT03829241|581761683|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
161100900|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
161100901|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
161100902|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
161100903|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
161100904|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
161100905|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
161100906|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
161100907|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
161100908|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
161100909|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
161100910|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
161100911|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
161100912|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
161100913|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
161100914|NCT03829241|581761682|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
161100915|NCT03829241|581761683|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
161100916|NCT00698451|581761684|FG000|Overall Study|Adverse Event|22|||
161100917|NCT00698451|581761684|FG000|Overall Study|Physician Decision|2|||
161100918|NCT00698451|581761684|FG000|Overall Study|Protocol Violation|6|||
161100919|NCT00698451|581761684|FG000|Overall Study|Withdrawal by Subject|6|||
161100920|NCT00698451|581761684|FG000|Overall Study|Disease progression|3|||
161100921|NCT01330914|581761685|FG000|Overall Study|Withdrawal by Subject|4|||
161100922|NCT01330914|581761685|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
161100923|NCT05352048|581761690|FG000|Overall Study|Lost to Follow-up|1|||
161100924|NCT05352048|581761690|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
161100925|NCT03085758|581761691|FG000|Overall Study|Death|26|||
161100926|NCT03085758|581761692|FG001|Overall Study|Death|24|||
161100927|NCT03085758|581761693|FG002|Overall Study|Death|53|||
161100928|NCT03085758|581761691|FG000|Overall Study|Lost to Follow-up|1|||
161100929|NCT03085758|581761692|FG001|Overall Study|Lost to Follow-up|1|||
161100930|NCT03085758|581761693|FG002|Overall Study|Lost to Follow-up|1|||
161100931|NCT03085758|581761691|FG000|Overall Study|Withdrawal by Subject|2|||
161100932|NCT03085758|581761692|FG001|Overall Study|Withdrawal by Subject|2|||
161100933|NCT03085758|581761693|FG002|Overall Study|Withdrawal by Subject|1|||
161100934|NCT03085758|581761691|FG000|Overall Study|Refusal to recall it up to day 90|0|||
161100935|NCT03085758|581761692|FG001|Overall Study|Refusal to recall it up to day 90|0|||
161100936|NCT03085758|581761693|FG002|Overall Study|Refusal to recall it up to day 90|1|||
161100937|NCT03085758|581761691|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
161100938|NCT03085758|581761692|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
161100939|NCT03085758|581761693|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
161100940|NCT03974334|581761697|FG000|Overall Study|Lost to Follow-up|1|||
161100941|NCT00024167|581761698|FG000|Overall Study|Death|53|||
161100942|NCT00024167|581761699|FG001|Overall Study|Death|47|||
161100943|NCT01109173|581761700|FG000|Overall Study|Adverse Event|15|||
161100944|NCT01109173|581761701|FG001|Overall Study|Adverse Event|17|||
161100945|NCT01109173|581761702|FG002|Overall Study|Adverse Event|9|||
161100946|NCT01109173|581761703|FG003|Overall Study|Adverse Event|6|||
161100947|NCT01109173|581761700|FG000|Overall Study|Lost to Follow-up|0|||
161100948|NCT01109173|581761701|FG001|Overall Study|Lost to Follow-up|1|||
161100949|NCT01109173|581761702|FG002|Overall Study|Lost to Follow-up|0|||
161100950|NCT01109173|581761703|FG003|Overall Study|Lost to Follow-up|0|||
161100951|NCT01109173|581761700|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
161100952|NCT01109173|581761701|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
161100953|NCT01109173|581761702|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
161100954|NCT01109173|581761703|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
161100955|NCT01109173|581761700|FG000|Overall Study|Noncompliance|0|||
161100956|NCT01109173|581761701|FG001|Overall Study|Noncompliance|1|||
161100957|NCT01109173|581761702|FG002|Overall Study|Noncompliance|0|||
161212368|NCT01042977|582160094|FG000|Overall Study|Administrative reason by sponsor|0|||
161100958|NCT01109173|581761703|FG003|Overall Study|Noncompliance|0|||
161100959|NCT01109173|581761700|FG000|Overall Study|Treatment Failure|25|||
161212369|NCT01042977|582160095|FG001|Overall Study|Administrative reason by sponsor|1|||
161100960|NCT01109173|581761701|FG001|Overall Study|Treatment Failure|32|||
161100961|NCT01109173|581761702|FG002|Overall Study|Treatment Failure|69|||
161100962|NCT01109173|581761703|FG003|Overall Study|Treatment Failure|64|||
161100963|NCT01109173|581761700|FG000|Overall Study|Protocol Violation|4|||
161100964|NCT01109173|581761701|FG001|Overall Study|Protocol Violation|5|||
161100965|NCT01109173|581761702|FG002|Overall Study|Protocol Violation|1|||
161100966|NCT01109173|581761703|FG003|Overall Study|Protocol Violation|2|||
161212370|NCT01042977|582160094|FG000|Overall Study|Various|3|||
161212371|NCT01042977|582160095|FG001|Overall Study|Various|0|||
161100967|NCT01109173|581761700|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
161100968|NCT01109173|581761701|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
161100969|NCT01109173|581761702|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
161100970|NCT01109173|581761703|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
161100971|NCT01109173|581761700|FG000|Overall Study|Not Specifiied|5|||
161100972|NCT01109173|581761701|FG001|Overall Study|Not Specifiied|4|||
161100973|NCT01109173|581761702|FG002|Overall Study|Not Specifiied|9|||
161100974|NCT01109173|581761703|FG003|Overall Study|Not Specifiied|14|||
161100975|NCT01019317|581761704|FG000|Overall Study|Not Eligible|4|||
161100976|NCT02545322|581761705|FG000|Overall Study|Withdrawal by Subject|3|||
161100977|NCT01807923|581761707|FG000|Overall Study|Adverse Event|2|||
161100978|NCT01807923|581761708|FG001|Overall Study|Adverse Event|1|||
161100979|NCT01807923|581761709|FG002|Overall Study|Adverse Event|2|||
161100980|NCT01807923|581761707|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161100981|NCT01807923|581761708|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161100982|NCT01807923|581761709|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161100983|NCT01807923|581761707|FG000|Overall Study|Physician Decision|0|||
161100984|NCT01807923|581761708|FG001|Overall Study|Physician Decision|0|||
161100985|NCT01807923|581761709|FG002|Overall Study|Physician Decision|1|||
161100986|NCT01807923|581761707|FG000|Overall Study|Not Eligible (Genotype)|0|||
161100987|NCT01807923|581761708|FG001|Overall Study|Not Eligible (Genotype)|0|||
161100988|NCT01807923|581761709|FG002|Overall Study|Not Eligible (Genotype)|1|||
161100989|NCT01807923|581761707|FG000|Overall Study|Randomized But Not Treated|3|||
161100990|NCT01807923|581761708|FG001|Overall Study|Randomized But Not Treated|2|||
161100991|NCT01807923|581761709|FG002|Overall Study|Randomized But Not Treated|5|||
161100992|NCT01237340|581761715|FG000|Overall Study|Adverse Event|3|||
161100993|NCT01237340|581761715|FG000|Overall Study|Withdrawal by Subject|1|||
161100994|NCT01237340|581761715|FG000|Overall Study|Early termination of the trial|36|||
161100995|NCT03836807|581761716|FG000|Overall Study|Physician Decision|1|||
161100996|NCT03836807|581761717|FG001|Overall Study|Physician Decision|0|||
161100997|NCT00685685|581761718|FG000|Washout Period of 7 Days|Adverse Event|2|||
161100998|NCT00685685|581761719|FG001|Washout Period of 7 Days|Adverse Event|0|||
161100999|NCT00685685|581761718|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161101000|NCT00685685|581761719|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161101001|NCT02019420|581761722|FG000|Overall Study|Did not receive study drug|2|||
161101002|NCT02019420|581761723|FG001|Overall Study|Did not receive study drug|2|||
161101003|NCT02019420|581761722|FG000|Overall Study|Withdrawal by Subject|1|||
161101004|NCT02019420|581761723|FG001|Overall Study|Withdrawal by Subject|3|||
161101005|NCT02019420|581761722|FG000|Overall Study|At request of sponsor or investigator|0|||
161101006|NCT02019420|581761723|FG001|Overall Study|At request of sponsor or investigator|1|||
161101007|NCT02019420|581761722|FG000|Overall Study|Death|104|||
161101008|NCT02019420|581761723|FG001|Overall Study|Death|99|||
161101009|NCT02019420|581761722|FG000|Overall Study|Transferred to other care facility|1|||
161101010|NCT02019420|581761723|FG001|Overall Study|Transferred to other care facility|1|||
161101011|NCT02014740|581761724|FG000|Overall Study|Lost to Follow-up|4|||
161101012|NCT02014740|581761725|FG001|Overall Study|Lost to Follow-up|4|||
161101013|NCT02014740|581761724|FG000|Overall Study|Withdrawal by Subject|2|||
161101014|NCT02014740|581761725|FG001|Overall Study|Withdrawal by Subject|1|||
161101015|NCT01130974|581761726|FG000|Overall Study|Protocol Violation|10|||
161101016|NCT01130974|581761727|FG001|Overall Study|Protocol Violation|10|||
161101017|NCT01130974|581761726|FG000|Overall Study|Withdrawal by Subject|0|||
161101018|NCT01130974|581761727|FG001|Overall Study|Withdrawal by Subject|1|||
161101019|NCT01130974|581761726|FG000|Overall Study|Ineligibility criteria|5|||
161101020|NCT01130974|581761727|FG001|Overall Study|Ineligibility criteria|2|||
161101021|NCT05118204|581761732|FG000|Overall Study|Lost to Follow-up|3|||
161101022|NCT05118204|581761733|FG001|Overall Study|Lost to Follow-up|2|||
161101023|NCT05118204|581761732|FG000|Overall Study|Withdrawal by Subject|0|||
161101024|NCT05118204|581761733|FG001|Overall Study|Withdrawal by Subject|2|||
161101025|NCT05393037|581761735|FG000|Part A|Death|1|||
161101026|NCT05393037|581761736|FG001|Part A|Death|0|||
161101027|NCT05393037|581761735|FG000|Part A|Lost to Follow-up|1|||
161101028|NCT05393037|581761736|FG001|Part A|Lost to Follow-up|1|||
161101029|NCT05393037|581761735|FG000|Part A|Withdrawal by Subject|2|||
161101030|NCT05393037|581761736|FG001|Part A|Withdrawal by Subject|4|||
161101031|NCT05393037|581761735|FG000|Part B|Lost to Follow-up|1|||
161101032|NCT05393037|581761736|FG001|Part B|Lost to Follow-up|0|||
161101033|NCT04409353|581761737|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
161101034|NCT04409353|581761738|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
161101035|NCT04409353|581761739|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
161101036|NCT04409353|581761737|FG000|Overall Study|Lost to Follow-up|6|||
161101037|NCT04409353|581761738|FG001|Overall Study|Lost to Follow-up|8|||
161101038|NCT04409353|581761739|FG002|Overall Study|Lost to Follow-up|7|||
161101039|NCT04409353|581761737|FG000|Overall Study|Major surgery during participation window|4|||
161101040|NCT04409353|581761738|FG001|Overall Study|Major surgery during participation window|3|||
161101041|NCT04409353|581761739|FG002|Overall Study|Major surgery during participation window|3|||
161323960|NCT01066871|582571969|FG000|Overall Study|Protocol Violation|1|||
161101042|NCT04409353|581761737|FG000|Overall Study|Life event occurred during participation window|3|||
161101043|NCT04409353|581761738|FG001|Overall Study|Life event occurred during participation window|2|||
161101044|NCT04409353|581761739|FG002|Overall Study|Life event occurred during participation window|4|||
161101045|NCT04409353|581761737|FG000|Overall Study|Lack of Efficacy|4|||
161101046|NCT04409353|581761738|FG001|Overall Study|Lack of Efficacy|1|||
161101047|NCT04409353|581761739|FG002|Overall Study|Lack of Efficacy|3|||
161101048|NCT04409353|581761737|FG000|Overall Study|Adverse Event|2|||
161101049|NCT04409353|581761738|FG001|Overall Study|Adverse Event|1|||
161101050|NCT04409353|581761739|FG002|Overall Study|Adverse Event|1|||
161101051|NCT04409353|581761737|FG000|Overall Study|Disease burden - unable to participate|0|||
161101052|NCT04409353|581761738|FG001|Overall Study|Disease burden - unable to participate|1|||
161101053|NCT04409353|581761739|FG002|Overall Study|Disease burden - unable to participate|1|||
161101054|NCT04409353|581761737|FG000|Overall Study|Intervention too complicated|1|||
161101055|NCT04409353|581761738|FG001|Overall Study|Intervention too complicated|0|||
161101056|NCT04409353|581761739|FG002|Overall Study|Intervention too complicated|1|||
161101057|NCT01012739|581761740|FG000|Treatment Period 1|Adverse Event|0|||
161101058|NCT01012739|581761741|FG001|Treatment Period 1|Adverse Event|0|||
161101059|NCT01012739|581761742|FG002|Treatment Period 1|Adverse Event|0|||
161101060|NCT01012739|581761743|FG003|Treatment Period 1|Adverse Event|1|||
161101061|NCT01012739|581761740|FG000|Treatment Period 2|Abnormal test procedure results|0|||
161101062|NCT01012739|581761741|FG001|Treatment Period 2|Abnormal test procedure results|0|||
161101063|NCT01012739|581761742|FG002|Treatment Period 2|Abnormal test procedure results|0|||
161101064|NCT01012739|581761743|FG003|Treatment Period 2|Abnormal test procedure results|1|||
161101065|NCT04540133|581761744|FG000|Overall Study|Lost to Follow-up|1|||
161101066|NCT04540133|581761745|FG001|Overall Study|Lost to Follow-up|0|||
161101067|NCT04014361|581761746|FG000|Period 2|Physician Decision|0|||
161101068|NCT04014361|581761747|FG001|Period 2|Physician Decision|0|||
161101069|NCT04014361|581761748|FG002|Period 2|Physician Decision|0|||
161101070|NCT04014361|581761749|FG003|Period 2|Physician Decision|1|||
161101071|NCT04014361|581761750|FG004|Period 2|Physician Decision|0|||
161101072|NCT04014361|581761751|FG005|Period 2|Physician Decision|0|||
161101073|NCT04014361|581761752|FG006|Period 2|Physician Decision|0|||
161101074|NCT04014361|581761753|FG007|Period 2|Physician Decision|0|||
161101075|NCT06308666|581761754|FG000|Overall Study|Withdrawal by Subject|1|||
161101076|NCT06308666|581761754|FG000|Overall Study|Protocol Violation|2|||
161101077|NCT04252287|581761756|FG000|Overall Study|Death|5|||
161101078|NCT04252287|581761757|FG001|Overall Study|Death|3|||
161101079|NCT04252287|581761756|FG000|Overall Study|Lost to Follow-up|4|||
161101080|NCT04252287|581761757|FG001|Overall Study|Lost to Follow-up|6|||
161101081|NCT04252287|581761756|FG000|Overall Study|Withdrawal by Subject|19|||
161101082|NCT04252287|581761757|FG001|Overall Study|Withdrawal by Subject|16|||
161101083|NCT04252287|581761756|FG000|Overall Study|Protocol Violation|3|||
161101084|NCT04252287|581761757|FG001|Overall Study|Protocol Violation|4|||
161101085|NCT04600336|581761760|FG000|Initial Treatment|Withdrawal by Subject|1|||
161101086|NCT04600336|581761761|FG001|Initial Treatment|Withdrawal by Subject|2|||
161101087|NCT04600336|581761762|FG002|Initial Treatment|Withdrawal by Subject|0|||
161101088|NCT04600336|581761763|FG003|Initial Treatment|Withdrawal by Subject|0|||
161101089|NCT04600336|581761760|FG000|Initial Treatment|Adverse Event|0|||
161101090|NCT04600336|581761761|FG001|Initial Treatment|Adverse Event|2|||
161101091|NCT04600336|581761762|FG002|Initial Treatment|Adverse Event|0|||
161101092|NCT04600336|581761763|FG003|Initial Treatment|Adverse Event|0|||
161101093|NCT04600336|581761760|FG000|Initial Treatment|Other complicating disease|0|||
161101094|NCT04600336|581761761|FG001|Initial Treatment|Other complicating disease|0|||
161101095|NCT04600336|581761762|FG002|Initial Treatment|Other complicating disease|1|||
161101096|NCT04600336|581761763|FG003|Initial Treatment|Other complicating disease|0|||
161101097|NCT04600336|581761760|FG000|Crossover Treatment|Withdrawal by Subject|0|||
161101098|NCT04600336|581761761|FG001|Crossover Treatment|Withdrawal by Subject|0|||
161101099|NCT04600336|581761762|FG002|Crossover Treatment|Withdrawal by Subject|2|||
161101100|NCT04600336|581761763|FG003|Crossover Treatment|Withdrawal by Subject|1|||
161212372|NCT02499354|582160096|FG000|Overall Study|Withdrawal by Subject|1|||
161101101|NCT04600336|581761760|FG000|Crossover Treatment|Adverse Event|0|||
161101102|NCT04600336|581761761|FG001|Crossover Treatment|Adverse Event|0|||
161101103|NCT04600336|581761762|FG002|Crossover Treatment|Adverse Event|1|||
161101104|NCT04600336|581761763|FG003|Crossover Treatment|Adverse Event|1|||
161101105|NCT03672461|581761764|FG000|Overall Study|COVID Related|4|||
161101106|NCT03672461|581761765|FG001|Overall Study|COVID Related|2|||
161101107|NCT03672461|581761764|FG000|Overall Study|Adverse Event|2|||
161101108|NCT03672461|581761765|FG001|Overall Study|Adverse Event|0|||
161101109|NCT03672461|581761764|FG000|Overall Study|Serious Adverse Event|0|||
161101110|NCT03672461|581761765|FG001|Overall Study|Serious Adverse Event|1|||
161101111|NCT03672461|581761764|FG000|Overall Study|Too Busy|3|||
161101112|NCT03672461|581761765|FG001|Overall Study|Too Busy|1|||
161101113|NCT03672461|581761764|FG000|Overall Study|Lost to Follow-up|1|||
161101114|NCT03672461|581761765|FG001|Overall Study|Lost to Follow-up|2|||
161101115|NCT03672461|581761764|FG000|Overall Study|Family|2|||
161101116|NCT03672461|581761765|FG001|Overall Study|Family|2|||
161101117|NCT03672461|581761764|FG000|Overall Study|No remote technology access|0|||
161101118|NCT03672461|581761765|FG001|Overall Study|No remote technology access|1|||
161101119|NCT03672461|581761764|FG000|Overall Study|Withdrawal by Subject|1|||
161101120|NCT03672461|581761765|FG001|Overall Study|Withdrawal by Subject|0|||
161101121|NCT03672461|581761764|FG000|Overall Study|Cannot tolerate intervention|1|||
161101122|NCT03672461|581761765|FG001|Overall Study|Cannot tolerate intervention|0|||
161101123|NCT03672461|581761764|FG000|Overall Study|Incomplete outcome data|6|||
161101124|NCT03672461|581761765|FG001|Overall Study|Incomplete outcome data|1|||
161101125|NCT00977574|581761766|FG000|Overall Study|Never Treated|4|||
161101126|NCT00977574|581761767|FG001|Overall Study|Never Treated|2|||
161101127|NCT00977574|581761768|FG002|Overall Study|Never Treated|4|||
161101128|NCT04223791|581761769|FG000|Overall Study|Lost to Follow-up|0|||
161101129|NCT04223791|581761770|FG001|Overall Study|Lost to Follow-up|4|||
161101130|NCT04223791|581761769|FG000|Overall Study|Physician Decision|5|||
161101131|NCT04223791|581761770|FG001|Overall Study|Physician Decision|1|||
161101132|NCT04223791|581761769|FG000|Overall Study|Protocol Violation|1|||
161101133|NCT04223791|581761770|FG001|Overall Study|Protocol Violation|1|||
161101134|NCT04223791|581761769|FG000|Overall Study|Withdrawal by Subject|10|||
161101135|NCT04223791|581761770|FG001|Overall Study|Withdrawal by Subject|12|||
161101136|NCT04223791|581761769|FG000|Overall Study|Pregnancy|1|||
161101137|NCT04223791|581761770|FG001|Overall Study|Pregnancy|1|||
161101138|NCT04223791|581761769|FG000|Overall Study|Ongoing in Study|305|||
161101139|NCT04223791|581761770|FG001|Overall Study|Ongoing in Study|302|||
161101146|NCT00332839|581762927|FG000|Core (Months 0 - 12)|Administrative problems|1|||
161101147|NCT00332839|581762928|FG001|Core (Months 0 - 12)|Administrative problems|1|||
161101148|NCT00332839|581762927|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
161101149|NCT00332839|581762928|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
161101150|NCT00332839|581762927|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
161101151|NCT00332839|581762928|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
161101152|NCT00332839|581762927|FG000|Core (Months 0 - 12)|Adverse Event|5|||
161101153|NCT00332839|581762928|FG001|Core (Months 0 - 12)|Adverse Event|15|||
161101154|NCT00332839|581762927|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
161101155|NCT00332839|581762928|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
161101156|NCT00332839|581762927|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
161101157|NCT00332839|581762928|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
161101158|NCT00332839|581762927|FG000|Follow-up (Months 12 - 60)|Death|1|||
161101159|NCT00332839|581762928|FG001|Follow-up (Months 12 - 60)|Death|1|||
161101160|NCT00594516|581762932|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
161101161|NCT00594516|581762933|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
161101162|NCT00594516|581762934|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
161101163|NCT00594516|581762932|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
161101164|NCT00594516|581762933|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
161101165|NCT00594516|581762934|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
161101166|NCT00594516|581762932|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
161101167|NCT00594516|581762933|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
161101168|NCT00594516|581762934|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
161101169|NCT00594516|581762932|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
161101170|NCT00594516|581762933|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
161101171|NCT00594516|581762934|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
161101172|NCT00594516|581762932|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
161101173|NCT00594516|581762933|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
161323961|NCT01066871|582571970|FG001|Overall Study|Protocol Violation|0|||
161101174|NCT00594516|581762934|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
161101175|NCT00594516|581762932|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
161101176|NCT00594516|581762933|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
161101177|NCT00594516|581762934|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
161101178|NCT00594516|581762932|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
161101179|NCT00594516|581762933|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
161101180|NCT00594516|581762934|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
161101181|NCT00594516|581762932|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
161101182|NCT00594516|581762933|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
161101183|NCT00594516|581762934|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
161101184|NCT00594516|581762932|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
161101185|NCT00594516|581762933|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
161101186|NCT00594516|581762934|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
161101187|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
161101188|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
161101189|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
161101190|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
161101191|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
161101192|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
161101193|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
161101194|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
161101195|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
161101196|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
161101197|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
161101198|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
161101199|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
161101200|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
161101201|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
161101202|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
161101203|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
161101204|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
161101205|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Early termination|0|||
161101206|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Early termination|0|||
161101207|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Early termination|34|||
161101208|NCT01493557|581762935|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
161101209|NCT01493557|581762936|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
161101210|NCT01493557|581762937|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
161101211|NCT01493557|581762935|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
161101212|NCT01493557|581762936|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
161101213|NCT01493557|581762937|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
161101214|NCT01493557|581762935|FG000|Randomized to Management Strategies|Other adverse event|8|||
161101215|NCT01493557|581762936|FG001|Randomized to Management Strategies|Other adverse event|5|||
161101216|NCT01493557|581762937|FG002|Randomized to Management Strategies|Other adverse event|0|||
161101217|NCT01493557|581762935|FG000|Randomized to Management Strategies|Protocol Violation|3|||
161101218|NCT01493557|581762936|FG001|Randomized to Management Strategies|Protocol Violation|0|||
161101219|NCT01493557|581762937|FG002|Randomized to Management Strategies|Protocol Violation|0|||
161101220|NCT01493557|581762935|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
161101221|NCT01493557|581762936|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
161101222|NCT01493557|581762937|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
161101223|NCT01493557|581762935|FG000|Randomized to Management Strategies|Other than stated above|1|||
161101224|NCT01493557|581762936|FG001|Randomized to Management Strategies|Other than stated above|3|||
161101225|NCT01493557|581762937|FG002|Randomized to Management Strategies|Other than stated above|0|||
161101226|NCT01493557|581762935|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
161101227|NCT01493557|581762936|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
161101228|NCT01493557|581762937|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
161101229|NCT01493557|581762935|FG000|Adding the Second Strategy|Other adverse event|1|||
161101230|NCT01493557|581762936|FG001|Adding the Second Strategy|Other adverse event|2|||
161101231|NCT01493557|581762937|FG002|Adding the Second Strategy|Other adverse event|0|||
161101232|NCT01493557|581762935|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
161101233|NCT01493557|581762936|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
161101234|NCT01493557|581762937|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
161101235|NCT02973425|581762938|FG000|Overall Study|Lost to Follow-up|49|||
161101236|NCT02973425|581762939|FG001|Overall Study|Lost to Follow-up|53|||
161101237|NCT03823404|581762940|FG000|Overall Study|Lost to Follow-up|1|||
161101238|NCT03823404|581762941|FG001|Overall Study|Lost to Follow-up|2|||
161101239|NCT03823404|581762942|FG002|Overall Study|Lost to Follow-up|3|||
161101240|NCT03823404|581762940|FG000|Overall Study|Protocol Violation|2|||
161101241|NCT03823404|581762941|FG001|Overall Study|Protocol Violation|0|||
161101242|NCT03823404|581762942|FG002|Overall Study|Protocol Violation|2|||
161101243|NCT03823404|581762940|FG000|Overall Study|Adverse Event|35|||
161101244|NCT03823404|581762941|FG001|Overall Study|Adverse Event|38|||
161101245|NCT03823404|581762942|FG002|Overall Study|Adverse Event|8|||
161323962|NCT01066871|582571971|FG002|Overall Study|Protocol Violation|3|||
161101246|NCT03823404|581762940|FG000|Overall Study|Withdrawal by Subject|38|||
161101247|NCT03823404|581762941|FG001|Overall Study|Withdrawal by Subject|40|||
161101248|NCT03823404|581762942|FG002|Overall Study|Withdrawal by Subject|35|||
161101249|NCT03823404|581762940|FG000|Overall Study|Death|4|||
161101250|NCT03823404|581762941|FG001|Overall Study|Death|0|||
161101251|NCT03823404|581762942|FG002|Overall Study|Death|0|||
161101252|NCT03823404|581762940|FG000|Overall Study|Other: Various reasons provided|5|||
161101253|NCT03823404|581762941|FG001|Overall Study|Other: Various reasons provided|5|||
161101254|NCT03823404|581762942|FG002|Overall Study|Other: Various reasons provided|6|||
161101255|NCT01087957|581762945|FG000|Overall Study|Death|2|||
161101256|NCT01087957|581762946|FG001|Overall Study|Death|2|||
161101257|NCT01087957|581762945|FG000|Overall Study|Lost to Follow-up|3|||
161101258|NCT01087957|581762946|FG001|Overall Study|Lost to Follow-up|4|||
161101259|NCT01087957|581762945|FG000|Overall Study|Protocol Violation|13|||
161101260|NCT01087957|581762946|FG001|Overall Study|Protocol Violation|25|||
161101261|NCT01087957|581762945|FG000|Overall Study|Withdrawal by Subject|18|||
161101262|NCT01087957|581762946|FG001|Overall Study|Withdrawal by Subject|15|||
161101263|NCT01087957|581762945|FG000|Overall Study|Physician Decision|5|||
161101264|NCT01087957|581762946|FG001|Overall Study|Physician Decision|9|||
161101265|NCT02224599|581762949|FG000|Overall Study|Physician Decision|1|||
161101266|NCT02224599|581762949|FG000|Overall Study|Progression of Disease|1|||
161101267|NCT01187550|581762951|FG000|Overall Study|Protocol Violation|3|||
161101268|NCT01187550|581762952|FG001|Overall Study|Protocol Violation|1|||
161101269|NCT01187550|581762951|FG000|Overall Study|Other|3|||
161101270|NCT01187550|581762952|FG001|Overall Study|Other|0|||
161101271|NCT01187550|581762951|FG000|Overall Study|Randomized but not treated|8|||
161101272|NCT01187550|581762952|FG001|Overall Study|Randomized but not treated|0|||
161101273|NCT00129623|581762953|FG000|Overall Study|Adverse Event|3|||
161101274|NCT00129623|581762954|FG001|Overall Study|Adverse Event|7|||
161101275|NCT00129623|581762953|FG000|Overall Study|Refused Treatment|5|||
161101276|NCT00129623|581762954|FG001|Overall Study|Refused Treatment|3|||
161101277|NCT00129623|581762953|FG000|Overall Study|Failure to Return|1|||
161101278|NCT00129623|581762954|FG001|Overall Study|Failure to Return|1|||
161101279|NCT00129623|581762953|FG000|Overall Study|Relocated job out of state|1|||
161101280|NCT00129623|581762954|FG001|Overall Study|Relocated job out of state|0|||
161101281|NCT00129623|581762953|FG000|Overall Study|Uncertainty to return|0|||
161101282|NCT00129623|581762954|FG001|Overall Study|Uncertainty to return|1|||
161101283|NCT00596934|581762955|FG000|Overall Study|Protocol Violation|1|||
161101284|NCT00596934|581762955|FG000|Overall Study|Withdrawal by Subject|1|||
161101285|NCT02315898|581762958|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
161101286|NCT02315898|581762959|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
161101287|NCT02315898|581762960|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
161101288|NCT02315898|581762961|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
161101289|NCT02445755|581762962|FG000|Overall Study|Withdrawal by Subject|2|||
161101290|NCT02445755|581762962|FG000|Overall Study|Protocol Violation|6|||
161101291|NCT02445755|581762962|FG000|Overall Study|Screen Failure|5|||
161101292|NCT01296035|581762973|FG000|Overall Study|Withdrawal by Subject|1|||
161101293|NCT01674712|581762976|FG000|Overall Study|Adverse Event|5|||
161101294|NCT01674712|581762977|FG001|Overall Study|Adverse Event|6|||
161101295|NCT01674712|581762978|FG002|Overall Study|Adverse Event|3|||
161101296|NCT01674712|581762979|FG003|Overall Study|Adverse Event|4|||
161101297|NCT01674712|581762980|FG004|Overall Study|Adverse Event|6|||
161101298|NCT01674712|581762976|FG000|Overall Study|Lost to Follow-up|1|||
161101299|NCT01674712|581762977|FG001|Overall Study|Lost to Follow-up|0|||
161101300|NCT01674712|581762978|FG002|Overall Study|Lost to Follow-up|0|||
161101301|NCT01674712|581762979|FG003|Overall Study|Lost to Follow-up|0|||
161101302|NCT01674712|581762980|FG004|Overall Study|Lost to Follow-up|0|||
161101303|NCT01674712|581762976|FG000|Overall Study|Protocol Violation|2|||
161101304|NCT01674712|581762977|FG001|Overall Study|Protocol Violation|0|||
161101305|NCT01674712|581762978|FG002|Overall Study|Protocol Violation|0|||
161101306|NCT01674712|581762979|FG003|Overall Study|Protocol Violation|0|||
161212373|NCT02499354|582160097|FG001|Overall Study|Withdrawal by Subject|0|||
161212374|NCT01677910|582160099|FG000|Double-Blind Treatment Period|Adverse Event|6|||
161101307|NCT01674712|581762980|FG004|Overall Study|Protocol Violation|0|||
161101308|NCT01674712|581762976|FG000|Overall Study|Withdrawal by Subject|2|||
161101309|NCT01674712|581762977|FG001|Overall Study|Withdrawal by Subject|2|||
161101310|NCT01674712|581762978|FG002|Overall Study|Withdrawal by Subject|5|||
161101311|NCT01674712|581762979|FG003|Overall Study|Withdrawal by Subject|4|||
161101312|NCT01674712|581762980|FG004|Overall Study|Withdrawal by Subject|3|||
161101313|NCT01674712|581762976|FG000|Overall Study|Administrative|0|||
161101314|NCT01674712|581762977|FG001|Overall Study|Administrative|1|||
161101315|NCT01674712|581762978|FG002|Overall Study|Administrative|0|||
161101316|NCT01674712|581762979|FG003|Overall Study|Administrative|0|||
161101317|NCT01674712|581762980|FG004|Overall Study|Administrative|1|||
161101318|NCT01674712|581762976|FG000|Overall Study|Lack of Efficacy|0|||
161101319|NCT01674712|581762977|FG001|Overall Study|Lack of Efficacy|0|||
161101320|NCT01674712|581762978|FG002|Overall Study|Lack of Efficacy|1|||
161101321|NCT01674712|581762979|FG003|Overall Study|Lack of Efficacy|0|||
161101322|NCT01674712|581762980|FG004|Overall Study|Lack of Efficacy|1|||
161101323|NCT00056862|581762981|FG000|Overall Study|Protocol Violation|1|||
161101324|NCT00056862|581762982|FG001|Overall Study|Protocol Violation|0|||
161101325|NCT01132612|581762984|FG000|Overall Study|Death|0|||
161101326|NCT01132612|581762985|FG001|Overall Study|Death|0|||
161101327|NCT01132612|581762986|FG002|Overall Study|Death|1|||
161101328|NCT01132612|581762984|FG000|Overall Study|Protocol deviation|0|||
161101329|NCT01132612|581762985|FG001|Overall Study|Protocol deviation|0|||
161101330|NCT01132612|581762986|FG002|Overall Study|Protocol deviation|3|||
161101331|NCT01132612|581762984|FG000|Overall Study|Lost to Follow-up|2|||
161101332|NCT01132612|581762985|FG001|Overall Study|Lost to Follow-up|2|||
161101333|NCT01132612|581762986|FG002|Overall Study|Lost to Follow-up|7|||
161101334|NCT01132612|581762984|FG000|Overall Study|Adverse Event|5|||
161101335|NCT01132612|581762985|FG001|Overall Study|Adverse Event|2|||
161101336|NCT01132612|581762986|FG002|Overall Study|Adverse Event|15|||
161101337|NCT01132612|581762984|FG000|Overall Study|Withdrawal by Subject|5|||
161101338|NCT01132612|581762985|FG001|Overall Study|Withdrawal by Subject|8|||
161101339|NCT01132612|581762986|FG002|Overall Study|Withdrawal by Subject|19|||
161101340|NCT01132612|581762984|FG000|Overall Study|Administrative problems|5|||
161101341|NCT01132612|581762985|FG001|Overall Study|Administrative problems|1|||
161101342|NCT01132612|581762986|FG002|Overall Study|Administrative problems|52|||
161101343|NCT01132612|581762984|FG000|Overall Study|Lack of Efficacy|23|||
161101344|NCT01132612|581762985|FG001|Overall Study|Lack of Efficacy|22|||
161101345|NCT01132612|581762986|FG002|Overall Study|Lack of Efficacy|73|||
161101346|NCT02252536|581762990|FG000|Overall Study|Lost to Follow-up|5|||
161101347|NCT02252536|581762991|FG001|Overall Study|Lost to Follow-up|3|||
161101348|NCT01438151|581762993|FG000|Overall Study|study terminated|8|||
161101349|NCT00006392|581763002|FG000|Overall Study|Ineligible|11|||
161101350|NCT00006392|581763003|FG001|Overall Study|Ineligible|3|||
161101351|NCT00006392|581763004|FG002|Overall Study|Ineligible|5|||
161101352|NCT00006392|581763005|FG003|Overall Study|Ineligible|5|||
161101353|NCT00006392|581763002|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
161101354|NCT00006392|581763003|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161101355|NCT00006392|581763004|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161101356|NCT00006392|581763005|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
161101357|NCT02459769|581763007|FG000|Overall Study|Withdrawal by Subject|7|||
161101358|NCT02459769|581763008|FG001|Overall Study|Withdrawal by Subject|4|||
161101359|NCT02459769|581763009|FG002|Overall Study|Withdrawal by Subject|8|||
161101360|NCT02459769|581763010|FG003|Overall Study|Withdrawal by Subject|5|||
161101361|NCT02459769|581763007|FG000|Overall Study|Lost to Follow-up|1|||
161101362|NCT02459769|581763008|FG001|Overall Study|Lost to Follow-up|0|||
161101363|NCT02459769|581763009|FG002|Overall Study|Lost to Follow-up|1|||
161101364|NCT02459769|581763010|FG003|Overall Study|Lost to Follow-up|0|||
161101365|NCT01186796|581763011|FG000|Overall Study|Adverse Event|3|||
161101366|NCT01186796|581763012|FG001|Overall Study|Adverse Event|0|||
161101367|NCT01186796|581763011|FG000|Overall Study|Withdrawal by Subject|1|||
161101368|NCT01186796|581763012|FG001|Overall Study|Withdrawal by Subject|1|||
161101369|NCT01186796|581763011|FG000|Overall Study|Protocol Violation|0|||
161101370|NCT01186796|581763012|FG001|Overall Study|Protocol Violation|1|||
161101371|NCT03838198|581763013|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161101372|NCT03838198|581763014|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161101373|NCT03838198|581763015|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
161101374|NCT03838198|581763016|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
161101375|NCT03838198|581763013|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
161101376|NCT03838198|581763014|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
161101377|NCT03838198|581763015|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
161101378|NCT03838198|581763016|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
161101379|NCT02378220|581763021|FG000|Overall Study|Death|6|||
161101380|NCT02378220|581763022|FG001|Overall Study|Death|1|||
161101381|NCT00578786|581763023|FG000|Overall Study|Adverse Event|27|||
161101382|NCT00578786|581763024|FG001|Overall Study|Adverse Event|37|||
161101383|NCT00578786|581763025|FG002|Overall Study|Adverse Event|17|||
161101384|NCT00578786|581763023|FG000|Overall Study|Lack of Efficacy|2|||
161101385|NCT00578786|581763024|FG001|Overall Study|Lack of Efficacy|5|||
161101386|NCT00578786|581763025|FG002|Overall Study|Lack of Efficacy|2|||
161101387|NCT00578786|581763023|FG000|Overall Study|Early Escape from Prior Study|2|||
161101388|NCT00578786|581763024|FG001|Overall Study|Early Escape from Prior Study|1|||
161101389|NCT00578786|581763025|FG002|Overall Study|Early Escape from Prior Study|2|||
161101390|NCT00578786|581763023|FG000|Overall Study|Withdrawal by Subject|7|||
161101391|NCT00578786|581763024|FG001|Overall Study|Withdrawal by Subject|8|||
161101392|NCT00578786|581763025|FG002|Overall Study|Withdrawal by Subject|5|||
161101393|NCT00578786|581763023|FG000|Overall Study|Protocol Violation|0|||
161101394|NCT00578786|581763024|FG001|Overall Study|Protocol Violation|3|||
161101395|NCT00578786|581763025|FG002|Overall Study|Protocol Violation|1|||
161101396|NCT00578786|581763023|FG000|Overall Study|Physician Decision|1|||
161101397|NCT00578786|581763024|FG001|Overall Study|Physician Decision|0|||
161101398|NCT00578786|581763025|FG002|Overall Study|Physician Decision|1|||
161101399|NCT00578786|581763023|FG000|Overall Study|Sponsor Decision|0|||
161101400|NCT00578786|581763024|FG001|Overall Study|Sponsor Decision|0|||
161101401|NCT00578786|581763025|FG002|Overall Study|Sponsor Decision|1|||
161101402|NCT00578786|581763023|FG000|Overall Study|Lost to Follow-up|0|||
161101403|NCT00578786|581763024|FG001|Overall Study|Lost to Follow-up|4|||
161101404|NCT00578786|581763025|FG002|Overall Study|Lost to Follow-up|0|||
161101405|NCT00578786|581763023|FG000|Overall Study|Pregnancy|0|||
161101406|NCT00578786|581763024|FG001|Overall Study|Pregnancy|1|||
161101407|NCT00578786|581763025|FG002|Overall Study|Pregnancy|0|||
161101408|NCT00578786|581763023|FG000|Overall Study|Not Otherwise Specified|0|||
161101409|NCT00578786|581763024|FG001|Overall Study|Not Otherwise Specified|4|||
161101410|NCT00578786|581763025|FG002|Overall Study|Not Otherwise Specified|1|||
161101411|NCT00578786|581763023|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
161101412|NCT00578786|581763024|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
161101413|NCT00578786|581763025|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
161101414|NCT00312221|581763026|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
161101415|NCT00312221|581763027|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161101416|NCT00312221|581763028|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161101417|NCT00312221|581763029|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
161101418|NCT00312221|581763026|FG000|Open-label Run-in Period|Adverse Event|74|||
161101419|NCT00312221|581763027|FG001|Open-label Run-in Period|Adverse Event|0|||
161101420|NCT00312221|581763028|FG002|Open-label Run-in Period|Adverse Event|0|||
161101421|NCT00312221|581763029|FG003|Open-label Run-in Period|Adverse Event|0|||
161101422|NCT00312221|581763026|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
161101423|NCT00312221|581763027|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161101424|NCT00312221|581763028|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161101425|NCT00312221|581763029|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
161101426|NCT00312221|581763026|FG000|Open-label Run-in Period|Administrative|42|||
161101427|NCT00312221|581763027|FG001|Open-label Run-in Period|Administrative|0|||
161101428|NCT00312221|581763028|FG002|Open-label Run-in Period|Administrative|0|||
161101429|NCT00312221|581763029|FG003|Open-label Run-in Period|Administrative|0|||
161101430|NCT00312221|581763026|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
161101431|NCT00312221|581763027|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161101432|NCT00312221|581763028|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161101433|NCT00312221|581763029|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
161101434|NCT00312221|581763026|FG000|Open-label Run-in Period|Did not qualify|5|||
161101435|NCT00312221|581763027|FG001|Open-label Run-in Period|Did not qualify|0|||
161101436|NCT00312221|581763028|FG002|Open-label Run-in Period|Did not qualify|0|||
161101437|NCT00312221|581763029|FG003|Open-label Run-in Period|Did not qualify|0|||
161101438|NCT00312221|581763026|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161101439|NCT00312221|581763027|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161101440|NCT00312221|581763028|FG002|Double-blind Phase|Withdrawal by Subject|8|||
161101441|NCT00312221|581763029|FG003|Double-blind Phase|Withdrawal by Subject|7|||
161101442|NCT00312221|581763026|FG000|Double-blind Phase|Adverse Event|0|||
161101443|NCT00312221|581763027|FG001|Double-blind Phase|Adverse Event|10|||
161101444|NCT00312221|581763028|FG002|Double-blind Phase|Adverse Event|19|||
161101445|NCT00312221|581763029|FG003|Double-blind Phase|Adverse Event|18|||
161101446|NCT00312221|581763026|FG000|Double-blind Phase|Lost to Follow-up|0|||
161101447|NCT00312221|581763027|FG001|Double-blind Phase|Lost to Follow-up|0|||
161101448|NCT00312221|581763028|FG002|Double-blind Phase|Lost to Follow-up|2|||
161101449|NCT00312221|581763029|FG003|Double-blind Phase|Lost to Follow-up|2|||
161323963|NCT01066871|582571972|FG003|Overall Study|Protocol Violation|2|||
161323964|NCT01066871|582571969|FG000|Overall Study|Lack of Efficacy|0|||
161323965|NCT01066871|582571970|FG001|Overall Study|Lack of Efficacy|0|||
161323966|NCT01066871|582571971|FG002|Overall Study|Lack of Efficacy|0|||
161323967|NCT01066871|582571972|FG003|Overall Study|Lack of Efficacy|1|||
161323968|NCT01066871|582571969|FG000|Overall Study|Withdrawal by Subject|3|||
161323969|NCT01066871|582571970|FG001|Overall Study|Withdrawal by Subject|1|||
161323970|NCT01066871|582571971|FG002|Overall Study|Withdrawal by Subject|0|||
161323971|NCT01066871|582571972|FG003|Overall Study|Withdrawal by Subject|0|||
161323972|NCT01066871|582571969|FG000|Overall Study|Other|0|||
161323973|NCT01066871|582571970|FG001|Overall Study|Other|2|||
161323974|NCT01066871|582571971|FG002|Overall Study|Other|1|||
161323975|NCT01066871|582571972|FG003|Overall Study|Other|2|||
161323976|NCT03373461|582571978|FG000|Part 2|Adverse Event|0|||
161323977|NCT03373461|582571979|FG001|Part 2|Adverse Event|1|||
161101450|NCT00312221|581763026|FG000|Double-blind Phase|Administrative|0|||
161101451|NCT00312221|581763027|FG001|Double-blind Phase|Administrative|26|||
161101452|NCT00312221|581763028|FG002|Double-blind Phase|Administrative|37|||
161323978|NCT03373461|582571980|FG002|Part 2|Adverse Event|0|||
161323979|NCT03373461|582571981|FG003|Part 2|Adverse Event|0|||
161323980|NCT03373461|582571982|FG004|Part 2|Adverse Event|1|||
161101453|NCT00312221|581763029|FG003|Double-blind Phase|Administrative|33|||
161323981|NCT01366638|582571983|FG000|Overall Study|Withdrawal by Subject|0|||
161101454|NCT00312221|581763026|FG000|Double-blind Phase|Lack of Efficacy|0|||
161101455|NCT00312221|581763027|FG001|Double-blind Phase|Lack of Efficacy|17|||
161101456|NCT00312221|581763028|FG002|Double-blind Phase|Lack of Efficacy|6|||
161101457|NCT00312221|581763029|FG003|Double-blind Phase|Lack of Efficacy|10|||
161101458|NCT02060721|581763031|FG000|Overall Study|Lost to Follow-up|1|||
161101459|NCT02060721|581763031|FG000|Overall Study|Physician Decision|2|||
161101460|NCT02060721|581763031|FG000|Overall Study|Death|14|||
161101461|NCT02060721|581763031|FG000|Overall Study|Withdrawal by Subject|2|||
161101462|NCT02060721|581763031|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
161101463|NCT05105789|581763032|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
161101464|NCT00728481|581763036|FG000|Overall Study|Withdrawal by Subject|0|||
161101465|NCT00728481|581763037|FG001|Overall Study|Withdrawal by Subject|1|||
161101466|NCT00728481|581763036|FG000|Overall Study|Adverse Event|0|||
161101467|NCT00728481|581763037|FG001|Overall Study|Adverse Event|1|||
161101468|NCT00728481|581763036|FG000|Overall Study|Study medication non-compliance|0|||
161101469|NCT00728481|581763037|FG001|Overall Study|Study medication non-compliance|2|||
161101470|NCT00728481|581763036|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
161101471|NCT00728481|581763037|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
161101472|NCT03690141|581763038|FG000|Overall Study|Adverse Event|5|||
161101473|NCT03690141|581763038|FG000|Overall Study|Withdrawal by Subject|3|||
161101474|NCT03690141|581763038|FG000|Overall Study|Physician Decision|4|||
161101475|NCT03690141|581763038|FG000|Overall Study|Disease progression|4|||
161101476|NCT04744285|581763039|FG000|Overall Study|Withdrawal by Subject|1|||
161101477|NCT04744285|581763040|FG001|Overall Study|Withdrawal by Subject|1|||
161101478|NCT04744285|581763041|FG002|Overall Study|Withdrawal by Subject|2|||
161101479|NCT04744285|581763042|FG003|Overall Study|Withdrawal by Subject|1|||
161101480|NCT02558231|581763045|FG000|Overall Study|Death|4|||
161101481|NCT02558231|581763046|FG001|Overall Study|Death|12|||
161101482|NCT02558231|581763045|FG000|Overall Study|Lost to Follow-up|7|||
161101483|NCT02558231|581763046|FG001|Overall Study|Lost to Follow-up|4|||
161101484|NCT02558231|581763045|FG000|Overall Study|Withdrawal by Subject|7|||
161101485|NCT02558231|581763046|FG001|Overall Study|Withdrawal by Subject|4|||
161101486|NCT02558231|581763045|FG000|Overall Study|Physician Decision|7|||
161101487|NCT02558231|581763046|FG001|Overall Study|Physician Decision|5|||
161101488|NCT02558231|581763045|FG000|Overall Study|Sponsor Decision|0|||
161101489|NCT02558231|581763046|FG001|Overall Study|Sponsor Decision|1|||
161101490|NCT03933397|581763047|FG000|Overall Study|No emergency department visit|65|||
161101491|NCT03933397|581763048|FG001|Overall Study|No emergency department visit|71|||
161101492|NCT03933397|581763047|FG000|Overall Study|Missed emergency department visit|25|||
161101493|NCT03933397|581763048|FG001|Overall Study|Missed emergency department visit|30|||
161101494|NCT03933397|581763047|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
161101495|NCT03933397|581763048|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
161101496|NCT03933397|581763047|FG000|Overall Study|Withdrawal by Subject|1|||
161101497|NCT03933397|581763048|FG001|Overall Study|Withdrawal by Subject|0|||
161101498|NCT03933397|581763047|FG000|Overall Study|Physician Decision|1|||
161101499|NCT03933397|581763048|FG001|Overall Study|Physician Decision|1|||
161101500|NCT03933397|581763047|FG000|Overall Study|missing pain score|1|||
161101501|NCT03933397|581763048|FG001|Overall Study|missing pain score|1|||
161101502|NCT03933397|581763047|FG000|Overall Study|Confirmed COVID-19|1|||
161101503|NCT03933397|581763048|FG001|Overall Study|Confirmed COVID-19|2|||
161101504|NCT02066051|581763050|FG000|Overall Study|Subject developed active GVHD|1|||
161101505|NCT01610687|581763053|FG000|Overall Study|Lack of Efficacy|26|||
161101506|NCT01610687|581763053|FG000|Overall Study|Adverse Event|18|||
161101507|NCT01610687|581763053|FG000|Overall Study|Moved out of area|6|||
161101508|NCT01610687|581763053|FG000|Overall Study|Withdrawal by Subject|7|||
161101509|NCT01610687|581763053|FG000|Overall Study|Lost to Follow-up|4|||
161101510|NCT01610687|581763053|FG000|Overall Study|Symptom control without study medication|2|||
161101511|NCT01610687|581763053|FG000|Overall Study|Unable to make journey|1|||
161101512|NCT01610687|581763053|FG000|Overall Study|Death|1|||
161101513|NCT01610687|581763053|FG000|Overall Study|Cannabis affecting job|1|||
161101514|NCT01610687|581763053|FG000|Overall Study|Felt more alter without study medication|1|||
161101515|NCT01272947|581763054|FG000|Overall Study|Abnormal Laboratory Value|2|||
161101516|NCT01272947|581763055|FG001|Overall Study|Abnormal Laboratory Value|2|||
161101517|NCT03675776|581763056|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
161101518|NCT03675776|581763057|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
161339972|NCT00042289|582633448|FG044|Overall Study|Other reason|0|||
161101519|NCT03675776|581763058|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
161101520|NCT03675776|581763056|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
161101521|NCT03675776|581763057|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161101522|NCT03675776|581763058|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161101523|NCT06132425|581763059|FG000|Overall Study|Withdrawal by Subject|3|||
161101524|NCT06132425|581763060|FG001|Overall Study|Withdrawal by Subject|0|||
161101525|NCT06132425|581763059|FG000|Overall Study|Did not follow study instructions|0|||
161339973|NCT00042289|582633449|FG045|Overall Study|Other reason|0|||
161339974|NCT00042289|582633450|FG046|Overall Study|Other reason|0|||
161101526|NCT06132425|581763060|FG001|Overall Study|Did not follow study instructions|2|||
161101527|NCT06132425|581763059|FG000|Overall Study|Lost to Follow-up|3|||
161101528|NCT06132425|581763060|FG001|Overall Study|Lost to Follow-up|5|||
161101529|NCT00671554|581763066|FG000|Overall Study|Disease progression|3|||
161101530|NCT00708175|581763074|FG000|Overall Study|Adverse Event|4|||
161101531|NCT00708175|581763075|FG001|Overall Study|Adverse Event|5|||
161101532|NCT00708175|581763074|FG000|Overall Study|Protocol Violation|2|||
161101533|NCT00708175|581763075|FG001|Overall Study|Protocol Violation|3|||
161101534|NCT00708175|581763074|FG000|Overall Study|Lost to Follow-up|5|||
161101535|NCT00708175|581763075|FG001|Overall Study|Lost to Follow-up|3|||
161101536|NCT00708175|581763074|FG000|Overall Study|Withdrawal by Subject|5|||
161101537|NCT00708175|581763075|FG001|Overall Study|Withdrawal by Subject|7|||
161101538|NCT00708175|581763074|FG000|Overall Study|BMD loss >7%|2|||
161101539|NCT00708175|581763075|FG001|Overall Study|BMD loss >7%|3|||
161101540|NCT04435782|581763077|FG000|Overall Study|Study terminated by sponsor|4|||
161101541|NCT04667247|581763078|FG000|Overall Study|Withdrawal by Subject|0|||
161101542|NCT04667247|581763079|FG001|Overall Study|Withdrawal by Subject|1|||
161101543|NCT01876251|581765010|FG000|Overall Study|Clinical progression|1|||
161101544|NCT01876251|581765011|FG001|Overall Study|Clinical progression|0|||
161101545|NCT01876251|581765012|FG002|Overall Study|Clinical progression|0|||
161101546|NCT01876251|581765010|FG000|Overall Study|Death|2|||
161101547|NCT01876251|581765011|FG001|Overall Study|Death|0|||
161101548|NCT01876251|581765012|FG002|Overall Study|Death|1|||
161101549|NCT01876251|581765010|FG000|Overall Study|Participant started new treatment|1|||
161101550|NCT01876251|581765011|FG001|Overall Study|Participant started new treatment|0|||
161101551|NCT01876251|581765012|FG002|Overall Study|Participant started new treatment|1|||
161101552|NCT01876251|581765010|FG000|Overall Study|Participant refused further follow-up|0|||
161101553|NCT01876251|581765011|FG001|Overall Study|Participant refused further follow-up|0|||
161101554|NCT01876251|581765012|FG002|Overall Study|Participant refused further follow-up|1|||
161101555|NCT01876251|581765010|FG000|Overall Study|Study terminated|1|||
161101556|NCT01876251|581765011|FG001|Overall Study|Study terminated|0|||
161101557|NCT01876251|581765012|FG002|Overall Study|Study terminated|0|||
161101558|NCT01876251|581765010|FG000|Overall Study|Objective progression or relapse|10|||
161101559|NCT01876251|581765011|FG001|Overall Study|Objective progression or relapse|3|||
161101560|NCT01876251|581765012|FG002|Overall Study|Objective progression or relapse|8|||
161101561|NCT01798992|581765025|FG000|Overall Study|Administrative withdrawal|0|||
161101562|NCT01798992|581765026|FG001|Overall Study|Administrative withdrawal|1|||
161101563|NCT01798992|581765027|FG002|Overall Study|Administrative withdrawal|0|||
161101564|NCT01798992|581765028|FG003|Overall Study|Administrative withdrawal|1|||
161101565|NCT01798992|581765025|FG000|Overall Study|Lost to Follow-up|0|||
161101566|NCT01798992|581765026|FG001|Overall Study|Lost to Follow-up|1|||
161101567|NCT01798992|581765027|FG002|Overall Study|Lost to Follow-up|1|||
161101568|NCT01798992|581765028|FG003|Overall Study|Lost to Follow-up|0|||
161101569|NCT01798992|581765025|FG000|Overall Study|Insufficient biopsy tissue|0|||
161101570|NCT01798992|581765026|FG001|Overall Study|Insufficient biopsy tissue|0|||
161101571|NCT01798992|581765027|FG002|Overall Study|Insufficient biopsy tissue|1|||
161101572|NCT01798992|581765028|FG003|Overall Study|Insufficient biopsy tissue|0|||
161101573|NCT01069120|581765029|FG000|Overall Study|Study prematurely terminated|27|||
161101574|NCT02294682|581765030|FG000|Overall Study|Could not swallow pills|1|||
161101575|NCT02294682|581765031|FG001|Overall Study|Could not swallow pills|0|||
161101576|NCT01516970|581765032|FG000|Overall Study|Lost to Follow-up|7|||
161101577|NCT01516970|581765033|FG001|Overall Study|Lost to Follow-up|8|||
161101578|NCT01516970|581765032|FG000|Overall Study|Adverse Event|1|||
161101579|NCT01516970|581765033|FG001|Overall Study|Adverse Event|5|||
161101580|NCT01516970|581765032|FG000|Overall Study|Withdrawal by Subject|1|||
161101581|NCT01516970|581765033|FG001|Overall Study|Withdrawal by Subject|1|||
161101582|NCT01516970|581765032|FG000|Overall Study|Other|9|||
161101583|NCT01516970|581765033|FG001|Overall Study|Other|7|||
161101584|NCT00434421|581765034|FG000|Overall Study|Withdrawal by Subject|1|||
161101585|NCT00434421|581765034|FG000|Overall Study|Non-compliance with study treatment|1|||
161101586|NCT01301456|581765035|FG000|Stage 1|Withdrawal by Subject|0|||
161101587|NCT01301456|581765036|FG001|Stage 1|Withdrawal by Subject|0|||
161101588|NCT01301456|581765037|FG002|Stage 1|Withdrawal by Subject|1|||
161101589|NCT01301456|581765038|FG003|Stage 1|Withdrawal by Subject|0|||
161101590|NCT01301456|581765039|FG004|Stage 1|Withdrawal by Subject|1|||
161101591|NCT01301456|581765040|FG005|Stage 1|Withdrawal by Subject|0|||
161101592|NCT01301456|581765041|FG006|Stage 1|Withdrawal by Subject|0|||
161101593|NCT01301456|581765042|FG007|Stage 1|Withdrawal by Subject|0|||
161101594|NCT01301456|581765043|FG008|Stage 1|Withdrawal by Subject|0|||
161101595|NCT01301456|581765044|FG009|Stage 1|Withdrawal by Subject|0|||
161101596|NCT01301456|581765045|FG010|Stage 1|Withdrawal by Subject|0|||
161101597|NCT01301456|581765046|FG011|Stage 1|Withdrawal by Subject|0|||
161101598|NCT01301456|581765035|FG000|Stage 1|Randomized but not treated|0|||
161101599|NCT01301456|581765036|FG001|Stage 1|Randomized but not treated|0|||
161101600|NCT01301456|581765037|FG002|Stage 1|Randomized but not treated|0|||
161101601|NCT01301456|581765038|FG003|Stage 1|Randomized but not treated|0|||
161101602|NCT01301456|581765039|FG004|Stage 1|Randomized but not treated|0|||
161101603|NCT01301456|581765040|FG005|Stage 1|Randomized but not treated|0|||
161101604|NCT01301456|581765041|FG006|Stage 1|Randomized but not treated|1|||
161101605|NCT01301456|581765042|FG007|Stage 1|Randomized but not treated|0|||
161101606|NCT01301456|581765043|FG008|Stage 1|Randomized but not treated|0|||
161101607|NCT01301456|581765044|FG009|Stage 1|Randomized but not treated|0|||
161101608|NCT01301456|581765045|FG010|Stage 1|Randomized but not treated|0|||
161101609|NCT01301456|581765046|FG011|Stage 1|Randomized but not treated|0|||
161101610|NCT01301456|581765035|FG000|Stage 2|Adverse Event|0|||
161101611|NCT01301456|581765036|FG001|Stage 2|Adverse Event|0|||
161101612|NCT01301456|581765037|FG002|Stage 2|Adverse Event|0|||
161101613|NCT01301456|581765038|FG003|Stage 2|Adverse Event|0|||
161101614|NCT01301456|581765039|FG004|Stage 2|Adverse Event|0|||
161101615|NCT01301456|581765040|FG005|Stage 2|Adverse Event|0|||
161101616|NCT01301456|581765041|FG006|Stage 2|Adverse Event|0|||
161101617|NCT01301456|581765042|FG007|Stage 2|Adverse Event|0|||
161101618|NCT01301456|581765043|FG008|Stage 2|Adverse Event|0|||
161101619|NCT01301456|581765044|FG009|Stage 2|Adverse Event|0|||
161101620|NCT01301456|581765045|FG010|Stage 2|Adverse Event|1|||
161101621|NCT01301456|581765046|FG011|Stage 2|Adverse Event|0|||
161101622|NCT01399190|581765049|FG000|Overall Study|Not Eligible for Final Analysis|5|||
161101623|NCT01399190|581765049|FG000|Overall Study|Adverse Event|8|||
161101624|NCT01399190|581765049|FG000|Overall Study|Participant's Request|5|||
161101625|NCT01399190|581765049|FG000|Overall Study|Physician Decision|2|||
161101626|NCT03239483|581765050|FG000|Overall Study|Lost to Follow-up|1|||
161101627|NCT03239483|581765051|FG001|Overall Study|Lost to Follow-up|0|||
161101628|NCT03239483|581765050|FG000|Overall Study|Withdrawal by Subject|1|||
161101629|NCT03239483|581765051|FG001|Overall Study|Withdrawal by Subject|0|||
161101630|NCT03678103|581765052|FG000|Overall Study|Withdrawn prior to completion|4|||
161101631|NCT00381563|581765055|FG000|Overall Study|Withdrawal by Subject|5|||
161101632|NCT00381563|581765056|FG001|Overall Study|Withdrawal by Subject|5|||
161101633|NCT00381563|581765055|FG000|Overall Study|Lost to Follow-up|2|||
161101634|NCT00381563|581765056|FG001|Overall Study|Lost to Follow-up|0|||
161101635|NCT00381563|581765055|FG000|Overall Study|Protocol Violation|0|||
161101636|NCT00381563|581765056|FG001|Overall Study|Protocol Violation|1|||
161101637|NCT05372653|581765062|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
161101638|NCT05372653|581765063|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
161101639|NCT05372653|581765062|FG000|Overall Study|Adverse Event|0|||
161101640|NCT05372653|581765063|FG001|Overall Study|Adverse Event|1|||
161101641|NCT00117507|581765064|FG000|Overall Study|Adverse Event|4|||
161101642|NCT00117507|581765064|FG000|Overall Study|Abnormal laboratory values|3|||
161101643|NCT00117507|581765064|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161101644|NCT00117507|581765064|FG000|Overall Study|Patient withdrew consent|4|||
161101645|NCT00117507|581765064|FG000|Overall Study|Death|3|||
161101646|NCT00866723|581765065|FG000|Overall Study|Withdrawal by Subject|1|||
161101647|NCT00866723|581765065|FG000|Overall Study|Disease Progression|4|||
161101648|NCT03740997|581765068|FG000|Overall Study|Withdrawal by Subject|1|||
161101649|NCT03740997|581765069|FG001|Overall Study|Withdrawal by Subject|0|||
161101650|NCT03740997|581765068|FG000|Overall Study|Participant was unable to complete study procedures|1|||
161101651|NCT03740997|581765069|FG001|Overall Study|Participant was unable to complete study procedures|0|||
161101652|NCT01003990|581765070|FG000|Overall Study|Adverse Event|8|||
161101653|NCT01003990|581765071|FG001|Overall Study|Adverse Event|5|||
161101654|NCT01003990|581765072|FG002|Overall Study|Adverse Event|11|||
161101655|NCT01003990|581765070|FG000|Overall Study|Death|0|||
161101656|NCT01003990|581765071|FG001|Overall Study|Death|8|||
161101657|NCT01003990|581765072|FG002|Overall Study|Death|1|||
161101658|NCT01003990|581765070|FG000|Overall Study|Lack of Efficacy|10|||
161101659|NCT01003990|581765071|FG001|Overall Study|Lack of Efficacy|2|||
161101660|NCT01003990|581765072|FG002|Overall Study|Lack of Efficacy|3|||
161101661|NCT01003990|581765070|FG000|Overall Study|Lost to Follow-up|30|||
161101662|NCT01003990|581765071|FG001|Overall Study|Lost to Follow-up|12|||
161101663|NCT01003990|581765072|FG002|Overall Study|Lost to Follow-up|7|||
161101664|NCT01003990|581765070|FG000|Overall Study|Reasons Not Identified|14|||
161101665|NCT01003990|581765071|FG001|Overall Study|Reasons Not Identified|13|||
161101666|NCT01003990|581765072|FG002|Overall Study|Reasons Not Identified|8|||
161101667|NCT01003990|581765070|FG000|Overall Study|Poor/Non-compliance|4|||
161101668|NCT01003990|581765071|FG001|Overall Study|Poor/Non-compliance|3|||
161101669|NCT01003990|581765072|FG002|Overall Study|Poor/Non-compliance|2|||
161101670|NCT01003990|581765070|FG000|Overall Study|Pregnancy|10|||
161101671|NCT01003990|581765071|FG001|Overall Study|Pregnancy|2|||
161101672|NCT01003990|581765072|FG002|Overall Study|Pregnancy|4|||
161101673|NCT01003990|581765070|FG000|Overall Study|No Longer Met Study Criteria|4|||
161101674|NCT01003990|581765071|FG001|Overall Study|No Longer Met Study Criteria|1|||
161101675|NCT01003990|581765072|FG002|Overall Study|No Longer Met Study Criteria|0|||
161101676|NCT01003990|581765070|FG000|Overall Study|Subject Withdrew Consent|12|||
161101677|NCT01003990|581765071|FG001|Overall Study|Subject Withdrew Consent|5|||
161101678|NCT01003990|581765072|FG002|Overall Study|Subject Withdrew Consent|7|||
161101679|NCT01271803|581765073|FG000|Overall Study|Progressive disease|0|||
161101680|NCT01271803|581765074|FG001|Overall Study|Progressive disease|0|||
161101681|NCT01271803|581765075|FG002|Overall Study|Progressive disease|2|||
161101682|NCT01271803|581765073|FG000|Overall Study|Death|53|||
161101683|NCT01271803|581765074|FG001|Overall Study|Death|34|||
161101684|NCT01271803|581765075|FG002|Overall Study|Death|0|||
161101685|NCT01271803|581765073|FG000|Overall Study|Withdrawal by Subject|1|||
161101686|NCT01271803|581765074|FG001|Overall Study|Withdrawal by Subject|5|||
161101687|NCT01271803|581765075|FG002|Overall Study|Withdrawal by Subject|0|||
161101688|NCT01271803|581765073|FG000|Overall Study|Lost to Follow-up|1|||
161101689|NCT01271803|581765074|FG001|Overall Study|Lost to Follow-up|0|||
161101690|NCT01271803|581765075|FG002|Overall Study|Lost to Follow-up|0|||
161101691|NCT04178967|581765076|FG000|Induction Period|Adverse Event|4|||
161101692|NCT04178967|581765077|FG001|Induction Period|Adverse Event|6|||
161101693|NCT04178967|581765078|FG002|Induction Period|Adverse Event|0|||
161101694|NCT04178967|581765079|FG003|Induction Period|Adverse Event|0|||
161101695|NCT04178967|581765080|FG004|Induction Period|Adverse Event|0|||
161101696|NCT04178967|581765081|FG005|Induction Period|Adverse Event|0|||
161101697|NCT04178967|581765082|FG006|Induction Period|Adverse Event|0|||
161101698|NCT04178967|581765083|FG007|Induction Period|Adverse Event|0|||
161101699|NCT04178967|581765084|FG008|Induction Period|Adverse Event|0|||
161101700|NCT04178967|581765085|FG009|Induction Period|Adverse Event|0|||
161101701|NCT04178967|581765086|FG010|Induction Period|Adverse Event|0|||
161101702|NCT04178967|581765076|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
161101703|NCT04178967|581765077|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
161101704|NCT04178967|581765078|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
161101705|NCT04178967|581765079|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
161101706|NCT04178967|581765080|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
161101707|NCT04178967|581765081|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
161101708|NCT04178967|581765082|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
161101709|NCT04178967|581765083|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
161101710|NCT04178967|581765084|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
161101711|NCT04178967|581765085|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
161101712|NCT04178967|581765086|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
161101713|NCT04178967|581765076|FG000|Induction Period|Lack of Efficacy|4|||
161101714|NCT04178967|581765077|FG001|Induction Period|Lack of Efficacy|1|||
161101715|NCT04178967|581765078|FG002|Induction Period|Lack of Efficacy|0|||
161101716|NCT04178967|581765079|FG003|Induction Period|Lack of Efficacy|0|||
161101717|NCT04178967|581765080|FG004|Induction Period|Lack of Efficacy|0|||
161101718|NCT04178967|581765081|FG005|Induction Period|Lack of Efficacy|0|||
161101719|NCT04178967|581765082|FG006|Induction Period|Lack of Efficacy|0|||
161101720|NCT04178967|581765083|FG007|Induction Period|Lack of Efficacy|0|||
161101721|NCT04178967|581765084|FG008|Induction Period|Lack of Efficacy|0|||
161101722|NCT04178967|581765085|FG009|Induction Period|Lack of Efficacy|0|||
161101723|NCT04178967|581765086|FG010|Induction Period|Lack of Efficacy|0|||
161101724|NCT04178967|581765076|FG000|Induction Period|Protocol Violation|0|||
161101725|NCT04178967|581765077|FG001|Induction Period|Protocol Violation|6|||
161101726|NCT04178967|581765078|FG002|Induction Period|Protocol Violation|0|||
161101727|NCT04178967|581765079|FG003|Induction Period|Protocol Violation|0|||
161101728|NCT04178967|581765080|FG004|Induction Period|Protocol Violation|0|||
161101729|NCT04178967|581765081|FG005|Induction Period|Protocol Violation|0|||
161101730|NCT04178967|581765082|FG006|Induction Period|Protocol Violation|0|||
161101731|NCT04178967|581765083|FG007|Induction Period|Protocol Violation|0|||
161101732|NCT04178967|581765084|FG008|Induction Period|Protocol Violation|0|||
161101733|NCT04178967|581765085|FG009|Induction Period|Protocol Violation|0|||
161101734|NCT04178967|581765086|FG010|Induction Period|Protocol Violation|0|||
161101735|NCT04178967|581765076|FG000|Induction Period|Withdrawal by Subject|6|||
161101736|NCT04178967|581765077|FG001|Induction Period|Withdrawal by Subject|4|||
161101737|NCT04178967|581765078|FG002|Induction Period|Withdrawal by Subject|0|||
161101738|NCT04178967|581765079|FG003|Induction Period|Withdrawal by Subject|0|||
161101739|NCT04178967|581765080|FG004|Induction Period|Withdrawal by Subject|0|||
161101740|NCT04178967|581765081|FG005|Induction Period|Withdrawal by Subject|0|||
161101741|NCT04178967|581765082|FG006|Induction Period|Withdrawal by Subject|0|||
161101742|NCT04178967|581765083|FG007|Induction Period|Withdrawal by Subject|0|||
161101743|NCT04178967|581765084|FG008|Induction Period|Withdrawal by Subject|0|||
161101744|NCT04178967|581765085|FG009|Induction Period|Withdrawal by Subject|0|||
161101745|NCT04178967|581765086|FG010|Induction Period|Withdrawal by Subject|0|||
161101746|NCT04178967|581765076|FG000|Induction Period|Lost to Follow-up|2|||
161101747|NCT04178967|581765077|FG001|Induction Period|Lost to Follow-up|0|||
161101748|NCT04178967|581765078|FG002|Induction Period|Lost to Follow-up|0|||
161101749|NCT04178967|581765079|FG003|Induction Period|Lost to Follow-up|0|||
161101750|NCT04178967|581765080|FG004|Induction Period|Lost to Follow-up|0|||
161101751|NCT04178967|581765081|FG005|Induction Period|Lost to Follow-up|0|||
161101752|NCT04178967|581765082|FG006|Induction Period|Lost to Follow-up|0|||
161101753|NCT04178967|581765083|FG007|Induction Period|Lost to Follow-up|0|||
161101754|NCT04178967|581765084|FG008|Induction Period|Lost to Follow-up|0|||
161101755|NCT04178967|581765085|FG009|Induction Period|Lost to Follow-up|0|||
161101756|NCT04178967|581765086|FG010|Induction Period|Lost to Follow-up|0|||
161101757|NCT04178967|581765076|FG000|Induction Period|Participant Missed Study Visits|0|||
161101758|NCT04178967|581765077|FG001|Induction Period|Participant Missed Study Visits|1|||
161101759|NCT04178967|581765078|FG002|Induction Period|Participant Missed Study Visits|0|||
161101760|NCT04178967|581765079|FG003|Induction Period|Participant Missed Study Visits|0|||
161101761|NCT04178967|581765080|FG004|Induction Period|Participant Missed Study Visits|0|||
161101762|NCT04178967|581765081|FG005|Induction Period|Participant Missed Study Visits|0|||
161101763|NCT04178967|581765082|FG006|Induction Period|Participant Missed Study Visits|0|||
161101764|NCT04178967|581765083|FG007|Induction Period|Participant Missed Study Visits|0|||
161101765|NCT04178967|581765084|FG008|Induction Period|Participant Missed Study Visits|0|||
161101766|NCT04178967|581765085|FG009|Induction Period|Participant Missed Study Visits|0|||
161101767|NCT04178967|581765086|FG010|Induction Period|Participant Missed Study Visits|0|||
161101768|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101769|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101770|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101771|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101772|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101773|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
161101774|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
161101775|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
161101776|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101777|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101778|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
161101779|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101780|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101781|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101782|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101783|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101784|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
161101785|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101786|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101787|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101788|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101789|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161101790|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101791|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101792|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101793|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161101794|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101795|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101796|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101797|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101798|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101799|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101800|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161101801|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101802|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101803|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101804|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101805|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101806|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101807|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
161101808|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101809|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101810|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101811|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
161101812|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101813|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101814|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101815|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101816|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
161101817|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
161101818|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101819|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
161101820|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101821|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101822|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161101823|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161101824|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161101825|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161101826|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161101827|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161101828|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
161101829|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
161101830|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
161101831|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161101832|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161101833|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
161101834|NCT04178967|581765076|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101835|NCT04178967|581765077|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101836|NCT04178967|581765078|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101837|NCT04178967|581765079|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161101838|NCT04178967|581765080|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101839|NCT04178967|581765081|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
161101840|NCT04178967|581765082|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161101841|NCT04178967|581765083|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
161101842|NCT04178967|581765084|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101843|NCT04178967|581765085|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101844|NCT04178967|581765086|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161101845|NCT04178967|581765076|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101846|NCT04178967|581765077|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101847|NCT04178967|581765078|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101848|NCT04178967|581765079|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101849|NCT04178967|581765080|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101850|NCT04178967|581765081|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101851|NCT04178967|581765082|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101852|NCT04178967|581765083|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101853|NCT04178967|581765084|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
161101854|NCT04178967|581765085|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
161101855|NCT04178967|581765086|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161101856|NCT04178967|581765076|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101857|NCT04178967|581765077|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101858|NCT04178967|581765078|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101859|NCT04178967|581765079|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101860|NCT04178967|581765080|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101861|NCT04178967|581765081|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101862|NCT04178967|581765082|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101863|NCT04178967|581765083|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161101864|NCT04178967|581765084|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
161101865|NCT04178967|581765085|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
161101866|NCT04178967|581765086|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
161101867|NCT04178967|581765076|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101868|NCT04178967|581765077|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101869|NCT04178967|581765078|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101870|NCT04178967|581765079|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101871|NCT04178967|581765080|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101872|NCT04178967|581765081|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101873|NCT04178967|581765082|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101874|NCT04178967|581765083|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101875|NCT04178967|581765084|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101876|NCT04178967|581765085|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
161101877|NCT04178967|581765086|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161101878|NCT04178967|581765076|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101879|NCT04178967|581765077|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101880|NCT04178967|581765078|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101881|NCT04178967|581765079|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101882|NCT04178967|581765080|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101883|NCT04178967|581765081|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101884|NCT04178967|581765082|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101885|NCT04178967|581765083|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161101886|NCT04178967|581765084|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
161101887|NCT04178967|581765085|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
161101888|NCT04178967|581765086|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161101889|NCT04178967|581765076|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101890|NCT04178967|581765077|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101891|NCT04178967|581765078|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101892|NCT04178967|581765079|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101893|NCT04178967|581765080|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101894|NCT04178967|581765081|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101895|NCT04178967|581765082|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101896|NCT04178967|581765083|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101897|NCT04178967|581765084|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101898|NCT04178967|581765085|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
161101899|NCT04178967|581765086|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
161101900|NCT04178967|581765076|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101901|NCT04178967|581765077|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101902|NCT04178967|581765078|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101903|NCT04178967|581765079|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101904|NCT04178967|581765080|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101905|NCT04178967|581765081|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101906|NCT04178967|581765082|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101907|NCT04178967|581765083|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101908|NCT04178967|581765084|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101909|NCT04178967|581765085|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
161101910|NCT04178967|581765086|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
161101911|NCT05211739|581765087|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
161101912|NCT05211739|581765088|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
161101913|NCT05211739|581765087|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
161101914|NCT05211739|581765088|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
161101915|NCT05211739|581765087|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
161101916|NCT05211739|581765088|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
161101917|NCT05211739|581765087|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
161101918|NCT05211739|581765088|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
161101919|NCT01975428|581765092|FG000|Overall Study|Lost to Follow-up|17|||
161101920|NCT01975428|581765093|FG001|Overall Study|Lost to Follow-up|4|||
161101921|NCT01975428|581765092|FG000|Overall Study|Withdrawal by Subject|3|||
161101922|NCT01975428|581765093|FG001|Overall Study|Withdrawal by Subject|10|||
161101923|NCT02187809|581765094|FG000|Overall Study|The study was terminated|3|||
161101924|NCT00628251|581765095|FG000|Randomised Part|Withdrawal by Subject|0|||
161101925|NCT00628251|581765096|FG001|Randomised Part|Withdrawal by Subject|0|||
161101926|NCT00628251|581765097|FG002|Randomised Part|Withdrawal by Subject|1|||
161101927|NCT00628251|581765095|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
161101928|NCT00628251|581765096|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
161101929|NCT00628251|581765097|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
161101930|NCT00628251|581765095|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
161101931|NCT00628251|581765096|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
161101932|NCT00628251|581765097|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
161101933|NCT00628251|581765095|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
161101934|NCT00628251|581765096|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
161101935|NCT00628251|581765097|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
161101936|NCT00628251|581765095|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
161101937|NCT00628251|581765096|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
161101938|NCT00628251|581765097|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
161101939|NCT00628251|581765095|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
161101940|NCT00628251|581765096|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
161101941|NCT00628251|581765097|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
161101942|NCT01505010|581765098|FG000|Overall Study|Protocol Violation|0|||
161101943|NCT01505010|581765099|FG001|Overall Study|Protocol Violation|1|||
161101944|NCT01505010|581765098|FG000|Overall Study|Lost to Follow-up|0|||
161101945|NCT01505010|581765099|FG001|Overall Study|Lost to Follow-up|1|||
161101946|NCT00995007|581765104|FG000|Overall Study|Withdrew consent|1|||
161101947|NCT00995007|581765105|FG001|Overall Study|Withdrew consent|0|||
161101948|NCT00995007|581765104|FG000|Overall Study|Refused further treatment|8|||
161101949|NCT00995007|581765105|FG001|Overall Study|Refused further treatment|2|||
161101950|NCT00995007|581765104|FG000|Overall Study|Toxicity|8|||
161101951|NCT00995007|581765105|FG001|Overall Study|Toxicity|0|||
161101952|NCT01294150|581765108|FG000|Overall Study|Physician Decision|2|||
161101953|NCT01294150|581765109|FG001|Overall Study|Physician Decision|2|||
161101954|NCT01093625|581765110|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
161101955|NCT01093625|581765111|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
161101956|NCT01093625|581765110|FG000|2-Week Visit|Withdrawal by Subject|1|||
161101957|NCT01093625|581765111|FG001|2-Week Visit|Withdrawal by Subject|0|||
161101958|NCT01093625|581765110|FG000|1-Month Visit|Lost to Follow-up|2|||
161101959|NCT01093625|581765111|FG001|1-Month Visit|Lost to Follow-up|0|||
161101960|NCT01093625|581765110|FG000|3-Month Visit|Lost to Follow-up|2|||
161101961|NCT01093625|581765111|FG001|3-Month Visit|Lost to Follow-up|0|||
161101962|NCT01093625|581765110|FG000|6-Month Visit|Withdrawal by Subject|6|||
161101963|NCT01093625|581765111|FG001|6-Month Visit|Withdrawal by Subject|7|||
161101964|NCT01093625|581765110|FG000|6-Month Visit|Lost to Follow-up|2|||
161101965|NCT01093625|581765111|FG001|6-Month Visit|Lost to Follow-up|2|||
161101966|NCT01093625|581765110|FG000|1-Year Visit|Lost to Follow-up|5|||
161101967|NCT01093625|581765111|FG001|1-Year Visit|Lost to Follow-up|3|||
161212375|NCT01677910|582160100|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161101968|NCT00698932|581765112|FG000|Overall Study|Adverse Event|0|||
161101969|NCT00698932|581765113|FG001|Overall Study|Adverse Event|2|||
161101970|NCT00698932|581765112|FG000|Overall Study|Incorrect enrollment|0|||
161101971|NCT00698932|581765113|FG001|Overall Study|Incorrect enrollment|2|||
161101972|NCT00698932|581765112|FG000|Overall Study|Study specific discontinuation criteria|3|||
161101973|NCT00698932|581765113|FG001|Overall Study|Study specific discontinuation criteria|4|||
161101974|NCT00698932|581765112|FG000|Overall Study|Withdrawal by Subject|11|||
161101975|NCT00698932|581765113|FG001|Overall Study|Withdrawal by Subject|23|||
161101976|NCT00698932|581765112|FG000|Overall Study|Lost to Follow-up|6|||
161101977|NCT00698932|581765113|FG001|Overall Study|Lost to Follow-up|1|||
161101978|NCT00698932|581765112|FG000|Overall Study|Severe non-compliance to protocol|1|||
161101979|NCT00698932|581765113|FG001|Overall Study|Severe non-compliance to protocol|2|||
161101980|NCT00698932|581765112|FG000|Overall Study|Safety reasons|0|||
161101981|NCT00698932|581765113|FG001|Overall Study|Safety reasons|2|||
161101982|NCT00698932|581765112|FG000|Overall Study|Death|1|||
161101983|NCT00698932|581765113|FG001|Overall Study|Death|0|||
161101984|NCT01245387|581765114|FG000|Overall Study|Lost to Follow-up|106|||
161101985|NCT01245387|581765114|FG000|Overall Study|Lack of Efficacy|195|||
161101986|NCT01245387|581765114|FG000|Overall Study|Adverse Event|9|||
161101987|NCT01245387|581765114|FG000|Overall Study|Death|3|||
161101988|NCT01245387|581765114|FG000|Overall Study|Other|131|||
161101989|NCT01245387|581765114|FG000|Overall Study|Missing discontinuation status|369|||
161101990|NCT00601705|581765115|FG000|Overall Study|Withdrawal by Subject|1|||
161101991|NCT04513665|581765116|FG000|Overall Study|Adverse Event|2|||
161101992|NCT04513665|581765117|FG001|Overall Study|Adverse Event|0|||
161101993|NCT04513665|581765116|FG000|Overall Study|Lack of Efficacy|14|||
161101994|NCT04513665|581765117|FG001|Overall Study|Lack of Efficacy|0|||
161101995|NCT02608879|581765121|FG000|Overall Study|Lost to Follow-up|1|||
161101996|NCT02608879|581765122|FG001|Overall Study|Lost to Follow-up|0|||
161101997|NCT02608879|581765123|FG002|Overall Study|Lost to Follow-up|0|||
161101998|NCT02608879|581765121|FG000|Overall Study|Did not meet continuation criteria|0|||
161101999|NCT02608879|581765122|FG001|Overall Study|Did not meet continuation criteria|0|||
161102000|NCT02608879|581765123|FG002|Overall Study|Did not meet continuation criteria|3|||
161102001|NCT04246801|581765124|FG000|Overall Study|Adverse Event|1|||
161102002|NCT04246801|581765125|FG001|Overall Study|Adverse Event|1|||
161102003|NCT04246801|581765124|FG000|Overall Study|Protocol Violation|1|||
161102004|NCT04246801|581765125|FG001|Overall Study|Protocol Violation|1|||
161102005|NCT04246801|581765124|FG000|Overall Study|Lack of Efficacy|0|||
161102006|NCT04246801|581765125|FG001|Overall Study|Lack of Efficacy|2|||
161102007|NCT04246801|581765124|FG000|Overall Study|Lost to Follow-up|1|||
161102008|NCT04246801|581765125|FG001|Overall Study|Lost to Follow-up|1|||
161102009|NCT04246801|581765124|FG000|Overall Study|Withdrawal by Subject|2|||
161102010|NCT04246801|581765125|FG001|Overall Study|Withdrawal by Subject|1|||
161102011|NCT01368042|581765129|FG000|Overall Study|Death|14|||
161102012|NCT01368042|581765129|FG000|Overall Study|Protocol Violation|11|||
161102013|NCT01368042|581765129|FG000|Overall Study|Lost to Follow-up|4|||
161102014|NCT01368042|581765129|FG000|Overall Study|Transplanted|1|||
161102015|NCT01621542|581765130|FG000|Overall Study|Adverse Event|0|||
161102016|NCT01621542|581765131|FG001|Overall Study|Adverse Event|0|||
161102017|NCT01621542|581765132|FG002|Overall Study|Adverse Event|1|||
161102018|NCT01621542|581765133|FG003|Overall Study|Adverse Event|3|||
161102019|NCT01621542|581765134|FG004|Overall Study|Adverse Event|0|||
161102020|NCT01621542|581765135|FG005|Overall Study|Adverse Event|0|||
161102021|NCT01621542|581765130|FG000|Overall Study|Death|0|||
161102022|NCT01621542|581765131|FG001|Overall Study|Death|1|||
161102023|NCT01621542|581765132|FG002|Overall Study|Death|0|||
161102024|NCT01621542|581765133|FG003|Overall Study|Death|0|||
161102025|NCT01621542|581765134|FG004|Overall Study|Death|0|||
161102026|NCT01621542|581765135|FG005|Overall Study|Death|0|||
161102027|NCT01621542|581765130|FG000|Overall Study|Physician Decision|1|||
161102028|NCT01621542|581765131|FG001|Overall Study|Physician Decision|0|||
161102029|NCT01621542|581765132|FG002|Overall Study|Physician Decision|1|||
161102030|NCT01621542|581765133|FG003|Overall Study|Physician Decision|13|||
161102031|NCT01621542|581765134|FG004|Overall Study|Physician Decision|3|||
161102032|NCT01621542|581765135|FG005|Overall Study|Physician Decision|1|||
161102033|NCT01621542|581765130|FG000|Overall Study|Withdrawal by Subject|2|||
161102034|NCT01621542|581765131|FG001|Overall Study|Withdrawal by Subject|0|||
161102035|NCT01621542|581765132|FG002|Overall Study|Withdrawal by Subject|1|||
161102036|NCT01621542|581765133|FG003|Overall Study|Withdrawal by Subject|3|||
161102037|NCT01621542|581765134|FG004|Overall Study|Withdrawal by Subject|3|||
161102038|NCT01621542|581765135|FG005|Overall Study|Withdrawal by Subject|3|||
161102039|NCT01621542|581765130|FG000|Overall Study|progression/treatment failure|2|||
161102040|NCT01621542|581765131|FG001|Overall Study|progression/treatment failure|4|||
161102041|NCT01621542|581765132|FG002|Overall Study|progression/treatment failure|3|||
161102042|NCT01621542|581765133|FG003|Overall Study|progression/treatment failure|7|||
161102043|NCT01621542|581765134|FG004|Overall Study|progression/treatment failure|3|||
161102044|NCT01621542|581765135|FG005|Overall Study|progression/treatment failure|5|||
161102045|NCT01621542|581765130|FG000|Overall Study|Protocol Violation|0|||
161102046|NCT01621542|581765131|FG001|Overall Study|Protocol Violation|0|||
161102047|NCT01621542|581765132|FG002|Overall Study|Protocol Violation|0|||
161102048|NCT01621542|581765133|FG003|Overall Study|Protocol Violation|1|||
161102049|NCT01621542|581765134|FG004|Overall Study|Protocol Violation|0|||
161102050|NCT01621542|581765135|FG005|Overall Study|Protocol Violation|0|||
161102051|NCT01621542|581765130|FG000|Overall Study|study stopped by sponsor|0|||
161102052|NCT01621542|581765131|FG001|Overall Study|study stopped by sponsor|0|||
161102053|NCT01621542|581765132|FG002|Overall Study|study stopped by sponsor|0|||
161102054|NCT01621542|581765133|FG003|Overall Study|study stopped by sponsor|1|||
161102055|NCT01621542|581765134|FG004|Overall Study|study stopped by sponsor|0|||
161102056|NCT01621542|581765135|FG005|Overall Study|study stopped by sponsor|0|||
161102057|NCT02632721|581765137|FG000|Overall Study|Adverse Event|0|||
161102058|NCT02632721|581765138|FG001|Overall Study|Adverse Event|0|||
161102059|NCT02632721|581765139|FG002|Overall Study|Adverse Event|2|||
161102060|NCT02632721|581765140|FG003|Overall Study|Adverse Event|5|||
161102061|NCT02632721|581765141|FG004|Overall Study|Adverse Event|3|||
161102062|NCT02632721|581765137|FG000|Overall Study|Dose limiting toxicity|0|||
161102063|NCT02632721|581765138|FG001|Overall Study|Dose limiting toxicity|0|||
161102064|NCT02632721|581765139|FG002|Overall Study|Dose limiting toxicity|0|||
161102065|NCT02632721|581765140|FG003|Overall Study|Dose limiting toxicity|1|||
161102066|NCT02632721|581765141|FG004|Overall Study|Dose limiting toxicity|0|||
161102067|NCT02632721|581765137|FG000|Overall Study|Progressive disease|3|||
161102068|NCT02632721|581765138|FG001|Overall Study|Progressive disease|0|||
161102069|NCT02632721|581765139|FG002|Overall Study|Progressive disease|4|||
161102070|NCT02632721|581765140|FG003|Overall Study|Progressive disease|6|||
161102071|NCT02632721|581765141|FG004|Overall Study|Progressive disease|5|||
161102072|NCT02632721|581765137|FG000|Overall Study|Refused to continue taking trial medication|0|||
161102073|NCT02632721|581765138|FG001|Overall Study|Refused to continue taking trial medication|1|||
161102074|NCT02632721|581765139|FG002|Overall Study|Refused to continue taking trial medication|1|||
161102075|NCT02632721|581765140|FG003|Overall Study|Refused to continue taking trial medication|1|||
161102076|NCT02632721|581765141|FG004|Overall Study|Refused to continue taking trial medication|2|||
161102077|NCT02632721|581765137|FG000|Overall Study|Inadequate clinical condition|0|||
161102078|NCT02632721|581765138|FG001|Overall Study|Inadequate clinical condition|0|||
161102079|NCT02632721|581765139|FG002|Overall Study|Inadequate clinical condition|0|||
161102080|NCT02632721|581765140|FG003|Overall Study|Inadequate clinical condition|0|||
161102081|NCT02632721|581765141|FG004|Overall Study|Inadequate clinical condition|1|||
161102082|NCT02632721|581765137|FG000|Overall Study|No meet eligibility|0|||
161102083|NCT02632721|581765138|FG001|Overall Study|No meet eligibility|0|||
161102084|NCT02632721|581765139|FG002|Overall Study|No meet eligibility|0|||
161102085|NCT02632721|581765140|FG003|Overall Study|No meet eligibility|0|||
161102086|NCT02632721|581765141|FG004|Overall Study|No meet eligibility|1|||
161102087|NCT02632721|581765137|FG000|Overall Study|Allergic reaction|0|||
161102088|NCT02632721|581765138|FG001|Overall Study|Allergic reaction|0|||
161102089|NCT02632721|581765139|FG002|Overall Study|Allergic reaction|0|||
161102090|NCT02632721|581765140|FG003|Overall Study|Allergic reaction|1|||
161102091|NCT02632721|581765141|FG004|Overall Study|Allergic reaction|0|||
161102092|NCT02632721|581765137|FG000|Overall Study|Receiving Decitabine locally|0|||
161102093|NCT02632721|581765138|FG001|Overall Study|Receiving Decitabine locally|0|||
161102094|NCT02632721|581765139|FG002|Overall Study|Receiving Decitabine locally|1|||
161102095|NCT02632721|581765140|FG003|Overall Study|Receiving Decitabine locally|0|||
161102096|NCT02632721|581765141|FG004|Overall Study|Receiving Decitabine locally|0|||
161102097|NCT02632721|581765137|FG000|Overall Study|No benefit from study treatment|1|||
161102098|NCT02632721|581765138|FG001|Overall Study|No benefit from study treatment|1|||
161102099|NCT02632721|581765139|FG002|Overall Study|No benefit from study treatment|0|||
161102100|NCT02632721|581765140|FG003|Overall Study|No benefit from study treatment|0|||
161102101|NCT02632721|581765141|FG004|Overall Study|No benefit from study treatment|1|||
161102102|NCT02632721|581765137|FG000|Overall Study|Patient wish for other treatment|0|||
161102103|NCT02632721|581765138|FG001|Overall Study|Patient wish for other treatment|1|||
161102104|NCT02632721|581765139|FG002|Overall Study|Patient wish for other treatment|0|||
161102105|NCT02632721|581765140|FG003|Overall Study|Patient wish for other treatment|0|||
161102106|NCT02632721|581765141|FG004|Overall Study|Patient wish for other treatment|0|||
161102107|NCT02632721|581765137|FG000|Overall Study|Relapsed Pneumonia|0|||
161102108|NCT02632721|581765138|FG001|Overall Study|Relapsed Pneumonia|0|||
161102109|NCT02632721|581765139|FG002|Overall Study|Relapsed Pneumonia|0|||
161102110|NCT02632721|581765140|FG003|Overall Study|Relapsed Pneumonia|0|||
161102111|NCT02632721|581765141|FG004|Overall Study|Relapsed Pneumonia|1|||
161102112|NCT02632721|581765137|FG000|Overall Study|Therapy refractory AML|0|||
161102113|NCT02632721|581765138|FG001|Overall Study|Therapy refractory AML|0|||
161102114|NCT02632721|581765139|FG002|Overall Study|Therapy refractory AML|0|||
161102115|NCT02632721|581765140|FG003|Overall Study|Therapy refractory AML|0|||
161102116|NCT02632721|581765141|FG004|Overall Study|Therapy refractory AML|1|||
161102117|NCT02632721|581765137|FG000|Overall Study|Increase of white blood cell count|0|||
161102118|NCT02632721|581765138|FG001|Overall Study|Increase of white blood cell count|0|||
161102119|NCT02632721|581765139|FG002|Overall Study|Increase of white blood cell count|0|||
161102120|NCT02632721|581765140|FG003|Overall Study|Increase of white blood cell count|0|||
161102121|NCT02632721|581765141|FG004|Overall Study|Increase of white blood cell count|1|||
161102122|NCT02632721|581765137|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161102123|NCT02632721|581765138|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161102124|NCT02632721|581765139|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
161102125|NCT02632721|581765140|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161102126|NCT02632721|581765141|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
161102127|NCT02663271|581765145|FG000|Overall Study|Withdrawal by Subject|5|||
161102128|NCT02663271|581765145|FG000|Overall Study|Lack of Efficacy|1|||
161102129|NCT01572675|581765146|FG000|Overall Study|End of prescribed treatment|140|||
161102130|NCT01572675|581765147|FG001|Overall Study|End of prescribed treatment|118|||
161212376|NCT01677910|582160101|FG002|Double-Blind Treatment Period|Adverse Event|3|||
161212377|NCT01677910|582160102|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161212378|NCT01677910|582160099|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161212379|NCT01677910|582160100|FG001|Double-Blind Treatment Period|Physician Decision|0|||
161212380|NCT01677910|582160101|FG002|Double-Blind Treatment Period|Physician Decision|1|||
161212381|NCT01677910|582160102|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161212382|NCT01677910|582160099|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
161212383|NCT01677910|582160100|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
161212384|NCT01677910|582160101|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
161212385|NCT01677910|582160102|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
161212386|NCT01677910|582160099|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
161212387|NCT01677910|582160100|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
161212388|NCT01677910|582160101|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
161212389|NCT01677910|582160102|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
161212390|NCT01677910|582160099|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
161212391|NCT01677910|582160100|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
161212392|NCT01677910|582160101|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
161212393|NCT01677910|582160102|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
161212394|NCT01677910|582160099|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161212395|NCT01677910|582160100|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161212396|NCT01677910|582160101|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161212397|NCT01677910|582160102|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
161212398|NCT01677910|582160099|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161212399|NCT01677910|582160100|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161212400|NCT01677910|582160101|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161212401|NCT01677910|582160102|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
161212402|NCT01677910|582160099|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161212403|NCT01677910|582160100|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161212404|NCT01677910|582160101|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161212405|NCT01677910|582160102|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
161212406|NCT01677910|582160099|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
161212407|NCT01677910|582160100|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
161212408|NCT01677910|582160101|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
161212409|NCT01677910|582160102|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
161212410|NCT01677910|582160099|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161212411|NCT01677910|582160100|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161212412|NCT01677910|582160101|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
161212413|NCT01677910|582160102|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
161212414|NCT01244815|582160105|FG000|Overall Study|Not Treated|0|||
161212415|NCT01244815|582160106|FG001|Overall Study|Not Treated|1|||
161212416|NCT01244815|582160107|FG002|Overall Study|Not Treated|0|||
161212417|NCT01244815|582160108|FG003|Overall Study|Not Treated|0|||
161212418|NCT01244815|582160105|FG000|Overall Study|Adverse Event|4|||
161212419|NCT01244815|582160106|FG001|Overall Study|Adverse Event|7|||
161212420|NCT01244815|582160107|FG002|Overall Study|Adverse Event|5|||
161212421|NCT01244815|582160108|FG003|Overall Study|Adverse Event|5|||
161212422|NCT01244815|582160105|FG000|Overall Study|Treatment Failure|0|||
161212423|NCT01244815|582160106|FG001|Overall Study|Treatment Failure|0|||
161212424|NCT01244815|582160107|FG002|Overall Study|Treatment Failure|0|||
161212425|NCT01244815|582160108|FG003|Overall Study|Treatment Failure|1|||
161212426|NCT01244815|582160105|FG000|Overall Study|Lost to Follow-up|3|||
161212427|NCT01244815|582160106|FG001|Overall Study|Lost to Follow-up|2|||
161212428|NCT01244815|582160107|FG002|Overall Study|Lost to Follow-up|3|||
161212429|NCT01244815|582160108|FG003|Overall Study|Lost to Follow-up|2|||
161212430|NCT01244815|582160105|FG000|Overall Study|Withdrawal by Subject|0|||
161212431|NCT01244815|582160106|FG001|Overall Study|Withdrawal by Subject|2|||
161212432|NCT01244815|582160107|FG002|Overall Study|Withdrawal by Subject|0|||
161212433|NCT01244815|582160108|FG003|Overall Study|Withdrawal by Subject|3|||
161212434|NCT01244815|582160105|FG000|Overall Study|Protocol Violation|7|||
161212435|NCT01244815|582160106|FG001|Overall Study|Protocol Violation|4|||
161212436|NCT01244815|582160107|FG002|Overall Study|Protocol Violation|3|||
161212437|NCT01244815|582160108|FG003|Overall Study|Protocol Violation|1|||
161212438|NCT01244815|582160105|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161212439|NCT01244815|582160106|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161212440|NCT01244815|582160107|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
161212441|NCT01244815|582160108|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
161212442|NCT01703741|582160111|FG000|Overall Study|Withdrawal by Subject|6|||
161212443|NCT01703741|582160111|FG000|Overall Study|Adverse Event|2|||
161212444|NCT01703741|582160111|FG000|Overall Study|Physician Decision|2|||
161212445|NCT01703741|582160111|FG000|Overall Study|Protocol Violation|1|||
161212446|NCT01703741|582160111|FG000|Overall Study|Lost to Follow-up|3|||
161102131|NCT01572675|581765146|FG000|Overall Study|Recovery|16|||
161102132|NCT01572675|581765147|FG001|Overall Study|Recovery|23|||
161102133|NCT01572675|581765146|FG000|Overall Study|Lack of Efficacy|31|||
161102134|NCT01572675|581765147|FG001|Overall Study|Lack of Efficacy|31|||
161102135|NCT01572675|581765146|FG000|Overall Study|Intolerance|6|||
161102136|NCT01572675|581765147|FG001|Overall Study|Intolerance|5|||
161102137|NCT01572675|581765146|FG000|Overall Study|Improved symptoms|8|||
161102138|NCT01572675|581765147|FG001|Overall Study|Improved symptoms|2|||
161102139|NCT01572675|581765146|FG000|Overall Study|Surgical intervention|3|||
161102140|NCT01572675|581765147|FG001|Overall Study|Surgical intervention|6|||
161102141|NCT01572675|581765146|FG000|Overall Study|Withdrawal by Subject|5|||
161102142|NCT01572675|581765147|FG001|Overall Study|Withdrawal by Subject|1|||
161102143|NCT01572675|581765146|FG000|Overall Study|Physician Decision|2|||
161102144|NCT01572675|581765147|FG001|Overall Study|Physician Decision|2|||
161102145|NCT01572675|581765146|FG000|Overall Study|Death unrelated to coxibs|1|||
161102146|NCT01572675|581765147|FG001|Overall Study|Death unrelated to coxibs|1|||
161102147|NCT01572675|581765146|FG000|Overall Study|Other disease detected|1|||
161102148|NCT01572675|581765147|FG001|Overall Study|Other disease detected|1|||
161102149|NCT01572675|581765146|FG000|Overall Study|Unknown reason|1|||
161102150|NCT01572675|581765147|FG001|Overall Study|Unknown reason|1|||
161102151|NCT01572675|581765146|FG000|Overall Study|Rheumatologist new evaluation|0|||
161102152|NCT01572675|581765147|FG001|Overall Study|Rheumatologist new evaluation|1|||
161102153|NCT01572675|581765146|FG000|Overall Study|Missing data|1|||
161102154|NCT01572675|581765147|FG001|Overall Study|Missing data|4|||
161102155|NCT01572675|581765146|FG000|Overall Study|Lost to Follow-up|22|||
161102156|NCT01572675|581765147|FG001|Overall Study|Lost to Follow-up|27|||
161102157|NCT03346057|581765149|FG000|Overall Study|Death|1|||
161102158|NCT03346057|581765150|FG001|Overall Study|Death|2|||
161102159|NCT03346057|581765151|FG002|Overall Study|Death|0|||
161102160|NCT03346057|581765152|FG003|Overall Study|Death|0|||
161102161|NCT03346057|581765149|FG000|Overall Study|Lost to Follow-up|0|||
161102162|NCT03346057|581765150|FG001|Overall Study|Lost to Follow-up|2|||
161102163|NCT03346057|581765151|FG002|Overall Study|Lost to Follow-up|1|||
161102164|NCT03346057|581765152|FG003|Overall Study|Lost to Follow-up|0|||
161102165|NCT03346057|581765149|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
161102166|NCT03346057|581765150|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
161102167|NCT03346057|581765151|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
161102168|NCT03346057|581765152|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
161102169|NCT03346057|581765149|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
161102170|NCT03346057|581765150|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
161102171|NCT03346057|581765151|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
161102172|NCT03346057|581765152|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
161102173|NCT03346057|581765149|FG000|Overall Study|Physician Decision|3|||
161102174|NCT03346057|581765150|FG001|Overall Study|Physician Decision|2|||
161102175|NCT03346057|581765151|FG002|Overall Study|Physician Decision|0|||
161102176|NCT03346057|581765152|FG003|Overall Study|Physician Decision|2|||
161102177|NCT03346057|581765149|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
161102178|NCT03346057|581765150|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
161102179|NCT03346057|581765151|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
161102180|NCT03346057|581765152|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
161102181|NCT03346057|581765149|FG000|Overall Study|Withdrawal by Subject|1|||
161102182|NCT03346057|581765150|FG001|Overall Study|Withdrawal by Subject|0|||
161102183|NCT03346057|581765151|FG002|Overall Study|Withdrawal by Subject|0|||
161102184|NCT03346057|581765152|FG003|Overall Study|Withdrawal by Subject|0|||
161102185|NCT01351623|581765153|FG000|Overall Study|Protocol Violation|2|||
161102186|NCT01351623|581765153|FG000|Overall Study|Adverse Event|4|||
161102187|NCT01351623|581765153|FG000|Overall Study|Withdrawal by Subject|1|||
161102188|NCT01351623|581765153|FG000|Overall Study|Death|2|||
161102189|NCT02966223|581765156|FG000|Overall Study|Physician Decision|3|||
161102190|NCT02966223|581765156|FG000|Overall Study|Withdrawal by Subject|11|||
161102191|NCT02966223|581765156|FG000|Overall Study|Lost to Follow-up|1|||
161102192|NCT04399122|581765157|FG000|Overall Study|Lost to Follow-up|2|||
161102193|NCT04399122|581765158|FG001|Overall Study|Lost to Follow-up|0|||
161102194|NCT04399122|581765157|FG000|Overall Study|Withdrawal by Subject|1|||
161102195|NCT04399122|581765158|FG001|Overall Study|Withdrawal by Subject|0|||
161102196|NCT04275297|581765162|FG000|Overall Study|Lost to Follow-up|1|||
161102197|NCT04275297|581765163|FG001|Overall Study|Lost to Follow-up|1|||
161102198|NCT01093326|581765164|FG000|Overall Study|Death|0|||
161102199|NCT01093326|581765165|FG001|Overall Study|Death|1|||
161102200|NCT01093326|581765166|FG002|Overall Study|Death|0|||
161102201|NCT01093326|581765164|FG000|Overall Study|Lack of Efficacy|7|||
161102202|NCT01093326|581765165|FG001|Overall Study|Lack of Efficacy|6|||
161102203|NCT01093326|581765166|FG002|Overall Study|Lack of Efficacy|3|||
161102204|NCT01093326|581765164|FG000|Overall Study|Lost to Follow-up|2|||
161102205|NCT01093326|581765165|FG001|Overall Study|Lost to Follow-up|5|||
161102206|NCT01093326|581765166|FG002|Overall Study|Lost to Follow-up|4|||
161102207|NCT01093326|581765164|FG000|Overall Study|Physician Decision|3|||
161102208|NCT01093326|581765165|FG001|Overall Study|Physician Decision|1|||
161102209|NCT01093326|581765166|FG002|Overall Study|Physician Decision|3|||
161102210|NCT01093326|581765164|FG000|Overall Study|Withdrawal by Subject|30|||
161102211|NCT01093326|581765165|FG001|Overall Study|Withdrawal by Subject|27|||
161102212|NCT01093326|581765166|FG002|Overall Study|Withdrawal by Subject|26|||
161102213|NCT01093326|581765164|FG000|Overall Study|Adverse Event|2|||
161102214|NCT01093326|581765165|FG001|Overall Study|Adverse Event|1|||
161102215|NCT01093326|581765166|FG002|Overall Study|Adverse Event|4|||
161102216|NCT01093326|581765164|FG000|Overall Study|Other|0|||
161102217|NCT01093326|581765165|FG001|Overall Study|Other|0|||
161102218|NCT01093326|581765166|FG002|Overall Study|Other|1|||
161102219|NCT04225806|581765167|FG000|Overall Study|Trial termination|15|||
161102220|NCT05460273|581765170|FG000|Overall Study|Death|43|||
161102221|NCT05460273|581765171|FG001|Overall Study|Death|9|||
161102222|NCT05460273|581765170|FG000|Overall Study|Lost to Follow-up|7|||
161102223|NCT05460273|581765171|FG001|Overall Study|Lost to Follow-up|0|||
161102224|NCT05460273|581765170|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
161102225|NCT05460273|581765171|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
161102226|NCT04124614|581765172|FG000|Placebo Run-in Period|Not Randomized|34|||
161102227|NCT04124614|581765173|FG001|Placebo Run-in Period|Not Randomized|0|||
161102228|NCT04124614|581765174|FG002|Placebo Run-in Period|Not Randomized|0|||
161102229|NCT04124614|581765172|FG000|Double Blind Treatment Period|Adverse Event|0|||
161102230|NCT04124614|581765173|FG001|Double Blind Treatment Period|Adverse Event|7|||
161102231|NCT04124614|581765174|FG002|Double Blind Treatment Period|Adverse Event|22|||
161102232|NCT04124614|581765172|FG000|Double Blind Treatment Period|Death|0|||
161102233|NCT04124614|581765173|FG001|Double Blind Treatment Period|Death|0|||
161102234|NCT04124614|581765174|FG002|Double Blind Treatment Period|Death|1|||
161102235|NCT04124614|581765172|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161102236|NCT04124614|581765173|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
161102237|NCT04124614|581765174|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
161102238|NCT04124614|581765172|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
161102239|NCT04124614|581765173|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
161102240|NCT04124614|581765174|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
161102241|NCT04124614|581765172|FG000|Double Blind Treatment Period|Physician Decision|0|||
161102242|NCT04124614|581765173|FG001|Double Blind Treatment Period|Physician Decision|0|||
161102243|NCT04124614|581765174|FG002|Double Blind Treatment Period|Physician Decision|3|||
161102244|NCT04124614|581765172|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
161102245|NCT04124614|581765173|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
161102246|NCT04124614|581765174|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
161102247|NCT04124614|581765172|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161102248|NCT04124614|581765173|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
161102249|NCT04124614|581765174|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
161102250|NCT04124614|581765172|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
161102251|NCT04124614|581765173|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
161102252|NCT04124614|581765174|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
161102253|NCT03876171|581766951|FG000|Overall Study|Withdrawal by Subject|3|||
161102254|NCT03876171|581766952|FG001|Overall Study|Withdrawal by Subject|3|||
161102255|NCT03876171|581766951|FG000|Overall Study|Re-arrest|0|||
161102256|NCT03876171|581766952|FG001|Overall Study|Re-arrest|4|||
161102257|NCT02012296|581766953|FG000|Overall Study|Lack of Efficacy|0|||
161102258|NCT02012296|581766954|FG001|Overall Study|Lack of Efficacy|0|||
161102259|NCT02012296|581766955|FG002|Overall Study|Lack of Efficacy|15|||
161102260|NCT02012296|581766953|FG000|Overall Study|Adverse Event|0|||
161102261|NCT02012296|581766954|FG001|Overall Study|Adverse Event|0|||
161102262|NCT02012296|581766955|FG002|Overall Study|Adverse Event|2|||
161102263|NCT02012296|581766953|FG000|Overall Study|Early study closure|0|||
161102264|NCT02012296|581766954|FG001|Overall Study|Early study closure|0|||
161102265|NCT02012296|581766955|FG002|Overall Study|Early study closure|5|||
161102266|NCT02012296|581766953|FG000|Overall Study|Protocol Violation|0|||
161102267|NCT02012296|581766954|FG001|Overall Study|Protocol Violation|1|||
161102268|NCT02012296|581766955|FG002|Overall Study|Protocol Violation|0|||
161102269|NCT00727649|581766956|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
161102270|NCT00727649|581766957|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
161102271|NCT00727649|581766956|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
161102272|NCT00727649|581766957|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
161102273|NCT00727649|581766956|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
161102274|NCT00727649|581766957|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
161102275|NCT00727649|581766956|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
161102276|NCT00727649|581766957|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
161102277|NCT00727649|581766956|FG000|Second Intervention (4-weeks)|Death|1|||
161102278|NCT00727649|581766957|FG001|Second Intervention (4-weeks)|Death|0|||
161102279|NCT00727649|581766956|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
161102280|NCT00727649|581766957|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
161102281|NCT00727649|581766956|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
161102282|NCT00727649|581766957|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
161102283|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
161102284|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161102285|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161102286|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161102287|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
161102288|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
161102289|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161102290|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161102291|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161102292|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
161102293|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
161102294|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161102295|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161102296|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161102297|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
161102298|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
161102299|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161102300|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161102301|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161102302|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
161102303|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
161102304|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161102305|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161102306|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161102307|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
161102308|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
161102309|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161102310|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161102311|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161102312|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
161102313|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
161102314|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161102315|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161102316|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161102317|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
161102318|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
161102319|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161102320|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161102321|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161102322|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
161102323|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
161102324|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161102325|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161102326|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161102327|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
161102328|NCT03627767|581766959|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
161102329|NCT03627767|581766960|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161102330|NCT03627767|581766961|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161102331|NCT03627767|581766962|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161102332|NCT03627767|581766963|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
161102333|NCT03627767|581766959|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
161102334|NCT03627767|581766960|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
161102335|NCT03627767|581766961|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
161102336|NCT03627767|581766962|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
161102337|NCT03627767|581766963|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
161102338|NCT03627767|581766959|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161102339|NCT03627767|581766960|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161102340|NCT03627767|581766961|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
161102341|NCT03627767|581766962|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
161102342|NCT03627767|581766963|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
161102343|NCT03627767|581766959|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
161102344|NCT03627767|581766960|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
161102345|NCT03627767|581766961|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
161102346|NCT03627767|581766962|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
161102347|NCT03627767|581766963|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
161102348|NCT03627767|581766959|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161102349|NCT03627767|581766960|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
161102350|NCT03627767|581766961|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
161102351|NCT03627767|581766962|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
161102352|NCT03627767|581766963|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
161102353|NCT03627767|581766959|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161102354|NCT03627767|581766960|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161102355|NCT03627767|581766961|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
161102356|NCT03627767|581766962|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161102357|NCT03627767|581766963|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
161102358|NCT03627767|581766959|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
161102359|NCT03627767|581766960|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
161102360|NCT03627767|581766961|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
161102361|NCT03627767|581766962|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
161102362|NCT03627767|581766963|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
161102363|NCT03627767|581766959|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161102364|NCT03627767|581766960|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161102365|NCT03627767|581766961|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161102366|NCT03627767|581766962|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
161102367|NCT03627767|581766963|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
161102368|NCT03627767|581766959|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161102369|NCT03627767|581766960|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161102370|NCT03627767|581766961|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161102371|NCT03627767|581766962|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
161102372|NCT03627767|581766963|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
161102373|NCT03627767|581766959|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161102374|NCT03627767|581766960|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161102375|NCT03627767|581766961|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161102376|NCT03627767|581766962|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
161102377|NCT03627767|581766963|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
161102378|NCT03627767|581766959|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
161102379|NCT03627767|581766960|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
161102380|NCT03627767|581766961|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
161102381|NCT03627767|581766962|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
161102382|NCT03627767|581766963|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
161102383|NCT00283049|581766964|FG000|Overall Study|Adverse Event|6|||
161102384|NCT00283049|581766965|FG001|Overall Study|Adverse Event|1|||
161102385|NCT00283049|581766966|FG002|Overall Study|Adverse Event|4|||
161102386|NCT00283049|581766964|FG000|Overall Study|Protocol Violation|3|||
161102387|NCT00283049|581766965|FG001|Overall Study|Protocol Violation|0|||
161102388|NCT00283049|581766966|FG002|Overall Study|Protocol Violation|3|||
161102389|NCT00283049|581766964|FG000|Overall Study|Death|1|||
161102390|NCT00283049|581766965|FG001|Overall Study|Death|1|||
161102391|NCT00283049|581766966|FG002|Overall Study|Death|1|||
161102392|NCT00283049|581766964|FG000|Overall Study|Lack of Efficacy|0|||
161102393|NCT00283049|581766965|FG001|Overall Study|Lack of Efficacy|1|||
161102394|NCT00283049|581766966|FG002|Overall Study|Lack of Efficacy|1|||
161102395|NCT00283049|581766964|FG000|Overall Study|Lost to Follow-up|4|||
161102396|NCT00283049|581766965|FG001|Overall Study|Lost to Follow-up|2|||
161102397|NCT00283049|581766966|FG002|Overall Study|Lost to Follow-up|5|||
161102398|NCT00283049|581766964|FG000|Overall Study|Withdrawal by Subject|26|||
161102399|NCT00283049|581766965|FG001|Overall Study|Withdrawal by Subject|24|||
161102400|NCT00283049|581766966|FG002|Overall Study|Withdrawal by Subject|19|||
161102401|NCT00283049|581766964|FG000|Overall Study|Discontinuation of Study|18|||
161102402|NCT00283049|581766965|FG001|Overall Study|Discontinuation of Study|16|||
161102403|NCT00283049|581766966|FG002|Overall Study|Discontinuation of Study|20|||
161102404|NCT00283049|581766964|FG000|Overall Study|No longer requires study treatment|0|||
161102405|NCT00283049|581766965|FG001|Overall Study|No longer requires study treatment|0|||
161102406|NCT00283049|581766966|FG002|Overall Study|No longer requires study treatment|1|||
161102407|NCT02953639|581766967|FG000|Overall Study|Adverse Event|2|||
161102408|NCT02953639|581766968|FG001|Overall Study|Adverse Event|0|||
161102409|NCT02953639|581766969|FG002|Overall Study|Adverse Event|1|||
161102410|NCT02953639|581766967|FG000|Overall Study|Lost to Follow-up|8|||
161102411|NCT02953639|581766968|FG001|Overall Study|Lost to Follow-up|4|||
161102412|NCT02953639|581766969|FG002|Overall Study|Lost to Follow-up|3|||
161102413|NCT02953639|581766967|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161102414|NCT02953639|581766968|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161102415|NCT02953639|581766969|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161102416|NCT02953639|581766967|FG000|Overall Study|Multiple Reasons|1|||
161102417|NCT02953639|581766968|FG001|Overall Study|Multiple Reasons|0|||
161102418|NCT02953639|581766969|FG002|Overall Study|Multiple Reasons|1|||
161102419|NCT02953639|581766967|FG000|Overall Study|Physician Decision|1|||
161102420|NCT02953639|581766968|FG001|Overall Study|Physician Decision|0|||
161102421|NCT02953639|581766969|FG002|Overall Study|Physician Decision|0|||
161102422|NCT02953639|581766967|FG000|Overall Study|Withdrawal by Subject|7|||
161102423|NCT02953639|581766968|FG001|Overall Study|Withdrawal by Subject|8|||
161102424|NCT02953639|581766969|FG002|Overall Study|Withdrawal by Subject|10|||
161102425|NCT02953639|581766967|FG000|Overall Study|Completed or Discontinued information is missing|1|||
161102426|NCT02953639|581766968|FG001|Overall Study|Completed or Discontinued information is missing|0|||
161102427|NCT02953639|581766969|FG002|Overall Study|Completed or Discontinued information is missing|0|||
161102428|NCT01667081|581766970|FG000|Overall Study|Death|43|||
161102429|NCT01667081|581766971|FG001|Overall Study|Death|3|||
161102430|NCT01667081|581766970|FG000|Overall Study|Lost to Follow-up|99|||
161102431|NCT01667081|581766971|FG001|Overall Study|Lost to Follow-up|48|||
161102432|NCT01667081|581766970|FG000|Overall Study|Physician Decision|16|||
161102433|NCT01667081|581766971|FG001|Overall Study|Physician Decision|2|||
161102434|NCT01667081|581766970|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
161102435|NCT01667081|581766971|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
161102436|NCT01667081|581766970|FG000|Overall Study|Withdrawal by Subject|90|||
161102437|NCT01667081|581766971|FG001|Overall Study|Withdrawal by Subject|35|||
161102438|NCT03034460|581766972|FG000|Overall Study|Adverse Event|0|||
161102439|NCT03034460|581766973|FG001|Overall Study|Adverse Event|1|||
161102440|NCT03034460|581766972|FG000|Overall Study|Withdrawal by Subject|2|||
161102441|NCT03034460|581766973|FG001|Overall Study|Withdrawal by Subject|2|||
161102442|NCT03034460|581766972|FG000|Overall Study|Personal Reasons|1|||
161102443|NCT03034460|581766973|FG001|Overall Study|Personal Reasons|0|||
161102444|NCT00295633|581766976|FG000|Overall Study|Lack of Efficacy|19|||
161102445|NCT00295633|581766977|FG001|Overall Study|Lack of Efficacy|7|||
161102446|NCT00295633|581766978|FG002|Overall Study|Lack of Efficacy|16|||
161102447|NCT00295633|581766976|FG000|Overall Study|Withdrawal of consent by subject|16|||
161102448|NCT00295633|581766977|FG001|Overall Study|Withdrawal of consent by subject|16|||
161102449|NCT00295633|581766978|FG002|Overall Study|Withdrawal of consent by subject|26|||
161102450|NCT00295633|581766976|FG000|Overall Study|Adverse Event|9|||
161102451|NCT00295633|581766977|FG001|Overall Study|Adverse Event|17|||
161102452|NCT00295633|581766978|FG002|Overall Study|Adverse Event|9|||
161102453|NCT00295633|581766976|FG000|Overall Study|Lost to Follow-up|6|||
161102454|NCT00295633|581766977|FG001|Overall Study|Lost to Follow-up|11|||
161102455|NCT00295633|581766978|FG002|Overall Study|Lost to Follow-up|7|||
161102456|NCT00295633|581766976|FG000|Overall Study|Physician Decision|9|||
161102457|NCT00295633|581766977|FG001|Overall Study|Physician Decision|10|||
161102458|NCT00295633|581766978|FG002|Overall Study|Physician Decision|8|||
161102459|NCT00295633|581766976|FG000|Overall Study|Poor/Noncompliance|2|||
161102460|NCT00295633|581766977|FG001|Overall Study|Poor/Noncompliance|2|||
161102461|NCT00295633|581766978|FG002|Overall Study|Poor/Noncompliance|6|||
161102462|NCT00295633|581766976|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
161102463|NCT00295633|581766977|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
161102464|NCT00295633|581766978|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
161102465|NCT00295633|581766976|FG000|Overall Study|Death|1|||
161102466|NCT00295633|581766977|FG001|Overall Study|Death|1|||
161102467|NCT00295633|581766978|FG002|Overall Study|Death|0|||
161102468|NCT00295633|581766976|FG000|Overall Study|Administrative reason by sponsor|0|||
161102469|NCT00295633|581766977|FG001|Overall Study|Administrative reason by sponsor|0|||
161102470|NCT00295633|581766978|FG002|Overall Study|Administrative reason by sponsor|1|||
161102471|NCT00763971|581766981|FG000|Overall Study|Adverse Event|5|||
161102472|NCT00763971|581766982|FG001|Overall Study|Adverse Event|2|||
161102473|NCT00763971|581766983|FG002|Overall Study|Adverse Event|4|||
161102474|NCT00763971|581766981|FG000|Overall Study|Protocol Violation|3|||
161102475|NCT00763971|581766982|FG001|Overall Study|Protocol Violation|3|||
161102476|NCT00763971|581766983|FG002|Overall Study|Protocol Violation|2|||
161102477|NCT00763971|581766981|FG000|Overall Study|Withdrawal by Subject|4|||
161102478|NCT00763971|581766982|FG001|Overall Study|Withdrawal by Subject|5|||
161102479|NCT00763971|581766983|FG002|Overall Study|Withdrawal by Subject|5|||
161102480|NCT00763971|581766981|FG000|Overall Study|Lost to Follow-up|0|||
161102481|NCT00763971|581766982|FG001|Overall Study|Lost to Follow-up|1|||
161102482|NCT00763971|581766983|FG002|Overall Study|Lost to Follow-up|0|||
161102483|NCT00763971|581766981|FG000|Overall Study|Lack of Efficacy|11|||
161102484|NCT00763971|581766982|FG001|Overall Study|Lack of Efficacy|22|||
161102485|NCT00763971|581766983|FG002|Overall Study|Lack of Efficacy|54|||
161102486|NCT00763971|581766981|FG000|Overall Study|Unable to swallow capsule|2|||
161102487|NCT00763971|581766982|FG001|Overall Study|Unable to swallow capsule|1|||
161102488|NCT00763971|581766983|FG002|Overall Study|Unable to swallow capsule|1|||
161102489|NCT00763971|581766981|FG000|Overall Study|Personal reason|3|||
161102490|NCT00763971|581766982|FG001|Overall Study|Personal reason|0|||
161102491|NCT00763971|581766983|FG002|Overall Study|Personal reason|0|||
161102492|NCT00763971|581766981|FG000|Overall Study|Exclusion criteria met|1|||
161102493|NCT00763971|581766982|FG001|Overall Study|Exclusion criteria met|0|||
161102494|NCT00763971|581766983|FG002|Overall Study|Exclusion criteria met|0|||
161102495|NCT00763971|581766981|FG000|Overall Study|Sponsor decision|1|||
161102496|NCT00763971|581766982|FG001|Overall Study|Sponsor decision|0|||
161102497|NCT00763971|581766983|FG002|Overall Study|Sponsor decision|0|||
161102498|NCT00763971|581766981|FG000|Overall Study|Due to holiday season|2|||
161102499|NCT00763971|581766982|FG001|Overall Study|Due to holiday season|0|||
161102500|NCT00763971|581766983|FG002|Overall Study|Due to holiday season|1|||
161102501|NCT00763971|581766981|FG000|Overall Study|Randomization error|0|||
161102502|NCT00763971|581766982|FG001|Overall Study|Randomization error|0|||
161102503|NCT00763971|581766983|FG002|Overall Study|Randomization error|1|||
161102504|NCT00763971|581766981|FG000|Overall Study|Medical monitor decision|0|||
161102505|NCT00763971|581766982|FG001|Overall Study|Medical monitor decision|0|||
161102506|NCT00763971|581766983|FG002|Overall Study|Medical monitor decision|1|||
161102507|NCT00763971|581766981|FG000|Overall Study|Moved to another country|0|||
161102508|NCT00763971|581766982|FG001|Overall Study|Moved to another country|1|||
161102509|NCT00763971|581766983|FG002|Overall Study|Moved to another country|0|||
161102510|NCT00763971|581766981|FG000|Overall Study|Subject wanted dose reduction|0|||
161102511|NCT00763971|581766982|FG001|Overall Study|Subject wanted dose reduction|1|||
161102512|NCT00763971|581766983|FG002|Overall Study|Subject wanted dose reduction|0|||
161102513|NCT00763971|581766981|FG000|Overall Study|Lack of availability|0|||
161102514|NCT00763971|581766982|FG001|Overall Study|Lack of availability|1|||
161102515|NCT00763971|581766983|FG002|Overall Study|Lack of availability|0|||
161102516|NCT00763971|581766981|FG000|Overall Study|Performed final visit on phone|0|||
161102517|NCT00763971|581766982|FG001|Overall Study|Performed final visit on phone|1|||
161102518|NCT00763971|581766983|FG002|Overall Study|Performed final visit on phone|0|||
161102519|NCT00763971|581766981|FG000|Overall Study|Participation in 489-326 required|1|||
161102520|NCT00763971|581766982|FG001|Overall Study|Participation in 489-326 required|0|||
161102521|NCT00763971|581766983|FG002|Overall Study|Participation in 489-326 required|0|||
161102522|NCT00884325|581766988|FG000|Overall Study|Lost to Follow-up|1|||
161102523|NCT00884325|581766989|FG001|Overall Study|Lost to Follow-up|2|||
161102524|NCT00884325|581766988|FG000|Overall Study|Lack of Efficacy|0|||
161102525|NCT00884325|581766989|FG001|Overall Study|Lack of Efficacy|1|||
161102526|NCT00884325|581766988|FG000|Overall Study|Withdrawal by Subject|1|||
161102527|NCT00884325|581766989|FG001|Overall Study|Withdrawal by Subject|1|||
161102528|NCT00884325|581766988|FG000|Overall Study|Not provided|1|||
161102529|NCT00884325|581766989|FG001|Overall Study|Not provided|0|||
161102530|NCT01641237|581766990|FG000|Period II|Withdrawal by Subject|1|||
161102531|NCT01641237|581766991|FG001|Period II|Withdrawal by Subject|0|||
161102532|NCT01641237|581766992|FG002|Period II|Withdrawal by Subject|0|||
161102533|NCT01641237|581766993|FG003|Period II|Withdrawal by Subject|0|||
161102534|NCT01641237|581766990|FG000|Period III|Lost to Follow-up|1|||
161102535|NCT01641237|581766991|FG001|Period III|Lost to Follow-up|0|||
161102536|NCT01641237|581766992|FG002|Period III|Lost to Follow-up|0|||
161102537|NCT01641237|581766993|FG003|Period III|Lost to Follow-up|0|||
161102538|NCT01446016|581766994|FG000|Overall Study|Lost to Follow-up|3|||
161102539|NCT01446016|581766994|FG000|Overall Study|Withdrawal by Subject|1|||
161102540|NCT01446016|581766994|FG000|Overall Study|Toxicity|3|||
161102541|NCT00404066|581767001|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
161102542|NCT00404066|581767001|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
161102543|NCT00711529|581767006|FG000|Overall Study|Protocol Violation|2|||
161102544|NCT00711529|581767007|FG001|Overall Study|Protocol Violation|0|||
161102545|NCT00711529|581767006|FG000|Overall Study|Withdrawal by Subject|2|||
161102546|NCT00711529|581767007|FG001|Overall Study|Withdrawal by Subject|6|||
161102547|NCT01849497|581767009|FG000|Overall Study|Withdrawal by Subject|1|||
161102548|NCT01849497|581767010|FG001|Overall Study|Withdrawal by Subject|2|||
161102549|NCT01849497|581767009|FG000|Overall Study|Sponsor Decision|0|||
161102550|NCT01849497|581767010|FG001|Overall Study|Sponsor Decision|1|||
161102551|NCT01849497|581767009|FG000|Overall Study|Lost to Follow-up|0|||
161102552|NCT01849497|581767010|FG001|Overall Study|Lost to Follow-up|1|||
161102553|NCT02146599|581767011|FG000|Overall Study|Failed to meet inclusion criteria|5|||
161102554|NCT02101021|581767012|FG000|Overall Study|Death|4|||
161102555|NCT02101021|581767013|FG001|Overall Study|Death|3|||
161102556|NCT02101021|581767014|FG002|Overall Study|Death|6|||
161102557|NCT02101021|581767015|FG003|Overall Study|Death|0|||
161102558|NCT02101021|581767016|FG004|Overall Study|Death|3|||
161102559|NCT02101021|581767012|FG000|Overall Study|Withdrew Consent from study|1|||
161102560|NCT02101021|581767013|FG001|Overall Study|Withdrew Consent from study|1|||
161102561|NCT02101021|581767014|FG002|Overall Study|Withdrew Consent from study|0|||
161102562|NCT02101021|581767015|FG003|Overall Study|Withdrew Consent from study|2|||
161102563|NCT02101021|581767016|FG004|Overall Study|Withdrew Consent from study|0|||
161102564|NCT02101021|581767012|FG000|Overall Study|Lost to Follow-up|1|||
161102565|NCT02101021|581767013|FG001|Overall Study|Lost to Follow-up|0|||
161102566|NCT02101021|581767014|FG002|Overall Study|Lost to Follow-up|0|||
161102567|NCT02101021|581767015|FG003|Overall Study|Lost to Follow-up|0|||
161102568|NCT02101021|581767016|FG004|Overall Study|Lost to Follow-up|0|||
161102569|NCT02101021|581767012|FG000|Overall Study|Study Terminated by Sponsor|1|||
161102570|NCT02101021|581767013|FG001|Overall Study|Study Terminated by Sponsor|0|||
161102571|NCT02101021|581767014|FG002|Overall Study|Study Terminated by Sponsor|1|||
161102572|NCT02101021|581767015|FG003|Overall Study|Study Terminated by Sponsor|1|||
161102573|NCT02101021|581767016|FG004|Overall Study|Study Terminated by Sponsor|1|||
161102574|NCT00544648|581767019|FG000|Overall Study|Withdrawal by Subject|1|||
161102575|NCT00544648|581767020|FG001|Overall Study|Withdrawal by Subject|0|||
161102576|NCT00544648|581767019|FG000|Overall Study|Adverse Event|1|||
161102577|NCT00544648|581767020|FG001|Overall Study|Adverse Event|1|||
161102578|NCT00544648|581767019|FG000|Overall Study|progression of disease|1|||
161102579|NCT00544648|581767020|FG001|Overall Study|progression of disease|0|||
161102580|NCT00999713|581767021|FG000|Overall Study|Physician Decision|2|||
161102581|NCT00999713|581767022|FG001|Overall Study|Physician Decision|0|||
161102582|NCT01326728|581767025|FG000|Overall Study|Death|13|||
161102583|NCT01326728|581767026|FG001|Overall Study|Death|0|||
161102584|NCT01326728|581767025|FG000|Overall Study|Early closure of study|34|||
161102585|NCT01326728|581767026|FG001|Overall Study|Early closure of study|9|||
161102586|NCT02536755|581767030|FG000|Overall Study|Adverse Event|4|||
161102587|NCT02322229|581767034|FG000|Overall Study|Physician Decision|2|||
161102588|NCT03065023|581767035|FG000|Overall Study|Progressive Disease|0|||
161102589|NCT03065023|581767036|FG001|Overall Study|Progressive Disease|1|||
161102590|NCT03065023|581767037|FG002|Overall Study|Progressive Disease|0|||
161102591|NCT03065023|581767038|FG003|Overall Study|Progressive Disease|0|||
161102592|NCT03065023|581767039|FG004|Overall Study|Progressive Disease|0|||
161102593|NCT03065023|581767035|FG000|Overall Study|Death|2|||
161102594|NCT03065023|581767036|FG001|Overall Study|Death|0|||
161102595|NCT03065023|581767037|FG002|Overall Study|Death|1|||
161102596|NCT03065023|581767038|FG003|Overall Study|Death|1|||
161102597|NCT03065023|581767039|FG004|Overall Study|Death|0|||
161102598|NCT03065023|581767035|FG000|Overall Study|Lost to Follow-up|0|||
161102599|NCT03065023|581767036|FG001|Overall Study|Lost to Follow-up|1|||
161102600|NCT03065023|581767037|FG002|Overall Study|Lost to Follow-up|0|||
161102601|NCT03065023|581767038|FG003|Overall Study|Lost to Follow-up|0|||
161102602|NCT03065023|581767039|FG004|Overall Study|Lost to Follow-up|0|||
161102603|NCT03065023|581767035|FG000|Overall Study|Participant Decision|0|||
161102604|NCT03065023|581767036|FG001|Overall Study|Participant Decision|0|||
161102605|NCT03065023|581767037|FG002|Overall Study|Participant Decision|0|||
161102606|NCT03065023|581767038|FG003|Overall Study|Participant Decision|1|||
161102607|NCT03065023|581767039|FG004|Overall Study|Participant Decision|0|||
161102608|NCT03065023|581767035|FG000|Overall Study|Withdrawal by Subject|0|||
161102609|NCT03065023|581767036|FG001|Overall Study|Withdrawal by Subject|0|||
161102610|NCT03065023|581767037|FG002|Overall Study|Withdrawal by Subject|0|||
161102611|NCT03065023|581767038|FG003|Overall Study|Withdrawal by Subject|1|||
161102612|NCT03065023|581767039|FG004|Overall Study|Withdrawal by Subject|0|||
161102613|NCT00705432|581767040|FG000|Treatment Period|Adverse Event|45|||
161102614|NCT00705432|581767041|FG001|Treatment Period|Adverse Event|37|||
161102615|NCT00705432|581767042|FG002|Treatment Period|Adverse Event|51|||
161102616|NCT00705432|581767043|FG003|Treatment Period|Adverse Event|12|||
161102617|NCT00705432|581767044|FG004|Treatment Period|Adverse Event|8|||
161102618|NCT00705432|581767045|FG005|Treatment Period|Adverse Event|9|||
161102619|NCT00705432|581767040|FG000|Treatment Period|Treatment failure|92|||
161102620|NCT00705432|581767041|FG001|Treatment Period|Treatment failure|42|||
161102621|NCT00705432|581767042|FG002|Treatment Period|Treatment failure|33|||
161102622|NCT00705432|581767043|FG003|Treatment Period|Treatment failure|25|||
161102623|NCT00705432|581767044|FG004|Treatment Period|Treatment failure|13|||
161102624|NCT00705432|581767045|FG005|Treatment Period|Treatment failure|14|||
161102625|NCT00705432|581767040|FG000|Treatment Period|Non medical reason|26|||
161102626|NCT00705432|581767041|FG001|Treatment Period|Non medical reason|32|||
161102627|NCT00705432|581767042|FG002|Treatment Period|Non medical reason|37|||
161102628|NCT00705432|581767043|FG003|Treatment Period|Non medical reason|4|||
161102629|NCT00705432|581767044|FG004|Treatment Period|Non medical reason|7|||
161102630|NCT00705432|581767045|FG005|Treatment Period|Non medical reason|7|||
161102631|NCT00705432|581767040|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
161102632|NCT00705432|581767041|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
161102633|NCT00705432|581767042|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
161102634|NCT00705432|581767043|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161102635|NCT00705432|581767044|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161102636|NCT00705432|581767045|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
161102637|NCT00705432|581767040|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
161102638|NCT00705432|581767041|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
161102639|NCT00705432|581767042|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
161102640|NCT00705432|581767043|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
161102641|NCT00705432|581767044|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
161102642|NCT00705432|581767045|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
161102643|NCT01102803|581767046|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
161102644|NCT01102803|581767047|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
161102645|NCT01102803|581767046|FG000|Post to Follow-Up|Lost to Follow-up|1|||
161102646|NCT01102803|581767047|FG001|Post to Follow-Up|Lost to Follow-up|3|||
161102647|NCT00521053|581767048|FG000|Observation Phase|Disease Progression|55|||
161102648|NCT00521053|581767048|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
161102649|NCT00521053|581767048|FG000|Observation Phase|Death|2|||
161102650|NCT00521053|581767048|FG000|Observation Phase|Adverse Event|1|||
161102651|NCT00521053|581767048|FG000|Observation Phase|Other non-study melanoma treatment|1|||
161102652|NCT00521053|581767048|FG000|Observation Phase|Physician Decision|1|||
161102653|NCT01557348|581767049|FG000|Overall Study|Adverse Event|6|||
161102654|NCT01557348|581767050|FG001|Overall Study|Adverse Event|16|||
161102655|NCT01557348|581767049|FG000|Overall Study|Infusion reaction event|5|||
161102656|NCT01557348|581767050|FG001|Overall Study|Infusion reaction event|5|||
161102657|NCT01557348|581767049|FG000|Overall Study|Death|7|||
161102658|NCT01557348|581767050|FG001|Overall Study|Death|4|||
161102659|NCT01557348|581767049|FG000|Overall Study|Insufficient Therapeutic Response|13|||
161102660|NCT01557348|581767050|FG001|Overall Study|Insufficient Therapeutic Response|28|||
161102661|NCT01557348|581767049|FG000|Overall Study|Withdrawal by Subject|5|||
161102662|NCT01557348|581767050|FG001|Overall Study|Withdrawal by Subject|4|||
161102663|NCT01557348|581767049|FG000|Overall Study|Lost to Follow-up|26|||
161102664|NCT01557348|581767050|FG001|Overall Study|Lost to Follow-up|22|||
161102665|NCT01557348|581767049|FG000|Overall Study|Administrative|18|||
161102666|NCT01557348|581767050|FG001|Overall Study|Administrative|11|||
161102667|NCT01667107|581767051|FG000|Overall Study|Adverse Event|4|||
161102668|NCT01667107|581767052|FG001|Overall Study|Adverse Event|3|||
161102669|NCT01667107|581767051|FG000|Overall Study|Tolerability issues|0|||
161102670|NCT01667107|581767052|FG001|Overall Study|Tolerability issues|2|||
161102671|NCT01667107|581767051|FG000|Overall Study|Protocol Violation|0|||
161102672|NCT01667107|581767052|FG001|Overall Study|Protocol Violation|1|||
161102673|NCT01667107|581767051|FG000|Overall Study|Lack of Efficacy|0|||
161102674|NCT01667107|581767052|FG001|Overall Study|Lack of Efficacy|1|||
161102675|NCT03427125|581767053|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
161102676|NCT03427125|581767054|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
161102677|NCT03427125|581767055|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
161102678|NCT02281357|581767056|FG000|Overall Study|Adverse Event|2|||
161212447|NCT01703741|582160111|FG000|Overall Study|Subject did not want to continue|2|||
161212448|NCT01703741|582160111|FG000|Overall Study|Subject cannot comply with study visits|1|||
161212449|NCT01703741|582160111|FG000|Overall Study|Subject started testosterone injections|1|||
161212450|NCT01170364|582160112|FG000|Overall Study|Protocol Violation|4|||
161212451|NCT01170364|582160113|FG001|Overall Study|Protocol Violation|1|||
161212452|NCT04132232|582160114|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
161212453|NCT04132232|582160115|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
161212454|NCT04132232|582160114|FG000|Overall Study|Lost to Follow-up|6|||
161212455|NCT04132232|582160115|FG001|Overall Study|Lost to Follow-up|7|||
161212456|NCT00368537|582160117|FG000|Randomization|No study drug dosed|13|||
161212457|NCT00368537|582160118|FG001|Randomization|No study drug dosed|6|||
161212458|NCT00368537|582160117|FG000|Baseline Participants|Lost to Follow-up|16|||
161212459|NCT00368537|582160118|FG001|Baseline Participants|Lost to Follow-up|17|||
161212460|NCT00368537|582160117|FG000|Baseline Participants|Withdrawal by Subject|6|||
161212461|NCT00368537|582160118|FG001|Baseline Participants|Withdrawal by Subject|4|||
161212462|NCT00368537|582160117|FG000|Baseline Participants|Death|1|||
161212463|NCT00368537|582160118|FG001|Baseline Participants|Death|2|||
161212464|NCT00368537|582160117|FG000|Baseline Participants|No susceptibility|1|||
161212465|NCT00368537|582160118|FG001|Baseline Participants|No susceptibility|0|||
161102679|NCT02281357|581767057|FG001|Overall Study|Adverse Event|1|||
161102680|NCT02281357|581767056|FG000|Overall Study|Lost to Follow-up|1|||
161102681|NCT02281357|581767057|FG001|Overall Study|Lost to Follow-up|0|||
161102682|NCT02281357|581767056|FG000|Overall Study|Withdrawal by Subject|4|||
161102683|NCT02281357|581767057|FG001|Overall Study|Withdrawal by Subject|3|||
161102684|NCT01162239|581767058|FG000|Treatment Phase|Withdrawal by Subject|1|||
161102685|NCT01162239|581767059|FG001|Treatment Phase|Withdrawal by Subject|3|||
161102686|NCT01162239|581767060|FG002|Treatment Phase|Withdrawal by Subject|2|||
161102687|NCT01162239|581767061|FG003|Treatment Phase|Withdrawal by Subject|3|||
161102688|NCT01162239|581767058|FG000|Treatment Phase|Death|0|||
161102689|NCT01162239|581767059|FG001|Treatment Phase|Death|0|||
161102690|NCT01162239|581767060|FG002|Treatment Phase|Death|0|||
161102691|NCT01162239|581767061|FG003|Treatment Phase|Death|1|||
161102692|NCT01162239|581767058|FG000|Treatment Phase|Lost to Follow-up|5|||
161102693|NCT01162239|581767059|FG001|Treatment Phase|Lost to Follow-up|4|||
161102694|NCT01162239|581767060|FG002|Treatment Phase|Lost to Follow-up|2|||
161102695|NCT01162239|581767061|FG003|Treatment Phase|Lost to Follow-up|1|||
161102696|NCT01162239|581767058|FG000|Extended Follow-up|Lost to Follow-up|8|||
161102697|NCT01162239|581767059|FG001|Extended Follow-up|Lost to Follow-up|13|||
161102698|NCT01162239|581767060|FG002|Extended Follow-up|Lost to Follow-up|8|||
161102699|NCT01162239|581767061|FG003|Extended Follow-up|Lost to Follow-up|6|||
161102700|NCT05975840|581767062|FG000|Overall Study|Other|1|||
161102701|NCT05975840|581767063|FG001|Overall Study|Other|0|||
161102702|NCT05975840|581767064|FG002|Overall Study|Other|0|||
161102703|NCT05975840|581767065|FG003|Overall Study|Other|0|||
161102704|NCT05975840|581767066|FG004|Overall Study|Other|1|||
161102705|NCT05975840|581767067|FG005|Overall Study|Other|0|||
161102706|NCT05975840|581767068|FG006|Overall Study|Other|0|||
161102707|NCT05975840|581767069|FG007|Overall Study|Other|0|||
161102708|NCT05975840|581767062|FG000|Overall Study|Lost to Follow-up|3|||
161102709|NCT05975840|581767063|FG001|Overall Study|Lost to Follow-up|6|||
161102710|NCT05975840|581767064|FG002|Overall Study|Lost to Follow-up|3|||
161102711|NCT05975840|581767065|FG003|Overall Study|Lost to Follow-up|1|||
161102712|NCT05975840|581767066|FG004|Overall Study|Lost to Follow-up|4|||
161102713|NCT05975840|581767067|FG005|Overall Study|Lost to Follow-up|1|||
161102714|NCT05975840|581767068|FG006|Overall Study|Lost to Follow-up|2|||
161102715|NCT05975840|581767069|FG007|Overall Study|Lost to Follow-up|4|||
161102716|NCT05975840|581767062|FG000|Overall Study|Migrated/moved from the study area|1|||
161102717|NCT05975840|581767063|FG001|Overall Study|Migrated/moved from the study area|0|||
161102718|NCT05975840|581767064|FG002|Overall Study|Migrated/moved from the study area|0|||
161102719|NCT05975840|581767065|FG003|Overall Study|Migrated/moved from the study area|0|||
161102720|NCT05975840|581767066|FG004|Overall Study|Migrated/moved from the study area|0|||
161102721|NCT05975840|581767067|FG005|Overall Study|Migrated/moved from the study area|0|||
161102722|NCT05975840|581767068|FG006|Overall Study|Migrated/moved from the study area|0|||
161102723|NCT05975840|581767069|FG007|Overall Study|Migrated/moved from the study area|0|||
161102724|NCT05975840|581767062|FG000|Overall Study|Withdrawal by Subject|0|||
161102725|NCT05975840|581767063|FG001|Overall Study|Withdrawal by Subject|5|||
161102726|NCT05975840|581767064|FG002|Overall Study|Withdrawal by Subject|2|||
161102727|NCT05975840|581767065|FG003|Overall Study|Withdrawal by Subject|2|||
161102728|NCT05975840|581767066|FG004|Overall Study|Withdrawal by Subject|0|||
161102729|NCT05975840|581767067|FG005|Overall Study|Withdrawal by Subject|2|||
161102730|NCT05975840|581767068|FG006|Overall Study|Withdrawal by Subject|2|||
161102731|NCT05975840|581767069|FG007|Overall Study|Withdrawal by Subject|1|||
161102732|NCT05975840|581767062|FG000|Overall Study|Protocol Violation|0|||
161102733|NCT05975840|581767063|FG001|Overall Study|Protocol Violation|1|||
161102734|NCT05975840|581767064|FG002|Overall Study|Protocol Violation|0|||
161102735|NCT05975840|581767065|FG003|Overall Study|Protocol Violation|0|||
161102736|NCT05975840|581767066|FG004|Overall Study|Protocol Violation|0|||
161102737|NCT05975840|581767067|FG005|Overall Study|Protocol Violation|0|||
161102738|NCT05975840|581767068|FG006|Overall Study|Protocol Violation|0|||
161323982|NCT01366638|582571984|FG001|Overall Study|Withdrawal by Subject|0|||
161323983|NCT01366638|582571985|FG002|Overall Study|Withdrawal by Subject|6|||
161323984|NCT01366638|582571983|FG000|Overall Study|Other|1|||
161323985|NCT01366638|582571984|FG001|Overall Study|Other|0|||
161323986|NCT01366638|582571985|FG002|Overall Study|Other|0|||
161323987|NCT01554163|582571987|FG000|Overall Study|Adverse Event|3|||
161323988|NCT01554163|582571988|FG001|Overall Study|Adverse Event|0|||
161323989|NCT01554163|582571987|FG000|Overall Study|Lack of Efficacy|1|||
161323990|NCT01554163|582571988|FG001|Overall Study|Lack of Efficacy|0|||
161323991|NCT01554163|582571987|FG000|Overall Study|Lost to Follow-up|1|||
161323992|NCT01554163|582571988|FG001|Overall Study|Lost to Follow-up|0|||
161323993|NCT01554163|582571987|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161323994|NCT01554163|582571988|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161323995|NCT01554163|582571987|FG000|Overall Study|Protocol Violation|0|||
161323996|NCT01554163|582571988|FG001|Overall Study|Protocol Violation|4|||
161323997|NCT01554163|582571987|FG000|Overall Study|Withdrawal by Subject|1|||
161323998|NCT01554163|582571988|FG001|Overall Study|Withdrawal by Subject|5|||
161323999|NCT01554163|582571987|FG000|Overall Study|Not Treated|1|||
161324000|NCT01554163|582571988|FG001|Overall Study|Not Treated|0|||
161324001|NCT01941537|582571989|FG000|Overall Study|Lack of Efficacy|1|||
161324002|NCT01941537|582571990|FG001|Overall Study|Lack of Efficacy|2|||
161324003|NCT01941537|582571989|FG000|Overall Study|Lost to Follow-up|1|||
161324004|NCT01941537|582571990|FG001|Overall Study|Lost to Follow-up|0|||
161324005|NCT01941537|582571989|FG000|Overall Study|Pregnancy|1|||
161324006|NCT01941537|582571990|FG001|Overall Study|Pregnancy|0|||
161324007|NCT01941537|582571989|FG000|Overall Study|Adverse Event|1|||
161324008|NCT01941537|582571990|FG001|Overall Study|Adverse Event|0|||
161324009|NCT01941537|582571989|FG000|Overall Study|Withdrawal by Subject|0|||
161324010|NCT01941537|582571990|FG001|Overall Study|Withdrawal by Subject|1|||
161324011|NCT02634983|582571991|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
161324012|NCT02634983|582571992|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
161324013|NCT00463801|582573474|FG000|Overall Study|Protocol Violation|1|||
161324014|NCT00463801|582573474|FG000|Overall Study|Lack of Efficacy|2|||
161324015|NCT00463801|582573474|FG000|Overall Study|Adverse Event|4|||
161324016|NCT00463801|582573474|FG000|Overall Study|Lost to Follow-up|5|||
161324017|NCT00463801|582573474|FG000|Overall Study|No longer require therapy|1|||
161324018|NCT00669318|582573475|FG000|Overall Study|Withdrawal by Subject|2|||
161324019|NCT04441788|582573477|FG000|Overall Study|Voluntary Withdrawl|0|||
161324020|NCT04441788|582573478|FG001|Overall Study|Voluntary Withdrawl|1|||
161324021|NCT04441788|582573479|FG002|Overall Study|Voluntary Withdrawl|0|||
161324022|NCT04441788|582573477|FG000|Overall Study|Ineligibility|1|||
161324023|NCT04441788|582573478|FG001|Overall Study|Ineligibility|0|||
161324024|NCT04441788|582573479|FG002|Overall Study|Ineligibility|0|||
161324025|NCT04441788|582573477|FG000|Overall Study|Adverse Event|0|||
161324026|NCT04441788|582573478|FG001|Overall Study|Adverse Event|0|||
161324027|NCT04441788|582573479|FG002|Overall Study|Adverse Event|4|||
161324028|NCT04441788|582573477|FG000|Overall Study|Study Terminated by Sponsor|16|||
161324029|NCT04441788|582573478|FG001|Overall Study|Study Terminated by Sponsor|16|||
161324030|NCT04441788|582573479|FG002|Overall Study|Study Terminated by Sponsor|12|||
161324031|NCT02315664|582573482|FG000|Overall Study|Lost to Follow-up|1|||
161324032|NCT02315664|582573483|FG001|Overall Study|Lost to Follow-up|1|||
161324033|NCT02315664|582573482|FG000|Overall Study|Withdrawal by Subject|0|||
161324034|NCT02315664|582573483|FG001|Overall Study|Withdrawal by Subject|3|||
161324035|NCT01677182|582573484|FG000|Overall Study|Adverse Event|2|||
161324036|NCT01677182|582573485|FG001|Overall Study|Adverse Event|1|||
161324037|NCT01677182|582573486|FG002|Overall Study|Adverse Event|8|||
161324038|NCT01677182|582573484|FG000|Overall Study|Protocol Violation|5|||
161324039|NCT01677182|582573485|FG001|Overall Study|Protocol Violation|1|||
161324040|NCT01677182|582573486|FG002|Overall Study|Protocol Violation|4|||
161324041|NCT01677182|582573484|FG000|Overall Study|Lost to Follow-up|4|||
161324042|NCT01677182|582573485|FG001|Overall Study|Lost to Follow-up|0|||
161324043|NCT01677182|582573486|FG002|Overall Study|Lost to Follow-up|3|||
161324044|NCT01677182|582573484|FG000|Overall Study|Withdrawal by Subject|7|||
161324045|NCT01677182|582573485|FG001|Overall Study|Withdrawal by Subject|12|||
161324046|NCT01677182|582573486|FG002|Overall Study|Withdrawal by Subject|10|||
161324047|NCT01677182|582573484|FG000|Overall Study|Study termination|12|||
161324048|NCT01677182|582573485|FG001|Overall Study|Study termination|9|||
161324049|NCT01677182|582573486|FG002|Overall Study|Study termination|11|||
161324050|NCT01677182|582573484|FG000|Overall Study|Lack of Efficacy|3|||
161324051|NCT01677182|582573485|FG001|Overall Study|Lack of Efficacy|0|||
161324052|NCT01677182|582573486|FG002|Overall Study|Lack of Efficacy|1|||
161324053|NCT01677182|582573484|FG000|Overall Study|Other reasons|1|||
161102739|NCT05975840|581767069|FG007|Overall Study|Protocol Violation|0|||
161324054|NCT01677182|582573485|FG001|Overall Study|Other reasons|5|||
161324055|NCT01677182|582573486|FG002|Overall Study|Other reasons|2|||
161324056|NCT00667992|582573489|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
161324057|NCT00667992|582573490|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
161324058|NCT00667992|582573489|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
161102740|NCT05975840|581767062|FG000|Overall Study|Adverse Event|0|||
161324059|NCT00667992|582573490|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
161324060|NCT00667992|582573489|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161324061|NCT00667992|582573490|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161324062|NCT00667992|582573489|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
161324063|NCT00667992|582573490|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
161324064|NCT00667992|582573489|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161324065|NCT00667992|582573490|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161324066|NCT00667992|582573489|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
161324067|NCT00667992|582573490|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
161324068|NCT00667992|582573489|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
161324069|NCT00667992|582573490|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
161324070|NCT00667992|582573489|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
161324071|NCT00667992|582573490|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
161324072|NCT00667992|582573489|FG000|Wash-out|Not within one doubling dilution|4|||
161324073|NCT00667992|582573490|FG001|Wash-out|Not within one doubling dilution|3|||
161324074|NCT00667992|582573489|FG000|Wash-out|Failure to wash-out|2|||
161324075|NCT00667992|582573490|FG001|Wash-out|Failure to wash-out|2|||
161324076|NCT00667992|582573489|FG000|Wash-out|Withdrawal by Subject|1|||
161324077|NCT00667992|582573490|FG001|Wash-out|Withdrawal by Subject|0|||
161324078|NCT00667992|582573489|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
161324079|NCT00667992|582573490|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
161324080|NCT00667992|582573489|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
161324081|NCT00667992|582573490|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
161324082|NCT00762762|582573494|FG000|Overall Study|Did not return for appointments|6|||
161324083|NCT00762762|582573495|FG001|Overall Study|Did not return for appointments|8|||
161324084|NCT02489448|582573496|FG000|Overall Study|Death|3|||
161324085|NCT02489448|582573496|FG000|Overall Study|Withdrawal by Subject|2|||
161324086|NCT03335813|582573499|FG000|Overall Study|Withdrawal by Subject|1|||
161324087|NCT03872843|582573500|FG000|Overall Study|Lost to Follow-up|5|||
161324088|NCT03872843|582573501|FG001|Overall Study|Lost to Follow-up|7|||
161324089|NCT00281697|582573502|FG000|Overall Study|> 60 days since last dose of study drug|4|||
161324090|NCT00281697|582573503|FG001|Overall Study|> 60 days since last dose of study drug|4|||
161324091|NCT00281697|582573502|FG000|Overall Study|Adverse Event|54|||
161324092|NCT00281697|582573503|FG001|Overall Study|Adverse Event|15|||
161324093|NCT00281697|582573502|FG000|Overall Study|Death|8|||
161324094|NCT00281697|582573503|FG001|Overall Study|Death|3|||
161324095|NCT00281697|582573502|FG000|Overall Study|Disease progression|279|||
161324096|NCT00281697|582573503|FG001|Overall Study|Disease progression|149|||
161324097|NCT00281697|582573502|FG000|Overall Study|Other|5|||
161324098|NCT00281697|582573503|FG001|Overall Study|Other|6|||
161324099|NCT00281697|582573502|FG000|Overall Study|Physician's decision to withdraw|15|||
161324100|NCT00281697|582573503|FG001|Overall Study|Physician's decision to withdraw|12|||
161102741|NCT05975840|581767063|FG001|Overall Study|Adverse Event|0|||
161102742|NCT05975840|581767064|FG002|Overall Study|Adverse Event|0|||
161102743|NCT05975840|581767065|FG003|Overall Study|Adverse Event|1|||
161102744|NCT05975840|581767066|FG004|Overall Study|Adverse Event|0|||
161102745|NCT05975840|581767067|FG005|Overall Study|Adverse Event|0|||
161212466|NCT00368537|582160117|FG000|Baseline Participants|Patient uncompliant|0|||
161212467|NCT00368537|582160118|FG001|Baseline Participants|Patient uncompliant|1|||
161212468|NCT01368276|582160130|FG000|Overall Study|Death|1|||
161212469|NCT01368276|582160131|FG001|Overall Study|Death|10|||
161324101|NCT00281697|582573502|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
161324102|NCT00281697|582573503|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
161324103|NCT00281697|582573502|FG000|Overall Study|Did not receive study drug|3|||
161324104|NCT00281697|582573503|FG001|Overall Study|Did not receive study drug|2|||
161324105|NCT02609386|582573506|FG000|Overall Study|Withdrawal by Subject|6|||
161324106|NCT02609386|582573507|FG001|Overall Study|Withdrawal by Subject|1|||
161324107|NCT02609386|582573506|FG000|Overall Study|Lost to Follow-up|3|||
161324108|NCT02609386|582573507|FG001|Overall Study|Lost to Follow-up|5|||
161324109|NCT02609386|582573506|FG000|Overall Study|Death|19|||
161324110|NCT02609386|582573507|FG001|Overall Study|Death|9|||
161324111|NCT02609386|582573506|FG000|Overall Study|Physician Decision|0|||
161324112|NCT02609386|582573507|FG001|Overall Study|Physician Decision|2|||
161324113|NCT00610168|582573509|FG000|Overall Study|Withdrawal by Subject|2|||
161324114|NCT00610168|582573510|FG001|Overall Study|Withdrawal by Subject|0|||
161324115|NCT00411450|582573511|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
161324116|NCT01059773|582573512|FG000|Overall Study|Adverse Event|2|||
161324117|NCT01059773|582573513|FG001|Overall Study|Adverse Event|2|||
161324118|NCT01059773|582573512|FG000|Overall Study|Withdrawal by Subject|1|||
161324119|NCT01059773|582573513|FG001|Overall Study|Withdrawal by Subject|5|||
161324120|NCT01059773|582573512|FG000|Overall Study|Lost to Follow-up|1|||
161324121|NCT01059773|582573513|FG001|Overall Study|Lost to Follow-up|1|||
161324122|NCT01059773|582573512|FG000|Overall Study|Pregnancy|1|||
161324123|NCT01059773|582573513|FG001|Overall Study|Pregnancy|1|||
161212470|NCT01427920|582160132|FG000|Overall Study|Adverse Event|1|||
161212471|NCT01427920|582160133|FG001|Overall Study|Adverse Event|2|||
161212472|NCT01427920|582160132|FG000|Overall Study|Lack of Efficacy|1|||
161212473|NCT01427920|582160133|FG001|Overall Study|Lack of Efficacy|0|||
161212474|NCT01427920|582160132|FG000|Overall Study|Protocol Violation|1|||
161212475|NCT01427920|582160133|FG001|Overall Study|Protocol Violation|3|||
161212476|NCT01427920|582160132|FG000|Overall Study|Withdrawal Criteria|4|||
161212477|NCT01427920|582160133|FG001|Overall Study|Withdrawal Criteria|4|||
161212478|NCT01427920|582160132|FG000|Overall Study|Unclassified|2|||
161212479|NCT01427920|582160133|FG001|Overall Study|Unclassified|8|||
161212480|NCT02041494|582160134|FG000|Overall Study|Death|1|||
161212481|NCT02041494|582160135|FG001|Overall Study|Death|3|||
161212482|NCT02041494|582160134|FG000|Overall Study|Lost to Follow-up|2|||
161212483|NCT02041494|582160135|FG001|Overall Study|Lost to Follow-up|6|||
161212484|NCT02041494|582160134|FG000|Overall Study|study terminated|16|||
161212485|NCT02041494|582160135|FG001|Overall Study|study terminated|11|||
161212486|NCT03341273|582160136|FG000|Overall Study|Lost to Follow-up|7|||
161212487|NCT03341273|582160137|FG001|Overall Study|Lost to Follow-up|7|||
161212488|NCT03341273|582160136|FG000|Overall Study|Withdrawal by Subject|4|||
161212489|NCT03341273|582160137|FG001|Overall Study|Withdrawal by Subject|2|||
161212490|NCT03341273|582160136|FG000|Overall Study|Physician Decision|1|||
161212491|NCT03341273|582160137|FG001|Overall Study|Physician Decision|0|||
161212492|NCT03341273|582160136|FG000|Overall Study|Protocol Violation|0|||
161212493|NCT03341273|582160137|FG001|Overall Study|Protocol Violation|1|||
161212494|NCT03341273|582160136|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161212495|NCT03341273|582160137|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
161212496|NCT03341273|582160136|FG000|Overall Study|Became ineligible after enrollment|1|||
161212497|NCT03341273|582160137|FG001|Overall Study|Became ineligible after enrollment|0|||
161212498|NCT03341273|582160136|FG000|Overall Study|Not Eligible at Enrollment|0|||
161212499|NCT03341273|582160137|FG001|Overall Study|Not Eligible at Enrollment|1|||
161212500|NCT03341273|582160136|FG000|Overall Study|Participant incarcerated|1|||
161212501|NCT03341273|582160137|FG001|Overall Study|Participant incarcerated|0|||
161212502|NCT01717456|582160145|FG000|End of Treatment|Physician Decision|0|||
161212503|NCT01717456|582160146|FG001|End of Treatment|Physician Decision|1|||
161212504|NCT01717456|582160145|FG000|End of Treatment|Lost to Follow-up|0|||
161212505|NCT01717456|582160146|FG001|End of Treatment|Lost to Follow-up|1|||
161212506|NCT01717456|582160145|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
161212507|NCT01717456|582160146|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
161212508|NCT02732561|582160148|FG000|Overall Study|Lost to Follow-up|1|||
161212509|NCT02732561|582160149|FG001|Overall Study|Lost to Follow-up|1|||
161212510|NCT02732561|582160148|FG000|Overall Study|Withdrawal by Subject|1|||
161212511|NCT02732561|582160149|FG001|Overall Study|Withdrawal by Subject|0|||
161212512|NCT00755937|582160152|FG000|Recruitment|Unknown if infliximab received|164|||
161212513|NCT00755937|582160152|FG000|Observational Follow-up|Lost to Follow-up|148|||
161212514|NCT02117479|582160155|FG000|Overall Study|Death|13|||
161212515|NCT02117479|582160156|FG001|Overall Study|Death|8|||
161212516|NCT02117479|582160155|FG000|Overall Study|Adverse Event|8|||
161324124|NCT01059773|582573512|FG000|Overall Study|Protocol Violation|6|||
161212517|NCT02117479|582160156|FG001|Overall Study|Adverse Event|16|||
161212518|NCT02117479|582160155|FG000|Overall Study|Subject decision|8|||
161212519|NCT02117479|582160156|FG001|Overall Study|Subject decision|9|||
161102746|NCT05975840|581767068|FG006|Overall Study|Adverse Event|0|||
161102747|NCT05975840|581767069|FG007|Overall Study|Adverse Event|0|||
161102748|NCT05975840|581767062|FG000|Overall Study|Death|0|||
161102749|NCT05975840|581767063|FG001|Overall Study|Death|1|||
161212520|NCT02117479|582160155|FG000|Overall Study|Disease progression|104|||
161212521|NCT02117479|582160156|FG001|Overall Study|Disease progression|108|||
161212522|NCT02117479|582160155|FG000|Overall Study|Noncompliance with study treatment|1|||
161212523|NCT02117479|582160156|FG001|Overall Study|Noncompliance with study treatment|0|||
161212524|NCT02117479|582160155|FG000|Overall Study|Study terminated by the sponsor|4|||
161212525|NCT02117479|582160156|FG001|Overall Study|Study terminated by the sponsor|6|||
161212526|NCT02117479|582160155|FG000|Overall Study|Physician Decision|7|||
161212527|NCT02117479|582160156|FG001|Overall Study|Physician Decision|2|||
161212528|NCT02117479|582160155|FG000|Overall Study|Other unspecified|11|||
160981499|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161102750|NCT05975840|581767064|FG002|Overall Study|Death|0|||
161102751|NCT05975840|581767065|FG003|Overall Study|Death|0|||
161102752|NCT05975840|581767066|FG004|Overall Study|Death|0|||
161102753|NCT05975840|581767067|FG005|Overall Study|Death|0|||
161102754|NCT05975840|581767068|FG006|Overall Study|Death|0|||
161102755|NCT05975840|581767069|FG007|Overall Study|Death|1|||
161212529|NCT02117479|582160156|FG001|Overall Study|Other unspecified|7|||
161212530|NCT00751998|582160163|FG000|Overall Study|Lost to Follow-up|7|||
161102756|NCT05390580|581767072|FG000|Overall Study|Physician Decision|3|||
161102757|NCT05390580|581767073|FG001|Overall Study|Physician Decision|2|||
161212531|NCT00751998|582160163|FG000|Overall Study|Death|11|||
161212532|NCT00751998|582160163|FG000|Overall Study|Withdrawal by Subject|2|||
161102758|NCT04448756|581767074|FG000|Overall Study|Adverse Event|0|||
161102759|NCT04448756|581767075|FG001|Overall Study|Adverse Event|1|||
161102760|NCT04448756|581767076|FG002|Overall Study|Adverse Event|0|||
161102761|NCT04448756|581767074|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
161102762|NCT04448756|581767075|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
161102763|NCT04448756|581767076|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
161102764|NCT04448756|581767074|FG000|Overall Study|Withdrawal by Subject|0|||
161102765|NCT04448756|581767075|FG001|Overall Study|Withdrawal by Subject|3|||
161102766|NCT04448756|581767076|FG002|Overall Study|Withdrawal by Subject|1|||
161102767|NCT04448756|581767074|FG000|Overall Study|Death|2|||
161102768|NCT04448756|581767075|FG001|Overall Study|Death|1|||
161102769|NCT04448756|581767076|FG002|Overall Study|Death|0|||
161102770|NCT02733185|581767077|FG000|Overall Study|Withdrawal by Subject|12|||
161102771|NCT02733185|581767078|FG001|Overall Study|Withdrawal by Subject|10|||
161102772|NCT02733185|581767079|FG002|Overall Study|Withdrawal by Subject|17|||
161102773|NCT02733185|581767080|FG003|Overall Study|Withdrawal by Subject|21|||
161102774|NCT02733185|581767077|FG000|Overall Study|Death|46|||
161102775|NCT02733185|581767078|FG001|Overall Study|Death|34|||
161102776|NCT02733185|581767079|FG002|Overall Study|Death|35|||
161102777|NCT02733185|581767080|FG003|Overall Study|Death|43|||
161102778|NCT02733185|581767077|FG000|Overall Study|Lost to Follow-up|17|||
161102779|NCT02733185|581767078|FG001|Overall Study|Lost to Follow-up|18|||
161102780|NCT02733185|581767079|FG002|Overall Study|Lost to Follow-up|16|||
161102781|NCT02733185|581767080|FG003|Overall Study|Lost to Follow-up|11|||
161102782|NCT02499770|581767083|FG000|Overall Study|Death|17|||
161102783|NCT02499770|581767084|FG001|Overall Study|Death|56|||
161102784|NCT02499770|581767083|FG000|Overall Study|Study completion|1|||
161102785|NCT02499770|581767084|FG001|Overall Study|Study completion|10|||
161102786|NCT02499770|581767083|FG000|Overall Study|Withdrawal by Subject|0|||
161102787|NCT02499770|581767084|FG001|Overall Study|Withdrawal by Subject|7|||
161102788|NCT02499770|581767083|FG000|Overall Study|Lost to Follow-up|0|||
161102789|NCT02499770|581767084|FG001|Overall Study|Lost to Follow-up|2|||
161102790|NCT02499770|581767083|FG000|Overall Study|Subject declined further treatment|1|||
161102791|NCT02499770|581767084|FG001|Overall Study|Subject declined further treatment|0|||
161102792|NCT02499770|581767083|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
161102793|NCT02499770|581767084|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
161102794|NCT02499770|581767083|FG000|Overall Study|Randomized but not enrolled|0|||
161102795|NCT02499770|581767084|FG001|Overall Study|Randomized but not enrolled|1|||
161102796|NCT02129205|581767087|FG000|Overall Study|Withdrawal by Subject|0|||
161102797|NCT02129205|581767088|FG001|Overall Study|Withdrawal by Subject|0|||
161102798|NCT02129205|581767089|FG002|Overall Study|Withdrawal by Subject|0|||
161102799|NCT02129205|581767090|FG003|Overall Study|Withdrawal by Subject|0|||
161102800|NCT02129205|581767091|FG004|Overall Study|Withdrawal by Subject|1|||
161102801|NCT02129205|581767092|FG005|Overall Study|Withdrawal by Subject|1|||
161102802|NCT02129205|581767093|FG006|Overall Study|Withdrawal by Subject|1|||
161102803|NCT02129205|581767094|FG007|Overall Study|Withdrawal by Subject|0|||
161102804|NCT02129205|581767095|FG008|Overall Study|Withdrawal by Subject|1|||
161102805|NCT02129205|581767096|FG009|Overall Study|Withdrawal by Subject|0|||
161102806|NCT02129205|581767087|FG000|Overall Study|Other|1|||
161102807|NCT02129205|581767088|FG001|Overall Study|Other|0|||
161102808|NCT02129205|581767089|FG002|Overall Study|Other|0|||
161102809|NCT02129205|581767090|FG003|Overall Study|Other|0|||
161102810|NCT02129205|581767091|FG004|Overall Study|Other|2|||
161102811|NCT02129205|581767092|FG005|Overall Study|Other|3|||
161102812|NCT02129205|581767093|FG006|Overall Study|Other|3|||
161102813|NCT02129205|581767094|FG007|Overall Study|Other|2|||
161102814|NCT02129205|581767095|FG008|Overall Study|Other|1|||
161102815|NCT02129205|581767096|FG009|Overall Study|Other|0|||
161102816|NCT02877927|581767097|FG000|Overall Study|Adverse Event|1|||
161102817|NCT02877927|581767098|FG001|Overall Study|Adverse Event|0|||
161102818|NCT02877927|581767097|FG000|Overall Study|Lost to Follow-up|37|||
161102819|NCT02877927|581767098|FG001|Overall Study|Lost to Follow-up|38|||
161102820|NCT02877927|581767097|FG000|Overall Study|Withdrawal by Subject|11|||
161102821|NCT02877927|581767098|FG001|Overall Study|Withdrawal by Subject|12|||
161102822|NCT02877927|581767097|FG000|Overall Study|Physician Decision|0|||
161102823|NCT02877927|581767098|FG001|Overall Study|Physician Decision|1|||
161102824|NCT02877927|581767097|FG000|Overall Study|Missed EOT/PTE Visit|5|||
161102825|NCT02877927|581767098|FG001|Overall Study|Missed EOT/PTE Visit|6|||
161102826|NCT04376060|581767100|FG000|Overall Study|Physician Decision|1|||
161102827|NCT01791803|581767103|FG000|Overall Study|Withdrawal by Subject|0|||
161102828|NCT01791803|581767104|FG001|Overall Study|Withdrawal by Subject|0|||
161102829|NCT01791803|581767105|FG002|Overall Study|Withdrawal by Subject|0|||
161102830|NCT01791803|581767106|FG003|Overall Study|Withdrawal by Subject|2|||
161102831|NCT01791803|581767103|FG000|Overall Study|Physician Decision|0|||
161212533|NCT02629133|582160165|FG000|Overall Study|Lost to Follow-up|3|||
161212534|NCT02629133|582160166|FG001|Overall Study|Lost to Follow-up|1|||
161102832|NCT01791803|581767104|FG001|Overall Study|Physician Decision|2|||
161102833|NCT01791803|581767105|FG002|Overall Study|Physician Decision|0|||
161102834|NCT01791803|581767106|FG003|Overall Study|Physician Decision|1|||
161102835|NCT01791803|581767103|FG000|Overall Study|Death|0|||
161102836|NCT01791803|581767104|FG001|Overall Study|Death|0|||
161102837|NCT01791803|581767105|FG002|Overall Study|Death|2|||
161102838|NCT01791803|581767106|FG003|Overall Study|Death|2|||
161102839|NCT04572854|581767107|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
161212535|NCT02629133|582160165|FG000|Overall Study|Withdrawal by Subject|1|||
161212536|NCT02629133|582160166|FG001|Overall Study|Withdrawal by Subject|1|||
161212537|NCT01223196|582160167|FG000|Overall Study|Lost to Follow-up|2|||
161212538|NCT01223196|582160168|FG001|Overall Study|Lost to Follow-up|0|||
161212539|NCT01223196|582160167|FG000|Overall Study|Physician Decision|1|||
161324125|NCT01059773|582573513|FG001|Overall Study|Protocol Violation|2|||
161324126|NCT01059773|582573512|FG000|Overall Study|Physician Decision|5|||
161324127|NCT01059773|582573513|FG001|Overall Study|Physician Decision|4|||
161324128|NCT01059773|582573512|FG000|Overall Study|Lack of Efficacy|3|||
161324129|NCT01059773|582573513|FG001|Overall Study|Lack of Efficacy|3|||
161324130|NCT01059773|582573512|FG000|Overall Study|Death|0|||
161324131|NCT01059773|582573513|FG001|Overall Study|Death|1|||
161324132|NCT01059773|582573512|FG000|Overall Study|Malignancy including squamous cell skin|0|||
161324133|NCT01059773|582573513|FG001|Overall Study|Malignancy including squamous cell skin|1|||
161324134|NCT01059773|582573512|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
161324135|NCT01059773|582573513|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
161324136|NCT01059773|582573512|FG000|Overall Study|Other|1|||
161324137|NCT01059773|582573513|FG001|Overall Study|Other|3|||
161324138|NCT01029262|582573516|FG000|Overall Study|Adverse Event|9|||
161324139|NCT01029262|582573517|FG001|Overall Study|Adverse Event|52|||
161324140|NCT01029262|582573516|FG000|Overall Study|Lack of therapeutic effect|57|||
161324141|NCT01029262|582573517|FG001|Overall Study|Lack of therapeutic effect|76|||
161324142|NCT01029262|582573516|FG000|Overall Study|Withdrawal by Subject|10|||
161324143|NCT01029262|582573517|FG001|Overall Study|Withdrawal by Subject|17|||
161324144|NCT01029262|582573516|FG000|Overall Study|Protocol Violation|2|||
161324145|NCT01029262|582573517|FG001|Overall Study|Protocol Violation|3|||
161324146|NCT01029262|582573516|FG000|Overall Study|Miscellaneous|1|||
161324147|NCT01029262|582573517|FG001|Overall Study|Miscellaneous|9|||
161324148|NCT01029262|582573516|FG000|Overall Study|Death|0|||
161324149|NCT01029262|582573517|FG001|Overall Study|Death|3|||
161324150|NCT03904420|582573518|FG000|Overall Study|Study terminated|2|||
161324151|NCT03904420|582573519|FG001|Overall Study|Study terminated|2|||
161324152|NCT01468454|582573520|FG000|Overall Study|Did not have surgery after PET|9|||
161324153|NCT02620787|582573521|FG000|Overall Study|Adverse Event|1|||
161324154|NCT02620787|582573522|FG001|Overall Study|Adverse Event|0|||
161324155|NCT02620787|582573521|FG000|Overall Study|Eligibility Criteria Not Met|1|||
161324156|NCT02620787|582573522|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161324157|NCT03060291|582573523|FG000|3-month Follow-up|Declined to respond|8|||
161324158|NCT03060291|582573524|FG001|3-month Follow-up|Declined to respond|10|||
161324159|NCT03060291|582573525|FG002|3-month Follow-up|Declined to respond|2|||
161324160|NCT03060291|582573523|FG000|6-month Follow-up|Declined to respond|7|||
161324161|NCT03060291|582573524|FG001|6-month Follow-up|Declined to respond|13|||
161324162|NCT03060291|582573525|FG002|6-month Follow-up|Declined to respond|4|||
161324163|NCT03060291|582573523|FG000|12-month Follow-up|Declined to respond|7|||
161324164|NCT03060291|582573524|FG001|12-month Follow-up|Declined to respond|16|||
161324165|NCT03060291|582573525|FG002|12-month Follow-up|Declined to respond|6|||
161324166|NCT01509664|582573528|FG000|Overall Study|Lost to Follow-up|15|||
161324167|NCT01509664|582573529|FG001|Overall Study|Lost to Follow-up|21|||
161324168|NCT03665077|582573532|FG000|Overall Study|Lost to Follow-up|2|||
161324169|NCT03665077|582573532|FG000|Overall Study|Physician Decision|2|||
161324170|NCT02959918|582573535|FG000|Overall Study|Adverse Event|1|||
161324171|NCT02959918|582573536|FG001|Overall Study|Adverse Event|1|||
161324172|NCT02959918|582573537|FG002|Overall Study|Adverse Event|2|||
161324173|NCT02959918|582573538|FG003|Overall Study|Adverse Event|0|||
161324174|NCT02959918|582573539|FG004|Overall Study|Adverse Event|0|||
161324175|NCT02959918|582573540|FG005|Overall Study|Adverse Event|2|||
161324176|NCT02959918|582573541|FG006|Overall Study|Adverse Event|2|||
161324177|NCT02959918|582573542|FG007|Overall Study|Adverse Event|1|||
161324178|NCT02959918|582573543|FG008|Overall Study|Adverse Event|2|||
161324179|NCT02959918|582573544|FG009|Overall Study|Adverse Event|1|||
161324180|NCT02959918|582573545|FG010|Overall Study|Adverse Event|1|||
161324181|NCT02959918|582573546|FG011|Overall Study|Adverse Event|3|||
161324182|NCT02959918|582573547|FG012|Overall Study|Adverse Event|2|||
161324183|NCT02959918|582573548|FG013|Overall Study|Adverse Event|4|||
161324184|NCT02959918|582573535|FG000|Overall Study|Lost to Follow-up|0|||
161324185|NCT02959918|582573536|FG001|Overall Study|Lost to Follow-up|0|||
161324186|NCT02959918|582573537|FG002|Overall Study|Lost to Follow-up|0|||
161324187|NCT02959918|582573538|FG003|Overall Study|Lost to Follow-up|0|||
161324188|NCT02959918|582573539|FG004|Overall Study|Lost to Follow-up|0|||
161324189|NCT02959918|582573540|FG005|Overall Study|Lost to Follow-up|0|||
161324190|NCT02959918|582573541|FG006|Overall Study|Lost to Follow-up|0|||
161324191|NCT02959918|582573542|FG007|Overall Study|Lost to Follow-up|0|||
161324192|NCT02959918|582573543|FG008|Overall Study|Lost to Follow-up|0|||
161324193|NCT02959918|582573544|FG009|Overall Study|Lost to Follow-up|1|||
161324194|NCT02959918|582573545|FG010|Overall Study|Lost to Follow-up|0|||
161324195|NCT02959918|582573546|FG011|Overall Study|Lost to Follow-up|0|||
161324196|NCT02959918|582573547|FG012|Overall Study|Lost to Follow-up|1|||
161324197|NCT02959918|582573548|FG013|Overall Study|Lost to Follow-up|0|||
161324198|NCT02959918|582573535|FG000|Overall Study|Withdrawal by Subject|0|||
161324199|NCT02959918|582573536|FG001|Overall Study|Withdrawal by Subject|0|||
161324200|NCT02959918|582573537|FG002|Overall Study|Withdrawal by Subject|1|||
161324201|NCT02959918|582573538|FG003|Overall Study|Withdrawal by Subject|2|||
161324202|NCT02959918|582573539|FG004|Overall Study|Withdrawal by Subject|0|||
161324203|NCT02959918|582573540|FG005|Overall Study|Withdrawal by Subject|0|||
161212540|NCT01223196|582160168|FG001|Overall Study|Physician Decision|0|||
161102840|NCT04572854|581767108|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
161102841|NCT04572854|581767109|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
161102842|NCT04572854|581767110|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
161102843|NCT04572854|581767107|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161102844|NCT04572854|581767108|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161102845|NCT04572854|581767109|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
161102846|NCT04572854|581767110|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
161102847|NCT00972777|581767113|FG000|Overall Study|Adverse Event|3|||
161102848|NCT00972777|581767114|FG001|Overall Study|Adverse Event|2|||
161102849|NCT00972777|581767113|FG000|Overall Study|Lost to Follow-up|0|||
161102850|NCT00972777|581767114|FG001|Overall Study|Lost to Follow-up|4|||
161102851|NCT00972777|581767113|FG000|Overall Study|Withdrawal by Subject|4|||
161102852|NCT00972777|581767114|FG001|Overall Study|Withdrawal by Subject|5|||
161102853|NCT00972777|581767113|FG000|Overall Study|Physician Decision|4|||
161102854|NCT00972777|581767114|FG001|Overall Study|Physician Decision|0|||
161102855|NCT00972777|581767113|FG000|Overall Study|Protocol Violation|0|||
161102856|NCT00972777|581767114|FG001|Overall Study|Protocol Violation|2|||
161102857|NCT00972777|581767113|FG000|Overall Study|Screening Failure|2|||
161102858|NCT00972777|581767114|FG001|Overall Study|Screening Failure|1|||
161102859|NCT00972777|581767113|FG000|Overall Study|Missed visit|1|||
161102860|NCT00972777|581767114|FG001|Overall Study|Missed visit|0|||
161102861|NCT07052682|581767117|FG000|Overall Study|Withdrawal by Subject|4|||
161102862|NCT05749952|581767118|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
161102863|NCT02246582|581768327|FG000|Overall Study|Withdrawal by Subject|3|||
161102864|NCT02246582|581768328|FG001|Overall Study|Withdrawal by Subject|4|||
161102865|NCT02060383|581768330|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
161102866|NCT02060383|581768331|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
161102867|NCT02060383|581768332|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
161102868|NCT02060383|581768333|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
161102869|NCT02060383|581768334|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
161102870|NCT02060383|581768330|FG000|Core Phase|Adverse Event|2|||
161102871|NCT02060383|581768331|FG001|Core Phase|Adverse Event|0|||
161102872|NCT02060383|581768332|FG002|Core Phase|Adverse Event|0|||
161102873|NCT02060383|581768333|FG003|Core Phase|Adverse Event|2|||
161102874|NCT02060383|581768334|FG004|Core Phase|Adverse Event|6|||
161102875|NCT02060383|581768330|FG000|Core Phase|Administrative problems|0|||
161212541|NCT01223196|582160167|FG000|Overall Study|Withdrawal by Subject|1|||
161102876|NCT02060383|581768331|FG001|Core Phase|Administrative problems|1|||
161102877|NCT02060383|581768332|FG002|Core Phase|Administrative problems|0|||
161102878|NCT02060383|581768333|FG003|Core Phase|Administrative problems|0|||
161102879|NCT02060383|581768334|FG004|Core Phase|Administrative problems|0|||
161102880|NCT02060383|581768330|FG000|Core Phase|Protocol Violation|0|||
161102881|NCT02060383|581768331|FG001|Core Phase|Protocol Violation|0|||
161102882|NCT02060383|581768332|FG002|Core Phase|Protocol Violation|0|||
161102883|NCT02060383|581768333|FG003|Core Phase|Protocol Violation|1|||
161102884|NCT02060383|581768334|FG004|Core Phase|Protocol Violation|0|||
161102885|NCT02060383|581768330|FG000|Core Phase|Withdrawal by Subject|0|||
161102886|NCT02060383|581768331|FG001|Core Phase|Withdrawal by Subject|0|||
161102887|NCT02060383|581768332|FG002|Core Phase|Withdrawal by Subject|0|||
161102888|NCT02060383|581768333|FG003|Core Phase|Withdrawal by Subject|4|||
161102889|NCT02060383|581768334|FG004|Core Phase|Withdrawal by Subject|2|||
161102890|NCT02060383|581768330|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
161102891|NCT02060383|581768331|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
161102892|NCT02060383|581768332|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161102893|NCT02060383|581768333|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
161102894|NCT02060383|581768334|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
161102895|NCT02060383|581768330|FG000|Extension Phase|Adverse Event|1|||
161102896|NCT02060383|581768331|FG001|Extension Phase|Adverse Event|1|||
161102897|NCT02060383|581768332|FG002|Extension Phase|Adverse Event|2|||
161102898|NCT02060383|581768333|FG003|Extension Phase|Adverse Event|0|||
161102899|NCT02060383|581768334|FG004|Extension Phase|Adverse Event|1|||
161102900|NCT02060383|581768330|FG000|Extension Phase|Withdrawal by Subject|0|||
161102901|NCT02060383|581768331|FG001|Extension Phase|Withdrawal by Subject|1|||
161102902|NCT02060383|581768332|FG002|Extension Phase|Withdrawal by Subject|0|||
161102903|NCT02060383|581768333|FG003|Extension Phase|Withdrawal by Subject|0|||
161102904|NCT02060383|581768334|FG004|Extension Phase|Withdrawal by Subject|2|||
161102905|NCT02060383|581768330|FG000|Extension Phase|Administrative problems|1|||
161102906|NCT02060383|581768331|FG001|Extension Phase|Administrative problems|0|||
161102907|NCT02060383|581768332|FG002|Extension Phase|Administrative problems|0|||
161102908|NCT02060383|581768333|FG003|Extension Phase|Administrative problems|0|||
161102909|NCT02060383|581768334|FG004|Extension Phase|Administrative problems|0|||
161102910|NCT02060383|581768330|FG000|Extension Phase|Death|0|||
161102911|NCT02060383|581768331|FG001|Extension Phase|Death|0|||
161102912|NCT02060383|581768332|FG002|Extension Phase|Death|1|||
161102913|NCT02060383|581768333|FG003|Extension Phase|Death|0|||
161102914|NCT02060383|581768334|FG004|Extension Phase|Death|1|||
161102915|NCT02060383|581768330|FG000|Extension Phase|Protocol Violation|0|||
161102916|NCT02060383|581768331|FG001|Extension Phase|Protocol Violation|0|||
161102917|NCT02060383|581768332|FG002|Extension Phase|Protocol Violation|0|||
161102918|NCT02060383|581768333|FG003|Extension Phase|Protocol Violation|0|||
161102919|NCT02060383|581768334|FG004|Extension Phase|Protocol Violation|1|||
161102920|NCT00761306|581768335|FG000|Overall Study|Adverse Event|5|||
161102921|NCT00761306|581768335|FG000|Overall Study|Lack of Efficacy|4|||
161102922|NCT00761306|581768335|FG000|Overall Study|Protocol Violation|2|||
161102923|NCT00761306|581768335|FG000|Overall Study|Withdrawal of Consent|3|||
161102924|NCT00761306|581768335|FG000|Overall Study|Lost to Follow-up|1|||
161102925|NCT00761306|581768335|FG000|Overall Study|Administrative or Other Reasons|5|||
161102926|NCT05162027|581768336|FG000|Overall Study|Adverse Event|1|||
161102927|NCT05162027|581768337|FG001|Overall Study|Adverse Event|0|||
161102928|NCT00525044|581768338|FG000|Overall Study|Lost to Follow-up|0|||
161102929|NCT00525044|581768339|FG001|Overall Study|Lost to Follow-up|1|||
161102930|NCT02460497|581768345|FG000|Overall Study|Participant Requested Withdrawal|4|||
161102931|NCT02460497|581768345|FG000|Overall Study|Non-Compliance|1|||
161102932|NCT02460497|581768345|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
161102933|NCT02460497|581768345|FG000|Overall Study|Lost to Follow-up|2|||
161102934|NCT02460497|581768345|FG000|Overall Study|Investigator Decision|1|||
161102935|NCT00908583|581768346|FG000|Phase 1|Withdrawal by Subject|1|||
161102936|NCT00908583|581768346|FG000|Phase 1|Adverse Event|4|||
161102937|NCT00908583|581768346|FG000|Phase 2|Physician Decision|1|||
161102938|NCT00908583|581768346|FG000|Phase 2|Adverse Event|1|||
161102939|NCT00908583|581768346|FG000|Phase 3|Adverse Event|2|||
161212542|NCT01223196|582160168|FG001|Overall Study|Withdrawal by Subject|0|||
161212543|NCT01238822|582160169|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
161212544|NCT02598193|582160170|FG000|Overall Study|Adverse Event|13|||
161212545|NCT02598193|582160170|FG000|Overall Study|Withdrawal by Subject|1|||
161102940|NCT00908583|581768346|FG000|Phase 4|Adverse Event|1|||
161102941|NCT00908583|581768346|FG000|Phase 4|Physician Decision|1|||
161102942|NCT00908583|581768346|FG000|Phase 5|Adverse Event|3|||
161102943|NCT00993954|581768347|FG000|Overall Study|Protocol Violation|21|||
161102944|NCT00993954|581768348|FG001|Overall Study|Protocol Violation|2|||
161102945|NCT00860951|581768351|FG000|Overall Study|Withdrawal by Subject|2|||
161102946|NCT00860951|581768351|FG000|Overall Study|Lost to Follow-up|5|||
161102947|NCT02982239|581768354|FG000|Overall Study|Lost to Follow-up|3|||
161102948|NCT02982239|581768355|FG001|Overall Study|Lost to Follow-up|2|||
161102949|NCT01650285|581768359|FG000|Overall Study|Adverse Event|1|||
161102950|NCT00907257|581768362|FG000|Overall Study|Adverse Event|0|||
161102951|NCT00907257|581768363|FG001|Overall Study|Adverse Event|4|||
161102952|NCT00907257|581768362|FG000|Overall Study|Protocol Violation|1|||
161102953|NCT00907257|581768363|FG001|Overall Study|Protocol Violation|2|||
161102954|NCT00907257|581768362|FG000|Overall Study|Lost to Follow-up|3|||
161102955|NCT00907257|581768363|FG001|Overall Study|Lost to Follow-up|3|||
161212546|NCT02598193|582160170|FG000|Overall Study|Listed in active lung transplant list|1|||
161102956|NCT00907257|581768362|FG000|Overall Study|Withdrawal by Subject|1|||
161102957|NCT00907257|581768363|FG001|Overall Study|Withdrawal by Subject|2|||
161102958|NCT00907257|581768362|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
161102959|NCT00907257|581768363|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
161102960|NCT00907257|581768362|FG000|Overall Study|Moved|1|||
161102961|NCT00907257|581768363|FG001|Overall Study|Moved|0|||
161102962|NCT00907257|581768362|FG000|Overall Study|Personal Reasons|6|||
161102963|NCT00907257|581768363|FG001|Overall Study|Personal Reasons|1|||
161102964|NCT04163900|581768364|FG000|Overall Study|Radiological disease progression|112|||
161102965|NCT04163900|581768365|FG001|Overall Study|Radiological disease progression|127|||
161102966|NCT04163900|581768364|FG000|Overall Study|Study closure|98|||
161102967|NCT04163900|581768365|FG001|Overall Study|Study closure|133|||
161102968|NCT04163900|581768364|FG000|Overall Study|Adverse Event|78|||
161102969|NCT04163900|581768365|FG001|Overall Study|Adverse Event|32|||
161102970|NCT04163900|581768364|FG000|Overall Study|Withdrawal by Subject|37|||
161102971|NCT04163900|581768365|FG001|Overall Study|Withdrawal by Subject|34|||
161102972|NCT04163900|581768364|FG000|Overall Study|Death|29|||
161102973|NCT04163900|581768365|FG001|Overall Study|Death|16|||
161102974|NCT04163900|581768364|FG000|Overall Study|Physician Decision|17|||
161102975|NCT04163900|581768365|FG001|Overall Study|Physician Decision|25|||
161102976|NCT04163900|581768364|FG000|Overall Study|Clinical disease progression|14|||
161102977|NCT04163900|581768365|FG001|Overall Study|Clinical disease progression|13|||
161102978|NCT04163900|581768364|FG000|Overall Study|Protocol Violation|3|||
161102979|NCT04163900|581768365|FG001|Overall Study|Protocol Violation|4|||
161102980|NCT04163900|581768364|FG000|Overall Study|Lost to Follow-up|0|||
161102981|NCT04163900|581768365|FG001|Overall Study|Lost to Follow-up|1|||
161102982|NCT01873417|581768367|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
161102983|NCT01873417|581768367|FG000|Overall Study|Adverse Event|24|||
161102984|NCT01873417|581768367|FG000|Overall Study|Lost to Follow-up|2|||
161102985|NCT01873417|581768367|FG000|Overall Study|Withdrawal by Subject|2|||
161102986|NCT01873417|581768367|FG000|Overall Study|Physician Decision|3|||
161102987|NCT00785044|581768368|FG000|Overall Study|Dosed at non-participating sites|152|||
161102988|NCT00785044|581768368|FG000|Overall Study|Death|77|||
161102989|NCT00785044|581768368|FG000|Overall Study|Lost to Follow-up|266|||
161102990|NCT00785044|581768368|FG000|Overall Study|Withdrawal by Subject|1|||
161102991|NCT01628107|581768369|FG000|Overall Study|Withdrawal by Subject|17|||
161102992|NCT01628107|581768369|FG000|Overall Study|Lost to Follow-up|4|||
161102993|NCT01628107|581768369|FG000|Overall Study|Adverse Event|33|||
161102994|NCT01628107|581768369|FG000|Overall Study|Physician Decision|2|||
161102995|NCT01628107|581768369|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
161102996|NCT01628107|581768369|FG000|Overall Study|Non-compliant with Study Procedures|10|||
161102997|NCT01628107|581768369|FG000|Overall Study|Not Treated|8|||
161102998|NCT01628107|581768369|FG000|Overall Study|Sponsor Decision|11|||
161102999|NCT01628107|581768369|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
161103000|NCT01628107|581768369|FG000|Overall Study|Relocated|8|||
161103001|NCT01628107|581768369|FG000|Overall Study|Kidney Transplant|9|||
161103002|NCT01628107|581768369|FG000|Overall Study|Use of Standard of Care|9|||
161103003|NCT01086410|581768370|FG000|Overall Study|Adverse Event|1|||
161103004|NCT01086410|581768371|FG001|Overall Study|Adverse Event|0|||
161103005|NCT01086410|581768372|FG002|Overall Study|Adverse Event|0|||
161103006|NCT01086410|581768373|FG003|Overall Study|Adverse Event|2|||
161103007|NCT01086410|581768370|FG000|Overall Study|Lack of Efficacy|1|||
161103008|NCT01086410|581768371|FG001|Overall Study|Lack of Efficacy|1|||
161103009|NCT01086410|581768372|FG002|Overall Study|Lack of Efficacy|0|||
161103010|NCT01086410|581768373|FG003|Overall Study|Lack of Efficacy|0|||
161103011|NCT01086410|581768370|FG000|Overall Study|Protocol Violation|1|||
161103012|NCT01086410|581768371|FG001|Overall Study|Protocol Violation|1|||
161103013|NCT01086410|581768372|FG002|Overall Study|Protocol Violation|0|||
161103014|NCT01086410|581768373|FG003|Overall Study|Protocol Violation|0|||
161103015|NCT01086410|581768370|FG000|Overall Study|Lost to Follow-up|0|||
161103016|NCT01086410|581768371|FG001|Overall Study|Lost to Follow-up|0|||
161103017|NCT01086410|581768372|FG002|Overall Study|Lost to Follow-up|1|||
161103018|NCT01086410|581768373|FG003|Overall Study|Lost to Follow-up|0|||
161103019|NCT01830855|581768374|FG000|Overall Study|Other|7|||
161103020|NCT01830855|581768375|FG001|Overall Study|Other|1|||
161103021|NCT01830855|581768376|FG002|Overall Study|Other|4|||
161103022|NCT01830855|581768377|FG003|Overall Study|Other|4|||
161103023|NCT01830855|581768374|FG000|Overall Study|Medication error without associated AE|1|||
161103024|NCT01830855|581768375|FG001|Overall Study|Medication error without associated AE|0|||
161103025|NCT01830855|581768376|FG002|Overall Study|Medication error without associated AE|0|||
161103026|NCT01830855|581768377|FG003|Overall Study|Medication error without associated AE|1|||
161103027|NCT01830855|581768374|FG000|Overall Study|Pregnancy|3|||
161103028|NCT01830855|581768375|FG001|Overall Study|Pregnancy|1|||
161103029|NCT01830855|581768376|FG002|Overall Study|Pregnancy|2|||
161103030|NCT01830855|581768377|FG003|Overall Study|Pregnancy|1|||
161103031|NCT01830855|581768374|FG000|Overall Study|No longer meets eligibility criteria|11|||
161103032|NCT01830855|581768375|FG001|Overall Study|No longer meets eligibility criteria|2|||
161103033|NCT01830855|581768376|FG002|Overall Study|No longer meets eligibility criteria|3|||
161103034|NCT01830855|581768377|FG003|Overall Study|No longer meets eligibility criteria|5|||
161103035|NCT01830855|581768374|FG000|Overall Study|Adverse Event|11|||
161103036|NCT01830855|581768375|FG001|Overall Study|Adverse Event|5|||
161103037|NCT01830855|581768376|FG002|Overall Study|Adverse Event|6|||
161103038|NCT01830855|581768377|FG003|Overall Study|Adverse Event|3|||
161103039|NCT01830855|581768374|FG000|Overall Study|Protocol deviation|10|||
161103040|NCT01830855|581768375|FG001|Overall Study|Protocol deviation|5|||
161103041|NCT01830855|581768376|FG002|Overall Study|Protocol deviation|6|||
161103042|NCT01830855|581768377|FG003|Overall Study|Protocol deviation|6|||
161103043|NCT01830855|581768374|FG000|Overall Study|Withdrawal by Subject|33|||
161103044|NCT01830855|581768375|FG001|Overall Study|Withdrawal by Subject|14|||
161103045|NCT01830855|581768376|FG002|Overall Study|Withdrawal by Subject|10|||
161103046|NCT01830855|581768377|FG003|Overall Study|Withdrawal by Subject|12|||
161103047|NCT01830855|581768374|FG000|Overall Study|No longer willing to participate|32|||
161103048|NCT01830855|581768375|FG001|Overall Study|No longer willing to participate|13|||
161103049|NCT01830855|581768376|FG002|Overall Study|No longer willing to participate|12|||
161103050|NCT01830855|581768377|FG003|Overall Study|No longer willing to participate|17|||
161103051|NCT01830855|581768374|FG000|Overall Study|Lost to Follow-up|47|||
161103052|NCT01830855|581768375|FG001|Overall Study|Lost to Follow-up|20|||
161103053|NCT01830855|581768376|FG002|Overall Study|Lost to Follow-up|23|||
161103054|NCT01830855|581768377|FG003|Overall Study|Lost to Follow-up|33|||
161103055|NCT01950247|581768379|FG000|Overall Study|Withdrawal by Subject|28|||
161103056|NCT01950247|581768380|FG001|Overall Study|Withdrawal by Subject|13|||
161103057|NCT01950247|581768379|FG000|Overall Study|Lost to Follow-up|18|||
161103058|NCT01950247|581768380|FG001|Overall Study|Lost to Follow-up|16|||
161103059|NCT01950247|581768379|FG000|Overall Study|Physician Decision|3|||
161103060|NCT01950247|581768380|FG001|Overall Study|Physician Decision|4|||
161103061|NCT01950247|581768379|FG000|Overall Study|Adverse Event|3|||
161103062|NCT01950247|581768380|FG001|Overall Study|Adverse Event|2|||
161103063|NCT01950247|581768379|FG000|Overall Study|Death|1|||
161103064|NCT01950247|581768380|FG001|Overall Study|Death|1|||
161103065|NCT01950247|581768379|FG000|Overall Study|Not Defined|4|||
161103066|NCT01950247|581768380|FG001|Overall Study|Not Defined|10|||
161103067|NCT02713542|581768381|FG000|Overall Study|Use of prohibited medication|14|||
161103068|NCT02713542|581768382|FG001|Overall Study|Use of prohibited medication|5|||
161103069|NCT02713542|581768381|FG000|Overall Study|Withdrawal by Subject|4|||
161103070|NCT02713542|581768382|FG001|Overall Study|Withdrawal by Subject|1|||
161103071|NCT03631667|581768383|FG000|Overall Study|Withdrawal by Subject|3|||
161103072|NCT01949155|581768395|FG000|Overall Study|Lost to Follow-up|1|||
161103073|NCT01949155|581768396|FG001|Overall Study|Lost to Follow-up|0|||
161103074|NCT01949155|581768395|FG000|Overall Study|Protocol Violation|1|||
161103075|NCT01949155|581768396|FG001|Overall Study|Protocol Violation|0|||
161103076|NCT05395104|581768397|FG000|Overall Study|Met Liver Stopping Criteria|1|||
161103077|NCT05395104|581768397|FG000|Overall Study|Withdrawal by Subject|1|||
161103078|NCT02448225|581768398|FG000|Overall Study|Withdrawal by Subject|1|||
161103079|NCT02448225|581768398|FG000|Overall Study|Did not get FSPG scan|18|||
161103080|NCT02448225|581768398|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
161103081|NCT01287364|581768403|FG000|Overall Study|Adverse Event|0|||
161103082|NCT01287364|581768404|FG001|Overall Study|Adverse Event|3|||
161103083|NCT01287364|581768403|FG000|Overall Study|Protocol Violation|5|||
161103084|NCT01287364|581768404|FG001|Overall Study|Protocol Violation|5|||
161103085|NCT01287364|581768403|FG000|Overall Study|Other Reason|4|||
161103086|NCT01287364|581768404|FG001|Overall Study|Other Reason|2|||
161103087|NCT04422990|581768406|FG000|Overall Study|Withdrawal by Subject|0|||
161103088|NCT04422990|581768407|FG001|Overall Study|Withdrawal by Subject|1|||
161103089|NCT04422990|581768406|FG000|Overall Study|Travel|3|||
161103090|NCT04422990|581768407|FG001|Overall Study|Travel|0|||
161103091|NCT00770770|581768412|FG000|Overall Study|Lost to Follow-up|1|||
161103092|NCT00770770|581768413|FG001|Overall Study|Lost to Follow-up|0|||
161103093|NCT00770770|581768412|FG000|Overall Study|Withdrawal by Subject|1|||
161103094|NCT00770770|581768413|FG001|Overall Study|Withdrawal by Subject|0|||
161103095|NCT00770770|581768412|FG000|Overall Study|Death|0|||
161103096|NCT00770770|581768413|FG001|Overall Study|Death|1|||
161103097|NCT00770770|581768412|FG000|Overall Study|Study Terminated|8|||
161103098|NCT00770770|581768413|FG001|Overall Study|Study Terminated|0|||
161103099|NCT02486653|581768414|FG000|Overall Study|Withdrawal by Subject|1|||
161103100|NCT02486653|581768415|FG001|Overall Study|Withdrawal by Subject|3|||
161103101|NCT02486653|581768414|FG000|Overall Study|Protocol Violation|1|||
161103102|NCT02486653|581768415|FG001|Overall Study|Protocol Violation|0|||
161103103|NCT02486653|581768414|FG000|Overall Study|surgery cancelled|4|||
161103104|NCT02486653|581768415|FG001|Overall Study|surgery cancelled|1|||
161103105|NCT00800436|581768416|FG000|Overall Study|Withdrawal by Subject|0|||
161103106|NCT00800436|581768417|FG001|Overall Study|Withdrawal by Subject|0|||
161103107|NCT00800436|581768418|FG002|Overall Study|Withdrawal by Subject|1|||
161103108|NCT00800436|581768419|FG003|Overall Study|Withdrawal by Subject|1|||
161103109|NCT00800436|581768420|FG004|Overall Study|Withdrawal by Subject|0|||
161103110|NCT00800436|581768421|FG005|Overall Study|Withdrawal by Subject|0|||
161103111|NCT00800436|581768422|FG006|Overall Study|Withdrawal by Subject|0|||
161103112|NCT01230554|581768425|FG000|Overall Study|Lost to Follow-up|2|||
161103113|NCT01230554|581768425|FG000|Overall Study|Inability to maintain visit schedule|1|||
161103114|NCT01006265|581768426|FG000|Overall Study|Lost to Follow-up|1|||
161103115|NCT01006265|581768427|FG001|Overall Study|Lost to Follow-up|0|||
161103116|NCT01006265|581768428|FG002|Overall Study|Lost to Follow-up|1|||
161103117|NCT01006265|581768429|FG003|Overall Study|Lost to Follow-up|0|||
161103118|NCT01006265|581768426|FG000|Overall Study|Withdrawal by Subject|4|||
161103119|NCT01006265|581768427|FG001|Overall Study|Withdrawal by Subject|7|||
161103120|NCT01006265|581768428|FG002|Overall Study|Withdrawal by Subject|5|||
161103121|NCT01006265|581768429|FG003|Overall Study|Withdrawal by Subject|5|||
161103122|NCT01006265|581768426|FG000|Overall Study|Administrative reason|1|||
161103123|NCT01006265|581768427|FG001|Overall Study|Administrative reason|2|||
161103124|NCT01006265|581768428|FG002|Overall Study|Administrative reason|3|||
161103125|NCT01006265|581768429|FG003|Overall Study|Administrative reason|0|||
161103126|NCT01177384|581768430|FG000|Overall Study|Adverse Event|6|||
161103127|NCT01177384|581768431|FG001|Overall Study|Adverse Event|4|||
161103128|NCT01177384|581768430|FG000|Overall Study|Lack of Efficacy|0|||
161103129|NCT01177384|581768431|FG001|Overall Study|Lack of Efficacy|1|||
161103130|NCT01177384|581768430|FG000|Overall Study|Lost to Follow-up|3|||
161103131|NCT01177384|581768431|FG001|Overall Study|Lost to Follow-up|4|||
161103132|NCT01177384|581768430|FG000|Overall Study|Physician Decision|0|||
161103133|NCT01177384|581768431|FG001|Overall Study|Physician Decision|3|||
161103134|NCT01177384|581768430|FG000|Overall Study|Protocol Violation|0|||
161103135|NCT01177384|581768431|FG001|Overall Study|Protocol Violation|2|||
161103136|NCT01177384|581768430|FG000|Overall Study|Withdrawal by Subject|5|||
161103137|NCT01177384|581768431|FG001|Overall Study|Withdrawal by Subject|12|||
161103138|NCT02921269|581768432|FG000|Overall Study|Did not complete DLT period|1|||
161103139|NCT01184053|581768433|FG000|Overall Study|progression while on treatment|3|||
161103140|NCT02301936|581768434|FG000|Overall Study|Lost to Follow-up|1|||
161103141|NCT02301936|581768435|FG001|Overall Study|Lost to Follow-up|0|||
161103142|NCT00601250|581768439|FG000|Overall Study|Adverse Event|3|||
161103143|NCT00601250|581768440|FG001|Overall Study|Adverse Event|9|||
161103144|NCT00601250|581768439|FG000|Overall Study|Protocol Violation|3|||
161103145|NCT00601250|581768440|FG001|Overall Study|Protocol Violation|2|||
161103146|NCT00601250|581768439|FG000|Overall Study|Lost to Follow-up|2|||
161103147|NCT00601250|581768440|FG001|Overall Study|Lost to Follow-up|6|||
161103148|NCT00601250|581768439|FG000|Overall Study|Withdrawal by Subject|4|||
161103149|NCT00601250|581768440|FG001|Overall Study|Withdrawal by Subject|13|||
161103150|NCT00601250|581768439|FG000|Overall Study|Other incl. lack of efficacy|2|||
161103151|NCT00601250|581768440|FG001|Overall Study|Other incl. lack of efficacy|9|||
161103152|NCT06950879|581768442|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
161103153|NCT03441334|581770286|FG000|Overall Study|Withdrawal by Subject|1|||
161103154|NCT03441334|581770287|FG001|Overall Study|Withdrawal by Subject|0|||
161103155|NCT00088907|581770288|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
161103156|NCT00088907|581770289|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
161103157|NCT00088907|581770288|FG000|Randomized Study (Step 1)|Adverse Event|14|||
161103158|NCT00088907|581770289|FG001|Randomized Study (Step 1)|Adverse Event|19|||
161103159|NCT00088907|581770288|FG000|Randomized Study (Step 1)|Death|11|||
161103160|NCT00088907|581770289|FG001|Randomized Study (Step 1)|Death|12|||
161103161|NCT00088907|581770288|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
161103162|NCT00088907|581770289|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
161103163|NCT00088907|581770288|FG000|Randomized Study (Step 1)|complicating disease|3|||
161103164|NCT00088907|581770289|FG001|Randomized Study (Step 1)|complicating disease|1|||
161103165|NCT00088907|581770288|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
161103166|NCT00088907|581770289|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
161103167|NCT00088907|581770288|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
161103168|NCT00088907|581770289|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
161103169|NCT00088907|581770288|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
161103170|NCT00088907|581770289|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
161103171|NCT00088907|581770288|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
161212547|NCT02598193|582160170|FG000|Overall Study|Does not want to take Nintedanib|1|||
161212548|NCT00928135|582160171|FG000|Overall Study|Withdrawal by Subject|1|||
161103172|NCT00088907|581770289|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
161103173|NCT00088907|581770288|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
161103174|NCT00088907|581770289|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
161103175|NCT00088907|581770288|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
161103176|NCT00088907|581770289|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
161103177|NCT03426787|581770296|FG000|Overall Study|Withdrawal by Subject|6|||
161103178|NCT03426787|581770296|FG000|Overall Study|Lost to Follow-up|7|||
161103179|NCT03426787|581770296|FG000|Overall Study|Unrelated to intervention death|1|||
161103180|NCT00257166|581770302|FG000|Overall Study|Adverse Event|18|||
161103181|NCT00257166|581770303|FG001|Overall Study|Adverse Event|13|||
161103182|NCT00257166|581770302|FG000|Overall Study|Laboratory abnormality|1|||
161103183|NCT00257166|581770303|FG001|Overall Study|Laboratory abnormality|0|||
161103184|NCT00257166|581770302|FG000|Overall Study|Lost to Follow-up|8|||
161103185|NCT00257166|581770303|FG001|Overall Study|Lost to Follow-up|1|||
161103186|NCT00257166|581770302|FG000|Overall Study|Withdrawal by Subject|9|||
161103187|NCT00257166|581770303|FG001|Overall Study|Withdrawal by Subject|2|||
161103188|NCT00257166|581770302|FG000|Overall Study|Other|16|||
161103189|NCT00257166|581770303|FG001|Overall Study|Other|21|||
161103190|NCT00257166|581770302|FG000|Overall Study|Randomized, but not treated|1|||
161103191|NCT00257166|581770303|FG001|Overall Study|Randomized, but not treated|0|||
161103192|NCT02592551|581770304|FG000|Overall Study|Not evaluable|1|||
161103193|NCT02592551|581770305|FG001|Overall Study|Not evaluable|3|||
161103194|NCT02592551|581770306|FG002|Overall Study|Not evaluable|0|||
161103195|NCT02553265|581770307|FG000|Enrollment|Death|0|||
161103196|NCT02553265|581770308|FG001|Enrollment|Death|0|||
161103197|NCT02553265|581770309|FG002|Enrollment|Death|1|||
161103198|NCT02553265|581770307|FG000|First Intervention (28 Days)|Adverse Event|1|||
161103199|NCT02553265|581770308|FG001|First Intervention (28 Days)|Adverse Event|0|||
161103200|NCT02553265|581770309|FG002|First Intervention (28 Days)|Adverse Event|0|||
161103201|NCT02553265|581770307|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
161103202|NCT02553265|581770308|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
161103203|NCT02553265|581770309|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
161103204|NCT02553265|581770307|FG000|Second Intervention (28 Days)|Adverse Event|1|||
161103205|NCT02553265|581770308|FG001|Second Intervention (28 Days)|Adverse Event|0|||
161103206|NCT02553265|581770309|FG002|Second Intervention (28 Days)|Adverse Event|0|||
161103207|NCT02553265|581770307|FG000|Third Intervention (28 Days)|Adverse Event|1|||
161103208|NCT02553265|581770308|FG001|Third Intervention (28 Days)|Adverse Event|0|||
161103209|NCT02553265|581770309|FG002|Third Intervention (28 Days)|Adverse Event|0|||
161103210|NCT02553265|581770307|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
161103211|NCT02553265|581770308|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
161103212|NCT02553265|581770309|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
161103213|NCT00659529|581770310|FG000|Overall Study|Withdrawal by Subject|4|||
161103214|NCT00659529|581770310|FG000|Overall Study|Protocol Violation|3|||
161103215|NCT00659529|581770310|FG000|Overall Study|Screen failure|9|||
161103216|NCT02230254|581770311|FG000|Overall Study|Lost to Follow-up|3|||
161103217|NCT00621751|581770312|FG000|Overall Study|Adverse Event|0|||
161103218|NCT00621751|581770313|FG001|Overall Study|Adverse Event|1|||
161103219|NCT02023242|581770314|FG000|Overall Study|Lost to Follow-up|3|||
161103220|NCT02023242|581770315|FG001|Overall Study|Lost to Follow-up|1|||
161103221|NCT02023242|581770314|FG000|Overall Study|Death|0|||
161103222|NCT02023242|581770315|FG001|Overall Study|Death|1|||
161103223|NCT00710879|581770321|FG000|Overall Study|Lost to Follow-up|2|||
161103224|NCT00710879|581770322|FG001|Overall Study|Lost to Follow-up|1|||
161103225|NCT00710879|581770321|FG000|Overall Study|Protocol Violation|0|||
161103226|NCT00710879|581770322|FG001|Overall Study|Protocol Violation|3|||
161103227|NCT01809132|581770323|FG000|Overall Study|Withdrawal by Subject|0|||
161103228|NCT01809132|581770324|FG001|Overall Study|Withdrawal by Subject|0|||
161103229|NCT01809132|581770325|FG002|Overall Study|Withdrawal by Subject|1|||
161103230|NCT04854434|581770326|FG000|Overall Study|Death|1|||
161103231|NCT04854434|581770327|FG001|Overall Study|Death|3|||
161103232|NCT04854434|581770328|FG002|Overall Study|Death|4|||
161103233|NCT04854434|581770326|FG000|Overall Study|Study Terminated by Sponsor|2|||
161103234|NCT04854434|581770327|FG001|Overall Study|Study Terminated by Sponsor|0|||
161103235|NCT04854434|581770328|FG002|Overall Study|Study Terminated by Sponsor|0|||
161103236|NCT04854434|581770326|FG000|Overall Study|Other|1|||
161103237|NCT04854434|581770327|FG001|Overall Study|Other|1|||
161103238|NCT04854434|581770328|FG002|Overall Study|Other|0|||
161103239|NCT03349775|581770329|FG000|Overall Study|Side Effects|1|||
161103240|NCT03349775|581770330|FG001|Overall Study|Side Effects|2|||
161103241|NCT03349775|581770329|FG000|Overall Study|Withdrawal by Subject|1|||
161103242|NCT03349775|581770330|FG001|Overall Study|Withdrawal by Subject|1|||
161103243|NCT03349775|581770329|FG000|Overall Study|No primary outcome measurements|0|||
161103244|NCT03349775|581770330|FG001|Overall Study|No primary outcome measurements|1|||
161103245|NCT04479436|581770335|FG000|Overall Study|Progressive disease|26|||
161103246|NCT04479436|581770336|FG001|Overall Study|Progressive disease|1|||
161103247|NCT04479436|581770335|FG000|Overall Study|Adverse Event|6|||
161103248|NCT04479436|581770336|FG001|Overall Study|Adverse Event|0|||
161103249|NCT04479436|581770335|FG000|Overall Study|Withdrawal by Subject|5|||
161103250|NCT04479436|581770336|FG001|Overall Study|Withdrawal by Subject|0|||
161103251|NCT04479436|581770335|FG000|Overall Study|Clinical progression|1|||
161103252|NCT04479436|581770336|FG001|Overall Study|Clinical progression|0|||
161103253|NCT04479436|581770335|FG000|Overall Study|Physician Decision|1|||
161103254|NCT04479436|581770336|FG001|Overall Study|Physician Decision|0|||
161103255|NCT03383289|581770344|FG000|Overall Study|Death|83|||
161103256|NCT03383289|581770345|FG001|Overall Study|Death|78|||
161103257|NCT03383289|581770344|FG000|Overall Study|discharge from facility|84|||
161103258|NCT03383289|581770345|FG001|Overall Study|discharge from facility|84|||
161103259|NCT03383289|581770344|FG000|Overall Study|Withdrawal by Subject|4|||
161103260|NCT03383289|581770345|FG001|Overall Study|Withdrawal by Subject|1|||
161103261|NCT04439071|581770346|FG000|Overall Study|Lost to Follow-up|0|||
161103262|NCT04439071|581770347|FG001|Overall Study|Lost to Follow-up|3|||
161103263|NCT04439071|581770346|FG000|Overall Study|Withdrawal by Subject|3|||
161103264|NCT04439071|581770347|FG001|Overall Study|Withdrawal by Subject|8|||
161103265|NCT04439071|581770346|FG000|Overall Study|Death|6|||
161103266|NCT04439071|581770347|FG001|Overall Study|Death|4|||
161103267|NCT04439071|581770346|FG000|Overall Study|Other than specified|3|||
161103268|NCT04439071|581770347|FG001|Overall Study|Other than specified|3|||
161103269|NCT04439071|581770346|FG000|Overall Study|Randomized but not treated|2|||
161103270|NCT04439071|581770347|FG001|Overall Study|Randomized but not treated|0|||
161103271|NCT00832117|581770348|FG000|Overall Study|Death|1|||
161103272|NCT00832117|581770348|FG000|Overall Study|Disease Progression|11|||
161103273|NCT00892177|581770349|FG000|Phase II|Ineligible|0|||
161103274|NCT00892177|581770350|FG001|Phase II|Ineligible|0|||
161103275|NCT00892177|581770351|FG002|Phase II|Ineligible|0|||
161103276|NCT00892177|581770352|FG003|Phase II|Ineligible|0|||
161103277|NCT00892177|581770353|FG004|Phase II|Ineligible|1|||
161103278|NCT00892177|581770354|FG005|Phase II|Ineligible|1|||
161103279|NCT00892177|581770349|FG000|Phase II|Withdrawal by Subject|0|||
161103280|NCT00892177|581770350|FG001|Phase II|Withdrawal by Subject|0|||
161103281|NCT00892177|581770351|FG002|Phase II|Withdrawal by Subject|0|||
161103282|NCT00892177|581770352|FG003|Phase II|Withdrawal by Subject|0|||
161103283|NCT00892177|581770353|FG004|Phase II|Withdrawal by Subject|4|||
161103284|NCT00892177|581770354|FG005|Phase II|Withdrawal by Subject|1|||
161103285|NCT03583450|581770355|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
161103286|NCT03583450|581770356|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
161103287|NCT01186939|581770357|FG000|Overall Study|Death|7|||
161103288|NCT01186939|581770357|FG000|Overall Study|Withdrawal by Subject|2|||
161103289|NCT01186939|581770357|FG000|Overall Study|No longer receiving clinical benefit|17|||
161103290|NCT01186939|581770357|FG000|Overall Study|Program closed|5|||
161103291|NCT01186939|581770357|FG000|Overall Study|Sponsor decision|4|||
161103292|NCT01186939|581770357|FG000|Overall Study|Started additional treatment|1|||
161103293|NCT01186939|581770357|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
161103294|NCT01186939|581770357|FG000|Overall Study|Myocardial infarction|1|||
161103295|NCT01186939|581770357|FG000|Overall Study|Bone marrow transplant|1|||
161103296|NCT01186939|581770357|FG000|Overall Study|Transformation to AML|1|||
161103297|NCT05097716|581770362|FG000|Period 1|Adverse Event|1|||
161103298|NCT05097716|581770362|FG000|Period 1|Close contact with highly-transmissible infection|1|||
161103299|NCT00791258|581770365|FG000|Overall Study|Adverse Event|87|||
161103300|NCT00791258|581770365|FG000|Overall Study|Lost to Follow-up|18|||
161103301|NCT00791258|581770365|FG000|Overall Study|Protocol Violation|109|||
161103302|NCT00791258|581770365|FG000|Overall Study|Withdrawal by Subject|40|||
161103303|NCT00791258|581770365|FG000|Overall Study|Did not take medication for >3 days|1|||
161212549|NCT00928135|582160172|FG001|Overall Study|Withdrawal by Subject|0|||
161212550|NCT01999322|582160173|FG000|Overall Study|Adverse Event|1|||
161212551|NCT01999322|582160174|FG001|Overall Study|Adverse Event|0|||
161103304|NCT00791258|581770365|FG000|Overall Study|subject left area|2|||
161103305|NCT00791258|581770365|FG000|Overall Study|non-compliance|3|||
161103306|NCT00791258|581770365|FG000|Overall Study|Subject incarcerated|1|||
161103307|NCT00791258|581770365|FG000|Overall Study|Subject required restricted medication|1|||
161103308|NCT00791258|581770365|FG000|Overall Study|Lack of Efficacy|1|||
161103309|NCT00436618|581770366|FG000|Overall Study|Withdrawal by Subject|5|||
161103310|NCT00436618|581770367|FG001|Overall Study|Withdrawal by Subject|8|||
161103311|NCT00436618|581770368|FG002|Overall Study|Withdrawal by Subject|11|||
161103312|NCT00436618|581770366|FG000|Overall Study|Adverse Event|8|||
161103313|NCT00436618|581770367|FG001|Overall Study|Adverse Event|8|||
161103314|NCT00436618|581770368|FG002|Overall Study|Adverse Event|9|||
161103315|NCT00436618|581770366|FG000|Overall Study|Alternate Treatment|3|||
161103316|NCT00436618|581770367|FG001|Overall Study|Alternate Treatment|4|||
161103317|NCT00436618|581770368|FG002|Overall Study|Alternate Treatment|12|||
161103318|NCT00436618|581770366|FG000|Overall Study|Other Medical Problems|3|||
161103319|NCT00436618|581770367|FG001|Overall Study|Other Medical Problems|1|||
161103320|NCT00436618|581770368|FG002|Overall Study|Other Medical Problems|7|||
161103321|NCT00436618|581770366|FG000|Overall Study|Death|4|||
161103322|NCT00436618|581770367|FG001|Overall Study|Death|2|||
161103323|NCT00436618|581770368|FG002|Overall Study|Death|3|||
161103324|NCT00436618|581770366|FG000|Overall Study|New Primary or Other Reasons|6|||
161103325|NCT00436618|581770367|FG001|Overall Study|New Primary or Other Reasons|2|||
161212552|NCT01963676|582161752|FG000|Overall Study|Withdrawal by Subject|1|||
161103326|NCT00436618|581770368|FG002|Overall Study|New Primary or Other Reasons|12|||
161103327|NCT00436618|581770366|FG000|Overall Study|Still on treatment|1|||
161103328|NCT00436618|581770367|FG001|Overall Study|Still on treatment|2|||
161103329|NCT00436618|581770368|FG002|Overall Study|Still on treatment|7|||
161103330|NCT00698204|581770369|FG000|Overall Study|Withdrawal by Subject|1|||
161103331|NCT00698204|581770370|FG001|Overall Study|Withdrawal by Subject|0|||
161103332|NCT00314249|581770371|FG000|Overall Study|Adverse Event|73|||
161103333|NCT00314249|581770372|FG001|Overall Study|Adverse Event|94|||
161103334|NCT00314249|581770371|FG000|Overall Study|Lack of Efficacy|33|||
161103335|NCT00314249|581770372|FG001|Overall Study|Lack of Efficacy|24|||
161103336|NCT00314249|581770371|FG000|Overall Study|Withdrawal by Subject|21|||
161103337|NCT00314249|581770372|FG001|Overall Study|Withdrawal by Subject|28|||
161103338|NCT00314249|581770371|FG000|Overall Study|Lost to Follow-up|15|||
161103339|NCT00314249|581770372|FG001|Overall Study|Lost to Follow-up|9|||
161103340|NCT00314249|581770371|FG000|Overall Study|Physician Decision|1|||
161103341|NCT00314249|581770372|FG001|Overall Study|Physician Decision|1|||
161103342|NCT00314249|581770371|FG000|Overall Study|Withdrawn for other reasons|4|||
161103343|NCT00314249|581770372|FG001|Overall Study|Withdrawn for other reasons|1|||
161103344|NCT00314249|581770371|FG000|Overall Study|Non-Compliant|5|||
161103345|NCT00314249|581770372|FG001|Overall Study|Non-Compliant|6|||
161103346|NCT00058552|581770373|FG000|Overall Study|Died prior to receiving treatment|4|||
161103347|NCT00058552|581770374|FG001|Overall Study|Died prior to receiving treatment|2|||
161103348|NCT00058552|581770373|FG000|Overall Study|Disease progression|52|||
161103349|NCT00058552|581770374|FG001|Overall Study|Disease progression|44|||
161103350|NCT00058552|581770373|FG000|Overall Study|Adverse Event|4|||
161103351|NCT00058552|581770374|FG001|Overall Study|Adverse Event|2|||
161103352|NCT00058552|581770373|FG000|Overall Study|Withdrawal by Subject|3|||
161103353|NCT00058552|581770374|FG001|Overall Study|Withdrawal by Subject|5|||
161103354|NCT00058552|581770373|FG000|Overall Study|Physician Decision|2|||
161103355|NCT00058552|581770374|FG001|Overall Study|Physician Decision|5|||
161103356|NCT00058552|581770373|FG000|Overall Study|Clinical disease progression|0|||
161103357|NCT00058552|581770374|FG001|Overall Study|Clinical disease progression|4|||
161103358|NCT02066311|581770375|FG000|Overall Study|Adverse Event|4|||
161103359|NCT02066311|581770375|FG000|Overall Study|Withdrawal by Subject|1|||
161103360|NCT01372150|581770378|FG000|Overall Study|Lack of Efficacy|3|||
161103361|NCT01372150|581770379|FG001|Overall Study|Lack of Efficacy|0|||
161103362|NCT01372150|581770380|FG002|Overall Study|Lack of Efficacy|1|||
161103363|NCT01372150|581770378|FG000|Overall Study|Lost to Follow-up|4|||
161103364|NCT01372150|581770379|FG001|Overall Study|Lost to Follow-up|5|||
161103365|NCT01372150|581770380|FG002|Overall Study|Lost to Follow-up|6|||
161103366|NCT01372150|581770378|FG000|Overall Study|Protocol Violation|1|||
161103367|NCT01372150|581770379|FG001|Overall Study|Protocol Violation|0|||
161103368|NCT01372150|581770380|FG002|Overall Study|Protocol Violation|3|||
161103369|NCT01372150|581770378|FG000|Overall Study|Withdrawal by Subject|2|||
161103370|NCT01372150|581770379|FG001|Overall Study|Withdrawal by Subject|7|||
161103371|NCT01372150|581770380|FG002|Overall Study|Withdrawal by Subject|2|||
161103372|NCT01372150|581770378|FG000|Overall Study|Other|1|||
161103373|NCT01372150|581770379|FG001|Overall Study|Other|0|||
161103374|NCT01372150|581770380|FG002|Overall Study|Other|2|||
161103375|NCT01372150|581770378|FG000|Overall Study|Adverse Event|2|||
161103376|NCT01372150|581770379|FG001|Overall Study|Adverse Event|1|||
161103377|NCT01372150|581770380|FG002|Overall Study|Adverse Event|2|||
161103378|NCT01372150|581770378|FG000|Overall Study|Randomized but not treated|0|||
161103379|NCT01372150|581770379|FG001|Overall Study|Randomized but not treated|1|||
161103380|NCT01372150|581770380|FG002|Overall Study|Randomized but not treated|0|||
161103381|NCT02316340|581770381|FG000|First Progression|Clinical progression|2|||
161103382|NCT02316340|581770382|FG001|First Progression|Clinical progression|1|||
161103383|NCT02316340|581770381|FG000|First Progression|Withdrawal by Subject|1|||
161103384|NCT02316340|581770382|FG001|First Progression|Withdrawal by Subject|0|||
161103385|NCT01835015|581770383|FG000|Overall Study|Adverse Event|0|||
161103386|NCT01835015|581770384|FG001|Overall Study|Adverse Event|0|||
161103387|NCT01835015|581770385|FG002|Overall Study|Adverse Event|1|||
161103388|NCT01835015|581770386|FG003|Overall Study|Adverse Event|0|||
161103389|NCT01835015|581770387|FG004|Overall Study|Adverse Event|0|||
161103390|NCT03781323|581770388|FG000|Overall Study|Withdrawal by Subject|1|||
161103391|NCT00975715|581770392|FG000|Titration Period|Adverse Event|6|||
161103392|NCT00975715|581770393|FG001|Titration Period|Adverse Event|0|||
161103393|NCT00975715|581770392|FG000|Titration Period|Protocol Violation|1|||
161103394|NCT00975715|581770393|FG001|Titration Period|Protocol Violation|0|||
161103395|NCT00975715|581770392|FG000|Maintenance Period|Adverse Event|2|||
161103396|NCT00975715|581770393|FG001|Maintenance Period|Adverse Event|1|||
161103397|NCT01241552|581770397|FG000|Overall Study|Lack of Efficacy|1|||
161103398|NCT01241552|581770398|FG001|Overall Study|Lack of Efficacy|0|||
161103399|NCT01241552|581770399|FG002|Overall Study|Lack of Efficacy|0|||
161103400|NCT01241552|581770400|FG003|Overall Study|Lack of Efficacy|0|||
161103401|NCT01241552|581770397|FG000|Overall Study|Death|26|||
161103402|NCT01241552|581770398|FG001|Overall Study|Death|30|||
161103403|NCT01241552|581770399|FG002|Overall Study|Death|20|||
161103404|NCT01241552|581770400|FG003|Overall Study|Death|25|||
161103405|NCT01241552|581770397|FG000|Overall Study|Adverse Event|1|||
161103406|NCT01241552|581770398|FG001|Overall Study|Adverse Event|1|||
161103407|NCT01241552|581770399|FG002|Overall Study|Adverse Event|0|||
161103408|NCT01241552|581770400|FG003|Overall Study|Adverse Event|0|||
161103409|NCT01241552|581770397|FG000|Overall Study|Technical Problems|2|||
161103410|NCT01241552|581770398|FG001|Overall Study|Technical Problems|0|||
161103411|NCT01241552|581770399|FG002|Overall Study|Technical Problems|2|||
161103412|NCT01241552|581770400|FG003|Overall Study|Technical Problems|2|||
161103413|NCT01241552|581770397|FG000|Overall Study|Progressive Disease|0|||
161103414|NCT01241552|581770398|FG001|Overall Study|Progressive Disease|0|||
161103415|NCT01241552|581770399|FG002|Overall Study|Progressive Disease|1|||
161103416|NCT01241552|581770400|FG003|Overall Study|Progressive Disease|2|||
161103417|NCT01241552|581770397|FG000|Overall Study|Protocol Violation|0|||
161103418|NCT01241552|581770398|FG001|Overall Study|Protocol Violation|2|||
161103419|NCT01241552|581770399|FG002|Overall Study|Protocol Violation|6|||
161103420|NCT01241552|581770400|FG003|Overall Study|Protocol Violation|1|||
161103421|NCT01241552|581770397|FG000|Overall Study|Withdrawal by Subject|7|||
161103422|NCT01241552|581770398|FG001|Overall Study|Withdrawal by Subject|15|||
161103423|NCT01241552|581770399|FG002|Overall Study|Withdrawal by Subject|14|||
161103424|NCT01241552|581770400|FG003|Overall Study|Withdrawal by Subject|15|||
161103425|NCT01241552|581770397|FG000|Overall Study|Physician Decision|2|||
161103426|NCT01241552|581770398|FG001|Overall Study|Physician Decision|4|||
161103427|NCT01241552|581770399|FG002|Overall Study|Physician Decision|2|||
161103428|NCT01241552|581770400|FG003|Overall Study|Physician Decision|3|||
161103429|NCT01241552|581770397|FG000|Overall Study|Lost to Follow-up|2|||
161103430|NCT01241552|581770398|FG001|Overall Study|Lost to Follow-up|11|||
161103431|NCT01241552|581770399|FG002|Overall Study|Lost to Follow-up|15|||
161103432|NCT01241552|581770400|FG003|Overall Study|Lost to Follow-up|16|||
161103433|NCT04004429|581770401|FG000|Overall Study|Protocol Violation|1|||
161103434|NCT04004429|581770402|FG001|Overall Study|Protocol Violation|0|||
161103435|NCT04004429|581770403|FG002|Overall Study|Protocol Violation|0|||
161103436|NCT04004429|581770401|FG000|Overall Study|Physician Decision|0|||
161103437|NCT04004429|581770402|FG001|Overall Study|Physician Decision|1|||
161103438|NCT04004429|581770403|FG002|Overall Study|Physician Decision|1|||
161103439|NCT04004429|581770401|FG000|Overall Study|Withdrawal by Subject|1|||
161103440|NCT04004429|581770402|FG001|Overall Study|Withdrawal by Subject|1|||
161103441|NCT04004429|581770403|FG002|Overall Study|Withdrawal by Subject|1|||
161103442|NCT00718549|581770404|FG000|Induction Phase|Disease Progression|1|||
161103443|NCT00718549|581770405|FG001|Induction Phase|Disease Progression|0|||
161103444|NCT00718549|581770406|FG002|Induction Phase|Disease Progression|0|||
161103445|NCT00718549|581770404|FG000|Induction Phase|Eligibility Criteria Violation|2|||
161103446|NCT00718549|581770405|FG001|Induction Phase|Eligibility Criteria Violation|0|||
161103447|NCT00718549|581770406|FG002|Induction Phase|Eligibility Criteria Violation|0|||
161103448|NCT00718549|581770404|FG000|Induction Phase|Early Termination - No Additional Info|59|||
161103449|NCT00718549|581770405|FG001|Induction Phase|Early Termination - No Additional Info|0|||
161103450|NCT00718549|581770406|FG002|Induction Phase|Early Termination - No Additional Info|0|||
161103451|NCT00718549|581770404|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
161103452|NCT00718549|581770405|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
161103453|NCT00718549|581770406|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
161103454|NCT00718549|581770404|FG000|Maintenance/ Observation Phase|Death|0|||
161103455|NCT00718549|581770405|FG001|Maintenance/ Observation Phase|Death|1|||
161103456|NCT00718549|581770406|FG002|Maintenance/ Observation Phase|Death|2|||
161103457|NCT00718549|581770404|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
161103458|NCT00718549|581770405|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
161103459|NCT00718549|581770406|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
161103460|NCT00718549|581770404|FG000|Maintenance/ Observation Phase|Progression|0|||
161103461|NCT00718549|581770405|FG001|Maintenance/ Observation Phase|Progression|5|||
161103462|NCT00718549|581770406|FG002|Maintenance/ Observation Phase|Progression|14|||
161103463|NCT00718549|581770404|FG000|Maintenance/ Observation Phase|Relapse|0|||
161103464|NCT00718549|581770405|FG001|Maintenance/ Observation Phase|Relapse|3|||
161103465|NCT00718549|581770406|FG002|Maintenance/ Observation Phase|Relapse|2|||
161103466|NCT02606461|581770407|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161103467|NCT02606461|581770408|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161103468|NCT02606461|581770409|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
161103469|NCT02606461|581770410|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161103470|NCT02606461|581770411|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161103471|NCT02606461|581770412|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
161103472|NCT00239226|581770413|FG000|Overall Study|permAF during stabilization period|0|||
161103473|NCT00239226|581770414|FG001|Overall Study|permAF during stabilization period|0|||
161103474|NCT00239226|581770415|FG002|Overall Study|permAF during stabilization period|0|||
161103475|NCT00239226|581770416|FG003|Overall Study|permAF during stabilization period|3|||
161103476|NCT00239226|581770413|FG000|Overall Study|Lost to Follow-up|1|||
161103477|NCT00239226|581770414|FG001|Overall Study|Lost to Follow-up|0|||
161103478|NCT00239226|581770415|FG002|Overall Study|Lost to Follow-up|1|||
161103479|NCT00239226|581770416|FG003|Overall Study|Lost to Follow-up|0|||
161103480|NCT01303965|581770418|FG000|Overall Study|Adverse Event|1|||
161103481|NCT01303965|581770419|FG001|Overall Study|Adverse Event|1|||
161103482|NCT01303965|581770418|FG000|Overall Study|Death|0|||
161103483|NCT01303965|581770419|FG001|Overall Study|Death|3|||
161103484|NCT01303965|581770418|FG000|Overall Study|Withdrawal by Subject|1|||
161103485|NCT01303965|581770419|FG001|Overall Study|Withdrawal by Subject|0|||
161103486|NCT01303965|581770418|FG000|Overall Study|Disease Progression|1|||
161103487|NCT01303965|581770419|FG001|Overall Study|Disease Progression|6|||
161103488|NCT00851682|581770424|FG000|Overall Study|screen failure|5|||
161103489|NCT00851682|581770425|FG001|Overall Study|screen failure|0|||
161103490|NCT01829425|581770426|FG000|Overall Study|Withdrawal by Subject|4|||
161103491|NCT01829425|581770427|FG001|Overall Study|Withdrawal by Subject|3|||
161103492|NCT01829425|581770426|FG000|Overall Study|Lost to Follow-up|2|||
161103493|NCT01829425|581770427|FG001|Overall Study|Lost to Follow-up|1|||
161103494|NCT03681951|581770428|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
161103495|NCT03681951|581770429|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103496|NCT03681951|581770430|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103497|NCT03681951|581770431|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103498|NCT03681951|581770432|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103499|NCT03681951|581770433|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103500|NCT03681951|581770434|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103501|NCT03681951|581770435|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
161103502|NCT03681951|581770428|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
161103503|NCT03681951|581770429|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103504|NCT03681951|581770430|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103505|NCT03681951|581770431|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103506|NCT03681951|581770432|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103507|NCT03681951|581770433|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103508|NCT03681951|581770434|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103509|NCT03681951|581770435|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
161103510|NCT03681951|581770428|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
161103511|NCT03681951|581770429|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103512|NCT03681951|581770430|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103513|NCT03681951|581770431|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103514|NCT03681951|581770432|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103515|NCT03681951|581770433|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103516|NCT03681951|581770434|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103517|NCT03681951|581770435|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
161103518|NCT00757003|581770439|FG000|Overall Study|Death|33|||
161103519|NCT00757003|581770439|FG000|Overall Study|Lost to Follow-up|9|||
161103520|NCT00757003|581770439|FG000|Overall Study|Withdrawal by Subject|4|||
161103521|NCT00757003|581770439|FG000|Overall Study|Surgically explanted|2|||
161103522|NCT00757003|581770439|FG000|Overall Study|Not implanted|1|||
161103523|NCT03044249|581770442|FG000|Overall Study|Adverse Event|4|||
161103524|NCT03044249|581770443|FG001|Overall Study|Adverse Event|9|||
161103525|NCT03044249|581770442|FG000|Overall Study|Lost to Follow-up|1|||
161103526|NCT03044249|581770443|FG001|Overall Study|Lost to Follow-up|0|||
161103527|NCT03044249|581770442|FG000|Overall Study|Non-compliance with Study Drug|1|||
161103528|NCT03044249|581770443|FG001|Overall Study|Non-compliance with Study Drug|0|||
161103529|NCT03044249|581770442|FG000|Overall Study|Study Terminated by Sponsor|2|||
161103530|NCT03044249|581770443|FG001|Overall Study|Study Terminated by Sponsor|0|||
161103531|NCT03044249|581770442|FG000|Overall Study|Withdrawal by Subject|2|||
161103532|NCT03044249|581770443|FG001|Overall Study|Withdrawal by Subject|5|||
161103533|NCT00955279|581770444|FG000|Overall Study|Other|0|||
161103534|NCT00955279|581770445|FG001|Overall Study|Other|0|||
161103535|NCT00955279|581770446|FG002|Overall Study|Other|3|||
161103536|NCT00955279|581770444|FG000|Overall Study|Death|1|||
161103537|NCT00955279|581770445|FG001|Overall Study|Death|1|||
161103538|NCT00955279|581770446|FG002|Overall Study|Death|1|||
161103539|NCT00955279|581770444|FG000|Overall Study|Lost to Follow-up|0|||
161103540|NCT00955279|581770445|FG001|Overall Study|Lost to Follow-up|3|||
161103541|NCT00955279|581770446|FG002|Overall Study|Lost to Follow-up|1|||
161103542|NCT00955279|581770444|FG000|Overall Study|Withdrawal by Subject|2|||
161103543|NCT00955279|581770445|FG001|Overall Study|Withdrawal by Subject|0|||
161103544|NCT00955279|581770446|FG002|Overall Study|Withdrawal by Subject|3|||
161103545|NCT00387764|581770457|FG000|Overall Study|Adverse Event|12|||
161103546|NCT00387764|581770457|FG000|Overall Study|Withdrawal by Subject|8|||
161103547|NCT00387764|581770457|FG000|Overall Study|Sponsor Terminated Study|1|||
161103548|NCT00387764|581770457|FG000|Overall Study|Physician Decision|1|||
161103549|NCT00387764|581770457|FG000|Overall Study|Other|2|||
161103550|NCT00387764|581770457|FG000|Overall Study|Death|7|||
161103551|NCT01174238|581770461|FG000|Overall Study|Lost to Follow-up|2|||
161103552|NCT00232141|581770465|FG000|Overall Study|Adverse Event|9|||
161103553|NCT00232141|581770466|FG001|Overall Study|Adverse Event|4|||
161103554|NCT00232141|581770465|FG000|Overall Study|Lack of Efficacy|0|||
161103555|NCT00232141|581770466|FG001|Overall Study|Lack of Efficacy|3|||
161103556|NCT00232141|581770465|FG000|Overall Study|Lost to Follow-up|9|||
161103557|NCT00232141|581770466|FG001|Overall Study|Lost to Follow-up|6|||
161103558|NCT00232141|581770465|FG000|Overall Study|Other|8|||
161103559|NCT00232141|581770466|FG001|Overall Study|Other|10|||
161103560|NCT00232141|581770465|FG000|Overall Study|Withdrawal by Subject|5|||
161103561|NCT00232141|581770466|FG001|Overall Study|Withdrawal by Subject|3|||
161103562|NCT01810016|581770467|FG000|Overall Study|Progressive disease|1|||
161103563|NCT01810016|581770468|FG001|Overall Study|Progressive disease|1|||
161103564|NCT01810016|581770469|FG002|Overall Study|Progressive disease|0|||
161103565|NCT01810016|581770467|FG000|Overall Study|Death|0|||
161103566|NCT01810016|581770468|FG001|Overall Study|Death|0|||
161103567|NCT01810016|581770469|FG002|Overall Study|Death|1|||
161103568|NCT04263896|581770470|FG000|Overall Study|Withdrawal by Subject|2|||
161103569|NCT04263896|581770471|FG001|Overall Study|Withdrawal by Subject|4|||
161103570|NCT04263896|581770470|FG000|Overall Study|converted to open procedure|0|||
161103571|NCT04263896|581770471|FG001|Overall Study|converted to open procedure|1|||
161103572|NCT04263896|581770470|FG000|Overall Study|Lost to Follow-up|9|||
161103573|NCT04263896|581770471|FG001|Overall Study|Lost to Follow-up|11|||
161103574|NCT04263896|581770470|FG000|Overall Study|surveys lost in mail|5|||
161103575|NCT04263896|581770471|FG001|Overall Study|surveys lost in mail|3|||
161103576|NCT04263896|581770470|FG000|Overall Study|excluded from analysis|1|||
161103577|NCT04263896|581770471|FG001|Overall Study|excluded from analysis|0|||
161103578|NCT02229539|581771553|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
161103579|NCT02229539|581771554|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
161103580|NCT02229539|581771555|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
161103581|NCT02229539|581771553|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
161103582|NCT02229539|581771554|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
161103583|NCT02229539|581771555|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
161103584|NCT02229539|581771553|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
161103585|NCT02229539|581771554|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
161103586|NCT02229539|581771555|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
161103587|NCT02229539|581771553|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
161103588|NCT02229539|581771554|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
161103589|NCT02229539|581771555|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
161103590|NCT02229539|581771553|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
161103591|NCT02229539|581771554|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
161103592|NCT02229539|581771555|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
161103593|NCT02229539|581771553|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
161103594|NCT02229539|581771554|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
161103595|NCT02229539|581771555|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
161103596|NCT00682448|581771556|FG000|Overall Study|Adverse Event|1|||
161103597|NCT00682448|581771557|FG001|Overall Study|Adverse Event|2|||
161103598|NCT00682448|581771556|FG000|Overall Study|Lack of Efficacy|1|||
161103599|NCT00682448|581771557|FG001|Overall Study|Lack of Efficacy|0|||
161103600|NCT00682448|581771556|FG000|Overall Study|Lost to Follow-up|1|||
161103601|NCT00682448|581771557|FG001|Overall Study|Lost to Follow-up|3|||
161103602|NCT00682448|581771556|FG000|Overall Study|Pregnancy|0|||
161103603|NCT00682448|581771557|FG001|Overall Study|Pregnancy|1|||
161103604|NCT00682448|581771556|FG000|Overall Study|Withdrawal by Subject|2|||
161103605|NCT00682448|581771557|FG001|Overall Study|Withdrawal by Subject|0|||
161103606|NCT04050670|581771560|FG000|Period 3|Physician Decision|0|||
161103607|NCT04050670|581771561|FG001|Period 3|Physician Decision|1|||
161103608|NCT04050670|581771562|FG002|Period 3|Physician Decision|0|||
161103609|NCT00268437|581771563|FG000|Overall Study|Ineligible|1|||
161103610|NCT01022996|581771567|FG000|Overall Study|Adverse Event|14|||
161103611|NCT01022996|581771567|FG000|Overall Study|Withdrawal by Subject|3|||
161103612|NCT01022996|581771567|FG000|Overall Study|Lost to Follow-up|1|||
161103613|NCT01022996|581771567|FG000|Overall Study|Administrative problems|6|||
161103614|NCT01022996|581771567|FG000|Overall Study|Disease Progression|32|||
161103615|NCT01022996|581771567|FG000|Overall Study|Protocol Violation|1|||
161103616|NCT02767323|581771568|FG000|Overall Study|Withdrawal by Subject|17|||
161103617|NCT02767323|581771569|FG001|Overall Study|Withdrawal by Subject|5|||
161103618|NCT02767323|581771570|FG002|Overall Study|Withdrawal by Subject|13|||
161103619|NCT02767323|581771571|FG003|Overall Study|Withdrawal by Subject|0|||
161103620|NCT02767323|581771568|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
161103621|NCT02767323|581771569|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
161103622|NCT02767323|581771570|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
161103623|NCT02767323|581771571|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
161103624|NCT00930722|581771572|FG000|Overall Study|Lost to Follow-up|16|||
161103625|NCT00930722|581771572|FG000|Overall Study|No longer willing to participate|9|||
161103626|NCT00930722|581771572|FG000|Overall Study|Study terminated by sponsor|2|||
161103627|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Adverse Event|2|||
161103628|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Adverse Event|2|||
161103629|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Adverse Event|4|||
161103630|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Adverse Event|0|||
161103631|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Adverse Event|0|||
161103632|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Progressive disease|0|||
161103633|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Progressive disease|0|||
161103634|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Progressive disease|1|||
161103635|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Progressive disease|0|||
161103636|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Progressive disease|0|||
161103637|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
161103638|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
161103639|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
161103640|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
161103641|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
161103642|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
161103643|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161103644|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161103645|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161103646|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
161103647|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
161103648|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
161103649|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
161103650|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
161103651|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
161103652|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
161103653|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
161103654|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
161103655|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
161103656|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
161103657|NCT03523728|581771573|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
161103658|NCT03523728|581771574|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
161103659|NCT03523728|581771575|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
161103660|NCT03523728|581771576|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
161103661|NCT03523728|581771577|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
161103662|NCT03523728|581771573|FG000|Stage 2 (24 Months)|Adverse Event|0|||
161103663|NCT03523728|581771574|FG001|Stage 2 (24 Months)|Adverse Event|0|||
161103664|NCT03523728|581771575|FG002|Stage 2 (24 Months)|Adverse Event|0|||
161103665|NCT03523728|581771576|FG003|Stage 2 (24 Months)|Adverse Event|1|||
161103666|NCT03523728|581771577|FG004|Stage 2 (24 Months)|Adverse Event|2|||
161103667|NCT03523728|581771573|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161103668|NCT03523728|581771574|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161103669|NCT03523728|581771575|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161103670|NCT03523728|581771576|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
161103671|NCT03523728|581771577|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
161103672|NCT03523728|581771573|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161103673|NCT03523728|581771574|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161103674|NCT03523728|581771575|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
161103675|NCT03523728|581771576|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
161103676|NCT03523728|581771577|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
161103677|NCT03523728|581771573|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
161103678|NCT03523728|581771574|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
161103679|NCT03523728|581771575|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
161103680|NCT03523728|581771576|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
161103681|NCT03523728|581771577|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
161103682|NCT03523728|581771573|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
161103683|NCT03523728|581771574|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
161103684|NCT03523728|581771575|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
161103685|NCT03523728|581771576|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
161103686|NCT03523728|581771577|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
161103687|NCT01274715|581771578|FG000|Overall Study|Lost to Follow-up|1|||
161103688|NCT01274715|581771578|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161103689|NCT01274715|581771578|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161103690|NCT01274715|581771578|FG000|Overall Study|After consent, met exclusion criteria.|1|||
161103691|NCT03945591|581771581|FG000|Overall Study|Participant not transplanted|1|||
161103692|NCT03945591|581771581|FG000|Overall Study|Change in treatment plan|3|||
161103693|NCT03945591|581771581|FG000|Overall Study|Adverse Event|1|||
161103694|NCT01118325|581771582|FG000|Overall Study|Adverse Event|1|||
161103695|NCT01118325|581771583|FG001|Overall Study|Adverse Event|0|||
161103696|NCT01118325|581771584|FG002|Overall Study|Adverse Event|1|||
161103697|NCT03334409|581771585|FG000|Overall Study|Did not meet inclusion criteria|1|||
161103698|NCT03334409|581771586|FG001|Overall Study|Did not meet inclusion criteria|0|||
161103699|NCT05215262|581771591|FG000|Overall Study|Lost to Follow-up|12|||
161103700|NCT05215262|581771592|FG001|Overall Study|Lost to Follow-up|0|||
161103701|NCT04880447|581771594|FG000|Overall Study|No vaccination information|1|||
161103702|NCT04880447|581771594|FG000|Overall Study|No adverse event information (missing information)|1|||
161103703|NCT04880447|581771594|FG000|Overall Study|Disease not covered in this study|35|||
161103704|NCT04060563|581771600|FG000|Overall Study|Lost to Follow-up|1|||
161103705|NCT04060563|581771601|FG001|Overall Study|Lost to Follow-up|1|||
161103706|NCT04060563|581771600|FG000|Overall Study|Physician Decision|0|||
161103707|NCT04060563|581771601|FG001|Overall Study|Physician Decision|1|||
161103708|NCT01379573|581771606|FG000|Overall Study|Lost to Follow-up|1|||
161103709|NCT01379573|581771606|FG000|Overall Study|Screen Failure|10|||
161103710|NCT01020448|581771620|FG000|Pre-assignment|Adverse Event|6|||
161103711|NCT01020448|581771620|FG000|Pre-assignment|Withdrawal by Subject|5|||
161103712|NCT01020448|581771620|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
161103713|NCT01020448|581771620|FG000|Treatment|Adverse Event|11|||
161103714|NCT01020448|581771620|FG000|Treatment|Consent Withdrawn|3|||
161103715|NCT01020448|581771620|FG000|Treatment|Disease Progression|2|||
161103716|NCT01020448|581771620|FG000|Treatment|Lack of Efficacy|8|||
161103717|NCT01020448|581771620|FG000|Treatment|Lost to Follow-up|2|||
161103718|NCT02871778|581771621|FG000|Part A: Treatment Period 1|Adverse Event|1|||
161103719|NCT02871778|581771622|FG001|Part A: Treatment Period 1|Adverse Event|1|||
161103720|NCT02871778|581771623|FG002|Part A: Treatment Period 1|Adverse Event|1|||
161103721|NCT02871778|581771624|FG003|Part A: Treatment Period 1|Adverse Event|0|||
161103722|NCT02871778|581771625|FG004|Part A: Treatment Period 1|Adverse Event|0|||
161103723|NCT02871778|581771626|FG005|Part A: Treatment Period 1|Adverse Event|0|||
161103724|NCT02871778|581771627|FG006|Part A: Treatment Period 1|Adverse Event|0|||
161103725|NCT02871778|581771628|FG007|Part A: Treatment Period 1|Adverse Event|0|||
161103726|NCT02871778|581771621|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161103727|NCT02871778|581771622|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161103728|NCT02871778|581771623|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161103729|NCT02871778|581771624|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
161103730|NCT02871778|581771625|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161103731|NCT02871778|581771626|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161103732|NCT02871778|581771627|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161103733|NCT02871778|581771628|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
161103734|NCT02871778|581771621|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103735|NCT02871778|581771622|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103736|NCT02871778|581771623|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
161103737|NCT02871778|581771624|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103738|NCT02871778|581771625|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103739|NCT02871778|581771626|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103740|NCT02871778|581771627|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103741|NCT02871778|581771628|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
161103742|NCT02871778|581771621|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103743|NCT02871778|581771622|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103744|NCT02871778|581771623|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
161103745|NCT02871778|581771624|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103746|NCT02871778|581771625|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103747|NCT02871778|581771626|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103748|NCT02871778|581771627|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103749|NCT02871778|581771628|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
161103750|NCT02871778|581771621|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103751|NCT02871778|581771622|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
161103752|NCT02871778|581771623|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103753|NCT02871778|581771624|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103754|NCT02871778|581771625|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103755|NCT02871778|581771626|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103756|NCT02871778|581771627|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103757|NCT02871778|581771628|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
161103758|NCT02871778|581771621|FG000|Part A: Treatment Period 2|Adverse Event|2|||
161103759|NCT02871778|581771622|FG001|Part A: Treatment Period 2|Adverse Event|2|||
161103760|NCT02871778|581771623|FG002|Part A: Treatment Period 2|Adverse Event|0|||
161103761|NCT02871778|581771624|FG003|Part A: Treatment Period 2|Adverse Event|0|||
161103762|NCT02871778|581771625|FG004|Part A: Treatment Period 2|Adverse Event|0|||
161103763|NCT02871778|581771626|FG005|Part A: Treatment Period 2|Adverse Event|0|||
161103764|NCT02871778|581771627|FG006|Part A: Treatment Period 2|Adverse Event|0|||
161103765|NCT02871778|581771628|FG007|Part A: Treatment Period 2|Adverse Event|0|||
161103766|NCT02871778|581771621|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103767|NCT02871778|581771622|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103768|NCT02871778|581771623|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103769|NCT02871778|581771624|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
161103770|NCT02871778|581771625|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103771|NCT02871778|581771626|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103772|NCT02871778|581771627|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103773|NCT02871778|581771628|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
161103774|NCT02871778|581771621|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
161103775|NCT02871778|581771622|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161103776|NCT02871778|581771623|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
161103777|NCT02871778|581771624|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161103778|NCT02871778|581771625|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161103779|NCT02871778|581771626|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161103780|NCT02871778|581771627|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161103781|NCT02871778|581771628|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
161103782|NCT02871778|581771621|FG000|Part B: Treatment Period 3|Adverse Event|0|||
161103783|NCT02871778|581771622|FG001|Part B: Treatment Period 3|Adverse Event|0|||
161103784|NCT02871778|581771623|FG002|Part B: Treatment Period 3|Adverse Event|0|||
161103785|NCT02871778|581771624|FG003|Part B: Treatment Period 3|Adverse Event|0|||
161103786|NCT02871778|581771625|FG004|Part B: Treatment Period 3|Adverse Event|1|||
161103787|NCT02871778|581771626|FG005|Part B: Treatment Period 3|Adverse Event|1|||
161103788|NCT02871778|581771627|FG006|Part B: Treatment Period 3|Adverse Event|1|||
161103789|NCT02871778|581771628|FG007|Part B: Treatment Period 3|Adverse Event|0|||
161103790|NCT02653300|581771629|FG000|Overall Study|Withdrawal by Subject|2|||
161103791|NCT01390272|581771640|FG000|Overall Study|Death|3|||
161103792|NCT01390272|581771641|FG001|Overall Study|Death|2|||
161103793|NCT01390272|581771640|FG000|Overall Study|Withdrawal by Subject|9|||
161103794|NCT01390272|581771641|FG001|Overall Study|Withdrawal by Subject|5|||
161103795|NCT01390272|581771640|FG000|Overall Study|Patient moved, no longer eligible|5|||
161103796|NCT01390272|581771641|FG001|Overall Study|Patient moved, no longer eligible|8|||
161103797|NCT00590044|581771642|FG000|Overall Study|Withdrawal by Subject|2|||
161103798|NCT00590044|581771643|FG001|Overall Study|Withdrawal by Subject|2|||
161103799|NCT00590044|581771642|FG000|Overall Study|wrong insulin arm assigned|1|||
161103800|NCT00590044|581771643|FG001|Overall Study|wrong insulin arm assigned|0|||
161103801|NCT00590044|581771642|FG000|Overall Study|Protocol Violation|1|||
161103802|NCT00590044|581771643|FG001|Overall Study|Protocol Violation|0|||
161103803|NCT01514136|581771644|FG000|Test Period 1; Test A|Protocol Violation|1|||
161103804|NCT01514136|581771645|FG001|Test Period 1; Test A|Protocol Violation|0|||
161103805|NCT01514136|581771646|FG002|Test Period 1; Test A|Protocol Violation|0|||
161103806|NCT01514136|581771647|FG003|Test Period 1; Test A|Protocol Violation|0|||
161103807|NCT01514136|581771648|FG004|Test Period 1; Test A|Protocol Violation|0|||
161103808|NCT01514136|581771649|FG005|Test Period 1; Test A|Protocol Violation|0|||
161103809|NCT01514136|581771650|FG006|Test Period 1; Test A|Protocol Violation|0|||
161103810|NCT01514136|581771651|FG007|Test Period 1; Test A|Protocol Violation|0|||
161103811|NCT01514136|581771644|FG000|Test Period 1; Test A|Break from study holiday|2|||
161103812|NCT01514136|581771645|FG001|Test Period 1; Test A|Break from study holiday|0|||
161103813|NCT01514136|581771646|FG002|Test Period 1; Test A|Break from study holiday|0|||
161103814|NCT01514136|581771647|FG003|Test Period 1; Test A|Break from study holiday|0|||
161103815|NCT01514136|581771648|FG004|Test Period 1; Test A|Break from study holiday|0|||
161103816|NCT01514136|581771649|FG005|Test Period 1; Test A|Break from study holiday|0|||
161103817|NCT01514136|581771650|FG006|Test Period 1; Test A|Break from study holiday|0|||
161103818|NCT01514136|581771651|FG007|Test Period 1; Test A|Break from study holiday|0|||
161103819|NCT01514136|581771644|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
161103820|NCT01514136|581771645|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
161103821|NCT01514136|581771646|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
161103822|NCT01514136|581771647|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
161103823|NCT01514136|581771648|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
161103824|NCT01514136|581771649|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
161103825|NCT01514136|581771650|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
161103826|NCT01514136|581771651|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
161103827|NCT01514136|581771644|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103828|NCT01514136|581771645|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103829|NCT01514136|581771646|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103830|NCT01514136|581771647|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
161103831|NCT01514136|581771648|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103832|NCT01514136|581771649|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103833|NCT01514136|581771650|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103834|NCT01514136|581771651|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
161103835|NCT01514136|581771644|FG000|Test Period 2; Test A*|Adverse Event|0|||
161103836|NCT01514136|581771645|FG001|Test Period 2; Test A*|Adverse Event|0|||
161103837|NCT01514136|581771646|FG002|Test Period 2; Test A*|Adverse Event|0|||
161103838|NCT01514136|581771647|FG003|Test Period 2; Test A*|Adverse Event|0|||
161103839|NCT01514136|581771648|FG004|Test Period 2; Test A*|Adverse Event|1|||
161103840|NCT01514136|581771649|FG005|Test Period 2; Test A*|Adverse Event|0|||
161103841|NCT01514136|581771650|FG006|Test Period 2; Test A*|Adverse Event|0|||
161103842|NCT01514136|581771651|FG007|Test Period 2; Test A*|Adverse Event|0|||
161103843|NCT01514136|581771644|FG000|Test Period 2; Test A*|Holiday|0|||
161103844|NCT01514136|581771645|FG001|Test Period 2; Test A*|Holiday|0|||
161103845|NCT01514136|581771646|FG002|Test Period 2; Test A*|Holiday|0|||
161103846|NCT01514136|581771647|FG003|Test Period 2; Test A*|Holiday|0|||
161103847|NCT01514136|581771648|FG004|Test Period 2; Test A*|Holiday|1|||
161103848|NCT01514136|581771649|FG005|Test Period 2; Test A*|Holiday|0|||
161103849|NCT01514136|581771650|FG006|Test Period 2; Test A*|Holiday|0|||
161103850|NCT01514136|581771651|FG007|Test Period 2; Test A*|Holiday|0|||
161103851|NCT01514136|581771644|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103852|NCT01514136|581771645|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103853|NCT01514136|581771646|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103854|NCT01514136|581771647|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103855|NCT01514136|581771648|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103856|NCT01514136|581771649|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
161103857|NCT01514136|581771650|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103858|NCT01514136|581771651|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
161103859|NCT01514136|581771644|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103860|NCT01514136|581771645|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103861|NCT01514136|581771646|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103862|NCT01514136|581771647|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103863|NCT01514136|581771648|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103864|NCT01514136|581771649|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103865|NCT01514136|581771650|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
161103866|NCT01514136|581771651|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
161103867|NCT01514136|581771644|FG000|Test Period 2; Test C*|holiday|0|||
161103868|NCT01514136|581771645|FG001|Test Period 2; Test C*|holiday|0|||
161103869|NCT01514136|581771646|FG002|Test Period 2; Test C*|holiday|0|||
161103870|NCT01514136|581771647|FG003|Test Period 2; Test C*|holiday|0|||
161103871|NCT01514136|581771648|FG004|Test Period 2; Test C*|holiday|0|||
161103872|NCT01514136|581771649|FG005|Test Period 2; Test C*|holiday|0|||
161103873|NCT01514136|581771650|FG006|Test Period 2; Test C*|holiday|1|||
161103874|NCT01514136|581771651|FG007|Test Period 2; Test C*|holiday|0|||
161103875|NCT01514136|581771644|FG000|Test Period 2; Test C*|Protocol Violation|0|||
161103876|NCT01514136|581771645|FG001|Test Period 2; Test C*|Protocol Violation|0|||
161103877|NCT01514136|581771646|FG002|Test Period 2; Test C*|Protocol Violation|0|||
161103878|NCT01514136|581771647|FG003|Test Period 2; Test C*|Protocol Violation|0|||
161103879|NCT01514136|581771648|FG004|Test Period 2; Test C*|Protocol Violation|0|||
161103880|NCT01514136|581771649|FG005|Test Period 2; Test C*|Protocol Violation|0|||
161103881|NCT01514136|581771650|FG006|Test Period 2; Test C*|Protocol Violation|1|||
161103882|NCT01514136|581771651|FG007|Test Period 2; Test C*|Protocol Violation|0|||
161103883|NCT02729740|581771656|FG000|Overall Study|Early Termination|130|||
161103884|NCT02729740|581771656|FG000|Overall Study|Other|1|||
161103885|NCT00888381|581771657|FG000|Overall Study|Lost to Follow-up|0|||
161103886|NCT00888381|581771658|FG001|Overall Study|Lost to Follow-up|1|||
161103887|NCT00307333|581771659|FG000|Overall Study|Lost to Follow-up|11|||
161103888|NCT00307333|581771660|FG001|Overall Study|Lost to Follow-up|3|||
161103889|NCT03785678|581771661|FG000|Overall Study|Death|44|||
161103890|NCT03785678|581771662|FG001|Overall Study|Death|42|||
161103891|NCT03785678|581771661|FG000|Overall Study|Lost to Follow-up|4|||
161103892|NCT03785678|581771662|FG001|Overall Study|Lost to Follow-up|2|||
161103893|NCT03785678|581771661|FG000|Overall Study|Physician Decision|0|||
161103894|NCT03785678|581771662|FG001|Overall Study|Physician Decision|2|||
161103895|NCT03785678|581771661|FG000|Overall Study|Withdrawal by Subject|5|||
161103896|NCT03785678|581771662|FG001|Overall Study|Withdrawal by Subject|3|||
161103897|NCT01159912|581771663|FG000|Overall Study|Adverse Event|2|||
161103898|NCT01159912|581771664|FG001|Overall Study|Adverse Event|2|||
161103899|NCT01159912|581771665|FG002|Overall Study|Adverse Event|3|||
161103900|NCT01159912|581771663|FG000|Overall Study|Lack of Efficacy|23|||
161103901|NCT01159912|581771664|FG001|Overall Study|Lack of Efficacy|15|||
161103902|NCT01159912|581771665|FG002|Overall Study|Lack of Efficacy|14|||
161103903|NCT01159912|581771663|FG000|Overall Study|Protocol Violation|1|||
161103904|NCT01159912|581771664|FG001|Overall Study|Protocol Violation|2|||
161103905|NCT01159912|581771665|FG002|Overall Study|Protocol Violation|3|||
161103906|NCT01159912|581771663|FG000|Overall Study|Lost to Follow-up|4|||
161103907|NCT01159912|581771664|FG001|Overall Study|Lost to Follow-up|0|||
161103908|NCT01159912|581771665|FG002|Overall Study|Lost to Follow-up|0|||
161103909|NCT01159912|581771663|FG000|Overall Study|Physician Decision|0|||
161103910|NCT01159912|581771664|FG001|Overall Study|Physician Decision|0|||
161103911|NCT01159912|581771665|FG002|Overall Study|Physician Decision|3|||
161103912|NCT01159912|581771663|FG000|Overall Study|Withdrawal by Subject|10|||
161103913|NCT01159912|581771664|FG001|Overall Study|Withdrawal by Subject|3|||
161103914|NCT01159912|581771665|FG002|Overall Study|Withdrawal by Subject|3|||
161103915|NCT00375219|581771666|FG000|Overall Study|Failure to achieve a response|16|||
161103916|NCT00375219|581771667|FG001|Overall Study|Failure to achieve a response|2|||
161103917|NCT00375219|581771668|FG002|Overall Study|Failure to achieve a response|0|||
161103918|NCT00375219|581771666|FG000|Overall Study|Adverse Event|8|||
161103919|NCT00375219|581771667|FG001|Overall Study|Adverse Event|2|||
161103920|NCT00375219|581771668|FG002|Overall Study|Adverse Event|1|||
161103921|NCT00375219|581771666|FG000|Overall Study|Protocol Violation|1|||
161103922|NCT00375219|581771667|FG001|Overall Study|Protocol Violation|0|||
161103923|NCT00375219|581771668|FG002|Overall Study|Protocol Violation|1|||
161103924|NCT00375219|581771666|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
161212553|NCT01963676|582161753|FG001|Overall Study|Withdrawal by Subject|0|||
161103925|NCT00375219|581771667|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
161103926|NCT00375219|581771668|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
161103927|NCT00375219|581771666|FG000|Overall Study|Lost to Follow-up|1|||
161103928|NCT00375219|581771667|FG001|Overall Study|Lost to Follow-up|1|||
161103929|NCT00375219|581771668|FG002|Overall Study|Lost to Follow-up|0|||
161103930|NCT00375219|581771666|FG000|Overall Study|Disease progression|18|||
161103931|NCT00375219|581771667|FG001|Overall Study|Disease progression|9|||
161103932|NCT00375219|581771668|FG002|Overall Study|Disease progression|12|||
161103933|NCT00375219|581771666|FG000|Overall Study|Death|4|||
161103934|NCT00375219|581771667|FG001|Overall Study|Death|3|||
161103935|NCT00375219|581771668|FG002|Overall Study|Death|7|||
161103936|NCT00375219|581771666|FG000|Overall Study|Hematologic resistance|1|||
161103937|NCT00375219|581771667|FG001|Overall Study|Hematologic resistance|0|||
161103938|NCT00375219|581771668|FG002|Overall Study|Hematologic resistance|0|||
161103939|NCT00375219|581771666|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
161103940|NCT00375219|581771667|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
161103941|NCT00375219|581771668|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
161103942|NCT00375219|581771666|FG000|Overall Study|Allograft|2|||
161103943|NCT00375219|581771667|FG001|Overall Study|Allograft|0|||
161103944|NCT00375219|581771668|FG002|Overall Study|Allograft|0|||
161103945|NCT00375219|581771666|FG000|Overall Study|Cord blood transplantation|1|||
161103946|NCT00375219|581771667|FG001|Overall Study|Cord blood transplantation|0|||
161103947|NCT00375219|581771668|FG002|Overall Study|Cord blood transplantation|0|||
161103948|NCT00375219|581771666|FG000|Overall Study|Withdrawal by Subject|1|||
161103949|NCT00375219|581771667|FG001|Overall Study|Withdrawal by Subject|0|||
161103950|NCT00375219|581771668|FG002|Overall Study|Withdrawal by Subject|0|||
161103951|NCT02684279|581771671|FG000|Overall Study|Adverse Event|87|||
161103952|NCT02684279|581771671|FG000|Overall Study|Lack of Efficacy|4|||
161103953|NCT02684279|581771671|FG000|Overall Study|Lost to Follow-up|61|||
161103954|NCT02684279|581771671|FG000|Overall Study|Protocol Violation|6|||
161103955|NCT02684279|581771671|FG000|Overall Study|Pregnancy|8|||
161103956|NCT02684279|581771671|FG000|Overall Study|Withdrawal by Subject|92|||
161103957|NCT02684279|581771671|FG000|Overall Study|non-compliance with study drug|9|||
161103958|NCT02684279|581771671|FG000|Overall Study|non compliance with study visits|2|||
161103959|NCT02684279|581771671|FG000|Overall Study|subject to have surgery|1|||
161103960|NCT02684279|581771671|FG000|Overall Study|family emergency|1|||
161103961|NCT02684279|581771671|FG000|Overall Study|Site closures|7|||
161103962|NCT02684279|581771671|FG000|Overall Study|Physician Decision|1|||
161103963|NCT00228566|581771672|FG000|Overall Study|Adverse Event|31|||
161103964|NCT00228566|581771672|FG000|Overall Study|Lack of Efficacy|14|||
161103965|NCT00228566|581771672|FG000|Overall Study|Lost to Follow-up|16|||
161103966|NCT00228566|581771672|FG000|Overall Study|Physician Decision|5|||
161103967|NCT00228566|581771672|FG000|Overall Study|Withdrawal by Subject|4|||
161103968|NCT00228566|581771672|FG000|Overall Study|Miscellaneous|1|||
161103969|NCT01479829|581771673|FG000|Overall Study|Withdrawal by Subject|8|||
161103970|NCT01479829|581771674|FG001|Overall Study|Withdrawal by Subject|10|||
161103971|NCT01444456|581771679|FG000|Overall Study|Withdrawal by Subject|21|||
161103972|NCT01444456|581771679|FG000|Overall Study|Physician Decision|9|||
161103973|NCT01444456|581771679|FG000|Overall Study|Lost to Follow-up|37|||
161103974|NCT01444456|581771679|FG000|Overall Study|Death|73|||
161103975|NCT01444456|581771679|FG000|Overall Study|Ineligibility determined|23|||
161103976|NCT01444456|581771679|FG000|Overall Study|Other|18|||
161103977|NCT01444456|581771679|FG000|Overall Study|Not treated|104|||
161103978|NCT02142738|581773323|FG000|Overall Study|Adverse Event|13|||
161103979|NCT02142738|581773324|FG001|Overall Study|Adverse Event|9|||
161103980|NCT02142738|581773323|FG000|Overall Study|Death|92|||
161103981|NCT02142738|581773324|FG001|Overall Study|Death|112|||
161103982|NCT02142738|581773323|FG000|Overall Study|Lost to Follow-up|0|||
161103983|NCT02142738|581773324|FG001|Overall Study|Lost to Follow-up|3|||
161103984|NCT02142738|581773323|FG000|Overall Study|Withdrawal by Subject|6|||
161103985|NCT02142738|581773324|FG001|Overall Study|Withdrawal by Subject|7|||
161103986|NCT02142738|581773323|FG000|Overall Study|Follow up ended by sponsor|43|||
161103987|NCT02142738|581773324|FG001|Overall Study|Follow up ended by sponsor|20|||
161103988|NCT00880555|581773326|FG000|Overall Study|Physician Decision|0|||
161103989|NCT00880555|581773327|FG001|Overall Study|Physician Decision|8|||
161103990|NCT00880555|581773328|FG002|Overall Study|Physician Decision|0|||
161103991|NCT00880555|581773329|FG003|Overall Study|Physician Decision|2|||
161103992|NCT00880555|581773330|FG004|Overall Study|Physician Decision|1|||
161103993|NCT00880555|581773331|FG005|Overall Study|Physician Decision|0|||
161103994|NCT00880555|581773326|FG000|Overall Study|Withdrawal by Subject|1|||
161103995|NCT00880555|581773327|FG001|Overall Study|Withdrawal by Subject|1|||
161103996|NCT00880555|581773328|FG002|Overall Study|Withdrawal by Subject|0|||
161103997|NCT00880555|581773329|FG003|Overall Study|Withdrawal by Subject|0|||
161103998|NCT00880555|581773330|FG004|Overall Study|Withdrawal by Subject|0|||
161103999|NCT00880555|581773331|FG005|Overall Study|Withdrawal by Subject|0|||
161104000|NCT00880555|581773326|FG000|Overall Study|Lack of resources (hired rater)|9|||
161104001|NCT00880555|581773327|FG001|Overall Study|Lack of resources (hired rater)|7|||
161104002|NCT00880555|581773328|FG002|Overall Study|Lack of resources (hired rater)|5|||
161104003|NCT00880555|581773329|FG003|Overall Study|Lack of resources (hired rater)|0|||
161104004|NCT00880555|581773330|FG004|Overall Study|Lack of resources (hired rater)|0|||
161104005|NCT00880555|581773331|FG005|Overall Study|Lack of resources (hired rater)|0|||
161104006|NCT00880555|581773326|FG000|Overall Study|Death|0|||
161104007|NCT00880555|581773327|FG001|Overall Study|Death|0|||
161104008|NCT00880555|581773328|FG002|Overall Study|Death|0|||
161104009|NCT00880555|581773329|FG003|Overall Study|Death|0|||
161104010|NCT00880555|581773330|FG004|Overall Study|Death|0|||
161104011|NCT00880555|581773331|FG005|Overall Study|Death|1|||
161104012|NCT00880555|581773326|FG000|Overall Study|Lost to Follow-up|0|||
161104013|NCT00880555|581773327|FG001|Overall Study|Lost to Follow-up|1|||
161104014|NCT00880555|581773328|FG002|Overall Study|Lost to Follow-up|0|||
161104015|NCT00880555|581773329|FG003|Overall Study|Lost to Follow-up|0|||
161104016|NCT00880555|581773330|FG004|Overall Study|Lost to Follow-up|0|||
161104017|NCT00880555|581773331|FG005|Overall Study|Lost to Follow-up|0|||
161104018|NCT04196803|581773332|FG000|Overall Study|Withdrawal by Subject|1|||
161104019|NCT04196803|581773333|FG001|Overall Study|Withdrawal by Subject|3|||
161104020|NCT04196803|581773332|FG000|Overall Study|Adverse Event|4|||
161104021|NCT04196803|581773333|FG001|Overall Study|Adverse Event|2|||
161104022|NCT04196803|581773332|FG000|Overall Study|Lost to Follow-up|0|||
161104023|NCT04196803|581773333|FG001|Overall Study|Lost to Follow-up|1|||
161104024|NCT01168973|581773334|FG000|Overall Study|Progressive Disease|341|||
161104025|NCT01168973|581773335|FG001|Overall Study|Progressive Disease|429|||
161104026|NCT01168973|581773334|FG000|Overall Study|Adverse Event|94|||
161104027|NCT01168973|581773335|FG001|Overall Study|Adverse Event|55|||
161104028|NCT01168973|581773334|FG000|Overall Study|Withdrawal by Subject|90|||
161104029|NCT01168973|581773335|FG001|Overall Study|Withdrawal by Subject|53|||
161104030|NCT01168973|581773334|FG000|Overall Study|Death|42|||
161104031|NCT01168973|581773335|FG001|Overall Study|Death|45|||
161104032|NCT01168973|581773334|FG000|Overall Study|Physician Decision|37|||
161104033|NCT01168973|581773335|FG001|Overall Study|Physician Decision|19|||
161104034|NCT01168973|581773334|FG000|Overall Study|Sponsor Decision|2|||
161104035|NCT01168973|581773335|FG001|Overall Study|Sponsor Decision|1|||
161104036|NCT01168973|581773334|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
161104037|NCT01168973|581773335|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
161104038|NCT00419120|581773339|FG000|Long Term Follow up Period|study ongoing|10|||
161104039|NCT00388505|581773340|FG000|Overall Study|Adverse Event or Death|43|||
161104040|NCT00388505|581773341|FG001|Overall Study|Adverse Event or Death|17|||
161104041|NCT00388505|581773340|FG000|Overall Study|Withdrawal by Subject|24|||
161104042|NCT00388505|581773341|FG001|Overall Study|Withdrawal by Subject|9|||
161104043|NCT00388505|581773340|FG000|Overall Study|Lost to Follow-up|5|||
161104044|NCT00388505|581773341|FG001|Overall Study|Lost to Follow-up|3|||
161104045|NCT00388505|581773340|FG000|Overall Study|Inappropriate Enrollment|0|||
161104046|NCT00388505|581773341|FG001|Overall Study|Inappropriate Enrollment|1|||
161104047|NCT00388505|581773340|FG000|Overall Study|Administrative Reason|1|||
161104048|NCT00388505|581773341|FG001|Overall Study|Administrative Reason|0|||
161104049|NCT00388505|581773340|FG000|Overall Study|Protocol Violation|6|||
161104050|NCT00388505|581773341|FG001|Overall Study|Protocol Violation|5|||
161104051|NCT00388505|581773340|FG000|Overall Study|Unable to classify|4|||
161104052|NCT00388505|581773341|FG001|Overall Study|Unable to classify|3|||
161104053|NCT02667275|581773343|FG000|Overall Study|Protocol Violation|11|||
161104054|NCT02667275|581773344|FG001|Overall Study|Protocol Violation|7|||
161104055|NCT02667275|581773343|FG000|Overall Study|Lost to Follow-up|0|||
161104056|NCT02667275|581773344|FG001|Overall Study|Lost to Follow-up|2|||
161104057|NCT02667275|581773343|FG000|Overall Study|Withdrawal by Subject|0|||
161104058|NCT02667275|581773344|FG001|Overall Study|Withdrawal by Subject|5|||
161104059|NCT02667275|581773343|FG000|Overall Study|Discontinued early without completing|0|||
161104060|NCT02667275|581773344|FG001|Overall Study|Discontinued early without completing|1|||
161104061|NCT01756040|581773345|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
161104062|NCT01756040|581773345|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
161104063|NCT01756040|581773345|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
161104064|NCT00467779|581773348|FG000|Stage 1|Adverse Event|1|||
161104065|NCT00467779|581773349|FG001|Stage 1|Adverse Event|0|||
161104066|NCT00467779|581773350|FG002|Stage 1|Adverse Event|0|||
161104067|NCT00467779|581773351|FG003|Stage 1|Adverse Event|0|||
161104068|NCT00467779|581773352|FG004|Stage 1|Adverse Event|0|||
161104069|NCT00467779|581773353|FG005|Stage 1|Adverse Event|1|||
161104070|NCT00467779|581773354|FG006|Stage 1|Adverse Event|2|||
161104071|NCT00467779|581773355|FG007|Stage 1|Adverse Event|1|||
161104072|NCT00467779|581773356|FG008|Stage 1|Adverse Event|0|||
161104073|NCT00467779|581773357|FG009|Stage 1|Adverse Event|0|||
161104074|NCT00467779|581773358|FG010|Stage 1|Adverse Event|0|||
161104075|NCT00467779|581773359|FG011|Stage 1|Adverse Event|0|||
161104076|NCT00467779|581773360|FG012|Stage 1|Adverse Event|0|||
161104077|NCT00467779|581773361|FG013|Stage 1|Adverse Event|0|||
161104078|NCT00467779|581773362|FG014|Stage 1|Adverse Event|0|||
161212554|NCT00766506|582161754|FG000|Overall Study|Use rescue medication after 3 hours|3|||
161212555|NCT00766506|582161755|FG001|Overall Study|Use rescue medication after 3 hours|0|||
161104079|NCT00467779|581773348|FG000|Stage 1|Disease Progression|2|||
161104080|NCT00467779|581773349|FG001|Stage 1|Disease Progression|2|||
161104081|NCT00467779|581773350|FG002|Stage 1|Disease Progression|2|||
161104082|NCT00467779|581773351|FG003|Stage 1|Disease Progression|3|||
161104083|NCT00467779|581773352|FG004|Stage 1|Disease Progression|2|||
161104084|NCT00467779|581773353|FG005|Stage 1|Disease Progression|2|||
161104085|NCT00467779|581773354|FG006|Stage 1|Disease Progression|4|||
161104086|NCT00467779|581773355|FG007|Stage 1|Disease Progression|5|||
161104087|NCT00467779|581773356|FG008|Stage 1|Disease Progression|0|||
161104088|NCT00467779|581773357|FG009|Stage 1|Disease Progression|0|||
161104089|NCT00467779|581773358|FG010|Stage 1|Disease Progression|0|||
161104090|NCT00467779|581773359|FG011|Stage 1|Disease Progression|0|||
161104091|NCT00467779|581773360|FG012|Stage 1|Disease Progression|0|||
161104092|NCT00467779|581773361|FG013|Stage 1|Disease Progression|0|||
161104093|NCT00467779|581773362|FG014|Stage 1|Disease Progression|0|||
161104094|NCT00467779|581773348|FG000|Stage 1|Unspecified Reason|1|||
161104095|NCT00467779|581773349|FG001|Stage 1|Unspecified Reason|0|||
161104096|NCT00467779|581773350|FG002|Stage 1|Unspecified Reason|1|||
161104097|NCT00467779|581773351|FG003|Stage 1|Unspecified Reason|0|||
161104098|NCT00467779|581773352|FG004|Stage 1|Unspecified Reason|1|||
161104099|NCT00467779|581773353|FG005|Stage 1|Unspecified Reason|2|||
161104100|NCT00467779|581773354|FG006|Stage 1|Unspecified Reason|0|||
161104101|NCT00467779|581773355|FG007|Stage 1|Unspecified Reason|0|||
161104102|NCT00467779|581773356|FG008|Stage 1|Unspecified Reason|0|||
161104103|NCT00467779|581773357|FG009|Stage 1|Unspecified Reason|0|||
161104104|NCT00467779|581773358|FG010|Stage 1|Unspecified Reason|0|||
161104105|NCT00467779|581773359|FG011|Stage 1|Unspecified Reason|0|||
161104106|NCT00467779|581773360|FG012|Stage 1|Unspecified Reason|0|||
161104107|NCT00467779|581773361|FG013|Stage 1|Unspecified Reason|0|||
161104108|NCT00467779|581773362|FG014|Stage 1|Unspecified Reason|0|||
161104109|NCT00467779|581773348|FG000|Stage 1|Physician Decision|0|||
161104110|NCT00467779|581773349|FG001|Stage 1|Physician Decision|1|||
161104111|NCT00467779|581773350|FG002|Stage 1|Physician Decision|0|||
161104112|NCT00467779|581773351|FG003|Stage 1|Physician Decision|0|||
161104113|NCT00467779|581773352|FG004|Stage 1|Physician Decision|0|||
161104114|NCT00467779|581773353|FG005|Stage 1|Physician Decision|0|||
161104115|NCT00467779|581773354|FG006|Stage 1|Physician Decision|0|||
161104116|NCT00467779|581773355|FG007|Stage 1|Physician Decision|0|||
161104117|NCT00467779|581773356|FG008|Stage 1|Physician Decision|0|||
161104118|NCT00467779|581773357|FG009|Stage 1|Physician Decision|0|||
161104119|NCT00467779|581773358|FG010|Stage 1|Physician Decision|0|||
161104120|NCT00467779|581773359|FG011|Stage 1|Physician Decision|0|||
161104121|NCT00467779|581773360|FG012|Stage 1|Physician Decision|0|||
161104122|NCT00467779|581773361|FG013|Stage 1|Physician Decision|0|||
161104123|NCT00467779|581773362|FG014|Stage 1|Physician Decision|0|||
161104124|NCT00467779|581773348|FG000|Stage 1|Withdrawal by Subject|0|||
161104125|NCT00467779|581773349|FG001|Stage 1|Withdrawal by Subject|0|||
161104126|NCT00467779|581773350|FG002|Stage 1|Withdrawal by Subject|0|||
161104127|NCT00467779|581773351|FG003|Stage 1|Withdrawal by Subject|0|||
161104128|NCT00467779|581773352|FG004|Stage 1|Withdrawal by Subject|0|||
161104129|NCT00467779|581773353|FG005|Stage 1|Withdrawal by Subject|0|||
161104130|NCT00467779|581773354|FG006|Stage 1|Withdrawal by Subject|1|||
161104131|NCT00467779|581773355|FG007|Stage 1|Withdrawal by Subject|1|||
161104132|NCT00467779|581773356|FG008|Stage 1|Withdrawal by Subject|0|||
161104133|NCT00467779|581773357|FG009|Stage 1|Withdrawal by Subject|0|||
161104134|NCT00467779|581773358|FG010|Stage 1|Withdrawal by Subject|0|||
161104135|NCT00467779|581773359|FG011|Stage 1|Withdrawal by Subject|0|||
161104136|NCT00467779|581773360|FG012|Stage 1|Withdrawal by Subject|0|||
161104137|NCT00467779|581773361|FG013|Stage 1|Withdrawal by Subject|0|||
161104138|NCT00467779|581773362|FG014|Stage 1|Withdrawal by Subject|0|||
161104139|NCT00467779|581773348|FG000|Stage 1A|Adverse Event|0|||
161104140|NCT00467779|581773349|FG001|Stage 1A|Adverse Event|0|||
161104141|NCT00467779|581773350|FG002|Stage 1A|Adverse Event|0|||
161104142|NCT00467779|581773351|FG003|Stage 1A|Adverse Event|0|||
161104143|NCT00467779|581773352|FG004|Stage 1A|Adverse Event|0|||
161104144|NCT00467779|581773353|FG005|Stage 1A|Adverse Event|0|||
161104145|NCT00467779|581773354|FG006|Stage 1A|Adverse Event|0|||
161104146|NCT00467779|581773355|FG007|Stage 1A|Adverse Event|0|||
161104147|NCT00467779|581773356|FG008|Stage 1A|Adverse Event|0|||
161104148|NCT00467779|581773357|FG009|Stage 1A|Adverse Event|0|||
161104149|NCT00467779|581773358|FG010|Stage 1A|Adverse Event|0|||
161104150|NCT00467779|581773359|FG011|Stage 1A|Adverse Event|0|||
161104151|NCT00467779|581773360|FG012|Stage 1A|Adverse Event|1|||
161104152|NCT00467779|581773361|FG013|Stage 1A|Adverse Event|0|||
161104153|NCT00467779|581773362|FG014|Stage 1A|Adverse Event|0|||
161104154|NCT00467779|581773348|FG000|Stage 1A|Death|0|||
161104155|NCT00467779|581773349|FG001|Stage 1A|Death|0|||
161104156|NCT00467779|581773350|FG002|Stage 1A|Death|0|||
161104157|NCT00467779|581773351|FG003|Stage 1A|Death|0|||
161104158|NCT00467779|581773352|FG004|Stage 1A|Death|0|||
161104159|NCT00467779|581773353|FG005|Stage 1A|Death|0|||
161104160|NCT00467779|581773354|FG006|Stage 1A|Death|0|||
161104161|NCT00467779|581773355|FG007|Stage 1A|Death|0|||
161104162|NCT00467779|581773356|FG008|Stage 1A|Death|0|||
161104163|NCT00467779|581773357|FG009|Stage 1A|Death|0|||
161104164|NCT00467779|581773358|FG010|Stage 1A|Death|0|||
161104165|NCT00467779|581773359|FG011|Stage 1A|Death|1|||
161104166|NCT00467779|581773360|FG012|Stage 1A|Death|1|||
161104167|NCT00467779|581773361|FG013|Stage 1A|Death|0|||
161104168|NCT00467779|581773362|FG014|Stage 1A|Death|0|||
161104169|NCT00467779|581773348|FG000|Stage 1A|Disease Progression|0|||
161104170|NCT00467779|581773349|FG001|Stage 1A|Disease Progression|0|||
161104171|NCT00467779|581773350|FG002|Stage 1A|Disease Progression|0|||
161104172|NCT00467779|581773351|FG003|Stage 1A|Disease Progression|0|||
161104173|NCT00467779|581773352|FG004|Stage 1A|Disease Progression|0|||
161104174|NCT00467779|581773353|FG005|Stage 1A|Disease Progression|0|||
161104175|NCT00467779|581773354|FG006|Stage 1A|Disease Progression|0|||
161104176|NCT00467779|581773355|FG007|Stage 1A|Disease Progression|0|||
161104177|NCT00467779|581773356|FG008|Stage 1A|Disease Progression|0|||
161104178|NCT00467779|581773357|FG009|Stage 1A|Disease Progression|2|||
161104179|NCT00467779|581773358|FG010|Stage 1A|Disease Progression|2|||
161104180|NCT00467779|581773359|FG011|Stage 1A|Disease Progression|5|||
161104181|NCT00467779|581773360|FG012|Stage 1A|Disease Progression|2|||
161104182|NCT00467779|581773361|FG013|Stage 1A|Disease Progression|0|||
161104183|NCT00467779|581773362|FG014|Stage 1A|Disease Progression|0|||
161104184|NCT00467779|581773348|FG000|Stage 1A|Physician Decision|0|||
161104185|NCT00467779|581773349|FG001|Stage 1A|Physician Decision|0|||
161104186|NCT00467779|581773350|FG002|Stage 1A|Physician Decision|0|||
161104187|NCT00467779|581773351|FG003|Stage 1A|Physician Decision|0|||
161104188|NCT00467779|581773352|FG004|Stage 1A|Physician Decision|0|||
161104189|NCT00467779|581773353|FG005|Stage 1A|Physician Decision|0|||
161104190|NCT00467779|581773354|FG006|Stage 1A|Physician Decision|0|||
161104191|NCT00467779|581773355|FG007|Stage 1A|Physician Decision|0|||
161104192|NCT00467779|581773356|FG008|Stage 1A|Physician Decision|0|||
161104193|NCT00467779|581773357|FG009|Stage 1A|Physician Decision|1|||
161104194|NCT00467779|581773358|FG010|Stage 1A|Physician Decision|0|||
161104195|NCT00467779|581773359|FG011|Stage 1A|Physician Decision|0|||
161104196|NCT00467779|581773360|FG012|Stage 1A|Physician Decision|0|||
161104197|NCT00467779|581773361|FG013|Stage 1A|Physician Decision|0|||
161104198|NCT00467779|581773362|FG014|Stage 1A|Physician Decision|0|||
161104199|NCT00467779|581773348|FG000|Stage 1A|Withdrawal by Subject|0|||
161104200|NCT00467779|581773349|FG001|Stage 1A|Withdrawal by Subject|0|||
161104201|NCT00467779|581773350|FG002|Stage 1A|Withdrawal by Subject|0|||
161104202|NCT00467779|581773351|FG003|Stage 1A|Withdrawal by Subject|0|||
161104203|NCT00467779|581773352|FG004|Stage 1A|Withdrawal by Subject|0|||
161104204|NCT00467779|581773353|FG005|Stage 1A|Withdrawal by Subject|0|||
161104205|NCT00467779|581773354|FG006|Stage 1A|Withdrawal by Subject|0|||
161104206|NCT00467779|581773355|FG007|Stage 1A|Withdrawal by Subject|0|||
161104207|NCT00467779|581773356|FG008|Stage 1A|Withdrawal by Subject|0|||
161104208|NCT00467779|581773357|FG009|Stage 1A|Withdrawal by Subject|0|||
161104209|NCT00467779|581773358|FG010|Stage 1A|Withdrawal by Subject|1|||
161104210|NCT00467779|581773359|FG011|Stage 1A|Withdrawal by Subject|1|||
161104211|NCT00467779|581773360|FG012|Stage 1A|Withdrawal by Subject|1|||
161104212|NCT00467779|581773361|FG013|Stage 1A|Withdrawal by Subject|0|||
161104213|NCT00467779|581773362|FG014|Stage 1A|Withdrawal by Subject|0|||
161104214|NCT00467779|581773348|FG000|Stage 1A|Unspecified Reason|0|||
161104215|NCT00467779|581773349|FG001|Stage 1A|Unspecified Reason|0|||
161104216|NCT00467779|581773350|FG002|Stage 1A|Unspecified Reason|0|||
161104217|NCT00467779|581773351|FG003|Stage 1A|Unspecified Reason|0|||
161104218|NCT00467779|581773352|FG004|Stage 1A|Unspecified Reason|0|||
161104219|NCT00467779|581773353|FG005|Stage 1A|Unspecified Reason|0|||
161104220|NCT00467779|581773354|FG006|Stage 1A|Unspecified Reason|0|||
161104221|NCT00467779|581773355|FG007|Stage 1A|Unspecified Reason|0|||
161104222|NCT00467779|581773356|FG008|Stage 1A|Unspecified Reason|0|||
161104223|NCT00467779|581773357|FG009|Stage 1A|Unspecified Reason|0|||
161104224|NCT00467779|581773358|FG010|Stage 1A|Unspecified Reason|0|||
161104225|NCT00467779|581773359|FG011|Stage 1A|Unspecified Reason|1|||
161104226|NCT00467779|581773360|FG012|Stage 1A|Unspecified Reason|1|||
161104227|NCT00467779|581773361|FG013|Stage 1A|Unspecified Reason|0|||
161104228|NCT00467779|581773362|FG014|Stage 1A|Unspecified Reason|0|||
161104229|NCT00467779|581773348|FG000|Stage 2|Adverse Event|0|||
161104230|NCT00467779|581773349|FG001|Stage 2|Adverse Event|0|||
161104231|NCT00467779|581773350|FG002|Stage 2|Adverse Event|0|||
161104232|NCT00467779|581773351|FG003|Stage 2|Adverse Event|0|||
161104233|NCT00467779|581773352|FG004|Stage 2|Adverse Event|0|||
161104234|NCT00467779|581773353|FG005|Stage 2|Adverse Event|0|||
161104235|NCT00467779|581773354|FG006|Stage 2|Adverse Event|0|||
161104236|NCT00467779|581773355|FG007|Stage 2|Adverse Event|0|||
161104237|NCT00467779|581773356|FG008|Stage 2|Adverse Event|1|||
161104238|NCT00467779|581773357|FG009|Stage 2|Adverse Event|0|||
161104239|NCT00467779|581773358|FG010|Stage 2|Adverse Event|0|||
161104240|NCT00467779|581773359|FG011|Stage 2|Adverse Event|0|||
161104241|NCT00467779|581773360|FG012|Stage 2|Adverse Event|0|||
161104242|NCT00467779|581773361|FG013|Stage 2|Adverse Event|0|||
161104243|NCT00467779|581773362|FG014|Stage 2|Adverse Event|0|||
161104244|NCT00467779|581773348|FG000|Stage 2|Death|0|||
161104245|NCT00467779|581773349|FG001|Stage 2|Death|0|||
161104246|NCT00467779|581773350|FG002|Stage 2|Death|0|||
161104247|NCT00467779|581773351|FG003|Stage 2|Death|0|||
161104248|NCT00467779|581773352|FG004|Stage 2|Death|0|||
161104249|NCT00467779|581773353|FG005|Stage 2|Death|0|||
161104250|NCT00467779|581773354|FG006|Stage 2|Death|0|||
161104251|NCT00467779|581773355|FG007|Stage 2|Death|0|||
161104252|NCT00467779|581773356|FG008|Stage 2|Death|1|||
161104253|NCT00467779|581773357|FG009|Stage 2|Death|0|||
161104254|NCT00467779|581773358|FG010|Stage 2|Death|0|||
161104255|NCT00467779|581773359|FG011|Stage 2|Death|0|||
161104256|NCT00467779|581773360|FG012|Stage 2|Death|0|||
161104257|NCT00467779|581773361|FG013|Stage 2|Death|0|||
161104258|NCT00467779|581773362|FG014|Stage 2|Death|0|||
161104259|NCT00467779|581773348|FG000|Stage 2|Disease Progression|0|||
161104260|NCT00467779|581773349|FG001|Stage 2|Disease Progression|0|||
161104261|NCT00467779|581773350|FG002|Stage 2|Disease Progression|0|||
161104262|NCT00467779|581773351|FG003|Stage 2|Disease Progression|0|||
161104263|NCT00467779|581773352|FG004|Stage 2|Disease Progression|0|||
161104264|NCT00467779|581773353|FG005|Stage 2|Disease Progression|0|||
161104265|NCT00467779|581773354|FG006|Stage 2|Disease Progression|0|||
161104266|NCT00467779|581773355|FG007|Stage 2|Disease Progression|0|||
161104267|NCT00467779|581773356|FG008|Stage 2|Disease Progression|16|||
161104268|NCT00467779|581773357|FG009|Stage 2|Disease Progression|0|||
161104269|NCT00467779|581773358|FG010|Stage 2|Disease Progression|0|||
161104270|NCT00467779|581773359|FG011|Stage 2|Disease Progression|0|||
161104271|NCT00467779|581773360|FG012|Stage 2|Disease Progression|0|||
161104272|NCT00467779|581773361|FG013|Stage 2|Disease Progression|0|||
161104273|NCT00467779|581773362|FG014|Stage 2|Disease Progression|0|||
161104274|NCT00467779|581773348|FG000|Stage 2|Unspecified Reason|0|||
161104275|NCT00467779|581773349|FG001|Stage 2|Unspecified Reason|0|||
161104276|NCT00467779|581773350|FG002|Stage 2|Unspecified Reason|0|||
161104277|NCT00467779|581773351|FG003|Stage 2|Unspecified Reason|0|||
161104278|NCT00467779|581773352|FG004|Stage 2|Unspecified Reason|0|||
161104279|NCT00467779|581773353|FG005|Stage 2|Unspecified Reason|0|||
161104280|NCT00467779|581773354|FG006|Stage 2|Unspecified Reason|0|||
161104281|NCT00467779|581773355|FG007|Stage 2|Unspecified Reason|0|||
161104282|NCT00467779|581773356|FG008|Stage 2|Unspecified Reason|3|||
161104283|NCT00467779|581773357|FG009|Stage 2|Unspecified Reason|0|||
161104284|NCT00467779|581773358|FG010|Stage 2|Unspecified Reason|0|||
161104285|NCT00467779|581773359|FG011|Stage 2|Unspecified Reason|0|||
161104286|NCT00467779|581773360|FG012|Stage 2|Unspecified Reason|0|||
161104287|NCT00467779|581773361|FG013|Stage 2|Unspecified Reason|0|||
161104288|NCT00467779|581773362|FG014|Stage 2|Unspecified Reason|0|||
161104289|NCT00467779|581773348|FG000|Stage 2A|Adverse Event|0|||
161104290|NCT00467779|581773349|FG001|Stage 2A|Adverse Event|0|||
161104291|NCT00467779|581773350|FG002|Stage 2A|Adverse Event|0|||
161104292|NCT00467779|581773351|FG003|Stage 2A|Adverse Event|0|||
161104293|NCT00467779|581773352|FG004|Stage 2A|Adverse Event|0|||
161104294|NCT00467779|581773353|FG005|Stage 2A|Adverse Event|0|||
161104295|NCT00467779|581773354|FG006|Stage 2A|Adverse Event|0|||
161104296|NCT00467779|581773355|FG007|Stage 2A|Adverse Event|0|||
161104297|NCT00467779|581773356|FG008|Stage 2A|Adverse Event|0|||
161104298|NCT00467779|581773357|FG009|Stage 2A|Adverse Event|0|||
161104299|NCT00467779|581773358|FG010|Stage 2A|Adverse Event|0|||
161104300|NCT00467779|581773359|FG011|Stage 2A|Adverse Event|0|||
161104301|NCT00467779|581773360|FG012|Stage 2A|Adverse Event|0|||
161104302|NCT00467779|581773361|FG013|Stage 2A|Adverse Event|2|||
161104303|NCT00467779|581773362|FG014|Stage 2A|Adverse Event|0|||
161104304|NCT00467779|581773348|FG000|Stage 2A|Death|0|||
161104305|NCT00467779|581773349|FG001|Stage 2A|Death|0|||
161104306|NCT00467779|581773350|FG002|Stage 2A|Death|0|||
161104307|NCT00467779|581773351|FG003|Stage 2A|Death|0|||
161104308|NCT00467779|581773352|FG004|Stage 2A|Death|0|||
161104309|NCT00467779|581773353|FG005|Stage 2A|Death|0|||
161104310|NCT00467779|581773354|FG006|Stage 2A|Death|0|||
161104311|NCT00467779|581773355|FG007|Stage 2A|Death|0|||
161104312|NCT00467779|581773356|FG008|Stage 2A|Death|0|||
161104313|NCT00467779|581773357|FG009|Stage 2A|Death|0|||
161104314|NCT00467779|581773358|FG010|Stage 2A|Death|0|||
161104315|NCT00467779|581773359|FG011|Stage 2A|Death|0|||
161104316|NCT00467779|581773360|FG012|Stage 2A|Death|0|||
161104317|NCT00467779|581773361|FG013|Stage 2A|Death|1|||
161104318|NCT00467779|581773362|FG014|Stage 2A|Death|0|||
161104319|NCT00467779|581773348|FG000|Stage 2A|Disease Progression|0|||
161104320|NCT00467779|581773349|FG001|Stage 2A|Disease Progression|0|||
161104321|NCT00467779|581773350|FG002|Stage 2A|Disease Progression|0|||
161104322|NCT00467779|581773351|FG003|Stage 2A|Disease Progression|0|||
161104323|NCT00467779|581773352|FG004|Stage 2A|Disease Progression|0|||
161104324|NCT00467779|581773353|FG005|Stage 2A|Disease Progression|0|||
161104325|NCT00467779|581773354|FG006|Stage 2A|Disease Progression|0|||
161104326|NCT00467779|581773355|FG007|Stage 2A|Disease Progression|0|||
161104327|NCT00467779|581773356|FG008|Stage 2A|Disease Progression|0|||
161104328|NCT00467779|581773357|FG009|Stage 2A|Disease Progression|0|||
161104329|NCT00467779|581773358|FG010|Stage 2A|Disease Progression|0|||
161104330|NCT00467779|581773359|FG011|Stage 2A|Disease Progression|0|||
161104331|NCT00467779|581773360|FG012|Stage 2A|Disease Progression|0|||
161104332|NCT00467779|581773361|FG013|Stage 2A|Disease Progression|10|||
161104333|NCT00467779|581773362|FG014|Stage 2A|Disease Progression|0|||
161104334|NCT00467779|581773348|FG000|Stage 2A|Unspecified Reason|0|||
161104335|NCT00467779|581773349|FG001|Stage 2A|Unspecified Reason|0|||
161104336|NCT00467779|581773350|FG002|Stage 2A|Unspecified Reason|0|||
161104337|NCT00467779|581773351|FG003|Stage 2A|Unspecified Reason|0|||
161104338|NCT00467779|581773352|FG004|Stage 2A|Unspecified Reason|0|||
161104339|NCT00467779|581773353|FG005|Stage 2A|Unspecified Reason|0|||
161104340|NCT00467779|581773354|FG006|Stage 2A|Unspecified Reason|0|||
161104341|NCT00467779|581773355|FG007|Stage 2A|Unspecified Reason|0|||
161104342|NCT00467779|581773356|FG008|Stage 2A|Unspecified Reason|0|||
161104343|NCT00467779|581773357|FG009|Stage 2A|Unspecified Reason|0|||
161104344|NCT00467779|581773358|FG010|Stage 2A|Unspecified Reason|0|||
161104345|NCT00467779|581773359|FG011|Stage 2A|Unspecified Reason|0|||
161104346|NCT00467779|581773360|FG012|Stage 2A|Unspecified Reason|0|||
161104347|NCT00467779|581773361|FG013|Stage 2A|Unspecified Reason|7|||
161104348|NCT00467779|581773362|FG014|Stage 2A|Unspecified Reason|0|||
161104349|NCT00467779|581773348|FG000|Stage 2A|Withdrawal by Subject|0|||
161104350|NCT00467779|581773349|FG001|Stage 2A|Withdrawal by Subject|0|||
161104351|NCT00467779|581773350|FG002|Stage 2A|Withdrawal by Subject|0|||
161104352|NCT00467779|581773351|FG003|Stage 2A|Withdrawal by Subject|0|||
161104353|NCT00467779|581773352|FG004|Stage 2A|Withdrawal by Subject|0|||
161104354|NCT00467779|581773353|FG005|Stage 2A|Withdrawal by Subject|0|||
161104355|NCT00467779|581773354|FG006|Stage 2A|Withdrawal by Subject|0|||
161104356|NCT00467779|581773355|FG007|Stage 2A|Withdrawal by Subject|0|||
161104357|NCT00467779|581773356|FG008|Stage 2A|Withdrawal by Subject|0|||
161104358|NCT00467779|581773357|FG009|Stage 2A|Withdrawal by Subject|0|||
161104359|NCT00467779|581773358|FG010|Stage 2A|Withdrawal by Subject|0|||
161104360|NCT00467779|581773359|FG011|Stage 2A|Withdrawal by Subject|0|||
161104361|NCT00467779|581773360|FG012|Stage 2A|Withdrawal by Subject|0|||
161104362|NCT00467779|581773361|FG013|Stage 2A|Withdrawal by Subject|1|||
161104363|NCT00467779|581773362|FG014|Stage 2A|Withdrawal by Subject|0|||
161104364|NCT00467779|581773348|FG000|Stage 3|Adverse Event|0|||
161104365|NCT00467779|581773349|FG001|Stage 3|Adverse Event|0|||
161104366|NCT00467779|581773350|FG002|Stage 3|Adverse Event|0|||
161104367|NCT00467779|581773351|FG003|Stage 3|Adverse Event|0|||
161104368|NCT00467779|581773352|FG004|Stage 3|Adverse Event|0|||
161104369|NCT00467779|581773353|FG005|Stage 3|Adverse Event|0|||
161104370|NCT00467779|581773354|FG006|Stage 3|Adverse Event|0|||
161104371|NCT00467779|581773355|FG007|Stage 3|Adverse Event|0|||
161104372|NCT00467779|581773356|FG008|Stage 3|Adverse Event|0|||
161104373|NCT00467779|581773357|FG009|Stage 3|Adverse Event|0|||
161104374|NCT00467779|581773358|FG010|Stage 3|Adverse Event|0|||
161104375|NCT00467779|581773359|FG011|Stage 3|Adverse Event|0|||
161104376|NCT00467779|581773360|FG012|Stage 3|Adverse Event|0|||
161104377|NCT00467779|581773361|FG013|Stage 3|Adverse Event|0|||
161104378|NCT00467779|581773362|FG014|Stage 3|Adverse Event|2|||
161104379|NCT00467779|581773348|FG000|Stage 3|Death|0|||
161104380|NCT00467779|581773349|FG001|Stage 3|Death|0|||
161104381|NCT00467779|581773350|FG002|Stage 3|Death|0|||
161104382|NCT00467779|581773351|FG003|Stage 3|Death|0|||
161104383|NCT00467779|581773352|FG004|Stage 3|Death|0|||
161104384|NCT00467779|581773353|FG005|Stage 3|Death|0|||
161104385|NCT00467779|581773354|FG006|Stage 3|Death|0|||
161104386|NCT00467779|581773355|FG007|Stage 3|Death|0|||
161104387|NCT00467779|581773356|FG008|Stage 3|Death|0|||
161104388|NCT00467779|581773357|FG009|Stage 3|Death|0|||
161104389|NCT00467779|581773358|FG010|Stage 3|Death|0|||
161104390|NCT00467779|581773359|FG011|Stage 3|Death|0|||
161104391|NCT00467779|581773360|FG012|Stage 3|Death|0|||
161104392|NCT00467779|581773361|FG013|Stage 3|Death|0|||
161104393|NCT00467779|581773362|FG014|Stage 3|Death|1|||
161104394|NCT00467779|581773348|FG000|Stage 3|Disease Progression|0|||
161104395|NCT00467779|581773349|FG001|Stage 3|Disease Progression|0|||
161104396|NCT00467779|581773350|FG002|Stage 3|Disease Progression|0|||
161104397|NCT00467779|581773351|FG003|Stage 3|Disease Progression|0|||
161104398|NCT00467779|581773352|FG004|Stage 3|Disease Progression|0|||
161104399|NCT00467779|581773353|FG005|Stage 3|Disease Progression|0|||
161104400|NCT00467779|581773354|FG006|Stage 3|Disease Progression|0|||
161104401|NCT00467779|581773355|FG007|Stage 3|Disease Progression|0|||
161104402|NCT00467779|581773356|FG008|Stage 3|Disease Progression|0|||
161104403|NCT00467779|581773357|FG009|Stage 3|Disease Progression|0|||
161104404|NCT00467779|581773358|FG010|Stage 3|Disease Progression|0|||
161104405|NCT00467779|581773359|FG011|Stage 3|Disease Progression|0|||
161104406|NCT00467779|581773360|FG012|Stage 3|Disease Progression|0|||
161104407|NCT00467779|581773361|FG013|Stage 3|Disease Progression|0|||
161104408|NCT00467779|581773362|FG014|Stage 3|Disease Progression|9|||
161104409|NCT00467779|581773348|FG000|Stage 3|Unspecified Reason|0|||
161104410|NCT00467779|581773349|FG001|Stage 3|Unspecified Reason|0|||
161104411|NCT00467779|581773350|FG002|Stage 3|Unspecified Reason|0|||
161104412|NCT00467779|581773351|FG003|Stage 3|Unspecified Reason|0|||
161104413|NCT00467779|581773352|FG004|Stage 3|Unspecified Reason|0|||
161104414|NCT00467779|581773353|FG005|Stage 3|Unspecified Reason|0|||
161104415|NCT00467779|581773354|FG006|Stage 3|Unspecified Reason|0|||
161104416|NCT00467779|581773355|FG007|Stage 3|Unspecified Reason|0|||
161104417|NCT00467779|581773356|FG008|Stage 3|Unspecified Reason|0|||
161104418|NCT00467779|581773357|FG009|Stage 3|Unspecified Reason|0|||
161104419|NCT00467779|581773358|FG010|Stage 3|Unspecified Reason|0|||
161104420|NCT00467779|581773359|FG011|Stage 3|Unspecified Reason|0|||
161104421|NCT00467779|581773360|FG012|Stage 3|Unspecified Reason|0|||
161104422|NCT00467779|581773361|FG013|Stage 3|Unspecified Reason|0|||
161104423|NCT00467779|581773362|FG014|Stage 3|Unspecified Reason|5|||
161104424|NCT01509079|581773363|FG000|Overall Study|Lack of Efficacy|0|||
161104425|NCT01509079|581773364|FG001|Overall Study|Lack of Efficacy|2|||
161104426|NCT01509079|581773363|FG000|Overall Study|started an excluded medication|0|||
161104427|NCT01509079|581773364|FG001|Overall Study|started an excluded medication|1|||
161104428|NCT01195090|581773365|FG000|Overall Study|Adverse Event|1|||
161104429|NCT01195090|581773366|FG001|Overall Study|Adverse Event|2|||
161104430|NCT01195090|581773365|FG000|Overall Study|Lost to Follow-up|2|||
161104431|NCT01195090|581773366|FG001|Overall Study|Lost to Follow-up|2|||
161104432|NCT01195090|581773365|FG000|Overall Study|Protocol Violation|3|||
161104433|NCT01195090|581773366|FG001|Overall Study|Protocol Violation|4|||
161104434|NCT05111041|581773367|FG000|Overall Study|Lost to Follow-up|6|||
161104435|NCT05111041|581773368|FG001|Overall Study|Lost to Follow-up|7|||
161104436|NCT05111041|581773367|FG000|Overall Study|Withdrawal by Subject|1|||
161104437|NCT05111041|581773368|FG001|Overall Study|Withdrawal by Subject|0|||
161104438|NCT04912245|581773369|FG000|Overall Study|Withdrawal by Subject|21|||
161104439|NCT04912245|581773370|FG001|Overall Study|Withdrawal by Subject|4|||
161104440|NCT04912245|581773369|FG000|Overall Study|Lost to Follow-up|5|||
161104441|NCT04912245|581773370|FG001|Overall Study|Lost to Follow-up|11|||
161104442|NCT01205230|581773371|FG000|Overall Study|Adverse Event|4|||
161104443|NCT01205230|581773372|FG001|Overall Study|Adverse Event|0|||
161104444|NCT01205230|581773371|FG000|Overall Study|Physician Decision|1|||
161104445|NCT01205230|581773372|FG001|Overall Study|Physician Decision|0|||
161104446|NCT00041080|581773373|FG000|Overall Study|Adverse Event|21|||
161104447|NCT00041080|581773374|FG001|Overall Study|Adverse Event|1|||
161104448|NCT00041080|581773373|FG000|Overall Study|Withdrawal by Subject|6|||
161104449|NCT00041080|581773374|FG001|Overall Study|Withdrawal by Subject|6|||
161104450|NCT00041080|581773373|FG000|Overall Study|Concommitant Illness/Other|1|||
161104451|NCT00041080|581773374|FG001|Overall Study|Concommitant Illness/Other|2|||
161104452|NCT00041080|581773373|FG000|Overall Study|Did not start therapy|1|||
161104453|NCT00041080|581773374|FG001|Overall Study|Did not start therapy|1|||
161104454|NCT00041080|581773373|FG000|Overall Study|Ineligible|1|||
161104455|NCT00041080|581773374|FG001|Overall Study|Ineligible|0|||
161104456|NCT01179672|581773375|FG000|Overall Study|Adverse Event|17|||
161104457|NCT01179672|581773376|FG001|Overall Study|Adverse Event|8|||
161104458|NCT01179672|581773375|FG000|Overall Study|Withdrawal by Subject|10|||
161104459|NCT01179672|581773376|FG001|Overall Study|Withdrawal by Subject|12|||
161104460|NCT01179672|581773375|FG000|Overall Study|Entry Criteria Not Met|0|||
161104461|NCT01179672|581773376|FG001|Overall Study|Entry Criteria Not Met|2|||
161104462|NCT01179672|581773375|FG000|Overall Study|Lost to Follow-up|0|||
161104463|NCT01179672|581773376|FG001|Overall Study|Lost to Follow-up|1|||
161104464|NCT01179672|581773375|FG000|Overall Study|Protocol Violation|2|||
161104465|NCT01179672|581773376|FG001|Overall Study|Protocol Violation|2|||
161104466|NCT01179672|581773375|FG000|Overall Study|Physician Decision|1|||
161104467|NCT01179672|581773376|FG001|Overall Study|Physician Decision|1|||
161104468|NCT01994382|581773377|FG000|Overall Study|Informed consent withdrawn|0|||
161104469|NCT01994382|581773378|FG001|Overall Study|Informed consent withdrawn|0|||
161104470|NCT01994382|581773379|FG002|Overall Study|Informed consent withdrawn|0|||
161104471|NCT01994382|581773380|FG003|Overall Study|Informed consent withdrawn|0|||
161104472|NCT01994382|581773381|FG004|Overall Study|Informed consent withdrawn|0|||
161104473|NCT01994382|581773382|FG005|Overall Study|Informed consent withdrawn|0|||
161104474|NCT01994382|581773383|FG006|Overall Study|Informed consent withdrawn|1|||
161104475|NCT01994382|581773384|FG007|Overall Study|Informed consent withdrawn|0|||
161104476|NCT01994382|581773385|FG008|Overall Study|Informed consent withdrawn|0|||
161104477|NCT01994382|581773386|FG009|Overall Study|Informed consent withdrawn|0|||
161104478|NCT01994382|581773387|FG010|Overall Study|Informed consent withdrawn|0|||
161104479|NCT01994382|581773388|FG011|Overall Study|Informed consent withdrawn|0|||
161104480|NCT01994382|581773389|FG012|Overall Study|Informed consent withdrawn|0|||
161104481|NCT01994382|581773390|FG013|Overall Study|Informed consent withdrawn|0|||
161104482|NCT01994382|581773391|FG014|Overall Study|Informed consent withdrawn|0|||
161104483|NCT01994382|581773392|FG015|Overall Study|Informed consent withdrawn|0|||
161104484|NCT01994382|581773393|FG016|Overall Study|Informed consent withdrawn|0|||
161104485|NCT01994382|581773377|FG000|Overall Study|Progressive disease|3|||
161104486|NCT01994382|581773378|FG001|Overall Study|Progressive disease|4|||
161104487|NCT01994382|581773379|FG002|Overall Study|Progressive disease|4|||
161104488|NCT01994382|581773380|FG003|Overall Study|Progressive disease|3|||
161104489|NCT01994382|581773381|FG004|Overall Study|Progressive disease|2|||
161104490|NCT01994382|581773382|FG005|Overall Study|Progressive disease|3|||
161212556|NCT00766506|582161754|FG000|Overall Study|Other|2|||
161104491|NCT01994382|581773383|FG006|Overall Study|Progressive disease|3|||
161104492|NCT01994382|581773384|FG007|Overall Study|Progressive disease|6|||
161104493|NCT01994382|581773385|FG008|Overall Study|Progressive disease|2|||
161104494|NCT01994382|581773386|FG009|Overall Study|Progressive disease|2|||
161104495|NCT01994382|581773387|FG010|Overall Study|Progressive disease|13|||
161104496|NCT01994382|581773388|FG011|Overall Study|Progressive disease|8|||
161104497|NCT01994382|581773389|FG012|Overall Study|Progressive disease|7|||
161104498|NCT01994382|581773390|FG013|Overall Study|Progressive disease|3|||
161104499|NCT01994382|581773391|FG014|Overall Study|Progressive disease|6|||
161104500|NCT01994382|581773392|FG015|Overall Study|Progressive disease|44|||
161104501|NCT01994382|581773393|FG016|Overall Study|Progressive disease|28|||
161104502|NCT01994382|581773377|FG000|Overall Study|Physician Decision|0|||
161104503|NCT01994382|581773378|FG001|Overall Study|Physician Decision|1|||
161104504|NCT01994382|581773379|FG002|Overall Study|Physician Decision|0|||
161104505|NCT01994382|581773380|FG003|Overall Study|Physician Decision|0|||
161104506|NCT01994382|581773381|FG004|Overall Study|Physician Decision|0|||
161104507|NCT01994382|581773382|FG005|Overall Study|Physician Decision|0|||
161212557|NCT00766506|582161755|FG001|Overall Study|Other|2|||
161212558|NCT03053622|582161756|FG000|Overall Study|Lost to Follow-up|0|||
161104508|NCT01994382|581773383|FG006|Overall Study|Physician Decision|0|||
161104509|NCT01994382|581773384|FG007|Overall Study|Physician Decision|0|||
161104510|NCT01994382|581773385|FG008|Overall Study|Physician Decision|0|||
161104511|NCT01994382|581773386|FG009|Overall Study|Physician Decision|0|||
161104512|NCT01994382|581773387|FG010|Overall Study|Physician Decision|3|||
161104513|NCT01994382|581773388|FG011|Overall Study|Physician Decision|1|||
161104514|NCT01994382|581773389|FG012|Overall Study|Physician Decision|1|||
161104515|NCT01994382|581773390|FG013|Overall Study|Physician Decision|0|||
161104516|NCT01994382|581773391|FG014|Overall Study|Physician Decision|1|||
161104517|NCT01994382|581773392|FG015|Overall Study|Physician Decision|4|||
161104518|NCT01994382|581773393|FG016|Overall Study|Physician Decision|2|||
161104519|NCT01994382|581773377|FG000|Overall Study|Death|0|||
161104520|NCT01994382|581773378|FG001|Overall Study|Death|0|||
161104521|NCT01994382|581773379|FG002|Overall Study|Death|0|||
161104522|NCT01994382|581773380|FG003|Overall Study|Death|0|||
161104523|NCT01994382|581773381|FG004|Overall Study|Death|1|||
161104524|NCT01994382|581773382|FG005|Overall Study|Death|0|||
161104525|NCT01994382|581773383|FG006|Overall Study|Death|0|||
161104526|NCT01994382|581773384|FG007|Overall Study|Death|0|||
161104527|NCT01994382|581773385|FG008|Overall Study|Death|1|||
161104528|NCT01994382|581773386|FG009|Overall Study|Death|1|||
161104529|NCT01994382|581773387|FG010|Overall Study|Death|0|||
161104530|NCT01994382|581773388|FG011|Overall Study|Death|0|||
161104531|NCT01994382|581773389|FG012|Overall Study|Death|0|||
161104532|NCT01994382|581773390|FG013|Overall Study|Death|0|||
161104533|NCT01994382|581773391|FG014|Overall Study|Death|0|||
161104534|NCT01994382|581773392|FG015|Overall Study|Death|1|||
161104535|NCT01994382|581773393|FG016|Overall Study|Death|0|||
161104536|NCT01994382|581773377|FG000|Overall Study|Adverse Event|0|||
161104537|NCT01994382|581773378|FG001|Overall Study|Adverse Event|1|||
161104538|NCT01994382|581773379|FG002|Overall Study|Adverse Event|2|||
161104539|NCT01994382|581773380|FG003|Overall Study|Adverse Event|0|||
161104540|NCT01994382|581773381|FG004|Overall Study|Adverse Event|0|||
161104541|NCT01994382|581773382|FG005|Overall Study|Adverse Event|0|||
161104542|NCT01994382|581773383|FG006|Overall Study|Adverse Event|0|||
161104543|NCT01994382|581773384|FG007|Overall Study|Adverse Event|0|||
161104544|NCT01994382|581773385|FG008|Overall Study|Adverse Event|0|||
161104545|NCT01994382|581773386|FG009|Overall Study|Adverse Event|0|||
161104546|NCT01994382|581773387|FG010|Overall Study|Adverse Event|15|||
161104547|NCT01994382|581773388|FG011|Overall Study|Adverse Event|2|||
161104548|NCT01994382|581773389|FG012|Overall Study|Adverse Event|7|||
161104549|NCT01994382|581773390|FG013|Overall Study|Adverse Event|3|||
161104550|NCT01994382|581773391|FG014|Overall Study|Adverse Event|17|||
161104551|NCT01994382|581773392|FG015|Overall Study|Adverse Event|6|||
161104552|NCT01994382|581773393|FG016|Overall Study|Adverse Event|3|||
161104553|NCT01994382|581773377|FG000|Overall Study|Other than specified|0|||
161104554|NCT01994382|581773378|FG001|Overall Study|Other than specified|0|||
161104555|NCT01994382|581773379|FG002|Overall Study|Other than specified|0|||
161104556|NCT01994382|581773380|FG003|Overall Study|Other than specified|0|||
161104557|NCT01994382|581773381|FG004|Overall Study|Other than specified|0|||
161104558|NCT01994382|581773382|FG005|Overall Study|Other than specified|0|||
161104559|NCT01994382|581773383|FG006|Overall Study|Other than specified|0|||
161104560|NCT01994382|581773384|FG007|Overall Study|Other than specified|0|||
161104561|NCT01994382|581773385|FG008|Overall Study|Other than specified|0|||
161104562|NCT01994382|581773386|FG009|Overall Study|Other than specified|0|||
161104563|NCT01994382|581773387|FG010|Overall Study|Other than specified|2|||
161104564|NCT01994382|581773388|FG011|Overall Study|Other than specified|0|||
161104565|NCT01994382|581773389|FG012|Overall Study|Other than specified|2|||
161104566|NCT01994382|581773390|FG013|Overall Study|Other than specified|0|||
161104567|NCT01994382|581773391|FG014|Overall Study|Other than specified|0|||
161104568|NCT01994382|581773392|FG015|Overall Study|Other than specified|4|||
161104569|NCT01994382|581773393|FG016|Overall Study|Other than specified|4|||
161104570|NCT01994382|581773377|FG000|Overall Study|Withdrawal by Subject|0|||
161104571|NCT01994382|581773378|FG001|Overall Study|Withdrawal by Subject|0|||
161104572|NCT01994382|581773379|FG002|Overall Study|Withdrawal by Subject|0|||
161104573|NCT01994382|581773380|FG003|Overall Study|Withdrawal by Subject|0|||
161104574|NCT01994382|581773381|FG004|Overall Study|Withdrawal by Subject|0|||
161104575|NCT01994382|581773382|FG005|Overall Study|Withdrawal by Subject|0|||
161104576|NCT01994382|581773383|FG006|Overall Study|Withdrawal by Subject|0|||
161104577|NCT01994382|581773384|FG007|Overall Study|Withdrawal by Subject|0|||
161104578|NCT01994382|581773385|FG008|Overall Study|Withdrawal by Subject|0|||
161104579|NCT01994382|581773386|FG009|Overall Study|Withdrawal by Subject|0|||
161104580|NCT01994382|581773387|FG010|Overall Study|Withdrawal by Subject|6|||
161104581|NCT01994382|581773388|FG011|Overall Study|Withdrawal by Subject|0|||
161104582|NCT01994382|581773389|FG012|Overall Study|Withdrawal by Subject|2|||
161212559|NCT03053622|582161757|FG001|Overall Study|Lost to Follow-up|0|||
161104583|NCT01994382|581773390|FG013|Overall Study|Withdrawal by Subject|0|||
161104584|NCT01994382|581773391|FG014|Overall Study|Withdrawal by Subject|4|||
161104585|NCT01994382|581773392|FG015|Overall Study|Withdrawal by Subject|3|||
161104586|NCT01994382|581773393|FG016|Overall Study|Withdrawal by Subject|0|||
161104587|NCT01994382|581773377|FG000|Overall Study|Lost to Follow-up|0|||
161104588|NCT01994382|581773378|FG001|Overall Study|Lost to Follow-up|0|||
161104589|NCT01994382|581773379|FG002|Overall Study|Lost to Follow-up|0|||
161104590|NCT01994382|581773380|FG003|Overall Study|Lost to Follow-up|0|||
161104591|NCT01994382|581773381|FG004|Overall Study|Lost to Follow-up|0|||
161104592|NCT01994382|581773382|FG005|Overall Study|Lost to Follow-up|0|||
161104593|NCT01994382|581773383|FG006|Overall Study|Lost to Follow-up|0|||
161104594|NCT01994382|581773384|FG007|Overall Study|Lost to Follow-up|0|||
161104595|NCT01994382|581773385|FG008|Overall Study|Lost to Follow-up|0|||
161104596|NCT01994382|581773386|FG009|Overall Study|Lost to Follow-up|0|||
161104597|NCT01994382|581773387|FG010|Overall Study|Lost to Follow-up|1|||
161104598|NCT01994382|581773388|FG011|Overall Study|Lost to Follow-up|0|||
161104599|NCT01994382|581773389|FG012|Overall Study|Lost to Follow-up|0|||
161104600|NCT01994382|581773390|FG013|Overall Study|Lost to Follow-up|0|||
161104601|NCT01994382|581773391|FG014|Overall Study|Lost to Follow-up|0|||
161104602|NCT01994382|581773392|FG015|Overall Study|Lost to Follow-up|0|||
161104603|NCT01994382|581773393|FG016|Overall Study|Lost to Follow-up|0|||
161104604|NCT01994382|581773377|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104605|NCT01994382|581773378|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104606|NCT01994382|581773379|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104607|NCT01994382|581773380|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104608|NCT01994382|581773381|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104609|NCT01994382|581773382|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104610|NCT01994382|581773383|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104611|NCT01994382|581773384|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104612|NCT01994382|581773385|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104613|NCT01994382|581773386|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104614|NCT01994382|581773387|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
161104615|NCT01994382|581773388|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104616|NCT01994382|581773389|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
161104617|NCT01994382|581773390|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104618|NCT01994382|581773391|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
161104619|NCT01994382|581773392|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
161104620|NCT01994382|581773393|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
161104621|NCT01994382|581773377|FG000|Overall Study|Protocol violation/noncompliance|0|||
161104622|NCT01994382|581773378|FG001|Overall Study|Protocol violation/noncompliance|0|||
161104623|NCT01994382|581773379|FG002|Overall Study|Protocol violation/noncompliance|0|||
161104624|NCT01994382|581773380|FG003|Overall Study|Protocol violation/noncompliance|0|||
161104625|NCT01994382|581773381|FG004|Overall Study|Protocol violation/noncompliance|0|||
161104626|NCT01994382|581773382|FG005|Overall Study|Protocol violation/noncompliance|0|||
161104627|NCT01994382|581773383|FG006|Overall Study|Protocol violation/noncompliance|0|||
161104628|NCT01994382|581773384|FG007|Overall Study|Protocol violation/noncompliance|0|||
161104629|NCT01994382|581773385|FG008|Overall Study|Protocol violation/noncompliance|0|||
161104630|NCT01994382|581773386|FG009|Overall Study|Protocol violation/noncompliance|0|||
161104631|NCT01994382|581773387|FG010|Overall Study|Protocol violation/noncompliance|0|||
161104632|NCT01994382|581773388|FG011|Overall Study|Protocol violation/noncompliance|1|||
161104633|NCT01994382|581773389|FG012|Overall Study|Protocol violation/noncompliance|0|||
161104634|NCT01994382|581773390|FG013|Overall Study|Protocol violation/noncompliance|0|||
161104635|NCT01994382|581773391|FG014|Overall Study|Protocol violation/noncompliance|0|||
161104636|NCT01994382|581773392|FG015|Overall Study|Protocol violation/noncompliance|0|||
161104637|NCT01994382|581773393|FG016|Overall Study|Protocol violation/noncompliance|2|||
161104638|NCT01994382|581773377|FG000|Overall Study|Rolled over to Phase 2a|0|||
161104639|NCT01994382|581773378|FG001|Overall Study|Rolled over to Phase 2a|0|||
161104640|NCT01994382|581773379|FG002|Overall Study|Rolled over to Phase 2a|1|||
161104641|NCT01994382|581773380|FG003|Overall Study|Rolled over to Phase 2a|0|||
161104642|NCT01994382|581773381|FG004|Overall Study|Rolled over to Phase 2a|0|||
161104643|NCT01994382|581773382|FG005|Overall Study|Rolled over to Phase 2a|0|||
161104644|NCT01994382|581773383|FG006|Overall Study|Rolled over to Phase 2a|0|||
161104645|NCT01994382|581773384|FG007|Overall Study|Rolled over to Phase 2a|0|||
161104646|NCT01994382|581773385|FG008|Overall Study|Rolled over to Phase 2a|0|||
161104647|NCT01994382|581773386|FG009|Overall Study|Rolled over to Phase 2a|2|||
161104648|NCT01994382|581773387|FG010|Overall Study|Rolled over to Phase 2a|0|||
161104649|NCT01994382|581773388|FG011|Overall Study|Rolled over to Phase 2a|0|||
161104650|NCT01994382|581773389|FG012|Overall Study|Rolled over to Phase 2a|0|||
161104651|NCT01994382|581773390|FG013|Overall Study|Rolled over to Phase 2a|0|||
161104652|NCT01994382|581773391|FG014|Overall Study|Rolled over to Phase 2a|0|||
161104653|NCT01994382|581773392|FG015|Overall Study|Rolled over to Phase 2a|0|||
161104654|NCT01994382|581773393|FG016|Overall Study|Rolled over to Phase 2a|0|||
161104655|NCT04667377|581773394|FG000|Dose Escalation Period|Other not specified below|3|||
161104656|NCT04667377|581773395|FG001|Dose Escalation Period|Other not specified below|3|||
161104657|NCT04667377|581773396|FG002|Dose Escalation Period|Other not specified below|2|||
161104658|NCT04667377|581773397|FG003|Dose Escalation Period|Other not specified below|1|||
161104659|NCT04667377|581773398|FG004|Dose Escalation Period|Other not specified below|3|||
161104660|NCT04667377|581773394|FG000|Dose Escalation Period|Protocol Violation|2|||
161104661|NCT04667377|581773395|FG001|Dose Escalation Period|Protocol Violation|2|||
161104662|NCT04667377|581773396|FG002|Dose Escalation Period|Protocol Violation|0|||
161104663|NCT04667377|581773397|FG003|Dose Escalation Period|Protocol Violation|2|||
161104664|NCT04667377|581773398|FG004|Dose Escalation Period|Protocol Violation|1|||
161104665|NCT04667377|581773394|FG000|Dose Escalation Period|Burden of study procedures|2|||
161104666|NCT04667377|581773395|FG001|Dose Escalation Period|Burden of study procedures|1|||
161104667|NCT04667377|581773396|FG002|Dose Escalation Period|Burden of study procedures|1|||
161104668|NCT04667377|581773397|FG003|Dose Escalation Period|Burden of study procedures|1|||
161104669|NCT04667377|581773398|FG004|Dose Escalation Period|Burden of study procedures|5|||
161104670|NCT04667377|581773394|FG000|Dose Escalation Period|Change of residence|0|||
161104671|NCT04667377|581773395|FG001|Dose Escalation Period|Change of residence|0|||
161104672|NCT04667377|581773396|FG002|Dose Escalation Period|Change of residence|1|||
161104673|NCT04667377|581773397|FG003|Dose Escalation Period|Change of residence|0|||
161104674|NCT04667377|581773398|FG004|Dose Escalation Period|Change of residence|0|||
161104675|NCT04667377|581773394|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
161104676|NCT04667377|581773395|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
161104677|NCT04667377|581773396|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
161104678|NCT04667377|581773397|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
161104679|NCT04667377|581773398|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
161104680|NCT04667377|581773394|FG000|Dose Escalation Period|Adverse Event|9|||
161104681|NCT04667377|581773395|FG001|Dose Escalation Period|Adverse Event|10|||
161104682|NCT04667377|581773396|FG002|Dose Escalation Period|Adverse Event|12|||
161104683|NCT04667377|581773397|FG003|Dose Escalation Period|Adverse Event|17|||
161104684|NCT04667377|581773398|FG004|Dose Escalation Period|Adverse Event|3|||
161104685|NCT04667377|581773394|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
161104686|NCT04667377|581773395|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
161104687|NCT04667377|581773396|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
161104688|NCT04667377|581773397|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
161104689|NCT04667377|581773398|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
161104690|NCT04667377|581773394|FG000|Dose Escalation Period|Not treated|1|||
161104691|NCT04667377|581773395|FG001|Dose Escalation Period|Not treated|0|||
161104692|NCT04667377|581773396|FG002|Dose Escalation Period|Not treated|0|||
161104693|NCT04667377|581773397|FG003|Dose Escalation Period|Not treated|0|||
161104694|NCT04667377|581773398|FG004|Dose Escalation Period|Not treated|0|||
161104695|NCT04667377|581773394|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
161104696|NCT04667377|581773395|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
161104697|NCT04667377|581773396|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
161104698|NCT04667377|581773397|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
161104699|NCT04667377|581773398|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
161104700|NCT04667377|581773394|FG000|Dose Escalation Period|Lost to Follow-up|0|||
161104701|NCT04667377|581773395|FG001|Dose Escalation Period|Lost to Follow-up|1|||
161104702|NCT04667377|581773396|FG002|Dose Escalation Period|Lost to Follow-up|0|||
161104703|NCT04667377|581773397|FG003|Dose Escalation Period|Lost to Follow-up|0|||
161104704|NCT04667377|581773398|FG004|Dose Escalation Period|Lost to Follow-up|0|||
161104705|NCT04667377|581773394|FG000|Maintenance Period|Perceived lack of efficacy|0|||
161104706|NCT04667377|581773395|FG001|Maintenance Period|Perceived lack of efficacy|2|||
161104707|NCT04667377|581773396|FG002|Maintenance Period|Perceived lack of efficacy|1|||
161104708|NCT04667377|581773397|FG003|Maintenance Period|Perceived lack of efficacy|0|||
161104709|NCT04667377|581773398|FG004|Maintenance Period|Perceived lack of efficacy|1|||
161104710|NCT04667377|581773394|FG000|Maintenance Period|Adverse Event|2|||
161104711|NCT04667377|581773395|FG001|Maintenance Period|Adverse Event|8|||
161104712|NCT04667377|581773396|FG002|Maintenance Period|Adverse Event|5|||
161104713|NCT04667377|581773397|FG003|Maintenance Period|Adverse Event|4|||
161104714|NCT04667377|581773398|FG004|Maintenance Period|Adverse Event|1|||
161104715|NCT04667377|581773394|FG000|Maintenance Period|Adverse event: COVID infection|0|||
161104716|NCT04667377|581773395|FG001|Maintenance Period|Adverse event: COVID infection|1|||
161104717|NCT04667377|581773396|FG002|Maintenance Period|Adverse event: COVID infection|0|||
161104718|NCT04667377|581773397|FG003|Maintenance Period|Adverse event: COVID infection|0|||
161104719|NCT04667377|581773398|FG004|Maintenance Period|Adverse event: COVID infection|0|||
161104720|NCT04667377|581773394|FG000|Maintenance Period|COVID-related|0|||
161104721|NCT04667377|581773395|FG001|Maintenance Period|COVID-related|0|||
161104722|NCT04667377|581773396|FG002|Maintenance Period|COVID-related|1|||
161104723|NCT04667377|581773397|FG003|Maintenance Period|COVID-related|1|||
161104724|NCT04667377|581773398|FG004|Maintenance Period|COVID-related|0|||
161104725|NCT04667377|581773394|FG000|Maintenance Period|Protocol Violation|1|||
161104726|NCT04667377|581773395|FG001|Maintenance Period|Protocol Violation|0|||
161104727|NCT04667377|581773396|FG002|Maintenance Period|Protocol Violation|0|||
161104728|NCT04667377|581773397|FG003|Maintenance Period|Protocol Violation|0|||
161104729|NCT04667377|581773398|FG004|Maintenance Period|Protocol Violation|1|||
161104730|NCT04667377|581773394|FG000|Maintenance Period|Burden of study procedures|1|||
161104731|NCT04667377|581773395|FG001|Maintenance Period|Burden of study procedures|2|||
161104732|NCT04667377|581773396|FG002|Maintenance Period|Burden of study procedures|0|||
161104733|NCT04667377|581773397|FG003|Maintenance Period|Burden of study procedures|1|||
161104734|NCT04667377|581773398|FG004|Maintenance Period|Burden of study procedures|0|||
161104735|NCT04667377|581773394|FG000|Maintenance Period|Change of residence|0|||
161104736|NCT04667377|581773395|FG001|Maintenance Period|Change of residence|1|||
161104737|NCT04667377|581773396|FG002|Maintenance Period|Change of residence|0|||
161104738|NCT04667377|581773397|FG003|Maintenance Period|Change of residence|0|||
161104739|NCT04667377|581773398|FG004|Maintenance Period|Change of residence|1|||
161104740|NCT04667377|581773394|FG000|Maintenance Period|Missing|1|||
161104741|NCT04667377|581773395|FG001|Maintenance Period|Missing|0|||
161104742|NCT04667377|581773396|FG002|Maintenance Period|Missing|0|||
161104743|NCT04667377|581773397|FG003|Maintenance Period|Missing|0|||
161104744|NCT04667377|581773398|FG004|Maintenance Period|Missing|0|||
161104745|NCT04667377|581773394|FG000|Maintenance Period|Other than listed above|2|||
161104746|NCT04667377|581773395|FG001|Maintenance Period|Other than listed above|0|||
161104747|NCT04667377|581773396|FG002|Maintenance Period|Other than listed above|3|||
161104748|NCT04667377|581773397|FG003|Maintenance Period|Other than listed above|2|||
161104749|NCT04667377|581773398|FG004|Maintenance Period|Other than listed above|6|||
161104750|NCT04667377|581773394|FG000|Maintenance Period|Withdrawal by Subject|0|||
161104751|NCT04667377|581773395|FG001|Maintenance Period|Withdrawal by Subject|1|||
161104752|NCT04667377|581773396|FG002|Maintenance Period|Withdrawal by Subject|0|||
161104753|NCT04667377|581773397|FG003|Maintenance Period|Withdrawal by Subject|0|||
161104754|NCT04667377|581773398|FG004|Maintenance Period|Withdrawal by Subject|0|||
161104755|NCT04667377|581773394|FG000|Maintenance Period|Lost to Follow-up|1|||
161104756|NCT04667377|581773395|FG001|Maintenance Period|Lost to Follow-up|0|||
161104757|NCT04667377|581773396|FG002|Maintenance Period|Lost to Follow-up|1|||
161104758|NCT04667377|581773397|FG003|Maintenance Period|Lost to Follow-up|0|||
161104759|NCT04667377|581773398|FG004|Maintenance Period|Lost to Follow-up|1|||
161104760|NCT01011439|581773399|FG000|Overall Study|Death|37|||
161104761|NCT01011439|581773399|FG000|Overall Study|Lost to Follow-up|4|||
161104762|NCT01011439|581773399|FG000|Overall Study|Withdrawal by Subject|1|||
161104763|NCT01011439|581773399|FG000|Overall Study|Sponsor's decision|15|||
161104764|NCT02428855|581773400|FG000|Overall Study|Withdrawal by Subject|2|||
161104765|NCT00210184|581773401|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
161104766|NCT00359021|581773402|FG000|Overall Study|Adverse Event|26|||
161104767|NCT00359021|581773403|FG001|Overall Study|Adverse Event|8|||
161104768|NCT00359021|581773402|FG000|Overall Study|Subject Non-Compliant|1|||
161104769|NCT00359021|581773403|FG001|Overall Study|Subject Non-Compliant|2|||
161104770|NCT00359021|581773402|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
161104771|NCT00359021|581773403|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
161104772|NCT00359021|581773402|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
161104773|NCT00359021|581773403|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
161104774|NCT00359021|581773402|FG000|Overall Study|Withdrawal by Subject|2|||
161104775|NCT00359021|581773403|FG001|Overall Study|Withdrawal by Subject|9|||
161104776|NCT00359021|581773402|FG000|Overall Study|Lost to Follow-up|1|||
161104777|NCT00359021|581773403|FG001|Overall Study|Lost to Follow-up|0|||
161104778|NCT00359021|581773402|FG000|Overall Study|Other|4|||
161104779|NCT00359021|581773403|FG001|Overall Study|Other|1|||
161104780|NCT00359021|581773402|FG000|Overall Study|Pregnancy|1|||
161104781|NCT00359021|581773403|FG001|Overall Study|Pregnancy|0|||
161104782|NCT03861936|581773404|FG000|Overall Study|Withdrawal by Subject|4|||
161104783|NCT03861936|581773405|FG001|Overall Study|Withdrawal by Subject|1|||
161104784|NCT03861936|581773406|FG002|Overall Study|Withdrawal by Subject|3|||
161104785|NCT03861936|581773404|FG000|Overall Study|Lost to Follow-up|5|||
161104786|NCT03861936|581773405|FG001|Overall Study|Lost to Follow-up|3|||
161104787|NCT03861936|581773406|FG002|Overall Study|Lost to Follow-up|3|||
161104788|NCT03861936|581773404|FG000|Overall Study|Physician Decision|0|||
161104789|NCT03861936|581773405|FG001|Overall Study|Physician Decision|1|||
161104790|NCT03861936|581773406|FG002|Overall Study|Physician Decision|0|||
161104791|NCT03861936|581773404|FG000|Overall Study|Protocol Deviation|0|||
161104792|NCT03861936|581773405|FG001|Overall Study|Protocol Deviation|0|||
161104793|NCT03861936|581773406|FG002|Overall Study|Protocol Deviation|1|||
161104794|NCT03861936|581773404|FG000|Overall Study|Reason not Specified|5|||
161104795|NCT03861936|581773405|FG001|Overall Study|Reason not Specified|5|||
161104796|NCT03861936|581773406|FG002|Overall Study|Reason not Specified|3|||
161104797|NCT03198520|581773411|FG000|Overall Study|Physician Decision|2|||
161104798|NCT03198520|581773411|FG000|Overall Study|Protocol Violation|2|||
161104799|NCT03198520|581773411|FG000|Overall Study|Withdrawal by Subject|1|||
161104800|NCT03198520|581773411|FG000|Overall Study|Study Ended|1|||
161104801|NCT01670539|581773412|FG000|Overall Study|Death|3|||
161104802|NCT01670539|581773413|FG001|Overall Study|Death|5|||
161104803|NCT01670539|581773412|FG000|Overall Study|Withdrawal by Subject|3|||
161104804|NCT01670539|581773413|FG001|Overall Study|Withdrawal by Subject|0|||
161104805|NCT04353596|581773414|FG000|Overall Study|Protocol Violation|4|||
161104806|NCT04353596|581773415|FG001|Overall Study|Protocol Violation|4|||
161104807|NCT04353596|581773414|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
161104808|NCT04353596|581773415|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
161104809|NCT01236573|581773418|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104810|NCT01236573|581773419|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104811|NCT01236573|581773420|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104812|NCT01236573|581773421|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104813|NCT01236573|581773422|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104814|NCT01236573|581773423|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104815|NCT01236573|581773424|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161104816|NCT01236573|581773425|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104817|NCT01236573|581773426|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161104818|NCT01236573|581773427|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
161104819|NCT01236573|581773428|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
161104820|NCT01236573|581773418|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104821|NCT01236573|581773419|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104822|NCT01236573|581773420|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104823|NCT01236573|581773421|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104824|NCT01236573|581773422|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104825|NCT01236573|581773423|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104826|NCT01236573|581773424|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104827|NCT01236573|581773425|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104828|NCT01236573|581773426|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
161104829|NCT01236573|581773427|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104830|NCT01236573|581773428|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
161104831|NCT01236573|581773418|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104832|NCT01236573|581773419|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104833|NCT01236573|581773420|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104834|NCT01236573|581773421|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104835|NCT01236573|581773422|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104836|NCT01236573|581773423|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104837|NCT01236573|581773424|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104838|NCT01236573|581773425|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104839|NCT01236573|581773426|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104840|NCT01236573|581773427|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
161104841|NCT01236573|581773428|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
161104842|NCT05418673|581773429|FG000|Overall Study|Study Terminated by Sponsor|2|||
161104843|NCT05418673|581773430|FG001|Overall Study|Study Terminated by Sponsor|4|||
161104844|NCT05418673|581773429|FG000|Overall Study|Lost to Follow-up|1|||
161104845|NCT05418673|581773430|FG001|Overall Study|Lost to Follow-up|0|||
161104846|NCT02665052|581773431|FG000|Overall Study|Lost to Follow-up|1|||
161104847|NCT02665052|581773432|FG001|Overall Study|Lost to Follow-up|0|||
161104848|NCT02665052|581773433|FG002|Overall Study|Lost to Follow-up|0|||
161104849|NCT02665052|581773434|FG003|Overall Study|Lost to Follow-up|0|||
161104850|NCT02665052|581773431|FG000|Overall Study|Withdrawal by Subject|1|||
161104851|NCT02665052|581773432|FG001|Overall Study|Withdrawal by Subject|1|||
161104852|NCT02665052|581773433|FG002|Overall Study|Withdrawal by Subject|0|||
161104853|NCT02665052|581773434|FG003|Overall Study|Withdrawal by Subject|5|||
161104854|NCT02665052|581773431|FG000|Overall Study|Adverse Event|1|||
161104855|NCT02665052|581773432|FG001|Overall Study|Adverse Event|1|||
161104856|NCT02665052|581773433|FG002|Overall Study|Adverse Event|0|||
161104857|NCT02665052|581773434|FG003|Overall Study|Adverse Event|0|||
161104858|NCT00823823|581773435|FG000|Overall Study|Lost to Follow-up|3|||
161104859|NCT00823823|581773436|FG001|Overall Study|Lost to Follow-up|1|||
161104860|NCT00823823|581773435|FG000|Overall Study|Protocol Violation|5|||
161104861|NCT00823823|581773436|FG001|Overall Study|Protocol Violation|5|||
161104862|NCT02234284|581773437|FG000|Overall Study|Death|4|||
161104863|NCT02234284|581773438|FG001|Overall Study|Death|2|||
161104864|NCT02234284|581773437|FG000|Overall Study|Withdrawal by Subject|1|||
161104865|NCT02234284|581773438|FG001|Overall Study|Withdrawal by Subject|0|||
161104866|NCT02234284|581773437|FG000|Overall Study|Lost to Follow-up|20|||
161104867|NCT02234284|581773438|FG001|Overall Study|Lost to Follow-up|7|||
161104868|NCT01986920|581773441|FG000|A- 101 25%|Withdrawal by Subject|1|||
161212560|NCT03053622|582161758|FG002|Overall Study|Lost to Follow-up|0|||
161212561|NCT03053622|582161759|FG003|Overall Study|Lost to Follow-up|1|||
161104869|NCT01986920|581773442|FG001|A- 101 25%|Withdrawal by Subject|0|||
161104870|NCT01986920|581773443|FG002|A- 101 25%|Withdrawal by Subject|0|||
161104871|NCT01986920|581773444|FG003|A- 101 25%|Withdrawal by Subject|0|||
161104872|NCT01986920|581773441|FG000|A-101 32.5%|Withdrawal by Subject|0|||
161104873|NCT01986920|581773442|FG001|A-101 32.5%|Withdrawal by Subject|1|||
161212562|NCT01246986|582161760|FG000|Overall Study|Lost to Follow-up|0|||
161212563|NCT01246986|582161761|FG001|Overall Study|Lost to Follow-up|1|||
161212564|NCT01246986|582161762|FG002|Overall Study|Lost to Follow-up|3|||
161104874|NCT01986920|581773443|FG002|A-101 32.5%|Withdrawal by Subject|0|||
161104875|NCT01986920|581773444|FG003|A-101 32.5%|Withdrawal by Subject|0|||
161104876|NCT01986920|581773441|FG000|A-101 40%|Withdrawal by Subject|0|||
161104877|NCT01986920|581773442|FG001|A-101 40%|Withdrawal by Subject|0|||
161104878|NCT01986920|581773443|FG002|A-101 40%|Withdrawal by Subject|1|||
161104879|NCT01986920|581773444|FG003|A-101 40%|Withdrawal by Subject|0|||
161104880|NCT01986920|581773441|FG000|Placebo|Withdrawal by Subject|0|||
161104881|NCT01986920|581773442|FG001|Placebo|Withdrawal by Subject|0|||
161104882|NCT01986920|581773443|FG002|Placebo|Withdrawal by Subject|0|||
161104883|NCT01986920|581773444|FG003|Placebo|Withdrawal by Subject|1|||
161104884|NCT03023059|581773447|FG000|Overall Study|Withdrawal by Subject|5|||
161104885|NCT01338415|581773448|FG000|Core + Extension|Adverse Event|8|||
161104886|NCT01338415|581773449|FG001|Core + Extension|Adverse Event|6|||
161104887|NCT01338415|581773450|FG002|Core + Extension|Adverse Event|0|||
161104888|NCT01338415|581773448|FG000|Core + Extension|Withdrawal by Subject|1|||
161104889|NCT01338415|581773449|FG001|Core + Extension|Withdrawal by Subject|1|||
161104890|NCT01338415|581773450|FG002|Core + Extension|Withdrawal by Subject|0|||
161104891|NCT01338415|581773448|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
161104892|NCT01338415|581773449|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
161104893|NCT01338415|581773450|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
161104894|NCT01338415|581773448|FG000|Core + Extension|Other (administrative reason)|1|||
161104895|NCT01338415|581773449|FG001|Core + Extension|Other (administrative reason)|0|||
161104896|NCT01338415|581773450|FG002|Core + Extension|Other (administrative reason)|0|||
161104897|NCT01338415|581773448|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
161104898|NCT01338415|581773449|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
161104899|NCT01338415|581773450|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
161104900|NCT01338415|581773448|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
161104901|NCT01338415|581773449|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
161104902|NCT01338415|581773450|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
161104903|NCT01338415|581773448|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
161104904|NCT01338415|581773449|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
161104905|NCT01338415|581773450|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
161104906|NCT01338415|581773448|FG000|Exceptional Use Treatment Period|Death|0|||
161104907|NCT01338415|581773449|FG001|Exceptional Use Treatment Period|Death|0|||
161104908|NCT01338415|581773450|FG002|Exceptional Use Treatment Period|Death|1|||
161104909|NCT00536809|581773451|FG000|Phase II|Adverse Event|1|||
161104910|NCT00536809|581773451|FG000|Phase II|Referred for surgical resection|1|||
161104911|NCT00233363|581773456|FG000|Overall Study|Adverse Event|1|||
161104912|NCT00233363|581773457|FG001|Overall Study|Adverse Event|2|||
161104913|NCT00233363|581773456|FG000|Overall Study|Lack of Efficacy|0|||
161104914|NCT00233363|581773457|FG001|Overall Study|Lack of Efficacy|2|||
161104915|NCT00233363|581773456|FG000|Overall Study|Withdrawal by Subject|1|||
161104916|NCT00233363|581773457|FG001|Overall Study|Withdrawal by Subject|1|||
161104917|NCT00233363|581773456|FG000|Overall Study|Aggravation of complication|1|||
161104918|NCT00233363|581773457|FG001|Overall Study|Aggravation of complication|0|||
161104919|NCT01526551|581773461|FG000|Overall Study|Lack of returned parental consent form|424|||
161104920|NCT00874770|581773462|FG000|Overall Study|Lack of Efficacy|2|||
161104921|NCT00874770|581773463|FG001|Overall Study|Lack of Efficacy|0|||
161104922|NCT00874770|581773464|FG002|Overall Study|Lack of Efficacy|0|||
161104923|NCT00874770|581773465|FG003|Overall Study|Lack of Efficacy|2|||
161104924|NCT00874770|581773462|FG000|Overall Study|Adverse Event|1|||
161104925|NCT00874770|581773463|FG001|Overall Study|Adverse Event|1|||
161104926|NCT00874770|581773464|FG002|Overall Study|Adverse Event|4|||
161104927|NCT00874770|581773465|FG003|Overall Study|Adverse Event|2|||
161104928|NCT00874770|581773462|FG000|Overall Study|Lost to Follow-up|1|||
161104929|NCT00874770|581773463|FG001|Overall Study|Lost to Follow-up|0|||
161104930|NCT00874770|581773464|FG002|Overall Study|Lost to Follow-up|0|||
161104931|NCT00874770|581773465|FG003|Overall Study|Lost to Follow-up|1|||
161104932|NCT00874770|581773462|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
161104933|NCT00874770|581773463|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
161104934|NCT00874770|581773464|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
161104935|NCT00874770|581773465|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
161104936|NCT01353508|581773466|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161104937|NCT01353508|581773467|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161104938|NCT01353508|581773468|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
161104939|NCT01353508|581773469|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
161104940|NCT01353508|581773466|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
161104941|NCT01353508|581773467|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161104942|NCT01353508|581773468|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161104943|NCT01353508|581773469|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
161104944|NCT00873366|581773470|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
161104945|NCT00873366|581773470|FG000|Overall Study|Off tamoxifen due to side effects|2|||
161104946|NCT00873366|581773470|FG000|Overall Study|Refused to continue DM-BT testing|3|||
161104947|NCT01576172|581773471|FG000|Overall Study|Ineligible|2|||
161104948|NCT01576172|581773472|FG001|Overall Study|Ineligible|1|||
161104949|NCT01576172|581773471|FG000|Overall Study|Withdrawal by Subject|2|||
161104950|NCT01576172|581773472|FG001|Overall Study|Withdrawal by Subject|0|||
161104951|NCT01576172|581773471|FG000|Overall Study|Insurance issue|1|||
161104952|NCT01576172|581773472|FG001|Overall Study|Insurance issue|0|||
161104953|NCT02844920|581773479|FG000|Overall Study|Lost to Follow-up|2|||
161104954|NCT00736034|581773482|FG000|Overall Study|Adverse Event|2|||
161104955|NCT01910116|581773485|FG000|Overall Study|Adverse Event|0|||
161104956|NCT01910116|581773486|FG001|Overall Study|Adverse Event|3|||
161104957|NCT01910116|581773485|FG000|Overall Study|Lack of Efficacy|3|||
161104958|NCT01910116|581773486|FG001|Overall Study|Lack of Efficacy|4|||
161104959|NCT01910116|581773485|FG000|Overall Study|Lost to Follow-up|1|||
161104960|NCT01910116|581773486|FG001|Overall Study|Lost to Follow-up|0|||
161104961|NCT01910116|581773485|FG000|Overall Study|Protocol Violation|1|||
161104962|NCT01910116|581773486|FG001|Overall Study|Protocol Violation|2|||
161104963|NCT01910116|581773485|FG000|Overall Study|Withdrawal by Subject|8|||
161104964|NCT01910116|581773486|FG001|Overall Study|Withdrawal by Subject|3|||
161104965|NCT01910116|581773485|FG000|Overall Study|uncertain allocation|1|||
161104966|NCT01910116|581773486|FG001|Overall Study|uncertain allocation|3|||
161104967|NCT01910116|581773485|FG000|Overall Study|incomplete data|0|||
161104968|NCT01910116|581773486|FG001|Overall Study|incomplete data|1|||
161104969|NCT02289352|581773487|FG000|Overall Study|Withdrawal by Subject|1|||
161104970|NCT02289352|581773488|FG001|Overall Study|Withdrawal by Subject|1|||
161104971|NCT02289352|581773489|FG002|Overall Study|Withdrawal by Subject|0|||
161104972|NCT03606980|581773490|FG000|Overall Study|Lost to Follow-up|3|||
161104973|NCT03606980|581773491|FG001|Overall Study|Lost to Follow-up|2|||
161104974|NCT03606980|581773492|FG002|Overall Study|Lost to Follow-up|3|||
161104975|NCT03606980|581773490|FG000|Overall Study|Withdrawal by Subject|1|||
161104976|NCT03606980|581773491|FG001|Overall Study|Withdrawal by Subject|0|||
161104977|NCT03606980|581773492|FG002|Overall Study|Withdrawal by Subject|4|||
161104978|NCT00911625|581773497|FG000|Overall Study|Lost to Follow-up|7|||
161104979|NCT00911625|581773498|FG001|Overall Study|Lost to Follow-up|0|||
161104980|NCT04166383|581773499|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
161104981|NCT04166383|581773499|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
161104982|NCT04166383|581773499|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
161104983|NCT03044886|581773500|FG000|Overall Study|Lost to Follow-up|15|||
161104984|NCT03044886|581773501|FG001|Overall Study|Lost to Follow-up|10|||
161104985|NCT03044886|581773502|FG002|Overall Study|Lost to Follow-up|12|||
161104986|NCT02374021|581773505|FG000|Overall Study|Adverse Event|1|||
161104987|NCT02374021|581773506|FG001|Overall Study|Adverse Event|0|||
161104988|NCT02374021|581773505|FG000|Overall Study|Lost to Follow-up|3|||
161104989|NCT02374021|581773506|FG001|Overall Study|Lost to Follow-up|2|||
161104990|NCT02374021|581773505|FG000|Overall Study|Physician Decision|0|||
161104991|NCT02374021|581773506|FG001|Overall Study|Physician Decision|3|||
161104992|NCT02374021|581773505|FG000|Overall Study|Withdrawal by Subject|6|||
161104993|NCT02374021|581773506|FG001|Overall Study|Withdrawal by Subject|5|||
161104994|NCT02374021|581773505|FG000|Overall Study|Poor Adherence|0|||
161104995|NCT02374021|581773506|FG001|Overall Study|Poor Adherence|1|||
161104996|NCT02374021|581773505|FG000|Overall Study|Scan protocol not followed|0|||
161104997|NCT02374021|581773506|FG001|Overall Study|Scan protocol not followed|1|||
161104998|NCT02374021|581773505|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
161104999|NCT02374021|581773506|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
161105000|NCT00732251|581773507|FG000|Overall Study|Lost to Follow-up|3|||
161105001|NCT00732251|581773507|FG000|Overall Study|Withdrawal by Subject|3|||
161105002|NCT00732251|581773507|FG000|Overall Study|Early Term due to Site Closure|1|||
161105003|NCT02615470|581775757|FG000|Overall Study|Lost to Follow-up|21|||
161105004|NCT02615470|581775758|FG001|Overall Study|Lost to Follow-up|32|||
161105005|NCT03713034|581775759|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
161105006|NCT03713034|581775760|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
161105007|NCT02982590|581775764|FG000|Overall Study|Lost to Follow-up|0|||
161105008|NCT02982590|581775765|FG001|Overall Study|Lost to Follow-up|1|||
161105009|NCT02982590|581775764|FG000|Overall Study|Death|4|||
161105010|NCT02982590|581775765|FG001|Overall Study|Death|0|||
161105011|NCT02807480|581775768|FG000|Overall Study|Withdrawal by Subject|14|||
161105012|NCT02807480|581775769|FG001|Overall Study|Withdrawal by Subject|10|||
161105013|NCT02163187|581775772|FG000|Overall Study|Device removed|1|||
161105014|NCT02163187|581775773|FG001|Overall Study|Device removed|0|||
161105015|NCT02163187|581775772|FG000|Overall Study|Progressive disease|1|||
161105016|NCT02163187|581775773|FG001|Overall Study|Progressive disease|0|||
161105017|NCT02369848|581775774|FG000|Overall Study|Death|1|||
161105018|NCT02369848|581775774|FG000|Overall Study|Withdrawal by Subject|2|||
161212565|NCT01246986|582161763|FG003|Overall Study|Lost to Follow-up|0|||
161212566|NCT01246986|582161764|FG004|Overall Study|Lost to Follow-up|0|||
161105019|NCT02369848|581775774|FG000|Overall Study|Lost to Follow-up|1|||
161105020|NCT03281668|581775777|FG000|Overall Study|Physician Decision|1|||
161105021|NCT03281668|581775777|FG000|Overall Study|scheduling conflict, family circumstance|2|||
161105022|NCT03281668|581775777|FG000|Overall Study|Withdrawal by Subject|4|||
161105023|NCT03281668|581775777|FG000|Overall Study|Lost to Follow-up|1|||
161105024|NCT01858532|581775780|FG000|Overall Study|Adverse Event|58|||
161105025|NCT01858532|581775781|FG001|Overall Study|Adverse Event|50|||
161105026|NCT01858532|581775782|FG002|Overall Study|Adverse Event|23|||
161105027|NCT01858532|581775783|FG003|Overall Study|Adverse Event|28|||
161212567|NCT01246986|582161765|FG005|Overall Study|Lost to Follow-up|1|||
161212568|NCT01246986|582161766|FG006|Overall Study|Lost to Follow-up|0|||
161212569|NCT01246986|582161760|FG000|Overall Study|Withdrawal by Subject|3|||
161212570|NCT01246986|582161761|FG001|Overall Study|Withdrawal by Subject|4|||
161212571|NCT01246986|582161762|FG002|Overall Study|Withdrawal by Subject|3|||
161212572|NCT01246986|582161763|FG003|Overall Study|Withdrawal by Subject|0|||
161212573|NCT01246986|582161764|FG004|Overall Study|Withdrawal by Subject|4|||
161212574|NCT01246986|582161765|FG005|Overall Study|Withdrawal by Subject|0|||
161212575|NCT01246986|582161766|FG006|Overall Study|Withdrawal by Subject|0|||
161212576|NCT01440647|582161771|FG000|Overall Study|Death|2|||
161212577|NCT01440647|582161772|FG001|Overall Study|Death|3|||
161212578|NCT01406873|582161786|FG000|Overall Study|Withdrawal by Subject|1|||
161212579|NCT01406873|582161787|FG001|Overall Study|Withdrawal by Subject|1|||
161212580|NCT03990389|582161788|FG000|Overall Study|Lost to Follow-up|3|||
161212581|NCT03990389|582161789|FG001|Overall Study|Lost to Follow-up|0|||
161212582|NCT00207714|582161790|FG000|Overall Study|Adverse Event|6|||
161212583|NCT00207714|582161791|FG001|Overall Study|Adverse Event|2|||
161212584|NCT00207714|582161792|FG002|Overall Study|Adverse Event|4|||
161212585|NCT00207714|582161793|FG003|Overall Study|Adverse Event|3|||
161212586|NCT00207714|582161794|FG004|Overall Study|Adverse Event|1|||
161212587|NCT00207714|582161790|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161212588|NCT00207714|582161791|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161212589|NCT00207714|582161792|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161212590|NCT00207714|582161793|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
161212591|NCT00207714|582161794|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
161212592|NCT00207714|582161790|FG000|Overall Study|Other|3|||
161212593|NCT00207714|582161791|FG001|Overall Study|Other|2|||
161212594|NCT00207714|582161792|FG002|Overall Study|Other|5|||
161212595|NCT00207714|582161793|FG003|Overall Study|Other|1|||
161212596|NCT00207714|582161794|FG004|Overall Study|Other|0|||
161212597|NCT03627195|582161795|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
161212598|NCT03627195|582161796|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161212599|NCT03627195|582161797|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161212600|NCT03627195|582161798|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161212601|NCT03627195|582161799|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161212602|NCT03627195|582161800|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
161212603|NCT02595528|582161804|FG000|Overall Study|Withdrawal by Subject|1|||
161212604|NCT02595528|582161805|FG001|Overall Study|Withdrawal by Subject|2|||
161212605|NCT02595528|582161806|FG002|Overall Study|Withdrawal by Subject|1|||
161212606|NCT02595528|582161807|FG003|Overall Study|Withdrawal by Subject|3|||
161212607|NCT02595528|582161804|FG000|Overall Study|Lost to Follow-up|1|||
161212608|NCT02595528|582161805|FG001|Overall Study|Lost to Follow-up|1|||
161212609|NCT02595528|582161806|FG002|Overall Study|Lost to Follow-up|0|||
161212610|NCT02595528|582161807|FG003|Overall Study|Lost to Follow-up|1|||
161212611|NCT03202511|582161808|FG000|Overall Study|Withdrawal by Subject|1|||
161212612|NCT03202511|582161809|FG001|Overall Study|Withdrawal by Subject|0|||
161212613|NCT00382291|582161813|FG000|Overall Study|Adverse Event|1|||
161212614|NCT00382291|582161814|FG001|Overall Study|Adverse Event|2|||
161212615|NCT00382291|582161815|FG002|Overall Study|Adverse Event|2|||
161212616|NCT00382291|582161813|FG000|Overall Study|Protocol Violation|1|||
161212617|NCT00382291|582161814|FG001|Overall Study|Protocol Violation|0|||
161212618|NCT00382291|582161815|FG002|Overall Study|Protocol Violation|0|||
161212619|NCT00382291|582161813|FG000|Overall Study|Temporary study suspension|2|||
161212620|NCT00382291|582161814|FG001|Overall Study|Temporary study suspension|2|||
161212621|NCT00382291|582161815|FG002|Overall Study|Temporary study suspension|5|||
161212622|NCT00382291|582161813|FG000|Overall Study|Withdrawal by Subject|0|||
161105028|NCT01858532|581775780|FG000|Overall Study|Withdrew consent|71|||
161212623|NCT00382291|582161814|FG001|Overall Study|Withdrawal by Subject|2|||
161212624|NCT00382291|582161815|FG002|Overall Study|Withdrawal by Subject|0|||
161212625|NCT00382291|582161813|FG000|Overall Study|Physician Decision|0|||
161212626|NCT00382291|582161814|FG001|Overall Study|Physician Decision|1|||
161212627|NCT00382291|582161815|FG002|Overall Study|Physician Decision|0|||
161212628|NCT00382291|582161813|FG000|Overall Study|Lack of Efficacy|0|||
161212629|NCT00382291|582161814|FG001|Overall Study|Lack of Efficacy|0|||
161212630|NCT00382291|582161815|FG002|Overall Study|Lack of Efficacy|1|||
161105029|NCT01858532|581775781|FG001|Overall Study|Withdrew consent|93|||
161105030|NCT01858532|581775782|FG002|Overall Study|Withdrew consent|46|||
161212631|NCT01326702|582161816|FG000|Overall Study|Other|1|||
161212632|NCT01326702|582161817|FG001|Overall Study|Other|0|||
161212633|NCT01326702|582161818|FG002|Overall Study|Other|0|||
161212634|NCT01326702|582161819|FG003|Overall Study|Other|0|||
161105031|NCT01858532|581775783|FG003|Overall Study|Withdrew consent|27|||
161105032|NCT01858532|581775780|FG000|Overall Study|Lost to Follow-up|17|||
161105033|NCT01858532|581775781|FG001|Overall Study|Lost to Follow-up|26|||
161105034|NCT01858532|581775782|FG002|Overall Study|Lost to Follow-up|11|||
161105035|NCT01858532|581775783|FG003|Overall Study|Lost to Follow-up|14|||
161105036|NCT01858532|581775780|FG000|Overall Study|Deterioration of medical status|3|||
161105037|NCT01858532|581775781|FG001|Overall Study|Deterioration of medical status|4|||
161105038|NCT01858532|581775782|FG002|Overall Study|Deterioration of medical status|3|||
161105039|NCT01858532|581775783|FG003|Overall Study|Deterioration of medical status|7|||
161105040|NCT01858532|581775780|FG000|Overall Study|Investigator request|3|||
161105041|NCT01858532|581775781|FG001|Overall Study|Investigator request|4|||
161105042|NCT01858532|581775782|FG002|Overall Study|Investigator request|2|||
161105043|NCT01858532|581775783|FG003|Overall Study|Investigator request|6|||
161105044|NCT01858532|581775780|FG000|Overall Study|Other, not specified|29|||
161105045|NCT01858532|581775781|FG001|Overall Study|Other, not specified|15|||
161105046|NCT01858532|581775782|FG002|Overall Study|Other, not specified|13|||
161105047|NCT01858532|581775783|FG003|Overall Study|Other, not specified|11|||
161105048|NCT02081534|581775789|FG000|Overall Study|Adverse Event|5|||
161105049|NCT02081534|581775790|FG001|Overall Study|Adverse Event|4|||
161105050|NCT02081534|581775791|FG002|Overall Study|Adverse Event|3|||
161105051|NCT02081534|581775792|FG003|Overall Study|Adverse Event|10|||
161105052|NCT02081534|581775793|FG004|Overall Study|Adverse Event|2|||
161105053|NCT02081534|581775794|FG005|Overall Study|Adverse Event|8|||
161105054|NCT02081534|581775795|FG006|Overall Study|Adverse Event|2|||
161105055|NCT02081534|581775789|FG000|Overall Study|Withdrawal by Subject|0|||
161105056|NCT02081534|581775790|FG001|Overall Study|Withdrawal by Subject|1|||
161105057|NCT02081534|581775791|FG002|Overall Study|Withdrawal by Subject|1|||
161105058|NCT02081534|581775792|FG003|Overall Study|Withdrawal by Subject|1|||
161105059|NCT02081534|581775793|FG004|Overall Study|Withdrawal by Subject|1|||
161105060|NCT02081534|581775794|FG005|Overall Study|Withdrawal by Subject|0|||
161105061|NCT02081534|581775795|FG006|Overall Study|Withdrawal by Subject|1|||
161105062|NCT02081534|581775789|FG000|Overall Study|Protocol Violation|0|||
161105063|NCT02081534|581775790|FG001|Overall Study|Protocol Violation|3|||
161105064|NCT02081534|581775791|FG002|Overall Study|Protocol Violation|0|||
161105065|NCT02081534|581775792|FG003|Overall Study|Protocol Violation|0|||
161105066|NCT02081534|581775793|FG004|Overall Study|Protocol Violation|0|||
161105067|NCT02081534|581775794|FG005|Overall Study|Protocol Violation|0|||
161105068|NCT02081534|581775795|FG006|Overall Study|Protocol Violation|1|||
161105069|NCT02081534|581775789|FG000|Overall Study|Lost to Follow-up|0|||
161105070|NCT02081534|581775790|FG001|Overall Study|Lost to Follow-up|0|||
161105071|NCT02081534|581775791|FG002|Overall Study|Lost to Follow-up|0|||
161105072|NCT02081534|581775792|FG003|Overall Study|Lost to Follow-up|2|||
161105073|NCT02081534|581775793|FG004|Overall Study|Lost to Follow-up|1|||
161105074|NCT02081534|581775794|FG005|Overall Study|Lost to Follow-up|1|||
161105075|NCT02081534|581775795|FG006|Overall Study|Lost to Follow-up|0|||
161105076|NCT01848288|581775800|FG000|Overall Study|Death|1|||
161105077|NCT01848288|581775800|FG000|Overall Study|Protocol Violation|1|||
161105078|NCT01848288|581775800|FG000|Overall Study|Withdrawal by Subject|1|||
161105079|NCT01007032|581775802|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
161105080|NCT01007032|581775803|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
161105081|NCT01007032|581775804|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
161105082|NCT01007032|581775805|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
161105083|NCT01007032|581775802|FG000|Overall Study|Withdrawal by Subject|0|||
161105084|NCT01007032|581775803|FG001|Overall Study|Withdrawal by Subject|0|||
161105085|NCT01007032|581775804|FG002|Overall Study|Withdrawal by Subject|0|||
161105086|NCT01007032|581775805|FG003|Overall Study|Withdrawal by Subject|1|||
161105087|NCT01841749|581775806|FG000|Overall Study|Protocol Violation|1|||
161105088|NCT02285920|581775807|FG000|Overall Study|Kidney transplantation|2|||
161105089|NCT02285920|581775808|FG001|Overall Study|Kidney transplantation|2|||
161105090|NCT02285920|581775809|FG002|Overall Study|Kidney transplantation|2|||
161105091|NCT02285920|581775810|FG003|Overall Study|Kidney transplantation|0|||
161105092|NCT02285920|581775807|FG000|Overall Study|Change to peritoneal dialysis|0|||
161105093|NCT02285920|581775808|FG001|Overall Study|Change to peritoneal dialysis|0|||
161105094|NCT02285920|581775809|FG002|Overall Study|Change to peritoneal dialysis|1|||
161105095|NCT02285920|581775810|FG003|Overall Study|Change to peritoneal dialysis|0|||
161105096|NCT02285920|581775807|FG000|Overall Study|Transfer to non-participating unit|0|||
161105097|NCT02285920|581775808|FG001|Overall Study|Transfer to non-participating unit|1|||
161105098|NCT02285920|581775809|FG002|Overall Study|Transfer to non-participating unit|0|||
161105099|NCT02285920|581775810|FG003|Overall Study|Transfer to non-participating unit|0|||
161105100|NCT02285920|581775807|FG000|Overall Study|Dialysis discontinuation|0|||
161105101|NCT02285920|581775808|FG001|Overall Study|Dialysis discontinuation|1|||
161105102|NCT02285920|581775809|FG002|Overall Study|Dialysis discontinuation|0|||
161105103|NCT02285920|581775810|FG003|Overall Study|Dialysis discontinuation|0|||
161105104|NCT02285920|581775807|FG000|Overall Study|Death|2|||
161105105|NCT02285920|581775808|FG001|Overall Study|Death|0|||
161105106|NCT02285920|581775809|FG002|Overall Study|Death|2|||
161105107|NCT02285920|581775810|FG003|Overall Study|Death|1|||
161105108|NCT00677820|581775811|FG000|Overall Study|Lost to Follow-up|1|||
161105109|NCT00677820|581775812|FG001|Overall Study|Lost to Follow-up|0|||
161105110|NCT02092350|581775822|FG000|Overall Study|Adverse Event|0|||
161105111|NCT02092350|581775823|FG001|Overall Study|Adverse Event|3|||
161105112|NCT02092350|581775822|FG000|Overall Study|Death|2|||
161105113|NCT02092350|581775823|FG001|Overall Study|Death|5|||
161105114|NCT02092350|581775822|FG000|Overall Study|Lost to Follow-up|3|||
161105115|NCT02092350|581775823|FG001|Overall Study|Lost to Follow-up|1|||
161105116|NCT02092350|581775822|FG000|Overall Study|Protocol Violation|1|||
161105117|NCT02092350|581775823|FG001|Overall Study|Protocol Violation|0|||
161105118|NCT02092350|581775822|FG000|Overall Study|Physician Decision|1|||
161105119|NCT02092350|581775823|FG001|Overall Study|Physician Decision|1|||
161105120|NCT02092350|581775822|FG000|Overall Study|Screen Failure|1|||
161105121|NCT02092350|581775823|FG001|Overall Study|Screen Failure|0|||
161105122|NCT02092350|581775822|FG000|Overall Study|Withdrawal by Subject|2|||
161105123|NCT02092350|581775823|FG001|Overall Study|Withdrawal by Subject|2|||
161105124|NCT00646906|581775825|FG000|Crossover Period 1|Withdrawal by Subject|1|||
161105125|NCT00646906|581775826|FG001|Crossover Period 1|Withdrawal by Subject|0|||
161105126|NCT00646906|581775827|FG002|Crossover Period 1|Withdrawal by Subject|0|||
161105127|NCT00646906|581775828|FG003|Crossover Period 1|Withdrawal by Subject|0|||
161105128|NCT00646906|581775829|FG004|Crossover Period 1|Withdrawal by Subject|0|||
161105129|NCT00646906|581775830|FG005|Crossover Period 1|Withdrawal by Subject|1|||
161105130|NCT00646906|581775831|FG006|Crossover Period 1|Withdrawal by Subject|0|||
161105131|NCT00646906|581775825|FG000|Crossover Period 2|Withdrawal by Subject|0|||
161105132|NCT00646906|581775826|FG001|Crossover Period 2|Withdrawal by Subject|1|||
161105133|NCT00646906|581775827|FG002|Crossover Period 2|Withdrawal by Subject|2|||
161105134|NCT00646906|581775828|FG003|Crossover Period 2|Withdrawal by Subject|1|||
161105135|NCT00646906|581775829|FG004|Crossover Period 2|Withdrawal by Subject|0|||
161105136|NCT00646906|581775830|FG005|Crossover Period 2|Withdrawal by Subject|0|||
161105137|NCT00646906|581775831|FG006|Crossover Period 2|Withdrawal by Subject|0|||
161105138|NCT00646906|581775825|FG000|Crossover Period 2|Physician Decision|0|||
161105139|NCT00646906|581775826|FG001|Crossover Period 2|Physician Decision|0|||
161105140|NCT00646906|581775827|FG002|Crossover Period 2|Physician Decision|0|||
161212635|NCT01326702|582161820|FG004|Overall Study|Other|0|||
161212636|NCT01326702|582161821|FG005|Overall Study|Other|1|||
161212637|NCT01326702|582161822|FG006|Overall Study|Other|0|||
161212638|NCT01326702|582161816|FG000|Overall Study|progressive disease|1|||
161212639|NCT01326702|582161817|FG001|Overall Study|progressive disease|1|||
161212640|NCT01326702|582161818|FG002|Overall Study|progressive disease|3|||
161212641|NCT01326702|582161819|FG003|Overall Study|progressive disease|1|||
161212642|NCT01326702|582161820|FG004|Overall Study|progressive disease|3|||
161212643|NCT01326702|582161821|FG005|Overall Study|progressive disease|2|||
161212644|NCT01326702|582161822|FG006|Overall Study|progressive disease|3|||
161212645|NCT01326702|582161816|FG000|Overall Study|Death|0|||
161212646|NCT01326702|582161817|FG001|Overall Study|Death|1|||
161212647|NCT01326702|582161818|FG002|Overall Study|Death|0|||
161212648|NCT01326702|582161819|FG003|Overall Study|Death|0|||
161212649|NCT01326702|582161820|FG004|Overall Study|Death|0|||
161212650|NCT01326702|582161821|FG005|Overall Study|Death|0|||
161212651|NCT01326702|582161822|FG006|Overall Study|Death|0|||
161212652|NCT01326702|582161816|FG000|Overall Study|Adverse Event|0|||
161212653|NCT01326702|582161817|FG001|Overall Study|Adverse Event|0|||
161212654|NCT01326702|582161818|FG002|Overall Study|Adverse Event|1|||
161212655|NCT01326702|582161819|FG003|Overall Study|Adverse Event|1|||
161212656|NCT01326702|582161820|FG004|Overall Study|Adverse Event|0|||
161212657|NCT01326702|582161821|FG005|Overall Study|Adverse Event|3|||
161212658|NCT01326702|582161822|FG006|Overall Study|Adverse Event|1|||
161212659|NCT01326702|582161816|FG000|Overall Study|Withdrawal by Subject|0|||
161212660|NCT01326702|582161817|FG001|Overall Study|Withdrawal by Subject|0|||
161212661|NCT01326702|582161818|FG002|Overall Study|Withdrawal by Subject|1|||
161212662|NCT01326702|582161819|FG003|Overall Study|Withdrawal by Subject|0|||
161105141|NCT00646906|581775828|FG003|Crossover Period 2|Physician Decision|0|||
161105142|NCT00646906|581775829|FG004|Crossover Period 2|Physician Decision|0|||
161105143|NCT00646906|581775830|FG005|Crossover Period 2|Physician Decision|0|||
161105144|NCT00646906|581775831|FG006|Crossover Period 2|Physician Decision|1|||
161212663|NCT01326702|582161820|FG004|Overall Study|Withdrawal by Subject|1|||
161212664|NCT01326702|582161821|FG005|Overall Study|Withdrawal by Subject|1|||
161212665|NCT01326702|582161822|FG006|Overall Study|Withdrawal by Subject|3|||
161105145|NCT00962390|581775841|FG000|Overall Study|Adverse Event|0|||
161105146|NCT00962390|581775842|FG001|Overall Study|Adverse Event|0|||
161105147|NCT00962390|581775843|FG002|Overall Study|Adverse Event|3|||
161105148|NCT00962390|581775844|FG003|Overall Study|Adverse Event|1|||
161212666|NCT01326702|582161816|FG000|Overall Study|Not Treated|0|||
161212667|NCT01326702|582161817|FG001|Overall Study|Not Treated|0|||
161212668|NCT01326702|582161818|FG002|Overall Study|Not Treated|0|||
161212669|NCT01326702|582161819|FG003|Overall Study|Not Treated|1|||
161212670|NCT01326702|582161820|FG004|Overall Study|Not Treated|0|||
161212671|NCT01326702|582161821|FG005|Overall Study|Not Treated|1|||
161212672|NCT01326702|582161822|FG006|Overall Study|Not Treated|0|||
161212673|NCT02082912|582161823|FG000|Overall Study|Physician Decision|0|||
161105149|NCT00962390|581775841|FG000|Overall Study|Lost to Follow-up|2|||
161105150|NCT00962390|581775842|FG001|Overall Study|Lost to Follow-up|2|||
161105151|NCT00962390|581775843|FG002|Overall Study|Lost to Follow-up|0|||
161105152|NCT00962390|581775844|FG003|Overall Study|Lost to Follow-up|0|||
161105153|NCT00962390|581775841|FG000|Overall Study|Protocol Violation|1|||
161105154|NCT00962390|581775842|FG001|Overall Study|Protocol Violation|0|||
161105155|NCT00962390|581775843|FG002|Overall Study|Protocol Violation|0|||
161105156|NCT00962390|581775844|FG003|Overall Study|Protocol Violation|0|||
161105157|NCT00962390|581775841|FG000|Overall Study|Withdrawal by Subject|1|||
161105158|NCT00962390|581775842|FG001|Overall Study|Withdrawal by Subject|1|||
161105159|NCT00962390|581775843|FG002|Overall Study|Withdrawal by Subject|1|||
161105160|NCT00962390|581775844|FG003|Overall Study|Withdrawal by Subject|0|||
161105161|NCT02613884|581775845|FG000|Overall Study|Death|1|||
161105162|NCT02613884|581775845|FG000|Overall Study|Lost to Follow-up|1|||
161105163|NCT00433914|581775848|FG000|Overall Study|Withdrawal by Subject|0|||
161105164|NCT00433914|581775849|FG001|Overall Study|Withdrawal by Subject|2|||
161105165|NCT00433914|581775848|FG000|Overall Study|Lost to Follow-up|0|||
161105166|NCT00433914|581775849|FG001|Overall Study|Lost to Follow-up|1|||
161105167|NCT04534491|581775850|FG000|Overall Study|Not completed end-of-study interview|24|||
161105168|NCT04534491|581775850|FG000|Overall Study|Non-users|70|||
161105169|NCT04534491|581775850|FG000|Overall Study|Non-verifiable users|58|||
161105170|NCT00766090|581775853|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105171|NCT00766090|581775854|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105172|NCT00766090|581775855|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105173|NCT00766090|581775856|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105174|NCT00766090|581775857|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105175|NCT00766090|581775858|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105176|NCT00766090|581775859|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105177|NCT00766090|581775860|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105178|NCT00766090|581775861|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
161105179|NCT00766090|581775862|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105180|NCT00766090|581775863|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105181|NCT00766090|581775864|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161105182|NCT00766090|581775853|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
161105183|NCT00766090|581775854|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105184|NCT00766090|581775855|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105185|NCT00766090|581775856|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105186|NCT00766090|581775857|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105187|NCT00766090|581775858|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105188|NCT00766090|581775859|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105189|NCT00766090|581775860|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105190|NCT00766090|581775861|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105191|NCT00766090|581775862|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105192|NCT00766090|581775863|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105193|NCT00766090|581775864|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
161105194|NCT00766090|581775853|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161105195|NCT00766090|581775854|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105196|NCT00766090|581775855|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105197|NCT00766090|581775856|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161105198|NCT00766090|581775857|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105199|NCT00766090|581775858|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105200|NCT00766090|581775859|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105201|NCT00766090|581775860|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105202|NCT00766090|581775861|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105203|NCT00766090|581775862|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105204|NCT00766090|581775863|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105205|NCT00766090|581775864|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161105206|NCT00766090|581775853|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105207|NCT00766090|581775854|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105208|NCT00766090|581775855|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
161105209|NCT00766090|581775856|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105210|NCT00766090|581775857|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105211|NCT00766090|581775858|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105212|NCT00766090|581775859|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105213|NCT00766090|581775860|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
161212674|NCT02082912|582161824|FG001|Overall Study|Physician Decision|1|||
161105214|NCT00766090|581775861|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105215|NCT00766090|581775862|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105216|NCT00766090|581775863|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105217|NCT00766090|581775864|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
161105218|NCT00766090|581775853|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105219|NCT00766090|581775854|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105220|NCT00766090|581775855|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105221|NCT00766090|581775856|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105222|NCT00766090|581775857|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
161105223|NCT00766090|581775858|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105224|NCT00766090|581775859|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105225|NCT00766090|581775860|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105226|NCT00766090|581775861|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105227|NCT00766090|581775862|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105228|NCT00766090|581775863|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105229|NCT00766090|581775864|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161105230|NCT00766090|581775853|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105231|NCT00766090|581775854|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105232|NCT00766090|581775855|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
161105233|NCT00766090|581775856|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105234|NCT00766090|581775857|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105235|NCT00766090|581775858|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105236|NCT00766090|581775859|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105237|NCT00766090|581775860|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105238|NCT00766090|581775861|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105239|NCT00766090|581775862|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105240|NCT00766090|581775863|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105241|NCT00766090|581775864|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
161105242|NCT00766090|581775853|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
161105243|NCT00766090|581775854|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
161105244|NCT00766090|581775855|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
161105245|NCT00766090|581775856|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
161105246|NCT00766090|581775857|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
161105247|NCT00766090|581775858|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
161105248|NCT00766090|581775859|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
161105249|NCT00766090|581775860|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
161105250|NCT00766090|581775861|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
161105251|NCT00766090|581775862|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
161105252|NCT00766090|581775863|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
161105253|NCT00766090|581775864|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
161105254|NCT00766090|581775853|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105255|NCT00766090|581775854|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105256|NCT00766090|581775855|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105257|NCT00766090|581775856|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105258|NCT00766090|581775857|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105259|NCT00766090|581775858|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
161105260|NCT00766090|581775859|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105261|NCT00766090|581775860|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105262|NCT00766090|581775861|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105263|NCT00766090|581775862|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105264|NCT00766090|581775863|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105265|NCT00766090|581775864|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
161105266|NCT00766090|581775853|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105267|NCT00766090|581775854|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161105268|NCT00766090|581775855|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105269|NCT00766090|581775856|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161105270|NCT00766090|581775857|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105271|NCT00766090|581775858|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105272|NCT00766090|581775859|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105273|NCT00766090|581775860|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105274|NCT00766090|581775861|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105275|NCT00766090|581775862|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105276|NCT00766090|581775863|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
161105277|NCT00766090|581775864|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
161105278|NCT00766090|581775853|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105279|NCT00766090|581775854|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105280|NCT00766090|581775855|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105281|NCT00766090|581775856|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105282|NCT00766090|581775857|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
161105283|NCT00766090|581775858|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105284|NCT00766090|581775859|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105285|NCT00766090|581775860|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105286|NCT00766090|581775861|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105287|NCT00766090|581775862|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105288|NCT00766090|581775863|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105289|NCT00766090|581775864|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
161105290|NCT03024970|581775867|FG000|First Intervention|Adverse Event|1|||
161105291|NCT03024970|581775868|FG001|First Intervention|Adverse Event|0|||
161105292|NCT03024970|581775867|FG000|Second Intervention|Lost to Follow-up|1|||
161105293|NCT03024970|581775868|FG001|Second Intervention|Lost to Follow-up|0|||
161105294|NCT00131469|581775870|FG000|Overall Study|Withdrawal by Subject|3|||
161105295|NCT00131469|581775871|FG001|Overall Study|Withdrawal by Subject|4|||
161105296|NCT00131469|581775870|FG000|Overall Study|Protocol Violation|3|||
161105297|NCT00131469|581775871|FG001|Overall Study|Protocol Violation|1|||
161105298|NCT00131469|581775870|FG000|Overall Study|Death|0|||
161105299|NCT00131469|581775871|FG001|Overall Study|Death|1|||
161105300|NCT00131469|581775870|FG000|Overall Study|Lost to Follow-up|0|||
161105301|NCT00131469|581775871|FG001|Overall Study|Lost to Follow-up|1|||
161105302|NCT00131469|581775870|FG000|Overall Study|scan not analyzable|3|||
161105303|NCT00131469|581775871|FG001|Overall Study|scan not analyzable|6|||
161105304|NCT00574288|581775872|FG000|Overall Study|Adverse Event|2|||
161105305|NCT00574288|581775873|FG001|Overall Study|Adverse Event|0|||
161105306|NCT00574288|581775874|FG002|Overall Study|Adverse Event|0|||
161105307|NCT00574288|581775875|FG003|Overall Study|Adverse Event|0|||
161105308|NCT00574288|581775876|FG004|Overall Study|Adverse Event|1|||
161105309|NCT00574288|581775877|FG005|Overall Study|Adverse Event|0|||
161105310|NCT00574288|581775878|FG006|Overall Study|Adverse Event|0|||
161105311|NCT00574288|581775872|FG000|Overall Study|Death|0|||
161105312|NCT00574288|581775873|FG001|Overall Study|Death|0|||
161105313|NCT00574288|581775874|FG002|Overall Study|Death|0|||
161105314|NCT00574288|581775875|FG003|Overall Study|Death|0|||
161105315|NCT00574288|581775876|FG004|Overall Study|Death|0|||
161105316|NCT00574288|581775877|FG005|Overall Study|Death|25|||
161105317|NCT00574288|581775878|FG006|Overall Study|Death|21|||
161105318|NCT00574288|581775872|FG000|Overall Study|Lost to Follow-up|0|||
161105319|NCT00574288|581775873|FG001|Overall Study|Lost to Follow-up|0|||
161105320|NCT00574288|581775874|FG002|Overall Study|Lost to Follow-up|0|||
161105321|NCT00574288|581775875|FG003|Overall Study|Lost to Follow-up|0|||
161105322|NCT00574288|581775876|FG004|Overall Study|Lost to Follow-up|0|||
161105323|NCT00574288|581775877|FG005|Overall Study|Lost to Follow-up|1|||
161105324|NCT00574288|581775878|FG006|Overall Study|Lost to Follow-up|2|||
161105325|NCT00574288|581775872|FG000|Overall Study|Study Terminated By Sponsor|0|||
161105326|NCT00574288|581775873|FG001|Overall Study|Study Terminated By Sponsor|0|||
161105327|NCT00574288|581775874|FG002|Overall Study|Study Terminated By Sponsor|0|||
161105328|NCT00574288|581775875|FG003|Overall Study|Study Terminated By Sponsor|0|||
161105329|NCT00574288|581775876|FG004|Overall Study|Study Terminated By Sponsor|0|||
161105330|NCT00574288|581775877|FG005|Overall Study|Study Terminated By Sponsor|0|||
161105331|NCT00574288|581775878|FG006|Overall Study|Study Terminated By Sponsor|5|||
161105332|NCT00574288|581775872|FG000|Overall Study|Progressive Disease|17|||
161105333|NCT00574288|581775873|FG001|Overall Study|Progressive Disease|2|||
161105334|NCT00574288|581775874|FG002|Overall Study|Progressive Disease|3|||
161105335|NCT00574288|581775875|FG003|Overall Study|Progressive Disease|2|||
161105336|NCT00574288|581775876|FG004|Overall Study|Progressive Disease|1|||
161105337|NCT00574288|581775877|FG005|Overall Study|Progressive Disease|0|||
161105338|NCT00574288|581775878|FG006|Overall Study|Progressive Disease|0|||
161105339|NCT00574288|581775872|FG000|Overall Study|Other|1|||
161105340|NCT00574288|581775873|FG001|Overall Study|Other|1|||
161105341|NCT00574288|581775874|FG002|Overall Study|Other|0|||
161105342|NCT00574288|581775875|FG003|Overall Study|Other|0|||
161105343|NCT00574288|581775876|FG004|Overall Study|Other|0|||
161105344|NCT00574288|581775877|FG005|Overall Study|Other|0|||
161105345|NCT00574288|581775878|FG006|Overall Study|Other|0|||
161105346|NCT01106027|581775879|FG000|Overall Study|Lost graft early, discontinued|1|||
161105347|NCT00369785|581775881|FG000|Overall Study|Physician Decision|3|||
161105348|NCT00369785|581775882|FG001|Overall Study|Physician Decision|2|||
161105349|NCT00369785|581775881|FG000|Overall Study|Death|1|||
161105350|NCT00369785|581775882|FG001|Overall Study|Death|2|||
161105351|NCT00369785|581775881|FG000|Overall Study|Withdrawal by Subject|7|||
161105352|NCT00369785|581775882|FG001|Overall Study|Withdrawal by Subject|6|||
161105353|NCT00369785|581775881|FG000|Overall Study|Toxicity|6|||
161105354|NCT00369785|581775882|FG001|Overall Study|Toxicity|4|||
161105355|NCT00369785|581775881|FG000|Overall Study|Never started|0|||
161105356|NCT00369785|581775882|FG001|Overall Study|Never started|2|||
161105357|NCT00369785|581775881|FG000|Overall Study|Progression|4|||
161105358|NCT00369785|581775882|FG001|Overall Study|Progression|4|||
161105359|NCT00369785|581775881|FG000|Overall Study|Multiple reasons|6|||
161105360|NCT00369785|581775882|FG001|Overall Study|Multiple reasons|5|||
161105361|NCT00800683|581775883|FG000|Overall Study|Adverse Event|11|||
161105362|NCT00800683|581775884|FG001|Overall Study|Adverse Event|8|||
161105363|NCT00800683|581775883|FG000|Overall Study|Lost to Follow-up|3|||
161105364|NCT00800683|581775884|FG001|Overall Study|Lost to Follow-up|1|||
161105365|NCT00800683|581775883|FG000|Overall Study|Withdrawal by Subject|1|||
161105366|NCT00800683|581775884|FG001|Overall Study|Withdrawal by Subject|7|||
161105367|NCT00800683|581775883|FG000|Overall Study|Lack of Efficacy|1|||
161105368|NCT00800683|581775884|FG001|Overall Study|Lack of Efficacy|1|||
161105369|NCT00800683|581775883|FG000|Overall Study|Other|1|||
161105370|NCT00800683|581775884|FG001|Overall Study|Other|2|||
161105371|NCT02247960|581775886|FG000|Patient Consent and Randomization|Physician Decision|2|||
161105372|NCT02247960|581775887|FG001|Patient Consent and Randomization|Physician Decision|2|||
161105373|NCT02247960|581775886|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
161105374|NCT02247960|581775887|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
161105375|NCT02247960|581775886|FG000|Catheter Removed|Lost to Follow-up|7|||
161105376|NCT02247960|581775887|FG001|Catheter Removed|Lost to Follow-up|10|||
161105377|NCT00356889|581775888|FG000|Overall Study|Protocol Violation|2|||
161105378|NCT00356889|581775888|FG000|Overall Study|Adverse Event|1|||
161105379|NCT02678416|581775889|FG000|Part 1|Withdrawal by Subject|1|||
161105380|NCT02678416|581775889|FG000|Part 2|Adverse Event|2|||
161105381|NCT02678416|581775889|FG000|Part 2|Withdrawal by Subject|1|||
161105382|NCT01848353|581775890|FG000|Phase 1|Withdrawal by Subject|3|||
161105383|NCT01848353|581775891|FG001|Phase 1|Withdrawal by Subject|1|||
161105384|NCT01848353|581775892|FG002|Phase 1|Withdrawal by Subject|0|||
161105385|NCT01848353|581775893|FG003|Phase 1|Withdrawal by Subject|0|||
161105386|NCT01848353|581775890|FG000|Phase 2|Withdrawal by Subject|3|||
161105387|NCT01848353|581775891|FG001|Phase 2|Withdrawal by Subject|2|||
161105388|NCT01848353|581775892|FG002|Phase 2|Withdrawal by Subject|0|||
161105389|NCT01848353|581775893|FG003|Phase 2|Withdrawal by Subject|0|||
161105390|NCT01848353|581775890|FG000|Phase 3|Withdrawal by Subject|1|||
161105391|NCT01848353|581775891|FG001|Phase 3|Withdrawal by Subject|1|||
161105392|NCT01848353|581775892|FG002|Phase 3|Withdrawal by Subject|0|||
161105393|NCT01848353|581775893|FG003|Phase 3|Withdrawal by Subject|0|||
161105394|NCT02361944|581775903|FG000|Overall Study|surgery cancellation|0|||
161105395|NCT02361944|581775904|FG001|Overall Study|surgery cancellation|1|||
161105396|NCT03123250|581775905|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
161105397|NCT00773136|581775935|FG000|Overall Study|Physician Decision|2|||
161105398|NCT02003014|581775942|FG000|Overall Study|Case report forms uncollected|9|||
161105399|NCT02003014|581775942|FG000|Overall Study|Treatment started after contract period|1|||
161105400|NCT02003014|581775942|FG000|Overall Study|Patient did not visit the study site|5|||
161105401|NCT02003014|581775942|FG000|Overall Study|Investigator's transfer|4|||
161105402|NCT03007979|581775945|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
161105403|NCT03734016|581775946|FG000|Overall Study|Sponsor Ended Study|225|||
161105404|NCT03734016|581775947|FG001|Overall Study|Sponsor Ended Study|200|||
161105405|NCT03734016|581775946|FG000|Overall Study|Death|69|||
161105406|NCT03734016|581775947|FG001|Overall Study|Death|83|||
161105407|NCT03734016|581775946|FG000|Overall Study|Withdrawal by Subject|21|||
161105408|NCT03734016|581775947|FG001|Overall Study|Withdrawal by Subject|27|||
161105409|NCT03734016|581775946|FG000|Overall Study|Physician Decision|1|||
161105410|NCT03734016|581775947|FG001|Overall Study|Physician Decision|12|||
161105411|NCT03734016|581775946|FG000|Overall Study|Lost to Follow-up|6|||
161105412|NCT03734016|581775947|FG001|Overall Study|Lost to Follow-up|2|||
161105413|NCT03734016|581775946|FG000|Overall Study|Miscellaneous|5|||
161105414|NCT03734016|581775947|FG001|Overall Study|Miscellaneous|1|||
161105415|NCT01298518|581775950|FG000|Overall Study|Withdrawal by Subject|0|||
161105416|NCT01298518|581775951|FG001|Overall Study|Withdrawal by Subject|0|||
161105417|NCT01298518|581775952|FG002|Overall Study|Withdrawal by Subject|1|||
161105418|NCT02273726|581775953|FG000|Overall Study|Death|70|||
161105419|NCT02273726|581775954|FG001|Overall Study|Death|62|||
161105420|NCT02273726|581775953|FG000|Overall Study|Withdrawal by Subject|41|||
161105421|NCT02273726|581775954|FG001|Overall Study|Withdrawal by Subject|29|||
161105422|NCT02273726|581775953|FG000|Overall Study|Kidney transplant|31|||
161105423|NCT02273726|581775954|FG001|Overall Study|Kidney transplant|39|||
161105424|NCT02273726|581775953|FG000|Overall Study|Physician Decision|30|||
161105425|NCT02273726|581775954|FG001|Overall Study|Physician Decision|15|||
161105426|NCT02273726|581775953|FG000|Overall Study|Adverse Event|27|||
161105427|NCT02273726|581775954|FG001|Overall Study|Adverse Event|9|||
161105428|NCT02273726|581775953|FG000|Overall Study|Lost to Follow-up|6|||
161105429|NCT02273726|581775954|FG001|Overall Study|Lost to Follow-up|3|||
161105430|NCT02273726|581775953|FG000|Overall Study|Lack of Efficacy|6|||
161105431|NCT02273726|581775954|FG001|Overall Study|Lack of Efficacy|1|||
161105432|NCT02273726|581775953|FG000|Overall Study|Protocol Violation|4|||
161105433|NCT02273726|581775954|FG001|Overall Study|Protocol Violation|0|||
161105434|NCT02273726|581775953|FG000|Overall Study|Other than specified|28|||
161105435|NCT02273726|581775954|FG001|Overall Study|Other than specified|30|||
161105436|NCT01979835|581775955|FG000|Primary Outcome SA Measurment|failed insertion|18|||
161105437|NCT01979835|581775955|FG000|Follow-up|Lost to Follow-up|32|||
161105438|NCT02737852|581777424|FG000|Overall Study|Withdrawal by Subject|2|||
161105439|NCT03688880|581777425|FG000|Overall Study|Withdrawal by Subject|0|||
161105440|NCT03688880|581777426|FG001|Overall Study|Withdrawal by Subject|2|||
161105441|NCT03688880|581777425|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
161105442|NCT03688880|581777426|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
161105443|NCT03688880|581777425|FG000|Overall Study|Lost to Follow-up|4|||
161105444|NCT03688880|581777426|FG001|Overall Study|Lost to Follow-up|7|||
161105445|NCT03688880|581777425|FG000|Overall Study|Adverse Event|0|||
161105446|NCT03688880|581777426|FG001|Overall Study|Adverse Event|2|||
161105447|NCT03688880|581777425|FG000|Overall Study|Device deficiencies|0|||
161105448|NCT03688880|581777426|FG001|Overall Study|Device deficiencies|2|||
161105449|NCT03688880|581777425|FG000|Overall Study|Other|10|||
161105450|NCT03688880|581777426|FG001|Overall Study|Other|16|||
161105451|NCT01704287|581777428|FG000|Initial Treatment Period|Death|139|||
161105452|NCT01704287|581777429|FG001|Initial Treatment Period|Death|129|||
161105453|NCT01704287|581777430|FG002|Initial Treatment Period|Death|71|||
161105454|NCT01704287|581777431|FG003|Initial Treatment Period|Death|0|||
161105455|NCT01704287|581777432|FG004|Initial Treatment Period|Death|0|||
161212675|NCT02266706|582161825|FG000|Overall Study|Withdrawal by Subject|0|||
161212676|NCT02266706|582161826|FG001|Overall Study|Withdrawal by Subject|1|||
161105456|NCT01704287|581777428|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
161105457|NCT01704287|581777429|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
161105458|NCT01704287|581777430|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
161105459|NCT01704287|581777431|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
161105460|NCT01704287|581777432|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
161105461|NCT01704287|581777428|FG000|Initial Treatment Period|Lost to Follow-up|5|||
161105462|NCT01704287|581777429|FG001|Initial Treatment Period|Lost to Follow-up|3|||
161105463|NCT01704287|581777430|FG002|Initial Treatment Period|Lost to Follow-up|0|||
161105464|NCT01704287|581777431|FG003|Initial Treatment Period|Lost to Follow-up|0|||
161105465|NCT01704287|581777432|FG004|Initial Treatment Period|Lost to Follow-up|0|||
161105466|NCT01704287|581777428|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
161105467|NCT01704287|581777429|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
161105468|NCT01704287|581777430|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
161105469|NCT01704287|581777431|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
161105470|NCT01704287|581777432|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
161105471|NCT01704287|581777428|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161105472|NCT01704287|581777429|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161105473|NCT01704287|581777430|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
161105474|NCT01704287|581777431|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
161105475|NCT01704287|581777432|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
161105476|NCT01704287|581777428|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
161105477|NCT01704287|581777429|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
161105478|NCT01704287|581777430|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
161105479|NCT01704287|581777431|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
161105480|NCT01704287|581777432|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
161105481|NCT01704287|581777428|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161105482|NCT01704287|581777429|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161105483|NCT01704287|581777430|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161105484|NCT01704287|581777431|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
161105485|NCT01704287|581777432|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
161105486|NCT04042740|581777433|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
161105487|NCT04042740|581777433|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
161105488|NCT01717287|581777434|FG000|Overall Study|Lost to Follow-up|0|||
161105489|NCT01717287|581777435|FG001|Overall Study|Lost to Follow-up|2|||
161105490|NCT01717287|581777434|FG000|Overall Study|Protocol Violation|0|||
161105491|NCT01717287|581777435|FG001|Overall Study|Protocol Violation|1|||
161105492|NCT04024228|581777436|FG000|Overall Study|Adverse Event|1|||
161105493|NCT04024228|581777437|FG001|Overall Study|Adverse Event|0|||
161105494|NCT04024228|581777436|FG000|Overall Study|Protocol Deviation|0|||
161105495|NCT04024228|581777437|FG001|Overall Study|Protocol Deviation|2|||
161105496|NCT04024228|581777436|FG000|Overall Study|Withdrawal by Subject|3|||
161105497|NCT04024228|581777437|FG001|Overall Study|Withdrawal by Subject|4|||
161105498|NCT00938717|581777441|FG000|Overall Study|Adverse Event|10|||
161105499|NCT00938717|581777442|FG001|Overall Study|Adverse Event|41|||
161105500|NCT00938717|581777441|FG000|Overall Study|Protocol Violation|11|||
161105501|NCT00938717|581777442|FG001|Overall Study|Protocol Violation|8|||
161105502|NCT00938717|581777441|FG000|Overall Study|Withdrawal by Subject|26|||
161105503|NCT00938717|581777442|FG001|Overall Study|Withdrawal by Subject|24|||
161105504|NCT00938717|581777441|FG000|Overall Study|Lost to Follow-up|13|||
161105505|NCT00938717|581777442|FG001|Overall Study|Lost to Follow-up|18|||
161105506|NCT00938717|581777441|FG000|Overall Study|Lack of Efficacy|33|||
161105507|NCT00938717|581777442|FG001|Overall Study|Lack of Efficacy|15|||
161105508|NCT00938717|581777441|FG000|Overall Study|Other reason|5|||
161105509|NCT00938717|581777442|FG001|Overall Study|Other reason|2|||
161105510|NCT01480284|581777443|FG000|Overall Study|Withdrawal by Subject|2|||
161105511|NCT01480284|581777444|FG001|Overall Study|Withdrawal by Subject|0|||
161105512|NCT01480284|581777443|FG000|Overall Study|Adverse Event|1|||
161105513|NCT01480284|581777444|FG001|Overall Study|Adverse Event|0|||
161105514|NCT01480284|581777443|FG000|Overall Study|Study closed/terminated|3|||
161105515|NCT01480284|581777444|FG001|Overall Study|Study closed/terminated|0|||
161105516|NCT01480284|581777443|FG000|Overall Study|Lost to Follow-up|1|||
161105517|NCT01480284|581777444|FG001|Overall Study|Lost to Follow-up|0|||
161105518|NCT01480284|581777443|FG000|Overall Study|Physician Decision|1|||
161105519|NCT01480284|581777444|FG001|Overall Study|Physician Decision|0|||
161105520|NCT00066742|581777447|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
161105521|NCT00066742|581777447|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
161105522|NCT00066742|581777447|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
161105523|NCT00066742|581777447|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
161105524|NCT00066742|581777447|FG000|Induction Chemoradiotherapy|Ineligible|3|||
161105525|NCT00066742|581777447|FG000|Consolidation Chemotherapy|not protocol specified|1|||
161105526|NCT00066742|581777447|FG000|Consolidation Chemotherapy|Ineligible|2|||
161105527|NCT02357134|581777449|FG000|Overall Study|Lost to Follow-up|1|||
161212677|NCT02266706|582161827|FG002|Overall Study|Withdrawal by Subject|1|||
161212678|NCT02266706|582161828|FG003|Overall Study|Withdrawal by Subject|0|||
161212679|NCT02266706|582161829|FG004|Overall Study|Withdrawal by Subject|0|||
161105528|NCT02357134|581777450|FG001|Overall Study|Lost to Follow-up|0|||
161105529|NCT02357134|581777451|FG002|Overall Study|Lost to Follow-up|0|||
161105530|NCT02357134|581777452|FG003|Overall Study|Lost to Follow-up|0|||
161212680|NCT02266706|582161830|FG005|Overall Study|Withdrawal by Subject|1|||
161105531|NCT02716675|581777453|FG000|Overall Study|Death|2|||
161105532|NCT02716675|581777454|FG001|Overall Study|Death|3|||
161105533|NCT02716675|581777455|FG002|Overall Study|Death|0|||
161105534|NCT02716675|581777453|FG000|Overall Study|Physician Decision|2|||
161105535|NCT02716675|581777454|FG001|Overall Study|Physician Decision|1|||
161105536|NCT02716675|581777455|FG002|Overall Study|Physician Decision|1|||
161105537|NCT02716675|581777453|FG000|Overall Study|Lost to Follow-up|100|||
161105538|NCT02716675|581777454|FG001|Overall Study|Lost to Follow-up|87|||
161105539|NCT02716675|581777455|FG002|Overall Study|Lost to Follow-up|99|||
161105540|NCT02716675|581777453|FG000|Overall Study|Withdrawal by Subject|22|||
161105541|NCT02716675|581777454|FG001|Overall Study|Withdrawal by Subject|25|||
161105542|NCT02716675|581777455|FG002|Overall Study|Withdrawal by Subject|20|||
161105543|NCT02716675|581777453|FG000|Overall Study|Protocol Violation|0|||
161105544|NCT02716675|581777454|FG001|Overall Study|Protocol Violation|3|||
161105545|NCT02716675|581777455|FG002|Overall Study|Protocol Violation|1|||
161105546|NCT02716675|581777453|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
161105547|NCT02716675|581777454|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
161105548|NCT02716675|581777455|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
161105549|NCT02716675|581777453|FG000|Overall Study|Other|38|||
161105550|NCT02716675|581777454|FG001|Overall Study|Other|47|||
161105551|NCT02716675|581777455|FG002|Overall Study|Other|48|||
161105552|NCT00290290|581777460|FG000|Overall Study|Death|3|||
161105553|NCT00290290|581777461|FG001|Overall Study|Death|4|||
161105554|NCT00290290|581777460|FG000|Overall Study|Withdrawal by Subject|2|||
161105555|NCT00290290|581777461|FG001|Overall Study|Withdrawal by Subject|2|||
161105556|NCT00290290|581777460|FG000|Overall Study|Underwent clean surgical procedure|13|||
161105557|NCT00290290|581777461|FG001|Overall Study|Underwent clean surgical procedure|12|||
161105558|NCT03374995|581777464|FG000|Overall Study|Withdrawal by Subject|0|||
161105559|NCT03374995|581777465|FG001|Overall Study|Withdrawal by Subject|1|||
161105560|NCT01383096|581777468|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161105561|NCT01383096|581777469|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161105562|NCT01383096|581777470|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
161105563|NCT01383096|581777468|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161105564|NCT01383096|581777469|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161105565|NCT01383096|581777470|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161105566|NCT01383096|581777468|FG000|Third Intervention (8 Days)|Elevated AST|0|||
161212681|NCT02266706|582161831|FG006|Overall Study|Withdrawal by Subject|0|||
161212682|NCT02266706|582161832|FG007|Overall Study|Withdrawal by Subject|0|||
161212683|NCT02266706|582161833|FG008|Overall Study|Withdrawal by Subject|0|||
161212684|NCT02266706|582161825|FG000|Overall Study|Screen failure|0|||
161105567|NCT01383096|581777469|FG001|Third Intervention (8 Days)|Elevated AST|1|||
161105568|NCT01383096|581777470|FG002|Third Intervention (8 Days)|Elevated AST|0|||
161105569|NCT01383096|581777468|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
161105570|NCT01383096|581777469|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
161105571|NCT01383096|581777470|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
161105572|NCT01383096|581777468|FG000|Third Intervention (8 Days)|Adverse Event|1|||
161105573|NCT01383096|581777469|FG001|Third Intervention (8 Days)|Adverse Event|0|||
161105574|NCT01383096|581777470|FG002|Third Intervention (8 Days)|Adverse Event|0|||
161105575|NCT01383096|581777468|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
161105576|NCT01383096|581777469|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
161105577|NCT01383096|581777470|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
161105578|NCT01383096|581777468|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
161105579|NCT01383096|581777469|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161105580|NCT01383096|581777470|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161105581|NCT01383096|581777468|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
161105582|NCT01383096|581777469|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161105583|NCT01383096|581777470|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
161105584|NCT01383096|581777468|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
161105585|NCT01383096|581777469|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161105586|NCT01383096|581777470|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
161105587|NCT01383096|581777468|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
161105588|NCT01383096|581777469|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
161105589|NCT01383096|581777470|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
161105590|NCT01383096|581777468|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
161105591|NCT01383096|581777469|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
161105592|NCT01383096|581777470|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
161105593|NCT01211535|581777471|FG000|Overall Study|Adverse Event|0|||
161105594|NCT01211535|581777472|FG001|Overall Study|Adverse Event|1|||
161105595|NCT03593850|581777480|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
161105596|NCT03593850|581777481|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
161105597|NCT00003895|581777482|FG000|Overall Study|Adverse Event|4|||
161105598|NCT00003895|581777483|FG001|Overall Study|Adverse Event|0|||
161105599|NCT00003895|581777482|FG000|Overall Study|Lack of Efficacy|1|||
161105600|NCT00003895|581777483|FG001|Overall Study|Lack of Efficacy|1|||
161105601|NCT00003895|581777482|FG000|Overall Study|Patient Vacation|2|||
161105602|NCT00003895|581777483|FG001|Overall Study|Patient Vacation|0|||
161105603|NCT00003895|581777482|FG000|Overall Study|Withdrawal by Subject|0|||
161105604|NCT00003895|581777483|FG001|Overall Study|Withdrawal by Subject|3|||
161105605|NCT01380730|581777484|FG000|Overall Study|Death|0|||
161105606|NCT01380730|581777485|FG001|Overall Study|Death|0|||
161105607|NCT01380730|581777486|FG002|Overall Study|Death|0|||
161105608|NCT01380730|581777487|FG003|Overall Study|Death|0|||
161105609|NCT01380730|581777488|FG004|Overall Study|Death|1|||
161105610|NCT01380730|581777489|FG005|Overall Study|Death|0|||
161105611|NCT01380730|581777490|FG006|Overall Study|Death|0|||
161105612|NCT01380730|581777491|FG007|Overall Study|Death|0|||
161105613|NCT02490475|581777492|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
161105614|NCT02490475|581777493|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
161105615|NCT02490475|581777494|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
161212685|NCT02266706|582161826|FG001|Overall Study|Screen failure|0|||
161212686|NCT02266706|582161827|FG002|Overall Study|Screen failure|0|||
161105616|NCT02490475|581777495|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
161105617|NCT02490475|581777492|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161105618|NCT02490475|581777493|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
161212687|NCT02266706|582161828|FG003|Overall Study|Screen failure|0|||
161212688|NCT02266706|582161829|FG004|Overall Study|Screen failure|0|||
161212689|NCT02266706|582161830|FG005|Overall Study|Screen failure|1|||
161105619|NCT02490475|581777494|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161105620|NCT02490475|581777495|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
161105621|NCT02490475|581777492|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
161105622|NCT02490475|581777493|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
161105623|NCT02490475|581777494|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
161105624|NCT02490475|581777495|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
161105625|NCT02490475|581777492|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
161105626|NCT02490475|581777493|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
161105627|NCT02490475|581777494|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
161105628|NCT02490475|581777495|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
161105629|NCT02490475|581777492|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
161105630|NCT02490475|581777493|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
161105631|NCT02490475|581777494|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
161105632|NCT02490475|581777495|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
161105633|NCT02490475|581777492|FG000|Period 2: Extension Phase|Refused Treatment|0|||
161105634|NCT02490475|581777493|FG001|Period 2: Extension Phase|Refused Treatment|0|||
161105635|NCT02490475|581777494|FG002|Period 2: Extension Phase|Refused Treatment|0|||
161105636|NCT02490475|581777495|FG003|Period 2: Extension Phase|Refused Treatment|1|||
161105637|NCT02490475|581777492|FG000|Period 2: Extension Phase|Adverse Event|0|||
161105638|NCT02490475|581777493|FG001|Period 2: Extension Phase|Adverse Event|0|||
161105639|NCT02490475|581777494|FG002|Period 2: Extension Phase|Adverse Event|1|||
161105640|NCT02490475|581777495|FG003|Period 2: Extension Phase|Adverse Event|0|||
161105641|NCT00616434|581777497|FG000|Overall Study|Adverse Event|5|||
161105642|NCT00616434|581777498|FG001|Overall Study|Adverse Event|2|||
161105643|NCT00616434|581777497|FG000|Overall Study|Physician Decision|0|||
161105644|NCT00616434|581777498|FG001|Overall Study|Physician Decision|4|||
161105645|NCT00616434|581777497|FG000|Overall Study|Withdrawal by Subject|1|||
161105646|NCT00616434|581777498|FG001|Overall Study|Withdrawal by Subject|1|||
161105647|NCT00616434|581777497|FG000|Overall Study|Protocol deviation|0|||
161105648|NCT00616434|581777498|FG001|Overall Study|Protocol deviation|1|||
161105649|NCT04784897|581777505|FG000|Overall Study|Death|4|||
161105650|NCT04784897|581777506|FG001|Overall Study|Death|2|||
161105651|NCT04784897|581777507|FG002|Overall Study|Death|1|||
161105652|NCT04784897|581777505|FG000|Overall Study|Withdrawal by Subject|0|||
161105653|NCT04784897|581777506|FG001|Overall Study|Withdrawal by Subject|0|||
161105654|NCT04784897|581777507|FG002|Overall Study|Withdrawal by Subject|1|||
161105655|NCT02319668|581777508|FG000|Overall Study|Other (Not specified)|0|||
161105656|NCT02319668|581777509|FG001|Overall Study|Other (Not specified)|2|||
161105657|NCT01161043|581777510|FG000|Overall Study|Withdrawal by Subject|3|||
161105658|NCT02164929|581777511|FG000|Overall Study|Converted to open procedure|1|||
161105659|NCT02164929|581777512|FG001|Overall Study|Converted to open procedure|0|||
161105660|NCT02164929|581777513|FG002|Overall Study|Converted to open procedure|0|||
161105661|NCT02164929|581777514|FG003|Overall Study|Converted to open procedure|2|||
161105662|NCT02164929|581777511|FG000|Overall Study|Failed regional block|0|||
161105663|NCT02164929|581777512|FG001|Overall Study|Failed regional block|0|||
161105664|NCT02164929|581777513|FG002|Overall Study|Failed regional block|1|||
161105665|NCT02164929|581777514|FG003|Overall Study|Failed regional block|0|||
161105666|NCT00365456|581777518|FG000|Trial Period I (12 Months)|Adverse Event|84|||
161105667|NCT00365456|581777519|FG001|Trial Period I (12 Months)|Adverse Event|0|||
161105668|NCT00365456|581777518|FG000|Trial Period I (12 Months)|Non-compliance|3|||
161105669|NCT00365456|581777519|FG001|Trial Period I (12 Months)|Non-compliance|0|||
161105670|NCT00365456|581777518|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
161105671|NCT00365456|581777519|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
161105672|NCT00365456|581777518|FG000|Trial Period I (12 Months)|Other|11|||
161105673|NCT00365456|581777519|FG001|Trial Period I (12 Months)|Other|0|||
161105674|NCT00365456|581777518|FG000|Trial Period II (12 Months)|Adverse Event|0|||
161105675|NCT00365456|581777519|FG001|Trial Period II (12 Months)|Adverse Event|6|||
161105676|NCT00365456|581777518|FG000|Trial Period II (12 Months)|Non-compliance|0|||
161105677|NCT00365456|581777519|FG001|Trial Period II (12 Months)|Non-compliance|2|||
161105678|NCT00365456|581777518|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
161105679|NCT00365456|581777519|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
161105680|NCT00365456|581777518|FG000|Trial Period II (12 Months)|Other|0|||
161105681|NCT00365456|581777519|FG001|Trial Period II (12 Months)|Other|1|||
161105682|NCT00365456|581777518|FG000|Trial Period III (12 Months)|Adverse Event|13|||
161105683|NCT00365456|581777519|FG001|Trial Period III (12 Months)|Adverse Event|3|||
161105684|NCT00365456|581777518|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
161105685|NCT00365456|581777519|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
161105686|NCT00365456|581777518|FG000|Trial Period III (12 Months)|Other|1|||
161105687|NCT00365456|581777519|FG001|Trial Period III (12 Months)|Other|1|||
161105688|NCT04754802|581777522|FG000|Overall Study|Lost to Follow-up|0|||
161105689|NCT04754802|581777523|FG001|Overall Study|Lost to Follow-up|2|||
161105690|NCT04754802|581777522|FG000|Overall Study|Withdrawal by Subject|2|||
161105691|NCT04754802|581777523|FG001|Overall Study|Withdrawal by Subject|0|||
161105692|NCT00701090|581777524|FG000|Overall Study|Adverse Event|11|||
161105693|NCT00701090|581777525|FG001|Overall Study|Adverse Event|2|||
161105694|NCT00701090|581777524|FG000|Overall Study|Death|0|||
161105695|NCT00701090|581777525|FG001|Overall Study|Death|1|||
161105696|NCT00701090|581777524|FG000|Overall Study|Lack of Efficacy|5|||
161105697|NCT00701090|581777525|FG001|Overall Study|Lack of Efficacy|4|||
161105698|NCT00701090|581777524|FG000|Overall Study|Lost to Follow-up|9|||
161105699|NCT00701090|581777525|FG001|Overall Study|Lost to Follow-up|9|||
161105700|NCT00701090|581777524|FG000|Overall Study|Physician Decision|3|||
161105701|NCT00701090|581777525|FG001|Overall Study|Physician Decision|4|||
161105702|NCT00701090|581777524|FG000|Overall Study|Protocol Violation|2|||
161105703|NCT00701090|581777525|FG001|Overall Study|Protocol Violation|3|||
161105704|NCT00701090|581777524|FG000|Overall Study|Withdrawal by Subject|11|||
161105705|NCT00701090|581777525|FG001|Overall Study|Withdrawal by Subject|16|||
161105706|NCT00701090|581777524|FG000|Overall Study|Other|7|||
161105707|NCT00701090|581777525|FG001|Overall Study|Other|12|||
161105708|NCT01299376|581777532|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
161105709|NCT01299376|581777533|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
161105710|NCT01299376|581777532|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
161105711|NCT01299376|581777533|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
161105712|NCT01299376|581777532|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
161105713|NCT01299376|581777533|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
161105714|NCT01299376|581777532|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
161105715|NCT01299376|581777533|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
161105716|NCT01299376|581777532|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
161105717|NCT01299376|581777533|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
161105718|NCT01299376|581777532|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
161105719|NCT01299376|581777533|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
161105720|NCT01299376|581777532|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
161105721|NCT01299376|581777533|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
161105722|NCT01299376|581777532|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
161105723|NCT01299376|581777533|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
161105724|NCT01299376|581777532|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
161105725|NCT01299376|581777533|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
161105726|NCT01299376|581777532|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
161105727|NCT01299376|581777533|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
161105728|NCT01299376|581777532|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
161105729|NCT01299376|581777533|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
161105730|NCT02463071|581777537|FG000|Overall Study|Adverse Event|3|||
161105731|NCT02463071|581777538|FG001|Overall Study|Adverse Event|5|||
161105732|NCT02463071|581777539|FG002|Overall Study|Adverse Event|1|||
161105733|NCT02463071|581777537|FG000|Overall Study|Death|1|||
161105734|NCT02463071|581777538|FG001|Overall Study|Death|0|||
161105735|NCT02463071|581777539|FG002|Overall Study|Death|0|||
161105736|NCT02463071|581777537|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161105737|NCT02463071|581777538|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161105738|NCT02463071|581777539|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161105739|NCT02463071|581777537|FG000|Overall Study|Reason not specified|7|||
161105740|NCT02463071|581777538|FG001|Overall Study|Reason not specified|9|||
161105741|NCT02463071|581777539|FG002|Overall Study|Reason not specified|4|||
161105742|NCT02463071|581777537|FG000|Overall Study|Protocol Violation|0|||
161105743|NCT02463071|581777538|FG001|Overall Study|Protocol Violation|2|||
161105744|NCT02463071|581777539|FG002|Overall Study|Protocol Violation|0|||
161105745|NCT02463071|581777537|FG000|Overall Study|Lost to Follow-up|0|||
161105746|NCT02463071|581777538|FG001|Overall Study|Lost to Follow-up|0|||
161105747|NCT02463071|581777539|FG002|Overall Study|Lost to Follow-up|1|||
161105748|NCT00175877|581777555|FG000|Overall Study|Adverse Event|136|||
161105749|NCT00175877|581777555|FG000|Overall Study|Withdrawal by Subject|141|||
161105750|NCT00175877|581777555|FG000|Overall Study|Lost to Follow-up|9|||
161105751|NCT00175877|581777555|FG000|Overall Study|Lack of Efficacy|26|||
161105752|NCT00175877|581777555|FG000|Overall Study|Protocol Violation|15|||
161105753|NCT00175877|581777555|FG000|Overall Study|Other Reason|20|||
161105754|NCT00175877|581777555|FG000|Overall Study|AE & Other|1|||
161105755|NCT00175877|581777555|FG000|Overall Study|Withdrawal by subject & Other|1|||
161105756|NCT02054325|581777556|FG000|Overall Study|Lost to Follow-up|8|||
161105757|NCT02054325|581777557|FG001|Overall Study|Lost to Follow-up|5|||
161105758|NCT00617604|581777560|FG000|Overall Study|Death|2|||
161105759|NCT00617604|581777561|FG001|Overall Study|Death|1|||
161105760|NCT00617604|581777560|FG000|Overall Study|Lost to Follow-up|1|||
161105761|NCT00617604|581777561|FG001|Overall Study|Lost to Follow-up|0|||
161105762|NCT00617604|581777560|FG000|Overall Study|Miscellaneous Reasons|8|||
161105763|NCT00617604|581777561|FG001|Overall Study|Miscellaneous Reasons|10|||
161105764|NCT00617604|581777560|FG000|Overall Study|Withdrawal by Subject|4|||
161105765|NCT00617604|581777561|FG001|Overall Study|Withdrawal by Subject|6|||
161105766|NCT00617604|581777560|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
161105767|NCT00617604|581777561|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
161105768|NCT02303704|581777562|FG000|Overall Study|Protocol Violation|5|||
161105769|NCT02303704|581777563|FG001|Overall Study|Protocol Violation|9|||
161105770|NCT00805025|581777564|FG000|Overall Study|Screened but not enrolled/treated|42|||
161105771|NCT00805025|581777564|FG000|Overall Study|Adverse Event|4|||
161105772|NCT00805025|581777564|FG000|Overall Study|Withdrawal by Subject|2|||
161105773|NCT00805025|581777564|FG000|Overall Study|Physician Decision|1|||
161105774|NCT04029961|581777570|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
161105775|NCT04029961|581777571|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
161105776|NCT04029961|581777570|FG000|Overall Study|Change in Treatment Course|0|||
161105777|NCT04029961|581777571|FG001|Overall Study|Change in Treatment Course|1|||
161105778|NCT00688155|581777575|FG000|Overall Study|Withdrawal by Subject|2|||
161105779|NCT00688155|581777576|FG001|Overall Study|Withdrawal by Subject|2|||
161105780|NCT00688155|581777577|FG002|Overall Study|Withdrawal by Subject|1|||
161105781|NCT00688155|581777578|FG003|Overall Study|Withdrawal by Subject|1|||
161105782|NCT01624259|581777583|FG000|Overall Study|Adverse Event|18|||
161105783|NCT01624259|581777584|FG001|Overall Study|Adverse Event|18|||
161105784|NCT01624259|581777583|FG000|Overall Study|Protocol Violation|1|||
161105785|NCT01624259|581777584|FG001|Overall Study|Protocol Violation|2|||
161105786|NCT01624259|581777583|FG000|Overall Study|Withdrawal by Subject|5|||
161105787|NCT01624259|581777584|FG001|Overall Study|Withdrawal by Subject|7|||
161105788|NCT01624259|581777583|FG000|Overall Study|Physician Decision|1|||
161105789|NCT01624259|581777584|FG001|Overall Study|Physician Decision|1|||
161105790|NCT01624259|581777583|FG000|Overall Study|Lost to Follow-up|2|||
161105791|NCT01624259|581777584|FG001|Overall Study|Lost to Follow-up|3|||
161105792|NCT01624259|581777583|FG000|Overall Study|Abnormal laboratory measure|3|||
161105793|NCT01624259|581777584|FG001|Overall Study|Abnormal laboratory measure|0|||
161105794|NCT03697720|581778856|FG000|Overall Study|Lost to Follow-up|7|||
161105795|NCT00382720|581778861|FG000|Overall Study|Adverse Event|21|||
161105796|NCT00382720|581778862|FG001|Overall Study|Adverse Event|23|||
161105797|NCT00382720|581778863|FG002|Overall Study|Adverse Event|15|||
161105798|NCT00382720|581778861|FG000|Overall Study|Protocol Violation|2|||
161105799|NCT00382720|581778862|FG001|Overall Study|Protocol Violation|5|||
161105800|NCT00382720|581778863|FG002|Overall Study|Protocol Violation|1|||
161105801|NCT00382720|581778861|FG000|Overall Study|Death|0|||
161105802|NCT00382720|581778862|FG001|Overall Study|Death|1|||
161105803|NCT00382720|581778863|FG002|Overall Study|Death|2|||
161105804|NCT00382720|581778861|FG000|Overall Study|Progressive disease|37|||
161105805|NCT00382720|581778862|FG001|Overall Study|Progressive disease|28|||
161105806|NCT00382720|581778863|FG002|Overall Study|Progressive disease|38|||
161105807|NCT00382720|581778861|FG000|Overall Study|Withdrew consent|1|||
161105808|NCT00382720|581778862|FG001|Overall Study|Withdrew consent|1|||
161105809|NCT00382720|581778863|FG002|Overall Study|Withdrew consent|2|||
161105810|NCT00382720|581778861|FG000|Overall Study|Withdrawal by Subject|11|||
161105811|NCT00382720|581778862|FG001|Overall Study|Withdrawal by Subject|20|||
161105812|NCT00382720|581778863|FG002|Overall Study|Withdrawal by Subject|12|||
161105813|NCT00382720|581778861|FG000|Overall Study|Surgery|1|||
161105814|NCT00382720|581778862|FG001|Overall Study|Surgery|1|||
161105815|NCT00382720|581778863|FG002|Overall Study|Surgery|4|||
161105816|NCT00382720|581778861|FG000|Overall Study|Patient did not receive study medication|1|||
161105817|NCT00382720|581778862|FG001|Overall Study|Patient did not receive study medication|1|||
161105818|NCT00382720|581778863|FG002|Overall Study|Patient did not receive study medication|4|||
161105819|NCT00382720|581778861|FG000|Overall Study|Clinically progressive disease|0|||
161105820|NCT00382720|581778862|FG001|Overall Study|Clinically progressive disease|1|||
161105821|NCT00382720|581778863|FG002|Overall Study|Clinically progressive disease|0|||
161105822|NCT00382720|581778861|FG000|Overall Study|Good prognosis|0|||
161105823|NCT00382720|581778862|FG001|Overall Study|Good prognosis|1|||
161105824|NCT00382720|581778863|FG002|Overall Study|Good prognosis|0|||
161105825|NCT00382720|581778861|FG000|Overall Study|Investigator/Clinical decision|5|||
161105826|NCT00382720|581778862|FG001|Overall Study|Investigator/Clinical decision|6|||
161105827|NCT00382720|581778863|FG002|Overall Study|Investigator/Clinical decision|6|||
161105828|NCT00382720|581778861|FG000|Overall Study|Discontinued at end of study|0|||
161105829|NCT00382720|581778862|FG001|Overall Study|Discontinued at end of study|1|||
161105830|NCT00382720|581778863|FG002|Overall Study|Discontinued at end of study|2|||
161105831|NCT01183143|581778866|FG000|Overall Study|Protocol Violation|115|||
161105832|NCT01183143|581778866|FG000|Overall Study|Withdrawal by Subject|19|||
161105833|NCT01183143|581778866|FG000|Overall Study|Subject Questionnaires not returned|5|||
161105834|NCT01183143|581778866|FG000|Overall Study|Subjects enrolled, but not treated|11|||
161105835|NCT04490395|581778867|FG000|Overall Study|Lost to Follow-up|0|||
161105836|NCT04490395|581778868|FG001|Overall Study|Lost to Follow-up|1|||
161105837|NCT05092919|581778871|FG000|Overall Study|Lost to Follow-up|7|||
161105838|NCT05092919|581778871|FG000|Overall Study|Withdrawal by Subject|2|||
161105839|NCT01942148|581778875|FG000|Overall Study|Adverse Event|4|||
161105840|NCT01942148|581778875|FG000|Overall Study|Lack of Efficacy|2|||
161105841|NCT01942148|581778875|FG000|Overall Study|Physician Decision|11|||
161105842|NCT01942148|581778875|FG000|Overall Study|Protocol Violation|1|||
161105843|NCT01942148|581778875|FG000|Overall Study|Withdrawal by Subject|8|||
161105844|NCT01942148|581778875|FG000|Overall Study|Use of the prohibition medicine|1|||
161105845|NCT02248259|581778876|FG000|Treatment Period 1|Adverse Event|0|||
161105846|NCT02248259|581778877|FG001|Treatment Period 1|Adverse Event|0|||
161105847|NCT02248259|581778878|FG002|Treatment Period 1|Adverse Event|1|||
161105848|NCT02248259|581778879|FG003|Treatment Period 1|Adverse Event|0|||
161105849|NCT00096785|581778880|FG000|Overall Study|Lost to Follow-up|1|||
161105850|NCT00096785|581778881|FG001|Overall Study|Lost to Follow-up|0|||
161105851|NCT00096785|581778880|FG000|Overall Study|Withdrawal by Subject|0|||
161105852|NCT00096785|581778881|FG001|Overall Study|Withdrawal by Subject|1|||
161105853|NCT00096785|581778880|FG000|Overall Study|Relocated|1|||
161105854|NCT00096785|581778881|FG001|Overall Study|Relocated|0|||
161105855|NCT01838616|581778882|FG000|Titration Period|Adverse Event|18|||
161105856|NCT01838616|581778883|FG001|Titration Period|Adverse Event|48|||
161105857|NCT01838616|581778882|FG000|Titration Period|Lack of Efficacy|5|||
161105858|NCT01838616|581778883|FG001|Titration Period|Lack of Efficacy|12|||
161105859|NCT01838616|581778882|FG000|Titration Period|Withdrawal by Subject|5|||
161105860|NCT01838616|581778883|FG001|Titration Period|Withdrawal by Subject|5|||
161105861|NCT01838616|581778882|FG000|Titration Period|Technical problems|1|||
161105862|NCT01838616|581778883|FG001|Titration Period|Technical problems|0|||
161105863|NCT01838616|581778882|FG000|Titration Period|Other|1|||
161105864|NCT01838616|581778883|FG001|Titration Period|Other|0|||
161105865|NCT01838616|581778882|FG000|Titration Period|Protocol Violation|0|||
161105866|NCT01838616|581778883|FG001|Titration Period|Protocol Violation|1|||
161105867|NCT01838616|581778882|FG000|Continuation Period|Lack of Efficacy|3|||
161105868|NCT01838616|581778883|FG001|Continuation Period|Lack of Efficacy|5|||
161105869|NCT01838616|581778882|FG000|Continuation Period|Adverse Event|8|||
161105870|NCT01838616|581778883|FG001|Continuation Period|Adverse Event|4|||
161105871|NCT01838616|581778882|FG000|Continuation Period|Protocol Violation|2|||
161105872|NCT01838616|581778883|FG001|Continuation Period|Protocol Violation|0|||
161105873|NCT01838616|581778882|FG000|Continuation Period|Lost to Follow-up|1|||
161105874|NCT01838616|581778883|FG001|Continuation Period|Lost to Follow-up|0|||
161105875|NCT01838616|581778882|FG000|Continuation Period|Withdrawal by Subject|0|||
161105876|NCT01838616|581778883|FG001|Continuation Period|Withdrawal by Subject|4|||
161105877|NCT01838616|581778882|FG000|Continuation Period|Technical problems|0|||
161105878|NCT01838616|581778883|FG001|Continuation Period|Technical problems|1|||
161105879|NCT01838616|581778882|FG000|Pick-up Arm|Lack of Efficacy|4|||
161105880|NCT01838616|581778883|FG001|Pick-up Arm|Lack of Efficacy|0|||
161105881|NCT01838616|581778882|FG000|Pick-up Arm|Adverse Event|9|||
161105882|NCT01838616|581778883|FG001|Pick-up Arm|Adverse Event|0|||
161105883|NCT01838616|581778882|FG000|Pick-up Arm|Withdrawal by Subject|1|||
161105884|NCT01838616|581778883|FG001|Pick-up Arm|Withdrawal by Subject|0|||
161105885|NCT01838616|581778882|FG000|Pick-up Arm|Technical problems|1|||
161105886|NCT01838616|581778883|FG001|Pick-up Arm|Technical problems|0|||
161105887|NCT02573870|581778884|FG000|Overall Study|Adverse Event|0|||
161105888|NCT02573870|581778885|FG001|Overall Study|Adverse Event|2|||
161105889|NCT02573870|581778884|FG000|Overall Study|Lack of Efficacy|0|||
161105890|NCT02573870|581778885|FG001|Overall Study|Lack of Efficacy|1|||
161105891|NCT02573870|581778884|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
161105892|NCT02573870|581778885|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
161105893|NCT02573870|581778884|FG000|Overall Study|Lost to Follow-up|0|||
161105894|NCT02573870|581778885|FG001|Overall Study|Lost to Follow-up|1|||
161105895|NCT02573870|581778884|FG000|Overall Study|Other: Fail to Meet Visit|0|||
161105896|NCT02573870|581778885|FG001|Overall Study|Other: Fail to Meet Visit|2|||
161105897|NCT00257725|581778886|FG000|Overall Study|Adverse Event|3|||
161105898|NCT00514514|581778887|FG000|Pre-phase|Death|10|||
161105899|NCT00514514|581778888|FG001|Pre-phase|Death|0|||
161105900|NCT00514514|581778889|FG002|Pre-phase|Death|0|||
161105901|NCT00514514|581778887|FG000|Pre-phase|administrative problems|2|||
161105902|NCT00514514|581778888|FG001|Pre-phase|administrative problems|0|||
161105903|NCT00514514|581778889|FG002|Pre-phase|administrative problems|0|||
161105904|NCT00514514|581778887|FG000|Pre-phase|Protocol Violation|6|||
161324204|NCT02959918|582573541|FG006|Overall Study|Withdrawal by Subject|1|||
161324205|NCT02959918|582573542|FG007|Overall Study|Withdrawal by Subject|0|||
161105905|NCT00514514|581778888|FG001|Pre-phase|Protocol Violation|0|||
161105906|NCT00514514|581778889|FG002|Pre-phase|Protocol Violation|0|||
161105907|NCT00514514|581778887|FG000|Pre-phase|condition no longer requires study drug|7|||
161105908|NCT00514514|581778888|FG001|Pre-phase|condition no longer requires study drug|0|||
161105909|NCT00514514|581778889|FG002|Pre-phase|condition no longer requires study drug|0|||
161105910|NCT00514514|581778887|FG000|Pre-phase|abnormal test procedure results|15|||
161105911|NCT00514514|581778888|FG001|Pre-phase|abnormal test procedure results|0|||
161105912|NCT00514514|581778889|FG002|Pre-phase|abnormal test procedure results|0|||
161105913|NCT00514514|581778887|FG000|Pre-phase|Lost to Follow-up|2|||
161105914|NCT00514514|581778888|FG001|Pre-phase|Lost to Follow-up|0|||
161105915|NCT00514514|581778889|FG002|Pre-phase|Lost to Follow-up|0|||
161105916|NCT00514514|581778887|FG000|Pre-phase|abnormal lab values|23|||
161105917|NCT00514514|581778888|FG001|Pre-phase|abnormal lab values|0|||
161105918|NCT00514514|581778889|FG002|Pre-phase|abnormal lab values|0|||
161105919|NCT00514514|581778887|FG000|Pre-phase|Lack of Efficacy|35|||
161105920|NCT00514514|581778888|FG001|Pre-phase|Lack of Efficacy|0|||
161105921|NCT00514514|581778889|FG002|Pre-phase|Lack of Efficacy|0|||
161105922|NCT00514514|581778887|FG000|Pre-phase|Adverse Event|137|||
161105923|NCT00514514|581778888|FG001|Pre-phase|Adverse Event|0|||
161105924|NCT00514514|581778889|FG002|Pre-phase|Adverse Event|0|||
161105925|NCT00514514|581778887|FG000|Pre-phase|Withdrawal by Subject|66|||
161105926|NCT00514514|581778888|FG001|Pre-phase|Withdrawal by Subject|0|||
161105927|NCT00514514|581778889|FG002|Pre-phase|Withdrawal by Subject|0|||
161105928|NCT00514514|581778887|FG000|Randomized - 9 Month|Death|3|||
161105929|NCT00514514|581778888|FG001|Randomized - 9 Month|Death|2|||
161105930|NCT00514514|581778889|FG002|Randomized - 9 Month|Death|2|||
161105931|NCT00514514|581778887|FG000|Randomized - 9 Month|Administrative problems|1|||
161105932|NCT00514514|581778888|FG001|Randomized - 9 Month|Administrative problems|1|||
161105933|NCT00514514|581778889|FG002|Randomized - 9 Month|Administrative problems|2|||
161105934|NCT00514514|581778887|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
161105935|NCT00514514|581778888|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
161105936|NCT00514514|581778889|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
161105937|NCT00514514|581778887|FG000|Randomized - 9 Month|Protocol Violation|1|||
161105938|NCT00514514|581778888|FG001|Randomized - 9 Month|Protocol Violation|1|||
161105939|NCT00514514|581778889|FG002|Randomized - 9 Month|Protocol Violation|0|||
161105940|NCT00514514|581778887|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
161105941|NCT00514514|581778888|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
161105942|NCT00514514|581778889|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
161105943|NCT00514514|581778887|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
161105944|NCT00514514|581778888|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
161105945|NCT00514514|581778889|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
161105946|NCT00514514|581778887|FG000|Randomized - 9 Month|Adverse Event|25|||
161105947|NCT00514514|581778888|FG001|Randomized - 9 Month|Adverse Event|44|||
161105948|NCT00514514|581778889|FG002|Randomized - 9 Month|Adverse Event|27|||
161105949|NCT00514514|581778887|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
161105950|NCT00514514|581778888|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
161105951|NCT00514514|581778889|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
161105952|NCT00514514|581778887|FG000|Extension - 4 Years|Lost to Follow-up|12|||
161105953|NCT00514514|581778888|FG001|Extension - 4 Years|Lost to Follow-up|10|||
161105954|NCT00514514|581778889|FG002|Extension - 4 Years|Lost to Follow-up|9|||
161105955|NCT00514514|581778887|FG000|Extension - 4 Years|Administrative problems|3|||
161105956|NCT00514514|581778888|FG001|Extension - 4 Years|Administrative problems|1|||
161105957|NCT00514514|581778889|FG002|Extension - 4 Years|Administrative problems|1|||
161105958|NCT00514514|581778887|FG000|Extension - 4 Years|Death|8|||
161105959|NCT00514514|581778888|FG001|Extension - 4 Years|Death|3|||
161105960|NCT00514514|581778889|FG002|Extension - 4 Years|Death|6|||
161105961|NCT00514514|581778887|FG000|Extension - 4 Years|Adverse Event|9|||
161105962|NCT00514514|581778888|FG001|Extension - 4 Years|Adverse Event|6|||
161105963|NCT00514514|581778889|FG002|Extension - 4 Years|Adverse Event|3|||
161105964|NCT00762892|581778892|FG000|Overall Study|Lost to Follow-up|2|||
161105965|NCT00762892|581778893|FG001|Overall Study|Lost to Follow-up|5|||
161105966|NCT00762892|581778892|FG000|Overall Study|Withdrawal by Subject|0|||
161105967|NCT00762892|581778893|FG001|Overall Study|Withdrawal by Subject|1|||
161105968|NCT00762892|581778892|FG000|Overall Study|Death|1|||
161105969|NCT00762892|581778893|FG001|Overall Study|Death|0|||
161105970|NCT00762892|581778892|FG000|Overall Study|Pregnancy|1|||
161105971|NCT00762892|581778893|FG001|Overall Study|Pregnancy|0|||
161105972|NCT00762892|581778892|FG000|Overall Study|Incarceration|1|||
161105973|NCT00762892|581778893|FG001|Overall Study|Incarceration|0|||
161105974|NCT02234479|581778894|FG000|Overall Study|Withdrawal by Subject|1|||
161105975|NCT02234479|581778895|FG001|Overall Study|Withdrawal by Subject|3|||
161105976|NCT00914927|581778896|FG000|Overall Study|Adverse Event|0|||
161105977|NCT00914927|581778897|FG001|Overall Study|Adverse Event|0|||
161105978|NCT00914927|581778898|FG002|Overall Study|Adverse Event|0|||
161105979|NCT00914927|581778899|FG003|Overall Study|Adverse Event|0|||
161105980|NCT00914927|581778900|FG004|Overall Study|Adverse Event|1|||
161105981|NCT00914927|581778901|FG005|Overall Study|Adverse Event|0|||
161105982|NCT00914927|581778902|FG006|Overall Study|Adverse Event|0|||
161105983|NCT00914927|581778896|FG000|Overall Study|Withdrawal by Subject|0|||
161105984|NCT00914927|581778897|FG001|Overall Study|Withdrawal by Subject|1|||
161105985|NCT00914927|581778898|FG002|Overall Study|Withdrawal by Subject|0|||
161105986|NCT00914927|581778899|FG003|Overall Study|Withdrawal by Subject|1|||
161105987|NCT00914927|581778900|FG004|Overall Study|Withdrawal by Subject|0|||
161105988|NCT00914927|581778901|FG005|Overall Study|Withdrawal by Subject|0|||
161105989|NCT00914927|581778902|FG006|Overall Study|Withdrawal by Subject|0|||
161105990|NCT00914927|581778896|FG000|Overall Study|Lost to Follow-up|0|||
161105991|NCT00914927|581778897|FG001|Overall Study|Lost to Follow-up|0|||
161105992|NCT00914927|581778898|FG002|Overall Study|Lost to Follow-up|0|||
161105993|NCT00914927|581778899|FG003|Overall Study|Lost to Follow-up|1|||
161105994|NCT00914927|581778900|FG004|Overall Study|Lost to Follow-up|0|||
161105995|NCT00914927|581778901|FG005|Overall Study|Lost to Follow-up|0|||
161105996|NCT00914927|581778902|FG006|Overall Study|Lost to Follow-up|0|||
161105997|NCT00914927|581778896|FG000|Overall Study|Administrative/Other|2|||
161105998|NCT00914927|581778897|FG001|Overall Study|Administrative/Other|1|||
161105999|NCT00914927|581778898|FG002|Overall Study|Administrative/Other|0|||
161106000|NCT00914927|581778899|FG003|Overall Study|Administrative/Other|0|||
161106001|NCT00914927|581778900|FG004|Overall Study|Administrative/Other|1|||
161106002|NCT00914927|581778901|FG005|Overall Study|Administrative/Other|0|||
161106003|NCT00914927|581778902|FG006|Overall Study|Administrative/Other|0|||
161106004|NCT01490814|581778903|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
161106005|NCT01490814|581778904|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
161106006|NCT01490814|581778903|FG000|Overall Study|Physician Decision|1|||
161106007|NCT01490814|581778904|FG001|Overall Study|Physician Decision|0|||
161106008|NCT01490814|581778903|FG000|Overall Study|Withdrawal by Subject|0|||
161106009|NCT01490814|581778904|FG001|Overall Study|Withdrawal by Subject|5|||
161106010|NCT01537198|581778905|FG000|Overall Study|RSV infection|2|||
161106011|NCT01537198|581778905|FG000|Overall Study|Adverse Event|4|||
161106012|NCT01537198|581778905|FG000|Overall Study|No Further Visits to the Clinic|37|||
161106013|NCT01537198|581778905|FG000|Overall Study|Other|111|||
161106014|NCT02170779|581778913|FG000|Overall Study|Withdrawal by Subject|1|||
161106015|NCT02170779|581778914|FG001|Overall Study|Withdrawal by Subject|0|||
161106016|NCT02170779|581778913|FG000|Overall Study|Lost to Follow-up|0|||
161106017|NCT02170779|581778914|FG001|Overall Study|Lost to Follow-up|1|||
161106018|NCT00935272|581778917|FG000|Overall Study|Lost to Follow-up|10|||
161106019|NCT00935272|581778918|FG001|Overall Study|Lost to Follow-up|3|||
161106020|NCT00935272|581778917|FG000|Overall Study|Withdrawal by Subject|8|||
161106021|NCT00935272|581778918|FG001|Overall Study|Withdrawal by Subject|2|||
161106022|NCT00935272|581778917|FG000|Overall Study|Physician Decision|1|||
161106023|NCT00935272|581778918|FG001|Overall Study|Physician Decision|0|||
161106024|NCT00935272|581778917|FG000|Overall Study|Protocol Violation|0|||
161106025|NCT00935272|581778918|FG001|Overall Study|Protocol Violation|1|||
161106026|NCT04340557|581778922|FG000|Overall Study|Transferred to ICU and/or death|1|||
161106027|NCT04340557|581778923|FG001|Overall Study|Transferred to ICU and/or death|2|||
161106028|NCT01221727|581778924|FG000|Overall Study|Physician Decision|2|||
161106029|NCT01221727|581778925|FG001|Overall Study|Physician Decision|0|||
161106030|NCT01221727|581778924|FG000|Overall Study|Withdrawal by Subject|1|||
161106031|NCT01221727|581778925|FG001|Overall Study|Withdrawal by Subject|1|||
161106032|NCT00529451|581778926|FG000|Overall Study|Subject withdrew consent|16|||
161106033|NCT00529451|581778927|FG001|Overall Study|Subject withdrew consent|21|||
161106034|NCT00529451|581778928|FG002|Overall Study|Subject withdrew consent|13|||
161106035|NCT00529451|581778929|FG003|Overall Study|Subject withdrew consent|12|||
161106036|NCT00529451|581778926|FG000|Overall Study|Adverse Event|9|||
161106037|NCT00529451|581778927|FG001|Overall Study|Adverse Event|16|||
161106038|NCT00529451|581778928|FG002|Overall Study|Adverse Event|14|||
161106039|NCT00529451|581778929|FG003|Overall Study|Adverse Event|8|||
161106040|NCT00529451|581778926|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
161106041|NCT00529451|581778927|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
161106042|NCT00529451|581778928|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
161106043|NCT00529451|581778929|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
161106044|NCT00529451|581778926|FG000|Overall Study|Lost to Follow-up|4|||
161106045|NCT00529451|581778927|FG001|Overall Study|Lost to Follow-up|7|||
161106046|NCT00529451|581778928|FG002|Overall Study|Lost to Follow-up|4|||
161106047|NCT00529451|581778929|FG003|Overall Study|Lost to Follow-up|4|||
161106048|NCT00529451|581778926|FG000|Overall Study|Protocol deviation|1|||
161106049|NCT00529451|581778927|FG001|Overall Study|Protocol deviation|1|||
161106050|NCT00529451|581778928|FG002|Overall Study|Protocol deviation|4|||
161106051|NCT00529451|581778929|FG003|Overall Study|Protocol deviation|1|||
161106052|NCT00529451|581778926|FG000|Overall Study|Administrative problems|1|||
161106053|NCT00529451|581778927|FG001|Overall Study|Administrative problems|1|||
161106054|NCT00529451|581778928|FG002|Overall Study|Administrative problems|0|||
161106055|NCT00529451|581778929|FG003|Overall Study|Administrative problems|2|||
161212690|NCT02266706|582161831|FG006|Overall Study|Screen failure|1|||
161212691|NCT02266706|582161832|FG007|Overall Study|Screen failure|0|||
161212692|NCT02266706|582161833|FG008|Overall Study|Screen failure|0|||
161212693|NCT02266706|582161825|FG000|Overall Study|Enrollment in another study|0|||
161212694|NCT02266706|582161826|FG001|Overall Study|Enrollment in another study|0|||
161212695|NCT02266706|582161827|FG002|Overall Study|Enrollment in another study|0|||
161106056|NCT03700320|581778930|FG000|Overall Study|Adverse Event|5|||
161212696|NCT02266706|582161828|FG003|Overall Study|Enrollment in another study|1|||
161212697|NCT02266706|582161829|FG004|Overall Study|Enrollment in another study|0|||
161106057|NCT03700320|581778931|FG001|Overall Study|Adverse Event|31|||
161106058|NCT03700320|581778930|FG000|Overall Study|Lack of Efficacy|2|||
161106059|NCT03700320|581778931|FG001|Overall Study|Lack of Efficacy|5|||
161106060|NCT03700320|581778930|FG000|Overall Study|Withdrawal by Subject|29|||
161106061|NCT03700320|581778931|FG001|Overall Study|Withdrawal by Subject|75|||
161106062|NCT03700320|581778930|FG000|Overall Study|Lost to Follow-up|16|||
161106063|NCT03700320|581778931|FG001|Overall Study|Lost to Follow-up|23|||
161324206|NCT02959918|582573543|FG008|Overall Study|Withdrawal by Subject|1|||
161106064|NCT03700320|581778930|FG000|Overall Study|Pregnancy|2|||
161106065|NCT03700320|581778931|FG001|Overall Study|Pregnancy|4|||
161106066|NCT03700320|581778930|FG000|Overall Study|Protocol Deviation|7|||
161106067|NCT03700320|581778931|FG001|Overall Study|Protocol Deviation|31|||
161106068|NCT03700320|581778930|FG000|Overall Study|Non-compliance with Study Drug|1|||
161106069|NCT03700320|581778931|FG001|Overall Study|Non-compliance with Study Drug|3|||
161106070|NCT03700320|581778930|FG000|Overall Study|Reason not Specified|0|||
161106071|NCT03700320|581778931|FG001|Overall Study|Reason not Specified|1|||
161106072|NCT04305275|581778932|FG000|Overall Study|Adverse Event|4|||
161106073|NCT04305275|581778933|FG001|Overall Study|Adverse Event|0|||
161106074|NCT04305275|581778932|FG000|Overall Study|Lost to Follow-up|1|||
161106075|NCT04305275|581778933|FG001|Overall Study|Lost to Follow-up|1|||
161106076|NCT04305275|581778932|FG000|Overall Study|Withdrawal by Participant|8|||
161106077|NCT04305275|581778933|FG001|Overall Study|Withdrawal by Participant|1|||
161106078|NCT00199836|581778936|FG000|Overall Study|Progressive Disease|5|||
161106079|NCT00199836|581778936|FG000|Overall Study|Death|1|||
161106080|NCT03061175|581778937|FG000|Baseline|Participant was deemed ineligible|1|||
161106081|NCT03061175|581778938|FG001|Baseline|Participant was deemed ineligible|0|||
161106082|NCT03061175|581778937|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
161106083|NCT03061175|581778938|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
161106084|NCT03061175|581778937|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
161106085|NCT03061175|581778938|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
161106086|NCT03061175|581778937|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
161106087|NCT03061175|581778938|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
161106088|NCT00760669|581778939|FG000|Overall Study|Not assessed for overall improvement|18|||
161106089|NCT00760669|581778939|FG000|Overall Study|Participants missing efficacy assessment|6|||
161106090|NCT00760669|581778939|FG000|Overall Study|Participants with overlapping cases|1|||
161106091|NCT00760669|581778939|FG000|Overall Study|Took drug before entering in contract|5|||
161106092|NCT02456662|581778948|FG000|Overall Study|Lost to Follow-up|2|||
161106093|NCT02456662|581778949|FG001|Overall Study|Lost to Follow-up|1|||
161106094|NCT00504153|581778954|FG000|Overall Study|Withdrawal by Subject|1|||
161106095|NCT00504153|581778954|FG000|Overall Study|Adverse Event|4|||
161106096|NCT00504153|581778954|FG000|Overall Study|Death|1|||
161106097|NCT01034540|581778955|FG000|Overall Study|Adverse Event|0|||
161106098|NCT01034540|581778956|FG001|Overall Study|Adverse Event|1|||
161106099|NCT00932425|581778959|FG000|Overall Study|Lost to Follow-up|0|||
161106100|NCT00932425|581778960|FG001|Overall Study|Lost to Follow-up|1|||
161106101|NCT00932425|581778959|FG000|Overall Study|Withdrawal by Subject|0|||
161106102|NCT00932425|581778960|FG001|Overall Study|Withdrawal by Subject|1|||
161106103|NCT01721876|581778961|FG000|Overall Study|Not treated|1|||
161106104|NCT01721876|581778962|FG001|Overall Study|Not treated|4|||
161106105|NCT01721876|581778961|FG000|Overall Study|Disease progression / relapse|123|||
161106106|NCT01721876|581778962|FG001|Overall Study|Disease progression / relapse|156|||
161106107|NCT01721876|581778961|FG000|Overall Study|Death|6|||
161106108|NCT01721876|581778962|FG001|Overall Study|Death|13|||
161106109|NCT01721876|581778961|FG000|Overall Study|Adverse Event|41|||
161106110|NCT01721876|581778962|FG001|Overall Study|Adverse Event|165|||
161106111|NCT01721876|581778961|FG000|Overall Study|Protocol Violation|2|||
161106112|NCT01721876|581778962|FG001|Overall Study|Protocol Violation|1|||
161106113|NCT01721876|581778961|FG000|Overall Study|Withdrawal by Subject|15|||
161106114|NCT01721876|581778962|FG001|Overall Study|Withdrawal by Subject|38|||
161106115|NCT01721876|581778961|FG000|Overall Study|Reason not listed|34|||
161106116|NCT01721876|581778962|FG001|Overall Study|Reason not listed|63|||
161106117|NCT01721876|581778961|FG000|Overall Study|Sponsor terminated trial|0|||
161106118|NCT01721876|581778962|FG001|Overall Study|Sponsor terminated trial|4|||
161106119|NCT01252810|581778963|FG000|Overall Study|Withdrawal by Subject|4|||
161106120|NCT01252810|581778964|FG001|Overall Study|Withdrawal by Subject|1|||
161106121|NCT01252810|581778963|FG000|Overall Study|Lost to Follow-up|0|||
161106122|NCT01252810|581778964|FG001|Overall Study|Lost to Follow-up|1|||
161106123|NCT01252810|581778963|FG000|Overall Study|Physician Decision|2|||
161106124|NCT01252810|581778964|FG001|Overall Study|Physician Decision|1|||
161106125|NCT01252810|581778963|FG000|Overall Study|Various reasons|8|||
161106126|NCT01252810|581778964|FG001|Overall Study|Various reasons|0|||
161106127|NCT03805750|581778965|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
161106128|NCT03805750|581778966|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
161106129|NCT02811549|581778967|FG000|Overall Study|Lost to Follow-up|1|||
161212698|NCT02266706|582161830|FG005|Overall Study|Enrollment in another study|0|||
161106130|NCT02811549|581778967|FG000|Overall Study|Withdrawal by Subject|3|||
161106131|NCT02811549|581778967|FG000|Overall Study|Subject screen failed|4|||
161106132|NCT02811549|581778967|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
161106133|NCT05293743|581778968|FG000|Overall Study|Withdrawal by Subject|1|||
161106134|NCT05293743|581778969|FG001|Overall Study|Withdrawal by Subject|0|||
161106135|NCT00493220|581778970|FG000|Third Intervention|Withdrawal by Subject|1|||
161106136|NCT00493220|581778971|FG001|Third Intervention|Withdrawal by Subject|0|||
161106137|NCT00493220|581778972|FG002|Third Intervention|Withdrawal by Subject|0|||
161106138|NCT00493220|581778973|FG003|Third Intervention|Withdrawal by Subject|0|||
161106139|NCT00493220|581778974|FG004|Third Intervention|Withdrawal by Subject|0|||
161106140|NCT00493220|581778975|FG005|Third Intervention|Withdrawal by Subject|0|||
161106141|NCT00310804|581778976|FG000|Overall Study|Lost to Follow-up|2|||
161106142|NCT00310804|581778977|FG001|Overall Study|Lost to Follow-up|0|||
161106143|NCT00310804|581778976|FG000|Overall Study|Withdrawal by Subject|3|||
161106144|NCT00310804|581778977|FG001|Overall Study|Withdrawal by Subject|0|||
161106145|NCT00445224|581778978|FG000|Specific Exercises|Withdrawal by Subject|3|||
161106146|NCT00445224|581778979|FG001|Specific Exercises|Withdrawal by Subject|3|||
161106147|NCT00445224|581778978|FG000|Specific Exercises|Withdrawal by Subject|1|||
161106148|NCT00445224|581778979|FG001|Specific Exercises|Withdrawal by Subject|0|||
161106149|NCT03184077|581778984|FG000|Overall Study|Lost to Follow-up|21|||
161106150|NCT03184077|581778985|FG001|Overall Study|Lost to Follow-up|21|||
161106151|NCT01889238|581778986|FG000|Overall Study|Death|1|||
161106152|NCT01889238|581778986|FG000|Overall Study|Withdrawal by Subject|1|||
161106153|NCT01889238|581778986|FG000|Overall Study|Adverse Event|6|||
161106154|NCT01889238|581778986|FG000|Overall Study|Disease Progression|104|||
161106155|NCT01889238|581778986|FG000|Overall Study|Other|6|||
161106156|NCT04136184|581778987|FG000|Overall Study|Lost to Follow-up|0|||
161106157|NCT04136184|581778988|FG001|Overall Study|Lost to Follow-up|3|||
161106158|NCT04136184|581778987|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
161106159|NCT04136184|581778988|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
161106160|NCT03318978|581778992|FG000|Overall Study|Withdrawal by Subject|1|||
161106161|NCT02844816|581778993|FG000|Overall Study|No protocol treatment received|5|||
161106162|NCT02844816|581778994|FG001|Overall Study|No protocol treatment received|1|||
161106163|NCT02844816|581778993|FG000|Overall Study|Ineligible|22|||
161106164|NCT02844816|581778994|FG001|Overall Study|Ineligible|15|||
161106165|NCT02844816|581778993|FG000|Overall Study|Participant refusal|5|||
161106166|NCT02844816|581778994|FG001|Overall Study|Participant refusal|5|||
161106167|NCT02844816|581778993|FG000|Overall Study|Adverse Event|5|||
161106168|NCT02844816|581778994|FG001|Overall Study|Adverse Event|4|||
161106169|NCT02844816|581778993|FG000|Overall Study|Death|0|||
161106170|NCT02844816|581778994|FG001|Overall Study|Death|1|||
161106171|NCT02844816|581778993|FG000|Overall Study|Disease progression/recurrence|50|||
161106172|NCT02844816|581778994|FG001|Overall Study|Disease progression/recurrence|24|||
161106173|NCT02844816|581778993|FG000|Overall Study|Physician Decision|1|||
161106174|NCT02844816|581778994|FG001|Overall Study|Physician Decision|1|||
161106175|NCT01200238|581778995|FG000|Overall Study|Adverse Event|2|||
161106176|NCT01200238|581778996|FG001|Overall Study|Adverse Event|1|||
161106177|NCT01200238|581778995|FG000|Overall Study|Progressive Disease|5|||
161106178|NCT01200238|581778996|FG001|Overall Study|Progressive Disease|8|||
161106179|NCT01200238|581778995|FG000|Overall Study|Withdrawal by Subject|0|||
161106180|NCT01200238|581778996|FG001|Overall Study|Withdrawal by Subject|1|||
161106181|NCT02717754|581778997|FG000|Overall Study|Incorrect Infusion Duration|0|||
161106182|NCT02717754|581778998|FG001|Overall Study|Incorrect Infusion Duration|0|||
161106183|NCT02717754|581778999|FG002|Overall Study|Incorrect Infusion Duration|0|||
161106184|NCT02717754|581779000|FG003|Overall Study|Incorrect Infusion Duration|10|||
161106185|NCT02717754|581779001|FG004|Overall Study|Incorrect Infusion Duration|20|||
161106186|NCT02717754|581779002|FG005|Overall Study|Incorrect Infusion Duration|20|||
161106187|NCT00482703|581779003|FG000|Overall Study|Poor compliance|1|||
161106188|NCT00482703|581779004|FG001|Overall Study|Poor compliance|0|||
161106189|NCT00667823|581779006|FG000|Overall Study|Lost to Follow-up|5|||
161106190|NCT00667823|581779006|FG000|Overall Study|Adverse Event|7|||
161106191|NCT00667823|581779006|FG000|Overall Study|Death|182|||
161106192|NCT00667823|581779006|FG000|Overall Study|Withdrawal by Subject|12|||
161106193|NCT00667823|581779006|FG000|Overall Study|Other|8|||
161106194|NCT00667823|581779006|FG000|Overall Study|Missing (completion page missing)|2|||
161106195|NCT04360551|581780840|FG000|Overall Study|Withdrawal by Subject|1|||
161106196|NCT04360551|581780841|FG001|Overall Study|Withdrawal by Subject|0|||
161324207|NCT02959918|582573544|FG009|Overall Study|Withdrawal by Subject|1|||
161106197|NCT03496012|581780845|FG000|Overall Study|Withdrawal by Subject|2|||
161106198|NCT03496012|581780846|FG001|Overall Study|Withdrawal by Subject|0|||
161106199|NCT03496012|581780847|FG002|Overall Study|Withdrawal by Subject|2|||
161106200|NCT03496012|581780845|FG000|Overall Study|Adverse Event|0|||
161106201|NCT03496012|581780846|FG001|Overall Study|Adverse Event|0|||
161106202|NCT03496012|581780847|FG002|Overall Study|Adverse Event|1|||
161106203|NCT03496012|581780845|FG000|Overall Study|Reason Not Specified|2|||
161106204|NCT03496012|581780846|FG001|Overall Study|Reason Not Specified|0|||
161106205|NCT03496012|581780847|FG002|Overall Study|Reason Not Specified|1|||
161106206|NCT02322125|581780848|FG000|Overall Study|Withdrawal by Subject|2|||
161106207|NCT04096274|581780857|FG000|Phase I|Lost to Follow-up|5|||
161106208|NCT04096274|581780858|FG001|Phase I|Lost to Follow-up|5|||
161106209|NCT04096274|581780857|FG000|Phase II|Lost to Follow-up|11|||
161106210|NCT04096274|581780858|FG001|Phase II|Lost to Follow-up|11|||
161106211|NCT00404820|581780859|FG000|Overall Study|Adverse Event|4|||
161106212|NCT00404820|581780860|FG001|Overall Study|Adverse Event|16|||
161106213|NCT00404820|581780859|FG000|Overall Study|Withdrawal by Subject|5|||
161106214|NCT00404820|581780860|FG001|Overall Study|Withdrawal by Subject|3|||
161106215|NCT00404820|581780859|FG000|Overall Study|Lost to Follow-up|7|||
161106216|NCT00404820|581780860|FG001|Overall Study|Lost to Follow-up|3|||
161106217|NCT00404820|581780859|FG000|Overall Study|Administrative problems|2|||
161106218|NCT00404820|581780860|FG001|Overall Study|Administrative problems|0|||
161106219|NCT00404820|581780859|FG000|Overall Study|Death|1|||
161106220|NCT00404820|581780860|FG001|Overall Study|Death|0|||
161106221|NCT00404820|581780859|FG000|Overall Study|Other|0|||
161106222|NCT00404820|581780860|FG001|Overall Study|Other|2|||
161106223|NCT01543152|581780861|FG000|Overall Study|Withdrawal by Subject|0|||
161106224|NCT01543152|581780862|FG001|Overall Study|Withdrawal by Subject|2|||
161106225|NCT01543152|581780863|FG002|Overall Study|Withdrawal by Subject|0|||
161106226|NCT01543152|581780864|FG003|Overall Study|Withdrawal by Subject|0|||
161106227|NCT01543152|581780865|FG004|Overall Study|Withdrawal by Subject|0|||
161106228|NCT02053168|581780866|FG000|Overall Study|Withdrawal by Subject|1|||
161106229|NCT02053168|581780866|FG000|Overall Study|Physician Decision|1|||
161106230|NCT02053168|581780866|FG000|Overall Study|Lost to Follow-up|1|||
161106231|NCT02687542|581780869|FG000|Overall Study|Medication error without associated AEs|0|||
161106232|NCT02687542|581780870|FG001|Overall Study|Medication error without associated AEs|0|||
161106233|NCT02687542|581780871|FG002|Overall Study|Medication error without associated AEs|0|||
161106234|NCT02687542|581780872|FG003|Overall Study|Medication error without associated AEs|0|||
161106235|NCT02687542|581780873|FG004|Overall Study|Medication error without associated AEs|1|||
161106236|NCT02687542|581780869|FG000|Overall Study|Lost to Follow-up|0|||
161106237|NCT02687542|581780870|FG001|Overall Study|Lost to Follow-up|0|||
161106238|NCT02687542|581780871|FG002|Overall Study|Lost to Follow-up|0|||
161106239|NCT02687542|581780872|FG003|Overall Study|Lost to Follow-up|0|||
161106240|NCT02687542|581780873|FG004|Overall Study|Lost to Follow-up|1|||
161106241|NCT02687542|581780869|FG000|Overall Study|Protocol Violation|0|||
161106242|NCT02687542|581780870|FG001|Overall Study|Protocol Violation|1|||
161106243|NCT02687542|581780871|FG002|Overall Study|Protocol Violation|0|||
161106244|NCT02687542|581780872|FG003|Overall Study|Protocol Violation|0|||
161106245|NCT02687542|581780873|FG004|Overall Study|Protocol Violation|0|||
161106246|NCT02687542|581780869|FG000|Overall Study|Other|5|||
161106247|NCT02687542|581780870|FG001|Overall Study|Other|9|||
161106248|NCT02687542|581780871|FG002|Overall Study|Other|10|||
161106249|NCT02687542|581780872|FG003|Overall Study|Other|6|||
161106250|NCT02687542|581780873|FG004|Overall Study|Other|5|||
161106251|NCT02687542|581780869|FG000|Overall Study|Adverse Event|3|||
161106252|NCT02687542|581780870|FG001|Overall Study|Adverse Event|1|||
161106253|NCT02687542|581780871|FG002|Overall Study|Adverse Event|3|||
161106254|NCT02687542|581780872|FG003|Overall Study|Adverse Event|2|||
161106255|NCT02687542|581780873|FG004|Overall Study|Adverse Event|9|||
161106256|NCT02687542|581780869|FG000|Overall Study|Withdrawal by Subject|0|||
161106257|NCT02687542|581780870|FG001|Overall Study|Withdrawal by Subject|1|||
161106258|NCT02687542|581780871|FG002|Overall Study|Withdrawal by Subject|1|||
161106259|NCT02687542|581780872|FG003|Overall Study|Withdrawal by Subject|2|||
161106260|NCT02687542|581780873|FG004|Overall Study|Withdrawal by Subject|4|||
161106261|NCT00176605|581780875|FG000|Overall Study|Withdrawal by Subject|2|||
161106262|NCT03785925|581780876|FG000|Overall Study|Withdrawal by Subject|15|||
161106263|NCT03785925|581780876|FG000|Overall Study|Lost to Follow-up|1|||
161106264|NCT00709111|581780877|FG000|Overall Study|Withdrawal by Subject|1|||
161106265|NCT00709111|581780877|FG000|Overall Study|Unable to attend clinic visits|1|||
161106266|NCT01735279|581780880|FG000|Overall Study|Lost to Follow-up|11|||
161106267|NCT01735279|581780881|FG001|Overall Study|Lost to Follow-up|8|||
161106268|NCT00806195|581780882|FG000|Overall Study|Death|6|||
161106269|NCT00806195|581780883|FG001|Overall Study|Death|0|||
161106270|NCT00806195|581780884|FG002|Overall Study|Death|1|||
161106271|NCT00806195|581780885|FG003|Overall Study|Death|0|||
161106272|NCT00806195|581780882|FG000|Overall Study|Adverse Event|25|||
161106273|NCT00806195|581780883|FG001|Overall Study|Adverse Event|5|||
161106274|NCT00806195|581780884|FG002|Overall Study|Adverse Event|11|||
161106275|NCT00806195|581780885|FG003|Overall Study|Adverse Event|2|||
161106276|NCT00806195|581780882|FG000|Overall Study|Withdrawal by Subject|119|||
161106277|NCT00806195|581780883|FG001|Overall Study|Withdrawal by Subject|31|||
161106278|NCT00806195|581780884|FG002|Overall Study|Withdrawal by Subject|76|||
161106279|NCT00806195|581780885|FG003|Overall Study|Withdrawal by Subject|35|||
161106280|NCT00806195|581780882|FG000|Overall Study|Lost to Follow-up|217|||
161106281|NCT00806195|581780883|FG001|Overall Study|Lost to Follow-up|66|||
161106282|NCT00806195|581780884|FG002|Overall Study|Lost to Follow-up|90|||
161106283|NCT00806195|581780885|FG003|Overall Study|Lost to Follow-up|34|||
161106284|NCT00806195|581780882|FG000|Overall Study|Inappropriate Enrollment|0|||
161324208|NCT02959918|582573545|FG010|Overall Study|Withdrawal by Subject|2|||
161106285|NCT00806195|581780883|FG001|Overall Study|Inappropriate Enrollment|1|||
161106286|NCT00806195|581780884|FG002|Overall Study|Inappropriate Enrollment|0|||
161106287|NCT00806195|581780885|FG003|Overall Study|Inappropriate Enrollment|0|||
161106288|NCT00806195|581780882|FG000|Overall Study|Administrative Reason|113|||
161106289|NCT00806195|581780883|FG001|Overall Study|Administrative Reason|35|||
161106290|NCT00806195|581780884|FG002|Overall Study|Administrative Reason|66|||
161106291|NCT00806195|581780885|FG003|Overall Study|Administrative Reason|26|||
161106292|NCT00806195|581780882|FG000|Overall Study|Protocol Violation|34|||
161106293|NCT00806195|581780883|FG001|Overall Study|Protocol Violation|24|||
161106294|NCT00806195|581780884|FG002|Overall Study|Protocol Violation|26|||
161106295|NCT00806195|581780885|FG003|Overall Study|Protocol Violation|9|||
161106296|NCT01519934|581780891|FG000|Overall Study|Lost to Follow-up|3|||
161106297|NCT00922480|581780892|FG000|Main Study|Protocol Violation|3|||
161106298|NCT00922480|581780893|FG001|Main Study|Protocol Violation|6|||
161106299|NCT00922480|581780892|FG000|Main Study|Adverse Event|6|||
161106300|NCT00922480|581780893|FG001|Main Study|Adverse Event|7|||
161106301|NCT00922480|581780892|FG000|Main Study|Lack of Efficacy|3|||
161106302|NCT00922480|581780893|FG001|Main Study|Lack of Efficacy|0|||
161106303|NCT00922480|581780892|FG000|Main Study|Withdrawal by Subject|20|||
161106304|NCT00922480|581780893|FG001|Main Study|Withdrawal by Subject|15|||
161106305|NCT00922480|581780892|FG000|Main Study|Lost to Follow-up|5|||
161106306|NCT00922480|581780893|FG001|Main Study|Lost to Follow-up|0|||
161106307|NCT00922480|581780892|FG000|Main Study|Physician Decision|0|||
161106308|NCT00922480|581780893|FG001|Main Study|Physician Decision|1|||
161106309|NCT00922480|581780892|FG000|Extension Study|Protocol Violation|3|||
161106310|NCT00922480|581780893|FG001|Extension Study|Protocol Violation|0|||
161106311|NCT00922480|581780892|FG000|Extension Study|Adverse Event|1|||
161106312|NCT00922480|581780893|FG001|Extension Study|Adverse Event|1|||
161106313|NCT00922480|581780892|FG000|Extension Study|Withdrawal by Subject|1|||
161106314|NCT00922480|581780893|FG001|Extension Study|Withdrawal by Subject|1|||
161106315|NCT00922480|581780892|FG000|Extension Study|Others|0|||
161106316|NCT00922480|581780893|FG001|Extension Study|Others|1|||
161106317|NCT00326209|581780900|FG000|Overall Study|Adverse Event|28|||
161106318|NCT00326209|581780900|FG000|Overall Study|Withdrawal by Subject|22|||
161106319|NCT00326209|581780900|FG000|Overall Study|Lack of Efficacy|31|||
161106320|NCT00326209|581780900|FG000|Overall Study|Lost to Follow-up|18|||
161106321|NCT00326209|581780900|FG000|Overall Study|Participant non-compliant|6|||
161106322|NCT00326209|581780900|FG000|Overall Study|Sponsor closed study|173|||
161106323|NCT00326209|581780900|FG000|Overall Study|Prohibited medication use|1|||
161106324|NCT00326209|581780900|FG000|Overall Study|Violation of entry criteria|1|||
161106325|NCT00326209|581780900|FG000|Overall Study|Withdrawn in error|1|||
161106326|NCT00326209|581780900|FG000|Overall Study|Pregnancy|1|||
161106327|NCT02138617|581780901|FG000|Overall Study|Death|1|||
161106328|NCT02138617|581780902|FG001|Overall Study|Death|2|||
161106329|NCT02138617|581780903|FG002|Overall Study|Death|2|||
161106330|NCT02138617|581780901|FG000|Overall Study|Adverse Event|8|||
161106331|NCT02138617|581780902|FG001|Overall Study|Adverse Event|5|||
161106332|NCT02138617|581780903|FG002|Overall Study|Adverse Event|2|||
161106333|NCT02138617|581780901|FG000|Overall Study|Disease Progression|20|||
161106334|NCT02138617|581780902|FG001|Overall Study|Disease Progression|13|||
161106335|NCT02138617|581780903|FG002|Overall Study|Disease Progression|4|||
161106336|NCT02138617|581780901|FG000|Overall Study|Withdrawal by Subject|7|||
161106337|NCT02138617|581780902|FG001|Overall Study|Withdrawal by Subject|10|||
161106338|NCT02138617|581780903|FG002|Overall Study|Withdrawal by Subject|2|||
161106339|NCT02138617|581780901|FG000|Overall Study|other complicating disease|0|||
161106340|NCT02138617|581780902|FG001|Overall Study|other complicating disease|2|||
161106341|NCT02138617|581780903|FG002|Overall Study|other complicating disease|0|||
161106342|NCT02138617|581780901|FG000|Overall Study|Protocol Violation|1|||
161106343|NCT02138617|581780902|FG001|Overall Study|Protocol Violation|0|||
161106344|NCT02138617|581780903|FG002|Overall Study|Protocol Violation|0|||
161106345|NCT02138617|581780901|FG000|Overall Study|Physician Decision|7|||
161106346|NCT02138617|581780902|FG001|Overall Study|Physician Decision|6|||
161106347|NCT02138617|581780903|FG002|Overall Study|Physician Decision|0|||
161106348|NCT02138617|581780901|FG000|Overall Study|financial reason|0|||
161106349|NCT02138617|581780902|FG001|Overall Study|financial reason|1|||
161106350|NCT02138617|581780903|FG002|Overall Study|financial reason|0|||
161106351|NCT02138617|581780901|FG000|Overall Study|other therapy|3|||
161106352|NCT02138617|581780902|FG001|Overall Study|other therapy|4|||
161106353|NCT02138617|581780903|FG002|Overall Study|other therapy|0|||
161106354|NCT01671111|581780905|FG000|Overall Study|Adverse Event|2|||
161106355|NCT01671111|581780905|FG000|Overall Study|Lack of Efficacy|1|||
161106356|NCT01671111|581780905|FG000|Overall Study|Withdrawal by Subject|2|||
161106357|NCT01671111|581780905|FG000|Overall Study|Physician Decision|1|||
161106358|NCT01671111|581780905|FG000|Overall Study|Other|24|||
161106359|NCT00496730|581780915|FG000|Overall Study|Lost to Follow-up|4|||
161106360|NCT00496730|581780916|FG001|Overall Study|Lost to Follow-up|3|||
161106361|NCT00496730|581780915|FG000|Overall Study|Withdrawal by Subject|2|||
161106362|NCT00496730|581780916|FG001|Overall Study|Withdrawal by Subject|2|||
161106363|NCT00113074|581780917|FG000|Overall Study|Lost to Follow-up|10|||
161106364|NCT00113074|581780918|FG001|Overall Study|Lost to Follow-up|10|||
161106365|NCT00113074|581780919|FG002|Overall Study|Lost to Follow-up|14|||
161106366|NCT03680911|581780920|FG000|At Home Treatment|Study Termination|3|||
161106367|NCT03680911|581780921|FG001|At Home Treatment|Study Termination|0|||
161106368|NCT03680911|581780920|FG000|At Home Treatment|Lost to Follow-up|0|||
161106369|NCT03680911|581780921|FG001|At Home Treatment|Lost to Follow-up|1|||
161106370|NCT03680911|581780920|FG000|At Home Treatment|Withdrawal by Subject|0|||
161106371|NCT03680911|581780921|FG001|At Home Treatment|Withdrawal by Subject|2|||
161106372|NCT03680911|581780920|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
161106373|NCT03680911|581780921|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
161106374|NCT03962738|581780922|FG000|Overall Study|Protocol Deviation|3|||
161106375|NCT03962738|581780923|FG001|Overall Study|Protocol Deviation|0|||
161106376|NCT03962738|581780924|FG002|Overall Study|Protocol Deviation|1|||
161106377|NCT03962738|581780925|FG003|Overall Study|Protocol Deviation|1|||
161106378|NCT03962738|581780922|FG000|Overall Study|Withdrawal by Subject|4|||
161106379|NCT03962738|581780923|FG001|Overall Study|Withdrawal by Subject|0|||
161106380|NCT03962738|581780924|FG002|Overall Study|Withdrawal by Subject|0|||
161106381|NCT03962738|581780925|FG003|Overall Study|Withdrawal by Subject|0|||
161106382|NCT03962738|581780922|FG000|Overall Study|Lost to Follow-up|0|||
161106383|NCT03962738|581780923|FG001|Overall Study|Lost to Follow-up|0|||
161106384|NCT03962738|581780924|FG002|Overall Study|Lost to Follow-up|1|||
161106385|NCT03962738|581780925|FG003|Overall Study|Lost to Follow-up|0|||
161106386|NCT04556136|581780929|FG000|Overall Study|Lost to Follow-up|6|||
161106387|NCT04556136|581780930|FG001|Overall Study|Lost to Follow-up|6|||
161106388|NCT04556136|581780929|FG000|Overall Study|Physician Decision|2|||
161106389|NCT04556136|581780930|FG001|Overall Study|Physician Decision|1|||
161106390|NCT04556136|581780929|FG000|Overall Study|Withdrawal by Subject|2|||
161106391|NCT04556136|581780930|FG001|Overall Study|Withdrawal by Subject|1|||
161106392|NCT03492554|581780933|FG000|Overall Study|Protocol Violation|0|||
161106393|NCT03492554|581780934|FG001|Overall Study|Protocol Violation|14|||
161106394|NCT01478360|581780935|FG000|Overall Study|Lost to Follow-up|1|||
161106395|NCT01478360|581780936|FG001|Overall Study|Lost to Follow-up|0|||
161106396|NCT01478360|581780935|FG000|Overall Study|Adverse Event|0|||
161106397|NCT01478360|581780936|FG001|Overall Study|Adverse Event|1|||
161106398|NCT01478360|581780935|FG000|Overall Study|Administrative problems|1|||
161106399|NCT01478360|581780936|FG001|Overall Study|Administrative problems|2|||
161106400|NCT03716050|581780937|FG000|Overall Study|Lost to Follow-up|0|||
161106401|NCT03716050|581780938|FG001|Overall Study|Lost to Follow-up|0|||
161106402|NCT03716050|581780939|FG002|Overall Study|Lost to Follow-up|1|||
161106403|NCT03716050|581780940|FG003|Overall Study|Lost to Follow-up|0|||
161106404|NCT03716050|581780941|FG004|Overall Study|Lost to Follow-up|0|||
161106405|NCT03716050|581780942|FG005|Overall Study|Lost to Follow-up|0|||
161106406|NCT03716050|581780943|FG006|Overall Study|Lost to Follow-up|0|||
161212699|NCT02266706|582161831|FG006|Overall Study|Enrollment in another study|0|||
161212700|NCT02266706|582161832|FG007|Overall Study|Enrollment in another study|0|||
161212701|NCT02266706|582161833|FG008|Overall Study|Enrollment in another study|0|||
161212702|NCT02614703|582161834|FG000|Overall Study|Withdrawal by Subject|7|||
161212703|NCT02614703|582161835|FG001|Overall Study|Withdrawal by Subject|1|||
161212704|NCT01977352|582161844|FG000|Overall Study|Lost to Follow-up|1|||
161212705|NCT01977352|582161845|FG001|Overall Study|Lost to Follow-up|2|||
161212706|NCT00409188|582161851|FG000|Overall Study|Ongoing at data cut-off|383|||
161212707|NCT00409188|582161852|FG001|Overall Study|Ongoing at data cut-off|175|||
161212708|NCT00856778|582161853|FG000|Overall Study|Adverse Event|7|||
161212709|NCT00856778|582161853|FG000|Overall Study|Withdrawal by Subject|10|||
161212710|NCT00856778|582161853|FG000|Overall Study|Study deviation|2|||
161212711|NCT00856778|582161853|FG000|Overall Study|Lost to Follow-up|5|||
161212712|NCT02270983|582161854|FG000|Overall Study|Adverse Event|3|||
161212713|NCT02270983|582161855|FG001|Overall Study|Adverse Event|2|||
161212714|NCT02270983|582161856|FG002|Overall Study|Adverse Event|6|||
161212715|NCT02270983|582161854|FG000|Overall Study|Lack of Efficacy|2|||
161212716|NCT02270983|582161855|FG001|Overall Study|Lack of Efficacy|1|||
161212717|NCT02270983|582161856|FG002|Overall Study|Lack of Efficacy|1|||
161212718|NCT02270983|582161854|FG000|Overall Study|Withdrawal by Subject|1|||
161212719|NCT02270983|582161855|FG001|Overall Study|Withdrawal by Subject|0|||
161212720|NCT02270983|582161856|FG002|Overall Study|Withdrawal by Subject|2|||
161212721|NCT02270983|582161854|FG000|Overall Study|Lost to Follow-up|1|||
161212722|NCT02270983|582161855|FG001|Overall Study|Lost to Follow-up|1|||
161212723|NCT02270983|582161856|FG002|Overall Study|Lost to Follow-up|2|||
161212724|NCT02270983|582161854|FG000|Overall Study|Protocol Violation|1|||
161106407|NCT03716050|581780944|FG007|Overall Study|Lost to Follow-up|0|||
161106408|NCT03716050|581780937|FG000|Overall Study|Physician Decision|0|||
161106409|NCT03716050|581780938|FG001|Overall Study|Physician Decision|0|||
161106410|NCT03716050|581780939|FG002|Overall Study|Physician Decision|0|||
161212725|NCT02270983|582161855|FG001|Overall Study|Protocol Violation|1|||
161212726|NCT02270983|582161856|FG002|Overall Study|Protocol Violation|1|||
161106411|NCT03716050|581780940|FG003|Overall Study|Physician Decision|1|||
161106412|NCT03716050|581780941|FG004|Overall Study|Physician Decision|0|||
161106413|NCT03716050|581780942|FG005|Overall Study|Physician Decision|0|||
161106414|NCT03716050|581780943|FG006|Overall Study|Physician Decision|0|||
161106415|NCT03716050|581780944|FG007|Overall Study|Physician Decision|0|||
161106416|NCT03716050|581780937|FG000|Overall Study|Protocol Violation|0|||
161106417|NCT03716050|581780938|FG001|Overall Study|Protocol Violation|0|||
161212727|NCT02270983|582161854|FG000|Overall Study|family emergency|0|||
161212728|NCT02270983|582161855|FG001|Overall Study|family emergency|1|||
161212729|NCT02270983|582161856|FG002|Overall Study|family emergency|0|||
161212730|NCT02270983|582161854|FG000|Overall Study|study procedure non-compliance|1|||
161212731|NCT02270983|582161855|FG001|Overall Study|study procedure non-compliance|0|||
161212732|NCT02270983|582161856|FG002|Overall Study|study procedure non-compliance|0|||
161106418|NCT03716050|581780939|FG002|Overall Study|Protocol Violation|0|||
161106419|NCT03716050|581780940|FG003|Overall Study|Protocol Violation|1|||
161106420|NCT03716050|581780941|FG004|Overall Study|Protocol Violation|0|||
161106421|NCT03716050|581780942|FG005|Overall Study|Protocol Violation|0|||
161106422|NCT03716050|581780943|FG006|Overall Study|Protocol Violation|0|||
161106423|NCT03716050|581780944|FG007|Overall Study|Protocol Violation|2|||
161106424|NCT02566577|581780945|FG000|Overall Study|Withdrawal by Subject|1|||
161106425|NCT02566577|581780946|FG001|Overall Study|Withdrawal by Subject|1|||
161106426|NCT02566577|581780945|FG000|Overall Study|Equipment failure|1|||
161106427|NCT02566577|581780946|FG001|Overall Study|Equipment failure|1|||
161106428|NCT02566577|581780945|FG000|Overall Study|Physical limitation|1|||
161106429|NCT02566577|581780946|FG001|Overall Study|Physical limitation|0|||
161106430|NCT01289821|581780947|FG000|Treatment Period|Withdrawal by Subject|1|||
161106431|NCT01289821|581780947|FG000|Treatment Period|Physician Decision|3|||
161106432|NCT01289821|581780947|FG000|Treatment Period|Adverse Event|4|||
161106433|NCT01289821|581780947|FG000|Treatment Period|Radiological Progression|43|||
161106434|NCT01289821|581780947|FG000|Treatment Period|Clinical Progression|2|||
161106435|NCT01289821|581780947|FG000|Treatment Period|Therapeutic procedure required|1|||
161106436|NCT01289821|581780947|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
161106437|NCT01289821|581780947|FG000|Safety Follow-up Period|Protocol Violation|3|||
161106438|NCT01289821|581780947|FG000|Safety Follow-up Period|Unspecified reason|1|||
161106439|NCT01289821|581780947|FG000|Survival Follow-up Period|Protocol Violation|1|||
161106440|NCT01289821|581780947|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
161106441|NCT01289821|581780947|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
161106442|NCT01010633|581780948|FG000|Overall Study|Adverse Event|1|||
161106443|NCT01010633|581780949|FG001|Overall Study|Adverse Event|1|||
161106444|NCT01010633|581780948|FG000|Overall Study|Protocol Violation|1|||
161106445|NCT01010633|581780949|FG001|Overall Study|Protocol Violation|2|||
161106446|NCT01010633|581780948|FG000|Overall Study|Withdrawal by Subject|2|||
161106447|NCT01010633|581780949|FG001|Overall Study|Withdrawal by Subject|1|||
161106448|NCT01010633|581780948|FG000|Overall Study|Investigator decision|0|||
161106449|NCT01010633|581780949|FG001|Overall Study|Investigator decision|1|||
161106450|NCT02941926|581780950|FG000|Core Phase|Progressive disease|1109|||
161106451|NCT02941926|581780950|FG000|Core Phase|Adverse Event|504|||
161106452|NCT02941926|581780950|FG000|Core Phase|Subject/guardian decision|127|||
161106453|NCT02941926|581780950|FG000|Core Phase|Physician Decision|112|||
161106454|NCT02941926|581780950|FG000|Core Phase|Death|46|||
161106455|NCT02941926|581780950|FG000|Core Phase|Protocol deviation|34|||
161106456|NCT02941926|581780950|FG000|Core Phase|Lost to Follow-up|8|||
161106457|NCT02941926|581780950|FG000|Core Phase|Technical problems|5|||
161106458|NCT02941926|581780950|FG000|Extension Phase|Physician Decision|155|||
161106459|NCT02941926|581780950|FG000|Extension Phase|Progressive disease|115|||
161106460|NCT02941926|581780950|FG000|Extension Phase|Adverse Event|13|||
161106461|NCT02941926|581780950|FG000|Extension Phase|Subject/Guardian decision|12|||
161106462|NCT02941926|581780950|FG000|Extension Phase|Death|6|||
161106463|NCT00097773|581780951|FG000|Overall Study|Lost to Follow-up|2|||
161106464|NCT00097773|581780952|FG001|Overall Study|Lost to Follow-up|2|||
161106465|NCT00097773|581780953|FG002|Overall Study|Lost to Follow-up|0|||
161106466|NCT00097773|581780954|FG003|Overall Study|Lost to Follow-up|1|||
161106467|NCT00097773|581780951|FG000|Overall Study|Physician Decision|2|||
161106468|NCT00097773|581780952|FG001|Overall Study|Physician Decision|2|||
161106469|NCT00097773|581780953|FG002|Overall Study|Physician Decision|3|||
161106470|NCT00097773|581780954|FG003|Overall Study|Physician Decision|1|||
161106471|NCT00097773|581780951|FG000|Overall Study|Withdrawal by Subject|3|||
161106472|NCT00097773|581780952|FG001|Overall Study|Withdrawal by Subject|3|||
161106473|NCT00097773|581780953|FG002|Overall Study|Withdrawal by Subject|3|||
161106474|NCT00097773|581780954|FG003|Overall Study|Withdrawal by Subject|1|||
161106475|NCT00097773|581780951|FG000|Overall Study|Adverse Event|0|||
161106476|NCT00097773|581780952|FG001|Overall Study|Adverse Event|1|||
161106477|NCT00097773|581780953|FG002|Overall Study|Adverse Event|0|||
161106478|NCT00097773|581780954|FG003|Overall Study|Adverse Event|0|||
161106479|NCT00097773|581780951|FG000|Overall Study|Other|1|||
161106480|NCT00097773|581780952|FG001|Overall Study|Other|0|||
161106481|NCT00097773|581780953|FG002|Overall Study|Other|2|||
161106482|NCT00097773|581780954|FG003|Overall Study|Other|0|||
161106483|NCT01009034|581780955|FG000|Overall Study|Lost to Follow-up|2|||
161106484|NCT01009034|581780955|FG000|Overall Study|Withdrawal by Subject|2|||
161106485|NCT01494350|581780956|FG000|Overall Study|Worsening of lesion|1|||
161106486|NCT00474708|581780957|FG000|Overall Study|Lack of Efficacy|11|||
161106487|NCT00474708|581780958|FG001|Overall Study|Lack of Efficacy|5|||
161106488|NCT00474708|581780957|FG000|Overall Study|Suicide ideation/behavior|0|||
161106489|NCT00474708|581780958|FG001|Overall Study|Suicide ideation/behavior|1|||
161106490|NCT00474708|581780957|FG000|Overall Study|Withdrawal by Subject|7|||
161106491|NCT00474708|581780958|FG001|Overall Study|Withdrawal by Subject|0|||
161106492|NCT00474708|581780957|FG000|Overall Study|Lack of compliance|12|||
161106493|NCT00474708|581780958|FG001|Overall Study|Lack of compliance|4|||
161106494|NCT00474708|581780957|FG000|Overall Study|Lost to Follow-up|18|||
161106495|NCT00474708|581780958|FG001|Overall Study|Lost to Follow-up|9|||
161106496|NCT00474708|581780957|FG000|Overall Study|Physician Decision|9|||
161106497|NCT00474708|581780958|FG001|Overall Study|Physician Decision|6|||
161106498|NCT02243865|581780961|FG000|Overall Study|Protocol Violation|1|||
161106499|NCT02243865|581780962|FG001|Overall Study|Protocol Violation|3|||
161106500|NCT02243865|581780961|FG000|Overall Study|Lost to Follow-up|1|||
161106501|NCT02243865|581780962|FG001|Overall Study|Lost to Follow-up|1|||
161106502|NCT02243865|581780961|FG000|Overall Study|Withdrawal by Subject|1|||
161106503|NCT02243865|581780962|FG001|Overall Study|Withdrawal by Subject|0|||
161106504|NCT02243865|581780961|FG000|Overall Study|Adverse Event|1|||
161106505|NCT02243865|581780962|FG001|Overall Study|Adverse Event|1|||
161106506|NCT05093322|581780963|FG000|Overall Study|Death|6|||
161106507|NCT05093322|581780964|FG001|Overall Study|Death|2|||
161106508|NCT05093322|581780963|FG000|Overall Study|Other|4|||
161106509|NCT05093322|581780964|FG001|Overall Study|Other|1|||
161106510|NCT00898443|581780965|FG000|Overall Study|Withdrawal by Subject|1|||
161106511|NCT00898443|581780966|FG001|Overall Study|Withdrawal by Subject|0|||
161106512|NCT00074581|581780968|FG000|Overall Study|Death|15|||
161106513|NCT00074581|581780969|FG001|Overall Study|Death|16|||
161106514|NCT00074581|581780968|FG000|Overall Study|Withdrawal by Subject|50|||
161106515|NCT00074581|581780969|FG001|Overall Study|Withdrawal by Subject|49|||
161106516|NCT00074581|581780968|FG000|Overall Study|Unable to adhere to visit schedule|13|||
161106517|NCT00074581|581780969|FG001|Overall Study|Unable to adhere to visit schedule|14|||
161106518|NCT00074581|581780968|FG000|Overall Study|Relocated|14|||
161106519|NCT00074581|581780969|FG001|Overall Study|Relocated|9|||
161106520|NCT00074581|581780968|FG000|Overall Study|Were withdrawn by investigator|5|||
161106521|NCT00074581|581780969|FG001|Overall Study|Were withdrawn by investigator|2|||
161106522|NCT00074581|581780968|FG000|Overall Study|Lost to Follow-up|16|||
161106523|NCT00074581|581780969|FG001|Overall Study|Lost to Follow-up|11|||
161106524|NCT00074581|581780968|FG000|Overall Study|Ended relationship w. index participant|117|||
161106525|NCT00074581|581780969|FG001|Overall Study|Ended relationship w. index participant|106|||
161106526|NCT00074581|581780968|FG000|Overall Study|Other|14|||
161106527|NCT00074581|581780969|FG001|Overall Study|Other|19|||
161106528|NCT01770912|581780970|FG000|Overall Study|Lost to Follow-up|2|||
161106529|NCT01770912|581780971|FG001|Overall Study|Lost to Follow-up|0|||
161106530|NCT01708291|581780972|FG000|Overall Study|fighting|2|||
161106531|NCT01708291|581780973|FG001|Overall Study|fighting|1|||
161106532|NCT03250832|581780974|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
161106533|NCT03250832|581780975|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
161106534|NCT03250832|581780976|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
161106535|NCT03250832|581780977|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
161106536|NCT03250832|581780978|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
161106537|NCT03250832|581780979|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
161106538|NCT03250832|581780980|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
161106539|NCT03250832|581780981|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
161106540|NCT03250832|581780982|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
161106541|NCT03250832|581780983|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
161106542|NCT03250832|581780984|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
161106543|NCT03250832|581780985|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
161106544|NCT03250832|581780974|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
161106545|NCT03250832|581780975|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
161106546|NCT03250832|581780976|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
161106547|NCT03250832|581780977|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
161106548|NCT03250832|581780978|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
161106549|NCT03250832|581780979|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
161106550|NCT03250832|581780980|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
161106551|NCT03250832|581780981|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161106552|NCT03250832|581780982|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161106553|NCT03250832|581780983|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161106554|NCT03250832|581780984|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161106555|NCT03250832|581780985|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
161106556|NCT03250832|581780974|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106557|NCT03250832|581780975|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106558|NCT03250832|581780976|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
161106559|NCT03250832|581780977|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106560|NCT03250832|581780978|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106561|NCT03250832|581780979|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106562|NCT03250832|581780980|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106563|NCT03250832|581780981|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106564|NCT03250832|581780982|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106565|NCT03250832|581780983|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106566|NCT03250832|581780984|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106567|NCT03250832|581780985|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
161106568|NCT03250832|581780974|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106569|NCT03250832|581780975|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106570|NCT03250832|581780976|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106571|NCT03250832|581780977|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106572|NCT03250832|581780978|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106573|NCT03250832|581780979|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106574|NCT03250832|581780980|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106575|NCT03250832|581780981|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
161106576|NCT03250832|581780982|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106577|NCT03250832|581780983|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106578|NCT03250832|581780984|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106579|NCT03250832|581780985|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
161106580|NCT03250832|581780974|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106581|NCT03250832|581780975|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106582|NCT03250832|581780976|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106583|NCT03250832|581780977|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106584|NCT03250832|581780978|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106585|NCT03250832|581780979|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106586|NCT03250832|581780980|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106587|NCT03250832|581780981|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
161106588|NCT03250832|581780982|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106589|NCT03250832|581780983|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106590|NCT03250832|581780984|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106591|NCT03250832|581780985|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
161106592|NCT03250832|581780974|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106593|NCT03250832|581780975|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106594|NCT03250832|581780976|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106595|NCT03250832|581780977|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106596|NCT03250832|581780978|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106597|NCT03250832|581780979|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106598|NCT03250832|581780980|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106599|NCT03250832|581780981|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
161106600|NCT03250832|581780982|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106601|NCT03250832|581780983|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106602|NCT03250832|581780984|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106603|NCT03250832|581780985|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
161106604|NCT03250832|581780974|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106605|NCT03250832|581780975|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106606|NCT03250832|581780976|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106607|NCT03250832|581780977|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106608|NCT03250832|581780978|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106609|NCT03250832|581780979|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106610|NCT03250832|581780980|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106611|NCT03250832|581780981|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
161106612|NCT03250832|581780982|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106613|NCT03250832|581780983|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106614|NCT03250832|581780984|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106615|NCT03250832|581780985|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
161106616|NCT03250832|581780974|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106617|NCT03250832|581780975|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106618|NCT03250832|581780976|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106619|NCT03250832|581780977|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106620|NCT03250832|581780978|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106621|NCT03250832|581780979|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106622|NCT03250832|581780980|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106623|NCT03250832|581780981|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
161106624|NCT03250832|581780982|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106625|NCT03250832|581780983|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106626|NCT03250832|581780984|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106627|NCT03250832|581780985|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
161106628|NCT03250832|581780974|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106629|NCT03250832|581780975|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106630|NCT03250832|581780976|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106631|NCT03250832|581780977|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106632|NCT03250832|581780978|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106633|NCT03250832|581780979|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106634|NCT03250832|581780980|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106635|NCT03250832|581780981|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106636|NCT03250832|581780982|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
161106637|NCT03250832|581780983|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
161106638|NCT03250832|581780984|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106639|NCT03250832|581780985|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
161106640|NCT03250832|581780974|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106641|NCT03250832|581780975|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106642|NCT03250832|581780976|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106643|NCT03250832|581780977|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106644|NCT03250832|581780978|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106645|NCT03250832|581780979|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106646|NCT03250832|581780980|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106647|NCT03250832|581780981|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106648|NCT03250832|581780982|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
161106649|NCT03250832|581780983|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
161106650|NCT03250832|581780984|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106651|NCT03250832|581780985|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
161106652|NCT03250832|581780974|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106653|NCT03250832|581780975|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106654|NCT03250832|581780976|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106655|NCT03250832|581780977|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106656|NCT03250832|581780978|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106657|NCT03250832|581780979|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106658|NCT03250832|581780980|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106659|NCT03250832|581780981|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106660|NCT03250832|581780982|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
161106661|NCT03250832|581780983|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
161106662|NCT03250832|581780984|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106663|NCT03250832|581780985|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
161106664|NCT03250832|581780974|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106665|NCT03250832|581780975|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106666|NCT03250832|581780976|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106667|NCT03250832|581780977|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106668|NCT03250832|581780978|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106669|NCT03250832|581780979|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106670|NCT03250832|581780980|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106671|NCT03250832|581780981|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106672|NCT03250832|581780982|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106673|NCT03250832|581780983|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106674|NCT03250832|581780984|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
161106675|NCT03250832|581780985|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
161106676|NCT04411628|581780987|FG000|Overall Study|Withdrawal by Subject|1|||
161106677|NCT04411628|581780988|FG001|Overall Study|Withdrawal by Subject|1|||
161106678|NCT04411628|581780989|FG002|Overall Study|Withdrawal by Subject|2|||
161106679|NCT04411628|581780990|FG003|Overall Study|Withdrawal by Subject|0|||
161106680|NCT04411628|581780987|FG000|Overall Study|Lost to Follow-up|0|||
161106681|NCT04411628|581780988|FG001|Overall Study|Lost to Follow-up|1|||
161106682|NCT04411628|581780989|FG002|Overall Study|Lost to Follow-up|0|||
161106683|NCT04411628|581780990|FG003|Overall Study|Lost to Follow-up|0|||
161106684|NCT01428661|581780991|FG000|Double-Masked Phase|Protocol Violation|9|||
161106685|NCT01428661|581780992|FG001|Double-Masked Phase|Protocol Violation|4|||
161106686|NCT01428661|581780993|FG002|Double-Masked Phase|Protocol Violation|0|||
161106687|NCT01428661|581780991|FG000|Double-Masked Phase|Adverse Event|13|||
161106688|NCT01428661|581780992|FG001|Double-Masked Phase|Adverse Event|4|||
161212733|NCT02270983|582161854|FG000|Overall Study|moved away from study site|0|||
161106689|NCT01428661|581780993|FG002|Double-Masked Phase|Adverse Event|0|||
161106690|NCT01428661|581780991|FG000|Double-Masked Phase|Lost to Follow-up|14|||
161106691|NCT01428661|581780992|FG001|Double-Masked Phase|Lost to Follow-up|14|||
161106692|NCT01428661|581780993|FG002|Double-Masked Phase|Lost to Follow-up|0|||
161106693|NCT01428661|581780991|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
161106694|NCT01428661|581780992|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
161106695|NCT01428661|581780993|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
161212734|NCT02270983|582161855|FG001|Overall Study|moved away from study site|1|||
161106696|NCT01428661|581780991|FG000|Double-Masked Phase|Lack of Efficacy|2|||
161106697|NCT01428661|581780992|FG001|Double-Masked Phase|Lack of Efficacy|1|||
161106698|NCT01428661|581780993|FG002|Double-Masked Phase|Lack of Efficacy|0|||
161106699|NCT01428661|581780991|FG000|Double-Masked Phase|*Various|1|||
161106700|NCT01428661|581780992|FG001|Double-Masked Phase|*Various|6|||
161106701|NCT01428661|581780993|FG002|Double-Masked Phase|*Various|0|||
161106702|NCT01428661|581780991|FG000|Open Label Extension|Protocol Violation|0|||
161106703|NCT01428661|581780992|FG001|Open Label Extension|Protocol Violation|0|||
161106704|NCT01428661|581780993|FG002|Open Label Extension|Protocol Violation|9|||
161106705|NCT01428661|581780991|FG000|Open Label Extension|Adverse Event|0|||
161106706|NCT01428661|581780992|FG001|Open Label Extension|Adverse Event|0|||
161106707|NCT01428661|581780993|FG002|Open Label Extension|Adverse Event|15|||
161106708|NCT01428661|581780991|FG000|Open Label Extension|Lost to Follow-up|0|||
161106709|NCT01428661|581780992|FG001|Open Label Extension|Lost to Follow-up|0|||
161106710|NCT01428661|581780993|FG002|Open Label Extension|Lost to Follow-up|38|||
161106711|NCT01428661|581780991|FG000|Open Label Extension|Withdrawal by Subject|0|||
161106712|NCT01428661|581780992|FG001|Open Label Extension|Withdrawal by Subject|0|||
161106713|NCT01428661|581780993|FG002|Open Label Extension|Withdrawal by Subject|49|||
161106714|NCT01428661|581780991|FG000|Open Label Extension|Lack of Efficacy|0|||
161106715|NCT01428661|581780992|FG001|Open Label Extension|Lack of Efficacy|0|||
161106716|NCT01428661|581780993|FG002|Open Label Extension|Lack of Efficacy|24|||
161106717|NCT01428661|581780991|FG000|Open Label Extension|**Various|0|||
161106718|NCT01428661|581780992|FG001|Open Label Extension|**Various|0|||
161106719|NCT01428661|581780993|FG002|Open Label Extension|**Various|185|||
161106720|NCT03828292|581780994|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161106721|NCT03828292|581780995|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
161106722|NCT03828292|581780996|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161106723|NCT03828292|581780997|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161106724|NCT03828292|581780998|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161106725|NCT03828292|581780999|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
161106726|NCT03828292|581780994|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161106727|NCT03828292|581780995|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161106728|NCT03828292|581780996|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
161106729|NCT03828292|581780997|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161106730|NCT03828292|581780998|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161106731|NCT03828292|581780999|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
161106732|NCT03828292|581780994|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161106733|NCT03828292|581780995|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161106734|NCT03828292|581780996|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161106735|NCT03828292|581780997|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
161106736|NCT03828292|581780998|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161106737|NCT03828292|581780999|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
161106738|NCT03828292|581780994|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161106739|NCT03828292|581780995|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161106740|NCT03828292|581780996|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161106741|NCT03828292|581780997|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
161106742|NCT03828292|581780998|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161106743|NCT03828292|581780999|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
161106744|NCT03828292|581780994|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161106745|NCT03828292|581780995|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161106746|NCT03828292|581780996|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
161106747|NCT03828292|581780997|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
161106748|NCT03828292|581780998|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161106749|NCT03828292|581780999|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
161106750|NCT06156215|581781000|FG000|Overall Study|Withdrawal by Subject|2|||
161106751|NCT06156215|581781001|FG001|Overall Study|Withdrawal by Subject|4|||
161106752|NCT06156215|581781002|FG002|Overall Study|Withdrawal by Subject|4|||
161106753|NCT06156215|581781003|FG003|Overall Study|Withdrawal by Subject|0|||
161106754|NCT06156215|581781004|FG004|Overall Study|Withdrawal by Subject|2|||
161106755|NCT06156215|581781005|FG005|Overall Study|Withdrawal by Subject|2|||
161106756|NCT06156215|581781000|FG000|Overall Study|Left ED without completing study|9|||
161106757|NCT06156215|581781001|FG001|Overall Study|Left ED without completing study|3|||
161106758|NCT06156215|581781002|FG002|Overall Study|Left ED without completing study|9|||
161106759|NCT06156215|581781003|FG003|Overall Study|Left ED without completing study|0|||
161106760|NCT06156215|581781004|FG004|Overall Study|Left ED without completing study|8|||
161106761|NCT06156215|581781005|FG005|Overall Study|Left ED without completing study|16|||
161106762|NCT06156215|581781000|FG000|Overall Study|Physician Decision|1|||
161106763|NCT06156215|581781001|FG001|Overall Study|Physician Decision|0|||
161106764|NCT06156215|581781002|FG002|Overall Study|Physician Decision|0|||
161106765|NCT06156215|581781003|FG003|Overall Study|Physician Decision|0|||
161106766|NCT06156215|581781004|FG004|Overall Study|Physician Decision|0|||
161106767|NCT06156215|581781005|FG005|Overall Study|Physician Decision|0|||
161106768|NCT06156215|581781000|FG000|Overall Study|Became or found ineligible|2|||
161106769|NCT06156215|581781001|FG001|Overall Study|Became or found ineligible|0|||
161106770|NCT06156215|581781002|FG002|Overall Study|Became or found ineligible|2|||
161106771|NCT06156215|581781003|FG003|Overall Study|Became or found ineligible|0|||
161106772|NCT06156215|581781004|FG004|Overall Study|Became or found ineligible|1|||
161106773|NCT06156215|581781005|FG005|Overall Study|Became or found ineligible|2|||
161106774|NCT04376827|581781006|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
161106775|NCT04376827|581781007|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
161106776|NCT04376827|581781006|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
161106777|NCT04376827|581781007|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
161106778|NCT04376827|581781006|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
161106779|NCT04376827|581781007|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
161106780|NCT04376827|581781006|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
161106781|NCT04376827|581781007|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
161106782|NCT04376827|581781006|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
161106783|NCT04376827|581781007|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
161106784|NCT01524198|581782672|FG000|Overall Study|Protocol Violation|8|||
161106785|NCT01524198|581782673|FG001|Overall Study|Protocol Violation|6|||
161106786|NCT01524198|581782672|FG000|Overall Study|Withdrawal by Subject|15|||
161106787|NCT01524198|581782673|FG001|Overall Study|Withdrawal by Subject|10|||
161106788|NCT02232802|581782674|FG000|Period 1|Sponsor request|1|||
161106789|NCT02232802|581782675|FG001|Period 1|Sponsor request|0|||
161106790|NCT02232802|581782674|FG000|Period 1|Adverse Event|1|||
161106791|NCT02232802|581782675|FG001|Period 1|Adverse Event|1|||
161106792|NCT00885703|581782681|FG000|Overall Study|Death|9|||
161106793|NCT00885703|581782682|FG001|Overall Study|Death|7|||
161106794|NCT00885703|581782683|FG002|Overall Study|Death|8|||
161106795|NCT00885703|581782684|FG003|Overall Study|Death|7|||
161106796|NCT00885703|581782685|FG004|Overall Study|Death|7|||
161106797|NCT00885703|581782686|FG005|Overall Study|Death|8|||
161106798|NCT00885703|581782687|FG006|Overall Study|Death|4|||
161106799|NCT00885703|581782681|FG000|Overall Study|Lost to Follow-up|0|||
161106800|NCT00885703|581782682|FG001|Overall Study|Lost to Follow-up|0|||
161106801|NCT00885703|581782683|FG002|Overall Study|Lost to Follow-up|1|||
161106802|NCT00885703|581782684|FG003|Overall Study|Lost to Follow-up|0|||
161106803|NCT00885703|581782685|FG004|Overall Study|Lost to Follow-up|0|||
161106804|NCT00885703|581782686|FG005|Overall Study|Lost to Follow-up|1|||
161106805|NCT00885703|581782687|FG006|Overall Study|Lost to Follow-up|0|||
161106806|NCT00885703|581782681|FG000|Overall Study|Withdrawal by Subject|0|||
161106807|NCT00885703|581782682|FG001|Overall Study|Withdrawal by Subject|0|||
161106808|NCT00885703|581782683|FG002|Overall Study|Withdrawal by Subject|0|||
161106809|NCT00885703|581782684|FG003|Overall Study|Withdrawal by Subject|1|||
161106810|NCT00885703|581782685|FG004|Overall Study|Withdrawal by Subject|3|||
161106811|NCT00885703|581782686|FG005|Overall Study|Withdrawal by Subject|1|||
161106812|NCT00885703|581782687|FG006|Overall Study|Withdrawal by Subject|1|||
161106813|NCT00885703|581782681|FG000|Overall Study|Ineligible (no CM)|1|||
161106814|NCT00885703|581782682|FG001|Overall Study|Ineligible (no CM)|3|||
161106815|NCT00885703|581782683|FG002|Overall Study|Ineligible (no CM)|2|||
161106816|NCT00885703|581782684|FG003|Overall Study|Ineligible (no CM)|1|||
161106817|NCT00885703|581782685|FG004|Overall Study|Ineligible (no CM)|2|||
161106818|NCT00885703|581782686|FG005|Overall Study|Ineligible (no CM)|3|||
161106819|NCT00885703|581782687|FG006|Overall Study|Ineligible (no CM)|1|||
161106820|NCT01490450|581782690|FG000|Period 1|Lack of Efficacy|2|||
161106821|NCT01490450|581782691|FG001|Period 1|Lack of Efficacy|0|||
161106822|NCT01490450|581782692|FG002|Period 1|Lack of Efficacy|3|||
161106823|NCT01490450|581782693|FG003|Period 1|Lack of Efficacy|0|||
161106824|NCT01490450|581782690|FG000|Period 1|Adverse Event|0|||
161106825|NCT01490450|581782691|FG001|Period 1|Adverse Event|0|||
161106826|NCT01490450|581782692|FG002|Period 1|Adverse Event|0|||
161106827|NCT01490450|581782693|FG003|Period 1|Adverse Event|5|||
161106828|NCT01490450|581782690|FG000|Period 1|Request to discontinue treatment|1|||
161106829|NCT01490450|581782691|FG001|Period 1|Request to discontinue treatment|0|||
161106830|NCT01490450|581782692|FG002|Period 1|Request to discontinue treatment|0|||
161106831|NCT01490450|581782693|FG003|Period 1|Request to discontinue treatment|0|||
161106832|NCT01490450|581782690|FG000|Period 1|Withdrawal by Subject|0|||
161106833|NCT01490450|581782691|FG001|Period 1|Withdrawal by Subject|0|||
161106834|NCT01490450|581782692|FG002|Period 1|Withdrawal by Subject|0|||
161106835|NCT01490450|581782693|FG003|Period 1|Withdrawal by Subject|3|||
161106836|NCT01490450|581782690|FG000|Period 1|No longer met study criteria|0|||
161106837|NCT01490450|581782691|FG001|Period 1|No longer met study criteria|1|||
161106838|NCT01490450|581782692|FG002|Period 1|No longer met study criteria|1|||
161106839|NCT01490450|581782693|FG003|Period 1|No longer met study criteria|0|||
161106840|NCT01490450|581782690|FG000|Period 2|Lack of Efficacy|0|||
161106841|NCT01490450|581782691|FG001|Period 2|Lack of Efficacy|0|||
161106842|NCT01490450|581782692|FG002|Period 2|Lack of Efficacy|0|||
161106843|NCT01490450|581782693|FG003|Period 2|Lack of Efficacy|1|||
161106844|NCT01490450|581782690|FG000|Period 2|Adverse Event|1|||
161106845|NCT01490450|581782691|FG001|Period 2|Adverse Event|1|||
161106846|NCT01490450|581782692|FG002|Period 2|Adverse Event|0|||
161106847|NCT01490450|581782693|FG003|Period 2|Adverse Event|1|||
161106848|NCT01490450|581782690|FG000|Period 2|Withdrawal by Subject|1|||
161106849|NCT01490450|581782691|FG001|Period 2|Withdrawal by Subject|0|||
161106850|NCT01490450|581782692|FG002|Period 2|Withdrawal by Subject|0|||
161106851|NCT01490450|581782693|FG003|Period 2|Withdrawal by Subject|0|||
161106852|NCT01490450|581782690|FG000|Period 2|Lost to Follow-up|0|||
161106853|NCT01490450|581782691|FG001|Period 2|Lost to Follow-up|0|||
161106854|NCT01490450|581782692|FG002|Period 2|Lost to Follow-up|0|||
161106855|NCT01490450|581782693|FG003|Period 2|Lost to Follow-up|2|||
161106856|NCT01462435|581782694|FG000|Overall Study|Lack of Efficacy|1|||
161106857|NCT01462435|581782695|FG001|Overall Study|Lack of Efficacy|0|||
161106858|NCT01462435|581782696|FG002|Overall Study|Lack of Efficacy|0|||
161106859|NCT01462435|581782697|FG003|Overall Study|Lack of Efficacy|3|||
161106860|NCT01462435|581782694|FG000|Overall Study|Physician Decision|0|||
161106861|NCT01462435|581782695|FG001|Overall Study|Physician Decision|0|||
161106862|NCT01462435|581782696|FG002|Overall Study|Physician Decision|1|||
161106863|NCT01462435|581782697|FG003|Overall Study|Physician Decision|0|||
161106864|NCT01462435|581782694|FG000|Overall Study|Withdrawal by Subject|0|||
161106865|NCT01462435|581782695|FG001|Overall Study|Withdrawal by Subject|0|||
161106866|NCT01462435|581782696|FG002|Overall Study|Withdrawal by Subject|0|||
161106867|NCT01462435|581782697|FG003|Overall Study|Withdrawal by Subject|1|||
161106868|NCT01462435|581782694|FG000|Overall Study|Lost to Follow-up|0|||
161106869|NCT01462435|581782695|FG001|Overall Study|Lost to Follow-up|0|||
161106870|NCT01462435|581782696|FG002|Overall Study|Lost to Follow-up|0|||
161106871|NCT01462435|581782697|FG003|Overall Study|Lost to Follow-up|1|||
161106872|NCT00636675|581782702|FG000|Overall Study|Lost to Follow-up|121|||
161106873|NCT00636675|581782703|FG001|Overall Study|Lost to Follow-up|31|||
161106874|NCT00636675|581782702|FG000|Overall Study|Withdrawal by Subject|19|||
161106875|NCT00636675|581782703|FG001|Overall Study|Withdrawal by Subject|10|||
161106876|NCT01227187|581782705|FG000|Overall Study|Physician Decision|0|||
161106877|NCT01227187|581782706|FG001|Overall Study|Physician Decision|0|||
161106878|NCT01227187|581782707|FG002|Overall Study|Physician Decision|0|||
161106879|NCT01227187|581782708|FG003|Overall Study|Physician Decision|1|||
161106880|NCT01566773|581782710|FG000|Overall Study|Protocol specified criteria|4|||
161106881|NCT01566773|581782710|FG000|Overall Study|Protocol Violation|4|||
161106882|NCT01566773|581782710|FG000|Overall Study|Withdrawal by Subject|9|||
161106883|NCT01566773|581782710|FG000|Overall Study|Administrative reason|1|||
161106884|NCT01566773|581782710|FG000|Overall Study|Adverse Event|10|||
161106885|NCT01566773|581782710|FG000|Overall Study|Physician Decision|2|||
161212735|NCT02270983|582161856|FG002|Overall Study|moved away from study site|0|||
161212736|NCT00265083|582161857|FG000|Overall Study|Adverse Event|5|||
161212737|NCT00265083|582161858|FG001|Overall Study|Adverse Event|13|||
161212738|NCT00265083|582161859|FG002|Overall Study|Adverse Event|15|||
161212739|NCT00265083|582161857|FG000|Overall Study|Lost to Follow-up|3|||
161106886|NCT00833053|581782711|FG000|Overall Study|Adverse Event|4|||
161106887|NCT00833053|581782712|FG001|Overall Study|Adverse Event|0|||
161106888|NCT00833053|581782711|FG000|Overall Study|Treatment Failure|3|||
161106889|NCT00833053|581782712|FG001|Overall Study|Treatment Failure|1|||
161212740|NCT00265083|582161858|FG001|Overall Study|Lost to Follow-up|4|||
161212741|NCT00265083|582161859|FG002|Overall Study|Lost to Follow-up|4|||
161212742|NCT00265083|582161857|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
161212743|NCT00265083|582161858|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161212744|NCT00265083|582161859|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
161212745|NCT00265083|582161857|FG000|Overall Study|Other|1|||
161212746|NCT00265083|582161858|FG001|Overall Study|Other|12|||
161212747|NCT00265083|582161859|FG002|Overall Study|Other|9|||
161212748|NCT03208933|582161863|FG000|Overall Study|Death|3|||
161212749|NCT03208933|582161863|FG000|Overall Study|Withdrawal by Subject|3|||
161212750|NCT03208933|582161863|FG000|Overall Study|Adverse Event|1|||
161212751|NCT03208933|582161863|FG000|Overall Study|Lost to Follow-up|2|||
161212752|NCT03208933|582161863|FG000|Overall Study|Physician Decision|3|||
161212753|NCT03208933|582161863|FG000|Overall Study|Protocol Violation|1|||
161212754|NCT00854620|582161864|FG000|Overall Study|Adverse Event|1|||
161212755|NCT00275028|582161869|FG000|Overall Study|Withdrew consent before treatment began|1|||
161212756|NCT00275028|582161869|FG000|Overall Study|Withdrawal by Subject|5|||
161212757|NCT00275028|582161869|FG000|Overall Study|Adverse Event|9|||
161212758|NCT00275028|582161869|FG000|Overall Study|Progressive Disease|30|||
161212759|NCT00275028|582161869|FG000|Overall Study|Physician Decision|2|||
161212760|NCT04356573|582161875|FG000|Overall Study|Didn't Qualify|1|||
161212761|NCT04356573|582161876|FG001|Overall Study|Didn't Qualify|0|||
161212762|NCT02487979|582161877|FG000|Overall Study|Physician Decision|2|||
161212763|NCT02487979|582161877|FG000|Overall Study|Withdrawal by Subject|2|||
161212764|NCT02487979|582161877|FG000|Overall Study|Progressive Disease|17|||
161212765|NCT02410837|582161878|FG000|Overall Study|Death|387|||
161212766|NCT02410837|582161878|FG000|Overall Study|Lost to Follow-up|50|||
161212767|NCT02410837|582161878|FG000|Overall Study|Withdrawal by Subject|44|||
161212768|NCT02410837|582161878|FG000|Overall Study|Physician Decision|6|||
161212769|NCT02410837|582161878|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
161212770|NCT00837577|582161879|FG000|Double-blind Period|Clinical Adverse Event|1|||
161212771|NCT00837577|582161880|FG001|Double-blind Period|Clinical Adverse Event|0|||
161212772|NCT00837577|582161879|FG000|Double-blind Period|Withdrawal by Subject|1|||
161212773|NCT00837577|582161880|FG001|Double-blind Period|Withdrawal by Subject|0|||
161212774|NCT00837577|582161879|FG000|Open-label Period|Clinical Adverse Event|2|||
161212775|NCT00837577|582161880|FG001|Open-label Period|Clinical Adverse Event|2|||
161212776|NCT00837577|582161879|FG000|Open-label Period|Laboratory Adverse Event|0|||
161212777|NCT00837577|582161880|FG001|Open-label Period|Laboratory Adverse Event|1|||
161212778|NCT00837577|582161879|FG000|Open-label Period|Lack of Efficacy|4|||
161212779|NCT00837577|582161880|FG001|Open-label Period|Lack of Efficacy|3|||
161212780|NCT00837577|582161879|FG000|Open-label Period|Withdrawal by Subject|1|||
161212781|NCT00837577|582161880|FG001|Open-label Period|Withdrawal by Subject|2|||
161212782|NCT00837577|582161879|FG000|Open-label Period|Other Reason|1|||
161212783|NCT00837577|582161880|FG001|Open-label Period|Other Reason|1|||
161212784|NCT00849524|582161885|FG000|Overall Study|Lack of Efficacy|3|||
161212785|NCT01825876|582161886|FG000|Period 2|Withdrawal by Subject|0|||
161212786|NCT01825876|582161887|FG001|Period 2|Withdrawal by Subject|1|||
161212787|NCT01027884|582161891|FG000|Overall Study|Adverse Event|2|||
161212788|NCT01027884|582161892|FG001|Overall Study|Adverse Event|1|||
161106890|NCT00833053|581782711|FG000|Overall Study|Withdrawal by Subject|0|||
161106891|NCT00833053|581782712|FG001|Overall Study|Withdrawal by Subject|1|||
161106892|NCT00833053|581782711|FG000|Overall Study|Protocol Violation|2|||
161106893|NCT00833053|581782712|FG001|Overall Study|Protocol Violation|1|||
161106894|NCT02187471|581782713|FG000|Overall Study|Protocol Violation|4|||
161106895|NCT02187471|581782714|FG001|Overall Study|Protocol Violation|5|||
161106896|NCT02187471|581782715|FG002|Overall Study|Protocol Violation|4|||
161106897|NCT02187471|581782716|FG003|Overall Study|Protocol Violation|4|||
161106898|NCT02187471|581782713|FG000|Overall Study|Missing|0|||
161106899|NCT02187471|581782714|FG001|Overall Study|Missing|0|||
161106900|NCT02187471|581782715|FG002|Overall Study|Missing|0|||
161106901|NCT02187471|581782716|FG003|Overall Study|Missing|1|||
161106902|NCT02187471|581782713|FG000|Overall Study|Lack of Efficacy|18|||
161106903|NCT02187471|581782714|FG001|Overall Study|Lack of Efficacy|9|||
161106904|NCT02187471|581782715|FG002|Overall Study|Lack of Efficacy|13|||
161106905|NCT02187471|581782716|FG003|Overall Study|Lack of Efficacy|11|||
161106906|NCT02187471|581782713|FG000|Overall Study|Adverse Event|24|||
161106907|NCT02187471|581782714|FG001|Overall Study|Adverse Event|34|||
161106908|NCT02187471|581782715|FG002|Overall Study|Adverse Event|44|||
161106909|NCT02187471|581782716|FG003|Overall Study|Adverse Event|36|||
161106910|NCT02187471|581782713|FG000|Overall Study|Withdrawal by Subject|23|||
161106911|NCT02187471|581782714|FG001|Overall Study|Withdrawal by Subject|29|||
161106912|NCT02187471|581782715|FG002|Overall Study|Withdrawal by Subject|22|||
161106913|NCT02187471|581782716|FG003|Overall Study|Withdrawal by Subject|24|||
161106914|NCT02187471|581782713|FG000|Overall Study|Other|7|||
161212789|NCT01027884|582161891|FG000|Overall Study|Protocol Violation|1|||
161212790|NCT01027884|582161892|FG001|Overall Study|Protocol Violation|0|||
161212791|NCT01027884|582161891|FG000|Overall Study|Non-compliance|1|||
161106915|NCT02187471|581782714|FG001|Overall Study|Other|5|||
161106916|NCT02187471|581782715|FG002|Overall Study|Other|3|||
161106917|NCT02187471|581782716|FG003|Overall Study|Other|4|||
161106918|NCT00957528|581782719|FG000|Overall Study|Protocol Violation|0|||
161106919|NCT00957528|581782720|FG001|Overall Study|Protocol Violation|1|||
161106920|NCT00957528|581782721|FG002|Overall Study|Protocol Violation|0|||
161212792|NCT01027884|582161892|FG001|Overall Study|Non-compliance|1|||
161106921|NCT00957528|581782719|FG000|Overall Study|Withdrawal by Subject|0|||
161106922|NCT00957528|581782720|FG001|Overall Study|Withdrawal by Subject|0|||
161106923|NCT00957528|581782721|FG002|Overall Study|Withdrawal by Subject|1|||
161106924|NCT02318667|581782722|FG000|Overall Study|Adverse Event|1|||
161106925|NCT02318667|581782722|FG000|Overall Study|Lack of Efficacy|6|||
161106926|NCT02318667|581782722|FG000|Overall Study|Protocol Violation|2|||
161106927|NCT01101438|581782724|FG000|Overall Study|Withdrawal by Subject|8|||
161106928|NCT01101438|581782725|FG001|Overall Study|Withdrawal by Subject|9|||
161212793|NCT01027884|582161891|FG000|Overall Study|Withdrawal by Subject|0|||
161212794|NCT01027884|582161892|FG001|Overall Study|Withdrawal by Subject|1|||
161212795|NCT01027884|582161891|FG000|Overall Study|Lost to Follow-up|0|||
161212796|NCT01027884|582161892|FG001|Overall Study|Lost to Follow-up|1|||
161212797|NCT01027884|582161891|FG000|Overall Study|Spinal fixation surgery|0|||
161212798|NCT01027884|582161892|FG001|Overall Study|Spinal fixation surgery|3|||
161212799|NCT03636542|582161894|FG000|Overall Study|Lost to Follow-up|1|||
161212800|NCT03636542|582161895|FG001|Overall Study|Lost to Follow-up|1|||
161106929|NCT02289742|581782734|FG000|First Wear Period|Adverse event prior to treatment|0|||
161106930|NCT02289742|581782735|FG001|First Wear Period|Adverse event prior to treatment|1|||
161106931|NCT02289742|581782736|FG002|First Wear Period|Adverse event prior to treatment|0|||
161106932|NCT02289742|581782737|FG003|First Wear Period|Adverse event prior to treatment|0|||
161106933|NCT02289742|581782734|FG000|First Wear Period|Adverse Event|0|||
161106934|NCT02289742|581782735|FG001|First Wear Period|Adverse Event|0|||
161106935|NCT02289742|581782736|FG002|First Wear Period|Adverse Event|1|||
161106936|NCT02289742|581782737|FG003|First Wear Period|Adverse Event|0|||
161106937|NCT02289742|581782734|FG000|First Wear Period|Other prior to treatment|0|||
161106938|NCT02289742|581782735|FG001|First Wear Period|Other prior to treatment|0|||
161106939|NCT02289742|581782736|FG002|First Wear Period|Other prior to treatment|0|||
161106940|NCT02289742|581782737|FG003|First Wear Period|Other prior to treatment|1|||
161106941|NCT02289742|581782734|FG000|Third Wear Period|Adverse Event|0|||
161106942|NCT02289742|581782735|FG001|Third Wear Period|Adverse Event|1|||
161106943|NCT02289742|581782736|FG002|Third Wear Period|Adverse Event|0|||
161106944|NCT02289742|581782737|FG003|Third Wear Period|Adverse Event|0|||
161106945|NCT02289742|581782734|FG000|Third Wear Period|Reason not given|0|||
161106946|NCT02289742|581782735|FG001|Third Wear Period|Reason not given|0|||
161106947|NCT02289742|581782736|FG002|Third Wear Period|Reason not given|0|||
161106948|NCT02289742|581782737|FG003|Third Wear Period|Reason not given|1|||
161106949|NCT02865018|581782738|FG000|Overall Study|Withdrawal by Subject|1|||
161106950|NCT00915772|581782739|FG000|Overall Study|Adverse Event|12|||
161106951|NCT00915772|581782740|FG001|Overall Study|Adverse Event|13|||
161106952|NCT00915772|581782741|FG002|Overall Study|Adverse Event|11|||
161106953|NCT00915772|581782739|FG000|Overall Study|Protocol Violation|4|||
161106954|NCT00915772|581782740|FG001|Overall Study|Protocol Violation|1|||
161212801|NCT03636542|582161894|FG000|Overall Study|Physician Decision|0|||
161212802|NCT03636542|582161895|FG001|Overall Study|Physician Decision|1|||
161212803|NCT03636542|582161894|FG000|Overall Study|Withdrawal by Subject|1|||
161212804|NCT03636542|582161895|FG001|Overall Study|Withdrawal by Subject|0|||
161212805|NCT03670537|582161896|FG000|Overall Study|Protocol Violation|1|||
161212806|NCT03751020|582161897|FG000|Overall Study|Withdrawal by Subject|2|||
161212807|NCT03751020|582161898|FG001|Overall Study|Withdrawal by Subject|0|||
161212808|NCT03751020|582161899|FG002|Overall Study|Withdrawal by Subject|0|||
161212809|NCT03751020|582161897|FG000|Overall Study|Lost to Follow-up|7|||
161212810|NCT03751020|582161898|FG001|Overall Study|Lost to Follow-up|4|||
161212811|NCT03751020|582161899|FG002|Overall Study|Lost to Follow-up|10|||
161212812|NCT02555618|582161900|FG000|Overall Study|Sponsor's Circumstances|1|||
161212813|NCT02555618|582161901|FG001|Overall Study|Sponsor's Circumstances|0|||
161212814|NCT02217345|582161902|FG000|Overall Study|Lost to Follow-up|2|||
161212815|NCT02217345|582161903|FG001|Overall Study|Lost to Follow-up|1|||
161212816|NCT02217345|582161902|FG000|Overall Study|Withdrawal by Subject|3|||
161212817|NCT02217345|582161903|FG001|Overall Study|Withdrawal by Subject|2|||
161212818|NCT02217345|582161902|FG000|Overall Study|Adverse Event|2|||
161212819|NCT02217345|582161903|FG001|Overall Study|Adverse Event|1|||
161212820|NCT02217345|582161902|FG000|Overall Study|Physician Decision|0|||
161212821|NCT02217345|582161903|FG001|Overall Study|Physician Decision|1|||
161212822|NCT00971204|582161904|FG000|Overall Study|Did not meet all criteria-not treated|14|||
161212823|NCT00971204|582161904|FG000|Overall Study|Lost to Follow-up|10|||
161212824|NCT02624518|582161905|FG000|Overall Study|Physician Decision|1|||
161212825|NCT02729194|582161906|FG000|Overall Study|Withdrawal by Subject|3|||
161212826|NCT00845026|582161907|FG000|Study Period III|Adverse Event|23|||
161212827|NCT00845026|582161908|FG001|Study Period III|Adverse Event|19|||
161212828|NCT00845026|582161907|FG000|Study Period III|Perceived lack of efficacy|27|||
161212829|NCT00845026|582161908|FG001|Study Period III|Perceived lack of efficacy|15|||
161212830|NCT00845026|582161907|FG000|Study Period III|Withdrawal by Subject|19|||
161212831|NCT00845026|582161908|FG001|Study Period III|Withdrawal by Subject|15|||
161212832|NCT00845026|582161907|FG000|Study Period III|Entry Criteria not met|8|||
161212833|NCT00845026|582161908|FG001|Study Period III|Entry Criteria not met|11|||
161212834|NCT00845026|582161907|FG000|Study Period III|Lost to Follow-up|4|||
161212835|NCT00845026|582161908|FG001|Study Period III|Lost to Follow-up|5|||
161106955|NCT00915772|581782741|FG002|Overall Study|Protocol Violation|2|||
161106956|NCT00915772|581782739|FG000|Overall Study|Lost to Follow-up|1|||
161106957|NCT00915772|581782740|FG001|Overall Study|Lost to Follow-up|2|||
161106958|NCT00915772|581782741|FG002|Overall Study|Lost to Follow-up|2|||
161212836|NCT00845026|582161907|FG000|Study Period III|Protocol Violation|8|||
161212837|NCT00845026|582161908|FG001|Study Period III|Protocol Violation|1|||
160865667|NCT02504151|580902947|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
160865668|NCT02504151|580902946|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161212838|NCT00845026|582161907|FG000|Study Period III|Scheduled conflict|3|||
161212839|NCT00845026|582161908|FG001|Study Period III|Scheduled conflict|1|||
161212840|NCT00845026|582161907|FG000|Study Period III|Subject is moving or has moved|2|||
160865669|NCT02504151|580902947|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
160865670|NCT02504151|580902946|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160865671|NCT02504151|580902947|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161212841|NCT00845026|582161908|FG001|Study Period III|Subject is moving or has moved|4|||
161212842|NCT00845026|582161907|FG000|Study Period III|Transportation issues|1|||
161212843|NCT00845026|582161908|FG001|Study Period III|Transportation issues|1|||
161212844|NCT00845026|582161907|FG000|Study Period IV|Adverse Event|4|||
161212845|NCT00845026|582161908|FG001|Study Period IV|Adverse Event|0|||
161212846|NCT00845026|582161907|FG000|Study Period IV|Perceived lack of efficacy|2|||
161212847|NCT00845026|582161908|FG001|Study Period IV|Perceived lack of efficacy|1|||
161212848|NCT00845026|582161907|FG000|Study Period IV|Protocol Violation|3|||
161212849|NCT00845026|582161908|FG001|Study Period IV|Protocol Violation|1|||
161212850|NCT00845026|582161907|FG000|Study Period IV|Lost to Follow-up|1|||
161212851|NCT00845026|582161908|FG001|Study Period IV|Lost to Follow-up|0|||
161212852|NCT00845026|582161907|FG000|Study Period IV|Withdrawal by Subject|4|||
161212853|NCT00845026|582161908|FG001|Study Period IV|Withdrawal by Subject|1|||
161212854|NCT00845026|582161907|FG000|Study Period IV|Entry Criteria Not Met|1|||
161212855|NCT00845026|582161908|FG001|Study Period IV|Entry Criteria Not Met|0|||
161212856|NCT00845026|582161907|FG000|Study Period IV|Subject is moving or has moved|0|||
161212857|NCT00845026|582161908|FG001|Study Period IV|Subject is moving or has moved|1|||
161212858|NCT00845026|582161907|FG000|Study Period IV|Scheduling conflict|1|||
161212859|NCT00845026|582161908|FG001|Study Period IV|Scheduling conflict|0|||
161212860|NCT01325532|582161909|FG000|Overall Study|Withdrawal by Subject|2|||
161212861|NCT01325532|582161910|FG001|Overall Study|Withdrawal by Subject|0|||
161212862|NCT00272961|582161911|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
161212863|NCT00272961|582161912|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161212864|NCT00272961|582161913|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161212865|NCT00272961|582161914|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161212866|NCT00272961|582161915|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
161212867|NCT00272961|582161911|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
161212868|NCT00272961|582161912|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161212869|NCT00272961|582161913|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161212870|NCT00272961|582161914|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161212871|NCT00272961|582161915|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
161212872|NCT00272961|582161911|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
161212873|NCT00272961|582161912|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161212874|NCT00272961|582161913|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161212875|NCT00272961|582161914|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161212876|NCT00272961|582161915|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
161212877|NCT00272961|582161911|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
161212878|NCT00272961|582161912|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161212879|NCT00272961|582161913|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161212880|NCT00272961|582161914|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161212881|NCT00272961|582161915|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
161212882|NCT00272961|582161911|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
161212883|NCT00272961|582161912|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
161212884|NCT00272961|582161913|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
161212885|NCT00272961|582161914|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
161212886|NCT00272961|582161915|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
161212887|NCT00272961|582161911|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
161212888|NCT00272961|582161912|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
161212889|NCT00272961|582161913|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
161212890|NCT00272961|582161914|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
161212891|NCT00272961|582161915|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
161212892|NCT00272961|582161911|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
161106959|NCT00915772|581782739|FG000|Overall Study|Lack of Efficacy|9|||
161106960|NCT00915772|581782740|FG001|Overall Study|Lack of Efficacy|15|||
161106961|NCT00915772|581782741|FG002|Overall Study|Lack of Efficacy|3|||
161106962|NCT00915772|581782739|FG000|Overall Study|Refused to continue trial medication|6|||
161106963|NCT00915772|581782740|FG001|Overall Study|Refused to continue trial medication|8|||
161106964|NCT00915772|581782741|FG002|Overall Study|Refused to continue trial medication|4|||
161106965|NCT00915772|581782739|FG000|Overall Study|Any other reason|4|||
161106966|NCT00915772|581782740|FG001|Overall Study|Any other reason|7|||
161212893|NCT00272961|582161912|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161212894|NCT00272961|582161913|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
161212895|NCT00272961|582161914|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161212896|NCT00272961|582161915|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
161212897|NCT00272961|582161911|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
161212898|NCT00272961|582161912|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
161212899|NCT00272961|582161913|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
161212900|NCT00272961|582161914|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
161212901|NCT00272961|582161915|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
161212902|NCT02766400|582161927|FG000|Overall Study|Death|1|||
161212903|NCT02766400|582161928|FG001|Overall Study|Death|2|||
161212904|NCT02766400|582161927|FG000|Overall Study|Withdrawal by Subject|1|||
161212905|NCT02766400|582161928|FG001|Overall Study|Withdrawal by Subject|0|||
161212906|NCT04556838|582161933|FG000|Overall Study|Withdrawal by Subject|3|||
161212907|NCT04556838|582161934|FG001|Overall Study|Withdrawal by Subject|1|||
161212908|NCT04556838|582161935|FG002|Overall Study|Withdrawal by Subject|2|||
161212909|NCT04556838|582161933|FG000|Overall Study|Adverse Event|0|||
161212910|NCT04556838|582161934|FG001|Overall Study|Adverse Event|1|||
161212911|NCT04556838|582161935|FG002|Overall Study|Adverse Event|1|||
161212912|NCT04556838|582161933|FG000|Overall Study|Lost to Follow-up|0|||
161212913|NCT04556838|582161934|FG001|Overall Study|Lost to Follow-up|0|||
161212914|NCT04556838|582161935|FG002|Overall Study|Lost to Follow-up|2|||
161212915|NCT04556838|582161933|FG000|Overall Study|Subject travel|0|||
161212916|NCT04556838|582161934|FG001|Overall Study|Subject travel|1|||
161212917|NCT04556838|582161935|FG002|Overall Study|Subject travel|0|||
161212918|NCT04556838|582161933|FG000|Overall Study|Physician Decision|1|||
161212919|NCT04556838|582161934|FG001|Overall Study|Physician Decision|0|||
161212920|NCT04556838|582161935|FG002|Overall Study|Physician Decision|0|||
161212921|NCT01458119|582161936|FG000|Overall Study|Physician Decision|4|||
161212922|NCT01458119|582161936|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
161212923|NCT01458119|582161936|FG000|Overall Study|Pregnancy|1|||
161212924|NCT01458119|582161936|FG000|Overall Study|Death|2|||
161212925|NCT01458119|582161936|FG000|Overall Study|Adverse Event|1|||
161212926|NCT01458119|582161936|FG000|Overall Study|Consent Withdrawn by Participant|8|||
161212927|NCT01458119|582161936|FG000|Overall Study|Non-compliance With Study Drug|3|||
161212928|NCT03770000|582164310|FG000|Overall Study|Premature discontinuation due to PD|0|||
161212929|NCT03770000|582164311|FG001|Overall Study|Premature discontinuation due to PD|0|||
161212930|NCT03770000|582164312|FG002|Overall Study|Premature discontinuation due to PD|1|||
161212931|NCT03770000|582164313|FG003|Overall Study|Premature discontinuation due to PD|3|||
161212932|NCT03770000|582164314|FG004|Overall Study|Premature discontinuation due to PD|2|||
161212933|NCT02290028|582164315|FG000|Overall Study|Death|217|||
161212934|NCT02290028|582164315|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
161212935|NCT02290028|582164315|FG000|Overall Study|No longer under care of study physician|76|||
161212936|NCT02290028|582164315|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
161212937|NCT02290028|582164315|FG000|Overall Study|Withdrawal by Subject|52|||
161212938|NCT02290028|582164315|FG000|Overall Study|Study site closure|44|||
160865672|NCT02504151|580902946|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
161212939|NCT02290028|582164315|FG000|Overall Study|Lost to Follow-up|34|||
161212940|NCT02290028|582164315|FG000|Overall Study|Miscellaneous|10|||
161212941|NCT02290028|582164315|FG000|Overall Study|Transition to EP PASSION|1295|||
161212942|NCT02290028|582164315|FG000|Overall Study|Planned study completion at 12 months|257|||
161212943|NCT00833547|582164316|FG000|Overall Study|Withdrawal by Subject|2|||
161212944|NCT00833547|582164317|FG001|Overall Study|Withdrawal by Subject|2|||
161212945|NCT01375010|582164320|FG000|Overall Study|Lost to Follow-up|8|||
161212946|NCT01375010|582164321|FG001|Overall Study|Lost to Follow-up|2|||
161212947|NCT01375010|582164320|FG000|Overall Study|Withdrawal by Subject|4|||
161212948|NCT01375010|582164321|FG001|Overall Study|Withdrawal by Subject|2|||
161212949|NCT02402933|582164323|FG000|Overall Study|Withdrawal by Subject|4|||
161212950|NCT02402933|582164323|FG000|Overall Study|Discontinued; Site Termination|10|||
161212951|NCT00830063|582164324|FG000|Overall Study|Adverse Event|7|||
161212952|NCT00830063|582164325|FG001|Overall Study|Adverse Event|13|||
161212953|NCT00830063|582164326|FG002|Overall Study|Adverse Event|16|||
161212954|NCT00830063|582164327|FG003|Overall Study|Adverse Event|13|||
161212955|NCT00830063|582164324|FG000|Overall Study|Death|1|||
161212956|NCT00830063|582164325|FG001|Overall Study|Death|0|||
161212957|NCT00830063|582164326|FG002|Overall Study|Death|0|||
161212958|NCT00830063|582164327|FG003|Overall Study|Death|0|||
161212959|NCT00830063|582164324|FG000|Overall Study|Lost to Follow-up|0|||
161212960|NCT00830063|582164325|FG001|Overall Study|Lost to Follow-up|0|||
161212961|NCT00830063|582164326|FG002|Overall Study|Lost to Follow-up|3|||
161212962|NCT00830063|582164327|FG003|Overall Study|Lost to Follow-up|1|||
161212963|NCT00830063|582164324|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
161212964|NCT00830063|582164325|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
161212965|NCT00830063|582164326|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
161212966|NCT00830063|582164327|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
161212967|NCT00830063|582164324|FG000|Overall Study|Lack of Efficacy|51|||
161212968|NCT00830063|582164325|FG001|Overall Study|Lack of Efficacy|23|||
161212969|NCT00830063|582164326|FG002|Overall Study|Lack of Efficacy|25|||
161212970|NCT00830063|582164327|FG003|Overall Study|Lack of Efficacy|32|||
161212971|NCT00830063|582164324|FG000|Overall Study|Other|5|||
161212972|NCT00830063|582164325|FG001|Overall Study|Other|5|||
161212973|NCT00830063|582164326|FG002|Overall Study|Other|8|||
161212974|NCT00830063|582164327|FG003|Overall Study|Other|6|||
161212975|NCT00830063|582164324|FG000|Overall Study|Withdrawal by Subject|16|||
161212976|NCT00830063|582164325|FG001|Overall Study|Withdrawal by Subject|10|||
161212977|NCT00830063|582164326|FG002|Overall Study|Withdrawal by Subject|16|||
161212978|NCT00830063|582164327|FG003|Overall Study|Withdrawal by Subject|13|||
161212979|NCT00830063|582164324|FG000|Overall Study|Protocol Violation|1|||
161212980|NCT00830063|582164325|FG001|Overall Study|Protocol Violation|0|||
161212981|NCT00830063|582164326|FG002|Overall Study|Protocol Violation|3|||
161212982|NCT00830063|582164327|FG003|Overall Study|Protocol Violation|2|||
161212983|NCT00830063|582164324|FG000|Overall Study|Randomized But Not Treated|0|||
161212984|NCT00830063|582164325|FG001|Overall Study|Randomized But Not Treated|2|||
161212985|NCT00830063|582164326|FG002|Overall Study|Randomized But Not Treated|0|||
161212986|NCT00830063|582164327|FG003|Overall Study|Randomized But Not Treated|2|||
161212987|NCT01847313|582164330|FG000|Overall Study|Death|0|||
161212988|NCT01847313|582164331|FG001|Overall Study|Death|1|||
161212989|NCT01847313|582164330|FG000|Overall Study|Withdrawal by Subject|0|||
161212990|NCT01847313|582164331|FG001|Overall Study|Withdrawal by Subject|1|||
161212991|NCT00598559|582164332|FG000|Overall Study|Adverse Event|11|||
161212992|NCT00598559|582164333|FG001|Overall Study|Adverse Event|7|||
161212993|NCT00598559|582164334|FG002|Overall Study|Adverse Event|0|||
161212994|NCT00598559|582164332|FG000|Overall Study|Withdrawal by Subject|2|||
161212995|NCT00598559|582164333|FG001|Overall Study|Withdrawal by Subject|2|||
161212996|NCT00598559|582164334|FG002|Overall Study|Withdrawal by Subject|0|||
161212997|NCT00598559|582164332|FG000|Overall Study|Protocol Non-compliance|1|||
161212998|NCT00598559|582164333|FG001|Overall Study|Protocol Non-compliance|0|||
161212999|NCT00598559|582164334|FG002|Overall Study|Protocol Non-compliance|0|||
161213000|NCT00598559|582164332|FG000|Overall Study|Early discharge from hospital|9|||
161213001|NCT00598559|582164333|FG001|Overall Study|Early discharge from hospital|12|||
161213002|NCT00598559|582164334|FG002|Overall Study|Early discharge from hospital|3|||
161213003|NCT00598559|582164332|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
161213004|NCT00598559|582164333|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
161213005|NCT00598559|582164334|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
161213006|NCT01059071|582164335|FG000|Overall Study|Lack of Efficacy|1|||
161213007|NCT01059071|582164336|FG001|Overall Study|Lack of Efficacy|4|||
161213008|NCT01059071|582164337|FG002|Overall Study|Lack of Efficacy|2|||
161213009|NCT01059071|582164338|FG003|Overall Study|Lack of Efficacy|3|||
161213010|NCT01059071|582164335|FG000|Overall Study|Withdrawal by Subject|1|||
161213011|NCT01059071|582164336|FG001|Overall Study|Withdrawal by Subject|0|||
161213012|NCT01059071|582164337|FG002|Overall Study|Withdrawal by Subject|0|||
161213013|NCT01059071|582164338|FG003|Overall Study|Withdrawal by Subject|2|||
161213014|NCT01059071|582164335|FG000|Overall Study|Physician Decision|0|||
161213015|NCT01059071|582164336|FG001|Overall Study|Physician Decision|0|||
161213016|NCT01059071|582164337|FG002|Overall Study|Physician Decision|0|||
161213017|NCT01059071|582164338|FG003|Overall Study|Physician Decision|1|||
161213018|NCT02962882|582164339|FG000|Overall Study|Adverse Event|2|||
161213019|NCT02962882|582164339|FG000|Overall Study|Withdrawal by Subject|2|||
161213020|NCT02962882|582164339|FG000|Overall Study|Transfer from ICU|32|||
161213021|NCT03763331|582164342|FG000|Overall Study|Lost to Follow-up|1|||
161213022|NCT03763331|582164343|FG001|Overall Study|Lost to Follow-up|0|||
161213023|NCT03763331|582164342|FG000|Overall Study|Withdrawal by Subject|1|||
161213024|NCT03763331|582164343|FG001|Overall Study|Withdrawal by Subject|0|||
161213025|NCT03763331|582164342|FG000|Overall Study|Non-compliance|0|||
161213026|NCT03763331|582164343|FG001|Overall Study|Non-compliance|3|||
161213027|NCT00936884|582164344|FG000|Double-blind|Withdrawal by Subject|6|||
161213028|NCT00936884|582164345|FG001|Double-blind|Withdrawal by Subject|4|||
161213029|NCT00936884|582164346|FG002|Double-blind|Withdrawal by Subject|0|||
161213030|NCT00936884|582164344|FG000|Double-blind|Death|2|||
161213031|NCT00936884|582164345|FG001|Double-blind|Death|1|||
161213032|NCT00936884|582164346|FG002|Double-blind|Death|0|||
161213033|NCT00936884|582164344|FG000|Double-blind|Lack of Efficacy|1|||
161213034|NCT00936884|582164345|FG001|Double-blind|Lack of Efficacy|1|||
161213035|NCT00936884|582164346|FG002|Double-blind|Lack of Efficacy|0|||
161213036|NCT00936884|582164344|FG000|Double-blind|Adverse Event|1|||
161213037|NCT00936884|582164345|FG001|Double-blind|Adverse Event|0|||
161213038|NCT00936884|582164346|FG002|Double-blind|Adverse Event|0|||
161213039|NCT00936884|582164344|FG000|Double-blind|Physician Decision|1|||
161213040|NCT00936884|582164345|FG001|Double-blind|Physician Decision|0|||
161213041|NCT00936884|582164346|FG002|Double-blind|Physician Decision|0|||
161213042|NCT00936884|582164344|FG000|Double-blind|No post baseline diary entry|1|||
161213043|NCT00936884|582164345|FG001|Double-blind|No post baseline diary entry|0|||
161213044|NCT00936884|582164346|FG002|Double-blind|No post baseline diary entry|0|||
161213045|NCT00936884|582164344|FG000|Double-blind|Did not receive study drug|0|||
161213046|NCT00936884|582164345|FG001|Double-blind|Did not receive study drug|1|||
161213047|NCT00936884|582164346|FG002|Double-blind|Did not receive study drug|0|||
161213048|NCT04741503|582164347|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
161213049|NCT04741503|582164348|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
161213050|NCT04741503|582164349|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
161213051|NCT04741503|582164347|FG000|Initial Enrollment|Overquotas removed|0|||
161213052|NCT04741503|582164348|FG001|Initial Enrollment|Overquotas removed|0|||
161213053|NCT04741503|582164349|FG002|Initial Enrollment|Overquotas removed|186|||
161213054|NCT04741503|582164347|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
161213055|NCT04741503|582164348|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
161213056|NCT04741503|582164349|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
161213057|NCT00597584|582164352|FG000|Overall Study|Adverse Event|4|||
161213058|NCT00597584|582164353|FG001|Overall Study|Adverse Event|2|||
161213059|NCT00597584|582164352|FG000|Overall Study|Death|53|||
161213060|NCT00597584|582164353|FG001|Overall Study|Death|30|||
161213061|NCT00597584|582164352|FG000|Overall Study|Lack of Efficacy|1|||
161213062|NCT00597584|582164353|FG001|Overall Study|Lack of Efficacy|0|||
161213063|NCT00597584|582164352|FG000|Overall Study|Lost to Follow-up|2|||
161213064|NCT00597584|582164353|FG001|Overall Study|Lost to Follow-up|4|||
161213065|NCT00597584|582164352|FG000|Overall Study|Physician Decision|3|||
161213066|NCT00597584|582164353|FG001|Overall Study|Physician Decision|0|||
161213067|NCT00597584|582164352|FG000|Overall Study|Pregnancy|2|||
161213068|NCT00597584|582164353|FG001|Overall Study|Pregnancy|0|||
161213069|NCT00597584|582164352|FG000|Overall Study|Withdrawal by Subject|44|||
161213070|NCT00597584|582164353|FG001|Overall Study|Withdrawal by Subject|12|||
161213071|NCT00597584|582164352|FG000|Overall Study|Discontinued Dialysis|0|||
161213072|NCT00597584|582164353|FG001|Overall Study|Discontinued Dialysis|1|||
161213073|NCT00597584|582164352|FG000|Overall Study|Lost ability to consent|1|||
161213074|NCT00597584|582164353|FG001|Overall Study|Lost ability to consent|1|||
161213075|NCT00597584|582164352|FG000|Overall Study|Never dosed|1|||
161213076|NCT00597584|582164353|FG001|Overall Study|Never dosed|0|||
161213077|NCT00597584|582164352|FG000|Overall Study|Relocation|8|||
161213078|NCT00597584|582164353|FG001|Overall Study|Relocation|6|||
161213079|NCT00597584|582164352|FG000|Overall Study|Renal transplant|9|||
161213080|NCT00597584|582164353|FG001|Overall Study|Renal transplant|7|||
161213081|NCT02280421|582164354|FG000|Washout (2 Weeks)|Adverse Event|0|||
161213082|NCT02280421|582164355|FG001|Washout (2 Weeks)|Adverse Event|1|||
161213083|NCT02280421|582164354|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161213084|NCT02280421|582164355|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
161213085|NCT02791659|582164361|FG000|Overall Study|Protocol Violation|0|||
161213086|NCT02791659|582164362|FG001|Overall Study|Protocol Violation|1|||
161213087|NCT00881959|582164363|FG000|Overall Study|Lost to Follow-up|2|||
161213088|NCT00881959|582164364|FG001|Overall Study|Lost to Follow-up|4|||
161213089|NCT03840811|582164365|FG000|Overall Study|Lost to Follow-up|0|||
161213090|NCT03840811|582164366|FG001|Overall Study|Lost to Follow-up|0|||
161213091|NCT03840811|582164367|FG002|Overall Study|Lost to Follow-up|1|||
161213092|NCT01904383|582164368|FG000|Overall Study|CRF not collected|117|||
161213093|NCT01904383|582164368|FG000|Overall Study|Reason not listed|147|||
161213094|NCT01904383|582164368|FG000|Overall Study|Lost to Follow-up|674|||
161213095|NCT01904383|582164368|FG000|Overall Study|Lack of Efficacy|370|||
161213096|NCT01904383|582164368|FG000|Overall Study|Improvement|141|||
161213097|NCT01904383|582164368|FG000|Overall Study|Adverse Event|271|||
161213098|NCT01904383|582164368|FG000|Overall Study|No patient visit after entry|54|||
161213099|NCT04313283|582164371|FG000|Overall Study|did not complete intervention|4|||
161213100|NCT04126733|582164372|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
161213101|NCT04126733|582164372|FG000|Treatment Period|Adverse Event|8|||
161213102|NCT04126733|582164372|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
161213103|NCT04126733|582164372|FG000|Treatment Period|Physician Decision|5|||
161213104|NCT04126733|582164372|FG000|Treatment Period|Death|1|||
161213105|NCT04126733|582164372|FG000|Treatment Period|Other Reasons|2|||
161213106|NCT04126733|582164372|FG000|Active Follow-up Period|Death|13|||
161213107|NCT04126733|582164372|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
161213108|NCT04126733|582164372|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
161213109|NCT04126733|582164372|FG000|Active Follow-up Period|Other Reasons|1|||
161213110|NCT04126733|582164372|FG000|Long-term Follow-up Period|Death|22|||
161213111|NCT04126733|582164372|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
161213112|NCT04126733|582164372|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
161213113|NCT02059187|582164377|FG000|Overall Study|Adverse Event|0|||
161213114|NCT02059187|582164378|FG001|Overall Study|Adverse Event|3|||
161213115|NCT02059187|582164377|FG000|Overall Study|Death|1|||
161213116|NCT02059187|582164378|FG001|Overall Study|Death|1|||
161213117|NCT02059187|582164377|FG000|Overall Study|Lost to Follow-up|9|||
161213118|NCT02059187|582164378|FG001|Overall Study|Lost to Follow-up|8|||
161213119|NCT02059187|582164377|FG000|Overall Study|Non-compliance with study drug|1|||
161213120|NCT02059187|582164378|FG001|Overall Study|Non-compliance with study drug|0|||
161213121|NCT02059187|582164377|FG000|Overall Study|Physician Decision|1|||
161213122|NCT02059187|582164378|FG001|Overall Study|Physician Decision|2|||
161213123|NCT02059187|582164377|FG000|Overall Study|Protocol Violation|1|||
161213124|NCT02059187|582164378|FG001|Overall Study|Protocol Violation|0|||
161213125|NCT02059187|582164377|FG000|Overall Study|Withdrawal by Subject|12|||
161213126|NCT02059187|582164378|FG001|Overall Study|Withdrawal by Subject|8|||
161213127|NCT01889862|582164379|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
161213128|NCT01889862|582164380|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161213129|NCT01889862|582164381|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161213130|NCT01889862|582164382|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161213131|NCT01889862|582164383|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
161213132|NCT01889862|582164379|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
161213133|NCT01889862|582164380|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161213134|NCT01889862|582164381|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161213135|NCT01889862|582164382|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161213136|NCT01889862|582164383|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
161213137|NCT01889862|582164379|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
161213138|NCT01889862|582164380|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161213139|NCT01889862|582164381|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161213140|NCT01889862|582164382|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161213141|NCT01889862|582164383|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
161213142|NCT01889862|582164379|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
161213143|NCT01889862|582164380|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161213144|NCT01889862|582164381|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161213145|NCT01889862|582164382|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161213146|NCT01889862|582164383|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
161213147|NCT01889862|582164379|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161213148|NCT01889862|582164380|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161213149|NCT01889862|582164381|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
161213150|NCT01889862|582164382|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161213151|NCT01889862|582164383|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
161213152|NCT01889862|582164379|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161213153|NCT01889862|582164380|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161213154|NCT01889862|582164381|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161213155|NCT01889862|582164382|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
161213156|NCT01889862|582164383|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
161213157|NCT01889862|582164379|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161213158|NCT01889862|582164380|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161213159|NCT01889862|582164381|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161213160|NCT01889862|582164382|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
161213161|NCT01889862|582164383|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
161213162|NCT01889862|582164379|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161213163|NCT01889862|582164380|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161213164|NCT01889862|582164381|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161213165|NCT01889862|582164382|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
161213166|NCT01889862|582164383|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
161213167|NCT01889862|582164379|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161213168|NCT01889862|582164380|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161213169|NCT01889862|582164381|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161213170|NCT01889862|582164382|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
161213171|NCT01889862|582164383|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
161213172|NCT01889862|582164379|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161213173|NCT01889862|582164380|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161213174|NCT01889862|582164381|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161213175|NCT01889862|582164382|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
161213176|NCT01889862|582164383|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
161213177|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
161213178|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161213179|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
161213180|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161213181|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161213182|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161213183|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
161213184|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
161213185|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
161213186|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
161213187|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
161213188|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
161213189|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
161213190|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161213191|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
161213192|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
161213193|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161213194|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161213195|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
161213196|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
161213197|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
161213198|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
161213199|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
161213200|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
161213201|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161213202|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161213203|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
161213204|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
161213205|NCT00528879|582164384|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
161213206|NCT00528879|582164385|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
161213207|NCT00528879|582164386|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
161213208|NCT00528879|582164387|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
161213209|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
161213210|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
161213211|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
161213212|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
161213213|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
161213214|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
161213215|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
161213216|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
161213217|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
161213218|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
161213219|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
161213220|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
161213221|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
161213222|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
161213223|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
161213224|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
161213225|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
161213226|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
161213227|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
161213228|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
161213229|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
161213230|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
161213231|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
161213232|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
161213233|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
161213234|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161213235|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161213236|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
161213237|NCT00528879|582164384|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161213238|NCT00528879|582164385|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161213239|NCT00528879|582164386|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
161213240|NCT00528879|582164387|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
161213241|NCT01159769|582164388|FG000|Overall Study|Adverse Event|1|||
161213242|NCT01507831|582164389|FG000|Overall Study|Randomized but not treated|0|||
161213243|NCT01507831|582164390|FG001|Overall Study|Randomized but not treated|3|||
161213244|NCT01507831|582164389|FG000|Overall Study|Adverse Event|48|||
161213245|NCT01507831|582164390|FG001|Overall Study|Adverse Event|113|||
161213246|NCT01507831|582164389|FG000|Overall Study|Death|6|||
161213247|NCT01507831|582164390|FG001|Overall Study|Death|2|||
161213248|NCT01507831|582164389|FG000|Overall Study|Poor compliance to protocol|38|||
161213249|NCT01507831|582164390|FG001|Overall Study|Poor compliance to protocol|60|||
161213250|NCT01507831|582164389|FG000|Overall Study|Physician Decision|0|||
161213251|NCT01507831|582164390|FG001|Overall Study|Physician Decision|4|||
161213252|NCT01507831|582164389|FG000|Overall Study|Participant moved|5|||
161213253|NCT01507831|582164390|FG001|Overall Study|Participant moved|19|||
161213254|NCT01507831|582164389|FG000|Overall Study|Consent withdrawn by participant|34|||
161213255|NCT01507831|582164390|FG001|Overall Study|Consent withdrawn by participant|72|||
161213256|NCT01507831|582164389|FG000|Overall Study|Related to study drug administration|5|||
161213257|NCT01507831|582164390|FG001|Overall Study|Related to study drug administration|14|||
161213258|NCT01507831|582164389|FG000|Overall Study|Last visit outside protocol visit window|51|||
161213259|NCT01507831|582164390|FG001|Overall Study|Last visit outside protocol visit window|143|||
161213260|NCT01507831|582164389|FG000|Overall Study|Selection criteria finally not met|0|||
161213261|NCT01507831|582164390|FG001|Overall Study|Selection criteria finally not met|1|||
161213262|NCT01507831|582164389|FG000|Overall Study|Site closure|0|||
161213263|NCT01507831|582164390|FG001|Overall Study|Site closure|3|||
161213264|NCT01507831|582164389|FG000|Overall Study|Potential lost to follow-up|3|||
161213265|NCT01507831|582164390|FG001|Overall Study|Potential lost to follow-up|0|||
161213266|NCT01507831|582164389|FG000|Overall Study|Other|3|||
161213267|NCT01507831|582164390|FG001|Overall Study|Other|6|||
161213268|NCT03652961|582164393|FG000|Overall Study|Lost to Follow-up|3|||
161213269|NCT03652961|582164393|FG000|Overall Study|Screen Failure|1|||
161213270|NCT01953783|582164396|FG000|Overall Study|Progressive disease|2|||
161213271|NCT01280981|582164397|FG000|Overall Study|Withdrawal by Subject|11|||
161213272|NCT01280981|582164397|FG000|Overall Study|Protocol Violation|2|||
161213273|NCT01280981|582164397|FG000|Overall Study|Lack of Efficacy|13|||
161213274|NCT01280981|582164397|FG000|Overall Study|Lost to Follow-up|3|||
161213275|NCT01280981|582164397|FG000|Overall Study|Adverse Event|6|||
161213276|NCT01280981|582164397|FG000|Overall Study|Irregular or discontinued menses|3|||
161213277|NCT01280981|582164397|FG000|Overall Study|Failed to return|45|||
161213278|NCT01280981|582164397|FG000|Overall Study|Non-compliance with protocol|3|||
161213279|NCT01280981|582164397|FG000|Overall Study|Withdrawal of consent|3|||
160861858|NCT02531802|580887854|FG009|Received Vaccination 2|Adverse Event|0|||
161213280|NCT01280981|582164397|FG000|Overall Study|Elective surgery|2|||
161213281|NCT01280981|582164397|FG000|Overall Study|Study site closure|1|||
161213282|NCT01252238|582164400|FG000|Overall Study|Sponsor terminated study|4|||
161213283|NCT01252238|582164401|FG001|Overall Study|Sponsor terminated study|4|||
161213284|NCT01252238|582164402|FG002|Overall Study|Sponsor terminated study|4|||
161213285|NCT01610167|582164403|FG000|Overall Study|Scheduling conflict.|0|||
161213286|NCT01610167|582164404|FG001|Overall Study|Scheduling conflict.|0|||
161213287|NCT01610167|582164405|FG002|Overall Study|Scheduling conflict.|2|||
161213288|NCT03276962|582164410|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
161213289|NCT03276962|582164411|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
161213290|NCT03276962|582164412|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
161213291|NCT03276962|582164413|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
161213292|NCT03276962|582164414|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
161213293|NCT03276962|582164410|FG000|Overall Study|Protocol Deviation|2|||
161213294|NCT03276962|582164411|FG001|Overall Study|Protocol Deviation|0|||
161213295|NCT03276962|582164412|FG002|Overall Study|Protocol Deviation|1|||
161213296|NCT03276962|582164413|FG003|Overall Study|Protocol Deviation|2|||
161213297|NCT03276962|582164414|FG004|Overall Study|Protocol Deviation|1|||
161213298|NCT03276962|582164410|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
161213299|NCT03276962|582164411|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161213300|NCT03276962|582164412|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
161213301|NCT03276962|582164413|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161213302|NCT03276962|582164414|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
161213303|NCT03276962|582164410|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
161213304|NCT03276962|582164411|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
161213305|NCT03276962|582164412|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
161213306|NCT03276962|582164413|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
161213307|NCT03276962|582164414|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
161213308|NCT03276962|582164410|FG000|Overall Study|Lost to Follow-up|10|||
161213309|NCT03276962|582164411|FG001|Overall Study|Lost to Follow-up|10|||
161213310|NCT03276962|582164412|FG002|Overall Study|Lost to Follow-up|4|||
161213311|NCT03276962|582164413|FG003|Overall Study|Lost to Follow-up|6|||
161213312|NCT03276962|582164414|FG004|Overall Study|Lost to Follow-up|10|||
161213313|NCT03276962|582164410|FG000|Overall Study|Other|0|||
161213314|NCT03276962|582164411|FG001|Overall Study|Other|2|||
161213315|NCT03276962|582164412|FG002|Overall Study|Other|0|||
161213316|NCT03276962|582164413|FG003|Overall Study|Other|2|||
161213317|NCT03276962|582164414|FG004|Overall Study|Other|1|||
161213318|NCT01358708|582164415|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161213319|NCT01358708|582164416|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161213320|NCT01358708|582164415|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161213321|NCT01358708|582164416|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
161213322|NCT03056001|582164420|FG000|Overall Study|Death|24|||
161213323|NCT01364298|582164421|FG000|Overall Study|Adverse Event|3|||
161213324|NCT01364298|582164422|FG001|Overall Study|Adverse Event|4|||
161213325|NCT01364298|582164421|FG000|Overall Study|Lack of adherence to treatment|1|||
161213326|NCT01364298|582164422|FG001|Overall Study|Lack of adherence to treatment|3|||
161213327|NCT01364298|582164421|FG000|Overall Study|Lack of Efficacy|1|||
161213328|NCT01364298|582164422|FG001|Overall Study|Lack of Efficacy|0|||
161213329|NCT01364298|582164421|FG000|Overall Study|Lost to Follow-up|5|||
161213330|NCT01364298|582164422|FG001|Overall Study|Lost to Follow-up|10|||
161213331|NCT01364298|582164421|FG000|Overall Study|Withdrawal by Subject|3|||
161213332|NCT01364298|582164422|FG001|Overall Study|Withdrawal by Subject|3|||
161213333|NCT01364298|582164421|FG000|Overall Study|Other|1|||
161213334|NCT01364298|582164422|FG001|Overall Study|Other|3|||
161213335|NCT03712228|582164423|FG000|Treatment Period 1|Lack of Efficacy|0|||
161213336|NCT03712228|582164424|FG001|Treatment Period 1|Lack of Efficacy|0|||
161213337|NCT03712228|582164425|FG002|Treatment Period 1|Lack of Efficacy|0|||
161213338|NCT03712228|582164426|FG003|Treatment Period 1|Lack of Efficacy|0|||
161213339|NCT03712228|582164427|FG004|Treatment Period 1|Lack of Efficacy|0|||
161213340|NCT03712228|582164428|FG005|Treatment Period 1|Lack of Efficacy|1|||
161213341|NCT03712228|582164423|FG000|Treatment Period 2|Pregnancy|0|||
161213342|NCT03712228|582164424|FG001|Treatment Period 2|Pregnancy|0|||
161213343|NCT03712228|582164425|FG002|Treatment Period 2|Pregnancy|0|||
161213344|NCT03712228|582164426|FG003|Treatment Period 2|Pregnancy|1|||
161213345|NCT03712228|582164427|FG004|Treatment Period 2|Pregnancy|0|||
161213346|NCT03712228|582164428|FG005|Treatment Period 2|Pregnancy|0|||
161213347|NCT03712228|582164423|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161213348|NCT03712228|582164424|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161213349|NCT03712228|582164425|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161213350|NCT03712228|582164426|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161213351|NCT03712228|582164427|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161213352|NCT03712228|582164428|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161213353|NCT01964105|582164429|FG000|Overall Study|Lost to Follow-up|2|||
161213354|NCT01964105|582164430|FG001|Overall Study|Lost to Follow-up|13|||
161213355|NCT01964105|582164431|FG002|Overall Study|Lost to Follow-up|0|||
161213356|NCT01254045|582164434|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
161213357|NCT01254045|582164435|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161213358|NCT01254045|582164436|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161213359|NCT01254045|582164437|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161213360|NCT01254045|582164438|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161213361|NCT01254045|582164439|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
161213362|NCT00597207|582164440|FG000|Overall Study|Lost to Follow-up|5|||
161213363|NCT00597207|582164441|FG001|Overall Study|Lost to Follow-up|7|||
161213364|NCT00520351|582164442|FG000|First Intervention|Withdrawal by Subject|1|||
161213365|NCT00520351|582164443|FG001|First Intervention|Withdrawal by Subject|1|||
161213366|NCT04288115|582164449|FG000|Overall Study|Withdrawal by Subject|0|||
161213367|NCT04288115|582164450|FG001|Overall Study|Withdrawal by Subject|1|||
161213368|NCT04288115|582164449|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
161213369|NCT04288115|582164450|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
161213370|NCT03499249|582164458|FG000|Overall Study|Physician Decision|1|||
161213371|NCT01374906|582164459|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161213372|NCT01374906|582164460|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161213373|NCT01374906|582164459|FG000|Overall Study|Administrative problems|2|||
161213374|NCT01374906|582164460|FG001|Overall Study|Administrative problems|2|||
161213375|NCT01374906|582164459|FG000|Overall Study|Adverse Event|10|||
161213376|NCT01374906|582164460|FG001|Overall Study|Adverse Event|11|||
161213377|NCT01374906|582164459|FG000|Overall Study|Death|0|||
161213378|NCT01374906|582164460|FG001|Overall Study|Death|2|||
161213379|NCT01374906|582164459|FG000|Overall Study|Protocol Violation|2|||
161213380|NCT01374906|582164460|FG001|Overall Study|Protocol Violation|2|||
161213381|NCT01374906|582164459|FG000|Overall Study|Withdrawal by Subject|15|||
161213382|NCT01374906|582164460|FG001|Overall Study|Withdrawal by Subject|9|||
161213383|NCT01374906|582164459|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
161213384|NCT01374906|582164460|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
161213385|NCT02475980|582164463|FG000|Overall Study|Lost to Follow-up|4|||
161213386|NCT02475980|582164463|FG000|Overall Study|Withdrawal by Subject|1|||
161213387|NCT00435825|582164469|FG000|Overall Study|Abnormality of Laboratory Test|0|||
161213388|NCT00435825|582164470|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161213389|NCT00435825|582164471|FG002|Overall Study|Abnormality of Laboratory Test|0|||
161213390|NCT00435825|582164472|FG003|Overall Study|Abnormality of Laboratory Test|0|||
161213391|NCT00435825|582164469|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161213392|NCT00435825|582164470|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161213393|NCT00435825|582164471|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161213394|NCT00435825|582164472|FG003|Overall Study|Insufficient Therapeutic Response|3|||
161213395|NCT00435825|582164469|FG000|Overall Study|Other Protocol Violation|1|||
161213396|NCT00435825|582164470|FG001|Overall Study|Other Protocol Violation|0|||
161213397|NCT00435825|582164471|FG002|Overall Study|Other Protocol Violation|0|||
161213398|NCT00435825|582164472|FG003|Overall Study|Other Protocol Violation|0|||
161213399|NCT00435825|582164469|FG000|Overall Study|Refused treatment|2|||
161213400|NCT00435825|582164470|FG001|Overall Study|Refused treatment|0|||
161213401|NCT00435825|582164471|FG002|Overall Study|Refused treatment|0|||
161213402|NCT00435825|582164472|FG003|Overall Study|Refused treatment|5|||
161213403|NCT00435825|582164469|FG000|Overall Study|Failure to return|5|||
161213404|NCT00435825|582164470|FG001|Overall Study|Failure to return|0|||
161213405|NCT00435825|582164471|FG002|Overall Study|Failure to return|4|||
161213406|NCT00435825|582164472|FG003|Overall Study|Failure to return|0|||
161213407|NCT00435825|582164469|FG000|Overall Study|Did not receive study drug|1|||
161213408|NCT00435825|582164470|FG001|Overall Study|Did not receive study drug|0|||
161213409|NCT00435825|582164471|FG002|Overall Study|Did not receive study drug|2|||
161213410|NCT00435825|582164472|FG003|Overall Study|Did not receive study drug|0|||
161213411|NCT00435825|582164469|FG000|Overall Study|Did not enter follow-up|0|||
161213412|NCT00435825|582164470|FG001|Overall Study|Did not enter follow-up|4|||
161213413|NCT00435825|582164471|FG002|Overall Study|Did not enter follow-up|1|||
161213414|NCT00435825|582164472|FG003|Overall Study|Did not enter follow-up|3|||
161213415|NCT00435825|582164469|FG000|Overall Study|Did not complete full follow-up period|6|||
161213416|NCT00435825|582164470|FG001|Overall Study|Did not complete full follow-up period|6|||
161213417|NCT00435825|582164471|FG002|Overall Study|Did not complete full follow-up period|4|||
161213418|NCT00435825|582164472|FG003|Overall Study|Did not complete full follow-up period|5|||
161213419|NCT03033069|582164473|FG000|Overall Study|Adverse Event|6|||
161213420|NCT03033069|582164474|FG001|Overall Study|Adverse Event|7|||
161213421|NCT03033069|582164475|FG002|Overall Study|Adverse Event|4|||
161213422|NCT03033069|582164476|FG003|Overall Study|Adverse Event|6|||
161213423|NCT03033069|582164473|FG000|Overall Study|Lack of Efficacy|0|||
161213424|NCT03033069|582164474|FG001|Overall Study|Lack of Efficacy|0|||
161213425|NCT03033069|582164475|FG002|Overall Study|Lack of Efficacy|1|||
161213426|NCT03033069|582164476|FG003|Overall Study|Lack of Efficacy|0|||
161213427|NCT03033069|582164473|FG000|Overall Study|Lost to Follow-up|6|||
161213428|NCT03033069|582164474|FG001|Overall Study|Lost to Follow-up|5|||
161213429|NCT03033069|582164475|FG002|Overall Study|Lost to Follow-up|5|||
161213430|NCT03033069|582164476|FG003|Overall Study|Lost to Follow-up|6|||
161213431|NCT03033069|582164473|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161213432|NCT03033069|582164474|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161213433|NCT03033069|582164475|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161324209|NCT02959918|582573546|FG011|Overall Study|Withdrawal by Subject|3|||
161324210|NCT02959918|582573547|FG012|Overall Study|Withdrawal by Subject|1|||
161324211|NCT02959918|582573548|FG013|Overall Study|Withdrawal by Subject|1|||
161324212|NCT02959918|582573535|FG000|Overall Study|Protocol Violation|0|||
161324213|NCT02959918|582573536|FG001|Overall Study|Protocol Violation|0|||
161324214|NCT02959918|582573537|FG002|Overall Study|Protocol Violation|1|||
161324215|NCT02959918|582573538|FG003|Overall Study|Protocol Violation|0|||
161324216|NCT02959918|582573539|FG004|Overall Study|Protocol Violation|0|||
161324217|NCT02959918|582573540|FG005|Overall Study|Protocol Violation|1|||
161324218|NCT02959918|582573541|FG006|Overall Study|Protocol Violation|0|||
161324219|NCT02959918|582573542|FG007|Overall Study|Protocol Violation|0|||
161324220|NCT02959918|582573543|FG008|Overall Study|Protocol Violation|2|||
161324221|NCT02959918|582573544|FG009|Overall Study|Protocol Violation|1|||
161324222|NCT02959918|582573545|FG010|Overall Study|Protocol Violation|0|||
161324223|NCT02959918|582573546|FG011|Overall Study|Protocol Violation|1|||
161324224|NCT02959918|582573547|FG012|Overall Study|Protocol Violation|1|||
161324225|NCT02959918|582573548|FG013|Overall Study|Protocol Violation|0|||
161324226|NCT02959918|582573535|FG000|Overall Study|Stopping Rule Met|1|||
161324227|NCT02959918|582573536|FG001|Overall Study|Stopping Rule Met|0|||
161324228|NCT02959918|582573537|FG002|Overall Study|Stopping Rule Met|3|||
161324229|NCT02959918|582573538|FG003|Overall Study|Stopping Rule Met|4|||
161324230|NCT02959918|582573539|FG004|Overall Study|Stopping Rule Met|5|||
161324231|NCT02959918|582573540|FG005|Overall Study|Stopping Rule Met|3|||
161324232|NCT02959918|582573541|FG006|Overall Study|Stopping Rule Met|2|||
161324233|NCT02959918|582573542|FG007|Overall Study|Stopping Rule Met|4|||
161324234|NCT02959918|582573543|FG008|Overall Study|Stopping Rule Met|1|||
161324235|NCT02959918|582573544|FG009|Overall Study|Stopping Rule Met|1|||
161324236|NCT02959918|582573545|FG010|Overall Study|Stopping Rule Met|3|||
161324237|NCT02959918|582573546|FG011|Overall Study|Stopping Rule Met|5|||
161324238|NCT02959918|582573547|FG012|Overall Study|Stopping Rule Met|2|||
161324239|NCT02959918|582573548|FG013|Overall Study|Stopping Rule Met|1|||
161324240|NCT02959918|582573535|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
161324241|NCT02959918|582573536|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
161324242|NCT02959918|582573537|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
161324243|NCT02959918|582573538|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
161324244|NCT02959918|582573539|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324245|NCT02959918|582573540|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324246|NCT02959918|582573541|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324247|NCT02959918|582573542|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324248|NCT02959918|582573543|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324249|NCT02959918|582573544|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324250|NCT02959918|582573545|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324251|NCT02959918|582573546|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324252|NCT02959918|582573547|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324253|NCT02959918|582573548|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
161324254|NCT02959918|582573535|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324255|NCT02959918|582573536|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324256|NCT02959918|582573537|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324257|NCT02959918|582573538|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324258|NCT02959918|582573539|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324259|NCT02959918|582573540|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324260|NCT02959918|582573541|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324261|NCT02959918|582573542|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
161324262|NCT02959918|582573543|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324263|NCT02959918|582573544|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324264|NCT02959918|582573545|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324265|NCT02959918|582573546|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324266|NCT02959918|582573547|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324267|NCT02959918|582573548|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
161324268|NCT02959918|582573535|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324269|NCT02959918|582573536|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324270|NCT02959918|582573537|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324271|NCT02959918|582573538|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324272|NCT02959918|582573539|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324273|NCT02959918|582573540|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161213434|NCT03033069|582164476|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161213435|NCT03033069|582164473|FG000|Overall Study|Protocol Deviation|0|||
161213436|NCT03033069|582164474|FG001|Overall Study|Protocol Deviation|1|||
161213437|NCT03033069|582164475|FG002|Overall Study|Protocol Deviation|0|||
161213438|NCT03033069|582164476|FG003|Overall Study|Protocol Deviation|0|||
161213439|NCT03033069|582164473|FG000|Overall Study|Withdrawal by Subject|10|||
161213440|NCT03033069|582164474|FG001|Overall Study|Withdrawal by Subject|10|||
161213441|NCT03033069|582164475|FG002|Overall Study|Withdrawal by Subject|11|||
161213442|NCT03033069|582164476|FG003|Overall Study|Withdrawal by Subject|6|||
161213443|NCT03033069|582164473|FG000|Overall Study|Withdrawal By Caregiver|1|||
161213444|NCT03033069|582164474|FG001|Overall Study|Withdrawal By Caregiver|0|||
161213445|NCT03033069|582164475|FG002|Overall Study|Withdrawal By Caregiver|0|||
161213446|NCT03033069|582164476|FG003|Overall Study|Withdrawal By Caregiver|0|||
161213447|NCT03033069|582164473|FG000|Overall Study|Reason not Specified|0|||
161213448|NCT03033069|582164474|FG001|Overall Study|Reason not Specified|1|||
161213449|NCT03033069|582164475|FG002|Overall Study|Reason not Specified|0|||
161213450|NCT03033069|582164476|FG003|Overall Study|Reason not Specified|1|||
161213451|NCT00430638|582164477|FG000|Overall Study|Adverse Event|15|||
161213452|NCT00430638|582164478|FG001|Overall Study|Adverse Event|15|||
161213453|NCT00430638|582164477|FG000|Overall Study|Uncontrolled blood pressure|48|||
161213454|NCT00430638|582164478|FG001|Overall Study|Uncontrolled blood pressure|13|||
161213455|NCT00430638|582164477|FG000|Overall Study|Lost to Follow-up|1|||
161213456|NCT00430638|582164478|FG001|Overall Study|Lost to Follow-up|7|||
161213457|NCT00430638|582164477|FG000|Overall Study|Protocol Violation|6|||
161213458|NCT00430638|582164478|FG001|Overall Study|Protocol Violation|4|||
161213459|NCT00430638|582164477|FG000|Overall Study|Withdrawal by Subject|4|||
161213460|NCT00430638|582164478|FG001|Overall Study|Withdrawal by Subject|6|||
161213461|NCT00430638|582164477|FG000|Overall Study|Non-compliant|2|||
161213462|NCT00430638|582164478|FG001|Overall Study|Non-compliant|1|||
161213463|NCT00430638|582164477|FG000|Overall Study|Other|2|||
161213464|NCT00430638|582164478|FG001|Overall Study|Other|2|||
161213465|NCT02367781|582164481|FG000|Overall Study|Withdrawal by Subject|20|||
161213466|NCT02367781|582164482|FG001|Overall Study|Withdrawal by Subject|13|||
161213467|NCT02367781|582164481|FG000|Overall Study|Protocol Violation|0|||
161213468|NCT02367781|582164482|FG001|Overall Study|Protocol Violation|1|||
161213469|NCT02367781|582164481|FG000|Overall Study|Physician Decision|7|||
161213470|NCT02367781|582164482|FG001|Overall Study|Physician Decision|0|||
161213471|NCT02367781|582164481|FG000|Overall Study|Randomized in Error|5|||
161213472|NCT02367781|582164482|FG001|Overall Study|Randomized in Error|4|||
161213473|NCT02367781|582164481|FG000|Overall Study|Non-Compliance|1|||
161213474|NCT02367781|582164482|FG001|Overall Study|Non-Compliance|0|||
161213475|NCT02367781|582164481|FG000|Overall Study|Lost to Follow-up|1|||
161213476|NCT02367781|582164482|FG001|Overall Study|Lost to Follow-up|2|||
161213477|NCT02367781|582164481|FG000|Overall Study|Death|330|||
161213478|NCT02367781|582164482|FG001|Overall Study|Death|176|||
161213479|NCT02367781|582164481|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
161213480|NCT02367781|582164482|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
161213481|NCT02367781|582164481|FG000|Overall Study|Prolonged Hospitalization|1|||
161213482|NCT02367781|582164482|FG001|Overall Study|Prolonged Hospitalization|0|||
161213483|NCT02367781|582164481|FG000|Overall Study|Death Prior First Dose|1|||
161213484|NCT02367781|582164482|FG001|Overall Study|Death Prior First Dose|0|||
161213485|NCT02367781|582164481|FG000|Overall Study|Administrative-Change Facility|1|||
161213486|NCT02367781|582164482|FG001|Overall Study|Administrative-Change Facility|0|||
161213487|NCT02367781|582164481|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
161213488|NCT02367781|582164482|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
161213489|NCT02367781|582164481|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
161213490|NCT02367781|582164482|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
161213491|NCT02367781|582164481|FG000|Overall Study|Study Terminated by Sponsor|3|||
161213492|NCT02367781|582164482|FG001|Overall Study|Study Terminated by Sponsor|1|||
161213493|NCT02367781|582164481|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
161213494|NCT02367781|582164482|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
161213495|NCT02367781|582164481|FG000|Overall Study|Sponsor Decision|2|||
161213496|NCT02367781|582164482|FG001|Overall Study|Sponsor Decision|0|||
161213497|NCT02367781|582164481|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
161213498|NCT02367781|582164482|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
161213499|NCT01529749|582164483|FG000|Overall Study|Lost to Follow-up|0|||
161213500|NCT01529749|582164484|FG001|Overall Study|Lost to Follow-up|1|||
161213501|NCT01529749|582164485|FG002|Overall Study|Lost to Follow-up|1|||
161213502|NCT01529749|582164486|FG003|Overall Study|Lost to Follow-up|0|||
161213503|NCT01529749|582164483|FG000|Overall Study|Physician Decision|0|||
161213504|NCT01529749|582164484|FG001|Overall Study|Physician Decision|0|||
161213505|NCT01529749|582164485|FG002|Overall Study|Physician Decision|0|||
161213506|NCT01529749|582164486|FG003|Overall Study|Physician Decision|1|||
161213507|NCT01529749|582164483|FG000|Overall Study|Withdrawal by Subject|0|||
161106967|NCT00915772|581782741|FG002|Overall Study|Any other reason|7|||
161106968|NCT00971178|581782754|FG000|Overall Study|Lost to Follow-up|2|||
161106969|NCT00971178|581782755|FG001|Overall Study|Lost to Follow-up|2|||
161106970|NCT00971178|581782756|FG002|Overall Study|Lost to Follow-up|2|||
161106971|NCT00714285|581782757|FG000|Overall Study|Lost to Follow-up|0|||
161106972|NCT00714285|581782758|FG001|Overall Study|Lost to Follow-up|2|||
161106973|NCT00714285|581782759|FG002|Overall Study|Lost to Follow-up|0|||
161106974|NCT00714285|581782760|FG003|Overall Study|Lost to Follow-up|1|||
161106975|NCT00714285|581782757|FG000|Overall Study|Migrated/moved from study area|0|||
161106976|NCT00714285|581782758|FG001|Overall Study|Migrated/moved from study area|1|||
161106977|NCT00714285|581782759|FG002|Overall Study|Migrated/moved from study area|0|||
161106978|NCT00714285|581782760|FG003|Overall Study|Migrated/moved from study area|0|||
161106979|NCT01231659|581782762|FG000|Overall Study|Adverse Event|9|||
161106980|NCT01231659|581782762|FG000|Overall Study|Disease Progression|48|||
161106981|NCT01231659|581782762|FG000|Overall Study|Death|2|||
161106982|NCT01231659|581782762|FG000|Overall Study|Patient refused to complete study visit|1|||
161106983|NCT01231659|581782762|FG000|Overall Study|Other protocol defined criteria|12|||
161106984|NCT01075412|581782763|FG000|Overall Study|Withdrawal by Subject|0|||
161106985|NCT01075412|581782764|FG001|Overall Study|Withdrawal by Subject|1|||
161106986|NCT00509067|581782765|FG000|Overall Study|Lost to Follow-up|1|||
161106987|NCT00509067|581782766|FG001|Overall Study|Lost to Follow-up|1|||
161106988|NCT00509067|581782765|FG000|Overall Study|Adverse Event|3|||
161106989|NCT00509067|581782766|FG001|Overall Study|Adverse Event|1|||
161106990|NCT00509067|581782765|FG000|Overall Study|Protocol Violation|0|||
161106991|NCT00509067|581782766|FG001|Overall Study|Protocol Violation|3|||
161106992|NCT00702325|581782780|FG000|Overall Study|Adverse Event|1|||
161106993|NCT00702325|581782781|FG001|Overall Study|Adverse Event|0|||
161106994|NCT00702325|581782780|FG000|Overall Study|Withdrawal by Subject|7|||
161106995|NCT00702325|581782781|FG001|Overall Study|Withdrawal by Subject|7|||
161106996|NCT00702325|581782780|FG000|Overall Study|Lost to Follow-up|3|||
161106997|NCT00702325|581782781|FG001|Overall Study|Lost to Follow-up|4|||
161106998|NCT00702325|581782780|FG000|Overall Study|Incorrect enrollment|5|||
161106999|NCT00702325|581782781|FG001|Overall Study|Incorrect enrollment|7|||
161107000|NCT00702325|581782780|FG000|Overall Study|Developed study discontinuation criteria|18|||
161107001|NCT00702325|581782781|FG001|Overall Study|Developed study discontinuation criteria|28|||
161107002|NCT00702325|581782780|FG000|Overall Study|Severe noncompliance to protocol|3|||
161107003|NCT00702325|581782781|FG001|Overall Study|Severe noncompliance to protocol|3|||
161107004|NCT00702325|581782780|FG000|Overall Study|Termination due to lab results|1|||
161107005|NCT00702325|581782781|FG001|Overall Study|Termination due to lab results|0|||
161107006|NCT00702325|581782780|FG000|Overall Study|Didn't follow study medication dosage|0|||
161107007|NCT00702325|581782781|FG001|Overall Study|Didn't follow study medication dosage|2|||
161107008|NCT00702325|581782780|FG000|Overall Study|Withdrew consent|0|||
161107009|NCT00702325|581782781|FG001|Overall Study|Withdrew consent|1|||
161107010|NCT00702325|581782780|FG000|Overall Study|Incorrectly Discontinued|0|||
161107011|NCT00702325|581782781|FG001|Overall Study|Incorrectly Discontinued|1|||
161107012|NCT00117598|581782782|FG000|Prior to Treatment Cross Over|Death|40|||
161107013|NCT00117598|581782783|FG001|Prior to Treatment Cross Over|Death|41|||
161107014|NCT00117598|581782784|FG002|Prior to Treatment Cross Over|Death|37|||
161107015|NCT00117598|581782785|FG003|Prior to Treatment Cross Over|Death|0|||
161107016|NCT00117598|581782786|FG004|Prior to Treatment Cross Over|Death|0|||
161107017|NCT00117598|581782782|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161107018|NCT00117598|581782783|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
161107019|NCT00117598|581782784|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
161107020|NCT00117598|581782785|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161107021|NCT00117598|581782786|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
161107022|NCT00117598|581782782|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
161107023|NCT00117598|581782783|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
161107024|NCT00117598|581782784|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
161107025|NCT00117598|581782785|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
161107026|NCT00117598|581782786|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
161107027|NCT00117598|581782782|FG000|Prior to Treatment Cross Over|Other|15|||
161107028|NCT00117598|581782783|FG001|Prior to Treatment Cross Over|Other|9|||
161107029|NCT00117598|581782784|FG002|Prior to Treatment Cross Over|Other|9|||
161107030|NCT00117598|581782785|FG003|Prior to Treatment Cross Over|Other|0|||
161107031|NCT00117598|581782786|FG004|Prior to Treatment Cross Over|Other|0|||
161107032|NCT00117598|581782782|FG000|After Treament Cross Over|Death|0|||
161107033|NCT00117598|581782783|FG001|After Treament Cross Over|Death|0|||
161107034|NCT00117598|581782784|FG002|After Treament Cross Over|Death|0|||
161107035|NCT00117598|581782785|FG003|After Treament Cross Over|Death|1|||
161107036|NCT00117598|581782786|FG004|After Treament Cross Over|Death|2|||
161107037|NCT00117598|581782782|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
161107038|NCT00117598|581782783|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
161107039|NCT00117598|581782784|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
161107040|NCT00117598|581782785|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
161107041|NCT00117598|581782786|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
161107042|NCT00117598|581782782|FG000|After Treament Cross Over|Other|0|||
161107043|NCT00117598|581782783|FG001|After Treament Cross Over|Other|0|||
161107044|NCT00117598|581782784|FG002|After Treament Cross Over|Other|0|||
161107045|NCT00117598|581782785|FG003|After Treament Cross Over|Other|1|||
161107046|NCT00117598|581782786|FG004|After Treament Cross Over|Other|2|||
161107047|NCT01235793|581782787|FG000|Overall Study|Death|6|||
161107048|NCT03098836|581782788|FG000|Overall Study|Adverse Event|1|||
161107049|NCT03098836|581782789|FG001|Overall Study|Adverse Event|3|||
161107050|NCT03098836|581782788|FG000|Overall Study|Lack of Efficacy|30|||
161107051|NCT03098836|581782789|FG001|Overall Study|Lack of Efficacy|15|||
161107052|NCT03098836|581782788|FG000|Overall Study|Physician Decision|2|||
161107053|NCT03098836|581782789|FG001|Overall Study|Physician Decision|1|||
161107054|NCT03098836|581782788|FG000|Overall Study|Withdrawal by Subject|3|||
161107055|NCT03098836|581782789|FG001|Overall Study|Withdrawal by Subject|2|||
161107056|NCT01660451|581782792|FG000|Overall Study|Protocol Violation|0|||
161107057|NCT01660451|581782793|FG001|Overall Study|Protocol Violation|1|||
161107058|NCT01660451|581782794|FG002|Overall Study|Protocol Violation|1|||
161107059|NCT01660451|581782792|FG000|Overall Study|AE not associated with clinical disease progression|13|||
161107060|NCT01660451|581782793|FG001|Overall Study|AE not associated with clinical disease progression|10|||
161107061|NCT01660451|581782794|FG002|Overall Study|AE not associated with clinical disease progression|40|||
161107062|NCT01660451|581782792|FG000|Overall Study|AE associated with clinical disease progression|1|||
161107063|NCT01660451|581782793|FG001|Overall Study|AE associated with clinical disease progression|3|||
161107064|NCT01660451|581782794|FG002|Overall Study|AE associated with clinical disease progression|11|||
161107065|NCT01660451|581782792|FG000|Overall Study|Sponsor Decision|0|||
161107066|NCT01660451|581782793|FG001|Overall Study|Sponsor Decision|0|||
161107067|NCT01660451|581782794|FG002|Overall Study|Sponsor Decision|1|||
161107068|NCT01660451|581782792|FG000|Overall Study|Protocol Deviation|0|||
161107069|NCT01660451|581782793|FG001|Overall Study|Protocol Deviation|0|||
161107070|NCT01660451|581782794|FG002|Overall Study|Protocol Deviation|1|||
161107071|NCT01660451|581782792|FG000|Overall Study|Physician Decision|1|||
161107072|NCT01660451|581782793|FG001|Overall Study|Physician Decision|2|||
161107073|NCT01660451|581782794|FG002|Overall Study|Physician Decision|5|||
161107074|NCT01660451|581782792|FG000|Overall Study|Withdrawal by Subject|1|||
161107075|NCT01660451|581782793|FG001|Overall Study|Withdrawal by Subject|1|||
161107076|NCT01660451|581782794|FG002|Overall Study|Withdrawal by Subject|20|||
161107077|NCT01660451|581782792|FG000|Overall Study|Trial closure.|0|||
161107078|NCT01660451|581782793|FG001|Overall Study|Trial closure.|0|||
161107079|NCT01660451|581782794|FG002|Overall Study|Trial closure.|1|||
161107080|NCT01660451|581782792|FG000|Overall Study|Switching to other therapy|0|||
161107081|NCT01660451|581782793|FG001|Overall Study|Switching to other therapy|1|||
161107082|NCT01660451|581782794|FG002|Overall Study|Switching to other therapy|1|||
161107083|NCT01660451|581782792|FG000|Overall Study|Progressive disease - clinical progression|4|||
161107084|NCT01660451|581782793|FG001|Overall Study|Progressive disease - clinical progression|10|||
161107085|NCT01660451|581782794|FG002|Overall Study|Progressive disease - clinical progression|9|||
161107086|NCT01660451|581782792|FG000|Overall Study|Progressive disease - radiological progression|12|||
161107087|NCT01660451|581782793|FG001|Overall Study|Progressive disease - radiological progression|23|||
161107088|NCT01660451|581782794|FG002|Overall Study|Progressive disease - radiological progression|50|||
161107089|NCT01660451|581782792|FG000|Overall Study|Death|1|||
161107090|NCT01660451|581782793|FG001|Overall Study|Death|0|||
161107091|NCT01660451|581782794|FG002|Overall Study|Death|1|||
161107092|NCT01660451|581782792|FG000|Overall Study|Other|0|||
161107093|NCT01660451|581782793|FG001|Overall Study|Other|0|||
161107094|NCT01660451|581782794|FG002|Overall Study|Other|1|||
161107095|NCT04688775|581782795|FG000|Placebo-controlled Period|Randomized, not treated|1|||
161107096|NCT04688775|581782796|FG001|Placebo-controlled Period|Randomized, not treated|1|||
161107097|NCT04688775|581782797|FG002|Placebo-controlled Period|Randomized, not treated|0|||
161107098|NCT04688775|581782798|FG003|Placebo-controlled Period|Randomized, not treated|0|||
161107099|NCT04688775|581782795|FG000|Placebo-controlled Period|Adverse Event|2|||
161107100|NCT04688775|581782796|FG001|Placebo-controlled Period|Adverse Event|0|||
161107101|NCT04688775|581782797|FG002|Placebo-controlled Period|Adverse Event|0|||
161107102|NCT04688775|581782798|FG003|Placebo-controlled Period|Adverse Event|0|||
161107103|NCT04688775|581782795|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
161107104|NCT04688775|581782796|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
161107105|NCT04688775|581782797|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
161107106|NCT04688775|581782798|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
161107107|NCT04688775|581782795|FG000|Placebo-controlled Period|Protocol Violation|0|||
161107108|NCT04688775|581782796|FG001|Placebo-controlled Period|Protocol Violation|1|||
161107109|NCT04688775|581782797|FG002|Placebo-controlled Period|Protocol Violation|0|||
161213508|NCT01529749|582164484|FG001|Overall Study|Withdrawal by Subject|1|||
161107110|NCT04688775|581782798|FG003|Placebo-controlled Period|Protocol Violation|0|||
161107111|NCT04688775|581782795|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161107112|NCT04688775|581782796|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
161107113|NCT04688775|581782797|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
161213509|NCT01529749|582164485|FG002|Overall Study|Withdrawal by Subject|1|||
161213510|NCT01529749|582164486|FG003|Overall Study|Withdrawal by Subject|0|||
161107114|NCT04688775|581782798|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
161107115|NCT04688775|581782795|FG000|Placebo-controlled Period|Other reasons|0|||
161107116|NCT04688775|581782796|FG001|Placebo-controlled Period|Other reasons|1|||
161213511|NCT01529749|582164483|FG000|Overall Study|Protocol Violation|0|||
161213512|NCT01529749|582164484|FG001|Overall Study|Protocol Violation|0|||
161213513|NCT01529749|582164485|FG002|Overall Study|Protocol Violation|0|||
161213514|NCT01529749|582164486|FG003|Overall Study|Protocol Violation|1|||
161213515|NCT00789828|582164487|FG000|Core Period (48 Weeks)|Administrative problems|0|||
161213516|NCT00789828|582164488|FG001|Core Period (48 Weeks)|Administrative problems|1|||
161213517|NCT00789828|582164487|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
161213518|NCT00789828|582164488|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
161213519|NCT00789828|582164487|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
161213520|NCT00789828|582164488|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
161213521|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
161213522|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
161213523|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
161213524|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
161213525|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
161213526|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
161213527|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
161213528|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
161213529|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|Death|1|||
161213530|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|Death|0|||
161213531|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
161213532|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
161213533|NCT00789828|582164487|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
161213534|NCT00789828|582164488|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
161213535|NCT02623426|582164489|FG000|Overall Study|Lost to Follow-up|0|||
161213536|NCT02623426|582164490|FG001|Overall Study|Lost to Follow-up|0|||
161213537|NCT02623426|582164491|FG002|Overall Study|Lost to Follow-up|1|||
161213538|NCT02623426|582164489|FG000|Overall Study|Withdrawal by Subject|1|||
161213539|NCT02623426|582164490|FG001|Overall Study|Withdrawal by Subject|2|||
161213540|NCT02623426|582164491|FG002|Overall Study|Withdrawal by Subject|2|||
161213541|NCT02094937|582164492|FG000|8 Weeks in Period 1|Adverse Event|9|||
161213542|NCT02094937|582164493|FG001|8 Weeks in Period 1|Adverse Event|0|||
161213543|NCT02094937|582164494|FG002|8 Weeks in Period 1|Adverse Event|0|||
161213544|NCT02094937|582164495|FG003|8 Weeks in Period 1|Adverse Event|0|||
161213545|NCT02094937|582164492|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
161213546|NCT02094937|582164493|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
161213547|NCT02094937|582164494|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
161213548|NCT02094937|582164495|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
161213549|NCT02094937|582164492|FG000|8 Weeks in Period 1|Protocol Violation|2|||
161213550|NCT02094937|582164493|FG001|8 Weeks in Period 1|Protocol Violation|0|||
161107117|NCT04688775|581782797|FG002|Placebo-controlled Period|Other reasons|0|||
161107118|NCT04688775|581782798|FG003|Placebo-controlled Period|Other reasons|0|||
161107119|NCT04688775|581782795|FG000|Delayed Start Period|Adverse Event|0|||
161107120|NCT04688775|581782796|FG001|Delayed Start Period|Adverse Event|0|||
161107121|NCT04688775|581782797|FG002|Delayed Start Period|Adverse Event|1|||
161107122|NCT04688775|581782798|FG003|Delayed Start Period|Adverse Event|0|||
161107123|NCT04688775|581782795|FG000|Delayed Start Period|Lack of Efficacy|0|||
161107124|NCT04688775|581782796|FG001|Delayed Start Period|Lack of Efficacy|0|||
161107125|NCT04688775|581782797|FG002|Delayed Start Period|Lack of Efficacy|0|||
161107126|NCT04688775|581782798|FG003|Delayed Start Period|Lack of Efficacy|3|||
161107127|NCT04688775|581782795|FG000|Delayed Start Period|Withdrawal by Subject|0|||
161107128|NCT04688775|581782796|FG001|Delayed Start Period|Withdrawal by Subject|0|||
161107129|NCT04688775|581782797|FG002|Delayed Start Period|Withdrawal by Subject|2|||
161107130|NCT04688775|581782798|FG003|Delayed Start Period|Withdrawal by Subject|4|||
161107131|NCT04688775|581782795|FG000|Delayed Start Period|Lost to Follow-up|0|||
161107132|NCT04688775|581782796|FG001|Delayed Start Period|Lost to Follow-up|0|||
161107133|NCT04688775|581782797|FG002|Delayed Start Period|Lost to Follow-up|2|||
161107134|NCT04688775|581782798|FG003|Delayed Start Period|Lost to Follow-up|1|||
161107135|NCT04688775|581782795|FG000|Delayed Start Period|other reasons|0|||
161107136|NCT04688775|581782796|FG001|Delayed Start Period|other reasons|0|||
161107137|NCT04688775|581782797|FG002|Delayed Start Period|other reasons|1|||
161107138|NCT04688775|581782798|FG003|Delayed Start Period|other reasons|0|||
161107139|NCT01536951|581782805|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107140|NCT01536951|581782806|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107141|NCT01536951|581782807|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
161107142|NCT01536951|581782808|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107143|NCT01536951|581782809|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107144|NCT01536951|581782810|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107145|NCT01536951|581782811|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107146|NCT01536951|581782812|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107147|NCT01536951|581782813|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
161107148|NCT01536951|581782805|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
161107149|NCT01536951|581782806|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
161107150|NCT01536951|581782807|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
161107151|NCT01536951|581782808|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
161107152|NCT01536951|581782809|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
161107153|NCT01536951|581782810|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
161107154|NCT01536951|581782811|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
161107155|NCT01536951|581782812|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
161107156|NCT01536951|581782813|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
161107157|NCT01843972|581782816|FG000|Overall Study|Withdrawal by Subject|0|||
161107158|NCT01843972|581782817|FG001|Overall Study|Withdrawal by Subject|0|||
161107159|NCT01843972|581782818|FG002|Overall Study|Withdrawal by Subject|0|||
161107160|NCT01843972|581782819|FG003|Overall Study|Withdrawal by Subject|0|||
161107161|NCT01843972|581782820|FG004|Overall Study|Withdrawal by Subject|1|||
161107162|NCT01843972|581782821|FG005|Overall Study|Withdrawal by Subject|0|||
161107163|NCT01843972|581782822|FG006|Overall Study|Withdrawal by Subject|0|||
161107164|NCT01843972|581782823|FG007|Overall Study|Withdrawal by Subject|0|||
161107165|NCT01843972|581782824|FG008|Overall Study|Withdrawal by Subject|0|||
161107166|NCT01843972|581782825|FG009|Overall Study|Withdrawal by Subject|0|||
161107167|NCT00545402|581782831|FG000|Overall Study|Discontinuation of treatment|17|||
161107168|NCT00545402|581782832|FG001|Overall Study|Discontinuation of treatment|9|||
161107169|NCT00545402|581782831|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
161107170|NCT00545402|581782832|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
161107171|NCT00545402|581782831|FG000|Overall Study|Death|5|||
161107172|NCT00545402|581782832|FG001|Overall Study|Death|7|||
161107173|NCT00545402|581782831|FG000|Overall Study|Graft loss|2|||
161107174|NCT00545402|581782832|FG001|Overall Study|Graft loss|4|||
161107175|NCT00545402|581782831|FG000|Overall Study|Withdrawal by Subject|0|||
161107176|NCT00545402|581782832|FG001|Overall Study|Withdrawal by Subject|1|||
161107177|NCT00545402|581782831|FG000|Overall Study|Protocol Violation|1|||
161107178|NCT00545402|581782832|FG001|Overall Study|Protocol Violation|0|||
161107179|NCT00545402|581782831|FG000|Overall Study|Reason not specified|1|||
161107180|NCT00545402|581782832|FG001|Overall Study|Reason not specified|1|||
161107181|NCT01984164|581782833|FG000|Overall Study|Withdrawal by Subject|4|||
161107182|NCT01984164|581782834|FG001|Overall Study|Withdrawal by Subject|3|||
161107183|NCT01984164|581782833|FG000|Overall Study|Adverse Event|5|||
161107184|NCT01984164|581782834|FG001|Overall Study|Adverse Event|19|||
161107185|NCT01984164|581782833|FG000|Overall Study|Lost to Follow-up|1|||
161107186|NCT01984164|581782834|FG001|Overall Study|Lost to Follow-up|3|||
161107187|NCT00427349|581782836|FG000|Overall Study|Lack of Efficacy|23|||
161107188|NCT00427349|581782836|FG000|Overall Study|Adverse Event|14|||
161107189|NCT00427349|581782836|FG000|Overall Study|Death|1|||
161107190|NCT00427349|581782836|FG000|Overall Study|Withdrawal by Subject|3|||
161107191|NCT00427349|581782836|FG000|Overall Study|Alternative therapy|1|||
161107192|NCT00427349|581782836|FG000|Overall Study|Other|2|||
161107193|NCT00427349|581782836|FG000|Overall Study|Ineligible|1|||
161107194|NCT00427349|581782836|FG000|Overall Study|Never started therapy|1|||
161107195|NCT00916279|581782839|FG000|Overall Study|Death|2|||
161107196|NCT00916279|581782839|FG000|Overall Study|Lost to Follow-up|2|||
161107197|NCT02592018|581782844|FG000|Overall Study|Adverse Event|1|||
161107198|NCT02592018|581782844|FG000|Overall Study|Lost to Follow-up|1|||
161107199|NCT00574145|581784190|FG000|Overall Study|Withdrawal by Subject|2|||
161107200|NCT00574145|581784191|FG001|Overall Study|Withdrawal by Subject|1|||
161107201|NCT03227471|581784192|FG000|Overall Study|Withdrawal by Subject|0|||
161107202|NCT03227471|581784193|FG001|Overall Study|Withdrawal by Subject|0|||
161107203|NCT03227471|581784194|FG002|Overall Study|Withdrawal by Subject|0|||
161107204|NCT03227471|581784195|FG003|Overall Study|Withdrawal by Subject|0|||
161107205|NCT03227471|581784196|FG004|Overall Study|Withdrawal by Subject|1|||
161107206|NCT03227471|581784197|FG005|Overall Study|Withdrawal by Subject|0|||
161107207|NCT03227471|581784198|FG006|Overall Study|Withdrawal by Subject|0|||
161107208|NCT03227471|581784199|FG007|Overall Study|Withdrawal by Subject|0|||
161107209|NCT03227471|581784200|FG008|Overall Study|Withdrawal by Subject|0|||
161107210|NCT03227471|581784201|FG009|Overall Study|Withdrawal by Subject|0|||
161107211|NCT03227471|581784202|FG010|Overall Study|Withdrawal by Subject|0|||
161107212|NCT03227471|581784203|FG011|Overall Study|Withdrawal by Subject|0|||
161107213|NCT03227471|581784204|FG012|Overall Study|Withdrawal by Subject|1|||
161107214|NCT03227471|581784205|FG013|Overall Study|Withdrawal by Subject|0|||
161107215|NCT03227471|581784206|FG014|Overall Study|Withdrawal by Subject|0|||
161107216|NCT03227471|581784192|FG000|Overall Study|Randomized, Never Dosed|0|||
161107217|NCT03227471|581784193|FG001|Overall Study|Randomized, Never Dosed|0|||
161107218|NCT03227471|581784194|FG002|Overall Study|Randomized, Never Dosed|0|||
161107219|NCT03227471|581784195|FG003|Overall Study|Randomized, Never Dosed|0|||
161107220|NCT03227471|581784196|FG004|Overall Study|Randomized, Never Dosed|0|||
161107221|NCT03227471|581784197|FG005|Overall Study|Randomized, Never Dosed|0|||
161107222|NCT03227471|581784198|FG006|Overall Study|Randomized, Never Dosed|0|||
161107223|NCT03227471|581784199|FG007|Overall Study|Randomized, Never Dosed|0|||
161107224|NCT03227471|581784200|FG008|Overall Study|Randomized, Never Dosed|0|||
161107225|NCT03227471|581784201|FG009|Overall Study|Randomized, Never Dosed|0|||
161107226|NCT03227471|581784202|FG010|Overall Study|Randomized, Never Dosed|0|||
161107227|NCT03227471|581784203|FG011|Overall Study|Randomized, Never Dosed|0|||
161107228|NCT03227471|581784204|FG012|Overall Study|Randomized, Never Dosed|0|||
161107229|NCT03227471|581784205|FG013|Overall Study|Randomized, Never Dosed|0|||
161107230|NCT03227471|581784206|FG014|Overall Study|Randomized, Never Dosed|1|||
161107231|NCT00736255|581784214|FG000|Overall Study|Adverse Event|1|||
161107232|NCT00736255|581784215|FG001|Overall Study|Adverse Event|0|||
161107233|NCT00736255|581784214|FG000|Overall Study|Physician Decision|1|||
161107234|NCT00736255|581784215|FG001|Overall Study|Physician Decision|0|||
161107235|NCT00736255|581784214|FG000|Overall Study|Non-compliance|1|||
161107236|NCT00736255|581784215|FG001|Overall Study|Non-compliance|1|||
161107237|NCT00346073|581784220|FG000|Overall Study|Serious Adverse Event|2|||
161107238|NCT00346073|581784221|FG001|Overall Study|Serious Adverse Event|0|||
161107239|NCT00346073|581784220|FG000|Overall Study|Lost to Follow-up|39|||
161107240|NCT00346073|581784221|FG001|Overall Study|Lost to Follow-up|24|||
161107241|NCT00980200|581784223|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
161107242|NCT00980200|581784224|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
161107243|NCT00980200|581784225|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
161107244|NCT00980200|581784226|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
161107245|NCT00980200|581784227|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
161107246|NCT00980200|581784223|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
161107247|NCT00980200|581784224|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
161107248|NCT00980200|581784225|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
161107249|NCT00980200|581784226|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
161107250|NCT00980200|581784227|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
161107251|NCT01617460|581784228|FG000|Overall Study|Adverse Event|10|||
161107252|NCT01617460|581784228|FG000|Overall Study|Physician Decision|16|||
161107253|NCT01617460|581784228|FG000|Overall Study|Protocol Violation|5|||
161107254|NCT01617460|581784228|FG000|Overall Study|Withdrawal by Subject|9|||
161107255|NCT00457015|581784230|FG000|Overall Study|Left study site against medical advice|0|||
161107256|NCT00457015|581784231|FG001|Overall Study|Left study site against medical advice|1|||
161107257|NCT03670953|581784232|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
161107258|NCT03670953|581784233|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161107259|NCT03670953|581784234|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161107260|NCT03670953|581784235|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
161107261|NCT03670953|581784232|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
161107262|NCT03670953|581784233|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161107263|NCT03670953|581784234|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161107264|NCT03670953|581784235|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
161107265|NCT03670953|581784232|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
161107266|NCT03670953|581784233|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161107267|NCT03670953|581784234|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161107268|NCT03670953|581784235|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
161107269|NCT03670953|581784232|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
161107270|NCT03670953|581784233|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161107271|NCT03670953|581784234|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161107272|NCT03670953|581784235|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
161107273|NCT03670953|581784232|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
161107274|NCT03670953|581784233|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161107275|NCT03670953|581784234|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161107276|NCT03670953|581784235|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
161107277|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161107278|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
161107279|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161107280|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
161107281|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161107282|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
161213551|NCT02094937|582164494|FG002|8 Weeks in Period 1|Protocol Violation|0|||
161213552|NCT02094937|582164495|FG003|8 Weeks in Period 1|Protocol Violation|0|||
161213553|NCT02094937|582164492|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
161213554|NCT02094937|582164493|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161213555|NCT02094937|582164494|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161213556|NCT02094937|582164495|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
161213557|NCT02094937|582164492|FG000|8 Weeks in Period 1|Physician Decision|1|||
161213558|NCT02094937|582164493|FG001|8 Weeks in Period 1|Physician Decision|0|||
161213559|NCT02094937|582164494|FG002|8 Weeks in Period 1|Physician Decision|0|||
161213560|NCT02094937|582164495|FG003|8 Weeks in Period 1|Physician Decision|0|||
161213561|NCT02094937|582164492|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
161213562|NCT02094937|582164493|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
161107283|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161107284|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
161107285|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161107286|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
161107287|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161213563|NCT02094937|582164494|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
161213564|NCT02094937|582164495|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
161213565|NCT02094937|582164492|FG000|12 Weeks in Period 2|Adverse Event|0|||
161107288|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
161107289|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161107290|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
161107291|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161107292|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
161107293|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161107294|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
161107295|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161107296|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
161107297|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161107298|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
161107299|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161107300|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
161107301|NCT03670953|581784232|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161107302|NCT03670953|581784233|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
161107303|NCT03670953|581784234|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161107304|NCT03670953|581784235|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
161107305|NCT03670953|581784232|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
161107306|NCT03670953|581784233|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
161107307|NCT03670953|581784234|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
161107308|NCT03670953|581784235|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
161107309|NCT03670953|581784232|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
161107310|NCT03670953|581784233|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
161107311|NCT03670953|581784234|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
161107312|NCT03670953|581784235|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
161107313|NCT03670953|581784232|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
161107314|NCT03670953|581784233|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
161107315|NCT03670953|581784234|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
161107316|NCT03670953|581784235|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
161107317|NCT03670953|581784232|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161107318|NCT03670953|581784233|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161107319|NCT03670953|581784234|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
161107320|NCT03670953|581784235|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
161107321|NCT03670953|581784232|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
161213566|NCT02094937|582164493|FG001|12 Weeks in Period 2|Adverse Event|2|||
161213567|NCT02094937|582164494|FG002|12 Weeks in Period 2|Adverse Event|4|||
161213568|NCT02094937|582164495|FG003|12 Weeks in Period 2|Adverse Event|1|||
161213569|NCT02094937|582164492|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
161213570|NCT02094937|582164493|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
161213571|NCT02094937|582164494|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
161213572|NCT02094937|582164495|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
161213573|NCT02094937|582164492|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
161213574|NCT02094937|582164493|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
161213575|NCT02094937|582164494|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
161213576|NCT02094937|582164495|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
161213577|NCT02094937|582164492|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
161213578|NCT02094937|582164493|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
161213579|NCT02094937|582164494|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
161213580|NCT02094937|582164495|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
161213581|NCT02094937|582164492|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
161213582|NCT02094937|582164493|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
161213583|NCT02094937|582164494|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
161213584|NCT02094937|582164495|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
161213585|NCT01133392|582164496|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
161213586|NCT01133392|582164497|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
161213587|NCT01133392|582164496|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
161213588|NCT01133392|582164497|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
161213589|NCT03751124|582164498|FG000|Overall Study|Adverse Event|4|||
161213590|NCT03751124|582164499|FG001|Overall Study|Adverse Event|3|||
161213591|NCT03751124|582164498|FG000|Overall Study|Protocol Deviation|0|||
161213592|NCT03751124|582164499|FG001|Overall Study|Protocol Deviation|1|||
161107322|NCT03670953|581784233|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
161107323|NCT03670953|581784234|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
161107324|NCT03670953|581784235|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
161213593|NCT03751124|582164498|FG000|Overall Study|Lost to Follow-up|6|||
161213594|NCT03751124|582164499|FG001|Overall Study|Lost to Follow-up|4|||
161213595|NCT03751124|582164498|FG000|Overall Study|Withdrawal by Subject|6|||
161213596|NCT03751124|582164499|FG001|Overall Study|Withdrawal by Subject|8|||
161213597|NCT03751124|582164498|FG000|Overall Study|Lack of Efficacy|1|||
161213598|NCT03751124|582164499|FG001|Overall Study|Lack of Efficacy|1|||
161213599|NCT03751124|582164498|FG000|Overall Study|Pregnancy|0|||
161213600|NCT03751124|582164499|FG001|Overall Study|Pregnancy|1|||
161213601|NCT03751124|582164498|FG000|Overall Study|Other|9|||
161213602|NCT03751124|582164499|FG001|Overall Study|Other|9|||
161213603|NCT03751124|582164498|FG000|Overall Study|Participants who did not receive any study drug|0|||
161213604|NCT03751124|582164499|FG001|Overall Study|Participants who did not receive any study drug|1|||
161213605|NCT00555399|582164502|FG000|Overall Study|Withdrawal by Subject|0|||
161213606|NCT00555399|582164503|FG001|Overall Study|Withdrawal by Subject|0|||
161213607|NCT00555399|582164504|FG002|Overall Study|Withdrawal by Subject|1|||
161213608|NCT00555399|582164505|FG003|Overall Study|Withdrawal by Subject|0|||
161213609|NCT00555399|582164506|FG004|Overall Study|Withdrawal by Subject|0|||
161213610|NCT00555399|582164507|FG005|Overall Study|Withdrawal by Subject|0|||
161213611|NCT00555399|582164508|FG006|Overall Study|Withdrawal by Subject|0|||
161213612|NCT00555399|582164509|FG007|Overall Study|Withdrawal by Subject|0|||
161213613|NCT00555399|582164510|FG008|Overall Study|Withdrawal by Subject|0|||
161213614|NCT00555399|582164511|FG009|Overall Study|Withdrawal by Subject|0|||
161213615|NCT00555399|582164512|FG010|Overall Study|Withdrawal by Subject|0|||
161213616|NCT00555399|582164513|FG011|Overall Study|Withdrawal by Subject|1|||
161213617|NCT00555399|582164502|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
161213618|NCT00555399|582164503|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
161213619|NCT00555399|582164504|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
161213620|NCT00555399|582164505|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
161213621|NCT00555399|582164506|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
161213622|NCT00555399|582164507|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
161213623|NCT00555399|582164508|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
161213624|NCT00555399|582164509|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
161213625|NCT00555399|582164510|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
161213626|NCT00555399|582164511|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
161213627|NCT00555399|582164512|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
161213628|NCT00555399|582164513|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
161213629|NCT05458895|582164514|FG000|Overall Study|Withdrawal by Subject|8|||
161213630|NCT05458895|582164514|FG000|Overall Study|Lost to Follow-up|17|||
161213631|NCT05458895|582164514|FG000|Overall Study|Pregnancy|2|||
161213632|NCT05458895|582164514|FG000|Overall Study|Withdrawal by Study Team|1|||
161213633|NCT04639310|582164515|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
161213634|NCT04639310|582164516|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
161213635|NCT05166421|582164517|FG000|Overall Study|Other|3|||
161213636|NCT05166421|582164518|FG001|Overall Study|Other|1|||
161213637|NCT05166421|582164519|FG002|Overall Study|Other|1|||
161213638|NCT05166421|582164517|FG000|Overall Study|Withdrawal by Subject|5|||
161213639|NCT05166421|582164518|FG001|Overall Study|Withdrawal by Subject|3|||
161213640|NCT05166421|582164519|FG002|Overall Study|Withdrawal by Subject|6|||
161213641|NCT05166421|582164517|FG000|Overall Study|Lost to Follow-up|4|||
161213642|NCT05166421|582164518|FG001|Overall Study|Lost to Follow-up|1|||
161213643|NCT05166421|582164519|FG002|Overall Study|Lost to Follow-up|7|||
161213644|NCT01155063|582166196|FG000|Overall Study|Adverse Event|1|||
161213645|NCT01155063|582166196|FG000|Overall Study|Withdrawal by Subject|1|||
161213646|NCT01155063|582166196|FG000|Overall Study|Study terminated by sponsor|87|||
161213647|NCT01663714|582166197|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
161213648|NCT01663714|582166197|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
161213649|NCT01663714|582166197|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
161213650|NCT01663714|582166197|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
161213651|NCT01663714|582166197|FG000|Long-Term Follow-Up|Death|4|||
161213652|NCT01663714|582166197|FG000|Long-Term Follow-Up|Non-compliance|1|||
161213653|NCT00515073|582166204|FG000|Overall Study|Withdrawal by Subject|1|||
161213654|NCT00515073|582166204|FG000|Overall Study|Physician Decision|1|||
161213655|NCT02764489|582166205|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
161213656|NCT02764489|582166206|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
161213657|NCT02764489|582166205|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
161213658|NCT02764489|582166206|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
161213659|NCT02764489|582166205|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
161213660|NCT02764489|582166206|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
161213661|NCT02764489|582166205|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
161213662|NCT02764489|582166206|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
161213663|NCT01625845|582166207|FG000|Overall Study|Adverse Event|1|||
161213664|NCT01625845|582166208|FG001|Overall Study|Adverse Event|2|||
161213665|NCT01625845|582166207|FG000|Overall Study|Lost to Follow-up|2|||
161213666|NCT01625845|582166208|FG001|Overall Study|Lost to Follow-up|1|||
161213667|NCT01625845|582166207|FG000|Overall Study|Withdrawal by Subject|2|||
161213668|NCT01625845|582166208|FG001|Overall Study|Withdrawal by Subject|0|||
161213669|NCT01294592|582166209|FG000|Overall Study|Adverse Event|28|||
161213670|NCT01294592|582166210|FG001|Overall Study|Adverse Event|13|||
161213671|NCT01294592|582166209|FG000|Overall Study|Lack of Efficacy|7|||
161213672|NCT01294592|582166210|FG001|Overall Study|Lack of Efficacy|5|||
161213673|NCT01294592|582166209|FG000|Overall Study|Protocol Violation|1|||
161213674|NCT01294592|582166210|FG001|Overall Study|Protocol Violation|7|||
161213675|NCT01294592|582166209|FG000|Overall Study|Lost to Follow-up|7|||
161213676|NCT01294592|582166210|FG001|Overall Study|Lost to Follow-up|9|||
161213677|NCT01294592|582166209|FG000|Overall Study|Physician Decision|6|||
161213678|NCT01294592|582166210|FG001|Overall Study|Physician Decision|11|||
161213679|NCT01294592|582166209|FG000|Overall Study|Withdrawal by Subject|28|||
161213680|NCT01294592|582166210|FG001|Overall Study|Withdrawal by Subject|28|||
161213681|NCT02853929|582166211|FG000|Overall Study|Lost to Follow-up|3|||
161213682|NCT02853929|582166212|FG001|Overall Study|Lost to Follow-up|0|||
161213683|NCT02853929|582166211|FG000|Overall Study|Withdrawal by Subject|1|||
161213684|NCT02853929|582166212|FG001|Overall Study|Withdrawal by Subject|0|||
161213685|NCT02853929|582166211|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
161213686|NCT02853929|582166212|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
161213687|NCT00693784|582166213|FG000|Overall Study|Lost to Follow-up|2|||
161213688|NCT00693784|582166213|FG000|Overall Study|Withdrawal by Subject|2|||
161213689|NCT02265952|582166214|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
161213690|NCT02265952|582166215|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
161213691|NCT02265952|582166214|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
161213692|NCT02265952|582166215|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
161213693|NCT00326885|582166218|FG000|Overall Study|Adverse Event|1|||
161213694|NCT00326885|582166218|FG000|Overall Study|Withdrawal by Subject|3|||
161213695|NCT00326885|582166218|FG000|Overall Study|Physician Decision|1|||
161213696|NCT00326885|582166218|FG000|Overall Study|Hospice withdrew consent|2|||
161213697|NCT00472446|582166219|FG000|Overall Study|Protocol Violation|0|||
161213698|NCT00472446|582166220|FG001|Overall Study|Protocol Violation|0|||
161213699|NCT00472446|582166221|FG002|Overall Study|Protocol Violation|0|||
161213700|NCT00472446|582166222|FG003|Overall Study|Protocol Violation|1|||
161213701|NCT00472446|582166219|FG000|Overall Study|Reintervention|0|||
161213702|NCT00472446|582166220|FG001|Overall Study|Reintervention|0|||
161213703|NCT00472446|582166221|FG002|Overall Study|Reintervention|1|||
161213704|NCT00472446|582166222|FG003|Overall Study|Reintervention|1|||
161213705|NCT00472446|582166219|FG000|Overall Study|Questionnaires not returned|5|||
161213706|NCT00472446|582166220|FG001|Overall Study|Questionnaires not returned|6|||
161213707|NCT00472446|582166221|FG002|Overall Study|Questionnaires not returned|6|||
161213708|NCT00472446|582166222|FG003|Overall Study|Questionnaires not returned|4|||
161213709|NCT03211156|582166224|FG000|Overall Study|Withdrawal by Subject|0|||
161213710|NCT03211156|582166225|FG001|Overall Study|Withdrawal by Subject|2|||
161213711|NCT03211156|582166224|FG000|Overall Study|Lost to Follow-up|1|||
161213712|NCT03211156|582166225|FG001|Overall Study|Lost to Follow-up|1|||
161213713|NCT03211156|582166224|FG000|Overall Study|Adverse Event|1|||
161213714|NCT03211156|582166225|FG001|Overall Study|Adverse Event|0|||
161213715|NCT00738673|582166228|FG000|Overall Study|Adverse Event|1|||
161213716|NCT00738673|582166229|FG001|Overall Study|Adverse Event|0|||
161213717|NCT00738673|582166228|FG000|Overall Study|Lack of Efficacy|19|||
161213718|NCT00738673|582166229|FG001|Overall Study|Lack of Efficacy|8|||
161213719|NCT00738673|582166228|FG000|Overall Study|Protocol Violation|1|||
161213720|NCT00738673|582166229|FG001|Overall Study|Protocol Violation|2|||
161213721|NCT00738673|582166228|FG000|Overall Study|Withdrawal by Subject|3|||
161213722|NCT00738673|582166229|FG001|Overall Study|Withdrawal by Subject|1|||
161213723|NCT02736227|582166230|FG000|Overall Study|Withdrawal by Subject|0|||
161213724|NCT02736227|582166231|FG001|Overall Study|Withdrawal by Subject|0|||
161213725|NCT02736227|582166232|FG002|Overall Study|Withdrawal by Subject|1|||
161213726|NCT02736227|582166230|FG000|Overall Study|Physician Decision|0|||
161213727|NCT02736227|582166231|FG001|Overall Study|Physician Decision|0|||
161213728|NCT02736227|582166232|FG002|Overall Study|Physician Decision|5|||
161213729|NCT02736227|582166230|FG000|Overall Study|Non Compliant|0|||
161213730|NCT02736227|582166231|FG001|Overall Study|Non Compliant|0|||
161213731|NCT02736227|582166232|FG002|Overall Study|Non Compliant|2|||
161213732|NCT03870997|582166246|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
161213733|NCT03870997|582166247|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
161213734|NCT03870997|582166248|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
161213735|NCT03870997|582166249|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
161213736|NCT03870997|582166250|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
161213737|NCT03870997|582166251|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
161213738|NCT03726437|582166252|FG000|Overall Study|Lost to Follow-up|85|||
161213739|NCT03726437|582166253|FG001|Overall Study|Lost to Follow-up|76|||
161213740|NCT01205529|582166262|FG000|Overall Study|Procedure Cancelled|4|||
161213741|NCT01205529|582166262|FG000|Overall Study|Withdrawal by Subject|2|||
161213742|NCT01205529|582166262|FG000|Overall Study|Physician Decision|4|||
161107325|NCT03670953|581784232|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161107326|NCT03670953|581784233|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161107327|NCT03670953|581784234|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
161107328|NCT03670953|581784235|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
161107329|NCT00937937|581784236|FG000|Overall Study|Adverse Event|6|||
161107330|NCT00937937|581784236|FG000|Overall Study|Withdrawal by Subject|2|||
161107331|NCT00937937|581784236|FG000|Overall Study|Progression/relapse|61|||
161107332|NCT00937937|581784236|FG000|Overall Study|Death|1|||
161107333|NCT00937937|581784236|FG000|Overall Study|Other|2|||
161107334|NCT00362414|581784237|FG000|Overall Study|Death|2|||
161107335|NCT00362414|581784237|FG000|Overall Study|Adverse Event|1|||
161107336|NCT01365039|581784244|FG000|Overall Study|Study related symptoms and complaints|1|||
161107337|NCT01365039|581784245|FG001|Overall Study|Study related symptoms and complaints|0|||
161107338|NCT00549939|581784252|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
161107339|NCT00549939|581784253|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
161107340|NCT00549939|581784254|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
161107341|NCT00549939|581784252|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
161107342|NCT00549939|581784253|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
161107343|NCT00549939|581784254|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
161107344|NCT00549939|581784252|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
161107345|NCT00549939|581784253|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
161107346|NCT00549939|581784254|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
161107347|NCT00549939|581784252|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
161107348|NCT00549939|581784253|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
161107349|NCT00549939|581784254|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
161107350|NCT00549939|581784252|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
161107351|NCT00549939|581784253|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
161107352|NCT00549939|581784254|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
161107353|NCT00549939|581784252|FG000|40-week Open Label Treatment Period|Other|0|||
161107354|NCT00549939|581784253|FG001|40-week Open Label Treatment Period|Other|1|||
161107355|NCT00549939|581784254|FG002|40-week Open Label Treatment Period|Other|4|||
161107356|NCT03677596|581784255|FG000|Overall Study|Adverse Event|0|||
161107357|NCT03677596|581784256|FG001|Overall Study|Adverse Event|1|||
161107358|NCT03677596|581784255|FG000|Overall Study|Death|10|||
161213743|NCT01205529|582166262|FG000|Overall Study|Unstable post op|15|||
161213744|NCT01205529|582166262|FG000|Overall Study|No longer met criteria|30|||
161213745|NCT00033631|582166263|FG000|Overall Study|Protocol Violation|14|||
161213746|NCT00033631|582166264|FG001|Overall Study|Protocol Violation|11|||
161213747|NCT00033631|582166263|FG000|Overall Study|Withdrawal by Subject|4|||
161213748|NCT00033631|582166264|FG001|Overall Study|Withdrawal by Subject|4|||
161213749|NCT04133519|582166267|FG000|Overall Study|Withdrawal by Subject|5|||
161213750|NCT04133519|582166268|FG001|Overall Study|Withdrawal by Subject|4|||
161107359|NCT03677596|581784256|FG001|Overall Study|Death|6|||
161107360|NCT03677596|581784255|FG000|Overall Study|Lost to Follow-up|0|||
161107361|NCT03677596|581784256|FG001|Overall Study|Lost to Follow-up|1|||
161107362|NCT03677596|581784255|FG000|Overall Study|Progressive Disease|8|||
161107363|NCT03677596|581784256|FG001|Overall Study|Progressive Disease|8|||
161107364|NCT03677596|581784255|FG000|Overall Study|Withdrawal by Subject|3|||
161107365|NCT03677596|581784256|FG001|Overall Study|Withdrawal by Subject|0|||
161107366|NCT03677596|581784255|FG000|Overall Study|Disease Relapse|2|||
161107367|NCT03677596|581784256|FG001|Overall Study|Disease Relapse|2|||
161107368|NCT03677596|581784255|FG000|Overall Study|Other|0|||
161107369|NCT03677596|581784256|FG001|Overall Study|Other|1|||
161213751|NCT04133519|582166267|FG000|Overall Study|Protocol Violation|0|||
161213752|NCT04133519|582166268|FG001|Overall Study|Protocol Violation|1|||
161213753|NCT04133519|582166267|FG000|Overall Study|Never started treatment|1|||
161213754|NCT04133519|582166268|FG001|Overall Study|Never started treatment|1|||
161107370|NCT00294060|581784257|FG000|Overall Study|Death|225|||
161107371|NCT00294060|581784257|FG000|Overall Study|Other|59|||
161107372|NCT00294060|581784257|FG000|Overall Study|Lost to Follow-up|55|||
161107373|NCT00294060|581784257|FG000|Overall Study|Withdrawal by Subject|11|||
161107374|NCT00294060|581784257|FG000|Overall Study|Physician Decision|797|||
161107375|NCT00294060|581784257|FG000|Overall Study|Medical condition|3|||
161107376|NCT00294060|581784257|FG000|Overall Study|Device explanted/not replaced|23|||
161107377|NCT00139776|581784258|FG000|Period I|Did not enter Period II|575|||
161107378|NCT00139776|581784259|FG001|Period I|Did not enter Period II|0|||
161107379|NCT00139776|581784260|FG002|Period I|Did not enter Period II|0|||
161107380|NCT00139776|581784261|FG003|Period I|Did not enter Period II|0|||
161107381|NCT00139776|581784258|FG000|Period II|Not Randomized into Period III|0|||
161107382|NCT00139776|581784259|FG001|Period II|Not Randomized into Period III|322|||
161107383|NCT00139776|581784260|FG002|Period II|Not Randomized into Period III|0|||
161107384|NCT00139776|581784261|FG003|Period II|Not Randomized into Period III|0|||
161107385|NCT00139776|581784258|FG000|Period III|Adverse Event|0|||
161107386|NCT00139776|581784259|FG001|Period III|Adverse Event|0|||
161107387|NCT00139776|581784260|FG002|Period III|Adverse Event|22|||
161107388|NCT00139776|581784261|FG003|Period III|Adverse Event|23|||
161107389|NCT00139776|581784258|FG000|Period III|Other|0|||
161107390|NCT00139776|581784259|FG001|Period III|Other|0|||
161107391|NCT00139776|581784260|FG002|Period III|Other|23|||
161107392|NCT00139776|581784261|FG003|Period III|Other|34|||
161107393|NCT00139776|581784258|FG000|Period III|Lack of Efficacy|0|||
161107394|NCT00139776|581784259|FG001|Period III|Lack of Efficacy|0|||
161107395|NCT00139776|581784260|FG002|Period III|Lack of Efficacy|10|||
161107396|NCT00139776|581784261|FG003|Period III|Lack of Efficacy|24|||
161107397|NCT00139776|581784258|FG000|Period III|Lost to Follow-up|0|||
161107398|NCT00139776|581784259|FG001|Period III|Lost to Follow-up|0|||
161107399|NCT00139776|581784260|FG002|Period III|Lost to Follow-up|5|||
161107400|NCT00139776|581784261|FG003|Period III|Lost to Follow-up|4|||
161107401|NCT00139776|581784258|FG000|Period III|Withdrawal by Subject|0|||
161107402|NCT00139776|581784259|FG001|Period III|Withdrawal by Subject|0|||
161107403|NCT00139776|581784260|FG002|Period III|Withdrawal by Subject|16|||
161107404|NCT00139776|581784261|FG003|Period III|Withdrawal by Subject|21|||
161107405|NCT00187096|581784262|FG000|Overall Study|unacceptable toxicity|0|||
161107406|NCT00187096|581784263|FG001|Overall Study|unacceptable toxicity|0|||
161107407|NCT00187096|581784264|FG002|Overall Study|unacceptable toxicity|1|||
161107408|NCT02161575|581784271|FG000|Overall Study|Protocol Violation|8|||
161107409|NCT02161575|581784271|FG000|Overall Study|Lack of Efficacy|1|||
161107410|NCT02161575|581784271|FG000|Overall Study|Adverse Event|2|||
161107411|NCT01970488|581784273|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
161107412|NCT01970488|581784274|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
161107413|NCT01970488|581784275|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161107414|NCT01970488|581784276|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161107415|NCT01970488|581784277|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
161107416|NCT01970488|581784273|FG000|Part 1: Through Week 16|Protocol Violation|1|||
161107417|NCT01970488|581784274|FG001|Part 1: Through Week 16|Protocol Violation|2|||
161107418|NCT01970488|581784275|FG002|Part 1: Through Week 16|Protocol Violation|0|||
161107419|NCT01970488|581784276|FG003|Part 1: Through Week 16|Protocol Violation|0|||
161107420|NCT01970488|581784277|FG004|Part 1: Through Week 16|Protocol Violation|0|||
161107421|NCT01970488|581784273|FG000|Part 1: Through Week 16|Adverse Event|6|||
161107422|NCT01970488|581784274|FG001|Part 1: Through Week 16|Adverse Event|5|||
161107423|NCT01970488|581784275|FG002|Part 1: Through Week 16|Adverse Event|0|||
161107424|NCT01970488|581784276|FG003|Part 1: Through Week 16|Adverse Event|0|||
161107425|NCT01970488|581784277|FG004|Part 1: Through Week 16|Adverse Event|0|||
161107426|NCT01970488|581784273|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
161107427|NCT01970488|581784274|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
161107428|NCT01970488|581784275|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
161107429|NCT01970488|581784276|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
161107430|NCT01970488|581784277|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
161107431|NCT01970488|581784273|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
161107432|NCT01970488|581784274|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
161107433|NCT01970488|581784275|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
161107434|NCT01970488|581784276|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
161107435|NCT01970488|581784277|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
161107436|NCT01970488|581784273|FG000|Part 2: Post Week 16|Physician Decision|0|||
161107437|NCT01970488|581784274|FG001|Part 2: Post Week 16|Physician Decision|0|||
161107438|NCT01970488|581784275|FG002|Part 2: Post Week 16|Physician Decision|0|||
161107439|NCT01970488|581784276|FG003|Part 2: Post Week 16|Physician Decision|0|||
161107440|NCT01970488|581784277|FG004|Part 2: Post Week 16|Physician Decision|1|||
161107441|NCT01970488|581784273|FG000|Part 2: Post Week 16|Non-compliance|0|||
161107442|NCT01970488|581784274|FG001|Part 2: Post Week 16|Non-compliance|0|||
161107443|NCT01970488|581784275|FG002|Part 2: Post Week 16|Non-compliance|1|||
161107444|NCT01970488|581784276|FG003|Part 2: Post Week 16|Non-compliance|0|||
161107445|NCT01970488|581784277|FG004|Part 2: Post Week 16|Non-compliance|0|||
161107446|NCT01970488|581784273|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
161107447|NCT01970488|581784274|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
161107448|NCT01970488|581784275|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
161107449|NCT01970488|581784276|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
161107450|NCT01970488|581784277|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
161107451|NCT01970488|581784273|FG000|Part 2: Post Week 16|Adverse Event|0|||
161107452|NCT01970488|581784274|FG001|Part 2: Post Week 16|Adverse Event|0|||
161107453|NCT01970488|581784275|FG002|Part 2: Post Week 16|Adverse Event|5|||
161107454|NCT01970488|581784276|FG003|Part 2: Post Week 16|Adverse Event|1|||
161107455|NCT01970488|581784277|FG004|Part 2: Post Week 16|Adverse Event|1|||
161107456|NCT01970488|581784273|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
161107457|NCT01970488|581784274|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
161107458|NCT01970488|581784275|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
161107459|NCT01970488|581784276|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
161107460|NCT01970488|581784277|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
161107461|NCT01970488|581784273|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
161107462|NCT01970488|581784274|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
161107463|NCT01970488|581784275|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
161107464|NCT01970488|581784276|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
161107465|NCT01970488|581784277|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
161107466|NCT01816061|581784278|FG000|Overall Study|Lost to Follow-up|13|||
161107467|NCT01816061|581784279|FG001|Overall Study|Lost to Follow-up|24|||
161107468|NCT05525689|581784280|FG000|Overall Study|Lost to Follow-up|1|||
161107469|NCT05525689|581784281|FG001|Overall Study|Lost to Follow-up|0|||
161107470|NCT01022502|581784286|FG000|Overall Study|Adverse Event|1|||
161107471|NCT01022502|581784286|FG000|Overall Study|employment related reasons|1|||
161107472|NCT01022502|581784286|FG000|Overall Study|Withdrawal by Subject|1|||
161107473|NCT00073528|581784296|FG000|Overall Study|Death|488|||
161107474|NCT00073528|581784297|FG001|Overall Study|Death|473|||
161107475|NCT00073528|581784296|FG000|Overall Study|Lost to Follow-up|52|||
161107476|NCT00073528|581784297|FG001|Overall Study|Lost to Follow-up|45|||
161107477|NCT00073528|581784296|FG000|Overall Study|Withdrawal by Subject|50|||
161107478|NCT00073528|581784297|FG001|Overall Study|Withdrawal by Subject|45|||
161107479|NCT00073528|581784296|FG000|Overall Study|Study terminated by Sponsor|10|||
161107480|NCT00073528|581784297|FG001|Overall Study|Study terminated by Sponsor|29|||
161107481|NCT00073528|581784296|FG000|Overall Study|Other|18|||
161107482|NCT00073528|581784297|FG001|Overall Study|Other|19|||
161107483|NCT00073528|581784296|FG000|Overall Study|Other|9|||
161107484|NCT00073528|581784297|FG001|Overall Study|Other|12|||
161107485|NCT00073528|581784296|FG000|Overall Study|Protocol Violation|3|||
161107486|NCT00073528|581784297|FG001|Overall Study|Protocol Violation|5|||
161107487|NCT03086057|581784298|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
161107488|NCT03086057|581784299|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
161107489|NCT03086057|581784300|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
161107490|NCT03086057|581784301|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
161107491|NCT03086057|581784298|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
161107492|NCT03086057|581784299|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
161107493|NCT03086057|581784300|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
161107494|NCT03086057|581784301|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
161107495|NCT03086057|581784298|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
161107496|NCT03086057|581784299|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
161107497|NCT03086057|581784300|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
161107498|NCT03086057|581784301|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
161107499|NCT03086057|581784298|FG000|Stage 1: PrEP Uptake|Death|1|||
161107500|NCT03086057|581784299|FG001|Stage 1: PrEP Uptake|Death|0|||
161107501|NCT03086057|581784300|FG002|Stage 1: PrEP Uptake|Death|0|||
161107502|NCT03086057|581784301|FG003|Stage 1: PrEP Uptake|Death|0|||
161107503|NCT03086057|581784298|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
161107504|NCT03086057|581784299|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
161107505|NCT03086057|581784300|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
161107506|NCT03086057|581784301|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
161107507|NCT03086057|581784298|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161107508|NCT03086057|581784299|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161107509|NCT03086057|581784300|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
161107510|NCT03086057|581784301|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
161107511|NCT03086057|581784298|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
161107512|NCT03086057|581784299|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
161107513|NCT03086057|581784300|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
161107514|NCT03086057|581784301|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
161107515|NCT03199040|581784306|FG000|Overall Study|Lack of Efficacy|2|||
161107516|NCT03199040|581784307|FG001|Overall Study|Lack of Efficacy|0|||
161107517|NCT03199040|581784306|FG000|Overall Study|Withdrawal by Subject|2|||
161107518|NCT03199040|581784307|FG001|Overall Study|Withdrawal by Subject|0|||
161107519|NCT03199040|581784306|FG000|Overall Study|Adverse Event|0|||
161107520|NCT03199040|581784307|FG001|Overall Study|Adverse Event|1|||
161107521|NCT03199040|581784306|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
161107522|NCT03199040|581784307|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
161107523|NCT01786603|581784308|FG000|Overall Study|Death|5|||
161107524|NCT01786603|581784309|FG001|Overall Study|Death|1|||
161107525|NCT01786603|581784308|FG000|Overall Study|Adverse Event|6|||
161107526|NCT01786603|581784309|FG001|Overall Study|Adverse Event|2|||
161107527|NCT01786603|581784308|FG000|Overall Study|Physician decision to withdraw|6|||
161107528|NCT01786603|581784309|FG001|Overall Study|Physician decision to withdraw|7|||
161107529|NCT01786603|581784308|FG000|Overall Study|Lost to Follow-up|1|||
161107530|NCT01786603|581784309|FG001|Overall Study|Lost to Follow-up|2|||
161107531|NCT01226459|581784310|FG000|Overall Study|Adverse Event|2|||
161107532|NCT01226459|581784311|FG001|Overall Study|Adverse Event|8|||
161107533|NCT01226459|581784310|FG000|Overall Study|Protocol Violation|4|||
161213755|NCT03840135|582166269|FG000|Overall Study|Protocol Violation|6|||
161213756|NCT03840135|582166270|FG001|Overall Study|Protocol Violation|1|||
161213757|NCT03840135|582166269|FG000|Overall Study|Withdrawal by Subject|1|||
161213758|NCT03840135|582166270|FG001|Overall Study|Withdrawal by Subject|0|||
161213759|NCT00667719|582166271|FG000|Overall Study|Adverse Event|39|||
161213760|NCT00667719|582166271|FG000|Overall Study|Abnormal Test Procedure|1|||
161213761|NCT00667719|582166271|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161213762|NCT00667719|582166271|FG000|Overall Study|Protocol Violation|3|||
161213763|NCT00667719|582166271|FG000|Overall Study|Withdrawal by Subject|17|||
161213764|NCT00667719|582166271|FG000|Overall Study|Lost to Follow-up|8|||
161213765|NCT00323609|582166272|FG000|Overall Study|Death|16|||
161213766|NCT00323609|582166273|FG001|Overall Study|Death|21|||
161213767|NCT00323609|582166274|FG002|Overall Study|Death|0|||
161213768|NCT00323609|582166275|FG003|Overall Study|Death|0|||
161213769|NCT00323609|582166272|FG000|Overall Study|Lost to Follow-up|9|||
161213770|NCT00323609|582166273|FG001|Overall Study|Lost to Follow-up|10|||
161213771|NCT00323609|582166274|FG002|Overall Study|Lost to Follow-up|0|||
161213772|NCT00323609|582166275|FG003|Overall Study|Lost to Follow-up|0|||
161213773|NCT00323609|582166272|FG000|Overall Study|Physician Decision|2|||
161213774|NCT00323609|582166273|FG001|Overall Study|Physician Decision|0|||
161213775|NCT00323609|582166274|FG002|Overall Study|Physician Decision|0|||
161213776|NCT00323609|582166275|FG003|Overall Study|Physician Decision|1|||
161213777|NCT00323609|582166272|FG000|Overall Study|Withdrawal by Subject|11|||
161213778|NCT00323609|582166273|FG001|Overall Study|Withdrawal by Subject|23|||
161213779|NCT00323609|582166274|FG002|Overall Study|Withdrawal by Subject|4|||
161213780|NCT00323609|582166275|FG003|Overall Study|Withdrawal by Subject|4|||
161213781|NCT00323609|582166272|FG000|Overall Study|Other non-VCF-related medical condition|3|||
161213782|NCT00323609|582166273|FG001|Overall Study|Other non-VCF-related medical condition|2|||
161213783|NCT00323609|582166274|FG002|Overall Study|Other non-VCF-related medical condition|0|||
161213784|NCT00323609|582166275|FG003|Overall Study|Other non-VCF-related medical condition|0|||
161213785|NCT00323609|582166272|FG000|Overall Study|Sponsor discontinued trial|29|||
161213786|NCT00323609|582166273|FG001|Overall Study|Sponsor discontinued trial|29|||
161213787|NCT00323609|582166274|FG002|Overall Study|Sponsor discontinued trial|0|||
161213788|NCT00323609|582166275|FG003|Overall Study|Sponsor discontinued trial|0|||
161213789|NCT00323609|582166272|FG000|Overall Study|Unrelenting or severe back pain|1|||
161213790|NCT00323609|582166273|FG001|Overall Study|Unrelenting or severe back pain|1|||
161213791|NCT00323609|582166274|FG002|Overall Study|Unrelenting or severe back pain|0|||
161213792|NCT00323609|582166275|FG003|Overall Study|Unrelenting or severe back pain|0|||
161213793|NCT00323609|582166272|FG000|Overall Study|Logistical withdrawal|9|||
161213794|NCT00323609|582166273|FG001|Overall Study|Logistical withdrawal|5|||
161213795|NCT00323609|582166274|FG002|Overall Study|Logistical withdrawal|0|||
161213796|NCT00323609|582166275|FG003|Overall Study|Logistical withdrawal|1|||
161213797|NCT00323609|582166272|FG000|Overall Study|Other reason|11|||
161213798|NCT00323609|582166273|FG001|Overall Study|Other reason|8|||
161213799|NCT00323609|582166274|FG002|Overall Study|Other reason|4|||
161213800|NCT00323609|582166275|FG003|Overall Study|Other reason|9|||
161213801|NCT01827371|582166276|FG000|Overall Study|Adverse Event|0|||
161213802|NCT01827371|582166277|FG001|Overall Study|Adverse Event|0|||
161213803|NCT01827371|582166278|FG002|Overall Study|Adverse Event|4|||
161213804|NCT01827371|582166279|FG003|Overall Study|Adverse Event|2|||
161213805|NCT01827371|582166276|FG000|Overall Study|Lost to Follow-up|0|||
161213806|NCT01827371|582166277|FG001|Overall Study|Lost to Follow-up|2|||
161213807|NCT01827371|582166278|FG002|Overall Study|Lost to Follow-up|0|||
161213808|NCT01827371|582166279|FG003|Overall Study|Lost to Follow-up|4|||
161213809|NCT01827371|582166276|FG000|Overall Study|Protocol Violation|1|||
161213810|NCT01827371|582166277|FG001|Overall Study|Protocol Violation|0|||
161213811|NCT01827371|582166278|FG002|Overall Study|Protocol Violation|0|||
161213812|NCT01827371|582166279|FG003|Overall Study|Protocol Violation|0|||
161213813|NCT01827371|582166276|FG000|Overall Study|Withdrawal by Subject|1|||
161213814|NCT01827371|582166277|FG001|Overall Study|Withdrawal by Subject|2|||
161213815|NCT01827371|582166278|FG002|Overall Study|Withdrawal by Subject|2|||
161213816|NCT01827371|582166279|FG003|Overall Study|Withdrawal by Subject|3|||
161213817|NCT01827371|582166276|FG000|Overall Study|Physician Decision|0|||
161213818|NCT01827371|582166277|FG001|Overall Study|Physician Decision|1|||
161213819|NCT01827371|582166278|FG002|Overall Study|Physician Decision|0|||
161213820|NCT01827371|582166279|FG003|Overall Study|Physician Decision|1|||
161213821|NCT01827371|582166276|FG000|Overall Study|Temporary study halt to vaccinations|11|||
161213822|NCT01827371|582166277|FG001|Overall Study|Temporary study halt to vaccinations|2|||
161213823|NCT01827371|582166278|FG002|Overall Study|Temporary study halt to vaccinations|5|||
161213824|NCT01827371|582166279|FG003|Overall Study|Temporary study halt to vaccinations|13|||
161213825|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213826|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213827|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213828|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
161213829|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213830|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213831|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213832|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213833|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213834|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
161213835|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161213836|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161213837|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Adverse Event|1|||
161213838|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Adverse Event|1|||
161213839|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Adverse Event|1|||
161213840|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Adverse Event|1|||
161213841|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Adverse Event|0|||
161213842|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Adverse Event|0|||
161213843|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Adverse Event|0|||
161213844|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Adverse Event|0|||
161213845|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
161213846|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
161213847|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
161213848|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
161213849|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
161213850|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
161213851|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
161213852|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
161213853|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
161213854|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
161213855|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161213856|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161213857|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161213858|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
161213859|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
161107534|NCT01226459|581784311|FG001|Overall Study|Protocol Violation|3|||
161107535|NCT01226459|581784310|FG000|Overall Study|Withdrawal by Subject|10|||
161107536|NCT01226459|581784311|FG001|Overall Study|Withdrawal by Subject|13|||
161107537|NCT01226459|581784310|FG000|Overall Study|Lost to Follow-up|4|||
161107538|NCT01226459|581784311|FG001|Overall Study|Lost to Follow-up|8|||
161107539|NCT01226459|581784310|FG000|Overall Study|Pregnancy|1|||
161107540|NCT01226459|581784311|FG001|Overall Study|Pregnancy|0|||
161107541|NCT01092143|581784319|FG000|Overall Study|Adverse Event|10|||
161107542|NCT01092143|581784320|FG001|Overall Study|Adverse Event|5|||
161107543|NCT01092143|581784321|FG002|Overall Study|Adverse Event|1|||
161107544|NCT01092143|581784322|FG003|Overall Study|Adverse Event|4|||
161107545|NCT01092143|581784323|FG004|Overall Study|Adverse Event|3|||
161107546|NCT01092143|581784319|FG000|Overall Study|Lost to Follow-up|1|||
161107547|NCT01092143|581784320|FG001|Overall Study|Lost to Follow-up|0|||
161107548|NCT01092143|581784321|FG002|Overall Study|Lost to Follow-up|1|||
161107549|NCT01092143|581784322|FG003|Overall Study|Lost to Follow-up|0|||
161107550|NCT01092143|581784323|FG004|Overall Study|Lost to Follow-up|0|||
161107551|NCT01092143|581784319|FG000|Overall Study|Consent withdrawn|2|||
161107552|NCT01092143|581784320|FG001|Overall Study|Consent withdrawn|1|||
161107553|NCT01092143|581784321|FG002|Overall Study|Consent withdrawn|0|||
161107554|NCT01092143|581784322|FG003|Overall Study|Consent withdrawn|1|||
161107555|NCT01092143|581784323|FG004|Overall Study|Consent withdrawn|3|||
161107556|NCT01092143|581784319|FG000|Overall Study|Not treated|0|||
161107557|NCT01092143|581784320|FG001|Overall Study|Not treated|0|||
161107558|NCT01092143|581784321|FG002|Overall Study|Not treated|1|||
161107559|NCT01092143|581784322|FG003|Overall Study|Not treated|0|||
161107560|NCT01092143|581784323|FG004|Overall Study|Not treated|0|||
161107561|NCT01092143|581784319|FG000|Overall Study|did not reversibility criteria|0|||
161107562|NCT01092143|581784320|FG001|Overall Study|did not reversibility criteria|0|||
161107563|NCT01092143|581784321|FG002|Overall Study|did not reversibility criteria|1|||
161107564|NCT01092143|581784322|FG003|Overall Study|did not reversibility criteria|0|||
161213860|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
161213861|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
161213862|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
161213863|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
161213864|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
161324274|NCT02959918|582573541|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324275|NCT02959918|582573542|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324276|NCT02959918|582573543|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
161107565|NCT01092143|581784323|FG004|Overall Study|did not reversibility criteria|0|||
161107566|NCT01092143|581784319|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
161107567|NCT01092143|581784320|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
161107568|NCT01092143|581784321|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
161107569|NCT01092143|581784322|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
161107570|NCT01092143|581784323|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
161107571|NCT01092143|581784319|FG000|Overall Study|Ineligible patient|1|||
161107572|NCT01092143|581784320|FG001|Overall Study|Ineligible patient|0|||
161107573|NCT01092143|581784321|FG002|Overall Study|Ineligible patient|0|||
161107574|NCT01092143|581784322|FG003|Overall Study|Ineligible patient|0|||
161107575|NCT01092143|581784323|FG004|Overall Study|Ineligible patient|0|||
161107576|NCT01092143|581784319|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
161107577|NCT01092143|581784320|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
161107578|NCT01092143|581784321|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
161107579|NCT01092143|581784322|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
161107580|NCT01092143|581784323|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
161107581|NCT01092143|581784319|FG000|Overall Study|Patient travel|0|||
161107582|NCT01092143|581784320|FG001|Overall Study|Patient travel|0|||
161107583|NCT01092143|581784321|FG002|Overall Study|Patient travel|0|||
161107584|NCT01092143|581784322|FG003|Overall Study|Patient travel|0|||
161107585|NCT01092143|581784323|FG004|Overall Study|Patient travel|1|||
161107586|NCT01092143|581784319|FG000|Overall Study|Non compliance with study medication|0|||
161107587|NCT01092143|581784320|FG001|Overall Study|Non compliance with study medication|0|||
161107588|NCT01092143|581784321|FG002|Overall Study|Non compliance with study medication|0|||
161107589|NCT01092143|581784322|FG003|Overall Study|Non compliance with study medication|0|||
161107590|NCT01092143|581784323|FG004|Overall Study|Non compliance with study medication|1|||
161107591|NCT01092143|581784319|FG000|Overall Study|Randomized by mistake|0|||
161107592|NCT01092143|581784320|FG001|Overall Study|Randomized by mistake|0|||
161107593|NCT01092143|581784321|FG002|Overall Study|Randomized by mistake|0|||
161107594|NCT01092143|581784322|FG003|Overall Study|Randomized by mistake|1|||
161107595|NCT01092143|581784323|FG004|Overall Study|Randomized by mistake|0|||
161107596|NCT01092143|581784319|FG000|Overall Study|Pregnancy|0|||
161107597|NCT01092143|581784320|FG001|Overall Study|Pregnancy|0|||
161107598|NCT01092143|581784321|FG002|Overall Study|Pregnancy|0|||
161107599|NCT01092143|581784322|FG003|Overall Study|Pregnancy|1|||
161107600|NCT01092143|581784323|FG004|Overall Study|Pregnancy|0|||
161107601|NCT03654976|581784327|FG000|Overall Study|Withdrawal by Subject|12|||
161107602|NCT03654976|581784328|FG001|Overall Study|Withdrawal by Subject|11|||
161107603|NCT03654976|581784327|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
161107604|NCT03654976|581784328|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
161107605|NCT03654976|581784327|FG000|Overall Study|Adverse Event|5|||
161107606|NCT03654976|581784328|FG001|Overall Study|Adverse Event|0|||
161107607|NCT03654976|581784327|FG000|Overall Study|Lost to Follow-up|2|||
161107608|NCT03654976|581784328|FG001|Overall Study|Lost to Follow-up|0|||
161107609|NCT03654976|581784327|FG000|Overall Study|Lack of Efficacy|0|||
161107610|NCT03654976|581784328|FG001|Overall Study|Lack of Efficacy|1|||
161107611|NCT03986866|581784329|FG000|Overall Study|Withdrawal by Subject|0|||
161107612|NCT03986866|581784330|FG001|Overall Study|Withdrawal by Subject|3|||
161107613|NCT03986866|581784329|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
161107614|NCT03986866|581784330|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
161107615|NCT00545064|581784331|FG000|Overall Study|Lost to Follow-up|3|||
161107616|NCT00545064|581784331|FG000|Overall Study|Withdrawal by Subject|2|||
161107617|NCT00545064|581784331|FG000|Overall Study|did not complete course of treatment|1|||
161107618|NCT00545064|581784331|FG000|Overall Study|cancel all appointments, no rebooking|1|||
161107619|NCT00545064|581784331|FG000|Overall Study|inclement weather|1|||
161107620|NCT01817751|581784332|FG000|Overall Study|Physician Decision|1|||
161107621|NCT00382018|581784333|FG000|Overall Study|Progression|0|||
161107622|NCT00382018|581784334|FG001|Overall Study|Progression|136|||
161107623|NCT00382018|581784335|FG002|Overall Study|Progression|51|||
161107624|NCT00382018|581784336|FG003|Overall Study|Progression|43|||
161107625|NCT00382018|581784333|FG000|Overall Study|Death|0|||
161107626|NCT00382018|581784334|FG001|Overall Study|Death|9|||
161107627|NCT00382018|581784335|FG002|Overall Study|Death|7|||
161107628|NCT00382018|581784336|FG003|Overall Study|Death|11|||
161107629|NCT00382018|581784333|FG000|Overall Study|Withdrawal by Subject|0|||
161107630|NCT00382018|581784334|FG001|Overall Study|Withdrawal by Subject|4|||
161107631|NCT00382018|581784335|FG002|Overall Study|Withdrawal by Subject|3|||
161107632|NCT00382018|581784336|FG003|Overall Study|Withdrawal by Subject|4|||
161107633|NCT00382018|581784333|FG000|Overall Study|Other, not protocol specified|0|||
161107634|NCT00382018|581784334|FG001|Overall Study|Other, not protocol specified|16|||
161107635|NCT00382018|581784335|FG002|Overall Study|Other, not protocol specified|3|||
161107636|NCT00382018|581784336|FG003|Overall Study|Other, not protocol specified|1|||
161107637|NCT05082376|581784339|FG000|Overall Study|Lost to Follow-up|2|||
161107638|NCT00290186|581784340|FG000|Overall Study|Adverse Event|1|||
161107639|NCT00290186|581784341|FG001|Overall Study|Adverse Event|1|||
161107640|NCT00290186|581784340|FG000|Overall Study|Lost to Follow-up|3|||
161107641|NCT00290186|581784341|FG001|Overall Study|Lost to Follow-up|2|||
161107642|NCT00290186|581784340|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
161107643|NCT00290186|581784341|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
161107644|NCT00290186|581784340|FG000|Overall Study|Withdrawal by Subject|0|||
161213865|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161213866|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161213867|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213868|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213869|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213870|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213871|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213872|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
161213873|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213874|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
161213875|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213876|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213877|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213878|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213879|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
161213880|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
161213881|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213882|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213883|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213884|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
161213885|NCT00950599|582166280|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
161213886|NCT00950599|582166281|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161213887|NCT00950599|582166282|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161213888|NCT00950599|582166283|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
161213889|NCT00950599|582166284|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
161213890|NCT00950599|582166285|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
161213891|NCT00950599|582166286|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161213892|NCT00950599|582166287|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
161213893|NCT00950599|582166288|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161213894|NCT00950599|582166289|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
161213895|NCT00950599|582166280|FG000|Follow-Up Period|Adverse Event|0|||
161213896|NCT00950599|582166281|FG001|Follow-Up Period|Adverse Event|0|||
161213897|NCT00950599|582166282|FG002|Follow-Up Period|Adverse Event|0|||
161213898|NCT00950599|582166283|FG003|Follow-Up Period|Adverse Event|0|||
161213899|NCT00950599|582166284|FG004|Follow-Up Period|Adverse Event|0|||
161213900|NCT00950599|582166285|FG005|Follow-Up Period|Adverse Event|0|||
161213901|NCT00950599|582166286|FG006|Follow-Up Period|Adverse Event|0|||
161107645|NCT00290186|581784341|FG001|Overall Study|Withdrawal by Subject|1|||
161107646|NCT03197493|581785807|FG000|Overall Study|Withdrawal by Subject|5|||
161107647|NCT00054704|581785808|FG000|Overall Study|Lack of Efficacy|2|||
161107648|NCT00054704|581785809|FG001|Overall Study|Lack of Efficacy|3|||
161107649|NCT00054704|581785808|FG000|Overall Study|Adverse Event|3|||
161107650|NCT00054704|581785809|FG001|Overall Study|Adverse Event|1|||
161107651|NCT00054704|581785808|FG000|Overall Study|Lost to Follow-up|0|||
161107652|NCT00054704|581785809|FG001|Overall Study|Lost to Follow-up|1|||
161107653|NCT01469182|581785812|FG000|Overall Study|Adverse Event|21|||
161107654|NCT01469182|581785813|FG001|Overall Study|Adverse Event|3|||
161107655|NCT01469182|581785812|FG000|Overall Study|Lost to Follow-up|3|||
161107656|NCT01469182|581785813|FG001|Overall Study|Lost to Follow-up|0|||
161107657|NCT01469182|581785812|FG000|Overall Study|Withdrawal by Subject|4|||
161107658|NCT01469182|581785813|FG001|Overall Study|Withdrawal by Subject|1|||
161107659|NCT01469182|581785812|FG000|Overall Study|Protocol Violation|4|||
161107660|NCT01469182|581785813|FG001|Overall Study|Protocol Violation|2|||
161107661|NCT01469182|581785812|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
161107662|NCT01469182|581785813|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
161107663|NCT02236520|581785815|FG000|Overall Study|Physician Decision|0|||
161107664|NCT02236520|581785816|FG001|Overall Study|Physician Decision|5|||
161107665|NCT02236520|581785817|FG002|Overall Study|Physician Decision|0|||
161107666|NCT02236520|581785818|FG003|Overall Study|Physician Decision|0|||
161107667|NCT02236520|581785815|FG000|Overall Study|Withdrawal by Subject|1|||
161107668|NCT02236520|581785816|FG001|Overall Study|Withdrawal by Subject|0|||
161107669|NCT02236520|581785817|FG002|Overall Study|Withdrawal by Subject|0|||
161213902|NCT00950599|582166287|FG007|Follow-Up Period|Adverse Event|0|||
161213903|NCT00950599|582166288|FG008|Follow-Up Period|Adverse Event|1|||
161213904|NCT00950599|582166289|FG009|Follow-Up Period|Adverse Event|0|||
161107670|NCT02236520|581785818|FG003|Overall Study|Withdrawal by Subject|1|||
161107671|NCT02236520|581785815|FG000|Overall Study|Pregnancy|1|||
161107672|NCT02236520|581785816|FG001|Overall Study|Pregnancy|0|||
161107673|NCT02236520|581785817|FG002|Overall Study|Pregnancy|0|||
161107674|NCT02236520|581785818|FG003|Overall Study|Pregnancy|0|||
161107675|NCT01785160|581785819|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
161107676|NCT01785160|581785819|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
161107677|NCT01033734|581785820|FG000|Overall Study|Withdrawal by Subject|1|||
161107678|NCT01360554|581785823|FG000|Overall Study|Death|359|||
161107679|NCT01360554|581785824|FG001|Overall Study|Death|371|||
161107680|NCT01360554|581785823|FG000|Overall Study|Lost to Follow-up|4|||
161213905|NCT00950599|582166280|FG000|Follow-Up Period|Lack of Efficacy|0|||
161213906|NCT00950599|582166281|FG001|Follow-Up Period|Lack of Efficacy|0|||
161213907|NCT00950599|582166282|FG002|Follow-Up Period|Lack of Efficacy|0|||
161107681|NCT01360554|581785824|FG001|Overall Study|Lost to Follow-up|4|||
161107682|NCT01360554|581785823|FG000|Overall Study|Withdrawal by Subject|23|||
161107683|NCT01360554|581785824|FG001|Overall Study|Withdrawal by Subject|24|||
161107684|NCT01360554|581785823|FG000|Overall Study|Study terminated by sponsor|49|||
161107685|NCT01360554|581785824|FG001|Overall Study|Study terminated by sponsor|37|||
161107686|NCT01360554|581785823|FG000|Overall Study|Other, not specified|1|||
161107687|NCT01360554|581785824|FG001|Overall Study|Other, not specified|0|||
161107688|NCT01360554|581785823|FG000|Overall Study|Randomized but not treated.|3|||
161107689|NCT01360554|581785824|FG001|Overall Study|Randomized but not treated.|3|||
161107690|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
161107691|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
161107692|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161107693|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161107694|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
161107695|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
161107696|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
161107697|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161107698|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
161107699|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161107700|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
161107701|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
161107702|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
161107703|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
161107704|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
161107705|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
161107706|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
161107707|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
161107708|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
161107709|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
161107710|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
161107711|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
161107712|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
161107713|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
161107714|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
161107715|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161107716|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161107717|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
161107718|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161107719|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
161107720|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107721|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161107722|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161107723|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161107724|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107725|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161107726|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161107727|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161107728|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161107729|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
161107730|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161107731|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
161107732|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
161107733|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
161107734|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161107735|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161107736|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161107737|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
161107738|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
161107739|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161107740|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161107741|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161107742|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161107743|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
161107744|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161107745|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
161107746|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161107747|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161107748|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161107749|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
161107750|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161107751|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
161107752|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161107753|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161107754|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161107755|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
161107756|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161107757|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
161107758|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161107759|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161107760|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161107761|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
161107762|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161107763|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
161107764|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161107765|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161107766|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161107767|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
161107768|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161107769|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161107770|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161107771|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
161107772|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161107773|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
161107774|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161107775|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161107776|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161107777|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
161107778|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161107779|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
161107780|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161107781|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161107782|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161107783|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161107784|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
161107785|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
161107786|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161107787|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161107788|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161107789|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161107790|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
161107791|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
161107792|NCT00111800|581785827|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161107793|NCT00111800|581785828|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161107794|NCT00111800|581785829|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161107795|NCT00111800|581785830|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161107796|NCT00111800|581785831|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
161107797|NCT00111800|581785832|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
161213908|NCT00950599|582166283|FG003|Follow-Up Period|Lack of Efficacy|0|||
161107798|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161107799|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
161107800|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
161107801|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
161107802|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161107803|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
161107804|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161107805|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
161107806|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
161107807|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161107808|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161107809|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
161107810|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161107811|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
161107812|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
161107813|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161107814|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
161107815|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
161107816|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161107817|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
161107818|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161107819|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161107820|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
161107821|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
161107822|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107823|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107824|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
161107825|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107826|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107827|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
161107828|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161107829|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
161107830|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161107831|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161107832|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161107833|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
161107834|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161107835|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161107836|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
161107837|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161107838|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161107839|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
161107840|NCT00111800|581785827|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161107841|NCT00111800|581785828|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161107842|NCT00111800|581785829|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
161107843|NCT00111800|581785830|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161107844|NCT00111800|581785831|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161107845|NCT00111800|581785832|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
161107846|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
161107847|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
161107848|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
161107849|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
161107850|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
161107851|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
161107852|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
161107853|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
161107854|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
161107855|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
161107856|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
161107857|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
161107858|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
161107859|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
161107860|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
161107861|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
161107862|NCT00094770|581785833|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
161107863|NCT00094770|581785834|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
161107864|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
161107865|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
161107866|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
161107867|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
161107868|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
161107869|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
161107870|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
161107871|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
161107872|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
161107873|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
161107874|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
161107875|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
161107876|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
161107877|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
161107878|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
161107879|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
161107880|NCT00094770|581785833|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
161107881|NCT00094770|581785834|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
161107882|NCT01911442|581785835|FG000|Overall Study|Adverse Event|2|||
161107883|NCT01911442|581785836|FG001|Overall Study|Adverse Event|2|||
161107884|NCT01911442|581785837|FG002|Overall Study|Adverse Event|4|||
161107885|NCT01911442|581785835|FG000|Overall Study|Lack of Efficacy|1|||
161107886|NCT01911442|581785836|FG001|Overall Study|Lack of Efficacy|1|||
161107887|NCT01911442|581785837|FG002|Overall Study|Lack of Efficacy|1|||
161107888|NCT01911442|581785835|FG000|Overall Study|Lost to Follow-up|2|||
161107889|NCT01911442|581785836|FG001|Overall Study|Lost to Follow-up|0|||
161107890|NCT01911442|581785837|FG002|Overall Study|Lost to Follow-up|1|||
161107891|NCT01911442|581785835|FG000|Overall Study|Withdrawal by Subject|1|||
161107892|NCT01911442|581785836|FG001|Overall Study|Withdrawal by Subject|0|||
161107893|NCT01911442|581785837|FG002|Overall Study|Withdrawal by Subject|6|||
161107894|NCT01911442|581785835|FG000|Overall Study|Mother's Work Schedule|0|||
161107895|NCT01911442|581785836|FG001|Overall Study|Mother's Work Schedule|1|||
161107896|NCT01911442|581785837|FG002|Overall Study|Mother's Work Schedule|0|||
161107897|NCT02752035|581785841|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
161107898|NCT02752035|581785842|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161107899|NCT02752035|581785843|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161107900|NCT02752035|581785844|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
161107901|NCT02752035|581785841|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
161107902|NCT02752035|581785842|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161107903|NCT02752035|581785843|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161107904|NCT02752035|581785844|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
161107905|NCT02752035|581785841|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
161107906|NCT02752035|581785842|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161107907|NCT02752035|581785843|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161107908|NCT02752035|581785844|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
161107909|NCT02752035|581785841|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
161107910|NCT02752035|581785842|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161107911|NCT02752035|581785843|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161107912|NCT02752035|581785844|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
161107913|NCT02752035|581785841|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
161107914|NCT02752035|581785842|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
161107915|NCT02752035|581785843|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
161107916|NCT02752035|581785844|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
161107917|NCT02752035|581785841|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
161107918|NCT02752035|581785842|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161107919|NCT02752035|581785843|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161107920|NCT02752035|581785844|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
161107921|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
161107922|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
161107923|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
161107924|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
161107925|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
161107926|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
161107927|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
161107928|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
161107929|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
161107930|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
161107931|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
161107932|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
161107933|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
161107934|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
161107935|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
161107936|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
161107937|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
161107938|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
161107939|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
161107940|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
161107941|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Death|0|||
161107942|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Death|25|||
161107943|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Death|13|||
161107944|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Death|4|||
161107945|NCT02752035|581785841|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
161107946|NCT02752035|581785842|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
161107947|NCT02752035|581785843|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
161107948|NCT02752035|581785844|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
161107949|NCT02752035|581785841|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
161107950|NCT02752035|581785842|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
161107951|NCT02752035|581785843|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
161107952|NCT02752035|581785844|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
161107953|NCT02752035|581785841|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
161107954|NCT02752035|581785842|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
161107955|NCT02752035|581785843|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
161107956|NCT02752035|581785844|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
161107957|NCT02752035|581785841|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
161107958|NCT02752035|581785842|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
161107959|NCT02752035|581785843|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
161107960|NCT02752035|581785844|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
161107961|NCT02752035|581785841|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161107962|NCT02752035|581785842|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
161107963|NCT02752035|581785843|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161107964|NCT02752035|581785844|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
161107965|NCT03668600|581785847|FG000|Overall Study|Study Terminated by the Sponsor|157|||
161107966|NCT03668600|581785847|FG000|Overall Study|Protocol Violation|1|||
161107967|NCT03668600|581785847|FG000|Overall Study|Pregnancy|1|||
161107968|NCT03668600|581785847|FG000|Overall Study|Lost to Follow-up|7|||
161107969|NCT03668600|581785847|FG000|Overall Study|Withdrawal by Subject|56|||
161107970|NCT03668600|581785847|FG000|Overall Study|Lack of Efficacy|7|||
161107971|NCT03668600|581785847|FG000|Overall Study|Adverse Event|1|||
161107972|NCT00424749|581785849|FG000|Overall Study|Withdrawal by Subject|1|||
161107973|NCT01263483|581785850|FG000|Overall Study|Adverse Event|4|||
161107974|NCT01263483|581785851|FG001|Overall Study|Adverse Event|0|||
161107975|NCT01263483|581785852|FG002|Overall Study|Adverse Event|3|||
161107976|NCT01263483|581785850|FG000|Overall Study|Withdrawal by Subject|1|||
161107977|NCT01263483|581785851|FG001|Overall Study|Withdrawal by Subject|0|||
161107978|NCT01263483|581785852|FG002|Overall Study|Withdrawal by Subject|0|||
161107979|NCT01263483|581785850|FG000|Overall Study|Lack of Efficacy|2|||
161107980|NCT01263483|581785851|FG001|Overall Study|Lack of Efficacy|0|||
161107981|NCT01263483|581785852|FG002|Overall Study|Lack of Efficacy|0|||
161107982|NCT01263483|581785850|FG000|Overall Study|Protocol Violation|0|||
161107983|NCT01263483|581785851|FG001|Overall Study|Protocol Violation|1|||
161107984|NCT01263483|581785852|FG002|Overall Study|Protocol Violation|1|||
161107985|NCT01263483|581785850|FG000|Overall Study|Participant Unavailability|0|||
161107986|NCT01263483|581785851|FG001|Overall Study|Participant Unavailability|1|||
160865673|NCT02504151|580902947|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
161213909|NCT00950599|582166284|FG004|Follow-Up Period|Lack of Efficacy|0|||
161213910|NCT00950599|582166285|FG005|Follow-Up Period|Lack of Efficacy|0|||
161213911|NCT00950599|582166286|FG006|Follow-Up Period|Lack of Efficacy|0|||
161213912|NCT00950599|582166287|FG007|Follow-Up Period|Lack of Efficacy|0|||
161213913|NCT00950599|582166288|FG008|Follow-Up Period|Lack of Efficacy|3|||
161213914|NCT00950599|582166289|FG009|Follow-Up Period|Lack of Efficacy|0|||
161213915|NCT00950599|582166280|FG000|Follow-Up Period|Lost to Follow-up|0|||
161213916|NCT00950599|582166281|FG001|Follow-Up Period|Lost to Follow-up|0|||
161213917|NCT00950599|582166282|FG002|Follow-Up Period|Lost to Follow-up|0|||
161213918|NCT00950599|582166283|FG003|Follow-Up Period|Lost to Follow-up|0|||
161213919|NCT00950599|582166284|FG004|Follow-Up Period|Lost to Follow-up|0|||
161213920|NCT00950599|582166285|FG005|Follow-Up Period|Lost to Follow-up|0|||
161213921|NCT00950599|582166286|FG006|Follow-Up Period|Lost to Follow-up|0|||
161213922|NCT00950599|582166287|FG007|Follow-Up Period|Lost to Follow-up|0|||
161213923|NCT00950599|582166288|FG008|Follow-Up Period|Lost to Follow-up|5|||
161213924|NCT00950599|582166289|FG009|Follow-Up Period|Lost to Follow-up|1|||
161213925|NCT00950599|582166280|FG000|Follow-Up Period|Physician Decision|0|||
161213926|NCT00950599|582166281|FG001|Follow-Up Period|Physician Decision|0|||
161213927|NCT00950599|582166282|FG002|Follow-Up Period|Physician Decision|0|||
161213928|NCT00950599|582166283|FG003|Follow-Up Period|Physician Decision|0|||
161213929|NCT00950599|582166284|FG004|Follow-Up Period|Physician Decision|0|||
161213930|NCT00950599|582166285|FG005|Follow-Up Period|Physician Decision|0|||
161213931|NCT00950599|582166286|FG006|Follow-Up Period|Physician Decision|0|||
161213932|NCT00950599|582166287|FG007|Follow-Up Period|Physician Decision|0|||
161213933|NCT00950599|582166288|FG008|Follow-Up Period|Physician Decision|1|||
161213934|NCT00950599|582166289|FG009|Follow-Up Period|Physician Decision|0|||
161213935|NCT00950599|582166280|FG000|Follow-Up Period|Poor/Noncompliance|0|||
161213936|NCT00950599|582166281|FG001|Follow-Up Period|Poor/Noncompliance|0|||
161213937|NCT00950599|582166282|FG002|Follow-Up Period|Poor/Noncompliance|0|||
161213938|NCT00950599|582166283|FG003|Follow-Up Period|Poor/Noncompliance|0|||
161213939|NCT00950599|582166284|FG004|Follow-Up Period|Poor/Noncompliance|0|||
161213940|NCT00950599|582166285|FG005|Follow-Up Period|Poor/Noncompliance|0|||
161213941|NCT00950599|582166286|FG006|Follow-Up Period|Poor/Noncompliance|0|||
161213942|NCT00950599|582166287|FG007|Follow-Up Period|Poor/Noncompliance|0|||
161213943|NCT00950599|582166288|FG008|Follow-Up Period|Poor/Noncompliance|1|||
161213944|NCT00950599|582166289|FG009|Follow-Up Period|Poor/Noncompliance|0|||
161213945|NCT00950599|582166280|FG000|Follow-Up Period|Subject withdrew Consent|0|||
161213946|NCT00950599|582166281|FG001|Follow-Up Period|Subject withdrew Consent|0|||
161213947|NCT00950599|582166282|FG002|Follow-Up Period|Subject withdrew Consent|0|||
161213948|NCT00950599|582166283|FG003|Follow-Up Period|Subject withdrew Consent|0|||
161213949|NCT00950599|582166284|FG004|Follow-Up Period|Subject withdrew Consent|0|||
161213950|NCT00950599|582166285|FG005|Follow-Up Period|Subject withdrew Consent|0|||
161213951|NCT00950599|582166286|FG006|Follow-Up Period|Subject withdrew Consent|0|||
161213952|NCT00950599|582166287|FG007|Follow-Up Period|Subject withdrew Consent|0|||
161213953|NCT00950599|582166288|FG008|Follow-Up Period|Subject withdrew Consent|2|||
161213954|NCT00950599|582166289|FG009|Follow-Up Period|Subject withdrew Consent|1|||
161213955|NCT01361607|582166292|FG000|Overall Study|Adverse Event|38|||
161213956|NCT01361607|582166293|FG001|Overall Study|Adverse Event|29|||
161213957|NCT01361607|582166292|FG000|Overall Study|Withdrawal by Subject|19|||
161213958|NCT01361607|582166293|FG001|Overall Study|Withdrawal by Subject|8|||
161213959|NCT01361607|582166292|FG000|Overall Study|Withdrawal by Investigator|5|||
161213960|NCT01361607|582166293|FG001|Overall Study|Withdrawal by Investigator|3|||
161213961|NCT01361607|582166292|FG000|Overall Study|Lost to Follow-up|1|||
161213962|NCT01361607|582166293|FG001|Overall Study|Lost to Follow-up|0|||
161213963|NCT01361607|582166292|FG000|Overall Study|Met Withdrawal Criteria|1|||
161213964|NCT01361607|582166293|FG001|Overall Study|Met Withdrawal Criteria|1|||
161213965|NCT02741271|582166302|FG000|Overall Study|Lost to Follow-up|2|||
161213966|NCT02741271|582166303|FG001|Overall Study|Lost to Follow-up|0|||
161213967|NCT02741271|582166302|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161213968|NCT02741271|582166303|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161213969|NCT00373685|582166304|FG000|Overall Study|Death|2|||
161213970|NCT00373685|582166305|FG001|Overall Study|Death|1|||
161213971|NCT00373685|582166304|FG000|Overall Study|Adverse Event|278|||
161213972|NCT00373685|582166305|FG001|Overall Study|Adverse Event|253|||
161213973|NCT00373685|582166304|FG000|Overall Study|Insufficient clinical response|169|||
161213974|NCT00373685|582166305|FG001|Overall Study|Insufficient clinical response|119|||
161213975|NCT00373685|582166304|FG000|Overall Study|Did not meet entrance criteria|167|||
161213976|NCT00373685|582166305|FG001|Overall Study|Did not meet entrance criteria|184|||
161213977|NCT00373685|582166304|FG000|Overall Study|Lost to follow up|83|||
161213978|NCT00373685|582166305|FG001|Overall Study|Lost to follow up|103|||
161213979|NCT00373685|582166304|FG000|Overall Study|No longer willing to participate|337|||
161213980|NCT00373685|582166305|FG001|Overall Study|No longer willing to participate|352|||
161213981|NCT00373685|582166304|FG000|Overall Study|Other|149|||
161213982|NCT00373685|582166305|FG001|Overall Study|Other|146|||
161213983|NCT00373685|582166304|FG000|Overall Study|Protocol Violation|191|||
161213984|NCT00373685|582166305|FG001|Overall Study|Protocol Violation|182|||
161107987|NCT01263483|581785852|FG002|Overall Study|Participant Unavailability|1|||
161107988|NCT01131676|581785857|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
161107989|NCT01131676|581785858|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
161107990|NCT01131676|581785859|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
161107991|NCT01131676|581785857|FG000|Discontinuation From Treatment|Not treated|4|||
161107992|NCT01131676|581785858|FG001|Discontinuation From Treatment|Not treated|2|||
161107993|NCT01131676|581785859|FG002|Discontinuation From Treatment|Not treated|2|||
161107994|NCT01131676|581785857|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
161107995|NCT01131676|581785858|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
161107996|NCT01131676|581785859|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
161107997|NCT01131676|581785857|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
161107998|NCT01131676|581785858|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
161107999|NCT01131676|581785859|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
161108000|NCT01131676|581785857|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
161108001|NCT01131676|581785858|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
161108002|NCT01131676|581785859|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
161108003|NCT01131676|581785857|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
161108004|NCT01131676|581785858|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
161108005|NCT01131676|581785859|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
161108006|NCT01131676|581785857|FG000|Discontinuation From Treatment|Other than those specified|162|||
161108007|NCT01131676|581785858|FG001|Discontinuation From Treatment|Other than those specified|142|||
161108008|NCT01131676|581785859|FG002|Discontinuation From Treatment|Other than those specified|125|||
161108009|NCT01131676|581785857|FG000|Discontinuation From Treatment|Adverse Event|303|||
161108010|NCT01131676|581785858|FG001|Discontinuation From Treatment|Adverse Event|267|||
161108011|NCT01131676|581785859|FG002|Discontinuation From Treatment|Adverse Event|273|||
161108012|NCT01131676|581785857|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
161108013|NCT01131676|581785858|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
161108014|NCT01131676|581785859|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
161108015|NCT01131676|581785857|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
161108016|NCT01131676|581785858|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
161108017|NCT01131676|581785859|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
161108018|NCT01131676|581785857|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
161108019|NCT01131676|581785858|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
161108020|NCT01131676|581785859|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
161108021|NCT01131676|581785857|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
161108022|NCT01131676|581785858|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
161108023|NCT01131676|581785859|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
161108024|NCT01131676|581785857|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
161142548|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142549|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142550|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142551|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142552|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142553|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142554|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142555|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142556|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142557|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142558|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142559|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142560|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142561|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
161142562|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
161142563|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Physician Decision|0|||
161142564|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Physician Decision|0|||
161142565|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Physician Decision|0|||
161142566|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Physician Decision|0|||
161142567|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Physician Decision|0|||
161142568|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Physician Decision|0|||
161142569|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Physician Decision|0|||
161142570|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Physician Decision|0|||
161142571|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Physician Decision|0|||
161142572|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Physician Decision|0|||
161142573|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Physician Decision|0|||
161142574|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Physician Decision|0|||
161142575|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Physician Decision|0|||
161213985|NCT00373685|582166304|FG000|Overall Study|Final Status Unknown|12|||
161213986|NCT00373685|582166305|FG001|Overall Study|Final Status Unknown|4|||
161213987|NCT00373685|582166304|FG000|Overall Study|Randomized, not treated|51|||
161213988|NCT00373685|582166305|FG001|Overall Study|Randomized, not treated|77|||
161213989|NCT02570165|582166306|FG000|Overall Study|Adverse Event|1|||
161213990|NCT02570165|582166307|FG001|Overall Study|Adverse Event|0|||
161213991|NCT02570165|582166308|FG002|Overall Study|Adverse Event|2|||
161213992|NCT02570165|582166309|FG003|Overall Study|Adverse Event|0|||
161213993|NCT02570165|582166310|FG004|Overall Study|Adverse Event|0|||
161213994|NCT02570165|582166311|FG005|Overall Study|Adverse Event|0|||
161213995|NCT02570165|582166312|FG006|Overall Study|Adverse Event|0|||
161213996|NCT02570165|582166306|FG000|Overall Study|Lack of Efficacy|0|||
161213997|NCT02570165|582166307|FG001|Overall Study|Lack of Efficacy|1|||
161213998|NCT02570165|582166308|FG002|Overall Study|Lack of Efficacy|0|||
161213999|NCT02570165|582166309|FG003|Overall Study|Lack of Efficacy|0|||
161214000|NCT02570165|582166310|FG004|Overall Study|Lack of Efficacy|4|||
161214001|NCT02570165|582166311|FG005|Overall Study|Lack of Efficacy|0|||
161214002|NCT02570165|582166312|FG006|Overall Study|Lack of Efficacy|0|||
161214003|NCT02570165|582166306|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
161214004|NCT02570165|582166307|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
161214005|NCT02570165|582166308|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
161214006|NCT02570165|582166309|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
161214007|NCT02570165|582166310|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
161214008|NCT02570165|582166311|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
161214009|NCT02570165|582166312|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
161214010|NCT02570165|582166306|FG000|Overall Study|Lost to Follow-up|0|||
161214011|NCT02570165|582166307|FG001|Overall Study|Lost to Follow-up|0|||
161214012|NCT02570165|582166308|FG002|Overall Study|Lost to Follow-up|1|||
161214013|NCT02570165|582166309|FG003|Overall Study|Lost to Follow-up|1|||
161214014|NCT02570165|582166310|FG004|Overall Study|Lost to Follow-up|0|||
161214015|NCT02570165|582166311|FG005|Overall Study|Lost to Follow-up|0|||
161214016|NCT02570165|582166312|FG006|Overall Study|Lost to Follow-up|0|||
161214017|NCT02570165|582166306|FG000|Overall Study|Physician Decision|0|||
161214018|NCT02570165|582166307|FG001|Overall Study|Physician Decision|1|||
161214019|NCT02570165|582166308|FG002|Overall Study|Physician Decision|0|||
161214020|NCT02570165|582166309|FG003|Overall Study|Physician Decision|0|||
161214021|NCT02570165|582166310|FG004|Overall Study|Physician Decision|0|||
161214022|NCT02570165|582166311|FG005|Overall Study|Physician Decision|0|||
161214023|NCT02570165|582166312|FG006|Overall Study|Physician Decision|0|||
161214024|NCT02570165|582166306|FG000|Overall Study|Withdrawal by Subject|0|||
161214025|NCT02570165|582166307|FG001|Overall Study|Withdrawal by Subject|0|||
161214026|NCT02570165|582166308|FG002|Overall Study|Withdrawal by Subject|0|||
161214027|NCT02570165|582166309|FG003|Overall Study|Withdrawal by Subject|2|||
161214028|NCT02570165|582166310|FG004|Overall Study|Withdrawal by Subject|1|||
161214029|NCT02570165|582166311|FG005|Overall Study|Withdrawal by Subject|0|||
161214030|NCT02570165|582166312|FG006|Overall Study|Withdrawal by Subject|0|||
161108025|NCT01131676|581785858|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
161108026|NCT01131676|581785859|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
161108027|NCT01131676|581785857|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
161108028|NCT01131676|581785858|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
161108029|NCT01131676|581785859|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
161108030|NCT04109222|581785860|FG000|Overall Study|Adverse Event|1|||
161108031|NCT04109222|581785861|FG001|Overall Study|Adverse Event|0|||
161108032|NCT04109222|581785862|FG002|Overall Study|Adverse Event|0|||
161108033|NCT02577406|581785863|FG000|Randomized Period|Death|1|||
161108034|NCT02577406|581785864|FG001|Randomized Period|Death|0|||
161108035|NCT02577406|581785863|FG000|Randomized Period|Other reasons|0|||
161108036|NCT02577406|581785864|FG001|Randomized Period|Other reasons|20|||
161108037|NCT02577406|581785863|FG000|Treatment Period|Death|38|||
161214031|NCT02570165|582166306|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
161214032|NCT02570165|582166307|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
161214033|NCT02570165|582166308|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
161214034|NCT02570165|582166309|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
161214035|NCT02570165|582166310|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
161214036|NCT02570165|582166311|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
161214037|NCT02570165|582166312|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
161214038|NCT02570165|582166306|FG000|Overall Study|Withdrawal Request by GSK|0|||
161214039|NCT02570165|582166307|FG001|Overall Study|Withdrawal Request by GSK|0|||
161108038|NCT02577406|581785864|FG001|Treatment Period|Death|23|||
161214040|NCT02570165|582166308|FG002|Overall Study|Withdrawal Request by GSK|2|||
161214041|NCT02570165|582166309|FG003|Overall Study|Withdrawal Request by GSK|0|||
161214042|NCT02570165|582166310|FG004|Overall Study|Withdrawal Request by GSK|0|||
161214043|NCT02570165|582166311|FG005|Overall Study|Withdrawal Request by GSK|0|||
161214044|NCT02570165|582166312|FG006|Overall Study|Withdrawal Request by GSK|0|||
161108039|NCT02577406|581785863|FG000|Treatment Period|Adverse Event|17|||
161108040|NCT02577406|581785864|FG001|Treatment Period|Adverse Event|12|||
161108041|NCT02577406|581785863|FG000|Treatment Period|Progressive Disease|53|||
161108042|NCT02577406|581785864|FG001|Treatment Period|Progressive Disease|37|||
161108043|NCT02577406|581785863|FG000|Treatment Period|Withdrawal by Subject|10|||
161108044|NCT02577406|581785864|FG001|Treatment Period|Withdrawal by Subject|24|||
161108045|NCT02577406|581785863|FG000|Treatment Period|Lost to Follow-up|0|||
161108046|NCT02577406|581785864|FG001|Treatment Period|Lost to Follow-up|1|||
161108047|NCT02577406|581785863|FG000|Treatment Period|Transition to commercially available treatment|1|||
161108048|NCT02577406|581785864|FG001|Treatment Period|Transition to commercially available treatment|1|||
161108049|NCT02577406|581785863|FG000|Treatment Period|Physician Decision|1|||
161108050|NCT02577406|581785864|FG001|Treatment Period|Physician Decision|0|||
161108051|NCT02577406|581785863|FG000|Treatment Period|Disease Relapse|28|||
161108052|NCT02577406|581785864|FG001|Treatment Period|Disease Relapse|1|||
161108053|NCT02577406|581785863|FG000|Treatment Period|Protocol Violation|0|||
161108054|NCT02577406|581785864|FG001|Treatment Period|Protocol Violation|1|||
161108055|NCT02577406|581785863|FG000|Treatment Period|Other Reasons|3|||
161108056|NCT02577406|581785864|FG001|Treatment Period|Other Reasons|39|||
161108057|NCT02577406|581785863|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
161108058|NCT02577406|581785864|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
161108059|NCT01111851|581785870|FG000|Overall Study|All planned PET scans were not obtained.|2|||
161108060|NCT01111851|581785871|FG001|Overall Study|All planned PET scans were not obtained.|0|||
161214045|NCT01789281|582166313|FG000|Overall Study|Disease progression|15|||
161214046|NCT01789281|582166314|FG001|Overall Study|Disease progression|4|||
161214047|NCT01789281|582166313|FG000|Overall Study|Adverse Event|5|||
161214048|NCT01789281|582166314|FG001|Overall Study|Adverse Event|5|||
161214049|NCT01789281|582166313|FG000|Overall Study|Withdrawal by Subject|1|||
161214050|NCT01789281|582166314|FG001|Overall Study|Withdrawal by Subject|0|||
161214051|NCT01789281|582166313|FG000|Overall Study|Lost to Follow-up|1|||
161214052|NCT01789281|582166314|FG001|Overall Study|Lost to Follow-up|0|||
161214053|NCT01789281|582166313|FG000|Overall Study|Administrative problems|0|||
161214054|NCT01789281|582166314|FG001|Overall Study|Administrative problems|1|||
161214055|NCT00411762|582166316|FG000|Overall Study|Withdrawal by Subject|5|||
161214056|NCT04428502|582166317|FG000|Overall Study|Did not meet entrance criteria|14|||
161214057|NCT02295280|582166319|FG000|Overall Study|Adverse Event|0|||
161214058|NCT02295280|582166320|FG001|Overall Study|Adverse Event|1|||
161214059|NCT02875067|582166321|FG000|Overall Study|Withdrawal by Subject|1|||
161214060|NCT02875067|582166321|FG000|Overall Study|Withdrawal by Termination of Study|5|||
161214061|NCT01430104|582166322|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
161214062|NCT02713243|582166324|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
161108061|NCT05500274|581785872|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
161108062|NCT05500274|581785873|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
161108063|NCT05500274|581785872|FG000|Overall Study|Lost to Follow-up|76|||
161108064|NCT05500274|581785873|FG001|Overall Study|Lost to Follow-up|51|||
161214063|NCT02713243|582166325|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
161214064|NCT02713243|582166324|FG000|Overall Study|Administrative problems|0|||
161214065|NCT02713243|582166325|FG001|Overall Study|Administrative problems|1|||
161214066|NCT02713243|582166324|FG000|Overall Study|Protocol deviation|0|||
161214067|NCT02713243|582166325|FG001|Overall Study|Protocol deviation|1|||
161214068|NCT03056352|582166326|FG000|Overall Study|Lost to Follow-up|1|||
161214069|NCT02971605|582166327|FG000|Overall Study|Withdrawal by Subject|1|||
161214070|NCT03262233|582167344|FG000|Overall Study|Withdrawal by Subject|12|||
161108065|NCT01961349|581785874|FG000|Overall Study|Withdrawal by Subject|1|||
161214071|NCT03262233|582167345|FG001|Overall Study|Withdrawal by Subject|8|||
161108066|NCT01961349|581785875|FG001|Overall Study|Withdrawal by Subject|4|||
161108067|NCT01961349|581785876|FG002|Overall Study|Withdrawal by Subject|0|||
161108068|NCT01961349|581785874|FG000|Overall Study|Adverse Event|0|||
161108069|NCT01961349|581785875|FG001|Overall Study|Adverse Event|0|||
161214072|NCT03262233|582167346|FG002|Overall Study|Withdrawal by Subject|21|||
161214073|NCT03262233|582167347|FG003|Overall Study|Withdrawal by Subject|13|||
161214074|NCT03262233|582167344|FG000|Overall Study|Declined due to shock|1|||
161214075|NCT03262233|582167345|FG001|Overall Study|Declined due to shock|2|||
161214076|NCT03262233|582167346|FG002|Overall Study|Declined due to shock|2|||
161214077|NCT03262233|582167347|FG003|Overall Study|Declined due to shock|3|||
161214078|NCT03262233|582167344|FG000|Overall Study|Protocol Violation|5|||
161214079|NCT03262233|582167345|FG001|Overall Study|Protocol Violation|10|||
161214080|NCT03262233|582167346|FG002|Overall Study|Protocol Violation|2|||
161214081|NCT03262233|582167347|FG003|Overall Study|Protocol Violation|13|||
161214082|NCT03262233|582167344|FG000|Overall Study|data collection artifact|0|||
161214083|NCT03262233|582167345|FG001|Overall Study|data collection artifact|1|||
161214084|NCT03262233|582167346|FG002|Overall Study|data collection artifact|0|||
161214085|NCT03262233|582167347|FG003|Overall Study|data collection artifact|0|||
161214086|NCT03877237|582167348|FG000|Overall Study|Adverse Event|1|||
161214087|NCT03877237|582167349|FG001|Overall Study|Adverse Event|2|||
161214088|NCT03877237|582167348|FG000|Overall Study|Death|3|||
161214089|NCT03877237|582167349|FG001|Overall Study|Death|2|||
161214090|NCT03877237|582167348|FG000|Overall Study|Physician Decision|1|||
161214091|NCT03877237|582167349|FG001|Overall Study|Physician Decision|0|||
161214092|NCT03877237|582167348|FG000|Overall Study|Withdrawal by Subject|0|||
161214093|NCT03877237|582167349|FG001|Overall Study|Withdrawal by Subject|2|||
161214094|NCT00566098|582167351|FG000|Collection of MILs|Withdrawal by Subject|1|||
161214095|NCT00566098|582167351|FG000|Collection of MILs|Relapsed|1|||
161214096|NCT00566098|582167351|FG000|Generation of MILs Product|Relapsed|1|||
161214097|NCT00566098|582167351|FG000|Administration of ASCT+MILs|Death|10|||
161214098|NCT00566098|582167351|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
161214099|NCT02236754|582167352|FG000|Overall Study|Withdrawal by Subject|1|||
161214100|NCT02236754|582167353|FG001|Overall Study|Withdrawal by Subject|0|||
161214101|NCT01270841|582167354|FG000|Overall Study|Adverse Event|0|||
161214102|NCT01270841|582167355|FG001|Overall Study|Adverse Event|1|||
161214103|NCT01270841|582167356|FG002|Overall Study|Adverse Event|0|||
161214104|NCT01270841|582167357|FG003|Overall Study|Adverse Event|3|||
161214105|NCT01270841|582167354|FG000|Overall Study|Withdrawal by Subject|3|||
161214106|NCT01270841|582167355|FG001|Overall Study|Withdrawal by Subject|2|||
161214107|NCT01270841|582167356|FG002|Overall Study|Withdrawal by Subject|3|||
161214108|NCT01270841|582167357|FG003|Overall Study|Withdrawal by Subject|3|||
161214109|NCT01270841|582167354|FG000|Overall Study|Lost to Follow-up|3|||
161214110|NCT01270841|582167355|FG001|Overall Study|Lost to Follow-up|1|||
161214111|NCT01270841|582167356|FG002|Overall Study|Lost to Follow-up|4|||
161214112|NCT01270841|582167357|FG003|Overall Study|Lost to Follow-up|2|||
161214113|NCT01270841|582167354|FG000|Overall Study|Physician Decision|0|||
161214114|NCT01270841|582167355|FG001|Overall Study|Physician Decision|1|||
161214115|NCT01270841|582167356|FG002|Overall Study|Physician Decision|0|||
161214116|NCT01270841|582167357|FG003|Overall Study|Physician Decision|0|||
161214117|NCT01270841|582167354|FG000|Overall Study|Did not qualify|6|||
161214118|NCT01270841|582167355|FG001|Overall Study|Did not qualify|3|||
161214119|NCT01270841|582167356|FG002|Overall Study|Did not qualify|4|||
161214120|NCT01270841|582167357|FG003|Overall Study|Did not qualify|5|||
161214121|NCT01270841|582167354|FG000|Overall Study|Protocol Violation|1|||
161214122|NCT01270841|582167355|FG001|Overall Study|Protocol Violation|5|||
161214123|NCT01270841|582167356|FG002|Overall Study|Protocol Violation|0|||
161214124|NCT01270841|582167357|FG003|Overall Study|Protocol Violation|0|||
161214125|NCT01270841|582167354|FG000|Overall Study|Enrolled in error|0|||
161214126|NCT01270841|582167355|FG001|Overall Study|Enrolled in error|1|||
161214127|NCT01270841|582167356|FG002|Overall Study|Enrolled in error|0|||
161214128|NCT01270841|582167357|FG003|Overall Study|Enrolled in error|0|||
161214129|NCT02092961|582167358|FG000|Overall Study|Not reported|1|||
161214130|NCT02092961|582167359|FG001|Overall Study|Not reported|0|||
161214131|NCT02092961|582167360|FG002|Overall Study|Not reported|1|||
161214132|NCT02092961|582167358|FG000|Overall Study|Study stopped|13|||
161214133|NCT02092961|582167359|FG001|Overall Study|Study stopped|9|||
161214134|NCT02092961|582167360|FG002|Overall Study|Study stopped|12|||
161214135|NCT02092961|582167358|FG000|Overall Study|Lack of therapeutic response|2|||
161214136|NCT02092961|582167359|FG001|Overall Study|Lack of therapeutic response|1|||
161214137|NCT02092961|582167360|FG002|Overall Study|Lack of therapeutic response|3|||
161214138|NCT02092961|582167358|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
161214139|NCT02092961|582167359|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
161214140|NCT02092961|582167360|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
161214141|NCT02092961|582167358|FG000|Overall Study|Adverse Event|2|||
161214142|NCT02092961|582167359|FG001|Overall Study|Adverse Event|4|||
161214143|NCT02092961|582167360|FG002|Overall Study|Adverse Event|0|||
161214144|NCT01623830|582167363|FG000|Overall Study|Withdrawal by Subject|6|||
161214145|NCT01623830|582167364|FG001|Overall Study|Withdrawal by Subject|7|||
161214146|NCT01623830|582167363|FG000|Overall Study|Exclusion from Study|1|||
161214147|NCT01623830|582167364|FG001|Overall Study|Exclusion from Study|2|||
161108070|NCT01961349|581785876|FG002|Overall Study|Adverse Event|1|||
161108071|NCT01961349|581785874|FG000|Overall Study|registration error, personal reason etc|2|||
161108072|NCT01961349|581785875|FG001|Overall Study|registration error, personal reason etc|2|||
161108073|NCT01961349|581785876|FG002|Overall Study|registration error, personal reason etc|1|||
161108074|NCT01854645|581785878|FG000|Overall Study|Protocol-Specified Criteria|13|||
161108075|NCT01854645|581785879|FG001|Overall Study|Protocol-Specified Criteria|10|||
161108076|NCT01854645|581785880|FG002|Overall Study|Protocol-Specified Criteria|8|||
161108077|NCT01854645|581785881|FG003|Overall Study|Protocol-Specified Criteria|5|||
161108078|NCT01854645|581785882|FG004|Overall Study|Protocol-Specified Criteria|7|||
161108079|NCT01854645|581785878|FG000|Overall Study|Administrative Reasons / Missing|0|||
161108080|NCT01854645|581785879|FG001|Overall Study|Administrative Reasons / Missing|0|||
161108081|NCT01854645|581785880|FG002|Overall Study|Administrative Reasons / Missing|0|||
161108082|NCT01854645|581785881|FG003|Overall Study|Administrative Reasons / Missing|1|||
161108083|NCT01854645|581785882|FG004|Overall Study|Administrative Reasons / Missing|1|||
161108084|NCT01854645|581785878|FG000|Overall Study|Protocol Violation|3|||
161108085|NCT01854645|581785879|FG001|Overall Study|Protocol Violation|0|||
161108086|NCT01854645|581785880|FG002|Overall Study|Protocol Violation|5|||
161108087|NCT01854645|581785881|FG003|Overall Study|Protocol Violation|4|||
161108088|NCT01854645|581785882|FG004|Overall Study|Protocol Violation|1|||
161108089|NCT01854645|581785878|FG000|Overall Study|Lost to Follow-up|10|||
161108090|NCT01854645|581785879|FG001|Overall Study|Lost to Follow-up|7|||
161108091|NCT01854645|581785880|FG002|Overall Study|Lost to Follow-up|8|||
161108092|NCT01854645|581785881|FG003|Overall Study|Lost to Follow-up|5|||
161108093|NCT01854645|581785882|FG004|Overall Study|Lost to Follow-up|0|||
161108094|NCT01854645|581785878|FG000|Overall Study|Physician Decision|1|||
161108095|NCT01854645|581785879|FG001|Overall Study|Physician Decision|5|||
161108096|NCT01854645|581785880|FG002|Overall Study|Physician Decision|3|||
161108097|NCT01854645|581785881|FG003|Overall Study|Physician Decision|3|||
161108098|NCT01854645|581785882|FG004|Overall Study|Physician Decision|7|||
161108099|NCT01854645|581785878|FG000|Overall Study|Withdrawal by Subject|31|||
161108100|NCT01854645|581785879|FG001|Overall Study|Withdrawal by Subject|41|||
161108101|NCT01854645|581785880|FG002|Overall Study|Withdrawal by Subject|30|||
161108102|NCT01854645|581785881|FG003|Overall Study|Withdrawal by Subject|21|||
161108103|NCT01854645|581785882|FG004|Overall Study|Withdrawal by Subject|24|||
161108104|NCT01854645|581785878|FG000|Overall Study|Lack of Efficacy|7|||
161108105|NCT01854645|581785879|FG001|Overall Study|Lack of Efficacy|12|||
161108106|NCT01854645|581785880|FG002|Overall Study|Lack of Efficacy|9|||
161108107|NCT01854645|581785881|FG003|Overall Study|Lack of Efficacy|3|||
161108108|NCT01854645|581785882|FG004|Overall Study|Lack of Efficacy|9|||
161108109|NCT01854645|581785878|FG000|Overall Study|Adverse Event|33|||
161108110|NCT01854645|581785879|FG001|Overall Study|Adverse Event|31|||
161108111|NCT01854645|581785880|FG002|Overall Study|Adverse Event|19|||
161108112|NCT01854645|581785881|FG003|Overall Study|Adverse Event|20|||
161108113|NCT01854645|581785882|FG004|Overall Study|Adverse Event|11|||
161108114|NCT00555477|581785883|FG000|Overall Study|Adverse Event|0|||
161108115|NCT00555477|581785884|FG001|Overall Study|Adverse Event|9|||
161108116|NCT00555477|581785883|FG000|Overall Study|Withdrawal by Subject|1|||
161108117|NCT00555477|581785884|FG001|Overall Study|Withdrawal by Subject|2|||
161108118|NCT00555477|581785883|FG000|Overall Study|Physician Decision|1|||
161108119|NCT00555477|581785884|FG001|Overall Study|Physician Decision|2|||
161108120|NCT04702737|581785885|FG000|Overall Study|Decision by Sponsor|1|||
161108121|NCT04702737|581785885|FG000|Overall Study|Withdrawal of Consent from Study|3|||
161108122|NCT04702737|581785885|FG000|Overall Study|Lost to Follow-up|1|||
161108123|NCT04702737|581785885|FG000|Overall Study|Death|35|||
161108124|NCT01977820|581785888|FG000|Overall Study|Sponsor terminated the study|1|||
161108125|NCT01977820|581785889|FG001|Overall Study|Sponsor terminated the study|1|||
161108126|NCT00475722|581785890|FG000|Overall Study|Withdrawal by Subject|12|||
161108127|NCT00475722|581785891|FG001|Overall Study|Withdrawal by Subject|12|||
161108128|NCT00475722|581785890|FG000|Overall Study|Protocol Violation|3|||
161108129|NCT00475722|581785891|FG001|Overall Study|Protocol Violation|0|||
161108130|NCT00698997|581785892|FG000|Overall Study|Lost to Follow-up|3|||
161108131|NCT00698997|581785893|FG001|Overall Study|Lost to Follow-up|0|||
161108132|NCT00698997|581785892|FG000|Overall Study|Withdrawal by Subject|7|||
161108133|NCT00698997|581785893|FG001|Overall Study|Withdrawal by Subject|27|||
161108134|NCT02568475|581785896|FG000|Overall Study|Lost to Follow-up|40|||
161108135|NCT02568475|581785897|FG001|Overall Study|Lost to Follow-up|39|||
161108136|NCT02568475|581785896|FG000|Overall Study|Withdrawal by Subject|2|||
161108137|NCT02568475|581785897|FG001|Overall Study|Withdrawal by Subject|0|||
161108138|NCT02568475|581785896|FG000|Overall Study|Discharged home|4|||
161108139|NCT02568475|581785897|FG001|Overall Study|Discharged home|4|||
161108140|NCT02568475|581785896|FG000|Overall Study|Short-term: Discharge location unknown|4|||
161108141|NCT02568475|581785897|FG001|Overall Study|Short-term: Discharge location unknown|0|||
161108142|NCT02568475|581785896|FG000|Overall Study|Transferred to another facility|1|||
161108143|NCT02568475|581785897|FG001|Overall Study|Transferred to another facility|0|||
161108144|NCT02625233|581785898|FG000|Overall Study|Adverse Event|2|||
161108145|NCT02625233|581785899|FG001|Overall Study|Adverse Event|0|||
161108146|NCT02064920|581785902|FG000|Overall Study|Adverse Event|0|||
161214148|NCT01605461|582167365|FG000|Overall Study|Lost to Follow-up|3|||
161214149|NCT01605461|582167365|FG000|Overall Study|Withdrawal by Subject|1|||
161214150|NCT00623623|582167368|FG000|Overall Study|Previous enrolment into this study|1|||
161214151|NCT00623623|582167369|FG001|Overall Study|Previous enrolment into this study|1|||
161214152|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
161214153|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161214154|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161214155|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161214156|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161214157|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161214158|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
161214159|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
161214160|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161214161|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161214162|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161214163|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161214164|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161214165|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
161214166|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
161214167|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
161214168|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
161214169|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
161214170|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
161214171|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
161214172|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
161214173|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
161214174|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161214175|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161214176|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161214177|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161214178|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161214179|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
161214180|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
161214181|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161214182|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161214183|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161214184|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161214185|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161214186|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
161214187|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
161214188|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
161214189|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
161214190|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
161214191|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
161214192|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
161214193|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
161214194|NCT00606684|582167370|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
161214195|NCT00606684|582167371|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161214196|NCT00606684|582167372|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161214197|NCT00606684|582167373|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161214198|NCT00606684|582167374|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161214199|NCT00606684|582167375|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161214200|NCT00606684|582167376|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
161214201|NCT00606684|582167370|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161214202|NCT00606684|582167371|FG001|Double-Blind Treatment Period|Adverse Event|3|||
161214203|NCT00606684|582167372|FG002|Double-Blind Treatment Period|Adverse Event|2|||
161214204|NCT00606684|582167373|FG003|Double-Blind Treatment Period|Adverse Event|4|||
161214205|NCT00606684|582167374|FG004|Double-Blind Treatment Period|Adverse Event|2|||
161214206|NCT00606684|582167375|FG005|Double-Blind Treatment Period|Adverse Event|0|||
161214207|NCT00606684|582167376|FG006|Double-Blind Treatment Period|Adverse Event|1|||
161214208|NCT00606684|582167370|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161324277|NCT02959918|582573544|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161214209|NCT00606684|582167371|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161214210|NCT00606684|582167372|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161214211|NCT00606684|582167373|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
161108147|NCT02064920|581785903|FG001|Overall Study|Adverse Event|4|||
161108148|NCT02064920|581785902|FG000|Overall Study|Physician Decision|0|||
161108149|NCT02064920|581785903|FG001|Overall Study|Physician Decision|1|||
161108150|NCT02064920|581785902|FG000|Overall Study|Technical Problems|0|||
161108151|NCT02064920|581785903|FG001|Overall Study|Technical Problems|1|||
161108152|NCT02064920|581785902|FG000|Overall Study|Withdrawal by Subject|1|||
161108153|NCT02064920|581785903|FG001|Overall Study|Withdrawal by Subject|3|||
161108154|NCT02109562|581785904|FG000|Overall Study|Insufficient clinical response|2|||
161108155|NCT02109562|581785905|FG001|Overall Study|Insufficient clinical response|0|||
161108156|NCT02109562|581785906|FG002|Overall Study|Insufficient clinical response|4|||
161108157|NCT02109562|581785904|FG000|Overall Study|Adverse Event|0|||
161108158|NCT02109562|581785905|FG001|Overall Study|Adverse Event|2|||
161108159|NCT02109562|581785906|FG002|Overall Study|Adverse Event|3|||
161214212|NCT00606684|582167374|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
161214213|NCT00606684|582167375|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
161214214|NCT00606684|582167376|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
161214215|NCT00606684|582167370|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161214216|NCT00606684|582167371|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
161214217|NCT00606684|582167372|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
161214218|NCT00606684|582167373|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
161214219|NCT00606684|582167374|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
161214220|NCT00606684|582167375|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
161214221|NCT00606684|582167376|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
161214222|NCT00606684|582167370|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
161214223|NCT00606684|582167371|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161214224|NCT00606684|582167372|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
161214225|NCT00606684|582167373|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161214226|NCT00606684|582167374|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
161214227|NCT00606684|582167375|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
161214228|NCT00606684|582167376|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
161214229|NCT00606684|582167370|FG000|Double-Blind Treatment Period|Physician Decision|0|||
161214230|NCT00606684|582167371|FG001|Double-Blind Treatment Period|Physician Decision|5|||
161214231|NCT00606684|582167372|FG002|Double-Blind Treatment Period|Physician Decision|1|||
161214232|NCT00606684|582167373|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161214233|NCT00606684|582167374|FG004|Double-Blind Treatment Period|Physician Decision|3|||
161214234|NCT00606684|582167375|FG005|Double-Blind Treatment Period|Physician Decision|1|||
161214235|NCT00606684|582167376|FG006|Double-Blind Treatment Period|Physician Decision|2|||
161214236|NCT00606684|582167370|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161214237|NCT00606684|582167371|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161214238|NCT00606684|582167372|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161214239|NCT00606684|582167373|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161214240|NCT00606684|582167374|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161214241|NCT00606684|582167375|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161214242|NCT00606684|582167376|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161214243|NCT03568500|582167380|FG000|Overall Study|Lost to Follow-up|1|||
161214244|NCT03568500|582167381|FG001|Overall Study|Lost to Follow-up|1|||
161214245|NCT03568500|582167382|FG002|Overall Study|Lost to Follow-up|2|||
161214246|NCT03568500|582167380|FG000|Overall Study|Adverse Event|1|||
161108160|NCT02109562|581785904|FG000|Overall Study|Lost to Follow-up|1|||
161108161|NCT02109562|581785905|FG001|Overall Study|Lost to Follow-up|0|||
161108162|NCT02109562|581785906|FG002|Overall Study|Lost to Follow-up|1|||
161108163|NCT02109562|581785904|FG000|Overall Study|Protocol Violation|0|||
161108164|NCT02109562|581785905|FG001|Overall Study|Protocol Violation|3|||
161108165|NCT02109562|581785906|FG002|Overall Study|Protocol Violation|1|||
161108166|NCT02109562|581785904|FG000|Overall Study|Withdrawal by Subject|20|||
161108167|NCT02109562|581785905|FG001|Overall Study|Withdrawal by Subject|25|||
161108168|NCT02109562|581785906|FG002|Overall Study|Withdrawal by Subject|21|||
161108169|NCT02109562|581785904|FG000|Overall Study|Physician Decision|3|||
161108170|NCT02109562|581785905|FG001|Overall Study|Physician Decision|4|||
161108171|NCT02109562|581785906|FG002|Overall Study|Physician Decision|5|||
161108172|NCT00262522|581785918|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
161108173|NCT00262522|581785919|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
161108174|NCT00262522|581785920|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
161108175|NCT00262522|581785921|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
161108176|NCT00262522|581785918|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
161108177|NCT00262522|581785919|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
161108178|NCT00262522|581785920|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
161108179|NCT00262522|581785921|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
161108180|NCT00262522|581785918|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
161108181|NCT00262522|581785919|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
161108182|NCT00262522|581785920|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
161108183|NCT00262522|581785921|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
161108184|NCT00262522|581785918|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
161108185|NCT00262522|581785919|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
161108186|NCT00262522|581785920|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
161108187|NCT00262522|581785921|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
161108188|NCT00262522|581785918|FG000|Study Start Through 8 Weeks|Death|1|||
161108189|NCT00262522|581785919|FG001|Study Start Through 8 Weeks|Death|0|||
161108190|NCT00262522|581785920|FG002|Study Start Through 8 Weeks|Death|0|||
161108191|NCT00262522|581785921|FG003|Study Start Through 8 Weeks|Death|0|||
161108192|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
161108193|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
161108194|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
161108195|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
161108196|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
161108197|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
161108198|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
161108199|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
161108200|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
161108201|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
161108202|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
161108203|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
161108204|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
161108205|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
161108206|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
161108207|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
161108208|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Death|2|||
161108209|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Death|0|||
161108210|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Death|1|||
161108211|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Death|0|||
161108212|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
161108213|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
161108214|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
161108215|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
161108216|NCT00262522|581785918|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
161108217|NCT00262522|581785919|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
161108218|NCT00262522|581785920|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
161108219|NCT00262522|581785921|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
161108220|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
161108221|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
161108222|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
161108223|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
161108224|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
161108225|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
161214247|NCT03568500|582167381|FG001|Overall Study|Adverse Event|1|||
161214248|NCT03568500|582167382|FG002|Overall Study|Adverse Event|2|||
161214249|NCT03568500|582167380|FG000|Overall Study|Physician Decision|1|||
161214250|NCT03568500|582167381|FG001|Overall Study|Physician Decision|0|||
161214251|NCT03568500|582167382|FG002|Overall Study|Physician Decision|0|||
161214252|NCT03568500|582167380|FG000|Overall Study|Withdrawal by Subject|4|||
161214253|NCT03568500|582167381|FG001|Overall Study|Withdrawal by Subject|2|||
161214254|NCT03568500|582167382|FG002|Overall Study|Withdrawal by Subject|0|||
161214255|NCT03568500|582167380|FG000|Overall Study|Technical Problems|2|||
161214256|NCT03568500|582167381|FG001|Overall Study|Technical Problems|1|||
161214257|NCT03568500|582167382|FG002|Overall Study|Technical Problems|0|||
161214258|NCT03568500|582167380|FG000|Overall Study|Participant Noncompliance|1|||
161214259|NCT03568500|582167381|FG001|Overall Study|Participant Noncompliance|1|||
161214260|NCT03568500|582167382|FG002|Overall Study|Participant Noncompliance|0|||
161214261|NCT00295854|582167392|FG000|Overall Study|Adverse Event|7|||
161214262|NCT00295854|582167393|FG001|Overall Study|Adverse Event|7|||
161214263|NCT00295854|582167394|FG002|Overall Study|Adverse Event|6|||
161214264|NCT00295854|582167392|FG000|Overall Study|Protocol Violation|1|||
161214265|NCT00295854|582167393|FG001|Overall Study|Protocol Violation|1|||
161214266|NCT00295854|582167394|FG002|Overall Study|Protocol Violation|1|||
161214267|NCT00295854|582167392|FG000|Overall Study|Lost to Follow-up|2|||
161214268|NCT00295854|582167393|FG001|Overall Study|Lost to Follow-up|0|||
161214269|NCT00295854|582167394|FG002|Overall Study|Lost to Follow-up|1|||
161214270|NCT00295854|582167392|FG000|Overall Study|Withdrawal by Subject|3|||
161214271|NCT00295854|582167393|FG001|Overall Study|Withdrawal by Subject|7|||
161214272|NCT00295854|582167394|FG002|Overall Study|Withdrawal by Subject|4|||
161214273|NCT00295854|582167392|FG000|Overall Study|did not continue to meet criteria|1|||
161214274|NCT00295854|582167393|FG001|Overall Study|did not continue to meet criteria|1|||
161214275|NCT00295854|582167394|FG002|Overall Study|did not continue to meet criteria|2|||
161214276|NCT00295854|582167392|FG000|Overall Study|required a prohibited medication|1|||
161214277|NCT00295854|582167393|FG001|Overall Study|required a prohibited medication|0|||
161214278|NCT00295854|582167394|FG002|Overall Study|required a prohibited medication|0|||
161214279|NCT00295854|582167392|FG000|Overall Study|Other|3|||
161214280|NCT00295854|582167393|FG001|Overall Study|Other|5|||
161214281|NCT00295854|582167394|FG002|Overall Study|Other|1|||
161214282|NCT03565211|582167395|FG000|Overall Study|Withdrawal by Subject|2|||
161214283|NCT03565211|582167395|FG000|Overall Study|Lost to Follow-up|1|||
161214284|NCT03565211|582167395|FG000|Overall Study|Adverse Event|44|||
161214285|NCT03565211|582167395|FG000|Overall Study|Personal issues|1|||
161214286|NCT03063632|582167399|FG000|Overall Study|Death|4|||
161214287|NCT03063632|582167400|FG001|Overall Study|Death|6|||
161214288|NCT03063632|582167399|FG000|Overall Study|Lost to Follow-up|0|||
161214289|NCT03063632|582167400|FG001|Overall Study|Lost to Follow-up|1|||
161214290|NCT03063632|582167399|FG000|Overall Study|Withdrawal by Subject|0|||
161214291|NCT03063632|582167400|FG001|Overall Study|Withdrawal by Subject|2|||
161214292|NCT03063632|582167399|FG000|Overall Study|Physician Decision|2|||
161214293|NCT03063632|582167400|FG001|Overall Study|Physician Decision|0|||
161214294|NCT03063632|582167399|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
161214295|NCT03063632|582167400|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
161214296|NCT00068237|582167401|FG000|Overall Study|Ineligible|3|||
161214297|NCT00068237|582167401|FG000|Overall Study|No protocol treatment received|2|||
161214298|NCT05288673|582167402|FG000|Overall Study|Consent withdrawn by subject|0|||
161214299|NCT05288673|582167403|FG001|Overall Study|Consent withdrawn by subject|0|||
161214300|NCT05288673|582167404|FG002|Overall Study|Consent withdrawn by subject|1|||
161214301|NCT01504867|582167405|FG000|Overall Study|Inclusion criteria not met|2|||
161214302|NCT01504867|582167406|FG001|Overall Study|Inclusion criteria not met|2|||
161214303|NCT01504867|582167405|FG000|Overall Study|Consent revoked|5|||
161214304|NCT01504867|582167406|FG001|Overall Study|Consent revoked|1|||
161214305|NCT00571922|582167407|FG000|Overall Study|Completion unknown|36|||
161214306|NCT00571922|582167408|FG001|Overall Study|Completion unknown|36|||
161214307|NCT01154153|582167413|FG000|Overall Study|Poor compliance to protocol|2|||
161214308|NCT01154153|582167414|FG001|Overall Study|Poor compliance to protocol|0|||
161214309|NCT01154153|582167413|FG000|Overall Study|Unable to use labs|2|||
161214310|NCT01154153|582167414|FG001|Overall Study|Unable to use labs|3|||
161214311|NCT01154153|582167413|FG000|Overall Study|Withdrew consent|1|||
161214312|NCT01154153|582167414|FG001|Overall Study|Withdrew consent|0|||
161214313|NCT02473510|582167415|FG000|Overall Study|Lost to Follow-up|1|||
161214314|NCT02473510|582167416|FG001|Overall Study|Lost to Follow-up|2|||
161214315|NCT00964223|582167417|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
161214316|NCT03439293|582167418|FG000|Overall Study|Death|22|||
161214317|NCT03439293|582167418|FG000|Overall Study|Withdrawal by Subject|8|||
161214318|NCT03439293|582167418|FG000|Overall Study|Lost to Follow-up|2|||
161214319|NCT03439293|582167418|FG000|Overall Study|Reason Not Specified|28|||
161214320|NCT03439293|582167418|FG000|Overall Study|Missing|1|||
161214321|NCT03404206|582167421|FG000|Overall Study|Withdrawal by Subject|1|||
161214322|NCT03404206|582167422|FG001|Overall Study|Withdrawal by Subject|1|||
161214323|NCT03404206|582167423|FG002|Overall Study|Withdrawal by Subject|0|||
161214324|NCT03404206|582167421|FG000|Overall Study|Lost to Follow-up|3|||
161214325|NCT03404206|582167422|FG001|Overall Study|Lost to Follow-up|1|||
161214326|NCT03404206|582167423|FG002|Overall Study|Lost to Follow-up|0|||
161214327|NCT05478603|582167424|FG000|Overall Study|Withdrawal by Subject|0|||
161214328|NCT05478603|582167425|FG001|Overall Study|Withdrawal by Subject|1|||
161214329|NCT05478603|582167426|FG002|Overall Study|Withdrawal by Subject|0|||
161214330|NCT05478603|582167427|FG003|Overall Study|Withdrawal by Subject|0|||
161214331|NCT03634488|582167430|FG000|Overall Study|Death|1|||
161214332|NCT03634488|582167431|FG001|Overall Study|Death|0|||
161214333|NCT03634488|582167432|FG002|Overall Study|Death|0|||
161214334|NCT03634488|582167430|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
161214335|NCT03634488|582167431|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
161108226|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
161108227|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
161108228|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
161108229|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
161108230|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
161108231|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
161108232|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
161108233|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
161108234|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
161108235|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
161108236|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Death|2|||
161108237|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Death|0|||
161108238|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Death|2|||
161108239|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Death|0|||
161108240|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
161108241|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
161108242|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
161108243|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
161108244|NCT00262522|581785918|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
161108245|NCT00262522|581785919|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
161108246|NCT00262522|581785920|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
161108247|NCT00262522|581785921|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
161108248|NCT01449461|581785933|FG000|Overall Study|Adverse Event|0|||
161108249|NCT01449461|581785934|FG001|Overall Study|Adverse Event|3|||
161108250|NCT01449461|581785935|FG002|Overall Study|Adverse Event|2|||
161108251|NCT01449461|581785936|FG003|Overall Study|Adverse Event|3|||
161108252|NCT01449461|581785937|FG004|Overall Study|Adverse Event|4|||
161108253|NCT01449461|581785938|FG005|Overall Study|Adverse Event|4|||
161108254|NCT01449461|581785933|FG000|Overall Study|Death|0|||
161108255|NCT01449461|581785934|FG001|Overall Study|Death|2|||
161108256|NCT01449461|581785935|FG002|Overall Study|Death|0|||
161108257|NCT01449461|581785936|FG003|Overall Study|Death|0|||
161108258|NCT01449461|581785937|FG004|Overall Study|Death|7|||
161108259|NCT01449461|581785938|FG005|Overall Study|Death|1|||
161108260|NCT01449461|581785933|FG000|Overall Study|Physician Decision|0|||
161108261|NCT01449461|581785934|FG001|Overall Study|Physician Decision|1|||
161108262|NCT01449461|581785935|FG002|Overall Study|Physician Decision|0|||
161108263|NCT01449461|581785936|FG003|Overall Study|Physician Decision|4|||
161108264|NCT01449461|581785937|FG004|Overall Study|Physician Decision|1|||
161108265|NCT01449461|581785938|FG005|Overall Study|Physician Decision|0|||
161108266|NCT01449461|581785933|FG000|Overall Study|Documented Progressive Disease|4|||
161108267|NCT01449461|581785934|FG001|Overall Study|Documented Progressive Disease|7|||
161108268|NCT01449461|581785935|FG002|Overall Study|Documented Progressive Disease|14|||
161108269|NCT01449461|581785936|FG003|Overall Study|Documented Progressive Disease|15|||
161108270|NCT01449461|581785937|FG004|Overall Study|Documented Progressive Disease|24|||
161108271|NCT01449461|581785938|FG005|Overall Study|Documented Progressive Disease|5|||
161108272|NCT01449461|581785933|FG000|Overall Study|Clinical Progressive Disease|2|||
161108273|NCT01449461|581785934|FG001|Overall Study|Clinical Progressive Disease|2|||
161108274|NCT01449461|581785935|FG002|Overall Study|Clinical Progressive Disease|0|||
161108275|NCT01449461|581785936|FG003|Overall Study|Clinical Progressive Disease|3|||
161108276|NCT01449461|581785937|FG004|Overall Study|Clinical Progressive Disease|4|||
161108277|NCT01449461|581785938|FG005|Overall Study|Clinical Progressive Disease|2|||
161108278|NCT01449461|581785933|FG000|Overall Study|Protocol Violation|0|||
161108279|NCT01449461|581785934|FG001|Overall Study|Protocol Violation|0|||
161108280|NCT01449461|581785935|FG002|Overall Study|Protocol Violation|0|||
161108281|NCT01449461|581785936|FG003|Overall Study|Protocol Violation|1|||
161108282|NCT01449461|581785937|FG004|Overall Study|Protocol Violation|0|||
161108283|NCT01449461|581785938|FG005|Overall Study|Protocol Violation|0|||
161108284|NCT01449461|581785933|FG000|Overall Study|Site Terminated by Sponsor|0|||
161108285|NCT01449461|581785934|FG001|Overall Study|Site Terminated by Sponsor|1|||
161108286|NCT01449461|581785935|FG002|Overall Study|Site Terminated by Sponsor|2|||
161108287|NCT01449461|581785936|FG003|Overall Study|Site Terminated by Sponsor|3|||
161108288|NCT01449461|581785937|FG004|Overall Study|Site Terminated by Sponsor|4|||
161108289|NCT01449461|581785938|FG005|Overall Study|Site Terminated by Sponsor|1|||
161108290|NCT01449461|581785933|FG000|Overall Study|Withdrawal by Subject|0|||
161108291|NCT01449461|581785934|FG001|Overall Study|Withdrawal by Subject|1|||
161108292|NCT01449461|581785935|FG002|Overall Study|Withdrawal by Subject|0|||
161108293|NCT01449461|581785936|FG003|Overall Study|Withdrawal by Subject|0|||
161108294|NCT01449461|581785937|FG004|Overall Study|Withdrawal by Subject|2|||
161108295|NCT01449461|581785938|FG005|Overall Study|Withdrawal by Subject|1|||
161108296|NCT01449461|581785933|FG000|Overall Study|Reason not Specified|0|||
161108297|NCT01449461|581785934|FG001|Overall Study|Reason not Specified|1|||
161108298|NCT01449461|581785935|FG002|Overall Study|Reason not Specified|0|||
161108299|NCT01449461|581785936|FG003|Overall Study|Reason not Specified|3|||
161108300|NCT01449461|581785937|FG004|Overall Study|Reason not Specified|2|||
161108301|NCT01449461|581785938|FG005|Overall Study|Reason not Specified|1|||
161108302|NCT05314517|581785939|FG000|Double-blind Period|Adverse Event|4|||
161108303|NCT05314517|581785940|FG001|Double-blind Period|Adverse Event|0|||
161108304|NCT05314517|581785941|FG002|Double-blind Period|Adverse Event|0|||
161108305|NCT05314517|581785942|FG003|Double-blind Period|Adverse Event|0|||
161108306|NCT05314517|581785939|FG000|Double-blind Period|Noncompliance|0|||
161108307|NCT05314517|581785940|FG001|Double-blind Period|Noncompliance|1|||
161108308|NCT05314517|581785941|FG002|Double-blind Period|Noncompliance|0|||
161108309|NCT05314517|581785942|FG003|Double-blind Period|Noncompliance|0|||
161108310|NCT05314517|581785939|FG000|Double-blind Period|Randomized, not treated|1|||
161108311|NCT05314517|581785940|FG001|Double-blind Period|Randomized, not treated|0|||
161108312|NCT05314517|581785941|FG002|Double-blind Period|Randomized, not treated|0|||
161108313|NCT05314517|581785942|FG003|Double-blind Period|Randomized, not treated|0|||
161108314|NCT05314517|581785939|FG000|Open-label Extension|Adverse Event|0|||
161108315|NCT05314517|581785940|FG001|Open-label Extension|Adverse Event|0|||
160865674|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
161108316|NCT05314517|581785941|FG002|Open-label Extension|Adverse Event|1|||
161108317|NCT05314517|581785942|FG003|Open-label Extension|Adverse Event|2|||
161108318|NCT05314517|581785939|FG000|Open-label Extension|Investigator decision|0|||
161108319|NCT05314517|581785940|FG001|Open-label Extension|Investigator decision|0|||
161108320|NCT05314517|581785941|FG002|Open-label Extension|Investigator decision|1|||
161108321|NCT05314517|581785942|FG003|Open-label Extension|Investigator decision|0|||
161108322|NCT05314517|581785939|FG000|Open-label Extension|Lost to Follow-up|0|||
161108323|NCT05314517|581785940|FG001|Open-label Extension|Lost to Follow-up|0|||
161108324|NCT05314517|581785941|FG002|Open-label Extension|Lost to Follow-up|0|||
161108325|NCT05314517|581785942|FG003|Open-label Extension|Lost to Follow-up|1|||
161214336|NCT03634488|582167432|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
161108326|NCT05314517|581785939|FG000|Open-label Extension|Withdrawal by Subject|0|||
161108327|NCT05314517|581785940|FG001|Open-label Extension|Withdrawal by Subject|0|||
161108328|NCT05314517|581785941|FG002|Open-label Extension|Withdrawal by Subject|1|||
161108329|NCT05314517|581785942|FG003|Open-label Extension|Withdrawal by Subject|2|||
161108330|NCT05314517|581785939|FG000|Open-label Extension|Use of prohibited medication|0|||
161108331|NCT05314517|581785940|FG001|Open-label Extension|Use of prohibited medication|0|||
161108332|NCT05314517|581785941|FG002|Open-label Extension|Use of prohibited medication|1|||
161108333|NCT05314517|581785942|FG003|Open-label Extension|Use of prohibited medication|0|||
161108334|NCT05314517|581785939|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
161108335|NCT05314517|581785940|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
161108336|NCT05314517|581785941|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
161108337|NCT05314517|581785942|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
161108338|NCT02710136|581785945|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
161108339|NCT02710136|581785946|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
161108340|NCT02269787|581785947|FG000|Overall Study|Lost to Follow-up|20|||
161108341|NCT02269787|581785948|FG001|Overall Study|Lost to Follow-up|6|||
161108342|NCT02269787|581785947|FG000|Overall Study|Death|2|||
161108343|NCT02269787|581785948|FG001|Overall Study|Death|3|||
161108344|NCT02269787|581785947|FG000|Overall Study|Incapacitated|0|||
161108345|NCT02269787|581785948|FG001|Overall Study|Incapacitated|1|||
161108346|NCT00798135|581785949|FG000|Overall Study|Disease progression, relapse|11|||
161108347|NCT00798135|581785949|FG000|Overall Study|Disease progression, refractory|1|||
161108348|NCT00798135|581785949|FG000|Overall Study|Physician Decision|1|||
161108349|NCT02228720|581785950|FG000|Open Label - Day 30|Lost to Follow-up|1|||
161108350|NCT00282295|581785953|FG000|Overall Study|Adverse Event|0|||
161108351|NCT00282295|581785954|FG001|Overall Study|Adverse Event|1|||
161108352|NCT00282295|581785955|FG002|Overall Study|Adverse Event|0|||
161108353|NCT00282295|581785953|FG000|Overall Study|Serious Adverse Events|0|||
161108354|NCT00282295|581785954|FG001|Overall Study|Serious Adverse Events|0|||
161108355|NCT00282295|581785955|FG002|Overall Study|Serious Adverse Events|1|||
161108356|NCT00282295|581785953|FG000|Overall Study|Protocol Violation|0|||
161108357|NCT00282295|581785954|FG001|Overall Study|Protocol Violation|2|||
161108358|NCT00282295|581785955|FG002|Overall Study|Protocol Violation|1|||
161108359|NCT00282295|581785953|FG000|Overall Study|Withdrawal by Subject|2|||
161108360|NCT00282295|581785954|FG001|Overall Study|Withdrawal by Subject|6|||
161108361|NCT00282295|581785955|FG002|Overall Study|Withdrawal by Subject|4|||
161108362|NCT00282295|581785953|FG000|Overall Study|Lost to Follow-up|1|||
161108363|NCT00282295|581785954|FG001|Overall Study|Lost to Follow-up|7|||
161108364|NCT00282295|581785955|FG002|Overall Study|Lost to Follow-up|2|||
161108365|NCT00282295|581785953|FG000|Overall Study|Other|0|||
161108366|NCT00282295|581785954|FG001|Overall Study|Other|1|||
161108367|NCT00282295|581785955|FG002|Overall Study|Other|0|||
161108368|NCT03337542|581785956|FG000|Overall Study|Withdrew Consent|17|||
161108369|NCT03337542|581785956|FG000|Overall Study|Allergic Adverse Event|1|||
161214337|NCT00869089|582167433|FG000|Overall Study|Lost to Follow-up|1|||
161108370|NCT03337542|581785956|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
161108371|NCT03337542|581785956|FG000|Overall Study|Lost to Follow-up|1|||
161108372|NCT03337542|581785956|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
161108373|NCT01401842|581785957|FG000|Overall Study|Withdrawal by Subject|3|||
161108374|NCT01401842|581785958|FG001|Overall Study|Withdrawal by Subject|2|||
161108375|NCT01401842|581785957|FG000|Overall Study|academic reason|4|||
161108376|NCT01401842|581785958|FG001|Overall Study|academic reason|1|||
161108377|NCT01401842|581785957|FG000|Overall Study|changed companies|20|||
161108378|NCT01401842|581785958|FG001|Overall Study|changed companies|34|||
161108379|NCT01401842|581785957|FG000|Overall Study|discharged from US Army|3|||
161108380|NCT01401842|581785958|FG001|Overall Study|discharged from US Army|4|||
161108381|NCT01401842|581785957|FG000|Overall Study|invalid follow-up strength data|1|||
161108382|NCT01401842|581785958|FG001|Overall Study|invalid follow-up strength data|4|||
161108383|NCT01401842|581785957|FG000|Overall Study|on profile|9|||
161108384|NCT01401842|581785958|FG001|Overall Study|on profile|5|||
161108385|NCT01401842|581785957|FG000|Overall Study|other/unknown|28|||
161108386|NCT01401842|581785958|FG001|Overall Study|other/unknown|17|||
161108387|NCT04198623|581787233|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
161108388|NCT05050318|581787239|FG000|Overall Study|Protocol Deviation|1|||
161108389|NCT05050318|581787240|FG001|Overall Study|Protocol Deviation|0|||
161108390|NCT05050318|581787241|FG002|Overall Study|Protocol Deviation|0|||
161108391|NCT04259411|581787242|FG000|Overall Study|Death|1|||
161108392|NCT04259411|581787242|FG000|Overall Study|Missed visit|2|||
161108393|NCT04183790|581787248|FG000|Overall Study|Participants did not rollover to Part B|12|||
161108394|NCT04183790|581787249|FG001|Overall Study|Participants did not rollover to Part B|0|||
161324278|NCT02959918|582573545|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161108395|NCT04183790|581787248|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
161108396|NCT04183790|581787249|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161108397|NCT04183790|581787248|FG000|Overall Study|Commercial drug is available for participant|6|||
161108398|NCT04183790|581787249|FG001|Overall Study|Commercial drug is available for participant|0|||
161108399|NCT04183790|581787248|FG000|Overall Study|Adverse Event|1|||
161108400|NCT04183790|581787249|FG001|Overall Study|Adverse Event|0|||
161108401|NCT04183790|581787248|FG000|Overall Study|Not enrolled in 107 study|0|||
161108402|NCT04183790|581787249|FG001|Overall Study|Not enrolled in 107 study|2|||
161108403|NCT01251653|581787250|FG000|Overall Study|Progressive Disease|1|||
161108404|NCT01251653|581787251|FG001|Overall Study|Progressive Disease|7|||
161108405|NCT01251653|581787252|FG002|Overall Study|Progressive Disease|16|||
161108406|NCT01251653|581787253|FG003|Overall Study|Progressive Disease|4|||
161108407|NCT01251653|581787254|FG004|Overall Study|Progressive Disease|0|||
161108408|NCT01251653|581787255|FG005|Overall Study|Progressive Disease|17|||
161108409|NCT01251653|581787256|FG006|Overall Study|Progressive Disease|14|||
161108410|NCT01251653|581787257|FG007|Overall Study|Progressive Disease|7|||
161108411|NCT01251653|581787258|FG008|Overall Study|Progressive Disease|5|||
161108412|NCT01251653|581787250|FG000|Overall Study|Dose-limiting toxicity|0|||
161108413|NCT01251653|581787251|FG001|Overall Study|Dose-limiting toxicity|1|||
161108414|NCT01251653|581787252|FG002|Overall Study|Dose-limiting toxicity|1|||
161108415|NCT01251653|581787253|FG003|Overall Study|Dose-limiting toxicity|1|||
161214338|NCT00869089|582167433|FG000|Overall Study|Withdrawal by Subject|1|||
161214339|NCT00869089|582167433|FG000|Overall Study|Screen Fail|1|||
161214340|NCT01169844|582167441|FG000|Overall Study|Adverse Event|0|||
161214341|NCT01169844|582167442|FG001|Overall Study|Adverse Event|1|||
161214342|NCT01169844|582167441|FG000|Overall Study|Patient withdrew consent|4|||
161214343|NCT01169844|582167442|FG001|Overall Study|Patient withdrew consent|0|||
161214344|NCT01169844|582167441|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161214345|NCT01169844|582167442|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161214346|NCT00990093|582167445|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
161214347|NCT00990093|582167446|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
161214348|NCT00990093|582167445|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
161214349|NCT00990093|582167446|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
161214350|NCT00990093|582167445|FG000|Test Period 1 (1-14 Days)|Other|1|||
161214351|NCT00990093|582167446|FG001|Test Period 1 (1-14 Days)|Other|0|||
161214352|NCT00990093|582167445|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
161214353|NCT00990093|582167446|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
161214354|NCT00990093|582167445|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
161214355|NCT00990093|582167446|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
161214356|NCT00990093|582167445|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
161214357|NCT00990093|582167446|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
161214358|NCT00990093|582167445|FG000|Test Period 2 (15-28 Days)|Other|0|||
161214359|NCT00990093|582167446|FG001|Test Period 2 (15-28 Days)|Other|1|||
161214360|NCT05003167|582167448|FG000|Overall Study|Withdrawal by Subject|1|||
161214361|NCT00530439|582167449|FG000|Overall Study|GDM|9|||
161214362|NCT00530439|582167450|FG001|Overall Study|GDM|3|||
161214363|NCT00530439|582167449|FG000|Overall Study|Withdraw|18|||
161214364|NCT00530439|582167450|FG001|Overall Study|Withdraw|14|||
161214365|NCT00530439|582167449|FG000|Overall Study|Missed abortion|1|||
161214366|NCT00530439|582167450|FG001|Overall Study|Missed abortion|4|||
161214367|NCT00530439|582167449|FG000|Overall Study|Misclassification|2|||
161214368|NCT00530439|582167450|FG001|Overall Study|Misclassification|0|||
161214369|NCT00530439|582167449|FG000|Overall Study|Twin pregnancy|0|||
161214370|NCT00530439|582167450|FG001|Overall Study|Twin pregnancy|2|||
161214371|NCT00530439|582167449|FG000|Overall Study|Severe malformation/abortion|0|||
161214372|NCT00530439|582167450|FG001|Overall Study|Severe malformation/abortion|3|||
161214373|NCT01010230|582167451|FG000|Overall Study|Withdrawal by Subject|6|||
161214374|NCT01010230|582167452|FG001|Overall Study|Withdrawal by Subject|5|||
161214375|NCT01010230|582167451|FG000|Overall Study|Lost to Follow-up|4|||
161214376|NCT01010230|582167452|FG001|Overall Study|Lost to Follow-up|2|||
161108416|NCT01251653|581787254|FG004|Overall Study|Dose-limiting toxicity|0|||
161108417|NCT01251653|581787255|FG005|Overall Study|Dose-limiting toxicity|0|||
161108418|NCT01251653|581787256|FG006|Overall Study|Dose-limiting toxicity|2|||
161108419|NCT01251653|581787257|FG007|Overall Study|Dose-limiting toxicity|0|||
161108420|NCT01251653|581787258|FG008|Overall Study|Dose-limiting toxicity|0|||
161108421|NCT01251653|581787250|FG000|Overall Study|Adverse Event|1|||
161108422|NCT01251653|581787251|FG001|Overall Study|Adverse Event|0|||
161108423|NCT01251653|581787252|FG002|Overall Study|Adverse Event|2|||
161108424|NCT01251653|581787253|FG003|Overall Study|Adverse Event|1|||
161108425|NCT01251653|581787254|FG004|Overall Study|Adverse Event|1|||
161108426|NCT01251653|581787255|FG005|Overall Study|Adverse Event|0|||
161108427|NCT01251653|581787256|FG006|Overall Study|Adverse Event|2|||
161108428|NCT01251653|581787257|FG007|Overall Study|Adverse Event|2|||
161108429|NCT01251653|581787258|FG008|Overall Study|Adverse Event|1|||
161108430|NCT01251653|581787250|FG000|Overall Study|Withdrawal by Subject|1|||
161108431|NCT01251653|581787251|FG001|Overall Study|Withdrawal by Subject|0|||
161108432|NCT01251653|581787252|FG002|Overall Study|Withdrawal by Subject|1|||
161108433|NCT01251653|581787253|FG003|Overall Study|Withdrawal by Subject|0|||
161108434|NCT01251653|581787254|FG004|Overall Study|Withdrawal by Subject|1|||
161108435|NCT01251653|581787255|FG005|Overall Study|Withdrawal by Subject|1|||
161108436|NCT01251653|581787256|FG006|Overall Study|Withdrawal by Subject|0|||
161108437|NCT01251653|581787257|FG007|Overall Study|Withdrawal by Subject|1|||
161108438|NCT01251653|581787258|FG008|Overall Study|Withdrawal by Subject|0|||
161108439|NCT01251653|581787250|FG000|Overall Study|Other reason not mentioned above|0|||
161108440|NCT01251653|581787251|FG001|Overall Study|Other reason not mentioned above|0|||
161108441|NCT01251653|581787252|FG002|Overall Study|Other reason not mentioned above|0|||
161214377|NCT00378482|582167457|FG000|Overall Study|Lost to Follow-up|1|||
161108442|NCT01251653|581787253|FG003|Overall Study|Other reason not mentioned above|0|||
161108443|NCT01251653|581787254|FG004|Overall Study|Other reason not mentioned above|0|||
161108444|NCT01251653|581787255|FG005|Overall Study|Other reason not mentioned above|0|||
161108445|NCT01251653|581787256|FG006|Overall Study|Other reason not mentioned above|0|||
161108446|NCT01251653|581787257|FG007|Overall Study|Other reason not mentioned above|2|||
161108447|NCT01251653|581787258|FG008|Overall Study|Other reason not mentioned above|0|||
161108448|NCT00847145|581787259|FG000|Overall Study|AE or Death|0|||
161108449|NCT00847145|581787260|FG001|Overall Study|AE or Death|1|||
161214378|NCT00378482|582167457|FG000|Overall Study|Lack of Efficacy|8|||
161108450|NCT00847145|581787261|FG002|Overall Study|AE or Death|1|||
161108451|NCT00847145|581787262|FG003|Overall Study|AE or Death|0|||
161108452|NCT00847145|581787263|FG004|Overall Study|AE or Death|0|||
161108453|NCT00847145|581787264|FG005|Overall Study|AE or Death|0|||
161108454|NCT00847145|581787265|FG006|Overall Study|AE or Death|0|||
161108455|NCT00847145|581787266|FG007|Overall Study|AE or Death|0|||
161108456|NCT00847145|581787259|FG000|Overall Study|Withdrawal by Subject|3|||
161108457|NCT00847145|581787260|FG001|Overall Study|Withdrawal by Subject|4|||
161108458|NCT00847145|581787261|FG002|Overall Study|Withdrawal by Subject|6|||
161108459|NCT00847145|581787262|FG003|Overall Study|Withdrawal by Subject|1|||
161108460|NCT00847145|581787263|FG004|Overall Study|Withdrawal by Subject|0|||
161108461|NCT00847145|581787264|FG005|Overall Study|Withdrawal by Subject|0|||
161108462|NCT00847145|581787265|FG006|Overall Study|Withdrawal by Subject|1|||
161108463|NCT00847145|581787266|FG007|Overall Study|Withdrawal by Subject|1|||
161108464|NCT00847145|581787259|FG000|Overall Study|Lost to Follow-up|3|||
161108465|NCT00847145|581787260|FG001|Overall Study|Lost to Follow-up|1|||
161108466|NCT00847145|581787261|FG002|Overall Study|Lost to Follow-up|1|||
161108467|NCT00847145|581787262|FG003|Overall Study|Lost to Follow-up|0|||
161108468|NCT00847145|581787263|FG004|Overall Study|Lost to Follow-up|4|||
161108469|NCT00847145|581787264|FG005|Overall Study|Lost to Follow-up|4|||
161108470|NCT00847145|581787265|FG006|Overall Study|Lost to Follow-up|8|||
161108471|NCT00847145|581787266|FG007|Overall Study|Lost to Follow-up|2|||
161108472|NCT00847145|581787259|FG000|Overall Study|Inappropriate enrollment|0|||
161108473|NCT00847145|581787260|FG001|Overall Study|Inappropriate enrollment|0|||
161108474|NCT00847145|581787261|FG002|Overall Study|Inappropriate enrollment|0|||
161108475|NCT00847145|581787262|FG003|Overall Study|Inappropriate enrollment|0|||
161108476|NCT00847145|581787263|FG004|Overall Study|Inappropriate enrollment|1|||
161108477|NCT00847145|581787264|FG005|Overall Study|Inappropriate enrollment|0|||
161108478|NCT00847145|581787265|FG006|Overall Study|Inappropriate enrollment|0|||
161108479|NCT00847145|581787266|FG007|Overall Study|Inappropriate enrollment|0|||
161108480|NCT00847145|581787259|FG000|Overall Study|Protocol Violation|0|||
161108481|NCT00847145|581787260|FG001|Overall Study|Protocol Violation|0|||
161108482|NCT00847145|581787261|FG002|Overall Study|Protocol Violation|3|||
161108483|NCT00847145|581787262|FG003|Overall Study|Protocol Violation|0|||
161108484|NCT00847145|581787263|FG004|Overall Study|Protocol Violation|1|||
161108485|NCT00847145|581787264|FG005|Overall Study|Protocol Violation|0|||
161108486|NCT00847145|581787265|FG006|Overall Study|Protocol Violation|0|||
161108487|NCT00847145|581787266|FG007|Overall Study|Protocol Violation|1|||
161108488|NCT02833974|581787267|FG000|Overall Study|Lost to Follow-up|1|||
161108489|NCT02833974|581787268|FG001|Overall Study|Lost to Follow-up|0|||
161108490|NCT02833974|581787267|FG000|Overall Study|Adverse Event|0|||
161108491|NCT02833974|581787268|FG001|Overall Study|Adverse Event|3|||
161108492|NCT01439282|581787269|FG000|Overall Study|Adverse Event|5|||
161108493|NCT01439282|581787270|FG001|Overall Study|Adverse Event|0|||
161108494|NCT01439282|581787269|FG000|Overall Study|Withdrawal by Subject|2|||
161108495|NCT01439282|581787270|FG001|Overall Study|Withdrawal by Subject|0|||
160865675|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
161108496|NCT01439282|581787269|FG000|Overall Study|Other|1|||
161108497|NCT01439282|581787270|FG001|Overall Study|Other|1|||
161108498|NCT04419610|581787271|FG000|Overall Study|Withdrawal by Subject|3|||
161108499|NCT04419610|581787272|FG001|Overall Study|Withdrawal by Subject|1|||
161108500|NCT04419610|581787271|FG000|Overall Study|Adverse Event|1|||
161214379|NCT00378482|582167457|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
161214380|NCT00378482|582167457|FG000|Overall Study|Withdrawal by Subject|4|||
161214381|NCT00378482|582167457|FG000|Overall Study|Adverse Event|9|||
161214382|NCT03185949|582167458|FG000|ITT Analysis|Withdrawal by Subject|4|||
161214383|NCT03185949|582167459|FG001|ITT Analysis|Withdrawal by Subject|3|||
161214384|NCT03185949|582167458|FG000|PP Analysis|Protocol Violation|2|||
161214385|NCT03185949|582167459|FG001|PP Analysis|Protocol Violation|2|||
161214386|NCT03185949|582167458|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
161214387|NCT03185949|582167459|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
161214388|NCT00343642|582169356|FG000|Overall Study|Lost to Follow-up|0|||
161214389|NCT00343642|582169357|FG001|Overall Study|Lost to Follow-up|1|||
161214390|NCT00343642|582169358|FG002|Overall Study|Lost to Follow-up|0|||
161214391|NCT00343642|582169356|FG000|Overall Study|Pregnancy|1|||
161214392|NCT00343642|582169357|FG001|Overall Study|Pregnancy|0|||
161214393|NCT00343642|582169358|FG002|Overall Study|Pregnancy|2|||
161214394|NCT00343642|582169356|FG000|Overall Study|Withdrawal by Subject|2|||
161214395|NCT00343642|582169357|FG001|Overall Study|Withdrawal by Subject|3|||
161214396|NCT00343642|582169358|FG002|Overall Study|Withdrawal by Subject|4|||
161214397|NCT00343642|582169356|FG000|Overall Study|Adverse Event|0|||
161214398|NCT00343642|582169357|FG001|Overall Study|Adverse Event|0|||
161214399|NCT00343642|582169358|FG002|Overall Study|Adverse Event|1|||
161214400|NCT00343642|582169356|FG000|Overall Study|Flare up|6|||
161214401|NCT00343642|582169357|FG001|Overall Study|Flare up|4|||
161214402|NCT00343642|582169358|FG002|Overall Study|Flare up|0|||
161214403|NCT00860574|582169361|FG000|Overall Study|Death|2|||
161214404|NCT00860574|582169361|FG000|Overall Study|Relapse|1|||
161214405|NCT02496221|582169362|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
161214406|NCT02496221|582169363|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
161214407|NCT02496221|582169362|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
161214408|NCT02496221|582169363|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
161214409|NCT02496221|582169362|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
161214410|NCT02496221|582169363|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
161214411|NCT01335399|582169364|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
161214412|NCT01335399|582169365|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
161214413|NCT01335399|582169364|FG000|Pre-treatment Period|Participant request to discontinue|0|||
161214414|NCT01335399|582169365|FG001|Pre-treatment Period|Participant request to discontinue|1|||
161214415|NCT01335399|582169364|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
161214416|NCT01335399|582169365|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
161214417|NCT01335399|582169364|FG000|Pre-treatment Period|Consent withdrawal|3|||
161214418|NCT01335399|582169365|FG001|Pre-treatment Period|Consent withdrawal|0|||
161214419|NCT01335399|582169364|FG000|Treatment Period|Disease progression|117|||
161214420|NCT01335399|582169365|FG001|Treatment Period|Disease progression|145|||
161214421|NCT01335399|582169364|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
161214422|NCT01335399|582169365|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
161214423|NCT01335399|582169364|FG000|Treatment Period|Study drug toxicity|52|||
161214424|NCT01335399|582169365|FG001|Treatment Period|Study drug toxicity|64|||
161214425|NCT01335399|582169364|FG000|Treatment Period|Participant request to discontinue|30|||
161214426|NCT01335399|582169365|FG001|Treatment Period|Participant request to discontinue|22|||
161214427|NCT01335399|582169364|FG000|Treatment Period|Other reasons|30|||
161214428|NCT01335399|582169365|FG001|Treatment Period|Other reasons|30|||
161214429|NCT01335399|582169364|FG000|Treatment Period|Consent withdrawal|10|||
161214430|NCT01335399|582169365|FG001|Treatment Period|Consent withdrawal|7|||
161214431|NCT01335399|582169364|FG000|Treatment Period|Death|7|||
161214432|NCT01335399|582169365|FG001|Treatment Period|Death|6|||
161214433|NCT01335399|582169364|FG000|Treatment Period|Poor/Non-compliance|3|||
161214434|NCT01335399|582169365|FG001|Treatment Period|Poor/Non-compliance|4|||
161214435|NCT01335399|582169364|FG000|Treatment Period|Lost to Follow-up|2|||
161214436|NCT01335399|582169365|FG001|Treatment Period|Lost to Follow-up|2|||
161214437|NCT01335399|582169364|FG000|Treatment Period|Maximum clinical benefit|1|||
161214438|NCT01335399|582169365|FG001|Treatment Period|Maximum clinical benefit|1|||
161214439|NCT01335399|582169364|FG000|Treatment Period|No longer meet study criteria|1|||
161214440|NCT01335399|582169365|FG001|Treatment Period|No longer meet study criteria|1|||
161214441|NCT01335399|582169364|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
161214442|NCT01335399|582169365|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
161214443|NCT01120600|582169368|FG000|Overall Study|Adverse Event|7|||
161324279|NCT02959918|582573546|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324280|NCT02959918|582573547|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324281|NCT02959918|582573548|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
161324282|NCT02959918|582573535|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161108501|NCT04419610|581787272|FG001|Overall Study|Adverse Event|0|||
161324283|NCT02959918|582573536|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324284|NCT02959918|582573537|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324285|NCT02959918|582573538|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324286|NCT02959918|582573539|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324287|NCT02959918|582573540|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324288|NCT02959918|582573541|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324289|NCT02959918|582573542|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324290|NCT02959918|582573543|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324291|NCT02959918|582573544|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
161324292|NCT02959918|582573545|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324293|NCT02959918|582573546|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324294|NCT02959918|582573547|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324295|NCT02959918|582573548|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
161324296|NCT02364388|582573549|FG000|Overall Study|Protocol Violation|1|||
161324297|NCT02364388|582573549|FG000|Overall Study|Technical Failure|3|||
161324298|NCT02364388|582573549|FG000|Overall Study|No OA/US data|2|||
161324299|NCT02364388|582573549|FG000|Overall Study|No Biopsy|2|||
161324300|NCT00837967|582573550|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
161324301|NCT00837967|582573551|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
161324302|NCT03061188|582573553|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
161324303|NCT03061188|582573554|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
161324304|NCT03061188|582573555|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
161324305|NCT03061188|582573556|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
161324306|NCT03061188|582573553|FG000|On Follow-up for 3 Years|Death|0|||
161324307|NCT03061188|582573554|FG001|On Follow-up for 3 Years|Death|3|||
161324308|NCT03061188|582573555|FG002|On Follow-up for 3 Years|Death|5|||
161324309|NCT03061188|582573556|FG003|On Follow-up for 3 Years|Death|4|||
161324310|NCT03061188|582573553|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161324311|NCT03061188|582573554|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161324312|NCT03061188|582573555|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
161324313|NCT03061188|582573556|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
161324314|NCT02504320|582573560|FG000|Treatment Period 1|Positive Drug Screen|0|||
161324315|NCT02504320|582573561|FG001|Treatment Period 1|Positive Drug Screen|0|||
161324316|NCT02504320|582573562|FG002|Treatment Period 1|Positive Drug Screen|1|||
161324317|NCT02504320|582573563|FG003|Treatment Period 1|Positive Drug Screen|0|||
161324318|NCT02504320|582573560|FG000|Treatment Period 2|Positive Drug Screen|0|||
161324319|NCT02504320|582573561|FG001|Treatment Period 2|Positive Drug Screen|1|||
161324320|NCT02504320|582573562|FG002|Treatment Period 2|Positive Drug Screen|0|||
161324321|NCT02504320|582573563|FG003|Treatment Period 2|Positive Drug Screen|0|||
161324322|NCT02504320|582573560|FG000|Treatment Period 3|Positive Drug Screen|0|||
161324323|NCT02504320|582573561|FG001|Treatment Period 3|Positive Drug Screen|0|||
161324324|NCT02504320|582573562|FG002|Treatment Period 3|Positive Drug Screen|0|||
161324325|NCT02504320|582573563|FG003|Treatment Period 3|Positive Drug Screen|1|||
161324326|NCT02504320|582573560|FG000|Treatment Period 3|Adverse Event|0|||
161324327|NCT02504320|582573561|FG001|Treatment Period 3|Adverse Event|0|||
161324328|NCT02504320|582573562|FG002|Treatment Period 3|Adverse Event|1|||
161324329|NCT02504320|582573563|FG003|Treatment Period 3|Adverse Event|0|||
161324330|NCT02306850|582573566|FG000|Overall Study|Lack of Efficacy|2|||
161324331|NCT02420262|582573567|FG000|Overall Study|Adverse Event|1|||
161108502|NCT04419610|581787271|FG000|Overall Study|discharged early|1|||
161108503|NCT04419610|581787272|FG001|Overall Study|discharged early|1|||
161108504|NCT04179734|581787276|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
161108505|NCT04179734|581787277|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
161108506|NCT04179734|581787276|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
161108507|NCT04179734|581787277|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
161108508|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
161108509|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
161108510|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
161108511|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161108512|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161324332|NCT02420262|582573568|FG001|Overall Study|Adverse Event|0|||
161324333|NCT02420262|582573567|FG000|Overall Study|Withdrawal by Subject|1|||
161324334|NCT02420262|582573568|FG001|Overall Study|Withdrawal by Subject|4|||
161324335|NCT02420262|582573567|FG000|Overall Study|Unclassified|0|||
161214444|NCT01120600|582169369|FG001|Overall Study|Adverse Event|7|||
161214445|NCT01120600|582169368|FG000|Overall Study|Excessive Bone Loss|0|||
161108513|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
161108514|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Death|2|||
161108515|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Death|0|||
161108516|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
161108517|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
161108518|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
161108519|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161108520|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
161108521|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161108522|NCT02603120|581787278|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
161108523|NCT02603120|581787279|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
161108524|NCT02603120|581787278|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
161108525|NCT02603120|581787279|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
161108526|NCT02603120|581787278|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
161108527|NCT02603120|581787279|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
161108528|NCT02603120|581787278|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
161108529|NCT02603120|581787279|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
161108530|NCT02603120|581787278|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
161108531|NCT02603120|581787279|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
161108532|NCT02603120|581787278|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
161108533|NCT02603120|581787279|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
161108534|NCT02603120|581787278|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
161108535|NCT02603120|581787279|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
161108536|NCT00916357|581787281|FG000|Period 1|Withdrawal by Subject|1|||
161108537|NCT00916357|581787282|FG001|Period 1|Withdrawal by Subject|0|||
161108538|NCT00916357|581787283|FG002|Period 1|Withdrawal by Subject|0|||
161108539|NCT00916357|581787284|FG003|Period 1|Withdrawal by Subject|0|||
161108540|NCT00916357|581787285|FG004|Period 1|Withdrawal by Subject|0|||
161108541|NCT00916357|581787286|FG005|Period 1|Withdrawal by Subject|0|||
161108542|NCT00916357|581787281|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
161108543|NCT00916357|581787282|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
161108544|NCT00916357|581787283|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
161108545|NCT00916357|581787284|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
161108546|NCT00916357|581787285|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
161108547|NCT00916357|581787286|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
161108548|NCT03807349|581787289|FG000|Overall Study|Early Study Termination|9|||
161214446|NCT01120600|582169369|FG001|Overall Study|Excessive Bone Loss|4|||
161214447|NCT01120600|582169368|FG000|Overall Study|Lost to Follow-up|1|||
161108549|NCT05807464|581787292|FG000|Overall Study|Adverse Event|1|||
161108550|NCT04451161|581787293|FG000|Overall Study|Lost to Follow-up|28|||
161108551|NCT04451161|581787294|FG001|Overall Study|Lost to Follow-up|37|||
161108552|NCT04451161|581787295|FG002|Overall Study|Lost to Follow-up|22|||
161108553|NCT04451161|581787296|FG003|Overall Study|Lost to Follow-up|13|||
161108554|NCT04451161|581787297|FG004|Overall Study|Lost to Follow-up|11|||
161214448|NCT01120600|582169369|FG001|Overall Study|Lost to Follow-up|3|||
161214449|NCT01120600|582169368|FG000|Overall Study|Physician Decision|1|||
161108555|NCT04451161|581787298|FG005|Overall Study|Lost to Follow-up|14|||
161108556|NCT04451161|581787293|FG000|Overall Study|Withdrawal by Subject|3|||
161108557|NCT04451161|581787294|FG001|Overall Study|Withdrawal by Subject|0|||
161108558|NCT04451161|581787295|FG002|Overall Study|Withdrawal by Subject|0|||
161108559|NCT04451161|581787296|FG003|Overall Study|Withdrawal by Subject|0|||
161108560|NCT04451161|581787297|FG004|Overall Study|Withdrawal by Subject|2|||
161108561|NCT04451161|581787298|FG005|Overall Study|Withdrawal by Subject|4|||
161108562|NCT01555151|581787302|FG000|Overall Study|Withdrawal by Subject|6|||
161108563|NCT01555151|581787303|FG001|Overall Study|Withdrawal by Subject|2|||
161108564|NCT01555151|581787304|FG002|Overall Study|Withdrawal by Subject|0|||
161108565|NCT01555151|581787305|FG003|Overall Study|Withdrawal by Subject|2|||
161108566|NCT01555151|581787302|FG000|Overall Study|Administrative|3|||
161108567|NCT01555151|581787303|FG001|Overall Study|Administrative|1|||
161108568|NCT01555151|581787304|FG002|Overall Study|Administrative|2|||
161108569|NCT01555151|581787305|FG003|Overall Study|Administrative|0|||
161108570|NCT01555151|581787302|FG000|Overall Study|Protocol Violation|3|||
161108571|NCT01555151|581787303|FG001|Overall Study|Protocol Violation|3|||
161108572|NCT01555151|581787304|FG002|Overall Study|Protocol Violation|3|||
161108573|NCT01555151|581787305|FG003|Overall Study|Protocol Violation|5|||
161108574|NCT01555151|581787302|FG000|Overall Study|Adverse Event|1|||
161108575|NCT01555151|581787303|FG001|Overall Study|Adverse Event|2|||
161108576|NCT01555151|581787304|FG002|Overall Study|Adverse Event|1|||
161108577|NCT01555151|581787305|FG003|Overall Study|Adverse Event|2|||
161108578|NCT01555151|581787302|FG000|Overall Study|Lost to Follow-up|0|||
161108579|NCT01555151|581787303|FG001|Overall Study|Lost to Follow-up|0|||
161108580|NCT01555151|581787304|FG002|Overall Study|Lost to Follow-up|0|||
161108581|NCT01555151|581787305|FG003|Overall Study|Lost to Follow-up|1|||
161108582|NCT02343159|581787306|FG000|Overall Study|Early Study Termination|16|||
161108583|NCT02343159|581787307|FG001|Overall Study|Early Study Termination|19|||
161108584|NCT02343159|581787308|FG002|Overall Study|Early Study Termination|23|||
161108585|NCT02343159|581787306|FG000|Overall Study|Physician Decision|2|||
161108586|NCT02343159|581787307|FG001|Overall Study|Physician Decision|0|||
161108587|NCT02343159|581787308|FG002|Overall Study|Physician Decision|1|||
161108588|NCT02343159|581787306|FG000|Overall Study|Withdrawal by Subject|3|||
161108589|NCT02343159|581787307|FG001|Overall Study|Withdrawal by Subject|0|||
161108590|NCT02343159|581787308|FG002|Overall Study|Withdrawal by Subject|2|||
161108591|NCT02343159|581787306|FG000|Overall Study|Lost to Follow-up|0|||
161108592|NCT02343159|581787307|FG001|Overall Study|Lost to Follow-up|2|||
161108593|NCT02343159|581787308|FG002|Overall Study|Lost to Follow-up|2|||
161108594|NCT02343159|581787306|FG000|Overall Study|Adverse Event|4|||
161108595|NCT02343159|581787307|FG001|Overall Study|Adverse Event|4|||
161108596|NCT02343159|581787308|FG002|Overall Study|Adverse Event|2|||
161108597|NCT02343159|581787306|FG000|Overall Study|Sponsor Decision|0|||
161108598|NCT02343159|581787307|FG001|Overall Study|Sponsor Decision|1|||
161108599|NCT02343159|581787308|FG002|Overall Study|Sponsor Decision|0|||
161108600|NCT02343159|581787306|FG000|Overall Study|Enrollment Error|1|||
161108601|NCT02343159|581787307|FG001|Overall Study|Enrollment Error|0|||
161108602|NCT02343159|581787308|FG002|Overall Study|Enrollment Error|0|||
161108603|NCT02114268|581787311|FG000|Overall Study|Lost to Follow-up|4|||
161108604|NCT02114268|581787312|FG001|Overall Study|Lost to Follow-up|1|||
161108605|NCT02114268|581787313|FG002|Overall Study|Lost to Follow-up|1|||
161108606|NCT02114268|581787314|FG003|Overall Study|Lost to Follow-up|0|||
161108607|NCT02114268|581787315|FG004|Overall Study|Lost to Follow-up|0|||
161108608|NCT02114268|581787316|FG005|Overall Study|Lost to Follow-up|2|||
161108609|NCT02114268|581787311|FG000|Overall Study|Withdrawal by Subject|1|||
161108610|NCT02114268|581787312|FG001|Overall Study|Withdrawal by Subject|0|||
161108611|NCT02114268|581787313|FG002|Overall Study|Withdrawal by Subject|0|||
161108612|NCT02114268|581787314|FG003|Overall Study|Withdrawal by Subject|0|||
161108613|NCT02114268|581787315|FG004|Overall Study|Withdrawal by Subject|0|||
161108614|NCT02114268|581787316|FG005|Overall Study|Withdrawal by Subject|1|||
161108615|NCT02114268|581787311|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
161108616|NCT02114268|581787312|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
161108617|NCT02114268|581787313|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
161108618|NCT02114268|581787314|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
161108619|NCT02114268|581787315|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
161214450|NCT01120600|582169369|FG001|Overall Study|Physician Decision|3|||
161214451|NCT01120600|582169368|FG000|Overall Study|Protocol Violation|0|||
161214452|NCT01120600|582169369|FG001|Overall Study|Protocol Violation|4|||
161214453|NCT01120600|582169368|FG000|Overall Study|Withdrawal by Subject|10|||
161214454|NCT01120600|582169369|FG001|Overall Study|Withdrawal by Subject|11|||
161214455|NCT01165242|582169372|FG000|Overall Study|Unreachable Subjects|1|||
161214456|NCT01165242|582169373|FG001|Overall Study|Unreachable Subjects|0|||
161214457|NCT01165242|582169374|FG002|Overall Study|Unreachable Subjects|0|||
161214458|NCT01165242|582169372|FG000|Overall Study|Incarcerated Subjects|0|||
161214459|NCT01165242|582169373|FG001|Overall Study|Incarcerated Subjects|1|||
161214460|NCT01165242|582169374|FG002|Overall Study|Incarcerated Subjects|0|||
161214461|NCT01165242|582169372|FG000|Overall Study|Visit 2 Declined by Subject|0|||
161214462|NCT01165242|582169373|FG001|Overall Study|Visit 2 Declined by Subject|0|||
161214463|NCT01165242|582169374|FG002|Overall Study|Visit 2 Declined by Subject|1|||
161214464|NCT01165242|582169372|FG000|Overall Study|Withdrawal by Subject|0|||
161214465|NCT01165242|582169373|FG001|Overall Study|Withdrawal by Subject|2|||
161214466|NCT01165242|582169374|FG002|Overall Study|Withdrawal by Subject|2|||
161214467|NCT01165242|582169372|FG000|Overall Study|Extended Holiday|0|||
161214468|NCT01165242|582169373|FG001|Overall Study|Extended Holiday|0|||
161214469|NCT01165242|582169374|FG002|Overall Study|Extended Holiday|1|||
161214470|NCT01165242|582169372|FG000|Overall Study|Lost to Follow-up|9|||
161214471|NCT01165242|582169373|FG001|Overall Study|Lost to Follow-up|7|||
161214472|NCT01165242|582169374|FG002|Overall Study|Lost to Follow-up|10|||
161214473|NCT03372083|582169375|FG000|Overall Study|Adverse Event|3|||
161214474|NCT03372083|582169375|FG000|Overall Study|Physician Decision|1|||
161214475|NCT03372083|582169375|FG000|Overall Study|Withdrawal by Subject|1|||
161214476|NCT01690520|582169376|FG000|Overall Study|Death|25|||
161214477|NCT01690520|582169377|FG001|Overall Study|Death|21|||
161214478|NCT01690520|582169376|FG000|Overall Study|Lost to Follow-up|2|||
161214479|NCT01690520|582169377|FG001|Overall Study|Lost to Follow-up|3|||
161214480|NCT01690520|582169376|FG000|Overall Study|Withdrawal by Subject|2|||
161214481|NCT01690520|582169377|FG001|Overall Study|Withdrawal by Subject|0|||
161214482|NCT01690520|582169376|FG000|Overall Study|Relapse|0|||
161214483|NCT01690520|582169377|FG001|Overall Study|Relapse|1|||
161214484|NCT01690520|582169376|FG000|Overall Study|Other|0|||
161214485|NCT01690520|582169377|FG001|Overall Study|Other|1|||
161214486|NCT01690520|582169376|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
161214487|NCT01690520|582169377|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
161214488|NCT02544633|582169380|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
161324336|NCT02420262|582573568|FG001|Overall Study|Unclassified|1|||
161108620|NCT02114268|581787316|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
161108621|NCT02790138|581787317|FG000|Overall Study|Adverse Event|5|||
161108622|NCT02790138|581787318|FG001|Overall Study|Adverse Event|2|||
161108623|NCT02790138|581787317|FG000|Overall Study|Significant Protocol Deviation|0|||
161108624|NCT02790138|581787318|FG001|Overall Study|Significant Protocol Deviation|1|||
161108625|NCT02790138|581787317|FG000|Overall Study|Lost to Follow-up|1|||
161108626|NCT02790138|581787318|FG001|Overall Study|Lost to Follow-up|0|||
161108627|NCT02790138|581787317|FG000|Overall Study|Voluntary Withdrawal|8|||
161108628|NCT02790138|581787318|FG001|Overall Study|Voluntary Withdrawal|9|||
161108629|NCT02790138|581787317|FG000|Overall Study|Lack of Efficacy|6|||
161108630|NCT02790138|581787318|FG001|Overall Study|Lack of Efficacy|7|||
161108631|NCT02790138|581787317|FG000|Overall Study|Reason not Specified|1|||
161108632|NCT02790138|581787318|FG001|Overall Study|Reason not Specified|0|||
161108633|NCT04037748|581787319|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161108634|NCT04037748|581787320|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161108635|NCT04037748|581787319|FG000|Treatment Period 1|Adverse Event|1|||
161108636|NCT04037748|581787320|FG001|Treatment Period 1|Adverse Event|1|||
161108637|NCT04037748|581787319|FG000|Treatment Period 1|Protocol Violation|4|||
161108638|NCT04037748|581787320|FG001|Treatment Period 1|Protocol Violation|5|||
161108639|NCT04037748|581787319|FG000|Treatment Period 2|Adverse Event|0|||
161108640|NCT04037748|581787320|FG001|Treatment Period 2|Adverse Event|1|||
161108641|NCT04037748|581787319|FG000|Treatment Period 2|Protocol Violation|2|||
161108642|NCT04037748|581787320|FG001|Treatment Period 2|Protocol Violation|0|||
161108643|NCT01506960|581787326|FG000|Overall Study|Did not meet angiographic criteria|47|||
161108644|NCT00397033|581787327|FG000|Overall Study|Adverse Event|7|||
161108645|NCT00397033|581787328|FG001|Overall Study|Adverse Event|10|||
161108646|NCT00397033|581787329|FG002|Overall Study|Adverse Event|4|||
161108647|NCT00397033|581787327|FG000|Overall Study|Lack of Efficacy|22|||
161108648|NCT00397033|581787328|FG001|Overall Study|Lack of Efficacy|12|||
161108649|NCT00397033|581787329|FG002|Overall Study|Lack of Efficacy|9|||
161108650|NCT00397033|581787327|FG000|Overall Study|Lost to Follow-up|3|||
161108651|NCT00397033|581787328|FG001|Overall Study|Lost to Follow-up|3|||
161108652|NCT00397033|581787329|FG002|Overall Study|Lost to Follow-up|3|||
161108653|NCT00397033|581787327|FG000|Overall Study|Withdrawal by Subject|12|||
161108654|NCT00397033|581787328|FG001|Overall Study|Withdrawal by Subject|7|||
161108655|NCT00397033|581787329|FG002|Overall Study|Withdrawal by Subject|5|||
161108656|NCT00397033|581787327|FG000|Overall Study|Other|0|||
161108657|NCT00397033|581787328|FG001|Overall Study|Other|5|||
161108658|NCT00397033|581787329|FG002|Overall Study|Other|2|||
161108659|NCT03519867|581787330|FG000|Overall Study|Adverse Event|1|||
161108660|NCT03519867|581787331|FG001|Overall Study|Adverse Event|1|||
161108661|NCT03519867|581787332|FG002|Overall Study|Adverse Event|0|||
161108662|NCT03519867|581787333|FG003|Overall Study|Adverse Event|0|||
161108663|NCT03519867|581787334|FG004|Overall Study|Adverse Event|0|||
161108664|NCT03519867|581787335|FG005|Overall Study|Adverse Event|0|||
161108665|NCT03519867|581787336|FG006|Overall Study|Adverse Event|0|||
161108666|NCT03519867|581787337|FG007|Overall Study|Adverse Event|0|||
161108667|NCT03519867|581787338|FG008|Overall Study|Adverse Event|0|||
161108668|NCT03519867|581787339|FG009|Overall Study|Adverse Event|0|||
161108669|NCT03519867|581787330|FG000|Overall Study|Protocol Violation|0|||
161108670|NCT03519867|581787331|FG001|Overall Study|Protocol Violation|0|||
161108671|NCT03519867|581787332|FG002|Overall Study|Protocol Violation|0|||
161108672|NCT03519867|581787333|FG003|Overall Study|Protocol Violation|0|||
161108673|NCT03519867|581787334|FG004|Overall Study|Protocol Violation|0|||
161108674|NCT03519867|581787335|FG005|Overall Study|Protocol Violation|1|||
161108675|NCT03519867|581787336|FG006|Overall Study|Protocol Violation|0|||
161108676|NCT03519867|581787337|FG007|Overall Study|Protocol Violation|0|||
161108677|NCT03519867|581787338|FG008|Overall Study|Protocol Violation|0|||
161108678|NCT03519867|581787339|FG009|Overall Study|Protocol Violation|0|||
161108679|NCT03519867|581787330|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108680|NCT03519867|581787331|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108681|NCT03519867|581787332|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108682|NCT03519867|581787333|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108683|NCT03519867|581787334|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108684|NCT03519867|581787335|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108685|NCT03519867|581787336|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
161108686|NCT03519867|581787337|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161214489|NCT02544633|582169381|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
161214490|NCT02544633|582169382|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
161214491|NCT02544633|582169383|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
161214492|NCT02544633|582169380|FG000|Treatment Period|Adverse Event|7|||
161214493|NCT02544633|582169381|FG001|Treatment Period|Adverse Event|4|||
161214494|NCT02544633|582169382|FG002|Treatment Period|Adverse Event|0|||
161214495|NCT02544633|582169383|FG003|Treatment Period|Adverse Event|5|||
161214496|NCT02544633|582169380|FG000|Treatment Period|Lack of Efficacy|17|||
161324337|NCT01210222|582573569|FG000|Overall Study|Ineligible|2|||
161214497|NCT02544633|582169381|FG001|Treatment Period|Lack of Efficacy|11|||
161214498|NCT02544633|582169382|FG002|Treatment Period|Lack of Efficacy|5|||
161214499|NCT02544633|582169383|FG003|Treatment Period|Lack of Efficacy|5|||
161214500|NCT02544633|582169380|FG000|Treatment Period|Global Deterioration of Health|3|||
161214501|NCT02544633|582169381|FG001|Treatment Period|Global Deterioration of Health|3|||
161214502|NCT02544633|582169382|FG002|Treatment Period|Global Deterioration of Health|0|||
161214503|NCT02544633|582169383|FG003|Treatment Period|Global Deterioration of Health|1|||
161214504|NCT02544633|582169380|FG000|Treatment Period|Withdrawal by Subject|1|||
161214505|NCT02544633|582169381|FG001|Treatment Period|Withdrawal by Subject|0|||
161214506|NCT02544633|582169382|FG002|Treatment Period|Withdrawal by Subject|0|||
161214507|NCT02544633|582169383|FG003|Treatment Period|Withdrawal by Subject|0|||
161108687|NCT03519867|581787338|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108688|NCT03519867|581787339|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
161108689|NCT03519867|581787330|FG000|Overall Study|Admin. of other reversal agent|1|||
161108690|NCT03519867|581787331|FG001|Overall Study|Admin. of other reversal agent|1|||
161108691|NCT03519867|581787332|FG002|Overall Study|Admin. of other reversal agent|0|||
161108692|NCT03519867|581787333|FG003|Overall Study|Admin. of other reversal agent|0|||
161108693|NCT03519867|581787334|FG004|Overall Study|Admin. of other reversal agent|0|||
161108694|NCT03519867|581787335|FG005|Overall Study|Admin. of other reversal agent|1|||
161108695|NCT03519867|581787336|FG006|Overall Study|Admin. of other reversal agent|0|||
161108696|NCT03519867|581787337|FG007|Overall Study|Admin. of other reversal agent|0|||
161108697|NCT03519867|581787338|FG008|Overall Study|Admin. of other reversal agent|0|||
161108698|NCT03519867|581787339|FG009|Overall Study|Admin. of other reversal agent|0|||
161108699|NCT03519867|581787330|FG000|Overall Study|Reason not provided|1|||
161108700|NCT03519867|581787331|FG001|Overall Study|Reason not provided|1|||
161108701|NCT03519867|581787332|FG002|Overall Study|Reason not provided|1|||
161108702|NCT03519867|581787333|FG003|Overall Study|Reason not provided|1|||
161108703|NCT03519867|581787334|FG004|Overall Study|Reason not provided|0|||
161108704|NCT03519867|581787335|FG005|Overall Study|Reason not provided|1|||
161108705|NCT03519867|581787336|FG006|Overall Study|Reason not provided|0|||
161108706|NCT03519867|581787337|FG007|Overall Study|Reason not provided|1|||
161108707|NCT03519867|581787338|FG008|Overall Study|Reason not provided|1|||
161108708|NCT03519867|581787339|FG009|Overall Study|Reason not provided|0|||
161214508|NCT02544633|582169380|FG000|Treatment Period|Lost to Follow-up|0|||
161108709|NCT01846624|581787340|FG000|Overall Study|Died during induction, no midostaurin|1|||
161214509|NCT02544633|582169381|FG001|Treatment Period|Lost to Follow-up|1|||
161108710|NCT01202279|581787343|FG000|Overall Study|Adverse Event|8|||
161108711|NCT01202279|581787344|FG001|Overall Study|Adverse Event|6|||
161108712|NCT01202279|581787343|FG000|Overall Study|Withdrawal by Subject|13|||
161108713|NCT01202279|581787344|FG001|Overall Study|Withdrawal by Subject|10|||
161108714|NCT01202279|581787343|FG000|Overall Study|Physician Decision|0|||
161108715|NCT01202279|581787344|FG001|Overall Study|Physician Decision|1|||
161108716|NCT01202279|581787343|FG000|Overall Study|Lost to Follow-up|10|||
161108717|NCT01202279|581787344|FG001|Overall Study|Lost to Follow-up|7|||
161108718|NCT01202279|581787343|FG000|Overall Study|Protocol Violation|1|||
161108719|NCT01202279|581787344|FG001|Overall Study|Protocol Violation|1|||
161108720|NCT01202279|581787343|FG000|Overall Study|study compliance|5|||
161108721|NCT01202279|581787344|FG001|Overall Study|study compliance|2|||
161108722|NCT03574753|581787345|FG000|Overall Study|Adverse Event|3|||
161108723|NCT03574753|581787345|FG000|Overall Study|Progression/relapse|19|||
161108724|NCT03574753|581787345|FG000|Overall Study|Death|1|||
161108725|NCT03472924|581787346|FG000|Overall Study|Adverse Event|1|||
161108726|NCT03472924|581787347|FG001|Overall Study|Adverse Event|0|||
161108727|NCT02546765|581787349|FG000|Overall Study|Withdrawal by Subject|0|||
161108728|NCT02546765|581787350|FG001|Overall Study|Withdrawal by Subject|1|||
161108729|NCT02546765|581787351|FG002|Overall Study|Withdrawal by Subject|0|||
161108730|NCT02546765|581787352|FG003|Overall Study|Withdrawal by Subject|0|||
160865676|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
161108731|NCT04425720|581787355|FG000|Overall Study|Withdrawal by Subject|0|||
161108732|NCT04425720|581787356|FG001|Overall Study|Withdrawal by Subject|20|||
161108733|NCT00807742|581787357|FG000|Overall Study|Death|9|||
161108734|NCT00807742|581787358|FG001|Overall Study|Death|2|||
161108735|NCT00807742|581787357|FG000|Overall Study|Withdrawal by Subject|2|||
161108736|NCT00807742|581787358|FG001|Overall Study|Withdrawal by Subject|1|||
161108737|NCT00807742|581787357|FG000|Overall Study|Lost to Follow-up|35|||
161108738|NCT00807742|581787358|FG001|Overall Study|Lost to Follow-up|51|||
161108739|NCT04814823|581787360|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
161108740|NCT05318937|581787364|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161108741|NCT05318937|581787365|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161108742|NCT05318937|581787364|FG000|Overall Study|Lost to Follow-up|0|||
161108743|NCT05318937|581787365|FG001|Overall Study|Lost to Follow-up|1|||
161108744|NCT05318937|581787364|FG000|Overall Study|Withdrawal by Subject|0|||
161108745|NCT05318937|581787365|FG001|Overall Study|Withdrawal by Subject|2|||
161108746|NCT05318937|581787364|FG000|Overall Study|Protocol Violation|0|||
161108747|NCT05318937|581787365|FG001|Overall Study|Protocol Violation|1|||
161108748|NCT04722042|581787366|FG000|Overall Study|Withdrawal by Subject|2|||
161108749|NCT04722042|581787367|FG001|Overall Study|Withdrawal by Subject|1|||
161108750|NCT04722042|581787368|FG002|Overall Study|Withdrawal by Subject|0|||
161108751|NCT01877915|581787369|FG000|Overall Study|Lost to Follow-up|10|||
161108752|NCT01877915|581787370|FG001|Overall Study|Lost to Follow-up|9|||
161108753|NCT01877915|581787369|FG000|Overall Study|Withdrawal by Subject|42|||
161108754|NCT01877915|581787370|FG001|Overall Study|Withdrawal by Subject|55|||
161108755|NCT01877915|581787369|FG000|Overall Study|Other|2|||
161108756|NCT01877915|581787370|FG001|Overall Study|Other|4|||
161108757|NCT01045798|581787375|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
161108758|NCT01045798|581787376|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
161108759|NCT01045798|581787375|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
161108760|NCT01045798|581787376|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
161108761|NCT01045798|581787375|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
161108762|NCT01045798|581787376|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
161108763|NCT01045798|581787375|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
161108764|NCT01045798|581787376|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
161108765|NCT00430482|581787382|FG000|Completed Treatment|Insufficient Treatment|7|||
161108766|NCT00430482|581787383|FG001|Completed Treatment|Insufficient Treatment|11|||
161108767|NCT03596866|581788554|FG000|Overall Study|Site terminated by Sponsor|64|||
161108768|NCT03596866|581788555|FG001|Overall Study|Site terminated by Sponsor|65|||
161108769|NCT03596866|581788554|FG000|Overall Study|Death|37|||
161108770|NCT03596866|581788555|FG001|Overall Study|Death|24|||
161108771|NCT03596866|581788554|FG000|Overall Study|Withdrawal by Subject|4|||
161108772|NCT03596866|581788555|FG001|Overall Study|Withdrawal by Subject|6|||
161108773|NCT03596866|581788554|FG000|Overall Study|Missing|0|||
161108774|NCT03596866|581788555|FG001|Overall Study|Missing|6|||
161108775|NCT03596866|581788554|FG000|Overall Study|Lost to Follow-up|2|||
161108776|NCT03596866|581788555|FG001|Overall Study|Lost to Follow-up|3|||
161108777|NCT03596866|581788554|FG000|Overall Study|Protocol Violation|1|||
161108778|NCT03596866|581788555|FG001|Overall Study|Protocol Violation|0|||
161108779|NCT03596866|581788554|FG000|Overall Study|Reason Not Specified|14|||
161108780|NCT03596866|581788555|FG001|Overall Study|Reason Not Specified|13|||
161108781|NCT00596947|581788556|FG000|Overall Study|study halted due to low enrollment|5|||
161108782|NCT00596947|581788557|FG001|Overall Study|study halted due to low enrollment|3|||
161108783|NCT00596947|581788556|FG000|Overall Study|Lost to Follow-up|1|||
161108784|NCT00596947|581788557|FG001|Overall Study|Lost to Follow-up|0|||
161108785|NCT03000179|581788558|FG000|Overall Study|Lost to Follow-up|2|||
161108786|NCT01431274|581788564|FG000|Overall Study|Adverse Event|51|||
161108787|NCT01431274|581788565|FG001|Overall Study|Adverse Event|37|||
161108788|NCT01431274|581788566|FG002|Overall Study|Adverse Event|43|||
161108789|NCT01431274|581788567|FG003|Overall Study|Adverse Event|30|||
161108790|NCT01431274|581788568|FG004|Overall Study|Adverse Event|37|||
161108791|NCT01431274|581788564|FG000|Overall Study|Consent withdrawn not due to AE|29|||
161108792|NCT01431274|581788565|FG001|Overall Study|Consent withdrawn not due to AE|20|||
161108793|NCT01431274|581788566|FG002|Overall Study|Consent withdrawn not due to AE|17|||
161108794|NCT01431274|581788567|FG003|Overall Study|Consent withdrawn not due to AE|20|||
161108795|NCT01431274|581788568|FG004|Overall Study|Consent withdrawn not due to AE|11|||
161324338|NCT01210222|582573569|FG000|Overall Study|Never treated|1|||
161108796|NCT01431274|581788564|FG000|Overall Study|Non compliant with protocol|5|||
161108797|NCT01431274|581788565|FG001|Overall Study|Non compliant with protocol|8|||
161108798|NCT01431274|581788566|FG002|Overall Study|Non compliant with protocol|4|||
161108799|NCT01431274|581788567|FG003|Overall Study|Non compliant with protocol|4|||
161108800|NCT01431274|581788568|FG004|Overall Study|Non compliant with protocol|4|||
161108801|NCT01431274|581788564|FG000|Overall Study|Lost to Follow-up|6|||
161108802|NCT01431274|581788565|FG001|Overall Study|Lost to Follow-up|7|||
161108803|NCT01431274|581788566|FG002|Overall Study|Lost to Follow-up|1|||
161108804|NCT01431274|581788567|FG003|Overall Study|Lost to Follow-up|4|||
161108805|NCT01431274|581788568|FG004|Overall Study|Lost to Follow-up|0|||
161108806|NCT01431274|581788564|FG000|Overall Study|Other reason not stated above|6|||
161108807|NCT01431274|581788565|FG001|Overall Study|Other reason not stated above|5|||
161108808|NCT01431274|581788566|FG002|Overall Study|Other reason not stated above|7|||
161108809|NCT01431274|581788567|FG003|Overall Study|Other reason not stated above|2|||
161108810|NCT01431274|581788568|FG004|Overall Study|Other reason not stated above|4|||
161108811|NCT00003702|581788569|FG000|Overall Study|Ineligible cell types|2|||
161108812|NCT00003702|581788570|FG001|Overall Study|Ineligible cell types|2|||
161108813|NCT00003702|581788569|FG000|Overall Study|Did not meet criteria for persistence|8|||
161108814|NCT00003702|581788570|FG001|Overall Study|Did not meet criteria for persistence|5|||
161108815|NCT00003702|581788569|FG000|Overall Study|WHO score > 6|2|||
161108816|NCT00003702|581788570|FG001|Overall Study|WHO score > 6|1|||
161108817|NCT00003702|581788569|FG000|Overall Study|Inadequate documentation of disease|1|||
161108818|NCT00003702|581788570|FG001|Overall Study|Inadequate documentation of disease|3|||
161108819|NCT00827606|581788571|FG000|Overall Study|Protocol Violation|4|||
161108820|NCT00827606|581788572|FG001|Overall Study|Protocol Violation|3|||
161108821|NCT00827606|581788571|FG000|Overall Study|Lost to Follow-up|3|||
161108822|NCT00827606|581788572|FG001|Overall Study|Lost to Follow-up|1|||
161108823|NCT00827606|581788571|FG000|Overall Study|Withdrawal by Subject|7|||
161108824|NCT00827606|581788572|FG001|Overall Study|Withdrawal by Subject|6|||
161108825|NCT00827606|581788571|FG000|Overall Study|Pregnancy|0|||
161108826|NCT00827606|581788572|FG001|Overall Study|Pregnancy|1|||
161108827|NCT00827606|581788571|FG000|Overall Study|Other|5|||
161108828|NCT00827606|581788572|FG001|Overall Study|Other|13|||
161108829|NCT00827606|581788571|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
161108830|NCT00827606|581788572|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
161108831|NCT00827606|581788571|FG000|Overall Study|Adverse Event|4|||
161108832|NCT00827606|581788572|FG001|Overall Study|Adverse Event|2|||
161108833|NCT00243386|581788577|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
161108834|NCT00243386|581788578|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
161108835|NCT00243386|581788579|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
161108836|NCT00243386|581788577|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
161108837|NCT00243386|581788578|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
161108838|NCT00243386|581788579|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
161108839|NCT00243386|581788577|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
161324339|NCT00941304|582573570|FG000|Overall Study|Lost to Follow-up|1|||
161108840|NCT00243386|581788578|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
161108841|NCT00243386|581788579|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
160865677|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
160865678|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
160865679|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
160865680|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
160865681|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
160865682|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
160865683|NCT00538902|580902948|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
160865684|NCT00538902|580902949|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
160865685|NCT00538902|580902950|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
160865686|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
160865687|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
160865688|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
160865689|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
160865690|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
160865691|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
160865692|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
160865693|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
160865694|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
160865695|NCT00538902|580902948|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
160865696|NCT00538902|580902949|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
160865697|NCT00538902|580902950|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
160865698|NCT01454102|580902951|FG000|Overall Study|Continuing in the treatment period|0|||
160865699|NCT01454102|580902952|FG001|Overall Study|Continuing in the treatment period|0|||
160865700|NCT01454102|580902953|FG002|Overall Study|Continuing in the treatment period|0|||
160865701|NCT01454102|580902954|FG003|Overall Study|Continuing in the treatment period|0|||
160865702|NCT01454102|580902955|FG004|Overall Study|Continuing in the treatment period|3|||
160865703|NCT01454102|580902956|FG005|Overall Study|Continuing in the treatment period|3|||
160865704|NCT01454102|580902957|FG006|Overall Study|Continuing in the treatment period|2|||
160865705|NCT01454102|580902958|FG007|Overall Study|Continuing in the treatment period|0|||
160865706|NCT01454102|580902959|FG008|Overall Study|Continuing in the treatment period|1|||
160865707|NCT01454102|580902960|FG009|Overall Study|Continuing in the treatment period|0|||
160865708|NCT01454102|580902961|FG010|Overall Study|Continuing in the treatment period|0|||
160865709|NCT01454102|580902962|FG011|Overall Study|Continuing in the treatment period|4|||
160865710|NCT01454102|580902963|FG012|Overall Study|Continuing in the treatment period|7|||
160865711|NCT01454102|580902964|FG013|Overall Study|Continuing in the treatment period|4|||
160865712|NCT01454102|580902965|FG014|Overall Study|Continuing in the treatment period|3|||
160865713|NCT01454102|580902966|FG015|Overall Study|Continuing in the treatment period|1|||
160865714|NCT00705016|580902967|FG000|Overall Study|Adverse Event|6|||
160865715|NCT00705016|580902968|FG001|Overall Study|Adverse Event|11|||
160865716|NCT00705016|580902969|FG002|Overall Study|Adverse Event|10|||
160865717|NCT00705016|580902967|FG000|Overall Study|Death|5|||
160865718|NCT00705016|580902968|FG001|Overall Study|Death|7|||
160865719|NCT00705016|580902969|FG002|Overall Study|Death|5|||
160865720|NCT00705016|580902967|FG000|Overall Study|Protocol Violation|0|||
160865721|NCT00705016|580902968|FG001|Overall Study|Protocol Violation|1|||
160865722|NCT00705016|580902969|FG002|Overall Study|Protocol Violation|1|||
161108842|NCT00243386|581788577|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
161108843|NCT00243386|581788578|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
161108844|NCT00243386|581788579|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
161108845|NCT00243386|581788577|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
161108846|NCT00243386|581788578|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
161108847|NCT00243386|581788579|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
161108848|NCT00243386|581788577|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
161108849|NCT00243386|581788578|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
161108850|NCT00243386|581788579|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
161108851|NCT00243386|581788577|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
161108852|NCT00243386|581788578|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
161108853|NCT00243386|581788579|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
161108854|NCT00243386|581788577|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
161108855|NCT00243386|581788578|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
161108856|NCT00243386|581788579|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
161108857|NCT04995055|581788580|FG000|Period 1|COVID-19 Related|1|||
161108858|NCT04995055|581788581|FG001|Period 1|COVID-19 Related|0|||
161108859|NCT04995055|581788580|FG000|Period 1|Withdrawal by Subject|0|||
161108860|NCT04995055|581788581|FG001|Period 1|Withdrawal by Subject|1|||
161108861|NCT04995055|581788580|FG000|Period 1|Subject discontinued due to timing|4|||
161108862|NCT04995055|581788581|FG001|Period 1|Subject discontinued due to timing|4|||
161108863|NCT01378858|581788583|FG000|Overall Study|Withdrawal by Subject|4|||
161108864|NCT01378858|581788584|FG001|Overall Study|Withdrawal by Subject|4|||
161108865|NCT04810689|581788585|FG000|Overall Study|Withdrawal by Subject|0|||
161108866|NCT04810689|581788586|FG001|Overall Study|Withdrawal by Subject|1|||
161214510|NCT02544633|582169382|FG002|Treatment Period|Lost to Follow-up|0|||
161214511|NCT02544633|582169383|FG003|Treatment Period|Lost to Follow-up|0|||
161214512|NCT02544633|582169380|FG000|Treatment Period|Death|0|||
161214513|NCT02544633|582169381|FG001|Treatment Period|Death|0|||
161214514|NCT02544633|582169382|FG002|Treatment Period|Death|1|||
161214515|NCT02544633|582169383|FG003|Treatment Period|Death|0|||
161214516|NCT02544633|582169380|FG000|Treatment Period|Non-compliance|0|||
161214517|NCT02544633|582169381|FG001|Treatment Period|Non-compliance|0|||
161214518|NCT02544633|582169382|FG002|Treatment Period|Non-compliance|1|||
161214519|NCT02544633|582169383|FG003|Treatment Period|Non-compliance|0|||
161214520|NCT02544633|582169380|FG000|Treatment Period|Clinical Disease Progression|0|||
161214521|NCT02544633|582169381|FG001|Treatment Period|Clinical Disease Progression|0|||
161214522|NCT02544633|582169382|FG002|Treatment Period|Clinical Disease Progression|0|||
161214523|NCT02544633|582169383|FG003|Treatment Period|Clinical Disease Progression|1|||
161214524|NCT02544633|582169380|FG000|Survival Follow-up Period|Death|12|||
161214525|NCT02544633|582169381|FG001|Survival Follow-up Period|Death|14|||
161214526|NCT02544633|582169382|FG002|Survival Follow-up Period|Death|3|||
161324340|NCT00941304|582573571|FG001|Overall Study|Lost to Follow-up|0|||
161324341|NCT00941304|582573572|FG002|Overall Study|Lost to Follow-up|0|||
161214527|NCT02544633|582169383|FG003|Survival Follow-up Period|Death|9|||
160865723|NCT00705016|580902967|FG000|Overall Study|Withdrawal by Subject|4|||
160865724|NCT00705016|580902968|FG001|Overall Study|Withdrawal by Subject|3|||
160865725|NCT00705016|580902969|FG002|Overall Study|Withdrawal by Subject|2|||
160865726|NCT00705016|580902967|FG000|Overall Study|Progressive Disease|33|||
160865727|NCT00705016|580902968|FG001|Overall Study|Progressive Disease|29|||
160865728|NCT00705016|580902969|FG002|Overall Study|Progressive Disease|33|||
160865729|NCT00705016|580902967|FG000|Overall Study|Symptomatic Deterioration|3|||
160865730|NCT00705016|580902968|FG001|Overall Study|Symptomatic Deterioration|1|||
160865731|NCT00705016|580902969|FG002|Overall Study|Symptomatic Deterioration|1|||
160865732|NCT00705016|580902967|FG000|Overall Study|Other|9|||
160865733|NCT00705016|580902968|FG001|Overall Study|Other|6|||
160865734|NCT00705016|580902969|FG002|Overall Study|Other|6|||
160865735|NCT00942604|580902972|FG000|Overall Study|Protocol Violation|1|||
160865736|NCT00942604|580902973|FG001|Overall Study|Protocol Violation|1|||
160865737|NCT00942604|580902972|FG000|Overall Study|Adverse Event|0|||
160865738|NCT00942604|580902973|FG001|Overall Study|Adverse Event|1|||
160865739|NCT00942604|580902972|FG000|Overall Study|Withdrawal by Subject|0|||
160865740|NCT00942604|580902973|FG001|Overall Study|Withdrawal by Subject|1|||
160865741|NCT00942604|580902972|FG000|Overall Study|Patient relocation|1|||
160865742|NCT00942604|580902973|FG001|Overall Study|Patient relocation|1|||
160865743|NCT01188343|580902974|FG000|Overall Study|Not vaccinated|0|||
160865744|NCT01188343|580902975|FG001|Overall Study|Not vaccinated|2|||
160865745|NCT01188343|580902976|FG002|Overall Study|Not vaccinated|1|||
160865746|NCT01188343|580902974|FG000|Overall Study|Withdrawal by Subject|1|||
160865747|NCT01188343|580902975|FG001|Overall Study|Withdrawal by Subject|24|||
160865748|NCT01188343|580902976|FG002|Overall Study|Withdrawal by Subject|0|||
160865749|NCT01663103|580902977|FG000|Overall Study|Withdrawal by Subject|1|||
160865750|NCT01663103|580902978|FG001|Overall Study|Withdrawal by Subject|2|||
160865751|NCT01663103|580902977|FG000|Overall Study|Adverse Event|1|||
161108867|NCT01358760|581788587|FG000|Overall Study|Adverse Event|3|||
161108868|NCT01358760|581788588|FG001|Overall Study|Adverse Event|4|||
161108869|NCT01358760|581788589|FG002|Overall Study|Adverse Event|3|||
161108870|NCT01358760|581788587|FG000|Overall Study|Lost to Follow-up|1|||
161108871|NCT01358760|581788588|FG001|Overall Study|Lost to Follow-up|1|||
161108872|NCT01358760|581788589|FG002|Overall Study|Lost to Follow-up|3|||
161108873|NCT01358760|581788587|FG000|Overall Study|Withdrawal by Subject|5|||
161108874|NCT01358760|581788588|FG001|Overall Study|Withdrawal by Subject|3|||
161108875|NCT01358760|581788589|FG002|Overall Study|Withdrawal by Subject|2|||
161108876|NCT01358760|581788587|FG000|Overall Study|Physician Decision|1|||
161108877|NCT01358760|581788588|FG001|Overall Study|Physician Decision|0|||
161108878|NCT01358760|581788589|FG002|Overall Study|Physician Decision|1|||
161108879|NCT01358760|581788587|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
161108880|NCT01358760|581788588|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
161108881|NCT01358760|581788589|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
161108882|NCT04695392|581788590|FG000|Overall Study|Withdrawn by parent/guardian|0|||
161108883|NCT04695392|581788591|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161108884|NCT04695392|581788590|FG000|Overall Study|Withdrawn by physician|0|||
161108885|NCT04695392|581788591|FG001|Overall Study|Withdrawn by physician|1|||
161108886|NCT00450723|581788592|FG000|Overall Study|Physician Decision|5|||
161108887|NCT01721057|581788595|FG000|Treatment Period|Withdrawal by Subject|11|||
161108888|NCT01721057|581788596|FG001|Treatment Period|Withdrawal by Subject|5|||
161108889|NCT01721057|581788597|FG002|Treatment Period|Withdrawal by Subject|8|||
161108890|NCT01721057|581788598|FG003|Treatment Period|Withdrawal by Subject|0|||
161108891|NCT01721057|581788599|FG004|Treatment Period|Withdrawal by Subject|0|||
161108892|NCT01721057|581788600|FG005|Treatment Period|Withdrawal by Subject|0|||
161108893|NCT01721057|581788601|FG006|Treatment Period|Withdrawal by Subject|0|||
161108894|NCT01721057|581788595|FG000|Treatment Period|Adverse Event|7|||
161108895|NCT01721057|581788596|FG001|Treatment Period|Adverse Event|10|||
161108896|NCT01721057|581788597|FG002|Treatment Period|Adverse Event|12|||
161108897|NCT01721057|581788598|FG003|Treatment Period|Adverse Event|0|||
161108898|NCT01721057|581788599|FG004|Treatment Period|Adverse Event|0|||
161214528|NCT02544633|582169380|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
161214529|NCT02544633|582169381|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
160865752|NCT01663103|580902978|FG001|Overall Study|Adverse Event|0|||
160865753|NCT01663103|580902977|FG000|Overall Study|dog bite|1|||
160865754|NCT01663103|580902978|FG001|Overall Study|dog bite|0|||
160865755|NCT04634253|580902983|FG000|Overall Study|Adverse Event|1|||
160865756|NCT04634253|580902984|FG001|Overall Study|Adverse Event|1|||
160865757|NCT04634253|580902985|FG002|Overall Study|Adverse Event|0|||
160865758|NCT04634253|580902983|FG000|Overall Study|Physician Decision|0|||
160865759|NCT04634253|580902984|FG001|Overall Study|Physician Decision|1|||
160865760|NCT04634253|580902985|FG002|Overall Study|Physician Decision|0|||
160865761|NCT04634253|580902983|FG000|Overall Study|Withdrawal by Subject|1|||
161108899|NCT01721057|581788600|FG005|Treatment Period|Adverse Event|0|||
161108900|NCT01721057|581788601|FG006|Treatment Period|Adverse Event|0|||
161108901|NCT01721057|581788595|FG000|Treatment Period|Lack of Efficacy|7|||
161108902|NCT01721057|581788596|FG001|Treatment Period|Lack of Efficacy|3|||
161108903|NCT01721057|581788597|FG002|Treatment Period|Lack of Efficacy|0|||
160865762|NCT04634253|580902984|FG001|Overall Study|Withdrawal by Subject|0|||
160865763|NCT04634253|580902985|FG002|Overall Study|Withdrawal by Subject|3|||
160865764|NCT01721044|580902986|FG000|Treatment Period|Adverse Event|7|||
160865765|NCT01721044|580902987|FG001|Treatment Period|Adverse Event|7|||
160865766|NCT01721044|580902988|FG002|Treatment Period|Adverse Event|10|||
161108904|NCT01721057|581788598|FG003|Treatment Period|Lack of Efficacy|0|||
161108905|NCT01721057|581788599|FG004|Treatment Period|Lack of Efficacy|0|||
161108906|NCT01721057|581788600|FG005|Treatment Period|Lack of Efficacy|0|||
161108907|NCT01721057|581788601|FG006|Treatment Period|Lack of Efficacy|0|||
161108908|NCT01721057|581788595|FG000|Treatment Period|Lost to Follow-up|1|||
161108909|NCT01721057|581788596|FG001|Treatment Period|Lost to Follow-up|0|||
161108910|NCT01721057|581788597|FG002|Treatment Period|Lost to Follow-up|0|||
161108911|NCT01721057|581788598|FG003|Treatment Period|Lost to Follow-up|0|||
161108912|NCT01721057|581788599|FG004|Treatment Period|Lost to Follow-up|0|||
161108913|NCT01721057|581788600|FG005|Treatment Period|Lost to Follow-up|0|||
161108914|NCT01721057|581788601|FG006|Treatment Period|Lost to Follow-up|0|||
161108915|NCT01721057|581788595|FG000|Treatment Period|Physician Decision|0|||
161108916|NCT01721057|581788596|FG001|Treatment Period|Physician Decision|1|||
161108917|NCT01721057|581788597|FG002|Treatment Period|Physician Decision|3|||
161108918|NCT01721057|581788598|FG003|Treatment Period|Physician Decision|0|||
161108919|NCT01721057|581788599|FG004|Treatment Period|Physician Decision|0|||
161108920|NCT01721057|581788600|FG005|Treatment Period|Physician Decision|0|||
161108921|NCT01721057|581788601|FG006|Treatment Period|Physician Decision|0|||
161108922|NCT01721057|581788595|FG000|Treatment Period|Death|2|||
161108923|NCT01721057|581788596|FG001|Treatment Period|Death|0|||
161108924|NCT01721057|581788597|FG002|Treatment Period|Death|0|||
161108925|NCT01721057|581788598|FG003|Treatment Period|Death|0|||
161108926|NCT01721057|581788599|FG004|Treatment Period|Death|0|||
161108927|NCT01721057|581788600|FG005|Treatment Period|Death|0|||
161108928|NCT01721057|581788601|FG006|Treatment Period|Death|0|||
161108929|NCT01721057|581788595|FG000|Rescue Period|Adverse Event|0|||
161108930|NCT01721057|581788596|FG001|Rescue Period|Adverse Event|0|||
161108931|NCT01721057|581788597|FG002|Rescue Period|Adverse Event|0|||
161108932|NCT01721057|581788598|FG003|Rescue Period|Adverse Event|1|||
161108933|NCT01721057|581788599|FG004|Rescue Period|Adverse Event|0|||
161108934|NCT01721057|581788600|FG005|Rescue Period|Adverse Event|0|||
161108935|NCT01721057|581788601|FG006|Rescue Period|Adverse Event|0|||
161108936|NCT01721057|581788595|FG000|Rescue Period|Lack of Efficacy|0|||
161108937|NCT01721057|581788596|FG001|Rescue Period|Lack of Efficacy|0|||
161108938|NCT01721057|581788597|FG002|Rescue Period|Lack of Efficacy|0|||
161108939|NCT01721057|581788598|FG003|Rescue Period|Lack of Efficacy|2|||
161108940|NCT01721057|581788599|FG004|Rescue Period|Lack of Efficacy|0|||
161108941|NCT01721057|581788600|FG005|Rescue Period|Lack of Efficacy|0|||
161108942|NCT01721057|581788601|FG006|Rescue Period|Lack of Efficacy|0|||
161108943|NCT02047253|581788602|FG000|Overall Study|Lost to Follow-up|8|||
161108944|NCT01987960|581788604|FG000|Period 1|Adverse Event|24|||
161108945|NCT01987960|581788605|FG001|Period 1|Adverse Event|0|||
161108946|NCT01987960|581788606|FG002|Period 1|Adverse Event|0|||
161108947|NCT01987960|581788607|FG003|Period 1|Adverse Event|0|||
161108948|NCT01987960|581788604|FG000|Period 1|Lack of Efficacy|4|||
161108949|NCT01987960|581788605|FG001|Period 1|Lack of Efficacy|0|||
161108950|NCT01987960|581788606|FG002|Period 1|Lack of Efficacy|0|||
161108951|NCT01987960|581788607|FG003|Period 1|Lack of Efficacy|0|||
161108952|NCT01987960|581788604|FG000|Period 1|Non-compliance with IMP|6|||
161108953|NCT01987960|581788605|FG001|Period 1|Non-compliance with IMP|0|||
161108954|NCT01987960|581788606|FG002|Period 1|Non-compliance with IMP|0|||
161108955|NCT01987960|581788607|FG003|Period 1|Non-compliance with IMP|0|||
161108956|NCT01987960|581788604|FG000|Period 1|Protocol Violation|12|||
161108957|NCT01987960|581788605|FG001|Period 1|Protocol Violation|0|||
161108958|NCT01987960|581788606|FG002|Period 1|Protocol Violation|0|||
161108959|NCT01987960|581788607|FG003|Period 1|Protocol Violation|0|||
161108960|NCT01987960|581788604|FG000|Period 1|Withdrawal by Subject|21|||
161108961|NCT01987960|581788605|FG001|Period 1|Withdrawal by Subject|0|||
161108962|NCT01987960|581788606|FG002|Period 1|Withdrawal by Subject|0|||
161108963|NCT01987960|581788607|FG003|Period 1|Withdrawal by Subject|0|||
160865767|NCT01721044|580902986|FG000|Treatment Period|Death|0|||
160865768|NCT01721044|580902987|FG001|Treatment Period|Death|0|||
160865769|NCT01721044|580902988|FG002|Treatment Period|Death|1|||
161108964|NCT01987960|581788604|FG000|Period 1|Lost to Follow-up|40|||
161108965|NCT01987960|581788605|FG001|Period 1|Lost to Follow-up|0|||
161108966|NCT01987960|581788606|FG002|Period 1|Lost to Follow-up|0|||
161108967|NCT01987960|581788607|FG003|Period 1|Lost to Follow-up|0|||
161108968|NCT01987960|581788604|FG000|Period 1|administrative or other reason|75|||
161108969|NCT01987960|581788605|FG001|Period 1|administrative or other reason|0|||
161108970|NCT01987960|581788606|FG002|Period 1|administrative or other reason|0|||
161108971|NCT01987960|581788607|FG003|Period 1|administrative or other reason|0|||
161108972|NCT01987960|581788604|FG000|Period 1|Withdrawal of consent before treatment|4|||
161108973|NCT01987960|581788605|FG001|Period 1|Withdrawal of consent before treatment|0|||
161108974|NCT01987960|581788606|FG002|Period 1|Withdrawal of consent before treatment|0|||
161108975|NCT01987960|581788607|FG003|Period 1|Withdrawal of consent before treatment|0|||
161108976|NCT01987960|581788604|FG000|Period 2|Adverse Event|0|||
161108977|NCT01987960|581788605|FG001|Period 2|Adverse Event|0|||
161108978|NCT01987960|581788606|FG002|Period 2|Adverse Event|1|||
161108979|NCT01987960|581788607|FG003|Period 2|Adverse Event|0|||
161108980|NCT01987960|581788604|FG000|Period 2|Withdrawal by Subject|0|||
161108981|NCT01987960|581788605|FG001|Period 2|Withdrawal by Subject|0|||
161108982|NCT01987960|581788606|FG002|Period 2|Withdrawal by Subject|1|||
161108983|NCT01987960|581788607|FG003|Period 2|Withdrawal by Subject|0|||
161108984|NCT01987960|581788604|FG000|Period 2|Administrative or other reason|0|||
161108985|NCT01987960|581788605|FG001|Period 2|Administrative or other reason|5|||
161108986|NCT01987960|581788606|FG002|Period 2|Administrative or other reason|7|||
161108987|NCT01987960|581788607|FG003|Period 2|Administrative or other reason|0|||
161108988|NCT01987960|581788604|FG000|Period 3|Adverse Event|0|||
161108989|NCT01987960|581788605|FG001|Period 3|Adverse Event|0|||
161108990|NCT01987960|581788606|FG002|Period 3|Adverse Event|0|||
161108991|NCT01987960|581788607|FG003|Period 3|Adverse Event|7|||
161108992|NCT01987960|581788604|FG000|Period 3|Non-compliance with IMP|0|||
161108993|NCT01987960|581788605|FG001|Period 3|Non-compliance with IMP|0|||
161108994|NCT01987960|581788606|FG002|Period 3|Non-compliance with IMP|0|||
161108995|NCT01987960|581788607|FG003|Period 3|Non-compliance with IMP|1|||
161108996|NCT01987960|581788604|FG000|Period 3|Protocol Violation|0|||
161108997|NCT01987960|581788605|FG001|Period 3|Protocol Violation|0|||
161108998|NCT01987960|581788606|FG002|Period 3|Protocol Violation|0|||
161108999|NCT01987960|581788607|FG003|Period 3|Protocol Violation|6|||
161109000|NCT01987960|581788604|FG000|Period 3|Withdrawal by Subject|0|||
161109001|NCT01987960|581788605|FG001|Period 3|Withdrawal by Subject|0|||
161109002|NCT01987960|581788606|FG002|Period 3|Withdrawal by Subject|0|||
161109003|NCT01987960|581788607|FG003|Period 3|Withdrawal by Subject|9|||
161109004|NCT01987960|581788604|FG000|Period 3|Lost to Follow-up|0|||
161109005|NCT01987960|581788605|FG001|Period 3|Lost to Follow-up|0|||
161109006|NCT01987960|581788606|FG002|Period 3|Lost to Follow-up|0|||
161109007|NCT01987960|581788607|FG003|Period 3|Lost to Follow-up|5|||
161109008|NCT01987960|581788604|FG000|Period 3|Administrative or other reason|0|||
161109009|NCT01987960|581788605|FG001|Period 3|Administrative or other reason|0|||
161109010|NCT01987960|581788606|FG002|Period 3|Administrative or other reason|0|||
160865770|NCT01721044|580902986|FG000|Treatment Period|Lack of Efficacy|16|||
160865771|NCT01721044|580902987|FG001|Treatment Period|Lack of Efficacy|4|||
160865772|NCT01721044|580902988|FG002|Treatment Period|Lack of Efficacy|4|||
161214530|NCT02544633|582169382|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
161214531|NCT02544633|582169383|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
161214532|NCT02544633|582169380|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
161214533|NCT02544633|582169381|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
161214534|NCT02544633|582169382|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
161214535|NCT02544633|582169383|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
161214536|NCT02544633|582169380|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
161214537|NCT02544633|582169381|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
161214538|NCT02544633|582169382|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
161214539|NCT02544633|582169383|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
161214540|NCT00928252|582169386|FG000|Overall Study|Physician Decision|3|||
161214541|NCT02257632|582169387|FG000|Overall Study|Withdrawal by Subject|0|||
161214542|NCT02257632|582169388|FG001|Overall Study|Withdrawal by Subject|1|||
161214543|NCT02257632|582169387|FG000|Overall Study|Adverse Event|1|||
160865773|NCT01721044|580902986|FG000|Treatment Period|Lost to Follow-up|0|||
160865774|NCT01721044|580902987|FG001|Treatment Period|Lost to Follow-up|0|||
160865775|NCT01721044|580902988|FG002|Treatment Period|Lost to Follow-up|1|||
160865776|NCT01721044|580902986|FG000|Treatment Period|Physician Decision|1|||
160865777|NCT01721044|580902987|FG001|Treatment Period|Physician Decision|0|||
160865778|NCT01721044|580902988|FG002|Treatment Period|Physician Decision|2|||
160865779|NCT01721044|580902986|FG000|Treatment Period|Protocol Violation|1|||
160865780|NCT01721044|580902987|FG001|Treatment Period|Protocol Violation|0|||
160865781|NCT01721044|580902988|FG002|Treatment Period|Protocol Violation|0|||
160865782|NCT01721044|580902986|FG000|Treatment Period|Withdrawal by Subject|7|||
160865783|NCT01721044|580902987|FG001|Treatment Period|Withdrawal by Subject|6|||
160865784|NCT01721044|580902988|FG002|Treatment Period|Withdrawal by Subject|1|||
160865785|NCT01499355|580902992|FG000|Run-In Period|Study Termination|15|||
160865786|NCT01499355|580902993|FG001|Run-In Period|Study Termination|0|||
160865787|NCT01499355|580902994|FG002|Run-In Period|Study Termination|0|||
160865788|NCT01499355|580902995|FG003|Run-In Period|Study Termination|0|||
160865789|NCT01499355|580902992|FG000|Run-In Period|Other|3|||
160865790|NCT01499355|580902993|FG001|Run-In Period|Other|0|||
160865791|NCT01499355|580902994|FG002|Run-In Period|Other|0|||
160865792|NCT01499355|580902995|FG003|Run-In Period|Other|0|||
160865793|NCT01499355|580902992|FG000|Run-In Period|Death|2|||
160865794|NCT01499355|580902993|FG001|Run-In Period|Death|0|||
160865795|NCT01499355|580902994|FG002|Run-In Period|Death|0|||
160865796|NCT01499355|580902995|FG003|Run-In Period|Death|0|||
160865797|NCT01499355|580902992|FG000|Run-In Period|Investigator Decision|2|||
160865798|NCT01499355|580902993|FG001|Run-In Period|Investigator Decision|0|||
161109011|NCT01987960|581788607|FG003|Period 3|Administrative or other reason|43|||
161109012|NCT00789880|581788609|FG000|Overall Study|Adverse Event|0|||
161109013|NCT00789880|581788610|FG001|Overall Study|Adverse Event|0|||
161109014|NCT00789880|581788611|FG002|Overall Study|Adverse Event|0|||
161109015|NCT00789880|581788612|FG003|Overall Study|Adverse Event|0|||
161109016|NCT00789880|581788613|FG004|Overall Study|Adverse Event|1|||
161109017|NCT00789880|581788614|FG005|Overall Study|Adverse Event|0|||
161109018|NCT00789880|581788609|FG000|Overall Study|Protocol Violation|0|||
161109019|NCT00789880|581788610|FG001|Overall Study|Protocol Violation|1|||
161109020|NCT00789880|581788611|FG002|Overall Study|Protocol Violation|0|||
161109021|NCT00789880|581788612|FG003|Overall Study|Protocol Violation|1|||
161109022|NCT00789880|581788613|FG004|Overall Study|Protocol Violation|0|||
160865799|NCT01499355|580902994|FG002|Run-In Period|Investigator Decision|0|||
160865800|NCT01499355|580902995|FG003|Run-In Period|Investigator Decision|0|||
160865801|NCT01499355|580902992|FG000|Run-In Period|Consent Withdrawn|1|||
161109023|NCT00789880|581788614|FG005|Overall Study|Protocol Violation|0|||
161109024|NCT00789880|581788609|FG000|Overall Study|Withdrawal by Subject|1|||
161109025|NCT00789880|581788610|FG001|Overall Study|Withdrawal by Subject|0|||
161109026|NCT00789880|581788611|FG002|Overall Study|Withdrawal by Subject|0|||
161109027|NCT00789880|581788612|FG003|Overall Study|Withdrawal by Subject|0|||
161109028|NCT00789880|581788613|FG004|Overall Study|Withdrawal by Subject|2|||
161109029|NCT00789880|581788614|FG005|Overall Study|Withdrawal by Subject|0|||
161109030|NCT01177683|581788615|FG000|Study Treatment|Disease Progressions during treatment|2|||
161109031|NCT01177683|581788616|FG001|Study Treatment|Disease Progressions during treatment|0|||
161109032|NCT01177683|581788617|FG002|Study Treatment|Disease Progressions during treatment|3|||
161109033|NCT01177683|581788615|FG000|Study Treatment|Adverse Event|0|||
161109034|NCT01177683|581788616|FG001|Study Treatment|Adverse Event|1|||
161109035|NCT01177683|581788617|FG002|Study Treatment|Adverse Event|12|||
161109036|NCT01177683|581788615|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161109037|NCT01177683|581788616|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
161109038|NCT01177683|581788617|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161109039|NCT01177683|581788615|FG000|Study Treatment|Alternative therapy|0|||
161109040|NCT01177683|581788616|FG001|Study Treatment|Alternative therapy|0|||
161109041|NCT01177683|581788617|FG002|Study Treatment|Alternative therapy|4|||
161109042|NCT01177683|581788615|FG000|Study Treatment|Physician Decision|1|||
161109043|NCT01177683|581788616|FG001|Study Treatment|Physician Decision|0|||
161109044|NCT01177683|581788617|FG002|Study Treatment|Physician Decision|1|||
161109045|NCT01177683|581788615|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
161109046|NCT01177683|581788616|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
161109047|NCT01177683|581788617|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
161109048|NCT01177683|581788615|FG000|Study Treatment|Symptomatic Deterioration|0|||
161109049|NCT01177683|581788616|FG001|Study Treatment|Symptomatic Deterioration|0|||
161109050|NCT01177683|581788617|FG002|Study Treatment|Symptomatic Deterioration|1|||
161109051|NCT01177683|581788615|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
161109052|NCT01177683|581788616|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
161109053|NCT01177683|581788617|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
161109054|NCT01177683|581788615|FG000|Follow up|Patient lost to follow up|0|||
161109055|NCT01177683|581788616|FG001|Follow up|Patient lost to follow up|0|||
161109056|NCT01177683|581788617|FG002|Follow up|Patient lost to follow up|2|||
161109057|NCT01177683|581788615|FG000|Follow up|Death|2|||
161109058|NCT01177683|581788616|FG001|Follow up|Death|1|||
161109059|NCT01177683|581788617|FG002|Follow up|Death|7|||
161109060|NCT01177683|581788615|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
161109061|NCT01177683|581788616|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
161109062|NCT01177683|581788617|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
161109063|NCT06347731|581788618|FG000|Overall Study|Death|1|||
161109064|NCT06347731|581788618|FG000|Overall Study|Protocol Violation|1|||
161109065|NCT06347731|581788618|FG000|Overall Study|Withdrawal by Subject|2|||
161109066|NCT00609986|581788622|FG000|Overall Study|Did not receive transplant or treatment|8|||
161109067|NCT00609986|581788623|FG001|Overall Study|Did not receive transplant or treatment|3|||
161109068|NCT03159091|581788624|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
161109069|NCT03159091|581788625|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
161109070|NCT03159091|581788624|FG000|Overall Study|Patient has taken no dose of study drug|0|||
161109071|NCT03159091|581788625|FG001|Overall Study|Patient has taken no dose of study drug|1|||
161109072|NCT02044133|581788626|FG000|Overall Study|Lost to Follow-up|1|||
161109073|NCT02044133|581788627|FG001|Overall Study|Lost to Follow-up|1|||
161109074|NCT02044133|581788626|FG000|Overall Study|Death|1|||
161109075|NCT02044133|581788627|FG001|Overall Study|Death|0|||
161109076|NCT02044133|581788626|FG000|Overall Study|Release|3|||
161109077|NCT02044133|581788627|FG001|Overall Study|Release|4|||
161109078|NCT02044133|581788626|FG000|Overall Study|Transfer|1|||
161109079|NCT02044133|581788627|FG001|Overall Study|Transfer|0|||
161109080|NCT02044133|581788626|FG000|Overall Study|refusal of blood sampling|0|||
161109081|NCT02044133|581788627|FG001|Overall Study|refusal of blood sampling|1|||
161214544|NCT02257632|582169388|FG001|Overall Study|Adverse Event|2|||
161109082|NCT04085523|581788628|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161214545|NCT02468557|582169389|FG000|Overall Study|Adverse Event|1|||
161214546|NCT02468557|582169389|FG000|Overall Study|Death|1|||
161214547|NCT02468557|582169389|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
161214548|NCT02468557|582169389|FG000|Overall Study|All Enrolled but Never Dosed|4|||
161214549|NCT02024698|582169393|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
161214550|NCT02024698|582169394|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
161214551|NCT03322462|582169395|FG000|Overall Study|Technical difficulties|2|||
161214552|NCT03322462|582169395|FG000|Overall Study|Other|1|||
161214553|NCT01393990|582169396|FG000|Overall Study|Adverse Event|0|||
161214554|NCT01393990|582169397|FG001|Overall Study|Adverse Event|0|||
161214555|NCT01393990|582169398|FG002|Overall Study|Adverse Event|0|||
161214556|NCT01393990|582169399|FG003|Overall Study|Adverse Event|0|||
161214557|NCT01393990|582169400|FG004|Overall Study|Adverse Event|0|||
161214558|NCT01393990|582169401|FG005|Overall Study|Adverse Event|0|||
161214559|NCT01393990|582169402|FG006|Overall Study|Adverse Event|0|||
161214560|NCT01393990|582169403|FG007|Overall Study|Adverse Event|0|||
161214561|NCT01393990|582169404|FG008|Overall Study|Adverse Event|0|||
161214562|NCT01393990|582169405|FG009|Overall Study|Adverse Event|0|||
161214563|NCT01393990|582169406|FG010|Overall Study|Adverse Event|0|||
161214564|NCT01393990|582169407|FG011|Overall Study|Adverse Event|0|||
161214565|NCT01393990|582169408|FG012|Overall Study|Adverse Event|0|||
161214566|NCT01393990|582169409|FG013|Overall Study|Adverse Event|0|||
161214567|NCT01393990|582169410|FG014|Overall Study|Adverse Event|1|||
161214568|NCT01393990|582169411|FG015|Overall Study|Adverse Event|1|||
161214569|NCT01393990|582169412|FG016|Overall Study|Adverse Event|0|||
161214570|NCT01393990|582169413|FG017|Overall Study|Adverse Event|0|||
161214571|NCT01393990|582169396|FG000|Overall Study|Progressive Disease|1|||
161214572|NCT01393990|582169397|FG001|Overall Study|Progressive Disease|0|||
161214573|NCT01393990|582169398|FG002|Overall Study|Progressive Disease|0|||
161214574|NCT01393990|582169399|FG003|Overall Study|Progressive Disease|1|||
161214575|NCT01393990|582169400|FG004|Overall Study|Progressive Disease|1|||
161214576|NCT01393990|582169401|FG005|Overall Study|Progressive Disease|1|||
161214577|NCT01393990|582169402|FG006|Overall Study|Progressive Disease|1|||
161214578|NCT01393990|582169403|FG007|Overall Study|Progressive Disease|1|||
161214579|NCT01393990|582169404|FG008|Overall Study|Progressive Disease|3|||
161214580|NCT01393990|582169405|FG009|Overall Study|Progressive Disease|1|||
161214581|NCT01393990|582169406|FG010|Overall Study|Progressive Disease|0|||
161214582|NCT01393990|582169407|FG011|Overall Study|Progressive Disease|0|||
161214583|NCT01393990|582169408|FG012|Overall Study|Progressive Disease|0|||
161324342|NCT00941304|582573573|FG003|Overall Study|Lost to Follow-up|0|||
161109083|NCT04085523|581788629|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161214584|NCT01393990|582169409|FG013|Overall Study|Progressive Disease|1|||
161214585|NCT01393990|582169410|FG014|Overall Study|Progressive Disease|6|||
161214586|NCT01393990|582169411|FG015|Overall Study|Progressive Disease|1|||
160861859|NCT02531802|580887855|FG010|Received Vaccination 2|Adverse Event|0|||
160861860|NCT02531802|580887856|FG011|Received Vaccination 2|Adverse Event|0|||
160865802|NCT01499355|580902993|FG001|Run-In Period|Consent Withdrawn|0|||
160865803|NCT01499355|580902994|FG002|Run-In Period|Consent Withdrawn|0|||
160865804|NCT01499355|580902995|FG003|Run-In Period|Consent Withdrawn|0|||
160865805|NCT01499355|580902992|FG000|Run-In Period|Adverse Event|8|||
160865806|NCT01499355|580902993|FG001|Run-In Period|Adverse Event|0|||
160865807|NCT01499355|580902994|FG002|Run-In Period|Adverse Event|0|||
160865808|NCT01499355|580902995|FG003|Run-In Period|Adverse Event|0|||
160865809|NCT01499355|580902992|FG000|Double-Blind Period|Adverse Event|0|||
160865810|NCT01499355|580902993|FG001|Double-Blind Period|Adverse Event|2|||
160865811|NCT01499355|580902994|FG002|Double-Blind Period|Adverse Event|3|||
160865812|NCT01499355|580902995|FG003|Double-Blind Period|Adverse Event|2|||
160865813|NCT01499355|580902992|FG000|Double-Blind Period|Study Termination|0|||
160865814|NCT01499355|580902993|FG001|Double-Blind Period|Study Termination|18|||
160865815|NCT01499355|580902994|FG002|Double-Blind Period|Study Termination|16|||
160865816|NCT01499355|580902995|FG003|Double-Blind Period|Study Termination|14|||
160865817|NCT01499355|580902992|FG000|Double-Blind Period|Other|0|||
160865818|NCT01499355|580902993|FG001|Double-Blind Period|Other|1|||
160865819|NCT01499355|580902994|FG002|Double-Blind Period|Other|2|||
160865820|NCT01499355|580902995|FG003|Double-Blind Period|Other|2|||
160865821|NCT01499355|580902992|FG000|Double-Blind Period|Death|0|||
160865822|NCT01499355|580902993|FG001|Double-Blind Period|Death|1|||
160865823|NCT01499355|580902994|FG002|Double-Blind Period|Death|0|||
160865824|NCT01499355|580902995|FG003|Double-Blind Period|Death|0|||
160865825|NCT01499355|580902992|FG000|Double-Blind Period|Investigator Decision|0|||
160865826|NCT01499355|580902993|FG001|Double-Blind Period|Investigator Decision|0|||
160865827|NCT01499355|580902994|FG002|Double-Blind Period|Investigator Decision|3|||
160865828|NCT01499355|580902995|FG003|Double-Blind Period|Investigator Decision|3|||
160865829|NCT01499355|580902992|FG000|Double-Blind Period|Consent Withdrawn|0|||
160865830|NCT01499355|580902993|FG001|Double-Blind Period|Consent Withdrawn|0|||
160865831|NCT01499355|580902994|FG002|Double-Blind Period|Consent Withdrawn|1|||
160865832|NCT01499355|580902995|FG003|Double-Blind Period|Consent Withdrawn|2|||
161109084|NCT04085523|581788630|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161109085|NCT04085523|581788631|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161109086|NCT04085523|581788632|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
161109087|NCT04085523|581788633|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
161109088|NCT05678257|581788634|FG000|Overall Study|Withdrawal by Subject|2|||
161109089|NCT05678257|581788635|FG001|Overall Study|Withdrawal by Subject|0|||
161109090|NCT05678257|581788636|FG002|Overall Study|Withdrawal by Subject|5|||
161109091|NCT05678257|581788634|FG000|Overall Study|Physician Decision|1|||
161109092|NCT05678257|581788635|FG001|Overall Study|Physician Decision|0|||
161109093|NCT05678257|581788636|FG002|Overall Study|Physician Decision|1|||
161109094|NCT05678257|581788634|FG000|Overall Study|Adverse Event|1|||
161109095|NCT05678257|581788635|FG001|Overall Study|Adverse Event|3|||
161109096|NCT05678257|581788636|FG002|Overall Study|Adverse Event|1|||
161109097|NCT05678257|581788634|FG000|Overall Study|Progressive disease|11|||
161109098|NCT05678257|581788635|FG001|Overall Study|Progressive disease|18|||
161109099|NCT05678257|581788636|FG002|Overall Study|Progressive disease|7|||
161109100|NCT05678257|581788634|FG000|Overall Study|No longer clinically benefitting|2|||
161109101|NCT05678257|581788635|FG001|Overall Study|No longer clinically benefitting|1|||
161109102|NCT05678257|581788636|FG002|Overall Study|No longer clinically benefitting|0|||
161109103|NCT05678257|581788634|FG000|Overall Study|Sponsor decision|5|||
161109104|NCT05678257|581788635|FG001|Overall Study|Sponsor decision|9|||
161109105|NCT05678257|581788636|FG002|Overall Study|Sponsor decision|8|||
161109106|NCT05678257|581788634|FG000|Overall Study|Protocol Violation|0|||
161109107|NCT05678257|581788635|FG001|Overall Study|Protocol Violation|0|||
161109108|NCT05678257|581788636|FG002|Overall Study|Protocol Violation|1|||
161109109|NCT05678257|581788634|FG000|Overall Study|Patient non-compliance|0|||
161109110|NCT05678257|581788635|FG001|Overall Study|Patient non-compliance|0|||
161109111|NCT05678257|581788636|FG002|Overall Study|Patient non-compliance|3|||
161109112|NCT02046096|581788637|FG000|Overall Study|Death|28|||
161109113|NCT02046096|581788638|FG001|Overall Study|Death|45|||
161109114|NCT02046096|581788637|FG000|Overall Study|Lost to Follow-up|9|||
161109115|NCT02046096|581788638|FG001|Overall Study|Lost to Follow-up|20|||
161109116|NCT02046096|581788637|FG000|Overall Study|Withdrawal by Subject|5|||
161109117|NCT02046096|581788638|FG001|Overall Study|Withdrawal by Subject|17|||
161109118|NCT02046096|581788637|FG000|Overall Study|Other endpoint|2|||
161109119|NCT02046096|581788638|FG001|Overall Study|Other endpoint|19|||
161109120|NCT03520959|581788639|FG000|Overall Study|Study terminated by Sponsor|0|||
161109121|NCT03520959|581788640|FG001|Overall Study|Study terminated by Sponsor|1|||
160865833|NCT01499355|580902992|FG000|Double-Blind Period|Lost to Follow-up|0|||
160865834|NCT01499355|580902993|FG001|Double-Blind Period|Lost to Follow-up|1|||
160865835|NCT01499355|580902994|FG002|Double-Blind Period|Lost to Follow-up|0|||
160865836|NCT01499355|580902995|FG003|Double-Blind Period|Lost to Follow-up|0|||
160865837|NCT01457703|580903002|FG000|Overall Study|Screen Failure|5|||
160865838|NCT01457703|580903003|FG001|Overall Study|Screen Failure|7|||
161109122|NCT04969276|581788642|FG000|Overall Study|Protocol Deviation|0|||
161109123|NCT04969276|581788643|FG001|Overall Study|Protocol Deviation|1|||
161109124|NCT04969276|581788644|FG002|Overall Study|Protocol Deviation|0|||
160865839|NCT01457703|580903002|FG000|Overall Study|Withdrawal by Subject|1|||
161109125|NCT04969276|581788642|FG000|Overall Study|Withdrawal by Subject|1|||
161109126|NCT04969276|581788643|FG001|Overall Study|Withdrawal by Subject|10|||
161109127|NCT04969276|581788644|FG002|Overall Study|Withdrawal by Subject|0|||
161109128|NCT04969276|581788642|FG000|Overall Study|Lost to Follow-up|0|||
161109129|NCT04969276|581788643|FG001|Overall Study|Lost to Follow-up|1|||
161109130|NCT04969276|581788644|FG002|Overall Study|Lost to Follow-up|0|||
161109131|NCT00943579|581788647|FG000|Overall Study|Adverse Event|4|||
161109132|NCT00943579|581788648|FG001|Overall Study|Adverse Event|3|||
161109133|NCT00943579|581788647|FG000|Overall Study|Lack of Efficacy|2|||
161109134|NCT00943579|581788648|FG001|Overall Study|Lack of Efficacy|2|||
161109135|NCT00687440|581788649|FG000|Overall Study|Adverse Event|3|||
161109136|NCT00687440|581788649|FG000|Overall Study|Lost to Follow-up|3|||
161109137|NCT00687440|581788649|FG000|Overall Study|Lack of Efficacy|2|||
161109138|NCT00687440|581788649|FG000|Overall Study|Death|2|||
161109139|NCT00687440|581788649|FG000|Overall Study|Other|1|||
161109140|NCT00687440|581788649|FG000|Overall Study|Missing|1|||
161109141|NCT01538628|581788659|FG000|Overall Study|Withdrawal by Subject|1|||
161109142|NCT01538628|581788660|FG001|Overall Study|Withdrawal by Subject|1|||
161109143|NCT01538628|581788659|FG000|Overall Study|Lost to Follow-up|0|||
161109144|NCT01538628|581788660|FG001|Overall Study|Lost to Follow-up|1|||
161109145|NCT00583024|581788661|FG000|Overall Study|Lost to Follow-up|4|||
160865840|NCT01457703|580903003|FG001|Overall Study|Withdrawal by Subject|4|||
160865841|NCT01658436|580903004|FG000|Overall Study|Adverse Event|6|||
160865842|NCT01658436|580903005|FG001|Overall Study|Adverse Event|5|||
160865843|NCT01658436|580903004|FG000|Overall Study|Physician Decision|1|||
160865844|NCT01658436|580903005|FG001|Overall Study|Physician Decision|0|||
160865845|NCT01658436|580903004|FG000|Overall Study|Progressive disease|12|||
160865846|NCT01658436|580903005|FG001|Overall Study|Progressive disease|4|||
160865847|NCT01658436|580903004|FG000|Overall Study|Study terminated by sponsor|0|||
160865848|NCT01658436|580903005|FG001|Overall Study|Study terminated by sponsor|1|||
160865849|NCT01658436|580903004|FG000|Overall Study|Subject/guardian decision|0|||
160865850|NCT01658436|580903005|FG001|Overall Study|Subject/guardian decision|1|||
160865851|NCT01658436|580903004|FG000|Overall Study|Death|1|||
160865852|NCT01658436|580903005|FG001|Overall Study|Death|0|||
160865853|NCT00686712|580903006|FG000|Overall Study|Protocol Violation|8|||
160865854|NCT00686712|580903007|FG001|Overall Study|Protocol Violation|8|||
160865855|NCT00686712|580903008|FG002|Overall Study|Protocol Violation|10|||
160865856|NCT00686712|580903006|FG000|Overall Study|Lost to Follow-up|1|||
160865857|NCT00686712|580903007|FG001|Overall Study|Lost to Follow-up|2|||
160865858|NCT00686712|580903008|FG002|Overall Study|Lost to Follow-up|3|||
160865859|NCT00686712|580903006|FG000|Overall Study|Adverse Event|1|||
160865860|NCT00686712|580903007|FG001|Overall Study|Adverse Event|1|||
160865861|NCT00686712|580903008|FG002|Overall Study|Adverse Event|0|||
160865862|NCT01318915|580903009|FG000|Overall Study|Lost to Follow-up|1|||
160865863|NCT04119414|580903010|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
160865864|NCT03313037|580903026|FG000|Overall Study|Protocol Violation|4|||
160865865|NCT03313037|580903027|FG001|Overall Study|Protocol Violation|1|||
160865866|NCT03313037|580903026|FG000|Overall Study|Other|1|||
160865867|NCT03313037|580903027|FG001|Overall Study|Other|1|||
160865868|NCT03313037|580903026|FG000|Overall Study|Withdrawal by Subject|4|||
160865869|NCT03313037|580903027|FG001|Overall Study|Withdrawal by Subject|3|||
160865870|NCT03313037|580903026|FG000|Overall Study|No longer meets eligibility criteria|1|||
160865871|NCT03313037|580903027|FG001|Overall Study|No longer meets eligibility criteria|7|||
160865872|NCT03313037|580903026|FG000|Overall Study|Lost to Follow-up|9|||
160865873|NCT03313037|580903027|FG001|Overall Study|Lost to Follow-up|8|||
160865874|NCT03313037|580903026|FG000|Overall Study|Randomized but not treated|1|||
160865875|NCT03313037|580903027|FG001|Overall Study|Randomized but not treated|0|||
160865876|NCT02760498|580903028|FG000|Overall Study|Adverse Event|3|||
160865877|NCT02760498|580903029|FG001|Overall Study|Adverse Event|3|||
160865878|NCT02760498|580903030|FG002|Overall Study|Adverse Event|1|||
160865879|NCT02760498|580903031|FG003|Overall Study|Adverse Event|1|||
160865880|NCT02760498|580903032|FG004|Overall Study|Adverse Event|0|||
160865881|NCT02760498|580903033|FG005|Overall Study|Adverse Event|6|||
160865882|NCT02760498|580903028|FG000|Overall Study|Death|7|||
160865883|NCT02760498|580903029|FG001|Overall Study|Death|5|||
160865884|NCT02760498|580903030|FG002|Overall Study|Death|5|||
160865885|NCT02760498|580903031|FG003|Overall Study|Death|7|||
160865886|NCT02760498|580903032|FG004|Overall Study|Death|0|||
161109146|NCT00449670|581789778|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
160865887|NCT02760498|580903033|FG005|Overall Study|Death|23|||
160865888|NCT02760498|580903028|FG000|Overall Study|Lost to Follow-up|0|||
160865889|NCT02760498|580903029|FG001|Overall Study|Lost to Follow-up|0|||
161109147|NCT00449670|581789779|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
161109148|NCT00449670|581789778|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
161109149|NCT00449670|581789779|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
160865890|NCT02760498|580903030|FG002|Overall Study|Lost to Follow-up|0|||
160865891|NCT02760498|580903031|FG003|Overall Study|Lost to Follow-up|0|||
161109150|NCT00449670|581789778|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
161214587|NCT01393990|582169412|FG016|Overall Study|Progressive Disease|0|||
160865892|NCT02760498|580903032|FG004|Overall Study|Lost to Follow-up|0|||
160865893|NCT02760498|580903033|FG005|Overall Study|Lost to Follow-up|3|||
160865894|NCT02760498|580903028|FG000|Overall Study|Non-compliance with study drug|0|||
160865895|NCT02760498|580903029|FG001|Overall Study|Non-compliance with study drug|2|||
160865896|NCT02760498|580903030|FG002|Overall Study|Non-compliance with study drug|0|||
160865897|NCT02760498|580903031|FG003|Overall Study|Non-compliance with study drug|0|||
160865898|NCT02760498|580903032|FG004|Overall Study|Non-compliance with study drug|0|||
160865899|NCT02760498|580903033|FG005|Overall Study|Non-compliance with study drug|0|||
160865900|NCT02760498|580903028|FG000|Overall Study|Participant decision|1|||
160865901|NCT02760498|580903029|FG001|Overall Study|Participant decision|4|||
160865902|NCT02760498|580903030|FG002|Overall Study|Participant decision|2|||
160865903|NCT02760498|580903031|FG003|Overall Study|Participant decision|2|||
160865904|NCT02760498|580903032|FG004|Overall Study|Participant decision|1|||
160865905|NCT02760498|580903033|FG005|Overall Study|Participant decision|6|||
160865906|NCT02760498|580903028|FG000|Overall Study|Sponsor decision|0|||
160865907|NCT02760498|580903029|FG001|Overall Study|Sponsor decision|0|||
160865908|NCT02760498|580903030|FG002|Overall Study|Sponsor decision|0|||
160865909|NCT02760498|580903031|FG003|Overall Study|Sponsor decision|3|||
160865910|NCT02760498|580903032|FG004|Overall Study|Sponsor decision|0|||
160865911|NCT02760498|580903033|FG005|Overall Study|Sponsor decision|0|||
160865912|NCT02760498|580903028|FG000|Overall Study|Physician Decision|3|||
160865913|NCT02760498|580903029|FG001|Overall Study|Physician Decision|4|||
160865914|NCT02760498|580903030|FG002|Overall Study|Physician Decision|1|||
160865915|NCT02760498|580903031|FG003|Overall Study|Physician Decision|4|||
160865916|NCT02760498|580903032|FG004|Overall Study|Physician Decision|0|||
160865917|NCT02760498|580903033|FG005|Overall Study|Physician Decision|2|||
160865918|NCT02760498|580903028|FG000|Overall Study|Disease progression|21|||
160865919|NCT02760498|580903029|FG001|Overall Study|Disease progression|19|||
160865920|NCT02760498|580903030|FG002|Overall Study|Disease progression|20|||
160865921|NCT02760498|580903031|FG003|Overall Study|Disease progression|18|||
160865922|NCT02760498|580903032|FG004|Overall Study|Disease progression|4|||
160865923|NCT02760498|580903033|FG005|Overall Study|Disease progression|55|||
160865924|NCT02760498|580903028|FG000|Overall Study|Withdrawal by Subject|4|||
160865925|NCT02760498|580903029|FG001|Overall Study|Withdrawal by Subject|7|||
160865926|NCT02760498|580903030|FG002|Overall Study|Withdrawal by Subject|5|||
160865927|NCT02760498|580903031|FG003|Overall Study|Withdrawal by Subject|1|||
160865928|NCT02760498|580903032|FG004|Overall Study|Withdrawal by Subject|0|||
160865929|NCT02760498|580903033|FG005|Overall Study|Withdrawal by Subject|6|||
160865930|NCT02760498|580903028|FG000|Overall Study|Other than specified|1|||
160865931|NCT02760498|580903029|FG001|Overall Study|Other than specified|6|||
160865932|NCT02760498|580903030|FG002|Overall Study|Other than specified|0|||
160865933|NCT02760498|580903031|FG003|Overall Study|Other than specified|3|||
160865934|NCT02760498|580903032|FG004|Overall Study|Other than specified|1|||
160865935|NCT02760498|580903033|FG005|Overall Study|Other than specified|0|||
160865936|NCT02760498|580903028|FG000|Overall Study|Not treated|0|||
160865937|NCT02760498|580903029|FG001|Overall Study|Not treated|0|||
160865938|NCT02760498|580903030|FG002|Overall Study|Not treated|0|||
160865939|NCT02760498|580903031|FG003|Overall Study|Not treated|0|||
160865940|NCT02760498|580903032|FG004|Overall Study|Not treated|0|||
160865941|NCT02760498|580903033|FG005|Overall Study|Not treated|2|||
160865942|NCT03067077|580903034|FG000|Overall Study|Did not receive surgery|4|||
160865943|NCT03067077|580903035|FG001|Overall Study|Did not receive surgery|5|||
160865944|NCT03067077|580903034|FG000|Overall Study|Lost to Follow-up|3|||
160865945|NCT03067077|580903035|FG001|Overall Study|Lost to Follow-up|2|||
160865946|NCT01198977|580903043|FG000|Overall Study|Lost to Follow-up|1|||
160865947|NCT01198977|580903044|FG001|Overall Study|Lost to Follow-up|0|||
160865948|NCT01588522|580903050|FG000|Overall Study|Withdrawal by Subject|1|||
160865949|NCT01588522|580903051|FG001|Overall Study|Withdrawal by Subject|5|||
160865950|NCT01588522|580903052|FG002|Overall Study|Withdrawal by Subject|3|||
160865951|NCT01588522|580903053|FG003|Overall Study|Withdrawal by Subject|1|||
160865952|NCT01588522|580903054|FG004|Overall Study|Withdrawal by Subject|2|||
160865953|NCT01588522|580903055|FG005|Overall Study|Withdrawal by Subject|0|||
160865954|NCT01588522|580903050|FG000|Overall Study|Lack of Efficacy|0|||
160865955|NCT01588522|580903051|FG001|Overall Study|Lack of Efficacy|0|||
160865956|NCT01588522|580903052|FG002|Overall Study|Lack of Efficacy|0|||
161214588|NCT01393990|582169413|FG017|Overall Study|Progressive Disease|0|||
160865957|NCT01588522|580903053|FG003|Overall Study|Lack of Efficacy|0|||
160865958|NCT01588522|580903054|FG004|Overall Study|Lack of Efficacy|1|||
160865959|NCT01588522|580903055|FG005|Overall Study|Lack of Efficacy|0|||
160865960|NCT01588522|580903050|FG000|Overall Study|Adverse Event|0|||
160865961|NCT01588522|580903051|FG001|Overall Study|Adverse Event|0|||
160865962|NCT01588522|580903052|FG002|Overall Study|Adverse Event|0|||
160865963|NCT01588522|580903053|FG003|Overall Study|Adverse Event|1|||
160865964|NCT01588522|580903054|FG004|Overall Study|Adverse Event|0|||
160865965|NCT01588522|580903055|FG005|Overall Study|Adverse Event|0|||
160865966|NCT01588522|580903050|FG000|Overall Study|Grade 2 alopecia|1|||
160865967|NCT01588522|580903051|FG001|Overall Study|Grade 2 alopecia|0|||
160865968|NCT01588522|580903052|FG002|Overall Study|Grade 2 alopecia|0|||
160865969|NCT01588522|580903053|FG003|Overall Study|Grade 2 alopecia|0|||
161214589|NCT01393990|582169396|FG000|Overall Study|Death|0|||
161214590|NCT01393990|582169397|FG001|Overall Study|Death|0|||
161214591|NCT01393990|582169398|FG002|Overall Study|Death|0|||
161214592|NCT01393990|582169399|FG003|Overall Study|Death|0|||
161214593|NCT01393990|582169400|FG004|Overall Study|Death|1|||
161214594|NCT01393990|582169401|FG005|Overall Study|Death|0|||
161214595|NCT01393990|582169402|FG006|Overall Study|Death|0|||
161214596|NCT01393990|582169403|FG007|Overall Study|Death|0|||
161214597|NCT01393990|582169404|FG008|Overall Study|Death|0|||
161214598|NCT01393990|582169405|FG009|Overall Study|Death|0|||
161214599|NCT01393990|582169406|FG010|Overall Study|Death|0|||
161214600|NCT01393990|582169407|FG011|Overall Study|Death|0|||
161214601|NCT01393990|582169408|FG012|Overall Study|Death|0|||
161214602|NCT01393990|582169409|FG013|Overall Study|Death|1|||
161214603|NCT01393990|582169410|FG014|Overall Study|Death|1|||
161214604|NCT01393990|582169411|FG015|Overall Study|Death|0|||
161214605|NCT01393990|582169412|FG016|Overall Study|Death|0|||
161214606|NCT01393990|582169413|FG017|Overall Study|Death|0|||
161214607|NCT01393990|582169396|FG000|Overall Study|Withdrawal by Subject|0|||
161214608|NCT01393990|582169397|FG001|Overall Study|Withdrawal by Subject|0|||
160865970|NCT01588522|580903054|FG004|Overall Study|Grade 2 alopecia|0|||
160865971|NCT01588522|580903055|FG005|Overall Study|Grade 2 alopecia|0|||
160865972|NCT01588522|580903050|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
160865973|NCT01588522|580903051|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
160865974|NCT01588522|580903052|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
160865975|NCT01588522|580903053|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
160865976|NCT01588522|580903054|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
160865977|NCT01588522|580903055|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
160865978|NCT01588522|580903050|FG000|Overall Study|Taken off taxane-based regimen|0|||
160865979|NCT01588522|580903051|FG001|Overall Study|Taken off taxane-based regimen|0|||
160865980|NCT01588522|580903052|FG002|Overall Study|Taken off taxane-based regimen|0|||
160865981|NCT01588522|580903053|FG003|Overall Study|Taken off taxane-based regimen|1|||
160865982|NCT01588522|580903054|FG004|Overall Study|Taken off taxane-based regimen|0|||
160865983|NCT01588522|580903055|FG005|Overall Study|Taken off taxane-based regimen|0|||
160865984|NCT01588522|580903050|FG000|Overall Study|Did not initiate chemotherapy|0|||
160865985|NCT01588522|580903051|FG001|Overall Study|Did not initiate chemotherapy|0|||
160865986|NCT01588522|580903052|FG002|Overall Study|Did not initiate chemotherapy|0|||
160865987|NCT01588522|580903053|FG003|Overall Study|Did not initiate chemotherapy|0|||
160865988|NCT01588522|580903054|FG004|Overall Study|Did not initiate chemotherapy|1|||
160865989|NCT01588522|580903055|FG005|Overall Study|Did not initiate chemotherapy|0|||
160865990|NCT02855125|580903060|FG000|Overall Study|Withdrawal by Subject|2|||
160865991|NCT02855125|580903061|FG001|Overall Study|Withdrawal by Subject|2|||
160865992|NCT02855125|580903060|FG000|Overall Study|Clinical Disease Progression|5|||
160865993|NCT02855125|580903061|FG001|Overall Study|Clinical Disease Progression|4|||
160865994|NCT02855125|580903060|FG000|Overall Study|Radiologic Disease Progression|36|||
160865995|NCT02855125|580903061|FG001|Overall Study|Radiologic Disease Progression|39|||
160865996|NCT02855125|580903060|FG000|Overall Study|Adverse Event|11|||
160865997|NCT02855125|580903061|FG001|Overall Study|Adverse Event|7|||
160865998|NCT02855125|580903060|FG000|Overall Study|Physician Decision|1|||
160865999|NCT02855125|580903061|FG001|Overall Study|Physician Decision|0|||
160866000|NCT02855125|580903060|FG000|Overall Study|On Treatment|9|||
160866001|NCT02855125|580903061|FG001|Overall Study|On Treatment|11|||
160866002|NCT02855125|580903060|FG000|Overall Study|Randomized but not treated|0|||
160866003|NCT02855125|580903061|FG001|Overall Study|Randomized but not treated|1|||
160866004|NCT04467905|580903062|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
160866005|NCT04467905|580903063|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
160866006|NCT04467905|580903064|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
160866007|NCT04467905|580903062|FG000|Overall Study|Conversion to SR|0|||
160866008|NCT04467905|580903063|FG001|Overall Study|Conversion to SR|0|||
160866009|NCT04467905|580903064|FG002|Overall Study|Conversion to SR|3|||
160866010|NCT04467905|580903062|FG000|Overall Study|Technical issue with Holter ECG|0|||
160866011|NCT04467905|580903063|FG001|Overall Study|Technical issue with Holter ECG|0|||
160866012|NCT04467905|580903064|FG002|Overall Study|Technical issue with Holter ECG|3|||
160866013|NCT04467905|580903062|FG000|Overall Study|Hemodynamic instability|0|||
161109151|NCT00449670|581789779|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
161109152|NCT00449670|581789778|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
161109153|NCT00449670|581789779|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
161109154|NCT00449670|581789778|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
161109155|NCT00449670|581789779|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
161109156|NCT00449670|581789778|FG000|Booster Phase (Study no.109873)|Other|0|||
161109157|NCT00449670|581789779|FG001|Booster Phase (Study no.109873)|Other|2|||
161109158|NCT01502709|581789780|FG000|Overall Study|Lost to Follow-up|4|||
161109159|NCT01502709|581789781|FG001|Overall Study|Lost to Follow-up|0|||
161109160|NCT02966509|581789787|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
161109161|NCT02966509|581789788|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
161109162|NCT02966509|581789787|FG000|Baseline Satisfaction Survey|Death|0|||
161109163|NCT02966509|581789788|FG001|Baseline Satisfaction Survey|Death|1|||
161109164|NCT02966509|581789787|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
161109165|NCT02966509|581789788|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
161109166|NCT02966509|581789787|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
161109167|NCT02966509|581789788|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
161109168|NCT02966509|581789787|FG000|6 Month Satisfaction Decision Survey|Death|22|||
161109169|NCT02966509|581789788|FG001|6 Month Satisfaction Decision Survey|Death|25|||
161109170|NCT02966509|581789787|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
160866014|NCT04467905|580903063|FG001|Overall Study|Hemodynamic instability|0|||
160866015|NCT04467905|580903064|FG002|Overall Study|Hemodynamic instability|1|||
160866016|NCT04467905|580903062|FG000|Overall Study|Site misinterpretation of protocol|0|||
160866017|NCT04467905|580903063|FG001|Overall Study|Site misinterpretation of protocol|0|||
160866018|NCT04467905|580903064|FG002|Overall Study|Site misinterpretation of protocol|1|||
160866019|NCT02514083|580903070|FG000|Overall Study|Adverse Event|1|||
161109171|NCT02966509|581789788|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
160866020|NCT02017405|580903071|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866021|NCT02017405|580903072|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866022|NCT02017405|580903073|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866023|NCT02017405|580903074|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866024|NCT02017405|580903075|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
160866025|NCT02017405|580903076|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
160866026|NCT02017405|580903071|FG000|Open-label Phase|Adverse Event|1|||
160866027|NCT02017405|580903072|FG001|Open-label Phase|Adverse Event|1|||
160866028|NCT02017405|580903073|FG002|Open-label Phase|Adverse Event|0|||
160866029|NCT02017405|580903074|FG003|Open-label Phase|Adverse Event|0|||
160866030|NCT02017405|580903075|FG004|Open-label Phase|Adverse Event|0|||
160866031|NCT02017405|580903076|FG005|Open-label Phase|Adverse Event|0|||
160866032|NCT01899040|580903077|FG000|Overall Study|Randomized in error|0|||
160866033|NCT01899040|580903078|FG001|Overall Study|Randomized in error|1|||
160866034|NCT01899040|580903079|FG002|Overall Study|Randomized in error|1|||
160866035|NCT01899040|580903077|FG000|Overall Study|Adverse Event|3|||
160866036|NCT01899040|580903078|FG001|Overall Study|Adverse Event|1|||
160866037|NCT01899040|580903079|FG002|Overall Study|Adverse Event|2|||
160866038|NCT01899040|580903077|FG000|Overall Study|Unspecified reasons|4|||
160866039|NCT01899040|580903078|FG001|Overall Study|Unspecified reasons|4|||
160866040|NCT01899040|580903079|FG002|Overall Study|Unspecified reasons|0|||
160866041|NCT01899040|580903077|FG000|Overall Study|Compliance issues|1|||
160866042|NCT01899040|580903078|FG001|Overall Study|Compliance issues|2|||
160866043|NCT01899040|580903079|FG002|Overall Study|Compliance issues|0|||
160866044|NCT04586205|580903088|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
160866045|NCT04586205|580903089|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
160866046|NCT02202759|580904899|FG000|Overall Study|Study Terminated by Sponsor|3|||
160866047|NCT02202759|580904900|FG001|Overall Study|Study Terminated by Sponsor|3|||
160866048|NCT02202759|580904901|FG002|Overall Study|Study Terminated by Sponsor|3|||
160866049|NCT02202759|580904899|FG000|Overall Study|Withdrawal by Subject|2|||
160866050|NCT02202759|580904900|FG001|Overall Study|Withdrawal by Subject|1|||
160866051|NCT02202759|580904901|FG002|Overall Study|Withdrawal by Subject|1|||
160866052|NCT02202759|580904899|FG000|Overall Study|Reason not Specified|4|||
160866053|NCT02202759|580904900|FG001|Overall Study|Reason not Specified|11|||
160866054|NCT02202759|580904901|FG002|Overall Study|Reason not Specified|10|||
160866055|NCT01590888|580904902|FG000|Overall Study|Adverse Event|3|||
160866056|NCT01590888|580904903|FG001|Overall Study|Adverse Event|0|||
160866057|NCT01590888|580904904|FG002|Overall Study|Adverse Event|1|||
160866058|NCT01590888|580904902|FG000|Overall Study|Lost to Follow-up|1|||
160866059|NCT01590888|580904903|FG001|Overall Study|Lost to Follow-up|0|||
160866060|NCT01590888|580904904|FG002|Overall Study|Lost to Follow-up|0|||
160866061|NCT04953728|580904905|FG000|Overall Study|Withdrawal by Subject|3|||
160866062|NCT04953728|580904905|FG000|Overall Study|Physician Decision|1|||
160866063|NCT01646125|580904906|FG000|Overall Study|Untreated|2|||
160866064|NCT01646125|580904907|FG001|Overall Study|Untreated|5|||
160866065|NCT01646125|580904906|FG000|Overall Study|Adverse Event|2|||
160866066|NCT01646125|580904907|FG001|Overall Study|Adverse Event|1|||
160866067|NCT01646125|580904906|FG000|Overall Study|Death|1|||
160866068|NCT01646125|580904907|FG001|Overall Study|Death|1|||
160866069|NCT01646125|580904906|FG000|Overall Study|Physician Decision|1|||
160866070|NCT01646125|580904907|FG001|Overall Study|Physician Decision|3|||
160866071|NCT01646125|580904906|FG000|Overall Study|Progressive disease|22|||
160866072|NCT01646125|580904907|FG001|Overall Study|Progressive disease|16|||
160866073|NCT01646125|580904906|FG000|Overall Study|Study terminated by sponsor|2|||
160866074|NCT01646125|580904907|FG001|Overall Study|Study terminated by sponsor|1|||
160866075|NCT01646125|580904906|FG000|Overall Study|Subject/Guardian decision|1|||
160866076|NCT01646125|580904907|FG001|Overall Study|Subject/Guardian decision|1|||
160866077|NCT02105662|580904908|FG000|Overall Study|Lost to Follow-up|5|||
160866078|NCT02105662|580904908|FG000|Overall Study|Withdrawal by Subject|1|||
160866079|NCT01417377|580904911|FG000|Overall Study|Lost to Follow-up|12|||
160866080|NCT01417377|580904911|FG000|Overall Study|Enrolled, but not treated|1|||
160866081|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
160866082|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
160866083|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
160866084|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
160866085|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
160866086|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
160866087|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
160866088|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
160866089|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
160866090|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
160866091|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
160866092|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
160866093|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
160866094|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
160866095|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
160866096|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
161324343|NCT00941304|582573574|FG004|Overall Study|Lost to Follow-up|0|||
161109172|NCT02966509|581789787|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
161109173|NCT02966509|581789788|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
161109174|NCT02966509|581789787|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
161109175|NCT02966509|581789788|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
161109176|NCT02966509|581789787|FG000|6 Month Satisfaction Survey|Death|36|||
161109177|NCT02966509|581789788|FG001|6 Month Satisfaction Survey|Death|33|||
161109178|NCT02966509|581789787|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
161109179|NCT02966509|581789788|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
161109180|NCT02966509|581789787|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
161109181|NCT02966509|581789788|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
161109182|NCT02966509|581789787|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
161109183|NCT02966509|581789788|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
161109184|NCT02966509|581789787|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
161109185|NCT02966509|581789788|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
161109186|NCT02966509|581789787|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
161109187|NCT02966509|581789788|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
161109188|NCT02982954|581789789|FG000|Overall Study|Death|55|||
161109189|NCT02982954|581789790|FG001|Overall Study|Death|29|||
161109190|NCT02982954|581789791|FG002|Overall Study|Death|15|||
161109191|NCT02982954|581789792|FG003|Overall Study|Death|20|||
161109192|NCT02982954|581789789|FG000|Overall Study|Lost to Follow-up|2|||
161109193|NCT02982954|581789790|FG001|Overall Study|Lost to Follow-up|1|||
161109194|NCT02982954|581789791|FG002|Overall Study|Lost to Follow-up|0|||
161109195|NCT02982954|581789792|FG003|Overall Study|Lost to Follow-up|0|||
161109196|NCT02982954|581789789|FG000|Overall Study|Participant withdrew consent|7|||
161109197|NCT02982954|581789790|FG001|Overall Study|Participant withdrew consent|5|||
161109198|NCT02982954|581789791|FG002|Overall Study|Participant withdrew consent|1|||
161109199|NCT02982954|581789792|FG003|Overall Study|Participant withdrew consent|1|||
161109200|NCT02982954|581789789|FG000|Overall Study|Other reasons|42|||
161109201|NCT02982954|581789790|FG001|Overall Study|Other reasons|17|||
161109202|NCT02982954|581789791|FG002|Overall Study|Other reasons|12|||
161109203|NCT02982954|581789792|FG003|Overall Study|Other reasons|3|||
161109204|NCT02982954|581789789|FG000|Overall Study|Premature site closure|0|||
161109205|NCT02982954|581789790|FG001|Overall Study|Premature site closure|0|||
161109206|NCT02982954|581789791|FG002|Overall Study|Premature site closure|0|||
161109207|NCT02982954|581789792|FG003|Overall Study|Premature site closure|1|||
161109208|NCT00516048|581789793|FG000|Overall Study|Death|0|||
161109209|NCT00516048|581789794|FG001|Overall Study|Death|0|||
161109210|NCT00516048|581789795|FG002|Overall Study|Death|1|||
161109211|NCT00516048|581789793|FG000|Overall Study|Subject Decision|0|||
161109212|NCT00516048|581789794|FG001|Overall Study|Subject Decision|2|||
161109213|NCT00516048|581789795|FG002|Overall Study|Subject Decision|0|||
161109214|NCT02263079|581789796|FG000|Overall Study|Physician Decision|1|||
161109215|NCT02263079|581789797|FG001|Overall Study|Physician Decision|0|||
161109216|NCT02263079|581789798|FG002|Overall Study|Physician Decision|0|||
161109217|NCT02263079|581789796|FG000|Overall Study|Withdrawal by Subject|2|||
161109218|NCT02263079|581789797|FG001|Overall Study|Withdrawal by Subject|8|||
161109219|NCT02263079|581789798|FG002|Overall Study|Withdrawal by Subject|0|||
161109220|NCT00402649|581789799|FG000|Overall Study|Lost to Follow-up|1|||
161109221|NCT00402649|581789799|FG000|Overall Study|Withdrawal by Subject|1|||
161109222|NCT01321710|581789805|FG000|Overall Study|Lost to Follow-up|4|||
161109223|NCT01321710|581789806|FG001|Overall Study|Lost to Follow-up|5|||
161109224|NCT01321710|581789807|FG002|Overall Study|Lost to Follow-up|0|||
161109225|NCT01761292|581789808|FG000|Part 1|Adverse Event|1|||
161109226|NCT01761292|581789808|FG000|Part 1|not receiving treatment in Part 1|1|||
161109227|NCT01761292|581789808|FG000|Extension 1|Withdrawal by Subject|1|||
161109228|NCT00840086|581789809|FG000|Overall Study|Adverse Event|1|||
161109229|NCT00840086|581789809|FG000|Overall Study|Protocol Violation|2|||
161109230|NCT00840086|581789809|FG000|Overall Study|Lost to Follow-up|1|||
161109231|NCT03332498|581789810|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
161109232|NCT03332498|581789811|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
161109233|NCT03332498|581789812|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
161109234|NCT03577730|581789813|FG000|Overall Study|Physician Decision|3|||
161109235|NCT03577730|581789814|FG001|Overall Study|Physician Decision|1|||
161109236|NCT03577730|581789813|FG000|Overall Study|Did not receive allocated intervention|1|||
161109237|NCT03577730|581789814|FG001|Overall Study|Did not receive allocated intervention|0|||
161109238|NCT03810781|581789816|FG000|Overall Study|COVID shut down|2|||
161109239|NCT05611671|581789821|FG000|Overall Study|Adverse Event|1|||
161214609|NCT01393990|582169398|FG002|Overall Study|Withdrawal by Subject|0|||
161214610|NCT01393990|582169399|FG003|Overall Study|Withdrawal by Subject|0|||
161109240|NCT05611671|581789822|FG001|Overall Study|Adverse Event|1|||
161109241|NCT05611671|581789823|FG002|Overall Study|Adverse Event|0|||
161109242|NCT05611671|581789824|FG003|Overall Study|Adverse Event|1|||
161109243|NCT05611671|581789821|FG000|Overall Study|Lack of Efficacy|1|||
161109244|NCT05611671|581789822|FG001|Overall Study|Lack of Efficacy|0|||
161109245|NCT05611671|581789823|FG002|Overall Study|Lack of Efficacy|1|||
160866097|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
160866098|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
160866099|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
160866100|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
160866101|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
160866102|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
160866103|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
160866104|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
160866105|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
160866106|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
160866107|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
160866108|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
160866109|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866110|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866111|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866112|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866113|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866114|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866115|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
160866116|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866117|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866118|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866119|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866120|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866121|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866122|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
160866123|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Transplant|0|||
160866124|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Transplant|1|||
160866125|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Transplant|0|||
160866126|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Transplant|0|||
160866127|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Transplant|0|||
160866128|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Transplant|1|||
160866129|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Transplant|0|||
160866130|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Transplant|0|||
160866131|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Transplant|0|||
160866132|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Transplant|0|||
160866133|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Transplant|0|||
160866134|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Transplant|0|||
160866135|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Transplant|0|||
160866136|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Transplant|0|||
160866137|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
160866138|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
160866139|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
160866140|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
160866141|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
160866142|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
160866143|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
160866144|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
160866145|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
160866146|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
160866147|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
160866148|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
160866149|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
160866150|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
160866151|NCT02113982|580904912|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
160866152|NCT02113982|580904913|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
160866153|NCT02113982|580904914|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
160866154|NCT02113982|580904915|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
160866155|NCT02113982|580904916|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
160866156|NCT02113982|580904917|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
160866157|NCT02113982|580904918|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
160866158|NCT02113982|580904919|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
160866159|NCT02113982|580904920|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
160866160|NCT02113982|580904921|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
160866161|NCT02113982|580904922|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
160866162|NCT02113982|580904923|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
160866163|NCT02113982|580904924|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
160866164|NCT02113982|580904925|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
160866165|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
160866166|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
160866167|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
160866168|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
160866169|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
160866170|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
160866171|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
160866172|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
160866173|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
160866174|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
160866175|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
160866176|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
160866177|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
160866178|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
160866179|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
160866180|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
160866181|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
160866182|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
160866183|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
160866184|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
160866185|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
160866186|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
160866187|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
160866188|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
160866189|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
160866190|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
160866191|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
160866192|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
160866193|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866194|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866195|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866196|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866197|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866198|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866199|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866200|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
160866201|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866202|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
160866203|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
160866204|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866205|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866206|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
160866207|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866208|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866209|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866210|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866211|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866212|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866213|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866214|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
160866215|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866216|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
160866217|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866218|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866219|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866220|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
160866221|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866222|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866223|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866224|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866225|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866226|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866227|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866228|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
160866229|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866230|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866231|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866232|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866233|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866234|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
160866235|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Transplant|0|||
160866236|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Transplant|0|||
160866237|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Transplant|0|||
160866238|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Transplant|0|||
160866239|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Transplant|0|||
161109246|NCT05611671|581789824|FG003|Overall Study|Lack of Efficacy|2|||
161109247|NCT05611671|581789821|FG000|Overall Study|Lost to Follow-up|0|||
161109248|NCT05611671|581789822|FG001|Overall Study|Lost to Follow-up|0|||
161109249|NCT05611671|581789823|FG002|Overall Study|Lost to Follow-up|0|||
161109250|NCT05611671|581789824|FG003|Overall Study|Lost to Follow-up|1|||
161109251|NCT05611671|581789821|FG000|Overall Study|Protocol Violation|0|||
161109252|NCT05611671|581789822|FG001|Overall Study|Protocol Violation|1|||
161109253|NCT05611671|581789823|FG002|Overall Study|Protocol Violation|0|||
161109254|NCT05611671|581789824|FG003|Overall Study|Protocol Violation|0|||
161109255|NCT05611671|581789821|FG000|Overall Study|Withdrawal by Subject|2|||
161109256|NCT05611671|581789822|FG001|Overall Study|Withdrawal by Subject|1|||
161109257|NCT05611671|581789823|FG002|Overall Study|Withdrawal by Subject|2|||
161109258|NCT05611671|581789824|FG003|Overall Study|Withdrawal by Subject|1|||
161109259|NCT00253643|581789825|FG000|Overall Study|Withdrawal by Subject|0|||
161109260|NCT00253643|581789826|FG001|Overall Study|Withdrawal by Subject|0|||
161109261|NCT00253643|581789827|FG002|Overall Study|Withdrawal by Subject|1|||
161109262|NCT00253643|581789828|FG003|Overall Study|Withdrawal by Subject|1|||
161109263|NCT00253643|581789825|FG000|Overall Study|Non-Compliance|0|||
161109264|NCT00253643|581789826|FG001|Overall Study|Non-Compliance|0|||
161109265|NCT00253643|581789827|FG002|Overall Study|Non-Compliance|0|||
161109266|NCT00253643|581789828|FG003|Overall Study|Non-Compliance|2|||
161109267|NCT01368536|581789829|FG000|Overall Study|Adverse Event|5|||
161109268|NCT01368536|581789830|FG001|Overall Study|Adverse Event|6|||
161109269|NCT01368536|581789831|FG002|Overall Study|Adverse Event|8|||
161109270|NCT01368536|581789829|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161109271|NCT01368536|581789830|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161109272|NCT01368536|581789831|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161109273|NCT01368536|581789829|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161109274|NCT01368536|581789830|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161109275|NCT01368536|581789831|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161109276|NCT01368536|581789829|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
161109277|NCT01368536|581789830|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161109278|NCT01368536|581789831|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161109279|NCT01368536|581789829|FG000|Overall Study|No longer required study medication|0|||
161109280|NCT01368536|581789830|FG001|Overall Study|No longer required study medication|0|||
161109281|NCT01368536|581789831|FG002|Overall Study|No longer required study medication|1|||
161109282|NCT01368536|581789829|FG000|Overall Study|Withdrawal by Subject|2|||
161109283|NCT01368536|581789830|FG001|Overall Study|Withdrawal by Subject|5|||
161109284|NCT01368536|581789831|FG002|Overall Study|Withdrawal by Subject|4|||
161109285|NCT01368536|581789829|FG000|Overall Study|Lost to Follow-up|3|||
161109286|NCT01368536|581789830|FG001|Overall Study|Lost to Follow-up|3|||
161109287|NCT01368536|581789831|FG002|Overall Study|Lost to Follow-up|5|||
161109288|NCT01368536|581789829|FG000|Overall Study|Administrative problems|34|||
161109289|NCT01368536|581789830|FG001|Overall Study|Administrative problems|39|||
161109290|NCT01368536|581789831|FG002|Overall Study|Administrative problems|35|||
161109291|NCT01368536|581789829|FG000|Overall Study|Protocol deviation|0|||
161109292|NCT01368536|581789830|FG001|Overall Study|Protocol deviation|3|||
161109293|NCT01368536|581789831|FG002|Overall Study|Protocol deviation|1|||
161109294|NCT03179891|581789832|FG000|First Intervention|Withdrawal by Subject|1|||
161109295|NCT03179891|581789833|FG001|First Intervention|Withdrawal by Subject|1|||
161109296|NCT03179891|581789832|FG000|First Intervention|Unspecified reason|1|||
161109297|NCT03179891|581789833|FG001|First Intervention|Unspecified reason|0|||
161109298|NCT03179891|581789832|FG000|First Intervention|Protocol Violation|0|||
161109299|NCT03179891|581789833|FG001|First Intervention|Protocol Violation|1|||
161109300|NCT00383084|581789840|FG000|Overall Study|Withdrawal by Subject|12|||
161109301|NCT00383084|581789841|FG001|Overall Study|Withdrawal by Subject|10|||
161109302|NCT02113436|581789842|FG000|Period 1: 8 Weeks|Adverse Event|1|||
161109303|NCT02113436|581789843|FG001|Period 1: 8 Weeks|Adverse Event|0|||
161109304|NCT02113436|581789844|FG002|Period 1: 8 Weeks|Adverse Event|0|||
161109305|NCT02113436|581789845|FG003|Period 1: 8 Weeks|Adverse Event|0|||
161109306|NCT02113436|581789842|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
161109307|NCT02113436|581789843|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
161214611|NCT01393990|582169400|FG004|Overall Study|Withdrawal by Subject|0|||
161214612|NCT01393990|582169401|FG005|Overall Study|Withdrawal by Subject|0|||
161214613|NCT01393990|582169402|FG006|Overall Study|Withdrawal by Subject|0|||
161214614|NCT01393990|582169403|FG007|Overall Study|Withdrawal by Subject|0|||
161109308|NCT02113436|581789844|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
161109309|NCT02113436|581789845|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
161109310|NCT02113436|581789842|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
161109311|NCT02113436|581789843|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
161109312|NCT02113436|581789844|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
161109313|NCT02113436|581789845|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
161109314|NCT02113436|581789842|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
161109315|NCT02113436|581789843|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161109316|NCT02113436|581789844|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161214615|NCT01393990|582169404|FG008|Overall Study|Withdrawal by Subject|0|||
160866240|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Transplant|0|||
160866241|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Transplant|0|||
160866242|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Transplant|0|||
160866243|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Transplant|0|||
160866244|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Transplant|4|||
160866245|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Transplant|2|||
160866246|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Transplant|0|||
160866247|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Transplant|0|||
160866248|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Transplant|0|||
160866249|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
160866250|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
160866251|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
160866252|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
160866253|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
160866254|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
160866255|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
160866256|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
160866257|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
160866258|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
160866259|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
160866260|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
160866261|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
160866262|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
160866263|NCT02113982|580904912|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
160866264|NCT02113982|580904913|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
160866265|NCT02113982|580904914|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
160866266|NCT02113982|580904915|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
160866267|NCT02113982|580904916|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
160866268|NCT02113982|580904917|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
160866269|NCT02113982|580904918|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
160866270|NCT02113982|580904919|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
160866271|NCT02113982|580904920|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
160866272|NCT02113982|580904921|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
160866273|NCT02113982|580904922|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
160866274|NCT02113982|580904923|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
160866275|NCT02113982|580904924|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
160866276|NCT02113982|580904925|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
160866277|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866278|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866279|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866280|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866281|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866282|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866283|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866284|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866285|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866286|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866287|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866288|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
160866289|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866290|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
160866291|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866292|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866293|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866294|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866295|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866296|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866297|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866298|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866299|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866300|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866301|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866302|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
160866303|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866304|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
160866305|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866306|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866307|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866308|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866309|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866310|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
161324344|NCT03293394|582573575|FG000|Follow-up (6 Months)|Adverse Event|4|||
161324345|NCT03293394|582573576|FG001|Follow-up (6 Months)|Adverse Event|2|||
161109317|NCT02113436|581789845|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
161109318|NCT02113436|581789842|FG000|Period 2: 16 Weeks|Adverse Event|0|||
161109319|NCT02113436|581789843|FG001|Period 2: 16 Weeks|Adverse Event|0|||
161109320|NCT02113436|581789844|FG002|Period 2: 16 Weeks|Adverse Event|4|||
161109321|NCT02113436|581789845|FG003|Period 2: 16 Weeks|Adverse Event|5|||
161109322|NCT02113436|581789842|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
161109323|NCT02113436|581789843|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
161109324|NCT02113436|581789844|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
161109325|NCT02113436|581789845|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
161109326|NCT02113436|581789842|FG000|Period 2: 16 Weeks|Physician Decision|0|||
161109327|NCT02113436|581789843|FG001|Period 2: 16 Weeks|Physician Decision|0|||
161109328|NCT02113436|581789844|FG002|Period 2: 16 Weeks|Physician Decision|2|||
161109329|NCT02113436|581789845|FG003|Period 2: 16 Weeks|Physician Decision|0|||
161109330|NCT02113436|581789842|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
161109331|NCT02113436|581789843|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
161109332|NCT02113436|581789844|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
161109333|NCT02113436|581789845|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
161109334|NCT01486927|581789846|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
161109335|NCT01486927|581789846|FG000|Overall Study|Physician Decision|1|||
161109336|NCT01486927|581789846|FG000|Overall Study|50 Exposure days not reached|2|||
161109337|NCT01486927|581789846|FG000|Overall Study|Withdrawal by Subject|8|||
161109338|NCT01486927|581789846|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
161109339|NCT02159729|581789847|FG000|Overall Study|Adverse Event|0|||
161109340|NCT02159729|581789848|FG001|Overall Study|Adverse Event|1|||
161109341|NCT02159729|581789847|FG000|Overall Study|Subject's Request|13|||
161109342|NCT02159729|581789848|FG001|Overall Study|Subject's Request|10|||
161109343|NCT02159729|581789847|FG000|Overall Study|Lost to Follow-up|24|||
161109344|NCT02159729|581789848|FG001|Overall Study|Lost to Follow-up|9|||
161109345|NCT02159729|581789847|FG000|Overall Study|Non compliance|2|||
161109346|NCT02159729|581789848|FG001|Overall Study|Non compliance|0|||
161109347|NCT02159729|581789847|FG000|Overall Study|Other Unspecified|3|||
161109348|NCT02159729|581789848|FG001|Overall Study|Other Unspecified|1|||
161109349|NCT02636582|581789849|FG000|Overall Study|Surgical Pathology|1|||
161109350|NCT02636582|581789850|FG001|Overall Study|Surgical Pathology|0|||
161109351|NCT00573430|581789851|FG000|Overall Study|Incorrect enrollment of randomization|0|||
161109352|NCT00573430|581789852|FG001|Overall Study|Incorrect enrollment of randomization|4|||
161109353|NCT00573430|581789853|FG002|Overall Study|Incorrect enrollment of randomization|3|||
161109354|NCT00573430|581789851|FG000|Overall Study|Adverse Event|0|||
161109355|NCT00573430|581789852|FG001|Overall Study|Adverse Event|0|||
161109356|NCT00573430|581789853|FG002|Overall Study|Adverse Event|2|||
161109357|NCT00573430|581789851|FG000|Overall Study|Withdrawal by Subject|1|||
161109358|NCT00573430|581789852|FG001|Overall Study|Withdrawal by Subject|0|||
161109359|NCT00573430|581789853|FG002|Overall Study|Withdrawal by Subject|1|||
161109360|NCT00573430|581789851|FG000|Overall Study|Protocol Violation|0|||
161109361|NCT00573430|581789852|FG001|Overall Study|Protocol Violation|1|||
161109362|NCT00573430|581789853|FG002|Overall Study|Protocol Violation|1|||
161109363|NCT00573430|581789851|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161109364|NCT00573430|581789852|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161109365|NCT00573430|581789853|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
161109366|NCT05895552|581789854|FG000|Overall Study|Adverse Event|2|||
161109367|NCT05895552|581789855|FG001|Overall Study|Adverse Event|2|||
161109368|NCT05895552|581789856|FG002|Overall Study|Adverse Event|1|||
161109369|NCT05895552|581789854|FG000|Overall Study|Lost to Follow-up|0|||
161109370|NCT05895552|581789855|FG001|Overall Study|Lost to Follow-up|1|||
161109371|NCT05895552|581789856|FG002|Overall Study|Lost to Follow-up|0|||
161109372|NCT05895552|581789854|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161109373|NCT05895552|581789855|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160866311|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866312|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866313|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866314|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866315|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866316|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
160866317|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866318|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
160866319|NCT02113982|580904912|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
160866320|NCT02113982|580904913|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
160866321|NCT02113982|580904914|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
160866322|NCT02113982|580904915|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
160866323|NCT02113982|580904916|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
160866324|NCT02113982|580904917|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
160866325|NCT02113982|580904918|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
160866326|NCT02113982|580904919|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
160866327|NCT02113982|580904920|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
160866328|NCT02113982|580904921|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
160866329|NCT02113982|580904922|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
160866330|NCT02113982|580904923|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
160866331|NCT02113982|580904924|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
160866332|NCT02113982|580904925|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
160866333|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866334|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866335|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866336|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866337|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866338|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866339|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866340|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866341|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866342|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866343|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866344|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866345|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
160866346|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
160866347|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866348|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866349|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866350|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866351|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866352|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866353|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866354|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866355|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866356|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866357|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866358|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
160866359|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
160866360|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
160866361|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866362|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866363|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866364|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866365|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866366|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866367|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866368|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866369|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866370|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866371|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866372|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
160866373|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
160866374|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
160866375|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866376|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866377|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866378|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866379|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866380|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866381|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866382|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866383|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866384|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866385|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866386|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
160866387|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
160866388|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
160866389|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866390|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866391|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866392|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866393|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866394|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866395|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866396|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866397|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866398|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866399|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866400|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866401|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
160866402|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
160866403|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866404|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866405|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866406|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866407|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866408|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866409|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866410|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866411|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866412|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866413|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866414|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866415|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
160866416|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
160866417|NCT02113982|580904912|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866418|NCT02113982|580904913|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866419|NCT02113982|580904914|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866420|NCT02113982|580904915|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866421|NCT02113982|580904916|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866422|NCT02113982|580904917|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866423|NCT02113982|580904918|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866424|NCT02113982|580904919|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866425|NCT02113982|580904920|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866426|NCT02113982|580904921|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866427|NCT02113982|580904922|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866428|NCT02113982|580904923|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866429|NCT02113982|580904924|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
160866430|NCT02113982|580904925|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
160866431|NCT01772316|580904926|FG000|Overall Study|Serious adverse event|1|||
160866432|NCT01772316|580904926|FG000|Overall Study|Inform consent withdrawn|1|||
160866433|NCT01772316|580904926|FG000|Overall Study|Withdrawn by sponsor decision|5|||
160866434|NCT02085161|580904928|FG000|Overall Study|Not Treated|1|||
160866435|NCT02085161|580904929|FG001|Overall Study|Not Treated|0|||
160866436|NCT02085161|580904930|FG002|Overall Study|Not Treated|0|||
160866437|NCT02085161|580904931|FG003|Overall Study|Not Treated|0|||
160866438|NCT02085161|580904928|FG000|Overall Study|Adverse Event|8|||
160866439|NCT02085161|580904929|FG001|Overall Study|Adverse Event|5|||
160866440|NCT02085161|580904930|FG002|Overall Study|Adverse Event|4|||
160866441|NCT02085161|580904931|FG003|Overall Study|Adverse Event|5|||
160866442|NCT02085161|580904928|FG000|Overall Study|Protocol Violation|0|||
160866443|NCT02085161|580904929|FG001|Overall Study|Protocol Violation|1|||
160866444|NCT02085161|580904930|FG002|Overall Study|Protocol Violation|0|||
160866445|NCT02085161|580904931|FG003|Overall Study|Protocol Violation|1|||
161324346|NCT01408901|582573577|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
161324347|NCT01408901|582573578|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
160866446|NCT02085161|580904928|FG000|Overall Study|Withdrawal by Subject|2|||
160866447|NCT02085161|580904929|FG001|Overall Study|Withdrawal by Subject|4|||
160866448|NCT02085161|580904930|FG002|Overall Study|Withdrawal by Subject|0|||
160866449|NCT02085161|580904931|FG003|Overall Study|Withdrawal by Subject|3|||
160866450|NCT02085161|580904928|FG000|Overall Study|Other Reason|1|||
160866451|NCT02085161|580904929|FG001|Overall Study|Other Reason|0|||
160866452|NCT02085161|580904930|FG002|Overall Study|Other Reason|1|||
160866453|NCT02085161|580904931|FG003|Overall Study|Other Reason|1|||
160866454|NCT00068692|580904942|FG000|Step 1: Registration|Disese progression/relapse|5|||
160866455|NCT00068692|580904943|FG001|Step 1: Registration|Disese progression/relapse|0|||
160866456|NCT00068692|580904944|FG002|Step 1: Registration|Disese progression/relapse|0|||
160866457|NCT00068692|580904945|FG003|Step 1: Registration|Disese progression/relapse|0|||
160866458|NCT00068692|580904946|FG004|Step 1: Registration|Disese progression/relapse|0|||
160866459|NCT00068692|580904947|FG005|Step 1: Registration|Disese progression/relapse|0|||
160866460|NCT00068692|580904948|FG006|Step 1: Registration|Disese progression/relapse|0|||
160866461|NCT00068692|580904949|FG007|Step 1: Registration|Disese progression/relapse|0|||
160866462|NCT00068692|580904942|FG000|Step 1: Registration|Adverse Event|7|||
160866463|NCT00068692|580904943|FG001|Step 1: Registration|Adverse Event|0|||
160866464|NCT00068692|580904944|FG002|Step 1: Registration|Adverse Event|0|||
160866465|NCT00068692|580904945|FG003|Step 1: Registration|Adverse Event|0|||
160866466|NCT00068692|580904946|FG004|Step 1: Registration|Adverse Event|0|||
160866467|NCT00068692|580904947|FG005|Step 1: Registration|Adverse Event|0|||
160866468|NCT00068692|580904948|FG006|Step 1: Registration|Adverse Event|0|||
160866469|NCT00068692|580904949|FG007|Step 1: Registration|Adverse Event|0|||
160866470|NCT00068692|580904942|FG000|Step 1: Registration|Death|1|||
160866471|NCT00068692|580904943|FG001|Step 1: Registration|Death|0|||
160866472|NCT00068692|580904944|FG002|Step 1: Registration|Death|0|||
160866473|NCT00068692|580904945|FG003|Step 1: Registration|Death|0|||
160866474|NCT00068692|580904946|FG004|Step 1: Registration|Death|0|||
160866475|NCT00068692|580904947|FG005|Step 1: Registration|Death|0|||
160866476|NCT00068692|580904948|FG006|Step 1: Registration|Death|0|||
160866477|NCT00068692|580904949|FG007|Step 1: Registration|Death|0|||
160866478|NCT00068692|580904942|FG000|Step 1: Registration|Withdrawal by Subject|11|||
160866479|NCT00068692|580904943|FG001|Step 1: Registration|Withdrawal by Subject|0|||
160866480|NCT00068692|580904944|FG002|Step 1: Registration|Withdrawal by Subject|0|||
160866481|NCT00068692|580904945|FG003|Step 1: Registration|Withdrawal by Subject|0|||
160866482|NCT00068692|580904946|FG004|Step 1: Registration|Withdrawal by Subject|0|||
161109374|NCT05895552|581789856|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161109375|NCT05895552|581789854|FG000|Overall Study|Protocol Deviation|0|||
161109376|NCT05895552|581789855|FG001|Overall Study|Protocol Deviation|0|||
161109377|NCT05895552|581789856|FG002|Overall Study|Protocol Deviation|2|||
161109378|NCT05895552|581789854|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161109379|NCT05895552|581789855|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161109380|NCT05895552|581789856|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
161109381|NCT05895552|581789854|FG000|Overall Study|Withdrawal by Subject|2|||
161109382|NCT05895552|581789855|FG001|Overall Study|Withdrawal by Subject|2|||
161109383|NCT05895552|581789856|FG002|Overall Study|Withdrawal by Subject|4|||
161109384|NCT03810911|581789857|FG000|Overall Study|Death|1|||
161109385|NCT03810911|581789858|FG001|Overall Study|Death|1|||
161109386|NCT03810911|581789857|FG000|Overall Study|Withdrawal by Subject|1|||
161109387|NCT03810911|581789858|FG001|Overall Study|Withdrawal by Subject|1|||
161109388|NCT04770532|581789859|FG000|Overall Study|Withdrawal by Subject|0|||
161109389|NCT04770532|581789860|FG001|Overall Study|Withdrawal by Subject|3|||
161109390|NCT04770532|581789859|FG000|Overall Study|Physician Decision|1|||
161109391|NCT04770532|581789860|FG001|Overall Study|Physician Decision|0|||
161109392|NCT04770532|581789859|FG000|Overall Study|Death|2|||
161109393|NCT04770532|581789860|FG001|Overall Study|Death|2|||
161109394|NCT00454857|581789864|FG000|Overall Study|Withdrawal by Subject|15|||
161109395|NCT00454857|581789864|FG000|Overall Study|Lost to Follow-up|16|||
161109396|NCT00454857|581789864|FG000|Overall Study|Noncompliance|6|||
161109397|NCT00454857|581789864|FG000|Overall Study|Death|5|||
161109398|NCT00454857|581789864|FG000|Overall Study|Other|11|||
161109399|NCT00454857|581789864|FG000|Overall Study|Reason unknown|1|||
161109400|NCT00829179|581789865|FG000|Overall Study|Withdrawal by Subject|1|||
161109401|NCT04707157|581789866|FG000|Overall Study|Adverse Event|12|||
161109402|NCT04707157|581789867|FG001|Overall Study|Adverse Event|3|||
161109403|NCT04707157|581789866|FG000|Overall Study|Lost to Follow-up|2|||
161109404|NCT04707157|581789867|FG001|Overall Study|Lost to Follow-up|0|||
161109405|NCT04707157|581789866|FG000|Overall Study|Sponsor's decision|1|||
161109406|NCT04707157|581789867|FG001|Overall Study|Sponsor's decision|0|||
160866483|NCT00068692|580904947|FG005|Step 1: Registration|Withdrawal by Subject|0|||
160866484|NCT00068692|580904948|FG006|Step 1: Registration|Withdrawal by Subject|0|||
161109407|NCT04707157|581789866|FG000|Overall Study|Physician Decision|8|||
160866485|NCT00068692|580904949|FG007|Step 1: Registration|Withdrawal by Subject|0|||
160866486|NCT00068692|580904942|FG000|Step 1: Registration|Alternative therapy|2|||
160981500|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
161109408|NCT04707157|581789867|FG001|Overall Study|Physician Decision|5|||
161109409|NCT04707157|581789866|FG000|Overall Study|Protocol Deviation|1|||
160866487|NCT00068692|580904943|FG001|Step 1: Registration|Alternative therapy|0|||
160866488|NCT00068692|580904944|FG002|Step 1: Registration|Alternative therapy|0|||
160866489|NCT00068692|580904945|FG003|Step 1: Registration|Alternative therapy|0|||
160866490|NCT00068692|580904946|FG004|Step 1: Registration|Alternative therapy|0|||
160866491|NCT00068692|580904947|FG005|Step 1: Registration|Alternative therapy|0|||
160866492|NCT00068692|580904948|FG006|Step 1: Registration|Alternative therapy|0|||
160866493|NCT00068692|580904949|FG007|Step 1: Registration|Alternative therapy|0|||
160866494|NCT00068692|580904942|FG000|Step 1: Registration|Complicating disease|2|||
160866495|NCT00068692|580904943|FG001|Step 1: Registration|Complicating disease|0|||
160866496|NCT00068692|580904944|FG002|Step 1: Registration|Complicating disease|0|||
160866497|NCT00068692|580904945|FG003|Step 1: Registration|Complicating disease|0|||
160866498|NCT00068692|580904946|FG004|Step 1: Registration|Complicating disease|0|||
160866499|NCT00068692|580904947|FG005|Step 1: Registration|Complicating disease|0|||
160866500|NCT00068692|580904948|FG006|Step 1: Registration|Complicating disease|0|||
160866501|NCT00068692|580904949|FG007|Step 1: Registration|Complicating disease|0|||
160866502|NCT00068692|580904942|FG000|Step 1: Registration|Protocol Violation|1|||
160866503|NCT00068692|580904943|FG001|Step 1: Registration|Protocol Violation|0|||
160866504|NCT00068692|580904944|FG002|Step 1: Registration|Protocol Violation|0|||
160866505|NCT00068692|580904945|FG003|Step 1: Registration|Protocol Violation|0|||
160866506|NCT00068692|580904946|FG004|Step 1: Registration|Protocol Violation|0|||
160866507|NCT00068692|580904947|FG005|Step 1: Registration|Protocol Violation|0|||
160866508|NCT00068692|580904948|FG006|Step 1: Registration|Protocol Violation|0|||
160866509|NCT00068692|580904949|FG007|Step 1: Registration|Protocol Violation|0|||
160866510|NCT00068692|580904942|FG000|Step 1: Registration|Not eligible|6|||
160866511|NCT00068692|580904943|FG001|Step 1: Registration|Not eligible|0|||
160866512|NCT00068692|580904944|FG002|Step 1: Registration|Not eligible|0|||
160866513|NCT00068692|580904945|FG003|Step 1: Registration|Not eligible|0|||
160866514|NCT00068692|580904946|FG004|Step 1: Registration|Not eligible|0|||
160866515|NCT00068692|580904947|FG005|Step 1: Registration|Not eligible|0|||
160866516|NCT00068692|580904948|FG006|Step 1: Registration|Not eligible|0|||
160866517|NCT00068692|580904949|FG007|Step 1: Registration|Not eligible|0|||
160866518|NCT00068692|580904942|FG000|Step 1: Registration|Other|2|||
160866519|NCT00068692|580904943|FG001|Step 1: Registration|Other|0|||
160866520|NCT00068692|580904944|FG002|Step 1: Registration|Other|0|||
160866521|NCT00068692|580904945|FG003|Step 1: Registration|Other|0|||
160866522|NCT00068692|580904946|FG004|Step 1: Registration|Other|0|||
160866523|NCT00068692|580904947|FG005|Step 1: Registration|Other|0|||
160866524|NCT00068692|580904948|FG006|Step 1: Registration|Other|0|||
160866525|NCT00068692|580904949|FG007|Step 1: Registration|Other|0|||
160866526|NCT00068692|580904942|FG000|Step 1: Registration|Not start protocol therapy|3|||
160866527|NCT00068692|580904943|FG001|Step 1: Registration|Not start protocol therapy|0|||
160866528|NCT00068692|580904944|FG002|Step 1: Registration|Not start protocol therapy|0|||
160866529|NCT00068692|580904945|FG003|Step 1: Registration|Not start protocol therapy|0|||
160866530|NCT00068692|580904946|FG004|Step 1: Registration|Not start protocol therapy|0|||
160866531|NCT00068692|580904947|FG005|Step 1: Registration|Not start protocol therapy|0|||
160866532|NCT00068692|580904948|FG006|Step 1: Registration|Not start protocol therapy|0|||
160866533|NCT00068692|580904949|FG007|Step 1: Registration|Not start protocol therapy|0|||
160866534|NCT00068692|580904942|FG000|Step 1: Registration|Registered but not randomized|0|||
160866535|NCT00068692|580904943|FG001|Step 1: Registration|Registered but not randomized|1|||
160866536|NCT00068692|580904944|FG002|Step 1: Registration|Registered but not randomized|0|||
160866537|NCT00068692|580904945|FG003|Step 1: Registration|Registered but not randomized|0|||
160866538|NCT00068692|580904946|FG004|Step 1: Registration|Registered but not randomized|0|||
160866539|NCT00068692|580904947|FG005|Step 1: Registration|Registered but not randomized|0|||
160866540|NCT00068692|580904948|FG006|Step 1: Registration|Registered but not randomized|0|||
160866541|NCT00068692|580904949|FG007|Step 1: Registration|Registered but not randomized|0|||
160866542|NCT00068692|580904942|FG000|Step 2: Randomization|Disesae progression/replase|0|||
160866543|NCT00068692|580904943|FG001|Step 2: Randomization|Disesae progression/replase|0|||
160866544|NCT00068692|580904944|FG002|Step 2: Randomization|Disesae progression/replase|1|||
160866545|NCT00068692|580904945|FG003|Step 2: Randomization|Disesae progression/replase|1|||
160866546|NCT00068692|580904946|FG004|Step 2: Randomization|Disesae progression/replase|0|||
160866547|NCT00068692|580904947|FG005|Step 2: Randomization|Disesae progression/replase|0|||
160866548|NCT00068692|580904948|FG006|Step 2: Randomization|Disesae progression/replase|0|||
160866549|NCT00068692|580904949|FG007|Step 2: Randomization|Disesae progression/replase|0|||
160866550|NCT00068692|580904942|FG000|Step 2: Randomization|Adverse Event|0|||
160866551|NCT00068692|580904943|FG001|Step 2: Randomization|Adverse Event|0|||
160866552|NCT00068692|580904944|FG002|Step 2: Randomization|Adverse Event|4|||
160866553|NCT00068692|580904945|FG003|Step 2: Randomization|Adverse Event|2|||
161214616|NCT01393990|582169405|FG009|Overall Study|Withdrawal by Subject|0|||
160866554|NCT00068692|580904946|FG004|Step 2: Randomization|Adverse Event|2|||
160866555|NCT00068692|580904947|FG005|Step 2: Randomization|Adverse Event|3|||
160866556|NCT00068692|580904948|FG006|Step 2: Randomization|Adverse Event|4|||
160866557|NCT00068692|580904949|FG007|Step 2: Randomization|Adverse Event|4|||
160866558|NCT00068692|580904942|FG000|Step 2: Randomization|Death|0|||
160866559|NCT00068692|580904943|FG001|Step 2: Randomization|Death|0|||
160866560|NCT00068692|580904944|FG002|Step 2: Randomization|Death|0|||
160866561|NCT00068692|580904945|FG003|Step 2: Randomization|Death|0|||
160866562|NCT00068692|580904946|FG004|Step 2: Randomization|Death|1|||
160866563|NCT00068692|580904947|FG005|Step 2: Randomization|Death|0|||
160866564|NCT00068692|580904948|FG006|Step 2: Randomization|Death|0|||
160866565|NCT00068692|580904949|FG007|Step 2: Randomization|Death|1|||
161214617|NCT01393990|582169406|FG010|Overall Study|Withdrawal by Subject|0|||
160866566|NCT00068692|580904942|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
160866567|NCT00068692|580904943|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
160866568|NCT00068692|580904944|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
160866569|NCT00068692|580904945|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
160866570|NCT00068692|580904946|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
160866571|NCT00068692|580904947|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
160866572|NCT00068692|580904948|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
160866573|NCT00068692|580904949|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
160866574|NCT00068692|580904942|FG000|Step 2: Randomization|alternative therapy|0|||
160866575|NCT00068692|580904943|FG001|Step 2: Randomization|alternative therapy|0|||
160866576|NCT00068692|580904944|FG002|Step 2: Randomization|alternative therapy|0|||
160866577|NCT00068692|580904945|FG003|Step 2: Randomization|alternative therapy|1|||
160866578|NCT00068692|580904946|FG004|Step 2: Randomization|alternative therapy|1|||
160866579|NCT00068692|580904947|FG005|Step 2: Randomization|alternative therapy|0|||
160866580|NCT00068692|580904948|FG006|Step 2: Randomization|alternative therapy|0|||
160866581|NCT00068692|580904949|FG007|Step 2: Randomization|alternative therapy|0|||
160866582|NCT00068692|580904942|FG000|Step 2: Randomization|Physician Decision|0|||
160866583|NCT00068692|580904943|FG001|Step 2: Randomization|Physician Decision|0|||
160866584|NCT00068692|580904944|FG002|Step 2: Randomization|Physician Decision|0|||
160866585|NCT00068692|580904945|FG003|Step 2: Randomization|Physician Decision|1|||
160866586|NCT00068692|580904946|FG004|Step 2: Randomization|Physician Decision|1|||
160866587|NCT00068692|580904947|FG005|Step 2: Randomization|Physician Decision|0|||
160866588|NCT00068692|580904948|FG006|Step 2: Randomization|Physician Decision|0|||
160866589|NCT00068692|580904949|FG007|Step 2: Randomization|Physician Decision|0|||
160866590|NCT00068692|580904942|FG000|Step 2: Randomization|Other|0|||
160866591|NCT00068692|580904943|FG001|Step 2: Randomization|Other|0|||
160866592|NCT00068692|580904944|FG002|Step 2: Randomization|Other|0|||
160866593|NCT00068692|580904945|FG003|Step 2: Randomization|Other|1|||
160866594|NCT00068692|580904946|FG004|Step 2: Randomization|Other|0|||
160866595|NCT00068692|580904947|FG005|Step 2: Randomization|Other|1|||
160866596|NCT00068692|580904948|FG006|Step 2: Randomization|Other|0|||
160866597|NCT00068692|580904949|FG007|Step 2: Randomization|Other|0|||
160866598|NCT00068692|580904942|FG000|Step 2: Randomization|never start protocol therapy|0|||
160866599|NCT00068692|580904943|FG001|Step 2: Randomization|never start protocol therapy|0|||
160866600|NCT00068692|580904944|FG002|Step 2: Randomization|never start protocol therapy|1|||
160866601|NCT00068692|580904945|FG003|Step 2: Randomization|never start protocol therapy|0|||
160866602|NCT00068692|580904946|FG004|Step 2: Randomization|never start protocol therapy|1|||
160866603|NCT00068692|580904947|FG005|Step 2: Randomization|never start protocol therapy|0|||
160866604|NCT00068692|580904948|FG006|Step 2: Randomization|never start protocol therapy|0|||
161109410|NCT04707157|581789867|FG001|Overall Study|Protocol Deviation|0|||
161109411|NCT04707157|581789866|FG000|Overall Study|Withdrawal by Subject|1|||
161109412|NCT04707157|581789867|FG001|Overall Study|Withdrawal by Subject|1|||
161109413|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
161109414|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
161109415|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Death|0|||
161109416|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Death|1|||
161109417|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
160866605|NCT00068692|580904949|FG007|Step 2: Randomization|never start protocol therapy|0|||
160866606|NCT01600716|580904951|FG000|Overall Study|Other Reasons|3|||
160866607|NCT01600716|580904952|FG001|Overall Study|Other Reasons|1|||
160866608|NCT01600716|580904951|FG000|Overall Study|Personal Reasons|0|||
160866609|NCT01600716|580904952|FG001|Overall Study|Personal Reasons|2|||
160866610|NCT01600716|580904951|FG000|Overall Study|Lost to Follow-up|0|||
160866611|NCT01600716|580904952|FG001|Overall Study|Lost to Follow-up|2|||
160866612|NCT01600716|580904951|FG000|Overall Study|Pregnancy|1|||
160866613|NCT01600716|580904952|FG001|Overall Study|Pregnancy|0|||
160866614|NCT01600716|580904951|FG000|Overall Study|Lack of Efficacy|2|||
160866615|NCT01600716|580904952|FG001|Overall Study|Lack of Efficacy|1|||
160866616|NCT01600716|580904951|FG000|Overall Study|Adverse Event|1|||
160866617|NCT01600716|580904952|FG001|Overall Study|Adverse Event|1|||
160866618|NCT03557034|580904955|FG000|Overall Study|Withdrawal by Subject|1|||
160866619|NCT03557034|580904956|FG001|Overall Study|Withdrawal by Subject|0|||
160866620|NCT03349034|580904959|FG000|Overall Study|catheters dislodged during transport|2|||
160866621|NCT03349034|580904960|FG001|Overall Study|catheters dislodged during transport|0|||
160866622|NCT03349034|580904959|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
160866623|NCT03349034|580904960|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
160866624|NCT03349034|580904959|FG000|Overall Study|soft tissue flap used|1|||
160866625|NCT03349034|580904960|FG001|Overall Study|soft tissue flap used|0|||
160866626|NCT03349034|580904959|FG000|Overall Study|Other|0|||
160866627|NCT03349034|580904960|FG001|Overall Study|Other|1|||
160866628|NCT01759446|580904961|FG000|Overall Study|Protocol Violation|1|||
160866629|NCT01759446|580904962|FG001|Overall Study|Protocol Violation|0|||
160866630|NCT01759446|580904963|FG002|Overall Study|Protocol Violation|1|||
160866631|NCT01759446|580904964|FG003|Overall Study|Protocol Violation|0|||
160866632|NCT01759446|580904965|FG004|Overall Study|Protocol Violation|0|||
160866633|NCT01759446|580904961|FG000|Overall Study|Withdrawal by Subject|0|||
160866634|NCT01759446|580904962|FG001|Overall Study|Withdrawal by Subject|1|||
160866635|NCT01759446|580904963|FG002|Overall Study|Withdrawal by Subject|0|||
160866636|NCT01759446|580904964|FG003|Overall Study|Withdrawal by Subject|1|||
160866637|NCT01759446|580904965|FG004|Overall Study|Withdrawal by Subject|0|||
160866638|NCT01760733|580904966|FG000|Waiting List|Death|18|||
160866639|NCT01760733|580904966|FG000|Waiting List|Removed from waiting list|41|||
160866640|NCT01760733|580904966|FG000|Waiting List|Not received a transplant yet|13|||
160866641|NCT01760733|580904966|FG000|Transplanted|Not reached 10 years post transplant|184|||
160866642|NCT01760733|580904966|FG000|Transplanted|Death|26|||
160866643|NCT01760733|580904966|FG000|Transplanted|Graft loss|7|||
160866644|NCT00815659|580904969|FG000|Overall Study|Adverse Event|9|||
160866645|NCT00815659|580904969|FG000|Overall Study|Withdrawal by Subject|9|||
160866646|NCT00815659|580904969|FG000|Overall Study|Lost to Follow-up|4|||
160866647|NCT00815659|580904969|FG000|Overall Study|Protocol Violation|1|||
160866648|NCT00719472|580904970|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
160866649|NCT00719472|580904970|FG000|Enrolled in Study|Subject decision to withdraw|8|||
160866650|NCT00719472|580904970|FG000|Enrolled in Study|Various Reasons|17|||
160866651|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
160866652|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Death|5|||
160866653|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
160866654|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
160866655|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
160866656|NCT00719472|580904970|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
160866657|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
160866658|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Death|6|||
160866659|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Disease progression|3|||
160866660|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
160866661|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
160866662|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
160866663|NCT00719472|580904970|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
160866664|NCT00123422|580904971|FG000|Overall Study|Physician Decision|2|||
160866665|NCT00123422|580904972|FG001|Overall Study|Physician Decision|2|||
160866666|NCT00123422|580904973|FG002|Overall Study|Physician Decision|6|||
160866667|NCT00123422|580904971|FG000|Overall Study|Withdrawal by Subject|1|||
160866668|NCT00123422|580904972|FG001|Overall Study|Withdrawal by Subject|2|||
160866669|NCT00123422|580904973|FG002|Overall Study|Withdrawal by Subject|2|||
160866670|NCT00123422|580904971|FG000|Overall Study|Lost to Follow-up|1|||
160866671|NCT00123422|580904972|FG001|Overall Study|Lost to Follow-up|2|||
160866672|NCT00123422|580904973|FG002|Overall Study|Lost to Follow-up|2|||
160866673|NCT03584789|580904981|FG000|Overall Study|refused EHR permission|19|||
160866674|NCT03584789|580904982|FG001|Overall Study|refused EHR permission|28|||
160866675|NCT03584789|580904983|FG002|Overall Study|refused EHR permission|23|||
160866676|NCT03584789|580904981|FG000|Overall Study|patients tied to a provider who retired|0|||
160866677|NCT03584789|580904982|FG001|Overall Study|patients tied to a provider who retired|0|||
160866678|NCT03584789|580904983|FG002|Overall Study|patients tied to a provider who retired|3|||
160866679|NCT04646044|580904985|FG000|Overall Study|Lost to Follow-up|0|||
161214618|NCT01393990|582169407|FG011|Overall Study|Withdrawal by Subject|0|||
161214619|NCT01393990|582169408|FG012|Overall Study|Withdrawal by Subject|0|||
161214620|NCT01393990|582169409|FG013|Overall Study|Withdrawal by Subject|0|||
161214621|NCT01393990|582169410|FG014|Overall Study|Withdrawal by Subject|1|||
160866680|NCT04646044|580904986|FG001|Overall Study|Lost to Follow-up|0|||
160866681|NCT04646044|580904987|FG002|Overall Study|Lost to Follow-up|1|||
160866682|NCT04646044|580904988|FG003|Overall Study|Lost to Follow-up|0|||
160866683|NCT04646044|580904985|FG000|Overall Study|Withdrawal by Subject|0|||
160866684|NCT04646044|580904986|FG001|Overall Study|Withdrawal by Subject|1|||
160866685|NCT04646044|580904987|FG002|Overall Study|Withdrawal by Subject|0|||
160866686|NCT04646044|580904988|FG003|Overall Study|Withdrawal by Subject|0|||
160866687|NCT00602472|580904989|FG000|Overall Study|Adverse Event|5|||
160866688|NCT00602472|580904990|FG001|Overall Study|Adverse Event|23|||
160866689|NCT00602472|580904989|FG000|Overall Study|Protocol Violation|4|||
160866690|NCT00602472|580904990|FG001|Overall Study|Protocol Violation|19|||
160866691|NCT00602472|580904989|FG000|Overall Study|Withdrawal by Subject|8|||
160866692|NCT00602472|580904990|FG001|Overall Study|Withdrawal by Subject|14|||
160866693|NCT00602472|580904989|FG000|Overall Study|Other incl. lack of efficacy|4|||
160866694|NCT00602472|580904990|FG001|Overall Study|Other incl. lack of efficacy|2|||
160866695|NCT01938716|580904991|FG000|Overall Study|Physician Decision|2|||
160866696|NCT01938716|580904991|FG000|Overall Study|Withdrawal by Subject|2|||
160866697|NCT01908803|580904992|FG000|Overall Study|Adverse Event|1|||
160866698|NCT01908803|580904993|FG001|Overall Study|Adverse Event|0|||
160866699|NCT01908803|580904992|FG000|Overall Study|Physician Decision|0|||
160866700|NCT01908803|580904993|FG001|Overall Study|Physician Decision|1|||
160866701|NCT01908803|580904992|FG000|Overall Study|Withdrawal by Subject|1|||
160866702|NCT01908803|580904993|FG001|Overall Study|Withdrawal by Subject|0|||
160866703|NCT01908803|580904992|FG000|Overall Study|Randomization Error|1|||
160866704|NCT01908803|580904993|FG001|Overall Study|Randomization Error|0|||
160866705|NCT01908803|580904992|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
160866706|NCT01908803|580904993|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
160866707|NCT00823615|580904994|FG000|Period 2|Lost to Follow-up|2|||
160866708|NCT00823615|580904995|FG001|Period 2|Lost to Follow-up|0|||
160866709|NCT00823615|580904994|FG000|Period 2|Time/Job Conflict|1|||
160866710|NCT00823615|580904995|FG001|Period 2|Time/Job Conflict|2|||
160866711|NCT00433004|580904996|FG000|Overall Study|Lost to Follow-up|5|||
160866712|NCT00433004|580904997|FG001|Overall Study|Lost to Follow-up|7|||
160866713|NCT00742235|580904998|FG000|Overall Study|Lost to Follow-up|0|||
160866714|NCT00742235|580904999|FG001|Overall Study|Lost to Follow-up|31|||
160866715|NCT03910244|580905001|FG000|Overall Study|Adverse Event|14|||
160866716|NCT03910244|580905002|FG001|Overall Study|Adverse Event|0|||
160866717|NCT03910244|580905001|FG000|Overall Study|Death|1|||
160866718|NCT03910244|580905002|FG001|Overall Study|Death|0|||
160866719|NCT03910244|580905001|FG000|Overall Study|Lost to Follow-up|0|||
160866720|NCT03910244|580905002|FG001|Overall Study|Lost to Follow-up|2|||
160866721|NCT03910244|580905001|FG000|Overall Study|Joint withdrawal decision|1|||
160866722|NCT03910244|580905002|FG001|Overall Study|Joint withdrawal decision|0|||
160866723|NCT03910244|580905001|FG000|Overall Study|Study Terminated by Sponsor|7|||
160866724|NCT03910244|580905002|FG001|Overall Study|Study Terminated by Sponsor|4|||
160866725|NCT03910244|580905001|FG000|Overall Study|Physician Decision|1|||
160866726|NCT03910244|580905002|FG001|Overall Study|Physician Decision|0|||
160866727|NCT03910244|580905001|FG000|Overall Study|Protocol Violation|1|||
160866728|NCT03910244|580905002|FG001|Overall Study|Protocol Violation|0|||
160866729|NCT03910244|580905001|FG000|Overall Study|Withdrawal by Subject|7|||
160866730|NCT03910244|580905002|FG001|Overall Study|Withdrawal by Subject|2|||
160866731|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
160866732|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
160866733|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
161109418|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
161109419|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
161109420|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
160866734|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
160866735|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
160866736|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
160866737|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
160866738|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
160866739|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
160866740|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
160866741|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
160866742|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
160866743|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
160866744|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
160866745|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
160866746|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160866747|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
160866748|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
160866749|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
160866750|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160866751|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
160866752|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
160866753|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160866754|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
160866755|NCT01106690|580905003|FG000|Core Period: Baseline to Week 26|Other|10|||
160866756|NCT01106690|580905004|FG001|Core Period: Baseline to Week 26|Other|2|||
160866757|NCT01106690|580905005|FG002|Core Period: Baseline to Week 26|Other|6|||
160866758|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160866759|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
160866760|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
160866761|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
160866762|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160866763|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
160866764|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
160866765|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160866766|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
160866767|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
160866768|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
160866769|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
160866770|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160866771|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
160866772|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
160866773|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Other|8|||
160866774|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Other|3|||
160866775|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Other|4|||
160866776|NCT01106690|580905003|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
160866777|NCT01106690|580905004|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160866778|NCT01106690|580905005|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
160866779|NCT02346721|580905006|FG000|Overall Study|Withdrew Consent|3|||
160866780|NCT02346721|580905006|FG000|Overall Study|Lack of Efficacy|1|||
161109421|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
161109422|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
161109423|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
161109424|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
161109425|NCT00843518|581789871|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
161109426|NCT00843518|581789872|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
161109427|NCT00133991|581789873|FG000|Overall Study|Death|4|||
161109428|NCT03418129|581789877|FG000|Overall Study|Lost to Follow-up|11|||
161109429|NCT03418129|581789878|FG001|Overall Study|Lost to Follow-up|20|||
161109430|NCT03418129|581789879|FG002|Overall Study|Lost to Follow-up|15|||
161109431|NCT03418129|581789877|FG000|Overall Study|Withdrawal by Subject|3|||
161109432|NCT03418129|581789878|FG001|Overall Study|Withdrawal by Subject|6|||
161109433|NCT03418129|581789879|FG002|Overall Study|Withdrawal by Subject|4|||
161109434|NCT02664272|581789882|FG000|Overall Study|Fluoroscopic images not made available|2|||
161109435|NCT03073980|581789883|FG000|Overall Study|Lost to Follow-up|10|||
161109436|NCT03073980|581789884|FG001|Overall Study|Lost to Follow-up|2|||
161109437|NCT03073980|581789885|FG002|Overall Study|Lost to Follow-up|9|||
161109438|NCT03073980|581789883|FG000|Overall Study|No post-procedure data|0|||
161109439|NCT03073980|581789884|FG001|Overall Study|No post-procedure data|0|||
161109440|NCT03073980|581789885|FG002|Overall Study|No post-procedure data|2|||
161109441|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
161109442|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
161109443|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
161109444|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
161109445|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
161109446|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
161109447|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161109448|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161109449|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
161109450|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
161109451|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161109452|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161109453|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
161109454|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
161109455|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
161109456|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
161109457|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
161109458|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
161109459|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
161109460|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
161109461|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
161109462|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
161109463|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161109464|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
161109465|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Death|2|||
161109466|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Death|1|||
161109467|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Death|0|||
161109468|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Death|0|||
161109469|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161109470|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
161109471|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161109472|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
161109473|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
161109474|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
161109475|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
161109476|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
161109477|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161109478|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161109479|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161109480|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161109481|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
161109482|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161109483|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161109484|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
161109485|NCT01940471|581789886|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
161214622|NCT01393990|582169411|FG015|Overall Study|Withdrawal by Subject|1|||
161109486|NCT01940471|581789887|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
161109487|NCT01940471|581789888|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
161214623|NCT01393990|582169412|FG016|Overall Study|Withdrawal by Subject|0|||
160866781|NCT03219528|580905016|FG000|Overall Study|Lost to Follow-up|5|||
160866782|NCT03219528|580905017|FG001|Overall Study|Lost to Follow-up|4|||
160866783|NCT03219528|580905016|FG000|Overall Study|Withdrawal by Subject|4|||
160866784|NCT03219528|580905017|FG001|Overall Study|Withdrawal by Subject|4|||
160866785|NCT03809104|580905018|FG000|Overall Study|Withdrawal by Subject|3|||
160866786|NCT00790842|580905019|FG000|Dose Level 1|Adverse Event|1|||
160866787|NCT00790842|580905020|FG001|Dose Level 1|Adverse Event|0|||
160866788|NCT00790842|580905021|FG002|Dose Level 1|Adverse Event|0|||
160866789|NCT00790842|580905022|FG003|Dose Level 1|Adverse Event|2|||
160866790|NCT00790842|580905023|FG004|Dose Level 1|Adverse Event|0|||
160866791|NCT00790842|580905024|FG005|Dose Level 1|Adverse Event|0|||
160866792|NCT00790842|580905025|FG006|Dose Level 1|Adverse Event|0|||
160866793|NCT00790842|580905026|FG007|Dose Level 1|Adverse Event|1|||
160866794|NCT00790842|580905027|FG008|Dose Level 1|Adverse Event|0|||
160866795|NCT00790842|580905028|FG009|Dose Level 1|Adverse Event|0|||
160866796|NCT00790842|580905029|FG010|Dose Level 1|Adverse Event|0|||
160866797|NCT00790842|580905019|FG000|Dose Level 1|Physician Decision|1|||
160866798|NCT00790842|580905020|FG001|Dose Level 1|Physician Decision|0|||
160866799|NCT00790842|580905021|FG002|Dose Level 1|Physician Decision|0|||
160866800|NCT00790842|580905022|FG003|Dose Level 1|Physician Decision|0|||
160866801|NCT00790842|580905023|FG004|Dose Level 1|Physician Decision|0|||
160866802|NCT00790842|580905024|FG005|Dose Level 1|Physician Decision|0|||
160866803|NCT00790842|580905025|FG006|Dose Level 1|Physician Decision|0|||
160866804|NCT00790842|580905026|FG007|Dose Level 1|Physician Decision|1|||
160866805|NCT00790842|580905027|FG008|Dose Level 1|Physician Decision|0|||
160866806|NCT00790842|580905028|FG009|Dose Level 1|Physician Decision|0|||
160866807|NCT00790842|580905029|FG010|Dose Level 1|Physician Decision|0|||
160866808|NCT00790842|580905019|FG000|Dose Level 1|Withdrawal by Subject|1|||
160866809|NCT00790842|580905020|FG001|Dose Level 1|Withdrawal by Subject|0|||
160866810|NCT00790842|580905021|FG002|Dose Level 1|Withdrawal by Subject|0|||
160866811|NCT00790842|580905022|FG003|Dose Level 1|Withdrawal by Subject|0|||
160866812|NCT00790842|580905023|FG004|Dose Level 1|Withdrawal by Subject|0|||
160866813|NCT00790842|580905024|FG005|Dose Level 1|Withdrawal by Subject|0|||
160866814|NCT00790842|580905025|FG006|Dose Level 1|Withdrawal by Subject|0|||
160866815|NCT00790842|580905026|FG007|Dose Level 1|Withdrawal by Subject|0|||
160866816|NCT00790842|580905027|FG008|Dose Level 1|Withdrawal by Subject|0|||
160866817|NCT00790842|580905028|FG009|Dose Level 1|Withdrawal by Subject|0|||
160866818|NCT00790842|580905029|FG010|Dose Level 1|Withdrawal by Subject|0|||
160866819|NCT00790842|580905019|FG000|Dose Level 2|Death|0|||
160866820|NCT00790842|580905020|FG001|Dose Level 2|Death|1|||
160866821|NCT00790842|580905021|FG002|Dose Level 2|Death|0|||
160866822|NCT00790842|580905022|FG003|Dose Level 2|Death|0|||
160866823|NCT00790842|580905023|FG004|Dose Level 2|Death|1|||
160866824|NCT00790842|580905024|FG005|Dose Level 2|Death|0|||
160866825|NCT00790842|580905025|FG006|Dose Level 2|Death|0|||
160866826|NCT00790842|580905026|FG007|Dose Level 2|Death|0|||
160866827|NCT00790842|580905027|FG008|Dose Level 2|Death|0|||
160866828|NCT00790842|580905028|FG009|Dose Level 2|Death|0|||
160866829|NCT00790842|580905029|FG010|Dose Level 2|Death|0|||
160866830|NCT00790842|580905019|FG000|Dose Level 2|Physician Decision|0|||
160866831|NCT00790842|580905020|FG001|Dose Level 2|Physician Decision|1|||
160866832|NCT00790842|580905021|FG002|Dose Level 2|Physician Decision|0|||
160866833|NCT00790842|580905022|FG003|Dose Level 2|Physician Decision|0|||
160866834|NCT00790842|580905023|FG004|Dose Level 2|Physician Decision|0|||
160866835|NCT00790842|580905024|FG005|Dose Level 2|Physician Decision|0|||
160866836|NCT00790842|580905025|FG006|Dose Level 2|Physician Decision|0|||
160866837|NCT00790842|580905026|FG007|Dose Level 2|Physician Decision|0|||
160866838|NCT00790842|580905027|FG008|Dose Level 2|Physician Decision|0|||
160866839|NCT00790842|580905028|FG009|Dose Level 2|Physician Decision|0|||
160866840|NCT00790842|580905029|FG010|Dose Level 2|Physician Decision|0|||
160866841|NCT00790842|580905019|FG000|Dose Level 2|Withdrawal by Subject|0|||
160866842|NCT00790842|580905020|FG001|Dose Level 2|Withdrawal by Subject|1|||
160866843|NCT00790842|580905021|FG002|Dose Level 2|Withdrawal by Subject|0|||
160866844|NCT00790842|580905022|FG003|Dose Level 2|Withdrawal by Subject|0|||
160866845|NCT00790842|580905023|FG004|Dose Level 2|Withdrawal by Subject|0|||
160866846|NCT00790842|580905024|FG005|Dose Level 2|Withdrawal by Subject|0|||
160866847|NCT00790842|580905025|FG006|Dose Level 2|Withdrawal by Subject|0|||
160866848|NCT00790842|580905026|FG007|Dose Level 2|Withdrawal by Subject|0|||
160866849|NCT00790842|580905027|FG008|Dose Level 2|Withdrawal by Subject|0|||
160866850|NCT00790842|580905028|FG009|Dose Level 2|Withdrawal by Subject|0|||
160866851|NCT00790842|580905029|FG010|Dose Level 2|Withdrawal by Subject|0|||
160866852|NCT00790842|580905019|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866853|NCT00790842|580905020|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866854|NCT00790842|580905021|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866855|NCT00790842|580905022|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866856|NCT00790842|580905023|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866857|NCT00790842|580905024|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866858|NCT00790842|580905025|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866859|NCT00790842|580905026|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866860|NCT00790842|580905027|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
160866861|NCT00790842|580905028|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866862|NCT00790842|580905029|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
160866863|NCT00790842|580905019|FG000|Dose Level 3|Adverse Event|0|||
160866864|NCT00790842|580905020|FG001|Dose Level 3|Adverse Event|0|||
160866865|NCT00790842|580905021|FG002|Dose Level 3|Adverse Event|1|||
160866866|NCT00790842|580905022|FG003|Dose Level 3|Adverse Event|0|||
160866867|NCT00790842|580905023|FG004|Dose Level 3|Adverse Event|0|||
160866868|NCT00790842|580905024|FG005|Dose Level 3|Adverse Event|0|||
160866869|NCT00790842|580905025|FG006|Dose Level 3|Adverse Event|0|||
160866870|NCT00790842|580905026|FG007|Dose Level 3|Adverse Event|0|||
160866871|NCT00790842|580905027|FG008|Dose Level 3|Adverse Event|0|||
160866872|NCT00790842|580905028|FG009|Dose Level 3|Adverse Event|0|||
160866873|NCT00790842|580905029|FG010|Dose Level 3|Adverse Event|0|||
160866874|NCT00790842|580905019|FG000|Dose Level 3|Withdrawal by Subject|0|||
160866875|NCT00790842|580905020|FG001|Dose Level 3|Withdrawal by Subject|0|||
160866876|NCT00790842|580905021|FG002|Dose Level 3|Withdrawal by Subject|3|||
160866877|NCT00790842|580905022|FG003|Dose Level 3|Withdrawal by Subject|0|||
160866878|NCT00790842|580905023|FG004|Dose Level 3|Withdrawal by Subject|0|||
160866879|NCT00790842|580905024|FG005|Dose Level 3|Withdrawal by Subject|0|||
160866880|NCT00790842|580905025|FG006|Dose Level 3|Withdrawal by Subject|0|||
160866881|NCT00790842|580905026|FG007|Dose Level 3|Withdrawal by Subject|0|||
160866882|NCT00790842|580905027|FG008|Dose Level 3|Withdrawal by Subject|0|||
160866883|NCT00790842|580905028|FG009|Dose Level 3|Withdrawal by Subject|2|||
160866884|NCT00790842|580905029|FG010|Dose Level 3|Withdrawal by Subject|0|||
160866885|NCT00790842|580905019|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866886|NCT00790842|580905020|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866887|NCT00790842|580905021|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866888|NCT00790842|580905022|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866889|NCT00790842|580905023|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866890|NCT00790842|580905024|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
160866891|NCT00790842|580905025|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866892|NCT00790842|580905026|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866893|NCT00790842|580905027|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866894|NCT00790842|580905028|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866895|NCT00790842|580905029|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
160866896|NCT00790842|580905019|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866897|NCT00790842|580905020|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866898|NCT00790842|580905021|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
160866899|NCT00790842|580905022|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866900|NCT00790842|580905023|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866901|NCT00790842|580905024|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866902|NCT00790842|580905025|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866903|NCT00790842|580905026|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866904|NCT00790842|580905027|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866905|NCT00790842|580905028|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866906|NCT00790842|580905029|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
160866907|NCT00790842|580905019|FG000|Dose Level 4|Adverse Event|0|||
160866908|NCT00790842|580905020|FG001|Dose Level 4|Adverse Event|0|||
160866909|NCT00790842|580905021|FG002|Dose Level 4|Adverse Event|0|||
160866910|NCT00790842|580905022|FG003|Dose Level 4|Adverse Event|0|||
160866911|NCT00790842|580905023|FG004|Dose Level 4|Adverse Event|0|||
160866912|NCT00790842|580905024|FG005|Dose Level 4|Adverse Event|0|||
160866913|NCT00790842|580905025|FG006|Dose Level 4|Adverse Event|1|||
160866914|NCT00790842|580905026|FG007|Dose Level 4|Adverse Event|0|||
160866915|NCT00790842|580905027|FG008|Dose Level 4|Adverse Event|0|||
160866916|NCT00790842|580905028|FG009|Dose Level 4|Adverse Event|0|||
160866917|NCT00790842|580905029|FG010|Dose Level 4|Adverse Event|0|||
160866918|NCT00790842|580905019|FG000|Dose Level 4|Physician Decision|0|||
160866919|NCT00790842|580905020|FG001|Dose Level 4|Physician Decision|0|||
160866920|NCT00790842|580905021|FG002|Dose Level 4|Physician Decision|0|||
160866921|NCT00790842|580905022|FG003|Dose Level 4|Physician Decision|0|||
160866922|NCT00790842|580905023|FG004|Dose Level 4|Physician Decision|0|||
160866923|NCT00790842|580905024|FG005|Dose Level 4|Physician Decision|0|||
160866924|NCT00790842|580905025|FG006|Dose Level 4|Physician Decision|1|||
160866925|NCT00790842|580905026|FG007|Dose Level 4|Physician Decision|0|||
160866926|NCT00790842|580905027|FG008|Dose Level 4|Physician Decision|0|||
160866927|NCT00790842|580905028|FG009|Dose Level 4|Physician Decision|0|||
160866928|NCT00790842|580905029|FG010|Dose Level 4|Physician Decision|1|||
160866929|NCT00790842|580905019|FG000|Dose Level 4|Withdrawal by Subject|0|||
160866930|NCT00790842|580905020|FG001|Dose Level 4|Withdrawal by Subject|0|||
160866931|NCT00790842|580905021|FG002|Dose Level 4|Withdrawal by Subject|0|||
160866932|NCT00790842|580905022|FG003|Dose Level 4|Withdrawal by Subject|0|||
160866933|NCT00790842|580905023|FG004|Dose Level 4|Withdrawal by Subject|0|||
160866934|NCT00790842|580905024|FG005|Dose Level 4|Withdrawal by Subject|0|||
160866935|NCT00790842|580905025|FG006|Dose Level 4|Withdrawal by Subject|0|||
160866936|NCT00790842|580905026|FG007|Dose Level 4|Withdrawal by Subject|0|||
160866937|NCT00790842|580905027|FG008|Dose Level 4|Withdrawal by Subject|0|||
160866938|NCT00790842|580905028|FG009|Dose Level 4|Withdrawal by Subject|0|||
160866939|NCT00790842|580905029|FG010|Dose Level 4|Withdrawal by Subject|1|||
160866940|NCT00790842|580905019|FG000|Expansion Cohort|Adverse Event|0|||
160866941|NCT00790842|580905020|FG001|Expansion Cohort|Adverse Event|0|||
160866942|NCT00790842|580905021|FG002|Expansion Cohort|Adverse Event|0|||
160866943|NCT00790842|580905022|FG003|Expansion Cohort|Adverse Event|0|||
160866944|NCT00790842|580905023|FG004|Expansion Cohort|Adverse Event|0|||
160866945|NCT00790842|580905024|FG005|Expansion Cohort|Adverse Event|0|||
160866946|NCT00790842|580905025|FG006|Expansion Cohort|Adverse Event|1|||
160866947|NCT00790842|580905026|FG007|Expansion Cohort|Adverse Event|0|||
160866948|NCT00790842|580905027|FG008|Expansion Cohort|Adverse Event|0|||
160866949|NCT00790842|580905028|FG009|Expansion Cohort|Adverse Event|0|||
160866950|NCT00790842|580905029|FG010|Expansion Cohort|Adverse Event|0|||
160866951|NCT00790842|580905019|FG000|Expansion Cohort|Death|0|||
160866952|NCT00790842|580905020|FG001|Expansion Cohort|Death|0|||
160866953|NCT00790842|580905021|FG002|Expansion Cohort|Death|2|||
160866954|NCT00790842|580905022|FG003|Expansion Cohort|Death|0|||
160866955|NCT00790842|580905023|FG004|Expansion Cohort|Death|0|||
160866956|NCT00790842|580905024|FG005|Expansion Cohort|Death|0|||
160866957|NCT00790842|580905025|FG006|Expansion Cohort|Death|0|||
160866958|NCT00790842|580905026|FG007|Expansion Cohort|Death|0|||
160866959|NCT00790842|580905027|FG008|Expansion Cohort|Death|0|||
160866960|NCT00790842|580905028|FG009|Expansion Cohort|Death|0|||
160866961|NCT00790842|580905029|FG010|Expansion Cohort|Death|0|||
160866962|NCT00790842|580905019|FG000|Expansion Cohort|Physician Decision|0|||
160866963|NCT00790842|580905020|FG001|Expansion Cohort|Physician Decision|0|||
160866964|NCT00790842|580905021|FG002|Expansion Cohort|Physician Decision|1|||
160866965|NCT00790842|580905022|FG003|Expansion Cohort|Physician Decision|0|||
160866966|NCT00790842|580905023|FG004|Expansion Cohort|Physician Decision|0|||
160866967|NCT00790842|580905024|FG005|Expansion Cohort|Physician Decision|0|||
160866968|NCT00790842|580905025|FG006|Expansion Cohort|Physician Decision|0|||
160866969|NCT00790842|580905026|FG007|Expansion Cohort|Physician Decision|0|||
160866970|NCT00790842|580905027|FG008|Expansion Cohort|Physician Decision|0|||
160866971|NCT00790842|580905028|FG009|Expansion Cohort|Physician Decision|0|||
160866972|NCT00790842|580905029|FG010|Expansion Cohort|Physician Decision|0|||
160866973|NCT00790842|580905019|FG000|Expansion Cohort|Withdrawal by Subject|0|||
160866974|NCT00790842|580905020|FG001|Expansion Cohort|Withdrawal by Subject|0|||
160866975|NCT00790842|580905021|FG002|Expansion Cohort|Withdrawal by Subject|3|||
160866976|NCT00790842|580905022|FG003|Expansion Cohort|Withdrawal by Subject|0|||
160866977|NCT00790842|580905023|FG004|Expansion Cohort|Withdrawal by Subject|0|||
160866978|NCT00790842|580905024|FG005|Expansion Cohort|Withdrawal by Subject|0|||
160866979|NCT00790842|580905025|FG006|Expansion Cohort|Withdrawal by Subject|0|||
160866980|NCT00790842|580905026|FG007|Expansion Cohort|Withdrawal by Subject|0|||
160866981|NCT00790842|580905027|FG008|Expansion Cohort|Withdrawal by Subject|0|||
160866982|NCT00790842|580905028|FG009|Expansion Cohort|Withdrawal by Subject|0|||
160866983|NCT00790842|580905029|FG010|Expansion Cohort|Withdrawal by Subject|0|||
160866984|NCT00790842|580905019|FG000|Expansion Cohort|Study Closure|0|||
160866985|NCT00790842|580905020|FG001|Expansion Cohort|Study Closure|0|||
160866986|NCT00790842|580905021|FG002|Expansion Cohort|Study Closure|1|||
160866987|NCT00790842|580905022|FG003|Expansion Cohort|Study Closure|0|||
160866988|NCT00790842|580905023|FG004|Expansion Cohort|Study Closure|0|||
160866989|NCT00790842|580905024|FG005|Expansion Cohort|Study Closure|0|||
160866990|NCT00790842|580905025|FG006|Expansion Cohort|Study Closure|0|||
160866991|NCT00790842|580905026|FG007|Expansion Cohort|Study Closure|0|||
160866992|NCT00790842|580905027|FG008|Expansion Cohort|Study Closure|0|||
160866993|NCT00790842|580905028|FG009|Expansion Cohort|Study Closure|0|||
160866994|NCT00790842|580905029|FG010|Expansion Cohort|Study Closure|0|||
160866995|NCT05029362|580905030|FG000|Overall Study|Lost to Follow-up|9|||
160866996|NCT00419952|580905032|FG000|Overall Study|Adverse Event|8|||
160866997|NCT00419952|580905033|FG001|Overall Study|Adverse Event|10|||
160866998|NCT00419952|580905032|FG000|Overall Study|Withdrawal by Subject|44|||
160866999|NCT00419952|580905033|FG001|Overall Study|Withdrawal by Subject|43|||
160867000|NCT00419952|580905032|FG000|Overall Study|Lost to Follow-up|43|||
160867001|NCT00419952|580905033|FG001|Overall Study|Lost to Follow-up|34|||
160867002|NCT00419952|580905032|FG000|Overall Study|Protocol Violation|32|||
160867003|NCT00419952|580905033|FG001|Overall Study|Protocol Violation|24|||
160867004|NCT00419952|580905032|FG000|Overall Study|Pregnancy|4|||
160867005|NCT00419952|580905033|FG001|Overall Study|Pregnancy|2|||
160867006|NCT00419952|580905032|FG000|Overall Study|Physician Decision|1|||
160867007|NCT00419952|580905033|FG001|Overall Study|Physician Decision|3|||
160867008|NCT00419952|580905032|FG000|Overall Study|Incorrectly enrolled|10|||
160867009|NCT00419952|580905033|FG001|Overall Study|Incorrectly enrolled|3|||
160867010|NCT00419952|580905032|FG000|Overall Study|Intake of prohibited medication|2|||
160867011|NCT00419952|580905033|FG001|Overall Study|Intake of prohibited medication|2|||
160867012|NCT00419952|580905032|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
160867013|NCT00419952|580905033|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
160867014|NCT00419952|580905032|FG000|Overall Study|Diary or medication non-compliance|2|||
160867015|NCT00419952|580905033|FG001|Overall Study|Diary or medication non-compliance|4|||
160867016|NCT00419952|580905032|FG000|Overall Study|Abnormal ECG|1|||
160867017|NCT00419952|580905033|FG001|Overall Study|Abnormal ECG|0|||
160867018|NCT03126591|580905038|FG000|Overall Study|Death|6|||
160867019|NCT03126591|580905039|FG001|Overall Study|Death|3|||
160867020|NCT03126591|580905040|FG002|Overall Study|Death|17|||
160867021|NCT03126591|580905038|FG000|Overall Study|Progressive Disease|0|||
160867022|NCT03126591|580905039|FG001|Overall Study|Progressive Disease|1|||
160867023|NCT03126591|580905040|FG002|Overall Study|Progressive Disease|2|||
160867024|NCT03126591|580905038|FG000|Overall Study|Terminated by Sponsor|0|||
160867025|NCT03126591|580905039|FG001|Overall Study|Terminated by Sponsor|1|||
160867026|NCT03126591|580905040|FG002|Overall Study|Terminated by Sponsor|4|||
160867027|NCT03126591|580905038|FG000|Overall Study|Withdrawal by Subject|1|||
160867028|NCT03126591|580905039|FG001|Overall Study|Withdrawal by Subject|1|||
160867029|NCT03126591|580905040|FG002|Overall Study|Withdrawal by Subject|4|||
160867030|NCT01285323|580905041|FG000|Overall Study|Adverse Event|9|||
160867031|NCT01285323|580905042|FG001|Overall Study|Adverse Event|8|||
160867032|NCT01285323|580905041|FG000|Overall Study|Lack of Efficacy|4|||
160867033|NCT01285323|580905042|FG001|Overall Study|Lack of Efficacy|2|||
160867034|NCT01285323|580905041|FG000|Overall Study|Withdrawal by Subject|15|||
160867035|NCT01285323|580905042|FG001|Overall Study|Withdrawal by Subject|11|||
160867036|NCT01285323|580905041|FG000|Overall Study|Protocol Violation|1|||
160867037|NCT01285323|580905042|FG001|Overall Study|Protocol Violation|2|||
160867038|NCT01285323|580905041|FG000|Overall Study|Non-compliance with study procedures|2|||
160867039|NCT01285323|580905042|FG001|Overall Study|Non-compliance with study procedures|3|||
160867040|NCT01285323|580905041|FG000|Overall Study|Lost to Follow-up|1|||
160867041|NCT01285323|580905042|FG001|Overall Study|Lost to Follow-up|1|||
160867042|NCT01285323|580905041|FG000|Overall Study|Other|1|||
160867043|NCT01285323|580905042|FG001|Overall Study|Other|3|||
160867044|NCT02351817|580905043|FG000|Period 1|Adverse Event|1|||
160867045|NCT02351817|580905044|FG001|Period 1|Adverse Event|2|||
160867046|NCT02351817|580905043|FG000|Period 1|Lack of Efficacy|0|||
160867047|NCT02351817|580905044|FG001|Period 1|Lack of Efficacy|1|||
160867048|NCT02351817|580905043|FG000|Period 2|Adverse Event|0|||
160867049|NCT02351817|580905044|FG001|Period 2|Adverse Event|2|||
160867050|NCT02351817|580905043|FG000|Period 2|Protocol Violation|1|||
160867051|NCT02351817|580905044|FG001|Period 2|Protocol Violation|0|||
160867052|NCT02488915|580905047|FG000|Overall Study|Death|21|||
160867053|NCT02488915|580905047|FG000|Overall Study|Lost to Follow-up|4|||
160867054|NCT02488915|580905047|FG000|Overall Study|Withdrawal by Subject|1|||
160867055|NCT01208207|580905051|FG000|Part I|Adverse Event|19|||
160867056|NCT01208207|580905052|FG001|Part I|Adverse Event|2|||
160867057|NCT01208207|580905053|FG002|Part I|Adverse Event|6|||
160867058|NCT01208207|580905054|FG003|Part I|Adverse Event|0|||
160867059|NCT01208207|580905055|FG004|Part I|Adverse Event|0|||
160867060|NCT01208207|580905056|FG005|Part I|Adverse Event|0|||
160867061|NCT01208207|580905057|FG006|Part I|Adverse Event|0|||
160867062|NCT01208207|580905051|FG000|Part I|Lack of Efficacy|21|||
160867063|NCT01208207|580905052|FG001|Part I|Lack of Efficacy|3|||
160867064|NCT01208207|580905053|FG002|Part I|Lack of Efficacy|2|||
160867065|NCT01208207|580905054|FG003|Part I|Lack of Efficacy|0|||
160867066|NCT01208207|580905055|FG004|Part I|Lack of Efficacy|0|||
160867067|NCT01208207|580905056|FG005|Part I|Lack of Efficacy|0|||
160867068|NCT01208207|580905057|FG006|Part I|Lack of Efficacy|0|||
160867069|NCT01208207|580905051|FG000|Part I|Lost to Follow-up|6|||
160867070|NCT01208207|580905052|FG001|Part I|Lost to Follow-up|1|||
160867071|NCT01208207|580905053|FG002|Part I|Lost to Follow-up|0|||
160867072|NCT01208207|580905054|FG003|Part I|Lost to Follow-up|0|||
160867073|NCT01208207|580905055|FG004|Part I|Lost to Follow-up|0|||
161214624|NCT01393990|582169413|FG017|Overall Study|Withdrawal by Subject|0|||
161214625|NCT00331630|582169422|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
161214626|NCT00331630|582169422|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
161214627|NCT00331630|582169422|FG000|Follow up for 5 Years|Death|5|||
161214628|NCT00331630|582169422|FG000|Follow up for 5 Years|Data collection was stopped|24|||
160867074|NCT01208207|580905056|FG005|Part I|Lost to Follow-up|0|||
160867075|NCT01208207|580905057|FG006|Part I|Lost to Follow-up|0|||
160867076|NCT01208207|580905051|FG000|Part I|Non-Compliance With Study Drug|1|||
160867077|NCT01208207|580905052|FG001|Part I|Non-Compliance With Study Drug|0|||
160867078|NCT01208207|580905053|FG002|Part I|Non-Compliance With Study Drug|1|||
160867079|NCT01208207|580905054|FG003|Part I|Non-Compliance With Study Drug|0|||
160867080|NCT01208207|580905055|FG004|Part I|Non-Compliance With Study Drug|0|||
160867081|NCT01208207|580905056|FG005|Part I|Non-Compliance With Study Drug|0|||
160867082|NCT01208207|580905057|FG006|Part I|Non-Compliance With Study Drug|0|||
160867083|NCT01208207|580905051|FG000|Part I|Physician Decision|0|||
160867084|NCT01208207|580905052|FG001|Part I|Physician Decision|1|||
160867085|NCT01208207|580905053|FG002|Part I|Physician Decision|0|||
160867086|NCT01208207|580905054|FG003|Part I|Physician Decision|0|||
160867087|NCT01208207|580905055|FG004|Part I|Physician Decision|0|||
160867088|NCT01208207|580905056|FG005|Part I|Physician Decision|0|||
160867089|NCT01208207|580905057|FG006|Part I|Physician Decision|0|||
161214629|NCT00720798|582169423|FG000|Overall Study|Adverse Event|304|||
160867090|NCT01208207|580905051|FG000|Part I|Progressive Disease|1|||
160867091|NCT01208207|580905052|FG001|Part I|Progressive Disease|0|||
160867092|NCT01208207|580905053|FG002|Part I|Progressive Disease|0|||
160867093|NCT01208207|580905054|FG003|Part I|Progressive Disease|0|||
160867094|NCT01208207|580905055|FG004|Part I|Progressive Disease|0|||
160867095|NCT01208207|580905056|FG005|Part I|Progressive Disease|0|||
160867096|NCT01208207|580905057|FG006|Part I|Progressive Disease|0|||
160867097|NCT01208207|580905051|FG000|Part I|Protocol Violation|8|||
160867098|NCT01208207|580905052|FG001|Part I|Protocol Violation|0|||
160867099|NCT01208207|580905053|FG002|Part I|Protocol Violation|2|||
160867100|NCT01208207|580905054|FG003|Part I|Protocol Violation|0|||
160867101|NCT01208207|580905055|FG004|Part I|Protocol Violation|0|||
160867102|NCT01208207|580905056|FG005|Part I|Protocol Violation|0|||
160867103|NCT01208207|580905057|FG006|Part I|Protocol Violation|0|||
160867104|NCT01208207|580905051|FG000|Part I|Withdrawal by Subject|14|||
160867105|NCT01208207|580905052|FG001|Part I|Withdrawal by Subject|4|||
160867106|NCT01208207|580905053|FG002|Part I|Withdrawal by Subject|4|||
160867107|NCT01208207|580905054|FG003|Part I|Withdrawal by Subject|0|||
160867108|NCT01208207|580905055|FG004|Part I|Withdrawal by Subject|0|||
160867109|NCT01208207|580905056|FG005|Part I|Withdrawal by Subject|0|||
160867110|NCT01208207|580905057|FG006|Part I|Withdrawal by Subject|0|||
160867111|NCT01208207|580905051|FG000|Part II|Withdrawal by Subject|0|||
160867112|NCT01208207|580905052|FG001|Part II|Withdrawal by Subject|0|||
160867113|NCT01208207|580905053|FG002|Part II|Withdrawal by Subject|0|||
160867114|NCT01208207|580905054|FG003|Part II|Withdrawal by Subject|10|||
160867115|NCT01208207|580905055|FG004|Part II|Withdrawal by Subject|9|||
160867116|NCT01208207|580905056|FG005|Part II|Withdrawal by Subject|3|||
160867117|NCT01208207|580905057|FG006|Part II|Withdrawal by Subject|5|||
160867118|NCT01208207|580905051|FG000|Part II|Adverse Event|0|||
160867119|NCT01208207|580905052|FG001|Part II|Adverse Event|0|||
160867120|NCT01208207|580905053|FG002|Part II|Adverse Event|0|||
160867121|NCT01208207|580905054|FG003|Part II|Adverse Event|5|||
160867122|NCT01208207|580905055|FG004|Part II|Adverse Event|9|||
160867123|NCT01208207|580905056|FG005|Part II|Adverse Event|4|||
160867124|NCT01208207|580905057|FG006|Part II|Adverse Event|2|||
160867125|NCT01208207|580905051|FG000|Part II|Lack of Efficacy|0|||
160867126|NCT01208207|580905052|FG001|Part II|Lack of Efficacy|0|||
160867127|NCT01208207|580905053|FG002|Part II|Lack of Efficacy|0|||
160867128|NCT01208207|580905054|FG003|Part II|Lack of Efficacy|6|||
160867129|NCT01208207|580905055|FG004|Part II|Lack of Efficacy|4|||
160867130|NCT01208207|580905056|FG005|Part II|Lack of Efficacy|3|||
160867131|NCT01208207|580905057|FG006|Part II|Lack of Efficacy|3|||
160867132|NCT01208207|580905051|FG000|Part II|Lost to Follow-up|0|||
160867133|NCT01208207|580905052|FG001|Part II|Lost to Follow-up|0|||
160867134|NCT01208207|580905053|FG002|Part II|Lost to Follow-up|0|||
160867135|NCT01208207|580905054|FG003|Part II|Lost to Follow-up|4|||
160867136|NCT01208207|580905055|FG004|Part II|Lost to Follow-up|0|||
160867137|NCT01208207|580905056|FG005|Part II|Lost to Follow-up|2|||
160867138|NCT01208207|580905057|FG006|Part II|Lost to Follow-up|1|||
160867139|NCT01208207|580905051|FG000|Part II|Non-Compliance With Study Drug|0|||
160867140|NCT01208207|580905052|FG001|Part II|Non-Compliance With Study Drug|0|||
160867141|NCT01208207|580905053|FG002|Part II|Non-Compliance With Study Drug|0|||
160867142|NCT01208207|580905054|FG003|Part II|Non-Compliance With Study Drug|4|||
160867143|NCT01208207|580905055|FG004|Part II|Non-Compliance With Study Drug|1|||
160867144|NCT01208207|580905056|FG005|Part II|Non-Compliance With Study Drug|1|||
160867145|NCT01208207|580905057|FG006|Part II|Non-Compliance With Study Drug|0|||
160867146|NCT01208207|580905051|FG000|Part II|Physician Decision|0|||
160867147|NCT01208207|580905052|FG001|Part II|Physician Decision|0|||
160867148|NCT01208207|580905053|FG002|Part II|Physician Decision|0|||
160867149|NCT01208207|580905054|FG003|Part II|Physician Decision|1|||
160867150|NCT01208207|580905055|FG004|Part II|Physician Decision|0|||
160867151|NCT01208207|580905056|FG005|Part II|Physician Decision|2|||
160867152|NCT01208207|580905057|FG006|Part II|Physician Decision|0|||
160867153|NCT01208207|580905051|FG000|Part II|Protocol Violation|0|||
160867154|NCT01208207|580905052|FG001|Part II|Protocol Violation|0|||
160867155|NCT01208207|580905053|FG002|Part II|Protocol Violation|0|||
160867156|NCT01208207|580905054|FG003|Part II|Protocol Violation|1|||
160867157|NCT01208207|580905055|FG004|Part II|Protocol Violation|0|||
160867158|NCT01208207|580905056|FG005|Part II|Protocol Violation|0|||
160867159|NCT01208207|580905057|FG006|Part II|Protocol Violation|0|||
160867160|NCT01208207|580905051|FG000|Part II|Technical Problems|0|||
160867161|NCT01208207|580905052|FG001|Part II|Technical Problems|0|||
160867162|NCT01208207|580905053|FG002|Part II|Technical Problems|0|||
160867163|NCT01208207|580905054|FG003|Part II|Technical Problems|1|||
160867164|NCT01208207|580905055|FG004|Part II|Technical Problems|0|||
160867165|NCT01208207|580905056|FG005|Part II|Technical Problems|1|||
160867166|NCT01208207|580905057|FG006|Part II|Technical Problems|0|||
160867167|NCT04041414|580905060|FG000|Overall Study|Lost to Follow-up|1|||
160867168|NCT04041414|580905061|FG001|Overall Study|Lost to Follow-up|2|||
160867169|NCT00665652|580905062|FG000|Overall Study|Adverse Event|4|||
160867170|NCT00665652|580905062|FG000|Overall Study|Death|1|||
160867171|NCT00665652|580905062|FG000|Overall Study|No longer met inclusion criteria.|1|||
160867172|NCT01782378|580905065|FG000|First Series|Lost to Follow-up|7|||
160867173|NCT01782378|580905066|FG001|First Series|Lost to Follow-up|8|||
160867174|NCT01782378|580905065|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
160867175|NCT01782378|580905066|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
160867176|NCT01782378|580905065|FG000|Second Series|Lost to Follow-up|8|||
160867177|NCT01782378|580905066|FG001|Second Series|Lost to Follow-up|7|||
160867178|NCT01782378|580905065|FG000|Second Series|Did not choose to complete S2 Optional|18|||
160867179|NCT01782378|580905066|FG001|Second Series|Did not choose to complete S2 Optional|0|||
160867180|NCT00830440|580905067|FG000|Overall Study|Protocol Violation|1|||
160867181|NCT00830440|580905068|FG001|Overall Study|Protocol Violation|0|||
160867182|NCT00830440|580905067|FG000|Overall Study|Withdrawal by Subject|1|||
160867183|NCT00830440|580905068|FG001|Overall Study|Withdrawal by Subject|0|||
160867184|NCT00830440|580905067|FG000|Overall Study|unsuccessful procedure|4|||
160867185|NCT00830440|580905068|FG001|Overall Study|unsuccessful procedure|0|||
160867186|NCT00830440|580905067|FG000|Overall Study|Adverse Event|2|||
160867187|NCT00830440|580905068|FG001|Overall Study|Adverse Event|0|||
160867188|NCT01656408|580905069|FG000|Overall Study|Adverse Event|0|||
160867189|NCT01656408|580905070|FG001|Overall Study|Adverse Event|0|||
160867190|NCT01656408|580905071|FG002|Overall Study|Adverse Event|1|||
160867191|NCT01656408|580905072|FG003|Overall Study|Adverse Event|0|||
160867192|NCT01656408|580905073|FG004|Overall Study|Adverse Event|0|||
160867193|NCT01656408|580905074|FG005|Overall Study|Adverse Event|1|||
160867194|NCT01656408|580905075|FG006|Overall Study|Adverse Event|1|||
160867195|NCT01656408|580905076|FG007|Overall Study|Adverse Event|0|||
160867196|NCT01656408|580905077|FG008|Overall Study|Adverse Event|1|||
160867197|NCT01656408|580905078|FG009|Overall Study|Adverse Event|0|||
160867198|NCT01656408|580905069|FG000|Overall Study|Physician Decision|1|||
160867199|NCT01656408|580905070|FG001|Overall Study|Physician Decision|0|||
160867200|NCT01656408|580905071|FG002|Overall Study|Physician Decision|1|||
160867201|NCT01656408|580905072|FG003|Overall Study|Physician Decision|0|||
160867202|NCT01656408|580905073|FG004|Overall Study|Physician Decision|1|||
160867203|NCT01656408|580905074|FG005|Overall Study|Physician Decision|1|||
160867204|NCT01656408|580905075|FG006|Overall Study|Physician Decision|0|||
160867205|NCT01656408|580905076|FG007|Overall Study|Physician Decision|1|||
160867206|NCT01656408|580905077|FG008|Overall Study|Physician Decision|1|||
160867207|NCT01656408|580905078|FG009|Overall Study|Physician Decision|3|||
160867208|NCT02420821|580905080|FG000|Overall Study|Lost to Follow-up|6|||
160867209|NCT02420821|580905081|FG001|Overall Study|Lost to Follow-up|6|||
160867210|NCT02420821|580905080|FG000|Overall Study|Non-compliance|0|||
160867211|NCT02420821|580905081|FG001|Overall Study|Non-compliance|2|||
160867212|NCT02420821|580905080|FG000|Overall Study|Physician Decision|6|||
160867213|NCT02420821|580905081|FG001|Overall Study|Physician Decision|2|||
160867214|NCT02420821|580905080|FG000|Overall Study|Withdrawal by Subject|32|||
160867215|NCT02420821|580905081|FG001|Overall Study|Withdrawal by Subject|25|||
160867216|NCT02420821|580905080|FG000|Overall Study|Death|270|||
160867217|NCT02420821|580905081|FG001|Overall Study|Death|263|||
160867218|NCT02420821|580905080|FG000|Overall Study|Study Terminated By Sponsor|145|||
160867219|NCT02420821|580905081|FG001|Overall Study|Study Terminated By Sponsor|149|||
160867220|NCT02420821|580905080|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
160867221|NCT02420821|580905081|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
160867222|NCT02420821|580905080|FG000|Overall Study|Adverse Event|0|||
160867223|NCT02420821|580905081|FG001|Overall Study|Adverse Event|1|||
160867224|NCT02420821|580905080|FG000|Overall Study|Protinuria|0|||
160867225|NCT02420821|580905081|FG001|Overall Study|Protinuria|1|||
160867226|NCT02420821|580905080|FG000|Overall Study|Progressive Disease|1|||
160867227|NCT02420821|580905081|FG001|Overall Study|Progressive Disease|1|||
160867228|NCT02420821|580905080|FG000|Overall Study|Disease Progression|0|||
160867229|NCT02420821|580905081|FG001|Overall Study|Disease Progression|1|||
160867230|NCT02420821|580905080|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
160867231|NCT02420821|580905081|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
160867232|NCT03987503|580905085|FG000|Overall Study|Lost to Follow-up|20|||
160867233|NCT03987503|580905085|FG000|Overall Study|Withdrawal by Subject|2|||
160867234|NCT00926237|580905086|FG000|Overall Study|Withdrawal by Subject|2|||
160867235|NCT00926237|580905087|FG001|Overall Study|Withdrawal by Subject|1|||
160867236|NCT02446899|580906812|FG000|Overall Study|Adverse Event|4|||
160867237|NCT02446899|580906813|FG001|Overall Study|Adverse Event|7|||
160867238|NCT02446899|580906812|FG000|Overall Study|Condition Under Investigation Worsened|1|||
160867239|NCT02446899|580906813|FG001|Overall Study|Condition Under Investigation Worsened|4|||
160867240|NCT02446899|580906812|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
160867241|NCT02446899|580906813|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
160867242|NCT02446899|580906812|FG000|Overall Study|Lack of Efficacy|2|||
160867243|NCT02446899|580906813|FG001|Overall Study|Lack of Efficacy|8|||
160867244|NCT02446899|580906812|FG000|Overall Study|Lost to Follow-up|1|||
160867245|NCT02446899|580906813|FG001|Overall Study|Lost to Follow-up|3|||
160867246|NCT02446899|580906812|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
160867247|NCT02446899|580906813|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
161214630|NCT00720798|582169423|FG000|Overall Study|Death|39|||
160867248|NCT02446899|580906812|FG000|Overall Study|Withdrawal by Subject|11|||
160867249|NCT02446899|580906813|FG001|Overall Study|Withdrawal by Subject|19|||
160867250|NCT02446899|580906812|FG000|Overall Study|Miscellaneous|5|||
160867251|NCT02446899|580906813|FG001|Overall Study|Miscellaneous|4|||
160867252|NCT02446899|580906812|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160867253|NCT02446899|580906813|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
160867254|NCT01002339|580906814|FG000|Overall Study|Withdrawal by Subject|0|||
160867255|NCT01002339|580906815|FG001|Overall Study|Withdrawal by Subject|1|||
160867256|NCT01002339|580906816|FG002|Overall Study|Withdrawal by Subject|0|||
160867257|NCT01002339|580906814|FG000|Overall Study|Incorrect treatment assignment|0|||
160867258|NCT01002339|580906815|FG001|Overall Study|Incorrect treatment assignment|0|||
160867259|NCT01002339|580906816|FG002|Overall Study|Incorrect treatment assignment|1|||
160867260|NCT01002339|580906814|FG000|Overall Study|Protocol Violation|0|||
160867261|NCT01002339|580906815|FG001|Overall Study|Protocol Violation|0|||
160867262|NCT01002339|580906816|FG002|Overall Study|Protocol Violation|2|||
160867263|NCT01002339|580906814|FG000|Overall Study|Lung cancer detected before transplant|0|||
160867264|NCT01002339|580906815|FG001|Overall Study|Lung cancer detected before transplant|0|||
160867265|NCT01002339|580906816|FG002|Overall Study|Lung cancer detected before transplant|1|||
160867266|NCT01002339|580906814|FG000|Overall Study|Randomized. Not transplanted|0|||
160867267|NCT01002339|580906815|FG001|Overall Study|Randomized. Not transplanted|0|||
160867268|NCT01002339|580906816|FG002|Overall Study|Randomized. Not transplanted|1|||
160867269|NCT05661409|580906817|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
160867270|NCT05661409|580906818|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
160867271|NCT05661409|580906819|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
160867272|NCT05661409|580906820|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
160867273|NCT05661409|580906821|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
160867274|NCT05661409|580906822|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
160867275|NCT05661409|580906817|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
160867276|NCT05661409|580906818|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
160867277|NCT05661409|580906819|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
160867278|NCT05661409|580906820|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
160867279|NCT05661409|580906821|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
160867280|NCT05661409|580906822|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
160867281|NCT05661409|580906817|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
160867282|NCT05661409|580906818|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
160867283|NCT05661409|580906819|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
160867284|NCT05661409|580906820|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
160867285|NCT05661409|580906821|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
160867286|NCT05661409|580906822|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
160867287|NCT05661409|580906817|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867288|NCT05661409|580906818|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867289|NCT05661409|580906819|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867290|NCT05661409|580906820|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867291|NCT05661409|580906821|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
160867292|NCT05661409|580906822|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
160867293|NCT05661409|580906817|FG000|Overall Study|Miscommu-nication about administration|0|||
160867294|NCT05661409|580906818|FG001|Overall Study|Miscommu-nication about administration|0|||
160867295|NCT05661409|580906819|FG002|Overall Study|Miscommu-nication about administration|0|||
160867296|NCT05661409|580906820|FG003|Overall Study|Miscommu-nication about administration|0|||
160867297|NCT05661409|580906821|FG004|Overall Study|Miscommu-nication about administration|0|||
160867298|NCT05661409|580906822|FG005|Overall Study|Miscommu-nication about administration|1|||
160867299|NCT04730271|580906825|FG000|Overall Study|Adverse Event|0|||
160867300|NCT04730271|580906826|FG001|Overall Study|Adverse Event|2|||
160867301|NCT04730271|580906825|FG000|Overall Study|Withdrawal by Subject|1|||
160867302|NCT04730271|580906826|FG001|Overall Study|Withdrawal by Subject|1|||
160867303|NCT04730271|580906825|FG000|Overall Study|Protocol Violation|7|||
160867304|NCT04730271|580906826|FG001|Overall Study|Protocol Violation|13|||
160867305|NCT04730271|580906825|FG000|Overall Study|Lost to Follow-up|3|||
160867306|NCT04730271|580906826|FG001|Overall Study|Lost to Follow-up|3|||
160867307|NCT04730271|580906825|FG000|Overall Study|Death|1|||
160867308|NCT04730271|580906826|FG001|Overall Study|Death|0|||
160867309|NCT00998296|580906827|FG000|Overall Study|Progressive disease|0|||
160867310|NCT00998296|580906828|FG001|Overall Study|Progressive disease|1|||
160867311|NCT00998296|580906829|FG002|Overall Study|Progressive disease|0|||
160867312|NCT00998296|580906830|FG003|Overall Study|Progressive disease|0|||
160867313|NCT00998296|580906831|FG004|Overall Study|Progressive disease|0|||
160867314|NCT00998296|580906832|FG005|Overall Study|Progressive disease|0|||
160867315|NCT00998296|580906833|FG006|Overall Study|Progressive disease|1|||
160867316|NCT00998296|580906834|FG007|Overall Study|Progressive disease|0|||
160867317|NCT00998296|580906835|FG008|Overall Study|Progressive disease|0|||
160867318|NCT00998296|580906836|FG009|Overall Study|Progressive disease|14|||
161324348|NCT01408901|582573579|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
160867319|NCT00998296|580906837|FG010|Overall Study|Progressive disease|5|||
160867320|NCT00998296|580906827|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867321|NCT00998296|580906828|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867322|NCT00998296|580906829|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867323|NCT00998296|580906830|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867324|NCT00998296|580906831|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
160867325|NCT00998296|580906832|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867326|NCT00998296|580906833|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867327|NCT00998296|580906834|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
160867328|NCT00998296|580906835|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
160867329|NCT00998296|580906836|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867330|NCT00998296|580906837|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
160867331|NCT00998296|580906827|FG000|Overall Study|Other adverse event|0|||
160867332|NCT00998296|580906828|FG001|Overall Study|Other adverse event|0|||
160867333|NCT00998296|580906829|FG002|Overall Study|Other adverse event|0|||
160867334|NCT00998296|580906830|FG003|Overall Study|Other adverse event|0|||
160867335|NCT00998296|580906831|FG004|Overall Study|Other adverse event|1|||
160867336|NCT00998296|580906832|FG005|Overall Study|Other adverse event|0|||
160867337|NCT00998296|580906833|FG006|Overall Study|Other adverse event|0|||
160867338|NCT00998296|580906834|FG007|Overall Study|Other adverse event|0|||
160867339|NCT00998296|580906835|FG008|Overall Study|Other adverse event|0|||
160867340|NCT00998296|580906836|FG009|Overall Study|Other adverse event|1|||
160867341|NCT00998296|580906837|FG010|Overall Study|Other adverse event|2|||
160867342|NCT00998296|580906827|FG000|Overall Study|Refused to continue taking trial med.|0|||
160867343|NCT00998296|580906828|FG001|Overall Study|Refused to continue taking trial med.|0|||
160867344|NCT00998296|580906829|FG002|Overall Study|Refused to continue taking trial med.|0|||
160867345|NCT00998296|580906830|FG003|Overall Study|Refused to continue taking trial med.|0|||
160867346|NCT00998296|580906831|FG004|Overall Study|Refused to continue taking trial med.|0|||
160867347|NCT00998296|580906832|FG005|Overall Study|Refused to continue taking trial med.|0|||
160867348|NCT00998296|580906833|FG006|Overall Study|Refused to continue taking trial med.|0|||
160867349|NCT00998296|580906834|FG007|Overall Study|Refused to continue taking trial med.|0|||
160867350|NCT00998296|580906835|FG008|Overall Study|Refused to continue taking trial med.|0|||
160867351|NCT00998296|580906836|FG009|Overall Study|Refused to continue taking trial med.|2|||
160867352|NCT00998296|580906837|FG010|Overall Study|Refused to continue taking trial med.|0|||
160867353|NCT00998296|580906827|FG000|Overall Study|Reason other than those specified above|0|||
160867354|NCT00998296|580906828|FG001|Overall Study|Reason other than those specified above|0|||
160867355|NCT00998296|580906829|FG002|Overall Study|Reason other than those specified above|0|||
160867356|NCT00998296|580906830|FG003|Overall Study|Reason other than those specified above|0|||
160867357|NCT00998296|580906831|FG004|Overall Study|Reason other than those specified above|0|||
160867358|NCT00998296|580906832|FG005|Overall Study|Reason other than those specified above|0|||
160867359|NCT00998296|580906833|FG006|Overall Study|Reason other than those specified above|0|||
160867360|NCT00998296|580906834|FG007|Overall Study|Reason other than those specified above|0|||
160867361|NCT00998296|580906835|FG008|Overall Study|Reason other than those specified above|0|||
160867362|NCT00998296|580906836|FG009|Overall Study|Reason other than those specified above|1|||
160867363|NCT00998296|580906837|FG010|Overall Study|Reason other than those specified above|0|||
160867364|NCT04396639|580906840|FG000|Overall Study|Withdrawal by Subject|1|||
160867365|NCT04396639|580906840|FG000|Overall Study|Other|1|||
160867366|NCT01544335|580906841|FG000|Overall Study|Lost to Follow-up|27|||
160867367|NCT01544335|580906841|FG000|Overall Study|Death|4|||
160867368|NCT01544335|580906841|FG000|Overall Study|Disease progression|3|||
160867369|NCT01544335|580906841|FG000|Overall Study|Baseline Measurements not Available|19|||
160867370|NCT01532986|580906842|FG000|Overall Study|Death|9|||
160867371|NCT01532986|580906843|FG001|Overall Study|Death|9|||
160867372|NCT01532986|580906842|FG000|Overall Study|Withdrawal by Subject|7|||
160867373|NCT01532986|580906843|FG001|Overall Study|Withdrawal by Subject|10|||
160867374|NCT01532986|580906842|FG000|Overall Study|Physician Decision|7|||
160867375|NCT01532986|580906843|FG001|Overall Study|Physician Decision|5|||
160867376|NCT00885170|580906846|FG000|Overall Study|Adverse Event|12|||
160867377|NCT00885170|580906847|FG001|Overall Study|Adverse Event|4|||
160867378|NCT00885170|580906846|FG000|Overall Study|Excessive bone loss|6|||
160867379|NCT00885170|580906847|FG001|Overall Study|Excessive bone loss|3|||
160867380|NCT00885170|580906846|FG000|Overall Study|Lost to Follow-up|2|||
160867381|NCT00885170|580906847|FG001|Overall Study|Lost to Follow-up|1|||
160867382|NCT00885170|580906846|FG000|Overall Study|Physician Decision|2|||
160867383|NCT00885170|580906847|FG001|Overall Study|Physician Decision|1|||
160867384|NCT00885170|580906846|FG000|Overall Study|Protocol Violation|3|||
160867385|NCT00885170|580906847|FG001|Overall Study|Protocol Violation|1|||
160867386|NCT00885170|580906846|FG000|Overall Study|Withdrawal by Subject|13|||
160867387|NCT00885170|580906847|FG001|Overall Study|Withdrawal by Subject|13|||
160867388|NCT03771664|580906848|FG000|Overall Study|Adverse Event|1|||
160867389|NCT03771664|580906849|FG001|Overall Study|Adverse Event|0|||
160867390|NCT03771664|580906848|FG000|Overall Study|Lost to Follow-up|1|||
160867391|NCT03771664|580906849|FG001|Overall Study|Lost to Follow-up|0|||
160867392|NCT03771664|580906848|FG000|Overall Study|Withdrawal by Participant|1|||
160867393|NCT03771664|580906849|FG001|Overall Study|Withdrawal by Participant|4|||
160867394|NCT03771664|580906848|FG000|Overall Study|Randomized but not Treated|0|||
160867395|NCT03771664|580906849|FG001|Overall Study|Randomized but not Treated|1|||
160867396|NCT02120898|580906850|FG000|Overall Study|Withdrawal by Subject|4|||
160867397|NCT02120898|580906851|FG001|Overall Study|Withdrawal by Subject|2|||
160867398|NCT02120898|580906852|FG002|Overall Study|Withdrawal by Subject|2|||
160867399|NCT02120898|580906850|FG000|Overall Study|Non-compliance with study drug|3|||
160867400|NCT02120898|580906851|FG001|Overall Study|Non-compliance with study drug|0|||
160867401|NCT02120898|580906852|FG002|Overall Study|Non-compliance with study drug|0|||
160867402|NCT02120898|580906850|FG000|Overall Study|Adverse Event|1|||
160867403|NCT02120898|580906851|FG001|Overall Study|Adverse Event|2|||
160867404|NCT02120898|580906852|FG002|Overall Study|Adverse Event|1|||
160867405|NCT02120898|580906850|FG000|Overall Study|Protocol Violation|1|||
160867406|NCT02120898|580906851|FG001|Overall Study|Protocol Violation|2|||
160867407|NCT02120898|580906852|FG002|Overall Study|Protocol Violation|0|||
160867408|NCT02120898|580906850|FG000|Overall Study|Lost to Follow-up|0|||
160867409|NCT02120898|580906851|FG001|Overall Study|Lost to Follow-up|0|||
161109488|NCT01940471|581789889|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
161109489|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
160867410|NCT02120898|580906852|FG002|Overall Study|Lost to Follow-up|1|||
160867411|NCT00561925|580906853|FG000|14 Day Lead-In Period|Adverse Event|38|||
160867412|NCT00561925|580906854|FG001|14 Day Lead-In Period|Adverse Event|0|||
160867413|NCT00561925|580906855|FG002|14 Day Lead-In Period|Adverse Event|0|||
160867414|NCT00561925|580906856|FG003|14 Day Lead-In Period|Adverse Event|0|||
160867415|NCT00561925|580906857|FG004|14 Day Lead-In Period|Adverse Event|0|||
160867416|NCT00561925|580906853|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
160867417|NCT00561925|580906854|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867418|NCT00561925|580906855|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867419|NCT00561925|580906856|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867420|NCT00561925|580906857|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
160867421|NCT00561925|580906853|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
161214631|NCT00720798|582169423|FG000|Overall Study|Insufficient Therapeutic Response|129|||
161214632|NCT00720798|582169423|FG000|Overall Study|Protocol Violation|4|||
161214633|NCT00720798|582169423|FG000|Overall Study|Refused Treatment|151|||
161214634|NCT00720798|582169423|FG000|Overall Study|Failure to Return|46|||
161214635|NCT00720798|582169423|FG000|Overall Study|Reason not Specified|83|||
161214636|NCT01312779|582169427|FG000|Overall Study|Withdrawal by Subject|2|||
160867422|NCT00561925|580906854|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
160867423|NCT00561925|580906855|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
160867424|NCT00561925|580906856|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
160867425|NCT00561925|580906857|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
160867426|NCT00561925|580906853|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
160867427|NCT00561925|580906854|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867428|NCT00561925|580906855|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867429|NCT00561925|580906856|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867430|NCT00561925|580906857|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
160867431|NCT00561925|580906853|FG000|14 Day Lead-In Period|Other|5|||
160867432|NCT00561925|580906854|FG001|14 Day Lead-In Period|Other|0|||
160867433|NCT00561925|580906855|FG002|14 Day Lead-In Period|Other|0|||
160867434|NCT00561925|580906856|FG003|14 Day Lead-In Period|Other|0|||
160867435|NCT00561925|580906857|FG004|14 Day Lead-In Period|Other|0|||
160867436|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
160867437|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
160867438|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
160867439|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
160867440|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
160867441|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
160867442|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
160867443|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
160867444|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
160867445|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
160867446|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
160867447|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
160867448|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
160867449|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
160867450|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
160867451|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
160867452|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
160867453|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
160867454|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
160867455|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
160867456|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
160867457|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
160867458|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
160867459|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
160867460|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
160867461|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
160867462|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
160867463|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
160867464|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
160867465|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
160867466|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Death|0|||
160867467|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Death|6|||
160867468|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Death|3|||
160867469|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Death|0|||
160867470|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Death|0|||
160867471|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867472|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
160867473|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
161214637|NCT01312779|582169427|FG000|Overall Study|Death|3|||
160867474|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867475|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
160867476|NCT00561925|580906853|FG000|144-week Double-blind, Double-dummy|Other|0|||
160867477|NCT00561925|580906854|FG001|144-week Double-blind, Double-dummy|Other|8|||
160867478|NCT00561925|580906855|FG002|144-week Double-blind, Double-dummy|Other|11|||
160867479|NCT00561925|580906856|FG003|144-week Double-blind, Double-dummy|Other|0|||
160867480|NCT00561925|580906857|FG004|144-week Double-blind, Double-dummy|Other|0|||
160867481|NCT00561925|580906853|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
160867482|NCT00561925|580906854|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
160867483|NCT00561925|580906855|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
160867484|NCT00561925|580906856|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
160867485|NCT00561925|580906857|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
160867486|NCT00684021|580906858|FG000|Overall Study|MRI Contraindicated|1|||
160867487|NCT00684021|580906859|FG001|Overall Study|MRI Contraindicated|1|||
160867488|NCT00684021|580906860|FG002|Overall Study|MRI Contraindicated|1|||
160867489|NCT00684021|580906861|FG003|Overall Study|MRI Contraindicated|0|||
160867490|NCT00684021|580906858|FG000|Overall Study|MRI not performed|0|||
160867491|NCT00684021|580906859|FG001|Overall Study|MRI not performed|1|||
160867492|NCT00684021|580906860|FG002|Overall Study|MRI not performed|1|||
160867493|NCT00684021|580906861|FG003|Overall Study|MRI not performed|2|||
160867494|NCT00684021|580906858|FG000|Overall Study|Death|1|||
160867495|NCT00684021|580906859|FG001|Overall Study|Death|0|||
160867496|NCT00684021|580906860|FG002|Overall Study|Death|0|||
160867497|NCT00684021|580906861|FG003|Overall Study|Death|0|||
160867498|NCT02161016|580906865|FG000|Overall Study|withdrawn by IRB|1|||
160867499|NCT02556177|580906869|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
160867500|NCT02556177|580906870|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
160867501|NCT03818321|580906873|FG000|Overall Study|Withdrawal by Subject|1|||
160867502|NCT03818321|580906874|FG001|Overall Study|Withdrawal by Subject|2|||
160867503|NCT00275509|580906875|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
160867504|NCT00275509|580906876|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
160867505|NCT00380367|580906878|FG000|Overall Study|Lost to Follow-up|1|||
160867506|NCT00380367|580906878|FG000|Overall Study|Withdrawal by Subject|1|||
160867507|NCT01812252|580906886|FG000|Overall Study|Persistent Disease|1|||
160867508|NCT01812252|580906887|FG001|Overall Study|Persistent Disease|0|||
160867509|NCT01812252|580906886|FG000|Overall Study|Not transplanted|11|||
160867510|NCT01812252|580906887|FG001|Overall Study|Not transplanted|11|||
160867511|NCT01812252|580906886|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
160867512|NCT01812252|580906887|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
160867513|NCT01812252|580906886|FG000|Overall Study|Withdrawal by Subject|1|||
160867514|NCT01812252|580906887|FG001|Overall Study|Withdrawal by Subject|1|||
160867515|NCT01812252|580906886|FG000|Overall Study|Screen Failure|1|||
160867516|NCT01812252|580906887|FG001|Overall Study|Screen Failure|0|||
160867517|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
160867518|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
160867519|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
161109490|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161109491|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
161109492|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
161109493|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161109494|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
160867520|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161109495|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
161324349|NCT01408901|582573580|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
161324350|NCT01408901|582573577|FG000|6-Week Follow-Up|Death|1|||
161324351|NCT01408901|582573578|FG001|6-Week Follow-Up|Death|0|||
161324352|NCT01408901|582573579|FG002|6-Week Follow-Up|Death|0|||
161324353|NCT01408901|582573580|FG003|6-Week Follow-Up|Death|0|||
161324354|NCT01408901|582573577|FG000|6-Week Follow-Up|Cancelled visit|0|||
161324355|NCT01408901|582573578|FG001|6-Week Follow-Up|Cancelled visit|1|||
161324356|NCT01408901|582573579|FG002|6-Week Follow-Up|Cancelled visit|0|||
160867521|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160867522|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
160867523|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
160867524|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
160867525|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
160867526|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
160867527|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
160867528|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
160867529|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
160867530|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
160867531|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
160867532|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
160867533|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
160867534|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
160867535|NCT03739203|580906892|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
161109496|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
161109497|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
160867536|NCT03739203|580906893|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
160867537|NCT03739203|580906894|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
161214638|NCT01312779|582169427|FG000|Overall Study|Not Implanted with Device|27|||
161214639|NCT00506753|582169428|FG000|Overall Study|Lost to Follow-up|21|||
161214640|NCT00506753|582169429|FG001|Overall Study|Lost to Follow-up|15|||
161214641|NCT01859390|582169430|FG000|Overall Study|Insufficient Sputum Collected|1|||
161214642|NCT01859390|582169431|FG001|Overall Study|Insufficient Sputum Collected|3|||
160867538|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
161214643|NCT01859390|582169430|FG000|Overall Study|Sample Missing Collection Date|0|||
160867539|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
160867540|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
160867541|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
160867542|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
160867543|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
160867544|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
160867545|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
160867546|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
160867547|NCT03739203|580906892|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
160867548|NCT03739203|580906893|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
160867549|NCT03739203|580906894|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
160867550|NCT03023397|580906895|FG000|Run-In|Failed screening allergen challenge|1|||
160867551|NCT03023397|580906896|FG001|Run-In|Failed screening allergen challenge|0|||
160867552|NCT03023397|580906897|FG002|Run-In|Failed screening allergen challenge|0|||
160867553|NCT03023397|580906895|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
160867554|NCT03023397|580906896|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
160867555|NCT03023397|580906897|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
160867556|NCT01519921|580906901|FG000|Overall Study|Adverse Event|10|||
160867557|NCT01519921|580906902|FG001|Overall Study|Adverse Event|9|||
160867558|NCT01519921|580906901|FG000|Overall Study|Lack of Efficacy|4|||
160867559|NCT01519921|580906902|FG001|Overall Study|Lack of Efficacy|3|||
160867560|NCT01519921|580906901|FG000|Overall Study|Withdrawal by Subject|3|||
160867561|NCT01519921|580906902|FG001|Overall Study|Withdrawal by Subject|0|||
160867562|NCT01519921|580906901|FG000|Overall Study|Lost to Follow-up|2|||
160867563|NCT01519921|580906902|FG001|Overall Study|Lost to Follow-up|1|||
160867564|NCT01519921|580906901|FG000|Overall Study|Treatment refusal|2|||
160867565|NCT01519921|580906902|FG001|Overall Study|Treatment refusal|1|||
160867566|NCT01519921|580906901|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
160867567|NCT01519921|580906902|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
160867568|NCT00363480|580906903|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
160867569|NCT00363480|580906903|FG000|Overall Study|Adverse Event|4|||
160867570|NCT00363480|580906903|FG000|Overall Study|Lost to Follow-up|5|||
160867571|NCT00363480|580906903|FG000|Overall Study|Withdrawal by Subject|5|||
160867572|NCT00363480|580906903|FG000|Overall Study|Non-compliance of subject|1|||
160867573|NCT00363480|580906903|FG000|Overall Study|Participant discontinued on its own|1|||
160867574|NCT03133793|580906908|FG000|Overall Study|Withdrawal by Subject|0|||
160867575|NCT03133793|580906909|FG001|Overall Study|Withdrawal by Subject|4|||
160867576|NCT03133793|580906910|FG002|Overall Study|Withdrawal by Subject|2|||
160867577|NCT03133793|580906911|FG003|Overall Study|Withdrawal by Subject|4|||
160867578|NCT03133793|580906908|FG000|Overall Study|Lost to Follow-up|1|||
160867579|NCT03133793|580906909|FG001|Overall Study|Lost to Follow-up|0|||
160867580|NCT03133793|580906910|FG002|Overall Study|Lost to Follow-up|2|||
160867581|NCT03133793|580906911|FG003|Overall Study|Lost to Follow-up|0|||
160867582|NCT03133793|580906908|FG000|Overall Study|Death|0|||
160867583|NCT03133793|580906909|FG001|Overall Study|Death|0|||
160867584|NCT03133793|580906910|FG002|Overall Study|Death|0|||
160867585|NCT03133793|580906911|FG003|Overall Study|Death|1|||
160867586|NCT03486834|580906912|FG000|Overall Study|Withdrawal by Subject|46|||
160867587|NCT03486834|580906913|FG001|Overall Study|Withdrawal by Subject|46|||
160867588|NCT03486834|580906914|FG002|Overall Study|Withdrawal by Subject|52|||
160867589|NCT03486834|580906912|FG000|Overall Study|Adverse Event|8|||
160867590|NCT03486834|580906913|FG001|Overall Study|Adverse Event|7|||
160867591|NCT03486834|580906914|FG002|Overall Study|Adverse Event|0|||
160867592|NCT03486834|580906912|FG000|Overall Study|Lost to Follow-up|41|||
160867593|NCT03486834|580906913|FG001|Overall Study|Lost to Follow-up|24|||
160867594|NCT03486834|580906914|FG002|Overall Study|Lost to Follow-up|39|||
160867595|NCT03486834|580906912|FG000|Overall Study|Non-compliance with Study Drug|2|||
160867596|NCT03486834|580906913|FG001|Overall Study|Non-compliance with Study Drug|2|||
160867597|NCT03486834|580906914|FG002|Overall Study|Non-compliance with Study Drug|0|||
160867598|NCT03486834|580906912|FG000|Overall Study|Physician Decision|5|||
160867599|NCT03486834|580906913|FG001|Overall Study|Physician Decision|2|||
160867600|NCT03486834|580906914|FG002|Overall Study|Physician Decision|3|||
160867601|NCT03486834|580906912|FG000|Overall Study|Pregnancy|10|||
160867602|NCT03486834|580906913|FG001|Overall Study|Pregnancy|12|||
160867603|NCT03486834|580906914|FG002|Overall Study|Pregnancy|12|||
160867604|NCT03486834|580906912|FG000|Overall Study|Protocol Deviation|2|||
160867605|NCT03486834|580906913|FG001|Overall Study|Protocol Deviation|3|||
160867606|NCT03486834|580906914|FG002|Overall Study|Protocol Deviation|3|||
160867607|NCT03486834|580906912|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160867608|NCT03486834|580906913|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160867609|NCT03486834|580906914|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160867610|NCT03486834|580906912|FG000|Overall Study|Randomized but not treated|4|||
160867611|NCT03486834|580906913|FG001|Overall Study|Randomized but not treated|4|||
160867612|NCT03486834|580906914|FG002|Overall Study|Randomized but not treated|1|||
160867613|NCT00432172|580906916|FG000|Overall Study|Physician Decision|0|||
160867614|NCT00432172|580906917|FG001|Overall Study|Physician Decision|0|||
160867615|NCT00432172|580906918|FG002|Overall Study|Physician Decision|2|||
160867616|NCT00432172|580906919|FG003|Overall Study|Physician Decision|0|||
160867617|NCT00432172|580906916|FG000|Overall Study|Adverse Event|4|||
160867618|NCT00432172|580906917|FG001|Overall Study|Adverse Event|2|||
160867619|NCT00432172|580906918|FG002|Overall Study|Adverse Event|4|||
160867620|NCT00432172|580906919|FG003|Overall Study|Adverse Event|3|||
160867621|NCT00432172|580906916|FG000|Overall Study|Disease progression|0|||
160867622|NCT00432172|580906917|FG001|Overall Study|Disease progression|2|||
160867623|NCT00432172|580906918|FG002|Overall Study|Disease progression|5|||
160867624|NCT00432172|580906919|FG003|Overall Study|Disease progression|1|||
160867625|NCT00432172|580906916|FG000|Overall Study|Withdrawal by Subject|0|||
160867626|NCT00432172|580906917|FG001|Overall Study|Withdrawal by Subject|1|||
160867627|NCT00432172|580906918|FG002|Overall Study|Withdrawal by Subject|0|||
160867628|NCT00432172|580906919|FG003|Overall Study|Withdrawal by Subject|2|||
160867629|NCT00432172|580906916|FG000|Overall Study|No treatment received|2|||
160867630|NCT00432172|580906917|FG001|Overall Study|No treatment received|2|||
160867631|NCT00432172|580906918|FG002|Overall Study|No treatment received|0|||
160867632|NCT00432172|580906919|FG003|Overall Study|No treatment received|1|||
160867633|NCT02141204|580906920|FG000|Overall Study|Lost to Follow-up|2|||
161109498|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
160867634|NCT02141204|580906921|FG001|Overall Study|Lost to Follow-up|1|||
160867635|NCT02141204|580906920|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
160867636|NCT02141204|580906921|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
160867637|NCT02141204|580906920|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
160867638|NCT02141204|580906921|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
160867639|NCT02141204|580906920|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
160867640|NCT02141204|580906921|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
160867641|NCT00515619|580906924|FG000|Overall Study|Adverse Event|34|||
160867642|NCT00515619|580906924|FG000|Overall Study|Lack of Efficacy|92|||
160867643|NCT00515619|580906924|FG000|Overall Study|Withdrawal by Subject|66|||
160867644|NCT00515619|580906924|FG000|Overall Study|Protocol Violation|3|||
160867645|NCT00515619|580906924|FG000|Overall Study|Lost to Follow-up|4|||
160867646|NCT00515619|580906924|FG000|Overall Study|Unsatisfactory compliance|6|||
160867647|NCT00515619|580906924|FG000|Overall Study|Other: Site discontinuing trials|2|||
160867648|NCT00515619|580906924|FG000|Overall Study|Other: Subject cannot attend visits|2|||
160867649|NCT00515619|580906924|FG000|Overall Study|Other: Subject required surgery|1|||
160867650|NCT00515619|580906924|FG000|Overall Study|Other: Subject moved to another country|1|||
160867651|NCT00515619|580906924|FG000|Overall Study|Other: Investigator decision|1|||
160867652|NCT00515619|580906924|FG000|Overall Study|Other: Subject became pregnant|1|||
160867653|NCT00515619|580906924|FG000|Overall Study|Other: Request from sponsor|1|||
160867654|NCT00515619|580906924|FG000|Overall Study|Other: Drug available on license|1|||
160867655|NCT00515619|580906924|FG000|Overall Study|Other: Subject interested in other AED|1|||
160867656|NCT02379091|580906925|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160867657|NCT02379091|580906926|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160867658|NCT02379091|580906927|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160867659|NCT02379091|580906928|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
160867660|NCT02379091|580906925|FG000|Overall Study|Principal Investigator Discretion|0|||
160867661|NCT02379091|580906926|FG001|Overall Study|Principal Investigator Discretion|1|||
160867662|NCT02379091|580906927|FG002|Overall Study|Principal Investigator Discretion|0|||
160867663|NCT02379091|580906928|FG003|Overall Study|Principal Investigator Discretion|0|||
160867664|NCT02379091|580906925|FG000|Overall Study|Lost to Follow-up|0|||
160867665|NCT02379091|580906926|FG001|Overall Study|Lost to Follow-up|0|||
160867666|NCT02379091|580906927|FG002|Overall Study|Lost to Follow-up|0|||
160867667|NCT02379091|580906928|FG003|Overall Study|Lost to Follow-up|1|||
160867668|NCT02379091|580906925|FG000|Overall Study|Voluntary Withdrawal|2|||
160867669|NCT02379091|580906926|FG001|Overall Study|Voluntary Withdrawal|5|||
160867670|NCT02379091|580906927|FG002|Overall Study|Voluntary Withdrawal|2|||
160867671|NCT02379091|580906928|FG003|Overall Study|Voluntary Withdrawal|4|||
160867672|NCT02379091|580906925|FG000|Overall Study|Study Termination|7|||
160867673|NCT02379091|580906926|FG001|Overall Study|Study Termination|2|||
160867674|NCT02379091|580906927|FG002|Overall Study|Study Termination|5|||
160867675|NCT02379091|580906928|FG003|Overall Study|Study Termination|8|||
160867676|NCT02379091|580906925|FG000|Overall Study|Lack of Efficacy|3|||
160867677|NCT02379091|580906926|FG001|Overall Study|Lack of Efficacy|0|||
160867678|NCT02379091|580906927|FG002|Overall Study|Lack of Efficacy|0|||
160867679|NCT02379091|580906928|FG003|Overall Study|Lack of Efficacy|0|||
160867680|NCT03326713|580906930|FG000|Overall Study|Death|2|||
160867681|NCT03326713|580906931|FG001|Overall Study|Death|1|||
160867682|NCT03326713|580906932|FG002|Overall Study|Death|0|||
160867683|NCT03326713|580906930|FG000|Overall Study|Lost to Follow-up|20|||
160867684|NCT03326713|580906931|FG001|Overall Study|Lost to Follow-up|21|||
160867685|NCT03326713|580906932|FG002|Overall Study|Lost to Follow-up|33|||
160867686|NCT03326713|580906930|FG000|Overall Study|Withdrawal by Subject|1|||
160867687|NCT03326713|580906931|FG001|Overall Study|Withdrawal by Subject|2|||
160867688|NCT03326713|580906932|FG002|Overall Study|Withdrawal by Subject|11|||
160867689|NCT03326713|580906930|FG000|Overall Study|Found Ineligible|11|||
160867690|NCT03326713|580906931|FG001|Overall Study|Found Ineligible|11|||
160867691|NCT03326713|580906932|FG002|Overall Study|Found Ineligible|8|||
160867692|NCT00771758|580906933|FG000|Overall Study|Adverse Event|2|||
160867693|NCT00771758|580906934|FG001|Overall Study|Adverse Event|8|||
160867694|NCT00771758|580906935|FG002|Overall Study|Adverse Event|1|||
160867695|NCT00771758|580906933|FG000|Overall Study|Lack of Efficacy|0|||
160867696|NCT00771758|580906934|FG001|Overall Study|Lack of Efficacy|2|||
160867697|NCT00771758|580906935|FG002|Overall Study|Lack of Efficacy|1|||
160867698|NCT00771758|580906933|FG000|Overall Study|Lost to Follow-up|1|||
160867699|NCT00771758|580906934|FG001|Overall Study|Lost to Follow-up|0|||
160867700|NCT00771758|580906935|FG002|Overall Study|Lost to Follow-up|0|||
160867701|NCT00771758|580906933|FG000|Overall Study|Protocol Violation|1|||
160867702|NCT00771758|580906934|FG001|Overall Study|Protocol Violation|0|||
160867703|NCT00771758|580906935|FG002|Overall Study|Protocol Violation|0|||
160867704|NCT00771758|580906933|FG000|Overall Study|Withdrawal by Subject|1|||
160867705|NCT00771758|580906934|FG001|Overall Study|Withdrawal by Subject|0|||
160867706|NCT00771758|580906935|FG002|Overall Study|Withdrawal by Subject|0|||
160867707|NCT00771758|580906933|FG000|Overall Study|Other|3|||
160867708|NCT00771758|580906934|FG001|Overall Study|Other|2|||
160867709|NCT00771758|580906935|FG002|Overall Study|Other|0|||
160867710|NCT00935584|580906936|FG000|Overall Study|Withdrawal by Subject|9|||
160867711|NCT00935584|580906937|FG001|Overall Study|Withdrawal by Subject|0|||
160867712|NCT00935584|580906936|FG000|Overall Study|Death|3|||
160867713|NCT00935584|580906937|FG001|Overall Study|Death|0|||
160867714|NCT00935584|580906936|FG000|Overall Study|Lost to Follow-up|8|||
160867715|NCT00935584|580906937|FG001|Overall Study|Lost to Follow-up|0|||
160867716|NCT00935584|580906936|FG000|Overall Study|No show|9|||
160867717|NCT00935584|580906937|FG001|Overall Study|No show|0|||
160867718|NCT00935584|580906936|FG000|Overall Study|Relocated|3|||
160867719|NCT00935584|580906937|FG001|Overall Study|Relocated|0|||
160867720|NCT00935584|580906936|FG000|Overall Study|Patient changed provider|3|||
160867721|NCT00935584|580906937|FG001|Overall Study|Patient changed provider|0|||
160867722|NCT00935584|580906936|FG000|Overall Study|Provider dropped out of study|14|||
160867723|NCT00935584|580906937|FG001|Overall Study|Provider dropped out of study|4|||
160867724|NCT00687193|580906938|FG000|Overall Study|Adverse Event|0|||
160867725|NCT00687193|580906939|FG001|Overall Study|Adverse Event|1|||
160867726|NCT00687193|580906940|FG002|Overall Study|Adverse Event|2|||
160867727|NCT00687193|580906941|FG003|Overall Study|Adverse Event|3|||
160867728|NCT00687193|580906942|FG004|Overall Study|Adverse Event|0|||
160867729|NCT00687193|580906943|FG005|Overall Study|Adverse Event|2|||
160867730|NCT00687193|580906938|FG000|Overall Study|Lack of Efficacy|1|||
160867731|NCT00687193|580906939|FG001|Overall Study|Lack of Efficacy|1|||
160867732|NCT00687193|580906940|FG002|Overall Study|Lack of Efficacy|0|||
160867733|NCT00687193|580906941|FG003|Overall Study|Lack of Efficacy|0|||
160867734|NCT00687193|580906942|FG004|Overall Study|Lack of Efficacy|0|||
160867735|NCT00687193|580906943|FG005|Overall Study|Lack of Efficacy|2|||
160867736|NCT00687193|580906938|FG000|Overall Study|Protocol Violation|1|||
160867737|NCT00687193|580906939|FG001|Overall Study|Protocol Violation|2|||
160867738|NCT00687193|580906940|FG002|Overall Study|Protocol Violation|0|||
160867739|NCT00687193|580906941|FG003|Overall Study|Protocol Violation|1|||
160867740|NCT00687193|580906942|FG004|Overall Study|Protocol Violation|2|||
160867741|NCT00687193|580906943|FG005|Overall Study|Protocol Violation|0|||
160867742|NCT02129699|580906944|FG000|Overall Study|Did not start treatment|3|||
160867743|NCT02129699|580906945|FG001|Overall Study|Did not start treatment|2|||
160867744|NCT01394016|580906946|FG000|Overall Study|Progressive Disease|2|||
160867745|NCT01394016|580906947|FG001|Overall Study|Progressive Disease|0|||
160867746|NCT01394016|580906948|FG002|Overall Study|Progressive Disease|0|||
160867747|NCT01394016|580906949|FG003|Overall Study|Progressive Disease|0|||
160867748|NCT01394016|580906950|FG004|Overall Study|Progressive Disease|0|||
160867749|NCT01394016|580906951|FG005|Overall Study|Progressive Disease|0|||
160867750|NCT01394016|580906952|FG006|Overall Study|Progressive Disease|0|||
160867751|NCT01394016|580906953|FG007|Overall Study|Progressive Disease|0|||
160867752|NCT01394016|580906954|FG008|Overall Study|Progressive Disease|0|||
160867753|NCT01394016|580906955|FG009|Overall Study|Progressive Disease|0|||
160867754|NCT01394016|580906956|FG010|Overall Study|Progressive Disease|0|||
160867755|NCT01394016|580906957|FG011|Overall Study|Progressive Disease|0|||
160867756|NCT01394016|580906958|FG012|Overall Study|Progressive Disease|0|||
160867757|NCT01394016|580906959|FG013|Overall Study|Progressive Disease|0|||
160867758|NCT01394016|580906960|FG014|Overall Study|Progressive Disease|0|||
160867759|NCT01394016|580906961|FG015|Overall Study|Progressive Disease|0|||
160867760|NCT01394016|580906962|FG016|Overall Study|Progressive Disease|0|||
160867761|NCT01394016|580906963|FG017|Overall Study|Progressive Disease|0|||
160867762|NCT01394016|580906964|FG018|Overall Study|Progressive Disease|0|||
160867763|NCT01394016|580906946|FG000|Overall Study|Withdrawal by Subject|0|||
160867764|NCT01394016|580906947|FG001|Overall Study|Withdrawal by Subject|0|||
160867765|NCT01394016|580906948|FG002|Overall Study|Withdrawal by Subject|0|||
160867766|NCT01394016|580906949|FG003|Overall Study|Withdrawal by Subject|0|||
160867767|NCT01394016|580906950|FG004|Overall Study|Withdrawal by Subject|0|||
160867768|NCT01394016|580906951|FG005|Overall Study|Withdrawal by Subject|0|||
160867769|NCT01394016|580906952|FG006|Overall Study|Withdrawal by Subject|0|||
160867770|NCT01394016|580906953|FG007|Overall Study|Withdrawal by Subject|1|||
160867771|NCT01394016|580906954|FG008|Overall Study|Withdrawal by Subject|1|||
160867772|NCT01394016|580906955|FG009|Overall Study|Withdrawal by Subject|1|||
160867773|NCT01394016|580906956|FG010|Overall Study|Withdrawal by Subject|4|||
160867774|NCT01394016|580906957|FG011|Overall Study|Withdrawal by Subject|0|||
160867775|NCT01394016|580906958|FG012|Overall Study|Withdrawal by Subject|0|||
160867776|NCT01394016|580906959|FG013|Overall Study|Withdrawal by Subject|3|||
160867777|NCT01394016|580906960|FG014|Overall Study|Withdrawal by Subject|1|||
160867778|NCT01394016|580906961|FG015|Overall Study|Withdrawal by Subject|3|||
160867779|NCT01394016|580906962|FG016|Overall Study|Withdrawal by Subject|1|||
160867780|NCT01394016|580906963|FG017|Overall Study|Withdrawal by Subject|1|||
160867781|NCT01394016|580906964|FG018|Overall Study|Withdrawal by Subject|2|||
160867782|NCT01394016|580906946|FG000|Overall Study|Adverse Event|0|||
160867783|NCT01394016|580906947|FG001|Overall Study|Adverse Event|0|||
160867784|NCT01394016|580906948|FG002|Overall Study|Adverse Event|0|||
160867785|NCT01394016|580906949|FG003|Overall Study|Adverse Event|0|||
160867786|NCT01394016|580906950|FG004|Overall Study|Adverse Event|0|||
160867787|NCT01394016|580906951|FG005|Overall Study|Adverse Event|0|||
160867788|NCT01394016|580906952|FG006|Overall Study|Adverse Event|0|||
160867789|NCT01394016|580906953|FG007|Overall Study|Adverse Event|0|||
160867790|NCT01394016|580906954|FG008|Overall Study|Adverse Event|0|||
160867791|NCT01394016|580906955|FG009|Overall Study|Adverse Event|1|||
160867792|NCT01394016|580906956|FG010|Overall Study|Adverse Event|0|||
160867793|NCT01394016|580906957|FG011|Overall Study|Adverse Event|0|||
160867794|NCT01394016|580906958|FG012|Overall Study|Adverse Event|0|||
160867795|NCT01394016|580906959|FG013|Overall Study|Adverse Event|0|||
160867796|NCT01394016|580906960|FG014|Overall Study|Adverse Event|0|||
160867797|NCT01394016|580906961|FG015|Overall Study|Adverse Event|0|||
160867798|NCT01394016|580906962|FG016|Overall Study|Adverse Event|1|||
160867799|NCT01394016|580906963|FG017|Overall Study|Adverse Event|1|||
160867800|NCT01394016|580906964|FG018|Overall Study|Adverse Event|0|||
160867801|NCT01394016|580906946|FG000|Overall Study|Sponsor Decision|0|||
160867802|NCT01394016|580906947|FG001|Overall Study|Sponsor Decision|0|||
160867803|NCT01394016|580906948|FG002|Overall Study|Sponsor Decision|0|||
160867804|NCT01394016|580906949|FG003|Overall Study|Sponsor Decision|0|||
160867805|NCT01394016|580906950|FG004|Overall Study|Sponsor Decision|0|||
160867806|NCT01394016|580906951|FG005|Overall Study|Sponsor Decision|0|||
160867807|NCT01394016|580906952|FG006|Overall Study|Sponsor Decision|0|||
160867808|NCT01394016|580906953|FG007|Overall Study|Sponsor Decision|0|||
160867809|NCT01394016|580906954|FG008|Overall Study|Sponsor Decision|0|||
160867810|NCT01394016|580906955|FG009|Overall Study|Sponsor Decision|0|||
160867811|NCT01394016|580906956|FG010|Overall Study|Sponsor Decision|0|||
160867812|NCT01394016|580906957|FG011|Overall Study|Sponsor Decision|0|||
160867813|NCT01394016|580906958|FG012|Overall Study|Sponsor Decision|1|||
160867814|NCT01394016|580906959|FG013|Overall Study|Sponsor Decision|0|||
160867815|NCT01394016|580906960|FG014|Overall Study|Sponsor Decision|0|||
160867816|NCT01394016|580906961|FG015|Overall Study|Sponsor Decision|0|||
160867817|NCT01394016|580906962|FG016|Overall Study|Sponsor Decision|0|||
160867818|NCT01394016|580906963|FG017|Overall Study|Sponsor Decision|0|||
160867819|NCT01394016|580906964|FG018|Overall Study|Sponsor Decision|0|||
160867820|NCT01394016|580906946|FG000|Overall Study|Lost to Follow-up|0|||
160867821|NCT01394016|580906947|FG001|Overall Study|Lost to Follow-up|0|||
160867822|NCT01394016|580906948|FG002|Overall Study|Lost to Follow-up|0|||
160867823|NCT01394016|580906949|FG003|Overall Study|Lost to Follow-up|0|||
160867824|NCT01394016|580906950|FG004|Overall Study|Lost to Follow-up|0|||
160867825|NCT01394016|580906951|FG005|Overall Study|Lost to Follow-up|0|||
160867826|NCT01394016|580906952|FG006|Overall Study|Lost to Follow-up|0|||
160867827|NCT01394016|580906953|FG007|Overall Study|Lost to Follow-up|0|||
160867828|NCT01394016|580906954|FG008|Overall Study|Lost to Follow-up|0|||
160867829|NCT01394016|580906955|FG009|Overall Study|Lost to Follow-up|0|||
160867830|NCT01394016|580906956|FG010|Overall Study|Lost to Follow-up|0|||
160867831|NCT01394016|580906957|FG011|Overall Study|Lost to Follow-up|0|||
160867832|NCT01394016|580906958|FG012|Overall Study|Lost to Follow-up|0|||
160867833|NCT01394016|580906959|FG013|Overall Study|Lost to Follow-up|0|||
160867834|NCT01394016|580906960|FG014|Overall Study|Lost to Follow-up|0|||
160867835|NCT01394016|580906961|FG015|Overall Study|Lost to Follow-up|0|||
160867836|NCT01394016|580906962|FG016|Overall Study|Lost to Follow-up|0|||
160867837|NCT01394016|580906963|FG017|Overall Study|Lost to Follow-up|0|||
160867838|NCT01394016|580906964|FG018|Overall Study|Lost to Follow-up|1|||
160867839|NCT03534804|580906965|FG000|Overall Study|Withdrawal by Subject|1|||
160867840|NCT04161157|580906969|FG000|Overall Study|Lost to Follow-up|4|||
160867841|NCT04161157|580906969|FG000|Overall Study|Death|3|||
160867842|NCT04161157|580906969|FG000|Overall Study|Ineligible|2|||
160867843|NCT04161157|580906969|FG000|Overall Study|Withdrawal by Subject|4|||
160867844|NCT05786651|580906973|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
160867845|NCT02331277|580908128|FG000|Overall Study|Withdrawal by Subject|1|||
161109499|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
161109500|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
161109501|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
161109502|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
160867846|NCT02331277|580908129|FG001|Overall Study|Withdrawal by Subject|0|||
160867847|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
160867848|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
160867849|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Patient requirement|20|||
160867850|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Death|5|||
160867851|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Change of therapy|6|||
160867852|NCT01071798|580908131|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
160867853|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
160867854|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
160867855|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
160867856|NCT01071798|580908131|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
160867857|NCT01177397|580908135|FG000|Overall Study|Protocol Violation|0|||
160867858|NCT01177397|580908136|FG001|Overall Study|Protocol Violation|0|||
160867859|NCT01177397|580908137|FG002|Overall Study|Protocol Violation|0|||
160867860|NCT01177397|580908138|FG003|Overall Study|Protocol Violation|0|||
160867861|NCT01177397|580908139|FG004|Overall Study|Protocol Violation|0|||
160867862|NCT01177397|580908140|FG005|Overall Study|Protocol Violation|1|||
160867863|NCT01177397|580908141|FG006|Overall Study|Protocol Violation|0|||
160867864|NCT01177397|580908142|FG007|Overall Study|Protocol Violation|0|||
160867865|NCT01177397|580908143|FG008|Overall Study|Protocol Violation|0|||
160867866|NCT01177397|580908144|FG009|Overall Study|Protocol Violation|0|||
160867867|NCT01177397|580908145|FG010|Overall Study|Protocol Violation|0|||
160867868|NCT01177397|580908146|FG011|Overall Study|Protocol Violation|0|||
160867869|NCT01177397|580908135|FG000|Overall Study|Lost to Follow-up|0|||
160867870|NCT01177397|580908136|FG001|Overall Study|Lost to Follow-up|0|||
160867871|NCT01177397|580908137|FG002|Overall Study|Lost to Follow-up|0|||
160867872|NCT01177397|580908138|FG003|Overall Study|Lost to Follow-up|0|||
160867873|NCT01177397|580908139|FG004|Overall Study|Lost to Follow-up|1|||
160867874|NCT01177397|580908140|FG005|Overall Study|Lost to Follow-up|0|||
160867875|NCT01177397|580908141|FG006|Overall Study|Lost to Follow-up|0|||
160867876|NCT01177397|580908142|FG007|Overall Study|Lost to Follow-up|2|||
160867877|NCT01177397|580908143|FG008|Overall Study|Lost to Follow-up|0|||
160867878|NCT01177397|580908144|FG009|Overall Study|Lost to Follow-up|0|||
160867879|NCT01177397|580908145|FG010|Overall Study|Lost to Follow-up|0|||
160867880|NCT01177397|580908146|FG011|Overall Study|Lost to Follow-up|0|||
160867881|NCT01177397|580908135|FG000|Overall Study|Death|0|||
160867882|NCT01177397|580908136|FG001|Overall Study|Death|0|||
160867883|NCT01177397|580908137|FG002|Overall Study|Death|1|||
160867884|NCT01177397|580908138|FG003|Overall Study|Death|1|||
160867885|NCT01177397|580908139|FG004|Overall Study|Death|0|||
160867886|NCT01177397|580908140|FG005|Overall Study|Death|0|||
160867887|NCT01177397|580908141|FG006|Overall Study|Death|0|||
160867888|NCT01177397|580908142|FG007|Overall Study|Death|5|||
160867889|NCT01177397|580908143|FG008|Overall Study|Death|2|||
160867890|NCT01177397|580908144|FG009|Overall Study|Death|1|||
160867891|NCT01177397|580908145|FG010|Overall Study|Death|0|||
160867892|NCT01177397|580908146|FG011|Overall Study|Death|0|||
160867893|NCT01177397|580908135|FG000|Overall Study|Withdrawal by Subject|0|||
160867894|NCT01177397|580908136|FG001|Overall Study|Withdrawal by Subject|0|||
160867895|NCT01177397|580908137|FG002|Overall Study|Withdrawal by Subject|1|||
160867896|NCT01177397|580908138|FG003|Overall Study|Withdrawal by Subject|1|||
160867897|NCT01177397|580908139|FG004|Overall Study|Withdrawal by Subject|1|||
160867898|NCT01177397|580908140|FG005|Overall Study|Withdrawal by Subject|2|||
160867899|NCT01177397|580908141|FG006|Overall Study|Withdrawal by Subject|0|||
160867900|NCT01177397|580908142|FG007|Overall Study|Withdrawal by Subject|5|||
160867901|NCT01177397|580908143|FG008|Overall Study|Withdrawal by Subject|9|||
160867902|NCT01177397|580908144|FG009|Overall Study|Withdrawal by Subject|1|||
160867903|NCT01177397|580908145|FG010|Overall Study|Withdrawal by Subject|1|||
160867904|NCT01177397|580908146|FG011|Overall Study|Withdrawal by Subject|0|||
160867905|NCT01177397|580908135|FG000|Overall Study|Adverse Event|0|||
160867906|NCT01177397|580908136|FG001|Overall Study|Adverse Event|0|||
160867907|NCT01177397|580908137|FG002|Overall Study|Adverse Event|1|||
160867908|NCT01177397|580908138|FG003|Overall Study|Adverse Event|2|||
160867909|NCT01177397|580908139|FG004|Overall Study|Adverse Event|0|||
160867910|NCT01177397|580908140|FG005|Overall Study|Adverse Event|12|||
160867911|NCT01177397|580908141|FG006|Overall Study|Adverse Event|1|||
160867912|NCT01177397|580908142|FG007|Overall Study|Adverse Event|14|||
160867913|NCT01177397|580908143|FG008|Overall Study|Adverse Event|8|||
160867914|NCT01177397|580908144|FG009|Overall Study|Adverse Event|6|||
160867915|NCT01177397|580908145|FG010|Overall Study|Adverse Event|3|||
160867916|NCT01177397|580908146|FG011|Overall Study|Adverse Event|7|||
160867917|NCT01177397|580908135|FG000|Overall Study|Disease progression|1|||
160867918|NCT01177397|580908136|FG001|Overall Study|Disease progression|2|||
160867919|NCT01177397|580908137|FG002|Overall Study|Disease progression|5|||
160867920|NCT01177397|580908138|FG003|Overall Study|Disease progression|5|||
160867921|NCT01177397|580908139|FG004|Overall Study|Disease progression|4|||
160867922|NCT01177397|580908140|FG005|Overall Study|Disease progression|10|||
161109503|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
160867923|NCT01177397|580908141|FG006|Overall Study|Disease progression|10|||
160867924|NCT01177397|580908142|FG007|Overall Study|Disease progression|21|||
160867925|NCT01177397|580908143|FG008|Overall Study|Disease progression|18|||
160867926|NCT01177397|580908144|FG009|Overall Study|Disease progression|12|||
160867927|NCT01177397|580908145|FG010|Overall Study|Disease progression|10|||
160867928|NCT01177397|580908146|FG011|Overall Study|Disease progression|8|||
160867929|NCT01177397|580908135|FG000|Overall Study|Other reasons|0|||
160867930|NCT01177397|580908136|FG001|Overall Study|Other reasons|0|||
160867931|NCT01177397|580908137|FG002|Overall Study|Other reasons|1|||
160867932|NCT01177397|580908138|FG003|Overall Study|Other reasons|0|||
160867933|NCT01177397|580908139|FG004|Overall Study|Other reasons|1|||
160867934|NCT01177397|580908140|FG005|Overall Study|Other reasons|1|||
160867935|NCT01177397|580908141|FG006|Overall Study|Other reasons|2|||
160867936|NCT01177397|580908142|FG007|Overall Study|Other reasons|6|||
160867937|NCT01177397|580908143|FG008|Overall Study|Other reasons|10|||
160867938|NCT01177397|580908144|FG009|Overall Study|Other reasons|8|||
160867939|NCT01177397|580908145|FG010|Overall Study|Other reasons|0|||
160867940|NCT01177397|580908146|FG011|Overall Study|Other reasons|2|||
160867941|NCT01528969|580908147|FG000|Overall Study|absent from the school at baseline|2|||
160867942|NCT01528969|580908148|FG001|Overall Study|absent from the school at baseline|0|||
160867943|NCT03085797|580908149|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
160867944|NCT03085797|580908150|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
160867945|NCT03085797|580908149|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
160867946|NCT03085797|580908150|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
160867947|NCT03085797|580908149|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
160867948|NCT03085797|580908150|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
160867949|NCT04050202|580908155|FG000|Overall Study|Lost to Follow-up|2|||
160867950|NCT01554241|580908156|FG000|Overall Study|Death|3|||
160867951|NCT01554241|580908157|FG001|Overall Study|Death|1|||
160867952|NCT01554241|580908158|FG002|Overall Study|Death|1|||
160867953|NCT01554241|580908159|FG003|Overall Study|Death|0|||
160867954|NCT01554241|580908156|FG000|Overall Study|protocol specified renal stone|0|||
160867955|NCT01554241|580908157|FG001|Overall Study|protocol specified renal stone|0|||
160867956|NCT01554241|580908158|FG002|Overall Study|protocol specified renal stone|0|||
160867957|NCT01554241|580908159|FG003|Overall Study|protocol specified renal stone|1|||
160867958|NCT01554241|580908156|FG000|Overall Study|protocol specified change in eGFR|0|||
160867959|NCT01554241|580908157|FG001|Overall Study|protocol specified change in eGFR|0|||
160867960|NCT01554241|580908158|FG002|Overall Study|protocol specified change in eGFR|1|||
160867961|NCT01554241|580908159|FG003|Overall Study|protocol specified change in eGFR|0|||
160867962|NCT01554241|580908156|FG000|Overall Study|Withdrawal by Subject|0|||
160867963|NCT01554241|580908157|FG001|Overall Study|Withdrawal by Subject|0|||
160867964|NCT01554241|580908158|FG002|Overall Study|Withdrawal by Subject|2|||
160867965|NCT01554241|580908159|FG003|Overall Study|Withdrawal by Subject|0|||
160867966|NCT03198507|580908162|FG000|Overall Study|Withdrawal by Subject|1|||
160867967|NCT03198507|580908163|FG001|Overall Study|Withdrawal by Subject|0|||
160867968|NCT00724698|580908164|FG000|Overall Study|Adverse Event|9|||
160867969|NCT00724698|580908164|FG000|Overall Study|Failure of Therapy|4|||
160867970|NCT00724698|580908164|FG000|Overall Study|Poor Compliance|16|||
160867971|NCT00724698|580908164|FG000|Overall Study|Lost to Follow-up|36|||
160867972|NCT00724698|580908164|FG000|Overall Study|No Info|25|||
160867973|NCT01411891|580908167|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
160867974|NCT01411891|580908168|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
160867975|NCT01075685|580908169|FG000|Overall Study|Protocol Violation|9|||
160867976|NCT01075685|580908170|FG001|Overall Study|Protocol Violation|1|||
160867977|NCT01075685|580908169|FG000|Overall Study|Withdrawal by Subject|20|||
160867978|NCT01075685|580908170|FG001|Overall Study|Withdrawal by Subject|5|||
160867979|NCT01075685|580908169|FG000|Overall Study|Lost to Follow-up|563|||
160867980|NCT01075685|580908170|FG001|Overall Study|Lost to Follow-up|220|||
160867981|NCT03196349|580908173|FG000|Overall Study|Did not receive study drug|0|||
160867982|NCT03196349|580908174|FG001|Overall Study|Did not receive study drug|1|||
160867983|NCT03196349|580908175|FG002|Overall Study|Did not receive study drug|2|||
160867984|NCT03196349|580908173|FG000|Overall Study|No data entered|2|||
160867985|NCT03196349|580908174|FG001|Overall Study|No data entered|4|||
160867986|NCT03196349|580908175|FG002|Overall Study|No data entered|0|||
160867987|NCT03196349|580908173|FG000|Overall Study|Study Terminated early|15|||
160867988|NCT03196349|580908174|FG001|Overall Study|Study Terminated early|9|||
160867989|NCT03196349|580908175|FG002|Overall Study|Study Terminated early|11|||
160867990|NCT03388164|580908180|FG000|Overall Study|Withdrawal by Subject|3|||
160867991|NCT03388164|580908181|FG001|Overall Study|Withdrawal by Subject|1|||
160867992|NCT03967444|580908182|FG000|Overall Study|Lost to Follow-up|1|||
160867993|NCT03967444|580908183|FG001|Overall Study|Lost to Follow-up|2|||
160867994|NCT00499083|580908191|FG000|Overall Study|Not evaluable|3|||
160867995|NCT00686686|580908192|FG000|Overall Study|Non-compliance|1|||
160867996|NCT00686686|580908192|FG000|Overall Study|Adverse Event|2|||
160867997|NCT00686686|580908192|FG000|Overall Study|Lost to Follow-up|3|||
160867998|NCT00477386|580908193|FG000|Overall Study|Adverse Event|4|||
160867999|NCT00477386|580908194|FG001|Overall Study|Adverse Event|8|||
160868000|NCT00477386|580908193|FG000|Overall Study|Disease progression, relapse|3|||
160868001|NCT00477386|580908194|FG001|Overall Study|Disease progression, relapse|4|||
160868002|NCT00477386|580908193|FG000|Overall Study|Disease progression, refractory|1|||
160868003|NCT00477386|580908194|FG001|Overall Study|Disease progression, refractory|3|||
160868004|NCT00477386|580908193|FG000|Overall Study|Other|1|||
160868005|NCT00477386|580908194|FG001|Overall Study|Other|2|||
160868006|NCT00477386|580908193|FG000|Overall Study|Physician Decision|1|||
160868007|NCT00477386|580908194|FG001|Overall Study|Physician Decision|0|||
160868008|NCT00477386|580908193|FG000|Overall Study|Withdrawal by Subject|1|||
160868009|NCT00477386|580908194|FG001|Overall Study|Withdrawal by Subject|0|||
160868010|NCT01254422|580908195|FG000|Overall Study|Protocol Violation|1|||
160868011|NCT01254422|580908196|FG001|Overall Study|Protocol Violation|0|||
160868012|NCT01254422|580908195|FG000|Overall Study|Adverse Event|1|||
160868013|NCT01254422|580908196|FG001|Overall Study|Adverse Event|0|||
160868014|NCT01254422|580908195|FG000|Overall Study|Serious adverse event|0|||
160868015|NCT01254422|580908196|FG001|Overall Study|Serious adverse event|1|||
160868016|NCT01254422|580908195|FG000|Overall Study|Lost to Follow-up|1|||
160868017|NCT01254422|580908196|FG001|Overall Study|Lost to Follow-up|0|||
160868018|NCT00643162|580908197|FG000|Overall Study|Withdrawal by Subject|1|||
160868019|NCT00643162|580908198|FG001|Overall Study|Withdrawal by Subject|1|||
160868020|NCT05038982|580908199|FG000|Overall Study|Withdrawal by Subject|0|||
160868021|NCT05038982|580908200|FG001|Overall Study|Withdrawal by Subject|2|||
160868022|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
160868023|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
160868024|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
160868025|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
160868026|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
160868027|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
160868028|NCT02592798|580908203|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
160868029|NCT02592798|580908204|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
160868030|NCT02592798|580908203|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
160868031|NCT02592798|580908204|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
160868032|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
160868033|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
160868034|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
160868035|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
160868036|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
160868037|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
160868038|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
160868039|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
160868040|NCT02592798|580908203|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
160868041|NCT02592798|580908204|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
160868042|NCT02592798|580908203|FG000|Transition From DB2 to OLE|Other reasons|1|||
160868043|NCT02592798|580908204|FG001|Transition From DB2 to OLE|Other reasons|0|||
160868044|NCT02592798|580908203|FG000|Open Label Period (OLE)|Other reasons|0|||
160868045|NCT02592798|580908204|FG001|Open Label Period (OLE)|Other reasons|2|||
160868046|NCT02592798|580908203|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
160868047|NCT02592798|580908204|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
160868048|NCT02592798|580908203|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
160868049|NCT02592798|580908204|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
160868050|NCT02592798|580908203|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
160868051|NCT02592798|580908204|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
160868052|NCT02592798|580908203|FG000|Open Label Period (OLE)|Adverse Event|0|||
160868053|NCT02592798|580908204|FG001|Open Label Period (OLE)|Adverse Event|1|||
160868054|NCT01143246|580908205|FG000|Overall Study|Adverse Event|24|||
160868055|NCT01143246|580908206|FG001|Overall Study|Adverse Event|28|||
160868056|NCT01143246|580908205|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
160868057|NCT01143246|580908206|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
160868058|NCT01143246|580908205|FG000|Overall Study|Lost to Follow-up|0|||
160868059|NCT01143246|580908206|FG001|Overall Study|Lost to Follow-up|1|||
160868060|NCT01143246|580908205|FG000|Overall Study|Death|16|||
160868061|NCT01143246|580908206|FG001|Overall Study|Death|15|||
160868062|NCT01143246|580908205|FG000|Overall Study|Reason not Specified|3|||
160868063|NCT01143246|580908206|FG001|Overall Study|Reason not Specified|5|||
160868064|NCT01146795|580908207|FG000|Overall Study|Withdrawal by Subject|4|||
160868065|NCT01146795|580908207|FG000|Overall Study|Adverse Event|6|||
161214644|NCT01859390|582169431|FG001|Overall Study|Sample Missing Collection Date|1|||
161214645|NCT01859390|582169430|FG000|Overall Study|Tube Cracked|0|||
160868066|NCT01146795|580908207|FG000|Overall Study|Still in treatment at study closure|10|||
160868067|NCT05375760|580908208|FG000|Overall Study|Adverse Event|1|||
160868068|NCT05375760|580908209|FG001|Overall Study|Adverse Event|0|||
160868069|NCT05375760|580908208|FG000|Overall Study|Death|0|||
161214646|NCT01859390|582169431|FG001|Overall Study|Tube Cracked|2|||
160868070|NCT05375760|580908209|FG001|Overall Study|Death|1|||
160868071|NCT05375760|580908208|FG000|Overall Study|Lost to Follow-up|6|||
160868072|NCT05375760|580908209|FG001|Overall Study|Lost to Follow-up|6|||
160868073|NCT05375760|580908208|FG000|Overall Study|Withdrawal by Subject|17|||
160868074|NCT05375760|580908209|FG001|Overall Study|Withdrawal by Subject|19|||
160868075|NCT05375760|580908208|FG000|Overall Study|Dosing halted by FDA|96|||
160868076|NCT05375760|580908209|FG001|Overall Study|Dosing halted by FDA|100|||
160868077|NCT05375760|580908208|FG000|Overall Study|Not compliant with study visit|2|||
160868078|NCT05375760|580908209|FG001|Overall Study|Not compliant with study visit|0|||
160868079|NCT05375760|580908208|FG000|Overall Study|Physician Decision|1|||
161109504|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
161214647|NCT01859390|582169430|FG000|Overall Study|Shipment Error|0|||
161214648|NCT01859390|582169431|FG001|Overall Study|Shipment Error|1|||
161214649|NCT02451670|582169432|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
161214650|NCT02451670|582169433|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
160868080|NCT05375760|580908209|FG001|Overall Study|Physician Decision|0|||
161214651|NCT03549130|582169439|FG000|Overall Study|Adverse Event|0|||
161214652|NCT03549130|582169440|FG001|Overall Study|Adverse Event|1|||
161214653|NCT03549130|582169439|FG000|Overall Study|Lost to Follow-up|0|||
161214654|NCT03549130|582169440|FG001|Overall Study|Lost to Follow-up|1|||
161214655|NCT01078623|582169441|FG000|Treatment Period 1|Adverse Event|1|||
161214656|NCT01078623|582169442|FG001|Treatment Period 1|Adverse Event|1|||
161214657|NCT01078623|582169443|FG002|Treatment Period 1|Adverse Event|1|||
161214658|NCT01078623|582169444|FG003|Treatment Period 1|Adverse Event|0|||
161214659|NCT01078623|582169445|FG004|Treatment Period 1|Adverse Event|0|||
161214660|NCT01078623|582169446|FG005|Treatment Period 1|Adverse Event|0|||
161214661|NCT01078623|582169447|FG006|Treatment Period 1|Adverse Event|1|||
161214662|NCT01078623|582169448|FG007|Treatment Period 1|Adverse Event|0|||
161214663|NCT01078623|582169449|FG008|Treatment Period 1|Adverse Event|1|||
161214664|NCT01078623|582169450|FG009|Treatment Period 1|Adverse Event|1|||
161214665|NCT01078623|582169451|FG010|Treatment Period 1|Adverse Event|0|||
161214666|NCT01078623|582169452|FG011|Treatment Period 1|Adverse Event|0|||
161214667|NCT01078623|582169453|FG012|Treatment Period 1|Adverse Event|0|||
161214668|NCT01078623|582169454|FG013|Treatment Period 1|Adverse Event|0|||
161214669|NCT01078623|582169455|FG014|Treatment Period 1|Adverse Event|0|||
161214670|NCT01078623|582169456|FG015|Treatment Period 1|Adverse Event|0|||
161214671|NCT01078623|582169457|FG016|Treatment Period 1|Adverse Event|0|||
161214672|NCT01078623|582169458|FG017|Treatment Period 1|Adverse Event|0|||
161214673|NCT01078623|582169459|FG018|Treatment Period 1|Adverse Event|0|||
161214674|NCT01078623|582169460|FG019|Treatment Period 1|Adverse Event|0|||
161214675|NCT01078623|582169441|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161214676|NCT01078623|582169442|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161214677|NCT01078623|582169443|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161214678|NCT01078623|582169444|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161214679|NCT01078623|582169445|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161214680|NCT01078623|582169446|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161214681|NCT01078623|582169447|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161214682|NCT01078623|582169448|FG007|Treatment Period 1|Withdrawal by Subject|1|||
161214683|NCT01078623|582169449|FG008|Treatment Period 1|Withdrawal by Subject|0|||
161214684|NCT01078623|582169450|FG009|Treatment Period 1|Withdrawal by Subject|0|||
161214685|NCT01078623|582169451|FG010|Treatment Period 1|Withdrawal by Subject|1|||
161214686|NCT01078623|582169452|FG011|Treatment Period 1|Withdrawal by Subject|0|||
161214687|NCT01078623|582169453|FG012|Treatment Period 1|Withdrawal by Subject|0|||
161214688|NCT01078623|582169454|FG013|Treatment Period 1|Withdrawal by Subject|0|||
161214689|NCT01078623|582169455|FG014|Treatment Period 1|Withdrawal by Subject|0|||
161214690|NCT01078623|582169456|FG015|Treatment Period 1|Withdrawal by Subject|0|||
161214691|NCT01078623|582169457|FG016|Treatment Period 1|Withdrawal by Subject|0|||
161214692|NCT01078623|582169458|FG017|Treatment Period 1|Withdrawal by Subject|0|||
161214693|NCT01078623|582169459|FG018|Treatment Period 1|Withdrawal by Subject|0|||
161214694|NCT01078623|582169460|FG019|Treatment Period 1|Withdrawal by Subject|0|||
161214695|NCT01078623|582169441|FG000|Treatment Period 1|Protocol Violation|0|||
161214696|NCT01078623|582169442|FG001|Treatment Period 1|Protocol Violation|0|||
161214697|NCT01078623|582169443|FG002|Treatment Period 1|Protocol Violation|0|||
161214698|NCT01078623|582169444|FG003|Treatment Period 1|Protocol Violation|0|||
161214699|NCT01078623|582169445|FG004|Treatment Period 1|Protocol Violation|0|||
161214700|NCT01078623|582169446|FG005|Treatment Period 1|Protocol Violation|1|||
161214701|NCT01078623|582169447|FG006|Treatment Period 1|Protocol Violation|0|||
161214702|NCT01078623|582169448|FG007|Treatment Period 1|Protocol Violation|0|||
161214703|NCT01078623|582169449|FG008|Treatment Period 1|Protocol Violation|0|||
161214704|NCT01078623|582169450|FG009|Treatment Period 1|Protocol Violation|0|||
161214705|NCT01078623|582169451|FG010|Treatment Period 1|Protocol Violation|0|||
161214706|NCT01078623|582169452|FG011|Treatment Period 1|Protocol Violation|0|||
161214707|NCT01078623|582169453|FG012|Treatment Period 1|Protocol Violation|0|||
161214708|NCT01078623|582169454|FG013|Treatment Period 1|Protocol Violation|0|||
161214709|NCT01078623|582169455|FG014|Treatment Period 1|Protocol Violation|0|||
161214710|NCT01078623|582169456|FG015|Treatment Period 1|Protocol Violation|0|||
161214711|NCT01078623|582169457|FG016|Treatment Period 1|Protocol Violation|0|||
161214712|NCT01078623|582169458|FG017|Treatment Period 1|Protocol Violation|0|||
161214713|NCT01078623|582169459|FG018|Treatment Period 1|Protocol Violation|0|||
161214714|NCT01078623|582169460|FG019|Treatment Period 1|Protocol Violation|0|||
161214715|NCT01078623|582169441|FG000|Treatment Period 2|Adverse Event|0|||
161214716|NCT01078623|582169442|FG001|Treatment Period 2|Adverse Event|0|||
161214717|NCT01078623|582169443|FG002|Treatment Period 2|Adverse Event|0|||
161214718|NCT01078623|582169444|FG003|Treatment Period 2|Adverse Event|0|||
161214719|NCT01078623|582169445|FG004|Treatment Period 2|Adverse Event|0|||
161214720|NCT01078623|582169446|FG005|Treatment Period 2|Adverse Event|0|||
161214721|NCT01078623|582169447|FG006|Treatment Period 2|Adverse Event|1|||
161214722|NCT01078623|582169448|FG007|Treatment Period 2|Adverse Event|0|||
161214723|NCT01078623|582169449|FG008|Treatment Period 2|Adverse Event|0|||
161214724|NCT01078623|582169450|FG009|Treatment Period 2|Adverse Event|0|||
160868081|NCT05375760|580908208|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
161214725|NCT01078623|582169451|FG010|Treatment Period 2|Adverse Event|0|||
161214726|NCT01078623|582169452|FG011|Treatment Period 2|Adverse Event|0|||
161214727|NCT01078623|582169453|FG012|Treatment Period 2|Adverse Event|0|||
161214728|NCT01078623|582169454|FG013|Treatment Period 2|Adverse Event|0|||
161214729|NCT01078623|582169455|FG014|Treatment Period 2|Adverse Event|0|||
161214730|NCT01078623|582169456|FG015|Treatment Period 2|Adverse Event|0|||
161214731|NCT01078623|582169457|FG016|Treatment Period 2|Adverse Event|0|||
161214732|NCT01078623|582169458|FG017|Treatment Period 2|Adverse Event|0|||
161214733|NCT01078623|582169459|FG018|Treatment Period 2|Adverse Event|1|||
161214734|NCT01078623|582169460|FG019|Treatment Period 2|Adverse Event|0|||
161214735|NCT01078623|582169441|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160868082|NCT05375760|580908209|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
161214736|NCT01078623|582169442|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161214737|NCT01078623|582169443|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160868083|NCT05375760|580908208|FG000|Overall Study|Participant moved|1|||
160868084|NCT05375760|580908209|FG001|Overall Study|Participant moved|0|||
160868085|NCT03853109|580908210|FG000|Overall Study|Withdrawal by Subject|0|||
160868086|NCT03853109|580908211|FG001|Overall Study|Withdrawal by Subject|0|||
160868087|NCT03853109|580908212|FG002|Overall Study|Withdrawal by Subject|1|||
160868088|NCT03853109|580908213|FG003|Overall Study|Withdrawal by Subject|2|||
160868089|NCT03853109|580908214|FG004|Overall Study|Withdrawal by Subject|1|||
160868090|NCT03853109|580908215|FG005|Overall Study|Withdrawal by Subject|4|||
160868091|NCT03853109|580908216|FG006|Overall Study|Withdrawal by Subject|5|||
160868092|NCT03853109|580908217|FG007|Overall Study|Withdrawal by Subject|3|||
160868093|NCT03853109|580908210|FG000|Overall Study|Decision by Sponsor|0|||
160868094|NCT03853109|580908211|FG001|Overall Study|Decision by Sponsor|0|||
160868095|NCT03853109|580908212|FG002|Overall Study|Decision by Sponsor|1|||
160868096|NCT03853109|580908213|FG003|Overall Study|Decision by Sponsor|0|||
160868097|NCT03853109|580908214|FG004|Overall Study|Decision by Sponsor|1|||
160868098|NCT03853109|580908215|FG005|Overall Study|Decision by Sponsor|1|||
160868099|NCT03853109|580908216|FG006|Overall Study|Decision by Sponsor|10|||
160868100|NCT03853109|580908217|FG007|Overall Study|Decision by Sponsor|2|||
160868101|NCT03853109|580908210|FG000|Overall Study|Lost to Follow-up|0|||
160868102|NCT03853109|580908211|FG001|Overall Study|Lost to Follow-up|0|||
160868103|NCT03853109|580908212|FG002|Overall Study|Lost to Follow-up|0|||
160868104|NCT03853109|580908213|FG003|Overall Study|Lost to Follow-up|0|||
160868105|NCT03853109|580908214|FG004|Overall Study|Lost to Follow-up|1|||
160868106|NCT03853109|580908215|FG005|Overall Study|Lost to Follow-up|3|||
160868107|NCT03853109|580908216|FG006|Overall Study|Lost to Follow-up|0|||
160868108|NCT03853109|580908217|FG007|Overall Study|Lost to Follow-up|0|||
160868109|NCT03853109|580908210|FG000|Overall Study|Death|2|||
160868110|NCT03853109|580908211|FG001|Overall Study|Death|5|||
160868111|NCT03853109|580908212|FG002|Overall Study|Death|8|||
160868112|NCT03853109|580908213|FG003|Overall Study|Death|10|||
160868113|NCT03853109|580908214|FG004|Overall Study|Death|3|||
160868114|NCT03853109|580908215|FG005|Overall Study|Death|20|||
160868115|NCT03853109|580908216|FG006|Overall Study|Death|10|||
160868116|NCT03853109|580908217|FG007|Overall Study|Death|5|||
160868117|NCT02745119|580908222|FG000|Overall Study|Adverse Event|1|||
160868118|NCT02745119|580908223|FG001|Overall Study|Adverse Event|0|||
160868119|NCT02745119|580908224|FG002|Overall Study|Adverse Event|1|||
160868120|NCT02745119|580908225|FG003|Overall Study|Adverse Event|3|||
160868121|NCT02745119|580908222|FG000|Overall Study|Death|3|||
160868122|NCT02745119|580908223|FG001|Overall Study|Death|3|||
160868123|NCT02745119|580908224|FG002|Overall Study|Death|0|||
160868124|NCT02745119|580908225|FG003|Overall Study|Death|4|||
160868125|NCT02745119|580908222|FG000|Overall Study|Lost to Follow-up|0|||
160868126|NCT02745119|580908223|FG001|Overall Study|Lost to Follow-up|0|||
160868127|NCT02745119|580908224|FG002|Overall Study|Lost to Follow-up|0|||
160868128|NCT02745119|580908225|FG003|Overall Study|Lost to Follow-up|1|||
160868129|NCT02745119|580908222|FG000|Overall Study|Protocol Deviation|0|||
160868130|NCT02745119|580908223|FG001|Overall Study|Protocol Deviation|0|||
161109505|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161109506|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
160868131|NCT02745119|580908224|FG002|Overall Study|Protocol Deviation|0|||
161109507|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
160868132|NCT02745119|580908225|FG003|Overall Study|Protocol Deviation|1|||
160868133|NCT02745119|580908222|FG000|Overall Study|Withdrawal by Subject|7|||
160868134|NCT02745119|580908223|FG001|Overall Study|Withdrawal by Subject|15|||
160868135|NCT02745119|580908224|FG002|Overall Study|Withdrawal by Subject|8|||
161109508|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
160868136|NCT02745119|580908225|FG003|Overall Study|Withdrawal by Subject|14|||
160868137|NCT02745119|580908222|FG000|Overall Study|Study Terminated by Sponsor|134|||
160868138|NCT02745119|580908223|FG001|Overall Study|Study Terminated by Sponsor|252|||
160868139|NCT02745119|580908224|FG002|Overall Study|Study Terminated by Sponsor|135|||
160868140|NCT02745119|580908225|FG003|Overall Study|Study Terminated by Sponsor|251|||
160868141|NCT02745119|580908222|FG000|Overall Study|Physician Decision|0|||
160868142|NCT02745119|580908223|FG001|Overall Study|Physician Decision|2|||
160868143|NCT02745119|580908224|FG002|Overall Study|Physician Decision|2|||
160868144|NCT02745119|580908225|FG003|Overall Study|Physician Decision|2|||
160868145|NCT02745119|580908222|FG000|Overall Study|Reason Not Specified|0|||
160868146|NCT02745119|580908223|FG001|Overall Study|Reason Not Specified|2|||
160868147|NCT02745119|580908224|FG002|Overall Study|Reason Not Specified|0|||
161214738|NCT01078623|582169444|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160868148|NCT02745119|580908225|FG003|Overall Study|Reason Not Specified|1|||
160868149|NCT00960999|580908226|FG000|Overall Study|Withdrawal by Subject|1|||
161214739|NCT01078623|582169445|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160868150|NCT00960999|580908227|FG001|Overall Study|Withdrawal by Subject|0|||
160868151|NCT00960999|580908226|FG000|Overall Study|Protocol Violation|5|||
160868152|NCT00960999|580908227|FG001|Overall Study|Protocol Violation|2|||
160868153|NCT00960999|580908226|FG000|Overall Study|RT dose constraints not met|2|||
160868154|NCT00960999|580908227|FG001|Overall Study|RT dose constraints not met|0|||
160868155|NCT00888940|580908228|FG000|Overall Study|Adverse Event|12|||
160868156|NCT00888940|580908229|FG001|Overall Study|Adverse Event|3|||
160868157|NCT00888940|580908228|FG000|Overall Study|Lost to Follow-up|5|||
160868158|NCT00888940|580908229|FG001|Overall Study|Lost to Follow-up|5|||
160868159|NCT00888940|580908228|FG000|Overall Study|Randomized Not Treated|11|||
160868160|NCT00888940|580908229|FG001|Overall Study|Randomized Not Treated|13|||
160868161|NCT02536963|580908230|FG000|Overall Study|Withdrawal by Subject|18|||
160868162|NCT02668393|580908231|FG000|Overall Study|Progressive disease|6|||
160868163|NCT02668393|580908232|FG001|Overall Study|Progressive disease|3|||
160868164|NCT02668393|580908231|FG000|Overall Study|Adverse Event|0|||
160868165|NCT02668393|580908232|FG001|Overall Study|Adverse Event|2|||
160868166|NCT02668393|580908231|FG000|Overall Study|Withdrawal from the trial|0|||
160868167|NCT02668393|580908232|FG001|Overall Study|Withdrawal from the trial|1|||
160868168|NCT02668393|580908231|FG000|Overall Study|Lack of benefit and side effects|1|||
160868169|NCT02668393|580908232|FG001|Overall Study|Lack of benefit and side effects|0|||
160868170|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
160868171|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
160868172|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
160868173|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
160868174|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
160868175|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
160868176|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
160868177|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
160868178|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
160868179|NCT00174187|580908233|FG000|Period 1 (up to 3 Years)|Other|0|||
160868180|NCT00174187|580908234|FG001|Period 1 (up to 3 Years)|Other|1|||
160868181|NCT00174187|580908235|FG002|Period 1 (up to 3 Years)|Other|0|||
160868182|NCT00174187|580908233|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
160868183|NCT00174187|580908234|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
160868184|NCT00174187|580908235|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
160868185|NCT00174187|580908233|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
160868186|NCT00174187|580908234|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
160868187|NCT00174187|580908235|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
160868188|NCT00174187|580908233|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
160868189|NCT00174187|580908234|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
160868190|NCT00174187|580908235|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
160868191|NCT00174187|580908233|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
160868192|NCT00174187|580908234|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
160868193|NCT00174187|580908235|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
160868194|NCT00174187|580908233|FG000|Period 2 (After 3 Years)|Other|0|||
160868195|NCT00174187|580908234|FG001|Period 2 (After 3 Years)|Other|0|||
160868196|NCT00174187|580908235|FG002|Period 2 (After 3 Years)|Other|5|||
160868197|NCT01285557|580908236|FG000|Overall Study|Death|173|||
160868198|NCT01285557|580908237|FG001|Overall Study|Death|90|||
160868199|NCT01285557|580908236|FG000|Overall Study|Lost to Follow-up|6|||
160868200|NCT01285557|580908237|FG001|Overall Study|Lost to Follow-up|2|||
160868201|NCT01285557|580908236|FG000|Overall Study|Withdrew Consent|6|||
160868202|NCT01285557|580908237|FG001|Overall Study|Withdrew Consent|1|||
160868203|NCT01285557|580908236|FG000|Overall Study|Sponsor Study Termination|23|||
160868204|NCT01285557|580908237|FG001|Overall Study|Sponsor Study Termination|13|||
160868205|NCT01285557|580908236|FG000|Overall Study|Randomized but not treated|1|||
160868206|NCT01285557|580908237|FG001|Overall Study|Randomized but not treated|1|||
160868207|NCT01285557|580908236|FG000|Overall Study|Study follow-up ongoing|28|||
160868208|NCT01285557|580908237|FG001|Overall Study|Study follow-up ongoing|14|||
160868209|NCT01285557|580908236|FG000|Overall Study|Sponsor Decision|2|||
160981501|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
160981502|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
161324357|NCT01408901|582573580|FG003|6-Week Follow-Up|Cancelled visit|2|||
160868210|NCT01285557|580908237|FG001|Overall Study|Sponsor Decision|1|||
160868211|NCT02991768|580908243|FG000|Overall Study|Physician Decision|4|||
160868212|NCT02273596|580910300|FG000|24-Week Treatment Period|Adverse Event|3|||
160868213|NCT02273596|580910300|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
160868214|NCT02273596|580910300|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
160868215|NCT02273596|580910300|FG000|24-Week Treatment Period|Physician Decision|1|||
160868216|NCT02273596|580910300|FG000|24-Week Treatment Period|Protocol Deviation|1|||
160868217|NCT02273596|580910300|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
160868218|NCT02273596|580910300|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
160868219|NCT02273596|580910300|FG000|Extension Period|Lost to Follow-up|1|||
160868220|NCT02273596|580910300|FG000|Extension Period|Protocol Deviation|1|||
160868221|NCT02139592|580910302|FG000|Overall Study|Case Report Forms Uncollected|8|||
160868222|NCT02873702|580910306|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
160868223|NCT02873702|580910307|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
160868224|NCT02873702|580910308|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
160868225|NCT02873702|580910309|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
160868226|NCT02873702|580910306|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
160868227|NCT02873702|580910307|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
160868228|NCT02873702|580910308|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
160868229|NCT02873702|580910309|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
160868230|NCT02873702|580910306|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
160868231|NCT02873702|580910307|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
160868232|NCT02873702|580910308|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
160868233|NCT02873702|580910309|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
160868234|NCT02873702|580910306|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
160868235|NCT02873702|580910307|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
160868236|NCT02873702|580910308|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
160868237|NCT02873702|580910309|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
160868238|NCT02873702|580910306|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
160868239|NCT02873702|580910307|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
160868240|NCT02873702|580910308|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
160868241|NCT02873702|580910309|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
160868242|NCT02803580|580910310|FG000|Overall Study|Death|13|||
160868243|NCT02803580|580910310|FG000|Overall Study|Lost to Follow-up|19|||
160868244|NCT02803580|580910310|FG000|Overall Study|Withdrawal by Subject|3|||
160868245|NCT02803580|580910310|FG000|Overall Study|Inclusion in clinical trial|1|||
161109509|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161109510|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161109511|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
161109512|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
161109513|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161109514|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161109515|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
161109516|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161214740|NCT01078623|582169446|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160868246|NCT01358721|580910313|FG000|Overall Study|Withdrawal by Subject|0|||
160868247|NCT01358721|580910314|FG001|Overall Study|Withdrawal by Subject|0|||
160868248|NCT01358721|580910315|FG002|Overall Study|Withdrawal by Subject|0|||
160868249|NCT01358721|580910316|FG003|Overall Study|Withdrawal by Subject|1|||
160868250|NCT01358721|580910313|FG000|Overall Study|Death|0|||
160868251|NCT01358721|580910314|FG001|Overall Study|Death|2|||
160868252|NCT01358721|580910315|FG002|Overall Study|Death|0|||
160868253|NCT01358721|580910316|FG003|Overall Study|Death|0|||
160868254|NCT01358721|580910313|FG000|Overall Study|Study Drug Toxicity|1|||
160868255|NCT01358721|580910314|FG001|Overall Study|Study Drug Toxicity|3|||
160868256|NCT01358721|580910315|FG002|Overall Study|Study Drug Toxicity|4|||
160868257|NCT01358721|580910316|FG003|Overall Study|Study Drug Toxicity|5|||
160868258|NCT01358721|580910313|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
160868259|NCT01358721|580910314|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
160868260|NCT01358721|580910315|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
160868261|NCT01358721|580910316|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
160868262|NCT01358721|580910313|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160868263|NCT01358721|580910314|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
160868264|NCT01358721|580910315|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
160868265|NCT01358721|580910316|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
160868266|NCT01358721|580910313|FG000|Overall Study|Adverse Event related to study drug|1|||
160868267|NCT01358721|580910314|FG001|Overall Study|Adverse Event related to study drug|0|||
160868268|NCT01358721|580910315|FG002|Overall Study|Adverse Event related to study drug|0|||
160868269|NCT01358721|580910316|FG003|Overall Study|Adverse Event related to study drug|1|||
160868270|NCT01358721|580910313|FG000|Overall Study|Disease Progression|19|||
160868271|NCT01358721|580910314|FG001|Overall Study|Disease Progression|15|||
160868272|NCT01358721|580910315|FG002|Overall Study|Disease Progression|17|||
160868273|NCT01358721|580910316|FG003|Overall Study|Disease Progression|15|||
160868274|NCT01358721|580910313|FG000|Overall Study|Out of State/Unmet Criteria|0|||
160868275|NCT01358721|580910314|FG001|Overall Study|Out of State/Unmet Criteria|0|||
160868276|NCT01358721|580910315|FG002|Overall Study|Out of State/Unmet Criteria|1|||
160868277|NCT01358721|580910316|FG003|Overall Study|Out of State/Unmet Criteria|0|||
160868278|NCT04614974|580910317|FG000|Overall Study|Lost to Follow-up|14|||
160868279|NCT04614974|580910318|FG001|Overall Study|Lost to Follow-up|11|||
160868280|NCT00658359|580910320|FG000|Overall Study|Death|3|||
160868281|NCT00658359|580910321|FG001|Overall Study|Death|1|||
160868282|NCT00658359|580910322|FG002|Overall Study|Death|2|||
160868283|NCT00658359|580910320|FG000|Overall Study|Adverse Event|13|||
160868284|NCT00658359|580910321|FG001|Overall Study|Adverse Event|6|||
160868285|NCT00658359|580910322|FG002|Overall Study|Adverse Event|9|||
160868286|NCT00658359|580910320|FG000|Overall Study|Protocol Violation|1|||
160868287|NCT00658359|580910321|FG001|Overall Study|Protocol Violation|0|||
160868288|NCT00658359|580910322|FG002|Overall Study|Protocol Violation|0|||
160868289|NCT00658359|580910320|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
160868290|NCT00658359|580910321|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
160868291|NCT00658359|580910322|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
160868292|NCT00658359|580910320|FG000|Overall Study|Withdrawal by Subject|7|||
160868293|NCT00658359|580910321|FG001|Overall Study|Withdrawal by Subject|4|||
160868294|NCT00658359|580910322|FG002|Overall Study|Withdrawal by Subject|2|||
160868295|NCT00658359|580910320|FG000|Overall Study|Lost to Follow-up|2|||
160868296|NCT00658359|580910321|FG001|Overall Study|Lost to Follow-up|2|||
160868297|NCT00658359|580910322|FG002|Overall Study|Lost to Follow-up|4|||
160868298|NCT00658359|580910320|FG000|Overall Study|Lack of Efficacy|0|||
160868299|NCT00658359|580910321|FG001|Overall Study|Lack of Efficacy|1|||
160868300|NCT00658359|580910322|FG002|Overall Study|Lack of Efficacy|0|||
160868301|NCT02754440|580910323|FG000|Overall Study|Protocol Violation|3|||
160868302|NCT02754440|580910324|FG001|Overall Study|Protocol Violation|2|||
160868303|NCT02754440|580910325|FG002|Overall Study|Protocol Violation|2|||
160868304|NCT02754440|580910326|FG003|Overall Study|Protocol Violation|6|||
160868305|NCT02754440|580910323|FG000|Overall Study|Adverse Event|3|||
160868306|NCT02754440|580910324|FG001|Overall Study|Adverse Event|1|||
160868307|NCT02754440|580910325|FG002|Overall Study|Adverse Event|0|||
160868308|NCT02754440|580910326|FG003|Overall Study|Adverse Event|9|||
160868309|NCT02754440|580910323|FG000|Overall Study|Withdrawal by Subject|0|||
160868310|NCT02754440|580910324|FG001|Overall Study|Withdrawal by Subject|0|||
160868311|NCT02754440|580910325|FG002|Overall Study|Withdrawal by Subject|0|||
160868312|NCT02754440|580910326|FG003|Overall Study|Withdrawal by Subject|1|||
160868313|NCT02754440|580910323|FG000|Overall Study|Equipment failure|0|||
160868314|NCT02754440|580910324|FG001|Overall Study|Equipment failure|5|||
160868315|NCT02754440|580910325|FG002|Overall Study|Equipment failure|5|||
160868316|NCT02754440|580910326|FG003|Overall Study|Equipment failure|7|||
160868317|NCT02754440|580910323|FG000|Overall Study|Subject issues not resulting in AE|0|||
160868318|NCT02754440|580910324|FG001|Overall Study|Subject issues not resulting in AE|0|||
160868319|NCT02754440|580910325|FG002|Overall Study|Subject issues not resulting in AE|0|||
160868320|NCT02754440|580910326|FG003|Overall Study|Subject issues not resulting in AE|12|||
160868321|NCT02560558|580910327|FG000|Overall Study|Adverse Event|1|||
160868322|NCT02560558|580910328|FG001|Overall Study|Adverse Event|0|||
160868323|NCT02560558|580910327|FG000|Overall Study|Death|0|||
160868324|NCT02560558|580910328|FG001|Overall Study|Death|2|||
160868325|NCT02560558|580910327|FG000|Overall Study|Lost to Follow-up|0|||
160868326|NCT02560558|580910328|FG001|Overall Study|Lost to Follow-up|4|||
160868327|NCT02560558|580910327|FG000|Overall Study|Protocol Violation|3|||
160868328|NCT02560558|580910328|FG001|Overall Study|Protocol Violation|0|||
160868329|NCT02560558|580910327|FG000|Overall Study|Withdrawal by Subject|3|||
160868330|NCT02560558|580910328|FG001|Overall Study|Withdrawal by Subject|0|||
160868331|NCT01189032|580910333|FG000|Overall Study|Adverse Event|1|||
160868332|NCT01189032|580910334|FG001|Overall Study|Adverse Event|3|||
160868333|NCT01189032|580910335|FG002|Overall Study|Adverse Event|4|||
160868334|NCT01189032|580910333|FG000|Overall Study|Lack of Efficacy|2|||
160868335|NCT01189032|580910334|FG001|Overall Study|Lack of Efficacy|3|||
160868336|NCT01189032|580910335|FG002|Overall Study|Lack of Efficacy|0|||
160868337|NCT01189032|580910333|FG000|Overall Study|Withdrawal by Subject|1|||
160868338|NCT01189032|580910334|FG001|Overall Study|Withdrawal by Subject|0|||
160868339|NCT01189032|580910335|FG002|Overall Study|Withdrawal by Subject|1|||
160868340|NCT01189032|580910333|FG000|Overall Study|Protocol Violation|1|||
160868341|NCT01189032|580910334|FG001|Overall Study|Protocol Violation|1|||
160868342|NCT01189032|580910335|FG002|Overall Study|Protocol Violation|1|||
160868343|NCT01995838|580910336|FG000|Overall Study|Lost to Follow-up|0|||
160868344|NCT01995838|580910337|FG001|Overall Study|Lost to Follow-up|1|||
160868345|NCT01995838|580910338|FG002|Overall Study|Lost to Follow-up|0|||
160868346|NCT01995838|580910339|FG003|Overall Study|Lost to Follow-up|0|||
160868347|NCT01995838|580910340|FG004|Overall Study|Lost to Follow-up|0|||
160868348|NCT01995838|580910341|FG005|Overall Study|Lost to Follow-up|0|||
160868349|NCT01995838|580910342|FG006|Overall Study|Lost to Follow-up|1|||
160868350|NCT01995838|580910336|FG000|Overall Study|Participant choice|2|||
160868351|NCT01995838|580910337|FG001|Overall Study|Participant choice|0|||
160868352|NCT01995838|580910338|FG002|Overall Study|Participant choice|0|||
160868353|NCT01995838|580910339|FG003|Overall Study|Participant choice|0|||
160868354|NCT01995838|580910340|FG004|Overall Study|Participant choice|0|||
160868355|NCT01995838|580910341|FG005|Overall Study|Participant choice|1|||
160868356|NCT01995838|580910342|FG006|Overall Study|Participant choice|1|||
160868357|NCT01995838|580910336|FG000|Overall Study|Adverse Event|0|||
160868358|NCT01995838|580910337|FG001|Overall Study|Adverse Event|0|||
160868359|NCT01995838|580910338|FG002|Overall Study|Adverse Event|0|||
160868360|NCT01995838|580910339|FG003|Overall Study|Adverse Event|0|||
160868361|NCT01995838|580910340|FG004|Overall Study|Adverse Event|0|||
160868362|NCT01995838|580910341|FG005|Overall Study|Adverse Event|0|||
160868363|NCT01995838|580910342|FG006|Overall Study|Adverse Event|1|||
160868364|NCT01995838|580910336|FG000|Overall Study|Withdrawal by Subject|0|||
160868365|NCT01995838|580910337|FG001|Overall Study|Withdrawal by Subject|0|||
160868366|NCT01995838|580910338|FG002|Overall Study|Withdrawal by Subject|0|||
160868367|NCT01995838|580910339|FG003|Overall Study|Withdrawal by Subject|0|||
160868368|NCT01995838|580910340|FG004|Overall Study|Withdrawal by Subject|1|||
160868369|NCT01995838|580910341|FG005|Overall Study|Withdrawal by Subject|0|||
160868370|NCT01995838|580910342|FG006|Overall Study|Withdrawal by Subject|0|||
160868371|NCT01995838|580910336|FG000|Overall Study|Other|3|||
160868372|NCT01995838|580910337|FG001|Overall Study|Other|1|||
160868373|NCT01995838|580910338|FG002|Overall Study|Other|0|||
160868374|NCT01995838|580910339|FG003|Overall Study|Other|2|||
160868375|NCT01995838|580910340|FG004|Overall Study|Other|1|||
160868376|NCT01995838|580910341|FG005|Overall Study|Other|1|||
160868377|NCT01995838|580910342|FG006|Overall Study|Other|2|||
160868378|NCT01967576|580910347|FG000|Overall Study|Withdrawal by Subject|3|||
160868379|NCT01967576|580910347|FG000|Overall Study|Progressed/Removed from treatment|1|||
160868380|NCT01967576|580910347|FG000|Overall Study|Study closing at site|1|||
160868381|NCT01967576|580910347|FG000|Overall Study|Adverse Event|1|||
160868382|NCT01967576|580910347|FG000|Overall Study|Refused further treatment|1|||
160868383|NCT02819804|580910348|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
160868384|NCT02858362|580910349|FG000|Overall Study|Protocol Violation|0|||
160868385|NCT02858362|580910350|FG001|Overall Study|Protocol Violation|1|||
161324358|NCT01408901|582573577|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
160868386|NCT02858362|580910351|FG002|Overall Study|Protocol Violation|0|||
160868387|NCT02858362|580910349|FG000|Overall Study|Withdrawal by Subject|1|||
160868388|NCT02858362|580910350|FG001|Overall Study|Withdrawal by Subject|0|||
160868389|NCT02858362|580910351|FG002|Overall Study|Withdrawal by Subject|0|||
160868390|NCT02858362|580910349|FG000|Overall Study|Early Study Termination|0|||
160868391|NCT02858362|580910350|FG001|Overall Study|Early Study Termination|0|||
160868392|NCT02858362|580910351|FG002|Overall Study|Early Study Termination|3|||
160868393|NCT02858362|580910349|FG000|Overall Study|Lost to Follow-up|1|||
160868394|NCT02858362|580910350|FG001|Overall Study|Lost to Follow-up|0|||
160868395|NCT02858362|580910351|FG002|Overall Study|Lost to Follow-up|0|||
160868396|NCT01821118|580910352|FG000|Overall Study|Death|0|||
160868397|NCT01821118|580910353|FG001|Overall Study|Death|1|||
160868398|NCT00345358|580910354|FG000|Primary Vaccination Phase|Other|0|||
160868399|NCT00345358|580910355|FG001|Primary Vaccination Phase|Other|1|||
160868400|NCT00345358|580910356|FG002|Primary Vaccination Phase|Other|1|||
160868401|NCT00345358|580910357|FG003|Primary Vaccination Phase|Other|0|||
160868402|NCT00345358|580910354|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
161109517|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161109518|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161109519|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
161109520|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
161109521|NCT01940471|581789886|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161109522|NCT01940471|581789887|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161109523|NCT01940471|581789888|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
161109524|NCT01940471|581789889|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161109525|NCT00418665|581789892|FG000|Treatment Period|Ineligibility determined|1|||
161109526|NCT00418665|581789893|FG001|Treatment Period|Ineligibility determined|1|||
161109527|NCT00418665|581789894|FG002|Treatment Period|Ineligibility determined|0|||
161109528|NCT00418665|581789892|FG000|Treatment Period|Adverse Event|2|||
161109529|NCT00418665|581789893|FG001|Treatment Period|Adverse Event|2|||
161109530|NCT00418665|581789894|FG002|Treatment Period|Adverse Event|0|||
161109531|NCT00418665|581789892|FG000|Treatment Period|Withdrawal by Subject|0|||
161109532|NCT00418665|581789893|FG001|Treatment Period|Withdrawal by Subject|3|||
161109533|NCT00418665|581789894|FG002|Treatment Period|Withdrawal by Subject|1|||
161109534|NCT00418665|581789892|FG000|Treatment Period|Requirement for alternative therapy|1|||
161109535|NCT00418665|581789893|FG001|Treatment Period|Requirement for alternative therapy|0|||
161109536|NCT00418665|581789894|FG002|Treatment Period|Requirement for alternative therapy|0|||
161109537|NCT00418665|581789892|FG000|Treatment Period|Physician Decision|1|||
161109538|NCT00418665|581789893|FG001|Treatment Period|Physician Decision|0|||
161109539|NCT00418665|581789894|FG002|Treatment Period|Physician Decision|3|||
161109540|NCT00418665|581789892|FG000|Treatment Extension|Adverse Event|1|||
161109541|NCT00418665|581789893|FG001|Treatment Extension|Adverse Event|0|||
161109542|NCT00418665|581789894|FG002|Treatment Extension|Adverse Event|0|||
161109543|NCT00418665|581789892|FG000|Treatment Extension|Withdrawal by Subject|1|||
161109544|NCT00418665|581789893|FG001|Treatment Extension|Withdrawal by Subject|0|||
161109545|NCT00418665|581789894|FG002|Treatment Extension|Withdrawal by Subject|0|||
161109546|NCT00418665|581789892|FG000|Treatment Extension|Requirement for alternative therapy|2|||
161109547|NCT00418665|581789893|FG001|Treatment Extension|Requirement for alternative therapy|2|||
161109548|NCT00418665|581789894|FG002|Treatment Extension|Requirement for alternative therapy|0|||
161109549|NCT00418665|581789892|FG000|Treatment Extension|Physician Decision|2|||
161109550|NCT00418665|581789893|FG001|Treatment Extension|Physician Decision|2|||
161109551|NCT00418665|581789894|FG002|Treatment Extension|Physician Decision|1|||
160868403|NCT00345358|580910355|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
160868404|NCT00345358|580910356|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
160868405|NCT00345358|580910357|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
160868406|NCT00345358|580910354|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
160868407|NCT00345358|580910355|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
160868408|NCT00345358|580910356|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
160868409|NCT00345358|580910357|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
160868410|NCT00345358|580910354|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
160868411|NCT00345358|580910355|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
160868412|NCT00345358|580910356|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
160868413|NCT00345358|580910357|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
160868414|NCT00345358|580910354|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
160868415|NCT00345358|580910355|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
160868416|NCT00345358|580910356|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
160868417|NCT00345358|580910357|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
160868418|NCT00345358|580910354|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
160868419|NCT00345358|580910355|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
160868420|NCT00345358|580910356|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
160868421|NCT00345358|580910357|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
160868422|NCT00346697|580910358|FG000|Overall Study|Lost to Follow-up|0|||
160868423|NCT00346697|580910359|FG001|Overall Study|Lost to Follow-up|1|||
160868424|NCT01012440|580910360|FG000|Overall Study|Withdrawal by Subject|2|||
160868425|NCT00131248|580910361|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
160868426|NCT00131248|580910362|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
160868427|NCT00318643|580910367|FG000|Overall Study|Adverse Event|0|||
160868428|NCT00318643|580910368|FG001|Overall Study|Adverse Event|0|||
160868429|NCT00318643|580910369|FG002|Overall Study|Adverse Event|0|||
160868430|NCT00318643|580910370|FG003|Overall Study|Adverse Event|0|||
160868431|NCT00318643|580910371|FG004|Overall Study|Adverse Event|1|||
160868432|NCT00318643|580910367|FG000|Overall Study|Participant's Decision|0|||
160868433|NCT00318643|580910368|FG001|Overall Study|Participant's Decision|0|||
160868434|NCT00318643|580910369|FG002|Overall Study|Participant's Decision|0|||
160868435|NCT00318643|580910370|FG003|Overall Study|Participant's Decision|0|||
160868436|NCT00318643|580910371|FG004|Overall Study|Participant's Decision|1|||
160868437|NCT00318643|580910367|FG000|Overall Study|Investigator's Decision|0|||
160868438|NCT00318643|580910368|FG001|Overall Study|Investigator's Decision|0|||
160868439|NCT00318643|580910369|FG002|Overall Study|Investigator's Decision|0|||
160868440|NCT00318643|580910370|FG003|Overall Study|Investigator's Decision|0|||
160868441|NCT00318643|580910371|FG004|Overall Study|Investigator's Decision|1|||
160868442|NCT02691507|580910374|FG000|Overall Study|Missed Visit 3|0|||
160868443|NCT02691507|580910375|FG001|Overall Study|Missed Visit 3|1|||
160868444|NCT02557139|580910376|FG000|Overall Study|Significant liver elevation|1|||
160868445|NCT02557139|580910377|FG001|Overall Study|Significant liver elevation|0|||
160868446|NCT02557139|580910378|FG002|Overall Study|Significant liver elevation|1|||
160868447|NCT02557139|580910376|FG000|Overall Study|Withdrawal by Subject|1|||
160868448|NCT02557139|580910377|FG001|Overall Study|Withdrawal by Subject|0|||
160868449|NCT02557139|580910378|FG002|Overall Study|Withdrawal by Subject|0|||
160868450|NCT02557139|580910376|FG000|Overall Study|Illness of prohibited medication|0|||
160868451|NCT02557139|580910377|FG001|Overall Study|Illness of prohibited medication|0|||
160868452|NCT02557139|580910378|FG002|Overall Study|Illness of prohibited medication|1|||
160868453|NCT02284243|580910379|FG000|Overall Study|Lack of Efficacy|3|||
160868454|NCT02284243|580910380|FG001|Overall Study|Lack of Efficacy|3|||
160868455|NCT02284243|580910379|FG000|Overall Study|Adverse Event|1|||
160868456|NCT02284243|580910380|FG001|Overall Study|Adverse Event|0|||
160868457|NCT01216189|580910381|FG000|Overall Study|Lost to Follow-up|21|||
160868458|NCT01216189|580910382|FG001|Overall Study|Lost to Follow-up|3|||
160868459|NCT01216189|580910381|FG000|Overall Study|Death|4|||
160868460|NCT01216189|580910382|FG001|Overall Study|Death|2|||
160868461|NCT04032093|580910383|FG000|Overall Study|Lost to Follow-up|7|||
161324359|NCT01408901|582573578|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
160868462|NCT04032093|580910384|FG001|Overall Study|Lost to Follow-up|7|||
160868463|NCT04032093|580910385|FG002|Overall Study|Lost to Follow-up|6|||
160868464|NCT04032093|580910386|FG003|Overall Study|Lost to Follow-up|10|||
160868465|NCT04032093|580910387|FG004|Overall Study|Lost to Follow-up|13|||
160868466|NCT04032093|580910388|FG005|Overall Study|Lost to Follow-up|7|||
160868467|NCT04032093|580910389|FG006|Overall Study|Lost to Follow-up|7|||
160868468|NCT04032093|580910390|FG007|Overall Study|Lost to Follow-up|5|||
160868469|NCT04032093|580910391|FG008|Overall Study|Lost to Follow-up|9|||
160868470|NCT04032093|580910392|FG009|Overall Study|Lost to Follow-up|12|||
160868471|NCT04032093|580910383|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868472|NCT04032093|580910384|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868473|NCT04032093|580910385|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868474|NCT04032093|580910386|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
160868475|NCT04032093|580910387|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
160868476|NCT04032093|580910388|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868477|NCT04032093|580910389|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868478|NCT04032093|580910390|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160868479|NCT04032093|580910391|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
160868480|NCT04032093|580910392|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
160868481|NCT04032093|580910383|FG000|Overall Study|Other|1|||
160868482|NCT04032093|580910384|FG001|Overall Study|Other|0|||
160868483|NCT04032093|580910385|FG002|Overall Study|Other|0|||
160868484|NCT04032093|580910386|FG003|Overall Study|Other|1|||
160868485|NCT04032093|580910387|FG004|Overall Study|Other|1|||
160868486|NCT04032093|580910388|FG005|Overall Study|Other|0|||
160868487|NCT04032093|580910389|FG006|Overall Study|Other|0|||
160868488|NCT04032093|580910390|FG007|Overall Study|Other|0|||
160868489|NCT04032093|580910391|FG008|Overall Study|Other|0|||
160868490|NCT04032093|580910392|FG009|Overall Study|Other|1|||
160868491|NCT04032093|580910383|FG000|Overall Study|Withdrawal by Subject|1|||
160868492|NCT04032093|580910384|FG001|Overall Study|Withdrawal by Subject|3|||
160868493|NCT04032093|580910385|FG002|Overall Study|Withdrawal by Subject|2|||
160868494|NCT04032093|580910386|FG003|Overall Study|Withdrawal by Subject|2|||
160868495|NCT04032093|580910387|FG004|Overall Study|Withdrawal by Subject|3|||
160868496|NCT04032093|580910388|FG005|Overall Study|Withdrawal by Subject|0|||
160868497|NCT04032093|580910389|FG006|Overall Study|Withdrawal by Subject|0|||
160868498|NCT04032093|580910390|FG007|Overall Study|Withdrawal by Subject|0|||
160868499|NCT04032093|580910391|FG008|Overall Study|Withdrawal by Subject|0|||
160868500|NCT04032093|580910392|FG009|Overall Study|Withdrawal by Subject|0|||
160868501|NCT04032093|580910383|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160868502|NCT04032093|580910384|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160868503|NCT04032093|580910385|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160868504|NCT04032093|580910386|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160868505|NCT04032093|580910387|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160868506|NCT04032093|580910388|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160868507|NCT04032093|580910389|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
160868508|NCT04032093|580910390|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
160868509|NCT04032093|580910391|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
160868510|NCT04032093|580910392|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
160868511|NCT04032093|580910383|FG000|Overall Study|Adverse Event|0|||
160868512|NCT04032093|580910384|FG001|Overall Study|Adverse Event|0|||
160868513|NCT04032093|580910385|FG002|Overall Study|Adverse Event|0|||
160868514|NCT04032093|580910386|FG003|Overall Study|Adverse Event|0|||
160868515|NCT04032093|580910387|FG004|Overall Study|Adverse Event|0|||
160868516|NCT04032093|580910388|FG005|Overall Study|Adverse Event|0|||
160868517|NCT04032093|580910389|FG006|Overall Study|Adverse Event|0|||
160868518|NCT04032093|580910390|FG007|Overall Study|Adverse Event|0|||
161214741|NCT01078623|582169447|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161214742|NCT01078623|582169448|FG007|Treatment Period 2|Withdrawal by Subject|0|||
161214743|NCT01078623|582169449|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161214744|NCT01078623|582169450|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161214745|NCT01078623|582169451|FG010|Treatment Period 2|Withdrawal by Subject|0|||
161214746|NCT01078623|582169452|FG011|Treatment Period 2|Withdrawal by Subject|0|||
161214747|NCT01078623|582169453|FG012|Treatment Period 2|Withdrawal by Subject|0|||
161214748|NCT01078623|582169454|FG013|Treatment Period 2|Withdrawal by Subject|0|||
161214749|NCT01078623|582169455|FG014|Treatment Period 2|Withdrawal by Subject|0|||
161214750|NCT01078623|582169456|FG015|Treatment Period 2|Withdrawal by Subject|0|||
161214751|NCT01078623|582169457|FG016|Treatment Period 2|Withdrawal by Subject|0|||
161214752|NCT01078623|582169458|FG017|Treatment Period 2|Withdrawal by Subject|0|||
161214753|NCT01078623|582169459|FG018|Treatment Period 2|Withdrawal by Subject|0|||
161214754|NCT01078623|582169460|FG019|Treatment Period 2|Withdrawal by Subject|0|||
161214755|NCT01078623|582169441|FG000|Treatment Period 3|Adverse Event|0|||
161214756|NCT01078623|582169442|FG001|Treatment Period 3|Adverse Event|0|||
161214757|NCT01078623|582169443|FG002|Treatment Period 3|Adverse Event|0|||
161214758|NCT01078623|582169444|FG003|Treatment Period 3|Adverse Event|0|||
161214759|NCT01078623|582169445|FG004|Treatment Period 3|Adverse Event|1|||
160868519|NCT04032093|580910391|FG008|Overall Study|Adverse Event|0|||
160868520|NCT04032093|580910392|FG009|Overall Study|Adverse Event|1|||
161214760|NCT01078623|582169446|FG005|Treatment Period 3|Adverse Event|0|||
160868521|NCT04032093|580910383|FG000|Overall Study|Physician Decision|0|||
160868522|NCT04032093|580910384|FG001|Overall Study|Physician Decision|0|||
160868523|NCT04032093|580910385|FG002|Overall Study|Physician Decision|0|||
160868524|NCT04032093|580910386|FG003|Overall Study|Physician Decision|0|||
160868525|NCT04032093|580910387|FG004|Overall Study|Physician Decision|0|||
160868526|NCT04032093|580910388|FG005|Overall Study|Physician Decision|1|||
160868527|NCT04032093|580910389|FG006|Overall Study|Physician Decision|0|||
160868528|NCT04032093|580910390|FG007|Overall Study|Physician Decision|0|||
161214761|NCT01078623|582169447|FG006|Treatment Period 3|Adverse Event|0|||
161214762|NCT01078623|582169448|FG007|Treatment Period 3|Adverse Event|0|||
161214763|NCT01078623|582169449|FG008|Treatment Period 3|Adverse Event|0|||
161214764|NCT01078623|582169450|FG009|Treatment Period 3|Adverse Event|0|||
160868529|NCT04032093|580910391|FG008|Overall Study|Physician Decision|0|||
160868530|NCT04032093|580910392|FG009|Overall Study|Physician Decision|0|||
160868531|NCT02699749|580910395|FG000|Overall Study|Other|0|||
160868532|NCT02699749|580910396|FG001|Overall Study|Other|0|||
160868533|NCT02699749|580910397|FG002|Overall Study|Other|2|||
160868534|NCT02699749|580910398|FG003|Overall Study|Other|0|||
160868535|NCT02699749|580910399|FG004|Overall Study|Other|0|||
160868536|NCT02699749|580910400|FG005|Overall Study|Other|1|||
160868537|NCT02699749|580910401|FG006|Overall Study|Other|1|||
160868538|NCT02699749|580910402|FG007|Overall Study|Other|0|||
160868539|NCT02699749|580910403|FG008|Overall Study|Other|0|||
160868540|NCT02699749|580910404|FG009|Overall Study|Other|0|||
160868541|NCT02699749|580910405|FG010|Overall Study|Other|1|||
160868542|NCT02699749|580910406|FG011|Overall Study|Other|0|||
160868543|NCT02699749|580910407|FG012|Overall Study|Other|0|||
160868544|NCT02699749|580910408|FG013|Overall Study|Other|0|||
160868545|NCT02699749|580910395|FG000|Overall Study|Progressive Disease|3|||
160868546|NCT02699749|580910396|FG001|Overall Study|Progressive Disease|3|||
160868547|NCT02699749|580910397|FG002|Overall Study|Progressive Disease|14|||
160868548|NCT02699749|580910398|FG003|Overall Study|Progressive Disease|3|||
160868549|NCT02699749|580910399|FG004|Overall Study|Progressive Disease|3|||
160868550|NCT02699749|580910400|FG005|Overall Study|Progressive Disease|7|||
160868551|NCT02699749|580910401|FG006|Overall Study|Progressive Disease|5|||
160868552|NCT02699749|580910402|FG007|Overall Study|Progressive Disease|5|||
160868553|NCT02699749|580910403|FG008|Overall Study|Progressive Disease|6|||
160868554|NCT02699749|580910404|FG009|Overall Study|Progressive Disease|6|||
160868555|NCT02699749|580910405|FG010|Overall Study|Progressive Disease|5|||
160868556|NCT02699749|580910406|FG011|Overall Study|Progressive Disease|4|||
160868557|NCT02699749|580910407|FG012|Overall Study|Progressive Disease|3|||
160868558|NCT02699749|580910408|FG013|Overall Study|Progressive Disease|5|||
160868559|NCT02699749|580910395|FG000|Overall Study|Death|0|||
160868560|NCT02699749|580910396|FG001|Overall Study|Death|0|||
160868561|NCT02699749|580910397|FG002|Overall Study|Death|0|||
160868562|NCT02699749|580910398|FG003|Overall Study|Death|0|||
160868563|NCT02699749|580910399|FG004|Overall Study|Death|0|||
160868564|NCT02699749|580910400|FG005|Overall Study|Death|0|||
160868565|NCT02699749|580910401|FG006|Overall Study|Death|0|||
160868566|NCT02699749|580910402|FG007|Overall Study|Death|0|||
160868567|NCT02699749|580910403|FG008|Overall Study|Death|0|||
160868568|NCT02699749|580910404|FG009|Overall Study|Death|0|||
160868569|NCT02699749|580910405|FG010|Overall Study|Death|0|||
160868570|NCT02699749|580910406|FG011|Overall Study|Death|0|||
160868571|NCT02699749|580910407|FG012|Overall Study|Death|0|||
160868572|NCT02699749|580910408|FG013|Overall Study|Death|1|||
160868573|NCT02699749|580910395|FG000|Overall Study|Lost to Follow-up|0|||
160868574|NCT02699749|580910396|FG001|Overall Study|Lost to Follow-up|0|||
160868575|NCT02699749|580910397|FG002|Overall Study|Lost to Follow-up|0|||
160868576|NCT02699749|580910398|FG003|Overall Study|Lost to Follow-up|0|||
160868577|NCT02699749|580910399|FG004|Overall Study|Lost to Follow-up|0|||
160868578|NCT02699749|580910400|FG005|Overall Study|Lost to Follow-up|1|||
160868579|NCT02699749|580910401|FG006|Overall Study|Lost to Follow-up|0|||
160868580|NCT02699749|580910402|FG007|Overall Study|Lost to Follow-up|1|||
160868581|NCT02699749|580910403|FG008|Overall Study|Lost to Follow-up|0|||
160868582|NCT02699749|580910404|FG009|Overall Study|Lost to Follow-up|0|||
160868583|NCT02699749|580910405|FG010|Overall Study|Lost to Follow-up|0|||
160868584|NCT02699749|580910406|FG011|Overall Study|Lost to Follow-up|0|||
160868585|NCT02699749|580910407|FG012|Overall Study|Lost to Follow-up|0|||
161109552|NCT00418665|581789892|FG000|Treatment Extension|Death|0|||
161109553|NCT00418665|581789893|FG001|Treatment Extension|Death|0|||
161109554|NCT00418665|581789894|FG002|Treatment Extension|Death|1|||
161109555|NCT00853749|581789895|FG000|Overall Study|Lost to Follow-up|0|||
161109556|NCT00853749|581789896|FG001|Overall Study|Lost to Follow-up|1|||
161109557|NCT01392677|581789899|FG000|Overall Study|Adverse Event|3|||
161109558|NCT01392677|581789900|FG001|Overall Study|Adverse Event|1|||
160868586|NCT02699749|580910408|FG013|Overall Study|Lost to Follow-up|0|||
161109559|NCT01392677|581789899|FG000|Overall Study|Withdrawal by Subject|0|||
160868587|NCT02377817|580910410|FG000|Overall Study|Transportation/childcare barriers.|2|||
160868588|NCT02377817|580910411|FG001|Overall Study|Transportation/childcare barriers.|0|||
160868589|NCT02377817|580910410|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
160868590|NCT02377817|580910411|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
160868591|NCT04139018|580910412|FG000|Overall Study|Screen fail|1|||
160868592|NCT04139018|580910413|FG001|Overall Study|Screen fail|0|||
160868593|NCT04139018|580910412|FG000|Overall Study|Withdrawal by Subject|2|||
161109560|NCT01392677|581789900|FG001|Overall Study|Withdrawal by Subject|2|||
161109561|NCT01392677|581789899|FG000|Overall Study|Incorrect enrollment|2|||
161109562|NCT01392677|581789900|FG001|Overall Study|Incorrect enrollment|3|||
160868594|NCT04139018|580910413|FG001|Overall Study|Withdrawal by Subject|0|||
160868595|NCT04139018|580910412|FG000|Overall Study|Lost to Follow-up|0|||
160868596|NCT04139018|580910413|FG001|Overall Study|Lost to Follow-up|1|||
160868597|NCT02565108|580910414|FG000|Overall Study|Adverse Event|1|||
160868598|NCT02565108|580910415|FG001|Overall Study|Adverse Event|0|||
160868599|NCT02565108|580910414|FG000|Overall Study|Withdrew Consent|1|||
161109563|NCT01392677|581789899|FG000|Overall Study|Other reason|3|||
161109564|NCT01392677|581789900|FG001|Overall Study|Other reason|2|||
161109565|NCT01357577|581789903|FG000|Overall Study|Lost to Follow-up|20|||
161109566|NCT01357577|581789904|FG001|Overall Study|Lost to Follow-up|16|||
161109567|NCT01357577|581789903|FG000|Overall Study|Withdrawal by Subject|16|||
161109568|NCT01357577|581789904|FG001|Overall Study|Withdrawal by Subject|8|||
161109569|NCT01357577|581789903|FG000|Overall Study|look at data in database?|1|||
161109570|NCT01357577|581789904|FG001|Overall Study|look at data in database?|2|||
161109571|NCT05493280|581789905|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
161109572|NCT05493280|581789906|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
161109573|NCT00766038|581791043|FG000|Overall Study|Lost to Follow-up|15|||
161109574|NCT00766038|581791044|FG001|Overall Study|Lost to Follow-up|14|||
161109575|NCT00307151|581791045|FG000|Overall Study|Death|4|||
161109576|NCT00307151|581791046|FG001|Overall Study|Death|3|||
161109577|NCT00307151|581791047|FG002|Overall Study|Death|10|||
161109578|NCT00307151|581791048|FG003|Overall Study|Death|3|||
161109579|NCT00307151|581791045|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161109580|NCT00307151|581791046|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161109581|NCT00307151|581791047|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161109582|NCT00307151|581791048|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161109583|NCT00307151|581791045|FG000|Overall Study|Subject unable to get to clinic|1|||
161109584|NCT00307151|581791046|FG001|Overall Study|Subject unable to get to clinic|0|||
161109585|NCT00307151|581791047|FG002|Overall Study|Subject unable to get to clinic|6|||
161109586|NCT00307151|581791048|FG003|Overall Study|Subject unable to get to clinic|2|||
161109587|NCT00307151|581791045|FG000|Overall Study|Withdrew consent|0|||
161109588|NCT00307151|581791046|FG001|Overall Study|Withdrew consent|1|||
161109589|NCT00307151|581791047|FG002|Overall Study|Withdrew consent|1|||
161109590|NCT00307151|581791048|FG003|Overall Study|Withdrew consent|3|||
161109591|NCT00307151|581791045|FG000|Overall Study|Not willing to adhere to study reqs|2|||
161109592|NCT00307151|581791046|FG001|Overall Study|Not willing to adhere to study reqs|0|||
161109593|NCT00307151|581791047|FG002|Overall Study|Not willing to adhere to study reqs|2|||
161109594|NCT00307151|581791048|FG003|Overall Study|Not willing to adhere to study reqs|2|||
161109595|NCT00307151|581791045|FG000|Overall Study|Clinic unable to contact subject|3|||
161109596|NCT00307151|581791046|FG001|Overall Study|Clinic unable to contact subject|3|||
161109597|NCT00307151|581791047|FG002|Overall Study|Clinic unable to contact subject|1|||
161109598|NCT00307151|581791048|FG003|Overall Study|Clinic unable to contact subject|1|||
161109599|NCT03703882|581791049|FG000|Overall Study|Adverse Event|1|||
161109600|NCT03703882|581791050|FG001|Overall Study|Adverse Event|0|||
161109601|NCT03703882|581791049|FG000|Overall Study|Lost to Follow-up|0|||
160868600|NCT02565108|580910415|FG001|Overall Study|Withdrew Consent|0|||
161109602|NCT03703882|581791050|FG001|Overall Study|Lost to Follow-up|2|||
160868601|NCT01310075|580910432|FG000|Overall Study|Lost to Follow-up|1|||
160868602|NCT01310075|580910433|FG001|Overall Study|Lost to Follow-up|0|||
160868603|NCT01310075|580910432|FG000|Overall Study|Physician Decision|10|||
160868604|NCT01310075|580910433|FG001|Overall Study|Physician Decision|7|||
160868605|NCT01310075|580910432|FG000|Overall Study|Protocol Violation|2|||
160868606|NCT01310075|580910433|FG001|Overall Study|Protocol Violation|2|||
160868607|NCT01310075|580910432|FG000|Overall Study|Withdrawal by Subject|1|||
160868608|NCT01310075|580910433|FG001|Overall Study|Withdrawal by Subject|1|||
160868609|NCT01696188|580910435|FG000|Overall Study|Protocol Violation|1|||
160868610|NCT01696188|580910436|FG001|Overall Study|Protocol Violation|1|||
160868611|NCT02425943|580910437|FG000|Overall Study|Adverse Event|3|||
160868612|NCT02425943|580910438|FG001|Overall Study|Adverse Event|1|||
160868613|NCT02425943|580910437|FG000|Overall Study|Lost to Follow-up|59|||
161109603|NCT03703882|581791049|FG000|Overall Study|Non-compliance with study drug|0|||
161109604|NCT03703882|581791050|FG001|Overall Study|Non-compliance with study drug|1|||
161109605|NCT03703882|581791049|FG000|Overall Study|Physician Decision|0|||
161109606|NCT03703882|581791050|FG001|Overall Study|Physician Decision|1|||
161109607|NCT03703882|581791049|FG000|Overall Study|Progressive disease|1|||
161109608|NCT03703882|581791050|FG001|Overall Study|Progressive disease|0|||
161109609|NCT03703882|581791049|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161109610|NCT03703882|581791050|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161109611|NCT03703882|581791049|FG000|Overall Study|Starting another treatment|0|||
161109612|NCT03703882|581791050|FG001|Overall Study|Starting another treatment|1|||
161109613|NCT03703882|581791049|FG000|Overall Study|noncompliance with study procedures|0|||
161109614|NCT03703882|581791050|FG001|Overall Study|noncompliance with study procedures|1|||
161109615|NCT05374525|581791056|FG000|Overall Study|Adverse Event|5|||
161109616|NCT05374525|581791057|FG001|Overall Study|Adverse Event|6|||
161109617|NCT05374525|581791056|FG000|Overall Study|Lost to Follow-up|3|||
161109618|NCT05374525|581791057|FG001|Overall Study|Lost to Follow-up|3|||
161109619|NCT05374525|581791056|FG000|Overall Study|Physician Decision|2|||
161109620|NCT05374525|581791057|FG001|Overall Study|Physician Decision|2|||
161109621|NCT05374525|581791056|FG000|Overall Study|Withdrawal by Subject|26|||
161109622|NCT05374525|581791057|FG001|Overall Study|Withdrawal by Subject|8|||
161109623|NCT01349101|581791060|FG000|Overall Study|Disease Progression|1|||
161109624|NCT01349101|581791061|FG001|Overall Study|Disease Progression|1|||
161109625|NCT01349101|581791060|FG000|Overall Study|Death|3|||
161109626|NCT01349101|581791061|FG001|Overall Study|Death|8|||
161109627|NCT01843842|581791064|FG000|Overall Study|Do not meet inclusion criteria|1|||
161109628|NCT01843842|581791065|FG001|Overall Study|Do not meet inclusion criteria|1|||
161109629|NCT02953340|581791066|FG000|Overall Study|Death|0|||
161109630|NCT02953340|581791067|FG001|Overall Study|Death|1|||
161109631|NCT02953340|581791066|FG000|Overall Study|Investigator Decision|3|||
161109632|NCT02953340|581791067|FG001|Overall Study|Investigator Decision|3|||
161109633|NCT02953340|581791066|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
161109634|NCT02953340|581791067|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
161109635|NCT02953340|581791066|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
161109636|NCT02953340|581791067|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
161109637|NCT02953340|581791066|FG000|Overall Study|Withdrawal by Subject|9|||
161109638|NCT02953340|581791067|FG001|Overall Study|Withdrawal by Subject|9|||
161109639|NCT02953340|581791066|FG000|Overall Study|Sponsor decision|0|||
161109640|NCT02953340|581791067|FG001|Overall Study|Sponsor decision|2|||
161109641|NCT02953340|581791066|FG000|Overall Study|Lost to Follow-up|3|||
161109642|NCT02953340|581791067|FG001|Overall Study|Lost to Follow-up|2|||
161109643|NCT02953340|581791066|FG000|Overall Study|Reason not specified|2|||
161109644|NCT02953340|581791067|FG001|Overall Study|Reason not specified|2|||
161109645|NCT01376778|581791068|FG000|Overall Study|Lost to Follow-up|3|||
161109646|NCT01376778|581791069|FG001|Overall Study|Lost to Follow-up|2|||
161109647|NCT00632099|581791070|FG000|Overall Study|Lost to Follow-up|3|||
161109648|NCT00632099|581791071|FG001|Overall Study|Lost to Follow-up|3|||
161109649|NCT00271596|581791074|FG000|Overall Study|Protocol Violation|1|||
161109650|NCT00271596|581791075|FG001|Overall Study|Protocol Violation|0|||
161109651|NCT00271596|581791074|FG000|Overall Study|Withdrawal by Subject|0|||
161109652|NCT00271596|581791075|FG001|Overall Study|Withdrawal by Subject|1|||
161109653|NCT04232553|581791076|FG000|Overall Study|Adverse Event|3|||
161109654|NCT04232553|581791077|FG001|Overall Study|Adverse Event|2|||
161109655|NCT04232553|581791078|FG002|Overall Study|Adverse Event|1|||
161109656|NCT04232553|581791079|FG003|Overall Study|Adverse Event|2|||
160868614|NCT02425943|580910438|FG001|Overall Study|Lost to Follow-up|37|||
160868615|NCT02425943|580910437|FG000|Overall Study|Protocol Violation|4|||
161109657|NCT04232553|581791080|FG004|Overall Study|Adverse Event|1|||
161109658|NCT04232553|581791081|FG005|Overall Study|Adverse Event|1|||
161109659|NCT04232553|581791082|FG006|Overall Study|Adverse Event|0|||
161109660|NCT04232553|581791083|FG007|Overall Study|Adverse Event|0|||
160868616|NCT02425943|580910438|FG001|Overall Study|Protocol Violation|1|||
160868617|NCT02425943|580910437|FG000|Overall Study|Withdrawal by Subject|64|||
160868618|NCT02425943|580910438|FG001|Overall Study|Withdrawal by Subject|31|||
160868619|NCT02425943|580910437|FG000|Overall Study|Other|6|||
160868620|NCT02425943|580910438|FG001|Overall Study|Other|0|||
161324360|NCT01408901|582573579|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
160868621|NCT01106248|580910440|FG000|Overall Study|Adverse Event|1|||
160868622|NCT01106248|580910440|FG000|Overall Study|Administrative|2|||
160868623|NCT01209325|580910441|FG000|Overall Study|Lost to Follow-up|24|||
160868624|NCT01209325|580910441|FG000|Overall Study|Adverse Event|1|||
160868625|NCT01209325|580910441|FG000|Overall Study|Relocated|3|||
160868626|NCT01209325|580910441|FG000|Overall Study|Refusal after starting therapy|8|||
160868627|NCT01209325|580910441|FG000|Overall Study|Protocol Violation|4|||
160868628|NCT01209325|580910441|FG000|Overall Study|Refusal prior to therapy|1|||
160868629|NCT01209325|580910441|FG000|Overall Study|Incarceration|2|||
160868630|NCT01160822|580910442|FG000|Overall Study|Adverse Event|0|||
160868631|NCT01160822|580910443|FG001|Overall Study|Adverse Event|0|||
160868632|NCT01160822|580910444|FG002|Overall Study|Adverse Event|0|||
160868633|NCT01160822|580910445|FG003|Overall Study|Adverse Event|0|||
160868634|NCT01160822|580910446|FG004|Overall Study|Adverse Event|1|||
160868635|NCT01160822|580910447|FG005|Overall Study|Adverse Event|2|||
160868636|NCT01160822|580910448|FG006|Overall Study|Adverse Event|5|||
160868637|NCT01160822|580910442|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160868638|NCT01160822|580910443|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160868639|NCT01160822|580910444|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160868640|NCT01160822|580910445|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160868641|NCT01160822|580910446|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
160868642|NCT01160822|580910447|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
160868643|NCT01160822|580910448|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
160868644|NCT01160822|580910442|FG000|Overall Study|Withdrawal by Subject|0|||
160868645|NCT01160822|580910443|FG001|Overall Study|Withdrawal by Subject|0|||
160868646|NCT01160822|580910444|FG002|Overall Study|Withdrawal by Subject|0|||
160868647|NCT01160822|580910445|FG003|Overall Study|Withdrawal by Subject|0|||
160868648|NCT01160822|580910446|FG004|Overall Study|Withdrawal by Subject|0|||
160868649|NCT01160822|580910447|FG005|Overall Study|Withdrawal by Subject|0|||
160868650|NCT01160822|580910448|FG006|Overall Study|Withdrawal by Subject|1|||
160868651|NCT01160822|580910442|FG000|Overall Study|Lost to Follow-up|0|||
160868652|NCT01160822|580910443|FG001|Overall Study|Lost to Follow-up|0|||
160868653|NCT01160822|580910444|FG002|Overall Study|Lost to Follow-up|0|||
160868654|NCT01160822|580910445|FG003|Overall Study|Lost to Follow-up|0|||
160868655|NCT01160822|580910446|FG004|Overall Study|Lost to Follow-up|1|||
160868656|NCT01160822|580910447|FG005|Overall Study|Lost to Follow-up|0|||
160868657|NCT01160822|580910448|FG006|Overall Study|Lost to Follow-up|0|||
160868658|NCT01160822|580910442|FG000|Overall Study|Administrative problems|0|||
160868659|NCT01160822|580910443|FG001|Overall Study|Administrative problems|0|||
160868660|NCT01160822|580910444|FG002|Overall Study|Administrative problems|0|||
160868661|NCT01160822|580910445|FG003|Overall Study|Administrative problems|0|||
160868662|NCT01160822|580910446|FG004|Overall Study|Administrative problems|1|||
160868663|NCT01160822|580910447|FG005|Overall Study|Administrative problems|0|||
160868664|NCT01160822|580910448|FG006|Overall Study|Administrative problems|0|||
160868665|NCT01160822|580910442|FG000|Overall Study|Protocol deviation|0|||
160868666|NCT01160822|580910443|FG001|Overall Study|Protocol deviation|0|||
160868667|NCT01160822|580910444|FG002|Overall Study|Protocol deviation|0|||
160868668|NCT01160822|580910445|FG003|Overall Study|Protocol deviation|0|||
160868669|NCT01160822|580910446|FG004|Overall Study|Protocol deviation|2|||
160868670|NCT01160822|580910447|FG005|Overall Study|Protocol deviation|0|||
160868671|NCT01160822|580910448|FG006|Overall Study|Protocol deviation|0|||
160868672|NCT01648751|580910461|FG000|Overall Study|Withdrawal by Subject|2|||
160868673|NCT01648751|580910462|FG001|Overall Study|Withdrawal by Subject|3|||
160868674|NCT03467750|580910464|FG000|Overall Study|Surgery canceled|1|||
160868675|NCT03467750|580910465|FG001|Overall Study|Surgery canceled|0|||
160868676|NCT03467750|580910464|FG000|Overall Study|Protocol Violation|1|||
160868677|NCT03467750|580910465|FG001|Overall Study|Protocol Violation|1|||
160868678|NCT03467750|580910464|FG000|Overall Study|Withdrawal by Subject|0|||
160868679|NCT03467750|580910465|FG001|Overall Study|Withdrawal by Subject|1|||
161214765|NCT01078623|582169451|FG010|Treatment Period 3|Adverse Event|0|||
161214766|NCT01078623|582169452|FG011|Treatment Period 3|Adverse Event|0|||
160868680|NCT05673876|580910466|FG000|Overall Study|Death|3|||
160868681|NCT05673876|580910467|FG001|Overall Study|Death|1|||
160868682|NCT05673876|580910466|FG000|Overall Study|Study Terminated by Sponsor|0|||
160868683|NCT05673876|580910467|FG001|Overall Study|Study Terminated by Sponsor|1|||
160868684|NCT05673876|580910466|FG000|Overall Study|Physician Decision|0|||
160868685|NCT05673876|580910467|FG001|Overall Study|Physician Decision|1|||
160868686|NCT03529422|580910468|FG000|Overall Study|Withdrawal by Subject|1|||
160868687|NCT03529422|580910468|FG000|Overall Study|Protocol Violation|1|||
160868688|NCT03529422|580910468|FG000|Overall Study|Disease progression|2|||
160868689|NCT02000115|580910471|FG000|Overall Study|Death|56|||
160868690|NCT02000115|580910472|FG001|Overall Study|Death|45|||
160868691|NCT02000115|580910473|FG002|Overall Study|Death|0|||
160868692|NCT02000115|580910474|FG003|Overall Study|Death|0|||
160868693|NCT02000115|580910471|FG000|Overall Study|Missed Visit|6|||
160868694|NCT02000115|580910472|FG001|Overall Study|Missed Visit|8|||
160868695|NCT02000115|580910473|FG002|Overall Study|Missed Visit|1|||
160868696|NCT02000115|580910474|FG003|Overall Study|Missed Visit|0|||
161214767|NCT01078623|582169453|FG012|Treatment Period 3|Adverse Event|0|||
160868697|NCT02000115|580910471|FG000|Overall Study|Protocol Violation|2|||
160868698|NCT02000115|580910472|FG001|Overall Study|Protocol Violation|1|||
160868699|NCT02000115|580910473|FG002|Overall Study|Protocol Violation|0|||
160868700|NCT02000115|580910474|FG003|Overall Study|Protocol Violation|0|||
160868701|NCT02000115|580910471|FG000|Overall Study|Physician Decision|2|||
160868702|NCT02000115|580910472|FG001|Overall Study|Physician Decision|0|||
160868703|NCT02000115|580910473|FG002|Overall Study|Physician Decision|0|||
160868704|NCT02000115|580910474|FG003|Overall Study|Physician Decision|0|||
160868705|NCT02000115|580910471|FG000|Overall Study|Withdrawal by Subject|11|||
160868706|NCT02000115|580910472|FG001|Overall Study|Withdrawal by Subject|11|||
160868707|NCT02000115|580910473|FG002|Overall Study|Withdrawal by Subject|0|||
160868708|NCT02000115|580910474|FG003|Overall Study|Withdrawal by Subject|0|||
160868709|NCT02000115|580910471|FG000|Overall Study|Lost to Follow-up|0|||
160868710|NCT02000115|580910472|FG001|Overall Study|Lost to Follow-up|1|||
160868711|NCT02000115|580910473|FG002|Overall Study|Lost to Follow-up|0|||
160868712|NCT02000115|580910474|FG003|Overall Study|Lost to Follow-up|0|||
160868713|NCT02000115|580910471|FG000|Overall Study|Non-compliance|2|||
160868714|NCT02000115|580910472|FG001|Overall Study|Non-compliance|1|||
160868715|NCT02000115|580910473|FG002|Overall Study|Non-compliance|0|||
160868716|NCT02000115|580910474|FG003|Overall Study|Non-compliance|0|||
160868717|NCT02000115|580910471|FG000|Overall Study|Withdrawn on day of randomization|0|||
160868718|NCT02000115|580910472|FG001|Overall Study|Withdrawn on day of randomization|1|||
160868719|NCT02000115|580910473|FG002|Overall Study|Withdrawn on day of randomization|0|||
160868720|NCT02000115|580910474|FG003|Overall Study|Withdrawn on day of randomization|0|||
160868721|NCT02000115|580910471|FG000|Overall Study|Still on Study|0|||
160868722|NCT02000115|580910472|FG001|Overall Study|Still on Study|0|||
160868723|NCT02000115|580910473|FG002|Overall Study|Still on Study|0|||
160868724|NCT02000115|580910474|FG003|Overall Study|Still on Study|53|||
160868725|NCT05006573|580910477|FG000|Double-blind Treatment Period|Physician Decision|2|||
160868726|NCT05006573|580910478|FG001|Double-blind Treatment Period|Physician Decision|0|||
160868727|NCT05006573|580910477|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
160868728|NCT05006573|580910478|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
160868729|NCT05006573|580910477|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
160868730|NCT05006573|580910478|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
160868731|NCT05006573|580910477|FG000|Double-blind Treatment Period|Protocol Violation|2|||
160868732|NCT05006573|580910478|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160868733|NCT05006573|580910477|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
160868734|NCT05006573|580910478|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
160868735|NCT05006573|580910477|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
160868736|NCT05006573|580910478|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
160868737|NCT01967238|580910479|FG000|Overall Study|Adverse Event|1|||
160868738|NCT01967238|580910480|FG001|Overall Study|Adverse Event|1|||
160868739|NCT01967238|580910481|FG002|Overall Study|Adverse Event|0|||
160868740|NCT01967238|580910479|FG000|Overall Study|Lost to Follow-up|1|||
160868741|NCT01967238|580910480|FG001|Overall Study|Lost to Follow-up|0|||
160868742|NCT01967238|580910481|FG002|Overall Study|Lost to Follow-up|1|||
160868743|NCT01967238|580910479|FG000|Overall Study|Withdrawal by Subject|0|||
160868744|NCT01967238|580910480|FG001|Overall Study|Withdrawal by Subject|0|||
160868745|NCT01967238|580910481|FG002|Overall Study|Withdrawal by Subject|1|||
160868746|NCT02484391|580910482|FG000|Overall Study|Lack of Efficacy|15|||
160868747|NCT02484391|580910483|FG001|Overall Study|Lack of Efficacy|14|||
160868748|NCT02484391|580910484|FG002|Overall Study|Lack of Efficacy|3|||
160868749|NCT02484391|580910482|FG000|Overall Study|Lost to Follow-up|0|||
160868750|NCT02484391|580910483|FG001|Overall Study|Lost to Follow-up|0|||
160868751|NCT02484391|580910484|FG002|Overall Study|Lost to Follow-up|2|||
160868752|NCT02484391|580910482|FG000|Overall Study|Physician Decision|1|||
160868753|NCT02484391|580910483|FG001|Overall Study|Physician Decision|3|||
160868754|NCT02484391|580910484|FG002|Overall Study|Physician Decision|0|||
160868755|NCT02484391|580910482|FG000|Overall Study|Went to Transplant|5|||
160868756|NCT02484391|580910483|FG001|Overall Study|Went to Transplant|3|||
160868757|NCT02484391|580910484|FG002|Overall Study|Went to Transplant|2|||
160868758|NCT04922216|580910488|FG000|Overall Study|Withdrawal by Subject|0|||
160868759|NCT04922216|580910489|FG001|Overall Study|Withdrawal by Subject|1|||
161109661|NCT04232553|581791084|FG008|Overall Study|Adverse Event|0|||
161109662|NCT04232553|581791076|FG000|Overall Study|Death|0|||
160868760|NCT04922216|580910490|FG002|Overall Study|Withdrawal by Subject|0|||
160868761|NCT04922216|580910491|FG003|Overall Study|Withdrawal by Subject|0|||
160868762|NCT04922216|580910492|FG004|Overall Study|Withdrawal by Subject|0|||
160868763|NCT04922216|580910493|FG005|Overall Study|Withdrawal by Subject|0|||
160868764|NCT04922216|580910494|FG006|Overall Study|Withdrawal by Subject|0|||
160868765|NCT04922216|580910495|FG007|Overall Study|Withdrawal by Subject|2|||
161109663|NCT04232553|581791077|FG001|Overall Study|Death|1|||
160868766|NCT04922216|580910496|FG008|Overall Study|Withdrawal by Subject|0|||
160868767|NCT04922216|580910497|FG009|Overall Study|Withdrawal by Subject|0|||
160868768|NCT04922216|580910498|FG010|Overall Study|Withdrawal by Subject|0|||
160868769|NCT04922216|580910499|FG011|Overall Study|Withdrawal by Subject|0|||
161214768|NCT01078623|582169454|FG013|Treatment Period 3|Adverse Event|1|||
161214769|NCT01078623|582169455|FG014|Treatment Period 3|Adverse Event|0|||
161214770|NCT01078623|582169456|FG015|Treatment Period 3|Adverse Event|0|||
161214771|NCT01078623|582169457|FG016|Treatment Period 3|Adverse Event|0|||
161214772|NCT01078623|582169458|FG017|Treatment Period 3|Adverse Event|0|||
161214773|NCT01078623|582169459|FG018|Treatment Period 3|Adverse Event|0|||
161214774|NCT01078623|582169460|FG019|Treatment Period 3|Adverse Event|0|||
161214775|NCT01078623|582169441|FG000|Treatment Period 4|Adverse Event|0|||
161324361|NCT01408901|582573580|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
161214776|NCT01078623|582169442|FG001|Treatment Period 4|Adverse Event|0|||
161214777|NCT01078623|582169443|FG002|Treatment Period 4|Adverse Event|1|||
161214778|NCT01078623|582169444|FG003|Treatment Period 4|Adverse Event|0|||
161109664|NCT04232553|581791078|FG002|Overall Study|Death|0|||
161109665|NCT04232553|581791079|FG003|Overall Study|Death|1|||
161109666|NCT04232553|581791080|FG004|Overall Study|Death|0|||
161109667|NCT04232553|581791081|FG005|Overall Study|Death|0|||
161109668|NCT04232553|581791082|FG006|Overall Study|Death|0|||
161109669|NCT04232553|581791083|FG007|Overall Study|Death|0|||
161109670|NCT04232553|581791084|FG008|Overall Study|Death|0|||
161109671|NCT04232553|581791076|FG000|Overall Study|Lack of Efficacy|0|||
161109672|NCT04232553|581791077|FG001|Overall Study|Lack of Efficacy|2|||
161109673|NCT04232553|581791078|FG002|Overall Study|Lack of Efficacy|0|||
161109674|NCT04232553|581791079|FG003|Overall Study|Lack of Efficacy|0|||
161109675|NCT04232553|581791080|FG004|Overall Study|Lack of Efficacy|0|||
161109676|NCT04232553|581791081|FG005|Overall Study|Lack of Efficacy|0|||
161109677|NCT04232553|581791082|FG006|Overall Study|Lack of Efficacy|0|||
161109678|NCT04232553|581791083|FG007|Overall Study|Lack of Efficacy|0|||
161109679|NCT04232553|581791084|FG008|Overall Study|Lack of Efficacy|1|||
161109680|NCT04232553|581791076|FG000|Overall Study|Lost to Follow-up|0|||
161109681|NCT04232553|581791077|FG001|Overall Study|Lost to Follow-up|1|||
161109682|NCT04232553|581791078|FG002|Overall Study|Lost to Follow-up|0|||
161109683|NCT04232553|581791079|FG003|Overall Study|Lost to Follow-up|0|||
161109684|NCT04232553|581791080|FG004|Overall Study|Lost to Follow-up|1|||
161109685|NCT04232553|581791081|FG005|Overall Study|Lost to Follow-up|0|||
161109686|NCT04232553|581791082|FG006|Overall Study|Lost to Follow-up|0|||
161109687|NCT04232553|581791083|FG007|Overall Study|Lost to Follow-up|0|||
161109688|NCT04232553|581791084|FG008|Overall Study|Lost to Follow-up|1|||
161109689|NCT04232553|581791076|FG000|Overall Study|Other - As reported by the investigator|0|||
161109690|NCT04232553|581791077|FG001|Overall Study|Other - As reported by the investigator|1|||
161109691|NCT04232553|581791078|FG002|Overall Study|Other - As reported by the investigator|0|||
161109692|NCT04232553|581791079|FG003|Overall Study|Other - As reported by the investigator|0|||
161109693|NCT04232553|581791080|FG004|Overall Study|Other - As reported by the investigator|0|||
161109694|NCT04232553|581791081|FG005|Overall Study|Other - As reported by the investigator|0|||
161109695|NCT04232553|581791082|FG006|Overall Study|Other - As reported by the investigator|0|||
161214779|NCT01078623|582169445|FG004|Treatment Period 4|Adverse Event|0|||
161214780|NCT01078623|582169446|FG005|Treatment Period 4|Adverse Event|0|||
161214781|NCT01078623|582169447|FG006|Treatment Period 4|Adverse Event|0|||
161214782|NCT01078623|582169448|FG007|Treatment Period 4|Adverse Event|0|||
161214783|NCT01078623|582169449|FG008|Treatment Period 4|Adverse Event|0|||
160868770|NCT04922216|580910500|FG012|Overall Study|Withdrawal by Subject|1|||
160868771|NCT04922216|580910501|FG013|Overall Study|Withdrawal by Subject|1|||
160868772|NCT04922216|580910502|FG014|Overall Study|Withdrawal by Subject|1|||
161214784|NCT01078623|582169450|FG009|Treatment Period 4|Adverse Event|0|||
161214785|NCT01078623|582169451|FG010|Treatment Period 4|Adverse Event|0|||
161214786|NCT01078623|582169452|FG011|Treatment Period 4|Adverse Event|0|||
161214787|NCT01078623|582169453|FG012|Treatment Period 4|Adverse Event|0|||
161214788|NCT01078623|582169454|FG013|Treatment Period 4|Adverse Event|0|||
161214789|NCT01078623|582169455|FG014|Treatment Period 4|Adverse Event|0|||
161214790|NCT01078623|582169456|FG015|Treatment Period 4|Adverse Event|0|||
161214791|NCT01078623|582169457|FG016|Treatment Period 4|Adverse Event|0|||
161109696|NCT04232553|581791083|FG007|Overall Study|Other - As reported by the investigator|0|||
161109697|NCT04232553|581791084|FG008|Overall Study|Other - As reported by the investigator|0|||
161109698|NCT04232553|581791076|FG000|Overall Study|Physician Decision|1|||
161109699|NCT04232553|581791077|FG001|Overall Study|Physician Decision|1|||
161109700|NCT04232553|581791078|FG002|Overall Study|Physician Decision|0|||
161109701|NCT04232553|581791079|FG003|Overall Study|Physician Decision|0|||
161109702|NCT04232553|581791080|FG004|Overall Study|Physician Decision|1|||
161109703|NCT04232553|581791081|FG005|Overall Study|Physician Decision|0|||
161109704|NCT04232553|581791082|FG006|Overall Study|Physician Decision|0|||
161109705|NCT04232553|581791083|FG007|Overall Study|Physician Decision|0|||
161109706|NCT04232553|581791084|FG008|Overall Study|Physician Decision|0|||
161109707|NCT04232553|581791076|FG000|Overall Study|Pregnancy|1|||
161109708|NCT04232553|581791077|FG001|Overall Study|Pregnancy|0|||
161109709|NCT04232553|581791078|FG002|Overall Study|Pregnancy|0|||
161109710|NCT04232553|581791079|FG003|Overall Study|Pregnancy|0|||
161109711|NCT04232553|581791080|FG004|Overall Study|Pregnancy|0|||
161109712|NCT04232553|581791081|FG005|Overall Study|Pregnancy|0|||
161109713|NCT04232553|581791082|FG006|Overall Study|Pregnancy|0|||
161109714|NCT04232553|581791083|FG007|Overall Study|Pregnancy|0|||
161109715|NCT04232553|581791084|FG008|Overall Study|Pregnancy|0|||
161109716|NCT04232553|581791076|FG000|Overall Study|Withdrawal by Subject|7|||
161109717|NCT04232553|581791077|FG001|Overall Study|Withdrawal by Subject|5|||
161214792|NCT01078623|582169458|FG017|Treatment Period 4|Adverse Event|0|||
160868773|NCT04922216|580910503|FG015|Overall Study|Withdrawal by Subject|0|||
160868774|NCT04922216|580910504|FG016|Overall Study|Withdrawal by Subject|0|||
160868775|NCT04922216|580910505|FG017|Overall Study|Withdrawal by Subject|1|||
160868776|NCT04922216|580910506|FG018|Overall Study|Withdrawal by Subject|1|||
160868777|NCT04922216|580910507|FG019|Overall Study|Withdrawal by Subject|1|||
160868778|NCT04922216|580910508|FG020|Overall Study|Withdrawal by Subject|1|||
160868779|NCT04922216|580910509|FG021|Overall Study|Withdrawal by Subject|0|||
160868780|NCT04922216|580910510|FG022|Overall Study|Withdrawal by Subject|0|||
160868781|NCT04922216|580910511|FG023|Overall Study|Withdrawal by Subject|2|||
160868782|NCT04922216|580910512|FG024|Overall Study|Withdrawal by Subject|0|||
160868783|NCT04922216|580910513|FG025|Overall Study|Withdrawal by Subject|0|||
160868784|NCT04922216|580910514|FG026|Overall Study|Withdrawal by Subject|1|||
160868785|NCT04922216|580910515|FG027|Overall Study|Withdrawal by Subject|0|||
160868786|NCT04922216|580910516|FG028|Overall Study|Withdrawal by Subject|0|||
160868787|NCT04922216|580910517|FG029|Overall Study|Withdrawal by Subject|0|||
160868788|NCT04922216|580910518|FG030|Overall Study|Withdrawal by Subject|1|||
160868789|NCT04922216|580910519|FG031|Overall Study|Withdrawal by Subject|0|||
160868790|NCT04922216|580910488|FG000|Overall Study|Lost to Follow-up|1|||
160868791|NCT04922216|580910489|FG001|Overall Study|Lost to Follow-up|0|||
160868792|NCT04922216|580910490|FG002|Overall Study|Lost to Follow-up|2|||
160868793|NCT04922216|580910491|FG003|Overall Study|Lost to Follow-up|0|||
160868794|NCT04922216|580910492|FG004|Overall Study|Lost to Follow-up|0|||
160868795|NCT04922216|580910493|FG005|Overall Study|Lost to Follow-up|2|||
160868796|NCT04922216|580910494|FG006|Overall Study|Lost to Follow-up|0|||
160868797|NCT04922216|580910495|FG007|Overall Study|Lost to Follow-up|1|||
160868798|NCT04922216|580910496|FG008|Overall Study|Lost to Follow-up|1|||
160868799|NCT04922216|580910497|FG009|Overall Study|Lost to Follow-up|2|||
160868800|NCT04922216|580910498|FG010|Overall Study|Lost to Follow-up|2|||
160868801|NCT04922216|580910499|FG011|Overall Study|Lost to Follow-up|1|||
161109718|NCT04232553|581791078|FG002|Overall Study|Withdrawal by Subject|0|||
161109719|NCT04232553|581791079|FG003|Overall Study|Withdrawal by Subject|0|||
161109720|NCT04232553|581791080|FG004|Overall Study|Withdrawal by Subject|2|||
161109721|NCT04232553|581791081|FG005|Overall Study|Withdrawal by Subject|2|||
161109722|NCT04232553|581791082|FG006|Overall Study|Withdrawal by Subject|0|||
161109723|NCT04232553|581791083|FG007|Overall Study|Withdrawal by Subject|2|||
161109724|NCT04232553|581791084|FG008|Overall Study|Withdrawal by Subject|0|||
161109725|NCT02969915|581791085|FG000|Overall Study|Death|104|||
161109726|NCT02969915|581791086|FG001|Overall Study|Death|125|||
161109727|NCT02969915|581791085|FG000|Overall Study|Lost to Follow-up|108|||
161109728|NCT02969915|581791086|FG001|Overall Study|Lost to Follow-up|112|||
161109729|NCT02969915|581791085|FG000|Overall Study|Censored due to COVID-19|481|||
161109730|NCT02969915|581791086|FG001|Overall Study|Censored due to COVID-19|471|||
161109731|NCT03625687|581791087|FG000|Overall Study|Death|1|||
161109732|NCT04206605|581791090|FG000|Overall Study|Adverse Event|0|||
161109733|NCT04206605|581791091|FG001|Overall Study|Adverse Event|1|||
161109734|NCT04206605|581791090|FG000|Overall Study|Withdrawal by Subject|1|||
161109735|NCT04206605|581791091|FG001|Overall Study|Withdrawal by Subject|0|||
161109736|NCT00589420|581791094|FG000|Overall Study|screen failure|1|||
161109737|NCT00841568|581791095|FG000|Overall Study|Adverse Event|1|||
161109738|NCT00841568|581791095|FG000|Overall Study|Death|1|||
161109739|NCT00841568|581791095|FG000|Overall Study|Withdrawal by Subject|2|||
161109740|NCT00841568|581791095|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
161109741|NCT01131520|581791101|FG000|Overall Study|Computer problem|1|||
161109742|NCT01131520|581791102|FG001|Overall Study|Computer problem|0|||
161109743|NCT01131520|581791101|FG000|Overall Study|Counselor not available|0|||
161109744|NCT01131520|581791102|FG001|Overall Study|Counselor not available|3|||
161109745|NCT01131520|581791101|FG000|Overall Study|Subject changed history after enrollment|0|||
161109746|NCT01131520|581791102|FG001|Overall Study|Subject changed history after enrollment|1|||
161109747|NCT03302975|581791106|FG000|Overall Study|Lost to Follow-up|4|||
161109748|NCT01436084|581791107|FG000|Overall Study|Disease Progression|2|||
161109749|NCT01436084|581791107|FG000|Overall Study|Withdrawal by Subject|1|||
161109750|NCT01436084|581791107|FG000|Overall Study|Early Closure of Study|1|||
161109751|NCT05998148|581791108|FG000|Allocation|Did not attend any appointments|1|||
161109752|NCT05998148|581791109|FG001|Allocation|Did not attend any appointments|4|||
160868802|NCT04922216|580910500|FG012|Overall Study|Lost to Follow-up|1|||
160868803|NCT04922216|580910501|FG013|Overall Study|Lost to Follow-up|0|||
160868804|NCT04922216|580910502|FG014|Overall Study|Lost to Follow-up|1|||
160868805|NCT04922216|580910503|FG015|Overall Study|Lost to Follow-up|0|||
160868806|NCT04922216|580910504|FG016|Overall Study|Lost to Follow-up|0|||
160868807|NCT04922216|580910505|FG017|Overall Study|Lost to Follow-up|2|||
160868808|NCT04922216|580910506|FG018|Overall Study|Lost to Follow-up|1|||
160868809|NCT04922216|580910507|FG019|Overall Study|Lost to Follow-up|0|||
161109753|NCT05998148|581791108|FG000|Follow-Up|Lost to Follow-up|1|||
161109754|NCT05998148|581791109|FG001|Follow-Up|Lost to Follow-up|2|||
161109755|NCT05998148|581791108|FG000|Follow-Up|Change in insurance|1|||
161109756|NCT05998148|581791109|FG001|Follow-Up|Change in insurance|1|||
161109757|NCT03834519|581791111|FG000|Overall Study|Lost to Follow-up|2|||
160868810|NCT04922216|580910508|FG020|Overall Study|Lost to Follow-up|1|||
160868811|NCT04922216|580910509|FG021|Overall Study|Lost to Follow-up|0|||
160868812|NCT04922216|580910510|FG022|Overall Study|Lost to Follow-up|2|||
160868813|NCT04922216|580910511|FG023|Overall Study|Lost to Follow-up|1|||
160868814|NCT04922216|580910512|FG024|Overall Study|Lost to Follow-up|0|||
160868815|NCT04922216|580910513|FG025|Overall Study|Lost to Follow-up|2|||
160868816|NCT04922216|580910514|FG026|Overall Study|Lost to Follow-up|0|||
160868817|NCT04922216|580910515|FG027|Overall Study|Lost to Follow-up|0|||
160868818|NCT04922216|580910516|FG028|Overall Study|Lost to Follow-up|1|||
160868819|NCT04922216|580910517|FG029|Overall Study|Lost to Follow-up|0|||
160868820|NCT04922216|580910518|FG030|Overall Study|Lost to Follow-up|2|||
160868821|NCT04922216|580910519|FG031|Overall Study|Lost to Follow-up|1|||
160868822|NCT03278249|580910520|FG000|Overall Study|Withdrawal by Subject|2|||
160868823|NCT03278249|580910520|FG000|Overall Study|Lost to Follow-up|1|||
160868824|NCT03207763|580912031|FG000|Overall Study|Lost to Follow-up|1|||
160868825|NCT03207763|580912032|FG001|Overall Study|Lost to Follow-up|0|||
160868826|NCT02102204|580912033|FG000|Overall Study|Withdrawal by Subject|137|||
160868827|NCT02102204|580912033|FG000|Overall Study|Death|92|||
160868828|NCT02102204|580912033|FG000|Overall Study|Lost to Follow-up|65|||
160868829|NCT02102204|580912033|FG000|Overall Study|Sponsor Decision|5|||
160868830|NCT02102204|580912033|FG000|Overall Study|Ongoing|5|||
160868831|NCT02605122|580912034|FG000|Overall Study|Withdrawal by Subject|4|||
160868832|NCT02605122|580912035|FG001|Overall Study|Withdrawal by Subject|1|||
160868833|NCT02605122|580912034|FG000|Overall Study|Lost to Follow-up|1|||
160868834|NCT02605122|580912035|FG001|Overall Study|Lost to Follow-up|1|||
160868835|NCT00990704|580912036|FG000|Overall Study|Adverse Event|1|||
160868836|NCT00990704|580912037|FG001|Overall Study|Adverse Event|1|||
160868837|NCT00990704|580912036|FG000|Overall Study|Physician Decision|0|||
160868838|NCT00990704|580912037|FG001|Overall Study|Physician Decision|1|||
160868839|NCT00807001|580912039|FG000|Overall Study|Non-compliance|0|||
160868840|NCT00807001|580912040|FG001|Overall Study|Non-compliance|1|||
160868841|NCT00807001|580912041|FG002|Overall Study|Non-compliance|0|||
160868842|NCT00807001|580912042|FG003|Overall Study|Non-compliance|0|||
160868843|NCT00807001|580912043|FG004|Overall Study|Non-compliance|0|||
160868844|NCT01399372|580912045|FG000|Overall Study|Protocol Violation|3|||
160868845|NCT01399372|580912046|FG001|Overall Study|Protocol Violation|1|||
160868846|NCT03773796|580912047|FG000|Overall Study|Adverse Event|1|||
160868847|NCT03773796|580912047|FG000|Overall Study|Withdrawal by Subject|1|||
160868848|NCT03773796|580912047|FG000|Overall Study|Lack of Efficacy|1|||
160868849|NCT03805659|580912049|FG000|Overall Study|Withdrawal by Subject|0|||
160868850|NCT03805659|580912050|FG001|Overall Study|Withdrawal by Subject|1|||
160868851|NCT01027273|580912052|FG000|Overall Study|Lost to Follow-up|57|||
160868852|NCT01027273|580912053|FG001|Overall Study|Lost to Follow-up|31|||
160868853|NCT01027273|580912052|FG000|Overall Study|Death|2|||
160868854|NCT01027273|580912053|FG001|Overall Study|Death|2|||
160868855|NCT00499616|580912056|FG000|Overall Study|Death|1|||
160868856|NCT00499616|580912057|FG001|Overall Study|Death|5|||
160868857|NCT00499616|580912058|FG002|Overall Study|Death|3|||
160868858|NCT00499616|580912059|FG003|Overall Study|Death|1|||
160868859|NCT00499616|580912056|FG000|Overall Study|Lack of Efficacy|5|||
160868860|NCT00499616|580912057|FG001|Overall Study|Lack of Efficacy|0|||
160868861|NCT00499616|580912058|FG002|Overall Study|Lack of Efficacy|19|||
160868862|NCT00499616|580912059|FG003|Overall Study|Lack of Efficacy|0|||
160868863|NCT00499616|580912056|FG000|Overall Study|Lost to Follow-up|0|||
160868864|NCT00499616|580912057|FG001|Overall Study|Lost to Follow-up|0|||
160868865|NCT00499616|580912058|FG002|Overall Study|Lost to Follow-up|1|||
160868866|NCT00499616|580912059|FG003|Overall Study|Lost to Follow-up|0|||
160868867|NCT00499616|580912056|FG000|Overall Study|Physician Decision|6|||
160868868|NCT00499616|580912057|FG001|Overall Study|Physician Decision|16|||
160868869|NCT00499616|580912058|FG002|Overall Study|Physician Decision|9|||
160868870|NCT00499616|580912059|FG003|Overall Study|Physician Decision|0|||
160868871|NCT00499616|580912056|FG000|Overall Study|Withdrawal by Subject|1|||
160868872|NCT00499616|580912057|FG001|Overall Study|Withdrawal by Subject|0|||
160868873|NCT00499616|580912058|FG002|Overall Study|Withdrawal by Subject|1|||
160868874|NCT00499616|580912059|FG003|Overall Study|Withdrawal by Subject|0|||
160868875|NCT00499616|580912056|FG000|Overall Study|Ineligible|1|||
160868876|NCT00499616|580912057|FG001|Overall Study|Ineligible|2|||
160868877|NCT00499616|580912058|FG002|Overall Study|Ineligible|0|||
160868878|NCT00499616|580912059|FG003|Overall Study|Ineligible|15|||
160868879|NCT00499616|580912056|FG000|Overall Study|Not evaluable|0|||
160868880|NCT00499616|580912057|FG001|Overall Study|Not evaluable|0|||
160868881|NCT00499616|580912058|FG002|Overall Study|Not evaluable|0|||
160868882|NCT00499616|580912059|FG003|Overall Study|Not evaluable|41|||
160868883|NCT00499616|580912056|FG000|Overall Study|Patient/Parent Refusal|1|||
161214793|NCT01078623|582169459|FG018|Treatment Period 4|Adverse Event|0|||
160868884|NCT00499616|580912057|FG001|Overall Study|Patient/Parent Refusal|5|||
160868885|NCT00499616|580912058|FG002|Overall Study|Patient/Parent Refusal|3|||
161214794|NCT01078623|582169460|FG019|Treatment Period 4|Adverse Event|0|||
160868886|NCT00499616|580912059|FG003|Overall Study|Patient/Parent Refusal|0|||
160868887|NCT02636595|580912060|FG000|Overall Study|Lost to Follow-up|1|||
160868888|NCT02636595|580912060|FG000|Overall Study|Other|1|||
160868889|NCT02223858|580912061|FG000|Overall Study|Death|1|||
160868890|NCT02223858|580912062|FG001|Overall Study|Death|1|||
160868891|NCT02223858|580912061|FG000|Overall Study|Lost to Follow-up|6|||
160868892|NCT02223858|580912062|FG001|Overall Study|Lost to Follow-up|11|||
160868893|NCT02223858|580912061|FG000|Overall Study|Withdrawal by Subject|8|||
160868894|NCT02223858|580912062|FG001|Overall Study|Withdrawal by Subject|5|||
160868895|NCT02223858|580912061|FG000|Overall Study|Refused|9|||
160868896|NCT02223858|580912062|FG001|Overall Study|Refused|9|||
161109758|NCT03834519|581791112|FG001|Overall Study|Lost to Follow-up|1|||
161109759|NCT03834519|581791111|FG000|Overall Study|Withdrawal by Subject|5|||
161109760|NCT03834519|581791112|FG001|Overall Study|Withdrawal by Subject|8|||
161109761|NCT03834519|581791111|FG000|Overall Study|Death|368|||
161109762|NCT03834519|581791112|FG001|Overall Study|Death|174|||
161109763|NCT03834519|581791111|FG000|Overall Study|Physician Decision|5|||
161109764|NCT03834519|581791112|FG001|Overall Study|Physician Decision|1|||
161109765|NCT03834519|581791111|FG000|Overall Study|Sponsor decision|149|||
161109766|NCT03834519|581791112|FG001|Overall Study|Sponsor decision|80|||
161109767|NCT04066491|581791116|FG000|Overall Study|Randomized, not treated|0|||
161109768|NCT04066491|581791117|FG001|Overall Study|Randomized, not treated|0|||
161109769|NCT04066491|581791118|FG002|Overall Study|Randomized, not treated|2|||
161109770|NCT01129921|581791122|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
161109771|NCT01129921|581791123|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
161109772|NCT01129921|581791122|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
161109773|NCT01129921|581791123|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
161109774|NCT01129921|581791122|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
161109775|NCT01129921|581791123|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
161109776|NCT01129921|581791122|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
161109777|NCT01129921|581791123|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
161109778|NCT01380379|581791124|FG000|Overall Study|Pregnancy|1|||
161109779|NCT05937165|581791127|FG000|Overall Study|Withdrawal by Subject|0|||
161109780|NCT05937165|581791128|FG001|Overall Study|Withdrawal by Subject|1|||
161109781|NCT06608368|581791129|FG000|Overall Study|Family Emergency|0|||
161109782|NCT06608368|581791130|FG001|Overall Study|Family Emergency|1|||
161109783|NCT06608368|581791131|FG002|Overall Study|Family Emergency|0|||
161109784|NCT06608368|581791129|FG000|Overall Study|Scheduling Issues|0|||
161109785|NCT06608368|581791130|FG001|Overall Study|Scheduling Issues|1|||
161109786|NCT06608368|581791131|FG002|Overall Study|Scheduling Issues|0|||
161109787|NCT03977974|581791132|FG000|Period 2|Adverse Event|0|||
161109788|NCT03977974|581791133|FG001|Period 2|Adverse Event|0|||
161109789|NCT03977974|581791134|FG002|Period 2|Adverse Event|0|||
161109790|NCT03977974|581791135|FG003|Period 2|Adverse Event|0|||
161109791|NCT03977974|581791136|FG004|Period 2|Adverse Event|1|||
161109792|NCT03977974|581791137|FG005|Period 2|Adverse Event|0|||
161109793|NCT03977974|581791138|FG006|Period 2|Adverse Event|0|||
161109794|NCT03977974|581791139|FG007|Period 2|Adverse Event|0|||
161109795|NCT03977974|581791140|FG008|Period 2|Adverse Event|0|||
161109796|NCT03977974|581791141|FG009|Period 2|Adverse Event|0|||
161109797|NCT03977974|581791142|FG010|Period 2|Adverse Event|0|||
161109798|NCT03977974|581791143|FG011|Period 2|Adverse Event|0|||
161109799|NCT03977974|581791144|FG012|Period 2|Adverse Event|0|||
161109800|NCT00075400|581792313|FG000|Overall Study|Ineligible: wrong primary|1|||
161109801|NCT00075400|581792313|FG000|Overall Study|Never treated|2|||
161109802|NCT00666458|581792320|FG000|Overall Study|Adverse Event|8|||
161109803|NCT00666458|581792321|FG001|Overall Study|Adverse Event|7|||
161109804|NCT00666458|581792320|FG000|Overall Study|Withdrawal by Subject|5|||
161109805|NCT00666458|581792321|FG001|Overall Study|Withdrawal by Subject|4|||
161109806|NCT00666458|581792320|FG000|Overall Study|Lost to Follow-up|0|||
161109807|NCT00666458|581792321|FG001|Overall Study|Lost to Follow-up|3|||
161109808|NCT00666458|581792320|FG000|Overall Study|Administrative reason by sponsor|1|||
161109809|NCT00666458|581792321|FG001|Overall Study|Administrative reason by sponsor|1|||
161109810|NCT00666458|581792320|FG000|Overall Study|Incorrect enrollment|7|||
161109811|NCT00666458|581792321|FG001|Overall Study|Incorrect enrollment|1|||
161109812|NCT00666458|581792320|FG000|Overall Study|Study specific discontinuation criteria|14|||
161109813|NCT00666458|581792321|FG001|Overall Study|Study specific discontinuation criteria|7|||
161109814|NCT00666458|581792320|FG000|Overall Study|Severe non-compliance to the protocol|1|||
161109815|NCT00666458|581792321|FG001|Overall Study|Severe non-compliance to the protocol|1|||
161109816|NCT00666458|581792320|FG000|Overall Study|Safety reasons|1|||
161109817|NCT00666458|581792321|FG001|Overall Study|Safety reasons|0|||
161109818|NCT00666458|581792320|FG000|Overall Study|Medical history of anemia|1|||
160868897|NCT00241839|580912064|FG000|Overall Study|Withdrawal by Subject|18|||
160868898|NCT00241839|580912065|FG001|Overall Study|Withdrawal by Subject|17|||
161109819|NCT00666458|581792321|FG001|Overall Study|Medical history of anemia|0|||
161109820|NCT02554019|581792322|FG000|Overall Study|Withdrawal by Subject|1|||
161109821|NCT02554019|581792323|FG001|Overall Study|Withdrawal by Subject|0|||
161109822|NCT02554019|581792324|FG002|Overall Study|Withdrawal by Subject|2|||
161109823|NCT02554019|581792322|FG000|Overall Study|Adverse Event|1|||
161109824|NCT02554019|581792323|FG001|Overall Study|Adverse Event|0|||
160868899|NCT00241839|580912064|FG000|Overall Study|Adverse Event|1|||
160868900|NCT00241839|580912065|FG001|Overall Study|Adverse Event|1|||
160868901|NCT00831181|580912068|FG000|Overall Study|Adverse Event|12|||
160868902|NCT04313244|580912069|FG000|Overall Study|Withdrawal of Consent|3|||
160868903|NCT04313244|580912070|FG001|Overall Study|Withdrawal of Consent|3|||
160868904|NCT04313244|580912069|FG000|Overall Study|Met Exclusion Criteria|1|||
160868905|NCT04313244|580912070|FG001|Overall Study|Met Exclusion Criteria|0|||
160868906|NCT04313244|580912069|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
160868907|NCT04313244|580912070|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
160868908|NCT02976038|580912071|FG000|Overall Study|Physician Decision|22|||
160868909|NCT02976038|580912071|FG000|Overall Study|Withdrawal by Subject|3|||
160868910|NCT02976038|580912071|FG000|Overall Study|Lost to Follow-up|2|||
160868911|NCT02976038|580912071|FG000|Overall Study|Adverse Event|1|||
160868912|NCT05021978|580912074|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
160868913|NCT05021978|580912075|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
160868914|NCT05021978|580912076|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
160868915|NCT05021978|580912077|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
160868916|NCT05021978|580912074|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
160868917|NCT05021978|580912075|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
160868918|NCT05021978|580912076|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
160868919|NCT05021978|580912077|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
160868920|NCT00196313|580912078|FG000|Overall Study|Protocol Violation|2|||
160868921|NCT00196313|580912079|FG001|Overall Study|Protocol Violation|3|||
160868922|NCT00196313|580912078|FG000|Overall Study|Withdrawal by Subject|3|||
160868923|NCT00196313|580912079|FG001|Overall Study|Withdrawal by Subject|1|||
160868924|NCT00196313|580912078|FG000|Overall Study|Adverse Event|3|||
160868925|NCT00196313|580912079|FG001|Overall Study|Adverse Event|1|||
160868926|NCT00196313|580912078|FG000|Overall Study|Subject Pregnant|1|||
160868927|NCT00196313|580912079|FG001|Overall Study|Subject Pregnant|1|||
160868928|NCT00196313|580912078|FG000|Overall Study|Lost to Follow-up|2|||
160868929|NCT00196313|580912079|FG001|Overall Study|Lost to Follow-up|2|||
160868930|NCT00043979|580912080|FG000|Period 1|recipient with progressive disease|7|||
160868931|NCT00043979|580912081|FG001|Period 1|recipient with progressive disease|4|||
160868932|NCT00043979|580912082|FG002|Period 1|recipient with progressive disease|3|||
160868933|NCT03096288|580912084|FG000|Overall Study|Withdrawal by Subject|0|||
160868934|NCT03096288|580912085|FG001|Overall Study|Withdrawal by Subject|1|||
160868935|NCT03096288|580912086|FG002|Overall Study|Withdrawal by Subject|0|||
160868936|NCT03096288|580912087|FG003|Overall Study|Withdrawal by Subject|1|||
160868937|NCT04639258|580912088|FG000|Overall Study|Screen failure|5|||
160868938|NCT04639258|580912088|FG000|Overall Study|Physician Decision|2|||
160868939|NCT04639258|580912088|FG000|Overall Study|Early study termination|3|||
160868940|NCT04639258|580912088|FG000|Overall Study|Withdrawal by Subject|1|||
160868941|NCT00414596|580912089|FG000|Overall Study|Protocol Violation|2|||
160868942|NCT01635153|580912092|FG000|Overall Study|Lost to Follow-up|40|||
160868943|NCT01635153|580912093|FG001|Overall Study|Lost to Follow-up|43|||
160868944|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Adverse Event|9|||
160868945|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Adverse Event|3|||
160868946|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Death|7|||
160868947|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Death|7|||
160868948|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
160868949|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
160868950|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Physician Decision|1|||
160868951|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Physician Decision|0|||
160868952|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
160868953|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
160868954|NCT02558296|580912094|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
160868955|NCT02558296|580912095|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
161109825|NCT02554019|581792324|FG002|Overall Study|Adverse Event|0|||
161109826|NCT02463409|581792325|FG000|Overall Study|Withdrawal by Subject|1|||
161109827|NCT02463409|581792325|FG000|Overall Study|Screen failure|1|||
160917922|NCT02673489|581094149|FG001|Treatment Period|Participant was incarcerated|1|||
161109828|NCT01444742|581792326|FG000|Overall Study|Death|1|||
160868956|NCT02558296|580912094|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
161214795|NCT01078623|582169441|FG000|Treatment Period 4|Withdrawal by Subject|0|||
161214796|NCT01078623|582169442|FG001|Treatment Period 4|Withdrawal by Subject|0|||
161214797|NCT01078623|582169443|FG002|Treatment Period 4|Withdrawal by Subject|0|||
161214798|NCT01078623|582169444|FG003|Treatment Period 4|Withdrawal by Subject|0|||
160868957|NCT02558296|580912095|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
160868958|NCT02558296|580912094|FG000|Completed the Study|Adverse Event|14|||
160868959|NCT02558296|580912095|FG001|Completed the Study|Adverse Event|5|||
160868960|NCT02558296|580912094|FG000|Completed the Study|Death|39|||
160868961|NCT02558296|580912095|FG001|Completed the Study|Death|25|||
160868962|NCT02558296|580912094|FG000|Completed the Study|Lost to Follow-up|31|||
160868963|NCT02558296|580912095|FG001|Completed the Study|Lost to Follow-up|23|||
160868964|NCT02558296|580912094|FG000|Completed the Study|Physician Decision|6|||
160868965|NCT02558296|580912095|FG001|Completed the Study|Physician Decision|0|||
160868966|NCT02558296|580912094|FG000|Completed the Study|Protocol Violation|2|||
160868967|NCT02558296|580912095|FG001|Completed the Study|Protocol Violation|1|||
160868968|NCT02558296|580912094|FG000|Completed the Study|Withdrawal by Subject|53|||
160868969|NCT02558296|580912095|FG001|Completed the Study|Withdrawal by Subject|31|||
160868970|NCT02558296|580912094|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
160868971|NCT02558296|580912095|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
160868972|NCT02919995|580912098|FG000|Overall Study|Adverse Event|0|||
160868973|NCT02919995|580912099|FG001|Overall Study|Adverse Event|0|||
160868974|NCT02919995|580912100|FG002|Overall Study|Adverse Event|0|||
160868975|NCT02919995|580912101|FG003|Overall Study|Adverse Event|0|||
160868976|NCT02919995|580912102|FG004|Overall Study|Adverse Event|0|||
160868977|NCT02919995|580912103|FG005|Overall Study|Adverse Event|1|||
160868978|NCT01263197|580912115|FG000|First Intervention (Period 1)|Adverse Event|0|||
160868979|NCT01263197|580912116|FG001|First Intervention (Period 1)|Adverse Event|0|||
160868980|NCT01263197|580912117|FG002|First Intervention (Period 1)|Adverse Event|0|||
160868981|NCT01263197|580912118|FG003|First Intervention (Period 1)|Adverse Event|0|||
160868982|NCT01263197|580912119|FG004|First Intervention (Period 1)|Adverse Event|0|||
160868983|NCT01263197|580912120|FG005|First Intervention (Period 1)|Adverse Event|1|||
160868984|NCT01263197|580912115|FG000|Washout Period 1|Protocol Violation|0|||
160868985|NCT01263197|580912116|FG001|Washout Period 1|Protocol Violation|0|||
160868986|NCT01263197|580912117|FG002|Washout Period 1|Protocol Violation|0|||
161214799|NCT01078623|582169445|FG004|Treatment Period 4|Withdrawal by Subject|0|||
161214800|NCT01078623|582169446|FG005|Treatment Period 4|Withdrawal by Subject|0|||
161214801|NCT01078623|582169447|FG006|Treatment Period 4|Withdrawal by Subject|0|||
160868987|NCT01263197|580912118|FG003|Washout Period 1|Protocol Violation|0|||
160868988|NCT01263197|580912119|FG004|Washout Period 1|Protocol Violation|1|||
160868989|NCT01263197|580912120|FG005|Washout Period 1|Protocol Violation|0|||
160868990|NCT01263197|580912115|FG000|Washout Period 2|Physician Decision|0|||
160868991|NCT01263197|580912116|FG001|Washout Period 2|Physician Decision|0|||
160868992|NCT01263197|580912117|FG002|Washout Period 2|Physician Decision|0|||
160868993|NCT01263197|580912118|FG003|Washout Period 2|Physician Decision|0|||
160868994|NCT01263197|580912119|FG004|Washout Period 2|Physician Decision|0|||
160868995|NCT01263197|580912120|FG005|Washout Period 2|Physician Decision|1|||
160868996|NCT01263197|580912115|FG000|Washout Period 2|Protocol Violation|0|||
161214802|NCT01078623|582169448|FG007|Treatment Period 4|Withdrawal by Subject|0|||
161214803|NCT01078623|582169449|FG008|Treatment Period 4|Withdrawal by Subject|0|||
161214804|NCT01078623|582169450|FG009|Treatment Period 4|Withdrawal by Subject|0|||
161214805|NCT01078623|582169451|FG010|Treatment Period 4|Withdrawal by Subject|0|||
161214806|NCT01078623|582169452|FG011|Treatment Period 4|Withdrawal by Subject|0|||
161214807|NCT01078623|582169453|FG012|Treatment Period 4|Withdrawal by Subject|0|||
161214808|NCT01078623|582169454|FG013|Treatment Period 4|Withdrawal by Subject|0|||
161214809|NCT01078623|582169455|FG014|Treatment Period 4|Withdrawal by Subject|0|||
161214810|NCT01078623|582169456|FG015|Treatment Period 4|Withdrawal by Subject|1|||
161214811|NCT01078623|582169457|FG016|Treatment Period 4|Withdrawal by Subject|0|||
161214812|NCT01078623|582169458|FG017|Treatment Period 4|Withdrawal by Subject|0|||
161214813|NCT01078623|582169459|FG018|Treatment Period 4|Withdrawal by Subject|0|||
161214814|NCT01078623|582169460|FG019|Treatment Period 4|Withdrawal by Subject|0|||
161214815|NCT00463866|582169461|FG000|Overall Study|Adverse Event|70|||
161214816|NCT00463866|582169462|FG001|Overall Study|Adverse Event|93|||
161214817|NCT00463866|582169461|FG000|Overall Study|Withdrawal by Subject|81|||
161214818|NCT00463866|582169462|FG001|Overall Study|Withdrawal by Subject|79|||
161214819|NCT00463866|582169461|FG000|Overall Study|Lost to Follow-up|46|||
161214820|NCT00463866|582169462|FG001|Overall Study|Lost to Follow-up|55|||
161214821|NCT00463866|582169461|FG000|Overall Study|Incorrect Enrolment|64|||
161214822|NCT00463866|582169462|FG001|Overall Study|Incorrect Enrolment|66|||
161214823|NCT00463866|582169461|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
161214824|NCT00463866|582169462|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
161214825|NCT00463866|582169461|FG000|Overall Study|Safety Reason|1|||
160868997|NCT01263197|580912116|FG001|Washout Period 2|Protocol Violation|0|||
160868998|NCT01263197|580912117|FG002|Washout Period 2|Protocol Violation|0|||
161109829|NCT02830880|581792327|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
161109830|NCT02830880|581792327|FG000|Overall Study|Death|1|||
161109831|NCT02830880|581792327|FG000|Overall Study|Physician Decision|1|||
161109832|NCT02349048|581792332|FG000|Overall Study|Withdrawal by Subject|4|||
161109833|NCT02349048|581792333|FG001|Overall Study|Withdrawal by Subject|0|||
161109834|NCT02349048|581792332|FG000|Overall Study|Lost to Follow-up|1|||
161109835|NCT02349048|581792333|FG001|Overall Study|Lost to Follow-up|0|||
161214826|NCT00463866|582169462|FG001|Overall Study|Safety Reason|3|||
161214827|NCT00463866|582169461|FG000|Overall Study|Mis-Randomization of subject|0|||
161214828|NCT00463866|582169462|FG001|Overall Study|Mis-Randomization of subject|1|||
161214829|NCT00463866|582169461|FG000|Overall Study|Other|22|||
160868999|NCT01263197|580912118|FG003|Washout Period 2|Protocol Violation|1|||
160869000|NCT01263197|580912119|FG004|Washout Period 2|Protocol Violation|0|||
160869001|NCT01263197|580912120|FG005|Washout Period 2|Protocol Violation|0|||
160869002|NCT01263197|580912115|FG000|Third Intervention (Period 3)|Adverse Event|0|||
160869003|NCT01263197|580912116|FG001|Third Intervention (Period 3)|Adverse Event|1|||
160869004|NCT01263197|580912117|FG002|Third Intervention (Period 3)|Adverse Event|0|||
160869005|NCT01263197|580912118|FG003|Third Intervention (Period 3)|Adverse Event|0|||
160869006|NCT01263197|580912119|FG004|Third Intervention (Period 3)|Adverse Event|0|||
160869007|NCT01263197|580912120|FG005|Third Intervention (Period 3)|Adverse Event|0|||
160869008|NCT02577718|580912121|FG000|Overall Study|Death|6|||
160869009|NCT02577718|580912121|FG000|Overall Study|Withdrawal by Subject|2|||
160869010|NCT00594815|580912123|FG000|Overall Study|Never Treated|3|||
160869011|NCT00594815|580912123|FG000|Overall Study|Withdrawal by Subject|2|||
160869012|NCT00594815|580912123|FG000|Overall Study|Toxicity|4|||
160869013|NCT01932437|580912125|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869014|NCT01932437|580912126|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869015|NCT01932437|580912127|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869016|NCT01932437|580912128|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869017|NCT01932437|580912129|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
160869018|NCT01932437|580912130|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
160869019|NCT04269889|580912131|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
160869020|NCT00949702|580912136|FG000|Overall Study|Death|40|||
160869021|NCT00949702|580912136|FG000|Overall Study|Disease progression|7|||
160869022|NCT00949702|580912136|FG000|Overall Study|Withdrawal of consent|1|||
160869023|NCT01654302|580912137|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
160869024|NCT01654302|580912138|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
160869025|NCT01286480|580912139|FG000|Overall Study|Withdrawal by Subject|5|||
160869026|NCT01286480|580912140|FG001|Overall Study|Withdrawal by Subject|3|||
160869027|NCT01918306|580912141|FG000|Overall Study|progresive disease|4|||
160869028|NCT01918306|580912142|FG001|Overall Study|progresive disease|0|||
160869029|NCT01918306|580912143|FG002|Overall Study|progresive disease|1|||
160869030|NCT01918306|580912144|FG003|Overall Study|progresive disease|1|||
160869031|NCT01918306|580912141|FG000|Overall Study|Withdrawal by Subject|0|||
160869032|NCT01918306|580912142|FG001|Overall Study|Withdrawal by Subject|0|||
160869033|NCT01918306|580912143|FG002|Overall Study|Withdrawal by Subject|0|||
160869034|NCT01918306|580912144|FG003|Overall Study|Withdrawal by Subject|2|||
160869035|NCT01918306|580912141|FG000|Overall Study|neutropenia|1|||
160869036|NCT01918306|580912142|FG001|Overall Study|neutropenia|0|||
160869037|NCT01918306|580912143|FG002|Overall Study|neutropenia|0|||
160869038|NCT01918306|580912144|FG003|Overall Study|neutropenia|0|||
160869039|NCT01918306|580912141|FG000|Overall Study|Lack of Efficacy|1|||
160869040|NCT01918306|580912142|FG001|Overall Study|Lack of Efficacy|0|||
160869041|NCT01918306|580912143|FG002|Overall Study|Lack of Efficacy|0|||
161109836|NCT01648790|581792338|FG000|Treatment 3|Withdrawal by Subject|0|||
161109837|NCT01648790|581792339|FG001|Treatment 3|Withdrawal by Subject|0|||
161109838|NCT01648790|581792340|FG002|Treatment 3|Withdrawal by Subject|0|||
161109839|NCT01648790|581792341|FG003|Treatment 3|Withdrawal by Subject|1|||
161109840|NCT01648790|581792342|FG004|Treatment 3|Withdrawal by Subject|0|||
161109841|NCT01278745|581792350|FG000|Overall Study|Death|2|||
161109842|NCT01278745|581792351|FG001|Overall Study|Death|5|||
161109843|NCT01278745|581792352|FG002|Overall Study|Death|7|||
161109844|NCT01278745|581792353|FG003|Overall Study|Death|0|||
161109845|NCT01278745|581792350|FG000|Overall Study|Physician Decision|1|||
161109846|NCT01278745|581792351|FG001|Overall Study|Physician Decision|0|||
161109847|NCT01278745|581792352|FG002|Overall Study|Physician Decision|0|||
161214830|NCT00463866|582169462|FG001|Overall Study|Other|22|||
161214831|NCT01084005|582169464|FG000|Overall Study|Adverse Event|1|||
161214832|NCT01084005|582169465|FG001|Overall Study|Adverse Event|8|||
160869042|NCT01918306|580912144|FG003|Overall Study|Lack of Efficacy|0|||
160869043|NCT01918306|580912141|FG000|Overall Study|progress disease, crossover|0|||
160869044|NCT01918306|580912142|FG001|Overall Study|progress disease, crossover|0|||
161109848|NCT01278745|581792353|FG003|Overall Study|Physician Decision|9|||
161109849|NCT01278745|581792350|FG000|Overall Study|Withdrawal by Subject|1|||
161109850|NCT01278745|581792351|FG001|Overall Study|Withdrawal by Subject|1|||
161109851|NCT01278745|581792352|FG002|Overall Study|Withdrawal by Subject|5|||
161214833|NCT01084005|582169464|FG000|Overall Study|Protocol Violation|3|||
161109852|NCT01278745|581792353|FG003|Overall Study|Withdrawal by Subject|1|||
161109853|NCT01278745|581792350|FG000|Overall Study|Sponsor Decision|1|||
161109854|NCT01278745|581792351|FG001|Overall Study|Sponsor Decision|0|||
161109855|NCT01278745|581792352|FG002|Overall Study|Sponsor Decision|62|||
161109856|NCT01278745|581792353|FG003|Overall Study|Sponsor Decision|6|||
161109857|NCT01278745|581792350|FG000|Overall Study|Ineligible|0|||
161109858|NCT01278745|581792351|FG001|Overall Study|Ineligible|0|||
161109859|NCT01278745|581792352|FG002|Overall Study|Ineligible|42|||
161109860|NCT01278745|581792353|FG003|Overall Study|Ineligible|61|||
161109861|NCT01278745|581792350|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
161109862|NCT01278745|581792351|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
161109863|NCT01278745|581792352|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
161109864|NCT01278745|581792353|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
161109865|NCT01148537|581792357|FG000|Overall Study|Withdrawal by Subject|1|||
161109866|NCT01148537|581792358|FG001|Overall Study|Withdrawal by Subject|0|||
161109867|NCT01148537|581792359|FG002|Overall Study|Withdrawal by Subject|2|||
161109868|NCT01148537|581792357|FG000|Overall Study|Adverse Event|2|||
161109869|NCT01148537|581792358|FG001|Overall Study|Adverse Event|0|||
161109870|NCT01148537|581792359|FG002|Overall Study|Adverse Event|1|||
161109871|NCT01923285|581792364|FG000|Overall Study|Withdrawal by Subject|7|||
161109872|NCT01923285|581792365|FG001|Overall Study|Withdrawal by Subject|6|||
161109873|NCT03374189|581792367|FG000|Overall Study|Lost to Follow-up|1|||
161109874|NCT03374189|581792368|FG001|Overall Study|Lost to Follow-up|0|||
161109875|NCT01517893|581792369|FG000|Overall Study|Withdrawal by Subject|3|||
161109876|NCT01517893|581792370|FG001|Overall Study|Withdrawal by Subject|0|||
161109877|NCT03462576|581792371|FG000|Overall Study|Protocol Violation|5|||
161109878|NCT03462576|581792372|FG001|Overall Study|Protocol Violation|11|||
161109879|NCT03462576|581792373|FG002|Overall Study|Protocol Violation|7|||
161109880|NCT03462576|581792371|FG000|Overall Study|Device Malfunction|0|||
161109881|NCT03462576|581792372|FG001|Overall Study|Device Malfunction|0|||
161109882|NCT03462576|581792373|FG002|Overall Study|Device Malfunction|1|||
161109883|NCT02018822|581792374|FG000|Overall Study|filling replaced by crown|0|||
161109884|NCT02018822|581792375|FG001|Overall Study|filling replaced by crown|1|||
161109885|NCT02018822|581792376|FG002|Overall Study|filling replaced by crown|0|||
161109886|NCT02018822|581792374|FG000|Overall Study|Physician Decision|0|||
161109887|NCT02018822|581792375|FG001|Overall Study|Physician Decision|1|||
161109888|NCT02018822|581792376|FG002|Overall Study|Physician Decision|1|||
161109889|NCT02018822|581792374|FG000|Overall Study|Lost to Follow-up|6|||
161109890|NCT02018822|581792375|FG001|Overall Study|Lost to Follow-up|6|||
161109891|NCT02018822|581792376|FG002|Overall Study|Lost to Follow-up|5|||
161109892|NCT03201458|581792377|FG000|Overall Study|No longer eligible|2|||
161109893|NCT03201458|581792378|FG001|Overall Study|No longer eligible|5|||
161109894|NCT03201458|581792377|FG000|Overall Study|Health event before starting|1|||
161109895|NCT03201458|581792378|FG001|Overall Study|Health event before starting|0|||
161109896|NCT03201458|581792377|FG000|Overall Study|Physician Decision|1|||
161109897|NCT03201458|581792378|FG001|Overall Study|Physician Decision|0|||
161109898|NCT00715026|581792379|FG000|Overall Study|Withdrawal by Subject|5|||
161109899|NCT00715026|581792379|FG000|Overall Study|Lost to Follow-up|3|||
161109900|NCT00715026|581792379|FG000|Overall Study|Protocol Violation|1|||
161109901|NCT00715026|581792379|FG000|Overall Study|Surgery done on non-study consented hip|1|||
161109902|NCT00750737|581792387|FG000|Overall Study|Withdrawal by Subject|3|||
161109903|NCT00750737|581792388|FG001|Overall Study|Withdrawal by Subject|3|||
161109904|NCT00865904|581792399|FG000|Overall Study|Randomized but not Treated|2|||
161109905|NCT00865904|581792400|FG001|Overall Study|Randomized but not Treated|0|||
161109906|NCT00865904|581792401|FG002|Overall Study|Randomized but not Treated|0|||
161109907|NCT00865904|581792402|FG003|Overall Study|Randomized but not Treated|1|||
161109908|NCT00865904|581792403|FG004|Overall Study|Randomized but not Treated|1|||
161109909|NCT01543828|581792404|FG000|Treatment 2|Lost to Follow-up|1|||
161324362|NCT01408901|582573577|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
161109910|NCT01543828|581792405|FG001|Treatment 2|Lost to Follow-up|0|||
161109911|NCT01069172|581792406|FG000|Overall Study|Withdrawal by Subject|1|||
161109912|NCT01069172|581792407|FG001|Overall Study|Withdrawal by Subject|0|||
161109913|NCT00711425|581792410|FG000|Overall Study|Protocol Violation|1|||
161109914|NCT00711425|581792410|FG000|Overall Study|Death|2|||
161109915|NCT00711425|581792410|FG000|Overall Study|Lost to Follow-up|1|||
161109916|NCT05879107|581792413|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
161109917|NCT05879107|581792414|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
161109918|NCT05879107|581792413|FG000|Overall Study|Migrated / moved from the study area|1|||
161109919|NCT05879107|581792414|FG001|Overall Study|Migrated / moved from the study area|1|||
161109920|NCT05879107|581792413|FG000|Overall Study|Lost to Follow-up|8|||
161109921|NCT05879107|581792414|FG001|Overall Study|Lost to Follow-up|13|||
161109922|NCT05879107|581792413|FG000|Overall Study|Death|0|||
161109923|NCT05879107|581792414|FG001|Overall Study|Death|2|||
161109924|NCT05879107|581792413|FG000|Overall Study|Other|0|||
161109925|NCT05879107|581792414|FG001|Overall Study|Other|3|||
161109926|NCT03901079|581792415|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
160869045|NCT01918306|580912143|FG002|Overall Study|progress disease, crossover|1|||
160869046|NCT01918306|580912144|FG003|Overall Study|progress disease, crossover|0|||
160869047|NCT02908672|580912149|FG000|Run-in Period|Death|12|||
160869048|NCT02908672|580912150|FG001|Run-in Period|Death|10|||
160869049|NCT02908672|580912151|FG002|Run-in Period|Death|0|||
160869050|NCT02908672|580912152|FG003|Run-in Period|Death|0|||
160869051|NCT02908672|580912149|FG000|Run-in Period|Lost to Follow-up|1|||
160869052|NCT02908672|580912150|FG001|Run-in Period|Lost to Follow-up|1|||
160869053|NCT02908672|580912151|FG002|Run-in Period|Lost to Follow-up|0|||
160869054|NCT02908672|580912152|FG003|Run-in Period|Lost to Follow-up|0|||
160869055|NCT02908672|580912149|FG000|Run-in Period|Reason Not Specified|2|||
160869056|NCT02908672|580912150|FG001|Run-in Period|Reason Not Specified|0|||
160869057|NCT02908672|580912151|FG002|Run-in Period|Reason Not Specified|0|||
160869058|NCT02908672|580912152|FG003|Run-in Period|Reason Not Specified|0|||
160869059|NCT02908672|580912149|FG000|Run-in Period|Protocol Violation|1|||
160869060|NCT02908672|580912150|FG001|Run-in Period|Protocol Violation|1|||
160869061|NCT02908672|580912151|FG002|Run-in Period|Protocol Violation|0|||
160869062|NCT02908672|580912152|FG003|Run-in Period|Protocol Violation|0|||
160869063|NCT02908672|580912149|FG000|Run-in Period|Study Ended by Sponsor|5|||
160869064|NCT02908672|580912150|FG001|Run-in Period|Study Ended by Sponsor|1|||
160869065|NCT02908672|580912151|FG002|Run-in Period|Study Ended by Sponsor|0|||
160869066|NCT02908672|580912152|FG003|Run-in Period|Study Ended by Sponsor|0|||
160869067|NCT02908672|580912149|FG000|Run-in Period|Withdrawal by Subject|3|||
160869068|NCT02908672|580912150|FG001|Run-in Period|Withdrawal by Subject|9|||
160869069|NCT02908672|580912151|FG002|Run-in Period|Withdrawal by Subject|0|||
160869070|NCT02908672|580912152|FG003|Run-in Period|Withdrawal by Subject|0|||
160869071|NCT02908672|580912149|FG000|Triple Combination Period|Death|0|||
160869072|NCT02908672|580912150|FG001|Triple Combination Period|Death|0|||
160869073|NCT02908672|580912151|FG002|Triple Combination Period|Death|150|||
160869074|NCT02908672|580912152|FG003|Triple Combination Period|Death|127|||
160869075|NCT02908672|580912149|FG000|Triple Combination Period|Lost to Follow-up|0|||
160869076|NCT02908672|580912150|FG001|Triple Combination Period|Lost to Follow-up|0|||
160869077|NCT02908672|580912151|FG002|Triple Combination Period|Lost to Follow-up|6|||
160869078|NCT02908672|580912152|FG003|Triple Combination Period|Lost to Follow-up|8|||
160869079|NCT02908672|580912149|FG000|Triple Combination Period|Reason Not Specified|0|||
160869080|NCT02908672|580912150|FG001|Triple Combination Period|Reason Not Specified|0|||
160869081|NCT02908672|580912151|FG002|Triple Combination Period|Reason Not Specified|0|||
160869082|NCT02908672|580912152|FG003|Triple Combination Period|Reason Not Specified|1|||
160869083|NCT02908672|580912149|FG000|Triple Combination Period|Physician Decision|0|||
160869084|NCT02908672|580912150|FG001|Triple Combination Period|Physician Decision|0|||
160869085|NCT02908672|580912151|FG002|Triple Combination Period|Physician Decision|1|||
160869086|NCT02908672|580912152|FG003|Triple Combination Period|Physician Decision|1|||
160869087|NCT02908672|580912149|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
160869088|NCT02908672|580912150|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
160869089|NCT02908672|580912151|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
160869090|NCT02908672|580912152|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
160869091|NCT02908672|580912149|FG000|Triple Combination Period|Withdrawal by Subject|0|||
160869092|NCT02908672|580912150|FG001|Triple Combination Period|Withdrawal by Subject|0|||
160869093|NCT02908672|580912151|FG002|Triple Combination Period|Withdrawal by Subject|13|||
160869094|NCT02908672|580912152|FG003|Triple Combination Period|Withdrawal by Subject|16|||
160869095|NCT01185080|580912156|FG000|Overall Study|Adverse Event|1|||
160869096|NCT01185080|580912157|FG001|Overall Study|Adverse Event|1|||
160869097|NCT01185080|580912158|FG002|Overall Study|Adverse Event|0|||
160869098|NCT01185080|580912156|FG000|Overall Study|Personal reasons|0|||
160869099|NCT01185080|580912157|FG001|Overall Study|Personal reasons|0|||
160869100|NCT01185080|580912158|FG002|Overall Study|Personal reasons|1|||
160869101|NCT02876601|580912159|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
160869102|NCT02876601|580912160|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
160869103|NCT02876601|580912161|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
160869104|NCT02876601|580912162|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
160869105|NCT06083506|580912164|FG000|Overall Study|Physician Decision|2|||
160869106|NCT06083506|580912164|FG000|Overall Study|Lack of Efficacy|1|||
160869107|NCT02864394|580912166|FG000|Overall Study|Death|184|||
160869108|NCT02864394|580912167|FG001|Overall Study|Death|189|||
160869109|NCT02864394|580912166|FG000|Overall Study|Lost to Follow-up|0|||
160869110|NCT02864394|580912167|FG001|Overall Study|Lost to Follow-up|2|||
160869111|NCT02864394|580912166|FG000|Overall Study|Sponsor Decision|26|||
160869112|NCT02864394|580912167|FG001|Overall Study|Sponsor Decision|11|||
160869113|NCT02864394|580912166|FG000|Overall Study|Withdrawal by Subject|3|||
160869114|NCT02864394|580912167|FG001|Overall Study|Withdrawal by Subject|10|||
160869115|NCT00905164|580912168|FG000|Period 1|Protocol Violation|0|||
160869116|NCT00905164|580912169|FG001|Period 1|Protocol Violation|1|||
160869117|NCT01442103|580913629|FG000|Overall Study|Lost to Follow-up|2|||
160869118|NCT03751657|580913631|FG000|Overall Study|Physician Decision|0|||
160869119|NCT03751657|580913632|FG001|Overall Study|Physician Decision|1|||
160869120|NCT03751657|580913631|FG000|Overall Study|Withdrawal by Subject|1|||
160869121|NCT03751657|580913632|FG001|Overall Study|Withdrawal by Subject|1|||
160869122|NCT03751657|580913631|FG000|Overall Study|Lost to Follow-up|2|||
160869123|NCT03751657|580913632|FG001|Overall Study|Lost to Follow-up|1|||
160869124|NCT03894813|580913639|FG000|Overall Study|Adverse Event|1|||
160869125|NCT03894813|580913640|FG001|Overall Study|Adverse Event|1|||
160869126|NCT03894813|580913639|FG000|Overall Study|Lack of Efficacy|3|||
160869127|NCT03894813|580913640|FG001|Overall Study|Lack of Efficacy|3|||
160869128|NCT03894813|580913639|FG000|Overall Study|Lost to Follow-up|1|||
160869129|NCT03894813|580913640|FG001|Overall Study|Lost to Follow-up|0|||
160869130|NCT03894813|580913639|FG000|Overall Study|Pregnancy|2|||
160869131|NCT03894813|580913640|FG001|Overall Study|Pregnancy|1|||
160869132|NCT03894813|580913639|FG000|Overall Study|Protocol Violation|3|||
160869133|NCT03894813|580913640|FG001|Overall Study|Protocol Violation|7|||
160869134|NCT03894813|580913639|FG000|Overall Study|Withdrawal by Subject|1|||
160869135|NCT03894813|580913640|FG001|Overall Study|Withdrawal by Subject|3|||
160869136|NCT03894813|580913639|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
160869137|NCT03894813|580913640|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
160869138|NCT02269267|580913642|FG000|Overall Study|Death|5|||
160869139|NCT02604160|580913643|FG000|Overall Study|Protocol Violation|0|||
160869140|NCT02604160|580913644|FG001|Overall Study|Protocol Violation|1|||
160869141|NCT02604160|580913643|FG000|Overall Study|Physician Decision|0|||
160869142|NCT02604160|580913644|FG001|Overall Study|Physician Decision|1|||
160869143|NCT01069900|580913647|FG000|Overall Study|Technical problems|0|||
160869144|NCT01069900|580913648|FG001|Overall Study|Technical problems|1|||
160869145|NCT01069900|580913647|FG000|Overall Study|Lost to Follow-up|7|||
160869146|NCT01069900|580913648|FG001|Overall Study|Lost to Follow-up|1|||
160869147|NCT01069900|580913647|FG000|Overall Study|Withdrawal by Subject|6|||
160869148|NCT01069900|580913648|FG001|Overall Study|Withdrawal by Subject|1|||
160869149|NCT01069900|580913647|FG000|Overall Study|Protocol Violation|4|||
160869150|NCT01069900|580913648|FG001|Overall Study|Protocol Violation|1|||
160869151|NCT01069900|580913647|FG000|Overall Study|Insufficient Therapeutic effect|1|||
160869152|NCT01069900|580913648|FG001|Overall Study|Insufficient Therapeutic effect|0|||
160869153|NCT00145158|580913649|FG000|Overall Study|premature withdrawal|2|||
160869154|NCT00145158|580913650|FG001|Overall Study|premature withdrawal|3|||
160869155|NCT02741518|580913651|FG000|Overall Study|Withdrawal by Subject|1|||
160869156|NCT02741518|580913652|FG001|Overall Study|Withdrawal by Subject|1|||
160869157|NCT00476008|580913655|FG000|Overall Study|Adverse Event|4|||
160869158|NCT00476008|580913656|FG001|Overall Study|Adverse Event|4|||
160869159|NCT00476008|580913655|FG000|Overall Study|Placebo concerns|2|||
160869160|NCT00476008|580913656|FG001|Overall Study|Placebo concerns|2|||
160869161|NCT00476008|580913655|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
160869162|NCT00476008|580913656|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
160869163|NCT00476008|580913655|FG000|Overall Study|Withdrawal by Subject|0|||
160869164|NCT00476008|580913656|FG001|Overall Study|Withdrawal by Subject|1|||
160869165|NCT00476008|580913655|FG000|Overall Study|Death|1|||
160869166|NCT00476008|580913656|FG001|Overall Study|Death|0|||
160869167|NCT01788358|580913657|FG000|Overall Study|Other|11|||
160869168|NCT01788358|580913657|FG000|Overall Study|Logistical difficulties|1|||
160869169|NCT01788358|580913657|FG000|Overall Study|Lost to Follow-up|5|||
160869170|NCT01788358|580913657|FG000|Overall Study|Protocol Violation|3|||
160869171|NCT01788358|580913657|FG000|Overall Study|Withdrawal by Subject|26|||
160869172|NCT01788358|580913657|FG000|Overall Study|Lack of Efficacy|1|||
160869173|NCT01788358|580913657|FG000|Overall Study|Adverse Event|51|||
160869174|NCT01168219|580913658|FG000|Overall Study|off study before starting treatment|2|||
160869175|NCT01168219|580913658|FG000|Overall Study|withdrew before transplant|1|||
160869176|NCT01168219|580913658|FG000|Overall Study|ineligible due to CML|2|||
160869177|NCT01227018|580913659|FG000|Overall Study|Disease progression|9|||
160869178|NCT01227018|580913659|FG000|Overall Study|Toxicity|2|||
160869179|NCT01227018|580913659|FG000|Overall Study|Withdrew after beginning treatment|4|||
160869180|NCT02948634|580913667|FG000|Overall Study|Lack of efficacy and study suspended|10|||
160869181|NCT02948634|580913668|FG001|Overall Study|Lack of efficacy and study suspended|2|||
160869182|NCT00753649|580913673|FG000|Overall Study|Migrated/moved from study area|1|||
160869183|NCT00753649|580913674|FG001|Overall Study|Migrated/moved from study area|0|||
160869184|NCT00753649|580913673|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
160869185|NCT00753649|580913674|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
160869186|NCT00753649|580913673|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
160869187|NCT00753649|580913674|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
160869188|NCT00753649|580913673|FG000|Overall Study|Protocol Violation|2|||
160869189|NCT00753649|580913674|FG001|Overall Study|Protocol Violation|0|||
160869190|NCT01039519|580913680|FG000|Treatment|Progressive disease|20|||
161109927|NCT02184195|581792416|FG000|Overall Study|Patient decision|5|||
161109928|NCT02184195|581792417|FG001|Overall Study|Patient decision|2|||
160869191|NCT01039519|580913680|FG000|Treatment|Treatment failure|2|||
160869192|NCT01039519|580913680|FG000|Treatment|Adverse Event|3|||
160869193|NCT01039519|580913680|FG000|Treatment|Physician Decision|2|||
160869194|NCT01039519|580913680|FG000|Survival Follow-up|Death|23|||
160869195|NCT01039519|580913680|FG000|Survival Follow-up|Sponsor decision|4|||
160869196|NCT01255436|580913683|FG000|Overall Study|Lost to Follow-up|178|||
161109929|NCT02184195|581792416|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161214834|NCT01084005|582169465|FG001|Overall Study|Protocol Violation|7|||
161214835|NCT01084005|582169464|FG000|Overall Study|Withdrawal by Subject|1|||
161214836|NCT01084005|582169465|FG001|Overall Study|Withdrawal by Subject|1|||
161214837|NCT01759381|582169468|FG000|Overall Study|Death|1|||
161214838|NCT01759381|582169469|FG001|Overall Study|Death|0|||
161214839|NCT03377556|582169470|FG000|Overall Study|Adverse Event|5|||
161214840|NCT03377556|582169470|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161214841|NCT03377556|582169470|FG000|Overall Study|Progression/relapse|38|||
161214842|NCT03377556|582169470|FG000|Overall Study|Death|3|||
161214843|NCT00827827|582169471|FG000|Overall Study|Lost to Follow-up|3|||
161214844|NCT00827827|582169472|FG001|Overall Study|Lost to Follow-up|0|||
161214845|NCT00827827|582169471|FG000|Overall Study|Fall at home- hospitalization|1|||
161214846|NCT00827827|582169472|FG001|Overall Study|Fall at home- hospitalization|0|||
161214847|NCT00827827|582169471|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
161214848|NCT00827827|582169472|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
161214849|NCT00827827|582169471|FG000|Overall Study|Gout|1|||
161214850|NCT00827827|582169472|FG001|Overall Study|Gout|0|||
161214851|NCT00827827|582169471|FG000|Overall Study|Transportation issues|1|||
161214852|NCT00827827|582169472|FG001|Overall Study|Transportation issues|0|||
161214853|NCT00827827|582169471|FG000|Overall Study|Burned with water at home|1|||
161214854|NCT00827827|582169472|FG001|Overall Study|Burned with water at home|0|||
161214855|NCT00447603|582169473|FG000|Screening|Withdrawal by Subject|1|||
161214856|NCT00447603|582169474|FG001|Screening|Withdrawal by Subject|0|||
161214857|NCT00447603|582169475|FG002|Screening|Withdrawal by Subject|0|||
161214858|NCT00447603|582169473|FG000|Screening|Protocol Violation|1|||
161214859|NCT00447603|582169474|FG001|Screening|Protocol Violation|0|||
161214860|NCT00447603|582169475|FG002|Screening|Protocol Violation|0|||
161214861|NCT00447603|582169473|FG000|Screening|Screen Failure|4|||
161214862|NCT00447603|582169474|FG001|Screening|Screen Failure|0|||
161214863|NCT00447603|582169475|FG002|Screening|Screen Failure|0|||
161109930|NCT02184195|581792417|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161109931|NCT02184195|581792416|FG000|Overall Study|Death|67|||
161214864|NCT00447603|582169473|FG000|Screening|Study Terminated by Sponsor|15|||
161214865|NCT00447603|582169474|FG001|Screening|Study Terminated by Sponsor|0|||
161214866|NCT00447603|582169475|FG002|Screening|Study Terminated by Sponsor|0|||
161214867|NCT00447603|582169473|FG000|Filter Period|Adverse Event|0|||
161214868|NCT00447603|582169474|FG001|Filter Period|Adverse Event|0|||
161214869|NCT00447603|582169475|FG002|Filter Period|Adverse Event|1|||
161214870|NCT00447603|582169473|FG000|Filter Period|Screen Failure|0|||
161214871|NCT00447603|582169474|FG001|Filter Period|Screen Failure|3|||
161214872|NCT00447603|582169475|FG002|Filter Period|Screen Failure|4|||
161214873|NCT00447603|582169473|FG000|Filter Period|Study terminated by Sponsor|0|||
161214874|NCT00447603|582169474|FG001|Filter Period|Study terminated by Sponsor|1|||
161214875|NCT00447603|582169475|FG002|Filter Period|Study terminated by Sponsor|10|||
161214876|NCT01967888|582169481|FG000|Overall Study|Lost to Follow-up|6|||
161214877|NCT01967888|582169482|FG001|Overall Study|Lost to Follow-up|4|||
161214878|NCT01967888|582169481|FG000|Overall Study|Withdrawal by Subject|1|||
161214879|NCT01967888|582169482|FG001|Overall Study|Withdrawal by Subject|1|||
161214880|NCT01967888|582169481|FG000|Overall Study|Did Not Have Transplant|1|||
161214881|NCT01967888|582169482|FG001|Overall Study|Did Not Have Transplant|0|||
161214882|NCT01967888|582169481|FG000|Overall Study|Research visit not done, data recorded|1|||
161214883|NCT01967888|582169482|FG001|Overall Study|Research visit not done, data recorded|0|||
161214884|NCT01967888|582169481|FG000|Overall Study|Subject excluded after randomization|1|||
161214885|NCT01967888|582169482|FG001|Overall Study|Subject excluded after randomization|0|||
161214886|NCT01967888|582169481|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
161214887|NCT01967888|582169482|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
161214888|NCT01967888|582169481|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
161109932|NCT02184195|581792417|FG001|Overall Study|Death|44|||
161109933|NCT02184195|581792416|FG000|Overall Study|Lost to Follow-up|1|||
161109934|NCT02184195|581792417|FG001|Overall Study|Lost to Follow-up|5|||
161109935|NCT02184195|581792416|FG000|Overall Study|Other|0|||
161109936|NCT02184195|581792417|FG001|Overall Study|Other|3|||
161109937|NCT00916149|581792418|FG000|Overall Study|Lost to Follow-up|3|||
161109938|NCT00916149|581792419|FG001|Overall Study|Lost to Follow-up|2|||
161109939|NCT00916149|581792420|FG002|Overall Study|Lost to Follow-up|0|||
161109940|NCT00916149|581792418|FG000|Overall Study|Unable to place scalp EEG leads|1|||
161109941|NCT00916149|581792419|FG001|Overall Study|Unable to place scalp EEG leads|0|||
161109942|NCT00916149|581792420|FG002|Overall Study|Unable to place scalp EEG leads|0|||
161109943|NCT03002155|581792421|FG000|Overall Study|Lost to Follow-up|1|||
161109944|NCT03002155|581792422|FG001|Overall Study|Lost to Follow-up|2|||
161109945|NCT03002155|581792421|FG000|Overall Study|Withdrawal by Subject|1|||
161109946|NCT03002155|581792422|FG001|Overall Study|Withdrawal by Subject|0|||
161109947|NCT03002155|581792421|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
161109948|NCT03002155|581792422|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
161109949|NCT00978029|581792423|FG000|Overall Study|Adverse Event|1|||
161109950|NCT00978029|581792424|FG001|Overall Study|Adverse Event|2|||
161214889|NCT01967888|582169482|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
161214890|NCT03175120|582169486|FG000|Overall Study|Adverse Event|2|||
161214891|NCT03175120|582169487|FG001|Overall Study|Adverse Event|2|||
161214892|NCT03175120|582169486|FG000|Overall Study|Protocol Violation|5|||
161214893|NCT03175120|582169487|FG001|Overall Study|Protocol Violation|2|||
161214894|NCT03175120|582169486|FG000|Overall Study|Lost to Follow-up|1|||
161214895|NCT03175120|582169487|FG001|Overall Study|Lost to Follow-up|0|||
161214896|NCT03175120|582169486|FG000|Overall Study|Withdrawal by Subject|2|||
161214897|NCT03175120|582169487|FG001|Overall Study|Withdrawal by Subject|5|||
161214898|NCT03175120|582169486|FG000|Overall Study|Other|2|||
161214899|NCT03175120|582169487|FG001|Overall Study|Other|3|||
161214900|NCT04120194|582169488|FG000|Overall Study|Lost to Follow-up|11|||
161214901|NCT04120194|582169489|FG001|Overall Study|Lost to Follow-up|8|||
161214902|NCT04120194|582169488|FG000|Overall Study|Adverse Event|4|||
161214903|NCT04120194|582169489|FG001|Overall Study|Adverse Event|5|||
161214904|NCT04120194|582169488|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
161214905|NCT04120194|582169489|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
161214906|NCT04120194|582169488|FG000|Overall Study|Miscellaneous|4|||
161214907|NCT04120194|582169489|FG001|Overall Study|Miscellaneous|5|||
161214908|NCT02622074|582169490|FG000|Overall Study|Death|4|||
161214909|NCT02622074|582169491|FG001|Overall Study|Death|0|||
161214910|NCT02622074|582169492|FG002|Overall Study|Death|0|||
161214911|NCT02622074|582169493|FG003|Overall Study|Death|1|||
161214912|NCT02622074|582169494|FG004|Overall Study|Death|1|||
161214913|NCT02622074|582169495|FG005|Overall Study|Death|0|||
161214914|NCT02622074|582169490|FG000|Overall Study|Withdrawal by Subject|0|||
161214915|NCT02622074|582169491|FG001|Overall Study|Withdrawal by Subject|1|||
161214916|NCT02622074|582169492|FG002|Overall Study|Withdrawal by Subject|0|||
161214917|NCT02622074|582169493|FG003|Overall Study|Withdrawal by Subject|0|||
161214918|NCT02622074|582169494|FG004|Overall Study|Withdrawal by Subject|0|||
161214919|NCT02622074|582169495|FG005|Overall Study|Withdrawal by Subject|0|||
161214920|NCT02114931|582169496|FG000|Overall Study|Withdrawal by Subject|15|||
161214921|NCT02114931|582169497|FG001|Overall Study|Withdrawal by Subject|18|||
161214922|NCT02114931|582169496|FG000|Overall Study|Adverse Event|4|||
161214923|NCT02114931|582169497|FG001|Overall Study|Adverse Event|6|||
161214924|NCT02114931|582169496|FG000|Overall Study|Lost to Follow-up|3|||
161214925|NCT02114931|582169497|FG001|Overall Study|Lost to Follow-up|3|||
161214926|NCT02114931|582169496|FG000|Overall Study|Physician Decision|1|||
161214927|NCT02114931|582169497|FG001|Overall Study|Physician Decision|2|||
161214928|NCT02114931|582169496|FG000|Overall Study|Other|2|||
161214929|NCT02114931|582169497|FG001|Overall Study|Other|1|||
161214930|NCT00986154|582169501|FG000|Overall Study|Death|136|||
161214931|NCT00986154|582169502|FG001|Overall Study|Death|127|||
161214932|NCT00986154|582169501|FG000|Overall Study|Lost to Follow-up|7|||
161214933|NCT00986154|582169502|FG001|Overall Study|Lost to Follow-up|4|||
161214934|NCT00986154|582169501|FG000|Overall Study|Withdrawal by Subject|32|||
161214935|NCT00986154|582169502|FG001|Overall Study|Withdrawal by Subject|33|||
161214936|NCT00986154|582169501|FG000|Overall Study|investigator/subject decide not continue|6|||
161214937|NCT00986154|582169502|FG001|Overall Study|investigator/subject decide not continue|3|||
161214938|NCT00986154|582169501|FG000|Overall Study|never received study drug|25|||
161214939|NCT00986154|582169502|FG001|Overall Study|never received study drug|27|||
161214940|NCT00267007|582169503|FG000|Overall Study|Withdrawal by Subject|6|||
161214941|NCT00267007|582169504|FG001|Overall Study|Withdrawal by Subject|0|||
161214942|NCT00267007|582169503|FG000|Overall Study|Lost to Follow-up|1|||
161214943|NCT00267007|582169504|FG001|Overall Study|Lost to Follow-up|0|||
161214944|NCT00267007|582169503|FG000|Overall Study|Non-compliance|0|||
161214945|NCT00267007|582169504|FG001|Overall Study|Non-compliance|1|||
161214946|NCT00267007|582169503|FG000|Overall Study|Adverse Event|1|||
161214947|NCT00267007|582169504|FG001|Overall Study|Adverse Event|0|||
161214948|NCT01684722|582169508|FG000|Overall Study|Lost to Follow-up|78|||
161214949|NCT01684722|582169509|FG001|Overall Study|Lost to Follow-up|56|||
161214950|NCT01684722|582169510|FG002|Overall Study|Lost to Follow-up|75|||
161214951|NCT01684722|582169511|FG003|Overall Study|Lost to Follow-up|89|||
161214952|NCT01684722|582169508|FG000|Overall Study|Death|19|||
161214953|NCT01684722|582169509|FG001|Overall Study|Death|21|||
161214954|NCT01684722|582169510|FG002|Overall Study|Death|19|||
161214955|NCT01684722|582169511|FG003|Overall Study|Death|21|||
161214956|NCT01664494|582169512|FG000|Overall Study|Withdrawal by Subject|27|||
161214957|NCT01664494|582169512|FG000|Overall Study|Death|18|||
161214958|NCT01664494|582169512|FG000|Overall Study|Other|49|||
161214959|NCT01664494|582169512|FG000|Overall Study|Lost to Follow-up|99|||
161214960|NCT00219557|582169513|FG000|Phase 1|Lack of Efficacy|3|||
161214961|NCT00219557|582169514|FG001|Phase 1|Lack of Efficacy|0|||
161214962|NCT00219557|582169515|FG002|Phase 1|Lack of Efficacy|0|||
161214963|NCT00219557|582169513|FG000|Phase 1|Adverse Event|2|||
161214964|NCT00219557|582169514|FG001|Phase 1|Adverse Event|0|||
161214965|NCT00219557|582169515|FG002|Phase 1|Adverse Event|0|||
161214966|NCT00219557|582169513|FG000|Phase 1|Withdrawal by Subject|1|||
161214967|NCT00219557|582169514|FG001|Phase 1|Withdrawal by Subject|0|||
161214968|NCT00219557|582169515|FG002|Phase 1|Withdrawal by Subject|0|||
160869197|NCT01255436|580913684|FG001|Overall Study|Lost to Follow-up|191|||
161214969|NCT00219557|582169513|FG000|Phase 1|Started chemotherapy at other institute|1|||
161214970|NCT00219557|582169514|FG001|Phase 1|Started chemotherapy at other institute|0|||
161214971|NCT00219557|582169515|FG002|Phase 1|Started chemotherapy at other institute|0|||
161214972|NCT00219557|582169513|FG000|Phase 2|Lack of Efficacy|0|||
161214973|NCT00219557|582169514|FG001|Phase 2|Lack of Efficacy|21|||
161214974|NCT00219557|582169515|FG002|Phase 2|Lack of Efficacy|15|||
161214975|NCT00219557|582169513|FG000|Phase 2|Adverse Event|0|||
161214976|NCT00219557|582169514|FG001|Phase 2|Adverse Event|22|||
161109951|NCT00978029|581792425|FG002|Overall Study|Adverse Event|5|||
161109952|NCT00978029|581792423|FG000|Overall Study|Withdrawal by Subject|0|||
161109953|NCT00978029|581792424|FG001|Overall Study|Withdrawal by Subject|0|||
161109954|NCT00978029|581792425|FG002|Overall Study|Withdrawal by Subject|1|||
161109955|NCT00978029|581792423|FG000|Overall Study|Protocol Violation|0|||
161109956|NCT00978029|581792424|FG001|Overall Study|Protocol Violation|1|||
161109957|NCT00978029|581792425|FG002|Overall Study|Protocol Violation|0|||
161109958|NCT00545298|581792426|FG000|Overall Study|Issues with Standard of Care|2|||
161109959|NCT00545298|581792427|FG001|Overall Study|Issues with Standard of Care|0|||
161109960|NCT00545298|581792428|FG002|Overall Study|Issues with Standard of Care|1|||
161109961|NCT01820364|581792429|FG000|Part I: LGX818|Death|1|||
161109962|NCT01820364|581792430|FG001|Part I: LGX818|Death|0|||
161109963|NCT01820364|581792429|FG000|Part I: LGX818|Administrative Problems|3|||
161109964|NCT01820364|581792430|FG001|Part I: LGX818|Administrative Problems|0|||
161109965|NCT01820364|581792429|FG000|Part I: LGX818|Adverse Event|6|||
161109966|NCT01820364|581792430|FG001|Part I: LGX818|Adverse Event|0|||
161109967|NCT01820364|581792429|FG000|Part I: LGX818|Disease Progression|4|||
161109968|NCT01820364|581792430|FG001|Part I: LGX818|Disease Progression|0|||
161109969|NCT01820364|581792429|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
161109970|NCT01820364|581792430|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
161109971|NCT01087775|581792433|FG000|Overall Study|failed inclusion criteria|2|||
161109972|NCT00974675|581792434|FG000|Overall Study|Adverse Event|2|||
161109973|NCT00974675|581792435|FG001|Overall Study|Adverse Event|1|||
161109974|NCT00974675|581792436|FG002|Overall Study|Adverse Event|1|||
161109975|NCT00974675|581792437|FG003|Overall Study|Adverse Event|1|||
161109976|NCT00974675|581792434|FG000|Overall Study|Physician Decision|0|||
161109977|NCT00974675|581792435|FG001|Overall Study|Physician Decision|0|||
161109978|NCT00974675|581792436|FG002|Overall Study|Physician Decision|1|||
161109979|NCT00974675|581792437|FG003|Overall Study|Physician Decision|0|||
161109980|NCT00974675|581792434|FG000|Overall Study|Participant on holiday; unable to attend|0|||
161109981|NCT00974675|581792435|FG001|Overall Study|Participant on holiday; unable to attend|0|||
161109982|NCT00974675|581792436|FG002|Overall Study|Participant on holiday; unable to attend|0|||
161109983|NCT00974675|581792437|FG003|Overall Study|Participant on holiday; unable to attend|1|||
161109984|NCT04506086|581792439|FG000|Overall Study|Withdrawal by Subject|2|||
161109985|NCT01293968|581792442|FG000|Overall Study|non-cooperation|3|||
161109986|NCT01293968|581792443|FG001|Overall Study|non-cooperation|3|||
161109987|NCT01484977|581792444|FG000|Overall Study|Adverse Event|8|||
161109988|NCT01484977|581792444|FG000|Overall Study|Lack of Efficacy|4|||
161109989|NCT01484977|581792444|FG000|Overall Study|Protocol Violation|6|||
161109990|NCT01484977|581792444|FG000|Overall Study|Lost to Follow-up|1|||
161109991|NCT01484977|581792444|FG000|Overall Study|Withdrawal by Subject|4|||
161109992|NCT01484977|581792444|FG000|Overall Study|Subject Protocol Non-compliant|1|||
161109993|NCT01484977|581792444|FG000|Overall Study|Moving Overseas|1|||
161109994|NCT01484977|581792444|FG000|Overall Study|Low White Blood Cell Count|1|||
161109995|NCT01484977|581792444|FG000|Overall Study|Lack of Compliance|1|||
161109996|NCT01133379|581792445|FG000|Overall Study|Withdrawal by Subject|0|||
161109997|NCT01133379|581792446|FG001|Overall Study|Withdrawal by Subject|1|||
161109998|NCT01133379|581792447|FG002|Overall Study|Withdrawal by Subject|1|||
161109999|NCT01133379|581792445|FG000|Overall Study|Lost to Follow-up|1|||
161110000|NCT01133379|581792446|FG001|Overall Study|Lost to Follow-up|1|||
161110001|NCT01133379|581792447|FG002|Overall Study|Lost to Follow-up|1|||
161110002|NCT00121108|581792450|FG000|Overall Study|Lost to Follow-up|10|||
161110003|NCT00121108|581792451|FG001|Overall Study|Lost to Follow-up|22|||
161110004|NCT00121108|581792450|FG000|Overall Study|Withdrawal by Subject|106|||
161110005|NCT00121108|581792451|FG001|Overall Study|Withdrawal by Subject|195|||
161110006|NCT00121108|581792450|FG000|Overall Study|Death|5|||
161110007|NCT00121108|581792451|FG001|Overall Study|Death|8|||
161110008|NCT03996876|581792452|FG000|Overall Study|Incomplete Data|2|||
161110009|NCT03996876|581792453|FG001|Overall Study|Incomplete Data|4|||
161110010|NCT03080883|581792459|FG000|Overall Study|Withdrawal by Subject|11|||
161110011|NCT03080883|581792460|FG001|Overall Study|Withdrawal by Subject|15|||
161110012|NCT03080883|581792459|FG000|Overall Study|Adverse Event|22|||
161110013|NCT03080883|581792460|FG001|Overall Study|Adverse Event|22|||
161110014|NCT03080883|581792459|FG000|Overall Study|Alternative Therapy|0|||
161110015|NCT03080883|581792460|FG001|Overall Study|Alternative Therapy|3|||
161110016|NCT03080883|581792459|FG000|Overall Study|Other Complicating Disease|9|||
161110017|NCT03080883|581792460|FG001|Overall Study|Other Complicating Disease|5|||
161110018|NCT03080883|581792459|FG000|Overall Study|Death|21|||
161110019|NCT03080883|581792460|FG001|Overall Study|Death|16|||
161110020|NCT03080883|581792459|FG000|Overall Study|Physician Decision|2|||
161110021|NCT03080883|581792460|FG001|Overall Study|Physician Decision|2|||
161110022|NCT03080883|581792459|FG000|Overall Study|Disease Progression|2|||
161110023|NCT03080883|581792460|FG001|Overall Study|Disease Progression|8|||
161110024|NCT03080883|581792459|FG000|Overall Study|Lost to Follow-up|1|||
161110025|NCT03080883|581792460|FG001|Overall Study|Lost to Follow-up|1|||
161110026|NCT00388973|581794096|FG000|Overall Study|Adverse Event|16|||
161110027|NCT00388973|581794097|FG001|Overall Study|Adverse Event|6|||
161110028|NCT00388973|581794096|FG000|Overall Study|Lack of Efficacy|1|||
161214977|NCT00219557|582169515|FG002|Phase 2|Adverse Event|2|||
161214978|NCT00219557|582169513|FG000|Phase 2|Death|0|||
161214979|NCT00219557|582169514|FG001|Phase 2|Death|8|||
161214980|NCT00219557|582169515|FG002|Phase 2|Death|2|||
161214981|NCT00219557|582169513|FG000|Phase 2|Other|0|||
161214982|NCT00219557|582169514|FG001|Phase 2|Other|8|||
161214983|NCT00219557|582169515|FG002|Phase 2|Other|6|||
161214984|NCT00219557|582169513|FG000|Phase 2|Withdrawal by Subject|0|||
161214985|NCT00219557|582169514|FG001|Phase 2|Withdrawal by Subject|9|||
161214986|NCT00219557|582169515|FG002|Phase 2|Withdrawal by Subject|5|||
161214987|NCT00219557|582169513|FG000|Phase 2|Treatment not received|0|||
161214988|NCT00219557|582169514|FG001|Phase 2|Treatment not received|1|||
161214989|NCT00219557|582169515|FG002|Phase 2|Treatment not received|3|||
161214990|NCT01612156|582169516|FG000|Overall Study|Protocol Violation|2|||
161214991|NCT01612156|582169517|FG001|Overall Study|Protocol Violation|0|||
161214992|NCT00410410|582169518|FG000|Induction Period (IP)|Death|1|||
161214993|NCT00410410|582169519|FG001|Induction Period (IP)|Death|0|||
161214994|NCT00410410|582169520|FG002|Induction Period (IP)|Death|0|||
161214995|NCT00410410|582169521|FG003|Induction Period (IP)|Death|0|||
161214996|NCT00410410|582169522|FG004|Induction Period (IP)|Death|0|||
161214997|NCT00410410|582169523|FG005|Induction Period (IP)|Death|0|||
161214998|NCT00410410|582169524|FG006|Induction Period (IP)|Death|0|||
161214999|NCT00410410|582169525|FG007|Induction Period (IP)|Death|0|||
161215000|NCT00410410|582169526|FG008|Induction Period (IP)|Death|0|||
161215001|NCT00410410|582169518|FG000|Induction Period (IP)|Adverse Event|3|||
161215002|NCT00410410|582169519|FG001|Induction Period (IP)|Adverse Event|4|||
161215003|NCT00410410|582169520|FG002|Induction Period (IP)|Adverse Event|2|||
161215004|NCT00410410|582169521|FG003|Induction Period (IP)|Adverse Event|4|||
161215005|NCT00410410|582169522|FG004|Induction Period (IP)|Adverse Event|1|||
161215006|NCT00410410|582169523|FG005|Induction Period (IP)|Adverse Event|0|||
161215007|NCT00410410|582169524|FG006|Induction Period (IP)|Adverse Event|0|||
161215008|NCT00410410|582169525|FG007|Induction Period (IP)|Adverse Event|0|||
161215009|NCT00410410|582169526|FG008|Induction Period (IP)|Adverse Event|0|||
161215010|NCT00410410|582169518|FG000|Induction Period (IP)|Lack of Efficacy|26|||
161215011|NCT00410410|582169519|FG001|Induction Period (IP)|Lack of Efficacy|24|||
161215012|NCT00410410|582169520|FG002|Induction Period (IP)|Lack of Efficacy|8|||
161215013|NCT00410410|582169521|FG003|Induction Period (IP)|Lack of Efficacy|8|||
161215014|NCT00410410|582169522|FG004|Induction Period (IP)|Lack of Efficacy|7|||
161215015|NCT00410410|582169523|FG005|Induction Period (IP)|Lack of Efficacy|7|||
161215016|NCT00410410|582169524|FG006|Induction Period (IP)|Lack of Efficacy|0|||
161215017|NCT00410410|582169525|FG007|Induction Period (IP)|Lack of Efficacy|0|||
161215018|NCT00410410|582169526|FG008|Induction Period (IP)|Lack of Efficacy|0|||
161215019|NCT00410410|582169518|FG000|Induction Period (IP)|Lost to Follow-up|2|||
161215020|NCT00410410|582169519|FG001|Induction Period (IP)|Lost to Follow-up|2|||
161215021|NCT00410410|582169520|FG002|Induction Period (IP)|Lost to Follow-up|2|||
161215022|NCT00410410|582169521|FG003|Induction Period (IP)|Lost to Follow-up|3|||
161215023|NCT00410410|582169522|FG004|Induction Period (IP)|Lost to Follow-up|0|||
161215024|NCT00410410|582169523|FG005|Induction Period (IP)|Lost to Follow-up|1|||
161215025|NCT00410410|582169524|FG006|Induction Period (IP)|Lost to Follow-up|0|||
161215026|NCT00410410|582169525|FG007|Induction Period (IP)|Lost to Follow-up|0|||
161215027|NCT00410410|582169526|FG008|Induction Period (IP)|Lost to Follow-up|0|||
161215028|NCT00410410|582169518|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
161215029|NCT00410410|582169519|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
161215030|NCT00410410|582169520|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
161215031|NCT00410410|582169521|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
161215032|NCT00410410|582169522|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
161215033|NCT00410410|582169523|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
161215034|NCT00410410|582169524|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
161215035|NCT00410410|582169525|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
161215036|NCT00410410|582169526|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
161215037|NCT00410410|582169518|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215038|NCT00410410|582169519|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215039|NCT00410410|582169520|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
161215040|NCT00410410|582169521|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215041|NCT00410410|582169522|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215042|NCT00410410|582169523|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215043|NCT00410410|582169524|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215044|NCT00410410|582169525|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215045|NCT00410410|582169526|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
161215046|NCT00410410|582169518|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215047|NCT00410410|582169519|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215048|NCT00410410|582169520|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215049|NCT00410410|582169521|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215050|NCT00410410|582169522|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
161215051|NCT00410410|582169523|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
161215052|NCT00410410|582169524|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215053|NCT00410410|582169525|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215054|NCT00410410|582169526|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
161215055|NCT00410410|582169518|FG000|Induction Period (IP)|Other|0|||
161215056|NCT00410410|582169519|FG001|Induction Period (IP)|Other|0|||
161215057|NCT00410410|582169520|FG002|Induction Period (IP)|Other|1|||
161215058|NCT00410410|582169521|FG003|Induction Period (IP)|Other|0|||
161215059|NCT00410410|582169522|FG004|Induction Period (IP)|Other|0|||
161215060|NCT00410410|582169523|FG005|Induction Period (IP)|Other|0|||
161215061|NCT00410410|582169524|FG006|Induction Period (IP)|Other|0|||
161215062|NCT00410410|582169525|FG007|Induction Period (IP)|Other|0|||
161215063|NCT00410410|582169526|FG008|Induction Period (IP)|Other|0|||
161215064|NCT00410410|582169518|FG000|Maintenance Period (MP)|Death|0|||
161215065|NCT00410410|582169519|FG001|Maintenance Period (MP)|Death|0|||
161215066|NCT00410410|582169520|FG002|Maintenance Period (MP)|Death|0|||
161215067|NCT00410410|582169521|FG003|Maintenance Period (MP)|Death|0|||
161215068|NCT00410410|582169522|FG004|Maintenance Period (MP)|Death|0|||
161215069|NCT00410410|582169523|FG005|Maintenance Period (MP)|Death|0|||
161215070|NCT00410410|582169524|FG006|Maintenance Period (MP)|Death|1|||
161215071|NCT00410410|582169525|FG007|Maintenance Period (MP)|Death|0|||
161215072|NCT00410410|582169526|FG008|Maintenance Period (MP)|Death|0|||
161215073|NCT00410410|582169518|FG000|Maintenance Period (MP)|Adverse Event|0|||
161215074|NCT00410410|582169519|FG001|Maintenance Period (MP)|Adverse Event|0|||
161215075|NCT00410410|582169520|FG002|Maintenance Period (MP)|Adverse Event|0|||
161215076|NCT00410410|582169521|FG003|Maintenance Period (MP)|Adverse Event|0|||
161215077|NCT00410410|582169522|FG004|Maintenance Period (MP)|Adverse Event|0|||
161215078|NCT00410410|582169523|FG005|Maintenance Period (MP)|Adverse Event|0|||
161215079|NCT00410410|582169524|FG006|Maintenance Period (MP)|Adverse Event|1|||
161215080|NCT00410410|582169525|FG007|Maintenance Period (MP)|Adverse Event|3|||
161215081|NCT00410410|582169526|FG008|Maintenance Period (MP)|Adverse Event|0|||
161215082|NCT00410410|582169518|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
161215083|NCT00410410|582169519|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
161215084|NCT00410410|582169520|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
161215085|NCT00410410|582169521|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
161215086|NCT00410410|582169522|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
161215087|NCT00410410|582169523|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
161215088|NCT00410410|582169524|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
161215089|NCT00410410|582169525|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
161215090|NCT00410410|582169526|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
161215091|NCT00410410|582169518|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
161215092|NCT00410410|582169519|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
161215093|NCT00410410|582169520|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
161215094|NCT00410410|582169521|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
161215095|NCT00410410|582169522|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
161215096|NCT00410410|582169523|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
161215097|NCT00410410|582169524|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
161215098|NCT00410410|582169525|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
161215099|NCT00410410|582169526|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
161215100|NCT00410410|582169518|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
161215101|NCT00410410|582169519|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
161215102|NCT00410410|582169520|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
161215103|NCT00410410|582169521|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
161215104|NCT00410410|582169522|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
161215105|NCT00410410|582169523|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
161215106|NCT00410410|582169524|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
161215107|NCT00410410|582169525|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
161215108|NCT00410410|582169526|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
160869198|NCT01255436|580913683|FG000|Overall Study|Death, stroke, or MI|4|||
161215109|NCT00410410|582169518|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215110|NCT00410410|582169519|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215111|NCT00410410|582169520|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215112|NCT00410410|582169521|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215113|NCT00410410|582169522|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215114|NCT00410410|582169523|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215115|NCT00410410|582169524|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
161215116|NCT00410410|582169525|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
161215117|NCT00410410|582169526|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
161215118|NCT00410410|582169518|FG000|Open-Label Period (OL)|Death|0|||
161215119|NCT00410410|582169519|FG001|Open-Label Period (OL)|Death|0|||
161215120|NCT00410410|582169520|FG002|Open-Label Period (OL)|Death|0|||
161215121|NCT00410410|582169521|FG003|Open-Label Period (OL)|Death|0|||
161215122|NCT00410410|582169522|FG004|Open-Label Period (OL)|Death|0|||
161215123|NCT00410410|582169523|FG005|Open-Label Period (OL)|Death|0|||
161215124|NCT00410410|582169524|FG006|Open-Label Period (OL)|Death|0|||
161215125|NCT00410410|582169525|FG007|Open-Label Period (OL)|Death|0|||
161215126|NCT00410410|582169526|FG008|Open-Label Period (OL)|Death|1|||
161215127|NCT00410410|582169518|FG000|Open-Label Period (OL)|Adverse Event|0|||
161215128|NCT00410410|582169519|FG001|Open-Label Period (OL)|Adverse Event|0|||
161215129|NCT00410410|582169520|FG002|Open-Label Period (OL)|Adverse Event|0|||
161215130|NCT00410410|582169521|FG003|Open-Label Period (OL)|Adverse Event|0|||
161215131|NCT00410410|582169522|FG004|Open-Label Period (OL)|Adverse Event|0|||
161215132|NCT00410410|582169523|FG005|Open-Label Period (OL)|Adverse Event|0|||
161215133|NCT00410410|582169524|FG006|Open-Label Period (OL)|Adverse Event|0|||
161215134|NCT00410410|582169525|FG007|Open-Label Period (OL)|Adverse Event|0|||
161215135|NCT00410410|582169526|FG008|Open-Label Period (OL)|Adverse Event|10|||
161215136|NCT00410410|582169518|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
161215137|NCT00410410|582169519|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
161215138|NCT00410410|582169520|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
161215139|NCT00410410|582169521|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
161215140|NCT00410410|582169522|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
161215141|NCT00410410|582169523|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
161215142|NCT00410410|582169524|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
161215143|NCT00410410|582169525|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
161215144|NCT00410410|582169526|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
161215145|NCT00410410|582169518|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
161215146|NCT00410410|582169519|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
161215147|NCT00410410|582169520|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
161215148|NCT00410410|582169521|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
161215149|NCT00410410|582169522|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
161215150|NCT00410410|582169523|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
161215151|NCT00410410|582169524|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
161215152|NCT00410410|582169525|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
161215153|NCT00410410|582169526|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
161215154|NCT00410410|582169518|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215155|NCT00410410|582169519|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215156|NCT00410410|582169520|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215157|NCT00410410|582169521|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215158|NCT00410410|582169522|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215159|NCT00410410|582169523|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215160|NCT00410410|582169524|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215161|NCT00410410|582169525|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
161215162|NCT00410410|582169526|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
161215163|NCT00410410|582169518|FG000|Open-Label Period (OL)|Pregnancy|0|||
161215164|NCT00410410|582169519|FG001|Open-Label Period (OL)|Pregnancy|0|||
161215165|NCT00410410|582169520|FG002|Open-Label Period (OL)|Pregnancy|0|||
161215166|NCT00410410|582169521|FG003|Open-Label Period (OL)|Pregnancy|0|||
161215167|NCT00410410|582169522|FG004|Open-Label Period (OL)|Pregnancy|0|||
161215168|NCT00410410|582169523|FG005|Open-Label Period (OL)|Pregnancy|0|||
161215169|NCT00410410|582169524|FG006|Open-Label Period (OL)|Pregnancy|0|||
161215170|NCT00410410|582169525|FG007|Open-Label Period (OL)|Pregnancy|0|||
161215171|NCT00410410|582169526|FG008|Open-Label Period (OL)|Pregnancy|1|||
161215172|NCT00410410|582169518|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215173|NCT00410410|582169519|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215174|NCT00410410|582169520|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215175|NCT00410410|582169521|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215176|NCT00410410|582169522|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215177|NCT00410410|582169523|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215178|NCT00410410|582169524|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215179|NCT00410410|582169525|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
161215180|NCT00410410|582169526|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
161215181|NCT00410410|582169518|FG000|Open-Label Period (OL)|Other|0|||
161215182|NCT00410410|582169519|FG001|Open-Label Period (OL)|Other|0|||
161215183|NCT00410410|582169520|FG002|Open-Label Period (OL)|Other|0|||
161215184|NCT00410410|582169521|FG003|Open-Label Period (OL)|Other|0|||
161215185|NCT00410410|582169522|FG004|Open-Label Period (OL)|Other|0|||
161324363|NCT01408901|582573578|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
160869199|NCT01255436|580913684|FG001|Overall Study|Death, stroke, or MI|3|||
161215186|NCT00410410|582169523|FG005|Open-Label Period (OL)|Other|0|||
161215187|NCT00410410|582169524|FG006|Open-Label Period (OL)|Other|0|||
161215188|NCT00410410|582169525|FG007|Open-Label Period (OL)|Other|0|||
161215189|NCT00410410|582169526|FG008|Open-Label Period (OL)|Other|7|||
161215190|NCT01783496|582169527|FG000|Overall Study|Lost to Follow-up|0|||
161215191|NCT01783496|582169528|FG001|Overall Study|Lost to Follow-up|0|||
161215192|NCT01783496|582169529|FG002|Overall Study|Lost to Follow-up|0|||
161215193|NCT01783496|582169530|FG003|Overall Study|Lost to Follow-up|2|||
160869200|NCT04816669|580913685|FG000|Part 1|Adverse Event|1|||
160869201|NCT04816669|580913686|FG001|Part 1|Adverse Event|1|||
160869202|NCT04816669|580913687|FG002|Part 1|Adverse Event|0|||
160869203|NCT04816669|580913688|FG003|Part 1|Adverse Event|0|||
161110029|NCT00388973|581794097|FG001|Overall Study|Lack of Efficacy|12|||
161110030|NCT00388973|581794096|FG000|Overall Study|Protocol Violation|3|||
161110031|NCT00388973|581794097|FG001|Overall Study|Protocol Violation|0|||
161110032|NCT00388973|581794096|FG000|Overall Study|Withdrawal by Subject|14|||
161110033|NCT00388973|581794097|FG001|Overall Study|Withdrawal by Subject|17|||
161110034|NCT00388973|581794096|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
161110035|NCT00388973|581794097|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
161110036|NCT00388973|581794096|FG000|Overall Study|Did not complete 61 days of treatment|5|||
161110037|NCT00388973|581794097|FG001|Overall Study|Did not complete 61 days of treatment|4|||
161110038|NCT00388973|581794096|FG000|Overall Study|Left region|0|||
161110039|NCT00388973|581794097|FG001|Overall Study|Left region|1|||
161110040|NCT00388973|581794096|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
161110041|NCT00388973|581794097|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
161110042|NCT01652885|581794098|FG000|Overall Study|Adverse Event|1|||
161110043|NCT03723707|581794099|FG000|Overall Study|Death|32|||
161110044|NCT03723707|581794100|FG001|Overall Study|Death|32|||
161110045|NCT03723707|581794099|FG000|Overall Study|Admitted to long term care|12|||
161110046|NCT03723707|581794100|FG001|Overall Study|Admitted to long term care|12|||
161110047|NCT03723707|581794099|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
161110048|NCT03723707|581794100|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
161110049|NCT03723707|581794099|FG000|Overall Study|Lost to Follow-up|40|||
161110050|NCT03723707|581794100|FG001|Overall Study|Lost to Follow-up|22|||
161110051|NCT03723707|581794099|FG000|Overall Study|Discontinued after study closure|24|||
161110052|NCT03723707|581794100|FG001|Overall Study|Discontinued after study closure|12|||
161110053|NCT00075023|581794101|FG000|Pilot Study|Physician Decision|1|||
161110054|NCT00075023|581794102|FG001|Pilot Study|Physician Decision|2|||
161110055|NCT00075023|581794101|FG000|Pilot Study|Withdrawal by Subject|1|||
161110056|NCT00075023|581794102|FG001|Pilot Study|Withdrawal by Subject|0|||
161110057|NCT04342871|581794103|FG000|Overall Study|Death|4|||
161110058|NCT04342871|581794103|FG000|Overall Study|Clinical deterioration/illness progression|2|||
161110059|NCT04342871|581794103|FG000|Overall Study|Did not complete baseline assessments|5|||
161110060|NCT04342871|581794103|FG000|Overall Study|Lost to Follow-up|13|||
161110061|NCT01429584|581794105|FG000|Overall Study|Withdrawal by Subject|1|||
161110062|NCT01429584|581794106|FG001|Overall Study|Withdrawal by Subject|0|||
161110063|NCT01429584|581794105|FG000|Overall Study|Protocol Violation|0|||
161110064|NCT01429584|581794106|FG001|Overall Study|Protocol Violation|1|||
161110065|NCT00750698|581794110|FG000|Overall Study|Withdrawal by Subject|1|||
161110066|NCT00750698|581794111|FG001|Overall Study|Withdrawal by Subject|0|||
161110067|NCT00750698|581794110|FG000|Overall Study|Progressive disease|5|||
161110068|NCT00750698|581794111|FG001|Overall Study|Progressive disease|2|||
161110069|NCT01999465|581794112|FG000|Overall Study|Lost to Follow-up|0|||
161110070|NCT01999465|581794113|FG001|Overall Study|Lost to Follow-up|2|||
161110071|NCT01999465|581794112|FG000|Overall Study|Protocol Violation|0|||
161110072|NCT01999465|581794113|FG001|Overall Study|Protocol Violation|1|||
161110073|NCT00390546|581794114|FG000|Overall Study|Renal impairment|1|||
161110074|NCT00390546|581794115|FG001|Overall Study|Renal impairment|0|||
161110075|NCT00390546|581794114|FG000|Overall Study|Physician Decision|5|||
161110076|NCT00390546|581794115|FG001|Overall Study|Physician Decision|5|||
161110077|NCT01308008|581794116|FG000|4 Weeks|Illness, disinterest, time|9|||
161110078|NCT01308008|581794117|FG001|4 Weeks|Illness, disinterest, time|2|||
161110079|NCT02325219|581794118|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
161110080|NCT02325219|581794119|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
161110081|NCT02325219|581794120|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161110082|NCT02325219|581794121|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161110083|NCT02325219|581794122|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
161110084|NCT02325219|581794118|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
161110085|NCT02325219|581794119|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
160869204|NCT04816669|580913685|FG000|Part 1|Lost to Follow-up|2|||
161110086|NCT02325219|581794120|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161110087|NCT02325219|581794121|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161110088|NCT02325219|581794122|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161110089|NCT02325219|581794118|FG000|Controlled Period (Week 0 - 16)|Other|0|||
161110090|NCT02325219|581794119|FG001|Controlled Period (Week 0 - 16)|Other|0|||
161110091|NCT02325219|581794120|FG002|Controlled Period (Week 0 - 16)|Other|1|||
161110092|NCT02325219|581794121|FG003|Controlled Period (Week 0 - 16)|Other|0|||
161110093|NCT02325219|581794122|FG004|Controlled Period (Week 0 - 16)|Other|0|||
161110094|NCT02325219|581794118|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161110095|NCT02325219|581794119|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161110096|NCT02325219|581794120|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
160869205|NCT04816669|580913686|FG001|Part 1|Lost to Follow-up|2|||
160869206|NCT04816669|580913687|FG002|Part 1|Lost to Follow-up|0|||
161110097|NCT02325219|581794121|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161110098|NCT02325219|581794122|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161110099|NCT02325219|581794118|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161110100|NCT02325219|581794119|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
161110101|NCT02325219|581794120|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161110102|NCT02325219|581794121|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161110103|NCT02325219|581794122|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
161110104|NCT02325219|581794118|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161110105|NCT02325219|581794119|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161110106|NCT02325219|581794120|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161110107|NCT02325219|581794121|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161110108|NCT02325219|581794122|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161110109|NCT04766021|581794123|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
161110110|NCT04766021|581794123|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
161110111|NCT02257372|581794124|FG000|Overall Study|Adverse Event|3|||
161110112|NCT02257372|581794125|FG001|Overall Study|Adverse Event|7|||
161110113|NCT02257372|581794124|FG000|Overall Study|Lack of Efficacy|2|||
161110114|NCT02257372|581794125|FG001|Overall Study|Lack of Efficacy|1|||
161110115|NCT02257372|581794124|FG000|Overall Study|Protocol Violation|1|||
161110116|NCT02257372|581794125|FG001|Overall Study|Protocol Violation|1|||
161110117|NCT02257372|581794124|FG000|Overall Study|Lost to Follow-up|0|||
161110118|NCT02257372|581794125|FG001|Overall Study|Lost to Follow-up|1|||
161110119|NCT02257372|581794124|FG000|Overall Study|Withdrew consent|1|||
161110120|NCT02257372|581794125|FG001|Overall Study|Withdrew consent|0|||
161110121|NCT02634151|581794126|FG000|Overall Study|Withdrawal by Subject|1|||
161110122|NCT02634151|581794127|FG001|Overall Study|Withdrawal by Subject|0|||
161110123|NCT02634151|581794126|FG000|Overall Study|Non-Compliance|0|||
161110124|NCT02634151|581794127|FG001|Overall Study|Non-Compliance|1|||
161110125|NCT02634151|581794126|FG000|Overall Study|Other|0|||
161110126|NCT02634151|581794127|FG001|Overall Study|Other|1|||
161110127|NCT00003535|581794129|FG000|Overall Study|Not evaluable|5|||
161110128|NCT02347098|581794130|FG000|Overall Study|Death|1|||
161110129|NCT02347098|581794131|FG001|Overall Study|Death|0|||
161110130|NCT02347098|581794130|FG000|Overall Study|Withdrawal by Subject|1|||
161110131|NCT02347098|581794131|FG001|Overall Study|Withdrawal by Subject|0|||
161110132|NCT02347098|581794130|FG000|Overall Study|Lost to Follow-up|2|||
161110133|NCT02347098|581794131|FG001|Overall Study|Lost to Follow-up|2|||
161110134|NCT02347098|581794130|FG000|Overall Study|Refuse Follow-up Visit|1|||
161110135|NCT02347098|581794131|FG001|Overall Study|Refuse Follow-up Visit|5|||
161110136|NCT02347098|581794130|FG000|Overall Study|no visit due to illness|2|||
161110137|NCT02347098|581794131|FG001|Overall Study|no visit due to illness|1|||
161110138|NCT02187172|581794132|FG000|Overall Study|Lost to Follow-up|1|||
161110139|NCT02187172|581794133|FG001|Overall Study|Lost to Follow-up|2|||
161110140|NCT02187172|581794132|FG000|Overall Study|Lack of Efficacy|1|||
161110141|NCT02187172|581794133|FG001|Overall Study|Lack of Efficacy|2|||
161110142|NCT02187172|581794132|FG000|Overall Study|Adverse Event|0|||
161110143|NCT02187172|581794133|FG001|Overall Study|Adverse Event|1|||
161110144|NCT02187172|581794132|FG000|Overall Study|Physician Decision|1|||
161110145|NCT02187172|581794133|FG001|Overall Study|Physician Decision|1|||
161110146|NCT00880399|581794134|FG000|Overall Study|Adverse Event|4|||
161110147|NCT00880399|581794135|FG001|Overall Study|Adverse Event|6|||
161110148|NCT00880399|581794136|FG002|Overall Study|Adverse Event|5|||
161110149|NCT00880399|581794134|FG000|Overall Study|Lack of Efficacy|1|||
161110150|NCT00880399|581794135|FG001|Overall Study|Lack of Efficacy|4|||
161110151|NCT00880399|581794136|FG002|Overall Study|Lack of Efficacy|2|||
161110152|NCT00880399|581794134|FG000|Overall Study|Protocol Violation|4|||
161110153|NCT00880399|581794135|FG001|Overall Study|Protocol Violation|4|||
161110154|NCT00880399|581794136|FG002|Overall Study|Protocol Violation|6|||
161110155|NCT00880399|581794134|FG000|Overall Study|Study closed/terminated|3|||
161110156|NCT00880399|581794135|FG001|Overall Study|Study closed/terminated|7|||
161110157|NCT00880399|581794136|FG002|Overall Study|Study closed/terminated|4|||
161110158|NCT00880399|581794134|FG000|Overall Study|Lost to Follow-up|8|||
161110159|NCT00880399|581794135|FG001|Overall Study|Lost to Follow-up|5|||
161110160|NCT00880399|581794136|FG002|Overall Study|Lost to Follow-up|3|||
161110161|NCT00880399|581794134|FG000|Overall Study|Physician Decision|5|||
161110162|NCT00880399|581794135|FG001|Overall Study|Physician Decision|0|||
161110163|NCT00880399|581794136|FG002|Overall Study|Physician Decision|3|||
161110164|NCT00880399|581794134|FG000|Overall Study|Withdrawal by Subject|6|||
161110165|NCT00880399|581794135|FG001|Overall Study|Withdrawal by Subject|3|||
161110166|NCT00880399|581794136|FG002|Overall Study|Withdrawal by Subject|3|||
161110167|NCT02181816|581794141|FG000|Overall Study|Case Report Forms Uncollected|38|||
161110168|NCT02181816|581794141|FG000|Overall Study|Protocol Deviation|21|||
161110169|NCT00909181|581794142|FG000|Overall Study|Lost to Follow-up|39|||
161110170|NCT00909181|581794143|FG001|Overall Study|Lost to Follow-up|18|||
161110171|NCT00909181|581794144|FG002|Overall Study|Lost to Follow-up|33|||
161110172|NCT03709654|581794145|FG000|Overall Study|Lost to Follow-up|1|||
161110173|NCT03709654|581794146|FG001|Overall Study|Lost to Follow-up|1|||
161110174|NCT03709654|581794145|FG000|Overall Study|Withdrawal by Subject|1|||
161110175|NCT03709654|581794146|FG001|Overall Study|Withdrawal by Subject|1|||
161110176|NCT03709654|581794145|FG000|Overall Study|Adverse Event|1|||
161110177|NCT03709654|581794146|FG001|Overall Study|Adverse Event|0|||
161110178|NCT01040351|581794147|FG000|Overall Study|poor ovarian response|1|||
161110179|NCT01040351|581794148|FG001|Overall Study|poor ovarian response|2|||
161110180|NCT00530894|581794153|FG000|Overall Study|Death|84|||
161110181|NCT00530894|581794154|FG001|Overall Study|Death|89|||
161110182|NCT00530894|581794155|FG002|Overall Study|Death|55|||
161110183|NCT00530894|581794156|FG003|Overall Study|Death|89|||
161110184|NCT00530894|581794153|FG000|Overall Study|Lost to Follow-up|1|||
161110185|NCT00530894|581794154|FG001|Overall Study|Lost to Follow-up|3|||
161110186|NCT00530894|581794155|FG002|Overall Study|Lost to Follow-up|0|||
161110187|NCT00530894|581794156|FG003|Overall Study|Lost to Follow-up|0|||
161110188|NCT00530894|581794153|FG000|Overall Study|Withdrawal by Subject|1|||
161110189|NCT00530894|581794154|FG001|Overall Study|Withdrawal by Subject|23|||
161110190|NCT00530894|581794155|FG002|Overall Study|Withdrawal by Subject|0|||
161110191|NCT00530894|581794156|FG003|Overall Study|Withdrawal by Subject|5|||
161110192|NCT00530894|581794153|FG000|Overall Study|Alive and censored prior to 1 year|2|||
161110193|NCT00530894|581794154|FG001|Overall Study|Alive and censored prior to 1 year|0|||
161110194|NCT00530894|581794155|FG002|Overall Study|Alive and censored prior to 1 year|0|||
161110195|NCT00530894|581794156|FG003|Overall Study|Alive and censored prior to 1 year|0|||
161110196|NCT02256540|581794157|FG000|Overall Study|Withdrawal by Subject|0|||
161110197|NCT02256540|581794158|FG001|Overall Study|Withdrawal by Subject|1|||
161110198|NCT02256540|581794159|FG002|Overall Study|Withdrawal by Subject|1|||
161110199|NCT02256540|581794157|FG000|Overall Study|Back pain preventing exercise|0|||
161110200|NCT02256540|581794158|FG001|Overall Study|Back pain preventing exercise|0|||
161110201|NCT02256540|581794159|FG002|Overall Study|Back pain preventing exercise|1|||
161110202|NCT01230242|581794160|FG000|Overall Study|Physician Decision|2|||
161110203|NCT01230242|581794160|FG000|Overall Study|Withdrawal by Subject|1|||
161110204|NCT02969187|581794161|FG000|Overall Study|Physician Decision|12|||
161110205|NCT02969187|581794162|FG001|Overall Study|Physician Decision|13|||
161110206|NCT03923426|581794163|FG000|Overall Study|Other|19|||
161110207|NCT03923426|581794163|FG000|Overall Study|Lost to Follow-up|16|||
161110208|NCT03923426|581794163|FG000|Overall Study|Death|107|||
161110209|NCT03923426|581794163|FG000|Overall Study|Incomplete response to question|13|||
161110210|NCT02576444|581794164|FG000|Overall Study|Death|1|||
161110211|NCT02576444|581794165|FG001|Overall Study|Death|1|||
161110212|NCT02576444|581794166|FG002|Overall Study|Death|0|||
161110213|NCT02576444|581794167|FG003|Overall Study|Death|0|||
161110214|NCT02576444|581794164|FG000|Overall Study|Withdrawal by Subject|0|||
161110215|NCT02576444|581794165|FG001|Overall Study|Withdrawal by Subject|0|||
161110216|NCT02576444|581794166|FG002|Overall Study|Withdrawal by Subject|2|||
161110217|NCT02576444|581794167|FG003|Overall Study|Withdrawal by Subject|0|||
161110218|NCT02576444|581794164|FG000|Overall Study|Adverse Event|0|||
161110219|NCT02576444|581794165|FG001|Overall Study|Adverse Event|0|||
161110220|NCT02576444|581794166|FG002|Overall Study|Adverse Event|1|||
161110221|NCT02576444|581794167|FG003|Overall Study|Adverse Event|0|||
161110222|NCT02576444|581794164|FG000|Overall Study|Physician Decision|0|||
161110223|NCT02576444|581794165|FG001|Overall Study|Physician Decision|0|||
161110224|NCT02576444|581794166|FG002|Overall Study|Physician Decision|1|||
161110225|NCT02576444|581794167|FG003|Overall Study|Physician Decision|0|||
161110226|NCT04416555|581794169|FG000|Overall Study|Withdrawal by Subject|0|||
161110227|NCT04416555|581794170|FG001|Overall Study|Withdrawal by Subject|3|||
161110228|NCT00530270|581794173|FG000|Overall Study|Protocol Violation|1|||
161110229|NCT00530270|581794174|FG001|Overall Study|Protocol Violation|0|||
161110230|NCT04744207|581794176|FG000|Treatment|Withdrawal by Subject|2|||
161110231|NCT04744207|581794177|FG001|Treatment|Withdrawal by Subject|0|||
161110232|NCT04744207|581794176|FG000|Treatment|Adverse Event|1|||
161110233|NCT04744207|581794177|FG001|Treatment|Adverse Event|2|||
161110234|NCT02973087|581794185|FG000|Overall Study|Withdrawal by Subject|2|||
161110235|NCT02973087|581794186|FG001|Overall Study|Withdrawal by Subject|1|||
161110236|NCT02973087|581794185|FG000|Overall Study|Adverse Event|1|||
161110237|NCT02973087|581794186|FG001|Overall Study|Adverse Event|0|||
161110238|NCT02973087|581794185|FG000|Overall Study|other|1|||
161110239|NCT02973087|581794186|FG001|Overall Study|other|1|||
161110240|NCT03710486|581794187|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
161110241|NCT03710486|581794188|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
161110242|NCT03710486|581794187|FG000|Overall Study|Missing|0|||
161110243|NCT03710486|581794188|FG001|Overall Study|Missing|2|||
161110244|NCT01147744|581794193|FG000|Overall Study|Protocol Violation|1|||
161110245|NCT01147744|581794194|FG001|Overall Study|Protocol Violation|0|||
161110246|NCT01147744|581794195|FG002|Overall Study|Protocol Violation|1|||
161110247|NCT01147744|581794196|FG003|Overall Study|Protocol Violation|0|||
161110248|NCT01147744|581794197|FG004|Overall Study|Protocol Violation|1|||
161110249|NCT01147744|581794198|FG005|Overall Study|Protocol Violation|3|||
161110250|NCT01147744|581794199|FG006|Overall Study|Protocol Violation|1|||
161110251|NCT01147744|581794193|FG000|Overall Study|Physician Decision|0|||
161110252|NCT01147744|581794194|FG001|Overall Study|Physician Decision|1|||
161215194|NCT01783496|582169531|FG004|Overall Study|Lost to Follow-up|0|||
161215195|NCT01783496|582169532|FG005|Overall Study|Lost to Follow-up|1|||
161110253|NCT01147744|581794195|FG002|Overall Study|Physician Decision|1|||
161110254|NCT01147744|581794196|FG003|Overall Study|Physician Decision|0|||
161110255|NCT01147744|581794197|FG004|Overall Study|Physician Decision|0|||
161110256|NCT01147744|581794198|FG005|Overall Study|Physician Decision|0|||
161110257|NCT01147744|581794199|FG006|Overall Study|Physician Decision|1|||
161110258|NCT01147744|581794193|FG000|Overall Study|Lack of Efficacy|11|||
161110259|NCT01147744|581794194|FG001|Overall Study|Lack of Efficacy|11|||
161110260|NCT01147744|581794195|FG002|Overall Study|Lack of Efficacy|9|||
161110261|NCT01147744|581794196|FG003|Overall Study|Lack of Efficacy|11|||
161110262|NCT01147744|581794197|FG004|Overall Study|Lack of Efficacy|13|||
161110263|NCT01147744|581794198|FG005|Overall Study|Lack of Efficacy|8|||
161110264|NCT01147744|581794199|FG006|Overall Study|Lack of Efficacy|7|||
161110265|NCT01147744|581794193|FG000|Overall Study|Adverse Event|1|||
161110266|NCT01147744|581794194|FG001|Overall Study|Adverse Event|2|||
161110267|NCT01147744|581794195|FG002|Overall Study|Adverse Event|3|||
161110268|NCT01147744|581794196|FG003|Overall Study|Adverse Event|0|||
161110269|NCT01147744|581794197|FG004|Overall Study|Adverse Event|2|||
161110270|NCT01147744|581794198|FG005|Overall Study|Adverse Event|1|||
161110271|NCT01147744|581794199|FG006|Overall Study|Adverse Event|2|||
161110272|NCT01147744|581794193|FG000|Overall Study|Withdrawal by Subject|8|||
161110273|NCT01147744|581794194|FG001|Overall Study|Withdrawal by Subject|4|||
161110274|NCT01147744|581794195|FG002|Overall Study|Withdrawal by Subject|2|||
161110275|NCT01147744|581794196|FG003|Overall Study|Withdrawal by Subject|2|||
161110276|NCT01147744|581794197|FG004|Overall Study|Withdrawal by Subject|2|||
161110277|NCT01147744|581794198|FG005|Overall Study|Withdrawal by Subject|5|||
161110278|NCT01147744|581794199|FG006|Overall Study|Withdrawal by Subject|2|||
161110279|NCT01147744|581794193|FG000|Overall Study|Lost to Follow-up|0|||
161110280|NCT01147744|581794194|FG001|Overall Study|Lost to Follow-up|1|||
161110281|NCT01147744|581794195|FG002|Overall Study|Lost to Follow-up|0|||
161110282|NCT01147744|581794196|FG003|Overall Study|Lost to Follow-up|0|||
161110283|NCT01147744|581794197|FG004|Overall Study|Lost to Follow-up|0|||
161110284|NCT01147744|581794198|FG005|Overall Study|Lost to Follow-up|0|||
161110285|NCT01147744|581794199|FG006|Overall Study|Lost to Follow-up|0|||
161110286|NCT01147744|581794193|FG000|Overall Study|Sponsor decision to amend protocol|7|||
161110287|NCT01147744|581794194|FG001|Overall Study|Sponsor decision to amend protocol|4|||
161110288|NCT01147744|581794195|FG002|Overall Study|Sponsor decision to amend protocol|2|||
161110289|NCT01147744|581794196|FG003|Overall Study|Sponsor decision to amend protocol|5|||
161110290|NCT01147744|581794197|FG004|Overall Study|Sponsor decision to amend protocol|7|||
161110291|NCT01147744|581794198|FG005|Overall Study|Sponsor decision to amend protocol|2|||
161110292|NCT01147744|581794199|FG006|Overall Study|Sponsor decision to amend protocol|6|||
161110293|NCT01147744|581794193|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161110294|NCT01147744|581794194|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161110295|NCT01147744|581794195|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161110296|NCT01147744|581794196|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161110297|NCT01147744|581794197|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161110298|NCT01147744|581794198|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161110299|NCT01147744|581794199|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161110300|NCT02090413|581794201|FG000|Overall Study|Adverse Event|11|||
161110301|NCT02090413|581794202|FG001|Overall Study|Adverse Event|15|||
161110302|NCT02090413|581794203|FG002|Overall Study|Adverse Event|20|||
161110303|NCT02090413|581794201|FG000|Overall Study|Flushing event|2|||
161110304|NCT02090413|581794202|FG001|Overall Study|Flushing event|0|||
161110305|NCT02090413|581794203|FG002|Overall Study|Flushing event|1|||
161110306|NCT02090413|581794201|FG000|Overall Study|Withdrawal by Subject|2|||
161110307|NCT02090413|581794202|FG001|Overall Study|Withdrawal by Subject|2|||
161110308|NCT02090413|581794203|FG002|Overall Study|Withdrawal by Subject|2|||
161110309|NCT02090413|581794201|FG000|Overall Study|Investigator Decision|1|||
161110310|NCT02090413|581794202|FG001|Overall Study|Investigator Decision|1|||
161110311|NCT02090413|581794203|FG002|Overall Study|Investigator Decision|0|||
161110312|NCT02090413|581794201|FG000|Overall Study|Other|2|||
161110313|NCT02090413|581794202|FG001|Overall Study|Other|1|||
161215196|NCT01783496|582169527|FG000|Overall Study|Withdrawal by Subject|1|||
161215197|NCT01783496|582169528|FG001|Overall Study|Withdrawal by Subject|0|||
161215198|NCT01783496|582169529|FG002|Overall Study|Withdrawal by Subject|0|||
161215199|NCT01783496|582169530|FG003|Overall Study|Withdrawal by Subject|0|||
161110314|NCT02090413|581794203|FG002|Overall Study|Other|0|||
161110315|NCT02090413|581794201|FG000|Overall Study|Lost to Follow-up|1|||
161110316|NCT02090413|581794202|FG001|Overall Study|Lost to Follow-up|1|||
161215200|NCT01783496|582169531|FG004|Overall Study|Withdrawal by Subject|0|||
161215201|NCT01783496|582169532|FG005|Overall Study|Withdrawal by Subject|0|||
161110317|NCT02090413|581794203|FG002|Overall Study|Lost to Follow-up|0|||
161110318|NCT05248295|581794204|FG000|Overall Study|found ineligible|4|||
161110319|NCT05248295|581794205|FG001|Overall Study|found ineligible|1|||
161215202|NCT01023269|582169533|FG000|Overall Study|early termination of the study|2|||
161215203|NCT01023269|582169534|FG001|Overall Study|early termination of the study|0|||
161110320|NCT05248295|581794204|FG000|Overall Study|Withdrawal by Subject|0|||
161110321|NCT05248295|581794205|FG001|Overall Study|Withdrawal by Subject|1|||
161110322|NCT05248295|581794204|FG000|Overall Study|Data loss: audio recording error|1|||
161110323|NCT05248295|581794205|FG001|Overall Study|Data loss: audio recording error|1|||
161110324|NCT04490018|581794206|FG000|Overall Study|Protocol Violation|0|||
161110325|NCT04490018|581794207|FG001|Overall Study|Protocol Violation|2|||
161110326|NCT04490018|581794208|FG002|Overall Study|Protocol Violation|1|||
161110327|NCT04490018|581794206|FG000|Overall Study|Lost to Follow-up|2|||
161110328|NCT04490018|581794207|FG001|Overall Study|Lost to Follow-up|2|||
161110329|NCT04490018|581794208|FG002|Overall Study|Lost to Follow-up|0|||
161110330|NCT04490018|581794206|FG000|Overall Study|Withdrawal by Subject|2|||
161110331|NCT04490018|581794207|FG001|Overall Study|Withdrawal by Subject|1|||
161110332|NCT04490018|581794208|FG002|Overall Study|Withdrawal by Subject|0|||
161110333|NCT04490018|581794206|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161110334|NCT04490018|581794207|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161110335|NCT04490018|581794208|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161110336|NCT02321930|581794209|FG000|Overall Study|Lost to Follow-up|1|||
161110337|NCT04857996|581794210|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
161110338|NCT04857996|581794211|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
161110339|NCT04857996|581794210|FG000|Overall Study|Lost to Follow-up|1|||
161110340|NCT04857996|581794211|FG001|Overall Study|Lost to Follow-up|3|||
161110341|NCT04857996|581794210|FG000|Overall Study|Site Closure|1|||
161110342|NCT04857996|581794211|FG001|Overall Study|Site Closure|0|||
161110343|NCT04857996|581794210|FG000|Overall Study|Withdrawal by Subject|1|||
161110344|NCT04857996|581794211|FG001|Overall Study|Withdrawal by Subject|0|||
161110345|NCT02988661|581794212|FG000|Overall Study|Death|2|||
161110346|NCT02988661|581794213|FG001|Overall Study|Death|18|||
161110347|NCT02988661|581794212|FG000|Overall Study|Lost to Follow-up|0|||
161110348|NCT02988661|581794213|FG001|Overall Study|Lost to Follow-up|33|||
161110349|NCT02988661|581794212|FG000|Overall Study|Withdrawal by Subject|0|||
161110350|NCT02988661|581794213|FG001|Overall Study|Withdrawal by Subject|6|||
161110351|NCT02988661|581794212|FG000|Overall Study|Unable to complete the 18-month survey|1|||
161110352|NCT02988661|581794213|FG001|Overall Study|Unable to complete the 18-month survey|27|||
161110353|NCT04050982|581794218|FG000|Overall Study|Did not meet eligibility criteria|0|||
161110354|NCT04050982|581794219|FG001|Overall Study|Did not meet eligibility criteria|1|||
161110355|NCT04050982|581794220|FG002|Overall Study|Did not meet eligibility criteria|0|||
161110356|NCT04050982|581794218|FG000|Overall Study|Withdrawal by Subject|1|||
161110357|NCT04050982|581794219|FG001|Overall Study|Withdrawal by Subject|0|||
161110358|NCT04050982|581794220|FG002|Overall Study|Withdrawal by Subject|0|||
161110359|NCT04050982|581794218|FG000|Overall Study|Unable to enroll on platform|1|||
161110360|NCT04050982|581794219|FG001|Overall Study|Unable to enroll on platform|0|||
161110361|NCT04050982|581794220|FG002|Overall Study|Unable to enroll on platform|0|||
161110362|NCT00597753|581794221|FG000|Overall Study|Adverse Event|6|||
161110363|NCT00597753|581794222|FG001|Overall Study|Adverse Event|2|||
161110364|NCT00597753|581794221|FG000|Overall Study|Death|55|||
161110365|NCT00597753|581794222|FG001|Overall Study|Death|29|||
161110366|NCT00597753|581794221|FG000|Overall Study|Lack of Efficacy|2|||
161110367|NCT00597753|581794222|FG001|Overall Study|Lack of Efficacy|0|||
161110368|NCT00597753|581794221|FG000|Overall Study|Lost to Follow-up|10|||
161110369|NCT00597753|581794222|FG001|Overall Study|Lost to Follow-up|3|||
161110370|NCT00597753|581794221|FG000|Overall Study|Physician Decision|5|||
161110371|NCT00597753|581794222|FG001|Overall Study|Physician Decision|1|||
161110372|NCT00597753|581794221|FG000|Overall Study|Pregnancy|1|||
161110373|NCT00597753|581794222|FG001|Overall Study|Pregnancy|0|||
161110374|NCT00597753|581794221|FG000|Overall Study|Withdrawal by Subject|35|||
161110375|NCT00597753|581794222|FG001|Overall Study|Withdrawal by Subject|12|||
161110376|NCT00597753|581794221|FG000|Overall Study|Discontinued Dialysis|0|||
161110377|NCT00597753|581794222|FG001|Overall Study|Discontinued Dialysis|1|||
161110378|NCT00597753|581794221|FG000|Overall Study|Never dosed|2|||
161110379|NCT00597753|581794222|FG001|Overall Study|Never dosed|0|||
161110380|NCT00597753|581794221|FG000|Overall Study|Noncompliance|2|||
161110381|NCT00597753|581794222|FG001|Overall Study|Noncompliance|1|||
161110382|NCT00597753|581794221|FG000|Overall Study|Relocation|17|||
161110383|NCT00597753|581794222|FG001|Overall Study|Relocation|6|||
161110384|NCT00597753|581794221|FG000|Overall Study|Renal transplant|10|||
161110385|NCT00597753|581794222|FG001|Overall Study|Renal transplant|3|||
161110386|NCT00597753|581794221|FG000|Overall Study|Site closed by sponsor|19|||
161110387|NCT00597753|581794222|FG001|Overall Study|Site closed by sponsor|7|||
161110388|NCT00597753|581794221|FG000|Overall Study|Site elected to close|2|||
161110389|NCT00597753|581794222|FG001|Overall Study|Site elected to close|4|||
161110390|NCT01417195|581795581|FG000|Overall Study|Stimulation failure|1|||
161110391|NCT01417195|581795582|FG001|Overall Study|Stimulation failure|0|||
161110392|NCT01417195|581795581|FG000|Overall Study|No embryos for transfer|0|||
161110393|NCT01417195|581795582|FG001|Overall Study|No embryos for transfer|1|||
161110394|NCT01417195|581795581|FG000|Overall Study|No transfer due to risk of OHSS|1|||
161110395|NCT01417195|581795582|FG001|Overall Study|No transfer due to risk of OHSS|0|||
160869207|NCT04816669|580913688|FG003|Part 1|Lost to Follow-up|0|||
160869208|NCT04816669|580913685|FG000|Part 1|Protocol Violation|0|||
160869209|NCT04816669|580913686|FG001|Part 1|Protocol Violation|1|||
160869210|NCT04816669|580913687|FG002|Part 1|Protocol Violation|0|||
160869211|NCT04816669|580913688|FG003|Part 1|Protocol Violation|0|||
160869212|NCT04816669|580913685|FG000|Part 1|Withdrawal by Subject|1|||
160869213|NCT04816669|580913686|FG001|Part 1|Withdrawal by Subject|2|||
160869214|NCT04816669|580913687|FG002|Part 1|Withdrawal by Subject|0|||
160869215|NCT04816669|580913688|FG003|Part 1|Withdrawal by Subject|0|||
160869216|NCT04816669|580913685|FG000|Part 2|Other|0|||
160869217|NCT04816669|580913686|FG001|Part 2|Other|0|||
161110396|NCT01417195|581795581|FG000|Overall Study|No transfer due to elevated progesterone|1|||
161110397|NCT01417195|581795582|FG001|Overall Study|No transfer due to elevated progesterone|0|||
161110398|NCT04640272|581795585|FG000|Overall Study|Subject moved out of area|1|||
161110399|NCT02535715|581795586|FG000|Overall Study|Withdrawal by Subject|0|||
161110400|NCT02535715|581795587|FG001|Overall Study|Withdrawal by Subject|0|||
161110401|NCT02535715|581795588|FG002|Overall Study|Withdrawal by Subject|1|||
161110402|NCT04353284|581795589|FG000|Overall Study|Adverse Event|1|||
161110403|NCT04353284|581795590|FG001|Overall Study|Adverse Event|1|||
161110404|NCT04353284|581795589|FG000|Overall Study|Lost to Follow-up|1|||
161110405|NCT04353284|581795590|FG001|Overall Study|Lost to Follow-up|0|||
161110406|NCT01438489|581795596|FG000|Overall Study|Lost to Follow-up|4|||
161110407|NCT01438489|581795597|FG001|Overall Study|Lost to Follow-up|2|||
161110408|NCT01438489|581795598|FG002|Overall Study|Lost to Follow-up|2|||
161110409|NCT01438489|581795596|FG000|Overall Study|Withdrawal by Subject|11|||
161110410|NCT01438489|581795597|FG001|Overall Study|Withdrawal by Subject|3|||
161110411|NCT01438489|581795598|FG002|Overall Study|Withdrawal by Subject|8|||
161110412|NCT01438489|581795596|FG000|Overall Study|Death|0|||
161110413|NCT01438489|581795597|FG001|Overall Study|Death|0|||
161110414|NCT01438489|581795598|FG002|Overall Study|Death|1|||
161110415|NCT01438489|581795596|FG000|Overall Study|Sponsor decision|4|||
161110416|NCT01438489|581795597|FG001|Overall Study|Sponsor decision|1|||
161110417|NCT01438489|581795598|FG002|Overall Study|Sponsor decision|4|||
161110418|NCT01438489|581795596|FG000|Overall Study|Subject choice/Subject moved|2|||
161110419|NCT01438489|581795597|FG001|Overall Study|Subject choice/Subject moved|1|||
161110420|NCT01438489|581795598|FG002|Overall Study|Subject choice/Subject moved|1|||
161110421|NCT01438489|581795596|FG000|Overall Study|Investigator decision|0|||
161110422|NCT01438489|581795597|FG001|Overall Study|Investigator decision|1|||
161110423|NCT01438489|581795598|FG002|Overall Study|Investigator decision|0|||
161110424|NCT01438489|581795596|FG000|Overall Study|AE/SAEs|2|||
161110425|NCT01438489|581795597|FG001|Overall Study|AE/SAEs|1|||
161110426|NCT01438489|581795598|FG002|Overall Study|AE/SAEs|1|||
161110427|NCT01438489|581795596|FG000|Overall Study|Received prohibited medication|1|||
161110428|NCT01438489|581795597|FG001|Overall Study|Received prohibited medication|0|||
161110429|NCT01438489|581795598|FG002|Overall Study|Received prohibited medication|0|||
161110430|NCT01438489|581795596|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
161110431|NCT01438489|581795597|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
161110432|NCT01438489|581795598|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
161110433|NCT01438489|581795596|FG000|Overall Study|Inadequate venous access|0|||
161110434|NCT01438489|581795597|FG001|Overall Study|Inadequate venous access|2|||
161110435|NCT01438489|581795598|FG002|Overall Study|Inadequate venous access|0|||
161110436|NCT00766532|581795599|FG000|Overall Study|Protocol Violation|2|||
161110437|NCT01372384|581795601|FG000|Overall Study|Progression of disease|3|||
161110438|NCT03370120|581795610|FG000|Overall Study|Adverse event, non-fatal|24|||
161110439|NCT03370120|581795610|FG000|Overall Study|Withdrawal by Subject|6|||
161110440|NCT03370120|581795610|FG000|Overall Study|Lost to Follow-up|1|||
161110441|NCT03370120|581795610|FG000|Overall Study|Lack of Efficacy|37|||
161110442|NCT03370120|581795610|FG000|Overall Study|Per sponsor's instructions|1|||
161110443|NCT03370120|581795610|FG000|Overall Study|Study was terminated by parent company UCB|2|||
161110444|NCT03370120|581795610|FG000|Overall Study|The study was ended by the promoter|3|||
161110445|NCT03370120|581795610|FG000|Overall Study|Discontinuation of drug development|3|||
161110446|NCT03370120|581795610|FG000|Overall Study|End of project|2|||
161110447|NCT03370120|581795610|FG000|Overall Study|Premature study closure|2|||
160869218|NCT04816669|580913687|FG002|Part 2|Other|1|||
160869219|NCT04816669|580913688|FG003|Part 2|Other|0|||
161110448|NCT03370120|581795610|FG000|Overall Study|Premature program termination|1|||
161110449|NCT03370120|581795610|FG000|Overall Study|Premature study termination|7|||
161110450|NCT03370120|581795610|FG000|Overall Study|Trial terminated by sponsor|2|||
161110451|NCT03370120|581795610|FG000|Overall Study|Trial discontinued by sponsor|2|||
161110452|NCT03370120|581795610|FG000|Overall Study|Study ended|15|||
161110453|NCT03370120|581795610|FG000|Overall Study|Clinical trial has been cancelled|1|||
161110454|NCT03370120|581795610|FG000|Overall Study|End of study per sponsor decision|2|||
161110455|NCT03370120|581795610|FG000|Overall Study|Promoter's decision|2|||
161110456|NCT03370120|581795610|FG000|Overall Study|The trial has been suspended|3|||
161215204|NCT00106028|582169535|FG000|Overall Study|Adverse Event|3|||
160869220|NCT04816669|580913685|FG000|Part 2|Withdrawal by Subject|0|||
160869221|NCT04816669|580913686|FG001|Part 2|Withdrawal by Subject|0|||
160869222|NCT04816669|580913687|FG002|Part 2|Withdrawal by Subject|0|||
161110457|NCT03370120|581795610|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
161110458|NCT03370120|581795610|FG000|Overall Study|Early termination by order of sponsor|2|||
161110459|NCT03370120|581795610|FG000|Overall Study|Discontinuation of the study|5|||
161110460|NCT03370120|581795610|FG000|Overall Study|End of clinical trial discontinuation|1|||
161110461|NCT03370120|581795610|FG000|Overall Study|Because the clinical trial ended halfway|4|||
161110462|NCT03370120|581795610|FG000|Overall Study|Development discontinued|5|||
161110463|NCT03370120|581795610|FG000|Overall Study|Padsenovil program closed|3|||
161110464|NCT03370120|581795610|FG000|Overall Study|End of project|2|||
161110465|NCT03370120|581795610|FG000|Overall Study|Termination of project|1|||
161110466|NCT03370120|581795610|FG000|Overall Study|The study was interrupted by sponsor|4|||
161110467|NCT03370120|581795610|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
161110468|NCT03370120|581795610|FG000|Overall Study|End of sponsor decision|1|||
161110469|NCT03370120|581795610|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
161110470|NCT03370120|581795610|FG000|Overall Study|Early termination of studies|5|||
161110471|NCT03370120|581795610|FG000|Overall Study|This study is ended early|1|||
161110472|NCT03370120|581795610|FG000|Overall Study|End of padsevonil program|2|||
161110473|NCT03370120|581795610|FG000|Overall Study|Decision of sponsor|6|||
161110474|NCT03370120|581795610|FG000|Overall Study|Asked by the sponsor|3|||
161110475|NCT03370120|581795610|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
161110476|NCT03370120|581795610|FG000|Overall Study|PI decision poor compliance from participant|1|||
161110477|NCT03370120|581795610|FG000|Overall Study|Promoter ended the study|3|||
161110478|NCT03370120|581795610|FG000|Overall Study|Premature study close by sponsor's decision|4|||
161110479|NCT03370120|581795610|FG000|Overall Study|Study terminated by sponsor|33|||
161110480|NCT03370120|581795610|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
161110481|NCT03370120|581795610|FG000|Overall Study|Sponsor decision to terminate study|63|||
161110482|NCT03370120|581795610|FG000|Overall Study|Program closure|3|||
161110483|NCT03370120|581795610|FG000|Overall Study|Study ended prematurely|1|||
161110484|NCT03370120|581795610|FG000|Overall Study|Study stopped by sponsor|2|||
161110485|NCT03370120|581795610|FG000|Overall Study|Program termination|55|||
161110486|NCT03370120|581795610|FG000|Overall Study|Sponsor decision|62|||
161110487|NCT03370120|581795610|FG000|Overall Study|Sponsor study closure|10|||
161110488|NCT00928889|581795614|FG000|Overall Study|Lost to Follow-up|3|||
161110489|NCT00928889|581795615|FG001|Overall Study|Lost to Follow-up|1|||
161110490|NCT00928889|581795614|FG000|Overall Study|Protocol Violation|0|||
161110491|NCT00928889|581795615|FG001|Overall Study|Protocol Violation|1|||
161110492|NCT00928889|581795614|FG000|Overall Study|Adverse Event|1|||
161110493|NCT00928889|581795615|FG001|Overall Study|Adverse Event|0|||
161110494|NCT00928889|581795614|FG000|Overall Study|Other|1|||
161110495|NCT00928889|581795615|FG001|Overall Study|Other|0|||
161110496|NCT02700412|581795616|FG000|Overall Study|Adverse Event|6|||
161110497|NCT02700412|581795616|FG000|Overall Study|Death|1|||
161110498|NCT02700412|581795616|FG000|Overall Study|Lack of Efficacy|19|||
161110499|NCT02700412|581795616|FG000|Overall Study|Protocol Violation|5|||
161110500|NCT02700412|581795616|FG000|Overall Study|Withdrawal by Subject|2|||
161110501|NCT02375724|581795624|FG000|Overall Study|Lack of Efficacy|1|||
161110502|NCT02375724|581795625|FG001|Overall Study|Lack of Efficacy|1|||
161110503|NCT02375724|581795624|FG000|Overall Study|Withdrawal by Subject|1|||
161110504|NCT02375724|581795625|FG001|Overall Study|Withdrawal by Subject|1|||
161110505|NCT02375724|581795624|FG000|Overall Study|Lost to Follow-up|1|||
161110506|NCT02375724|581795625|FG001|Overall Study|Lost to Follow-up|0|||
161110507|NCT02375724|581795624|FG000|Overall Study|Protocol Violation|1|||
161110508|NCT02375724|581795625|FG001|Overall Study|Protocol Violation|0|||
161110509|NCT02375724|581795624|FG000|Overall Study|Adverse Event|2|||
161110510|NCT02375724|581795625|FG001|Overall Study|Adverse Event|4|||
161110511|NCT04712110|581795626|FG000|Overall Study|Lost to Follow-up|0|||
161110512|NCT04712110|581795627|FG001|Overall Study|Lost to Follow-up|1|||
161110513|NCT04712110|581795626|FG000|Overall Study|Withdrawal by Subject|0|||
161110514|NCT04712110|581795627|FG001|Overall Study|Withdrawal by Subject|4|||
161110515|NCT04712110|581795626|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
161110516|NCT04712110|581795627|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
161110517|NCT01356407|581795628|FG000|Overall Study|Lost to Follow-up|2|||
161110518|NCT01356407|581795629|FG001|Overall Study|Lost to Follow-up|0|||
161110519|NCT01356407|581795628|FG000|Overall Study|Patient Withdrew Consent|2|||
161110520|NCT01356407|581795629|FG001|Overall Study|Patient Withdrew Consent|1|||
161110521|NCT01356407|581795628|FG000|Overall Study|Could not afford IMP administration|0|||
161110522|NCT01356407|581795629|FG001|Overall Study|Could not afford IMP administration|1|||
161110523|NCT01356407|581795628|FG000|Overall Study|Not complete Endoscopy|2|||
161110524|NCT01356407|581795629|FG001|Overall Study|Not complete Endoscopy|2|||
161110525|NCT01197521|581795632|FG000|Overall Study|Not reported|24|||
161110526|NCT01197521|581795633|FG001|Overall Study|Not reported|25|||
161110527|NCT01197521|581795634|FG002|Overall Study|Not reported|21|||
161110528|NCT01197521|581795632|FG000|Overall Study|Enrolment in long term extension|42|||
161110529|NCT01197521|581795633|FG001|Overall Study|Enrolment in long term extension|36|||
160869223|NCT04816669|580913688|FG003|Part 2|Withdrawal by Subject|1|||
160869224|NCT04816669|580913685|FG000|Part 2|Lost to Follow-up|0|||
160869225|NCT04816669|580913686|FG001|Part 2|Lost to Follow-up|0|||
160869226|NCT04816669|580913687|FG002|Part 2|Lost to Follow-up|1|||
160869227|NCT04816669|580913688|FG003|Part 2|Lost to Follow-up|0|||
160869228|NCT01229267|580913689|FG000|Overall Study|Adverse Event|4|||
160869229|NCT01229267|580913690|FG001|Overall Study|Adverse Event|6|||
160869230|NCT01229267|580913691|FG002|Overall Study|Adverse Event|3|||
160869231|NCT01229267|580913692|FG003|Overall Study|Adverse Event|2|||
160869232|NCT01229267|580913693|FG004|Overall Study|Adverse Event|10|||
160869233|NCT01229267|580913689|FG000|Overall Study|Death|40|||
160869234|NCT01229267|580913690|FG001|Overall Study|Death|37|||
161110530|NCT01197521|581795634|FG002|Overall Study|Enrolment in long term extension|87|||
161110531|NCT01197521|581795632|FG000|Overall Study|Severe non-compliance to protocol|1|||
161110532|NCT01197521|581795633|FG001|Overall Study|Severe non-compliance to protocol|3|||
161110533|NCT01197521|581795634|FG002|Overall Study|Severe non-compliance to protocol|3|||
161110534|NCT01197521|581795632|FG000|Overall Study|Lack of therapeutic response|2|||
161110535|NCT01197521|581795633|FG001|Overall Study|Lack of therapeutic response|3|||
161110536|NCT01197521|581795634|FG002|Overall Study|Lack of therapeutic response|4|||
161110537|NCT01197521|581795632|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
161110538|NCT01197521|581795633|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
161110539|NCT01197521|581795634|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
161110540|NCT01197521|581795632|FG000|Overall Study|Lost to Follow-up|3|||
161110541|NCT01197521|581795633|FG001|Overall Study|Lost to Follow-up|2|||
161110542|NCT01197521|581795634|FG002|Overall Study|Lost to Follow-up|2|||
161110543|NCT01197521|581795632|FG000|Overall Study|Adverse Event|25|||
161110544|NCT01197521|581795633|FG001|Overall Study|Adverse Event|28|||
161110545|NCT01197521|581795634|FG002|Overall Study|Adverse Event|24|||
161110546|NCT01309659|581795635|FG000|Overall Study|Protocol Violation|0|||
161110547|NCT01309659|581795636|FG001|Overall Study|Protocol Violation|1|||
161110548|NCT02285777|581795637|FG000|Overall Study|Withdrawal by Subject|1|||
161110549|NCT02285777|581795638|FG001|Overall Study|Withdrawal by Subject|1|||
161110550|NCT02285777|581795637|FG000|Overall Study|Lost to Follow-up|4|||
161110551|NCT02285777|581795638|FG001|Overall Study|Lost to Follow-up|2|||
161110552|NCT01074190|581795639|FG000|Overall Study|Emergency Cesarean Delivery|1|||
161110553|NCT01074190|581795640|FG001|Overall Study|Emergency Cesarean Delivery|2|||
161110554|NCT01074190|581795641|FG002|Overall Study|Emergency Cesarean Delivery|1|||
161110555|NCT01074190|581795639|FG000|Overall Study|Protocol Violation|2|||
161110556|NCT01074190|581795640|FG001|Overall Study|Protocol Violation|1|||
161110557|NCT01074190|581795641|FG002|Overall Study|Protocol Violation|0|||
161110558|NCT01074190|581795639|FG000|Overall Study|Delivered in under 90 minutes|0|||
161110559|NCT01074190|581795640|FG001|Overall Study|Delivered in under 90 minutes|2|||
161110560|NCT01074190|581795641|FG002|Overall Study|Delivered in under 90 minutes|1|||
161110561|NCT01074190|581795639|FG000|Overall Study|Subject withdrew consent|1|||
161110562|NCT01074190|581795640|FG001|Overall Study|Subject withdrew consent|1|||
161110563|NCT01074190|581795641|FG002|Overall Study|Subject withdrew consent|1|||
161110564|NCT04607148|581795642|FG000|Overall Study|Withdrawal by Subject|0|||
161110565|NCT04607148|581795643|FG001|Overall Study|Withdrawal by Subject|4|||
161110566|NCT04607148|581795644|FG002|Overall Study|Withdrawal by Subject|2|||
161110567|NCT04607148|581795645|FG003|Overall Study|Withdrawal by Subject|8|||
161110568|NCT04607148|581795642|FG000|Overall Study|Study Terminated by Sponsor|14|||
161110569|NCT04607148|581795643|FG001|Overall Study|Study Terminated by Sponsor|59|||
161110570|NCT04607148|581795644|FG002|Overall Study|Study Terminated by Sponsor|9|||
161110571|NCT04607148|581795645|FG003|Overall Study|Study Terminated by Sponsor|39|||
161110572|NCT04607148|581795642|FG000|Overall Study|Sponsor Decision|0|||
161110573|NCT04607148|581795643|FG001|Overall Study|Sponsor Decision|0|||
161110574|NCT04607148|581795644|FG002|Overall Study|Sponsor Decision|1|||
161110575|NCT04607148|581795645|FG003|Overall Study|Sponsor Decision|0|||
161110576|NCT04607148|581795642|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160869235|NCT01229267|580913691|FG002|Overall Study|Death|35|||
160869236|NCT01229267|580913692|FG003|Overall Study|Death|13|||
160869237|NCT01229267|580913693|FG004|Overall Study|Death|103|||
160869238|NCT01229267|580913689|FG000|Overall Study|Withdrawal by Subject|23|||
161110577|NCT04607148|581795643|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161110578|NCT04607148|581795644|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161110579|NCT04607148|581795645|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161110580|NCT04607148|581795642|FG000|Overall Study|Lost to Follow-up|0|||
161110581|NCT04607148|581795643|FG001|Overall Study|Lost to Follow-up|2|||
161110582|NCT04607148|581795644|FG002|Overall Study|Lost to Follow-up|0|||
161110583|NCT04607148|581795645|FG003|Overall Study|Lost to Follow-up|0|||
161110584|NCT04607148|581795642|FG000|Overall Study|Death|0|||
161110585|NCT04607148|581795643|FG001|Overall Study|Death|3|||
160869239|NCT01229267|580913690|FG001|Overall Study|Withdrawal by Subject|22|||
160869240|NCT01229267|580913691|FG002|Overall Study|Withdrawal by Subject|32|||
160869241|NCT01229267|580913692|FG003|Overall Study|Withdrawal by Subject|14|||
160869242|NCT01229267|580913693|FG004|Overall Study|Withdrawal by Subject|59|||
161110586|NCT04607148|581795644|FG002|Overall Study|Death|0|||
161110587|NCT04607148|581795645|FG003|Overall Study|Death|1|||
161215205|NCT00106028|582169536|FG001|Overall Study|Adverse Event|2|||
161215206|NCT00106028|582169535|FG000|Overall Study|Protocol Violation|1|||
161215207|NCT00106028|582169536|FG001|Overall Study|Protocol Violation|1|||
161215208|NCT00106028|582169535|FG000|Overall Study|Withdrawal by Subject|2|||
161215209|NCT00106028|582169536|FG001|Overall Study|Withdrawal by Subject|8|||
161215210|NCT00106028|582169535|FG000|Overall Study|Lost to Follow-up|0|||
161215211|NCT00106028|582169536|FG001|Overall Study|Lost to Follow-up|1|||
161215212|NCT00947011|582169537|FG000|Overall Study|Study was terminated,PI left institution|12|||
161215213|NCT05266456|582169540|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
161215214|NCT05266456|582169541|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
161215215|NCT05266456|582169542|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
161215216|NCT05266456|582169543|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
161215217|NCT05266456|582169540|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161215218|NCT05266456|582169541|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161215219|NCT05266456|582169542|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
161215220|NCT05266456|582169543|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
161215221|NCT05266456|582169540|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
161215222|NCT05266456|582169541|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
161215223|NCT05266456|582169542|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
161215224|NCT05266456|582169543|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
161215225|NCT05266456|582169540|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161215226|NCT05266456|582169541|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161215227|NCT05266456|582169542|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
161215228|NCT05266456|582169543|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
161215229|NCT05266456|582169540|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
161215230|NCT05266456|582169541|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
161215231|NCT05266456|582169542|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
161215232|NCT05266456|582169543|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
161215233|NCT02746705|582169550|FG000|Overall Study|Physician Decision|1|||
161215234|NCT02746705|582169551|FG001|Overall Study|Physician Decision|1|||
161215235|NCT02746705|582169550|FG000|Overall Study|Lost to Follow-up|1|||
161215236|NCT02746705|582169551|FG001|Overall Study|Lost to Follow-up|0|||
161215237|NCT02746705|582169550|FG000|Overall Study|outlier scores deemed not valid|0|||
161215238|NCT02746705|582169551|FG001|Overall Study|outlier scores deemed not valid|1|||
161215239|NCT00479401|582169552|FG000|Overall Study|Adverse Event|24|||
161215240|NCT00479401|582169553|FG001|Overall Study|Adverse Event|20|||
161215241|NCT00479401|582169554|FG002|Overall Study|Adverse Event|4|||
161215242|NCT00479401|582169552|FG000|Overall Study|Lack of Efficacy|2|||
161215243|NCT00479401|582169553|FG001|Overall Study|Lack of Efficacy|2|||
161215244|NCT00479401|582169554|FG002|Overall Study|Lack of Efficacy|4|||
161215245|NCT00479401|582169552|FG000|Overall Study|Protocol Violation|2|||
161215246|NCT00479401|582169553|FG001|Overall Study|Protocol Violation|1|||
161215247|NCT00479401|582169554|FG002|Overall Study|Protocol Violation|1|||
161215248|NCT00479401|582169552|FG000|Overall Study|Lost to Follow-up|1|||
161215249|NCT00479401|582169553|FG001|Overall Study|Lost to Follow-up|1|||
161215250|NCT00479401|582169554|FG002|Overall Study|Lost to Follow-up|1|||
161215251|NCT00479401|582169552|FG000|Overall Study|Withdrawal by Subject|16|||
161215252|NCT00479401|582169553|FG001|Overall Study|Withdrawal by Subject|10|||
161215253|NCT00479401|582169554|FG002|Overall Study|Withdrawal by Subject|2|||
161215254|NCT00479401|582169552|FG000|Overall Study|Exclusion criteria, relocation|4|||
161215255|NCT00479401|582169553|FG001|Overall Study|Exclusion criteria, relocation|3|||
161215256|NCT00479401|582169554|FG002|Overall Study|Exclusion criteria, relocation|0|||
161215257|NCT02806232|582171399|FG000|Overall Study|Lost to Follow-up|1|||
161215258|NCT02806232|582171400|FG001|Overall Study|Lost to Follow-up|2|||
161215259|NCT02806232|582171401|FG002|Overall Study|Lost to Follow-up|1|||
161215260|NCT02806232|582171402|FG003|Overall Study|Lost to Follow-up|0|||
161215261|NCT02806232|582171403|FG004|Overall Study|Lost to Follow-up|0|||
161215262|NCT02806232|582171404|FG005|Overall Study|Lost to Follow-up|1|||
161215263|NCT02806232|582171405|FG006|Overall Study|Lost to Follow-up|0|||
161215264|NCT02806232|582171406|FG007|Overall Study|Lost to Follow-up|0|||
161324364|NCT01408901|582573579|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161324365|NCT01408901|582573580|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
161215265|NCT02806232|582171407|FG008|Overall Study|Lost to Follow-up|0|||
161215266|NCT02806232|582171399|FG000|Overall Study|Withdrawal by Subject|0|||
161215267|NCT02806232|582171400|FG001|Overall Study|Withdrawal by Subject|2|||
161215268|NCT02806232|582171401|FG002|Overall Study|Withdrawal by Subject|0|||
161215269|NCT02806232|582171402|FG003|Overall Study|Withdrawal by Subject|0|||
161215270|NCT02806232|582171403|FG004|Overall Study|Withdrawal by Subject|2|||
161215271|NCT02806232|582171404|FG005|Overall Study|Withdrawal by Subject|1|||
161215272|NCT02806232|582171405|FG006|Overall Study|Withdrawal by Subject|0|||
161215273|NCT02806232|582171406|FG007|Overall Study|Withdrawal by Subject|0|||
161215274|NCT02806232|582171407|FG008|Overall Study|Withdrawal by Subject|0|||
161215275|NCT00434161|582171408|FG000|Overall Study|Adverse Event|5|||
161215276|NCT00434161|582171409|FG001|Overall Study|Adverse Event|1|||
161215277|NCT00434161|582171410|FG002|Overall Study|Adverse Event|4|||
161215278|NCT00434161|582171408|FG000|Overall Study|Lost to Follow-up|0|||
161215279|NCT00434161|582171409|FG001|Overall Study|Lost to Follow-up|1|||
161215280|NCT00434161|582171410|FG002|Overall Study|Lost to Follow-up|0|||
161215281|NCT00434161|582171408|FG000|Overall Study|Death|1|||
161215282|NCT00434161|582171409|FG001|Overall Study|Death|0|||
161215283|NCT00434161|582171410|FG002|Overall Study|Death|1|||
161215284|NCT00434161|582171408|FG000|Overall Study|Non-Compliance|1|||
161215285|NCT00434161|582171409|FG001|Overall Study|Non-Compliance|1|||
161215286|NCT00434161|582171410|FG002|Overall Study|Non-Compliance|0|||
161215287|NCT00434161|582171408|FG000|Overall Study|Withdrawal by Subject|2|||
161215288|NCT00434161|582171409|FG001|Overall Study|Withdrawal by Subject|0|||
161215289|NCT00434161|582171410|FG002|Overall Study|Withdrawal by Subject|3|||
161215290|NCT00434161|582171408|FG000|Overall Study|Logistical error study assessments|1|||
161215291|NCT00434161|582171409|FG001|Overall Study|Logistical error study assessments|0|||
161215292|NCT00434161|582171410|FG002|Overall Study|Logistical error study assessments|3|||
161215293|NCT02482805|582171414|FG000|Overall Study|Lost to Follow-up|4|||
161215294|NCT02482805|582171415|FG001|Overall Study|Lost to Follow-up|4|||
161215295|NCT02482805|582171416|FG002|Overall Study|Lost to Follow-up|0|||
161215296|NCT01267266|582171418|FG000|Enrollment Phase|Withdrawal by Subject|2|||
161215297|NCT01267266|582171419|FG001|Enrollment Phase|Withdrawal by Subject|0|||
161215298|NCT01267266|582171418|FG000|Lead-in Phase|Lack of Efficacy|20|||
161215299|NCT01267266|582171419|FG001|Lead-in Phase|Lack of Efficacy|0|||
161215300|NCT01267266|582171418|FG000|Lead-in Phase|Adverse Event|2|||
161215301|NCT01267266|582171419|FG001|Lead-in Phase|Adverse Event|0|||
161215302|NCT01267266|582171418|FG000|Lead-in Phase|Withdrawal by Subject|1|||
161215303|NCT01267266|582171419|FG001|Lead-in Phase|Withdrawal by Subject|0|||
161215304|NCT02480010|582171425|FG000|Overall Study|Adverse Event|3|||
161215305|NCT02480010|582171426|FG001|Overall Study|Adverse Event|1|||
161215306|NCT02480010|582171425|FG000|Overall Study|Death|1|||
161215307|NCT02480010|582171426|FG001|Overall Study|Death|0|||
160869243|NCT01229267|580913689|FG000|Overall Study|Protocol Violation|0|||
160869244|NCT01229267|580913690|FG001|Overall Study|Protocol Violation|1|||
161110588|NCT04607148|581795642|FG000|Overall Study|Adverse Event|0|||
161110589|NCT04607148|581795643|FG001|Overall Study|Adverse Event|1|||
161110590|NCT04607148|581795644|FG002|Overall Study|Adverse Event|0|||
161110591|NCT04607148|581795645|FG003|Overall Study|Adverse Event|0|||
161110592|NCT00290342|581795646|FG000|Overall Study|Other|0|||
161110593|NCT00290342|581795647|FG001|Overall Study|Other|1|||
161110594|NCT00290342|581795646|FG000|Overall Study|Withdrawal by Subject|6|||
161110595|NCT00290342|581795647|FG001|Overall Study|Withdrawal by Subject|4|||
161110596|NCT00290342|581795646|FG000|Overall Study|Lost to Follow-up|1|||
161110597|NCT00290342|581795647|FG001|Overall Study|Lost to Follow-up|0|||
161110598|NCT00912028|581795650|FG000|Overall Study|Lost to Follow-up|2|||
161110599|NCT00912028|581795651|FG001|Overall Study|Lost to Follow-up|3|||
161110600|NCT00912028|581795652|FG002|Overall Study|Lost to Follow-up|0|||
161110601|NCT00912028|581795653|FG003|Overall Study|Lost to Follow-up|1|||
161110602|NCT00912028|581795654|FG004|Overall Study|Lost to Follow-up|3|||
161110603|NCT00912028|581795650|FG000|Overall Study|Withdrawal by Subject|3|||
161110604|NCT00912028|581795651|FG001|Overall Study|Withdrawal by Subject|0|||
161110605|NCT00912028|581795652|FG002|Overall Study|Withdrawal by Subject|0|||
161110606|NCT00912028|581795653|FG003|Overall Study|Withdrawal by Subject|0|||
161110607|NCT00912028|581795654|FG004|Overall Study|Withdrawal by Subject|0|||
161110608|NCT02285998|581795655|FG000|Overall Study|Adverse Event|9|||
161110609|NCT02285998|581795656|FG001|Overall Study|Adverse Event|8|||
161110610|NCT02285998|581795655|FG000|Overall Study|Physician Decision|1|||
161110611|NCT02285998|581795656|FG001|Overall Study|Physician Decision|2|||
161110612|NCT02285998|581795655|FG000|Overall Study|Lost to Follow-up|176|||
161110613|NCT02285998|581795656|FG001|Overall Study|Lost to Follow-up|172|||
161110614|NCT02285998|581795655|FG000|Overall Study|Withdrawal by Subject|53|||
161110615|NCT02285998|581795656|FG001|Overall Study|Withdrawal by Subject|61|||
161110616|NCT02285998|581795655|FG000|Overall Study|Other Reasons|7|||
161110617|NCT02285998|581795656|FG001|Overall Study|Other Reasons|10|||
161110618|NCT01793142|581795657|FG000|Overall Study|Randomized not treated|7|||
161110619|NCT03029143|581795658|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
161110620|NCT03029143|581795659|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
161110621|NCT03029143|581795660|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
161110622|NCT03029143|581795658|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
161110623|NCT03029143|581795659|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
161110624|NCT03029143|581795660|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
161110625|NCT03029143|581795658|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
161215308|NCT02480010|582171425|FG000|Overall Study|Insufficient therapeutic response|31|||
161215309|NCT02480010|582171426|FG001|Overall Study|Insufficient therapeutic response|29|||
161215310|NCT02480010|582171425|FG000|Overall Study|Refused Treatment|0|||
161215311|NCT02480010|582171426|FG001|Overall Study|Refused Treatment|3|||
161215312|NCT00910858|582171444|FG000|Pharmacokinetic Phase|Adverse Event|1|||
161215313|NCT00910858|582171445|FG001|Pharmacokinetic Phase|Adverse Event|0|||
161215314|NCT00910858|582171446|FG002|Pharmacokinetic Phase|Adverse Event|0|||
161110626|NCT03029143|581795659|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
161110627|NCT03029143|581795660|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
161110628|NCT03029143|581795658|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
161110629|NCT03029143|581795659|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
161110630|NCT03029143|581795660|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
161110631|NCT03029143|581795658|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
161110632|NCT03029143|581795659|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
161110633|NCT03029143|581795660|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
161110634|NCT03029143|581795658|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
161110635|NCT03029143|581795659|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
161110636|NCT03029143|581795660|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
161110637|NCT03029143|581795658|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
161110638|NCT03029143|581795659|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
161110639|NCT03029143|581795660|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
161110640|NCT03029143|581795658|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161110641|NCT03029143|581795659|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161110642|NCT03029143|581795660|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
161110643|NCT03029143|581795658|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
161110644|NCT03029143|581795659|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
161110645|NCT03029143|581795660|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
161110646|NCT03029143|581795658|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161110647|NCT03029143|581795659|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
161110648|NCT03029143|581795660|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
161110649|NCT03029143|581795658|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
161110650|NCT03029143|581795659|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
161110651|NCT03029143|581795660|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
161110652|NCT02829138|581795661|FG000|Overall Study|Withdrawal by Subject|1|||
161110653|NCT02829138|581795662|FG001|Overall Study|Withdrawal by Subject|0|||
161110654|NCT01394627|581795663|FG000|First Intervention (1 Day)|poor intravenous access|0|||
161110655|NCT01394627|581795664|FG001|First Intervention (1 Day)|poor intravenous access|1|||
161110656|NCT01394627|581795663|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
161110657|NCT01394627|581795664|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
161110658|NCT00825162|581795667|FG000|Overall Study|Withdrawal by Subject|11|||
161110659|NCT00825162|581795668|FG001|Overall Study|Withdrawal by Subject|13|||
161110660|NCT00825162|581795669|FG002|Overall Study|Withdrawal by Subject|3|||
161110661|NCT00825162|581795667|FG000|Overall Study|Lost to Follow-up|9|||
161110662|NCT00825162|581795668|FG001|Overall Study|Lost to Follow-up|6|||
161110663|NCT00825162|581795669|FG002|Overall Study|Lost to Follow-up|3|||
161110664|NCT00825162|581795667|FG000|Overall Study|Physician Decision|2|||
161110665|NCT00825162|581795668|FG001|Overall Study|Physician Decision|0|||
161110666|NCT00825162|581795669|FG002|Overall Study|Physician Decision|0|||
161110667|NCT00825162|581795667|FG000|Overall Study|Move away from the study area|1|||
161110668|NCT00825162|581795668|FG001|Overall Study|Move away from the study area|0|||
161110669|NCT00825162|581795669|FG002|Overall Study|Move away from the study area|0|||
161110670|NCT00825162|581795667|FG000|Overall Study|Unable to attend the study visit|5|||
161110671|NCT00825162|581795668|FG001|Overall Study|Unable to attend the study visit|2|||
161110672|NCT00825162|581795669|FG002|Overall Study|Unable to attend the study visit|0|||
161110673|NCT00258674|581795677|FG000|Overall Study|Death|32|||
161110674|NCT00258674|581795678|FG001|Overall Study|Death|53|||
161110675|NCT00258674|581795679|FG002|Overall Study|Death|34|||
161110676|NCT01279850|581795680|FG000|Overall Study|Protocol Violation|50|||
161110677|NCT01279850|581795680|FG000|Overall Study|No Drug Administration Information|7|||
161110678|NCT01279850|581795680|FG000|Overall Study|No Visit After Treatment|34|||
161110679|NCT01342484|581795689|FG000|Overall Study|Other Reasons|1|||
161110680|NCT01342484|581795690|FG001|Overall Study|Other Reasons|0|||
161110681|NCT01342484|581795691|FG002|Overall Study|Other Reasons|0|||
161110682|NCT01342484|581795689|FG000|Overall Study|Protocol Violation|0|||
161110683|NCT01342484|581795690|FG001|Overall Study|Protocol Violation|0|||
161110684|NCT01342484|581795691|FG002|Overall Study|Protocol Violation|1|||
161110685|NCT01342484|581795689|FG000|Overall Study|Withdrawal by Subject|1|||
161110686|NCT01342484|581795690|FG001|Overall Study|Withdrawal by Subject|0|||
161110687|NCT01342484|581795691|FG002|Overall Study|Withdrawal by Subject|0|||
161110688|NCT00432042|581795692|FG000|Overall Study|Protocol Violation|2|||
161110689|NCT00432042|581795693|FG001|Overall Study|Protocol Violation|0|||
161110690|NCT00432042|581795694|FG002|Overall Study|Protocol Violation|0|||
161110691|NCT00432042|581795692|FG000|Overall Study|Withdrawal by Subject|0|||
161110692|NCT00432042|581795693|FG001|Overall Study|Withdrawal by Subject|0|||
161110693|NCT00432042|581795694|FG002|Overall Study|Withdrawal by Subject|2|||
161110694|NCT00432042|581795692|FG000|Overall Study|Lost to Follow-up|5|||
161110695|NCT00432042|581795693|FG001|Overall Study|Lost to Follow-up|1|||
161110696|NCT00432042|581795694|FG002|Overall Study|Lost to Follow-up|0|||
161110697|NCT01744665|581795696|FG000|Monitoring Phase|Adverse Event|4|||
161110698|NCT01744665|581795696|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
161110699|NCT01744665|581795696|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
161110700|NCT01744665|581795696|FG000|Monitoring Phase|Withdrawal by Subject|5|||
161110701|NCT01744665|581795696|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
161110702|NCT01744665|581795696|FG000|Consolidation Phase|Adverse Event|2|||
161110703|NCT01744665|581795696|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
161110704|NCT01744665|581795696|FG000|Consolidation Phase|Withdrawal by Subject|4|||
161110705|NCT01744665|581795696|FG000|Consolidation Phase|Administrative problems|9|||
161110706|NCT01744665|581795696|FG000|Re-initiation Phase|Administrative problems|10|||
161110707|NCT01744665|581795696|FG000|Re-initiation Phase|Adverse Event|1|||
161110708|NCT01744665|581795696|FG000|Re-initiation Phase|No longer required treatment|1|||
161110709|NCT01744665|581795696|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
161110710|NCT00492752|581795697|FG000|Double Blind Treatment|Death|13|||
161110711|NCT00492752|581795698|FG001|Double Blind Treatment|Death|0|||
161110712|NCT00492752|581795699|FG002|Double Blind Treatment|Death|2|||
161110713|NCT00492752|581795700|FG003|Double Blind Treatment|Death|0|||
161110714|NCT00492752|581795697|FG000|Double Blind Treatment|Adverse Event|1|||
161110715|NCT00492752|581795698|FG001|Double Blind Treatment|Adverse Event|0|||
161110716|NCT00492752|581795699|FG002|Double Blind Treatment|Adverse Event|0|||
161110717|NCT00492752|581795700|FG003|Double Blind Treatment|Adverse Event|0|||
161110718|NCT00492752|581795697|FG000|Double Blind Treatment|Protocol Violation|0|||
161110719|NCT00492752|581795698|FG001|Double Blind Treatment|Protocol Violation|0|||
161110720|NCT00492752|581795699|FG002|Double Blind Treatment|Protocol Violation|1|||
161110721|NCT00492752|581795700|FG003|Double Blind Treatment|Protocol Violation|0|||
161110722|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
161110723|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
161110724|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
161110725|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
161110726|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
161110727|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
161110728|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
161110729|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
161110730|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
161110731|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
161110732|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
161110733|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
161110734|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
161110735|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
161110736|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
161110737|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
161110738|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
161110739|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
161110740|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
161110741|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
161110742|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
160869245|NCT01229267|580913691|FG002|Overall Study|Protocol Violation|0|||
160869246|NCT01229267|580913692|FG003|Overall Study|Protocol Violation|0|||
160869247|NCT01229267|580913693|FG004|Overall Study|Protocol Violation|0|||
160869248|NCT01229267|580913689|FG000|Overall Study|Progressive disease|0|||
160869249|NCT01229267|580913690|FG001|Overall Study|Progressive disease|0|||
160869250|NCT01229267|580913691|FG002|Overall Study|Progressive disease|0|||
160869251|NCT01229267|580913692|FG003|Overall Study|Progressive disease|0|||
160869252|NCT01229267|580913693|FG004|Overall Study|Progressive disease|1|||
160869253|NCT01229267|580913689|FG000|Overall Study|Physician Decision|8|||
160869254|NCT01229267|580913690|FG001|Overall Study|Physician Decision|11|||
160869255|NCT01229267|580913691|FG002|Overall Study|Physician Decision|8|||
160869256|NCT01229267|580913692|FG003|Overall Study|Physician Decision|3|||
160869257|NCT01229267|580913693|FG004|Overall Study|Physician Decision|25|||
160869258|NCT01229267|580913689|FG000|Overall Study|Lost to Follow-up|6|||
160869259|NCT01229267|580913690|FG001|Overall Study|Lost to Follow-up|5|||
160869260|NCT01229267|580913691|FG002|Overall Study|Lost to Follow-up|8|||
160869261|NCT01229267|580913692|FG003|Overall Study|Lost to Follow-up|3|||
160869262|NCT01229267|580913693|FG004|Overall Study|Lost to Follow-up|22|||
160869263|NCT00808080|580913697|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
160869264|NCT01837823|580913700|FG000|Overall Study|Lost to Follow-up|6|||
160869265|NCT03052400|580913701|FG000|Overall Study|Lost to Follow-up|1|||
160869266|NCT03052400|580913702|FG001|Overall Study|Lost to Follow-up|0|||
160869267|NCT03052400|580913701|FG000|Overall Study|Withdrawal by Subject|0|||
160869268|NCT03052400|580913702|FG001|Overall Study|Withdrawal by Subject|1|||
160869269|NCT00867815|580913703|FG000|Overall Study|Lost to Follow-up|1|||
160869270|NCT00001213|580913704|FG000|Overall Study|Death|18|||
160869271|NCT00859456|580913705|FG000|Overall Study|Adverse Event|3|||
160869272|NCT00859456|580913705|FG000|Overall Study|Progressive disease|2|||
160869273|NCT00859456|580913705|FG000|Overall Study|Non-compliance|3|||
160869274|NCT05782179|580913709|FG000|Overall Study|Adverse Event|0|||
160869275|NCT05782179|580913710|FG001|Overall Study|Adverse Event|0|||
160869276|NCT05782179|580913711|FG002|Overall Study|Adverse Event|2|||
160869277|NCT05782179|580913712|FG003|Overall Study|Adverse Event|0|||
160869278|NCT05782179|580913713|FG004|Overall Study|Adverse Event|0|||
160869279|NCT05782179|580913714|FG005|Overall Study|Adverse Event|0|||
160869280|NCT06170242|580913715|FG000|Overall Study|Lost to Follow-up|0|||
160869281|NCT06170242|580913716|FG001|Overall Study|Lost to Follow-up|0|||
160869282|NCT06170242|580913717|FG002|Overall Study|Lost to Follow-up|1|||
160869283|NCT06170242|580913718|FG003|Overall Study|Lost to Follow-up|1|||
160869284|NCT00927953|580913719|FG000|Overall Study|Death|2|||
160869285|NCT00927953|580913720|FG001|Overall Study|Death|1|||
160869286|NCT01491607|580913721|FG000|Overall Study|Lost to Follow-up|7|||
160869287|NCT01491607|580913721|FG000|Overall Study|Withdrawal by Subject|3|||
160869288|NCT02194985|580913724|FG000|Overall Study|Adverse Event|1|||
160869289|NCT02194985|580913724|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
160869290|NCT02194985|580913724|FG000|Overall Study|Physician Decision|4|||
160869291|NCT02194985|580913724|FG000|Overall Study|Lost to Follow-up|1|||
160869292|NCT02194985|580913724|FG000|Overall Study|Withdrawal by Subject|2|||
160869293|NCT01733680|580913727|FG000|Overall Study|Withdrawal by Subject|0|||
160869294|NCT01733680|580913728|FG001|Overall Study|Withdrawal by Subject|1|||
160869295|NCT02839200|580913731|FG000|Overall Study|Withdrawal by Subject|2|||
160869296|NCT02839200|580913732|FG001|Overall Study|Withdrawal by Subject|0|||
160869297|NCT02839200|580913733|FG002|Overall Study|Withdrawal by Subject|1|||
160869298|NCT02839200|580913734|FG003|Overall Study|Withdrawal by Subject|0|||
160869299|NCT02839200|580913735|FG004|Overall Study|Withdrawal by Subject|0|||
160869300|NCT02839200|580913736|FG005|Overall Study|Withdrawal by Subject|1|||
160869301|NCT02839200|580913731|FG000|Overall Study|Lost to Follow-up|2|||
160869302|NCT02839200|580913732|FG001|Overall Study|Lost to Follow-up|0|||
160869303|NCT02839200|580913733|FG002|Overall Study|Lost to Follow-up|0|||
161110743|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161110744|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
161110745|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
161110746|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
160869304|NCT02839200|580913734|FG003|Overall Study|Lost to Follow-up|0|||
160869305|NCT02839200|580913735|FG004|Overall Study|Lost to Follow-up|1|||
160869306|NCT02839200|580913736|FG005|Overall Study|Lost to Follow-up|0|||
160869307|NCT02839200|580913731|FG000|Overall Study|Adverse Event|0|||
160869308|NCT02839200|580913732|FG001|Overall Study|Adverse Event|0|||
160869309|NCT02839200|580913733|FG002|Overall Study|Adverse Event|0|||
160869310|NCT02839200|580913734|FG003|Overall Study|Adverse Event|0|||
160869311|NCT02839200|580913735|FG004|Overall Study|Adverse Event|1|||
160869312|NCT02839200|580913736|FG005|Overall Study|Adverse Event|0|||
160869313|NCT02839200|580913731|FG000|Overall Study|Randomized in error|0|||
160869314|NCT02839200|580913732|FG001|Overall Study|Randomized in error|1|||
160869315|NCT02839200|580913733|FG002|Overall Study|Randomized in error|0|||
160869316|NCT02839200|580913734|FG003|Overall Study|Randomized in error|0|||
160869317|NCT02839200|580913735|FG004|Overall Study|Randomized in error|0|||
160869318|NCT02839200|580913736|FG005|Overall Study|Randomized in error|0|||
161215315|NCT00910858|582171444|FG000|Monotherapy Phase|Adverse Event|3|||
161215316|NCT00910858|582171445|FG001|Monotherapy Phase|Adverse Event|2|||
161215317|NCT00910858|582171446|FG002|Monotherapy Phase|Adverse Event|0|||
161215318|NCT00910858|582171444|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
161215319|NCT00910858|582171445|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
161215320|NCT00910858|582171446|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
161215321|NCT00910858|582171444|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
161215322|NCT00910858|582171445|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
161215323|NCT00910858|582171446|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
161215324|NCT00910858|582171444|FG000|Monotherapy Phase|Protocol Violation|1|||
161215325|NCT00910858|582171445|FG001|Monotherapy Phase|Protocol Violation|0|||
161215326|NCT00910858|582171446|FG002|Monotherapy Phase|Protocol Violation|0|||
161215327|NCT00910858|582171444|FG000|Monotherapy Phase|Other|3|||
161215328|NCT00910858|582171445|FG001|Monotherapy Phase|Other|4|||
161215329|NCT00910858|582171446|FG002|Monotherapy Phase|Other|2|||
161215330|NCT00910858|582171444|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
161215331|NCT00910858|582171445|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
161110747|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
161110748|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161110749|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
161110750|NCT00492752|581795697|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
161110751|NCT00492752|581795698|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161110752|NCT00492752|581795699|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161110753|NCT00492752|581795700|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
161110754|NCT03803059|581795701|FG000|Overall Study|Protocol Violation|2|||
161110755|NCT03803059|581795701|FG000|Overall Study|Lost to Follow-up|1|||
161110756|NCT05419128|581795705|FG000|Overall Study|Withdrawal by Subject|1|||
161110757|NCT05419128|581795706|FG001|Overall Study|Withdrawal by Subject|1|||
161110758|NCT05419128|581795707|FG002|Overall Study|Withdrawal by Subject|0|||
161110759|NCT05419128|581795708|FG003|Overall Study|Withdrawal by Subject|1|||
161110760|NCT05419128|581795709|FG004|Overall Study|Withdrawal by Subject|1|||
161110761|NCT05419128|581795710|FG005|Overall Study|Withdrawal by Subject|0|||
161110762|NCT05419128|581795705|FG000|Overall Study|Lost to Follow-up|0|||
161110763|NCT05419128|581795706|FG001|Overall Study|Lost to Follow-up|0|||
161110764|NCT05419128|581795707|FG002|Overall Study|Lost to Follow-up|1|||
161110765|NCT05419128|581795708|FG003|Overall Study|Lost to Follow-up|0|||
161110766|NCT05419128|581795709|FG004|Overall Study|Lost to Follow-up|0|||
161110767|NCT05419128|581795710|FG005|Overall Study|Lost to Follow-up|1|||
161110768|NCT02581202|581795711|FG000|Overall Study|Lack of Efficacy|2|||
161110769|NCT02581202|581795711|FG000|Overall Study|Withdrawal by Subject|4|||
161110770|NCT02581202|581795711|FG000|Overall Study|Lost to Follow-up|5|||
161110771|NCT02581202|581795711|FG000|Overall Study|Pregnancy|3|||
161110772|NCT04649255|581797388|FG000|Overall Study|Death|9|||
161110773|NCT04649255|581797388|FG000|Overall Study|Withdrawal by Subject|1|||
161110774|NCT02222207|581797389|FG000|Overall Study|Death|1|||
161110775|NCT02222207|581797389|FG000|Overall Study|Other reasons|2|||
161110776|NCT02222207|581797389|FG000|Overall Study|Adverse Event|1|||
161110777|NCT04682405|581797390|FG000|Overall Study|Adverse Event|0|||
161110778|NCT04682405|581797391|FG001|Overall Study|Adverse Event|1|||
161110779|NCT00747643|581797392|FG000|Overall Study|Withdrawal by Subject|36|||
161110780|NCT00747643|581797393|FG001|Overall Study|Withdrawal by Subject|27|||
161110781|NCT03557281|581797394|FG000|Overall Study|Investigator discretion|0|||
161110782|NCT03557281|581797395|FG001|Overall Study|Investigator discretion|0|||
161110783|NCT03557281|581797396|FG002|Overall Study|Investigator discretion|1|||
161110784|NCT03557281|581797397|FG003|Overall Study|Investigator discretion|0|||
161110785|NCT03557281|581797398|FG004|Overall Study|Investigator discretion|0|||
161110786|NCT03557281|581797394|FG000|Overall Study|Withdrawal by Subject|0|||
161110787|NCT03557281|581797395|FG001|Overall Study|Withdrawal by Subject|1|||
161110788|NCT03557281|581797396|FG002|Overall Study|Withdrawal by Subject|1|||
161110789|NCT03557281|581797397|FG003|Overall Study|Withdrawal by Subject|1|||
161110790|NCT03557281|581797398|FG004|Overall Study|Withdrawal by Subject|2|||
161110791|NCT03557281|581797394|FG000|Overall Study|Randomized, but did not receive treatment|0|||
161110792|NCT03557281|581797395|FG001|Overall Study|Randomized, but did not receive treatment|0|||
161110793|NCT03557281|581797396|FG002|Overall Study|Randomized, but did not receive treatment|0|||
161110794|NCT03557281|581797397|FG003|Overall Study|Randomized, but did not receive treatment|0|||
161110795|NCT03557281|581797398|FG004|Overall Study|Randomized, but did not receive treatment|1|||
161110796|NCT01199042|581797399|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
161215332|NCT00910858|582171446|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
161215333|NCT00910858|582171444|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
161215334|NCT00910858|582171445|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
161215335|NCT00910858|582171446|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
161324366|NCT01408901|582573577|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
161324367|NCT01408901|582573578|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
160869319|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
160869320|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
161110797|NCT01199042|581797399|FG000|At Home (3 Months)|Lost to Follow-up|1|||
161110798|NCT03357731|581797404|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
161110799|NCT03357731|581797405|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
161110800|NCT03357731|581797406|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
161110801|NCT03357731|581797407|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
161110802|NCT03357731|581797408|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
161110803|NCT03357731|581797409|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
161110804|NCT03357731|581797404|FG000|Overall Study|Acute bradycardia and hypotension|0|||
161110805|NCT03357731|581797405|FG001|Overall Study|Acute bradycardia and hypotension|0|||
161110806|NCT03357731|581797406|FG002|Overall Study|Acute bradycardia and hypotension|0|||
161110807|NCT03357731|581797407|FG003|Overall Study|Acute bradycardia and hypotension|1|||
161110808|NCT03357731|581797408|FG004|Overall Study|Acute bradycardia and hypotension|0|||
161110809|NCT03357731|581797409|FG005|Overall Study|Acute bradycardia and hypotension|0|||
161110810|NCT03357731|581797404|FG000|Overall Study|Adverse Event|0|||
161110811|NCT03357731|581797405|FG001|Overall Study|Adverse Event|0|||
161110812|NCT03357731|581797406|FG002|Overall Study|Adverse Event|0|||
161110813|NCT03357731|581797407|FG003|Overall Study|Adverse Event|0|||
161110814|NCT03357731|581797408|FG004|Overall Study|Adverse Event|0|||
161110815|NCT03357731|581797409|FG005|Overall Study|Adverse Event|1|||
161110816|NCT03357731|581797404|FG000|Overall Study|Hypotension|0|||
161110817|NCT03357731|581797405|FG001|Overall Study|Hypotension|0|||
161110818|NCT03357731|581797406|FG002|Overall Study|Hypotension|1|||
161110819|NCT03357731|581797407|FG003|Overall Study|Hypotension|1|||
161110820|NCT03357731|581797408|FG004|Overall Study|Hypotension|0|||
161110821|NCT03357731|581797409|FG005|Overall Study|Hypotension|0|||
161110822|NCT03357731|581797404|FG000|Overall Study|Lost to Follow-up|0|||
161110823|NCT03357731|581797405|FG001|Overall Study|Lost to Follow-up|0|||
161110824|NCT03357731|581797406|FG002|Overall Study|Lost to Follow-up|0|||
161110825|NCT03357731|581797407|FG003|Overall Study|Lost to Follow-up|1|||
161110826|NCT03357731|581797408|FG004|Overall Study|Lost to Follow-up|0|||
161110827|NCT03357731|581797409|FG005|Overall Study|Lost to Follow-up|0|||
161110828|NCT01773109|581797410|FG000|Overall Study|Symptomatic Progression|2|||
161110829|NCT01773109|581797410|FG000|Overall Study|Death|1|||
161110830|NCT01239342|581797411|FG000|Overall Study|Adverse Event|1|||
161110831|NCT01239342|581797412|FG001|Overall Study|Adverse Event|0|||
161110832|NCT01239342|581797411|FG000|Overall Study|Withdrawal by Subject|1|||
161110833|NCT01239342|581797412|FG001|Overall Study|Withdrawal by Subject|5|||
161110834|NCT01239342|581797411|FG000|Overall Study|Reason Unknown|1|||
161110835|NCT01239342|581797412|FG001|Overall Study|Reason Unknown|1|||
161110836|NCT01849874|581797415|FG000|Overall Study|Death|89|||
161110837|NCT01849874|581797416|FG001|Overall Study|Death|42|||
161110838|NCT01849874|581797415|FG000|Overall Study|Withdrawal by Subject|17|||
161110839|NCT01849874|581797416|FG001|Overall Study|Withdrawal by Subject|16|||
161110840|NCT01849874|581797415|FG000|Overall Study|Lost to Follow-up|3|||
161110841|NCT01849874|581797416|FG001|Overall Study|Lost to Follow-up|2|||
161110842|NCT01849874|581797415|FG000|Overall Study|Study Termination By Sponsor|93|||
161110843|NCT01849874|581797416|FG001|Overall Study|Study Termination By Sponsor|48|||
160869321|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
161110844|NCT01849874|581797415|FG000|Overall Study|Completed as per protocol amendment 6|3|||
161110845|NCT01849874|581797416|FG001|Overall Study|Completed as per protocol amendment 6|0|||
161110846|NCT01849874|581797415|FG000|Overall Study|Physician Decision|7|||
161110847|NCT01849874|581797416|FG001|Overall Study|Physician Decision|1|||
161110848|NCT01849874|581797415|FG000|Overall Study|Other|16|||
161110849|NCT01849874|581797416|FG001|Overall Study|Other|4|||
161110850|NCT03719690|581797424|FG000|Overall Study|Withdrawal by Subject|5|||
161110851|NCT03719690|581797425|FG001|Overall Study|Withdrawal by Subject|10|||
161110852|NCT03719690|581797424|FG000|Overall Study|Death|40|||
161110853|NCT03719690|581797425|FG001|Overall Study|Death|149|||
161110854|NCT03719690|581797424|FG000|Overall Study|Miscellaneous|12|||
161110855|NCT03719690|581797425|FG001|Overall Study|Miscellaneous|56|||
160869322|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
160869323|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
160869324|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
160869325|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
160869326|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
160869327|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
160869328|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
160869329|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
160869330|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
160869331|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
160869332|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
160869333|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
160869334|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
161110856|NCT03719690|581797424|FG000|Overall Study|Lost to Follow-up|2|||
161110857|NCT03719690|581797425|FG001|Overall Study|Lost to Follow-up|18|||
161110858|NCT03719690|581797424|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
161110859|NCT03719690|581797425|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
161110860|NCT01471015|581797432|FG000|Overall Study|Death|0|||
161110861|NCT01471015|581797433|FG001|Overall Study|Death|1|||
161110862|NCT01471015|581797434|FG002|Overall Study|Death|1|||
161110863|NCT04206020|581797435|FG000|Overall Study|Adverse Event|1|||
161110864|NCT04206020|581797436|FG001|Overall Study|Adverse Event|4|||
161110865|NCT04206020|581797435|FG000|Overall Study|Protocol Violation|2|||
161110866|NCT04206020|581797436|FG001|Overall Study|Protocol Violation|0|||
161110867|NCT04206020|581797435|FG000|Overall Study|Withdrawal by Subject|2|||
161110868|NCT04206020|581797436|FG001|Overall Study|Withdrawal by Subject|0|||
161110869|NCT04206020|581797435|FG000|Overall Study|Lost to Follow-up|2|||
161110870|NCT04206020|581797436|FG001|Overall Study|Lost to Follow-up|0|||
161110871|NCT04206020|581797435|FG000|Overall Study|Pregnancy|0|||
161110872|NCT04206020|581797436|FG001|Overall Study|Pregnancy|1|||
161110873|NCT04206020|581797435|FG000|Overall Study|Unable to attend visits|1|||
161110874|NCT04206020|581797436|FG001|Overall Study|Unable to attend visits|2|||
161110875|NCT04962022|581797437|FG000|Period 1|Withdrawal by Subject|1|||
161110876|NCT04962022|581797438|FG001|Period 1|Withdrawal by Subject|0|||
161110877|NCT02055820|581797445|FG000|Phase I: Dose-Finding|Death|1|||
161110878|NCT02055820|581797446|FG001|Phase I: Dose-Finding|Death|0|||
161110879|NCT02055820|581797447|FG002|Phase I: Dose-Finding|Death|1|||
161110880|NCT02055820|581797448|FG003|Phase I: Dose-Finding|Death|2|||
161110881|NCT02055820|581797449|FG004|Phase I: Dose-Finding|Death|0|||
161110882|NCT02055820|581797450|FG005|Phase I: Dose-Finding|Death|1|||
161110883|NCT02055820|581797451|FG006|Phase I: Dose-Finding|Death|1|||
161110884|NCT02055820|581797452|FG007|Phase I: Dose-Finding|Death|0|||
161110885|NCT02055820|581797453|FG008|Phase I: Dose-Finding|Death|0|||
161110886|NCT02055820|581797454|FG009|Phase I: Dose-Finding|Death|0|||
161110887|NCT02055820|581797445|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110888|NCT02055820|581797446|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110889|NCT02055820|581797447|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110890|NCT02055820|581797448|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110891|NCT02055820|581797449|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110892|NCT02055820|581797450|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
161110893|NCT02055820|581797451|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110894|NCT02055820|581797452|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110895|NCT02055820|581797453|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110896|NCT02055820|581797454|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
161110897|NCT02055820|581797445|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110898|NCT02055820|581797446|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110899|NCT02055820|581797447|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110900|NCT02055820|581797448|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
161110901|NCT02055820|581797449|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110902|NCT02055820|581797450|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110903|NCT02055820|581797451|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
161110904|NCT02055820|581797452|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110905|NCT02055820|581797453|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110906|NCT02055820|581797454|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
161110907|NCT02055820|581797445|FG000|Phase II: Expansion|Death|0|||
161110908|NCT02055820|581797446|FG001|Phase II: Expansion|Death|0|||
161110909|NCT02055820|581797447|FG002|Phase II: Expansion|Death|0|||
161110910|NCT02055820|581797448|FG003|Phase II: Expansion|Death|0|||
161110911|NCT02055820|581797449|FG004|Phase II: Expansion|Death|33|||
161110912|NCT02055820|581797450|FG005|Phase II: Expansion|Death|0|||
161110913|NCT02055820|581797451|FG006|Phase II: Expansion|Death|0|||
161110914|NCT02055820|581797452|FG007|Phase II: Expansion|Death|0|||
161110915|NCT02055820|581797453|FG008|Phase II: Expansion|Death|0|||
161110916|NCT02055820|581797454|FG009|Phase II: Expansion|Death|0|||
161110917|NCT02055820|581797445|FG000|Phase II: Expansion|Lost to Follow-up|0|||
160869335|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
160869336|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
160869337|NCT02952820|580913737|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
160869338|NCT02952820|580913738|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
160869339|NCT02952820|580913739|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
160869340|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
160869341|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
160869342|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
161110918|NCT02055820|581797446|FG001|Phase II: Expansion|Lost to Follow-up|0|||
161110919|NCT02055820|581797447|FG002|Phase II: Expansion|Lost to Follow-up|0|||
161110920|NCT02055820|581797448|FG003|Phase II: Expansion|Lost to Follow-up|0|||
161110921|NCT02055820|581797449|FG004|Phase II: Expansion|Lost to Follow-up|4|||
161110922|NCT02055820|581797450|FG005|Phase II: Expansion|Lost to Follow-up|0|||
161110923|NCT02055820|581797451|FG006|Phase II: Expansion|Lost to Follow-up|0|||
161110924|NCT02055820|581797452|FG007|Phase II: Expansion|Lost to Follow-up|0|||
161110925|NCT02055820|581797453|FG008|Phase II: Expansion|Lost to Follow-up|0|||
161110926|NCT02055820|581797454|FG009|Phase II: Expansion|Lost to Follow-up|0|||
161110927|NCT02055820|581797445|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
161110928|NCT02055820|581797446|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
161110929|NCT02055820|581797447|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
161110930|NCT02055820|581797448|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
161110931|NCT02055820|581797449|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
161110932|NCT02055820|581797450|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
161110933|NCT02055820|581797451|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
161110934|NCT02055820|581797452|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
161110935|NCT02055820|581797453|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
161110936|NCT02055820|581797454|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
161110937|NCT03962101|581797455|FG000|Overall Study|Adverse Event|1|||
161110938|NCT03962101|581797455|FG000|Overall Study|Physician Decision|2|||
161110939|NCT03962101|581797455|FG000|Overall Study|Not related to medical events|1|||
161110940|NCT03548935|581797456|FG000|Overall Study|Withdrawal by Subject|26|||
161110941|NCT03548935|581797457|FG001|Overall Study|Withdrawal by Subject|17|||
161110942|NCT03548935|581797456|FG000|Overall Study|Lost to Follow-up|39|||
161110943|NCT03548935|581797457|FG001|Overall Study|Lost to Follow-up|28|||
161110944|NCT03548935|581797456|FG000|Overall Study|Death|1|||
161110945|NCT03548935|581797457|FG001|Overall Study|Death|1|||
161110946|NCT02919436|581797460|FG000|Overall Study|Did not undergo surgery|16|||
161110947|NCT02919436|581797461|FG001|Overall Study|Did not undergo surgery|20|||
161110948|NCT02919436|581797460|FG000|Overall Study|Enrolled before trial registration|44|||
161110949|NCT02919436|581797461|FG001|Overall Study|Enrolled before trial registration|33|||
161110950|NCT00804570|581797462|FG000|Overall Study|Adverse Event|14|||
161110951|NCT00804570|581797463|FG001|Overall Study|Adverse Event|7|||
161110952|NCT00804570|581797462|FG000|Overall Study|Lack of Efficacy|0|||
161110953|NCT00804570|581797463|FG001|Overall Study|Lack of Efficacy|1|||
161110954|NCT00804570|581797462|FG000|Overall Study|Lost to Follow-up|18|||
161110955|NCT00804570|581797463|FG001|Overall Study|Lost to Follow-up|21|||
161110956|NCT00804570|581797462|FG000|Overall Study|Entry criteria not met|5|||
161110957|NCT00804570|581797463|FG001|Overall Study|Entry criteria not met|5|||
161110958|NCT00804570|581797462|FG000|Overall Study|Protocol Violation|12|||
161110959|NCT00804570|581797463|FG001|Overall Study|Protocol Violation|16|||
161110960|NCT00804570|581797462|FG000|Overall Study|Physician Decision|1|||
161110961|NCT00804570|581797463|FG001|Overall Study|Physician Decision|2|||
161110962|NCT00804570|581797462|FG000|Overall Study|Sponsor decision|1|||
161110963|NCT00804570|581797463|FG001|Overall Study|Sponsor decision|4|||
161110964|NCT00804570|581797462|FG000|Overall Study|Withdrawal by Subject|21|||
161110965|NCT00804570|581797463|FG001|Overall Study|Withdrawal by Subject|38|||
161110966|NCT01056510|581797466|FG000|Overall Study|Dropout Before Start of Treatment|1|||
161110967|NCT01056510|581797467|FG001|Overall Study|Dropout Before Start of Treatment|1|||
161110968|NCT01056510|581797466|FG000|Overall Study|Withdrawal by Subject|4|||
161110969|NCT01056510|581797467|FG001|Overall Study|Withdrawal by Subject|2|||
161110970|NCT01056510|581797466|FG000|Overall Study|Death|29|||
161110971|NCT01056510|581797467|FG001|Overall Study|Death|34|||
161110972|NCT01056510|581797466|FG000|Overall Study|Noncompliance|1|||
161110973|NCT01056510|581797467|FG001|Overall Study|Noncompliance|3|||
161110974|NCT01056510|581797466|FG000|Overall Study|Physician Decision|4|||
161110975|NCT01056510|581797467|FG001|Overall Study|Physician Decision|5|||
161110976|NCT01056510|581797466|FG000|Overall Study|Lost to Follow-up|5|||
161110977|NCT01056510|581797467|FG001|Overall Study|Lost to Follow-up|6|||
161110978|NCT01056510|581797466|FG000|Overall Study|Other|10|||
161110979|NCT01056510|581797467|FG001|Overall Study|Other|12|||
161110980|NCT01056510|581797466|FG000|Overall Study|Missing|0|||
161110981|NCT01056510|581797467|FG001|Overall Study|Missing|1|||
161110982|NCT03451084|581797470|FG000|Overall Study|Withdrawal by Subject|2|||
161110983|NCT03451084|581797471|FG001|Overall Study|Withdrawal by Subject|1|||
161110984|NCT03451084|581797472|FG002|Overall Study|Withdrawal by Subject|2|||
161110985|NCT03451084|581797473|FG003|Overall Study|Withdrawal by Subject|1|||
161110986|NCT03451084|581797470|FG000|Overall Study|Disease recurrence|0|||
161215336|NCT00910858|582171444|FG000|Combined Treatment Phase|Protocol Violation|1|||
161215337|NCT00910858|582171445|FG001|Combined Treatment Phase|Protocol Violation|0|||
161215338|NCT00910858|582171446|FG002|Combined Treatment Phase|Protocol Violation|0|||
161215339|NCT00910858|582171444|FG000|Combined Treatment Phase|Other|0|||
161215340|NCT00910858|582171445|FG001|Combined Treatment Phase|Other|2|||
161215341|NCT00910858|582171446|FG002|Combined Treatment Phase|Other|1|||
161215342|NCT01907737|582171459|FG000|Overall Study|Withdrawal by Subject|1|||
161215343|NCT01165684|582171460|FG000|Overall Study|Adverse Event|1|||
161215344|NCT01165684|582171461|FG001|Overall Study|Adverse Event|1|||
161215345|NCT01165684|582171460|FG000|Overall Study|Lack of Efficacy|2|||
161215346|NCT01165684|582171461|FG001|Overall Study|Lack of Efficacy|1|||
161215347|NCT01165684|582171460|FG000|Overall Study|Protocol Violation|7|||
161215348|NCT01165684|582171461|FG001|Overall Study|Protocol Violation|15|||
161215349|NCT01165684|582171460|FG000|Overall Study|Withdrawal Criteria|2|||
161215350|NCT01165684|582171461|FG001|Overall Study|Withdrawal Criteria|13|||
161215351|NCT01165684|582171460|FG000|Overall Study|Unclassified|16|||
161215352|NCT01165684|582171461|FG001|Overall Study|Unclassified|22|||
161215353|NCT01886300|582171482|FG000|Overall Study|Trial terminated by sponsor|16|||
161215354|NCT00901628|582171483|FG000|Overall Study|disconnection of catheter|4|||
161215355|NCT00901628|582171484|FG001|Overall Study|disconnection of catheter|8|||
161215356|NCT00901628|582171483|FG000|Overall Study|disconnection of drain|0|||
161215357|NCT00901628|582171484|FG001|Overall Study|disconnection of drain|1|||
161215358|NCT00901628|582171483|FG000|Overall Study|peroneal nerve palsy|0|||
161215359|NCT00901628|582171484|FG001|Overall Study|peroneal nerve palsy|1|||
161215360|NCT00608205|582171485|FG000|Overall Study|Adverse Event|3|||
161215361|NCT00608205|582171486|FG001|Overall Study|Adverse Event|2|||
161215362|NCT00608205|582171485|FG000|Overall Study|Patient non-compliant|0|||
161215363|NCT00608205|582171486|FG001|Overall Study|Patient non-compliant|1|||
161215364|NCT02008721|582171489|FG000|Overall Study|Withdrawal by Subject|5|||
161215365|NCT02008721|582171490|FG001|Overall Study|Withdrawal by Subject|1|||
161215366|NCT02008721|582171489|FG000|Overall Study|Death|4|||
161215367|NCT02008721|582171490|FG001|Overall Study|Death|2|||
161215368|NCT02008721|582171489|FG000|Overall Study|Adverse Event|3|||
161215369|NCT02008721|582171490|FG001|Overall Study|Adverse Event|5|||
161215370|NCT02008721|582171489|FG000|Overall Study|Protocol Violation|3|||
161215371|NCT02008721|582171490|FG001|Overall Study|Protocol Violation|2|||
161215372|NCT01797120|582171493|FG000|Overall Study|Disesae progression|37|||
161215373|NCT01797120|582171494|FG001|Overall Study|Disesae progression|49|||
161215374|NCT01797120|582171493|FG000|Overall Study|Adverse Event|13|||
161215375|NCT01797120|582171494|FG001|Overall Study|Adverse Event|5|||
161215376|NCT01797120|582171493|FG000|Overall Study|Withdrawal by Subject|6|||
161215377|NCT01797120|582171494|FG001|Overall Study|Withdrawal by Subject|6|||
161215378|NCT01797120|582171493|FG000|Overall Study|Symptomatic progression|2|||
161215379|NCT01797120|582171494|FG001|Overall Study|Symptomatic progression|1|||
161215380|NCT01797120|582171493|FG000|Overall Study|Non-compliance|1|||
161215381|NCT01797120|582171494|FG001|Overall Study|Non-compliance|0|||
161215382|NCT01797120|582171493|FG000|Overall Study|Physician Decision|3|||
161215383|NCT01797120|582171494|FG001|Overall Study|Physician Decision|0|||
161215384|NCT01797120|582171493|FG000|Overall Study|still on treatment|2|||
161215385|NCT01797120|582171494|FG001|Overall Study|still on treatment|4|||
161215386|NCT01797120|582171493|FG000|Overall Study|never start protocol therapy|2|||
161215387|NCT01797120|582171494|FG001|Overall Study|never start protocol therapy|0|||
161215388|NCT01003886|582171495|FG000|Overall Study|Lack of Efficacy|5|||
161324368|NCT01408901|582573579|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
161324369|NCT01408901|582573580|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
161324370|NCT01408901|582573577|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
161324371|NCT01408901|582573578|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
161324372|NCT01408901|582573579|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
161324373|NCT01408901|582573580|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
161324374|NCT01408901|582573577|FG000|26-Week Follow-Up|Death|0|||
161324375|NCT01408901|582573578|FG001|26-Week Follow-Up|Death|1|||
161324376|NCT01408901|582573579|FG002|26-Week Follow-Up|Death|0|||
161324377|NCT01408901|582573580|FG003|26-Week Follow-Up|Death|0|||
161324378|NCT02497404|582573581|FG000|Overall Study|Adverse Event|1|||
161215389|NCT01003886|582171495|FG000|Overall Study|Lost to Follow-up|169|||
161215390|NCT01003886|582171495|FG000|Overall Study|Withdrawal by Subject|39|||
161215391|NCT01003886|582171495|FG000|Overall Study|Other|14|||
161215392|NCT01003886|582171495|FG000|Overall Study|Adverse Event|3|||
161215393|NCT00909727|582171513|FG000|Overall Study|Adverse Event|1|||
161215394|NCT00909727|582171514|FG001|Overall Study|Adverse Event|0|||
161215395|NCT00909727|582171513|FG000|Overall Study|Wrong Genotype|1|||
161215396|NCT00909727|582171514|FG001|Overall Study|Wrong Genotype|0|||
161215397|NCT00909727|582171513|FG000|Overall Study|Withdrawal of Consent|1|||
161324379|NCT02098395|582573584|FG000|Overall Study|Protocol Violation|2|||
161215398|NCT00909727|582171514|FG001|Overall Study|Withdrawal of Consent|0|||
161215399|NCT00909727|582171513|FG000|Overall Study|Prohibited Medication|1|||
161215400|NCT00909727|582171514|FG001|Overall Study|Prohibited Medication|0|||
161215401|NCT05751629|582171515|FG000|Overall Study|Withdrawal by Subject|6|||
161110987|NCT03451084|581797471|FG001|Overall Study|Disease recurrence|2|||
161110988|NCT03451084|581797472|FG002|Overall Study|Disease recurrence|0|||
161110989|NCT03451084|581797473|FG003|Overall Study|Disease recurrence|0|||
161110990|NCT03451084|581797470|FG000|Overall Study|Lack of Efficacy|0|||
161110991|NCT03451084|581797471|FG001|Overall Study|Lack of Efficacy|3|||
161110992|NCT03451084|581797472|FG002|Overall Study|Lack of Efficacy|0|||
161110993|NCT03451084|581797473|FG003|Overall Study|Lack of Efficacy|1|||
161110994|NCT03451084|581797470|FG000|Overall Study|Death|1|||
161110995|NCT03451084|581797471|FG001|Overall Study|Death|0|||
161110996|NCT03451084|581797472|FG002|Overall Study|Death|2|||
161110997|NCT03451084|581797473|FG003|Overall Study|Death|0|||
161110998|NCT03451084|581797470|FG000|Overall Study|Physician Decision|0|||
161110999|NCT03451084|581797471|FG001|Overall Study|Physician Decision|0|||
161111000|NCT03451084|581797472|FG002|Overall Study|Physician Decision|2|||
161111001|NCT03451084|581797473|FG003|Overall Study|Physician Decision|2|||
161111002|NCT03451084|581797470|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
161111003|NCT03451084|581797471|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
161111004|NCT03451084|581797472|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
161111005|NCT03451084|581797473|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
161111006|NCT02121262|581797476|FG000|Overall Study|Adverse Event|6|||
161111007|NCT02121262|581797477|FG001|Overall Study|Adverse Event|3|||
161111008|NCT02121262|581797476|FG000|Overall Study|Lack of Efficacy|3|||
161111009|NCT02121262|581797477|FG001|Overall Study|Lack of Efficacy|0|||
161111010|NCT02121262|581797476|FG000|Overall Study|Personal Reasons|19|||
161111011|NCT02121262|581797477|FG001|Overall Study|Personal Reasons|5|||
161111012|NCT02121262|581797476|FG000|Overall Study|Protocol Violation|1|||
161111013|NCT02121262|581797477|FG001|Overall Study|Protocol Violation|1|||
161111014|NCT02121262|581797476|FG000|Overall Study|Participant Dropped-out|0|||
161111015|NCT02121262|581797477|FG001|Overall Study|Participant Dropped-out|1|||
161111016|NCT02121262|581797476|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
161111017|NCT02121262|581797477|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
161111018|NCT02121262|581797476|FG000|Overall Study|Consent Withdrawn|1|||
161111019|NCT02121262|581797477|FG001|Overall Study|Consent Withdrawn|0|||
161111020|NCT02716987|581797478|FG000|Overall Study|Ligand synthesis failure|0|||
161111021|NCT02716987|581797479|FG001|Overall Study|Ligand synthesis failure|0|||
161111022|NCT02716987|581797480|FG002|Overall Study|Ligand synthesis failure|1|||
161111023|NCT02716987|581797481|FG003|Overall Study|Ligand synthesis failure|0|||
161111024|NCT02716987|581797482|FG004|Overall Study|Ligand synthesis failure|0|||
161111025|NCT02716987|581797483|FG005|Overall Study|Ligand synthesis failure|0|||
161111026|NCT02716987|581797478|FG000|Overall Study|Withdrawal by Subject|0|||
161111027|NCT02716987|581797479|FG001|Overall Study|Withdrawal by Subject|0|||
161111028|NCT02716987|581797480|FG002|Overall Study|Withdrawal by Subject|0|||
161111029|NCT02716987|581797481|FG003|Overall Study|Withdrawal by Subject|0|||
161111030|NCT02716987|581797482|FG004|Overall Study|Withdrawal by Subject|1|||
161111031|NCT02716987|581797483|FG005|Overall Study|Withdrawal by Subject|1|||
161111032|NCT01553188|581797484|FG000|Overall Study|Patient choice|1|||
161111033|NCT01553188|581797485|FG001|Overall Study|Patient choice|0|||
161111034|NCT01553188|581797486|FG002|Overall Study|Patient choice|0|||
161111035|NCT01553188|581797487|FG003|Overall Study|Patient choice|0|||
161111036|NCT01553188|581797484|FG000|Overall Study|Intercurrent illness and adverse event|0|||
161111037|NCT01553188|581797485|FG001|Overall Study|Intercurrent illness and adverse event|1|||
161111038|NCT01553188|581797486|FG002|Overall Study|Intercurrent illness and adverse event|2|||
161111039|NCT01553188|581797487|FG003|Overall Study|Intercurrent illness and adverse event|0|||
161215402|NCT05751629|582171515|FG000|Overall Study|Death|25|||
161215403|NCT05751629|582171515|FG000|Overall Study|Study Site Closed|9|||
161215404|NCT05751629|582171515|FG000|Overall Study|Physician Decision|1|||
161215405|NCT01909466|582171517|FG000|Overall Study|Lost to Follow-up|5|||
161215406|NCT01909466|582171518|FG001|Overall Study|Lost to Follow-up|7|||
161215407|NCT01909466|582171517|FG000|Overall Study|Adverse Event|3|||
161215408|NCT01909466|582171518|FG001|Overall Study|Adverse Event|4|||
161215409|NCT01909466|582171517|FG000|Overall Study|Met Withdrawal Criteria|0|||
161215410|NCT01909466|582171518|FG001|Overall Study|Met Withdrawal Criteria|3|||
161215411|NCT01909466|582171517|FG000|Overall Study|Physician Decision|2|||
161215412|NCT01909466|582171518|FG001|Overall Study|Physician Decision|0|||
161215413|NCT01909466|582171517|FG000|Overall Study|Withdrawal by Subject|11|||
161215414|NCT01909466|582171518|FG001|Overall Study|Withdrawal by Subject|9|||
161215415|NCT01909466|582171517|FG000|Overall Study|Lack of Efficacy|1|||
160869343|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
160869344|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
161215416|NCT01909466|582171518|FG001|Overall Study|Lack of Efficacy|0|||
161215417|NCT00672620|582171524|FG000|Overall Study|Adverse Event|7|||
161215418|NCT00672620|582171525|FG001|Overall Study|Adverse Event|7|||
161215419|NCT00672620|582171526|FG002|Overall Study|Adverse Event|12|||
161215420|NCT00672620|582171527|FG003|Overall Study|Adverse Event|17|||
161215421|NCT00672620|582171524|FG000|Overall Study|Lack of Efficacy|1|||
161215422|NCT00672620|582171525|FG001|Overall Study|Lack of Efficacy|2|||
161215423|NCT00672620|582171526|FG002|Overall Study|Lack of Efficacy|2|||
161215424|NCT00672620|582171527|FG003|Overall Study|Lack of Efficacy|0|||
161215425|NCT00672620|582171524|FG000|Overall Study|Noncompliance with Study Drug|3|||
161215426|NCT00672620|582171525|FG001|Overall Study|Noncompliance with Study Drug|4|||
161215427|NCT00672620|582171526|FG002|Overall Study|Noncompliance with Study Drug|0|||
161215428|NCT00672620|582171527|FG003|Overall Study|Noncompliance with Study Drug|2|||
161215429|NCT00672620|582171524|FG000|Overall Study|Protocol Deviations|5|||
161215430|NCT00672620|582171525|FG001|Overall Study|Protocol Deviations|7|||
161215431|NCT00672620|582171526|FG002|Overall Study|Protocol Deviations|2|||
161215432|NCT00672620|582171527|FG003|Overall Study|Protocol Deviations|5|||
161215433|NCT00672620|582171524|FG000|Overall Study|Withdrawal of Consent|6|||
160869345|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
160869346|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
161215434|NCT00672620|582171525|FG001|Overall Study|Withdrawal of Consent|12|||
161215435|NCT00672620|582171526|FG002|Overall Study|Withdrawal of Consent|5|||
161215436|NCT00672620|582171527|FG003|Overall Study|Withdrawal of Consent|6|||
161215437|NCT00672620|582171524|FG000|Overall Study|Lost to Follow-up|8|||
161215438|NCT00672620|582171525|FG001|Overall Study|Lost to Follow-up|19|||
161215439|NCT00672620|582171526|FG002|Overall Study|Lost to Follow-up|8|||
161215440|NCT00672620|582171527|FG003|Overall Study|Lost to Follow-up|11|||
161215441|NCT00672620|582171524|FG000|Overall Study|Reason not Specified|3|||
161215442|NCT00672620|582171525|FG001|Overall Study|Reason not Specified|3|||
161215443|NCT00672620|582171526|FG002|Overall Study|Reason not Specified|2|||
161215444|NCT00672620|582171527|FG003|Overall Study|Reason not Specified|1|||
161215445|NCT00772577|582171528|FG000|Overall Study|Adverse Event|6|||
161111040|NCT01617070|581797489|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
161111041|NCT04544475|581797490|FG000|Overall Study|Withdrawal by Subject|1|||
161111042|NCT04544475|581797491|FG001|Overall Study|Withdrawal by Subject|3|||
161111043|NCT03223428|581797492|FG000|Overall Study|No longer taking Xermelo|27|||
161111044|NCT03223428|581797492|FG000|Overall Study|Declined Consent|1|||
161111045|NCT03223428|581797492|FG000|Overall Study|Non-responders|56|||
161111046|NCT03223428|581797492|FG000|Overall Study|Withdrawal by Subject|14|||
161111047|NCT02230384|581797494|FG000|Phase 1|Lost to Follow-up|1|||
161111048|NCT02230384|581797495|FG001|Phase 1|Lost to Follow-up|0|||
161111049|NCT02230384|581797494|FG000|Phase 1|Physician Decision|0|||
161111050|NCT02230384|581797495|FG001|Phase 1|Physician Decision|1|||
161111051|NCT02230384|581797494|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
161111052|NCT02230384|581797495|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
161111053|NCT02230384|581797494|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
161111054|NCT02230384|581797495|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
161111055|NCT02230384|581797494|FG000|Phase 2 - Switch|Adverse Event|2|||
161111056|NCT02230384|581797495|FG001|Phase 2 - Switch|Adverse Event|0|||
161111057|NCT00808236|581797496|FG000|Overall Study|Was not resuscitated|50|||
161111058|NCT00808236|581797497|FG001|Overall Study|Was not resuscitated|56|||
161111059|NCT00808236|581797496|FG000|Overall Study|Pre-defined exclusion|13|||
161111060|NCT00808236|581797497|FG001|Overall Study|Pre-defined exclusion|3|||
161111061|NCT00808236|581797496|FG000|Overall Study|Lost to Follow-up|1|||
161111062|NCT00808236|581797497|FG001|Overall Study|Lost to Follow-up|1|||
161111063|NCT00808236|581797496|FG000|Overall Study|Physician Decision|0|||
161111064|NCT00808236|581797497|FG001|Overall Study|Physician Decision|1|||
161111065|NCT00808236|581797496|FG000|Overall Study|Death|18|||
161111066|NCT00808236|581797497|FG001|Overall Study|Death|30|||
161111067|NCT00961220|581797498|FG000|Overall Study|Adverse Event|3|||
161111068|NCT00961220|581797498|FG000|Overall Study|Lack of Efficacy|1|||
161111069|NCT00961220|581797498|FG000|Overall Study|No IV access for O6BG|1|||
161111070|NCT00961220|581797498|FG000|Overall Study|O6BG no longer supplied|1|||
161111071|NCT00961220|581797498|FG000|Overall Study|Complete Response prior to 12 courses|1|||
161111072|NCT05376215|581797499|FG000|Overall Study|Withdrawal by Subject|2|||
161111073|NCT05376215|581797500|FG001|Overall Study|Withdrawal by Subject|1|||
161111074|NCT05376215|581797499|FG000|Overall Study|Lost to Follow-up|0|||
161111075|NCT05376215|581797500|FG001|Overall Study|Lost to Follow-up|1|||
161111076|NCT01301950|581797501|FG000|Overall Study|Surgery was cancelled by patient|0|||
161111077|NCT01301950|581797502|FG001|Overall Study|Surgery was cancelled by patient|1|||
161111078|NCT00942175|581797503|FG000|Overall Study|Adverse Event|2|||
161111079|NCT00942175|581797504|FG001|Overall Study|Adverse Event|1|||
161111080|NCT00942175|581797505|FG002|Overall Study|Adverse Event|0|||
161111081|NCT00942175|581797506|FG003|Overall Study|Adverse Event|0|||
161111082|NCT00942175|581797503|FG000|Overall Study|Protocol Violation|0|||
161111083|NCT00942175|581797504|FG001|Overall Study|Protocol Violation|1|||
161111084|NCT00942175|581797505|FG002|Overall Study|Protocol Violation|2|||
161111085|NCT00942175|581797506|FG003|Overall Study|Protocol Violation|0|||
161111086|NCT00942175|581797503|FG000|Overall Study|Pregnancy|0|||
161111087|NCT00942175|581797504|FG001|Overall Study|Pregnancy|0|||
161111088|NCT00942175|581797505|FG002|Overall Study|Pregnancy|0|||
161111089|NCT00942175|581797506|FG003|Overall Study|Pregnancy|1|||
161111090|NCT00942175|581797503|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
161111091|NCT00942175|581797504|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
161111092|NCT00942175|581797505|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
161111093|NCT00942175|581797506|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
161111094|NCT00942175|581797503|FG000|Overall Study|Low Platelet Count|0|||
161111095|NCT00942175|581797504|FG001|Overall Study|Low Platelet Count|2|||
161111096|NCT00942175|581797505|FG002|Overall Study|Low Platelet Count|0|||
161111097|NCT00942175|581797506|FG003|Overall Study|Low Platelet Count|0|||
161111098|NCT01066585|581797507|FG000|Overall Study|Protocol Violation|1|||
161111099|NCT01066585|581797508|FG001|Overall Study|Protocol Violation|0|||
161111100|NCT01066585|581797507|FG000|Overall Study|Withdrawal by Subject|0|||
161111101|NCT01066585|581797508|FG001|Overall Study|Withdrawal by Subject|3|||
161111102|NCT04041284|581797510|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
161111103|NCT04041284|581797511|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
161111104|NCT04041284|581797510|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
161111105|NCT04041284|581797511|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
161111106|NCT04041284|581797510|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
161111107|NCT04041284|581797511|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
161111108|NCT04041284|581797510|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
161111109|NCT04041284|581797511|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
161111110|NCT04041284|581797510|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
161111111|NCT04041284|581797511|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
161111112|NCT04041284|581797510|FG000|DB Phase (12 Weeks)|Other than specified|1|||
161111113|NCT04041284|581797511|FG001|DB Phase (12 Weeks)|Other than specified|0|||
161111114|NCT04041284|581797510|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
161111115|NCT04041284|581797511|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
161111116|NCT04041284|581797510|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
161111117|NCT04041284|581797511|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
161111118|NCT04041284|581797510|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
161111119|NCT04041284|581797511|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
161111120|NCT04041284|581797510|FG000|OL Phase (12 Weeks)|Other than specified|6|||
161111121|NCT04041284|581797511|FG001|OL Phase (12 Weeks)|Other than specified|2|||
161111122|NCT00886600|581797512|FG000|Double-blind Monotherapy|Adverse Event|1|||
161111123|NCT00886600|581797513|FG001|Double-blind Monotherapy|Adverse Event|1|||
161111124|NCT00886600|581797514|FG002|Double-blind Monotherapy|Adverse Event|1|||
161111125|NCT00886600|581797515|FG003|Double-blind Monotherapy|Adverse Event|1|||
161111126|NCT00886600|581797512|FG000|Double-blind Monotherapy|Protocol Violation|0|||
161111127|NCT00886600|581797513|FG001|Double-blind Monotherapy|Protocol Violation|0|||
161111128|NCT00886600|581797514|FG002|Double-blind Monotherapy|Protocol Violation|0|||
161111129|NCT00886600|581797515|FG003|Double-blind Monotherapy|Protocol Violation|1|||
161111130|NCT00886600|581797512|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
161111131|NCT00886600|581797513|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
161111132|NCT00886600|581797514|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
161111133|NCT00886600|581797515|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
161111134|NCT00886600|581797512|FG000|Combination Therapy Period|Adverse Event|0|||
161111135|NCT00886600|581797513|FG001|Combination Therapy Period|Adverse Event|0|||
161111136|NCT00886600|581797514|FG002|Combination Therapy Period|Adverse Event|1|||
161111137|NCT00886600|581797515|FG003|Combination Therapy Period|Adverse Event|0|||
161111138|NCT00886600|581797512|FG000|Combination Therapy Period|Protocol Violation|0|||
161111139|NCT00886600|581797513|FG001|Combination Therapy Period|Protocol Violation|0|||
161111140|NCT00886600|581797514|FG002|Combination Therapy Period|Protocol Violation|1|||
161111141|NCT00886600|581797515|FG003|Combination Therapy Period|Protocol Violation|0|||
161111142|NCT02016820|581797517|FG000|Overall Study|Lost to Follow-up|2|||
161111143|NCT02016820|581797518|FG001|Overall Study|Lost to Follow-up|4|||
161111144|NCT00884273|581797519|FG000|Overall Study|Adverse Event|0|||
161111145|NCT00884273|581797520|FG001|Overall Study|Adverse Event|2|||
161111146|NCT00884273|581797519|FG000|Overall Study|Protocol Violation|1|||
161111147|NCT00884273|581797520|FG001|Overall Study|Protocol Violation|3|||
161111148|NCT00884273|581797519|FG000|Overall Study|Practical reasons|1|||
161111149|NCT00884273|581797520|FG001|Overall Study|Practical reasons|0|||
161111150|NCT00578136|581797521|FG000|Overall Study|Not given intervention|1|||
161111151|NCT00578136|581797522|FG001|Overall Study|Not given intervention|1|||
161111152|NCT01840579|581797525|FG000|Overall Study|Status not recorded|0|||
161111153|NCT01840579|581797526|FG001|Overall Study|Status not recorded|0|||
161111154|NCT01840579|581797527|FG002|Overall Study|Status not recorded|2|||
161111155|NCT01840579|581797528|FG003|Overall Study|Status not recorded|3|||
161111156|NCT01840579|581797529|FG004|Overall Study|Status not recorded|4|||
161111157|NCT01840579|581797530|FG005|Overall Study|Status not recorded|3|||
161111158|NCT01840579|581797531|FG006|Overall Study|Status not recorded|0|||
161111159|NCT01840579|581797532|FG007|Overall Study|Status not recorded|3|||
161111160|NCT01840579|581797533|FG008|Overall Study|Status not recorded|3|||
161111161|NCT01840579|581797534|FG009|Overall Study|Status not recorded|3|||
161111162|NCT01840579|581797525|FG000|Overall Study|Progressive disease|3|||
161111163|NCT01840579|581797526|FG001|Overall Study|Progressive disease|5|||
161111164|NCT01840579|581797527|FG002|Overall Study|Progressive disease|0|||
161111165|NCT01840579|581797528|FG003|Overall Study|Progressive disease|0|||
161111166|NCT01840579|581797529|FG004|Overall Study|Progressive disease|0|||
161111167|NCT01840579|581797530|FG005|Overall Study|Progressive disease|0|||
161111168|NCT01840579|581797531|FG006|Overall Study|Progressive disease|0|||
161111169|NCT01840579|581797532|FG007|Overall Study|Progressive disease|0|||
161111170|NCT01840579|581797533|FG008|Overall Study|Progressive disease|0|||
161111171|NCT01840579|581797534|FG009|Overall Study|Progressive disease|0|||
161215446|NCT00772577|582171529|FG001|Overall Study|Adverse Event|3|||
161111172|NCT01840579|581797525|FG000|Overall Study|Ongoing in study|0|||
161111173|NCT01840579|581797526|FG001|Overall Study|Ongoing in study|1|||
161111174|NCT01840579|581797527|FG002|Overall Study|Ongoing in study|0|||
161111175|NCT01840579|581797528|FG003|Overall Study|Ongoing in study|0|||
161111176|NCT01840579|581797529|FG004|Overall Study|Ongoing in study|0|||
161111177|NCT01840579|581797530|FG005|Overall Study|Ongoing in study|0|||
161111178|NCT01840579|581797531|FG006|Overall Study|Ongoing in study|0|||
161111179|NCT01840579|581797532|FG007|Overall Study|Ongoing in study|0|||
161111180|NCT01840579|581797533|FG008|Overall Study|Ongoing in study|0|||
161111181|NCT01840579|581797534|FG009|Overall Study|Ongoing in study|0|||
161111182|NCT01840579|581797525|FG000|Overall Study|Death|0|||
161111183|NCT01840579|581797526|FG001|Overall Study|Death|0|||
161111184|NCT01840579|581797527|FG002|Overall Study|Death|0|||
161111185|NCT01840579|581797528|FG003|Overall Study|Death|0|||
161111186|NCT01840579|581797529|FG004|Overall Study|Death|0|||
161111187|NCT01840579|581797530|FG005|Overall Study|Death|1|||
161111188|NCT01840579|581797531|FG006|Overall Study|Death|0|||
161111189|NCT01840579|581797532|FG007|Overall Study|Death|0|||
161215447|NCT00772577|582171528|FG000|Overall Study|Abnormal laboratory values|0|||
161215448|NCT00772577|582171529|FG001|Overall Study|Abnormal laboratory values|1|||
161215449|NCT00772577|582171528|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161215450|NCT00772577|582171529|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161215451|NCT00772577|582171528|FG000|Overall Study|Patient withdrew consent|8|||
161215452|NCT00772577|582171529|FG001|Overall Study|Patient withdrew consent|5|||
161215453|NCT00772577|582171528|FG000|Overall Study|Lost to Follow-up|4|||
161215454|NCT00772577|582171529|FG001|Overall Study|Lost to Follow-up|3|||
161215455|NCT00772577|582171528|FG000|Overall Study|Administrative problems|2|||
161215456|NCT00772577|582171529|FG001|Overall Study|Administrative problems|1|||
161215457|NCT00772577|582171528|FG000|Overall Study|Protocol Deviation|3|||
161215458|NCT00772577|582171529|FG001|Overall Study|Protocol Deviation|2|||
161215459|NCT02965820|582171530|FG000|Period 2, Second 30 Days|Adverse Event|1|||
161215460|NCT02965820|582171531|FG001|Period 2, Second 30 Days|Adverse Event|1|||
161215461|NCT01567306|582171532|FG000|Overall Study|Protocol Violation|2|||
161215462|NCT01567306|582171533|FG001|Overall Study|Protocol Violation|2|||
161215463|NCT01567306|582171534|FG002|Overall Study|Protocol Violation|0|||
160869347|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
160869348|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
160869349|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
160869350|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
160869351|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
160869352|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
160869353|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
160869354|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
160869355|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
160869356|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
160869357|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
160869358|NCT02952820|580913737|FG000|Active Treatment Period (6 Months)|Not treated|0|||
160869359|NCT02952820|580913738|FG001|Active Treatment Period (6 Months)|Not treated|0|||
160869360|NCT02952820|580913739|FG002|Active Treatment Period (6 Months)|Not treated|1|||
160869361|NCT03614156|580913740|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
160869362|NCT03614156|580913741|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
160869363|NCT03614156|580913742|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
160869364|NCT03614156|580913743|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
160869365|NCT03614156|580913740|FG000|Open-Label Treatment Period|Adverse Event|7|||
160869366|NCT03614156|580913741|FG001|Open-Label Treatment Period|Adverse Event|0|||
160869367|NCT03614156|580913742|FG002|Open-Label Treatment Period|Adverse Event|0|||
160869368|NCT03614156|580913743|FG003|Open-Label Treatment Period|Adverse Event|0|||
160869369|NCT03614156|580913740|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
160869370|NCT03614156|580913741|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161215464|NCT01567306|582171535|FG003|Overall Study|Protocol Violation|3|||
161215465|NCT01567306|582171536|FG004|Overall Study|Protocol Violation|1|||
161215466|NCT01567306|582171537|FG005|Overall Study|Protocol Violation|1|||
161215467|NCT01567306|582171532|FG000|Overall Study|Change site living|1|||
160869371|NCT03614156|580913742|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161215468|NCT01567306|582171533|FG001|Overall Study|Change site living|0|||
161215469|NCT01567306|582171534|FG002|Overall Study|Change site living|0|||
161215470|NCT01567306|582171535|FG003|Overall Study|Change site living|0|||
161215471|NCT01567306|582171536|FG004|Overall Study|Change site living|0|||
161111190|NCT01840579|581797533|FG008|Overall Study|Death|0|||
161111191|NCT01840579|581797534|FG009|Overall Study|Death|0|||
161111192|NCT01840579|581797525|FG000|Overall Study|Adverse Event|0|||
161111193|NCT01840579|581797526|FG001|Overall Study|Adverse Event|1|||
161111194|NCT01840579|581797527|FG002|Overall Study|Adverse Event|0|||
161111195|NCT01840579|581797528|FG003|Overall Study|Adverse Event|0|||
161111196|NCT01840579|581797529|FG004|Overall Study|Adverse Event|0|||
161111197|NCT01840579|581797530|FG005|Overall Study|Adverse Event|0|||
161111198|NCT01840579|581797531|FG006|Overall Study|Adverse Event|0|||
161111199|NCT01840579|581797532|FG007|Overall Study|Adverse Event|0|||
161111200|NCT01840579|581797533|FG008|Overall Study|Adverse Event|0|||
161111201|NCT01840579|581797534|FG009|Overall Study|Adverse Event|0|||
161111202|NCT01840579|581797525|FG000|Overall Study|Follow-up ended by Sponsor|0|||
161111203|NCT01840579|581797526|FG001|Overall Study|Follow-up ended by Sponsor|0|||
161111204|NCT01840579|581797527|FG002|Overall Study|Follow-up ended by Sponsor|0|||
161111205|NCT01840579|581797528|FG003|Overall Study|Follow-up ended by Sponsor|0|||
161111206|NCT01840579|581797529|FG004|Overall Study|Follow-up ended by Sponsor|0|||
161111207|NCT01840579|581797530|FG005|Overall Study|Follow-up ended by Sponsor|0|||
161111208|NCT01840579|581797531|FG006|Overall Study|Follow-up ended by Sponsor|2|||
161111209|NCT01840579|581797532|FG007|Overall Study|Follow-up ended by Sponsor|0|||
161111210|NCT01840579|581797533|FG008|Overall Study|Follow-up ended by Sponsor|0|||
161111211|NCT01840579|581797534|FG009|Overall Study|Follow-up ended by Sponsor|0|||
161111212|NCT02437864|581797537|FG000|Overall Study|Protocol Violation|4|||
161111213|NCT02437864|581797538|FG001|Overall Study|Protocol Violation|0|||
161111214|NCT00645593|581797541|FG000|Overall Study|Later found to be ineligible|1|||
161111215|NCT00645593|581797542|FG001|Overall Study|Later found to be ineligible|0|||
161111216|NCT01585272|581797543|FG000|Overall Study|Adverse Event|22|||
161111217|NCT01585272|581797543|FG000|Overall Study|Protocol Violation|7|||
161111218|NCT01585272|581797543|FG000|Overall Study|Withdrawal by Subject|10|||
161111219|NCT04218201|581799282|FG000|Overall Study|Death|0|||
161111220|NCT04218201|581799283|FG001|Overall Study|Death|0|||
161111221|NCT04218201|581799284|FG002|Overall Study|Death|2|||
161111222|NCT04218201|581799285|FG003|Overall Study|Death|0|||
161111223|NCT04218201|581799282|FG000|Overall Study|Unable to contact participant|4|||
161111224|NCT04218201|581799283|FG001|Overall Study|Unable to contact participant|0|||
161111225|NCT04218201|581799284|FG002|Overall Study|Unable to contact participant|3|||
161111226|NCT04218201|581799285|FG003|Overall Study|Unable to contact participant|0|||
161111227|NCT04218201|581799282|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
161111228|NCT04218201|581799283|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161111229|NCT04218201|581799284|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161111230|NCT04218201|581799285|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
161111231|NCT04218201|581799282|FG000|Overall Study|Withdrawal by Subject|2|||
161111232|NCT04218201|581799283|FG001|Overall Study|Withdrawal by Subject|0|||
161111233|NCT04218201|581799284|FG002|Overall Study|Withdrawal by Subject|0|||
161111234|NCT04218201|581799285|FG003|Overall Study|Withdrawal by Subject|0|||
161111235|NCT04218201|581799282|FG000|Overall Study|PCP plans to leave practice|0|||
161111236|NCT04218201|581799283|FG001|Overall Study|PCP plans to leave practice|8|||
161111237|NCT04218201|581799284|FG002|Overall Study|PCP plans to leave practice|0|||
161111238|NCT04218201|581799285|FG003|Overall Study|PCP plans to leave practice|5|||
161111239|NCT04218201|581799282|FG000|Overall Study|Reduced panel|0|||
161111240|NCT04218201|581799283|FG001|Overall Study|Reduced panel|0|||
161111241|NCT04218201|581799284|FG002|Overall Study|Reduced panel|0|||
161111242|NCT04218201|581799285|FG003|Overall Study|Reduced panel|1|||
161111243|NCT04218201|581799282|FG000|Overall Study|No longer interested in participating|0|||
161111244|NCT04218201|581799283|FG001|Overall Study|No longer interested in participating|1|||
161111245|NCT04218201|581799284|FG002|Overall Study|No longer interested in participating|0|||
161111246|NCT04218201|581799285|FG003|Overall Study|No longer interested in participating|0|||
161111247|NCT04036708|581799294|FG000|Overall Study|Lost to Follow-up|14|||
161111248|NCT04036708|581799295|FG001|Overall Study|Lost to Follow-up|4|||
161111249|NCT04036708|581799296|FG002|Overall Study|Lost to Follow-up|14|||
161111250|NCT04036708|581799297|FG003|Overall Study|Lost to Follow-up|4|||
161111251|NCT02918864|581799298|FG000|Overall Study|Withdrawal by Subject|1|||
161111252|NCT02918864|581799299|FG001|Overall Study|Withdrawal by Subject|1|||
161215472|NCT01567306|582171537|FG005|Overall Study|Change site living|0|||
161111253|NCT02918864|581799298|FG000|Overall Study|Lost to Follow-up|3|||
161111254|NCT02918864|581799299|FG001|Overall Study|Lost to Follow-up|2|||
161215473|NCT01567306|582171532|FG000|Overall Study|Adverse Event|0|||
161111255|NCT02104583|581799302|FG000|Overall Study|New ICD or CRT-D implanted|2|||
161111256|NCT02104583|581799303|FG001|Overall Study|New ICD or CRT-D implanted|0|||
161111257|NCT02104583|581799304|FG002|Overall Study|New ICD or CRT-D implanted|1|||
161111258|NCT02104583|581799305|FG003|Overall Study|New ICD or CRT-D implanted|0|||
161111259|NCT02104583|581799306|FG004|Overall Study|New ICD or CRT-D implanted|0|||
161111260|NCT02104583|581799302|FG000|Overall Study|Death|2|||
161111261|NCT02104583|581799303|FG001|Overall Study|Death|1|||
161111262|NCT02104583|581799304|FG002|Overall Study|Death|3|||
161111263|NCT02104583|581799305|FG003|Overall Study|Death|3|||
161215474|NCT01567306|582171533|FG001|Overall Study|Adverse Event|0|||
161215475|NCT01567306|582171534|FG002|Overall Study|Adverse Event|0|||
161215476|NCT01567306|582171535|FG003|Overall Study|Adverse Event|2|||
161215477|NCT01567306|582171536|FG004|Overall Study|Adverse Event|4|||
161215478|NCT01567306|582171537|FG005|Overall Study|Adverse Event|1|||
161215479|NCT01567306|582171532|FG000|Overall Study|Lost to Follow-up|0|||
161215480|NCT01567306|582171533|FG001|Overall Study|Lost to Follow-up|0|||
161215481|NCT01567306|582171534|FG002|Overall Study|Lost to Follow-up|0|||
161215482|NCT01567306|582171535|FG003|Overall Study|Lost to Follow-up|0|||
161215483|NCT01567306|582171536|FG004|Overall Study|Lost to Follow-up|2|||
161215484|NCT01567306|582171537|FG005|Overall Study|Lost to Follow-up|0|||
161215485|NCT01567306|582171532|FG000|Overall Study|Withdrawal by Subject|0|||
161215486|NCT01567306|582171533|FG001|Overall Study|Withdrawal by Subject|0|||
161215487|NCT01567306|582171534|FG002|Overall Study|Withdrawal by Subject|0|||
161215488|NCT01567306|582171535|FG003|Overall Study|Withdrawal by Subject|0|||
161215489|NCT01567306|582171536|FG004|Overall Study|Withdrawal by Subject|0|||
161215490|NCT01567306|582171537|FG005|Overall Study|Withdrawal by Subject|1|||
161215491|NCT04272775|582171545|FG000|Overall Study|Study Terminated by Sponsor|1|||
161215492|NCT04272775|582171546|FG001|Overall Study|Study Terminated by Sponsor|0|||
161215493|NCT04272775|582171545|FG000|Overall Study|Protocol Violation|0|||
161215494|NCT04272775|582171546|FG001|Overall Study|Protocol Violation|1|||
161215495|NCT04272775|582171545|FG000|Overall Study|Symptomatic Deterioration|1|||
161215496|NCT04272775|582171546|FG001|Overall Study|Symptomatic Deterioration|1|||
161215497|NCT04272775|582171545|FG000|Overall Study|Withdrawal by Subject|1|||
161215498|NCT04272775|582171546|FG001|Overall Study|Withdrawal by Subject|2|||
161215499|NCT04272775|582171545|FG000|Overall Study|Adverse Event|1|||
161215500|NCT04272775|582171546|FG001|Overall Study|Adverse Event|2|||
161215501|NCT04272775|582171545|FG000|Overall Study|Progressive Disease|3|||
161215502|NCT04272775|582171546|FG001|Overall Study|Progressive Disease|1|||
161215503|NCT02063698|582171553|FG000|Overall Study|did not complete booklet for days 2-8|1|||
161215504|NCT02063698|582171554|FG001|Overall Study|did not complete booklet for days 2-8|2|||
161215505|NCT02124746|582171557|FG000|Overall Study|Adverse Event|2|||
161215506|NCT02124746|582171558|FG001|Overall Study|Adverse Event|1|||
161215507|NCT02124746|582171559|FG002|Overall Study|Adverse Event|2|||
161215508|NCT02124746|582171557|FG000|Overall Study|Death|2|||
161215509|NCT02124746|582171558|FG001|Overall Study|Death|1|||
161215510|NCT02124746|582171559|FG002|Overall Study|Death|3|||
161215511|NCT02124746|582171557|FG000|Overall Study|Lack of Efficacy|3|||
161215512|NCT02124746|582171558|FG001|Overall Study|Lack of Efficacy|2|||
161215513|NCT02124746|582171559|FG002|Overall Study|Lack of Efficacy|2|||
161215514|NCT02124746|582171557|FG000|Overall Study|Physician Decision|6|||
161215515|NCT02124746|582171558|FG001|Overall Study|Physician Decision|4|||
161215516|NCT02124746|582171559|FG002|Overall Study|Physician Decision|5|||
161215517|NCT02124746|582171557|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161215518|NCT02124746|582171558|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161215519|NCT02124746|582171559|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161215520|NCT02124746|582171557|FG000|Overall Study|Withdrawal by Subject|3|||
161215521|NCT02124746|582171558|FG001|Overall Study|Withdrawal by Subject|3|||
161215522|NCT02124746|582171559|FG002|Overall Study|Withdrawal by Subject|0|||
161215523|NCT02124746|582171557|FG000|Overall Study|Study Terminated by Sponsor|0|||
161215524|NCT02124746|582171558|FG001|Overall Study|Study Terminated by Sponsor|0|||
161215525|NCT02124746|582171559|FG002|Overall Study|Study Terminated by Sponsor|6|||
161215526|NCT02124746|582171557|FG000|Overall Study|Disease Progression|3|||
161215527|NCT02124746|582171558|FG001|Overall Study|Disease Progression|6|||
161215528|NCT02124746|582171559|FG002|Overall Study|Disease Progression|4|||
161215529|NCT03124381|582171565|FG000|Overall Study|Lost to Follow-up|1|||
161215530|NCT03124381|582171566|FG001|Overall Study|Lost to Follow-up|1|||
161215531|NCT03124381|582171565|FG000|Overall Study|Withdrawal by Subject|6|||
161215532|NCT03124381|582171566|FG001|Overall Study|Withdrawal by Subject|3|||
161215533|NCT03124381|582171565|FG000|Overall Study|Protocol Violation|0|||
161215534|NCT03124381|582171566|FG001|Overall Study|Protocol Violation|1|||
161215535|NCT03124381|582171565|FG000|Overall Study|Adverse Event|1|||
161215536|NCT03124381|582171566|FG001|Overall Study|Adverse Event|1|||
161215537|NCT03124381|582171565|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
161215538|NCT03124381|582171566|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
161215539|NCT03210259|582171572|FG000|12-Week Run-in Period|Adverse Event|1|||
161215540|NCT03210259|582171573|FG001|12-Week Run-in Period|Adverse Event|0|||
161215541|NCT03210259|582171574|FG002|12-Week Run-in Period|Adverse Event|0|||
161215542|NCT03210259|582171572|FG000|12-Week Run-in Period|Death|1|||
161215543|NCT03210259|582171573|FG001|12-Week Run-in Period|Death|0|||
161215544|NCT03210259|582171574|FG002|12-Week Run-in Period|Death|0|||
161215545|NCT03210259|582171572|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
161215546|NCT03210259|582171573|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
161215547|NCT03210259|582171574|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
161215548|NCT03210259|582171572|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
161215549|NCT03210259|582171573|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
161215550|NCT03210259|582171574|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
161215551|NCT03210259|582171572|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
161215552|NCT03210259|582171573|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
161215553|NCT03210259|582171574|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
161215554|NCT03210259|582171572|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
161215555|NCT03210259|582171573|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
161215556|NCT03210259|582171574|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
161215557|NCT03210259|582171572|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
161215558|NCT03210259|582171573|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
161215559|NCT03210259|582171574|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
161215560|NCT03210259|582171572|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
161215561|NCT03210259|582171573|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
161215562|NCT03210259|582171574|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
161215563|NCT03210259|582171572|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
161215564|NCT03210259|582171573|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
161111264|NCT02104583|581799306|FG004|Overall Study|Death|5|||
161111265|NCT02104583|581799302|FG000|Overall Study|Subject required cardiac ablation|6|||
161111266|NCT02104583|581799303|FG001|Overall Study|Subject required cardiac ablation|4|||
161111267|NCT02104583|581799304|FG002|Overall Study|Subject required cardiac ablation|4|||
161111268|NCT02104583|581799305|FG003|Overall Study|Subject required cardiac ablation|5|||
161111269|NCT02104583|581799306|FG004|Overall Study|Subject required cardiac ablation|4|||
161111270|NCT02104583|581799302|FG000|Overall Study|Subject required prohibited medication|0|||
161111271|NCT02104583|581799303|FG001|Overall Study|Subject required prohibited medication|1|||
161111272|NCT02104583|581799304|FG002|Overall Study|Subject required prohibited medication|1|||
161111273|NCT02104583|581799305|FG003|Overall Study|Subject required prohibited medication|0|||
161111274|NCT02104583|581799306|FG004|Overall Study|Subject required prohibited medication|1|||
161111275|NCT02104583|581799302|FG000|Overall Study|Withdrew Consent|3|||
161111276|NCT02104583|581799303|FG001|Overall Study|Withdrew Consent|2|||
161111277|NCT02104583|581799304|FG002|Overall Study|Withdrew Consent|0|||
161111278|NCT02104583|581799305|FG003|Overall Study|Withdrew Consent|2|||
161111279|NCT02104583|581799306|FG004|Overall Study|Withdrew Consent|1|||
161111280|NCT02104583|581799302|FG000|Overall Study|Investigator's Discretion|1|||
161111281|NCT02104583|581799303|FG001|Overall Study|Investigator's Discretion|0|||
161111282|NCT02104583|581799304|FG002|Overall Study|Investigator's Discretion|0|||
161111283|NCT02104583|581799305|FG003|Overall Study|Investigator's Discretion|0|||
161111284|NCT02104583|581799306|FG004|Overall Study|Investigator's Discretion|0|||
161111285|NCT02104583|581799302|FG000|Overall Study|Protocol Violation|0|||
161111286|NCT02104583|581799303|FG001|Overall Study|Protocol Violation|0|||
161215565|NCT03210259|582171574|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
161215566|NCT03210259|582171572|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
161324380|NCT02098395|582573585|FG001|Overall Study|Protocol Violation|2|||
161111287|NCT02104583|581799304|FG002|Overall Study|Protocol Violation|1|||
161111288|NCT02104583|581799305|FG003|Overall Study|Protocol Violation|0|||
161215567|NCT03210259|582171573|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
160917923|NCT02673489|581094148|FG000|Treatment Period|Adverse Event|0|||
161215568|NCT03210259|582171574|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
161215569|NCT03210259|582171572|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
161215570|NCT03210259|582171573|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
161215571|NCT03210259|582171574|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
161215572|NCT02533999|582171575|FG000|Overall Study|Lost to Follow-up|3|||
161215573|NCT02533999|582171576|FG001|Overall Study|Lost to Follow-up|5|||
161215574|NCT02533999|582171575|FG000|Overall Study|Protocol Violation|3|||
161215575|NCT02533999|582171576|FG001|Overall Study|Protocol Violation|0|||
161215576|NCT02533999|582171575|FG000|Overall Study|Adverse Event|0|||
161215577|NCT02533999|582171576|FG001|Overall Study|Adverse Event|1|||
161215578|NCT02533999|582171575|FG000|Overall Study|Randomized but intervention not received|0|||
161215579|NCT02533999|582171576|FG001|Overall Study|Randomized but intervention not received|1|||
161215580|NCT05017493|582171577|FG000|Overall Study|Withdrawal by Subject|26|||
161215581|NCT05017493|582171578|FG001|Overall Study|Withdrawal by Subject|0|||
161215582|NCT05017493|582171577|FG000|Overall Study|Physician Decision|15|||
161215583|NCT05017493|582171578|FG001|Overall Study|Physician Decision|0|||
161215584|NCT05017493|582171577|FG000|Overall Study|Protocol Violation|81|||
161215585|NCT05017493|582171578|FG001|Overall Study|Protocol Violation|0|||
161215586|NCT03940586|582171582|FG000|Overall Study|Death|3|||
161215587|NCT03940586|582171583|FG001|Overall Study|Death|2|||
161215588|NCT03940586|582171584|FG002|Overall Study|Death|0|||
161215589|NCT03940586|582171582|FG000|Overall Study|Physician Decision|1|||
161215590|NCT03940586|582171583|FG001|Overall Study|Physician Decision|0|||
161215591|NCT03940586|582171584|FG002|Overall Study|Physician Decision|1|||
161215592|NCT03940586|582171582|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
161215593|NCT03940586|582171583|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
161215594|NCT03940586|582171584|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
161215595|NCT03940586|582171582|FG000|Overall Study|Not Treated|0|||
161215596|NCT03940586|582171583|FG001|Overall Study|Not Treated|2|||
161215597|NCT03940586|582171584|FG002|Overall Study|Not Treated|0|||
161215598|NCT02006147|582171585|FG000|Overall Study|Protocol Violation|1|||
161215599|NCT02006147|582171586|FG001|Overall Study|Protocol Violation|1|||
161215600|NCT02006147|582171587|FG002|Overall Study|Protocol Violation|0|||
161215601|NCT02006147|582171588|FG003|Overall Study|Protocol Violation|0|||
161215602|NCT02006147|582171585|FG000|Overall Study|Withdrawal by Subject|0|||
161215603|NCT02006147|582171586|FG001|Overall Study|Withdrawal by Subject|1|||
161215604|NCT02006147|582171587|FG002|Overall Study|Withdrawal by Subject|0|||
161215605|NCT02006147|582171588|FG003|Overall Study|Withdrawal by Subject|0|||
161215606|NCT02006147|582171585|FG000|Overall Study|Withdrawal by Sponsor|1|||
161215607|NCT02006147|582171586|FG001|Overall Study|Withdrawal by Sponsor|0|||
161215608|NCT02006147|582171587|FG002|Overall Study|Withdrawal by Sponsor|0|||
161215609|NCT02006147|582171588|FG003|Overall Study|Withdrawal by Sponsor|0|||
161215610|NCT00345683|582171589|FG000|Overall Study|Lost to Follow-up|19|||
161215611|NCT00345683|582171590|FG001|Overall Study|Lost to Follow-up|7|||
161215612|NCT00345683|582171589|FG000|Overall Study|Other|6|||
161215613|NCT00345683|582171590|FG001|Overall Study|Other|2|||
161215614|NCT03182686|582171591|FG000|Overall Study|Lost to Follow-up|2|||
161215615|NCT03182686|582171592|FG001|Overall Study|Lost to Follow-up|0|||
161215616|NCT03182686|582171591|FG000|Overall Study|Adverse Event|2|||
161215617|NCT03182686|582171592|FG001|Overall Study|Adverse Event|0|||
161215618|NCT03182686|582171591|FG000|Overall Study|Withdrawal by Subject|3|||
161215619|NCT03182686|582171592|FG001|Overall Study|Withdrawal by Subject|0|||
161215620|NCT01154127|582171593|FG000|Period 1 (21 Days)|Adverse Event|3|||
161215621|NCT01154127|582171594|FG001|Period 1 (21 Days)|Adverse Event|4|||
161215622|NCT01154127|582171593|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
161215623|NCT01154127|582171594|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
161215624|NCT01154127|582171593|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
161215625|NCT01154127|582171594|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
161215626|NCT01154127|582171593|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
161215627|NCT01154127|582171594|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
161215628|NCT01154127|582171593|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
161215629|NCT01154127|582171594|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
161215630|NCT01697449|582171595|FG000|Overall Study|Disease progression|47|||
161215631|NCT01697449|582171595|FG000|Overall Study|Adverse Event|7|||
161215632|NCT01697449|582171595|FG000|Overall Study|Lost to Follow-up|5|||
160917924|NCT02673489|581094149|FG001|Treatment Period|Adverse Event|1|||
161215633|NCT01697449|582171595|FG000|Overall Study|Withdrawal by Subject|2|||
161215634|NCT01697449|582171595|FG000|Overall Study|Physician Decision|1|||
161215635|NCT01697449|582171595|FG000|Overall Study|Death|2|||
161215636|NCT01697449|582171595|FG000|Overall Study|Other|1|||
161215637|NCT01697449|582171595|FG000|Overall Study|Missing|25|||
161215638|NCT05037409|582171596|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
161215639|NCT05037409|582171597|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
161215640|NCT05037409|582171598|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
161215641|NCT04147611|582171600|FG000|Overall Study|Physician Decision|0|||
161215642|NCT04147611|582171601|FG001|Overall Study|Physician Decision|1|||
161215643|NCT01585831|582171604|FG000|Overall Study|Physician Decision|0|||
161215644|NCT01585831|582171605|FG001|Overall Study|Physician Decision|1|||
161215645|NCT01585831|582171604|FG000|Overall Study|Withdrawal by Subject|2|||
161215646|NCT01585831|582171605|FG001|Overall Study|Withdrawal by Subject|1|||
161215647|NCT01123980|582171606|FG000|Overall Study|Adverse Event|1|||
161215648|NCT01123980|582171607|FG001|Overall Study|Adverse Event|1|||
161215649|NCT01123980|582171606|FG000|Overall Study|Lack of Efficacy|1|||
161215650|NCT01123980|582171607|FG001|Overall Study|Lack of Efficacy|0|||
161215651|NCT01123980|582171606|FG000|Overall Study|Physician Decision|0|||
161215652|NCT01123980|582171607|FG001|Overall Study|Physician Decision|1|||
161215653|NCT01123980|582171606|FG000|Overall Study|Lost to Follow-up|0|||
161215654|NCT01123980|582171607|FG001|Overall Study|Lost to Follow-up|6|||
161215655|NCT01123980|582171606|FG000|Overall Study|Protocol Violation|6|||
161215656|NCT01123980|582171607|FG001|Overall Study|Protocol Violation|6|||
161215657|NCT01123980|582171606|FG000|Overall Study|Withdrawal by Subject|5|||
161215658|NCT01123980|582171607|FG001|Overall Study|Withdrawal by Subject|3|||
161215659|NCT01123980|582171606|FG000|Overall Study|Unclassified|6|||
161215660|NCT01123980|582171607|FG001|Overall Study|Unclassified|7|||
161215661|NCT04385199|582171608|FG000|Overall Study|Withdrawal by Subject|1|||
161215662|NCT04385199|582171609|FG001|Overall Study|Withdrawal by Subject|0|||
161215663|NCT01225991|582171610|FG000|Overall Study|Withdrawal by Subject|6|||
161215664|NCT04444752|582171611|FG000|Overall Study|Adverse Event|1|||
161215665|NCT04444752|582171612|FG001|Overall Study|Adverse Event|0|||
161215666|NCT04444752|582171613|FG002|Overall Study|Adverse Event|0|||
161215667|NCT04444752|582171614|FG003|Overall Study|Adverse Event|2|||
161215668|NCT04444752|582171611|FG000|Overall Study|Lost to Follow-up|2|||
161215669|NCT04444752|582171612|FG001|Overall Study|Lost to Follow-up|6|||
161215670|NCT04444752|582171613|FG002|Overall Study|Lost to Follow-up|2|||
161215671|NCT04444752|582171614|FG003|Overall Study|Lost to Follow-up|5|||
161215672|NCT04444752|582171611|FG000|Overall Study|Physician Decision|0|||
161215673|NCT04444752|582171612|FG001|Overall Study|Physician Decision|0|||
161215674|NCT04444752|582171613|FG002|Overall Study|Physician Decision|0|||
161215675|NCT04444752|582171614|FG003|Overall Study|Physician Decision|2|||
161215676|NCT04444752|582171611|FG000|Overall Study|Pregnancy|0|||
161215677|NCT04444752|582171612|FG001|Overall Study|Pregnancy|0|||
161215678|NCT04444752|582171613|FG002|Overall Study|Pregnancy|0|||
161215679|NCT04444752|582171614|FG003|Overall Study|Pregnancy|1|||
161215680|NCT04444752|582171611|FG000|Overall Study|Withdrawal by Subject|6|||
161215681|NCT04444752|582171612|FG001|Overall Study|Withdrawal by Subject|5|||
161215682|NCT04444752|582171613|FG002|Overall Study|Withdrawal by Subject|3|||
161215683|NCT04444752|582171614|FG003|Overall Study|Withdrawal by Subject|4|||
161215684|NCT04444752|582171611|FG000|Overall Study|Protocol Violation|1|||
161215685|NCT04444752|582171612|FG001|Overall Study|Protocol Violation|1|||
161215686|NCT04444752|582171613|FG002|Overall Study|Protocol Violation|0|||
161215687|NCT04444752|582171614|FG003|Overall Study|Protocol Violation|0|||
161215688|NCT04444752|582171611|FG000|Overall Study|Patient moving out of town|1|||
161215689|NCT04444752|582171612|FG001|Overall Study|Patient moving out of town|0|||
161215690|NCT04444752|582171613|FG002|Overall Study|Patient moving out of town|0|||
161215691|NCT04444752|582171614|FG003|Overall Study|Patient moving out of town|1|||
161215692|NCT04444752|582171611|FG000|Overall Study|Lack of Efficacy|0|||
161215693|NCT04444752|582171612|FG001|Overall Study|Lack of Efficacy|0|||
161215694|NCT04444752|582171613|FG002|Overall Study|Lack of Efficacy|0|||
161215695|NCT04444752|582171614|FG003|Overall Study|Lack of Efficacy|1|||
161215696|NCT04444752|582171611|FG000|Overall Study|Death|0|||
161215697|NCT04444752|582171612|FG001|Overall Study|Death|0|||
161215698|NCT04444752|582171613|FG002|Overall Study|Death|1|||
161215699|NCT04444752|582171614|FG003|Overall Study|Death|0|||
161215700|NCT00579254|582171615|FG000|Overall Study|Lost to Follow-up|39|||
161215701|NCT00579254|582171615|FG000|Overall Study|Discontinued when study terminated|73|||
161215702|NCT02557672|582171616|FG000|Overall Study|Withdrawal by Subject|4|||
161215703|NCT02557672|582171617|FG001|Overall Study|Withdrawal by Subject|2|||
161215704|NCT03705169|582171618|FG000|Overall Study|Lost to Follow-up|0|||
161215705|NCT03705169|582171619|FG001|Overall Study|Lost to Follow-up|0|||
161215706|NCT03705169|582171620|FG002|Overall Study|Lost to Follow-up|0|||
161215707|NCT03705169|582171621|FG003|Overall Study|Lost to Follow-up|2|||
161215708|NCT03705169|582171622|FG004|Overall Study|Lost to Follow-up|0|||
161215709|NCT03705169|582171623|FG005|Overall Study|Lost to Follow-up|2|||
161215710|NCT03705169|582171624|FG006|Overall Study|Lost to Follow-up|1|||
161215711|NCT03705169|582171625|FG007|Overall Study|Lost to Follow-up|0|||
161215712|NCT03705169|582171626|FG008|Overall Study|Lost to Follow-up|0|||
160869372|NCT03614156|580913743|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
160869373|NCT03614156|580913740|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
160869374|NCT03614156|580913741|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
160869375|NCT03614156|580913742|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
160869376|NCT03614156|580913743|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
160869377|NCT03614156|580913740|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
160869378|NCT03614156|580913741|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
160869379|NCT03614156|580913742|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
160869380|NCT03614156|580913743|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
161215713|NCT03705169|582171627|FG009|Overall Study|Lost to Follow-up|1|||
161215714|NCT03705169|582171618|FG000|Overall Study|Adverse Event|0|||
161215715|NCT03705169|582171619|FG001|Overall Study|Adverse Event|0|||
161215716|NCT03705169|582171620|FG002|Overall Study|Adverse Event|0|||
161215717|NCT03705169|582171621|FG003|Overall Study|Adverse Event|1|||
161215718|NCT03705169|582171622|FG004|Overall Study|Adverse Event|0|||
161215719|NCT03705169|582171623|FG005|Overall Study|Adverse Event|0|||
161215720|NCT03705169|582171624|FG006|Overall Study|Adverse Event|0|||
161215721|NCT03705169|582171625|FG007|Overall Study|Adverse Event|0|||
161215722|NCT03705169|582171626|FG008|Overall Study|Adverse Event|0|||
161215723|NCT03705169|582171627|FG009|Overall Study|Adverse Event|0|||
161215724|NCT03705169|582171618|FG000|Overall Study|Site Closure|0|||
161215725|NCT03705169|582171619|FG001|Overall Study|Site Closure|0|||
161215726|NCT03705169|582171620|FG002|Overall Study|Site Closure|0|||
160869381|NCT03614156|580913740|FG000|Open-Label Treatment Period|Protocol Violation|2|||
161111289|NCT02104583|581799306|FG004|Overall Study|Protocol Violation|0|||
161111290|NCT02104583|581799302|FG000|Overall Study|Adverse Event|3|||
161111291|NCT02104583|581799303|FG001|Overall Study|Adverse Event|3|||
161111292|NCT02104583|581799304|FG002|Overall Study|Adverse Event|6|||
161111293|NCT02104583|581799305|FG003|Overall Study|Adverse Event|6|||
161111294|NCT02104583|581799306|FG004|Overall Study|Adverse Event|1|||
161111295|NCT02104583|581799302|FG000|Overall Study|Lost to Follow-up|1|||
161111296|NCT02104583|581799303|FG001|Overall Study|Lost to Follow-up|0|||
161111297|NCT02104583|581799304|FG002|Overall Study|Lost to Follow-up|0|||
161111298|NCT02104583|581799305|FG003|Overall Study|Lost to Follow-up|0|||
161111299|NCT02104583|581799306|FG004|Overall Study|Lost to Follow-up|0|||
161111300|NCT02104583|581799302|FG000|Overall Study|Randomized but Never Treated|0|||
161111301|NCT02104583|581799303|FG001|Overall Study|Randomized but Never Treated|0|||
161111302|NCT02104583|581799304|FG002|Overall Study|Randomized but Never Treated|0|||
161111303|NCT02104583|581799305|FG003|Overall Study|Randomized but Never Treated|1|||
161111304|NCT02104583|581799306|FG004|Overall Study|Randomized but Never Treated|0|||
161111305|NCT00129766|581799307|FG000|Overall Study|Death|3|||
161111306|NCT00129766|581799308|FG001|Overall Study|Death|8|||
161111307|NCT00129766|581799307|FG000|Overall Study|Withdrawal of consent|31|||
161111308|NCT00129766|581799308|FG001|Overall Study|Withdrawal of consent|30|||
161111309|NCT00129766|581799307|FG000|Overall Study|Lost to Follow-up|26|||
161111310|NCT00129766|581799308|FG001|Overall Study|Lost to Follow-up|21|||
161111311|NCT01230307|581799310|FG000|Overall Study|LVAD Placement|0|||
161111312|NCT01230307|581799311|FG001|Overall Study|LVAD Placement|2|||
161111313|NCT04773106|581799312|FG000|Overall Study|Withdrawal by Subject|3|||
161111314|NCT04773106|581799312|FG000|Overall Study|Death|1|||
161111315|NCT02819635|581799313|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
161111316|NCT02819635|581799314|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
161111317|NCT02819635|581799315|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
161111318|NCT02819635|581799316|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
161111319|NCT02819635|581799317|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
161111320|NCT02819635|581799318|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
161111321|NCT02819635|581799319|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
161111322|NCT02819635|581799320|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161111323|NCT02819635|581799321|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161111324|NCT02819635|581799322|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161111325|NCT02819635|581799323|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161215727|NCT03705169|582171621|FG003|Overall Study|Site Closure|1|||
161215728|NCT03705169|582171622|FG004|Overall Study|Site Closure|0|||
160869382|NCT03614156|580913741|FG001|Open-Label Treatment Period|Protocol Violation|0|||
161111326|NCT02819635|581799324|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
161111327|NCT02819635|581799313|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111328|NCT02819635|581799314|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111329|NCT02819635|581799315|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111330|NCT02819635|581799316|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111331|NCT02819635|581799317|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
161215729|NCT03705169|582171623|FG005|Overall Study|Site Closure|0|||
161215730|NCT03705169|582171624|FG006|Overall Study|Site Closure|0|||
161215731|NCT03705169|582171625|FG007|Overall Study|Site Closure|0|||
161215732|NCT03705169|582171626|FG008|Overall Study|Site Closure|0|||
161111332|NCT02819635|581799318|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
161215733|NCT03705169|582171627|FG009|Overall Study|Site Closure|0|||
161215734|NCT03705169|582171618|FG000|Overall Study|Did not receive study treatment|0|||
161215735|NCT03705169|582171619|FG001|Overall Study|Did not receive study treatment|0|||
161215736|NCT03705169|582171620|FG002|Overall Study|Did not receive study treatment|0|||
161215737|NCT03705169|582171621|FG003|Overall Study|Did not receive study treatment|1|||
161215738|NCT03705169|582171622|FG004|Overall Study|Did not receive study treatment|0|||
161215739|NCT03705169|582171623|FG005|Overall Study|Did not receive study treatment|0|||
161215740|NCT03705169|582171624|FG006|Overall Study|Did not receive study treatment|0|||
161215741|NCT03705169|582171625|FG007|Overall Study|Did not receive study treatment|0|||
161215742|NCT03705169|582171626|FG008|Overall Study|Did not receive study treatment|0|||
161215743|NCT03705169|582171627|FG009|Overall Study|Did not receive study treatment|0|||
161215744|NCT03705169|582171618|FG000|Overall Study|Concerns about study visit compliance|0|||
161215745|NCT03705169|582171619|FG001|Overall Study|Concerns about study visit compliance|0|||
161215746|NCT03705169|582171620|FG002|Overall Study|Concerns about study visit compliance|0|||
161215747|NCT03705169|582171621|FG003|Overall Study|Concerns about study visit compliance|1|||
161215748|NCT03705169|582171622|FG004|Overall Study|Concerns about study visit compliance|0|||
161215749|NCT03705169|582171623|FG005|Overall Study|Concerns about study visit compliance|0|||
161215750|NCT03705169|582171624|FG006|Overall Study|Concerns about study visit compliance|0|||
161215751|NCT03705169|582171625|FG007|Overall Study|Concerns about study visit compliance|0|||
161215752|NCT03705169|582171626|FG008|Overall Study|Concerns about study visit compliance|0|||
161215753|NCT03705169|582171627|FG009|Overall Study|Concerns about study visit compliance|0|||
161215754|NCT01133821|582173665|FG000|Overall Study|Lost to Follow-up|8|||
161215755|NCT01133821|582173666|FG001|Overall Study|Lost to Follow-up|11|||
161215756|NCT01133821|582173665|FG000|Overall Study|Withdrawal by Subject|8|||
161215757|NCT01133821|582173666|FG001|Overall Study|Withdrawal by Subject|3|||
161215758|NCT01133821|582173665|FG000|Overall Study|preferred other treatment|1|||
161215759|NCT01133821|582173666|FG001|Overall Study|preferred other treatment|1|||
161215760|NCT01133821|582173665|FG000|Overall Study|Protocol Violation|0|||
161215761|NCT01133821|582173666|FG001|Overall Study|Protocol Violation|1|||
161215762|NCT01133821|582173665|FG000|Overall Study|Refused participation|1|||
161215763|NCT01133821|582173666|FG001|Overall Study|Refused participation|3|||
161215764|NCT03342898|582173667|FG000|Overall Study|Adverse Event|3|||
161215765|NCT03342898|582173668|FG001|Overall Study|Adverse Event|1|||
161215766|NCT03342898|582173669|FG002|Overall Study|Adverse Event|0|||
161215767|NCT03342898|582173667|FG000|Overall Study|Lost to Follow-up|44|||
161215768|NCT03342898|582173668|FG001|Overall Study|Lost to Follow-up|40|||
161215769|NCT03342898|582173669|FG002|Overall Study|Lost to Follow-up|42|||
161215770|NCT03342898|582173667|FG000|Overall Study|Withdrawal of Consent|5|||
161215771|NCT03342898|582173668|FG001|Overall Study|Withdrawal of Consent|9|||
161215772|NCT03342898|582173669|FG002|Overall Study|Withdrawal of Consent|11|||
161215773|NCT03342898|582173667|FG000|Overall Study|Death|0|||
161215774|NCT03342898|582173668|FG001|Overall Study|Death|1|||
161215775|NCT03342898|582173669|FG002|Overall Study|Death|1|||
161215776|NCT03342898|582173667|FG000|Overall Study|Reason not Specified|2|||
161215777|NCT03342898|582173668|FG001|Overall Study|Reason not Specified|2|||
161215778|NCT03342898|582173669|FG002|Overall Study|Reason not Specified|0|||
161215779|NCT01387282|582173670|FG000|Overall Study|Death|47|||
161215780|NCT01387282|582173671|FG001|Overall Study|Death|16|||
161215781|NCT01387282|582173670|FG000|Overall Study|Other|5|||
161215782|NCT01387282|582173671|FG001|Overall Study|Other|1|||
161215783|NCT01387282|582173670|FG000|Overall Study|Unrelated AE|6|||
161215784|NCT01387282|582173671|FG001|Overall Study|Unrelated AE|4|||
161215785|NCT01387282|582173670|FG000|Overall Study|Withdrawal by patient|33|||
161215786|NCT01387282|582173671|FG001|Overall Study|Withdrawal by patient|23|||
161215787|NCT01387282|582173670|FG000|Overall Study|Study drug-related AE|2|||
161215788|NCT01387282|582173671|FG001|Overall Study|Study drug-related AE|2|||
161215789|NCT01387282|582173670|FG000|Overall Study|Lost to Follow-up|4|||
161215790|NCT01387282|582173671|FG001|Overall Study|Lost to Follow-up|1|||
161215791|NCT03997448|582173674|FG000|Study Treatment|Disease Progression|1|||
161215792|NCT03997448|582173674|FG000|Study Treatment|Symptomatic Deterioration|1|||
161215793|NCT03997448|582173674|FG000|Follow up|Death|2|||
161215794|NCT03997448|582173674|FG000|Follow up|study terminated|1|||
161215795|NCT01621490|582173675|FG000|Overall Study|Subject no longer meets study criteria|0|||
161215796|NCT01621490|582173676|FG001|Overall Study|Subject no longer meets study criteria|0|||
161215797|NCT01621490|582173677|FG002|Overall Study|Subject no longer meets study criteria|0|||
161215798|NCT01621490|582173678|FG003|Overall Study|Subject no longer meets study criteria|0|||
161215799|NCT01621490|582173679|FG004|Overall Study|Subject no longer meets study criteria|1|||
161215800|NCT01621490|582173680|FG005|Overall Study|Subject no longer meets study criteria|0|||
161215801|NCT01621490|582173681|FG006|Overall Study|Subject no longer meets study criteria|0|||
161215802|NCT01621490|582173682|FG007|Overall Study|Subject no longer meets study criteria|0|||
161215803|NCT01621490|582173683|FG008|Overall Study|Subject no longer meets study criteria|0|||
161215804|NCT01621490|582173684|FG009|Overall Study|Subject no longer meets study criteria|0|||
161215805|NCT01621490|582173685|FG010|Overall Study|Subject no longer meets study criteria|0|||
161215806|NCT01621490|582173675|FG000|Overall Study|Maximum clinical benefit|3|||
161215807|NCT01621490|582173676|FG001|Overall Study|Maximum clinical benefit|2|||
161215808|NCT01621490|582173677|FG002|Overall Study|Maximum clinical benefit|0|||
161215809|NCT01621490|582173678|FG003|Overall Study|Maximum clinical benefit|0|||
161215810|NCT01621490|582173679|FG004|Overall Study|Maximum clinical benefit|0|||
161215811|NCT01621490|582173680|FG005|Overall Study|Maximum clinical benefit|0|||
161215812|NCT01621490|582173681|FG006|Overall Study|Maximum clinical benefit|1|||
161215813|NCT01621490|582173682|FG007|Overall Study|Maximum clinical benefit|2|||
161215814|NCT01621490|582173683|FG008|Overall Study|Maximum clinical benefit|2|||
161215815|NCT01621490|582173684|FG009|Overall Study|Maximum clinical benefit|0|||
161215816|NCT01621490|582173685|FG010|Overall Study|Maximum clinical benefit|0|||
161215817|NCT01621490|582173675|FG000|Overall Study|Withdrawal by Subject|1|||
161215818|NCT01621490|582173676|FG001|Overall Study|Withdrawal by Subject|0|||
161215819|NCT01621490|582173677|FG002|Overall Study|Withdrawal by Subject|0|||
161215820|NCT01621490|582173678|FG003|Overall Study|Withdrawal by Subject|0|||
161215821|NCT01621490|582173679|FG004|Overall Study|Withdrawal by Subject|0|||
161215822|NCT01621490|582173680|FG005|Overall Study|Withdrawal by Subject|1|||
161215823|NCT01621490|582173681|FG006|Overall Study|Withdrawal by Subject|0|||
161215824|NCT01621490|582173682|FG007|Overall Study|Withdrawal by Subject|0|||
161215825|NCT01621490|582173683|FG008|Overall Study|Withdrawal by Subject|0|||
161215826|NCT01621490|582173684|FG009|Overall Study|Withdrawal by Subject|0|||
161215827|NCT01621490|582173685|FG010|Overall Study|Withdrawal by Subject|0|||
161215828|NCT01621490|582173675|FG000|Overall Study|Subject request to discontinue study|1|||
161215829|NCT01621490|582173676|FG001|Overall Study|Subject request to discontinue study|3|||
161215830|NCT01621490|582173677|FG002|Overall Study|Subject request to discontinue study|1|||
161215831|NCT01621490|582173678|FG003|Overall Study|Subject request to discontinue study|1|||
161215832|NCT01621490|582173679|FG004|Overall Study|Subject request to discontinue study|0|||
161215833|NCT01621490|582173680|FG005|Overall Study|Subject request to discontinue study|2|||
161215834|NCT01621490|582173681|FG006|Overall Study|Subject request to discontinue study|1|||
161215835|NCT01621490|582173682|FG007|Overall Study|Subject request to discontinue study|0|||
161215836|NCT01621490|582173683|FG008|Overall Study|Subject request to discontinue study|1|||
161215837|NCT01621490|582173684|FG009|Overall Study|Subject request to discontinue study|0|||
161215838|NCT01621490|582173685|FG010|Overall Study|Subject request to discontinue study|0|||
161215839|NCT01621490|582173675|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161215840|NCT01621490|582173676|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161215841|NCT01621490|582173677|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161215842|NCT01621490|582173678|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161215843|NCT01621490|582173679|FG004|Overall Study|Adverse event unrelated to study drug|0|||
161215844|NCT01621490|582173680|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161215845|NCT01621490|582173681|FG006|Overall Study|Adverse event unrelated to study drug|0|||
161215846|NCT01621490|582173682|FG007|Overall Study|Adverse event unrelated to study drug|2|||
161215847|NCT01621490|582173683|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161215848|NCT01621490|582173684|FG009|Overall Study|Adverse event unrelated to study drug|0|||
161215849|NCT01621490|582173685|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161111333|NCT02819635|581799319|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
161111334|NCT02819635|581799320|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111335|NCT02819635|581799321|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111336|NCT02819635|581799322|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111337|NCT02819635|581799323|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111338|NCT02819635|581799324|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
161111339|NCT02819635|581799313|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111340|NCT02819635|581799314|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111341|NCT02819635|581799315|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111342|NCT02819635|581799316|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111343|NCT02819635|581799317|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161215850|NCT01621490|582173675|FG000|Overall Study|Disease progression|27|||
161215851|NCT01621490|582173676|FG001|Overall Study|Disease progression|28|||
161215852|NCT01621490|582173677|FG002|Overall Study|Disease progression|1|||
161215853|NCT01621490|582173678|FG003|Overall Study|Disease progression|5|||
161215854|NCT01621490|582173679|FG004|Overall Study|Disease progression|3|||
161111344|NCT02819635|581799318|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
161111345|NCT02819635|581799319|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
161215855|NCT01621490|582173680|FG005|Overall Study|Disease progression|8|||
161215856|NCT01621490|582173681|FG006|Overall Study|Disease progression|7|||
161215857|NCT01621490|582173682|FG007|Overall Study|Disease progression|1|||
161215858|NCT01621490|582173683|FG008|Overall Study|Disease progression|4|||
161215859|NCT01621490|582173684|FG009|Overall Study|Disease progression|1|||
161215860|NCT01621490|582173685|FG010|Overall Study|Disease progression|1|||
161215861|NCT01621490|582173675|FG000|Overall Study|Study drug toxicity|1|||
161215862|NCT01621490|582173676|FG001|Overall Study|Study drug toxicity|4|||
161215863|NCT01621490|582173677|FG002|Overall Study|Study drug toxicity|5|||
161215864|NCT01621490|582173678|FG003|Overall Study|Study drug toxicity|3|||
161215865|NCT01621490|582173679|FG004|Overall Study|Study drug toxicity|1|||
161215866|NCT01621490|582173680|FG005|Overall Study|Study drug toxicity|10|||
161215867|NCT01621490|582173681|FG006|Overall Study|Study drug toxicity|1|||
161215868|NCT01621490|582173682|FG007|Overall Study|Study drug toxicity|4|||
161215869|NCT01621490|582173683|FG008|Overall Study|Study drug toxicity|1|||
161215870|NCT01621490|582173684|FG009|Overall Study|Study drug toxicity|0|||
161215871|NCT01621490|582173685|FG010|Overall Study|Study drug toxicity|0|||
161215872|NCT01621490|582173675|FG000|Overall Study|Death|0|||
161215873|NCT01621490|582173676|FG001|Overall Study|Death|0|||
161215874|NCT01621490|582173677|FG002|Overall Study|Death|0|||
161215875|NCT01621490|582173678|FG003|Overall Study|Death|0|||
161215876|NCT01621490|582173679|FG004|Overall Study|Death|0|||
161215877|NCT01621490|582173680|FG005|Overall Study|Death|0|||
161215878|NCT01621490|582173681|FG006|Overall Study|Death|0|||
161215879|NCT01621490|582173682|FG007|Overall Study|Death|0|||
161215880|NCT01621490|582173683|FG008|Overall Study|Death|1|||
161215881|NCT01621490|582173684|FG009|Overall Study|Death|0|||
161215882|NCT01621490|582173685|FG010|Overall Study|Death|0|||
161215883|NCT01621490|582173675|FG000|Overall Study|Other reasons|7|||
161215884|NCT01621490|582173676|FG001|Overall Study|Other reasons|6|||
161215885|NCT01621490|582173677|FG002|Overall Study|Other reasons|4|||
161215886|NCT01621490|582173678|FG003|Overall Study|Other reasons|1|||
161215887|NCT01621490|582173679|FG004|Overall Study|Other reasons|1|||
161215888|NCT01621490|582173680|FG005|Overall Study|Other reasons|3|||
161215889|NCT01621490|582173681|FG006|Overall Study|Other reasons|1|||
161215890|NCT01621490|582173682|FG007|Overall Study|Other reasons|1|||
161215891|NCT01621490|582173683|FG008|Overall Study|Other reasons|1|||
161215892|NCT01621490|582173684|FG009|Overall Study|Other reasons|0|||
161215893|NCT01621490|582173685|FG010|Overall Study|Other reasons|0|||
161215894|NCT00461500|582173686|FG000|Overall Study|Adverse Event|1|||
161215895|NCT00461500|582173687|FG001|Overall Study|Adverse Event|0|||
161215896|NCT00461500|582173686|FG000|Overall Study|Lack of Efficacy|0|||
161215897|NCT00461500|582173687|FG001|Overall Study|Lack of Efficacy|1|||
161215898|NCT00461500|582173686|FG000|Overall Study|Expired Drug Treatment|1|||
161215899|NCT00461500|582173687|FG001|Overall Study|Expired Drug Treatment|1|||
161215900|NCT00461500|582173686|FG000|Overall Study|Study Stopped|1|||
161215901|NCT00461500|582173687|FG001|Overall Study|Study Stopped|2|||
161215902|NCT00461500|582173686|FG000|Overall Study|Drug Treatment Misuse|1|||
161215903|NCT00461500|582173687|FG001|Overall Study|Drug Treatment Misuse|0|||
161215904|NCT00461500|582173686|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
161215905|NCT00461500|582173687|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
161215906|NCT00461500|582173686|FG000|Overall Study|Lost to Follow-up|2|||
161215907|NCT00461500|582173687|FG001|Overall Study|Lost to Follow-up|2|||
161215908|NCT01513551|582173688|FG000|Overall Study|Death|0|||
161215909|NCT01513551|582173689|FG001|Overall Study|Death|1|||
161215910|NCT01513551|582173690|FG002|Overall Study|Death|0|||
161215911|NCT01513551|582173688|FG000|Overall Study|Lost to Follow-up|3|||
161215912|NCT01513551|582173689|FG001|Overall Study|Lost to Follow-up|5|||
161215913|NCT01513551|582173690|FG002|Overall Study|Lost to Follow-up|2|||
161215914|NCT01513551|582173688|FG000|Overall Study|Withdrawal by Subject|1|||
161215915|NCT01513551|582173689|FG001|Overall Study|Withdrawal by Subject|0|||
161215916|NCT01513551|582173690|FG002|Overall Study|Withdrawal by Subject|2|||
161215917|NCT01513551|582173688|FG000|Overall Study|Randomized but not vaccinated|0|||
161215918|NCT01513551|582173689|FG001|Overall Study|Randomized but not vaccinated|0|||
161215919|NCT01513551|582173690|FG002|Overall Study|Randomized but not vaccinated|1|||
161215920|NCT01806597|582173691|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
161215921|NCT01806597|582173692|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
161215922|NCT01806597|582173693|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161215923|NCT01806597|582173694|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161215924|NCT01806597|582173695|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
161215925|NCT01806597|582173696|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
161215926|NCT01806597|582173691|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
161215927|NCT01806597|582173692|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161215928|NCT01806597|582173693|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161215929|NCT01806597|582173694|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161215930|NCT01806597|582173695|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
160869383|NCT03614156|580913742|FG002|Open-Label Treatment Period|Protocol Violation|0|||
161111346|NCT02819635|581799320|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111347|NCT02819635|581799321|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111348|NCT02819635|581799322|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111349|NCT02819635|581799323|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111350|NCT02819635|581799324|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
161111351|NCT02819635|581799313|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111352|NCT02819635|581799314|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111353|NCT02819635|581799315|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111354|NCT02819635|581799316|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111355|NCT02819635|581799317|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111356|NCT02819635|581799318|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111357|NCT02819635|581799319|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
161111358|NCT02819635|581799320|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111359|NCT02819635|581799321|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111360|NCT02819635|581799322|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111361|NCT02819635|581799323|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111362|NCT02819635|581799324|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
161111363|NCT02819635|581799313|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
161111364|NCT02819635|581799314|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
161111365|NCT02819635|581799315|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
161111366|NCT02819635|581799316|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
161111367|NCT02819635|581799317|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
161111368|NCT02819635|581799318|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
161111369|NCT02819635|581799319|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
161111370|NCT02819635|581799320|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161111371|NCT02819635|581799321|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161111372|NCT02819635|581799322|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161111373|NCT02819635|581799323|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161111374|NCT02819635|581799324|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
161111375|NCT02819635|581799313|FG000|Substudy 2, Part 2|Adverse Event|0|||
161111376|NCT02819635|581799314|FG001|Substudy 2, Part 2|Adverse Event|0|||
161111377|NCT02819635|581799315|FG002|Substudy 2, Part 2|Adverse Event|0|||
161111378|NCT02819635|581799316|FG003|Substudy 2, Part 2|Adverse Event|0|||
161111379|NCT02819635|581799317|FG004|Substudy 2, Part 2|Adverse Event|0|||
161111380|NCT02819635|581799318|FG005|Substudy 2, Part 2|Adverse Event|4|||
161111381|NCT02819635|581799319|FG006|Substudy 2, Part 2|Adverse Event|0|||
161111382|NCT02819635|581799320|FG007|Substudy 2, Part 2|Adverse Event|0|||
161111383|NCT02819635|581799321|FG008|Substudy 2, Part 2|Adverse Event|0|||
161111384|NCT02819635|581799322|FG009|Substudy 2, Part 2|Adverse Event|0|||
161111385|NCT02819635|581799323|FG010|Substudy 2, Part 2|Adverse Event|0|||
161111386|NCT02819635|581799324|FG011|Substudy 2, Part 2|Adverse Event|0|||
161111387|NCT02819635|581799313|FG000|Substudy 2, Part 2|Withdrew consent|0|||
161111388|NCT02819635|581799314|FG001|Substudy 2, Part 2|Withdrew consent|0|||
161111389|NCT02819635|581799315|FG002|Substudy 2, Part 2|Withdrew consent|0|||
161111390|NCT02819635|581799316|FG003|Substudy 2, Part 2|Withdrew consent|0|||
161111391|NCT02819635|581799317|FG004|Substudy 2, Part 2|Withdrew consent|0|||
161111392|NCT02819635|581799318|FG005|Substudy 2, Part 2|Withdrew consent|3|||
161111393|NCT02819635|581799319|FG006|Substudy 2, Part 2|Withdrew consent|1|||
161111394|NCT02819635|581799320|FG007|Substudy 2, Part 2|Withdrew consent|0|||
161111395|NCT02819635|581799321|FG008|Substudy 2, Part 2|Withdrew consent|0|||
161111396|NCT02819635|581799322|FG009|Substudy 2, Part 2|Withdrew consent|0|||
161111397|NCT02819635|581799323|FG010|Substudy 2, Part 2|Withdrew consent|0|||
161111398|NCT02819635|581799324|FG011|Substudy 2, Part 2|Withdrew consent|0|||
161111399|NCT02819635|581799313|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
161111400|NCT02819635|581799314|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
161111401|NCT02819635|581799315|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
161111402|NCT02819635|581799316|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
161111403|NCT02819635|581799317|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
161111404|NCT02819635|581799318|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
161111405|NCT02819635|581799319|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
161111406|NCT02819635|581799320|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
161111407|NCT02819635|581799321|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
161215931|NCT01806597|582173696|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
161215932|NCT01806597|582173691|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161324381|NCT02098395|582573586|FG002|Overall Study|Protocol Violation|0|||
161111408|NCT02819635|581799322|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
161111409|NCT02819635|581799323|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
161111410|NCT02819635|581799324|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
161111411|NCT02819635|581799313|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111412|NCT02819635|581799314|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111413|NCT02819635|581799315|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111414|NCT02819635|581799316|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111415|NCT02819635|581799317|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111416|NCT02819635|581799318|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111417|NCT02819635|581799319|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
161111418|NCT02819635|581799320|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111419|NCT02819635|581799321|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111420|NCT02819635|581799322|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111421|NCT02819635|581799323|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111422|NCT02819635|581799324|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
161111423|NCT02819635|581799313|FG000|Substudy 2, Part 2|Other, not specified|0|||
161111424|NCT02819635|581799314|FG001|Substudy 2, Part 2|Other, not specified|0|||
161111425|NCT02819635|581799315|FG002|Substudy 2, Part 2|Other, not specified|0|||
161111426|NCT02819635|581799316|FG003|Substudy 2, Part 2|Other, not specified|0|||
161111427|NCT02819635|581799317|FG004|Substudy 2, Part 2|Other, not specified|0|||
161111428|NCT02819635|581799318|FG005|Substudy 2, Part 2|Other, not specified|4|||
161111429|NCT02819635|581799319|FG006|Substudy 2, Part 2|Other, not specified|8|||
161111430|NCT02819635|581799320|FG007|Substudy 2, Part 2|Other, not specified|0|||
161111431|NCT02819635|581799321|FG008|Substudy 2, Part 2|Other, not specified|0|||
161111432|NCT02819635|581799322|FG009|Substudy 2, Part 2|Other, not specified|0|||
161111433|NCT02819635|581799323|FG010|Substudy 2, Part 2|Other, not specified|0|||
161111434|NCT02819635|581799324|FG011|Substudy 2, Part 2|Other, not specified|0|||
161111435|NCT02819635|581799313|FG000|Substudy 3|Adverse Event|0|||
161111436|NCT02819635|581799314|FG001|Substudy 3|Adverse Event|0|||
161111437|NCT02819635|581799315|FG002|Substudy 3|Adverse Event|0|||
161111438|NCT02819635|581799316|FG003|Substudy 3|Adverse Event|0|||
161111439|NCT02819635|581799317|FG004|Substudy 3|Adverse Event|0|||
161111440|NCT02819635|581799318|FG005|Substudy 3|Adverse Event|0|||
161111441|NCT02819635|581799319|FG006|Substudy 3|Adverse Event|0|||
161111442|NCT02819635|581799320|FG007|Substudy 3|Adverse Event|0|||
161111443|NCT02819635|581799321|FG008|Substudy 3|Adverse Event|32|||
161111444|NCT02819635|581799322|FG009|Substudy 3|Adverse Event|3|||
161111445|NCT02819635|581799323|FG010|Substudy 3|Adverse Event|12|||
161111446|NCT02819635|581799324|FG011|Substudy 3|Adverse Event|18|||
161111447|NCT02819635|581799313|FG000|Substudy 3|Withdrew consent|0|||
161111448|NCT02819635|581799314|FG001|Substudy 3|Withdrew consent|0|||
161111449|NCT02819635|581799315|FG002|Substudy 3|Withdrew consent|0|||
161111450|NCT02819635|581799316|FG003|Substudy 3|Withdrew consent|0|||
161111451|NCT02819635|581799317|FG004|Substudy 3|Withdrew consent|0|||
161111452|NCT02819635|581799318|FG005|Substudy 3|Withdrew consent|0|||
161111453|NCT02819635|581799319|FG006|Substudy 3|Withdrew consent|0|||
161111454|NCT02819635|581799320|FG007|Substudy 3|Withdrew consent|0|||
161111455|NCT02819635|581799321|FG008|Substudy 3|Withdrew consent|11|||
161111456|NCT02819635|581799322|FG009|Substudy 3|Withdrew consent|1|||
161111457|NCT02819635|581799323|FG010|Substudy 3|Withdrew consent|4|||
161111458|NCT02819635|581799324|FG011|Substudy 3|Withdrew consent|9|||
161111459|NCT02819635|581799313|FG000|Substudy 3|Lost to Follow-up|0|||
161111460|NCT02819635|581799314|FG001|Substudy 3|Lost to Follow-up|0|||
161111461|NCT02819635|581799315|FG002|Substudy 3|Lost to Follow-up|0|||
161111462|NCT02819635|581799316|FG003|Substudy 3|Lost to Follow-up|0|||
161111463|NCT02819635|581799317|FG004|Substudy 3|Lost to Follow-up|0|||
161111464|NCT02819635|581799318|FG005|Substudy 3|Lost to Follow-up|0|||
161111465|NCT02819635|581799319|FG006|Substudy 3|Lost to Follow-up|0|||
161111466|NCT02819635|581799320|FG007|Substudy 3|Lost to Follow-up|0|||
161111467|NCT02819635|581799321|FG008|Substudy 3|Lost to Follow-up|1|||
161111468|NCT02819635|581799322|FG009|Substudy 3|Lost to Follow-up|0|||
161111469|NCT02819635|581799323|FG010|Substudy 3|Lost to Follow-up|1|||
161111470|NCT02819635|581799324|FG011|Substudy 3|Lost to Follow-up|1|||
161111471|NCT02819635|581799313|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111472|NCT02819635|581799314|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
161324382|NCT02098395|582573587|FG003|Overall Study|Protocol Violation|7|||
161111473|NCT02819635|581799315|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111474|NCT02819635|581799316|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111475|NCT02819635|581799317|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111476|NCT02819635|581799318|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111477|NCT02819635|581799319|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111478|NCT02819635|581799320|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111479|NCT02819635|581799321|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111480|NCT02819635|581799322|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111481|NCT02819635|581799323|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
161111482|NCT02819635|581799324|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
161111483|NCT02819635|581799313|FG000|Substudy 3|Other, not specified|0|||
161111484|NCT02819635|581799314|FG001|Substudy 3|Other, not specified|0|||
161111485|NCT02819635|581799315|FG002|Substudy 3|Other, not specified|0|||
161111486|NCT02819635|581799316|FG003|Substudy 3|Other, not specified|0|||
161111487|NCT02819635|581799317|FG004|Substudy 3|Other, not specified|0|||
161111488|NCT02819635|581799318|FG005|Substudy 3|Other, not specified|0|||
161111489|NCT02819635|581799319|FG006|Substudy 3|Other, not specified|0|||
161111490|NCT02819635|581799320|FG007|Substudy 3|Other, not specified|0|||
161111491|NCT02819635|581799321|FG008|Substudy 3|Other, not specified|202|||
161111492|NCT02819635|581799322|FG009|Substudy 3|Other, not specified|5|||
161111493|NCT02819635|581799323|FG010|Substudy 3|Other, not specified|89|||
161111494|NCT02819635|581799324|FG011|Substudy 3|Other, not specified|39|||
161111495|NCT01349465|581799326|FG000|Overall Study|Adverse Event|1|||
161111496|NCT01349465|581799327|FG001|Overall Study|Adverse Event|0|||
161111497|NCT01349465|581799326|FG000|Overall Study|Death|3|||
161111498|NCT01349465|581799327|FG001|Overall Study|Death|0|||
161111499|NCT01349465|581799326|FG000|Overall Study|Lost to Follow-up|10|||
161111500|NCT01349465|581799327|FG001|Overall Study|Lost to Follow-up|1|||
161111501|NCT01349465|581799326|FG000|Overall Study|Withdrawal by Subject|4|||
161111502|NCT01349465|581799327|FG001|Overall Study|Withdrawal by Subject|2|||
161111503|NCT01349465|581799326|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
161111504|NCT01349465|581799327|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
161111505|NCT04329702|581799330|FG000|Overall Study|illness|3|||
161111506|NCT04329702|581799331|FG001|Overall Study|illness|4|||
161111507|NCT04329702|581799332|FG002|Overall Study|illness|0|||
161111508|NCT04329702|581799330|FG000|Overall Study|Lost to Follow-up|0|||
161111509|NCT04329702|581799331|FG001|Overall Study|Lost to Follow-up|0|||
161111510|NCT04329702|581799332|FG002|Overall Study|Lost to Follow-up|2|||
161111511|NCT04329702|581799330|FG000|Overall Study|Death|0|||
161111512|NCT04329702|581799331|FG001|Overall Study|Death|2|||
161111513|NCT04329702|581799332|FG002|Overall Study|Death|0|||
161111514|NCT01476475|581799333|FG000|Overall Study|Adverse Event|6|||
161111515|NCT01476475|581799334|FG001|Overall Study|Adverse Event|0|||
161111516|NCT01476475|581799333|FG000|Overall Study|Poor compliance to protocol|1|||
161111517|NCT01476475|581799334|FG001|Overall Study|Poor compliance to protocol|1|||
161111518|NCT01476475|581799333|FG000|Overall Study|Other reasons|4|||
161111519|NCT01476475|581799334|FG001|Overall Study|Other reasons|2|||
161111520|NCT00751400|581799335|FG000|Overall Study|Lost to Follow-up|10|||
161111521|NCT01918007|581799339|FG000|Overall Study|Baseline oximetry not acceptable|11|||
161111522|NCT01918007|581799340|FG001|Overall Study|Baseline oximetry not acceptable|7|||
161111523|NCT01918007|581799339|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
161111524|NCT01918007|581799340|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
161111525|NCT01918007|581799339|FG000|Overall Study|Lost to Follow-up|4|||
161111526|NCT01918007|581799340|FG001|Overall Study|Lost to Follow-up|7|||
161111527|NCT01146873|581799348|FG000|Overall Study|Transfer out|0|||
161111528|NCT01146873|581799349|FG001|Overall Study|Transfer out|6|||
161111529|NCT03200366|581799352|FG000|Patient Navigation Intervention Given|Death|0|||
161111530|NCT03200366|581799353|FG001|Patient Navigation Intervention Given|Death|2|||
161111531|NCT03200366|581799354|FG002|Patient Navigation Intervention Given|Death|0|||
161111532|NCT03200366|581799352|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
161111533|NCT03200366|581799353|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
161111534|NCT03200366|581799354|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
161111535|NCT03200366|581799352|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
161111536|NCT03200366|581799353|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
161111537|NCT03200366|581799354|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
161111538|NCT03200366|581799352|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
161111539|NCT03200366|581799353|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
161111540|NCT03200366|581799354|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
161111541|NCT03200366|581799352|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
161111542|NCT03200366|581799353|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
161111543|NCT03200366|581799354|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
161111544|NCT03200366|581799352|FG000|6 Month Post-Baseline Interview|Death|1|||
161111545|NCT03200366|581799353|FG001|6 Month Post-Baseline Interview|Death|1|||
161111546|NCT03200366|581799354|FG002|6 Month Post-Baseline Interview|Death|1|||
161111547|NCT03200366|581799352|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
161111548|NCT03200366|581799353|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
161111549|NCT03200366|581799354|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
161111550|NCT03200366|581799352|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
161111551|NCT03200366|581799353|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
161111552|NCT03200366|581799354|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
161111553|NCT03200366|581799352|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
161111554|NCT03200366|581799353|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
161111555|NCT03200366|581799354|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
161111556|NCT03200366|581799352|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
161111557|NCT03200366|581799353|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
161215933|NCT01806597|582173692|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
161215934|NCT01806597|582173693|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161215935|NCT01806597|582173694|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161215936|NCT01806597|582173695|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161215937|NCT01806597|582173696|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
161215938|NCT01806597|582173691|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
161215939|NCT01806597|582173692|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
161215940|NCT01806597|582173693|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161215941|NCT01806597|582173694|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161215942|NCT01806597|582173695|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
161215943|NCT01806597|582173696|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
161215944|NCT01806597|582173691|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161215945|NCT01806597|582173692|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
161215946|NCT01806597|582173693|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161215947|NCT01806597|582173694|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161215948|NCT01806597|582173695|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161215949|NCT01806597|582173696|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
161215950|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
161215951|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
161215952|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
161215953|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
161215954|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
161215955|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
161215956|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
161215957|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
161215958|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
161215959|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
161215960|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
161215961|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
161215962|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
161215963|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161215964|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161215965|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161215966|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161215967|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
161215968|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
161215969|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
161215970|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161215971|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161215972|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161215973|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
161215974|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
161215975|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161215976|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161215977|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161215978|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161215979|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
161215980|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161215981|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
161215982|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161215983|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
161215984|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161215985|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
161215986|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
161215987|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
161215988|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
161215989|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
161215990|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
161215991|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
161215992|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
161215993|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
161215994|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
161215995|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
161215996|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
161215997|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
161111558|NCT03200366|581799354|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
161111559|NCT03200366|581799352|FG000|9 Month Post-Baseline Interview|Death|1|||
161111560|NCT03200366|581799353|FG001|9 Month Post-Baseline Interview|Death|1|||
161111561|NCT03200366|581799354|FG002|9 Month Post-Baseline Interview|Death|1|||
161111562|NCT03200366|581799352|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
161111563|NCT03200366|581799353|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
161111564|NCT03200366|581799354|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
161111565|NCT03200366|581799352|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
161111566|NCT03200366|581799353|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
161111567|NCT03200366|581799354|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
161111568|NCT03200366|581799352|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
161111569|NCT03200366|581799353|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
161111570|NCT03200366|581799354|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
161111571|NCT00405067|581799355|FG000|Overall Study|Adverse Event|4|||
161111572|NCT00405067|581799356|FG001|Overall Study|Adverse Event|9|||
161111573|NCT00405067|581799357|FG002|Overall Study|Adverse Event|4|||
161111574|NCT00405067|581799355|FG000|Overall Study|Lost to Follow-up|0|||
161111575|NCT00405067|581799356|FG001|Overall Study|Lost to Follow-up|0|||
161111576|NCT00405067|581799357|FG002|Overall Study|Lost to Follow-up|1|||
161111577|NCT00552175|581799358|FG000|Overall Study|Lack of Efficacy|2|||
161111578|NCT00552175|581799359|FG001|Overall Study|Lack of Efficacy|0|||
161111579|NCT00552175|581799360|FG002|Overall Study|Lack of Efficacy|1|||
161111580|NCT00552175|581799358|FG000|Overall Study|Adverse Event|9|||
161111581|NCT00552175|581799359|FG001|Overall Study|Adverse Event|9|||
161111582|NCT00552175|581799360|FG002|Overall Study|Adverse Event|10|||
161111583|NCT00552175|581799358|FG000|Overall Study|Withdrawal by Subject|2|||
161111584|NCT00552175|581799359|FG001|Overall Study|Withdrawal by Subject|2|||
161111585|NCT00552175|581799360|FG002|Overall Study|Withdrawal by Subject|1|||
161111586|NCT00552175|581799358|FG000|Overall Study|Lost to Follow-up|0|||
161111587|NCT00552175|581799359|FG001|Overall Study|Lost to Follow-up|0|||
161111588|NCT00552175|581799360|FG002|Overall Study|Lost to Follow-up|1|||
161111589|NCT00552175|581799358|FG000|Overall Study|Entry Criteria Not Met|1|||
161111590|NCT00552175|581799359|FG001|Overall Study|Entry Criteria Not Met|1|||
161111591|NCT00552175|581799360|FG002|Overall Study|Entry Criteria Not Met|0|||
161111592|NCT00552175|581799358|FG000|Overall Study|Reason Not Specified|3|||
161111593|NCT00552175|581799359|FG001|Overall Study|Reason Not Specified|1|||
161111594|NCT00552175|581799360|FG002|Overall Study|Reason Not Specified|1|||
161111595|NCT00631020|581799361|FG000|Overall Study|Lost to Follow-up|7|||
161111596|NCT00631020|581799361|FG000|Overall Study|Incarcerated|1|||
161111597|NCT01399788|581799368|FG000|First Intervention Period|Adverse Event|1|||
161111598|NCT01399788|581799369|FG001|First Intervention Period|Adverse Event|0|||
161111599|NCT02409290|581799370|FG000|Overall Study|Protocol Violation|3|||
161111600|NCT02409290|581799371|FG001|Overall Study|Protocol Violation|6|||
161111601|NCT02409290|581799372|FG002|Overall Study|Protocol Violation|9|||
161111602|NCT02409290|581799373|FG003|Overall Study|Protocol Violation|4|||
161111603|NCT02409290|581799370|FG000|Overall Study|No positive culture/no baseline sample|3|||
161111604|NCT02409290|581799371|FG001|Overall Study|No positive culture/no baseline sample|9|||
161215998|NCT01806597|582173691|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
161215999|NCT01806597|582173692|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161216000|NCT01806597|582173693|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161216001|NCT01806597|582173694|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161216002|NCT01806597|582173695|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161216003|NCT01806597|582173696|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
161216004|NCT01806597|582173691|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161216005|NCT01806597|582173692|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161216006|NCT01806597|582173693|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161216007|NCT01806597|582173694|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161216008|NCT01806597|582173695|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
161216009|NCT01806597|582173696|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
161216010|NCT01806597|582173691|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161216011|NCT01806597|582173692|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161216012|NCT01806597|582173693|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161216013|NCT01806597|582173694|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161216014|NCT01806597|582173695|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
161216015|NCT01806597|582173696|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
161216016|NCT01806597|582173691|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161216017|NCT01806597|582173692|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161216018|NCT01806597|582173693|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161216019|NCT01806597|582173694|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161216020|NCT01806597|582173695|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
161216021|NCT01806597|582173696|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
161216022|NCT01806597|582173691|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161216023|NCT01806597|582173692|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161216024|NCT01806597|582173693|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161216025|NCT01806597|582173694|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161216026|NCT01806597|582173695|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
161216027|NCT01806597|582173696|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
161216028|NCT01806597|582173691|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161216029|NCT01806597|582173692|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161216030|NCT01806597|582173693|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161216031|NCT01806597|582173694|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161216032|NCT01806597|582173695|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
161216033|NCT01806597|582173696|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
161216034|NCT01144663|582173699|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
161216035|NCT01144663|582173700|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
161216036|NCT01144663|582173701|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
161216037|NCT01144663|582173702|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
161216038|NCT01144663|582173699|FG000|Primary Vaccination Phase|Adverse Event|1|||
161216039|NCT01144663|582173700|FG001|Primary Vaccination Phase|Adverse Event|0|||
161216040|NCT01144663|582173701|FG002|Primary Vaccination Phase|Adverse Event|0|||
161216041|NCT01144663|582173702|FG003|Primary Vaccination Phase|Adverse Event|1|||
161216042|NCT01144663|582173699|FG000|Primary Vaccination Phase|Protocol Violation|2|||
161216043|NCT01144663|582173700|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161216044|NCT01144663|582173701|FG002|Primary Vaccination Phase|Protocol Violation|1|||
161216045|NCT01144663|582173702|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161216046|NCT01144663|582173699|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
161216047|NCT01144663|582173700|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
161216048|NCT01144663|582173701|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
161216049|NCT01144663|582173702|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
161216050|NCT01144663|582173699|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
161216051|NCT01144663|582173700|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
161216052|NCT01144663|582173701|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
161216053|NCT01144663|582173702|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
161216054|NCT01144663|582173699|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
161216055|NCT01144663|582173700|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
161216056|NCT01144663|582173701|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
161216057|NCT01144663|582173702|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
161216058|NCT01144663|582173699|FG000|Primary Vaccination Phase|Other|0|||
161216059|NCT01144663|582173700|FG001|Primary Vaccination Phase|Other|1|||
161216060|NCT01144663|582173701|FG002|Primary Vaccination Phase|Other|0|||
161216061|NCT01144663|582173702|FG003|Primary Vaccination Phase|Other|2|||
161216062|NCT01144663|582173699|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
161216063|NCT01144663|582173700|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
160869384|NCT03614156|580913743|FG003|Open-Label Treatment Period|Protocol Violation|0|||
161216064|NCT01144663|582173701|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
161216065|NCT01144663|582173702|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
161216066|NCT01144663|582173699|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
161216067|NCT01144663|582173700|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
161216068|NCT01144663|582173701|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
161216069|NCT01144663|582173702|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
161216070|NCT01144663|582173699|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
161216071|NCT01144663|582173700|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
161216072|NCT01144663|582173701|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
161216073|NCT01144663|582173702|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
161216074|NCT01144663|582173699|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
161216075|NCT01144663|582173700|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
161216076|NCT01144663|582173701|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
161216077|NCT01144663|582173702|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
161216078|NCT01144663|582173699|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
161216079|NCT01144663|582173700|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
161216080|NCT01144663|582173701|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
161216081|NCT01144663|582173702|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
161216082|NCT01144663|582173699|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
161216083|NCT01144663|582173700|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
161216084|NCT01144663|582173701|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
161216085|NCT01144663|582173702|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
161216086|NCT01335477|582173704|FG000|Overall Study|Adverse Event|30|||
161216087|NCT01335477|582173705|FG001|Overall Study|Adverse Event|42|||
161216088|NCT01335477|582173704|FG000|Overall Study|Non compliant with protocol|0|||
161216089|NCT01335477|582173705|FG001|Overall Study|Non compliant with protocol|2|||
161216090|NCT01335477|582173704|FG000|Overall Study|Lost to Follow-up|1|||
161216091|NCT01335477|582173705|FG001|Overall Study|Lost to Follow-up|2|||
161216092|NCT01335477|582173704|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
161216093|NCT01335477|582173705|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
161216094|NCT01335477|582173704|FG000|Overall Study|Not treated|1|||
161216095|NCT01335477|582173705|FG001|Overall Study|Not treated|2|||
161216096|NCT01335477|582173704|FG000|Overall Study|Reason other than those stated above|2|||
161216097|NCT01335477|582173705|FG001|Overall Study|Reason other than those stated above|2|||
161216098|NCT02038634|582173707|FG000|Overall Study|Lost to Follow-up|0|||
161216099|NCT02038634|582173708|FG001|Overall Study|Lost to Follow-up|1|||
161216100|NCT01706198|582173710|FG000|Overall Study|Adverse Event|12|||
161216101|NCT01706198|582173711|FG001|Overall Study|Adverse Event|15|||
161216102|NCT01706198|582173710|FG000|Overall Study|Protocol Violation|7|||
161216103|NCT01706198|582173711|FG001|Overall Study|Protocol Violation|5|||
161216104|NCT01706198|582173710|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
161216105|NCT01706198|582173711|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
161216106|NCT01706198|582173710|FG000|Overall Study|Lost to Follow-up|97|||
161216107|NCT01706198|582173711|FG001|Overall Study|Lost to Follow-up|93|||
161216108|NCT01706198|582173710|FG000|Overall Study|Physician Decision|23|||
161216109|NCT01706198|582173711|FG001|Overall Study|Physician Decision|37|||
161216110|NCT01706198|582173710|FG000|Overall Study|Withdrawal by Subject|23|||
161216111|NCT01706198|582173711|FG001|Overall Study|Withdrawal by Subject|31|||
161216112|NCT01473758|582173712|FG000|Cycle 1|Adverse Event|10|||
161216113|NCT01473758|582173713|FG001|Cycle 1|Adverse Event|2|||
161216114|NCT01473758|582173714|FG002|Cycle 1|Adverse Event|0|||
161216115|NCT01473758|582173715|FG003|Cycle 1|Adverse Event|0|||
161216116|NCT01473758|582173712|FG000|Cycle 1|Withdrawal by Subject|1|||
161216117|NCT01473758|582173713|FG001|Cycle 1|Withdrawal by Subject|1|||
161216118|NCT01473758|582173714|FG002|Cycle 1|Withdrawal by Subject|0|||
161216119|NCT01473758|582173715|FG003|Cycle 1|Withdrawal by Subject|0|||
161216120|NCT01473758|582173712|FG000|Cycle 2|Adverse Event|0|||
161216121|NCT01473758|582173713|FG001|Cycle 2|Adverse Event|0|||
161216122|NCT01473758|582173714|FG002|Cycle 2|Adverse Event|5|||
161216123|NCT01473758|582173715|FG003|Cycle 2|Adverse Event|0|||
161216124|NCT02763579|582173716|FG000|Global Period|Death|167|||
161216125|NCT02763579|582173717|FG001|Global Period|Death|151|||
161216126|NCT02763579|582173718|FG002|Global Period|Death|0|||
161216127|NCT02763579|582173719|FG003|Global Period|Death|0|||
161216128|NCT02763579|582173716|FG000|Global Period|Lost to Follow-up|2|||
161216129|NCT02763579|582173717|FG001|Global Period|Lost to Follow-up|4|||
161216130|NCT02763579|582173718|FG002|Global Period|Lost to Follow-up|0|||
161216131|NCT02763579|582173719|FG003|Global Period|Lost to Follow-up|0|||
161216132|NCT02763579|582173716|FG000|Global Period|Physician Decision|0|||
161216133|NCT02763579|582173717|FG001|Global Period|Physician Decision|2|||
161216134|NCT02763579|582173718|FG002|Global Period|Physician Decision|0|||
161216135|NCT02763579|582173719|FG003|Global Period|Physician Decision|0|||
161216136|NCT02763579|582173716|FG000|Global Period|Study Terminated By Sponsor|21|||
161216137|NCT02763579|582173717|FG001|Global Period|Study Terminated By Sponsor|26|||
161216138|NCT02763579|582173718|FG002|Global Period|Study Terminated By Sponsor|0|||
161216139|NCT02763579|582173719|FG003|Global Period|Study Terminated By Sponsor|0|||
161216140|NCT02763579|582173716|FG000|Global Period|Withdrawal by Subject|12|||
161216141|NCT02763579|582173717|FG001|Global Period|Withdrawal by Subject|18|||
161216142|NCT02763579|582173718|FG002|Global Period|Withdrawal by Subject|0|||
161216143|NCT02763579|582173719|FG003|Global Period|Withdrawal by Subject|0|||
161216144|NCT02763579|582173716|FG000|China Period|Death|0|||
161216145|NCT02763579|582173717|FG001|China Period|Death|0|||
161216146|NCT02763579|582173718|FG002|China Period|Death|46|||
161216147|NCT02763579|582173719|FG003|China Period|Death|48|||
161216148|NCT02763579|582173716|FG000|China Period|Lost to Follow-up|0|||
161216149|NCT02763579|582173717|FG001|China Period|Lost to Follow-up|0|||
161216150|NCT02763579|582173718|FG002|China Period|Lost to Follow-up|1|||
161216151|NCT02763579|582173719|FG003|China Period|Lost to Follow-up|1|||
161216152|NCT02763579|582173716|FG000|China Period|Physician Decision|0|||
161216153|NCT02763579|582173717|FG001|China Period|Physician Decision|0|||
161216154|NCT02763579|582173718|FG002|China Period|Physician Decision|0|||
161216155|NCT02763579|582173719|FG003|China Period|Physician Decision|1|||
161216156|NCT02763579|582173716|FG000|China Period|Study Terminated By Sponsor|0|||
161216157|NCT02763579|582173717|FG001|China Period|Study Terminated By Sponsor|0|||
161216158|NCT02763579|582173718|FG002|China Period|Study Terminated By Sponsor|3|||
161216159|NCT02763579|582173719|FG003|China Period|Study Terminated By Sponsor|4|||
161216160|NCT02763579|582173716|FG000|China Period|Withdrawal by Subject|0|||
161216161|NCT02763579|582173717|FG001|China Period|Withdrawal by Subject|0|||
161216162|NCT02763579|582173718|FG002|China Period|Withdrawal by Subject|3|||
161216163|NCT02763579|582173719|FG003|China Period|Withdrawal by Subject|3|||
161216164|NCT03572933|582173720|FG000|Overall Study|Adverse Event|4|||
161216165|NCT03572933|582173721|FG001|Overall Study|Adverse Event|1|||
161216166|NCT03572933|582173720|FG000|Overall Study|Withdrawal by Subject|0|||
161216167|NCT03572933|582173721|FG001|Overall Study|Withdrawal by Subject|1|||
161216168|NCT01764854|582173725|FG000|Overall Study|Adverse Event|0|||
161216169|NCT01764854|582173726|FG001|Overall Study|Adverse Event|0|||
161216170|NCT01764854|582173727|FG002|Overall Study|Adverse Event|2|||
161216171|NCT01764854|582173728|FG003|Overall Study|Adverse Event|0|||
161216172|NCT01764854|582173725|FG000|Overall Study|Withdrawal by Subject|0|||
161216173|NCT01764854|582173726|FG001|Overall Study|Withdrawal by Subject|0|||
161111605|NCT02409290|581799372|FG002|Overall Study|No positive culture/no baseline sample|6|||
161111606|NCT02409290|581799373|FG003|Overall Study|No positive culture/no baseline sample|5|||
161111607|NCT02409290|581799370|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
161111608|NCT02409290|581799371|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161111609|NCT02409290|581799372|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161111610|NCT02409290|581799373|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
161111611|NCT04251910|581799378|FG000|Overall Study|Covid 19 lockdown|0|||
161111612|NCT04251910|581799379|FG001|Overall Study|Covid 19 lockdown|5|||
161111613|NCT04251910|581799380|FG002|Overall Study|Covid 19 lockdown|0|||
161111614|NCT04251910|581799381|FG003|Overall Study|Covid 19 lockdown|4|||
161111615|NCT04251910|581799382|FG004|Overall Study|Covid 19 lockdown|0|||
161111616|NCT04251910|581799383|FG005|Overall Study|Covid 19 lockdown|0|||
161111617|NCT04251910|581799378|FG000|Overall Study|Assisted living facility was closed|0|||
161111618|NCT04251910|581799379|FG001|Overall Study|Assisted living facility was closed|0|||
161111619|NCT04251910|581799380|FG002|Overall Study|Assisted living facility was closed|0|||
161111620|NCT04251910|581799381|FG003|Overall Study|Assisted living facility was closed|0|||
161111621|NCT04251910|581799382|FG004|Overall Study|Assisted living facility was closed|1|||
161111622|NCT04251910|581799383|FG005|Overall Study|Assisted living facility was closed|0|||
161111623|NCT05289570|581799385|FG000|Overall Study|Physician Decision|1|||
161111624|NCT00777101|581799390|FG000|Overall Study|Death|48|||
161111625|NCT00777101|581799391|FG001|Overall Study|Death|43|||
161111626|NCT00777101|581799390|FG000|Overall Study|Withdrawal by Subject|11|||
161111627|NCT00777101|581799391|FG001|Overall Study|Withdrawal by Subject|6|||
161111628|NCT00777101|581799390|FG000|Overall Study|Lost to Follow-up|2|||
161111629|NCT00777101|581799391|FG001|Overall Study|Lost to Follow-up|1|||
161111630|NCT00777101|581799390|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161111631|NCT00777101|581799391|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161111632|NCT00777101|581799390|FG000|Overall Study|Failed to Return|0|||
161111633|NCT00777101|581799391|FG001|Overall Study|Failed to Return|1|||
161111634|NCT00282334|581799393|FG000|Overall Study|Withdrawal by Subject|8|||
161111635|NCT00282334|581799394|FG001|Overall Study|Withdrawal by Subject|5|||
161111636|NCT00964743|581799404|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
161111637|NCT03317795|581799405|FG000|Overall Study|IUD Expulsion|1|||
161111638|NCT03317795|581799406|FG001|Overall Study|IUD Expulsion|0|||
161111639|NCT03317795|581799405|FG000|Overall Study|Lost to Follow-up|1|||
161216174|NCT01764854|582173727|FG002|Overall Study|Withdrawal by Subject|1|||
161216175|NCT01764854|582173728|FG003|Overall Study|Withdrawal by Subject|0|||
161216176|NCT01764854|582173725|FG000|Overall Study|relocation|0|||
161111640|NCT03317795|581799406|FG001|Overall Study|Lost to Follow-up|3|||
161111641|NCT03317795|581799405|FG000|Overall Study|Treatment change|0|||
161111642|NCT03317795|581799406|FG001|Overall Study|Treatment change|3|||
161111643|NCT03317795|581799405|FG000|Overall Study|Intolerance of medication|0|||
161111644|NCT03317795|581799406|FG001|Overall Study|Intolerance of medication|1|||
161111645|NCT00501007|581799407|FG000|Overall Study|Inclusion criteria not met.|29|||
161111646|NCT00501007|581799408|FG001|Overall Study|Inclusion criteria not met.|25|||
161111647|NCT03917823|581799409|FG000|Overall Study|Lost to Follow-up|1|||
161111648|NCT03917823|581799410|FG001|Overall Study|Lost to Follow-up|1|||
161111649|NCT03917823|581799409|FG000|Overall Study|Withdrawal by Subject|0|||
161111650|NCT03917823|581799410|FG001|Overall Study|Withdrawal by Subject|1|||
161111651|NCT02424253|581799413|FG000|Overall Study|Other, unspecified|1|||
161111652|NCT02424253|581799414|FG001|Overall Study|Other, unspecified|0|||
161111653|NCT02424253|581799413|FG000|Overall Study|Compliance problems|1|||
161111654|NCT02424253|581799414|FG001|Overall Study|Compliance problems|0|||
161111655|NCT02424253|581799413|FG000|Overall Study|Physician Decision|2|||
161111656|NCT02424253|581799414|FG001|Overall Study|Physician Decision|0|||
161111657|NCT02424253|581799413|FG000|Overall Study|Lack of Efficacy|0|||
161111658|NCT02424253|581799414|FG001|Overall Study|Lack of Efficacy|7|||
161111659|NCT02424253|581799413|FG000|Overall Study|Adverse Event|2|||
161111660|NCT02424253|581799414|FG001|Overall Study|Adverse Event|0|||
161111661|NCT02424253|581799413|FG000|Overall Study|Consent withdrawn by subject|4|||
161111662|NCT02424253|581799414|FG001|Overall Study|Consent withdrawn by subject|1|||
161111663|NCT02424253|581799413|FG000|Overall Study|Lost to Follow-up|1|||
161111664|NCT02424253|581799414|FG001|Overall Study|Lost to Follow-up|1|||
161111665|NCT00473343|581799415|FG000|Overall Study|Adverse Event|9|||
161111666|NCT00473343|581799415|FG000|Overall Study|Lost to Follow-up|8|||
161111667|NCT00473343|581799415|FG000|Overall Study|Treatment failure|27|||
161111668|NCT00473343|581799415|FG000|Overall Study|Withdrew consent|3|||
161111669|NCT00473343|581799415|FG000|Overall Study|Other un-specified reason|3|||
161111670|NCT02290873|581799416|FG000|Overall Study|Withdrawal by Subject|0|||
161111671|NCT02290873|581799417|FG001|Overall Study|Withdrawal by Subject|1|||
161111672|NCT02290873|581799418|FG002|Overall Study|Withdrawal by Subject|1|||
161111673|NCT02290873|581799416|FG000|Overall Study|Nellcor device error|1|||
161111674|NCT02290873|581799417|FG001|Overall Study|Nellcor device error|0|||
161111675|NCT02290873|581799418|FG002|Overall Study|Nellcor device error|0|||
161111676|NCT02290873|581799416|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
161111677|NCT02290873|581799417|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
161111678|NCT02290873|581799418|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
161111679|NCT02290873|581799416|FG000|Overall Study|Protocol Violation|0|||
161111680|NCT02290873|581799417|FG001|Overall Study|Protocol Violation|0|||
161111681|NCT02290873|581799418|FG002|Overall Study|Protocol Violation|1|||
161111682|NCT03715153|581799419|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
161111683|NCT03715153|581799420|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
161111684|NCT03715153|581799419|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
161111685|NCT03715153|581799420|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
161111686|NCT03715153|581799419|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
161111687|NCT03715153|581799420|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
161111688|NCT03715153|581799419|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
161111689|NCT03715153|581799420|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
161111690|NCT03715153|581799419|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
161111691|NCT03715153|581799420|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
161111692|NCT03715153|581799419|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
161111693|NCT03715153|581799420|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
161111694|NCT01519765|581799425|FG000|Overall Study|Adverse Event|0|||
161111695|NCT01519765|581799426|FG001|Overall Study|Adverse Event|1|||
161111696|NCT01519765|581799425|FG000|Overall Study|Lack of Efficacy|2|||
161111697|NCT01519765|581799426|FG001|Overall Study|Lack of Efficacy|0|||
161111698|NCT01519765|581799425|FG000|Overall Study|Protocol Violation|1|||
161111699|NCT01519765|581799426|FG001|Overall Study|Protocol Violation|0|||
161111700|NCT01519765|581799425|FG000|Overall Study|Withdrawal by Subject|0|||
161111701|NCT01519765|581799426|FG001|Overall Study|Withdrawal by Subject|1|||
161111702|NCT04126083|581799427|FG000|Overall Study|Withdrawal by Subject|1|||
161111703|NCT04013529|581799432|FG000|Overall Study|Withdrawal by Subject|1|||
161111704|NCT04013529|581799433|FG001|Overall Study|Withdrawal by Subject|1|||
161111705|NCT03116698|581799434|FG000|Overall Study|Adverse Event|1|||
161111706|NCT03116698|581799435|FG001|Overall Study|Adverse Event|1|||
161111707|NCT03116698|581799436|FG002|Overall Study|Adverse Event|1|||
161111708|NCT03116698|581799437|FG003|Overall Study|Adverse Event|0|||
161111709|NCT03116698|581799434|FG000|Overall Study|Withdrawal by Subject|1|||
161111710|NCT03116698|581799435|FG001|Overall Study|Withdrawal by Subject|4|||
161111711|NCT03116698|581799436|FG002|Overall Study|Withdrawal by Subject|5|||
161111712|NCT03116698|581799437|FG003|Overall Study|Withdrawal by Subject|2|||
161111713|NCT03116698|581799434|FG000|Overall Study|Lost to Follow-up|2|||
161111714|NCT03116698|581799435|FG001|Overall Study|Lost to Follow-up|0|||
161216177|NCT01764854|582173726|FG001|Overall Study|relocation|0|||
161216178|NCT01764854|582173727|FG002|Overall Study|relocation|2|||
161216179|NCT01764854|582173728|FG003|Overall Study|relocation|0|||
161216180|NCT01764854|582173725|FG000|Overall Study|Protocol Violation|0|||
161216181|NCT01764854|582173726|FG001|Overall Study|Protocol Violation|0|||
161216182|NCT01764854|582173727|FG002|Overall Study|Protocol Violation|1|||
161216183|NCT01764854|582173728|FG003|Overall Study|Protocol Violation|2|||
161216184|NCT00829413|582173729|FG000|Overall Study|No study drug admimnistered|13|||
161216185|NCT00829413|582173729|FG000|Overall Study|Training Patients|67|||
161216186|NCT00829413|582173729|FG000|Overall Study|No truth standard procedure available|9|||
161216187|NCT00829413|582173729|FG000|Overall Study|Technically inadequate truth standard|2|||
161216188|NCT00829413|582173729|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
161216189|NCT00294723|582173733|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
161216190|NCT00294723|582173734|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
161216191|NCT00294723|582173735|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
161216192|NCT00294723|582173733|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
161216193|NCT00294723|582173734|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
161216194|NCT00294723|582173735|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
161216195|NCT00294723|582173733|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
161216196|NCT00294723|582173734|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
161216197|NCT00294723|582173735|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
161216198|NCT00294723|582173733|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
161216199|NCT00294723|582173734|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
161216200|NCT00294723|582173735|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
161111715|NCT03116698|581799436|FG002|Overall Study|Lost to Follow-up|0|||
161111716|NCT03116698|581799437|FG003|Overall Study|Lost to Follow-up|0|||
161111717|NCT03116698|581799434|FG000|Overall Study|Physician Decision|1|||
161111718|NCT03116698|581799435|FG001|Overall Study|Physician Decision|1|||
161111719|NCT03116698|581799436|FG002|Overall Study|Physician Decision|0|||
161111720|NCT03116698|581799437|FG003|Overall Study|Physician Decision|0|||
161111721|NCT03116698|581799434|FG000|Overall Study|Protocol Violation|1|||
161111722|NCT03116698|581799435|FG001|Overall Study|Protocol Violation|0|||
161111723|NCT03116698|581799436|FG002|Overall Study|Protocol Violation|0|||
161111724|NCT03116698|581799437|FG003|Overall Study|Protocol Violation|0|||
161111725|NCT03116698|581799434|FG000|Overall Study|Death|0|||
161111726|NCT03116698|581799435|FG001|Overall Study|Death|0|||
161111727|NCT03116698|581799436|FG002|Overall Study|Death|2|||
161111728|NCT03116698|581799437|FG003|Overall Study|Death|0|||
161111729|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
161111730|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
161111731|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
161111732|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
161111733|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
161111734|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
161111735|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
161111736|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
161111737|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to death|4|||
161111738|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to death|3|||
161111739|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
161111740|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
161111741|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
161111742|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
161111743|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
161111744|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
161111745|NCT02258451|581799438|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
161111746|NCT02258451|581799439|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
161111747|NCT02258451|581799438|FG000|Overall Study|Other reason|1|||
161111748|NCT02258451|581799439|FG001|Overall Study|Other reason|1|||
161111749|NCT02258451|581799438|FG000|Overall Study|Never treated|2|||
161111750|NCT02258451|581799439|FG001|Overall Study|Never treated|3|||
161111751|NCT00517751|581799444|FG000|Overall Study|Death|3|||
161111752|NCT00517751|581799444|FG000|Overall Study|Withdrawal by Subject|37|||
161111753|NCT00517751|581799444|FG000|Overall Study|Lost to Follow-up|4|||
161111754|NCT00517751|581799444|FG000|Overall Study|patient not over due|6|||
161216201|NCT00294723|582173733|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
161216202|NCT00294723|582173734|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
161216203|NCT00294723|582173735|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
160869385|NCT03614156|580913740|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
161216204|NCT00294723|582173733|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
161216205|NCT00294723|582173734|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
161216206|NCT00294723|582173735|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
161216207|NCT00294723|582173733|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
161216208|NCT00294723|582173734|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
161216209|NCT00294723|582173735|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
161216210|NCT00294723|582173733|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
161216211|NCT00294723|582173734|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
161216212|NCT00294723|582173735|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
161216213|NCT00294723|582173733|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
161216214|NCT00294723|582173734|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
161216215|NCT00294723|582173735|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
161216216|NCT00294723|582173733|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
161216217|NCT00294723|582173734|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
161216218|NCT00294723|582173735|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
161216219|NCT00294723|582173733|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161216220|NCT00294723|582173734|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161216221|NCT00294723|582173735|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
161216222|NCT00294723|582173733|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
161216223|NCT00294723|582173734|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
161216224|NCT00294723|582173735|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
161216225|NCT00891774|582173736|FG000|Overall Study|Lost to Follow-up|5|||
161216226|NCT00891774|582173736|FG000|Overall Study|Illness (Self/Mother)|3|||
161216227|NCT00891774|582173736|FG000|Overall Study|Withdrawal by Subject|2|||
161216228|NCT00891774|582173736|FG000|Overall Study|Protocol Violation|4|||
161216229|NCT01958281|582173737|FG000|Overall Study|Lack of Efficacy|5|||
161216230|NCT01958281|582173738|FG001|Overall Study|Lack of Efficacy|2|||
161216231|NCT01958281|582173739|FG002|Overall Study|Lack of Efficacy|0|||
161216232|NCT01958281|582173737|FG000|Overall Study|Adverse Event|0|||
161216233|NCT01958281|582173738|FG001|Overall Study|Adverse Event|2|||
161216234|NCT01958281|582173739|FG002|Overall Study|Adverse Event|0|||
161216235|NCT01958281|582173737|FG000|Overall Study|Withdrew Consent|1|||
161216236|NCT01958281|582173738|FG001|Overall Study|Withdrew Consent|0|||
161216237|NCT01958281|582173739|FG002|Overall Study|Withdrew Consent|0|||
161216238|NCT03255031|582173742|FG000|Overall Study|Adverse Event|5|||
161216239|NCT03255031|582173743|FG001|Overall Study|Adverse Event|3|||
161216240|NCT03255031|582173742|FG000|Overall Study|Physician Decision|2|||
161216241|NCT03255031|582173743|FG001|Overall Study|Physician Decision|1|||
161216242|NCT03255031|582173742|FG000|Overall Study|Withdrawal by Subject|9|||
161216243|NCT03255031|582173743|FG001|Overall Study|Withdrawal by Subject|3|||
161216244|NCT01809314|582173744|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
161216245|NCT01809314|582173744|FG000|Overall Study|Adverse Event|6|||
161216246|NCT01809314|582173744|FG000|Overall Study|Insufficient Therapeutic Response|14|||
161216247|NCT01809314|582173744|FG000|Overall Study|Lost to Follow-up|724|||
161216248|NCT01092702|582173745|FG000|Overall Study|Withdrawal by Subject|7|||
161216249|NCT01092702|582173745|FG000|Overall Study|Lost to Follow-up|2|||
161216250|NCT00863057|582173746|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161216251|NCT00863057|582173747|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161216252|NCT00863057|582173748|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
161216253|NCT00863057|582173749|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
161216254|NCT00863057|582173746|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161216255|NCT00863057|582173747|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
161216256|NCT00863057|582173748|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161216257|NCT00863057|582173749|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
161216258|NCT00863057|582173746|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
161216259|NCT00863057|582173747|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
161324383|NCT02098395|582573584|FG000|Overall Study|Withdrawal by Subject|10|||
161216260|NCT00863057|582173748|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
161216261|NCT00863057|582173749|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
161216262|NCT00863057|582173746|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
161216263|NCT00863057|582173747|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
161216264|NCT00863057|582173748|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
161216265|NCT00863057|582173749|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
161216266|NCT00545233|582173753|FG000|Overall Study|Adverse Event|10|||
161216267|NCT00545233|582173754|FG001|Overall Study|Adverse Event|5|||
161216268|NCT00545233|582173753|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
161216269|NCT00545233|582173754|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161216270|NCT00545233|582173753|FG000|Overall Study|Protocol Violation|2|||
161216271|NCT00545233|582173754|FG001|Overall Study|Protocol Violation|0|||
161216272|NCT00545233|582173753|FG000|Overall Study|Refused Treatment|9|||
161216273|NCT00545233|582173754|FG001|Overall Study|Refused Treatment|7|||
161216274|NCT00545233|582173753|FG000|Overall Study|Failure to Return|4|||
161216275|NCT00545233|582173754|FG001|Overall Study|Failure to Return|6|||
161216276|NCT00545233|582173753|FG000|Overall Study|Insufficient response|14|||
161216277|NCT00545233|582173754|FG001|Overall Study|Insufficient response|15|||
161216278|NCT00545233|582173753|FG000|Overall Study|Physician Decision|2|||
161216279|NCT00545233|582173754|FG001|Overall Study|Physician Decision|1|||
161216280|NCT06371079|582173755|FG000|Overall Study|Missing data|88|||
161216281|NCT06371079|582173756|FG001|Overall Study|Missing data|247|||
161216282|NCT01238211|582173757|FG000|Overall Study|Continues active treatment|31|||
161216283|NCT01238211|582173757|FG000|Overall Study|Adverse Event|7|||
161216284|NCT01238211|582173757|FG000|Overall Study|Death|4|||
161216285|NCT01238211|582173757|FG000|Overall Study|Relapse/Progression|2|||
161216286|NCT01238211|582173757|FG000|Overall Study|Withdrawal by Subject|7|||
161216287|NCT01238211|582173757|FG000|Overall Study|Non-protocol treatment|4|||
161216288|NCT01238211|582173757|FG000|Overall Study|Investigator/Patient Decision|3|||
161216289|NCT00449930|582173758|FG000|Overall Study|Adverse Event|9|||
161216290|NCT00449930|582173759|FG001|Overall Study|Adverse Event|19|||
161216291|NCT00449930|582173758|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
161216292|NCT00449930|582173759|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
161216293|NCT00449930|582173758|FG000|Overall Study|Lack of Efficacy|10|||
161216294|NCT00449930|582173759|FG001|Overall Study|Lack of Efficacy|1|||
161216295|NCT00449930|582173758|FG000|Overall Study|Lost to Follow-up|9|||
161216296|NCT00449930|582173759|FG001|Overall Study|Lost to Follow-up|14|||
161216297|NCT00449930|582173758|FG000|Overall Study|Physician Decision|1|||
161216298|NCT00449930|582173759|FG001|Overall Study|Physician Decision|2|||
161216299|NCT00449930|582173758|FG000|Overall Study|Protocol Violation|14|||
161216300|NCT00449930|582173759|FG001|Overall Study|Protocol Violation|15|||
161216301|NCT00449930|582173758|FG000|Overall Study|Withdrawal by Subject|16|||
161216302|NCT00449930|582173759|FG001|Overall Study|Withdrawal by Subject|23|||
161216303|NCT00449930|582173758|FG000|Overall Study|Glycemic discontinuation criteria|1|||
161216304|NCT00449930|582173759|FG001|Overall Study|Glycemic discontinuation criteria|1|||
161216305|NCT00575328|582173761|FG000|Overall Study|Adverse Event|1|||
161216306|NCT00575328|582173762|FG001|Overall Study|Adverse Event|1|||
161216307|NCT00575328|582173761|FG000|Overall Study|Lost to Follow-up|2|||
161216308|NCT00575328|582173762|FG001|Overall Study|Lost to Follow-up|1|||
161216309|NCT02868281|582173763|FG000|Overall Study|Adverse Event|2|||
161216310|NCT02868281|582173764|FG001|Overall Study|Adverse Event|2|||
161216311|NCT02868281|582173763|FG000|Overall Study|Protocol Violation|13|||
161216312|NCT02868281|582173764|FG001|Overall Study|Protocol Violation|10|||
161216313|NCT02868281|582173763|FG000|Overall Study|Lost to Follow-up|3|||
161216314|NCT02868281|582173764|FG001|Overall Study|Lost to Follow-up|6|||
161216315|NCT02868281|582173763|FG000|Overall Study|Withdrawal by Subject|11|||
161216316|NCT02868281|582173764|FG001|Overall Study|Withdrawal by Subject|15|||
161216317|NCT02868281|582173763|FG000|Overall Study|Physician Decision|2|||
161216318|NCT02868281|582173764|FG001|Overall Study|Physician Decision|0|||
161216319|NCT02868281|582173763|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
161216320|NCT02868281|582173764|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
161216321|NCT02868281|582173763|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
161216322|NCT02868281|582173764|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
161216323|NCT02868281|582173763|FG000|Overall Study|Long journey/moving away|1|||
161216324|NCT02868281|582173764|FG001|Overall Study|Long journey/moving away|1|||
161216325|NCT01722266|582173765|FG000|Overall Study|Withdrawal by Subject|1|||
161216326|NCT01722266|582173766|FG001|Overall Study|Withdrawal by Subject|2|||
161216327|NCT01722266|582173767|FG002|Overall Study|Withdrawal by Subject|0|||
161216328|NCT01722266|582173768|FG003|Overall Study|Withdrawal by Subject|0|||
161216329|NCT01722266|582173765|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
161216330|NCT01722266|582173766|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
161216331|NCT01722266|582173767|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
161216332|NCT01722266|582173768|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
161216333|NCT01722266|582173765|FG000|Overall Study|Dropped out due to Nausea|0|||
161216334|NCT01722266|582173766|FG001|Overall Study|Dropped out due to Nausea|0|||
161216335|NCT01722266|582173767|FG002|Overall Study|Dropped out due to Nausea|2|||
161216336|NCT01722266|582173768|FG003|Overall Study|Dropped out due to Nausea|0|||
161216337|NCT00124449|582173773|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
161216338|NCT00124449|582173774|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
161216339|NCT00124449|582173773|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
161216340|NCT00124449|582173774|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
161216341|NCT00124449|582173773|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
161216342|NCT00124449|582173774|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
161216343|NCT00124449|582173773|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
161216344|NCT00124449|582173774|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
161216345|NCT00124449|582173773|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
161216346|NCT00124449|582173774|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
161216347|NCT00124449|582173773|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
161216348|NCT00124449|582173774|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
161216349|NCT00124449|582173773|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
161216350|NCT00124449|582173774|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
161216351|NCT00124449|582173773|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
161216352|NCT00124449|582173774|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
161216353|NCT00124449|582173773|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
161216354|NCT00124449|582173774|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
161216355|NCT00124449|582173773|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
161216356|NCT00124449|582173774|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
161216357|NCT00124449|582173773|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
161216358|NCT00124449|582173774|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
161216359|NCT00124449|582173773|FG000|18-Month Untreated Observation Period|Relocated|1|||
161216360|NCT00124449|582173774|FG001|18-Month Untreated Observation Period|Relocated|0|||
161216361|NCT03811249|582173775|FG000|Overall Study|Withdrawal by Subject|44|||
161216362|NCT03811249|582173775|FG000|Overall Study|Missed Visit|24|||
161216363|NCT04304950|582173780|FG000|Overall Study|Lost to Follow-up|1|||
161216364|NCT04304950|582173781|FG001|Overall Study|Lost to Follow-up|1|||
161216365|NCT01337050|582173786|FG000|Overall Study|Death|0|||
161216366|NCT01337050|582173787|FG001|Overall Study|Death|0|||
161216367|NCT01337050|582173788|FG002|Overall Study|Death|4|||
161216368|NCT01337050|582173786|FG000|Overall Study|Other|4|||
161111755|NCT00517751|581799444|FG000|Overall Study|Patient not due for visit|76|||
161111756|NCT00517751|581799444|FG000|Overall Study|Missing|3|||
161111757|NCT03021499|581799447|FG000|Overall Study|Adverse Event|1|||
161111758|NCT03021499|581799448|FG001|Overall Study|Adverse Event|0|||
161111759|NCT03021499|581799447|FG000|Overall Study|Death|1|||
161111760|NCT03021499|581799448|FG001|Overall Study|Death|5|||
161111761|NCT03021499|581799447|FG000|Overall Study|Lack of Efficacy|0|||
161111762|NCT03021499|581799448|FG001|Overall Study|Lack of Efficacy|1|||
161111763|NCT03021499|581799447|FG000|Overall Study|Lost to Follow-up|1|||
161111764|NCT03021499|581799448|FG001|Overall Study|Lost to Follow-up|3|||
161111765|NCT03021499|581799447|FG000|Overall Study|Physician Decision|2|||
161111766|NCT03021499|581799448|FG001|Overall Study|Physician Decision|3|||
161216369|NCT01337050|582173787|FG001|Overall Study|Other|6|||
161216370|NCT01337050|582173788|FG002|Overall Study|Other|8|||
161216371|NCT01337050|582173786|FG000|Overall Study|Participants refused further follow-up|0|||
161216372|NCT01337050|582173787|FG001|Overall Study|Participants refused further follow-up|7|||
161216373|NCT01337050|582173788|FG002|Overall Study|Participants refused further follow-up|7|||
161111767|NCT03021499|581799447|FG000|Overall Study|Pregnancy|1|||
161216374|NCT00003102|582173789|FG000|Overall Study|Physician Decision|1|||
161111768|NCT03021499|581799448|FG001|Overall Study|Pregnancy|0|||
161216375|NCT00003102|582173790|FG001|Overall Study|Physician Decision|1|||
161216376|NCT00003102|582173791|FG002|Overall Study|Physician Decision|0|||
161216377|NCT00003102|582173789|FG000|Overall Study|Progressive Disease|0|||
161216378|NCT00003102|582173790|FG001|Overall Study|Progressive Disease|1|||
161216379|NCT00003102|582173791|FG002|Overall Study|Progressive Disease|0|||
161216380|NCT00003102|582173789|FG000|Overall Study|Adverse Event|0|||
161216381|NCT00003102|582173790|FG001|Overall Study|Adverse Event|1|||
161216382|NCT00003102|582173791|FG002|Overall Study|Adverse Event|1|||
161216383|NCT00003102|582173789|FG000|Overall Study|Death|0|||
161216384|NCT00003102|582173790|FG001|Overall Study|Death|0|||
161216385|NCT00003102|582173791|FG002|Overall Study|Death|1|||
161216386|NCT01559818|582173794|FG000|Overall Study|Physician Decision|1|||
161216387|NCT01559818|582173794|FG000|Overall Study|Pregnancy|1|||
161216388|NCT01559818|582173794|FG000|Overall Study|Study terminated by Sponsor|4|||
161216389|NCT01559818|582173794|FG000|Overall Study|Withdrawal by Subject|1|||
161216390|NCT01512979|582173795|FG000|Overall Study|Adverse Event|2|||
161216391|NCT01512979|582173796|FG001|Overall Study|Adverse Event|2|||
161216392|NCT01512979|582173795|FG000|Overall Study|Protocol Violation|1|||
161216393|NCT01512979|582173796|FG001|Overall Study|Protocol Violation|4|||
161216394|NCT01512979|582173795|FG000|Overall Study|Lost to Follow-up|2|||
161216395|NCT01512979|582173796|FG001|Overall Study|Lost to Follow-up|5|||
161216396|NCT01512979|582173795|FG000|Overall Study|Withdrawal by Subject|1|||
161216397|NCT01512979|582173796|FG001|Overall Study|Withdrawal by Subject|2|||
161216398|NCT01512979|582173795|FG000|Overall Study|Reason other than stated above|13|||
161216399|NCT01512979|582173796|FG001|Overall Study|Reason other than stated above|9|||
160869386|NCT03614156|580913741|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
160869387|NCT03614156|580913742|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
160869388|NCT03614156|580913743|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
160869389|NCT03614156|580913740|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
160869390|NCT03614156|580913741|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
160869391|NCT03614156|580913742|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
160869392|NCT03614156|580913743|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
160869393|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
160869394|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
160869395|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
160869396|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
160869397|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161216400|NCT00125359|582173797|FG000|Overall Study|Death|4|||
161216401|NCT00125359|582173797|FG000|Overall Study|Adverse Event|5|||
161216402|NCT00125359|582173797|FG000|Overall Study|Physician Decision|14|||
161216403|NCT00529568|582173798|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
161216404|NCT00529568|582173799|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
161216405|NCT00529568|582173800|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
160869398|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
160869399|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160869400|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161111769|NCT03021499|581799447|FG000|Overall Study|Withdrawal by Subject|7|||
161111770|NCT03021499|581799448|FG001|Overall Study|Withdrawal by Subject|14|||
161111771|NCT03021499|581799447|FG000|Overall Study|Prohibited medication required|1|||
161111772|NCT03021499|581799448|FG001|Overall Study|Prohibited medication required|0|||
161111773|NCT03021499|581799447|FG000|Overall Study|Protocol non-compliance|1|||
161111774|NCT03021499|581799448|FG001|Overall Study|Protocol non-compliance|1|||
161111775|NCT03021499|581799447|FG000|Overall Study|None of the above|0|||
161111776|NCT03021499|581799448|FG001|Overall Study|None of the above|4|||
161111777|NCT03021499|581799447|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
161111778|NCT03021499|581799448|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
161111779|NCT00495820|581799449|FG000|Overall Study|Adverse Event|1|||
161111780|NCT00495820|581799450|FG001|Overall Study|Adverse Event|1|||
161111781|NCT00820950|581799451|FG000|Overall Study|Scheduling Conflict|0|||
161111782|NCT00820950|581799452|FG001|Overall Study|Scheduling Conflict|0|||
161111783|NCT00820950|581799453|FG002|Overall Study|Scheduling Conflict|0|||
161111784|NCT00820950|581799454|FG003|Overall Study|Scheduling Conflict|0|||
161111785|NCT00820950|581799455|FG004|Overall Study|Scheduling Conflict|0|||
161111786|NCT00820950|581799456|FG005|Overall Study|Scheduling Conflict|0|||
161111787|NCT00820950|581799457|FG006|Overall Study|Scheduling Conflict|1|||
161216406|NCT00529568|582173798|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
161216407|NCT00529568|582173799|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
160869401|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161111788|NCT00820950|581799458|FG007|Overall Study|Scheduling Conflict|1|||
161111789|NCT00820950|581799459|FG008|Overall Study|Scheduling Conflict|0|||
161111790|NCT00820950|581799460|FG009|Overall Study|Scheduling Conflict|0|||
161111791|NCT00820950|581799451|FG000|Overall Study|Protocol Violation|1|||
161216408|NCT00529568|582173800|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
161324384|NCT02098395|582573585|FG001|Overall Study|Withdrawal by Subject|10|||
161324385|NCT02098395|582573586|FG002|Overall Study|Withdrawal by Subject|5|||
161216409|NCT00529568|582173798|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
161216410|NCT00529568|582173799|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
161216411|NCT00529568|582173800|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
161216412|NCT00529568|582173798|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
161216413|NCT00529568|582173799|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
161216414|NCT00529568|582173800|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
161216415|NCT00529568|582173798|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
160869402|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161216416|NCT00529568|582173799|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
161216417|NCT00529568|582173800|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
161216418|NCT00529568|582173798|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
161216419|NCT00529568|582173799|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
161216420|NCT00529568|582173800|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
161216421|NCT00529568|582173798|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
161216422|NCT00529568|582173799|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
161216423|NCT00529568|582173800|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
161216424|NCT00529568|582173798|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
161216425|NCT00529568|582173799|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
161216426|NCT00529568|582173800|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
161216427|NCT00529568|582173798|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
161216428|NCT00529568|582173799|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
161216429|NCT00529568|582173800|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
161216430|NCT00529568|582173798|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
161216431|NCT00529568|582173799|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
161216432|NCT00529568|582173800|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
161216433|NCT00529568|582173798|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
161216434|NCT00529568|582173799|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
161216435|NCT00529568|582173800|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
161216436|NCT04049552|582173801|FG000|Overall Study|Lost to Follow-up|1|||
161216437|NCT01201356|582173802|FG000|Overall Study|Adverse Event|170|||
161216438|NCT01201356|582173802|FG000|Overall Study|Abnormal laboratory value(s)|51|||
161216439|NCT01201356|582173802|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161216440|NCT01201356|582173802|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
161216441|NCT01201356|582173802|FG000|Overall Study|Condition no longer requires study drug|12|||
161216442|NCT01201356|582173802|FG000|Overall Study|Withdrawal by Subject|144|||
161216443|NCT01201356|582173802|FG000|Overall Study|Lost to Follow-up|50|||
161216444|NCT01201356|582173802|FG000|Overall Study|administrative problems|74|||
161216445|NCT01201356|582173802|FG000|Overall Study|Death|16|||
161216446|NCT01201356|582173802|FG000|Overall Study|Protocol Violation|12|||
161216447|NCT00738920|582173804|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
161216448|NCT00738920|582173805|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
161216449|NCT00738920|582173806|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
161216450|NCT00738920|582173804|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
161216451|NCT00738920|582173805|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
161216452|NCT00738920|582173806|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
161216453|NCT00738920|582173804|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
161216454|NCT00738920|582173805|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
161216455|NCT00738920|582173806|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
161216456|NCT00738920|582173804|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
161216457|NCT00738920|582173805|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
160869403|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
160869404|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
160869405|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
160869406|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
160869407|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
160869408|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
160869409|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
160869410|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
160869411|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
160869412|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
160869413|NCT03614156|580913740|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
161216458|NCT00738920|582173806|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
161216459|NCT00738920|582173804|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
161216460|NCT00738920|582173805|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
160869414|NCT03614156|580913741|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
161216461|NCT00738920|582173806|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
161216462|NCT00738920|582173804|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
161216463|NCT00738920|582173805|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
161216464|NCT00738920|582173806|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
161216465|NCT00738920|582173804|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
161216466|NCT00738920|582173805|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
161216467|NCT00738920|582173806|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
161216468|NCT00738920|582173804|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
161216469|NCT00738920|582173805|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
161216470|NCT00738920|582173806|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
161216471|NCT00738920|582173804|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
161216472|NCT00738920|582173805|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
161216473|NCT00738920|582173806|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
161216474|NCT00738920|582173804|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
161216475|NCT00738920|582173805|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
161216476|NCT00738920|582173806|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
161216477|NCT02173301|582173810|FG000|Overall Study|Adverse Event|7|||
161216478|NCT02173301|582173811|FG001|Overall Study|Adverse Event|8|||
161216479|NCT02173301|582173812|FG002|Overall Study|Adverse Event|13|||
161216480|NCT02173301|582173813|FG003|Overall Study|Adverse Event|5|||
161216481|NCT02173301|582173810|FG000|Overall Study|Withdrawal by Subject|8|||
161216482|NCT02173301|582173811|FG001|Overall Study|Withdrawal by Subject|10|||
161216483|NCT02173301|582173812|FG002|Overall Study|Withdrawal by Subject|4|||
161216484|NCT02173301|582173813|FG003|Overall Study|Withdrawal by Subject|8|||
161216485|NCT02173301|582173810|FG000|Overall Study|Lost to Follow-up|4|||
161216486|NCT02173301|582173811|FG001|Overall Study|Lost to Follow-up|4|||
161216487|NCT02173301|582173812|FG002|Overall Study|Lost to Follow-up|2|||
161216488|NCT02173301|582173813|FG003|Overall Study|Lost to Follow-up|2|||
161216489|NCT02173301|582173810|FG000|Overall Study|Protocol Violation|0|||
161216490|NCT02173301|582173811|FG001|Overall Study|Protocol Violation|1|||
161216491|NCT02173301|582173812|FG002|Overall Study|Protocol Violation|0|||
161216492|NCT02173301|582173813|FG003|Overall Study|Protocol Violation|0|||
161216493|NCT02173301|582173810|FG000|Overall Study|Physician Decision|0|||
161216494|NCT02173301|582173811|FG001|Overall Study|Physician Decision|0|||
161216495|NCT02173301|582173812|FG002|Overall Study|Physician Decision|1|||
161216496|NCT02173301|582173813|FG003|Overall Study|Physician Decision|0|||
161216497|NCT02173301|582173810|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
161216498|NCT02173301|582173811|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161216499|NCT02173301|582173812|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161216500|NCT02173301|582173813|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
161216501|NCT04079842|582173816|FG000|Overall Study|Request of subject|2|||
161216502|NCT04079842|582173816|FG000|Overall Study|Unable to draw Arterial samples|1|||
161216503|NCT02904200|582173817|FG000|Overall Study|Withdrawal by Subject|1|||
161216504|NCT02904200|582173818|FG001|Overall Study|Withdrawal by Subject|0|||
161216505|NCT02133352|582173819|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
161216506|NCT00433381|582175768|FG000|Overall Study|Ineligible / no protocol treatment|3|||
161216507|NCT00433381|582175769|FG001|Overall Study|Ineligible / no protocol treatment|3|||
161216508|NCT00458302|582175770|FG000|Overall Study|Adverse Event|4|||
161216509|NCT00458302|582175771|FG001|Overall Study|Adverse Event|14|||
161216510|NCT00458302|582175770|FG000|Overall Study|Pregnancy|2|||
161216511|NCT00458302|582175771|FG001|Overall Study|Pregnancy|1|||
161216512|NCT00458302|582175770|FG000|Overall Study|Protocol Violation|0|||
161216513|NCT00458302|582175771|FG001|Overall Study|Protocol Violation|2|||
161216514|NCT00458302|582175770|FG000|Overall Study|Withdrawal by Subject|6|||
161216515|NCT00458302|582175771|FG001|Overall Study|Withdrawal by Subject|4|||
161216516|NCT00458302|582175770|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
161216517|NCT00458302|582175771|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
161216518|NCT00458302|582175770|FG000|Overall Study|Study Termination By Sponsor|1|||
161216519|NCT00458302|582175771|FG001|Overall Study|Study Termination By Sponsor|0|||
161216520|NCT00458302|582175770|FG000|Overall Study|Lost to Follow-up|2|||
161216521|NCT00458302|582175771|FG001|Overall Study|Lost to Follow-up|0|||
161216522|NCT00458302|582175770|FG000|Overall Study|Other|4|||
161216523|NCT00458302|582175771|FG001|Overall Study|Other|2|||
161216524|NCT00549198|582175772|FG000|Overall Study|Adverse Event|28|||
161216525|NCT00549198|582175773|FG001|Overall Study|Adverse Event|26|||
161216526|NCT00549198|582175772|FG000|Overall Study|Insufficient Viral Load Response|4|||
161216527|NCT00549198|582175773|FG001|Overall Study|Insufficient Viral Load Response|2|||
161216528|NCT00549198|582175772|FG000|Overall Study|Protocol-defined Virological Failure|7|||
161216529|NCT00549198|582175773|FG001|Overall Study|Protocol-defined Virological Failure|0|||
161216530|NCT00549198|582175772|FG000|Overall Study|Non-compliance|2|||
161216531|NCT00549198|582175773|FG001|Overall Study|Non-compliance|4|||
161216532|NCT00549198|582175772|FG000|Overall Study|Lost to Follow-up|7|||
161216533|NCT00549198|582175773|FG001|Overall Study|Lost to Follow-up|8|||
161216534|NCT00549198|582175772|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
161216535|NCT00549198|582175773|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
161216536|NCT00549198|582175772|FG000|Overall Study|Protocol Violation|7|||
161216537|NCT00549198|582175773|FG001|Overall Study|Protocol Violation|2|||
161216538|NCT00549198|582175772|FG000|Overall Study|Investigator Decision|4|||
161216539|NCT00549198|582175773|FG001|Overall Study|Investigator Decision|3|||
161216540|NCT00549198|582175772|FG000|Overall Study|Withdrawal by Subject|7|||
161216541|NCT00549198|582175773|FG001|Overall Study|Withdrawal by Subject|7|||
161216542|NCT00549198|582175772|FG000|Overall Study|Disease Progression|1|||
161216543|NCT00549198|582175773|FG001|Overall Study|Disease Progression|0|||
161216544|NCT00549198|582175772|FG000|Overall Study|Participant Moved|2|||
161216545|NCT00549198|582175773|FG001|Overall Study|Participant Moved|0|||
161216546|NCT00549198|582175772|FG000|Overall Study|Participant not able to perform Week 96|1|||
161216547|NCT00549198|582175773|FG001|Overall Study|Participant not able to perform Week 96|0|||
161216548|NCT00549198|582175772|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
161216549|NCT00549198|582175773|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
161216550|NCT00549198|582175772|FG000|Overall Study|Prohibited Medication|1|||
161216551|NCT00549198|582175773|FG001|Overall Study|Prohibited Medication|2|||
161216552|NCT00549198|582175772|FG000|Overall Study|Participant planning pregnancy|1|||
161216553|NCT00549198|582175773|FG001|Overall Study|Participant planning pregnancy|0|||
161216554|NCT00549198|582175772|FG000|Overall Study|Participant overweight, no scan possible|1|||
161216555|NCT00549198|582175773|FG001|Overall Study|Participant overweight, no scan possible|0|||
161216556|NCT00549198|582175772|FG000|Overall Study|No scan facilities|0|||
161216557|NCT00549198|582175773|FG001|Overall Study|No scan facilities|2|||
161216558|NCT00549198|582175772|FG000|Overall Study|Pregnancy|0|||
161216559|NCT00549198|582175773|FG001|Overall Study|Pregnancy|3|||
161216560|NCT00549198|582175772|FG000|Overall Study|Not Exposed to Study Drug|3|||
161216561|NCT00549198|582175773|FG001|Overall Study|Not Exposed to Study Drug|4|||
161216562|NCT01034137|582175785|FG000|Overall Study|Adverse Event|9|||
161216563|NCT01034137|582175786|FG001|Overall Study|Adverse Event|10|||
161216564|NCT01034137|582175787|FG002|Overall Study|Adverse Event|8|||
161216565|NCT01034137|582175785|FG000|Overall Study|Withdrawal by Subject|4|||
161216566|NCT01034137|582175786|FG001|Overall Study|Withdrawal by Subject|3|||
161216567|NCT01034137|582175787|FG002|Overall Study|Withdrawal by Subject|3|||
161216568|NCT01034137|582175785|FG000|Overall Study|Lack of Efficacy|9|||
161216569|NCT01034137|582175786|FG001|Overall Study|Lack of Efficacy|4|||
161216570|NCT01034137|582175787|FG002|Overall Study|Lack of Efficacy|13|||
161216571|NCT01034137|582175785|FG000|Overall Study|Protocol Violation|2|||
161216572|NCT01034137|582175786|FG001|Overall Study|Protocol Violation|2|||
161216573|NCT01034137|582175787|FG002|Overall Study|Protocol Violation|1|||
161216574|NCT01034137|582175785|FG000|Overall Study|Refused treatment or did not cooperate|2|||
161216575|NCT01034137|582175786|FG001|Overall Study|Refused treatment or did not cooperate|0|||
161216576|NCT01034137|582175787|FG002|Overall Study|Refused treatment or did not cooperate|1|||
161216577|NCT01034137|582175785|FG000|Overall Study|Administrative or other|2|||
161216578|NCT01034137|582175786|FG001|Overall Study|Administrative or other|3|||
161216579|NCT01034137|582175787|FG002|Overall Study|Administrative or other|4|||
161216580|NCT03273387|582175788|FG000|Overall Study|Death|2|||
161216581|NCT03273387|582175789|FG001|Overall Study|Death|2|||
161216582|NCT03273387|582175788|FG000|Overall Study|Withdrawal by Subject|1|||
161216583|NCT03273387|582175789|FG001|Overall Study|Withdrawal by Subject|1|||
161216584|NCT01405950|582175790|FG000|Overall Study|Withdrawal by Subject|1|||
161216585|NCT01405950|582175791|FG001|Overall Study|Withdrawal by Subject|0|||
161216586|NCT01405950|582175792|FG002|Overall Study|Withdrawal by Subject|0|||
161216587|NCT01405950|582175793|FG003|Overall Study|Withdrawal by Subject|0|||
161216588|NCT01381900|582175794|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
161216589|NCT01381900|582175795|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
161216590|NCT01381900|582175796|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
161216591|NCT01381900|582175794|FG000|Overall Study|Adverse Event|4|||
161216592|NCT01381900|582175795|FG001|Overall Study|Adverse Event|6|||
161216593|NCT01381900|582175796|FG002|Overall Study|Adverse Event|7|||
161216594|NCT01381900|582175794|FG000|Overall Study|Noncompliance with study drug|0|||
161216595|NCT01381900|582175795|FG001|Overall Study|Noncompliance with study drug|0|||
161324386|NCT02098395|582573587|FG003|Overall Study|Withdrawal by Subject|13|||
161216596|NCT01381900|582175796|FG002|Overall Study|Noncompliance with study drug|1|||
161216597|NCT01381900|582175794|FG000|Overall Study|Physician Decision|0|||
161216598|NCT01381900|582175795|FG001|Overall Study|Physician Decision|1|||
161216599|NCT01381900|582175796|FG002|Overall Study|Physician Decision|1|||
161216600|NCT01381900|582175794|FG000|Overall Study|Protocol Violation|0|||
161216601|NCT01381900|582175795|FG001|Overall Study|Protocol Violation|1|||
161216602|NCT01381900|582175796|FG002|Overall Study|Protocol Violation|1|||
161216603|NCT01381900|582175794|FG000|Overall Study|Withdrawal by Subject|0|||
161216604|NCT01381900|582175795|FG001|Overall Study|Withdrawal by Subject|0|||
161216605|NCT01381900|582175796|FG002|Overall Study|Withdrawal by Subject|1|||
161216606|NCT01381900|582175794|FG000|Overall Study|Early withdraw|3|||
161216607|NCT01381900|582175795|FG001|Overall Study|Early withdraw|1|||
161216608|NCT01381900|582175796|FG002|Overall Study|Early withdraw|1|||
161216609|NCT01772368|582175798|FG000|Overall Study|Adverse Event|1|||
161216610|NCT01772368|582175798|FG000|Overall Study|Withdrawal by Subject|3|||
161216611|NCT01772368|582175798|FG000|Overall Study|Protocol Violation|2|||
161216612|NCT01772368|582175798|FG000|Overall Study|Other|1|||
161216613|NCT02668783|582175802|FG000|Overall Study|Pregnancy|0|||
161216614|NCT02668783|582175803|FG001|Overall Study|Pregnancy|1|||
161216615|NCT02668783|582175802|FG000|Overall Study|Protocol Violation|2|||
161216616|NCT02668783|582175803|FG001|Overall Study|Protocol Violation|1|||
161216617|NCT02668783|582175802|FG000|Overall Study|Study terminated by sponsor|9|||
161216618|NCT02668783|582175803|FG001|Overall Study|Study terminated by sponsor|10|||
161216619|NCT02668783|582175802|FG000|Overall Study|Subject moved|1|||
161216620|NCT02668783|582175803|FG001|Overall Study|Subject moved|0|||
161216621|NCT02668783|582175802|FG000|Overall Study|Withdrawal by Subject|1|||
161216622|NCT02668783|582175803|FG001|Overall Study|Withdrawal by Subject|0|||
161216623|NCT00112489|582175804|FG000|Overall Study|Refused further treatment|8|||
161216624|NCT00112489|582175804|FG000|Overall Study|Adverse Event|12|||
161216625|NCT00112489|582175804|FG000|Overall Study|Death|2|||
161216626|NCT00112489|582175804|FG000|Overall Study|Other, Not Specified|9|||
161216627|NCT00112489|582175804|FG000|Overall Study|Patient never treated|2|||
161216628|NCT00112489|582175804|FG000|Overall Study|Ineligible|7|||
161216629|NCT02891200|582175809|FG000|Overall Study|Lost to Follow-up|31|||
161216630|NCT02891200|582175810|FG001|Overall Study|Lost to Follow-up|36|||
161216631|NCT02891200|582175809|FG000|Overall Study|Death|10|||
161216632|NCT02891200|582175810|FG001|Overall Study|Death|9|||
161216633|NCT02891200|582175809|FG000|Overall Study|Withdrawal by Subject|1|||
161216634|NCT02891200|582175810|FG001|Overall Study|Withdrawal by Subject|4|||
161216635|NCT04480463|582175811|FG000|Overall Study|Death|0|||
161216636|NCT04480463|582175812|FG001|Overall Study|Death|1|||
161216637|NCT04480463|582175811|FG000|Overall Study|Adverse Event|6|||
161216638|NCT04480463|582175812|FG001|Overall Study|Adverse Event|8|||
161216639|NCT04480463|582175811|FG000|Overall Study|Lost to Follow-up|3|||
161216640|NCT04480463|582175812|FG001|Overall Study|Lost to Follow-up|2|||
161216641|NCT04480463|582175811|FG000|Overall Study|Physician Decision|2|||
161216642|NCT04480463|582175812|FG001|Overall Study|Physician Decision|5|||
161216643|NCT04480463|582175811|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
161216644|NCT04480463|582175812|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
161216645|NCT04480463|582175811|FG000|Overall Study|Protocol Violation|2|||
161216646|NCT04480463|582175812|FG001|Overall Study|Protocol Violation|1|||
161216647|NCT04480463|582175811|FG000|Overall Study|Withdrawal by Subject|6|||
161216648|NCT04480463|582175812|FG001|Overall Study|Withdrawal by Subject|7|||
161216649|NCT04480463|582175811|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
161216650|NCT04480463|582175812|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
161216651|NCT04480463|582175811|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
161216652|NCT04480463|582175812|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
161216653|NCT04480463|582175811|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
161216654|NCT04480463|582175812|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
161216655|NCT04480463|582175811|FG000|Overall Study|Other|6|||
161216656|NCT04480463|582175812|FG001|Overall Study|Other|4|||
161216657|NCT02231710|582175813|FG000|Overall Study|Physician Decision|1|||
161216658|NCT01339910|582175814|FG000|Overall Study|Withdrawal by Subject|1|||
161216659|NCT01339910|582175815|FG001|Overall Study|Withdrawal by Subject|0|||
161216660|NCT01339910|582175814|FG000|Overall Study|Physician Decision|1|||
161216661|NCT01339910|582175815|FG001|Overall Study|Physician Decision|0|||
160869415|NCT03614156|580913742|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
160869416|NCT03614156|580913743|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
161216662|NCT01339910|582175814|FG000|Overall Study|Disease relapse|1|||
161216663|NCT01339910|582175815|FG001|Overall Study|Disease relapse|4|||
161216664|NCT01399723|582175816|FG000|Overall Study|Lost to Follow-up|0|||
161216665|NCT01399723|582175817|FG001|Overall Study|Lost to Follow-up|1|||
161216666|NCT00673361|582175818|FG000|Overall Study|Screen Failure|2|||
161216667|NCT00124020|582175826|FG000|Overall Study|Death|67|||
161216668|NCT00124020|582175827|FG001|Overall Study|Death|71|||
161216669|NCT00124020|582175826|FG000|Overall Study|Withdrawal by Subject|13|||
161216670|NCT00124020|582175827|FG001|Overall Study|Withdrawal by Subject|11|||
161216671|NCT00124020|582175826|FG000|Overall Study|Lost to Follow-up|5|||
161216672|NCT00124020|582175827|FG001|Overall Study|Lost to Follow-up|8|||
161216673|NCT00124020|582175826|FG000|Overall Study|Other|1|||
161216674|NCT00124020|582175827|FG001|Overall Study|Other|1|||
161216675|NCT00124020|582175826|FG000|Overall Study|Transfer to another hospital|2|||
161216676|NCT00124020|582175827|FG001|Overall Study|Transfer to another hospital|0|||
161216677|NCT00268346|582175828|FG000|Overall Study|Adverse Event|0|||
161216678|NCT00268346|582175829|FG001|Overall Study|Adverse Event|1|||
161216679|NCT00268346|582175828|FG000|Overall Study|Death|0|||
161216680|NCT00268346|582175829|FG001|Overall Study|Death|1|||
161216681|NCT00268346|582175828|FG000|Overall Study|Withdrawal by Subject|0|||
161216682|NCT00268346|582175829|FG001|Overall Study|Withdrawal by Subject|1|||
161216683|NCT01799590|582175830|FG000|Overall Study|Adverse Event|13|||
161216684|NCT01799590|582175831|FG001|Overall Study|Adverse Event|7|||
161216685|NCT01799590|582175832|FG002|Overall Study|Adverse Event|5|||
161216686|NCT01799590|582175830|FG000|Overall Study|Pregnancy|2|||
161216687|NCT01799590|582175831|FG001|Overall Study|Pregnancy|0|||
161216688|NCT01799590|582175832|FG002|Overall Study|Pregnancy|0|||
161216689|NCT01799590|582175830|FG000|Overall Study|Lack of Efficacy|3|||
161216690|NCT01799590|582175831|FG001|Overall Study|Lack of Efficacy|1|||
161216691|NCT01799590|582175832|FG002|Overall Study|Lack of Efficacy|3|||
161216692|NCT01799590|582175830|FG000|Overall Study|Participants convenience|4|||
161216693|NCT01799590|582175831|FG001|Overall Study|Participants convenience|4|||
161216694|NCT01799590|582175832|FG002|Overall Study|Participants convenience|2|||
161216695|NCT01799590|582175830|FG000|Overall Study|Aggravation of complications|0|||
161216696|NCT01799590|582175831|FG001|Overall Study|Aggravation of complications|1|||
161216697|NCT01799590|582175832|FG002|Overall Study|Aggravation of complications|1|||
161216698|NCT01799590|582175830|FG000|Overall Study|Using drugs with restricted days of use|0|||
161216699|NCT01799590|582175831|FG001|Overall Study|Using drugs with restricted days of use|3|||
161216700|NCT01799590|582175832|FG002|Overall Study|Using drugs with restricted days of use|2|||
161216701|NCT01799590|582175830|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
161216702|NCT01799590|582175831|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
161216703|NCT01799590|582175832|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
161216704|NCT01799590|582175830|FG000|Overall Study|Other|3|||
161216705|NCT01799590|582175831|FG001|Overall Study|Other|0|||
161216706|NCT01799590|582175832|FG002|Overall Study|Other|1|||
161216707|NCT00752791|582175835|FG000|Overall Study|Adverse Event|7|||
161216708|NCT00752791|582175835|FG000|Overall Study|Withdrawal by Subject|1|||
161216709|NCT00752791|582175835|FG000|Overall Study|Physician Decision|1|||
161216710|NCT00752791|582175835|FG000|Overall Study|Death|1|||
161216711|NCT00752791|582175835|FG000|Overall Study|Renal transplant|3|||
161216712|NCT00752791|582175835|FG000|Overall Study|Switched to hemodialysis|2|||
161216713|NCT00752791|582175835|FG000|Overall Study|Protocol deviation|1|||
161216714|NCT01769378|582175840|FG000|Overall Study|Adverse Event|10|||
161216715|NCT01769378|582175841|FG001|Overall Study|Adverse Event|0|||
161216716|NCT01769378|582175840|FG000|Overall Study|Entry criteria not met|1|||
161216717|NCT01769378|582175841|FG001|Overall Study|Entry criteria not met|0|||
161216718|NCT01769378|582175840|FG000|Overall Study|Protocol Violation|1|||
161216719|NCT01769378|582175841|FG001|Overall Study|Protocol Violation|1|||
161216720|NCT01769378|582175840|FG000|Overall Study|Withdrawal by Subject|10|||
161216721|NCT01769378|582175841|FG001|Overall Study|Withdrawal by Subject|3|||
161216722|NCT01769378|582175840|FG000|Overall Study|Sponsor Decision|1|||
161216723|NCT01769378|582175841|FG001|Overall Study|Sponsor Decision|0|||
161216724|NCT01769378|582175840|FG000|Overall Study|Lost to Follow-up|2|||
161216725|NCT01769378|582175841|FG001|Overall Study|Lost to Follow-up|0|||
161216726|NCT01977092|582175842|FG000|Overall Study|Death|3|||
161216727|NCT01977092|582175843|FG001|Overall Study|Death|4|||
161216728|NCT01977092|582175842|FG000|Overall Study|Lost to Follow-up|23|||
161216729|NCT01977092|582175843|FG001|Overall Study|Lost to Follow-up|14|||
161216730|NCT01977092|582175842|FG000|Overall Study|Withdrawal by Subject|2|||
161216731|NCT01977092|582175843|FG001|Overall Study|Withdrawal by Subject|1|||
161216732|NCT01977092|582175842|FG000|Overall Study|In prison|3|||
161324387|NCT02098395|582573584|FG000|Overall Study|Adverse Event|12|||
161216733|NCT01977092|582175843|FG001|Overall Study|In prison|11|||
161216734|NCT03038113|582175844|FG000|Overall Study|Withdrawal by Subject|0|||
161216735|NCT03038113|582175845|FG001|Overall Study|Withdrawal by Subject|0|||
161216736|NCT03038113|582175846|FG002|Overall Study|Withdrawal by Subject|1|||
161216737|NCT03038113|582175847|FG003|Overall Study|Withdrawal by Subject|0|||
161216738|NCT03038113|582175848|FG004|Overall Study|Withdrawal by Subject|0|||
161216739|NCT03038113|582175849|FG005|Overall Study|Withdrawal by Subject|0|||
161216740|NCT03038113|582175850|FG006|Overall Study|Withdrawal by Subject|0|||
161216741|NCT03038113|582175851|FG007|Overall Study|Withdrawal by Subject|0|||
161216742|NCT03038113|582175852|FG008|Overall Study|Withdrawal by Subject|0|||
161216743|NCT03038113|582175853|FG009|Overall Study|Withdrawal by Subject|0|||
161216744|NCT03038113|582175854|FG010|Overall Study|Withdrawal by Subject|0|||
161216745|NCT03038113|582175855|FG011|Overall Study|Withdrawal by Subject|0|||
161216746|NCT03038113|582175856|FG012|Overall Study|Withdrawal by Subject|0|||
161216747|NCT03038113|582175857|FG013|Overall Study|Withdrawal by Subject|1|||
161216748|NCT03038113|582175844|FG000|Overall Study|Lost to Follow-up|0|||
161216749|NCT03038113|582175845|FG001|Overall Study|Lost to Follow-up|0|||
161216750|NCT03038113|582175846|FG002|Overall Study|Lost to Follow-up|0|||
160869417|NCT03614156|580913740|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
160869418|NCT03614156|580913741|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
160869419|NCT03614156|580913742|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
160869420|NCT03614156|580913743|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
160869421|NCT03614156|580913740|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
160869422|NCT03614156|580913741|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
160869423|NCT03614156|580913742|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
160869424|NCT03614156|580913743|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
160869425|NCT03614156|580913740|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
160869426|NCT03614156|580913741|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
160869427|NCT03614156|580913742|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
160869428|NCT03614156|580913743|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
160869429|NCT03070964|580913745|FG000|Overall Study|Progressive disease|8|||
160869430|NCT03070964|580913745|FG000|Overall Study|Treatment-unrelated adverse event|2|||
160869431|NCT03070964|580913745|FG000|Overall Study|Never treated|1|||
160869432|NCT03070964|580913745|FG000|Overall Study|Physician Decision|1|||
160869433|NCT03070964|580913745|FG000|Overall Study|Withdrawal by Subject|1|||
160869434|NCT03070964|580913745|FG000|Overall Study|Adverse Event|1|||
160869435|NCT01094119|580913746|FG000|Overall Study|Lack of Efficacy|2|||
160869436|NCT01094119|580913747|FG001|Overall Study|Lack of Efficacy|4|||
160869437|NCT00834093|580913748|FG000|Overall Study|Progressive Disease|3|||
160869438|NCT00834093|580913748|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
160869439|NCT01587924|580913749|FG000|Overall Study|Adverse Event|0|||
160869440|NCT01587924|580913750|FG001|Overall Study|Adverse Event|2|||
160869441|NCT01587924|580913751|FG002|Overall Study|Adverse Event|0|||
160869442|NCT01587924|580913752|FG003|Overall Study|Adverse Event|0|||
160869443|NCT01587924|580913749|FG000|Overall Study|Protocol Violation|2|||
160869444|NCT01587924|580913750|FG001|Overall Study|Protocol Violation|1|||
160869445|NCT01587924|580913751|FG002|Overall Study|Protocol Violation|2|||
160869446|NCT01587924|580913752|FG003|Overall Study|Protocol Violation|1|||
160869447|NCT01587924|580913749|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
160869448|NCT01587924|580913750|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
160869449|NCT01587924|580913751|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
160869450|NCT01587924|580913752|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
160869451|NCT01587924|580913749|FG000|Overall Study|Withdrawal by Subject|0|||
160869452|NCT01587924|580913750|FG001|Overall Study|Withdrawal by Subject|1|||
160869453|NCT01587924|580913751|FG002|Overall Study|Withdrawal by Subject|1|||
160869454|NCT01587924|580913752|FG003|Overall Study|Withdrawal by Subject|0|||
160869455|NCT01578486|580913753|FG000|Overall Study|Physician Decision|3|||
160869456|NCT01578486|580913753|FG000|Overall Study|Withdrawal by Subject|2|||
160869457|NCT00357903|580913755|FG000|Overall Study|Adverse Event|87|||
160869458|NCT00357903|580913756|FG001|Overall Study|Adverse Event|4|||
160869459|NCT00357903|580913755|FG000|Overall Study|Death|33|||
160869460|NCT00357903|580913756|FG001|Overall Study|Death|0|||
160869461|NCT00357903|580913755|FG000|Overall Study|Lost to Follow-up|23|||
160869462|NCT00357903|580913756|FG001|Overall Study|Lost to Follow-up|4|||
160869463|NCT00357903|580913755|FG000|Overall Study|Physician Decision|39|||
160869464|NCT00357903|580913756|FG001|Overall Study|Physician Decision|5|||
160869465|NCT00357903|580913755|FG000|Overall Study|Withdrawal by Subject|57|||
160869466|NCT00357903|580913756|FG001|Overall Study|Withdrawal by Subject|7|||
160869467|NCT00357903|580913755|FG000|Overall Study|Completed month 12 only|0|||
161216751|NCT03038113|582175847|FG003|Overall Study|Lost to Follow-up|0|||
161216752|NCT03038113|582175848|FG004|Overall Study|Lost to Follow-up|0|||
161216753|NCT03038113|582175849|FG005|Overall Study|Lost to Follow-up|0|||
161324388|NCT02098395|582573585|FG001|Overall Study|Adverse Event|19|||
161324389|NCT02098395|582573586|FG002|Overall Study|Adverse Event|34|||
160869468|NCT00357903|580913756|FG001|Overall Study|Completed month 12 only|1|||
160869469|NCT00357903|580913755|FG000|Overall Study|Protocol issues|14|||
160869470|NCT00357903|580913756|FG001|Overall Study|Protocol issues|3|||
160869471|NCT00357903|580913755|FG000|Overall Study|Response status|61|||
160869472|NCT00357903|580913756|FG001|Overall Study|Response status|9|||
160869473|NCT00357903|580913755|FG000|Overall Study|Other|49|||
160869474|NCT00357903|580913756|FG001|Overall Study|Other|10|||
160869475|NCT00606593|580913757|FG000|Overall Study|Adverse Event|0|||
160869476|NCT00606593|580913758|FG001|Overall Study|Adverse Event|0|||
160869477|NCT00606593|580913759|FG002|Overall Study|Adverse Event|0|||
160869478|NCT00606593|580913760|FG003|Overall Study|Adverse Event|1|||
160869479|NCT00606593|580913761|FG004|Overall Study|Adverse Event|1|||
160869480|NCT00606593|580913762|FG005|Overall Study|Adverse Event|0|||
160869481|NCT00606593|580913763|FG006|Overall Study|Adverse Event|1|||
160869482|NCT00606593|580913764|FG007|Overall Study|Adverse Event|2|||
160869483|NCT00606593|580913765|FG008|Overall Study|Adverse Event|1|||
160869484|NCT00606593|580913766|FG009|Overall Study|Adverse Event|0|||
160869485|NCT00606593|580913757|FG000|Overall Study|Withdrawal of consent|1|||
160869486|NCT00606593|580913758|FG001|Overall Study|Withdrawal of consent|0|||
160869487|NCT00606593|580913759|FG002|Overall Study|Withdrawal of consent|1|||
160869488|NCT00606593|580913760|FG003|Overall Study|Withdrawal of consent|0|||
160869489|NCT00606593|580913761|FG004|Overall Study|Withdrawal of consent|0|||
161111792|NCT00820950|581799452|FG001|Overall Study|Protocol Violation|1|||
161111793|NCT00820950|581799453|FG002|Overall Study|Protocol Violation|0|||
161111794|NCT00820950|581799454|FG003|Overall Study|Protocol Violation|0|||
161111795|NCT00820950|581799455|FG004|Overall Study|Protocol Violation|0|||
161111796|NCT00820950|581799456|FG005|Overall Study|Protocol Violation|0|||
161111797|NCT00820950|581799457|FG006|Overall Study|Protocol Violation|0|||
161111798|NCT00820950|581799458|FG007|Overall Study|Protocol Violation|0|||
161111799|NCT00820950|581799459|FG008|Overall Study|Protocol Violation|0|||
161111800|NCT00820950|581799460|FG009|Overall Study|Protocol Violation|0|||
161111801|NCT00609791|581800956|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
161111802|NCT02484911|581800958|FG000|Overall Study|Withdrawal by Subject|2|||
161111803|NCT02484911|581800959|FG001|Overall Study|Withdrawal by Subject|1|||
161111804|NCT02484911|581800958|FG000|Overall Study|Protocol Violation|2|||
161111805|NCT02484911|581800959|FG001|Overall Study|Protocol Violation|1|||
161111806|NCT04129528|581800960|FG000|Overall Study|Adverse Event|1|||
161111807|NCT04129528|581800961|FG001|Overall Study|Adverse Event|0|||
161111808|NCT04129528|581800960|FG000|Overall Study|Physician Decision|1|||
161111809|NCT04129528|581800961|FG001|Overall Study|Physician Decision|1|||
161111810|NCT04129528|581800960|FG000|Overall Study|Withdrawal by Subject|1|||
161111811|NCT04129528|581800961|FG001|Overall Study|Withdrawal by Subject|1|||
161111812|NCT00490568|581800965|FG000|Overall Study|Adverse Event|116|||
161111813|NCT00490568|581800965|FG000|Overall Study|Lost to Follow-up|13|||
161111814|NCT00490568|581800965|FG000|Overall Study|Protocol Violation|45|||
161111815|NCT00490568|581800965|FG000|Overall Study|Withdrawal by Subject|135|||
161111816|NCT00490568|581800965|FG000|Overall Study|Still in the study at termination|974|||
161111817|NCT00490568|581800965|FG000|Overall Study|Other|1|||
161111818|NCT00490568|581800965|FG000|Overall Study|Exclusion criteria met|1|||
161111819|NCT00490568|581800965|FG000|Overall Study|Caregiver related|20|||
161111820|NCT00490568|581800965|FG000|Overall Study|Abnormal ECG|25|||
161111821|NCT00490568|581800965|FG000|Overall Study|Participant refused follow-up|9|||
161111822|NCT00490568|581800965|FG000|Overall Study|Legal representative withdrew consent|1|||
161111823|NCT00490568|581800965|FG000|Overall Study|Disease progression|4|||
161111824|NCT00490568|581800965|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
161111825|NCT00490568|581800965|FG000|Overall Study|Investigator decision|3|||
161111826|NCT00490568|581800965|FG000|Overall Study|Non-Compliance|7|||
161111827|NCT00490568|581800965|FG000|Overall Study|Efficacy related|3|||
161111828|NCT00490568|581800965|FG000|Overall Study|Participant died|1|||
161111829|NCT00490568|581800965|FG000|Overall Study|Participant withdrawal due to surgery|1|||
161111830|NCT03927105|581800968|FG000|Overall Study|Death|1|||
161111831|NCT03927105|581800968|FG000|Overall Study|In observation for potential re-treatment|2|||
161111832|NCT03927105|581800968|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
161111833|NCT01351389|581800970|FG000|Overall Study|Withdrawal by Subject|7|||
161111834|NCT01351389|581800971|FG001|Overall Study|Withdrawal by Subject|0|||
161111835|NCT01351389|581800970|FG000|Overall Study|did not complete intervention|23|||
161111836|NCT01351389|581800971|FG001|Overall Study|did not complete intervention|15|||
161111837|NCT01902966|581800976|FG000|Overall Study|Death|1|||
161111838|NCT01902966|581800976|FG000|Overall Study|Physician Decision|1|||
161111839|NCT01902966|581800976|FG000|Overall Study|Withdrawal by Subject|1|||
161111840|NCT01549275|581800977|FG000|Overall Study|Lost to Follow-up|1|||
161111841|NCT01549275|581800978|FG001|Overall Study|Lost to Follow-up|0|||
161111842|NCT01081912|581800986|FG000|Conversion/Titration|Adverse Event|47|||
161111843|NCT01081912|581800987|FG001|Conversion/Titration|Adverse Event|0|||
161111844|NCT01081912|581800988|FG002|Conversion/Titration|Adverse Event|0|||
161111845|NCT01081912|581800986|FG000|Conversion/Titration|Lack of Efficacy|17|||
161111846|NCT01081912|581800987|FG001|Conversion/Titration|Lack of Efficacy|0|||
161111847|NCT01081912|581800988|FG002|Conversion/Titration|Lack of Efficacy|0|||
161111848|NCT01081912|581800986|FG000|Conversion/Titration|Lost to Follow-up|5|||
161111849|NCT01081912|581800987|FG001|Conversion/Titration|Lost to Follow-up|0|||
161111850|NCT01081912|581800988|FG002|Conversion/Titration|Lost to Follow-up|0|||
161111851|NCT01081912|581800986|FG000|Conversion/Titration|Physician Decision|2|||
161111852|NCT01081912|581800987|FG001|Conversion/Titration|Physician Decision|0|||
161111853|NCT01081912|581800988|FG002|Conversion/Titration|Physician Decision|0|||
160869490|NCT00606593|580913762|FG005|Overall Study|Withdrawal of consent|0|||
161111854|NCT01081912|581800986|FG000|Conversion/Titration|Protocol Violation|67|||
161111855|NCT01081912|581800987|FG001|Conversion/Titration|Protocol Violation|0|||
161111856|NCT01081912|581800988|FG002|Conversion/Titration|Protocol Violation|0|||
161111857|NCT01081912|581800986|FG000|Conversion/Titration|Withdrawal by Subject|23|||
161111858|NCT01081912|581800987|FG001|Conversion/Titration|Withdrawal by Subject|0|||
161111859|NCT01081912|581800988|FG002|Conversion/Titration|Withdrawal by Subject|0|||
161111860|NCT01081912|581800986|FG000|Conversion/Titration|Non-Compliance|47|||
161111861|NCT01081912|581800987|FG001|Conversion/Titration|Non-Compliance|0|||
161111862|NCT01081912|581800988|FG002|Conversion/Titration|Non-Compliance|0|||
161111863|NCT01081912|581800986|FG000|Maintenance Treatment|Adverse Event|0|||
161111864|NCT01081912|581800987|FG001|Maintenance Treatment|Adverse Event|2|||
161111865|NCT01081912|581800988|FG002|Maintenance Treatment|Adverse Event|12|||
161111866|NCT01081912|581800986|FG000|Maintenance Treatment|Lack of Efficacy|0|||
161111867|NCT01081912|581800987|FG001|Maintenance Treatment|Lack of Efficacy|14|||
161111868|NCT01081912|581800988|FG002|Maintenance Treatment|Lack of Efficacy|64|||
161111869|NCT01081912|581800986|FG000|Maintenance Treatment|Lost to Follow-up|0|||
161111870|NCT01081912|581800987|FG001|Maintenance Treatment|Lost to Follow-up|1|||
161111871|NCT01081912|581800988|FG002|Maintenance Treatment|Lost to Follow-up|0|||
161111872|NCT01081912|581800986|FG000|Maintenance Treatment|Physician Decision|0|||
161111873|NCT01081912|581800987|FG001|Maintenance Treatment|Physician Decision|0|||
161111874|NCT01081912|581800988|FG002|Maintenance Treatment|Physician Decision|1|||
161111875|NCT01081912|581800986|FG000|Maintenance Treatment|Protocol Violation|0|||
161111876|NCT01081912|581800987|FG001|Maintenance Treatment|Protocol Violation|1|||
161111877|NCT01081912|581800988|FG002|Maintenance Treatment|Protocol Violation|2|||
161111878|NCT01081912|581800986|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
161111879|NCT01081912|581800987|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
161111880|NCT01081912|581800988|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
161111881|NCT01081912|581800986|FG000|Maintenance Treatment|Non-Compliance|0|||
161111882|NCT01081912|581800987|FG001|Maintenance Treatment|Non-Compliance|4|||
161111883|NCT01081912|581800988|FG002|Maintenance Treatment|Non-Compliance|7|||
161111884|NCT01081912|581800986|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
161111885|NCT01081912|581800987|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
161111886|NCT01081912|581800988|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
161111887|NCT01140451|581800990|FG000|Overall Study|Withdrawal by Subject|26|||
161111888|NCT01140451|581800991|FG001|Overall Study|Withdrawal by Subject|33|||
161111889|NCT01140451|581800990|FG000|Overall Study|Adverse Event|2|||
161111890|NCT01140451|581800991|FG001|Overall Study|Adverse Event|6|||
161111891|NCT01140451|581800990|FG000|Overall Study|Physician Decision|5|||
161111892|NCT01140451|581800991|FG001|Overall Study|Physician Decision|3|||
161111893|NCT01140451|581800990|FG000|Overall Study|Lost to Follow-up|2|||
161111894|NCT01140451|581800991|FG001|Overall Study|Lost to Follow-up|0|||
161111895|NCT01140451|581800990|FG000|Overall Study|Participants Planning Pregnancy|3|||
161111896|NCT01140451|581800991|FG001|Overall Study|Participants Planning Pregnancy|0|||
161111897|NCT00441974|581800995|FG000|Overall Study|Adverse Event|6|||
161111898|NCT00441974|581800995|FG000|Overall Study|Consent Withdrawn|35|||
161111899|NCT00441974|581800995|FG000|Overall Study|Lost to Follow-up|80|||
161111900|NCT00441974|581800995|FG000|Overall Study|Protocol Violation|7|||
161111901|NCT02614859|581800996|FG000|Overall Study|Physician Decision|0|||
161111902|NCT02614859|581800997|FG001|Overall Study|Physician Decision|1|||
161111903|NCT03571646|581801000|FG000|Overall Study|Adverse Event|1|||
161111904|NCT03571646|581801001|FG001|Overall Study|Adverse Event|0|||
161111905|NCT03571646|581801000|FG000|Overall Study|Withdrawal by Subject|1|||
161111906|NCT03571646|581801001|FG001|Overall Study|Withdrawal by Subject|1|||
161111907|NCT03972969|581801002|FG000|3-month Follow-up|Death|1|||
161111908|NCT03972969|581801003|FG001|3-month Follow-up|Death|1|||
161111909|NCT03972969|581801004|FG002|3-month Follow-up|Death|0|||
161111910|NCT03972969|581801002|FG000|6-month Follow-up|Death|1|||
161111911|NCT03972969|581801003|FG001|6-month Follow-up|Death|1|||
161111912|NCT03972969|581801004|FG002|6-month Follow-up|Death|1|||
161111913|NCT03972969|581801002|FG000|6-month Follow-up|Lost to Follow-up|2|||
161111914|NCT03972969|581801003|FG001|6-month Follow-up|Lost to Follow-up|2|||
161111915|NCT03972969|581801004|FG002|6-month Follow-up|Lost to Follow-up|2|||
161111916|NCT04677959|581801005|FG000|Overall Study|Adverse Event|1|||
161111917|NCT04677959|581801006|FG001|Overall Study|Adverse Event|9|||
161111918|NCT04677959|581801005|FG000|Overall Study|Withdrawal by Subject|2|||
161111919|NCT04677959|581801006|FG001|Overall Study|Withdrawal by Subject|15|||
161111920|NCT04677959|581801005|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161111921|NCT04677959|581801006|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161111922|NCT04677959|581801005|FG000|Overall Study|Non-compliance with study drug|0|||
161111923|NCT04677959|581801006|FG001|Overall Study|Non-compliance with study drug|2|||
161111924|NCT04677959|581801005|FG000|Overall Study|Protocol deviation|0|||
161111925|NCT04677959|581801006|FG001|Overall Study|Protocol deviation|11|||
161111926|NCT04677959|581801005|FG000|Overall Study|Lost to Follow-up|9|||
161216754|NCT03038113|582175850|FG006|Overall Study|Lost to Follow-up|1|||
161216755|NCT03038113|582175851|FG007|Overall Study|Lost to Follow-up|0|||
161216756|NCT03038113|582175852|FG008|Overall Study|Lost to Follow-up|0|||
161216757|NCT03038113|582175853|FG009|Overall Study|Lost to Follow-up|0|||
161216758|NCT03038113|582175854|FG010|Overall Study|Lost to Follow-up|0|||
161216759|NCT03038113|582175855|FG011|Overall Study|Lost to Follow-up|0|||
161216760|NCT03038113|582175856|FG012|Overall Study|Lost to Follow-up|0|||
161216761|NCT03038113|582175857|FG013|Overall Study|Lost to Follow-up|0|||
161216762|NCT02784106|582175860|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
161216763|NCT02784106|582175861|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
161216764|NCT02784106|582175862|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161216765|NCT02784106|582175863|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
161216766|NCT02784106|582175860|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
161216767|NCT02784106|582175861|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
161216768|NCT02784106|582175862|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161216769|NCT02784106|582175863|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161216770|NCT02784106|582175860|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
161216771|NCT02784106|582175861|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161216772|NCT02784106|582175862|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161216773|NCT02784106|582175863|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
161216774|NCT02784106|582175860|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
161216775|NCT02784106|582175861|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161216776|NCT02784106|582175862|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161216777|NCT02784106|582175863|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161216778|NCT02784106|582175860|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
161216779|NCT02784106|582175861|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
161216780|NCT02784106|582175862|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
161216781|NCT02784106|582175863|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
161216782|NCT02784106|582175860|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
161216783|NCT02784106|582175861|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
161216784|NCT02784106|582175862|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
161216785|NCT02784106|582175863|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
161216786|NCT02927847|582175865|FG000|Overall Study|Lost to Follow-up|1|||
161216787|NCT02927847|582175866|FG001|Overall Study|Lost to Follow-up|0|||
161216788|NCT02927847|582175865|FG000|Overall Study|Withdrawal by Subject|4|||
161216789|NCT02927847|582175866|FG001|Overall Study|Withdrawal by Subject|2|||
161216790|NCT02927847|582175865|FG000|Overall Study|PI withdrawn due to missed visits|1|||
161216791|NCT02927847|582175866|FG001|Overall Study|PI withdrawn due to missed visits|1|||
161216792|NCT00553540|582175867|FG000|Overall Study|discharged after first visit|2|||
161216793|NCT00553540|582175868|FG001|Overall Study|discharged after first visit|5|||
161216794|NCT01755858|582175871|FG000|Overall Study|Adverse Event|1|||
161216795|NCT01755858|582175872|FG001|Overall Study|Adverse Event|1|||
161216796|NCT03882047|582175873|FG000|Overall Study|Adverse Event|0|||
161216797|NCT03882047|582175874|FG001|Overall Study|Adverse Event|2|||
161216798|NCT03882047|582175875|FG002|Overall Study|Adverse Event|2|||
161216799|NCT03882047|582175873|FG000|Overall Study|Treatment Failure|3|||
161216800|NCT03882047|582175874|FG001|Overall Study|Treatment Failure|3|||
161216801|NCT03882047|582175875|FG002|Overall Study|Treatment Failure|12|||
161216802|NCT03882047|582175873|FG000|Overall Study|Lost to Follow-up|0|||
161216803|NCT03882047|582175874|FG001|Overall Study|Lost to Follow-up|1|||
161216804|NCT03882047|582175875|FG002|Overall Study|Lost to Follow-up|0|||
161216805|NCT03882047|582175873|FG000|Overall Study|Did Not Wish to Continue|1|||
161216806|NCT03882047|582175874|FG001|Overall Study|Did Not Wish to Continue|4|||
161216807|NCT03882047|582175875|FG002|Overall Study|Did Not Wish to Continue|1|||
161216808|NCT03882047|582175873|FG000|Overall Study|Noncompliance With Protocol|2|||
161216809|NCT03882047|582175874|FG001|Overall Study|Noncompliance With Protocol|0|||
161216810|NCT03882047|582175875|FG002|Overall Study|Noncompliance With Protocol|0|||
161216811|NCT03882047|582175873|FG000|Overall Study|Did Not Meet Eligibility|0|||
161216812|NCT03882047|582175874|FG001|Overall Study|Did Not Meet Eligibility|0|||
161216813|NCT03882047|582175875|FG002|Overall Study|Did Not Meet Eligibility|1|||
161216814|NCT00175019|582175877|FG000|Overall Study|Adverse Event|54|||
161216815|NCT00175019|582175878|FG001|Overall Study|Adverse Event|22|||
161216816|NCT00175019|582175879|FG002|Overall Study|Adverse Event|2|||
161216817|NCT00175019|582175877|FG000|Overall Study|Protocol Violation|6|||
161216818|NCT00175019|582175878|FG001|Overall Study|Protocol Violation|3|||
161216819|NCT00175019|582175879|FG002|Overall Study|Protocol Violation|3|||
161216820|NCT00175019|582175877|FG000|Overall Study|Lost to Follow-up|42|||
161216821|NCT00175019|582175878|FG001|Overall Study|Lost to Follow-up|39|||
160869491|NCT00606593|580913763|FG006|Overall Study|Withdrawal of consent|0|||
160869492|NCT00606593|580913764|FG007|Overall Study|Withdrawal of consent|0|||
161216822|NCT00175019|582175879|FG002|Overall Study|Lost to Follow-up|9|||
161216823|NCT00175019|582175877|FG000|Overall Study|Did not continue under Amendment 4|1|||
161216824|NCT00175019|582175878|FG001|Overall Study|Did not continue under Amendment 4|1|||
161111927|NCT04677959|581801006|FG001|Overall Study|Lost to Follow-up|13|||
161111928|NCT04677959|581801005|FG000|Overall Study|Other than specified|0|||
161111929|NCT04677959|581801006|FG001|Overall Study|Other than specified|8|||
161111930|NCT00732303|581801007|FG000|Overall Study|Study Terminated|2|||
161111931|NCT00283595|581801008|FG000|Overall Study|Withdrawal by Subject|1|||
161111932|NCT00283595|581801009|FG001|Overall Study|Withdrawal by Subject|2|||
161111933|NCT04718974|581801013|FG000|Overall Study|Death|0|||
161111934|NCT04718974|581801014|FG001|Overall Study|Death|2|||
161111935|NCT04718974|581801013|FG000|Overall Study|Lost to Follow-up|10|||
161111936|NCT04718974|581801014|FG001|Overall Study|Lost to Follow-up|20|||
161111937|NCT04718974|581801013|FG000|Overall Study|Transferred out|2|||
161111938|NCT04718974|581801014|FG001|Overall Study|Transferred out|4|||
161111939|NCT00845728|581801015|FG000|Overall Study|Abnormal laboratory value (s)|2|||
161111940|NCT00845728|581801016|FG001|Overall Study|Abnormal laboratory value (s)|2|||
161111941|NCT00845728|581801015|FG000|Overall Study|Patient's inability to use the device|4|||
161111942|NCT00845728|581801016|FG001|Overall Study|Patient's inability to use the device|6|||
161111943|NCT00845728|581801015|FG000|Overall Study|Abnormal test procedure result (s)|7|||
161111944|NCT00845728|581801016|FG001|Overall Study|Abnormal test procedure result (s)|2|||
161111945|NCT00845728|581801015|FG000|Overall Study|Lost to Follow-up|22|||
161111946|NCT00845728|581801016|FG001|Overall Study|Lost to Follow-up|13|||
161111947|NCT00845728|581801015|FG000|Overall Study|Death|24|||
161111948|NCT00845728|581801016|FG001|Overall Study|Death|26|||
161111949|NCT00845728|581801015|FG000|Overall Study|Administrative Problems|34|||
161111950|NCT00845728|581801016|FG001|Overall Study|Administrative Problems|26|||
161111951|NCT00845728|581801015|FG000|Overall Study|Protocol Violation|36|||
161111952|NCT00845728|581801016|FG001|Overall Study|Protocol Violation|24|||
161111953|NCT00845728|581801015|FG000|Overall Study|Lack of Efficacy|51|||
161111954|NCT00845728|581801016|FG001|Overall Study|Lack of Efficacy|39|||
161111955|NCT00845728|581801015|FG000|Overall Study|Adverse Event|101|||
161111956|NCT00845728|581801016|FG001|Overall Study|Adverse Event|96|||
161111957|NCT00845728|581801015|FG000|Overall Study|Withdrawal by Subject|105|||
161111958|NCT00845728|581801016|FG001|Overall Study|Withdrawal by Subject|108|||
161111959|NCT01389752|581801017|FG000|Study Period 1|Sponsor decision|0|||
161111960|NCT01389752|581801018|FG001|Study Period 1|Sponsor decision|2|||
161111961|NCT01389752|581801017|FG000|Study Period 2|Sponsor decision|1|||
161111962|NCT01389752|581801018|FG001|Study Period 2|Sponsor decision|0|||
161111963|NCT03259074|581801019|FG000|Overall Study|Adverse Event|9|||
161111964|NCT03259074|581801020|FG001|Overall Study|Adverse Event|12|||
161111965|NCT03259074|581801021|FG002|Overall Study|Adverse Event|8|||
161111966|NCT03259074|581801019|FG000|Overall Study|Death|1|||
161111967|NCT03259074|581801020|FG001|Overall Study|Death|1|||
161111968|NCT03259074|581801021|FG002|Overall Study|Death|3|||
161111969|NCT03259074|581801019|FG000|Overall Study|Lost to Follow-up|2|||
161111970|NCT03259074|581801020|FG001|Overall Study|Lost to Follow-up|4|||
161111971|NCT03259074|581801021|FG002|Overall Study|Lost to Follow-up|3|||
161111972|NCT03259074|581801019|FG000|Overall Study|New Therapy For Study Indication|1|||
161111973|NCT03259074|581801020|FG001|Overall Study|New Therapy For Study Indication|2|||
161111974|NCT03259074|581801021|FG002|Overall Study|New Therapy For Study Indication|2|||
161111975|NCT03259074|581801019|FG000|Overall Study|Physician Decision|4|||
161111976|NCT03259074|581801020|FG001|Overall Study|Physician Decision|12|||
161111977|NCT03259074|581801021|FG002|Overall Study|Physician Decision|10|||
161111978|NCT03259074|581801019|FG000|Overall Study|Pregnancy|1|||
161111979|NCT03259074|581801020|FG001|Overall Study|Pregnancy|1|||
161111980|NCT03259074|581801021|FG002|Overall Study|Pregnancy|0|||
161111981|NCT03259074|581801019|FG000|Overall Study|Progressive Disease|1|||
161111982|NCT03259074|581801020|FG001|Overall Study|Progressive Disease|0|||
161111983|NCT03259074|581801021|FG002|Overall Study|Progressive Disease|0|||
161111984|NCT03259074|581801019|FG000|Overall Study|Protocol Deviation|1|||
161111985|NCT03259074|581801020|FG001|Overall Study|Protocol Deviation|1|||
161111986|NCT03259074|581801021|FG002|Overall Study|Protocol Deviation|3|||
161111987|NCT03259074|581801019|FG000|Overall Study|Subject/Guardian Decision|13|||
161111988|NCT03259074|581801020|FG001|Overall Study|Subject/Guardian Decision|16|||
161111989|NCT03259074|581801021|FG002|Overall Study|Subject/Guardian Decision|14|||
161111990|NCT01576549|581801032|FG000|Overall Study|Sponsor Decision|2|||
161111991|NCT00053417|581801033|FG000|Overall Study|Adverse Event|1|||
161111992|NCT00053417|581801034|FG001|Overall Study|Adverse Event|0|||
161111993|NCT00053417|581801035|FG002|Overall Study|Adverse Event|1|||
161111994|NCT00053417|581801036|FG003|Overall Study|Adverse Event|5|||
161111995|NCT00053417|581801033|FG000|Overall Study|Non-Compliance|0|||
161111996|NCT00053417|581801034|FG001|Overall Study|Non-Compliance|0|||
161111997|NCT00053417|581801035|FG002|Overall Study|Non-Compliance|0|||
161111998|NCT00053417|581801036|FG003|Overall Study|Non-Compliance|1|||
161111999|NCT00053417|581801033|FG000|Overall Study|Withdrawal by Subject|0|||
161112000|NCT00053417|581801034|FG001|Overall Study|Withdrawal by Subject|1|||
161112001|NCT00053417|581801035|FG002|Overall Study|Withdrawal by Subject|0|||
161112002|NCT00053417|581801036|FG003|Overall Study|Withdrawal by Subject|0|||
161112003|NCT00053417|581801033|FG000|Overall Study|Lost to Follow-up|1|||
161216825|NCT00175019|582175879|FG002|Overall Study|Did not continue under Amendment 4|2|||
161216826|NCT00175019|582175877|FG000|Overall Study|Personal Reason(s)|39|||
161216827|NCT00175019|582175878|FG001|Overall Study|Personal Reason(s)|31|||
161216828|NCT00175019|582175879|FG002|Overall Study|Personal Reason(s)|8|||
161216829|NCT00175019|582175877|FG000|Overall Study|Therapeutic Failure|10|||
161216830|NCT00175019|582175878|FG001|Overall Study|Therapeutic Failure|38|||
161216831|NCT00175019|582175879|FG002|Overall Study|Therapeutic Failure|22|||
161216832|NCT00175019|582175877|FG000|Overall Study|Gout Flare|2|||
161216833|NCT00175019|582175878|FG001|Overall Study|Gout Flare|3|||
161216834|NCT00175019|582175879|FG002|Overall Study|Gout Flare|0|||
161216835|NCT00175019|582175877|FG000|Overall Study|Reason Not Specified|40|||
161216836|NCT00175019|582175878|FG001|Overall Study|Reason Not Specified|34|||
161216837|NCT00175019|582175879|FG002|Overall Study|Reason Not Specified|11|||
161216838|NCT00475852|582175884|FG000|Overall Study|Death|444|||
161216839|NCT00475852|582175885|FG001|Overall Study|Death|456|||
161216840|NCT00475852|582175884|FG000|Overall Study|Withdrawal by Subject|19|||
161216841|NCT00475852|582175885|FG001|Overall Study|Withdrawal by Subject|24|||
161216842|NCT00475852|582175884|FG000|Overall Study|Lost to Follow-up|54|||
161216843|NCT00475852|582175885|FG001|Overall Study|Lost to Follow-up|68|||
161216844|NCT00297479|582175886|FG000|Overall Study|Lost to Follow-up|37|||
161216845|NCT00297479|582175887|FG001|Overall Study|Lost to Follow-up|54|||
161216846|NCT00297479|582175888|FG002|Overall Study|Lost to Follow-up|51|||
161216847|NCT03263819|582175889|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
161216848|NCT03263819|582175890|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
161216849|NCT00686920|582175892|FG000|Overall Study|Death|45|||
161216850|NCT00686920|582175893|FG001|Overall Study|Death|14|||
161216851|NCT00686920|582175892|FG000|Overall Study|Liver Transplant|23|||
161216852|NCT00686920|582175893|FG001|Overall Study|Liver Transplant|8|||
161216853|NCT00686920|582175892|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
161216854|NCT00686920|582175893|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
161216855|NCT00686920|582175892|FG000|Overall Study|Withdrawal by Subject|23|||
161216856|NCT00686920|582175893|FG001|Overall Study|Withdrawal by Subject|5|||
161216857|NCT00686920|582175892|FG000|Overall Study|Protocol Violation|2|||
161216858|NCT00686920|582175893|FG001|Overall Study|Protocol Violation|1|||
161216859|NCT00686920|582175892|FG000|Overall Study|Adverse Event|10|||
161216860|NCT00686920|582175893|FG001|Overall Study|Adverse Event|2|||
161216861|NCT00686920|582175892|FG000|Overall Study|Personal Reason|0|||
161216862|NCT00686920|582175893|FG001|Overall Study|Personal Reason|1|||
161216863|NCT00686920|582175892|FG000|Overall Study|Lost to Follow-up|15|||
161216864|NCT00686920|582175893|FG001|Overall Study|Lost to Follow-up|3|||
161216865|NCT00686920|582175892|FG000|Overall Study|Moved to Another State|1|||
161216866|NCT00686920|582175893|FG001|Overall Study|Moved to Another State|0|||
161216867|NCT00686920|582175892|FG000|Overall Study|Transferred to Nursing Home|1|||
161216868|NCT00686920|582175893|FG001|Overall Study|Transferred to Nursing Home|0|||
161216869|NCT00686920|582175892|FG000|Overall Study|Noncompliance|9|||
161216870|NCT00686920|582175893|FG001|Overall Study|Noncompliance|0|||
161216871|NCT00686920|582175892|FG000|Overall Study|Principal Investigator Decision|2|||
161216872|NCT00686920|582175893|FG001|Overall Study|Principal Investigator Decision|0|||
161216873|NCT00814658|582175897|FG000|Overall Study|Lost to Follow-up|0|||
161216874|NCT00814658|582175898|FG001|Overall Study|Lost to Follow-up|1|||
161216875|NCT00814658|582175897|FG000|Overall Study|Physician Decision|1|||
161216876|NCT00814658|582175898|FG001|Overall Study|Physician Decision|0|||
161216877|NCT00814658|582175897|FG000|Overall Study|Adverse Event|3|||
161216878|NCT00814658|582175898|FG001|Overall Study|Adverse Event|3|||
161216879|NCT01141283|582175899|FG000|Overall Study|Adverse Event|56|||
161216880|NCT01141283|582175899|FG000|Overall Study|Lost to Follow-up|4|||
161216881|NCT01141283|582175899|FG000|Overall Study|Withdrawal by Subject|14|||
161216882|NCT01141283|582175899|FG000|Overall Study|Administrative|4|||
161216883|NCT01141283|582175899|FG000|Overall Study|Lack of Efficacy|10|||
161216884|NCT02974114|582175902|FG000|Overall Study|Other (Not specified)|0|||
161216885|NCT02974114|582175903|FG001|Overall Study|Other (Not specified)|1|||
161216886|NCT02974114|582175904|FG002|Overall Study|Other (Not specified)|2|||
161216887|NCT01335464|582175908|FG000|Overall Study|Adverse Event|15|||
161216888|NCT01335464|582175909|FG001|Overall Study|Adverse Event|25|||
161216889|NCT01335464|582175908|FG000|Overall Study|Non compliant with protocol|2|||
161216890|NCT01335464|582175909|FG001|Overall Study|Non compliant with protocol|0|||
161216891|NCT01335464|582175908|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
161216892|NCT01335464|582175909|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
161216893|NCT01335464|582175908|FG000|Overall Study|Not treated|2|||
161216894|NCT01335464|582175909|FG001|Overall Study|Not treated|0|||
161216895|NCT01335464|582175908|FG000|Overall Study|Reason other than those stated above|1|||
161216896|NCT01335464|582175909|FG001|Overall Study|Reason other than those stated above|1|||
161216897|NCT00096486|582175914|FG000|Overall Study|Withdrawal by Subject|0|||
161216898|NCT00096486|582175915|FG001|Overall Study|Withdrawal by Subject|0|||
161216899|NCT00096486|582175916|FG002|Overall Study|Withdrawal by Subject|1|||
161216900|NCT00096486|582175917|FG003|Overall Study|Withdrawal by Subject|1|||
161216901|NCT00096486|582175914|FG000|Overall Study|Not Treated|0|||
161112004|NCT00053417|581801034|FG001|Overall Study|Lost to Follow-up|1|||
161112005|NCT00053417|581801035|FG002|Overall Study|Lost to Follow-up|0|||
161112006|NCT00053417|581801036|FG003|Overall Study|Lost to Follow-up|0|||
161112007|NCT04081363|581801037|FG000|Overall Study|Withdrawal by Subject|1|||
161112008|NCT04081363|581801038|FG001|Overall Study|Withdrawal by Subject|0|||
161112009|NCT00705783|581801039|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
161112010|NCT00705783|581801040|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
161112011|NCT00705783|581801041|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
161112012|NCT00705783|581801039|FG000|Conversion Phase|Lost to Follow-up|13|||
161112013|NCT00705783|581801040|FG001|Conversion Phase|Lost to Follow-up|0|||
161112014|NCT00705783|581801041|FG002|Conversion Phase|Lost to Follow-up|0|||
161112015|NCT00705783|581801039|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
161112016|NCT00705783|581801040|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
161112017|NCT00705783|581801041|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
161112018|NCT00705783|581801039|FG000|Conversion Phase|Withdrawn by Investigator|4|||
161112019|NCT00705783|581801040|FG001|Conversion Phase|Withdrawn by Investigator|0|||
161112020|NCT00705783|581801041|FG002|Conversion Phase|Withdrawn by Investigator|0|||
161112021|NCT00705783|581801039|FG000|Conversion Phase|Withdrew Consent|24|||
161112022|NCT00705783|581801040|FG001|Conversion Phase|Withdrew Consent|0|||
161112023|NCT00705783|581801041|FG002|Conversion Phase|Withdrew Consent|0|||
161112024|NCT00705783|581801039|FG000|Conversion Phase|Protocol Deviation|2|||
161112025|NCT00705783|581801040|FG001|Conversion Phase|Protocol Deviation|0|||
161112026|NCT00705783|581801041|FG002|Conversion Phase|Protocol Deviation|0|||
161112027|NCT00705783|581801039|FG000|Conversion Phase|Adverse Event|11|||
161112028|NCT00705783|581801040|FG001|Conversion Phase|Adverse Event|0|||
161112029|NCT00705783|581801041|FG002|Conversion Phase|Adverse Event|0|||
161112030|NCT00705783|581801039|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
161112031|NCT00705783|581801040|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161112032|NCT00705783|581801041|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161112033|NCT00705783|581801039|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
161112034|NCT00705783|581801040|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161112035|NCT00705783|581801041|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161112036|NCT00705783|581801039|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
161112037|NCT00705783|581801040|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
161112038|NCT00705783|581801041|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
161112039|NCT00705783|581801039|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
161112040|NCT00705783|581801040|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
161112041|NCT00705783|581801041|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
161112042|NCT00705783|581801039|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
161112043|NCT00705783|581801040|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161112044|NCT00705783|581801041|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161112045|NCT00705783|581801039|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
161112046|NCT00705783|581801040|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161112047|NCT00705783|581801041|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161112048|NCT00705783|581801039|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
161112049|NCT00705783|581801040|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
161112050|NCT00705783|581801041|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
161112051|NCT00705783|581801039|FG000|Oral Stabilization Phase|Adverse Event|14|||
161112052|NCT00705783|581801040|FG001|Oral Stabilization Phase|Adverse Event|0|||
161112053|NCT00705783|581801041|FG002|Oral Stabilization Phase|Adverse Event|0|||
161112054|NCT00705783|581801039|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
161112055|NCT00705783|581801040|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161112056|NCT00705783|581801041|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161112057|NCT00705783|581801039|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
161112058|NCT00705783|581801040|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161112059|NCT00705783|581801041|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161112060|NCT00705783|581801039|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
161112061|NCT00705783|581801040|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
161112062|NCT00705783|581801041|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
161112063|NCT00705783|581801039|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
161216902|NCT00096486|582175915|FG001|Overall Study|Not Treated|0|||
161216903|NCT00096486|582175916|FG002|Overall Study|Not Treated|1|||
160869493|NCT00606593|580913765|FG008|Overall Study|Withdrawal of consent|0|||
160869494|NCT00606593|580913766|FG009|Overall Study|Withdrawal of consent|0|||
160869495|NCT00606593|580913757|FG000|Overall Study|Administrative/Other|0|||
160869496|NCT00606593|580913758|FG001|Overall Study|Administrative/Other|0|||
160869497|NCT00606593|580913759|FG002|Overall Study|Administrative/Other|1|||
160869498|NCT00606593|580913760|FG003|Overall Study|Administrative/Other|0|||
160869499|NCT00606593|580913761|FG004|Overall Study|Administrative/Other|0|||
161112064|NCT00705783|581801040|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
161112065|NCT00705783|581801041|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
161112066|NCT00705783|581801039|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
161112067|NCT00705783|581801040|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
161112068|NCT00705783|581801041|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
161112069|NCT00705783|581801039|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
161112070|NCT00705783|581801040|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
161112071|NCT00705783|581801041|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
161112072|NCT00705783|581801039|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
161112073|NCT00705783|581801040|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
161112074|NCT00705783|581801041|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
161112075|NCT00705783|581801039|FG000|Depot Stabilization Phase|Adverse Event|17|||
161112076|NCT00705783|581801040|FG001|Depot Stabilization Phase|Adverse Event|0|||
161112077|NCT00705783|581801041|FG002|Depot Stabilization Phase|Adverse Event|0|||
161112078|NCT00705783|581801039|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
161112079|NCT00705783|581801040|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161112080|NCT00705783|581801041|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161112081|NCT00705783|581801039|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
161112082|NCT00705783|581801040|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161112083|NCT00705783|581801041|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161112084|NCT00705783|581801039|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
161112085|NCT00705783|581801040|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
161112086|NCT00705783|581801041|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
161112087|NCT00705783|581801039|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
161112088|NCT00705783|581801040|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
161112089|NCT00705783|581801041|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
161112090|NCT00705783|581801039|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
161112091|NCT00705783|581801040|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
161112092|NCT00705783|581801041|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
161112093|NCT00705783|581801039|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
161112094|NCT00705783|581801040|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161112095|NCT00705783|581801041|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
161112096|NCT00705783|581801039|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
161112097|NCT00705783|581801040|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
161112098|NCT00705783|581801041|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
161112099|NCT00705783|581801039|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
161112100|NCT00705783|581801040|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
161112101|NCT00705783|581801041|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
161112102|NCT00705783|581801039|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
161112103|NCT00705783|581801040|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
161112104|NCT00705783|581801041|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
161112105|NCT00705783|581801039|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
161216904|NCT00096486|582175917|FG003|Overall Study|Not Treated|1|||
161216905|NCT00580983|582175918|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
161216906|NCT00665626|582175919|FG000|Overall Study|Lack of Efficacy|8|||
161216907|NCT00665626|582175920|FG001|Overall Study|Lack of Efficacy|5|||
160869500|NCT00606593|580913762|FG005|Overall Study|Administrative/Other|0|||
160869501|NCT00606593|580913763|FG006|Overall Study|Administrative/Other|0|||
160869502|NCT00606593|580913764|FG007|Overall Study|Administrative/Other|0|||
160869503|NCT00606593|580913765|FG008|Overall Study|Administrative/Other|0|||
160869504|NCT00606593|580913766|FG009|Overall Study|Administrative/Other|0|||
160869505|NCT03181529|580913767|FG000|Overall Study|Withdrawal by Subject|1|||
160869506|NCT03181529|580913768|FG001|Overall Study|Withdrawal by Subject|1|||
160869507|NCT03181529|580913767|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
160869508|NCT03181529|580913768|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
160869509|NCT00607373|580913771|FG000|Treatment Period|Adverse Event|0|||
160869510|NCT00607373|580913772|FG001|Treatment Period|Adverse Event|4|||
160869511|NCT00607373|580913771|FG000|Treatment Period|Physician Decision|0|||
161112106|NCT00705783|581801040|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
160869512|NCT00607373|580913772|FG001|Treatment Period|Physician Decision|1|||
160869513|NCT00607373|580913771|FG000|Treatment Period|Withdrawal by Subject|0|||
160981503|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
161112107|NCT00705783|581801041|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
161112108|NCT00705783|581801039|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
161112109|NCT00705783|581801040|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
161112110|NCT00705783|581801041|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
161112111|NCT02182687|581801042|FG000|Overall Study|Withdrawal by Subject|4|||
161112112|NCT02182687|581801043|FG001|Overall Study|Withdrawal by Subject|0|||
161112113|NCT02182687|581801042|FG000|Overall Study|Adverse Event|1|||
161112114|NCT02182687|581801043|FG001|Overall Study|Adverse Event|0|||
161112115|NCT02182687|581801042|FG000|Overall Study|Lost to Follow-up|0|||
161112116|NCT02182687|581801043|FG001|Overall Study|Lost to Follow-up|1|||
161112117|NCT02830776|581801052|FG000|Overall Study|Lost to Follow-up|1|||
161112118|NCT01765920|581801060|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
161112119|NCT01765920|581801061|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
161112120|NCT01765920|581801060|FG000|Overall Study|Patient code disclosure|0|||
161112121|NCT01765920|581801061|FG001|Overall Study|Patient code disclosure|1|||
161112122|NCT02025907|581801062|FG000|Overall Study|Lack of Efficacy|1|||
161112123|NCT02025907|581801063|FG001|Overall Study|Lack of Efficacy|0|||
161112124|NCT02025907|581801062|FG000|Overall Study|Withdrawal by Subject|15|||
161112125|NCT02025907|581801063|FG001|Overall Study|Withdrawal by Subject|8|||
161112126|NCT02025907|581801062|FG000|Overall Study|Protocol Violation|2|||
161112127|NCT02025907|581801063|FG001|Overall Study|Protocol Violation|0|||
161112128|NCT02025907|581801062|FG000|Overall Study|Physician Decision|2|||
161112129|NCT02025907|581801063|FG001|Overall Study|Physician Decision|0|||
161112130|NCT02025907|581801062|FG000|Overall Study|Lost to Follow-up|2|||
161112131|NCT02025907|581801063|FG001|Overall Study|Lost to Follow-up|2|||
161112132|NCT02025907|581801062|FG000|Overall Study|Adverse Event|3|||
161112133|NCT02025907|581801063|FG001|Overall Study|Adverse Event|1|||
161112134|NCT02025907|581801062|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
161112135|NCT02025907|581801063|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
161112136|NCT02411539|581801064|FG000|Overall Study|Lost to Follow-up|2|||
161112137|NCT02411539|581801065|FG001|Overall Study|Lost to Follow-up|0|||
161112138|NCT02411539|581801064|FG000|Overall Study|Confounding medical condition|0|||
161112139|NCT02411539|581801065|FG001|Overall Study|Confounding medical condition|1|||
161112140|NCT01422915|581801066|FG000|Overall Study|Adverse Event|1|||
161112141|NCT01549002|581801069|FG000|Overall Study|Excessive pain|0|||
161112142|NCT01549002|581801070|FG001|Overall Study|Excessive pain|2|||
161112143|NCT01549002|581801069|FG000|Overall Study|Moderate sedation required|0|||
161112144|NCT01549002|581801070|FG001|Overall Study|Moderate sedation required|2|||
161112145|NCT00135668|581801071|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
161112146|NCT00135668|581801072|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
161112147|NCT00135668|581801073|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
161112148|NCT00135668|581801074|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
161112149|NCT00932360|581801075|FG000|Washout (One Week)|Withdrawal by Subject|0|||
161112150|NCT00932360|581801076|FG001|Washout (One Week)|Withdrawal by Subject|0|||
161112151|NCT00932360|581801077|FG002|Washout (One Week)|Withdrawal by Subject|0|||
161112152|NCT00932360|581801078|FG003|Washout (One Week)|Withdrawal by Subject|0|||
161112153|NCT00932360|581801079|FG004|Washout (One Week)|Withdrawal by Subject|2|||
161112154|NCT00932360|581801080|FG005|Washout (One Week)|Withdrawal by Subject|0|||
161112155|NCT01892163|581801083|FG000|Overall Study|Death|1|||
161112156|NCT01892163|581801084|FG001|Overall Study|Death|1|||
161112157|NCT01892163|581801083|FG000|Overall Study|Lost to Follow-up|1|||
161112158|NCT01892163|581801084|FG001|Overall Study|Lost to Follow-up|0|||
161112159|NCT04143009|581801085|FG000|Pilot Trial|Lost to Follow-up|0|||
161112160|NCT04143009|581801086|FG001|Pilot Trial|Lost to Follow-up|1|||
161112161|NCT04143009|581801087|FG002|Pilot Trial|Lost to Follow-up|1|||
161112162|NCT02577146|581801092|FG000|Overall Study|Lost to Follow-up|8|||
161112163|NCT02577146|581801092|FG000|Overall Study|Physician Decision|3|||
161112164|NCT02577146|581801092|FG000|Overall Study|Screen Failure|17|||
161112165|NCT00781911|581801093|FG000|Overall Study|Adverse Event|4|||
161112166|NCT00781911|581801094|FG001|Overall Study|Adverse Event|4|||
161112167|NCT00781911|581801093|FG000|Overall Study|Withdrawal by Subject|1|||
161112168|NCT00781911|581801094|FG001|Overall Study|Withdrawal by Subject|2|||
161112169|NCT00781911|581801093|FG000|Overall Study|Physician Decision|0|||
161112170|NCT00781911|581801094|FG001|Overall Study|Physician Decision|2|||
161112171|NCT00781911|581801093|FG000|Overall Study|Sponsor Decision|1|||
161112172|NCT00781911|581801094|FG001|Overall Study|Sponsor Decision|0|||
161112173|NCT01357655|581801095|FG000|Overall Study|Administrative Reason by Sponsor|45|||
161112174|NCT01357655|581801096|FG001|Overall Study|Administrative Reason by Sponsor|0|||
161112175|NCT01357655|581801095|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161112176|NCT01357655|581801096|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
161112177|NCT01357655|581801095|FG000|Overall Study|Disease Progression|1|||
161112178|NCT01357655|581801096|FG001|Overall Study|Disease Progression|0|||
161112179|NCT01357655|581801095|FG000|Overall Study|Lost to Follow-up|2|||
161112180|NCT01357655|581801096|FG001|Overall Study|Lost to Follow-up|0|||
161112181|NCT01357655|581801095|FG000|Overall Study|Maximum Clinical Benefit|2|||
161112182|NCT01357655|581801096|FG001|Overall Study|Maximum Clinical Benefit|0|||
161112183|NCT01357655|581801095|FG000|Overall Study|Reason Unspecified|1|||
161112184|NCT01357655|581801096|FG001|Overall Study|Reason Unspecified|0|||
161112185|NCT01357655|581801095|FG000|Overall Study|Study Drug Toxicity|11|||
161112186|NCT01357655|581801096|FG001|Overall Study|Study Drug Toxicity|0|||
161112187|NCT01357655|581801095|FG000|Overall Study|Subject Withdrew Consent|1|||
161112188|NCT01357655|581801096|FG001|Overall Study|Subject Withdrew Consent|0|||
161112189|NCT00361270|581801100|FG000|Overall Study|Death|0|||
161216908|NCT00665626|582175919|FG000|Overall Study|Lost to Follow-up|0|||
161216909|NCT00665626|582175920|FG001|Overall Study|Lost to Follow-up|2|||
161216910|NCT00665626|582175919|FG000|Overall Study|Withdrawal by Subject|0|||
161216911|NCT00665626|582175920|FG001|Overall Study|Withdrawal by Subject|1|||
161216912|NCT00665626|582175919|FG000|Overall Study|Protocol Violation|0|||
161216913|NCT00665626|582175920|FG001|Overall Study|Protocol Violation|2|||
161216914|NCT00665626|582175919|FG000|Overall Study|Adverse Event|1|||
161216915|NCT00665626|582175920|FG001|Overall Study|Adverse Event|9|||
161216916|NCT00665626|582175919|FG000|Overall Study|Due to exclusion criteria|0|||
161216917|NCT00665626|582175920|FG001|Overall Study|Due to exclusion criteria|1|||
161216918|NCT00665626|582175919|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
161216919|NCT00665626|582175920|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
161216920|NCT00665626|582175919|FG000|Overall Study|Unably to comply with dosing regimen|0|||
161216921|NCT00665626|582175920|FG001|Overall Study|Unably to comply with dosing regimen|1|||
161216922|NCT00665626|582175919|FG000|Overall Study|Death|1|||
161216923|NCT00665626|582175920|FG001|Overall Study|Death|0|||
161216924|NCT00585039|582175921|FG000|Overall Study|medication spilled|2|||
161216925|NCT00585039|582175922|FG001|Overall Study|medication spilled|0|||
161216926|NCT00185211|582175926|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
160981504|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
161112190|NCT00361270|581801101|FG001|Overall Study|Death|0|||
161112191|NCT00361270|581801102|FG002|Overall Study|Death|0|||
161112192|NCT00361270|581801103|FG003|Overall Study|Death|2|||
160869514|NCT00607373|580913772|FG001|Treatment Period|Withdrawal by Subject|1|||
161112193|NCT00361270|581801100|FG000|Overall Study|Lost to Follow-up|4|||
161112194|NCT00361270|581801101|FG001|Overall Study|Lost to Follow-up|1|||
161112195|NCT00361270|581801102|FG002|Overall Study|Lost to Follow-up|0|||
161112196|NCT00361270|581801103|FG003|Overall Study|Lost to Follow-up|0|||
161112197|NCT00361270|581801100|FG000|Overall Study|Physician Decision|0|||
161112198|NCT00361270|581801101|FG001|Overall Study|Physician Decision|0|||
161112199|NCT00361270|581801102|FG002|Overall Study|Physician Decision|1|||
161112200|NCT00361270|581801103|FG003|Overall Study|Physician Decision|0|||
161112201|NCT00361270|581801100|FG000|Overall Study|Protocol Violation|9|||
161112202|NCT00361270|581801101|FG001|Overall Study|Protocol Violation|4|||
161112203|NCT00361270|581801102|FG002|Overall Study|Protocol Violation|5|||
161112204|NCT00361270|581801103|FG003|Overall Study|Protocol Violation|4|||
161112205|NCT00361270|581801100|FG000|Overall Study|Withdrawal by Subject|6|||
161112206|NCT00361270|581801101|FG001|Overall Study|Withdrawal by Subject|6|||
161112207|NCT00361270|581801102|FG002|Overall Study|Withdrawal by Subject|3|||
161112208|NCT00361270|581801103|FG003|Overall Study|Withdrawal by Subject|7|||
161112209|NCT00361270|581801100|FG000|Overall Study|Afraid of Hypnosis|1|||
161112210|NCT00361270|581801101|FG001|Overall Study|Afraid of Hypnosis|2|||
161112211|NCT00361270|581801102|FG002|Overall Study|Afraid of Hypnosis|0|||
161112212|NCT00361270|581801103|FG003|Overall Study|Afraid of Hypnosis|0|||
161112213|NCT00361270|581801100|FG000|Overall Study|Problems with Transportation|4|||
161112214|NCT00361270|581801101|FG001|Overall Study|Problems with Transportation|0|||
161112215|NCT00361270|581801102|FG002|Overall Study|Problems with Transportation|0|||
161112216|NCT00361270|581801103|FG003|Overall Study|Problems with Transportation|0|||
161112217|NCT00361270|581801100|FG000|Overall Study|Adverse Event|0|||
161112218|NCT00361270|581801101|FG001|Overall Study|Adverse Event|1|||
161112219|NCT00361270|581801102|FG002|Overall Study|Adverse Event|1|||
161112220|NCT00361270|581801103|FG003|Overall Study|Adverse Event|0|||
161112221|NCT01423851|581801108|FG000|Whole Study|Disease progression|2|||
161112222|NCT01423851|581801109|FG001|Whole Study|Disease progression|1|||
161112223|NCT01423851|581801110|FG002|Whole Study|Disease progression|1|||
161112224|NCT01423851|581801111|FG003|Whole Study|Disease progression|4|||
161112225|NCT01423851|581801112|FG004|Whole Study|Disease progression|1|||
161112226|NCT01423851|581801113|FG005|Whole Study|Disease progression|3|||
161112227|NCT01423851|581801114|FG006|Whole Study|Disease progression|1|||
161112228|NCT01423851|581801115|FG007|Whole Study|Disease progression|4|||
161112229|NCT01423851|581801116|FG008|Whole Study|Disease progression|0|||
161112230|NCT01423851|581801117|FG009|Whole Study|Disease progression|2|||
161112231|NCT01423851|581801118|FG010|Whole Study|Disease progression|10|||
161112232|NCT01423851|581801108|FG000|Whole Study|Physician Decision|0|||
161112233|NCT01423851|581801109|FG001|Whole Study|Physician Decision|1|||
161112234|NCT01423851|581801110|FG002|Whole Study|Physician Decision|2|||
161112235|NCT01423851|581801111|FG003|Whole Study|Physician Decision|0|||
161112236|NCT01423851|581801112|FG004|Whole Study|Physician Decision|2|||
161112237|NCT01423851|581801113|FG005|Whole Study|Physician Decision|0|||
161112238|NCT01423851|581801114|FG006|Whole Study|Physician Decision|2|||
161112239|NCT01423851|581801115|FG007|Whole Study|Physician Decision|1|||
161112240|NCT01423851|581801116|FG008|Whole Study|Physician Decision|3|||
161112241|NCT01423851|581801117|FG009|Whole Study|Physician Decision|4|||
161112242|NCT01423851|581801118|FG010|Whole Study|Physician Decision|12|||
161112243|NCT01423851|581801108|FG000|Whole Study|Withdrawal by Subject|1|||
161112244|NCT01423851|581801109|FG001|Whole Study|Withdrawal by Subject|1|||
161112245|NCT01423851|581801110|FG002|Whole Study|Withdrawal by Subject|0|||
161112246|NCT01423851|581801111|FG003|Whole Study|Withdrawal by Subject|0|||
161112247|NCT01423851|581801112|FG004|Whole Study|Withdrawal by Subject|0|||
161112248|NCT01423851|581801113|FG005|Whole Study|Withdrawal by Subject|0|||
161112249|NCT01423851|581801114|FG006|Whole Study|Withdrawal by Subject|0|||
161112250|NCT01423851|581801115|FG007|Whole Study|Withdrawal by Subject|0|||
161112251|NCT01423851|581801116|FG008|Whole Study|Withdrawal by Subject|2|||
161112252|NCT01423851|581801117|FG009|Whole Study|Withdrawal by Subject|0|||
161112253|NCT01423851|581801118|FG010|Whole Study|Withdrawal by Subject|4|||
161112254|NCT01423851|581801108|FG000|Whole Study|Adverse Event|0|||
161112255|NCT01423851|581801109|FG001|Whole Study|Adverse Event|0|||
161112256|NCT01423851|581801110|FG002|Whole Study|Adverse Event|0|||
161112257|NCT01423851|581801111|FG003|Whole Study|Adverse Event|2|||
161112258|NCT01423851|581801112|FG004|Whole Study|Adverse Event|0|||
161216927|NCT00185211|582175927|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
161216928|NCT00185211|582175926|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
161216929|NCT00185211|582175927|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
161112259|NCT01423851|581801113|FG005|Whole Study|Adverse Event|0|||
161112260|NCT01423851|581801114|FG006|Whole Study|Adverse Event|0|||
161112261|NCT01423851|581801115|FG007|Whole Study|Adverse Event|3|||
161112262|NCT01423851|581801116|FG008|Whole Study|Adverse Event|3|||
161112263|NCT01423851|581801117|FG009|Whole Study|Adverse Event|2|||
161112264|NCT01423851|581801118|FG010|Whole Study|Adverse Event|3|||
161112265|NCT05885737|581801122|FG000|DB Period|Adverse Event|4|||
161112266|NCT05885737|581801123|FG001|DB Period|Adverse Event|4|||
161112267|NCT05885737|581801122|FG000|DB Period|Lost to Follow-up|0|||
161112268|NCT05885737|581801123|FG001|DB Period|Lost to Follow-up|1|||
161112269|NCT05885737|581801122|FG000|DB Period|Physician Decision|2|||
161216930|NCT00185211|582175926|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
161216931|NCT00185211|582175927|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
161216932|NCT00185211|582175926|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
161216933|NCT00185211|582175927|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
161216934|NCT00185211|582175926|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
161216935|NCT00185211|582175927|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
161216936|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
161216937|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
161216938|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
161216939|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
161216940|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
161216941|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
161216942|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
161216943|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
161216944|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
161216945|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
161216946|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
161216947|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
161216948|NCT00185211|582175926|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
161216949|NCT00185211|582175927|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
161216950|NCT01759537|582175928|FG000|Overall Study|Death|1|||
161216951|NCT01759537|582175929|FG001|Overall Study|Death|1|||
161216952|NCT01759537|582175928|FG000|Overall Study|Pregnancy|1|||
161216953|NCT01759537|582175929|FG001|Overall Study|Pregnancy|1|||
161216954|NCT01759537|582175928|FG000|Overall Study|Lost to Follow-up|9|||
161216955|NCT01759537|582175929|FG001|Overall Study|Lost to Follow-up|9|||
161216956|NCT01759537|582175928|FG000|Overall Study|Accident involving jaw fracture|1|||
161216957|NCT01759537|582175929|FG001|Overall Study|Accident involving jaw fracture|1|||
161216958|NCT01759537|582175928|FG000|Overall Study|Subcrestal implant too coronal|1|||
161216959|NCT01759537|582175929|FG001|Overall Study|Subcrestal implant too coronal|1|||
161216960|NCT00420290|582175930|FG000|Overall Study|Adverse Event|3|||
161216961|NCT00420290|582175931|FG001|Overall Study|Adverse Event|1|||
161216962|NCT00420290|582175930|FG000|Overall Study|Withdrawal by Subject|0|||
161216963|NCT00420290|582175931|FG001|Overall Study|Withdrawal by Subject|2|||
161216964|NCT00420290|582175930|FG000|Overall Study|did not meet inclusion/exclusion|1|||
161216965|NCT00420290|582175931|FG001|Overall Study|did not meet inclusion/exclusion|1|||
161216966|NCT04582266|582177594|FG000|Overall Study|Lost to Follow-up|7|||
161216967|NCT04582266|582177595|FG001|Overall Study|Lost to Follow-up|5|||
161216968|NCT04582266|582177594|FG000|Overall Study|Withdrawal by Subject|1|||
161216969|NCT04582266|582177595|FG001|Overall Study|Withdrawal by Subject|0|||
161216970|NCT04582266|582177594|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
161216971|NCT04582266|582177595|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
161216972|NCT01466686|582177602|FG000|Overall Study|Withdrawal by Subject|1|||
161216973|NCT02049359|582177603|FG000|Overall Study|Lost to Follow-up|26|||
161216974|NCT02049359|582177604|FG001|Overall Study|Lost to Follow-up|19|||
161216975|NCT00387712|582177607|FG000|Overall Study|Physician Decision|6|||
161216976|NCT00387712|582177608|FG001|Overall Study|Physician Decision|4|||
161216977|NCT00387712|582177607|FG000|Overall Study|Lost to Follow-up|17|||
161216978|NCT00387712|582177608|FG001|Overall Study|Lost to Follow-up|20|||
161216979|NCT00387712|582177607|FG000|Overall Study|Withdrawal by Subject|6|||
161216980|NCT00387712|582177608|FG001|Overall Study|Withdrawal by Subject|12|||
161216981|NCT02322879|582177610|FG000|First Intervention|Physician Decision|1|||
161216982|NCT02322879|582177611|FG001|First Intervention|Physician Decision|0|||
161216983|NCT02043366|582177614|FG000|Overall Study|Lost to Follow-up|2|||
161216984|NCT02043366|582177615|FG001|Overall Study|Lost to Follow-up|2|||
161216985|NCT02043366|582177616|FG002|Overall Study|Lost to Follow-up|2|||
161216986|NCT02043366|582177617|FG003|Overall Study|Lost to Follow-up|2|||
161216987|NCT02043366|582177618|FG004|Overall Study|Lost to Follow-up|2|||
161216988|NCT02043366|582177619|FG005|Overall Study|Lost to Follow-up|2|||
161216989|NCT01489956|582177620|FG000|Overall Study|Lost to Follow-up|1|||
161216990|NCT01489956|582177621|FG001|Overall Study|Lost to Follow-up|0|||
161216991|NCT01489956|582177622|FG002|Overall Study|Lost to Follow-up|0|||
161216992|NCT01489956|582177620|FG000|Overall Study|Withdrawal by Subject|0|||
161216993|NCT01489956|582177621|FG001|Overall Study|Withdrawal by Subject|0|||
161216994|NCT01489956|582177622|FG002|Overall Study|Withdrawal by Subject|1|||
161216995|NCT01698320|582177630|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
161216996|NCT01698320|582177631|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
161216997|NCT01698320|582177632|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
161216998|NCT01698320|582177630|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
161216999|NCT01698320|582177631|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
161217000|NCT01698320|582177632|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
160869515|NCT00607373|580913771|FG000|Follow-up Period|Other|0|||
160869516|NCT00607373|580913772|FG001|Follow-up Period|Other|1|||
160869517|NCT00607373|580913771|FG000|Follow-up Period|Protocol Violation|0|||
160869518|NCT00607373|580913772|FG001|Follow-up Period|Protocol Violation|1|||
160869519|NCT00607373|580913771|FG000|Follow-up Period|Withdrawal by Subject|1|||
160869520|NCT00607373|580913772|FG001|Follow-up Period|Withdrawal by Subject|3|||
160869521|NCT04949490|580913773|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869522|NCT04949490|580913774|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869523|NCT04949490|580913775|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869524|NCT04949490|580913776|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
160869525|NCT04949490|580913777|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869526|NCT04949490|580913778|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
160869527|NCT04949490|580913773|FG000|Group A and Group B|Withdrawal by Subject|0|||
160869528|NCT04949490|580913774|FG001|Group A and Group B|Withdrawal by Subject|0|||
160869529|NCT04949490|580913775|FG002|Group A and Group B|Withdrawal by Subject|1|||
160869530|NCT04949490|580913776|FG003|Group A and Group B|Withdrawal by Subject|0|||
160869531|NCT04949490|580913777|FG004|Group A and Group B|Withdrawal by Subject|0|||
160869532|NCT04949490|580913778|FG005|Group A and Group B|Withdrawal by Subject|0|||
161112270|NCT05885737|581801123|FG001|DB Period|Physician Decision|0|||
161112271|NCT05885737|581801122|FG000|DB Period|Withdrawal by Subject|12|||
161112272|NCT05885737|581801123|FG001|DB Period|Withdrawal by Subject|6|||
161112273|NCT05885737|581801122|FG000|DB Period|Other: Unspecified|2|||
161112274|NCT05885737|581801123|FG001|DB Period|Other: Unspecified|2|||
161112275|NCT05885737|581801122|FG000|OLE Period|Adverse Event|3|||
161112276|NCT05885737|581801123|FG001|OLE Period|Adverse Event|2|||
161112277|NCT05885737|581801122|FG000|OLE Period|Physician Decision|1|||
161112278|NCT05885737|581801123|FG001|OLE Period|Physician Decision|0|||
161112279|NCT05885737|581801122|FG000|OLE Period|Withdrawal by Subject|5|||
161112280|NCT05885737|581801123|FG001|OLE Period|Withdrawal by Subject|5|||
161112281|NCT05885737|581801122|FG000|OLE Period|Other: Unspecified|2|||
161112282|NCT05885737|581801123|FG001|OLE Period|Other: Unspecified|1|||
161112283|NCT00789529|581802828|FG000|Overall Study|Withdrawal by Subject|0|||
161112284|NCT00789529|581802829|FG001|Overall Study|Withdrawal by Subject|1|||
160869533|NCT04949490|580913773|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869534|NCT04949490|580913774|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
161112285|NCT00789529|581802828|FG000|Overall Study|Other Reason|1|||
161112286|NCT00789529|581802829|FG001|Overall Study|Other Reason|0|||
161112287|NCT01870401|581802830|FG000|Overall Study|Death|48|||
161112288|NCT01870401|581802831|FG001|Overall Study|Death|24|||
161112289|NCT01870401|581802830|FG000|Overall Study|Withdrawal by Subject|39|||
161112290|NCT01870401|581802831|FG001|Overall Study|Withdrawal by Subject|26|||
161112291|NCT01870401|581802830|FG000|Overall Study|Lost to Follow-up|19|||
161112292|NCT01870401|581802831|FG001|Overall Study|Lost to Follow-up|14|||
161112293|NCT01870401|581802830|FG000|Overall Study|Other|9|||
161112294|NCT01870401|581802831|FG001|Overall Study|Other|7|||
161112295|NCT01870401|581802830|FG000|Overall Study|On-going in the Study|35|||
161112296|NCT01870401|581802831|FG001|Overall Study|On-going in the Study|25|||
161112297|NCT01135498|581802832|FG000|Overall Study|Adverse Event|20|||
161112298|NCT01135498|581802832|FG000|Overall Study|Progressive disease|38|||
161112299|NCT01135498|581802832|FG000|Overall Study|Investigator judgement|25|||
161112300|NCT01135498|581802832|FG000|Overall Study|Withdrawal by Subject|4|||
161112301|NCT01135498|581802832|FG000|Overall Study|Death|1|||
161112302|NCT01135498|581802832|FG000|Overall Study|Ongoing at time of analysis|2|||
161112303|NCT01192022|581802833|FG000|Overall Study|Withdrawal of Consent|3|||
161112304|NCT01192022|581802834|FG001|Overall Study|Withdrawal of Consent|1|||
161112305|NCT01192022|581802835|FG002|Overall Study|Withdrawal of Consent|0|||
161112306|NCT01192022|581802836|FG003|Overall Study|Withdrawal of Consent|0|||
161112307|NCT01192022|581802837|FG004|Overall Study|Withdrawal of Consent|0|||
161112308|NCT01192022|581802833|FG000|Overall Study|Lost to Follow-up|4|||
161112309|NCT01192022|581802834|FG001|Overall Study|Lost to Follow-up|2|||
161112310|NCT01192022|581802835|FG002|Overall Study|Lost to Follow-up|1|||
161112311|NCT01192022|581802836|FG003|Overall Study|Lost to Follow-up|1|||
161112312|NCT01192022|581802837|FG004|Overall Study|Lost to Follow-up|0|||
161112313|NCT01192022|581802833|FG000|Overall Study|Adverse Event|1|||
161112314|NCT01192022|581802834|FG001|Overall Study|Adverse Event|0|||
161112315|NCT01192022|581802835|FG002|Overall Study|Adverse Event|0|||
161112316|NCT01192022|581802836|FG003|Overall Study|Adverse Event|0|||
161112317|NCT01192022|581802837|FG004|Overall Study|Adverse Event|0|||
161112318|NCT01192022|581802833|FG000|Overall Study|Fatal Adverse Event|4|||
161112319|NCT01192022|581802834|FG001|Overall Study|Fatal Adverse Event|6|||
161112320|NCT01192022|581802835|FG002|Overall Study|Fatal Adverse Event|0|||
161112321|NCT01192022|581802836|FG003|Overall Study|Fatal Adverse Event|0|||
161112322|NCT01192022|581802837|FG004|Overall Study|Fatal Adverse Event|1|||
161112323|NCT01192022|581802833|FG000|Overall Study|Physician withdrew-patient hardship|1|||
161112324|NCT01192022|581802834|FG001|Overall Study|Physician withdrew-patient hardship|0|||
161112325|NCT01192022|581802835|FG002|Overall Study|Physician withdrew-patient hardship|0|||
161112326|NCT01192022|581802836|FG003|Overall Study|Physician withdrew-patient hardship|0|||
161112327|NCT01192022|581802837|FG004|Overall Study|Physician withdrew-patient hardship|0|||
161112328|NCT01192022|581802833|FG000|Overall Study|Patient too sick from chemotherapy|0|||
161112329|NCT01192022|581802834|FG001|Overall Study|Patient too sick from chemotherapy|1|||
161112330|NCT01192022|581802835|FG002|Overall Study|Patient too sick from chemotherapy|0|||
161112331|NCT01192022|581802836|FG003|Overall Study|Patient too sick from chemotherapy|0|||
161112332|NCT01192022|581802837|FG004|Overall Study|Patient too sick from chemotherapy|0|||
161112333|NCT01192022|581802833|FG000|Overall Study|Patient needed surgery|0|||
161112334|NCT01192022|581802834|FG001|Overall Study|Patient needed surgery|1|||
161112335|NCT01192022|581802835|FG002|Overall Study|Patient needed surgery|0|||
161112336|NCT01192022|581802836|FG003|Overall Study|Patient needed surgery|0|||
161112337|NCT01192022|581802837|FG004|Overall Study|Patient needed surgery|0|||
161112338|NCT01192022|581802833|FG000|Overall Study|Parents did not allow all follow up|0|||
161112339|NCT01192022|581802834|FG001|Overall Study|Parents did not allow all follow up|0|||
161112340|NCT01192022|581802835|FG002|Overall Study|Parents did not allow all follow up|0|||
161112341|NCT01192022|581802836|FG003|Overall Study|Parents did not allow all follow up|1|||
161112342|NCT01192022|581802837|FG004|Overall Study|Parents did not allow all follow up|0|||
161112343|NCT04839978|581802838|FG000|Overall Study|Lost to Follow-up|135|||
161112344|NCT04839978|581802839|FG001|Overall Study|Lost to Follow-up|147|||
161112345|NCT03551509|581802840|FG000|Overall Study|Lost to Follow-up|0|||
161112346|NCT03551509|581802841|FG001|Overall Study|Lost to Follow-up|1|||
161112347|NCT03551509|581802842|FG002|Overall Study|Lost to Follow-up|0|||
161217001|NCT01698320|582177630|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
161217002|NCT01698320|582177631|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
161217003|NCT01698320|582177632|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
161217004|NCT01698320|582177630|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
161217005|NCT01698320|582177631|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
161217006|NCT01698320|582177632|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
161217007|NCT01698320|582177630|FG000|12-Week Double-Blind Period|Adverse Event|0|||
161217008|NCT01698320|582177631|FG001|12-Week Double-Blind Period|Adverse Event|1|||
161217009|NCT01698320|582177632|FG002|12-Week Double-Blind Period|Adverse Event|1|||
161217010|NCT01698320|582177630|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
161217011|NCT01698320|582177631|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
161217012|NCT01698320|582177632|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
161217013|NCT01698320|582177630|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
161217014|NCT01698320|582177631|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
161217015|NCT01698320|582177632|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
161217016|NCT01698320|582177630|FG000|12-Week Double-Blind Period|Pregnancy|0|||
161217017|NCT01698320|582177631|FG001|12-Week Double-Blind Period|Pregnancy|1|||
161217018|NCT01698320|582177632|FG002|12-Week Double-Blind Period|Pregnancy|1|||
161217019|NCT01698320|582177630|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
161217020|NCT01698320|582177631|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
161217021|NCT01698320|582177632|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
161217022|NCT01698320|582177630|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
161217023|NCT01698320|582177631|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
161217024|NCT01698320|582177632|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
161217025|NCT01698320|582177630|FG000|40-Week Open-Label Period|Adverse Event|0|||
161217026|NCT01698320|582177631|FG001|40-Week Open-Label Period|Adverse Event|3|||
161217027|NCT01698320|582177632|FG002|40-Week Open-Label Period|Adverse Event|2|||
161217028|NCT01698320|582177630|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
161217029|NCT01698320|582177631|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
161217030|NCT01698320|582177632|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
161217031|NCT01698320|582177630|FG000|40-Week Open-Label Period|Pregnancy|0|||
161217032|NCT01698320|582177631|FG001|40-Week Open-Label Period|Pregnancy|2|||
161217033|NCT01698320|582177632|FG002|40-Week Open-Label Period|Pregnancy|1|||
161217034|NCT01698320|582177630|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
161217035|NCT01698320|582177631|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
161217036|NCT01698320|582177632|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
161217037|NCT01698320|582177630|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
161217038|NCT01698320|582177631|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
161217039|NCT01698320|582177632|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
161217040|NCT02087046|582177633|FG000|Overall Study|Adverse Event|4|||
161217041|NCT02087046|582177633|FG000|Overall Study|Death|1|||
161217042|NCT02087046|582177633|FG000|Overall Study|Lost to Follow-up|3|||
161217043|NCT02087046|582177633|FG000|Overall Study|Withdrawal by Subject|2|||
161217044|NCT02087046|582177633|FG000|Overall Study|Physician Decision|1|||
161217045|NCT01107535|582177634|FG000|Overall Study|Death|5|||
161217046|NCT02444533|582177635|FG000|Overall Study|Not able to complete forms|0|||
161217047|NCT02444533|582177636|FG001|Overall Study|Not able to complete forms|2|||
161217048|NCT02444533|582177635|FG000|Overall Study|Only gave post-procedure complications|2|||
161217049|NCT02444533|582177636|FG001|Overall Study|Only gave post-procedure complications|2|||
161217050|NCT01155583|582177637|FG000|Phase I|Screen failure - did not start treatment|0|||
161217051|NCT01155583|582177638|FG001|Phase I|Screen failure - did not start treatment|0|||
161217052|NCT01155583|582177639|FG002|Phase I|Screen failure - did not start treatment|0|||
161217053|NCT01155583|582177640|FG003|Phase I|Screen failure - did not start treatment|0|||
161217054|NCT01155583|582177641|FG004|Phase I|Screen failure - did not start treatment|1|||
161217055|NCT01155583|582177642|FG005|Phase I|Screen failure - did not start treatment|0|||
161217056|NCT01155583|582177643|FG006|Phase I|Screen failure - did not start treatment|0|||
161217057|NCT01155583|582177644|FG007|Phase I|Screen failure - did not start treatment|2|||
161217058|NCT01155583|582177645|FG008|Phase I|Screen failure - did not start treatment|0|||
161217059|NCT01155583|582177637|FG000|Phase I|Withdrawal by Subject|0|||
161217060|NCT01155583|582177638|FG001|Phase I|Withdrawal by Subject|0|||
161217061|NCT01155583|582177639|FG002|Phase I|Withdrawal by Subject|0|||
161217062|NCT01155583|582177640|FG003|Phase I|Withdrawal by Subject|0|||
161217063|NCT01155583|582177641|FG004|Phase I|Withdrawal by Subject|0|||
161217064|NCT01155583|582177642|FG005|Phase I|Withdrawal by Subject|0|||
160869535|NCT04949490|580913775|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869536|NCT04949490|580913776|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869537|NCT04949490|580913777|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
160869538|NCT04949490|580913778|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
160869539|NCT04949490|580913773|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869540|NCT04949490|580913774|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869541|NCT04949490|580913775|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869542|NCT04949490|580913776|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869543|NCT04949490|580913777|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
160869544|NCT04949490|580913778|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
160869545|NCT05232682|580913779|FG000|Overall Study|Lost to Follow-up|2|||
160869546|NCT04730804|580913780|FG000|Overall Study|Physician Decision|0|||
160869547|NCT04730804|580913781|FG001|Overall Study|Physician Decision|0|||
160869548|NCT04730804|580913782|FG002|Overall Study|Physician Decision|0|||
160869549|NCT04730804|580913783|FG003|Overall Study|Physician Decision|0|||
160869550|NCT04730804|580913784|FG004|Overall Study|Physician Decision|0|||
161112348|NCT00122681|581802843|FG000|Overall Study|Adverse Event|20|||
161112349|NCT00122681|581802844|FG001|Overall Study|Adverse Event|16|||
161112350|NCT00122681|581802843|FG000|Overall Study|Lost to Follow-up|1080|||
161112351|NCT00122681|581802844|FG001|Overall Study|Lost to Follow-up|1097|||
161112352|NCT00122681|581802843|FG000|Overall Study|Protocol Violation|7|||
161112353|NCT00122681|581802844|FG001|Overall Study|Protocol Violation|10|||
161112354|NCT00122681|581802843|FG000|Overall Study|Withdrawal by Subject|257|||
161112355|NCT00122681|581802844|FG001|Overall Study|Withdrawal by Subject|251|||
161112356|NCT00122681|581802843|FG000|Overall Study|Personal reasons|150|||
161112357|NCT00122681|581802844|FG001|Overall Study|Personal reasons|147|||
161112358|NCT02037295|581802845|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
161112359|NCT02037295|581802846|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
161112360|NCT02037295|581802847|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
161112361|NCT02037295|581802848|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
161112362|NCT03776175|581802849|FG000|Treatment Period (42 Days)|Adverse Event|0|||
161112363|NCT03776175|581802850|FG001|Treatment Period (42 Days)|Adverse Event|1|||
161112364|NCT03776175|581802851|FG002|Treatment Period (42 Days)|Adverse Event|1|||
161112365|NCT03776175|581802852|FG003|Treatment Period (42 Days)|Adverse Event|0|||
161112366|NCT03776175|581802849|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
161112367|NCT03776175|581802850|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
161112368|NCT03776175|581802851|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
161112369|NCT03776175|581802852|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
161112370|NCT03776175|581802849|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
161112371|NCT03776175|581802850|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
161112372|NCT03776175|581802851|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
161112373|NCT03776175|581802852|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
161112374|NCT03776175|581802849|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
161112375|NCT03776175|581802850|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
161112376|NCT03776175|581802851|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
161112377|NCT03776175|581802852|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
161112378|NCT03776175|581802849|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
161112379|NCT03776175|581802850|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
161112380|NCT03776175|581802851|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
161112381|NCT03776175|581802852|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
161112382|NCT03776175|581802849|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161112383|NCT03776175|581802850|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161112384|NCT03776175|581802851|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
161112385|NCT03776175|581802852|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
161112386|NCT02770547|581802858|FG000|Overall Study|Patient non-compliant|1|||
161112387|NCT02770547|581802859|FG001|Overall Study|Patient non-compliant|0|||
161112388|NCT02770547|581802858|FG000|Overall Study|Adverse Event|0|||
161112389|NCT02770547|581802859|FG001|Overall Study|Adverse Event|1|||
161112390|NCT00783094|581802860|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
161112391|NCT00783094|581802861|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
161112392|NCT00783094|581802862|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
161112393|NCT00783094|581802860|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
161112394|NCT00783094|581802861|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
160869551|NCT04730804|580913785|FG005|Overall Study|Physician Decision|1|||
161112395|NCT00783094|581802862|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
161112396|NCT00783094|581802860|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
160869552|NCT04730804|580913780|FG000|Overall Study|Withdrawal by Subject|0|||
161112397|NCT00783094|581802861|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
161112398|NCT00783094|581802862|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
161217065|NCT01155583|582177643|FG006|Phase I|Withdrawal by Subject|0|||
161217066|NCT01155583|582177644|FG007|Phase I|Withdrawal by Subject|1|||
161217067|NCT01155583|582177645|FG008|Phase I|Withdrawal by Subject|0|||
161217068|NCT02040766|582177650|FG000|Overall Study|Adverse Event|1|||
161217069|NCT02040766|582177651|FG001|Overall Study|Adverse Event|1|||
161217070|NCT02040766|582177652|FG002|Overall Study|Adverse Event|1|||
161217071|NCT02040766|582177653|FG003|Overall Study|Adverse Event|0|||
161217072|NCT02040766|582177654|FG004|Overall Study|Adverse Event|2|||
161217073|NCT02040766|582177650|FG000|Overall Study|Withdrawal by Subject|4|||
161217074|NCT02040766|582177651|FG001|Overall Study|Withdrawal by Subject|3|||
161217075|NCT02040766|582177652|FG002|Overall Study|Withdrawal by Subject|2|||
161217076|NCT02040766|582177653|FG003|Overall Study|Withdrawal by Subject|3|||
161217077|NCT02040766|582177654|FG004|Overall Study|Withdrawal by Subject|2|||
161217078|NCT02040766|582177650|FG000|Overall Study|Non-compliance|0|||
161217079|NCT02040766|582177651|FG001|Overall Study|Non-compliance|1|||
161217080|NCT02040766|582177652|FG002|Overall Study|Non-compliance|0|||
161217081|NCT02040766|582177653|FG003|Overall Study|Non-compliance|0|||
161217082|NCT02040766|582177654|FG004|Overall Study|Non-compliance|0|||
161217083|NCT02040766|582177650|FG000|Overall Study|Protocol Violation|2|||
161217084|NCT02040766|582177651|FG001|Overall Study|Protocol Violation|1|||
161217085|NCT02040766|582177652|FG002|Overall Study|Protocol Violation|2|||
161217086|NCT02040766|582177653|FG003|Overall Study|Protocol Violation|3|||
161217087|NCT02040766|582177654|FG004|Overall Study|Protocol Violation|0|||
161217088|NCT02040766|582177650|FG000|Overall Study|Lost to Follow-up|4|||
161217089|NCT02040766|582177651|FG001|Overall Study|Lost to Follow-up|1|||
161217090|NCT02040766|582177652|FG002|Overall Study|Lost to Follow-up|3|||
161217091|NCT02040766|582177653|FG003|Overall Study|Lost to Follow-up|1|||
161217092|NCT02040766|582177654|FG004|Overall Study|Lost to Follow-up|4|||
161217093|NCT02040766|582177650|FG000|Overall Study|Not reported|1|||
161217094|NCT02040766|582177651|FG001|Overall Study|Not reported|0|||
161217095|NCT02040766|582177652|FG002|Overall Study|Not reported|0|||
161217096|NCT02040766|582177653|FG003|Overall Study|Not reported|0|||
161217097|NCT02040766|582177654|FG004|Overall Study|Not reported|0|||
161217098|NCT02040766|582177650|FG000|Overall Study|Lack of Efficacy|6|||
161217099|NCT02040766|582177651|FG001|Overall Study|Lack of Efficacy|3|||
161217100|NCT02040766|582177652|FG002|Overall Study|Lack of Efficacy|4|||
161217101|NCT02040766|582177653|FG003|Overall Study|Lack of Efficacy|6|||
161217102|NCT02040766|582177654|FG004|Overall Study|Lack of Efficacy|5|||
161217103|NCT00602030|582177655|FG000|Lead-in Phase|Disease Progression|2|||
161217104|NCT00602030|582177656|FG001|Lead-in Phase|Disease Progression|3|||
161217105|NCT00602030|582177657|FG002|Lead-in Phase|Disease Progression|0|||
161217106|NCT00602030|582177658|FG003|Lead-in Phase|Disease Progression|0|||
161217107|NCT00602030|582177659|FG004|Lead-in Phase|Disease Progression|0|||
161217108|NCT00602030|582177655|FG000|Lead-in Phase|Adverse Event|0|||
161217109|NCT00602030|582177656|FG001|Lead-in Phase|Adverse Event|2|||
161217110|NCT00602030|582177657|FG002|Lead-in Phase|Adverse Event|0|||
161217111|NCT00602030|582177658|FG003|Lead-in Phase|Adverse Event|0|||
161217112|NCT00602030|582177659|FG004|Lead-in Phase|Adverse Event|0|||
161217113|NCT00602030|582177655|FG000|Double-blind Phase|Disease progression|0|||
161217114|NCT00602030|582177656|FG001|Double-blind Phase|Disease progression|0|||
161217115|NCT00602030|582177657|FG002|Double-blind Phase|Disease progression|33|||
161217116|NCT00602030|582177658|FG003|Double-blind Phase|Disease progression|30|||
161217117|NCT00602030|582177659|FG004|Double-blind Phase|Disease progression|0|||
161217118|NCT00602030|582177655|FG000|Double-blind Phase|Adverse Event|0|||
161217119|NCT00602030|582177656|FG001|Double-blind Phase|Adverse Event|0|||
161217120|NCT00602030|582177657|FG002|Double-blind Phase|Adverse Event|9|||
161217121|NCT00602030|582177658|FG003|Double-blind Phase|Adverse Event|18|||
161217122|NCT00602030|582177659|FG004|Double-blind Phase|Adverse Event|0|||
161217123|NCT00602030|582177655|FG000|Double-blind Phase|Consent withdrawal|0|||
161217124|NCT00602030|582177656|FG001|Double-blind Phase|Consent withdrawal|0|||
161217125|NCT00602030|582177657|FG002|Double-blind Phase|Consent withdrawal|4|||
161217126|NCT00602030|582177658|FG003|Double-blind Phase|Consent withdrawal|3|||
161217127|NCT00602030|582177659|FG004|Double-blind Phase|Consent withdrawal|0|||
161217128|NCT00602030|582177655|FG000|Double-blind Phase|Death|0|||
161217129|NCT00602030|582177656|FG001|Double-blind Phase|Death|0|||
161217130|NCT00602030|582177657|FG002|Double-blind Phase|Death|3|||
161217131|NCT00602030|582177658|FG003|Double-blind Phase|Death|3|||
161217132|NCT00602030|582177659|FG004|Double-blind Phase|Death|0|||
161217133|NCT00602030|582177655|FG000|Double-blind Phase|Administrative decision|0|||
161217134|NCT00602030|582177656|FG001|Double-blind Phase|Administrative decision|0|||
161217135|NCT00602030|582177657|FG002|Double-blind Phase|Administrative decision|0|||
161217136|NCT00602030|582177658|FG003|Double-blind Phase|Administrative decision|2|||
161217137|NCT00602030|582177659|FG004|Double-blind Phase|Administrative decision|0|||
161217138|NCT00602030|582177655|FG000|Double-blind Phase|Ineligibility|0|||
161217139|NCT00602030|582177656|FG001|Double-blind Phase|Ineligibility|0|||
161217140|NCT00602030|582177657|FG002|Double-blind Phase|Ineligibility|0|||
161217141|NCT00602030|582177658|FG003|Double-blind Phase|Ineligibility|1|||
161217142|NCT00602030|582177659|FG004|Double-blind Phase|Ineligibility|0|||
161217143|NCT00602030|582177655|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
161217144|NCT00602030|582177656|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
161217145|NCT00602030|582177657|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
161217146|NCT00602030|582177658|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
161217147|NCT00602030|582177659|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
161217148|NCT00602030|582177655|FG000|Double-blind Phase|Reason not specified|0|||
161217149|NCT00602030|582177656|FG001|Double-blind Phase|Reason not specified|0|||
161217150|NCT00602030|582177657|FG002|Double-blind Phase|Reason not specified|4|||
161217151|NCT00602030|582177658|FG003|Double-blind Phase|Reason not specified|2|||
161217152|NCT00602030|582177659|FG004|Double-blind Phase|Reason not specified|0|||
161217153|NCT00602030|582177655|FG000|Crossover Phase|Disease Progression|0|||
161217154|NCT00602030|582177656|FG001|Crossover Phase|Disease Progression|0|||
161217155|NCT00602030|582177657|FG002|Crossover Phase|Disease Progression|0|||
161217156|NCT00602030|582177658|FG003|Crossover Phase|Disease Progression|0|||
161217157|NCT00602030|582177659|FG004|Crossover Phase|Disease Progression|11|||
161217158|NCT00602030|582177655|FG000|Crossover Phase|Adverse Event|0|||
161217159|NCT00602030|582177656|FG001|Crossover Phase|Adverse Event|0|||
161217160|NCT00602030|582177657|FG002|Crossover Phase|Adverse Event|0|||
161217161|NCT00602030|582177658|FG003|Crossover Phase|Adverse Event|0|||
161324390|NCT02098395|582573587|FG003|Overall Study|Adverse Event|2|||
161217162|NCT00602030|582177659|FG004|Crossover Phase|Adverse Event|3|||
161217163|NCT00602030|582177655|FG000|Crossover Phase|Consent withdrawal|0|||
161217164|NCT00602030|582177656|FG001|Crossover Phase|Consent withdrawal|0|||
161217165|NCT00602030|582177657|FG002|Crossover Phase|Consent withdrawal|0|||
161217166|NCT00602030|582177658|FG003|Crossover Phase|Consent withdrawal|0|||
161217167|NCT00602030|582177659|FG004|Crossover Phase|Consent withdrawal|2|||
161217168|NCT01580020|582177660|FG000|Overall Study|Lack of Efficacy|0|||
161217169|NCT01580020|582177661|FG001|Overall Study|Lack of Efficacy|5|||
161217170|NCT01580020|582177662|FG002|Overall Study|Lack of Efficacy|0|||
161217171|NCT01580020|582177663|FG003|Overall Study|Lack of Efficacy|1|||
161217172|NCT01580020|582177660|FG000|Overall Study|Withdrawal by Subject|0|||
161217173|NCT01580020|582177661|FG001|Overall Study|Withdrawal by Subject|1|||
161217174|NCT01580020|582177662|FG002|Overall Study|Withdrawal by Subject|1|||
161217175|NCT01580020|582177663|FG003|Overall Study|Withdrawal by Subject|0|||
161217176|NCT01580020|582177660|FG000|Overall Study|Adverse Event|1|||
161217177|NCT01580020|582177661|FG001|Overall Study|Adverse Event|1|||
161217178|NCT01580020|582177662|FG002|Overall Study|Adverse Event|1|||
161217179|NCT01580020|582177663|FG003|Overall Study|Adverse Event|1|||
161217180|NCT01580020|582177660|FG000|Overall Study|Administrative Problems|0|||
161217181|NCT01580020|582177661|FG001|Overall Study|Administrative Problems|0|||
161217182|NCT01580020|582177662|FG002|Overall Study|Administrative Problems|1|||
161217183|NCT01580020|582177663|FG003|Overall Study|Administrative Problems|0|||
161217184|NCT01580020|582177660|FG000|Overall Study|Lost to Follow-up|0|||
161217185|NCT01580020|582177661|FG001|Overall Study|Lost to Follow-up|0|||
161217186|NCT01580020|582177662|FG002|Overall Study|Lost to Follow-up|1|||
161217187|NCT01580020|582177663|FG003|Overall Study|Lost to Follow-up|0|||
161217188|NCT01208402|582177668|FG000|Overall Study|Withdrawal by Subject|1|||
161217189|NCT01208402|582177669|FG001|Overall Study|Withdrawal by Subject|0|||
161217190|NCT01571635|582177671|FG000|Overall Study|Adverse Event|3|||
161217191|NCT01571635|582177672|FG001|Overall Study|Adverse Event|0|||
161217192|NCT01571635|582177673|FG002|Overall Study|Adverse Event|2|||
161217193|NCT01571635|582177674|FG003|Overall Study|Adverse Event|3|||
161217194|NCT01571635|582177675|FG004|Overall Study|Adverse Event|5|||
161217195|NCT01571635|582177671|FG000|Overall Study|Other reasons|2|||
161217196|NCT01571635|582177672|FG001|Overall Study|Other reasons|1|||
161217197|NCT01571635|582177673|FG002|Overall Study|Other reasons|2|||
161217198|NCT01571635|582177674|FG003|Overall Study|Other reasons|2|||
161217199|NCT01571635|582177675|FG004|Overall Study|Other reasons|1|||
161217200|NCT01571635|582177671|FG000|Overall Study|Study terminated by sponsor|0|||
161217201|NCT01571635|582177672|FG001|Overall Study|Study terminated by sponsor|4|||
161217202|NCT01571635|582177673|FG002|Overall Study|Study terminated by sponsor|1|||
160981505|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161217203|NCT01571635|582177674|FG003|Overall Study|Study terminated by sponsor|3|||
161217204|NCT01571635|582177675|FG004|Overall Study|Study terminated by sponsor|1|||
161217205|NCT01571635|582177671|FG000|Overall Study|Withdrew consent|1|||
161217206|NCT01571635|582177672|FG001|Overall Study|Withdrew consent|1|||
161217207|NCT01571635|582177673|FG002|Overall Study|Withdrew consent|2|||
161217208|NCT01571635|582177674|FG003|Overall Study|Withdrew consent|3|||
161217209|NCT01571635|582177675|FG004|Overall Study|Withdrew consent|0|||
161217210|NCT01571635|582177671|FG000|Overall Study|Lack of Efficacy|0|||
161217211|NCT01571635|582177672|FG001|Overall Study|Lack of Efficacy|2|||
161217212|NCT01571635|582177673|FG002|Overall Study|Lack of Efficacy|0|||
161217213|NCT01571635|582177674|FG003|Overall Study|Lack of Efficacy|1|||
161217214|NCT01571635|582177675|FG004|Overall Study|Lack of Efficacy|2|||
161112399|NCT00783094|581802860|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
161112400|NCT00783094|581802861|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
161112401|NCT00783094|581802862|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
161112402|NCT00783094|581802860|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
161112403|NCT00783094|581802861|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
161112404|NCT00783094|581802862|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
161112405|NCT00783094|581802860|FG000|Open-Label Extension Period|Adverse Event|12|||
161112406|NCT00783094|581802861|FG001|Open-Label Extension Period|Adverse Event|7|||
161112407|NCT00783094|581802862|FG002|Open-Label Extension Period|Adverse Event|16|||
161112408|NCT00783094|581802860|FG000|Open-Label Extension Period|Death|0|||
161112409|NCT00783094|581802861|FG001|Open-Label Extension Period|Death|0|||
161112410|NCT00783094|581802862|FG002|Open-Label Extension Period|Death|1|||
161112411|NCT00783094|581802860|FG000|Open-Label Extension Period|Protocol Violation|4|||
161112412|NCT00783094|581802861|FG001|Open-Label Extension Period|Protocol Violation|5|||
161112413|NCT00783094|581802862|FG002|Open-Label Extension Period|Protocol Violation|7|||
161112414|NCT00783094|581802860|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
161112415|NCT00783094|581802861|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
161112416|NCT00783094|581802862|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
161112417|NCT00783094|581802860|FG000|Open-Label Extension Period|Physician Decision|4|||
161112418|NCT00783094|581802861|FG001|Open-Label Extension Period|Physician Decision|2|||
161112419|NCT00783094|581802862|FG002|Open-Label Extension Period|Physician Decision|3|||
161112420|NCT00783094|581802860|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
161112421|NCT00783094|581802861|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
161112422|NCT00783094|581802862|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
161112423|NCT01324232|581802863|FG000|Overall Study|Protocol Violation|0|||
161112424|NCT01324232|581802864|FG001|Overall Study|Protocol Violation|0|||
161112425|NCT01324232|581802865|FG002|Overall Study|Protocol Violation|0|||
161112426|NCT01324232|581802866|FG003|Overall Study|Protocol Violation|2|||
161112427|NCT01324232|581802863|FG000|Overall Study|Missing|0|||
161112428|NCT01324232|581802864|FG001|Overall Study|Missing|0|||
161112429|NCT01324232|581802865|FG002|Overall Study|Missing|1|||
161112430|NCT01324232|581802866|FG003|Overall Study|Missing|0|||
161112431|NCT01324232|581802863|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
161112432|NCT01324232|581802864|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
161112433|NCT01324232|581802865|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
161112434|NCT01324232|581802866|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
161112435|NCT01324232|581802863|FG000|Overall Study|Lack of Efficacy|2|||
161112436|NCT01324232|581802864|FG001|Overall Study|Lack of Efficacy|1|||
161112437|NCT01324232|581802865|FG002|Overall Study|Lack of Efficacy|2|||
161112438|NCT01324232|581802866|FG003|Overall Study|Lack of Efficacy|2|||
161112439|NCT01324232|581802863|FG000|Overall Study|Participant Refused Medication|0|||
161112440|NCT01324232|581802864|FG001|Overall Study|Participant Refused Medication|1|||
161112441|NCT01324232|581802865|FG002|Overall Study|Participant Refused Medication|0|||
161112442|NCT01324232|581802866|FG003|Overall Study|Participant Refused Medication|0|||
161112443|NCT01324232|581802863|FG000|Overall Study|Intercurrent illness|0|||
161112444|NCT01324232|581802864|FG001|Overall Study|Intercurrent illness|0|||
161112445|NCT01324232|581802865|FG002|Overall Study|Intercurrent illness|0|||
161112446|NCT01324232|581802866|FG003|Overall Study|Intercurrent illness|1|||
161112447|NCT01324232|581802863|FG000|Overall Study|Adverse Event|2|||
161112448|NCT01324232|581802864|FG001|Overall Study|Adverse Event|5|||
161112449|NCT01324232|581802865|FG002|Overall Study|Adverse Event|6|||
161112450|NCT01324232|581802866|FG003|Overall Study|Adverse Event|6|||
161112451|NCT01324232|581802863|FG000|Overall Study|Withdrawal by Subject|0|||
161112452|NCT01324232|581802864|FG001|Overall Study|Withdrawal by Subject|3|||
161112453|NCT01324232|581802865|FG002|Overall Study|Withdrawal by Subject|4|||
161112454|NCT01324232|581802866|FG003|Overall Study|Withdrawal by Subject|0|||
161112455|NCT01324232|581802863|FG000|Overall Study|Lost to Follow-up|1|||
161217215|NCT01783730|582177679|FG000|Overall Study|Failed to meet inclusion criteria|6|||
161217216|NCT01841359|582177680|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
161217217|NCT01841359|582177680|FG000|Overall Study|Concommitant medical issues|2|||
161217218|NCT01841359|582177680|FG000|Overall Study|Adverse Event|3|||
161217219|NCT01841359|582177680|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
161217220|NCT02151461|582177681|FG000|Overall Study|Adverse Event|5|||
161217221|NCT02151461|582177682|FG001|Overall Study|Adverse Event|1|||
161217222|NCT02151461|582177683|FG002|Overall Study|Adverse Event|0|||
161217223|NCT02151461|582177684|FG003|Overall Study|Adverse Event|2|||
161217224|NCT02151461|582177681|FG000|Overall Study|Lost to Follow-up|0|||
161217225|NCT02151461|582177682|FG001|Overall Study|Lost to Follow-up|0|||
161217226|NCT02151461|582177683|FG002|Overall Study|Lost to Follow-up|1|||
161217227|NCT02151461|582177684|FG003|Overall Study|Lost to Follow-up|1|||
161217228|NCT02151461|582177681|FG000|Overall Study|Withdrawal by Subject|1|||
161217229|NCT02151461|582177682|FG001|Overall Study|Withdrawal by Subject|0|||
161217230|NCT02151461|582177683|FG002|Overall Study|Withdrawal by Subject|1|||
161217231|NCT02151461|582177684|FG003|Overall Study|Withdrawal by Subject|1|||
161217232|NCT02151461|582177681|FG000|Overall Study|Treatment discontinuation|0|||
161217233|NCT02151461|582177682|FG001|Overall Study|Treatment discontinuation|0|||
161217234|NCT02151461|582177683|FG002|Overall Study|Treatment discontinuation|1|||
161217235|NCT02151461|582177684|FG003|Overall Study|Treatment discontinuation|0|||
161217236|NCT02168270|582177685|FG000|Overall Study|Lack of Efficacy|4|||
161217237|NCT01738581|582177686|FG000|Overall Study|Lost to Follow-up|1|||
161217238|NCT01738581|582177687|FG001|Overall Study|Lost to Follow-up|0|||
161217239|NCT00947856|582177694|FG000|Treatment Period|Progressive Disease|33|||
161217240|NCT00947856|582177695|FG001|Treatment Period|Progressive Disease|12|||
161217241|NCT00947856|582177694|FG000|Treatment Period|Adverse Event|15|||
161217242|NCT00947856|582177695|FG001|Treatment Period|Adverse Event|9|||
161217243|NCT00947856|582177694|FG000|Treatment Period|Physician Decision|14|||
161217244|NCT00947856|582177695|FG001|Treatment Period|Physician Decision|6|||
161217245|NCT00947856|582177694|FG000|Treatment Period|Study Stopped by Sponsor|4|||
161217246|NCT00947856|582177695|FG001|Treatment Period|Study Stopped by Sponsor|4|||
161217247|NCT00947856|582177694|FG000|Treatment Period|Withdrawal by Subject|12|||
161217248|NCT00947856|582177695|FG001|Treatment Period|Withdrawal by Subject|1|||
161217249|NCT00947856|582177694|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
161217250|NCT00947856|582177695|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
161217251|NCT00947856|582177694|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
161217252|NCT00947856|582177695|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
161217253|NCT00947856|582177694|FG000|Follow-up Period|Lost to Follow-up|7|||
161217254|NCT00947856|582177695|FG001|Follow-up Period|Lost to Follow-up|0|||
161217255|NCT00947856|582177694|FG000|Follow-up Period|Patient unavailable for site visits|1|||
161217256|NCT00947856|582177695|FG001|Follow-up Period|Patient unavailable for site visits|0|||
161217257|NCT00947856|582177694|FG000|Follow-up Period|Withdrawal by Subject|1|||
161217258|NCT00947856|582177695|FG001|Follow-up Period|Withdrawal by Subject|0|||
161217259|NCT02191579|582177696|FG000|Treatment 1|Multiple Reasons Specified|27|||
161217260|NCT02191579|582177697|FG001|Treatment 1|Multiple Reasons Specified|58|||
161217261|NCT02191579|582177696|FG000|Treatment 2|Multiple Reasons Specified|0|||
161217262|NCT02191579|582177697|FG001|Treatment 2|Multiple Reasons Specified|25|||
161217263|NCT02280356|582177700|FG000|Overall Study|Not Treated|2|||
161217264|NCT02280356|582177700|FG000|Overall Study|Withdrawal by Subject|1|||
161217265|NCT02280356|582177700|FG000|Overall Study|Not evaluable|2|||
161217266|NCT01086215|582177701|FG000|Overall Study|Death|14|||
161217267|NCT01086215|582177702|FG001|Overall Study|Death|8|||
161217268|NCT01086215|582177703|FG002|Overall Study|Death|8|||
161217269|NCT01086215|582177704|FG003|Overall Study|Death|1|||
161217270|NCT01086215|582177701|FG000|Overall Study|Lost to Follow-up|22|||
161217271|NCT01086215|582177702|FG001|Overall Study|Lost to Follow-up|39|||
161217272|NCT01086215|582177703|FG002|Overall Study|Lost to Follow-up|18|||
161217273|NCT01086215|582177704|FG003|Overall Study|Lost to Follow-up|2|||
161217274|NCT01965652|582177705|FG000|Overall Study|Adverse Event|40|||
161217275|NCT01965652|582177706|FG001|Overall Study|Adverse Event|37|||
161217276|NCT01965652|582177705|FG000|Overall Study|Withdrawal by Subject|62|||
161217277|NCT01965652|582177706|FG001|Overall Study|Withdrawal by Subject|69|||
161217278|NCT01965652|582177705|FG000|Overall Study|Lost to Follow-up|53|||
161217279|NCT01965652|582177706|FG001|Overall Study|Lost to Follow-up|40|||
161217280|NCT01965652|582177705|FG000|Overall Study|Protocol Violation|34|||
161217281|NCT01965652|582177706|FG001|Overall Study|Protocol Violation|38|||
161217282|NCT01965652|582177705|FG000|Overall Study|Death|3|||
161217283|NCT01965652|582177706|FG001|Overall Study|Death|4|||
161217284|NCT01965652|582177705|FG000|Overall Study|Other - Miscellaneous|18|||
161217285|NCT01965652|582177706|FG001|Overall Study|Other - Miscellaneous|21|||
161217286|NCT01965652|582177705|FG000|Overall Study|Pregnancy|0|||
161217287|NCT01965652|582177706|FG001|Overall Study|Pregnancy|1|||
161217288|NCT01121900|582177711|FG000|First Intervention Period|Adverse Event|1|||
161217289|NCT01121900|582177712|FG001|First Intervention Period|Adverse Event|1|||
161217290|NCT01121900|582177711|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161217291|NCT01121900|582177712|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161217292|NCT03493698|582177713|FG000|Treatment Period C|Adverse Event|1|||
161217293|NCT03493698|582177713|FG000|Treatment Period C|Withdrawal by Subject|1|||
161217294|NCT00408876|582177714|FG000|Overall Study|Adverse Event|9|||
161217295|NCT00408876|582177715|FG001|Overall Study|Adverse Event|17|||
161217296|NCT00408876|582177716|FG002|Overall Study|Adverse Event|27|||
161217297|NCT00408876|582177717|FG003|Overall Study|Adverse Event|10|||
161217298|NCT00408876|582177714|FG000|Overall Study|Withdrawal by Subject|3|||
161217299|NCT00408876|582177715|FG001|Overall Study|Withdrawal by Subject|6|||
161217300|NCT00408876|582177716|FG002|Overall Study|Withdrawal by Subject|6|||
161217301|NCT00408876|582177717|FG003|Overall Study|Withdrawal by Subject|14|||
161217302|NCT00408876|582177714|FG000|Overall Study|Lack of Efficacy|2|||
161217303|NCT00408876|582177715|FG001|Overall Study|Lack of Efficacy|4|||
161217304|NCT00408876|582177716|FG002|Overall Study|Lack of Efficacy|5|||
161217305|NCT00408876|582177717|FG003|Overall Study|Lack of Efficacy|6|||
161217306|NCT00408876|582177714|FG000|Overall Study|Lost to Follow-up|1|||
161217307|NCT00408876|582177715|FG001|Overall Study|Lost to Follow-up|6|||
161217308|NCT00408876|582177716|FG002|Overall Study|Lost to Follow-up|5|||
161217309|NCT00408876|582177717|FG003|Overall Study|Lost to Follow-up|2|||
161217310|NCT00408876|582177714|FG000|Overall Study|Protocol Violation|0|||
161217311|NCT00408876|582177715|FG001|Overall Study|Protocol Violation|3|||
161217312|NCT00408876|582177716|FG002|Overall Study|Protocol Violation|4|||
161217313|NCT00408876|582177717|FG003|Overall Study|Protocol Violation|3|||
161217314|NCT00408876|582177714|FG000|Overall Study|Physician Decision|1|||
161217315|NCT00408876|582177715|FG001|Overall Study|Physician Decision|0|||
161217316|NCT00408876|582177716|FG002|Overall Study|Physician Decision|3|||
161217317|NCT00408876|582177717|FG003|Overall Study|Physician Decision|0|||
161217318|NCT00291330|582177718|FG000|Overall Study|Adverse Event|47|||
161217319|NCT00291330|582177719|FG001|Overall Study|Adverse Event|40|||
161217320|NCT00291330|582177718|FG000|Overall Study|Protocol Violation|13|||
161217321|NCT00291330|582177719|FG001|Overall Study|Protocol Violation|20|||
161217322|NCT00291330|582177718|FG000|Overall Study|Lost to Follow-up|16|||
161217323|NCT00291330|582177719|FG001|Overall Study|Lost to Follow-up|11|||
161217324|NCT00291330|582177718|FG000|Overall Study|Withdrawal by Subject|22|||
161217325|NCT00291330|582177719|FG001|Overall Study|Withdrawal by Subject|25|||
161217326|NCT00291330|582177718|FG000|Overall Study|Other|3|||
161217327|NCT00291330|582177719|FG001|Overall Study|Other|1|||
161217328|NCT04071626|582177723|FG000|Overall Study|Withdrawal by Subject|1|||
161217329|NCT04071626|582177724|FG001|Overall Study|Withdrawal by Subject|1|||
161217330|NCT04071626|582177723|FG000|Overall Study|Protocol Violation|0|||
161217331|NCT04071626|582177724|FG001|Overall Study|Protocol Violation|1|||
161217332|NCT00931385|582177725|FG000|Overall Study|Adverse Event|2|||
161217333|NCT00931385|582177726|FG001|Overall Study|Adverse Event|1|||
161217334|NCT00931385|582177727|FG002|Overall Study|Adverse Event|0|||
161217335|NCT00931385|582177728|FG003|Overall Study|Adverse Event|3|||
161217336|NCT00931385|582177725|FG000|Overall Study|Protocol Violation|0|||
161217337|NCT00931385|582177726|FG001|Overall Study|Protocol Violation|0|||
161217338|NCT00931385|582177727|FG002|Overall Study|Protocol Violation|1|||
161217339|NCT00931385|582177728|FG003|Overall Study|Protocol Violation|0|||
161217340|NCT00931385|582177725|FG000|Overall Study|Withdrawal by Subject|0|||
161217341|NCT00931385|582177726|FG001|Overall Study|Withdrawal by Subject|1|||
161217342|NCT00931385|582177727|FG002|Overall Study|Withdrawal by Subject|0|||
161217343|NCT00931385|582177728|FG003|Overall Study|Withdrawal by Subject|1|||
161217344|NCT00931385|582177725|FG000|Overall Study|Lost to Follow-up|0|||
161217345|NCT00931385|582177726|FG001|Overall Study|Lost to Follow-up|0|||
161217346|NCT00931385|582177727|FG002|Overall Study|Lost to Follow-up|0|||
161217347|NCT00931385|582177728|FG003|Overall Study|Lost to Follow-up|1|||
161217348|NCT02230085|582177731|FG000|Overall Study|Physician Decision|1|||
161217349|NCT02230085|582177731|FG000|Overall Study|Withdrawal by Subject|3|||
161217350|NCT00811070|582177732|FG000|Overall Study|Death|0|||
161217351|NCT00811070|582177733|FG001|Overall Study|Death|0|||
161217352|NCT00811070|582177734|FG002|Overall Study|Death|0|||
161217353|NCT00811070|582177735|FG003|Overall Study|Death|2|||
161217354|NCT00811070|582177736|FG004|Overall Study|Death|5|||
161217355|NCT00811070|582177737|FG005|Overall Study|Death|0|||
161217356|NCT00811070|582177732|FG000|Overall Study|Other|1|||
161217357|NCT00811070|582177733|FG001|Overall Study|Other|0|||
161217358|NCT00811070|582177734|FG002|Overall Study|Other|0|||
161217359|NCT00811070|582177735|FG003|Overall Study|Other|0|||
161217360|NCT00811070|582177736|FG004|Overall Study|Other|0|||
161217361|NCT00811070|582177737|FG005|Overall Study|Other|0|||
161217362|NCT00811070|582177732|FG000|Overall Study|Withdrawal by Subject|0|||
161217363|NCT00811070|582177733|FG001|Overall Study|Withdrawal by Subject|1|||
161217364|NCT00811070|582177734|FG002|Overall Study|Withdrawal by Subject|0|||
161217365|NCT00811070|582177735|FG003|Overall Study|Withdrawal by Subject|0|||
161217366|NCT00811070|582177736|FG004|Overall Study|Withdrawal by Subject|0|||
161217367|NCT00811070|582177737|FG005|Overall Study|Withdrawal by Subject|0|||
161217368|NCT00811070|582177732|FG000|Overall Study|Physician Decision|0|||
160869553|NCT04730804|580913781|FG001|Overall Study|Withdrawal by Subject|0|||
160869554|NCT04730804|580913782|FG002|Overall Study|Withdrawal by Subject|0|||
160869555|NCT04730804|580913783|FG003|Overall Study|Withdrawal by Subject|0|||
160869556|NCT04730804|580913784|FG004|Overall Study|Withdrawal by Subject|1|||
160869557|NCT04730804|580913785|FG005|Overall Study|Withdrawal by Subject|2|||
160869558|NCT02656693|580915573|FG000|Overall Study|Pregnancy|1|||
160869559|NCT02656693|580915574|FG001|Overall Study|Pregnancy|1|||
160869560|NCT02656693|580915575|FG002|Overall Study|Pregnancy|1|||
160869561|NCT02656693|580915573|FG000|Overall Study|Bariatric surgery|0|||
160869562|NCT02656693|580915574|FG001|Overall Study|Bariatric surgery|1|||
160869563|NCT02656693|580915575|FG002|Overall Study|Bariatric surgery|2|||
160869564|NCT02565784|580915576|FG000|First Treatment|Adverse Event|1|||
160869565|NCT02565784|580915576|FG000|First Treatment|Withdrawal by Subject|1|||
160869566|NCT02565784|580915576|FG000|Second Treatment|Withdrawal by Subject|2|||
160869567|NCT01596062|580915577|FG000|Overall Study|Adverse Event|1|||
160869568|NCT01596062|580915578|FG001|Overall Study|Adverse Event|0|||
160869569|NCT01596062|580915579|FG002|Overall Study|Adverse Event|2|||
160869570|NCT01596062|580915577|FG000|Overall Study|Lack of Efficacy|0|||
160869571|NCT01596062|580915578|FG001|Overall Study|Lack of Efficacy|0|||
160869572|NCT01596062|580915579|FG002|Overall Study|Lack of Efficacy|1|||
160869573|NCT03180840|580915580|FG000|Overall Study|Withdrawal by Subject|1|||
160869574|NCT02863419|580915587|FG000|Overall Study|Lost to Follow-up|0|||
160869575|NCT02863419|580915588|FG001|Overall Study|Lost to Follow-up|1|||
160869576|NCT02863419|580915589|FG002|Overall Study|Lost to Follow-up|4|||
160869577|NCT02863419|580915587|FG000|Overall Study|Withdrawal by Subject|5|||
160869578|NCT02863419|580915588|FG001|Overall Study|Withdrawal by Subject|5|||
160869579|NCT02863419|580915589|FG002|Overall Study|Withdrawal by Subject|3|||
160869580|NCT02863419|580915587|FG000|Overall Study|Died|3|||
160869581|NCT02863419|580915588|FG001|Overall Study|Died|4|||
160869582|NCT02863419|580915589|FG002|Overall Study|Died|1|||
160869583|NCT00297258|580915592|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
160869584|NCT00297258|580915592|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
160869585|NCT00297258|580915592|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
160869586|NCT00297258|580915592|FG000|Overall Study|Intercurrent Illness|3|||
160869587|NCT00297258|580915592|FG000|Overall Study|Intercurrent Death|2|||
160869588|NCT00297258|580915592|FG000|Overall Study|Deteriorization of General Condition|1|||
161112456|NCT01324232|581802864|FG001|Overall Study|Lost to Follow-up|0|||
161112457|NCT01324232|581802865|FG002|Overall Study|Lost to Follow-up|0|||
161112458|NCT01324232|581802866|FG003|Overall Study|Lost to Follow-up|0|||
161112459|NCT02513329|581802867|FG000|Overall Study|Lost to Follow-up|5|||
161112460|NCT02513329|581802868|FG001|Overall Study|Lost to Follow-up|2|||
161112461|NCT00661531|581802869|FG000|Overall Study|Withdrawal by Subject|3|||
161112462|NCT03134599|581802871|FG000|Week 1|Lost to Follow-up|0|||
161112463|NCT03134599|581802872|FG001|Week 1|Lost to Follow-up|0|||
161112464|NCT03134599|581802873|FG002|Week 1|Lost to Follow-up|0|||
161112465|NCT03134599|581802874|FG003|Week 1|Lost to Follow-up|0|||
161112466|NCT03134599|581802875|FG004|Week 1|Lost to Follow-up|1|||
161112467|NCT03134599|581802876|FG005|Week 1|Lost to Follow-up|0|||
161112468|NCT03134599|581802871|FG000|Week 2|Lost to Follow-up|1|||
161112469|NCT03134599|581802872|FG001|Week 2|Lost to Follow-up|0|||
161112470|NCT03134599|581802873|FG002|Week 2|Lost to Follow-up|0|||
161112471|NCT03134599|581802874|FG003|Week 2|Lost to Follow-up|1|||
161112472|NCT03134599|581802875|FG004|Week 2|Lost to Follow-up|1|||
161112473|NCT03134599|581802876|FG005|Week 2|Lost to Follow-up|0|||
161112474|NCT03134599|581802871|FG000|Week 3|Lost to Follow-up|0|||
161112475|NCT03134599|581802872|FG001|Week 3|Lost to Follow-up|0|||
161112476|NCT03134599|581802873|FG002|Week 3|Lost to Follow-up|0|||
161112477|NCT03134599|581802874|FG003|Week 3|Lost to Follow-up|1|||
161112478|NCT03134599|581802875|FG004|Week 3|Lost to Follow-up|0|||
161112479|NCT03134599|581802876|FG005|Week 3|Lost to Follow-up|1|||
161112480|NCT05440539|581802877|FG000|Overall Study|Lost to Follow-up|4|||
160869589|NCT00297258|580915592|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
160869590|NCT00297258|580915592|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
160869591|NCT00297258|580915592|FG000|Overall Study|Switch to Commercial Treatment|1|||
161112481|NCT05440539|581802878|FG001|Overall Study|Lost to Follow-up|4|||
161112482|NCT05440539|581802877|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
161112483|NCT05440539|581802878|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
161112484|NCT00393887|581802879|FG000|Overall Study|Physician Decision|5|||
161112485|NCT00393887|581802880|FG001|Overall Study|Physician Decision|0|||
161112486|NCT00393887|581802879|FG000|Overall Study|Lost to Follow-up|11|||
161112487|NCT00393887|581802880|FG001|Overall Study|Lost to Follow-up|9|||
160869592|NCT00297258|580915592|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
160869593|NCT02454517|580915593|FG000|Overall Study|Withdrawal by Subject|3|||
160869594|NCT02454517|580915594|FG001|Overall Study|Withdrawal by Subject|0|||
160869595|NCT02454517|580915593|FG000|Overall Study|Lost to Follow-up|4|||
160869596|NCT02454517|580915594|FG001|Overall Study|Lost to Follow-up|7|||
160869597|NCT02454517|580915593|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
161112488|NCT01265615|581802881|FG000|Overall Study|Protocol Violation|2|||
161112489|NCT01265615|581802882|FG001|Overall Study|Protocol Violation|2|||
161112490|NCT01265615|581802883|FG002|Overall Study|Protocol Violation|4|||
161217369|NCT00811070|582177733|FG001|Overall Study|Physician Decision|0|||
161217370|NCT00811070|582177734|FG002|Overall Study|Physician Decision|0|||
161217371|NCT00811070|582177735|FG003|Overall Study|Physician Decision|0|||
161217372|NCT00811070|582177736|FG004|Overall Study|Physician Decision|0|||
161217373|NCT00811070|582177737|FG005|Overall Study|Physician Decision|1|||
161217374|NCT01629693|582177740|FG000|Overall Study|Lost to Follow-up|2|||
161217375|NCT01629693|582177741|FG001|Overall Study|Lost to Follow-up|4|||
161217376|NCT01629693|582177740|FG000|Overall Study|Withdrawal by Subject|2|||
161217377|NCT01629693|582177741|FG001|Overall Study|Withdrawal by Subject|2|||
161217378|NCT01629693|582177740|FG000|Overall Study|Adverse Event|1|||
161217379|NCT01629693|582177741|FG001|Overall Study|Adverse Event|0|||
161217380|NCT01629693|582177740|FG000|Overall Study|Investigator decision|0|||
161217381|NCT01629693|582177741|FG001|Overall Study|Investigator decision|1|||
161217382|NCT01629693|582177740|FG000|Overall Study|Poor comfort of study lenses|0|||
161217383|NCT01629693|582177741|FG001|Overall Study|Poor comfort of study lenses|2|||
161217384|NCT01629693|582177740|FG000|Overall Study|Subject decision unrelated to AE|0|||
161217385|NCT01629693|582177741|FG001|Overall Study|Subject decision unrelated to AE|1|||
161217386|NCT03740100|582177742|FG000|Overall Study|Adverse Event|1|||
161217387|NCT03740100|582177742|FG000|Overall Study|Death|1|||
161217388|NCT02046369|582177743|FG000|Overall Study|Adverse Event|3|||
161217389|NCT02046369|582177744|FG001|Overall Study|Adverse Event|3|||
161217390|NCT02046369|582177743|FG000|Overall Study|Lack of Efficacy|3|||
161217391|NCT02046369|582177744|FG001|Overall Study|Lack of Efficacy|3|||
161217392|NCT02046369|582177743|FG000|Overall Study|Lost to Follow-up|3|||
161217393|NCT02046369|582177744|FG001|Overall Study|Lost to Follow-up|3|||
161217394|NCT02046369|582177743|FG000|Overall Study|Protocol Violation|1|||
161217395|NCT02046369|582177744|FG001|Overall Study|Protocol Violation|2|||
161217396|NCT02046369|582177743|FG000|Overall Study|Withdrawal by Subject|3|||
161217397|NCT02046369|582177744|FG001|Overall Study|Withdrawal by Subject|6|||
161217398|NCT02046369|582177743|FG000|Overall Study|never received study drug|0|||
161217399|NCT02046369|582177744|FG001|Overall Study|never received study drug|1|||
161217400|NCT02046369|582177743|FG000|Overall Study|non compliance|1|||
161217401|NCT02046369|582177744|FG001|Overall Study|non compliance|0|||
161217402|NCT03120520|582177745|FG000|Overall Study|Lost to Follow-up|1|||
161217403|NCT03120520|582177746|FG001|Overall Study|Lost to Follow-up|1|||
161217404|NCT03120520|582177747|FG002|Overall Study|Lost to Follow-up|1|||
161217405|NCT03120520|582177748|FG003|Overall Study|Lost to Follow-up|1|||
161217406|NCT03120520|582177745|FG000|Overall Study|Withdrawal by Subject|3|||
161217407|NCT03120520|582177746|FG001|Overall Study|Withdrawal by Subject|2|||
161217408|NCT03120520|582177747|FG002|Overall Study|Withdrawal by Subject|3|||
161217409|NCT03120520|582177748|FG003|Overall Study|Withdrawal by Subject|2|||
161217410|NCT03120520|582177745|FG000|Overall Study|Other|0|||
161217411|NCT03120520|582177746|FG001|Overall Study|Other|1|||
161217412|NCT03120520|582177747|FG002|Overall Study|Other|0|||
161217413|NCT03120520|582177748|FG003|Overall Study|Other|0|||
161217414|NCT04345471|582177750|FG000|Overall Study|Adverse Event|8|||
161217415|NCT04345471|582177751|FG001|Overall Study|Adverse Event|5|||
161217416|NCT04345471|582177752|FG002|Overall Study|Adverse Event|6|||
161217417|NCT04345471|582177750|FG000|Overall Study|Lack of Efficacy|1|||
161217418|NCT04345471|582177751|FG001|Overall Study|Lack of Efficacy|1|||
161217419|NCT04345471|582177752|FG002|Overall Study|Lack of Efficacy|0|||
161217420|NCT04345471|582177750|FG000|Overall Study|Protocol Violation|0|||
161217421|NCT04345471|582177751|FG001|Overall Study|Protocol Violation|1|||
161217422|NCT04345471|582177752|FG002|Overall Study|Protocol Violation|2|||
161217423|NCT04345471|582177750|FG000|Overall Study|Withdrawal by Subject|10|||
161217424|NCT04345471|582177751|FG001|Overall Study|Withdrawal by Subject|5|||
161217425|NCT04345471|582177752|FG002|Overall Study|Withdrawal by Subject|10|||
161217426|NCT01025193|582177753|FG000|Overall Study|Protocol Violation|1|||
161217427|NCT01025193|582177753|FG000|Overall Study|Adverse Event|3|||
161217428|NCT02378506|582177756|FG000|Overall Study|Lack of Efficacy|3|||
161217429|NCT02378506|582177756|FG000|Overall Study|Withdrawal by Subject|4|||
161217430|NCT02378506|582177756|FG000|Overall Study|Protocol Violation|2|||
161217431|NCT02378506|582177756|FG000|Overall Study|Death|1|||
161217432|NCT02378506|582177756|FG000|Overall Study|Adverse Event|14|||
161217433|NCT02378506|582177756|FG000|Overall Study|Randomized But Not Treated|1|||
161217434|NCT01715415|582177761|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
161217435|NCT01715415|582177762|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
161217436|NCT01715415|582177761|FG000|Double-blind Treatment|Adverse Event|3|||
161217437|NCT01715415|582177762|FG001|Double-blind Treatment|Adverse Event|0|||
161217438|NCT01715415|582177761|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
161217439|NCT01715415|582177762|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
161217440|NCT01715415|582177761|FG000|Double-blind Treatment|Other|1|||
161217441|NCT01715415|582177762|FG001|Double-blind Treatment|Other|0|||
161217442|NCT01715415|582177761|FG000|Open-label Treatment|Adverse Event|0|||
161217443|NCT01715415|582177762|FG001|Open-label Treatment|Adverse Event|1|||
160869598|NCT02454517|580915594|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
160869599|NCT00473382|580915595|FG000|Core Study|Adverse Event|3|||
160869600|NCT00473382|580915596|FG001|Core Study|Adverse Event|1|||
160869601|NCT00473382|580915597|FG002|Core Study|Adverse Event|1|||
160869602|NCT00473382|580915595|FG000|Core Study|Death|3|||
160869603|NCT00473382|580915596|FG001|Core Study|Death|5|||
160869604|NCT00473382|580915597|FG002|Core Study|Death|10|||
160869605|NCT00473382|580915595|FG000|Core Study|Lost to Follow-up|3|||
160869606|NCT00473382|580915596|FG001|Core Study|Lost to Follow-up|3|||
160869607|NCT00473382|580915597|FG002|Core Study|Lost to Follow-up|3|||
160869608|NCT00473382|580915595|FG000|Core Study|Physician Decision|1|||
160869609|NCT00473382|580915596|FG001|Core Study|Physician Decision|2|||
160869610|NCT00473382|580915597|FG002|Core Study|Physician Decision|2|||
160869611|NCT00473382|580915595|FG000|Core Study|Subject non-compliance|5|||
160869612|NCT00473382|580915596|FG001|Core Study|Subject non-compliance|2|||
160869613|NCT00473382|580915597|FG002|Core Study|Subject non-compliance|1|||
160869614|NCT00473382|580915595|FG000|Core Study|Subject needed other treatment|1|||
160869615|NCT00473382|580915596|FG001|Core Study|Subject needed other treatment|3|||
160869616|NCT00473382|580915597|FG002|Core Study|Subject needed other treatment|2|||
160869617|NCT00473382|580915595|FG000|Core Study|Subject's decision|12|||
160869618|NCT00473382|580915596|FG001|Core Study|Subject's decision|11|||
160869619|NCT00473382|580915597|FG002|Core Study|Subject's decision|10|||
160869620|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
160869621|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
160869622|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
160869623|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Death|1|||
160869624|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Death|3|||
160869625|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Death|3|||
160869626|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
160869627|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
161112491|NCT01265615|581802884|FG003|Overall Study|Protocol Violation|3|||
161112492|NCT01732796|581802885|FG000|Overall Study|Adverse Event|16|||
161112493|NCT01732796|581802886|FG001|Overall Study|Adverse Event|16|||
161112494|NCT01732796|581802887|FG002|Overall Study|Adverse Event|4|||
161112495|NCT01732796|581802885|FG000|Overall Study|Lack of Efficacy|21|||
161112496|NCT01732796|581802886|FG001|Overall Study|Lack of Efficacy|18|||
161112497|NCT01732796|581802887|FG002|Overall Study|Lack of Efficacy|5|||
161112498|NCT01732796|581802885|FG000|Overall Study|Lost to Follow-up|2|||
161112499|NCT01732796|581802886|FG001|Overall Study|Lost to Follow-up|0|||
161112500|NCT01732796|581802887|FG002|Overall Study|Lost to Follow-up|0|||
161112501|NCT01732796|581802885|FG000|Overall Study|Withdrawal by Subject|6|||
161112502|NCT01732796|581802886|FG001|Overall Study|Withdrawal by Subject|8|||
161112503|NCT01732796|581802887|FG002|Overall Study|Withdrawal by Subject|2|||
161112504|NCT01732796|581802885|FG000|Overall Study|Other reason not defined above|1|||
161112505|NCT01732796|581802886|FG001|Overall Study|Other reason not defined above|0|||
161112506|NCT01732796|581802887|FG002|Overall Study|Other reason not defined above|2|||
161112507|NCT00876187|581802889|FG000|Overall Study|Adverse Event|14|||
161112508|NCT00876187|581802890|FG001|Overall Study|Adverse Event|12|||
161112509|NCT00876187|581802891|FG002|Overall Study|Adverse Event|19|||
161112510|NCT00876187|581802892|FG003|Overall Study|Adverse Event|29|||
161112511|NCT00876187|581802893|FG004|Overall Study|Adverse Event|10|||
161112512|NCT00876187|581802889|FG000|Overall Study|Lack of Efficacy|59|||
161112513|NCT00876187|581802890|FG001|Overall Study|Lack of Efficacy|34|||
161112514|NCT00876187|581802891|FG002|Overall Study|Lack of Efficacy|45|||
161112515|NCT00876187|581802892|FG003|Overall Study|Lack of Efficacy|34|||
161112516|NCT00876187|581802893|FG004|Overall Study|Lack of Efficacy|59|||
161112517|NCT00876187|581802889|FG000|Overall Study|Lost to Follow-up|9|||
161112518|NCT00876187|581802890|FG001|Overall Study|Lost to Follow-up|10|||
161112519|NCT00876187|581802891|FG002|Overall Study|Lost to Follow-up|8|||
161112520|NCT00876187|581802892|FG003|Overall Study|Lost to Follow-up|8|||
161112521|NCT00876187|581802893|FG004|Overall Study|Lost to Follow-up|11|||
161112522|NCT00876187|581802889|FG000|Overall Study|Protocol Violation|6|||
160869628|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
160869629|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
160869630|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
161112523|NCT00876187|581802890|FG001|Overall Study|Protocol Violation|7|||
161112524|NCT00876187|581802891|FG002|Overall Study|Protocol Violation|7|||
161112525|NCT00876187|581802892|FG003|Overall Study|Protocol Violation|6|||
161217444|NCT01715415|582177761|FG000|Open-label Treatment|Subject Noncompliant|0|||
160869631|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
160869632|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
161112526|NCT00876187|581802893|FG004|Overall Study|Protocol Violation|3|||
161112527|NCT00876187|581802889|FG000|Overall Study|Withdrawal by Subject|16|||
161112528|NCT00876187|581802890|FG001|Overall Study|Withdrawal by Subject|26|||
161112529|NCT00876187|581802891|FG002|Overall Study|Withdrawal by Subject|32|||
161112530|NCT00876187|581802892|FG003|Overall Study|Withdrawal by Subject|38|||
161112531|NCT00876187|581802893|FG004|Overall Study|Withdrawal by Subject|37|||
160869633|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
160869634|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
160869635|NCT00473382|580915595|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
160869636|NCT00473382|580915596|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
160869637|NCT00473382|580915597|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
160869638|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
160869639|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
160869640|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
160869641|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Death|1|||
160869642|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Death|7|||
160869643|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Death|4|||
160869644|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
160869645|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
160869646|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
160869647|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
160869648|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
160869649|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
160869650|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
160869651|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
160869652|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
160869653|NCT00473382|580915595|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
160869654|NCT00473382|580915596|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
160869655|NCT00473382|580915597|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
160869656|NCT02999672|580915598|FG000|Overall Study|Death|0|||
160869657|NCT02999672|580915599|FG001|Overall Study|Death|1|||
160869658|NCT02999672|580915598|FG000|Overall Study|Study Terminated by Sponsor|0|||
160869659|NCT02999672|580915599|FG001|Overall Study|Study Terminated by Sponsor|1|||
160869660|NCT02999672|580915598|FG000|Overall Study|Progressive Disease|9|||
160869661|NCT02999672|580915599|FG001|Overall Study|Progressive Disease|5|||
160869662|NCT02999672|580915598|FG000|Overall Study|Adverse Event|4|||
160869663|NCT02999672|580915599|FG001|Overall Study|Adverse Event|0|||
160869664|NCT03565497|580915600|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
160869665|NCT03565497|580915601|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
160869666|NCT03565497|580915602|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
160869667|NCT03565497|580915600|FG000|Overall Study|Lost to Follow-up|1|||
160869668|NCT03565497|580915601|FG001|Overall Study|Lost to Follow-up|1|||
160869669|NCT03565497|580915602|FG002|Overall Study|Lost to Follow-up|2|||
160869670|NCT03565497|580915600|FG000|Overall Study|Withdrawal by Subject|1|||
160869671|NCT03565497|580915601|FG001|Overall Study|Withdrawal by Subject|1|||
160869672|NCT03565497|580915602|FG002|Overall Study|Withdrawal by Subject|1|||
160869673|NCT01470326|580915603|FG000|Overall Study|Protocol Violation|32|||
160869674|NCT01470326|580915603|FG000|Overall Study|No Drug Administration Information|2|||
160869675|NCT01470326|580915603|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
160869676|NCT01166282|580915604|FG000|Open-label Period|Adverse Event|0|||
160869677|NCT01166282|580915605|FG001|Open-label Period|Adverse Event|0|||
160869678|NCT01166282|580915606|FG002|Open-label Period|Adverse Event|6|||
160869679|NCT01166282|580915604|FG000|Open-label Period|Withdrawal by Subject|0|||
160869680|NCT01166282|580915605|FG001|Open-label Period|Withdrawal by Subject|0|||
160869681|NCT01166282|580915606|FG002|Open-label Period|Withdrawal by Subject|4|||
160869682|NCT01166282|580915604|FG000|Open-label Period|Lack of Efficacy|0|||
160869683|NCT01166282|580915605|FG001|Open-label Period|Lack of Efficacy|0|||
160869684|NCT01166282|580915606|FG002|Open-label Period|Lack of Efficacy|2|||
160869685|NCT01166282|580915604|FG000|Open-label Period|Remission|0|||
160869686|NCT01166282|580915605|FG001|Open-label Period|Remission|0|||
160869687|NCT01166282|580915606|FG002|Open-label Period|Remission|4|||
160869688|NCT01166282|580915604|FG000|Open-label Period|Irregular Compliance|0|||
160869689|NCT01166282|580915605|FG001|Open-label Period|Irregular Compliance|0|||
160869690|NCT01166282|580915606|FG002|Open-label Period|Irregular Compliance|1|||
160869691|NCT02561832|580915607|FG000|Overall Study|Withdrawal by Subject|1|||
160869692|NCT02561832|580915608|FG001|Overall Study|Withdrawal by Subject|1|||
160869693|NCT02561832|580915607|FG000|Overall Study|Adverse Event|3|||
160869694|NCT02561832|580915608|FG001|Overall Study|Adverse Event|0|||
160869695|NCT02561832|580915607|FG000|Overall Study|Disease progression|3|||
160869696|NCT02561832|580915608|FG001|Overall Study|Disease progression|3|||
160869697|NCT02892448|580915615|FG000|Overall Study|Screening failure|2|||
160869698|NCT02892448|580915616|FG001|Overall Study|Screening failure|2|||
160869699|NCT02892448|580915617|FG002|Overall Study|Screening failure|1|||
160869700|NCT02023697|580915619|FG000|Treatment Period|Radiological progression|13|||
160869701|NCT02023697|580915620|FG001|Treatment Period|Radiological progression|17|||
160869702|NCT02023697|580915621|FG002|Treatment Period|Radiological progression|26|||
160869703|NCT02023697|580915619|FG000|Treatment Period|Never Treated|5|||
161217445|NCT01715415|582177762|FG001|Open-label Treatment|Subject Noncompliant|1|||
161217446|NCT01015612|582177763|FG000|Overall Study|Death|113|||
161217447|NCT01015612|582177763|FG000|Overall Study|Withdrawal by Subject|40|||
161217448|NCT00972153|582177766|FG000|Overall Study|Equipment malfunction during case|0|||
161217449|NCT00972153|582177767|FG001|Overall Study|Equipment malfunction during case|1|||
161217450|NCT00972153|582177768|FG002|Overall Study|Equipment malfunction during case|0|||
161217451|NCT01077713|582177769|FG000|Overall Study|Withdrawal by Subject|1|||
161217452|NCT01077713|582177770|FG001|Overall Study|Withdrawal by Subject|2|||
161217453|NCT01077713|582177769|FG000|Overall Study|Progressive Disease (PD)|0|||
161217454|NCT01077713|582177770|FG001|Overall Study|Progressive Disease (PD)|1|||
161217455|NCT01077713|582177769|FG000|Overall Study|Death|28|||
161217456|NCT01077713|582177770|FG001|Overall Study|Death|29|||
161217457|NCT01077713|582177769|FG000|Overall Study|Lost to Follow-up|1|||
161217458|NCT01077713|582177770|FG001|Overall Study|Lost to Follow-up|1|||
161217459|NCT01077713|582177769|FG000|Overall Study|Adverse Event|2|||
161217460|NCT01077713|582177770|FG001|Overall Study|Adverse Event|1|||
161217461|NCT01077713|582177769|FG000|Overall Study|Other|4|||
161217462|NCT01077713|582177770|FG001|Overall Study|Other|2|||
161217463|NCT04136626|582177771|FG000|Treatment Phase|Withdrawal by Subject|1|||
161217464|NCT04136626|582177772|FG001|Treatment Phase|Withdrawal by Subject|9|||
161217465|NCT04136626|582177771|FG000|Treatment Phase|Adverse Event|1|||
161217466|NCT04136626|582177772|FG001|Treatment Phase|Adverse Event|0|||
161217467|NCT04136626|582177771|FG000|Treatment Phase|Lost to Follow-up|1|||
161217468|NCT04136626|582177772|FG001|Treatment Phase|Lost to Follow-up|5|||
161217469|NCT04136626|582177771|FG000|12-month Follow-up|Lost to Follow-up|8|||
161217470|NCT04136626|582177772|FG001|12-month Follow-up|Lost to Follow-up|7|||
161217471|NCT01299038|582179501|FG000|Overall Study|Withdrawal by Subject|1|||
161217472|NCT01299038|582179502|FG001|Overall Study|Withdrawal by Subject|0|||
161217473|NCT03347695|582179519|FG000|Overall Study|Death|0|||
161217474|NCT03347695|582179520|FG001|Overall Study|Death|4|||
160869704|NCT02023697|580915620|FG001|Treatment Period|Never Treated|6|||
160869705|NCT02023697|580915621|FG002|Treatment Period|Never Treated|10|||
160869706|NCT02023697|580915619|FG000|Treatment Period|Adverse Event|13|||
160869707|NCT02023697|580915620|FG001|Treatment Period|Adverse Event|25|||
160869708|NCT02023697|580915621|FG002|Treatment Period|Adverse Event|23|||
160869709|NCT02023697|580915619|FG000|Treatment Period|Logistical difficulties|1|||
160869710|NCT02023697|580915620|FG001|Treatment Period|Logistical difficulties|1|||
160869711|NCT02023697|580915621|FG002|Treatment Period|Logistical difficulties|1|||
160869712|NCT02023697|580915619|FG000|Treatment Period|Clinical progression|10|||
160869713|NCT02023697|580915620|FG001|Treatment Period|Clinical progression|8|||
160869714|NCT02023697|580915621|FG002|Treatment Period|Clinical progression|28|||
160869715|NCT02023697|580915619|FG000|Treatment Period|Withdrawal by Subject|4|||
160869716|NCT02023697|580915620|FG001|Treatment Period|Withdrawal by Subject|5|||
160869717|NCT02023697|580915621|FG002|Treatment Period|Withdrawal by Subject|13|||
160869718|NCT02023697|580915619|FG000|Treatment Period|Safety outcome reached|0|||
160869719|NCT02023697|580915620|FG001|Treatment Period|Safety outcome reached|1|||
160869720|NCT02023697|580915621|FG002|Treatment Period|Safety outcome reached|0|||
160869721|NCT02023697|580915619|FG000|Treatment Period|Physician Decision|0|||
160869722|NCT02023697|580915620|FG001|Treatment Period|Physician Decision|0|||
160869723|NCT02023697|580915621|FG002|Treatment Period|Physician Decision|1|||
160869724|NCT02023697|580915619|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
160869725|NCT02023697|580915620|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
160869726|NCT02023697|580915621|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
160869727|NCT02023697|580915619|FG000|Active Follow-up Period|Lost to Follow-up|1|||
160869728|NCT02023697|580915620|FG001|Active Follow-up Period|Lost to Follow-up|1|||
160869729|NCT02023697|580915621|FG002|Active Follow-up Period|Lost to Follow-up|1|||
160869730|NCT02023697|580915619|FG000|Active Follow-up Period|Deterioration of general condition|1|||
160869731|NCT02023697|580915620|FG001|Active Follow-up Period|Deterioration of general condition|1|||
160869732|NCT02023697|580915621|FG002|Active Follow-up Period|Deterioration of general condition|1|||
160869733|NCT02023697|580915619|FG000|Active Follow-up Period|Other unspecified|2|||
160869734|NCT02023697|580915620|FG001|Active Follow-up Period|Other unspecified|0|||
160869735|NCT02023697|580915621|FG002|Active Follow-up Period|Other unspecified|1|||
160869736|NCT02023697|580915619|FG000|Active Follow-up Period|Clinical progression|0|||
160869737|NCT02023697|580915620|FG001|Active Follow-up Period|Clinical progression|2|||
160869738|NCT02023697|580915621|FG002|Active Follow-up Period|Clinical progression|1|||
160869739|NCT02023697|580915619|FG000|Active Follow-up Period|Radiological progression|0|||
161217475|NCT03347695|582179519|FG000|Overall Study|Lost to Follow-up|0|||
161217476|NCT03347695|582179520|FG001|Overall Study|Lost to Follow-up|1|||
161217477|NCT04633837|582179521|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
161217478|NCT04633837|582179522|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
161217479|NCT04467697|582179525|FG000|Overall Study|Adverse Event|2|||
161217480|NCT04467697|582179525|FG000|Overall Study|Lost to Follow-up|6|||
161217481|NCT04467697|582179525|FG000|Overall Study|Withdrawal by Subject|9|||
161217482|NCT04467697|582179525|FG000|Overall Study|Protocol Violation|3|||
160869740|NCT02023697|580915620|FG001|Active Follow-up Period|Radiological progression|0|||
161112532|NCT00876187|581802889|FG000|Overall Study|Entered extension study|101|||
161112533|NCT00876187|581802890|FG001|Overall Study|Entered extension study|120|||
161112534|NCT00876187|581802891|FG002|Overall Study|Entered extension study|156|||
161112535|NCT00876187|581802892|FG003|Overall Study|Entered extension study|151|||
161112536|NCT00876187|581802893|FG004|Overall Study|Entered extension study|144|||
161112537|NCT00876187|581802889|FG000|Overall Study|Randomized but not treated|3|||
161112538|NCT00876187|581802890|FG001|Overall Study|Randomized but not treated|1|||
161112539|NCT00876187|581802891|FG002|Overall Study|Randomized but not treated|3|||
161112540|NCT00876187|581802892|FG003|Overall Study|Randomized but not treated|2|||
161112541|NCT00876187|581802893|FG004|Overall Study|Randomized but not treated|3|||
161112542|NCT00876187|581802889|FG000|Overall Study|Other|2|||
161112543|NCT00876187|581802890|FG001|Overall Study|Other|5|||
161112544|NCT00876187|581802891|FG002|Overall Study|Other|9|||
161112545|NCT00876187|581802892|FG003|Overall Study|Other|7|||
161112546|NCT00876187|581802893|FG004|Overall Study|Other|4|||
161112547|NCT00838331|581802894|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
161112548|NCT01379274|581802895|FG000|Overall Study|funding withdrawn|1|||
161112549|NCT03287219|581802899|FG000|Overall Study|Protocol Violation|0|||
161112550|NCT03287219|581802900|FG001|Overall Study|Protocol Violation|2|||
161112551|NCT00957008|581802901|FG000|Overall Study|Withdrawal by Subject|13|||
161112552|NCT00957008|581802902|FG001|Overall Study|Withdrawal by Subject|10|||
161112553|NCT00957008|581802903|FG002|Overall Study|Withdrawal by Subject|12|||
161112554|NCT00957008|581802904|FG003|Overall Study|Withdrawal by Subject|16|||
161112555|NCT00957008|581802901|FG000|Overall Study|Lost to Follow-up|3|||
161112556|NCT00957008|581802902|FG001|Overall Study|Lost to Follow-up|1|||
161112557|NCT00957008|581802903|FG002|Overall Study|Lost to Follow-up|3|||
161112558|NCT00957008|581802904|FG003|Overall Study|Lost to Follow-up|4|||
161112559|NCT00957008|581802901|FG000|Overall Study|Physician Decision|1|||
161112560|NCT00957008|581802902|FG001|Overall Study|Physician Decision|0|||
161112561|NCT00957008|581802903|FG002|Overall Study|Physician Decision|1|||
161112562|NCT00957008|581802904|FG003|Overall Study|Physician Decision|1|||
161112563|NCT00957008|581802901|FG000|Overall Study|Relocated; Family conflict|4|||
161112564|NCT00957008|581802902|FG001|Overall Study|Relocated; Family conflict|1|||
161112565|NCT00957008|581802903|FG002|Overall Study|Relocated; Family conflict|1|||
161112566|NCT00957008|581802904|FG003|Overall Study|Relocated; Family conflict|3|||
161112567|NCT01265797|581802916|FG000|Run-in Month|Withdrawal by Subject|0|||
161112568|NCT01265797|581802917|FG001|Run-in Month|Withdrawal by Subject|4|||
161112569|NCT01265797|581802916|FG000|Run-in Month|1st seizure during run-in month|0|||
161112570|NCT01265797|581802917|FG001|Run-in Month|1st seizure during run-in month|1|||
161112571|NCT01265797|581802916|FG000|Blinded Month|Lack of Efficacy|5|||
161112572|NCT01265797|581802917|FG001|Blinded Month|Lack of Efficacy|0|||
161112573|NCT01265797|581802916|FG000|Blinded Month|Lost to Follow-up|1|||
161112574|NCT01265797|581802917|FG001|Blinded Month|Lost to Follow-up|0|||
161112575|NCT01265797|581802916|FG000|Blinded Month|Protocol Violation|2|||
161112576|NCT01265797|581802917|FG001|Blinded Month|Protocol Violation|1|||
161112577|NCT01265797|581802916|FG000|Blinded Month|Adverse Event|2|||
161112578|NCT01265797|581802917|FG001|Blinded Month|Adverse Event|0|||
161112579|NCT01265797|581802916|FG000|Blinded Month|Diary data incomplete|0|||
161112580|NCT01265797|581802917|FG001|Blinded Month|Diary data incomplete|1|||
161112581|NCT01265797|581802916|FG000|Open Label Month|Lost to Follow-up|0|||
161112582|NCT01265797|581802917|FG001|Open Label Month|Lost to Follow-up|1|||
161112583|NCT00939783|581802918|FG000|Overall Study|Death|6|||
161112584|NCT00939783|581802918|FG000|Overall Study|Adverse Event|39|||
161112585|NCT00939783|581802918|FG000|Overall Study|Study Terminated by Sponsor|498|||
161112586|NCT00939783|581802918|FG000|Overall Study|Withdrawal by Subject|78|||
161112587|NCT00939783|581802918|FG000|Overall Study|Other|16|||
161112588|NCT00939783|581802918|FG000|Overall Study|Lost to Follow-up|8|||
161112589|NCT00939783|581802918|FG000|Overall Study|Protocol Violation|3|||
161112590|NCT00939783|581802918|FG000|Overall Study|Enrolled but not treated|1|||
161112591|NCT03631732|581802929|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
161112592|NCT03631732|581802930|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
161112593|NCT03631732|581802929|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
161112594|NCT03631732|581802930|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
161112595|NCT03631732|581802929|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
161112596|NCT03631732|581802930|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
161217483|NCT03907280|582179526|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
161217484|NCT03907280|582179527|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
161217485|NCT03907280|582179528|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
161217486|NCT02711956|582179532|FG000|Overall Study|Adverse Event|0|||
161112597|NCT03631732|581802929|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
161112598|NCT03631732|581802930|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
161112599|NCT03631732|581802929|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
161112600|NCT03631732|581802930|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
161112601|NCT03631732|581802929|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
161217487|NCT02711956|582179533|FG001|Overall Study|Adverse Event|0|||
161217488|NCT02711956|582179534|FG002|Overall Study|Adverse Event|0|||
161217489|NCT02711956|582179535|FG003|Overall Study|Adverse Event|1|||
161217490|NCT02711956|582179536|FG004|Overall Study|Adverse Event|2|||
161217491|NCT02711956|582179537|FG005|Overall Study|Adverse Event|0|||
161217492|NCT02711956|582179538|FG006|Overall Study|Adverse Event|0|||
161217493|NCT02711956|582179539|FG007|Overall Study|Adverse Event|1|||
161217494|NCT02711956|582179540|FG008|Overall Study|Adverse Event|1|||
161217495|NCT02711956|582179541|FG009|Overall Study|Adverse Event|1|||
161217496|NCT02711956|582179542|FG010|Overall Study|Adverse Event|1|||
161217497|NCT02711956|582179543|FG011|Overall Study|Adverse Event|0|||
161217498|NCT02711956|582179544|FG012|Overall Study|Adverse Event|0|||
161217499|NCT02711956|582179545|FG013|Overall Study|Adverse Event|0|||
161217500|NCT02711956|582179546|FG014|Overall Study|Adverse Event|2|||
161217501|NCT02711956|582179532|FG000|Overall Study|Physician Decision|0|||
161217502|NCT02711956|582179533|FG001|Overall Study|Physician Decision|0|||
161217503|NCT02711956|582179534|FG002|Overall Study|Physician Decision|0|||
161217504|NCT02711956|582179535|FG003|Overall Study|Physician Decision|2|||
161217505|NCT02711956|582179536|FG004|Overall Study|Physician Decision|0|||
161217506|NCT02711956|582179537|FG005|Overall Study|Physician Decision|0|||
161217507|NCT02711956|582179538|FG006|Overall Study|Physician Decision|0|||
161217508|NCT02711956|582179539|FG007|Overall Study|Physician Decision|0|||
161217509|NCT02711956|582179540|FG008|Overall Study|Physician Decision|0|||
161217510|NCT02711956|582179541|FG009|Overall Study|Physician Decision|0|||
161217511|NCT02711956|582179542|FG010|Overall Study|Physician Decision|0|||
161217512|NCT02711956|582179543|FG011|Overall Study|Physician Decision|0|||
161217513|NCT02711956|582179544|FG012|Overall Study|Physician Decision|0|||
161217514|NCT02711956|582179545|FG013|Overall Study|Physician Decision|0|||
161217515|NCT02711956|582179546|FG014|Overall Study|Physician Decision|0|||
161217516|NCT02711956|582179532|FG000|Overall Study|Withdrawal by Subject|0|||
161217517|NCT02711956|582179533|FG001|Overall Study|Withdrawal by Subject|0|||
161217518|NCT02711956|582179534|FG002|Overall Study|Withdrawal by Subject|0|||
161217519|NCT02711956|582179535|FG003|Overall Study|Withdrawal by Subject|0|||
160869741|NCT02023697|580915621|FG002|Active Follow-up Period|Radiological progression|1|||
160869742|NCT02023697|580915619|FG000|Active Follow-up Period|Death|83|||
160869743|NCT02023697|580915620|FG001|Active Follow-up Period|Death|82|||
160869744|NCT02023697|580915621|FG002|Active Follow-up Period|Death|87|||
160869745|NCT02023697|580915619|FG000|Long-term Follow-up Period|Death|9|||
160869746|NCT02023697|580915620|FG001|Long-term Follow-up Period|Death|6|||
160869747|NCT02023697|580915621|FG002|Long-term Follow-up Period|Death|4|||
160869748|NCT02023697|580915619|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
160869749|NCT02023697|580915620|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
160869750|NCT02023697|580915621|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
160869751|NCT02023697|580915619|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
160869752|NCT02023697|580915620|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
160869753|NCT02023697|580915621|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
160869754|NCT02023697|580915619|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
160869755|NCT02023697|580915620|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
160869756|NCT02023697|580915621|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
160869757|NCT02023697|580915619|FG000|Long-term Follow-up Period|Technical problems|0|||
161112602|NCT03631732|581802930|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
161112603|NCT03631732|581802929|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
161112604|NCT03631732|581802930|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
161112605|NCT03631732|581802929|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
161112606|NCT03631732|581802930|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
161112607|NCT03631732|581802929|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
161112608|NCT03631732|581802930|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
161112609|NCT03631732|581802929|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
161112610|NCT03631732|581802930|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
161112611|NCT01439204|581802931|FG000|Overall Study|Withdrawal by Subject|0|||
161112612|NCT01439204|581802932|FG001|Overall Study|Withdrawal by Subject|1|||
161112613|NCT01439204|581802931|FG000|Overall Study|Lost to Follow-up|0|||
161112614|NCT01439204|581802932|FG001|Overall Study|Lost to Follow-up|2|||
161112615|NCT01439204|581802931|FG000|Overall Study|No longer meets study criteria|1|||
161112616|NCT01439204|581802932|FG001|Overall Study|No longer meets study criteria|0|||
161112617|NCT01439204|581802931|FG000|Overall Study|poor/non-compliance|3|||
161112618|NCT01439204|581802932|FG001|Overall Study|poor/non-compliance|0|||
161112619|NCT01251367|581802933|FG000|Overall Study|Protocol Violation|1|||
161112620|NCT01251367|581802933|FG000|Overall Study|Lack of Efficacy|2|||
161112621|NCT01251367|581802933|FG000|Overall Study|Adverse Event|19|||
161112622|NCT01251367|581802933|FG000|Overall Study|Withdrawal by Subject|36|||
161112623|NCT01251367|581802933|FG000|Overall Study|Lost to Follow-up|5|||
161112624|NCT01251367|581802933|FG000|Overall Study|Subject Required Alternative Treatment|7|||
161112625|NCT01251367|581802933|FG000|Overall Study|No Study Drug Available|1|||
161112626|NCT01251367|581802933|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
161112627|NCT01251367|581802933|FG000|Overall Study|End of Study Visit Performed in Error|1|||
161112628|NCT02255409|581802934|FG000|Overall Study|Administrative Reason|3|||
161112629|NCT02255409|581802935|FG001|Overall Study|Administrative Reason|7|||
161112630|NCT02255409|581802934|FG000|Overall Study|Withdrawal by Subject|1|||
161112631|NCT02255409|581802935|FG001|Overall Study|Withdrawal by Subject|5|||
161112632|NCT02255409|581802934|FG000|Overall Study|Lost to Follow-up|10|||
161112633|NCT02255409|581802935|FG001|Overall Study|Lost to Follow-up|19|||
161112634|NCT02370615|581802939|FG000|Overall Study|Adverse Event|1|||
161112635|NCT02370615|581802940|FG001|Overall Study|Adverse Event|0|||
161112636|NCT00455013|581802941|FG000|Short Term Period|Adverse Event|2|||
161112637|NCT00455013|581802942|FG001|Short Term Period|Adverse Event|5|||
161112638|NCT00455013|581802943|FG002|Short Term Period|Adverse Event|0|||
161112639|NCT00455013|581802941|FG000|Short Term Period|Withdrawal by Subject|0|||
161112640|NCT00455013|581802942|FG001|Short Term Period|Withdrawal by Subject|0|||
161112641|NCT00455013|581802943|FG002|Short Term Period|Withdrawal by Subject|1|||
161112642|NCT00455013|581802941|FG000|Short Term Period|Lack of Efficacy|4|||
161112643|NCT00455013|581802942|FG001|Short Term Period|Lack of Efficacy|0|||
161112644|NCT00455013|581802943|FG002|Short Term Period|Lack of Efficacy|0|||
161112645|NCT00455013|581802941|FG000|Short Term Period|Other|0|||
161112646|NCT00455013|581802942|FG001|Short Term Period|Other|0|||
161112647|NCT00455013|581802943|FG002|Short Term Period|Other|1|||
161112648|NCT00455013|581802941|FG000|Long Term Extension (LTE)|Adverse Event|0|||
161112649|NCT00455013|581802942|FG001|Long Term Extension (LTE)|Adverse Event|1|||
161112650|NCT00455013|581802943|FG002|Long Term Extension (LTE)|Adverse Event|1|||
161217520|NCT02711956|582179536|FG004|Overall Study|Withdrawal by Subject|0|||
161112651|NCT00455013|581802941|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
161112652|NCT00455013|581802942|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
161112653|NCT00455013|581802943|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
161112654|NCT00455013|581802941|FG000|Long Term Extension (LTE)|Death|1|||
161112655|NCT00455013|581802942|FG001|Long Term Extension (LTE)|Death|1|||
161112656|NCT00455013|581802943|FG002|Long Term Extension (LTE)|Death|0|||
161217521|NCT02711956|582179537|FG005|Overall Study|Withdrawal by Subject|0|||
161217522|NCT02711956|582179538|FG006|Overall Study|Withdrawal by Subject|1|||
161217523|NCT02711956|582179539|FG007|Overall Study|Withdrawal by Subject|0|||
161217524|NCT02711956|582179540|FG008|Overall Study|Withdrawal by Subject|0|||
161217525|NCT02711956|582179541|FG009|Overall Study|Withdrawal by Subject|0|||
161217526|NCT02711956|582179542|FG010|Overall Study|Withdrawal by Subject|0|||
161217527|NCT02711956|582179543|FG011|Overall Study|Withdrawal by Subject|1|||
161217528|NCT02711956|582179544|FG012|Overall Study|Withdrawal by Subject|6|||
161217529|NCT02711956|582179545|FG013|Overall Study|Withdrawal by Subject|0|||
161217530|NCT02711956|582179546|FG014|Overall Study|Withdrawal by Subject|1|||
161217531|NCT02711956|582179532|FG000|Overall Study|Clinical progression|1|||
161217532|NCT02711956|582179533|FG001|Overall Study|Clinical progression|0|||
161217533|NCT02711956|582179534|FG002|Overall Study|Clinical progression|0|||
161217534|NCT02711956|582179535|FG003|Overall Study|Clinical progression|0|||
161217535|NCT02711956|582179536|FG004|Overall Study|Clinical progression|0|||
161217536|NCT02711956|582179537|FG005|Overall Study|Clinical progression|0|||
161217537|NCT02711956|582179538|FG006|Overall Study|Clinical progression|1|||
161217538|NCT02711956|582179539|FG007|Overall Study|Clinical progression|0|||
161217539|NCT02711956|582179540|FG008|Overall Study|Clinical progression|1|||
161217540|NCT02711956|582179541|FG009|Overall Study|Clinical progression|0|||
161217541|NCT02711956|582179542|FG010|Overall Study|Clinical progression|0|||
161217542|NCT02711956|582179543|FG011|Overall Study|Clinical progression|2|||
161217543|NCT02711956|582179544|FG012|Overall Study|Clinical progression|4|||
161217544|NCT02711956|582179545|FG013|Overall Study|Clinical progression|1|||
161217545|NCT02711956|582179546|FG014|Overall Study|Clinical progression|1|||
161217546|NCT02711956|582179532|FG000|Overall Study|Radiographic progression|1|||
161217547|NCT02711956|582179533|FG001|Overall Study|Radiographic progression|1|||
161217548|NCT02711956|582179534|FG002|Overall Study|Radiographic progression|2|||
161217549|NCT02711956|582179535|FG003|Overall Study|Radiographic progression|0|||
161217550|NCT02711956|582179536|FG004|Overall Study|Radiographic progression|1|||
161217551|NCT02711956|582179537|FG005|Overall Study|Radiographic progression|0|||
161217552|NCT02711956|582179538|FG006|Overall Study|Radiographic progression|0|||
161217553|NCT02711956|582179539|FG007|Overall Study|Radiographic progression|0|||
161217554|NCT02711956|582179540|FG008|Overall Study|Radiographic progression|2|||
161217555|NCT02711956|582179541|FG009|Overall Study|Radiographic progression|1|||
161217556|NCT02711956|582179542|FG010|Overall Study|Radiographic progression|0|||
161217557|NCT02711956|582179543|FG011|Overall Study|Radiographic progression|5|||
161217558|NCT02711956|582179544|FG012|Overall Study|Radiographic progression|3|||
160869758|NCT02023697|580915620|FG001|Long-term Follow-up Period|Technical problems|0|||
160869759|NCT02023697|580915621|FG002|Long-term Follow-up Period|Technical problems|1|||
160869760|NCT02023697|580915619|FG000|Long-term Follow-up Period|Other unspecified|6|||
160869761|NCT02023697|580915620|FG001|Long-term Follow-up Period|Other unspecified|3|||
160869762|NCT02023697|580915621|FG002|Long-term Follow-up Period|Other unspecified|5|||
160869763|NCT00541385|580915622|FG000|Overall Study|Adverse Event|6|||
160869764|NCT00541385|580915623|FG001|Overall Study|Adverse Event|3|||
160869765|NCT00541385|580915622|FG000|Overall Study|Withdrawal by Subject|2|||
160869766|NCT00541385|580915623|FG001|Overall Study|Withdrawal by Subject|2|||
160869767|NCT00541385|580915622|FG000|Overall Study|Lost to Follow-up|6|||
160869768|NCT00541385|580915623|FG001|Overall Study|Lost to Follow-up|1|||
160869769|NCT00541385|580915622|FG000|Overall Study|Parasite reappearance/malaria|67|||
160869770|NCT00541385|580915623|FG001|Overall Study|Parasite reappearance/malaria|32|||
160869771|NCT01469377|580915624|FG000|Overall Study|Protocol Deviation|7|||
160869772|NCT01469377|580915625|FG001|Overall Study|Protocol Deviation|10|||
160869773|NCT01469377|580915626|FG002|Overall Study|Protocol Deviation|10|||
160869774|NCT01469377|580915624|FG000|Overall Study|Lost to Follow-up|3|||
160869775|NCT01469377|580915625|FG001|Overall Study|Lost to Follow-up|2|||
160869776|NCT01469377|580915626|FG002|Overall Study|Lost to Follow-up|5|||
160869777|NCT01469377|580915624|FG000|Overall Study|Withdrawal of Consent|12|||
160869778|NCT01469377|580915625|FG001|Overall Study|Withdrawal of Consent|14|||
160869779|NCT01469377|580915626|FG002|Overall Study|Withdrawal of Consent|15|||
160869780|NCT01469377|580915624|FG000|Overall Study|Adverse Event|8|||
160869781|NCT01469377|580915625|FG001|Overall Study|Adverse Event|18|||
160869782|NCT01469377|580915626|FG002|Overall Study|Adverse Event|36|||
160869783|NCT01469377|580915624|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160869784|NCT01469377|580915625|FG001|Overall Study|Insufficient Therapeutic Response|4|||
160869785|NCT01469377|580915626|FG002|Overall Study|Insufficient Therapeutic Response|0|||
160869786|NCT01469377|580915624|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160869787|NCT01469377|580915625|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160869788|NCT01469377|580915626|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160869789|NCT03857867|580915627|FG000|Overall Study|Physician Decision|1|||
160869790|NCT00885534|580915628|FG000|Overall Study|Patient deemed ineligible|1|||
160869791|NCT02453711|580915629|FG000|Overall Study|Withdrawal by Subject|5|||
160869792|NCT02453711|580915630|FG001|Overall Study|Withdrawal by Subject|4|||
160869793|NCT02453711|580915631|FG002|Overall Study|Withdrawal by Subject|6|||
160869794|NCT02453711|580915632|FG003|Overall Study|Withdrawal by Subject|4|||
160869795|NCT02453711|580915633|FG004|Overall Study|Withdrawal by Subject|1|||
161112657|NCT00455013|581802941|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
161112658|NCT00455013|581802942|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
161112659|NCT00455013|581802943|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
161112660|NCT00455013|581802941|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
161112661|NCT00455013|581802942|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
161112662|NCT00455013|581802943|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
161112663|NCT00455013|581802941|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
161112664|NCT00455013|581802942|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
161112665|NCT00455013|581802943|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
161112666|NCT00455013|581802941|FG000|Long Term Extension (LTE)|non-specified|0|||
161112667|NCT00455013|581802942|FG001|Long Term Extension (LTE)|non-specified|0|||
161112668|NCT00455013|581802943|FG002|Long Term Extension (LTE)|non-specified|1|||
161112669|NCT00078325|581802944|FG000|Overall Study|Adverse Event|15|||
161112670|NCT00078325|581802945|FG001|Overall Study|Adverse Event|10|||
161112671|NCT00078325|581802946|FG002|Overall Study|Adverse Event|5|||
161112672|NCT00078325|581802944|FG000|Overall Study|Protocol Violation|2|||
161112673|NCT00078325|581802945|FG001|Overall Study|Protocol Violation|2|||
161112674|NCT00078325|581802946|FG002|Overall Study|Protocol Violation|0|||
161112675|NCT00078325|581802944|FG000|Overall Study|Withdrawal by Subject|1|||
161112676|NCT00078325|581802945|FG001|Overall Study|Withdrawal by Subject|5|||
160869796|NCT02453711|580915634|FG005|Overall Study|Withdrawal by Subject|1|||
160869797|NCT02453711|580915635|FG006|Overall Study|Withdrawal by Subject|0|||
160869798|NCT02453711|580915636|FG007|Overall Study|Withdrawal by Subject|1|||
160869799|NCT02453711|580915637|FG008|Overall Study|Withdrawal by Subject|7|||
160869800|NCT02453711|580915629|FG000|Overall Study|Lost to Follow-up|5|||
160869801|NCT02453711|580915630|FG001|Overall Study|Lost to Follow-up|3|||
160869802|NCT02453711|580915631|FG002|Overall Study|Lost to Follow-up|2|||
160869803|NCT02453711|580915632|FG003|Overall Study|Lost to Follow-up|3|||
160869804|NCT02453711|580915633|FG004|Overall Study|Lost to Follow-up|1|||
160869805|NCT02453711|580915634|FG005|Overall Study|Lost to Follow-up|5|||
160869806|NCT02453711|580915635|FG006|Overall Study|Lost to Follow-up|2|||
160869807|NCT02453711|580915636|FG007|Overall Study|Lost to Follow-up|6|||
161112677|NCT00078325|581802946|FG002|Overall Study|Withdrawal by Subject|3|||
161112678|NCT00078325|581802944|FG000|Overall Study|Lost to Follow-up|0|||
161112679|NCT00078325|581802945|FG001|Overall Study|Lost to Follow-up|1|||
160869808|NCT02453711|580915637|FG008|Overall Study|Lost to Follow-up|6|||
160869809|NCT02453711|580915629|FG000|Overall Study|Death|0|||
160869810|NCT02453711|580915630|FG001|Overall Study|Death|0|||
160869811|NCT02453711|580915631|FG002|Overall Study|Death|0|||
160869812|NCT02453711|580915632|FG003|Overall Study|Death|0|||
160869813|NCT02453711|580915633|FG004|Overall Study|Death|0|||
160869814|NCT02453711|580915634|FG005|Overall Study|Death|0|||
160869815|NCT02453711|580915635|FG006|Overall Study|Death|1|||
160869816|NCT02453711|580915636|FG007|Overall Study|Death|0|||
160869817|NCT02453711|580915637|FG008|Overall Study|Death|0|||
160869818|NCT02453711|580915629|FG000|Overall Study|Unclassified|1|||
160869819|NCT02453711|580915630|FG001|Overall Study|Unclassified|0|||
160869820|NCT02453711|580915631|FG002|Overall Study|Unclassified|1|||
160869821|NCT02453711|580915632|FG003|Overall Study|Unclassified|0|||
160869822|NCT02453711|580915633|FG004|Overall Study|Unclassified|0|||
160869823|NCT02453711|580915634|FG005|Overall Study|Unclassified|0|||
160869824|NCT02453711|580915635|FG006|Overall Study|Unclassified|0|||
160869825|NCT02453711|580915636|FG007|Overall Study|Unclassified|0|||
160869826|NCT02453711|580915637|FG008|Overall Study|Unclassified|0|||
160869827|NCT00314795|580915642|FG000|Overall Study|Adverse Event|8|||
160869828|NCT00314795|580915642|FG000|Overall Study|Death|4|||
160869829|NCT00314795|580915642|FG000|Overall Study|Reason not Specified|3|||
160869830|NCT00314795|580915642|FG000|Overall Study|Renal Transplant|3|||
160869831|NCT00314795|580915642|FG000|Overall Study|Participants Withdrew Consent|2|||
160869832|NCT02170077|580915647|FG000|Overall Study|Withdrawal by Subject|3|||
160869833|NCT02170077|580915648|FG001|Overall Study|Withdrawal by Subject|4|||
160869834|NCT02170077|580915649|FG002|Overall Study|Withdrawal by Subject|2|||
160869835|NCT02170077|580915647|FG000|Overall Study|Adverse Event|4|||
160869836|NCT02170077|580915648|FG001|Overall Study|Adverse Event|4|||
160869837|NCT02170077|580915649|FG002|Overall Study|Adverse Event|4|||
160869838|NCT02170077|580915647|FG000|Overall Study|Lost to Follow-up|0|||
160869839|NCT02170077|580915648|FG001|Overall Study|Lost to Follow-up|1|||
160869840|NCT02170077|580915649|FG002|Overall Study|Lost to Follow-up|0|||
160869841|NCT02170077|580915647|FG000|Overall Study|Exclusion criteria|2|||
160869842|NCT02170077|580915648|FG001|Overall Study|Exclusion criteria|2|||
160869843|NCT02170077|580915649|FG002|Overall Study|Exclusion criteria|5|||
160869844|NCT02170077|580915647|FG000|Overall Study|Exacerbation of seizures|0|||
160869845|NCT02170077|580915648|FG001|Overall Study|Exacerbation of seizures|2|||
160869846|NCT02170077|580915649|FG002|Overall Study|Exacerbation of seizures|1|||
160869847|NCT01780974|580915654|FG000|Overall Study|Death|1|||
160869848|NCT01780974|580915655|FG001|Overall Study|Death|0|||
160869849|NCT01780974|580915654|FG000|Overall Study|Adverse Event|1|||
160869850|NCT01780974|580915655|FG001|Overall Study|Adverse Event|3|||
160869851|NCT02447003|580915663|FG000|Overall Study|Other|0|||
160869852|NCT02447003|580915664|FG001|Overall Study|Other|4|||
160869853|NCT02447003|580915663|FG000|Overall Study|Site discontinued|0|||
160869854|NCT02447003|580915664|FG001|Overall Study|Site discontinued|2|||
160869855|NCT02447003|580915663|FG000|Overall Study|Physician Decision|0|||
160869856|NCT02447003|580915664|FG001|Overall Study|Physician Decision|1|||
160869857|NCT02447003|580915663|FG000|Overall Study|Withdrawal by Subject|4|||
160869858|NCT02447003|580915664|FG001|Overall Study|Withdrawal by Subject|3|||
160869859|NCT02447003|580915663|FG000|Overall Study|Sponsor Decision|6|||
160869860|NCT02447003|580915664|FG001|Overall Study|Sponsor Decision|11|||
160869861|NCT02447003|580915663|FG000|Overall Study|Progressive Disease|1|||
161112680|NCT00078325|581802946|FG002|Overall Study|Lost to Follow-up|1|||
161112681|NCT00078325|581802944|FG000|Overall Study|Physician Decision|2|||
161112682|NCT00078325|581802945|FG001|Overall Study|Physician Decision|0|||
161112683|NCT00078325|581802946|FG002|Overall Study|Physician Decision|1|||
161112684|NCT00078325|581802944|FG000|Overall Study|Miscellaneous|1|||
161112685|NCT00078325|581802945|FG001|Overall Study|Miscellaneous|1|||
161112686|NCT00078325|581802946|FG002|Overall Study|Miscellaneous|1|||
161112687|NCT03610724|581802947|FG000|Overall Study|Death|17|||
161112688|NCT03610724|581802947|FG000|Overall Study|Lost to Follow-up|1|||
161112689|NCT03610724|581802947|FG000|Overall Study|Physician Decision|1|||
161112690|NCT03610724|581802947|FG000|Overall Study|Died prior to infusion|1|||
161112691|NCT01473563|581802948|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
161112692|NCT00754793|581802949|FG000|Overall Study|voluntary withdrawn from study|0|||
161217559|NCT02711956|582179545|FG013|Overall Study|Radiographic progression|0|||
160869862|NCT02447003|580915664|FG001|Overall Study|Progressive Disease|0|||
160869863|NCT02447003|580915663|FG000|Overall Study|Lost to Follow-up|5|||
160869864|NCT02447003|580915664|FG001|Overall Study|Lost to Follow-up|0|||
160869865|NCT02447003|580915663|FG000|Overall Study|Death|154|||
160869866|NCT02447003|580915664|FG001|Overall Study|Death|63|||
160869867|NCT00750438|580915665|FG000|Overall Study|Protocol Violation|4|||
161112693|NCT00754793|581802950|FG001|Overall Study|voluntary withdrawn from study|1|||
160869868|NCT00750438|580915666|FG001|Overall Study|Protocol Violation|1|||
160869869|NCT00750438|580915665|FG000|Overall Study|Physician Decision|2|||
160869870|NCT00750438|580915666|FG001|Overall Study|Physician Decision|2|||
161112694|NCT02943564|581802952|FG000|Overall Study|Miscellaneous Reasons|0|||
161112695|NCT02943564|581802953|FG001|Overall Study|Miscellaneous Reasons|0|||
160869871|NCT00750438|580915665|FG000|Overall Study|Withdrawal by Subject|1|||
160869872|NCT00750438|580915666|FG001|Overall Study|Withdrawal by Subject|1|||
161112696|NCT02943564|581802954|FG002|Overall Study|Miscellaneous Reasons|3|||
161112697|NCT02943564|581802952|FG000|Overall Study|Site terminated by sponsor|0|||
161112698|NCT02943564|581802953|FG001|Overall Study|Site terminated by sponsor|1|||
161112699|NCT02943564|581802954|FG002|Overall Study|Site terminated by sponsor|0|||
161112700|NCT02943564|581802952|FG000|Overall Study|Non-compliance with study drug|0|||
161112701|NCT02943564|581802953|FG001|Overall Study|Non-compliance with study drug|1|||
161112702|NCT02943564|581802954|FG002|Overall Study|Non-compliance with study drug|0|||
161112703|NCT02943564|581802952|FG000|Overall Study|Pregnancy|0|||
161112704|NCT02943564|581802953|FG001|Overall Study|Pregnancy|1|||
161112705|NCT02943564|581802954|FG002|Overall Study|Pregnancy|1|||
161112706|NCT02943564|581802952|FG000|Overall Study|Protocol Violation|2|||
161112707|NCT02943564|581802953|FG001|Overall Study|Protocol Violation|2|||
161112708|NCT02943564|581802954|FG002|Overall Study|Protocol Violation|2|||
161112709|NCT02943564|581802952|FG000|Overall Study|Lost to Follow-up|1|||
161112710|NCT02943564|581802953|FG001|Overall Study|Lost to Follow-up|0|||
161112711|NCT02943564|581802954|FG002|Overall Study|Lost to Follow-up|0|||
161112712|NCT02943564|581802952|FG000|Overall Study|Withdrawal by Subject|6|||
161112713|NCT02943564|581802953|FG001|Overall Study|Withdrawal by Subject|5|||
161112714|NCT02943564|581802954|FG002|Overall Study|Withdrawal by Subject|2|||
161112715|NCT02943564|581802952|FG000|Overall Study|Adverse Event|1|||
161112716|NCT02943564|581802953|FG001|Overall Study|Adverse Event|2|||
161112717|NCT02943564|581802954|FG002|Overall Study|Adverse Event|1|||
161112718|NCT02943564|581802952|FG000|Overall Study|Lack of Efficacy|0|||
161112719|NCT02943564|581802953|FG001|Overall Study|Lack of Efficacy|1|||
161112720|NCT02943564|581802954|FG002|Overall Study|Lack of Efficacy|0|||
161112721|NCT02536313|581802955|FG000|Overall Study|Lack of Efficacy|0|||
161112722|NCT02536313|581802956|FG001|Overall Study|Lack of Efficacy|1|||
161112723|NCT00917150|581802957|FG000|Overall Study|Adverse Event|12|||
161112724|NCT00917150|581802958|FG001|Overall Study|Adverse Event|7|||
161112725|NCT00917150|581802959|FG002|Overall Study|Adverse Event|12|||
161112726|NCT00917150|581802960|FG003|Overall Study|Adverse Event|11|||
161112727|NCT00917150|581802957|FG000|Overall Study|Death|1|||
161112728|NCT00917150|581802958|FG001|Overall Study|Death|4|||
161112729|NCT00917150|581802959|FG002|Overall Study|Death|3|||
161112730|NCT00917150|581802960|FG003|Overall Study|Death|2|||
161112731|NCT00917150|581802957|FG000|Overall Study|Lost to Follow-up|1|||
161112732|NCT00917150|581802958|FG001|Overall Study|Lost to Follow-up|0|||
161112733|NCT00917150|581802959|FG002|Overall Study|Lost to Follow-up|4|||
161112734|NCT00917150|581802960|FG003|Overall Study|Lost to Follow-up|2|||
161112735|NCT00917150|581802957|FG000|Overall Study|Physician Decision|0|||
161112736|NCT00917150|581802958|FG001|Overall Study|Physician Decision|2|||
161112737|NCT00917150|581802959|FG002|Overall Study|Physician Decision|0|||
161112738|NCT00917150|581802960|FG003|Overall Study|Physician Decision|1|||
161112739|NCT00917150|581802957|FG000|Overall Study|Protocol Violation|5|||
161112740|NCT00917150|581802958|FG001|Overall Study|Protocol Violation|5|||
161112741|NCT00917150|581802959|FG002|Overall Study|Protocol Violation|3|||
161112742|NCT00917150|581802960|FG003|Overall Study|Protocol Violation|5|||
161112743|NCT00917150|581802957|FG000|Overall Study|Withdrawal by Subject|15|||
161112744|NCT00917150|581802958|FG001|Overall Study|Withdrawal by Subject|16|||
161112745|NCT00917150|581802959|FG002|Overall Study|Withdrawal by Subject|18|||
161112746|NCT00917150|581802960|FG003|Overall Study|Withdrawal by Subject|11|||
161112747|NCT00917150|581802957|FG000|Overall Study|Other than specified|3|||
161112748|NCT00917150|581802958|FG001|Overall Study|Other than specified|3|||
161112749|NCT00917150|581802959|FG002|Overall Study|Other than specified|2|||
161112750|NCT00917150|581802960|FG003|Overall Study|Other than specified|2|||
161112751|NCT03891264|581802962|FG000|Overall Study|Adverse Event|1|||
161112752|NCT03891264|581802962|FG000|Overall Study|Withdrawal by Subject|2|||
161112753|NCT03891264|581802962|FG000|Overall Study|Physician Decision|2|||
161112754|NCT01924182|581802963|FG000|Overall Study|Withdrawal by Subject|1|||
161112755|NCT01924182|581802964|FG001|Overall Study|Withdrawal by Subject|0|||
161112756|NCT00993265|581802966|FG000|Overall Study|Adverse Event|1|||
161112757|NCT00993265|581802967|FG001|Overall Study|Adverse Event|0|||
161112758|NCT00993265|581802966|FG000|Overall Study|Changed dose of concomitant drug|2|||
161112759|NCT00993265|581802967|FG001|Overall Study|Changed dose of concomitant drug|0|||
161112760|NCT00993265|581802966|FG000|Overall Study|Non-compliant with study medication|1|||
161112761|NCT00993265|581802967|FG001|Overall Study|Non-compliant with study medication|0|||
161217560|NCT02711956|582179546|FG014|Overall Study|Radiographic progression|1|||
161112762|NCT00219284|581802968|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
161112763|NCT00219284|581802969|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
161112764|NCT00219284|581802968|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
161112765|NCT00219284|581802969|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
161112766|NCT00219284|581802968|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
161217561|NCT02711956|582179532|FG000|Overall Study|PSA progression with clinical progression|0|||
161112767|NCT00219284|581802969|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
161112768|NCT00219284|581802968|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
161112769|NCT00219284|581802969|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
161112770|NCT00219284|581802968|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
161112771|NCT00219284|581802969|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
161217562|NCT02711956|582179533|FG001|Overall Study|PSA progression with clinical progression|0|||
161217563|NCT02711956|582179534|FG002|Overall Study|PSA progression with clinical progression|0|||
161217564|NCT02711956|582179535|FG003|Overall Study|PSA progression with clinical progression|0|||
161217565|NCT02711956|582179536|FG004|Overall Study|PSA progression with clinical progression|1|||
161217566|NCT02711956|582179537|FG005|Overall Study|PSA progression with clinical progression|0|||
161217567|NCT02711956|582179538|FG006|Overall Study|PSA progression with clinical progression|0|||
161217568|NCT02711956|582179539|FG007|Overall Study|PSA progression with clinical progression|0|||
161217569|NCT02711956|582179540|FG008|Overall Study|PSA progression with clinical progression|0|||
161217570|NCT02711956|582179541|FG009|Overall Study|PSA progression with clinical progression|0|||
161217571|NCT02711956|582179542|FG010|Overall Study|PSA progression with clinical progression|0|||
161217572|NCT02711956|582179543|FG011|Overall Study|PSA progression with clinical progression|0|||
161217573|NCT02711956|582179544|FG012|Overall Study|PSA progression with clinical progression|1|||
161217574|NCT02711956|582179545|FG013|Overall Study|PSA progression with clinical progression|1|||
161217575|NCT02711956|582179546|FG014|Overall Study|PSA progression with clinical progression|0|||
161217576|NCT02711956|582179532|FG000|Overall Study|PSA progression with radiographic progression|0|||
161217577|NCT02711956|582179533|FG001|Overall Study|PSA progression with radiographic progression|1|||
161217578|NCT02711956|582179534|FG002|Overall Study|PSA progression with radiographic progression|0|||
161217579|NCT02711956|582179535|FG003|Overall Study|PSA progression with radiographic progression|0|||
161217580|NCT02711956|582179536|FG004|Overall Study|PSA progression with radiographic progression|0|||
161217581|NCT02711956|582179537|FG005|Overall Study|PSA progression with radiographic progression|2|||
161217582|NCT02711956|582179538|FG006|Overall Study|PSA progression with radiographic progression|2|||
161217583|NCT02711956|582179539|FG007|Overall Study|PSA progression with radiographic progression|1|||
161217584|NCT02711956|582179540|FG008|Overall Study|PSA progression with radiographic progression|0|||
161217585|NCT02711956|582179541|FG009|Overall Study|PSA progression with radiographic progression|1|||
161217586|NCT02711956|582179542|FG010|Overall Study|PSA progression with radiographic progression|0|||
160869873|NCT03848728|580915667|FG000|Overall Study|Death|16|||
160869874|NCT03848728|580915668|FG001|Overall Study|Death|13|||
160869875|NCT03848728|580915667|FG000|Overall Study|Outmigrated to non-study community|98|||
160869876|NCT03848728|580915668|FG001|Overall Study|Outmigrated to non-study community|106|||
161112772|NCT00219284|581802968|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
161112773|NCT00219284|581802969|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
161112774|NCT00219284|581802968|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
161112775|NCT00219284|581802969|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
161112776|NCT00219284|581802968|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
161112777|NCT00219284|581802969|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
161112778|NCT00219284|581802968|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
161112779|NCT00219284|581802969|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
161112780|NCT05003622|581802970|FG000|Overall Study|Progressive disease|2|||
161112781|NCT05003622|581802970|FG000|Overall Study|Withdrawal by Subject|1|||
161112782|NCT01692275|581802972|FG000|Overall Study|Lost to Follow-up|57|||
161112783|NCT01692275|581802973|FG001|Overall Study|Lost to Follow-up|48|||
161112784|NCT01692275|581802972|FG000|Overall Study|Withdrawal by Subject|9|||
161112785|NCT01692275|581802973|FG001|Overall Study|Withdrawal by Subject|11|||
161112786|NCT01624662|581802974|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
161112787|NCT01624662|581802975|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161112788|NCT01624662|581802976|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161112789|NCT01624662|581802977|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
161112790|NCT01624662|581802974|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
161112791|NCT01624662|581802975|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
161112792|NCT01624662|581802976|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161112793|NCT01624662|581802977|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161112794|NCT01624662|581802974|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161112795|NCT01624662|581802975|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
161112796|NCT01624662|581802976|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161112797|NCT01624662|581802977|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161112798|NCT01624662|581802974|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
161112799|NCT01624662|581802975|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161112800|NCT01624662|581802976|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
161112801|NCT01624662|581802977|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161112802|NCT01624662|581802974|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161112803|NCT01624662|581802975|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161112804|NCT01624662|581802976|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161112805|NCT01624662|581802977|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161112806|NCT01624662|581802974|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
160869877|NCT03848728|580915667|FG000|Overall Study|Transfered to non-study clinic|32|||
160869878|NCT03848728|580915668|FG001|Overall Study|Transfered to non-study clinic|48|||
161112807|NCT01624662|581802975|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
161112808|NCT01624662|581802976|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161112809|NCT01624662|581802977|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161112810|NCT01624662|581802974|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161112811|NCT01624662|581802975|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161112812|NCT01624662|581802976|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161112813|NCT01624662|581802977|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161112814|NCT02356562|581804419|FG000|Overall Study|Withdrawal by Subject|0|||
161112815|NCT02356562|581804420|FG001|Overall Study|Withdrawal by Subject|1|||
161112816|NCT02356562|581804419|FG000|Overall Study|Re-entered treatment in a previous study|1|||
161112817|NCT02356562|581804420|FG001|Overall Study|Re-entered treatment in a previous study|0|||
161112818|NCT02356562|581804419|FG000|Overall Study|site closure|1|||
161112819|NCT02356562|581804420|FG001|Overall Study|site closure|0|||
161112820|NCT00412750|581804421|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161112821|NCT00412750|581804422|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161112822|NCT00412750|581804423|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161112823|NCT00412750|581804421|FG000|Overall Study|Administrative problems|21|||
161112824|NCT00412750|581804422|FG001|Overall Study|Administrative problems|17|||
161112825|NCT00412750|581804423|FG002|Overall Study|Administrative problems|14|||
161112826|NCT00412750|581804421|FG000|Overall Study|Adverse Event|8|||
161112827|NCT00412750|581804422|FG001|Overall Study|Adverse Event|3|||
161112828|NCT00412750|581804423|FG002|Overall Study|Adverse Event|3|||
161112829|NCT00412750|581804421|FG000|Overall Study|Lost to Follow-up|1|||
161112830|NCT00412750|581804422|FG001|Overall Study|Lost to Follow-up|0|||
161112831|NCT00412750|581804423|FG002|Overall Study|Lost to Follow-up|1|||
161112832|NCT00412750|581804421|FG000|Overall Study|Withdrawal by Subject|0|||
161112833|NCT00412750|581804422|FG001|Overall Study|Withdrawal by Subject|1|||
161112834|NCT00412750|581804423|FG002|Overall Study|Withdrawal by Subject|2|||
161112835|NCT00412750|581804421|FG000|Overall Study|Lack of Efficacy|0|||
161112836|NCT00412750|581804422|FG001|Overall Study|Lack of Efficacy|0|||
161112837|NCT00412750|581804423|FG002|Overall Study|Lack of Efficacy|3|||
161112838|NCT00874120|581804430|FG000|First Intervention|Adverse Event|0|||
161112839|NCT00874120|581804431|FG001|First Intervention|Adverse Event|1|||
161112840|NCT00874120|581804430|FG000|First Intervention|Withdrawal by Subject|2|||
161112841|NCT00874120|581804431|FG001|First Intervention|Withdrawal by Subject|0|||
161112842|NCT00874120|581804430|FG000|First Intervention|Lost to Follow-up|0|||
161112843|NCT00874120|581804431|FG001|First Intervention|Lost to Follow-up|1|||
161112844|NCT00874120|581804430|FG000|First Intervention|Protocol Violation|3|||
161112845|NCT00874120|581804431|FG001|First Intervention|Protocol Violation|0|||
161112846|NCT00874120|581804430|FG000|First Intervention|positive drug test|1|||
161112847|NCT00874120|581804431|FG001|First Intervention|positive drug test|0|||
161112848|NCT00874120|581804430|FG000|Second Intervention|Withdrawal by Subject|1|||
161112849|NCT00874120|581804431|FG001|Second Intervention|Withdrawal by Subject|0|||
161112850|NCT00874120|581804430|FG000|Second Intervention|Protocol Violation|1|||
161112851|NCT00874120|581804431|FG001|Second Intervention|Protocol Violation|0|||
161112852|NCT00105443|581804437|FG000|Double-Blind Treatment|Adverse Event|1|||
161112853|NCT00105443|581804438|FG001|Double-Blind Treatment|Adverse Event|0|||
161112854|NCT00105443|581804439|FG002|Double-Blind Treatment|Adverse Event|0|||
161112855|NCT00105443|581804440|FG003|Double-Blind Treatment|Adverse Event|0|||
160869879|NCT03848728|580915667|FG000|Overall Study|Withdrawal by Subject|1|||
161112856|NCT00105443|581804437|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
161112857|NCT00105443|581804438|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
161112858|NCT00105443|581804439|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
161112859|NCT00105443|581804440|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
161112860|NCT00105443|581804437|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
161112861|NCT00105443|581804438|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
161112862|NCT00105443|581804439|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
161112863|NCT00105443|581804440|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
161217587|NCT02711956|582179543|FG011|Overall Study|PSA progression with radiographic progression|1|||
161217588|NCT02711956|582179544|FG012|Overall Study|PSA progression with radiographic progression|2|||
161217589|NCT02711956|582179545|FG013|Overall Study|PSA progression with radiographic progression|3|||
161217590|NCT02711956|582179546|FG014|Overall Study|PSA progression with radiographic progression|3|||
161217591|NCT05487456|582179547|FG000|Overall Study|Withdrawal by Subject|0|||
161217592|NCT05487456|582179548|FG001|Overall Study|Withdrawal by Subject|0|||
161217593|NCT05487456|582179549|FG002|Overall Study|Withdrawal by Subject|1|||
161217594|NCT05487456|582179550|FG003|Overall Study|Withdrawal by Subject|0|||
161217595|NCT03294538|582179553|FG000|Overall Study|Adverse Event|0|||
161217596|NCT03294538|582179554|FG001|Overall Study|Adverse Event|1|||
161217597|NCT03294538|582179555|FG002|Overall Study|Adverse Event|1|||
161217598|NCT03294538|582179553|FG000|Overall Study|Lost to Follow-up|1|||
161217599|NCT03294538|582179554|FG001|Overall Study|Lost to Follow-up|0|||
161217600|NCT03294538|582179555|FG002|Overall Study|Lost to Follow-up|0|||
161217601|NCT03294538|582179553|FG000|Overall Study|Outside of Visit Window|4|||
161217602|NCT03294538|582179554|FG001|Overall Study|Outside of Visit Window|4|||
161217603|NCT03294538|582179555|FG002|Overall Study|Outside of Visit Window|1|||
161217604|NCT01238848|582179561|FG000|Overall Study|Physician Decision|13|||
161217605|NCT01238848|582179562|FG001|Overall Study|Physician Decision|5|||
161217606|NCT00723554|582179563|FG000|Overall Study|Adverse Event|12|||
161217607|NCT00723554|582179563|FG000|Overall Study|Investigator's judgement|5|||
161217608|NCT00723554|582179563|FG000|Overall Study|Inhaled medication other than iloprost|4|||
161217609|NCT00723554|582179563|FG000|Overall Study|Withdrawal of consent|3|||
161217610|NCT00723554|582179563|FG000|Overall Study|Other|3|||
161217611|NCT00723554|582179563|FG000|Overall Study|Lost to Follow-up|1|||
161217612|NCT00723554|582179563|FG000|Overall Study|Non-compliance|1|||
161217613|NCT01405820|582179564|FG000|Randomized Treatment Period|Adverse Event|3|||
161217614|NCT01405820|582179565|FG001|Randomized Treatment Period|Adverse Event|3|||
161217615|NCT01405820|582179566|FG002|Randomized Treatment Period|Adverse Event|3|||
161217616|NCT01405820|582179567|FG003|Randomized Treatment Period|Adverse Event|0|||
161217617|NCT01405820|582179568|FG004|Randomized Treatment Period|Adverse Event|2|||
161217618|NCT01405820|582179569|FG005|Randomized Treatment Period|Adverse Event|1|||
161217619|NCT01405820|582179564|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
161217620|NCT01405820|582179565|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
161217621|NCT01405820|582179566|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
161217622|NCT01405820|582179567|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
161217623|NCT01405820|582179568|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
161217624|NCT01405820|582179569|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
161217625|NCT01405820|582179564|FG000|Randomized Treatment Period|Other|2|||
161217626|NCT01405820|582179565|FG001|Randomized Treatment Period|Other|2|||
161217627|NCT01405820|582179566|FG002|Randomized Treatment Period|Other|1|||
161217628|NCT01405820|582179567|FG003|Randomized Treatment Period|Other|1|||
161217629|NCT01405820|582179568|FG004|Randomized Treatment Period|Other|0|||
161217630|NCT01405820|582179569|FG005|Randomized Treatment Period|Other|0|||
161217631|NCT01405820|582179564|FG000|Randomized Treatment Period|Physician Decision|0|||
161217632|NCT01405820|582179565|FG001|Randomized Treatment Period|Physician Decision|2|||
161217633|NCT01405820|582179566|FG002|Randomized Treatment Period|Physician Decision|1|||
161217634|NCT01405820|582179567|FG003|Randomized Treatment Period|Physician Decision|0|||
161217635|NCT01405820|582179568|FG004|Randomized Treatment Period|Physician Decision|0|||
161217636|NCT01405820|582179569|FG005|Randomized Treatment Period|Physician Decision|0|||
161217637|NCT01405820|582179564|FG000|Randomized Treatment Period|Rescue|0|||
161217638|NCT01405820|582179565|FG001|Randomized Treatment Period|Rescue|1|||
161217639|NCT01405820|582179566|FG002|Randomized Treatment Period|Rescue|13|||
161217640|NCT01405820|582179567|FG003|Randomized Treatment Period|Rescue|10|||
161217641|NCT01405820|582179568|FG004|Randomized Treatment Period|Rescue|8|||
161217642|NCT01405820|582179569|FG005|Randomized Treatment Period|Rescue|8|||
161217643|NCT01405820|582179564|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
161217644|NCT01405820|582179565|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
161217645|NCT01405820|582179566|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
161217646|NCT01405820|582179567|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
161217647|NCT01405820|582179568|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
161217648|NCT01405820|582179569|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
161217649|NCT01405820|582179564|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
161217650|NCT01405820|582179565|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
161217651|NCT01405820|582179566|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
161217652|NCT01405820|582179567|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
161324391|NCT02098395|582573584|FG000|Overall Study|Lost to Follow-up|2|||
160869880|NCT03848728|580915668|FG001|Overall Study|Withdrawal by Subject|0|||
160869881|NCT00536744|580915671|FG000|Overall Study|Adverse Event|13|||
160869882|NCT00536744|580915672|FG001|Overall Study|Adverse Event|10|||
160869883|NCT00536744|580915671|FG000|Overall Study|Death|2|||
160869884|NCT00536744|580915672|FG001|Overall Study|Death|1|||
160869885|NCT00536744|580915671|FG000|Overall Study|Physician Decision|3|||
161112864|NCT00105443|581804437|FG000|Double-Blind Treatment|Physician Decision|1|||
161112865|NCT00105443|581804438|FG001|Double-Blind Treatment|Physician Decision|0|||
161112866|NCT00105443|581804439|FG002|Double-Blind Treatment|Physician Decision|2|||
161112867|NCT00105443|581804440|FG003|Double-Blind Treatment|Physician Decision|0|||
161112868|NCT00105443|581804437|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
161112869|NCT00105443|581804438|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
161112870|NCT00105443|581804439|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
161112871|NCT00105443|581804440|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
161112872|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
161112873|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
161112874|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
161112875|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
161112876|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
161112877|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
161112878|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
161112879|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
161112880|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
161112881|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
161112882|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
161112883|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
161112884|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
161112885|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
161112886|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
161112887|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
161112888|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
161112889|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
161112890|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
161112891|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
161112892|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161112893|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
161112894|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161112895|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
161112896|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
161112897|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
161112898|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
161112899|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
161112900|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
161112901|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
161112902|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
161112903|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
161112904|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
161112905|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
161112906|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
161112907|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
161112908|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161112909|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161112910|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
161112911|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
161112912|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
161112913|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161112914|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161112915|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
161112916|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161112917|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161112918|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
161324392|NCT02098395|582573585|FG001|Overall Study|Lost to Follow-up|1|||
160869886|NCT00536744|580915672|FG001|Overall Study|Physician Decision|1|||
160869887|NCT00536744|580915671|FG000|Overall Study|Lost to Follow-up|3|||
160869888|NCT00536744|580915672|FG001|Overall Study|Lost to Follow-up|5|||
161217653|NCT01405820|582179568|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
161217654|NCT01405820|582179569|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
161217655|NCT01405820|582179564|FG000|Randomized Treatment Period|Death|0|||
161217656|NCT01405820|582179565|FG001|Randomized Treatment Period|Death|0|||
161217657|NCT01405820|582179566|FG002|Randomized Treatment Period|Death|0|||
161217658|NCT01405820|582179567|FG003|Randomized Treatment Period|Death|1|||
161217659|NCT01405820|582179568|FG004|Randomized Treatment Period|Death|0|||
161217660|NCT01405820|582179569|FG005|Randomized Treatment Period|Death|0|||
161217661|NCT01405820|582179564|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161217662|NCT01405820|582179565|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161217663|NCT01405820|582179566|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161217664|NCT01405820|582179567|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
161217665|NCT01405820|582179568|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161217666|NCT01405820|582179569|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
161217667|NCT01405820|582179564|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
161217668|NCT01405820|582179565|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
161217669|NCT01405820|582179566|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
161217670|NCT01405820|582179567|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
161217671|NCT01405820|582179568|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
161217672|NCT01405820|582179569|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
161217673|NCT01405820|582179564|FG000|Open-Label Treatment Period|Other|1|||
161217674|NCT01405820|582179565|FG001|Open-Label Treatment Period|Other|1|||
161217675|NCT01405820|582179566|FG002|Open-Label Treatment Period|Other|1|||
161217676|NCT01405820|582179567|FG003|Open-Label Treatment Period|Other|1|||
161217677|NCT01405820|582179568|FG004|Open-Label Treatment Period|Other|1|||
161217678|NCT01405820|582179569|FG005|Open-Label Treatment Period|Other|1|||
161217679|NCT01405820|582179564|FG000|Open-Label Treatment Period|Physician Decision|0|||
161217680|NCT01405820|582179565|FG001|Open-Label Treatment Period|Physician Decision|0|||
161217681|NCT01405820|582179566|FG002|Open-Label Treatment Period|Physician Decision|1|||
161217682|NCT01405820|582179567|FG003|Open-Label Treatment Period|Physician Decision|2|||
161217683|NCT01405820|582179568|FG004|Open-Label Treatment Period|Physician Decision|1|||
161217684|NCT01405820|582179569|FG005|Open-Label Treatment Period|Physician Decision|0|||
161217685|NCT01405820|582179564|FG000|Open-Label Treatment Period|Adverse Event|0|||
161217686|NCT01405820|582179565|FG001|Open-Label Treatment Period|Adverse Event|0|||
161217687|NCT01405820|582179566|FG002|Open-Label Treatment Period|Adverse Event|0|||
161217688|NCT01405820|582179567|FG003|Open-Label Treatment Period|Adverse Event|1|||
161217689|NCT01405820|582179568|FG004|Open-Label Treatment Period|Adverse Event|0|||
161217690|NCT01405820|582179569|FG005|Open-Label Treatment Period|Adverse Event|0|||
161217691|NCT03222141|582179572|FG000|Overall Study|Death|15|||
161217692|NCT03222141|582179572|FG000|Overall Study|Lost to Follow-up|3|||
161217693|NCT01894984|582179576|FG000|Overall Study|Other|314|||
161217694|NCT01894984|582179577|FG001|Overall Study|Other|175|||
161217695|NCT00827359|582179578|FG000|Overall Study|Progressive Diseas|19|||
161217696|NCT00827359|582179578|FG000|Overall Study|Unacceptable Toxicity|5|||
161217697|NCT00827359|582179578|FG000|Overall Study|Ineligible|1|||
161217698|NCT02436135|582179579|FG000|Overall Study|Progressive Disease|3|||
161217699|NCT02436135|582179580|FG001|Overall Study|Progressive Disease|1|||
161217700|NCT02436135|582179579|FG000|Overall Study|Investigator Discretion|1|||
161217701|NCT02436135|582179580|FG001|Overall Study|Investigator Discretion|2|||
161217702|NCT02436135|582179579|FG000|Overall Study|Adverse Event|1|||
161217703|NCT02436135|582179580|FG001|Overall Study|Adverse Event|0|||
161217704|NCT02436135|582179579|FG000|Overall Study|Withdrawal by Participant|1|||
161217705|NCT02436135|582179580|FG001|Overall Study|Withdrawal by Participant|0|||
161217706|NCT02436135|582179579|FG000|Overall Study|Study Terminated By Sponsor|0|||
161217707|NCT02436135|582179580|FG001|Overall Study|Study Terminated By Sponsor|1|||
161217708|NCT01427803|582179581|FG000|Overall Study|Lost to Follow-up|32|||
161217709|NCT01427803|582179582|FG001|Overall Study|Lost to Follow-up|26|||
161217710|NCT01427803|582179581|FG000|Overall Study|Withdrawal by Subject|20|||
161217711|NCT01427803|582179582|FG001|Overall Study|Withdrawal by Subject|0|||
161217712|NCT01427803|582179581|FG000|Overall Study|Unable to complete full treatment period|6|||
161217713|NCT01427803|582179582|FG001|Overall Study|Unable to complete full treatment period|0|||
161217714|NCT01427803|582179581|FG000|Overall Study|Protocol Violation|1|||
161217715|NCT01427803|582179582|FG001|Overall Study|Protocol Violation|0|||
161217716|NCT01427803|582179581|FG000|Overall Study|Physician Decision|3|||
161217717|NCT01427803|582179582|FG001|Overall Study|Physician Decision|0|||
161217718|NCT01427803|582179581|FG000|Overall Study|did not take product|1|||
161217719|NCT01427803|582179582|FG001|Overall Study|did not take product|0|||
161217720|NCT03567057|582179584|FG000|Overall Study|Adverse Event|56|||
161217721|NCT03567057|582179585|FG001|Overall Study|Adverse Event|53|||
161217722|NCT03567057|582179586|FG002|Overall Study|Adverse Event|28|||
161217723|NCT03567057|582179584|FG000|Overall Study|Withdrawal by Subject|22|||
161217724|NCT03567057|582179585|FG001|Overall Study|Withdrawal by Subject|24|||
161217725|NCT03567057|582179586|FG002|Overall Study|Withdrawal by Subject|13|||
161217726|NCT03567057|582179584|FG000|Overall Study|Lost to Follow-up|3|||
161217727|NCT03567057|582179585|FG001|Overall Study|Lost to Follow-up|5|||
161217728|NCT03567057|582179586|FG002|Overall Study|Lost to Follow-up|2|||
160869889|NCT00536744|580915671|FG000|Overall Study|Withdrawal by Subject|7|||
160869890|NCT00536744|580915672|FG001|Overall Study|Withdrawal by Subject|8|||
160869891|NCT00536744|580915671|FG000|Overall Study|PI tried alternative treatment|1|||
160869892|NCT00536744|580915672|FG001|Overall Study|PI tried alternative treatment|3|||
161217729|NCT03567057|582179584|FG000|Overall Study|COVID-19 pandemic|4|||
161217730|NCT03567057|582179585|FG001|Overall Study|COVID-19 pandemic|3|||
161217731|NCT03567057|582179586|FG002|Overall Study|COVID-19 pandemic|0|||
161217732|NCT03567057|582179584|FG000|Overall Study|Non-compliance with study drug|4|||
161217733|NCT03567057|582179585|FG001|Overall Study|Non-compliance with study drug|2|||
161217734|NCT03567057|582179586|FG002|Overall Study|Non-compliance with study drug|0|||
161217735|NCT03567057|582179584|FG000|Overall Study|Lack of Efficacy|3|||
161217736|NCT03567057|582179585|FG001|Overall Study|Lack of Efficacy|0|||
161217737|NCT03567057|582179586|FG002|Overall Study|Lack of Efficacy|1|||
161217738|NCT03567057|582179584|FG000|Overall Study|Death|1|||
161217739|NCT03567057|582179585|FG001|Overall Study|Death|0|||
161217740|NCT03567057|582179586|FG002|Overall Study|Death|0|||
161217741|NCT03567057|582179584|FG000|Overall Study|Physician Decision|1|||
161217742|NCT03567057|582179585|FG001|Overall Study|Physician Decision|0|||
161217743|NCT03567057|582179586|FG002|Overall Study|Physician Decision|0|||
161217744|NCT03567057|582179584|FG000|Overall Study|Unstable medical condition|1|||
161217745|NCT03567057|582179585|FG001|Overall Study|Unstable medical condition|0|||
161217746|NCT03567057|582179586|FG002|Overall Study|Unstable medical condition|0|||
161217747|NCT03567057|582179584|FG000|Overall Study|Medical history event|0|||
161217748|NCT03567057|582179585|FG001|Overall Study|Medical history event|0|||
161217749|NCT03567057|582179586|FG002|Overall Study|Medical history event|1|||
161217750|NCT03567057|582179584|FG000|Overall Study|Other|0|||
161217751|NCT03567057|582179585|FG001|Overall Study|Other|0|||
161217752|NCT03567057|582179586|FG002|Overall Study|Other|1|||
161217753|NCT00886483|582179589|FG000|Overall Study|Lost to Follow-up|0|||
161217754|NCT00886483|582179590|FG001|Overall Study|Lost to Follow-up|1|||
161217755|NCT00886483|582179589|FG000|Overall Study|Pursue medications|1|||
161217756|NCT00886483|582179590|FG001|Overall Study|Pursue medications|2|||
161217757|NCT00886483|582179589|FG000|Overall Study|Distance to center, poor grades|1|||
161217758|NCT00886483|582179590|FG001|Overall Study|Distance to center, poor grades|0|||
161217759|NCT01001169|582179591|FG000|Overall Study|Withdrawal by Subject|2|||
161217760|NCT01001169|582179592|FG001|Overall Study|Withdrawal by Subject|1|||
161217761|NCT01271933|582179593|FG000|Single-Blind Phase|Lack of Efficacy|37|||
161217762|NCT01271933|582179594|FG001|Single-Blind Phase|Lack of Efficacy|0|||
161217763|NCT01271933|582179595|FG002|Single-Blind Phase|Lack of Efficacy|0|||
161217764|NCT01271933|582179593|FG000|Single-Blind Phase|Lost to Follow-up|10|||
161217765|NCT01271933|582179594|FG001|Single-Blind Phase|Lost to Follow-up|0|||
161217766|NCT01271933|582179595|FG002|Single-Blind Phase|Lost to Follow-up|0|||
161217767|NCT01271933|582179593|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
161217768|NCT01271933|582179594|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
161217769|NCT01271933|582179595|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
161217770|NCT01271933|582179593|FG000|Single-Blind Phase|Protocol Violation|3|||
161217771|NCT01271933|582179594|FG001|Single-Blind Phase|Protocol Violation|0|||
161217772|NCT01271933|582179595|FG002|Single-Blind Phase|Protocol Violation|0|||
161217773|NCT01271933|582179593|FG000|Single-Blind Phase|Adverse Event|52|||
161217774|NCT01271933|582179594|FG001|Single-Blind Phase|Adverse Event|0|||
161217775|NCT01271933|582179595|FG002|Single-Blind Phase|Adverse Event|0|||
161217776|NCT01271933|582179593|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
161217777|NCT01271933|582179594|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
161217778|NCT01271933|582179595|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
161217779|NCT01271933|582179593|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
161217780|NCT01271933|582179594|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
161217781|NCT01271933|582179595|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
161217782|NCT01271933|582179593|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
161217783|NCT01271933|582179594|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
160869893|NCT00787644|580915673|FG000|Overall Study|Lost to Follow-up|1|||
161217784|NCT01271933|582179595|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
160869894|NCT00787644|580915674|FG001|Overall Study|Lost to Follow-up|1|||
161217785|NCT01271933|582179593|FG000|Double-Blind Phase|Randomized but not treated|0|||
160869895|NCT00787644|580915673|FG000|Overall Study|Withdrawal by Subject|1|||
160869896|NCT00787644|580915674|FG001|Overall Study|Withdrawal by Subject|1|||
160869897|NCT01642589|580915678|FG000|Overall Study|Withdrawal by Subject|1|||
160869898|NCT01642589|580915679|FG001|Overall Study|Withdrawal by Subject|1|||
160869899|NCT01108185|580915680|FG000|Overall Study|Non-compliance|15|||
160869900|NCT01108185|580915680|FG000|Overall Study|Lost to Follow-up|12|||
160869901|NCT02581410|580915685|FG000|Vaccination Phase|Adverse Event|2|||
161217786|NCT01271933|582179594|FG001|Double-Blind Phase|Randomized but not treated|0|||
161217787|NCT01271933|582179595|FG002|Double-Blind Phase|Randomized but not treated|1|||
161217788|NCT01271933|582179593|FG000|Double-Blind Phase|Lack of Efficacy|0|||
161217789|NCT01271933|582179594|FG001|Double-Blind Phase|Lack of Efficacy|6|||
161217790|NCT01271933|582179595|FG002|Double-Blind Phase|Lack of Efficacy|9|||
161217791|NCT01271933|582179593|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161217792|NCT01271933|582179594|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161217793|NCT01271933|582179595|FG002|Double-Blind Phase|Lost to Follow-up|1|||
161217794|NCT01271933|582179593|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161217795|NCT01271933|582179594|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161217796|NCT01271933|582179595|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
161217797|NCT01271933|582179593|FG000|Double-Blind Phase|Adverse Event|0|||
161217798|NCT01271933|582179594|FG001|Double-Blind Phase|Adverse Event|3|||
161217799|NCT01271933|582179595|FG002|Double-Blind Phase|Adverse Event|0|||
161217800|NCT01271933|582179593|FG000|Double-Blind Phase|Participant request-personal reason|0|||
161217801|NCT01271933|582179594|FG001|Double-Blind Phase|Participant request-personal reason|1|||
161217802|NCT01271933|582179595|FG002|Double-Blind Phase|Participant request-personal reason|0|||
161217803|NCT01138150|582179596|FG000|Overall Study|blood unable to be processed|0|||
161217804|NCT01138150|582179597|FG001|Overall Study|blood unable to be processed|1|||
161217805|NCT01138150|582179596|FG000|Overall Study|Physician Decision|1|||
161217806|NCT01138150|582179597|FG001|Overall Study|Physician Decision|0|||
161217807|NCT01620983|582179598|FG000|Overall Study|Lost to Follow-up|8|||
161217808|NCT01620983|582179599|FG001|Overall Study|Lost to Follow-up|4|||
161217809|NCT01620983|582179600|FG002|Overall Study|Lost to Follow-up|9|||
161217810|NCT01620983|582179598|FG000|Overall Study|Withdrawal by Subject|6|||
161217811|NCT01620983|582179599|FG001|Overall Study|Withdrawal by Subject|8|||
161217812|NCT01620983|582179600|FG002|Overall Study|Withdrawal by Subject|1|||
161217813|NCT01620983|582179598|FG000|Overall Study|Death|2|||
161217814|NCT01620983|582179599|FG001|Overall Study|Death|0|||
161217815|NCT01620983|582179600|FG002|Overall Study|Death|0|||
161217816|NCT01620983|582179598|FG000|Overall Study|Physician Decision|3|||
161217817|NCT01620983|582179599|FG001|Overall Study|Physician Decision|10|||
161217818|NCT01620983|582179600|FG002|Overall Study|Physician Decision|5|||
161217819|NCT00798889|582179602|FG000|Overall Study|Adverse Event|53|||
161217820|NCT00798889|582179602|FG000|Overall Study|Protocol Violation|2|||
161217821|NCT00798889|582179602|FG000|Overall Study|Withdrawal by Subject|31|||
161217822|NCT00798889|582179602|FG000|Overall Study|Lost to Follow-up|1|||
161217823|NCT00798889|582179602|FG000|Overall Study|Lack of Efficacy|213|||
161217824|NCT00798889|582179602|FG000|Overall Study|Decision of Sponsor|11|||
161217825|NCT00798889|582179602|FG000|Overall Study|Enrolled, Not treated|3|||
161217826|NCT00617461|582179603|FG000|First Treatment Intervention Period|Adverse Event|2|||
161217827|NCT00617461|582179604|FG001|First Treatment Intervention Period|Adverse Event|0|||
161217828|NCT00617461|582179603|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
161217829|NCT00617461|582179604|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
161217830|NCT00617461|582179603|FG000|First Treatment Intervention Period|Protocol Violation|2|||
161217831|NCT00617461|582179604|FG001|First Treatment Intervention Period|Protocol Violation|1|||
161217832|NCT00617461|582179603|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
161217833|NCT00617461|582179604|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
161217834|NCT00617461|582179603|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
161217835|NCT00617461|582179604|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
161217836|NCT00617461|582179603|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
161217837|NCT00617461|582179604|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
161217838|NCT00617461|582179603|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
161217839|NCT00617461|582179604|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
161217840|NCT00617461|582179603|FG000|Second Treatment Intervention Period|Adverse Event|0|||
161217841|NCT00617461|582179604|FG001|Second Treatment Intervention Period|Adverse Event|1|||
161217842|NCT00617461|582179603|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
161217843|NCT00617461|582179604|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
161217844|NCT00617461|582179603|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
161217845|NCT00617461|582179604|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
161217846|NCT00617461|582179603|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
161217847|NCT00617461|582179604|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
161217848|NCT01724359|582179605|FG000|Overall Study|Adverse Event|10|||
161217849|NCT01724359|582179605|FG000|Overall Study|Death|1|||
161217850|NCT01724359|582179605|FG000|Overall Study|Other|20|||
161217851|NCT05085964|582179606|FG000|Overall Study|Premature termination of study|21|||
161217852|NCT05085964|582179607|FG001|Overall Study|Premature termination of study|0|||
161217853|NCT03156270|582179612|FG000|Overall Study|Failed pre-treatment screening|1|||
161217854|NCT03156270|582179612|FG000|Overall Study|Lost to Follow-up|1|||
161217855|NCT00591253|582179613|FG000|Overall Study|Adverse Event|3|||
161217856|NCT00591253|582179614|FG001|Overall Study|Adverse Event|3|||
161217857|NCT00591253|582179615|FG002|Overall Study|Adverse Event|1|||
161217858|NCT00591253|582179613|FG000|Overall Study|Protocol Violation|2|||
161217859|NCT00591253|582179614|FG001|Overall Study|Protocol Violation|2|||
161217860|NCT00591253|582179615|FG002|Overall Study|Protocol Violation|2|||
161217861|NCT00591253|582179613|FG000|Overall Study|Lost to Follow-up|2|||
161217862|NCT00591253|582179614|FG001|Overall Study|Lost to Follow-up|4|||
161217863|NCT00591253|582179615|FG002|Overall Study|Lost to Follow-up|0|||
161217864|NCT00591253|582179613|FG000|Overall Study|Withdrawal by Subject|1|||
161217865|NCT00591253|582179614|FG001|Overall Study|Withdrawal by Subject|7|||
160869902|NCT02581410|580915686|FG001|Vaccination Phase|Adverse Event|1|||
160869903|NCT02581410|580915685|FG000|Vaccination Phase|Withdrawal by Subject|0|||
161112919|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
161112920|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
161112921|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
161112922|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
161112923|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
161112924|NCT00105443|581804437|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
161112925|NCT00105443|581804438|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
161112926|NCT00105443|581804439|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
161112927|NCT00105443|581804440|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
161112928|NCT01623271|581804443|FG000|Overall Study|Withdrawal by Subject|2|||
161112929|NCT01611974|581804444|FG000|Overall Study|Death|10|||
161112930|NCT01611974|581804445|FG001|Overall Study|Death|12|||
161112931|NCT01611974|581804446|FG002|Overall Study|Death|10|||
161112932|NCT01611974|581804444|FG000|Overall Study|Lost to Follow-up|0|||
161112933|NCT01611974|581804445|FG001|Overall Study|Lost to Follow-up|1|||
161112934|NCT01611974|581804446|FG002|Overall Study|Lost to Follow-up|0|||
161112935|NCT01611974|581804444|FG000|Overall Study|Physician Decision|5|||
161112936|NCT01611974|581804445|FG001|Overall Study|Physician Decision|1|||
161112937|NCT01611974|581804446|FG002|Overall Study|Physician Decision|2|||
161112938|NCT01611974|581804444|FG000|Overall Study|Withdrawal by Subject|0|||
161112939|NCT01611974|581804445|FG001|Overall Study|Withdrawal by Subject|1|||
161112940|NCT01611974|581804446|FG002|Overall Study|Withdrawal by Subject|4|||
161112941|NCT00522431|581804447|FG000|Overall Study|Adverse Event|5|||
161112942|NCT00522431|581804447|FG000|Overall Study|Protocol Violation|2|||
161112943|NCT00522431|581804447|FG000|Overall Study|Withdrawal by Subject|2|||
161112944|NCT00522431|581804447|FG000|Overall Study|Subject non-compliance|1|||
161112945|NCT00522431|581804447|FG000|Overall Study|Other/unknown|1|||
161112946|NCT03808077|581804448|FG000|Overall Study|Physician Decision|2|||
161112947|NCT03808077|581804449|FG001|Overall Study|Physician Decision|3|||
161112948|NCT03808077|581804448|FG000|Overall Study|Withdrawal by Subject|1|||
161112949|NCT03808077|581804449|FG001|Overall Study|Withdrawal by Subject|0|||
161112950|NCT03808077|581804448|FG000|Overall Study|Equipment Issues|2|||
161112951|NCT03808077|581804449|FG001|Overall Study|Equipment Issues|1|||
161112952|NCT02004262|581804452|FG000|Overall Study|Death|67|||
161112953|NCT02004262|581804453|FG001|Overall Study|Death|64|||
161112954|NCT02004262|581804454|FG002|Overall Study|Death|66|||
161112955|NCT02004262|581804455|FG003|Overall Study|Death|28|||
161112956|NCT02004262|581804456|FG004|Overall Study|Death|29|||
161112957|NCT02004262|581804457|FG005|Overall Study|Death|22|||
161112958|NCT02004262|581804452|FG000|Overall Study|Withdrawal by Subject|1|||
161112959|NCT02004262|581804453|FG001|Overall Study|Withdrawal by Subject|0|||
161112960|NCT02004262|581804454|FG002|Overall Study|Withdrawal by Subject|4|||
161112961|NCT02004262|581804455|FG003|Overall Study|Withdrawal by Subject|0|||
161112962|NCT02004262|581804456|FG004|Overall Study|Withdrawal by Subject|1|||
161112963|NCT02004262|581804457|FG005|Overall Study|Withdrawal by Subject|3|||
161112964|NCT02004262|581804452|FG000|Overall Study|Lost to Follow-up|1|||
161112965|NCT02004262|581804453|FG001|Overall Study|Lost to Follow-up|1|||
161112966|NCT02004262|581804454|FG002|Overall Study|Lost to Follow-up|0|||
161112967|NCT02004262|581804455|FG003|Overall Study|Lost to Follow-up|0|||
161112968|NCT02004262|581804456|FG004|Overall Study|Lost to Follow-up|0|||
161112969|NCT02004262|581804457|FG005|Overall Study|Lost to Follow-up|0|||
161112970|NCT02004262|581804452|FG000|Overall Study|Study Terminated by Sponsor|4|||
161112971|NCT02004262|581804453|FG001|Overall Study|Study Terminated by Sponsor|3|||
161112972|NCT02004262|581804454|FG002|Overall Study|Study Terminated by Sponsor|2|||
161112973|NCT02004262|581804455|FG003|Overall Study|Study Terminated by Sponsor|1|||
161112974|NCT02004262|581804456|FG004|Overall Study|Study Terminated by Sponsor|1|||
161112975|NCT02004262|581804457|FG005|Overall Study|Study Terminated by Sponsor|5|||
161112976|NCT03703102|581804458|FG000|Overall Study|Adverse Event|4|||
161217866|NCT00591253|582179615|FG002|Overall Study|Withdrawal by Subject|6|||
161112977|NCT03703102|581804459|FG001|Overall Study|Adverse Event|3|||
161112978|NCT03703102|581804460|FG002|Overall Study|Adverse Event|7|||
161112979|NCT03703102|581804461|FG003|Overall Study|Adverse Event|3|||
161112980|NCT03703102|581804462|FG004|Overall Study|Adverse Event|13|||
161112981|NCT03703102|581804458|FG000|Overall Study|Lack of Efficacy|4|||
161112982|NCT03703102|581804459|FG001|Overall Study|Lack of Efficacy|0|||
161112983|NCT03703102|581804460|FG002|Overall Study|Lack of Efficacy|1|||
161112984|NCT03703102|581804461|FG003|Overall Study|Lack of Efficacy|4|||
161217867|NCT00591253|582179613|FG000|Overall Study|Lack of Efficacy|1|||
161217868|NCT00591253|582179614|FG001|Overall Study|Lack of Efficacy|0|||
161112985|NCT03703102|581804462|FG004|Overall Study|Lack of Efficacy|1|||
161112986|NCT03703102|581804458|FG000|Overall Study|Lost to Follow-up|0|||
161112987|NCT03703102|581804459|FG001|Overall Study|Lost to Follow-up|0|||
161112988|NCT03703102|581804460|FG002|Overall Study|Lost to Follow-up|1|||
161112989|NCT03703102|581804461|FG003|Overall Study|Lost to Follow-up|2|||
161112990|NCT03703102|581804462|FG004|Overall Study|Lost to Follow-up|2|||
161217869|NCT00591253|582179615|FG002|Overall Study|Lack of Efficacy|3|||
161217870|NCT00591253|582179613|FG000|Overall Study|Other|5|||
161217871|NCT00591253|582179614|FG001|Overall Study|Other|5|||
161217872|NCT00591253|582179615|FG002|Overall Study|Other|3|||
161217873|NCT00252187|582179616|FG000|Overall Study|Adverse Event|3|||
161217874|NCT00252187|582179617|FG001|Overall Study|Adverse Event|1|||
161217875|NCT00252187|582179616|FG000|Overall Study|Withdrawal by Subject|1|||
161217876|NCT00252187|582179617|FG001|Overall Study|Withdrawal by Subject|0|||
161217877|NCT01752920|582179620|FG000|Overall Study|Adverse Event|1|||
161217878|NCT01752920|582179621|FG001|Overall Study|Adverse Event|0|||
161217879|NCT01752920|582179622|FG002|Overall Study|Adverse Event|5|||
161217880|NCT01752920|582179623|FG003|Overall Study|Adverse Event|10|||
161217881|NCT01752920|582179620|FG000|Overall Study|Clinical Disease Progression|6|||
161217882|NCT01752920|582179621|FG001|Overall Study|Clinical Disease Progression|4|||
161217883|NCT01752920|582179622|FG002|Overall Study|Clinical Disease Progression|1|||
161217884|NCT01752920|582179623|FG003|Overall Study|Clinical Disease Progression|13|||
161217885|NCT01752920|582179620|FG000|Overall Study|Physician Decision|1|||
161217886|NCT01752920|582179621|FG001|Overall Study|Physician Decision|0|||
161217887|NCT01752920|582179622|FG002|Overall Study|Physician Decision|0|||
161217888|NCT01752920|582179623|FG003|Overall Study|Physician Decision|3|||
161217889|NCT01752920|582179620|FG000|Overall Study|Radiographic Disease Progression|20|||
161217890|NCT01752920|582179621|FG001|Overall Study|Radiographic Disease Progression|7|||
161217891|NCT01752920|582179622|FG002|Overall Study|Radiographic Disease Progression|12|||
161217892|NCT01752920|582179623|FG003|Overall Study|Radiographic Disease Progression|29|||
161217893|NCT01752920|582179620|FG000|Overall Study|Study Terminated by Sponsor|0|||
161217894|NCT01752920|582179621|FG001|Overall Study|Study Terminated by Sponsor|0|||
161217895|NCT01752920|582179622|FG002|Overall Study|Study Terminated by Sponsor|0|||
161217896|NCT01752920|582179623|FG003|Overall Study|Study Terminated by Sponsor|1|||
161217897|NCT01752920|582179620|FG000|Overall Study|Withdrawal by Subject|0|||
161217898|NCT01752920|582179621|FG001|Overall Study|Withdrawal by Subject|1|||
161217899|NCT01752920|582179622|FG002|Overall Study|Withdrawal by Subject|0|||
161217900|NCT01752920|582179623|FG003|Overall Study|Withdrawal by Subject|1|||
161217901|NCT01752920|582179620|FG000|Overall Study|Lack of clinical benefit|1|||
161217902|NCT01752920|582179621|FG001|Overall Study|Lack of clinical benefit|1|||
161217903|NCT01752920|582179622|FG002|Overall Study|Lack of clinical benefit|1|||
161217904|NCT01752920|582179623|FG003|Overall Study|Lack of clinical benefit|1|||
161217905|NCT00771901|582179624|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
161217906|NCT00771901|582179625|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
161217907|NCT00771901|582179626|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
161217908|NCT02862535|582179627|FG000|Overall Study|Death|7|||
161217909|NCT02862535|582179628|FG001|Overall Study|Death|3|||
161217910|NCT02862535|582179629|FG002|Overall Study|Death|2|||
161217911|NCT02862535|582179630|FG003|Overall Study|Death|5|||
161217912|NCT02862535|582179627|FG000|Overall Study|Study Terminated by Sponsor|1|||
161217913|NCT02862535|582179628|FG001|Overall Study|Study Terminated by Sponsor|3|||
161217914|NCT02862535|582179629|FG002|Overall Study|Study Terminated by Sponsor|8|||
161217915|NCT02862535|582179630|FG003|Overall Study|Study Terminated by Sponsor|5|||
161217916|NCT02862535|582179627|FG000|Overall Study|Enrolled, not Treated|1|||
161217917|NCT02862535|582179628|FG001|Overall Study|Enrolled, not Treated|0|||
161217918|NCT02862535|582179629|FG002|Overall Study|Enrolled, not Treated|0|||
161217919|NCT02862535|582179630|FG003|Overall Study|Enrolled, not Treated|1|||
161217920|NCT00566709|582179636|FG000|Overall Study|Protocol Violation|5|||
161217921|NCT00566709|582179637|FG001|Overall Study|Protocol Violation|0|||
161217922|NCT01829295|582179638|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
161217923|NCT01829295|582179639|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
161217924|NCT01829295|582179640|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
161217925|NCT01829295|582179641|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
161217926|NCT01829295|582179638|FG000|6-12 Months|Adverse Event|0|||
161217927|NCT01829295|582179639|FG001|6-12 Months|Adverse Event|0|||
161217928|NCT01829295|582179640|FG002|6-12 Months|Adverse Event|3|||
161324393|NCT02098395|582573586|FG002|Overall Study|Lost to Follow-up|0|||
161112991|NCT03703102|581804458|FG000|Overall Study|Physician Decision|2|||
161112992|NCT03703102|581804459|FG001|Overall Study|Physician Decision|2|||
161112993|NCT03703102|581804460|FG002|Overall Study|Physician Decision|2|||
161112994|NCT03703102|581804461|FG003|Overall Study|Physician Decision|2|||
161112995|NCT03703102|581804462|FG004|Overall Study|Physician Decision|4|||
161112996|NCT03703102|581804458|FG000|Overall Study|Withdrawal by Subject|7|||
161112997|NCT03703102|581804459|FG001|Overall Study|Withdrawal by Subject|5|||
161112998|NCT03703102|581804460|FG002|Overall Study|Withdrawal by Subject|5|||
161112999|NCT03703102|581804461|FG003|Overall Study|Withdrawal by Subject|5|||
161113000|NCT03703102|581804462|FG004|Overall Study|Withdrawal by Subject|9|||
161113001|NCT03703102|581804458|FG000|Overall Study|Ineligibility|0|||
161113002|NCT03703102|581804459|FG001|Overall Study|Ineligibility|0|||
161113003|NCT03703102|581804460|FG002|Overall Study|Ineligibility|1|||
161113004|NCT03703102|581804461|FG003|Overall Study|Ineligibility|0|||
161113005|NCT03703102|581804462|FG004|Overall Study|Ineligibility|0|||
160869904|NCT02581410|580915686|FG001|Vaccination Phase|Withdrawal by Subject|1|||
160869905|NCT02581410|580915685|FG000|Vaccination Phase|Migrated/moved from study area|0|||
160869906|NCT02581410|580915686|FG001|Vaccination Phase|Migrated/moved from study area|1|||
160869907|NCT02581410|580915685|FG000|End of Study Phase|Adverse Event|4|||
160869908|NCT02581410|580915686|FG001|End of Study Phase|Adverse Event|3|||
160869909|NCT02581410|580915685|FG000|End of Study Phase|Withdrawal by Subject|1|||
160869910|NCT02581410|580915686|FG001|End of Study Phase|Withdrawal by Subject|2|||
160869911|NCT02581410|580915685|FG000|End of Study Phase|Migrated/moved from study area|0|||
160869912|NCT02581410|580915686|FG001|End of Study Phase|Migrated/moved from study area|3|||
160869913|NCT02581410|580915685|FG000|End of Study Phase|Lost to Follow-up|0|||
160869914|NCT02581410|580915686|FG001|End of Study Phase|Lost to Follow-up|2|||
160869915|NCT02581410|580915685|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
160869916|NCT02581410|580915686|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
160869917|NCT00670748|580915688|FG000|Overall Study|Death during treatment|1|||
160869918|NCT00670748|580915689|FG001|Overall Study|Death during treatment|1|||
160869919|NCT00670748|580915690|FG002|Overall Study|Death during treatment|1|||
160869920|NCT00670748|580915691|FG003|Overall Study|Death during treatment|0|||
160869921|NCT00670748|580915688|FG000|Overall Study|Not off study|2|||
160869922|NCT00670748|580915689|FG001|Overall Study|Not off study|1|||
160869923|NCT00670748|580915690|FG002|Overall Study|Not off study|1|||
160869924|NCT00670748|580915691|FG003|Overall Study|Not off study|1|||
160869925|NCT00759941|580915692|FG000|Overall Study|Use of medication|1|||
160869926|NCT00759941|580915693|FG001|Overall Study|Use of medication|0|||
160869927|NCT00759941|580915692|FG000|Overall Study|Adverse Event|1|||
160869928|NCT00759941|580915693|FG001|Overall Study|Adverse Event|0|||
160869929|NCT00759941|580915692|FG000|Overall Study|Exited in error by site|1|||
160869930|NCT00759941|580915693|FG001|Overall Study|Exited in error by site|1|||
160869931|NCT02736578|580915694|FG000|Overall Study|Adverse Event|1|||
160869932|NCT02736578|580915695|FG001|Overall Study|Adverse Event|0|||
160869933|NCT00354432|580915696|FG000|Overall Study|Adverse Event|3|||
160869934|NCT00354432|580915697|FG001|Overall Study|Adverse Event|1|||
160869935|NCT00354432|580915698|FG002|Overall Study|Adverse Event|5|||
160869936|NCT00354432|580915699|FG003|Overall Study|Adverse Event|5|||
160869937|NCT00354432|580915696|FG000|Overall Study|Off/Toxicity|3|||
161217929|NCT01829295|582179641|FG003|6-12 Months|Adverse Event|2|||
161217930|NCT01829295|582179638|FG000|6-12 Months|Lost to Follow-up|2|||
161217931|NCT01829295|582179639|FG001|6-12 Months|Lost to Follow-up|0|||
161217932|NCT01829295|582179640|FG002|6-12 Months|Lost to Follow-up|0|||
161217933|NCT01829295|582179641|FG003|6-12 Months|Lost to Follow-up|0|||
161217934|NCT01829295|582179638|FG000|6-12 Months|Withdrawal by Subject|2|||
161217935|NCT01829295|582179639|FG001|6-12 Months|Withdrawal by Subject|2|||
161217936|NCT01829295|582179640|FG002|6-12 Months|Withdrawal by Subject|0|||
161217937|NCT01829295|582179641|FG003|6-12 Months|Withdrawal by Subject|0|||
161217938|NCT02629965|582179644|FG000|Period 1|Adverse Event|1|||
161217939|NCT02629965|582179645|FG001|Period 1|Adverse Event|0|||
161217940|NCT02629965|582179644|FG000|Period 1|Unexpected worsening of disease|2|||
161217941|NCT02629965|582179645|FG001|Period 1|Unexpected worsening of disease|0|||
161217942|NCT02629965|582179644|FG000|Period 1|Other than listed above|1|||
161217943|NCT02629965|582179645|FG001|Period 1|Other than listed above|2|||
161217944|NCT02629965|582179644|FG000|Period 2|Adverse Event|1|||
161217945|NCT02629965|582179645|FG001|Period 2|Adverse Event|0|||
161217946|NCT03443869|582179646|FG000|Overall Study|Death|3|||
161217947|NCT03443869|582179647|FG001|Overall Study|Death|3|||
161217948|NCT03443869|582179646|FG000|Overall Study|Withdrawal by Subject|34|||
161217949|NCT03443869|582179647|FG001|Overall Study|Withdrawal by Subject|22|||
161217950|NCT03443869|582179646|FG000|Overall Study|Lost to Follow-up|1|||
161217951|NCT03443869|582179647|FG001|Overall Study|Lost to Follow-up|2|||
160869938|NCT00354432|580915697|FG001|Overall Study|Off/Toxicity|7|||
160869939|NCT00354432|580915698|FG002|Overall Study|Off/Toxicity|5|||
160869940|NCT00354432|580915699|FG003|Overall Study|Off/Toxicity|5|||
160869941|NCT03863080|580915700|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
160869942|NCT03863080|580915701|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
161113006|NCT03703102|581804458|FG000|Overall Study|Protocol Deviation|4|||
161113007|NCT03703102|581804459|FG001|Overall Study|Protocol Deviation|4|||
161113008|NCT03703102|581804460|FG002|Overall Study|Protocol Deviation|3|||
161113009|NCT03703102|581804461|FG003|Overall Study|Protocol Deviation|0|||
161113010|NCT03703102|581804462|FG004|Overall Study|Protocol Deviation|0|||
161113011|NCT03703102|581804458|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161113012|NCT03703102|581804459|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161113013|NCT03703102|581804460|FG002|Overall Study|Non-Compliance with Study Drug|2|||
161113014|NCT03703102|581804461|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161113015|NCT03703102|581804462|FG004|Overall Study|Non-Compliance with Study Drug|4|||
161113016|NCT02311153|581804463|FG000|Overall Study|Lost to Follow-up|5|||
161113017|NCT02311153|581804464|FG001|Overall Study|Lost to Follow-up|7|||
161113018|NCT01967628|581804465|FG000|Overall Study|Withdrawal by Subject|2|||
161113019|NCT01967628|581804466|FG001|Overall Study|Withdrawal by Subject|0|||
161113020|NCT01967628|581804465|FG000|Overall Study|Unable to complete bronchoscopy|4|||
161113021|NCT01967628|581804466|FG001|Overall Study|Unable to complete bronchoscopy|6|||
161113022|NCT01967628|581804465|FG000|Overall Study|Lost to Follow-up|1|||
161113023|NCT01967628|581804466|FG001|Overall Study|Lost to Follow-up|0|||
161113024|NCT01967628|581804465|FG000|Overall Study|Low protein concentration in sample|20|||
161113025|NCT01967628|581804466|FG001|Overall Study|Low protein concentration in sample|25|||
161113026|NCT00930761|581804471|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
161113027|NCT00930761|581804472|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
161113028|NCT00930761|581804471|FG000|Overall Study|less than 3 music therapy sessions|0|||
161113029|NCT00930761|581804472|FG001|Overall Study|less than 3 music therapy sessions|3|||
161113030|NCT01970995|581804474|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161113031|NCT01970995|581804475|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161113032|NCT01970995|581804476|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161113033|NCT01970995|581804474|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
161113034|NCT01970995|581804475|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
161113035|NCT01970995|581804476|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
161113036|NCT03699007|581804477|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
161113037|NCT03699007|581804478|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
161113038|NCT03699007|581804477|FG000|6-month Follow Up|Lost to Follow-up|2|||
161113039|NCT03699007|581804478|FG001|6-month Follow Up|Lost to Follow-up|3|||
161113040|NCT01709435|581804479|FG000|Overall Study|Adverse Event|1|||
161113041|NCT01709435|581804480|FG001|Overall Study|Adverse Event|1|||
161113042|NCT01709435|581804481|FG002|Overall Study|Adverse Event|1|||
161113043|NCT01709435|581804482|FG003|Overall Study|Adverse Event|0|||
161113044|NCT01709435|581804483|FG004|Overall Study|Adverse Event|0|||
161113045|NCT01709435|581804484|FG005|Overall Study|Adverse Event|1|||
160869943|NCT03863080|580915702|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
160869944|NCT03863080|580915703|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
161113046|NCT01709435|581804479|FG000|Overall Study|Lack of Efficacy|5|||
161113047|NCT01709435|581804480|FG001|Overall Study|Lack of Efficacy|7|||
161113048|NCT01709435|581804481|FG002|Overall Study|Lack of Efficacy|2|||
161113049|NCT01709435|581804482|FG003|Overall Study|Lack of Efficacy|2|||
161113050|NCT01709435|581804483|FG004|Overall Study|Lack of Efficacy|6|||
161113051|NCT01709435|581804484|FG005|Overall Study|Lack of Efficacy|3|||
161217952|NCT03443869|582179646|FG000|Overall Study|Physician Decision|3|||
161217953|NCT03443869|582179647|FG001|Overall Study|Physician Decision|3|||
161217954|NCT03443869|582179646|FG000|Overall Study|Other|4|||
161217955|NCT03443869|582179647|FG001|Overall Study|Other|4|||
161217956|NCT02390219|582179648|FG000|Overall Study|Death|1|||
161217957|NCT02390219|582179648|FG000|Overall Study|Physician Decision|1|||
161217958|NCT02390219|582179648|FG000|Overall Study|Adverse Event|6|||
161217959|NCT02390219|582179648|FG000|Overall Study|Withdrawal by Subject|1|||
161217960|NCT02390219|582179648|FG000|Overall Study|Lost to Follow-up|2|||
161217961|NCT02390219|582179648|FG000|Overall Study|Other|2|||
161217962|NCT00299728|582179649|FG000|Overall Study|Lost to Follow-up|0|||
161217963|NCT00299728|582179650|FG001|Overall Study|Lost to Follow-up|1|||
161217964|NCT00299728|582179649|FG000|Overall Study|Withdrawal by Subject|0|||
161217965|NCT00299728|582179650|FG001|Overall Study|Withdrawal by Subject|1|||
161217966|NCT00299728|582179649|FG000|Overall Study|Progressive disease|0|||
161217967|NCT00299728|582179650|FG001|Overall Study|Progressive disease|1|||
161217968|NCT01855126|582179653|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
161217969|NCT01855126|582179654|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
161217970|NCT01855126|582179653|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161217971|NCT01855126|582179654|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
161217972|NCT01360632|582179657|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
161217973|NCT01360632|582179658|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
161217974|NCT01360632|582179659|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
161217975|NCT01360632|582179660|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
161217976|NCT01360632|582179661|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
161217977|NCT01360632|582179657|FG000|Phase A (8 Weeks)|Adverse Event|60|||
161217978|NCT01360632|582179658|FG001|Phase A (8 Weeks)|Adverse Event|0|||
161217979|NCT01360632|582179659|FG002|Phase A (8 Weeks)|Adverse Event|0|||
161217980|NCT01360632|582179660|FG003|Phase A (8 Weeks)|Adverse Event|0|||
161217981|NCT01360632|582179661|FG004|Phase A (8 Weeks)|Adverse Event|0|||
161217982|NCT01360632|582179657|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
161217983|NCT01360632|582179658|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161217984|NCT01360632|582179659|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161217985|NCT01360632|582179660|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161217986|NCT01360632|582179661|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
161217987|NCT01360632|582179657|FG000|Phase A (8 Weeks)|Physician Decision|10|||
161217988|NCT01360632|582179658|FG001|Phase A (8 Weeks)|Physician Decision|0|||
161217989|NCT01360632|582179659|FG002|Phase A (8 Weeks)|Physician Decision|0|||
161217990|NCT01360632|582179660|FG003|Phase A (8 Weeks)|Physician Decision|0|||
161217991|NCT01360632|582179661|FG004|Phase A (8 Weeks)|Physician Decision|0|||
161217992|NCT01360632|582179657|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
161217993|NCT01360632|582179658|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161217994|NCT01360632|582179659|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161217995|NCT01360632|582179660|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161217996|NCT01360632|582179661|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
161217997|NCT01360632|582179657|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
161217998|NCT01360632|582179658|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
161217999|NCT01360632|582179659|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
161218000|NCT01360632|582179660|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
161218001|NCT01360632|582179661|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
161218002|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
161218003|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
161218004|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
161218005|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
161218006|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
161218007|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Adverse Event|0|||
161218008|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Adverse Event|3|||
161218009|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Adverse Event|9|||
161218010|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Adverse Event|3|||
161218011|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Adverse Event|0|||
161218012|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161218013|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161218014|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
161218015|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
161218016|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161218017|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Physician Decision|0|||
161218018|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Physician Decision|0|||
161218019|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Physician Decision|0|||
161218020|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Physician Decision|1|||
161218021|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Physician Decision|0|||
161218022|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161218023|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
161218024|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
161218025|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
161218026|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161218027|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
161218028|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
161218029|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
161218030|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
161218031|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
161218032|NCT01360632|582179657|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
161218033|NCT01360632|582179658|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
161218034|NCT01360632|582179659|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
161218035|NCT01360632|582179660|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
161218036|NCT01360632|582179661|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
161218037|NCT01360632|582179657|FG000|Phase A+|Lost to Follow-up|0|||
161218038|NCT01360632|582179658|FG001|Phase A+|Lost to Follow-up|0|||
161218039|NCT01360632|582179659|FG002|Phase A+|Lost to Follow-up|0|||
161218040|NCT01360632|582179660|FG003|Phase A+|Lost to Follow-up|0|||
161218041|NCT01360632|582179661|FG004|Phase A+|Lost to Follow-up|2|||
161218042|NCT01360632|582179657|FG000|Phase A+|Adverse Event|0|||
161218043|NCT01360632|582179658|FG001|Phase A+|Adverse Event|0|||
161218044|NCT01360632|582179659|FG002|Phase A+|Adverse Event|0|||
161218045|NCT01360632|582179660|FG003|Phase A+|Adverse Event|0|||
161218046|NCT01360632|582179661|FG004|Phase A+|Adverse Event|2|||
161218047|NCT01360632|582179657|FG000|Phase A+|Met Withdrawal Criteria|0|||
161218048|NCT01360632|582179658|FG001|Phase A+|Met Withdrawal Criteria|0|||
161218049|NCT01360632|582179659|FG002|Phase A+|Met Withdrawal Criteria|0|||
161218050|NCT01360632|582179660|FG003|Phase A+|Met Withdrawal Criteria|0|||
161218051|NCT01360632|582179661|FG004|Phase A+|Met Withdrawal Criteria|7|||
161218052|NCT01360632|582179657|FG000|Phase A+|Physician Decision|0|||
161218053|NCT01360632|582179658|FG001|Phase A+|Physician Decision|0|||
161218054|NCT01360632|582179659|FG002|Phase A+|Physician Decision|0|||
161218055|NCT01360632|582179660|FG003|Phase A+|Physician Decision|0|||
161218056|NCT01360632|582179661|FG004|Phase A+|Physician Decision|3|||
161218057|NCT01360632|582179657|FG000|Phase A+|Withdrawal by Subject|0|||
161218058|NCT01360632|582179658|FG001|Phase A+|Withdrawal by Subject|0|||
161218059|NCT01360632|582179659|FG002|Phase A+|Withdrawal by Subject|0|||
161218060|NCT01360632|582179660|FG003|Phase A+|Withdrawal by Subject|0|||
160869945|NCT03863080|580915700|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
160869946|NCT03863080|580915701|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
160869947|NCT03863080|580915702|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
160869948|NCT03863080|580915703|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
160869949|NCT03863080|580915700|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
160869950|NCT03863080|580915701|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
160869951|NCT03863080|580915702|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
160869952|NCT03863080|580915703|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
160869953|NCT00802945|580915706|FG000|Overall Study|Death|27|||
160869954|NCT00802945|580915707|FG001|Overall Study|Death|23|||
160869955|NCT00802945|580915706|FG000|Overall Study|Terminated by sponsor|8|||
160869956|NCT00802945|580915707|FG001|Overall Study|Terminated by sponsor|12|||
160869957|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
160869958|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
160869959|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
160869960|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
160869961|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
160869962|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
160869963|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
160869964|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
160869965|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
160869966|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
160869967|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
160869968|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
160869969|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
160869970|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
160869971|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
161218061|NCT01360632|582179661|FG004|Phase A+|Withdrawal by Subject|8|||
161218062|NCT01360632|582179657|FG000|Phase A+|Protocol Deviation|0|||
161218063|NCT01360632|582179658|FG001|Phase A+|Protocol Deviation|0|||
160869972|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
160869973|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
160869974|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
161218064|NCT01360632|582179659|FG002|Phase A+|Protocol Deviation|0|||
161218065|NCT01360632|582179660|FG003|Phase A+|Protocol Deviation|0|||
160869975|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
161218066|NCT01360632|582179661|FG004|Phase A+|Protocol Deviation|3|||
161218067|NCT01298596|582179662|FG000|Overall Study|Withdrawal by Subject|1|||
161218068|NCT01298596|582179663|FG001|Overall Study|Withdrawal by Subject|1|||
161218069|NCT01298596|582179662|FG000|Overall Study|Death|5|||
161113052|NCT01709435|581804479|FG000|Overall Study|Physician Decision|0|||
161113053|NCT01709435|581804480|FG001|Overall Study|Physician Decision|1|||
161113054|NCT01709435|581804481|FG002|Overall Study|Physician Decision|0|||
161113055|NCT01709435|581804482|FG003|Overall Study|Physician Decision|1|||
161113056|NCT01709435|581804483|FG004|Overall Study|Physician Decision|2|||
161113057|NCT01709435|581804484|FG005|Overall Study|Physician Decision|0|||
161113058|NCT01709435|581804479|FG000|Overall Study|Withdrawal by Subject|0|||
161113059|NCT01709435|581804480|FG001|Overall Study|Withdrawal by Subject|0|||
161113060|NCT01709435|581804481|FG002|Overall Study|Withdrawal by Subject|3|||
161113061|NCT01709435|581804482|FG003|Overall Study|Withdrawal by Subject|0|||
161113062|NCT01709435|581804483|FG004|Overall Study|Withdrawal by Subject|2|||
161113063|NCT01709435|581804484|FG005|Overall Study|Withdrawal by Subject|2|||
161113064|NCT01780662|581804485|FG000|Overall Study|Adverse Event|1|||
161113065|NCT01780662|581804486|FG001|Overall Study|Adverse Event|0|||
161113066|NCT01780662|581804487|FG002|Overall Study|Adverse Event|2|||
161113067|NCT01780662|581804485|FG000|Overall Study|Physician Decision|0|||
161113068|NCT01780662|581804486|FG001|Overall Study|Physician Decision|5|||
161113069|NCT01780662|581804487|FG002|Overall Study|Physician Decision|7|||
161113070|NCT01780662|581804485|FG000|Overall Study|Protocol Violation|0|||
161113071|NCT01780662|581804486|FG001|Overall Study|Protocol Violation|1|||
161113072|NCT01780662|581804487|FG002|Overall Study|Protocol Violation|0|||
161113073|NCT01780662|581804485|FG000|Overall Study|Ineligible|0|||
161113074|NCT01780662|581804486|FG001|Overall Study|Ineligible|0|||
161113075|NCT01780662|581804487|FG002|Overall Study|Ineligible|1|||
161113076|NCT01263639|581804488|FG000|Overall Study|Lost to Follow-up|66|||
161113077|NCT01263639|581804489|FG001|Overall Study|Lost to Follow-up|70|||
161113078|NCT01263639|581804488|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
161113079|NCT01263639|581804489|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
161113080|NCT03975920|581804491|FG000|Overall Study|Lost to Follow-up|1|||
161113081|NCT03975920|581804492|FG001|Overall Study|Lost to Follow-up|2|||
161113082|NCT03975920|581804491|FG000|Overall Study|Protocol Violation|1|||
161113083|NCT03975920|581804492|FG001|Overall Study|Protocol Violation|1|||
161113084|NCT03975920|581804491|FG000|Overall Study|Did not complete survey|2|||
161113085|NCT03975920|581804492|FG001|Overall Study|Did not complete survey|1|||
161113086|NCT01081249|581804493|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
161113087|NCT01081249|581804494|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
161113088|NCT02980224|581804496|FG000|Overall Study|Adverse Event|4|||
161113089|NCT02980224|581804497|FG001|Overall Study|Adverse Event|1|||
161113090|NCT02980224|581804496|FG000|Overall Study|Withdrawal by Subject|0|||
161113091|NCT02980224|581804497|FG001|Overall Study|Withdrawal by Subject|2|||
161113092|NCT00606320|581804500|FG000|Overall Study|Adverse Event|3|||
161113093|NCT00606320|581804500|FG000|Overall Study|Lack of Efficacy|5|||
161113094|NCT00606320|581804500|FG000|Overall Study|Physician Decision|7|||
161113095|NCT00606320|581804500|FG000|Overall Study|Protocol Violation|8|||
161113096|NCT00606320|581804500|FG000|Overall Study|Withdrawal by Subject|10|||
161113097|NCT00606320|581804500|FG000|Overall Study|Progression to depressive phase|4|||
161113098|NCT04839380|581804501|FG000|Overall Study|Withdrawal by Subject|2|||
161113099|NCT04839380|581804501|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
161113100|NCT00879645|581804502|FG000|Overall Study|Adverse Event|1|||
161113101|NCT00879645|581804503|FG001|Overall Study|Adverse Event|0|||
161113102|NCT00879645|581804504|FG002|Overall Study|Adverse Event|0|||
161113103|NCT00879645|581804505|FG003|Overall Study|Adverse Event|0|||
161113104|NCT00749996|581804506|FG000|Overall Study|Lost to Follow-up|7|||
160981506|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161113105|NCT00749996|581804507|FG001|Overall Study|Lost to Follow-up|4|||
161113106|NCT00749996|581804506|FG000|Overall Study|Withdrawal by Subject|5|||
161113107|NCT00749996|581804507|FG001|Overall Study|Withdrawal by Subject|4|||
161113108|NCT00749996|581804506|FG000|Overall Study|Protocol Violation|2|||
161113109|NCT00749996|581804507|FG001|Overall Study|Protocol Violation|3|||
161113110|NCT00749996|581804506|FG000|Overall Study|Physician Decision|2|||
161113111|NCT00749996|581804507|FG001|Overall Study|Physician Decision|0|||
161113112|NCT00749996|581804506|FG000|Overall Study|Pregnancy|0|||
161113113|NCT00749996|581804507|FG001|Overall Study|Pregnancy|2|||
161113114|NCT00749996|581804506|FG000|Overall Study|Adverse Event|1|||
161113115|NCT00749996|581804507|FG001|Overall Study|Adverse Event|0|||
160869976|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
160869977|NCT05307692|580915708|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
160869978|NCT05307692|580915709|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
160869979|NCT05307692|580915710|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
160869980|NCT05307692|580915711|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
160869981|NCT05307692|580915708|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
160869982|NCT05307692|580915709|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
160869983|NCT05307692|580915710|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
160869984|NCT05307692|580915711|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
160869985|NCT05307692|580915708|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
160869986|NCT05307692|580915709|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
160869987|NCT05307692|580915710|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
160869988|NCT05307692|580915711|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
160869989|NCT04500158|580915712|FG000|Overall Study|Physician Decision|17|||
160869990|NCT04500158|580915713|FG001|Overall Study|Physician Decision|11|||
160869991|NCT03493464|580915716|FG000|Overall Study|Surgery not performed|1|||
160869992|NCT01077050|580917282|FG000|Overall Study|Subjects signed ICF could not be located|1|||
160869993|NCT01077050|580917282|FG000|Overall Study|Screen failure|8|||
160869994|NCT03126344|580917296|FG000|Overall Study|Lost to Follow-up|0|||
160869995|NCT03126344|580917297|FG001|Overall Study|Lost to Follow-up|0|||
160869996|NCT03126344|580917298|FG002|Overall Study|Lost to Follow-up|5|||
160869997|NCT01715857|580917299|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
160869998|NCT02563067|580917300|FG000|Overall Study|Subject/guardian decision|14|||
160869999|NCT02563067|580917301|FG001|Overall Study|Subject/guardian decision|20|||
160870000|NCT02563067|580917302|FG002|Overall Study|Subject/guardian decision|16|||
160870001|NCT02563067|580917300|FG000|Overall Study|Physician Decision|0|||
160870002|NCT02563067|580917301|FG001|Overall Study|Physician Decision|1|||
160870003|NCT02563067|580917302|FG002|Overall Study|Physician Decision|3|||
160870004|NCT02563067|580917300|FG000|Overall Study|Lost to Follow-up|1|||
160870005|NCT02563067|580917301|FG001|Overall Study|Lost to Follow-up|2|||
160870006|NCT02563067|580917302|FG002|Overall Study|Lost to Follow-up|0|||
160870007|NCT02563067|580917300|FG000|Overall Study|Technical problems|0|||
160870008|NCT02563067|580917301|FG001|Overall Study|Technical problems|1|||
160870009|NCT02563067|580917302|FG002|Overall Study|Technical problems|0|||
160870010|NCT02563067|580917300|FG000|Overall Study|Lack of Efficacy|1|||
161113116|NCT00749996|581804506|FG000|Overall Study|Death|1|||
161113117|NCT00749996|581804507|FG001|Overall Study|Death|0|||
161113118|NCT00996944|581804508|FG000|Double-blind Treatment Period|Adverse Event|2|||
161113119|NCT00996944|581804509|FG001|Double-blind Treatment Period|Adverse Event|1|||
161113120|NCT00996944|581804508|FG000|Double-blind Treatment Period|Protocol Violation|1|||
161113121|NCT00996944|581804509|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161113122|NCT00996944|581804508|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
161113123|NCT00996944|581804509|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
161113124|NCT00996944|581804508|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161113125|NCT00996944|581804509|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161113126|NCT00996944|581804508|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
161113127|NCT00996944|581804509|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
161113128|NCT03775421|581804512|FG000|Overall Study|Lost to Follow-up|2|||
161113129|NCT03775421|581804512|FG000|Overall Study|Withdrawal by Subject|10|||
161113130|NCT03775421|581804512|FG000|Overall Study|Physician Decision|3|||
161113131|NCT03775421|581804512|FG000|Overall Study|Death|1|||
161113132|NCT03775421|581804512|FG000|Overall Study|Study Terminated by Sponsor|94|||
161113133|NCT02250274|581804515|FG000|Overall Study|Insufficient blood draw amount|7|||
161113134|NCT02250274|581804516|FG001|Overall Study|Insufficient blood draw amount|6|||
161113135|NCT00583362|581804517|FG000|Overall Study|Adverse Event|44|||
161113136|NCT00583362|581804517|FG000|Overall Study|Lack of Efficacy|22|||
161113137|NCT00583362|581804517|FG000|Overall Study|Lost to Follow-up|4|||
161113138|NCT00583362|581804517|FG000|Overall Study|Non-compliance with study drug|28|||
161113139|NCT00583362|581804517|FG000|Overall Study|Pregnancy|7|||
161113140|NCT00583362|581804517|FG000|Overall Study|Miscommunication of visit window|5|||
161113141|NCT00583362|581804517|FG000|Overall Study|Current site closed|7|||
161113142|NCT00583362|581804517|FG000|Overall Study|Subject not dosed in LBSL99|1|||
161113143|NCT00583362|581804517|FG000|Overall Study|Subject moved out of the country/state|2|||
161113144|NCT00583362|581804517|FG000|Overall Study|Missed visits due to staff changes|1|||
161113145|NCT00583362|581804517|FG000|Overall Study|Misunderstanding of protocol|1|||
161113146|NCT00583362|581804517|FG000|Overall Study|Behavioral problems and non-compliance|1|||
161113147|NCT00583362|581804517|FG000|Overall Study|Sponsor request due to missed doses|1|||
161113148|NCT00583362|581804517|FG000|Overall Study|Physician Decision|19|||
161113149|NCT00583362|581804517|FG000|Overall Study|Protocol Violation|2|||
160870011|NCT02563067|580917301|FG001|Overall Study|Lack of Efficacy|0|||
160870012|NCT02563067|580917302|FG002|Overall Study|Lack of Efficacy|0|||
160870013|NCT02563067|580917300|FG000|Overall Study|Death|0|||
160870014|NCT02563067|580917301|FG001|Overall Study|Death|1|||
161113150|NCT00583362|581804517|FG000|Overall Study|Withdrawal by Subject|57|||
161218070|NCT01298596|582179663|FG001|Overall Study|Death|3|||
161218071|NCT01298596|582179662|FG000|Overall Study|Lost to Follow-up|6|||
161218072|NCT01298596|582179663|FG001|Overall Study|Lost to Follow-up|14|||
161218073|NCT01298596|582179662|FG000|Overall Study|Referred for further management|16|||
161218074|NCT01298596|582179663|FG001|Overall Study|Referred for further management|15|||
161218075|NCT03387059|582179669|FG000|Overall Study|Study termination|5|||
161218076|NCT03387059|582179670|FG001|Overall Study|Study termination|4|||
161218077|NCT01606137|582179671|FG000|Overall Study|Adverse Event|85|||
161218078|NCT01606137|582179671|FG000|Overall Study|Withdrawal by Subject|74|||
161218079|NCT01606137|582179671|FG000|Overall Study|Lack of Efficacy|56|||
161218080|NCT01606137|582179671|FG000|Overall Study|Lost to Follow-up|15|||
161218081|NCT01606137|582179671|FG000|Overall Study|Protocol Violation|1|||
161218082|NCT01606137|582179671|FG000|Overall Study|Patient non-compliance|9|||
161218083|NCT01606137|582179671|FG000|Overall Study|Death|1|||
161218084|NCT01606137|582179671|FG000|Overall Study|Decreased/no pain|4|||
161218085|NCT01606137|582179671|FG000|Overall Study|Issues with driving|4|||
161218086|NCT01606137|582179671|FG000|Overall Study|multiple sclerosis less stable|1|||
161218087|NCT01606137|582179671|FG000|Overall Study|Increased bilirubin|1|||
161218088|NCT01606137|582179671|FG000|Overall Study|Spray causes nausea|1|||
161218089|NCT01606137|582179671|FG000|Overall Study|Not enough improvement|4|||
161218090|NCT01606137|582179671|FG000|Overall Study|Wanted to try another treatment|1|||
161218091|NCT01606137|582179671|FG000|Overall Study|Patient leaving country|1|||
161218092|NCT01606137|582179671|FG000|Overall Study|Personal reasons|1|||
161218093|NCT01606137|582179671|FG000|Overall Study|Unable to tolerate study med. taste|1|||
161218094|NCT01606137|582179671|FG000|Overall Study|Patient moving|1|||
161218095|NCT01606137|582179671|FG000|Overall Study|Unable to collect consistent data|1|||
161218096|NCT04578548|582179673|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161218097|NCT04578548|582179674|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161218098|NCT04578548|582179673|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
161218099|NCT04578548|582179674|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
161218100|NCT04578548|582179673|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
161218101|NCT04578548|582179674|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161218102|NCT04578548|582179673|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
161218103|NCT04578548|582179674|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
161218104|NCT04578548|582179673|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
161218105|NCT04578548|582179674|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161218106|NCT04578548|582179673|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
161218107|NCT04578548|582179674|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
161218108|NCT00982410|582181224|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
161218109|NCT00982410|582181225|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
161218110|NCT00982410|582181224|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
161218111|NCT00982410|582181225|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
161218112|NCT00982410|582181224|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
161218113|NCT00982410|582181225|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
161218114|NCT00982410|582181224|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
161218115|NCT00982410|582181225|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
161218116|NCT00982410|582181224|FG000|6-month Follow-up Assessment|participant no transportation|1|||
161218117|NCT00982410|582181225|FG001|6-month Follow-up Assessment|participant no transportation|0|||
161218118|NCT00982410|582181224|FG000|6-month Follow-up Assessment|incarceration|0|||
161218119|NCT00982410|582181225|FG001|6-month Follow-up Assessment|incarceration|2|||
161218120|NCT00982410|582181224|FG000|6-month Follow-up Assessment|patent surgery|0|||
161218121|NCT00982410|582181225|FG001|6-month Follow-up Assessment|patent surgery|1|||
161218122|NCT00982410|582181224|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
161218123|NCT00982410|582181225|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
161218124|NCT00982410|582181224|FG000|12-month Follow-up Assessment|Death|0|||
161218125|NCT00982410|582181225|FG001|12-month Follow-up Assessment|Death|2|||
161218126|NCT00982410|582181224|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
161218127|NCT00982410|582181225|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
161218128|NCT00982410|582181224|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
161218129|NCT00982410|582181225|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
161218130|NCT00982410|582181224|FG000|12-month Follow-up Assessment|incarceration|2|||
161218131|NCT00982410|582181225|FG001|12-month Follow-up Assessment|incarceration|1|||
161218132|NCT00982410|582181224|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
161218133|NCT00982410|582181225|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
161218134|NCT02034799|582181228|FG000|Overall Study|Withdrawal by Subject|0|||
161218135|NCT02034799|582181229|FG001|Overall Study|Withdrawal by Subject|2|||
161218136|NCT02034799|582181228|FG000|Overall Study|Lost to Follow-up|0|||
161218137|NCT02034799|582181229|FG001|Overall Study|Lost to Follow-up|1|||
161218138|NCT02034799|582181228|FG000|Overall Study|Death|2|||
161218139|NCT02034799|582181229|FG001|Overall Study|Death|1|||
161218140|NCT03381248|582181237|FG000|0-6 Months|Withdrawal by Subject|4|||
161218141|NCT03381248|582181238|FG001|0-6 Months|Withdrawal by Subject|1|||
161218142|NCT03381248|582181237|FG000|0-6 Months|Lost to Follow-up|3|||
161218143|NCT03381248|582181238|FG001|0-6 Months|Lost to Follow-up|2|||
161218144|NCT03381248|582181237|FG000|0-6 Months|Lack of Efficacy|1|||
161218145|NCT03381248|582181238|FG001|0-6 Months|Lack of Efficacy|0|||
161218146|NCT03381248|582181237|FG000|0-6 Months|Adverse Event|1|||
161218147|NCT03381248|582181238|FG001|0-6 Months|Adverse Event|0|||
161218148|NCT03381248|582181237|FG000|0-6 Months|Protocol Violation|2|||
161218149|NCT03381248|582181238|FG001|0-6 Months|Protocol Violation|1|||
161218150|NCT03381248|582181237|FG000|0-6 Months|Physician Decision|1|||
161218151|NCT03381248|582181238|FG001|0-6 Months|Physician Decision|0|||
161218152|NCT03381248|582181237|FG000|0-6 Months|Planning another procedure|1|||
161218153|NCT03381248|582181238|FG001|0-6 Months|Planning another procedure|2|||
161218154|NCT03381248|582181237|FG000|6-12 Months|Withdrawal by Subject|1|||
161218155|NCT03381248|582181238|FG001|6-12 Months|Withdrawal by Subject|3|||
161218156|NCT03381248|582181237|FG000|6-12 Months|Lost to Follow-up|0|||
161218157|NCT03381248|582181238|FG001|6-12 Months|Lost to Follow-up|2|||
161218158|NCT03381248|582181237|FG000|6-12 Months|Protocol Violation|3|||
161218159|NCT03381248|582181238|FG001|6-12 Months|Protocol Violation|2|||
161218160|NCT03381248|582181237|FG000|6-12 Months|Planning another procedure|6|||
161218161|NCT03381248|582181238|FG001|6-12 Months|Planning another procedure|2|||
161218162|NCT03381248|582181237|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
161218163|NCT03381248|582181238|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
161218164|NCT03381248|582181237|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
161218165|NCT03381248|582181238|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
161218166|NCT03381248|582181237|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
161218167|NCT03381248|582181238|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
161218168|NCT05188521|582181243|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
161218169|NCT05188521|582181244|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
161218170|NCT01341639|582181245|FG000|Infant Series|Protocol Violation|1|||
161218171|NCT01341639|582181246|FG001|Infant Series|Protocol Violation|0|||
161218172|NCT01341639|582181245|FG000|Infant Series|Not Vaccinated|0|||
161218173|NCT01341639|582181246|FG001|Infant Series|Not Vaccinated|1|||
161218174|NCT01341639|582181245|FG000|Infant Series|Adverse Event|0|||
161218175|NCT01341639|582181246|FG001|Infant Series|Adverse Event|5|||
161218176|NCT01341639|582181245|FG000|Infant Series|Withdrawal by Subject|11|||
161218177|NCT01341639|582181246|FG001|Infant Series|Withdrawal by Subject|8|||
161218178|NCT01341639|582181245|FG000|Infant Series|Lost to Follow-up|0|||
161218179|NCT01341639|582181246|FG001|Infant Series|Lost to Follow-up|2|||
161218180|NCT01341639|582181245|FG000|Infant Series|Site 0048 Participants|17|||
161218181|NCT01341639|582181246|FG001|Infant Series|Site 0048 Participants|16|||
161218182|NCT01341639|582181245|FG000|Interim Period|Withdrawal by Subject|6|||
161218183|NCT01341639|582181246|FG001|Interim Period|Withdrawal by Subject|7|||
161218184|NCT01341639|582181245|FG000|Interim Period|Lost to Follow-up|2|||
161218185|NCT01341639|582181246|FG001|Interim Period|Lost to Follow-up|0|||
161218186|NCT01341639|582181245|FG000|Interim Period|Physician Decision|0|||
161218187|NCT01341639|582181246|FG001|Interim Period|Physician Decision|1|||
161218188|NCT01341639|582181245|FG000|Interim Period|Protocol Violation|0|||
161218189|NCT01341639|582181246|FG001|Interim Period|Protocol Violation|1|||
161218190|NCT01341639|582181245|FG000|Post-Treatment|Withdrawal by Subject|0|||
161218191|NCT01341639|582181246|FG001|Post-Treatment|Withdrawal by Subject|1|||
161218192|NCT01341639|582181245|FG000|Post-Treatment|Adverse Event|0|||
161218193|NCT01341639|582181246|FG001|Post-Treatment|Adverse Event|2|||
160870015|NCT02563067|580917302|FG002|Overall Study|Death|1|||
160870016|NCT02563067|580917300|FG000|Overall Study|Adverse Event|2|||
160870017|NCT02563067|580917301|FG001|Overall Study|Adverse Event|1|||
160870018|NCT02563067|580917302|FG002|Overall Study|Adverse Event|0|||
160870019|NCT02563067|580917300|FG000|Overall Study|Death post Treatment/safety period|1|||
160870020|NCT02563067|580917301|FG001|Overall Study|Death post Treatment/safety period|0|||
161113151|NCT01378104|581804523|FG000|Overall Study|Adverse Event|8|||
161113152|NCT01378104|581804524|FG001|Overall Study|Adverse Event|8|||
161113153|NCT01378104|581804523|FG000|Overall Study|Lack of Efficacy|7|||
161113154|NCT01378104|581804524|FG001|Overall Study|Lack of Efficacy|5|||
161113155|NCT01378104|581804523|FG000|Overall Study|Withdrawal by Subject|12|||
161113156|NCT01378104|581804524|FG001|Overall Study|Withdrawal by Subject|13|||
161113157|NCT02287623|581804525|FG000|Overall Study|Protocol Violation|0|||
161113158|NCT02287623|581804526|FG001|Overall Study|Protocol Violation|1|||
161113159|NCT02700997|581804535|FG000|Overall Study|Did not undergo CT imaging|1|||
161113160|NCT02700997|581804535|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
161113161|NCT00205855|581804538|FG000|Overall Study|Only received temporary implants|16|||
161113162|NCT00205855|581804538|FG000|Overall Study|Withdrawal by Subject|5|||
161113163|NCT00506883|581804541|FG000|Overall Study|Lost to Follow-up|1|||
161113164|NCT00506883|581804542|FG001|Overall Study|Lost to Follow-up|1|||
161113165|NCT00506883|581804543|FG002|Overall Study|Lost to Follow-up|1|||
161113166|NCT00506883|581804541|FG000|Overall Study|Withdrawal by Subject|1|||
161113167|NCT00506883|581804542|FG001|Overall Study|Withdrawal by Subject|0|||
161113168|NCT00506883|581804543|FG002|Overall Study|Withdrawal by Subject|1|||
161113169|NCT00506883|581804541|FG000|Overall Study|Lack of Efficacy|0|||
161113170|NCT00506883|581804542|FG001|Overall Study|Lack of Efficacy|1|||
161113171|NCT00506883|581804543|FG002|Overall Study|Lack of Efficacy|1|||
161113172|NCT00506883|581804541|FG000|Overall Study|Other|5|||
161113173|NCT00506883|581804542|FG001|Overall Study|Other|1|||
161113174|NCT00506883|581804543|FG002|Overall Study|Other|1|||
161113175|NCT01445951|581804545|FG000|Overall Study|Adverse Event|16|||
161113176|NCT01445951|581804546|FG001|Overall Study|Adverse Event|9|||
161113177|NCT01445951|581804547|FG002|Overall Study|Adverse Event|0|||
161113178|NCT01445951|581804545|FG000|Overall Study|Protocol Violation|2|||
161113179|NCT01445951|581804546|FG001|Overall Study|Protocol Violation|2|||
161113180|NCT01445951|581804547|FG002|Overall Study|Protocol Violation|2|||
161113181|NCT01445951|581804545|FG000|Overall Study|Withdrawal by Subject|21|||
161113182|NCT01445951|581804546|FG001|Overall Study|Withdrawal by Subject|16|||
161113183|NCT01445951|581804547|FG002|Overall Study|Withdrawal by Subject|8|||
161113184|NCT01445951|581804545|FG000|Overall Study|Physician Decision|3|||
161113185|NCT01445951|581804546|FG001|Overall Study|Physician Decision|1|||
161113186|NCT01445951|581804547|FG002|Overall Study|Physician Decision|0|||
161113187|NCT01445951|581804545|FG000|Overall Study|Lost to Follow-up|1|||
161113188|NCT01445951|581804546|FG001|Overall Study|Lost to Follow-up|2|||
161113189|NCT01445951|581804547|FG002|Overall Study|Lost to Follow-up|4|||
161113190|NCT01445951|581804545|FG000|Overall Study|Pregnancy|0|||
161113191|NCT01445951|581804546|FG001|Overall Study|Pregnancy|1|||
161113192|NCT01445951|581804547|FG002|Overall Study|Pregnancy|4|||
161113193|NCT01445951|581804545|FG000|Overall Study|Death|0|||
161113194|NCT01445951|581804546|FG001|Overall Study|Death|0|||
161113195|NCT01445951|581804547|FG002|Overall Study|Death|1|||
161113196|NCT01445951|581804545|FG000|Overall Study|Non-compliance with study drug|1|||
161113197|NCT01445951|581804546|FG001|Overall Study|Non-compliance with study drug|2|||
161113198|NCT01445951|581804547|FG002|Overall Study|Non-compliance with study drug|0|||
161113199|NCT01445951|581804545|FG000|Overall Study|Non-compliance with protocol|0|||
161113200|NCT01445951|581804546|FG001|Overall Study|Non-compliance with protocol|1|||
161113201|NCT01445951|581804547|FG002|Overall Study|Non-compliance with protocol|0|||
161113202|NCT01445951|581804545|FG000|Overall Study|Sponsor decision - subject travel|0|||
161113203|NCT01445951|581804546|FG001|Overall Study|Sponsor decision - subject travel|1|||
161113204|NCT01445951|581804547|FG002|Overall Study|Sponsor decision - subject travel|0|||
161113205|NCT01445951|581804545|FG000|Overall Study|Cough|0|||
161113206|NCT01445951|581804546|FG001|Overall Study|Cough|1|||
161113207|NCT01445951|581804547|FG002|Overall Study|Cough|0|||
161113208|NCT02739620|581804553|FG000|Overall Study|Lost to Follow-up|3|||
161113209|NCT02739620|581804554|FG001|Overall Study|Lost to Follow-up|1|||
161113210|NCT02739620|581804553|FG000|Overall Study|Adverse Event|0|||
161113211|NCT02739620|581804554|FG001|Overall Study|Adverse Event|1|||
161113212|NCT00786565|581804555|FG000|Enrollment Prior to Surgery|Site Closed|3|||
161113213|NCT00786565|581804555|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
161113214|NCT00786565|581804555|FG000|Post Surgery|Abnormal macular pucker|1|||
161113215|NCT00786565|581804555|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
161113216|NCT05513625|581804558|FG000|Overall Study|Withdrawal by Subject|1|||
160870021|NCT02563067|580917302|FG002|Overall Study|Death post Treatment/safety period|0|||
160870022|NCT03544333|580917303|FG000|Overall Study|Withdrawal by Subject|1|||
161113217|NCT03765138|581804560|FG000|Overall Study|Lost to Follow-up|1|||
161113218|NCT01210690|581804569|FG000|Overall Study|Adverse Event|7|||
161113219|NCT01210690|581804569|FG000|Overall Study|Lack of Efficacy|12|||
161113220|NCT01210690|581804569|FG000|Overall Study|Lost to Follow-up|3|||
161113221|NCT01210690|581804569|FG000|Overall Study|Disease Remission|1|||
161113222|NCT01210690|581804569|FG000|Overall Study|Withdrawal by Subject|1|||
161113223|NCT01210690|581804569|FG000|Overall Study|Patient refused to swallow|1|||
161113224|NCT01210690|581804569|FG000|Overall Study|Patient could not take glucose|1|||
161113225|NCT00470054|581804570|FG000|Overall Study|Ineligible|1|||
161113226|NCT01439555|581804571|FG000|Overall Study|Protocol Violation|1|||
161113227|NCT04869345|581804577|FG000|Overall Study|Lost to Follow-up|8|||
161113228|NCT04869345|581804578|FG001|Overall Study|Lost to Follow-up|3|||
161113229|NCT05264740|581804583|FG000|Baseline|Withdrawal by Subject|0|||
161113230|NCT05264740|581804584|FG001|Baseline|Withdrawal by Subject|1|||
161113231|NCT05264740|581804583|FG000|Follow Up 1|Lost to Follow-up|1|||
161113232|NCT05264740|581804584|FG001|Follow Up 1|Lost to Follow-up|1|||
161113233|NCT05264740|581804583|FG000|Follow Up 1|Withdrawal by Subject|0|||
161113234|NCT05264740|581804584|FG001|Follow Up 1|Withdrawal by Subject|1|||
161113235|NCT05264740|581804583|FG000|Follow Up 2|Lost to Follow-up|1|||
161113236|NCT05264740|581804584|FG001|Follow Up 2|Lost to Follow-up|4|||
161113237|NCT05264740|581804583|FG000|Follow Up 3|Lost to Follow-up|7|||
161113238|NCT05264740|581804584|FG001|Follow Up 3|Lost to Follow-up|4|||
161113239|NCT01157078|581806478|FG000|Overall Study|Withdrawal by Subject|12|||
161113240|NCT01157078|581806479|FG001|Overall Study|Withdrawal by Subject|14|||
161113241|NCT01157078|581806478|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161113242|NCT01157078|581806479|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161113243|NCT01157078|581806478|FG000|Overall Study|Adverse Event|6|||
161113244|NCT01157078|581806479|FG001|Overall Study|Adverse Event|6|||
161113245|NCT01157078|581806478|FG000|Overall Study|Severe non-compliance to protocol|2|||
161113246|NCT01157078|581806479|FG001|Overall Study|Severe non-compliance to protocol|4|||
161113247|NCT01157078|581806478|FG000|Overall Study|Condition under investigation worsened|0|||
161113248|NCT01157078|581806479|FG001|Overall Study|Condition under investigation worsened|1|||
161113249|NCT01157078|581806478|FG000|Overall Study|Lack of Efficacy|2|||
161113250|NCT01157078|581806479|FG001|Overall Study|Lack of Efficacy|0|||
161113251|NCT01157078|581806478|FG000|Overall Study|Study-specific withdrawal criteria|2|||
161113252|NCT01157078|581806479|FG001|Overall Study|Study-specific withdrawal criteria|2|||
161113253|NCT01157078|581806478|FG000|Overall Study|Lost to Follow-up|7|||
161113254|NCT01157078|581806479|FG001|Overall Study|Lost to Follow-up|5|||
161113255|NCT01157078|581806478|FG000|Overall Study|Other|2|||
161113256|NCT01157078|581806479|FG001|Overall Study|Other|4|||
161113257|NCT00132132|581806482|FG000|Overall Study|Lost to Follow-up|7|||
161113258|NCT00132132|581806483|FG001|Overall Study|Lost to Follow-up|2|||
161113259|NCT02145741|581806484|FG000|Overall Study|Progressive disease|3|||
161113260|NCT02145741|581806485|FG001|Overall Study|Progressive disease|6|||
161113261|NCT02145741|581806486|FG002|Overall Study|Progressive disease|6|||
161113262|NCT02145741|581806484|FG000|Overall Study|quality issue with the administered drug|3|||
161113263|NCT02145741|581806485|FG001|Overall Study|quality issue with the administered drug|0|||
161113264|NCT02145741|581806486|FG002|Overall Study|quality issue with the administered drug|0|||
161113265|NCT01594853|581806487|FG000|Overall Study|Withdrawal by Subject|1|||
161113266|NCT01594853|581806488|FG001|Overall Study|Withdrawal by Subject|1|||
161113267|NCT01594853|581806487|FG000|Overall Study|Lost to Follow-up|1|||
161113268|NCT01594853|581806488|FG001|Overall Study|Lost to Follow-up|1|||
161113269|NCT01594853|581806487|FG000|Overall Study|noncompliance with exercise|0|||
161113270|NCT01594853|581806488|FG001|Overall Study|noncompliance with exercise|1|||
161113271|NCT00769002|581806489|FG000|Overall Study|Study was not completed, no data|9|||
161113272|NCT00769002|581806490|FG001|Overall Study|Study was not completed, no data|9|||
161113273|NCT03246958|581806496|FG000|Overall Study|Withdrawal by Subject|0|||
161113274|NCT03246958|581806497|FG001|Overall Study|Withdrawal by Subject|1|||
161113275|NCT03246958|581806498|FG002|Overall Study|Withdrawal by Subject|0|||
161113276|NCT03246958|581806499|FG003|Overall Study|Withdrawal by Subject|0|||
161113277|NCT03246958|581806500|FG004|Overall Study|Withdrawal by Subject|0|||
161113278|NCT03246958|581806501|FG005|Overall Study|Withdrawal by Subject|1|||
161113279|NCT03246958|581806502|FG006|Overall Study|Withdrawal by Subject|0|||
161113280|NCT03246958|581806496|FG000|Overall Study|Progression|13|||
161113281|NCT03246958|581806497|FG001|Overall Study|Progression|9|||
161113282|NCT03246958|581806498|FG002|Overall Study|Progression|3|||
161113283|NCT03246958|581806499|FG003|Overall Study|Progression|2|||
161113284|NCT03246958|581806500|FG004|Overall Study|Progression|1|||
161113285|NCT03246958|581806501|FG005|Overall Study|Progression|2|||
161113286|NCT03246958|581806502|FG006|Overall Study|Progression|1|||
161113287|NCT03246958|581806496|FG000|Overall Study|Adverse Event|2|||
161113288|NCT03246958|581806497|FG001|Overall Study|Adverse Event|2|||
161218194|NCT02224456|582181247|FG000|Overall Study|Lack of Efficacy|1|||
161218195|NCT02224456|582181247|FG000|Overall Study|Lost to Follow-up|15|||
161113289|NCT03246958|581806498|FG002|Overall Study|Adverse Event|0|||
161113290|NCT03246958|581806499|FG003|Overall Study|Adverse Event|1|||
161113291|NCT03246958|581806500|FG004|Overall Study|Adverse Event|1|||
161113292|NCT03246958|581806501|FG005|Overall Study|Adverse Event|0|||
161113293|NCT03246958|581806502|FG006|Overall Study|Adverse Event|2|||
161113294|NCT03246958|581806496|FG000|Overall Study|Death|0|||
161113295|NCT03246958|581806497|FG001|Overall Study|Death|1|||
161113296|NCT03246958|581806498|FG002|Overall Study|Death|0|||
161218196|NCT02224456|582181247|FG000|Overall Study|Withdrawal by Subject|9|||
161218197|NCT02224456|582181247|FG000|Overall Study|Physician Decision|3|||
161218198|NCT02224456|582181247|FG000|Overall Study|Death|2|||
161218199|NCT02224456|582181247|FG000|Overall Study|Pregnancy|4|||
161218200|NCT02224456|582181247|FG000|Overall Study|Protocol Violation|1|||
161218201|NCT02224456|582181247|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
161218202|NCT01241461|582181248|FG000|Overall Study|Progressive Disease|3|||
161218203|NCT01241461|582181249|FG001|Overall Study|Progressive Disease|6|||
161218204|NCT01379781|582181250|FG000|Overall Study|Lost to Follow-up|11|||
161218205|NCT01379781|582181251|FG001|Overall Study|Lost to Follow-up|8|||
161218206|NCT02247479|582181252|FG000|Overall Study|Adverse Event|8|||
161218207|NCT02247479|582181253|FG001|Overall Study|Adverse Event|9|||
161218208|NCT02247479|582181254|FG002|Overall Study|Adverse Event|8|||
161218209|NCT02247479|582181252|FG000|Overall Study|Death|5|||
161218210|NCT02247479|582181253|FG001|Overall Study|Death|4|||
161218211|NCT02247479|582181254|FG002|Overall Study|Death|6|||
161218212|NCT02247479|582181252|FG000|Overall Study|Lost to Follow-up|3|||
161218213|NCT02247479|582181253|FG001|Overall Study|Lost to Follow-up|3|||
161218214|NCT02247479|582181254|FG002|Overall Study|Lost to Follow-up|1|||
161218215|NCT02247479|582181252|FG000|Overall Study|Non-compliance|0|||
161218216|NCT02247479|582181253|FG001|Overall Study|Non-compliance|0|||
161218217|NCT02247479|582181254|FG002|Overall Study|Non-compliance|1|||
161218218|NCT02247479|582181252|FG000|Overall Study|Withdrawal by Subject|25|||
161218219|NCT02247479|582181253|FG001|Overall Study|Withdrawal by Subject|29|||
161218220|NCT02247479|582181254|FG002|Overall Study|Withdrawal by Subject|24|||
161218221|NCT02247479|582181252|FG000|Overall Study|Study Terminated by Sponsor|98|||
161218222|NCT02247479|582181253|FG001|Overall Study|Study Terminated by Sponsor|88|||
161218223|NCT02247479|582181254|FG002|Overall Study|Study Terminated by Sponsor|94|||
161218224|NCT02247479|582181252|FG000|Overall Study|Physician Decision|1|||
161218225|NCT02247479|582181253|FG001|Overall Study|Physician Decision|0|||
161218226|NCT02247479|582181254|FG002|Overall Study|Physician Decision|2|||
161218227|NCT02247479|582181252|FG000|Overall Study|Unspecified Reason|2|||
161218228|NCT02247479|582181253|FG001|Overall Study|Unspecified Reason|5|||
161218229|NCT02247479|582181254|FG002|Overall Study|Unspecified Reason|2|||
161218230|NCT03740698|582181255|FG000|Overall Study|Physician Decision|0|||
161218231|NCT03740698|582181256|FG001|Overall Study|Physician Decision|1|||
161218232|NCT03740698|582181257|FG002|Overall Study|Physician Decision|1|||
161218233|NCT05216978|582181266|FG000|Overall Study|Withdrawal by Subject|3|||
161218234|NCT05216978|582181266|FG000|Overall Study|Lost to Follow-up|5|||
161218235|NCT00658320|582181268|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
161218236|NCT00658320|582181269|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
161218237|NCT00658320|582181268|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
161218238|NCT00658320|582181269|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
160870023|NCT03544333|580917304|FG001|Overall Study|Withdrawal by Subject|0|||
160870024|NCT00475306|580917309|FG000|Overall Study|Protocol Violation|1|||
160870025|NCT00475306|580917310|FG001|Overall Study|Protocol Violation|1|||
160870026|NCT00475306|580917311|FG002|Overall Study|Protocol Violation|0|||
160870027|NCT00475306|580917312|FG003|Overall Study|Protocol Violation|1|||
160870028|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
160870029|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
160870030|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
160870031|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
160870032|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
160870033|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
160870034|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
160870035|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
160870036|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
160870037|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
160870038|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
160870039|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
160870040|NCT02405442|580917314|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
160870041|NCT02405442|580917315|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
160870042|NCT02405442|580917316|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
160870043|NCT02405442|580917317|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
160870044|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
160870045|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
161218239|NCT00658320|582181268|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
161218240|NCT00658320|582181269|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
161218241|NCT00658320|582181268|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
161218242|NCT00658320|582181269|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
161218243|NCT02410252|582181277|FG000|Overall Study|Withdrawal by Subject|4|||
161218244|NCT02410252|582181277|FG000|Overall Study|Physician Decision|2|||
161218245|NCT03433001|582181287|FG000|Overall Study|Lack of Efficacy|109|||
160870046|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
160870047|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
160870048|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
160870049|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
160870050|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
161218246|NCT03433001|582181287|FG000|Overall Study|Adverse Event|69|||
161218247|NCT03433001|582181287|FG000|Overall Study|Withdrawal by Subject|10|||
161218248|NCT03433001|582181287|FG000|Overall Study|Death|12|||
161218249|NCT03433001|582181287|FG000|Overall Study|Lost to Follow-up|4|||
161218250|NCT03433001|582181287|FG000|Overall Study|Other|25|||
161218251|NCT01007916|582181293|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
161218252|NCT01007916|582181294|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
161218253|NCT01007916|582181293|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
161218254|NCT01007916|582181294|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
161218255|NCT01162499|582181299|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
161218256|NCT01162499|582181300|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
161218257|NCT02884206|582181303|FG000|Valsartan Run-in Period|Death|1|||
161218258|NCT02884206|582181304|FG001|Valsartan Run-in Period|Death|0|||
161218259|NCT02884206|582181305|FG002|Valsartan Run-in Period|Death|0|||
161218260|NCT02884206|582181303|FG000|Valsartan Run-in Period|Adverse Event|31|||
161218261|NCT02884206|582181304|FG001|Valsartan Run-in Period|Adverse Event|0|||
161218262|NCT02884206|582181305|FG002|Valsartan Run-in Period|Adverse Event|0|||
161218263|NCT02884206|582181303|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
161218264|NCT02884206|582181304|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
161218265|NCT02884206|582181305|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
161218266|NCT02884206|582181303|FG000|Valsartan Run-in Period|Protocol deviation|4|||
161218267|NCT02884206|582181304|FG001|Valsartan Run-in Period|Protocol deviation|0|||
161218268|NCT02884206|582181305|FG002|Valsartan Run-in Period|Protocol deviation|0|||
161218269|NCT02884206|582181303|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
161218270|NCT02884206|582181304|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
161218271|NCT02884206|582181305|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
161218272|NCT02884206|582181303|FG000|Valsartan Run-in Period|Physician Decision|1|||
161218273|NCT02884206|582181304|FG001|Valsartan Run-in Period|Physician Decision|0|||
161218274|NCT02884206|582181305|FG002|Valsartan Run-in Period|Physician Decision|0|||
161218275|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Adverse Event|38|||
161218276|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Adverse Event|0|||
161218277|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Adverse Event|0|||
161218278|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Death|2|||
161218279|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Death|0|||
161218280|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Death|0|||
161218281|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
161218282|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
161218283|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
161218284|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
161218285|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
161218286|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
161218287|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
161218288|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
161218289|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
161218290|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Physician Decision|1|||
161218291|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Physician Decision|0|||
161218292|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Physician Decision|0|||
161218293|NCT02884206|582181303|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
161218294|NCT02884206|582181304|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
161218295|NCT02884206|582181305|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
161218296|NCT02884206|582181303|FG000|Double-Blind Period|Death|0|||
161218297|NCT02884206|582181304|FG001|Double-Blind Period|Death|28|||
161218298|NCT02884206|582181305|FG002|Double-Blind Period|Death|39|||
161218299|NCT02884206|582181303|FG000|Double-Blind Period|Patient/guardian decision|0|||
161218300|NCT02884206|582181304|FG001|Double-Blind Period|Patient/guardian decision|10|||
161218301|NCT02884206|582181305|FG002|Double-Blind Period|Patient/guardian decision|13|||
161218302|NCT02884206|582181303|FG000|Double-Blind Period|Lost to Follow-up|0|||
161218303|NCT02884206|582181304|FG001|Double-Blind Period|Lost to Follow-up|4|||
161218304|NCT02884206|582181305|FG002|Double-Blind Period|Lost to Follow-up|4|||
161218305|NCT02884206|582181303|FG000|Double-Blind Period|Physician Decision|0|||
161218306|NCT02884206|582181304|FG001|Double-Blind Period|Physician Decision|2|||
161218307|NCT02884206|582181305|FG002|Double-Blind Period|Physician Decision|0|||
161218308|NCT02884206|582181303|FG000|Double-Blind Period|Adverse Event|0|||
161218309|NCT02884206|582181304|FG001|Double-Blind Period|Adverse Event|0|||
161218310|NCT02884206|582181305|FG002|Double-Blind Period|Adverse Event|3|||
161218311|NCT02884206|582181303|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
161218312|NCT02884206|582181304|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
161324394|NCT02098395|582573587|FG003|Overall Study|Lost to Follow-up|3|||
161113297|NCT03246958|581806499|FG003|Overall Study|Death|0|||
161113298|NCT03246958|581806500|FG004|Overall Study|Death|0|||
161113299|NCT03246958|581806501|FG005|Overall Study|Death|0|||
161113300|NCT03246958|581806502|FG006|Overall Study|Death|0|||
161113301|NCT03246958|581806496|FG000|Overall Study|Physician Decision|0|||
161113302|NCT03246958|581806497|FG001|Overall Study|Physician Decision|0|||
161113303|NCT03246958|581806498|FG002|Overall Study|Physician Decision|0|||
161113304|NCT03246958|581806499|FG003|Overall Study|Physician Decision|1|||
161113305|NCT03246958|581806500|FG004|Overall Study|Physician Decision|0|||
161113306|NCT03246958|581806501|FG005|Overall Study|Physician Decision|0|||
161113307|NCT03246958|581806502|FG006|Overall Study|Physician Decision|0|||
161113308|NCT03246958|581806496|FG000|Overall Study|Never start treatment|1|||
161113309|NCT03246958|581806497|FG001|Overall Study|Never start treatment|0|||
161113310|NCT03246958|581806498|FG002|Overall Study|Never start treatment|0|||
161113311|NCT03246958|581806499|FG003|Overall Study|Never start treatment|0|||
161113312|NCT03246958|581806500|FG004|Overall Study|Never start treatment|0|||
161113313|NCT03246958|581806501|FG005|Overall Study|Never start treatment|0|||
161113314|NCT03246958|581806502|FG006|Overall Study|Never start treatment|0|||
161113315|NCT03246958|581806496|FG000|Overall Study|Over enrollment|0|||
161113316|NCT03246958|581806497|FG001|Overall Study|Over enrollment|2|||
161113317|NCT03246958|581806498|FG002|Overall Study|Over enrollment|0|||
161113318|NCT03246958|581806499|FG003|Overall Study|Over enrollment|0|||
161113319|NCT03246958|581806500|FG004|Overall Study|Over enrollment|0|||
161113320|NCT03246958|581806501|FG005|Overall Study|Over enrollment|0|||
161113321|NCT03246958|581806502|FG006|Overall Study|Over enrollment|0|||
161113322|NCT01650636|581806505|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
161113323|NCT01650636|581806506|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
161113324|NCT01650636|581806505|FG000|Washout up to 5 Months|Physician Decision|2|||
161113325|NCT01650636|581806506|FG001|Washout up to 5 Months|Physician Decision|2|||
161113326|NCT01650636|581806505|FG000|Washout up to 5 Months|Death|1|||
161113327|NCT01650636|581806506|FG001|Washout up to 5 Months|Death|0|||
161113328|NCT01650636|581806505|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
161113329|NCT01650636|581806506|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
161113330|NCT01650636|581806505|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
161113331|NCT01650636|581806506|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
161113332|NCT01650636|581806505|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
161113333|NCT01650636|581806506|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
161113334|NCT01560780|581806507|FG000|Overall Study|Death|2|||
161113335|NCT01560780|581806508|FG001|Overall Study|Death|1|||
161113336|NCT01560780|581806507|FG000|Overall Study|Patient Preference|11|||
161113337|NCT01560780|581806508|FG001|Overall Study|Patient Preference|11|||
161113338|NCT01118351|581806509|FG000|Overall Study|Adverse Event|3|||
161113339|NCT01118351|581806509|FG000|Overall Study|Withdrawal by Subject|1|||
161113340|NCT00811135|581806510|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
161113341|NCT00811135|581806510|FG000|Overall Study|Death|3|||
161113342|NCT00811135|581806510|FG000|Overall Study|Protocol Violation|2|||
161113343|NCT00811135|581806510|FG000|Overall Study|Violation of Selection Criteria|1|||
161113344|NCT00811135|581806510|FG000|Overall Study|Refused Treatment|1|||
161113345|NCT00811135|581806510|FG000|Overall Study|Withdrawal by Subject|3|||
161113346|NCT00811135|581806510|FG000|Overall Study|Administrative/Other Unspecified|11|||
161113347|NCT00811135|581806510|FG000|Overall Study|Ongoing|59|||
161113348|NCT02192827|581806512|FG000|Overall Study|Lost to Follow-up|25|||
161113349|NCT02192827|581806513|FG001|Overall Study|Lost to Follow-up|27|||
161113350|NCT02192827|581806512|FG000|Overall Study|Given additional steroids with admission|13|||
161113351|NCT02192827|581806513|FG001|Overall Study|Given additional steroids with admission|11|||
161113352|NCT01500278|581806515|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
161113353|NCT01500278|581806516|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
161113354|NCT01500278|581806515|FG000|Week 0 - Week 12|Protocol Violation|10|||
161113355|NCT01500278|581806516|FG001|Week 0 - Week 12|Protocol Violation|16|||
161113356|NCT01500278|581806515|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
161113357|NCT01500278|581806516|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
161113358|NCT01500278|581806515|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
161113359|NCT01500278|581806516|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
161113360|NCT01500278|581806515|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
161113361|NCT01500278|581806516|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
161113362|NCT01500278|581806515|FG000|Week 0 - Week 12|Patient decision|1|||
161113363|NCT01500278|581806516|FG001|Week 0 - Week 12|Patient decision|0|||
161113364|NCT01500278|581806515|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
161113365|NCT01500278|581806516|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
161113366|NCT01500278|581806515|FG000|Week 0 - Week 12|Investigator decision|1|||
161113367|NCT01500278|581806516|FG001|Week 0 - Week 12|Investigator decision|0|||
161113368|NCT01500278|581806515|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
161113369|NCT01500278|581806516|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
161113370|NCT01500278|581806515|FG000|Week 0 - Week 12|Sponsor decision|1|||
161113371|NCT01500278|581806516|FG001|Week 0 - Week 12|Sponsor decision|0|||
161113372|NCT01500278|581806515|FG000|Week 0 - Week 12|Personal reason|0|||
160870051|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
160870052|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
160870053|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
160870054|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
160870055|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
160870056|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
160870057|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
161113373|NCT01500278|581806516|FG001|Week 0 - Week 12|Personal reason|1|||
161113374|NCT01500278|581806515|FG000|Week 0 - Week 12|Other serious disease|0|||
161113375|NCT01500278|581806516|FG001|Week 0 - Week 12|Other serious disease|1|||
161113376|NCT01500278|581806515|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
161113377|NCT01500278|581806516|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
161113378|NCT01500278|581806515|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
161113379|NCT01500278|581806516|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
161113380|NCT01500278|581806515|FG000|Week 13 - Week 104|Protocol Violation|6|||
161113381|NCT01500278|581806516|FG001|Week 13 - Week 104|Protocol Violation|6|||
161113382|NCT01500278|581806515|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
161113383|NCT01500278|581806516|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
161113384|NCT01500278|581806515|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
161113385|NCT01500278|581806516|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
161113386|NCT01500278|581806515|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
161113387|NCT01500278|581806516|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
161113388|NCT01500278|581806515|FG000|Week 13 - Week 104|Non/bad compliance|7|||
161113389|NCT01500278|581806516|FG001|Week 13 - Week 104|Non/bad compliance|5|||
161113390|NCT01500278|581806515|FG000|Week 13 - Week 104|Recurrent infections|1|||
161113391|NCT01500278|581806516|FG001|Week 13 - Week 104|Recurrent infections|0|||
161113392|NCT01500278|581806515|FG000|Week 13 - Week 104|False positive test|1|||
161113393|NCT01500278|581806516|FG001|Week 13 - Week 104|False positive test|2|||
161113394|NCT01500278|581806515|FG000|Week 13 - Week 104|Sponsor request|4|||
161113395|NCT01500278|581806516|FG001|Week 13 - Week 104|Sponsor request|0|||
161113396|NCT01500278|581806515|FG000|Week 13 - Week 104|Withdrawn in error|1|||
161113397|NCT01500278|581806516|FG001|Week 13 - Week 104|Withdrawn in error|0|||
161113398|NCT01500278|581806515|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
161113399|NCT01500278|581806516|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
161113400|NCT01500278|581806515|FG000|Week 13 - Week 104|Protocol deviation|1|||
161113401|NCT01500278|581806516|FG001|Week 13 - Week 104|Protocol deviation|0|||
161113402|NCT01500278|581806515|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
161113403|NCT01500278|581806516|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
161113404|NCT01500278|581806515|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
161113405|NCT01500278|581806516|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
161113406|NCT01500278|581806515|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
161113407|NCT01500278|581806516|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
161113408|NCT01500278|581806515|FG000|Week 13 - Week 104|Relocation|0|||
161113409|NCT01500278|581806516|FG001|Week 13 - Week 104|Relocation|1|||
161113410|NCT01500278|581806515|FG000|Week 13 - Week 104|Sponsor decision|0|||
161113411|NCT01500278|581806516|FG001|Week 13 - Week 104|Sponsor decision|2|||
161113412|NCT01500278|581806515|FG000|Week 13 - Week 104|Medical monitor decision|0|||
161113413|NCT01500278|581806516|FG001|Week 13 - Week 104|Medical monitor decision|2|||
161113414|NCT01500278|581806515|FG000|Week 13 - Week 104|Personal reason|0|||
161113415|NCT01500278|581806516|FG001|Week 13 - Week 104|Personal reason|1|||
161113416|NCT01500278|581806515|FG000|Week 13 - Week 104|Not completed|0|||
161113417|NCT01500278|581806516|FG001|Week 13 - Week 104|Not completed|1|||
161113418|NCT01500278|581806515|FG000|Week 13 - Week 104|Death|2|||
161113419|NCT01500278|581806516|FG001|Week 13 - Week 104|Death|4|||
161113420|NCT01500278|581806515|FG000|Week 13 - Week 104|Adverse Event|54|||
161113421|NCT01500278|581806516|FG001|Week 13 - Week 104|Adverse Event|54|||
161113422|NCT00414453|581806517|FG000|Overall Study|Abnormal lab work|16|||
161113423|NCT00183274|581806518|FG000|Phase 1: Open-Label|Adverse Event|31|||
161113424|NCT00183274|581806519|FG001|Phase 1: Open-Label|Adverse Event|0|||
161113425|NCT00183274|581806520|FG002|Phase 1: Open-Label|Adverse Event|0|||
161113426|NCT00183274|581806521|FG003|Phase 1: Open-Label|Adverse Event|0|||
161113427|NCT00183274|581806522|FG004|Phase 1: Open-Label|Adverse Event|0|||
161113428|NCT00183274|581806523|FG005|Phase 1: Open-Label|Adverse Event|0|||
161113429|NCT00183274|581806518|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
161113430|NCT00183274|581806519|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
161113431|NCT00183274|581806520|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
161113432|NCT00183274|581806521|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
161113433|NCT00183274|581806522|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
161113434|NCT00183274|581806523|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
161113435|NCT00183274|581806518|FG000|Phase 1: Open-Label|Protocol Violation|11|||
161113436|NCT00183274|581806519|FG001|Phase 1: Open-Label|Protocol Violation|0|||
161113437|NCT00183274|581806520|FG002|Phase 1: Open-Label|Protocol Violation|0|||
161113438|NCT00183274|581806521|FG003|Phase 1: Open-Label|Protocol Violation|0|||
161113439|NCT00183274|581806522|FG004|Phase 1: Open-Label|Protocol Violation|0|||
161218313|NCT02884206|582181305|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
161218314|NCT03487796|582181306|FG000|Overall Study|Lost to Follow-up|18|||
161218315|NCT03487796|582181307|FG001|Overall Study|Lost to Follow-up|6|||
161218316|NCT00613574|582181311|FG000|Overall Study|Adverse Event|3|||
161218317|NCT00613574|582181311|FG000|Overall Study|Lost to Follow-up|2|||
161218318|NCT00613574|582181311|FG000|Overall Study|Other|1|||
161218319|NCT04604184|582181315|FG000|Overall Study|Adverse Event|5|||
161218320|NCT04604184|582181316|FG001|Overall Study|Adverse Event|5|||
161218321|NCT04604184|582181315|FG000|Overall Study|Death|2|||
161218322|NCT04604184|582181316|FG001|Overall Study|Death|1|||
161218323|NCT04604184|582181315|FG000|Overall Study|Withdrawal by Subject|1|||
161218324|NCT04604184|582181316|FG001|Overall Study|Withdrawal by Subject|3|||
161218325|NCT04604184|582181315|FG000|Overall Study|Not treated|2|||
161113440|NCT00183274|581806523|FG005|Phase 1: Open-Label|Protocol Violation|0|||
161113441|NCT00183274|581806518|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
161113442|NCT00183274|581806519|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
161113443|NCT00183274|581806520|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
161113444|NCT00183274|581806521|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
161113445|NCT00183274|581806522|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
161113446|NCT00183274|581806523|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
161113447|NCT00183274|581806518|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
161113448|NCT00183274|581806519|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
161113449|NCT00183274|581806520|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
161113450|NCT00183274|581806521|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
161113451|NCT00183274|581806522|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
161113452|NCT00183274|581806523|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
161113453|NCT00183274|581806518|FG000|Phase 1: Open-Label|Other|9|||
161113454|NCT00183274|581806519|FG001|Phase 1: Open-Label|Other|0|||
161113455|NCT00183274|581806520|FG002|Phase 1: Open-Label|Other|0|||
161113456|NCT00183274|581806521|FG003|Phase 1: Open-Label|Other|0|||
161113457|NCT00183274|581806522|FG004|Phase 1: Open-Label|Other|0|||
161113458|NCT00183274|581806523|FG005|Phase 1: Open-Label|Other|0|||
161113459|NCT00183274|581806518|FG000|Phase 2: Double-Blind|Relapsed|0|||
161113460|NCT00183274|581806519|FG001|Phase 2: Double-Blind|Relapsed|8|||
161113461|NCT00183274|581806520|FG002|Phase 2: Double-Blind|Relapsed|29|||
161113462|NCT00183274|581806521|FG003|Phase 2: Double-Blind|Relapsed|0|||
161113463|NCT00183274|581806522|FG004|Phase 2: Double-Blind|Relapsed|0|||
161113464|NCT00183274|581806523|FG005|Phase 2: Double-Blind|Relapsed|0|||
161113465|NCT00183274|581806518|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161113466|NCT00183274|581806519|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
161113467|NCT00183274|581806520|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
161113468|NCT00183274|581806521|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161113469|NCT00183274|581806522|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161113470|NCT00183274|581806523|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
161113471|NCT00183274|581806518|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161113472|NCT00183274|581806519|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161113473|NCT00183274|581806520|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
161113474|NCT00183274|581806521|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
161113475|NCT00183274|581806522|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
161113476|NCT00183274|581806523|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
161113477|NCT00183274|581806518|FG000|Phase 3: Double-Blind|Relapsed|0|||
161113478|NCT00183274|581806519|FG001|Phase 3: Double-Blind|Relapsed|0|||
161113479|NCT00183274|581806520|FG002|Phase 3: Double-Blind|Relapsed|0|||
161113480|NCT00183274|581806521|FG003|Phase 3: Double-Blind|Relapsed|1|||
161113481|NCT00183274|581806522|FG004|Phase 3: Double-Blind|Relapsed|11|||
161113482|NCT00183274|581806523|FG005|Phase 3: Double-Blind|Relapsed|2|||
161113483|NCT03882970|581806528|FG000|Overall Study|Adverse Event|5|||
161113484|NCT03882970|581806529|FG001|Overall Study|Adverse Event|7|||
161113485|NCT03882970|581806530|FG002|Overall Study|Adverse Event|3|||
161113486|NCT03882970|581806531|FG003|Overall Study|Adverse Event|1|||
161113487|NCT03882970|581806528|FG000|Overall Study|Death|1|||
161113488|NCT03882970|581806529|FG001|Overall Study|Death|2|||
161113489|NCT03882970|581806530|FG002|Overall Study|Death|1|||
161113490|NCT03882970|581806531|FG003|Overall Study|Death|1|||
161113491|NCT03882970|581806528|FG000|Overall Study|Lost to Follow-up|8|||
161113492|NCT03882970|581806529|FG001|Overall Study|Lost to Follow-up|9|||
161113493|NCT03882970|581806530|FG002|Overall Study|Lost to Follow-up|5|||
161113494|NCT03882970|581806531|FG003|Overall Study|Lost to Follow-up|5|||
161113495|NCT03882970|581806528|FG000|Overall Study|Physician Decision|0|||
161113496|NCT03882970|581806529|FG001|Overall Study|Physician Decision|2|||
161113497|NCT03882970|581806530|FG002|Overall Study|Physician Decision|2|||
161113498|NCT03882970|581806531|FG003|Overall Study|Physician Decision|2|||
161113499|NCT03882970|581806528|FG000|Overall Study|Protocol Violation|2|||
161113500|NCT03882970|581806529|FG001|Overall Study|Protocol Violation|0|||
161113501|NCT03882970|581806530|FG002|Overall Study|Protocol Violation|0|||
161218326|NCT04604184|582181316|FG001|Overall Study|Not treated|2|||
161218327|NCT04604184|582181315|FG000|Overall Study|Due to sponsor decision|9|||
161218328|NCT04604184|582181316|FG001|Overall Study|Due to sponsor decision|7|||
161218329|NCT04604184|582181315|FG000|Overall Study|Physician Decision|0|||
160870058|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
160870059|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
160870060|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
160870061|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
161113502|NCT03882970|581806531|FG003|Overall Study|Protocol Violation|0|||
161113503|NCT03882970|581806528|FG000|Overall Study|Withdrawal by Subject|8|||
161113504|NCT03882970|581806529|FG001|Overall Study|Withdrawal by Subject|17|||
161113505|NCT03882970|581806530|FG002|Overall Study|Withdrawal by Subject|7|||
161113506|NCT03882970|581806531|FG003|Overall Study|Withdrawal by Subject|22|||
161113507|NCT03882970|581806528|FG000|Overall Study|Personal Reason|2|||
161113508|NCT03882970|581806529|FG001|Overall Study|Personal Reason|3|||
161113509|NCT03882970|581806530|FG002|Overall Study|Personal Reason|1|||
161113510|NCT03882970|581806531|FG003|Overall Study|Personal Reason|3|||
161113511|NCT02863809|581806532|FG000|Overall Study|Adverse Event|8|||
161113512|NCT02863809|581806533|FG001|Overall Study|Adverse Event|8|||
161113513|NCT02863809|581806532|FG000|Overall Study|Withdrawal by Subject|0|||
161113514|NCT02863809|581806533|FG001|Overall Study|Withdrawal by Subject|1|||
161113515|NCT02863809|581806532|FG000|Overall Study|Lost to Follow-up|1|||
161113516|NCT02863809|581806533|FG001|Overall Study|Lost to Follow-up|1|||
161113517|NCT02863809|581806532|FG000|Overall Study|Death|1|||
161113518|NCT02863809|581806533|FG001|Overall Study|Death|0|||
161113519|NCT02813694|581806536|FG000|Overall Study|Physician Decision|0|||
161113520|NCT02813694|581806537|FG001|Overall Study|Physician Decision|1|||
161113521|NCT02813694|581806536|FG000|Overall Study|Withdrawal by Subject|10|||
161113522|NCT02813694|581806537|FG001|Overall Study|Withdrawal by Subject|9|||
161113523|NCT02813694|581806536|FG000|Overall Study|Lost to Follow-up|1|||
161113524|NCT02813694|581806537|FG001|Overall Study|Lost to Follow-up|1|||
161113525|NCT02813694|581806536|FG000|Overall Study|Death|3|||
161113526|NCT02813694|581806537|FG001|Overall Study|Death|3|||
161113527|NCT02813694|581806536|FG000|Overall Study|Randomized- did not receive study drug|2|||
161113528|NCT02813694|581806537|FG001|Overall Study|Randomized- did not receive study drug|0|||
161113529|NCT02813694|581806536|FG000|Overall Study|Patient hospitalized|1|||
161113530|NCT02813694|581806537|FG001|Overall Study|Patient hospitalized|0|||
161113531|NCT01227044|581806538|FG000|Overall Study|Lost to Follow-up|5|||
161113532|NCT01227044|581806539|FG001|Overall Study|Lost to Follow-up|7|||
161113533|NCT01227044|581806538|FG000|Overall Study|Discontinued Intervention|1|||
161113534|NCT01227044|581806539|FG001|Overall Study|Discontinued Intervention|2|||
161113535|NCT04247061|581806540|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
161113536|NCT04247061|581806540|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
161113537|NCT04247061|581806540|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
161113538|NCT02039375|581806549|FG000|Overall Study|Lost to Follow-up|2|||
161113539|NCT04770389|581806550|FG000|Overall Study|Adverse Event|1|||
161113540|NCT04770389|581806551|FG001|Overall Study|Adverse Event|2|||
161113541|NCT04770389|581806552|FG002|Overall Study|Adverse Event|0|||
161113542|NCT04770389|581806553|FG003|Overall Study|Adverse Event|1|||
161113543|NCT04770389|581806550|FG000|Overall Study|Withdrawal by Subject|0|||
161113544|NCT04770389|581806551|FG001|Overall Study|Withdrawal by Subject|2|||
161113545|NCT04770389|581806552|FG002|Overall Study|Withdrawal by Subject|1|||
161113546|NCT04770389|581806553|FG003|Overall Study|Withdrawal by Subject|0|||
161113547|NCT04770389|581806550|FG000|Overall Study|Failed attempt to draw blood|1|||
161113548|NCT04770389|581806551|FG001|Overall Study|Failed attempt to draw blood|0|||
161113549|NCT04770389|581806552|FG002|Overall Study|Failed attempt to draw blood|0|||
161113550|NCT04770389|581806553|FG003|Overall Study|Failed attempt to draw blood|0|||
161113551|NCT04770389|581806550|FG000|Overall Study|Left the country|0|||
161113552|NCT04770389|581806551|FG001|Overall Study|Left the country|0|||
161113553|NCT04770389|581806552|FG002|Overall Study|Left the country|1|||
161113554|NCT04770389|581806553|FG003|Overall Study|Left the country|2|||
161113555|NCT04770389|581806550|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
161113556|NCT04770389|581806551|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
161113557|NCT04770389|581806552|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
161113558|NCT04770389|581806553|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
161113559|NCT04770389|581806550|FG000|Overall Study|Lost to Follow-up|0|||
161113560|NCT04770389|581806551|FG001|Overall Study|Lost to Follow-up|0|||
161113561|NCT04770389|581806552|FG002|Overall Study|Lost to Follow-up|0|||
161113562|NCT04770389|581806553|FG003|Overall Study|Lost to Follow-up|1|||
161113563|NCT04770389|581806550|FG000|Overall Study|Moved away from study site|0|||
161113564|NCT04770389|581806551|FG001|Overall Study|Moved away from study site|1|||
161113565|NCT04770389|581806552|FG002|Overall Study|Moved away from study site|0|||
161113566|NCT04770389|581806553|FG003|Overall Study|Moved away from study site|0|||
161113567|NCT00794157|581806554|FG000|Overall Study|Adverse Event|4|||
161113568|NCT00794157|581806555|FG001|Overall Study|Adverse Event|1|||
161113569|NCT00794157|581806556|FG002|Overall Study|Adverse Event|8|||
161113570|NCT00794157|581806554|FG000|Overall Study|Subject withdrew consent|2|||
161113571|NCT00794157|581806555|FG001|Overall Study|Subject withdrew consent|0|||
160870062|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
160870063|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
160870064|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
160870065|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
160870066|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
160870067|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
160870068|NCT02405442|580917314|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
160870069|NCT02405442|580917315|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
160870070|NCT02405442|580917316|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
160870071|NCT02405442|580917317|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
160870072|NCT02405442|580917314|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
160870073|NCT02405442|580917315|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
160870074|NCT02405442|580917316|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
160870075|NCT02405442|580917317|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
160870076|NCT02405442|580917314|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
160870077|NCT02405442|580917315|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
160870078|NCT02405442|580917316|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
160870079|NCT02405442|580917317|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
160870080|NCT02405442|580917314|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
161113572|NCT00794157|581806556|FG002|Overall Study|Subject withdrew consent|3|||
161113573|NCT00794157|581806554|FG000|Overall Study|Lost to Follow-up|2|||
161113574|NCT00794157|581806555|FG001|Overall Study|Lost to Follow-up|0|||
161113575|NCT00794157|581806556|FG002|Overall Study|Lost to Follow-up|1|||
161113576|NCT00794157|581806554|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161113577|NCT00794157|581806555|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161113578|NCT00794157|581806556|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161113579|NCT00794157|581806554|FG000|Overall Study|Administrative problems|1|||
161113580|NCT00794157|581806555|FG001|Overall Study|Administrative problems|7|||
161113581|NCT00794157|581806556|FG002|Overall Study|Administrative problems|4|||
161113582|NCT00794157|581806554|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161113583|NCT00794157|581806555|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161113584|NCT00794157|581806556|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161113585|NCT00794157|581806554|FG000|Overall Study|Protocol deviation|0|||
161113586|NCT00794157|581806555|FG001|Overall Study|Protocol deviation|1|||
161113587|NCT00794157|581806556|FG002|Overall Study|Protocol deviation|1|||
161113588|NCT04486950|581806562|FG000|Overall Study|Lost to Follow-up|0|||
161113589|NCT04486950|581806563|FG001|Overall Study|Lost to Follow-up|0|||
161113590|NCT04486950|581806564|FG002|Overall Study|Lost to Follow-up|0|||
161113591|NCT04486950|581806565|FG003|Overall Study|Lost to Follow-up|0|||
161113592|NCT04486950|581806566|FG004|Overall Study|Lost to Follow-up|0|||
161113593|NCT04486950|581806567|FG005|Overall Study|Lost to Follow-up|1|||
161113594|NCT04486950|581806568|FG006|Overall Study|Lost to Follow-up|0|||
161113595|NCT02821715|581806569|FG000|Overall Study|Protocol Violation|1|||
161113596|NCT02821715|581806570|FG001|Overall Study|Protocol Violation|0|||
161113597|NCT02821715|581806571|FG002|Overall Study|Protocol Violation|0|||
161113598|NCT02821715|581806572|FG003|Overall Study|Protocol Violation|0|||
161113599|NCT02821715|581806573|FG004|Overall Study|Protocol Violation|0|||
161113600|NCT02821715|581806574|FG005|Overall Study|Protocol Violation|0|||
161113601|NCT00640328|581806575|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161113602|NCT00640328|581806576|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
161113603|NCT00640328|581806577|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161113604|NCT00640328|581806578|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161113605|NCT00640328|581806579|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161113606|NCT00640328|581806580|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
161113607|NCT00640328|581806575|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161113608|NCT00640328|581806576|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161113609|NCT00640328|581806577|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161113610|NCT00640328|581806578|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161113611|NCT00640328|581806579|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
161113612|NCT00640328|581806580|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
161113613|NCT00640328|581806575|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161113614|NCT00640328|581806576|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161113615|NCT00640328|581806577|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
161113616|NCT00640328|581806578|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161113617|NCT00640328|581806579|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161113618|NCT00640328|581806580|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
161113619|NCT00640328|581806575|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161113620|NCT00640328|581806576|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
161113621|NCT00640328|581806577|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161113622|NCT00640328|581806578|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
161113623|NCT00640328|581806579|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161113624|NCT00640328|581806580|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
161113625|NCT02374099|581806581|FG000|Overall Study|Adverse Event|1|||
161113626|NCT02374099|581806582|FG001|Overall Study|Adverse Event|0|||
161113627|NCT02374099|581806581|FG000|Overall Study|Progressive Disease|35|||
161113628|NCT02374099|581806582|FG001|Overall Study|Progressive Disease|40|||
161113629|NCT02374099|581806581|FG000|Overall Study|Withdrawal by Subject|5|||
161113630|NCT02374099|581806582|FG001|Overall Study|Withdrawal by Subject|1|||
161113631|NCT02374099|581806581|FG000|Overall Study|Miscellaneous|2|||
161113632|NCT02374099|581806582|FG001|Overall Study|Miscellaneous|3|||
161113633|NCT02374099|581806581|FG000|Overall Study|Randomized, but not treated|2|||
161113634|NCT02374099|581806582|FG001|Overall Study|Randomized, but not treated|1|||
161113635|NCT02374099|581806581|FG000|Overall Study|Study Terminated by Sponsor|3|||
161113636|NCT02374099|581806582|FG001|Overall Study|Study Terminated by Sponsor|4|||
161113637|NCT01033825|581806583|FG000|Overall Study|Withdrawal by Subject|2|||
161113638|NCT01033825|581806584|FG001|Overall Study|Withdrawal by Subject|3|||
161113639|NCT01033825|581806585|FG002|Overall Study|Withdrawal by Subject|2|||
161113640|NCT01033825|581806586|FG003|Overall Study|Withdrawal by Subject|1|||
161113641|NCT01033825|581806587|FG004|Overall Study|Withdrawal by Subject|1|||
161113642|NCT01033825|581806588|FG005|Overall Study|Withdrawal by Subject|0|||
161113643|NCT01033825|581806589|FG006|Overall Study|Withdrawal by Subject|0|||
161113644|NCT01033825|581806583|FG000|Overall Study|Adverse Event|0|||
161113645|NCT01033825|581806584|FG001|Overall Study|Adverse Event|0|||
161113646|NCT01033825|581806585|FG002|Overall Study|Adverse Event|0|||
161113647|NCT01033825|581806586|FG003|Overall Study|Adverse Event|1|||
161113648|NCT01033825|581806587|FG004|Overall Study|Adverse Event|0|||
161113649|NCT01033825|581806588|FG005|Overall Study|Adverse Event|0|||
161113650|NCT01033825|581806589|FG006|Overall Study|Adverse Event|0|||
161113651|NCT01033825|581806583|FG000|Overall Study|Protocol Violation|1|||
161113652|NCT01033825|581806584|FG001|Overall Study|Protocol Violation|0|||
161113653|NCT01033825|581806585|FG002|Overall Study|Protocol Violation|0|||
161113654|NCT01033825|581806586|FG003|Overall Study|Protocol Violation|0|||
161113655|NCT01033825|581806587|FG004|Overall Study|Protocol Violation|0|||
161113656|NCT01033825|581806588|FG005|Overall Study|Protocol Violation|0|||
161113657|NCT01033825|581806589|FG006|Overall Study|Protocol Violation|0|||
161113658|NCT01033825|581806583|FG000|Overall Study|Other|0|||
161113659|NCT01033825|581806584|FG001|Overall Study|Other|0|||
161113660|NCT01033825|581806585|FG002|Overall Study|Other|0|||
161113661|NCT01033825|581806586|FG003|Overall Study|Other|0|||
161113662|NCT01033825|581806587|FG004|Overall Study|Other|1|||
161113663|NCT01033825|581806588|FG005|Overall Study|Other|0|||
161113664|NCT01033825|581806589|FG006|Overall Study|Other|0|||
161113665|NCT04294719|581806590|FG000|Overall Study|Withdrawal by Subject|1|||
161113666|NCT01714687|581806591|FG000|Overall Study|Withdrawal by Subject|1|||
161113667|NCT01714687|581806592|FG001|Overall Study|Withdrawal by Subject|0|||
161113668|NCT01714687|581806591|FG000|Overall Study|Lost to Follow-up|2|||
161113669|NCT01714687|581806592|FG001|Overall Study|Lost to Follow-up|4|||
161113670|NCT00788372|581806593|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
161113671|NCT00788372|581806593|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
161113672|NCT00788372|581806593|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
161113673|NCT00788372|581806593|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
161113674|NCT00788372|581806593|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
161113675|NCT00788372|581806593|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
161113676|NCT00788372|581806593|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
161113677|NCT01464307|581806598|FG000|Main Period|Death|0|||
161113678|NCT01464307|581806599|FG001|Main Period|Death|1|||
161113679|NCT01464307|581806598|FG000|Main Period|Adverse Event|6|||
161113680|NCT01464307|581806599|FG001|Main Period|Adverse Event|1|||
161113681|NCT01464307|581806598|FG000|Main Period|Lack of Efficacy|2|||
161113682|NCT01464307|581806599|FG001|Main Period|Lack of Efficacy|0|||
161113683|NCT01464307|581806598|FG000|Main Period|Withdrawal by Subject|5|||
161113684|NCT01464307|581806599|FG001|Main Period|Withdrawal by Subject|2|||
161113685|NCT01464307|581806598|FG000|Main Period|Predefined discontinuation criteria|2|||
161113686|NCT01464307|581806599|FG001|Main Period|Predefined discontinuation criteria|1|||
161113687|NCT01464307|581806598|FG000|Open-Label Extension Period|Adverse Event|15|||
161113688|NCT01464307|581806599|FG001|Open-Label Extension Period|Adverse Event|0|||
161113689|NCT01464307|581806598|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
161218330|NCT04604184|582181316|FG001|Overall Study|Physician Decision|1|||
161113690|NCT01464307|581806599|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
161113691|NCT01464307|581806598|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
161113692|NCT01464307|581806599|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
161113693|NCT01464307|581806598|FG000|Open-Label Extension Period|Death|1|||
161113694|NCT01464307|581806599|FG001|Open-Label Extension Period|Death|0|||
161113695|NCT01464307|581806598|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161113696|NCT01464307|581806599|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
161218331|NCT04604184|582181315|FG000|Overall Study|Transfer to healthcare|1|||
160870081|NCT02405442|580917315|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
160870082|NCT02405442|580917316|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
160870083|NCT02405442|580917317|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
160870084|NCT03830892|580917321|FG000|Overall Study|Physician Decision|2|||
160870085|NCT03830892|580917322|FG001|Overall Study|Physician Decision|3|||
160870086|NCT03830892|580917321|FG000|Overall Study|Study terminated due to COVID|4|||
160870087|NCT03830892|580917322|FG001|Overall Study|Study terminated due to COVID|0|||
160870088|NCT03830892|580917321|FG000|Overall Study|Protocol Violation|0|||
160870089|NCT03830892|580917322|FG001|Overall Study|Protocol Violation|1|||
160870090|NCT03830892|580917321|FG000|Overall Study|Withdrawal by Subject|0|||
160870091|NCT03830892|580917322|FG001|Overall Study|Withdrawal by Subject|2|||
160870092|NCT01499277|580917323|FG000|Overall Study|Adverse Event|3|||
160870093|NCT01499277|580917324|FG001|Overall Study|Adverse Event|6|||
160870094|NCT01499277|580917323|FG000|Overall Study|Death|3|||
160870095|NCT01499277|580917324|FG001|Overall Study|Death|2|||
160870096|NCT01499277|580917323|FG000|Overall Study|Lost to Follow-up|15|||
160870097|NCT01499277|580917324|FG001|Overall Study|Lost to Follow-up|8|||
160870098|NCT01499277|580917323|FG000|Overall Study|Protocol Violation|2|||
160870099|NCT01499277|580917324|FG001|Overall Study|Protocol Violation|3|||
160870100|NCT01499277|580917323|FG000|Overall Study|Withdrawal by Subject|16|||
160870101|NCT01499277|580917324|FG001|Overall Study|Withdrawal by Subject|6|||
160870102|NCT01499277|580917323|FG000|Overall Study|Lack of therapeutic response and other|8|||
160870103|NCT01499277|580917324|FG001|Overall Study|Lack of therapeutic response and other|7|||
160870104|NCT00975689|580917325|FG000|Overall Study|Adverse Event|0|||
160870105|NCT00975689|580917326|FG001|Overall Study|Adverse Event|3|||
160870106|NCT00975689|580917325|FG000|Overall Study|Withdrawal by Subject|1|||
160870107|NCT00975689|580917326|FG001|Overall Study|Withdrawal by Subject|0|||
160870108|NCT00975689|580917325|FG000|Overall Study|Physician Decision|1|||
160870109|NCT00975689|580917326|FG001|Overall Study|Physician Decision|0|||
160870110|NCT00372593|580917329|FG000|Overall Study|Adverse Event|43|||
160870111|NCT00372593|580917330|FG001|Overall Study|Adverse Event|45|||
160870112|NCT00372593|580917331|FG002|Overall Study|Adverse Event|0|||
160870113|NCT00372593|580917329|FG000|Overall Study|Death|16|||
160870114|NCT00372593|580917330|FG001|Overall Study|Death|20|||
160870115|NCT00372593|580917331|FG002|Overall Study|Death|1|||
160870116|NCT00372593|580917329|FG000|Overall Study|Lack of Efficacy|82|||
160870117|NCT00372593|580917330|FG001|Overall Study|Lack of Efficacy|71|||
160870118|NCT00372593|580917331|FG002|Overall Study|Lack of Efficacy|2|||
160870119|NCT00372593|580917329|FG000|Overall Study|Lost to Follow-up|1|||
160870120|NCT00372593|580917330|FG001|Overall Study|Lost to Follow-up|0|||
161113697|NCT01464307|581806598|FG000|Open-Label Extension Period|Non-compliance|9|||
161113698|NCT01464307|581806599|FG001|Open-Label Extension Period|Non-compliance|0|||
161113699|NCT01464307|581806598|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
161113700|NCT01464307|581806599|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
161113701|NCT03099187|581806607|FG000|Double-blind Treatment|Adverse Event|19|||
161113702|NCT03099187|581806608|FG001|Double-blind Treatment|Adverse Event|1|||
161113703|NCT03099187|581806609|FG002|Double-blind Treatment|Adverse Event|0|||
161113704|NCT03099187|581806610|FG003|Double-blind Treatment|Adverse Event|0|||
161113705|NCT03099187|581806607|FG000|Double-blind Treatment|Death|1|||
161113706|NCT03099187|581806608|FG001|Double-blind Treatment|Death|3|||
161113707|NCT03099187|581806609|FG002|Double-blind Treatment|Death|0|||
161113708|NCT03099187|581806610|FG003|Double-blind Treatment|Death|0|||
161113709|NCT03099187|581806607|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161113710|NCT03099187|581806608|FG001|Double-blind Treatment|Lack of Efficacy|0|||
161113711|NCT03099187|581806609|FG002|Double-blind Treatment|Lack of Efficacy|0|||
161113712|NCT03099187|581806610|FG003|Double-blind Treatment|Lack of Efficacy|0|||
161113713|NCT03099187|581806607|FG000|Double-blind Treatment|Physician Decision|2|||
161113714|NCT03099187|581806608|FG001|Double-blind Treatment|Physician Decision|1|||
161113715|NCT03099187|581806609|FG002|Double-blind Treatment|Physician Decision|0|||
161218332|NCT04604184|582181316|FG001|Overall Study|Transfer to healthcare|0|||
160870121|NCT00372593|580917331|FG002|Overall Study|Lost to Follow-up|0|||
160870122|NCT00372593|580917329|FG000|Overall Study|Physician Decision|42|||
160870123|NCT00372593|580917330|FG001|Overall Study|Physician Decision|41|||
160870124|NCT00372593|580917331|FG002|Overall Study|Physician Decision|0|||
160870125|NCT00372593|580917329|FG000|Overall Study|Ineligible|20|||
160870126|NCT00372593|580917330|FG001|Overall Study|Ineligible|21|||
160870127|NCT00372593|580917331|FG002|Overall Study|Ineligible|1|||
160870128|NCT02974543|580917332|FG000|Overall Study|Withdrawal by Subject|1|||
160870129|NCT02974543|580917333|FG001|Overall Study|Withdrawal by Subject|0|||
160870130|NCT03534180|580917334|FG000|Overall Study|Withdrawal by Subject|1|||
160870131|NCT00220636|580917335|FG000|Overall Study|Withdrawal by Subject|4|||
160870132|NCT00330967|580917336|FG000|Overall Study|Withdrawal by Subject|0|||
160870133|NCT00330967|580917337|FG001|Overall Study|Withdrawal by Subject|5|||
160870134|NCT00330967|580917336|FG000|Overall Study|Physician Decision|0|||
161113716|NCT03099187|581806610|FG003|Double-blind Treatment|Physician Decision|0|||
161113717|NCT03099187|581806607|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
161218333|NCT00582036|582181317|FG000|Overall Study|Withdrawal by Subject|0|||
161113718|NCT03099187|581806608|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
161113719|NCT03099187|581806609|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
161113720|NCT03099187|581806610|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
161113721|NCT03099187|581806607|FG000|Double-blind Treatment|Lung transplantation|0|||
161113722|NCT03099187|581806608|FG001|Double-blind Treatment|Lung transplantation|1|||
161113723|NCT03099187|581806609|FG002|Double-blind Treatment|Lung transplantation|0|||
161113724|NCT03099187|581806610|FG003|Double-blind Treatment|Lung transplantation|0|||
161113725|NCT03099187|581806607|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
161113726|NCT03099187|581806608|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
161113727|NCT03099187|581806609|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
161113728|NCT03099187|581806610|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
161113729|NCT03099187|581806607|FG000|Double-blind Treatment|Disease progression|0|||
161113730|NCT03099187|581806608|FG001|Double-blind Treatment|Disease progression|1|||
161113731|NCT03099187|581806609|FG002|Double-blind Treatment|Disease progression|0|||
161113732|NCT03099187|581806610|FG003|Double-blind Treatment|Disease progression|0|||
161113733|NCT03099187|581806607|FG000|Double-blind Treatment|Randomization error|0|||
161113734|NCT03099187|581806608|FG001|Double-blind Treatment|Randomization error|2|||
161113735|NCT03099187|581806609|FG002|Double-blind Treatment|Randomization error|0|||
161113736|NCT03099187|581806610|FG003|Double-blind Treatment|Randomization error|0|||
161113737|NCT03099187|581806607|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
161113738|NCT03099187|581806608|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
161113739|NCT03099187|581806609|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
161113740|NCT03099187|581806610|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
161113741|NCT03099187|581806607|FG000|12-month Safety Follow-up|Adverse Event|0|||
161113742|NCT03099187|581806608|FG001|12-month Safety Follow-up|Adverse Event|0|||
161113743|NCT03099187|581806609|FG002|12-month Safety Follow-up|Adverse Event|5|||
161113744|NCT03099187|581806610|FG003|12-month Safety Follow-up|Adverse Event|12|||
161113745|NCT03099187|581806607|FG000|12-month Safety Follow-up|Death|0|||
161113746|NCT03099187|581806608|FG001|12-month Safety Follow-up|Death|0|||
161113747|NCT03099187|581806609|FG002|12-month Safety Follow-up|Death|7|||
161113748|NCT03099187|581806610|FG003|12-month Safety Follow-up|Death|9|||
161113749|NCT03099187|581806607|FG000|12-month Safety Follow-up|Lung transplantation|0|||
161113750|NCT03099187|581806608|FG001|12-month Safety Follow-up|Lung transplantation|0|||
161113751|NCT03099187|581806609|FG002|12-month Safety Follow-up|Lung transplantation|2|||
161113752|NCT03099187|581806610|FG003|12-month Safety Follow-up|Lung transplantation|1|||
161113753|NCT03099187|581806607|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
161113754|NCT03099187|581806608|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
161113755|NCT03099187|581806609|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
161113756|NCT03099187|581806610|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
161113757|NCT03099187|581806607|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
161113758|NCT03099187|581806608|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
161113759|NCT03099187|581806609|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
161113760|NCT03099187|581806610|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
161113761|NCT03099187|581806607|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
161113762|NCT03099187|581806608|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
161113763|NCT03099187|581806609|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
161113764|NCT03099187|581806610|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
161113765|NCT03099187|581806607|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
161113766|NCT03099187|581806608|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
161113767|NCT03099187|581806609|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
161324395|NCT02098395|582573584|FG000|Overall Study|Unclassified|0|||
161113768|NCT03099187|581806610|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
161113769|NCT03885089|581806611|FG000|Overall Study|No informed consent for publication of study results|2|||
161113770|NCT03349099|581806612|FG000|Overall Study|Physician Decision|3|||
161218334|NCT00582036|582181318|FG001|Overall Study|Withdrawal by Subject|1|||
161218335|NCT01625377|582181319|FG000|Overall Study|Death|1|||
161218336|NCT01625377|582181320|FG001|Overall Study|Death|1|||
161218337|NCT01625377|582181319|FG000|Overall Study|Administrative Problem|1|||
161218338|NCT01625377|582181320|FG001|Overall Study|Administrative Problem|1|||
161218339|NCT01625377|582181319|FG000|Overall Study|Protocol Violation|0|||
161218340|NCT01625377|582181320|FG001|Overall Study|Protocol Violation|3|||
161218341|NCT01625377|582181319|FG000|Overall Study|Adverse Event|3|||
161218342|NCT01625377|582181320|FG001|Overall Study|Adverse Event|16|||
161218343|NCT01625377|582181319|FG000|Overall Study|Graft loss|1|||
161218344|NCT01625377|582181320|FG001|Overall Study|Graft loss|0|||
161218345|NCT01625377|582181319|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161218346|NCT01625377|582181320|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161218347|NCT01625377|582181319|FG000|Overall Study|Abnormal laboratory values|1|||
161218348|NCT01625377|582181320|FG001|Overall Study|Abnormal laboratory values|0|||
161218349|NCT01090765|582181323|FG000|Overall Study|Patient withdrew consent|0|||
161218350|NCT01090765|582181324|FG001|Overall Study|Patient withdrew consent|0|||
161218351|NCT01090765|582181325|FG002|Overall Study|Patient withdrew consent|0|||
161218352|NCT01090765|582181326|FG003|Overall Study|Patient withdrew consent|0|||
161218353|NCT01090765|582181327|FG004|Overall Study|Patient withdrew consent|1|||
161218354|NCT01090765|582181328|FG005|Overall Study|Patient withdrew consent|1|||
161218355|NCT01090765|582181323|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
161218356|NCT01090765|582181324|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
161218357|NCT01090765|582181325|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
161218358|NCT01090765|582181326|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
161218359|NCT01090765|582181327|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
161218360|NCT01090765|582181328|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
161218361|NCT01090765|582181323|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
161218362|NCT01090765|582181324|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
161218363|NCT01090765|582181325|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
161218364|NCT01090765|582181326|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
161218365|NCT01090765|582181327|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
161218366|NCT01090765|582181328|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
161218367|NCT00678392|582181329|FG000|Overall Study|Adverse Event|0|||
161218368|NCT00678392|582181330|FG001|Overall Study|Adverse Event|6|||
161218369|NCT00678392|582181329|FG000|Overall Study|Death|280|||
161218370|NCT00678392|582181330|FG001|Overall Study|Death|269|||
161218371|NCT00678392|582181329|FG000|Overall Study|Lost to Follow-up|15|||
161218372|NCT00678392|582181330|FG001|Overall Study|Lost to Follow-up|13|||
161218373|NCT00678392|582181329|FG000|Overall Study|Objective Progression or Relapse|3|||
161218374|NCT00678392|582181330|FG001|Overall Study|Objective Progression or Relapse|8|||
161218375|NCT00678392|582181329|FG000|Overall Study|Sponsor's Decision|1|||
161218376|NCT00678392|582181330|FG001|Overall Study|Sponsor's Decision|2|||
161218377|NCT00678392|582181329|FG000|Overall Study|Withdrawal by Subject|4|||
161218378|NCT00678392|582181330|FG001|Overall Study|Withdrawal by Subject|4|||
161218379|NCT00678392|582181329|FG000|Overall Study|Randomized But Not Treated|2|||
161218380|NCT00678392|582181330|FG001|Overall Study|Randomized But Not Treated|7|||
161218381|NCT00678392|582181329|FG000|Overall Study|Other|56|||
161218382|NCT00678392|582181330|FG001|Overall Study|Other|53|||
161218383|NCT03341507|582181331|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
161218384|NCT01787825|582181332|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
161218385|NCT01787825|582181333|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
161218386|NCT01787825|582181332|FG000|Overall Study|Data Not Analyzable|5|||
161218387|NCT01787825|582181333|FG001|Overall Study|Data Not Analyzable|1|||
161218388|NCT00718159|582181335|FG000|Overall Study|Progressive Disease|3|||
161218389|NCT00718159|582181336|FG001|Overall Study|Progressive Disease|3|||
161218390|NCT00718159|582181337|FG002|Overall Study|Progressive Disease|2|||
161218391|NCT00718159|582181338|FG003|Overall Study|Progressive Disease|0|||
161218392|NCT00718159|582181339|FG004|Overall Study|Progressive Disease|6|||
161218393|NCT00718159|582181340|FG005|Overall Study|Progressive Disease|0|||
161218394|NCT00718159|582181341|FG006|Overall Study|Progressive Disease|0|||
160870135|NCT00330967|580917337|FG001|Overall Study|Physician Decision|9|||
160870136|NCT01237899|580917338|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
160870137|NCT01237899|580917339|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
160870138|NCT01237899|580917340|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
161218395|NCT00718159|582181335|FG000|Overall Study|Death due to Adverse Event|0|||
161218396|NCT00718159|582181336|FG001|Overall Study|Death due to Adverse Event|0|||
160870139|NCT01237899|580917341|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
161218397|NCT00718159|582181337|FG002|Overall Study|Death due to Adverse Event|0|||
161218398|NCT00718159|582181338|FG003|Overall Study|Death due to Adverse Event|2|||
161218399|NCT00718159|582181339|FG004|Overall Study|Death due to Adverse Event|2|||
161218400|NCT00718159|582181340|FG005|Overall Study|Death due to Adverse Event|0|||
161218401|NCT00718159|582181341|FG006|Overall Study|Death due to Adverse Event|0|||
160870140|NCT01237899|580917342|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
161218402|NCT00718159|582181335|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
161218403|NCT00718159|582181336|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
161218404|NCT00718159|582181337|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
161218405|NCT00718159|582181338|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
161113771|NCT03349099|581806613|FG001|Overall Study|Physician Decision|4|||
161113772|NCT03349099|581806612|FG000|Overall Study|Stone migrated from the kidney|1|||
161113773|NCT03349099|581806613|FG001|Overall Study|Stone migrated from the kidney|0|||
161113774|NCT00278993|581806614|FG000|Overall Study|Adverse Event|24|||
161113775|NCT00278993|581806614|FG000|Overall Study|Withdrawal by Subject|5|||
161113776|NCT00278993|581806614|FG000|Overall Study|Progressive Disease|65|||
161113777|NCT00278993|581806614|FG000|Overall Study|Physician Decision|9|||
161113778|NCT00278993|581806614|FG000|Overall Study|Not Otherwise Specified|4|||
161113779|NCT04194528|581806615|FG000|Overall Study|Adverse Event|1|||
161113780|NCT00528021|581806617|FG000|Overall Study|Lack of Efficacy|17|||
161113781|NCT00528021|581806618|FG001|Overall Study|Lack of Efficacy|13|||
161113782|NCT00528021|581806619|FG002|Overall Study|Lack of Efficacy|7|||
161113783|NCT00528021|581806620|FG003|Overall Study|Lack of Efficacy|9|||
161113784|NCT03921424|581806627|FG000|Overall Study|Lost to Follow-up|0|||
161113785|NCT03921424|581806628|FG001|Overall Study|Lost to Follow-up|1|||
161113786|NCT03921424|581806627|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161113787|NCT03921424|581806628|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161113788|NCT01246583|581806637|FG000|Overall Study|Lost to Follow-up|0|||
161113789|NCT01246583|581806638|FG001|Overall Study|Lost to Follow-up|0|||
161113790|NCT01246583|581806639|FG002|Overall Study|Lost to Follow-up|0|||
161113791|NCT01246583|581806640|FG003|Overall Study|Lost to Follow-up|1|||
161113792|NCT01246583|581806637|FG000|Overall Study|Protocol Violation|0|||
161113793|NCT01246583|581806638|FG001|Overall Study|Protocol Violation|0|||
161113794|NCT01246583|581806639|FG002|Overall Study|Protocol Violation|1|||
161113795|NCT01246583|581806640|FG003|Overall Study|Protocol Violation|0|||
161113796|NCT01246583|581806637|FG000|Overall Study|Withdrawal by Subject|1|||
161113797|NCT01246583|581806638|FG001|Overall Study|Withdrawal by Subject|0|||
161113798|NCT01246583|581806639|FG002|Overall Study|Withdrawal by Subject|0|||
161113799|NCT01246583|581806640|FG003|Overall Study|Withdrawal by Subject|0|||
161113800|NCT05054114|581806644|FG000|Overall Study|Protocol Violation|13|||
161113801|NCT05054114|581806645|FG001|Overall Study|Protocol Violation|1|||
161113802|NCT05054114|581806644|FG000|Overall Study|Pregnancy|0|||
161113803|NCT05054114|581806645|FG001|Overall Study|Pregnancy|1|||
161113804|NCT01806779|581806646|FG000|Overall Study|Physician Decision|2|||
161113805|NCT01806779|581806647|FG001|Overall Study|Physician Decision|0|||
161113806|NCT01806779|581806648|FG002|Overall Study|Physician Decision|1|||
161113807|NCT01806779|581806646|FG000|Overall Study|Lack of Efficacy|1|||
161113808|NCT01806779|581806647|FG001|Overall Study|Lack of Efficacy|1|||
161113809|NCT01806779|581806648|FG002|Overall Study|Lack of Efficacy|0|||
161113810|NCT01806779|581806646|FG000|Overall Study|Lost to Follow-up|19|||
161113811|NCT01806779|581806647|FG001|Overall Study|Lost to Follow-up|20|||
161113812|NCT01806779|581806648|FG002|Overall Study|Lost to Follow-up|0|||
161113813|NCT01806779|581806646|FG000|Overall Study|Withdrawal by Subject|20|||
161113814|NCT01806779|581806647|FG001|Overall Study|Withdrawal by Subject|23|||
161113815|NCT01806779|581806648|FG002|Overall Study|Withdrawal by Subject|22|||
161113816|NCT00805480|581806649|FG000|Overall Study|Withdrawal by Subject|13|||
161113817|NCT00805480|581806650|FG001|Overall Study|Withdrawal by Subject|5|||
161113818|NCT00805480|581806651|FG002|Overall Study|Withdrawal by Subject|11|||
161113819|NCT00805480|581806652|FG003|Overall Study|Withdrawal by Subject|5|||
161113820|NCT00805480|581806649|FG000|Overall Study|Lost to Follow-up|1|||
161113821|NCT00805480|581806650|FG001|Overall Study|Lost to Follow-up|2|||
161113822|NCT00805480|581806651|FG002|Overall Study|Lost to Follow-up|0|||
161113823|NCT00805480|581806652|FG003|Overall Study|Lost to Follow-up|0|||
161113824|NCT00805480|581806649|FG000|Overall Study|Adverse Event|0|||
161113825|NCT00805480|581806650|FG001|Overall Study|Adverse Event|0|||
161113826|NCT00805480|581806651|FG002|Overall Study|Adverse Event|1|||
161113827|NCT00805480|581806652|FG003|Overall Study|Adverse Event|0|||
161113828|NCT02595450|581806655|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
161113829|NCT02595450|581806655|FG000|Overall Study|Enrolled, but not treated|8|||
161218406|NCT00718159|582181339|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
161113830|NCT03077685|581806659|FG000|Overall Study|Lost to Follow-up|0|||
161113831|NCT03077685|581806660|FG001|Overall Study|Lost to Follow-up|0|||
161113832|NCT03077685|581806661|FG002|Overall Study|Lost to Follow-up|0|||
161113833|NCT03077685|581806662|FG003|Overall Study|Lost to Follow-up|0|||
161113834|NCT03077685|581806663|FG004|Overall Study|Lost to Follow-up|1|||
161113835|NCT03077685|581806659|FG000|Overall Study|Death|0|||
161113836|NCT03077685|581806660|FG001|Overall Study|Death|0|||
161113837|NCT03077685|581806661|FG002|Overall Study|Death|1|||
161113838|NCT03077685|581806662|FG003|Overall Study|Death|1|||
161113839|NCT03077685|581806663|FG004|Overall Study|Death|3|||
161113840|NCT03077685|581806659|FG000|Overall Study|Withdrawal by Subject|0|||
161113841|NCT03077685|581806660|FG001|Overall Study|Withdrawal by Subject|0|||
161113842|NCT03077685|581806661|FG002|Overall Study|Withdrawal by Subject|0|||
160870141|NCT01237899|580917343|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
160870142|NCT01237899|580917344|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
160870143|NCT01237899|580917345|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
160870144|NCT01237899|580917346|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
160870145|NCT01237899|580917347|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
160870146|NCT01237899|580917348|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
160870147|NCT00790088|580917349|FG000|Overall Study|Protocol Violation|11|||
160870148|NCT00790088|580917349|FG000|Overall Study|Withdrawal by Subject|17|||
160870149|NCT00790088|580917349|FG000|Overall Study|Lost to Follow-up|7|||
160870150|NCT00790088|580917349|FG000|Overall Study|Physician Decision|4|||
160870151|NCT00337675|580917350|FG000|Overall Study|Adverse Event|10|||
160870152|NCT00337675|580917351|FG001|Overall Study|Adverse Event|9|||
160870153|NCT00337675|580917352|FG002|Overall Study|Adverse Event|19|||
160870154|NCT00337675|580917350|FG000|Overall Study|Lack of Efficacy|10|||
160870155|NCT00337675|580917351|FG001|Overall Study|Lack of Efficacy|7|||
160870156|NCT00337675|580917352|FG002|Overall Study|Lack of Efficacy|9|||
160870157|NCT00337675|580917350|FG000|Overall Study|Lost to Follow-up|22|||
160870158|NCT00337675|580917351|FG001|Overall Study|Lost to Follow-up|19|||
160870159|NCT00337675|580917352|FG002|Overall Study|Lost to Follow-up|17|||
160870160|NCT00337675|580917350|FG000|Overall Study|Physician Decision|9|||
160870161|NCT00337675|580917351|FG001|Overall Study|Physician Decision|17|||
160870162|NCT00337675|580917352|FG002|Overall Study|Physician Decision|14|||
161113843|NCT03077685|581806662|FG003|Overall Study|Withdrawal by Subject|2|||
161113844|NCT03077685|581806663|FG004|Overall Study|Withdrawal by Subject|1|||
161113845|NCT03077685|581806659|FG000|Overall Study|Physician Decision|0|||
161113846|NCT03077685|581806660|FG001|Overall Study|Physician Decision|0|||
161113847|NCT03077685|581806661|FG002|Overall Study|Physician Decision|1|||
161113848|NCT03077685|581806662|FG003|Overall Study|Physician Decision|0|||
161113849|NCT03077685|581806663|FG004|Overall Study|Physician Decision|3|||
161113850|NCT03077685|581806659|FG000|Overall Study|Disease Progression|1|||
161113851|NCT03077685|581806660|FG001|Overall Study|Disease Progression|0|||
161113852|NCT03077685|581806661|FG002|Overall Study|Disease Progression|0|||
161113853|NCT03077685|581806662|FG003|Overall Study|Disease Progression|2|||
161113854|NCT03077685|581806663|FG004|Overall Study|Disease Progression|1|||
161113855|NCT03077685|581806659|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
161113856|NCT03077685|581806660|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
161113857|NCT03077685|581806661|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
161113858|NCT03077685|581806662|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
161113859|NCT03077685|581806663|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
161113860|NCT03077685|581806659|FG000|Overall Study|Subject entered hospice care|0|||
161113861|NCT03077685|581806660|FG001|Overall Study|Subject entered hospice care|0|||
161113862|NCT03077685|581806661|FG002|Overall Study|Subject entered hospice care|0|||
161113863|NCT03077685|581806662|FG003|Overall Study|Subject entered hospice care|0|||
161113864|NCT03077685|581806663|FG004|Overall Study|Subject entered hospice care|1|||
161113865|NCT02116777|581806664|FG000|Overall Study|Adverse Event|0|||
160870163|NCT00337675|580917350|FG000|Overall Study|Protocol Violation|21|||
161113866|NCT02116777|581806665|FG001|Overall Study|Adverse Event|0|||
161113867|NCT02116777|581806666|FG002|Overall Study|Adverse Event|0|||
161113868|NCT02116777|581806667|FG003|Overall Study|Adverse Event|0|||
161113869|NCT02116777|581806668|FG004|Overall Study|Adverse Event|2|||
161113870|NCT02116777|581806669|FG005|Overall Study|Adverse Event|2|||
161113871|NCT02116777|581806670|FG006|Overall Study|Adverse Event|0|||
161113872|NCT02116777|581806664|FG000|Overall Study|Death|0|||
161113873|NCT02116777|581806665|FG001|Overall Study|Death|0|||
161113874|NCT02116777|581806666|FG002|Overall Study|Death|0|||
161113875|NCT02116777|581806667|FG003|Overall Study|Death|1|||
161113876|NCT02116777|581806668|FG004|Overall Study|Death|0|||
161113877|NCT02116777|581806669|FG005|Overall Study|Death|0|||
161113878|NCT02116777|581806670|FG006|Overall Study|Death|0|||
161113879|NCT02116777|581806664|FG000|Overall Study|Lack of Efficacy|3|||
161113880|NCT02116777|581806665|FG001|Overall Study|Lack of Efficacy|3|||
161113881|NCT02116777|581806666|FG002|Overall Study|Lack of Efficacy|3|||
161113882|NCT02116777|581806667|FG003|Overall Study|Lack of Efficacy|8|||
161113883|NCT02116777|581806668|FG004|Overall Study|Lack of Efficacy|4|||
161113884|NCT02116777|581806669|FG005|Overall Study|Lack of Efficacy|1|||
161113885|NCT02116777|581806670|FG006|Overall Study|Lack of Efficacy|9|||
161113886|NCT02116777|581806664|FG000|Overall Study|Physician Decision|0|||
160870164|NCT00337675|580917351|FG001|Overall Study|Protocol Violation|24|||
160870165|NCT00337675|580917352|FG002|Overall Study|Protocol Violation|19|||
160870166|NCT00337675|580917350|FG000|Overall Study|Withdrawal by Subject|25|||
160870167|NCT00337675|580917351|FG001|Overall Study|Withdrawal by Subject|25|||
160870168|NCT00337675|580917352|FG002|Overall Study|Withdrawal by Subject|19|||
161113887|NCT02116777|581806665|FG001|Overall Study|Physician Decision|0|||
161113888|NCT02116777|581806666|FG002|Overall Study|Physician Decision|0|||
161113889|NCT02116777|581806667|FG003|Overall Study|Physician Decision|2|||
161113890|NCT02116777|581806668|FG004|Overall Study|Physician Decision|0|||
161113891|NCT02116777|581806669|FG005|Overall Study|Physician Decision|0|||
161113892|NCT02116777|581806670|FG006|Overall Study|Physician Decision|0|||
161113893|NCT02116777|581806664|FG000|Overall Study|Protocol Violation|0|||
161113894|NCT02116777|581806665|FG001|Overall Study|Protocol Violation|0|||
161113895|NCT02116777|581806666|FG002|Overall Study|Protocol Violation|0|||
161113896|NCT02116777|581806667|FG003|Overall Study|Protocol Violation|1|||
161113897|NCT02116777|581806668|FG004|Overall Study|Protocol Violation|0|||
161113898|NCT02116777|581806669|FG005|Overall Study|Protocol Violation|0|||
161113899|NCT02116777|581806670|FG006|Overall Study|Protocol Violation|0|||
161113900|NCT02116777|581806664|FG000|Overall Study|Withdrawal by Subject|0|||
161113901|NCT02116777|581806665|FG001|Overall Study|Withdrawal by Subject|0|||
161113902|NCT02116777|581806666|FG002|Overall Study|Withdrawal by Subject|0|||
161113903|NCT02116777|581806667|FG003|Overall Study|Withdrawal by Subject|1|||
161113904|NCT02116777|581806668|FG004|Overall Study|Withdrawal by Subject|0|||
161113905|NCT02116777|581806669|FG005|Overall Study|Withdrawal by Subject|0|||
161113906|NCT02116777|581806670|FG006|Overall Study|Withdrawal by Subject|0|||
161113907|NCT00102960|581806673|FG000|Overall Study|Death|23|||
161113908|NCT00102960|581806674|FG001|Overall Study|Death|11|||
161113909|NCT00102960|581806675|FG002|Overall Study|Death|11|||
161113910|NCT00102960|581806673|FG000|Overall Study|Lost to Follow-up|6|||
161113911|NCT00102960|581806674|FG001|Overall Study|Lost to Follow-up|12|||
161113912|NCT00102960|581806675|FG002|Overall Study|Lost to Follow-up|16|||
161113913|NCT00102960|581806673|FG000|Overall Study|Withdrawal by Subject|1|||
161113914|NCT00102960|581806674|FG001|Overall Study|Withdrawal by Subject|0|||
161113915|NCT00102960|581806675|FG002|Overall Study|Withdrawal by Subject|1|||
161113916|NCT03770260|581808285|FG000|Overall Study|Disease progression|0|||
161113917|NCT03770260|581808286|FG001|Overall Study|Disease progression|1|||
161113918|NCT03770260|581808287|FG002|Overall Study|Disease progression|0|||
161113919|NCT03770260|581808288|FG003|Overall Study|Disease progression|0|||
161113920|NCT03040999|581808289|FG000|Overall Study|Lost to Follow-up|2|||
161113921|NCT03040999|581808290|FG001|Overall Study|Lost to Follow-up|2|||
161113922|NCT03040999|581808289|FG000|Overall Study|Withdrawal by Subject|12|||
161113923|NCT03040999|581808290|FG001|Overall Study|Withdrawal by Subject|13|||
161113924|NCT03040999|581808289|FG000|Overall Study|Death|155|||
161113925|NCT03040999|581808290|FG001|Overall Study|Death|171|||
161113926|NCT03040999|581808289|FG000|Overall Study|Physician Decision|0|||
161113927|NCT03040999|581808290|FG001|Overall Study|Physician Decision|3|||
161113928|NCT01395394|581808291|FG000|Baseline Study Visit|Protocol Violation|1|||
161113929|NCT01395394|581808292|FG001|Baseline Study Visit|Protocol Violation|0|||
161113930|NCT01395394|581808293|FG002|Baseline Study Visit|Protocol Violation|0|||
161113931|NCT05121480|581808294|FG000|Overall Study|Lack of Efficacy|2|||
161113932|NCT05121480|581808295|FG001|Overall Study|Lack of Efficacy|2|||
161113933|NCT05121480|581808296|FG002|Overall Study|Lack of Efficacy|1|||
161113934|NCT05121480|581808297|FG003|Overall Study|Lack of Efficacy|4|||
161113935|NCT05121480|581808298|FG004|Overall Study|Lack of Efficacy|0|||
161113936|NCT05121480|581808299|FG005|Overall Study|Lack of Efficacy|1|||
161113937|NCT05121480|581808300|FG006|Overall Study|Lack of Efficacy|0|||
161113938|NCT05121480|581808301|FG007|Overall Study|Lack of Efficacy|2|||
161113939|NCT05121480|581808294|FG000|Overall Study|Treatment Failure|0|||
161113940|NCT05121480|581808295|FG001|Overall Study|Treatment Failure|2|||
161113941|NCT05121480|581808296|FG002|Overall Study|Treatment Failure|0|||
161113942|NCT05121480|581808297|FG003|Overall Study|Treatment Failure|1|||
161113943|NCT05121480|581808298|FG004|Overall Study|Treatment Failure|0|||
161113944|NCT05121480|581808299|FG005|Overall Study|Treatment Failure|0|||
161113945|NCT05121480|581808300|FG006|Overall Study|Treatment Failure|0|||
161113946|NCT05121480|581808301|FG007|Overall Study|Treatment Failure|0|||
161113947|NCT05121480|581808294|FG000|Overall Study|Adverse Event|0|||
161113948|NCT05121480|581808295|FG001|Overall Study|Adverse Event|1|||
161113949|NCT05121480|581808296|FG002|Overall Study|Adverse Event|0|||
161113950|NCT05121480|581808297|FG003|Overall Study|Adverse Event|5|||
161113951|NCT05121480|581808298|FG004|Overall Study|Adverse Event|3|||
161113952|NCT05121480|581808299|FG005|Overall Study|Adverse Event|2|||
161113953|NCT05121480|581808300|FG006|Overall Study|Adverse Event|0|||
161113954|NCT05121480|581808301|FG007|Overall Study|Adverse Event|4|||
161113955|NCT05121480|581808294|FG000|Overall Study|Withdrawal by Subject|4|||
161113956|NCT05121480|581808295|FG001|Overall Study|Withdrawal by Subject|9|||
161113957|NCT05121480|581808296|FG002|Overall Study|Withdrawal by Subject|1|||
161218407|NCT00718159|582181340|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
161218408|NCT00718159|582181341|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
161113958|NCT05121480|581808297|FG003|Overall Study|Withdrawal by Subject|8|||
161113959|NCT05121480|581808298|FG004|Overall Study|Withdrawal by Subject|0|||
161113960|NCT05121480|581808299|FG005|Overall Study|Withdrawal by Subject|9|||
161113961|NCT05121480|581808300|FG006|Overall Study|Withdrawal by Subject|0|||
161113962|NCT05121480|581808301|FG007|Overall Study|Withdrawal by Subject|4|||
161113963|NCT05121480|581808294|FG000|Overall Study|Non-compliance with the protocol|0|||
161113964|NCT05121480|581808295|FG001|Overall Study|Non-compliance with the protocol|0|||
161113965|NCT05121480|581808296|FG002|Overall Study|Non-compliance with the protocol|0|||
161113966|NCT05121480|581808297|FG003|Overall Study|Non-compliance with the protocol|0|||
161113967|NCT05121480|581808298|FG004|Overall Study|Non-compliance with the protocol|1|||
161113968|NCT05121480|581808299|FG005|Overall Study|Non-compliance with the protocol|6|||
161218409|NCT00718159|582181335|FG000|Overall Study|Investigator Decision|0|||
161218410|NCT00718159|582181336|FG001|Overall Study|Investigator Decision|0|||
161218411|NCT00718159|582181337|FG002|Overall Study|Investigator Decision|0|||
161218412|NCT00718159|582181338|FG003|Overall Study|Investigator Decision|0|||
161218413|NCT00718159|582181339|FG004|Overall Study|Investigator Decision|0|||
161218414|NCT00718159|582181340|FG005|Overall Study|Investigator Decision|1|||
161218415|NCT00718159|582181341|FG006|Overall Study|Investigator Decision|1|||
161218416|NCT01401478|582181353|FG000|Overall Study|Study drug not available|6|||
161218417|NCT01401478|582181353|FG000|Overall Study|Adverse Event|5|||
161218418|NCT01401478|582181353|FG000|Overall Study|Hyperphosphatemia|5|||
161218419|NCT01401478|582181353|FG000|Overall Study|Lost to Follow-up|5|||
161218420|NCT01401478|582181353|FG000|Overall Study|Kidney transplantation|3|||
161218421|NCT01401478|582181353|FG000|Overall Study|Withdrawal by Subject|3|||
161218422|NCT01401478|582181353|FG000|Overall Study|Blood samples not available|1|||
161218423|NCT01401478|582181353|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
161218424|NCT01401478|582181353|FG000|Overall Study|Low intact parathyroid hormone|1|||
161218425|NCT01401478|582181353|FG000|Overall Study|Serious adverse event|1|||
161218426|NCT01814137|582181355|FG000|Overall Study|Adverse Event|0|||
161218427|NCT01814137|582181356|FG001|Overall Study|Adverse Event|1|||
161218428|NCT01814137|582181355|FG000|Overall Study|Withdrawal by Subject|2|||
161218429|NCT01814137|582181356|FG001|Overall Study|Withdrawal by Subject|2|||
161218430|NCT01814137|582181355|FG000|Overall Study|Physician Decision|1|||
161218431|NCT01814137|582181356|FG001|Overall Study|Physician Decision|1|||
161218432|NCT01814137|582181355|FG000|Overall Study|Unclassified|2|||
161218433|NCT01814137|582181356|FG001|Overall Study|Unclassified|1|||
161218434|NCT03412019|582181357|FG000|Overall Study|Withdrawal by Subject|1|||
161218435|NCT03412019|582181358|FG001|Overall Study|Withdrawal by Subject|1|||
161218436|NCT00415532|582181359|FG000|Treatment Period|Adverse Event|2|||
161218437|NCT00415532|582181360|FG001|Treatment Period|Adverse Event|3|||
161218438|NCT00415532|582181359|FG000|Treatment Period|Death|2|||
161218439|NCT00415532|582181360|FG001|Treatment Period|Death|1|||
161218440|NCT00415532|582181359|FG000|Treatment Period|Lost to Follow-up|1|||
161218441|NCT00415532|582181360|FG001|Treatment Period|Lost to Follow-up|1|||
161218442|NCT00415532|582181359|FG000|Treatment Period|Protocol Violation|1|||
161218443|NCT00415532|582181360|FG001|Treatment Period|Protocol Violation|0|||
161218444|NCT00415532|582181359|FG000|Treatment Period|Withdrawal by Subject|6|||
161218445|NCT00415532|582181360|FG001|Treatment Period|Withdrawal by Subject|6|||
161218446|NCT00415532|582181359|FG000|Treatment Period|Other|2|||
161218447|NCT00415532|582181360|FG001|Treatment Period|Other|2|||
161218448|NCT00415532|582181359|FG000|Treatment Period|Ineligibility determined|1|||
161218449|NCT00415532|582181360|FG001|Treatment Period|Ineligibility determined|1|||
161218450|NCT00415532|582181359|FG000|Treatment Period|Noncompliance|1|||
161218451|NCT00415532|582181360|FG001|Treatment Period|Noncompliance|1|||
161218452|NCT00415532|582181359|FG000|Treatment Period|Requirement for alternative therapy|1|||
161218453|NCT00415532|582181360|FG001|Treatment Period|Requirement for alternative therapy|0|||
161218454|NCT00415532|582181359|FG000|Safety Follow Up Period|Adverse Event|1|||
161218455|NCT00415532|582181360|FG001|Safety Follow Up Period|Adverse Event|3|||
161218456|NCT00415532|582181359|FG000|Safety Follow Up Period|Death|3|||
161218457|NCT00415532|582181360|FG001|Safety Follow Up Period|Death|0|||
161218458|NCT00415532|582181359|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
161218459|NCT00415532|582181360|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
161218460|NCT00415532|582181359|FG000|Safety Follow Up Period|Other|1|||
161218461|NCT00415532|582181360|FG001|Safety Follow Up Period|Other|4|||
161218462|NCT00415532|582181359|FG000|Safety Follow Up Period|Ineligibility determined|1|||
161218463|NCT00415532|582181360|FG001|Safety Follow Up Period|Ineligibility determined|1|||
161218464|NCT00415532|582181359|FG000|Safety Follow Up Period|Noncompliance|1|||
161218465|NCT00415532|582181360|FG001|Safety Follow Up Period|Noncompliance|0|||
161218466|NCT00415532|582181359|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
161218467|NCT00415532|582181360|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
161218468|NCT01952574|582181361|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
161218469|NCT01952574|582181362|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
161218470|NCT01952574|582181363|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
161218471|NCT01952574|582181364|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
161218472|NCT01952574|582181365|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161218473|NCT01952574|582181366|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161218474|NCT01952574|582181367|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161218475|NCT01952574|582181361|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
161218476|NCT01952574|582181362|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
161218477|NCT01952574|582181363|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
161218478|NCT01952574|582181364|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
161218479|NCT01952574|582181365|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
161218480|NCT01952574|582181366|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
161218481|NCT01952574|582181367|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
161218482|NCT01952574|582181361|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
160870169|NCT00337675|580917350|FG000|Overall Study|Progressive Disease|0|||
160870170|NCT00337675|580917351|FG001|Overall Study|Progressive Disease|2|||
160870171|NCT00337675|580917352|FG002|Overall Study|Progressive Disease|0|||
160870172|NCT00337675|580917350|FG000|Overall Study|Trial Terminated|0|||
160870173|NCT00337675|580917351|FG001|Overall Study|Trial Terminated|0|||
160870174|NCT00337675|580917352|FG002|Overall Study|Trial Terminated|2|||
160870175|NCT02015637|580917356|FG000|Overall Study|Lost to Follow-up|3|||
160870176|NCT02015637|580917357|FG001|Overall Study|Lost to Follow-up|5|||
160870177|NCT02015637|580917356|FG000|Overall Study|Adverse Event|3|||
160870178|NCT02015637|580917357|FG001|Overall Study|Adverse Event|0|||
160870179|NCT02015637|580917356|FG000|Overall Study|Did not take study drug|2|||
160870180|NCT02015637|580917357|FG001|Overall Study|Did not take study drug|0|||
160870181|NCT03682770|580917370|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870182|NCT03682770|580917371|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
160870183|NCT03682770|580917372|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870184|NCT03682770|580917373|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870185|NCT03682770|580917374|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870186|NCT03682770|580917375|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870187|NCT03682770|580917376|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
160870188|NCT03682770|580917370|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
160870189|NCT03682770|580917371|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
160870190|NCT03682770|580917372|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160870191|NCT03682770|580917373|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160870192|NCT03682770|580917374|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
160870193|NCT03682770|580917375|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161113969|NCT05121480|581808300|FG006|Overall Study|Non-compliance with the protocol|0|||
161113970|NCT05121480|581808301|FG007|Overall Study|Non-compliance with the protocol|1|||
161113971|NCT05121480|581808294|FG000|Overall Study|Lost to Follow-up|0|||
161113972|NCT05121480|581808295|FG001|Overall Study|Lost to Follow-up|4|||
161113973|NCT05121480|581808296|FG002|Overall Study|Lost to Follow-up|1|||
161113974|NCT05121480|581808297|FG003|Overall Study|Lost to Follow-up|3|||
161113975|NCT05121480|581808298|FG004|Overall Study|Lost to Follow-up|1|||
161113976|NCT05121480|581808299|FG005|Overall Study|Lost to Follow-up|1|||
161113977|NCT05121480|581808300|FG006|Overall Study|Lost to Follow-up|1|||
161113978|NCT05121480|581808301|FG007|Overall Study|Lost to Follow-up|4|||
161113979|NCT05121480|581808294|FG000|Overall Study|Physician Decision|0|||
161113980|NCT05121480|581808295|FG001|Overall Study|Physician Decision|0|||
161113981|NCT05121480|581808296|FG002|Overall Study|Physician Decision|0|||
161218483|NCT01952574|582181362|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
161218484|NCT01952574|582181363|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
161218485|NCT01952574|582181364|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
160870194|NCT03682770|580917376|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
161113982|NCT05121480|581808297|FG003|Overall Study|Physician Decision|0|||
161113983|NCT05121480|581808298|FG004|Overall Study|Physician Decision|0|||
161113984|NCT05121480|581808299|FG005|Overall Study|Physician Decision|1|||
161113985|NCT05121480|581808300|FG006|Overall Study|Physician Decision|0|||
161113986|NCT05121480|581808301|FG007|Overall Study|Physician Decision|1|||
161218486|NCT01952574|582181365|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
160870195|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161113987|NCT05121480|581808294|FG000|Overall Study|Other Reason|0|||
161113988|NCT05121480|581808295|FG001|Overall Study|Other Reason|0|||
161113989|NCT05121480|581808296|FG002|Overall Study|Other Reason|0|||
161218487|NCT01952574|582181366|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
161113990|NCT05121480|581808297|FG003|Overall Study|Other Reason|0|||
161113991|NCT05121480|581808298|FG004|Overall Study|Other Reason|0|||
161113992|NCT05121480|581808299|FG005|Overall Study|Other Reason|1|||
161113993|NCT05121480|581808300|FG006|Overall Study|Other Reason|1|||
161113994|NCT05121480|581808301|FG007|Overall Study|Other Reason|1|||
161113995|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
161113996|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
161113997|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161113998|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161113999|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
161114000|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
161114001|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
161114002|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161114003|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161114004|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
161114005|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
161114006|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
161114007|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161114008|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161114009|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
161114010|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
161114011|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
161114012|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161114013|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161114014|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
161114015|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
161114016|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
161114017|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161114018|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161114019|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
161114020|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
161114021|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
161114022|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161114023|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
161114024|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
160870196|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
161114025|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
161114026|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
161114027|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161114028|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161114029|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
161114030|NCT02831673|581808308|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
161114031|NCT02831673|581808309|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
161114032|NCT02831673|581808310|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161114033|NCT02831673|581808311|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161114034|NCT02831673|581808312|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
161114035|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161114036|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161114037|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
161114038|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
161114039|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
161114040|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161114041|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161114042|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
161114043|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
161114044|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
161114045|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161114046|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161114047|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161114048|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
161114049|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
161114050|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161114051|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161114052|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
161114053|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
161114054|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
161114055|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161114056|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161114057|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
161114058|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
161114059|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
161114060|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161114061|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161114062|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
161114063|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
161114064|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
161114065|NCT02831673|581808308|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161114066|NCT02831673|581808309|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161114067|NCT02831673|581808310|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
161114068|NCT02831673|581808311|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
161114069|NCT02831673|581808312|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
161114070|NCT02831673|581808308|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161114071|NCT02831673|581808309|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161114072|NCT02831673|581808310|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161114073|NCT02831673|581808311|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
161114074|NCT02831673|581808312|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
161114075|NCT02831673|581808308|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161114076|NCT02831673|581808309|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161114077|NCT02831673|581808310|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161114078|NCT02831673|581808311|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
161114079|NCT02831673|581808312|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
161114080|NCT02831673|581808308|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161114081|NCT02831673|581808309|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161114082|NCT02831673|581808310|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161114083|NCT02831673|581808311|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
161114084|NCT02831673|581808312|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
161114085|NCT02831673|581808308|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161114086|NCT02831673|581808309|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161114087|NCT02831673|581808310|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160870197|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
160870198|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
160870199|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160870200|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160870201|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
160870202|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870203|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161114088|NCT02831673|581808311|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
161114089|NCT02831673|581808312|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
161114090|NCT02831673|581808308|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161114091|NCT02831673|581808309|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161114092|NCT02831673|581808310|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161114093|NCT02831673|581808311|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
161114094|NCT02831673|581808312|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
161114095|NCT00150592|581808313|FG000|Overall Study|Adverse Event|4|||
161114096|NCT00150592|581808314|FG001|Overall Study|Adverse Event|1|||
161114097|NCT00150592|581808313|FG000|Overall Study|Protocol Violation|1|||
161114098|NCT00150592|581808314|FG001|Overall Study|Protocol Violation|0|||
161114099|NCT00150592|581808313|FG000|Overall Study|Withdrawal by Subject|1|||
161114100|NCT00150592|581808314|FG001|Overall Study|Withdrawal by Subject|2|||
161114101|NCT00150592|581808313|FG000|Overall Study|Non-compliance|1|||
161114102|NCT00150592|581808314|FG001|Overall Study|Non-compliance|0|||
161114103|NCT00477165|581808316|FG000|Overall Study|Adverse Event|7|||
161114104|NCT00477165|581808317|FG001|Overall Study|Adverse Event|2|||
161114105|NCT01823679|581808318|FG000|Overall Study|Death|1|||
161114106|NCT02135692|581808322|FG000|Overall Study|Adverse Event|3|||
161114107|NCT02135692|581808322|FG000|Overall Study|Lack of Efficacy|2|||
161114108|NCT02135692|581808322|FG000|Overall Study|Protocol Violation|2|||
161114109|NCT02135692|581808322|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
161114110|NCT02135692|581808322|FG000|Overall Study|Product commercially available|159|||
161114111|NCT02135692|581808322|FG000|Overall Study|Study closed/terminated|153|||
161114112|NCT02135692|581808322|FG000|Overall Study|Lost to Follow-up|4|||
161114113|NCT02135692|581808322|FG000|Overall Study|Withdrawal by Subject|15|||
161114114|NCT01097746|581808324|FG000|Overall Study|Adverse Event|4|||
161114115|NCT01097746|581808324|FG000|Overall Study|taken off study before any treatment given|1|||
161114116|NCT02495844|581808325|FG000|Overall Study|Lack of Efficacy|1|||
161114117|NCT02495844|581808326|FG001|Overall Study|Lack of Efficacy|2|||
161114118|NCT02495844|581808325|FG000|Overall Study|AE, non-fatal|0|||
161114119|NCT02495844|581808326|FG001|Overall Study|AE, non-fatal|1|||
161114120|NCT02495844|581808325|FG000|Overall Study|Hepatitis Positivity|0|||
161114121|NCT02495844|581808326|FG001|Overall Study|Hepatitis Positivity|1|||
161114122|NCT00623480|581808327|FG000|Overall Study|Lost to Follow-up|0|||
161114123|NCT00623480|581808328|FG001|Overall Study|Lost to Follow-up|1|||
161114124|NCT00623480|581808327|FG000|Overall Study|Withdrawal by Subject|2|||
161114125|NCT00623480|581808328|FG001|Overall Study|Withdrawal by Subject|4|||
161114126|NCT00623480|581808327|FG000|Overall Study|Lack of Efficacy|1|||
161114127|NCT00623480|581808328|FG001|Overall Study|Lack of Efficacy|0|||
161114128|NCT00623480|581808327|FG000|Overall Study|Non-compliant with study medication|4|||
161114129|NCT00623480|581808328|FG001|Overall Study|Non-compliant with study medication|0|||
161114130|NCT00623480|581808327|FG000|Overall Study|Protocol Violation|0|||
161114131|NCT00623480|581808328|FG001|Overall Study|Protocol Violation|1|||
161114132|NCT00623480|581808327|FG000|Overall Study|Site closed by sponsor|0|||
161114133|NCT00623480|581808328|FG001|Overall Study|Site closed by sponsor|1|||
161114134|NCT00960661|581808329|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
161114135|NCT00960661|581808330|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
161114136|NCT00960661|581808331|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
161114137|NCT00960661|581808329|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
161114138|NCT00960661|581808330|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
161114139|NCT00960661|581808331|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
161114140|NCT00960661|581808329|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
161114141|NCT00960661|581808330|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
160870204|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870205|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
160870206|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161114142|NCT00960661|581808331|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
161114143|NCT00960661|581808329|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
161114144|NCT00960661|581808330|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
161114145|NCT00960661|581808331|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
161114146|NCT00960661|581808329|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
161114147|NCT00960661|581808330|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
160870207|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
161114148|NCT00960661|581808331|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
161114149|NCT00960661|581808329|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
161114150|NCT00960661|581808330|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
161114151|NCT00960661|581808331|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
161114152|NCT00960661|581808329|FG000|Interventional Phase|Adverse Event|0|||
161114153|NCT00960661|581808330|FG001|Interventional Phase|Adverse Event|17|||
161114154|NCT00960661|581808331|FG002|Interventional Phase|Adverse Event|8|||
161114155|NCT00960661|581808329|FG000|Interventional Phase|Death|0|||
161114156|NCT00960661|581808330|FG001|Interventional Phase|Death|1|||
161114157|NCT00960661|581808331|FG002|Interventional Phase|Death|0|||
161114158|NCT00960661|581808329|FG000|Interventional Phase|Lost to Follow-up|0|||
161114159|NCT00960661|581808330|FG001|Interventional Phase|Lost to Follow-up|0|||
161114160|NCT00960661|581808331|FG002|Interventional Phase|Lost to Follow-up|2|||
161114161|NCT00960661|581808329|FG000|Interventional Phase|entry criteria not met|0|||
161114162|NCT00960661|581808330|FG001|Interventional Phase|entry criteria not met|3|||
161114163|NCT00960661|581808331|FG002|Interventional Phase|entry criteria not met|0|||
161114164|NCT00960661|581808329|FG000|Interventional Phase|Protocol Violation|0|||
161114165|NCT00960661|581808330|FG001|Interventional Phase|Protocol Violation|7|||
161114166|NCT00960661|581808331|FG002|Interventional Phase|Protocol Violation|2|||
161114167|NCT00960661|581808329|FG000|Interventional Phase|Withdrawal by Subject|0|||
161114168|NCT00960661|581808330|FG001|Interventional Phase|Withdrawal by Subject|18|||
161114169|NCT00960661|581808331|FG002|Interventional Phase|Withdrawal by Subject|29|||
161114170|NCT00960661|581808329|FG000|Interventional Phase|Physician Decision|0|||
161114171|NCT00960661|581808330|FG001|Interventional Phase|Physician Decision|3|||
161114172|NCT00960661|581808331|FG002|Interventional Phase|Physician Decision|5|||
161218488|NCT01952574|582181367|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
161114173|NCT00960661|581808329|FG000|Interventional Phase|sponsor decision|0|||
161114174|NCT00960661|581808330|FG001|Interventional Phase|sponsor decision|1|||
161324396|NCT02098395|582573585|FG001|Overall Study|Unclassified|0|||
161218489|NCT01952574|582181361|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
161218490|NCT01952574|582181362|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161218491|NCT01952574|582181363|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
161218492|NCT01952574|582181364|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
161218493|NCT01952574|582181365|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
161218494|NCT01952574|582181366|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
161218495|NCT01952574|582181367|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
161218496|NCT01952574|582181361|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
161218497|NCT01952574|582181362|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
161218498|NCT01952574|582181363|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
161218499|NCT01952574|582181364|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
161218500|NCT01952574|582181365|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
161218501|NCT01952574|582181366|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
161218502|NCT01952574|582181367|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
161218503|NCT01952574|582181361|FG000|Open-label Treatment Phase|Missing|0|||
161218504|NCT01952574|582181362|FG001|Open-label Treatment Phase|Missing|0|||
161218505|NCT01952574|582181363|FG002|Open-label Treatment Phase|Missing|0|||
161218506|NCT01952574|582181364|FG003|Open-label Treatment Phase|Missing|0|||
161218507|NCT01952574|582181365|FG004|Open-label Treatment Phase|Missing|4|||
161218508|NCT01952574|582181366|FG005|Open-label Treatment Phase|Missing|0|||
161218509|NCT01952574|582181367|FG006|Open-label Treatment Phase|Missing|0|||
161218510|NCT01952574|582181361|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
161218511|NCT01952574|582181362|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161218512|NCT01952574|582181363|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
161218513|NCT01952574|582181364|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
161218514|NCT01952574|582181365|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
161218515|NCT01952574|582181366|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
161218516|NCT01952574|582181367|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
161218517|NCT01952574|582181361|FG000|Open-label Treatment Phase|Death|0|||
161218518|NCT01952574|582181362|FG001|Open-label Treatment Phase|Death|0|||
161218519|NCT01952574|582181363|FG002|Open-label Treatment Phase|Death|0|||
161218520|NCT01952574|582181364|FG003|Open-label Treatment Phase|Death|0|||
161218521|NCT01952574|582181365|FG004|Open-label Treatment Phase|Death|1|||
161218522|NCT01952574|582181366|FG005|Open-label Treatment Phase|Death|0|||
161218523|NCT01952574|582181367|FG006|Open-label Treatment Phase|Death|0|||
161218524|NCT01952574|582181361|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161218525|NCT01952574|582181362|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161218526|NCT01952574|582181363|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161218527|NCT01952574|582181364|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161218528|NCT01952574|582181365|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161218529|NCT01952574|582181366|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
161218530|NCT01952574|582181367|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
161218531|NCT01952574|582181361|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
161218532|NCT01952574|582181362|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
161218533|NCT01952574|582181363|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
161218534|NCT01952574|582181364|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
161218535|NCT01952574|582181365|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
161218536|NCT01952574|582181366|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
161218537|NCT01952574|582181367|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
161218538|NCT01821625|582181375|FG000|Overall Study|Withdrawal by Subject|2|||
161218539|NCT01821625|582181375|FG000|Overall Study|Lack of Efficacy|2|||
161218540|NCT01821625|582181375|FG000|Overall Study|Adverse Event|1|||
161218541|NCT01821625|582181375|FG000|Overall Study|Medical contraindication|1|||
161218542|NCT01620489|582181377|FG000|Overall Study|Adverse Event|17|||
161218543|NCT01620489|582181378|FG001|Overall Study|Adverse Event|4|||
161218544|NCT01620489|582181377|FG000|Overall Study|Protocol Violation|0|||
161218545|NCT01620489|582181378|FG001|Overall Study|Protocol Violation|3|||
161218546|NCT01620489|582181377|FG000|Overall Study|Withdrawal Criteria|17|||
161218547|NCT01620489|582181378|FG001|Overall Study|Withdrawal Criteria|25|||
161218548|NCT01620489|582181377|FG000|Overall Study|Unclassified|1|||
161218549|NCT01620489|582181378|FG001|Overall Study|Unclassified|2|||
161218550|NCT00871169|582181379|FG000|Overall Study|Protocol Violation|1|||
161218551|NCT00871169|582181379|FG000|Overall Study|Patient did not receive study treatment|2|||
161218552|NCT00593333|582181380|FG000|Overall Study|Lost to Follow-up|10|||
161218553|NCT00593333|582181381|FG001|Overall Study|Lost to Follow-up|11|||
161218554|NCT01328054|582181382|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
161218555|NCT01328054|582181383|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
161324397|NCT02098395|582573586|FG002|Overall Study|Unclassified|3|||
160870208|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
160870209|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870210|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870211|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
160870212|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
160870213|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870214|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870215|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
160870216|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870217|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870218|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
160870219|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870220|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870221|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870222|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
160870223|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870224|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870225|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
160870226|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870227|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870228|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870229|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
160870230|NCT03682770|580917370|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870231|NCT03682770|580917371|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870232|NCT03682770|580917372|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870233|NCT03682770|580917373|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
160870234|NCT03682770|580917374|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870235|NCT03682770|580917375|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870236|NCT03682770|580917376|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
160870237|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870238|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870239|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870240|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
160870241|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
160870242|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
160870243|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
160870244|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870245|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870246|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870247|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870248|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
160870249|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870250|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
160870251|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870252|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870253|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870254|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870255|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870256|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
160870257|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
160870258|NCT03682770|580917370|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870259|NCT03682770|580917371|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870260|NCT03682770|580917372|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
161114175|NCT00960661|581808331|FG002|Interventional Phase|sponsor decision|0|||
161114176|NCT00960661|581808329|FG000|Interventional Phase|Lack of Efficacy|0|||
161114177|NCT00960661|581808330|FG001|Interventional Phase|Lack of Efficacy|2|||
161114178|NCT00960661|581808331|FG002|Interventional Phase|Lack of Efficacy|0|||
161114179|NCT02699892|581808332|FG000|Overall Study|Other|36|||
161114180|NCT00847912|581808333|FG000|Overall Study|Protocol Violation|6|||
161114181|NCT00847912|581808334|FG001|Overall Study|Protocol Violation|7|||
161114182|NCT00847912|581808333|FG000|Overall Study|Withdrawal by Subject|3|||
161218556|NCT01328054|582181382|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
161114183|NCT00847912|581808334|FG001|Overall Study|Withdrawal by Subject|6|||
161114184|NCT01496885|581808335|FG000|Overall Study|Lost to Follow-up|13|||
161218557|NCT01328054|582181383|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
161218558|NCT01328054|582181382|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
161218559|NCT01328054|582181383|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
161218560|NCT00254397|582181384|FG000|Overall Study|Disease Progression|4|||
161218561|NCT00254397|582181385|FG001|Overall Study|Disease Progression|1|||
161218562|NCT00254397|582181386|FG002|Overall Study|Disease Progression|16|||
161218563|NCT00254397|582181387|FG003|Overall Study|Disease Progression|23|||
161218564|NCT00254397|582181384|FG000|Overall Study|Non-Compliant|0|||
161218565|NCT00254397|582181385|FG001|Overall Study|Non-Compliant|0|||
161218566|NCT00254397|582181386|FG002|Overall Study|Non-Compliant|0|||
160870261|NCT03682770|580917373|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870262|NCT03682770|580917374|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
160870263|NCT03682770|580917375|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
161218567|NCT00254397|582181387|FG003|Overall Study|Non-Compliant|1|||
161218568|NCT00254397|582181384|FG000|Overall Study|Adverse Event|2|||
161218569|NCT00254397|582181385|FG001|Overall Study|Adverse Event|0|||
161218570|NCT00254397|582181386|FG002|Overall Study|Adverse Event|3|||
161218571|NCT00254397|582181387|FG003|Overall Study|Adverse Event|1|||
161218572|NCT05028751|582181395|FG000|Overall Study|Study Terminated by Sponsor|3|||
161218573|NCT05028751|582181396|FG001|Overall Study|Study Terminated by Sponsor|0|||
161218574|NCT05028751|582181397|FG002|Overall Study|Study Terminated by Sponsor|0|||
161218575|NCT05028751|582181398|FG003|Overall Study|Study Terminated by Sponsor|0|||
161218576|NCT05028751|582181395|FG000|Overall Study|Death|9|||
161218577|NCT05028751|582181396|FG001|Overall Study|Death|3|||
161218578|NCT05028751|582181397|FG002|Overall Study|Death|2|||
161218579|NCT05028751|582181398|FG003|Overall Study|Death|4|||
161218580|NCT05028751|582181395|FG000|Overall Study|Withdrawal by Subject|0|||
160870264|NCT03682770|580917376|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
160870265|NCT02362282|580917377|FG000|Overall Study|Withdrawal by Subject|1|||
160870266|NCT02362282|580917378|FG001|Overall Study|Withdrawal by Subject|0|||
160870267|NCT02004093|580917379|FG000|Overall Study|Death|2|||
160870268|NCT02004093|580917380|FG001|Overall Study|Death|1|||
160870269|NCT02004093|580917379|FG000|Overall Study|Lack of Efficacy|66|||
160870270|NCT02004093|580917380|FG001|Overall Study|Lack of Efficacy|62|||
160870271|NCT02004093|580917379|FG000|Overall Study|Protocol Violation|0|||
160870272|NCT02004093|580917380|FG001|Overall Study|Protocol Violation|1|||
160870273|NCT02004093|580917379|FG000|Overall Study|Lost to Follow-up|0|||
160870274|NCT02004093|580917380|FG001|Overall Study|Lost to Follow-up|1|||
160870275|NCT02004093|580917379|FG000|Overall Study|Withdrawal by Subject|3|||
160870276|NCT02004093|580917380|FG001|Overall Study|Withdrawal by Subject|7|||
160870277|NCT02004093|580917379|FG000|Overall Study|Other|3|||
160870278|NCT02004093|580917380|FG001|Overall Study|Other|1|||
160870279|NCT04085289|580917381|FG000|Overall Study|Withdrawal by Subject|0|||
160870280|NCT04085289|580917382|FG001|Overall Study|Withdrawal by Subject|0|||
160870281|NCT04085289|580917383|FG002|Overall Study|Withdrawal by Subject|1|||
160870282|NCT01317277|580917386|FG000|Overall Study|Lost to Follow-up|3|||
160870283|NCT01317277|580917387|FG001|Overall Study|Lost to Follow-up|1|||
160870284|NCT01317277|580917386|FG000|Overall Study|Lost MEMS|1|||
160870285|NCT01317277|580917387|FG001|Overall Study|Lost MEMS|1|||
160870286|NCT01317277|580917386|FG000|Overall Study|Unable to comply with intervention|1|||
160870287|NCT01317277|580917387|FG001|Overall Study|Unable to comply with intervention|0|||
160870288|NCT01317277|580917386|FG000|Overall Study|Withdrawal by Subject|1|||
160870289|NCT01317277|580917387|FG001|Overall Study|Withdrawal by Subject|0|||
160870290|NCT01317277|580917386|FG000|Overall Study|Adverse Event|1|||
160870291|NCT01317277|580917387|FG001|Overall Study|Adverse Event|0|||
160870292|NCT00774566|580917388|FG000|Overall Study|Protocol Violation|18|||
160870293|NCT00774566|580917389|FG001|Overall Study|Protocol Violation|15|||
160870294|NCT04896073|580917394|FG000|Overall Study|Screen failure|0|||
160870295|NCT04896073|580917395|FG001|Overall Study|Screen failure|2|||
160870296|NCT04896073|580917394|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
160870297|NCT04896073|580917395|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
160870298|NCT01262989|580917396|FG000|Period 1|Lost to Follow-up|1|||
160870299|NCT01262989|580917397|FG001|Period 1|Lost to Follow-up|1|||
160870300|NCT01262989|580917396|FG000|Period 1|Intercurrent disease|0|||
160870301|NCT01262989|580917397|FG001|Period 1|Intercurrent disease|1|||
160870302|NCT01262989|580917396|FG000|Period 1|Positive answer for exclusion criteria|0|||
160870303|NCT01262989|580917397|FG001|Period 1|Positive answer for exclusion criteria|1|||
160870304|NCT01262989|580917396|FG000|Period 2|Intercurrent disease|0|||
161218581|NCT05028751|582181396|FG001|Overall Study|Withdrawal by Subject|0|||
161218582|NCT05028751|582181397|FG002|Overall Study|Withdrawal by Subject|1|||
161218583|NCT05028751|582181398|FG003|Overall Study|Withdrawal by Subject|0|||
161218584|NCT05028751|582181395|FG000|Overall Study|Miscellaneous|2|||
160870305|NCT01262989|580917397|FG001|Period 2|Intercurrent disease|1|||
160870306|NCT03599089|580917398|FG000|Overall Study|Lost to Follow-up|1|||
160870307|NCT03599089|580917399|FG001|Overall Study|Lost to Follow-up|0|||
161218585|NCT05028751|582181396|FG001|Overall Study|Miscellaneous|0|||
161218586|NCT05028751|582181397|FG002|Overall Study|Miscellaneous|0|||
161218587|NCT05028751|582181398|FG003|Overall Study|Miscellaneous|0|||
161218588|NCT03586830|582181400|FG000|Overall Study|Site terminated by Sponsor|1|||
160870308|NCT03599089|580917400|FG002|Overall Study|Lost to Follow-up|0|||
160870309|NCT03599089|580917401|FG003|Overall Study|Lost to Follow-up|0|||
160870310|NCT03599089|580917398|FG000|Overall Study|Withdrawal by Subject|2|||
160870311|NCT03599089|580917399|FG001|Overall Study|Withdrawal by Subject|1|||
160870312|NCT03599089|580917400|FG002|Overall Study|Withdrawal by Subject|0|||
160870313|NCT03599089|580917401|FG003|Overall Study|Withdrawal by Subject|0|||
160870314|NCT03599089|580917398|FG000|Overall Study|Lack of Efficacy|0|||
160870315|NCT03599089|580917399|FG001|Overall Study|Lack of Efficacy|0|||
160870316|NCT03599089|580917400|FG002|Overall Study|Lack of Efficacy|1|||
160870317|NCT03599089|580917401|FG003|Overall Study|Lack of Efficacy|2|||
160870318|NCT03214666|580917402|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870319|NCT03214666|580917403|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870320|NCT03214666|580917404|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870321|NCT03214666|580917405|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870322|NCT03214666|580917406|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
160870323|NCT03214666|580917407|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
160870324|NCT03048578|580917408|FG000|Overall Study|Withdrawal by Subject|5|||
160870325|NCT03048578|580917409|FG001|Overall Study|Withdrawal by Subject|6|||
160870326|NCT03048578|580917408|FG000|Overall Study|Lost to Follow-up|22|||
160870327|NCT03048578|580917409|FG001|Overall Study|Lost to Follow-up|10|||
160870328|NCT03048578|580917408|FG000|Overall Study|Adverse Event|1|||
160870329|NCT03048578|580917409|FG001|Overall Study|Adverse Event|2|||
160870330|NCT03048578|580917408|FG000|Overall Study|Terminated|3|||
160870331|NCT03048578|580917409|FG001|Overall Study|Terminated|2|||
160870332|NCT00459186|580917415|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
160870333|NCT00459186|580917415|FG000|PET Imaging and Assessment|Adverse Event|3|||
160870334|NCT02500797|580917416|FG000|Overall Study|Cancel (rapid disease progression)|0|||
160870335|NCT02500797|580917417|FG001|Overall Study|Cancel (rapid disease progression)|0|||
160870336|NCT02500797|580917418|FG002|Overall Study|Cancel (rapid disease progression)|0|||
160870337|NCT02500797|580917419|FG003|Overall Study|Cancel (rapid disease progression)|0|||
160870338|NCT02500797|580917420|FG004|Overall Study|Cancel (rapid disease progression)|1|||
160870339|NCT02500797|580917421|FG005|Overall Study|Cancel (rapid disease progression)|1|||
160870340|NCT02500797|580917422|FG006|Overall Study|Cancel (rapid disease progression)|0|||
160870341|NCT02500797|580917423|FG007|Overall Study|Cancel (rapid disease progression)|0|||
160870342|NCT02500797|580917416|FG000|Overall Study|Withdrawal by Subject|1|||
160870343|NCT02500797|580917417|FG001|Overall Study|Withdrawal by Subject|0|||
160870344|NCT02500797|580917418|FG002|Overall Study|Withdrawal by Subject|0|||
160870345|NCT02500797|580917419|FG003|Overall Study|Withdrawal by Subject|0|||
160870346|NCT02500797|580917420|FG004|Overall Study|Withdrawal by Subject|0|||
160870347|NCT02500797|580917421|FG005|Overall Study|Withdrawal by Subject|0|||
160870348|NCT02500797|580917422|FG006|Overall Study|Withdrawal by Subject|0|||
160870349|NCT02500797|580917423|FG007|Overall Study|Withdrawal by Subject|0|||
160870350|NCT00357006|580917430|FG000|Overall Study|Lost to Follow-up|1|||
160870351|NCT00357006|580917431|FG001|Overall Study|Lost to Follow-up|2|||
160870352|NCT00357006|580917432|FG002|Overall Study|Lost to Follow-up|1|||
160870353|NCT00357006|580917430|FG000|Overall Study|Withdrawal by Subject|1|||
160870354|NCT00357006|580917431|FG001|Overall Study|Withdrawal by Subject|3|||
160870355|NCT00357006|580917432|FG002|Overall Study|Withdrawal by Subject|2|||
160870356|NCT03710161|580917433|FG000|Overall Study|Study halted due to COVID pandemic|3|||
160870357|NCT03710161|580917434|FG001|Overall Study|Study halted due to COVID pandemic|2|||
160870358|NCT02637037|580917437|FG000|Overall Study|Positive drug screen at admission|1|||
160870359|NCT02637037|580917438|FG001|Overall Study|Positive drug screen at admission|0|||
160870360|NCT02637037|580917437|FG000|Overall Study|Withdrawal by Subject|2|||
160870361|NCT02637037|580917438|FG001|Overall Study|Withdrawal by Subject|1|||
160870362|NCT02637037|580917437|FG000|Overall Study|Adverse Event|1|||
160870363|NCT02637037|580917438|FG001|Overall Study|Adverse Event|0|||
161218589|NCT03586830|582181401|FG001|Overall Study|Site terminated by Sponsor|4|||
161218590|NCT03586830|582181402|FG002|Overall Study|Site terminated by Sponsor|3|||
161218591|NCT03586830|582181403|FG003|Overall Study|Site terminated by Sponsor|3|||
161218592|NCT03586830|582181400|FG000|Overall Study|Lost to Follow-up|0|||
161218593|NCT03586830|582181401|FG001|Overall Study|Lost to Follow-up|2|||
161218594|NCT03586830|582181402|FG002|Overall Study|Lost to Follow-up|2|||
161218595|NCT03586830|582181403|FG003|Overall Study|Lost to Follow-up|1|||
161218596|NCT03586830|582181400|FG000|Overall Study|Withdrawal by Subject|1|||
161218597|NCT03586830|582181401|FG001|Overall Study|Withdrawal by Subject|0|||
160870364|NCT00074490|580917446|FG000|Overall Study|Progressive malignancy|0|||
160870365|NCT00074490|580917447|FG001|Overall Study|Progressive malignancy|7|||
160870366|NCT00074490|580917448|FG002|Overall Study|Progressive malignancy|0|||
160870367|NCT00074490|580917449|FG003|Overall Study|Progressive malignancy|0|||
160870368|NCT00074490|580917450|FG004|Overall Study|Progressive malignancy|3|||
160870369|NCT00074490|580917451|FG005|Overall Study|Progressive malignancy|0|||
160870370|NCT04139798|580917454|FG000|Overall Study|Withdrawal by Subject|6|||
160870371|NCT04139798|580917455|FG001|Overall Study|Withdrawal by Subject|5|||
161218598|NCT03586830|582181402|FG002|Overall Study|Withdrawal by Subject|3|||
161218599|NCT03586830|582181403|FG003|Overall Study|Withdrawal by Subject|1|||
161218600|NCT00395083|582181404|FG000|Overall Study|Withdrawal by Subject|6|||
161218601|NCT00395083|582181405|FG001|Overall Study|Withdrawal by Subject|5|||
161218602|NCT00395083|582181404|FG000|Overall Study|Developed another disease|4|||
161218603|NCT00395083|582181405|FG001|Overall Study|Developed another disease|3|||
161218604|NCT00628745|582181410|FG000|Overall Study|Withdrawal by Subject|63|||
161218605|NCT00628745|582181411|FG001|Overall Study|Withdrawal by Subject|3|||
161218606|NCT00628745|582181412|FG002|Overall Study|Withdrawal by Subject|9|||
161218607|NCT00628745|582181413|FG003|Overall Study|Withdrawal by Subject|2|||
161218608|NCT00628745|582181414|FG004|Overall Study|Withdrawal by Subject|69|||
161218609|NCT00628745|582181410|FG000|Overall Study|Does not meet inclusion criteria|0|||
161218610|NCT00628745|582181411|FG001|Overall Study|Does not meet inclusion criteria|12|||
161218611|NCT00628745|582181412|FG002|Overall Study|Does not meet inclusion criteria|0|||
161218612|NCT00628745|582181413|FG003|Overall Study|Does not meet inclusion criteria|0|||
161218613|NCT00628745|582181414|FG004|Overall Study|Does not meet inclusion criteria|18|||
161218614|NCT00628745|582181410|FG000|Overall Study|Participation in an interventional clinical trial|81|||
161218615|NCT00628745|582181411|FG001|Overall Study|Participation in an interventional clinical trial|4|||
161218616|NCT00628745|582181412|FG002|Overall Study|Participation in an interventional clinical trial|7|||
161218617|NCT00628745|582181413|FG003|Overall Study|Participation in an interventional clinical trial|0|||
161218618|NCT00628745|582181414|FG004|Overall Study|Participation in an interventional clinical trial|63|||
161218619|NCT00628745|582181410|FG000|Overall Study|Physician Decision|8|||
161218620|NCT00628745|582181411|FG001|Overall Study|Physician Decision|4|||
161218621|NCT00628745|582181412|FG002|Overall Study|Physician Decision|3|||
161218622|NCT00628745|582181413|FG003|Overall Study|Physician Decision|0|||
161218623|NCT00628745|582181414|FG004|Overall Study|Physician Decision|30|||
161218624|NCT00628745|582181410|FG000|Overall Study|Lost to Follow-up|109|||
161218625|NCT00628745|582181411|FG001|Overall Study|Lost to Follow-up|7|||
161218626|NCT00628745|582181412|FG002|Overall Study|Lost to Follow-up|7|||
161218627|NCT00628745|582181413|FG003|Overall Study|Lost to Follow-up|0|||
161218628|NCT00628745|582181414|FG004|Overall Study|Lost to Follow-up|498|||
161218629|NCT00628745|582181410|FG000|Overall Study|Death|197|||
161218630|NCT00628745|582181411|FG001|Overall Study|Death|81|||
161218631|NCT00628745|582181412|FG002|Overall Study|Death|12|||
161218632|NCT00628745|582181413|FG003|Overall Study|Death|4|||
161218633|NCT00628745|582181414|FG004|Overall Study|Death|939|||
161218634|NCT00628745|582181410|FG000|Overall Study|Participant transferred to another THAOS site|6|||
161218635|NCT00628745|582181411|FG001|Overall Study|Participant transferred to another THAOS site|0|||
161218636|NCT00628745|582181412|FG002|Overall Study|Participant transferred to another THAOS site|0|||
161218637|NCT00628745|582181413|FG003|Overall Study|Participant transferred to another THAOS site|0|||
161218638|NCT00628745|582181414|FG004|Overall Study|Participant transferred to another THAOS site|7|||
161218639|NCT00628745|582181410|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
161218640|NCT00628745|582181411|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
161218641|NCT00628745|582181412|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
161218642|NCT00628745|582181413|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
161218643|NCT00628745|582181414|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
161218644|NCT00628745|582181410|FG000|Overall Study|Site closure|152|||
161218645|NCT00628745|582181411|FG001|Overall Study|Site closure|146|||
161218646|NCT00628745|582181412|FG002|Overall Study|Site closure|6|||
161218647|NCT00628745|582181413|FG003|Overall Study|Site closure|8|||
161218648|NCT00628745|582181414|FG004|Overall Study|Site closure|691|||
161218649|NCT00628745|582181410|FG000|Overall Study|Duplicate participant|0|||
161218650|NCT00628745|582181411|FG001|Overall Study|Duplicate participant|0|||
161218651|NCT00628745|582181412|FG002|Overall Study|Duplicate participant|0|||
161218652|NCT00628745|582181413|FG003|Overall Study|Duplicate participant|0|||
161218653|NCT00628745|582181414|FG004|Overall Study|Duplicate participant|1|||
161218654|NCT00628745|582181410|FG000|Overall Study|Missing|4|||
161218655|NCT00628745|582181411|FG001|Overall Study|Missing|3|||
161218656|NCT00628745|582181412|FG002|Overall Study|Missing|0|||
161218657|NCT00628745|582181413|FG003|Overall Study|Missing|0|||
161218658|NCT00628745|582181414|FG004|Overall Study|Missing|10|||
161218659|NCT00628745|582181410|FG000|Overall Study|Othe reasons|987|||
161218660|NCT00628745|582181411|FG001|Overall Study|Othe reasons|373|||
161218661|NCT00628745|582181412|FG002|Overall Study|Othe reasons|105|||
161218662|NCT00628745|582181413|FG003|Overall Study|Othe reasons|1|||
161218663|NCT00628745|582181414|FG004|Overall Study|Othe reasons|1772|||
161218664|NCT00322556|582183165|FG000|Overall Study|Adverse Event|1|||
161218665|NCT00322556|582183165|FG000|Overall Study|Withdrawal by Subject|1|||
161218666|NCT00322556|582183165|FG000|Overall Study|Lost to Follow-up|3|||
161218667|NCT00322556|582183165|FG000|Overall Study|Other Reason|7|||
161218668|NCT01590433|582183166|FG000|Overall Study|Lost to Follow-up|20|||
161218669|NCT01590433|582183167|FG001|Overall Study|Lost to Follow-up|8|||
160870372|NCT04139798|580917454|FG000|Overall Study|Lost to Follow-up|2|||
160870373|NCT04139798|580917455|FG001|Overall Study|Lost to Follow-up|5|||
160870374|NCT04139798|580917454|FG000|Overall Study|Discontinued|4|||
160870375|NCT04139798|580917455|FG001|Overall Study|Discontinued|2|||
161218670|NCT01590433|582183166|FG000|Overall Study|Withdrawal by Subject|21|||
161218671|NCT01590433|582183167|FG001|Overall Study|Withdrawal by Subject|11|||
161218672|NCT01590433|582183166|FG000|Overall Study|Adverse Event|11|||
161218673|NCT01590433|582183167|FG001|Overall Study|Adverse Event|3|||
161218674|NCT00555009|582183168|FG000|Overall Study|Withdrawal by Subject|0|||
161218675|NCT00555009|582183169|FG001|Overall Study|Withdrawal by Subject|1|||
161218676|NCT00555009|582183168|FG000|Overall Study|Terminated by Sponsor|2|||
161218677|NCT00555009|582183169|FG001|Overall Study|Terminated by Sponsor|5|||
161218678|NCT02040428|582183170|FG000|Overall Study|Death|4|||
161218679|NCT02040428|582183171|FG001|Overall Study|Death|3|||
161218680|NCT02040428|582183170|FG000|Overall Study|Withdrawal by Subject|1|||
161218681|NCT02040428|582183171|FG001|Overall Study|Withdrawal by Subject|1|||
161218682|NCT02058628|582183172|FG000|Overall Study|Adverse Event|1|||
161218683|NCT02058628|582183173|FG001|Overall Study|Adverse Event|0|||
161218684|NCT02058628|582183172|FG000|Overall Study|Withdrawal by Subject|2|||
161218685|NCT02058628|582183173|FG001|Overall Study|Withdrawal by Subject|2|||
161218686|NCT02058628|582183172|FG000|Overall Study|Lost to Follow-up|2|||
161218687|NCT02058628|582183173|FG001|Overall Study|Lost to Follow-up|4|||
161218688|NCT02058628|582183172|FG000|Overall Study|Not in time schedule|0|||
161218689|NCT02058628|582183173|FG001|Overall Study|Not in time schedule|1|||
161218690|NCT02058628|582183172|FG000|Overall Study|The visit date was not in timeline|0|||
161218691|NCT02058628|582183173|FG001|Overall Study|The visit date was not in timeline|1|||
161218692|NCT02058628|582183172|FG000|Overall Study|A lot of time for study for participant|1|||
161218693|NCT02058628|582183173|FG001|Overall Study|A lot of time for study for participant|0|||
161218694|NCT02058628|582183172|FG000|Overall Study|Non compliance|1|||
161218695|NCT02058628|582183173|FG001|Overall Study|Non compliance|0|||
161218696|NCT00832078|582183174|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
161218697|NCT00832078|582183175|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
161218698|NCT00832078|582183174|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
161218699|NCT00832078|582183175|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
161218700|NCT02961920|582183178|FG000|Overall Study|did not achive stydy protocol schedule|1|||
161218701|NCT02961920|582183179|FG001|Overall Study|did not achive stydy protocol schedule|1|||
161218702|NCT01452529|582183180|FG000|Run-in Period|Adverse Event|96|||
161218703|NCT01452529|582183181|FG001|Run-in Period|Adverse Event|0|||
161218704|NCT01452529|582183182|FG002|Run-in Period|Adverse Event|0|||
161218705|NCT01452529|582183180|FG000|Run-in Period|Withdrawal by Subject|49|||
161218706|NCT01452529|582183181|FG001|Run-in Period|Withdrawal by Subject|0|||
161218707|NCT01452529|582183182|FG002|Run-in Period|Withdrawal by Subject|0|||
161218708|NCT01452529|582183180|FG000|Run-in Period|Lost to Follow-up|19|||
161218709|NCT01452529|582183181|FG001|Run-in Period|Lost to Follow-up|0|||
161218710|NCT01452529|582183182|FG002|Run-in Period|Lost to Follow-up|0|||
161218711|NCT01452529|582183180|FG000|Run-in Period|Lack of Efficacy|46|||
161218712|NCT01452529|582183181|FG001|Run-in Period|Lack of Efficacy|0|||
161218713|NCT01452529|582183182|FG002|Run-in Period|Lack of Efficacy|0|||
161218714|NCT01452529|582183180|FG000|Run-in Period|Confirmed or suspected diversion|23|||
161218715|NCT01452529|582183181|FG001|Run-in Period|Confirmed or suspected diversion|0|||
161218716|NCT01452529|582183182|FG002|Run-in Period|Confirmed or suspected diversion|0|||
161218717|NCT01452529|582183180|FG000|Run-in Period|Administrative|21|||
161218718|NCT01452529|582183181|FG001|Run-in Period|Administrative|0|||
161218719|NCT01452529|582183182|FG002|Run-in Period|Administrative|0|||
161218720|NCT01452529|582183180|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
161218721|NCT01452529|582183181|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
161218722|NCT01452529|582183182|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
161218723|NCT01452529|582183180|FG000|Double-blind (DB) Period|Adverse Event|0|||
161218724|NCT01452529|582183181|FG001|Double-blind (DB) Period|Adverse Event|18|||
160870376|NCT04139798|580917454|FG000|Overall Study|Adverse Event|1|||
161218725|NCT01452529|582183182|FG002|Double-blind (DB) Period|Adverse Event|11|||
161218726|NCT01452529|582183180|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
161218727|NCT01452529|582183181|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
161218728|NCT01452529|582183182|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
161218729|NCT01452529|582183180|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
161218730|NCT01452529|582183181|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
161218731|NCT01452529|582183182|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
161218732|NCT01452529|582183180|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
161218733|NCT01452529|582183181|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
161218734|NCT01452529|582183182|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
161218735|NCT01452529|582183180|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
161218736|NCT01452529|582183181|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
161218737|NCT01452529|582183182|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
160870377|NCT04139798|580917455|FG001|Overall Study|Adverse Event|3|||
160870378|NCT04139798|580917454|FG000|Overall Study|Protocol Violation|1|||
161218738|NCT01452529|582183180|FG000|Double-blind (DB) Period|Administrative|0|||
161218739|NCT01452529|582183181|FG001|Double-blind (DB) Period|Administrative|11|||
161218740|NCT01452529|582183182|FG002|Double-blind (DB) Period|Administrative|7|||
161218741|NCT03551730|582183183|FG000|Overall Study|Adverse Event|1|||
161218742|NCT03551730|582183184|FG001|Overall Study|Adverse Event|0|||
161218743|NCT03551730|582183185|FG002|Overall Study|Adverse Event|0|||
161218744|NCT03551730|582183186|FG003|Overall Study|Adverse Event|0|||
161218745|NCT00671879|582183187|FG000|Overall Study|Withdrawal by Subject|0|||
161218746|NCT00671879|582183188|FG001|Overall Study|Withdrawal by Subject|4|||
161218747|NCT00671879|582183189|FG002|Overall Study|Withdrawal by Subject|6|||
161218748|NCT04527471|582183192|FG000|Overall Study|Adverse Event|1|||
161218749|NCT04527471|582183193|FG001|Overall Study|Adverse Event|0|||
161218750|NCT04527471|582183192|FG000|Overall Study|Lost to Follow-up|1|||
161218751|NCT04527471|582183193|FG001|Overall Study|Lost to Follow-up|0|||
161218752|NCT01628120|582183202|FG000|Overall Study|Withdrawal by Subject|7|||
161218753|NCT01628120|582183202|FG000|Overall Study|Adverse Event|12|||
161218754|NCT01628120|582183202|FG000|Overall Study|Lost to Follow-up|1|||
161218755|NCT01628120|582183202|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
161218756|NCT01628120|582183202|FG000|Overall Study|Non-compliant with Study Procedures|1|||
161218757|NCT01628120|582183202|FG000|Overall Study|Not Treated|3|||
161218758|NCT01628120|582183202|FG000|Overall Study|Sponsor Decision|5|||
161218759|NCT01628120|582183202|FG000|Overall Study|Switched Dialysis Method|2|||
161218760|NCT01628120|582183202|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
161218761|NCT01628120|582183202|FG000|Overall Study|Moved or Relocated|5|||
161218762|NCT01628120|582183202|FG000|Overall Study|Kidney Transplant|2|||
161218763|NCT01628120|582183202|FG000|Overall Study|Use of Standard of Care|1|||
161218764|NCT01165996|582183205|FG000|Overall Study|Death|1|||
161218765|NCT01165996|582183205|FG000|Overall Study|Physician Decision|1|||
161218766|NCT00096265|582183206|FG000|Overall Study|Ineligible|1|||
161218767|NCT00096265|582183207|FG001|Overall Study|Ineligible|0|||
161218768|NCT00096265|582183208|FG002|Overall Study|Ineligible|0|||
161218769|NCT01506323|582183209|FG000|Overall Study|Lost to Follow-up|5|||
161218770|NCT01506323|582183210|FG001|Overall Study|Lost to Follow-up|4|||
161218771|NCT01506323|582183209|FG000|Overall Study|Withdrawal by Subject|4|||
161218772|NCT01506323|582183210|FG001|Overall Study|Withdrawal by Subject|4|||
161218773|NCT01506323|582183209|FG000|Overall Study|Lack of Efficacy|1|||
161218774|NCT01506323|582183210|FG001|Overall Study|Lack of Efficacy|3|||
161218775|NCT01506323|582183209|FG000|Overall Study|Moved out of area|5|||
161218776|NCT01506323|582183210|FG001|Overall Study|Moved out of area|2|||
161218777|NCT01506323|582183209|FG000|Overall Study|Schedule or Transportation conflict|8|||
161218778|NCT01506323|582183210|FG001|Overall Study|Schedule or Transportation conflict|0|||
161218779|NCT01506323|582183209|FG000|Overall Study|Started another treatment|1|||
161218780|NCT01506323|582183210|FG001|Overall Study|Started another treatment|0|||
161218781|NCT02232074|582183213|FG000|Overall Study|Withdrawal by Subject|5|||
161218782|NCT02232074|582183214|FG001|Overall Study|Withdrawal by Subject|3|||
161218783|NCT02232074|582183213|FG000|Overall Study|No legal concerns at baseline|36|||
161218784|NCT02232074|582183214|FG001|Overall Study|No legal concerns at baseline|41|||
161218785|NCT02232074|582183213|FG000|Overall Study|deemed ineligible|0|||
161218786|NCT02232074|582183214|FG001|Overall Study|deemed ineligible|1|||
161218787|NCT01927757|582183215|FG000|Overall Study|Withdrawal by Subject|14|||
161218788|NCT01927757|582183215|FG000|Overall Study|Lost to Follow-up|2|||
161218789|NCT01927757|582183215|FG000|Overall Study|Decision by Sponsor|2|||
161218790|NCT01927757|582183215|FG000|Overall Study|Other|1|||
161218791|NCT01927757|582183215|FG000|Overall Study|Ethical Reasons|4|||
161218792|NCT00444795|582183217|FG000|Overall Study|Not Treated|1|||
161218793|NCT00444795|582183217|FG000|Overall Study|Treated Prior to the Contract Date|2|||
161218794|NCT00988169|582183218|FG000|Overall Study|Withdrawal by Subject|1|||
161218795|NCT00704418|582183219|FG000|Overall Study|Withdrawal by Subject|2|||
161218796|NCT00704418|582183220|FG001|Overall Study|Withdrawal by Subject|0|||
160870379|NCT04139798|580917455|FG001|Overall Study|Protocol Violation|0|||
160870380|NCT01526733|580917456|FG000|Phase 1|Protocol Violation|1|||
160870381|NCT01526733|580917457|FG001|Phase 1|Protocol Violation|0|||
160870382|NCT01526733|580917456|FG000|Phase 1|Withdrawal by Subject|1|||
160870383|NCT01526733|580917457|FG001|Phase 1|Withdrawal by Subject|1|||
161218797|NCT00704418|582183219|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
161218798|NCT00704418|582183220|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
161218799|NCT02637076|582183221|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
161218800|NCT02637076|582183222|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
161218801|NCT02637076|582183221|FG000|Overall Study|Withdrawal by Subject|0|||
161218802|NCT02637076|582183222|FG001|Overall Study|Withdrawal by Subject|4|||
161218803|NCT00130520|582183223|FG000|Overall Study|Adverse Event|11|||
161218804|NCT00130520|582183223|FG000|Overall Study|Death|1|||
161218805|NCT00130520|582183223|FG000|Overall Study|Physician Decision|1|||
160870384|NCT02506244|580917458|FG000|Overall Study|Did not undergo active monitoring|458|||
161218806|NCT00130520|582183223|FG000|Overall Study|Withdrawal by Subject|1|||
161218807|NCT00130520|582183223|FG000|Overall Study|Disease Progression|23|||
160870385|NCT02506244|580917459|FG001|Overall Study|Did not undergo active monitoring|459|||
160870386|NCT02506244|580917460|FG002|Overall Study|Did not undergo active monitoring|0|||
160870387|NCT05615922|580917465|FG000|Overall Study|Lost to Follow-up|1|||
160870388|NCT04774094|580917471|FG000|Overall Study|Other|2|||
160870389|NCT04774094|580917471|FG000|Overall Study|Withdrawal by Subject|9|||
160870390|NCT04774094|580917471|FG000|Overall Study|Lost to Follow-up|7|||
160870391|NCT04774094|580917471|FG000|Overall Study|Lack of Efficacy|5|||
160870392|NCT04774094|580917471|FG000|Overall Study|Death|17|||
160870393|NCT04774094|580917471|FG000|Overall Study|Adverse Event|4|||
160870394|NCT02374450|580917472|FG000|Overall Study|Protocol Violation|0|||
160870395|NCT02374450|580917473|FG001|Overall Study|Protocol Violation|1|||
160870396|NCT02374450|580917474|FG002|Overall Study|Protocol Violation|0|||
160870397|NCT02374450|580917472|FG000|Overall Study|Withdrawal by Subject|91|||
160870398|NCT02374450|580917473|FG001|Overall Study|Withdrawal by Subject|110|||
160870399|NCT02374450|580917474|FG002|Overall Study|Withdrawal by Subject|4|||
160870400|NCT02374450|580917472|FG000|Overall Study|Lost to Follow-up|168|||
160870401|NCT02374450|580917473|FG001|Overall Study|Lost to Follow-up|194|||
160870402|NCT02374450|580917474|FG002|Overall Study|Lost to Follow-up|138|||
160870403|NCT02374450|580917472|FG000|Overall Study|Death|173|||
160870404|NCT02374450|580917473|FG001|Overall Study|Death|185|||
160870405|NCT02374450|580917474|FG002|Overall Study|Death|81|||
160870406|NCT02374450|580917472|FG000|Overall Study|Migrated from the study area|538|||
160870407|NCT02374450|580917473|FG001|Overall Study|Migrated from the study area|648|||
160870408|NCT02374450|580917474|FG002|Overall Study|Migrated from the study area|181|||
160870409|NCT02374450|580917472|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
160870410|NCT02374450|580917473|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
160870411|NCT02374450|580917474|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
160870412|NCT02374450|580917472|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
160870413|NCT02374450|580917473|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
160870414|NCT02374450|580917474|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
160870415|NCT02374450|580917472|FG000|Overall Study|Other|0|||
160870416|NCT02374450|580917473|FG001|Overall Study|Other|21|||
160870417|NCT02374450|580917474|FG002|Overall Study|Other|79|||
160870418|NCT01006291|580918950|FG000|Overall Study|Adverse Event|2|||
160870419|NCT01006291|580918951|FG001|Overall Study|Adverse Event|1|||
160870420|NCT01006291|580918952|FG002|Overall Study|Adverse Event|2|||
160870421|NCT01006291|580918950|FG000|Overall Study|Lack of Efficacy|2|||
160870422|NCT01006291|580918951|FG001|Overall Study|Lack of Efficacy|2|||
160870423|NCT01006291|580918952|FG002|Overall Study|Lack of Efficacy|1|||
160870424|NCT01006291|580918950|FG000|Overall Study|Protocol Violation|3|||
160870425|NCT01006291|580918951|FG001|Overall Study|Protocol Violation|3|||
160870426|NCT01006291|580918952|FG002|Overall Study|Protocol Violation|3|||
160870427|NCT01006291|580918950|FG000|Overall Study|Withdrawal criteria|5|||
160870428|NCT01006291|580918951|FG001|Overall Study|Withdrawal criteria|4|||
160870429|NCT01006291|580918952|FG002|Overall Study|Withdrawal criteria|4|||
160870430|NCT01006291|580918950|FG000|Overall Study|Other|14|||
161218808|NCT00130520|582183223|FG000|Overall Study|Protocol non-compliance|1|||
161218809|NCT00130520|582183223|FG000|Overall Study|Did not meet re-treatment criteria|1|||
161218810|NCT01464827|582183224|FG000|Overall Study|Adverse Event|0|||
161218811|NCT01464827|582183225|FG001|Overall Study|Adverse Event|0|||
161218812|NCT01464827|582183226|FG002|Overall Study|Adverse Event|0|||
161218813|NCT01464827|582183227|FG003|Overall Study|Adverse Event|0|||
161218814|NCT01464827|582183228|FG004|Overall Study|Adverse Event|0|||
161218815|NCT01464827|582183229|FG005|Overall Study|Adverse Event|0|||
161218816|NCT01464827|582183230|FG006|Overall Study|Adverse Event|0|||
161218817|NCT01464827|582183231|FG007|Overall Study|Adverse Event|0|||
161218818|NCT01464827|582183232|FG008|Overall Study|Adverse Event|0|||
161218819|NCT01464827|582183233|FG009|Overall Study|Adverse Event|0|||
161218820|NCT01464827|582183234|FG010|Overall Study|Adverse Event|0|||
161218821|NCT01464827|582183235|FG011|Overall Study|Adverse Event|0|||
161218822|NCT01464827|582183236|FG012|Overall Study|Adverse Event|1|||
161218823|NCT01464827|582183237|FG013|Overall Study|Adverse Event|0|||
160870431|NCT01006291|580918951|FG001|Overall Study|Other|14|||
160870432|NCT01006291|580918952|FG002|Overall Study|Other|17|||
161218824|NCT01464827|582183224|FG000|Overall Study|Withdrawal by Subject|1|||
160870433|NCT00684060|580918953|FG000|Overall Study|Lost to Follow-up|1|||
161218825|NCT01464827|582183225|FG001|Overall Study|Withdrawal by Subject|0|||
161218826|NCT01464827|582183226|FG002|Overall Study|Withdrawal by Subject|0|||
160870434|NCT00684060|580918954|FG001|Overall Study|Lost to Follow-up|0|||
160870435|NCT00684060|580918953|FG000|Overall Study|New stenosis identified|1|||
160870436|NCT00684060|580918954|FG001|Overall Study|New stenosis identified|0|||
161218827|NCT01464827|582183227|FG003|Overall Study|Withdrawal by Subject|0|||
161218828|NCT01464827|582183228|FG004|Overall Study|Withdrawal by Subject|1|||
161218829|NCT01464827|582183229|FG005|Overall Study|Withdrawal by Subject|0|||
161218830|NCT01464827|582183230|FG006|Overall Study|Withdrawal by Subject|0|||
160870437|NCT00684060|580918953|FG000|Overall Study|Unable to collect MRI|1|||
160870438|NCT00684060|580918954|FG001|Overall Study|Unable to collect MRI|2|||
160870439|NCT00684060|580918953|FG000|Overall Study|Death|0|||
161218831|NCT01464827|582183231|FG007|Overall Study|Withdrawal by Subject|1|||
160870440|NCT00684060|580918954|FG001|Overall Study|Death|1|||
160870441|NCT00702715|580918959|FG000|Overall Study|Lost to Follow-up|1|||
160870442|NCT00702715|580918960|FG001|Overall Study|Lost to Follow-up|0|||
160870443|NCT01677377|580918961|FG000|Overall Study|Protocol Violation|1|||
160870444|NCT01677377|580918962|FG001|Overall Study|Protocol Violation|0|||
160870445|NCT01677377|580918963|FG002|Overall Study|Protocol Violation|0|||
160870446|NCT01677377|580918961|FG000|Overall Study|Lost to Follow-up|0|||
160870447|NCT01677377|580918962|FG001|Overall Study|Lost to Follow-up|1|||
160870448|NCT01677377|580918963|FG002|Overall Study|Lost to Follow-up|1|||
160870449|NCT01677377|580918961|FG000|Overall Study|Withdrawal by Subject|0|||
160870450|NCT01677377|580918962|FG001|Overall Study|Withdrawal by Subject|0|||
160870451|NCT01677377|580918963|FG002|Overall Study|Withdrawal by Subject|3|||
160870452|NCT01677377|580918961|FG000|Overall Study|Lack of Efficacy|0|||
160870453|NCT01677377|580918962|FG001|Overall Study|Lack of Efficacy|0|||
160870454|NCT01677377|580918963|FG002|Overall Study|Lack of Efficacy|1|||
160870455|NCT01677377|580918961|FG000|Overall Study|Pregnancy|0|||
160870456|NCT01677377|580918962|FG001|Overall Study|Pregnancy|0|||
160870457|NCT01677377|580918963|FG002|Overall Study|Pregnancy|1|||
160870458|NCT02260180|580918964|FG000|Overall Study|Adverse Event|2|||
160870459|NCT02260180|580918965|FG001|Overall Study|Adverse Event|0|||
160870460|NCT02260180|580918966|FG002|Overall Study|Adverse Event|1|||
160870461|NCT01193257|580918967|FG000|Overall Study|Death|202|||
160870462|NCT01193257|580918968|FG001|Overall Study|Death|391|||
160870463|NCT01193257|580918967|FG000|Overall Study|Study termination by sponsor|0|||
160870464|NCT01193257|580918968|FG001|Overall Study|Study termination by sponsor|3|||
160870465|NCT01193257|580918967|FG000|Overall Study|Withdrawal by Subject|26|||
160870466|NCT01193257|580918968|FG001|Overall Study|Withdrawal by Subject|86|||
160870467|NCT01193257|580918967|FG000|Overall Study|Lost to Follow-up|2|||
160870468|NCT01193257|580918968|FG001|Overall Study|Lost to Follow-up|3|||
161114185|NCT01496885|581808335|FG000|Overall Study|Withdrawal by Subject|7|||
161114186|NCT01496885|581808335|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
161114187|NCT01496885|581808335|FG000|Overall Study|Death|1|||
161114188|NCT03273166|581808336|FG000|Overall Study|Withdrawn prior to Completion|31|||
161114189|NCT01294670|581808337|FG000|Overall Study|Not treated|1|||
161114190|NCT01294670|581808338|FG001|Overall Study|Not treated|0|||
161114191|NCT01294670|581808339|FG002|Overall Study|Not treated|0|||
161114192|NCT01294670|581808340|FG003|Overall Study|Not treated|0|||
161114193|NCT01294670|581808341|FG004|Overall Study|Not treated|0|||
161114194|NCT02083380|581808342|FG000|Overall Study|Lack of Efficacy|68|||
161114195|NCT02083380|581808343|FG001|Overall Study|Lack of Efficacy|79|||
161114196|NCT02083380|581808344|FG002|Overall Study|Lack of Efficacy|64|||
161114197|NCT02083380|581808342|FG000|Overall Study|Withdrawal by Subject|9|||
161114198|NCT02083380|581808343|FG001|Overall Study|Withdrawal by Subject|3|||
161114199|NCT02083380|581808344|FG002|Overall Study|Withdrawal by Subject|7|||
161114200|NCT02083380|581808342|FG000|Overall Study|Physician Decision|1|||
161114201|NCT02083380|581808343|FG001|Overall Study|Physician Decision|6|||
161114202|NCT02083380|581808344|FG002|Overall Study|Physician Decision|3|||
161114203|NCT02083380|581808342|FG000|Overall Study|Adverse Event|0|||
161114204|NCT02083380|581808343|FG001|Overall Study|Adverse Event|0|||
161114205|NCT02083380|581808344|FG002|Overall Study|Adverse Event|1|||
161114206|NCT02083380|581808342|FG000|Overall Study|Lost to Follow-up|5|||
161114207|NCT02083380|581808343|FG001|Overall Study|Lost to Follow-up|3|||
161114208|NCT02083380|581808344|FG002|Overall Study|Lost to Follow-up|3|||
161114209|NCT02083380|581808342|FG000|Overall Study|Other|8|||
161114210|NCT02083380|581808343|FG001|Overall Study|Other|4|||
161114211|NCT02083380|581808344|FG002|Overall Study|Other|6|||
161114212|NCT02412787|581808345|FG000|Overall Study|Withdrawal by Subject|9|||
161114213|NCT02412787|581808345|FG000|Overall Study|Participation Terminated by Investigator|1|||
161114214|NCT02412787|581808345|FG000|Overall Study|Site Terminated by Sponsor|21|||
161114215|NCT02412787|581808345|FG000|Overall Study|Technical Problems|1|||
161114216|NCT02412787|581808345|FG000|Overall Study|Reason Not Specified|1|||
161114217|NCT00001379|581808346|FG000|Initial Treatment|Disease progression|21|||
161114218|NCT00001379|581808347|FG001|Initial Treatment|Disease progression|3|||
160870469|NCT01193257|580918967|FG000|Overall Study|Unblinded due to futility|135|||
160870470|NCT01193257|580918968|FG001|Overall Study|Unblinded due to futility|251|||
160870471|NCT01330108|580918984|FG000|Overall Study|Withdrawal by Subject|4|||
161114219|NCT00001379|581808348|FG002|Initial Treatment|Disease progression|0|||
161114220|NCT00001379|581808349|FG003|Initial Treatment|Disease progression|0|||
161114221|NCT00001379|581808346|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
161114222|NCT00001379|581808347|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
161114223|NCT00001379|581808348|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
161114224|NCT00001379|581808349|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
161114225|NCT00001379|581808346|FG000|Initial Treatment|Received alternative treatment|2|||
161114226|NCT00001379|581808347|FG001|Initial Treatment|Received alternative treatment|1|||
160870472|NCT04849559|580918989|FG000|Overall Study|Withdrawal by Subject|2|||
160870473|NCT04849559|580918990|FG001|Overall Study|Withdrawal by Subject|1|||
160870474|NCT02910986|580918991|FG000|Overall Study|non-Latina|14|||
160870475|NCT02910986|580918992|FG001|Overall Study|non-Latina|13|||
160870476|NCT02910986|580918993|FG002|Overall Study|non-Latina|12|||
161218832|NCT01464827|582183232|FG008|Overall Study|Withdrawal by Subject|0|||
161218833|NCT01464827|582183233|FG009|Overall Study|Withdrawal by Subject|0|||
161218834|NCT01464827|582183234|FG010|Overall Study|Withdrawal by Subject|0|||
161218835|NCT01464827|582183235|FG011|Overall Study|Withdrawal by Subject|0|||
160870477|NCT02910986|580918991|FG000|Overall Study|Failure to return T! survey|72|||
160870478|NCT02910986|580918992|FG001|Overall Study|Failure to return T! survey|84|||
160870479|NCT02910986|580918993|FG002|Overall Study|Failure to return T! survey|72|||
160870480|NCT02910986|580918991|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
160870481|NCT02910986|580918992|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
160870482|NCT02910986|580918993|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
160870483|NCT02910986|580918991|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
160870484|NCT02910986|580918992|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
160870485|NCT02910986|580918993|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
160870486|NCT02304367|580918994|FG000|Overall Study|Lack of Response to Bruosumab|1|||
160870487|NCT02304367|580918994|FG000|Overall Study|Sponsor Decision|3|||
160870488|NCT02304367|580918994|FG000|Overall Study|Death|2|||
160870489|NCT02304367|580918994|FG000|Overall Study|Physician Decision|1|||
160870490|NCT02304367|580918994|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
160870491|NCT03527732|580918995|FG000|Overall Study|Lost to Follow-up|21|||
160870492|NCT03527732|580918996|FG001|Overall Study|Lost to Follow-up|23|||
160870493|NCT03527732|580918997|FG002|Overall Study|Lost to Follow-up|80|||
160870494|NCT03527732|580918998|FG003|Overall Study|Lost to Follow-up|62|||
160870495|NCT03527732|580918999|FG004|Overall Study|Lost to Follow-up|12|||
160870496|NCT03527732|580919000|FG005|Overall Study|Lost to Follow-up|20|||
160870497|NCT00470275|580919001|FG000|Overall Study|Death|1|||
160870498|NCT00470275|580919001|FG000|Overall Study|Lack of Efficacy|7|||
160870499|NCT00470275|580919001|FG000|Overall Study|Withdrawal by Subject|2|||
160870500|NCT02207088|580919002|FG000|Overall Study|Adverse Event|2|||
160870501|NCT03306173|580919004|FG000|Overall Study|Lost to Follow-up|16|||
160870502|NCT03306173|580919005|FG001|Overall Study|Lost to Follow-up|23|||
161218836|NCT01464827|582183236|FG012|Overall Study|Withdrawal by Subject|0|||
161218837|NCT01464827|582183237|FG013|Overall Study|Withdrawal by Subject|0|||
161218838|NCT01464827|582183224|FG000|Overall Study|Lost to Follow-up|0|||
161218839|NCT01464827|582183225|FG001|Overall Study|Lost to Follow-up|2|||
161218840|NCT01464827|582183226|FG002|Overall Study|Lost to Follow-up|0|||
161218841|NCT01464827|582183227|FG003|Overall Study|Lost to Follow-up|2|||
161218842|NCT01464827|582183228|FG004|Overall Study|Lost to Follow-up|3|||
161218843|NCT01464827|582183229|FG005|Overall Study|Lost to Follow-up|1|||
161218844|NCT01464827|582183230|FG006|Overall Study|Lost to Follow-up|2|||
161218845|NCT01464827|582183231|FG007|Overall Study|Lost to Follow-up|2|||
161218846|NCT01464827|582183232|FG008|Overall Study|Lost to Follow-up|0|||
161218847|NCT01464827|582183233|FG009|Overall Study|Lost to Follow-up|0|||
161218848|NCT01464827|582183234|FG010|Overall Study|Lost to Follow-up|0|||
161218849|NCT01464827|582183235|FG011|Overall Study|Lost to Follow-up|1|||
161218850|NCT01464827|582183236|FG012|Overall Study|Lost to Follow-up|0|||
161218851|NCT01464827|582183237|FG013|Overall Study|Lost to Follow-up|1|||
161218852|NCT01464827|582183224|FG000|Overall Study|Other|2|||
161218853|NCT01464827|582183225|FG001|Overall Study|Other|3|||
161218854|NCT01464827|582183226|FG002|Overall Study|Other|0|||
161218855|NCT01464827|582183227|FG003|Overall Study|Other|2|||
161218856|NCT01464827|582183228|FG004|Overall Study|Other|3|||
161218857|NCT01464827|582183229|FG005|Overall Study|Other|0|||
161218858|NCT01464827|582183230|FG006|Overall Study|Other|1|||
161218859|NCT01464827|582183231|FG007|Overall Study|Other|0|||
161218860|NCT01464827|582183232|FG008|Overall Study|Other|3|||
160870503|NCT03306173|580919004|FG000|Overall Study|Withdrawal by Subject|4|||
160870504|NCT03306173|580919005|FG001|Overall Study|Withdrawal by Subject|3|||
160870505|NCT03306173|580919004|FG000|Overall Study|Discontinued|4|||
160870506|NCT03306173|580919005|FG001|Overall Study|Discontinued|4|||
160870507|NCT00573144|580919006|FG000|Overall Study|Withdrawal by Subject|2|||
160870508|NCT00573144|580919007|FG001|Overall Study|Withdrawal by Subject|3|||
160870509|NCT03339219|580919010|FG000|Overall Study|Death|12|||
160870510|NCT03339219|580919010|FG000|Overall Study|Site Terminated by Sponsor|22|||
161218861|NCT01464827|582183233|FG009|Overall Study|Other|1|||
161218862|NCT01464827|582183234|FG010|Overall Study|Other|2|||
161218863|NCT01464827|582183235|FG011|Overall Study|Other|0|||
161218864|NCT01464827|582183236|FG012|Overall Study|Other|1|||
161218865|NCT01464827|582183237|FG013|Overall Study|Other|0|||
161218866|NCT01464827|582183224|FG000|Overall Study|Not Treated|0|||
161218867|NCT01464827|582183225|FG001|Overall Study|Not Treated|2|||
160870511|NCT03339219|580919010|FG000|Overall Study|Withdrawal by Subject|1|||
160870512|NCT03155841|580919016|FG000|Overall Study|Protocol Violation|3|||
160870513|NCT03155841|580919017|FG001|Overall Study|Protocol Violation|4|||
160870514|NCT04308291|580919018|FG000|Run-In Phase|Withdrawal by Subject|4|||
160870515|NCT04308291|580919018|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
161218868|NCT01464827|582183226|FG002|Overall Study|Not Treated|0|||
161218869|NCT01464827|582183227|FG003|Overall Study|Not Treated|0|||
161218870|NCT01464827|582183228|FG004|Overall Study|Not Treated|1|||
161218871|NCT01464827|582183229|FG005|Overall Study|Not Treated|0|||
161218872|NCT01464827|582183230|FG006|Overall Study|Not Treated|1|||
161218873|NCT01464827|582183231|FG007|Overall Study|Not Treated|0|||
161218874|NCT01464827|582183232|FG008|Overall Study|Not Treated|0|||
161218875|NCT01464827|582183233|FG009|Overall Study|Not Treated|2|||
161218876|NCT01464827|582183234|FG010|Overall Study|Not Treated|0|||
161218877|NCT01464827|582183235|FG011|Overall Study|Not Treated|1|||
161218878|NCT01464827|582183236|FG012|Overall Study|Not Treated|0|||
161218879|NCT01464827|582183237|FG013|Overall Study|Not Treated|2|||
161218880|NCT01075763|582183238|FG000|Overall Study|Lost to Follow-up|2|||
161218881|NCT01075763|582183239|FG001|Overall Study|Lost to Follow-up|1|||
161218882|NCT01075763|582183238|FG000|Overall Study|Lack of Efficacy|0|||
160870516|NCT04308291|580919018|FG000|Study Phase 6-M|Physician Decision|2|||
160870517|NCT04308291|580919018|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
160870518|NCT04308291|580919018|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
160870519|NCT04308291|580919018|FG000|Study Phase 12-M|Physician Decision|2|||
160870520|NCT04308291|580919018|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
160870521|NCT04411667|580919019|FG000|Overall Study|Physician Decision|1|||
160870522|NCT04411667|580919020|FG001|Overall Study|Physician Decision|0|||
160870523|NCT00714870|580919024|FG000|Overall Study|Lost to Follow-up|22|||
160870524|NCT00714870|580919025|FG001|Overall Study|Lost to Follow-up|5|||
160870525|NCT00714870|580919024|FG000|Overall Study|patient unable to come b/c back pain|1|||
160870526|NCT00714870|580919025|FG001|Overall Study|patient unable to come b/c back pain|0|||
160870527|NCT00714870|580919024|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
160870528|NCT00714870|580919025|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
160870529|NCT03399552|580919026|FG000|Overall Study|No evidence of disease|1|||
160870530|NCT03399552|580919026|FG000|Overall Study|Unevaluable|1|||
160870531|NCT02357368|580919027|FG000|Overall Study|Lost to Follow-up|0|||
160870532|NCT02357368|580919028|FG001|Overall Study|Lost to Follow-up|0|||
160870533|NCT02357368|580919029|FG002|Overall Study|Lost to Follow-up|0|||
160870534|NCT02357368|580919030|FG003|Overall Study|Lost to Follow-up|1|||
161218883|NCT01075763|582183239|FG001|Overall Study|Lack of Efficacy|1|||
161218884|NCT01075763|582183238|FG000|Overall Study|Withdrawal by Subject|2|||
161218885|NCT01075763|582183239|FG001|Overall Study|Withdrawal by Subject|2|||
161218886|NCT00586521|582183240|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
161218887|NCT03083483|582183241|FG000|Overall Study|Adverse Event|1|||
161218888|NCT03083483|582183242|FG001|Overall Study|Adverse Event|1|||
161218889|NCT03083483|582183243|FG002|Overall Study|Adverse Event|1|||
161218890|NCT03083483|582183241|FG000|Overall Study|Lost to Follow-up|2|||
161218891|NCT03083483|582183242|FG001|Overall Study|Lost to Follow-up|1|||
161218892|NCT03083483|582183243|FG002|Overall Study|Lost to Follow-up|1|||
161218893|NCT03083483|582183241|FG000|Overall Study|technological issues|1|||
161218894|NCT03083483|582183242|FG001|Overall Study|technological issues|0|||
161218895|NCT03083483|582183243|FG002|Overall Study|technological issues|1|||
161218896|NCT02710071|582183244|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
161218897|NCT02710071|582183245|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
161218898|NCT02710071|582183244|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
161218899|NCT02710071|582183245|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
161218900|NCT01751412|582183251|FG000|Overall Study|Disease Progression Before Treatment|1|||
161218901|NCT03734237|582183252|FG000|Overall Study|Lost to Follow-up|1|||
161218902|NCT03734237|582183253|FG001|Overall Study|Lost to Follow-up|3|||
161218903|NCT03734237|582183254|FG002|Overall Study|Lost to Follow-up|0|||
161218904|NCT03734237|582183252|FG000|Overall Study|Withdrawal by Subject|7|||
161218905|NCT03734237|582183253|FG001|Overall Study|Withdrawal by Subject|9|||
161218906|NCT03734237|582183254|FG002|Overall Study|Withdrawal by Subject|10|||
161218907|NCT01844583|582183255|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
161218908|NCT01844583|582183256|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
161218909|NCT00958256|582183258|FG000|Overall Study|Adverse Event|3|||
161218910|NCT05431153|582183259|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161218911|NCT05431153|582183260|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160870535|NCT02357368|580919027|FG000|Overall Study|Pregnancy|3|||
160870536|NCT02357368|580919028|FG001|Overall Study|Pregnancy|2|||
160870537|NCT02357368|580919029|FG002|Overall Study|Pregnancy|0|||
160870538|NCT02357368|580919030|FG003|Overall Study|Pregnancy|0|||
160870539|NCT02357368|580919027|FG000|Overall Study|Withdrawal by Subject|3|||
160870540|NCT02357368|580919028|FG001|Overall Study|Withdrawal by Subject|1|||
161218912|NCT05431153|582183261|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161218913|NCT05431153|582183262|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161218914|NCT05431153|582183263|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161218915|NCT05431153|582183264|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161218916|NCT00989261|582183265|FG000|Overall Study|Still in follow up|12|||
161218917|NCT00989261|582183266|FG001|Overall Study|Still in follow up|21|||
161218918|NCT00989261|582183265|FG000|Overall Study|Withdrawal by Subject|0|||
161218919|NCT00989261|582183266|FG001|Overall Study|Withdrawal by Subject|1|||
160870541|NCT02357368|580919029|FG002|Overall Study|Withdrawal by Subject|1|||
160870542|NCT02357368|580919030|FG003|Overall Study|Withdrawal by Subject|2|||
161218920|NCT00989261|582183265|FG000|Overall Study|Lost to Follow-up|3|||
160870543|NCT01931566|580919031|FG000|Overall Study|Randomized But Not Treated|6|||
160870544|NCT01931566|580919032|FG001|Overall Study|Randomized But Not Treated|9|||
160870545|NCT01931566|580919033|FG002|Overall Study|Randomized But Not Treated|14|||
160870546|NCT01931566|580919031|FG000|Overall Study|Adverse Event|37|||
160870547|NCT01931566|580919032|FG001|Overall Study|Adverse Event|167|||
160870548|NCT01931566|580919033|FG002|Overall Study|Adverse Event|132|||
161218921|NCT00989261|582183266|FG001|Overall Study|Lost to Follow-up|0|||
161218922|NCT00782509|582183267|FG000|Overall Study|Adverse Event|20|||
160870549|NCT01931566|580919031|FG000|Overall Study|Major Protocol Deviation|5|||
160870550|NCT01931566|580919032|FG001|Overall Study|Major Protocol Deviation|14|||
160870551|NCT01931566|580919033|FG002|Overall Study|Major Protocol Deviation|21|||
160870552|NCT01931566|580919031|FG000|Overall Study|Lost to Follow-up|3|||
160870553|NCT01931566|580919032|FG001|Overall Study|Lost to Follow-up|26|||
161218923|NCT00782509|582183268|FG001|Overall Study|Adverse Event|10|||
161218924|NCT00782509|582183269|FG002|Overall Study|Adverse Event|20|||
161218925|NCT00782509|582183267|FG000|Overall Study|Lost to Follow-up|1|||
161218926|NCT00782509|582183268|FG001|Overall Study|Lost to Follow-up|2|||
161218927|NCT00782509|582183269|FG002|Overall Study|Lost to Follow-up|3|||
161218928|NCT00782509|582183267|FG000|Overall Study|Withdrawal by Subject|3|||
161218929|NCT00782509|582183268|FG001|Overall Study|Withdrawal by Subject|5|||
161218930|NCT00782509|582183269|FG002|Overall Study|Withdrawal by Subject|8|||
161218931|NCT00782509|582183267|FG000|Overall Study|Non compliance with protocol|2|||
161218932|NCT00782509|582183268|FG001|Overall Study|Non compliance with protocol|0|||
161218933|NCT00782509|582183269|FG002|Overall Study|Non compliance with protocol|0|||
161218934|NCT00782509|582183267|FG000|Overall Study|Other reasons not stated above|5|||
161218935|NCT00782509|582183268|FG001|Overall Study|Other reasons not stated above|2|||
161218936|NCT00782509|582183269|FG002|Overall Study|Other reasons not stated above|3|||
161218937|NCT00782509|582183267|FG000|Overall Study|Lack of Efficacy|10|||
161218938|NCT00782509|582183268|FG001|Overall Study|Lack of Efficacy|5|||
161218939|NCT00782509|582183269|FG002|Overall Study|Lack of Efficacy|2|||
161218940|NCT01798485|582183270|FG000|Overall Study|Adverse Event|32|||
161218941|NCT01798485|582183271|FG001|Overall Study|Adverse Event|40|||
161218942|NCT01798485|582183270|FG000|Overall Study|Withdrawal by Subject|27|||
161218943|NCT01798485|582183271|FG001|Overall Study|Withdrawal by Subject|31|||
161218944|NCT01798485|582183270|FG000|Overall Study|Lost to Follow-up|0|||
161218945|NCT01798485|582183271|FG001|Overall Study|Lost to Follow-up|3|||
161218946|NCT01798485|582183270|FG000|Overall Study|Physician Decision|14|||
161218947|NCT01798485|582183271|FG001|Overall Study|Physician Decision|10|||
161218948|NCT01798485|582183270|FG000|Overall Study|Objective Disease Progression|152|||
161218949|NCT01798485|582183271|FG001|Overall Study|Objective Disease Progression|106|||
161218950|NCT01798485|582183270|FG000|Overall Study|Death|25|||
161218951|NCT01798485|582183271|FG001|Overall Study|Death|22|||
161218952|NCT01798485|582183270|FG000|Overall Study|Sponsor Decision|61|||
161218953|NCT01798485|582183271|FG001|Overall Study|Sponsor Decision|54|||
161218954|NCT01798485|582183270|FG000|Overall Study|Clinical Progression|35|||
161218955|NCT01798485|582183271|FG001|Overall Study|Clinical Progression|24|||
160870554|NCT01931566|580919033|FG002|Overall Study|Lost to Follow-up|23|||
160870555|NCT01931566|580919031|FG000|Overall Study|Voluntary Withdrawal|78|||
160870556|NCT01931566|580919032|FG001|Overall Study|Voluntary Withdrawal|245|||
160870557|NCT01931566|580919033|FG002|Overall Study|Voluntary Withdrawal|225|||
160870558|NCT01931566|580919031|FG000|Overall Study|Study Termination|289|||
160870559|NCT01931566|580919032|FG001|Overall Study|Study Termination|968|||
160870560|NCT01931566|580919033|FG002|Overall Study|Study Termination|1037|||
160870561|NCT01931566|580919031|FG000|Overall Study|Reason Not Specified|11|||
160870562|NCT01931566|580919032|FG001|Overall Study|Reason Not Specified|47|||
160870563|NCT01931566|580919033|FG002|Overall Study|Reason Not Specified|53|||
160870564|NCT01931566|580919031|FG000|Overall Study|Missing|0|||
160870565|NCT01931566|580919032|FG001|Overall Study|Missing|0|||
160870566|NCT01931566|580919033|FG002|Overall Study|Missing|1|||
160870567|NCT01147874|580919038|FG000|Overall Study|Adverse Event|5|||
160870568|NCT01147874|580919038|FG000|Overall Study|Investigator's Request|1|||
160870569|NCT01147874|580919038|FG000|Overall Study|Lost to Follow-up|25|||
161218956|NCT03687125|582183272|FG000|Overall Study|Progressive Disease|2|||
161218957|NCT03687125|582183273|FG001|Overall Study|Progressive Disease|1|||
161218958|NCT03687125|582183272|FG000|Overall Study|Protocol Violation|1|||
161218959|NCT03687125|582183273|FG001|Overall Study|Protocol Violation|0|||
161218960|NCT00770991|582183274|FG000|Overall Study|Physician Decision|2|||
161218961|NCT00770991|582183275|FG001|Overall Study|Physician Decision|0|||
161218962|NCT00770991|582183274|FG000|Overall Study|Withdrawal by Subject|1|||
161218963|NCT00770991|582183275|FG001|Overall Study|Withdrawal by Subject|0|||
161218964|NCT00770991|582183274|FG000|Overall Study|Adverse Event|1|||
161218965|NCT00770991|582183275|FG001|Overall Study|Adverse Event|5|||
161218966|NCT00770991|582183274|FG000|Overall Study|Pregnancy|1|||
161218967|NCT00770991|582183275|FG001|Overall Study|Pregnancy|0|||
161218968|NCT01992107|582183276|FG000|Overall Study|Administrative reasons|2|||
160870570|NCT01147874|580919038|FG000|Overall Study|Other|5|||
160870571|NCT01147874|580919038|FG000|Overall Study|Protocol Violation|5|||
160870572|NCT01147874|580919038|FG000|Overall Study|Sponsor's Decision|2|||
161218969|NCT01992107|582183277|FG001|Overall Study|Administrative reasons|0|||
161114227|NCT00001379|581808348|FG002|Initial Treatment|Received alternative treatment|0|||
161114228|NCT00001379|581808349|FG003|Initial Treatment|Received alternative treatment|0|||
161114229|NCT00001379|581808346|FG000|Initial Treatment|Refused further treatment|2|||
161114230|NCT00001379|581808347|FG001|Initial Treatment|Refused further treatment|0|||
161114231|NCT00001379|581808348|FG002|Initial Treatment|Refused further treatment|0|||
161114232|NCT00001379|581808349|FG003|Initial Treatment|Refused further treatment|0|||
161114233|NCT00001379|581808346|FG000|Initial Treatment|Did not receive protocol treatment|0|||
161114234|NCT00001379|581808347|FG001|Initial Treatment|Did not receive protocol treatment|0|||
161114235|NCT00001379|581808348|FG002|Initial Treatment|Did not receive protocol treatment|5|||
161114236|NCT00001379|581808349|FG003|Initial Treatment|Did not receive protocol treatment|0|||
161114237|NCT00001379|581808346|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161114238|NCT00001379|581808347|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161114239|NCT00001379|581808348|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
161114240|NCT00001379|581808349|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
161114241|NCT00001379|581808346|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
161114242|NCT00001379|581808347|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
161114243|NCT00001379|581808348|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
161114244|NCT00001379|581808349|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
161114245|NCT00001379|581808346|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
161114246|NCT00001379|581808347|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
161114247|NCT00001379|581808348|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
161114248|NCT00001379|581808349|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
161114249|NCT00001379|581808346|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
161114250|NCT00001379|581808347|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161114251|NCT00001379|581808348|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161114252|NCT00001379|581808349|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
161114253|NCT00001379|581808346|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
161114254|NCT00001379|581808347|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
161114255|NCT00001379|581808348|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
161114256|NCT00001379|581808349|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
161114257|NCT01032915|581808352|FG000|Overall Study|Adverse Event|2|||
161114258|NCT01032915|581808353|FG001|Overall Study|Adverse Event|2|||
161114259|NCT01032915|581808354|FG002|Overall Study|Adverse Event|1|||
161114260|NCT01032915|581808355|FG003|Overall Study|Adverse Event|1|||
161114261|NCT01032915|581808352|FG000|Overall Study|Abnormal test procedure result|0|||
161114262|NCT01032915|581808353|FG001|Overall Study|Abnormal test procedure result|0|||
161114263|NCT01032915|581808354|FG002|Overall Study|Abnormal test procedure result|1|||
161114264|NCT01032915|581808355|FG003|Overall Study|Abnormal test procedure result|0|||
161114265|NCT01032915|581808352|FG000|Overall Study|Withdrawal by Subject|0|||
161114266|NCT01032915|581808353|FG001|Overall Study|Withdrawal by Subject|3|||
161114267|NCT01032915|581808354|FG002|Overall Study|Withdrawal by Subject|1|||
161114268|NCT01032915|581808355|FG003|Overall Study|Withdrawal by Subject|1|||
161114269|NCT01032915|581808352|FG000|Overall Study|Administrative reasons|5|||
161114270|NCT01032915|581808353|FG001|Overall Study|Administrative reasons|6|||
161114271|NCT01032915|581808354|FG002|Overall Study|Administrative reasons|4|||
161114272|NCT01032915|581808355|FG003|Overall Study|Administrative reasons|4|||
161114273|NCT01032915|581808352|FG000|Overall Study|Protocol Violation|1|||
161114274|NCT01032915|581808353|FG001|Overall Study|Protocol Violation|0|||
161114275|NCT01032915|581808354|FG002|Overall Study|Protocol Violation|0|||
161114276|NCT01032915|581808355|FG003|Overall Study|Protocol Violation|1|||
161114277|NCT01577186|581808356|FG000|Overall Study|Adverse Event|23|||
161114278|NCT01577186|581808356|FG000|Overall Study|Death|1|||
161114279|NCT01577186|581808356|FG000|Overall Study|Lost to Follow-up|28|||
161114280|NCT01577186|581808356|FG000|Overall Study|Withdrawal by Subject|35|||
161114281|NCT01577186|581808356|FG000|Overall Study|Insufficient Response|18|||
161114282|NCT01577186|581808356|FG000|Overall Study|Ineligible to Continue|15|||
161114283|NCT01577186|581808356|FG000|Overall Study|Non-Compliant|8|||
161114284|NCT01577186|581808356|FG000|Overall Study|Other|2|||
161114285|NCT02797808|581808358|FG000|Overall Study|Withdrawal by Subject|1|||
161114286|NCT02797808|581808359|FG001|Overall Study|Withdrawal by Subject|1|||
161114287|NCT02797808|581808358|FG000|Overall Study|Physician Decision|6|||
161114288|NCT02797808|581808359|FG001|Overall Study|Physician Decision|2|||
161114289|NCT00535132|581808362|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
161114290|NCT00535132|581808363|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
161114291|NCT00535132|581808362|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
161218970|NCT01992107|582183278|FG002|Overall Study|Administrative reasons|0|||
161114292|NCT00535132|581808363|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
161218971|NCT01992107|582183276|FG000|Overall Study|Adverse Event|0|||
161218972|NCT01992107|582183277|FG001|Overall Study|Adverse Event|1|||
160870573|NCT01147874|580919038|FG000|Overall Study|Withdrawal by Subject|24|||
160870574|NCT02991040|580919039|FG000|Overall Study|Withdrawal by Subject|2|||
160870575|NCT02991040|580919039|FG000|Overall Study|Lost to Follow-up|2|||
161114293|NCT00264875|581808364|FG000|Overall Study|Adverse Event|6|||
161114294|NCT00264875|581808364|FG000|Overall Study|Lost to Follow-up|6|||
161114295|NCT00264875|581808364|FG000|Overall Study|Protocol Violation|11|||
161114296|NCT00264875|581808364|FG000|Overall Study|Withdrawal by Subject|7|||
161114297|NCT01157364|581808367|FG000|Overall Study|Other Reasons|1|||
161114298|NCT01157364|581808368|FG001|Overall Study|Other Reasons|1|||
161114299|NCT01157364|581808369|FG002|Overall Study|Other Reasons|2|||
161114300|NCT01157364|581808370|FG003|Overall Study|Other Reasons|1|||
161114301|NCT01157364|581808371|FG004|Overall Study|Other Reasons|0|||
161114302|NCT01157364|581808372|FG005|Overall Study|Other Reasons|0|||
161114303|NCT01157364|581808367|FG000|Overall Study|Personal Reasons|0|||
161114304|NCT01157364|581808368|FG001|Overall Study|Personal Reasons|2|||
161114305|NCT01157364|581808369|FG002|Overall Study|Personal Reasons|0|||
161114306|NCT01157364|581808370|FG003|Overall Study|Personal Reasons|0|||
161114307|NCT01157364|581808371|FG004|Overall Study|Personal Reasons|1|||
161114308|NCT01157364|581808372|FG005|Overall Study|Personal Reasons|1|||
161114309|NCT01157364|581808367|FG000|Overall Study|Lost to Follow-up|1|||
161114310|NCT01157364|581808368|FG001|Overall Study|Lost to Follow-up|0|||
161114311|NCT01157364|581808369|FG002|Overall Study|Lost to Follow-up|1|||
161114312|NCT01157364|581808370|FG003|Overall Study|Lost to Follow-up|0|||
161114313|NCT01157364|581808371|FG004|Overall Study|Lost to Follow-up|0|||
161114314|NCT01157364|581808372|FG005|Overall Study|Lost to Follow-up|0|||
161114315|NCT01157364|581808367|FG000|Overall Study|Lack of Efficacy|0|||
161114316|NCT01157364|581808368|FG001|Overall Study|Lack of Efficacy|0|||
161114317|NCT01157364|581808369|FG002|Overall Study|Lack of Efficacy|0|||
161114318|NCT01157364|581808370|FG003|Overall Study|Lack of Efficacy|1|||
161114319|NCT01157364|581808371|FG004|Overall Study|Lack of Efficacy|0|||
161114320|NCT01157364|581808372|FG005|Overall Study|Lack of Efficacy|0|||
161114321|NCT01157364|581808367|FG000|Overall Study|Adverse Event|0|||
161114322|NCT01157364|581808368|FG001|Overall Study|Adverse Event|1|||
161114323|NCT01157364|581808369|FG002|Overall Study|Adverse Event|1|||
161114324|NCT01157364|581808370|FG003|Overall Study|Adverse Event|0|||
161114325|NCT01157364|581808371|FG004|Overall Study|Adverse Event|1|||
161114326|NCT01157364|581808372|FG005|Overall Study|Adverse Event|0|||
161114327|NCT00586495|581808377|FG000|Treatment Period|Adverse Event|11|||
161114328|NCT00586495|581808377|FG000|Treatment Period|Death|1|||
161114329|NCT00586495|581808377|FG000|Treatment Period|Protocol Violation|1|||
161114330|NCT00586495|581808377|FG000|Treatment Period|Withdrawal by Subject|1|||
161114331|NCT00586495|581808377|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
161114332|NCT00586495|581808377|FG000|Treatment Period|Switch to commercial drug|10|||
161114333|NCT00586495|581808377|FG000|Follow-up|Death|40|||
161114334|NCT00586495|581808377|FG000|Follow-up|Lost to Follow-up|1|||
161114335|NCT00586495|581808377|FG000|Follow-up|Withdrawal by Subject|4|||
161114336|NCT00586495|581808377|FG000|Follow-up|Protocol driven decision point|37|||
161114337|NCT00586495|581808377|FG000|Follow-up|Switch to commercial drug|10|||
161114338|NCT00143312|581808378|FG000|Overall Study|Death|11|||
161114339|NCT00143312|581808378|FG000|Overall Study|Adverse Event|2|||
161114340|NCT00143312|581808378|FG000|Overall Study|Lost to Follow-up|1|||
161114341|NCT00143312|581808378|FG000|Overall Study|Other|1|||
161114342|NCT00143312|581808378|FG000|Overall Study|Withdrawal by Subject|1|||
161114343|NCT01029366|581808379|FG000|Overall Study|Withdrawal by Subject|1|||
161114344|NCT01029366|581808380|FG001|Overall Study|Withdrawal by Subject|0|||
161114345|NCT01029366|581808379|FG000|Overall Study|Death|1|||
161114346|NCT01029366|581808380|FG001|Overall Study|Death|1|||
161114347|NCT01029366|581808379|FG000|Overall Study|disease progression|2|||
161114348|NCT01029366|581808380|FG001|Overall Study|disease progression|0|||
161114349|NCT01029366|581808379|FG000|Overall Study|manufacturing failure|0|||
160870576|NCT04287517|580919040|FG000|Overall Study|Withdrawal by Subject|1|||
160870577|NCT04287517|580919041|FG001|Overall Study|Withdrawal by Subject|1|||
161114350|NCT01029366|581808380|FG001|Overall Study|manufacturing failure|1|||
161114351|NCT01046877|581808381|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
161114352|NCT01046877|581808381|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
161114353|NCT01827670|581808382|FG000|Overall Study|Withdrawal of Consent|3|||
161114354|NCT01827670|581808383|FG001|Overall Study|Withdrawal of Consent|2|||
161114355|NCT01827670|581808382|FG000|Overall Study|Lost to Follow-up|0|||
161114356|NCT01827670|581808383|FG001|Overall Study|Lost to Follow-up|1|||
160870578|NCT01869764|580919048|FG000|Overall Study|Withdrawal by Subject|0|||
161114357|NCT00563186|581808388|FG000|Overall Study|LOS<48 hours|97|||
161114358|NCT00563186|581808389|FG001|Overall Study|LOS<48 hours|74|||
161114359|NCT00563186|581808388|FG000|Overall Study|Incomplete data|1|||
161114360|NCT00563186|581808389|FG001|Overall Study|Incomplete data|1|||
161114361|NCT01136655|581808393|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
160870579|NCT01869764|580919049|FG001|Overall Study|Withdrawal by Subject|2|||
161114362|NCT01136655|581808393|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
161114363|NCT01136655|581808393|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
161218973|NCT01992107|582183278|FG002|Overall Study|Adverse Event|0|||
160870580|NCT02175030|580919050|FG000|Overall Study|Failed screen after consent|7|||
160870581|NCT02175030|580919051|FG001|Overall Study|Failed screen after consent|6|||
160870582|NCT02175030|580919050|FG000|Overall Study|Failed IUD Insertion|20|||
161114364|NCT01136655|581808393|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
161114365|NCT01970501|581808394|FG000|Overall Study|Discontinuation of study by sponsor|16|||
161114366|NCT01970501|581808395|FG001|Overall Study|Discontinuation of study by sponsor|14|||
161114367|NCT01970501|581808394|FG000|Overall Study|Withdrawal by Subject|6|||
161114368|NCT01970501|581808395|FG001|Overall Study|Withdrawal by Subject|7|||
161114369|NCT01970501|581808394|FG000|Overall Study|Adverse Event|2|||
161114370|NCT01970501|581808395|FG001|Overall Study|Adverse Event|4|||
161114371|NCT01970501|581808394|FG000|Overall Study|Death|1|||
161114372|NCT01970501|581808395|FG001|Overall Study|Death|3|||
161114373|NCT01970501|581808394|FG000|Overall Study|Physician Decision|2|||
161114374|NCT01970501|581808395|FG001|Overall Study|Physician Decision|0|||
161114375|NCT00708123|581808396|FG000|Period 1|Protocol Violation|0|||
161114376|NCT00708123|581808397|FG001|Period 1|Protocol Violation|1|||
161114377|NCT00708123|581808398|FG002|Period 1|Protocol Violation|0|||
161114378|NCT00708123|581808399|FG003|Period 1|Protocol Violation|1|||
161114379|NCT00708123|581808400|FG004|Period 1|Protocol Violation|0|||
161114380|NCT00708123|581808396|FG000|Period 1|Adverse Event|0|||
161114381|NCT00708123|581808397|FG001|Period 1|Adverse Event|0|||
161114382|NCT00708123|581808398|FG002|Period 1|Adverse Event|1|||
161114383|NCT00708123|581808399|FG003|Period 1|Adverse Event|0|||
161114384|NCT00708123|581808400|FG004|Period 1|Adverse Event|0|||
161114385|NCT00708123|581808396|FG000|Period 2|Protocol Violation|0|||
161114386|NCT00708123|581808397|FG001|Period 2|Protocol Violation|0|||
161114387|NCT00708123|581808398|FG002|Period 2|Protocol Violation|0|||
161114388|NCT00708123|581808399|FG003|Period 2|Protocol Violation|1|||
161114389|NCT00708123|581808400|FG004|Period 2|Protocol Violation|0|||
161114390|NCT00708123|581808396|FG000|Period 2|Other Reason|1|||
161114391|NCT00708123|581808397|FG001|Period 2|Other Reason|0|||
161114392|NCT00708123|581808398|FG002|Period 2|Other Reason|0|||
161114393|NCT00708123|581808399|FG003|Period 2|Other Reason|0|||
161114394|NCT00708123|581808400|FG004|Period 2|Other Reason|0|||
161114395|NCT00708123|581808396|FG000|Period 3|Lost to Follow-up|0|||
161114396|NCT00708123|581808397|FG001|Period 3|Lost to Follow-up|0|||
161114397|NCT00708123|581808398|FG002|Period 3|Lost to Follow-up|1|||
161114398|NCT00708123|581808399|FG003|Period 3|Lost to Follow-up|1|||
161114399|NCT00708123|581808400|FG004|Period 3|Lost to Follow-up|0|||
161114400|NCT00708123|581808396|FG000|Period 4|Protocol Violation|0|||
161114401|NCT00708123|581808397|FG001|Period 4|Protocol Violation|1|||
161114402|NCT00708123|581808398|FG002|Period 4|Protocol Violation|0|||
161114403|NCT00708123|581808399|FG003|Period 4|Protocol Violation|0|||
161114404|NCT00708123|581808400|FG004|Period 4|Protocol Violation|0|||
161114405|NCT02970292|581808401|FG000|Overall Study|Physician Decision|1|||
161114406|NCT02970292|581808402|FG001|Overall Study|Physician Decision|1|||
161114407|NCT02970292|581808401|FG000|Overall Study|Withdrawal by Subject|11|||
161114408|NCT02970292|581808402|FG001|Overall Study|Withdrawal by Subject|5|||
161114409|NCT02970292|581808401|FG000|Overall Study|Noncompliance with study drug|2|||
161114410|NCT02970292|581808402|FG001|Overall Study|Noncompliance with study drug|2|||
161114411|NCT02970292|581808401|FG000|Overall Study|Adverse Event|5|||
161114412|NCT02970292|581808402|FG001|Overall Study|Adverse Event|0|||
161114413|NCT02970292|581808401|FG000|Overall Study|Lack of Efficacy|1|||
161114414|NCT02970292|581808402|FG001|Overall Study|Lack of Efficacy|0|||
161114415|NCT02970292|581808401|FG000|Overall Study|Lost to Follow-up|1|||
161114416|NCT02970292|581808402|FG001|Overall Study|Lost to Follow-up|0|||
161114417|NCT02970292|581808401|FG000|Overall Study|Protocol Violation|2|||
161114418|NCT02970292|581808402|FG001|Overall Study|Protocol Violation|0|||
161114419|NCT02970292|581808401|FG000|Overall Study|Other|1|||
161114420|NCT02970292|581808402|FG001|Overall Study|Other|0|||
161114421|NCT00814892|581808403|FG000|Overall Study|Disease Progression|1|||
161114422|NCT00814892|581808403|FG000|Overall Study|Study Termination|1|||
161114423|NCT00845650|581808404|FG000|Overall Study|Withdrawal by Subject|0|||
161114424|NCT00845650|581808405|FG001|Overall Study|Withdrawal by Subject|0|||
161114425|NCT00845650|581808406|FG002|Overall Study|Withdrawal by Subject|0|||
161114426|NCT00845650|581808407|FG003|Overall Study|Withdrawal by Subject|0|||
161114427|NCT00845650|581808408|FG004|Overall Study|Withdrawal by Subject|2|||
161114428|NCT00845650|581808409|FG005|Overall Study|Withdrawal by Subject|0|||
161114429|NCT00845650|581808404|FG000|Overall Study|Lost to Follow-up|0|||
161114430|NCT00845650|581808405|FG001|Overall Study|Lost to Follow-up|0|||
161114431|NCT00845650|581808406|FG002|Overall Study|Lost to Follow-up|3|||
161114432|NCT00845650|581808407|FG003|Overall Study|Lost to Follow-up|1|||
161114433|NCT00845650|581808408|FG004|Overall Study|Lost to Follow-up|0|||
161114434|NCT00845650|581808409|FG005|Overall Study|Lost to Follow-up|1|||
161114435|NCT00845650|581808404|FG000|Overall Study|Sponsor hold on dosing|0|||
161114436|NCT00845650|581808405|FG001|Overall Study|Sponsor hold on dosing|0|||
161114437|NCT00845650|581808406|FG002|Overall Study|Sponsor hold on dosing|0|||
161114438|NCT00845650|581808407|FG003|Overall Study|Sponsor hold on dosing|0|||
161114439|NCT00845650|581808408|FG004|Overall Study|Sponsor hold on dosing|1|||
161114440|NCT00845650|581808409|FG005|Overall Study|Sponsor hold on dosing|1|||
160870583|NCT02175030|580919051|FG001|Overall Study|Failed IUD Insertion|21|||
160870584|NCT02175030|580919050|FG000|Overall Study|Physician Decision|1|||
160870585|NCT02175030|580919051|FG001|Overall Study|Physician Decision|1|||
160870586|NCT02175030|580919050|FG000|Overall Study|Lost to Follow-up|6|||
160870587|NCT02175030|580919051|FG001|Overall Study|Lost to Follow-up|6|||
160870588|NCT02175030|580919050|FG000|Overall Study|Withdrawal by Subject|1|||
161218974|NCT01992107|582183276|FG000|Overall Study|Lost to Follow-up|46|||
161218975|NCT01992107|582183277|FG001|Overall Study|Lost to Follow-up|22|||
161218976|NCT01992107|582183278|FG002|Overall Study|Lost to Follow-up|26|||
161218977|NCT01992107|582183276|FG000|Overall Study|noncompliance and were unavailable|7|||
161218978|NCT01992107|582183277|FG001|Overall Study|noncompliance and were unavailable|3|||
161218979|NCT01992107|582183278|FG002|Overall Study|noncompliance and were unavailable|2|||
161218980|NCT01992107|582183276|FG000|Overall Study|Withdrawal by Subject|13|||
161218981|NCT01992107|582183277|FG001|Overall Study|Withdrawal by Subject|7|||
161218982|NCT01992107|582183278|FG002|Overall Study|Withdrawal by Subject|8|||
161218983|NCT02022007|582183279|FG000|Overall Study|Withdrawal by Subject|1|||
161218984|NCT02022007|582183280|FG001|Overall Study|Withdrawal by Subject|1|||
161218985|NCT02022007|582183281|FG002|Overall Study|Withdrawal by Subject|1|||
161218986|NCT02022007|582183279|FG000|Overall Study|Noncompliant|0|||
161218987|NCT02022007|582183280|FG001|Overall Study|Noncompliant|0|||
161218988|NCT02022007|582183281|FG002|Overall Study|Noncompliant|1|||
161218989|NCT01214603|582183283|FG000|Overall Study|Adverse Event|0|||
161218990|NCT01214603|582183284|FG001|Overall Study|Adverse Event|0|||
161218991|NCT01214603|582183285|FG002|Overall Study|Adverse Event|1|||
161218992|NCT01214603|582183283|FG000|Overall Study|Death|1|||
161218993|NCT01214603|582183284|FG001|Overall Study|Death|0|||
161218994|NCT01214603|582183285|FG002|Overall Study|Death|0|||
161218995|NCT01214603|582183283|FG000|Overall Study|Progressive Disease|4|||
161218996|NCT01214603|582183284|FG001|Overall Study|Progressive Disease|1|||
161218997|NCT01214603|582183285|FG002|Overall Study|Progressive Disease|3|||
161218998|NCT00192296|582183288|FG000|Overall Study|Withdrawal by Subject|0|||
161218999|NCT00192296|582183289|FG001|Overall Study|Withdrawal by Subject|1|||
161219000|NCT00192296|582183290|FG002|Overall Study|Withdrawal by Subject|0|||
161219001|NCT00192296|582183291|FG003|Overall Study|Withdrawal by Subject|0|||
161219002|NCT02536378|582183298|FG000|Overall Study|Physician Decision|0|||
161219003|NCT02536378|582183299|FG001|Overall Study|Physician Decision|2|||
161219004|NCT02536378|582183298|FG000|Overall Study|Withdrawal by Subject|0|||
161219005|NCT02536378|582183299|FG001|Overall Study|Withdrawal by Subject|1|||
161219006|NCT02536378|582183298|FG000|Overall Study|Death|1|||
161219007|NCT02536378|582183299|FG001|Overall Study|Death|2|||
161219008|NCT02536378|582183298|FG000|Overall Study|Patient refused further follow up|6|||
161219009|NCT02536378|582183299|FG001|Overall Study|Patient refused further follow up|2|||
161219010|NCT00457665|582183304|FG000|12 Months|Drug allergy|1|||
161219011|NCT00457665|582183305|FG001|12 Months|Drug allergy|1|||
161219012|NCT00457665|582183304|FG000|12 Months|High HIV viral load|5|||
161219013|NCT00457665|582183305|FG001|12 Months|High HIV viral load|1|||
161219014|NCT00457665|582183304|FG000|12 Months|Lipodystrophy|2|||
161219015|NCT00457665|582183305|FG001|12 Months|Lipodystrophy|0|||
161219016|NCT00457665|582183304|FG000|12 Months|Withdrawal by Subject|0|||
161219017|NCT00457665|582183305|FG001|12 Months|Withdrawal by Subject|2|||
161219018|NCT00457665|582183304|FG000|12 Months|Abnormal Liver function tests|0|||
161219019|NCT00457665|582183305|FG001|12 Months|Abnormal Liver function tests|5|||
161219020|NCT00457665|582183304|FG000|24 Months|Withdrawal by Subject|3|||
161219021|NCT00457665|582183305|FG001|24 Months|Withdrawal by Subject|2|||
161219022|NCT00457665|582183304|FG000|24 Months|Lipodystrophy|1|||
161219023|NCT00457665|582183305|FG001|24 Months|Lipodystrophy|1|||
161219024|NCT00457665|582183304|FG000|24 Months|Abnormal liver function tests|1|||
161219025|NCT00457665|582183305|FG001|24 Months|Abnormal liver function tests|5|||
161219026|NCT00446654|582183306|FG000|Overall Study|Withdrawal by Subject|1|||
161219027|NCT00446654|582183307|FG001|Overall Study|Withdrawal by Subject|0|||
161219028|NCT00446654|582183306|FG000|Overall Study|Adverse Event|1|||
161219029|NCT00446654|582183307|FG001|Overall Study|Adverse Event|0|||
161219030|NCT02535000|582183308|FG000|Overall Study|Cancellation of surgery.|1|||
160870589|NCT02175030|580919051|FG001|Overall Study|Withdrawal by Subject|4|||
161219031|NCT02535000|582183309|FG001|Overall Study|Cancellation of surgery.|2|||
161219032|NCT01102777|582183314|FG000|Overall Study|Death|2|||
161219033|NCT01102777|582183315|FG001|Overall Study|Death|6|||
161219034|NCT01102777|582183314|FG000|Overall Study|Lost to Follow-up|7|||
160870590|NCT02533453|580919052|FG000|Overall Study|Adverse Event|6|||
161219035|NCT01102777|582183315|FG001|Overall Study|Lost to Follow-up|10|||
161219036|NCT00706706|582183316|FG000|Overall Study|Death|53|||
161219037|NCT00706706|582183316|FG000|Overall Study|Lost to Follow-up|7|||
161219038|NCT00706706|582183316|FG000|Overall Study|Study endpoint had reached|45|||
161219039|NCT02175966|582183321|FG000|Follow-up Period|Lack of Efficacy|10|||
161219040|NCT02175966|582183322|FG001|Follow-up Period|Lack of Efficacy|6|||
161219041|NCT00210626|582183323|FG000|Overall Study|Adverse Event|1|||
161219042|NCT00210626|582183324|FG001|Overall Study|Adverse Event|2|||
161219043|NCT00210626|582183323|FG000|Overall Study|Protocol Violation|1|||
161219044|NCT00210626|582183324|FG001|Overall Study|Protocol Violation|5|||
161219045|NCT00210626|582183323|FG000|Overall Study|Lost to Follow-up|11|||
160870591|NCT02533453|580919052|FG000|Overall Study|Protocol Violation|1|||
160870592|NCT02533453|580919052|FG000|Overall Study|Withdrawal by Subject|2|||
160870593|NCT01273519|580919057|FG000|Overall Study|Adverse Event|3|||
160870594|NCT01273519|580919058|FG001|Overall Study|Adverse Event|0|||
160870595|NCT01273519|580919059|FG002|Overall Study|Adverse Event|0|||
160870596|NCT01273519|580919057|FG000|Overall Study|Lost to Follow-up|2|||
160870597|NCT01273519|580919058|FG001|Overall Study|Lost to Follow-up|1|||
160870598|NCT01273519|580919059|FG002|Overall Study|Lost to Follow-up|3|||
160870599|NCT01273519|580919057|FG000|Overall Study|Lack of Efficacy|8|||
160870600|NCT01273519|580919058|FG001|Overall Study|Lack of Efficacy|3|||
160870601|NCT01273519|580919059|FG002|Overall Study|Lack of Efficacy|4|||
160870602|NCT01273519|580919057|FG000|Overall Study|Other|6|||
160870603|NCT01273519|580919058|FG001|Overall Study|Other|1|||
160870604|NCT01273519|580919059|FG002|Overall Study|Other|1|||
160870605|NCT03695367|580919060|FG000|Overall Study|Missed the Day 28 visit.|1|||
160870606|NCT03695367|580919061|FG001|Overall Study|Missed the Day 28 visit.|0|||
160870607|NCT03695367|580919060|FG000|Overall Study|Lost to Follow-up|0|||
160870608|NCT03695367|580919061|FG001|Overall Study|Lost to Follow-up|1|||
160870609|NCT03695367|580919060|FG000|Overall Study|Withdrawal by Subject|0|||
160870610|NCT03695367|580919061|FG001|Overall Study|Withdrawal by Subject|1|||
160870611|NCT03695367|580919060|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
160870612|NCT03695367|580919061|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
160870613|NCT00068419|580919064|FG000|Overall Study|Adverse Event|3|||
160870614|NCT00068419|580919064|FG000|Overall Study|Lack of Efficacy|24|||
160870615|NCT00068419|580919064|FG000|Overall Study|Lost to Follow-up|1|||
160870616|NCT00068419|580919064|FG000|Overall Study|Physician Decision|7|||
160870617|NCT00068419|580919064|FG000|Overall Study|Withdrawal by Subject|14|||
160870618|NCT00068419|580919064|FG000|Overall Study|Ineligible|11|||
160870619|NCT00396253|580919068|FG000|Overall Study|Protocol Violation|1|||
160870620|NCT00396253|580919068|FG000|Overall Study|Withdrawal by Subject|7|||
160870621|NCT00396253|580919068|FG000|Overall Study|Death|3|||
160870622|NCT00396253|580919068|FG000|Overall Study|Physician Decision|1|||
160870623|NCT00396253|580919068|FG000|Overall Study|Change in eligibility status|1|||
160870624|NCT00092443|580919069|FG000|Overall Study|Adverse Event|9|||
160870625|NCT00092443|580919070|FG001|Overall Study|Adverse Event|13|||
160870626|NCT00092443|580919069|FG000|Overall Study|Lost to Follow-up|7|||
160870627|NCT00092443|580919070|FG001|Overall Study|Lost to Follow-up|3|||
160870628|NCT00092443|580919069|FG000|Overall Study|Protocol Violation|11|||
160870629|NCT00092443|580919070|FG001|Overall Study|Protocol Violation|9|||
160870630|NCT00092443|580919069|FG000|Overall Study|Withdrawal by Subject|9|||
160870631|NCT00092443|580919070|FG001|Overall Study|Withdrawal by Subject|11|||
160870632|NCT00092443|580919069|FG000|Overall Study|Moved|5|||
160870633|NCT00092443|580919070|FG001|Overall Study|Moved|5|||
160870634|NCT00092443|580919069|FG000|Overall Study|Other|17|||
160870635|NCT00092443|580919070|FG001|Overall Study|Other|13|||
160870636|NCT04717336|580919071|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
160870637|NCT04717336|580919072|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
160870638|NCT04717336|580919071|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
160870639|NCT04717336|580919072|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
160870640|NCT02039843|580919073|FG000|Randomization and Observation Period|Adverse Event|2|||
160870641|NCT02039843|580919074|FG001|Randomization and Observation Period|Adverse Event|0|||
160870642|NCT02039843|580919073|FG000|Randomization and Observation Period|Death|1|||
160870643|NCT02039843|580919074|FG001|Randomization and Observation Period|Death|0|||
160870644|NCT02039843|580919073|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
161114441|NCT00845650|581808404|FG000|Overall Study|Unable to access IV line|1|||
161114442|NCT00845650|581808405|FG001|Overall Study|Unable to access IV line|0|||
161114443|NCT00845650|581808406|FG002|Overall Study|Unable to access IV line|0|||
161114444|NCT00845650|581808407|FG003|Overall Study|Unable to access IV line|0|||
161114445|NCT00845650|581808408|FG004|Overall Study|Unable to access IV line|0|||
161114446|NCT00845650|581808409|FG005|Overall Study|Unable to access IV line|0|||
161114447|NCT00531752|581808412|FG000|First Double-blind Intervention Period|Adverse Event|2|||
161114448|NCT00531752|581808413|FG001|First Double-blind Intervention Period|Adverse Event|0|||
161114449|NCT00531752|581808414|FG002|First Double-blind Intervention Period|Adverse Event|1|||
161114450|NCT00531752|581808415|FG003|First Double-blind Intervention Period|Adverse Event|1|||
161114451|NCT00531752|581808412|FG000|First Double-blind Intervention Period|Other|1|||
161114452|NCT00531752|581808413|FG001|First Double-blind Intervention Period|Other|4|||
161114453|NCT00531752|581808414|FG002|First Double-blind Intervention Period|Other|4|||
161114454|NCT00531752|581808415|FG003|First Double-blind Intervention Period|Other|0|||
161114455|NCT00531752|581808412|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
161114456|NCT00531752|581808413|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
161114457|NCT00531752|581808414|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
161219046|NCT00210626|582183324|FG001|Overall Study|Lost to Follow-up|11|||
160870645|NCT02039843|580919074|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
161219047|NCT00210626|582183323|FG000|Overall Study|Death|1|||
161219048|NCT00210626|582183324|FG001|Overall Study|Death|0|||
161219049|NCT00210626|582183323|FG000|Overall Study|Withdrawal by Subject|29|||
161219050|NCT00210626|582183324|FG001|Overall Study|Withdrawal by Subject|20|||
161219051|NCT00210626|582183323|FG000|Overall Study|Physician Decision|0|||
161219052|NCT00210626|582183324|FG001|Overall Study|Physician Decision|2|||
161219053|NCT00210626|582183323|FG000|Overall Study|Sponser Request|1|||
161219054|NCT00210626|582183324|FG001|Overall Study|Sponser Request|0|||
161219055|NCT00210626|582183323|FG000|Overall Study|Other|4|||
161219056|NCT00210626|582183324|FG001|Overall Study|Other|5|||
161219057|NCT03469271|582183325|FG000|Overall Study|Withdrawal by Subject|2|||
161219058|NCT03469271|582183326|FG001|Overall Study|Withdrawal by Subject|0|||
161219059|NCT03469271|582183327|FG002|Overall Study|Withdrawal by Subject|0|||
161219060|NCT03469271|582183328|FG003|Overall Study|Withdrawal by Subject|1|||
161219061|NCT02123459|582183329|FG000|Washout Period (1 Day)|Adverse Event|1|||
161219062|NCT02123459|582183330|FG001|Washout Period (1 Day)|Adverse Event|0|||
161219063|NCT02196506|582183331|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
161219064|NCT02196506|582183332|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
161219065|NCT02196506|582183333|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
161219066|NCT02196506|582183334|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
161219067|NCT02196506|582183331|FG000|Phase A|Withdrawal by Subject|34|||
161219068|NCT02196506|582183332|FG001|Phase A|Withdrawal by Subject|0|||
161219069|NCT02196506|582183333|FG002|Phase A|Withdrawal by Subject|0|||
161219070|NCT02196506|582183334|FG003|Phase A|Withdrawal by Subject|0|||
161219071|NCT02196506|582183331|FG000|Phase A|Adverse Event|22|||
161219072|NCT02196506|582183332|FG001|Phase A|Adverse Event|0|||
161219073|NCT02196506|582183333|FG002|Phase A|Adverse Event|0|||
161219074|NCT02196506|582183334|FG003|Phase A|Adverse Event|0|||
161219075|NCT02196506|582183331|FG000|Phase A|Lost to Follow-up|9|||
161219076|NCT02196506|582183332|FG001|Phase A|Lost to Follow-up|0|||
161219077|NCT02196506|582183333|FG002|Phase A|Lost to Follow-up|0|||
161219078|NCT02196506|582183334|FG003|Phase A|Lost to Follow-up|0|||
161219079|NCT02196506|582183331|FG000|Phase A|Protocol deviation|12|||
161219080|NCT02196506|582183332|FG001|Phase A|Protocol deviation|0|||
161219081|NCT02196506|582183333|FG002|Phase A|Protocol deviation|0|||
161219082|NCT02196506|582183334|FG003|Phase A|Protocol deviation|0|||
161219083|NCT02196506|582183331|FG000|Phase A|Participant withdrawn by investigator|10|||
161219084|NCT02196506|582183332|FG001|Phase A|Participant withdrawn by investigator|0|||
161219085|NCT02196506|582183333|FG002|Phase A|Participant withdrawn by investigator|0|||
161219086|NCT02196506|582183334|FG003|Phase A|Participant withdrawn by investigator|0|||
161219087|NCT02196506|582183331|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
161219088|NCT02196506|582183332|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
161219089|NCT02196506|582183333|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
161219090|NCT02196506|582183334|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
161219091|NCT02196506|582183331|FG000|Phase B|Lack of Efficacy|0|||
161219092|NCT02196506|582183332|FG001|Phase B|Lack of Efficacy|1|||
161219093|NCT02196506|582183333|FG002|Phase B|Lack of Efficacy|2|||
161219094|NCT02196506|582183334|FG003|Phase B|Lack of Efficacy|0|||
161219095|NCT02196506|582183331|FG000|Phase B|Withdrawal by Participant|0|||
161219096|NCT02196506|582183332|FG001|Phase B|Withdrawal by Participant|8|||
161219097|NCT02196506|582183333|FG002|Phase B|Withdrawal by Participant|1|||
161219098|NCT02196506|582183334|FG003|Phase B|Withdrawal by Participant|0|||
161219099|NCT02196506|582183331|FG000|Phase B|Adverse Event|0|||
161219100|NCT02196506|582183332|FG001|Phase B|Adverse Event|4|||
161219101|NCT02196506|582183333|FG002|Phase B|Adverse Event|1|||
161219102|NCT02196506|582183334|FG003|Phase B|Adverse Event|0|||
161219103|NCT02196506|582183331|FG000|Phase B|Lost to Follow-up|0|||
161219104|NCT02196506|582183332|FG001|Phase B|Lost to Follow-up|2|||
161219105|NCT02196506|582183333|FG002|Phase B|Lost to Follow-up|1|||
161219106|NCT02196506|582183334|FG003|Phase B|Lost to Follow-up|0|||
161219107|NCT02196506|582183331|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
161219108|NCT02196506|582183332|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
161219109|NCT02196506|582183333|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
161219110|NCT02196506|582183334|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
161219111|NCT02196506|582183331|FG000|Phase A+|Withdrawal by Participant|0|||
161219112|NCT02196506|582183332|FG001|Phase A+|Withdrawal by Participant|0|||
161219113|NCT02196506|582183333|FG002|Phase A+|Withdrawal by Participant|0|||
161219114|NCT02196506|582183334|FG003|Phase A+|Withdrawal by Participant|5|||
161219115|NCT02196506|582183331|FG000|Phase A+|Adverse Event|0|||
161219116|NCT02196506|582183332|FG001|Phase A+|Adverse Event|0|||
161219117|NCT02196506|582183333|FG002|Phase A+|Adverse Event|0|||
161219118|NCT02196506|582183334|FG003|Phase A+|Adverse Event|1|||
161219119|NCT02196506|582183331|FG000|Phase A+|Lost to Follow-up|0|||
161219120|NCT02196506|582183332|FG001|Phase A+|Lost to Follow-up|0|||
161219121|NCT02196506|582183333|FG002|Phase A+|Lost to Follow-up|0|||
161219122|NCT02196506|582183334|FG003|Phase A+|Lost to Follow-up|6|||
161219123|NCT02196506|582183331|FG000|Phase A+|Participant withdrawn by investigator|0|||
161219124|NCT02196506|582183332|FG001|Phase A+|Participant withdrawn by investigator|0|||
161219125|NCT02196506|582183333|FG002|Phase A+|Participant withdrawn by investigator|0|||
161219126|NCT02196506|582183334|FG003|Phase A+|Participant withdrawn by investigator|1|||
161219127|NCT01070394|582183335|FG000|Overall Study|Adverse Event|6|||
160870646|NCT02039843|580919073|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
160870647|NCT02039843|580919074|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
160870648|NCT02039843|580919073|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
160870649|NCT02039843|580919074|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
160870650|NCT02039843|580919073|FG000|Pairing With a Study Dog|Death|1|||
160870651|NCT02039843|580919074|FG001|Pairing With a Study Dog|Death|0|||
160870652|NCT02039843|580919073|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
160870653|NCT02039843|580919074|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
160870654|NCT02039843|580919073|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
160870655|NCT02039843|580919074|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
160870656|NCT02039843|580919073|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
160870657|NCT02039843|580919074|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
160870658|NCT01958164|580919077|FG000|Overall Study|Adverse Event|0|||
160870659|NCT01958164|580919078|FG001|Overall Study|Adverse Event|2|||
160870660|NCT01958164|580919077|FG000|Overall Study|Lost to Follow-up|2|||
160870661|NCT01958164|580919078|FG001|Overall Study|Lost to Follow-up|3|||
160870662|NCT00740857|580919079|FG000|Overall Study|Withdrawal by Subject|1|||
160870663|NCT00740857|580919080|FG001|Overall Study|Withdrawal by Subject|0|||
160870664|NCT00740857|580919081|FG002|Overall Study|Withdrawal by Subject|0|||
160870665|NCT02963506|580919082|FG000|Double-Blind Period|Adverse Event|0|||
160870666|NCT02963506|580919083|FG001|Double-Blind Period|Adverse Event|0|||
160870667|NCT02963506|580919084|FG002|Double-Blind Period|Adverse Event|1|||
160870668|NCT02963506|580919085|FG003|Double-Blind Period|Adverse Event|0|||
160870669|NCT02963506|580919086|FG004|Double-Blind Period|Adverse Event|0|||
160870670|NCT02963506|580919087|FG005|Double-Blind Period|Adverse Event|0|||
160870671|NCT02963506|580919088|FG006|Double-Blind Period|Adverse Event|0|||
160870672|NCT02963506|580919089|FG007|Double-Blind Period|Adverse Event|0|||
160870673|NCT02963506|580919090|FG008|Double-Blind Period|Adverse Event|0|||
160870674|NCT02963506|580919091|FG009|Double-Blind Period|Adverse Event|0|||
160870675|NCT02963506|580919092|FG010|Double-Blind Period|Adverse Event|0|||
160870676|NCT02963506|580919093|FG011|Double-Blind Period|Adverse Event|0|||
160870677|NCT02963506|580919094|FG012|Double-Blind Period|Adverse Event|0|||
160870678|NCT02963506|580919082|FG000|Double-Blind Period|Death|0|||
160870679|NCT02963506|580919083|FG001|Double-Blind Period|Death|0|||
160870680|NCT02963506|580919084|FG002|Double-Blind Period|Death|0|||
160870681|NCT02963506|580919085|FG003|Double-Blind Period|Death|1|||
160870682|NCT02963506|580919086|FG004|Double-Blind Period|Death|0|||
160870683|NCT02963506|580919087|FG005|Double-Blind Period|Death|0|||
160870684|NCT02963506|580919088|FG006|Double-Blind Period|Death|0|||
160870685|NCT02963506|580919089|FG007|Double-Blind Period|Death|0|||
160870686|NCT02963506|580919090|FG008|Double-Blind Period|Death|0|||
160870687|NCT02963506|580919091|FG009|Double-Blind Period|Death|0|||
160870688|NCT02963506|580919092|FG010|Double-Blind Period|Death|0|||
160870689|NCT02963506|580919093|FG011|Double-Blind Period|Death|0|||
160870690|NCT02963506|580919094|FG012|Double-Blind Period|Death|0|||
160870691|NCT02963506|580919082|FG000|Double-Blind Period|Lost to Follow-up|0|||
160870692|NCT02963506|580919083|FG001|Double-Blind Period|Lost to Follow-up|1|||
160870693|NCT02963506|580919084|FG002|Double-Blind Period|Lost to Follow-up|0|||
160870694|NCT02963506|580919085|FG003|Double-Blind Period|Lost to Follow-up|0|||
160870695|NCT02963506|580919086|FG004|Double-Blind Period|Lost to Follow-up|0|||
160870696|NCT02963506|580919087|FG005|Double-Blind Period|Lost to Follow-up|0|||
160870697|NCT02963506|580919088|FG006|Double-Blind Period|Lost to Follow-up|0|||
160870698|NCT02963506|580919089|FG007|Double-Blind Period|Lost to Follow-up|0|||
160870699|NCT02963506|580919090|FG008|Double-Blind Period|Lost to Follow-up|0|||
160870700|NCT02963506|580919091|FG009|Double-Blind Period|Lost to Follow-up|0|||
160870701|NCT02963506|580919092|FG010|Double-Blind Period|Lost to Follow-up|0|||
160870702|NCT02963506|580919093|FG011|Double-Blind Period|Lost to Follow-up|0|||
160870703|NCT02963506|580919094|FG012|Double-Blind Period|Lost to Follow-up|0|||
160870704|NCT02963506|580919082|FG000|Double-Blind Period|Withdrawal by Subject|0|||
160870705|NCT02963506|580919083|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160870706|NCT02963506|580919084|FG002|Double-Blind Period|Withdrawal by Subject|1|||
160870707|NCT02963506|580919085|FG003|Double-Blind Period|Withdrawal by Subject|1|||
160870708|NCT02963506|580919086|FG004|Double-Blind Period|Withdrawal by Subject|0|||
160870709|NCT02963506|580919087|FG005|Double-Blind Period|Withdrawal by Subject|0|||
160870710|NCT02963506|580919088|FG006|Double-Blind Period|Withdrawal by Subject|0|||
160870711|NCT02963506|580919089|FG007|Double-Blind Period|Withdrawal by Subject|0|||
160870712|NCT02963506|580919090|FG008|Double-Blind Period|Withdrawal by Subject|0|||
160870713|NCT02963506|580919091|FG009|Double-Blind Period|Withdrawal by Subject|0|||
160870714|NCT02963506|580919092|FG010|Double-Blind Period|Withdrawal by Subject|0|||
160870715|NCT02963506|580919093|FG011|Double-Blind Period|Withdrawal by Subject|0|||
160870716|NCT02963506|580919094|FG012|Double-Blind Period|Withdrawal by Subject|0|||
160870717|NCT02963506|580919082|FG000|Double-Blind Period|No compliance|0|||
160870718|NCT02963506|580919083|FG001|Double-Blind Period|No compliance|1|||
160870719|NCT02963506|580919084|FG002|Double-Blind Period|No compliance|0|||
160870720|NCT02963506|580919085|FG003|Double-Blind Period|No compliance|0|||
160870721|NCT02963506|580919086|FG004|Double-Blind Period|No compliance|0|||
160870722|NCT02963506|580919087|FG005|Double-Blind Period|No compliance|0|||
160870723|NCT02963506|580919088|FG006|Double-Blind Period|No compliance|0|||
160870724|NCT02963506|580919089|FG007|Double-Blind Period|No compliance|0|||
160870725|NCT02963506|580919090|FG008|Double-Blind Period|No compliance|0|||
160870726|NCT02963506|580919091|FG009|Double-Blind Period|No compliance|0|||
160870727|NCT02963506|580919092|FG010|Double-Blind Period|No compliance|0|||
160870728|NCT02963506|580919093|FG011|Double-Blind Period|No compliance|0|||
160870729|NCT02963506|580919094|FG012|Double-Blind Period|No compliance|0|||
160870730|NCT02963506|580919082|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870731|NCT02963506|580919083|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
160870732|NCT02963506|580919084|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870733|NCT02963506|580919085|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870734|NCT02963506|580919086|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870735|NCT02963506|580919087|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870736|NCT02963506|580919088|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870737|NCT02963506|580919089|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870738|NCT02963506|580919090|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870739|NCT02963506|580919091|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870740|NCT02963506|580919092|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870741|NCT02963506|580919093|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870742|NCT02963506|580919094|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
160870743|NCT02963506|580919082|FG000|Dose-Blind Period|Adverse Event|0|||
160870744|NCT02963506|580919083|FG001|Dose-Blind Period|Adverse Event|0|||
160870745|NCT02963506|580919084|FG002|Dose-Blind Period|Adverse Event|0|||
160870746|NCT02963506|580919085|FG003|Dose-Blind Period|Adverse Event|0|||
160870747|NCT02963506|580919086|FG004|Dose-Blind Period|Adverse Event|0|||
160870748|NCT02963506|580919087|FG005|Dose-Blind Period|Adverse Event|1|||
160870749|NCT02963506|580919088|FG006|Dose-Blind Period|Adverse Event|3|||
160870750|NCT02963506|580919089|FG007|Dose-Blind Period|Adverse Event|2|||
160870751|NCT02963506|580919090|FG008|Dose-Blind Period|Adverse Event|2|||
160870752|NCT02963506|580919091|FG009|Dose-Blind Period|Adverse Event|2|||
160870753|NCT02963506|580919092|FG010|Dose-Blind Period|Adverse Event|1|||
160870754|NCT02963506|580919093|FG011|Dose-Blind Period|Adverse Event|1|||
160870755|NCT02963506|580919094|FG012|Dose-Blind Period|Adverse Event|6|||
160870756|NCT02963506|580919082|FG000|Dose-Blind Period|Lack of Efficacy|0|||
160870757|NCT02963506|580919083|FG001|Dose-Blind Period|Lack of Efficacy|0|||
160870758|NCT02963506|580919084|FG002|Dose-Blind Period|Lack of Efficacy|0|||
160870759|NCT02963506|580919085|FG003|Dose-Blind Period|Lack of Efficacy|0|||
160870760|NCT02963506|580919086|FG004|Dose-Blind Period|Lack of Efficacy|0|||
160870761|NCT02963506|580919087|FG005|Dose-Blind Period|Lack of Efficacy|0|||
160870762|NCT02963506|580919088|FG006|Dose-Blind Period|Lack of Efficacy|0|||
160870763|NCT02963506|580919089|FG007|Dose-Blind Period|Lack of Efficacy|1|||
160870764|NCT02963506|580919090|FG008|Dose-Blind Period|Lack of Efficacy|0|||
160870765|NCT02963506|580919091|FG009|Dose-Blind Period|Lack of Efficacy|1|||
160870766|NCT02963506|580919092|FG010|Dose-Blind Period|Lack of Efficacy|0|||
160870767|NCT02963506|580919093|FG011|Dose-Blind Period|Lack of Efficacy|0|||
160870768|NCT02963506|580919094|FG012|Dose-Blind Period|Lack of Efficacy|0|||
160870769|NCT02963506|580919082|FG000|Dose-Blind Period|Lost to Follow-up|0|||
160870770|NCT02963506|580919083|FG001|Dose-Blind Period|Lost to Follow-up|0|||
160870771|NCT02963506|580919084|FG002|Dose-Blind Period|Lost to Follow-up|0|||
160870772|NCT02963506|580919085|FG003|Dose-Blind Period|Lost to Follow-up|0|||
160870773|NCT02963506|580919086|FG004|Dose-Blind Period|Lost to Follow-up|0|||
160870774|NCT02963506|580919087|FG005|Dose-Blind Period|Lost to Follow-up|1|||
161114458|NCT00531752|581808415|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
161114459|NCT00531752|581808412|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
161114460|NCT00531752|581808413|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
161114461|NCT00531752|581808414|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
161114462|NCT00531752|581808415|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
161114463|NCT00531752|581808412|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
161114464|NCT00531752|581808413|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
161114465|NCT00531752|581808414|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
161114466|NCT00531752|581808415|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
161114467|NCT00531752|581808412|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
160870775|NCT02963506|580919088|FG006|Dose-Blind Period|Lost to Follow-up|0|||
160870776|NCT02963506|580919089|FG007|Dose-Blind Period|Lost to Follow-up|0|||
160870777|NCT02963506|580919090|FG008|Dose-Blind Period|Lost to Follow-up|1|||
160870778|NCT02963506|580919091|FG009|Dose-Blind Period|Lost to Follow-up|0|||
160870779|NCT02963506|580919092|FG010|Dose-Blind Period|Lost to Follow-up|0|||
160870780|NCT02963506|580919093|FG011|Dose-Blind Period|Lost to Follow-up|1|||
160870781|NCT02963506|580919094|FG012|Dose-Blind Period|Lost to Follow-up|0|||
160870782|NCT02963506|580919082|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
160870783|NCT02963506|580919083|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
160870784|NCT02963506|580919084|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
160870785|NCT02963506|580919085|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
160870786|NCT02963506|580919086|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
160870787|NCT02963506|580919087|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
160870788|NCT02963506|580919088|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
160870789|NCT02963506|580919089|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
160870790|NCT02963506|580919090|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
160870791|NCT02963506|580919091|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
160870792|NCT02963506|580919092|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
160870793|NCT02963506|580919093|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
160870794|NCT02963506|580919094|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
160870795|NCT02963506|580919082|FG000|Dose-Blind Period|Sponsor decision|0|||
160870796|NCT02963506|580919083|FG001|Dose-Blind Period|Sponsor decision|0|||
160870797|NCT02963506|580919084|FG002|Dose-Blind Period|Sponsor decision|0|||
160870798|NCT02963506|580919085|FG003|Dose-Blind Period|Sponsor decision|0|||
160870799|NCT02963506|580919086|FG004|Dose-Blind Period|Sponsor decision|0|||
160870800|NCT02963506|580919087|FG005|Dose-Blind Period|Sponsor decision|1|||
160870801|NCT02963506|580919088|FG006|Dose-Blind Period|Sponsor decision|0|||
160870802|NCT02963506|580919089|FG007|Dose-Blind Period|Sponsor decision|0|||
160870803|NCT02963506|580919090|FG008|Dose-Blind Period|Sponsor decision|0|||
160870804|NCT02963506|580919091|FG009|Dose-Blind Period|Sponsor decision|0|||
160870805|NCT02963506|580919092|FG010|Dose-Blind Period|Sponsor decision|0|||
160870806|NCT02963506|580919093|FG011|Dose-Blind Period|Sponsor decision|0|||
160870807|NCT02963506|580919094|FG012|Dose-Blind Period|Sponsor decision|0|||
160870808|NCT02963506|580919082|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870809|NCT02963506|580919083|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870810|NCT02963506|580919084|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870811|NCT02963506|580919085|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870812|NCT02963506|580919086|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870813|NCT02963506|580919087|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870814|NCT02963506|580919088|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870815|NCT02963506|580919089|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870816|NCT02963506|580919090|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870817|NCT02963506|580919091|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870818|NCT02963506|580919092|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870819|NCT02963506|580919093|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
160870820|NCT02963506|580919094|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
160870821|NCT01724346|580919095|FG000|Overall Study|Death|42|||
160870822|NCT01724346|580919096|FG001|Overall Study|Death|42|||
160870823|NCT01724346|580919095|FG000|Overall Study|Lost to Follow-up|5|||
160870824|NCT01724346|580919096|FG001|Overall Study|Lost to Follow-up|1|||
160870825|NCT01724346|580919095|FG000|Overall Study|Withdrawal by Subject|27|||
160870826|NCT01724346|580919096|FG001|Overall Study|Withdrawal by Subject|19|||
160870827|NCT01724346|580919095|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
160870828|NCT01724346|580919096|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
160870829|NCT00525161|580919099|FG000|Overall Study|Adverse Event|1|||
160870830|NCT01076361|580919100|FG000|Overall Study|22 leads were excluded from analysis|21|||
160870831|NCT00943072|580921111|FG000|Overall Study|Adverse Event|0|||
160870832|NCT00943072|580921112|FG001|Overall Study|Adverse Event|3|||
160870833|NCT00943072|580921111|FG000|Overall Study|Death|0|||
160870834|NCT00943072|580921112|FG001|Overall Study|Death|2|||
160870835|NCT00943072|580921111|FG000|Overall Study|Withdrawal by Subject|3|||
160870836|NCT00943072|580921112|FG001|Overall Study|Withdrawal by Subject|1|||
160870837|NCT00943072|580921111|FG000|Overall Study|Protocol Violation|0|||
160870838|NCT00943072|580921112|FG001|Overall Study|Protocol Violation|1|||
160870839|NCT00943072|580921111|FG000|Overall Study|Lost to Follow-up|1|||
160870840|NCT00943072|580921112|FG001|Overall Study|Lost to Follow-up|2|||
160870841|NCT00943072|580921111|FG000|Overall Study|Lack of Efficacy|0|||
160870842|NCT00943072|580921112|FG001|Overall Study|Lack of Efficacy|4|||
160870843|NCT00943072|580921111|FG000|Overall Study|Other|1|||
160870844|NCT00943072|580921112|FG001|Overall Study|Other|1|||
160870845|NCT00423917|580921113|FG000|Overall Study|Cancel|2|||
160870846|NCT00423917|580921113|FG000|Overall Study|Ineligible|1|||
161114468|NCT00531752|581808413|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
160870847|NCT00555061|580921114|FG000|Overall Study|Adverse Event|3|||
160870848|NCT00555061|580921114|FG000|Overall Study|Protocol Violation|1|||
160870849|NCT00555061|580921114|FG000|Overall Study|Lost to Follow-up|2|||
161114469|NCT00531752|581808414|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
161114470|NCT00531752|581808415|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
160870850|NCT00555061|580921114|FG000|Overall Study|Withdrawal by Subject|2|||
160870851|NCT00555061|580921114|FG000|Overall Study|Participant enrolled, but never treated|1|||
160870852|NCT01175083|580921115|FG000|Primary Epoch|Withdrawal by Subject|0|||
160870853|NCT01175083|580921116|FG001|Primary Epoch|Withdrawal by Subject|0|||
160870854|NCT01175083|580921117|FG002|Primary Epoch|Withdrawal by Subject|0|||
160870855|NCT01175083|580921118|FG003|Primary Epoch|Withdrawal by Subject|0|||
160870856|NCT01175083|580921119|FG004|Primary Epoch|Withdrawal by Subject|0|||
160870857|NCT01175083|580921120|FG005|Primary Epoch|Withdrawal by Subject|2|||
160870858|NCT01175083|580921115|FG000|Primary Epoch|Lost to Follow-up|0|||
160870859|NCT01175083|580921116|FG001|Primary Epoch|Lost to Follow-up|0|||
160870860|NCT01175083|580921117|FG002|Primary Epoch|Lost to Follow-up|0|||
160870861|NCT01175083|580921118|FG003|Primary Epoch|Lost to Follow-up|0|||
160870862|NCT01175083|580921119|FG004|Primary Epoch|Lost to Follow-up|0|||
160870863|NCT01175083|580921120|FG005|Primary Epoch|Lost to Follow-up|1|||
160870864|NCT01175083|580921115|FG000|Booster Epoch|Death|0|||
160870865|NCT01175083|580921116|FG001|Booster Epoch|Death|0|||
160870866|NCT01175083|580921117|FG002|Booster Epoch|Death|1|||
160870867|NCT01175083|580921118|FG003|Booster Epoch|Death|0|||
160870868|NCT01175083|580921119|FG004|Booster Epoch|Death|0|||
160870869|NCT01175083|580921120|FG005|Booster Epoch|Death|0|||
160870870|NCT01175083|580921115|FG000|Booster Epoch|Withdrawal by Subject|0|||
160870871|NCT01175083|580921116|FG001|Booster Epoch|Withdrawal by Subject|0|||
160870872|NCT01175083|580921117|FG002|Booster Epoch|Withdrawal by Subject|0|||
160870873|NCT01175083|580921118|FG003|Booster Epoch|Withdrawal by Subject|1|||
160870874|NCT01175083|580921119|FG004|Booster Epoch|Withdrawal by Subject|0|||
160870875|NCT01175083|580921120|FG005|Booster Epoch|Withdrawal by Subject|0|||
160870876|NCT02881567|580921121|FG000|Overall Study|Adverse Event|1|||
160870877|NCT02881567|580921121|FG000|Overall Study|Lost to Follow-up|3|||
160870878|NCT02881567|580921121|FG000|Overall Study|Consent withdrawn|1|||
160870879|NCT02881567|580921121|FG000|Overall Study|Investigator decision|1|||
160870880|NCT02881567|580921121|FG000|Overall Study|Study terminated by sponsor|9|||
160870881|NCT02881567|580921121|FG000|Overall Study|Reason not Specified|3|||
160870882|NCT00373113|580921123|FG000|Overall Study|Death|1|||
160870883|NCT00373113|580921124|FG001|Overall Study|Death|7|||
160870884|NCT00373113|580921123|FG000|Overall Study|Adverse Event|38|||
160870885|NCT00373113|580921124|FG001|Overall Study|Adverse Event|24|||
160870886|NCT00373113|580921123|FG000|Overall Study|Study terminated by sponsor|9|||
160870887|NCT00373113|580921124|FG001|Overall Study|Study terminated by sponsor|1|||
160870888|NCT00373113|580921123|FG000|Overall Study|Global deterioration of health status|10|||
160870889|NCT00373113|580921124|FG001|Overall Study|Global deterioration of health status|7|||
160870890|NCT00373113|580921123|FG000|Overall Study|Lost to Follow-up|1|||
160870891|NCT00373113|580921124|FG001|Overall Study|Lost to Follow-up|3|||
160870892|NCT00373113|580921123|FG000|Overall Study|Objective progression or relapse|150|||
160870893|NCT00373113|580921124|FG001|Overall Study|Objective progression or relapse|169|||
160870894|NCT00373113|580921123|FG000|Overall Study|Other|14|||
160870895|NCT00373113|580921124|FG001|Overall Study|Other|17|||
160870896|NCT00373113|580921123|FG000|Overall Study|Protocol Violation|5|||
160870897|NCT00373113|580921124|FG001|Overall Study|Protocol Violation|1|||
160870898|NCT00373113|580921123|FG000|Overall Study|Withdrawal by Subject|10|||
160870899|NCT00373113|580921124|FG001|Overall Study|Withdrawal by Subject|15|||
160870900|NCT03275350|580921125|FG000|Overall Study|Lost to Follow-up|4|||
160870901|NCT03275350|580921126|FG001|Overall Study|Lost to Follow-up|6|||
160870902|NCT03275350|580921125|FG000|Overall Study|Death|2|||
160870903|NCT03275350|580921126|FG001|Overall Study|Death|1|||
160870904|NCT03275350|580921125|FG000|Overall Study|Physician Decision|1|||
160870905|NCT03275350|580921126|FG001|Overall Study|Physician Decision|0|||
160870906|NCT03275350|580921125|FG000|Overall Study|Incarcerated|1|||
160870907|NCT03275350|580921126|FG001|Overall Study|Incarcerated|1|||
160870908|NCT03656562|580921127|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
160870909|NCT03656562|580921128|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
160870910|NCT03656562|580921129|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
160870911|NCT03656562|580921130|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
160870912|NCT03656562|580921127|FG000|Overall Study|Physician Decision|1|||
160870913|NCT03656562|580921128|FG001|Overall Study|Physician Decision|2|||
160870914|NCT03656562|580921129|FG002|Overall Study|Physician Decision|0|||
160870915|NCT03656562|580921130|FG003|Overall Study|Physician Decision|0|||
160870916|NCT03656562|580921127|FG000|Overall Study|Subject Decision|3|||
160870917|NCT03656562|580921128|FG001|Overall Study|Subject Decision|5|||
160870918|NCT03656562|580921129|FG002|Overall Study|Subject Decision|0|||
160870919|NCT03656562|580921130|FG003|Overall Study|Subject Decision|2|||
160870920|NCT00905645|580921131|FG000|Overall Study|Death (not device related)|10|||
160870921|NCT00905645|580921132|FG001|Overall Study|Death (not device related)|4|||
160870922|NCT00905645|580921133|FG002|Overall Study|Death (not device related)|15|||
160870923|NCT00905645|580921134|FG003|Overall Study|Death (not device related)|8|||
160870924|NCT00905645|580921131|FG000|Overall Study|Explantation of study device(s)|78|||
160870925|NCT00905645|580921132|FG001|Overall Study|Explantation of study device(s)|47|||
160870926|NCT00905645|580921133|FG002|Overall Study|Explantation of study device(s)|28|||
160870927|NCT00905645|580921134|FG003|Overall Study|Explantation of study device(s)|21|||
160870928|NCT00905645|580921131|FG000|Overall Study|Subject Request|41|||
160870929|NCT00905645|580921132|FG001|Overall Study|Subject Request|17|||
160870930|NCT00905645|580921133|FG002|Overall Study|Subject Request|13|||
160870931|NCT00905645|580921134|FG003|Overall Study|Subject Request|11|||
160870932|NCT00905645|580921131|FG000|Overall Study|Lost to Follow-up|299|||
160870933|NCT00905645|580921132|FG001|Overall Study|Lost to Follow-up|103|||
160870934|NCT00905645|580921133|FG002|Overall Study|Lost to Follow-up|51|||
160870935|NCT00905645|580921134|FG003|Overall Study|Lost to Follow-up|12|||
160870936|NCT01386970|580921135|FG000|Overall Study|Withdrawal by Subject|0|||
160870937|NCT01386970|580921136|FG001|Overall Study|Withdrawal by Subject|1|||
160870938|NCT01386970|580921135|FG000|Overall Study|Adverse Event|4|||
160870939|NCT01386970|580921136|FG001|Overall Study|Adverse Event|1|||
160870940|NCT04269265|580921137|FG000|Overall Study|Physician Decision|1|||
160870941|NCT04269265|580921137|FG000|Overall Study|Withdrawal by Subject|1|||
160870942|NCT04269265|580921137|FG000|Overall Study|Overenrolled (sample size reached)|4|||
160870943|NCT04439136|580921138|FG000|Overall Study|Ineligible|1|||
160870944|NCT04439136|580921138|FG000|Overall Study|Never Started Treatment|2|||
160870945|NCT04439136|580921138|FG000|Overall Study|Adverse Event|4|||
160870946|NCT04439136|580921138|FG000|Overall Study|Death|3|||
160870947|NCT04439136|580921138|FG000|Overall Study|Disease Progression|27|||
160870948|NCT04439136|580921138|FG000|Overall Study|Alternative Therapy|1|||
160870949|NCT04439136|580921138|FG000|Overall Study|Increased Tumor Burden|1|||
160870950|NCT04439136|580921138|FG000|Overall Study|Symptomatic Detrioration|1|||
160870951|NCT04693234|580921139|FG000|Overall Study|Death|79|||
160870952|NCT04693234|580921140|FG001|Overall Study|Death|19|||
160870953|NCT04693234|580921139|FG000|Overall Study|Sponsor Ended Study|47|||
160870954|NCT04693234|580921140|FG001|Overall Study|Sponsor Ended Study|18|||
160870955|NCT04693234|580921139|FG000|Overall Study|Withdrawal by Subject|10|||
160870956|NCT04693234|580921140|FG001|Overall Study|Withdrawal by Subject|2|||
160870957|NCT04693234|580921139|FG000|Overall Study|Lost to Follow-up|2|||
160870958|NCT04693234|580921140|FG001|Overall Study|Lost to Follow-up|1|||
160870959|NCT02578706|580921143|FG000|Overall Study|Withdrawal by Subject|1|||
160870960|NCT02578706|580921144|FG001|Overall Study|Withdrawal by Subject|0|||
160870961|NCT02578706|580921145|FG002|Overall Study|Withdrawal by Subject|0|||
160870962|NCT02578706|580921143|FG000|Overall Study|Lost to Follow-up|0|||
160870963|NCT02578706|580921144|FG001|Overall Study|Lost to Follow-up|4|||
160870964|NCT02578706|580921145|FG002|Overall Study|Lost to Follow-up|0|||
160870965|NCT02578706|580921143|FG000|Overall Study|Physician Decision|0|||
160870966|NCT02578706|580921144|FG001|Overall Study|Physician Decision|1|||
160870967|NCT02578706|580921145|FG002|Overall Study|Physician Decision|0|||
160870968|NCT00578292|580921146|FG000|Overall Study|Death|1|||
160870969|NCT00578292|580921146|FG000|Overall Study|Graft failure|2|||
160870970|NCT03901469|580921147|FG000|Overall Study|Radiographic Progression|4|||
160870971|NCT03901469|580921148|FG001|Overall Study|Radiographic Progression|6|||
160870972|NCT03901469|580921149|FG002|Overall Study|Radiographic Progression|3|||
160870973|NCT03901469|580921150|FG003|Overall Study|Radiographic Progression|30|||
160870974|NCT03901469|580921151|FG004|Overall Study|Radiographic Progression|7|||
160870975|NCT03901469|580921152|FG005|Overall Study|Radiographic Progression|2|||
160870976|NCT03901469|580921153|FG006|Overall Study|Radiographic Progression|11|||
160870977|NCT03901469|580921147|FG000|Overall Study|Clinical Progression|0|||
160870978|NCT03901469|580921148|FG001|Overall Study|Clinical Progression|2|||
160870979|NCT03901469|580921149|FG002|Overall Study|Clinical Progression|0|||
160870980|NCT03901469|580921150|FG003|Overall Study|Clinical Progression|7|||
160870981|NCT03901469|580921151|FG004|Overall Study|Clinical Progression|6|||
160870982|NCT03901469|580921152|FG005|Overall Study|Clinical Progression|0|||
160870983|NCT03901469|580921153|FG006|Overall Study|Clinical Progression|2|||
160870984|NCT03901469|580921147|FG000|Overall Study|Adverse Event|1|||
160870985|NCT03901469|580921148|FG001|Overall Study|Adverse Event|0|||
160870986|NCT03901469|580921149|FG002|Overall Study|Adverse Event|0|||
160870987|NCT03901469|580921150|FG003|Overall Study|Adverse Event|0|||
160870988|NCT03901469|580921151|FG004|Overall Study|Adverse Event|0|||
160870989|NCT03901469|580921152|FG005|Overall Study|Adverse Event|0|||
160870990|NCT03901469|580921153|FG006|Overall Study|Adverse Event|9|||
160870991|NCT03901469|580921147|FG000|Overall Study|Physician Decision|0|||
160870992|NCT03901469|580921148|FG001|Overall Study|Physician Decision|0|||
160870993|NCT03901469|580921149|FG002|Overall Study|Physician Decision|0|||
160870994|NCT03901469|580921150|FG003|Overall Study|Physician Decision|1|||
160870995|NCT03901469|580921151|FG004|Overall Study|Physician Decision|0|||
160870996|NCT03901469|580921152|FG005|Overall Study|Physician Decision|0|||
160870997|NCT03901469|580921153|FG006|Overall Study|Physician Decision|0|||
160870998|NCT03901469|580921147|FG000|Overall Study|Withdrawal by Subject|0|||
160870999|NCT03901469|580921148|FG001|Overall Study|Withdrawal by Subject|0|||
160871000|NCT03901469|580921149|FG002|Overall Study|Withdrawal by Subject|0|||
160871001|NCT03901469|580921150|FG003|Overall Study|Withdrawal by Subject|0|||
160871002|NCT03901469|580921151|FG004|Overall Study|Withdrawal by Subject|2|||
160871003|NCT03901469|580921152|FG005|Overall Study|Withdrawal by Subject|0|||
160871004|NCT03901469|580921153|FG006|Overall Study|Withdrawal by Subject|8|||
160871005|NCT03901469|580921147|FG000|Overall Study|Death|0|||
160871006|NCT03901469|580921148|FG001|Overall Study|Death|0|||
160871007|NCT03901469|580921149|FG002|Overall Study|Death|0|||
160871008|NCT03901469|580921150|FG003|Overall Study|Death|3|||
160871009|NCT03901469|580921151|FG004|Overall Study|Death|5|||
160871010|NCT03901469|580921152|FG005|Overall Study|Death|0|||
160871011|NCT03901469|580921153|FG006|Overall Study|Death|1|||
160871012|NCT03901469|580921147|FG000|Overall Study|Termination of study by sponsor|0|||
160871013|NCT03901469|580921148|FG001|Overall Study|Termination of study by sponsor|0|||
160871014|NCT03901469|580921149|FG002|Overall Study|Termination of study by sponsor|0|||
160871015|NCT03901469|580921150|FG003|Overall Study|Termination of study by sponsor|0|||
160871016|NCT03901469|580921151|FG004|Overall Study|Termination of study by sponsor|1|||
160871017|NCT03901469|580921152|FG005|Overall Study|Termination of study by sponsor|1|||
160871018|NCT03901469|580921153|FG006|Overall Study|Termination of study by sponsor|0|||
160871019|NCT03901469|580921147|FG000|Overall Study|Not Reported|1|||
160871020|NCT03901469|580921148|FG001|Overall Study|Not Reported|0|||
160871021|NCT03901469|580921149|FG002|Overall Study|Not Reported|0|||
160871022|NCT03901469|580921150|FG003|Overall Study|Not Reported|1|||
160871023|NCT03901469|580921151|FG004|Overall Study|Not Reported|0|||
160871024|NCT03901469|580921152|FG005|Overall Study|Not Reported|0|||
160871025|NCT03901469|580921153|FG006|Overall Study|Not Reported|1|||
160871026|NCT01662102|580921159|FG000|Overall Study|Sponsor's decision|1|||
160871027|NCT01662102|580921160|FG001|Overall Study|Sponsor's decision|0|||
160871028|NCT02586207|580921161|FG000|Overall Study|Physician Decision|1|||
160871029|NCT02586207|580921161|FG000|Overall Study|Withdrawal by Subject|1|||
160871030|NCT00392769|580921163|FG000|Overall Study|Clinical Deterioration|9|||
160871031|NCT00392769|580921163|FG000|Overall Study|Adverse Event|1|||
160871032|NCT00439517|580921165|FG000|Overall Study|Subject on treatment|1|||
160871033|NCT00439517|580921166|FG001|Overall Study|Subject on treatment|0|||
160871034|NCT00439517|580921165|FG000|Overall Study|Subject in survival follow-up|1|||
160871035|NCT00439517|580921166|FG001|Overall Study|Subject in survival follow-up|0|||
160871036|NCT01077076|580921169|FG000|First Intervention|Withdrawal by Subject|1|||
160871037|NCT01077076|580921170|FG001|First Intervention|Withdrawal by Subject|0|||
160871038|NCT01077076|580921171|FG002|First Intervention|Withdrawal by Subject|0|||
160871039|NCT01077076|580921172|FG003|First Intervention|Withdrawal by Subject|0|||
160871040|NCT01077076|580921173|FG004|First Intervention|Withdrawal by Subject|0|||
160871041|NCT01077076|580921174|FG005|First Intervention|Withdrawal by Subject|0|||
160871042|NCT01077076|580921169|FG000|Third Intervention|Death in the participant's family|0|||
160871043|NCT01077076|580921170|FG001|Third Intervention|Death in the participant's family|0|||
160871044|NCT01077076|580921171|FG002|Third Intervention|Death in the participant's family|0|||
160871045|NCT01077076|580921172|FG003|Third Intervention|Death in the participant's family|0|||
160871046|NCT01077076|580921173|FG004|Third Intervention|Death in the participant's family|0|||
160871047|NCT01077076|580921174|FG005|Third Intervention|Death in the participant's family|1|||
160871048|NCT00060840|580921177|FG000|Overall Study|Change in surgical plan|2|||
160871049|NCT00060840|580921178|FG001|Overall Study|Change in surgical plan|6|||
160871050|NCT00060840|580921177|FG000|Overall Study|Death|0|||
160871051|NCT00060840|580921178|FG001|Overall Study|Death|1|||
160871052|NCT00060840|580921177|FG000|Overall Study|Withdrawal by Subject|0|||
160871053|NCT00060840|580921178|FG001|Overall Study|Withdrawal by Subject|1|||
160871054|NCT00060840|580921177|FG000|Overall Study|Subinvestigator unavailable|0|||
160871055|NCT00060840|580921178|FG001|Overall Study|Subinvestigator unavailable|1|||
160871056|NCT00060840|580921177|FG000|Overall Study|Physician Decision|1|||
160871057|NCT00060840|580921178|FG001|Overall Study|Physician Decision|0|||
160871058|NCT00060840|580921177|FG000|Overall Study|Other|1|||
160871059|NCT00060840|580921178|FG001|Overall Study|Other|0|||
160871060|NCT01388335|580921179|FG000|Period 1|Progressive Disease|1|||
160871061|NCT01388335|580921179|FG000|Period 2|Progressive Disease|2|||
160871062|NCT01388335|580921179|FG000|Period 2|Sponsor Decision|1|||
160871063|NCT01388335|580921179|FG000|Safety Extension|Progressive Disease|7|||
160871064|NCT01415882|580921180|FG000|Overall Study|Ineligible|1|||
160871065|NCT01415882|580921181|FG001|Overall Study|Ineligible|0|||
160871066|NCT01415882|580921182|FG002|Overall Study|Ineligible|0|||
160871067|NCT01415882|580921183|FG003|Overall Study|Ineligible|3|||
160871068|NCT01415882|580921184|FG004|Overall Study|Ineligible|0|||
160871069|NCT01415882|580921180|FG000|Overall Study|Withdrawal by Subject|0|||
160871070|NCT01415882|580921181|FG001|Overall Study|Withdrawal by Subject|1|||
160871071|NCT01415882|580921182|FG002|Overall Study|Withdrawal by Subject|0|||
160871072|NCT01415882|580921183|FG003|Overall Study|Withdrawal by Subject|1|||
160871073|NCT01415882|580921184|FG004|Overall Study|Withdrawal by Subject|0|||
161114471|NCT00531752|581808412|FG000|Second Double-blind Intervention Period|Other|1|||
161114472|NCT00531752|581808413|FG001|Second Double-blind Intervention Period|Other|1|||
161114473|NCT00531752|581808414|FG002|Second Double-blind Intervention Period|Other|0|||
161114474|NCT00531752|581808415|FG003|Second Double-blind Intervention Period|Other|0|||
161114475|NCT00531752|581808412|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161114476|NCT00531752|581808413|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161114477|NCT00531752|581808414|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161114478|NCT00531752|581808415|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
161114479|NCT00531752|581808412|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161114480|NCT00531752|581808413|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161324398|NCT02098395|582573587|FG003|Overall Study|Unclassified|2|||
160871074|NCT00976560|580921185|FG000|Overall Study|Adverse Event|5|||
160871075|NCT00976560|580921186|FG001|Overall Study|Adverse Event|5|||
160871076|NCT00976560|580921185|FG000|Overall Study|Lack of Efficacy|3|||
160871077|NCT00976560|580921186|FG001|Overall Study|Lack of Efficacy|5|||
160871078|NCT00976560|580921185|FG000|Overall Study|Protocol Violation|1|||
160871079|NCT00976560|580921186|FG001|Overall Study|Protocol Violation|0|||
160871080|NCT00976560|580921185|FG000|Overall Study|Lost to Follow-up|1|||
160871081|NCT00976560|580921186|FG001|Overall Study|Lost to Follow-up|0|||
160871082|NCT00976560|580921185|FG000|Overall Study|Physician Decision|2|||
160871083|NCT00976560|580921186|FG001|Overall Study|Physician Decision|0|||
160871084|NCT00976560|580921185|FG000|Overall Study|Withdrawal by Subject|2|||
160871085|NCT00976560|580921186|FG001|Overall Study|Withdrawal by Subject|3|||
160871086|NCT00125164|580921189|FG000|Overall Study|Adverse Event|0|||
160871087|NCT00125164|580921190|FG001|Overall Study|Adverse Event|0|||
160871088|NCT00125164|580921191|FG002|Overall Study|Adverse Event|2|||
160871089|NCT00125164|580921192|FG003|Overall Study|Adverse Event|4|||
160871090|NCT00125164|580921189|FG000|Overall Study|Lost to Follow-up|0|||
160871091|NCT00125164|580921190|FG001|Overall Study|Lost to Follow-up|0|||
160871092|NCT00125164|580921191|FG002|Overall Study|Lost to Follow-up|1|||
160871093|NCT00125164|580921192|FG003|Overall Study|Lost to Follow-up|1|||
160871094|NCT00125164|580921189|FG000|Overall Study|Withdrawal by Subject|2|||
160871095|NCT00125164|580921190|FG001|Overall Study|Withdrawal by Subject|0|||
160871096|NCT00125164|580921191|FG002|Overall Study|Withdrawal by Subject|1|||
160871097|NCT00125164|580921192|FG003|Overall Study|Withdrawal by Subject|1|||
160871098|NCT01339052|580921196|FG000|Overall Study|Disease progression|13|||
160871099|NCT01339052|580921197|FG001|Overall Study|Disease progression|46|||
160871100|NCT01339052|580921196|FG000|Overall Study|Adverse Event|1|||
160871101|NCT01339052|580921197|FG001|Overall Study|Adverse Event|1|||
160871102|NCT01339052|580921196|FG000|Overall Study|Withdrawal by Subject|0|||
160871103|NCT01339052|580921197|FG001|Overall Study|Withdrawal by Subject|3|||
160871104|NCT01339052|580921196|FG000|Overall Study|Physician Decision|1|||
160871105|NCT01339052|580921197|FG001|Overall Study|Physician Decision|0|||
160871106|NCT01301027|580921200|FG000|Overall Study|Physician Decision|2|||
160871107|NCT01301027|580921201|FG001|Overall Study|Physician Decision|0|||
161219128|NCT01070394|582183335|FG000|Overall Study|Withdrawal by Subject|1|||
161219129|NCT00066807|582183336|FG000|Overall Study|Study was terminated early|14|||
161219130|NCT00066807|582183337|FG001|Overall Study|Study was terminated early|15|||
160871108|NCT01301027|580921200|FG000|Overall Study|Withdrawal by Subject|2|||
161219131|NCT04014959|582185473|FG000|Baseline MRI and Assessments|Physician Decision|2|||
161219132|NCT04014959|582185473|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
161219133|NCT04014959|582185473|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
161219134|NCT02004847|582185475|FG000|Overall Study|Protocol Violation|1|||
161219135|NCT02004847|582185476|FG001|Overall Study|Protocol Violation|1|||
161219136|NCT01132118|582185477|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
161219137|NCT01132118|582185478|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
161219138|NCT01132118|582185477|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160871109|NCT01301027|580921201|FG001|Overall Study|Withdrawal by Subject|3|||
160871110|NCT01301027|580921200|FG000|Overall Study|Adverse Event|0|||
160871111|NCT01301027|580921201|FG001|Overall Study|Adverse Event|2|||
160871112|NCT01301027|580921200|FG000|Overall Study|Fracture|1|||
160871113|NCT01301027|580921201|FG001|Overall Study|Fracture|3|||
160871114|NCT01301027|580921200|FG000|Overall Study|Transplant|0|||
160871115|NCT01301027|580921201|FG001|Overall Study|Transplant|2|||
160871116|NCT01301027|580921200|FG000|Overall Study|Volume Overload|3|||
160871117|NCT01301027|580921201|FG001|Overall Study|Volume Overload|0|||
160871118|NCT04939415|580921202|FG000|Overall Study|Withdrawal by Subject|1|||
160871119|NCT04939415|580921203|FG001|Overall Study|Withdrawal by Subject|3|||
160871120|NCT04939415|580921202|FG000|Overall Study|Lost to Follow-up|0|||
160871121|NCT04939415|580921203|FG001|Overall Study|Lost to Follow-up|2|||
160871122|NCT01354314|580921207|FG000|Overall Study|Lost to Follow-up|1|||
160871123|NCT01354314|580921208|FG001|Overall Study|Lost to Follow-up|0|||
160871124|NCT01354314|580921209|FG002|Overall Study|Lost to Follow-up|1|||
160871125|NCT01354314|580921210|FG003|Overall Study|Lost to Follow-up|1|||
160871126|NCT01354314|580921207|FG000|Overall Study|Withdrawal by Subject|0|||
160871127|NCT01354314|580921208|FG001|Overall Study|Withdrawal by Subject|0|||
160871128|NCT01354314|580921209|FG002|Overall Study|Withdrawal by Subject|1|||
160871129|NCT01354314|580921210|FG003|Overall Study|Withdrawal by Subject|0|||
160871130|NCT01354314|580921207|FG000|Overall Study|Adverse Event|0|||
161219139|NCT01132118|582185478|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
160871131|NCT01354314|580921208|FG001|Overall Study|Adverse Event|0|||
160871132|NCT01354314|580921209|FG002|Overall Study|Adverse Event|0|||
160871133|NCT01354314|580921210|FG003|Overall Study|Adverse Event|1|||
160871134|NCT01354314|580921207|FG000|Overall Study|Protocol Violation|1|||
160871135|NCT01354314|580921208|FG001|Overall Study|Protocol Violation|1|||
161219140|NCT01132118|582185477|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
161219141|NCT01132118|582185478|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
161219142|NCT00313703|582185482|FG000|Overall Study|Lost to Follow-up|11|||
160871136|NCT01354314|580921209|FG002|Overall Study|Protocol Violation|0|||
160871137|NCT01354314|580921210|FG003|Overall Study|Protocol Violation|0|||
160871138|NCT01354314|580921207|FG000|Overall Study|Less than 90% Adherence|4|||
160871139|NCT01354314|580921208|FG001|Overall Study|Less than 90% Adherence|2|||
160871140|NCT01354314|580921209|FG002|Overall Study|Less than 90% Adherence|6|||
160871141|NCT01354314|580921210|FG003|Overall Study|Less than 90% Adherence|4|||
160871142|NCT00478023|580921211|FG000|Overall Study|Adverse Event|11|||
160871143|NCT00478023|580921212|FG001|Overall Study|Adverse Event|7|||
160871144|NCT00478023|580921213|FG002|Overall Study|Adverse Event|8|||
160871145|NCT00478023|580921214|FG003|Overall Study|Adverse Event|14|||
160871146|NCT00478023|580921215|FG004|Overall Study|Adverse Event|6|||
160871147|NCT00478023|580921211|FG000|Overall Study|Death|1|||
160871148|NCT00478023|580921212|FG001|Overall Study|Death|0|||
160871149|NCT00478023|580921213|FG002|Overall Study|Death|0|||
160871150|NCT00478023|580921214|FG003|Overall Study|Death|0|||
160871151|NCT00478023|580921215|FG004|Overall Study|Death|0|||
160871152|NCT00478023|580921211|FG000|Overall Study|Lack of Efficacy|11|||
160871153|NCT00478023|580921212|FG001|Overall Study|Lack of Efficacy|10|||
160871154|NCT00478023|580921213|FG002|Overall Study|Lack of Efficacy|4|||
160871155|NCT00478023|580921214|FG003|Overall Study|Lack of Efficacy|5|||
160871156|NCT00478023|580921215|FG004|Overall Study|Lack of Efficacy|41|||
160871157|NCT00478023|580921211|FG000|Overall Study|Lost to Follow-up|3|||
160871158|NCT00478023|580921212|FG001|Overall Study|Lost to Follow-up|1|||
160871159|NCT00478023|580921213|FG002|Overall Study|Lost to Follow-up|1|||
160871160|NCT00478023|580921214|FG003|Overall Study|Lost to Follow-up|1|||
160871161|NCT00478023|580921215|FG004|Overall Study|Lost to Follow-up|0|||
160871162|NCT00478023|580921211|FG000|Overall Study|Withdrawal by Subject|2|||
160871163|NCT00478023|580921212|FG001|Overall Study|Withdrawal by Subject|3|||
160871164|NCT00478023|580921213|FG002|Overall Study|Withdrawal by Subject|2|||
160871165|NCT00478023|580921214|FG003|Overall Study|Withdrawal by Subject|4|||
160871166|NCT00478023|580921215|FG004|Overall Study|Withdrawal by Subject|5|||
160871167|NCT00478023|580921211|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
160871168|NCT00478023|580921212|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
160871169|NCT00478023|580921213|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
160871170|NCT00478023|580921214|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
160871171|NCT00478023|580921215|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
160871172|NCT00369265|580921217|FG000|Overall Study|Study terminated|4|||
160871173|NCT00369265|580921218|FG001|Overall Study|Study terminated|7|||
160871174|NCT03895840|580921219|FG000|Overall Study|Withdrawal by Subject|21|||
160871175|NCT00611026|580921222|FG000|Randomized to Double-blind Treatment|Not treated|2|||
160871176|NCT00611026|580921223|FG001|Randomized to Double-blind Treatment|Not treated|1|||
160871177|NCT00611026|580921224|FG002|Randomized to Double-blind Treatment|Not treated|3|||
160871178|NCT00611026|580921222|FG000|Double-blind Treatment Period|Death|1|||
160871179|NCT00611026|580921223|FG001|Double-blind Treatment Period|Death|0|||
160871180|NCT00611026|580921224|FG002|Double-blind Treatment Period|Death|0|||
160871181|NCT00611026|580921222|FG000|Double-blind Treatment Period|Adverse Event|9|||
160871182|NCT00611026|580921223|FG001|Double-blind Treatment Period|Adverse Event|28|||
160871183|NCT00611026|580921224|FG002|Double-blind Treatment Period|Adverse Event|46|||
160871184|NCT00611026|580921222|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
160871185|NCT00611026|580921223|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
160871186|NCT00611026|580921224|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
160871187|NCT00611026|580921222|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
160871188|NCT00611026|580921223|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
161114481|NCT00531752|581808414|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161114482|NCT00531752|581808415|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
161114483|NCT01883635|581808417|FG000|Overall Study|Withdrawal by Subject|4|||
161114484|NCT01883635|581808418|FG001|Overall Study|Withdrawal by Subject|0|||
161114485|NCT00761514|581808419|FG000|Overall Study|Adverse Event|1|||
161114486|NCT00761514|581808419|FG000|Overall Study|Withdrawal by Subject|2|||
161114487|NCT00761514|581808419|FG000|Overall Study|Lost to Follow-up|1|||
161114488|NCT00761514|581808419|FG000|Overall Study|Health insurance didn't cover study drug|1|||
161114489|NCT00761514|581808419|FG000|Overall Study|Problem complying with study visit|1|||
161114490|NCT00761514|581808419|FG000|Overall Study|Unable to pay for medications|1|||
161114491|NCT00159861|581808420|FG000|Core Study - 16 Weeks|Death|3|||
161114492|NCT00159861|581808421|FG001|Core Study - 16 Weeks|Death|0|||
161114493|NCT00159861|581808420|FG000|Core Study - 16 Weeks|Adverse Event|12|||
161114494|NCT00159861|581808421|FG001|Core Study - 16 Weeks|Adverse Event|6|||
161114495|NCT00159861|581808420|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
161114496|NCT00159861|581808421|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
161114497|NCT00159861|581808420|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
161114498|NCT00159861|581808421|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
160871189|NCT00611026|580921224|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
161114499|NCT00159861|581808420|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
161114500|NCT00159861|581808421|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
161114501|NCT00159861|581808420|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
160871190|NCT00611026|580921222|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
160871191|NCT00611026|580921223|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
160871192|NCT00611026|580921224|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
160871193|NCT00611026|580921222|FG000|Double-blind Treatment Period|Other|13|||
160871194|NCT00611026|580921223|FG001|Double-blind Treatment Period|Other|20|||
160871195|NCT00611026|580921224|FG002|Double-blind Treatment Period|Other|18|||
160871196|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
161219143|NCT00313703|582185483|FG001|Overall Study|Lost to Follow-up|2|||
161219144|NCT00313703|582185484|FG002|Overall Study|Lost to Follow-up|5|||
161219145|NCT00313703|582185485|FG003|Overall Study|Lost to Follow-up|12|||
161219146|NCT03031899|582185486|FG000|Overall Study|Protocol Violation|1|||
161219147|NCT03031899|582185486|FG000|Overall Study|lesion disappeared after stopping habit|1|||
161219148|NCT01664052|582185487|FG000|Phase 1|No device placement|6|||
161219149|NCT01664052|582185488|FG001|Phase 1|No device placement|0|||
161219150|NCT01664052|582185487|FG000|Phase 1|No HSG 1 hr post placement|1|||
161219151|NCT01664052|582185488|FG001|Phase 1|No HSG 1 hr post placement|0|||
161219152|NCT01664052|582185487|FG000|Phase 2|No device placement|0|||
161219153|NCT01664052|582185488|FG001|Phase 2|No device placement|4|||
161219154|NCT03705351|582185492|FG000|Overall Study|Study termination|3|||
161219155|NCT03705351|582185492|FG000|Overall Study|Death|1|||
160871197|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
160871198|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
160871199|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
160871200|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871201|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871202|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871203|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871204|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871205|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871206|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
160871207|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871208|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871209|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871210|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
160871211|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
160871212|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
160871213|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
160871214|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871215|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871216|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871217|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
160871218|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871219|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
160871220|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871221|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871222|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871223|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
160871224|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
160871225|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
160871226|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
160871227|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
160871228|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
160871229|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
160871230|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
160871231|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
160871232|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871233|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871234|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871235|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871236|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871237|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871238|NCT05019521|580921225|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871239|NCT05019521|580921226|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871240|NCT05019521|580921227|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871241|NCT05019521|580921228|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
161219156|NCT03705351|582185492|FG000|Overall Study|Lack of Efficacy|2|||
161219157|NCT03705351|582185492|FG000|Overall Study|Withdrawal by Subject|1|||
160871242|NCT05019521|580921229|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871243|NCT05019521|580921230|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160981507|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161219158|NCT00633152|582185495|FG000|Overall Study|Adverse Event|1|||
161219159|NCT00633152|582185496|FG001|Overall Study|Adverse Event|0|||
161219160|NCT00633152|582185495|FG000|Overall Study|Randomized, did not receive study drug|5|||
160871244|NCT05019521|580921231|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871245|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
160871246|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
160871247|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
160871248|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871249|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871250|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
160871251|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
160871252|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871253|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
160871254|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871255|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871256|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871257|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
160871258|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
160871259|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
160871260|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871261|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871262|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
160871263|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
160871264|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
160871265|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
160871266|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871267|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
160871268|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
160871269|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871270|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871271|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871272|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
160871273|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871274|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
160871275|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
160871276|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871277|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
160871278|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871279|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
160871280|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871281|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871282|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871283|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871284|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871285|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
160871286|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
160871287|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871288|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
160871289|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
160871290|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871291|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871292|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
160871293|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
160871294|NCT05019521|580921225|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
161219161|NCT00633152|582185496|FG001|Overall Study|Randomized, did not receive study drug|2|||
161219162|NCT00633152|582185495|FG000|Overall Study|Withdrawal by Subject|1|||
161219163|NCT00633152|582185496|FG001|Overall Study|Withdrawal by Subject|1|||
161219164|NCT00633152|582185495|FG000|Overall Study|Lost to Follow-up|4|||
161219165|NCT00633152|582185496|FG001|Overall Study|Lost to Follow-up|1|||
161219166|NCT00633152|582185495|FG000|Overall Study|Miscellaneous Other|3|||
161219167|NCT00633152|582185496|FG001|Overall Study|Miscellaneous Other|2|||
161219168|NCT02180061|582185497|FG000|Overall Study|Adverse Event|4|||
161219169|NCT02180061|582185498|FG001|Overall Study|Adverse Event|2|||
161219170|NCT02180061|582185497|FG000|Overall Study|Clinical Progression|5|||
160871295|NCT05019521|580921226|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
160871296|NCT05019521|580921227|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
161219171|NCT02180061|582185498|FG001|Overall Study|Clinical Progression|1|||
160871297|NCT05019521|580921228|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
160871298|NCT05019521|580921229|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
160871299|NCT05019521|580921230|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
160871300|NCT05019521|580921231|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
160871301|NCT00760617|580921232|FG000|Overall Study|Adverse Event|5|||
160871302|NCT00760617|580921233|FG001|Overall Study|Adverse Event|2|||
160871303|NCT00760617|580921234|FG002|Overall Study|Adverse Event|0|||
160871304|NCT00760617|580921232|FG000|Overall Study|Lost to Follow-up|0|||
161114502|NCT00159861|581808421|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
161114503|NCT00159861|581808420|FG000|Extension Study - up to 3 Years|Death|24|||
161114504|NCT00159861|581808421|FG001|Extension Study - up to 3 Years|Death|28|||
161114505|NCT00159861|581808420|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
161114506|NCT00159861|581808421|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
161114507|NCT00159861|581808420|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
161114508|NCT00159861|581808421|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
161114509|NCT00159861|581808420|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
161114510|NCT00159861|581808421|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
161114511|NCT00159861|581808420|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
161114512|NCT00159861|581808421|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
161114513|NCT00894556|581808425|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
161114514|NCT00894556|581808426|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
161114515|NCT00894556|581808427|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
161114516|NCT00894556|581808428|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
161114517|NCT00894556|581808425|FG000|Treatment Phase|Lost to Follow-up|2|||
161114518|NCT00894556|581808426|FG001|Treatment Phase|Lost to Follow-up|3|||
161114519|NCT00894556|581808427|FG002|Treatment Phase|Lost to Follow-up|1|||
161114520|NCT00894556|581808428|FG003|Treatment Phase|Lost to Follow-up|0|||
161114521|NCT00894556|581808425|FG000|Treatment Phase|Lack of Qualifying Event|2|||
161114522|NCT00894556|581808426|FG001|Treatment Phase|Lack of Qualifying Event|1|||
161114523|NCT00894556|581808427|FG002|Treatment Phase|Lack of Qualifying Event|0|||
161114524|NCT00894556|581808428|FG003|Treatment Phase|Lack of Qualifying Event|0|||
161114525|NCT01979536|581808432|FG000|Overall Study|Physician Decision|2|||
161114526|NCT01979536|581808433|FG001|Overall Study|Physician Decision|3|||
161114527|NCT01979536|581808432|FG000|Overall Study|Withdrawal by Subject|0|||
161114528|NCT01979536|581808433|FG001|Overall Study|Withdrawal by Subject|1|||
161114529|NCT01979536|581808432|FG000|Overall Study|Refusal|0|||
161114530|NCT01979536|581808433|FG001|Overall Study|Refusal|1|||
161114531|NCT01979536|581808432|FG000|Overall Study|Relapse|0|||
161114532|NCT01979536|581808433|FG001|Overall Study|Relapse|1|||
161114533|NCT01979536|581808432|FG000|Overall Study|Study terminated by Sponsor|0|||
161114534|NCT01979536|581808433|FG001|Overall Study|Study terminated by Sponsor|1|||
161114535|NCT01979536|581808432|FG000|Overall Study|Did not start treatment|0|||
161114536|NCT01979536|581808433|FG001|Overall Study|Did not start treatment|1|||
161114537|NCT00733954|581808436|FG000|Overall Study|Lost to Follow-up|5|||
161114538|NCT00733954|581808437|FG001|Overall Study|Lost to Follow-up|2|||
161114539|NCT00733954|581808436|FG000|Overall Study|Protocol Violation|1|||
161114540|NCT00733954|581808437|FG001|Overall Study|Protocol Violation|0|||
161114541|NCT00733954|581808436|FG000|Overall Study|Withdrawal by Subject|2|||
161114542|NCT00733954|581808437|FG001|Overall Study|Withdrawal by Subject|0|||
161114543|NCT02663453|581808438|FG000|Overall Study|Death|4|||
161114544|NCT02663453|581808439|FG001|Overall Study|Death|4|||
161114545|NCT02663453|581808438|FG000|Overall Study|Withdrawal by Subject|1|||
161114546|NCT02663453|581808439|FG001|Overall Study|Withdrawal by Subject|0|||
161114547|NCT01964352|581809532|FG000|Overall Study|Adverse Event|13|||
161114548|NCT01964352|581809533|FG001|Overall Study|Adverse Event|3|||
161114549|NCT01964352|581809534|FG002|Overall Study|Adverse Event|4|||
161114550|NCT01964352|581809535|FG003|Overall Study|Adverse Event|3|||
161114551|NCT01964352|581809532|FG000|Overall Study|Lack of Efficacy|6|||
161114552|NCT01964352|581809533|FG001|Overall Study|Lack of Efficacy|0|||
161114553|NCT01964352|581809534|FG002|Overall Study|Lack of Efficacy|0|||
161219172|NCT02180061|582185497|FG000|Overall Study|Progressive Disease|15|||
161114554|NCT01964352|581809535|FG003|Overall Study|Lack of Efficacy|0|||
161114555|NCT01964352|581809532|FG000|Overall Study|Protocol Violation|2|||
161114556|NCT01964352|581809533|FG001|Overall Study|Protocol Violation|4|||
161114557|NCT01964352|581809534|FG002|Overall Study|Protocol Violation|0|||
161114558|NCT01964352|581809535|FG003|Overall Study|Protocol Violation|2|||
161114559|NCT01964352|581809532|FG000|Overall Study|Lost to Follow-up|1|||
161114560|NCT01964352|581809533|FG001|Overall Study|Lost to Follow-up|0|||
161114561|NCT01964352|581809534|FG002|Overall Study|Lost to Follow-up|0|||
161219173|NCT02180061|582185498|FG001|Overall Study|Progressive Disease|5|||
161114562|NCT01964352|581809535|FG003|Overall Study|Lost to Follow-up|1|||
161114563|NCT01964352|581809532|FG000|Overall Study|Withdrawal by Subject|4|||
161114564|NCT01964352|581809533|FG001|Overall Study|Withdrawal by Subject|2|||
161219174|NCT02180061|582185497|FG000|Overall Study|Physician Decision|1|||
161219175|NCT02180061|582185498|FG001|Overall Study|Physician Decision|0|||
160871305|NCT00760617|580921233|FG001|Overall Study|Lost to Follow-up|0|||
160871306|NCT00760617|580921234|FG002|Overall Study|Lost to Follow-up|5|||
160871307|NCT04625101|580921235|FG000|Overall Study|Withdrawal by Subject|0|||
160871308|NCT04625101|580921236|FG001|Overall Study|Withdrawal by Subject|1|||
160871309|NCT04625101|580921235|FG000|Overall Study|Protocol Deviation|1|||
160871310|NCT04625101|580921236|FG001|Overall Study|Protocol Deviation|0|||
160871311|NCT00467753|580921238|FG000|Overall Study|Lost to Follow-up|1|||
160871312|NCT00467753|580921239|FG001|Overall Study|Lost to Follow-up|2|||
160871313|NCT00467753|580921238|FG000|Overall Study|Adverse Event|2|||
160871314|NCT00467753|580921239|FG001|Overall Study|Adverse Event|0|||
160871315|NCT02817464|580921240|FG000|Overall Study|Lost to Follow-up|1|||
160871316|NCT02817464|580921241|FG001|Overall Study|Lost to Follow-up|0|||
160871317|NCT02817464|580921240|FG000|Overall Study|Discontinued early due to personal decision|1|||
160871318|NCT02817464|580921241|FG001|Overall Study|Discontinued early due to personal decision|1|||
160871319|NCT01026324|580921243|FG000|Follow up/Survival|Withdrawal by Subject|1|||
160871320|NCT01026324|580921244|FG001|Follow up/Survival|Withdrawal by Subject|0|||
160871321|NCT01026324|580921245|FG002|Follow up/Survival|Withdrawal by Subject|0|||
160871322|NCT01500720|580921252|FG000|Overall Study|Randomized But Not Treated|1|||
160871323|NCT01500720|580921253|FG001|Overall Study|Randomized But Not Treated|1|||
160871324|NCT01500720|580921252|FG000|Overall Study|Other|4|||
160871325|NCT01500720|580921253|FG001|Overall Study|Other|8|||
160871326|NCT02624986|580921255|FG000|Overall Study|Death|0|||
160871327|NCT02624986|580921256|FG001|Overall Study|Death|1|||
160871328|NCT02624986|580921257|FG002|Overall Study|Death|2|||
160871329|NCT02624986|580921258|FG003|Overall Study|Death|2|||
160871330|NCT02624986|580921259|FG004|Overall Study|Death|2|||
160871331|NCT02624986|580921260|FG005|Overall Study|Death|0|||
160871332|NCT02624986|580921261|FG006|Overall Study|Death|0|||
160871333|NCT02624986|580921262|FG007|Overall Study|Death|1|||
160871334|NCT02624986|580921255|FG000|Overall Study|Study Terminated by Sponsor|1|||
160871335|NCT02624986|580921256|FG001|Overall Study|Study Terminated by Sponsor|1|||
160871336|NCT02624986|580921257|FG002|Overall Study|Study Terminated by Sponsor|0|||
160871337|NCT02624986|580921258|FG003|Overall Study|Study Terminated by Sponsor|1|||
160871338|NCT02624986|580921259|FG004|Overall Study|Study Terminated by Sponsor|2|||
160871339|NCT02624986|580921260|FG005|Overall Study|Study Terminated by Sponsor|2|||
160871340|NCT02624986|580921261|FG006|Overall Study|Study Terminated by Sponsor|4|||
160871341|NCT02624986|580921262|FG007|Overall Study|Study Terminated by Sponsor|3|||
160871342|NCT02624986|580921255|FG000|Overall Study|Progressive Disease|0|||
160871343|NCT02624986|580921256|FG001|Overall Study|Progressive Disease|1|||
160871344|NCT02624986|580921257|FG002|Overall Study|Progressive Disease|0|||
160871345|NCT02624986|580921258|FG003|Overall Study|Progressive Disease|0|||
160871346|NCT02624986|580921259|FG004|Overall Study|Progressive Disease|0|||
160871347|NCT02624986|580921260|FG005|Overall Study|Progressive Disease|0|||
160871348|NCT02624986|580921261|FG006|Overall Study|Progressive Disease|0|||
160871349|NCT02624986|580921262|FG007|Overall Study|Progressive Disease|0|||
160871350|NCT02624986|580921255|FG000|Overall Study|Protocol Violation|1|||
160871351|NCT02624986|580921256|FG001|Overall Study|Protocol Violation|0|||
160871352|NCT02624986|580921257|FG002|Overall Study|Protocol Violation|0|||
160871353|NCT02624986|580921258|FG003|Overall Study|Protocol Violation|0|||
160871354|NCT02624986|580921259|FG004|Overall Study|Protocol Violation|0|||
160871355|NCT02624986|580921260|FG005|Overall Study|Protocol Violation|0|||
160871356|NCT02624986|580921261|FG006|Overall Study|Protocol Violation|0|||
160871357|NCT02624986|580921262|FG007|Overall Study|Protocol Violation|0|||
160871358|NCT02624986|580921255|FG000|Overall Study|Withdrawal by Subject|0|||
160871359|NCT02624986|580921256|FG001|Overall Study|Withdrawal by Subject|0|||
160871360|NCT02624986|580921257|FG002|Overall Study|Withdrawal by Subject|0|||
160871361|NCT02624986|580921258|FG003|Overall Study|Withdrawal by Subject|0|||
160871362|NCT02624986|580921259|FG004|Overall Study|Withdrawal by Subject|0|||
160871363|NCT02624986|580921260|FG005|Overall Study|Withdrawal by Subject|0|||
160871364|NCT02624986|580921261|FG006|Overall Study|Withdrawal by Subject|0|||
160871365|NCT02624986|580921262|FG007|Overall Study|Withdrawal by Subject|1|||
160871366|NCT03532451|580921263|FG000|Overall Study|Withdrawal by Subject|0|||
161114565|NCT01964352|581809534|FG002|Overall Study|Withdrawal by Subject|1|||
160871367|NCT03532451|580921264|FG001|Overall Study|Withdrawal by Subject|1|||
160871368|NCT03532451|580921263|FG000|Overall Study|Did not undergo surgery|1|||
160871369|NCT03532451|580921264|FG001|Overall Study|Did not undergo surgery|1|||
160871370|NCT01287741|580921272|FG000|Overall Study|Withdrawal by Subject|35|||
160871371|NCT01287741|580921273|FG001|Overall Study|Withdrawal by Subject|38|||
160871372|NCT01287741|580921272|FG000|Overall Study|Protocol Violation|2|||
160871373|NCT01287741|580921273|FG001|Overall Study|Protocol Violation|0|||
160871374|NCT01287741|580921272|FG000|Overall Study|Physician Decision|15|||
160871375|NCT01287741|580921273|FG001|Overall Study|Physician Decision|23|||
160871376|NCT01287741|580921272|FG000|Overall Study|Non-compliance|8|||
160871377|NCT01287741|580921273|FG001|Overall Study|Non-compliance|6|||
160871378|NCT01287741|580921272|FG000|Overall Study|Lost to Follow-up|10|||
160871379|NCT01287741|580921273|FG001|Overall Study|Lost to Follow-up|8|||
160871380|NCT01287741|580921272|FG000|Overall Study|Death|32|||
160871381|NCT01287741|580921273|FG001|Overall Study|Death|44|||
160871382|NCT01287741|580921272|FG000|Overall Study|Adverse Event|4|||
161114566|NCT01964352|581809535|FG003|Overall Study|Withdrawal by Subject|0|||
160871383|NCT01287741|580921273|FG001|Overall Study|Adverse Event|6|||
160871384|NCT01287741|580921272|FG000|Overall Study|Study terminated by Sponsor|307|||
160871385|NCT01287741|580921273|FG001|Overall Study|Study terminated by Sponsor|315|||
160871386|NCT01287741|580921272|FG000|Overall Study|Progressive disease|190|||
160871387|NCT01287741|580921273|FG001|Overall Study|Progressive disease|166|||
160871388|NCT01287741|580921272|FG000|Overall Study|Reason not specified|23|||
160871389|NCT01287741|580921273|FG001|Overall Study|Reason not specified|9|||
160871390|NCT02930018|580921274|FG000|Overall Study|Lost to Follow-up|1|||
160871391|NCT02930018|580921275|FG001|Overall Study|Lost to Follow-up|1|||
160871392|NCT02930018|580921274|FG000|Overall Study|Withdrawal by Subject|5|||
160871393|NCT02930018|580921275|FG001|Overall Study|Withdrawal by Subject|2|||
160871394|NCT02807402|580921276|FG000|Overall Study|Failure to Return|1|||
160871395|NCT02807402|580921276|FG000|Overall Study|Death|3|||
160871396|NCT02807402|580921276|FG000|Overall Study|Other|2|||
160871397|NCT01865552|580922748|FG000|Period 1|Adverse Event|1|||
160871398|NCT01865552|580922749|FG001|Period 1|Adverse Event|0|||
160871399|NCT01865552|580922750|FG002|Period 1|Adverse Event|0|||
160871400|NCT01865552|580922751|FG003|Period 1|Adverse Event|1|||
160871401|NCT01865552|580922752|FG004|Period 1|Adverse Event|1|||
160871402|NCT01865552|580922753|FG005|Period 1|Adverse Event|1|||
160871403|NCT01865552|580922748|FG000|Period 1|Pathological lab|0|||
160871404|NCT01865552|580922749|FG001|Period 1|Pathological lab|0|||
160871405|NCT01865552|580922750|FG002|Period 1|Pathological lab|0|||
160871406|NCT01865552|580922751|FG003|Period 1|Pathological lab|0|||
160871407|NCT01865552|580922752|FG004|Period 1|Pathological lab|1|||
160871408|NCT01865552|580922753|FG005|Period 1|Pathological lab|0|||
160871409|NCT01865552|580922748|FG000|Period 1|Other|0|||
160871410|NCT01865552|580922749|FG001|Period 1|Other|0|||
160871411|NCT01865552|580922750|FG002|Period 1|Other|0|||
160871412|NCT01865552|580922751|FG003|Period 1|Other|0|||
160871413|NCT01865552|580922752|FG004|Period 1|Other|1|||
160871414|NCT01865552|580922753|FG005|Period 1|Other|0|||
160871415|NCT03079102|580922756|FG000|Overall Study|Physician Decision|0|||
160871416|NCT03079102|580922757|FG001|Overall Study|Physician Decision|1|||
160871417|NCT02923921|580922758|FG000|Overall Study|Sponsor Decision|39|||
160871418|NCT02923921|580922759|FG001|Overall Study|Sponsor Decision|38|||
161219176|NCT01579474|582185499|FG000|Overall Study|Adverse Event|1|||
161219177|NCT01579474|582185500|FG001|Overall Study|Adverse Event|13|||
161219178|NCT01579474|582185501|FG002|Overall Study|Adverse Event|2|||
161219179|NCT01579474|582185502|FG003|Overall Study|Adverse Event|0|||
161219180|NCT01579474|582185503|FG004|Overall Study|Adverse Event|0|||
161219181|NCT01579474|582185504|FG005|Overall Study|Adverse Event|1|||
161219182|NCT01579474|582185499|FG000|Overall Study|Lack of Efficacy|1|||
161219183|NCT01579474|582185500|FG001|Overall Study|Lack of Efficacy|0|||
161219184|NCT01579474|582185501|FG002|Overall Study|Lack of Efficacy|0|||
161219185|NCT01579474|582185502|FG003|Overall Study|Lack of Efficacy|0|||
161219186|NCT01579474|582185503|FG004|Overall Study|Lack of Efficacy|1|||
161219187|NCT01579474|582185504|FG005|Overall Study|Lack of Efficacy|0|||
160871419|NCT02923921|580922758|FG000|Overall Study|Lost to Follow-up|1|||
161219188|NCT01579474|582185499|FG000|Overall Study|Withdrawal by Subject|1|||
161219189|NCT01579474|582185500|FG001|Overall Study|Withdrawal by Subject|0|||
161219190|NCT01579474|582185501|FG002|Overall Study|Withdrawal by Subject|0|||
161219191|NCT01579474|582185502|FG003|Overall Study|Withdrawal by Subject|0|||
161219192|NCT01579474|582185503|FG004|Overall Study|Withdrawal by Subject|0|||
161219193|NCT01579474|582185504|FG005|Overall Study|Withdrawal by Subject|0|||
161219194|NCT02295774|582185505|FG000|Overall Study|Physician Decision|1|||
161219195|NCT02295774|582185505|FG000|Overall Study|Withdrawal by Subject|2|||
161219196|NCT03532009|582185509|FG000|Overall Study|Other|1|||
160871420|NCT02923921|580922759|FG001|Overall Study|Lost to Follow-up|0|||
161219197|NCT03532009|582185510|FG001|Overall Study|Other|1|||
160871421|NCT02923921|580922758|FG000|Overall Study|Withdrawal by Subject|6|||
160871422|NCT02923921|580922759|FG001|Overall Study|Withdrawal by Subject|13|||
160871423|NCT02923921|580922758|FG000|Overall Study|Unknown, Not Collected|7|||
160871424|NCT02923921|580922759|FG001|Overall Study|Unknown, Not Collected|6|||
160871425|NCT03083873|580922760|FG000|Overall Study|Death|6|||
160871426|NCT03083873|580922761|FG001|Overall Study|Death|15|||
160871427|NCT03083873|580922762|FG002|Overall Study|Death|13|||
160871428|NCT03083873|580922763|FG003|Overall Study|Death|9|||
160871429|NCT03083873|580922764|FG004|Overall Study|Death|0|||
161219198|NCT03532009|582185509|FG000|Overall Study|Death|1|||
161114567|NCT01964352|581809532|FG000|Overall Study|Other than stated above|0|||
161114568|NCT01964352|581809533|FG001|Overall Study|Other than stated above|2|||
161114569|NCT01964352|581809534|FG002|Overall Study|Other than stated above|1|||
161114570|NCT01964352|581809535|FG003|Overall Study|Other than stated above|2|||
161114571|NCT01908101|581809536|FG000|Overall Study|Physician Decision|1|||
161114572|NCT01908101|581809536|FG000|Overall Study|Withdrawal by Subject|1|||
161114573|NCT01908101|581809536|FG000|Overall Study|Incorrect Diagnosis|2|||
161114574|NCT01908101|581809536|FG000|Overall Study|Incorrect Starting Dose|1|||
161114575|NCT01908101|581809536|FG000|Overall Study|Did not complete the first cycle|4|||
161114576|NCT01394939|581809537|FG000|Overall Study|Adverse Event|1|||
161114577|NCT01394939|581809538|FG001|Overall Study|Adverse Event|3|||
161114578|NCT01394939|581809539|FG002|Overall Study|Adverse Event|0|||
161114579|NCT01394939|581809540|FG003|Overall Study|Adverse Event|2|||
161114580|NCT01394939|581809537|FG000|Overall Study|Death|0|||
161114581|NCT01394939|581809538|FG001|Overall Study|Death|2|||
161114582|NCT01394939|581809539|FG002|Overall Study|Death|0|||
161114583|NCT01394939|581809540|FG003|Overall Study|Death|0|||
161114584|NCT01394939|581809537|FG000|Overall Study|Physician Decision|0|||
161114585|NCT01394939|581809538|FG001|Overall Study|Physician Decision|1|||
161114586|NCT01394939|581809539|FG002|Overall Study|Physician Decision|0|||
161114587|NCT01394939|581809540|FG003|Overall Study|Physician Decision|0|||
161114588|NCT01394939|581809537|FG000|Overall Study|Withdrawal by Subject|0|||
161114589|NCT01394939|581809538|FG001|Overall Study|Withdrawal by Subject|2|||
161114590|NCT01394939|581809539|FG002|Overall Study|Withdrawal by Subject|0|||
161114591|NCT01394939|581809540|FG003|Overall Study|Withdrawal by Subject|2|||
161114592|NCT01394939|581809537|FG000|Overall Study|Others|0|||
160871430|NCT03083873|580922760|FG000|Overall Study|Sponsor Terminated Study|0|||
160871431|NCT03083873|580922761|FG001|Overall Study|Sponsor Terminated Study|1|||
160871432|NCT03083873|580922762|FG002|Overall Study|Sponsor Terminated Study|2|||
160871433|NCT03083873|580922763|FG003|Overall Study|Sponsor Terminated Study|3|||
160871434|NCT03083873|580922764|FG004|Overall Study|Sponsor Terminated Study|0|||
160871435|NCT03083873|580922760|FG000|Overall Study|Lost to Follow-up|0|||
160871436|NCT03083873|580922761|FG001|Overall Study|Lost to Follow-up|1|||
160871437|NCT03083873|580922762|FG002|Overall Study|Lost to Follow-up|1|||
160871438|NCT03083873|580922763|FG003|Overall Study|Lost to Follow-up|0|||
160871439|NCT03083873|580922764|FG004|Overall Study|Lost to Follow-up|0|||
160871440|NCT03083873|580922760|FG000|Overall Study|Withdrawal by Subject|2|||
160871441|NCT03083873|580922761|FG001|Overall Study|Withdrawal by Subject|0|||
160871442|NCT03083873|580922762|FG002|Overall Study|Withdrawal by Subject|0|||
160871443|NCT03083873|580922763|FG003|Overall Study|Withdrawal by Subject|0|||
160871444|NCT03083873|580922764|FG004|Overall Study|Withdrawal by Subject|0|||
160871445|NCT03083873|580922760|FG000|Overall Study|Did Not Receive TIL|2|||
160871446|NCT03083873|580922761|FG001|Overall Study|Did Not Receive TIL|5|||
160871447|NCT03083873|580922762|FG002|Overall Study|Did Not Receive TIL|3|||
160871448|NCT03083873|580922763|FG003|Overall Study|Did Not Receive TIL|1|||
160871449|NCT03083873|580922764|FG004|Overall Study|Did Not Receive TIL|0|||
160871450|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
160871451|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
160871452|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
160871453|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
160871454|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
160871455|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
160981508|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
161114593|NCT01394939|581809538|FG001|Overall Study|Others|2|||
161114594|NCT01394939|581809539|FG002|Overall Study|Others|0|||
161114595|NCT01394939|581809540|FG003|Overall Study|Others|3|||
161114596|NCT01659320|581809548|FG000|Overall Study|Withdrawal by Subject|2|||
161114597|NCT01659320|581809548|FG000|Overall Study|Physician Decision|1|||
161114598|NCT01514682|581809549|FG000|Overall Study|Withdrawal by Subject|2|||
161114599|NCT01514682|581809550|FG001|Overall Study|Withdrawal by Subject|3|||
161114600|NCT01514682|581809549|FG000|Overall Study|Physician Decision|4|||
161114601|NCT01514682|581809550|FG001|Overall Study|Physician Decision|3|||
161114602|NCT00590590|581809551|FG000|Overall Study|Lack of Efficacy|1|||
161114603|NCT00590590|581809552|FG001|Overall Study|Lack of Efficacy|2|||
161114604|NCT00590590|581809553|FG002|Overall Study|Lack of Efficacy|0|||
161114605|NCT00590590|581809551|FG000|Overall Study|Adverse Event|1|||
161114606|NCT00590590|581809552|FG001|Overall Study|Adverse Event|0|||
161114607|NCT00590590|581809553|FG002|Overall Study|Adverse Event|0|||
161114608|NCT00590590|581809551|FG000|Overall Study|Protocol Violation|0|||
161114609|NCT00590590|581809552|FG001|Overall Study|Protocol Violation|0|||
161114610|NCT00590590|581809553|FG002|Overall Study|Protocol Violation|2|||
161114611|NCT00590590|581809551|FG000|Overall Study|Lost to Follow-up|4|||
161114612|NCT00590590|581809552|FG001|Overall Study|Lost to Follow-up|1|||
161114613|NCT00590590|581809553|FG002|Overall Study|Lost to Follow-up|2|||
161114614|NCT00590590|581809551|FG000|Overall Study|Withdrawal by Subject|0|||
161114615|NCT00590590|581809552|FG001|Overall Study|Withdrawal by Subject|1|||
161114616|NCT00590590|581809553|FG002|Overall Study|Withdrawal by Subject|1|||
161114617|NCT00590590|581809551|FG000|Overall Study|Did not complete due to study closure|1|||
161114618|NCT00590590|581809552|FG001|Overall Study|Did not complete due to study closure|1|||
161114619|NCT00590590|581809553|FG002|Overall Study|Did not complete due to study closure|1|||
161114620|NCT00590590|581809551|FG000|Overall Study|Did not complete study|0|||
161114621|NCT00590590|581809552|FG001|Overall Study|Did not complete study|1|||
161114622|NCT00590590|581809553|FG002|Overall Study|Did not complete study|0|||
161114623|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
161219199|NCT03532009|582185510|FG001|Overall Study|Death|1|||
161219200|NCT03532009|582185509|FG000|Overall Study|Withdrawal by Patient|0|||
161219201|NCT03532009|582185510|FG001|Overall Study|Withdrawal by Patient|2|||
161219202|NCT00368966|582185511|FG000|Infant Series|Withdrawal by Subject|11|||
161219203|NCT00368966|582185512|FG001|Infant Series|Withdrawal by Subject|6|||
161219204|NCT00368966|582185511|FG000|Infant Series|Protocol Violation|2|||
161114624|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161114625|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161114626|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
161114627|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
161219205|NCT00368966|582185512|FG001|Infant Series|Protocol Violation|1|||
160871456|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
160871457|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
160871458|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
160871459|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
160871460|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
160871461|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
161219206|NCT00368966|582185511|FG000|Infant Series|Lost to Follow-up|2|||
160871462|NCT00479687|580922765|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
160871463|NCT00479687|580922766|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
160871464|NCT00479687|580922767|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
160871465|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
160871466|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
160871467|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
160871468|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
160871469|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
160871470|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
160871471|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
160871472|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
160871473|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
160871474|NCT00479687|580922765|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
160871475|NCT00479687|580922766|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
160871476|NCT00479687|580922767|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
160871477|NCT00295880|580922768|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
160871478|NCT00295880|580922768|FG000|Overall Study|Unit randomization did not occur|1|||
160871479|NCT01474239|580922769|FG000|Overall Study|Disease Progression|37|||
160871480|NCT01474239|580922770|FG001|Overall Study|Disease Progression|25|||
160871481|NCT01474239|580922769|FG000|Overall Study|Adverse Event|12|||
160871482|NCT01474239|580922770|FG001|Overall Study|Adverse Event|3|||
160871483|NCT01474239|580922769|FG000|Overall Study|Withdrawal by Subject|1|||
160871484|NCT01474239|580922770|FG001|Overall Study|Withdrawal by Subject|2|||
160871485|NCT01474239|580922769|FG000|Overall Study|Death|1|||
160871486|NCT01474239|580922770|FG001|Overall Study|Death|1|||
160871487|NCT01474239|580922769|FG000|Overall Study|Clinical Disease Progression|7|||
160871488|NCT01474239|580922770|FG001|Overall Study|Clinical Disease Progression|1|||
160871489|NCT01474239|580922769|FG000|Overall Study|Withdrawal for Economic Reason|1|||
160871490|NCT01474239|580922770|FG001|Overall Study|Withdrawal for Economic Reason|0|||
160871491|NCT00854113|580922771|FG000|Overall Study|Adverse Event|0|||
160871492|NCT00854113|580922772|FG001|Overall Study|Adverse Event|0|||
160871493|NCT00854113|580922773|FG002|Overall Study|Adverse Event|0|||
160871494|NCT00854113|580922774|FG003|Overall Study|Adverse Event|0|||
160871495|NCT00854113|580922775|FG004|Overall Study|Adverse Event|0|||
160871496|NCT00854113|580922776|FG005|Overall Study|Adverse Event|0|||
160871497|NCT00854113|580922777|FG006|Overall Study|Adverse Event|0|||
160871498|NCT00854113|580922778|FG007|Overall Study|Adverse Event|2|||
160871499|NCT00854113|580922779|FG008|Overall Study|Adverse Event|0|||
160871500|NCT00854113|580922780|FG009|Overall Study|Adverse Event|0|||
160871501|NCT00854113|580922781|FG010|Overall Study|Adverse Event|0|||
160871502|NCT00854113|580922771|FG000|Overall Study|Withdrawal by Subject|0|||
160871503|NCT00854113|580922772|FG001|Overall Study|Withdrawal by Subject|0|||
160871504|NCT00854113|580922773|FG002|Overall Study|Withdrawal by Subject|0|||
160871505|NCT00854113|580922774|FG003|Overall Study|Withdrawal by Subject|0|||
160871506|NCT00854113|580922775|FG004|Overall Study|Withdrawal by Subject|0|||
160871507|NCT00854113|580922776|FG005|Overall Study|Withdrawal by Subject|0|||
161219207|NCT00368966|582185512|FG001|Infant Series|Lost to Follow-up|0|||
161219208|NCT00368966|582185511|FG000|Infant Series|Randomization error|0|||
161219209|NCT00368966|582185512|FG001|Infant Series|Randomization error|1|||
161219210|NCT00368966|582185511|FG000|Infant Series|Failed to meet eligibility criteria|0|||
161219211|NCT00368966|582185512|FG001|Infant Series|Failed to meet eligibility criteria|1|||
161219212|NCT00368966|582185511|FG000|Infant Series|Adverse Event|0|||
161219213|NCT00368966|582185512|FG001|Infant Series|Adverse Event|1|||
161219214|NCT00368966|582185511|FG000|Infant Series|Failed to return|1|||
161219215|NCT00368966|582185512|FG001|Infant Series|Failed to return|0|||
161219216|NCT00368966|582185511|FG000|After Infant|Failed to return|3|||
161219217|NCT00368966|582185512|FG001|After Infant|Failed to return|1|||
161219218|NCT00368966|582185511|FG000|After Infant|Adverse Event|1|||
160871508|NCT00854113|580922777|FG006|Overall Study|Withdrawal by Subject|0|||
160871509|NCT00854113|580922778|FG007|Overall Study|Withdrawal by Subject|1|||
161219219|NCT00368966|582185512|FG001|After Infant|Adverse Event|2|||
161219220|NCT00368966|582185511|FG000|After Infant|Withdrawal by Subject|1|||
161219221|NCT00368966|582185512|FG001|After Infant|Withdrawal by Subject|1|||
161219222|NCT00368966|582185511|FG000|After Infant|Death|1|||
161219223|NCT00368966|582185512|FG001|After Infant|Death|0|||
161219224|NCT00368966|582185511|FG000|After Infant|Lost to Follow-up|0|||
160871510|NCT00854113|580922779|FG008|Overall Study|Withdrawal by Subject|1|||
160871511|NCT00854113|580922780|FG009|Overall Study|Withdrawal by Subject|0|||
160871512|NCT00854113|580922781|FG010|Overall Study|Withdrawal by Subject|0|||
160871513|NCT00796419|580922783|FG000|Overall Study|Death|0|||
160871514|NCT00796419|580922784|FG001|Overall Study|Death|1|||
160871515|NCT00539864|580922787|FG000|Overall Study|Lost to Follow-up|0|||
160871516|NCT00539864|580922788|FG001|Overall Study|Lost to Follow-up|1|||
160871517|NCT00539864|580922787|FG000|Overall Study|Withdrawal by Subject|1|||
161219225|NCT00368966|582185512|FG001|After Infant|Lost to Follow-up|1|||
160871518|NCT00539864|580922788|FG001|Overall Study|Withdrawal by Subject|1|||
160871519|NCT01250145|580922789|FG000|Overall Study|Adverse Event|2|||
160871520|NCT01250145|580922790|FG001|Overall Study|Adverse Event|1|||
160871521|NCT01250145|580922789|FG000|Overall Study|Withdrawal by Subject|0|||
160871522|NCT01250145|580922790|FG001|Overall Study|Withdrawal by Subject|4|||
160871523|NCT02840799|580922793|FG000|Phase 1|Physician Decision|1|||
160871524|NCT02840799|580922794|FG001|Phase 1|Physician Decision|3|||
160871525|NCT02840799|580922793|FG000|Phase 1|Withdrawal by Subject|4|||
160871526|NCT02840799|580922794|FG001|Phase 1|Withdrawal by Subject|0|||
160871527|NCT02840799|580922793|FG000|Phase 2 (Crossover)|Adverse Event|0|||
160871528|NCT02840799|580922794|FG001|Phase 2 (Crossover)|Adverse Event|1|||
160871529|NCT02840799|580922793|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
160871530|NCT02840799|580922794|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
160871531|NCT03983317|580922795|FG000|Overall Study|Physician Decision|5|||
160871532|NCT02687191|580922800|FG000|Overall Study|Death|0|||
160871533|NCT02687191|580922801|FG001|Overall Study|Death|1|||
160871534|NCT02687191|580922802|FG002|Overall Study|Death|1|||
160871535|NCT02687191|580922803|FG003|Overall Study|Death|0|||
160871536|NCT02687191|580922804|FG004|Overall Study|Death|1|||
160871537|NCT02687191|580922805|FG005|Overall Study|Death|1|||
160871538|NCT02687191|580922800|FG000|Overall Study|Withdrawal by Subject|0|||
160871539|NCT02687191|580922801|FG001|Overall Study|Withdrawal by Subject|0|||
160871540|NCT02687191|580922802|FG002|Overall Study|Withdrawal by Subject|0|||
160871541|NCT02687191|580922803|FG003|Overall Study|Withdrawal by Subject|1|||
160871542|NCT02687191|580922804|FG004|Overall Study|Withdrawal by Subject|0|||
160871543|NCT02687191|580922805|FG005|Overall Study|Withdrawal by Subject|0|||
160871544|NCT01864603|580922808|FG000|Stage 2|DSMB design modification|86056|||
160871545|NCT01864603|580922809|FG001|Stage 2|DSMB design modification|92558|||
160871546|NCT04661579|580922812|FG000|Overall Study|Lost to Follow-up|19|||
160871547|NCT04661579|580922813|FG001|Overall Study|Lost to Follow-up|10|||
160871548|NCT04661579|580922814|FG002|Overall Study|Lost to Follow-up|2|||
160871549|NCT04661579|580922815|FG003|Overall Study|Lost to Follow-up|7|||
160871550|NCT04661579|580922816|FG004|Overall Study|Lost to Follow-up|11|||
160871551|NCT04661579|580922812|FG000|Overall Study|Physician Decision|2|||
160871552|NCT04661579|580922813|FG001|Overall Study|Physician Decision|0|||
160871553|NCT04661579|580922814|FG002|Overall Study|Physician Decision|0|||
160871554|NCT04661579|580922815|FG003|Overall Study|Physician Decision|1|||
160871555|NCT04661579|580922816|FG004|Overall Study|Physician Decision|0|||
160871556|NCT04661579|580922812|FG000|Overall Study|Withdrawal by Subject|1|||
160871557|NCT04661579|580922813|FG001|Overall Study|Withdrawal by Subject|4|||
160871558|NCT04661579|580922814|FG002|Overall Study|Withdrawal by Subject|0|||
160871559|NCT04661579|580922815|FG003|Overall Study|Withdrawal by Subject|2|||
160871560|NCT04661579|580922816|FG004|Overall Study|Withdrawal by Subject|0|||
160871561|NCT04661579|580922812|FG000|Overall Study|Death|1|||
160871562|NCT04661579|580922813|FG001|Overall Study|Death|0|||
160871563|NCT04661579|580922814|FG002|Overall Study|Death|0|||
160871564|NCT04661579|580922815|FG003|Overall Study|Death|0|||
160871565|NCT04661579|580922816|FG004|Overall Study|Death|0|||
160871566|NCT04661579|580922812|FG000|Overall Study|Other|1|||
160871567|NCT04661579|580922813|FG001|Overall Study|Other|2|||
160871568|NCT04661579|580922814|FG002|Overall Study|Other|1|||
160871569|NCT04661579|580922815|FG003|Overall Study|Other|1|||
160871570|NCT04661579|580922816|FG004|Overall Study|Other|1|||
160871571|NCT04661579|580922812|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
160871572|NCT04661579|580922813|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
160871573|NCT04661579|580922814|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
160871574|NCT04661579|580922815|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
160871575|NCT04661579|580922816|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
160871576|NCT04335136|580922817|FG000|Overall Study|Death|8|||
161114628|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161114629|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161114630|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
161114631|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
161114632|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
160871577|NCT04335136|580922818|FG001|Overall Study|Death|4|||
160871578|NCT04335136|580922817|FG000|Overall Study|Lost to Follow-up|2|||
160871579|NCT04335136|580922818|FG001|Overall Study|Lost to Follow-up|0|||
160871580|NCT04335136|580922817|FG000|Overall Study|Protocol Violation|1|||
160871581|NCT04335136|580922818|FG001|Overall Study|Protocol Violation|0|||
160871582|NCT04335136|580922817|FG000|Overall Study|Withdrawal by Subject|1|||
160871583|NCT04335136|580922818|FG001|Overall Study|Withdrawal by Subject|1|||
160871584|NCT04335136|580922817|FG000|Overall Study|Health-threatening condition|0|||
160871585|NCT04335136|580922818|FG001|Overall Study|Health-threatening condition|1|||
160871586|NCT04335136|580922817|FG000|Overall Study|Adverse Event|0|||
160871587|NCT04335136|580922818|FG001|Overall Study|Adverse Event|1|||
160871588|NCT04335136|580922817|FG000|Overall Study|Erroneously randomized|2|||
160871589|NCT04335136|580922818|FG001|Overall Study|Erroneously randomized|0|||
160871590|NCT01396447|580922819|FG000|Overall Study|Did Not Receive Treatment|3|||
161219226|NCT00368966|582185511|FG000|Toddler Dose|Withdrawal by Subject|1|||
161219227|NCT00368966|582185512|FG001|Toddler Dose|Withdrawal by Subject|1|||
161219228|NCT00368966|582185511|FG000|Toddler Dose|Lost to Follow-up|0|||
161219229|NCT00368966|582185512|FG001|Toddler Dose|Lost to Follow-up|2|||
161219230|NCT02866175|582185517|FG000|Overall Study|Adverse Event|56|||
161219231|NCT02866175|582185518|FG001|Overall Study|Adverse Event|54|||
161219232|NCT02866175|582185517|FG000|Overall Study|Withdrawal by Subject|31|||
161219233|NCT02866175|582185518|FG001|Overall Study|Withdrawal by Subject|52|||
161219234|NCT02866175|582185517|FG000|Overall Study|Death|30|||
161219235|NCT02866175|582185518|FG001|Overall Study|Death|23|||
161219236|NCT02866175|582185517|FG000|Overall Study|Other|7|||
161219237|NCT02866175|582185518|FG001|Overall Study|Other|14|||
161219238|NCT02866175|582185517|FG000|Overall Study|Progressive disease|1|||
161219239|NCT02866175|582185518|FG001|Overall Study|Progressive disease|1|||
161219240|NCT02866175|582185517|FG000|Overall Study|Lost to Follow-up|2|||
161219241|NCT02866175|582185518|FG001|Overall Study|Lost to Follow-up|0|||
161219242|NCT02866175|582185517|FG000|Overall Study|Lack of Efficacy|0|||
161219243|NCT02866175|582185518|FG001|Overall Study|Lack of Efficacy|1|||
161219244|NCT02866175|582185517|FG000|Overall Study|Physician Decision|3|||
161219245|NCT02866175|582185518|FG001|Overall Study|Physician Decision|15|||
161219246|NCT02866175|582185517|FG000|Overall Study|Did not receive treatment|5|||
161219247|NCT02866175|582185518|FG001|Overall Study|Did not receive treatment|15|||
161219248|NCT01694485|582185521|FG000|Overall Study|Withdrawal by Subject|20|||
161219249|NCT01694485|582185522|FG001|Overall Study|Withdrawal by Subject|6|||
161219250|NCT01694485|582185523|FG002|Overall Study|Withdrawal by Subject|7|||
161219251|NCT01694485|582185524|FG003|Overall Study|Withdrawal by Subject|25|||
161219252|NCT01694485|582185525|FG004|Overall Study|Withdrawal by Subject|18|||
161219253|NCT01694485|582185521|FG000|Overall Study|Sponsor Decision|3|||
161219254|NCT01694485|582185522|FG001|Overall Study|Sponsor Decision|0|||
161219255|NCT01694485|582185523|FG002|Overall Study|Sponsor Decision|0|||
160871591|NCT01396447|580922820|FG001|Overall Study|Did Not Receive Treatment|2|||
161219256|NCT01694485|582185524|FG003|Overall Study|Sponsor Decision|2|||
161219257|NCT01694485|582185525|FG004|Overall Study|Sponsor Decision|0|||
161219258|NCT01694485|582185521|FG000|Overall Study|Lost to Follow-up|9|||
161219259|NCT01694485|582185522|FG001|Overall Study|Lost to Follow-up|1|||
161114633|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161114634|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
161114635|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
161114636|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161114637|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161114638|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
161114639|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
161114640|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161114641|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161114642|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
161114643|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
161114644|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161114645|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161114646|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
161114647|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
161114648|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161114649|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161114650|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
161114651|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
161114652|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161114653|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161114654|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
161114655|NCT03605680|581809555|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
161114656|NCT03605680|581809556|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161114657|NCT03605680|581809557|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161114658|NCT03605680|581809558|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
161114659|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
161114660|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
161114661|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
161114662|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
161114663|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
161114664|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
161114665|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
161114666|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
161114667|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161114668|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161114669|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161114670|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161114671|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161114672|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161114673|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
161114674|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
161114675|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
161114676|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
161114677|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
161114678|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
161114679|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
161114680|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
161114681|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
161114682|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
161114683|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
161114684|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161114685|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
161114686|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
161219260|NCT01694485|582185523|FG002|Overall Study|Lost to Follow-up|6|||
160871592|NCT01396447|580922821|FG002|Overall Study|Did Not Receive Treatment|1|||
160871593|NCT01396447|580922822|FG003|Overall Study|Did Not Receive Treatment|0|||
160871594|NCT01396447|580922819|FG000|Overall Study|Adverse Event|15|||
160871595|NCT01396447|580922820|FG001|Overall Study|Adverse Event|12|||
160871596|NCT01396447|580922821|FG002|Overall Study|Adverse Event|12|||
160871597|NCT01396447|580922822|FG003|Overall Study|Adverse Event|17|||
160871598|NCT01396447|580922819|FG000|Overall Study|Insufficient Therapeutic Response|5|||
160871599|NCT01396447|580922820|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160871600|NCT01396447|580922821|FG002|Overall Study|Insufficient Therapeutic Response|2|||
160871601|NCT01396447|580922822|FG003|Overall Study|Insufficient Therapeutic Response|4|||
160871602|NCT01396447|580922819|FG000|Overall Study|Protocol Violation|5|||
160871603|NCT01396447|580922820|FG001|Overall Study|Protocol Violation|2|||
160871604|NCT01396447|580922821|FG002|Overall Study|Protocol Violation|3|||
160871605|NCT01396447|580922822|FG003|Overall Study|Protocol Violation|7|||
160871606|NCT01396447|580922819|FG000|Overall Study|Withdrawal of Consent|11|||
160871607|NCT01396447|580922820|FG001|Overall Study|Withdrawal of Consent|9|||
160871608|NCT01396447|580922821|FG002|Overall Study|Withdrawal of Consent|4|||
160871609|NCT01396447|580922822|FG003|Overall Study|Withdrawal of Consent|15|||
160871610|NCT01396447|580922819|FG000|Overall Study|Lost to Follow-up|4|||
160871611|NCT01396447|580922820|FG001|Overall Study|Lost to Follow-up|8|||
160871612|NCT01396447|580922821|FG002|Overall Study|Lost to Follow-up|7|||
160871613|NCT01396447|580922822|FG003|Overall Study|Lost to Follow-up|9|||
160871614|NCT01396447|580922819|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160871615|NCT01396447|580922820|FG001|Overall Study|Other Miscellaneous Reasons|2|||
160871616|NCT01396447|580922821|FG002|Overall Study|Other Miscellaneous Reasons|1|||
160871617|NCT01396447|580922822|FG003|Overall Study|Other Miscellaneous Reasons|0|||
160871618|NCT01402102|580922823|FG000|Overall Study|Protocol Violation|1|||
160871619|NCT01402102|580922824|FG001|Overall Study|Protocol Violation|0|||
160871620|NCT01402102|580922823|FG000|Overall Study|Insufficiency of compliance|1|||
160871621|NCT01402102|580922824|FG001|Overall Study|Insufficiency of compliance|1|||
160871622|NCT01402102|580922823|FG000|Overall Study|Withdrawal by Subject|0|||
160871623|NCT01402102|580922824|FG001|Overall Study|Withdrawal by Subject|2|||
160871624|NCT04838626|580922825|FG000|Overall Study|Adverse Event|2|||
160871625|NCT04838626|580922825|FG000|Overall Study|Physician Decision|6|||
160871626|NCT04838626|580922825|FG000|Overall Study|Protocol Violation|3|||
160871627|NCT04838626|580922825|FG000|Overall Study|Withdrawal by Subject|9|||
160871628|NCT04838626|580922825|FG000|Overall Study|Technical Problems|2|||
160871629|NCT00670306|580922828|FG000|Overall Study|Adverse Event|8|||
160871630|NCT00670306|580922828|FG000|Overall Study|Lack of Efficacy|10|||
160871631|NCT00670306|580922828|FG000|Overall Study|Withdrawal by Subject|9|||
160871632|NCT00670306|580922828|FG000|Overall Study|Physician Decision|1|||
160871633|NCT00670306|580922828|FG000|Overall Study|Lost to Follow-up|8|||
160871634|NCT00670306|580922828|FG000|Overall Study|incl/excl criterias did not meet|19|||
160871635|NCT01192191|580922829|FG000|Overall Study|Adverse Event|7|||
160871636|NCT01192191|580922830|FG001|Overall Study|Adverse Event|12|||
160871637|NCT01192191|580922829|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
160871638|NCT01192191|580922830|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
160871639|NCT01192191|580922829|FG000|Overall Study|Lost to Follow-up|0|||
160871640|NCT01192191|580922830|FG001|Overall Study|Lost to Follow-up|1|||
160871641|NCT01192191|580922829|FG000|Overall Study|Withdrawal by Subject|1|||
160871642|NCT01192191|580922830|FG001|Overall Study|Withdrawal by Subject|6|||
160871643|NCT01047553|580922831|FG000|Overall Study|Adverse Event|10|||
160871644|NCT01047553|580922832|FG001|Overall Study|Adverse Event|5|||
160871645|NCT01047553|580922831|FG000|Overall Study|Withdrawal by Subject|4|||
160871646|NCT01047553|580922832|FG001|Overall Study|Withdrawal by Subject|2|||
160871647|NCT01047553|580922831|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
160871648|NCT01047553|580922832|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
160871649|NCT01047553|580922831|FG000|Overall Study|Lost to Follow-up|1|||
160871650|NCT01047553|580922832|FG001|Overall Study|Lost to Follow-up|0|||
160871651|NCT01047553|580922831|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
160871652|NCT01047553|580922832|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
160871653|NCT01047553|580922831|FG000|Overall Study|PI's decision|0|||
161114687|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
161114688|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
161114689|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
160871654|NCT01047553|580922832|FG001|Overall Study|PI's decision|1|||
160871655|NCT04292899|580922834|FG000|Overall Study|Death|21|||
160871656|NCT04292899|580922835|FG001|Overall Study|Death|28|||
160871657|NCT04292899|580922836|FG002|Overall Study|Death|188|||
160871658|NCT04292899|580922837|FG003|Overall Study|Death|371|||
160871659|NCT04292899|580922834|FG000|Overall Study|Lost to Follow-up|8|||
160871660|NCT04292899|580922835|FG001|Overall Study|Lost to Follow-up|4|||
160871661|NCT04292899|580922836|FG002|Overall Study|Lost to Follow-up|22|||
160871662|NCT04292899|580922837|FG003|Overall Study|Lost to Follow-up|235|||
160871663|NCT04292899|580922834|FG000|Overall Study|Withdrew consent|1|||
160871664|NCT04292899|580922835|FG001|Overall Study|Withdrew consent|0|||
160871665|NCT04292899|580922836|FG002|Overall Study|Withdrew consent|11|||
161114690|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
161114691|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
161114692|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
161114693|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
161114694|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
161114695|NCT03605680|581809555|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
161114696|NCT03605680|581809556|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
161114697|NCT03605680|581809557|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
161114698|NCT03605680|581809558|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
161114699|NCT00647556|581809559|FG000|Overall Study|Adverse Event|0|||
161114700|NCT00647556|581809560|FG001|Overall Study|Adverse Event|1|||
161114701|NCT00647556|581809559|FG000|Overall Study|Lost to Follow-up|1|||
161114702|NCT00647556|581809560|FG001|Overall Study|Lost to Follow-up|0|||
161114703|NCT00647556|581809559|FG000|Overall Study|Protocol Violation|0|||
161114704|NCT00647556|581809560|FG001|Overall Study|Protocol Violation|1|||
161114705|NCT00647556|581809559|FG000|Overall Study|Withdrawal by Subject|1|||
161114706|NCT00647556|581809560|FG001|Overall Study|Withdrawal by Subject|0|||
161114707|NCT00647556|581809559|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
161114708|NCT00647556|581809560|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
161114709|NCT04677712|581809561|FG000|Overall Study|Lost to Follow-up|0|||
161114710|NCT04677712|581809562|FG001|Overall Study|Lost to Follow-up|1|||
161114711|NCT04677712|581809563|FG002|Overall Study|Lost to Follow-up|0|||
161114712|NCT04677712|581809564|FG003|Overall Study|Lost to Follow-up|0|||
160871666|NCT04292899|580922837|FG003|Overall Study|Withdrew consent|32|||
160871667|NCT04292899|580922834|FG000|Overall Study|Adverse Event|2|||
160871668|NCT04292899|580922835|FG001|Overall Study|Adverse Event|1|||
160871669|NCT04292899|580922836|FG002|Overall Study|Adverse Event|2|||
160871670|NCT04292899|580922837|FG003|Overall Study|Adverse Event|2|||
160871671|NCT04292899|580922834|FG000|Overall Study|Investigator's Discretion|0|||
160871672|NCT04292899|580922835|FG001|Overall Study|Investigator's Discretion|0|||
160871673|NCT04292899|580922836|FG002|Overall Study|Investigator's Discretion|0|||
160871674|NCT04292899|580922837|FG003|Overall Study|Investigator's Discretion|3|||
161219261|NCT01694485|582185524|FG003|Overall Study|Lost to Follow-up|10|||
161219262|NCT01694485|582185525|FG004|Overall Study|Lost to Follow-up|7|||
161219263|NCT01694485|582185521|FG000|Overall Study|Death|1|||
161219264|NCT01694485|582185522|FG001|Overall Study|Death|0|||
161219265|NCT01694485|582185523|FG002|Overall Study|Death|0|||
161219266|NCT01694485|582185524|FG003|Overall Study|Death|1|||
161219267|NCT01694485|582185525|FG004|Overall Study|Death|0|||
161219268|NCT02907203|582185526|FG000|Overall Study|Death|1|||
161219269|NCT02907203|582185526|FG000|Overall Study|Lost to Follow-up|3|||
161219270|NCT02907203|582185526|FG000|Overall Study|Withdrawal by Subject|3|||
161219271|NCT02907203|582185526|FG000|Overall Study|Surgical bypass|1|||
161219272|NCT01418352|582185527|FG000|Overall Study|Lost to Follow-up|2|||
161219273|NCT01418352|582185528|FG001|Overall Study|Lost to Follow-up|0|||
161219274|NCT01418352|582185529|FG002|Overall Study|Lost to Follow-up|0|||
161219275|NCT01418352|582185530|FG003|Overall Study|Lost to Follow-up|0|||
161219276|NCT01418352|582185527|FG000|Overall Study|Adverse Event|0|||
161219277|NCT01418352|582185528|FG001|Overall Study|Adverse Event|1|||
161219278|NCT01418352|582185529|FG002|Overall Study|Adverse Event|0|||
161219279|NCT01418352|582185530|FG003|Overall Study|Adverse Event|0|||
161219280|NCT01418352|582185527|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
160871675|NCT04292899|580922834|FG000|Overall Study|Non-compliance With Study Drug|0|||
160871676|NCT04292899|580922835|FG001|Overall Study|Non-compliance With Study Drug|0|||
160871677|NCT04292899|580922836|FG002|Overall Study|Non-compliance With Study Drug|0|||
160871678|NCT04292899|580922837|FG003|Overall Study|Non-compliance With Study Drug|1|||
160871679|NCT04292899|580922834|FG000|Overall Study|Protocol Violation|0|||
160871680|NCT04292899|580922835|FG001|Overall Study|Protocol Violation|0|||
160871681|NCT04292899|580922836|FG002|Overall Study|Protocol Violation|0|||
160871682|NCT04292899|580922837|FG003|Overall Study|Protocol Violation|1|||
160871683|NCT00948441|580922838|FG000|Overall Study|no longer meet inclusion criteria|1|||
160871684|NCT00948441|580922839|FG001|Overall Study|no longer meet inclusion criteria|4|||
160871685|NCT05340478|580922844|FG000|Overall Study|Scheduling Issues|10|||
160871686|NCT05340478|580922845|FG001|Overall Study|Scheduling Issues|4|||
160871687|NCT05340478|580922844|FG000|Overall Study|Neither member of dyad started treatment|2|||
160871688|NCT05340478|580922845|FG001|Overall Study|Neither member of dyad started treatment|2|||
160871689|NCT05340478|580922844|FG000|Overall Study|Withdrawn from study|2|||
160871690|NCT05340478|580922845|FG001|Overall Study|Withdrawn from study|2|||
160871691|NCT05340478|580922844|FG000|Overall Study|Lost to Follow-up|1|||
160871692|NCT05340478|580922845|FG001|Overall Study|Lost to Follow-up|4|||
160871693|NCT01032889|580922846|FG000|Overall Study|Adverse Event|2|||
160871694|NCT01032889|580922847|FG001|Overall Study|Adverse Event|2|||
160871695|NCT01032889|580922848|FG002|Overall Study|Adverse Event|0|||
160871696|NCT01032889|580922846|FG000|Overall Study|Withdrawal of Consent|1|||
160871697|NCT01032889|580922847|FG001|Overall Study|Withdrawal of Consent|2|||
160871698|NCT01032889|580922848|FG002|Overall Study|Withdrawal of Consent|1|||
160871699|NCT01032889|580922846|FG000|Overall Study|Patient Request|0|||
160871700|NCT01032889|580922847|FG001|Overall Study|Patient Request|1|||
160871701|NCT01032889|580922848|FG002|Overall Study|Patient Request|0|||
160871702|NCT01032889|580922846|FG000|Overall Study|Lost to Follow-up|1|||
160871703|NCT01032889|580922847|FG001|Overall Study|Lost to Follow-up|1|||
160871704|NCT01032889|580922848|FG002|Overall Study|Lost to Follow-up|0|||
160871705|NCT01032889|580922846|FG000|Overall Study|Lack of Submental Fat|2|||
160871706|NCT01032889|580922847|FG001|Overall Study|Lack of Submental Fat|8|||
160871707|NCT01032889|580922848|FG002|Overall Study|Lack of Submental Fat|1|||
160871708|NCT01032889|580922846|FG000|Overall Study|Miscellaneous Reasons|2|||
160871709|NCT01032889|580922847|FG001|Overall Study|Miscellaneous Reasons|1|||
161219281|NCT01418352|582185528|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
160871710|NCT01032889|580922848|FG002|Overall Study|Miscellaneous Reasons|1|||
160871711|NCT02116205|580922849|FG000|Overall Study|Withdrawal by Subject|2|||
160871712|NCT02116205|580922850|FG001|Overall Study|Withdrawal by Subject|4|||
160871713|NCT02116205|580922851|FG002|Overall Study|Withdrawal by Subject|1|||
161219282|NCT01418352|582185529|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
161219283|NCT01418352|582185530|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
161219284|NCT01418352|582185527|FG000|Overall Study|Subject Withdrew Consent|0|||
161219285|NCT01418352|582185528|FG001|Overall Study|Subject Withdrew Consent|1|||
160871714|NCT02116205|580922852|FG003|Overall Study|Withdrawal by Subject|3|||
160871715|NCT02116205|580922849|FG000|Overall Study|Lost to Follow-up|0|||
160871716|NCT02116205|580922850|FG001|Overall Study|Lost to Follow-up|2|||
160871717|NCT02116205|580922851|FG002|Overall Study|Lost to Follow-up|1|||
161219286|NCT01418352|582185529|FG002|Overall Study|Subject Withdrew Consent|2|||
161219287|NCT01418352|582185530|FG003|Overall Study|Subject Withdrew Consent|1|||
161219288|NCT01418352|582185527|FG000|Overall Study|Protocol Deviation|0|||
161219289|NCT01418352|582185528|FG001|Overall Study|Protocol Deviation|0|||
161114713|NCT04677712|581809565|FG004|Overall Study|Lost to Follow-up|0|||
161114714|NCT04677712|581809566|FG005|Overall Study|Lost to Follow-up|0|||
161114715|NCT00711100|581809567|FG000|Overall Study|Lack of Efficacy|5|||
161114716|NCT00711100|581809567|FG000|Overall Study|Withdrawal by Subject|8|||
161114717|NCT02915523|581809571|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
161114718|NCT02915523|581809572|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
161114719|NCT02915523|581809573|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
160871718|NCT02116205|580922852|FG003|Overall Study|Lost to Follow-up|2|||
160871719|NCT02116205|580922849|FG000|Overall Study|Physician Decision|0|||
160871720|NCT02116205|580922850|FG001|Overall Study|Physician Decision|1|||
160871721|NCT02116205|580922851|FG002|Overall Study|Physician Decision|1|||
160871722|NCT02116205|580922852|FG003|Overall Study|Physician Decision|1|||
160871723|NCT02116205|580922849|FG000|Overall Study|Exclusion criteria|0|||
160871724|NCT02116205|580922850|FG001|Overall Study|Exclusion criteria|0|||
160871725|NCT02116205|580922851|FG002|Overall Study|Exclusion criteria|1|||
160871726|NCT02116205|580922852|FG003|Overall Study|Exclusion criteria|0|||
160871727|NCT00630838|580922857|FG000|Overall Study|Death|0|||
160871728|NCT00630838|580922858|FG001|Overall Study|Death|1|||
160871729|NCT00630838|580922857|FG000|Overall Study|Lost to Follow-up|0|||
160871730|NCT00630838|580922858|FG001|Overall Study|Lost to Follow-up|1|||
160871731|NCT00928408|580922859|FG000|Overall Study|Other|2|||
160871732|NCT00928408|580922859|FG000|Overall Study|Withdrawal by Subject|4|||
160871733|NCT00928408|580922859|FG000|Overall Study|Death|5|||
160871734|NCT00928408|580922859|FG000|Overall Study|Lost to Follow-up|12|||
160871735|NCT00256997|580922864|FG000|Overall Study|Protocol Violation|1|||
160871736|NCT00256997|580922865|FG001|Overall Study|Protocol Violation|4|||
160871737|NCT00256997|580922864|FG000|Overall Study|Lack of Efficacy|1|||
160871738|NCT00256997|580922865|FG001|Overall Study|Lack of Efficacy|4|||
160871739|NCT00256997|580922864|FG000|Overall Study|Death|2|||
160871740|NCT00256997|580922865|FG001|Overall Study|Death|0|||
160871741|NCT00256997|580922864|FG000|Overall Study|Adverse Event|4|||
160871742|NCT00256997|580922865|FG001|Overall Study|Adverse Event|0|||
160871743|NCT00256997|580922864|FG000|Overall Study|Lost to Follow-up|3|||
160871744|NCT00256997|580922865|FG001|Overall Study|Lost to Follow-up|5|||
160871745|NCT00256997|580922864|FG000|Overall Study|Withdrawal by Subject|13|||
160871746|NCT00256997|580922865|FG001|Overall Study|Withdrawal by Subject|3|||
160871747|NCT00256997|580922864|FG000|Overall Study|Started but not treated|2|||
160871748|NCT00256997|580922865|FG001|Overall Study|Started but not treated|0|||
160871749|NCT00256997|580922864|FG000|Overall Study|Other|5|||
160871750|NCT00256997|580922865|FG001|Overall Study|Other|8|||
160871751|NCT00256997|580922864|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
160871752|NCT00256997|580922865|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
160871753|NCT00256997|580922864|FG000|Overall Study|Participant Non-compliant|3|||
160871754|NCT00256997|580922865|FG001|Overall Study|Participant Non-compliant|6|||
160871755|NCT00256997|580922864|FG000|Overall Study|Investigator Withdrew Participant|2|||
160871756|NCT00256997|580922865|FG001|Overall Study|Investigator Withdrew Participant|1|||
160871757|NCT04672655|580922868|FG000|Overall Study|Lost to Follow-up|12|||
160871758|NCT04672655|580922869|FG001|Overall Study|Lost to Follow-up|17|||
160871759|NCT04672655|580922868|FG000|Overall Study|Withdrawal by Subject|1|||
160871760|NCT04672655|580922869|FG001|Overall Study|Withdrawal by Subject|0|||
160871761|NCT04672655|580922868|FG000|Overall Study|Withdrawal by Study|1|||
160871762|NCT04672655|580922869|FG001|Overall Study|Withdrawal by Study|0|||
160871763|NCT01326104|580922870|FG000|Overall Study|progressed prior to vaccine|0|||
160871764|NCT01326104|580922871|FG001|Overall Study|progressed prior to vaccine|2|||
160871765|NCT01326104|580922870|FG000|Overall Study|unable to make vaccine|0|||
160871766|NCT01326104|580922871|FG001|Overall Study|unable to make vaccine|2|||
160871767|NCT03843541|580922872|FG000|Overall Study|Adverse Event|4|||
160871768|NCT03843541|580922873|FG001|Overall Study|Adverse Event|2|||
160871769|NCT03843541|580922874|FG002|Overall Study|Adverse Event|3|||
160871770|NCT03843541|580922872|FG000|Overall Study|Death|1|||
160871771|NCT03843541|580922873|FG001|Overall Study|Death|0|||
161114720|NCT02915523|581809574|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
161114721|NCT02915523|581809571|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
161114722|NCT02915523|581809572|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
161114723|NCT02915523|581809573|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
161114724|NCT02915523|581809574|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
161114725|NCT02915523|581809571|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161114726|NCT02915523|581809572|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
161114727|NCT02915523|581809573|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161114728|NCT02915523|581809574|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
161114729|NCT02915523|581809571|FG000|Expansion Phase (Phase 2)|Death|0|||
161114730|NCT02915523|581809572|FG001|Expansion Phase (Phase 2)|Death|0|||
160871772|NCT03843541|580922874|FG002|Overall Study|Death|0|||
160871773|NCT03843541|580922872|FG000|Overall Study|Lack of adherence to study medication|0|||
160871774|NCT03843541|580922873|FG001|Overall Study|Lack of adherence to study medication|0|||
160871775|NCT03843541|580922874|FG002|Overall Study|Lack of adherence to study medication|1|||
160871776|NCT03843541|580922872|FG000|Overall Study|Physician Decision|1|||
160871777|NCT03843541|580922873|FG001|Overall Study|Physician Decision|2|||
160871778|NCT03843541|580922874|FG002|Overall Study|Physician Decision|2|||
160871779|NCT03843541|580922872|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
160871780|NCT03843541|580922873|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
161114731|NCT02915523|581809573|FG002|Expansion Phase (Phase 2)|Death|26|||
160871781|NCT03843541|580922874|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
160871782|NCT03843541|580922872|FG000|Overall Study|Withdrawal by Subject|6|||
160871783|NCT03843541|580922873|FG001|Overall Study|Withdrawal by Subject|9|||
160871784|NCT03843541|580922874|FG002|Overall Study|Withdrawal by Subject|7|||
160871785|NCT03843541|580922872|FG000|Overall Study|Administration of rescue mucolytic|0|||
160871786|NCT03843541|580922873|FG001|Overall Study|Administration of rescue mucolytic|0|||
160871787|NCT03843541|580922874|FG002|Overall Study|Administration of rescue mucolytic|1|||
160871788|NCT03843541|580922872|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
160871789|NCT03843541|580922873|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
160871790|NCT03843541|580922874|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
160871791|NCT04163016|580922875|FG000|Enrollment|Adverse Event|1|||
160871792|NCT04163016|580922876|FG001|Enrollment|Adverse Event|0|||
160871793|NCT04163016|580922877|FG002|Enrollment|Adverse Event|0|||
160871794|NCT04163016|580922878|FG003|Enrollment|Adverse Event|0|||
160871795|NCT04163016|580922875|FG000|Treatment|Adverse Event|0|||
160871796|NCT04163016|580922876|FG001|Treatment|Adverse Event|1|||
160871797|NCT04163016|580922877|FG002|Treatment|Adverse Event|0|||
160871798|NCT04163016|580922878|FG003|Treatment|Adverse Event|0|||
160871799|NCT04163016|580922875|FG000|Treatment|Withdrawal by Subject|0|||
160871800|NCT04163016|580922876|FG001|Treatment|Withdrawal by Subject|2|||
160871801|NCT04163016|580922877|FG002|Treatment|Withdrawal by Subject|0|||
160871802|NCT04163016|580922878|FG003|Treatment|Withdrawal by Subject|0|||
160871803|NCT04163016|580922875|FG000|Treatment|Indeterminate TB-test|0|||
160871804|NCT04163016|580922876|FG001|Treatment|Indeterminate TB-test|0|||
160871805|NCT04163016|580922877|FG002|Treatment|Indeterminate TB-test|0|||
160871806|NCT04163016|580922878|FG003|Treatment|Indeterminate TB-test|1|||
160871807|NCT04163016|580922875|FG000|Treatment|Participant did not want to continue in study|0|||
160871808|NCT04163016|580922876|FG001|Treatment|Participant did not want to continue in study|0|||
160871809|NCT04163016|580922877|FG002|Treatment|Participant did not want to continue in study|0|||
160871810|NCT04163016|580922878|FG003|Treatment|Participant did not want to continue in study|1|||
160871811|NCT01104311|580922885|FG000|Overall Study|Withdrawal by Subject|6|||
160871812|NCT01104311|580922886|FG001|Overall Study|Withdrawal by Subject|6|||
160871813|NCT01104311|580922885|FG000|Overall Study|Protocol Violation|0|||
160871814|NCT01104311|580922886|FG001|Overall Study|Protocol Violation|1|||
160871815|NCT01104311|580922885|FG000|Overall Study|Physician Decision|2|||
161114732|NCT02915523|581809574|FG003|Expansion Phase (Phase 2)|Death|53|||
161114733|NCT02915523|581809571|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
161114734|NCT02915523|581809572|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
161114735|NCT02915523|581809573|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
161114736|NCT02915523|581809574|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
161114737|NCT02915523|581809571|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
161114738|NCT02915523|581809572|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
161114739|NCT02915523|581809573|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
161114740|NCT02915523|581809574|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
161114741|NCT02915523|581809571|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161114742|NCT02915523|581809572|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161114743|NCT02915523|581809573|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
161114744|NCT02915523|581809574|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
161114745|NCT00708500|581809579|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
161114746|NCT00708500|581809580|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
161114747|NCT00708500|581809581|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
161114748|NCT00708500|581809579|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
161114749|NCT00708500|581809580|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
161114750|NCT00708500|581809581|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
161114751|NCT00708500|581809579|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
161114752|NCT00708500|581809580|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
161114753|NCT00708500|581809581|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
161114754|NCT00708500|581809579|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
161114755|NCT00708500|581809580|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
161114756|NCT00708500|581809581|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
160871816|NCT01104311|580922886|FG001|Overall Study|Physician Decision|2|||
160871817|NCT01104311|580922885|FG000|Overall Study|low compliance|1|||
161114757|NCT00708500|581809579|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
161114758|NCT00708500|581809580|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
161114759|NCT00708500|581809581|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
161114760|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
161114761|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
161114762|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
160871818|NCT01104311|580922886|FG001|Overall Study|low compliance|1|||
161219290|NCT01418352|582185529|FG002|Overall Study|Protocol Deviation|1|||
161219291|NCT01418352|582185530|FG003|Overall Study|Protocol Deviation|0|||
160871819|NCT01104311|580922885|FG000|Overall Study|Adverse Event|1|||
161219292|NCT01418352|582185527|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
161219293|NCT01418352|582185528|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161219294|NCT01418352|582185529|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161219295|NCT01418352|582185530|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
161219296|NCT00619619|582185531|FG000|Overall Study|Physician Decision|0|||
161219297|NCT00619619|582185532|FG001|Overall Study|Physician Decision|0|||
161219298|NCT00619619|582185533|FG002|Overall Study|Physician Decision|1|||
161219299|NCT00619619|582185534|FG003|Overall Study|Physician Decision|0|||
161219300|NCT00619619|582185535|FG004|Overall Study|Physician Decision|0|||
161219301|NCT00619619|582185536|FG005|Overall Study|Physician Decision|0|||
161219302|NCT00619619|582185537|FG006|Overall Study|Physician Decision|0|||
161219303|NCT00619619|582185538|FG007|Overall Study|Physician Decision|0|||
161219304|NCT00619619|582185531|FG000|Overall Study|Protocol Violation|0|||
161219305|NCT00619619|582185532|FG001|Overall Study|Protocol Violation|0|||
161219306|NCT00619619|582185533|FG002|Overall Study|Protocol Violation|0|||
161219307|NCT00619619|582185534|FG003|Overall Study|Protocol Violation|1|||
161219308|NCT00619619|582185535|FG004|Overall Study|Protocol Violation|0|||
161219309|NCT00619619|582185536|FG005|Overall Study|Protocol Violation|0|||
161219310|NCT00619619|582185537|FG006|Overall Study|Protocol Violation|1|||
161219311|NCT00619619|582185538|FG007|Overall Study|Protocol Violation|1|||
160871820|NCT01104311|580922886|FG001|Overall Study|Adverse Event|2|||
160871821|NCT04434937|580922888|FG000|Overall Study|Death|4|||
160871822|NCT04434937|580922888|FG000|Overall Study|Withdrawal by Subject|1|||
160871823|NCT04434937|580922888|FG000|Overall Study|Transitioned to Rollover Study|19|||
160871824|NCT04434937|580922888|FG000|Overall Study|Progressive Disease|18|||
160871825|NCT04193189|580922893|FG000|Overall Study|Lost to Follow-up|9|||
160871826|NCT04193189|580922894|FG001|Overall Study|Lost to Follow-up|7|||
160871827|NCT04193189|580922895|FG002|Overall Study|Lost to Follow-up|9|||
160871828|NCT04193189|580922896|FG003|Overall Study|Lost to Follow-up|0|||
160871829|NCT04193189|580922893|FG000|Overall Study|Withdrawal by Subject|1|||
160871830|NCT04193189|580922894|FG001|Overall Study|Withdrawal by Subject|2|||
160871831|NCT04193189|580922895|FG002|Overall Study|Withdrawal by Subject|2|||
160871832|NCT04193189|580922896|FG003|Overall Study|Withdrawal by Subject|0|||
160871833|NCT04193189|580922893|FG000|Overall Study|Death|1|||
160871834|NCT04193189|580922894|FG001|Overall Study|Death|1|||
160871835|NCT04193189|580922895|FG002|Overall Study|Death|0|||
160871836|NCT04193189|580922896|FG003|Overall Study|Death|0|||
160871837|NCT04193189|580922893|FG000|Overall Study|Protocol Violation|0|||
160871838|NCT04193189|580922894|FG001|Overall Study|Protocol Violation|0|||
160871839|NCT04193189|580922895|FG002|Overall Study|Protocol Violation|0|||
160871840|NCT04193189|580922896|FG003|Overall Study|Protocol Violation|1|||
160871841|NCT01243242|580924461|FG000|Overall Study|Adverse Event|1|||
160871842|NCT01243242|580924462|FG001|Overall Study|Adverse Event|1|||
160871843|NCT01243242|580924461|FG000|Overall Study|Withdrawal by Subject|1|||
160871844|NCT01243242|580924462|FG001|Overall Study|Withdrawal by Subject|1|||
160871845|NCT01243242|580924461|FG000|Overall Study|Physician Decision|0|||
160871846|NCT01243242|580924462|FG001|Overall Study|Physician Decision|1|||
160871847|NCT01243242|580924461|FG000|Overall Study|sponsor decision|0|||
160871848|NCT01243242|580924462|FG001|Overall Study|sponsor decision|1|||
160871849|NCT01243242|580924461|FG000|Overall Study|non compliance|1|||
160871850|NCT01243242|580924462|FG001|Overall Study|non compliance|0|||
160871851|NCT01349049|580924468|FG000|Overall Study|Disease progression|3|||
160871852|NCT01349049|580924469|FG001|Overall Study|Disease progression|5|||
160871853|NCT01349049|580924470|FG002|Overall Study|Disease progression|3|||
160871854|NCT01349049|580924471|FG003|Overall Study|Disease progression|2|||
160871855|NCT01349049|580924472|FG004|Overall Study|Disease progression|2|||
160871856|NCT01349049|580924473|FG005|Overall Study|Disease progression|2|||
160871857|NCT01349049|580924474|FG006|Overall Study|Disease progression|3|||
160871858|NCT01349049|580924475|FG007|Overall Study|Disease progression|2|||
160871859|NCT01349049|580924476|FG008|Overall Study|Disease progression|33|||
160871860|NCT01349049|580924468|FG000|Overall Study|Adverse Event|0|||
161219312|NCT00619619|582185531|FG000|Overall Study|Adverse Event|0|||
161219313|NCT00619619|582185532|FG001|Overall Study|Adverse Event|0|||
160871861|NCT01349049|580924469|FG001|Overall Study|Adverse Event|1|||
161219314|NCT00619619|582185533|FG002|Overall Study|Adverse Event|0|||
161219315|NCT00619619|582185534|FG003|Overall Study|Adverse Event|0|||
161219316|NCT00619619|582185535|FG004|Overall Study|Adverse Event|2|||
160871862|NCT01349049|580924470|FG002|Overall Study|Adverse Event|0|||
160871863|NCT01349049|580924471|FG003|Overall Study|Adverse Event|0|||
160871864|NCT01349049|580924472|FG004|Overall Study|Adverse Event|0|||
160871865|NCT01349049|580924473|FG005|Overall Study|Adverse Event|3|||
160871866|NCT01349049|580924474|FG006|Overall Study|Adverse Event|1|||
161219317|NCT00619619|582185536|FG005|Overall Study|Adverse Event|0|||
161219318|NCT00619619|582185537|FG006|Overall Study|Adverse Event|0|||
160871867|NCT01349049|580924475|FG007|Overall Study|Adverse Event|0|||
160871868|NCT01349049|580924476|FG008|Overall Study|Adverse Event|4|||
160871869|NCT01349049|580924468|FG000|Overall Study|Physician Decision|0|||
160871870|NCT01349049|580924469|FG001|Overall Study|Physician Decision|1|||
160871871|NCT01349049|580924470|FG002|Overall Study|Physician Decision|0|||
161219319|NCT00619619|582185538|FG007|Overall Study|Adverse Event|2|||
161114763|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
161114764|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
161114765|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
161114766|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
161114767|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
161114768|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
161114769|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
161114770|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
161114771|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
161114772|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
161114773|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
161114774|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
161114775|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
160871872|NCT01349049|580924471|FG003|Overall Study|Physician Decision|0|||
160871873|NCT01349049|580924472|FG004|Overall Study|Physician Decision|0|||
160871874|NCT01349049|580924473|FG005|Overall Study|Physician Decision|0|||
160871875|NCT01349049|580924474|FG006|Overall Study|Physician Decision|0|||
160871876|NCT01349049|580924475|FG007|Overall Study|Physician Decision|0|||
160871877|NCT01349049|580924476|FG008|Overall Study|Physician Decision|2|||
160871878|NCT01349049|580924468|FG000|Overall Study|Protocol Violation|0|||
160871879|NCT01349049|580924469|FG001|Overall Study|Protocol Violation|0|||
160871880|NCT01349049|580924470|FG002|Overall Study|Protocol Violation|0|||
160871881|NCT01349049|580924471|FG003|Overall Study|Protocol Violation|0|||
160871882|NCT01349049|580924472|FG004|Overall Study|Protocol Violation|0|||
160871883|NCT01349049|580924473|FG005|Overall Study|Protocol Violation|0|||
160871884|NCT01349049|580924474|FG006|Overall Study|Protocol Violation|0|||
161114776|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
161114777|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
161114778|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
161114779|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
161114780|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
161114781|NCT00708500|581809579|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
161114782|NCT00708500|581809580|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
161114783|NCT00708500|581809581|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
161114784|NCT00708500|581809579|FG000|FOLLOWUP|Adverse Event|0|||
161114785|NCT00708500|581809580|FG001|FOLLOWUP|Adverse Event|1|||
161114786|NCT00708500|581809581|FG002|FOLLOWUP|Adverse Event|0|||
161114787|NCT00708500|581809579|FG000|FOLLOWUP|Lost to Follow-up|1|||
161114788|NCT00708500|581809580|FG001|FOLLOWUP|Lost to Follow-up|6|||
161114789|NCT00708500|581809581|FG002|FOLLOWUP|Lost to Follow-up|4|||
161114790|NCT00708500|581809579|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
161114791|NCT00708500|581809580|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
161114792|NCT00708500|581809581|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
161114793|NCT00708500|581809579|FG000|FOLLOWUP|Subject withdrew consent|31|||
160871885|NCT01349049|580924475|FG007|Overall Study|Protocol Violation|0|||
160871886|NCT01349049|580924476|FG008|Overall Study|Protocol Violation|1|||
160871887|NCT01349049|580924468|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
160871888|NCT01349049|580924469|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
160871889|NCT01349049|580924470|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
160871890|NCT01349049|580924471|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
160871891|NCT01349049|580924472|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
160871892|NCT01349049|580924473|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
160871893|NCT01349049|580924474|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
160871894|NCT01349049|580924475|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
160871895|NCT01349049|580924476|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
160871896|NCT01349049|580924468|FG000|Overall Study|Other|0|||
160871897|NCT01349049|580924469|FG001|Overall Study|Other|0|||
160871898|NCT01349049|580924470|FG002|Overall Study|Other|0|||
160871899|NCT01349049|580924471|FG003|Overall Study|Other|0|||
160871900|NCT01349049|580924472|FG004|Overall Study|Other|0|||
160871901|NCT01349049|580924473|FG005|Overall Study|Other|1|||
160871902|NCT01349049|580924474|FG006|Overall Study|Other|0|||
160871903|NCT01349049|580924475|FG007|Overall Study|Other|0|||
160871904|NCT01349049|580924476|FG008|Overall Study|Other|4|||
160871905|NCT01349049|580924468|FG000|Overall Study|Death|0|||
160871906|NCT01349049|580924469|FG001|Overall Study|Death|0|||
160871907|NCT01349049|580924470|FG002|Overall Study|Death|0|||
160871908|NCT01349049|580924471|FG003|Overall Study|Death|0|||
160871909|NCT01349049|580924472|FG004|Overall Study|Death|0|||
160871910|NCT01349049|580924473|FG005|Overall Study|Death|0|||
160871911|NCT01349049|580924474|FG006|Overall Study|Death|0|||
160871912|NCT01349049|580924475|FG007|Overall Study|Death|1|||
160871913|NCT01349049|580924476|FG008|Overall Study|Death|5|||
160871914|NCT01349049|580924468|FG000|Overall Study|Non-compliance|0|||
160871915|NCT01349049|580924469|FG001|Overall Study|Non-compliance|0|||
160871916|NCT01349049|580924470|FG002|Overall Study|Non-compliance|0|||
160871917|NCT01349049|580924471|FG003|Overall Study|Non-compliance|1|||
160871918|NCT01349049|580924472|FG004|Overall Study|Non-compliance|0|||
160871919|NCT01349049|580924473|FG005|Overall Study|Non-compliance|0|||
160871920|NCT01349049|580924474|FG006|Overall Study|Non-compliance|0|||
160871921|NCT01349049|580924475|FG007|Overall Study|Non-compliance|0|||
160871922|NCT01349049|580924476|FG008|Overall Study|Non-compliance|0|||
160871923|NCT01349049|580924468|FG000|Overall Study|Withdrawal by Subject|0|||
160871924|NCT01349049|580924469|FG001|Overall Study|Withdrawal by Subject|0|||
160871925|NCT01349049|580924470|FG002|Overall Study|Withdrawal by Subject|0|||
160871926|NCT01349049|580924471|FG003|Overall Study|Withdrawal by Subject|0|||
160871927|NCT01349049|580924472|FG004|Overall Study|Withdrawal by Subject|0|||
160871928|NCT01349049|580924473|FG005|Overall Study|Withdrawal by Subject|0|||
160871929|NCT01349049|580924474|FG006|Overall Study|Withdrawal by Subject|0|||
160871930|NCT01349049|580924475|FG007|Overall Study|Withdrawal by Subject|0|||
160871931|NCT01349049|580924476|FG008|Overall Study|Withdrawal by Subject|6|||
160871932|NCT00552188|580924480|FG000|Overall Study|Adverse Event|0|||
160871933|NCT00552188|580924481|FG001|Overall Study|Adverse Event|2|||
160871934|NCT00552188|580924480|FG000|Overall Study|Lost to Follow-up|2|||
160871935|NCT00552188|580924481|FG001|Overall Study|Lost to Follow-up|1|||
160871936|NCT00552188|580924480|FG000|Overall Study|Withdrawal of consent|0|||
160871937|NCT00552188|580924481|FG001|Overall Study|Withdrawal of consent|1|||
160871938|NCT00552188|580924480|FG000|Overall Study|Subject returned to home country|0|||
160871939|NCT00552188|580924481|FG001|Overall Study|Subject returned to home country|1|||
160871940|NCT01256294|580924482|FG000|Overall Study|Adverse Event|1|||
160871941|NCT01256294|580924483|FG001|Overall Study|Adverse Event|0|||
160871942|NCT01256294|580924482|FG000|Overall Study|Withdrawal by Subject|1|||
160871943|NCT01256294|580924483|FG001|Overall Study|Withdrawal by Subject|1|||
160871944|NCT01256294|580924482|FG000|Overall Study|Protocol deviation|2|||
160871945|NCT01256294|580924483|FG001|Overall Study|Protocol deviation|1|||
160871946|NCT04681352|580924484|FG000|Overall Study|Lost to Follow-up|2|||
160871947|NCT04681352|580924484|FG000|Overall Study|Withdrawal by Subject|22|||
160871948|NCT03887702|580924485|FG000|Overall Study|Study terminated|0|||
160871949|NCT03887702|580924486|FG001|Overall Study|Study terminated|0|||
160871950|NCT03887702|580924487|FG002|Overall Study|Study terminated|2|||
160871951|NCT03887702|580924488|FG003|Overall Study|Study terminated|2|||
160871952|NCT01643772|580924489|FG000|Overall Study|Protocol Violation|0|||
160871953|NCT01643772|580924490|FG001|Overall Study|Protocol Violation|0|||
160871954|NCT01643772|580924491|FG002|Overall Study|Protocol Violation|0|||
160871955|NCT01643772|580924492|FG003|Overall Study|Protocol Violation|1|||
160871956|NCT01643772|580924489|FG000|Overall Study|Adverse Event|0|||
161219320|NCT01507896|582185539|FG000|Overall Study|Withdrawal by Subject|1|||
160871957|NCT01643772|580924490|FG001|Overall Study|Adverse Event|0|||
160871958|NCT01643772|580924491|FG002|Overall Study|Adverse Event|0|||
160871959|NCT01643772|580924492|FG003|Overall Study|Adverse Event|1|||
160871960|NCT01675544|580924495|FG000|Overall Study|Withdrawal by Subject|2|||
160871961|NCT03860818|580924496|FG000|Overall Study|Death|144|||
160871962|NCT03860818|580924497|FG001|Overall Study|Death|195|||
160871963|NCT03860818|580924496|FG000|Overall Study|Graft Loss|32|||
160871964|NCT03860818|580924497|FG001|Overall Study|Graft Loss|45|||
160871965|NCT00792571|580924498|FG000|Overall Study|Death|1|||
160871966|NCT00792571|580924498|FG000|Overall Study|Adverse Event|4|||
160871967|NCT00792571|580924498|FG000|Overall Study|Withdrawal by Subject|1|||
160871968|NCT00792571|580924498|FG000|Overall Study|Other|4|||
160871969|NCT02600819|580924499|FG000|GEN Phase|Adverse Event|2|||
160871970|NCT02600819|580924500|FG001|GEN Phase|Adverse Event|0|||
160871971|NCT02600819|580924499|FG000|GEN Phase|Death|2|||
160871972|NCT02600819|580924500|FG001|GEN Phase|Death|0|||
160871973|NCT02600819|580924499|FG000|GEN Phase|Investigator's Discretion|4|||
160871974|NCT02600819|580924500|FG001|GEN Phase|Investigator's Discretion|0|||
160871975|NCT02600819|580924499|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
160871976|NCT02600819|580924500|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
160871977|NCT02600819|580924499|FG000|GEN Phase|Withdrew Consent|5|||
160871978|NCT02600819|580924500|FG001|GEN Phase|Withdrew Consent|0|||
160871979|NCT02600819|580924499|FG000|GEN Phase|Lost to Follow-up|2|||
160871980|NCT02600819|580924500|FG001|GEN Phase|Lost to Follow-up|0|||
160871981|NCT00505778|580924501|FG000|Overall Study|Adverse Event|2|||
160871982|NCT00505778|580924502|FG001|Overall Study|Adverse Event|7|||
160871983|NCT00505778|580924501|FG000|Overall Study|Physician Decision|8|||
160871984|NCT00505778|580924502|FG001|Overall Study|Physician Decision|14|||
160871985|NCT00505778|580924501|FG000|Overall Study|Lost to Follow-up|17|||
160871986|NCT00505778|580924502|FG001|Overall Study|Lost to Follow-up|23|||
160871987|NCT00505778|580924501|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
160871988|NCT00505778|580924502|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
160871989|NCT00505778|580924501|FG000|Overall Study|Protocol Violation|7|||
160871990|NCT00505778|580924502|FG001|Overall Study|Protocol Violation|9|||
160871991|NCT00505778|580924501|FG000|Overall Study|Withdrawal by Subject|29|||
160871992|NCT00505778|580924502|FG001|Overall Study|Withdrawal by Subject|14|||
160871993|NCT00505778|580924501|FG000|Overall Study|Relapse|65|||
160871994|NCT00505778|580924502|FG001|Overall Study|Relapse|65|||
160871995|NCT00505778|580924501|FG000|Overall Study|Took No Study Drug|2|||
160871996|NCT00505778|580924502|FG001|Overall Study|Took No Study Drug|2|||
160871997|NCT01621802|580924504|FG000|Overall Study|Protocol Violation|0|||
160871998|NCT01621802|580924505|FG001|Overall Study|Protocol Violation|0|||
160871999|NCT01621802|580924506|FG002|Overall Study|Protocol Violation|0|||
160872000|NCT01621802|580924507|FG003|Overall Study|Protocol Violation|0|||
160872001|NCT01621802|580924508|FG004|Overall Study|Protocol Violation|0|||
160872002|NCT01621802|580924509|FG005|Overall Study|Protocol Violation|1|||
160872003|NCT01621802|580924504|FG000|Overall Study|Withdrawal by Subject|8|||
160872004|NCT01621802|580924505|FG001|Overall Study|Withdrawal by Subject|4|||
160872005|NCT01621802|580924506|FG002|Overall Study|Withdrawal by Subject|4|||
160872006|NCT01621802|580924507|FG003|Overall Study|Withdrawal by Subject|2|||
160872007|NCT01621802|580924508|FG004|Overall Study|Withdrawal by Subject|2|||
160872008|NCT01621802|580924509|FG005|Overall Study|Withdrawal by Subject|0|||
160872009|NCT01621802|580924504|FG000|Overall Study|Migrated/moved from study area|0|||
160872010|NCT01621802|580924505|FG001|Overall Study|Migrated/moved from study area|0|||
160872011|NCT01621802|580924506|FG002|Overall Study|Migrated/moved from study area|2|||
160872012|NCT01621802|580924507|FG003|Overall Study|Migrated/moved from study area|0|||
160872013|NCT01621802|580924508|FG004|Overall Study|Migrated/moved from study area|1|||
160872014|NCT01621802|580924509|FG005|Overall Study|Migrated/moved from study area|0|||
160872015|NCT01621802|580924504|FG000|Overall Study|Others|3|||
160872016|NCT01621802|580924505|FG001|Overall Study|Others|3|||
160872017|NCT01621802|580924506|FG002|Overall Study|Others|3|||
160872018|NCT01621802|580924507|FG003|Overall Study|Others|2|||
160872019|NCT01621802|580924508|FG004|Overall Study|Others|1|||
160872020|NCT01621802|580924509|FG005|Overall Study|Others|0|||
160872021|NCT01621802|580924504|FG000|Overall Study|Lost to Follow-up|36|||
160872022|NCT01621802|580924505|FG001|Overall Study|Lost to Follow-up|16|||
160872023|NCT01621802|580924506|FG002|Overall Study|Lost to Follow-up|24|||
160872024|NCT01621802|580924507|FG003|Overall Study|Lost to Follow-up|7|||
160872025|NCT01621802|580924508|FG004|Overall Study|Lost to Follow-up|31|||
160872026|NCT01621802|580924509|FG005|Overall Study|Lost to Follow-up|11|||
160872027|NCT03790696|580924510|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
160872028|NCT03790696|580924511|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
160872029|NCT01149148|580924512|FG000|Overall Study|Lost to Follow-up|1|||
160872030|NCT01149148|580924513|FG001|Overall Study|Lost to Follow-up|2|||
160872031|NCT01149148|580924512|FG000|Overall Study|Death|1|||
160872032|NCT01149148|580924513|FG001|Overall Study|Death|0|||
161219321|NCT01507896|582185539|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
160872033|NCT03436082|580924514|FG000|Overall Study|Did not undergo procedure|1|||
160872034|NCT03436082|580924515|FG001|Overall Study|Did not undergo procedure|0|||
160872035|NCT04896086|580924516|FG000|Overall Study|Lost to Follow-up|0|||
160872036|NCT04896086|580924517|FG001|Overall Study|Lost to Follow-up|2|||
160872037|NCT04896086|580924518|FG002|Overall Study|Lost to Follow-up|1|||
160872038|NCT04896086|580924519|FG003|Overall Study|Lost to Follow-up|0|||
160872039|NCT04896086|580924520|FG004|Overall Study|Lost to Follow-up|0|||
160872040|NCT04896086|580924516|FG000|Overall Study|Physician Decision|0|||
160872041|NCT04896086|580924517|FG001|Overall Study|Physician Decision|1|||
160872042|NCT04896086|580924518|FG002|Overall Study|Physician Decision|0|||
160872043|NCT04896086|580924519|FG003|Overall Study|Physician Decision|0|||
160872044|NCT04896086|580924520|FG004|Overall Study|Physician Decision|0|||
160872045|NCT04896086|580924516|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872046|NCT04896086|580924517|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872047|NCT04896086|580924518|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872048|NCT04896086|580924519|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
160872049|NCT04896086|580924520|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
160872050|NCT04896086|580924516|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872051|NCT04896086|580924517|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872052|NCT04896086|580924518|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872053|NCT04896086|580924519|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
160872054|NCT04896086|580924520|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
160872055|NCT02249832|580924523|FG000|Overall Study|Withdrawal by Subject|3|||
160872056|NCT02249832|580924523|FG000|Overall Study|Lost to Follow-up|10|||
160872057|NCT04881942|580924530|FG000|Overall Study|Adverse Event|0|||
160872058|NCT04881942|580924531|FG001|Overall Study|Adverse Event|0|||
160872059|NCT04881942|580924532|FG002|Overall Study|Adverse Event|0|||
160872060|NCT04881942|580924533|FG003|Overall Study|Adverse Event|0|||
160872061|NCT04881942|580924534|FG004|Overall Study|Adverse Event|1|||
160872062|NCT04881942|580924530|FG000|Overall Study|Alternates|0|||
160872063|NCT04881942|580924531|FG001|Overall Study|Alternates|0|||
160872064|NCT04881942|580924532|FG002|Overall Study|Alternates|0|||
160872065|NCT04881942|580924533|FG003|Overall Study|Alternates|0|||
160872066|NCT04881942|580924534|FG004|Overall Study|Alternates|2|||
160872067|NCT02423902|580924535|FG000|Overall Study|Disease progression|1|||
160872068|NCT02423902|580924536|FG001|Overall Study|Disease progression|4|||
160872069|NCT02136069|580924537|FG000|Overall Study|UC flare-up|1|||
160872070|NCT02136069|580924538|FG001|Overall Study|UC flare-up|0|||
160872071|NCT02136069|580924537|FG000|Overall Study|Adverse Event|6|||
160872072|NCT02136069|580924538|FG001|Overall Study|Adverse Event|8|||
160872073|NCT02136069|580924537|FG000|Overall Study|Death|0|||
160872074|NCT02136069|580924538|FG001|Overall Study|Death|1|||
160872075|NCT02136069|580924537|FG000|Overall Study|Lack of Efficacy|10|||
160872076|NCT02136069|580924538|FG001|Overall Study|Lack of Efficacy|4|||
160872077|NCT02136069|580924537|FG000|Overall Study|Lost to Follow-up|1|||
160872078|NCT02136069|580924538|FG001|Overall Study|Lost to Follow-up|0|||
160872079|NCT02136069|580924537|FG000|Overall Study|Non-Compliance|1|||
160872080|NCT02136069|580924538|FG001|Overall Study|Non-Compliance|0|||
160872081|NCT02136069|580924537|FG000|Overall Study|Physician Decision|5|||
160872082|NCT02136069|580924538|FG001|Overall Study|Physician Decision|4|||
160872083|NCT02136069|580924537|FG000|Overall Study|Withdrawal by Subject|10|||
160872084|NCT02136069|580924538|FG001|Overall Study|Withdrawal by Subject|11|||
160872085|NCT02675634|580924539|FG000|Test Period 1|Adverse Event|0|||
160872086|NCT02675634|580924540|FG001|Test Period 1|Adverse Event|1|||
160872087|NCT02675634|580924541|FG002|Test Period 1|Adverse Event|0|||
160872088|NCT02675634|580924542|FG003|Test Period 1|Adverse Event|1|||
160872089|NCT02675634|580924543|FG004|Test Period 1|Adverse Event|0|||
160872090|NCT02675634|580924544|FG005|Test Period 1|Adverse Event|0|||
160872091|NCT02675634|580924539|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
160872092|NCT02675634|580924540|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
160872093|NCT02675634|580924541|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
160872094|NCT02675634|580924542|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
160872095|NCT02675634|580924543|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
161114794|NCT00708500|581809580|FG001|FOLLOWUP|Subject withdrew consent|4|||
161114795|NCT00708500|581809581|FG002|FOLLOWUP|Subject withdrew consent|5|||
161114796|NCT00708500|581809579|FG000|FOLLOWUP|Non-compliance with protocol|5|||
161114797|NCT00708500|581809580|FG001|FOLLOWUP|Non-compliance with protocol|0|||
161114798|NCT00708500|581809581|FG002|FOLLOWUP|Non-compliance with protocol|1|||
161114799|NCT00382993|581809597|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
161114800|NCT00382993|581809598|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
161114801|NCT00382993|581809597|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
161114802|NCT00382993|581809598|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
161114803|NCT00382993|581809597|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
160872096|NCT02675634|580924544|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
160872097|NCT02675634|580924539|FG000|Test Period 2|Lack of Efficacy|1|||
160872098|NCT02675634|580924540|FG001|Test Period 2|Lack of Efficacy|0|||
160872099|NCT02675634|580924541|FG002|Test Period 2|Lack of Efficacy|0|||
161114804|NCT00382993|581809598|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
161324399|NCT00110357|582573593|FG000|Overall Study|Deterioration without progression|2|||
161324400|NCT00110357|582573594|FG001|Overall Study|Deterioration without progression|0|||
160872100|NCT02675634|580924542|FG003|Test Period 2|Lack of Efficacy|0|||
160872101|NCT02675634|580924543|FG004|Test Period 2|Lack of Efficacy|0|||
160872102|NCT02675634|580924544|FG005|Test Period 2|Lack of Efficacy|0|||
160872103|NCT02675634|580924539|FG000|Test Period 2|Adverse Event|0|||
160872104|NCT02675634|580924540|FG001|Test Period 2|Adverse Event|0|||
160872105|NCT02675634|580924541|FG002|Test Period 2|Adverse Event|0|||
160872106|NCT02675634|580924542|FG003|Test Period 2|Adverse Event|0|||
160872107|NCT02675634|580924543|FG004|Test Period 2|Adverse Event|0|||
160872108|NCT02675634|580924544|FG005|Test Period 2|Adverse Event|1|||
161219322|NCT00490061|582185540|FG000|Overall Study|Physician Decision|1|||
161219323|NCT00952484|582185541|FG000|Overall Study|Withdrawal by Subject|0|||
161219324|NCT00952484|582185542|FG001|Overall Study|Withdrawal by Subject|1|||
161219325|NCT00952484|582185543|FG002|Overall Study|Withdrawal by Subject|0|||
161219326|NCT02750306|582185544|FG000|Overall Study|Withdrawal by Subject|5|||
161219327|NCT02750306|582185545|FG001|Overall Study|Withdrawal by Subject|2|||
161219328|NCT02750306|582185544|FG000|Overall Study|Protocol Violation|1|||
161219329|NCT02750306|582185545|FG001|Overall Study|Protocol Violation|0|||
161219330|NCT00585351|582185551|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
161219331|NCT00585351|582185552|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
161219332|NCT00585351|582185553|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
161219333|NCT00585351|582185554|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
161219334|NCT00585351|582185555|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
161219335|NCT00585351|582185556|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
161219336|NCT00585351|582185557|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
161219337|NCT00585351|582185558|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
161219338|NCT00585351|582185551|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
161219339|NCT00585351|582185552|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
161219340|NCT00585351|582185553|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
161219341|NCT00585351|582185554|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
161219342|NCT00585351|582185555|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
161219343|NCT00585351|582185556|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
161219344|NCT00585351|582185557|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
161219345|NCT00585351|582185558|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
161219346|NCT00585351|582185551|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
161219347|NCT00585351|582185552|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
161219348|NCT00585351|582185553|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
161219349|NCT00585351|582185554|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
160872109|NCT00811018|580924545|FG000|Overall Study|Additional Chronic Treatment|31|||
160872110|NCT00811018|580924545|FG000|Overall Study|Adverse Event|79|||
160872111|NCT00811018|580924545|FG000|Overall Study|Death|147|||
160872112|NCT00811018|580924545|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
160872113|NCT00811018|580924545|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
160872114|NCT00811018|580924545|FG000|Overall Study|Investigator Decision|57|||
160872115|NCT00811018|580924545|FG000|Overall Study|Lost to Follow-up|19|||
160872116|NCT00811018|580924545|FG000|Overall Study|Pregnancy|6|||
160872117|NCT00811018|580924545|FG000|Overall Study|Sponsor Decision|450|||
160872118|NCT00811018|580924545|FG000|Overall Study|Withdrawal by Subject|70|||
160872119|NCT00811018|580924545|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
160872120|NCT00811018|580924545|FG000|Overall Study|Other|26|||
160872121|NCT04154189|580924546|FG000|Overall Study|Withdrawal by Subject|4|||
160872122|NCT04154189|580924547|FG001|Overall Study|Withdrawal by Subject|6|||
160872123|NCT04154189|580924546|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
160872124|NCT04154189|580924547|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
160872125|NCT04154189|580924546|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
160872126|NCT04154189|580924547|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
160872127|NCT04154189|580924546|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
161219350|NCT00585351|582185555|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
161219351|NCT00585351|582185556|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
161219352|NCT00585351|582185557|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
160872128|NCT04154189|580924547|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
160872129|NCT04154189|580924546|FG000|Overall Study|Death|25|||
160872130|NCT04154189|580924547|FG001|Overall Study|Death|25|||
160872131|NCT00845897|580924550|FG000|Overall Study|Lost to Follow-up|1|||
160872132|NCT00845897|580924551|FG001|Overall Study|Lost to Follow-up|1|||
160872133|NCT00845897|580924552|FG002|Overall Study|Lost to Follow-up|0|||
160872134|NCT00845897|580924550|FG000|Overall Study|Withdrawal by Subject|0|||
160872135|NCT00845897|580924551|FG001|Overall Study|Withdrawal by Subject|3|||
160872136|NCT00845897|580924552|FG002|Overall Study|Withdrawal by Subject|2|||
160872137|NCT00845897|580924550|FG000|Overall Study|Ulcer did not heal|1|||
160872138|NCT00845897|580924551|FG001|Overall Study|Ulcer did not heal|0|||
160872139|NCT00845897|580924552|FG002|Overall Study|Ulcer did not heal|1|||
160872140|NCT00845897|580924550|FG000|Overall Study|Too ill to participate|0|||
160872141|NCT00845897|580924551|FG001|Overall Study|Too ill to participate|1|||
160872142|NCT00845897|580924552|FG002|Overall Study|Too ill to participate|0|||
160872143|NCT02722499|580924554|FG000|Overall Study|Lost to Follow-up|2|||
160872144|NCT02722499|580924555|FG001|Overall Study|Lost to Follow-up|0|||
160872145|NCT02722499|580924556|FG002|Overall Study|Lost to Follow-up|1|||
160872146|NCT04999852|580924557|FG000|Overall Study|Withdrawal by Subject|11|||
160872147|NCT04999852|580924558|FG001|Overall Study|Withdrawal by Subject|1|||
160872148|NCT04999852|580924557|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
160872149|NCT04999852|580924558|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
160872150|NCT05626322|580924559|FG000|Overall Study|Death|2|||
160872151|NCT05626322|580924560|FG001|Overall Study|Death|0|||
160872152|NCT05626322|580924561|FG002|Overall Study|Death|0|||
160872153|NCT05626322|580924559|FG000|Overall Study|Physician Decision|1|||
160872154|NCT05626322|580924560|FG001|Overall Study|Physician Decision|0|||
160872155|NCT05626322|580924561|FG002|Overall Study|Physician Decision|0|||
160872156|NCT05626322|580924559|FG000|Overall Study|Progressive Disease|0|||
160872157|NCT05626322|580924560|FG001|Overall Study|Progressive Disease|1|||
160872158|NCT05626322|580924561|FG002|Overall Study|Progressive Disease|1|||
160872159|NCT05626322|580924559|FG000|Overall Study|Study terminated by sponsor|0|||
160872160|NCT05626322|580924560|FG001|Overall Study|Study terminated by sponsor|1|||
160872161|NCT05626322|580924561|FG002|Overall Study|Study terminated by sponsor|0|||
160872162|NCT04758637|580924564|FG000|Overall Study|Lost to Follow-up|0|||
160872163|NCT04758637|580924565|FG001|Overall Study|Lost to Follow-up|1|||
160872164|NCT04758637|580924566|FG002|Overall Study|Lost to Follow-up|0|||
160872165|NCT04758637|580924567|FG003|Overall Study|Lost to Follow-up|0|||
160872166|NCT03610269|580924568|FG000|Overall Study|Physician Decision|10|||
160872167|NCT03610269|580924568|FG000|Overall Study|Protocol Violation|1|||
160872168|NCT03610269|580924568|FG000|Overall Study|Unable to draw blood|1|||
160872169|NCT03610269|580924568|FG000|Overall Study|Screen fail|4|||
160872170|NCT00067002|580924569|FG000|Overall Study|Early Death|1|||
161114805|NCT00382993|581809597|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
161114806|NCT00382993|581809598|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
161114807|NCT00382993|581809597|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
161114808|NCT00382993|581809598|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
161114809|NCT00382993|581809597|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
161114810|NCT00382993|581809598|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
161114811|NCT00382993|581809597|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
161114812|NCT00382993|581809598|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
161114813|NCT00382993|581809597|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
161114814|NCT00382993|581809598|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
161114815|NCT00382993|581809597|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
161114816|NCT00382993|581809598|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
161114817|NCT00382993|581809597|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
161114818|NCT00382993|581809598|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
161114819|NCT00607386|581809601|FG000|Overall Study|Physician Decision|1|||
161114820|NCT00440947|581809602|FG000|36-Week Induction Phase|Adverse Event|16|||
161114821|NCT00440947|581809603|FG001|36-Week Induction Phase|Adverse Event|0|||
161114822|NCT00440947|581809604|FG002|36-Week Induction Phase|Adverse Event|0|||
161114823|NCT00440947|581809605|FG003|36-Week Induction Phase|Adverse Event|0|||
161114824|NCT00440947|581809606|FG004|36-Week Induction Phase|Adverse Event|0|||
161114825|NCT00440947|581809602|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
161114826|NCT00440947|581809603|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161114827|NCT00440947|581809604|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161114828|NCT00440947|581809605|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161114829|NCT00440947|581809606|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
161114830|NCT00440947|581809602|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
161114831|NCT00440947|581809603|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
160872171|NCT00067002|580924570|FG001|Overall Study|Early Death|2|||
161114832|NCT00440947|581809604|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161114833|NCT00440947|581809605|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161114834|NCT00440947|581809606|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
161114835|NCT00440947|581809602|FG000|36-Week Induction Phase|Non-compliance|10|||
161114836|NCT00440947|581809603|FG001|36-Week Induction Phase|Non-compliance|0|||
161114837|NCT00440947|581809604|FG002|36-Week Induction Phase|Non-compliance|0|||
161114838|NCT00440947|581809605|FG003|36-Week Induction Phase|Non-compliance|0|||
161114839|NCT00440947|581809606|FG004|36-Week Induction Phase|Non-compliance|0|||
161114840|NCT00440947|581809602|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
161114841|NCT00440947|581809603|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
161114842|NCT00440947|581809604|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
161114843|NCT00440947|581809605|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
161114844|NCT00440947|581809606|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
161114845|NCT00440947|581809602|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
161114846|NCT00440947|581809603|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
161114847|NCT00440947|581809604|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
161114848|NCT00440947|581809605|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
161114849|NCT00440947|581809606|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
161114850|NCT00440947|581809602|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
161114851|NCT00440947|581809603|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161114852|NCT00440947|581809604|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161114853|NCT00440947|581809605|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161114854|NCT00440947|581809606|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
161114855|NCT00440947|581809602|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
161114856|NCT00440947|581809603|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
161114857|NCT00440947|581809604|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
161114858|NCT00440947|581809605|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
161114859|NCT00440947|581809606|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
161114860|NCT00440947|581809602|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
161114861|NCT00440947|581809603|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161114862|NCT00440947|581809604|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161114863|NCT00440947|581809605|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161114864|NCT00440947|581809606|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
161114865|NCT00440947|581809602|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
161114866|NCT00440947|581809603|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161114867|NCT00440947|581809604|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161114868|NCT00440947|581809605|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161114869|NCT00440947|581809606|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
161114870|NCT00440947|581809602|FG000|36-Week Induction Phase|Incarceration|3|||
161114871|NCT00440947|581809603|FG001|36-Week Induction Phase|Incarceration|0|||
161114872|NCT00440947|581809604|FG002|36-Week Induction Phase|Incarceration|0|||
161114873|NCT00440947|581809605|FG003|36-Week Induction Phase|Incarceration|0|||
161114874|NCT00440947|581809606|FG004|36-Week Induction Phase|Incarceration|0|||
161114875|NCT00440947|581809602|FG000|36-Week Induction Phase|Pregnancy|1|||
161114876|NCT00440947|581809603|FG001|36-Week Induction Phase|Pregnancy|0|||
161114877|NCT00440947|581809604|FG002|36-Week Induction Phase|Pregnancy|0|||
161114878|NCT00440947|581809605|FG003|36-Week Induction Phase|Pregnancy|0|||
161114879|NCT00440947|581809606|FG004|36-Week Induction Phase|Pregnancy|0|||
161114880|NCT00440947|581809602|FG000|48-Week Randomization Phase|Adverse Event|0|||
161114881|NCT00440947|581809603|FG001|48-Week Randomization Phase|Adverse Event|2|||
161114882|NCT00440947|581809604|FG002|48-Week Randomization Phase|Adverse Event|5|||
161114883|NCT00440947|581809605|FG003|48-Week Randomization Phase|Adverse Event|0|||
161114884|NCT00440947|581809606|FG004|48-Week Randomization Phase|Adverse Event|0|||
161114885|NCT00440947|581809602|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161114886|NCT00440947|581809603|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
161114887|NCT00440947|581809604|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
161114888|NCT00440947|581809605|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161114889|NCT00440947|581809606|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
161114890|NCT00440947|581809602|FG000|48-Week Randomization Phase|Non-compliance|0|||
161114891|NCT00440947|581809603|FG001|48-Week Randomization Phase|Non-compliance|3|||
161114892|NCT00440947|581809604|FG002|48-Week Randomization Phase|Non-compliance|4|||
161114893|NCT00440947|581809605|FG003|48-Week Randomization Phase|Non-compliance|0|||
161114894|NCT00440947|581809606|FG004|48-Week Randomization Phase|Non-compliance|0|||
161114895|NCT00440947|581809602|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
161114896|NCT00440947|581809603|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
161114897|NCT00440947|581809604|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
161257853|NCT01961687|582323497|FG000|Overall Study|Unable to meet follow-up requirements|1|||
160872172|NCT00067002|580924569|FG000|Overall Study|Delayed|1|||
160872173|NCT00067002|580924570|FG001|Overall Study|Delayed|1|||
160872174|NCT00067002|580924569|FG000|Overall Study|Graft Failure|5|||
160872175|NCT00067002|580924570|FG001|Overall Study|Graft Failure|6|||
160872176|NCT03350672|580924571|FG000|Overall Study|Withdrawal by Subject|7|||
160872177|NCT03350672|580924572|FG001|Overall Study|Withdrawal by Subject|0|||
160872178|NCT03350672|580924573|FG002|Overall Study|Withdrawal by Subject|0|||
160872179|NCT01599637|580924574|FG000|Overall Study|administrative problems|0|||
160872180|NCT01599637|580924575|FG001|Overall Study|administrative problems|2|||
160872181|NCT01599637|580924576|FG002|Overall Study|administrative problems|0|||
160872182|NCT01599637|580924574|FG000|Overall Study|Adverse Event|1|||
160872183|NCT01599637|580924575|FG001|Overall Study|Adverse Event|0|||
160872184|NCT01599637|580924576|FG002|Overall Study|Adverse Event|0|||
160872185|NCT04476797|580924579|FG000|Overall Study|Withdrawal by Subject|1|||
160872186|NCT04476797|580924580|FG001|Overall Study|Withdrawal by Subject|0|||
160872187|NCT04476797|580924581|FG002|Overall Study|Withdrawal by Subject|0|||
160872188|NCT04476797|580924579|FG000|Overall Study|Death|0|||
160872189|NCT04476797|580924580|FG001|Overall Study|Death|1|||
160872190|NCT04476797|580924581|FG002|Overall Study|Death|2|||
160872191|NCT04476797|580924579|FG000|Overall Study|Sponsor Terminated Study|0|||
160872192|NCT04476797|580924580|FG001|Overall Study|Sponsor Terminated Study|18|||
160872193|NCT04476797|580924581|FG002|Overall Study|Sponsor Terminated Study|17|||
160872194|NCT02395081|580924582|FG000|Overall Study|Withdrawal by Subject|1|||
160872195|NCT02395081|580924583|FG001|Overall Study|Withdrawal by Subject|1|||
160872196|NCT02395081|580924584|FG002|Overall Study|Withdrawal by Subject|0|||
160872197|NCT02395081|580924582|FG000|Overall Study|Moved where blood couldn't be collected|4|||
160872198|NCT02395081|580924583|FG001|Overall Study|Moved where blood couldn't be collected|1|||
160872199|NCT02395081|580924584|FG002|Overall Study|Moved where blood couldn't be collected|3|||
160872200|NCT02395081|580924582|FG000|Overall Study|Fetal Loss|2|||
160872201|NCT02395081|580924583|FG001|Overall Study|Fetal Loss|3|||
160872202|NCT02395081|580924584|FG002|Overall Study|Fetal Loss|1|||
160872203|NCT02721966|580924585|FG000|Overall Study|Protocol Violation|1|||
160872204|NCT02721966|580924586|FG001|Overall Study|Protocol Violation|0|||
160872205|NCT02721966|580924587|FG002|Overall Study|Protocol Violation|0|||
160872206|NCT02721966|580924588|FG003|Overall Study|Protocol Violation|0|||
160872207|NCT02721966|580924589|FG004|Overall Study|Protocol Violation|0|||
160872208|NCT02721966|580924585|FG000|Overall Study|Withdrawal by Subject|9|||
160872209|NCT02721966|580924586|FG001|Overall Study|Withdrawal by Subject|2|||
160872210|NCT02721966|580924587|FG002|Overall Study|Withdrawal by Subject|3|||
160872211|NCT02721966|580924588|FG003|Overall Study|Withdrawal by Subject|7|||
160872212|NCT02721966|580924589|FG004|Overall Study|Withdrawal by Subject|0|||
160872213|NCT02721966|580924585|FG000|Overall Study|Adverse Event|4|||
160872214|NCT02721966|580924586|FG001|Overall Study|Adverse Event|4|||
160872215|NCT02721966|580924587|FG002|Overall Study|Adverse Event|3|||
160872216|NCT02721966|580924588|FG003|Overall Study|Adverse Event|0|||
160872217|NCT02721966|580924589|FG004|Overall Study|Adverse Event|0|||
160872218|NCT02721966|580924585|FG000|Overall Study|Death|1|||
160872219|NCT02721966|580924586|FG001|Overall Study|Death|0|||
160872220|NCT02721966|580924587|FG002|Overall Study|Death|0|||
160872221|NCT02721966|580924588|FG003|Overall Study|Death|0|||
160872222|NCT02721966|580924589|FG004|Overall Study|Death|0|||
160872223|NCT02721966|580924585|FG000|Overall Study|Lack of Efficacy|7|||
160872224|NCT02721966|580924586|FG001|Overall Study|Lack of Efficacy|4|||
160872225|NCT02721966|580924587|FG002|Overall Study|Lack of Efficacy|0|||
160872226|NCT02721966|580924588|FG003|Overall Study|Lack of Efficacy|0|||
160872227|NCT02721966|580924589|FG004|Overall Study|Lack of Efficacy|0|||
160872228|NCT02721966|580924585|FG000|Overall Study|Lost to Follow-up|0|||
160872229|NCT02721966|580924586|FG001|Overall Study|Lost to Follow-up|0|||
161219353|NCT00585351|582185558|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
161219354|NCT00585351|582185551|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
161219355|NCT00585351|582185552|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
160872230|NCT02721966|580924587|FG002|Overall Study|Lost to Follow-up|3|||
160872231|NCT02721966|580924588|FG003|Overall Study|Lost to Follow-up|0|||
160872232|NCT02721966|580924589|FG004|Overall Study|Lost to Follow-up|0|||
160872233|NCT02721966|580924585|FG000|Overall Study|Physician Decision|1|||
160872234|NCT02721966|580924586|FG001|Overall Study|Physician Decision|1|||
160872235|NCT02721966|580924587|FG002|Overall Study|Physician Decision|0|||
160872236|NCT02721966|580924588|FG003|Overall Study|Physician Decision|0|||
160872237|NCT02721966|580924589|FG004|Overall Study|Physician Decision|0|||
160872238|NCT02721966|580924585|FG000|Overall Study|Pregnancy|1|||
161219356|NCT00585351|582185553|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
160872239|NCT02721966|580924586|FG001|Overall Study|Pregnancy|0|||
160872240|NCT02721966|580924587|FG002|Overall Study|Pregnancy|0|||
160872241|NCT02721966|580924588|FG003|Overall Study|Pregnancy|0|||
160872242|NCT02721966|580924589|FG004|Overall Study|Pregnancy|0|||
160872243|NCT02721966|580924585|FG000|Overall Study|Did not continue to period 2|5|||
160872244|NCT02721966|580924586|FG001|Overall Study|Did not continue to period 2|12|||
160872245|NCT02721966|580924587|FG002|Overall Study|Did not continue to period 2|0|||
160872246|NCT02721966|580924588|FG003|Overall Study|Did not continue to period 2|0|||
160872247|NCT02721966|580924589|FG004|Overall Study|Did not continue to period 2|5|||
160872248|NCT04200352|580924590|FG000|Overall Study|Death|1|||
160872249|NCT04200352|580924590|FG000|Overall Study|Adverse Event|6|||
160872250|NCT04200352|580924590|FG000|Overall Study|Withdrawal by parent/guardian|6|||
160872251|NCT04200352|580924590|FG000|Overall Study|Lack of Efficacy|1|||
160872252|NCT04200352|580924590|FG000|Overall Study|Other than specified|6|||
160872253|NCT02541604|580924591|FG000|Overall Study|Death|6|||
160872254|NCT02541604|580924592|FG001|Overall Study|Death|5|||
160872255|NCT02541604|580924593|FG002|Overall Study|Death|7|||
160872256|NCT02541604|580924594|FG003|Overall Study|Death|2|||
160872257|NCT02541604|580924595|FG004|Overall Study|Death|9|||
160872258|NCT02541604|580924596|FG005|Overall Study|Death|8|||
160872259|NCT02541604|580924597|FG006|Overall Study|Death|9|||
160872260|NCT02541604|580924598|FG007|Overall Study|Death|9|||
160872261|NCT02541604|580924599|FG008|Overall Study|Death|3|||
160872262|NCT02541604|580924600|FG009|Overall Study|Death|4|||
160872263|NCT02541604|580924601|FG010|Overall Study|Death|2|||
160872264|NCT02541604|580924602|FG011|Overall Study|Death|3|||
160872265|NCT02541604|580924591|FG000|Overall Study|Lost to Follow-up|2|||
160872266|NCT02541604|580924592|FG001|Overall Study|Lost to Follow-up|0|||
160872267|NCT02541604|580924593|FG002|Overall Study|Lost to Follow-up|1|||
160872268|NCT02541604|580924594|FG003|Overall Study|Lost to Follow-up|0|||
160872269|NCT02541604|580924595|FG004|Overall Study|Lost to Follow-up|0|||
160872270|NCT02541604|580924596|FG005|Overall Study|Lost to Follow-up|1|||
160872271|NCT02541604|580924597|FG006|Overall Study|Lost to Follow-up|1|||
160872272|NCT02541604|580924598|FG007|Overall Study|Lost to Follow-up|0|||
160872273|NCT02541604|580924599|FG008|Overall Study|Lost to Follow-up|0|||
160872274|NCT02541604|580924600|FG009|Overall Study|Lost to Follow-up|0|||
160872275|NCT02541604|580924601|FG010|Overall Study|Lost to Follow-up|0|||
160872276|NCT02541604|580924602|FG011|Overall Study|Lost to Follow-up|0|||
160872277|NCT02541604|580924591|FG000|Overall Study|Withdrawal by Subject|2|||
160872278|NCT02541604|580924592|FG001|Overall Study|Withdrawal by Subject|0|||
160872279|NCT02541604|580924593|FG002|Overall Study|Withdrawal by Subject|1|||
160872280|NCT02541604|580924594|FG003|Overall Study|Withdrawal by Subject|0|||
160872281|NCT02541604|580924595|FG004|Overall Study|Withdrawal by Subject|1|||
160872282|NCT02541604|580924596|FG005|Overall Study|Withdrawal by Subject|1|||
160872283|NCT02541604|580924597|FG006|Overall Study|Withdrawal by Subject|0|||
160872284|NCT02541604|580924598|FG007|Overall Study|Withdrawal by Subject|0|||
160872285|NCT02541604|580924599|FG008|Overall Study|Withdrawal by Subject|1|||
160872286|NCT02541604|580924600|FG009|Overall Study|Withdrawal by Subject|0|||
160872287|NCT02541604|580924601|FG010|Overall Study|Withdrawal by Subject|0|||
160872288|NCT02541604|580924602|FG011|Overall Study|Withdrawal by Subject|0|||
160872289|NCT02541604|580924591|FG000|Overall Study|Study Terminated by Sponsor|1|||
160872290|NCT02541604|580924592|FG001|Overall Study|Study Terminated by Sponsor|4|||
160872291|NCT02541604|580924593|FG002|Overall Study|Study Terminated by Sponsor|2|||
160872292|NCT02541604|580924594|FG003|Overall Study|Study Terminated by Sponsor|1|||
160872293|NCT02541604|580924595|FG004|Overall Study|Study Terminated by Sponsor|0|||
160872294|NCT02541604|580924596|FG005|Overall Study|Study Terminated by Sponsor|0|||
160872295|NCT02541604|580924597|FG006|Overall Study|Study Terminated by Sponsor|0|||
160872296|NCT02541604|580924598|FG007|Overall Study|Study Terminated by Sponsor|0|||
160872297|NCT02541604|580924599|FG008|Overall Study|Study Terminated by Sponsor|0|||
160872298|NCT02541604|580924600|FG009|Overall Study|Study Terminated by Sponsor|0|||
160872299|NCT02541604|580924601|FG010|Overall Study|Study Terminated by Sponsor|0|||
160872300|NCT02541604|580924602|FG011|Overall Study|Study Terminated by Sponsor|0|||
160872301|NCT02541604|580924591|FG000|Overall Study|Medical condition may jeopardize safety|0|||
160872302|NCT02541604|580924592|FG001|Overall Study|Medical condition may jeopardize safety|0|||
160872303|NCT02541604|580924593|FG002|Overall Study|Medical condition may jeopardize safety|0|||
160872304|NCT02541604|580924594|FG003|Overall Study|Medical condition may jeopardize safety|0|||
161114898|NCT00440947|581809605|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
161114899|NCT00440947|581809606|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
160872305|NCT02541604|580924595|FG004|Overall Study|Medical condition may jeopardize safety|0|||
160872306|NCT02541604|580924596|FG005|Overall Study|Medical condition may jeopardize safety|0|||
160872307|NCT02541604|580924597|FG006|Overall Study|Medical condition may jeopardize safety|0|||
160872308|NCT02541604|580924598|FG007|Overall Study|Medical condition may jeopardize safety|1|||
160872309|NCT02541604|580924599|FG008|Overall Study|Medical condition may jeopardize safety|0|||
160872310|NCT02541604|580924600|FG009|Overall Study|Medical condition may jeopardize safety|0|||
160872311|NCT02541604|580924601|FG010|Overall Study|Medical condition may jeopardize safety|0|||
160872312|NCT02541604|580924602|FG011|Overall Study|Medical condition may jeopardize safety|0|||
160872313|NCT00828204|580924603|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
160872314|NCT00828204|580924604|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
160872315|NCT00828204|580924603|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
160872316|NCT00828204|580924604|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
160872317|NCT00828204|580924603|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
160872318|NCT00828204|580924604|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
160872319|NCT00828204|580924603|FG000|Main Study: After Study Restart|Adverse Event|0|||
160872320|NCT00828204|580924604|FG001|Main Study: After Study Restart|Adverse Event|2|||
160872321|NCT00828204|580924603|FG000|Main Study: After Study Restart|Noncompliance|0|||
160872322|NCT00828204|580924604|FG001|Main Study: After Study Restart|Noncompliance|1|||
160872323|NCT00828204|580924603|FG000|Extension Study|Lost to Follow-up|0|||
160872324|NCT00828204|580924604|FG001|Extension Study|Lost to Follow-up|1|||
160872325|NCT00828204|580924603|FG000|Extension Study|Physician Decision|0|||
160872326|NCT00828204|580924604|FG001|Extension Study|Physician Decision|2|||
161114900|NCT00440947|581809602|FG000|48-Week Randomization Phase|Protocol Violation|0|||
161114901|NCT00440947|581809603|FG001|48-Week Randomization Phase|Protocol Violation|0|||
161114902|NCT00440947|581809604|FG002|48-Week Randomization Phase|Protocol Violation|1|||
161114903|NCT00440947|581809605|FG003|48-Week Randomization Phase|Protocol Violation|0|||
161114904|NCT00440947|581809606|FG004|48-Week Randomization Phase|Protocol Violation|0|||
161114905|NCT00440947|581809602|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
161114906|NCT00440947|581809603|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
161114907|NCT00440947|581809604|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
161114908|NCT00440947|581809605|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
161114909|NCT00440947|581809606|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
161114910|NCT00440947|581809602|FG000|48-Week Randomization Phase|Pregnancy|0|||
161114911|NCT00440947|581809603|FG001|48-Week Randomization Phase|Pregnancy|0|||
161114912|NCT00440947|581809604|FG002|48-Week Randomization Phase|Pregnancy|1|||
161114913|NCT00440947|581809605|FG003|48-Week Randomization Phase|Pregnancy|0|||
161114914|NCT00440947|581809606|FG004|48-Week Randomization Phase|Pregnancy|0|||
161114915|NCT00440947|581809602|FG000|48-Week Randomization Phase|Incarceration|0|||
161114916|NCT00440947|581809603|FG001|48-Week Randomization Phase|Incarceration|3|||
161114917|NCT00440947|581809604|FG002|48-Week Randomization Phase|Incarceration|0|||
161114918|NCT00440947|581809605|FG003|48-Week Randomization Phase|Incarceration|0|||
161114919|NCT00440947|581809606|FG004|48-Week Randomization Phase|Incarceration|0|||
161114920|NCT00440947|581809602|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161114921|NCT00440947|581809603|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
161114922|NCT00440947|581809604|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161114923|NCT00440947|581809605|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161114924|NCT00440947|581809606|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
161114925|NCT00440947|581809602|FG000|48-Week Randomization Phase|Physician Decision|0|||
161114926|NCT00440947|581809603|FG001|48-Week Randomization Phase|Physician Decision|2|||
161114927|NCT00440947|581809604|FG002|48-Week Randomization Phase|Physician Decision|0|||
161114928|NCT00440947|581809605|FG003|48-Week Randomization Phase|Physician Decision|0|||
161114929|NCT00440947|581809606|FG004|48-Week Randomization Phase|Physician Decision|0|||
161114930|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
161114931|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
161114932|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
161114933|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
161114934|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
161114935|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161114936|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161114937|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
161114938|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
161114939|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
161114940|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161114941|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161114942|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
161114943|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
161114944|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
161114945|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
161114946|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
161114947|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
161114948|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
161114949|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
161114950|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161114951|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161114952|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
161114953|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
161114954|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
161114955|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
161114956|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
160872327|NCT00806819|580924605|FG000|Overall Study|progressive disease (modified RECIST )|217|||
160872328|NCT00806819|580924606|FG001|Overall Study|progressive disease (modified RECIST )|216|||
160872329|NCT00806819|580924605|FG000|Overall Study|Worsening or AE of underlying disease|18|||
160872330|NCT00806819|580924606|FG001|Overall Study|Worsening or AE of underlying disease|25|||
160872331|NCT00806819|580924605|FG000|Overall Study|Other AE|38|||
160872332|NCT00806819|580924606|FG001|Overall Study|Other AE|40|||
160872333|NCT00806819|580924605|FG000|Overall Study|Protocol Violation|9|||
160872334|NCT00806819|580924606|FG001|Overall Study|Protocol Violation|4|||
160872335|NCT00806819|580924605|FG000|Overall Study|Lost to Follow-up|1|||
160872336|NCT00806819|580924606|FG001|Overall Study|Lost to Follow-up|0|||
160872337|NCT00806819|580924605|FG000|Overall Study|Withdrawal by Subject|32|||
160872338|NCT00806819|580924606|FG001|Overall Study|Withdrawal by Subject|29|||
160872339|NCT00806819|580924605|FG000|Overall Study|Not treated|6|||
160872340|NCT00806819|580924606|FG001|Overall Study|Not treated|3|||
160872341|NCT00806819|580924605|FG000|Overall Study|Reasons other than stated above|25|||
160872342|NCT00806819|580924606|FG001|Overall Study|Reasons other than stated above|41|||
160872343|NCT02840461|580924609|FG000|Overall Study|Adverse Event|1|||
160872344|NCT02840461|580924610|FG001|Overall Study|Adverse Event|5|||
160872345|NCT02840461|580924611|FG002|Overall Study|Adverse Event|3|||
160872346|NCT02840461|580924609|FG000|Overall Study|Lost to Follow-up|10|||
160872347|NCT02840461|580924610|FG001|Overall Study|Lost to Follow-up|7|||
160872348|NCT02840461|580924611|FG002|Overall Study|Lost to Follow-up|6|||
160872349|NCT02840461|580924609|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
160872350|NCT02840461|580924610|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
160872351|NCT02840461|580924611|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
160872352|NCT02840461|580924609|FG000|Overall Study|Protocol Violation|2|||
160872353|NCT02840461|580924610|FG001|Overall Study|Protocol Violation|3|||
160872354|NCT02840461|580924611|FG002|Overall Study|Protocol Violation|1|||
160872355|NCT02840461|580924609|FG000|Overall Study|Withdrawal by Subject|10|||
160872356|NCT02840461|580924610|FG001|Overall Study|Withdrawal by Subject|6|||
160872357|NCT02840461|580924611|FG002|Overall Study|Withdrawal by Subject|2|||
160872358|NCT02840461|580924609|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
160872359|NCT02840461|580924610|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
160872360|NCT02840461|580924611|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
160872361|NCT01737502|580924612|FG000|Phase I|Disease progression|2|||
160872362|NCT01737502|580924613|FG001|Phase I|Disease progression|3|||
160872363|NCT01737502|580924612|FG000|Phase I|Complicating disease|1|||
160872364|NCT01737502|580924613|FG001|Phase I|Complicating disease|0|||
160872365|NCT01737502|580924612|FG000|Phase II|Adverse Event|0|||
160872366|NCT01737502|580924613|FG001|Phase II|Adverse Event|3|||
160872367|NCT01737502|580924612|FG000|Phase II|Disease progression|0|||
160872368|NCT01737502|580924613|FG001|Phase II|Disease progression|18|||
160872369|NCT01737502|580924612|FG000|Phase II|Death|0|||
160872370|NCT01737502|580924613|FG001|Phase II|Death|1|||
160872371|NCT01737502|580924612|FG000|Phase II|Transition to hospice care|0|||
160872372|NCT01737502|580924613|FG001|Phase II|Transition to hospice care|1|||
160872373|NCT04549545|580925603|FG000|Initial Period|Withdrawal by Subject|4|||
160872374|NCT04549545|580925604|FG001|Initial Period|Withdrawal by Subject|0|||
160872375|NCT04549545|580925603|FG000|Initial Period|Additional ENT Procedure|3|||
160872376|NCT04549545|580925604|FG001|Initial Period|Additional ENT Procedure|0|||
160872377|NCT04549545|580925603|FG000|Initial Period|Lost to Follow-up|3|||
160872378|NCT04549545|580925604|FG001|Initial Period|Lost to Follow-up|1|||
160872379|NCT04549545|580925603|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
160872380|NCT04549545|580925604|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
160872381|NCT04549545|580925603|FG000|Crossover Period|Additional ENT Procedure|0|||
160872382|NCT04549545|580925604|FG001|Crossover Period|Additional ENT Procedure|6|||
160872383|NCT04549545|580925603|FG000|Crossover Period|Lost to Follow-up|0|||
160872384|NCT04549545|580925604|FG001|Crossover Period|Lost to Follow-up|1|||
160872385|NCT04549545|580925603|FG000|Crossover Period|Withdrawal by Subject|0|||
160872386|NCT04549545|580925604|FG001|Crossover Period|Withdrawal by Subject|4|||
160872387|NCT00243269|580925608|FG000|Overall Study|Protocol Violation|2|||
160872388|NCT00243269|580925609|FG001|Overall Study|Protocol Violation|1|||
160872389|NCT00243269|580925610|FG002|Overall Study|Protocol Violation|0|||
160872390|NCT00243269|580925611|FG003|Overall Study|Protocol Violation|1|||
160872391|NCT00243269|580925608|FG000|Overall Study|Lost to Follow-up|1|||
161257854|NCT00614926|582323498|FG000|Overall Study|Burden of travel|1|||
160872392|NCT00243269|580925609|FG001|Overall Study|Lost to Follow-up|0|||
160872393|NCT00243269|580925610|FG002|Overall Study|Lost to Follow-up|1|||
160872394|NCT00243269|580925611|FG003|Overall Study|Lost to Follow-up|3|||
160872395|NCT00485134|580925617|FG000|Overall Study|Lost to Follow-up|1|||
160872396|NCT00485134|580925618|FG001|Overall Study|Lost to Follow-up|0|||
160872397|NCT00485134|580925619|FG002|Overall Study|Lost to Follow-up|0|||
160872398|NCT00485134|580925620|FG003|Overall Study|Lost to Follow-up|0|||
160872399|NCT00485134|580925621|FG004|Overall Study|Lost to Follow-up|0|||
160872400|NCT00485134|580925622|FG005|Overall Study|Lost to Follow-up|0|||
160872401|NCT00485134|580925623|FG006|Overall Study|Lost to Follow-up|0|||
160872402|NCT00485134|580925624|FG007|Overall Study|Lost to Follow-up|0|||
160872403|NCT00485134|580925617|FG000|Overall Study|Withdrawal by Subject|0|||
160872404|NCT00485134|580925618|FG001|Overall Study|Withdrawal by Subject|1|||
160872405|NCT00485134|580925619|FG002|Overall Study|Withdrawal by Subject|0|||
160872406|NCT00485134|580925620|FG003|Overall Study|Withdrawal by Subject|0|||
160872407|NCT00485134|580925621|FG004|Overall Study|Withdrawal by Subject|0|||
160872408|NCT00485134|580925622|FG005|Overall Study|Withdrawal by Subject|0|||
160872409|NCT00485134|580925623|FG006|Overall Study|Withdrawal by Subject|0|||
160872410|NCT00485134|580925624|FG007|Overall Study|Withdrawal by Subject|0|||
160872411|NCT00485134|580925617|FG000|Overall Study|Change in health status|0|||
160872412|NCT00485134|580925618|FG001|Overall Study|Change in health status|1|||
160872413|NCT00485134|580925619|FG002|Overall Study|Change in health status|2|||
160872414|NCT00485134|580925620|FG003|Overall Study|Change in health status|1|||
161219357|NCT00585351|582185554|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161219358|NCT00585351|582185555|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161219359|NCT00585351|582185556|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161219360|NCT00585351|582185557|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161219361|NCT00585351|582185558|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
161219362|NCT00585351|582185551|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161219363|NCT00585351|582185552|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161219364|NCT00585351|582185553|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161219365|NCT00585351|582185554|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161219366|NCT00585351|582185555|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161219367|NCT00585351|582185556|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
161219368|NCT00585351|582185557|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
161219369|NCT00585351|582185558|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
161219370|NCT00585351|582185551|FG000|Enrollment Period (Intervention)|Death|0|||
161219371|NCT00585351|582185552|FG001|Enrollment Period (Intervention)|Death|0|||
161219372|NCT00585351|582185553|FG002|Enrollment Period (Intervention)|Death|0|||
161219373|NCT00585351|582185554|FG003|Enrollment Period (Intervention)|Death|0|||
161219374|NCT00585351|582185555|FG004|Enrollment Period (Intervention)|Death|1|||
161219375|NCT00585351|582185556|FG005|Enrollment Period (Intervention)|Death|0|||
161219376|NCT00585351|582185557|FG006|Enrollment Period (Intervention)|Death|1|||
161219377|NCT00585351|582185558|FG007|Enrollment Period (Intervention)|Death|0|||
161219378|NCT00585351|582185551|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161219379|NCT00585351|582185552|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161219380|NCT00585351|582185553|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161219381|NCT00585351|582185554|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161219382|NCT00585351|582185555|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
161219383|NCT00585351|582185556|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
161219384|NCT00585351|582185557|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161219385|NCT00585351|582185558|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
161219386|NCT04317781|582185561|FG000|Overall Study|Adverse Event|1|||
161219387|NCT04317781|582185561|FG000|Overall Study|Disease relapse|1|||
161219388|NCT04317781|582185561|FG000|Overall Study|Withdrawal by Subject|1|||
161219389|NCT01875445|582185563|FG000|Overall Study|Lost to Follow-up|5|||
161219390|NCT01875445|582185564|FG001|Overall Study|Lost to Follow-up|0|||
161219391|NCT01875445|582185563|FG000|Overall Study|Withdrawal by Subject|2|||
161219392|NCT01875445|582185564|FG001|Overall Study|Withdrawal by Subject|0|||
160872415|NCT00485134|580925621|FG004|Overall Study|Change in health status|0|||
161219393|NCT03760510|582185565|FG000|Overall Study|Not ventilated for 24 hours|105|||
161219394|NCT03760510|582185566|FG001|Overall Study|Not ventilated for 24 hours|97|||
161219395|NCT03361956|582185567|FG000|Overall Study|Adverse Event|1|||
161219396|NCT03361956|582185568|FG001|Overall Study|Adverse Event|0|||
161219397|NCT03361956|582185569|FG002|Overall Study|Adverse Event|1|||
161219398|NCT03361956|582185570|FG003|Overall Study|Adverse Event|1|||
161219399|NCT03361956|582185571|FG004|Overall Study|Adverse Event|0|||
161219400|NCT03361956|582185567|FG000|Overall Study|Other|0|||
161219401|NCT03361956|582185568|FG001|Overall Study|Other|0|||
161219402|NCT03361956|582185569|FG002|Overall Study|Other|0|||
161219403|NCT03361956|582185570|FG003|Overall Study|Other|1|||
161219404|NCT03361956|582185571|FG004|Overall Study|Other|0|||
161219405|NCT03361956|582185567|FG000|Overall Study|Withdrawal by Subject|2|||
161219406|NCT03361956|582185568|FG001|Overall Study|Withdrawal by Subject|2|||
161219407|NCT03361956|582185569|FG002|Overall Study|Withdrawal by Subject|2|||
161219408|NCT03361956|582185570|FG003|Overall Study|Withdrawal by Subject|0|||
160872416|NCT00485134|580925622|FG005|Overall Study|Change in health status|1|||
160872417|NCT00485134|580925623|FG006|Overall Study|Change in health status|0|||
160872418|NCT00485134|580925624|FG007|Overall Study|Change in health status|0|||
160872419|NCT00485134|580925617|FG000|Overall Study|Withdrew for adverse event|0|||
161219409|NCT03361956|582185571|FG004|Overall Study|Withdrawal by Subject|3|||
161219410|NCT03361956|582185567|FG000|Overall Study|Disease Relapse|0|||
161219411|NCT03361956|582185568|FG001|Overall Study|Disease Relapse|0|||
161219412|NCT03361956|582185569|FG002|Overall Study|Disease Relapse|1|||
161219413|NCT03361956|582185570|FG003|Overall Study|Disease Relapse|0|||
161219414|NCT03361956|582185571|FG004|Overall Study|Disease Relapse|0|||
161219415|NCT03361956|582185567|FG000|Overall Study|Physician Decision|0|||
160872420|NCT00485134|580925618|FG001|Overall Study|Withdrew for adverse event|0|||
160872421|NCT00485134|580925619|FG002|Overall Study|Withdrew for adverse event|1|||
161219416|NCT03361956|582185568|FG001|Overall Study|Physician Decision|2|||
160872422|NCT00485134|580925620|FG003|Overall Study|Withdrew for adverse event|0|||
160872423|NCT00485134|580925621|FG004|Overall Study|Withdrew for adverse event|0|||
160872424|NCT00485134|580925622|FG005|Overall Study|Withdrew for adverse event|0|||
160872425|NCT00485134|580925623|FG006|Overall Study|Withdrew for adverse event|0|||
160872426|NCT00485134|580925624|FG007|Overall Study|Withdrew for adverse event|0|||
160872427|NCT00485134|580925617|FG000|Overall Study|Positive drug test|0|||
160872428|NCT00485134|580925618|FG001|Overall Study|Positive drug test|0|||
160872429|NCT00485134|580925619|FG002|Overall Study|Positive drug test|0|||
160872430|NCT00485134|580925620|FG003|Overall Study|Positive drug test|0|||
160872431|NCT00485134|580925621|FG004|Overall Study|Positive drug test|2|||
160872432|NCT00485134|580925622|FG005|Overall Study|Positive drug test|1|||
160872433|NCT00485134|580925623|FG006|Overall Study|Positive drug test|0|||
160872434|NCT00485134|580925624|FG007|Overall Study|Positive drug test|0|||
160872435|NCT00485134|580925617|FG000|Overall Study|Non-compliance|0|||
160872436|NCT00485134|580925618|FG001|Overall Study|Non-compliance|0|||
160872437|NCT00485134|580925619|FG002|Overall Study|Non-compliance|0|||
160872438|NCT00485134|580925620|FG003|Overall Study|Non-compliance|0|||
160872439|NCT00485134|580925621|FG004|Overall Study|Non-compliance|1|||
160872440|NCT00485134|580925622|FG005|Overall Study|Non-compliance|2|||
160872441|NCT00485134|580925623|FG006|Overall Study|Non-compliance|2|||
160872442|NCT00485134|580925624|FG007|Overall Study|Non-compliance|0|||
160872443|NCT00485134|580925617|FG000|Overall Study|Unable to comply with study schedule|0|||
160872444|NCT00485134|580925618|FG001|Overall Study|Unable to comply with study schedule|0|||
160872445|NCT00485134|580925619|FG002|Overall Study|Unable to comply with study schedule|0|||
160872446|NCT00485134|580925620|FG003|Overall Study|Unable to comply with study schedule|0|||
160872447|NCT00485134|580925621|FG004|Overall Study|Unable to comply with study schedule|0|||
160872448|NCT00485134|580925622|FG005|Overall Study|Unable to comply with study schedule|0|||
160872449|NCT00485134|580925623|FG006|Overall Study|Unable to comply with study schedule|0|||
160872450|NCT00485134|580925624|FG007|Overall Study|Unable to comply with study schedule|1|||
160872451|NCT00485134|580925617|FG000|Overall Study|Pregnancy|0|||
160872452|NCT00485134|580925618|FG001|Overall Study|Pregnancy|0|||
160872453|NCT00485134|580925619|FG002|Overall Study|Pregnancy|0|||
160872454|NCT00485134|580925620|FG003|Overall Study|Pregnancy|0|||
160872455|NCT00485134|580925621|FG004|Overall Study|Pregnancy|0|||
160872456|NCT00485134|580925622|FG005|Overall Study|Pregnancy|0|||
160872457|NCT00485134|580925623|FG006|Overall Study|Pregnancy|1|||
160872458|NCT00485134|580925624|FG007|Overall Study|Pregnancy|0|||
160872459|NCT00970684|580925625|FG000|Overall Study|Lack of Efficacy|5|||
160872460|NCT00970684|580925625|FG000|Overall Study|Adverse Event|4|||
160872461|NCT00970684|580925625|FG000|Overall Study|Withdrawal by Subject|1|||
160872462|NCT00481091|580925626|FG000|Overall Study|Withdrawal by Subject|0|||
160872463|NCT00481091|580925627|FG001|Overall Study|Withdrawal by Subject|1|||
160872464|NCT00481091|580925628|FG002|Overall Study|Withdrawal by Subject|1|||
160872465|NCT00481091|580925629|FG003|Overall Study|Withdrawal by Subject|0|||
160872466|NCT00481091|580925630|FG004|Overall Study|Withdrawal by Subject|0|||
160872467|NCT00481091|580925631|FG005|Overall Study|Withdrawal by Subject|0|||
160872468|NCT00481091|580925632|FG006|Overall Study|Withdrawal by Subject|0|||
160872469|NCT00481091|580925633|FG007|Overall Study|Withdrawal by Subject|0|||
160872470|NCT00481091|580925634|FG008|Overall Study|Withdrawal by Subject|1|||
160872471|NCT00481091|580925635|FG009|Overall Study|Withdrawal by Subject|6|||
160872472|NCT00481091|580925626|FG000|Overall Study|Other, Not Specified|0|||
160872473|NCT00481091|580925627|FG001|Overall Study|Other, Not Specified|1|||
161114957|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
161114958|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
161114959|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
161114960|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161114961|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161114962|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
161219417|NCT03361956|582185569|FG002|Overall Study|Physician Decision|0|||
161219418|NCT03361956|582185570|FG003|Overall Study|Physician Decision|1|||
161219419|NCT03361956|582185571|FG004|Overall Study|Physician Decision|0|||
161219420|NCT03361956|582185567|FG000|Overall Study|Lost to Follow-up|0|||
160872474|NCT00481091|580925628|FG002|Overall Study|Other, Not Specified|1|||
160872475|NCT00481091|580925629|FG003|Overall Study|Other, Not Specified|0|||
160872476|NCT00481091|580925630|FG004|Overall Study|Other, Not Specified|0|||
160872477|NCT00481091|580925631|FG005|Overall Study|Other, Not Specified|1|||
160872478|NCT00481091|580925632|FG006|Overall Study|Other, Not Specified|0|||
160872479|NCT00481091|580925633|FG007|Overall Study|Other, Not Specified|0|||
160872480|NCT00481091|580925634|FG008|Overall Study|Other, Not Specified|0|||
160872481|NCT00481091|580925635|FG009|Overall Study|Other, Not Specified|4|||
161219421|NCT03361956|582185568|FG001|Overall Study|Lost to Follow-up|0|||
160872482|NCT00481091|580925626|FG000|Overall Study|Adverse Event|1|||
160872483|NCT00481091|580925627|FG001|Overall Study|Adverse Event|2|||
160872484|NCT00481091|580925628|FG002|Overall Study|Adverse Event|0|||
161114963|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
160872485|NCT00481091|580925629|FG003|Overall Study|Adverse Event|1|||
160872486|NCT00481091|580925630|FG004|Overall Study|Adverse Event|1|||
160872487|NCT00481091|580925631|FG005|Overall Study|Adverse Event|1|||
160872488|NCT00481091|580925632|FG006|Overall Study|Adverse Event|2|||
160872489|NCT00481091|580925633|FG007|Overall Study|Adverse Event|1|||
160872490|NCT00481091|580925634|FG008|Overall Study|Adverse Event|1|||
160872491|NCT00481091|580925635|FG009|Overall Study|Adverse Event|6|||
160872492|NCT00481091|580925626|FG000|Overall Study|Progressive disease clinical|0|||
160872493|NCT00481091|580925627|FG001|Overall Study|Progressive disease clinical|0|||
160872494|NCT00481091|580925628|FG002|Overall Study|Progressive disease clinical|0|||
160872495|NCT00481091|580925629|FG003|Overall Study|Progressive disease clinical|0|||
160872496|NCT00481091|580925630|FG004|Overall Study|Progressive disease clinical|0|||
160872497|NCT00481091|580925631|FG005|Overall Study|Progressive disease clinical|0|||
160872498|NCT00481091|580925632|FG006|Overall Study|Progressive disease clinical|0|||
160872499|NCT00481091|580925633|FG007|Overall Study|Progressive disease clinical|0|||
160872500|NCT00481091|580925634|FG008|Overall Study|Progressive disease clinical|1|||
160872501|NCT00481091|580925635|FG009|Overall Study|Progressive disease clinical|7|||
160872502|NCT00481091|580925626|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
160872503|NCT00481091|580925627|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
160872504|NCT00481091|580925628|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872505|NCT00481091|580925629|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872506|NCT00481091|580925630|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872507|NCT00481091|580925631|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
160872508|NCT00481091|580925632|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872509|NCT00481091|580925633|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872510|NCT00481091|580925634|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872511|NCT00481091|580925635|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
160872512|NCT00481091|580925626|FG000|Overall Study|Progressive disease other|1|||
160872513|NCT00481091|580925627|FG001|Overall Study|Progressive disease other|1|||
160872514|NCT00481091|580925628|FG002|Overall Study|Progressive disease other|0|||
160872515|NCT00481091|580925629|FG003|Overall Study|Progressive disease other|1|||
160872516|NCT00481091|580925630|FG004|Overall Study|Progressive disease other|1|||
160872517|NCT00481091|580925631|FG005|Overall Study|Progressive disease other|1|||
160872518|NCT00481091|580925632|FG006|Overall Study|Progressive disease other|0|||
160872519|NCT00481091|580925633|FG007|Overall Study|Progressive disease other|2|||
160872520|NCT00481091|580925634|FG008|Overall Study|Progressive disease other|0|||
160872521|NCT00481091|580925635|FG009|Overall Study|Progressive disease other|0|||
160872522|NCT00481091|580925626|FG000|Overall Study|No reason given|0|||
160872523|NCT00481091|580925627|FG001|Overall Study|No reason given|0|||
160872524|NCT00481091|580925628|FG002|Overall Study|No reason given|1|||
160872525|NCT00481091|580925629|FG003|Overall Study|No reason given|1|||
160872526|NCT00481091|580925630|FG004|Overall Study|No reason given|1|||
160872527|NCT00481091|580925631|FG005|Overall Study|No reason given|0|||
160872528|NCT00481091|580925632|FG006|Overall Study|No reason given|1|||
160872529|NCT00481091|580925633|FG007|Overall Study|No reason given|1|||
160872530|NCT00481091|580925634|FG008|Overall Study|No reason given|1|||
160872531|NCT00481091|580925635|FG009|Overall Study|No reason given|4|||
160872532|NCT04294680|580925636|FG000|Overall Study|Withdrawal by Subject|2|||
160872533|NCT04294680|580925637|FG001|Overall Study|Withdrawal by Subject|1|||
160872534|NCT04294680|580925636|FG000|Overall Study|Follow-up visits completed outside of window|1|||
160872535|NCT04294680|580925637|FG001|Overall Study|Follow-up visits completed outside of window|0|||
160872536|NCT02078960|580925640|FG000|Treatment Period|Other|0|||
160872537|NCT02078960|580925641|FG001|Treatment Period|Other|0|||
160872538|NCT02078960|580925642|FG002|Treatment Period|Other|1|||
160872539|NCT02078960|580925640|FG000|Treatment Period|Lack of Efficacy|0|||
160872540|NCT02078960|580925641|FG001|Treatment Period|Lack of Efficacy|1|||
160872541|NCT02078960|580925642|FG002|Treatment Period|Lack of Efficacy|0|||
160872542|NCT02078960|580925640|FG000|Treatment Period|Disease progression - accelerated phase|0|||
160872543|NCT02078960|580925641|FG001|Treatment Period|Disease progression - accelerated phase|1|||
160872544|NCT02078960|580925642|FG002|Treatment Period|Disease progression - accelerated phase|0|||
160872545|NCT02078960|580925640|FG000|Treatment Period|Disease progression - blast phase|1|||
160872546|NCT02078960|580925641|FG001|Treatment Period|Disease progression - blast phase|0|||
160872547|NCT02078960|580925642|FG002|Treatment Period|Disease progression - blast phase|0|||
160872548|NCT02078960|580925640|FG000|Treatment Period|Withdrawal by Subject|0|||
161219422|NCT03361956|582185569|FG002|Overall Study|Lost to Follow-up|1|||
160872549|NCT02078960|580925641|FG001|Treatment Period|Withdrawal by Subject|1|||
160872550|NCT02078960|580925642|FG002|Treatment Period|Withdrawal by Subject|1|||
160872551|NCT02078960|580925640|FG000|Treatment Period|Adverse Event|1|||
160872552|NCT02078960|580925641|FG001|Treatment Period|Adverse Event|0|||
160872553|NCT02078960|580925642|FG002|Treatment Period|Adverse Event|0|||
160872554|NCT02078960|580925640|FG000|Treatment Period|Death|0|||
160872555|NCT02078960|580925641|FG001|Treatment Period|Death|0|||
160872556|NCT02078960|580925642|FG002|Treatment Period|Death|1|||
161114964|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
161114965|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
161114966|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
161114967|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
161114968|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
161114969|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
161114970|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
161114971|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
161114972|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
161114973|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
161114974|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
161114975|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
161114976|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
161114977|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
161114978|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
161114979|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
161114980|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161114981|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161114982|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
161114983|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
161114984|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
161114985|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Other|0|||
161114986|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Other|0|||
161114987|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Other|0|||
161114988|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Other|1|||
161114989|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Other|0|||
161114990|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
161114991|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
161114992|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
161114993|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
161114994|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
161114995|NCT00440947|581809602|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161114996|NCT00440947|581809603|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161114997|NCT00440947|581809604|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161114998|NCT00440947|581809605|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
161114999|NCT00440947|581809606|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
161115000|NCT01834274|581809607|FG000|Overall Study|Study Termination|41|||
161115001|NCT01834274|581809608|FG001|Overall Study|Study Termination|38|||
161115002|NCT01834274|581809607|FG000|Overall Study|Withdrawal by Subject|1|||
161115003|NCT01834274|581809608|FG001|Overall Study|Withdrawal by Subject|1|||
161115004|NCT01834274|581809607|FG000|Overall Study|Lost to Follow-up|3|||
161115005|NCT01834274|581809608|FG001|Overall Study|Lost to Follow-up|1|||
161115006|NCT01834274|581809607|FG000|Overall Study|Other|2|||
161115007|NCT01834274|581809608|FG001|Overall Study|Other|1|||
161115008|NCT02941627|581809619|FG000|Overall Study|Death|1|||
161115009|NCT02941627|581809619|FG000|Overall Study|Surgical failure|1|||
161115010|NCT02941627|581809619|FG000|Overall Study|cholesteatoma prevented implantation|1|||
161115011|NCT00513500|581809620|FG000|Overall Study|Lost to Follow-up|35|||
161115012|NCT00513500|581809621|FG001|Overall Study|Lost to Follow-up|39|||
161115013|NCT00513500|581809620|FG000|Overall Study|Death|2|||
161115014|NCT00513500|581809621|FG001|Overall Study|Death|1|||
161115015|NCT00513500|581809620|FG000|Overall Study|Hospitalized|4|||
161115016|NCT00513500|581809621|FG001|Overall Study|Hospitalized|14|||
161115017|NCT00517829|581809622|FG000|Overall Study|Adverse Event|22|||
161115018|NCT00517829|581809623|FG001|Overall Study|Adverse Event|34|||
161115019|NCT00517829|581809622|FG000|Overall Study|Disease Progression|39|||
161115020|NCT00517829|581809623|FG001|Overall Study|Disease Progression|32|||
161115021|NCT00517829|581809622|FG000|Overall Study|Patient Request|6|||
161115022|NCT00517829|581809623|FG001|Overall Study|Patient Request|5|||
161115023|NCT00517829|581809622|FG000|Overall Study|Investigator Request|5|||
161115024|NCT00517829|581809623|FG001|Overall Study|Investigator Request|3|||
161115025|NCT00517829|581809622|FG000|Overall Study|Other|3|||
161115026|NCT00517829|581809623|FG001|Overall Study|Other|1|||
161115027|NCT00446511|581809624|FG000|Overall Study|Adverse Event|7|||
161115028|NCT00446511|581809625|FG001|Overall Study|Adverse Event|2|||
161219423|NCT03361956|582185570|FG003|Overall Study|Lost to Follow-up|1|||
161219424|NCT03361956|582185571|FG004|Overall Study|Lost to Follow-up|2|||
161219425|NCT00871728|582185573|FG000|Overall Study|Adverse Event|1|||
161219426|NCT00871728|582185573|FG000|Overall Study|Protocol Violation|7|||
161115029|NCT00446511|581809626|FG002|Overall Study|Adverse Event|3|||
161115030|NCT00446511|581809627|FG003|Overall Study|Adverse Event|1|||
161115031|NCT00446511|581809624|FG000|Overall Study|Protocol Violation|0|||
161115032|NCT00446511|581809625|FG001|Overall Study|Protocol Violation|0|||
161219427|NCT00871728|582185573|FG000|Overall Study|Lost to Follow-up|2|||
160872557|NCT02078960|580925640|FG000|Follow-up Period|Death|2|||
160872558|NCT02078960|580925641|FG001|Follow-up Period|Death|0|||
160872559|NCT02078960|580925642|FG002|Follow-up Period|Death|0|||
160872560|NCT02078960|580925640|FG000|Follow-up Period|Lost to Follow-up|0|||
160872561|NCT02078960|580925641|FG001|Follow-up Period|Lost to Follow-up|1|||
160872562|NCT02078960|580925642|FG002|Follow-up Period|Lost to Follow-up|0|||
160872563|NCT04605991|580925644|FG000|Overall Study|Adverse Event|5|||
160872564|NCT04605991|580925644|FG000|Overall Study|Lack of Efficacy|1|||
160872565|NCT04605991|580925644|FG000|Overall Study|Lost to Follow-up|8|||
160872566|NCT04605991|580925644|FG000|Overall Study|Physician Decision|4|||
160872567|NCT04605991|580925644|FG000|Overall Study|Withdrawal by Subject|14|||
160872568|NCT04605991|580925644|FG000|Overall Study|Non-compliance with study|1|||
160872569|NCT00859638|580925645|FG000|Overall Study|Lost to Follow-up|6|||
160872570|NCT00859638|580925646|FG001|Overall Study|Lost to Follow-up|1|||
160872571|NCT00859638|580925645|FG000|Overall Study|Withdrawal by Subject|3|||
160872572|NCT00859638|580925646|FG001|Overall Study|Withdrawal by Subject|2|||
160872573|NCT00859638|580925645|FG000|Overall Study|Ill health|1|||
160872574|NCT00859638|580925646|FG001|Overall Study|Ill health|1|||
160872575|NCT00771953|580925647|FG000|Overall Study|Adverse Event|5|||
160872576|NCT00771953|580925648|FG001|Overall Study|Adverse Event|3|||
160872577|NCT00771953|580925647|FG000|Overall Study|Death|2|||
160872578|NCT00771953|580925648|FG001|Overall Study|Death|2|||
160872579|NCT00771953|580925647|FG000|Overall Study|Progression before active Tx|1|||
160872580|NCT00771953|580925648|FG001|Overall Study|Progression before active Tx|2|||
160872581|NCT00771953|580925647|FG000|Overall Study|Sponsor decision|1|||
160872582|NCT00771953|580925648|FG001|Overall Study|Sponsor decision|0|||
160872583|NCT00771953|580925647|FG000|Overall Study|Other complicating disease|1|||
160872584|NCT00771953|580925648|FG001|Overall Study|Other complicating disease|0|||
160872585|NCT00771953|580925647|FG000|Overall Study|Withdrawal by Subject|0|||
160872586|NCT00771953|580925648|FG001|Overall Study|Withdrawal by Subject|3|||
160872587|NCT00947193|580925649|FG000|Overall Study|Lost to Follow-up|1|||
160872588|NCT00947193|580925650|FG001|Overall Study|Lost to Follow-up|0|||
160872589|NCT00947193|580925649|FG000|Overall Study|Withdrawal by Subject|1|||
160872590|NCT00947193|580925650|FG001|Overall Study|Withdrawal by Subject|0|||
160872591|NCT00947193|580925649|FG000|Overall Study|Factor VIII >1%|1|||
160872592|NCT00947193|580925650|FG001|Overall Study|Factor VIII >1%|0|||
160872593|NCT04364984|580925651|FG000|Overall Study|Death|2|||
160872594|NCT04364984|580925652|FG001|Overall Study|Death|2|||
160872595|NCT04364984|580925653|FG002|Overall Study|Death|0|||
160872596|NCT01349959|580925654|FG000|Overall Study|Adverse Event|7|||
160872597|NCT02722304|580925655|FG000|Overall Study|Study Terminated by Sponsor|1|||
160872598|NCT02722304|580925656|FG001|Overall Study|Study Terminated by Sponsor|0|||
160872599|NCT02722304|580925657|FG002|Overall Study|Study Terminated by Sponsor|2|||
160872600|NCT02722304|580925658|FG003|Overall Study|Study Terminated by Sponsor|1|||
160872601|NCT02722304|580925659|FG004|Overall Study|Study Terminated by Sponsor|1|||
160872602|NCT02722304|580925655|FG000|Overall Study|Other|0|||
160872603|NCT02722304|580925656|FG001|Overall Study|Other|0|||
160872604|NCT02722304|580925657|FG002|Overall Study|Other|0|||
160872605|NCT02722304|580925658|FG003|Overall Study|Other|1|||
160872606|NCT02722304|580925659|FG004|Overall Study|Other|1|||
160872607|NCT01727024|580925662|FG000|Period 1|Lost to Follow-up|1|||
160872608|NCT01727024|580925663|FG001|Period 1|Lost to Follow-up|1|||
160872609|NCT01727024|580925662|FG000|Period 1|Withdrawal by Subject|2|||
160872610|NCT01727024|580925663|FG001|Period 1|Withdrawal by Subject|3|||
160872611|NCT02920242|580925664|FG000|Overall Study|Withdrawal by Subject|1|||
160872612|NCT02920242|580925665|FG001|Overall Study|Withdrawal by Subject|0|||
160872613|NCT02920242|580925666|FG002|Overall Study|Withdrawal by Subject|1|||
160872614|NCT02920242|580925664|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
160872615|NCT02920242|580925665|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
160872616|NCT02920242|580925666|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
160872617|NCT04995419|580925672|FG000|Overall Study|Withdrawal by Subject|3|||
160872618|NCT04995419|580925672|FG000|Overall Study|Progressive Disease|19|||
160872619|NCT04995419|580925672|FG000|Overall Study|Adverse Event|2|||
160872620|NCT04995419|580925672|FG000|Overall Study|Ongoing|16|||
160872621|NCT02948088|580925673|FG000|Overall Study|Lost to Follow-up|8|||
160872622|NCT02948088|580925673|FG000|Overall Study|Death|1|||
160872623|NCT02948088|580925673|FG000|Overall Study|Withdrawal by Subject|4|||
160872624|NCT02948088|580925673|FG000|Overall Study|Other|2|||
160872625|NCT00634101|580925674|FG000|Overall Study|Study Terminated|3|||
160872626|NCT00634101|580925675|FG001|Overall Study|Study Terminated|3|||
160872627|NCT00634101|580925674|FG000|Overall Study|Lost to Follow-up|2|||
160872628|NCT00634101|580925675|FG001|Overall Study|Lost to Follow-up|0|||
160872629|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
161115033|NCT00446511|581809626|FG002|Overall Study|Protocol Violation|0|||
161115034|NCT00446511|581809627|FG003|Overall Study|Protocol Violation|1|||
161115035|NCT00446511|581809624|FG000|Overall Study|Withdrawal by Subject|0|||
160872630|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
160872631|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
160872632|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
161219428|NCT00871728|582185573|FG000|Overall Study|Failed to Visit Hospital|4|||
161219429|NCT00871728|582185573|FG000|Overall Study|Participant Non-compliance|1|||
161219430|NCT00871728|582185573|FG000|Overall Study|Withdrawal of Informed Consent|5|||
161219431|NCT04147715|582185574|FG000|Overall Study|Adverse Event|0|||
161219432|NCT04147715|582185575|FG001|Overall Study|Adverse Event|0|||
161219433|NCT04147715|582185576|FG002|Overall Study|Adverse Event|0|||
161219434|NCT04147715|582185577|FG003|Overall Study|Adverse Event|0|||
161219435|NCT04147715|582185578|FG004|Overall Study|Adverse Event|0|||
161219436|NCT04147715|582185579|FG005|Overall Study|Adverse Event|0|||
161219437|NCT04147715|582185580|FG006|Overall Study|Adverse Event|0|||
161219438|NCT04147715|582185581|FG007|Overall Study|Adverse Event|2|||
161219439|NCT04147715|582185582|FG008|Overall Study|Adverse Event|1|||
161115036|NCT00446511|581809625|FG001|Overall Study|Withdrawal by Subject|0|||
161115037|NCT00446511|581809626|FG002|Overall Study|Withdrawal by Subject|0|||
161115038|NCT00446511|581809627|FG003|Overall Study|Withdrawal by Subject|3|||
161115039|NCT00446511|581809624|FG000|Overall Study|Administrative Problems|3|||
161115040|NCT00446511|581809625|FG001|Overall Study|Administrative Problems|0|||
161115041|NCT00446511|581809626|FG002|Overall Study|Administrative Problems|4|||
161115042|NCT00446511|581809627|FG003|Overall Study|Administrative Problems|1|||
161115043|NCT01265550|581809628|FG000|Pre Randomization|Withdrawal by Subject|0|||
161115044|NCT01265550|581809629|FG001|Pre Randomization|Withdrawal by Subject|0|||
161115045|NCT01265550|581809630|FG002|Pre Randomization|Withdrawal by Subject|0|||
161115046|NCT01265550|581809631|FG003|Pre Randomization|Withdrawal by Subject|70|||
161115047|NCT01265550|581809628|FG000|Pre Randomization|Technical Exclusions|0|||
161115048|NCT01265550|581809629|FG001|Pre Randomization|Technical Exclusions|0|||
161115049|NCT01265550|581809630|FG002|Pre Randomization|Technical Exclusions|0|||
161115050|NCT01265550|581809631|FG003|Pre Randomization|Technical Exclusions|54|||
161115051|NCT01265550|581809628|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
161115052|NCT01265550|581809629|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
161115053|NCT01265550|581809630|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
161115054|NCT01265550|581809631|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
161115055|NCT01265550|581809628|FG000|Pre Randomization|Non-GERD organic disorders|0|||
161115056|NCT01265550|581809629|FG001|Pre Randomization|Non-GERD organic disorders|0|||
161115057|NCT01265550|581809630|FG002|Pre Randomization|Non-GERD organic disorders|0|||
161115058|NCT01265550|581809631|FG003|Pre Randomization|Non-GERD organic disorders|23|||
161115059|NCT01265550|581809628|FG000|Pre Randomization|Functional heartburn|0|||
161115060|NCT01265550|581809629|FG001|Pre Randomization|Functional heartburn|0|||
161115061|NCT01265550|581809630|FG002|Pre Randomization|Functional heartburn|0|||
161115062|NCT01265550|581809631|FG003|Pre Randomization|Functional heartburn|99|||
161115063|NCT01073267|581809635|FG000|Overall Study|Disease Progression|3|||
161115064|NCT03873714|581809638|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
161115065|NCT00677014|581809639|FG000|Overall Study|Lost to Follow-up|20|||
161115066|NCT00677014|581809640|FG001|Overall Study|Lost to Follow-up|12|||
161115067|NCT00677014|581809641|FG002|Overall Study|Lost to Follow-up|24|||
161115068|NCT00677014|581809639|FG000|Overall Study|Death|6|||
161115069|NCT00677014|581809640|FG001|Overall Study|Death|15|||
161115070|NCT00677014|581809641|FG002|Overall Study|Death|7|||
161115071|NCT00677014|581809639|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
161115072|NCT00677014|581809640|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
161115073|NCT00677014|581809641|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
161115074|NCT01326546|581809644|FG000|Overall Study|Lost to Follow-up|8|||
161115075|NCT01326546|581809645|FG001|Overall Study|Lost to Follow-up|7|||
161115076|NCT01326546|581809644|FG000|Overall Study|Protocol Violation|3|||
161115077|NCT01326546|581809645|FG001|Overall Study|Protocol Violation|4|||
161115078|NCT01326546|581809644|FG000|Overall Study|Pregnancy|0|||
161115079|NCT01326546|581809645|FG001|Overall Study|Pregnancy|1|||
161115080|NCT01326546|581809644|FG000|Overall Study|Adverse Event|1|||
161115081|NCT01326546|581809645|FG001|Overall Study|Adverse Event|0|||
161115082|NCT01326546|581809644|FG000|Overall Study|Withdrawal by Subject|5|||
161115083|NCT01326546|581809645|FG001|Overall Study|Withdrawal by Subject|1|||
161115084|NCT00923130|581809648|FG000|Overall Study|Stopped treatment due to progression|17|||
161219440|NCT04147715|582185583|FG009|Overall Study|Adverse Event|0|||
161115085|NCT00923130|581809648|FG000|Overall Study|Death|1|||
161219441|NCT04147715|582185584|FG010|Overall Study|Adverse Event|0|||
161219442|NCT04147715|582185585|FG011|Overall Study|Adverse Event|0|||
161115086|NCT00923130|581809648|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
161115087|NCT00923130|581809648|FG000|Overall Study|Switched to alternative treatment|2|||
161115088|NCT00923130|581809648|FG000|Overall Study|Refused further treatment|2|||
161219443|NCT02418910|582185587|FG000|Overall Study|Lost to Follow-up|3|||
161219444|NCT02418910|582185587|FG000|Overall Study|Withdrawal by Subject|4|||
161219445|NCT02472977|582185593|FG000|Overall Study|Disease progression|4|||
161219446|NCT02472977|582185594|FG001|Overall Study|Disease progression|25|||
161219447|NCT02472977|582185595|FG002|Overall Study|Disease progression|6|||
161219448|NCT02472977|582185593|FG000|Overall Study|Withdrawal by Subject|0|||
161219449|NCT02472977|582185594|FG001|Overall Study|Withdrawal by Subject|1|||
161219450|NCT02472977|582185595|FG002|Overall Study|Withdrawal by Subject|0|||
161219451|NCT02472977|582185593|FG000|Overall Study|Study drug toxicity|2|||
161219452|NCT02472977|582185594|FG001|Overall Study|Study drug toxicity|0|||
161219453|NCT02472977|582185595|FG002|Overall Study|Study drug toxicity|2|||
161219454|NCT02472977|582185593|FG000|Overall Study|Subject request to discontinue treatment|0|||
161115089|NCT03693625|581809649|FG000|Overall Study|Adverse Event|2|||
161115090|NCT03693625|581809650|FG001|Overall Study|Adverse Event|0|||
161219455|NCT02472977|582185594|FG001|Overall Study|Subject request to discontinue treatment|1|||
161219456|NCT02472977|582185595|FG002|Overall Study|Subject request to discontinue treatment|0|||
161219457|NCT02330081|582185601|FG000|Overall Study|Adverse Event|1|||
161219458|NCT02330081|582185601|FG000|Overall Study|Donation did not meet criteria|1|||
161219459|NCT02330081|582185601|FG000|Overall Study|Protocol Violation|6|||
161219460|NCT02277769|582185602|FG000|Overall Study|Protocol Violation|3|||
161219461|NCT02277769|582185603|FG001|Overall Study|Protocol Violation|3|||
161219462|NCT02277769|582185604|FG002|Overall Study|Protocol Violation|5|||
161219463|NCT02277769|582185602|FG000|Overall Study|Lack of Efficacy|17|||
161219464|NCT02277769|582185603|FG001|Overall Study|Lack of Efficacy|0|||
161219465|NCT02277769|582185604|FG002|Overall Study|Lack of Efficacy|4|||
161219466|NCT02277769|582185602|FG000|Overall Study|Adverse Event|14|||
161219467|NCT02277769|582185603|FG001|Overall Study|Adverse Event|2|||
161219468|NCT02277769|582185604|FG002|Overall Study|Adverse Event|4|||
161219469|NCT02277769|582185602|FG000|Overall Study|Other than specified above|12|||
161219470|NCT02277769|582185603|FG001|Overall Study|Other than specified above|8|||
161219471|NCT02277769|582185604|FG002|Overall Study|Other than specified above|5|||
161219472|NCT03775681|582185608|FG000|Overall Study|Physician Decision|3|||
161219473|NCT00616928|582185609|FG000|Overall Study|Adverse Event|6|||
161219474|NCT00616928|582185610|FG001|Overall Study|Adverse Event|3|||
161219475|NCT00616928|582185611|FG002|Overall Study|Adverse Event|2|||
161219476|NCT00616928|582185612|FG003|Overall Study|Adverse Event|2|||
161219477|NCT00616928|582185609|FG000|Overall Study|Other|51|||
161219478|NCT00616928|582185610|FG001|Overall Study|Other|8|||
161219479|NCT00616928|582185611|FG002|Overall Study|Other|15|||
161115091|NCT03693625|581809649|FG000|Overall Study|Study Terminated By Sponsor|20|||
161115092|NCT03693625|581809650|FG001|Overall Study|Study Terminated By Sponsor|7|||
161115093|NCT03693625|581809649|FG000|Overall Study|Withdrawal by Subject|1|||
161115094|NCT03693625|581809650|FG001|Overall Study|Withdrawal by Subject|1|||
161115095|NCT04294901|581809651|FG000|Overall Study|Death|86|||
161115096|NCT04294901|581809652|FG001|Overall Study|Death|110|||
161115097|NCT04294901|581809651|FG000|Overall Study|Provider did not have historical control patients|581|||
161115098|NCT04294901|581809652|FG001|Overall Study|Provider did not have historical control patients|0|||
161115099|NCT04294901|581809651|FG000|Overall Study|Provider did not have intervention patients|0|||
161115100|NCT04294901|581809652|FG001|Overall Study|Provider did not have intervention patients|98|||
161115101|NCT01934556|581809655|FG000|Overall Study|Withdrawal by Subject|0|||
161115102|NCT01934556|581809656|FG001|Overall Study|Withdrawal by Subject|1|||
161219480|NCT00616928|582185612|FG003|Overall Study|Other|5|||
161219481|NCT00616928|582185609|FG000|Overall Study|Lost to Follow-up|5|||
161219482|NCT00616928|582185610|FG001|Overall Study|Lost to Follow-up|7|||
161219483|NCT00616928|582185611|FG002|Overall Study|Lost to Follow-up|0|||
161219484|NCT00616928|582185612|FG003|Overall Study|Lost to Follow-up|0|||
161219485|NCT00895583|582185613|FG000|Overall Study|Adverse Event|28|||
161219486|NCT00895583|582185614|FG001|Overall Study|Adverse Event|4|||
161219487|NCT00895583|582185613|FG000|Overall Study|Death|2|||
161219488|NCT00895583|582185614|FG001|Overall Study|Death|1|||
160872633|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
160872634|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
160872635|NCT00139477|580925676|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
160872636|NCT00139477|580925677|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
160872637|NCT00139477|580925676|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
160872638|NCT00139477|580925677|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
160981509|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161115103|NCT01934556|581809657|FG002|Overall Study|Withdrawal by Subject|1|||
161115104|NCT01934556|581809655|FG000|Overall Study|Lost to Follow-up|4|||
161115105|NCT01934556|581809656|FG001|Overall Study|Lost to Follow-up|10|||
161115106|NCT01934556|581809657|FG002|Overall Study|Lost to Follow-up|7|||
161115107|NCT01934556|581809655|FG000|Overall Study|Death|1|||
161115108|NCT01934556|581809656|FG001|Overall Study|Death|5|||
161115109|NCT01934556|581809657|FG002|Overall Study|Death|2|||
161115110|NCT05038020|581809659|FG000|Overall Study|Early Termination|3|||
161115111|NCT05038020|581809660|FG001|Overall Study|Early Termination|0|||
161115112|NCT03416153|581809662|FG000|Overall Study|Physician Decision|1|||
161115113|NCT03416153|581809663|FG001|Overall Study|Physician Decision|1|||
161115114|NCT03416153|581809662|FG000|Overall Study|Withdrawal by Subject|1|||
161115115|NCT03416153|581809663|FG001|Overall Study|Withdrawal by Subject|0|||
161115116|NCT03657043|581811385|FG000|Overall Study|Withdrawal by Subject|1|||
161115117|NCT03657043|581811386|FG001|Overall Study|Withdrawal by Subject|1|||
161115118|NCT03657043|581811387|FG002|Overall Study|Withdrawal by Subject|0|||
161115119|NCT03657043|581811388|FG003|Overall Study|Withdrawal by Subject|0|||
161115120|NCT03657043|581811389|FG004|Overall Study|Withdrawal by Subject|4|||
161115121|NCT03657043|581811385|FG000|Overall Study|Study closure by Sponsor|0|||
161115122|NCT03657043|581811386|FG001|Overall Study|Study closure by Sponsor|2|||
161115123|NCT03657043|581811387|FG002|Overall Study|Study closure by Sponsor|0|||
161115124|NCT03657043|581811388|FG003|Overall Study|Study closure by Sponsor|0|||
161115125|NCT03657043|581811389|FG004|Overall Study|Study closure by Sponsor|17|||
161115126|NCT03657043|581811385|FG000|Overall Study|Lost to Follow-up|0|||
161115127|NCT03657043|581811386|FG001|Overall Study|Lost to Follow-up|0|||
161115128|NCT03657043|581811387|FG002|Overall Study|Lost to Follow-up|0|||
161115129|NCT03657043|581811388|FG003|Overall Study|Lost to Follow-up|0|||
161115130|NCT03657043|581811389|FG004|Overall Study|Lost to Follow-up|4|||
161115131|NCT03657043|581811385|FG000|Overall Study|Death|6|||
161115132|NCT03657043|581811386|FG001|Overall Study|Death|5|||
161115133|NCT03657043|581811387|FG002|Overall Study|Death|0|||
161115134|NCT03657043|581811388|FG003|Overall Study|Death|0|||
161115135|NCT03657043|581811389|FG004|Overall Study|Death|53|||
161115136|NCT03657043|581811385|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
161115137|NCT03657043|581811386|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
161115138|NCT03657043|581811387|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
161115139|NCT03657043|581811388|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
161115140|NCT03657043|581811389|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
161115141|NCT03657043|581811385|FG000|Overall Study|Adverse Event|0|||
161115142|NCT03657043|581811386|FG001|Overall Study|Adverse Event|0|||
161115143|NCT03657043|581811387|FG002|Overall Study|Adverse Event|0|||
161115144|NCT03657043|581811388|FG003|Overall Study|Adverse Event|0|||
161115145|NCT03657043|581811389|FG004|Overall Study|Adverse Event|2|||
161115146|NCT03657043|581811385|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
161115147|NCT03657043|581811386|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
161115148|NCT03657043|581811387|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
161115149|NCT03657043|581811388|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
161115150|NCT03657043|581811389|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
161115151|NCT03657043|581811385|FG000|Overall Study|Withdrawal - declined follow-up|0|||
161115152|NCT03657043|581811386|FG001|Overall Study|Withdrawal - declined follow-up|0|||
161115153|NCT03657043|581811387|FG002|Overall Study|Withdrawal - declined follow-up|0|||
161115154|NCT03657043|581811388|FG003|Overall Study|Withdrawal - declined follow-up|0|||
161115155|NCT03657043|581811389|FG004|Overall Study|Withdrawal - declined follow-up|1|||
161115156|NCT01995071|581811390|FG000|Overall Study|Adverse Event|0|||
161115157|NCT01995071|581811391|FG001|Overall Study|Adverse Event|0|||
161115158|NCT01995071|581811392|FG002|Overall Study|Adverse Event|0|||
161115159|NCT01995071|581811393|FG003|Overall Study|Adverse Event|0|||
161115160|NCT01995071|581811394|FG004|Overall Study|Adverse Event|0|||
161115161|NCT01995071|581811395|FG005|Overall Study|Adverse Event|0|||
161115162|NCT01995071|581811396|FG006|Overall Study|Adverse Event|1|||
161115163|NCT01995071|581811397|FG007|Overall Study|Adverse Event|0|||
161115164|NCT01995071|581811398|FG008|Overall Study|Adverse Event|0|||
161115165|NCT01995071|581811399|FG009|Overall Study|Adverse Event|0|||
161115166|NCT01995071|581811400|FG010|Overall Study|Adverse Event|0|||
161115167|NCT01995071|581811401|FG011|Overall Study|Adverse Event|0|||
161115168|NCT01995071|581811390|FG000|Overall Study|Moved|0|||
161115169|NCT01995071|581811391|FG001|Overall Study|Moved|0|||
161115170|NCT01995071|581811392|FG002|Overall Study|Moved|1|||
160872639|NCT00139477|580925676|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
160872640|NCT00139477|580925677|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
160872641|NCT00139477|580925676|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
160872642|NCT00139477|580925677|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
160872643|NCT03776812|580925678|FG000|Overall Study|Death|53|||
160872644|NCT03776812|580925679|FG001|Overall Study|Death|49|||
160872645|NCT03776812|580925680|FG002|Overall Study|Death|56|||
161115171|NCT01995071|581811393|FG003|Overall Study|Moved|0|||
161115172|NCT01995071|581811394|FG004|Overall Study|Moved|1|||
161115173|NCT01995071|581811395|FG005|Overall Study|Moved|0|||
161115174|NCT01995071|581811396|FG006|Overall Study|Moved|0|||
161115175|NCT01995071|581811397|FG007|Overall Study|Moved|0|||
161115176|NCT01995071|581811398|FG008|Overall Study|Moved|0|||
161115177|NCT01995071|581811399|FG009|Overall Study|Moved|0|||
161115178|NCT01995071|581811400|FG010|Overall Study|Moved|1|||
161115179|NCT01995071|581811401|FG011|Overall Study|Moved|0|||
160872646|NCT03776812|580925678|FG000|Overall Study|Withdrawal by Subject|1|||
160872647|NCT03776812|580925679|FG001|Overall Study|Withdrawal by Subject|7|||
160872648|NCT03776812|580925680|FG002|Overall Study|Withdrawal by Subject|2|||
160872649|NCT03776812|580925678|FG000|Overall Study|Lost to Follow-up|1|||
160872650|NCT03776812|580925679|FG001|Overall Study|Lost to Follow-up|1|||
160872651|NCT03776812|580925680|FG002|Overall Study|Lost to Follow-up|0|||
160872652|NCT03776812|580925678|FG000|Overall Study|Did not enter long-term follow-up|3|||
160872653|NCT03776812|580925679|FG001|Overall Study|Did not enter long-term follow-up|3|||
160872654|NCT03776812|580925680|FG002|Overall Study|Did not enter long-term follow-up|2|||
160872655|NCT02442804|580925684|FG000|Overall Study|Withdrawal by Subject|0|||
160872656|NCT02442804|580925685|FG001|Overall Study|Withdrawal by Subject|1|||
160872657|NCT02442804|580925684|FG000|Overall Study|Adverse Event|1|||
160872658|NCT02442804|580925685|FG001|Overall Study|Adverse Event|0|||
160872659|NCT02527421|580925689|FG000|Overall Study|Withdrawal by Subject|1|||
160872660|NCT02527421|580925690|FG001|Overall Study|Withdrawal by Subject|0|||
160872661|NCT00993148|580925691|FG000|Overall Study|Lost to Follow-up|2|||
160872662|NCT00993148|580925691|FG000|Overall Study|never initiated treatment|1|||
160872663|NCT00560352|580925708|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160872664|NCT00560352|580925709|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160872665|NCT00560352|580925710|FG002|Overall Study|Adverse event unrelated to study drug|1|||
160872666|NCT00560352|580925708|FG000|Overall Study|Study drug toxicity|3|||
160872667|NCT00560352|580925709|FG001|Overall Study|Study drug toxicity|0|||
160872668|NCT00560352|580925710|FG002|Overall Study|Study drug toxicity|1|||
160872669|NCT00560352|580925708|FG000|Overall Study|Disease progression|0|||
160872670|NCT00560352|580925709|FG001|Overall Study|Disease progression|1|||
160872671|NCT00560352|580925710|FG002|Overall Study|Disease progression|1|||
161115180|NCT01995071|581811390|FG000|Overall Study|Lost to Follow-up|1|||
161115181|NCT01995071|581811391|FG001|Overall Study|Lost to Follow-up|0|||
161115182|NCT01995071|581811392|FG002|Overall Study|Lost to Follow-up|0|||
161115183|NCT01995071|581811393|FG003|Overall Study|Lost to Follow-up|0|||
161115184|NCT01995071|581811394|FG004|Overall Study|Lost to Follow-up|0|||
161115185|NCT01995071|581811395|FG005|Overall Study|Lost to Follow-up|0|||
161115186|NCT01995071|581811396|FG006|Overall Study|Lost to Follow-up|0|||
161115187|NCT01995071|581811397|FG007|Overall Study|Lost to Follow-up|1|||
161115188|NCT01995071|581811398|FG008|Overall Study|Lost to Follow-up|1|||
161115189|NCT01995071|581811399|FG009|Overall Study|Lost to Follow-up|0|||
161115190|NCT01995071|581811400|FG010|Overall Study|Lost to Follow-up|0|||
161115191|NCT01995071|581811401|FG011|Overall Study|Lost to Follow-up|0|||
161115192|NCT01995071|581811390|FG000|Overall Study|Incarcerated|0|||
161115193|NCT01995071|581811391|FG001|Overall Study|Incarcerated|0|||
161115194|NCT01995071|581811392|FG002|Overall Study|Incarcerated|0|||
161115195|NCT01995071|581811393|FG003|Overall Study|Incarcerated|0|||
161115196|NCT01995071|581811394|FG004|Overall Study|Incarcerated|0|||
161115197|NCT01995071|581811395|FG005|Overall Study|Incarcerated|0|||
161115198|NCT01995071|581811396|FG006|Overall Study|Incarcerated|0|||
161115199|NCT01995071|581811397|FG007|Overall Study|Incarcerated|1|||
161115200|NCT01995071|581811398|FG008|Overall Study|Incarcerated|0|||
161115201|NCT01995071|581811399|FG009|Overall Study|Incarcerated|0|||
161115202|NCT01995071|581811400|FG010|Overall Study|Incarcerated|0|||
161115203|NCT01995071|581811401|FG011|Overall Study|Incarcerated|0|||
161115204|NCT00772954|581811406|FG000|Overall Study|Adverse Event|0|||
161115205|NCT00772954|581811407|FG001|Overall Study|Adverse Event|0|||
161115206|NCT00772954|581811408|FG002|Overall Study|Adverse Event|1|||
161115207|NCT01661140|581811409|FG000|Open-Label Period|Adverse Event|44|||
161115208|NCT01661140|581811410|FG001|Open-Label Period|Adverse Event|0|||
161115209|NCT01661140|581811411|FG002|Open-Label Period|Adverse Event|0|||
161115210|NCT01661140|581811409|FG000|Open-Label Period|Protocol Violation|3|||
161115211|NCT01661140|581811410|FG001|Open-Label Period|Protocol Violation|0|||
161115212|NCT01661140|581811411|FG002|Open-Label Period|Protocol Violation|0|||
161115213|NCT01661140|581811409|FG000|Open-Label Period|Withdrawal by Subject|5|||
161115214|NCT01661140|581811410|FG001|Open-Label Period|Withdrawal by Subject|0|||
161115215|NCT01661140|581811411|FG002|Open-Label Period|Withdrawal by Subject|0|||
161115216|NCT01661140|581811409|FG000|Open-Label Period|Investigator Decision|3|||
161115217|NCT01661140|581811410|FG001|Open-Label Period|Investigator Decision|0|||
161115218|NCT01661140|581811411|FG002|Open-Label Period|Investigator Decision|0|||
161115219|NCT01661140|581811409|FG000|Open-Label Period|Death|1|||
160872672|NCT00560352|580925708|FG000|Overall Study|Withdrawal by Subject|1|||
161115220|NCT01661140|581811410|FG001|Open-Label Period|Death|0|||
161115221|NCT01661140|581811411|FG002|Open-Label Period|Death|0|||
161115222|NCT01661140|581811409|FG000|Open-Label Period|Administrative/Other|1|||
161115223|NCT01661140|581811410|FG001|Open-Label Period|Administrative/Other|0|||
161115224|NCT01661140|581811411|FG002|Open-Label Period|Administrative/Other|0|||
161115225|NCT01661140|581811409|FG000|Open-Label Period|Sponsor termination|16|||
160872673|NCT00560352|580925709|FG001|Overall Study|Withdrawal by Subject|1|||
160872674|NCT00560352|580925710|FG002|Overall Study|Withdrawal by Subject|1|||
160872675|NCT00560352|580925708|FG000|Overall Study|Maximum clinical benefit|1|||
160872676|NCT00560352|580925709|FG001|Overall Study|Maximum clinical benefit|0|||
161115226|NCT01661140|581811410|FG001|Open-Label Period|Sponsor termination|0|||
161219489|NCT00895583|582185613|FG000|Overall Study|Physician Decision|3|||
161219490|NCT00895583|582185614|FG001|Overall Study|Physician Decision|1|||
161219491|NCT00895583|582185613|FG000|Overall Study|Lost to Follow-up|1|||
161219492|NCT00895583|582185614|FG001|Overall Study|Lost to Follow-up|3|||
161219493|NCT00895583|582185613|FG000|Overall Study|Protocol Violation|1|||
161219494|NCT00895583|582185614|FG001|Overall Study|Protocol Violation|0|||
161219495|NCT00895583|582185613|FG000|Overall Study|Withdrawal by Subject|4|||
161219496|NCT00895583|582185614|FG001|Overall Study|Withdrawal by Subject|2|||
161219497|NCT00895583|582185613|FG000|Overall Study|Lack of Efficacy|5|||
161219498|NCT00895583|582185614|FG001|Overall Study|Lack of Efficacy|0|||
161219499|NCT00895583|582185613|FG000|Overall Study|Other|0|||
161219500|NCT00895583|582185614|FG001|Overall Study|Other|1|||
161219501|NCT04535583|582185625|FG000|Overall Study|Lost to Follow-up|1|||
161219502|NCT04535583|582185625|FG000|Overall Study|Physician Decision|1|||
161219503|NCT04535583|582185625|FG000|Overall Study|Withdrawal by Subject|1|||
161219504|NCT01078090|582185626|FG000|Overall Study|Lost to Follow-up|2363|||
161219505|NCT01078090|582185626|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
161219506|NCT01078090|582185626|FG000|Overall Study|Lack of Efficacy|1193|||
161219507|NCT01078090|582185626|FG000|Overall Study|ADR and lack of efficacy|61|||
161219508|NCT01078090|582185626|FG000|Overall Study|Other|523|||
161219509|NCT01748890|582185628|FG000|Overall Study|Insufficient recruitment for analysis|4|||
161219510|NCT02669264|582185629|FG000|Overall Study|Death|5|||
161219511|NCT02669264|582185630|FG001|Overall Study|Death|5|||
161219512|NCT02669264|582185631|FG002|Overall Study|Death|3|||
161219513|NCT02669264|582185632|FG003|Overall Study|Death|3|||
161219514|NCT02669264|582185633|FG004|Overall Study|Death|3|||
161219515|NCT02669264|582185634|FG005|Overall Study|Death|6|||
161219516|NCT02669264|582185635|FG006|Overall Study|Death|3|||
161219517|NCT02669264|582185629|FG000|Overall Study|Withdrawal by Subject|0|||
161219518|NCT02669264|582185630|FG001|Overall Study|Withdrawal by Subject|1|||
161219519|NCT02669264|582185631|FG002|Overall Study|Withdrawal by Subject|0|||
161219520|NCT02669264|582185632|FG003|Overall Study|Withdrawal by Subject|0|||
161219521|NCT02669264|582185633|FG004|Overall Study|Withdrawal by Subject|1|||
161219522|NCT02669264|582185634|FG005|Overall Study|Withdrawal by Subject|0|||
161219523|NCT02669264|582185635|FG006|Overall Study|Withdrawal by Subject|0|||
161219524|NCT02669264|582185629|FG000|Overall Study|Lost to Follow-up|0|||
161219525|NCT02669264|582185630|FG001|Overall Study|Lost to Follow-up|0|||
161219526|NCT02669264|582185631|FG002|Overall Study|Lost to Follow-up|0|||
161219527|NCT02669264|582185632|FG003|Overall Study|Lost to Follow-up|0|||
161219528|NCT02669264|582185633|FG004|Overall Study|Lost to Follow-up|1|||
161219529|NCT02669264|582185634|FG005|Overall Study|Lost to Follow-up|0|||
161219530|NCT02669264|582185635|FG006|Overall Study|Lost to Follow-up|0|||
161219531|NCT02669264|582185629|FG000|Overall Study|Miscellaneous|0|||
161219532|NCT02669264|582185630|FG001|Overall Study|Miscellaneous|0|||
161219533|NCT02669264|582185631|FG002|Overall Study|Miscellaneous|0|||
161219534|NCT02669264|582185632|FG003|Overall Study|Miscellaneous|0|||
161219535|NCT02669264|582185633|FG004|Overall Study|Miscellaneous|0|||
161219536|NCT02669264|582185634|FG005|Overall Study|Miscellaneous|0|||
161219537|NCT02669264|582185635|FG006|Overall Study|Miscellaneous|2|||
161219538|NCT03035227|582185636|FG000|Overall Study|study stopped due to PI leaving institut|1|||
161219539|NCT03035227|582185637|FG001|Overall Study|study stopped due to PI leaving institut|1|||
161219540|NCT02100956|582185638|FG000|At Least One Week Between Injections|Adverse Event|0|||
161219541|NCT02100956|582185639|FG001|At Least One Week Between Injections|Adverse Event|1|||
161219542|NCT03529955|582185640|FG000|Overall Study|Adverse Event|1|||
161219543|NCT03529955|582185640|FG000|Overall Study|Lack of Efficacy|1|||
161219544|NCT03016078|582185644|FG000|Overall Study|Protocol Violation|1|||
161219545|NCT03016078|582185644|FG000|Overall Study|Protocol Violation|1|||
160872677|NCT00560352|580925710|FG002|Overall Study|Maximum clinical benefit|0|||
160872678|NCT03892967|580925711|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
160872679|NCT03892967|580925712|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
160872680|NCT03892967|580925713|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
161219546|NCT01098240|582185645|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
161219547|NCT01098240|582185646|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161219548|NCT01098240|582185647|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161219549|NCT01098240|582185645|FG000|Open-Label Phase|Protocol Violation|4|||
161219550|NCT01098240|582185646|FG001|Open-Label Phase|Protocol Violation|0|||
161219551|NCT01098240|582185647|FG002|Open-Label Phase|Protocol Violation|0|||
161219552|NCT01098240|582185645|FG000|Open-Label Phase|Lost to Follow-up|13|||
161219553|NCT01098240|582185646|FG001|Open-Label Phase|Lost to Follow-up|0|||
161219554|NCT01098240|582185647|FG002|Open-Label Phase|Lost to Follow-up|0|||
161219555|NCT01098240|582185645|FG000|Open-Label Phase|Other|19|||
161219556|NCT01098240|582185646|FG001|Open-Label Phase|Other|0|||
161219557|NCT01098240|582185647|FG002|Open-Label Phase|Other|0|||
161219558|NCT01098240|582185645|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
161219559|NCT01098240|582185646|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161219560|NCT01098240|582185647|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
160872681|NCT03892967|580925714|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
161219561|NCT01098240|582185645|FG000|Open-Label Phase|Pregnancy|1|||
160872682|NCT03892967|580925715|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
161219562|NCT01098240|582185646|FG001|Open-Label Phase|Pregnancy|0|||
161219563|NCT01098240|582185647|FG002|Open-Label Phase|Pregnancy|0|||
161219564|NCT01098240|582185645|FG000|Open-Label Phase|Withdrawal by Subject|9|||
161219565|NCT01098240|582185646|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161219566|NCT01098240|582185647|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160872683|NCT03892967|580925711|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
160872684|NCT03892967|580925712|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
160872685|NCT03892967|580925713|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
161219567|NCT01098240|582185645|FG000|Open-Label Phase|Adverse Event|12|||
161219568|NCT01098240|582185646|FG001|Open-Label Phase|Adverse Event|0|||
161219569|NCT01098240|582185647|FG002|Open-Label Phase|Adverse Event|0|||
161219570|NCT01098240|582185645|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
160872686|NCT03892967|580925714|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
160872687|NCT03892967|580925715|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
160872688|NCT03892967|580925711|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
160872689|NCT03892967|580925712|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
160872690|NCT03892967|580925713|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
160872691|NCT03892967|580925714|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
160872692|NCT03892967|580925715|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
160872693|NCT03892967|580925711|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
160872694|NCT03892967|580925712|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
160872695|NCT03892967|580925713|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
160872696|NCT03892967|580925714|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
160872697|NCT03892967|580925715|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
160872698|NCT03892967|580925711|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
160872699|NCT03892967|580925712|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
160872700|NCT03892967|580925713|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
160872701|NCT03892967|580925714|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
160872702|NCT03892967|580925715|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
160872703|NCT03892967|580925711|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
160872704|NCT03892967|580925712|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
160872705|NCT03892967|580925713|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
160872706|NCT03892967|580925714|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
160872707|NCT03892967|580925715|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
160872708|NCT03568461|580925719|FG000|Overall Study|Death|7|||
160872709|NCT03568461|580925719|FG000|Overall Study|Physician Decision|5|||
160872710|NCT03568461|580925719|FG000|Overall Study|Subject decision|5|||
160872711|NCT03568461|580925719|FG000|Overall Study|Lost to Follow-up|1|||
160872712|NCT03387085|580925723|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
160872713|NCT01296672|580927805|FG000|Overall Study|Lost to Follow-up|73|||
160872714|NCT01296672|580927806|FG001|Overall Study|Lost to Follow-up|18|||
160872715|NCT01311024|580927810|FG000|Overall Study|Protocol Violation|35|||
161219571|NCT01098240|582185646|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
161219572|NCT01098240|582185647|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
161219573|NCT01098240|582185645|FG000|Double-Blind Phase|Protocol Violation|0|||
161219574|NCT01098240|582185646|FG001|Double-Blind Phase|Protocol Violation|2|||
161219575|NCT01098240|582185647|FG002|Double-Blind Phase|Protocol Violation|4|||
161219576|NCT01098240|582185645|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161219577|NCT01098240|582185646|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161219578|NCT01098240|582185647|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161219579|NCT01098240|582185645|FG000|Double-Blind Phase|Other|0|||
161219580|NCT01098240|582185646|FG001|Double-Blind Phase|Other|2|||
161219581|NCT01098240|582185647|FG002|Double-Blind Phase|Other|2|||
160872716|NCT01311024|580927811|FG001|Overall Study|Protocol Violation|22|||
160872717|NCT04643158|580927818|FG000|Overall Study|Study terminated by sponsor|0|||
160872718|NCT04643158|580927819|FG001|Overall Study|Study terminated by sponsor|0|||
160872719|NCT04643158|580927820|FG002|Overall Study|Study terminated by sponsor|1|||
160872720|NCT04643158|580927821|FG003|Overall Study|Study terminated by sponsor|0|||
160872721|NCT04643158|580927822|FG004|Overall Study|Study terminated by sponsor|0|||
160872722|NCT04643158|580927823|FG005|Overall Study|Study terminated by sponsor|1|||
160872723|NCT04643158|580927824|FG006|Overall Study|Study terminated by sponsor|0|||
160872724|NCT04643158|580927818|FG000|Overall Study|Global/country situation|0|||
160872725|NCT04643158|580927819|FG001|Overall Study|Global/country situation|0|||
160872726|NCT04643158|580927820|FG002|Overall Study|Global/country situation|1|||
160872727|NCT04643158|580927821|FG003|Overall Study|Global/country situation|0|||
160872728|NCT04643158|580927822|FG004|Overall Study|Global/country situation|0|||
160872729|NCT04643158|580927823|FG005|Overall Study|Global/country situation|0|||
160872730|NCT04643158|580927824|FG006|Overall Study|Global/country situation|0|||
160872731|NCT04643158|580927818|FG000|Overall Study|Withdrawal by Subject|0|||
160872732|NCT04643158|580927819|FG001|Overall Study|Withdrawal by Subject|0|||
160872733|NCT04643158|580927820|FG002|Overall Study|Withdrawal by Subject|0|||
160872734|NCT04643158|580927821|FG003|Overall Study|Withdrawal by Subject|0|||
160872735|NCT04643158|580927822|FG004|Overall Study|Withdrawal by Subject|0|||
160872736|NCT04643158|580927823|FG005|Overall Study|Withdrawal by Subject|1|||
160872737|NCT04643158|580927824|FG006|Overall Study|Withdrawal by Subject|0|||
160872738|NCT04329806|580927825|FG000|Overall Study|Physician Decision|3|||
160872739|NCT04329806|580927826|FG001|Overall Study|Physician Decision|4|||
160872740|NCT00622440|580927839|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
160872741|NCT00622440|580927840|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
160872742|NCT00622440|580927839|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
160872743|NCT00622440|580927840|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
160872744|NCT00622440|580927839|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
160872745|NCT00622440|580927840|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
160872746|NCT00622440|580927839|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
160872747|NCT00622440|580927840|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
160872748|NCT00856518|580927848|FG000|Overall Study|Lost to Follow-up|4|||
160872749|NCT00856518|580927849|FG001|Overall Study|Lost to Follow-up|2|||
160872750|NCT02867384|580927850|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
160872751|NCT02867384|580927851|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
160872752|NCT02867384|580927852|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
160872753|NCT02867384|580927850|FG000|Overall Study|Progression/ Relapse|15|||
160872754|NCT02867384|580927851|FG001|Overall Study|Progression/ Relapse|19|||
160872755|NCT02867384|580927852|FG002|Overall Study|Progression/ Relapse|0|||
160872756|NCT02867384|580927850|FG000|Overall Study|Adverse Event|13|||
160872757|NCT02867384|580927851|FG001|Overall Study|Adverse Event|1|||
160872758|NCT02867384|580927852|FG002|Overall Study|Adverse Event|0|||
160872759|NCT02867384|580927850|FG000|Overall Study|Withdrawal by Subject|6|||
160872760|NCT02867384|580927851|FG001|Overall Study|Withdrawal by Subject|5|||
160872761|NCT02867384|580927852|FG002|Overall Study|Withdrawal by Subject|0|||
160872762|NCT02867384|580927850|FG000|Overall Study|Physician Decision|1|||
160872763|NCT02867384|580927851|FG001|Overall Study|Physician Decision|2|||
160872764|NCT02867384|580927852|FG002|Overall Study|Physician Decision|0|||
160872765|NCT02867384|580927850|FG000|Overall Study|Patient compliance|1|||
160872766|NCT02867384|580927851|FG001|Overall Study|Patient compliance|0|||
160872767|NCT02867384|580927852|FG002|Overall Study|Patient compliance|0|||
160872768|NCT02867384|580927850|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
160872769|NCT02867384|580927851|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
160872770|NCT02867384|580927852|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
160872771|NCT02867384|580927850|FG000|Overall Study|Never start treatment|3|||
160872772|NCT02867384|580927851|FG001|Overall Study|Never start treatment|0|||
160872773|NCT02867384|580927852|FG002|Overall Study|Never start treatment|0|||
160872774|NCT01652534|580927853|FG000|Overall Study|Lack of Efficacy|1|||
160872775|NCT01652534|580927854|FG001|Overall Study|Lack of Efficacy|0|||
160872776|NCT01941186|580927855|FG000|Follow-up|Lost to Follow-up|1|||
160872777|NCT01941186|580927856|FG001|Follow-up|Lost to Follow-up|0|||
160872778|NCT02105961|580927857|FG000|Overall Study|Adverse Event|18|||
160872779|NCT02105961|580927858|FG001|Overall Study|Adverse Event|7|||
161115227|NCT01661140|581811411|FG002|Open-Label Period|Sponsor termination|0|||
161115228|NCT01661140|581811409|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
160872780|NCT02105961|580927859|FG002|Overall Study|Adverse Event|13|||
160872781|NCT02105961|580927857|FG000|Overall Study|Lack of Efficacy|3|||
160872782|NCT02105961|580927858|FG001|Overall Study|Lack of Efficacy|0|||
160872783|NCT02105961|580927859|FG002|Overall Study|Lack of Efficacy|3|||
160872784|NCT02105961|580927857|FG000|Overall Study|Lost to Follow-up|2|||
160872785|NCT02105961|580927858|FG001|Overall Study|Lost to Follow-up|0|||
160872786|NCT02105961|580927859|FG002|Overall Study|Lost to Follow-up|1|||
161115229|NCT01661140|581811410|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
161115230|NCT01661140|581811411|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
161115231|NCT01661140|581811409|FG000|Open-Label Period|Lost to Follow-up|2|||
161115232|NCT01661140|581811410|FG001|Open-Label Period|Lost to Follow-up|0|||
161115233|NCT01661140|581811411|FG002|Open-Label Period|Lost to Follow-up|0|||
161115234|NCT01661140|581811409|FG000|Double-Blind Period|Refused Treatment|0|||
161115235|NCT01661140|581811410|FG001|Double-Blind Period|Refused Treatment|0|||
161115236|NCT01661140|581811411|FG002|Double-Blind Period|Refused Treatment|1|||
161115237|NCT01661140|581811409|FG000|Double-Blind Period|Adverse Event|0|||
161115238|NCT01661140|581811410|FG001|Double-Blind Period|Adverse Event|16|||
161115239|NCT01661140|581811411|FG002|Double-Blind Period|Adverse Event|18|||
161115240|NCT01661140|581811409|FG000|Double-Blind Period|Protocol Violation|0|||
161115241|NCT01661140|581811410|FG001|Double-Blind Period|Protocol Violation|2|||
161115242|NCT01661140|581811411|FG002|Double-Blind Period|Protocol Violation|3|||
161115243|NCT01661140|581811409|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161115244|NCT01661140|581811410|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161115245|NCT01661140|581811411|FG002|Double-Blind Period|Withdrawal by Subject|3|||
161115246|NCT01661140|581811409|FG000|Double-Blind Period|Investigator's Decision|0|||
161115247|NCT01661140|581811410|FG001|Double-Blind Period|Investigator's Decision|1|||
161115248|NCT01661140|581811411|FG002|Double-Blind Period|Investigator's Decision|2|||
161115249|NCT01661140|581811409|FG000|Double-Blind Period|Sponsor Termination|0|||
161115250|NCT01661140|581811410|FG001|Double-Blind Period|Sponsor Termination|14|||
161115251|NCT01661140|581811411|FG002|Double-Blind Period|Sponsor Termination|17|||
161115252|NCT01661140|581811409|FG000|Double-Blind Period|Administrative/Other|0|||
161115253|NCT01661140|581811410|FG001|Double-Blind Period|Administrative/Other|7|||
161115254|NCT01661140|581811411|FG002|Double-Blind Period|Administrative/Other|6|||
161115255|NCT02239939|581811412|FG000|Overall Study|Adverse Event|1|||
161115256|NCT02239939|581811413|FG001|Overall Study|Adverse Event|0|||
161115257|NCT02239939|581811412|FG000|Overall Study|Withdrawal by Subject|1|||
161115258|NCT02239939|581811413|FG001|Overall Study|Withdrawal by Subject|1|||
161115259|NCT02239939|581811412|FG000|Overall Study|Lost to Follow-up|0|||
161115260|NCT02239939|581811413|FG001|Overall Study|Lost to Follow-up|1|||
161115261|NCT03865706|581811419|FG000|Overall Study|Death|0|||
161115262|NCT03865706|581811420|FG001|Overall Study|Death|3|||
161115263|NCT03865706|581811421|FG002|Overall Study|Death|1|||
161115264|NCT02095535|581811422|FG000|Recruitment|Protocol Violation|2|||
161115265|NCT02646982|581811423|FG000|Overall Study|Adverse Event|1|||
161115266|NCT02646982|581811424|FG001|Overall Study|Adverse Event|1|||
161115267|NCT02646982|581811423|FG000|Overall Study|Withdrawal by Subject|2|||
161115268|NCT02646982|581811424|FG001|Overall Study|Withdrawal by Subject|1|||
161115269|NCT01877187|581811425|FG000|Overall Study|Death|2|||
161115270|NCT01877187|581811425|FG000|Overall Study|Withdrawal by Subject|4|||
161115271|NCT01877187|581811425|FG000|Overall Study|Lost to Follow-up|3|||
161115272|NCT01877187|581811425|FG000|Overall Study|Declining clinical status|11|||
161324401|NCT00110357|582573593|FG000|Overall Study|Disease progression/relapse|20|||
161115273|NCT01877187|581811425|FG000|Overall Study|Liver transplant|2|||
160872787|NCT02105961|580927857|FG000|Overall Study|Physician Decision|3|||
160872788|NCT02105961|580927858|FG001|Overall Study|Physician Decision|3|||
160872789|NCT02105961|580927859|FG002|Overall Study|Physician Decision|2|||
160872790|NCT02105961|580927857|FG000|Overall Study|Withdrawal by Subject|15|||
160872791|NCT02105961|580927858|FG001|Overall Study|Withdrawal by Subject|7|||
160872792|NCT02105961|580927859|FG002|Overall Study|Withdrawal by Subject|11|||
160872793|NCT00934362|580927863|FG000|Overall Study|Adverse Event|1|||
160872794|NCT00934362|580927864|FG001|Overall Study|Adverse Event|0|||
160872795|NCT01092117|580927867|FG000|Index Procedure to 1 Month|Death|1|||
160872796|NCT01092117|580927867|FG000|1 Month|Death|1|||
160872797|NCT01092117|580927867|FG000|1 Month|Withdrawal by Subject|1|||
160872798|NCT01092117|580927867|FG000|1 Month|Lost to Follow-up|1|||
160872799|NCT01092117|580927867|FG000|6 Months|Death|2|||
160872800|NCT01092117|580927867|FG000|6 Months|Withdrawal by Subject|3|||
160872801|NCT01092117|580927867|FG000|12 Month|Death|11|||
160872802|NCT01092117|580927867|FG000|12 Month|Withdrawal by Subject|2|||
160872803|NCT01092117|580927867|FG000|12 Month|Lost to Follow-up|1|||
160872804|NCT01092117|580927867|FG000|Year 2|Death|5|||
160872805|NCT01092117|580927867|FG000|Year 2|Withdrawal by Subject|4|||
160872806|NCT01092117|580927867|FG000|Year 2|Lost to Follow-up|1|||
160872807|NCT01092117|580927867|FG000|Year 3|Death|7|||
160872808|NCT01092117|580927867|FG000|Year 3|Withdrawal by Subject|9|||
160872809|NCT01092117|580927867|FG000|Year 3|Lost to Follow-up|3|||
160872810|NCT01092117|580927867|FG000|Year 4|Death|8|||
160872811|NCT01092117|580927867|FG000|Year 4|Withdrawal by Subject|4|||
160872812|NCT01092117|580927867|FG000|Year 4|Lost to Follow-up|4|||
160872813|NCT04380519|580927868|FG000|Overall Study|Withdrawal by Subject|4|||
160872814|NCT04380519|580927869|FG001|Overall Study|Withdrawal by Subject|0|||
160872815|NCT04380519|580927870|FG002|Overall Study|Withdrawal by Subject|1|||
160872816|NCT04380519|580927868|FG000|Overall Study|Death|14|||
160872817|NCT04380519|580927869|FG001|Overall Study|Death|9|||
160872818|NCT04380519|580927870|FG002|Overall Study|Death|6|||
160872819|NCT04380519|580927868|FG000|Overall Study|Adverse Event|0|||
160872820|NCT04380519|580927869|FG001|Overall Study|Adverse Event|1|||
160872821|NCT04380519|580927870|FG002|Overall Study|Adverse Event|0|||
160872822|NCT04380519|580927868|FG000|Overall Study|relatives' decision|0|||
160872823|NCT04380519|580927869|FG001|Overall Study|relatives' decision|1|||
160872824|NCT04380519|580927870|FG002|Overall Study|relatives' decision|0|||
160872825|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
160872826|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
160872827|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
160872828|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
160872829|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
160872830|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
160872831|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
160872832|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
160872833|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
160872834|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
160872835|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
160872836|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
160872837|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
160872838|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
160872839|NCT04173494|580927871|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
161115274|NCT02590588|581811432|FG000|Overall Study|Adverse Event|1|||
161115275|NCT01780831|581811440|FG000|Overall Study|Withdrawal by Subject|0|||
161115276|NCT01780831|581811441|FG001|Overall Study|Withdrawal by Subject|0|||
161115277|NCT01780831|581811442|FG002|Overall Study|Withdrawal by Subject|4|||
161115278|NCT01780831|581811443|FG003|Overall Study|Withdrawal by Subject|0|||
161115279|NCT01780831|581811440|FG000|Overall Study|Lost to Follow-up|0|||
161115280|NCT01780831|581811441|FG001|Overall Study|Lost to Follow-up|0|||
161115281|NCT01780831|581811442|FG002|Overall Study|Lost to Follow-up|0|||
160872840|NCT04173494|580927872|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
161115282|NCT01780831|581811443|FG003|Overall Study|Lost to Follow-up|1|||
160872841|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
161115283|NCT00794677|581811444|FG000|First Intervention|Withdrawal by Subject|2|||
161115284|NCT00794677|581811445|FG001|First Intervention|Withdrawal by Subject|0|||
160872842|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
160872843|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
160872844|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
160872845|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
160872846|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
161115285|NCT01965262|581811458|FG000|Second Intervention (7 Days)|Discontinued|0|||
161115286|NCT01965262|581811459|FG001|Second Intervention (7 Days)|Discontinued|1|||
160872847|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
160872848|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
160872849|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
160872850|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
160872851|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
160872852|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
160872853|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
160872854|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
160872855|NCT04173494|580927871|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
160872856|NCT04173494|580927872|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
160872857|NCT01623050|580927873|FG000|Overall Study|Lost to Follow-up|9|||
160872858|NCT00526071|580927876|FG000|Overall Study|Adverse Event|1|||
160872859|NCT00526071|580927876|FG000|Overall Study|Withdrawal by Subject|1|||
160872860|NCT00526071|580927876|FG000|Overall Study|Lack of Response to Study Drug|4|||
160872861|NCT01191762|580927877|FG000|Overall Study|Adverse Event|1|||
160872862|NCT01191762|580927878|FG001|Overall Study|Adverse Event|0|||
160872863|NCT03023813|580927881|FG000|Overall Study|Lost to Follow-up|1|||
160872864|NCT03023813|580927882|FG001|Overall Study|Lost to Follow-up|2|||
160872865|NCT03023813|580927883|FG002|Overall Study|Lost to Follow-up|0|||
160872866|NCT00393861|580927884|FG000|Overall Study|Adverse Event|2|||
160872867|NCT00393861|580927884|FG000|Overall Study|Disease Progression|24|||
160872868|NCT03710083|580927885|FG000|Overall Study|Withdrawal by Subject|2|||
160872869|NCT03710083|580927885|FG000|Overall Study|Unsuccessful Procedure|1|||
160872870|NCT05300763|580927886|FG000|Overall Study|Adverse Event|0|||
160872871|NCT05300763|580927887|FG001|Overall Study|Adverse Event|1|||
160872872|NCT05300763|580927886|FG000|Overall Study|Major Protocol Deviation|1|||
160872873|NCT05300763|580927887|FG001|Overall Study|Major Protocol Deviation|0|||
160872874|NCT05300763|580927886|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
160872875|NCT05300763|580927887|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
160872876|NCT01485172|580927888|FG000|Overall Study|Adverse Event|2|||
160872877|NCT01485172|580927889|FG001|Overall Study|Adverse Event|1|||
160872878|NCT01485172|580927890|FG002|Overall Study|Adverse Event|2|||
160872879|NCT01485172|580927891|FG003|Overall Study|Adverse Event|2|||
160872880|NCT01485172|580927892|FG004|Overall Study|Adverse Event|1|||
160872881|NCT01485172|580927893|FG005|Overall Study|Adverse Event|2|||
160872882|NCT01485172|580927888|FG000|Overall Study|Lack of Efficacy|2|||
160872883|NCT01485172|580927889|FG001|Overall Study|Lack of Efficacy|0|||
160872884|NCT01485172|580927890|FG002|Overall Study|Lack of Efficacy|0|||
160872885|NCT01485172|580927891|FG003|Overall Study|Lack of Efficacy|0|||
160872886|NCT01485172|580927892|FG004|Overall Study|Lack of Efficacy|0|||
160872887|NCT01485172|580927893|FG005|Overall Study|Lack of Efficacy|0|||
160872888|NCT01485172|580927888|FG000|Overall Study|Protocol Violation|0|||
160872889|NCT01485172|580927889|FG001|Overall Study|Protocol Violation|0|||
160872890|NCT01485172|580927890|FG002|Overall Study|Protocol Violation|4|||
160872891|NCT01485172|580927891|FG003|Overall Study|Protocol Violation|5|||
160872892|NCT01485172|580927892|FG004|Overall Study|Protocol Violation|1|||
160872893|NCT01485172|580927893|FG005|Overall Study|Protocol Violation|0|||
160872894|NCT01485172|580927888|FG000|Overall Study|Protocol defined stopping criteria|1|||
160872895|NCT01485172|580927889|FG001|Overall Study|Protocol defined stopping criteria|0|||
160872896|NCT01485172|580927890|FG002|Overall Study|Protocol defined stopping criteria|0|||
160872897|NCT01485172|580927891|FG003|Overall Study|Protocol defined stopping criteria|0|||
160872898|NCT01485172|580927892|FG004|Overall Study|Protocol defined stopping criteria|1|||
160872899|NCT01485172|580927893|FG005|Overall Study|Protocol defined stopping criteria|0|||
160872900|NCT01485172|580927888|FG000|Overall Study|Lost to Follow-up|0|||
160872901|NCT01485172|580927889|FG001|Overall Study|Lost to Follow-up|0|||
160872902|NCT01485172|580927890|FG002|Overall Study|Lost to Follow-up|1|||
160872903|NCT01485172|580927891|FG003|Overall Study|Lost to Follow-up|0|||
160872904|NCT01485172|580927892|FG004|Overall Study|Lost to Follow-up|0|||
160872905|NCT01485172|580927893|FG005|Overall Study|Lost to Follow-up|1|||
160872906|NCT01485172|580927888|FG000|Overall Study|Physician Decision|0|||
161115287|NCT01965262|581811458|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
161115288|NCT01965262|581811459|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
161115289|NCT01965262|581811458|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
161115290|NCT01965262|581811459|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
161115291|NCT03016325|581811468|FG000|Treatment Period|Participant withdrew consent|0|||
161115292|NCT03016325|581811469|FG001|Treatment Period|Participant withdrew consent|1|||
161115293|NCT03016325|581811470|FG002|Treatment Period|Participant withdrew consent|0|||
161115294|NCT03016325|581811471|FG003|Treatment Period|Participant withdrew consent|0|||
161115295|NCT03016325|581811472|FG004|Treatment Period|Participant withdrew consent|0|||
161115296|NCT03016325|581811473|FG005|Treatment Period|Participant withdrew consent|0|||
161115297|NCT03016325|581811474|FG006|Treatment Period|Participant withdrew consent|0|||
160872907|NCT01485172|580927889|FG001|Overall Study|Physician Decision|0|||
160872908|NCT01485172|580927890|FG002|Overall Study|Physician Decision|0|||
161115298|NCT03016325|581811475|FG007|Treatment Period|Participant withdrew consent|0|||
160872909|NCT01485172|580927891|FG003|Overall Study|Physician Decision|0|||
160872910|NCT01485172|580927892|FG004|Overall Study|Physician Decision|1|||
160872911|NCT01485172|580927893|FG005|Overall Study|Physician Decision|0|||
160872912|NCT01485172|580927888|FG000|Overall Study|Withdrawal by Subject|2|||
161115299|NCT03016325|581811468|FG000|Treatment Period|Death|0|||
161115300|NCT03016325|581811469|FG001|Treatment Period|Death|0|||
161115301|NCT03016325|581811470|FG002|Treatment Period|Death|0|||
161115302|NCT03016325|581811471|FG003|Treatment Period|Death|0|||
161115303|NCT03016325|581811472|FG004|Treatment Period|Death|2|||
161115304|NCT03016325|581811473|FG005|Treatment Period|Death|0|||
161115305|NCT03016325|581811474|FG006|Treatment Period|Death|0|||
161115306|NCT03016325|581811475|FG007|Treatment Period|Death|0|||
161115307|NCT03016325|581811468|FG000|Treatment Period|Participant refuses assessments|0|||
161115308|NCT03016325|581811469|FG001|Treatment Period|Participant refuses assessments|0|||
161219582|NCT01098240|582185645|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
161219583|NCT01098240|582185646|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
161219584|NCT01098240|582185647|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
161219585|NCT01098240|582185645|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
161219586|NCT01098240|582185646|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
161219587|NCT01098240|582185647|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
161219588|NCT01098240|582185645|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161219589|NCT01098240|582185646|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
160872913|NCT01485172|580927889|FG001|Overall Study|Withdrawal by Subject|0|||
160872914|NCT01485172|580927890|FG002|Overall Study|Withdrawal by Subject|0|||
160872915|NCT01485172|580927891|FG003|Overall Study|Withdrawal by Subject|1|||
160872916|NCT01485172|580927892|FG004|Overall Study|Withdrawal by Subject|1|||
160872917|NCT01485172|580927893|FG005|Overall Study|Withdrawal by Subject|1|||
160872918|NCT01587014|580927894|FG000|Overall Study|Death|2|||
160872919|NCT01409811|580927895|FG000|Overall Study|Insurance denial|1|||
160872920|NCT00838513|580927896|FG000|Screening Period|Screen Failure|3|||
160872921|NCT00838513|580927896|FG000|Extension Treatment Period|Death|1|||
160872922|NCT00838513|580927896|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
160872923|NCT00975780|580927902|FG000|Follow Up|Death|88|||
160872924|NCT00975780|580927903|FG001|Follow Up|Death|122|||
160872925|NCT00975780|580927902|FG000|Follow Up|Facility Withdrawal|7|||
160872926|NCT00975780|580927903|FG001|Follow Up|Facility Withdrawal|23|||
160872927|NCT00975780|580927902|FG000|Follow Up|Discharged from Facility|7|||
160872928|NCT00975780|580927903|FG001|Follow Up|Discharged from Facility|12|||
160872929|NCT00441064|580927904|FG000|Overall Study|Adverse Event|1|||
160872930|NCT00441064|580927905|FG001|Overall Study|Adverse Event|0|||
160872931|NCT00441064|580927904|FG000|Overall Study|Abnormal laboratory values|0|||
160872932|NCT00441064|580927905|FG001|Overall Study|Abnormal laboratory values|2|||
160872933|NCT00441064|580927904|FG000|Overall Study|Abnormal test procedure results|0|||
160872934|NCT00441064|580927905|FG001|Overall Study|Abnormal test procedure results|1|||
160872935|NCT00441064|580927904|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160872936|NCT00441064|580927905|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160872937|NCT00441064|580927904|FG000|Overall Study|Protocol Deviation|3|||
160872938|NCT00441064|580927905|FG001|Overall Study|Protocol Deviation|2|||
160872939|NCT00441064|580927904|FG000|Overall Study|Patient withdrew consent|5|||
160872940|NCT00441064|580927905|FG001|Overall Study|Patient withdrew consent|2|||
160872941|NCT03051178|580927906|FG000|Overall Study|Withdrawal by Subject|5|||
160872942|NCT00953056|580927907|FG000|Overall Study|Withdrew Consent|0|||
160872943|NCT00953056|580927908|FG001|Overall Study|Withdrew Consent|0|||
160872944|NCT00953056|580927909|FG002|Overall Study|Withdrew Consent|0|||
160872945|NCT00953056|580927910|FG003|Overall Study|Withdrew Consent|0|||
160872946|NCT00953056|580927911|FG004|Overall Study|Withdrew Consent|2|||
160872947|NCT00953056|580927912|FG005|Overall Study|Withdrew Consent|3|||
160872948|NCT00953056|580927907|FG000|Overall Study|Serious Adverse Event|0|||
160872949|NCT00953056|580927908|FG001|Overall Study|Serious Adverse Event|0|||
160872950|NCT00953056|580927909|FG002|Overall Study|Serious Adverse Event|0|||
160872951|NCT00953056|580927910|FG003|Overall Study|Serious Adverse Event|0|||
160872952|NCT00953056|580927911|FG004|Overall Study|Serious Adverse Event|0|||
160872953|NCT00953056|580927912|FG005|Overall Study|Serious Adverse Event|1|||
160872954|NCT03962504|580927913|FG000|Overall Study|Other|11|||
160872955|NCT03962504|580927914|FG001|Overall Study|Other|32|||
160872956|NCT02813577|580927915|FG000|Overall Study|Study terminated|4|||
160872957|NCT01976741|580927916|FG000|Overall Study|Withdrawal by Subject|1|||
160872958|NCT01976741|580927917|FG001|Overall Study|Withdrawal by Subject|0|||
160872959|NCT01976741|580927918|FG002|Overall Study|Withdrawal by Subject|1|||
160872960|NCT01976741|580927919|FG003|Overall Study|Withdrawal by Subject|1|||
160872961|NCT01976741|580927920|FG004|Overall Study|Withdrawal by Subject|0|||
160872962|NCT01976741|580927921|FG005|Overall Study|Withdrawal by Subject|0|||
160872963|NCT01976741|580927922|FG006|Overall Study|Withdrawal by Subject|1|||
160872964|NCT01976741|580927923|FG007|Overall Study|Withdrawal by Subject|4|||
160872965|NCT01976741|580927924|FG008|Overall Study|Withdrawal by Subject|0|||
160872966|NCT01976741|580927925|FG009|Overall Study|Withdrawal by Subject|0|||
160872967|NCT01976741|580927916|FG000|Overall Study|Adverse Event|0|||
160872968|NCT01976741|580927917|FG001|Overall Study|Adverse Event|0|||
161219590|NCT01098240|582185647|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
161219591|NCT01098240|582185645|FG000|Double-Blind Phase|Adverse Event|0|||
161219592|NCT01098240|582185646|FG001|Double-Blind Phase|Adverse Event|3|||
161219593|NCT01098240|582185647|FG002|Double-Blind Phase|Adverse Event|3|||
161219594|NCT03507439|582185648|FG000|Overall Study|Other|2|||
161219595|NCT03507439|582185649|FG001|Overall Study|Other|1|||
160872969|NCT01976741|580927918|FG002|Overall Study|Adverse Event|2|||
160872970|NCT01976741|580927919|FG003|Overall Study|Adverse Event|0|||
160872971|NCT01976741|580927920|FG004|Overall Study|Adverse Event|0|||
160872972|NCT01976741|580927921|FG005|Overall Study|Adverse Event|0|||
160872973|NCT01976741|580927922|FG006|Overall Study|Adverse Event|3|||
160872974|NCT01976741|580927923|FG007|Overall Study|Adverse Event|8|||
160872975|NCT01976741|580927924|FG008|Overall Study|Adverse Event|1|||
160872976|NCT01976741|580927925|FG009|Overall Study|Adverse Event|4|||
160872977|NCT03566485|580927936|FG000|Overall Study|Disease progression|5|||
160872978|NCT03566485|580927937|FG001|Overall Study|Disease progression|4|||
160872979|NCT03566485|580927936|FG000|Overall Study|Clinical progression|0|||
160872980|NCT03566485|580927937|FG001|Overall Study|Clinical progression|1|||
160872981|NCT03566485|580927936|FG000|Overall Study|Toxicity|0|||
160872982|NCT03566485|580927937|FG001|Overall Study|Toxicity|2|||
160872983|NCT00048074|580927938|FG000|Overall Study|Adverse Event|46|||
160872984|NCT00048074|580927939|FG001|Overall Study|Adverse Event|41|||
160872985|NCT00048074|580927940|FG002|Overall Study|Adverse Event|53|||
160872986|NCT00048074|580927938|FG000|Overall Study|Death|3|||
160872987|NCT00048074|580927939|FG001|Overall Study|Death|3|||
160872988|NCT00048074|580927940|FG002|Overall Study|Death|2|||
160872989|NCT00048074|580927938|FG000|Overall Study|Lost to Follow-up|2|||
160872990|NCT00048074|580927939|FG001|Overall Study|Lost to Follow-up|6|||
160872991|NCT00048074|580927940|FG002|Overall Study|Lost to Follow-up|6|||
160872992|NCT00048074|580927938|FG000|Overall Study|Withdrawal by Subject|28|||
160872993|NCT00048074|580927939|FG001|Overall Study|Withdrawal by Subject|30|||
160872994|NCT00048074|580927940|FG002|Overall Study|Withdrawal by Subject|35|||
160872995|NCT00048074|580927938|FG000|Overall Study|Protocol Violation|1|||
160872996|NCT00048074|580927939|FG001|Overall Study|Protocol Violation|3|||
160872997|NCT00048074|580927940|FG002|Overall Study|Protocol Violation|0|||
160872998|NCT00048074|580927938|FG000|Overall Study|Study participation was terminated|0|||
160872999|NCT00048074|580927939|FG001|Overall Study|Study participation was terminated|1|||
160873000|NCT00048074|580927940|FG002|Overall Study|Study participation was terminated|0|||
160873001|NCT00048074|580927938|FG000|Overall Study|Husband ill|0|||
160873002|NCT00048074|580927939|FG001|Overall Study|Husband ill|1|||
160873003|NCT00048074|580927940|FG002|Overall Study|Husband ill|0|||
160873004|NCT00048074|580927938|FG000|Overall Study|Poor compliance|0|||
160873005|NCT00048074|580927939|FG001|Overall Study|Poor compliance|1|||
160873006|NCT00048074|580927940|FG002|Overall Study|Poor compliance|0|||
160873007|NCT00048074|580927938|FG000|Overall Study|Out of station|0|||
160873008|NCT00048074|580927939|FG001|Overall Study|Out of station|1|||
160873009|NCT00048074|580927940|FG002|Overall Study|Out of station|1|||
160873010|NCT00048074|580927938|FG000|Overall Study|Social reasons|1|||
160873011|NCT00048074|580927939|FG001|Overall Study|Social reasons|0|||
160873012|NCT00048074|580927940|FG002|Overall Study|Social reasons|0|||
160873013|NCT02873377|580927941|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
160873014|NCT02873377|580927942|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
160873015|NCT02873377|580927941|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
160873016|NCT02873377|580927942|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
160873017|NCT01583296|580927943|FG000|Overall Study|Withdrawal by Subject|11|||
160873018|NCT01583296|580927944|FG001|Overall Study|Withdrawal by Subject|10|||
160873019|NCT01063283|580927945|FG000|Cycle 1|Adverse Event|2|||
160873020|NCT01063283|580927946|FG001|Cycle 1|Adverse Event|0|||
160873021|NCT01063283|580927947|FG002|Cycle 1|Adverse Event|0|||
160873022|NCT01063283|580927945|FG000|Cycle 1|Technical failure in data collection|1|||
160873023|NCT01063283|580927946|FG001|Cycle 1|Technical failure in data collection|0|||
160873024|NCT01063283|580927947|FG002|Cycle 1|Technical failure in data collection|0|||
160873025|NCT02504216|580927950|FG000|Overall Study|Lost to Follow-up|3|||
160873026|NCT02504216|580927951|FG001|Overall Study|Lost to Follow-up|3|||
160873027|NCT02504216|580927950|FG000|Overall Study|Withdrawal by Subject|8|||
160873028|NCT02504216|580927951|FG001|Overall Study|Withdrawal by Subject|12|||
160873029|NCT00223080|580927952|FG000|Overall Study|Withdrawal by Subject|253|||
160873030|NCT00223080|580927953|FG001|Overall Study|Withdrawal by Subject|232|||
160873031|NCT00223080|580927952|FG000|Overall Study|Required contraindicated med|0|||
160873032|NCT00223080|580927953|FG001|Overall Study|Required contraindicated med|1|||
160873033|NCT00223080|580927952|FG000|Overall Study|Non-compliant|7|||
160873034|NCT00223080|580927953|FG001|Overall Study|Non-compliant|7|||
160873035|NCT00223080|580927952|FG000|Overall Study|Moved from study area|37|||
160873036|NCT00223080|580927953|FG001|Overall Study|Moved from study area|47|||
161115309|NCT03016325|581811470|FG002|Treatment Period|Participant refuses assessments|1|||
161115310|NCT03016325|581811471|FG003|Treatment Period|Participant refuses assessments|0|||
161115311|NCT03016325|581811472|FG004|Treatment Period|Participant refuses assessments|0|||
161115312|NCT03016325|581811473|FG005|Treatment Period|Participant refuses assessments|0|||
160873037|NCT00223080|580927952|FG000|Overall Study|Lost to Follow-up|259|||
160873038|NCT00223080|580927953|FG001|Overall Study|Lost to Follow-up|284|||
160873039|NCT00223080|580927952|FG000|Overall Study|Death|85|||
161115313|NCT03016325|581811474|FG006|Treatment Period|Participant refuses assessments|0|||
161115314|NCT03016325|581811475|FG007|Treatment Period|Participant refuses assessments|0|||
161115315|NCT03016325|581811468|FG000|32-Day Follow-Up Period|Death|2|||
160873040|NCT00223080|580927953|FG001|Overall Study|Death|74|||
160873041|NCT00223080|580927952|FG000|Overall Study|Other|14|||
160873042|NCT00223080|580927953|FG001|Overall Study|Other|11|||
160873043|NCT00223080|580927952|FG000|Overall Study|Reason not provided|141|||
160873044|NCT00223080|580927953|FG001|Overall Study|Reason not provided|140|||
160873045|NCT00223080|580927952|FG000|Overall Study|Adverse Event|0|||
160873046|NCT00223080|580927953|FG001|Overall Study|Adverse Event|1|||
160873047|NCT02598583|580927954|FG000|Extension Period|Withdrawal by Subject|1|||
160873048|NCT02598583|580927955|FG001|Extension Period|Withdrawal by Subject|0|||
160873049|NCT03237286|580927956|FG000|Overall Study|Withdrawal by Subject|1|||
160873050|NCT03237286|580927957|FG001|Overall Study|Withdrawal by Subject|0|||
160873051|NCT03237286|580927958|FG002|Overall Study|Withdrawal by Subject|2|||
160873052|NCT03237286|580927956|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
160873053|NCT03237286|580927957|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
160873054|NCT03237286|580927958|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
160873055|NCT02792829|580927966|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873056|NCT02792829|580927967|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
160873057|NCT02792829|580927968|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873058|NCT02792829|580927969|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873059|NCT02792829|580927970|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873060|NCT02792829|580927971|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873061|NCT02792829|580927972|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873062|NCT02792829|580927973|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
160873063|NCT02792829|580927966|FG000|Treatment Period 2|Adverse Event|0|||
160873064|NCT02792829|580927967|FG001|Treatment Period 2|Adverse Event|0|||
160873065|NCT02792829|580927968|FG002|Treatment Period 2|Adverse Event|0|||
160873066|NCT02792829|580927969|FG003|Treatment Period 2|Adverse Event|0|||
160873067|NCT02792829|580927970|FG004|Treatment Period 2|Adverse Event|1|||
160873068|NCT02792829|580927971|FG005|Treatment Period 2|Adverse Event|0|||
160873069|NCT02792829|580927972|FG006|Treatment Period 2|Adverse Event|1|||
160873070|NCT02792829|580927973|FG007|Treatment Period 2|Adverse Event|1|||
160873071|NCT02792829|580927966|FG000|Treatment Period 2|Use of proscribed medications|0|||
160873072|NCT02792829|580927967|FG001|Treatment Period 2|Use of proscribed medications|0|||
160873073|NCT02792829|580927968|FG002|Treatment Period 2|Use of proscribed medications|0|||
160873074|NCT02792829|580927969|FG003|Treatment Period 2|Use of proscribed medications|0|||
160873075|NCT02792829|580927970|FG004|Treatment Period 2|Use of proscribed medications|0|||
160873076|NCT02792829|580927971|FG005|Treatment Period 2|Use of proscribed medications|0|||
160873077|NCT02792829|580927972|FG006|Treatment Period 2|Use of proscribed medications|0|||
160873078|NCT02792829|580927973|FG007|Treatment Period 2|Use of proscribed medications|1|||
160873079|NCT01262820|580927974|FG000|Overall Study|Adverse Event|5|||
160873080|NCT01262820|580927974|FG000|Overall Study|Lack of Efficacy|9|||
160873081|NCT01262820|580927974|FG000|Overall Study|Drug held for 21+ days|1|||
160873082|NCT00104520|580927975|FG000|Overall Study|Unrelated adverse event|34|||
160873083|NCT00104520|580927976|FG001|Overall Study|Unrelated adverse event|47|||
160873084|NCT00104520|580927975|FG000|Overall Study|Study drug intolerance|0|||
160873085|NCT00104520|580927976|FG001|Overall Study|Study drug intolerance|1|||
160873086|NCT00104520|580927975|FG000|Overall Study|Related adverse event|13|||
160873087|NCT00104520|580927976|FG001|Overall Study|Related adverse event|15|||
160873088|NCT00104520|580927975|FG000|Overall Study|Lost to Follow-up|1|||
160873089|NCT00104520|580927976|FG001|Overall Study|Lost to Follow-up|0|||
160873090|NCT00104520|580927975|FG000|Overall Study|Noncompliance|0|||
160873091|NCT00104520|580927976|FG001|Overall Study|Noncompliance|2|||
160873092|NCT00104520|580927975|FG000|Overall Study|Personal/administrative|1|||
160873093|NCT00104520|580927976|FG001|Overall Study|Personal/administrative|1|||
160873094|NCT00104520|580927975|FG000|Overall Study|Other|1|||
160873095|NCT00104520|580927976|FG001|Overall Study|Other|5|||
160873096|NCT00912197|580927983|FG000|Overall Study|Withdrawal by Subject|3|||
160873097|NCT00912197|580927984|FG001|Overall Study|Withdrawal by Subject|3|||
160873098|NCT03304249|580927987|FG000|Overall Study|Lost to Follow-up|8|||
160873099|NCT03304249|580927988|FG001|Overall Study|Lost to Follow-up|10|||
160873100|NCT03304249|580927987|FG000|Overall Study|Withdrawal by Subject|12|||
160873101|NCT03304249|580927988|FG001|Overall Study|Withdrawal by Subject|2|||
160873102|NCT03304249|580927987|FG000|Overall Study|Moved Out of District|4|||
160873103|NCT03304249|580927988|FG001|Overall Study|Moved Out of District|2|||
160873104|NCT05064358|580927992|FG000|Overall Study|Death|23|||
160873105|NCT05064358|580927993|FG001|Overall Study|Death|23|||
160873106|NCT05064358|580927994|FG002|Overall Study|Death|25|||
160873107|NCT05064358|580927995|FG003|Overall Study|Death|21|||
160873108|NCT05064358|580927996|FG004|Overall Study|Death|5|||
160873109|NCT05064358|580927992|FG000|Overall Study|Lost to Follow-up|1|||
160873110|NCT05064358|580927993|FG001|Overall Study|Lost to Follow-up|2|||
160873111|NCT05064358|580927994|FG002|Overall Study|Lost to Follow-up|0|||
160873112|NCT05064358|580927995|FG003|Overall Study|Lost to Follow-up|2|||
160873113|NCT05064358|580927996|FG004|Overall Study|Lost to Follow-up|0|||
160873114|NCT05064358|580927992|FG000|Overall Study|Physician Decision|1|||
160873115|NCT05064358|580927993|FG001|Overall Study|Physician Decision|1|||
161219596|NCT03507439|582185648|FG000|Overall Study|Withdrawal by Subject|1|||
160873116|NCT05064358|580927994|FG002|Overall Study|Physician Decision|2|||
160873117|NCT05064358|580927995|FG003|Overall Study|Physician Decision|0|||
160873118|NCT05064358|580927996|FG004|Overall Study|Physician Decision|0|||
160873119|NCT05064358|580927992|FG000|Overall Study|Withdrawal by Subject|4|||
160873120|NCT05064358|580927993|FG001|Overall Study|Withdrawal by Subject|5|||
160873121|NCT05064358|580927994|FG002|Overall Study|Withdrawal by Subject|3|||
160873122|NCT05064358|580927995|FG003|Overall Study|Withdrawal by Subject|6|||
160873123|NCT05064358|580927996|FG004|Overall Study|Withdrawal by Subject|3|||
160873124|NCT05064358|580927992|FG000|Overall Study|Ongoing at the time of analysis|1|||
160873125|NCT05064358|580927993|FG001|Overall Study|Ongoing at the time of analysis|2|||
160873126|NCT05064358|580927994|FG002|Overall Study|Ongoing at the time of analysis|2|||
160873127|NCT05064358|580927995|FG003|Overall Study|Ongoing at the time of analysis|2|||
160873128|NCT05064358|580927996|FG004|Overall Study|Ongoing at the time of analysis|2|||
160873129|NCT04976192|580927998|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873130|NCT04976192|580927999|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
160873131|NCT04976192|580928000|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873132|NCT04976192|580928001|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873133|NCT04976192|580928002|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873134|NCT04976192|580928003|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873135|NCT04976192|580928004|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873136|NCT04976192|580928005|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873137|NCT04976192|580928006|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873138|NCT04976192|580928007|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
160873139|NCT04976192|580927998|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
160873140|NCT04976192|580927999|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
160873141|NCT04976192|580928000|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
160873142|NCT04976192|580928001|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160873143|NCT04976192|580928002|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873144|NCT04976192|580928003|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873145|NCT04976192|580928004|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873146|NCT04976192|580928005|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873147|NCT04976192|580928006|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873148|NCT04976192|580928007|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873149|NCT04976192|580927998|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
160873150|NCT04976192|580927999|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873151|NCT04976192|580928000|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
160873152|NCT04976192|580928001|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873153|NCT04976192|580928002|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873154|NCT04976192|580928003|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873155|NCT04976192|580928004|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873156|NCT04976192|580928005|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873157|NCT04976192|580928006|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873158|NCT04976192|580928007|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
160873159|NCT04976192|580927998|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873160|NCT04976192|580927999|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873161|NCT04976192|580928000|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873162|NCT04976192|580928001|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160873163|NCT04976192|580928002|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
160873164|NCT04976192|580928003|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
160873165|NCT04976192|580928004|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160873166|NCT04976192|580928005|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
160873167|NCT04976192|580928006|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
160873168|NCT04976192|580928007|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
160873169|NCT04976192|580927998|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873170|NCT04976192|580927999|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873171|NCT04976192|580928000|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161115316|NCT03016325|581811469|FG001|32-Day Follow-Up Period|Death|0|||
161115317|NCT03016325|581811470|FG002|32-Day Follow-Up Period|Death|5|||
161115318|NCT03016325|581811471|FG003|32-Day Follow-Up Period|Death|6|||
161115319|NCT03016325|581811472|FG004|32-Day Follow-Up Period|Death|3|||
160873172|NCT04976192|580928001|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873173|NCT04976192|580928002|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
160873174|NCT04976192|580928003|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
161115320|NCT03016325|581811473|FG005|32-Day Follow-Up Period|Death|0|||
160873175|NCT04976192|580928004|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873176|NCT04976192|580928005|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873177|NCT04976192|580928006|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873178|NCT04976192|580928007|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
160873179|NCT04976192|580927998|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873180|NCT04976192|580927999|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873181|NCT04976192|580928000|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873182|NCT04976192|580928001|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873183|NCT04976192|580928002|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873184|NCT04976192|580928003|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160873185|NCT04976192|580928004|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873186|NCT04976192|580928005|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873187|NCT04976192|580928006|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873188|NCT04976192|580928007|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160873189|NCT01395524|580929793|FG000|Overall Study|Non-compliance with study schedule|1|||
160873190|NCT01395524|580929794|FG001|Overall Study|Non-compliance with study schedule|0|||
160873191|NCT01395524|580929795|FG002|Overall Study|Non-compliance with study schedule|1|||
160873192|NCT01395524|580929793|FG000|Overall Study|Lost to Follow-up|3|||
160873193|NCT01395524|580929794|FG001|Overall Study|Lost to Follow-up|1|||
160873194|NCT01395524|580929795|FG002|Overall Study|Lost to Follow-up|1|||
160873195|NCT01395524|580929793|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
160873196|NCT01395524|580929794|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
160873197|NCT01395524|580929795|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
160873198|NCT01395524|580929793|FG000|Overall Study|Severe noncompliance with protocol|1|||
160873199|NCT01395524|580929794|FG001|Overall Study|Severe noncompliance with protocol|0|||
160873200|NCT01395524|580929795|FG002|Overall Study|Severe noncompliance with protocol|0|||
160873201|NCT01395524|580929793|FG000|Overall Study|Adverse Event|4|||
160873202|NCT01395524|580929794|FG001|Overall Study|Adverse Event|4|||
160873203|NCT01395524|580929795|FG002|Overall Study|Adverse Event|3|||
160873204|NCT01395524|580929793|FG000|Overall Study|Death|1|||
160873205|NCT01395524|580929794|FG001|Overall Study|Death|0|||
160873206|NCT01395524|580929795|FG002|Overall Study|Death|0|||
160873207|NCT01395524|580929793|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160873208|NCT01395524|580929794|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160873209|NCT01395524|580929795|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
160873210|NCT01395524|580929793|FG000|Overall Study|Withdrawal by Subject|4|||
160873211|NCT01395524|580929794|FG001|Overall Study|Withdrawal by Subject|8|||
160873212|NCT01395524|580929795|FG002|Overall Study|Withdrawal by Subject|8|||
160873213|NCT01395524|580929793|FG000|Overall Study|Did not receive treatment|1|||
160873214|NCT01395524|580929794|FG001|Overall Study|Did not receive treatment|1|||
160873215|NCT01395524|580929795|FG002|Overall Study|Did not receive treatment|3|||
160873216|NCT01395524|580929793|FG000|Overall Study|Subject had spinal surgery|0|||
160873217|NCT01395524|580929794|FG001|Overall Study|Subject had spinal surgery|0|||
160873218|NCT01395524|580929795|FG002|Overall Study|Subject had spinal surgery|1|||
160873219|NCT00122980|580929806|FG000|Overall Study|Death|0|||
160873220|NCT00122980|580929807|FG001|Overall Study|Death|1|||
160873221|NCT00122980|580929806|FG000|Overall Study|Physician Decision|2|||
160873222|NCT00122980|580929807|FG001|Overall Study|Physician Decision|0|||
160873223|NCT00122980|580929806|FG000|Overall Study|Protocol Violation|5|||
160873224|NCT00122980|580929807|FG001|Overall Study|Protocol Violation|1|||
160873225|NCT00122980|580929806|FG000|Overall Study|Withdrawal by Subject|2|||
160873226|NCT00122980|580929807|FG001|Overall Study|Withdrawal by Subject|3|||
160873227|NCT00122980|580929806|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
160873228|NCT00122980|580929807|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
160873229|NCT00122980|580929806|FG000|Overall Study|Study termination|27|||
160873230|NCT00122980|580929807|FG001|Overall Study|Study termination|35|||
160873231|NCT02175199|580929808|FG000|Overall Study|Withdrawal by Subject|1|||
160873232|NCT02175199|580929809|FG001|Overall Study|Withdrawal by Subject|5|||
160873233|NCT02175199|580929808|FG000|Overall Study|Randomized in Error|1|||
160873234|NCT02175199|580929809|FG001|Overall Study|Randomized in Error|0|||
160873235|NCT02175199|580929808|FG000|Overall Study|Sponsor Decision|1|||
160873236|NCT02175199|580929809|FG001|Overall Study|Sponsor Decision|0|||
160873237|NCT01124864|580929810|FG000|Overall Study|Follow up phase competed as per protocol|18|||
160873238|NCT01124864|580929811|FG001|Overall Study|Follow up phase competed as per protocol|22|||
160873239|NCT01124864|580929812|FG002|Overall Study|Follow up phase competed as per protocol|24|||
161219597|NCT03507439|582185649|FG001|Overall Study|Withdrawal by Subject|0|||
161219598|NCT03507439|582185648|FG000|Overall Study|Death|1|||
160873240|NCT01124864|580929813|FG003|Overall Study|Follow up phase competed as per protocol|18|||
160873241|NCT01124864|580929814|FG004|Overall Study|Follow up phase competed as per protocol|26|||
160873242|NCT01124864|580929815|FG005|Overall Study|Follow up phase competed as per protocol|2|||
160873243|NCT01124864|580929810|FG000|Overall Study|Death|6|||
160873244|NCT01124864|580929811|FG001|Overall Study|Death|9|||
161219599|NCT03507439|582185649|FG001|Overall Study|Death|1|||
161219600|NCT00874757|582185650|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
161219601|NCT03346538|582186623|FG000|Overall Study|Physician Decision|0|||
161219602|NCT03346538|582186624|FG001|Overall Study|Physician Decision|1|||
161219603|NCT03346538|582186625|FG002|Overall Study|Physician Decision|0|||
161219604|NCT03346538|582186623|FG000|Overall Study|Withdrawal by Subject|3|||
161219605|NCT03346538|582186624|FG001|Overall Study|Withdrawal by Subject|2|||
161219606|NCT03346538|582186625|FG002|Overall Study|Withdrawal by Subject|0|||
161219607|NCT03346538|582186623|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
161219608|NCT03346538|582186624|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
161219609|NCT03346538|582186625|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
161219610|NCT02220920|582186626|FG000|Overall Study|Adverse Event|1|||
161219611|NCT02220920|582186627|FG001|Overall Study|Adverse Event|0|||
161219612|NCT02220920|582186626|FG000|Overall Study|Lack of Efficacy|0|||
161219613|NCT02220920|582186627|FG001|Overall Study|Lack of Efficacy|1|||
161219614|NCT02220920|582186626|FG000|Overall Study|Withdrawal by Subject|1|||
161219615|NCT02220920|582186627|FG001|Overall Study|Withdrawal by Subject|0|||
161219616|NCT02220920|582186626|FG000|Overall Study|Conflict with the stopping criteria|1|||
161219617|NCT02220920|582186627|FG001|Overall Study|Conflict with the stopping criteria|2|||
161219618|NCT01644890|582186631|FG000|Overall Study|Adverse Event|7|||
161219619|NCT01644890|582186632|FG001|Overall Study|Adverse Event|20|||
161219620|NCT01644890|582186631|FG000|Overall Study|Death|1|||
161219621|NCT01644890|582186632|FG001|Overall Study|Death|3|||
160873245|NCT01124864|580929812|FG002|Overall Study|Death|6|||
161219622|NCT01644890|582186631|FG000|Overall Study|Physician Decision|3|||
161219623|NCT01644890|582186632|FG001|Overall Study|Physician Decision|9|||
161219624|NCT01644890|582186631|FG000|Overall Study|Protocol Violation|6|||
161219625|NCT01644890|582186632|FG001|Overall Study|Protocol Violation|7|||
160873246|NCT01124864|580929813|FG003|Overall Study|Death|2|||
160873247|NCT01124864|580929814|FG004|Overall Study|Death|1|||
160873248|NCT01124864|580929815|FG005|Overall Study|Death|0|||
160873249|NCT01124864|580929810|FG000|Overall Study|Withdrawal by Subject|2|||
160873250|NCT01124864|580929811|FG001|Overall Study|Withdrawal by Subject|3|||
160873251|NCT01124864|580929812|FG002|Overall Study|Withdrawal by Subject|4|||
160873252|NCT01124864|580929813|FG003|Overall Study|Withdrawal by Subject|0|||
160873253|NCT01124864|580929814|FG004|Overall Study|Withdrawal by Subject|2|||
160873254|NCT01124864|580929815|FG005|Overall Study|Withdrawal by Subject|1|||
161115321|NCT03016325|581811474|FG006|32-Day Follow-Up Period|Death|0|||
161115322|NCT03016325|581811475|FG007|32-Day Follow-Up Period|Death|0|||
161115323|NCT03016325|581811468|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
161115324|NCT03016325|581811469|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
161115325|NCT03016325|581811470|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
161115326|NCT03016325|581811471|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
161115327|NCT03016325|581811472|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
161115328|NCT03016325|581811473|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
161115329|NCT03016325|581811474|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
161115330|NCT03016325|581811475|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
161115331|NCT03016325|581811468|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
161115332|NCT03016325|581811469|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
161115333|NCT03016325|581811470|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
161115334|NCT03016325|581811471|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
161115335|NCT03016325|581811472|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
161115336|NCT03016325|581811473|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
161115337|NCT03016325|581811474|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
161115338|NCT03016325|581811475|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
161115339|NCT03016325|581811468|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
161115340|NCT03016325|581811469|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
161115341|NCT03016325|581811470|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
161115342|NCT03016325|581811471|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
161115343|NCT03016325|581811472|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
161115344|NCT03016325|581811473|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
161115345|NCT03016325|581811474|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
161115346|NCT03016325|581811475|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
161115347|NCT03016325|581811468|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
161115348|NCT03016325|581811469|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
161115349|NCT03016325|581811470|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
161115350|NCT03016325|581811471|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
161115351|NCT03016325|581811472|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
161115352|NCT03016325|581811473|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
161115353|NCT03016325|581811474|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
161115354|NCT03016325|581811475|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
161115355|NCT03016325|581811468|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115356|NCT03016325|581811469|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115357|NCT03016325|581811470|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
161115358|NCT03016325|581811471|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115359|NCT03016325|581811472|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115360|NCT03016325|581811473|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115361|NCT03016325|581811474|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115362|NCT03016325|581811475|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
161115363|NCT03016325|581811468|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115364|NCT03016325|581811469|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
161115365|NCT03016325|581811470|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115366|NCT03016325|581811471|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115367|NCT03016325|581811472|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115368|NCT03016325|581811473|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115369|NCT03016325|581811474|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115370|NCT03016325|581811475|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
161115371|NCT03016325|581811468|FG000|182-Day Follow-Up Period|Death|3|||
161115372|NCT03016325|581811469|FG001|182-Day Follow-Up Period|Death|3|||
161115373|NCT03016325|581811470|FG002|182-Day Follow-Up Period|Death|11|||
161115374|NCT03016325|581811471|FG003|182-Day Follow-Up Period|Death|12|||
161219626|NCT01644890|582186631|FG000|Overall Study|Withdrawal by Subject|19|||
161219627|NCT01644890|582186632|FG001|Overall Study|Withdrawal by Subject|27|||
161219628|NCT01644890|582186631|FG000|Overall Study|Progression Disease|160|||
160873255|NCT01124864|580929810|FG000|Overall Study|Lost to Follow-up|1|||
160873256|NCT01124864|580929811|FG001|Overall Study|Lost to Follow-up|1|||
160873257|NCT01124864|580929812|FG002|Overall Study|Lost to Follow-up|0|||
160873258|NCT01124864|580929813|FG003|Overall Study|Lost to Follow-up|1|||
160873259|NCT01124864|580929814|FG004|Overall Study|Lost to Follow-up|0|||
160873260|NCT01124864|580929815|FG005|Overall Study|Lost to Follow-up|0|||
160873261|NCT01124864|580929810|FG000|Overall Study|Protocol Violation|1|||
160873262|NCT01124864|580929811|FG001|Overall Study|Protocol Violation|0|||
160873263|NCT01124864|580929812|FG002|Overall Study|Protocol Violation|0|||
160873264|NCT01124864|580929813|FG003|Overall Study|Protocol Violation|0|||
160873265|NCT01124864|580929814|FG004|Overall Study|Protocol Violation|1|||
160873266|NCT01124864|580929815|FG005|Overall Study|Protocol Violation|0|||
160873267|NCT00798759|580929818|FG000|Overall Study|Adverse Event|3|||
160873268|NCT00798759|580929819|FG001|Overall Study|Adverse Event|3|||
160873269|NCT00798759|580929818|FG000|Overall Study|Lost to Follow-up|1|||
160873270|NCT00798759|580929819|FG001|Overall Study|Lost to Follow-up|1|||
160873271|NCT00798759|580929818|FG000|Overall Study|Protocol Violation|4|||
160873272|NCT00798759|580929819|FG001|Overall Study|Protocol Violation|8|||
160873273|NCT00798759|580929818|FG000|Overall Study|Other|0|||
160873274|NCT00798759|580929819|FG001|Overall Study|Other|1|||
160873275|NCT00724711|580929820|FG000|Overall Study|Adverse Event|7|||
160873276|NCT00724711|580929821|FG001|Overall Study|Adverse Event|3|||
160873277|NCT00724711|580929820|FG000|Overall Study|Pregnancy|0|||
160873278|NCT00724711|580929821|FG001|Overall Study|Pregnancy|1|||
160873279|NCT00724711|580929820|FG000|Overall Study|Lack of Efficacy|0|||
160873280|NCT00724711|580929821|FG001|Overall Study|Lack of Efficacy|1|||
160873281|NCT00724711|580929820|FG000|Overall Study|Physician Decision|0|||
160873282|NCT00724711|580929821|FG001|Overall Study|Physician Decision|3|||
160873283|NCT00724711|580929820|FG000|Overall Study|Withdrawal by Subject|5|||
160873284|NCT00724711|580929821|FG001|Overall Study|Withdrawal by Subject|4|||
160873285|NCT00724711|580929820|FG000|Overall Study|Lost to Follow-up|4|||
160873286|NCT00724711|580929821|FG001|Overall Study|Lost to Follow-up|5|||
160873287|NCT00724711|580929820|FG000|Overall Study|Protocol Violation|1|||
160873288|NCT00724711|580929821|FG001|Overall Study|Protocol Violation|0|||
160873289|NCT01368562|580929824|FG000|Overall Study|Adverse Event|1|||
160873290|NCT01368562|580929824|FG000|Overall Study|Disease progression|1|||
160873291|NCT01368562|580929824|FG000|Overall Study|Lost to Follow-up|1|||
160873292|NCT01368562|580929824|FG000|Overall Study|Death|6|||
160873293|NCT01368562|580929824|FG000|Overall Study|Unresponsive to treatment|5|||
160873294|NCT01368562|580929824|FG000|Overall Study|Other|3|||
160873295|NCT01368562|580929824|FG000|Overall Study|Other than specified|2|||
160873296|NCT02147561|580929825|FG000|Overall Study|Lost to Follow-up|3|||
160873297|NCT02147561|580929825|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
160873298|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
161115375|NCT03016325|581811472|FG004|182-Day Follow-Up Period|Death|9|||
161115376|NCT03016325|581811473|FG005|182-Day Follow-Up Period|Death|0|||
161115377|NCT03016325|581811474|FG006|182-Day Follow-Up Period|Death|0|||
161115378|NCT03016325|581811475|FG007|182-Day Follow-Up Period|Death|1|||
161115379|NCT03016325|581811468|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
161115380|NCT03016325|581811469|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115381|NCT03016325|581811470|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115382|NCT03016325|581811471|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115383|NCT03016325|581811472|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115384|NCT03016325|581811473|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115385|NCT03016325|581811474|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115386|NCT03016325|581811475|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
161115387|NCT03016325|581811468|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
161115388|NCT03016325|581811469|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
161115389|NCT03016325|581811470|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
161115390|NCT03016325|581811471|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
161115391|NCT03016325|581811472|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
161115392|NCT03016325|581811473|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
161115393|NCT03016325|581811474|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
160873299|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
160873300|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
160873301|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
160873302|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
160873303|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
160873304|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
160873305|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
160873306|NCT02283762|580929828|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
160873307|NCT02283762|580929829|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
160873308|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
161219629|NCT01644890|582186632|FG001|Overall Study|Progression Disease|131|||
160873309|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
160873310|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
160873311|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
160873312|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
160873313|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
160873314|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
160873315|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
160873316|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
160873317|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
160873318|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
160873319|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
160873320|NCT02283762|580929828|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
160873321|NCT02283762|580929829|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
160873322|NCT00202878|580929833|FG000|Overall Study|Death|964|||
160873323|NCT00202878|580929834|FG001|Overall Study|Death|968|||
160873324|NCT00202878|580929833|FG000|Overall Study|Only Vital Status Known|357|||
160873325|NCT00202878|580929834|FG001|Overall Study|Only Vital Status Known|356|||
160873326|NCT00202878|580929833|FG000|Overall Study|Lost to Follow-up|44|||
160873327|NCT00202878|580929834|FG001|Overall Study|Lost to Follow-up|49|||
160873328|NCT00202878|580929833|FG000|Overall Study|Site Closure|39|||
160873329|NCT00202878|580929834|FG001|Overall Study|Site Closure|36|||
160873330|NCT00202878|580929833|FG000|Overall Study|Withdrawal by Subject|795|||
160873331|NCT00202878|580929834|FG001|Overall Study|Withdrawal by Subject|808|||
160873332|NCT02123472|580929835|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
160873333|NCT02123472|580929836|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
160873334|NCT00918736|580929837|FG000|Overall Study|Withdrawal by Subject|4|||
160873335|NCT00035932|580929841|FG000|Overall Study|Adverse Event|10|||
160873336|NCT00035932|580929842|FG001|Overall Study|Adverse Event|9|||
160873337|NCT00035932|580929843|FG002|Overall Study|Adverse Event|9|||
160873338|NCT00035932|580929841|FG000|Overall Study|Death|0|||
160873339|NCT00035932|580929842|FG001|Overall Study|Death|0|||
160873340|NCT00035932|580929843|FG002|Overall Study|Death|1|||
160873341|NCT00035932|580929841|FG000|Overall Study|Disease Progression / Relapse|1|||
160873342|NCT00035932|580929842|FG001|Overall Study|Disease Progression / Relapse|1|||
160873343|NCT00035932|580929843|FG002|Overall Study|Disease Progression / Relapse|0|||
160873344|NCT00035932|580929841|FG000|Overall Study|Lost to Follow-up|4|||
160873345|NCT00035932|580929842|FG001|Overall Study|Lost to Follow-up|4|||
160873346|NCT00035932|580929843|FG002|Overall Study|Lost to Follow-up|3|||
160873347|NCT00035932|580929841|FG000|Overall Study|Noncompliance|6|||
160873348|NCT00035932|580929842|FG001|Overall Study|Noncompliance|7|||
160873349|NCT00035932|580929843|FG002|Overall Study|Noncompliance|6|||
160873350|NCT00035932|580929841|FG000|Overall Study|Protocol Violation While on Study|0|||
160873351|NCT00035932|580929842|FG001|Overall Study|Protocol Violation While on Study|1|||
160873352|NCT00035932|580929843|FG002|Overall Study|Protocol Violation While on Study|2|||
160873353|NCT00035932|580929841|FG000|Overall Study|Withdrawal by Subject|1|||
160873354|NCT00035932|580929842|FG001|Overall Study|Withdrawal by Subject|5|||
160873355|NCT00035932|580929843|FG002|Overall Study|Withdrawal by Subject|0|||
160873356|NCT00035932|580929841|FG000|Overall Study|Study Termination by Sponsor|1|||
160873357|NCT00035932|580929842|FG001|Overall Study|Study Termination by Sponsor|0|||
160873358|NCT00035932|580929843|FG002|Overall Study|Study Termination by Sponsor|0|||
160873359|NCT00035932|580929841|FG000|Overall Study|Lack of Efficacy|33|||
160873360|NCT00035932|580929842|FG001|Overall Study|Lack of Efficacy|33|||
160873361|NCT00035932|580929843|FG002|Overall Study|Lack of Efficacy|28|||
160873362|NCT00889720|580929846|FG000|Overall Study|Withdrawal by Subject|4|||
160873363|NCT00889720|580929846|FG000|Overall Study|Other|4|||
160873364|NCT04080167|580929847|FG000|Overall Study|Lost to Follow-up-Patients|7|||
160873365|NCT04080167|580929848|FG001|Overall Study|Lost to Follow-up-Patients|14|||
160873366|NCT04080167|580929849|FG002|Overall Study|Lost to Follow-up-Patients|0|||
160873367|NCT04080167|580929847|FG000|Overall Study|Lost to Follow-up-Providers|2|||
161115394|NCT03016325|581811475|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
161115395|NCT03016325|581811468|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115396|NCT03016325|581811469|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115397|NCT03016325|581811470|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115398|NCT03016325|581811471|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115399|NCT03016325|581811472|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
160873368|NCT04080167|580929848|FG001|Overall Study|Lost to Follow-up-Providers|2|||
160873369|NCT04080167|580929849|FG002|Overall Study|Lost to Follow-up-Providers|0|||
160873370|NCT04080167|580929847|FG000|Overall Study|Withdrawal by Subject|1|||
160873371|NCT04080167|580929848|FG001|Overall Study|Withdrawal by Subject|2|||
160873372|NCT04080167|580929849|FG002|Overall Study|Withdrawal by Subject|0|||
160873373|NCT04080167|580929847|FG000|Overall Study|Withdrawal by Provider|0|||
160873374|NCT04080167|580929848|FG001|Overall Study|Withdrawal by Provider|0|||
160873375|NCT04080167|580929849|FG002|Overall Study|Withdrawal by Provider|4|||
160873376|NCT04080167|580929847|FG000|Overall Study|Death-Patient|2|||
160873377|NCT04080167|580929848|FG001|Overall Study|Death-Patient|1|||
160873378|NCT04080167|580929849|FG002|Overall Study|Death-Patient|0|||
160873379|NCT04080167|580929847|FG000|Overall Study|Hydroxyurea New Starts|0|||
160873380|NCT04080167|580929848|FG001|Overall Study|Hydroxyurea New Starts|0|||
160873381|NCT04080167|580929849|FG002|Overall Study|Hydroxyurea New Starts|1|||
160873382|NCT04080167|580929847|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
160873383|NCT04080167|580929848|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
160873384|NCT04080167|580929849|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
160873385|NCT02100696|580929850|FG000|Induction Phase|Adverse Event|0|||
160873386|NCT02100696|580929851|FG001|Induction Phase|Adverse Event|0|||
160873387|NCT02100696|580929852|FG002|Induction Phase|Adverse Event|1|||
160873388|NCT02100696|580929853|FG003|Induction Phase|Adverse Event|0|||
160873389|NCT02100696|580929854|FG004|Induction Phase|Adverse Event|0|||
160873390|NCT02100696|580929855|FG005|Induction Phase|Adverse Event|0|||
161219630|NCT01644890|582186631|FG000|Overall Study|Clinical Progression|6|||
161219631|NCT01644890|582186632|FG001|Overall Study|Clinical Progression|6|||
161219632|NCT01644890|582186631|FG000|Overall Study|> 28 days since last dose of study drug|6|||
161219633|NCT01644890|582186632|FG001|Overall Study|> 28 days since last dose of study drug|3|||
161219634|NCT01644890|582186631|FG000|Overall Study|Other|8|||
161219635|NCT01644890|582186632|FG001|Overall Study|Other|9|||
161219636|NCT01413204|582186633|FG000|Overall Study|Adverse Event|1|||
161219637|NCT01413204|582186634|FG001|Overall Study|Adverse Event|2|||
161219638|NCT01413204|582186635|FG002|Overall Study|Adverse Event|2|||
161219639|NCT01413204|582186633|FG000|Overall Study|Physician Decision|3|||
161219640|NCT01413204|582186634|FG001|Overall Study|Physician Decision|0|||
161219641|NCT01413204|582186635|FG002|Overall Study|Physician Decision|2|||
161115400|NCT03016325|581811473|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115401|NCT03016325|581811474|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115402|NCT03016325|581811475|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
161115403|NCT03016325|581811468|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115404|NCT03016325|581811469|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115405|NCT03016325|581811470|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115406|NCT03016325|581811471|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115407|NCT03016325|581811472|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
161219642|NCT01413204|582186633|FG000|Overall Study|Withdrawal by Subject|1|||
161219643|NCT01413204|582186634|FG001|Overall Study|Withdrawal by Subject|4|||
161219644|NCT01413204|582186635|FG002|Overall Study|Withdrawal by Subject|4|||
161219645|NCT01413204|582186633|FG000|Overall Study|Clearly not eligible for the study|0|||
161219646|NCT01413204|582186634|FG001|Overall Study|Clearly not eligible for the study|0|||
161219647|NCT01413204|582186635|FG002|Overall Study|Clearly not eligible for the study|1|||
161219648|NCT01413204|582186633|FG000|Overall Study|Fasting plasma glucose level increased|1|||
161219649|NCT01413204|582186634|FG001|Overall Study|Fasting plasma glucose level increased|0|||
160873391|NCT02100696|580929850|FG000|Induction Phase|Lost to Follow-up|1|||
160873392|NCT02100696|580929851|FG001|Induction Phase|Lost to Follow-up|0|||
160873393|NCT02100696|580929852|FG002|Induction Phase|Lost to Follow-up|1|||
160873394|NCT02100696|580929853|FG003|Induction Phase|Lost to Follow-up|0|||
160873395|NCT02100696|580929854|FG004|Induction Phase|Lost to Follow-up|0|||
160873396|NCT02100696|580929855|FG005|Induction Phase|Lost to Follow-up|0|||
160873397|NCT02100696|580929850|FG000|Induction Phase|Protocol Violation|0|||
160873398|NCT02100696|580929851|FG001|Induction Phase|Protocol Violation|1|||
160873399|NCT02100696|580929852|FG002|Induction Phase|Protocol Violation|1|||
160873400|NCT02100696|580929853|FG003|Induction Phase|Protocol Violation|0|||
160873401|NCT02100696|580929854|FG004|Induction Phase|Protocol Violation|0|||
160873402|NCT02100696|580929855|FG005|Induction Phase|Protocol Violation|0|||
160873403|NCT02100696|580929850|FG000|Induction Phase|Withdrawal by Subject|8|||
160873404|NCT02100696|580929851|FG001|Induction Phase|Withdrawal by Subject|2|||
160873405|NCT02100696|580929852|FG002|Induction Phase|Withdrawal by Subject|13|||
160873406|NCT02100696|580929853|FG003|Induction Phase|Withdrawal by Subject|0|||
160873407|NCT02100696|580929854|FG004|Induction Phase|Withdrawal by Subject|0|||
160873408|NCT02100696|580929855|FG005|Induction Phase|Withdrawal by Subject|0|||
161115408|NCT03016325|581811473|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115409|NCT03016325|581811474|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115410|NCT03016325|581811475|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
161115411|NCT03016325|581811468|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161115412|NCT03016325|581811469|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161219650|NCT01413204|582186635|FG002|Overall Study|Fasting plasma glucose level increased|10|||
161219651|NCT02497391|582186636|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
161219652|NCT02497391|582186637|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
161219653|NCT02497391|582186638|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
161219654|NCT02497391|582186639|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
161219655|NCT02497391|582186640|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
160873409|NCT02100696|580929850|FG000|Induction Phase|Physician Decision|1|||
160873410|NCT02100696|580929851|FG001|Induction Phase|Physician Decision|0|||
160873411|NCT02100696|580929852|FG002|Induction Phase|Physician Decision|2|||
160873412|NCT02100696|580929853|FG003|Induction Phase|Physician Decision|0|||
160873413|NCT02100696|580929854|FG004|Induction Phase|Physician Decision|0|||
160873414|NCT02100696|580929855|FG005|Induction Phase|Physician Decision|0|||
160873415|NCT02100696|580929850|FG000|Induction Phase|Multiple Reasons|5|||
160873416|NCT02100696|580929851|FG001|Induction Phase|Multiple Reasons|2|||
160873417|NCT02100696|580929852|FG002|Induction Phase|Multiple Reasons|8|||
161219656|NCT02497391|582186641|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
161219657|NCT02497391|582186636|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
161219658|NCT02497391|582186637|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
161219659|NCT02497391|582186638|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
161219660|NCT02497391|582186639|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
161219661|NCT02497391|582186640|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
161219662|NCT02497391|582186641|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
161219663|NCT02497391|582186636|FG000|Period 3 (14 Days)|Adverse Event|0|||
161219664|NCT02497391|582186637|FG001|Period 3 (14 Days)|Adverse Event|1|||
161219665|NCT02497391|582186638|FG002|Period 3 (14 Days)|Adverse Event|0|||
161219666|NCT02497391|582186639|FG003|Period 3 (14 Days)|Adverse Event|0|||
161219667|NCT02497391|582186640|FG004|Period 3 (14 Days)|Adverse Event|0|||
161219668|NCT02497391|582186641|FG005|Period 3 (14 Days)|Adverse Event|0|||
161219669|NCT02497391|582186636|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
161219670|NCT02497391|582186637|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
161219671|NCT02497391|582186638|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
161219672|NCT02497391|582186639|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
160873418|NCT02100696|580929853|FG003|Induction Phase|Multiple Reasons|0|||
160873419|NCT02100696|580929854|FG004|Induction Phase|Multiple Reasons|0|||
160873420|NCT02100696|580929855|FG005|Induction Phase|Multiple Reasons|0|||
160873421|NCT02100696|580929850|FG000|Maintenance Phase|Adverse Event|0|||
160873422|NCT02100696|580929851|FG001|Maintenance Phase|Adverse Event|0|||
160873423|NCT02100696|580929852|FG002|Maintenance Phase|Adverse Event|0|||
160873424|NCT02100696|580929853|FG003|Maintenance Phase|Adverse Event|0|||
160873425|NCT02100696|580929854|FG004|Maintenance Phase|Adverse Event|0|||
160873426|NCT02100696|580929855|FG005|Maintenance Phase|Adverse Event|2|||
160873427|NCT02100696|580929850|FG000|Maintenance Phase|Lost to Follow-up|0|||
160873428|NCT02100696|580929851|FG001|Maintenance Phase|Lost to Follow-up|0|||
160873429|NCT02100696|580929852|FG002|Maintenance Phase|Lost to Follow-up|0|||
160873430|NCT02100696|580929853|FG003|Maintenance Phase|Lost to Follow-up|0|||
160873431|NCT02100696|580929854|FG004|Maintenance Phase|Lost to Follow-up|1|||
160873432|NCT02100696|580929855|FG005|Maintenance Phase|Lost to Follow-up|0|||
160873433|NCT02100696|580929850|FG000|Maintenance Phase|Protocol Violation|0|||
160873434|NCT02100696|580929851|FG001|Maintenance Phase|Protocol Violation|0|||
160873435|NCT02100696|580929852|FG002|Maintenance Phase|Protocol Violation|0|||
160873436|NCT02100696|580929853|FG003|Maintenance Phase|Protocol Violation|0|||
160873437|NCT02100696|580929854|FG004|Maintenance Phase|Protocol Violation|1|||
160873438|NCT02100696|580929855|FG005|Maintenance Phase|Protocol Violation|0|||
160873439|NCT02100696|580929850|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160873440|NCT02100696|580929851|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160873441|NCT02100696|580929852|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160873442|NCT02100696|580929853|FG003|Maintenance Phase|Withdrawal by Subject|1|||
160873443|NCT02100696|580929854|FG004|Maintenance Phase|Withdrawal by Subject|4|||
160873444|NCT02100696|580929855|FG005|Maintenance Phase|Withdrawal by Subject|2|||
160873445|NCT02100696|580929850|FG000|Maintenance Phase|Physician Decision|0|||
160873446|NCT02100696|580929851|FG001|Maintenance Phase|Physician Decision|0|||
160873447|NCT02100696|580929852|FG002|Maintenance Phase|Physician Decision|0|||
160873448|NCT02100696|580929853|FG003|Maintenance Phase|Physician Decision|0|||
160873449|NCT02100696|580929854|FG004|Maintenance Phase|Physician Decision|1|||
160873450|NCT02100696|580929855|FG005|Maintenance Phase|Physician Decision|0|||
160873451|NCT02100696|580929850|FG000|Maintenance Phase|Multiple Reasons|0|||
160873452|NCT02100696|580929851|FG001|Maintenance Phase|Multiple Reasons|0|||
160873453|NCT02100696|580929852|FG002|Maintenance Phase|Multiple Reasons|0|||
160873454|NCT02100696|580929853|FG003|Maintenance Phase|Multiple Reasons|0|||
160873455|NCT02100696|580929854|FG004|Maintenance Phase|Multiple Reasons|2|||
160873456|NCT02100696|580929855|FG005|Maintenance Phase|Multiple Reasons|1|||
160873457|NCT03865381|580929859|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
160873458|NCT03865381|580929859|FG000|Overall Study|Withdrawal by Subject|2|||
160873459|NCT00452361|580929868|FG000|Overall Study|Adverse Event|8|||
160873460|NCT00452361|580929869|FG001|Overall Study|Adverse Event|0|||
161219673|NCT02497391|582186640|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
161219674|NCT02497391|582186641|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
160873461|NCT00452361|580929868|FG000|Overall Study|Withdrawal by Subject|0|||
160873462|NCT00452361|580929869|FG001|Overall Study|Withdrawal by Subject|1|||
160873463|NCT00452361|580929868|FG000|Overall Study|Premature termination|13|||
160873464|NCT00452361|580929869|FG001|Overall Study|Premature termination|9|||
160873465|NCT01010867|580929872|FG000|Overall Study|< 50% adherence to probiotic|1|||
160873466|NCT01668589|580929873|FG000|Overall Study|Lost to Follow-up|29|||
161219675|NCT02497391|582186636|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
161219676|NCT02497391|582186637|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
160873467|NCT01668589|580929874|FG001|Overall Study|Lost to Follow-up|37|||
160873468|NCT01668589|580929875|FG002|Overall Study|Lost to Follow-up|15|||
161219677|NCT02497391|582186638|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
161219678|NCT02497391|582186639|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
161219679|NCT02497391|582186640|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
161219680|NCT02497391|582186641|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
160873469|NCT01668589|580929876|FG003|Overall Study|Lost to Follow-up|5|||
160873470|NCT01668589|580929873|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
160873471|NCT01668589|580929874|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
160873472|NCT01668589|580929875|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
160873473|NCT01668589|580929876|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
160873474|NCT01668589|580929873|FG000|Overall Study|Death|12|||
160873475|NCT01668589|580929874|FG001|Overall Study|Death|3|||
160873476|NCT01668589|580929875|FG002|Overall Study|Death|2|||
160873477|NCT01668589|580929876|FG003|Overall Study|Death|11|||
160873478|NCT01668589|580929873|FG000|Overall Study|Other|44|||
160873479|NCT01668589|580929874|FG001|Overall Study|Other|10|||
160873480|NCT01668589|580929875|FG002|Overall Study|Other|7|||
160873481|NCT01668589|580929876|FG003|Overall Study|Other|15|||
160873482|NCT02954172|580929877|FG000|Overall Study|Protocol Violation|3|||
160873483|NCT02954172|580929878|FG001|Overall Study|Protocol Violation|0|||
160873484|NCT02954172|580929877|FG000|Overall Study|allergic reaction|2|||
160873485|NCT02954172|580929878|FG001|Overall Study|allergic reaction|1|||
160873486|NCT02954172|580929877|FG000|Overall Study|non-measurable lesions at baseline|1|||
160873487|NCT02954172|580929878|FG001|Overall Study|non-measurable lesions at baseline|2|||
160873488|NCT00233064|580929879|FG000|Overall Study|Lost to Follow-up|7|||
160873489|NCT00233064|580929880|FG001|Overall Study|Lost to Follow-up|7|||
160873490|NCT00233064|580929879|FG000|Overall Study|Withdrawal by Subject|5|||
160873491|NCT00233064|580929880|FG001|Overall Study|Withdrawal by Subject|3|||
160873492|NCT00233064|580929879|FG000|Overall Study|Death|0|||
160873493|NCT00233064|580929880|FG001|Overall Study|Death|1|||
160873494|NCT00233064|580929879|FG000|Overall Study|Relocation|0|||
160873495|NCT00233064|580929880|FG001|Overall Study|Relocation|1|||
160873496|NCT00233064|580929879|FG000|Overall Study|Protocol Violation|1|||
160873497|NCT00233064|580929880|FG001|Overall Study|Protocol Violation|0|||
160873498|NCT00233064|580929879|FG000|Overall Study|Moved to Dom. Republic|1|||
160873499|NCT00233064|580929880|FG001|Overall Study|Moved to Dom. Republic|0|||
160873500|NCT02302339|580929881|FG000|Overall Study|Lost to Follow-up|1|||
160873501|NCT02302339|580929882|FG001|Overall Study|Lost to Follow-up|0|||
160873502|NCT02302339|580929883|FG002|Overall Study|Lost to Follow-up|0|||
160873503|NCT02302339|580929884|FG003|Overall Study|Lost to Follow-up|0|||
160873504|NCT02302339|580929881|FG000|Overall Study|Withdrawal by Subject|0|||
160873505|NCT02302339|580929882|FG001|Overall Study|Withdrawal by Subject|2|||
160873506|NCT02302339|580929883|FG002|Overall Study|Withdrawal by Subject|1|||
160873507|NCT02302339|580929884|FG003|Overall Study|Withdrawal by Subject|0|||
160873508|NCT02752165|580929888|FG000|Overall Study|Withdrawal by Subject|6|||
160873509|NCT02752165|580929889|FG001|Overall Study|Withdrawal by Subject|6|||
160873510|NCT02752165|580929888|FG000|Overall Study|Protocol Violation|6|||
160873511|NCT02752165|580929889|FG001|Overall Study|Protocol Violation|5|||
160873512|NCT02752165|580929888|FG000|Overall Study|Lost to Follow-up|33|||
160873513|NCT02752165|580929889|FG001|Overall Study|Lost to Follow-up|38|||
160873514|NCT01120964|580929890|FG000|Overall Study|Did not receive full treatment|1|||
160873515|NCT01120964|580929891|FG001|Overall Study|Did not receive full treatment|0|||
160873516|NCT01704599|580929895|FG000|Overall Study|Adverse Event|1|||
160873517|NCT04421027|580929898|FG000|Treatment Period|Adverse Event|5|||
160873518|NCT04421027|580929899|FG001|Treatment Period|Adverse Event|3|||
160873519|NCT04421027|580929900|FG002|Treatment Period|Adverse Event|0|||
160873520|NCT04421027|580929901|FG003|Treatment Period|Adverse Event|0|||
160873521|NCT04421027|580929898|FG000|Treatment Period|Death|98|||
160873522|NCT04421027|580929899|FG001|Treatment Period|Death|61|||
160873523|NCT04421027|580929900|FG002|Treatment Period|Death|0|||
160873524|NCT04421027|580929901|FG003|Treatment Period|Death|0|||
160873525|NCT04421027|580929898|FG000|Treatment Period|Lost to Follow-up|22|||
160873526|NCT04421027|580929899|FG001|Treatment Period|Lost to Follow-up|20|||
160873527|NCT04421027|580929900|FG002|Treatment Period|Lost to Follow-up|0|||
160873528|NCT04421027|580929901|FG003|Treatment Period|Lost to Follow-up|0|||
160873529|NCT04421027|580929898|FG000|Treatment Period|Other-Unknown|15|||
160873530|NCT04421027|580929899|FG001|Treatment Period|Other-Unknown|9|||
160873531|NCT04421027|580929900|FG002|Treatment Period|Other-Unknown|0|||
160873532|NCT04421027|580929901|FG003|Treatment Period|Other-Unknown|0|||
161115413|NCT03016325|581811470|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161115414|NCT03016325|581811471|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
160873533|NCT04421027|580929898|FG000|Treatment Period|Physician Decision|1|||
160873534|NCT04421027|580929899|FG001|Treatment Period|Physician Decision|1|||
160873535|NCT04421027|580929900|FG002|Treatment Period|Physician Decision|0|||
160873536|NCT04421027|580929901|FG003|Treatment Period|Physician Decision|0|||
160873537|NCT04421027|580929898|FG000|Treatment Period|Withdrawal by Subject|7|||
160873538|NCT04421027|580929899|FG001|Treatment Period|Withdrawal by Subject|12|||
160873539|NCT04421027|580929900|FG002|Treatment Period|Withdrawal by Subject|0|||
160873540|NCT04421027|580929901|FG003|Treatment Period|Withdrawal by Subject|0|||
160873541|NCT04421027|580929898|FG000|Treatment Period|Randomized Not Dosed|9|||
160873542|NCT04421027|580929899|FG001|Treatment Period|Randomized Not Dosed|14|||
160873543|NCT04421027|580929900|FG002|Treatment Period|Randomized Not Dosed|0|||
160873544|NCT04421027|580929901|FG003|Treatment Period|Randomized Not Dosed|0|||
160873545|NCT04421027|580929898|FG000|Follow-Up Period|Adverse Event|0|||
160873546|NCT04421027|580929899|FG001|Follow-Up Period|Adverse Event|0|||
160873547|NCT04421027|580929900|FG002|Follow-Up Period|Adverse Event|0|||
160873548|NCT04421027|580929901|FG003|Follow-Up Period|Adverse Event|3|||
160873549|NCT04421027|580929898|FG000|Follow-Up Period|Death|0|||
160873550|NCT04421027|580929899|FG001|Follow-Up Period|Death|0|||
160873551|NCT04421027|580929900|FG002|Follow-Up Period|Death|16|||
160873552|NCT04421027|580929901|FG003|Follow-Up Period|Death|17|||
160873553|NCT04421027|580929898|FG000|Follow-Up Period|Lost to Follow-up|0|||
160873554|NCT04421027|580929899|FG001|Follow-Up Period|Lost to Follow-up|0|||
160873555|NCT04421027|580929900|FG002|Follow-Up Period|Lost to Follow-up|7|||
160873556|NCT04421027|580929901|FG003|Follow-Up Period|Lost to Follow-up|7|||
160873557|NCT04421027|580929898|FG000|Follow-Up Period|Protocol Deviation|0|||
160873558|NCT04421027|580929899|FG001|Follow-Up Period|Protocol Deviation|0|||
160873559|NCT04421027|580929900|FG002|Follow-Up Period|Protocol Deviation|1|||
160873560|NCT04421027|580929901|FG003|Follow-Up Period|Protocol Deviation|0|||
160873561|NCT04421027|580929898|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
160873562|NCT04421027|580929899|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
160873563|NCT04421027|580929900|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
160873564|NCT04421027|580929901|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
160873565|NCT04421027|580929898|FG000|Follow-Up Period|Left message, participant did not call back|0|||
160873566|NCT04421027|580929899|FG001|Follow-Up Period|Left message, participant did not call back|0|||
160873567|NCT04421027|580929900|FG002|Follow-Up Period|Left message, participant did not call back|0|||
160873568|NCT04421027|580929901|FG003|Follow-Up Period|Left message, participant did not call back|1|||
160873569|NCT04421027|580929898|FG000|Follow-Up Period|Participant died|0|||
160873570|NCT04421027|580929899|FG001|Follow-Up Period|Participant died|0|||
160873571|NCT04421027|580929900|FG002|Follow-Up Period|Participant died|0|||
160873572|NCT04421027|580929901|FG003|Follow-Up Period|Participant died|1|||
160873573|NCT04421027|580929898|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
160873574|NCT04421027|580929899|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
160873575|NCT04421027|580929900|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
160873576|NCT04421027|580929901|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
160873577|NCT00494676|580929902|FG000|Allocation|Withdrawal by Subject|2|||
160873578|NCT00494676|580929903|FG001|Allocation|Withdrawal by Subject|4|||
160873579|NCT00494676|580929902|FG000|First Intervention|Withdrawal by Subject|1|||
160873580|NCT00494676|580929903|FG001|First Intervention|Withdrawal by Subject|3|||
160873581|NCT00494676|580929902|FG000|Second Intervention|Withdrawal by Subject|1|||
160873582|NCT00494676|580929903|FG001|Second Intervention|Withdrawal by Subject|1|||
160873583|NCT04073225|580929904|FG000|Overall Study|Lost to Follow-up|4|||
160873584|NCT04073225|580929905|FG001|Overall Study|Lost to Follow-up|3|||
160873585|NCT04238819|580929913|FG000|Overall Study|Ongoing Treatment|0|||
160873586|NCT04238819|580929914|FG001|Overall Study|Ongoing Treatment|0|||
160873587|NCT04238819|580929915|FG002|Overall Study|Ongoing Treatment|0|||
160873588|NCT04238819|580929916|FG003|Overall Study|Ongoing Treatment|0|||
160873589|NCT04238819|580929917|FG004|Overall Study|Ongoing Treatment|1|||
160873590|NCT04238819|580929918|FG005|Overall Study|Ongoing Treatment|4|||
160873591|NCT04238819|580929919|FG006|Overall Study|Ongoing Treatment|0|||
160873592|NCT04238819|580929913|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
160873593|NCT04238819|580929914|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
160873594|NCT04238819|580929915|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
160873595|NCT04238819|580929916|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
160873596|NCT04238819|580929917|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
160873597|NCT04238819|580929918|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
160873598|NCT04238819|580929919|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
160873599|NCT02529553|580929923|FG000|Overall Study|Progressive Disease|1|||
160873600|NCT02529553|580929924|FG001|Overall Study|Progressive Disease|0|||
160873601|NCT02529553|580929925|FG002|Overall Study|Progressive Disease|1|||
160873602|NCT02529553|580929926|FG003|Overall Study|Progressive Disease|3|||
160873603|NCT02529553|580929927|FG004|Overall Study|Progressive Disease|2|||
160873604|NCT02529553|580929928|FG005|Overall Study|Progressive Disease|3|||
160873605|NCT02529553|580929929|FG006|Overall Study|Progressive Disease|3|||
160873606|NCT02529553|580929930|FG007|Overall Study|Progressive Disease|5|||
160873607|NCT02529553|580929931|FG008|Overall Study|Progressive Disease|3|||
160873608|NCT02529553|580929923|FG000|Overall Study|Physician Decision|0|||
160873609|NCT02529553|580929924|FG001|Overall Study|Physician Decision|1|||
160873610|NCT02529553|580929925|FG002|Overall Study|Physician Decision|0|||
160873611|NCT02529553|580929926|FG003|Overall Study|Physician Decision|0|||
160873612|NCT02529553|580929927|FG004|Overall Study|Physician Decision|1|||
161219681|NCT01060670|582186644|FG000|Run In|screen failure|0|||
161219682|NCT01060670|582186645|FG001|Run In|screen failure|238|||
161219683|NCT00056160|582186654|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
160873613|NCT02529553|580929928|FG005|Overall Study|Physician Decision|0|||
160873614|NCT02529553|580929929|FG006|Overall Study|Physician Decision|0|||
160873615|NCT02529553|580929930|FG007|Overall Study|Physician Decision|0|||
160873616|NCT02529553|580929931|FG008|Overall Study|Physician Decision|0|||
160873617|NCT02529553|580929923|FG000|Overall Study|Withdrawal by Subject|0|||
160873618|NCT02529553|580929924|FG001|Overall Study|Withdrawal by Subject|0|||
160873619|NCT02529553|580929925|FG002|Overall Study|Withdrawal by Subject|0|||
160873620|NCT02529553|580929926|FG003|Overall Study|Withdrawal by Subject|0|||
160873621|NCT02529553|580929927|FG004|Overall Study|Withdrawal by Subject|0|||
160873622|NCT02529553|580929928|FG005|Overall Study|Withdrawal by Subject|1|||
160873623|NCT02529553|580929929|FG006|Overall Study|Withdrawal by Subject|0|||
160873624|NCT02529553|580929930|FG007|Overall Study|Withdrawal by Subject|1|||
160873625|NCT02529553|580929931|FG008|Overall Study|Withdrawal by Subject|0|||
160873626|NCT05767749|580929932|FG000|Overall Study|Withdrawal by Subject|0|||
160873627|NCT05767749|580929933|FG001|Overall Study|Withdrawal by Subject|0|||
160873628|NCT05767749|580929934|FG002|Overall Study|Withdrawal by Subject|2|||
160873629|NCT05767749|580929935|FG003|Overall Study|Withdrawal by Subject|2|||
160873630|NCT05767749|580929936|FG004|Overall Study|Withdrawal by Subject|2|||
160873631|NCT05767749|580929937|FG005|Overall Study|Withdrawal by Subject|2|||
160873632|NCT00114517|580929938|FG000|Overall Study|Adverse Event|6|||
160873633|NCT00114517|580929939|FG001|Overall Study|Adverse Event|1|||
160873634|NCT00114517|580929940|FG002|Overall Study|Adverse Event|6|||
160873635|NCT00114517|580929941|FG003|Overall Study|Adverse Event|3|||
160873636|NCT00114517|580929938|FG000|Overall Study|Lost to Follow-up|2|||
160873637|NCT00114517|580929939|FG001|Overall Study|Lost to Follow-up|2|||
160873638|NCT00114517|580929940|FG002|Overall Study|Lost to Follow-up|2|||
160873639|NCT00114517|580929941|FG003|Overall Study|Lost to Follow-up|1|||
160873640|NCT00114517|580929938|FG000|Overall Study|Too busy|3|||
160873641|NCT00114517|580929939|FG001|Overall Study|Too busy|1|||
160873642|NCT00114517|580929940|FG002|Overall Study|Too busy|1|||
160873643|NCT00114517|580929941|FG003|Overall Study|Too busy|2|||
160873644|NCT00114517|580929938|FG000|Overall Study|Moved from area|0|||
160873645|NCT00114517|580929939|FG001|Overall Study|Moved from area|3|||
160873646|NCT00114517|580929940|FG002|Overall Study|Moved from area|2|||
160873647|NCT00114517|580929941|FG003|Overall Study|Moved from area|1|||
160873648|NCT00114517|580929938|FG000|Overall Study|Did not want estradiol|1|||
160873649|NCT00114517|580929939|FG001|Overall Study|Did not want estradiol|1|||
160873650|NCT00114517|580929940|FG002|Overall Study|Did not want estradiol|0|||
160873651|NCT00114517|580929941|FG003|Overall Study|Did not want estradiol|0|||
160873652|NCT00114517|580929938|FG000|Overall Study|Armed-services duty|0|||
160873653|NCT00114517|580929939|FG001|Overall Study|Armed-services duty|1|||
160873654|NCT00114517|580929940|FG002|Overall Study|Armed-services duty|0|||
160873655|NCT00114517|580929941|FG003|Overall Study|Armed-services duty|1|||
160873656|NCT00114517|580929938|FG000|Overall Study|Competing family issue|0|||
160873657|NCT00114517|580929939|FG001|Overall Study|Competing family issue|1|||
160873658|NCT00114517|580929940|FG002|Overall Study|Competing family issue|0|||
160873659|NCT00114517|580929941|FG003|Overall Study|Competing family issue|1|||
160873660|NCT00114517|580929938|FG000|Overall Study|Physician Decision|0|||
160873661|NCT00114517|580929939|FG001|Overall Study|Physician Decision|1|||
160873662|NCT00114517|580929940|FG002|Overall Study|Physician Decision|0|||
160873663|NCT00114517|580929941|FG003|Overall Study|Physician Decision|0|||
160873664|NCT00114517|580929938|FG000|Overall Study|Lost interest|0|||
160873665|NCT00114517|580929939|FG001|Overall Study|Lost interest|0|||
160873666|NCT00114517|580929940|FG002|Overall Study|Lost interest|1|||
160873667|NCT00114517|580929941|FG003|Overall Study|Lost interest|0|||
160873668|NCT00114517|580929938|FG000|Overall Study|Weight increase|0|||
160873669|NCT00114517|580929939|FG001|Overall Study|Weight increase|0|||
160873670|NCT00114517|580929940|FG002|Overall Study|Weight increase|1|||
160873671|NCT00114517|580929941|FG003|Overall Study|Weight increase|0|||
160873672|NCT00114517|580929938|FG000|Overall Study|Concern about blood clots|0|||
160873673|NCT00114517|580929939|FG001|Overall Study|Concern about blood clots|0|||
160873674|NCT00114517|580929940|FG002|Overall Study|Concern about blood clots|1|||
160873675|NCT00114517|580929941|FG003|Overall Study|Concern about blood clots|0|||
160873676|NCT00114517|580929938|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
160873677|NCT00114517|580929939|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
160873678|NCT00114517|580929940|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
160873679|NCT00114517|580929941|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
160873680|NCT00924027|580929942|FG000|Overall Study|Lost to Further Follow-Up|4|||
160873681|NCT00924027|580929943|FG001|Overall Study|Lost to Further Follow-Up|0|||
160873682|NCT00924027|580929944|FG002|Overall Study|Lost to Further Follow-Up|0|||
160873683|NCT00924027|580929945|FG003|Overall Study|Lost to Further Follow-Up|0|||
160873684|NCT00924027|580929942|FG000|Overall Study|Physician Decision|1|||
160873685|NCT00924027|580929943|FG001|Overall Study|Physician Decision|0|||
160873686|NCT00924027|580929944|FG002|Overall Study|Physician Decision|0|||
160873687|NCT00924027|580929945|FG003|Overall Study|Physician Decision|1|||
160873688|NCT00924027|580929942|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
160873689|NCT00924027|580929943|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
161219684|NCT00056160|582186655|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
160873690|NCT00924027|580929944|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
160873691|NCT00924027|580929945|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
160873692|NCT00924027|580929942|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
160873693|NCT00924027|580929943|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
160873694|NCT00924027|580929944|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
160873695|NCT00924027|580929945|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
160873696|NCT00924027|580929942|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
160873697|NCT00924027|580929943|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
160873698|NCT00924027|580929944|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
160873699|NCT00924027|580929945|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
160873700|NCT03387111|580931342|FG000|Overall Study|Progressive Disease|3|||
160873701|NCT03387111|580931342|FG000|Overall Study|Other|1|||
160873702|NCT00727441|580931344|FG000|Overall Study|Disease Progression|11|||
160873703|NCT00727441|580931345|FG001|Overall Study|Disease Progression|14|||
160873704|NCT00727441|580931346|FG002|Overall Study|Disease Progression|17|||
160873705|NCT00727441|580931344|FG000|Overall Study|Eligibility|7|||
160873706|NCT00727441|580931345|FG001|Overall Study|Eligibility|5|||
160873707|NCT00727441|580931346|FG002|Overall Study|Eligibility|7|||
160873708|NCT00727441|580931344|FG000|Overall Study|Death|0|||
160873709|NCT00727441|580931345|FG001|Overall Study|Death|1|||
160873710|NCT00727441|580931346|FG002|Overall Study|Death|1|||
160873711|NCT00727441|580931344|FG000|Overall Study|Physician Decision|0|||
160873712|NCT00727441|580931345|FG001|Overall Study|Physician Decision|1|||
160873713|NCT00727441|580931346|FG002|Overall Study|Physician Decision|0|||
160873714|NCT00727441|580931344|FG000|Overall Study|Withdrawal by Subject|0|||
160873715|NCT00727441|580931345|FG001|Overall Study|Withdrawal by Subject|1|||
160873716|NCT00727441|580931346|FG002|Overall Study|Withdrawal by Subject|0|||
161219685|NCT00056160|582186654|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
161219686|NCT00056160|582186655|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
161219687|NCT00056160|582186654|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
161219688|NCT00056160|582186655|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
161219689|NCT00056160|582186654|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
161219690|NCT00056160|582186655|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
161219691|NCT00056160|582186654|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
161219692|NCT00056160|582186655|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
161219693|NCT00056160|582186654|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
161219694|NCT00056160|582186655|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
161219695|NCT00056160|582186654|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
161219696|NCT00056160|582186655|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
161219697|NCT00056160|582186654|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
161219698|NCT00056160|582186655|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
161219699|NCT00056160|582186654|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
161219700|NCT00056160|582186655|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
161219701|NCT00056160|582186654|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
161219702|NCT00056160|582186655|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
161219703|NCT00056160|582186654|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
161219704|NCT00056160|582186655|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
161219705|NCT00056160|582186654|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
161219706|NCT00056160|582186655|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
161219707|NCT00056160|582186654|FG000|Final Follow-up|Transferred into expanded access study.|3|||
161219708|NCT00056160|582186655|FG001|Final Follow-up|Transferred into expanded access study.|0|||
160873717|NCT01239992|580931347|FG000|Overall Study|Withdrawal by Subject|2|||
160873718|NCT00535288|580931348|FG000|Overall Study|Adverse Event|20|||
160873719|NCT00535288|580931349|FG001|Overall Study|Adverse Event|19|||
160873720|NCT00535288|580931350|FG002|Overall Study|Adverse Event|25|||
160873721|NCT00535288|580931351|FG003|Overall Study|Adverse Event|20|||
160873722|NCT00535288|580931352|FG004|Overall Study|Adverse Event|30|||
160873723|NCT00535288|580931348|FG000|Overall Study|Lost to Follow-up|0|||
160873724|NCT00535288|580931349|FG001|Overall Study|Lost to Follow-up|3|||
160873725|NCT00535288|580931350|FG002|Overall Study|Lost to Follow-up|0|||
160873726|NCT00535288|580931351|FG003|Overall Study|Lost to Follow-up|0|||
160873727|NCT00535288|580931352|FG004|Overall Study|Lost to Follow-up|0|||
160873728|NCT00535288|580931348|FG000|Overall Study|Lack of Efficacy|26|||
160873729|NCT00535288|580931349|FG001|Overall Study|Lack of Efficacy|3|||
160873730|NCT00535288|580931350|FG002|Overall Study|Lack of Efficacy|4|||
160873731|NCT00535288|580931351|FG003|Overall Study|Lack of Efficacy|4|||
160873732|NCT00535288|580931352|FG004|Overall Study|Lack of Efficacy|7|||
160873733|NCT00535288|580931348|FG000|Overall Study|Unwilling to cooperate|6|||
160873734|NCT00535288|580931349|FG001|Overall Study|Unwilling to cooperate|6|||
161219709|NCT00056160|582186654|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
161257855|NCT00614926|582323499|FG001|Overall Study|Burden of travel|0|||
160873735|NCT00535288|580931350|FG002|Overall Study|Unwilling to cooperate|3|||
160873736|NCT00535288|580931351|FG003|Overall Study|Unwilling to cooperate|3|||
160873737|NCT00535288|580931352|FG004|Overall Study|Unwilling to cooperate|4|||
160873738|NCT00535288|580931348|FG000|Overall Study|Other|2|||
160873739|NCT00535288|580931349|FG001|Overall Study|Other|1|||
160873740|NCT00535288|580931350|FG002|Overall Study|Other|1|||
160873741|NCT00535288|580931351|FG003|Overall Study|Other|2|||
160873742|NCT00535288|580931352|FG004|Overall Study|Other|1|||
160873743|NCT02810444|580931353|FG000|Overall Study|Screen Failures|14|||
160873744|NCT02810444|580931353|FG000|Overall Study|Withdrawal by Subject|4|||
160873745|NCT02810444|580931353|FG000|Overall Study|Adverse Event|3|||
160873746|NCT00745849|580931354|FG000|First Intervention|Withdrawal by Subject|0|||
160873747|NCT00745849|580931355|FG001|First Intervention|Withdrawal by Subject|1|||
160873748|NCT00745849|580931354|FG000|First Intervention|Lost to Follow-up|1|||
160873749|NCT00745849|580931355|FG001|First Intervention|Lost to Follow-up|1|||
160873750|NCT00745849|580931354|FG000|Second Intervention|Lost to Follow-up|2|||
160873751|NCT00745849|580931355|FG001|Second Intervention|Lost to Follow-up|1|||
160873752|NCT01139008|580931356|FG000|Overall Study|Withdrawal by Subject|5|||
160873753|NCT01139008|580931356|FG000|Overall Study|Non-compliant, lost product|1|||
160873754|NCT02848729|580931359|FG000|Overall Study|Withdrawal by Subject|1|||
160873755|NCT02848729|580931360|FG001|Overall Study|Withdrawal by Subject|0|||
160873756|NCT02848729|580931359|FG000|Overall Study|Emesis|15|||
160873757|NCT02848729|580931360|FG001|Overall Study|Emesis|11|||
160873758|NCT03390101|580931361|FG000|Weeks 0-12|Withdrawal by Subject|0|||
160873759|NCT03390101|580931362|FG001|Weeks 0-12|Withdrawal by Subject|1|||
160873760|NCT03390101|580931363|FG002|Weeks 0-12|Withdrawal by Subject|1|||
160873761|NCT03390101|580931361|FG000|Weeks 0-12|Lost to Follow-up|0|||
160873762|NCT03390101|580931362|FG001|Weeks 0-12|Lost to Follow-up|1|||
160873763|NCT03390101|580931363|FG002|Weeks 0-12|Lost to Follow-up|0|||
160873764|NCT03390101|580931361|FG000|Weeks 12-54|Withdrawal by Subject|0|||
160873765|NCT03390101|580931362|FG001|Weeks 12-54|Withdrawal by Subject|3|||
160873766|NCT03390101|580931363|FG002|Weeks 12-54|Withdrawal by Subject|1|||
160873767|NCT03390101|580931361|FG000|Weeks 12-54|Pregnancy|1|||
160873768|NCT03390101|580931362|FG001|Weeks 12-54|Pregnancy|0|||
160873769|NCT03390101|580931363|FG002|Weeks 12-54|Pregnancy|0|||
160873770|NCT03390101|580931361|FG000|Weeks 12-54|Adverse Event|2|||
160873771|NCT03390101|580931362|FG001|Weeks 12-54|Adverse Event|1|||
160873772|NCT03390101|580931363|FG002|Weeks 12-54|Adverse Event|1|||
160873773|NCT04838977|580931364|FG000|Overall Study|Lost to Follow-up|2|||
160873774|NCT04838977|580931365|FG001|Overall Study|Lost to Follow-up|3|||
160873775|NCT04838977|580931364|FG000|Overall Study|Withdrawal by Subject|1|||
160873776|NCT04838977|580931365|FG001|Overall Study|Withdrawal by Subject|1|||
160873777|NCT05367492|580931366|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
160873778|NCT05367492|580931367|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
160873779|NCT05367492|580931368|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
160873780|NCT05367492|580931366|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
160873781|NCT05367492|580931367|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
160873782|NCT05367492|580931368|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
160873783|NCT05367492|580931366|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
160873784|NCT05367492|580931367|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
160873785|NCT05367492|580931368|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
160873786|NCT05367492|580931366|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
160873787|NCT05367492|580931367|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
161115415|NCT03016325|581811472|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161115416|NCT03016325|581811473|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161115417|NCT03016325|581811474|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161115418|NCT03016325|581811475|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
161115419|NCT03016325|581811468|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115420|NCT03016325|581811469|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
161115421|NCT03016325|581811470|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115422|NCT03016325|581811471|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115423|NCT03016325|581811472|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115424|NCT03016325|581811473|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115425|NCT03016325|581811474|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115426|NCT03016325|581811475|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
161115427|NCT03016325|581811468|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161115428|NCT03016325|581811469|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161115429|NCT03016325|581811470|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161115430|NCT03016325|581811471|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161219710|NCT00056160|582186655|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
160873788|NCT05367492|580931368|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
160873789|NCT00950859|580931372|FG000|Overall Study|Adverse Event|3|||
160873790|NCT00950859|580931373|FG001|Overall Study|Adverse Event|3|||
160873791|NCT00950859|580931372|FG000|Overall Study|Insufficient Viral Load Response|12|||
160873792|NCT00950859|580931373|FG001|Overall Study|Insufficient Viral Load Response|3|||
160873793|NCT00950859|580931372|FG000|Overall Study|Protocol Violation|1|||
160873794|NCT00950859|580931373|FG001|Overall Study|Protocol Violation|1|||
160873795|NCT00950859|580931372|FG000|Overall Study|Lost to Follow-up|0|||
160873796|NCT00950859|580931373|FG001|Overall Study|Lost to Follow-up|3|||
160873797|NCT01463007|580931375|FG000|Overall Study|Physician Decision|1|||
160873798|NCT03583385|580931376|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161115431|NCT03016325|581811472|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
161115432|NCT03016325|581811473|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
161115433|NCT03016325|581811474|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
161115434|NCT03016325|581811475|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
161115435|NCT03681119|581811476|FG000|Overall Study|No specific reason|4|||
161115436|NCT03681119|581811477|FG001|Overall Study|No specific reason|0|||
161115437|NCT03681119|581811476|FG000|Overall Study|Sickness|2|||
161115438|NCT03681119|581811477|FG001|Overall Study|Sickness|0|||
161115439|NCT01152021|581811480|FG000|Overall Study|Adverse Event|4|||
161115440|NCT01152021|581811481|FG001|Overall Study|Adverse Event|4|||
161115441|NCT01152021|581811480|FG000|Overall Study|Study drug had expired|1|||
161115442|NCT01152021|581811481|FG001|Overall Study|Study drug had expired|0|||
161115443|NCT01152021|581811480|FG000|Overall Study|Physician Decision|1|||
161219711|NCT00056160|582186654|FG000|Final Follow-up|Adverse Event|1|||
161115444|NCT01152021|581811481|FG001|Overall Study|Physician Decision|1|||
161115445|NCT01152021|581811480|FG000|Overall Study|No access to study drug in Pharmacy|0|||
161115446|NCT01152021|581811481|FG001|Overall Study|No access to study drug in Pharmacy|1|||
161115447|NCT02595723|581811482|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
161115448|NCT02595723|581811483|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
161115449|NCT02595723|581811484|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
161115450|NCT02595723|581811482|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
161115451|NCT02595723|581811483|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
161115452|NCT02595723|581811484|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
161115453|NCT04288154|581811485|FG000|Overall Study|Withdrawal by Subject|9|||
161115454|NCT04288154|581811486|FG001|Overall Study|Withdrawal by Subject|9|||
161115455|NCT01902290|581811492|FG000|Overall Study|Withdrawal by Subject|19|||
161115456|NCT01902290|581811493|FG001|Overall Study|Withdrawal by Subject|27|||
161115457|NCT01902290|581811492|FG000|Overall Study|Lost to Follow-up|2|||
161115458|NCT01902290|581811493|FG001|Overall Study|Lost to Follow-up|2|||
161115459|NCT01902290|581811492|FG000|Overall Study|Death|1|||
161115460|NCT01902290|581811493|FG001|Overall Study|Death|0|||
161115461|NCT01902290|581811492|FG000|Overall Study|Sponsor Decision|26|||
161115462|NCT01902290|581811493|FG001|Overall Study|Sponsor Decision|24|||
161115463|NCT00769184|581811494|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
161115464|NCT00769184|581811495|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
161115465|NCT00769184|581811494|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
161219712|NCT00056160|582186655|FG001|Final Follow-up|Adverse Event|0|||
160873799|NCT03583385|580931377|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160873800|NCT03583385|580931376|FG000|Treatment Period 2|Adverse Event|1|||
160873801|NCT03583385|580931377|FG001|Treatment Period 2|Adverse Event|0|||
160873802|NCT00545272|580931381|FG000|Overall Study|Protocol deviation|0|||
160873803|NCT00545272|580931382|FG001|Overall Study|Protocol deviation|1|||
160873804|NCT00545272|580931383|FG002|Overall Study|Protocol deviation|0|||
160873805|NCT00545272|580931384|FG003|Overall Study|Protocol deviation|1|||
160873806|NCT00545272|580931385|FG004|Overall Study|Protocol deviation|0|||
160873807|NCT00545272|580931386|FG005|Overall Study|Protocol deviation|1|||
160873808|NCT00545272|580931381|FG000|Overall Study|Adverse Event|0|||
160873809|NCT00545272|580931382|FG001|Overall Study|Adverse Event|0|||
160873810|NCT00545272|580931383|FG002|Overall Study|Adverse Event|1|||
160873811|NCT00545272|580931384|FG003|Overall Study|Adverse Event|0|||
160873812|NCT00545272|580931385|FG004|Overall Study|Adverse Event|0|||
160873813|NCT00545272|580931386|FG005|Overall Study|Adverse Event|1|||
160873814|NCT00545272|580931381|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160873815|NCT00545272|580931382|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160873816|NCT00545272|580931383|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160873817|NCT00545272|580931384|FG003|Overall Study|Abnormal laboratory value(s)|0|||
160873818|NCT00545272|580931385|FG004|Overall Study|Abnormal laboratory value(s)|0|||
160873819|NCT00545272|580931386|FG005|Overall Study|Abnormal laboratory value(s)|1|||
160873820|NCT00545272|580931381|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160873821|NCT00545272|580931382|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160873822|NCT00545272|580931383|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160873823|NCT00545272|580931384|FG003|Overall Study|Abnormal test procedure result(s)|0|||
160873824|NCT00545272|580931385|FG004|Overall Study|Abnormal test procedure result(s)|1|||
160873825|NCT00545272|580931386|FG005|Overall Study|Abnormal test procedure result(s)|0|||
160873826|NCT00545272|580931381|FG000|Overall Study|Lost to Follow-up|0|||
160873827|NCT00545272|580931382|FG001|Overall Study|Lost to Follow-up|0|||
160873828|NCT00545272|580931383|FG002|Overall Study|Lost to Follow-up|0|||
160873829|NCT00545272|580931384|FG003|Overall Study|Lost to Follow-up|0|||
160873830|NCT00545272|580931385|FG004|Overall Study|Lost to Follow-up|1|||
160873831|NCT00545272|580931386|FG005|Overall Study|Lost to Follow-up|0|||
160873832|NCT02934503|580931387|FG000|Overall Study|progression of disease|3|||
160873833|NCT02934503|580931387|FG000|Overall Study|Withdrawal by Subject|1|||
160873834|NCT00724867|580931388|FG000|Overall Study|Adverse Event|25|||
160873835|NCT00724867|580931388|FG000|Overall Study|Lack of Efficacy|14|||
160873836|NCT00724867|580931388|FG000|Overall Study|Lost to Follow-up|12|||
160873837|NCT00724867|580931388|FG000|Overall Study|Non-compliance with study drug|6|||
160873838|NCT00724867|580931388|FG000|Overall Study|Physician Decision|17|||
160873839|NCT00724867|580931388|FG000|Overall Study|Protocol Violation|1|||
160873840|NCT00724867|580931388|FG000|Overall Study|Withdrawal by Subject|31|||
160873841|NCT00724867|580931388|FG000|Overall Study|Sponsor decision to end study|14|||
160873842|NCT00724867|580931388|FG000|Overall Study|Subject incarcerated|1|||
161115466|NCT00769184|581811495|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
161115467|NCT00769184|581811494|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
161115468|NCT00769184|581811495|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
161115469|NCT00385255|581811496|FG000|Overall Study|Serious Adverse Event|1|||
161115470|NCT00385255|581811497|FG001|Overall Study|Serious Adverse Event|2|||
161115471|NCT00385255|581811496|FG000|Overall Study|Protocol Violation|0|||
161115472|NCT00385255|581811497|FG001|Overall Study|Protocol Violation|4|||
161115473|NCT00385255|581811496|FG000|Overall Study|Withdrawal by Subject|0|||
161115474|NCT00385255|581811497|FG001|Overall Study|Withdrawal by Subject|8|||
161115475|NCT00385255|581811496|FG000|Overall Study|Migrated/moved from study area|0|||
161115476|NCT00385255|581811497|FG001|Overall Study|Migrated/moved from study area|1|||
161115477|NCT00385255|581811496|FG000|Overall Study|Lost to Follow-up|20|||
161115478|NCT00385255|581811497|FG001|Overall Study|Lost to Follow-up|58|||
161115479|NCT00835237|581811502|FG000|Overall Study|Lost to Follow-up|4|||
161115480|NCT00835237|581811503|FG001|Overall Study|Lost to Follow-up|0|||
161115481|NCT00835237|581811502|FG000|Overall Study|Withdrawal by Subject|2|||
161219713|NCT01469364|582186656|FG000|Overall Study|Adverse Event|1|||
161219714|NCT01469364|582186656|FG000|Overall Study|Withdrawal by Subject|1|||
161219715|NCT02811861|582186660|FG000|Overall Study|Radiological Disease Progression|123|||
160873843|NCT00724867|580931388|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
160873844|NCT00724867|580931388|FG000|Overall Study|Subject moved out of state|1|||
160873845|NCT00724867|580931388|FG000|Overall Study|Elected to exit due to site closure|2|||
160873846|NCT03539549|580931389|FG000|Overall Study|Adverse Event|12|||
161115482|NCT00835237|581811503|FG001|Overall Study|Withdrawal by Subject|0|||
161115483|NCT00606086|581811507|FG000|Overall Study|Adverse Event|1|||
161115484|NCT00606086|581811508|FG001|Overall Study|Adverse Event|1|||
161219716|NCT02811861|582186661|FG001|Overall Study|Radiological Disease Progression|97|||
160873847|NCT03539549|580931389|FG000|Overall Study|Lost to Follow-up|1|||
160873848|NCT03539549|580931389|FG000|Overall Study|Death|2|||
160873849|NCT03539549|580931389|FG000|Overall Study|Progressive Disease|1|||
160873850|NCT03539549|580931389|FG000|Overall Study|Reason not Specified|1|||
160873851|NCT00436345|580931390|FG000|Overall Study|ICU resident beyond follow-up period|3|||
160873852|NCT00436345|580931391|FG001|Overall Study|ICU resident beyond follow-up period|0|||
160873853|NCT04027608|580931392|FG000|Overall Study|Withdrawal by Subject|13|||
160873854|NCT04027608|580931393|FG001|Overall Study|Withdrawal by Subject|2|||
160873855|NCT04027608|580931392|FG000|Overall Study|Protocol Violation|2|||
160873856|NCT04027608|580931393|FG001|Overall Study|Protocol Violation|1|||
160873857|NCT04027608|580931392|FG000|Overall Study|Physician Decision|1|||
160873858|NCT04027608|580931393|FG001|Overall Study|Physician Decision|0|||
160873859|NCT04027608|580931392|FG000|Overall Study|Lost to Follow-up|20|||
160873860|NCT04027608|580931393|FG001|Overall Study|Lost to Follow-up|4|||
160873861|NCT04248491|580931394|FG000|Overall Study|Lost to Follow-up|1|||
160873862|NCT04248491|580931395|FG001|Overall Study|Lost to Follow-up|0|||
160873863|NCT01652469|580931401|FG000|Overall Study|Withdrawal by Subject|1|||
160873864|NCT01652469|580931402|FG001|Overall Study|Withdrawal by Subject|4|||
160873865|NCT01652469|580931401|FG000|Overall Study|Lost to Follow-up|0|||
160873866|NCT01652469|580931402|FG001|Overall Study|Lost to Follow-up|2|||
160873867|NCT01049009|580931403|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160873868|NCT01049009|580931404|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160873869|NCT01049009|580931403|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160873870|NCT01049009|580931404|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160873871|NCT01049009|580931403|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
160873872|NCT01049009|580931404|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
160873873|NCT01049009|580931403|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
160873874|NCT01049009|580931404|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
160873875|NCT02644109|580931406|FG000|Overall Study|Adverse Event|0|||
160873876|NCT02644109|580931407|FG001|Overall Study|Adverse Event|4|||
160873877|NCT02474069|580931408|FG000|Selection Phase (SP)|Adverse Event|8|||
160873878|NCT02474069|580931409|FG001|Selection Phase (SP)|Adverse Event|0|||
160873879|NCT02474069|580931410|FG002|Selection Phase (SP)|Adverse Event|0|||
160873880|NCT02474069|580931408|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
160873881|NCT02474069|580931409|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
160873882|NCT02474069|580931410|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
160873883|NCT02474069|580931408|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
160873884|NCT02474069|580931409|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
160873885|NCT02474069|580931410|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
160873886|NCT02474069|580931408|FG000|Selection Phase (SP)|Physician Decision|1|||
160873887|NCT02474069|580931409|FG001|Selection Phase (SP)|Physician Decision|0|||
160873888|NCT02474069|580931410|FG002|Selection Phase (SP)|Physician Decision|0|||
160873889|NCT02474069|580931408|FG000|Selection Phase (SP)|Protocol Violation|1|||
160873890|NCT02474069|580931409|FG001|Selection Phase (SP)|Protocol Violation|0|||
160873891|NCT02474069|580931410|FG002|Selection Phase (SP)|Protocol Violation|0|||
160873892|NCT02474069|580931408|FG000|Selection Phase (SP)|No longer requires treatment|1|||
160873893|NCT02474069|580931409|FG001|Selection Phase (SP)|No longer requires treatment|0|||
160873894|NCT02474069|580931410|FG002|Selection Phase (SP)|No longer requires treatment|0|||
160873895|NCT02474069|580931408|FG000|Selection Phase (SP)|Technical Problem|1|||
160873896|NCT02474069|580931409|FG001|Selection Phase (SP)|Technical Problem|0|||
160873897|NCT02474069|580931410|FG002|Selection Phase (SP)|Technical Problem|0|||
160873898|NCT02474069|580931408|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
160873899|NCT02474069|580931409|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
160873900|NCT02474069|580931410|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
160873901|NCT02474069|580931408|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
160873902|NCT02474069|580931409|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
160873903|NCT02474069|580931410|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
160873904|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
160873905|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
160873906|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
160873907|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
160873908|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
160873909|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
160873910|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
160873911|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
160873912|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
160873913|NCT02474069|580931408|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
160873914|NCT02474069|580931409|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
161115485|NCT00606086|581811507|FG000|Overall Study|Lost to Follow-up|4|||
161115486|NCT00606086|581811508|FG001|Overall Study|Lost to Follow-up|8|||
161115487|NCT00606086|581811507|FG000|Overall Study|Protocol Violation|1|||
161115488|NCT00606086|581811508|FG001|Overall Study|Protocol Violation|0|||
161115489|NCT00606086|581811507|FG000|Overall Study|Withdrawal by Subject|5|||
161115490|NCT00606086|581811508|FG001|Overall Study|Withdrawal by Subject|3|||
161115491|NCT00606086|581811507|FG000|Overall Study|Non-compliance|0|||
161115492|NCT00606086|581811508|FG001|Overall Study|Non-compliance|1|||
161115493|NCT00606086|581811507|FG000|Overall Study|Randomized, not treated|1|||
160873915|NCT02474069|580931410|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
160873916|NCT01474018|580931411|FG000|Overall Study|Lost to Follow-up|0|||
160873917|NCT01474018|580931412|FG001|Overall Study|Lost to Follow-up|1|||
160873918|NCT01474018|580931411|FG000|Overall Study|Withdrawal by Subject|0|||
160873919|NCT01474018|580931412|FG001|Overall Study|Withdrawal by Subject|2|||
160873920|NCT03801031|580931413|FG000|Overall Study|Lost to Follow-up|1|||
160873921|NCT03801031|580931414|FG001|Overall Study|Lost to Follow-up|0|||
160873922|NCT03801031|580931413|FG000|Overall Study|Unable to comply|1|||
160873923|NCT03801031|580931414|FG001|Overall Study|Unable to comply|0|||
160873924|NCT03801031|580931413|FG000|Overall Study|Withdrawal by Subject|0|||
160873925|NCT03801031|580931414|FG001|Overall Study|Withdrawal by Subject|1|||
160873926|NCT01942733|580931415|FG000|Overall Study|Lost to Follow-up|1|||
160873927|NCT01942733|580931415|FG000|Overall Study|Non-compliance with IMP|1|||
160873928|NCT01942733|580931415|FG000|Overall Study|Administrative|1|||
160873929|NCT00126490|580931416|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
160873930|NCT03462511|580931418|FG000|Overall Study|Withdrawal by Subject|2|||
160873931|NCT03462511|580931419|FG001|Overall Study|Withdrawal by Subject|3|||
160873932|NCT02925416|580931420|FG000|Overall Study|Adverse Event|2|||
160873933|NCT02925416|580931421|FG001|Overall Study|Adverse Event|0|||
160873934|NCT02625909|580931422|FG000|Overall Study|Death|2|||
160873935|NCT02625909|580931423|FG001|Overall Study|Death|0|||
160873936|NCT02625909|580931422|FG000|Overall Study|Lost to Follow-up|3|||
160873937|NCT02625909|580931423|FG001|Overall Study|Lost to Follow-up|5|||
160873938|NCT02625909|580931422|FG000|Overall Study|Lack of Efficacy|9|||
160873939|NCT02625909|580931423|FG001|Overall Study|Lack of Efficacy|2|||
160873940|NCT02625909|580931422|FG000|Overall Study|Reinfection|3|||
160873941|NCT02625909|580931423|FG001|Overall Study|Reinfection|2|||
160873942|NCT01598506|580931424|FG000|Overall Study|Withdrawal by Subject|2|||
160873943|NCT02067676|580931429|FG000|Overall Study|Withdrawal by Subject|1|||
160873944|NCT02067676|580931430|FG001|Overall Study|Withdrawal by Subject|0|||
160873945|NCT02067676|580931431|FG002|Overall Study|Withdrawal by Subject|0|||
160873946|NCT02067676|580931432|FG003|Overall Study|Withdrawal by Subject|0|||
160873947|NCT02067676|580931433|FG004|Overall Study|Withdrawal by Subject|0|||
160873948|NCT02067676|580931434|FG005|Overall Study|Withdrawal by Subject|0|||
160873949|NCT00476229|580931435|FG000|Overall Study|Progressive shortness of breath|1|||
160873950|NCT01387542|580931442|FG000|Overall Study|Adverse Event|3|||
160873951|NCT01387542|580931442|FG000|Overall Study|Withdrawal by Subject|1|||
160873952|NCT01387542|580931442|FG000|Overall Study|Changed diagnosis|1|||
160873953|NCT01387542|580931442|FG000|Overall Study|Insufficient response|1|||
160873954|NCT01387542|580931442|FG000|Overall Study|Non-compliant|1|||
160873955|NCT01387542|580931442|FG000|Overall Study|Lost to Follow-up|1|||
160873956|NCT01761240|580931445|FG000|Overall Study|Progressive disease:radiology assessment|3|||
160873957|NCT01761240|580931446|FG001|Overall Study|Progressive disease:radiology assessment|3|||
160873958|NCT01761240|580931447|FG002|Overall Study|Progressive disease:radiology assessment|0|||
160873959|NCT01761240|580931448|FG003|Overall Study|Progressive disease:radiology assessment|0|||
160873960|NCT01761240|580931449|FG004|Overall Study|Progressive disease:radiology assessment|0|||
160873961|NCT01761240|580931445|FG000|Overall Study|Progressive disease:clinical assessment|0|||
160873962|NCT01761240|580931446|FG001|Overall Study|Progressive disease:clinical assessment|0|||
160873963|NCT01761240|580931447|FG002|Overall Study|Progressive disease:clinical assessment|3|||
160873964|NCT01761240|580931448|FG003|Overall Study|Progressive disease:clinical assessment|1|||
160873965|NCT01761240|580931449|FG004|Overall Study|Progressive disease:clinical assessment|0|||
160873966|NCT01761240|580931445|FG000|Overall Study|Withdrawal by Subject|0|||
160873967|NCT01761240|580931446|FG001|Overall Study|Withdrawal by Subject|0|||
161115494|NCT00606086|581811508|FG001|Overall Study|Randomized, not treated|2|||
161115495|NCT01929408|581811509|FG000|Overall Study|received HCT as initial treatment|8|||
161115496|NCT01015768|581811512|FG000|Overall Study|Some subject data unuseable|4|||
161115497|NCT01015768|581811513|FG001|Overall Study|Some subject data unuseable|4|||
161115498|NCT01627860|581811514|FG000|Overall Study|Adverse Event|9|||
161115499|NCT01627860|581811515|FG001|Overall Study|Adverse Event|4|||
161115500|NCT01627860|581811514|FG000|Overall Study|Withdrawal by Subject|2|||
161115501|NCT01627860|581811515|FG001|Overall Study|Withdrawal by Subject|1|||
161115502|NCT01627860|581811514|FG000|Overall Study|Seizure frequency doubled|0|||
161115503|NCT01627860|581811515|FG001|Overall Study|Seizure frequency doubled|1|||
161115504|NCT01627860|581811514|FG000|Overall Study|Protocol Violation|1|||
161115505|NCT01627860|581811515|FG001|Overall Study|Protocol Violation|0|||
161115506|NCT01225731|581811516|FG000|Part 1|Did not meet eligibility criteria|1|||
161115507|NCT01225731|581811517|FG001|Part 1|Did not meet eligibility criteria|0|||
161115508|NCT01225731|581811518|FG002|Part 1|Did not meet eligibility criteria|0|||
161115509|NCT01225731|581811519|FG003|Part 1|Did not meet eligibility criteria|0|||
161115510|NCT01225731|581811520|FG004|Part 1|Did not meet eligibility criteria|1|||
160873968|NCT01761240|580931447|FG002|Overall Study|Withdrawal by Subject|0|||
160873969|NCT01761240|580931448|FG003|Overall Study|Withdrawal by Subject|3|||
160873970|NCT01761240|580931449|FG004|Overall Study|Withdrawal by Subject|1|||
160873971|NCT01761240|580931445|FG000|Overall Study|Adverse Event|0|||
160873972|NCT01761240|580931446|FG001|Overall Study|Adverse Event|0|||
160873973|NCT01761240|580931447|FG002|Overall Study|Adverse Event|0|||
161115511|NCT01225731|581811521|FG005|Part 1|Did not meet eligibility criteria|0|||
161115512|NCT01225731|581811522|FG006|Part 1|Did not meet eligibility criteria|0|||
161115513|NCT01225731|581811523|FG007|Part 1|Did not meet eligibility criteria|0|||
161115514|NCT01225731|581811524|FG008|Part 1|Did not meet eligibility criteria|0|||
161115515|NCT01225731|581811525|FG009|Part 1|Did not meet eligibility criteria|0|||
161115516|NCT01225731|581811526|FG010|Part 1|Did not meet eligibility criteria|0|||
161115517|NCT01225731|581811527|FG011|Part 1|Did not meet eligibility criteria|0|||
161115518|NCT01225731|581811528|FG012|Part 1|Did not meet eligibility criteria|0|||
161115519|NCT01225731|581811516|FG000|Part 1|Adverse Event|1|||
161115520|NCT01225731|581811517|FG001|Part 1|Adverse Event|2|||
161115521|NCT01225731|581811518|FG002|Part 1|Adverse Event|1|||
161115522|NCT01225731|581811519|FG003|Part 1|Adverse Event|1|||
161115523|NCT01225731|581811520|FG004|Part 1|Adverse Event|1|||
161115524|NCT01225731|581811521|FG005|Part 1|Adverse Event|0|||
161115525|NCT01225731|581811522|FG006|Part 1|Adverse Event|0|||
161115526|NCT01225731|581811523|FG007|Part 1|Adverse Event|0|||
161115527|NCT01225731|581811524|FG008|Part 1|Adverse Event|0|||
161115528|NCT01225731|581811525|FG009|Part 1|Adverse Event|0|||
161115529|NCT01225731|581811526|FG010|Part 1|Adverse Event|0|||
161115530|NCT01225731|581811527|FG011|Part 1|Adverse Event|0|||
161115531|NCT01225731|581811528|FG012|Part 1|Adverse Event|0|||
161115532|NCT01225731|581811516|FG000|Part 1|Withdrawal by Subject|0|||
161115533|NCT01225731|581811517|FG001|Part 1|Withdrawal by Subject|3|||
161115534|NCT01225731|581811518|FG002|Part 1|Withdrawal by Subject|0|||
161115535|NCT01225731|581811519|FG003|Part 1|Withdrawal by Subject|0|||
161115536|NCT01225731|581811520|FG004|Part 1|Withdrawal by Subject|4|||
161115537|NCT01225731|581811521|FG005|Part 1|Withdrawal by Subject|0|||
161219717|NCT02811861|582186662|FG002|Overall Study|Radiological Disease Progression|174|||
161219718|NCT02811861|582186660|FG000|Overall Study|Clinical Disease Progression|20|||
161219719|NCT02811861|582186661|FG001|Overall Study|Clinical Disease Progression|19|||
161219720|NCT02811861|582186662|FG002|Overall Study|Clinical Disease Progression|22|||
161219721|NCT02811861|582186660|FG000|Overall Study|Adverse Event|63|||
161219722|NCT02811861|582186661|FG001|Overall Study|Adverse Event|60|||
161219723|NCT02811861|582186662|FG002|Overall Study|Adverse Event|41|||
161219724|NCT02811861|582186660|FG000|Overall Study|Lost to Follow-up|0|||
161219725|NCT02811861|582186661|FG001|Overall Study|Lost to Follow-up|0|||
161219726|NCT02811861|582186662|FG002|Overall Study|Lost to Follow-up|1|||
161219727|NCT02811861|582186660|FG000|Overall Study|Subject Choice|29|||
161219728|NCT02811861|582186661|FG001|Overall Study|Subject Choice|17|||
160873974|NCT01761240|580931448|FG003|Overall Study|Adverse Event|1|||
160873975|NCT01761240|580931449|FG004|Overall Study|Adverse Event|6|||
161115538|NCT01225731|581811522|FG006|Part 1|Withdrawal by Subject|0|||
161115539|NCT01225731|581811523|FG007|Part 1|Withdrawal by Subject|0|||
161115540|NCT01225731|581811524|FG008|Part 1|Withdrawal by Subject|0|||
161115541|NCT01225731|581811525|FG009|Part 1|Withdrawal by Subject|0|||
161115542|NCT01225731|581811526|FG010|Part 1|Withdrawal by Subject|0|||
161115543|NCT01225731|581811527|FG011|Part 1|Withdrawal by Subject|0|||
161115544|NCT01225731|581811528|FG012|Part 1|Withdrawal by Subject|0|||
161115545|NCT01225731|581811516|FG000|Part 1|Protocol Violation|0|||
161219729|NCT02811861|582186662|FG002|Overall Study|Subject Choice|23|||
161219730|NCT02811861|582186660|FG000|Overall Study|Withdrawal by Subject|4|||
161219731|NCT02811861|582186661|FG001|Overall Study|Withdrawal by Subject|4|||
161219732|NCT02811861|582186662|FG002|Overall Study|Withdrawal by Subject|9|||
161219733|NCT02811861|582186660|FG000|Overall Study|Other|4|||
161219734|NCT02811861|582186661|FG001|Overall Study|Other|13|||
161219735|NCT02811861|582186662|FG002|Overall Study|Other|3|||
161115546|NCT01225731|581811517|FG001|Part 1|Protocol Violation|0|||
161115547|NCT01225731|581811518|FG002|Part 1|Protocol Violation|0|||
161115548|NCT01225731|581811519|FG003|Part 1|Protocol Violation|1|||
161115549|NCT01225731|581811520|FG004|Part 1|Protocol Violation|0|||
161115550|NCT01225731|581811521|FG005|Part 1|Protocol Violation|0|||
161115551|NCT01225731|581811522|FG006|Part 1|Protocol Violation|0|||
161115552|NCT01225731|581811523|FG007|Part 1|Protocol Violation|0|||
161219736|NCT02811861|582186660|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
161219737|NCT02811861|582186661|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
160873976|NCT01761240|580931445|FG000|Overall Study|Death|0|||
160873977|NCT01761240|580931446|FG001|Overall Study|Death|1|||
160873978|NCT01761240|580931447|FG002|Overall Study|Death|1|||
160873979|NCT01761240|580931448|FG003|Overall Study|Death|2|||
160873980|NCT01761240|580931449|FG004|Overall Study|Death|1|||
160873981|NCT01761240|580931445|FG000|Overall Study|Non-compliance|0|||
160873982|NCT01761240|580931446|FG001|Overall Study|Non-compliance|0|||
160873983|NCT01761240|580931447|FG002|Overall Study|Non-compliance|1|||
160873984|NCT01761240|580931448|FG003|Overall Study|Non-compliance|0|||
160873985|NCT01761240|580931449|FG004|Overall Study|Non-compliance|0|||
160873986|NCT05422638|580931450|FG000|Overall Study|Withdrawal by Subject|8|||
160873987|NCT05422638|580931451|FG001|Overall Study|Withdrawal by Subject|2|||
160873988|NCT01827956|580931452|FG000|Overall Study|Protocol Violation|3|||
160873989|NCT04393454|580931453|FG000|Overall Study|Death|1|||
160873990|NCT04393454|580931453|FG000|Overall Study|Lost to Follow-up|1|||
160873991|NCT02621151|580931454|FG000|Overall Study|Not eligible for trial|6|||
160873992|NCT04695977|580931459|FG000|Overall Study|Sponsor Decision|9|||
160873993|NCT04695977|580931460|FG001|Overall Study|Sponsor Decision|4|||
160873994|NCT04695977|580931459|FG000|Overall Study|Death|2|||
160873995|NCT04695977|580931460|FG001|Overall Study|Death|5|||
160873996|NCT04236141|580932640|FG000|Overall Study|Death|18|||
160873997|NCT04236141|580932641|FG001|Overall Study|Death|10|||
160873998|NCT04236141|580932640|FG000|Overall Study|Withdrawal by Participant|1|||
160873999|NCT04236141|580932641|FG001|Overall Study|Withdrawal by Participant|0|||
161115553|NCT01225731|581811524|FG008|Part 1|Protocol Violation|0|||
161115554|NCT01225731|581811525|FG009|Part 1|Protocol Violation|0|||
161115555|NCT01225731|581811526|FG010|Part 1|Protocol Violation|0|||
161115556|NCT01225731|581811527|FG011|Part 1|Protocol Violation|0|||
161115557|NCT01225731|581811528|FG012|Part 1|Protocol Violation|0|||
161115558|NCT01225731|581811516|FG000|Part 2|Protocol Violation|0|||
161115559|NCT01225731|581811517|FG001|Part 2|Protocol Violation|0|||
161115560|NCT01225731|581811518|FG002|Part 2|Protocol Violation|0|||
161115561|NCT01225731|581811519|FG003|Part 2|Protocol Violation|0|||
161115562|NCT01225731|581811520|FG004|Part 2|Protocol Violation|0|||
161115563|NCT01225731|581811521|FG005|Part 2|Protocol Violation|1|||
161115564|NCT01225731|581811522|FG006|Part 2|Protocol Violation|0|||
161115565|NCT01225731|581811523|FG007|Part 2|Protocol Violation|0|||
161115566|NCT01225731|581811524|FG008|Part 2|Protocol Violation|1|||
161115567|NCT01225731|581811525|FG009|Part 2|Protocol Violation|0|||
161115568|NCT01225731|581811526|FG010|Part 2|Protocol Violation|0|||
161115569|NCT01225731|581811527|FG011|Part 2|Protocol Violation|0|||
161115570|NCT01225731|581811528|FG012|Part 2|Protocol Violation|0|||
161115571|NCT01225731|581811516|FG000|Part 2|Adverse Event|0|||
161115572|NCT01225731|581811517|FG001|Part 2|Adverse Event|0|||
161115573|NCT01225731|581811518|FG002|Part 2|Adverse Event|0|||
161115574|NCT01225731|581811519|FG003|Part 2|Adverse Event|0|||
161115575|NCT01225731|581811520|FG004|Part 2|Adverse Event|0|||
161115576|NCT01225731|581811521|FG005|Part 2|Adverse Event|0|||
161115577|NCT01225731|581811522|FG006|Part 2|Adverse Event|4|||
161115578|NCT01225731|581811523|FG007|Part 2|Adverse Event|4|||
161115579|NCT01225731|581811524|FG008|Part 2|Adverse Event|2|||
161115580|NCT01225731|581811525|FG009|Part 2|Adverse Event|0|||
161115581|NCT01225731|581811526|FG010|Part 2|Adverse Event|0|||
161115582|NCT01225731|581811527|FG011|Part 2|Adverse Event|0|||
161115583|NCT01225731|581811528|FG012|Part 2|Adverse Event|0|||
161115584|NCT01225731|581811516|FG000|Part 2|Lack of Efficacy|0|||
161115585|NCT01225731|581811517|FG001|Part 2|Lack of Efficacy|0|||
161115586|NCT01225731|581811518|FG002|Part 2|Lack of Efficacy|0|||
161115587|NCT01225731|581811519|FG003|Part 2|Lack of Efficacy|0|||
161115588|NCT01225731|581811520|FG004|Part 2|Lack of Efficacy|0|||
161115589|NCT01225731|581811521|FG005|Part 2|Lack of Efficacy|1|||
161219738|NCT02811861|582186662|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
161219739|NCT02811861|582186660|FG000|Overall Study|Randomized but not treated|2|||
161115590|NCT01225731|581811522|FG006|Part 2|Lack of Efficacy|0|||
160874000|NCT04236141|580932640|FG000|Overall Study|Reason not Specified|1|||
160874001|NCT04236141|580932641|FG001|Overall Study|Reason not Specified|0|||
160874002|NCT04236141|580932640|FG000|Overall Study|Study terminated by Sponsor|8|||
160874003|NCT04236141|580932641|FG001|Overall Study|Study terminated by Sponsor|4|||
160874004|NCT00130247|580932642|FG000|Overall Study|Pregnancy|1|||
160874005|NCT00130247|580932643|FG001|Overall Study|Pregnancy|0|||
160874006|NCT00130247|580932642|FG000|Overall Study|Post-randomization exclusion|1|||
160874007|NCT00130247|580932643|FG001|Overall Study|Post-randomization exclusion|2|||
160874008|NCT00130247|580932642|FG000|Overall Study|Not compliant with DOT|0|||
160874009|NCT00130247|580932643|FG001|Overall Study|Not compliant with DOT|2|||
160874010|NCT01761162|580932648|FG000|Overall Study|Withdrawal by Subject|3|||
160874011|NCT02160899|580932653|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
160874012|NCT02160899|580932654|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161115591|NCT01225731|581811523|FG007|Part 2|Lack of Efficacy|12|||
161115592|NCT01225731|581811524|FG008|Part 2|Lack of Efficacy|3|||
161115593|NCT01225731|581811525|FG009|Part 2|Lack of Efficacy|0|||
161115594|NCT01225731|581811526|FG010|Part 2|Lack of Efficacy|0|||
161115595|NCT01225731|581811527|FG011|Part 2|Lack of Efficacy|0|||
161115596|NCT01225731|581811528|FG012|Part 2|Lack of Efficacy|0|||
161219740|NCT02811861|582186661|FG001|Overall Study|Randomized but not treated|3|||
160874013|NCT02160899|580932655|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
160874014|NCT02160899|580932656|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
160874015|NCT02160899|580932657|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
160874016|NCT02160899|580932658|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
160874017|NCT04129151|580932659|FG000|Overall Study|Adverse Event|1|||
160874018|NCT04129151|580932659|FG000|Overall Study|Disease Progression|7|||
160874019|NCT04129151|580932659|FG000|Overall Study|Study closure|1|||
160874020|NCT04473235|580932660|FG000|Overall Study|Lost to Follow-up|6|||
160874021|NCT04473235|580932661|FG001|Overall Study|Lost to Follow-up|5|||
160874022|NCT04473235|580932660|FG000|Overall Study|Declined continuation|2|||
160874023|NCT04473235|580932661|FG001|Overall Study|Declined continuation|0|||
160874024|NCT04473235|580932660|FG000|Overall Study|Physician Decision|1|||
160874025|NCT04473235|580932661|FG001|Overall Study|Physician Decision|1|||
160874026|NCT04473235|580932660|FG000|Overall Study|Protocol Violation|10|||
160874027|NCT04473235|580932661|FG001|Overall Study|Protocol Violation|6|||
160874028|NCT01945710|580932664|FG000|Overall Study|Progressive Disease|5|||
160874029|NCT01945710|580932665|FG001|Overall Study|Progressive Disease|4|||
160874030|NCT01945710|580932666|FG002|Overall Study|Progressive Disease|3|||
160874031|NCT01945710|580932667|FG003|Overall Study|Progressive Disease|2|||
160874032|NCT01945710|580932668|FG004|Overall Study|Progressive Disease|7|||
160874033|NCT01945710|580932669|FG005|Overall Study|Progressive Disease|3|||
160874034|NCT01945710|580932670|FG006|Overall Study|Progressive Disease|19|||
160874035|NCT01945710|580932664|FG000|Overall Study|Adverse Event|0|||
160874036|NCT01945710|580932665|FG001|Overall Study|Adverse Event|1|||
160874037|NCT01945710|580932666|FG002|Overall Study|Adverse Event|0|||
160874038|NCT01945710|580932667|FG003|Overall Study|Adverse Event|0|||
161115597|NCT01225731|581811516|FG000|Part 2|Pregnancy|0|||
161115598|NCT01225731|581811517|FG001|Part 2|Pregnancy|0|||
161115599|NCT01225731|581811518|FG002|Part 2|Pregnancy|0|||
161115600|NCT01225731|581811519|FG003|Part 2|Pregnancy|0|||
161115601|NCT01225731|581811520|FG004|Part 2|Pregnancy|0|||
161115602|NCT01225731|581811521|FG005|Part 2|Pregnancy|0|||
161115603|NCT01225731|581811522|FG006|Part 2|Pregnancy|1|||
161115604|NCT01225731|581811523|FG007|Part 2|Pregnancy|0|||
161115605|NCT01225731|581811524|FG008|Part 2|Pregnancy|1|||
161115606|NCT01225731|581811525|FG009|Part 2|Pregnancy|0|||
161115607|NCT01225731|581811526|FG010|Part 2|Pregnancy|0|||
161115608|NCT01225731|581811527|FG011|Part 2|Pregnancy|0|||
161115609|NCT01225731|581811528|FG012|Part 2|Pregnancy|0|||
161115610|NCT01225731|581811516|FG000|Part 2|Lost to Follow-up|0|||
161115611|NCT01225731|581811517|FG001|Part 2|Lost to Follow-up|0|||
161115612|NCT01225731|581811518|FG002|Part 2|Lost to Follow-up|0|||
161115613|NCT01225731|581811519|FG003|Part 2|Lost to Follow-up|0|||
161115614|NCT01225731|581811520|FG004|Part 2|Lost to Follow-up|0|||
161115615|NCT01225731|581811521|FG005|Part 2|Lost to Follow-up|0|||
161115616|NCT01225731|581811522|FG006|Part 2|Lost to Follow-up|0|||
161115617|NCT01225731|581811523|FG007|Part 2|Lost to Follow-up|3|||
161115618|NCT01225731|581811524|FG008|Part 2|Lost to Follow-up|1|||
161115619|NCT01225731|581811525|FG009|Part 2|Lost to Follow-up|0|||
161115620|NCT01225731|581811526|FG010|Part 2|Lost to Follow-up|0|||
161115621|NCT01225731|581811527|FG011|Part 2|Lost to Follow-up|0|||
161115622|NCT01225731|581811528|FG012|Part 2|Lost to Follow-up|0|||
161115623|NCT01225731|581811516|FG000|Part 2|Physician Decision|0|||
161115624|NCT01225731|581811517|FG001|Part 2|Physician Decision|0|||
161115625|NCT01225731|581811518|FG002|Part 2|Physician Decision|0|||
161115626|NCT01225731|581811519|FG003|Part 2|Physician Decision|0|||
161115627|NCT01225731|581811520|FG004|Part 2|Physician Decision|0|||
161115628|NCT01225731|581811521|FG005|Part 2|Physician Decision|0|||
161115629|NCT01225731|581811522|FG006|Part 2|Physician Decision|0|||
161115630|NCT01225731|581811523|FG007|Part 2|Physician Decision|2|||
160874039|NCT01945710|580932668|FG004|Overall Study|Adverse Event|0|||
160874040|NCT01945710|580932669|FG005|Overall Study|Adverse Event|0|||
160874041|NCT01945710|580932670|FG006|Overall Study|Adverse Event|0|||
160874042|NCT01945710|580932664|FG000|Overall Study|Other|2|||
160874043|NCT01945710|580932665|FG001|Overall Study|Other|0|||
160874044|NCT01945710|580932666|FG002|Overall Study|Other|3|||
160874045|NCT01945710|580932667|FG003|Overall Study|Other|1|||
160874046|NCT01945710|580932668|FG004|Overall Study|Other|1|||
160874047|NCT01945710|580932669|FG005|Overall Study|Other|0|||
160874048|NCT01945710|580932670|FG006|Overall Study|Other|4|||
160874049|NCT01945710|580932664|FG000|Overall Study|Withdrawal by Subject|0|||
161115631|NCT01225731|581811524|FG008|Part 2|Physician Decision|2|||
161115632|NCT01225731|581811525|FG009|Part 2|Physician Decision|0|||
161115633|NCT01225731|581811526|FG010|Part 2|Physician Decision|0|||
161115634|NCT01225731|581811527|FG011|Part 2|Physician Decision|0|||
161115635|NCT01225731|581811528|FG012|Part 2|Physician Decision|0|||
160874050|NCT01945710|580932665|FG001|Overall Study|Withdrawal by Subject|1|||
160874051|NCT01945710|580932666|FG002|Overall Study|Withdrawal by Subject|1|||
160874052|NCT01945710|580932667|FG003|Overall Study|Withdrawal by Subject|0|||
161115636|NCT01225731|581811516|FG000|Part 2|Withdrawal by Subject|0|||
161115637|NCT01225731|581811517|FG001|Part 2|Withdrawal by Subject|0|||
161115638|NCT01225731|581811518|FG002|Part 2|Withdrawal by Subject|0|||
161115639|NCT01225731|581811519|FG003|Part 2|Withdrawal by Subject|0|||
161115640|NCT01225731|581811520|FG004|Part 2|Withdrawal by Subject|0|||
160874053|NCT01945710|580932668|FG004|Overall Study|Withdrawal by Subject|1|||
160874054|NCT01945710|580932669|FG005|Overall Study|Withdrawal by Subject|0|||
160874055|NCT01945710|580932670|FG006|Overall Study|Withdrawal by Subject|0|||
160874056|NCT02730195|580932671|FG000|Overall Study|Withdrawal by Subject|1|||
160874057|NCT02785770|580932672|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
160874058|NCT02785770|580932673|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
160874059|NCT02785770|580932674|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
160874060|NCT02785770|580932675|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
160874061|NCT02785770|580932672|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
160874062|NCT02785770|580932673|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
160874063|NCT02785770|580932674|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
160874064|NCT02785770|580932675|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
160874065|NCT02785770|580932672|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
160874066|NCT02785770|580932673|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
160874067|NCT02785770|580932674|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
160874068|NCT02785770|580932675|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
160874069|NCT01088048|580932679|FG000|Overall Study|Adverse Event|7|||
160874070|NCT01088048|580932680|FG001|Overall Study|Adverse Event|9|||
160874071|NCT01088048|580932681|FG002|Overall Study|Adverse Event|7|||
160874072|NCT01088048|580932682|FG003|Overall Study|Adverse Event|5|||
160874073|NCT01088048|580932683|FG004|Overall Study|Adverse Event|6|||
160874074|NCT01088048|580932684|FG005|Overall Study|Adverse Event|3|||
160874075|NCT01088048|580932685|FG006|Overall Study|Adverse Event|3|||
160874076|NCT01088048|580932686|FG007|Overall Study|Adverse Event|0|||
160874077|NCT01088048|580932687|FG008|Overall Study|Adverse Event|2|||
160874078|NCT01088048|580932688|FG009|Overall Study|Adverse Event|2|||
160874079|NCT01088048|580932679|FG000|Overall Study|Withdrew Consent|1|||
160874080|NCT01088048|580932680|FG001|Overall Study|Withdrew Consent|1|||
160874081|NCT01088048|580932681|FG002|Overall Study|Withdrew Consent|1|||
160874082|NCT01088048|580932682|FG003|Overall Study|Withdrew Consent|1|||
160874083|NCT01088048|580932683|FG004|Overall Study|Withdrew Consent|2|||
160874084|NCT01088048|580932684|FG005|Overall Study|Withdrew Consent|1|||
160874085|NCT01088048|580932685|FG006|Overall Study|Withdrew Consent|0|||
160874086|NCT01088048|580932686|FG007|Overall Study|Withdrew Consent|2|||
160874087|NCT01088048|580932687|FG008|Overall Study|Withdrew Consent|2|||
160874088|NCT01088048|580932688|FG009|Overall Study|Withdrew Consent|1|||
160874089|NCT01088048|580932679|FG000|Overall Study|Concomitant Medication Prohibited|1|||
160874090|NCT01088048|580932680|FG001|Overall Study|Concomitant Medication Prohibited|0|||
160874091|NCT01088048|580932681|FG002|Overall Study|Concomitant Medication Prohibited|0|||
160874092|NCT01088048|580932682|FG003|Overall Study|Concomitant Medication Prohibited|0|||
160874093|NCT01088048|580932683|FG004|Overall Study|Concomitant Medication Prohibited|0|||
160874094|NCT01088048|580932684|FG005|Overall Study|Concomitant Medication Prohibited|0|||
160874095|NCT01088048|580932685|FG006|Overall Study|Concomitant Medication Prohibited|0|||
160874096|NCT01088048|580932686|FG007|Overall Study|Concomitant Medication Prohibited|0|||
160874097|NCT01088048|580932687|FG008|Overall Study|Concomitant Medication Prohibited|0|||
160874098|NCT01088048|580932688|FG009|Overall Study|Concomitant Medication Prohibited|0|||
160874099|NCT01088048|580932679|FG000|Overall Study|Investigator Request|2|||
160874100|NCT01088048|580932680|FG001|Overall Study|Investigator Request|2|||
160874101|NCT01088048|580932681|FG002|Overall Study|Investigator Request|0|||
160874102|NCT01088048|580932682|FG003|Overall Study|Investigator Request|0|||
160874103|NCT01088048|580932683|FG004|Overall Study|Investigator Request|3|||
160874104|NCT01088048|580932684|FG005|Overall Study|Investigator Request|1|||
160874105|NCT01088048|580932685|FG006|Overall Study|Investigator Request|1|||
160874106|NCT01088048|580932686|FG007|Overall Study|Investigator Request|0|||
160874107|NCT01088048|580932687|FG008|Overall Study|Investigator Request|0|||
160874108|NCT01088048|580932688|FG009|Overall Study|Investigator Request|0|||
160874109|NCT01088048|580932679|FG000|Overall Study|Patient Non-compliance|0|||
160874110|NCT01088048|580932680|FG001|Overall Study|Patient Non-compliance|1|||
160874111|NCT01088048|580932681|FG002|Overall Study|Patient Non-compliance|0|||
160874112|NCT01088048|580932682|FG003|Overall Study|Patient Non-compliance|0|||
160874113|NCT01088048|580932683|FG004|Overall Study|Patient Non-compliance|0|||
160874114|NCT01088048|580932684|FG005|Overall Study|Patient Non-compliance|0|||
160874115|NCT01088048|580932685|FG006|Overall Study|Patient Non-compliance|0|||
160874116|NCT01088048|580932686|FG007|Overall Study|Patient Non-compliance|0|||
160874117|NCT01088048|580932687|FG008|Overall Study|Patient Non-compliance|0|||
160874118|NCT01088048|580932688|FG009|Overall Study|Patient Non-compliance|0|||
160874119|NCT01088048|580932679|FG000|Overall Study|Disease Progression|7|||
160874120|NCT01088048|580932680|FG001|Overall Study|Disease Progression|4|||
160874121|NCT01088048|580932681|FG002|Overall Study|Disease Progression|3|||
160874122|NCT01088048|580932682|FG003|Overall Study|Disease Progression|5|||
161115641|NCT01225731|581811521|FG005|Part 2|Withdrawal by Subject|1|||
161115642|NCT01225731|581811522|FG006|Part 2|Withdrawal by Subject|3|||
161115643|NCT01225731|581811523|FG007|Part 2|Withdrawal by Subject|4|||
160874123|NCT01088048|580932683|FG004|Overall Study|Disease Progression|3|||
161115644|NCT01225731|581811524|FG008|Part 2|Withdrawal by Subject|1|||
161115645|NCT01225731|581811525|FG009|Part 2|Withdrawal by Subject|0|||
161115646|NCT01225731|581811526|FG010|Part 2|Withdrawal by Subject|0|||
161115647|NCT01225731|581811527|FG011|Part 2|Withdrawal by Subject|0|||
161115648|NCT01225731|581811528|FG012|Part 2|Withdrawal by Subject|0|||
161115649|NCT01225731|581811516|FG000|Part 3|Adverse Event|0|||
161115650|NCT01225731|581811517|FG001|Part 3|Adverse Event|0|||
161324402|NCT00110357|582573594|FG001|Overall Study|Disease progression/relapse|15|||
161324403|NCT00110357|582573593|FG000|Overall Study|Study Closure|1|||
161324404|NCT00110357|582573594|FG001|Overall Study|Study Closure|0|||
161324405|NCT00110357|582573593|FG000|Overall Study|Study Drug Toxicity|1|||
161324406|NCT00110357|582573594|FG001|Overall Study|Study Drug Toxicity|3|||
161324407|NCT00110357|582573593|FG000|Overall Study|Withdrawal by Subject|3|||
161324408|NCT00110357|582573594|FG001|Overall Study|Withdrawal by Subject|1|||
161324409|NCT05285787|582573595|FG000|Overall Study|Withdrawal by Subject|1|||
161324410|NCT04004260|582573596|FG000|Overall Study|Withdrawal by Subject|7|||
161324411|NCT04004260|582573597|FG001|Overall Study|Withdrawal by Subject|3|||
161324412|NCT04004260|582573596|FG000|Overall Study|Lost to Follow-up|22|||
161324413|NCT04004260|582573597|FG001|Overall Study|Lost to Follow-up|12|||
161324414|NCT04004260|582573596|FG000|Overall Study|Did not engage in intervention|13|||
161324415|NCT04004260|582573597|FG001|Overall Study|Did not engage in intervention|17|||
161324416|NCT00320788|582573601|FG000|Overall Study|Adverse Event|0|||
161324417|NCT00320788|582573602|FG001|Overall Study|Adverse Event|0|||
161324418|NCT00320788|582573603|FG002|Overall Study|Adverse Event|0|||
161324419|NCT00320788|582573604|FG003|Overall Study|Adverse Event|1|||
161324420|NCT00320788|582573605|FG004|Overall Study|Adverse Event|0|||
161324421|NCT00320788|582573601|FG000|Overall Study|Death|0|||
161324422|NCT00320788|582573602|FG001|Overall Study|Death|0|||
161324423|NCT00320788|582573603|FG002|Overall Study|Death|1|||
161324424|NCT00320788|582573604|FG003|Overall Study|Death|0|||
161324425|NCT00320788|582573605|FG004|Overall Study|Death|1|||
161115651|NCT01225731|581811518|FG002|Part 3|Adverse Event|0|||
161115652|NCT01225731|581811519|FG003|Part 3|Adverse Event|0|||
161324426|NCT00320788|582573601|FG000|Overall Study|Lost to Follow-up|0|||
161324427|NCT00320788|582573602|FG001|Overall Study|Lost to Follow-up|2|||
161324428|NCT00320788|582573603|FG002|Overall Study|Lost to Follow-up|1|||
161324429|NCT00320788|582573604|FG003|Overall Study|Lost to Follow-up|0|||
161324430|NCT00320788|582573605|FG004|Overall Study|Lost to Follow-up|0|||
161324431|NCT00320788|582573601|FG000|Overall Study|Decision by the Sponsor|1|||
160874124|NCT01088048|580932684|FG005|Overall Study|Disease Progression|3|||
160874125|NCT01088048|580932685|FG006|Overall Study|Disease Progression|2|||
160874126|NCT01088048|580932686|FG007|Overall Study|Disease Progression|1|||
160874127|NCT01088048|580932687|FG008|Overall Study|Disease Progression|0|||
160874128|NCT01088048|580932688|FG009|Overall Study|Disease Progression|0|||
160874129|NCT01088048|580932679|FG000|Overall Study|Death|1|||
160874130|NCT01088048|580932680|FG001|Overall Study|Death|5|||
160874131|NCT01088048|580932681|FG002|Overall Study|Death|3|||
160874132|NCT01088048|580932682|FG003|Overall Study|Death|3|||
160874133|NCT01088048|580932683|FG004|Overall Study|Death|1|||
160874134|NCT01088048|580932684|FG005|Overall Study|Death|3|||
160874135|NCT01088048|580932685|FG006|Overall Study|Death|0|||
160874136|NCT01088048|580932686|FG007|Overall Study|Death|0|||
160874137|NCT01088048|580932687|FG008|Overall Study|Death|3|||
160874138|NCT01088048|580932688|FG009|Overall Study|Death|1|||
160874139|NCT01088048|580932679|FG000|Overall Study|Other|3|||
160874140|NCT01088048|580932680|FG001|Overall Study|Other|5|||
160874141|NCT01088048|580932681|FG002|Overall Study|Other|0|||
160874142|NCT01088048|580932682|FG003|Overall Study|Other|0|||
160874143|NCT01088048|580932683|FG004|Overall Study|Other|2|||
160874144|NCT01088048|580932684|FG005|Overall Study|Other|0|||
160874145|NCT01088048|580932685|FG006|Overall Study|Other|0|||
160874146|NCT01088048|580932686|FG007|Overall Study|Other|2|||
160874147|NCT01088048|580932687|FG008|Overall Study|Other|0|||
160874148|NCT01088048|580932688|FG009|Overall Study|Other|0|||
160874149|NCT01343693|580932689|FG000|Overall Study|Lost to Follow-up|9|||
160874150|NCT00265148|580932690|FG000|Overall Study|Adverse Event|2|||
160874151|NCT00265148|580932691|FG001|Overall Study|Adverse Event|2|||
160874152|NCT00265148|580932690|FG000|Overall Study|Lack of Efficacy|0|||
160874153|NCT00265148|580932691|FG001|Overall Study|Lack of Efficacy|2|||
160874154|NCT00265148|580932690|FG000|Overall Study|Protocol Violation|3|||
160874155|NCT00265148|580932691|FG001|Overall Study|Protocol Violation|2|||
160874156|NCT00265148|580932690|FG000|Overall Study|Lost to Follow-up|0|||
160874157|NCT00265148|580932691|FG001|Overall Study|Lost to Follow-up|1|||
160874158|NCT00265148|580932690|FG000|Overall Study|Withdrawal by Subject|2|||
160874159|NCT00265148|580932691|FG001|Overall Study|Withdrawal by Subject|1|||
160874160|NCT00265148|580932690|FG000|Overall Study|Physician Decision|1|||
160874161|NCT00265148|580932691|FG001|Overall Study|Physician Decision|0|||
160874162|NCT00265148|580932690|FG000|Overall Study|Increasing frailty|0|||
160874163|NCT00265148|580932691|FG001|Overall Study|Increasing frailty|1|||
160874164|NCT00265148|580932690|FG000|Overall Study|Subject chose to change of the dose|1|||
160874165|NCT00265148|580932691|FG001|Overall Study|Subject chose to change of the dose|0|||
160874166|NCT03760731|580932697|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
160874167|NCT03760731|580932698|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
160874168|NCT03760731|580932697|FG000|Treatment|Attended less than 70% of sessions|10|||
160874169|NCT03760731|580932698|FG001|Treatment|Attended less than 70% of sessions|15|||
160874170|NCT01092546|580932699|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
160874171|NCT01970358|580932700|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
160874172|NCT01970358|580932700|FG000|Overall Study|Ineligible at time of second consent|4|||
160874173|NCT01667419|580932701|FG000|Overall Study|Reason Not Specified|1|||
160874174|NCT01667419|580932702|FG001|Overall Study|Reason Not Specified|0|||
160874175|NCT01667419|580932703|FG002|Overall Study|Reason Not Specified|0|||
160874176|NCT01667419|580932704|FG003|Overall Study|Reason Not Specified|0|||
160874177|NCT01667419|580932701|FG000|Overall Study|Withdrawal by Subject|16|||
160874178|NCT01667419|580932702|FG001|Overall Study|Withdrawal by Subject|8|||
160874179|NCT01667419|580932703|FG002|Overall Study|Withdrawal by Subject|9|||
160874180|NCT01667419|580932704|FG003|Overall Study|Withdrawal by Subject|8|||
160874181|NCT01667419|580932701|FG000|Overall Study|Non-compliance|0|||
160874182|NCT01667419|580932702|FG001|Overall Study|Non-compliance|0|||
160874183|NCT01667419|580932703|FG002|Overall Study|Non-compliance|0|||
161115653|NCT01225731|581811520|FG004|Part 3|Adverse Event|0|||
161115654|NCT01225731|581811521|FG005|Part 3|Adverse Event|0|||
161115655|NCT01225731|581811522|FG006|Part 3|Adverse Event|0|||
161115656|NCT01225731|581811523|FG007|Part 3|Adverse Event|0|||
161115657|NCT01225731|581811524|FG008|Part 3|Adverse Event|0|||
161115658|NCT01225731|581811525|FG009|Part 3|Adverse Event|0|||
161115659|NCT01225731|581811526|FG010|Part 3|Adverse Event|1|||
161115660|NCT01225731|581811527|FG011|Part 3|Adverse Event|1|||
161219741|NCT02811861|582186662|FG002|Overall Study|Randomized but not treated|17|||
160874184|NCT01667419|580932704|FG003|Overall Study|Non-compliance|1|||
161219742|NCT04081337|582186666|FG000|Overall Study|Adverse Event|0|||
160874185|NCT01667419|580932701|FG000|Overall Study|Protocol Violation|1|||
161219743|NCT04081337|582186667|FG001|Overall Study|Adverse Event|1|||
160874186|NCT01667419|580932702|FG001|Overall Study|Protocol Violation|0|||
160874187|NCT01667419|580932703|FG002|Overall Study|Protocol Violation|0|||
160874188|NCT01667419|580932704|FG003|Overall Study|Protocol Violation|0|||
160874189|NCT01667419|580932701|FG000|Overall Study|Lost to Follow-up|7|||
160874190|NCT01667419|580932702|FG001|Overall Study|Lost to Follow-up|6|||
160874191|NCT01667419|580932703|FG002|Overall Study|Lost to Follow-up|2|||
160874192|NCT01667419|580932704|FG003|Overall Study|Lost to Follow-up|4|||
161115661|NCT01225731|581811528|FG012|Part 3|Adverse Event|0|||
161115662|NCT01225731|581811516|FG000|Part 3|Lost to Follow-up|0|||
161115663|NCT01225731|581811517|FG001|Part 3|Lost to Follow-up|0|||
161115664|NCT01225731|581811518|FG002|Part 3|Lost to Follow-up|0|||
161115665|NCT01225731|581811519|FG003|Part 3|Lost to Follow-up|0|||
161115666|NCT01225731|581811520|FG004|Part 3|Lost to Follow-up|0|||
161115667|NCT01225731|581811521|FG005|Part 3|Lost to Follow-up|0|||
161115668|NCT01225731|581811522|FG006|Part 3|Lost to Follow-up|0|||
161115669|NCT01225731|581811523|FG007|Part 3|Lost to Follow-up|0|||
161115670|NCT01225731|581811524|FG008|Part 3|Lost to Follow-up|0|||
161115671|NCT01225731|581811525|FG009|Part 3|Lost to Follow-up|0|||
160874193|NCT01667419|580932701|FG000|Overall Study|Death|18|||
160874194|NCT01667419|580932702|FG001|Overall Study|Death|33|||
160874195|NCT01667419|580932703|FG002|Overall Study|Death|25|||
160874196|NCT01667419|580932704|FG003|Overall Study|Death|26|||
160874197|NCT03869216|580932706|FG000|Overall Study|prostate removed during the study|1|||
160874198|NCT03869216|580932707|FG001|Overall Study|prostate removed during the study|1|||
160874199|NCT03869216|580932706|FG000|Overall Study|Withdrawal by Subject|0|||
160874200|NCT03869216|580932707|FG001|Overall Study|Withdrawal by Subject|1|||
160874201|NCT03869216|580932706|FG000|Overall Study|Lost to Follow-up|3|||
160874202|NCT03869216|580932707|FG001|Overall Study|Lost to Follow-up|12|||
160874203|NCT03869216|580932706|FG000|Overall Study|Changed clinical site or moved out of city|5|||
160874204|NCT03869216|580932707|FG001|Overall Study|Changed clinical site or moved out of city|9|||
160874205|NCT03869216|580932706|FG000|Overall Study|No primary care appointment scheduled|10|||
160874206|NCT03869216|580932707|FG001|Overall Study|No primary care appointment scheduled|4|||
160874207|NCT03869216|580932706|FG000|Overall Study|Death|1|||
160874208|NCT03869216|580932707|FG001|Overall Study|Death|1|||
160874209|NCT03646123|580932708|FG000|Overall Study|Withdrawal by Subject|2|||
160874210|NCT03646123|580932709|FG001|Overall Study|Withdrawal by Subject|2|||
160874211|NCT03646123|580932710|FG002|Overall Study|Withdrawal by Subject|3|||
160874212|NCT03646123|580932708|FG000|Overall Study|Study termination by sponsor|0|||
160874213|NCT03646123|580932709|FG001|Overall Study|Study termination by sponsor|45|||
160874214|NCT03646123|580932710|FG002|Overall Study|Study termination by sponsor|139|||
160874215|NCT03646123|580932708|FG000|Overall Study|Lost to Follow-up|4|||
160874216|NCT03646123|580932709|FG001|Overall Study|Lost to Follow-up|10|||
160874217|NCT03646123|580932710|FG002|Overall Study|Lost to Follow-up|10|||
160874218|NCT03646123|580932708|FG000|Overall Study|Death|2|||
160874219|NCT03646123|580932709|FG001|Overall Study|Death|1|||
160874220|NCT03646123|580932710|FG002|Overall Study|Death|1|||
160874221|NCT03646123|580932708|FG000|Overall Study|Other|2|||
160874222|NCT03646123|580932709|FG001|Overall Study|Other|0|||
160874223|NCT03646123|580932710|FG002|Overall Study|Other|2|||
160874224|NCT01068600|580932711|FG000|Overall Study|Withdrawal by Subject|5|||
160874225|NCT01068600|580932712|FG001|Overall Study|Withdrawal by Subject|6|||
160874226|NCT01068600|580932711|FG000|Overall Study|Adverse Event|3|||
160874227|NCT01068600|580932712|FG001|Overall Study|Adverse Event|3|||
160874228|NCT01068600|580932711|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160874229|NCT01068600|580932712|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160874230|NCT01068600|580932711|FG000|Overall Study|Lost to Follow-up|1|||
160874231|NCT01068600|580932712|FG001|Overall Study|Lost to Follow-up|2|||
160874232|NCT01068600|580932711|FG000|Overall Study|Protocol deviation|1|||
160874233|NCT01068600|580932712|FG001|Overall Study|Protocol deviation|1|||
161219744|NCT04081337|582186666|FG000|Overall Study|Withdrawal by Subject|2|||
161219745|NCT04081337|582186667|FG001|Overall Study|Withdrawal by Subject|0|||
161219746|NCT04081337|582186666|FG000|Overall Study|Physician Decision|1|||
161219747|NCT04081337|582186667|FG001|Overall Study|Physician Decision|2|||
161219748|NCT04081337|582186666|FG000|Overall Study|Lost to Follow-up|1|||
161219749|NCT04081337|582186667|FG001|Overall Study|Lost to Follow-up|0|||
161219750|NCT06624072|582186668|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
161219751|NCT06624072|582186669|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
161219752|NCT06624072|582186670|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
161219753|NCT00416520|582186683|FG000|Open-label Period|Adverse Event|28|||
161219754|NCT00416520|582186684|FG001|Open-label Period|Adverse Event|10|||
161219755|NCT00416520|582186685|FG002|Open-label Period|Adverse Event|0|||
161219756|NCT00416520|582186686|FG003|Open-label Period|Adverse Event|0|||
161219757|NCT00416520|582186683|FG000|Open-label Period|Death|2|||
161219758|NCT00416520|582186684|FG001|Open-label Period|Death|1|||
161219759|NCT00416520|582186685|FG002|Open-label Period|Death|0|||
161219760|NCT00416520|582186686|FG003|Open-label Period|Death|0|||
161219761|NCT00416520|582186683|FG000|Open-label Period|Lack of Efficacy|8|||
161219762|NCT00416520|582186684|FG001|Open-label Period|Lack of Efficacy|1|||
161219763|NCT00416520|582186685|FG002|Open-label Period|Lack of Efficacy|0|||
161219764|NCT00416520|582186686|FG003|Open-label Period|Lack of Efficacy|0|||
161219765|NCT00416520|582186683|FG000|Open-label Period|Protocol Violation|3|||
161219766|NCT00416520|582186684|FG001|Open-label Period|Protocol Violation|3|||
161219767|NCT00416520|582186685|FG002|Open-label Period|Protocol Violation|0|||
160874234|NCT01068600|580932711|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160874235|NCT01068600|580932712|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160874236|NCT01068600|580932711|FG000|Overall Study|Administrative problems|0|||
160874237|NCT01068600|580932712|FG001|Overall Study|Administrative problems|1|||
161219768|NCT00416520|582186686|FG003|Open-label Period|Protocol Violation|0|||
161219769|NCT00416520|582186683|FG000|Open-label Period|Withdrawal by Subject|16|||
161219770|NCT00416520|582186684|FG001|Open-label Period|Withdrawal by Subject|5|||
160874238|NCT01519869|580932713|FG000|Overall Study|Lost to Follow-up|1|||
160874239|NCT04075734|580932714|FG000|Overall Study|Lost to Follow-up|1|||
160874240|NCT04075734|580932715|FG001|Overall Study|Lost to Follow-up|1|||
161219771|NCT00416520|582186685|FG002|Open-label Period|Withdrawal by Subject|0|||
161219772|NCT00416520|582186686|FG003|Open-label Period|Withdrawal by Subject|0|||
160874241|NCT04075734|580932716|FG002|Overall Study|Lost to Follow-up|0|||
160874242|NCT04075734|580932714|FG000|Overall Study|Withdrawal by Subject|3|||
161115672|NCT01225731|581811526|FG010|Part 3|Lost to Follow-up|1|||
160874243|NCT04075734|580932715|FG001|Overall Study|Withdrawal by Subject|0|||
160874244|NCT04075734|580932716|FG002|Overall Study|Withdrawal by Subject|0|||
160874245|NCT02433080|580932718|FG000|Overall Study|Lost to Follow-up|1|||
160874246|NCT02433080|580932719|FG001|Overall Study|Lost to Follow-up|2|||
160874247|NCT02433080|580932718|FG000|Overall Study|Withdrawal by Subject|0|||
160874248|NCT02433080|580932719|FG001|Overall Study|Withdrawal by Subject|2|||
160874249|NCT02367833|580932721|FG000|Overall Study|Withdrawal by Subject|1|||
160874250|NCT02367833|580932722|FG001|Overall Study|Withdrawal by Subject|1|||
160874251|NCT02367833|580932723|FG002|Overall Study|Withdrawal by Subject|0|||
160874252|NCT02167139|580932724|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
160874253|NCT02167139|580932725|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
160874254|NCT02167139|580932726|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
160874255|NCT02167139|580932727|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
160874256|NCT02167139|580932724|FG000|Randomised, Double-blind|Adverse Event|2|||
160874257|NCT02167139|580932725|FG001|Randomised, Double-blind|Adverse Event|9|||
160874258|NCT02167139|580932726|FG002|Randomised, Double-blind|Adverse Event|0|||
160874259|NCT02167139|580932727|FG003|Randomised, Double-blind|Adverse Event|0|||
160874260|NCT02167139|580932724|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
160874261|NCT02167139|580932725|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
160874262|NCT02167139|580932726|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
160874263|NCT02167139|580932727|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
160874264|NCT02167139|580932724|FG000|Randomised, Double-blind|Other|3|||
160874265|NCT02167139|580932725|FG001|Randomised, Double-blind|Other|0|||
160874266|NCT02167139|580932726|FG002|Randomised, Double-blind|Other|0|||
160874267|NCT02167139|580932727|FG003|Randomised, Double-blind|Other|0|||
160874268|NCT02167139|580932724|FG000|Transition-extension|Adverse Event|2|||
160874269|NCT02167139|580932725|FG001|Transition-extension|Adverse Event|0|||
160874270|NCT02167139|580932726|FG002|Transition-extension|Adverse Event|2|||
160874271|NCT02167139|580932727|FG003|Transition-extension|Adverse Event|3|||
160874272|NCT02167139|580932724|FG000|Transition-extension|Withdrawal by Subject|2|||
160874273|NCT02167139|580932725|FG001|Transition-extension|Withdrawal by Subject|0|||
160874274|NCT02167139|580932726|FG002|Transition-extension|Withdrawal by Subject|4|||
160874275|NCT02167139|580932727|FG003|Transition-extension|Withdrawal by Subject|1|||
160874276|NCT02167139|580932724|FG000|Transition-extension|Lack of Efficacy|0|||
160874277|NCT02167139|580932725|FG001|Transition-extension|Lack of Efficacy|0|||
161115673|NCT01225731|581811527|FG011|Part 3|Lost to Follow-up|2|||
161115674|NCT01225731|581811528|FG012|Part 3|Lost to Follow-up|1|||
160874278|NCT02167139|580932726|FG002|Transition-extension|Lack of Efficacy|1|||
160874279|NCT02167139|580932727|FG003|Transition-extension|Lack of Efficacy|1|||
160874280|NCT02167139|580932724|FG000|Transition-extension|Other|1|||
160874281|NCT02167139|580932725|FG001|Transition-extension|Other|0|||
161115675|NCT01225731|581811516|FG000|Part 3|Physician Decision|0|||
161115676|NCT01225731|581811517|FG001|Part 3|Physician Decision|0|||
161115677|NCT01225731|581811518|FG002|Part 3|Physician Decision|0|||
161115678|NCT01225731|581811519|FG003|Part 3|Physician Decision|0|||
161115679|NCT01225731|581811520|FG004|Part 3|Physician Decision|0|||
161115680|NCT01225731|581811521|FG005|Part 3|Physician Decision|0|||
161115681|NCT01225731|581811522|FG006|Part 3|Physician Decision|0|||
161115682|NCT01225731|581811523|FG007|Part 3|Physician Decision|0|||
161115683|NCT01225731|581811524|FG008|Part 3|Physician Decision|0|||
161115684|NCT01225731|581811525|FG009|Part 3|Physician Decision|0|||
161115685|NCT01225731|581811526|FG010|Part 3|Physician Decision|0|||
161115686|NCT01225731|581811527|FG011|Part 3|Physician Decision|1|||
161115687|NCT01225731|581811528|FG012|Part 3|Physician Decision|2|||
161115688|NCT01225731|581811516|FG000|Part 3|Withdrawal by Subject|0|||
161115689|NCT01225731|581811517|FG001|Part 3|Withdrawal by Subject|0|||
161115690|NCT01225731|581811518|FG002|Part 3|Withdrawal by Subject|0|||
161115691|NCT01225731|581811519|FG003|Part 3|Withdrawal by Subject|0|||
161115692|NCT01225731|581811520|FG004|Part 3|Withdrawal by Subject|0|||
161115693|NCT01225731|581811521|FG005|Part 3|Withdrawal by Subject|0|||
161115694|NCT01225731|581811522|FG006|Part 3|Withdrawal by Subject|0|||
161115695|NCT01225731|581811523|FG007|Part 3|Withdrawal by Subject|0|||
161115696|NCT01225731|581811524|FG008|Part 3|Withdrawal by Subject|0|||
161115697|NCT01225731|581811525|FG009|Part 3|Withdrawal by Subject|0|||
161115698|NCT01225731|581811526|FG010|Part 3|Withdrawal by Subject|4|||
161115699|NCT01225731|581811527|FG011|Part 3|Withdrawal by Subject|6|||
161115700|NCT01225731|581811528|FG012|Part 3|Withdrawal by Subject|4|||
161115701|NCT00577642|581811529|FG000|Overall Study|Clinical Disease Progression|1|||
161115702|NCT00542269|581811538|FG000|Overall Study|Adverse Event|10|||
161115703|NCT00542269|581811539|FG001|Overall Study|Adverse Event|4|||
161115704|NCT00542269|581811540|FG002|Overall Study|Adverse Event|5|||
161115705|NCT00542269|581811538|FG000|Overall Study|Protocol Violation|1|||
161115706|NCT00542269|581811539|FG001|Overall Study|Protocol Violation|1|||
161115707|NCT00542269|581811540|FG002|Overall Study|Protocol Violation|0|||
161115708|NCT00542269|581811538|FG000|Overall Study|Withdrawal by Subject|1|||
161115709|NCT00542269|581811539|FG001|Overall Study|Withdrawal by Subject|0|||
161115710|NCT00542269|581811540|FG002|Overall Study|Withdrawal by Subject|0|||
161115711|NCT00542269|581811538|FG000|Overall Study|Administrative problems|1|||
161115712|NCT00542269|581811539|FG001|Overall Study|Administrative problems|1|||
161115713|NCT00542269|581811540|FG002|Overall Study|Administrative problems|1|||
161115714|NCT00652366|581811541|FG000|Overall Study|Adverse Event|8|||
161115715|NCT00652366|581811542|FG001|Overall Study|Adverse Event|4|||
161115716|NCT00652366|581811543|FG002|Overall Study|Adverse Event|7|||
161115717|NCT00652366|581811544|FG003|Overall Study|Adverse Event|17|||
161115718|NCT00652366|581811545|FG004|Overall Study|Adverse Event|13|||
161115719|NCT00652366|581811541|FG000|Overall Study|Death|5|||
161115720|NCT00652366|581811542|FG001|Overall Study|Death|4|||
161115721|NCT00652366|581811543|FG002|Overall Study|Death|1|||
161115722|NCT00652366|581811544|FG003|Overall Study|Death|8|||
161115723|NCT00652366|581811545|FG004|Overall Study|Death|5|||
161115724|NCT00652366|581811541|FG000|Overall Study|Lack of Efficacy|84|||
161115725|NCT00652366|581811542|FG001|Overall Study|Lack of Efficacy|58|||
161115726|NCT00652366|581811543|FG002|Overall Study|Lack of Efficacy|53|||
161115727|NCT00652366|581811544|FG003|Overall Study|Lack of Efficacy|133|||
161115728|NCT00652366|581811545|FG004|Overall Study|Lack of Efficacy|13|||
161115729|NCT00652366|581811541|FG000|Overall Study|Violation of Selection Criteria|0|||
161115730|NCT00652366|581811542|FG001|Overall Study|Violation of Selection Criteria|0|||
161115731|NCT00652366|581811543|FG002|Overall Study|Violation of Selection Criteria|1|||
161115732|NCT00652366|581811544|FG003|Overall Study|Violation of Selection Criteria|0|||
161115733|NCT00652366|581811545|FG004|Overall Study|Violation of Selection Criteria|0|||
161115734|NCT00652366|581811541|FG000|Overall Study|Protocol Violation|1|||
161115735|NCT00652366|581811542|FG001|Overall Study|Protocol Violation|0|||
161115736|NCT00652366|581811543|FG002|Overall Study|Protocol Violation|0|||
161115737|NCT00652366|581811544|FG003|Overall Study|Protocol Violation|0|||
161115738|NCT00652366|581811545|FG004|Overall Study|Protocol Violation|0|||
161115739|NCT00652366|581811541|FG000|Overall Study|Refused treatment|3|||
161115740|NCT00652366|581811542|FG001|Overall Study|Refused treatment|7|||
161115741|NCT00652366|581811543|FG002|Overall Study|Refused treatment|6|||
161115742|NCT00652366|581811544|FG003|Overall Study|Refused treatment|17|||
161115743|NCT00652366|581811545|FG004|Overall Study|Refused treatment|5|||
161115744|NCT00652366|581811541|FG000|Overall Study|Other|5|||
161115745|NCT00652366|581811542|FG001|Overall Study|Other|2|||
161115746|NCT00652366|581811543|FG002|Overall Study|Other|3|||
161115747|NCT00652366|581811544|FG003|Overall Study|Other|4|||
161115748|NCT00652366|581811545|FG004|Overall Study|Other|0|||
161115749|NCT02069899|581811546|FG000|Overall Study|Adverse Event|6|||
161115750|NCT02069899|581811547|FG001|Overall Study|Adverse Event|0|||
161115751|NCT02069899|581811548|FG002|Overall Study|Adverse Event|1|||
161115752|NCT02069899|581811546|FG000|Overall Study|Withdrawal by Participant|2|||
161115753|NCT02069899|581811547|FG001|Overall Study|Withdrawal by Participant|0|||
161115754|NCT02069899|581811548|FG002|Overall Study|Withdrawal by Participant|0|||
161115755|NCT02069899|581811546|FG000|Overall Study|Lost to Follow-up|1|||
161115756|NCT02069899|581811547|FG001|Overall Study|Lost to Follow-up|0|||
161115757|NCT02069899|581811548|FG002|Overall Study|Lost to Follow-up|1|||
161115758|NCT02069899|581811546|FG000|Overall Study|Other|4|||
161115759|NCT02069899|581811547|FG001|Overall Study|Other|0|||
161115760|NCT02069899|581811548|FG002|Overall Study|Other|0|||
161115761|NCT02069899|581811546|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
161115762|NCT02069899|581811547|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
161115763|NCT02069899|581811548|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
161115764|NCT02069899|581811546|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
161115765|NCT02069899|581811547|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
161115766|NCT02069899|581811548|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
161115767|NCT00490451|581811549|FG000|Overall Study|Adverse Event|3|||
161115768|NCT00490451|581811550|FG001|Overall Study|Adverse Event|3|||
161115769|NCT00490451|581811549|FG000|Overall Study|Death|3|||
161115770|NCT00490451|581811550|FG001|Overall Study|Death|1|||
161115771|NCT00490451|581811549|FG000|Overall Study|Withdrawal by Subject|2|||
161115772|NCT00490451|581811550|FG001|Overall Study|Withdrawal by Subject|0|||
161115773|NCT00490451|581811549|FG000|Overall Study|Investigator Decision|1|||
161115774|NCT00490451|581811550|FG001|Overall Study|Investigator Decision|0|||
161219773|NCT00416520|582186683|FG000|Open-label Period|Other Reasons|3|||
161219774|NCT00416520|582186684|FG001|Open-label Period|Other Reasons|12|||
161219775|NCT00416520|582186685|FG002|Open-label Period|Other Reasons|0|||
161219776|NCT00416520|582186686|FG003|Open-label Period|Other Reasons|0|||
161219777|NCT00416520|582186683|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161219778|NCT00416520|582186684|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161219779|NCT00416520|582186685|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
161219780|NCT00416520|582186686|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
161219781|NCT00416520|582186683|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161219782|NCT00416520|582186684|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161219783|NCT00416520|582186685|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
161219784|NCT00416520|582186686|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
161219785|NCT00416520|582186683|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
161219786|NCT00416520|582186684|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
161219787|NCT00416520|582186685|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
161219788|NCT00416520|582186686|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
161219789|NCT01387737|582186687|FG000|Overall Study|Adverse Event|20|||
161219790|NCT01387737|582186688|FG001|Overall Study|Adverse Event|30|||
161219791|NCT01387737|582186687|FG000|Overall Study|Lack of Efficacy|1|||
161219792|NCT01387737|582186688|FG001|Overall Study|Lack of Efficacy|0|||
161219793|NCT01387737|582186687|FG000|Overall Study|Physician Decision|3|||
161219794|NCT01387737|582186688|FG001|Overall Study|Physician Decision|10|||
161219795|NCT01387737|582186687|FG000|Overall Study|Withdrawal by Subject|27|||
161219796|NCT01387737|582186688|FG001|Overall Study|Withdrawal by Subject|31|||
161219797|NCT01387737|582186687|FG000|Overall Study|Clearly not eligible for the study|1|||
161219798|NCT01387737|582186688|FG001|Overall Study|Clearly not eligible for the study|3|||
161219799|NCT00707954|582186690|FG000|Overall Study|Physician Decision|0|||
161219800|NCT00707954|582186691|FG001|Overall Study|Physician Decision|0|||
161219801|NCT00707954|582186692|FG002|Overall Study|Physician Decision|0|||
161115775|NCT00490451|581811549|FG000|Overall Study|Protocol Violation|1|||
161115776|NCT00490451|581811550|FG001|Overall Study|Protocol Violation|0|||
161115777|NCT00490451|581811549|FG000|Overall Study|Progressive Disease|53|||
161115778|NCT00490451|581811550|FG001|Overall Study|Progressive Disease|34|||
161115779|NCT01181011|581811553|FG000|Overall Study|Adverse Event|2|||
161115780|NCT01181011|581811553|FG000|Overall Study|Lost to Follow-up|1|||
161115781|NCT00401375|581811554|FG000|Overall Study|Protocol Violation|2|||
161115782|NCT00401375|581811555|FG001|Overall Study|Protocol Violation|2|||
161115783|NCT00401375|581811556|FG002|Overall Study|Protocol Violation|1|||
161115784|NCT00401375|581811554|FG000|Overall Study|Adverse Event|6|||
161115785|NCT00401375|581811555|FG001|Overall Study|Adverse Event|11|||
161115786|NCT00401375|581811556|FG002|Overall Study|Adverse Event|10|||
161115787|NCT00401375|581811554|FG000|Overall Study|Withdrawal by Subject|9|||
161115788|NCT00401375|581811555|FG001|Overall Study|Withdrawal by Subject|7|||
161115789|NCT00401375|581811556|FG002|Overall Study|Withdrawal by Subject|7|||
161115790|NCT00401375|581811554|FG000|Overall Study|Lost to Follow-up|0|||
161115791|NCT00401375|581811555|FG001|Overall Study|Lost to Follow-up|1|||
161115792|NCT00401375|581811556|FG002|Overall Study|Lost to Follow-up|1|||
161115793|NCT00401375|581811554|FG000|Overall Study|Other than specified|2|||
161115794|NCT00401375|581811555|FG001|Overall Study|Other than specified|1|||
161115795|NCT00401375|581811556|FG002|Overall Study|Other than specified|3|||
161115796|NCT00401375|581811554|FG000|Overall Study|Randomized but not treated|3|||
161115797|NCT00401375|581811555|FG001|Overall Study|Randomized but not treated|3|||
161115798|NCT00401375|581811556|FG002|Overall Study|Randomized but not treated|3|||
161115799|NCT00950664|581811557|FG000|First Intervention|Lost to Follow-up|1|||
161115800|NCT00950664|581811558|FG001|First Intervention|Lost to Follow-up|3|||
161115801|NCT00950664|581811557|FG000|First Intervention|Withdrawal by Subject|2|||
161115802|NCT00950664|581811558|FG001|First Intervention|Withdrawal by Subject|2|||
161115803|NCT03152019|581811559|FG000|Overall Study|Adverse Event|0|||
161115804|NCT03152019|581811560|FG001|Overall Study|Adverse Event|1|||
161115805|NCT00081159|581811562|FG000|Overall Study|Withdrawal by Subject|0|||
161115806|NCT00081159|581811563|FG001|Overall Study|Withdrawal by Subject|3|||
161115807|NCT00081159|581811562|FG000|Overall Study|Myelosuppression prior to treatment|0|||
161219802|NCT00707954|582186693|FG003|Overall Study|Physician Decision|0|||
161219803|NCT00707954|582186694|FG004|Overall Study|Physician Decision|1|||
161219804|NCT00449072|582186697|FG000|Overall Study|Adverse Event|3|||
161219805|NCT00449072|582186698|FG001|Overall Study|Adverse Event|1|||
161219806|NCT00449072|582186697|FG000|Overall Study|Protocol Violation|14|||
161219807|NCT00449072|582186698|FG001|Overall Study|Protocol Violation|12|||
161219808|NCT00449072|582186697|FG000|Overall Study|Lost to Follow-up|5|||
161115808|NCT00081159|581811563|FG001|Overall Study|Myelosuppression prior to treatment|1|||
161115809|NCT00081159|581811562|FG000|Overall Study|Lost to Follow-up|2|||
161115810|NCT00081159|581811563|FG001|Overall Study|Lost to Follow-up|1|||
161115811|NCT01187953|581811566|FG000|Overall Study|Death|11|||
161115812|NCT01187953|581811567|FG001|Overall Study|Death|13|||
161219809|NCT00449072|582186698|FG001|Overall Study|Lost to Follow-up|7|||
161219810|NCT00449072|582186697|FG000|Overall Study|Withdrawal by Subject|11|||
161115813|NCT01187953|581811566|FG000|Overall Study|Adverse Event|1|||
161219811|NCT00449072|582186698|FG001|Overall Study|Withdrawal by Subject|8|||
161219812|NCT00449072|582186697|FG000|Overall Study|Lack of Efficacy|1|||
161219813|NCT00449072|582186698|FG001|Overall Study|Lack of Efficacy|1|||
161219814|NCT00449072|582186697|FG000|Overall Study|Physician Decision|1|||
161219815|NCT00449072|582186698|FG001|Overall Study|Physician Decision|0|||
161219816|NCT00449072|582186697|FG000|Overall Study|Not treated|0|||
161219817|NCT00449072|582186698|FG001|Overall Study|Not treated|1|||
161219818|NCT00449072|582186697|FG000|Overall Study|Excluded medication|0|||
161219819|NCT00449072|582186698|FG001|Overall Study|Excluded medication|2|||
161219820|NCT00449072|582186697|FG000|Overall Study|Non-compliance|2|||
161219821|NCT00449072|582186698|FG001|Overall Study|Non-compliance|5|||
161219822|NCT00449072|582186697|FG000|Overall Study|Sponsor decision|1|||
161219823|NCT00449072|582186698|FG001|Overall Study|Sponsor decision|3|||
161219824|NCT00449072|582186697|FG000|Overall Study|Relocation|3|||
161219825|NCT00449072|582186698|FG001|Overall Study|Relocation|2|||
161219826|NCT06509100|582186701|FG000|Overall Study|Withdrawal by Subject|1|||
161219827|NCT06509100|582186701|FG000|Overall Study|Lost to Follow-up|1|||
161219828|NCT05002569|582186704|FG000|Randomized|Withdrew Consent|3|||
161219829|NCT05002569|582186705|FG001|Randomized|Withdrew Consent|0|||
161219830|NCT05002569|582186704|FG000|Randomized|No longer meets study criteria|0|||
161219831|NCT05002569|582186705|FG001|Randomized|No longer meets study criteria|1|||
161219832|NCT05002569|582186704|FG000|Randomized|AE unrelated to study drug|1|||
161219833|NCT05002569|582186705|FG001|Randomized|AE unrelated to study drug|0|||
161219834|NCT05002569|582186704|FG000|Treatment Period|Requested to Discontinue|26|||
161219835|NCT05002569|582186705|FG001|Treatment Period|Requested to Discontinue|5|||
161219836|NCT05002569|582186704|FG000|Treatment Period|Withdrew Consent|7|||
161219837|NCT05002569|582186705|FG001|Treatment Period|Withdrew Consent|1|||
161219838|NCT05002569|582186704|FG000|Treatment Period|Study Drug Toxicity|114|||
161219839|NCT05002569|582186705|FG001|Treatment Period|Study Drug Toxicity|64|||
161219840|NCT05002569|582186704|FG000|Treatment Period|AE unrelated to study drug|6|||
161219841|NCT05002569|582186705|FG001|Treatment Period|AE unrelated to study drug|12|||
161219842|NCT05002569|582186704|FG000|Treatment Period|Disease Recurrence|102|||
161219843|NCT05002569|582186705|FG001|Treatment Period|Disease Recurrence|128|||
161219844|NCT05002569|582186704|FG000|Treatment Period|Other Reasons|4|||
161115814|NCT01187953|581811567|FG001|Overall Study|Adverse Event|2|||
161115815|NCT01187953|581811566|FG000|Overall Study|Lost to Follow-up|0|||
161115816|NCT01187953|581811567|FG001|Overall Study|Lost to Follow-up|3|||
161115817|NCT01187953|581811566|FG000|Overall Study|Withdrawal by Subject|3|||
161115818|NCT01187953|581811567|FG001|Overall Study|Withdrawal by Subject|3|||
161115819|NCT02457637|581811570|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
161115820|NCT01035905|581811572|FG000|Overall Study|Lack of Efficacy|1|||
161115821|NCT01035905|581811573|FG001|Overall Study|Lack of Efficacy|1|||
161115822|NCT01273883|581811574|FG000|First Intervention|Adverse Event|2|||
161115823|NCT01273883|581811575|FG001|First Intervention|Adverse Event|1|||
161115824|NCT01273883|581811574|FG000|Second Intervention|Lost to Follow-up|1|||
161115825|NCT01273883|581811575|FG001|Second Intervention|Lost to Follow-up|1|||
161115826|NCT01273883|581811574|FG000|Second Intervention|Lack of Efficacy|1|||
161115827|NCT01273883|581811575|FG001|Second Intervention|Lack of Efficacy|0|||
161115828|NCT01553136|581811577|FG000|Overall Study|Adverse Event|3|||
161115829|NCT01553136|581811578|FG001|Overall Study|Adverse Event|2|||
161115830|NCT01553136|581811577|FG000|Overall Study|Withdrawal by Subject|2|||
161115831|NCT01553136|581811578|FG001|Overall Study|Withdrawal by Subject|3|||
161115832|NCT01553136|581811577|FG000|Overall Study|Lost to Follow-up|4|||
161115833|NCT01553136|581811578|FG001|Overall Study|Lost to Follow-up|10|||
161115834|NCT01553136|581811577|FG000|Overall Study|Physician Decision|2|||
161115835|NCT01553136|581811578|FG001|Overall Study|Physician Decision|3|||
161115836|NCT01553136|581811577|FG000|Overall Study|Scheduling Difficulties|5|||
161115837|NCT01553136|581811578|FG001|Overall Study|Scheduling Difficulties|4|||
161115838|NCT03468855|581813038|FG000|Overall Study|Adverse Event|2|||
161115839|NCT03468855|581813038|FG000|Overall Study|Lost to Follow-up|5|||
161115840|NCT03468855|581813038|FG000|Overall Study|Withdrawal by Subject|3|||
161115841|NCT03468855|581813038|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
161115842|NCT02068547|581813039|FG000|Overall Study|Lost to Follow-up|3|||
161115843|NCT02068547|581813040|FG001|Overall Study|Lost to Follow-up|3|||
161115844|NCT02068547|581813039|FG000|Overall Study|Physician Decision|1|||
161115845|NCT02068547|581813040|FG001|Overall Study|Physician Decision|0|||
161219845|NCT05002569|582186705|FG001|Treatment Period|Other Reasons|7|||
161115846|NCT00880893|581813041|FG000|Overall Study|Protocol Violation|13|||
161115847|NCT00880893|581813042|FG001|Overall Study|Protocol Violation|1|||
161115848|NCT00880893|581813041|FG000|Overall Study|Withdrawal by Subject|15|||
161115849|NCT00880893|581813042|FG001|Overall Study|Withdrawal by Subject|11|||
161219846|NCT05002569|582186704|FG000|Treatment Period|Death|1|||
161219847|NCT05002569|582186705|FG001|Treatment Period|Death|1|||
161219848|NCT05002569|582186704|FG000|Follow Up|Death|78|||
161219849|NCT05002569|582186705|FG001|Follow Up|Death|69|||
161219850|NCT05002569|582186704|FG000|Follow Up|Lost to Follow-up|3|||
161219851|NCT05002569|582186705|FG001|Follow Up|Lost to Follow-up|3|||
161219852|NCT05002569|582186704|FG000|Follow Up|Withdrew consent|17|||
161219853|NCT05002569|582186705|FG001|Follow Up|Withdrew consent|16|||
161219854|NCT05002569|582186704|FG000|Follow Up|Other Reasons|444|||
161219855|NCT05002569|582186705|FG001|Follow Up|Other Reasons|452|||
161219856|NCT05245617|582186711|FG000|Overall Study|Withdrawal by Subject|1|||
161219857|NCT04041570|582186715|FG000|Overall Study|Moved from Area|0|||
161219858|NCT04041570|582186716|FG001|Overall Study|Moved from Area|2|||
161219859|NCT03425331|582186717|FG000|Overall Study|Withdrawal by Subject|1|||
161219860|NCT03425331|582186717|FG000|Overall Study|Death|1|||
161219861|NCT03425331|582186717|FG000|Overall Study|Adverse Event|1|||
161219862|NCT03425331|582186717|FG000|Overall Study|Disease Progression|2|||
161219863|NCT05211336|582186718|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
161219864|NCT05211336|582186719|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
161219865|NCT05211336|582186718|FG000|Overall Study|Progressive disease|0|||
161219866|NCT05211336|582186719|FG001|Overall Study|Progressive disease|4|||
161219867|NCT05211336|582186718|FG000|Overall Study|Death due to myocardial infarction|0|||
161219868|NCT05211336|582186719|FG001|Overall Study|Death due to myocardial infarction|1|||
161219869|NCT05211336|582186718|FG000|Overall Study|Death due to unknown cause|0|||
161219870|NCT05211336|582186719|FG001|Overall Study|Death due to unknown cause|1|||
161219871|NCT05211336|582186718|FG000|Overall Study|Worsening kidney function and quality of response|0|||
161219872|NCT05211336|582186719|FG001|Overall Study|Worsening kidney function and quality of response|1|||
161219873|NCT03433274|582186720|FG000|Overall Study|Withdrawal by Subject|2|||
161219874|NCT03433274|582186720|FG000|Overall Study|Missed visit|5|||
161219875|NCT03433274|582186720|FG000|Overall Study|Death|23|||
161219876|NCT00441584|582186721|FG000|Overall Study|Lack of Efficacy|79|||
161219877|NCT00441584|582186721|FG000|Overall Study|Withdrawal by Subject|8|||
161219878|NCT00441584|582186721|FG000|Overall Study|Adverse Event|6|||
161219879|NCT00441584|582186721|FG000|Overall Study|Protocol Violation|5|||
161219880|NCT00441584|582186721|FG000|Overall Study|Lost to Follow-up|4|||
161219881|NCT00441584|582186721|FG000|Overall Study|Failure to meet eligibility criteria|3|||
161219882|NCT02337829|582186722|FG000|Overall Study|Death|0|||
161219883|NCT02337829|582186723|FG001|Overall Study|Death|1|||
161219884|NCT02337829|582186724|FG002|Overall Study|Death|0|||
161219885|NCT02337829|582186725|FG003|Overall Study|Death|0|||
161219886|NCT02337829|582186722|FG000|Overall Study|Study terminated by sponsor|12|||
161219887|NCT02337829|582186723|FG001|Overall Study|Study terminated by sponsor|10|||
161219888|NCT02337829|582186724|FG002|Overall Study|Study terminated by sponsor|5|||
161219889|NCT02337829|582186725|FG003|Overall Study|Study terminated by sponsor|6|||
161219890|NCT02337829|582186722|FG000|Overall Study|discontinued for other reasons|6|||
161219891|NCT02337829|582186723|FG001|Overall Study|discontinued for other reasons|3|||
161219892|NCT02337829|582186724|FG002|Overall Study|discontinued for other reasons|1|||
161219893|NCT02337829|582186725|FG003|Overall Study|discontinued for other reasons|4|||
161219894|NCT00542386|582186728|FG000|Overall Study|Adverse Event|1|||
161219895|NCT00542386|582186729|FG001|Overall Study|Adverse Event|7|||
161219896|NCT00542386|582186730|FG002|Overall Study|Adverse Event|7|||
161219897|NCT00542386|582186731|FG003|Overall Study|Adverse Event|8|||
161219898|NCT00542386|582186732|FG004|Overall Study|Adverse Event|13|||
161219899|NCT00542386|582186733|FG005|Overall Study|Adverse Event|4|||
161219900|NCT00542386|582186728|FG000|Overall Study|Death|0|||
161219901|NCT00542386|582186729|FG001|Overall Study|Death|0|||
161219902|NCT00542386|582186730|FG002|Overall Study|Death|1|||
161219903|NCT00542386|582186731|FG003|Overall Study|Death|2|||
161219904|NCT00542386|582186732|FG004|Overall Study|Death|1|||
161219905|NCT00542386|582186733|FG005|Overall Study|Death|2|||
161219906|NCT00542386|582186728|FG000|Overall Study|Lack of Efficacy|32|||
161219907|NCT00542386|582186729|FG001|Overall Study|Lack of Efficacy|12|||
161219908|NCT00542386|582186730|FG002|Overall Study|Lack of Efficacy|10|||
161219909|NCT00542386|582186731|FG003|Overall Study|Lack of Efficacy|13|||
161219910|NCT00542386|582186732|FG004|Overall Study|Lack of Efficacy|7|||
161219911|NCT00542386|582186733|FG005|Overall Study|Lack of Efficacy|31|||
161219912|NCT00542386|582186728|FG000|Overall Study|Physician Decision|1|||
161219913|NCT00542386|582186729|FG001|Overall Study|Physician Decision|0|||
161219914|NCT00542386|582186730|FG002|Overall Study|Physician Decision|0|||
161219915|NCT00542386|582186731|FG003|Overall Study|Physician Decision|1|||
161219916|NCT00542386|582186732|FG004|Overall Study|Physician Decision|0|||
161219917|NCT00542386|582186733|FG005|Overall Study|Physician Decision|0|||
161219918|NCT00542386|582186728|FG000|Overall Study|Protocol Violation|0|||
161219919|NCT00542386|582186729|FG001|Overall Study|Protocol Violation|0|||
161219920|NCT00542386|582186730|FG002|Overall Study|Protocol Violation|1|||
161219921|NCT00542386|582186731|FG003|Overall Study|Protocol Violation|0|||
161219922|NCT00542386|582186732|FG004|Overall Study|Protocol Violation|0|||
161219923|NCT00542386|582186733|FG005|Overall Study|Protocol Violation|4|||
161219924|NCT00542386|582186728|FG000|Overall Study|Withdrawal by Subject|5|||
161219925|NCT00542386|582186729|FG001|Overall Study|Withdrawal by Subject|8|||
161219926|NCT00542386|582186730|FG002|Overall Study|Withdrawal by Subject|10|||
161219927|NCT00542386|582186731|FG003|Overall Study|Withdrawal by Subject|11|||
161219928|NCT00542386|582186732|FG004|Overall Study|Withdrawal by Subject|15|||
161219929|NCT00542386|582186733|FG005|Overall Study|Withdrawal by Subject|7|||
161219930|NCT00542386|582186728|FG000|Overall Study|Other Reasons|4|||
161219931|NCT00542386|582186729|FG001|Overall Study|Other Reasons|1|||
160874282|NCT02167139|580932726|FG002|Transition-extension|Other|1|||
160874283|NCT02167139|580932727|FG003|Transition-extension|Other|0|||
160874284|NCT02167139|580932724|FG000|Transition-extension|Lost to Follow-up|1|||
160874285|NCT02167139|580932725|FG001|Transition-extension|Lost to Follow-up|0|||
160874286|NCT02167139|580932726|FG002|Transition-extension|Lost to Follow-up|0|||
160874287|NCT02167139|580932727|FG003|Transition-extension|Lost to Follow-up|0|||
160874288|NCT00996333|580932728|FG000|Overall Study|Screen failure|1|||
160874289|NCT00996333|580932728|FG000|Overall Study|Withdrawal by Subject|1|||
160874290|NCT00996333|580932728|FG000|Overall Study|Death|4|||
160874291|NCT00996333|580932728|FG000|Overall Study|Adverse Event|1|||
160874292|NCT00996333|580932728|FG000|Overall Study|Physician Decision|1|||
160874293|NCT00996333|580932728|FG000|Overall Study|Other|5|||
160874294|NCT01015638|580932729|FG000|Overall Study|Withdrawal by Subject|1|||
160874295|NCT01015638|580932730|FG001|Overall Study|Withdrawal by Subject|0|||
160874296|NCT02164461|580932731|FG000|Overall Study|Adverse Event|0|||
160874297|NCT02164461|580932732|FG001|Overall Study|Adverse Event|0|||
160874298|NCT02164461|580932733|FG002|Overall Study|Adverse Event|1|||
160874299|NCT02164461|580932731|FG000|Overall Study|Disease Progression|1|||
160874300|NCT02164461|580932732|FG001|Overall Study|Disease Progression|3|||
160874301|NCT02164461|580932733|FG002|Overall Study|Disease Progression|4|||
160874302|NCT02164461|580932731|FG000|Overall Study|Withdrawal by Subject|0|||
160874303|NCT02164461|580932732|FG001|Overall Study|Withdrawal by Subject|3|||
160874304|NCT02164461|580932733|FG002|Overall Study|Withdrawal by Subject|0|||
161115850|NCT00880893|581813041|FG000|Overall Study|Lost to Follow-up|76|||
161115851|NCT00880893|581813042|FG001|Overall Study|Lost to Follow-up|33|||
161115852|NCT00880893|581813041|FG000|Overall Study|Serious adverse event|3|||
161115853|NCT00880893|581813042|FG001|Overall Study|Serious adverse event|0|||
161115854|NCT01736579|581813046|FG000|Overall Study|Termination of Study by Sponsor|2|||
161115855|NCT01736579|581813047|FG001|Overall Study|Termination of Study by Sponsor|2|||
161115856|NCT02404103|581813054|FG000|Overall Study|Adverse Event|1|||
161115857|NCT02404103|581813055|FG001|Overall Study|Adverse Event|0|||
161115858|NCT02404103|581813054|FG000|Overall Study|Lost to Follow-up|3|||
161115859|NCT02404103|581813055|FG001|Overall Study|Lost to Follow-up|3|||
161115860|NCT01783678|581813056|FG000|Overall Study|Randomized but Not Treated|0|||
161115861|NCT01783678|581813057|FG001|Overall Study|Randomized but Not Treated|0|||
161115862|NCT01783678|581813058|FG002|Overall Study|Randomized but Not Treated|0|||
161115863|NCT01783678|581813059|FG003|Overall Study|Randomized but Not Treated|1|||
161115864|NCT01783678|581813060|FG004|Overall Study|Randomized but Not Treated|0|||
161115865|NCT01783678|581813061|FG005|Overall Study|Randomized but Not Treated|0|||
161115866|NCT01783678|581813056|FG000|Overall Study|Lack of Efficacy|1|||
161115867|NCT01783678|581813057|FG001|Overall Study|Lack of Efficacy|13|||
161115868|NCT01783678|581813058|FG002|Overall Study|Lack of Efficacy|1|||
161115869|NCT01783678|581813059|FG003|Overall Study|Lack of Efficacy|3|||
161115870|NCT01783678|581813060|FG004|Overall Study|Lack of Efficacy|6|||
161115871|NCT01783678|581813061|FG005|Overall Study|Lack of Efficacy|5|||
161115872|NCT01783678|581813056|FG000|Overall Study|Lost to Follow-up|0|||
161115873|NCT01783678|581813057|FG001|Overall Study|Lost to Follow-up|4|||
161115874|NCT01783678|581813058|FG002|Overall Study|Lost to Follow-up|0|||
161115875|NCT01783678|581813059|FG003|Overall Study|Lost to Follow-up|2|||
161115876|NCT01783678|581813060|FG004|Overall Study|Lost to Follow-up|1|||
161115877|NCT01783678|581813061|FG005|Overall Study|Lost to Follow-up|0|||
161115878|NCT01783678|581813056|FG000|Overall Study|Withdrew Consent|1|||
161115879|NCT01783678|581813057|FG001|Overall Study|Withdrew Consent|1|||
161115880|NCT01783678|581813058|FG002|Overall Study|Withdrew Consent|0|||
161115881|NCT01783678|581813059|FG003|Overall Study|Withdrew Consent|2|||
161115882|NCT01783678|581813060|FG004|Overall Study|Withdrew Consent|0|||
161115883|NCT01783678|581813061|FG005|Overall Study|Withdrew Consent|0|||
161115884|NCT01979523|581813065|FG000|Overall Study|Withdrawal by Subject|1|||
161115885|NCT01979523|581813066|FG001|Overall Study|Withdrawal by Subject|0|||
161115886|NCT00631371|581813074|FG000|Overall Study|Lost to Follow-up|24|||
161115887|NCT00631371|581813075|FG001|Overall Study|Lost to Follow-up|19|||
161115888|NCT00631371|581813074|FG000|Overall Study|Other reason|5|||
161115889|NCT00631371|581813075|FG001|Overall Study|Other reason|12|||
161115890|NCT00631371|581813074|FG000|Overall Study|subject request|38|||
161115891|NCT00631371|581813075|FG001|Overall Study|subject request|45|||
161115892|NCT00631371|581813074|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
161115893|NCT00631371|581813075|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
161115894|NCT00631371|581813074|FG000|Overall Study|Death|263|||
160874305|NCT00324961|580932737|FG000|Overall Study|Adverse Event|5|||
160874306|NCT00324961|580932737|FG000|Overall Study|Consent Withdrawn|11|||
160874307|NCT00324961|580932737|FG000|Overall Study|Lost to Follow-up|22|||
161115895|NCT00631371|581813075|FG001|Overall Study|Death|239|||
161115896|NCT03354663|581813076|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
161115897|NCT03354663|581813076|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
161115898|NCT03354663|581813076|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
161115899|NCT03354663|581813076|FG000|Completed 30-day Visit|Missed Visit|1|||
160874308|NCT00324961|580932737|FG000|Overall Study|Protocol Violation|3|||
160874309|NCT00324961|580932737|FG000|Overall Study|Other|2|||
161115900|NCT05594173|581813079|FG000|Overall Study|Adverse Event|1|||
160874310|NCT00344487|580932738|FG000|Overall Study|immunologic failure|1|||
160874311|NCT04927364|580932741|FG000|Overall Study|Withdrawal by Subject|3|||
160874312|NCT04927364|580932741|FG000|Overall Study|Unable to complete preassessment MRI|1|||
160874313|NCT05188053|580932745|FG000|Overall Study|Lost to Follow-up|23|||
160874314|NCT05188053|580932746|FG001|Overall Study|Lost to Follow-up|30|||
160874315|NCT05188053|580932745|FG000|Overall Study|Protocol Violation|16|||
160874316|NCT05188053|580932746|FG001|Overall Study|Protocol Violation|16|||
160874317|NCT05188053|580932745|FG000|Overall Study|Physician Decision|3|||
160874318|NCT05188053|580932746|FG001|Overall Study|Physician Decision|0|||
160874319|NCT05188053|580932745|FG000|Overall Study|Withdrawal by Subject|0|||
160874320|NCT05188053|580932746|FG001|Overall Study|Withdrawal by Subject|1|||
160874321|NCT04198714|580932750|FG000|Overall Study|Physician Decision|0|||
160874322|NCT04198714|580932751|FG001|Overall Study|Physician Decision|1|||
160874323|NCT02355184|580932755|FG000|Overall Study|Lost to Follow-up|2|||
160874324|NCT02355184|580932755|FG000|Overall Study|Study Terminated|10|||
160874325|NCT01657461|580934166|FG000|Overall Study|Death|9|||
160874326|NCT01657461|580934167|FG001|Overall Study|Death|12|||
160874327|NCT01657461|580934166|FG000|Overall Study|Lost to Follow-up|0|||
160874328|NCT01657461|580934167|FG001|Overall Study|Lost to Follow-up|3|||
160874329|NCT01657461|580934166|FG000|Overall Study|Physician Decision|0|||
160874330|NCT01657461|580934167|FG001|Overall Study|Physician Decision|2|||
160874331|NCT01657461|580934166|FG000|Overall Study|Withdrawal by Subject|1|||
160874332|NCT01657461|580934167|FG001|Overall Study|Withdrawal by Subject|3|||
160874333|NCT01868542|580934168|FG000|Overall Study|Protocol Violation|0|||
160874334|NCT01868542|580934169|FG001|Overall Study|Protocol Violation|1|||
160874335|NCT01868542|580934168|FG000|Overall Study|Unclassified|0|||
160874336|NCT01868542|580934169|FG001|Overall Study|Unclassified|1|||
160874337|NCT03844945|580934170|FG000|Overall Study|Adverse Event|1|||
160874338|NCT03844945|580934171|FG001|Overall Study|Adverse Event|1|||
160874339|NCT03844945|580934172|FG002|Overall Study|Adverse Event|4|||
160874340|NCT03844945|580934173|FG003|Overall Study|Adverse Event|0|||
160874341|NCT03844945|580934170|FG000|Overall Study|Withdrawal by Subject|0|||
160874342|NCT03844945|580934171|FG001|Overall Study|Withdrawal by Subject|0|||
160874343|NCT03844945|580934172|FG002|Overall Study|Withdrawal by Subject|1|||
160874344|NCT03844945|580934173|FG003|Overall Study|Withdrawal by Subject|0|||
160874345|NCT03844945|580934170|FG000|Overall Study|Lack of Efficacy|0|||
160874346|NCT03844945|580934171|FG001|Overall Study|Lack of Efficacy|0|||
160874347|NCT03844945|580934172|FG002|Overall Study|Lack of Efficacy|0|||
160874348|NCT03844945|580934173|FG003|Overall Study|Lack of Efficacy|1|||
160874349|NCT03254459|580934175|FG000|Overall Study|Adverse Event|7|||
160874350|NCT03254459|580934176|FG001|Overall Study|Adverse Event|20|||
160874351|NCT03254459|580934175|FG000|Overall Study|Withdrawal by Subject Consent|3|||
160874352|NCT03254459|580934176|FG001|Overall Study|Withdrawal by Subject Consent|1|||
160874353|NCT03254459|580934175|FG000|Overall Study|Lost to Follow-up|0|||
160874354|NCT03254459|580934176|FG001|Overall Study|Lost to Follow-up|1|||
160874355|NCT03254459|580934175|FG000|Overall Study|Miscellaneous|0|||
160874356|NCT03254459|580934176|FG001|Overall Study|Miscellaneous|1|||
160874357|NCT01754727|580934177|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
160874358|NCT01904773|580934180|FG000|Screen|Screen failure|3|||
160874359|NCT01904773|580934181|FG001|Screen|Screen failure|0|||
160874360|NCT01904773|580934182|FG002|Screen|Screen failure|0|||
160874361|NCT01904773|580934183|FG003|Screen|Screen failure|0|||
160874362|NCT01904773|580934184|FG004|Screen|Screen failure|0|||
160874363|NCT01904773|580934185|FG005|Screen|Screen failure|0|||
160874364|NCT01904773|580934186|FG006|Screen|Screen failure|0|||
160874365|NCT01904773|580934187|FG007|Screen|Screen failure|0|||
160874366|NCT01904773|580934188|FG008|Screen|Screen failure|0|||
160874367|NCT01904773|580934180|FG000|Screen|Withdrawal by Subject|1|||
160874368|NCT01904773|580934181|FG001|Screen|Withdrawal by Subject|0|||
160874369|NCT01904773|580934182|FG002|Screen|Withdrawal by Subject|0|||
160874370|NCT01904773|580934183|FG003|Screen|Withdrawal by Subject|0|||
161115901|NCT05594173|581813079|FG000|Overall Study|COVID-19 Pandemic|2|||
161115902|NCT00763139|581813080|FG000|Overall Study|Adverse Event|4|||
161115903|NCT00763139|581813081|FG001|Overall Study|Adverse Event|2|||
161115904|NCT00763139|581813080|FG000|Overall Study|Withdrawal by Subject|0|||
161115905|NCT00763139|581813081|FG001|Overall Study|Withdrawal by Subject|1|||
161115906|NCT00763139|581813080|FG000|Overall Study|med change not allowed by protocol|1|||
161115907|NCT00763139|581813081|FG001|Overall Study|med change not allowed by protocol|0|||
161115908|NCT05634577|581813082|FG000|Overall Study|Lost to Follow-up|1|||
161115909|NCT05634577|581813082|FG000|Overall Study|Withdrawal by Subject|1|||
161115910|NCT03468309|581813083|FG000|Overall Study|Lost to Follow-up|4|||
161115911|NCT03468309|581813083|FG000|Overall Study|Withdrawal by Subject|2|||
160874371|NCT01904773|580934184|FG004|Screen|Withdrawal by Subject|0|||
160874372|NCT01904773|580934185|FG005|Screen|Withdrawal by Subject|0|||
160874373|NCT01904773|580934186|FG006|Screen|Withdrawal by Subject|0|||
160874374|NCT01904773|580934187|FG007|Screen|Withdrawal by Subject|0|||
160874375|NCT01904773|580934188|FG008|Screen|Withdrawal by Subject|0|||
160874376|NCT01904773|580934180|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
161115912|NCT00713700|581813085|FG000|Overall Study|Lost to Follow-up|3|||
161115913|NCT00713700|581813085|FG000|Overall Study|Withdrawal by Subject|1|||
160874377|NCT01904773|580934181|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874378|NCT01904773|580934182|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874379|NCT01904773|580934183|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
161115914|NCT00781456|581813086|FG000|Overall Study|Adverse Event|3|||
161115915|NCT00781456|581813087|FG001|Overall Study|Adverse Event|3|||
161115916|NCT00781456|581813086|FG000|Overall Study|Withdrawal by Subject|3|||
161115917|NCT00781456|581813087|FG001|Overall Study|Withdrawal by Subject|5|||
161115918|NCT00781456|581813086|FG000|Overall Study|Protocol Violation|4|||
161115919|NCT00781456|581813087|FG001|Overall Study|Protocol Violation|1|||
161115920|NCT00781456|581813086|FG000|Overall Study|Noncompliance With Protocol|1|||
161115921|NCT00781456|581813087|FG001|Overall Study|Noncompliance With Protocol|1|||
161115922|NCT00781456|581813086|FG000|Overall Study|Lost to Follow-up|10|||
161115923|NCT00781456|581813087|FG001|Overall Study|Lost to Follow-up|5|||
161115924|NCT00781456|581813086|FG000|Overall Study|Other Reason, Unknown|0|||
161115925|NCT00781456|581813087|FG001|Overall Study|Other Reason, Unknown|1|||
161115926|NCT02631200|581813090|FG000|First Period|Death|1|||
161115927|NCT02631200|581813091|FG001|First Period|Death|2|||
161115928|NCT02631200|581813090|FG000|First Period|Patient ill-health|2|||
161115929|NCT02631200|581813091|FG001|First Period|Patient ill-health|4|||
161115930|NCT02631200|581813090|FG000|First Period|Withdrawal by Subject|4|||
161115931|NCT02631200|581813091|FG001|First Period|Withdrawal by Subject|1|||
161115932|NCT02631200|581813090|FG000|Deferred Period|Death|0|||
161115933|NCT02631200|581813091|FG001|Deferred Period|Death|1|||
161115934|NCT02631200|581813090|FG000|Deferred Period|Received kidney transplant|0|||
161115935|NCT02631200|581813091|FG001|Deferred Period|Received kidney transplant|1|||
161115936|NCT02631200|581813090|FG000|Deferred Period|Withdrawal by Subject|0|||
161115937|NCT02631200|581813091|FG001|Deferred Period|Withdrawal by Subject|2|||
161115938|NCT02631200|581813090|FG000|Deferred Period|Lost to Follow-up|0|||
161115939|NCT02631200|581813091|FG001|Deferred Period|Lost to Follow-up|1|||
161115940|NCT04091087|581813096|FG000|Overall Study|Not treated|1|||
161115941|NCT04091087|581813097|FG001|Overall Study|Not treated|0|||
161115942|NCT04091087|581813096|FG000|Overall Study|Adverse Event|4|||
161115943|NCT04091087|581813097|FG001|Overall Study|Adverse Event|4|||
161115944|NCT04091087|581813096|FG000|Overall Study|Protocol Violation|0|||
161115945|NCT04091087|581813097|FG001|Overall Study|Protocol Violation|1|||
161115946|NCT04091087|581813096|FG000|Overall Study|Withdrawal by Subject|5|||
161115947|NCT04091087|581813097|FG001|Overall Study|Withdrawal by Subject|2|||
161115948|NCT04152161|581813098|FG000|Overall Study|Death|0|||
161115949|NCT04152161|581813099|FG001|Overall Study|Death|1|||
161115950|NCT04152161|581813098|FG000|Overall Study|Physician Decision|0|||
161115951|NCT04152161|581813099|FG001|Overall Study|Physician Decision|1|||
161115952|NCT04152161|581813098|FG000|Overall Study|Lost to Follow-up|9|||
161115953|NCT04152161|581813099|FG001|Overall Study|Lost to Follow-up|3|||
161115954|NCT04152161|581813098|FG000|Overall Study|Protocol Violation|1|||
161115955|NCT04152161|581813099|FG001|Overall Study|Protocol Violation|0|||
161115956|NCT04152161|581813098|FG000|Overall Study|Withdrawal by Subject|29|||
161115957|NCT04152161|581813099|FG001|Overall Study|Withdrawal by Subject|28|||
161115958|NCT04152161|581813098|FG000|Overall Study|Sponsor termination of study|750|||
161115959|NCT04152161|581813099|FG001|Overall Study|Sponsor termination of study|755|||
161115960|NCT04152161|581813098|FG000|Overall Study|Other|20|||
161115961|NCT04152161|581813099|FG001|Overall Study|Other|18|||
161115962|NCT03363321|581813101|FG000|Overall Study|Withdrawal by Subject|0|||
161115963|NCT03363321|581813102|FG001|Overall Study|Withdrawal by Subject|1|||
161115964|NCT03363321|581813103|FG002|Overall Study|Withdrawal by Subject|0|||
161115965|NCT03363321|581813104|FG003|Overall Study|Withdrawal by Subject|1|||
161115966|NCT03363321|581813105|FG004|Overall Study|Withdrawal by Subject|0|||
161115967|NCT00915681|581813106|FG000|Overall Study|Screening failures|46|||
161115968|NCT03221751|581813109|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
161115969|NCT03221751|581813110|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
161115970|NCT01784861|581813111|FG000|Overall Study|Adverse Event|0|||
161115971|NCT01784861|581813112|FG001|Overall Study|Adverse Event|0|||
161115972|NCT01784861|581813113|FG002|Overall Study|Adverse Event|1|||
161115973|NCT01784861|581813114|FG003|Overall Study|Adverse Event|2|||
161115974|NCT01784861|581813115|FG004|Overall Study|Adverse Event|1|||
161115975|NCT01784861|581813116|FG005|Overall Study|Adverse Event|0|||
161115976|NCT01784861|581813111|FG000|Overall Study|Withdrawal by Subject|0|||
161115977|NCT01784861|581813112|FG001|Overall Study|Withdrawal by Subject|0|||
161115978|NCT01784861|581813113|FG002|Overall Study|Withdrawal by Subject|0|||
161115979|NCT01784861|581813114|FG003|Overall Study|Withdrawal by Subject|1|||
161115980|NCT01784861|581813115|FG004|Overall Study|Withdrawal by Subject|0|||
161115981|NCT01784861|581813116|FG005|Overall Study|Withdrawal by Subject|0|||
161115982|NCT01784861|581813111|FG000|Overall Study|Physician Decision|0|||
161115983|NCT01784861|581813112|FG001|Overall Study|Physician Decision|0|||
161115984|NCT01784861|581813113|FG002|Overall Study|Physician Decision|0|||
161115985|NCT01784861|581813114|FG003|Overall Study|Physician Decision|2|||
161115986|NCT01784861|581813115|FG004|Overall Study|Physician Decision|0|||
161115987|NCT01784861|581813116|FG005|Overall Study|Physician Decision|1|||
161115988|NCT02599961|581813119|FG000|Overall Study|Withdrawal by Subject|1|||
161219932|NCT00542386|582186730|FG002|Overall Study|Other Reasons|4|||
161219933|NCT00542386|582186731|FG003|Overall Study|Other Reasons|3|||
161219934|NCT00542386|582186732|FG004|Overall Study|Other Reasons|4|||
161219935|NCT00542386|582186733|FG005|Overall Study|Other Reasons|2|||
161219936|NCT02227849|582186736|FG000|Overall Study|Adverse Event|4|||
161219937|NCT02227849|582186736|FG000|Overall Study|Physician Decision|1|||
161219938|NCT02227849|582186736|FG000|Overall Study|Withdrawal by Subject|3|||
161219939|NCT04864405|582186737|FG000|Overall Study|Withdrawal by Subject|4|||
161219940|NCT04864405|582186738|FG001|Overall Study|Withdrawal by Subject|6|||
161219941|NCT04864405|582186737|FG000|Overall Study|Did not want endocrine therapy|3|||
161219942|NCT04864405|582186738|FG001|Overall Study|Did not want endocrine therapy|5|||
161219943|NCT04029090|582186739|FG000|Overall Study|Protocol Violation|1|||
161219944|NCT04029090|582186740|FG001|Overall Study|Protocol Violation|0|||
161219945|NCT04029090|582186741|FG002|Overall Study|Protocol Violation|0|||
161219946|NCT04029090|582186739|FG000|Overall Study|Withdrawal by Subject|0|||
161219947|NCT04029090|582186740|FG001|Overall Study|Withdrawal by Subject|1|||
161219948|NCT04029090|582186741|FG002|Overall Study|Withdrawal by Subject|0|||
161219949|NCT00506441|582186742|FG000|Period 1; Open-label Period|Adverse Event|21|||
161219950|NCT00506441|582186743|FG001|Period 1; Open-label Period|Adverse Event|0|||
161219951|NCT00506441|582186742|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
161219952|NCT00506441|582186743|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
161219953|NCT00506441|582186742|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
161219954|NCT00506441|582186743|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
161219955|NCT00506441|582186742|FG000|Period 1; Open-label Period|Physician Decision|5|||
161219956|NCT00506441|582186743|FG001|Period 1; Open-label Period|Physician Decision|0|||
161219957|NCT00506441|582186742|FG000|Period 1; Open-label Period|Protocol Violation|9|||
161219958|NCT00506441|582186743|FG001|Period 1; Open-label Period|Protocol Violation|0|||
161219959|NCT00506441|582186742|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
161219960|NCT00506441|582186743|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
161219961|NCT00506441|582186742|FG000|Period 1; Open-label Period|Other Reasons|13|||
161219962|NCT00506441|582186743|FG001|Period 1; Open-label Period|Other Reasons|0|||
161219963|NCT00506441|582186742|FG000|Period 2; Double-blind Period|Adverse Event|0|||
161219964|NCT00506441|582186743|FG001|Period 2; Double-blind Period|Adverse Event|1|||
161219965|NCT00506441|582186742|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
161219966|NCT00506441|582186743|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
161219967|NCT00506441|582186742|FG000|Period 2; Double-blind Period|Physician Decision|1|||
161219968|NCT00506441|582186743|FG001|Period 2; Double-blind Period|Physician Decision|1|||
161219969|NCT00506441|582186742|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
161219970|NCT00506441|582186743|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
161219971|NCT00506441|582186742|FG000|Period 2; Double-blind Period|Other Reason|1|||
161219972|NCT00506441|582186743|FG001|Period 2; Double-blind Period|Other Reason|1|||
161219973|NCT00501046|582186744|FG000|Overall Study|Adverse Event|21|||
161219974|NCT00501046|582186745|FG001|Overall Study|Adverse Event|25|||
161219975|NCT00501046|582186744|FG000|Overall Study|Death|23|||
161219976|NCT00501046|582186745|FG001|Overall Study|Death|30|||
161219977|NCT00501046|582186744|FG000|Overall Study|Lost to Follow-up|14|||
161219978|NCT00501046|582186745|FG001|Overall Study|Lost to Follow-up|13|||
161219979|NCT00501046|582186744|FG000|Overall Study|Physician Decision|7|||
161219980|NCT00501046|582186745|FG001|Overall Study|Physician Decision|2|||
161219981|NCT00501046|582186744|FG000|Overall Study|Pregnancy|0|||
161219982|NCT00501046|582186745|FG001|Overall Study|Pregnancy|3|||
161219983|NCT00501046|582186744|FG000|Overall Study|Protocol Violation|2|||
161219984|NCT00501046|582186745|FG001|Overall Study|Protocol Violation|1|||
161219985|NCT00501046|582186744|FG000|Overall Study|Withdrawal by Subject|84|||
161219986|NCT00501046|582186745|FG001|Overall Study|Withdrawal by Subject|83|||
161219987|NCT00501046|582186744|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
161219988|NCT00501046|582186745|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
161219989|NCT05056727|582186746|FG000|Initiation Phase|Lost to Follow-up|1|||
161219990|NCT05056727|582186747|FG001|Initiation Phase|Lost to Follow-up|0|||
161219991|NCT05056727|582186748|FG002|Initiation Phase|Lost to Follow-up|0|||
161219992|NCT05056727|582186749|FG003|Initiation Phase|Lost to Follow-up|0|||
161219993|NCT05056727|582186746|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
161219994|NCT05056727|582186747|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
161219995|NCT05056727|582186748|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
161219996|NCT05056727|582186749|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
161219997|NCT05056727|582186746|FG000|Initiation Phase|Withdrawal by Subject|9|||
161219998|NCT05056727|582186747|FG001|Initiation Phase|Withdrawal by Subject|0|||
161219999|NCT05056727|582186748|FG002|Initiation Phase|Withdrawal by Subject|0|||
161220000|NCT05056727|582186749|FG003|Initiation Phase|Withdrawal by Subject|0|||
161220001|NCT05056727|582186746|FG000|Initiation Phase|Physician Decision|4|||
161220002|NCT05056727|582186747|FG001|Initiation Phase|Physician Decision|0|||
161220003|NCT05056727|582186748|FG002|Initiation Phase|Physician Decision|0|||
161220004|NCT05056727|582186749|FG003|Initiation Phase|Physician Decision|0|||
160874380|NCT01904773|580934184|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874381|NCT01904773|580934185|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874382|NCT01904773|580934186|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874383|NCT01904773|580934187|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874384|NCT01904773|580934188|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
160874385|NCT01904773|580934180|FG000|First Intervention|Adverse Event|0|||
160874386|NCT01904773|580934181|FG001|First Intervention|Adverse Event|0|||
160874387|NCT01904773|580934182|FG002|First Intervention|Adverse Event|0|||
160874388|NCT01904773|580934183|FG003|First Intervention|Adverse Event|0|||
160874389|NCT01904773|580934184|FG004|First Intervention|Adverse Event|0|||
160874390|NCT01904773|580934185|FG005|First Intervention|Adverse Event|0|||
160874391|NCT01904773|580934186|FG006|First Intervention|Adverse Event|1|||
160874392|NCT01904773|580934187|FG007|First Intervention|Adverse Event|0|||
160874393|NCT01904773|580934188|FG008|First Intervention|Adverse Event|0|||
160874394|NCT01904773|580934180|FG000|Placebo Washout First Intervention|Condition worsened|0|||
160874395|NCT01904773|580934181|FG001|Placebo Washout First Intervention|Condition worsened|1|||
160874396|NCT01904773|580934182|FG002|Placebo Washout First Intervention|Condition worsened|0|||
160874397|NCT01904773|580934183|FG003|Placebo Washout First Intervention|Condition worsened|0|||
160874398|NCT01904773|580934184|FG004|Placebo Washout First Intervention|Condition worsened|0|||
160874399|NCT01904773|580934185|FG005|Placebo Washout First Intervention|Condition worsened|0|||
161115989|NCT02599961|581813119|FG000|Overall Study|Subject Non-Compliance|2|||
161115990|NCT02599961|581813119|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
161115991|NCT02599961|581813119|FG000|Overall Study|Other, Not Specified|3|||
161115992|NCT00618410|581813120|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
161115993|NCT00618410|581813121|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
161115994|NCT00464334|581813122|FG000|Overall Study|Adverse Event|0|||
161115995|NCT00464334|581813123|FG001|Overall Study|Adverse Event|0|||
161115996|NCT00464334|581813124|FG002|Overall Study|Adverse Event|0|||
161115997|NCT00464334|581813125|FG003|Overall Study|Adverse Event|1|||
161115998|NCT00464334|581813126|FG004|Overall Study|Adverse Event|1|||
161115999|NCT00464334|581813127|FG005|Overall Study|Adverse Event|1|||
161116000|NCT00464334|581813128|FG006|Overall Study|Adverse Event|0|||
161116001|NCT00464334|581813129|FG007|Overall Study|Adverse Event|0|||
161116002|NCT00464334|581813130|FG008|Overall Study|Adverse Event|2|||
161116003|NCT00464334|581813131|FG009|Overall Study|Adverse Event|1|||
161116004|NCT00464334|581813132|FG010|Overall Study|Adverse Event|2|||
161116005|NCT00464334|581813122|FG000|Overall Study|Lack of Efficacy|0|||
161116006|NCT00464334|581813123|FG001|Overall Study|Lack of Efficacy|1|||
161116007|NCT00464334|581813124|FG002|Overall Study|Lack of Efficacy|0|||
161116008|NCT00464334|581813125|FG003|Overall Study|Lack of Efficacy|0|||
161116009|NCT00464334|581813126|FG004|Overall Study|Lack of Efficacy|0|||
161116010|NCT00464334|581813127|FG005|Overall Study|Lack of Efficacy|0|||
161116011|NCT00464334|581813128|FG006|Overall Study|Lack of Efficacy|0|||
161116012|NCT00464334|581813129|FG007|Overall Study|Lack of Efficacy|0|||
161116013|NCT00464334|581813130|FG008|Overall Study|Lack of Efficacy|0|||
161116014|NCT00464334|581813131|FG009|Overall Study|Lack of Efficacy|0|||
161116015|NCT00464334|581813132|FG010|Overall Study|Lack of Efficacy|0|||
161116016|NCT00464334|581813122|FG000|Overall Study|Lost to Follow-up|0|||
161116017|NCT00464334|581813123|FG001|Overall Study|Lost to Follow-up|0|||
161116018|NCT00464334|581813124|FG002|Overall Study|Lost to Follow-up|1|||
161116019|NCT00464334|581813125|FG003|Overall Study|Lost to Follow-up|0|||
161116020|NCT00464334|581813126|FG004|Overall Study|Lost to Follow-up|1|||
161116021|NCT00464334|581813127|FG005|Overall Study|Lost to Follow-up|0|||
161116022|NCT00464334|581813128|FG006|Overall Study|Lost to Follow-up|1|||
161116023|NCT00464334|581813129|FG007|Overall Study|Lost to Follow-up|0|||
161116024|NCT00464334|581813130|FG008|Overall Study|Lost to Follow-up|0|||
161116025|NCT00464334|581813131|FG009|Overall Study|Lost to Follow-up|0|||
161116026|NCT00464334|581813132|FG010|Overall Study|Lost to Follow-up|2|||
161116027|NCT00464334|581813122|FG000|Overall Study|Progressive Disease|0|||
161116028|NCT00464334|581813123|FG001|Overall Study|Progressive Disease|0|||
161116029|NCT00464334|581813124|FG002|Overall Study|Progressive Disease|0|||
161116030|NCT00464334|581813125|FG003|Overall Study|Progressive Disease|0|||
161116031|NCT00464334|581813126|FG004|Overall Study|Progressive Disease|0|||
161116032|NCT00464334|581813127|FG005|Overall Study|Progressive Disease|1|||
161116033|NCT00464334|581813128|FG006|Overall Study|Progressive Disease|0|||
161116034|NCT00464334|581813129|FG007|Overall Study|Progressive Disease|0|||
161116035|NCT00464334|581813130|FG008|Overall Study|Progressive Disease|1|||
161116036|NCT00464334|581813131|FG009|Overall Study|Progressive Disease|0|||
161116037|NCT00464334|581813132|FG010|Overall Study|Progressive Disease|0|||
161116038|NCT00464334|581813122|FG000|Overall Study|Study Terminated by Sponsor|0|||
161116039|NCT00464334|581813123|FG001|Overall Study|Study Terminated by Sponsor|0|||
161116040|NCT00464334|581813124|FG002|Overall Study|Study Terminated by Sponsor|0|||
161116041|NCT00464334|581813125|FG003|Overall Study|Study Terminated by Sponsor|1|||
161116042|NCT00464334|581813126|FG004|Overall Study|Study Terminated by Sponsor|0|||
161116043|NCT00464334|581813127|FG005|Overall Study|Study Terminated by Sponsor|0|||
161116044|NCT00464334|581813128|FG006|Overall Study|Study Terminated by Sponsor|0|||
161116045|NCT00464334|581813129|FG007|Overall Study|Study Terminated by Sponsor|0|||
161220005|NCT05056727|582186746|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161220006|NCT05056727|582186747|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
161220007|NCT05056727|582186748|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161220008|NCT05056727|582186749|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
161220009|NCT05056727|582186746|FG000|Run-in Phase|Death|0|||
161220010|NCT05056727|582186747|FG001|Run-in Phase|Death|3|||
161220011|NCT05056727|582186748|FG002|Run-in Phase|Death|0|||
161220012|NCT05056727|582186749|FG003|Run-in Phase|Death|0|||
160874400|NCT01904773|580934186|FG006|Placebo Washout First Intervention|Condition worsened|0|||
161220013|NCT05056727|582186746|FG000|Run-in Phase|Withdrawal by Subject|0|||
161220014|NCT05056727|582186747|FG001|Run-in Phase|Withdrawal by Subject|25|||
160874401|NCT01904773|580934187|FG007|Placebo Washout First Intervention|Condition worsened|0|||
160874402|NCT01904773|580934188|FG008|Placebo Washout First Intervention|Condition worsened|0|||
161220015|NCT05056727|582186748|FG002|Run-in Phase|Withdrawal by Subject|0|||
161220016|NCT05056727|582186749|FG003|Run-in Phase|Withdrawal by Subject|0|||
161220017|NCT05056727|582186746|FG000|Run-in Phase|Physician Decision|0|||
161220018|NCT05056727|582186747|FG001|Run-in Phase|Physician Decision|20|||
161220019|NCT05056727|582186748|FG002|Run-in Phase|Physician Decision|0|||
161220020|NCT05056727|582186749|FG003|Run-in Phase|Physician Decision|0|||
161220021|NCT05056727|582186746|FG000|Run-in Phase|Lost to Follow-up|0|||
161220022|NCT05056727|582186747|FG001|Run-in Phase|Lost to Follow-up|1|||
161220023|NCT05056727|582186748|FG002|Run-in Phase|Lost to Follow-up|0|||
161220024|NCT05056727|582186749|FG003|Run-in Phase|Lost to Follow-up|0|||
161220025|NCT05056727|582186746|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
161220026|NCT05056727|582186747|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
161220027|NCT05056727|582186748|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
161220028|NCT05056727|582186749|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
161220029|NCT05056727|582186746|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161220030|NCT05056727|582186747|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161220031|NCT05056727|582186748|FG002|Maintenance Phase|Withdrawal by Subject|19|||
161220032|NCT05056727|582186749|FG003|Maintenance Phase|Withdrawal by Subject|21|||
161220033|NCT05056727|582186746|FG000|Maintenance Phase|Physician Decision|0|||
161220034|NCT05056727|582186747|FG001|Maintenance Phase|Physician Decision|0|||
161220035|NCT05056727|582186748|FG002|Maintenance Phase|Physician Decision|4|||
161220036|NCT05056727|582186749|FG003|Maintenance Phase|Physician Decision|16|||
161220037|NCT05056727|582186746|FG000|Maintenance Phase|Lost to Follow-up|0|||
161220038|NCT05056727|582186747|FG001|Maintenance Phase|Lost to Follow-up|0|||
161220039|NCT05056727|582186748|FG002|Maintenance Phase|Lost to Follow-up|2|||
161220040|NCT05056727|582186749|FG003|Maintenance Phase|Lost to Follow-up|2|||
161220041|NCT05056727|582186746|FG000|Maintenance Phase|Death|0|||
161220042|NCT05056727|582186747|FG001|Maintenance Phase|Death|0|||
161220043|NCT05056727|582186748|FG002|Maintenance Phase|Death|4|||
161220044|NCT05056727|582186749|FG003|Maintenance Phase|Death|2|||
161220045|NCT02622113|582186750|FG000|Overall Study|Adverse Event|4|||
161220046|NCT02622113|582186751|FG001|Overall Study|Adverse Event|4|||
161220047|NCT02622113|582186750|FG000|Overall Study|Physician Decision|0|||
161220048|NCT02622113|582186751|FG001|Overall Study|Physician Decision|1|||
161220049|NCT02622113|582186750|FG000|Overall Study|Withdrawal by Subject|0|||
161220050|NCT02622113|582186751|FG001|Overall Study|Withdrawal by Subject|2|||
161220051|NCT02622113|582186750|FG000|Overall Study|Stopping Criteria|1|||
161220052|NCT02622113|582186751|FG001|Overall Study|Stopping Criteria|3|||
161220053|NCT03289208|582186753|FG000|Overall Study|Adverse Event|1|||
161220054|NCT03289208|582186754|FG001|Overall Study|Adverse Event|0|||
161220055|NCT03289208|582186755|FG002|Overall Study|Adverse Event|0|||
161220056|NCT01840605|582187651|FG000|Overall Study|Adverse Event|0|||
161220057|NCT01840605|582187652|FG001|Overall Study|Adverse Event|1|||
161220058|NCT01840605|582187651|FG000|Overall Study|Physician Decision|2|||
161220059|NCT01840605|582187652|FG001|Overall Study|Physician Decision|1|||
161220060|NCT04969939|582187653|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161220061|NCT04969939|582187654|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161220062|NCT04969939|582187655|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161220063|NCT04969939|582187656|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
161220064|NCT04969939|582187657|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161220065|NCT04969939|582187658|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161220066|NCT04969939|582187659|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
161220067|NCT04969939|582187653|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
161220068|NCT04969939|582187654|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
161220069|NCT04969939|582187655|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
161220070|NCT04969939|582187656|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
161220071|NCT04969939|582187657|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
161220072|NCT04969939|582187658|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
161220073|NCT04969939|582187659|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
161220074|NCT04969939|582187653|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161220075|NCT04969939|582187654|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161116046|NCT00464334|581813130|FG008|Overall Study|Study Terminated by Sponsor|0|||
161116047|NCT00464334|581813131|FG009|Overall Study|Study Terminated by Sponsor|0|||
161116048|NCT00464334|581813132|FG010|Overall Study|Study Terminated by Sponsor|0|||
161116049|NCT00464334|581813122|FG000|Overall Study|Withdrawal by Subject|1|||
161116050|NCT00464334|581813123|FG001|Overall Study|Withdrawal by Subject|7|||
161116051|NCT00464334|581813124|FG002|Overall Study|Withdrawal by Subject|4|||
161116052|NCT00464334|581813125|FG003|Overall Study|Withdrawal by Subject|2|||
161116053|NCT00464334|581813126|FG004|Overall Study|Withdrawal by Subject|2|||
161116054|NCT00464334|581813127|FG005|Overall Study|Withdrawal by Subject|2|||
161116055|NCT00464334|581813128|FG006|Overall Study|Withdrawal by Subject|2|||
161116056|NCT00464334|581813129|FG007|Overall Study|Withdrawal by Subject|1|||
161116057|NCT00464334|581813130|FG008|Overall Study|Withdrawal by Subject|3|||
161116058|NCT00464334|581813131|FG009|Overall Study|Withdrawal by Subject|0|||
161116059|NCT00464334|581813132|FG010|Overall Study|Withdrawal by Subject|0|||
161116060|NCT01857869|581813133|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
161116061|NCT01857869|581813134|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
161116062|NCT01857869|581813135|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
161116063|NCT01857869|581813136|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
161116064|NCT01857869|581813137|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
161116065|NCT01857869|581813138|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
161116066|NCT01857869|581813139|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
161116067|NCT01857869|581813140|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
161116068|NCT01857869|581813141|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
161116069|NCT01857869|581813142|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
161116070|NCT01857869|581813133|FG000|Primary/Challenge Phase|Pregnancy|1|||
161116071|NCT01857869|581813134|FG001|Primary/Challenge Phase|Pregnancy|0|||
161116072|NCT01857869|581813135|FG002|Primary/Challenge Phase|Pregnancy|0|||
161116073|NCT01857869|581813136|FG003|Primary/Challenge Phase|Pregnancy|0|||
161116074|NCT01857869|581813137|FG004|Primary/Challenge Phase|Pregnancy|0|||
161220076|NCT04969939|582187655|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161220077|NCT04969939|582187656|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
161220078|NCT04969939|582187657|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161220079|NCT04969939|582187658|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161220080|NCT04969939|582187659|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
161220081|NCT04969939|582187653|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161220082|NCT04969939|582187654|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161220083|NCT04969939|582187655|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161220084|NCT04969939|582187656|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
161220085|NCT04969939|582187657|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161220086|NCT04969939|582187658|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161220087|NCT04969939|582187659|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
161220088|NCT04969939|582187653|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161220089|NCT04969939|582187654|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161220090|NCT04969939|582187655|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161220091|NCT04969939|582187656|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
161220092|NCT04969939|582187657|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161220093|NCT04969939|582187658|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161220094|NCT04969939|582187659|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
161220095|NCT04969939|582187653|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161220096|NCT04969939|582187654|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161220097|NCT04969939|582187655|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161220098|NCT04969939|582187656|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161220099|NCT04969939|582187657|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
161220100|NCT04969939|582187658|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
161220101|NCT04969939|582187659|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
161220102|NCT03843359|582187660|FG000|Escalation Phase|Lost to Follow-up|0|||
161220103|NCT03843359|582187661|FG001|Escalation Phase|Lost to Follow-up|0|||
161220104|NCT03843359|582187662|FG002|Escalation Phase|Lost to Follow-up|0|||
161220105|NCT03843359|582187663|FG003|Escalation Phase|Lost to Follow-up|0|||
161220106|NCT03843359|582187664|FG004|Escalation Phase|Lost to Follow-up|0|||
161220107|NCT03843359|582187665|FG005|Escalation Phase|Lost to Follow-up|0|||
161220108|NCT03843359|582187666|FG006|Escalation Phase|Lost to Follow-up|0|||
161220109|NCT03843359|582187667|FG007|Escalation Phase|Lost to Follow-up|0|||
161220110|NCT03843359|582187668|FG008|Escalation Phase|Lost to Follow-up|1|||
161220111|NCT03843359|582187669|FG009|Escalation Phase|Lost to Follow-up|0|||
161220112|NCT03843359|582187670|FG010|Escalation Phase|Lost to Follow-up|0|||
161220113|NCT03843359|582187671|FG011|Escalation Phase|Lost to Follow-up|0|||
161220114|NCT03843359|582187672|FG012|Escalation Phase|Lost to Follow-up|0|||
161116075|NCT01857869|581813138|FG005|Primary/Challenge Phase|Pregnancy|0|||
161116076|NCT01857869|581813139|FG006|Primary/Challenge Phase|Pregnancy|0|||
161257856|NCT00614926|582323498|FG000|Overall Study|Adverse Event|3|||
161116077|NCT01857869|581813140|FG007|Primary/Challenge Phase|Pregnancy|0|||
161116078|NCT01857869|581813141|FG008|Primary/Challenge Phase|Pregnancy|0|||
161116079|NCT01857869|581813142|FG009|Primary/Challenge Phase|Pregnancy|0|||
161116080|NCT01857869|581813133|FG000|Primary/Challenge Phase|Protocol Violation|1|||
161116081|NCT01857869|581813134|FG001|Primary/Challenge Phase|Protocol Violation|0|||
161116082|NCT01857869|581813135|FG002|Primary/Challenge Phase|Protocol Violation|0|||
161116083|NCT01857869|581813136|FG003|Primary/Challenge Phase|Protocol Violation|0|||
161116084|NCT01857869|581813137|FG004|Primary/Challenge Phase|Protocol Violation|0|||
161116085|NCT01857869|581813138|FG005|Primary/Challenge Phase|Protocol Violation|0|||
161116086|NCT01857869|581813139|FG006|Primary/Challenge Phase|Protocol Violation|0|||
161116087|NCT01857869|581813140|FG007|Primary/Challenge Phase|Protocol Violation|0|||
161116088|NCT01857869|581813141|FG008|Primary/Challenge Phase|Protocol Violation|0|||
161116089|NCT01857869|581813142|FG009|Primary/Challenge Phase|Protocol Violation|0|||
161116090|NCT01857869|581813133|FG000|Primary/Challenge Phase|Other|1|||
161116091|NCT01857869|581813134|FG001|Primary/Challenge Phase|Other|1|||
161116092|NCT01857869|581813135|FG002|Primary/Challenge Phase|Other|0|||
161116093|NCT01857869|581813136|FG003|Primary/Challenge Phase|Other|0|||
161116094|NCT01857869|581813137|FG004|Primary/Challenge Phase|Other|0|||
161116095|NCT01857869|581813138|FG005|Primary/Challenge Phase|Other|0|||
161116096|NCT01857869|581813139|FG006|Primary/Challenge Phase|Other|0|||
161116097|NCT01857869|581813140|FG007|Primary/Challenge Phase|Other|0|||
161116098|NCT01857869|581813141|FG008|Primary/Challenge Phase|Other|0|||
161116099|NCT01857869|581813142|FG009|Primary/Challenge Phase|Other|0|||
161116100|NCT01857869|581813133|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116101|NCT01857869|581813134|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116102|NCT01857869|581813135|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116103|NCT01857869|581813136|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
161116104|NCT01857869|581813137|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116105|NCT01857869|581813138|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116106|NCT01857869|581813139|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116107|NCT01857869|581813140|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116108|NCT01857869|581813141|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116109|NCT01857869|581813142|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
161116110|NCT01857869|581813133|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116111|NCT01857869|581813134|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116112|NCT01857869|581813135|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116113|NCT01857869|581813136|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
161116114|NCT01857869|581813137|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116115|NCT01857869|581813138|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116116|NCT01857869|581813139|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116117|NCT01857869|581813140|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116118|NCT01857869|581813141|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116119|NCT01857869|581813142|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
161116120|NCT00906087|581813158|FG000|Initial Washout|Withdrawal by Subject|1|||
161116121|NCT00906087|581813158|FG000|Initial Washout|Physician Decision|1|||
161116122|NCT02898259|581813159|FG000|Overall Study|Adverse Event|0|||
161116123|NCT02898259|581813160|FG001|Overall Study|Adverse Event|0|||
161116124|NCT02898259|581813161|FG002|Overall Study|Adverse Event|1|||
161116125|NCT02898259|581813162|FG003|Overall Study|Adverse Event|0|||
161116126|NCT02898259|581813163|FG004|Overall Study|Adverse Event|0|||
161116127|NCT02898259|581813159|FG000|Overall Study|Lack of Efficacy|1|||
161116128|NCT02898259|581813160|FG001|Overall Study|Lack of Efficacy|1|||
161116129|NCT02898259|581813161|FG002|Overall Study|Lack of Efficacy|3|||
161116130|NCT02898259|581813162|FG003|Overall Study|Lack of Efficacy|0|||
161116131|NCT02898259|581813163|FG004|Overall Study|Lack of Efficacy|0|||
161116132|NCT02898259|581813159|FG000|Overall Study|Lost to Follow-up|0|||
161116133|NCT02898259|581813160|FG001|Overall Study|Lost to Follow-up|0|||
161116134|NCT02898259|581813161|FG002|Overall Study|Lost to Follow-up|1|||
161116135|NCT02898259|581813162|FG003|Overall Study|Lost to Follow-up|0|||
161116136|NCT02898259|581813163|FG004|Overall Study|Lost to Follow-up|0|||
161116137|NCT02898259|581813159|FG000|Overall Study|Transformation before study began|0|||
161116138|NCT02898259|581813160|FG001|Overall Study|Transformation before study began|0|||
161116139|NCT02898259|581813161|FG002|Overall Study|Transformation before study began|0|||
161116140|NCT02898259|581813162|FG003|Overall Study|Transformation before study began|1|||
161116141|NCT02898259|581813163|FG004|Overall Study|Transformation before study began|0|||
161116142|NCT01087905|581813177|FG000|Overall Study|Lost to Follow-up|24|||
161116143|NCT01087905|581813178|FG001|Overall Study|Lost to Follow-up|28|||
161116144|NCT01087905|581813179|FG002|Overall Study|Lost to Follow-up|18|||
161116145|NCT01087905|581813180|FG003|Overall Study|Lost to Follow-up|31|||
161116146|NCT01087905|581813181|FG004|Overall Study|Lost to Follow-up|27|||
161116147|NCT01087905|581813182|FG005|Overall Study|Lost to Follow-up|25|||
161116148|NCT01087905|581813183|FG006|Overall Study|Lost to Follow-up|20|||
161116149|NCT01087905|581813184|FG007|Overall Study|Lost to Follow-up|24|||
161116150|NCT01087905|581813177|FG000|Overall Study|Withdrawal by Subject|5|||
161116151|NCT01087905|581813178|FG001|Overall Study|Withdrawal by Subject|4|||
161116152|NCT01087905|581813179|FG002|Overall Study|Withdrawal by Subject|4|||
161116153|NCT01087905|581813180|FG003|Overall Study|Withdrawal by Subject|5|||
161116154|NCT01087905|581813181|FG004|Overall Study|Withdrawal by Subject|4|||
161116155|NCT01087905|581813182|FG005|Overall Study|Withdrawal by Subject|3|||
161116156|NCT01087905|581813183|FG006|Overall Study|Withdrawal by Subject|3|||
161116157|NCT01087905|581813184|FG007|Overall Study|Withdrawal by Subject|5|||
161116158|NCT00790907|581813185|FG000|Overall Study|Adverse Event|9|||
161116159|NCT00790907|581813186|FG001|Overall Study|Adverse Event|7|||
161116160|NCT00790907|581813187|FG002|Overall Study|Adverse Event|6|||
161116161|NCT00790907|581813185|FG000|Overall Study|Physician Decision|304|||
161116162|NCT00790907|581813186|FG001|Overall Study|Physician Decision|271|||
161116163|NCT00790907|581813187|FG002|Overall Study|Physician Decision|255|||
161116164|NCT00790907|581813185|FG000|Overall Study|Withdrawal by Subject|1|||
161116165|NCT00790907|581813186|FG001|Overall Study|Withdrawal by Subject|7|||
161116166|NCT00790907|581813187|FG002|Overall Study|Withdrawal by Subject|5|||
161116167|NCT00790907|581813185|FG000|Overall Study|Bleeding Event|11|||
161116168|NCT00790907|581813186|FG001|Overall Study|Bleeding Event|16|||
161116169|NCT00790907|581813187|FG002|Overall Study|Bleeding Event|21|||
161116170|NCT00790907|581813185|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
161116171|NCT00790907|581813186|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
161116172|NCT00790907|581813187|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
161116173|NCT00790907|581813185|FG000|Overall Study|Qualifying Condition Not Present|29|||
161116174|NCT00790907|581813186|FG001|Overall Study|Qualifying Condition Not Present|14|||
161116175|NCT00790907|581813187|FG002|Overall Study|Qualifying Condition Not Present|16|||
161116176|NCT00790907|581813185|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
161116177|NCT00790907|581813186|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
161116178|NCT00790907|581813187|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
161116179|NCT00790907|581813185|FG000|Overall Study|Did Not Receive Study Drug|10|||
161116180|NCT00790907|581813186|FG001|Overall Study|Did Not Receive Study Drug|0|||
161116181|NCT00790907|581813187|FG002|Overall Study|Did Not Receive Study Drug|0|||
161116182|NCT00774345|581813188|FG000|Pre-treatment|Other reasons|2|||
161116183|NCT00774345|581813189|FG001|Pre-treatment|Other reasons|0|||
161116184|NCT00774345|581813188|FG000|Treatment|Adverse Event|61|||
161116185|NCT00774345|581813189|FG001|Treatment|Adverse Event|15|||
161116186|NCT00774345|581813188|FG000|Treatment|Progressive Disease without histologic transformation|51|||
161116187|NCT00774345|581813189|FG001|Treatment|Progressive Disease without histologic transformation|111|||
161116188|NCT00774345|581813188|FG000|Treatment|Progressive Disease with histologic transformation|4|||
161116189|NCT00774345|581813189|FG001|Treatment|Progressive Disease with histologic transformation|2|||
161220115|NCT03843359|582187673|FG013|Escalation Phase|Lost to Follow-up|0|||
161220116|NCT03843359|582187674|FG014|Escalation Phase|Lost to Follow-up|0|||
161220117|NCT03843359|582187675|FG015|Escalation Phase|Lost to Follow-up|0|||
161220118|NCT03843359|582187660|FG000|Escalation Phase|Physician Decision|0|||
161220119|NCT03843359|582187661|FG001|Escalation Phase|Physician Decision|0|||
161220120|NCT03843359|582187662|FG002|Escalation Phase|Physician Decision|1|||
161220121|NCT03843359|582187663|FG003|Escalation Phase|Physician Decision|0|||
161220122|NCT03843359|582187664|FG004|Escalation Phase|Physician Decision|0|||
161220123|NCT03843359|582187665|FG005|Escalation Phase|Physician Decision|1|||
161220124|NCT03843359|582187666|FG006|Escalation Phase|Physician Decision|0|||
161220125|NCT03843359|582187667|FG007|Escalation Phase|Physician Decision|0|||
161116190|NCT00774345|581813188|FG000|Treatment|Withdrawal by Subject|5|||
161116191|NCT00774345|581813189|FG001|Treatment|Withdrawal by Subject|2|||
161116192|NCT00774345|581813188|FG000|Treatment|Lost to Follow-up|1|||
161116193|NCT00774345|581813189|FG001|Treatment|Lost to Follow-up|1|||
161220126|NCT03843359|582187668|FG008|Escalation Phase|Physician Decision|0|||
161220127|NCT03843359|582187669|FG009|Escalation Phase|Physician Decision|0|||
161220128|NCT03843359|582187670|FG010|Escalation Phase|Physician Decision|0|||
161220129|NCT03843359|582187671|FG011|Escalation Phase|Physician Decision|0|||
161220130|NCT03843359|582187672|FG012|Escalation Phase|Physician Decision|0|||
161220131|NCT03843359|582187673|FG013|Escalation Phase|Physician Decision|0|||
161220132|NCT03843359|582187674|FG014|Escalation Phase|Physician Decision|0|||
161220133|NCT03843359|582187675|FG015|Escalation Phase|Physician Decision|0|||
161220134|NCT03843359|582187660|FG000|Escalation Phase|Investigator site closed|0|||
161220135|NCT03843359|582187661|FG001|Escalation Phase|Investigator site closed|1|||
161220136|NCT03843359|582187662|FG002|Escalation Phase|Investigator site closed|0|||
161220137|NCT03843359|582187663|FG003|Escalation Phase|Investigator site closed|1|||
161220138|NCT03843359|582187664|FG004|Escalation Phase|Investigator site closed|1|||
161220139|NCT03843359|582187665|FG005|Escalation Phase|Investigator site closed|0|||
161220140|NCT03843359|582187666|FG006|Escalation Phase|Investigator site closed|1|||
161220141|NCT03843359|582187667|FG007|Escalation Phase|Investigator site closed|0|||
161220142|NCT03843359|582187668|FG008|Escalation Phase|Investigator site closed|2|||
161220143|NCT03843359|582187669|FG009|Escalation Phase|Investigator site closed|0|||
161220144|NCT03843359|582187670|FG010|Escalation Phase|Investigator site closed|0|||
161220145|NCT03843359|582187671|FG011|Escalation Phase|Investigator site closed|0|||
161220146|NCT03843359|582187672|FG012|Escalation Phase|Investigator site closed|0|||
161220147|NCT03843359|582187673|FG013|Escalation Phase|Investigator site closed|0|||
161220148|NCT03843359|582187674|FG014|Escalation Phase|Investigator site closed|0|||
161220149|NCT03843359|582187675|FG015|Escalation Phase|Investigator site closed|0|||
161220150|NCT03843359|582187660|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
161220151|NCT03843359|582187661|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
161220152|NCT03843359|582187662|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
161220153|NCT03843359|582187663|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
161220154|NCT03843359|582187664|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
161220155|NCT03843359|582187665|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
161220156|NCT03843359|582187666|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
161220157|NCT03843359|582187667|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
161220158|NCT03843359|582187668|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
161220159|NCT03843359|582187669|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
161220160|NCT03843359|582187670|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
161220161|NCT03843359|582187671|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
161220162|NCT03843359|582187672|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
161220163|NCT03843359|582187673|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
161220164|NCT03843359|582187674|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
161220165|NCT03843359|582187675|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
161220166|NCT03843359|582187660|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220167|NCT03843359|582187661|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220168|NCT03843359|582187662|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
161220169|NCT03843359|582187663|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220170|NCT03843359|582187664|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
161220171|NCT03843359|582187665|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220172|NCT03843359|582187666|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220173|NCT03843359|582187667|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220174|NCT03843359|582187668|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220175|NCT03843359|582187669|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220176|NCT03843359|582187670|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220177|NCT03843359|582187671|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220178|NCT03843359|582187672|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220179|NCT03843359|582187673|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220180|NCT03843359|582187674|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220181|NCT03843359|582187675|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161220182|NCT03843359|582187660|FG000|Crossover|Withdrawal by Subject|0|||
161220183|NCT03843359|582187661|FG001|Crossover|Withdrawal by Subject|0|||
161220184|NCT03843359|582187662|FG002|Crossover|Withdrawal by Subject|0|||
161220185|NCT03843359|582187663|FG003|Crossover|Withdrawal by Subject|0|||
161220186|NCT03843359|582187664|FG004|Crossover|Withdrawal by Subject|0|||
161220187|NCT03843359|582187665|FG005|Crossover|Withdrawal by Subject|0|||
161220188|NCT03843359|582187666|FG006|Crossover|Withdrawal by Subject|0|||
161220189|NCT03843359|582187667|FG007|Crossover|Withdrawal by Subject|0|||
161220190|NCT03843359|582187668|FG008|Crossover|Withdrawal by Subject|0|||
161220191|NCT03843359|582187669|FG009|Crossover|Withdrawal by Subject|0|||
161220192|NCT03843359|582187670|FG010|Crossover|Withdrawal by Subject|0|||
161220193|NCT03843359|582187671|FG011|Crossover|Withdrawal by Subject|0|||
161220194|NCT03843359|582187672|FG012|Crossover|Withdrawal by Subject|0|||
161220195|NCT03843359|582187673|FG013|Crossover|Withdrawal by Subject|0|||
161220196|NCT03843359|582187674|FG014|Crossover|Withdrawal by Subject|0|||
161220197|NCT03843359|582187675|FG015|Crossover|Withdrawal by Subject|1|||
161220198|NCT03843359|582187660|FG000|Crossover|Investigator site closed|0|||
161220199|NCT03843359|582187661|FG001|Crossover|Investigator site closed|0|||
161220200|NCT03843359|582187662|FG002|Crossover|Investigator site closed|0|||
161220201|NCT03843359|582187663|FG003|Crossover|Investigator site closed|0|||
161220202|NCT03843359|582187664|FG004|Crossover|Investigator site closed|0|||
161220203|NCT03843359|582187665|FG005|Crossover|Investigator site closed|0|||
161220204|NCT03843359|582187666|FG006|Crossover|Investigator site closed|0|||
161220205|NCT03843359|582187667|FG007|Crossover|Investigator site closed|0|||
161220206|NCT03843359|582187668|FG008|Crossover|Investigator site closed|0|||
161220207|NCT03843359|582187669|FG009|Crossover|Investigator site closed|0|||
161220208|NCT03843359|582187670|FG010|Crossover|Investigator site closed|0|||
161116194|NCT00774345|581813188|FG000|Treatment|Death|4|||
161116195|NCT00774345|581813189|FG001|Treatment|Death|0|||
161116196|NCT00774345|581813188|FG000|Treatment|Other Reasons|32|||
161116197|NCT00774345|581813189|FG001|Treatment|Other Reasons|26|||
161116198|NCT03436862|581813190|FG000|Overall Study|Adverse Event|4|||
161116199|NCT03436862|581813190|FG000|Overall Study|Progressive Disease|2|||
161116200|NCT04703075|581813193|FG000|Overall Study|Adverse Event|11|||
161116201|NCT04703075|581813194|FG001|Overall Study|Adverse Event|7|||
161116202|NCT04703075|581813193|FG000|Overall Study|Lost to Follow-up|6|||
161116203|NCT04703075|581813194|FG001|Overall Study|Lost to Follow-up|12|||
161116204|NCT04703075|581813193|FG000|Overall Study|Physician Decision|3|||
161116205|NCT04703075|581813194|FG001|Overall Study|Physician Decision|0|||
161116206|NCT04703075|581813193|FG000|Overall Study|Moved|0|||
161116207|NCT04703075|581813194|FG001|Overall Study|Moved|2|||
161116208|NCT04703075|581813193|FG000|Overall Study|Index INH Resistant|0|||
161116209|NCT04703075|581813194|FG001|Overall Study|Index INH Resistant|1|||
161116210|NCT04703075|581813193|FG000|Overall Study|Lack of Efficacy|6|||
161116211|NCT04703075|581813194|FG001|Overall Study|Lack of Efficacy|18|||
161116212|NCT01119248|581813195|FG000|Overall Study|Physician Decision|5|||
161116213|NCT00550680|581813196|FG000|Overall Study|Administrative Reasons|1|||
161116214|NCT00550680|581813196|FG000|Overall Study|Adverse Event|5|||
161116215|NCT00550680|581813196|FG000|Overall Study|Death|3|||
161116216|NCT00550680|581813196|FG000|Overall Study|Early Improvement|1|||
161116217|NCT00550680|581813196|FG000|Overall Study|Lost to Follow-up|3|||
161116218|NCT00550680|581813196|FG000|Overall Study|Lack of Efficacy|1|||
161116219|NCT00550680|581813196|FG000|Overall Study|Other|10|||
161116220|NCT00550680|581813196|FG000|Overall Study|Protocol Violation|7|||
161116221|NCT00550680|581813196|FG000|Overall Study|Refused Treatment|19|||
161116222|NCT00550680|581813196|FG000|Overall Study|Screen Failure|6|||
161116223|NCT01967550|581813197|FG000|Overall Study|Withdrawal by Subject|1|||
161116224|NCT01967550|581813198|FG001|Overall Study|Withdrawal by Subject|0|||
161116225|NCT01967550|581813197|FG000|Overall Study|Adverse Event|2|||
161116226|NCT01967550|581813198|FG001|Overall Study|Adverse Event|0|||
161116227|NCT01967550|581813197|FG000|Overall Study|Protocol Violation|2|||
161116228|NCT01967550|581813198|FG001|Overall Study|Protocol Violation|1|||
161116229|NCT01967550|581813197|FG000|Overall Study|Non Compliance|0|||
161116230|NCT01967550|581813198|FG001|Overall Study|Non Compliance|1|||
161116231|NCT02867995|581813202|FG000|Overall Study|Withdrawal by Subject|0|||
161116232|NCT02867995|581813203|FG001|Overall Study|Withdrawal by Subject|1|||
161116233|NCT02867995|581813202|FG000|Overall Study|Lost to Follow-up|0|||
161116234|NCT02867995|581813203|FG001|Overall Study|Lost to Follow-up|2|||
161116235|NCT01534533|581813204|FG000|Overall Study|Lost to Follow-up|3|||
161116236|NCT01534533|581813205|FG001|Overall Study|Lost to Follow-up|0|||
161116237|NCT01534533|581813206|FG002|Overall Study|Lost to Follow-up|4|||
161116238|NCT01534533|581813207|FG003|Overall Study|Lost to Follow-up|3|||
161116239|NCT01534533|581813204|FG000|Overall Study|Withdrawal by Subject|5|||
161116240|NCT01534533|581813205|FG001|Overall Study|Withdrawal by Subject|3|||
161116241|NCT01534533|581813206|FG002|Overall Study|Withdrawal by Subject|4|||
161116242|NCT01534533|581813207|FG003|Overall Study|Withdrawal by Subject|1|||
161116243|NCT03315871|581813208|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
161116244|NCT03315871|581813209|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
161116245|NCT03315871|581813210|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
161116246|NCT03315871|581813208|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
161116247|NCT03315871|581813209|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
161116248|NCT03315871|581813210|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
161116249|NCT03315871|581813208|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
161116250|NCT03315871|581813209|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
161116251|NCT03315871|581813210|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
161116252|NCT03315871|581813208|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
161116253|NCT03315871|581813209|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
161116254|NCT03315871|581813210|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
161116255|NCT03315871|581813208|FG000|PROSTVAC + CV301|Progressive disease|0|||
161220209|NCT03843359|582187671|FG011|Crossover|Investigator site closed|0|||
161220210|NCT03843359|582187672|FG012|Crossover|Investigator site closed|0|||
161220211|NCT03843359|582187673|FG013|Crossover|Investigator site closed|0|||
161220212|NCT03843359|582187674|FG014|Crossover|Investigator site closed|2|||
161220213|NCT03843359|582187675|FG015|Crossover|Investigator site closed|2|||
161220214|NCT03843359|582187660|FG000|Crossover|Ongoing at the time of analysis|0|||
161220215|NCT03843359|582187661|FG001|Crossover|Ongoing at the time of analysis|0|||
161220216|NCT03843359|582187662|FG002|Crossover|Ongoing at the time of analysis|0|||
161220217|NCT03843359|582187663|FG003|Crossover|Ongoing at the time of analysis|0|||
161220218|NCT03843359|582187664|FG004|Crossover|Ongoing at the time of analysis|0|||
161220219|NCT03843359|582187665|FG005|Crossover|Ongoing at the time of analysis|0|||
161220220|NCT03843359|582187666|FG006|Crossover|Ongoing at the time of analysis|0|||
161220221|NCT03843359|582187667|FG007|Crossover|Ongoing at the time of analysis|0|||
161220222|NCT03843359|582187668|FG008|Crossover|Ongoing at the time of analysis|0|||
161220223|NCT03843359|582187669|FG009|Crossover|Ongoing at the time of analysis|0|||
161220224|NCT03843359|582187670|FG010|Crossover|Ongoing at the time of analysis|0|||
161220225|NCT03843359|582187671|FG011|Crossover|Ongoing at the time of analysis|0|||
161220226|NCT03843359|582187672|FG012|Crossover|Ongoing at the time of analysis|0|||
161220227|NCT03843359|582187673|FG013|Crossover|Ongoing at the time of analysis|1|||
161220228|NCT03843359|582187674|FG014|Crossover|Ongoing at the time of analysis|0|||
161220229|NCT03843359|582187675|FG015|Crossover|Ongoing at the time of analysis|0|||
161220230|NCT05308472|582187676|FG000|Overall Study|Adverse Event|0|||
161220231|NCT05308472|582187677|FG001|Overall Study|Adverse Event|0|||
161220232|NCT05308472|582187678|FG002|Overall Study|Adverse Event|3|||
161220233|NCT03075527|582187679|FG000|Overall Study|Death|1|||
161220234|NCT03075527|582187679|FG000|Overall Study|Withdrawal by Subject|1|||
161220235|NCT03075527|582187679|FG000|Overall Study|Physician Decision|3|||
161220236|NCT03075527|582187679|FG000|Overall Study|Progression/Relapse|14|||
161220237|NCT05359003|582187684|FG000|Overall Study|Withdrawal by Subject|1|||
160874403|NCT01904773|580934180|FG000|Fifth Intervention|Adverse Event|0|||
160874404|NCT01904773|580934181|FG001|Fifth Intervention|Adverse Event|0|||
160874405|NCT01904773|580934182|FG002|Fifth Intervention|Adverse Event|0|||
160874406|NCT01904773|580934183|FG003|Fifth Intervention|Adverse Event|0|||
161220238|NCT05359003|582187685|FG001|Overall Study|Withdrawal by Subject|3|||
161116256|NCT03315871|581813209|FG001|PROSTVAC + CV301|Progressive disease|0|||
161220239|NCT06202521|582187688|FG000|Overall Study|Withdrawal by Subject|0|||
161220240|NCT06202521|582187689|FG001|Overall Study|Withdrawal by Subject|1|||
161220241|NCT06202521|582187690|FG002|Overall Study|Withdrawal by Subject|0|||
161220242|NCT06202521|582187691|FG003|Overall Study|Withdrawal by Subject|1|||
161220243|NCT06202521|582187688|FG000|Overall Study|Adverse Event|0|||
161220244|NCT06202521|582187689|FG001|Overall Study|Adverse Event|0|||
161220245|NCT06202521|582187690|FG002|Overall Study|Adverse Event|1|||
161220246|NCT06202521|582187691|FG003|Overall Study|Adverse Event|0|||
161220247|NCT02717611|582187695|FG000|Overall Study|Death|13|||
161220248|NCT02717611|582187695|FG000|Overall Study|Withdrawal by Subject|6|||
161220249|NCT02717611|582187695|FG000|Overall Study|Active, not recruiting|40|||
161220250|NCT02717611|582187695|FG000|Overall Study|Complicating disease|1|||
161220251|NCT05182606|582187700|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
161116257|NCT03315871|581813210|FG002|PROSTVAC + CV301|Progressive disease|1|||
161116258|NCT03315871|581813208|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
161116259|NCT03315871|581813209|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
161116260|NCT03315871|581813210|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
161116261|NCT04099251|581815158|FG000|Pre-Treatment|Other reasons|1|||
161116262|NCT04099251|581815159|FG001|Pre-Treatment|Other reasons|0|||
161116263|NCT04099251|581815158|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
161116264|NCT04099251|581815159|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
161116265|NCT04099251|581815158|FG000|Blinded Treatment Phase|Other reasons|16|||
161116266|NCT04099251|581815159|FG001|Blinded Treatment Phase|Other reasons|7|||
161116267|NCT04099251|581815158|FG000|Blinded Treatment Phase|Disease recurrence|26|||
161116268|NCT04099251|581815159|FG001|Blinded Treatment Phase|Disease recurrence|41|||
161116269|NCT04099251|581815158|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
161116270|NCT04099251|581815159|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
161116271|NCT04099251|581815158|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
161116272|NCT04099251|581815159|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
161116273|NCT04099251|581815158|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
161116274|NCT04099251|581815159|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
161116275|NCT04099251|581815158|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
161116276|NCT04099251|581815159|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
161116277|NCT04099251|581815158|FG000|Blinded Treatment Phase|Death|6|||
161116278|NCT04099251|581815159|FG001|Blinded Treatment Phase|Death|2|||
161116279|NCT04099251|581815158|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
161116280|NCT04099251|581815159|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
161116281|NCT04099251|581815158|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
161220252|NCT02619682|582187705|FG000|Overall Study|Withdrawal by Subject|3|||
161220253|NCT02619682|582187705|FG000|Overall Study|Lack of Efficacy|8|||
161220254|NCT02619682|582187705|FG000|Overall Study|new secondary cancer|1|||
161220255|NCT02619682|582187705|FG000|Overall Study|post surgery complications|2|||
161220256|NCT01861522|582187706|FG000|Overall Study|Adverse Event|1|||
161220257|NCT01861522|582187707|FG001|Overall Study|Adverse Event|0|||
161220258|NCT01861522|582187706|FG000|Overall Study|Withdrawal by Subject|2|||
161220259|NCT01861522|582187707|FG001|Overall Study|Withdrawal by Subject|0|||
161220260|NCT00500682|582187708|FG000|Overall Study|Adverse Event|37|||
161220261|NCT00500682|582187709|FG001|Overall Study|Adverse Event|29|||
161220262|NCT00500682|582187708|FG000|Overall Study|Death|25|||
161220263|NCT00500682|582187709|FG001|Overall Study|Death|16|||
161220264|NCT00500682|582187708|FG000|Overall Study|Lost to Follow-up|11|||
161220265|NCT00500682|582187709|FG001|Overall Study|Lost to Follow-up|11|||
161220266|NCT00500682|582187708|FG000|Overall Study|Physician Decision|6|||
161220267|NCT00500682|582187709|FG001|Overall Study|Physician Decision|10|||
161220268|NCT00500682|582187708|FG000|Overall Study|Pregnancy|2|||
161220269|NCT00500682|582187709|FG001|Overall Study|Pregnancy|0|||
161220270|NCT00500682|582187708|FG000|Overall Study|Protocol Violation|1|||
161220271|NCT00500682|582187709|FG001|Overall Study|Protocol Violation|3|||
161220272|NCT00500682|582187708|FG000|Overall Study|Withdrawal by Subject|80|||
161220273|NCT00500682|582187709|FG001|Overall Study|Withdrawal by Subject|74|||
161220274|NCT00500682|582187708|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
161220275|NCT00500682|582187709|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
161220276|NCT01680159|582187710|FG000|Screening Period|Not meet criteria for dose-up period|7|||
161220277|NCT01680159|582187710|FG000|Increased Dose Period|Adverse Event|6|||
161220278|NCT01680159|582187710|FG000|Increased Dose Period|Withdrawal by Subject|2|||
161220279|NCT01995058|582187711|FG000|Overall Study|Sponsor Decision to terminate study|14|||
161220280|NCT01995058|582187712|FG001|Overall Study|Sponsor Decision to terminate study|12|||
161220281|NCT01995058|582187713|FG002|Overall Study|Sponsor Decision to terminate study|12|||
161220282|NCT01995058|582187714|FG003|Overall Study|Sponsor Decision to terminate study|10|||
161220283|NCT01995058|582187711|FG000|Overall Study|Progressive Disease|0|||
161220284|NCT01995058|582187712|FG001|Overall Study|Progressive Disease|1|||
161220285|NCT01995058|582187713|FG002|Overall Study|Progressive Disease|1|||
161220286|NCT01995058|582187714|FG003|Overall Study|Progressive Disease|1|||
161220287|NCT01995058|582187711|FG000|Overall Study|Adverse Event|0|||
161220288|NCT01995058|582187712|FG001|Overall Study|Adverse Event|0|||
161220289|NCT01995058|582187713|FG002|Overall Study|Adverse Event|0|||
161220290|NCT01995058|582187714|FG003|Overall Study|Adverse Event|1|||
161220291|NCT01995058|582187711|FG000|Overall Study|Lack of Efficacy|0|||
161220292|NCT01995058|582187712|FG001|Overall Study|Lack of Efficacy|0|||
161220293|NCT01995058|582187713|FG002|Overall Study|Lack of Efficacy|0|||
161220294|NCT01995058|582187714|FG003|Overall Study|Lack of Efficacy|1|||
161220295|NCT01995058|582187711|FG000|Overall Study|No Treatment Given|0|||
161220296|NCT01995058|582187712|FG001|Overall Study|No Treatment Given|0|||
161220297|NCT01995058|582187713|FG002|Overall Study|No Treatment Given|0|||
161220298|NCT01995058|582187714|FG003|Overall Study|No Treatment Given|1|||
161220299|NCT03611309|582187720|FG000|Overall Study|Lost to Follow-up|16|||
161220300|NCT03611309|582187721|FG001|Overall Study|Lost to Follow-up|8|||
161220301|NCT03611309|582187720|FG000|Overall Study|Withdrawal by Subject|5|||
161220302|NCT03611309|582187721|FG001|Overall Study|Withdrawal by Subject|5|||
161220303|NCT03611309|582187720|FG000|Overall Study|Physician Decision|0|||
161220304|NCT03611309|582187721|FG001|Overall Study|Physician Decision|2|||
161220305|NCT00772382|582187722|FG000|Overall Study|Adverse Event|19|||
161220306|NCT00772382|582187722|FG000|Overall Study|Death|6|||
161220307|NCT00772382|582187722|FG000|Overall Study|Lack of Efficacy|4|||
161220308|NCT00772382|582187722|FG000|Overall Study|Physician Decision|5|||
161220309|NCT00772382|582187722|FG000|Overall Study|Protocol Violation|1|||
161220310|NCT00772382|582187722|FG000|Overall Study|Withdrawal by Subject|10|||
161220311|NCT00772382|582187722|FG000|Overall Study|Other Reasons|10|||
161220312|NCT04526899|582187723|FG000|Overall Study|Withdrawal by Subject|3|||
161220313|NCT04526899|582187724|FG001|Overall Study|Withdrawal by Subject|2|||
161220314|NCT04526899|582187725|FG002|Overall Study|Withdrawal by Subject|2|||
161220315|NCT04526899|582187723|FG000|Overall Study|Lost to Follow-up|3|||
161220316|NCT04526899|582187724|FG001|Overall Study|Lost to Follow-up|3|||
161220317|NCT04526899|582187725|FG002|Overall Study|Lost to Follow-up|1|||
161220318|NCT04526899|582187723|FG000|Overall Study|Investigator's decision|1|||
161220319|NCT04526899|582187724|FG001|Overall Study|Investigator's decision|0|||
161220320|NCT04526899|582187725|FG002|Overall Study|Investigator's decision|0|||
161220321|NCT04526899|582187723|FG000|Overall Study|Death|33|||
161220322|NCT04526899|582187724|FG001|Overall Study|Death|17|||
161220323|NCT04526899|582187725|FG002|Overall Study|Death|13|||
161220324|NCT04526899|582187723|FG000|Overall Study|Other|1|||
161220325|NCT04526899|582187724|FG001|Overall Study|Other|0|||
161220326|NCT04526899|582187725|FG002|Overall Study|Other|0|||
161220327|NCT04526899|582187723|FG000|Overall Study|On-Treatment|19|||
161220328|NCT04526899|582187724|FG001|Overall Study|On-Treatment|10|||
161220329|NCT04526899|582187725|FG002|Overall Study|On-Treatment|12|||
161220330|NCT04526899|582187723|FG000|Overall Study|Survival Follow-up|34|||
161220331|NCT04526899|582187724|FG001|Overall Study|Survival Follow-up|14|||
161220332|NCT04526899|582187725|FG002|Overall Study|Survival Follow-up|16|||
161220333|NCT05576012|582187730|FG000|Overall Study|Physician Decision|0|||
161220334|NCT05576012|582187731|FG001|Overall Study|Physician Decision|0|||
161220335|NCT05576012|582187732|FG002|Overall Study|Physician Decision|0|||
161220336|NCT05576012|582187733|FG003|Overall Study|Physician Decision|0|||
161220337|NCT05576012|582187734|FG004|Overall Study|Physician Decision|0|||
161220338|NCT05576012|582187735|FG005|Overall Study|Physician Decision|0|||
161220339|NCT05576012|582187736|FG006|Overall Study|Physician Decision|0|||
161220340|NCT05576012|582187737|FG007|Overall Study|Physician Decision|0|||
161220341|NCT05576012|582187738|FG008|Overall Study|Physician Decision|1|||
161220342|NCT05576012|582187739|FG009|Overall Study|Physician Decision|0|||
161220343|NCT03731182|582188377|FG000|Overall Study|Lost to Follow-up|2|||
161220344|NCT03731182|582188378|FG001|Overall Study|Lost to Follow-up|0|||
161220345|NCT03731182|582188377|FG000|Overall Study|Physician Decision|1|||
161220346|NCT03731182|582188378|FG001|Overall Study|Physician Decision|0|||
161220347|NCT03731182|582188377|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
161220348|NCT03731182|582188378|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161220349|NCT03036579|582188385|FG000|2 Years|Lost to Follow-up|1|||
161220350|NCT03036579|582188386|FG001|2 Years|Lost to Follow-up|0|||
161220351|NCT03036579|582188385|FG000|3 Years|Lost to Follow-up|0|||
161220352|NCT03036579|582188386|FG001|3 Years|Lost to Follow-up|1|||
161220353|NCT02352337|582188387|FG000|Overall Study|Patients never treated|4|||
161220354|NCT02352337|582188388|FG001|Overall Study|Patients never treated|1|||
161220355|NCT02352337|582188389|FG002|Overall Study|Patients never treated|2|||
161220356|NCT02458638|582188392|FG000|Overall Study|Death|309|||
161220357|NCT02458638|582188392|FG000|Overall Study|End of Cohort/End of Study|67|||
161220358|NCT02458638|582188392|FG000|Overall Study|Lost to Follow-up|31|||
161220359|NCT02458638|582188392|FG000|Overall Study|Other Reasons|4|||
161220360|NCT02458638|582188392|FG000|Overall Study|Physician Decision|1|||
161220361|NCT02458638|582188392|FG000|Overall Study|Withdrawal by Subject|47|||
161220362|NCT02623959|582188404|FG000|Overall Study|Progression|0|||
161220363|NCT02623959|582188405|FG001|Overall Study|Progression|1|||
161220364|NCT00135707|582188406|FG000|Overall Study|Lost to Follow-up|94|||
161220365|NCT00135707|582188407|FG001|Overall Study|Lost to Follow-up|89|||
161220366|NCT00135707|582188406|FG000|Overall Study|Withdrawal by Subject|0|||
161220367|NCT00135707|582188407|FG001|Overall Study|Withdrawal by Subject|1|||
161220368|NCT00135707|582188406|FG000|Overall Study|Institutional review board request|1|||
161220369|NCT00135707|582188407|FG001|Overall Study|Institutional review board request|0|||
161220370|NCT00576901|582188411|FG000|Overall Study|Withdrawal by Subject|1|||
161220371|NCT00576901|582188411|FG000|Overall Study|Disease course|1|||
161220372|NCT00576901|582188411|FG000|Overall Study|Protocol Violation|1|||
161220373|NCT02398188|582188412|FG000|Overall Study|Adverse Event|2|||
161220374|NCT02398188|582188413|FG001|Overall Study|Adverse Event|3|||
161220375|NCT02398188|582188412|FG000|Overall Study|Lost to Follow-up|5|||
161220376|NCT02398188|582188413|FG001|Overall Study|Lost to Follow-up|0|||
161220377|NCT02398188|582188412|FG000|Overall Study|Non-compliance|4|||
161220378|NCT02398188|582188413|FG001|Overall Study|Non-compliance|4|||
161220379|NCT02398188|582188412|FG000|Overall Study|Protocol Violation|6|||
161220380|NCT02398188|582188413|FG001|Overall Study|Protocol Violation|10|||
161220381|NCT02398188|582188412|FG000|Overall Study|Sponsor Decision|2|||
161220382|NCT02398188|582188413|FG001|Overall Study|Sponsor Decision|1|||
161220383|NCT02398188|582188412|FG000|Overall Study|Pregnancy|1|||
161220384|NCT02398188|582188413|FG001|Overall Study|Pregnancy|0|||
161220385|NCT02398188|582188412|FG000|Overall Study|Withdrawal by Subject|7|||
161220386|NCT02398188|582188413|FG001|Overall Study|Withdrawal by Subject|16|||
161220387|NCT01259869|582188414|FG000|Overall Study|Duplicated registration|1|||
161220388|NCT00220701|582188415|FG000|Overall Study|Lost to Follow-up|5|||
161220389|NCT00220701|582188416|FG001|Overall Study|Lost to Follow-up|4|||
161220390|NCT01612000|582188418|FG000|Overall Study|Lost to Follow-up|6|||
161220391|NCT01612000|582188419|FG001|Overall Study|Lost to Follow-up|4|||
161220392|NCT01612000|582188420|FG002|Overall Study|Lost to Follow-up|4|||
161220393|NCT01612000|582188421|FG003|Overall Study|Lost to Follow-up|8|||
161220394|NCT01612000|582188418|FG000|Overall Study|Physician Decision|0|||
161220395|NCT01612000|582188419|FG001|Overall Study|Physician Decision|0|||
161220396|NCT01612000|582188420|FG002|Overall Study|Physician Decision|1|||
161220397|NCT01612000|582188421|FG003|Overall Study|Physician Decision|0|||
161220398|NCT01612000|582188418|FG000|Overall Study|Withdrawal by Subject|3|||
161220399|NCT01612000|582188419|FG001|Overall Study|Withdrawal by Subject|1|||
161220400|NCT01612000|582188420|FG002|Overall Study|Withdrawal by Subject|2|||
161220401|NCT01612000|582188421|FG003|Overall Study|Withdrawal by Subject|2|||
161220402|NCT03996005|582188431|FG000|Overall Study|Withdrawal by Subject|1|||
161220403|NCT04567615|582188432|FG000|Randomization|Participant withdrew consent|1|||
161220404|NCT04567615|582188433|FG001|Randomization|Participant withdrew consent|0|||
161220405|NCT04567615|582188434|FG002|Randomization|Participant withdrew consent|0|||
161220406|NCT04567615|582188432|FG000|Randomization|Adverse event unrelated to study drug|0|||
161220407|NCT04567615|582188433|FG001|Randomization|Adverse event unrelated to study drug|1|||
161220408|NCT04567615|582188434|FG002|Randomization|Adverse event unrelated to study drug|0|||
161220409|NCT04567615|582188432|FG000|Treatment Period|Participant Withdrew Consent|2|||
161220410|NCT04567615|582188433|FG001|Treatment Period|Participant Withdrew Consent|5|||
161220411|NCT04567615|582188434|FG002|Treatment Period|Participant Withdrew Consent|1|||
161220412|NCT04567615|582188432|FG000|Treatment Period|Death|1|||
161220413|NCT04567615|582188433|FG001|Treatment Period|Death|2|||
161220414|NCT04567615|582188434|FG002|Treatment Period|Death|0|||
161220415|NCT04567615|582188432|FG000|Treatment Period|Lost to Follow-up|0|||
161220416|NCT04567615|582188433|FG001|Treatment Period|Lost to Follow-up|1|||
161220417|NCT04567615|582188434|FG002|Treatment Period|Lost to Follow-up|0|||
161220418|NCT04567615|582188432|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161220419|NCT04567615|582188433|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
161220420|NCT04567615|582188434|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
161220421|NCT04567615|582188432|FG000|Treatment Period|Disease Progression|85|||
161220422|NCT04567615|582188433|FG001|Treatment Period|Disease Progression|63|||
161220423|NCT04567615|582188434|FG002|Treatment Period|Disease Progression|16|||
161220424|NCT04567615|582188432|FG000|Treatment Period|Study Drug Toxicity|3|||
161220425|NCT04567615|582188433|FG001|Treatment Period|Study Drug Toxicity|10|||
161220426|NCT04567615|582188434|FG002|Treatment Period|Study Drug Toxicity|4|||
161220427|NCT04567615|582188432|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
161220428|NCT04567615|582188433|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
161220429|NCT04567615|582188434|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
161220430|NCT04567615|582188432|FG000|Treatment Period|Other Reasons|1|||
161220431|NCT04567615|582188433|FG001|Treatment Period|Other Reasons|2|||
161220432|NCT04567615|582188434|FG002|Treatment Period|Other Reasons|0|||
161220433|NCT04567615|582188432|FG000|Treatment Period|Still On-going Treatment|21|||
161116282|NCT04099251|581815159|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
161116283|NCT04099251|581815158|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
161116284|NCT04099251|581815159|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
161116285|NCT04099251|581815158|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
161116286|NCT04099251|581815159|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
161116287|NCT04099251|581815158|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
161116288|NCT04099251|581815159|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
161116289|NCT04099251|581815158|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
161116290|NCT04099251|581815159|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
161116291|NCT04099251|581815158|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
161116292|NCT04099251|581815159|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
161116293|NCT04099251|581815158|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
161116294|NCT04099251|581815159|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
161116295|NCT04099251|581815158|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
161116296|NCT04099251|581815159|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
161116297|NCT04311502|581815160|FG000|Overall Study|Death|1|||
161116298|NCT04311502|581815161|FG001|Overall Study|Death|1|||
161116299|NCT04311502|581815162|FG002|Overall Study|Death|1|||
161116300|NCT04311502|581815160|FG000|Overall Study|Lost to Follow-up|2|||
161116301|NCT04311502|581815161|FG001|Overall Study|Lost to Follow-up|3|||
161116302|NCT04311502|581815162|FG002|Overall Study|Lost to Follow-up|0|||
161116303|NCT04311502|581815160|FG000|Overall Study|Participant is in prison|1|||
161116304|NCT04311502|581815161|FG001|Overall Study|Participant is in prison|0|||
161116305|NCT04311502|581815162|FG002|Overall Study|Participant is in prison|0|||
161116306|NCT04311502|581815160|FG000|Overall Study|Participant moved out of country|1|||
161116307|NCT04311502|581815161|FG001|Overall Study|Participant moved out of country|0|||
161116308|NCT04311502|581815162|FG002|Overall Study|Participant moved out of country|0|||
161116309|NCT04311502|581815160|FG000|Overall Study|Withdrawal by Subject|2|||
161116310|NCT04311502|581815161|FG001|Overall Study|Withdrawal by Subject|0|||
161220434|NCT04567615|582188433|FG001|Treatment Period|Still On-going Treatment|22|||
161220435|NCT04567615|582188434|FG002|Treatment Period|Still On-going Treatment|2|||
161220436|NCT01022112|582188436|FG000|Overall Study|Adverse Event|1|||
161220437|NCT01022112|582188437|FG001|Overall Study|Adverse Event|2|||
161220438|NCT01022112|582188438|FG002|Overall Study|Adverse Event|0|||
161220439|NCT01022112|582188439|FG003|Overall Study|Adverse Event|1|||
161220440|NCT01022112|582188440|FG004|Overall Study|Adverse Event|0|||
161220441|NCT01022112|582188436|FG000|Overall Study|Lack of Efficacy|1|||
161220442|NCT01022112|582188437|FG001|Overall Study|Lack of Efficacy|0|||
161220443|NCT01022112|582188438|FG002|Overall Study|Lack of Efficacy|0|||
161220444|NCT01022112|582188439|FG003|Overall Study|Lack of Efficacy|0|||
161220445|NCT01022112|582188440|FG004|Overall Study|Lack of Efficacy|1|||
161220446|NCT01022112|582188436|FG000|Overall Study|Physician Decision|0|||
161220447|NCT01022112|582188437|FG001|Overall Study|Physician Decision|0|||
161220448|NCT01022112|582188438|FG002|Overall Study|Physician Decision|1|||
161220449|NCT01022112|582188439|FG003|Overall Study|Physician Decision|0|||
161220450|NCT01022112|582188440|FG004|Overall Study|Physician Decision|1|||
161220451|NCT01022112|582188436|FG000|Overall Study|Withdrawal by Subject|0|||
161220452|NCT01022112|582188437|FG001|Overall Study|Withdrawal by Subject|1|||
161220453|NCT01022112|582188438|FG002|Overall Study|Withdrawal by Subject|2|||
161220454|NCT01022112|582188439|FG003|Overall Study|Withdrawal by Subject|2|||
161220455|NCT01022112|582188440|FG004|Overall Study|Withdrawal by Subject|1|||
161220456|NCT01022112|582188436|FG000|Overall Study|Fasting plasma glucose level increased|1|||
161220457|NCT01022112|582188437|FG001|Overall Study|Fasting plasma glucose level increased|0|||
161220458|NCT01022112|582188438|FG002|Overall Study|Fasting plasma glucose level increased|0|||
161220459|NCT01022112|582188439|FG003|Overall Study|Fasting plasma glucose level increased|0|||
161220460|NCT01022112|582188440|FG004|Overall Study|Fasting plasma glucose level increased|7|||
161220461|NCT07174544|582188441|FG000|Overall Study|Lost to Follow-up|43|||
161220462|NCT07174544|582188442|FG001|Overall Study|Lost to Follow-up|15|||
161220463|NCT03419234|582188443|FG000|Overall Study|Disease progression|37|||
161220464|NCT03419234|582188444|FG001|Overall Study|Disease progression|36|||
161220465|NCT03419234|582188443|FG000|Overall Study|Adverse Event|6|||
161220466|NCT03419234|582188444|FG001|Overall Study|Adverse Event|9|||
161220467|NCT03419234|582188443|FG000|Overall Study|Withdrawal by Subject|9|||
161220468|NCT03419234|582188444|FG001|Overall Study|Withdrawal by Subject|7|||
161220469|NCT03419234|582188443|FG000|Overall Study|Death|5|||
161220470|NCT03419234|582188444|FG001|Overall Study|Death|1|||
161220471|NCT03419234|582188443|FG000|Overall Study|Alternative therapy|4|||
161220472|NCT03419234|582188444|FG001|Overall Study|Alternative therapy|2|||
161220473|NCT03419234|582188443|FG000|Overall Study|PSA progression|8|||
161220474|NCT03419234|582188444|FG001|Overall Study|PSA progression|10|||
161220475|NCT03419234|582188443|FG000|Overall Study|Rising PSA and bone issues|3|||
161220476|NCT03419234|582188444|FG001|Overall Study|Rising PSA and bone issues|2|||
161220477|NCT03419234|582188443|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
161220478|NCT03419234|582188444|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
161220479|NCT03419234|582188443|FG000|Overall Study|Physician Decision|12|||
161220480|NCT03419234|582188444|FG001|Overall Study|Physician Decision|11|||
161220481|NCT03419234|582188443|FG000|Overall Study|Second malignancy|1|||
161220482|NCT03419234|582188444|FG001|Overall Study|Second malignancy|0|||
161220483|NCT03419234|582188443|FG000|Overall Study|Insurance status change/patient could not afford|2|||
161220484|NCT03419234|582188444|FG001|Overall Study|Insurance status change/patient could not afford|1|||
161220485|NCT03419234|582188443|FG000|Overall Study|Non-compliance|1|||
161220486|NCT03419234|582188444|FG001|Overall Study|Non-compliance|3|||
161220487|NCT03419234|582188443|FG000|Overall Study|Mistakenly off treatment|1|||
161220488|NCT03419234|582188444|FG001|Overall Study|Mistakenly off treatment|0|||
161220489|NCT03419234|582188443|FG000|Overall Study|Transition to hospice|1|||
161220490|NCT03419234|582188444|FG001|Overall Study|Transition to hospice|0|||
161220491|NCT03419234|582188443|FG000|Overall Study|Still on treatment|9|||
161220492|NCT03419234|582188444|FG001|Overall Study|Still on treatment|8|||
161220493|NCT03419234|582188443|FG000|Overall Study|Never received protocol therapy|2|||
161220494|NCT03419234|582188444|FG001|Overall Study|Never received protocol therapy|4|||
161220495|NCT03419234|582188443|FG000|Overall Study|Other complicating disease|0|||
161220496|NCT03419234|582188444|FG001|Overall Study|Other complicating disease|1|||
161220497|NCT03419234|582188443|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
161220498|NCT03419234|582188444|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
161220499|NCT00635778|582190034|FG000|Overall Study|Adverse Event|1|||
161220500|NCT00635778|582190035|FG001|Overall Study|Adverse Event|0|||
161220501|NCT00635778|582190036|FG002|Overall Study|Adverse Event|0|||
161220502|NCT00635778|582190037|FG003|Overall Study|Adverse Event|3|||
161220503|NCT00635778|582190038|FG004|Overall Study|Adverse Event|3|||
161220504|NCT00635778|582190039|FG005|Overall Study|Adverse Event|6|||
161220505|NCT00635778|582190040|FG006|Overall Study|Adverse Event|1|||
161220506|NCT00635778|582190034|FG000|Overall Study|Withdrawal by Subject|0|||
161220507|NCT00635778|582190035|FG001|Overall Study|Withdrawal by Subject|0|||
161220508|NCT00635778|582190036|FG002|Overall Study|Withdrawal by Subject|0|||
161220509|NCT00635778|582190037|FG003|Overall Study|Withdrawal by Subject|1|||
161220510|NCT00635778|582190038|FG004|Overall Study|Withdrawal by Subject|0|||
161220511|NCT00635778|582190039|FG005|Overall Study|Withdrawal by Subject|1|||
161220512|NCT00635778|582190040|FG006|Overall Study|Withdrawal by Subject|1|||
161220513|NCT00635778|582190034|FG000|Overall Study|Progressive disease|0|||
161220514|NCT00635778|582190035|FG001|Overall Study|Progressive disease|3|||
161220515|NCT00635778|582190036|FG002|Overall Study|Progressive disease|3|||
161220516|NCT00635778|582190037|FG003|Overall Study|Progressive disease|4|||
161220517|NCT00635778|582190038|FG004|Overall Study|Progressive disease|5|||
161220518|NCT00635778|582190039|FG005|Overall Study|Progressive disease|14|||
161220519|NCT00635778|582190040|FG006|Overall Study|Progressive disease|4|||
161220520|NCT01180244|582190046|FG000|Overall Study|Lack of Efficacy|0|||
161220521|NCT01180244|582190047|FG001|Overall Study|Lack of Efficacy|7|||
161220522|NCT01180244|582190046|FG000|Overall Study|Physician Decision|3|||
161220523|NCT01180244|582190047|FG001|Overall Study|Physician Decision|0|||
160874407|NCT01904773|580934184|FG004|Fifth Intervention|Adverse Event|0|||
160874408|NCT01904773|580934185|FG005|Fifth Intervention|Adverse Event|0|||
160874409|NCT01904773|580934186|FG006|Fifth Intervention|Adverse Event|0|||
160874410|NCT01904773|580934187|FG007|Fifth Intervention|Adverse Event|1|||
160874411|NCT01904773|580934188|FG008|Fifth Intervention|Adverse Event|0|||
160874412|NCT01904773|580934180|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874413|NCT01904773|580934181|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
160874414|NCT01904773|580934182|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874415|NCT01904773|580934183|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874416|NCT01904773|580934184|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874417|NCT01904773|580934185|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874418|NCT01904773|580934186|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874419|NCT01904773|580934187|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874420|NCT01904773|580934188|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
160874421|NCT00220779|580934189|FG000|Overall Study|Adverse Event|1|||
160874422|NCT00220779|580934190|FG001|Overall Study|Adverse Event|0|||
160874423|NCT00220779|580934191|FG002|Overall Study|Adverse Event|0|||
160874424|NCT00220779|580934189|FG000|Overall Study|Withdrawal by Subject|1|||
160874425|NCT00220779|580934190|FG001|Overall Study|Withdrawal by Subject|4|||
160874426|NCT00220779|580934191|FG002|Overall Study|Withdrawal by Subject|1|||
160874427|NCT00220779|580934189|FG000|Overall Study|Non-compliance|1|||
160874428|NCT00220779|580934190|FG001|Overall Study|Non-compliance|0|||
160874429|NCT00220779|580934191|FG002|Overall Study|Non-compliance|0|||
160874430|NCT00220779|580934189|FG000|Overall Study|Too time consuming|1|||
160874431|NCT00220779|580934190|FG001|Overall Study|Too time consuming|0|||
160874432|NCT00220779|580934191|FG002|Overall Study|Too time consuming|0|||
160874433|NCT00220779|580934189|FG000|Overall Study|Pregnancy|0|||
160874434|NCT00220779|580934190|FG001|Overall Study|Pregnancy|0|||
160874435|NCT00220779|580934191|FG002|Overall Study|Pregnancy|2|||
160874436|NCT00220779|580934189|FG000|Overall Study|Lack of Efficacy|3|||
160874437|NCT00220779|580934190|FG001|Overall Study|Lack of Efficacy|0|||
160874438|NCT00220779|580934191|FG002|Overall Study|Lack of Efficacy|1|||
161116311|NCT04311502|581815162|FG002|Overall Study|Withdrawal by Subject|0|||
160874439|NCT04518995|580934192|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
160874440|NCT04518995|580934193|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
160874441|NCT04518995|580934194|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
160874442|NCT04518995|580934192|FG000|Overall Study|Lack of Efficacy|2|||
160874443|NCT04518995|580934193|FG001|Overall Study|Lack of Efficacy|1|||
160874444|NCT04518995|580934194|FG002|Overall Study|Lack of Efficacy|0|||
160874445|NCT04518995|580934192|FG000|Overall Study|Non-compliance With Study Drug|0|||
160874446|NCT04518995|580934193|FG001|Overall Study|Non-compliance With Study Drug|3|||
160874447|NCT04518995|580934194|FG002|Overall Study|Non-compliance With Study Drug|2|||
160874448|NCT04518995|580934192|FG000|Overall Study|Pregnancy|0|||
160874449|NCT04518995|580934193|FG001|Overall Study|Pregnancy|0|||
160874450|NCT04518995|580934194|FG002|Overall Study|Pregnancy|1|||
160874451|NCT04518995|580934192|FG000|Overall Study|Protocol Violation|2|||
160874452|NCT04518995|580934193|FG001|Overall Study|Protocol Violation|0|||
160874453|NCT04518995|580934194|FG002|Overall Study|Protocol Violation|1|||
161116312|NCT04311502|581815160|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
161116313|NCT04311502|581815161|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
161116314|NCT04311502|581815162|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
161116315|NCT05032157|581815169|FG000|Overall Study|Adverse Event|12|||
161116316|NCT05032157|581815170|FG001|Overall Study|Adverse Event|7|||
161116317|NCT05032157|581815169|FG000|Overall Study|Pregnancy|0|||
161116318|NCT05032157|581815170|FG001|Overall Study|Pregnancy|2|||
161116319|NCT05032157|581815169|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161116320|NCT05032157|581815170|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
161116321|NCT05032157|581815169|FG000|Overall Study|Protocol Deviation|8|||
161116322|NCT05032157|581815170|FG001|Overall Study|Protocol Deviation|4|||
161116323|NCT05032157|581815169|FG000|Overall Study|Lost to Follow-up|1|||
161116324|NCT05032157|581815170|FG001|Overall Study|Lost to Follow-up|3|||
161116325|NCT05032157|581815169|FG000|Overall Study|Physician Decision|7|||
161116326|NCT05032157|581815170|FG001|Overall Study|Physician Decision|2|||
161116327|NCT05032157|581815169|FG000|Overall Study|Patient Decision|38|||
160874454|NCT04518995|580934192|FG000|Overall Study|Reason not Specified|4|||
160874455|NCT04518995|580934193|FG001|Overall Study|Reason not Specified|11|||
160874456|NCT04518995|580934194|FG002|Overall Study|Reason not Specified|2|||
160874457|NCT04518995|580934192|FG000|Overall Study|Lost to Follow-up|1|||
160874458|NCT04518995|580934193|FG001|Overall Study|Lost to Follow-up|10|||
161116328|NCT05032157|581815170|FG001|Overall Study|Patient Decision|19|||
161116329|NCT03451773|581815171|FG000|Overall Study|Death on study|1|||
161116330|NCT03451773|581815172|FG001|Overall Study|Death on study|5|||
160874459|NCT04518995|580934194|FG002|Overall Study|Lost to Follow-up|6|||
160874460|NCT01511055|580934197|FG000|Overall Study|Withdrawal by Subject|6|||
161116331|NCT03451773|581815171|FG000|Overall Study|Death during follow-up period|0|||
161116332|NCT03451773|581815172|FG001|Overall Study|Death during follow-up period|1|||
161116333|NCT02627495|581815175|FG000|Overall Study|Withdrawal by Subject|4|||
161116334|NCT02543528|581815176|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161116335|NCT02543528|581815177|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161116336|NCT02543528|581815178|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161116337|NCT02543528|581815179|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
161116338|NCT02543528|581815180|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
161116339|NCT02543528|581815176|FG000|Adaptation Period|Lens Handling Difficultes|0|||
161116340|NCT02543528|581815177|FG001|Adaptation Period|Lens Handling Difficultes|0|||
161116341|NCT02543528|581815178|FG002|Adaptation Period|Lens Handling Difficultes|0|||
161116342|NCT02543528|581815179|FG003|Adaptation Period|Lens Handling Difficultes|0|||
161116343|NCT02543528|581815180|FG004|Adaptation Period|Lens Handling Difficultes|8|||
161116344|NCT02543528|581815176|FG000|Adaptation Period|Lost to Follow-up|0|||
161116345|NCT02543528|581815177|FG001|Adaptation Period|Lost to Follow-up|0|||
161116346|NCT02543528|581815178|FG002|Adaptation Period|Lost to Follow-up|0|||
161116347|NCT02543528|581815179|FG003|Adaptation Period|Lost to Follow-up|0|||
161116348|NCT02543528|581815180|FG004|Adaptation Period|Lost to Follow-up|14|||
161116349|NCT02543528|581815176|FG000|Adaptation Period|Adverse Event|0|||
161116350|NCT02543528|581815177|FG001|Adaptation Period|Adverse Event|0|||
161116351|NCT02543528|581815178|FG002|Adaptation Period|Adverse Event|0|||
161116352|NCT02543528|581815179|FG003|Adaptation Period|Adverse Event|0|||
161116353|NCT02543528|581815180|FG004|Adaptation Period|Adverse Event|2|||
161116354|NCT02543528|581815176|FG000|Extended Wear Period|Adverse Event|17|||
161116355|NCT02543528|581815177|FG001|Extended Wear Period|Adverse Event|11|||
161116356|NCT02543528|581815178|FG002|Extended Wear Period|Adverse Event|16|||
161116357|NCT02543528|581815179|FG003|Extended Wear Period|Adverse Event|3|||
161116358|NCT02543528|581815180|FG004|Extended Wear Period|Adverse Event|0|||
161116359|NCT02543528|581815176|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
161116360|NCT02543528|581815177|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
161116361|NCT02543528|581815178|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
161220524|NCT01180244|582190046|FG000|Overall Study|Adverse Event|1|||
160874461|NCT04590248|580934198|FG000|Overall Study|Lost to Follow-up|1|||
161116362|NCT02543528|581815179|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
161116363|NCT02543528|581815180|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
161116364|NCT02543528|581815176|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
161116365|NCT02543528|581815177|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161116366|NCT02543528|581815178|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161116367|NCT02543528|581815179|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161116368|NCT02543528|581815180|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
161116369|NCT02543528|581815176|FG000|Extended Wear Period|Lost to Follow-up|0|||
161116370|NCT02543528|581815177|FG001|Extended Wear Period|Lost to Follow-up|1|||
161116371|NCT02543528|581815178|FG002|Extended Wear Period|Lost to Follow-up|2|||
161116372|NCT02543528|581815179|FG003|Extended Wear Period|Lost to Follow-up|1|||
161116373|NCT02543528|581815180|FG004|Extended Wear Period|Lost to Follow-up|0|||
161116374|NCT02543528|581815176|FG000|Extended Wear Period|Withdrawal by Subject|10|||
161116375|NCT02543528|581815177|FG001|Extended Wear Period|Withdrawal by Subject|9|||
161116376|NCT02543528|581815178|FG002|Extended Wear Period|Withdrawal by Subject|4|||
161116377|NCT02543528|581815179|FG003|Extended Wear Period|Withdrawal by Subject|5|||
161116378|NCT02543528|581815180|FG004|Extended Wear Period|Withdrawal by Subject|0|||
161116379|NCT01408147|581815181|FG000|Overall Study|Withdrawal by Subject|0|||
160874462|NCT04590248|580934198|FG000|Overall Study|Withdrawal by Subject|16|||
160874463|NCT04590248|580934198|FG000|Overall Study|Other|2|||
160874464|NCT02052414|580934201|FG000|Overall Study|Adverse Event|12|||
160874465|NCT02052414|580934201|FG000|Overall Study|Lack of Efficacy|2|||
161116380|NCT01408147|581815182|FG001|Overall Study|Withdrawal by Subject|1|||
161116381|NCT01042600|581815183|FG000|Overall Study|Ineligible|1|||
161116382|NCT01042600|581815184|FG001|Overall Study|Ineligible|0|||
161116383|NCT00621504|581815185|FG000|Overall Study|Adverse Event|1|||
161116384|NCT00621504|581815186|FG001|Overall Study|Adverse Event|3|||
161116385|NCT00621504|581815185|FG000|Overall Study|At the request of sponsor/investigator|1|||
161116386|NCT00621504|581815186|FG001|Overall Study|At the request of sponsor/investigator|0|||
161116387|NCT00621504|581815185|FG000|Overall Study|Withdrew consent|9|||
161116388|NCT00621504|581815186|FG001|Overall Study|Withdrew consent|6|||
161116389|NCT00621504|581815185|FG000|Overall Study|Lost to Follow-up|8|||
161116390|NCT00621504|581815186|FG001|Overall Study|Lost to Follow-up|10|||
161116391|NCT00621504|581815185|FG000|Overall Study|Other|1|||
161116392|NCT00621504|581815186|FG001|Overall Study|Other|0|||
161116393|NCT00621504|581815185|FG000|Overall Study|Death|6|||
161116394|NCT00621504|581815186|FG001|Overall Study|Death|6|||
161116395|NCT03311711|581815189|FG000|Overall Study|Death|1|||
161116396|NCT03311711|581815190|FG001|Overall Study|Death|0|||
161116397|NCT03311711|581815191|FG002|Overall Study|Death|0|||
161116398|NCT03311711|581815192|FG003|Overall Study|Death|0|||
161116399|NCT03311711|581815193|FG004|Overall Study|Death|0|||
161116400|NCT03311711|581815194|FG005|Overall Study|Death|0|||
161116401|NCT03311711|581815195|FG006|Overall Study|Death|1|||
161116402|NCT03311711|581815196|FG007|Overall Study|Death|0|||
161116403|NCT03311711|581815197|FG008|Overall Study|Death|1|||
161116404|NCT03311711|581815198|FG009|Overall Study|Death|0|||
161116405|NCT03311711|581815189|FG000|Overall Study|Death of dyad partner|0|||
161116406|NCT03311711|581815190|FG001|Overall Study|Death of dyad partner|1|||
161116407|NCT03311711|581815191|FG002|Overall Study|Death of dyad partner|0|||
161116408|NCT03311711|581815192|FG003|Overall Study|Death of dyad partner|0|||
161116409|NCT03311711|581815193|FG004|Overall Study|Death of dyad partner|0|||
161116410|NCT03311711|581815194|FG005|Overall Study|Death of dyad partner|0|||
161116411|NCT03311711|581815195|FG006|Overall Study|Death of dyad partner|0|||
161116412|NCT03311711|581815196|FG007|Overall Study|Death of dyad partner|1|||
161116413|NCT03311711|581815197|FG008|Overall Study|Death of dyad partner|0|||
161116414|NCT03311711|581815198|FG009|Overall Study|Death of dyad partner|1|||
161116415|NCT03311711|581815189|FG000|Overall Study|Lost to Follow-up|2|||
161116416|NCT03311711|581815190|FG001|Overall Study|Lost to Follow-up|2|||
161116417|NCT03311711|581815191|FG002|Overall Study|Lost to Follow-up|0|||
161116418|NCT03311711|581815192|FG003|Overall Study|Lost to Follow-up|0|||
161116419|NCT03311711|581815193|FG004|Overall Study|Lost to Follow-up|0|||
161116420|NCT03311711|581815194|FG005|Overall Study|Lost to Follow-up|0|||
161220525|NCT01180244|582190047|FG001|Overall Study|Adverse Event|0|||
161220526|NCT01180244|582190046|FG000|Overall Study|Withdrawal by Subject|0|||
161220527|NCT01180244|582190047|FG001|Overall Study|Withdrawal by Subject|1|||
161220528|NCT01180244|582190046|FG000|Overall Study|Protocol Violation|1|||
161220529|NCT01180244|582190047|FG001|Overall Study|Protocol Violation|0|||
161220530|NCT01180244|582190046|FG000|Overall Study|Lost to Follow-up|1|||
161220531|NCT01180244|582190047|FG001|Overall Study|Lost to Follow-up|0|||
161220532|NCT02385526|582190048|FG000|Overall Study|Withdrawal by Subject|0|||
161220533|NCT02385526|582190049|FG001|Overall Study|Withdrawal by Subject|2|||
161220534|NCT02385526|582190050|FG002|Overall Study|Withdrawal by Subject|0|||
161220535|NCT02385526|582190048|FG000|Overall Study|Lost to Follow-up|0|||
161220536|NCT02385526|582190049|FG001|Overall Study|Lost to Follow-up|1|||
161220537|NCT02385526|582190050|FG002|Overall Study|Lost to Follow-up|0|||
161220538|NCT02385526|582190048|FG000|Overall Study|Physician Decision|1|||
161220539|NCT02385526|582190049|FG001|Overall Study|Physician Decision|0|||
161220540|NCT02385526|582190050|FG002|Overall Study|Physician Decision|0|||
161220541|NCT02385526|582190048|FG000|Overall Study|Protocol Violation|1|||
161220542|NCT02385526|582190049|FG001|Overall Study|Protocol Violation|0|||
160874466|NCT02052414|580934201|FG000|Overall Study|Withdrawal by Subject|3|||
160874467|NCT00813943|580934207|FG000|Overall Study|Ongoing at cut-off date|5|||
161220543|NCT02385526|582190050|FG002|Overall Study|Protocol Violation|0|||
161220544|NCT00620763|582190051|FG000|Period: First Intervention|Withdrawal by Subject|0|||
161220545|NCT00620763|582190052|FG001|Period: First Intervention|Withdrawal by Subject|2|||
161220546|NCT00620763|582190051|FG000|Period: First Intervention|Protocol Violation|0|||
161220547|NCT00620763|582190052|FG001|Period: First Intervention|Protocol Violation|3|||
161220548|NCT00620763|582190051|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
161220549|NCT00620763|582190052|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
161116421|NCT03311711|581815195|FG006|Overall Study|Lost to Follow-up|1|||
161116422|NCT03311711|581815196|FG007|Overall Study|Lost to Follow-up|1|||
161116423|NCT03311711|581815197|FG008|Overall Study|Lost to Follow-up|0|||
161116424|NCT03311711|581815198|FG009|Overall Study|Lost to Follow-up|0|||
161116425|NCT03311711|581815189|FG000|Overall Study|Withdrawal by Subject|1|||
161116426|NCT03311711|581815190|FG001|Overall Study|Withdrawal by Subject|1|||
161116427|NCT03311711|581815191|FG002|Overall Study|Withdrawal by Subject|0|||
161116428|NCT03311711|581815192|FG003|Overall Study|Withdrawal by Subject|0|||
161116429|NCT03311711|581815193|FG004|Overall Study|Withdrawal by Subject|0|||
161116430|NCT03311711|581815194|FG005|Overall Study|Withdrawal by Subject|0|||
161116431|NCT03311711|581815195|FG006|Overall Study|Withdrawal by Subject|3|||
161116432|NCT03311711|581815196|FG007|Overall Study|Withdrawal by Subject|3|||
161116433|NCT03311711|581815197|FG008|Overall Study|Withdrawal by Subject|0|||
161116434|NCT03311711|581815198|FG009|Overall Study|Withdrawal by Subject|0|||
161116435|NCT02229552|581815199|FG000|Baseline|Withdrawal by Subject|6|||
161116436|NCT02229552|581815199|FG000|1-year Follow up|Withdrawal by Subject|7|||
161116437|NCT02229552|581815199|FG000|1-year Follow up|Lost to Follow-up|18|||
161116438|NCT02229552|581815199|FG000|2-Year Follow up|Withdrawal by Subject|9|||
161116439|NCT02229552|581815199|FG000|2-Year Follow up|Lost to Follow-up|17|||
161116440|NCT00706134|581815200|FG000|Overall Study|Adverse Event|8|||
161116441|NCT00706134|581815201|FG001|Overall Study|Adverse Event|7|||
161116442|NCT00706134|581815202|FG002|Overall Study|Adverse Event|2|||
161116443|NCT00706134|581815203|FG003|Overall Study|Adverse Event|3|||
161116444|NCT00706134|581815200|FG000|Overall Study|Lost to Follow-up|0|||
161116445|NCT00706134|581815201|FG001|Overall Study|Lost to Follow-up|1|||
161116446|NCT00706134|581815202|FG002|Overall Study|Lost to Follow-up|0|||
161116447|NCT00706134|581815203|FG003|Overall Study|Lost to Follow-up|0|||
161116448|NCT00706134|581815200|FG000|Overall Study|Protocol Violation|0|||
161116449|NCT00706134|581815201|FG001|Overall Study|Protocol Violation|6|||
161116450|NCT00706134|581815202|FG002|Overall Study|Protocol Violation|0|||
161116451|NCT00706134|581815203|FG003|Overall Study|Protocol Violation|3|||
161116452|NCT00706134|581815200|FG000|Overall Study|Withdrawal by Subject|1|||
161116453|NCT00706134|581815201|FG001|Overall Study|Withdrawal by Subject|2|||
161116454|NCT00706134|581815202|FG002|Overall Study|Withdrawal by Subject|1|||
161116455|NCT00706134|581815203|FG003|Overall Study|Withdrawal by Subject|0|||
161116456|NCT00706134|581815200|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161116457|NCT00706134|581815201|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161116458|NCT00706134|581815202|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
161116459|NCT00706134|581815203|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
161116460|NCT00706134|581815200|FG000|Overall Study|Did not meet study criteria|2|||
161116461|NCT00706134|581815201|FG001|Overall Study|Did not meet study criteria|0|||
161116462|NCT00706134|581815202|FG002|Overall Study|Did not meet study criteria|0|||
161116463|NCT00706134|581815203|FG003|Overall Study|Did not meet study criteria|0|||
161116464|NCT01339559|581815210|FG000|Overall Study|Adverse Event|92|||
161116465|NCT01339559|581815210|FG000|Overall Study|Death|5|||
161116466|NCT01339559|581815210|FG000|Overall Study|Lack of Efficacy|164|||
161116467|NCT01339559|581815210|FG000|Overall Study|Lost to Follow-up|22|||
161116468|NCT01339559|581815210|FG000|Overall Study|Subject choice|89|||
161116469|NCT01339559|581815210|FG000|Overall Study|Protocol Violation|15|||
161116470|NCT01339559|581815210|FG000|Overall Study|Study closure at site|1|||
161116471|NCT01339559|581815210|FG000|Overall Study|Incarcerated|2|||
161116472|NCT01339559|581815210|FG000|Overall Study|Epilepsy surgery|1|||
161116473|NCT01339559|581815210|FG000|Overall Study|Pregnancy planned|2|||
161116474|NCT01339559|581815210|FG000|Overall Study|Left the country|1|||
161116475|NCT01339559|581815210|FG000|Overall Study|Investigator decision|2|||
161116476|NCT01339559|581815210|FG000|Overall Study|Patient didn't wish to continue|1|||
161116477|NCT01339559|581815210|FG000|Overall Study|PI decision|1|||
161116478|NCT00971945|581815211|FG000|Overall Study|Progressive Disease|3|||
161116479|NCT00971945|581815211|FG000|Overall Study|Change in treatment policy|1|||
161116480|NCT00971945|581815211|FG000|Overall Study|Other reasons|2|||
161116481|NCT01049035|581815215|FG000|Overall Study|Serious adverse event|0|||
161116482|NCT01049035|581815216|FG001|Overall Study|Serious adverse event|1|||
161116483|NCT01049035|581815217|FG002|Overall Study|Serious adverse event|1|||
161116484|NCT01049035|581815218|FG003|Overall Study|Serious adverse event|2|||
161116485|NCT01049035|581815219|FG004|Overall Study|Serious adverse event|0|||
161116486|NCT01049035|581815220|FG005|Overall Study|Serious adverse event|0|||
161116487|NCT01049035|581815221|FG006|Overall Study|Serious adverse event|0|||
161116488|NCT01049035|581815215|FG000|Overall Study|Other adverse event (AE)|0|||
161116489|NCT01049035|581815216|FG001|Overall Study|Other adverse event (AE)|0|||
161116490|NCT01049035|581815217|FG002|Overall Study|Other adverse event (AE)|0|||
161116491|NCT01049035|581815218|FG003|Overall Study|Other adverse event (AE)|1|||
161116492|NCT01049035|581815219|FG004|Overall Study|Other adverse event (AE)|0|||
161116493|NCT01049035|581815220|FG005|Overall Study|Other adverse event (AE)|0|||
161116494|NCT01049035|581815221|FG006|Overall Study|Other adverse event (AE)|0|||
161116495|NCT01049035|581815215|FG000|Overall Study|Non-compliance with the protocol|12|||
161116496|NCT01049035|581815216|FG001|Overall Study|Non-compliance with the protocol|6|||
161116497|NCT01049035|581815217|FG002|Overall Study|Non-compliance with the protocol|14|||
161116498|NCT01049035|581815218|FG003|Overall Study|Non-compliance with the protocol|5|||
161116499|NCT01049035|581815219|FG004|Overall Study|Non-compliance with the protocol|3|||
161116500|NCT01049035|581815220|FG005|Overall Study|Non-compliance with the protocol|4|||
161116501|NCT01049035|581815221|FG006|Overall Study|Non-compliance with the protocol|10|||
161116502|NCT01049035|581815215|FG000|Overall Study|Lost to Follow-up|5|||
161116503|NCT01049035|581815216|FG001|Overall Study|Lost to Follow-up|4|||
161116504|NCT01049035|581815217|FG002|Overall Study|Lost to Follow-up|4|||
161116505|NCT01049035|581815218|FG003|Overall Study|Lost to Follow-up|1|||
161116506|NCT01049035|581815219|FG004|Overall Study|Lost to Follow-up|0|||
161116507|NCT01049035|581815220|FG005|Overall Study|Lost to Follow-up|3|||
161116508|NCT01049035|581815221|FG006|Overall Study|Lost to Follow-up|3|||
161116509|NCT01049035|581815215|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
161116510|NCT01049035|581815216|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
161116511|NCT01049035|581815217|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
161116512|NCT01049035|581815218|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
161116513|NCT01049035|581815219|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
161116514|NCT01049035|581815220|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
161116515|NCT01049035|581815221|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
161116516|NCT00746252|581815222|FG000|Overall Study|weight gain >7.5 %|1|||
161116517|NCT00746252|581815223|FG001|Overall Study|weight gain >7.5 %|2|||
161116518|NCT01137773|581815224|FG000|Overall Study|Death|3|||
161116519|NCT01137773|581815225|FG001|Overall Study|Death|3|||
161116520|NCT01137773|581815224|FG000|Overall Study|Lost to Follow-up|6|||
161116521|NCT01137773|581815225|FG001|Overall Study|Lost to Follow-up|0|||
161116522|NCT01391000|581815227|FG000|Overall Study|Lost to Follow-up|2|||
161116523|NCT01391000|581815228|FG001|Overall Study|Lost to Follow-up|0|||
161116524|NCT03548051|581815232|FG000|Overall Study|Death|1|||
161116525|NCT03548051|581815233|FG001|Overall Study|Death|1|||
161116526|NCT03548051|581815232|FG000|Overall Study|Withdrawal by Subject|1|||
161116527|NCT03548051|581815233|FG001|Overall Study|Withdrawal by Subject|0|||
161116528|NCT00082888|581815234|FG000|Overall Study|Ineligible|1|||
161116529|NCT00082888|581815235|FG001|Overall Study|Ineligible|0|||
161116530|NCT00082888|581815236|FG002|Overall Study|Ineligible|0|||
161116531|NCT03860961|581815237|FG000|Overall Study|Withdrawal by Subject|6|||
161116532|NCT03860961|581815238|FG001|Overall Study|Withdrawal by Subject|11|||
161116533|NCT03860961|581815237|FG000|Overall Study|Death|10|||
161116534|NCT03860961|581815238|FG001|Overall Study|Death|6|||
161116535|NCT03860961|581815237|FG000|Overall Study|Incomplete two-year data|4|||
161116536|NCT03860961|581815238|FG001|Overall Study|Incomplete two-year data|0|||
161116537|NCT00817531|581815240|FG000|Overall Study|Adverse Event|1|||
161116538|NCT00817531|581815240|FG000|Overall Study|Lack of Efficacy|1|||
161116539|NCT00812214|581815241|FG000|Overall Study|Lost to Follow-up|3|||
161116540|NCT00812214|581815242|FG001|Overall Study|Lost to Follow-up|1|||
161116541|NCT03325673|581815245|FG000|Overall Study|Adverse Event|4|||
161116542|NCT03325673|581815246|FG001|Overall Study|Adverse Event|0|||
161116543|NCT02684981|581815247|FG000|Overall Study|Permanently discontinued the treatment|157|||
161116544|NCT02684981|581815248|FG001|Overall Study|Permanently discontinued the treatment|161|||
161116545|NCT02684981|581815249|FG002|Overall Study|Permanently discontinued the treatment|110|||
161116546|NCT02684981|581815247|FG000|Overall Study|Other|83|||
161116547|NCT02684981|581815248|FG001|Overall Study|Other|49|||
161116548|NCT02684981|581815249|FG002|Overall Study|Other|17|||
161116549|NCT00820898|581815252|FG000|Overall Study|Inelgible - wrong primary site|1|||
161116550|NCT00452699|581815255|FG000|Overall Study|Adverse Event|10|||
161116551|NCT00452699|581815256|FG001|Overall Study|Adverse Event|3|||
161116552|NCT00452699|581815255|FG000|Overall Study|Lack of Efficacy|6|||
161116553|NCT00452699|581815256|FG001|Overall Study|Lack of Efficacy|4|||
161116554|NCT00452699|581815255|FG000|Overall Study|Lost to Follow-up|6|||
161116555|NCT00452699|581815256|FG001|Overall Study|Lost to Follow-up|9|||
161116556|NCT00452699|581815255|FG000|Overall Study|Protocol Violation|21|||
161116557|NCT00452699|581815256|FG001|Overall Study|Protocol Violation|25|||
161116558|NCT00452699|581815255|FG000|Overall Study|Withdrawal by Subject|26|||
161116559|NCT00452699|581815256|FG001|Overall Study|Withdrawal by Subject|25|||
161116560|NCT00452699|581815255|FG000|Overall Study|Other|12|||
161116561|NCT00452699|581815256|FG001|Overall Study|Other|7|||
161116562|NCT00493870|581815259|FG000|Overall Study|Lost to Follow-up|12|||
161116563|NCT00493870|581815260|FG001|Overall Study|Lost to Follow-up|15|||
161116564|NCT00272038|581815261|FG000|Overall Study|withdrew before they received 2 cycles|7|||
161116565|NCT03189446|581815262|FG000|Overall Study|Adverse Event|2|||
161116566|NCT03189446|581815262|FG000|Overall Study|Withdrawal by Subject|2|||
161116567|NCT03189446|581815262|FG000|Overall Study|Physician Decision|1|||
161116568|NCT00883337|581815263|FG000|Core Treatment Period|Adverse Event|9|||
161116569|NCT00883337|581815264|FG001|Core Treatment Period|Adverse Event|12|||
161116570|NCT00883337|581815265|FG002|Core Treatment Period|Adverse Event|22|||
161116571|NCT00883337|581815263|FG000|Core Treatment Period|Lack of Efficacy|7|||
161220550|NCT00729859|582190055|FG000|Overall Study|Adverse Event|0|||
161220551|NCT00729859|582190056|FG001|Overall Study|Adverse Event|1|||
161220552|NCT00729859|582190057|FG002|Overall Study|Adverse Event|0|||
161220553|NCT00729859|582190055|FG000|Overall Study|Withdrawal by Subject|0|||
161220554|NCT00729859|582190056|FG001|Overall Study|Withdrawal by Subject|1|||
161220555|NCT00729859|582190057|FG002|Overall Study|Withdrawal by Subject|0|||
161220556|NCT01689974|582190063|FG000|Overall Study|Termination of Study|5|||
161220557|NCT01689974|582190064|FG001|Overall Study|Termination of Study|5|||
161220558|NCT00681863|582190065|FG000|Overall Study|Adverse Event|1|||
161220559|NCT00681863|582190065|FG000|Overall Study|Lost to Follow-up|2|||
161220560|NCT00681863|582190065|FG000|Overall Study|Lack of Efficacy|2|||
161220561|NCT00681863|582190065|FG000|Overall Study|Other|18|||
161220562|NCT01388647|582190068|FG000|Overall Study|Adverse Event|1|||
161220563|NCT01388647|582190069|FG001|Overall Study|Adverse Event|2|||
161220564|NCT01006707|582190070|FG000|Study Session 1|Lost to Follow-up|2|||
161220565|NCT01006707|582190071|FG001|Study Session 1|Lost to Follow-up|0|||
161220566|NCT01006707|582190072|FG002|Study Session 1|Lost to Follow-up|0|||
161220567|NCT01006707|582190070|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
161220568|NCT01006707|582190071|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
161220569|NCT01006707|582190072|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
161220570|NCT00760383|582190073|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
161220571|NCT00760383|582190074|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
161220572|NCT01842958|582190076|FG000|Overall Study|Lost to Follow-up|1|||
161220573|NCT01842958|582190077|FG001|Overall Study|Lost to Follow-up|1|||
161220574|NCT01829477|582190078|FG000|Overall Study|Study Terminated by Sponsor|15|||
161220575|NCT01829477|582190079|FG001|Overall Study|Study Terminated by Sponsor|15|||
161220576|NCT01829477|582190078|FG000|Overall Study|Withdrawal by Subject|1|||
161220577|NCT01829477|582190079|FG001|Overall Study|Withdrawal by Subject|0|||
161220578|NCT03465891|582190081|FG000|Overall Study|Withdrawal by Subject|0|||
161220579|NCT03465891|582190082|FG001|Overall Study|Withdrawal by Subject|1|||
161220580|NCT03465891|582190081|FG000|Overall Study|Disease progression|1|||
161220581|NCT03465891|582190082|FG001|Overall Study|Disease progression|0|||
161220582|NCT02737306|582190084|FG000|Overall Study|Adverse Event|3|||
161220583|NCT02737306|582190085|FG001|Overall Study|Adverse Event|0|||
161220584|NCT02737306|582190084|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
161220585|NCT02737306|582190085|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
161220586|NCT03361423|582190086|FG000|Overall Study|Withdrawal by Subject|4|||
161220587|NCT03361423|582190087|FG001|Overall Study|Withdrawal by Subject|3|||
161220588|NCT03361423|582190086|FG000|Overall Study|Did not treat|19|||
161220589|NCT03361423|582190087|FG001|Overall Study|Did not treat|18|||
161220590|NCT03361423|582190086|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
161220591|NCT03361423|582190087|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
161220592|NCT03361423|582190086|FG000|Overall Study|Missing data|4|||
161220593|NCT03361423|582190087|FG001|Overall Study|Missing data|1|||
161220594|NCT01336894|582190088|FG000|Follow-up|Study terminated prematurely|2|||
161220595|NCT01336894|582190089|FG001|Follow-up|Study terminated prematurely|7|||
161220596|NCT05034731|582190090|FG000|Overall Study|Screen fail|1|||
161220597|NCT05034731|582190091|FG001|Overall Study|Screen fail|1|||
161220598|NCT00622908|582190092|FG000|Overall Study|Protocol Violation|1|||
161220599|NCT00622908|582190093|FG001|Overall Study|Protocol Violation|0|||
161220600|NCT00622908|582190092|FG000|Overall Study|Adverse Event|0|||
161220601|NCT00622908|582190093|FG001|Overall Study|Adverse Event|1|||
161220602|NCT00622908|582190092|FG000|Overall Study|Lack of Efficacy|1|||
161220603|NCT00622908|582190093|FG001|Overall Study|Lack of Efficacy|7|||
161116572|NCT00883337|581815264|FG001|Core Treatment Period|Lack of Efficacy|4|||
161116573|NCT00883337|581815265|FG002|Core Treatment Period|Lack of Efficacy|2|||
161116574|NCT00883337|581815263|FG000|Core Treatment Period|Lost to Follow-up|1|||
161116575|NCT00883337|581815264|FG001|Core Treatment Period|Lost to Follow-up|1|||
161116576|NCT00883337|581815265|FG002|Core Treatment Period|Lost to Follow-up|0|||
161116577|NCT00883337|581815263|FG000|Core Treatment Period|Withdrawal by Subject|2|||
161116578|NCT00883337|581815264|FG001|Core Treatment Period|Withdrawal by Subject|2|||
161116579|NCT00883337|581815265|FG002|Core Treatment Period|Withdrawal by Subject|6|||
161220604|NCT00622908|582190092|FG000|Overall Study|Lost to Follow-up|1|||
161220605|NCT00622908|582190093|FG001|Overall Study|Lost to Follow-up|0|||
161220606|NCT00622908|582190092|FG000|Overall Study|Refusal|0|||
161220607|NCT00622908|582190093|FG001|Overall Study|Refusal|1|||
161220608|NCT00622908|582190092|FG000|Overall Study|Termination by study sponser|0|||
161220609|NCT00622908|582190093|FG001|Overall Study|Termination by study sponser|1|||
161220610|NCT03937466|582190094|FG000|Overall Study|not eligbile after the 2-week diary|9|||
161220611|NCT03937466|582190094|FG000|Overall Study|never returned their diary|6|||
161220612|NCT03937466|582190094|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
161220613|NCT03937466|582190094|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
161116580|NCT00883337|581815263|FG000|Core Treatment Period|Wish to be pregnant|1|||
161116581|NCT00883337|581815264|FG001|Core Treatment Period|Wish to be pregnant|2|||
161116582|NCT00883337|581815265|FG002|Core Treatment Period|Wish to be pregnant|1|||
161220614|NCT01725451|582190102|FG000|Period 1|Withdrawal by Subject|1|||
161220615|NCT01725451|582190103|FG001|Period 1|Withdrawal by Subject|0|||
161220616|NCT01725451|582190104|FG002|Period 1|Withdrawal by Subject|0|||
161220617|NCT01725451|582190105|FG003|Period 1|Withdrawal by Subject|0|||
161220618|NCT01725451|582190102|FG000|Washout From Period 3|Protocol Violation|0|||
161220619|NCT01725451|582190103|FG001|Washout From Period 3|Protocol Violation|0|||
161220620|NCT01725451|582190104|FG002|Washout From Period 3|Protocol Violation|1|||
161220621|NCT01725451|582190105|FG003|Washout From Period 3|Protocol Violation|0|||
161220622|NCT01725451|582190102|FG000|Washout From Period 3|Adverse Event|0|||
161220623|NCT01725451|582190103|FG001|Washout From Period 3|Adverse Event|1|||
161220624|NCT01725451|582190104|FG002|Washout From Period 3|Adverse Event|0|||
161220625|NCT01725451|582190105|FG003|Washout From Period 3|Adverse Event|0|||
161220626|NCT01725451|582190102|FG000|Period 4|Adverse Event|0|||
161220627|NCT01725451|582190103|FG001|Period 4|Adverse Event|0|||
161220628|NCT01725451|582190104|FG002|Period 4|Adverse Event|1|||
161220629|NCT01725451|582190105|FG003|Period 4|Adverse Event|0|||
161220630|NCT00358826|582190109|FG000|Core Study|Adverse Event|1|||
161220631|NCT00358826|582190110|FG001|Core Study|Adverse Event|3|||
161220632|NCT00358826|582190111|FG002|Core Study|Adverse Event|1|||
161220633|NCT00358826|582190112|FG003|Core Study|Adverse Event|1|||
161220634|NCT00358826|582190113|FG004|Core Study|Adverse Event|0|||
161220635|NCT00358826|582190114|FG005|Core Study|Adverse Event|0|||
161220636|NCT00358826|582190115|FG006|Core Study|Adverse Event|0|||
161220637|NCT00358826|582190116|FG007|Core Study|Adverse Event|0|||
161220638|NCT00358826|582190109|FG000|Core Study|Withdrawal by Subject|2|||
161220639|NCT00358826|582190110|FG001|Core Study|Withdrawal by Subject|2|||
161220640|NCT00358826|582190111|FG002|Core Study|Withdrawal by Subject|0|||
161220641|NCT00358826|582190112|FG003|Core Study|Withdrawal by Subject|0|||
161220642|NCT00358826|582190113|FG004|Core Study|Withdrawal by Subject|0|||
161220643|NCT00358826|582190114|FG005|Core Study|Withdrawal by Subject|0|||
161220644|NCT00358826|582190115|FG006|Core Study|Withdrawal by Subject|0|||
161220645|NCT00358826|582190116|FG007|Core Study|Withdrawal by Subject|0|||
161220646|NCT00358826|582190109|FG000|Core Study|Lost to Follow-up|0|||
161220647|NCT00358826|582190110|FG001|Core Study|Lost to Follow-up|0|||
161220648|NCT00358826|582190111|FG002|Core Study|Lost to Follow-up|0|||
161220649|NCT00358826|582190112|FG003|Core Study|Lost to Follow-up|1|||
161220650|NCT00358826|582190113|FG004|Core Study|Lost to Follow-up|0|||
161220651|NCT00358826|582190114|FG005|Core Study|Lost to Follow-up|0|||
161220652|NCT00358826|582190115|FG006|Core Study|Lost to Follow-up|0|||
161220653|NCT00358826|582190116|FG007|Core Study|Lost to Follow-up|0|||
161220654|NCT00358826|582190109|FG000|Core Study|Physician Decision|0|||
161220655|NCT00358826|582190110|FG001|Core Study|Physician Decision|0|||
161220656|NCT00358826|582190111|FG002|Core Study|Physician Decision|1|||
161220657|NCT00358826|582190112|FG003|Core Study|Physician Decision|0|||
161220658|NCT00358826|582190113|FG004|Core Study|Physician Decision|0|||
161220659|NCT00358826|582190114|FG005|Core Study|Physician Decision|0|||
161220660|NCT00358826|582190115|FG006|Core Study|Physician Decision|0|||
161116583|NCT00883337|581815263|FG000|Core Treatment Period|Poor compliance to protocol|0|||
161116584|NCT00883337|581815264|FG001|Core Treatment Period|Poor compliance to protocol|0|||
161116585|NCT00883337|581815265|FG002|Core Treatment Period|Poor compliance to protocol|1|||
161116586|NCT00883337|581815263|FG000|Core Treatment Period|Other than above|0|||
161116587|NCT00883337|581815264|FG001|Core Treatment Period|Other than above|1|||
161116588|NCT00883337|581815265|FG002|Core Treatment Period|Other than above|1|||
161116589|NCT00883337|581815263|FG000|Extension Treatment Period|Adverse Event|8|||
161116590|NCT00883337|581815264|FG001|Extension Treatment Period|Adverse Event|5|||
161116591|NCT00883337|581815265|FG002|Extension Treatment Period|Adverse Event|5|||
161116592|NCT00883337|581815263|FG000|Extension Treatment Period|Lack of Efficacy|8|||
161116593|NCT00883337|581815264|FG001|Extension Treatment Period|Lack of Efficacy|8|||
161116594|NCT00883337|581815265|FG002|Extension Treatment Period|Lack of Efficacy|8|||
161116595|NCT00883337|581815263|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
161116596|NCT00883337|581815264|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
161116597|NCT00883337|581815265|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
161116598|NCT00883337|581815263|FG000|Extension Treatment Period|Lost to Follow-up|1|||
161116599|NCT00883337|581815264|FG001|Extension Treatment Period|Lost to Follow-up|0|||
161116600|NCT00883337|581815265|FG002|Extension Treatment Period|Lost to Follow-up|0|||
161116601|NCT00883337|581815263|FG000|Extension Treatment Period|Other than above|10|||
161116602|NCT00883337|581815264|FG001|Extension Treatment Period|Other than above|9|||
161116603|NCT00883337|581815265|FG002|Extension Treatment Period|Other than above|5|||
161220661|NCT00358826|582190116|FG007|Core Study|Physician Decision|0|||
161220662|NCT00358826|582190109|FG000|MDCT Substudy|Adverse Event|0|||
161220663|NCT00358826|582190110|FG001|MDCT Substudy|Adverse Event|0|||
161220664|NCT00358826|582190111|FG002|MDCT Substudy|Adverse Event|0|||
161220665|NCT00358826|582190112|FG003|MDCT Substudy|Adverse Event|0|||
161220666|NCT00358826|582190113|FG004|MDCT Substudy|Adverse Event|1|||
161220667|NCT00358826|582190114|FG005|MDCT Substudy|Adverse Event|0|||
161220668|NCT00358826|582190115|FG006|MDCT Substudy|Adverse Event|0|||
161220669|NCT00358826|582190116|FG007|MDCT Substudy|Adverse Event|0|||
161220670|NCT00358826|582190109|FG000|MDCT Substudy|Lost to Follow-up|0|||
161220671|NCT00358826|582190110|FG001|MDCT Substudy|Lost to Follow-up|0|||
161220672|NCT00358826|582190111|FG002|MDCT Substudy|Lost to Follow-up|0|||
161220673|NCT00358826|582190112|FG003|MDCT Substudy|Lost to Follow-up|0|||
161220674|NCT00358826|582190113|FG004|MDCT Substudy|Lost to Follow-up|0|||
161220675|NCT00358826|582190114|FG005|MDCT Substudy|Lost to Follow-up|1|||
161220676|NCT00358826|582190115|FG006|MDCT Substudy|Lost to Follow-up|0|||
161220677|NCT00358826|582190116|FG007|MDCT Substudy|Lost to Follow-up|0|||
161220678|NCT00358826|582190109|FG000|MDCT Substudy|Withdrawal by Subject|0|||
161220679|NCT00358826|582190110|FG001|MDCT Substudy|Withdrawal by Subject|0|||
161220680|NCT00358826|582190111|FG002|MDCT Substudy|Withdrawal by Subject|0|||
161220681|NCT00358826|582190112|FG003|MDCT Substudy|Withdrawal by Subject|0|||
161220682|NCT00358826|582190113|FG004|MDCT Substudy|Withdrawal by Subject|0|||
161220683|NCT00358826|582190114|FG005|MDCT Substudy|Withdrawal by Subject|1|||
161220684|NCT00358826|582190115|FG006|MDCT Substudy|Withdrawal by Subject|0|||
161220685|NCT00358826|582190116|FG007|MDCT Substudy|Withdrawal by Subject|0|||
161220686|NCT00903383|582190117|FG000|Overall Study|Adverse Event|1|||
161220687|NCT00903383|582190118|FG001|Overall Study|Adverse Event|2|||
161220688|NCT00903383|582190119|FG002|Overall Study|Adverse Event|3|||
161220689|NCT00903383|582190120|FG003|Overall Study|Adverse Event|1|||
161220690|NCT00903383|582190117|FG000|Overall Study|Physician Decision|1|||
161220691|NCT00903383|582190118|FG001|Overall Study|Physician Decision|2|||
161220692|NCT00903383|582190119|FG002|Overall Study|Physician Decision|0|||
161220693|NCT00903383|582190120|FG003|Overall Study|Physician Decision|0|||
161220694|NCT00903383|582190117|FG000|Overall Study|Lost to Follow-up|0|||
161220695|NCT00903383|582190118|FG001|Overall Study|Lost to Follow-up|0|||
161220696|NCT00903383|582190119|FG002|Overall Study|Lost to Follow-up|0|||
161220697|NCT00903383|582190120|FG003|Overall Study|Lost to Follow-up|1|||
161220698|NCT00903383|582190117|FG000|Overall Study|Decision of Sponsor|1|||
161220699|NCT00903383|582190118|FG001|Overall Study|Decision of Sponsor|0|||
161220700|NCT00903383|582190119|FG002|Overall Study|Decision of Sponsor|0|||
161220701|NCT00903383|582190120|FG003|Overall Study|Decision of Sponsor|0|||
161220702|NCT00903383|582190117|FG000|Overall Study|Withdrawal by Subject|4|||
161220703|NCT00903383|582190118|FG001|Overall Study|Withdrawal by Subject|1|||
161220704|NCT00903383|582190119|FG002|Overall Study|Withdrawal by Subject|0|||
161220705|NCT00903383|582190120|FG003|Overall Study|Withdrawal by Subject|2|||
161116604|NCT03548558|581815267|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
161116605|NCT03548558|581815268|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
161116606|NCT03548558|581815269|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161116607|NCT03548558|581815270|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
161116608|NCT03548558|581815271|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161116609|NCT03548558|581815272|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161116610|NCT03548558|581815273|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
161116611|NCT03548558|581815267|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
161116612|NCT03548558|581815268|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
161116613|NCT03548558|581815269|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
161116614|NCT03548558|581815270|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
161116615|NCT03548558|581815271|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
161116616|NCT03548558|581815272|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
161116617|NCT03548558|581815273|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
161116618|NCT03548558|581815267|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
161116619|NCT03548558|581815268|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
161116620|NCT03548558|581815269|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
161116621|NCT03548558|581815270|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
161116622|NCT03548558|581815271|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
161116623|NCT03548558|581815272|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
161116624|NCT03548558|581815273|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
161116625|NCT03548558|581815267|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161116626|NCT03548558|581815268|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161116627|NCT03548558|581815269|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161116628|NCT03548558|581815270|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
161116629|NCT03548558|581815271|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
161116630|NCT03548558|581815272|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
161116631|NCT03548558|581815273|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
161116632|NCT03548558|581815267|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161220706|NCT00903383|582190117|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
161220707|NCT00903383|582190118|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
161220708|NCT00903383|582190119|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
161220709|NCT00903383|582190120|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
161220710|NCT00903383|582190117|FG000|Overall Study|Patient Decision|0|||
161116633|NCT03548558|581815268|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161116634|NCT03548558|581815269|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161220711|NCT00903383|582190118|FG001|Overall Study|Patient Decision|0|||
161220712|NCT00903383|582190119|FG002|Overall Study|Patient Decision|0|||
161220713|NCT00903383|582190120|FG003|Overall Study|Patient Decision|1|||
161220714|NCT00283686|582190126|FG000|Overall Study|Death|1|||
161220715|NCT00283686|582190127|FG001|Overall Study|Death|1|||
161220716|NCT00283686|582190128|FG002|Overall Study|Death|1|||
161220717|NCT00283686|582190129|FG003|Overall Study|Death|0|||
161220718|NCT00283686|582190126|FG000|Overall Study|Lost to Follow-up|21|||
161220719|NCT00283686|582190127|FG001|Overall Study|Lost to Follow-up|31|||
161220720|NCT00283686|582190128|FG002|Overall Study|Lost to Follow-up|26|||
161220721|NCT00283686|582190129|FG003|Overall Study|Lost to Follow-up|20|||
161220722|NCT00283686|582190126|FG000|Overall Study|Less than full participation|7|||
161220723|NCT00283686|582190127|FG001|Overall Study|Less than full participation|9|||
161220724|NCT00283686|582190128|FG002|Overall Study|Less than full participation|6|||
161220725|NCT00283686|582190129|FG003|Overall Study|Less than full participation|12|||
161220726|NCT02087059|582190130|FG000|Overall Study|Disease Progression|1|||
161220727|NCT02087059|582190130|FG000|Overall Study|Adverse Event|5|||
161220728|NCT02087059|582190130|FG000|Overall Study|Lost to Follow-up|1|||
161220729|NCT01851590|582190131|FG000|Overall Study|Withdrawal by Subject|0|||
161220730|NCT01851590|582190132|FG001|Overall Study|Withdrawal by Subject|0|||
161220731|NCT01851590|582190133|FG002|Overall Study|Withdrawal by Subject|1|||
161220732|NCT01851590|582190131|FG000|Overall Study|Adverse Event|0|||
161220733|NCT01851590|582190132|FG001|Overall Study|Adverse Event|0|||
161220734|NCT01851590|582190133|FG002|Overall Study|Adverse Event|2|||
161220735|NCT01851590|582190131|FG000|Overall Study|Lack of Efficacy|0|||
161220736|NCT01851590|582190132|FG001|Overall Study|Lack of Efficacy|1|||
161220737|NCT01851590|582190133|FG002|Overall Study|Lack of Efficacy|0|||
161220738|NCT00696709|582190135|FG000|Overall Study|Withdrawal by Subject|1|||
161220739|NCT00696709|582190136|FG001|Overall Study|Withdrawal by Subject|2|||
161220740|NCT00696709|582190137|FG002|Overall Study|Withdrawal by Subject|1|||
161220741|NCT00696709|582190138|FG003|Overall Study|Withdrawal by Subject|4|||
161220742|NCT00696709|582190139|FG004|Overall Study|Withdrawal by Subject|3|||
161220743|NCT00696709|582190135|FG000|Overall Study|Protocol Violation|1|||
161220744|NCT00696709|582190136|FG001|Overall Study|Protocol Violation|0|||
161220745|NCT00696709|582190137|FG002|Overall Study|Protocol Violation|0|||
161220746|NCT00696709|582190138|FG003|Overall Study|Protocol Violation|0|||
161220747|NCT00696709|582190139|FG004|Overall Study|Protocol Violation|0|||
161220748|NCT00696709|582190135|FG000|Overall Study|Lost to Follow-up|1|||
161220749|NCT00696709|582190136|FG001|Overall Study|Lost to Follow-up|1|||
161220750|NCT00696709|582190137|FG002|Overall Study|Lost to Follow-up|0|||
161220751|NCT00696709|582190138|FG003|Overall Study|Lost to Follow-up|0|||
161220752|NCT00696709|582190139|FG004|Overall Study|Lost to Follow-up|0|||
161220753|NCT00696709|582190135|FG000|Overall Study|Adverse Event|0|||
161220754|NCT00696709|582190136|FG001|Overall Study|Adverse Event|0|||
161220755|NCT00696709|582190137|FG002|Overall Study|Adverse Event|0|||
161220756|NCT00696709|582190138|FG003|Overall Study|Adverse Event|1|||
161220757|NCT00696709|582190139|FG004|Overall Study|Adverse Event|0|||
161220758|NCT00310856|582190140|FG000|Overall Study|Withdrawal by Subject|2|||
161220759|NCT00310856|582190141|FG001|Overall Study|Withdrawal by Subject|2|||
161220760|NCT00310856|582190142|FG002|Overall Study|Withdrawal by Subject|2|||
161220761|NCT00310856|582190140|FG000|Overall Study|Lost to Follow-up|1|||
161220762|NCT00310856|582190141|FG001|Overall Study|Lost to Follow-up|2|||
161220763|NCT00310856|582190142|FG002|Overall Study|Lost to Follow-up|6|||
161220764|NCT00310856|582190140|FG000|Overall Study|Inappropriate enrollment|1|||
161220765|NCT00310856|582190141|FG001|Overall Study|Inappropriate enrollment|1|||
161220766|NCT00310856|582190142|FG002|Overall Study|Inappropriate enrollment|0|||
161220767|NCT00310856|582190140|FG000|Overall Study|Unable to classify|1|||
161220768|NCT00310856|582190141|FG001|Overall Study|Unable to classify|0|||
161220769|NCT00310856|582190142|FG002|Overall Study|Unable to classify|0|||
161220770|NCT01306253|582190146|FG000|Overall Study|Lost to Follow-up|1|||
161220771|NCT01306253|582190147|FG001|Overall Study|Lost to Follow-up|1|||
161220772|NCT01261325|582190148|FG000|Overall Study|Lack of Efficacy|1|||
161220773|NCT01261325|582190149|FG001|Overall Study|Lack of Efficacy|1|||
161220774|NCT01261325|582190150|FG002|Overall Study|Lack of Efficacy|0|||
161220775|NCT01261325|582190148|FG000|Overall Study|Withdrawal by Subject|2|||
161220776|NCT01261325|582190149|FG001|Overall Study|Withdrawal by Subject|2|||
161220777|NCT01261325|582190150|FG002|Overall Study|Withdrawal by Subject|4|||
161220778|NCT01261325|582190148|FG000|Overall Study|SAE, non-fatal|1|||
161220779|NCT01261325|582190149|FG001|Overall Study|SAE, non-fatal|5|||
161220780|NCT01261325|582190150|FG002|Overall Study|SAE, non-fatal|1|||
161220781|NCT01261325|582190148|FG000|Overall Study|AE, non-serious non-fatal|9|||
161220782|NCT01261325|582190149|FG001|Overall Study|AE, non-serious non-fatal|15|||
161220783|NCT01261325|582190150|FG002|Overall Study|AE, non-serious non-fatal|13|||
161220784|NCT01261325|582190148|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161220785|NCT01261325|582190149|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161220786|NCT01261325|582190150|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161220787|NCT01261325|582190148|FG000|Overall Study|Non Compliance|2|||
161220788|NCT01261325|582190149|FG001|Overall Study|Non Compliance|0|||
161220789|NCT01261325|582190150|FG002|Overall Study|Non Compliance|0|||
161257857|NCT00614926|582323499|FG001|Overall Study|Adverse Event|0|||
161116635|NCT03548558|581815270|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
161116636|NCT03548558|581815271|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
161116637|NCT03548558|581815272|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
161116638|NCT03548558|581815273|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
161116639|NCT03548558|581815267|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161116640|NCT03548558|581815268|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161116641|NCT03548558|581815269|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161116642|NCT03548558|581815270|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
161116643|NCT03548558|581815271|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
161116644|NCT03548558|581815272|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
161116645|NCT03548558|581815273|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
161116646|NCT02669017|581815274|FG000|Overall Study|Death|1|||
161116647|NCT02669017|581815275|FG001|Overall Study|Death|2|||
161116648|NCT02669017|581815276|FG002|Overall Study|Death|2|||
161116649|NCT02669017|581815277|FG003|Overall Study|Death|3|||
161116650|NCT02669017|581815278|FG004|Overall Study|Death|8|||
161116651|NCT02669017|581815279|FG005|Overall Study|Death|18|||
161116652|NCT02669017|581815280|FG006|Overall Study|Death|10|||
161116653|NCT02669017|581815281|FG007|Overall Study|Death|47|||
161116654|NCT02669017|581815282|FG008|Overall Study|Death|20|||
161116655|NCT02669017|581815274|FG000|Overall Study|Withdrawal by Subject|0|||
161116656|NCT02669017|581815275|FG001|Overall Study|Withdrawal by Subject|0|||
161116657|NCT02669017|581815276|FG002|Overall Study|Withdrawal by Subject|0|||
161116658|NCT02669017|581815277|FG003|Overall Study|Withdrawal by Subject|1|||
161116659|NCT02669017|581815278|FG004|Overall Study|Withdrawal by Subject|2|||
161116660|NCT02669017|581815279|FG005|Overall Study|Withdrawal by Subject|0|||
161116661|NCT02669017|581815280|FG006|Overall Study|Withdrawal by Subject|0|||
161116662|NCT02669017|581815281|FG007|Overall Study|Withdrawal by Subject|2|||
161116663|NCT02669017|581815282|FG008|Overall Study|Withdrawal by Subject|2|||
161116664|NCT02669017|581815274|FG000|Overall Study|Lost to Follow-up|0|||
161116665|NCT02669017|581815275|FG001|Overall Study|Lost to Follow-up|0|||
161116666|NCT02669017|581815276|FG002|Overall Study|Lost to Follow-up|0|||
161116667|NCT02669017|581815277|FG003|Overall Study|Lost to Follow-up|0|||
161116668|NCT02669017|581815278|FG004|Overall Study|Lost to Follow-up|0|||
161116669|NCT02669017|581815279|FG005|Overall Study|Lost to Follow-up|0|||
161116670|NCT02669017|581815280|FG006|Overall Study|Lost to Follow-up|0|||
161116671|NCT02669017|581815281|FG007|Overall Study|Lost to Follow-up|0|||
161116672|NCT02669017|581815282|FG008|Overall Study|Lost to Follow-up|1|||
161116673|NCT02669017|581815274|FG000|Overall Study|Miscellaneous|0|||
161116674|NCT02669017|581815275|FG001|Overall Study|Miscellaneous|0|||
161116675|NCT02669017|581815276|FG002|Overall Study|Miscellaneous|0|||
161116676|NCT02669017|581815277|FG003|Overall Study|Miscellaneous|0|||
161116677|NCT02669017|581815278|FG004|Overall Study|Miscellaneous|2|||
161116678|NCT02669017|581815279|FG005|Overall Study|Miscellaneous|1|||
161116679|NCT02669017|581815280|FG006|Overall Study|Miscellaneous|1|||
161116680|NCT02669017|581815281|FG007|Overall Study|Miscellaneous|13|||
161116681|NCT02669017|581815282|FG008|Overall Study|Miscellaneous|2|||
161116682|NCT02559687|581815283|FG000|Overall Study|Death|112|||
161116683|NCT02559687|581815283|FG000|Overall Study|Sponsor Decision|5|||
161116684|NCT02559687|581815283|FG000|Overall Study|Withdrawal by Subject|4|||
161116685|NCT03245450|581815285|FG000|Overall Study|Radiological disease progression|3|||
161116686|NCT03245450|581815286|FG001|Overall Study|Radiological disease progression|3|||
161116687|NCT03245450|581815287|FG002|Overall Study|Radiological disease progression|2|||
161116688|NCT03245450|581815288|FG003|Overall Study|Radiological disease progression|2|||
161116689|NCT03245450|581815289|FG004|Overall Study|Radiological disease progression|7|||
161116690|NCT03245450|581815290|FG005|Overall Study|Radiological disease progression|6|||
161116691|NCT03245450|581815291|FG006|Overall Study|Radiological disease progression|6|||
161116692|NCT03245450|581815285|FG000|Overall Study|Clinical disease progression|0|||
161116693|NCT03245450|581815286|FG001|Overall Study|Clinical disease progression|0|||
161116694|NCT03245450|581815287|FG002|Overall Study|Clinical disease progression|1|||
161116695|NCT03245450|581815288|FG003|Overall Study|Clinical disease progression|0|||
161116696|NCT03245450|581815289|FG004|Overall Study|Clinical disease progression|0|||
161116697|NCT03245450|581815290|FG005|Overall Study|Clinical disease progression|2|||
161116698|NCT03245450|581815291|FG006|Overall Study|Clinical disease progression|0|||
161116699|NCT03245450|581815285|FG000|Overall Study|Other|0|||
161116700|NCT03245450|581815286|FG001|Overall Study|Other|0|||
161116701|NCT03245450|581815287|FG002|Overall Study|Other|0|||
161116702|NCT03245450|581815288|FG003|Overall Study|Other|1|||
161116703|NCT03245450|581815289|FG004|Overall Study|Other|1|||
161116704|NCT03245450|581815290|FG005|Overall Study|Other|1|||
161116705|NCT03245450|581815291|FG006|Overall Study|Other|1|||
161116706|NCT03245450|581815285|FG000|Overall Study|Withdrawal by Subject|0|||
161116707|NCT03245450|581815286|FG001|Overall Study|Withdrawal by Subject|1|||
161116708|NCT03245450|581815287|FG002|Overall Study|Withdrawal by Subject|0|||
161116709|NCT03245450|581815288|FG003|Overall Study|Withdrawal by Subject|0|||
161220790|NCT01261325|582190148|FG000|Overall Study|Patient Randomized by Mistake|0|||
161220791|NCT01261325|582190149|FG001|Overall Study|Patient Randomized by Mistake|1|||
161220792|NCT01261325|582190150|FG002|Overall Study|Patient Randomized by Mistake|0|||
161220793|NCT01261325|582190148|FG000|Overall Study|Erroneously Randomized|1|||
161220794|NCT01261325|582190149|FG001|Overall Study|Erroneously Randomized|0|||
161220795|NCT01261325|582190150|FG002|Overall Study|Erroneously Randomized|0|||
161220796|NCT01261325|582190148|FG000|Overall Study|Screen Failure|1|||
161220797|NCT01261325|582190149|FG001|Overall Study|Screen Failure|0|||
161220798|NCT01261325|582190150|FG002|Overall Study|Screen Failure|0|||
161220799|NCT01261325|582190148|FG000|Overall Study|Randomized in Error|0|||
161220800|NCT01261325|582190149|FG001|Overall Study|Randomized in Error|0|||
161220801|NCT01261325|582190150|FG002|Overall Study|Randomized in Error|1|||
161220802|NCT01261325|582190148|FG000|Overall Study|Protocol Violation|0|||
161220803|NCT01261325|582190149|FG001|Overall Study|Protocol Violation|3|||
161220804|NCT01261325|582190150|FG002|Overall Study|Protocol Violation|1|||
161220805|NCT01261325|582190148|FG000|Overall Study|Lost to Follow-up|0|||
161220806|NCT01261325|582190149|FG001|Overall Study|Lost to Follow-up|1|||
161220807|NCT01261325|582190150|FG002|Overall Study|Lost to Follow-up|3|||
161220808|NCT01261325|582190148|FG000|Overall Study|AE, serious fatal|0|||
161220809|NCT01261325|582190149|FG001|Overall Study|AE, serious fatal|0|||
161220810|NCT01261325|582190150|FG002|Overall Study|AE, serious fatal|2|||
161220811|NCT00543439|582190151|FG000|Period 1|Adverse Event|0|||
161220812|NCT00543439|582190152|FG001|Period 1|Adverse Event|2|||
161220813|NCT00543439|582190153|FG002|Period 1|Adverse Event|1|||
161220814|NCT00543439|582190151|FG000|Period 1|Withdrawal by Subject|1|||
161220815|NCT00543439|582190152|FG001|Period 1|Withdrawal by Subject|1|||
161220816|NCT00543439|582190153|FG002|Period 1|Withdrawal by Subject|0|||
161220817|NCT00543439|582190151|FG000|Period 1|Physician Decision|0|||
161220818|NCT00543439|582190152|FG001|Period 1|Physician Decision|0|||
161220819|NCT00543439|582190153|FG002|Period 1|Physician Decision|1|||
161220820|NCT00543439|582190151|FG000|Period 2|Protocol Violation|1|||
161220821|NCT00543439|582190152|FG001|Period 2|Protocol Violation|0|||
161220822|NCT00543439|582190153|FG002|Period 2|Protocol Violation|1|||
161220823|NCT00543439|582190151|FG000|Period 2|Adverse Event|0|||
161220824|NCT00543439|582190152|FG001|Period 2|Adverse Event|1|||
161220825|NCT00543439|582190153|FG002|Period 2|Adverse Event|1|||
161220826|NCT01211769|582190156|FG000|Overall Study|Lost to Follow-up|7|||
161220827|NCT01211769|582190157|FG001|Overall Study|Lost to Follow-up|9|||
161220828|NCT01211769|582190158|FG002|Overall Study|Lost to Follow-up|5|||
161220829|NCT01211769|582190159|FG003|Overall Study|Lost to Follow-up|9|||
161220830|NCT01211769|582190156|FG000|Overall Study|Physician Decision|2|||
161220831|NCT01211769|582190157|FG001|Overall Study|Physician Decision|0|||
161220832|NCT01211769|582190158|FG002|Overall Study|Physician Decision|2|||
161220833|NCT01211769|582190159|FG003|Overall Study|Physician Decision|1|||
161220834|NCT01211769|582190156|FG000|Overall Study|Adverse Event|0|||
161220835|NCT01211769|582190157|FG001|Overall Study|Adverse Event|1|||
161220836|NCT01211769|582190158|FG002|Overall Study|Adverse Event|1|||
161220837|NCT01211769|582190159|FG003|Overall Study|Adverse Event|1|||
161220838|NCT01709383|582190166|FG000|Overall Study|Lost to Follow-up|1|||
161220839|NCT01709383|582190167|FG001|Overall Study|Lost to Follow-up|0|||
161220840|NCT01484028|582190168|FG000|Period 1|Lost to Follow-up|0|||
161220841|NCT01484028|582190169|FG001|Period 1|Lost to Follow-up|1|||
161220842|NCT01484028|582190170|FG002|Period 1|Lost to Follow-up|0|||
161220843|NCT01484028|582190171|FG003|Period 1|Lost to Follow-up|0|||
161220844|NCT01484028|582190168|FG000|Period 1|Non-Compliance to Protocol|0|||
161220845|NCT01484028|582190169|FG001|Period 1|Non-Compliance to Protocol|1|||
161220846|NCT01484028|582190170|FG002|Period 1|Non-Compliance to Protocol|0|||
161220847|NCT01484028|582190171|FG003|Period 1|Non-Compliance to Protocol|1|||
161220848|NCT01484028|582190168|FG000|Period 1|Lens Discomfort|0|||
161220849|NCT01484028|582190169|FG001|Period 1|Lens Discomfort|1|||
161220850|NCT01484028|582190170|FG002|Period 1|Lens Discomfort|0|||
161220851|NCT01484028|582190171|FG003|Period 1|Lens Discomfort|0|||
161220852|NCT00146770|582190183|FG000|Overall Study|Adverse Event|2|||
161220853|NCT00146770|582190184|FG001|Overall Study|Adverse Event|0|||
161220854|NCT00146770|582190183|FG000|Overall Study|Pregnancy|1|||
161220855|NCT00146770|582190184|FG001|Overall Study|Pregnancy|0|||
161220856|NCT00146770|582190183|FG000|Overall Study|Withdrawal by Subject|2|||
161220857|NCT00146770|582190184|FG001|Overall Study|Withdrawal by Subject|0|||
160874468|NCT00813943|580934208|FG001|Overall Study|Ongoing at cut-off date|5|||
161220858|NCT02826603|582190187|FG000|Overall Study|Adverse Event|17|||
161220859|NCT02826603|582190188|FG001|Overall Study|Adverse Event|9|||
161220860|NCT02826603|582190187|FG000|Overall Study|Lack of Efficacy|4|||
161220861|NCT02826603|582190188|FG001|Overall Study|Lack of Efficacy|9|||
161220862|NCT02826603|582190187|FG000|Overall Study|Lost to Follow-up|13|||
161220863|NCT02826603|582190188|FG001|Overall Study|Lost to Follow-up|12|||
161220864|NCT02826603|582190187|FG000|Overall Study|Noncompliance with treatment|0|||
161220865|NCT02826603|582190188|FG001|Overall Study|Noncompliance with treatment|2|||
161220866|NCT02826603|582190187|FG000|Overall Study|Physician Decision|1|||
161220867|NCT02826603|582190188|FG001|Overall Study|Physician Decision|7|||
161220868|NCT02826603|582190187|FG000|Overall Study|Pregnancy|1|||
161220869|NCT02826603|582190188|FG001|Overall Study|Pregnancy|2|||
161116710|NCT03245450|581815289|FG004|Overall Study|Withdrawal by Subject|0|||
161116711|NCT03245450|581815290|FG005|Overall Study|Withdrawal by Subject|0|||
161116712|NCT03245450|581815291|FG006|Overall Study|Withdrawal by Subject|0|||
161116713|NCT03245450|581815285|FG000|Overall Study|Adverse Event|0|||
161116714|NCT03245450|581815286|FG001|Overall Study|Adverse Event|0|||
161116715|NCT03245450|581815287|FG002|Overall Study|Adverse Event|0|||
161116716|NCT03245450|581815288|FG003|Overall Study|Adverse Event|0|||
161116717|NCT03245450|581815289|FG004|Overall Study|Adverse Event|1|||
161116718|NCT03245450|581815290|FG005|Overall Study|Adverse Event|0|||
161116719|NCT03245450|581815291|FG006|Overall Study|Adverse Event|2|||
161116720|NCT02429414|581815292|FG000|Overall Study|Physician Decision|0|||
161116721|NCT02429414|581815293|FG001|Overall Study|Physician Decision|1|||
161116722|NCT01098071|581815303|FG000|Overall Study|Surgery (adenoidectomy)|2|||
161116723|NCT01098071|581815303|FG000|Overall Study|Lost to Follow-up|13|||
161116724|NCT01604265|581815307|FG000|Overall Study|Adverse Event|1|||
161116725|NCT01604265|581815308|FG001|Overall Study|Adverse Event|0|||
161116726|NCT01604265|581815307|FG000|Overall Study|Withdrawal by Subject|1|||
161116727|NCT01604265|581815308|FG001|Overall Study|Withdrawal by Subject|0|||
161116728|NCT01903837|581815311|FG000|Part A|Withdrawal by Subject|4|||
161116729|NCT01903837|581815312|FG001|Part A|Withdrawal by Subject|9|||
161116730|NCT01903837|581815313|FG002|Part A|Withdrawal by Subject|8|||
161116731|NCT01903837|581815314|FG003|Part A|Withdrawal by Subject|5|||
161116732|NCT01903837|581815311|FG000|Part A|Adverse Event|3|||
161116733|NCT01903837|581815312|FG001|Part A|Adverse Event|6|||
161116734|NCT01903837|581815313|FG002|Part A|Adverse Event|9|||
161116735|NCT01903837|581815314|FG003|Part A|Adverse Event|6|||
161116736|NCT01903837|581815311|FG000|Part A|Lost to Follow-up|9|||
161116737|NCT01903837|581815312|FG001|Part A|Lost to Follow-up|7|||
161116738|NCT01903837|581815313|FG002|Part A|Lost to Follow-up|7|||
161116739|NCT01903837|581815314|FG003|Part A|Lost to Follow-up|2|||
161116740|NCT01903837|581815311|FG000|Part A|Non-compliance with study drug|1|||
161116741|NCT01903837|581815312|FG001|Part A|Non-compliance with study drug|4|||
161116742|NCT01903837|581815313|FG002|Part A|Non-compliance with study drug|4|||
161116743|NCT01903837|581815314|FG003|Part A|Non-compliance with study drug|0|||
161116744|NCT01903837|581815311|FG000|Part A|Physician Decision|1|||
161116745|NCT01903837|581815312|FG001|Part A|Physician Decision|1|||
161116746|NCT01903837|581815313|FG002|Part A|Physician Decision|0|||
161116747|NCT01903837|581815314|FG003|Part A|Physician Decision|0|||
161116748|NCT01903837|581815311|FG000|Part A|Protocol Violation|1|||
161116749|NCT01903837|581815312|FG001|Part A|Protocol Violation|1|||
161116750|NCT01903837|581815313|FG002|Part A|Protocol Violation|0|||
161116751|NCT01903837|581815314|FG003|Part A|Protocol Violation|0|||
161116752|NCT01903837|581815311|FG000|Part B|Lost to Follow-up|0|||
161116753|NCT01903837|581815312|FG001|Part B|Lost to Follow-up|3|||
161116754|NCT01903837|581815313|FG002|Part B|Lost to Follow-up|3|||
161116755|NCT01903837|581815314|FG003|Part B|Lost to Follow-up|4|||
161116756|NCT01903837|581815311|FG000|Part B|Withdrawal by Subject|1|||
161116757|NCT01903837|581815312|FG001|Part B|Withdrawal by Subject|2|||
161116758|NCT01903837|581815313|FG002|Part B|Withdrawal by Subject|0|||
161116759|NCT01903837|581815314|FG003|Part B|Withdrawal by Subject|3|||
161116760|NCT01903837|581815311|FG000|Part B|Adverse Event|3|||
161116761|NCT01903837|581815312|FG001|Part B|Adverse Event|0|||
161116762|NCT01903837|581815313|FG002|Part B|Adverse Event|2|||
161116763|NCT01903837|581815314|FG003|Part B|Adverse Event|0|||
161116764|NCT01903837|581815311|FG000|Part B|Non-compliance with study drug|2|||
161116765|NCT01903837|581815312|FG001|Part B|Non-compliance with study drug|0|||
161116766|NCT01903837|581815313|FG002|Part B|Non-compliance with study drug|0|||
161116767|NCT01903837|581815314|FG003|Part B|Non-compliance with study drug|1|||
161116768|NCT01903837|581815311|FG000|Part B|Incarceration|2|||
161116769|NCT01903837|581815312|FG001|Part B|Incarceration|0|||
161116770|NCT01903837|581815313|FG002|Part B|Incarceration|0|||
161220870|NCT02826603|582190187|FG000|Overall Study|Protocol Violation|3|||
161116771|NCT01903837|581815314|FG003|Part B|Incarceration|1|||
161116772|NCT01903837|581815311|FG000|Part B|Physician Decision|1|||
161116773|NCT01903837|581815312|FG001|Part B|Physician Decision|0|||
161116774|NCT01903837|581815313|FG002|Part B|Physician Decision|0|||
161116775|NCT01903837|581815314|FG003|Part B|Physician Decision|2|||
161116776|NCT01903837|581815311|FG000|Part B|Lack of Efficacy|0|||
161116777|NCT01903837|581815312|FG001|Part B|Lack of Efficacy|1|||
161116778|NCT01903837|581815313|FG002|Part B|Lack of Efficacy|0|||
161116779|NCT01903837|581815314|FG003|Part B|Lack of Efficacy|0|||
161116780|NCT02706873|581815315|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
161116781|NCT02706873|581815316|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
161116782|NCT02706873|581815317|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
161116783|NCT02706873|581815318|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
161116784|NCT02706873|581815315|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
161220871|NCT02826603|582190188|FG001|Overall Study|Protocol Violation|3|||
161220872|NCT02826603|582190187|FG000|Overall Study|Withdrawal by Subject|20|||
161220873|NCT02826603|582190188|FG001|Overall Study|Withdrawal by Subject|19|||
161220874|NCT02826603|582190187|FG000|Overall Study|Death|2|||
161220875|NCT02826603|582190188|FG001|Overall Study|Death|0|||
161220876|NCT02826603|582190187|FG000|Overall Study|New therapy for study indication|0|||
161220877|NCT02826603|582190188|FG001|Overall Study|New therapy for study indication|1|||
161220878|NCT02668302|582190189|FG000|Overall Study|Withdrawal by Subject|1|||
161220879|NCT02668302|582190190|FG001|Overall Study|Withdrawal by Subject|0|||
161220880|NCT03558997|582190191|FG000|Overall Study|Adverse Event|0|||
161220881|NCT03558997|582190192|FG001|Overall Study|Adverse Event|2|||
161220882|NCT03558997|582190193|FG002|Overall Study|Adverse Event|5|||
161220883|NCT03558997|582190194|FG003|Overall Study|Adverse Event|1|||
161220884|NCT03558997|582190191|FG000|Overall Study|Physician Decision|0|||
161220885|NCT03558997|582190192|FG001|Overall Study|Physician Decision|0|||
161220886|NCT03558997|582190193|FG002|Overall Study|Physician Decision|1|||
161220887|NCT03558997|582190194|FG003|Overall Study|Physician Decision|0|||
161220888|NCT03558997|582190191|FG000|Overall Study|Withdrawal by Subject|1|||
161220889|NCT03558997|582190192|FG001|Overall Study|Withdrawal by Subject|0|||
161220890|NCT03558997|582190193|FG002|Overall Study|Withdrawal by Subject|1|||
161220891|NCT03558997|582190194|FG003|Overall Study|Withdrawal by Subject|1|||
161220892|NCT03558997|582190191|FG000|Overall Study|Lost to Follow-up|0|||
161220893|NCT03558997|582190192|FG001|Overall Study|Lost to Follow-up|0|||
161220894|NCT03558997|582190193|FG002|Overall Study|Lost to Follow-up|1|||
161220895|NCT03558997|582190194|FG003|Overall Study|Lost to Follow-up|0|||
161220896|NCT00526890|582190198|FG000|Overall Study|Adverse Event|2|||
161220897|NCT04128696|582190199|FG000|Overall Study|Lost to Follow-up|3|||
161220898|NCT04128696|582190200|FG001|Overall Study|Lost to Follow-up|7|||
161220899|NCT04128696|582190199|FG000|Overall Study|Withdrawal by Subject|12|||
161220900|NCT04128696|582190200|FG001|Overall Study|Withdrawal by Subject|11|||
161220901|NCT04128696|582190199|FG000|Overall Study|Study Closed/Terminated|26|||
161220902|NCT04128696|582190200|FG001|Overall Study|Study Closed/Terminated|38|||
161220903|NCT04128696|582190199|FG000|Overall Study|Physician Decision|2|||
161220904|NCT04128696|582190200|FG001|Overall Study|Physician Decision|3|||
161220905|NCT03280537|582190205|FG000|Overall Study|Withdrawal by Subject|2|||
161220906|NCT03280537|582190206|FG001|Overall Study|Withdrawal by Subject|4|||
161220907|NCT01588106|582190207|FG000|Overall Study|Withdrawal by Subject|5|||
161220908|NCT01588106|582190208|FG001|Overall Study|Withdrawal by Subject|4|||
161220909|NCT03083132|582190209|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
161116785|NCT02706873|581815316|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
161116786|NCT02706873|581815317|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
161116787|NCT02706873|581815318|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
161116788|NCT02706873|581815315|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
161116789|NCT02706873|581815316|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161116790|NCT02706873|581815317|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
161116791|NCT02706873|581815318|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
161116792|NCT02706873|581815315|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
161116793|NCT02706873|581815316|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
161116794|NCT02706873|581815317|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
161116795|NCT02706873|581815318|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
161116796|NCT02706873|581815315|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
161116797|NCT02706873|581815316|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
161116798|NCT02706873|581815317|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
161116799|NCT02706873|581815318|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
161116800|NCT02706873|581815315|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
161116801|NCT02706873|581815316|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
161116802|NCT02706873|581815317|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
161116803|NCT02706873|581815318|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
161116804|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
161220910|NCT03083132|582190210|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
161220911|NCT03083132|582190209|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
161220912|NCT03083132|582190210|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
161220913|NCT03083132|582190209|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
161220914|NCT03083132|582190210|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
161220915|NCT02995837|582190211|FG000|Overall Study|Lost to Follow-up|9|||
161220916|NCT02995837|582190212|FG001|Overall Study|Lost to Follow-up|8|||
161220917|NCT03118739|582190213|FG000|Overall Study|Physician Decision|0|||
161220918|NCT03118739|582190214|FG001|Overall Study|Physician Decision|1|||
161220919|NCT03118739|582190213|FG000|Overall Study|Withdrawal by Subject|5|||
161220920|NCT03118739|582190214|FG001|Overall Study|Withdrawal by Subject|3|||
160874469|NCT00813943|580934209|FG002|Overall Study|Ongoing at cut-off date|3|||
161116805|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
161116806|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
161116807|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
161116808|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
161220921|NCT03118739|582190213|FG000|Overall Study|Lost to Follow-up|2|||
161220922|NCT03118739|582190214|FG001|Overall Study|Lost to Follow-up|0|||
161220923|NCT01859702|582190215|FG000|Overall Study|Protocol deviation|3|||
161220924|NCT01859702|582190215|FG000|Overall Study|Adverse Event|2|||
161220925|NCT01893138|582190216|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161220926|NCT01893138|582190217|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161220927|NCT01893138|582190216|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
161220928|NCT01893138|582190217|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
161220929|NCT01893138|582190216|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
161220930|NCT01893138|582190217|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
161220931|NCT01893138|582190216|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
161220932|NCT01893138|582190217|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
161220933|NCT01893138|582190216|FG000|Open Label - Unblinded Period|Adverse Event|1|||
161220934|NCT01893138|582190217|FG001|Open Label - Unblinded Period|Adverse Event|0|||
161220935|NCT01326026|582190218|FG000|Overall Study|Adverse Event|4|||
161220936|NCT01326026|582190219|FG001|Overall Study|Adverse Event|3|||
161220937|NCT01326026|582190218|FG000|Overall Study|Withdrawal Criteria|5|||
161116809|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
161116810|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
161116811|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
161116812|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
161116813|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
161116814|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
161116815|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
161116816|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
161116817|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
161116818|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
161116819|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
161116820|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161116821|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161116822|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
161116823|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
161116824|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
161116825|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
161116826|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
161116827|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
161116828|NCT02706873|581815315|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
161116829|NCT02706873|581815316|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
161116830|NCT02706873|581815317|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
161116831|NCT02706873|581815318|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
161116832|NCT05098041|581815321|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
161116833|NCT00705939|581815322|FG000|Overall Study|Protocol Violation|0|||
161116834|NCT00705939|581815323|FG001|Overall Study|Protocol Violation|0|||
161116835|NCT00705939|581815324|FG002|Overall Study|Protocol Violation|1|||
161116836|NCT00705939|581815322|FG000|Overall Study|Withdrawal by Subject|0|||
161116837|NCT00705939|581815323|FG001|Overall Study|Withdrawal by Subject|1|||
161116838|NCT00705939|581815324|FG002|Overall Study|Withdrawal by Subject|3|||
161116839|NCT00705939|581815322|FG000|Overall Study|Physician Decision|0|||
161116840|NCT00705939|581815323|FG001|Overall Study|Physician Decision|1|||
161220938|NCT01326026|582190219|FG001|Overall Study|Withdrawal Criteria|7|||
161220939|NCT01326026|582190218|FG000|Overall Study|Other|3|||
161220940|NCT01326026|582190219|FG001|Overall Study|Other|3|||
161220941|NCT04317053|582190223|FG000|Overall Study|Withdrawn (screen failure)|4|||
161220942|NCT04317053|582190224|FG001|Overall Study|Withdrawn (screen failure)|2|||
161220943|NCT00289458|582190225|FG000|Overall Study|Death|1|||
161220944|NCT00289458|582190226|FG001|Overall Study|Death|0|||
161220945|NCT00289458|582190227|FG002|Overall Study|Death|0|||
161220946|NCT00289458|582190225|FG000|Overall Study|Physician Decision|3|||
161220947|NCT00289458|582190226|FG001|Overall Study|Physician Decision|4|||
161220948|NCT00289458|582190227|FG002|Overall Study|Physician Decision|2|||
161220949|NCT00289458|582190225|FG000|Overall Study|Withdrawal by Subject|2|||
161116841|NCT00705939|581815324|FG002|Overall Study|Physician Decision|0|||
161116842|NCT00797732|581815328|FG000|Overall Study|Withdrawal by Subject|3|||
161116843|NCT00797732|581815329|FG001|Overall Study|Withdrawal by Subject|3|||
161116844|NCT00797732|581815330|FG002|Overall Study|Withdrawal by Subject|0|||
161116845|NCT00797732|581815328|FG000|Overall Study|Lost to Follow-up|1|||
161116846|NCT00797732|581815329|FG001|Overall Study|Lost to Follow-up|0|||
161220950|NCT00289458|582190226|FG001|Overall Study|Withdrawal by Subject|2|||
161220951|NCT00289458|582190227|FG002|Overall Study|Withdrawal by Subject|4|||
161220952|NCT04274192|582190228|FG000|Overall Study|Protocol Violation|1|||
161220953|NCT04274192|582190229|FG001|Overall Study|Protocol Violation|0|||
161116847|NCT00797732|581815330|FG002|Overall Study|Lost to Follow-up|0|||
161220954|NCT04680052|582191631|FG000|Overall Study|Ongoing|244|||
161116848|NCT00797732|581815328|FG000|Overall Study|Death|1|||
161116849|NCT00797732|581815329|FG001|Overall Study|Death|0|||
161220955|NCT04680052|582191632|FG001|Overall Study|Ongoing|229|||
161220956|NCT04680052|582191633|FG002|Overall Study|Ongoing|39|||
161220957|NCT04680052|582191634|FG003|Overall Study|Ongoing|46|||
161220958|NCT04680052|582191631|FG000|Overall Study|Death|15|||
161220959|NCT04680052|582191632|FG001|Overall Study|Death|22|||
161220960|NCT04680052|582191633|FG002|Overall Study|Death|7|||
161220961|NCT04680052|582191634|FG003|Overall Study|Death|1|||
161220962|NCT04680052|582191631|FG000|Overall Study|Lost to Follow-up|3|||
161220963|NCT04680052|582191632|FG001|Overall Study|Lost to Follow-up|2|||
161220964|NCT04680052|582191633|FG002|Overall Study|Lost to Follow-up|0|||
161220965|NCT04680052|582191634|FG003|Overall Study|Lost to Follow-up|1|||
161220966|NCT04680052|582191631|FG000|Overall Study|Withdrawal by Subject|11|||
161220967|NCT04680052|582191632|FG001|Overall Study|Withdrawal by Subject|19|||
161220968|NCT04680052|582191633|FG002|Overall Study|Withdrawal by Subject|7|||
161220969|NCT04680052|582191634|FG003|Overall Study|Withdrawal by Subject|5|||
161220970|NCT04680052|582191631|FG000|Overall Study|Missing|0|||
161220971|NCT04680052|582191632|FG001|Overall Study|Missing|1|||
161220972|NCT04680052|582191633|FG002|Overall Study|Missing|0|||
161220973|NCT04680052|582191634|FG003|Overall Study|Missing|0|||
161220974|NCT04680052|582191631|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161220975|NCT04680052|582191632|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
161220976|NCT04680052|582191633|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161220977|NCT04680052|582191634|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
161220978|NCT04680052|582191631|FG000|Overall Study|Physician Decision|0|||
161220979|NCT04680052|582191632|FG001|Overall Study|Physician Decision|1|||
161220980|NCT04680052|582191633|FG002|Overall Study|Physician Decision|0|||
161220981|NCT04680052|582191634|FG003|Overall Study|Physician Decision|0|||
161220982|NCT00759148|582191636|FG000|Overall Study|Adverse Event|1|||
161220983|NCT00759148|582191637|FG001|Overall Study|Adverse Event|6|||
161220984|NCT00759148|582191636|FG000|Overall Study|Withdrawal by Subject|3|||
161220985|NCT00759148|582191637|FG001|Overall Study|Withdrawal by Subject|7|||
161220986|NCT00759148|582191636|FG000|Overall Study|Lost to Follow-up|3|||
161220987|NCT00759148|582191637|FG001|Overall Study|Lost to Follow-up|9|||
161220988|NCT00759148|582191636|FG000|Overall Study|Treatment Failure|6|||
161220989|NCT00759148|582191637|FG001|Overall Study|Treatment Failure|10|||
161220990|NCT00759148|582191636|FG000|Overall Study|Reason not given|1|||
161220991|NCT00759148|582191637|FG001|Overall Study|Reason not given|0|||
161220992|NCT01073020|582191638|FG000|Overall Study|Withdrawal by Subject|6|||
161220993|NCT01073020|582191639|FG001|Overall Study|Withdrawal by Subject|4|||
161116850|NCT00797732|581815330|FG002|Overall Study|Death|0|||
161116851|NCT00797732|581815328|FG000|Overall Study|Not meet inclusion criteria|0|||
161116852|NCT00797732|581815329|FG001|Overall Study|Not meet inclusion criteria|0|||
161116853|NCT00797732|581815330|FG002|Overall Study|Not meet inclusion criteria|7|||
161116854|NCT00797732|581815328|FG000|Overall Study|Excluded due to time constraints|0|||
161116855|NCT00797732|581815329|FG001|Overall Study|Excluded due to time constraints|0|||
161116856|NCT00797732|581815330|FG002|Overall Study|Excluded due to time constraints|24|||
161116857|NCT00797732|581815328|FG000|Overall Study|Refused to Participate|0|||
161116858|NCT00797732|581815329|FG001|Overall Study|Refused to Participate|0|||
161116859|NCT00797732|581815330|FG002|Overall Study|Refused to Participate|123|||
161116860|NCT03948178|581815331|FG000|Overall Study|Protocol Violation|1|||
161116861|NCT03948178|581815331|FG000|Overall Study|Lost to Follow-up|2|||
161116862|NCT03948178|581815331|FG000|Overall Study|Withdrawal by Subject|2|||
161116863|NCT03948178|581815331|FG000|Overall Study|Reason not known|2|||
161116864|NCT03948178|581815331|FG000|Overall Study|Personal reason|14|||
161116865|NCT03948178|581815331|FG000|Overall Study|Disease progression|30|||
161116866|NCT03948178|581815331|FG000|Overall Study|Adverse Event|12|||
161116867|NCT03948178|581815331|FG000|Overall Study|Sponsor terminated study|164|||
161116868|NCT01297270|581815332|FG000|Overall Study|Adverse Event|19|||
161116869|NCT01297270|581815333|FG001|Overall Study|Adverse Event|32|||
161116870|NCT01297270|581815334|FG002|Overall Study|Adverse Event|5|||
161116871|NCT01297270|581815332|FG000|Overall Study|Lack of Efficacy|15|||
161116872|NCT01297270|581815333|FG001|Overall Study|Lack of Efficacy|17|||
161116873|NCT01297270|581815334|FG002|Overall Study|Lack of Efficacy|15|||
161116874|NCT01297270|581815332|FG000|Overall Study|Lost to Follow-up|1|||
161116875|NCT01297270|581815333|FG001|Overall Study|Lost to Follow-up|2|||
161116876|NCT01297270|581815334|FG002|Overall Study|Lost to Follow-up|1|||
161220994|NCT01073020|582191640|FG002|Overall Study|Withdrawal by Subject|1|||
161116877|NCT01297270|581815332|FG000|Overall Study|Protocol Violation|0|||
161220995|NCT01073020|582191641|FG003|Overall Study|Withdrawal by Subject|2|||
161220996|NCT01073020|582191638|FG000|Overall Study|Physician Decision|1|||
161220997|NCT01073020|582191639|FG001|Overall Study|Physician Decision|0|||
161220998|NCT01073020|582191640|FG002|Overall Study|Physician Decision|2|||
161220999|NCT01073020|582191641|FG003|Overall Study|Physician Decision|0|||
161116878|NCT01297270|581815333|FG001|Overall Study|Protocol Violation|2|||
161116879|NCT01297270|581815334|FG002|Overall Study|Protocol Violation|0|||
161116880|NCT01297270|581815332|FG000|Overall Study|Withdrawal by Subject|7|||
161116881|NCT01297270|581815333|FG001|Overall Study|Withdrawal by Subject|15|||
161221000|NCT01073020|582191638|FG000|Overall Study|Death|0|||
161221001|NCT01073020|582191639|FG001|Overall Study|Death|1|||
161221002|NCT01073020|582191640|FG002|Overall Study|Death|0|||
161221003|NCT01073020|582191641|FG003|Overall Study|Death|0|||
161221004|NCT00094302|582191644|FG000|Overall Study|Lost to Follow-up|43|||
161221005|NCT00094302|582191645|FG001|Overall Study|Lost to Follow-up|41|||
161221006|NCT00094302|582191644|FG000|Overall Study|Physician Decision|5|||
161221007|NCT00094302|582191645|FG001|Overall Study|Physician Decision|8|||
161221008|NCT00094302|582191644|FG000|Overall Study|Withdrawal by Subject|103|||
161221009|NCT00094302|582191645|FG001|Overall Study|Withdrawal by Subject|111|||
161221010|NCT00094302|582191644|FG000|Overall Study|Death|266|||
161221011|NCT00094302|582191645|FG001|Overall Study|Death|246|||
161221012|NCT03329027|582191646|FG000|Overall Study|Lost to Follow-up|1|||
161221013|NCT03329027|582191647|FG001|Overall Study|Lost to Follow-up|0|||
161221014|NCT03329027|582191648|FG002|Overall Study|Lost to Follow-up|1|||
161221015|NCT03329027|582191646|FG000|Overall Study|Protocol Violation|9|||
161221016|NCT03329027|582191647|FG001|Overall Study|Protocol Violation|5|||
161221017|NCT03329027|582191648|FG002|Overall Study|Protocol Violation|7|||
161221018|NCT02761980|582191655|FG000|Overall Study|Adverse Event|4|||
161221019|NCT02761980|582191656|FG001|Overall Study|Adverse Event|6|||
161221020|NCT02761980|582191657|FG002|Overall Study|Adverse Event|5|||
161221021|NCT02761980|582191658|FG003|Overall Study|Adverse Event|6|||
161221022|NCT02761980|582191655|FG000|Overall Study|Withdrawal by Subject|0|||
161221023|NCT02761980|582191656|FG001|Overall Study|Withdrawal by Subject|1|||
161116882|NCT01297270|581815334|FG002|Overall Study|Withdrawal by Subject|7|||
161116883|NCT01297270|581815332|FG000|Overall Study|Other reason not defined above|3|||
161116884|NCT01297270|581815333|FG001|Overall Study|Other reason not defined above|3|||
161116885|NCT01297270|581815334|FG002|Overall Study|Other reason not defined above|1|||
161116886|NCT01297270|581815332|FG000|Overall Study|Not treated|0|||
161116887|NCT01297270|581815333|FG001|Overall Study|Not treated|1|||
161116888|NCT01297270|581815334|FG002|Overall Study|Not treated|0|||
161116889|NCT01895322|581815335|FG000|Overall Study|Adverse Event|1|||
161116890|NCT01895322|581815335|FG000|Overall Study|Withdrawal by Subject|2|||
161116891|NCT01895322|581815335|FG000|Overall Study|Protocol Violation|10|||
161116892|NCT02728830|581815342|FG000|Overall Study|Exclusionary Surgery|9|||
161116893|NCT02728830|581815342|FG000|Overall Study|Exclusionary Pathology|6|||
161116894|NCT02728830|581815342|FG000|Overall Study|Physician Decision|3|||
161116895|NCT02728830|581815342|FG000|Overall Study|Withdrawal by Subject|2|||
161116896|NCT02728830|581815342|FG000|Overall Study|Lost to Follow-up|1|||
161116897|NCT02728830|581815342|FG000|Overall Study|Exclusionary Lab Values|1|||
161116898|NCT02728830|581815342|FG000|Overall Study|Contraindicated Illness|1|||
161116899|NCT02728830|581815342|FG000|Overall Study|Language Barrier|1|||
161116900|NCT00391222|581815343|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161116901|NCT00391222|581815344|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161116902|NCT00391222|581815345|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
161116903|NCT00391222|581815346|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
161116904|NCT00391222|581815343|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161116905|NCT00391222|581815344|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161116906|NCT00391222|581815345|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
161116907|NCT00391222|581815346|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
161116908|NCT00391222|581815343|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161116909|NCT00391222|581815344|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161116910|NCT00391222|581815345|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
161116911|NCT00391222|581815346|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
161116912|NCT00391222|581815343|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161116913|NCT00391222|581815344|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161116914|NCT00391222|581815345|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
161116915|NCT00391222|581815346|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
161116916|NCT00391222|581815343|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
161116917|NCT00391222|581815344|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
161221024|NCT02761980|582191657|FG002|Overall Study|Withdrawal by Subject|0|||
161221025|NCT02761980|582191658|FG003|Overall Study|Withdrawal by Subject|0|||
161221026|NCT02761980|582191655|FG000|Overall Study|Other|0|||
161221027|NCT02761980|582191656|FG001|Overall Study|Other|0|||
161221028|NCT02761980|582191657|FG002|Overall Study|Other|1|||
161221029|NCT02761980|582191658|FG003|Overall Study|Other|0|||
161116918|NCT00391222|581815345|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
161116919|NCT00391222|581815346|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
161116920|NCT00391222|581815343|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
161221030|NCT00101582|582191663|FG000|Overall Study|Ineligibility determined|0|||
161221031|NCT00101582|582191664|FG001|Overall Study|Ineligibility determined|1|||
161221032|NCT00101582|582191663|FG000|Overall Study|Adverse Event|1|||
161221033|NCT00101582|582191664|FG001|Overall Study|Adverse Event|4|||
161221034|NCT00101582|582191663|FG000|Overall Study|Withdrawal by Subject|6|||
161116921|NCT00391222|581815344|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
161116922|NCT00391222|581815345|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
161221035|NCT00101582|582191664|FG001|Overall Study|Withdrawal by Subject|4|||
161221036|NCT00101582|582191663|FG000|Overall Study|Physician Decision|1|||
161221037|NCT00101582|582191664|FG001|Overall Study|Physician Decision|0|||
161221038|NCT00101582|582191663|FG000|Overall Study|Death|3|||
161221039|NCT00101582|582191664|FG001|Overall Study|Death|5|||
161221040|NCT00101582|582191663|FG000|Overall Study|Other|0|||
161221041|NCT00101582|582191664|FG001|Overall Study|Other|1|||
161221042|NCT01907087|582191665|FG000|Overall Study|Withdrawal by Subject|1|||
161221043|NCT01919190|582191666|FG000|Overall Study|Intra-op findings, etc.|3|||
161221044|NCT01919190|582191667|FG001|Overall Study|Intra-op findings, etc.|0|||
161221045|NCT03355742|582191668|FG000|Overall Study|Lost to Follow-up|4|||
161221046|NCT03355742|582191668|FG000|Overall Study|Withdrawal by Subject|29|||
161221047|NCT03355742|582191668|FG000|Overall Study|Physician Decision|6|||
161221048|NCT03355742|582191668|FG000|Overall Study|Death|55|||
161221049|NCT03355742|582191668|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
161221050|NCT02207621|582191670|FG000|Overall Study|Adverse Event|71|||
161221051|NCT02207621|582191671|FG001|Overall Study|Adverse Event|15|||
161221052|NCT02207621|582191672|FG002|Overall Study|Adverse Event|132|||
161221053|NCT02207621|582191670|FG000|Overall Study|Withdrawal by Subject|9|||
161221054|NCT02207621|582191671|FG001|Overall Study|Withdrawal by Subject|9|||
161221055|NCT02207621|582191672|FG002|Overall Study|Withdrawal by Subject|13|||
161221056|NCT02207621|582191670|FG000|Overall Study|Non-Compliant|3|||
161221057|NCT02207621|582191671|FG001|Overall Study|Non-Compliant|3|||
161221058|NCT02207621|582191672|FG002|Overall Study|Non-Compliant|1|||
161221059|NCT02207621|582191670|FG000|Overall Study|Lost to Follow-up|1|||
161221060|NCT02207621|582191671|FG001|Overall Study|Lost to Follow-up|0|||
161221061|NCT02207621|582191672|FG002|Overall Study|Lost to Follow-up|3|||
161221062|NCT02207621|582191670|FG000|Overall Study|Lack of Efficacy|10|||
161221063|NCT02207621|582191671|FG001|Overall Study|Lack of Efficacy|2|||
161221064|NCT02207621|582191672|FG002|Overall Study|Lack of Efficacy|4|||
161221065|NCT02207621|582191670|FG000|Overall Study|Disallowed Concurrent Medication|2|||
161221066|NCT02207621|582191671|FG001|Overall Study|Disallowed Concurrent Medication|5|||
161221067|NCT02207621|582191672|FG002|Overall Study|Disallowed Concurrent Medication|2|||
161221068|NCT02207621|582191670|FG000|Overall Study|Physician Decision|1|||
161221069|NCT02207621|582191671|FG001|Overall Study|Physician Decision|2|||
161221070|NCT02207621|582191672|FG002|Overall Study|Physician Decision|2|||
161221071|NCT02207621|582191670|FG000|Overall Study|Protocol Violation|4|||
161221072|NCT02207621|582191671|FG001|Overall Study|Protocol Violation|10|||
161221073|NCT02207621|582191672|FG002|Overall Study|Protocol Violation|6|||
161221074|NCT02207621|582191670|FG000|Overall Study|Death|2|||
161221075|NCT02207621|582191671|FG001|Overall Study|Death|0|||
161221076|NCT02207621|582191672|FG002|Overall Study|Death|0|||
161221077|NCT02207621|582191670|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
161221078|NCT02207621|582191671|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
161221079|NCT02207621|582191672|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
161221080|NCT02848599|582191673|FG000|Overall Study|Protocol Violation|7|||
161221081|NCT02848599|582191674|FG001|Overall Study|Protocol Violation|9|||
161221082|NCT04828161|582191675|FG000|Overall Study|Withdrawal by Subject|0|||
161221083|NCT04828161|582191676|FG001|Overall Study|Withdrawal by Subject|3|||
161221084|NCT04828161|582191677|FG002|Overall Study|Withdrawal by Subject|3|||
161221085|NCT04828161|582191678|FG003|Overall Study|Withdrawal by Subject|4|||
161221086|NCT04828161|582191675|FG000|Overall Study|Lost to Follow-up|1|||
161221087|NCT04828161|582191676|FG001|Overall Study|Lost to Follow-up|4|||
161221088|NCT04828161|582191677|FG002|Overall Study|Lost to Follow-up|2|||
161221089|NCT04828161|582191678|FG003|Overall Study|Lost to Follow-up|2|||
161221090|NCT04828161|582191675|FG000|Overall Study|Other|2|||
161221091|NCT04828161|582191676|FG001|Overall Study|Other|0|||
161221092|NCT04828161|582191677|FG002|Overall Study|Other|2|||
161221093|NCT04828161|582191678|FG003|Overall Study|Other|0|||
161221094|NCT04828161|582191675|FG000|Overall Study|Death|0|||
161221095|NCT04828161|582191676|FG001|Overall Study|Death|0|||
161221096|NCT04828161|582191677|FG002|Overall Study|Death|0|||
161221097|NCT04828161|582191678|FG003|Overall Study|Death|2|||
161221098|NCT02524379|582191687|FG000|Overall Study|Death|1|||
161221099|NCT01829464|582191688|FG000|Overall Study|Adverse Event|1|||
161221100|NCT01829464|582191689|FG001|Overall Study|Adverse Event|0|||
161221101|NCT01829464|582191690|FG002|Overall Study|Adverse Event|0|||
161221102|NCT01829464|582191688|FG000|Overall Study|Lost to Follow-up|0|||
161221103|NCT01829464|582191689|FG001|Overall Study|Lost to Follow-up|0|||
161221104|NCT01829464|582191690|FG002|Overall Study|Lost to Follow-up|1|||
161221105|NCT01829464|582191688|FG000|Overall Study|Withdrawal by Subject|2|||
161221106|NCT01829464|582191689|FG001|Overall Study|Withdrawal by Subject|0|||
161221107|NCT01829464|582191690|FG002|Overall Study|Withdrawal by Subject|0|||
161221108|NCT01829464|582191688|FG000|Overall Study|Study terminated by sponsor|25|||
161221109|NCT01829464|582191689|FG001|Overall Study|Study terminated by sponsor|28|||
161221110|NCT01829464|582191690|FG002|Overall Study|Study terminated by sponsor|25|||
161221111|NCT01829464|582191688|FG000|Overall Study|Lack of Efficacy|0|||
161221112|NCT01829464|582191689|FG001|Overall Study|Lack of Efficacy|1|||
161221113|NCT01829464|582191690|FG002|Overall Study|Lack of Efficacy|0|||
161221114|NCT00812253|582191695|FG000|Overall Study|Withdrawal by Subject|3|||
161221115|NCT00812253|582191696|FG001|Overall Study|Withdrawal by Subject|2|||
161221116|NCT00812253|582191695|FG000|Overall Study|Protocol Violation|1|||
161221117|NCT00812253|582191696|FG001|Overall Study|Protocol Violation|1|||
161221118|NCT00812253|582191695|FG000|Overall Study|Lost to Follow-up|2|||
161221119|NCT00812253|582191696|FG001|Overall Study|Lost to Follow-up|0|||
161221120|NCT01884025|582191697|FG000|Overall Study|Lost to Follow-up|3|||
161221121|NCT01884025|582191698|FG001|Overall Study|Lost to Follow-up|4|||
161221122|NCT04903288|582191699|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
161221123|NCT04903288|582191699|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
161221124|NCT04903288|582191699|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
161221125|NCT04903288|582191699|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
161221126|NCT03209570|582191703|FG000|Overall Study|Death|1|||
161221127|NCT03209570|582191704|FG001|Overall Study|Death|0|||
161221128|NCT03209570|582191703|FG000|Overall Study|Incomplete Data|8|||
161221129|NCT03209570|582191704|FG001|Overall Study|Incomplete Data|10|||
161221130|NCT03209570|582191703|FG000|Overall Study|Protocol Violation|1|||
161221131|NCT03209570|582191704|FG001|Overall Study|Protocol Violation|0|||
161221132|NCT03209570|582191703|FG000|Overall Study|Withdrawal by Subject|0|||
161221133|NCT03209570|582191704|FG001|Overall Study|Withdrawal by Subject|3|||
161221134|NCT00755326|582191706|FG000|Overall Study|Lost to Follow-up|2|||
161221135|NCT00755326|582191707|FG001|Overall Study|Lost to Follow-up|3|||
161221136|NCT00634907|582191713|FG000|Overall Study|Withdrawal by Subject|3|||
161221137|NCT00634907|582191714|FG001|Overall Study|Withdrawal by Subject|0|||
161221138|NCT00634907|582191713|FG000|Overall Study|Physician Decision|3|||
161221139|NCT00634907|582191714|FG001|Overall Study|Physician Decision|9|||
161221140|NCT00634907|582191713|FG000|Overall Study|Withdrawal by Subject|11|||
161221141|NCT00634907|582191714|FG001|Overall Study|Withdrawal by Subject|8|||
161221142|NCT01338636|582191717|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
161221143|NCT01595009|582191720|FG000|Core|Patients completed per protocol|85|||
161221144|NCT01595009|582191721|FG001|Core|Patients completed per protocol|44|||
161221145|NCT01595009|582191722|FG002|Core|Patients completed per protocol|0|||
161221146|NCT01595009|582191723|FG003|Core|Patients completed per protocol|0|||
161221147|NCT01595009|582191720|FG000|Core|Adverse Event|19|||
161221148|NCT01595009|582191721|FG001|Core|Adverse Event|23|||
161221149|NCT01595009|582191722|FG002|Core|Adverse Event|0|||
161221150|NCT01595009|582191723|FG003|Core|Adverse Event|0|||
161221151|NCT01595009|582191720|FG000|Core|Disease progression|14|||
161221152|NCT01595009|582191721|FG001|Core|Disease progression|26|||
161221153|NCT01595009|582191722|FG002|Core|Disease progression|0|||
161221154|NCT01595009|582191723|FG003|Core|Disease progression|0|||
161221155|NCT01595009|582191720|FG000|Core|Withdrawal by Subject|4|||
161221156|NCT01595009|582191721|FG001|Core|Withdrawal by Subject|17|||
161221157|NCT01595009|582191722|FG002|Core|Withdrawal by Subject|0|||
161221158|NCT01595009|582191723|FG003|Core|Withdrawal by Subject|0|||
161221159|NCT01595009|582191720|FG000|Core|Death|3|||
161221160|NCT01595009|582191721|FG001|Core|Death|6|||
161221161|NCT01595009|582191722|FG002|Core|Death|0|||
161221162|NCT01595009|582191723|FG003|Core|Death|0|||
161221163|NCT01595009|582191720|FG000|Core|Lost to Follow-up|1|||
160874470|NCT00387790|580934216|FG000|Overall Study|Adverse Event|5|||
160874471|NCT00387790|580934216|FG000|Overall Study|Lack of Efficacy|2|||
161221164|NCT01595009|582191721|FG001|Core|Lost to Follow-up|2|||
161221165|NCT01595009|582191722|FG002|Core|Lost to Follow-up|0|||
161221166|NCT01595009|582191723|FG003|Core|Lost to Follow-up|0|||
161221167|NCT01595009|582191720|FG000|Core|Protocol deviation|0|||
161221168|NCT01595009|582191721|FG001|Core|Protocol deviation|1|||
161221169|NCT01595009|582191722|FG002|Core|Protocol deviation|0|||
161221170|NCT01595009|582191723|FG003|Core|Protocol deviation|0|||
161221171|NCT01595009|582191720|FG000|Core|Administrative problems|0|||
161221172|NCT01595009|582191721|FG001|Core|Administrative problems|1|||
161221173|NCT01595009|582191722|FG002|Core|Administrative problems|0|||
161221174|NCT01595009|582191723|FG003|Core|Administrative problems|0|||
161221175|NCT01595009|582191720|FG000|Extension|Administrative problems|0|||
161221176|NCT01595009|582191721|FG001|Extension|Administrative problems|0|||
161221177|NCT01595009|582191722|FG002|Extension|Administrative problems|0|||
161221178|NCT01595009|582191723|FG003|Extension|Administrative problems|1|||
161221179|NCT01595009|582191720|FG000|Extension|Patients completed per protocol|0|||
161221180|NCT01595009|582191721|FG001|Extension|Patients completed per protocol|0|||
161221181|NCT01595009|582191722|FG002|Extension|Patients completed per protocol|0|||
161221182|NCT01595009|582191723|FG003|Extension|Patients completed per protocol|2|||
161221183|NCT01595009|582191720|FG000|Extension|Disease progression|0|||
161221184|NCT01595009|582191721|FG001|Extension|Disease progression|0|||
161221185|NCT01595009|582191722|FG002|Extension|Disease progression|4|||
161221186|NCT01595009|582191723|FG003|Extension|Disease progression|7|||
161221187|NCT01595009|582191720|FG000|Extension|Adverse Event|0|||
161221188|NCT01595009|582191721|FG001|Extension|Adverse Event|0|||
161221189|NCT01595009|582191722|FG002|Extension|Adverse Event|0|||
161221190|NCT01595009|582191723|FG003|Extension|Adverse Event|1|||
161221191|NCT00818623|582191724|FG000|Overall Study|Adverse Event|1|||
161221192|NCT00818623|582191725|FG001|Overall Study|Adverse Event|0|||
161221193|NCT00818623|582191726|FG002|Overall Study|Adverse Event|1|||
161221194|NCT00818623|582191727|FG003|Overall Study|Adverse Event|0|||
161221195|NCT00818623|582191728|FG004|Overall Study|Adverse Event|0|||
161221196|NCT00818623|582191729|FG005|Overall Study|Adverse Event|1|||
161221197|NCT00818623|582191730|FG006|Overall Study|Adverse Event|0|||
161221198|NCT00818623|582191731|FG007|Overall Study|Adverse Event|0|||
161221199|NCT00818623|582191724|FG000|Overall Study|Bad prostate specific antigen response|0|||
161221200|NCT00818623|582191725|FG001|Overall Study|Bad prostate specific antigen response|3|||
161221201|NCT00818623|582191726|FG002|Overall Study|Bad prostate specific antigen response|2|||
161221202|NCT00818623|582191727|FG003|Overall Study|Bad prostate specific antigen response|5|||
161221203|NCT00818623|582191728|FG004|Overall Study|Bad prostate specific antigen response|0|||
161221204|NCT00818623|582191729|FG005|Overall Study|Bad prostate specific antigen response|1|||
161221205|NCT00818623|582191730|FG006|Overall Study|Bad prostate specific antigen response|0|||
161221206|NCT00818623|582191731|FG007|Overall Study|Bad prostate specific antigen response|0|||
161221207|NCT00818623|582191724|FG000|Overall Study|Withdrawal by Subject|0|||
161221208|NCT00818623|582191725|FG001|Overall Study|Withdrawal by Subject|1|||
161221209|NCT00818623|582191726|FG002|Overall Study|Withdrawal by Subject|1|||
161221210|NCT00818623|582191727|FG003|Overall Study|Withdrawal by Subject|0|||
161221211|NCT00818623|582191728|FG004|Overall Study|Withdrawal by Subject|0|||
161221212|NCT00818623|582191729|FG005|Overall Study|Withdrawal by Subject|1|||
161221213|NCT00818623|582191730|FG006|Overall Study|Withdrawal by Subject|1|||
161221214|NCT00818623|582191731|FG007|Overall Study|Withdrawal by Subject|1|||
161221215|NCT00818623|582191724|FG000|Overall Study|Protocol Violation|1|||
161221216|NCT00818623|582191725|FG001|Overall Study|Protocol Violation|0|||
161221217|NCT00818623|582191726|FG002|Overall Study|Protocol Violation|0|||
161221218|NCT00818623|582191727|FG003|Overall Study|Protocol Violation|0|||
161221219|NCT00818623|582191728|FG004|Overall Study|Protocol Violation|1|||
161221220|NCT00818623|582191729|FG005|Overall Study|Protocol Violation|0|||
161221221|NCT00818623|582191730|FG006|Overall Study|Protocol Violation|1|||
161221222|NCT00818623|582191731|FG007|Overall Study|Protocol Violation|0|||
161221223|NCT00818623|582191724|FG000|Overall Study|Need of additional treatment|0|||
161221224|NCT00818623|582191725|FG001|Overall Study|Need of additional treatment|0|||
161221225|NCT00818623|582191726|FG002|Overall Study|Need of additional treatment|0|||
161221226|NCT00818623|582191727|FG003|Overall Study|Need of additional treatment|0|||
161221227|NCT00818623|582191728|FG004|Overall Study|Need of additional treatment|1|||
161221228|NCT00818623|582191729|FG005|Overall Study|Need of additional treatment|0|||
161221229|NCT00818623|582191730|FG006|Overall Study|Need of additional treatment|0|||
161221230|NCT00818623|582191731|FG007|Overall Study|Need of additional treatment|0|||
161221231|NCT00818623|582191724|FG000|Overall Study|Lack of trial drug at site|0|||
161221232|NCT00818623|582191725|FG001|Overall Study|Lack of trial drug at site|0|||
161221233|NCT00818623|582191726|FG002|Overall Study|Lack of trial drug at site|0|||
161221234|NCT00818623|582191727|FG003|Overall Study|Lack of trial drug at site|0|||
161221235|NCT00818623|582191728|FG004|Overall Study|Lack of trial drug at site|2|||
161221236|NCT00818623|582191729|FG005|Overall Study|Lack of trial drug at site|0|||
161221237|NCT00818623|582191730|FG006|Overall Study|Lack of trial drug at site|1|||
161221238|NCT00818623|582191731|FG007|Overall Study|Lack of trial drug at site|0|||
161221239|NCT00818623|582191724|FG000|Overall Study|Disease progression|0|||
161221240|NCT00818623|582191725|FG001|Overall Study|Disease progression|0|||
161221241|NCT00818623|582191726|FG002|Overall Study|Disease progression|0|||
161221242|NCT00818623|582191727|FG003|Overall Study|Disease progression|0|||
161221243|NCT00818623|582191728|FG004|Overall Study|Disease progression|0|||
161221244|NCT00818623|582191729|FG005|Overall Study|Disease progression|0|||
161221245|NCT00818623|582191730|FG006|Overall Study|Disease progression|1|||
161221246|NCT00818623|582191731|FG007|Overall Study|Disease progression|0|||
161221247|NCT00299156|582191732|FG000|Period 2 (Randomized)|Screen Failure|0|||
161221248|NCT00299156|582191733|FG001|Period 2 (Randomized)|Screen Failure|1|||
161221249|NCT00299156|582191734|FG002|Period 2 (Randomized)|Screen Failure|0|||
161221250|NCT01166568|582191735|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
161221251|NCT01166568|582191736|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
161221252|NCT01166568|582191737|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
161221253|NCT01166568|582191735|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
161221254|NCT01166568|582191736|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
161221255|NCT01166568|582191737|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
161221256|NCT01166568|582191735|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
161221257|NCT01166568|582191736|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161221258|NCT01166568|582191737|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
161221259|NCT02015793|582191740|FG000|Overall Study|Adverse Event|3|||
161221260|NCT02015793|582191741|FG001|Overall Study|Adverse Event|3|||
161221261|NCT02015793|582191740|FG000|Overall Study|Withdrawal by Subject|1|||
161221262|NCT02015793|582191741|FG001|Overall Study|Withdrawal by Subject|1|||
161221263|NCT00320593|582191742|FG000|Overall Study|Lost to Follow-up|3|||
161221264|NCT00320593|582191743|FG001|Overall Study|Lost to Follow-up|0|||
161221265|NCT00320593|582191742|FG000|Overall Study|Moved to another state|1|||
161221266|NCT00320593|582191743|FG001|Overall Study|Moved to another state|0|||
161221267|NCT00320593|582191742|FG000|Overall Study|Withdrawal by Subject|2|||
161221268|NCT00320593|582191743|FG001|Overall Study|Withdrawal by Subject|1|||
161221269|NCT00320593|582191742|FG000|Overall Study|Withdrawal by clinical center|1|||
161221270|NCT00320593|582191743|FG001|Overall Study|Withdrawal by clinical center|0|||
161221271|NCT01076166|582191744|FG000|Overall Study|Adverse Event|3|||
161221272|NCT01076166|582191744|FG000|Overall Study|Symptoms improved/resolved|6|||
161221273|NCT00321711|582191752|FG000|Part A|Adverse Event|3|||
161221274|NCT00321711|582191753|FG001|Part A|Adverse Event|3|||
161221275|NCT00321711|582191754|FG002|Part A|Adverse Event|2|||
161221276|NCT00321711|582191755|FG003|Part A|Adverse Event|0|||
161221277|NCT00321711|582191756|FG004|Part A|Adverse Event|0|||
161221278|NCT00321711|582191752|FG000|Part A|Withdrawal by Subject|1|||
161221279|NCT00321711|582191753|FG001|Part A|Withdrawal by Subject|1|||
161221280|NCT00321711|582191754|FG002|Part A|Withdrawal by Subject|1|||
161221281|NCT00321711|582191755|FG003|Part A|Withdrawal by Subject|0|||
161221282|NCT00321711|582191756|FG004|Part A|Withdrawal by Subject|0|||
161221283|NCT00321711|582191752|FG000|Part A|Disease progression|0|||
161221284|NCT00321711|582191753|FG001|Part A|Disease progression|1|||
161221285|NCT00321711|582191754|FG002|Part A|Disease progression|0|||
161221286|NCT00321711|582191755|FG003|Part A|Disease progression|0|||
161221287|NCT00321711|582191756|FG004|Part A|Disease progression|0|||
161221288|NCT00321711|582191752|FG000|Part A|Requirement for alternative therapy|0|||
161221289|NCT00321711|582191753|FG001|Part A|Requirement for alternative therapy|2|||
161221290|NCT00321711|582191754|FG002|Part A|Requirement for alternative therapy|1|||
161221291|NCT00321711|582191755|FG003|Part A|Requirement for alternative therapy|0|||
161221292|NCT00321711|582191756|FG004|Part A|Requirement for alternative therapy|0|||
161221293|NCT00321711|582191752|FG000|Part A|Physician Decision|0|||
161221294|NCT00321711|582191753|FG001|Part A|Physician Decision|1|||
161221295|NCT00321711|582191754|FG002|Part A|Physician Decision|3|||
161221296|NCT00321711|582191755|FG003|Part A|Physician Decision|0|||
161221297|NCT00321711|582191756|FG004|Part A|Physician Decision|0|||
161221298|NCT00321711|582191752|FG000|Part A|Other|1|||
161221299|NCT00321711|582191753|FG001|Part A|Other|2|||
161221300|NCT00321711|582191754|FG002|Part A|Other|3|||
161221301|NCT00321711|582191755|FG003|Part A|Other|0|||
161221302|NCT00321711|582191756|FG004|Part A|Other|0|||
161221303|NCT00321711|582191752|FG000|Part A|Protocol deviation|0|||
161221304|NCT00321711|582191753|FG001|Part A|Protocol deviation|0|||
161221305|NCT00321711|582191754|FG002|Part A|Protocol deviation|1|||
161221306|NCT00321711|582191755|FG003|Part A|Protocol deviation|0|||
161221307|NCT00321711|582191756|FG004|Part A|Protocol deviation|0|||
161221308|NCT00321711|582191752|FG000|Part B|Noncompliance|0|||
161221309|NCT00321711|582191753|FG001|Part B|Noncompliance|0|||
161221310|NCT00321711|582191754|FG002|Part B|Noncompliance|0|||
161221311|NCT00321711|582191755|FG003|Part B|Noncompliance|0|||
161221312|NCT00321711|582191756|FG004|Part B|Noncompliance|1|||
161221313|NCT00321711|582191752|FG000|Part B|Adverse Event|0|||
161221314|NCT00321711|582191753|FG001|Part B|Adverse Event|0|||
161221315|NCT00321711|582191754|FG002|Part B|Adverse Event|0|||
161221316|NCT00321711|582191755|FG003|Part B|Adverse Event|2|||
161221317|NCT00321711|582191756|FG004|Part B|Adverse Event|1|||
161221318|NCT00321711|582191752|FG000|Part B|Disease progression|0|||
161221319|NCT00321711|582191753|FG001|Part B|Disease progression|0|||
161221320|NCT00321711|582191754|FG002|Part B|Disease progression|0|||
161221321|NCT00321711|582191755|FG003|Part B|Disease progression|1|||
161221322|NCT00321711|582191756|FG004|Part B|Disease progression|0|||
161221323|NCT00321711|582191752|FG000|Part B|Physician Decision|0|||
161221324|NCT00321711|582191753|FG001|Part B|Physician Decision|0|||
161221325|NCT00321711|582191754|FG002|Part B|Physician Decision|0|||
161221326|NCT00321711|582191755|FG003|Part B|Physician Decision|1|||
161221327|NCT00321711|582191756|FG004|Part B|Physician Decision|2|||
161221328|NCT00321711|582191752|FG000|Part B|Death|0|||
161221329|NCT00321711|582191753|FG001|Part B|Death|0|||
161221330|NCT00321711|582191754|FG002|Part B|Death|0|||
161221331|NCT00321711|582191755|FG003|Part B|Death|2|||
161221332|NCT00321711|582191756|FG004|Part B|Death|1|||
161221333|NCT02843074|582191757|FG000|Overall Study|Withdrawal by Subject|5|||
161221334|NCT02843074|582191757|FG000|Overall Study|Progressive disease|1|||
161221335|NCT02843074|582191757|FG000|Overall Study|Physician Decision|1|||
161221336|NCT02843074|582191757|FG000|Overall Study|Lost to Follow-up|1|||
161116923|NCT00391222|581815346|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
161116924|NCT00391222|581815343|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
161116925|NCT00391222|581815344|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
161116926|NCT00391222|581815345|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
161116927|NCT00391222|581815346|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
161116928|NCT00391222|581815343|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
161116929|NCT00391222|581815344|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
161116930|NCT00391222|581815345|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
161116931|NCT00391222|581815346|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
161116932|NCT00391222|581815343|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
161116933|NCT00391222|581815344|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
161116934|NCT00391222|581815345|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
161116935|NCT00391222|581815346|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
161116936|NCT00391222|581815343|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
161116937|NCT00391222|581815344|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
161116938|NCT00391222|581815345|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
161116939|NCT00391222|581815346|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
161116940|NCT00391222|581815343|FG000|Period III (Double-Blind Treatment)|Other|6|||
161116941|NCT00391222|581815344|FG001|Period III (Double-Blind Treatment)|Other|1|||
161116942|NCT00391222|581815345|FG002|Period III (Double-Blind Treatment)|Other|6|||
161116943|NCT00391222|581815346|FG003|Period III (Double-Blind Treatment)|Other|0|||
161116944|NCT01505634|581815347|FG000|Overall Study|Withdrawal by Subject|2|||
161116945|NCT01505634|581815348|FG001|Overall Study|Withdrawal by Subject|5|||
161116946|NCT01505634|581815349|FG002|Overall Study|Withdrawal by Subject|1|||
161116947|NCT01505634|581815347|FG000|Overall Study|Physician Decision|1|||
161116948|NCT01505634|581815348|FG001|Overall Study|Physician Decision|1|||
161116949|NCT01505634|581815349|FG002|Overall Study|Physician Decision|0|||
161116950|NCT01505634|581815347|FG000|Overall Study|Adverse Event|1|||
161116951|NCT01505634|581815348|FG001|Overall Study|Adverse Event|0|||
161116952|NCT01505634|581815349|FG002|Overall Study|Adverse Event|0|||
161116953|NCT01505634|581815347|FG000|Overall Study|Insufficient supply of drug at site|1|||
161116954|NCT01505634|581815348|FG001|Overall Study|Insufficient supply of drug at site|0|||
161116955|NCT01505634|581815349|FG002|Overall Study|Insufficient supply of drug at site|0|||
161116956|NCT01505634|581815347|FG000|Overall Study|Protocol Violation|2|||
161116957|NCT01505634|581815348|FG001|Overall Study|Protocol Violation|0|||
161116958|NCT01505634|581815349|FG002|Overall Study|Protocol Violation|0|||
161116959|NCT01505634|581815347|FG000|Overall Study|Lost to Follow-up|1|||
161116960|NCT01505634|581815348|FG001|Overall Study|Lost to Follow-up|4|||
161116961|NCT01505634|581815349|FG002|Overall Study|Lost to Follow-up|4|||
161116962|NCT01505634|581815347|FG000|Overall Study|Death|1|||
161116963|NCT01505634|581815348|FG001|Overall Study|Death|0|||
161116964|NCT01505634|581815349|FG002|Overall Study|Death|0|||
161116965|NCT01505634|581815347|FG000|Overall Study|In a conflict zone|0|||
161116966|NCT01505634|581815348|FG001|Overall Study|In a conflict zone|0|||
161116967|NCT01505634|581815349|FG002|Overall Study|In a conflict zone|1|||
161116968|NCT00960843|581815350|FG000|Overall Study|Lost to Follow-up|2|||
161116969|NCT00960843|581815351|FG001|Overall Study|Lost to Follow-up|0|||
161116970|NCT00960843|581815350|FG000|Overall Study|Protocol Violation|0|||
161116971|NCT00960843|581815351|FG001|Overall Study|Protocol Violation|4|||
161116972|NCT00960843|581815350|FG000|Overall Study|Repeated needle dislodgment|0|||
161221337|NCT02843074|582191757|FG000|Overall Study|Death|9|||
161116973|NCT00960843|581815351|FG001|Overall Study|Repeated needle dislodgment|1|||
161116974|NCT00254501|581815352|FG000|Overall Study|Lost to Follow-up|1|||
161116975|NCT00254501|581815353|FG001|Overall Study|Lost to Follow-up|1|||
161116976|NCT01100437|581815355|FG000|Titration/Stabilization|Adverse Event|0|||
161221338|NCT01564758|582191758|FG000|Overall Study|Death|8|||
161221339|NCT01564758|582191758|FG000|Overall Study|Adverse Event|3|||
161221340|NCT01564758|582191758|FG000|Overall Study|Other|3|||
161221341|NCT01186978|582191759|FG000|Overall Study|Withdrawal by Subject|1|||
161221342|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
161116977|NCT01100437|581815356|FG001|Titration/Stabilization|Adverse Event|0|||
161116978|NCT01100437|581815357|FG002|Titration/Stabilization|Adverse Event|4|||
161116979|NCT01100437|581815355|FG000|Titration/Stabilization|Non-compliance|0|||
161116980|NCT01100437|581815356|FG001|Titration/Stabilization|Non-compliance|0|||
161116981|NCT01100437|581815357|FG002|Titration/Stabilization|Non-compliance|1|||
161116982|NCT01100437|581815355|FG000|Titration/Stabilization|Sponsor canceled study|0|||
161116983|NCT01100437|581815356|FG001|Titration/Stabilization|Sponsor canceled study|0|||
161116984|NCT01100437|581815357|FG002|Titration/Stabilization|Sponsor canceled study|1|||
161116985|NCT01100437|581815355|FG000|Maintenance|Withdrawal by Subject|0|||
161116986|NCT01100437|581815356|FG001|Maintenance|Withdrawal by Subject|0|||
161116987|NCT01100437|581815357|FG002|Maintenance|Withdrawal by Subject|1|||
161116988|NCT01100437|581815355|FG000|Maintenance|Sponsor termination of study|0|||
161116989|NCT01100437|581815356|FG001|Maintenance|Sponsor termination of study|0|||
161116990|NCT01100437|581815357|FG002|Maintenance|Sponsor termination of study|1|||
161116991|NCT01014689|581815360|FG000|Overall Study|Lack of Efficacy|0|||
161116992|NCT01014689|581815361|FG001|Overall Study|Lack of Efficacy|1|||
161116993|NCT01014689|581815360|FG000|Overall Study|Adverse Event|3|||
161116994|NCT01014689|581815361|FG001|Overall Study|Adverse Event|0|||
161116995|NCT01014689|581815360|FG000|Overall Study|Withdrawal by Subject|5|||
161116996|NCT01014689|581815361|FG001|Overall Study|Withdrawal by Subject|4|||
161116997|NCT01014689|581815360|FG000|Overall Study|Protocol Violation|1|||
161116998|NCT01014689|581815361|FG001|Overall Study|Protocol Violation|1|||
161116999|NCT01014689|581815360|FG000|Overall Study|Lost to Follow-up|3|||
161117000|NCT01014689|581815361|FG001|Overall Study|Lost to Follow-up|7|||
161117001|NCT01014689|581815360|FG000|Overall Study|Pregnancy|1|||
161117002|NCT01014689|581815361|FG001|Overall Study|Pregnancy|0|||
161117003|NCT00333359|581815367|FG000|Overall Study|Adverse Event|29|||
161117004|NCT00333359|581815368|FG001|Overall Study|Adverse Event|35|||
161117005|NCT00333359|581815367|FG000|Overall Study|Withdrawal by Subject|19|||
161117006|NCT00333359|581815368|FG001|Overall Study|Withdrawal by Subject|37|||
161117007|NCT00333359|581815367|FG000|Overall Study|Physician Decision|2|||
161117008|NCT00333359|581815368|FG001|Overall Study|Physician Decision|2|||
161117009|NCT00333359|581815367|FG000|Overall Study|Protocol Non-compliance|2|||
161117010|NCT00333359|581815368|FG001|Overall Study|Protocol Non-compliance|8|||
161117011|NCT00333359|581815367|FG000|Overall Study|Lost to Follow-up|15|||
161117012|NCT00333359|581815368|FG001|Overall Study|Lost to Follow-up|25|||
161117013|NCT00333359|581815367|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
161117014|NCT00333359|581815368|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
161117015|NCT00333359|581815367|FG000|Overall Study|Treatment Failure|3|||
161117016|NCT00333359|581815368|FG001|Overall Study|Treatment Failure|8|||
161117017|NCT00333359|581815367|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
161117018|NCT00333359|581815368|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
161117019|NCT00328627|581818450|FG000|Overall Study|Hyperglycemic Rescue|41|||
161221343|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
161221344|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
161221345|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
161221346|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
161221347|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
161221348|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
161221349|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
161221350|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
161221351|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
161221352|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
161221353|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
161117020|NCT00328627|581818451|FG001|Overall Study|Hyperglycemic Rescue|18|||
161117021|NCT00328627|581818452|FG002|Overall Study|Hyperglycemic Rescue|16|||
161117022|NCT00328627|581818453|FG003|Overall Study|Hyperglycemic Rescue|13|||
161117023|NCT00328627|581818454|FG004|Overall Study|Hyperglycemic Rescue|6|||
161117024|NCT00328627|581818455|FG005|Overall Study|Hyperglycemic Rescue|5|||
161117025|NCT00328627|581818456|FG006|Overall Study|Hyperglycemic Rescue|19|||
161117026|NCT00328627|581818457|FG007|Overall Study|Hyperglycemic Rescue|6|||
161117027|NCT00328627|581818458|FG008|Overall Study|Hyperglycemic Rescue|6|||
161117028|NCT00328627|581818459|FG009|Overall Study|Hyperglycemic Rescue|11|||
161117029|NCT00328627|581818460|FG010|Overall Study|Hyperglycemic Rescue|3|||
161117030|NCT00328627|581818461|FG011|Overall Study|Hyperglycemic Rescue|2|||
161117031|NCT00328627|581818450|FG000|Overall Study|Adverse Event|3|||
161117032|NCT00328627|581818451|FG001|Overall Study|Adverse Event|1|||
161117033|NCT00328627|581818452|FG002|Overall Study|Adverse Event|2|||
161117034|NCT00328627|581818453|FG003|Overall Study|Adverse Event|3|||
161117035|NCT00328627|581818454|FG004|Overall Study|Adverse Event|1|||
161117036|NCT00328627|581818455|FG005|Overall Study|Adverse Event|2|||
161117037|NCT00328627|581818456|FG006|Overall Study|Adverse Event|1|||
161117038|NCT00328627|581818457|FG007|Overall Study|Adverse Event|2|||
161117039|NCT00328627|581818458|FG008|Overall Study|Adverse Event|0|||
161117040|NCT00328627|581818459|FG009|Overall Study|Adverse Event|7|||
161117041|NCT00328627|581818460|FG010|Overall Study|Adverse Event|5|||
161117042|NCT00328627|581818461|FG011|Overall Study|Adverse Event|4|||
161117043|NCT00328627|581818450|FG000|Overall Study|Protocol Violation|2|||
161117044|NCT00328627|581818451|FG001|Overall Study|Protocol Violation|2|||
161117045|NCT00328627|581818452|FG002|Overall Study|Protocol Violation|2|||
161117046|NCT00328627|581818453|FG003|Overall Study|Protocol Violation|8|||
161117047|NCT00328627|581818454|FG004|Overall Study|Protocol Violation|5|||
161117048|NCT00328627|581818455|FG005|Overall Study|Protocol Violation|5|||
161117049|NCT00328627|581818456|FG006|Overall Study|Protocol Violation|6|||
161117050|NCT00328627|581818457|FG007|Overall Study|Protocol Violation|2|||
161117051|NCT00328627|581818458|FG008|Overall Study|Protocol Violation|1|||
161117052|NCT00328627|581818459|FG009|Overall Study|Protocol Violation|4|||
161117053|NCT00328627|581818460|FG010|Overall Study|Protocol Violation|6|||
161117054|NCT00328627|581818461|FG011|Overall Study|Protocol Violation|2|||
161117055|NCT00328627|581818450|FG000|Overall Study|Lost to Follow-up|4|||
161117056|NCT00328627|581818451|FG001|Overall Study|Lost to Follow-up|2|||
161117057|NCT00328627|581818452|FG002|Overall Study|Lost to Follow-up|2|||
161117058|NCT00328627|581818453|FG003|Overall Study|Lost to Follow-up|4|||
161117059|NCT00328627|581818454|FG004|Overall Study|Lost to Follow-up|0|||
161117060|NCT00328627|581818455|FG005|Overall Study|Lost to Follow-up|2|||
161117061|NCT00328627|581818456|FG006|Overall Study|Lost to Follow-up|3|||
161117062|NCT00328627|581818457|FG007|Overall Study|Lost to Follow-up|0|||
161117063|NCT00328627|581818458|FG008|Overall Study|Lost to Follow-up|3|||
161117064|NCT00328627|581818459|FG009|Overall Study|Lost to Follow-up|2|||
161117065|NCT00328627|581818460|FG010|Overall Study|Lost to Follow-up|0|||
161117066|NCT00328627|581818461|FG011|Overall Study|Lost to Follow-up|1|||
161117067|NCT00328627|581818450|FG000|Overall Study|Withdrawal by Subject|5|||
161117068|NCT00328627|581818451|FG001|Overall Study|Withdrawal by Subject|4|||
161117069|NCT00328627|581818452|FG002|Overall Study|Withdrawal by Subject|5|||
161117070|NCT00328627|581818453|FG003|Overall Study|Withdrawal by Subject|6|||
161117071|NCT00328627|581818454|FG004|Overall Study|Withdrawal by Subject|2|||
161117072|NCT00328627|581818455|FG005|Overall Study|Withdrawal by Subject|5|||
161117073|NCT00328627|581818456|FG006|Overall Study|Withdrawal by Subject|4|||
161117074|NCT00328627|581818457|FG007|Overall Study|Withdrawal by Subject|4|||
161117075|NCT00328627|581818458|FG008|Overall Study|Withdrawal by Subject|4|||
161117076|NCT00328627|581818459|FG009|Overall Study|Withdrawal by Subject|5|||
161117077|NCT00328627|581818460|FG010|Overall Study|Withdrawal by Subject|2|||
161117078|NCT00328627|581818461|FG011|Overall Study|Withdrawal by Subject|7|||
161117079|NCT00328627|581818450|FG000|Overall Study|Pregnancy|0|||
161117080|NCT00328627|581818451|FG001|Overall Study|Pregnancy|1|||
161117081|NCT00328627|581818452|FG002|Overall Study|Pregnancy|0|||
161117082|NCT00328627|581818453|FG003|Overall Study|Pregnancy|0|||
161117083|NCT00328627|581818454|FG004|Overall Study|Pregnancy|0|||
161117084|NCT00328627|581818455|FG005|Overall Study|Pregnancy|0|||
161117085|NCT00328627|581818456|FG006|Overall Study|Pregnancy|0|||
161117086|NCT00328627|581818457|FG007|Overall Study|Pregnancy|0|||
161117087|NCT00328627|581818458|FG008|Overall Study|Pregnancy|0|||
161117088|NCT00328627|581818459|FG009|Overall Study|Pregnancy|0|||
161117089|NCT00328627|581818460|FG010|Overall Study|Pregnancy|0|||
161117090|NCT00328627|581818461|FG011|Overall Study|Pregnancy|0|||
161117091|NCT00328627|581818450|FG000|Overall Study|Physician Decision|4|||
161117092|NCT00328627|581818451|FG001|Overall Study|Physician Decision|3|||
161117093|NCT00328627|581818452|FG002|Overall Study|Physician Decision|1|||
161117094|NCT00328627|581818453|FG003|Overall Study|Physician Decision|2|||
161117095|NCT00328627|581818454|FG004|Overall Study|Physician Decision|1|||
161117096|NCT00328627|581818455|FG005|Overall Study|Physician Decision|1|||
161117097|NCT00328627|581818456|FG006|Overall Study|Physician Decision|1|||
161117098|NCT00328627|581818457|FG007|Overall Study|Physician Decision|0|||
161117099|NCT00328627|581818458|FG008|Overall Study|Physician Decision|3|||
161117100|NCT00328627|581818459|FG009|Overall Study|Physician Decision|2|||
161117101|NCT00328627|581818460|FG010|Overall Study|Physician Decision|1|||
161117102|NCT00328627|581818461|FG011|Overall Study|Physician Decision|0|||
161117103|NCT00328627|581818450|FG000|Overall Study|Other|0|||
161117104|NCT00328627|581818451|FG001|Overall Study|Other|0|||
161117105|NCT00328627|581818452|FG002|Overall Study|Other|0|||
161117106|NCT00328627|581818453|FG003|Overall Study|Other|1|||
161221354|NCT01227668|582191760|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
161221355|NCT01227668|582191761|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
161221356|NCT01227668|582191760|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
161221357|NCT01227668|582191761|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
161221358|NCT01227668|582191760|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
161221359|NCT01227668|582191761|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
161221360|NCT01227668|582191760|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
161221361|NCT01227668|582191761|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
161221362|NCT01227668|582191760|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
161221363|NCT01227668|582191761|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
161221364|NCT01227668|582191760|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
161221365|NCT01227668|582191761|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
161221366|NCT03264066|582191762|FG000|Overall Study|Adverse Event|1|||
161221367|NCT03264066|582191763|FG001|Overall Study|Adverse Event|1|||
161221368|NCT03264066|582191764|FG002|Overall Study|Adverse Event|0|||
161221369|NCT03264066|582191765|FG003|Overall Study|Adverse Event|0|||
161221370|NCT03264066|582191766|FG004|Overall Study|Adverse Event|0|||
161221371|NCT03264066|582191767|FG005|Overall Study|Adverse Event|0|||
161221372|NCT03264066|582191762|FG000|Overall Study|Death|12|||
161221373|NCT03264066|582191763|FG001|Overall Study|Death|12|||
161221374|NCT03264066|582191764|FG002|Overall Study|Death|8|||
161221375|NCT03264066|582191765|FG003|Overall Study|Death|10|||
161221376|NCT03264066|582191766|FG004|Overall Study|Death|6|||
161221377|NCT03264066|582191767|FG005|Overall Study|Death|1|||
161221378|NCT03264066|582191762|FG000|Overall Study|Lost to Follow-up|1|||
161221379|NCT03264066|582191763|FG001|Overall Study|Lost to Follow-up|0|||
161221380|NCT03264066|582191764|FG002|Overall Study|Lost to Follow-up|0|||
161221381|NCT03264066|582191765|FG003|Overall Study|Lost to Follow-up|0|||
161221382|NCT03264066|582191766|FG004|Overall Study|Lost to Follow-up|0|||
161221383|NCT03264066|582191767|FG005|Overall Study|Lost to Follow-up|0|||
161221384|NCT03264066|582191762|FG000|Overall Study|Progressive Disease|0|||
161221385|NCT03264066|582191763|FG001|Overall Study|Progressive Disease|2|||
161221386|NCT03264066|582191764|FG002|Overall Study|Progressive Disease|1|||
161221387|NCT03264066|582191765|FG003|Overall Study|Progressive Disease|0|||
161221388|NCT03264066|582191766|FG004|Overall Study|Progressive Disease|0|||
161221389|NCT03264066|582191767|FG005|Overall Study|Progressive Disease|0|||
161221390|NCT03264066|582191762|FG000|Overall Study|Study Terminated by Sponsor|5|||
161221391|NCT03264066|582191763|FG001|Overall Study|Study Terminated by Sponsor|5|||
161221392|NCT03264066|582191764|FG002|Overall Study|Study Terminated by Sponsor|8|||
161221393|NCT03264066|582191765|FG003|Overall Study|Study Terminated by Sponsor|5|||
161221394|NCT03264066|582191766|FG004|Overall Study|Study Terminated by Sponsor|1|||
161221395|NCT03264066|582191767|FG005|Overall Study|Study Terminated by Sponsor|2|||
161221396|NCT03264066|582191762|FG000|Overall Study|Withdrawal by Subject|1|||
161221397|NCT03264066|582191763|FG001|Overall Study|Withdrawal by Subject|0|||
161221398|NCT03264066|582191764|FG002|Overall Study|Withdrawal by Subject|0|||
161221399|NCT03264066|582191765|FG003|Overall Study|Withdrawal by Subject|5|||
161221400|NCT03264066|582191766|FG004|Overall Study|Withdrawal by Subject|0|||
161221401|NCT03264066|582191767|FG005|Overall Study|Withdrawal by Subject|0|||
161221402|NCT01193517|582191772|FG000|Overall Study|Early Progression|1|||
161221403|NCT01193517|582191773|FG001|Overall Study|Early Progression|0|||
161221404|NCT01193517|582191774|FG002|Overall Study|Early Progression|0|||
161221405|NCT00905489|582191775|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
161221406|NCT00905489|582191775|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
161221407|NCT00905489|582191775|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
161221408|NCT00583596|582191778|FG000|Overall Study|Lost to Follow-up|110|||
161221409|NCT00583596|582191778|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
161221410|NCT00583596|582191778|FG000|Overall Study|Death|2|||
161221411|NCT00583596|582191778|FG000|Overall Study|Withdrawal by Subject|6|||
161221412|NCT00583596|582191778|FG000|Overall Study|Lost to Follow-up|94|||
161221413|NCT00583596|582191778|FG000|Overall Study|Data not complete|1|||
161221414|NCT00583596|582191778|FG000|Overall Study|Not consented|15|||
161221415|NCT00583596|582191778|FG000|Overall Study|Outside f-up window|26|||
161221416|NCT01688037|582191781|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
161221417|NCT01688037|582191782|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
161221418|NCT01688037|582191783|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
161221419|NCT01688037|582191781|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
161221420|NCT01688037|582191782|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
161221421|NCT01688037|582191783|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
161221422|NCT01688037|582191781|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
161221423|NCT01688037|582191782|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
161221424|NCT01688037|582191783|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
161221425|NCT01688037|582191781|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161221426|NCT01688037|582191782|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
161221427|NCT01688037|582191783|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
161221428|NCT01688037|582191781|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
161221429|NCT01688037|582191782|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
161221430|NCT01688037|582191783|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
161221431|NCT01688037|582191781|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
161221432|NCT01688037|582191782|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
161221433|NCT01688037|582191783|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
161221434|NCT01688037|582191781|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
161221435|NCT01688037|582191782|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
161221436|NCT01688037|582191783|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
161221437|NCT01688037|582191781|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
161221438|NCT01688037|582191782|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
161221439|NCT01688037|582191783|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
161221440|NCT01688037|582191781|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
161221441|NCT01688037|582191782|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
161221442|NCT01688037|582191783|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
161221443|NCT01688037|582191781|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
161221444|NCT01688037|582191782|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
161221445|NCT01688037|582191783|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
161221446|NCT00836927|582192933|FG000|Overall Study|Progressive disease|2|||
161221447|NCT00836927|582192934|FG001|Overall Study|Progressive disease|0|||
161221448|NCT00836927|582192935|FG002|Overall Study|Progressive disease|0|||
161221449|NCT00836927|582192936|FG003|Overall Study|Progressive disease|1|||
161221450|NCT00836927|582192937|FG004|Overall Study|Progressive disease|1|||
161221451|NCT00836927|582192933|FG000|Overall Study|Withdrawal by Subject|1|||
161221452|NCT00836927|582192934|FG001|Overall Study|Withdrawal by Subject|0|||
161221453|NCT00836927|582192935|FG002|Overall Study|Withdrawal by Subject|0|||
161221454|NCT00836927|582192936|FG003|Overall Study|Withdrawal by Subject|0|||
161221455|NCT00836927|582192937|FG004|Overall Study|Withdrawal by Subject|0|||
161221456|NCT03093454|582192938|FG000|Overall Study|Withdrawal by Subject|1|||
161221457|NCT03093454|582192939|FG001|Overall Study|Withdrawal by Subject|1|||
161221458|NCT03093454|582192938|FG000|Overall Study|Scheduling conflict|3|||
161221459|NCT03093454|582192939|FG001|Overall Study|Scheduling conflict|1|||
161221460|NCT03093454|582192938|FG000|Overall Study|Physician Decision|2|||
161221461|NCT03093454|582192939|FG001|Overall Study|Physician Decision|1|||
161221462|NCT02173704|582192940|FG000|Overall Study|Adverse Event|1|||
161221463|NCT02173704|582192941|FG001|Overall Study|Adverse Event|0|||
161221464|NCT02173704|582192940|FG000|Overall Study|Lost to Follow-up|1|||
161221465|NCT02173704|582192941|FG001|Overall Study|Lost to Follow-up|0|||
161221466|NCT02173704|582192940|FG000|Overall Study|Other|1|||
161221467|NCT02173704|582192941|FG001|Overall Study|Other|0|||
161221468|NCT02173704|582192940|FG000|Overall Study|Protocol Violation|1|||
161221469|NCT02173704|582192941|FG001|Overall Study|Protocol Violation|0|||
161221470|NCT02173704|582192940|FG000|Overall Study|Withdrawal by Subject|9|||
161221471|NCT02173704|582192941|FG001|Overall Study|Withdrawal by Subject|4|||
161221472|NCT04956666|582192942|FG000|Overall Study|Adverse Event|18|||
161221473|NCT04956666|582192942|FG000|Overall Study|Physician Decision|5|||
161221474|NCT02623829|582192946|FG000|Overall Study|Lost to Follow-up|1|||
161221475|NCT02623829|582192947|FG001|Overall Study|Lost to Follow-up|1|||
161221476|NCT00662025|582192948|FG000|Overall Study|Objective progression or relapse|51|||
161221477|NCT00662025|582192948|FG000|Overall Study|Adverse Event|7|||
161221478|NCT00662025|582192948|FG000|Overall Study|Withdrawal by Subject|1|||
161221479|NCT00662025|582192948|FG000|Overall Study|Results of other clinical study|2|||
161221480|NCT00662025|582192948|FG000|Overall Study|Target lesion cannot be evaluated|1|||
161221481|NCT00662025|582192948|FG000|Overall Study|Domestic circumstances|1|||
161221482|NCT01333033|582192952|FG000|Overall Study|Ineligible|0|||
161221483|NCT01333033|582192953|FG001|Overall Study|Ineligible|0|||
161221484|NCT01333033|582192954|FG002|Overall Study|Ineligible|0|||
161221485|NCT01333033|582192955|FG003|Overall Study|Ineligible|0|||
161221486|NCT01333033|582192956|FG004|Overall Study|Ineligible|6|||
161221487|NCT01333033|582192957|FG005|Overall Study|Ineligible|8|||
161221488|NCT01333033|582192952|FG000|Overall Study|Withdrawal by Subject|0|||
161221489|NCT01333033|582192953|FG001|Overall Study|Withdrawal by Subject|0|||
161221490|NCT01333033|582192954|FG002|Overall Study|Withdrawal by Subject|0|||
161221491|NCT01333033|582192955|FG003|Overall Study|Withdrawal by Subject|0|||
161221492|NCT01333033|582192956|FG004|Overall Study|Withdrawal by Subject|4|||
161221493|NCT01333033|582192957|FG005|Overall Study|Withdrawal by Subject|2|||
161221494|NCT01333033|582192952|FG000|Overall Study|PET inevaluable|0|||
161221495|NCT01333033|582192953|FG001|Overall Study|PET inevaluable|0|||
161221496|NCT01333033|582192954|FG002|Overall Study|PET inevaluable|0|||
161221497|NCT01333033|582192955|FG003|Overall Study|PET inevaluable|0|||
161221498|NCT01333033|582192956|FG004|Overall Study|PET inevaluable|2|||
161221499|NCT01333033|582192957|FG005|Overall Study|PET inevaluable|4|||
161221500|NCT01333033|582192952|FG000|Overall Study|Adverse Event|0|||
161221501|NCT01333033|582192953|FG001|Overall Study|Adverse Event|0|||
161221502|NCT01333033|582192954|FG002|Overall Study|Adverse Event|0|||
161221503|NCT01333033|582192955|FG003|Overall Study|Adverse Event|0|||
161221504|NCT01333033|582192956|FG004|Overall Study|Adverse Event|2|||
161117107|NCT00328627|581818454|FG004|Overall Study|Other|0|||
161117108|NCT00328627|581818455|FG005|Overall Study|Other|0|||
161117109|NCT00328627|581818456|FG006|Overall Study|Other|1|||
161117110|NCT00328627|581818457|FG007|Overall Study|Other|0|||
161117111|NCT00328627|581818458|FG008|Overall Study|Other|0|||
161117112|NCT00328627|581818459|FG009|Overall Study|Other|1|||
161117113|NCT00328627|581818460|FG010|Overall Study|Other|1|||
161117114|NCT00328627|581818461|FG011|Overall Study|Other|0|||
161117115|NCT02049944|581818462|FG000|Overall Study|Protocol Violation|2|||
161117116|NCT03691974|581818465|FG000|Overall Study|Physician Decision|1|||
161117117|NCT03691974|581818466|FG001|Overall Study|Physician Decision|0|||
161117118|NCT03691974|581818465|FG000|Overall Study|Adverse Event|1|||
161117119|NCT03691974|581818466|FG001|Overall Study|Adverse Event|0|||
161117120|NCT03691974|581818465|FG000|Overall Study|Withdrawal by Subject|11|||
161117121|NCT03691974|581818466|FG001|Overall Study|Withdrawal by Subject|9|||
161117122|NCT03691974|581818465|FG000|Overall Study|Protocol Violation|1|||
161117123|NCT03691974|581818466|FG001|Overall Study|Protocol Violation|0|||
161117124|NCT03691974|581818465|FG000|Overall Study|Lost to Follow-up|8|||
161117125|NCT03691974|581818466|FG001|Overall Study|Lost to Follow-up|7|||
161117126|NCT00513409|581818467|FG000|Overall Study|Adverse Event|0|||
161117127|NCT00513409|581818468|FG001|Overall Study|Adverse Event|1|||
161117128|NCT00513409|581818467|FG000|Overall Study|Withdrawal by Subject|0|||
161117129|NCT00513409|581818468|FG001|Overall Study|Withdrawal by Subject|2|||
161117130|NCT00513409|581818467|FG000|Overall Study|Lost to Follow-up|0|||
161117131|NCT00513409|581818468|FG001|Overall Study|Lost to Follow-up|1|||
161117132|NCT00513409|581818467|FG000|Overall Study|Physician Decision|1|||
161117133|NCT00513409|581818468|FG001|Overall Study|Physician Decision|0|||
161117134|NCT00513409|581818467|FG000|Overall Study|Visit 3 not done|1|||
161117135|NCT00513409|581818468|FG001|Overall Study|Visit 3 not done|2|||
161117136|NCT00691483|581818469|FG000|Overall Study|Adverse Event|14|||
161117137|NCT00691483|581818470|FG001|Overall Study|Adverse Event|6|||
161117138|NCT00691483|581818469|FG000|Overall Study|Lost to Follow-up|17|||
161117139|NCT00691483|581818470|FG001|Overall Study|Lost to Follow-up|10|||
161117140|NCT00691483|581818469|FG000|Overall Study|Withdrawal by Subject|24|||
161117141|NCT00691483|581818470|FG001|Overall Study|Withdrawal by Subject|7|||
161117142|NCT00691483|581818469|FG000|Overall Study|Other known cause|6|||
161117143|NCT00691483|581818470|FG001|Overall Study|Other known cause|1|||
161117144|NCT00691483|581818469|FG000|Overall Study|Randomized by not treated|7|||
161117145|NCT00691483|581818470|FG001|Overall Study|Randomized by not treated|1|||
161117146|NCT02105454|581818473|FG000|Overall Study|Withdrawal by Subject|1|||
161117147|NCT00326898|581818474|FG000|Overall Study|Disease progression|52|||
161117148|NCT00326898|581818475|FG001|Overall Study|Disease progression|54|||
161117149|NCT00326898|581818476|FG002|Overall Study|Disease progression|102|||
161117150|NCT00326898|581818474|FG000|Overall Study|Adverse Event|124|||
161117151|NCT00326898|581818475|FG001|Overall Study|Adverse Event|128|||
161117152|NCT00326898|581818476|FG002|Overall Study|Adverse Event|33|||
161117153|NCT00326898|581818474|FG000|Overall Study|Death|2|||
161117154|NCT00326898|581818475|FG001|Overall Study|Death|0|||
161117155|NCT00326898|581818476|FG002|Overall Study|Death|0|||
161117156|NCT00326898|581818474|FG000|Overall Study|Withdrawal by Subject|134|||
161117157|NCT00326898|581818475|FG001|Overall Study|Withdrawal by Subject|128|||
161117158|NCT00326898|581818476|FG002|Overall Study|Withdrawal by Subject|32|||
161117159|NCT00326898|581818474|FG000|Overall Study|Alternative therapy|1|||
161117160|NCT00326898|581818475|FG001|Overall Study|Alternative therapy|0|||
161117161|NCT00326898|581818476|FG002|Overall Study|Alternative therapy|0|||
161117162|NCT00326898|581818474|FG000|Overall Study|Other complicating disease|5|||
161117163|NCT00326898|581818475|FG001|Overall Study|Other complicating disease|5|||
161117164|NCT00326898|581818476|FG002|Overall Study|Other complicating disease|4|||
161117165|NCT00326898|581818474|FG000|Overall Study|Other/Missing/Unknown|33|||
161117166|NCT00326898|581818475|FG001|Overall Study|Other/Missing/Unknown|28|||
161117167|NCT00326898|581818476|FG002|Overall Study|Other/Missing/Unknown|32|||
161117168|NCT03847987|581818477|FG000|Overall Study|Lost to Follow-up|1|||
161117169|NCT03847987|581818478|FG001|Overall Study|Lost to Follow-up|0|||
161117170|NCT03847987|581818477|FG000|Overall Study|Adverse Event|2|||
161117171|NCT03847987|581818478|FG001|Overall Study|Adverse Event|0|||
161117172|NCT01709149|581818490|FG000|Open-label Lead-in Phase|Adverse Event|109|||
161117173|NCT01709149|581818491|FG001|Open-label Lead-in Phase|Adverse Event|0|||
161117174|NCT01709149|581818492|FG002|Open-label Lead-in Phase|Adverse Event|0|||
161117175|NCT01709149|581818490|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
161117176|NCT01709149|581818491|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
161117177|NCT01709149|581818492|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
161117178|NCT01709149|581818490|FG000|Open-label Lead-in Phase|Death|1|||
161117179|NCT01709149|581818491|FG001|Open-label Lead-in Phase|Death|0|||
161117180|NCT01709149|581818492|FG002|Open-label Lead-in Phase|Death|0|||
161117181|NCT01709149|581818490|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
161117182|NCT01709149|581818491|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
161117183|NCT01709149|581818492|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
161117184|NCT01709149|581818490|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
161117185|NCT01709149|581818491|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
161221505|NCT01333033|582192957|FG005|Overall Study|Adverse Event|1|||
161221506|NCT01333033|582192952|FG000|Overall Study|Progression|0|||
161221507|NCT01333033|582192953|FG001|Overall Study|Progression|0|||
161221508|NCT01333033|582192954|FG002|Overall Study|Progression|0|||
161221509|NCT01333033|582192955|FG003|Overall Study|Progression|0|||
161221510|NCT01333033|582192956|FG004|Overall Study|Progression|0|||
161221511|NCT01333033|582192957|FG005|Overall Study|Progression|1|||
161221512|NCT01333033|582192952|FG000|Overall Study|MD Decision|0|||
161221513|NCT01333033|582192953|FG001|Overall Study|MD Decision|0|||
161221514|NCT01333033|582192954|FG002|Overall Study|MD Decision|0|||
161221515|NCT01333033|582192955|FG003|Overall Study|MD Decision|0|||
161221516|NCT01333033|582192956|FG004|Overall Study|MD Decision|0|||
161221517|NCT01333033|582192957|FG005|Overall Study|MD Decision|2|||
161221518|NCT02752776|582192972|FG000|Overall Study|Adverse Event|15|||
161221519|NCT02752776|582192973|FG001|Overall Study|Adverse Event|23|||
161117186|NCT01709149|581818492|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
161221520|NCT02752776|582192974|FG002|Overall Study|Adverse Event|11|||
161221521|NCT02752776|582192972|FG000|Overall Study|Lack of Efficacy|2|||
161221522|NCT02752776|582192973|FG001|Overall Study|Lack of Efficacy|6|||
161221523|NCT02752776|582192974|FG002|Overall Study|Lack of Efficacy|14|||
161117187|NCT01709149|581818490|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161117188|NCT01709149|581818491|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
161117189|NCT01709149|581818492|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
161117190|NCT01709149|581818490|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
161117191|NCT01709149|581818491|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
161117192|NCT01709149|581818492|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
161117193|NCT01709149|581818490|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
161117194|NCT01709149|581818491|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
161117195|NCT01709149|581818492|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
161117196|NCT01709149|581818490|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
161117197|NCT01709149|581818491|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
161117198|NCT01709149|581818492|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
161117199|NCT01709149|581818490|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161117200|NCT01709149|581818491|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
161117201|NCT01709149|581818492|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161117202|NCT03509350|581818493|FG000|Overall Study|Withdrawal by Subject|0|||
161117203|NCT03509350|581818494|FG001|Overall Study|Withdrawal by Subject|2|||
161117204|NCT00763815|581818495|FG000|Overall Study|Adverse Event|14|||
161117205|NCT00763815|581818496|FG001|Overall Study|Adverse Event|29|||
161117206|NCT00763815|581818495|FG000|Overall Study|Lack of Efficacy|10|||
161117207|NCT00763815|581818496|FG001|Overall Study|Lack of Efficacy|11|||
161117208|NCT00763815|581818495|FG000|Overall Study|Poor Compliance to Protocol|6|||
161117209|NCT00763815|581818496|FG001|Overall Study|Poor Compliance to Protocol|6|||
161117210|NCT00763815|581818495|FG000|Overall Study|Lost to Follow-up|2|||
161117211|NCT00763815|581818496|FG001|Overall Study|Lost to Follow-up|4|||
161117212|NCT00763815|581818495|FG000|Overall Study|Early Termination|1|||
161117213|NCT00763815|581818496|FG001|Overall Study|Early Termination|0|||
161117214|NCT00763815|581818495|FG000|Overall Study|Familial and Personal Reasons|9|||
161117215|NCT00763815|581818496|FG001|Overall Study|Familial and Personal Reasons|16|||
161117216|NCT00763815|581818495|FG000|Overall Study|Physician Decision|1|||
161117217|NCT00763815|581818496|FG001|Overall Study|Physician Decision|0|||
161117218|NCT00763815|581818495|FG000|Overall Study|Withdrawal by Subject|7|||
161117219|NCT00763815|581818496|FG001|Overall Study|Withdrawal by Subject|12|||
161221524|NCT02752776|582192972|FG000|Overall Study|Lost to Follow-up|11|||
161221525|NCT02752776|582192973|FG001|Overall Study|Lost to Follow-up|12|||
161221526|NCT02752776|582192974|FG002|Overall Study|Lost to Follow-up|4|||
161221527|NCT02752776|582192972|FG000|Overall Study|Non-compliance with study treatment|0|||
161221528|NCT02752776|582192973|FG001|Overall Study|Non-compliance with study treatment|0|||
161117220|NCT00763815|581818495|FG000|Overall Study|Protocol Violation|2|||
161117221|NCT00763815|581818496|FG001|Overall Study|Protocol Violation|5|||
161117222|NCT00763815|581818495|FG000|Overall Study|Sponsor's Decision|0|||
161117223|NCT00763815|581818496|FG001|Overall Study|Sponsor's Decision|1|||
161117224|NCT04951037|581818497|FG000|Overall Study|Lost to Follow-up|16|||
161117225|NCT04951037|581818497|FG000|Overall Study|Withdrawal by Subject|5|||
161117226|NCT04951037|581818497|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
161117227|NCT05630937|581818498|FG000|Overall Study|Study terminated by sponsor|1|||
161221529|NCT02752776|582192974|FG002|Overall Study|Non-compliance with study treatment|1|||
161221530|NCT02752776|582192972|FG000|Overall Study|Physician Decision|2|||
161221531|NCT02752776|582192973|FG001|Overall Study|Physician Decision|6|||
161221532|NCT02752776|582192974|FG002|Overall Study|Physician Decision|2|||
161221533|NCT02752776|582192972|FG000|Overall Study|Pregnancy|1|||
161221534|NCT02752776|582192973|FG001|Overall Study|Pregnancy|6|||
161221535|NCT02752776|582192974|FG002|Overall Study|Pregnancy|3|||
161221536|NCT02752776|582192972|FG000|Overall Study|Protocol Violation|10|||
161221537|NCT02752776|582192973|FG001|Overall Study|Protocol Violation|13|||
161221538|NCT02752776|582192974|FG002|Overall Study|Protocol Violation|6|||
161221539|NCT02752776|582192972|FG000|Overall Study|Subject/guardian decision|8|||
161221540|NCT02752776|582192973|FG001|Overall Study|Subject/guardian decision|6|||
161221541|NCT02752776|582192974|FG002|Overall Study|Subject/guardian decision|4|||
161221542|NCT02752776|582192972|FG000|Overall Study|Death|0|||
161221543|NCT02752776|582192973|FG001|Overall Study|Death|0|||
161221544|NCT02752776|582192974|FG002|Overall Study|Death|1|||
161117228|NCT05630937|581818499|FG001|Overall Study|Study terminated by sponsor|1|||
161117229|NCT05630937|581818500|FG002|Overall Study|Study terminated by sponsor|8|||
161117230|NCT05630937|581818501|FG003|Overall Study|Study terminated by sponsor|0|||
161117231|NCT05630937|581818498|FG000|Overall Study|Lost to Follow-up|0|||
161117232|NCT05630937|581818499|FG001|Overall Study|Lost to Follow-up|0|||
161117233|NCT05630937|581818500|FG002|Overall Study|Lost to Follow-up|1|||
161117234|NCT05630937|581818501|FG003|Overall Study|Lost to Follow-up|0|||
161117235|NCT05630937|581818498|FG000|Overall Study|Enrolled but not treated|0|||
161117236|NCT05630937|581818499|FG001|Overall Study|Enrolled but not treated|0|||
161117237|NCT05630937|581818500|FG002|Overall Study|Enrolled but not treated|0|||
161117238|NCT05630937|581818501|FG003|Overall Study|Enrolled but not treated|1|||
161117239|NCT00267748|581818503|FG000|Non-randomized Period|Progressive disease|10|||
161117240|NCT00267748|581818504|FG001|Non-randomized Period|Progressive disease|0|||
161117241|NCT00267748|581818505|FG002|Non-randomized Period|Progressive disease|0|||
161117242|NCT00267748|581818503|FG000|Non-randomized Period|Adverse Event|8|||
161117243|NCT00267748|581818504|FG001|Non-randomized Period|Adverse Event|0|||
161117244|NCT00267748|581818505|FG002|Non-randomized Period|Adverse Event|0|||
161117245|NCT00267748|581818503|FG000|Non-randomized Period|Death|1|||
161117246|NCT00267748|581818504|FG001|Non-randomized Period|Death|0|||
161117247|NCT00267748|581818505|FG002|Non-randomized Period|Death|0|||
161117248|NCT00267748|581818503|FG000|Non-randomized Period|Participant not willing to participate|1|||
161117249|NCT00267748|581818504|FG001|Non-randomized Period|Participant not willing to participate|0|||
161117250|NCT00267748|581818505|FG002|Non-randomized Period|Participant not willing to participate|0|||
161117251|NCT00267748|581818503|FG000|Non-randomized Period|Other|3|||
161117252|NCT00267748|581818504|FG001|Non-randomized Period|Other|0|||
161117253|NCT00267748|581818505|FG002|Non-randomized Period|Other|0|||
161117254|NCT00267748|581818503|FG000|Randomized Period|Death|0|||
161117255|NCT00267748|581818504|FG001|Randomized Period|Death|2|||
161117256|NCT00267748|581818505|FG002|Randomized Period|Death|3|||
161117257|NCT00267748|581818503|FG000|Randomized Period|Adverse Event|0|||
161117258|NCT00267748|581818504|FG001|Randomized Period|Adverse Event|23|||
161117259|NCT00267748|581818505|FG002|Randomized Period|Adverse Event|25|||
161117260|NCT00267748|581818503|FG000|Randomized Period|Global deterioration of health status|0|||
161117261|NCT00267748|581818504|FG001|Randomized Period|Global deterioration of health status|6|||
161117262|NCT00267748|581818505|FG002|Randomized Period|Global deterioration of health status|7|||
161117263|NCT00267748|581818503|FG000|Randomized Period|Lost to Follow-up|0|||
161117264|NCT00267748|581818504|FG001|Randomized Period|Lost to Follow-up|1|||
161117265|NCT00267748|581818505|FG002|Randomized Period|Lost to Follow-up|0|||
161117266|NCT00267748|581818503|FG000|Randomized Period|Objective progression or relapse|0|||
161117267|NCT00267748|581818504|FG001|Randomized Period|Objective progression or relapse|77|||
161117268|NCT00267748|581818505|FG002|Randomized Period|Objective progression or relapse|86|||
161117269|NCT00267748|581818503|FG000|Randomized Period|Withdrawal by Subject|0|||
161117270|NCT00267748|581818504|FG001|Randomized Period|Withdrawal by Subject|9|||
161117271|NCT00267748|581818505|FG002|Randomized Period|Withdrawal by Subject|2|||
161117272|NCT00267748|581818503|FG000|Randomized Period|Other|0|||
161221545|NCT02752776|582192972|FG000|Overall Study|Withdrawal by Subject|3|||
161221546|NCT02752776|582192973|FG001|Overall Study|Withdrawal by Subject|4|||
161221547|NCT02752776|582192974|FG002|Overall Study|Withdrawal by Subject|2|||
161221548|NCT01816477|582192975|FG000|Overall Study|Withdrawal by Subject|13|||
161221549|NCT01816477|582192976|FG001|Overall Study|Withdrawal by Subject|1|||
161117273|NCT00267748|581818504|FG001|Randomized Period|Other|9|||
161117274|NCT00267748|581818505|FG002|Randomized Period|Other|6|||
161117275|NCT00267748|581818503|FG000|Randomized Period|randomized but not treated|0|||
161117276|NCT00267748|581818504|FG001|Randomized Period|randomized but not treated|0|||
161117277|NCT00267748|581818505|FG002|Randomized Period|randomized but not treated|3|||
161117278|NCT02432235|581818510|FG000|Overall Study|Death|1|||
161117279|NCT02432235|581818511|FG001|Overall Study|Death|1|||
161117280|NCT02432235|581818512|FG002|Overall Study|Death|2|||
161117281|NCT02432235|581818513|FG003|Overall Study|Death|2|||
161117282|NCT02432235|581818514|FG004|Overall Study|Death|1|||
161117283|NCT02432235|581818515|FG005|Overall Study|Death|3|||
161117284|NCT02432235|581818516|FG006|Overall Study|Death|11|||
161117285|NCT02432235|581818517|FG007|Overall Study|Death|15|||
161257858|NCT02999984|582323500|FG000|Overall Study|Treatment Failure|1|||
161221550|NCT01816477|582192975|FG000|Overall Study|Unable to tolerate catheter placement|3|||
161221551|NCT01816477|582192976|FG001|Overall Study|Unable to tolerate catheter placement|0|||
161221552|NCT02162758|582192977|FG000|Overall Study|Study termination|0|||
161221553|NCT02162758|582192978|FG001|Overall Study|Study termination|1|||
161221554|NCT03213210|582192979|FG000|Overall Study|Lost to Follow-up|2|||
161221555|NCT03213210|582192979|FG000|Overall Study|Study termination|3|||
161221556|NCT01716754|582192980|FG000|Overall Study|Death|0|||
161221557|NCT01716754|582192981|FG001|Overall Study|Death|0|||
161221558|NCT01716754|582192982|FG002|Overall Study|Death|0|||
161221559|NCT01716754|582192983|FG003|Overall Study|Death|1|||
161221560|NCT01716754|582192980|FG000|Overall Study|Protocol deviation|0|||
161221561|NCT01716754|582192981|FG001|Overall Study|Protocol deviation|2|||
161221562|NCT01716754|582192982|FG002|Overall Study|Protocol deviation|7|||
161221563|NCT01716754|582192983|FG003|Overall Study|Protocol deviation|2|||
161221564|NCT01716754|582192980|FG000|Overall Study|Non-compliance with study treatment|0|||
161221565|NCT01716754|582192981|FG001|Overall Study|Non-compliance with study treatment|0|||
161221566|NCT01716754|582192982|FG002|Overall Study|Non-compliance with study treatment|1|||
161221567|NCT01716754|582192983|FG003|Overall Study|Non-compliance with study treatment|0|||
161221568|NCT01716754|582192980|FG000|Overall Study|Physician Decision|1|||
161221569|NCT01716754|582192981|FG001|Overall Study|Physician Decision|0|||
161221570|NCT01716754|582192982|FG002|Overall Study|Physician Decision|0|||
161221571|NCT01716754|582192983|FG003|Overall Study|Physician Decision|0|||
161221572|NCT01716754|582192980|FG000|Overall Study|Lost to Follow-up|1|||
161221573|NCT01716754|582192981|FG001|Overall Study|Lost to Follow-up|0|||
161221574|NCT01716754|582192982|FG002|Overall Study|Lost to Follow-up|0|||
161221575|NCT01716754|582192983|FG003|Overall Study|Lost to Follow-up|1|||
161221576|NCT01716754|582192980|FG000|Overall Study|Adverse Event|4|||
161221577|NCT01716754|582192981|FG001|Overall Study|Adverse Event|2|||
161221578|NCT01716754|582192982|FG002|Overall Study|Adverse Event|2|||
161221579|NCT01716754|582192983|FG003|Overall Study|Adverse Event|1|||
161221580|NCT01716754|582192980|FG000|Overall Study|Withdrawal by Subject|5|||
161221581|NCT01716754|582192981|FG001|Overall Study|Withdrawal by Subject|0|||
161221582|NCT01716754|582192982|FG002|Overall Study|Withdrawal by Subject|4|||
161221583|NCT01716754|582192983|FG003|Overall Study|Withdrawal by Subject|3|||
161221584|NCT02110706|582193001|FG000|Overall Study|Adverse Event|2|||
161221585|NCT02110706|582193002|FG001|Overall Study|Adverse Event|3|||
161221586|NCT02110706|582193001|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
161221587|NCT02110706|582193002|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
161221588|NCT00947427|582193004|FG000|Overall Study|Withdrawal by Subject|1|||
161221589|NCT00947427|582193005|FG001|Overall Study|Withdrawal by Subject|3|||
161221590|NCT00947427|582193004|FG000|Overall Study|Protocol Violation|0|||
161221591|NCT00947427|582193005|FG001|Overall Study|Protocol Violation|1|||
161221592|NCT01348542|582193007|FG000|Overall Study|Withdrawal by Subject|3|||
161221593|NCT01348542|582193008|FG001|Overall Study|Withdrawal by Subject|0|||
161221594|NCT02115256|582193020|FG000|Overall Study|Withdrawal by Subject|0|||
161221595|NCT02115256|582193021|FG001|Overall Study|Withdrawal by Subject|1|||
161221596|NCT01789320|582193024|FG000|Overall Study|Re-enrolled into study|1|||
161221597|NCT01789320|582193024|FG000|Overall Study|Lost to Follow-up|1|||
161221598|NCT01533428|582193033|FG000|Overall Study|Adverse Event|0|||
161221599|NCT01533428|582193034|FG001|Overall Study|Adverse Event|1|||
161221600|NCT01533428|582193033|FG000|Overall Study|Lost to Follow-up|2|||
161221601|NCT01533428|582193034|FG001|Overall Study|Lost to Follow-up|1|||
161221602|NCT01533428|582193033|FG000|Overall Study|Withdrawal by Subject|7|||
161221603|NCT01533428|582193034|FG001|Overall Study|Withdrawal by Subject|6|||
161221604|NCT02102490|582193038|FG000|Overall Study|Death|6|||
161221605|NCT02102490|582193038|FG000|Overall Study|Lost to Follow-up|1|||
161221606|NCT00095199|582193041|FG000|Overall Study|Adverse Event|40|||
161221607|NCT00095199|582193042|FG001|Overall Study|Adverse Event|22|||
161221608|NCT00095199|582193043|FG002|Overall Study|Adverse Event|26|||
161221609|NCT00095199|582193044|FG003|Overall Study|Adverse Event|11|||
161221610|NCT00095199|582193041|FG000|Overall Study|Progressive disease|213|||
161221611|NCT00095199|582193042|FG001|Overall Study|Progressive disease|179|||
161221612|NCT00095199|582193043|FG002|Overall Study|Progressive disease|105|||
161221613|NCT00095199|582193044|FG003|Overall Study|Progressive disease|98|||
161221614|NCT00095199|582193041|FG000|Overall Study|Death|10|||
161221615|NCT00095199|582193042|FG001|Overall Study|Death|6|||
161221616|NCT00095199|582193043|FG002|Overall Study|Death|11|||
161221617|NCT00095199|582193044|FG003|Overall Study|Death|9|||
161221618|NCT00095199|582193041|FG000|Overall Study|Withdrawal by Subject|21|||
161221619|NCT00095199|582193042|FG001|Overall Study|Withdrawal by Subject|16|||
161221620|NCT00095199|582193043|FG002|Overall Study|Withdrawal by Subject|13|||
161221621|NCT00095199|582193044|FG003|Overall Study|Withdrawal by Subject|22|||
161221622|NCT00095199|582193041|FG000|Overall Study|Protocol Violation|4|||
161221623|NCT00095199|582193042|FG001|Overall Study|Protocol Violation|4|||
161221624|NCT00095199|582193043|FG002|Overall Study|Protocol Violation|2|||
161221625|NCT00095199|582193044|FG003|Overall Study|Protocol Violation|0|||
161221626|NCT00095199|582193041|FG000|Overall Study|Liver function test results elevated|0|||
161257859|NCT02310789|582323503|FG000|Overall Study|Adverse Event|1|||
161117286|NCT02432235|581818518|FG008|Overall Study|Death|15|||
161117287|NCT02432235|581818519|FG009|Overall Study|Death|3|||
161117288|NCT02432235|581818520|FG010|Overall Study|Death|1|||
161117289|NCT02432235|581818521|FG011|Overall Study|Death|0|||
161117290|NCT02432235|581818510|FG000|Overall Study|Withdrawal by Subject|0|||
161117291|NCT02432235|581818511|FG001|Overall Study|Withdrawal by Subject|1|||
161117292|NCT02432235|581818512|FG002|Overall Study|Withdrawal by Subject|0|||
161117293|NCT02432235|581818513|FG003|Overall Study|Withdrawal by Subject|0|||
161117294|NCT02432235|581818514|FG004|Overall Study|Withdrawal by Subject|0|||
161117295|NCT02432235|581818515|FG005|Overall Study|Withdrawal by Subject|2|||
161117296|NCT02432235|581818516|FG006|Overall Study|Withdrawal by Subject|5|||
161117297|NCT02432235|581818517|FG007|Overall Study|Withdrawal by Subject|3|||
161117298|NCT02432235|581818518|FG008|Overall Study|Withdrawal by Subject|1|||
161117299|NCT02432235|581818519|FG009|Overall Study|Withdrawal by Subject|0|||
161117300|NCT02432235|581818520|FG010|Overall Study|Withdrawal by Subject|0|||
161117301|NCT02432235|581818521|FG011|Overall Study|Withdrawal by Subject|0|||
161117302|NCT02432235|581818510|FG000|Overall Study|Lost to Follow-up|0|||
161117303|NCT02432235|581818511|FG001|Overall Study|Lost to Follow-up|0|||
161117304|NCT02432235|581818512|FG002|Overall Study|Lost to Follow-up|0|||
161117305|NCT02432235|581818513|FG003|Overall Study|Lost to Follow-up|0|||
161117306|NCT02432235|581818514|FG004|Overall Study|Lost to Follow-up|0|||
161117307|NCT02432235|581818515|FG005|Overall Study|Lost to Follow-up|1|||
161117308|NCT02432235|581818516|FG006|Overall Study|Lost to Follow-up|0|||
161117309|NCT02432235|581818517|FG007|Overall Study|Lost to Follow-up|0|||
161117310|NCT02432235|581818518|FG008|Overall Study|Lost to Follow-up|1|||
161117311|NCT02432235|581818519|FG009|Overall Study|Lost to Follow-up|0|||
161117312|NCT02432235|581818520|FG010|Overall Study|Lost to Follow-up|0|||
161117313|NCT02432235|581818521|FG011|Overall Study|Lost to Follow-up|0|||
161117314|NCT02432235|581818510|FG000|Overall Study|Miscellaneous|0|||
161117315|NCT02432235|581818511|FG001|Overall Study|Miscellaneous|0|||
161117316|NCT02432235|581818512|FG002|Overall Study|Miscellaneous|0|||
161117317|NCT02432235|581818513|FG003|Overall Study|Miscellaneous|0|||
161117318|NCT02432235|581818514|FG004|Overall Study|Miscellaneous|1|||
161117319|NCT02432235|581818515|FG005|Overall Study|Miscellaneous|6|||
161117320|NCT02432235|581818516|FG006|Overall Study|Miscellaneous|2|||
161117321|NCT02432235|581818517|FG007|Overall Study|Miscellaneous|2|||
161117322|NCT02432235|581818518|FG008|Overall Study|Miscellaneous|4|||
161117323|NCT02432235|581818519|FG009|Overall Study|Miscellaneous|0|||
161117324|NCT02432235|581818520|FG010|Overall Study|Miscellaneous|0|||
161117325|NCT02432235|581818521|FG011|Overall Study|Miscellaneous|1|||
161117326|NCT00401752|581818522|FG000|Overall Study|Adverse Event|2|||
161117327|NCT00401752|581818523|FG001|Overall Study|Adverse Event|5|||
161221627|NCT00095199|582193042|FG001|Overall Study|Liver function test results elevated|0|||
161221628|NCT00095199|582193043|FG002|Overall Study|Liver function test results elevated|1|||
161221629|NCT00095199|582193044|FG003|Overall Study|Liver function test results elevated|1|||
161221630|NCT00095199|582193041|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
161221631|NCT00095199|582193042|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
161221632|NCT00095199|582193043|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
161117328|NCT00401752|581818522|FG000|Overall Study|Withdrawal by Subject|2|||
161117329|NCT00401752|581818523|FG001|Overall Study|Withdrawal by Subject|6|||
161117330|NCT00401752|581818522|FG000|Overall Study|Lost to Follow-up|1|||
161117331|NCT00401752|581818523|FG001|Overall Study|Lost to Follow-up|4|||
161117332|NCT00401752|581818522|FG000|Overall Study|Development of any exclusion criteria|4|||
161117333|NCT00401752|581818523|FG001|Overall Study|Development of any exclusion criteria|2|||
161221633|NCT00095199|582193044|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
161221634|NCT00095199|582193041|FG000|Overall Study|Physician Decision|5|||
161221635|NCT00095199|582193042|FG001|Overall Study|Physician Decision|6|||
161221636|NCT00095199|582193043|FG002|Overall Study|Physician Decision|1|||
161117334|NCT00401752|581818522|FG000|Overall Study|Physician Decision|1|||
161117335|NCT00401752|581818523|FG001|Overall Study|Physician Decision|1|||
161117336|NCT01347554|581818524|FG000|Overall Study|Lack of Efficacy|7|||
161117337|NCT01347554|581818525|FG001|Overall Study|Lack of Efficacy|11|||
161117338|NCT03603496|581818526|FG000|Overall Study|Death|19|||
161117339|NCT03603496|581818527|FG001|Overall Study|Death|24|||
161117340|NCT03603496|581818526|FG000|Overall Study|Lost to Follow-up|141|||
161117341|NCT03603496|581818527|FG001|Overall Study|Lost to Follow-up|141|||
161117342|NCT03603496|581818526|FG000|Overall Study|Withdrawal by Subject|26|||
161117343|NCT03603496|581818527|FG001|Overall Study|Withdrawal by Subject|20|||
161117344|NCT00004259|581818528|FG000|Overall Study|Protocol Violation|1|||
161117345|NCT00004259|581818529|FG001|Overall Study|Protocol Violation|2|||
161117346|NCT00004259|581818530|FG002|Overall Study|Protocol Violation|0|||
161117347|NCT00004259|581818531|FG003|Overall Study|Protocol Violation|0|||
161117348|NCT00004259|581818528|FG000|Overall Study|Withdrawal by Subject|0|||
161117349|NCT00004259|581818529|FG001|Overall Study|Withdrawal by Subject|2|||
161117350|NCT00004259|581818530|FG002|Overall Study|Withdrawal by Subject|0|||
161117351|NCT00004259|581818531|FG003|Overall Study|Withdrawal by Subject|0|||
161117352|NCT03594227|581818532|FG000|Overall Study|Adverse Event|2|||
161117353|NCT03594227|581818533|FG001|Overall Study|Adverse Event|1|||
161221637|NCT00095199|582193044|FG003|Overall Study|Physician Decision|1|||
161221638|NCT00095199|582193041|FG000|Overall Study|Not eligible|1|||
161221639|NCT00095199|582193042|FG001|Overall Study|Not eligible|7|||
161221640|NCT00095199|582193043|FG002|Overall Study|Not eligible|0|||
161221641|NCT00095199|582193044|FG003|Overall Study|Not eligible|1|||
161221642|NCT00095199|582193041|FG000|Overall Study|Started Palliative Radiotherapy|1|||
161221643|NCT00095199|582193042|FG001|Overall Study|Started Palliative Radiotherapy|0|||
161221644|NCT00095199|582193043|FG002|Overall Study|Started Palliative Radiotherapy|0|||
161221645|NCT00095199|582193044|FG003|Overall Study|Started Palliative Radiotherapy|0|||
161221646|NCT00095199|582193041|FG000|Overall Study|Started radiotherapy regimen|0|||
161221647|NCT00095199|582193042|FG001|Overall Study|Started radiotherapy regimen|1|||
161221648|NCT00095199|582193043|FG002|Overall Study|Started radiotherapy regimen|0|||
161221649|NCT00095199|582193044|FG003|Overall Study|Started radiotherapy regimen|0|||
161221650|NCT00095199|582193041|FG000|Overall Study|Primary tumor removed in other surgery|0|||
161221651|NCT00095199|582193042|FG001|Overall Study|Primary tumor removed in other surgery|1|||
161221652|NCT00095199|582193043|FG002|Overall Study|Primary tumor removed in other surgery|0|||
161221653|NCT00095199|582193044|FG003|Overall Study|Primary tumor removed in other surgery|0|||
161221654|NCT00095199|582193041|FG000|Overall Study|Data inadvertently lost by site|1|||
161221655|NCT00095199|582193042|FG001|Overall Study|Data inadvertently lost by site|0|||
161221656|NCT00095199|582193043|FG002|Overall Study|Data inadvertently lost by site|0|||
161221657|NCT00095199|582193044|FG003|Overall Study|Data inadvertently lost by site|0|||
161221658|NCT03896490|582193079|FG000|Overall Study|Withdrawal by Subject|1|||
161221659|NCT03896490|582193080|FG001|Overall Study|Withdrawal by Subject|1|||
161221660|NCT00385541|582193083|FG000|Overall Study|severe pain, clinician requested unblind|0|||
161221661|NCT00385541|582193084|FG001|Overall Study|severe pain, clinician requested unblind|1|||
161221662|NCT00929708|582193085|FG000|Overall Study|Protocol Violation|2|||
161221663|NCT00929708|582193086|FG001|Overall Study|Protocol Violation|1|||
161221664|NCT00929708|582193087|FG002|Overall Study|Protocol Violation|1|||
161221665|NCT00929708|582193088|FG003|Overall Study|Protocol Violation|1|||
161221666|NCT00929708|582193089|FG004|Overall Study|Protocol Violation|1|||
161221667|NCT00929708|582193085|FG000|Overall Study|Withdrawal by Subject|2|||
161221668|NCT00929708|582193086|FG001|Overall Study|Withdrawal by Subject|0|||
161221669|NCT00929708|582193087|FG002|Overall Study|Withdrawal by Subject|0|||
161221670|NCT00929708|582193088|FG003|Overall Study|Withdrawal by Subject|2|||
161221671|NCT00929708|582193089|FG004|Overall Study|Withdrawal by Subject|1|||
161221672|NCT00929708|582193085|FG000|Overall Study|Adverse Event|0|||
161221673|NCT00929708|582193086|FG001|Overall Study|Adverse Event|0|||
161221674|NCT00929708|582193087|FG002|Overall Study|Adverse Event|0|||
161221675|NCT00929708|582193088|FG003|Overall Study|Adverse Event|0|||
161221676|NCT00929708|582193089|FG004|Overall Study|Adverse Event|3|||
161221677|NCT00929708|582193085|FG000|Overall Study|Physician Decision|0|||
161221678|NCT00929708|582193086|FG001|Overall Study|Physician Decision|2|||
161221679|NCT00929708|582193087|FG002|Overall Study|Physician Decision|2|||
161221680|NCT00929708|582193088|FG003|Overall Study|Physician Decision|2|||
161221681|NCT00929708|582193089|FG004|Overall Study|Physician Decision|1|||
161221682|NCT00929708|582193085|FG000|Overall Study|Lost to Follow-up|0|||
161221683|NCT00929708|582193086|FG001|Overall Study|Lost to Follow-up|0|||
161221684|NCT00929708|582193087|FG002|Overall Study|Lost to Follow-up|0|||
161221685|NCT00929708|582193088|FG003|Overall Study|Lost to Follow-up|1|||
161221686|NCT00929708|582193089|FG004|Overall Study|Lost to Follow-up|0|||
161221687|NCT03495869|582193090|FG000|Overall Study|Lost to Follow-up|4|||
161221688|NCT03495869|582193091|FG001|Overall Study|Lost to Follow-up|17|||
161221689|NCT03495869|582193092|FG002|Overall Study|Lost to Follow-up|8|||
161221690|NCT03495869|582193093|FG003|Overall Study|Lost to Follow-up|14|||
161221691|NCT03495869|582193090|FG000|Overall Study|Withdrawal by Subject|0|||
161221692|NCT03495869|582193091|FG001|Overall Study|Withdrawal by Subject|3|||
161221693|NCT03495869|582193092|FG002|Overall Study|Withdrawal by Subject|0|||
161221694|NCT03495869|582193093|FG003|Overall Study|Withdrawal by Subject|3|||
161221695|NCT03495869|582193090|FG000|Overall Study|Dropped from study|0|||
161221696|NCT03495869|582193091|FG001|Overall Study|Dropped from study|7|||
161221697|NCT03495869|582193092|FG002|Overall Study|Dropped from study|2|||
161221698|NCT03495869|582193093|FG003|Overall Study|Dropped from study|4|||
161221699|NCT02154529|582193094|FG000|Overall Study|Death|1|||
161221700|NCT02154529|582193095|FG001|Overall Study|Death|1|||
161221701|NCT02154529|582193096|FG002|Overall Study|Death|5|||
161221702|NCT02154529|582193097|FG003|Overall Study|Death|1|||
161221703|NCT02154529|582193094|FG000|Overall Study|Termination of study by sponsor|2|||
161221704|NCT02154529|582193095|FG001|Overall Study|Termination of study by sponsor|2|||
161221705|NCT02154529|582193096|FG002|Overall Study|Termination of study by sponsor|3|||
161221706|NCT02154529|582193097|FG003|Overall Study|Termination of study by sponsor|1|||
160874472|NCT00387790|580934216|FG000|Overall Study|Physician Decision|2|||
160874473|NCT00387790|580934216|FG000|Overall Study|Withdrawal by Subject|3|||
161221707|NCT02154529|582193094|FG000|Overall Study|Lost to Follow-up|1|||
161221708|NCT02154529|582193095|FG001|Overall Study|Lost to Follow-up|0|||
161221709|NCT02154529|582193096|FG002|Overall Study|Lost to Follow-up|0|||
161221710|NCT02154529|582193097|FG003|Overall Study|Lost to Follow-up|0|||
161257860|NCT01197417|582323504|FG000|Overall Study|Physician Decision|3|||
161117354|NCT03594227|581818534|FG002|Overall Study|Adverse Event|0|||
161117355|NCT03594227|581818535|FG003|Overall Study|Adverse Event|2|||
161117356|NCT03594227|581818532|FG000|Overall Study|Lost to Follow-up|1|||
161117357|NCT03594227|581818533|FG001|Overall Study|Lost to Follow-up|1|||
161117358|NCT03594227|581818534|FG002|Overall Study|Lost to Follow-up|1|||
161117359|NCT03594227|581818535|FG003|Overall Study|Lost to Follow-up|0|||
161117360|NCT03594227|581818532|FG000|Overall Study|Withdrawal by Subject|1|||
161117361|NCT03594227|581818533|FG001|Overall Study|Withdrawal by Subject|1|||
161117362|NCT03594227|581818534|FG002|Overall Study|Withdrawal by Subject|1|||
161117363|NCT03594227|581818535|FG003|Overall Study|Withdrawal by Subject|1|||
161117364|NCT03594227|581818532|FG000|Overall Study|Pregnancy|0|||
161117365|NCT03594227|581818533|FG001|Overall Study|Pregnancy|1|||
161117366|NCT03594227|581818534|FG002|Overall Study|Pregnancy|0|||
161117367|NCT03594227|581818535|FG003|Overall Study|Pregnancy|0|||
161117368|NCT03594227|581818532|FG000|Overall Study|Sponsor Decision|0|||
161117369|NCT03594227|581818533|FG001|Overall Study|Sponsor Decision|0|||
161117370|NCT03594227|581818534|FG002|Overall Study|Sponsor Decision|0|||
161117371|NCT03594227|581818535|FG003|Overall Study|Sponsor Decision|1|||
161117372|NCT03594227|581818532|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
161117373|NCT03594227|581818533|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
161117374|NCT03594227|581818534|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
161117375|NCT03594227|581818535|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
161117376|NCT01618214|581818541|FG000|Overall Study|Adverse Event|3|||
161117377|NCT01618214|581818542|FG001|Overall Study|Adverse Event|1|||
161117378|NCT01618214|581818541|FG000|Overall Study|Lack of Efficacy|1|||
161117379|NCT01618214|581818542|FG001|Overall Study|Lack of Efficacy|1|||
161117380|NCT01618214|581818541|FG000|Overall Study|Protocol Violation|1|||
161117381|NCT01618214|581818542|FG001|Overall Study|Protocol Violation|4|||
161117382|NCT01618214|581818541|FG000|Overall Study|Withdrawal Criteria|1|||
161117383|NCT01618214|581818542|FG001|Overall Study|Withdrawal Criteria|2|||
161117384|NCT01618214|581818541|FG000|Overall Study|Unclassified|4|||
161117385|NCT01618214|581818542|FG001|Overall Study|Unclassified|5|||
161117386|NCT02873936|581818548|FG000|Overall Study|Withdrew Consent|4|||
161117387|NCT02873936|581818549|FG001|Overall Study|Withdrew Consent|11|||
161117388|NCT02873936|581818550|FG002|Overall Study|Withdrew Consent|20|||
161117389|NCT02873936|581818548|FG000|Overall Study|Investigator's Discretion|3|||
161117390|NCT02873936|581818549|FG001|Overall Study|Investigator's Discretion|5|||
161117391|NCT02873936|581818550|FG002|Overall Study|Investigator's Discretion|4|||
161117392|NCT02873936|581818548|FG000|Overall Study|Adverse Event|3|||
161117393|NCT02873936|581818549|FG001|Overall Study|Adverse Event|5|||
161117394|NCT02873936|581818550|FG002|Overall Study|Adverse Event|3|||
161117395|NCT02873936|581818548|FG000|Overall Study|Protocol Violation|0|||
161117396|NCT02873936|581818549|FG001|Overall Study|Protocol Violation|1|||
161117397|NCT02873936|581818550|FG002|Overall Study|Protocol Violation|3|||
161117398|NCT02873936|581818548|FG000|Overall Study|Lost to Follow-up|1|||
161117399|NCT02873936|581818549|FG001|Overall Study|Lost to Follow-up|1|||
161117400|NCT02873936|581818550|FG002|Overall Study|Lost to Follow-up|1|||
161117401|NCT02873936|581818548|FG000|Overall Study|Non-compliance With Study Drug|1|||
161117402|NCT02873936|581818549|FG001|Overall Study|Non-compliance With Study Drug|0|||
161117403|NCT02873936|581818550|FG002|Overall Study|Non-compliance With Study Drug|1|||
161117404|NCT02873936|581818548|FG000|Overall Study|Randomized but not Dosed|1|||
161117405|NCT02873936|581818549|FG001|Overall Study|Randomized but not Dosed|0|||
161117406|NCT02873936|581818550|FG002|Overall Study|Randomized but not Dosed|0|||
161117407|NCT02054897|581818552|FG000|Overall Study|Withdrawal by Subject|2|||
161117408|NCT02054897|581818553|FG001|Overall Study|Withdrawal by Subject|0|||
161117409|NCT02054897|581818554|FG002|Overall Study|Withdrawal by Subject|2|||
161117410|NCT02054897|581818552|FG000|Overall Study|Missing follow-up information|3|||
161257861|NCT01197417|582323505|FG001|Overall Study|Physician Decision|2|||
160874474|NCT00387790|580934216|FG000|Overall Study|Ineligible for study|2|||
160874475|NCT03860259|580934223|FG000|Overall Study|Lost to Follow-up|5|||
160874476|NCT03860259|580934224|FG001|Overall Study|Lost to Follow-up|5|||
160874477|NCT03860259|580934223|FG000|Overall Study|Protocol Violation|1|||
160874478|NCT03860259|580934224|FG001|Overall Study|Protocol Violation|0|||
161117411|NCT02054897|581818553|FG001|Overall Study|Missing follow-up information|5|||
161117412|NCT02054897|581818554|FG002|Overall Study|Missing follow-up information|3|||
161117413|NCT02054897|581818552|FG000|Overall Study|Lost to Follow-up|4|||
161117414|NCT02054897|581818553|FG001|Overall Study|Lost to Follow-up|2|||
161117415|NCT02054897|581818554|FG002|Overall Study|Lost to Follow-up|7|||
161117416|NCT02054897|581818552|FG000|Overall Study|Randomized but not exposed|1|||
161117417|NCT02054897|581818553|FG001|Overall Study|Randomized but not exposed|0|||
161117418|NCT02054897|581818554|FG002|Overall Study|Randomized but not exposed|0|||
161117419|NCT01508702|581818559|FG000|Overall Study|Adverse Event|7|||
161117420|NCT01508702|581818560|FG001|Overall Study|Adverse Event|3|||
161117421|NCT01508702|581818559|FG000|Overall Study|Gout flare|2|||
161117422|NCT01508702|581818560|FG001|Overall Study|Gout flare|0|||
161117423|NCT01508702|581818559|FG000|Overall Study|Protocol Violation|2|||
161117424|NCT01508702|581818560|FG001|Overall Study|Protocol Violation|1|||
161117425|NCT01508702|581818559|FG000|Overall Study|Lost to Follow-up|1|||
161117426|NCT01508702|581818560|FG001|Overall Study|Lost to Follow-up|2|||
161117427|NCT01508702|581818559|FG000|Overall Study|Withdrawal by Subject|11|||
161117428|NCT01508702|581818560|FG001|Overall Study|Withdrawal by Subject|7|||
161117429|NCT04472429|581818561|FG000|Randomized Period|Ongoing|90|||
161117430|NCT04472429|581818562|FG001|Randomized Period|Ongoing|40|||
161117431|NCT04472429|581818563|FG002|Randomized Period|Ongoing|0|||
161117432|NCT04472429|581818561|FG000|Randomized Period|Death|52|||
161117433|NCT04472429|581818562|FG001|Randomized Period|Death|37|||
161117434|NCT04472429|581818563|FG002|Randomized Period|Death|0|||
161117435|NCT04472429|581818561|FG000|Randomized Period|Lost to Follow-up|4|||
161117436|NCT04472429|581818562|FG001|Randomized Period|Lost to Follow-up|0|||
161117437|NCT04472429|581818563|FG002|Randomized Period|Lost to Follow-up|0|||
161117438|NCT04472429|581818561|FG000|Randomized Period|Physician Decision|1|||
161117439|NCT04472429|581818562|FG001|Randomized Period|Physician Decision|2|||
161117440|NCT04472429|581818563|FG002|Randomized Period|Physician Decision|0|||
161117441|NCT04472429|581818561|FG000|Randomized Period|Withdrawal by Subject|6|||
161117442|NCT04472429|581818562|FG001|Randomized Period|Withdrawal by Subject|5|||
161117443|NCT04472429|581818563|FG002|Randomized Period|Withdrawal by Subject|0|||
161117444|NCT04472429|581818561|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
161117445|NCT04472429|581818562|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
161117446|NCT04472429|581818563|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
161117447|NCT04472429|581818561|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
161117448|NCT04472429|581818562|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
161117449|NCT04472429|581818563|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
161117450|NCT04472429|581818561|FG000|Open-label Monotherapy Period|Ongoing|0|||
161117451|NCT04472429|581818562|FG001|Open-label Monotherapy Period|Ongoing|0|||
161117452|NCT04472429|581818563|FG002|Open-label Monotherapy Period|Ongoing|32|||
161117453|NCT04472429|581818561|FG000|Open-label Monotherapy Period|Death|0|||
161117454|NCT04472429|581818562|FG001|Open-label Monotherapy Period|Death|0|||
161117455|NCT04472429|581818563|FG002|Open-label Monotherapy Period|Death|35|||
161117456|NCT04472429|581818561|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
161117457|NCT04472429|581818562|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
161117458|NCT04472429|581818563|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
161117459|NCT01180660|581818564|FG000|Overall Study|Changed to open surgery|1|||
161117460|NCT01180660|581818565|FG001|Overall Study|Changed to open surgery|0|||
161117461|NCT00250835|581818566|FG000|Overall Study|Withdrawal by Subject|1|||
161117462|NCT03461757|581818567|FG000|Overall Study|Adverse Event|1|||
161117463|NCT03461757|581818568|FG001|Overall Study|Adverse Event|0|||
161117464|NCT03461757|581818567|FG000|Overall Study|Lost to Follow-up|13|||
161117465|NCT03461757|581818568|FG001|Overall Study|Lost to Follow-up|7|||
161117466|NCT03461757|581818567|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
161117467|NCT03461757|581818568|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
161117468|NCT03461757|581818567|FG000|Overall Study|Non-compliance with study treatment|0|||
161117469|NCT03461757|581818568|FG001|Overall Study|Non-compliance with study treatment|1|||
161117470|NCT03461757|581818567|FG000|Overall Study|Pregnancy|2|||
161117471|NCT03461757|581818568|FG001|Overall Study|Pregnancy|0|||
161117472|NCT03461757|581818567|FG000|Overall Study|Protocol Violation|1|||
161117473|NCT03461757|581818568|FG001|Overall Study|Protocol Violation|1|||
161117474|NCT03461757|581818567|FG000|Overall Study|Withdrawal by Subject|7|||
161117475|NCT03461757|581818568|FG001|Overall Study|Withdrawal by Subject|7|||
161117476|NCT03461757|581818567|FG000|Overall Study|Other Reasons|1|||
161117477|NCT03461757|581818568|FG001|Overall Study|Other Reasons|4|||
161117478|NCT03861559|581818569|FG000|Overall Study|Adverse Event|0|||
161117479|NCT03861559|581818570|FG001|Overall Study|Adverse Event|2|||
161117480|NCT03861559|581818569|FG000|Overall Study|Treatment failure|0|||
161117481|NCT03861559|581818570|FG001|Overall Study|Treatment failure|2|||
161117482|NCT03861559|581818569|FG000|Overall Study|Noncompliance|1|||
161117483|NCT03861559|581818570|FG001|Overall Study|Noncompliance|1|||
161117484|NCT03861559|581818569|FG000|Overall Study|Did not meet eligibility requirements|1|||
161117485|NCT03861559|581818570|FG001|Overall Study|Did not meet eligibility requirements|0|||
161117486|NCT00879697|581818573|FG000|Overall Study|Physician Decision|2|||
161117487|NCT00879697|581818574|FG001|Overall Study|Physician Decision|2|||
161117488|NCT01836783|581818579|FG000|Overall Study|Withdrawal by Subject|0|||
161117489|NCT01836783|581818580|FG001|Overall Study|Withdrawal by Subject|2|||
161117490|NCT04489888|581818584|FG000|Overall Study|Death|75|||
161117491|NCT04489888|581818584|FG000|Overall Study|Sponsor Decision|26|||
161117492|NCT03829657|581818592|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
161117493|NCT03829657|581818593|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
161117494|NCT03829657|581818594|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
161117495|NCT03829657|581818595|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
161117496|NCT03829657|581818596|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
161117497|NCT03829657|581818592|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
161117498|NCT03829657|581818593|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161117499|NCT03829657|581818594|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161117500|NCT03829657|581818595|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161117501|NCT03829657|581818596|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161117502|NCT03829657|581818592|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
161117503|NCT03829657|581818593|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
161117504|NCT03829657|581818594|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
161117505|NCT03829657|581818595|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
161117506|NCT03829657|581818596|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
161117507|NCT03829657|581818592|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
161117508|NCT03829657|581818593|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
161117509|NCT03829657|581818594|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
161117510|NCT03829657|581818595|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161117511|NCT03829657|581818596|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161117512|NCT03829657|581818592|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
161117513|NCT03829657|581818593|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
161117514|NCT03829657|581818594|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
161117515|NCT03829657|581818595|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
161117516|NCT03829657|581818596|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
161117517|NCT03829657|581818592|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
161117518|NCT03829657|581818593|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
161117519|NCT03829657|581818594|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
161117520|NCT03829657|581818595|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
161117521|NCT03829657|581818596|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
161117522|NCT03829657|581818592|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161117523|NCT03829657|581818593|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161117524|NCT03829657|581818594|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161117525|NCT03829657|581818595|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
161117526|NCT03829657|581818596|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
161117527|NCT03829657|581818592|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161117528|NCT03829657|581818593|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161117529|NCT03829657|581818594|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
161117530|NCT03829657|581818595|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
161117531|NCT03829657|581818596|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
161117532|NCT03829657|581818592|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161117533|NCT03829657|581818593|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161117534|NCT03829657|581818594|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
161117535|NCT03829657|581818595|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
161117536|NCT03829657|581818596|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
161117537|NCT03829657|581818592|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161117538|NCT03829657|581818593|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161117539|NCT03829657|581818594|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161117540|NCT03829657|581818595|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
161117541|NCT03829657|581818596|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
161117542|NCT04418076|581818597|FG000|Overall Study|Death|1|||
161117543|NCT04418076|581818598|FG001|Overall Study|Death|0|||
161117544|NCT04418076|581818599|FG002|Overall Study|Death|0|||
161117545|NCT04418076|581818600|FG003|Overall Study|Death|0|||
161117546|NCT04418076|581818597|FG000|Overall Study|Lost to Follow-up|2|||
161221711|NCT05440097|582194137|FG000|Overall Study|Withdrawal by Subject|154|||
161221712|NCT05440097|582194137|FG000|Overall Study|Death|2|||
161221713|NCT05440097|582194137|FG000|Overall Study|Physician Decision|2|||
161221714|NCT05440097|582194137|FG000|Overall Study|Lost to Follow-up|56|||
161221715|NCT05440097|582194137|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
161221716|NCT02081599|582194138|FG000|Period 1：Double-blind Period|Adverse Event|3|||
160874479|NCT02280408|580934225|FG000|Overall Study|Lost to Follow-up|0|||
160874480|NCT02280408|580934226|FG001|Overall Study|Lost to Follow-up|2|||
160874481|NCT02280408|580934227|FG002|Overall Study|Lost to Follow-up|0|||
160874482|NCT02280408|580934228|FG003|Overall Study|Lost to Follow-up|0|||
160874483|NCT00486291|580934234|FG000|Overall Study|Adverse Event|3|||
161221717|NCT02081599|582194139|FG001|Period 1：Double-blind Period|Adverse Event|0|||
161221718|NCT02081599|582194138|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
161221719|NCT02081599|582194139|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
161221720|NCT02081599|582194138|FG000|Period 1：Double-blind Period|Physician Decision|1|||
161221721|NCT02081599|582194139|FG001|Period 1：Double-blind Period|Physician Decision|0|||
161221722|NCT02081599|582194138|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
161221723|NCT02081599|582194139|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
161221724|NCT02081599|582194138|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
161221725|NCT02081599|582194139|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
161221726|NCT02081599|582194138|FG000|Period 1：Double-blind Period|stopping criteria|1|||
161221727|NCT02081599|582194139|FG001|Period 1：Double-blind Period|stopping criteria|0|||
161221728|NCT02081599|582194138|FG000|Period 2：Open-label Period|Adverse Event|1|||
161221729|NCT02081599|582194139|FG001|Period 2：Open-label Period|Adverse Event|0|||
161221730|NCT02081599|582194138|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
161221731|NCT02081599|582194139|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
161221732|NCT02081599|582194138|FG000|Period 2：Open-label Period|Physician Decision|1|||
161221733|NCT02081599|582194139|FG001|Period 2：Open-label Period|Physician Decision|0|||
161221734|NCT02081599|582194138|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
161221735|NCT02081599|582194139|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
161221736|NCT02146430|582194149|FG000|Overall Study|Protocol Violation|5|||
161221737|NCT02146430|582194150|FG001|Overall Study|Protocol Violation|4|||
161221738|NCT02146430|582194151|FG002|Overall Study|Protocol Violation|8|||
161221739|NCT02146430|582194152|FG003|Overall Study|Protocol Violation|6|||
161221740|NCT02146430|582194149|FG000|Overall Study|Lack of Efficacy|13|||
161221741|NCT02146430|582194150|FG001|Overall Study|Lack of Efficacy|11|||
161221742|NCT02146430|582194151|FG002|Overall Study|Lack of Efficacy|8|||
161221743|NCT02146430|582194152|FG003|Overall Study|Lack of Efficacy|5|||
161221744|NCT02146430|582194149|FG000|Overall Study|Adverse Event|20|||
161221745|NCT02146430|582194150|FG001|Overall Study|Adverse Event|40|||
161221746|NCT02146430|582194151|FG002|Overall Study|Adverse Event|32|||
161221747|NCT02146430|582194152|FG003|Overall Study|Adverse Event|49|||
161221748|NCT02146430|582194149|FG000|Overall Study|Reason missing or not reported|2|||
161221749|NCT02146430|582194150|FG001|Overall Study|Reason missing or not reported|3|||
161221750|NCT02146430|582194151|FG002|Overall Study|Reason missing or not reported|4|||
161221751|NCT02146430|582194152|FG003|Overall Study|Reason missing or not reported|5|||
161221752|NCT02146430|582194149|FG000|Overall Study|Withdrawal by Subject|27|||
161221753|NCT02146430|582194150|FG001|Overall Study|Withdrawal by Subject|29|||
161221754|NCT02146430|582194151|FG002|Overall Study|Withdrawal by Subject|30|||
161221755|NCT02146430|582194152|FG003|Overall Study|Withdrawal by Subject|34|||
161221756|NCT03312530|582194153|FG000|Overall Study|Death|5|||
161221757|NCT03312530|582194154|FG001|Overall Study|Death|5|||
161221758|NCT03312530|582194155|FG002|Overall Study|Death|4|||
161221759|NCT03312530|582194156|FG003|Overall Study|Death|10|||
161221760|NCT03312530|582194157|FG004|Overall Study|Death|8|||
161221761|NCT03312530|582194153|FG000|Overall Study|Lost to Follow-up|0|||
161221762|NCT03312530|582194154|FG001|Overall Study|Lost to Follow-up|0|||
161221763|NCT03312530|582194155|FG002|Overall Study|Lost to Follow-up|0|||
161221764|NCT03312530|582194156|FG003|Overall Study|Lost to Follow-up|1|||
161221765|NCT03312530|582194157|FG004|Overall Study|Lost to Follow-up|0|||
161221766|NCT03312530|582194153|FG000|Overall Study|Participant in another sponsor study.|0|||
161221767|NCT03312530|582194154|FG001|Overall Study|Participant in another sponsor study.|0|||
161221768|NCT03312530|582194155|FG002|Overall Study|Participant in another sponsor study.|0|||
161221769|NCT03312530|582194156|FG003|Overall Study|Participant in another sponsor study.|1|||
161221770|NCT03312530|582194157|FG004|Overall Study|Participant in another sponsor study.|0|||
161221771|NCT03312530|582194153|FG000|Overall Study|Study terminated by sponsor|1|||
161221772|NCT03312530|582194154|FG001|Overall Study|Study terminated by sponsor|0|||
161221773|NCT03312530|582194155|FG002|Overall Study|Study terminated by sponsor|2|||
161221774|NCT03312530|582194156|FG003|Overall Study|Study terminated by sponsor|3|||
161221775|NCT03312530|582194157|FG004|Overall Study|Study terminated by sponsor|7|||
161221776|NCT03312530|582194153|FG000|Overall Study|Withdrawal by Subject|0|||
161221777|NCT03312530|582194154|FG001|Overall Study|Withdrawal by Subject|1|||
161221778|NCT03312530|582194155|FG002|Overall Study|Withdrawal by Subject|0|||
161221779|NCT03312530|582194156|FG003|Overall Study|Withdrawal by Subject|0|||
161221780|NCT03312530|582194157|FG004|Overall Study|Withdrawal by Subject|0|||
161221781|NCT03312530|582194153|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161221782|NCT03312530|582194154|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161221783|NCT03312530|582194155|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161221784|NCT03312530|582194156|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
161221785|NCT03312530|582194157|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
161221786|NCT03093324|582194158|FG000|Overall Study|Adverse Event|4|||
161221787|NCT03093324|582194159|FG001|Overall Study|Adverse Event|15|||
161221788|NCT03093324|582194158|FG000|Overall Study|Lost to Follow-up|1|||
161221789|NCT03093324|582194159|FG001|Overall Study|Lost to Follow-up|0|||
161221790|NCT03093324|582194158|FG000|Overall Study|Protocol Deviation|2|||
161221791|NCT03093324|582194159|FG001|Overall Study|Protocol Deviation|2|||
161221792|NCT03093324|582194158|FG000|Overall Study|Withdrawal by Subject|2|||
161221793|NCT03093324|582194159|FG001|Overall Study|Withdrawal by Subject|2|||
161221794|NCT01767597|582194160|FG000|Overall Study|Incomplete intervention|3|||
161221795|NCT01767597|582194161|FG001|Overall Study|Incomplete intervention|1|||
161221796|NCT01767597|582194160|FG000|Overall Study|Withdrawal by Subject|1|||
161221797|NCT01767597|582194161|FG001|Overall Study|Withdrawal by Subject|0|||
161221798|NCT05342753|582194162|FG000|Overall Study|Withdrawal by Subject|6|||
161221799|NCT05342753|582194162|FG000|Overall Study|Lost to Follow-up|1|||
161221800|NCT00614055|582194165|FG000|Overall Study|Adverse Event|1|||
161221801|NCT00614055|582194166|FG001|Overall Study|Adverse Event|0|||
161221802|NCT00614055|582194167|FG002|Overall Study|Adverse Event|0|||
161221803|NCT00614055|582194165|FG000|Overall Study|Protocol Violation|2|||
161221804|NCT00614055|582194166|FG001|Overall Study|Protocol Violation|2|||
161221805|NCT00614055|582194167|FG002|Overall Study|Protocol Violation|1|||
161221806|NCT00614055|582194165|FG000|Overall Study|Lack of Efficacy|0|||
161221807|NCT00614055|582194166|FG001|Overall Study|Lack of Efficacy|0|||
161221808|NCT00614055|582194167|FG002|Overall Study|Lack of Efficacy|2|||
161221809|NCT00614055|582194165|FG000|Overall Study|Unclassified|1|||
161221810|NCT00614055|582194166|FG001|Overall Study|Unclassified|4|||
161221811|NCT00614055|582194167|FG002|Overall Study|Unclassified|2|||
161221812|NCT04583579|582194170|FG000|Overall Study|Lost to Follow-up|4|||
161221813|NCT02006706|582194172|FG000|Overall Study|Lost to Follow-up|1|||
161221814|NCT05590585|582194173|FG000|Overall Study|Lost to Follow-up|3|||
161221815|NCT05590585|582194173|FG000|Overall Study|Withdrawal by Subject|1|||
161117547|NCT04418076|581818598|FG001|Overall Study|Lost to Follow-up|5|||
161117548|NCT04418076|581818599|FG002|Overall Study|Lost to Follow-up|1|||
161117549|NCT04418076|581818600|FG003|Overall Study|Lost to Follow-up|2|||
161117550|NCT04418076|581818597|FG000|Overall Study|Withdrawal by Subject|1|||
161117551|NCT04418076|581818598|FG001|Overall Study|Withdrawal by Subject|0|||
161117552|NCT04418076|581818599|FG002|Overall Study|Withdrawal by Subject|1|||
161117553|NCT04418076|581818600|FG003|Overall Study|Withdrawal by Subject|1|||
161117554|NCT04418076|581818597|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
161117555|NCT04418076|581818598|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
161117556|NCT04418076|581818599|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
161117557|NCT04418076|581818600|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
161117558|NCT00562588|581818604|FG000|Overall Study|Adverse Event|40|||
161117559|NCT00562588|581818605|FG001|Overall Study|Adverse Event|58|||
161117560|NCT00562588|581818604|FG000|Overall Study|Protocol Violation|30|||
161117561|NCT00562588|581818605|FG001|Overall Study|Protocol Violation|26|||
161117562|NCT00562588|581818604|FG000|Overall Study|Lost to Follow-up|12|||
161117563|NCT00562588|581818605|FG001|Overall Study|Lost to Follow-up|4|||
161117564|NCT00562588|581818604|FG000|Overall Study|Withdrawal by Subject|10|||
161117565|NCT00562588|581818605|FG001|Overall Study|Withdrawal by Subject|9|||
161117566|NCT00562588|581818604|FG000|Overall Study|Other|0|||
161117567|NCT00562588|581818605|FG001|Overall Study|Other|2|||
161117568|NCT01452152|581818606|FG000|Overall Study|Study termination by sponsor|5|||
161117569|NCT01452152|581818607|FG001|Overall Study|Study termination by sponsor|0|||
161117570|NCT01452152|581818608|FG002|Overall Study|Study termination by sponsor|4|||
161117571|NCT01982292|581820141|FG000|Overall Study|Adverse Event|2|||
161117572|NCT01982292|581820142|FG001|Overall Study|Adverse Event|0|||
161117573|NCT01982292|581820141|FG000|Overall Study|Death|1|||
161117574|NCT01982292|581820142|FG001|Overall Study|Death|0|||
161117575|NCT01982292|581820141|FG000|Overall Study|Lost to Follow-up|2|||
161117576|NCT01982292|581820142|FG001|Overall Study|Lost to Follow-up|0|||
161117577|NCT01982292|581820141|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
161117578|NCT01982292|581820142|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
161117579|NCT01982292|581820141|FG000|Overall Study|Protocol Deviation|1|||
161117580|NCT01982292|581820142|FG001|Overall Study|Protocol Deviation|0|||
161117581|NCT01982292|581820141|FG000|Overall Study|Patient/Guardian Decision|3|||
161117582|NCT01982292|581820142|FG001|Overall Study|Patient/Guardian Decision|1|||
161117583|NCT01982292|581820141|FG000|Overall Study|Technical Problems|2|||
161117584|NCT01982292|581820142|FG001|Overall Study|Technical Problems|0|||
161117585|NCT04623242|581820149|FG000|Overall Study|Withdrawal by Subject|7|||
161117586|NCT04623242|581820150|FG001|Overall Study|Withdrawal by Subject|12|||
161117587|NCT04623242|581820151|FG002|Overall Study|Withdrawal by Subject|5|||
161117588|NCT04623242|581820152|FG003|Overall Study|Withdrawal by Subject|7|||
161117589|NCT04623242|581820153|FG004|Overall Study|Withdrawal by Subject|0|||
161117590|NCT04623242|581820149|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
161221816|NCT01673009|582194174|FG000|Overall Study|Physician Decision|5|||
161221817|NCT01673009|582194174|FG000|Overall Study|Withdrawal by Subject|8|||
161221818|NCT04161144|582194175|FG000|Overall Study|Withdrawal by Subject|0|||
161117591|NCT04623242|581820150|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
161117592|NCT04623242|581820151|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
161117593|NCT04623242|581820152|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
161117594|NCT04623242|581820153|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
161221819|NCT04161144|582194176|FG001|Overall Study|Withdrawal by Subject|1|||
161221820|NCT04161144|582194175|FG000|Overall Study|Protocol Violation|1|||
161221821|NCT04161144|582194176|FG001|Overall Study|Protocol Violation|0|||
161221822|NCT04700449|582194180|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
161221823|NCT04700449|582194181|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
161221824|NCT04700449|582194182|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
161221825|NCT04700449|582194183|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
161221826|NCT04700449|582194180|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
161221827|NCT04700449|582194181|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
161221828|NCT04700449|582194182|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
161221829|NCT04700449|582194183|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
161221830|NCT04700449|582194180|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161221831|NCT04700449|582194181|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161221832|NCT04700449|582194182|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
161221833|NCT04700449|582194183|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
161221834|NCT04700449|582194180|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
161221835|NCT04700449|582194181|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161221836|NCT04700449|582194182|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161221837|NCT04700449|582194183|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
161221838|NCT04700449|582194180|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
161221839|NCT04700449|582194181|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
161221840|NCT04700449|582194182|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
161221841|NCT04700449|582194183|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
161221842|NCT04700449|582194180|FG000|Stage 1: Double-Blind Period|Other|0|||
161221843|NCT04700449|582194181|FG001|Stage 1: Double-Blind Period|Other|0|||
161117595|NCT04623242|581820149|FG000|Overall Study|Subject unblinded to mutation status|0|||
161117596|NCT04623242|581820150|FG001|Overall Study|Subject unblinded to mutation status|0|||
161117597|NCT04623242|581820151|FG002|Overall Study|Subject unblinded to mutation status|0|||
161117598|NCT04623242|581820152|FG003|Overall Study|Subject unblinded to mutation status|13|||
161117599|NCT04623242|581820153|FG004|Overall Study|Subject unblinded to mutation status|0|||
161117600|NCT02921971|581820154|FG000|Overall Study|Adverse Event|1|||
161117601|NCT02921971|581820155|FG001|Overall Study|Adverse Event|2|||
161117602|NCT02921971|581820154|FG000|Overall Study|Lack of Efficacy|3|||
161117603|NCT02921971|581820155|FG001|Overall Study|Lack of Efficacy|1|||
161117604|NCT02921971|581820154|FG000|Overall Study|Other than specified above|2|||
161117605|NCT02921971|581820155|FG001|Overall Study|Other than specified above|1|||
161117606|NCT02721355|581820156|FG000|Overall Study|Lost to Follow-up|6|||
161117607|NCT02721355|581820157|FG001|Overall Study|Lost to Follow-up|1|||
161117608|NCT00356278|581820158|FG000|Overall Study|Withdrawal by Subject|25|||
161117609|NCT00356278|581820159|FG001|Overall Study|Withdrawal by Subject|15|||
161117610|NCT00356278|581820160|FG002|Overall Study|Withdrawal by Subject|19|||
161117611|NCT00527605|581820165|FG000|Overall Study|Adverse Event|3|||
161117612|NCT00527605|581820166|FG001|Overall Study|Adverse Event|0|||
161117613|NCT00527605|581820165|FG000|Overall Study|Withdrawal by Subject|3|||
161117614|NCT00527605|581820166|FG001|Overall Study|Withdrawal by Subject|7|||
161117615|NCT00527605|581820165|FG000|Overall Study|Lost to Follow-up|6|||
161117616|NCT00527605|581820166|FG001|Overall Study|Lost to Follow-up|2|||
161117617|NCT00527605|581820165|FG000|Overall Study|Protocol Violation|1|||
161117618|NCT00527605|581820166|FG001|Overall Study|Protocol Violation|2|||
161117619|NCT01363986|581820170|FG000|Overall Study|Disease progression|1|||
161117620|NCT01637142|581820171|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
161117621|NCT02605642|581820172|FG000|Overall Study|Other|11|||
161117622|NCT02605642|581820173|FG001|Overall Study|Other|1|||
161117623|NCT02605642|581820172|FG000|Overall Study|Participant non-compliance|2|||
161117624|NCT02605642|581820173|FG001|Overall Study|Participant non-compliance|4|||
161117625|NCT02605642|581820172|FG000|Overall Study|Physician Decision|10|||
161117626|NCT02605642|581820173|FG001|Overall Study|Physician Decision|0|||
161117627|NCT02605642|581820172|FG000|Overall Study|Lost to Follow-up|12|||
161117628|NCT02605642|581820173|FG001|Overall Study|Lost to Follow-up|1|||
161117629|NCT02605642|581820172|FG000|Overall Study|Adverse Event|14|||
161117630|NCT02605642|581820173|FG001|Overall Study|Adverse Event|2|||
161117631|NCT02605642|581820172|FG000|Overall Study|Withdrawal by Subject|23|||
161117632|NCT02605642|581820173|FG001|Overall Study|Withdrawal by Subject|2|||
161117633|NCT02605642|581820172|FG000|Overall Study|Lack of response|24|||
161117634|NCT02605642|581820173|FG001|Overall Study|Lack of response|11|||
161117635|NCT02111564|581820176|FG000|Overall Study|Death|109|||
161117636|NCT02111564|581820177|FG001|Overall Study|Death|120|||
161117637|NCT02111564|581820176|FG000|Overall Study|Lost to Follow-up|2|||
161117638|NCT02111564|581820177|FG001|Overall Study|Lost to Follow-up|3|||
161117639|NCT02111564|581820176|FG000|Overall Study|Withdrawal by Subject|20|||
161117640|NCT02111564|581820177|FG001|Overall Study|Withdrawal by Subject|20|||
161117641|NCT00687362|581820178|FG000|Overall Study|Protocol Violation|2|||
161117642|NCT00687362|581820178|FG000|Overall Study|Withdrawal by Subject|1|||
161117643|NCT01268293|581820183|FG000|Overall Study|Disease progression|7|||
161117644|NCT01268293|581820183|FG000|Overall Study|Adverse Event|1|||
161117645|NCT01268293|581820183|FG000|Overall Study|Subject choice|1|||
161117646|NCT02597855|581820184|FG000|Overall Study|Lost to Follow-up|2|||
161117647|NCT02597855|581820185|FG001|Overall Study|Lost to Follow-up|1|||
161117648|NCT03704194|581820186|FG000|Overall Study|Withdrawal by Subject|0|||
161117649|NCT03704194|581820187|FG001|Overall Study|Withdrawal by Subject|1|||
161117650|NCT00925015|581820188|FG000|Overall Study|Adverse Event|1|||
161117651|NCT00925015|581820189|FG001|Overall Study|Adverse Event|2|||
161117652|NCT00925015|581820190|FG002|Overall Study|Adverse Event|1|||
161117653|NCT00925015|581820188|FG000|Overall Study|Physician Decision|0|||
161117654|NCT00925015|581820189|FG001|Overall Study|Physician Decision|1|||
161117655|NCT00925015|581820190|FG002|Overall Study|Physician Decision|0|||
161117656|NCT00925015|581820188|FG000|Overall Study|Progressive Disease|7|||
161117657|NCT00925015|581820189|FG001|Overall Study|Progressive Disease|3|||
161117658|NCT00925015|581820190|FG002|Overall Study|Progressive Disease|4|||
161117659|NCT00925015|581820188|FG000|Overall Study|Withdrawal by Subject|0|||
161117660|NCT00925015|581820189|FG001|Overall Study|Withdrawal by Subject|0|||
161117661|NCT00925015|581820190|FG002|Overall Study|Withdrawal by Subject|1|||
161117662|NCT00179309|581820197|FG000|Treatment|Toxicity|2|||
161117663|NCT00179309|581820198|FG001|Treatment|Toxicity|3|||
161117664|NCT00179309|581820197|FG000|Treatment|Withdrawal by Subject|1|||
161117665|NCT00179309|581820198|FG001|Treatment|Withdrawal by Subject|2|||
161117666|NCT00179309|581820197|FG000|Treatment|Allergy|1|||
161117667|NCT00179309|581820198|FG001|Treatment|Allergy|0|||
161117668|NCT04986202|581820199|FG000|Overall Study|Death|10|||
161117669|NCT04986202|581820200|FG001|Overall Study|Death|3|||
161117670|NCT04986202|581820201|FG002|Overall Study|Death|10|||
161117671|NCT04986202|581820199|FG000|Overall Study|Physician Decision|3|||
161117672|NCT04986202|581820200|FG001|Overall Study|Physician Decision|1|||
161117673|NCT04986202|581820201|FG002|Overall Study|Physician Decision|2|||
161117674|NCT04986202|581820199|FG000|Overall Study|Withdrawal by Subject|4|||
161117675|NCT04986202|581820200|FG001|Overall Study|Withdrawal by Subject|2|||
161117676|NCT04986202|581820201|FG002|Overall Study|Withdrawal by Subject|4|||
161117677|NCT05131204|581820202|FG000|Overall Study|Sponsor request|2|||
161117678|NCT05131204|581820203|FG001|Overall Study|Sponsor request|1|||
161117679|NCT01777152|581820206|FG000|Overall Study|Withdrawal by Subject|22|||
161117680|NCT01777152|581820207|FG001|Overall Study|Withdrawal by Subject|16|||
161117681|NCT01777152|581820206|FG000|Overall Study|Lost to Follow-up|3|||
161117682|NCT01777152|581820207|FG001|Overall Study|Lost to Follow-up|5|||
161117683|NCT01777152|581820206|FG000|Overall Study|Death|68|||
161117684|NCT01777152|581820207|FG001|Overall Study|Death|89|||
161117685|NCT01777152|581820206|FG000|Overall Study|Not eligible, no study drug received|1|||
161117686|NCT01777152|581820207|FG001|Overall Study|Not eligible, no study drug received|0|||
161117687|NCT01777152|581820206|FG000|Overall Study|Change of diagnosis|1|||
161117688|NCT01777152|581820207|FG001|Overall Study|Change of diagnosis|0|||
161117689|NCT02469090|581820208|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
161117690|NCT02469090|581820209|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
161117691|NCT02469090|581820210|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
161117692|NCT02469090|581820208|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
161117693|NCT02469090|581820209|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
161117694|NCT02469090|581820210|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
161117695|NCT02469090|581820208|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
161117696|NCT02469090|581820209|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
161117697|NCT02469090|581820210|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
161117698|NCT02469090|581820208|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
161117699|NCT02469090|581820209|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
161117700|NCT02469090|581820210|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
161117701|NCT02469090|581820208|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
161117702|NCT02469090|581820209|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
161117703|NCT02469090|581820210|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
161117704|NCT02469090|581820208|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
161117705|NCT02469090|581820209|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
161117706|NCT02469090|581820210|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
161117707|NCT02469090|581820208|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
161117708|NCT02469090|581820209|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
161117709|NCT02469090|581820210|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
161117710|NCT02469090|581820208|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
161117711|NCT02469090|581820209|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
161117712|NCT02469090|581820210|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
161117713|NCT03823391|581820214|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
161117714|NCT03823391|581820215|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
161117715|NCT03823391|581820214|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
161117716|NCT03823391|581820215|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
161117717|NCT05882318|581820217|FG000|Overall Study|Withdrawal by Subject|1|||
161117718|NCT05882318|581820218|FG001|Overall Study|Withdrawal by Subject|0|||
161117719|NCT05882318|581820217|FG000|Overall Study|Protocol Violation|0|||
161117720|NCT05882318|581820218|FG001|Overall Study|Protocol Violation|1|||
161117721|NCT03042468|581820219|FG000|Overall Study|Death|0|||
161117722|NCT03042468|581820220|FG001|Overall Study|Death|1|||
161117723|NCT03042468|581820221|FG002|Overall Study|Death|1|||
161117724|NCT03042468|581820222|FG003|Overall Study|Death|0|||
161117725|NCT03042468|581820223|FG004|Overall Study|Death|0|||
161117726|NCT03042468|581820224|FG005|Overall Study|Death|0|||
161117727|NCT03042468|581820219|FG000|Overall Study|Withdrawal by Subject|0|||
161117728|NCT03042468|581820220|FG001|Overall Study|Withdrawal by Subject|0|||
161117729|NCT03042468|581820221|FG002|Overall Study|Withdrawal by Subject|0|||
161117730|NCT03042468|581820222|FG003|Overall Study|Withdrawal by Subject|0|||
161117731|NCT03042468|581820223|FG004|Overall Study|Withdrawal by Subject|0|||
161117732|NCT03042468|581820224|FG005|Overall Study|Withdrawal by Subject|1|||
161117733|NCT03042468|581820219|FG000|Overall Study|Lost to Follow-up|0|||
161117734|NCT03042468|581820220|FG001|Overall Study|Lost to Follow-up|0|||
161117735|NCT03042468|581820221|FG002|Overall Study|Lost to Follow-up|0|||
161117736|NCT03042468|581820222|FG003|Overall Study|Lost to Follow-up|0|||
161117737|NCT03042468|581820223|FG004|Overall Study|Lost to Follow-up|1|||
161117738|NCT03042468|581820224|FG005|Overall Study|Lost to Follow-up|1|||
161117739|NCT01485627|581820225|FG000|Overall Study|Patient withdrew|6|||
161117740|NCT01485627|581820226|FG001|Overall Study|Patient withdrew|5|||
161117741|NCT01485627|581820225|FG000|Overall Study|Patient died|3|||
161117742|NCT01485627|581820226|FG001|Overall Study|Patient died|1|||
161117743|NCT01485627|581820225|FG000|Overall Study|Patient lost to followup|0|||
161117744|NCT01485627|581820226|FG001|Overall Study|Patient lost to followup|1|||
161117745|NCT01485627|581820225|FG000|Overall Study|Caregiver withdrew|3|||
161117746|NCT01485627|581820226|FG001|Overall Study|Caregiver withdrew|3|||
161117747|NCT01485627|581820225|FG000|Overall Study|Caregiver lost to follow up|11|||
161117748|NCT01485627|581820226|FG001|Overall Study|Caregiver lost to follow up|12|||
161117749|NCT01485627|581820225|FG000|Overall Study|Caregiver died|1|||
161117750|NCT01485627|581820226|FG001|Overall Study|Caregiver died|0|||
161117751|NCT01485627|581820225|FG000|Overall Study|caregiver was not bereaved|42|||
161117752|NCT01485627|581820226|FG001|Overall Study|caregiver was not bereaved|35|||
161117753|NCT01425203|581820227|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
161117754|NCT01425203|581820228|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
161117755|NCT01425203|581820229|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
161117756|NCT01425203|581820227|FG000|Treatment Phase|Failure at futility timepoint|8|||
161117757|NCT01425203|581820228|FG001|Treatment Phase|Failure at futility timepoint|27|||
161117758|NCT01425203|581820229|FG002|Treatment Phase|Failure at futility timepoint|0|||
161117759|NCT01425203|581820227|FG000|Treatment Phase|Other virologic failure criteria|5|||
161117760|NCT01425203|581820228|FG001|Treatment Phase|Other virologic failure criteria|3|||
161117761|NCT01425203|581820229|FG002|Treatment Phase|Other virologic failure criteria|0|||
161117762|NCT01425203|581820227|FG000|Treatment Phase|Unidentified reasons|11|||
161117763|NCT01425203|581820228|FG001|Treatment Phase|Unidentified reasons|5|||
161117764|NCT01425203|581820229|FG002|Treatment Phase|Unidentified reasons|0|||
161117765|NCT01425203|581820227|FG000|Treatment Phase|Did not receive treatment|0|||
161117766|NCT01425203|581820228|FG001|Treatment Phase|Did not receive treatment|1|||
161117767|NCT01425203|581820229|FG002|Treatment Phase|Did not receive treatment|0|||
161117768|NCT01425203|581820227|FG000|Crossover Phase|Failure at futility timepoint|0|||
161117769|NCT01425203|581820228|FG001|Crossover Phase|Failure at futility timepoint|0|||
161117770|NCT01425203|581820229|FG002|Crossover Phase|Failure at futility timepoint|3|||
161117771|NCT01425203|581820227|FG000|Crossover Phase|Other virologic failure criteria|0|||
161117772|NCT01425203|581820228|FG001|Crossover Phase|Other virologic failure criteria|0|||
161117773|NCT01425203|581820229|FG002|Crossover Phase|Other virologic failure criteria|3|||
161117774|NCT00290433|581820232|FG000|Overall Study|Disease Progression|13|||
161117775|NCT00290433|581820232|FG000|Overall Study|Adverse Event|14|||
161117776|NCT00290433|581820232|FG000|Overall Study|Withdrawal by Subject|1|||
161117777|NCT00290433|581820232|FG000|Overall Study|Non-Compliance|1|||
161117778|NCT00290433|581820232|FG000|Overall Study|Congestive Heart Failure|1|||
161221844|NCT04700449|582194182|FG002|Stage 1: Double-Blind Period|Other|1|||
161221845|NCT04700449|582194183|FG003|Stage 1: Double-Blind Period|Other|0|||
161221846|NCT04700449|582194180|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
161221847|NCT04700449|582194181|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
161221848|NCT04700449|582194182|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
161221849|NCT04700449|582194183|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
161221850|NCT04700449|582194180|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161117779|NCT00290433|581820232|FG000|Overall Study|Transplant in CR|5|||
161117780|NCT00290433|581820232|FG000|Overall Study|Unrelated Infection/Death|1|||
161117781|NCT02275338|581820237|FG000|Overall Study|Adverse Event|15|||
161117782|NCT02275338|581820237|FG000|Overall Study|Lack of Efficacy|3|||
161117783|NCT02275338|581820237|FG000|Overall Study|Withdrawal by Subject|4|||
161117784|NCT02275338|581820237|FG000|Overall Study|Disease progression (death)|1|||
161117785|NCT02275338|581820237|FG000|Overall Study|Ineligible to start Phase 2|4|||
161117786|NCT02275338|581820237|FG000|Overall Study|Reason not specified|5|||
161117787|NCT02275338|581820237|FG000|Overall Study|Does not meet entry criteria|1|||
161117788|NCT01665807|581820241|FG000|Overall Study|Withdrawal by Subject|2|||
161117789|NCT01665807|581820242|FG001|Overall Study|Withdrawal by Subject|0|||
160874484|NCT00486291|580934235|FG001|Overall Study|Adverse Event|4|||
161221851|NCT04700449|582194181|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161221852|NCT04700449|582194182|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
161117790|NCT01665807|581820243|FG002|Overall Study|Withdrawal by Subject|1|||
161117791|NCT02937818|581820252|FG000|Overall Study|Participants decision|2|||
161117792|NCT02937818|581820253|FG001|Overall Study|Participants decision|1|||
161117793|NCT02937818|581820254|FG002|Overall Study|Participants decision|1|||
161117794|NCT02937818|581820255|FG003|Overall Study|Participants decision|1|||
161117795|NCT02937818|581820252|FG000|Overall Study|Adverse Event|2|||
161117796|NCT02937818|581820253|FG001|Overall Study|Adverse Event|4|||
161117797|NCT02937818|581820254|FG002|Overall Study|Adverse Event|1|||
161117798|NCT02937818|581820255|FG003|Overall Study|Adverse Event|1|||
161117799|NCT02937818|581820252|FG000|Overall Study|Disease progression|17|||
161117800|NCT02937818|581820253|FG001|Overall Study|Disease progression|15|||
161117801|NCT02937818|581820254|FG002|Overall Study|Disease progression|7|||
161117802|NCT02937818|581820255|FG003|Overall Study|Disease progression|19|||
161117803|NCT02937818|581820252|FG000|Overall Study|Condition under investigation worsened|0|||
161117804|NCT02937818|581820253|FG001|Overall Study|Condition under investigation worsened|0|||
161117805|NCT02937818|581820254|FG002|Overall Study|Condition under investigation worsened|1|||
161117806|NCT02937818|581820255|FG003|Overall Study|Condition under investigation worsened|0|||
161117807|NCT01400451|581820268|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
161117808|NCT01400451|581820269|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
161117809|NCT01400451|581820270|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
161117810|NCT01400451|581820268|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
161117811|NCT01400451|581820269|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
161117812|NCT01400451|581820270|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
161117813|NCT01400451|581820268|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
161117814|NCT01400451|581820269|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
161117815|NCT01400451|581820270|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
161117816|NCT01400451|581820268|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
161117817|NCT01400451|581820269|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
161117818|NCT01400451|581820270|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
161117819|NCT01400451|581820268|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
161117820|NCT01400451|581820269|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
161117821|NCT01400451|581820270|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
161117822|NCT00574275|581820271|FG000|Overall Study|Randomized but not treated|2|||
161117823|NCT00574275|581820272|FG001|Overall Study|Randomized but not treated|3|||
161117824|NCT00574275|581820271|FG000|Overall Study|Adverse Event|32|||
161117825|NCT00574275|581820272|FG001|Overall Study|Adverse Event|76|||
161117826|NCT00574275|581820271|FG000|Overall Study|Disease progression|160|||
161117827|NCT00574275|581820272|FG001|Overall Study|Disease progression|146|||
161117828|NCT00574275|581820271|FG000|Overall Study|Lost to Follow-up|2|||
161117829|NCT00574275|581820272|FG001|Overall Study|Lost to Follow-up|1|||
161117830|NCT00574275|581820271|FG000|Overall Study|Study stopped based on DMC decision|62|||
161117831|NCT00574275|581820272|FG001|Overall Study|Study stopped based on DMC decision|23|||
161117832|NCT00574275|581820271|FG000|Overall Study|Withdrawal by Subject|15|||
161117833|NCT00574275|581820272|FG001|Overall Study|Withdrawal by Subject|17|||
161117834|NCT00574275|581820271|FG000|Overall Study|Error calculating tumor measurement|1|||
161117835|NCT00574275|581820272|FG001|Overall Study|Error calculating tumor measurement|0|||
161117836|NCT00574275|581820271|FG000|Overall Study|Physician Decision|1|||
161117837|NCT00574275|581820272|FG001|Overall Study|Physician Decision|1|||
161117838|NCT00574275|581820271|FG000|Overall Study|Protocol Violation|0|||
161117839|NCT00574275|581820272|FG001|Overall Study|Protocol Violation|1|||
161117840|NCT00574275|581820271|FG000|Overall Study|Patient and Investigator decision|0|||
161117841|NCT00574275|581820272|FG001|Overall Study|Patient and Investigator decision|1|||
161117842|NCT00574275|581820271|FG000|Overall Study|Insurance change|0|||
161117843|NCT00574275|581820272|FG001|Overall Study|Insurance change|1|||
161117844|NCT00574275|581820271|FG000|Overall Study|Operation for curative intent|0|||
161117845|NCT00574275|581820272|FG001|Overall Study|Operation for curative intent|1|||
161117846|NCT00889265|581820275|FG000|Overall Study|Adverse Event|1|||
161117847|NCT00889265|581820275|FG000|Overall Study|Lost to Follow-up|5|||
161117848|NCT00889265|581820275|FG000|Overall Study|Protocol Violation|1|||
161117849|NCT03028870|581820276|FG000|Overall Study|Adverse Event|7|||
161117850|NCT03028870|581820277|FG001|Overall Study|Adverse Event|4|||
161117851|NCT03028870|581820278|FG002|Overall Study|Adverse Event|3|||
161117852|NCT03028870|581820279|FG003|Overall Study|Adverse Event|3|||
161117853|NCT03028870|581820276|FG000|Overall Study|Withdrawal by Subject|1|||
161117854|NCT03028870|581820277|FG001|Overall Study|Withdrawal by Subject|1|||
161117855|NCT03028870|581820278|FG002|Overall Study|Withdrawal by Subject|1|||
161117856|NCT03028870|581820279|FG003|Overall Study|Withdrawal by Subject|2|||
161117857|NCT03028870|581820276|FG000|Overall Study|Lost to Follow-up|1|||
161117858|NCT03028870|581820277|FG001|Overall Study|Lost to Follow-up|0|||
161117859|NCT03028870|581820278|FG002|Overall Study|Lost to Follow-up|0|||
161117860|NCT03028870|581820279|FG003|Overall Study|Lost to Follow-up|0|||
161117861|NCT03028870|581820276|FG000|Overall Study|Lack of Efficacy|3|||
161117862|NCT03028870|581820277|FG001|Overall Study|Lack of Efficacy|0|||
161221853|NCT04700449|582194183|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
161221854|NCT04700449|582194180|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161221855|NCT04700449|582194181|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161221856|NCT04700449|582194182|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
161221857|NCT04700449|582194183|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
161221858|NCT04700449|582194180|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161221859|NCT04700449|582194181|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161221860|NCT04700449|582194182|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
161221861|NCT04700449|582194183|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
161221862|NCT04700449|582194180|FG000|Stage 2 Sub-study 1|Other|1|||
161221863|NCT04700449|582194181|FG001|Stage 2 Sub-study 1|Other|2|||
161221864|NCT04700449|582194182|FG002|Stage 2 Sub-study 1|Other|0|||
161221865|NCT04700449|582194183|FG003|Stage 2 Sub-study 1|Other|0|||
161221866|NCT04700449|582194180|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
161221867|NCT04700449|582194181|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
161221868|NCT04700449|582194182|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
161221869|NCT04700449|582194183|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
161221870|NCT04700449|582194180|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161221871|NCT04700449|582194181|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161221872|NCT04700449|582194182|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
161221873|NCT04700449|582194183|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
161221874|NCT04700449|582194180|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161221875|NCT04700449|582194181|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161221876|NCT04700449|582194182|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
161221877|NCT04700449|582194183|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
161221878|NCT04700449|582194180|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161221879|NCT04700449|582194181|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161221880|NCT04700449|582194182|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
161221881|NCT04700449|582194183|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
161221882|NCT04700449|582194180|FG000|Stage 2 Sub-study 2|Other|0|||
161221883|NCT04700449|582194181|FG001|Stage 2 Sub-study 2|Other|0|||
161221884|NCT04700449|582194182|FG002|Stage 2 Sub-study 2|Other|0|||
161221885|NCT04700449|582194183|FG003|Stage 2 Sub-study 2|Other|5|||
161221886|NCT06041646|582194184|FG000|Overall Study|Withdrawal by Subject|1|||
161221887|NCT01000337|582194185|FG000|Overall Study|Lost to Follow-up|4|||
161221888|NCT01000337|582194186|FG001|Overall Study|Lost to Follow-up|3|||
161221889|NCT03901963|582194187|FG000|Overall Study|Lost to Follow-up|1|||
161221890|NCT03901963|582194188|FG001|Overall Study|Lost to Follow-up|1|||
161221891|NCT03901963|582194187|FG000|Overall Study|Physician Decision|1|||
161221892|NCT03901963|582194188|FG001|Overall Study|Physician Decision|2|||
161221893|NCT03901963|582194187|FG000|Overall Study|Protocol Violation|1|||
161221894|NCT03901963|582194188|FG001|Overall Study|Protocol Violation|1|||
161221895|NCT03901963|582194187|FG000|Overall Study|Withdrawal by Subject|4|||
161221896|NCT03901963|582194188|FG001|Overall Study|Withdrawal by Subject|11|||
161221897|NCT03901963|582194187|FG000|Overall Study|Ongoing|84|||
161221898|NCT03901963|582194188|FG001|Overall Study|Ongoing|73|||
161221899|NCT03901963|582194187|FG000|Overall Study|Randomized but not treated|3|||
161221900|NCT03901963|582194188|FG001|Overall Study|Randomized but not treated|3|||
161221901|NCT02854436|582194189|FG000|Overall Study|Adverse Event|1|||
161221902|NCT02854436|582194189|FG000|Overall Study|Death|208|||
161221903|NCT02854436|582194189|FG000|Overall Study|Lost to Follow-up|5|||
161221904|NCT02854436|582194189|FG000|Overall Study|Withdrawal by Subject|24|||
161221905|NCT02854436|582194189|FG000|Overall Study|Other|45|||
161221906|NCT02854436|582194189|FG000|Overall Study|Physician Decision|6|||
161221907|NCT01700621|582194190|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
161221908|NCT01700621|582194191|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
161221909|NCT01700621|582194190|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
161221910|NCT01700621|582194191|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
161221911|NCT01700621|582194190|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
161221912|NCT01700621|582194191|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
161221913|NCT00384033|582194198|FG000|Overall Study|Adverse Event|10|||
161221914|NCT00384033|582194199|FG001|Overall Study|Adverse Event|8|||
161221915|NCT00384033|582194200|FG002|Overall Study|Adverse Event|11|||
161221916|NCT00384033|582194201|FG003|Overall Study|Adverse Event|20|||
161221917|NCT00384033|582194198|FG000|Overall Study|Failed to return|1|||
161221918|NCT00384033|582194199|FG001|Overall Study|Failed to return|3|||
161221919|NCT00384033|582194200|FG002|Overall Study|Failed to return|2|||
161221920|NCT00384033|582194201|FG003|Overall Study|Failed to return|2|||
161221921|NCT00384033|582194198|FG000|Overall Study|Physician Decision|1|||
161221922|NCT00384033|582194199|FG001|Overall Study|Physician Decision|0|||
161221923|NCT00384033|582194200|FG002|Overall Study|Physician Decision|0|||
161221924|NCT00384033|582194201|FG003|Overall Study|Physician Decision|0|||
161221925|NCT00384033|582194198|FG000|Overall Study|Lost to Follow-up|6|||
161221926|NCT00384033|582194199|FG001|Overall Study|Lost to Follow-up|12|||
161221927|NCT00384033|582194200|FG002|Overall Study|Lost to Follow-up|7|||
161221928|NCT00384033|582194201|FG003|Overall Study|Lost to Follow-up|7|||
161221929|NCT00384033|582194198|FG000|Overall Study|Other|2|||
161221930|NCT00384033|582194199|FG001|Overall Study|Other|0|||
161221931|NCT00384033|582194200|FG002|Overall Study|Other|0|||
161221932|NCT00384033|582194201|FG003|Overall Study|Other|0|||
161221933|NCT00384033|582194198|FG000|Overall Study|Protocol Violation|5|||
161221934|NCT00384033|582194199|FG001|Overall Study|Protocol Violation|0|||
161221935|NCT00384033|582194200|FG002|Overall Study|Protocol Violation|5|||
161221936|NCT00384033|582194201|FG003|Overall Study|Protocol Violation|6|||
161221937|NCT00384033|582194198|FG000|Overall Study|Withdrawal by Subject|6|||
161221938|NCT00384033|582194199|FG001|Overall Study|Withdrawal by Subject|2|||
161221939|NCT00384033|582194200|FG002|Overall Study|Withdrawal by Subject|5|||
161221940|NCT00384033|582194201|FG003|Overall Study|Withdrawal by Subject|2|||
161221941|NCT00384033|582194198|FG000|Overall Study|Lack of Efficacy|7|||
161221942|NCT00384033|582194199|FG001|Overall Study|Lack of Efficacy|3|||
161221943|NCT00384033|582194200|FG002|Overall Study|Lack of Efficacy|3|||
161221944|NCT00384033|582194201|FG003|Overall Study|Lack of Efficacy|1|||
161221945|NCT00384033|582194198|FG000|Overall Study|Randomized but not treated|3|||
161221946|NCT00384033|582194199|FG001|Overall Study|Randomized but not treated|7|||
161221947|NCT00384033|582194200|FG002|Overall Study|Randomized but not treated|10|||
161221948|NCT00384033|582194201|FG003|Overall Study|Randomized but not treated|2|||
161221949|NCT03349333|582194202|FG000|Overall Study|Progression of Disease|36|||
161221950|NCT03349333|582194202|FG000|Overall Study|Adverse Event|11|||
161221951|NCT03349333|582194202|FG000|Overall Study|Other|6|||
161221952|NCT03349333|582194202|FG000|Overall Study|Withdrawal by Subject|5|||
161221953|NCT03349333|582194202|FG000|Overall Study|Conditions interfere with participation|2|||
161221954|NCT03349333|582194202|FG000|Overall Study|Physician Decision|2|||
161221955|NCT03349333|582194202|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
161221956|NCT03349333|582194202|FG000|Overall Study|Patients in treatment less than 24 month|8|||
161221957|NCT02985151|582194203|FG000|Original Randomization|Withdrawal by Subject|0|||
161221958|NCT02985151|582194204|FG001|Original Randomization|Withdrawal by Subject|1|||
161221959|NCT02116803|582194207|FG000|Overall Study|Adverse Event|2|||
161221960|NCT02116803|582194208|FG001|Overall Study|Adverse Event|1|||
161221961|NCT02116803|582194207|FG000|Overall Study|Physician Decision|1|||
161221962|NCT02116803|582194208|FG001|Overall Study|Physician Decision|0|||
161221963|NCT02116803|582194207|FG000|Overall Study|Progressive disease|4|||
161221964|NCT02116803|582194208|FG001|Overall Study|Progressive disease|0|||
161221965|NCT02116803|582194207|FG000|Overall Study|Study terminated by sponsor|2|||
161221966|NCT02116803|582194208|FG001|Overall Study|Study terminated by sponsor|1|||
161221967|NCT02116803|582194207|FG000|Overall Study|Death|1|||
161221968|NCT02116803|582194208|FG001|Overall Study|Death|0|||
161221969|NCT00684671|582194209|FG000|Overall Study|Adverse Event|1|||
161221970|NCT00684671|582194210|FG001|Overall Study|Adverse Event|0|||
161221971|NCT00684671|582194211|FG002|Overall Study|Adverse Event|0|||
161221972|NCT00684671|582194209|FG000|Overall Study|Lost to Follow-up|1|||
161221973|NCT00684671|582194210|FG001|Overall Study|Lost to Follow-up|0|||
161221974|NCT00684671|582194211|FG002|Overall Study|Lost to Follow-up|0|||
161221975|NCT00684671|582194209|FG000|Overall Study|Alcoholic dependance|1|||
161221976|NCT00684671|582194210|FG001|Overall Study|Alcoholic dependance|0|||
161221977|NCT00684671|582194211|FG002|Overall Study|Alcoholic dependance|0|||
161221978|NCT04128007|582194212|FG000|Overall Study|Withdrawal by Subject|9|||
161221979|NCT04128007|582194213|FG001|Overall Study|Withdrawal by Subject|6|||
161221980|NCT04128007|582194212|FG000|Overall Study|Protocol Violation|1|||
161221981|NCT04128007|582194213|FG001|Overall Study|Protocol Violation|0|||
161221982|NCT04128007|582194212|FG000|Overall Study|Lost to Follow-up|8|||
161221983|NCT04128007|582194213|FG001|Overall Study|Lost to Follow-up|7|||
161221984|NCT04128007|582194212|FG000|Overall Study|Adverse Event|5|||
161221985|NCT04128007|582194213|FG001|Overall Study|Adverse Event|2|||
161221986|NCT04128007|582194212|FG000|Overall Study|Not reported|0|||
161221987|NCT04128007|582194213|FG001|Overall Study|Not reported|2|||
161221988|NCT00481247|582194216|FG000|Overall Study|Death|0|||
161221989|NCT00481247|582194217|FG001|Overall Study|Death|1|||
161221990|NCT00481247|582194216|FG000|Overall Study|Disease progression|18|||
161221991|NCT00481247|582194217|FG001|Overall Study|Disease progression|22|||
161221992|NCT00481247|582194216|FG000|Overall Study|Intolerance|42|||
161221993|NCT00481247|582194217|FG001|Overall Study|Intolerance|17|||
161221994|NCT00481247|582194216|FG000|Overall Study|Treatment failure|10|||
161221995|NCT00481247|582194217|FG001|Overall Study|Treatment failure|14|||
161221996|NCT00481247|582194216|FG000|Overall Study|AE unrelated to study drug|13|||
161221997|NCT00481247|582194217|FG001|Overall Study|AE unrelated to study drug|4|||
161221998|NCT00481247|582194216|FG000|Overall Study|Withdrawal by Subject|8|||
161221999|NCT00481247|582194217|FG001|Overall Study|Withdrawal by Subject|13|||
161222000|NCT00481247|582194216|FG000|Overall Study|Pregnancy|2|||
161222001|NCT00481247|582194217|FG001|Overall Study|Pregnancy|1|||
161222002|NCT00481247|582194216|FG000|Overall Study|Lost to Follow-up|1|||
161222003|NCT00481247|582194217|FG001|Overall Study|Lost to Follow-up|2|||
161222004|NCT00481247|582194216|FG000|Overall Study|Poor compliance/noncompliance|1|||
161222005|NCT00481247|582194217|FG001|Overall Study|Poor compliance/noncompliance|7|||
161222006|NCT00481247|582194216|FG000|Overall Study|Administrative reason by sponsor|157|||
161222007|NCT00481247|582194217|FG001|Overall Study|Administrative reason by sponsor|162|||
161222008|NCT00481247|582194216|FG000|Overall Study|Varied|6|||
160874485|NCT00486291|580934234|FG000|Overall Study|Lost to Follow-up|3|||
161222009|NCT00481247|582194217|FG001|Overall Study|Varied|15|||
161222010|NCT00481247|582194216|FG000|Overall Study|Did not receive treatment|1|||
161222011|NCT00481247|582194217|FG001|Overall Study|Did not receive treatment|2|||
161222012|NCT04281485|582194218|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
161222013|NCT04281485|582194219|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
161222014|NCT04281485|582194218|FG000|Overall Study|Ongoing (Safety data collection)|10|||
161222015|NCT04281485|582194219|FG001|Overall Study|Ongoing (Safety data collection)|5|||
161222016|NCT04317599|582194220|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
161222017|NCT04317599|582194220|FG000|Overall Study|treatment outside standard of care|4|||
161222018|NCT03933202|582194221|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
161222019|NCT03933202|582194222|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
161222020|NCT03933202|582194221|FG000|Overall Study|Participant transferred care|1|||
161222021|NCT03933202|582194222|FG001|Overall Study|Participant transferred care|0|||
161222022|NCT03933202|582194221|FG000|Overall Study|Site research department closing|1|||
161222023|NCT03933202|582194222|FG001|Overall Study|Site research department closing|0|||
161222024|NCT03933202|582194221|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
161222025|NCT03933202|582194222|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
161222026|NCT03933202|582194221|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
161222027|NCT03933202|582194222|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
161222028|NCT03933202|582194221|FG000|Overall Study|Participant changed primary neurology provider|1|||
161222029|NCT03933202|582194222|FG001|Overall Study|Participant changed primary neurology provider|0|||
161222030|NCT03933202|582194221|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
161222031|NCT03933202|582194222|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
161222032|NCT03933202|582194221|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
161222033|NCT03933202|582194222|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
161222034|NCT03933202|582194221|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
161222035|NCT03933202|582194222|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
161222036|NCT03933202|582194221|FG000|Overall Study|Missed visit|0|||
161222037|NCT03933202|582194222|FG001|Overall Study|Missed visit|1|||
161222038|NCT03933202|582194221|FG000|Overall Study|Investigator decision|4|||
161222039|NCT03933202|582194222|FG001|Overall Study|Investigator decision|0|||
161222040|NCT03933202|582194221|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
161222041|NCT03933202|582194222|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
161222042|NCT03933202|582194221|FG000|Overall Study|Withdrawal by Subject|10|||
161222043|NCT03933202|582194222|FG001|Overall Study|Withdrawal by Subject|8|||
161222044|NCT03933202|582194221|FG000|Overall Study|Death|2|||
161222045|NCT03933202|582194222|FG001|Overall Study|Death|0|||
161222046|NCT03933202|582194221|FG000|Overall Study|Progressive disease|0|||
161222047|NCT03933202|582194222|FG001|Overall Study|Progressive disease|3|||
161222048|NCT03933202|582194221|FG000|Overall Study|Protocol non-compliance|6|||
161222049|NCT03933202|582194222|FG001|Overall Study|Protocol non-compliance|3|||
161222050|NCT03933202|582194221|FG000|Overall Study|Lost to Follow-up|16|||
161222051|NCT03933202|582194222|FG001|Overall Study|Lost to Follow-up|8|||
161222052|NCT03933202|582194221|FG000|Overall Study|Adverse Event|3|||
161222053|NCT03933202|582194222|FG001|Overall Study|Adverse Event|0|||
161222054|NCT05658523|582194223|FG000|Baseline|No blood draw|1|||
161222055|NCT05658523|582194224|FG001|Baseline|No blood draw|0|||
161222056|NCT05658523|582194225|FG002|Baseline|No blood draw|0|||
161222057|NCT05658523|582194223|FG000|28 Days|Lost to Follow-up|1|||
161222058|NCT05658523|582194224|FG001|28 Days|Lost to Follow-up|0|||
161222059|NCT05658523|582194225|FG002|28 Days|Lost to Follow-up|0|||
161222060|NCT05658523|582194223|FG000|28 Days|Withdrawal by Subject|1|||
161222061|NCT05658523|582194224|FG001|28 Days|Withdrawal by Subject|1|||
161117863|NCT03028870|581820278|FG002|Overall Study|Lack of Efficacy|0|||
161117864|NCT03028870|581820279|FG003|Overall Study|Lack of Efficacy|0|||
161117865|NCT03028870|581820276|FG000|Overall Study|Administrative|5|||
161117866|NCT03028870|581820277|FG001|Overall Study|Administrative|5|||
161117867|NCT03028870|581820278|FG002|Overall Study|Administrative|12|||
161117868|NCT03028870|581820279|FG003|Overall Study|Administrative|4|||
161117869|NCT01967537|581820282|FG000|Overall Study|Withdrawal by Subject|52|||
161117870|NCT01967537|581820282|FG000|Overall Study|Refuse treatment|2|||
161117871|NCT01967537|581820282|FG000|Overall Study|Lost to Follow-up|6|||
161117872|NCT00317109|581820285|FG000|Overall Study|Withdrawal by Subject|2|||
161117873|NCT00317109|581820286|FG001|Overall Study|Withdrawal by Subject|0|||
161117874|NCT00317109|581820285|FG000|Overall Study|Migated/moved from study area|1|||
161117875|NCT00317109|581820286|FG001|Overall Study|Migated/moved from study area|0|||
161117876|NCT02425826|581820288|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
161117877|NCT02425826|581820289|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
161117878|NCT02425826|581820290|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
161117879|NCT02425826|581820288|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
161117880|NCT02425826|581820289|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
161117881|NCT02425826|581820290|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
161222062|NCT05658523|582194225|FG002|28 Days|Withdrawal by Subject|0|||
161222063|NCT05658523|582194223|FG000|28 Days|Visit missed|0|||
161222064|NCT05658523|582194224|FG001|28 Days|Visit missed|4|||
161222065|NCT05658523|582194225|FG002|28 Days|Visit missed|0|||
161222066|NCT05658523|582194223|FG000|6 Months|Lost to Follow-up|1|||
161222067|NCT05658523|582194224|FG001|6 Months|Lost to Follow-up|7|||
161222068|NCT05658523|582194225|FG002|6 Months|Lost to Follow-up|2|||
161222069|NCT05658523|582194223|FG000|6 Months|Withdrawal by Subject|1|||
161222070|NCT05658523|582194224|FG001|6 Months|Withdrawal by Subject|3|||
161222071|NCT05658523|582194225|FG002|6 Months|Withdrawal by Subject|4|||
161222072|NCT05658523|582194223|FG000|6 Months|Visit missed|5|||
161222073|NCT05658523|582194224|FG001|6 Months|Visit missed|7|||
161222074|NCT05658523|582194225|FG002|6 Months|Visit missed|0|||
161222075|NCT05658523|582194223|FG000|6 Months|No blood draw|0|||
161222076|NCT05658523|582194224|FG001|6 Months|No blood draw|0|||
161222077|NCT05658523|582194225|FG002|6 Months|No blood draw|1|||
161222078|NCT05658523|582194223|FG000|12 Months|Lost to Follow-up|2|||
161222079|NCT05658523|582194224|FG001|12 Months|Lost to Follow-up|6|||
161222080|NCT05658523|582194225|FG002|12 Months|Lost to Follow-up|3|||
161222081|NCT05658523|582194223|FG000|12 Months|Withdrawal by Subject|4|||
161222082|NCT05658523|582194224|FG001|12 Months|Withdrawal by Subject|4|||
161222083|NCT05658523|582194225|FG002|12 Months|Withdrawal by Subject|2|||
161222084|NCT05658523|582194223|FG000|12 Months|Visit missed|4|||
161222085|NCT05658523|582194224|FG001|12 Months|Visit missed|8|||
161222086|NCT05658523|582194225|FG002|12 Months|Visit missed|8|||
161222087|NCT05658523|582194223|FG000|18 Months|Lost to Follow-up|5|||
161222088|NCT05658523|582194224|FG001|18 Months|Lost to Follow-up|8|||
161222089|NCT05658523|582194225|FG002|18 Months|Lost to Follow-up|2|||
161222090|NCT05658523|582194223|FG000|18 Months|Withdrawal by Subject|17|||
161222091|NCT05658523|582194224|FG001|18 Months|Withdrawal by Subject|9|||
161222092|NCT05658523|582194225|FG002|18 Months|Withdrawal by Subject|16|||
161222093|NCT05658523|582194223|FG000|18 Months|Visit missed|12|||
161222094|NCT05658523|582194224|FG001|18 Months|Visit missed|14|||
161222095|NCT05658523|582194225|FG002|18 Months|Visit missed|6|||
161222096|NCT00628212|582194226|FG000|Overall Study|Adverse Event|2|||
161222097|NCT00628212|582194227|FG001|Overall Study|Adverse Event|0|||
161222098|NCT00628212|582194228|FG002|Overall Study|Adverse Event|1|||
161222099|NCT00628212|582194229|FG003|Overall Study|Adverse Event|2|||
161222100|NCT00628212|582194226|FG000|Overall Study|Physician Decision|1|||
161222101|NCT00628212|582194227|FG001|Overall Study|Physician Decision|1|||
161222102|NCT00628212|582194228|FG002|Overall Study|Physician Decision|2|||
161222103|NCT00628212|582194229|FG003|Overall Study|Physician Decision|3|||
161222104|NCT02427607|582194230|FG000|Overall Study|Withdrawal by Subject|1|||
161222105|NCT03211416|582194231|FG000|Overall Study|Adverse Event|7|||
161222106|NCT03211416|582194231|FG000|Overall Study|Lack of Efficacy|2|||
161222107|NCT03211416|582194231|FG000|Overall Study|Physician Decision|1|||
161222108|NCT03199274|582194232|FG000|Overall Study|Withdrawal by Subject|4|||
161222109|NCT03199274|582194233|FG001|Overall Study|Withdrawal by Subject|0|||
161222110|NCT03199274|582194232|FG000|Overall Study|Lost to Follow-up|0|||
161222111|NCT03199274|582194233|FG001|Overall Study|Lost to Follow-up|1|||
161222112|NCT03199274|582194232|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
161222113|NCT03199274|582194233|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
161222114|NCT00656019|582194236|FG000|Overall Study|Not Eligible|10|||
161222115|NCT00656019|582194237|FG001|Overall Study|Not Eligible|0|||
161222116|NCT00656019|582194238|FG002|Overall Study|Not Eligible|0|||
161222117|NCT00656019|582194239|FG003|Overall Study|Not Eligible|0|||
161222118|NCT00656019|582194236|FG000|Overall Study|Withdrawal by Subject|2|||
161222119|NCT00656019|582194237|FG001|Overall Study|Withdrawal by Subject|0|||
161222120|NCT00656019|582194238|FG002|Overall Study|Withdrawal by Subject|0|||
161222121|NCT00656019|582194239|FG003|Overall Study|Withdrawal by Subject|0|||
161222122|NCT00656019|582194236|FG000|Overall Study|Lost to Follow-up|2|||
161222123|NCT00656019|582194237|FG001|Overall Study|Lost to Follow-up|1|||
161222124|NCT00656019|582194238|FG002|Overall Study|Lost to Follow-up|0|||
161222125|NCT00656019|582194239|FG003|Overall Study|Lost to Follow-up|0|||
161222126|NCT00859469|582194242|FG000|Overall Study|Adverse Event|2|||
161222127|NCT00859469|582194242|FG000|Overall Study|Lack of Efficacy|9|||
161222128|NCT00859469|582194242|FG000|Overall Study|Withdrawal by Subject|1|||
161222129|NCT00859469|582194242|FG000|Overall Study|Death|16|||
161222130|NCT04071769|582194243|FG000|Overall Study|Lost to Follow-up|3|||
161222131|NCT04071769|582194243|FG000|Overall Study|Physician Decision|2|||
161222132|NCT04071769|582194243|FG000|Overall Study|Withdrawal by Subject|8|||
161222133|NCT00669955|582194244|FG000|Overall Study|Adverse Event|3|||
161222134|NCT00669955|582194245|FG001|Overall Study|Adverse Event|5|||
161222135|NCT00669955|582194244|FG000|Overall Study|Death|0|||
161222136|NCT00669955|582194245|FG001|Overall Study|Death|1|||
161222137|NCT00669955|582194244|FG000|Overall Study|Withdrawal by Subject|2|||
161222138|NCT00669955|582194245|FG001|Overall Study|Withdrawal by Subject|3|||
161222139|NCT00669955|582194244|FG000|Overall Study|Lost to Follow-up|5|||
161222140|NCT00669955|582194245|FG001|Overall Study|Lost to Follow-up|7|||
161222141|NCT00669955|582194244|FG000|Overall Study|Protocol Violation|2|||
161222142|NCT00669955|582194245|FG001|Overall Study|Protocol Violation|7|||
161222143|NCT00669955|582194244|FG000|Overall Study|Investigator Sponsor Judgement|0|||
161222144|NCT00669955|582194245|FG001|Overall Study|Investigator Sponsor Judgement|1|||
161222145|NCT00669955|582194244|FG000|Overall Study|not compliant with study drug/visit|2|||
161222146|NCT00669955|582194245|FG001|Overall Study|not compliant with study drug/visit|3|||
161222147|NCT01890707|582194246|FG000|Overall Study|Lost to Follow-up|1|||
161222148|NCT01890707|582194247|FG001|Overall Study|Lost to Follow-up|1|||
161222149|NCT00356200|582195393|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
161222150|NCT00356200|582195394|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
161222151|NCT00356200|582195393|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
161222152|NCT00356200|582195394|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
161222153|NCT02909673|582195395|FG000|Overall Study|Did not meet inclusion criteria|129|||
161222154|NCT02909673|582195396|FG001|Overall Study|Did not meet inclusion criteria|29|||
161222155|NCT02909673|582195395|FG000|Overall Study|Surveys lost by scanner|95|||
161222156|NCT02909673|582195396|FG001|Overall Study|Surveys lost by scanner|2|||
161222157|NCT02909673|582195395|FG000|Overall Study|Tracking info missing|0|||
161222158|NCT02909673|582195396|FG001|Overall Study|Tracking info missing|5|||
161222159|NCT00783796|582195399|FG000|Overall Study|Did not receive any stent|4|||
161222160|NCT00783796|582195399|FG000|Overall Study|Received non-XIENCE V stent|1|||
161222161|NCT00783796|582195399|FG000|Overall Study|Received commercial XIENCE V stent|1|||
161222162|NCT01215942|582195400|FG000|Treatment Period|Adverse Event|15|||
161222163|NCT01215942|582195401|FG001|Treatment Period|Adverse Event|26|||
161222164|NCT01215942|582195400|FG000|Treatment Period|Death|2|||
161222165|NCT01215942|582195401|FG001|Treatment Period|Death|4|||
161222166|NCT01215942|582195400|FG000|Treatment Period|Lack of Efficacy|23|||
161222167|NCT01215942|582195401|FG001|Treatment Period|Lack of Efficacy|62|||
161222168|NCT01215942|582195400|FG000|Treatment Period|Lost to Follow-up|3|||
161222169|NCT01215942|582195401|FG001|Treatment Period|Lost to Follow-up|4|||
161222170|NCT01215942|582195400|FG000|Treatment Period|Withdrawal by Subject|17|||
161222171|NCT01215942|582195401|FG001|Treatment Period|Withdrawal by Subject|40|||
161222172|NCT01215942|582195400|FG000|Treatment Period|Physician Decision|5|||
161222173|NCT01215942|582195401|FG001|Treatment Period|Physician Decision|5|||
161222174|NCT01215942|582195400|FG000|Treatment Period|Protocol Violation|0|||
161222175|NCT01215942|582195401|FG001|Treatment Period|Protocol Violation|1|||
161222176|NCT01215942|582195400|FG000|Treatment Period|Sponsor Decision|349|||
161222177|NCT01215942|582195401|FG001|Treatment Period|Sponsor Decision|530|||
161222178|NCT01215942|582195400|FG000|Post-Treatment Follow-Up Period|Death|0|||
161222179|NCT01215942|582195401|FG001|Post-Treatment Follow-Up Period|Death|1|||
161222180|NCT01215942|582195400|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161222181|NCT01215942|582195401|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161222182|NCT01215942|582195400|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
161222183|NCT01215942|582195401|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
161222184|NCT01215942|582195400|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
161222185|NCT01215942|582195401|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
161222186|NCT01215942|582195400|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
161222187|NCT01215942|582195401|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
161222188|NCT03305055|582195402|FG000|Overall Study|Withdrawal by Subject|0|||
161222189|NCT03305055|582195403|FG001|Overall Study|Withdrawal by Subject|1|||
161222190|NCT03305055|582195402|FG000|Overall Study|Adverse Event|1|||
161222191|NCT03305055|582195403|FG001|Overall Study|Adverse Event|1|||
161222192|NCT02540356|582195404|FG000|Overall Study|Terminated due to disease progression|1|||
161222193|NCT02540356|582195405|FG001|Overall Study|Terminated due to disease progression|0|||
161222194|NCT01399736|582195406|FG000|Overall Study|Withdrawal by Subject|4|||
161222195|NCT01399736|582195407|FG001|Overall Study|Withdrawal by Subject|2|||
161222196|NCT01399736|582195406|FG000|Overall Study|Lost to Follow-up|0|||
161222197|NCT01399736|582195407|FG001|Overall Study|Lost to Follow-up|2|||
161222198|NCT03500484|582195408|FG000|Overall Study|Adverse Event|2|||
161222199|NCT03500484|582195409|FG001|Overall Study|Adverse Event|0|||
161222200|NCT03500484|582195408|FG000|Overall Study|Physician Decision|1|||
161222201|NCT03500484|582195409|FG001|Overall Study|Physician Decision|0|||
161222202|NCT03500484|582195408|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
161222203|NCT03500484|582195409|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
161222204|NCT02795104|582195410|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
160874486|NCT00486291|580934235|FG001|Overall Study|Lost to Follow-up|7|||
161222205|NCT02795104|582195411|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
161222206|NCT02795104|582195412|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
161222207|NCT02795104|582195410|FG000|Overall Study|Withdrawal by Subject|0|||
161222208|NCT02795104|582195411|FG001|Overall Study|Withdrawal by Subject|2|||
161222209|NCT02795104|582195412|FG002|Overall Study|Withdrawal by Subject|0|||
161222210|NCT02795104|582195410|FG000|Overall Study|Lost to Follow-up|0|||
161222211|NCT02795104|582195411|FG001|Overall Study|Lost to Follow-up|0|||
161222212|NCT02795104|582195412|FG002|Overall Study|Lost to Follow-up|1|||
161222213|NCT03335371|582195413|FG000|Overall Study|Lost to Follow-up|0|||
161222214|NCT03335371|582195414|FG001|Overall Study|Lost to Follow-up|0|||
161222215|NCT03335371|582195415|FG002|Overall Study|Lost to Follow-up|0|||
161117882|NCT02425826|581820288|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
161117883|NCT02425826|581820289|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
161117884|NCT02425826|581820290|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
161117885|NCT02425826|581820288|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
161117886|NCT02425826|581820289|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
161117887|NCT02425826|581820290|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
161117888|NCT02425826|581820288|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
161117889|NCT02425826|581820289|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
161117890|NCT02425826|581820290|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
161117891|NCT02425826|581820288|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
161117892|NCT02425826|581820289|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
161117893|NCT02425826|581820290|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
161117894|NCT02425826|581820288|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
161117895|NCT02425826|581820289|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
161117896|NCT02425826|581820290|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
161117897|NCT02425826|581820288|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
161117898|NCT02425826|581820289|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
161117899|NCT02425826|581820290|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
161117900|NCT02425826|581820288|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
161117901|NCT02425826|581820289|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
161117902|NCT02425826|581820290|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
161117903|NCT02425826|581820288|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
161117904|NCT02425826|581820289|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
161117905|NCT02425826|581820290|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
161117906|NCT02500121|581820291|FG000|Overall Study|Lost to Follow-up|0|||
161117907|NCT02500121|581820292|FG001|Overall Study|Lost to Follow-up|1|||
161117908|NCT02500121|581820291|FG000|Overall Study|Withdrawal by Subject|1|||
161117909|NCT02500121|581820292|FG001|Overall Study|Withdrawal by Subject|1|||
161117910|NCT02500121|581820291|FG000|Overall Study|Death|26|||
161117911|NCT02500121|581820292|FG001|Overall Study|Death|24|||
161117912|NCT04942925|581820294|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161117913|NCT04942925|581820295|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161117914|NCT04942925|581820294|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
161117915|NCT04942925|581820295|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
161117916|NCT02124564|581820296|FG000|Treatment Period|Adverse Event|2|||
161117917|NCT02124564|581820296|FG000|Treatment Period|Lack of Efficacy|3|||
161117918|NCT02124564|581820296|FG000|Treatment Period|Withdrawal by Subject|2|||
161117919|NCT01344876|581820297|FG000|Overall Study|Adverse Event|0|||
161117920|NCT01344876|581820298|FG001|Overall Study|Adverse Event|0|||
161117921|NCT01344876|581820299|FG002|Overall Study|Adverse Event|0|||
161117922|NCT01344876|581820300|FG003|Overall Study|Adverse Event|0|||
161117923|NCT01344876|581820301|FG004|Overall Study|Adverse Event|1|||
161117924|NCT01344876|581820297|FG000|Overall Study|Withdrawal by Subject|0|||
161117925|NCT01344876|581820298|FG001|Overall Study|Withdrawal by Subject|0|||
161117926|NCT01344876|581820299|FG002|Overall Study|Withdrawal by Subject|1|||
161117927|NCT01344876|581820300|FG003|Overall Study|Withdrawal by Subject|0|||
161117928|NCT01344876|581820301|FG004|Overall Study|Withdrawal by Subject|0|||
161117929|NCT01344876|581820297|FG000|Overall Study|Definite progression of primary disease|1|||
161117930|NCT01344876|581820298|FG001|Overall Study|Definite progression of primary disease|0|||
161117931|NCT01344876|581820299|FG002|Overall Study|Definite progression of primary disease|0|||
161117932|NCT01344876|581820300|FG003|Overall Study|Definite progression of primary disease|3|||
161117933|NCT01344876|581820301|FG004|Overall Study|Definite progression of primary disease|0|||
161117934|NCT05107765|581820302|FG000|Overall Study|Lost to Follow-up|4|||
161117935|NCT05107765|581820303|FG001|Overall Study|Lost to Follow-up|1|||
161117936|NCT05107765|581820302|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
161117937|NCT05107765|581820303|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
161117938|NCT05107765|581820302|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
161117939|NCT05107765|581820303|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
161117940|NCT03368170|581821973|FG000|Overall Study|Adverse Event|2|||
161117941|NCT03368170|581821974|FG001|Overall Study|Adverse Event|1|||
161117942|NCT03047980|581821975|FG000|Overall Study|Adverse Event|1|||
161117943|NCT02164981|581821976|FG000|Started|Withdrawal by Subject|2|||
161117944|NCT02164981|581821977|FG001|Started|Withdrawal by Subject|1|||
161117945|NCT02164981|581821978|FG002|Started|Withdrawal by Subject|0|||
161117946|NCT02164981|581821976|FG000|Started|Protocol Violation|2|||
161117947|NCT02164981|581821977|FG001|Started|Protocol Violation|0|||
161117948|NCT02164981|581821978|FG002|Started|Protocol Violation|0|||
161117949|NCT02164981|581821976|FG000|Started|Adverse Event|1|||
161117950|NCT02164981|581821977|FG001|Started|Adverse Event|2|||
161117951|NCT02164981|581821978|FG002|Started|Adverse Event|0|||
161222216|NCT03335371|582195416|FG003|Overall Study|Lost to Follow-up|0|||
161222217|NCT03335371|582195417|FG004|Overall Study|Lost to Follow-up|1|||
161222218|NCT03335371|582195413|FG000|Overall Study|Withdrawal by Subject|0|||
161222219|NCT03335371|582195414|FG001|Overall Study|Withdrawal by Subject|0|||
161222220|NCT03335371|582195415|FG002|Overall Study|Withdrawal by Subject|0|||
161222221|NCT03335371|582195416|FG003|Overall Study|Withdrawal by Subject|0|||
161222222|NCT03335371|582195417|FG004|Overall Study|Withdrawal by Subject|1|||
161222223|NCT03335371|582195413|FG000|Overall Study|Randomization Error|0|||
161222224|NCT03335371|582195414|FG001|Overall Study|Randomization Error|0|||
161222225|NCT03335371|582195415|FG002|Overall Study|Randomization Error|1|||
161222226|NCT03335371|582195416|FG003|Overall Study|Randomization Error|0|||
161222227|NCT03335371|582195417|FG004|Overall Study|Randomization Error|0|||
161222228|NCT00998881|582195421|FG000|Overall Study|Adverse Event|2|||
161222229|NCT00998881|582195422|FG001|Overall Study|Adverse Event|2|||
161222230|NCT00998881|582195421|FG000|Overall Study|Lack of Efficacy|1|||
161222231|NCT00998881|582195422|FG001|Overall Study|Lack of Efficacy|0|||
161222232|NCT00998881|582195421|FG000|Overall Study|Physician Decision|3|||
161222233|NCT00998881|582195422|FG001|Overall Study|Physician Decision|0|||
161222234|NCT00998881|582195421|FG000|Overall Study|Withdrawal by Subject|1|||
161222235|NCT00998881|582195422|FG001|Overall Study|Withdrawal by Subject|0|||
161222236|NCT00998881|582195421|FG000|Overall Study|Personal matter|1|||
161222237|NCT00998881|582195422|FG001|Overall Study|Personal matter|0|||
161117952|NCT02164981|581821976|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
161117953|NCT02164981|581821977|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
161117954|NCT02164981|581821978|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
161117955|NCT02164981|581821976|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
161117956|NCT02164981|581821977|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
161117957|NCT02164981|581821978|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
161117958|NCT02164981|581821976|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
161117959|NCT02164981|581821977|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
161117960|NCT02164981|581821978|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
161117961|NCT01761266|581821984|FG000|Overall Study|Death|415|||
161117962|NCT01761266|581821985|FG001|Overall Study|Death|402|||
161117963|NCT01761266|581821984|FG000|Overall Study|Lost to Follow-up|8|||
161117964|NCT01761266|581821985|FG001|Overall Study|Lost to Follow-up|12|||
161117965|NCT01761266|581821984|FG000|Overall Study|Withdrawal by Subject|14|||
161117966|NCT01761266|581821985|FG001|Overall Study|Withdrawal by Subject|10|||
161117967|NCT01761266|581821984|FG000|Overall Study|Sponsor Decision|41|||
161117968|NCT01761266|581821985|FG001|Overall Study|Sponsor Decision|52|||
161117969|NCT01662440|581821986|FG000|Overall Study|Adverse Event|1|||
161117970|NCT01662440|581821987|FG001|Overall Study|Adverse Event|0|||
161117971|NCT01662440|581821988|FG002|Overall Study|Adverse Event|0|||
161117972|NCT01662440|581821989|FG003|Overall Study|Adverse Event|1|||
161117973|NCT01662440|581821986|FG000|Overall Study|Death|0|||
161117974|NCT01662440|581821987|FG001|Overall Study|Death|1|||
161117975|NCT01662440|581821988|FG002|Overall Study|Death|0|||
161117976|NCT01662440|581821989|FG003|Overall Study|Death|0|||
161117977|NCT01662440|581821986|FG000|Overall Study|Lost to Follow-up|2|||
161117978|NCT01662440|581821987|FG001|Overall Study|Lost to Follow-up|2|||
161117979|NCT01662440|581821988|FG002|Overall Study|Lost to Follow-up|4|||
161117980|NCT01662440|581821989|FG003|Overall Study|Lost to Follow-up|1|||
161117981|NCT01662440|581821986|FG000|Overall Study|Subject moved to another country.|0|||
161117982|NCT01662440|581821987|FG001|Overall Study|Subject moved to another country.|1|||
161117983|NCT01662440|581821988|FG002|Overall Study|Subject moved to another country.|0|||
161117984|NCT01662440|581821989|FG003|Overall Study|Subject moved to another country.|0|||
161117985|NCT01662440|581821986|FG000|Overall Study|Protocol Violation|1|||
161117986|NCT01662440|581821987|FG001|Overall Study|Protocol Violation|0|||
161117987|NCT01662440|581821988|FG002|Overall Study|Protocol Violation|0|||
161117988|NCT01662440|581821989|FG003|Overall Study|Protocol Violation|0|||
161117989|NCT01662440|581821986|FG000|Overall Study|Withdrawal by Subject|5|||
161117990|NCT01662440|581821987|FG001|Overall Study|Withdrawal by Subject|2|||
161117991|NCT01662440|581821988|FG002|Overall Study|Withdrawal by Subject|2|||
161117992|NCT01662440|581821989|FG003|Overall Study|Withdrawal by Subject|2|||
161117993|NCT00112905|581821990|FG000|Overall Study|Adverse Event|4|||
161117994|NCT00112905|581821990|FG000|Overall Study|Death|1|||
161117995|NCT00112905|581821990|FG000|Overall Study|Ineligibility|5|||
161117996|NCT00112905|581821990|FG000|Overall Study|Alternative treatment|1|||
161117997|NCT00112905|581821990|FG000|Overall Study|performance status was deteiorating|1|||
161117998|NCT01765673|581821991|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
161117999|NCT02600507|581821992|FG000|Overall Study|Adverse Event|3|||
161118000|NCT02600507|581821993|FG001|Overall Study|Adverse Event|15|||
161118001|NCT02600507|581821994|FG002|Overall Study|Adverse Event|5|||
161118002|NCT02600507|581821992|FG000|Overall Study|Lack of Efficacy|3|||
161118003|NCT02600507|581821993|FG001|Overall Study|Lack of Efficacy|8|||
161118004|NCT02600507|581821994|FG002|Overall Study|Lack of Efficacy|5|||
161118005|NCT02600507|581821992|FG000|Overall Study|Lost to Follow-up|3|||
161118006|NCT02600507|581821993|FG001|Overall Study|Lost to Follow-up|5|||
161118007|NCT02600507|581821994|FG002|Overall Study|Lost to Follow-up|2|||
161118008|NCT02600507|581821992|FG000|Overall Study|Protocol Violation|12|||
161222238|NCT02649231|582195425|FG000|Overall Study|Adverse Event|0|||
161222239|NCT02649231|582195426|FG001|Overall Study|Adverse Event|0|||
161222240|NCT02649231|582195427|FG002|Overall Study|Adverse Event|0|||
161222241|NCT02649231|582195428|FG003|Overall Study|Adverse Event|1|||
161222242|NCT02649231|582195425|FG000|Overall Study|Lost to Follow-up|2|||
161222243|NCT02649231|582195426|FG001|Overall Study|Lost to Follow-up|1|||
161222244|NCT02649231|582195427|FG002|Overall Study|Lost to Follow-up|1|||
161222245|NCT02649231|582195428|FG003|Overall Study|Lost to Follow-up|0|||
161222246|NCT02649231|582195425|FG000|Overall Study|Withdrawal by Subject|0|||
161222247|NCT02649231|582195426|FG001|Overall Study|Withdrawal by Subject|1|||
161222248|NCT02649231|582195427|FG002|Overall Study|Withdrawal by Subject|0|||
161222249|NCT02649231|582195428|FG003|Overall Study|Withdrawal by Subject|1|||
161222250|NCT02649231|582195425|FG000|Overall Study|Protocol Violation|2|||
161222251|NCT02649231|582195426|FG001|Overall Study|Protocol Violation|1|||
161222252|NCT02649231|582195427|FG002|Overall Study|Protocol Violation|1|||
161222253|NCT02649231|582195428|FG003|Overall Study|Protocol Violation|0|||
161222254|NCT02970669|582195429|FG000|Double-blind Period|Adverse Event|4|||
161222255|NCT02970669|582195430|FG001|Double-blind Period|Adverse Event|0|||
161222256|NCT02970669|582195429|FG000|Double-blind Period|Death|1|||
161222257|NCT02970669|582195430|FG001|Double-blind Period|Death|0|||
161222258|NCT02970669|582195429|FG000|Double-blind Period|Study terminated by sponsor|1|||
161222259|NCT02970669|582195430|FG001|Double-blind Period|Study terminated by sponsor|2|||
161222260|NCT02970669|582195429|FG000|Double-blind Period|Physician Decision|0|||
161222261|NCT02970669|582195430|FG001|Double-blind Period|Physician Decision|2|||
161222262|NCT02970669|582195429|FG000|Double-blind Period|Withdrawal by Subject|2|||
161222263|NCT02970669|582195430|FG001|Double-blind Period|Withdrawal by Subject|2|||
161222264|NCT02970669|582195429|FG000|Open-label Period|Withdrawal by Subject|2|||
161222265|NCT02970669|582195430|FG001|Open-label Period|Withdrawal by Subject|2|||
161222266|NCT02970669|582195429|FG000|Open-label Period|Adverse Event|1|||
161222267|NCT02970669|582195430|FG001|Open-label Period|Adverse Event|0|||
161222268|NCT02970669|582195429|FG000|Open-label Period|Physician Decision|1|||
161222269|NCT02970669|582195430|FG001|Open-label Period|Physician Decision|0|||
161222270|NCT00876733|582195433|FG000|Overall Study|Adverse Event|34|||
161222271|NCT00876733|582195434|FG001|Overall Study|Adverse Event|20|||
161222272|NCT00876733|582195435|FG002|Overall Study|Adverse Event|10|||
161222273|NCT00876733|582195436|FG003|Overall Study|Adverse Event|3|||
161222274|NCT00876733|582195433|FG000|Overall Study|Lack of Efficacy|17|||
161222275|NCT00876733|582195434|FG001|Overall Study|Lack of Efficacy|9|||
161222276|NCT00876733|582195435|FG002|Overall Study|Lack of Efficacy|10|||
161222277|NCT00876733|582195436|FG003|Overall Study|Lack of Efficacy|1|||
161222278|NCT00876733|582195433|FG000|Overall Study|Lost to Follow-up|26|||
161222279|NCT00876733|582195434|FG001|Overall Study|Lost to Follow-up|10|||
161222280|NCT00876733|582195435|FG002|Overall Study|Lost to Follow-up|3|||
161222281|NCT00876733|582195436|FG003|Overall Study|Lost to Follow-up|2|||
161222282|NCT00876733|582195433|FG000|Overall Study|Data not available|14|||
161222283|NCT00876733|582195434|FG001|Overall Study|Data not available|3|||
161222284|NCT00876733|582195435|FG002|Overall Study|Data not available|7|||
161222285|NCT00876733|582195436|FG003|Overall Study|Data not available|1|||
161222286|NCT02611752|582195439|FG000|Overall Study|Adverse Event|0|||
161222287|NCT02611752|582195440|FG001|Overall Study|Adverse Event|1|||
161222288|NCT03521999|582195441|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
161222289|NCT03521999|582195442|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
161222290|NCT03521999|582195441|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
161222291|NCT03521999|582195442|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
161222292|NCT03521999|582195441|FG000|Completed 3 Month Follow up|Death|0|||
161222293|NCT03521999|582195442|FG001|Completed 3 Month Follow up|Death|1|||
161222294|NCT03521999|582195441|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
161222295|NCT03521999|582195442|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
161222296|NCT03495986|582195445|FG000|Overall Study|Physician Decision|1|||
161222297|NCT03495986|582195446|FG001|Overall Study|Physician Decision|0|||
161222298|NCT03495986|582195445|FG000|Overall Study|Withdrawal by Subject|1|||
161222299|NCT03495986|582195446|FG001|Overall Study|Withdrawal by Subject|1|||
161222300|NCT03495986|582195445|FG000|Overall Study|Withdrawal by Subject|1|||
161222301|NCT03495986|582195446|FG001|Overall Study|Withdrawal by Subject|0|||
161222302|NCT04182204|582195447|FG000|Safety Run-in|Lost to Follow-up|1|||
161222303|NCT04182204|582195448|FG001|Safety Run-in|Lost to Follow-up|0|||
161222304|NCT04182204|582195449|FG002|Safety Run-in|Lost to Follow-up|0|||
161222305|NCT04182204|582195447|FG000|Safety Run-in|Withdrawal by Subject|2|||
161222306|NCT04182204|582195448|FG001|Safety Run-in|Withdrawal by Subject|0|||
161222307|NCT04182204|582195449|FG002|Safety Run-in|Withdrawal by Subject|0|||
161222308|NCT04182204|582195447|FG000|Safety Run-in|Death|7|||
161222309|NCT04182204|582195448|FG001|Safety Run-in|Death|0|||
161222310|NCT04182204|582195449|FG002|Safety Run-in|Death|0|||
161222311|NCT04182204|582195447|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
161222312|NCT04182204|582195448|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
161222313|NCT04182204|582195449|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
161222314|NCT04182204|582195447|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
161222315|NCT04182204|582195448|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
161222316|NCT04182204|582195449|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
161222317|NCT04182204|582195447|FG000|Randomized Controlled Trial|Death|0|||
161222318|NCT04182204|582195448|FG001|Randomized Controlled Trial|Death|83|||
161222319|NCT04182204|582195449|FG002|Randomized Controlled Trial|Death|66|||
161222320|NCT05476679|582195450|FG000|Overall Study|Withdrawal by Subject|0|||
161222321|NCT05476679|582195451|FG001|Overall Study|Withdrawal by Subject|0|||
161222322|NCT05476679|582195452|FG002|Overall Study|Withdrawal by Subject|0|||
161222323|NCT05476679|582195453|FG003|Overall Study|Withdrawal by Subject|1|||
161222324|NCT05476679|582195454|FG004|Overall Study|Withdrawal by Subject|0|||
161222325|NCT05476679|582195450|FG000|Overall Study|Lost to Follow-up|0|||
161222326|NCT05476679|582195451|FG001|Overall Study|Lost to Follow-up|0|||
161222327|NCT05476679|582195452|FG002|Overall Study|Lost to Follow-up|0|||
161222328|NCT05476679|582195453|FG003|Overall Study|Lost to Follow-up|1|||
161222329|NCT05476679|582195454|FG004|Overall Study|Lost to Follow-up|0|||
161222330|NCT01214330|582195455|FG000|Overall Study|Withdrawal by Subject|2|||
161222331|NCT01214330|582195455|FG000|Overall Study|Withdrawal by Subject|2|||
161222332|NCT00249821|582195456|FG000|Overall Study|Technical problem|0|||
161222333|NCT00249821|582195457|FG001|Overall Study|Technical problem|1|||
161222334|NCT00686036|582195460|FG000|Overall Study|Adverse Event|3|||
161222335|NCT00686036|582195461|FG001|Overall Study|Adverse Event|0|||
161222336|NCT00686036|582195460|FG000|Overall Study|Withdrawal by Subject|3|||
161222337|NCT00686036|582195461|FG001|Overall Study|Withdrawal by Subject|1|||
161222338|NCT00686036|582195460|FG000|Overall Study|Study terminated by AstraZeneca|2|||
161222339|NCT00686036|582195461|FG001|Overall Study|Study terminated by AstraZeneca|1|||
161222340|NCT00686036|582195460|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
161222341|NCT00686036|582195461|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
161222342|NCT00686036|582195460|FG000|Overall Study|Other reasons not identified|0|||
161222343|NCT00686036|582195461|FG001|Overall Study|Other reasons not identified|4|||
161222344|NCT01411995|582195462|FG000|Overall Study|Failed IUD insertion|0|||
161222345|NCT01411995|582195463|FG001|Overall Study|Failed IUD insertion|1|||
161222346|NCT03212170|582195464|FG000|Overall Study|Withdrawal by Subject|1|||
161222347|NCT01937364|582195465|FG000|Overall Study|Adverse Event|2|||
161222348|NCT01937364|582195466|FG001|Overall Study|Adverse Event|1|||
161222349|NCT00467584|582195467|FG000|Overall Study|Withdrawal by Subject|4|||
161222350|NCT00467584|582195468|FG001|Overall Study|Withdrawal by Subject|5|||
161222351|NCT00467584|582195469|FG002|Overall Study|Withdrawal by Subject|1|||
161222352|NCT02482571|582195470|FG000|Overall Study|Adverse Event|1|||
161222353|NCT02482571|582195470|FG000|Overall Study|Scanner or Respiract failure|3|||
161222354|NCT02482571|582195470|FG000|Overall Study|Withdrawal by Subject|4|||
161222355|NCT01498484|582195474|FG000|Overall Study|Death|6|||
161222356|NCT01498484|582195475|FG001|Overall Study|Death|3|||
161222357|NCT01498484|582195476|FG002|Overall Study|Death|1|||
161222358|NCT01498484|582195477|FG003|Overall Study|Death|1|||
161222359|NCT01498484|582195478|FG004|Overall Study|Death|0|||
161222360|NCT01498484|582195479|FG005|Overall Study|Death|0|||
161222361|NCT01498484|582195480|FG006|Overall Study|Death|10|||
161222362|NCT01498484|582195481|FG007|Overall Study|Death|1|||
161222363|NCT01498484|582195482|FG008|Overall Study|Death|0|||
161222364|NCT01498484|582195474|FG000|Overall Study|Physician Decision|3|||
161222365|NCT01498484|582195475|FG001|Overall Study|Physician Decision|2|||
161222366|NCT01498484|582195476|FG002|Overall Study|Physician Decision|1|||
161222367|NCT01498484|582195477|FG003|Overall Study|Physician Decision|1|||
161222368|NCT01498484|582195478|FG004|Overall Study|Physician Decision|0|||
161222369|NCT01498484|582195479|FG005|Overall Study|Physician Decision|0|||
161222370|NCT01498484|582195480|FG006|Overall Study|Physician Decision|8|||
161222371|NCT01498484|582195481|FG007|Overall Study|Physician Decision|13|||
161222372|NCT01498484|582195482|FG008|Overall Study|Physician Decision|1|||
161222373|NCT01498484|582195474|FG000|Overall Study|Adverse Event|0|||
161222374|NCT01498484|582195475|FG001|Overall Study|Adverse Event|0|||
161222375|NCT01498484|582195476|FG002|Overall Study|Adverse Event|0|||
161222376|NCT01498484|582195477|FG003|Overall Study|Adverse Event|0|||
161222377|NCT01498484|582195478|FG004|Overall Study|Adverse Event|0|||
161222378|NCT01498484|582195479|FG005|Overall Study|Adverse Event|1|||
161324432|NCT00320788|582573602|FG001|Overall Study|Decision by the Sponsor|1|||
161324433|NCT00320788|582573603|FG002|Overall Study|Decision by the Sponsor|0|||
161222379|NCT01498484|582195480|FG006|Overall Study|Adverse Event|0|||
161222380|NCT01498484|582195481|FG007|Overall Study|Adverse Event|0|||
161222381|NCT01498484|582195482|FG008|Overall Study|Adverse Event|0|||
161222382|NCT01498484|582195474|FG000|Overall Study|Withdrawal by Subject|0|||
161222383|NCT01498484|582195475|FG001|Overall Study|Withdrawal by Subject|0|||
161222384|NCT01498484|582195476|FG002|Overall Study|Withdrawal by Subject|0|||
161222385|NCT01498484|582195477|FG003|Overall Study|Withdrawal by Subject|1|||
161222386|NCT01498484|582195478|FG004|Overall Study|Withdrawal by Subject|0|||
161222387|NCT01498484|582195479|FG005|Overall Study|Withdrawal by Subject|0|||
161222388|NCT01498484|582195480|FG006|Overall Study|Withdrawal by Subject|1|||
161222389|NCT01498484|582195481|FG007|Overall Study|Withdrawal by Subject|0|||
161222390|NCT01498484|582195482|FG008|Overall Study|Withdrawal by Subject|0|||
161222391|NCT01498484|582195474|FG000|Overall Study|Other|5|||
161324434|NCT00320788|582573604|FG003|Overall Study|Decision by the Sponsor|0|||
161222392|NCT01498484|582195475|FG001|Overall Study|Other|2|||
161222393|NCT01498484|582195476|FG002|Overall Study|Other|0|||
161222394|NCT01498484|582195477|FG003|Overall Study|Other|0|||
161222395|NCT01498484|582195478|FG004|Overall Study|Other|1|||
161222396|NCT01498484|582195479|FG005|Overall Study|Other|0|||
161222397|NCT01498484|582195480|FG006|Overall Study|Other|3|||
161222398|NCT01498484|582195481|FG007|Overall Study|Other|0|||
161222399|NCT01498484|582195482|FG008|Overall Study|Other|1|||
161222400|NCT05550532|582195486|FG000|Overall Study|Withdrawal by Subject|8|||
161222401|NCT05550532|582195487|FG001|Overall Study|Withdrawal by Subject|3|||
161222402|NCT05550532|582195486|FG000|Overall Study|Adverse Event|2|||
161222403|NCT05550532|582195487|FG001|Overall Study|Adverse Event|3|||
161222404|NCT05550532|582195486|FG000|Overall Study|Lost to Follow-up|4|||
161222405|NCT05550532|582195487|FG001|Overall Study|Lost to Follow-up|0|||
161222406|NCT05550532|582195486|FG000|Overall Study|Other|0|||
161222407|NCT05550532|582195487|FG001|Overall Study|Other|4|||
161222408|NCT03626857|582195491|FG000|Overall Study|Adverse Event|9|||
161222409|NCT03626857|582195492|FG001|Overall Study|Adverse Event|7|||
161222410|NCT03626857|582195491|FG000|Overall Study|Lost to Follow-up|8|||
161222411|NCT03626857|582195492|FG001|Overall Study|Lost to Follow-up|8|||
161222412|NCT03626857|582195491|FG000|Overall Study|Withdrawal by Subject|2|||
161222413|NCT03626857|582195492|FG001|Overall Study|Withdrawal by Subject|2|||
161222414|NCT03626857|582195491|FG000|Overall Study|Protocol Violation|1|||
161222415|NCT03626857|582195492|FG001|Overall Study|Protocol Violation|3|||
161222416|NCT01301833|582195493|FG000|Overall Study|Adverse Event|7|||
161222417|NCT01301833|582195494|FG001|Overall Study|Adverse Event|5|||
161222418|NCT01301833|582195495|FG002|Overall Study|Adverse Event|5|||
161222419|NCT01301833|582195496|FG003|Overall Study|Adverse Event|5|||
161222420|NCT01301833|582195493|FG000|Overall Study|Lack of Efficacy|1|||
161222421|NCT01301833|582195494|FG001|Overall Study|Lack of Efficacy|1|||
161222422|NCT01301833|582195495|FG002|Overall Study|Lack of Efficacy|0|||
161222423|NCT01301833|582195496|FG003|Overall Study|Lack of Efficacy|0|||
161222424|NCT01301833|582195493|FG000|Overall Study|Physician Decision|3|||
161222425|NCT01301833|582195494|FG001|Overall Study|Physician Decision|1|||
161222426|NCT01301833|582195495|FG002|Overall Study|Physician Decision|1|||
161222427|NCT01301833|582195496|FG003|Overall Study|Physician Decision|0|||
161222428|NCT01301833|582195493|FG000|Overall Study|Withdrawal by Subject|3|||
161222429|NCT01301833|582195494|FG001|Overall Study|Withdrawal by Subject|1|||
161222430|NCT01301833|582195495|FG002|Overall Study|Withdrawal by Subject|1|||
161222431|NCT01301833|582195496|FG003|Overall Study|Withdrawal by Subject|2|||
161222432|NCT01301833|582195493|FG000|Overall Study|Personal matter|1|||
161222433|NCT01301833|582195494|FG001|Overall Study|Personal matter|0|||
161222434|NCT01301833|582195495|FG002|Overall Study|Personal matter|0|||
161222435|NCT01301833|582195496|FG003|Overall Study|Personal matter|0|||
161222436|NCT04820842|582197098|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161222437|NCT04820842|582197099|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
161222438|NCT04820842|582197100|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
161222439|NCT04820842|582197101|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161222440|NCT04820842|582197102|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161222441|NCT04820842|582197103|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161222442|NCT04820842|582197104|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
161222443|NCT04820842|582197098|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
161222444|NCT04820842|582197099|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
161222445|NCT04820842|582197100|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
161222446|NCT04820842|582197101|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222447|NCT04820842|582197102|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222448|NCT04820842|582197103|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222449|NCT04820842|582197104|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222450|NCT04820842|582197098|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161222451|NCT04820842|582197099|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
161222452|NCT04820842|582197100|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161222453|NCT04820842|582197101|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161222454|NCT04820842|582197102|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161222455|NCT04820842|582197103|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161222456|NCT04820842|582197104|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
161222457|NCT04820842|582197098|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222458|NCT04820842|582197099|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222459|NCT04820842|582197100|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222460|NCT04820842|582197101|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
161222461|NCT04820842|582197102|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222462|NCT04820842|582197103|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
161222463|NCT04820842|582197104|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
161222464|NCT01691508|582197105|FG000|Overall Study|Adverse Event|3|||
161222465|NCT01691508|582197106|FG001|Overall Study|Adverse Event|3|||
161222466|NCT01691508|582197105|FG000|Overall Study|Withdrawal by Subject|1|||
161222467|NCT01691508|582197106|FG001|Overall Study|Withdrawal by Subject|0|||
161222468|NCT01296932|582197107|FG000|Overall Study|Dose limiting toxicity|0|||
161222469|NCT01296932|582197108|FG001|Overall Study|Dose limiting toxicity|0|||
161222470|NCT01296932|582197109|FG002|Overall Study|Dose limiting toxicity|0|||
161222471|NCT01296932|582197110|FG003|Overall Study|Dose limiting toxicity|0|||
161222472|NCT01296932|582197111|FG004|Overall Study|Dose limiting toxicity|0|||
161222473|NCT01296932|582197112|FG005|Overall Study|Dose limiting toxicity|0|||
161222474|NCT01296932|582197113|FG006|Overall Study|Dose limiting toxicity|1|||
161222475|NCT01296932|582197114|FG007|Overall Study|Dose limiting toxicity|0|||
161222476|NCT01296932|582197115|FG008|Overall Study|Dose limiting toxicity|1|||
161222477|NCT01296932|582197107|FG000|Overall Study|Progressive disease|2|||
161222478|NCT01296932|582197108|FG001|Overall Study|Progressive disease|0|||
161222479|NCT01296932|582197109|FG002|Overall Study|Progressive disease|1|||
161222480|NCT01296932|582197110|FG003|Overall Study|Progressive disease|1|||
161222481|NCT01296932|582197111|FG004|Overall Study|Progressive disease|2|||
161222482|NCT01296932|582197112|FG005|Overall Study|Progressive disease|3|||
161222483|NCT01296932|582197113|FG006|Overall Study|Progressive disease|1|||
161222484|NCT01296932|582197114|FG007|Overall Study|Progressive disease|0|||
161222485|NCT01296932|582197115|FG008|Overall Study|Progressive disease|0|||
161222486|NCT01296932|582197107|FG000|Overall Study|Withdrawal by Subject|0|||
161222487|NCT01296932|582197108|FG001|Overall Study|Withdrawal by Subject|0|||
161222488|NCT01296932|582197109|FG002|Overall Study|Withdrawal by Subject|1|||
161222489|NCT01296932|582197110|FG003|Overall Study|Withdrawal by Subject|1|||
161222490|NCT01296932|582197111|FG004|Overall Study|Withdrawal by Subject|0|||
161222491|NCT01296932|582197112|FG005|Overall Study|Withdrawal by Subject|0|||
161222492|NCT01296932|582197113|FG006|Overall Study|Withdrawal by Subject|3|||
161222493|NCT01296932|582197114|FG007|Overall Study|Withdrawal by Subject|0|||
161222494|NCT01296932|582197115|FG008|Overall Study|Withdrawal by Subject|0|||
161222495|NCT01296932|582197107|FG000|Overall Study|Adverse Event|1|||
161222496|NCT01296932|582197108|FG001|Overall Study|Adverse Event|1|||
161222497|NCT01296932|582197109|FG002|Overall Study|Adverse Event|1|||
161222498|NCT01296932|582197110|FG003|Overall Study|Adverse Event|2|||
161222499|NCT01296932|582197111|FG004|Overall Study|Adverse Event|1|||
161222500|NCT01296932|582197112|FG005|Overall Study|Adverse Event|0|||
161222501|NCT01296932|582197113|FG006|Overall Study|Adverse Event|0|||
161222502|NCT01296932|582197114|FG007|Overall Study|Adverse Event|0|||
161222503|NCT01296932|582197115|FG008|Overall Study|Adverse Event|1|||
161222504|NCT01296932|582197107|FG000|Overall Study|Investigator decision|0|||
161222505|NCT01296932|582197108|FG001|Overall Study|Investigator decision|1|||
161222506|NCT01296932|582197109|FG002|Overall Study|Investigator decision|0|||
161222507|NCT01296932|582197110|FG003|Overall Study|Investigator decision|1|||
161222508|NCT01296932|582197111|FG004|Overall Study|Investigator decision|0|||
161222509|NCT01296932|582197112|FG005|Overall Study|Investigator decision|0|||
161222510|NCT01296932|582197113|FG006|Overall Study|Investigator decision|1|||
161222511|NCT01296932|582197114|FG007|Overall Study|Investigator decision|0|||
161222512|NCT01296932|582197115|FG008|Overall Study|Investigator decision|1|||
161222513|NCT01296932|582197107|FG000|Overall Study|No clinical benefit anymore|0|||
161222514|NCT01296932|582197108|FG001|Overall Study|No clinical benefit anymore|1|||
161222515|NCT01296932|582197109|FG002|Overall Study|No clinical benefit anymore|0|||
161222516|NCT01296932|582197110|FG003|Overall Study|No clinical benefit anymore|0|||
161222517|NCT01296932|582197111|FG004|Overall Study|No clinical benefit anymore|0|||
161222518|NCT01296932|582197112|FG005|Overall Study|No clinical benefit anymore|0|||
161222519|NCT01296932|582197113|FG006|Overall Study|No clinical benefit anymore|0|||
161222520|NCT01296932|582197114|FG007|Overall Study|No clinical benefit anymore|0|||
161222521|NCT01296932|582197115|FG008|Overall Study|No clinical benefit anymore|0|||
161222522|NCT01296932|582197107|FG000|Overall Study|Physician Decision|0|||
161222523|NCT01296932|582197108|FG001|Overall Study|Physician Decision|0|||
161222524|NCT01296932|582197109|FG002|Overall Study|Physician Decision|1|||
161222525|NCT01296932|582197110|FG003|Overall Study|Physician Decision|0|||
161222526|NCT01296932|582197111|FG004|Overall Study|Physician Decision|0|||
161222527|NCT01296932|582197112|FG005|Overall Study|Physician Decision|0|||
161222528|NCT01296932|582197113|FG006|Overall Study|Physician Decision|0|||
161222529|NCT01296932|582197114|FG007|Overall Study|Physician Decision|0|||
161222530|NCT01296932|582197115|FG008|Overall Study|Physician Decision|0|||
161222531|NCT01296932|582197107|FG000|Overall Study|IV problems, administration not possible|0|||
161222532|NCT01296932|582197108|FG001|Overall Study|IV problems, administration not possible|0|||
160874487|NCT00486291|580934234|FG000|Overall Study|protocol non-compliance|10|||
160874488|NCT00486291|580934235|FG001|Overall Study|protocol non-compliance|15|||
161118009|NCT02600507|581821993|FG001|Overall Study|Protocol Violation|4|||
161118010|NCT02600507|581821994|FG002|Overall Study|Protocol Violation|4|||
161118011|NCT02600507|581821992|FG000|Overall Study|Physician Decision|1|||
161118012|NCT02600507|581821993|FG001|Overall Study|Physician Decision|0|||
161118013|NCT02600507|581821994|FG002|Overall Study|Physician Decision|1|||
161118014|NCT02600507|581821992|FG000|Overall Study|Withdrawal by Subject|7|||
161118015|NCT02600507|581821993|FG001|Overall Study|Withdrawal by Subject|11|||
161118016|NCT02600507|581821994|FG002|Overall Study|Withdrawal by Subject|7|||
161118017|NCT02600507|581821992|FG000|Overall Study|Other|0|||
161118018|NCT02600507|581821993|FG001|Overall Study|Other|1|||
161118019|NCT02600507|581821994|FG002|Overall Study|Other|1|||
161118020|NCT04541004|581821999|FG000|Overall Study|Adverse Event|2|||
161118021|NCT05048719|581822000|FG000|Overall Study|Withdrawal by Subject|2|||
161118022|NCT05048719|581822001|FG001|Overall Study|Withdrawal by Subject|1|||
161118023|NCT05048719|581822002|FG002|Overall Study|Withdrawal by Subject|3|||
161118024|NCT05048719|581822003|FG003|Overall Study|Withdrawal by Subject|1|||
161118025|NCT05048719|581822004|FG004|Overall Study|Withdrawal by Subject|0|||
161118026|NCT05048719|581822005|FG005|Overall Study|Withdrawal by Subject|2|||
161118027|NCT05048719|581822006|FG006|Overall Study|Withdrawal by Subject|1|||
161118028|NCT05048719|581822007|FG007|Overall Study|Withdrawal by Subject|1|||
161118029|NCT05048719|581822008|FG008|Overall Study|Withdrawal by Subject|0|||
161118030|NCT05048719|581822000|FG000|Overall Study|Death|1|||
161118031|NCT05048719|581822001|FG001|Overall Study|Death|0|||
161118032|NCT05048719|581822002|FG002|Overall Study|Death|0|||
161118033|NCT05048719|581822003|FG003|Overall Study|Death|0|||
161118034|NCT05048719|581822004|FG004|Overall Study|Death|0|||
161118035|NCT05048719|581822005|FG005|Overall Study|Death|0|||
161118036|NCT05048719|581822006|FG006|Overall Study|Death|0|||
161118037|NCT05048719|581822007|FG007|Overall Study|Death|0|||
161118038|NCT05048719|581822008|FG008|Overall Study|Death|0|||
161118039|NCT05048719|581822000|FG000|Overall Study|Adverse Event|0|||
161118040|NCT05048719|581822001|FG001|Overall Study|Adverse Event|1|||
161118041|NCT05048719|581822002|FG002|Overall Study|Adverse Event|2|||
161118042|NCT05048719|581822003|FG003|Overall Study|Adverse Event|0|||
161118043|NCT05048719|581822004|FG004|Overall Study|Adverse Event|1|||
161118044|NCT05048719|581822005|FG005|Overall Study|Adverse Event|0|||
161118045|NCT05048719|581822006|FG006|Overall Study|Adverse Event|0|||
161118046|NCT05048719|581822007|FG007|Overall Study|Adverse Event|0|||
161118047|NCT05048719|581822008|FG008|Overall Study|Adverse Event|0|||
161118048|NCT05048719|581822000|FG000|Overall Study|Lost to Follow-up|0|||
161118049|NCT05048719|581822001|FG001|Overall Study|Lost to Follow-up|0|||
161118050|NCT05048719|581822002|FG002|Overall Study|Lost to Follow-up|1|||
161118051|NCT05048719|581822003|FG003|Overall Study|Lost to Follow-up|3|||
161118052|NCT05048719|581822004|FG004|Overall Study|Lost to Follow-up|1|||
161118053|NCT05048719|581822005|FG005|Overall Study|Lost to Follow-up|1|||
161118054|NCT05048719|581822006|FG006|Overall Study|Lost to Follow-up|1|||
161118055|NCT05048719|581822007|FG007|Overall Study|Lost to Follow-up|1|||
161118056|NCT05048719|581822008|FG008|Overall Study|Lost to Follow-up|0|||
161118057|NCT05048719|581822000|FG000|Overall Study|Physician Decision|0|||
161118058|NCT05048719|581822001|FG001|Overall Study|Physician Decision|0|||
161118059|NCT05048719|581822002|FG002|Overall Study|Physician Decision|0|||
161118060|NCT05048719|581822003|FG003|Overall Study|Physician Decision|0|||
161118061|NCT05048719|581822004|FG004|Overall Study|Physician Decision|0|||
161118062|NCT05048719|581822005|FG005|Overall Study|Physician Decision|0|||
161118063|NCT05048719|581822006|FG006|Overall Study|Physician Decision|0|||
161118064|NCT05048719|581822007|FG007|Overall Study|Physician Decision|1|||
161118065|NCT05048719|581822008|FG008|Overall Study|Physician Decision|1|||
161118066|NCT05048719|581822000|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
161118067|NCT05048719|581822001|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118068|NCT05048719|581822002|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118069|NCT05048719|581822003|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118070|NCT05048719|581822004|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118071|NCT05048719|581822005|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118072|NCT05048719|581822006|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
160874489|NCT00486291|580934234|FG000|Overall Study|requirement for restricted medication|0|||
161118073|NCT05048719|581822007|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118074|NCT05048719|581822008|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
161118075|NCT05048719|581822000|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118076|NCT05048719|581822001|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
161118077|NCT05048719|581822002|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118078|NCT05048719|581822003|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118079|NCT05048719|581822004|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118080|NCT05048719|581822005|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118081|NCT05048719|581822006|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118082|NCT05048719|581822007|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118083|NCT05048719|581822008|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
161118084|NCT05048719|581822000|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118085|NCT05048719|581822001|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
161118086|NCT05048719|581822002|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118087|NCT05048719|581822003|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118088|NCT05048719|581822004|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118089|NCT05048719|581822005|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118090|NCT05048719|581822006|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118091|NCT05048719|581822007|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118092|NCT05048719|581822008|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
161118093|NCT05048719|581822000|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118094|NCT05048719|581822001|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118095|NCT05048719|581822002|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118096|NCT05048719|581822003|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
161118097|NCT05048719|581822004|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118098|NCT05048719|581822005|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118099|NCT05048719|581822006|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118100|NCT05048719|581822007|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118101|NCT05048719|581822008|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
161118102|NCT05048719|581822000|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118103|NCT05048719|581822001|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118104|NCT05048719|581822002|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118105|NCT05048719|581822003|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118106|NCT05048719|581822004|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118107|NCT05048719|581822005|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
161118108|NCT05048719|581822006|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118109|NCT05048719|581822007|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118110|NCT05048719|581822008|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
161118111|NCT00605085|581822009|FG000|Overall Study|Withdrawal by Subject|8|||
161118112|NCT00605085|581822010|FG001|Overall Study|Withdrawal by Subject|5|||
161118113|NCT00605085|581822009|FG000|Overall Study|Adverse Event|9|||
161118114|NCT00605085|581822010|FG001|Overall Study|Adverse Event|5|||
161118115|NCT00605085|581822009|FG000|Overall Study|Pregnancy|2|||
161118116|NCT00605085|581822010|FG001|Overall Study|Pregnancy|0|||
161118117|NCT00605085|581822009|FG000|Overall Study|Protocol Violation|3|||
161118118|NCT00605085|581822010|FG001|Overall Study|Protocol Violation|2|||
161118119|NCT00605085|581822009|FG000|Overall Study|Lost to Follow-up|10|||
161118120|NCT00605085|581822010|FG001|Overall Study|Lost to Follow-up|5|||
161118121|NCT00605085|581822009|FG000|Overall Study|administrative reasons|18|||
161118122|NCT00605085|581822010|FG001|Overall Study|administrative reasons|8|||
161118123|NCT03257267|581822011|FG000|Overall Study|Adverse Event|17|||
161118124|NCT03257267|581822012|FG001|Overall Study|Adverse Event|7|||
161118125|NCT03257267|581822011|FG000|Overall Study|Death|96|||
161118126|NCT03257267|581822012|FG001|Overall Study|Death|98|||
161118127|NCT03257267|581822011|FG000|Overall Study|Lost to Follow-up|2|||
161118128|NCT03257267|581822012|FG001|Overall Study|Lost to Follow-up|2|||
161118129|NCT03257267|581822011|FG000|Overall Study|Non-compliance with Study Drug|0|||
161222533|NCT01296932|582197109|FG002|Overall Study|IV problems, administration not possible|1|||
161222534|NCT01296932|582197110|FG003|Overall Study|IV problems, administration not possible|0|||
161222535|NCT01296932|582197111|FG004|Overall Study|IV problems, administration not possible|0|||
161222536|NCT01296932|582197112|FG005|Overall Study|IV problems, administration not possible|0|||
161222537|NCT01296932|582197113|FG006|Overall Study|IV problems, administration not possible|0|||
161222538|NCT01296932|582197114|FG007|Overall Study|IV problems, administration not possible|0|||
161222539|NCT01296932|582197115|FG008|Overall Study|IV problems, administration not possible|0|||
161222540|NCT01296932|582197107|FG000|Overall Study|per protocol|0|||
161222541|NCT01296932|582197108|FG001|Overall Study|per protocol|0|||
161222542|NCT01296932|582197109|FG002|Overall Study|per protocol|1|||
161222543|NCT01296932|582197110|FG003|Overall Study|per protocol|1|||
161222544|NCT01296932|582197111|FG004|Overall Study|per protocol|0|||
161222545|NCT01296932|582197112|FG005|Overall Study|per protocol|0|||
161222546|NCT01296932|582197113|FG006|Overall Study|per protocol|0|||
161222547|NCT01296932|582197114|FG007|Overall Study|per protocol|0|||
161222548|NCT01296932|582197115|FG008|Overall Study|per protocol|0|||
161118130|NCT03257267|581822012|FG001|Overall Study|Non-compliance with Study Drug|2|||
161118131|NCT03257267|581822011|FG000|Overall Study|Participant Decision|35|||
161118132|NCT03257267|581822012|FG001|Overall Study|Participant Decision|43|||
161118133|NCT03257267|581822011|FG000|Overall Study|Sponsor Decision|1|||
161118134|NCT03257267|581822012|FG001|Overall Study|Sponsor Decision|0|||
161118135|NCT03257267|581822011|FG000|Overall Study|Physician Decision|1|||
161118136|NCT03257267|581822012|FG001|Overall Study|Physician Decision|3|||
161118137|NCT03257267|581822011|FG000|Overall Study|Disease Progression|109|||
161118138|NCT03257267|581822012|FG001|Overall Study|Disease Progression|121|||
161118139|NCT03257267|581822011|FG000|Overall Study|Withdrawal by Subject|8|||
161118140|NCT03257267|581822012|FG001|Overall Study|Withdrawal by Subject|26|||
161118141|NCT03257267|581822011|FG000|Overall Study|Other|0|||
161118142|NCT03257267|581822012|FG001|Overall Study|Other|2|||
161118143|NCT03445000|581822013|FG000|Overall Study|Disease progression|8|||
161118144|NCT03445000|581822013|FG000|Overall Study|Adverse Event|3|||
161118145|NCT03445000|581822013|FG000|Overall Study|Death|2|||
161118146|NCT03445000|581822013|FG000|Overall Study|Physician Decision|1|||
161118147|NCT03409744|581822014|FG000|Overall Study|Death|2|||
161118148|NCT03409744|581822014|FG000|Overall Study|Physician Decision|5|||
161118149|NCT03409744|581822014|FG000|Overall Study|Pregnancy|1|||
161118150|NCT03409744|581822014|FG000|Overall Study|Lost to Follow-up|1|||
161118151|NCT03409744|581822014|FG000|Overall Study|Protocol Violation|1|||
161118152|NCT04872101|581822015|FG000|Overall Study|Withdrawal by Subject|10|||
161118153|NCT04872101|581822016|FG001|Overall Study|Withdrawal by Subject|16|||
161118154|NCT04872101|581822015|FG000|Overall Study|Lack of Efficacy|6|||
161118155|NCT04872101|581822016|FG001|Overall Study|Lack of Efficacy|14|||
161118156|NCT04872101|581822015|FG000|Overall Study|Adverse Event|1|||
161118157|NCT04872101|581822016|FG001|Overall Study|Adverse Event|6|||
161118158|NCT04872101|581822015|FG000|Overall Study|Lost to Follow-up|2|||
161118159|NCT04872101|581822016|FG001|Overall Study|Lost to Follow-up|1|||
161118160|NCT04872101|581822015|FG000|Overall Study|Pregnancy|2|||
161118161|NCT04872101|581822016|FG001|Overall Study|Pregnancy|0|||
161118162|NCT04872101|581822015|FG000|Overall Study|Prohibited Medication|1|||
161118163|NCT04872101|581822016|FG001|Overall Study|Prohibited Medication|0|||
161118164|NCT04872101|581822015|FG000|Overall Study|Not dosed|1|||
161118165|NCT04872101|581822016|FG001|Overall Study|Not dosed|0|||
161118166|NCT05804877|581822017|FG000|Overall Study|Lost to Follow-up|1|||
161118167|NCT05804877|581822018|FG001|Overall Study|Lost to Follow-up|3|||
161118168|NCT05804877|581822017|FG000|Overall Study|Withdrawal by Subject|1|||
161118169|NCT05804877|581822018|FG001|Overall Study|Withdrawal by Subject|0|||
161118170|NCT05804877|581822017|FG000|Overall Study|Withdrawal by Subject|1|||
161118171|NCT05804877|581822018|FG001|Overall Study|Withdrawal by Subject|0|||
161118172|NCT00879229|581822019|FG000|Overall Study|Study terminated by Sponsor|13|||
161118173|NCT00879229|581822020|FG001|Overall Study|Study terminated by Sponsor|12|||
161118174|NCT00879229|581822019|FG000|Overall Study|Death|4|||
161118175|NCT00879229|581822020|FG001|Overall Study|Death|2|||
161118176|NCT00879229|581822019|FG000|Overall Study|Adverse Event|2|||
161118177|NCT00879229|581822020|FG001|Overall Study|Adverse Event|0|||
161118178|NCT00879229|581822019|FG000|Overall Study|Withdrawal by Subject|1|||
161118179|NCT00879229|581822020|FG001|Overall Study|Withdrawal by Subject|0|||
161118180|NCT00879229|581822019|FG000|Overall Study|Clinical status did not improve|1|||
161118181|NCT00879229|581822020|FG001|Overall Study|Clinical status did not improve|0|||
161118182|NCT00879229|581822019|FG000|Overall Study|Other|1|||
161118183|NCT00879229|581822020|FG001|Overall Study|Other|0|||
161118184|NCT00264004|581822021|FG000|Overall Study|Adverse Event|2|||
161118185|NCT00264004|581822022|FG001|Overall Study|Adverse Event|3|||
161118186|NCT00264004|581822023|FG002|Overall Study|Adverse Event|6|||
161118187|NCT00264004|581822024|FG003|Overall Study|Adverse Event|4|||
161118188|NCT00264004|581822021|FG000|Overall Study|Withdrawal by Subject|0|||
161118189|NCT00264004|581822022|FG001|Overall Study|Withdrawal by Subject|1|||
161118190|NCT00264004|581822023|FG002|Overall Study|Withdrawal by Subject|2|||
161118191|NCT00264004|581822024|FG003|Overall Study|Withdrawal by Subject|2|||
161118192|NCT00264004|581822021|FG000|Overall Study|Other|2|||
161118193|NCT00264004|581822022|FG001|Overall Study|Other|2|||
161118194|NCT00264004|581822023|FG002|Overall Study|Other|0|||
161118195|NCT00264004|581822024|FG003|Overall Study|Other|3|||
161118196|NCT00264004|581822021|FG000|Overall Study|Development study specific disc. crit.|1|||
161222549|NCT01296932|582197107|FG000|Overall Study|Low benefit and too many side effects|0|||
161118197|NCT00264004|581822022|FG001|Overall Study|Development study specific disc. crit.|0|||
161118198|NCT00264004|581822023|FG002|Overall Study|Development study specific disc. crit.|1|||
161118199|NCT00264004|581822024|FG003|Overall Study|Development study specific disc. crit.|0|||
161118200|NCT00264004|581822021|FG000|Overall Study|Cond. under inv. worsened|9|||
161118201|NCT00264004|581822022|FG001|Overall Study|Cond. under inv. worsened|5|||
161118202|NCT00264004|581822023|FG002|Overall Study|Cond. under inv. worsened|3|||
161118203|NCT00264004|581822024|FG003|Overall Study|Cond. under inv. worsened|4|||
161118204|NCT00264004|581822021|FG000|Overall Study|Not treated|3|||
161118205|NCT00264004|581822022|FG001|Overall Study|Not treated|0|||
161118206|NCT00264004|581822023|FG002|Overall Study|Not treated|2|||
161118207|NCT00264004|581822024|FG003|Overall Study|Not treated|2|||
161118208|NCT02475681|581822025|FG000|Overall Study|Death|16|||
161118209|NCT02475681|581822026|FG001|Overall Study|Death|6|||
161118210|NCT02475681|581822027|FG002|Overall Study|Death|9|||
161118211|NCT02475681|581822025|FG000|Overall Study|Physician Decision|0|||
161118212|NCT02475681|581822026|FG001|Overall Study|Physician Decision|3|||
161118213|NCT02475681|581822027|FG002|Overall Study|Physician Decision|1|||
161118214|NCT02475681|581822025|FG000|Overall Study|Withdrawal by Subject|12|||
161118215|NCT02475681|581822026|FG001|Overall Study|Withdrawal by Subject|6|||
161118216|NCT02475681|581822027|FG002|Overall Study|Withdrawal by Subject|9|||
161118217|NCT02475681|581822025|FG000|Overall Study|Lost to Follow-up|2|||
161118218|NCT02475681|581822026|FG001|Overall Study|Lost to Follow-up|1|||
161118219|NCT02475681|581822027|FG002|Overall Study|Lost to Follow-up|3|||
161118220|NCT02475681|581822025|FG000|Overall Study|Ongoing in Study|0|||
161118221|NCT02475681|581822026|FG001|Overall Study|Ongoing in Study|163|||
161118222|NCT02475681|581822027|FG002|Overall Study|Ongoing in Study|157|||
161118223|NCT02475681|581822025|FG000|Overall Study|Reasons other than above listed|2|||
161118224|NCT02475681|581822026|FG001|Overall Study|Reasons other than above listed|0|||
161118225|NCT02475681|581822027|FG002|Overall Study|Reasons other than above listed|0|||
161118226|NCT01262365|581822031|FG000|Overall Study|Lack of Efficacy|35|||
161118227|NCT01262365|581822032|FG001|Overall Study|Lack of Efficacy|30|||
161118228|NCT01262365|581822033|FG002|Overall Study|Lack of Efficacy|47|||
161118229|NCT01262365|581822031|FG000|Overall Study|Protocol Violation|3|||
161118230|NCT01262365|581822032|FG001|Overall Study|Protocol Violation|1|||
161118231|NCT01262365|581822033|FG002|Overall Study|Protocol Violation|1|||
161118232|NCT01262365|581822031|FG000|Overall Study|Lost to Follow-up|3|||
161118233|NCT01262365|581822032|FG001|Overall Study|Lost to Follow-up|7|||
161118234|NCT01262365|581822033|FG002|Overall Study|Lost to Follow-up|6|||
161118235|NCT01262365|581822031|FG000|Overall Study|Withdrawal by Subject|17|||
161118236|NCT01262365|581822032|FG001|Overall Study|Withdrawal by Subject|22|||
161118237|NCT01262365|581822033|FG002|Overall Study|Withdrawal by Subject|22|||
161118238|NCT01262365|581822031|FG000|Overall Study|Death|1|||
161118239|NCT01262365|581822032|FG001|Overall Study|Death|2|||
161118240|NCT01262365|581822033|FG002|Overall Study|Death|1|||
161118241|NCT01262365|581822031|FG000|Overall Study|Adverse Event|26|||
161118242|NCT01262365|581822032|FG001|Overall Study|Adverse Event|16|||
161118243|NCT01262365|581822033|FG002|Overall Study|Adverse Event|11|||
161118244|NCT01262365|581822031|FG000|Overall Study|sponsor decision|1|||
161118245|NCT01262365|581822032|FG001|Overall Study|sponsor decision|1|||
161118246|NCT01262365|581822033|FG002|Overall Study|sponsor decision|0|||
161118247|NCT01262365|581822031|FG000|Overall Study|Randomization error|1|||
161118248|NCT01262365|581822032|FG001|Overall Study|Randomization error|0|||
161118249|NCT01262365|581822033|FG002|Overall Study|Randomization error|2|||
161118250|NCT01262365|581822031|FG000|Overall Study|Non-compliance|1|||
161118251|NCT01262365|581822032|FG001|Overall Study|Non-compliance|0|||
161118252|NCT01262365|581822033|FG002|Overall Study|Non-compliance|2|||
161118253|NCT01262365|581822031|FG000|Overall Study|Suspected pregnancy|1|||
161118254|NCT01262365|581822032|FG001|Overall Study|Suspected pregnancy|0|||
161118255|NCT01262365|581822033|FG002|Overall Study|Suspected pregnancy|0|||
161118256|NCT01262365|581822031|FG000|Overall Study|Patient pregnant|1|||
161118257|NCT01262365|581822032|FG001|Overall Study|Patient pregnant|0|||
161118258|NCT01262365|581822033|FG002|Overall Study|Patient pregnant|1|||
161118259|NCT01262365|581822031|FG000|Overall Study|Toxicity related to study drug|0|||
161118260|NCT01262365|581822032|FG001|Overall Study|Toxicity related to study drug|1|||
161118261|NCT01262365|581822033|FG002|Overall Study|Toxicity related to study drug|0|||
161118262|NCT01262365|581822031|FG000|Overall Study|Cannot tolerate the protocol|0|||
161118263|NCT01262365|581822032|FG001|Overall Study|Cannot tolerate the protocol|1|||
161118264|NCT01262365|581822033|FG002|Overall Study|Cannot tolerate the protocol|0|||
161118265|NCT01262365|581822031|FG000|Overall Study|Patient unavailable|0|||
161118266|NCT01262365|581822032|FG001|Overall Study|Patient unavailable|0|||
161118267|NCT01262365|581822033|FG002|Overall Study|Patient unavailable|1|||
161118268|NCT01592760|581822037|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
161222550|NCT01296932|582197108|FG001|Overall Study|Low benefit and too many side effects|0|||
161118269|NCT01592760|581822038|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
161118270|NCT01592760|581822039|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
161118271|NCT04312009|581822040|FG000|Overall Study|Withdrawal by Subject|2|||
161118272|NCT04312009|581822041|FG001|Overall Study|Withdrawal by Subject|1|||
161118273|NCT02354703|581822044|FG000|Overall Study|Withdrawal by Subject|1|||
161118274|NCT02354703|581822045|FG001|Overall Study|Withdrawal by Subject|1|||
161118275|NCT02354703|581822046|FG002|Overall Study|Withdrawal by Subject|1|||
161118276|NCT02354703|581822047|FG003|Overall Study|Withdrawal by Subject|1|||
161118277|NCT02354703|581822044|FG000|Overall Study|Lost to Follow-up|2|||
161118278|NCT02354703|581822045|FG001|Overall Study|Lost to Follow-up|7|||
161118279|NCT02354703|581822046|FG002|Overall Study|Lost to Follow-up|9|||
161118280|NCT02354703|581822047|FG003|Overall Study|Lost to Follow-up|2|||
161118281|NCT02354703|581822044|FG000|Overall Study|Adverse Event|0|||
161118282|NCT02354703|581822045|FG001|Overall Study|Adverse Event|0|||
161118283|NCT02354703|581822046|FG002|Overall Study|Adverse Event|1|||
161118284|NCT02354703|581822047|FG003|Overall Study|Adverse Event|0|||
161118285|NCT04681170|581822056|FG000|Stratified Enrolment & run-in|Death|1|||
161222551|NCT01296932|582197109|FG002|Overall Study|Low benefit and too many side effects|0|||
161222552|NCT01296932|582197110|FG003|Overall Study|Low benefit and too many side effects|0|||
161222553|NCT01296932|582197111|FG004|Overall Study|Low benefit and too many side effects|0|||
161222554|NCT01296932|582197112|FG005|Overall Study|Low benefit and too many side effects|0|||
161222555|NCT01296932|582197113|FG006|Overall Study|Low benefit and too many side effects|0|||
161222556|NCT01296932|582197114|FG007|Overall Study|Low benefit and too many side effects|1|||
161222557|NCT01296932|582197115|FG008|Overall Study|Low benefit and too many side effects|0|||
161222558|NCT01296932|582197107|FG000|Overall Study|No adequate treatment response|0|||
161222559|NCT01296932|582197108|FG001|Overall Study|No adequate treatment response|0|||
161222560|NCT01296932|582197109|FG002|Overall Study|No adequate treatment response|0|||
161222561|NCT01296932|582197110|FG003|Overall Study|No adequate treatment response|0|||
161222562|NCT01296932|582197111|FG004|Overall Study|No adequate treatment response|0|||
161222563|NCT01296932|582197112|FG005|Overall Study|No adequate treatment response|0|||
161222564|NCT01296932|582197113|FG006|Overall Study|No adequate treatment response|0|||
161222565|NCT01296932|582197114|FG007|Overall Study|No adequate treatment response|1|||
161222566|NCT01296932|582197115|FG008|Overall Study|No adequate treatment response|0|||
161222567|NCT01296932|582197107|FG000|Overall Study|Dosage already reduced, AE still present|0|||
161222568|NCT01296932|582197108|FG001|Overall Study|Dosage already reduced, AE still present|0|||
161222569|NCT01296932|582197109|FG002|Overall Study|Dosage already reduced, AE still present|0|||
161222570|NCT01296932|582197110|FG003|Overall Study|Dosage already reduced, AE still present|0|||
161222571|NCT01296932|582197111|FG004|Overall Study|Dosage already reduced, AE still present|0|||
161222572|NCT01296932|582197112|FG005|Overall Study|Dosage already reduced, AE still present|0|||
161222573|NCT01296932|582197113|FG006|Overall Study|Dosage already reduced, AE still present|0|||
161222574|NCT01296932|582197114|FG007|Overall Study|Dosage already reduced, AE still present|0|||
161222575|NCT01296932|582197115|FG008|Overall Study|Dosage already reduced, AE still present|1|||
161222576|NCT02489318|582197118|FG000|Randomized|Withdrawal by Subject|0|||
161222577|NCT02489318|582197119|FG001|Randomized|Withdrawal by Subject|1|||
161222578|NCT02489318|582197118|FG000|Treated|Adverse Event|19|||
161222579|NCT02489318|582197119|FG001|Treated|Adverse Event|62|||
161222580|NCT02489318|582197118|FG000|Treated|Death|13|||
161222581|NCT02489318|582197119|FG001|Treated|Death|11|||
161222582|NCT02489318|582197118|FG000|Treated|Physician Decision|4|||
161222583|NCT02489318|582197119|FG001|Treated|Physician Decision|6|||
161222584|NCT02489318|582197118|FG000|Treated|Protocol Violation|1|||
161222585|NCT02489318|582197119|FG001|Treated|Protocol Violation|2|||
161222586|NCT02489318|582197118|FG000|Treated|Withdrawal by Subject|37|||
161222587|NCT02489318|582197119|FG001|Treated|Withdrawal by Subject|36|||
161222588|NCT02489318|582197118|FG000|Treated|Other: Progressive Disease|245|||
161222589|NCT02489318|582197119|FG001|Treated|Other: Progressive Disease|138|||
161222590|NCT02489318|582197118|FG000|Treated|Other|0|||
161222591|NCT02489318|582197119|FG001|Treated|Other|2|||
161222592|NCT02489318|582197118|FG000|Treated|Ongoing|0|||
161222593|NCT02489318|582197119|FG001|Treated|Ongoing|267|||
161222594|NCT02637557|582197125|FG000|Overall Study|Adverse Event|3|||
161222595|NCT02637557|582197126|FG001|Overall Study|Adverse Event|1|||
161222596|NCT02637557|582197127|FG002|Overall Study|Adverse Event|3|||
161222597|NCT02637557|582197128|FG003|Overall Study|Adverse Event|3|||
161222598|NCT02637557|582197125|FG000|Overall Study|Lost to Follow-up|1|||
161222599|NCT02637557|582197126|FG001|Overall Study|Lost to Follow-up|1|||
161222600|NCT02637557|582197127|FG002|Overall Study|Lost to Follow-up|0|||
161222601|NCT02637557|582197128|FG003|Overall Study|Lost to Follow-up|1|||
161222602|NCT02637557|582197125|FG000|Overall Study|Physician Decision|1|||
161222603|NCT02637557|582197126|FG001|Overall Study|Physician Decision|0|||
161222604|NCT02637557|582197127|FG002|Overall Study|Physician Decision|0|||
161222605|NCT02637557|582197128|FG003|Overall Study|Physician Decision|0|||
161222606|NCT02637557|582197125|FG000|Overall Study|Protocol Violation|2|||
161222607|NCT02637557|582197126|FG001|Overall Study|Protocol Violation|0|||
161222608|NCT02637557|582197127|FG002|Overall Study|Protocol Violation|2|||
161222609|NCT02637557|582197128|FG003|Overall Study|Protocol Violation|1|||
161222610|NCT02637557|582197125|FG000|Overall Study|Withdrawal by Subject|1|||
161222611|NCT02637557|582197126|FG001|Overall Study|Withdrawal by Subject|3|||
161222612|NCT02637557|582197127|FG002|Overall Study|Withdrawal by Subject|4|||
161222613|NCT02637557|582197128|FG003|Overall Study|Withdrawal by Subject|2|||
161222614|NCT05218655|582197129|FG000|Overall Study|Adverse Event|6|||
161222615|NCT05218655|582197129|FG000|Overall Study|Sponsor's decision|85|||
161222616|NCT05218655|582197129|FG000|Overall Study|Death|1|||
161222617|NCT05218655|582197129|FG000|Overall Study|Lost to Follow-up|3|||
161222618|NCT05218655|582197129|FG000|Overall Study|Withdrawal by Subject|3|||
161222619|NCT05218655|582197129|FG000|Overall Study|Other than specified|3|||
161222620|NCT02228382|582197132|FG000|Overall Study|Death|5|||
161222621|NCT02228382|582197133|FG001|Overall Study|Death|7|||
161222622|NCT02228382|582197134|FG002|Overall Study|Death|5|||
161222623|NCT02228382|582197135|FG003|Overall Study|Death|0|||
161222624|NCT02228382|582197136|FG004|Overall Study|Death|2|||
161222625|NCT02228382|582197132|FG000|Overall Study|Participant refused further follow-up|0|||
161222626|NCT02228382|582197133|FG001|Overall Study|Participant refused further follow-up|0|||
161222627|NCT02228382|582197134|FG002|Overall Study|Participant refused further follow-up|1|||
161222628|NCT02228382|582197135|FG003|Overall Study|Participant refused further follow-up|0|||
161222629|NCT02228382|582197136|FG004|Overall Study|Participant refused further follow-up|0|||
161222630|NCT02228382|582197132|FG000|Overall Study|Study terminated by sponsor|3|||
161222631|NCT02228382|582197133|FG001|Overall Study|Study terminated by sponsor|5|||
161222632|NCT02228382|582197134|FG002|Overall Study|Study terminated by sponsor|7|||
161222633|NCT02228382|582197135|FG003|Overall Study|Study terminated by sponsor|0|||
161222634|NCT02228382|582197136|FG004|Overall Study|Study terminated by sponsor|0|||
161222635|NCT02228382|582197132|FG000|Overall Study|Lost to Follow-up|0|||
161222636|NCT02228382|582197133|FG001|Overall Study|Lost to Follow-up|0|||
161222637|NCT02228382|582197134|FG002|Overall Study|Lost to Follow-up|3|||
161222638|NCT02228382|582197135|FG003|Overall Study|Lost to Follow-up|1|||
161222639|NCT02228382|582197136|FG004|Overall Study|Lost to Follow-up|0|||
161222640|NCT02228382|582197132|FG000|Overall Study|Withdrawal by Subject|0|||
161222641|NCT02228382|582197133|FG001|Overall Study|Withdrawal by Subject|3|||
161222642|NCT02228382|582197134|FG002|Overall Study|Withdrawal by Subject|2|||
161222643|NCT02228382|582197135|FG003|Overall Study|Withdrawal by Subject|1|||
161222644|NCT02228382|582197136|FG004|Overall Study|Withdrawal by Subject|0|||
161222645|NCT02228382|582197132|FG000|Overall Study|Other|2|||
161222646|NCT02228382|582197133|FG001|Overall Study|Other|3|||
161222647|NCT02228382|582197134|FG002|Overall Study|Other|3|||
161222648|NCT02228382|582197135|FG003|Overall Study|Other|0|||
161222649|NCT02228382|582197136|FG004|Overall Study|Other|0|||
161222650|NCT02396381|582197137|FG000|Overall Study|Adverse Event|3|||
161222651|NCT02396381|582197138|FG001|Overall Study|Adverse Event|2|||
161222652|NCT02396381|582197137|FG000|Overall Study|Withdrawal by Subject|33|||
161222653|NCT02396381|582197138|FG001|Overall Study|Withdrawal by Subject|24|||
161222654|NCT02396381|582197137|FG000|Overall Study|Lost to Follow-up|49|||
161222655|NCT02396381|582197138|FG001|Overall Study|Lost to Follow-up|31|||
161222656|NCT02396381|582197137|FG000|Overall Study|Protocol Violation|1|||
161222657|NCT02396381|582197138|FG001|Overall Study|Protocol Violation|0|||
161222658|NCT02396381|582197137|FG000|Overall Study|Site terminated by sponsor|7|||
161222659|NCT02396381|582197138|FG001|Overall Study|Site terminated by sponsor|8|||
161222660|NCT02396381|582197137|FG000|Overall Study|Physician Decision|5|||
161222661|NCT02396381|582197138|FG001|Overall Study|Physician Decision|5|||
161222662|NCT02396381|582197137|FG000|Overall Study|Pregnancy|2|||
161222663|NCT02396381|582197138|FG001|Overall Study|Pregnancy|0|||
161222664|NCT02396381|582197137|FG000|Overall Study|Non-compliance with study procedures|1|||
161222665|NCT02396381|582197138|FG001|Overall Study|Non-compliance with study procedures|0|||
161222666|NCT02396381|582197137|FG000|Overall Study|Moved out of town/state|1|||
161222667|NCT02396381|582197138|FG001|Overall Study|Moved out of town/state|3|||
161222668|NCT02396381|582197137|FG000|Overall Study|Could not complete visit|1|||
161222669|NCT02396381|582197138|FG001|Overall Study|Could not complete visit|0|||
161222670|NCT02396381|582197137|FG000|Overall Study|Possible conflict of interest|1|||
161222671|NCT02396381|582197138|FG001|Overall Study|Possible conflict of interest|0|||
161222672|NCT02396381|582197137|FG000|Overall Study|Randomization/Screening Error|3|||
161222673|NCT02396381|582197138|FG001|Overall Study|Randomization/Screening Error|1|||
161222674|NCT02918162|582197139|FG000|Overall Study|Withdrawal by Subject|1|||
161222675|NCT02918162|582197139|FG000|Overall Study|Omental Disease|1|||
161222676|NCT00395226|582197140|FG000|Overall Study|Adverse Event|4|||
161222677|NCT00395226|582197141|FG001|Overall Study|Adverse Event|3|||
161222678|NCT00395226|582197140|FG000|Overall Study|Withdrawal by Subject|0|||
161222679|NCT00395226|582197141|FG001|Overall Study|Withdrawal by Subject|1|||
161222680|NCT00395226|582197140|FG000|Overall Study|Lost to Follow-up|0|||
161222681|NCT00395226|582197141|FG001|Overall Study|Lost to Follow-up|1|||
161222682|NCT02655237|582197144|FG000|Overall Study|Adverse Event|10|||
161222683|NCT02655237|582197145|FG001|Overall Study|Adverse Event|7|||
161222684|NCT02655237|582197144|FG000|Overall Study|Protocol Deviation|2|||
161222685|NCT02655237|582197145|FG001|Overall Study|Protocol Deviation|0|||
161222686|NCT02655237|582197144|FG000|Overall Study|Withdrawal by Participant|1|||
161222687|NCT02655237|582197145|FG001|Overall Study|Withdrawal by Participant|2|||
161222688|NCT02655237|582197144|FG000|Overall Study|Lack of Efficacy|0|||
161222689|NCT02655237|582197145|FG001|Overall Study|Lack of Efficacy|1|||
161222690|NCT02655237|582197144|FG000|Overall Study|Recovery Leading to Surgery|2|||
161222691|NCT02655237|582197145|FG001|Overall Study|Recovery Leading to Surgery|1|||
161222692|NCT02655237|582197144|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
161222693|NCT02655237|582197145|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
161222694|NCT02655237|582197144|FG000|Overall Study|Randomized but Not Treated|1|||
161222695|NCT02655237|582197145|FG001|Overall Study|Randomized but Not Treated|0|||
161222696|NCT03679741|582197146|FG000|Period 1|No longer meet eligibility criteria|1|||
161222697|NCT03679741|582197147|FG001|Period 1|No longer meet eligibility criteria|0|||
161222698|NCT03679741|582197146|FG000|Period 1|Lost to Follow-up|0|||
161222699|NCT03679741|582197147|FG001|Period 1|Lost to Follow-up|1|||
161222700|NCT03679741|582197146|FG000|Period 1|Adverse Event|1|||
161222701|NCT03679741|582197147|FG001|Period 1|Adverse Event|1|||
161222702|NCT03679741|582197146|FG000|Period 1|Withdrawal by Subject|0|||
161222703|NCT03679741|582197147|FG001|Period 1|Withdrawal by Subject|1|||
161222704|NCT03679741|582197146|FG000|Period 2|Adverse Event|2|||
161222705|NCT03679741|582197147|FG001|Period 2|Adverse Event|1|||
161222706|NCT03679741|582197146|FG000|Period 2|Withdrawal by Subject|1|||
161222707|NCT03679741|582197147|FG001|Period 2|Withdrawal by Subject|1|||
161222708|NCT02227862|582197149|FG000|Overall Study|Protocol Violation|7|||
161222709|NCT02227862|582197150|FG001|Overall Study|Protocol Violation|9|||
161222710|NCT02227862|582197149|FG000|Overall Study|Other|0|||
161222711|NCT02227862|582197150|FG001|Overall Study|Other|2|||
161222712|NCT02227862|582197149|FG000|Overall Study|Adverse Event|4|||
161222713|NCT02227862|582197150|FG001|Overall Study|Adverse Event|3|||
161222714|NCT02227862|582197149|FG000|Overall Study|Withdrawal by Subject|7|||
161222715|NCT02227862|582197150|FG001|Overall Study|Withdrawal by Subject|6|||
161222716|NCT02227862|582197149|FG000|Overall Study|Lost to Follow-up|1|||
161222717|NCT02227862|582197150|FG001|Overall Study|Lost to Follow-up|2|||
161222718|NCT05014204|582197151|FG000|Overall Study|Withdrawal by Subject|1|||
161222719|NCT05014204|582197151|FG000|Overall Study|Physician Decision|1|||
161222720|NCT02035137|582197152|FG000|Overall Study|Physician Decision|0|||
161222721|NCT02035137|582197153|FG001|Overall Study|Physician Decision|0|||
161222722|NCT02035137|582197154|FG002|Overall Study|Physician Decision|1|||
161222723|NCT02035137|582197152|FG000|Overall Study|Withdrawal by Subject|0|||
161222724|NCT02035137|582197153|FG001|Overall Study|Withdrawal by Subject|1|||
161222725|NCT02035137|582197154|FG002|Overall Study|Withdrawal by Subject|2|||
161222726|NCT02035137|582197152|FG000|Overall Study|Ineligible|0|||
161222727|NCT02035137|582197153|FG001|Overall Study|Ineligible|1|||
161222728|NCT02035137|582197154|FG002|Overall Study|Ineligible|2|||
161118286|NCT04681170|581822057|FG001|Stratified Enrolment & run-in|Death|0|||
161118287|NCT04681170|581822056|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
161118288|NCT04681170|581822057|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
161118289|NCT04681170|581822056|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
161118290|NCT04681170|581822057|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
161118291|NCT04681170|581822056|FG000|Open Label Efficacy Phase|Adverse Event|0|||
161118292|NCT04681170|581822057|FG001|Open Label Efficacy Phase|Adverse Event|2|||
161118293|NCT04681170|581822056|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
161118294|NCT04681170|581822057|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
161118295|NCT04681170|581822056|FG000|Open Label Safety Phase|AEs and none compliance|0|||
161118296|NCT04681170|581822057|FG001|Open Label Safety Phase|AEs and none compliance|1|||
161118297|NCT02468648|581822062|FG000|Overall Study|Death|1|||
161118298|NCT00488982|581822063|FG000|Course 1|Physician Decision|0|||
161118299|NCT00488982|581822064|FG001|Course 1|Physician Decision|2|||
161118300|NCT00488982|581822065|FG002|Course 1|Physician Decision|4|||
161118301|NCT00488982|581822063|FG000|Course 1|Withdrawal by Subject|0|||
161118302|NCT00488982|581822064|FG001|Course 1|Withdrawal by Subject|8|||
161118303|NCT00488982|581822065|FG002|Course 1|Withdrawal by Subject|2|||
161118304|NCT00488982|581822063|FG000|Course 1|nonprotocol therapy|0|||
161118305|NCT00488982|581822064|FG001|Course 1|nonprotocol therapy|2|||
161118306|NCT00488982|581822065|FG002|Course 1|nonprotocol therapy|2|||
161118307|NCT00488982|581822063|FG000|Course 1|Adverse Event|0|||
161118308|NCT00488982|581822064|FG001|Course 1|Adverse Event|0|||
161118309|NCT00488982|581822065|FG002|Course 1|Adverse Event|6|||
161118310|NCT01368835|581822066|FG000|Overall Study|Inclusion criteria/photography quality|22|||
161118311|NCT01368835|581822066|FG000|Overall Study|Lost to Follow-up|11|||
161118312|NCT01678144|581822067|FG000|Stage 1: MAR Classic|Adverse Event|1|||
161118313|NCT02754726|581822068|FG000|Overall Study|Progressive Disease by RECIST|13|||
161118314|NCT02754726|581822068|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
161118315|NCT02754726|581822068|FG000|Overall Study|Clinical Disease Progression|5|||
161118316|NCT02754726|581822068|FG000|Overall Study|Adverse Event|3|||
161118317|NCT02754726|581822068|FG000|Overall Study|Withdrawal by Subject|1|||
161118318|NCT02754726|581822068|FG000|Overall Study|Tolerability|1|||
161118319|NCT03806127|581822077|FG000|Overall Study|Withdrawal by Subject|4|||
161118320|NCT03806127|581822078|FG001|Overall Study|Withdrawal by Subject|5|||
161118321|NCT03806127|581822077|FG000|Overall Study|Protocol Violation|3|||
161118322|NCT03806127|581822078|FG001|Overall Study|Protocol Violation|1|||
161222729|NCT02035137|582197152|FG000|Overall Study|Disease progression prior to treatment start|2|||
161222730|NCT02035137|582197153|FG001|Overall Study|Disease progression prior to treatment start|0|||
161118323|NCT03806127|581822077|FG000|Overall Study|Adverse Event|3|||
161222731|NCT02035137|582197154|FG002|Overall Study|Disease progression prior to treatment start|0|||
161118324|NCT03806127|581822078|FG001|Overall Study|Adverse Event|0|||
161118325|NCT03806127|581822077|FG000|Overall Study|Unable to Complete Procedures|0|||
161222732|NCT00113490|582197158|FG000|Overall Study|Withdrawal by Subject|1|||
161222733|NCT00113490|582197159|FG001|Overall Study|Withdrawal by Subject|3|||
161222734|NCT00113490|582197158|FG000|Overall Study|Lost to Follow-up|1|||
161118326|NCT03806127|581822078|FG001|Overall Study|Unable to Complete Procedures|1|||
161118327|NCT03806127|581822077|FG000|Overall Study|Pregnancy|0|||
161118328|NCT03806127|581822078|FG001|Overall Study|Pregnancy|1|||
161118329|NCT03806127|581822077|FG000|Overall Study|Lost to Follow-up|5|||
161222735|NCT00113490|582197159|FG001|Overall Study|Lost to Follow-up|0|||
161222736|NCT00819247|582197160|FG000|Overall Study|Adverse Event|0|||
161118330|NCT03806127|581822078|FG001|Overall Study|Lost to Follow-up|1|||
161118331|NCT03806127|581822077|FG000|Overall Study|Physician Decision|1|||
161118332|NCT03806127|581822078|FG001|Overall Study|Physician Decision|1|||
161118333|NCT03806127|581822077|FG000|Overall Study|Could Not Come Due to Covid|1|||
161118334|NCT03806127|581822078|FG001|Overall Study|Could Not Come Due to Covid|0|||
161118335|NCT03806127|581822077|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
161118336|NCT03806127|581822078|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
161118337|NCT03806127|581822077|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
161118338|NCT03806127|581822078|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
161118339|NCT03806127|581822077|FG000|Overall Study|Covid 19 Restrictions|2|||
161118340|NCT03806127|581822078|FG001|Overall Study|Covid 19 Restrictions|0|||
161118341|NCT03806127|581822077|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
161118342|NCT03806127|581822078|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
161118343|NCT03806127|581822077|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
161118344|NCT03806127|581822078|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
161118345|NCT03446885|581822082|FG000|Overall Study|Lost to Follow-up|1|||
161118346|NCT03446885|581822083|FG001|Overall Study|Lost to Follow-up|0|||
161118347|NCT03446885|581822082|FG000|Overall Study|Did not complete entire visit|1|||
161118348|NCT03446885|581822083|FG001|Overall Study|Did not complete entire visit|0|||
161118349|NCT01289015|581822086|FG000|Overall Study|Protocol Violation|12|||
161118350|NCT01289015|581822087|FG001|Overall Study|Protocol Violation|9|||
161118351|NCT01289015|581822086|FG000|Overall Study|Adverse Event|3|||
161118352|NCT01289015|581822087|FG001|Overall Study|Adverse Event|0|||
161118353|NCT01289015|581822086|FG000|Overall Study|Lost to Follow-up|33|||
161118354|NCT01289015|581822087|FG001|Overall Study|Lost to Follow-up|17|||
161118355|NCT01289015|581822086|FG000|Overall Study|Withdrawal by Subject|17|||
161118356|NCT01289015|581822087|FG001|Overall Study|Withdrawal by Subject|8|||
161118357|NCT01289015|581822086|FG000|Overall Study|Disease progression|1|||
161118358|NCT01289015|581822087|FG001|Overall Study|Disease progression|0|||
161118359|NCT01289015|581822086|FG000|Overall Study|Negative baseline culture and others|33|||
161118360|NCT01289015|581822087|FG001|Overall Study|Negative baseline culture and others|20|||
161118361|NCT05030311|581822092|FG000|Overall Study|Technical problems|0|||
161118362|NCT05030311|581822093|FG001|Overall Study|Technical problems|1|||
161118363|NCT05030311|581822092|FG000|Overall Study|Withdrawal by Subject|31|||
161118364|NCT05030311|581822093|FG001|Overall Study|Withdrawal by Subject|17|||
161118365|NCT05030311|581822092|FG000|Overall Study|Adverse Event|13|||
161118366|NCT05030311|581822093|FG001|Overall Study|Adverse Event|5|||
161118367|NCT05030311|581822092|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161118368|NCT05030311|581822093|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161118369|NCT05030311|581822092|FG000|Overall Study|Physician Decision|5|||
161118370|NCT05030311|581822093|FG001|Overall Study|Physician Decision|2|||
161118371|NCT05030311|581822092|FG000|Overall Study|Lost to Follow-up|5|||
161118372|NCT05030311|581822093|FG001|Overall Study|Lost to Follow-up|1|||
161118373|NCT05030311|581822092|FG000|Overall Study|Protocol Violation|4|||
161118374|NCT05030311|581822093|FG001|Overall Study|Protocol Violation|4|||
161118375|NCT02264990|581822100|FG000|Overall Study|Death|255|||
161118376|NCT02264990|581822101|FG001|Overall Study|Death|250|||
161118377|NCT02264990|581822100|FG000|Overall Study|Withdrawal by Subject|4|||
161118378|NCT02264990|581822101|FG001|Overall Study|Withdrawal by Subject|5|||
161118379|NCT02264990|581822100|FG000|Overall Study|Lost to Follow-up|1|||
161118380|NCT02264990|581822101|FG001|Overall Study|Lost to Follow-up|3|||
161118381|NCT02264990|581822100|FG000|Overall Study|Other|0|||
161118382|NCT02264990|581822101|FG001|Overall Study|Other|1|||
161118383|NCT03031301|581822103|FG000|Overall Study|Protocol Violation|4|||
161118384|NCT03031301|581822104|FG001|Overall Study|Protocol Violation|8|||
161118385|NCT03031301|581822103|FG000|Overall Study|Withdrawal by Subject|7|||
161118386|NCT03031301|581822104|FG001|Overall Study|Withdrawal by Subject|4|||
161118387|NCT03031301|581822103|FG000|Overall Study|Lost to Follow-up|4|||
161118388|NCT03031301|581822104|FG001|Overall Study|Lost to Follow-up|12|||
161118389|NCT03031301|581822103|FG000|Overall Study|Noncompliance|1|||
161118390|NCT03031301|581822104|FG001|Overall Study|Noncompliance|3|||
161118391|NCT03031301|581822103|FG000|Overall Study|Technical issue|1|||
161118392|NCT03031301|581822104|FG001|Overall Study|Technical issue|1|||
161118393|NCT03031301|581822103|FG000|Overall Study|Adverse Event|1|||
161118394|NCT03031301|581822104|FG001|Overall Study|Adverse Event|0|||
161118395|NCT01100944|581822106|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
161118396|NCT01100944|581822107|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
161118397|NCT01100944|581822108|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
161222737|NCT00819247|582197161|FG001|Overall Study|Adverse Event|5|||
161118398|NCT01100944|581822106|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
161118399|NCT01100944|581822107|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
161118400|NCT01100944|581822108|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
161118401|NCT01100944|581822106|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
161118402|NCT01100944|581822107|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
161118403|NCT01100944|581822108|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
161118404|NCT01100944|581822106|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
161118405|NCT01100944|581822107|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
161222738|NCT00819247|582197162|FG002|Overall Study|Adverse Event|3|||
161222739|NCT00819247|582197160|FG000|Overall Study|Insufficient testosterone response|5|||
161222740|NCT00819247|582197161|FG001|Overall Study|Insufficient testosterone response|8|||
161222741|NCT00819247|582197162|FG002|Overall Study|Insufficient testosterone response|10|||
161222742|NCT00819247|582197160|FG000|Overall Study|Withdrawal by Subject|1|||
161222743|NCT00819247|582197161|FG001|Overall Study|Withdrawal by Subject|0|||
161222744|NCT00819247|582197162|FG002|Overall Study|Withdrawal by Subject|0|||
161222745|NCT00819247|582197160|FG000|Overall Study|Protocol Violation|1|||
161222746|NCT00819247|582197161|FG001|Overall Study|Protocol Violation|0|||
161222747|NCT00819247|582197162|FG002|Overall Study|Protocol Violation|1|||
161222748|NCT00819247|582197160|FG000|Overall Study|Mistakenly withdrawn|0|||
161222749|NCT00819247|582197161|FG001|Overall Study|Mistakenly withdrawn|1|||
161222750|NCT00819247|582197162|FG002|Overall Study|Mistakenly withdrawn|0|||
161222751|NCT00819247|582197160|FG000|Overall Study|Bad prostate-specific antigen response|3|||
161222752|NCT00819247|582197161|FG001|Overall Study|Bad prostate-specific antigen response|2|||
161222753|NCT00819247|582197162|FG002|Overall Study|Bad prostate-specific antigen response|0|||
161222754|NCT00819247|582197160|FG000|Overall Study|Other|1|||
161222755|NCT00819247|582197161|FG001|Overall Study|Other|0|||
161222756|NCT00819247|582197162|FG002|Overall Study|Other|0|||
161222757|NCT04471935|582197163|FG000|Overall Study|Withdrawal by Subject|1|||
161222758|NCT04471935|582197163|FG000|Overall Study|Deemed ineligible to participate|1|||
161222759|NCT00948675|582197164|FG000|Overall Study|Lost to Follow-up|1|||
161222760|NCT00948675|582197165|FG001|Overall Study|Lost to Follow-up|0|||
161222761|NCT01654380|582197169|FG000|Part B, Period 1|Physician Decision|0|||
161222762|NCT01654380|582197170|FG001|Part B, Period 1|Physician Decision|0|||
161222763|NCT01654380|582197171|FG002|Part B, Period 1|Physician Decision|1|||
161118406|NCT01100944|581822108|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
161118407|NCT00070941|581822109|FG000|Overall Study|Adverse Event|10|||
161118408|NCT00070941|581822110|FG001|Overall Study|Adverse Event|8|||
161118409|NCT00070941|581822111|FG002|Overall Study|Adverse Event|4|||
161118410|NCT01888640|581822113|FG000|Overall Study|Lost to Follow-up|1|||
161118411|NCT01888640|581822114|FG001|Overall Study|Lost to Follow-up|2|||
161118412|NCT01888640|581822115|FG002|Overall Study|Lost to Follow-up|0|||
161118413|NCT01888640|581822113|FG000|Overall Study|Withdrawal by Subject|15|||
161118414|NCT01888640|581822114|FG001|Overall Study|Withdrawal by Subject|11|||
161118415|NCT01888640|581822115|FG002|Overall Study|Withdrawal by Subject|4|||
161118416|NCT01888640|581822113|FG000|Overall Study|Minimum dose not met|10|||
161118417|NCT01888640|581822114|FG001|Overall Study|Minimum dose not met|16|||
161118418|NCT01888640|581822115|FG002|Overall Study|Minimum dose not met|0|||
161118419|NCT01888640|581822113|FG000|Overall Study|Given wrong unit (placebo)|1|||
161118420|NCT01888640|581822114|FG001|Overall Study|Given wrong unit (placebo)|0|||
161118421|NCT01888640|581822115|FG002|Overall Study|Given wrong unit (placebo)|0|||
161118422|NCT01888640|581822113|FG000|Overall Study|Excluded for prior TENS|0|||
161118423|NCT01888640|581822114|FG001|Overall Study|Excluded for prior TENS|1|||
161118424|NCT01888640|581822115|FG002|Overall Study|Excluded for prior TENS|0|||
161118425|NCT01888640|581822113|FG000|Overall Study|Researcher Termination of Participant|0|||
161118426|NCT01888640|581822114|FG001|Overall Study|Researcher Termination of Participant|1|||
161118427|NCT01888640|581822115|FG002|Overall Study|Researcher Termination of Participant|1|||
161118428|NCT00109707|581822116|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
161118429|NCT00109707|581822117|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
161118430|NCT00109707|581822118|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
161118431|NCT00109707|581822116|FG000|Overall Study|Abnormal laboratory values|1|||
161118432|NCT00109707|581822117|FG001|Overall Study|Abnormal laboratory values|0|||
161118433|NCT00109707|581822118|FG002|Overall Study|Abnormal laboratory values|0|||
161118434|NCT00109707|581822116|FG000|Overall Study|Administrative problems|2|||
161118435|NCT00109707|581822117|FG001|Overall Study|Administrative problems|0|||
161118436|NCT00109707|581822118|FG002|Overall Study|Administrative problems|1|||
161118437|NCT00109707|581822116|FG000|Overall Study|Adverse Event|10|||
161118438|NCT00109707|581822117|FG001|Overall Study|Adverse Event|2|||
161118439|NCT00109707|581822118|FG002|Overall Study|Adverse Event|3|||
161118440|NCT00109707|581822116|FG000|Overall Study|Death|4|||
161118441|NCT00109707|581822117|FG001|Overall Study|Death|0|||
161118442|NCT00109707|581822118|FG002|Overall Study|Death|0|||
161118443|NCT00109707|581822116|FG000|Overall Study|Disease progression|12|||
161222764|NCT01654380|582197172|FG003|Part B, Period 1|Physician Decision|0|||
161118444|NCT00109707|581822117|FG001|Overall Study|Disease progression|4|||
161118445|NCT00109707|581822118|FG002|Overall Study|Disease progression|3|||
161222765|NCT04652453|582197173|FG000|Overall Study|Death|8|||
161222766|NCT04652453|582197174|FG001|Overall Study|Death|2|||
161222767|NCT04652453|582197175|FG002|Overall Study|Death|0|||
161222768|NCT04652453|582197173|FG000|Overall Study|Hospice|5|||
161222769|NCT04652453|582197174|FG001|Overall Study|Hospice|5|||
161222770|NCT04652453|582197175|FG002|Overall Study|Hospice|0|||
161222771|NCT04652453|582197173|FG000|Overall Study|Withdrawal by Subject|2|||
161222772|NCT04652453|582197174|FG001|Overall Study|Withdrawal by Subject|0|||
161222773|NCT04652453|582197175|FG002|Overall Study|Withdrawal by Subject|0|||
161222774|NCT06331156|582197176|FG000|Overall Study|Adverse Event|1|||
161222775|NCT06331156|582197177|FG001|Overall Study|Adverse Event|0|||
161222776|NCT06331156|582197176|FG000|Overall Study|Lost to Follow-up|1|||
161222777|NCT06331156|582197177|FG001|Overall Study|Lost to Follow-up|0|||
161222778|NCT06331156|582197176|FG000|Overall Study|Migrated / Moved from the study area|4|||
161222779|NCT06331156|582197177|FG001|Overall Study|Migrated / Moved from the study area|3|||
161222780|NCT06331156|582197176|FG000|Overall Study|Other|7|||
161222781|NCT06331156|582197177|FG001|Overall Study|Other|0|||
161222782|NCT06331156|582197176|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
161222783|NCT06331156|582197177|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
161222784|NCT05845645|582197178|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222785|NCT05845645|582197179|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222786|NCT05845645|582197180|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
161222787|NCT05845645|582197181|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222788|NCT05845645|582197182|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222789|NCT05845645|582197183|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222790|NCT05845645|582197184|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222791|NCT05845645|582197185|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222792|NCT05845645|582197186|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222793|NCT05845645|582197187|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222794|NCT05845645|582197188|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222795|NCT05845645|582197189|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
161222796|NCT05845645|582197178|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222797|NCT05845645|582197179|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222798|NCT05845645|582197180|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222799|NCT05845645|582197181|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222800|NCT05845645|582197182|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222801|NCT05845645|582197183|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222802|NCT05845645|582197184|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222803|NCT05845645|582197185|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222804|NCT05845645|582197186|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222805|NCT05845645|582197187|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
161222806|NCT05845645|582197188|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222807|NCT05845645|582197189|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
161222808|NCT01199601|582197195|FG000|Overall Study|Lost to Follow-up|47|||
161222809|NCT01199601|582197196|FG001|Overall Study|Lost to Follow-up|66|||
161222810|NCT01199601|582197195|FG000|Overall Study|Withdrawal by Subject|15|||
160874490|NCT00486291|580934235|FG001|Overall Study|requirement for restricted medication|3|||
161118446|NCT00109707|581822116|FG000|Overall Study|Lost to Follow-up|3|||
161118447|NCT00109707|581822117|FG001|Overall Study|Lost to Follow-up|0|||
161222811|NCT01199601|582197196|FG001|Overall Study|Withdrawal by Subject|3|||
161222812|NCT01199601|582197195|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
161222813|NCT01199601|582197196|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
161118448|NCT00109707|581822118|FG002|Overall Study|Lost to Follow-up|0|||
161118449|NCT00109707|581822116|FG000|Overall Study|Protocol Violation|1|||
161118450|NCT00109707|581822117|FG001|Overall Study|Protocol Violation|0|||
161118451|NCT00109707|581822118|FG002|Overall Study|Protocol Violation|0|||
161118452|NCT00109707|581822116|FG000|Overall Study|Patient withdrew consent|6|||
161118453|NCT00109707|581822117|FG001|Overall Study|Patient withdrew consent|1|||
161118454|NCT00109707|581822118|FG002|Overall Study|Patient withdrew consent|0|||
161118455|NCT02199080|581822119|FG000|Overall Study|Protocol Violation|12|||
161118456|NCT01277549|581822120|FG000|Overall Study|Failed to meet eligibility criteria|13|||
161118457|NCT01277549|581822121|FG001|Overall Study|Failed to meet eligibility criteria|9|||
161118458|NCT01277549|581822120|FG000|Overall Study|Withdrawal by Subject|1|||
161118459|NCT01277549|581822121|FG001|Overall Study|Withdrawal by Subject|3|||
161118460|NCT01277549|581822120|FG000|Overall Study|Protocol Violation|10|||
161118461|NCT01277549|581822121|FG001|Overall Study|Protocol Violation|1|||
161118462|NCT01277549|581822120|FG000|Overall Study|Physician Decision|2|||
161118463|NCT01277549|581822121|FG001|Overall Study|Physician Decision|1|||
161118464|NCT00623428|581822124|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
161118465|NCT00623428|581822125|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
161118466|NCT00623428|581822124|FG000|Treatment Period|Death|0|||
161222814|NCT00278512|582197197|FG000|Overall Study|Death|1|||
161222815|NCT00278512|582197198|FG001|Overall Study|Death|0|||
161118467|NCT00623428|581822125|FG001|Treatment Period|Death|1|||
161118468|NCT00623428|581822124|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
161118469|NCT00623428|581822125|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
161118470|NCT00623428|581822124|FG000|Treatment Period|Insufficient therapeutic response|0|||
161118471|NCT00623428|581822125|FG001|Treatment Period|Insufficient therapeutic response|2|||
161118472|NCT00623428|581822124|FG000|Treatment Period|Other|0|||
161118473|NCT00623428|581822125|FG001|Treatment Period|Other|1|||
161118474|NCT00623428|581822124|FG000|Treatment Period|Withdrawal by Subject|0|||
161118475|NCT00623428|581822125|FG001|Treatment Period|Withdrawal by Subject|1|||
161118476|NCT00623428|581822124|FG000|Follow-up Period|Relapse post-treatment|11|||
161118477|NCT00623428|581822125|FG001|Follow-up Period|Relapse post-treatment|3|||
161118478|NCT00623428|581822124|FG000|Follow-up Period|Failure to return|10|||
161118479|NCT00623428|581822125|FG001|Follow-up Period|Failure to return|2|||
161118480|NCT00623428|581822124|FG000|Follow-up Period|Patient withdrew consent|5|||
161118481|NCT00623428|581822125|FG001|Follow-up Period|Patient withdrew consent|4|||
161118482|NCT00623428|581822124|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
161118483|NCT00623428|581822125|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
161118484|NCT00623428|581822124|FG000|Follow-up Period|Did not cooperate|0|||
161118485|NCT00623428|581822125|FG001|Follow-up Period|Did not cooperate|3|||
161118486|NCT00623428|581822124|FG000|Follow-up Period|Reason not specified|1|||
161118487|NCT00623428|581822125|FG001|Follow-up Period|Reason not specified|1|||
161118488|NCT00623428|581822124|FG000|Follow-up Period|Death|0|||
161118489|NCT00623428|581822125|FG001|Follow-up Period|Death|1|||
161118490|NCT01692301|581822126|FG000|Overall Study|Adverse Event|15|||
161118491|NCT01692301|581822127|FG001|Overall Study|Adverse Event|12|||
161118492|NCT01692301|581822126|FG000|Overall Study|Death|1|||
161118493|NCT01692301|581822127|FG001|Overall Study|Death|2|||
161118494|NCT01692301|581822126|FG000|Overall Study|Lack of Efficacy|0|||
161118495|NCT01692301|581822127|FG001|Overall Study|Lack of Efficacy|5|||
161118496|NCT01692301|581822126|FG000|Overall Study|Non-compliance with study treatment|1|||
161118497|NCT01692301|581822127|FG001|Overall Study|Non-compliance with study treatment|2|||
161118498|NCT01692301|581822126|FG000|Overall Study|Protocol deviation|9|||
161118499|NCT01692301|581822127|FG001|Overall Study|Protocol deviation|2|||
161118500|NCT01692301|581822126|FG000|Overall Study|Patient/guardian decision|16|||
161118501|NCT01692301|581822127|FG001|Overall Study|Patient/guardian decision|15|||
161118502|NCT01692301|581822126|FG000|Overall Study|Technical problems|0|||
161118503|NCT01692301|581822127|FG001|Overall Study|Technical problems|1|||
161118504|NCT01692301|581822126|FG000|Overall Study|Physician Decision|2|||
161118505|NCT01692301|581822127|FG001|Overall Study|Physician Decision|2|||
161118506|NCT01692301|581822126|FG000|Overall Study|Lost to Follow-up|1|||
161118507|NCT01692301|581822127|FG001|Overall Study|Lost to Follow-up|1|||
161118508|NCT01142726|581822128|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
161118509|NCT01142726|581822129|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
161118510|NCT01142726|581822130|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
161118511|NCT01142726|581822128|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
161118512|NCT01142726|581822129|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
161118513|NCT01142726|581822130|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
161118514|NCT01142726|581822128|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
161118515|NCT01142726|581822129|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
161118516|NCT01142726|581822130|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
161118517|NCT01142726|581822128|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
161118518|NCT01142726|581822129|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
161118519|NCT01142726|581822130|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
161118520|NCT01142726|581822128|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
161118521|NCT01142726|581822129|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
161118522|NCT01142726|581822130|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
161118523|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
161118524|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
161118525|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
161118526|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
161118527|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
161118528|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
161118529|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
161118530|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
161118531|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
161118532|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
161118533|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
161118534|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
161118535|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
161118536|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
161118537|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
161222816|NCT01620177|582197199|FG000|Overall Study|Failure at Screening Visit|43|||
161118538|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
161222817|NCT01620177|582197199|FG000|Overall Study|Withdrawal by Subject|26|||
161222818|NCT01620177|582197199|FG000|Overall Study|Lost to Follow-up|7|||
161222819|NCT01620177|582197199|FG000|Overall Study|Physician Decision|2|||
161222820|NCT01620177|582197199|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
161222821|NCT00423800|582197200|FG000|Overall Study|Protocol Violation|0|||
161222822|NCT00423800|582197201|FG001|Overall Study|Protocol Violation|1|||
161222823|NCT00814320|582197202|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
161222824|NCT00814320|582197203|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
161222825|NCT00814320|582197202|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
161222826|NCT00814320|582197203|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
161222827|NCT00814320|582197202|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
161222828|NCT00814320|582197203|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
161222829|NCT00814320|582197202|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
161222830|NCT00814320|582197203|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
161222831|NCT00814320|582197202|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
161222832|NCT00814320|582197203|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
161222833|NCT00814320|582197202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
161222834|NCT00814320|582197203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
161222835|NCT00814320|582197202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
161222836|NCT00814320|582197203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
161222837|NCT00814320|582197202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
161222838|NCT00814320|582197203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
161222839|NCT00814320|582197202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
161222840|NCT00814320|582197203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
161222841|NCT00814320|582197202|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
161222842|NCT00814320|582197203|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
161222843|NCT00619385|582197204|FG000|Overall Study|Adverse Event|0|||
161222844|NCT00619385|582197205|FG001|Overall Study|Adverse Event|0|||
161222845|NCT00619385|582197206|FG002|Overall Study|Adverse Event|3|||
161222846|NCT00619385|582197204|FG000|Overall Study|Other|1|||
161222847|NCT00619385|582197205|FG001|Overall Study|Other|2|||
161222848|NCT00619385|582197206|FG002|Overall Study|Other|1|||
161222849|NCT02041702|582197211|FG000|Overall Study|Lost to Follow-up|1|||
161222850|NCT02041702|582197212|FG001|Overall Study|Lost to Follow-up|6|||
161222851|NCT02041702|582197211|FG000|Overall Study|Death|4|||
161222852|NCT02041702|582197212|FG001|Overall Study|Death|0|||
161222853|NCT02041702|582197211|FG000|Overall Study|Withdrawal by Subject|4|||
161222854|NCT02041702|582197212|FG001|Overall Study|Withdrawal by Subject|3|||
161222855|NCT02041702|582197211|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
160874491|NCT04413617|580934240|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874492|NCT04413617|580934241|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874493|NCT04413617|580934242|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874494|NCT04413617|580934243|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
160874495|NCT04413617|580934244|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
160874496|NCT04413617|580934240|FG000|Overall Study|Protocol Violation|0|||
160874497|NCT04413617|580934241|FG001|Overall Study|Protocol Violation|1|||
160874498|NCT04413617|580934242|FG002|Overall Study|Protocol Violation|0|||
160874499|NCT04413617|580934243|FG003|Overall Study|Protocol Violation|0|||
160874500|NCT04413617|580934244|FG004|Overall Study|Protocol Violation|1|||
160874501|NCT04413617|580934240|FG000|Overall Study|Lack of Efficacy|2|||
160874502|NCT04413617|580934241|FG001|Overall Study|Lack of Efficacy|0|||
160874503|NCT04413617|580934242|FG002|Overall Study|Lack of Efficacy|2|||
160874504|NCT04413617|580934243|FG003|Overall Study|Lack of Efficacy|1|||
160874505|NCT04413617|580934244|FG004|Overall Study|Lack of Efficacy|0|||
160874506|NCT04413617|580934240|FG000|Overall Study|Withdrawal by Subject|3|||
160874507|NCT04413617|580934241|FG001|Overall Study|Withdrawal by Subject|4|||
160874508|NCT04413617|580934242|FG002|Overall Study|Withdrawal by Subject|2|||
160874509|NCT04413617|580934243|FG003|Overall Study|Withdrawal by Subject|5|||
160874510|NCT04413617|580934244|FG004|Overall Study|Withdrawal by Subject|3|||
161222856|NCT02041702|582197212|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
161222857|NCT02041702|582197211|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
161222858|NCT02041702|582197212|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
161222859|NCT00203307|582197213|FG000|First Intervention|Adverse Event|2|||
161222860|NCT00203307|582197214|FG001|First Intervention|Adverse Event|0|||
161222861|NCT03730103|582197215|FG000|Overall Study|Did not meet inclusion criteria|0|||
161222862|NCT03730103|582197216|FG001|Overall Study|Did not meet inclusion criteria|5|||
161222863|NCT02789111|582197217|FG000|Overall Study|Withdrawal by Subject|1|||
161222864|NCT02789111|582197218|FG001|Overall Study|Withdrawal by Subject|4|||
161222865|NCT01488578|582197219|FG000|Overall Study|Protocol Violation|1836|||
161222866|NCT02308111|582197220|FG000|Overall Study|Adverse Event|31|||
161222867|NCT02308111|582197221|FG001|Overall Study|Adverse Event|19|||
161222868|NCT02308111|582197220|FG000|Overall Study|Death|9|||
161222869|NCT02308111|582197221|FG001|Overall Study|Death|6|||
161222870|NCT02308111|582197220|FG000|Overall Study|Lost to Follow-up|2|||
161222871|NCT02308111|582197221|FG001|Overall Study|Lost to Follow-up|7|||
161222872|NCT02308111|582197220|FG000|Overall Study|Physician Decision|6|||
161222873|NCT02308111|582197221|FG001|Overall Study|Physician Decision|17|||
161222874|NCT02308111|582197220|FG000|Overall Study|Protocol Violation|0|||
161222875|NCT02308111|582197221|FG001|Overall Study|Protocol Violation|1|||
161222876|NCT02308111|582197220|FG000|Overall Study|Withdrawal by Subject|28|||
161222877|NCT02308111|582197221|FG001|Overall Study|Withdrawal by Subject|38|||
161222878|NCT02308111|582197220|FG000|Overall Study|Study Terminated by Sponsor|72|||
161222879|NCT02308111|582197221|FG001|Overall Study|Study Terminated by Sponsor|61|||
161222880|NCT02308111|582197220|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
161222881|NCT02308111|582197221|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
161222882|NCT02308111|582197220|FG000|Overall Study|Site Closure|3|||
161222883|NCT02308111|582197221|FG001|Overall Study|Site Closure|3|||
161222884|NCT02308111|582197220|FG000|Overall Study|Non-compliance with Study Drug|3|||
161222885|NCT02308111|582197221|FG001|Overall Study|Non-compliance with Study Drug|1|||
161222886|NCT02308111|582197220|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
161222887|NCT02308111|582197221|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
161222888|NCT02308111|582197220|FG000|Overall Study|Liver Transplant|3|||
161222889|NCT02308111|582197221|FG001|Overall Study|Liver Transplant|3|||
161222890|NCT02308111|582197220|FG000|Overall Study|Liver Transplant Waitlist|2|||
161222891|NCT02308111|582197221|FG001|Overall Study|Liver Transplant Waitlist|2|||
161222892|NCT02308111|582197220|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
161222893|NCT02308111|582197221|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
161222894|NCT03271528|582197222|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
161222895|NCT03271528|582197223|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
161222896|NCT03271528|582197222|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
161222897|NCT03271528|582197223|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
161222898|NCT03271528|582197222|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
161222899|NCT03271528|582197223|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
161222900|NCT03271528|582197222|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
161222901|NCT03271528|582197223|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
161222902|NCT03271528|582197222|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
161222903|NCT03271528|582197223|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
161222904|NCT03271528|582197222|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
161222905|NCT03271528|582197223|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
161222906|NCT03271528|582197222|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
161222907|NCT03271528|582197223|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
161222908|NCT00717756|582197225|FG000|Overall Study|Withdrawal by Subject|1|||
161222909|NCT01873859|582197230|FG000|Overall Study|Withdrawal by Subject|0|||
161222910|NCT01873859|582197231|FG001|Overall Study|Withdrawal by Subject|4|||
161222911|NCT01364870|582197232|FG000|Overall Study|Withdrawal by Subject|13|||
161222912|NCT01364870|582197233|FG001|Overall Study|Withdrawal by Subject|24|||
161222913|NCT01364870|582197234|FG002|Overall Study|Withdrawal by Subject|10|||
161222914|NCT01364870|582197232|FG000|Overall Study|Adverse Event|8|||
161222915|NCT01364870|582197233|FG001|Overall Study|Adverse Event|6|||
161222916|NCT01364870|582197234|FG002|Overall Study|Adverse Event|4|||
161222917|NCT01364870|582197232|FG000|Overall Study|Protocol Violation|1|||
161222918|NCT01364870|582197233|FG001|Overall Study|Protocol Violation|0|||
161222919|NCT01364870|582197234|FG002|Overall Study|Protocol Violation|0|||
161222920|NCT01309919|582197235|FG000|Overall Study|Did not receive a postpartum IUD|17|||
161222921|NCT01309919|582197236|FG001|Overall Study|Did not receive a postpartum IUD|48|||
161222922|NCT01896297|582197243|FG000|Overall Study|Died in post treatment phase|1|||
161222923|NCT00003782|582197246|FG000|Overall Study|No follow up data|30|||
161222924|NCT00003782|582197247|FG001|Overall Study|No follow up data|31|||
161222925|NCT00003782|582197248|FG002|Overall Study|No follow up data|26|||
161222926|NCT04543136|582198796|FG000|Overall Study|Withdrawal by Subject|0|||
161222927|NCT04543136|582198797|FG001|Overall Study|Withdrawal by Subject|1|||
161222928|NCT04543136|582198798|FG002|Overall Study|Withdrawal by Subject|0|||
161222929|NCT04543136|582198799|FG003|Overall Study|Withdrawal by Subject|1|||
161222930|NCT04543136|582198800|FG004|Overall Study|Withdrawal by Subject|0|||
161222931|NCT04543136|582198801|FG005|Overall Study|Withdrawal by Subject|0|||
161222932|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
161222933|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
161222934|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222935|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222936|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222937|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
161222938|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
161222939|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222940|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222941|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222942|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222943|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222944|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222945|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
161222946|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222947|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222948|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222949|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222950|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222951|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
161222952|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
161222953|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222954|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222955|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222956|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222957|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222958|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222959|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
161222960|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
161222961|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222962|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222963|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222964|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222965|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222966|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
161222967|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222968|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222969|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222970|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222971|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222972|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222973|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
161222974|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222975|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161118539|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
161118540|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
161118541|NCT01142726|581822128|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
161118542|NCT01142726|581822129|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
161118543|NCT01142726|581822130|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
161118544|NCT01142726|581822128|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
161118545|NCT01142726|581822129|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
161118546|NCT01142726|581822130|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
161118547|NCT01142726|581822128|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161118548|NCT01142726|581822129|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161118549|NCT01142726|581822130|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
161118550|NCT01142726|581822128|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
161118551|NCT01142726|581822129|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
161118552|NCT01142726|581822130|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
161118553|NCT01142726|581822128|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
161118554|NCT01142726|581822129|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
161118555|NCT01142726|581822130|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
161118556|NCT01568593|581822131|FG000|Overall Study|Lack of Efficacy|4|||
161118557|NCT01568593|581822132|FG001|Overall Study|Lack of Efficacy|1|||
161118558|NCT01568593|581822131|FG000|Overall Study|Adverse Event|3|||
161118559|NCT01568593|581822132|FG001|Overall Study|Adverse Event|2|||
161118560|NCT02228590|581822133|FG000|Overall Study|Withdrawal by Subject|1|||
161118561|NCT02109484|581822134|FG000|Overall Study|Lost to Follow-up|0|||
161118562|NCT02109484|581822135|FG001|Overall Study|Lost to Follow-up|0|||
161118563|NCT02109484|581822136|FG002|Overall Study|Lost to Follow-up|0|||
161118564|NCT02109484|581822137|FG003|Overall Study|Lost to Follow-up|1|||
161118565|NCT02109484|581822138|FG004|Overall Study|Lost to Follow-up|1|||
161118566|NCT02109484|581822139|FG005|Overall Study|Lost to Follow-up|0|||
161118567|NCT02109484|581822140|FG006|Overall Study|Lost to Follow-up|1|||
161118568|NCT02109484|581822141|FG007|Overall Study|Lost to Follow-up|0|||
161118569|NCT02109484|581822134|FG000|Overall Study|Withdrawal by Subject|0|||
161118570|NCT02109484|581822135|FG001|Overall Study|Withdrawal by Subject|0|||
161118571|NCT02109484|581822136|FG002|Overall Study|Withdrawal by Subject|0|||
161118572|NCT02109484|581822137|FG003|Overall Study|Withdrawal by Subject|0|||
161118573|NCT02109484|581822138|FG004|Overall Study|Withdrawal by Subject|1|||
161118574|NCT02109484|581822139|FG005|Overall Study|Withdrawal by Subject|1|||
161118575|NCT02109484|581822140|FG006|Overall Study|Withdrawal by Subject|1|||
161118576|NCT02109484|581822141|FG007|Overall Study|Withdrawal by Subject|0|||
161118577|NCT02109484|581822134|FG000|Overall Study|Physician Decision|0|||
161118578|NCT02109484|581822135|FG001|Overall Study|Physician Decision|0|||
161118579|NCT02109484|581822136|FG002|Overall Study|Physician Decision|0|||
161118580|NCT02109484|581822137|FG003|Overall Study|Physician Decision|0|||
161118581|NCT02109484|581822138|FG004|Overall Study|Physician Decision|2|||
161118582|NCT02109484|581822139|FG005|Overall Study|Physician Decision|0|||
161118583|NCT02109484|581822140|FG006|Overall Study|Physician Decision|0|||
161118584|NCT02109484|581822141|FG007|Overall Study|Physician Decision|0|||
161118585|NCT02109484|581822134|FG000|Overall Study|Death|0|||
161118586|NCT02109484|581822135|FG001|Overall Study|Death|0|||
161118587|NCT02109484|581822136|FG002|Overall Study|Death|0|||
161118588|NCT02109484|581822137|FG003|Overall Study|Death|0|||
161118589|NCT02109484|581822138|FG004|Overall Study|Death|0|||
161118590|NCT02109484|581822139|FG005|Overall Study|Death|0|||
161118591|NCT02109484|581822140|FG006|Overall Study|Death|0|||
161118592|NCT02109484|581822141|FG007|Overall Study|Death|2|||
161118593|NCT02109484|581822134|FG000|Overall Study|Moved away from study area|0|||
161118594|NCT02109484|581822135|FG001|Overall Study|Moved away from study area|0|||
161118595|NCT02109484|581822136|FG002|Overall Study|Moved away from study area|0|||
161118596|NCT02109484|581822137|FG003|Overall Study|Moved away from study area|0|||
161118597|NCT02109484|581822138|FG004|Overall Study|Moved away from study area|0|||
161118598|NCT02109484|581822139|FG005|Overall Study|Moved away from study area|0|||
161118599|NCT02109484|581822140|FG006|Overall Study|Moved away from study area|1|||
161118600|NCT02109484|581822141|FG007|Overall Study|Moved away from study area|1|||
161118601|NCT02111993|581822142|FG000|Overall Study|Physician Decision|5|||
161118602|NCT02111993|581822143|FG001|Overall Study|Physician Decision|4|||
161118603|NCT00419380|581822144|FG000|Overall Study|Lack of Efficacy|1|||
161118604|NCT00419380|581822145|FG001|Overall Study|Lack of Efficacy|7|||
161118605|NCT00419380|581822144|FG000|Overall Study|Physician Decision|0|||
161118606|NCT00419380|581822145|FG001|Overall Study|Physician Decision|1|||
161118607|NCT00419380|581822144|FG000|Overall Study|Lost to Follow-up|0|||
161118608|NCT00419380|581822145|FG001|Overall Study|Lost to Follow-up|1|||
161118609|NCT00419380|581822144|FG000|Overall Study|Withdrawal by Subject|0|||
161118610|NCT00419380|581822145|FG001|Overall Study|Withdrawal by Subject|1|||
161118611|NCT00494091|581823693|FG000|Overall Study|Death|5|||
161118612|NCT00494091|581823694|FG001|Overall Study|Death|54|||
161118613|NCT00494091|581823693|FG000|Overall Study|Lost to Follow-up|0|||
161118614|NCT00494091|581823694|FG001|Overall Study|Lost to Follow-up|4|||
161222976|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222977|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222978|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222979|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
161222980|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
161222981|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222982|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222983|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222984|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222985|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222986|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222987|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
161222988|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222989|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222990|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222991|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222992|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222993|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222994|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
161222995|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222996|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222997|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222998|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161222999|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161223000|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161223001|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
161223002|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161223003|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161223004|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
161223005|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223006|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223007|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
161223008|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
161223009|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223010|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223011|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223012|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223013|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223014|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223015|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
161223016|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223017|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
161223018|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223019|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223020|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223021|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
161223022|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223023|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223024|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223025|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223026|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223027|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223028|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223029|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
161223030|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
161223031|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223032|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223033|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223034|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223035|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
161223036|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223037|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223038|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223039|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223040|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223041|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223042|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223043|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
161223044|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223045|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223046|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223047|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
161223048|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
161223049|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223050|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223051|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
161223052|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
161223053|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223054|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223055|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223056|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223057|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
161223058|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223059|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223060|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223061|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223062|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223063|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223064|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223065|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
161223066|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
161223067|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223068|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223069|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223070|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223071|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
161223072|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223073|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223074|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223075|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223076|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223077|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223078|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223079|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223080|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
161223081|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223082|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223083|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223084|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223085|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
161223086|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223087|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223088|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223089|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
161223090|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223091|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223092|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223093|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223094|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223095|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223096|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223097|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223098|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223099|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
161223100|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223101|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223102|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223103|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223104|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223105|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223106|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223107|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
161223108|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
161223109|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223110|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223111|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223112|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223113|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
161223114|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223115|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223116|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223117|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223118|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223119|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223120|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223121|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
161223122|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223123|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223124|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223125|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223126|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223127|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
161223128|NCT04033445|582198803|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223129|NCT04033445|582198804|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223130|NCT04033445|582198805|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223131|NCT04033445|582198806|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223132|NCT04033445|582198807|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223133|NCT04033445|582198808|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223134|NCT04033445|582198809|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223135|NCT04033445|582198810|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
161223136|NCT04033445|582198811|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223137|NCT04033445|582198812|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223138|NCT04033445|582198813|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223139|NCT04033445|582198814|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223140|NCT04033445|582198815|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223141|NCT04033445|582198816|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
161223142|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223143|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223144|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223145|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223146|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223147|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223148|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223149|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223150|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
161223151|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
161223152|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
161223153|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
161223154|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
161223155|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
161223156|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223157|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223158|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223159|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223160|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223161|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223162|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223163|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223164|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
161223165|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
161223166|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
161223167|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
161223168|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
161223169|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
161223170|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223171|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223172|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223173|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223174|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223175|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223176|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223177|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223178|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223179|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223180|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161223181|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161223182|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
161223183|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
161223184|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223185|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223186|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223187|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223188|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223189|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223190|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223191|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223192|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223193|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
161223194|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
161223195|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
161223196|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
161223197|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
161223198|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223199|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223200|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223201|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223202|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223203|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223204|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223205|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223206|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
161223207|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
161223208|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
161223209|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
161223210|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
161223211|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
161223212|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223213|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223214|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223215|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223216|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223217|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223218|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223219|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223220|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223221|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223222|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223223|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223224|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
161223225|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
161223226|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223227|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223228|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223229|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223230|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223231|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223232|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223233|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223234|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
161223235|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
161223236|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
161223237|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
161223238|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
161223239|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
161223240|NCT04033445|582198803|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223241|NCT04033445|582198804|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223242|NCT04033445|582198805|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223243|NCT04033445|582198806|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223244|NCT04033445|582198807|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223245|NCT04033445|582198808|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223246|NCT04033445|582198809|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223247|NCT04033445|582198810|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223248|NCT04033445|582198811|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223249|NCT04033445|582198812|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161223250|NCT04033445|582198813|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223251|NCT04033445|582198814|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161223252|NCT04033445|582198815|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
161223253|NCT04033445|582198816|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
161223254|NCT02985957|582198821|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161223255|NCT02985957|582198822|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161223256|NCT02985957|582198823|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161223257|NCT02985957|582198824|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161223258|NCT02985957|582198825|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161223259|NCT02985957|582198826|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161223260|NCT02985957|582198827|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161223261|NCT02985957|582198821|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
161223262|NCT02985957|582198822|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161223263|NCT02985957|582198823|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
161223264|NCT02985957|582198824|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
161223265|NCT02985957|582198825|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
161223266|NCT02985957|582198826|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
161223267|NCT02985957|582198827|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
161223268|NCT02985957|582198821|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161223269|NCT02985957|582198822|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161223270|NCT02985957|582198823|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161223271|NCT02985957|582198824|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161223272|NCT02985957|582198825|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161223273|NCT02985957|582198826|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161223274|NCT02985957|582198827|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161223275|NCT02985957|582198821|FG000|Treatment Period|Death|0|||
161223276|NCT02985957|582198822|FG001|Treatment Period|Death|0|||
161223277|NCT02985957|582198823|FG002|Treatment Period|Death|0|||
161223278|NCT02985957|582198824|FG003|Treatment Period|Death|0|||
161223279|NCT02985957|582198825|FG004|Treatment Period|Death|1|||
161223280|NCT02985957|582198826|FG005|Treatment Period|Death|0|||
161223281|NCT02985957|582198827|FG006|Treatment Period|Death|0|||
161223282|NCT02985957|582198821|FG000|Treatment Period|Participant withdrew consent|0|||
161223283|NCT02985957|582198822|FG001|Treatment Period|Participant withdrew consent|0|||
161223284|NCT02985957|582198823|FG002|Treatment Period|Participant withdrew consent|0|||
161223285|NCT02985957|582198824|FG003|Treatment Period|Participant withdrew consent|1|||
161223286|NCT02985957|582198825|FG004|Treatment Period|Participant withdrew consent|3|||
161223287|NCT02985957|582198826|FG005|Treatment Period|Participant withdrew consent|0|||
161223288|NCT02985957|582198827|FG006|Treatment Period|Participant withdrew consent|1|||
161223289|NCT02985957|582198821|FG000|Treatment Period|Lost to Follow-up|0|||
161223290|NCT02985957|582198822|FG001|Treatment Period|Lost to Follow-up|0|||
161223291|NCT02985957|582198823|FG002|Treatment Period|Lost to Follow-up|0|||
161223292|NCT02985957|582198824|FG003|Treatment Period|Lost to Follow-up|0|||
161223293|NCT02985957|582198825|FG004|Treatment Period|Lost to Follow-up|1|||
161223294|NCT02985957|582198826|FG005|Treatment Period|Lost to Follow-up|0|||
161223295|NCT02985957|582198827|FG006|Treatment Period|Lost to Follow-up|0|||
161223296|NCT02985957|582198821|FG000|Treatment Period|Other reasons|0|||
161223297|NCT02985957|582198822|FG001|Treatment Period|Other reasons|0|||
161223298|NCT02985957|582198823|FG002|Treatment Period|Other reasons|1|||
161223299|NCT02985957|582198824|FG003|Treatment Period|Other reasons|3|||
161223300|NCT02985957|582198825|FG004|Treatment Period|Other reasons|5|||
161223301|NCT02985957|582198826|FG005|Treatment Period|Other reasons|0|||
161223302|NCT02985957|582198827|FG006|Treatment Period|Other reasons|1|||
161223303|NCT02985957|582198821|FG000|Treatment Period|Not reported|0|||
161223304|NCT02985957|582198822|FG001|Treatment Period|Not reported|2|||
161223305|NCT02985957|582198823|FG002|Treatment Period|Not reported|2|||
161223306|NCT02985957|582198824|FG003|Treatment Period|Not reported|5|||
161223307|NCT02985957|582198825|FG004|Treatment Period|Not reported|0|||
161223308|NCT02985957|582198826|FG005|Treatment Period|Not reported|0|||
161223309|NCT02985957|582198827|FG006|Treatment Period|Not reported|0|||
161223310|NCT02985957|582198821|FG000|Treatment Period|Maximum clinical benefit|0|||
161223311|NCT02985957|582198822|FG001|Treatment Period|Maximum clinical benefit|0|||
161223312|NCT02985957|582198823|FG002|Treatment Period|Maximum clinical benefit|1|||
161223313|NCT02985957|582198824|FG003|Treatment Period|Maximum clinical benefit|1|||
161223314|NCT02985957|582198825|FG004|Treatment Period|Maximum clinical benefit|0|||
161223315|NCT02985957|582198826|FG005|Treatment Period|Maximum clinical benefit|0|||
161223316|NCT02985957|582198827|FG006|Treatment Period|Maximum clinical benefit|2|||
161223317|NCT02985957|582198821|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
161223318|NCT02985957|582198822|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
161223319|NCT02985957|582198823|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
160874511|NCT04413617|580934240|FG000|Overall Study|Death|1|||
160874512|NCT04413617|580934241|FG001|Overall Study|Death|0|||
160874513|NCT04413617|580934242|FG002|Overall Study|Death|0|||
161223320|NCT02985957|582198824|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
161223321|NCT02985957|582198825|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
161223322|NCT02985957|582198826|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
161223323|NCT02985957|582198827|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
161223324|NCT02985957|582198821|FG000|Treatment Period|Study drug toxicity|1|||
161223325|NCT02985957|582198822|FG001|Treatment Period|Study drug toxicity|23|||
161223326|NCT02985957|582198823|FG002|Treatment Period|Study drug toxicity|20|||
161223327|NCT02985957|582198824|FG003|Treatment Period|Study drug toxicity|12|||
161223328|NCT02985957|582198825|FG004|Treatment Period|Study drug toxicity|20|||
161223329|NCT02985957|582198826|FG005|Treatment Period|Study drug toxicity|3|||
161223330|NCT02985957|582198827|FG006|Treatment Period|Study drug toxicity|5|||
161223331|NCT02985957|582198821|FG000|Treatment Period|Disease progression|0|||
161223332|NCT02985957|582198822|FG001|Treatment Period|Disease progression|16|||
161223333|NCT02985957|582198823|FG002|Treatment Period|Disease progression|20|||
161223334|NCT02985957|582198824|FG003|Treatment Period|Disease progression|40|||
161223335|NCT02985957|582198825|FG004|Treatment Period|Disease progression|29|||
161223336|NCT02985957|582198826|FG005|Treatment Period|Disease progression|11|||
161223337|NCT02985957|582198827|FG006|Treatment Period|Disease progression|28|||
161223338|NCT02985957|582198821|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
161223339|NCT02985957|582198822|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
161223340|NCT02985957|582198823|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
161223341|NCT02985957|582198824|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
161223342|NCT02985957|582198825|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
161223343|NCT02985957|582198826|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
161223344|NCT02985957|582198827|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
161223345|NCT02985957|582198821|FG000|Treatment Period|Poor/Non-Compliance|0|||
161223346|NCT02985957|582198822|FG001|Treatment Period|Poor/Non-Compliance|0|||
161223347|NCT02985957|582198823|FG002|Treatment Period|Poor/Non-Compliance|0|||
161223348|NCT02985957|582198824|FG003|Treatment Period|Poor/Non-Compliance|0|||
161223349|NCT02985957|582198825|FG004|Treatment Period|Poor/Non-Compliance|1|||
161223350|NCT02985957|582198826|FG005|Treatment Period|Poor/Non-Compliance|1|||
161223351|NCT02985957|582198827|FG006|Treatment Period|Poor/Non-Compliance|0|||
161223352|NCT02978326|582198832|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
161223353|NCT02978326|582198833|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
161223354|NCT02978326|582198834|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
161223355|NCT02978326|582198832|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
161223356|NCT02978326|582198833|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
161223357|NCT02978326|582198834|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
161223358|NCT02978326|582198832|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
161223359|NCT02978326|582198833|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
161223360|NCT02978326|582198834|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
161223361|NCT02978326|582198832|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
161223362|NCT02978326|582198833|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
161223363|NCT02978326|582198834|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
161223364|NCT03748641|582198837|FG000|Overall Study|Ongoing|155|||
161223365|NCT03748641|582198838|FG001|Overall Study|Ongoing|148|||
161223366|NCT03748641|582198839|FG002|Overall Study|Ongoing|66|||
161223367|NCT03748641|582198840|FG003|Overall Study|Ongoing|79|||
161223368|NCT03748641|582198841|FG004|Overall Study|Ongoing|84|||
161223369|NCT03748641|582198837|FG000|Overall Study|Death|54|||
160874514|NCT04413617|580934243|FG003|Overall Study|Death|0|||
160874515|NCT04413617|580934244|FG004|Overall Study|Death|0|||
160874516|NCT04413617|580934240|FG000|Overall Study|Adverse Event|1|||
161223370|NCT03748641|582198838|FG001|Overall Study|Death|59|||
161223371|NCT03748641|582198839|FG002|Overall Study|Death|51|||
161223372|NCT03748641|582198840|FG003|Overall Study|Death|42|||
161223373|NCT03748641|582198841|FG004|Overall Study|Death|9|||
161223374|NCT03748641|582198837|FG000|Overall Study|Lost to Follow-up|0|||
161223375|NCT03748641|582198838|FG001|Overall Study|Lost to Follow-up|2|||
161223376|NCT03748641|582198839|FG002|Overall Study|Lost to Follow-up|1|||
161223377|NCT03748641|582198840|FG003|Overall Study|Lost to Follow-up|0|||
161223378|NCT03748641|582198841|FG004|Overall Study|Lost to Follow-up|0|||
161223379|NCT03748641|582198837|FG000|Overall Study|Withdrawal by Subject|3|||
161223380|NCT03748641|582198838|FG001|Overall Study|Withdrawal by Subject|2|||
161223381|NCT03748641|582198839|FG002|Overall Study|Withdrawal by Subject|5|||
161223382|NCT03748641|582198840|FG003|Overall Study|Withdrawal by Subject|3|||
161223383|NCT03748641|582198841|FG004|Overall Study|Withdrawal by Subject|2|||
161223384|NCT00437281|582198842|FG000|Overall Study|Adverse Event|0|||
161223385|NCT00437281|582198843|FG001|Overall Study|Adverse Event|0|||
161223386|NCT00437281|582198844|FG002|Overall Study|Adverse Event|0|||
161223387|NCT00437281|582198845|FG003|Overall Study|Adverse Event|1|||
161223388|NCT00437281|582198846|FG004|Overall Study|Adverse Event|0|||
161223389|NCT00437281|582198847|FG005|Overall Study|Adverse Event|1|||
161223390|NCT00437281|582198848|FG006|Overall Study|Adverse Event|0|||
161223391|NCT00437281|582198849|FG007|Overall Study|Adverse Event|0|||
161223392|NCT00437281|582198850|FG008|Overall Study|Adverse Event|0|||
161223393|NCT00437281|582198851|FG009|Overall Study|Adverse Event|1|||
161223394|NCT00437281|582198852|FG010|Overall Study|Adverse Event|0|||
161223395|NCT00437281|582198853|FG011|Overall Study|Adverse Event|0|||
161223396|NCT00437281|582198854|FG012|Overall Study|Adverse Event|0|||
161223397|NCT00437281|582198855|FG013|Overall Study|Adverse Event|1|||
161223398|NCT00437281|582198856|FG014|Overall Study|Adverse Event|1|||
161223399|NCT00437281|582198857|FG015|Overall Study|Adverse Event|0|||
161223400|NCT00437281|582198858|FG016|Overall Study|Adverse Event|0|||
161223401|NCT00437281|582198859|FG017|Overall Study|Adverse Event|0|||
161223402|NCT00437281|582198860|FG018|Overall Study|Adverse Event|1|||
161223403|NCT00437281|582198861|FG019|Overall Study|Adverse Event|0|||
161223404|NCT00437281|582198842|FG000|Overall Study|Lost to Follow-up|0|||
161223405|NCT00437281|582198843|FG001|Overall Study|Lost to Follow-up|0|||
161223406|NCT00437281|582198844|FG002|Overall Study|Lost to Follow-up|0|||
161223407|NCT00437281|582198845|FG003|Overall Study|Lost to Follow-up|0|||
161223408|NCT00437281|582198846|FG004|Overall Study|Lost to Follow-up|0|||
161223409|NCT00437281|582198847|FG005|Overall Study|Lost to Follow-up|0|||
161223410|NCT00437281|582198848|FG006|Overall Study|Lost to Follow-up|0|||
161223411|NCT00437281|582198849|FG007|Overall Study|Lost to Follow-up|0|||
161223412|NCT00437281|582198850|FG008|Overall Study|Lost to Follow-up|0|||
161223413|NCT00437281|582198851|FG009|Overall Study|Lost to Follow-up|0|||
161223414|NCT00437281|582198852|FG010|Overall Study|Lost to Follow-up|0|||
161223415|NCT00437281|582198853|FG011|Overall Study|Lost to Follow-up|0|||
161223416|NCT00437281|582198854|FG012|Overall Study|Lost to Follow-up|0|||
161223417|NCT00437281|582198855|FG013|Overall Study|Lost to Follow-up|0|||
161223418|NCT00437281|582198856|FG014|Overall Study|Lost to Follow-up|0|||
161223419|NCT00437281|582198857|FG015|Overall Study|Lost to Follow-up|0|||
161223420|NCT00437281|582198858|FG016|Overall Study|Lost to Follow-up|0|||
161223421|NCT00437281|582198859|FG017|Overall Study|Lost to Follow-up|0|||
161223422|NCT00437281|582198860|FG018|Overall Study|Lost to Follow-up|0|||
161223423|NCT00437281|582198861|FG019|Overall Study|Lost to Follow-up|1|||
161223424|NCT04684524|582198862|FG000|Overall Study|Other|2|||
161223425|NCT04684524|582198863|FG001|Overall Study|Other|0|||
161223426|NCT04684524|582198862|FG000|Overall Study|Withdrawal by Subject|5|||
161223427|NCT04684524|582198863|FG001|Overall Study|Withdrawal by Subject|3|||
161223428|NCT04684524|582198862|FG000|Overall Study|Adverse Event|1|||
161223429|NCT04684524|582198863|FG001|Overall Study|Adverse Event|1|||
161223430|NCT00926289|582198864|FG000|Overall Study|Adverse Event|9|||
161223431|NCT00926289|582198865|FG001|Overall Study|Adverse Event|11|||
161223432|NCT00926289|582198864|FG000|Overall Study|Protocol Violation|8|||
161223433|NCT00926289|582198865|FG001|Overall Study|Protocol Violation|12|||
161223434|NCT00926289|582198864|FG000|Overall Study|Lost to Follow-up|3|||
161223435|NCT00926289|582198865|FG001|Overall Study|Lost to Follow-up|6|||
161223436|NCT00926289|582198864|FG000|Overall Study|Withdrawal by Subject|4|||
161223437|NCT00926289|582198865|FG001|Overall Study|Withdrawal by Subject|4|||
161223438|NCT00926289|582198864|FG000|Overall Study|Other|1|||
161223439|NCT00926289|582198865|FG001|Overall Study|Other|3|||
161223440|NCT04104646|582198866|FG000|Overall Study|Withdrawal by Subject|1|||
161223441|NCT04104646|582198867|FG001|Overall Study|Withdrawal by Subject|1|||
161223442|NCT04104646|582198866|FG000|Overall Study|Lost to Follow-up|1|||
161223443|NCT04104646|582198867|FG001|Overall Study|Lost to Follow-up|0|||
161223444|NCT04104646|582198866|FG000|Overall Study|Physician Decision|2|||
161223445|NCT04104646|582198867|FG001|Overall Study|Physician Decision|0|||
161223446|NCT00753714|582198868|FG000|Overall Study|Lack of Efficacy|21|||
161223447|NCT00753714|582198869|FG001|Overall Study|Lack of Efficacy|34|||
161223448|NCT00753714|582198868|FG000|Overall Study|Adverse Event|26|||
161223449|NCT00753714|582198869|FG001|Overall Study|Adverse Event|18|||
161223450|NCT00753714|582198868|FG000|Overall Study|Protocol Violation|1|||
161223451|NCT00753714|582198869|FG001|Overall Study|Protocol Violation|0|||
161223452|NCT00753714|582198868|FG000|Overall Study|Lost to Follow-up|0|||
161223453|NCT00753714|582198869|FG001|Overall Study|Lost to Follow-up|1|||
161223454|NCT00753714|582198868|FG000|Overall Study|Withdrawal by Subject|2|||
161223455|NCT00753714|582198869|FG001|Overall Study|Withdrawal by Subject|1|||
161223456|NCT00753714|582198868|FG000|Overall Study|Death|3|||
161223457|NCT00753714|582198869|FG001|Overall Study|Death|3|||
161223458|NCT00753714|582198868|FG000|Overall Study|Other|7|||
161223459|NCT00753714|582198869|FG001|Overall Study|Other|5|||
161223460|NCT03387098|582198870|FG000|Overall Study|progressive disease|1|||
161223461|NCT03387098|582198870|FG000|Overall Study|Withdrawal by Subject|2|||
161223462|NCT03387098|582198870|FG000|Overall Study|study terminated by sponsor|1|||
161223463|NCT02292238|582198871|FG000|Overall Study|Protocol Violation|1|||
161223464|NCT02292238|582198872|FG001|Overall Study|Protocol Violation|2|||
161223465|NCT02292238|582198871|FG000|Overall Study|Withdrawal by Subject|2|||
161223466|NCT02292238|582198872|FG001|Overall Study|Withdrawal by Subject|1|||
161223467|NCT02292238|582198871|FG000|Overall Study|Lost to Follow-up|1|||
161223468|NCT02292238|582198872|FG001|Overall Study|Lost to Follow-up|0|||
161223469|NCT02292238|582198871|FG000|Overall Study|Physician Decision|0|||
161223470|NCT02292238|582198872|FG001|Overall Study|Physician Decision|1|||
161223471|NCT04000009|582198873|FG000|Overall Study|Adverse Event|13|||
161223472|NCT04000009|582198873|FG000|Overall Study|Lack of Efficacy|7|||
161223473|NCT04000009|582198873|FG000|Overall Study|Lost to Follow-up|8|||
161223474|NCT04000009|582198873|FG000|Overall Study|Noncompliance with study drug|4|||
161223475|NCT04000009|582198873|FG000|Overall Study|Physician Decision|1|||
161223476|NCT04000009|582198873|FG000|Overall Study|Use of prohibited medication|3|||
161223477|NCT04000009|582198873|FG000|Overall Study|Pregnancy|1|||
161223478|NCT04000009|582198873|FG000|Overall Study|Withdrawal by Subject|22|||
161223479|NCT04000009|582198873|FG000|Overall Study|Study terminated by sponsor|98|||
161223480|NCT04000009|582198873|FG000|Overall Study|Not further specified|8|||
161223481|NCT01754259|582198878|FG000|Overall Study|Withdrawal by Subject|2|||
161223482|NCT01754259|582198879|FG001|Overall Study|Withdrawal by Subject|4|||
161223483|NCT01754259|582198878|FG000|Overall Study|Adverse Event|3|||
161223484|NCT01754259|582198879|FG001|Overall Study|Adverse Event|1|||
161223485|NCT01754259|582198878|FG000|Overall Study|Lost to Follow-up|0|||
161223486|NCT01754259|582198879|FG001|Overall Study|Lost to Follow-up|1|||
161223487|NCT02829918|582198880|FG000|Overall Study|Death|2|||
161223488|NCT02829918|582198880|FG000|Overall Study|Withdrawal by Subject|4|||
161223489|NCT02829918|582198880|FG000|Overall Study|Adverse Event|1|||
161223490|NCT02829918|582198880|FG000|Overall Study|Progression|1|||
161223491|NCT00491504|582198883|FG000|Overall Study|Adverse Event|0|||
161223492|NCT00491504|582198884|FG001|Overall Study|Adverse Event|1|||
161223493|NCT00491504|582198885|FG002|Overall Study|Adverse Event|0|||
161223494|NCT00491504|582198886|FG003|Overall Study|Adverse Event|0|||
161223495|NCT00491504|582198883|FG000|Overall Study|Withdrawal by Subject|0|||
161223496|NCT00491504|582198884|FG001|Overall Study|Withdrawal by Subject|0|||
161223497|NCT00491504|582198885|FG002|Overall Study|Withdrawal by Subject|1|||
161223498|NCT00491504|582198886|FG003|Overall Study|Withdrawal by Subject|2|||
161223499|NCT00491504|582198883|FG000|Overall Study|Protocol Violation|0|||
161223500|NCT00491504|582198884|FG001|Overall Study|Protocol Violation|0|||
161223501|NCT00491504|582198885|FG002|Overall Study|Protocol Violation|3|||
161223502|NCT00491504|582198886|FG003|Overall Study|Protocol Violation|2|||
161223503|NCT00673790|582198887|FG000|Overall Study|Adverse Event|23|||
161223504|NCT00673790|582198888|FG001|Overall Study|Adverse Event|14|||
161223505|NCT00673790|582198889|FG002|Overall Study|Adverse Event|2|||
161223506|NCT00673790|582198887|FG000|Overall Study|Lack of Efficacy|2|||
161223507|NCT00673790|582198888|FG001|Overall Study|Lack of Efficacy|2|||
161223508|NCT00673790|582198889|FG002|Overall Study|Lack of Efficacy|2|||
161223509|NCT00673790|582198887|FG000|Overall Study|Protocol Violation|6|||
161223510|NCT00673790|582198888|FG001|Overall Study|Protocol Violation|9|||
161223511|NCT00673790|582198889|FG002|Overall Study|Protocol Violation|1|||
161223512|NCT00673790|582198887|FG000|Overall Study|Withdrawal by Subject|7|||
161223513|NCT00673790|582198888|FG001|Overall Study|Withdrawal by Subject|4|||
161223514|NCT00673790|582198889|FG002|Overall Study|Withdrawal by Subject|1|||
161223515|NCT00673790|582198887|FG000|Overall Study|Lost to Follow-up|6|||
161223516|NCT00673790|582198888|FG001|Overall Study|Lost to Follow-up|6|||
161223517|NCT00673790|582198889|FG002|Overall Study|Lost to Follow-up|5|||
161223518|NCT00673790|582198887|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
161223519|NCT00673790|582198888|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
161223520|NCT00673790|582198889|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
161223521|NCT00673790|582198887|FG000|Overall Study|Poor compliance|1|||
161223522|NCT00673790|582198888|FG001|Overall Study|Poor compliance|0|||
161223523|NCT00673790|582198889|FG002|Overall Study|Poor compliance|0|||
161223524|NCT00673790|582198887|FG000|Overall Study|Participated in two Nebivolol studies|0|||
161223525|NCT00673790|582198888|FG001|Overall Study|Participated in two Nebivolol studies|0|||
161223526|NCT00673790|582198889|FG002|Overall Study|Participated in two Nebivolol studies|1|||
161223527|NCT00673790|582198887|FG000|Overall Study|Unconfirmed pregnancy|0|||
161223528|NCT00673790|582198888|FG001|Overall Study|Unconfirmed pregnancy|1|||
161223529|NCT00673790|582198889|FG002|Overall Study|Unconfirmed pregnancy|0|||
161223530|NCT00673790|582198887|FG000|Overall Study|Randomization criteria not met|0|||
161223531|NCT00673790|582198888|FG001|Overall Study|Randomization criteria not met|1|||
161223532|NCT00673790|582198889|FG002|Overall Study|Randomization criteria not met|0|||
161223533|NCT03977584|582198890|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
161223534|NCT03977584|582198891|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
161223535|NCT03977584|582198892|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
161223536|NCT02257736|582198896|FG000|Overall Study|Progressive disease|365|||
161223537|NCT02257736|582198897|FG001|Overall Study|Progressive disease|327|||
161223538|NCT02257736|582198896|FG000|Overall Study|Adverse Event|45|||
161223539|NCT02257736|582198897|FG001|Overall Study|Adverse Event|56|||
161223540|NCT02257736|582198896|FG000|Overall Study|Withdrawal by Subject|21|||
161223541|NCT02257736|582198897|FG001|Overall Study|Withdrawal by Subject|38|||
161223542|NCT02257736|582198896|FG000|Overall Study|Death|11|||
160874517|NCT04413617|580934241|FG001|Overall Study|Adverse Event|0|||
160874518|NCT04413617|580934242|FG002|Overall Study|Adverse Event|0|||
160874519|NCT04413617|580934243|FG003|Overall Study|Adverse Event|1|||
161223543|NCT02257736|582198897|FG001|Overall Study|Death|6|||
161223544|NCT02257736|582198896|FG000|Overall Study|Physician Decision|5|||
161223545|NCT02257736|582198897|FG001|Overall Study|Physician Decision|9|||
161223546|NCT02257736|582198896|FG000|Overall Study|Non-Compliance with study drug|1|||
161223547|NCT02257736|582198897|FG001|Overall Study|Non-Compliance with study drug|2|||
161223548|NCT02257736|582198896|FG000|Overall Study|Protocol Violation|1|||
161223549|NCT02257736|582198897|FG001|Overall Study|Protocol Violation|0|||
161223550|NCT02257736|582198896|FG000|Overall Study|Other|1|||
161223551|NCT02257736|582198897|FG001|Overall Study|Other|7|||
161223552|NCT02257736|582198896|FG000|Overall Study|Randomized, not treated|1|||
161223553|NCT02257736|582198897|FG001|Overall Study|Randomized, not treated|2|||
161223554|NCT00745251|582198905|FG000|Overall Study|Adverse Event|1|||
161223555|NCT00745251|582198906|FG001|Overall Study|Adverse Event|2|||
161223556|NCT00745251|582198905|FG000|Overall Study|Withdrawal by Subject|1|||
161223557|NCT00745251|582198906|FG001|Overall Study|Withdrawal by Subject|1|||
161223558|NCT03390504|582198907|FG000|Overall Study|Lost to Follow-up|2|||
161223559|NCT03390504|582198908|FG001|Overall Study|Lost to Follow-up|4|||
161223560|NCT03390504|582198909|FG002|Overall Study|Lost to Follow-up|0|||
161223561|NCT03390504|582198910|FG003|Overall Study|Lost to Follow-up|1|||
161223562|NCT03390504|582198907|FG000|Overall Study|Withdrawal by Subject|3|||
161223563|NCT03390504|582198908|FG001|Overall Study|Withdrawal by Subject|15|||
161223564|NCT03390504|582198909|FG002|Overall Study|Withdrawal by Subject|5|||
161223565|NCT03390504|582198910|FG003|Overall Study|Withdrawal by Subject|2|||
161223566|NCT03390504|582198907|FG000|Overall Study|Other|1|||
161223567|NCT03390504|582198908|FG001|Overall Study|Other|2|||
161223568|NCT03390504|582198909|FG002|Overall Study|Other|2|||
161223569|NCT03390504|582198910|FG003|Overall Study|Other|6|||
161223570|NCT03850509|582198911|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
161223571|NCT03850509|582198912|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
161223572|NCT00969332|582198913|FG000|Overall Study|Physician Decision|8|||
161223573|NCT00969332|582198913|FG000|Overall Study|Withdrawal by Subject|3|||
160874520|NCT04413617|580934244|FG004|Overall Study|Adverse Event|1|||
160874521|NCT04413617|580934240|FG000|Overall Study|COVID-19|0|||
160874522|NCT04413617|580934241|FG001|Overall Study|COVID-19|1|||
160874523|NCT04413617|580934242|FG002|Overall Study|COVID-19|0|||
160874524|NCT04413617|580934243|FG003|Overall Study|COVID-19|0|||
161223574|NCT02666430|582198914|FG000|Period 1|Lost to Follow-up|1|||
161223575|NCT02666430|582198915|FG001|Period 1|Lost to Follow-up|0|||
161223576|NCT02666430|582198914|FG000|Period 1|Adverse Event|0|||
161223577|NCT02666430|582198915|FG001|Period 1|Adverse Event|1|||
161223578|NCT02666430|582198914|FG000|Period 2|Withdrawal by Subject|1|||
161223579|NCT02666430|582198915|FG001|Period 2|Withdrawal by Subject|4|||
161223580|NCT02666430|582198914|FG000|Period 3|Lost to Follow-up|1|||
161223581|NCT02666430|582198915|FG001|Period 3|Lost to Follow-up|0|||
161223582|NCT03828461|582198916|FG000|Overall Study|Lost to Follow-up|1|||
161223583|NCT03828461|582198916|FG000|Overall Study|Withdrawal by Subject|3|||
161223584|NCT00576199|582198917|FG000|Overall Study|Adverse Event|12|||
161223585|NCT00576199|582198917|FG000|Overall Study|Insufficient Therapeutic Response|14|||
161223586|NCT00576199|582198917|FG000|Overall Study|Refused Treatment|2|||
161223587|NCT00576199|582198917|FG000|Overall Study|Reason Unspecified|2|||
161118615|NCT00494091|581823693|FG000|Overall Study|Other|1|||
161118616|NCT00494091|581823694|FG001|Overall Study|Other|11|||
161118617|NCT00494091|581823693|FG000|Overall Study|Withdrawal by Subject|0|||
161118618|NCT00494091|581823694|FG001|Overall Study|Withdrawal by Subject|7|||
161118619|NCT01652287|581823696|FG000|Overall Study|Withdrawal by Subject|2|||
161118620|NCT01652287|581823697|FG001|Overall Study|Withdrawal by Subject|0|||
161118621|NCT00699348|581823702|FG000|Overall Study|Death|6|||
161118622|NCT00699348|581823702|FG000|Overall Study|Adverse Event|15|||
161118623|NCT00699348|581823702|FG000|Overall Study|Withdrawal by Subject|11|||
161118624|NCT00699348|581823702|FG000|Overall Study|Protocol Violation|10|||
161118625|NCT00699348|581823702|FG000|Overall Study|Lack of Efficacy|8|||
161118626|NCT00699348|581823702|FG000|Overall Study|Failure to return|1|||
161118627|NCT00699348|581823702|FG000|Overall Study|Blood transfusion|24|||
161118628|NCT00699348|581823702|FG000|Overall Study|Renal transplantation|10|||
161118629|NCT00699348|581823702|FG000|Overall Study|Other|5|||
161118630|NCT00122135|581823703|FG000|Overall Study|Withdrawal by Subject|3|||
161118631|NCT00122135|581823704|FG001|Overall Study|Withdrawal by Subject|0|||
161118632|NCT00559507|581823705|FG000|Overall Study|Not treated, patient ineligible|3|||
161118633|NCT02118792|581823706|FG000|Overall Study|Withdrawal by Subject|6|||
161118634|NCT02118792|581823707|FG001|Overall Study|Withdrawal by Subject|3|||
161118635|NCT02118792|581823706|FG000|Overall Study|Lost to Follow-up|4|||
161118636|NCT02118792|581823707|FG001|Overall Study|Lost to Follow-up|4|||
161118637|NCT02118792|581823706|FG000|Overall Study|Adverse Event|5|||
161118638|NCT02118792|581823707|FG001|Overall Study|Adverse Event|4|||
161118639|NCT02118792|581823706|FG000|Overall Study|Withdrawal by parent/guardian|14|||
161118640|NCT02118792|581823707|FG001|Overall Study|Withdrawal by parent/guardian|20|||
161118641|NCT02118792|581823706|FG000|Overall Study|Other|1|||
161118642|NCT02118792|581823707|FG001|Overall Study|Other|6|||
161118643|NCT02118792|581823706|FG000|Overall Study|Randomised but not treated|1|||
161118644|NCT02118792|581823707|FG001|Overall Study|Randomised but not treated|0|||
161118645|NCT01885000|581823708|FG000|Overall Study|Adverse Event|1|||
161118646|NCT01885000|581823709|FG001|Overall Study|Adverse Event|0|||
161118647|NCT01885000|581823708|FG000|Overall Study|Withdrawal by Subject|1|||
161118648|NCT01885000|581823709|FG001|Overall Study|Withdrawal by Subject|1|||
161118649|NCT01885000|581823708|FG000|Overall Study|Protocol Violation|0|||
161118650|NCT01885000|581823709|FG001|Overall Study|Protocol Violation|1|||
161118651|NCT02792842|581823710|FG000|Overall Study|Adverse Event|4|||
161118652|NCT02792842|581823711|FG001|Overall Study|Adverse Event|2|||
161118653|NCT02792842|581823712|FG002|Overall Study|Adverse Event|3|||
161118654|NCT02792842|581823710|FG000|Overall Study|Withdrawal by Subject|0|||
161118655|NCT02792842|581823711|FG001|Overall Study|Withdrawal by Subject|1|||
161118656|NCT02792842|581823712|FG002|Overall Study|Withdrawal by Subject|2|||
161118657|NCT02792842|581823710|FG000|Overall Study|Lost to Follow-up|0|||
161118658|NCT02792842|581823711|FG001|Overall Study|Lost to Follow-up|0|||
161118659|NCT02792842|581823712|FG002|Overall Study|Lost to Follow-up|1|||
161118660|NCT02792842|581823710|FG000|Overall Study|Schedule delay|0|||
161118661|NCT02792842|581823711|FG001|Overall Study|Schedule delay|1|||
161118662|NCT02792842|581823712|FG002|Overall Study|Schedule delay|1|||
161118663|NCT03557359|581823719|FG000|Dose 1: 240 mg|Adverse Event|1|||
161118664|NCT03557359|581823720|FG001|Dose 1: 240 mg|Adverse Event|0|||
161118665|NCT05980299|581823725|FG000|Overall Study|Death|28|||
161118666|NCT05980299|581823726|FG001|Overall Study|Death|0|||
161118667|NCT05980299|581823725|FG000|Overall Study|Discharged from Nursing Home|9|||
161118668|NCT05980299|581823726|FG001|Overall Study|Discharged from Nursing Home|0|||
161118669|NCT05980299|581823725|FG000|Overall Study|Lost to Follow-up|0|||
161118670|NCT05980299|581823726|FG001|Overall Study|Lost to Follow-up|10|||
161118671|NCT01294800|581823727|FG000|Overall Study|Adverse Event|7|||
161118672|NCT01294800|581823728|FG001|Overall Study|Adverse Event|6|||
161118673|NCT01294800|581823729|FG002|Overall Study|Adverse Event|12|||
161118674|NCT01294800|581823730|FG003|Overall Study|Adverse Event|5|||
161118675|NCT01294800|581823727|FG000|Overall Study|Subject Withdrew Consent|2|||
161118676|NCT01294800|581823728|FG001|Overall Study|Subject Withdrew Consent|2|||
161118677|NCT01294800|581823729|FG002|Overall Study|Subject Withdrew Consent|2|||
161118678|NCT01294800|581823730|FG003|Overall Study|Subject Withdrew Consent|11|||
161118679|NCT01294800|581823727|FG000|Overall Study|Lost to Follow-up|0|||
161118680|NCT01294800|581823728|FG001|Overall Study|Lost to Follow-up|0|||
161118681|NCT01294800|581823729|FG002|Overall Study|Lost to Follow-up|1|||
161118682|NCT01294800|581823730|FG003|Overall Study|Lost to Follow-up|0|||
161118683|NCT01294800|581823727|FG000|Overall Study|Non-compliance With Protocol|0|||
161118684|NCT01294800|581823728|FG001|Overall Study|Non-compliance With Protocol|1|||
160874525|NCT04413617|580934244|FG004|Overall Study|COVID-19|0|||
161118685|NCT01294800|581823729|FG002|Overall Study|Non-compliance With Protocol|1|||
161118686|NCT01294800|581823730|FG003|Overall Study|Non-compliance With Protocol|0|||
161118687|NCT01294800|581823727|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
161118688|NCT01294800|581823728|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
161118689|NCT01294800|581823729|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
161118690|NCT01294800|581823730|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
161118691|NCT01662895|581823731|FG000|Overall Study|Lost to Follow-up|0|||
161118692|NCT01662895|581823732|FG001|Overall Study|Lost to Follow-up|1|||
161118693|NCT05048342|581823733|FG000|Overall Study|Adverse Event|1|||
161118694|NCT05048342|581823733|FG000|Overall Study|Subject decision|2|||
161118695|NCT01441063|581823734|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
161118696|NCT01441063|581823734|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
161118697|NCT00493038|581823735|FG000|Treatment|Adverse Event|8|||
161118698|NCT00493038|581823736|FG001|Treatment|Adverse Event|4|||
161118699|NCT00493038|581823735|FG000|Treatment|Lost to Follow-up|5|||
161118700|NCT00493038|581823736|FG001|Treatment|Lost to Follow-up|3|||
161118701|NCT00493038|581823735|FG000|Treatment|Withdrawal by Subject|11|||
161118702|NCT00493038|581823736|FG001|Treatment|Withdrawal by Subject|12|||
161118703|NCT00493038|581823735|FG000|Treatment|Other|0|||
161118704|NCT00493038|581823736|FG001|Treatment|Other|1|||
161118705|NCT00493038|581823735|FG000|Follow-up|Lost to Follow-up|1|||
161118706|NCT00493038|581823736|FG001|Follow-up|Lost to Follow-up|0|||
161118707|NCT03345472|581823738|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
161118708|NCT03345472|581823738|FG000|Implant to 3 Months|Physician Decision|1|||
161118709|NCT03345472|581823738|FG000|Implant to 3 Months|Adverse Event|1|||
161118710|NCT03345472|581823738|FG000|3 Months to 12 Months|Physician Decision|3|||
161118711|NCT03345472|581823738|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
161118712|NCT03345472|581823738|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
161118713|NCT03345472|581823738|FG000|3 Months to 12 Months|Adverse Event|1|||
161118714|NCT03345472|581823738|FG000|3 Months to 12 Months|Death|1|||
161118715|NCT04607733|581823741|FG000|Overall Study|Lost to Follow-up|1|||
161118716|NCT04607733|581823742|FG001|Overall Study|Lost to Follow-up|0|||
161118717|NCT04607733|581823743|FG002|Overall Study|Lost to Follow-up|0|||
161118718|NCT04607733|581823744|FG003|Overall Study|Lost to Follow-up|1|||
161118719|NCT04607733|581823745|FG004|Overall Study|Lost to Follow-up|1|||
161118720|NCT04607733|581823746|FG005|Overall Study|Lost to Follow-up|0|||
161118721|NCT04607733|581823741|FG000|Overall Study|Withdrawal by Subject|0|||
161118722|NCT04607733|581823742|FG001|Overall Study|Withdrawal by Subject|0|||
161118723|NCT04607733|581823743|FG002|Overall Study|Withdrawal by Subject|0|||
161118724|NCT04607733|581823744|FG003|Overall Study|Withdrawal by Subject|0|||
161118725|NCT04607733|581823745|FG004|Overall Study|Withdrawal by Subject|1|||
161118726|NCT04607733|581823746|FG005|Overall Study|Withdrawal by Subject|0|||
161118727|NCT02296242|581823772|FG000|Overall Study|Death|1|||
161118728|NCT02296242|581823773|FG001|Overall Study|Death|1|||
161118729|NCT02296242|581823774|FG002|Overall Study|Death|1|||
161118730|NCT02296242|581823775|FG003|Overall Study|Death|1|||
161118731|NCT02296242|581823776|FG004|Overall Study|Death|1|||
161118732|NCT02296242|581823772|FG000|Overall Study|Withdrawal by Subject|0|||
161118733|NCT02296242|581823773|FG001|Overall Study|Withdrawal by Subject|0|||
161118734|NCT02296242|581823774|FG002|Overall Study|Withdrawal by Subject|1|||
161118735|NCT02296242|581823775|FG003|Overall Study|Withdrawal by Subject|1|||
161118736|NCT02296242|581823776|FG004|Overall Study|Withdrawal by Subject|3|||
161118737|NCT02296242|581823772|FG000|Overall Study|Disease Progression|1|||
161118738|NCT02296242|581823773|FG001|Overall Study|Disease Progression|3|||
161118739|NCT02296242|581823774|FG002|Overall Study|Disease Progression|2|||
161118740|NCT02296242|581823775|FG003|Overall Study|Disease Progression|8|||
161118741|NCT02296242|581823776|FG004|Overall Study|Disease Progression|11|||
161118742|NCT02296242|581823772|FG000|Overall Study|Unacceptable Toxicity|0|||
161118743|NCT02296242|581823773|FG001|Overall Study|Unacceptable Toxicity|0|||
161118744|NCT02296242|581823774|FG002|Overall Study|Unacceptable Toxicity|0|||
161118745|NCT02296242|581823775|FG003|Overall Study|Unacceptable Toxicity|0|||
161118746|NCT02296242|581823776|FG004|Overall Study|Unacceptable Toxicity|1|||
161118747|NCT02296242|581823772|FG000|Overall Study|Patient Condition Changed|0|||
161118748|NCT02296242|581823773|FG001|Overall Study|Patient Condition Changed|0|||
161118749|NCT02296242|581823774|FG002|Overall Study|Patient Condition Changed|2|||
161118750|NCT02296242|581823775|FG003|Overall Study|Patient Condition Changed|0|||
161118751|NCT02296242|581823776|FG004|Overall Study|Patient Condition Changed|1|||
161118752|NCT02296242|581823772|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
161118753|NCT02296242|581823773|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
161118754|NCT02296242|581823774|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
161118755|NCT02296242|581823775|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
161118756|NCT02296242|581823776|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
161118757|NCT02296242|581823772|FG000|Overall Study|Lost to Follow-up|1|||
161118758|NCT02296242|581823773|FG001|Overall Study|Lost to Follow-up|0|||
161118759|NCT02296242|581823774|FG002|Overall Study|Lost to Follow-up|0|||
161118760|NCT02296242|581823775|FG003|Overall Study|Lost to Follow-up|0|||
161118761|NCT02296242|581823776|FG004|Overall Study|Lost to Follow-up|0|||
161118762|NCT02296242|581823772|FG000|Overall Study|Need for Hydroxyurea|2|||
161118763|NCT02296242|581823773|FG001|Overall Study|Need for Hydroxyurea|0|||
161118764|NCT02296242|581823774|FG002|Overall Study|Need for Hydroxyurea|0|||
161118765|NCT02296242|581823775|FG003|Overall Study|Need for Hydroxyurea|0|||
161118766|NCT02296242|581823776|FG004|Overall Study|Need for Hydroxyurea|0|||
161118767|NCT02296242|581823772|FG000|Overall Study|Screened for Other Protocol|0|||
161118768|NCT02296242|581823773|FG001|Overall Study|Screened for Other Protocol|1|||
161118769|NCT02296242|581823774|FG002|Overall Study|Screened for Other Protocol|0|||
161118770|NCT02296242|581823775|FG003|Overall Study|Screened for Other Protocol|0|||
161118771|NCT02296242|581823776|FG004|Overall Study|Screened for Other Protocol|0|||
161118772|NCT02296242|581823772|FG000|Overall Study|Physician Decision|0|||
161118773|NCT02296242|581823773|FG001|Overall Study|Physician Decision|1|||
161118774|NCT02296242|581823774|FG002|Overall Study|Physician Decision|0|||
161118775|NCT02296242|581823775|FG003|Overall Study|Physician Decision|1|||
161118776|NCT02296242|581823776|FG004|Overall Study|Physician Decision|0|||
161118777|NCT02296242|581823772|FG000|Overall Study|Alternative Treatment|0|||
161118778|NCT02296242|581823773|FG001|Overall Study|Alternative Treatment|0|||
161118779|NCT02296242|581823774|FG002|Overall Study|Alternative Treatment|0|||
161118780|NCT02296242|581823775|FG003|Overall Study|Alternative Treatment|1|||
161118781|NCT02296242|581823776|FG004|Overall Study|Alternative Treatment|0|||
161118782|NCT02296242|581823772|FG000|Overall Study|Adverse Event|0|||
161118783|NCT02296242|581823773|FG001|Overall Study|Adverse Event|0|||
161118784|NCT02296242|581823774|FG002|Overall Study|Adverse Event|0|||
161118785|NCT02296242|581823775|FG003|Overall Study|Adverse Event|1|||
161118786|NCT02296242|581823776|FG004|Overall Study|Adverse Event|0|||
161118787|NCT02296242|581823772|FG000|Overall Study|Lack of Efficacy|0|||
161118788|NCT02296242|581823773|FG001|Overall Study|Lack of Efficacy|0|||
161118789|NCT02296242|581823774|FG002|Overall Study|Lack of Efficacy|0|||
161118790|NCT02296242|581823775|FG003|Overall Study|Lack of Efficacy|0|||
161118791|NCT02296242|581823776|FG004|Overall Study|Lack of Efficacy|3|||
161118792|NCT01639833|581823777|FG000|Overall Study|Death|4|||
161118793|NCT01639833|581823778|FG001|Overall Study|Death|2|||
161118794|NCT01639833|581823777|FG000|Overall Study|Withdrawal by Subject|2|||
161118795|NCT01639833|581823778|FG001|Overall Study|Withdrawal by Subject|2|||
161118796|NCT03504397|581823784|FG000|Overall Study|Progressive Disease|151|||
161118797|NCT03504397|581823785|FG001|Overall Study|Progressive Disease|199|||
161118798|NCT03504397|581823784|FG000|Overall Study|Withdrawal by Subject|29|||
161118799|NCT03504397|581823785|FG001|Overall Study|Withdrawal by Subject|17|||
161118800|NCT03504397|581823784|FG000|Overall Study|Lost to Follow-up|1|||
161118801|NCT03504397|581823785|FG001|Overall Study|Lost to Follow-up|0|||
161118802|NCT03504397|581823784|FG000|Overall Study|Death|14|||
161118803|NCT03504397|581823785|FG001|Overall Study|Death|16|||
161118804|NCT03504397|581823784|FG000|Overall Study|Adverse Event|40|||
161118805|NCT03504397|581823785|FG001|Overall Study|Adverse Event|14|||
161118806|NCT03504397|581823784|FG000|Overall Study|miscellaneous|17|||
161118807|NCT03504397|581823785|FG001|Overall Study|miscellaneous|15|||
161118808|NCT03504397|581823784|FG000|Overall Study|Protocol deviation|1|||
161118809|NCT03504397|581823785|FG001|Overall Study|Protocol deviation|0|||
161118810|NCT03504397|581823784|FG000|Overall Study|Participants who did not take the study drug|4|||
161118811|NCT03504397|581823785|FG001|Overall Study|Participants who did not take the study drug|4|||
161118812|NCT02443883|581823786|FG000|Overall Study|Adverse Event|0|||
161118813|NCT02443883|581823787|FG001|Overall Study|Adverse Event|1|||
161118814|NCT02443883|581823788|FG002|Overall Study|Adverse Event|0|||
161118815|NCT02443883|581823789|FG003|Overall Study|Adverse Event|0|||
161118816|NCT02443883|581823786|FG000|Overall Study|Lost to Follow-up|3|||
161118817|NCT02443883|581823787|FG001|Overall Study|Lost to Follow-up|2|||
161118818|NCT02443883|581823788|FG002|Overall Study|Lost to Follow-up|1|||
161118819|NCT02443883|581823789|FG003|Overall Study|Lost to Follow-up|0|||
161118820|NCT02443883|581823786|FG000|Overall Study|Physician Decision|1|||
161118821|NCT02443883|581823787|FG001|Overall Study|Physician Decision|1|||
161118822|NCT02443883|581823788|FG002|Overall Study|Physician Decision|0|||
161118823|NCT02443883|581823789|FG003|Overall Study|Physician Decision|3|||
161118824|NCT02443883|581823786|FG000|Overall Study|Withdrawal by Subject|1|||
161118825|NCT02443883|581823787|FG001|Overall Study|Withdrawal by Subject|0|||
161118826|NCT02443883|581823788|FG002|Overall Study|Withdrawal by Subject|0|||
161118827|NCT02443883|581823789|FG003|Overall Study|Withdrawal by Subject|2|||
161118828|NCT02443883|581823786|FG000|Overall Study|Randomized, but never treated|1|||
161118829|NCT02443883|581823787|FG001|Overall Study|Randomized, but never treated|0|||
161118830|NCT02443883|581823788|FG002|Overall Study|Randomized, but never treated|0|||
161118831|NCT02443883|581823789|FG003|Overall Study|Randomized, but never treated|0|||
161118832|NCT01097863|581823790|FG000|Overall Study|Discomfort|1|||
161118833|NCT01097863|581823791|FG001|Overall Study|Discomfort|0|||
161118834|NCT01097863|581823792|FG002|Overall Study|Discomfort|1|||
161118835|NCT01097863|581823790|FG000|Overall Study|Did not return for final visit|0|||
161118836|NCT01097863|581823791|FG001|Overall Study|Did not return for final visit|0|||
161118837|NCT01097863|581823792|FG002|Overall Study|Did not return for final visit|1|||
161223588|NCT03922477|582198919|FG000|Overall Study|Death|9|||
161223589|NCT03922477|582198919|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
161223590|NCT03922477|582198919|FG000|Overall Study|Physician Decision|1|||
161223591|NCT03922477|582198919|FG000|Overall Study|Withdrawal by Subject|2|||
161223592|NCT03095352|582198923|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
161223593|NCT03095352|582198924|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
160874526|NCT00984620|580934245|FG000|Overall Study|Adverse Event|5|||
161118838|NCT00796315|581823793|FG000|Overall Study|Protocol Violation|0|||
161223594|NCT01618305|582198925|FG000|Overall Study|Death|0|||
161223595|NCT01618305|582198926|FG001|Overall Study|Death|1|||
161223596|NCT01618305|582198925|FG000|Overall Study|Lost to Follow-up|11|||
161223597|NCT01618305|582198926|FG001|Overall Study|Lost to Follow-up|7|||
161223598|NCT01618305|582198925|FG000|Overall Study|Protocol Violation|1|||
161223599|NCT01618305|582198926|FG001|Overall Study|Protocol Violation|0|||
161223600|NCT01618305|582198925|FG000|Overall Study|Withdrawal by Subject|3|||
161223601|NCT01618305|582198926|FG001|Overall Study|Withdrawal by Subject|2|||
161223602|NCT01565083|582198927|FG000|Overall Study|Withdrawal by Subject|6|||
161223603|NCT01565083|582198928|FG001|Overall Study|Withdrawal by Subject|4|||
161223604|NCT01565083|582198927|FG000|Overall Study|Lost to Follow-up|2|||
161118839|NCT00796315|581823794|FG001|Overall Study|Protocol Violation|1|||
161118840|NCT00796315|581823795|FG002|Overall Study|Protocol Violation|0|||
161118841|NCT03099707|581823796|FG000|Overall Study|Withdrawal by Subject|0|||
161118842|NCT03099707|581823797|FG001|Overall Study|Withdrawal by Subject|3|||
161118843|NCT03099707|581823796|FG000|Overall Study|Lost to Follow-up|0|||
161118844|NCT03099707|581823797|FG001|Overall Study|Lost to Follow-up|1|||
161118845|NCT03167073|581823798|FG000|Overall Study|Stillbirth|1|||
161118846|NCT03167073|581823799|FG001|Overall Study|Stillbirth|0|||
161118847|NCT01294579|581823806|FG000|Overall Study|Disease progression|12|||
161118848|NCT01294579|581823806|FG000|Overall Study|Adverse Event|11|||
161118849|NCT01294579|581823806|FG000|Overall Study|Study closed/terminated|3|||
161118850|NCT01294579|581823806|FG000|Overall Study|Lost to Follow-up|1|||
161118851|NCT01294579|581823806|FG000|Overall Study|Physician Decision|3|||
161118852|NCT01294579|581823806|FG000|Overall Study|Withdrawal by Subject|5|||
161118853|NCT02788747|581823807|FG000|Overall Study|Adverse Event|1|||
161118854|NCT02788747|581823808|FG001|Overall Study|Adverse Event|0|||
161118855|NCT02788747|581823809|FG002|Overall Study|Adverse Event|0|||
161118856|NCT00562354|581823810|FG000|Overall Study|Physician Decision|0|||
161118857|NCT00562354|581823811|FG001|Overall Study|Physician Decision|1|||
161118858|NCT00562354|581823810|FG000|Overall Study|Lost to Follow-up|0|||
161118859|NCT00562354|581823811|FG001|Overall Study|Lost to Follow-up|1|||
161118860|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
161118861|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
161118862|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
161118863|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
161118864|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
161118865|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
161118866|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
161118867|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
161118868|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
161118869|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
161118870|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
161118871|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
161118872|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
161118873|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
161118874|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
161118875|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
161118876|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
161118877|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
161118878|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
161118879|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
161118880|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
161118881|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
161118882|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
161118883|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
161118884|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
161118885|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
161118886|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
161223605|NCT01565083|582198928|FG001|Overall Study|Lost to Follow-up|7|||
161223606|NCT01565083|582198927|FG000|Overall Study|Death|22|||
161324435|NCT00320788|582573605|FG004|Overall Study|Decision by the Sponsor|1|||
161324436|NCT00320788|582573601|FG000|Overall Study|Other|1|||
161223607|NCT01565083|582198928|FG001|Overall Study|Death|23|||
161324437|NCT00320788|582573602|FG001|Overall Study|Other|2|||
161223608|NCT01565083|582198927|FG000|Overall Study|Other|3|||
161223609|NCT01565083|582198928|FG001|Overall Study|Other|5|||
161223610|NCT01960816|582198929|FG000|Overall Study|Lost to Follow-up|1|||
161223611|NCT05431686|582198930|FG000|Overall Study|unable to schedule|10|||
161223612|NCT01118728|582198945|FG000|Overall Study|Adverse Event|17|||
161223613|NCT01118728|582198945|FG000|Overall Study|Lack of Efficacy|27|||
161223614|NCT01118728|582198945|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
161223615|NCT01118728|582198945|FG000|Overall Study|Withdrawal by Subject|3|||
161223616|NCT01118728|582198945|FG000|Overall Study|Lost to Follow-up|4|||
161223617|NCT01736553|582198946|FG000|Overall Study|Death|12|||
161223618|NCT01736553|582198947|FG001|Overall Study|Death|0|||
161223619|NCT01736553|582198946|FG000|Overall Study|Withdrawal by Subject|5|||
161223620|NCT01736553|582198947|FG001|Overall Study|Withdrawal by Subject|2|||
160874527|NCT00984620|580934246|FG001|Overall Study|Adverse Event|5|||
160874528|NCT00984620|580934245|FG000|Overall Study|Lost to Follow-up|1|||
160874529|NCT00984620|580934246|FG001|Overall Study|Lost to Follow-up|1|||
160874530|NCT00984620|580934245|FG000|Overall Study|Withdrawal by Subject|0|||
160874531|NCT00984620|580934246|FG001|Overall Study|Withdrawal by Subject|2|||
160874532|NCT00984620|580934245|FG000|Overall Study|reason other than listed above|0|||
160874533|NCT00984620|580934246|FG001|Overall Study|reason other than listed above|4|||
160874534|NCT01703754|580934247|FG000|Overall Study|Clinically significant disease progression|2|||
161223621|NCT01736553|582198946|FG000|Overall Study|Lost to Follow-up|2|||
161223622|NCT01736553|582198947|FG001|Overall Study|Lost to Follow-up|2|||
161223623|NCT05328375|582200050|FG000|Overall Study|Withdrawal by Subject|0|||
161223624|NCT05328375|582200051|FG001|Overall Study|Withdrawal by Subject|1|||
161223625|NCT02178709|582200052|FG000|Overall Study|Adverse Event|5|||
161223626|NCT02178709|582200052|FG000|Overall Study|Death|2|||
161223627|NCT02178709|582200052|FG000|Overall Study|Withdrawal by Subject|2|||
161223628|NCT02178709|582200052|FG000|Overall Study|Physician Decision|2|||
161223629|NCT02178709|582200052|FG000|Overall Study|Disease Progression|5|||
161223630|NCT02192905|582200055|FG000|Overall Study|Lost to Follow-up|1|||
161223631|NCT01691859|582200056|FG000|Overall Study|Adverse Event|19|||
161223632|NCT01691859|582200056|FG000|Overall Study|Lack of Efficacy|11|||
161223633|NCT01691859|582200056|FG000|Overall Study|Protocol Violation|4|||
161223634|NCT01691859|582200056|FG000|Overall Study|Product commercially available|221|||
161223635|NCT01691859|582200056|FG000|Overall Study|Study closed/terminated|50|||
161223636|NCT01691859|582200056|FG000|Overall Study|Lost to Follow-up|5|||
161223637|NCT01691859|582200056|FG000|Overall Study|Physician Decision|6|||
161223638|NCT01691859|582200056|FG000|Overall Study|Withdrawal by Subject|31|||
161223639|NCT00862979|582200059|FG000|Overall Study|Adverse Event|6|||
161223640|NCT00862979|582200060|FG001|Overall Study|Adverse Event|3|||
161223641|NCT00862979|582200059|FG000|Overall Study|Protocol Violation|0|||
161223642|NCT00862979|582200060|FG001|Overall Study|Protocol Violation|1|||
161223643|NCT00862979|582200059|FG000|Overall Study|Patient withdrew consent|2|||
161223644|NCT00862979|582200060|FG001|Overall Study|Patient withdrew consent|1|||
161223645|NCT00862979|582200059|FG000|Overall Study|Administrative problems|0|||
161223646|NCT00862979|582200060|FG001|Overall Study|Administrative problems|1|||
161223647|NCT00862979|582200059|FG000|Overall Study|Death|0|||
161223648|NCT00862979|582200060|FG001|Overall Study|Death|1|||
161223649|NCT00992407|582200064|FG000|Overall Study|Protocol Violation|2|||
161223650|NCT00992407|582200065|FG001|Overall Study|Protocol Violation|1|||
161223651|NCT00992407|582200064|FG000|Overall Study|Lost to Follow-up|3|||
161223652|NCT00992407|582200065|FG001|Overall Study|Lost to Follow-up|3|||
161223653|NCT00992407|582200064|FG000|Overall Study|Adverse Event|3|||
161223654|NCT00992407|582200065|FG001|Overall Study|Adverse Event|2|||
161223655|NCT00992407|582200064|FG000|Overall Study|protocol Violation & Adverse events|2|||
161223656|NCT00992407|582200065|FG001|Overall Study|protocol Violation & Adverse events|4|||
161223657|NCT00992407|582200064|FG000|Overall Study|Other|2|||
161223658|NCT00992407|582200065|FG001|Overall Study|Other|0|||
161223659|NCT00992407|582200064|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
161223660|NCT00992407|582200065|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
161223661|NCT00992407|582200064|FG000|Overall Study|Study medication not administered|17|||
161223662|NCT00992407|582200065|FG001|Overall Study|Study medication not administered|13|||
161223663|NCT03738332|582200066|FG000|Overall Study|Withdrawal by Subject|1|||
161223664|NCT01521559|582200067|FG000|Overall Study|Adverse Event|0|||
161223665|NCT01521559|582200068|FG001|Overall Study|Adverse Event|4|||
161223666|NCT01521559|582200067|FG000|Overall Study|Death|1|||
161223667|NCT01521559|582200068|FG001|Overall Study|Death|0|||
161223668|NCT01521559|582200067|FG000|Overall Study|Withdrawal by Subject|9|||
161223669|NCT01521559|582200068|FG001|Overall Study|Withdrawal by Subject|11|||
161223670|NCT01521559|582200067|FG000|Overall Study|Lost to Follow-up|3|||
161223671|NCT01521559|582200068|FG001|Overall Study|Lost to Follow-up|1|||
161223672|NCT01521559|582200067|FG000|Overall Study|Protocol Violation|1|||
161223673|NCT01521559|582200068|FG001|Overall Study|Protocol Violation|0|||
161223674|NCT01521559|582200067|FG000|Overall Study|Other|1|||
161223675|NCT01521559|582200068|FG001|Overall Study|Other|2|||
161223676|NCT02336737|582200069|FG000|Overall Study|Withdrawal by Subject|5|||
161223677|NCT02336737|582200069|FG000|Overall Study|Physician Decision|8|||
161223678|NCT00275002|582200072|FG000|Overall Study|Death|1|||
161223679|NCT00275002|582200073|FG001|Overall Study|Death|0|||
161223680|NCT00275002|582200072|FG000|Overall Study|Disease progression|21|||
161223681|NCT00275002|582200073|FG001|Overall Study|Disease progression|15|||
161223682|NCT00275002|582200072|FG000|Overall Study|Adverse Event|0|||
161118887|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
161118888|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
160874535|NCT01703754|580934248|FG001|Overall Study|Clinically significant disease progression|2|||
160874536|NCT01703754|580934249|FG002|Overall Study|Clinically significant disease progression|1|||
160874537|NCT01703754|580934247|FG000|Overall Study|Adverse Event|1|||
160874538|NCT01703754|580934248|FG001|Overall Study|Adverse Event|1|||
160874539|NCT01703754|580934249|FG002|Overall Study|Adverse Event|0|||
160874540|NCT01703754|580934247|FG000|Overall Study|Withdrawal by Subject|2|||
160874541|NCT01703754|580934248|FG001|Overall Study|Withdrawal by Subject|0|||
161118889|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
161118890|NCT00784654|581823812|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
161118891|NCT00784654|581823813|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
161118892|NCT00784654|581823814|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
161118893|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
161118894|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
161118895|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
161118896|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
161118897|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
161118898|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
161118899|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161118900|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161118901|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
161118902|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
161118903|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
161118904|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
161118905|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161118906|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Adverse Event|1|||
161118907|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Adverse Event|1|||
161118908|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
161118909|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
161118910|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
161118911|NCT00784654|581823812|FG000|Randomized Withdrawal Period|Family reasons|0|||
161118912|NCT00784654|581823813|FG001|Randomized Withdrawal Period|Family reasons|0|||
161118913|NCT00784654|581823814|FG002|Randomized Withdrawal Period|Family reasons|1|||
161118914|NCT01026831|581823815|FG000|Overall Study|Adverse Event|4|||
161118915|NCT01026831|581823816|FG001|Overall Study|Adverse Event|3|||
161118916|NCT01026831|581823815|FG000|Overall Study|Lost to Follow-up|2|||
161118917|NCT01026831|581823816|FG001|Overall Study|Lost to Follow-up|0|||
161118918|NCT01026831|581823815|FG000|Overall Study|Physician Decision|1|||
161118919|NCT01026831|581823816|FG001|Overall Study|Physician Decision|1|||
161118920|NCT01026831|581823815|FG000|Overall Study|Protocol Violation|0|||
161118921|NCT01026831|581823816|FG001|Overall Study|Protocol Violation|2|||
161118922|NCT01026831|581823815|FG000|Overall Study|Withdrawal by Subject|7|||
161118923|NCT01026831|581823816|FG001|Overall Study|Withdrawal by Subject|5|||
161118924|NCT01079182|581823817|FG000|Overall Study|Lost to Follow-up|1634|||
161118925|NCT01079182|581823817|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
161118926|NCT01079182|581823817|FG000|Overall Study|Lack of Efficacy|514|||
161118927|NCT01079182|581823817|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
161118928|NCT01079182|581823817|FG000|Overall Study|Reasons not Evaluated|271|||
161118929|NCT04417894|581823818|FG000|Overall Study|Lost to Follow-up|3|||
161118930|NCT04417894|581823819|FG001|Overall Study|Lost to Follow-up|0|||
161118931|NCT04417894|581823818|FG000|Overall Study|Withdrawal by Subject|7|||
161118932|NCT04417894|581823819|FG001|Overall Study|Withdrawal by Subject|6|||
161118933|NCT04417894|581823818|FG000|Overall Study|Lack of Efficacy|3|||
161118934|NCT04417894|581823819|FG001|Overall Study|Lack of Efficacy|1|||
161118935|NCT00262873|581823820|FG000|Overall Study|Adverse Event|3|||
161118936|NCT00262873|581823820|FG000|Overall Study|Withdrawal by Subject|5|||
161118937|NCT00844753|581823821|FG000|Overall Study|Lack of Efficacy|1|||
161118938|NCT00844753|581823822|FG001|Overall Study|Lack of Efficacy|0|||
161118939|NCT00844753|581823823|FG002|Overall Study|Lack of Efficacy|2|||
161118940|NCT00844753|581823824|FG003|Overall Study|Lack of Efficacy|2|||
161118941|NCT00844753|581823821|FG000|Overall Study|Adverse Event|3|||
161118942|NCT00844753|581823822|FG001|Overall Study|Adverse Event|2|||
161118943|NCT00844753|581823823|FG002|Overall Study|Adverse Event|5|||
161118944|NCT00844753|581823824|FG003|Overall Study|Adverse Event|5|||
161118945|NCT00844753|581823821|FG000|Overall Study|Lost to Follow-up|1|||
161223683|NCT00275002|582200073|FG001|Overall Study|Adverse Event|1|||
161223684|NCT00638157|582200086|FG000|Overall Study|Adverse Event|0|||
160874542|NCT01703754|580934249|FG002|Overall Study|Withdrawal by Subject|0|||
161223685|NCT00638157|582200087|FG001|Overall Study|Adverse Event|1|||
161223686|NCT00638157|582200086|FG000|Overall Study|Clinical (symptomatic) failure|1|||
161223687|NCT00638157|582200087|FG001|Overall Study|Clinical (symptomatic) failure|1|||
161223688|NCT00638157|582200086|FG000|Overall Study|Microbiological failure|1|||
161223689|NCT00638157|582200087|FG001|Overall Study|Microbiological failure|0|||
161223690|NCT00638157|582200086|FG000|Overall Study|Lost to Follow-up|1|||
161223691|NCT00638157|582200087|FG001|Overall Study|Lost to Follow-up|0|||
161223692|NCT00638157|582200086|FG000|Overall Study|Physician Decision|1|||
161223693|NCT00638157|582200087|FG001|Overall Study|Physician Decision|0|||
161223694|NCT00638157|582200086|FG000|Overall Study|Other|1|||
161223695|NCT00638157|582200087|FG001|Overall Study|Other|2|||
161223696|NCT00638157|582200086|FG000|Overall Study|Randomized, not treated|2|||
161223697|NCT00638157|582200087|FG001|Overall Study|Randomized, not treated|0|||
161223698|NCT02365597|582200088|FG000|Overall Study|Lost to Follow-up|0|||
161223699|NCT02365597|582200089|FG001|Overall Study|Lost to Follow-up|1|||
161223700|NCT02365597|582200090|FG002|Overall Study|Lost to Follow-up|0|||
161223701|NCT02365597|582200091|FG003|Overall Study|Lost to Follow-up|1|||
161223702|NCT02365597|582200088|FG000|Overall Study|Withdrawal by Subject|1|||
161223703|NCT02365597|582200089|FG001|Overall Study|Withdrawal by Subject|8|||
161223704|NCT02365597|582200090|FG002|Overall Study|Withdrawal by Subject|5|||
161223705|NCT02365597|582200091|FG003|Overall Study|Withdrawal by Subject|1|||
161223706|NCT02365597|582200088|FG000|Overall Study|Sponsor's decision|1|||
161223707|NCT02365597|582200089|FG001|Overall Study|Sponsor's decision|3|||
161223708|NCT02365597|582200090|FG002|Overall Study|Sponsor's decision|13|||
161223709|NCT02365597|582200091|FG003|Overall Study|Sponsor's decision|0|||
161223710|NCT02365597|582200088|FG000|Overall Study|Other|0|||
161223711|NCT02365597|582200089|FG001|Overall Study|Other|4|||
161223712|NCT02365597|582200090|FG002|Overall Study|Other|0|||
161223713|NCT02365597|582200091|FG003|Overall Study|Other|0|||
161223714|NCT02365597|582200088|FG000|Overall Study|Enrolled but not treated|0|||
161223715|NCT02365597|582200089|FG001|Overall Study|Enrolled but not treated|1|||
161223716|NCT02365597|582200090|FG002|Overall Study|Enrolled but not treated|1|||
161223717|NCT02365597|582200091|FG003|Overall Study|Enrolled but not treated|0|||
161223718|NCT02365597|582200088|FG000|Overall Study|Ongoing|0|||
161223719|NCT02365597|582200089|FG001|Overall Study|Ongoing|0|||
161223720|NCT02365597|582200090|FG002|Overall Study|Ongoing|0|||
161223721|NCT02365597|582200091|FG003|Overall Study|Ongoing|17|||
161223722|NCT04309474|582200092|FG000|Overall Study|Randomized but not treated|0|||
161223723|NCT04309474|582200093|FG001|Overall Study|Randomized but not treated|2|||
161223724|NCT04309474|582200092|FG000|Overall Study|Adverse Event|4|||
161223725|NCT04309474|582200093|FG001|Overall Study|Adverse Event|1|||
161223726|NCT04309474|582200092|FG000|Overall Study|Withdrawal by Subject|6|||
161223727|NCT04309474|582200093|FG001|Overall Study|Withdrawal by Subject|9|||
161223728|NCT04309474|582200092|FG000|Overall Study|Lost to Follow-up|1|||
161223729|NCT04309474|582200093|FG001|Overall Study|Lost to Follow-up|2|||
161223730|NCT04309474|582200092|FG000|Overall Study|Not disclosed|10|||
161223731|NCT04309474|582200093|FG001|Overall Study|Not disclosed|6|||
161223732|NCT04670068|582200094|FG000|Overall Study|Progressive Disease|1|||
161223733|NCT04670068|582200095|FG001|Overall Study|Progressive Disease|1|||
161223734|NCT04670068|582200094|FG000|Overall Study|Withdrawal by Subject|1|||
161223735|NCT04670068|582200095|FG001|Overall Study|Withdrawal by Subject|0|||
161223736|NCT00601354|582200099|FG000|Overall Study|Lost to Follow-up|4|||
161223737|NCT00601354|582200100|FG001|Overall Study|Lost to Follow-up|5|||
161223738|NCT03466411|582200101|FG000|Overall Study|Lost to Follow-up|0|||
161223739|NCT03466411|582200102|FG001|Overall Study|Lost to Follow-up|1|||
161223740|NCT03466411|582200103|FG002|Overall Study|Lost to Follow-up|1|||
161223741|NCT03466411|582200104|FG003|Overall Study|Lost to Follow-up|0|||
161223742|NCT03466411|582200105|FG004|Overall Study|Lost to Follow-up|0|||
161223743|NCT03466411|582200106|FG005|Overall Study|Lost to Follow-up|0|||
161223744|NCT03466411|582200107|FG006|Overall Study|Lost to Follow-up|1|||
161223745|NCT03466411|582200108|FG007|Overall Study|Lost to Follow-up|1|||
161223746|NCT03466411|582200109|FG008|Overall Study|Lost to Follow-up|0|||
161223747|NCT03466411|582200110|FG009|Overall Study|Lost to Follow-up|1|||
161223748|NCT03466411|582200111|FG010|Overall Study|Lost to Follow-up|1|||
161223749|NCT03466411|582200112|FG011|Overall Study|Lost to Follow-up|1|||
161223750|NCT03466411|582200113|FG012|Overall Study|Lost to Follow-up|0|||
161223751|NCT03466411|582200101|FG000|Overall Study|Withdrawal by Subject|14|||
161223752|NCT03466411|582200102|FG001|Overall Study|Withdrawal by Subject|7|||
161223753|NCT03466411|582200103|FG002|Overall Study|Withdrawal by Subject|8|||
161223754|NCT03466411|582200104|FG003|Overall Study|Withdrawal by Subject|4|||
161223755|NCT03466411|582200105|FG004|Overall Study|Withdrawal by Subject|6|||
161223756|NCT03466411|582200106|FG005|Overall Study|Withdrawal by Subject|3|||
161223757|NCT03466411|582200107|FG006|Overall Study|Withdrawal by Subject|6|||
161223758|NCT03466411|582200108|FG007|Overall Study|Withdrawal by Subject|9|||
161223759|NCT03466411|582200109|FG008|Overall Study|Withdrawal by Subject|6|||
161223760|NCT03466411|582200110|FG009|Overall Study|Withdrawal by Subject|11|||
161223761|NCT03466411|582200111|FG010|Overall Study|Withdrawal by Subject|14|||
161223762|NCT03466411|582200112|FG011|Overall Study|Withdrawal by Subject|12|||
161223763|NCT03466411|582200113|FG012|Overall Study|Withdrawal by Subject|7|||
161223764|NCT03466411|582200101|FG000|Overall Study|Other|1|||
161223765|NCT03466411|582200102|FG001|Overall Study|Other|1|||
161223766|NCT03466411|582200103|FG002|Overall Study|Other|0|||
161223767|NCT03466411|582200104|FG003|Overall Study|Other|1|||
161223768|NCT03466411|582200105|FG004|Overall Study|Other|2|||
161223769|NCT03466411|582200106|FG005|Overall Study|Other|0|||
161223770|NCT03466411|582200107|FG006|Overall Study|Other|0|||
161223771|NCT03466411|582200108|FG007|Overall Study|Other|0|||
161223772|NCT03466411|582200109|FG008|Overall Study|Other|0|||
161223773|NCT03466411|582200110|FG009|Overall Study|Other|1|||
161223774|NCT03466411|582200111|FG010|Overall Study|Other|2|||
161223775|NCT03466411|582200112|FG011|Overall Study|Other|0|||
161223776|NCT03466411|582200113|FG012|Overall Study|Other|0|||
161223777|NCT03466411|582200101|FG000|Overall Study|Randomized but not Treated|0|||
161223778|NCT03466411|582200102|FG001|Overall Study|Randomized but not Treated|0|||
161223779|NCT03466411|582200103|FG002|Overall Study|Randomized but not Treated|0|||
161223780|NCT03466411|582200104|FG003|Overall Study|Randomized but not Treated|0|||
161223781|NCT03466411|582200105|FG004|Overall Study|Randomized but not Treated|0|||
161223782|NCT03466411|582200106|FG005|Overall Study|Randomized but not Treated|0|||
161223783|NCT03466411|582200107|FG006|Overall Study|Randomized but not Treated|1|||
161223784|NCT03466411|582200108|FG007|Overall Study|Randomized but not Treated|0|||
161223785|NCT03466411|582200109|FG008|Overall Study|Randomized but not Treated|0|||
161223786|NCT03466411|582200110|FG009|Overall Study|Randomized but not Treated|0|||
161223787|NCT03466411|582200111|FG010|Overall Study|Randomized but not Treated|0|||
161223788|NCT03466411|582200112|FG011|Overall Study|Randomized but not Treated|0|||
161223789|NCT03466411|582200113|FG012|Overall Study|Randomized but not Treated|0|||
161223790|NCT00319956|582200114|FG000|Overall Study|Death|20|||
161223791|NCT00319956|582200115|FG001|Overall Study|Death|24|||
161223792|NCT02607800|582200116|FG000|Overall Study|Lost to Follow-up|7|||
161223793|NCT02607800|582200117|FG001|Overall Study|Lost to Follow-up|10|||
161118946|NCT00844753|581823822|FG001|Overall Study|Lost to Follow-up|1|||
161118947|NCT00844753|581823823|FG002|Overall Study|Lost to Follow-up|0|||
161118948|NCT00844753|581823824|FG003|Overall Study|Lost to Follow-up|1|||
161118949|NCT00844753|581823821|FG000|Overall Study|could not swallow medication|2|||
161118950|NCT00844753|581823822|FG001|Overall Study|could not swallow medication|0|||
161118951|NCT00844753|581823823|FG002|Overall Study|could not swallow medication|0|||
161118952|NCT00844753|581823824|FG003|Overall Study|could not swallow medication|0|||
161118953|NCT00844753|581823821|FG000|Overall Study|Withdrawal by Subject|1|||
161118954|NCT00844753|581823822|FG001|Overall Study|Withdrawal by Subject|0|||
161118955|NCT00844753|581823823|FG002|Overall Study|Withdrawal by Subject|0|||
161118956|NCT00844753|581823824|FG003|Overall Study|Withdrawal by Subject|3|||
161118957|NCT00903175|581823831|FG000|Period 1 - First Line|Adverse Event|36|||
161118958|NCT00903175|581823832|FG001|Period 1 - First Line|Adverse Event|50|||
161118959|NCT00903175|581823831|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
161118960|NCT00903175|581823832|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
161118961|NCT00903175|581823831|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
161118962|NCT00903175|581823832|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
161118963|NCT00903175|581823831|FG000|Period 1 - First Line|Protocol Violation|3|||
161118964|NCT00903175|581823832|FG001|Period 1 - First Line|Protocol Violation|3|||
161118965|NCT00903175|581823831|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
161118966|NCT00903175|581823832|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
161118967|NCT00903175|581823831|FG000|Period 1 - First Line|Administrative problems|12|||
161118968|NCT00903175|581823832|FG001|Period 1 - First Line|Administrative problems|13|||
161118969|NCT00903175|581823831|FG000|Period 1 - First Line|Death|17|||
161118970|NCT00903175|581823832|FG001|Period 1 - First Line|Death|10|||
161118971|NCT00903175|581823831|FG000|Period 2 - Second Line|Missing|1|||
161118972|NCT00903175|581823832|FG001|Period 2 - Second Line|Missing|0|||
161118973|NCT00903175|581823831|FG000|Period 2 - Second Line|Adverse Event|16|||
161118974|NCT00903175|581823832|FG001|Period 2 - Second Line|Adverse Event|20|||
161118975|NCT00903175|581823831|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
161223794|NCT02607800|582200116|FG000|Overall Study|Withdrew Consent|2|||
161223795|NCT02607800|582200117|FG001|Overall Study|Withdrew Consent|0|||
161223796|NCT02607800|582200116|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
161223797|NCT02607800|582200117|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
161118976|NCT00903175|581823832|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
161118977|NCT00903175|581823831|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
161118978|NCT00903175|581823832|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
161118979|NCT00903175|581823831|FG000|Period 2 - Second Line|Administrative problems|19|||
161223798|NCT01185288|582200118|FG000|Overall Study|Adverse Event|7|||
161223799|NCT01185288|582200119|FG001|Overall Study|Adverse Event|6|||
161223800|NCT01185288|582200118|FG000|Overall Study|Withdrawal by Subject|6|||
161223801|NCT01185288|582200119|FG001|Overall Study|Withdrawal by Subject|4|||
161223802|NCT01185288|582200118|FG000|Overall Study|Lost to Follow-up|2|||
161223803|NCT01185288|582200119|FG001|Overall Study|Lost to Follow-up|5|||
161118980|NCT00903175|581823832|FG001|Period 2 - Second Line|Administrative problems|9|||
161118981|NCT00903175|581823831|FG000|Period 2 - Second Line|Death|5|||
161118982|NCT00903175|581823832|FG001|Period 2 - Second Line|Death|2|||
161118983|NCT03074474|581823835|FG000|Overall Study|Lost to Follow-up|10|||
161118984|NCT03074474|581823835|FG000|Overall Study|Withdrawal by Subject|10|||
161118985|NCT03074474|581823835|FG000|Overall Study|Death|4|||
161118986|NCT03074474|581823835|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
161118987|NCT00371865|581823845|FG000|Overall Study|Lack of Efficacy|0|||
161118988|NCT00371865|581823846|FG001|Overall Study|Lack of Efficacy|2|||
161118989|NCT00371865|581823845|FG000|Overall Study|Protocol Violation|3|||
161118990|NCT00371865|581823846|FG001|Overall Study|Protocol Violation|2|||
161118991|NCT00371865|581823845|FG000|Overall Study|Withdrawal by Subject|12|||
161118992|NCT00371865|581823846|FG001|Overall Study|Withdrawal by Subject|10|||
161118993|NCT05073458|581823850|FG000|24-week Double-blind Period|Adverse Event|1|||
161118994|NCT05073458|581823851|FG001|24-week Double-blind Period|Adverse Event|0|||
161118995|NCT05073458|581823850|FG000|24-week Double-blind Period|Physician Decision|1|||
161118996|NCT05073458|581823851|FG001|24-week Double-blind Period|Physician Decision|0|||
161118997|NCT05073458|581823850|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
161118998|NCT05073458|581823851|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
161118999|NCT05073458|581823850|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
161119000|NCT05073458|581823851|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
161119001|NCT05073458|581823850|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
161119002|NCT05073458|581823851|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
161119003|NCT05073458|581823850|FG000|24-week Open-label Period|Adverse Event|1|||
161119004|NCT05073458|581823851|FG001|24-week Open-label Period|Adverse Event|2|||
161119005|NCT01627899|581823859|FG000|Overall Study|Study terminated early by sponsor.|5|||
161119006|NCT01430455|581823863|FG000|Overall Study|Withdrawal by Subject|1|||
161119007|NCT01430455|581823863|FG000|Overall Study|Switched to follow-up phase|1|||
161119008|NCT01425008|581823867|FG000|Dose Escalation Phase|Progressive Disease|2|||
161119009|NCT01425008|581823868|FG001|Dose Escalation Phase|Progressive Disease|3|||
161119010|NCT01425008|581823869|FG002|Dose Escalation Phase|Progressive Disease|2|||
161119011|NCT01425008|581823870|FG003|Dose Escalation Phase|Progressive Disease|3|||
161119012|NCT01425008|581823871|FG004|Dose Escalation Phase|Progressive Disease|5|||
161119013|NCT01425008|581823872|FG005|Dose Escalation Phase|Progressive Disease|4|||
161119014|NCT01425008|581823873|FG006|Dose Escalation Phase|Progressive Disease|0|||
161119015|NCT01425008|581823874|FG007|Dose Escalation Phase|Progressive Disease|2|||
161119016|NCT01425008|581823875|FG008|Dose Escalation Phase|Progressive Disease|6|||
161119017|NCT01425008|581823876|FG009|Dose Escalation Phase|Progressive Disease|2|||
161119018|NCT01425008|581823877|FG010|Dose Escalation Phase|Progressive Disease|0|||
161119019|NCT01425008|581823878|FG011|Dose Escalation Phase|Progressive Disease|0|||
161119020|NCT01425008|581823879|FG012|Dose Escalation Phase|Progressive Disease|0|||
161119021|NCT01425008|581823880|FG013|Dose Escalation Phase|Progressive Disease|0|||
161119022|NCT01425008|581823881|FG014|Dose Escalation Phase|Progressive Disease|0|||
161119023|NCT01425008|581823882|FG015|Dose Escalation Phase|Progressive Disease|0|||
161119024|NCT01425008|581823883|FG016|Dose Escalation Phase|Progressive Disease|0|||
161119025|NCT01425008|581823884|FG017|Dose Escalation Phase|Progressive Disease|0|||
161119026|NCT01425008|581823885|FG018|Dose Escalation Phase|Progressive Disease|0|||
161119027|NCT01425008|581823867|FG000|Dose Escalation Phase|Adverse Event|2|||
161119028|NCT01425008|581823868|FG001|Dose Escalation Phase|Adverse Event|0|||
161119029|NCT01425008|581823869|FG002|Dose Escalation Phase|Adverse Event|0|||
161119030|NCT01425008|581823870|FG003|Dose Escalation Phase|Adverse Event|0|||
161119031|NCT01425008|581823871|FG004|Dose Escalation Phase|Adverse Event|0|||
161119032|NCT01425008|581823872|FG005|Dose Escalation Phase|Adverse Event|2|||
161119033|NCT01425008|581823873|FG006|Dose Escalation Phase|Adverse Event|0|||
161119034|NCT01425008|581823874|FG007|Dose Escalation Phase|Adverse Event|0|||
161119035|NCT01425008|581823875|FG008|Dose Escalation Phase|Adverse Event|2|||
161119036|NCT01425008|581823876|FG009|Dose Escalation Phase|Adverse Event|0|||
161119037|NCT01425008|581823877|FG010|Dose Escalation Phase|Adverse Event|0|||
161119038|NCT01425008|581823878|FG011|Dose Escalation Phase|Adverse Event|0|||
161119039|NCT01425008|581823879|FG012|Dose Escalation Phase|Adverse Event|0|||
161119040|NCT01425008|581823880|FG013|Dose Escalation Phase|Adverse Event|0|||
161119041|NCT01425008|581823881|FG014|Dose Escalation Phase|Adverse Event|0|||
161119042|NCT01425008|581823882|FG015|Dose Escalation Phase|Adverse Event|0|||
161119043|NCT01425008|581823883|FG016|Dose Escalation Phase|Adverse Event|0|||
161119044|NCT01425008|581823884|FG017|Dose Escalation Phase|Adverse Event|0|||
161119045|NCT01425008|581823885|FG018|Dose Escalation Phase|Adverse Event|0|||
161119046|NCT01425008|581823867|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119047|NCT01425008|581823868|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119048|NCT01425008|581823869|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119049|NCT01425008|581823870|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119050|NCT01425008|581823871|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161119051|NCT01425008|581823872|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119052|NCT01425008|581823873|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
161223804|NCT01185288|582200118|FG000|Overall Study|Lack of Efficacy|2|||
161223805|NCT01185288|582200119|FG001|Overall Study|Lack of Efficacy|0|||
160874543|NCT01561313|580934250|FG000|Overall Study|Withdrawal by Subject|1|||
160874544|NCT01561313|580934251|FG001|Overall Study|Withdrawal by Subject|0|||
160874545|NCT01561313|580934250|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
160874546|NCT01561313|580934251|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
161119053|NCT01425008|581823874|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161119054|NCT01425008|581823875|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161119055|NCT01425008|581823876|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119056|NCT01425008|581823877|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119057|NCT01425008|581823878|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119058|NCT01425008|581823879|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119059|NCT01425008|581823880|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119060|NCT01425008|581823881|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119061|NCT01425008|581823882|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119062|NCT01425008|581823883|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119063|NCT01425008|581823884|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119064|NCT01425008|581823885|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161119065|NCT01425008|581823867|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161119066|NCT01425008|581823868|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161119067|NCT01425008|581823869|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161119068|NCT01425008|581823870|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161119069|NCT01425008|581823871|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
161119070|NCT01425008|581823872|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
161119071|NCT01425008|581823873|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
161119072|NCT01425008|581823874|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
161119073|NCT01425008|581823875|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
161119074|NCT01425008|581823876|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
161119075|NCT01425008|581823877|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
161119076|NCT01425008|581823878|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
161119077|NCT01425008|581823879|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
161119078|NCT01425008|581823880|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
161119079|NCT01425008|581823881|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
161119080|NCT01425008|581823882|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
161119081|NCT01425008|581823883|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
161119082|NCT01425008|581823884|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
161119083|NCT01425008|581823885|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
161119084|NCT01425008|581823867|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119085|NCT01425008|581823868|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119086|NCT01425008|581823869|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
161119087|NCT01425008|581823870|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119088|NCT01425008|581823871|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119089|NCT01425008|581823872|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119090|NCT01425008|581823873|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119091|NCT01425008|581823874|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119092|NCT01425008|581823875|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
161119093|NCT01425008|581823876|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
161119094|NCT01425008|581823877|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119095|NCT01425008|581823878|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119096|NCT01425008|581823879|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119097|NCT01425008|581823880|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119098|NCT01425008|581823881|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119099|NCT01425008|581823882|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119100|NCT01425008|581823883|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119101|NCT01425008|581823884|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119102|NCT01425008|581823885|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
161119103|NCT01425008|581823867|FG000|Dose Escalation Phase|Other|0|||
161119104|NCT01425008|581823868|FG001|Dose Escalation Phase|Other|0|||
161119105|NCT01425008|581823869|FG002|Dose Escalation Phase|Other|0|||
161119106|NCT01425008|581823870|FG003|Dose Escalation Phase|Other|0|||
161119107|NCT01425008|581823871|FG004|Dose Escalation Phase|Other|0|||
161119108|NCT01425008|581823872|FG005|Dose Escalation Phase|Other|0|||
161119109|NCT01425008|581823873|FG006|Dose Escalation Phase|Other|0|||
161119110|NCT01425008|581823874|FG007|Dose Escalation Phase|Other|0|||
161119111|NCT01425008|581823875|FG008|Dose Escalation Phase|Other|1|||
161119112|NCT01425008|581823876|FG009|Dose Escalation Phase|Other|0|||
161119113|NCT01425008|581823877|FG010|Dose Escalation Phase|Other|0|||
161119114|NCT01425008|581823878|FG011|Dose Escalation Phase|Other|0|||
161223806|NCT01185288|582200118|FG000|Overall Study|Investigator discretion|1|||
161223807|NCT01185288|582200119|FG001|Overall Study|Investigator discretion|0|||
160874547|NCT06173063|580934256|FG000|Overall Study|Withdrawal by Subject|2|||
160874548|NCT01925131|580935559|FG000|Overall Study|Death|0|||
160874549|NCT01925131|580935560|FG001|Overall Study|Death|0|||
160874550|NCT01925131|580935561|FG002|Overall Study|Death|1|||
160874551|NCT01925131|580935562|FG003|Overall Study|Death|0|||
160874552|NCT01925131|580935563|FG004|Overall Study|Death|0|||
160874553|NCT01925131|580935564|FG005|Overall Study|Death|0|||
160874554|NCT01925131|580935559|FG000|Overall Study|Progression/Relapse|1|||
161119115|NCT01425008|581823879|FG012|Dose Escalation Phase|Other|0|||
161119116|NCT01425008|581823880|FG013|Dose Escalation Phase|Other|0|||
161119117|NCT01425008|581823881|FG014|Dose Escalation Phase|Other|0|||
161119118|NCT01425008|581823882|FG015|Dose Escalation Phase|Other|0|||
161119119|NCT01425008|581823883|FG016|Dose Escalation Phase|Other|0|||
161119120|NCT01425008|581823884|FG017|Dose Escalation Phase|Other|0|||
161119121|NCT01425008|581823885|FG018|Dose Escalation Phase|Other|0|||
161119122|NCT01425008|581823867|FG000|Dose Expansion Phase|Progressive Disease|0|||
161119123|NCT01425008|581823868|FG001|Dose Expansion Phase|Progressive Disease|0|||
161119124|NCT01425008|581823869|FG002|Dose Expansion Phase|Progressive Disease|0|||
161119125|NCT01425008|581823870|FG003|Dose Expansion Phase|Progressive Disease|0|||
161119126|NCT01425008|581823871|FG004|Dose Expansion Phase|Progressive Disease|0|||
161119127|NCT01425008|581823872|FG005|Dose Expansion Phase|Progressive Disease|0|||
161119128|NCT01425008|581823873|FG006|Dose Expansion Phase|Progressive Disease|0|||
161119129|NCT01425008|581823874|FG007|Dose Expansion Phase|Progressive Disease|0|||
161119130|NCT01425008|581823875|FG008|Dose Expansion Phase|Progressive Disease|0|||
161119131|NCT01425008|581823876|FG009|Dose Expansion Phase|Progressive Disease|0|||
161119132|NCT01425008|581823877|FG010|Dose Expansion Phase|Progressive Disease|10|||
161119133|NCT01425008|581823878|FG011|Dose Expansion Phase|Progressive Disease|4|||
161119134|NCT01425008|581823879|FG012|Dose Expansion Phase|Progressive Disease|12|||
161119135|NCT01425008|581823880|FG013|Dose Expansion Phase|Progressive Disease|1|||
161119136|NCT01425008|581823881|FG014|Dose Expansion Phase|Progressive Disease|5|||
161119137|NCT01425008|581823882|FG015|Dose Expansion Phase|Progressive Disease|8|||
161119138|NCT01425008|581823883|FG016|Dose Expansion Phase|Progressive Disease|9|||
161119139|NCT01425008|581823884|FG017|Dose Expansion Phase|Progressive Disease|2|||
161119140|NCT01425008|581823885|FG018|Dose Expansion Phase|Progressive Disease|10|||
161119141|NCT01425008|581823867|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
161119142|NCT01425008|581823868|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
161119143|NCT01425008|581823869|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
161119144|NCT01425008|581823870|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
161119145|NCT01425008|581823871|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
161119146|NCT01425008|581823872|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
161119147|NCT01425008|581823873|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
161119148|NCT01425008|581823874|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
161119149|NCT01425008|581823875|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
161119150|NCT01425008|581823876|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
161119151|NCT01425008|581823877|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
161119152|NCT01425008|581823878|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
161119153|NCT01425008|581823879|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
161119154|NCT01425008|581823880|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
161119155|NCT01425008|581823881|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
161119156|NCT01425008|581823882|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
161119157|NCT01425008|581823883|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
161119158|NCT01425008|581823884|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
161119159|NCT01425008|581823885|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
161119160|NCT01425008|581823867|FG000|Dose Expansion Phase|Other|0|||
161119161|NCT01425008|581823868|FG001|Dose Expansion Phase|Other|0|||
161119162|NCT01425008|581823869|FG002|Dose Expansion Phase|Other|0|||
161119163|NCT01425008|581823870|FG003|Dose Expansion Phase|Other|0|||
161119164|NCT01425008|581823871|FG004|Dose Expansion Phase|Other|0|||
161119165|NCT01425008|581823872|FG005|Dose Expansion Phase|Other|0|||
161119166|NCT01425008|581823873|FG006|Dose Expansion Phase|Other|0|||
161119167|NCT01425008|581823874|FG007|Dose Expansion Phase|Other|0|||
161119168|NCT01425008|581823875|FG008|Dose Expansion Phase|Other|0|||
161119169|NCT01425008|581823876|FG009|Dose Expansion Phase|Other|0|||
161119170|NCT01425008|581823877|FG010|Dose Expansion Phase|Other|0|||
161119171|NCT01425008|581823878|FG011|Dose Expansion Phase|Other|0|||
161119172|NCT01425008|581823879|FG012|Dose Expansion Phase|Other|1|||
161119173|NCT01425008|581823880|FG013|Dose Expansion Phase|Other|0|||
161119174|NCT01425008|581823881|FG014|Dose Expansion Phase|Other|0|||
161119175|NCT01425008|581823882|FG015|Dose Expansion Phase|Other|0|||
161119176|NCT01425008|581823883|FG016|Dose Expansion Phase|Other|2|||
161119177|NCT01425008|581823884|FG017|Dose Expansion Phase|Other|0|||
161119178|NCT01425008|581823885|FG018|Dose Expansion Phase|Other|4|||
160874555|NCT01925131|580935560|FG001|Overall Study|Progression/Relapse|1|||
160874556|NCT01925131|580935561|FG002|Overall Study|Progression/Relapse|4|||
160874557|NCT01925131|580935562|FG003|Overall Study|Progression/Relapse|0|||
161119179|NCT01425008|581823867|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119180|NCT01425008|581823868|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
161324438|NCT00320788|582573603|FG002|Overall Study|Other|1|||
160874558|NCT01925131|580935563|FG004|Overall Study|Progression/Relapse|0|||
160874559|NCT01925131|580935564|FG005|Overall Study|Progression/Relapse|1|||
160874560|NCT01925131|580935559|FG000|Overall Study|Patient Refusal|1|||
160874561|NCT01925131|580935560|FG001|Overall Study|Patient Refusal|0|||
160874562|NCT01925131|580935561|FG002|Overall Study|Patient Refusal|0|||
160874563|NCT01925131|580935562|FG003|Overall Study|Patient Refusal|0|||
161119181|NCT01425008|581823869|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119182|NCT01425008|581823870|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119183|NCT01425008|581823871|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119184|NCT01425008|581823872|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119185|NCT01425008|581823873|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119186|NCT01425008|581823874|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119187|NCT01425008|581823875|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119188|NCT01425008|581823876|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119189|NCT01425008|581823877|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
161119190|NCT01425008|581823878|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
161119191|NCT01425008|581823879|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119192|NCT01425008|581823880|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119193|NCT01425008|581823881|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119194|NCT01425008|581823882|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
161119195|NCT01425008|581823883|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
161119196|NCT01425008|581823884|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
161119197|NCT01425008|581823885|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
161119198|NCT01425008|581823867|FG000|Dose Expansion Phase|Adverse Event|0|||
161119199|NCT01425008|581823868|FG001|Dose Expansion Phase|Adverse Event|0|||
161119200|NCT01425008|581823869|FG002|Dose Expansion Phase|Adverse Event|0|||
161119201|NCT01425008|581823870|FG003|Dose Expansion Phase|Adverse Event|0|||
161119202|NCT01425008|581823871|FG004|Dose Expansion Phase|Adverse Event|0|||
161119203|NCT01425008|581823872|FG005|Dose Expansion Phase|Adverse Event|0|||
161119204|NCT01425008|581823873|FG006|Dose Expansion Phase|Adverse Event|0|||
161119205|NCT01425008|581823874|FG007|Dose Expansion Phase|Adverse Event|0|||
161119206|NCT01425008|581823875|FG008|Dose Expansion Phase|Adverse Event|0|||
161119207|NCT01425008|581823876|FG009|Dose Expansion Phase|Adverse Event|0|||
161119208|NCT01425008|581823877|FG010|Dose Expansion Phase|Adverse Event|2|||
161119209|NCT01425008|581823878|FG011|Dose Expansion Phase|Adverse Event|3|||
161119210|NCT01425008|581823879|FG012|Dose Expansion Phase|Adverse Event|3|||
161119211|NCT01425008|581823880|FG013|Dose Expansion Phase|Adverse Event|0|||
161119212|NCT01425008|581823881|FG014|Dose Expansion Phase|Adverse Event|1|||
161119213|NCT01425008|581823882|FG015|Dose Expansion Phase|Adverse Event|1|||
161119214|NCT01425008|581823883|FG016|Dose Expansion Phase|Adverse Event|5|||
161119215|NCT01425008|581823884|FG017|Dose Expansion Phase|Adverse Event|0|||
161119216|NCT01425008|581823885|FG018|Dose Expansion Phase|Adverse Event|3|||
161119217|NCT01425008|581823867|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
161119218|NCT01425008|581823868|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
161119219|NCT01425008|581823869|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
161119220|NCT01425008|581823870|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
161119221|NCT01425008|581823871|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
161119222|NCT01425008|581823872|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
161119223|NCT01425008|581823873|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
161119224|NCT01425008|581823874|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
161119225|NCT01425008|581823875|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
161119226|NCT01425008|581823876|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
161119227|NCT01425008|581823877|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
161119228|NCT01425008|581823878|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
161119229|NCT01425008|581823879|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
161119230|NCT01425008|581823880|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
161119231|NCT01425008|581823881|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
161119232|NCT01425008|581823882|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
161119233|NCT01425008|581823883|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
161119234|NCT01425008|581823884|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
161119235|NCT01425008|581823885|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
161119236|NCT01425008|581823867|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119237|NCT01425008|581823868|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119238|NCT01425008|581823869|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119239|NCT01425008|581823870|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119240|NCT01425008|581823871|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119241|NCT01425008|581823872|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119242|NCT01425008|581823873|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119243|NCT01425008|581823874|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119244|NCT01425008|581823875|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119245|NCT01425008|581823876|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119246|NCT01425008|581823877|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161324439|NCT00320788|582573604|FG003|Overall Study|Other|1|||
160874564|NCT01925131|580935563|FG004|Overall Study|Patient Refusal|0|||
161223808|NCT01185288|582200118|FG000|Overall Study|Did not meet inclusion criteria|1|||
161223809|NCT01185288|582200119|FG001|Overall Study|Did not meet inclusion criteria|0|||
161223810|NCT01185288|582200118|FG000|Overall Study|Noncompliance|0|||
161223811|NCT01185288|582200119|FG001|Overall Study|Noncompliance|1|||
161223812|NCT02974153|582200120|FG000|Overall Study|Adverse Event|6|||
161223813|NCT02974153|582200121|FG001|Overall Study|Adverse Event|0|||
161223814|NCT02974153|582200122|FG002|Overall Study|Adverse Event|1|||
161223815|NCT02974153|582200120|FG000|Overall Study|Lack of Efficacy|6|||
161223816|NCT02974153|582200121|FG001|Overall Study|Lack of Efficacy|5|||
161223817|NCT02974153|582200122|FG002|Overall Study|Lack of Efficacy|10|||
161223818|NCT02974153|582200120|FG000|Overall Study|Lost to Follow-up|9|||
161223819|NCT02974153|582200121|FG001|Overall Study|Lost to Follow-up|10|||
161223820|NCT02974153|582200122|FG002|Overall Study|Lost to Follow-up|17|||
161223821|NCT02974153|582200120|FG000|Overall Study|Physician Decision|0|||
161223822|NCT02974153|582200121|FG001|Overall Study|Physician Decision|2|||
161223823|NCT02974153|582200122|FG002|Overall Study|Physician Decision|1|||
161223824|NCT02974153|582200120|FG000|Overall Study|Withdrawal by Subject|9|||
161223825|NCT02974153|582200121|FG001|Overall Study|Withdrawal by Subject|16|||
161223826|NCT02974153|582200122|FG002|Overall Study|Withdrawal by Subject|11|||
161223827|NCT02974153|582200120|FG000|Overall Study|Study Burden|8|||
161223828|NCT02974153|582200121|FG001|Overall Study|Study Burden|7|||
161223829|NCT02974153|582200122|FG002|Overall Study|Study Burden|3|||
161223830|NCT02974153|582200120|FG000|Overall Study|Other|14|||
160874565|NCT01925131|580935564|FG005|Overall Study|Patient Refusal|0|||
160874566|NCT01925131|580935559|FG000|Overall Study|Adverse Event|0|||
160874567|NCT01925131|580935560|FG001|Overall Study|Adverse Event|0|||
160874568|NCT01925131|580935561|FG002|Overall Study|Adverse Event|2|||
160874569|NCT01925131|580935562|FG003|Overall Study|Adverse Event|0|||
160874570|NCT01925131|580935563|FG004|Overall Study|Adverse Event|1|||
160874571|NCT01925131|580935564|FG005|Overall Study|Adverse Event|3|||
160874572|NCT01925131|580935559|FG000|Overall Study|Other - Not Protocol Specified|3|||
161223831|NCT02974153|582200121|FG001|Overall Study|Other|8|||
161223832|NCT02974153|582200122|FG002|Overall Study|Other|7|||
161223833|NCT01202747|582200123|FG000|Overall Study|Withdrawal by Subject|1|||
161223834|NCT01446913|582200124|FG000|Overall Study|Significant illness|1|||
161223835|NCT01446913|582200125|FG001|Overall Study|Significant illness|1|||
161223836|NCT01446913|582200126|FG002|Overall Study|Significant illness|1|||
161223837|NCT01446913|582200124|FG000|Overall Study|Withdrawal by Subject|5|||
161223838|NCT01446913|582200125|FG001|Overall Study|Withdrawal by Subject|3|||
161223839|NCT01446913|582200126|FG002|Overall Study|Withdrawal by Subject|5|||
161223840|NCT01446913|582200124|FG000|Overall Study|Physician Decision|0|||
160874573|NCT01925131|580935560|FG001|Overall Study|Other - Not Protocol Specified|1|||
160874574|NCT01925131|580935561|FG002|Overall Study|Other - Not Protocol Specified|2|||
160874575|NCT01925131|580935562|FG003|Overall Study|Other - Not Protocol Specified|5|||
160874576|NCT01925131|580935563|FG004|Overall Study|Other - Not Protocol Specified|10|||
160874577|NCT01925131|580935564|FG005|Overall Study|Other - Not Protocol Specified|6|||
160874578|NCT05091567|580935565|FG000|Enrollment Phase|Death|37|||
160874579|NCT05091567|580935566|FG001|Enrollment Phase|Death|0|||
161223841|NCT01446913|582200125|FG001|Overall Study|Physician Decision|0|||
161223842|NCT01446913|582200126|FG002|Overall Study|Physician Decision|2|||
161223843|NCT01446913|582200124|FG000|Overall Study|Lost to Follow-up|3|||
161223844|NCT01446913|582200125|FG001|Overall Study|Lost to Follow-up|5|||
161223845|NCT01446913|582200126|FG002|Overall Study|Lost to Follow-up|3|||
161223846|NCT02521948|582200127|FG000|Overall Study|Adverse Event|2|||
161223847|NCT02521948|582200127|FG000|Overall Study|Death|4|||
161223848|NCT02521948|582200127|FG000|Overall Study|Lost to Follow-up|1|||
161223849|NCT02521948|582200127|FG000|Overall Study|Did not attend one or both follow-ups|6|||
161223850|NCT04471428|582200128|FG000|Overall Study|Withdrawal by Subject|29|||
161223851|NCT04471428|582200129|FG001|Overall Study|Withdrawal by Subject|4|||
161223852|NCT04471428|582200128|FG000|Overall Study|Physician Decision|0|||
161223853|NCT04471428|582200129|FG001|Overall Study|Physician Decision|1|||
160874580|NCT05091567|580935567|FG002|Enrollment Phase|Death|0|||
160874581|NCT05091567|580935565|FG000|Enrollment Phase|Adverse Event|21|||
161223854|NCT04471428|582200128|FG000|Overall Study|Reason Not Specified|0|||
161223855|NCT04471428|582200129|FG001|Overall Study|Reason Not Specified|2|||
161223856|NCT04471428|582200128|FG000|Overall Study|Death|131|||
161223857|NCT04471428|582200129|FG001|Overall Study|Death|147|||
161223858|NCT04471428|582200128|FG000|Overall Study|Lost to Follow-up|0|||
161223859|NCT04471428|582200129|FG001|Overall Study|Lost to Follow-up|3|||
161223860|NCT04471428|582200128|FG000|Overall Study|Study Terminated by Sponsor|20|||
161223861|NCT04471428|582200129|FG001|Overall Study|Study Terminated by Sponsor|29|||
161223862|NCT03504852|582200130|FG000|Overall Study|Withdrawal of informed consent|2|||
160874582|NCT05091567|580935566|FG001|Enrollment Phase|Adverse Event|0|||
160874583|NCT05091567|580935567|FG002|Enrollment Phase|Adverse Event|0|||
161223863|NCT03504852|582200131|FG001|Overall Study|Withdrawal of informed consent|1|||
161223864|NCT03504852|582200132|FG002|Overall Study|Withdrawal of informed consent|0|||
161223865|NCT03504852|582200130|FG000|Overall Study|Withdrawal by Subject|5|||
161223866|NCT03504852|582200131|FG001|Overall Study|Withdrawal by Subject|5|||
161223867|NCT03504852|582200132|FG002|Overall Study|Withdrawal by Subject|1|||
161223868|NCT03504852|582200130|FG000|Overall Study|Lost to Follow-up|4|||
161223869|NCT03504852|582200131|FG001|Overall Study|Lost to Follow-up|1|||
161223870|NCT03504852|582200132|FG002|Overall Study|Lost to Follow-up|0|||
161223871|NCT03504852|582200130|FG000|Overall Study|New therapy for study indication|1|||
161223872|NCT03504852|582200131|FG001|Overall Study|New therapy for study indication|0|||
161223873|NCT03504852|582200132|FG002|Overall Study|New therapy for study indication|0|||
161223874|NCT03504852|582200130|FG000|Overall Study|Lack of Efficacy|1|||
161223875|NCT03504852|582200131|FG001|Overall Study|Lack of Efficacy|2|||
161223876|NCT03504852|582200132|FG002|Overall Study|Lack of Efficacy|0|||
161119247|NCT01425008|581823878|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161223877|NCT03504852|582200130|FG000|Overall Study|Death|0|||
161223878|NCT03504852|582200131|FG001|Overall Study|Death|1|||
161223879|NCT03504852|582200132|FG002|Overall Study|Death|0|||
161223880|NCT03504852|582200130|FG000|Overall Study|Adverse Event|4|||
161223881|NCT03504852|582200131|FG001|Overall Study|Adverse Event|8|||
161223882|NCT03504852|582200132|FG002|Overall Study|Adverse Event|2|||
161223883|NCT02928848|582200133|FG000|Arm 2|Withdrawal by Subject|1|||
161223884|NCT02928848|582200134|FG001|Arm 2|Withdrawal by Subject|0|||
161223885|NCT03290079|582200135|FG000|Overall Study|Death|2|||
161223886|NCT00663871|582200136|FG000|Overall Study|Lost to Follow-up|5|||
161223887|NCT00663871|582200137|FG001|Overall Study|Lost to Follow-up|5|||
161223888|NCT00663871|582200136|FG000|Overall Study|Withdrawal by Subject|5|||
161223889|NCT00663871|582200137|FG001|Overall Study|Withdrawal by Subject|2|||
161223890|NCT00582309|582200138|FG000|Overall Study|Protocol Violation|0|||
161223891|NCT00582309|582200139|FG001|Overall Study|Protocol Violation|0|||
161223892|NCT00582309|582200140|FG002|Overall Study|Protocol Violation|2|||
161223893|NCT00319449|582200146|FG000|Overall Study|Subject did not wish to continue|1|||
161223894|NCT00319449|582200147|FG001|Overall Study|Subject did not wish to continue|0|||
161119248|NCT01425008|581823879|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119249|NCT01425008|581823880|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119250|NCT01425008|581823881|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119251|NCT01425008|581823882|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119252|NCT01425008|581823883|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119253|NCT01425008|581823884|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161119254|NCT01425008|581823885|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
161119255|NCT04818593|581823886|FG000|Overall Study|Low Oocyte Yield|8|||
161119256|NCT04818593|581823887|FG001|Overall Study|Low Oocyte Yield|8|||
161119257|NCT04818593|581823886|FG000|Overall Study|Not ICSI Insemination|7|||
161119258|NCT04818593|581823887|FG001|Overall Study|Not ICSI Insemination|7|||
161119259|NCT04818593|581823886|FG000|Overall Study|Poor Sperm Quality|2|||
161119260|NCT04818593|581823887|FG001|Overall Study|Poor Sperm Quality|2|||
161119261|NCT04818593|581823886|FG000|Overall Study|Withdrawal by Subject|2|||
161119262|NCT04818593|581823887|FG001|Overall Study|Withdrawal by Subject|2|||
161119263|NCT04818593|581823886|FG000|Overall Study|Conversion to IUI due to low response|1|||
161119264|NCT04818593|581823887|FG001|Overall Study|Conversion to IUI due to low response|1|||
161119265|NCT05061719|581823888|FG000|Overall Study|Adverse Event|60|||
161119266|NCT05061719|581823888|FG000|Overall Study|Death|1|||
161119267|NCT05061719|581823888|FG000|Overall Study|Lack of Efficacy|7|||
161119268|NCT05061719|581823888|FG000|Overall Study|Lost to Follow-up|5|||
161119269|NCT05061719|581823888|FG000|Overall Study|Pregnancy|1|||
161119270|NCT05061719|581823888|FG000|Overall Study|Protocol Violation|8|||
161119271|NCT05061719|581823888|FG000|Overall Study|Withdrawal by Subject|41|||
161119272|NCT05061719|581823888|FG000|Overall Study|Site Closure|2|||
161119273|NCT04179175|581825884|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
161119274|NCT04179175|581825885|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
161119275|NCT04179175|581825886|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
161119276|NCT04179175|581825887|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
161119277|NCT04179175|581825888|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
161119278|NCT04179175|581825889|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
161119279|NCT04179175|581825884|FG000|Overall Study|Adverse Event|5|||
161119280|NCT04179175|581825885|FG001|Overall Study|Adverse Event|3|||
161119281|NCT04179175|581825886|FG002|Overall Study|Adverse Event|3|||
161119282|NCT04179175|581825887|FG003|Overall Study|Adverse Event|4|||
161119283|NCT04179175|581825888|FG004|Overall Study|Adverse Event|6|||
161119284|NCT04179175|581825889|FG005|Overall Study|Adverse Event|6|||
161119285|NCT04179175|581825884|FG000|Overall Study|Lack of Efficacy|5|||
161119286|NCT04179175|581825885|FG001|Overall Study|Lack of Efficacy|1|||
161223895|NCT00319449|582200146|FG000|Overall Study|Noncompliance with the protocol|1|||
161223896|NCT00319449|582200147|FG001|Overall Study|Noncompliance with the protocol|0|||
161223897|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
161223898|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
161223899|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
161223900|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
161223901|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
160874584|NCT05091567|580935565|FG000|Enrollment Phase|Progressive Disease|10|||
160874585|NCT05091567|580935566|FG001|Enrollment Phase|Progressive Disease|0|||
160874586|NCT05091567|580935567|FG002|Enrollment Phase|Progressive Disease|0|||
160874587|NCT05091567|580935565|FG000|Enrollment Phase|Withdrawal by Subject|8|||
160874588|NCT05091567|580935566|FG001|Enrollment Phase|Withdrawal by Subject|0|||
160874589|NCT05091567|580935567|FG002|Enrollment Phase|Withdrawal by Subject|0|||
160874590|NCT05091567|580935565|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
160874591|NCT05091567|580935566|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
161119287|NCT04179175|581825886|FG002|Overall Study|Lack of Efficacy|3|||
161119288|NCT04179175|581825887|FG003|Overall Study|Lack of Efficacy|2|||
161119289|NCT04179175|581825888|FG004|Overall Study|Lack of Efficacy|18|||
161119290|NCT04179175|581825889|FG005|Overall Study|Lack of Efficacy|7|||
161119291|NCT04179175|581825884|FG000|Overall Study|Lost to Follow-up|5|||
161119292|NCT04179175|581825885|FG001|Overall Study|Lost to Follow-up|3|||
161119293|NCT04179175|581825886|FG002|Overall Study|Lost to Follow-up|2|||
161119294|NCT04179175|581825887|FG003|Overall Study|Lost to Follow-up|2|||
161119295|NCT04179175|581825888|FG004|Overall Study|Lost to Follow-up|4|||
161119296|NCT04179175|581825889|FG005|Overall Study|Lost to Follow-up|5|||
161119297|NCT04179175|581825884|FG000|Overall Study|Physician Decision|2|||
161119298|NCT04179175|581825885|FG001|Overall Study|Physician Decision|0|||
161119299|NCT04179175|581825886|FG002|Overall Study|Physician Decision|2|||
161119300|NCT04179175|581825887|FG003|Overall Study|Physician Decision|3|||
161119301|NCT04179175|581825888|FG004|Overall Study|Physician Decision|1|||
161119302|NCT04179175|581825889|FG005|Overall Study|Physician Decision|1|||
161119303|NCT04179175|581825884|FG000|Overall Study|Pregnancy|3|||
161119304|NCT04179175|581825885|FG001|Overall Study|Pregnancy|0|||
161119305|NCT04179175|581825886|FG002|Overall Study|Pregnancy|3|||
161119306|NCT04179175|581825887|FG003|Overall Study|Pregnancy|0|||
161119307|NCT04179175|581825888|FG004|Overall Study|Pregnancy|1|||
161119308|NCT04179175|581825889|FG005|Overall Study|Pregnancy|2|||
161119309|NCT04179175|581825884|FG000|Overall Study|Withdrawal by Subject|22|||
161119310|NCT04179175|581825885|FG001|Overall Study|Withdrawal by Subject|10|||
161119311|NCT04179175|581825886|FG002|Overall Study|Withdrawal by Subject|12|||
161119312|NCT04179175|581825887|FG003|Overall Study|Withdrawal by Subject|8|||
161119313|NCT04179175|581825888|FG004|Overall Study|Withdrawal by Subject|23|||
161119314|NCT04179175|581825889|FG005|Overall Study|Withdrawal by Subject|31|||
161119315|NCT04179175|581825884|FG000|Overall Study|Technical problems|0|||
161119316|NCT04179175|581825885|FG001|Overall Study|Technical problems|0|||
161119317|NCT04179175|581825886|FG002|Overall Study|Technical problems|1|||
161119318|NCT04179175|581825887|FG003|Overall Study|Technical problems|1|||
161119319|NCT04179175|581825888|FG004|Overall Study|Technical problems|0|||
161119320|NCT04179175|581825889|FG005|Overall Study|Technical problems|0|||
161119321|NCT03215030|581825895|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
161119322|NCT03215030|581825896|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
161119323|NCT03215030|581825897|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119324|NCT03215030|581825898|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
161119325|NCT03215030|581825899|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119326|NCT03215030|581825900|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119327|NCT03215030|581825901|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119328|NCT03215030|581825902|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119329|NCT03215030|581825903|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119330|NCT03215030|581825904|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119331|NCT03215030|581825905|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119332|NCT03215030|581825906|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
161119333|NCT03215030|581825895|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161119334|NCT03215030|581825896|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119335|NCT03215030|581825897|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119336|NCT03215030|581825898|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161119337|NCT03215030|581825899|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119338|NCT03215030|581825900|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119339|NCT03215030|581825901|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119340|NCT03215030|581825902|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119341|NCT03215030|581825903|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119342|NCT03215030|581825904|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119343|NCT03215030|581825905|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119344|NCT03215030|581825906|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161119345|NCT03215030|581825895|FG000|Part 1: Dose Escalation|Death|15|||
161119346|NCT03215030|581825896|FG001|Part 1: Dose Escalation|Death|6|||
161119347|NCT03215030|581825897|FG002|Part 1: Dose Escalation|Death|6|||
161119348|NCT03215030|581825898|FG003|Part 1: Dose Escalation|Death|8|||
161119349|NCT03215030|581825899|FG004|Part 1: Dose Escalation|Death|0|||
161119350|NCT03215030|581825900|FG005|Part 1: Dose Escalation|Death|0|||
161119351|NCT03215030|581825901|FG006|Part 1: Dose Escalation|Death|0|||
161119352|NCT03215030|581825902|FG007|Part 1: Dose Escalation|Death|0|||
161119353|NCT03215030|581825903|FG008|Part 1: Dose Escalation|Death|0|||
161223902|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
161223903|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
161223904|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
161223905|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
161223906|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
161223907|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
161223908|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
161223909|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
161223910|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
161223911|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
161223912|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
161223913|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
161223914|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
161223915|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
161223916|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
161223917|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
161223918|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
161223919|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
161223920|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
161223921|NCT00455533|582200148|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
161223922|NCT00455533|582200149|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
161223923|NCT00455533|582200150|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
161223924|NCT00455533|582200148|FG000|Period Two: Randomized Period|Death|0|||
161223925|NCT00455533|582200149|FG001|Period Two: Randomized Period|Death|0|||
161223926|NCT00455533|582200150|FG002|Period Two: Randomized Period|Death|3|||
161223927|NCT00455533|582200148|FG000|Period Two: Randomized Period|Disease Progression|0|||
161223928|NCT00455533|582200149|FG001|Period Two: Randomized Period|Disease Progression|1|||
161223929|NCT00455533|582200150|FG002|Period Two: Randomized Period|Disease Progression|1|||
161223930|NCT00455533|582200148|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
161223931|NCT00455533|582200149|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
161223932|NCT00455533|582200150|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
161223933|NCT00455533|582200148|FG000|Period Two: Randomized Period|Other - need reasons|0|||
161223934|NCT00455533|582200149|FG001|Period Two: Randomized Period|Other - need reasons|1|||
161223935|NCT00455533|582200150|FG002|Period Two: Randomized Period|Other - need reasons|0|||
161223936|NCT00455533|582200148|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
161223937|NCT00455533|582200149|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
161223938|NCT00455533|582200150|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
161223939|NCT00455533|582200148|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
161223940|NCT00455533|582200149|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
161223941|NCT00455533|582200150|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
161223942|NCT02415959|582200151|FG000|Overall Study|Adverse Event|0|||
161223943|NCT02415959|582200152|FG001|Overall Study|Adverse Event|1|||
161223944|NCT02415959|582200153|FG002|Overall Study|Adverse Event|0|||
161223945|NCT02415959|582200154|FG003|Overall Study|Adverse Event|0|||
161223946|NCT02415959|582200155|FG004|Overall Study|Adverse Event|0|||
161223947|NCT02415959|582200151|FG000|Overall Study|Protocol Violation|0|||
161223948|NCT02415959|582200152|FG001|Overall Study|Protocol Violation|0|||
161223949|NCT02415959|582200153|FG002|Overall Study|Protocol Violation|0|||
161223950|NCT02415959|582200154|FG003|Overall Study|Protocol Violation|1|||
161223951|NCT02415959|582200155|FG004|Overall Study|Protocol Violation|0|||
161223952|NCT01497938|582200157|FG000|Overall Study|Adverse Event|0|||
161223953|NCT01497938|582200158|FG001|Overall Study|Adverse Event|1|||
161223954|NCT01497938|582200157|FG000|Overall Study|Physician Decision|0|||
161223955|NCT01497938|582200158|FG001|Overall Study|Physician Decision|1|||
161223956|NCT01497938|582200157|FG000|Overall Study|Withdrawal by Subject|4|||
161223957|NCT01497938|582200158|FG001|Overall Study|Withdrawal by Subject|0|||
161223958|NCT01497938|582200157|FG000|Overall Study|Device Violation|1|||
161223959|NCT01497938|582200158|FG001|Overall Study|Device Violation|0|||
161223960|NCT00365352|582200159|FG000|Overall Study|Adverse Event|6|||
160874592|NCT05091567|580935567|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
160874593|NCT05091567|580935565|FG000|Enrollment Phase|Physician Decision|3|||
160874594|NCT05091567|580935566|FG001|Enrollment Phase|Physician Decision|0|||
161223961|NCT00365352|582200160|FG001|Overall Study|Adverse Event|7|||
161223962|NCT00365352|582200161|FG002|Overall Study|Adverse Event|8|||
161223963|NCT00365352|582200159|FG000|Overall Study|Participant Withdrew Consent|8|||
161223964|NCT00365352|582200160|FG001|Overall Study|Participant Withdrew Consent|3|||
161223965|NCT00365352|582200161|FG002|Overall Study|Participant Withdrew Consent|4|||
161223966|NCT00365352|582200159|FG000|Overall Study|Lack of Efficacy|3|||
161223967|NCT00365352|582200160|FG001|Overall Study|Lack of Efficacy|0|||
161223968|NCT00365352|582200161|FG002|Overall Study|Lack of Efficacy|0|||
161223969|NCT00365352|582200159|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
161223970|NCT00365352|582200160|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
161223971|NCT00365352|582200161|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
161223972|NCT00365352|582200159|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
161223973|NCT00365352|582200160|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
161223974|NCT00365352|582200161|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
161223975|NCT00365352|582200159|FG000|Overall Study|Lost to Follow-up|1|||
161223976|NCT00365352|582200160|FG001|Overall Study|Lost to Follow-up|1|||
161223977|NCT00365352|582200161|FG002|Overall Study|Lost to Follow-up|0|||
161223978|NCT00365352|582200159|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
161223979|NCT00365352|582200160|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
161223980|NCT00365352|582200161|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
161223981|NCT03708211|582200162|FG000|Overall Study|Progressive Disease|10|||
161223982|NCT03708211|582200163|FG001|Overall Study|Progressive Disease|7|||
161223983|NCT03708211|582200162|FG000|Overall Study|Withdrawal by Subject|0|||
161119354|NCT03215030|581825904|FG009|Part 1: Dose Escalation|Death|0|||
161119355|NCT03215030|581825905|FG010|Part 1: Dose Escalation|Death|0|||
161119356|NCT03215030|581825906|FG011|Part 1: Dose Escalation|Death|0|||
161119357|NCT03215030|581825895|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
161119358|NCT03215030|581825896|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
161119359|NCT03215030|581825897|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
161119360|NCT03215030|581825898|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
161119361|NCT03215030|581825899|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
161119362|NCT03215030|581825900|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
161119363|NCT03215030|581825901|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
161119364|NCT03215030|581825902|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
161119365|NCT03215030|581825903|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
161119366|NCT03215030|581825904|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
161119367|NCT03215030|581825905|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
161119368|NCT03215030|581825906|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
161119369|NCT03215030|581825895|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119370|NCT03215030|581825896|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119371|NCT03215030|581825897|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119372|NCT03215030|581825898|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119373|NCT03215030|581825899|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119374|NCT03215030|581825900|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119375|NCT03215030|581825901|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119376|NCT03215030|581825902|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
161119377|NCT03215030|581825903|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119378|NCT03215030|581825904|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119379|NCT03215030|581825905|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119380|NCT03215030|581825906|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
161119381|NCT03215030|581825895|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119382|NCT03215030|581825896|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119383|NCT03215030|581825897|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119384|NCT03215030|581825898|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119385|NCT03215030|581825899|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161119386|NCT03215030|581825900|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161119387|NCT03215030|581825901|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
161119388|NCT03215030|581825902|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
161119389|NCT03215030|581825903|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119390|NCT03215030|581825904|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119391|NCT03215030|581825905|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119392|NCT03215030|581825906|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161119393|NCT03215030|581825895|FG000|Part 2: Dose Expansion|Death|0|||
161119394|NCT03215030|581825896|FG001|Part 2: Dose Expansion|Death|0|||
161119395|NCT03215030|581825897|FG002|Part 2: Dose Expansion|Death|0|||
161119396|NCT03215030|581825898|FG003|Part 2: Dose Expansion|Death|0|||
161119397|NCT03215030|581825899|FG004|Part 2: Dose Expansion|Death|3|||
161119398|NCT03215030|581825900|FG005|Part 2: Dose Expansion|Death|1|||
161119399|NCT03215030|581825901|FG006|Part 2: Dose Expansion|Death|5|||
161119400|NCT03215030|581825902|FG007|Part 2: Dose Expansion|Death|4|||
161119401|NCT03215030|581825903|FG008|Part 2: Dose Expansion|Death|0|||
161119402|NCT03215030|581825904|FG009|Part 2: Dose Expansion|Death|0|||
161119403|NCT03215030|581825905|FG010|Part 2: Dose Expansion|Death|0|||
161119404|NCT03215030|581825906|FG011|Part 2: Dose Expansion|Death|0|||
161119405|NCT03215030|581825895|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
161119406|NCT03215030|581825896|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
161119407|NCT03215030|581825897|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
161119408|NCT03215030|581825898|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
161119409|NCT03215030|581825899|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
161119410|NCT03215030|581825900|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
161324440|NCT00320788|582573605|FG004|Overall Study|Other|1|||
161223984|NCT03708211|582200163|FG001|Overall Study|Withdrawal by Subject|1|||
161223985|NCT03708211|582200162|FG000|Overall Study|Other|2|||
161223986|NCT03708211|582200163|FG001|Overall Study|Other|0|||
161223987|NCT05514119|582201527|FG000|Overall Study|Ineligible due to disease progression|1|||
161223988|NCT02946385|582201528|FG000|Overall Study|Lost to Follow-up|0|||
161223989|NCT02946385|582201529|FG001|Overall Study|Lost to Follow-up|0|||
161223990|NCT02946385|582201530|FG002|Overall Study|Lost to Follow-up|3|||
161223991|NCT02946385|582201531|FG003|Overall Study|Lost to Follow-up|0|||
161223992|NCT02946385|582201532|FG004|Overall Study|Lost to Follow-up|2|||
161223993|NCT02946385|582201533|FG005|Overall Study|Lost to Follow-up|1|||
161223994|NCT04849988|582201534|FG000|Overall Study|Lack of Efficacy|3|||
161223995|NCT04849988|582201535|FG001|Overall Study|Lack of Efficacy|4|||
161223996|NCT04849988|582201536|FG002|Overall Study|Lack of Efficacy|1|||
161223997|NCT04849988|582201537|FG003|Overall Study|Lack of Efficacy|4|||
161223998|NCT04849988|582201534|FG000|Overall Study|Other reasons|1|||
161223999|NCT04849988|582201535|FG001|Overall Study|Other reasons|2|||
161224000|NCT04849988|582201536|FG002|Overall Study|Other reasons|2|||
161224001|NCT04849988|582201537|FG003|Overall Study|Other reasons|1|||
161224002|NCT01402908|582201542|FG000|Overall Study|Withdrawal by Subject|30|||
161224003|NCT01402908|582201543|FG001|Overall Study|Withdrawal by Subject|17|||
161224004|NCT01402908|582201542|FG000|Overall Study|Lost to Follow-up|3|||
161224005|NCT01402908|582201543|FG001|Overall Study|Lost to Follow-up|1|||
161224006|NCT01402908|582201542|FG000|Overall Study|Physician Decision|1|||
161224007|NCT01402908|582201543|FG001|Overall Study|Physician Decision|0|||
161224008|NCT01739790|582201544|FG000|Overall Study|Early Trial Termination|2|||
161224009|NCT01739790|582201545|FG001|Overall Study|Early Trial Termination|4|||
161224010|NCT01893905|582201546|FG000|Overall Study|Withdrawal by Subject|1|||
161224011|NCT01893905|582201547|FG001|Overall Study|Withdrawal by Subject|0|||
161224012|NCT01893905|582201546|FG000|Overall Study|Adverse Event|9|||
161224013|NCT01893905|582201547|FG001|Overall Study|Adverse Event|3|||
161224014|NCT01893905|582201546|FG000|Overall Study|Lack of Efficacy|5|||
161224015|NCT01893905|582201547|FG001|Overall Study|Lack of Efficacy|7|||
161224016|NCT01893905|582201546|FG000|Overall Study|Lost to Follow-up|1|||
161224017|NCT01893905|582201547|FG001|Overall Study|Lost to Follow-up|0|||
161224018|NCT01893905|582201546|FG000|Overall Study|Protocol Violation|6|||
161224019|NCT01893905|582201547|FG001|Overall Study|Protocol Violation|1|||
161224020|NCT01893905|582201546|FG000|Overall Study|Lack of adherence to treatment|2|||
161224021|NCT01893905|582201547|FG001|Overall Study|Lack of adherence to treatment|0|||
161224022|NCT01893905|582201546|FG000|Overall Study|Other reason|1|||
161224023|NCT01893905|582201547|FG001|Overall Study|Other reason|3|||
161224024|NCT00278200|582201549|FG000|Overall Study|Death|1|||
161224025|NCT00278200|582201550|FG001|Overall Study|Death|3|||
161224026|NCT00278200|582201549|FG000|Overall Study|Physician Decision|0|||
161224027|NCT00278200|582201550|FG001|Overall Study|Physician Decision|1|||
161224028|NCT02688400|582201553|FG000|Overall Study|Protocol Violation|2|||
161224029|NCT02688400|582201554|FG001|Overall Study|Protocol Violation|5|||
161224030|NCT02688400|582201553|FG000|Overall Study|Lack of Efficacy|7|||
161224031|NCT02688400|582201554|FG001|Overall Study|Lack of Efficacy|7|||
161224032|NCT02688400|582201553|FG000|Overall Study|Adverse Event|21|||
161224033|NCT02688400|582201554|FG001|Overall Study|Adverse Event|12|||
161224034|NCT02688400|582201553|FG000|Overall Study|Withdrawal by Subject|15|||
161224035|NCT02688400|582201554|FG001|Overall Study|Withdrawal by Subject|13|||
161224036|NCT02688400|582201553|FG000|Overall Study|No study medication intake|1|||
161224037|NCT02688400|582201554|FG001|Overall Study|No study medication intake|4|||
161224038|NCT02688400|582201553|FG000|Overall Study|Lost to Follow-up|0|||
161224039|NCT02688400|582201554|FG001|Overall Study|Lost to Follow-up|3|||
161224040|NCT05568225|582201559|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
161119411|NCT03215030|581825901|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
161119412|NCT03215030|581825902|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
161119413|NCT03215030|581825903|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
161119414|NCT03215030|581825904|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
161119415|NCT03215030|581825905|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
161119416|NCT03215030|581825906|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
161119417|NCT03215030|581825895|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
161119418|NCT03215030|581825896|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
161119419|NCT03215030|581825897|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
161119420|NCT03215030|581825898|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
161119421|NCT03215030|581825899|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
161119422|NCT03215030|581825900|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
161119423|NCT03215030|581825901|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
161119424|NCT03215030|581825902|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
161119425|NCT03215030|581825903|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
161224041|NCT05568225|582201560|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
161224042|NCT05568225|582201561|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
161224043|NCT05568225|582201559|FG000|Primary Treatment Period|Physician Decision|0|||
161224044|NCT05568225|582201560|FG001|Primary Treatment Period|Physician Decision|1|||
161224045|NCT05568225|582201561|FG002|Primary Treatment Period|Physician Decision|0|||
161224046|NCT05568225|582201559|FG000|Primary Treatment Period|Disease progression|0|||
161224047|NCT05568225|582201560|FG001|Primary Treatment Period|Disease progression|1|||
161224048|NCT05568225|582201561|FG002|Primary Treatment Period|Disease progression|0|||
161224049|NCT05568225|582201559|FG000|Primary Treatment Period|Lack of Efficacy|0|||
161224050|NCT05568225|582201560|FG001|Primary Treatment Period|Lack of Efficacy|1|||
161224051|NCT05568225|582201561|FG002|Primary Treatment Period|Lack of Efficacy|0|||
161224052|NCT05568225|582201559|FG000|Primary Treatment Period|Withdrawal of conset|1|||
161224053|NCT05568225|582201560|FG001|Primary Treatment Period|Withdrawal of conset|0|||
161224054|NCT05568225|582201561|FG002|Primary Treatment Period|Withdrawal of conset|4|||
161224055|NCT05568225|582201559|FG000|Primary Treatment Period|Adverse Event|1|||
161224056|NCT05568225|582201560|FG001|Primary Treatment Period|Adverse Event|0|||
161224057|NCT05568225|582201561|FG002|Primary Treatment Period|Adverse Event|0|||
161224058|NCT05568225|582201559|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
161224059|NCT05568225|582201560|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
161224060|NCT05568225|582201561|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
161224061|NCT05568225|582201559|FG000|Extension Treatment Period|Protocol Violation|0|||
161224062|NCT05568225|582201560|FG001|Extension Treatment Period|Protocol Violation|0|||
161224063|NCT05568225|582201561|FG002|Extension Treatment Period|Protocol Violation|1|||
161224064|NCT05568225|582201559|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161224065|NCT05568225|582201560|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161224066|NCT05568225|582201561|FG002|Extension Treatment Period|Lack of Efficacy|1|||
161224067|NCT01027143|582201564|FG000|Overall Study|Lost to Follow-up|9|||
161224068|NCT01027143|582201565|FG001|Overall Study|Lost to Follow-up|4|||
161224069|NCT03519256|582201574|FG000|Overall Study|Disease recurrence|4|||
161224070|NCT03519256|582201575|FG001|Overall Study|Disease recurrence|4|||
161324441|NCT00320788|582573601|FG000|Overall Study|Physician Decision|1|||
161324442|NCT00320788|582573602|FG001|Overall Study|Physician Decision|1|||
161324443|NCT00320788|582573603|FG002|Overall Study|Physician Decision|0|||
161324444|NCT00320788|582573604|FG003|Overall Study|Physician Decision|0|||
161324445|NCT00320788|582573605|FG004|Overall Study|Physician Decision|0|||
161324446|NCT00320788|582573601|FG000|Overall Study|Protocol Violation|0|||
161324447|NCT00320788|582573602|FG001|Overall Study|Protocol Violation|0|||
161324448|NCT00320788|582573603|FG002|Overall Study|Protocol Violation|0|||
161324449|NCT00320788|582573604|FG003|Overall Study|Protocol Violation|0|||
161324450|NCT00320788|582573605|FG004|Overall Study|Protocol Violation|1|||
161324451|NCT00320788|582573601|FG000|Overall Study|Withdrawal by Subject|3|||
161324452|NCT00320788|582573602|FG001|Overall Study|Withdrawal by Subject|0|||
161324453|NCT00320788|582573603|FG002|Overall Study|Withdrawal by Subject|0|||
161324454|NCT00320788|582573604|FG003|Overall Study|Withdrawal by Subject|3|||
161324455|NCT00320788|582573605|FG004|Overall Study|Withdrawal by Subject|1|||
161324456|NCT04633226|582573607|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161324457|NCT04633226|582573607|FG000|Overall Study|Randomized by mistake without study treatment|1|||
161324458|NCT01398358|582573619|FG000|Overall Study|Lost to Follow-up|11|||
161324459|NCT01398358|582573620|FG001|Overall Study|Lost to Follow-up|21|||
161324460|NCT01398358|582573621|FG002|Overall Study|Lost to Follow-up|18|||
161324461|NCT01398358|582573619|FG000|Overall Study|Withdrawal by Subject|3|||
161324462|NCT01398358|582573620|FG001|Overall Study|Withdrawal by Subject|2|||
161324463|NCT01398358|582573621|FG002|Overall Study|Withdrawal by Subject|2|||
161324464|NCT01398358|582573619|FG000|Overall Study|no longer eligible|1|||
161324465|NCT01398358|582573620|FG001|Overall Study|no longer eligible|0|||
161324466|NCT01398358|582573621|FG002|Overall Study|no longer eligible|1|||
161324467|NCT00003896|582573624|FG000|Overall Study|Adverse Event|16|||
161324468|NCT00003896|582573624|FG000|Overall Study|Withdrawal by Subject|1|||
161324469|NCT00003896|582573624|FG000|Overall Study|Lack of Efficacy|1|||
161324470|NCT00003896|582573624|FG000|Overall Study|Death|3|||
161324471|NCT00003896|582573624|FG000|Overall Study|not protocol specified|3|||
161324472|NCT00003896|582573624|FG000|Overall Study|ineligible|5|||
161324473|NCT02559570|582573627|FG000|Overall Study|Adverse Event|0|||
161324474|NCT02559570|582573628|FG001|Overall Study|Adverse Event|2|||
161324475|NCT02559570|582573629|FG002|Overall Study|Adverse Event|0|||
161324476|NCT02559570|582573630|FG003|Overall Study|Adverse Event|1|||
161324477|NCT02559570|582573631|FG004|Overall Study|Adverse Event|0|||
161324478|NCT02559570|582573627|FG000|Overall Study|Withdrawal of Consent|0|||
161324479|NCT02559570|582573628|FG001|Overall Study|Withdrawal of Consent|0|||
161324480|NCT02559570|582573629|FG002|Overall Study|Withdrawal of Consent|1|||
161324481|NCT02559570|582573630|FG003|Overall Study|Withdrawal of Consent|2|||
161324482|NCT02559570|582573631|FG004|Overall Study|Withdrawal of Consent|1|||
161224071|NCT03519256|582201576|FG002|Overall Study|Disease recurrence|5|||
161324483|NCT02559570|582573627|FG000|Overall Study|Lost to Follow-up|1|||
161324484|NCT02559570|582573628|FG001|Overall Study|Lost to Follow-up|0|||
161324485|NCT02559570|582573629|FG002|Overall Study|Lost to Follow-up|0|||
161324486|NCT02559570|582573630|FG003|Overall Study|Lost to Follow-up|0|||
161324487|NCT02559570|582573631|FG004|Overall Study|Lost to Follow-up|0|||
161324488|NCT02559570|582573627|FG000|Overall Study|Protocol Violation|1|||
161324489|NCT02559570|582573628|FG001|Overall Study|Protocol Violation|0|||
161324490|NCT02559570|582573629|FG002|Overall Study|Protocol Violation|0|||
161224072|NCT03519256|582201577|FG003|Overall Study|Disease recurrence|2|||
161224073|NCT03519256|582201574|FG000|Overall Study|Study drug toxicity|0|||
161224074|NCT03519256|582201575|FG001|Overall Study|Study drug toxicity|2|||
161224075|NCT03519256|582201576|FG002|Overall Study|Study drug toxicity|5|||
161224076|NCT03519256|582201577|FG003|Overall Study|Study drug toxicity|2|||
161224077|NCT03519256|582201574|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161224078|NCT03519256|582201575|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161224079|NCT03519256|582201576|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161224080|NCT03519256|582201577|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161224081|NCT03519256|582201574|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161224082|NCT03519256|582201575|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161224083|NCT03519256|582201576|FG002|Overall Study|Participant request to discontinue study treatment|0|||
161224084|NCT03519256|582201577|FG003|Overall Study|Participant request to discontinue study treatment|2|||
161224085|NCT03519256|582201574|FG000|Overall Study|Other reasons|0|||
161224086|NCT03519256|582201575|FG001|Overall Study|Other reasons|0|||
161224087|NCT03519256|582201576|FG002|Overall Study|Other reasons|2|||
161224088|NCT03519256|582201577|FG003|Overall Study|Other reasons|0|||
161224089|NCT03519256|582201574|FG000|Overall Study|Disease progression|6|||
161224090|NCT03519256|582201575|FG001|Overall Study|Disease progression|3|||
161224091|NCT03519256|582201576|FG002|Overall Study|Disease progression|2|||
161224092|NCT03519256|582201577|FG003|Overall Study|Disease progression|1|||
161224093|NCT03519256|582201574|FG000|Overall Study|Lost to Follow-up|0|||
161224094|NCT03519256|582201575|FG001|Overall Study|Lost to Follow-up|1|||
161224095|NCT03519256|582201576|FG002|Overall Study|Lost to Follow-up|0|||
161224096|NCT03519256|582201577|FG003|Overall Study|Lost to Follow-up|0|||
161224097|NCT02207231|582201578|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
161224098|NCT02207231|582201579|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
161224099|NCT02207231|582201580|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
161224100|NCT02207231|582201581|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
161224101|NCT02207231|582201578|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
161224102|NCT02207231|582201579|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
161224103|NCT02207231|582201580|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
161224104|NCT02207231|582201581|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
161224105|NCT02207231|582201578|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161224106|NCT02207231|582201579|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161224107|NCT02207231|582201580|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
161224108|NCT02207231|582201581|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
161224109|NCT02207231|582201578|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
161224110|NCT02207231|582201579|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
161224111|NCT02207231|582201580|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
161224112|NCT02207231|582201581|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
161224113|NCT02207231|582201578|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161224114|NCT02207231|582201579|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161224115|NCT02207231|582201580|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
161224116|NCT02207231|582201581|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
161224117|NCT02207231|582201578|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
161224118|NCT02207231|582201579|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
161224119|NCT02207231|582201580|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
161224120|NCT02207231|582201581|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
161224121|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
161224122|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
161224123|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
161224124|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
161224125|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161224126|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161224127|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
161224128|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
161224129|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
161224130|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
161224131|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
161224132|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
161224133|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
161224134|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
161224135|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
161224136|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
161224137|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
161224138|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
161224139|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
161224140|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
161224141|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161224142|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
161224143|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161224144|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
161224145|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
161224146|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
161224147|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
161224148|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
161224149|NCT02207231|582201578|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
161224150|NCT02207231|582201579|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
161224151|NCT02207231|582201580|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
161224152|NCT02207231|582201581|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
161224153|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
161224154|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
161224155|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
161224156|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
161224157|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
161224158|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
161224159|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
161224160|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
161224161|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
161224162|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
161224163|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
161224164|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
161224165|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
161224166|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
161224167|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
161224168|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
161224169|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
161224170|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
161224171|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
161224172|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
161224173|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
161224174|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
161224175|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
161224176|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
161224177|NCT02207231|582201578|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
161224178|NCT02207231|582201579|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
161224179|NCT02207231|582201580|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
161224180|NCT02207231|582201581|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
161224181|NCT00421174|582201582|FG000|Overall Study|Withdrawal by Subject|0|||
161224182|NCT00421174|582201583|FG001|Overall Study|Withdrawal by Subject|1|||
161224183|NCT00421174|582201582|FG000|Overall Study|Ineligible due to infection|2|||
161224184|NCT00421174|582201583|FG001|Overall Study|Ineligible due to infection|0|||
161224185|NCT01290263|582201586|FG000|Overall Study|Adverse Event|0|||
161224186|NCT01290263|582201587|FG001|Overall Study|Adverse Event|0|||
161224187|NCT01290263|582201588|FG002|Overall Study|Adverse Event|0|||
161224188|NCT01290263|582201589|FG003|Overall Study|Adverse Event|1|||
161224189|NCT01290263|582201590|FG004|Overall Study|Adverse Event|1|||
161224190|NCT01290263|582201586|FG000|Overall Study|Lack of Efficacy|8|||
161224191|NCT01290263|582201587|FG001|Overall Study|Lack of Efficacy|2|||
161224192|NCT01290263|582201588|FG002|Overall Study|Lack of Efficacy|7|||
161224193|NCT01290263|582201589|FG003|Overall Study|Lack of Efficacy|24|||
161224194|NCT01290263|582201590|FG004|Overall Study|Lack of Efficacy|33|||
161224195|NCT01290263|582201586|FG000|Overall Study|Withdrawal by Subject|3|||
161224196|NCT01290263|582201587|FG001|Overall Study|Withdrawal by Subject|1|||
161224197|NCT01290263|582201588|FG002|Overall Study|Withdrawal by Subject|0|||
161224198|NCT01290263|582201589|FG003|Overall Study|Withdrawal by Subject|1|||
161224199|NCT01290263|582201590|FG004|Overall Study|Withdrawal by Subject|2|||
161224200|NCT01290263|582201586|FG000|Overall Study|Participant Non-Compliance|0|||
161224201|NCT01290263|582201587|FG001|Overall Study|Participant Non-Compliance|0|||
161224202|NCT01290263|582201588|FG002|Overall Study|Participant Non-Compliance|0|||
161224203|NCT01290263|582201589|FG003|Overall Study|Participant Non-Compliance|1|||
161224204|NCT01290263|582201590|FG004|Overall Study|Participant Non-Compliance|1|||
161224205|NCT00576381|582201594|FG000|Overall Study|Reoperation|3|||
161224206|NCT00576381|582201594|FG000|Overall Study|Adverse Event|4|||
161224207|NCT02518113|582201598|FG000|Overall Study|Adverse Event|1|||
161224208|NCT02518113|582201599|FG001|Overall Study|Adverse Event|0|||
161224209|NCT02518113|582201600|FG002|Overall Study|Adverse Event|1|||
161224210|NCT02518113|582201601|FG003|Overall Study|Adverse Event|0|||
161224211|NCT02518113|582201598|FG000|Overall Study|Death|1|||
161224212|NCT02518113|582201599|FG001|Overall Study|Death|2|||
161224213|NCT02518113|582201600|FG002|Overall Study|Death|0|||
161224214|NCT02518113|582201601|FG003|Overall Study|Death|0|||
161224215|NCT02518113|582201598|FG000|Overall Study|Physician Decision|0|||
161224216|NCT02518113|582201599|FG001|Overall Study|Physician Decision|1|||
161224217|NCT02518113|582201600|FG002|Overall Study|Physician Decision|0|||
161224218|NCT02518113|582201601|FG003|Overall Study|Physician Decision|0|||
161224219|NCT02518113|582201598|FG000|Overall Study|Progressive Disease|1|||
161224220|NCT02518113|582201599|FG001|Overall Study|Progressive Disease|2|||
161224221|NCT02518113|582201600|FG002|Overall Study|Progressive Disease|3|||
161224222|NCT02518113|582201601|FG003|Overall Study|Progressive Disease|0|||
161224223|NCT00797108|582201602|FG000|Overall Study|Adverse Event|1|||
161224224|NCT00797108|582201603|FG001|Overall Study|Adverse Event|0|||
161224225|NCT00797108|582201604|FG002|Overall Study|Adverse Event|3|||
161224226|NCT00797108|582201602|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
161224227|NCT00797108|582201603|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
161224228|NCT00797108|582201604|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
161224229|NCT00797108|582201602|FG000|Overall Study|Global Deterioration of Health Status|0|||
161224230|NCT00797108|582201603|FG001|Overall Study|Global Deterioration of Health Status|1|||
161224231|NCT00797108|582201604|FG002|Overall Study|Global Deterioration of Health Status|0|||
161224232|NCT00797108|582201602|FG000|Overall Study|Lack of Efficacy|1|||
161224233|NCT00797108|582201603|FG001|Overall Study|Lack of Efficacy|0|||
161224234|NCT00797108|582201604|FG002|Overall Study|Lack of Efficacy|1|||
161224235|NCT00797108|582201602|FG000|Overall Study|Other|0|||
161224236|NCT00797108|582201603|FG001|Overall Study|Other|0|||
161224237|NCT00797108|582201604|FG002|Overall Study|Other|2|||
161224238|NCT00797108|582201602|FG000|Overall Study|Randomized but not Treated|2|||
161224239|NCT00797108|582201603|FG001|Overall Study|Randomized but not Treated|0|||
161224240|NCT00797108|582201604|FG002|Overall Study|Randomized but not Treated|0|||
161224241|NCT00287118|582201605|FG000|Overall Study|Adverse Event|30|||
161224242|NCT00287118|582201605|FG000|Overall Study|Death|1|||
161224243|NCT00287118|582201605|FG000|Overall Study|Lack of Efficacy|11|||
161224244|NCT00287118|582201605|FG000|Overall Study|Lost to Follow-up|1|||
161224245|NCT00287118|582201605|FG000|Overall Study|Protocol Violation|2|||
161224246|NCT00287118|582201605|FG000|Overall Study|Other|7|||
161224247|NCT02324465|582201606|FG000|Overall Study|device failure|0|||
161224248|NCT02324465|582201607|FG001|Overall Study|device failure|1|||
161224249|NCT01631864|582201608|FG000|Overall Study|Withdrawal by Subject|0|||
161224250|NCT01631864|582201609|FG001|Overall Study|Withdrawal by Subject|1|||
161224251|NCT01631864|582201608|FG000|Overall Study|Adverse Event|2|||
161224252|NCT01631864|582201609|FG001|Overall Study|Adverse Event|3|||
161224253|NCT01031537|582201610|FG000|Overall Study|medical reasons not related to study|3|||
161224254|NCT01031537|582201610|FG000|Overall Study|Lack of Efficacy|1|||
161224255|NCT01031537|582201610|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
161224256|NCT01031537|582201610|FG000|Overall Study|moved, met exclusion criteria|10|||
161224257|NCT01031537|582201610|FG000|Overall Study|Withdrawal by Subject|5|||
161224258|NCT01031537|582201610|FG000|Overall Study|PI removal, no longer met eligibility|12|||
161224259|NCT02187042|582201621|FG000|Overall Study|Death|1|||
161224260|NCT02187042|582201622|FG001|Overall Study|Death|1|||
161224261|NCT02187042|582201621|FG000|Overall Study|Toxicity|6|||
161224262|NCT02187042|582201622|FG001|Overall Study|Toxicity|5|||
161224263|NCT02187042|582201621|FG000|Overall Study|Participant choice|1|||
161224264|NCT02187042|582201622|FG001|Overall Study|Participant choice|0|||
161224265|NCT02187042|582201621|FG000|Overall Study|Doctor choice|1|||
161224266|NCT02187042|582201622|FG001|Overall Study|Doctor choice|0|||
161224267|NCT02187042|582201621|FG000|Overall Study|Progressive disease|4|||
161224268|NCT02187042|582201622|FG001|Overall Study|Progressive disease|8|||
161224269|NCT01766921|582201627|FG000|Overall Study|Administrative Reason|5|||
161224270|NCT01766921|582201628|FG001|Overall Study|Administrative Reason|5|||
161224271|NCT01766921|582201627|FG000|Overall Study|Death|1|||
161224272|NCT01766921|582201628|FG001|Overall Study|Death|1|||
161224273|NCT01766921|582201627|FG000|Overall Study|Lost to Follow-up|1|||
161224274|NCT01766921|582201628|FG001|Overall Study|Lost to Follow-up|3|||
161224275|NCT01766921|582201627|FG000|Overall Study|Unclassified|2|||
161224276|NCT01766921|582201628|FG001|Overall Study|Unclassified|2|||
161224277|NCT01766921|582201627|FG000|Overall Study|Protocol Violation|1|||
161224278|NCT01766921|582201628|FG001|Overall Study|Protocol Violation|1|||
161224279|NCT01766921|582201627|FG000|Overall Study|Withdrawal by Subject|14|||
161224280|NCT01766921|582201628|FG001|Overall Study|Withdrawal by Subject|5|||
161224281|NCT00386009|582201629|FG000|Overall Study|Adverse Event|0|||
161224282|NCT00386009|582201630|FG001|Overall Study|Adverse Event|2|||
161224283|NCT00386009|582201629|FG000|Overall Study|Death|1|||
161224284|NCT00386009|582201630|FG001|Overall Study|Death|0|||
161224285|NCT00386009|582201629|FG000|Overall Study|Entry Criteria Not Met|0|||
161224286|NCT00386009|582201630|FG001|Overall Study|Entry Criteria Not Met|2|||
161224287|NCT00386009|582201629|FG000|Overall Study|Lost to Follow-up|1|||
161224288|NCT00386009|582201630|FG001|Overall Study|Lost to Follow-up|1|||
161224289|NCT00386009|582201629|FG000|Overall Study|Protocol Violation|1|||
161224290|NCT00386009|582201630|FG001|Overall Study|Protocol Violation|0|||
161224291|NCT00386009|582201629|FG000|Overall Study|Sponsor Decision|1|||
161224292|NCT00386009|582201630|FG001|Overall Study|Sponsor Decision|1|||
161224293|NCT00386009|582201629|FG000|Overall Study|Withdrawal by Subject|5|||
161224294|NCT00386009|582201630|FG001|Overall Study|Withdrawal by Subject|4|||
161224295|NCT02549495|582201634|FG000|Overall Study|Death|2|||
160874595|NCT05091567|580935567|FG002|Enrollment Phase|Physician Decision|0|||
161224296|NCT02549495|582201634|FG000|Overall Study|Withdrawal by Subject|5|||
161224297|NCT02549495|582201634|FG000|Overall Study|Physician Decision|22|||
161224298|NCT02549495|582201634|FG000|Overall Study|Lost to Follow-up|6|||
161224299|NCT02549495|582201634|FG000|Overall Study|Protocol Violation|6|||
161224300|NCT05876091|582201637|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
161224301|NCT03402893|582201638|FG000|Overall Study|Withdrawal by Subject|1|||
161224302|NCT03462719|582201639|FG000|Overall Study|Withdrawal by Subject|4|||
161224303|NCT03462719|582201640|FG001|Overall Study|Withdrawal by Subject|3|||
161224304|NCT03462719|582201639|FG000|Overall Study|Ongoing|87|||
161224305|NCT03462719|582201640|FG001|Overall Study|Ongoing|72|||
161224306|NCT04799158|582201641|FG000|Run-In Period|Adverse Event|6|||
161224307|NCT04799158|582201642|FG001|Run-In Period|Adverse Event|0|||
161224308|NCT04799158|582201643|FG002|Run-In Period|Adverse Event|0|||
161224309|NCT04799158|582201644|FG003|Run-In Period|Adverse Event|0|||
161224310|NCT04799158|582201645|FG004|Run-In Period|Adverse Event|0|||
161224311|NCT04799158|582201641|FG000|Run-In Period|Lost to Follow-up|4|||
161224312|NCT04799158|582201642|FG001|Run-In Period|Lost to Follow-up|0|||
161224313|NCT04799158|582201643|FG002|Run-In Period|Lost to Follow-up|0|||
161224314|NCT04799158|582201644|FG003|Run-In Period|Lost to Follow-up|0|||
161224315|NCT04799158|582201645|FG004|Run-In Period|Lost to Follow-up|0|||
161224316|NCT04799158|582201641|FG000|Run-In Period|Significant Protocol Deviation|1|||
161224317|NCT04799158|582201642|FG001|Run-In Period|Significant Protocol Deviation|0|||
161224318|NCT04799158|582201643|FG002|Run-In Period|Significant Protocol Deviation|0|||
161224319|NCT04799158|582201644|FG003|Run-In Period|Significant Protocol Deviation|0|||
161224320|NCT04799158|582201645|FG004|Run-In Period|Significant Protocol Deviation|0|||
161224321|NCT04799158|582201641|FG000|Run-In Period|Withdrawal by Subject|11|||
161224322|NCT04799158|582201642|FG001|Run-In Period|Withdrawal by Subject|0|||
161224323|NCT04799158|582201643|FG002|Run-In Period|Withdrawal by Subject|0|||
161224324|NCT04799158|582201644|FG003|Run-In Period|Withdrawal by Subject|0|||
161224325|NCT04799158|582201645|FG004|Run-In Period|Withdrawal by Subject|0|||
161224326|NCT04799158|582201641|FG000|Run-In Period|Miscellaneous|3|||
161224327|NCT04799158|582201642|FG001|Run-In Period|Miscellaneous|0|||
161224328|NCT04799158|582201643|FG002|Run-In Period|Miscellaneous|0|||
161224329|NCT04799158|582201644|FG003|Run-In Period|Miscellaneous|0|||
161224330|NCT04799158|582201645|FG004|Run-In Period|Miscellaneous|0|||
161224331|NCT04799158|582201641|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
161224332|NCT04799158|582201642|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161224333|NCT04799158|582201643|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161224334|NCT04799158|582201644|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161224335|NCT04799158|582201645|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
161224336|NCT04799158|582201641|FG000|On-Demand Treatment Period|Adverse Event|0|||
161224337|NCT04799158|582201642|FG001|On-Demand Treatment Period|Adverse Event|1|||
161224338|NCT04799158|582201643|FG002|On-Demand Treatment Period|Adverse Event|0|||
161224339|NCT04799158|582201644|FG003|On-Demand Treatment Period|Adverse Event|0|||
161224340|NCT04799158|582201645|FG004|On-Demand Treatment Period|Adverse Event|1|||
161224341|NCT04799158|582201641|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
161224342|NCT04799158|582201642|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
161224343|NCT04799158|582201643|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
161224344|NCT04799158|582201644|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
161224345|NCT04799158|582201645|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
161224346|NCT04799158|582201641|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161224347|NCT04799158|582201642|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161224348|NCT04799158|582201643|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161224349|NCT04799158|582201644|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
161224350|NCT04799158|582201645|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
161224351|NCT04799158|582201641|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
161324491|NCT02559570|582573630|FG003|Overall Study|Protocol Violation|0|||
161224352|NCT04799158|582201642|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
161224353|NCT04799158|582201643|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
161224354|NCT04799158|582201644|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
161224355|NCT04799158|582201645|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
161224356|NCT04799158|582201641|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
161224357|NCT04799158|582201642|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
161224358|NCT04799158|582201643|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
161224359|NCT04799158|582201644|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
161224360|NCT04799158|582201645|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
161224361|NCT04799158|582201641|FG000|On-Demand Treatment Period|Miscellaneous|0|||
161224362|NCT04799158|582201642|FG001|On-Demand Treatment Period|Miscellaneous|0|||
161224363|NCT04799158|582201643|FG002|On-Demand Treatment Period|Miscellaneous|0|||
161224364|NCT04799158|582201644|FG003|On-Demand Treatment Period|Miscellaneous|0|||
161224365|NCT04799158|582201645|FG004|On-Demand Treatment Period|Miscellaneous|1|||
161224366|NCT00679783|582201650|FG000|Overall Study|Adverse Event|0|||
161224367|NCT00679783|582201651|FG001|Overall Study|Adverse Event|0|||
161224368|NCT00679783|582201652|FG002|Overall Study|Adverse Event|0|||
161224369|NCT00679783|582201653|FG003|Overall Study|Adverse Event|3|||
161224370|NCT00679783|582201654|FG004|Overall Study|Adverse Event|0|||
161224371|NCT00679783|582201655|FG005|Overall Study|Adverse Event|0|||
161224372|NCT00679783|582201656|FG006|Overall Study|Adverse Event|1|||
161224373|NCT00679783|582201650|FG000|Overall Study|Lack of Efficacy|0|||
161224374|NCT00679783|582201651|FG001|Overall Study|Lack of Efficacy|1|||
161224375|NCT00679783|582201652|FG002|Overall Study|Lack of Efficacy|0|||
161224376|NCT00679783|582201653|FG003|Overall Study|Lack of Efficacy|2|||
161224377|NCT00679783|582201654|FG004|Overall Study|Lack of Efficacy|0|||
161224378|NCT00679783|582201655|FG005|Overall Study|Lack of Efficacy|0|||
161224379|NCT00679783|582201656|FG006|Overall Study|Lack of Efficacy|0|||
161224380|NCT00679783|582201650|FG000|Overall Study|Withdrawal by Subject|0|||
161224381|NCT00679783|582201651|FG001|Overall Study|Withdrawal by Subject|0|||
161224382|NCT00679783|582201652|FG002|Overall Study|Withdrawal by Subject|1|||
161224383|NCT00679783|582201653|FG003|Overall Study|Withdrawal by Subject|1|||
161224384|NCT00679783|582201654|FG004|Overall Study|Withdrawal by Subject|0|||
161224385|NCT00679783|582201655|FG005|Overall Study|Withdrawal by Subject|0|||
161224386|NCT00679783|582201656|FG006|Overall Study|Withdrawal by Subject|0|||
161224387|NCT00679783|582201650|FG000|Overall Study|Not Captured|0|||
161224388|NCT00679783|582201651|FG001|Overall Study|Not Captured|0|||
161224389|NCT00679783|582201652|FG002|Overall Study|Not Captured|0|||
161224390|NCT00679783|582201653|FG003|Overall Study|Not Captured|5|||
161224391|NCT00679783|582201654|FG004|Overall Study|Not Captured|0|||
161224392|NCT00679783|582201655|FG005|Overall Study|Not Captured|0|||
161224393|NCT00679783|582201656|FG006|Overall Study|Not Captured|0|||
161224394|NCT00679783|582201650|FG000|Overall Study|Ongoing at data cut-off|2|||
161224395|NCT00679783|582201651|FG001|Overall Study|Ongoing at data cut-off|2|||
161224396|NCT00679783|582201652|FG002|Overall Study|Ongoing at data cut-off|0|||
161224397|NCT00679783|582201653|FG003|Overall Study|Ongoing at data cut-off|9|||
161224398|NCT00679783|582201654|FG004|Overall Study|Ongoing at data cut-off|1|||
161224399|NCT00679783|582201655|FG005|Overall Study|Ongoing at data cut-off|0|||
161224400|NCT00679783|582201656|FG006|Overall Study|Ongoing at data cut-off|0|||
161224401|NCT01485536|582201657|FG000|Overall Study|Withdrawal by Subject|3|||
161224402|NCT01485536|582201657|FG000|Overall Study|Adverse Event|1|||
161224403|NCT02626949|582201658|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
161224404|NCT02626949|582201659|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
161224405|NCT02626949|582201658|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
161224406|NCT02626949|582201659|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
161224407|NCT02626949|582201658|FG000|Enrolled|Lost to Follow-up|7|||
161224408|NCT02626949|582201659|FG001|Enrolled|Lost to Follow-up|6|||
161224409|NCT02626949|582201658|FG000|Enrolled|Withdrawal by Subject|3|||
161224410|NCT02626949|582201659|FG001|Enrolled|Withdrawal by Subject|2|||
161224411|NCT00601484|582201660|FG000|Overall Study|Adverse Event|0|||
161324492|NCT02559570|582573631|FG004|Overall Study|Protocol Violation|1|||
161324493|NCT02559570|582573627|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161224412|NCT00601484|582201661|FG001|Overall Study|Adverse Event|1|||
161224413|NCT00601484|582201660|FG000|Overall Study|Lost to Follow-up|4|||
161224414|NCT00601484|582201661|FG001|Overall Study|Lost to Follow-up|3|||
161224415|NCT00601484|582201660|FG000|Overall Study|Lack of Efficacy|0|||
161224416|NCT00601484|582201661|FG001|Overall Study|Lack of Efficacy|2|||
161224417|NCT00601484|582201660|FG000|Overall Study|Withdrawal by Subject|1|||
161224418|NCT00601484|582201661|FG001|Overall Study|Withdrawal by Subject|1|||
161224419|NCT00601484|582201660|FG000|Overall Study|Randomized, but not treated|0|||
161224420|NCT00601484|582201661|FG001|Overall Study|Randomized, but not treated|1|||
161224421|NCT02779855|582201662|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
161224422|NCT02779855|582201663|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
160874596|NCT05091567|580935565|FG000|Enrollment Phase|Protocol Violation|2|||
160874597|NCT05091567|580935566|FG001|Enrollment Phase|Protocol Violation|0|||
160874598|NCT05091567|580935567|FG002|Enrollment Phase|Protocol Violation|0|||
160874599|NCT05091567|580935565|FG000|Enrollment Phase|Reason not Specified|1|||
160874600|NCT05091567|580935566|FG001|Enrollment Phase|Reason not Specified|0|||
160874601|NCT05091567|580935567|FG002|Enrollment Phase|Reason not Specified|0|||
160874602|NCT05091567|580935565|FG000|Randomized Phase|Death|0|||
160874603|NCT05091567|580935566|FG001|Randomized Phase|Death|135|||
160874604|NCT05091567|580935567|FG002|Randomized Phase|Death|112|||
160874605|NCT05091567|580935565|FG000|Randomized Phase|Progressive Disease|0|||
160874606|NCT05091567|580935566|FG001|Randomized Phase|Progressive Disease|2|||
160874607|NCT05091567|580935567|FG002|Randomized Phase|Progressive Disease|0|||
160874608|NCT05091567|580935565|FG000|Randomized Phase|Withdrawal by Subject|0|||
160874609|NCT05091567|580935566|FG001|Randomized Phase|Withdrawal by Subject|1|||
160874610|NCT05091567|580935567|FG002|Randomized Phase|Withdrawal by Subject|3|||
160874611|NCT05091567|580935565|FG000|Randomized Phase|Lost to Follow-up|0|||
160874612|NCT05091567|580935566|FG001|Randomized Phase|Lost to Follow-up|1|||
160874613|NCT05091567|580935567|FG002|Randomized Phase|Lost to Follow-up|1|||
160874614|NCT05091567|580935565|FG000|Randomized Phase|Ongoing in Study|0|||
160874615|NCT05091567|580935566|FG001|Randomized Phase|Ongoing in Study|102|||
160874616|NCT05091567|580935567|FG002|Randomized Phase|Ongoing in Study|126|||
160874617|NCT01696929|580935568|FG000|Overall Study|Physician Decision|1|||
160874618|NCT01129583|580935569|FG000|Overall Study|Death|1|||
160874619|NCT01129583|580935570|FG001|Overall Study|Death|0|||
160874620|NCT01129583|580935569|FG000|Overall Study|Lost to Follow-up|1|||
160874621|NCT01129583|580935570|FG001|Overall Study|Lost to Follow-up|1|||
160874622|NCT01129583|580935569|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
160874623|NCT01129583|580935570|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
160874624|NCT02891070|580935576|FG000|Overall Study|Adverse Event|1|||
160874625|NCT02891070|580935577|FG001|Overall Study|Adverse Event|0|||
160874626|NCT02891070|580935576|FG000|Overall Study|Physician Decision|0|||
160874627|NCT02891070|580935577|FG001|Overall Study|Physician Decision|1|||
160874628|NCT02891070|580935576|FG000|Overall Study|Lost to Follow-up|4|||
160874629|NCT02891070|580935577|FG001|Overall Study|Lost to Follow-up|4|||
160874630|NCT02891070|580935576|FG000|Overall Study|Other|1|||
160874631|NCT02891070|580935577|FG001|Overall Study|Other|0|||
160874632|NCT02891070|580935576|FG000|Overall Study|Protocol Violation|0|||
160874633|NCT02891070|580935577|FG001|Overall Study|Protocol Violation|1|||
160874634|NCT02891070|580935576|FG000|Overall Study|Withdrawal by Subject|1|||
160874635|NCT02891070|580935577|FG001|Overall Study|Withdrawal by Subject|2|||
160874636|NCT02891070|580935576|FG000|Overall Study|Death|3|||
160874637|NCT02891070|580935577|FG001|Overall Study|Death|0|||
160874638|NCT02704143|580935578|FG000|Overall Study|disease progression|10|||
160874639|NCT01235598|580935581|FG000|Overall Study|Adverse Event|0|||
160874640|NCT01235598|580935582|FG001|Overall Study|Adverse Event|3|||
160874641|NCT01235598|580935581|FG000|Overall Study|Lack of Efficacy|0|||
160874642|NCT01235598|580935582|FG001|Overall Study|Lack of Efficacy|1|||
160874643|NCT01235598|580935581|FG000|Overall Study|Withdrawal by Subject|1|||
160874644|NCT01235598|580935582|FG001|Overall Study|Withdrawal by Subject|0|||
160874645|NCT02551991|580935583|FG000|Overall Study|Death|5|||
160874646|NCT02551991|580935584|FG001|Overall Study|Death|7|||
160874647|NCT02551991|580935585|FG002|Overall Study|Death|8|||
160874648|NCT02551991|580935586|FG003|Overall Study|Death|7|||
160874649|NCT02551991|580935587|FG004|Overall Study|Death|17|||
160874650|NCT02551991|580935583|FG000|Overall Study|Withdrawal by Subject|1|||
160874651|NCT02551991|580935584|FG001|Overall Study|Withdrawal by Subject|0|||
160874652|NCT02551991|580935585|FG002|Overall Study|Withdrawal by Subject|0|||
161119426|NCT03215030|581825904|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
161119427|NCT03215030|581825905|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
161119428|NCT03215030|581825906|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
161119429|NCT03215030|581825895|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119430|NCT03215030|581825896|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119431|NCT03215030|581825897|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119432|NCT03215030|581825898|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119433|NCT03215030|581825899|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119434|NCT03215030|581825900|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119435|NCT03215030|581825901|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160874653|NCT02551991|580935586|FG003|Overall Study|Withdrawal by Subject|0|||
161119436|NCT03215030|581825902|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119437|NCT03215030|581825903|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
161119438|NCT03215030|581825904|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
161119439|NCT03215030|581825905|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
160874654|NCT02551991|580935587|FG004|Overall Study|Withdrawal by Subject|2|||
160874655|NCT02551991|580935583|FG000|Overall Study|Lost to Follow-up|0|||
160874656|NCT02551991|580935584|FG001|Overall Study|Lost to Follow-up|0|||
160874657|NCT02551991|580935585|FG002|Overall Study|Lost to Follow-up|1|||
160874658|NCT02551991|580935586|FG003|Overall Study|Lost to Follow-up|0|||
160874659|NCT02551991|580935587|FG004|Overall Study|Lost to Follow-up|0|||
160874660|NCT02551991|580935583|FG000|Overall Study|Sponsor Decision|1|||
160874661|NCT02551991|580935584|FG001|Overall Study|Sponsor Decision|0|||
160874662|NCT02551991|580935585|FG002|Overall Study|Sponsor Decision|1|||
160874663|NCT02551991|580935586|FG003|Overall Study|Sponsor Decision|0|||
160874664|NCT02551991|580935587|FG004|Overall Study|Sponsor Decision|5|||
160874665|NCT02551991|580935583|FG000|Overall Study|Other|0|||
160874666|NCT02551991|580935584|FG001|Overall Study|Other|0|||
160874667|NCT02551991|580935585|FG002|Overall Study|Other|0|||
160874668|NCT02551991|580935586|FG003|Overall Study|Other|0|||
160874669|NCT02551991|580935587|FG004|Overall Study|Other|1|||
160874670|NCT00395343|580935588|FG000|Overall Study|Adverse Event|13|||
160874671|NCT00395343|580935589|FG001|Overall Study|Adverse Event|5|||
160874672|NCT00395343|580935588|FG000|Overall Study|Lack of Efficacy|0|||
160874673|NCT00395343|580935589|FG001|Overall Study|Lack of Efficacy|1|||
160874674|NCT00395343|580935588|FG000|Overall Study|Lost to Follow-up|4|||
160874675|NCT00395343|580935589|FG001|Overall Study|Lost to Follow-up|4|||
160874676|NCT00395343|580935588|FG000|Overall Study|Physician Decision|2|||
160874677|NCT00395343|580935589|FG001|Overall Study|Physician Decision|4|||
160874678|NCT00395343|580935588|FG000|Overall Study|Protocol Violation|6|||
160874679|NCT00395343|580935589|FG001|Overall Study|Protocol Violation|8|||
160874680|NCT00395343|580935588|FG000|Overall Study|Withdrawal by Subject|11|||
160874681|NCT00395343|580935589|FG001|Overall Study|Withdrawal by Subject|12|||
160874682|NCT00395343|580935588|FG000|Overall Study|Other|5|||
160874683|NCT00395343|580935589|FG001|Overall Study|Other|2|||
160874684|NCT00942994|580935593|FG000|Overall Study|Adverse Event|7|||
160874685|NCT00942994|580935594|FG001|Overall Study|Adverse Event|4|||
160874686|NCT00942994|580935593|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160874687|NCT00942994|580935594|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160874688|NCT00942994|580935593|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160874689|NCT00942994|580935594|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160874690|NCT00942994|580935593|FG000|Overall Study|Patient withdrew consent|5|||
160874691|NCT00942994|580935594|FG001|Overall Study|Patient withdrew consent|8|||
160874692|NCT00942994|580935593|FG000|Overall Study|Lost to Follow-up|1|||
161119440|NCT03215030|581825906|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
161119441|NCT03215030|581825895|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119442|NCT03215030|581825896|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119443|NCT03215030|581825897|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119444|NCT03215030|581825898|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119445|NCT03215030|581825899|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119446|NCT03215030|581825900|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119447|NCT03215030|581825901|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119448|NCT03215030|581825902|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119449|NCT03215030|581825903|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
161119450|NCT03215030|581825904|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
161119451|NCT03215030|581825905|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119452|NCT03215030|581825906|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
161119453|NCT03215030|581825895|FG000|Part 3: Dose Extension|Death|0|||
161119454|NCT03215030|581825896|FG001|Part 3: Dose Extension|Death|0|||
161119455|NCT03215030|581825897|FG002|Part 3: Dose Extension|Death|0|||
161119456|NCT03215030|581825898|FG003|Part 3: Dose Extension|Death|0|||
161119457|NCT03215030|581825899|FG004|Part 3: Dose Extension|Death|0|||
161119458|NCT03215030|581825900|FG005|Part 3: Dose Extension|Death|0|||
161119459|NCT03215030|581825901|FG006|Part 3: Dose Extension|Death|0|||
161119460|NCT03215030|581825902|FG007|Part 3: Dose Extension|Death|0|||
161119461|NCT03215030|581825903|FG008|Part 3: Dose Extension|Death|19|||
161119462|NCT03215030|581825904|FG009|Part 3: Dose Extension|Death|20|||
161119463|NCT03215030|581825905|FG010|Part 3: Dose Extension|Death|0|||
161119464|NCT03215030|581825906|FG011|Part 3: Dose Extension|Death|0|||
161119465|NCT03215030|581825895|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
161119466|NCT03215030|581825896|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
161119467|NCT03215030|581825897|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
161119468|NCT03215030|581825898|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
161119469|NCT03215030|581825899|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
161119470|NCT03215030|581825900|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
161119471|NCT03215030|581825901|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
161119472|NCT03215030|581825902|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
161119473|NCT03215030|581825903|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
161119474|NCT03215030|581825904|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
161119475|NCT03215030|581825905|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
161119476|NCT03215030|581825906|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
161119477|NCT03215030|581825895|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119478|NCT03215030|581825896|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119479|NCT03215030|581825897|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119480|NCT03215030|581825898|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119481|NCT03215030|581825899|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161224423|NCT02779855|582201664|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
161224424|NCT00462982|582201677|FG000|Overall Study|Adverse Event|1|||
161224425|NCT00462982|582201677|FG000|Overall Study|Patient Not Treated|2|||
161224426|NCT05665595|582203401|FG000|Overall Study|Ongoing|692|||
161224427|NCT05665595|582203402|FG001|Overall Study|Ongoing|698|||
161224428|NCT05665595|582203401|FG000|Overall Study|Withdrawal by Subject|2|||
161224429|NCT05665595|582203402|FG001|Overall Study|Withdrawal by Subject|2|||
161224430|NCT05665595|582203401|FG000|Overall Study|Lost to Follow-up|1|||
161224431|NCT05665595|582203402|FG001|Overall Study|Lost to Follow-up|0|||
161224432|NCT05665595|582203401|FG000|Overall Study|Death|6|||
161224433|NCT05665595|582203402|FG001|Overall Study|Death|1|||
161224434|NCT02581345|582203403|FG000|Part 1: up to Week 16|Adverse Event|3|||
161224435|NCT02581345|582203404|FG001|Part 1: up to Week 16|Adverse Event|8|||
161224436|NCT02581345|582203405|FG002|Part 1: up to Week 16|Adverse Event|0|||
161224437|NCT02581345|582203406|FG003|Part 1: up to Week 16|Adverse Event|0|||
161224438|NCT02581345|582203403|FG000|Part 1: up to Week 16|Physician Decision|2|||
161224439|NCT02581345|582203404|FG001|Part 1: up to Week 16|Physician Decision|4|||
161224440|NCT02581345|582203405|FG002|Part 1: up to Week 16|Physician Decision|0|||
161224441|NCT02581345|582203406|FG003|Part 1: up to Week 16|Physician Decision|0|||
161224442|NCT02581345|582203403|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
161224443|NCT02581345|582203404|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
161224444|NCT02581345|582203405|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
161224445|NCT02581345|582203406|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
161224446|NCT02581345|582203403|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
161224447|NCT02581345|582203404|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
161224448|NCT02581345|582203405|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
161224449|NCT02581345|582203406|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
160874693|NCT00942994|580935594|FG001|Overall Study|Lost to Follow-up|4|||
161224450|NCT02581345|582203403|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
161224451|NCT02581345|582203404|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
161224452|NCT02581345|582203405|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
161224453|NCT02581345|582203406|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
161224454|NCT02581345|582203403|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
161224455|NCT02581345|582203404|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
161224456|NCT02581345|582203405|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
161224457|NCT02581345|582203406|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
161224458|NCT02581345|582203403|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
161224459|NCT02581345|582203404|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
161224460|NCT02581345|582203405|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
161224461|NCT02581345|582203406|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
161224462|NCT02581345|582203403|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
160874694|NCT00942994|580935593|FG000|Overall Study|Protocol deviation|1|||
160874695|NCT00942994|580935594|FG001|Overall Study|Protocol deviation|2|||
160874696|NCT04491604|580935595|FG000|Overall Study|Withdrawal by Subject|3|||
160874697|NCT01874340|580935598|FG000|Overall Study|Study terminated by Sponsor|6|||
160874698|NCT01874340|580935599|FG001|Overall Study|Study terminated by Sponsor|8|||
160874699|NCT01874340|580935600|FG002|Overall Study|Study terminated by Sponsor|8|||
160874700|NCT01874340|580935601|FG003|Overall Study|Study terminated by Sponsor|4|||
160874701|NCT01874340|580935598|FG000|Overall Study|Withdrawal by Subject|0|||
160874702|NCT01874340|580935599|FG001|Overall Study|Withdrawal by Subject|0|||
160874703|NCT01874340|580935600|FG002|Overall Study|Withdrawal by Subject|0|||
160874704|NCT01874340|580935601|FG003|Overall Study|Withdrawal by Subject|1|||
160874705|NCT00689117|580935605|FG000|Overall Study|Adverse Event|6|||
160874706|NCT00689117|580935606|FG001|Overall Study|Adverse Event|0|||
160874707|NCT00689117|580935607|FG002|Overall Study|Adverse Event|5|||
160874708|NCT00689117|580935608|FG003|Overall Study|Adverse Event|0|||
160874709|NCT00689117|580935605|FG000|Overall Study|Lost to Follow-up|26|||
160874710|NCT00689117|580935606|FG001|Overall Study|Lost to Follow-up|19|||
160874711|NCT00689117|580935607|FG002|Overall Study|Lost to Follow-up|17|||
160874712|NCT00689117|580935608|FG003|Overall Study|Lost to Follow-up|11|||
160874713|NCT00689117|580935605|FG000|Overall Study|Lack of Efficacy|1|||
160874714|NCT00689117|580935606|FG001|Overall Study|Lack of Efficacy|2|||
160874715|NCT00689117|580935607|FG002|Overall Study|Lack of Efficacy|2|||
160874716|NCT00689117|580935608|FG003|Overall Study|Lack of Efficacy|2|||
160874717|NCT00689117|580935605|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
160874718|NCT00689117|580935606|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
161224463|NCT02581345|582203404|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
161224464|NCT02581345|582203405|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
161224465|NCT02581345|582203406|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
161224466|NCT02581345|582203403|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
161224467|NCT02581345|582203404|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
161224468|NCT02581345|582203405|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
161224469|NCT02581345|582203406|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
161224470|NCT02581345|582203403|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
161224471|NCT02581345|582203404|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
160874719|NCT00689117|580935607|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
160874720|NCT00689117|580935608|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
160874721|NCT00689117|580935605|FG000|Overall Study|Withdrawal by Subject|19|||
160874722|NCT00689117|580935606|FG001|Overall Study|Withdrawal by Subject|18|||
160874723|NCT00689117|580935607|FG002|Overall Study|Withdrawal by Subject|26|||
160874724|NCT00689117|580935608|FG003|Overall Study|Withdrawal by Subject|13|||
160874725|NCT00689117|580935605|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
160874726|NCT00689117|580935606|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
160874727|NCT00689117|580935607|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
160874728|NCT00689117|580935608|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
160874729|NCT00689117|580935605|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160874730|NCT00689117|580935606|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
160874731|NCT00689117|580935607|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160874732|NCT00689117|580935608|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160874733|NCT00689117|580935605|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
160874734|NCT00689117|580935606|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
160874735|NCT00689117|580935607|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
160874736|NCT00689117|580935608|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
160874737|NCT00689117|580935605|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
160874738|NCT00689117|580935606|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
160874739|NCT00689117|580935607|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
160874740|NCT00689117|580935608|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
160874741|NCT00689117|580935605|FG000|Overall Study|Use of Prohibitive Medication|2|||
160874742|NCT00689117|580935606|FG001|Overall Study|Use of Prohibitive Medication|1|||
160874743|NCT00689117|580935607|FG002|Overall Study|Use of Prohibitive Medication|3|||
160874744|NCT00689117|580935608|FG003|Overall Study|Use of Prohibitive Medication|0|||
160874745|NCT00689117|580935605|FG000|Overall Study|Pregnancy|0|||
160874746|NCT00689117|580935606|FG001|Overall Study|Pregnancy|2|||
160874747|NCT00689117|580935607|FG002|Overall Study|Pregnancy|0|||
160874748|NCT00689117|580935608|FG003|Overall Study|Pregnancy|2|||
160874749|NCT00689117|580935605|FG000|Overall Study|Incarceration|2|||
160874750|NCT00689117|580935606|FG001|Overall Study|Incarceration|0|||
160874751|NCT00689117|580935607|FG002|Overall Study|Incarceration|0|||
160874752|NCT00689117|580935608|FG003|Overall Study|Incarceration|0|||
160874753|NCT00689117|580935605|FG000|Overall Study|Fear of Birth Defects|0|||
160874754|NCT00689117|580935606|FG001|Overall Study|Fear of Birth Defects|0|||
160874755|NCT00689117|580935607|FG002|Overall Study|Fear of Birth Defects|1|||
160874756|NCT00689117|580935608|FG003|Overall Study|Fear of Birth Defects|0|||
160874757|NCT00689117|580935605|FG000|Overall Study|Transportation|1|||
160874758|NCT00689117|580935606|FG001|Overall Study|Transportation|0|||
160874759|NCT00689117|580935607|FG002|Overall Study|Transportation|0|||
160874760|NCT00689117|580935608|FG003|Overall Study|Transportation|0|||
160874761|NCT00689117|580935605|FG000|Overall Study|Patient Withdrew from Study|0|||
160874762|NCT00689117|580935606|FG001|Overall Study|Patient Withdrew from Study|0|||
160874763|NCT00689117|580935607|FG002|Overall Study|Patient Withdrew from Study|0|||
160874764|NCT00689117|580935608|FG003|Overall Study|Patient Withdrew from Study|1|||
160874765|NCT00689117|580935605|FG000|Overall Study|Personal Reason|0|||
160874766|NCT00689117|580935606|FG001|Overall Study|Personal Reason|1|||
160874767|NCT00689117|580935607|FG002|Overall Study|Personal Reason|0|||
160874768|NCT00689117|580935608|FG003|Overall Study|Personal Reason|0|||
160874769|NCT00689117|580935605|FG000|Overall Study|Dispensing Error|0|||
160874770|NCT00689117|580935606|FG001|Overall Study|Dispensing Error|1|||
160874771|NCT00689117|580935607|FG002|Overall Study|Dispensing Error|0|||
160874772|NCT00689117|580935608|FG003|Overall Study|Dispensing Error|0|||
160874773|NCT01536067|580935610|FG000|Overall Study|Disease Progression|1|||
160874774|NCT02597478|580935611|FG000|Overall Study|Withdrawal by Subject|2|||
160874775|NCT02597478|580935612|FG001|Overall Study|Withdrawal by Subject|0|||
160874776|NCT02597478|580935611|FG000|Overall Study|Change of opioid dose|1|||
160874777|NCT02597478|580935612|FG001|Overall Study|Change of opioid dose|0|||
160874778|NCT02597478|580935611|FG000|Overall Study|Insufficient exertional dyspnea|0|||
160874779|NCT02597478|580935612|FG001|Overall Study|Insufficient exertional dyspnea|1|||
160874780|NCT02386189|580935615|FG000|Overall Study|Lost to Follow-up|2|||
160874781|NCT02386189|580935616|FG001|Overall Study|Lost to Follow-up|3|||
160874782|NCT02386189|580935615|FG000|Overall Study|Withdrawal by Subject|1|||
160874783|NCT02386189|580935616|FG001|Overall Study|Withdrawal by Subject|0|||
160874784|NCT02386189|580935615|FG000|Overall Study|Death|1|||
160874785|NCT02386189|580935616|FG001|Overall Study|Death|0|||
160874786|NCT04657666|580935617|FG000|Period 1|Withdrawal of participant consent|2|||
160874787|NCT04657666|580935618|FG001|Period 1|Withdrawal of participant consent|1|||
160874788|NCT04657666|580935617|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
160874789|NCT04657666|580935618|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
160874790|NCT04657666|580935617|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
160874791|NCT04657666|580935618|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
160874792|NCT04657666|580935617|FG000|Period 2|Other|2|||
160874793|NCT04657666|580935618|FG001|Period 2|Other|0|||
160874794|NCT04657666|580935617|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
160874795|NCT04657666|580935618|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
160874796|NCT00606905|580935619|FG000|Overall Study|No Pregnancy|9|||
160874797|NCT00606905|580935620|FG001|Overall Study|No Pregnancy|6|||
160874798|NCT00606905|580935619|FG000|Overall Study|Non-Index Pregnancy|1|||
160874799|NCT00606905|580935620|FG001|Overall Study|Non-Index Pregnancy|4|||
160874800|NCT00606905|580935619|FG000|Overall Study|Withdrew|5|||
160874801|NCT00606905|580935620|FG001|Overall Study|Withdrew|5|||
160874802|NCT03120351|580935622|FG000|Overall Study|Physician Decision|1|||
160874803|NCT03120351|580935623|FG001|Overall Study|Physician Decision|1|||
160874804|NCT04931888|580935625|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
160874805|NCT04931888|580935626|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
160874806|NCT04931888|580935627|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
160874807|NCT04931888|580935628|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
160874808|NCT01022398|580935629|FG000|Overall Study|Study terminated|2|||
160874809|NCT01022398|580935630|FG001|Overall Study|Study terminated|2|||
160874810|NCT02969408|580935632|FG000|Overall Study|Adverse Event|2|||
160874811|NCT02969408|580935632|FG000|Overall Study|Withdrawal by Subject|8|||
160874812|NCT02969408|580935632|FG000|Overall Study|Lost to Follow-up|4|||
160874813|NCT02969408|580935632|FG000|Overall Study|Protocol Violation|1|||
160874814|NCT02969408|580935632|FG000|Overall Study|Other than specified|1|||
160874815|NCT04540198|580935633|FG000|Overall Study|Lost to Follow-up|25|||
160874816|NCT04540198|580935634|FG001|Overall Study|Lost to Follow-up|23|||
160874817|NCT04540198|580935633|FG000|Overall Study|Withdrawal by Subject|15|||
160874818|NCT04540198|580935634|FG001|Overall Study|Withdrawal by Subject|9|||
160874819|NCT04540198|580935633|FG000|Overall Study|Discontinued|1|||
160874820|NCT04540198|580935634|FG001|Overall Study|Discontinued|0|||
160874821|NCT02350478|580935635|FG000|Overall Study|Lost to Follow-up|5|||
160874822|NCT02350478|580935636|FG001|Overall Study|Lost to Follow-up|1|||
160874823|NCT02779556|580935637|FG000|Baseline|Partial baseline interview completed|1|||
160874824|NCT02779556|580935638|FG001|Baseline|Partial baseline interview completed|0|||
160874825|NCT02779556|580935637|FG000|3 Months|Lost to Follow-up|40|||
160874826|NCT02779556|580935638|FG001|3 Months|Lost to Follow-up|29|||
160874827|NCT02779556|580935637|FG000|3 Months|Missed 3 month clinic visit|27|||
160874828|NCT02779556|580935638|FG001|3 Months|Missed 3 month clinic visit|19|||
160874829|NCT02779556|580935637|FG000|6 Month|Lost to Follow-up|33|||
160874830|NCT02779556|580935638|FG001|6 Month|Lost to Follow-up|39|||
160874831|NCT02779556|580935637|FG000|6 Month HbA1c|No value collected during window|69|||
160874832|NCT02779556|580935638|FG001|6 Month HbA1c|No value collected during window|50|||
160874833|NCT02779556|580935637|FG000|12 Month HbA1c|No value collected during window|138|||
160874834|NCT02779556|580935638|FG001|12 Month HbA1c|No value collected during window|102|||
160874835|NCT03110770|580935639|FG000|Overall Study|Death|1|||
160874836|NCT03110770|580935640|FG001|Overall Study|Death|0|||
160874837|NCT03110770|580935641|FG002|Overall Study|Death|0|||
160874838|NCT03110770|580935642|FG003|Overall Study|Death|1|||
160874839|NCT03110770|580935643|FG004|Overall Study|Death|0|||
160874840|NCT03110770|580935639|FG000|Overall Study|Enrolled but did not receive product|0|||
160874841|NCT03110770|580935640|FG001|Overall Study|Enrolled but did not receive product|0|||
160874842|NCT03110770|580935641|FG002|Overall Study|Enrolled but did not receive product|0|||
160874843|NCT03110770|580935642|FG003|Overall Study|Enrolled but did not receive product|8|||
160874844|NCT03110770|580935643|FG004|Overall Study|Enrolled but did not receive product|7|||
160874845|NCT03110770|580935639|FG000|Overall Study|Lost to Follow-up|0|||
160874846|NCT03110770|580935640|FG001|Overall Study|Lost to Follow-up|0|||
160874847|NCT03110770|580935641|FG002|Overall Study|Lost to Follow-up|0|||
160874848|NCT03110770|580935642|FG003|Overall Study|Lost to Follow-up|53|||
160874849|NCT03110770|580935643|FG004|Overall Study|Lost to Follow-up|45|||
160874850|NCT03110770|580935639|FG000|Overall Study|Investigator Decision|0|||
160874851|NCT03110770|580935640|FG001|Overall Study|Investigator Decision|0|||
160874852|NCT03110770|580935641|FG002|Overall Study|Investigator Decision|0|||
160874853|NCT03110770|580935642|FG003|Overall Study|Investigator Decision|5|||
160874854|NCT03110770|580935643|FG004|Overall Study|Investigator Decision|3|||
160874855|NCT03110770|580935639|FG000|Overall Study|Withdrawal by Subject|0|||
160874856|NCT03110770|580935640|FG001|Overall Study|Withdrawal by Subject|0|||
160874857|NCT03110770|580935641|FG002|Overall Study|Withdrawal by Subject|0|||
160874858|NCT03110770|580935642|FG003|Overall Study|Withdrawal by Subject|24|||
160874859|NCT03110770|580935643|FG004|Overall Study|Withdrawal by Subject|24|||
160874860|NCT03110770|580935639|FG000|Overall Study|Moved from area|5|||
160874861|NCT03110770|580935640|FG001|Overall Study|Moved from area|0|||
160874862|NCT03110770|580935641|FG002|Overall Study|Moved from area|2|||
160874863|NCT03110770|580935642|FG003|Overall Study|Moved from area|42|||
160874864|NCT03110770|580935643|FG004|Overall Study|Moved from area|43|||
160874865|NCT03110770|580935639|FG000|Overall Study|Illness/Injury unrelated to product|0|||
160874866|NCT03110770|580935640|FG001|Overall Study|Illness/Injury unrelated to product|0|||
160874867|NCT03110770|580935641|FG002|Overall Study|Illness/Injury unrelated to product|0|||
161224472|NCT02581345|582203405|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
161224473|NCT02581345|582203406|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
161224474|NCT02581345|582203403|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
161224475|NCT02581345|582203404|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
161224476|NCT02581345|582203405|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
161224477|NCT02581345|582203406|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
161224478|NCT02581345|582203403|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
161224479|NCT02581345|582203404|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
161224480|NCT02581345|582203405|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
161224481|NCT02581345|582203406|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
161224482|NCT01768858|582203407|FG000|Overall Study|Lost to Follow-up|9|||
161224483|NCT01768858|582203407|FG000|Overall Study|Lack of Efficacy|8|||
161224484|NCT01768858|582203407|FG000|Overall Study|Serious Adverse Event|1|||
161224485|NCT01768858|582203407|FG000|Overall Study|Participant moved to Germany|1|||
161224486|NCT01768858|582203407|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
161224487|NCT01768858|582203407|FG000|Overall Study|Exanthema|1|||
161224488|NCT01768858|582203407|FG000|Overall Study|Withdrawal by Subject|1|||
161224489|NCT03471078|582203419|FG000|Overall Study|Withdrawal by Subject|9|||
161224490|NCT03471078|582203420|FG001|Overall Study|Withdrawal by Subject|1|||
161224491|NCT03471078|582203419|FG000|Overall Study|Adverse Event|4|||
161224492|NCT03471078|582203420|FG001|Overall Study|Adverse Event|1|||
161224493|NCT03471078|582203419|FG000|Overall Study|Physician Decision|3|||
161224494|NCT03471078|582203420|FG001|Overall Study|Physician Decision|2|||
161224495|NCT03471078|582203419|FG000|Overall Study|Death|2|||
161224496|NCT03471078|582203420|FG001|Overall Study|Death|0|||
161224497|NCT03471078|582203419|FG000|Overall Study|Other|3|||
161224498|NCT03471078|582203420|FG001|Overall Study|Other|2|||
161224499|NCT00502775|582203428|FG000|Overall Study|Adverse Event|1|||
161224500|NCT00502775|582203429|FG001|Overall Study|Adverse Event|2|||
161224501|NCT00502775|582203430|FG002|Overall Study|Adverse Event|1|||
161224502|NCT00502775|582203428|FG000|Overall Study|Protocol Violation|1|||
161224503|NCT00502775|582203429|FG001|Overall Study|Protocol Violation|5|||
161224504|NCT00502775|582203430|FG002|Overall Study|Protocol Violation|2|||
161224505|NCT00502775|582203428|FG000|Overall Study|Withdrawal by Subject|1|||
161224506|NCT00502775|582203429|FG001|Overall Study|Withdrawal by Subject|1|||
161224507|NCT00502775|582203430|FG002|Overall Study|Withdrawal by Subject|2|||
161224508|NCT00502775|582203428|FG000|Overall Study|Sponsor Terminated Study|1|||
161224509|NCT00502775|582203429|FG001|Overall Study|Sponsor Terminated Study|0|||
161224510|NCT00502775|582203430|FG002|Overall Study|Sponsor Terminated Study|1|||
161224511|NCT00502775|582203428|FG000|Overall Study|Non-compliance with eDiary|4|||
161224512|NCT00502775|582203429|FG001|Overall Study|Non-compliance with eDiary|1|||
161224513|NCT00502775|582203430|FG002|Overall Study|Non-compliance with eDiary|1|||
161224514|NCT00502775|582203428|FG000|Overall Study|Subject unable to swallow capsule|1|||
161224515|NCT00502775|582203429|FG001|Overall Study|Subject unable to swallow capsule|0|||
161224516|NCT00502775|582203430|FG002|Overall Study|Subject unable to swallow capsule|1|||
161224517|NCT00502775|582203428|FG000|Overall Study|Logpad compliance <80%|1|||
161224518|NCT00502775|582203429|FG001|Overall Study|Logpad compliance <80%|0|||
161224519|NCT00502775|582203430|FG002|Overall Study|Logpad compliance <80%|0|||
161224520|NCT00502775|582203428|FG000|Overall Study|Randomized in error|0|||
161119482|NCT03215030|581825900|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119483|NCT03215030|581825901|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119484|NCT03215030|581825902|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119485|NCT03215030|581825903|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119486|NCT03215030|581825904|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
161119487|NCT03215030|581825905|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
161119488|NCT03215030|581825906|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
161119489|NCT01745146|581825907|FG000|Overall Study|Withdrawal by Subject|1|||
161119490|NCT01745146|581825908|FG001|Overall Study|Withdrawal by Subject|3|||
161119491|NCT01745146|581825907|FG000|Overall Study|Lost to Follow-up|2|||
161224521|NCT00502775|582203429|FG001|Overall Study|Randomized in error|1|||
161224522|NCT00502775|582203430|FG002|Overall Study|Randomized in error|1|||
161224523|NCT00502775|582203428|FG000|Overall Study|Non-compliance|0|||
161224524|NCT00502775|582203429|FG001|Overall Study|Non-compliance|2|||
161224525|NCT00502775|582203430|FG002|Overall Study|Non-compliance|2|||
161224526|NCT00502775|582203428|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
161224527|NCT00502775|582203429|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
161224528|NCT00502775|582203430|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
161224529|NCT00502775|582203428|FG000|Overall Study|Declining pollen counts|0|||
161224530|NCT00502775|582203429|FG001|Overall Study|Declining pollen counts|1|||
161224531|NCT00502775|582203430|FG002|Overall Study|Declining pollen counts|1|||
161224532|NCT00502775|582203428|FG000|Overall Study|Subject in jail|0|||
161224533|NCT00502775|582203429|FG001|Overall Study|Subject in jail|1|||
161224534|NCT00502775|582203430|FG002|Overall Study|Subject in jail|0|||
161224535|NCT00502775|582203428|FG000|Overall Study|Subject took disallowed drug|0|||
161224536|NCT00502775|582203429|FG001|Overall Study|Subject took disallowed drug|0|||
161224537|NCT00502775|582203430|FG002|Overall Study|Subject took disallowed drug|1|||
161224538|NCT02309099|582203434|FG000|Overall Study|Adverse Event|2|||
161224539|NCT02309099|582203435|FG001|Overall Study|Adverse Event|0|||
161224540|NCT02819362|582203437|FG000|Overall Study|On-site MRI could not be performed|70|||
160874868|NCT03110770|580935642|FG003|Overall Study|Illness/Injury unrelated to product|0|||
160874869|NCT03110770|580935643|FG004|Overall Study|Illness/Injury unrelated to product|1|||
160874870|NCT01086358|580935646|FG000|First Intervention|Lost to Follow-up|9|||
160874871|NCT01086358|580935647|FG001|First Intervention|Lost to Follow-up|4|||
160874872|NCT01086358|580935646|FG000|First Intervention|Withdrawal by Subject|0|||
160874873|NCT01086358|580935647|FG001|First Intervention|Withdrawal by Subject|1|||
160874874|NCT01086358|580935646|FG000|Second Intervention|Lost to Follow-up|4|||
160874875|NCT01086358|580935647|FG001|Second Intervention|Lost to Follow-up|4|||
160874876|NCT02888119|580935650|FG000|Overall Study|Lost to Follow-up|5|||
160874877|NCT02888119|580935651|FG001|Overall Study|Lost to Follow-up|4|||
161224541|NCT01545076|582203438|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
161224542|NCT01545076|582203439|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
161224543|NCT01545076|582203440|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
161224544|NCT01545076|582203441|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
161224545|NCT01545076|582203442|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
161224546|NCT01545076|582203438|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
161224547|NCT01545076|582203439|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
161224548|NCT01545076|582203440|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
161224549|NCT01545076|582203441|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
161224550|NCT01545076|582203442|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
161224551|NCT01545076|582203438|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
161224552|NCT01545076|582203439|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
161224553|NCT01545076|582203440|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
161224554|NCT01545076|582203441|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
161224555|NCT01545076|582203442|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
161224556|NCT01545076|582203438|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
161224557|NCT01545076|582203439|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161224558|NCT01545076|582203440|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161224559|NCT01545076|582203441|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161224560|NCT01545076|582203442|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
161224561|NCT01545076|582203438|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
161224562|NCT01545076|582203439|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161224563|NCT01545076|582203440|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161224564|NCT01545076|582203441|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161224565|NCT01545076|582203442|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
161224566|NCT01545076|582203438|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161224567|NCT01545076|582203439|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161224568|NCT01545076|582203440|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161224569|NCT01545076|582203441|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
161224570|NCT01545076|582203442|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
161224571|NCT01545076|582203438|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
161224572|NCT01545076|582203439|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
161224573|NCT01545076|582203440|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
161224574|NCT01545076|582203441|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
161224575|NCT01545076|582203442|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
161224576|NCT01545076|582203438|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161224577|NCT01545076|582203439|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
161224578|NCT01545076|582203440|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
161224579|NCT01545076|582203441|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161224580|NCT01545076|582203442|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
161224581|NCT01545076|582203438|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
161224582|NCT01545076|582203439|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
161224583|NCT01545076|582203440|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
161224584|NCT01545076|582203441|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
160874878|NCT02888119|580935652|FG002|Overall Study|Lost to Follow-up|0|||
160874879|NCT03330002|580935656|FG000|Overall Study|Lost to Follow-up|15|||
160874880|NCT03330002|580935656|FG000|Overall Study|Death|7|||
161224585|NCT01545076|582203442|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
161224586|NCT05456529|582203443|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
161224587|NCT05456529|582203443|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
161257862|NCT01197417|582323504|FG000|Overall Study|Withdrawal by Subject|2|||
160874881|NCT00833417|580935657|FG000|Overall Study|Adverse Event|5|||
160874882|NCT00833417|580935658|FG001|Overall Study|Adverse Event|16|||
160874883|NCT00833417|580935657|FG000|Overall Study|Death|1|||
160874884|NCT00833417|580935658|FG001|Overall Study|Death|3|||
160874885|NCT00833417|580935657|FG000|Overall Study|Lost to Follow-up|1|||
161119492|NCT01745146|581825908|FG001|Overall Study|Lost to Follow-up|0|||
161119493|NCT00130832|581825909|FG000|Overall Study|Adverse Event|1|||
161119494|NCT00130832|581825910|FG001|Overall Study|Adverse Event|1|||
161119495|NCT00130832|581825909|FG000|Overall Study|Lost to Follow-up|1|||
161119496|NCT00130832|581825910|FG001|Overall Study|Lost to Follow-up|2|||
161119497|NCT00130832|581825909|FG000|Overall Study|Protocol Violation|6|||
161119498|NCT00130832|581825910|FG001|Overall Study|Protocol Violation|8|||
161119499|NCT00130832|581825909|FG000|Overall Study|Withdrawal by Subject|6|||
161119500|NCT00130832|581825910|FG001|Overall Study|Withdrawal by Subject|1|||
161119501|NCT00130832|581825909|FG000|Overall Study|Moved|2|||
161119502|NCT00130832|581825910|FG001|Overall Study|Moved|2|||
161119503|NCT00130832|581825909|FG000|Overall Study|Other|0|||
161119504|NCT00130832|581825910|FG001|Overall Study|Other|3|||
161119505|NCT00984204|581825918|FG000|Overall Study|Death|1|||
161119506|NCT00984204|581825918|FG000|Overall Study|Lost to Follow-up|4|||
161119507|NCT00984204|581825918|FG000|Overall Study|Lack of Efficacy|10|||
161119508|NCT04478708|581825921|FG000|Overall Study|Lost to Follow-up|0|||
161119509|NCT04478708|581825922|FG001|Overall Study|Lost to Follow-up|0|||
161119510|NCT04478708|581825923|FG002|Overall Study|Lost to Follow-up|0|||
161119511|NCT04478708|581825924|FG003|Overall Study|Lost to Follow-up|0|||
161119512|NCT04478708|581825925|FG004|Overall Study|Lost to Follow-up|0|||
161119513|NCT04478708|581825926|FG005|Overall Study|Lost to Follow-up|0|||
161119514|NCT04478708|581825927|FG006|Overall Study|Lost to Follow-up|0|||
161119515|NCT04478708|581825928|FG007|Overall Study|Lost to Follow-up|0|||
161119516|NCT04478708|581825929|FG008|Overall Study|Lost to Follow-up|1|||
161119517|NCT04478708|581825930|FG009|Overall Study|Lost to Follow-up|1|||
161119518|NCT04478708|581825931|FG010|Overall Study|Lost to Follow-up|1|||
161119519|NCT04478708|581825932|FG011|Overall Study|Lost to Follow-up|2|||
161119520|NCT04478708|581825933|FG012|Overall Study|Lost to Follow-up|1|||
161119521|NCT04478708|581825934|FG013|Overall Study|Lost to Follow-up|0|||
161119522|NCT04478708|581825935|FG014|Overall Study|Lost to Follow-up|0|||
161119523|NCT04478708|581825936|FG015|Overall Study|Lost to Follow-up|0|||
161119524|NCT04478708|581825937|FG016|Overall Study|Lost to Follow-up|0|||
161119525|NCT04478708|581825921|FG000|Overall Study|Withdrawal of consent from study|0|||
161119526|NCT04478708|581825922|FG001|Overall Study|Withdrawal of consent from study|1|||
161119527|NCT04478708|581825923|FG002|Overall Study|Withdrawal of consent from study|2|||
161119528|NCT04478708|581825924|FG003|Overall Study|Withdrawal of consent from study|0|||
161119529|NCT04478708|581825925|FG004|Overall Study|Withdrawal of consent from study|1|||
161119530|NCT04478708|581825926|FG005|Overall Study|Withdrawal of consent from study|1|||
161119531|NCT04478708|581825927|FG006|Overall Study|Withdrawal of consent from study|1|||
161119532|NCT04478708|581825928|FG007|Overall Study|Withdrawal of consent from study|0|||
161119533|NCT04478708|581825929|FG008|Overall Study|Withdrawal of consent from study|0|||
161119534|NCT04478708|581825930|FG009|Overall Study|Withdrawal of consent from study|0|||
161119535|NCT04478708|581825931|FG010|Overall Study|Withdrawal of consent from study|4|||
161119536|NCT04478708|581825932|FG011|Overall Study|Withdrawal of consent from study|3|||
161119537|NCT04478708|581825933|FG012|Overall Study|Withdrawal of consent from study|0|||
161119538|NCT04478708|581825934|FG013|Overall Study|Withdrawal of consent from study|0|||
161119539|NCT04478708|581825935|FG014|Overall Study|Withdrawal of consent from study|1|||
161119540|NCT04478708|581825936|FG015|Overall Study|Withdrawal of consent from study|0|||
161119541|NCT04478708|581825937|FG016|Overall Study|Withdrawal of consent from study|4|||
161119542|NCT01869114|581825938|FG000|Overall Study|Death|19|||
160874886|NCT00833417|580935658|FG001|Overall Study|Lost to Follow-up|2|||
160874887|NCT00833417|580935657|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
160874888|NCT00833417|580935658|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
160874889|NCT00833417|580935657|FG000|Overall Study|Patient Decision to Withdraw|4|||
160874890|NCT00833417|580935658|FG001|Overall Study|Patient Decision to Withdraw|23|||
160874891|NCT00833417|580935657|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
160874892|NCT00833417|580935658|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
160874893|NCT00833417|580935657|FG000|Overall Study|Disease Progression|18|||
160874894|NCT00833417|580935658|FG001|Overall Study|Disease Progression|17|||
160874895|NCT00833417|580935657|FG000|Overall Study|Reason Not Specified|0|||
160874896|NCT00833417|580935658|FG001|Overall Study|Reason Not Specified|1|||
160874897|NCT01625260|580935659|FG000|Overall Study|Adverse Event|3|||
160874898|NCT01625260|580935660|FG001|Overall Study|Adverse Event|0|||
160874899|NCT01625260|580935659|FG000|Overall Study|Study Terminated by Investigator|2|||
161119543|NCT01869114|581825939|FG001|Overall Study|Death|18|||
161119544|NCT01869114|581825940|FG002|Overall Study|Death|8|||
161119545|NCT01869114|581825938|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
161119546|NCT01869114|581825939|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
161119547|NCT01869114|581825940|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
161119548|NCT01869114|581825938|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
161119549|NCT01869114|581825939|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
161119550|NCT01869114|581825940|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
161119551|NCT01869114|581825938|FG000|Overall Study|Withdrawal by Subject|0|||
161119552|NCT01869114|581825939|FG001|Overall Study|Withdrawal by Subject|3|||
161119553|NCT01869114|581825940|FG002|Overall Study|Withdrawal by Subject|0|||
161119554|NCT01869114|581825938|FG000|Overall Study|Disease Progression|0|||
161119555|NCT01869114|581825939|FG001|Overall Study|Disease Progression|1|||
161119556|NCT01869114|581825940|FG002|Overall Study|Disease Progression|0|||
161119557|NCT01407926|581825941|FG000|Overall Study|Lost to Follow-up|55|||
161119558|NCT04232696|581825943|FG000|Overall Study|Implant attempted but not completed|5|||
161119559|NCT04232696|581825944|FG001|Overall Study|Implant attempted but not completed|2|||
161324494|NCT02559570|582573628|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161324495|NCT02559570|582573629|FG002|Overall Study|Other Miscellaneous Reasons|1|||
161324496|NCT02559570|582573630|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161324497|NCT02559570|582573631|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161324498|NCT01243177|582573639|FG000|Overall Study|Lack of Efficacy|47|||
161324499|NCT01243177|582573640|FG001|Overall Study|Lack of Efficacy|31|||
161324500|NCT01243177|582573639|FG000|Overall Study|Protocol Violation|11|||
161324501|NCT01243177|582573640|FG001|Overall Study|Protocol Violation|10|||
161324502|NCT01243177|582573639|FG000|Overall Study|Lost to Follow-up|15|||
161324503|NCT01243177|582573640|FG001|Overall Study|Lost to Follow-up|18|||
161324504|NCT01243177|582573639|FG000|Overall Study|Withdrawal by Subject|46|||
161324505|NCT01243177|582573640|FG001|Overall Study|Withdrawal by Subject|38|||
161324506|NCT01243177|582573639|FG000|Overall Study|AE, serious fatal|0|||
161324507|NCT01243177|582573640|FG001|Overall Study|AE, serious fatal|1|||
161324508|NCT01243177|582573639|FG000|Overall Study|SAE, non-fatal|7|||
161324509|NCT01243177|582573640|FG001|Overall Study|SAE, non-fatal|9|||
161324510|NCT01243177|582573639|FG000|Overall Study|AE, non-serious non-fatal|40|||
161324511|NCT01243177|582573640|FG001|Overall Study|AE, non-serious non-fatal|58|||
161324512|NCT01243177|582573639|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
161324513|NCT01243177|582573640|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
161324514|NCT01243177|582573639|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161324515|NCT01243177|582573640|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161324516|NCT01243177|582573639|FG000|Overall Study|Other Reason|11|||
161324517|NCT01243177|582573640|FG001|Overall Study|Other Reason|12|||
161324518|NCT05259163|582575616|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
161324519|NCT05259163|582575617|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
161324520|NCT05251233|582575618|FG000|Overall Study|Disease progression - did not start treatment|0|||
161324521|NCT05251233|582575619|FG001|Overall Study|Disease progression - did not start treatment|0|||
161324522|NCT05251233|582575620|FG002|Overall Study|Disease progression - did not start treatment|5|||
161324523|NCT05251233|582575618|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
161324524|NCT05251233|582575619|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
161324525|NCT05251233|582575620|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
161324526|NCT05251233|582575618|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
161324527|NCT05251233|582575619|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
161324528|NCT05251233|582575620|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
161324529|NCT05251233|582575618|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
161324530|NCT05251233|582575619|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
161324531|NCT05251233|582575620|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
161324532|NCT05251233|582575618|FG000|Overall Study|Death - did not start treatment|3|||
161324533|NCT05251233|582575619|FG001|Overall Study|Death - did not start treatment|0|||
161324534|NCT05251233|582575620|FG002|Overall Study|Death - did not start treatment|0|||
161324535|NCT05251233|582575618|FG000|Overall Study|Withdrawal by Subject|2|||
161324536|NCT05251233|582575619|FG001|Overall Study|Withdrawal by Subject|2|||
161324537|NCT05251233|582575620|FG002|Overall Study|Withdrawal by Subject|0|||
161324538|NCT05251233|582575618|FG000|Overall Study|Other complicating disease|2|||
161324539|NCT05251233|582575619|FG001|Overall Study|Other complicating disease|1|||
161324540|NCT05251233|582575620|FG002|Overall Study|Other complicating disease|0|||
161324541|NCT05251233|582575618|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
161324542|NCT05251233|582575619|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
161324543|NCT05251233|582575620|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
161324544|NCT05251233|582575618|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
161324545|NCT05251233|582575619|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
161324546|NCT05251233|582575620|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
161324547|NCT00452439|582575624|FG000|Overall Study|Lost to Follow-up|1|||
161324548|NCT00452439|582575625|FG001|Overall Study|Lost to Follow-up|1|||
161324549|NCT00452439|582575624|FG000|Overall Study|Refused Treatment|4|||
161324550|NCT00452439|582575625|FG001|Overall Study|Refused Treatment|3|||
161324551|NCT00452439|582575624|FG000|Overall Study|Death|3|||
161324552|NCT00452439|582575625|FG001|Overall Study|Death|1|||
161324553|NCT00452439|582575624|FG000|Overall Study|Bone Marrow Transplant|0|||
161324554|NCT00452439|582575625|FG001|Overall Study|Bone Marrow Transplant|1|||
161224588|NCT05456529|582203443|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
161224589|NCT05456529|582203443|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
161224590|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
161224591|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
161224592|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Physician Decision|2|||
161224593|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
161224594|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
161224595|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
161224596|NCT05456529|582203443|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
161224597|NCT00561730|582203444|FG000|Overall Study|Adverse Event|2|||
161224598|NCT00561730|582203444|FG000|Overall Study|Handling of the drug|1|||
161224599|NCT00561730|582203444|FG000|Overall Study|Lost to Follow-up|5|||
161224600|NCT00561730|582203444|FG000|Overall Study|Not specified reasons|1|||
161224601|NCT03194464|582203445|FG000|Overall Study|data not usable|2|||
161224602|NCT02750761|582203449|FG000|Overall Study|Lost to Follow-up|0|||
160874900|NCT01625260|580935660|FG001|Overall Study|Study Terminated by Investigator|0|||
160874901|NCT01625260|580935659|FG000|Overall Study|Disease Progression|2|||
160874902|NCT01625260|580935660|FG001|Overall Study|Disease Progression|0|||
160874903|NCT01625260|580935659|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
160874904|NCT01625260|580935660|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
160874905|NCT05573386|580935661|FG000|Overall Study|Withdrawal by Subject|3|||
160874906|NCT05573386|580935662|FG001|Overall Study|Withdrawal by Subject|2|||
160874907|NCT01776307|580935668|FG000|Overall Study|Not dosed|0|||
160874908|NCT01776307|580935669|FG001|Overall Study|Not dosed|0|||
160874909|NCT01776307|580935670|FG002|Overall Study|Not dosed|1|||
160874910|NCT02745145|580935676|FG000|Overall Study|Adverse Event|1|||
160874911|NCT02745145|580935677|FG001|Overall Study|Adverse Event|0|||
160874912|NCT02745145|580935678|FG002|Overall Study|Adverse Event|0|||
160874913|NCT02745145|580935676|FG000|Overall Study|Death|0|||
160874914|NCT02745145|580935677|FG001|Overall Study|Death|1|||
160874915|NCT02745145|580935678|FG002|Overall Study|Death|0|||
160874916|NCT02745145|580935676|FG000|Overall Study|Progressive disease|0|||
160874917|NCT02745145|580935677|FG001|Overall Study|Progressive disease|0|||
160874918|NCT02745145|580935678|FG002|Overall Study|Progressive disease|1|||
160874919|NCT02745145|580935676|FG000|Overall Study|Withdrew consent|1|||
160874920|NCT02745145|580935677|FG001|Overall Study|Withdrew consent|1|||
160874921|NCT02745145|580935678|FG002|Overall Study|Withdrew consent|1|||
160874922|NCT02745145|580935676|FG000|Overall Study|Study Termination|8|||
160874923|NCT02745145|580935677|FG001|Overall Study|Study Termination|3|||
160874924|NCT02745145|580935678|FG002|Overall Study|Study Termination|7|||
160874925|NCT01297491|580935687|FG000|Overall Study|Adverse Event|11|||
160874926|NCT01297491|580935688|FG001|Overall Study|Adverse Event|6|||
160874927|NCT01297491|580935687|FG000|Overall Study|Physician Decision|3|||
160874928|NCT01297491|580935688|FG001|Overall Study|Physician Decision|2|||
160874929|NCT01297491|580935687|FG000|Overall Study|Progressive disease|11|||
160874930|NCT01297491|580935688|FG001|Overall Study|Progressive disease|20|||
160874931|NCT01297491|580935687|FG000|Overall Study|Patient/Guardian decision|3|||
160874932|NCT01297491|580935688|FG001|Overall Study|Patient/Guardian decision|4|||
160874933|NCT01297491|580935687|FG000|Overall Study|Death|2|||
160874934|NCT01297491|580935688|FG001|Overall Study|Death|1|||
160874935|NCT00775593|580935694|FG000|Overall Study|Unmet eligibility criteria|6|||
160874936|NCT00775593|580935694|FG000|Overall Study|Death|1|||
160874937|NCT03530124|580935699|FG000|Overall Study|Withdrawal by Subject|0|||
160874938|NCT03530124|580935700|FG001|Overall Study|Withdrawal by Subject|1|||
160874939|NCT03530124|580935699|FG000|Overall Study|Protocol Violation|1|||
160874940|NCT03530124|580935700|FG001|Overall Study|Protocol Violation|0|||
160874941|NCT03530124|580935699|FG000|Overall Study|Discharged prior to study completion|1|||
160874942|NCT03530124|580935700|FG001|Overall Study|Discharged prior to study completion|0|||
160874943|NCT02379637|580935701|FG000|Overall Study|Protocol Violation|0|||
160874944|NCT02379637|580935702|FG001|Overall Study|Protocol Violation|1|||
161224603|NCT02750761|582203450|FG001|Overall Study|Lost to Follow-up|0|||
161224604|NCT02750761|582203451|FG002|Overall Study|Lost to Follow-up|1|||
161224605|NCT02750761|582203452|FG003|Overall Study|Lost to Follow-up|0|||
161324555|NCT00452439|582575624|FG000|Overall Study|Too Ill to Continue|0|||
160874945|NCT02379637|580935701|FG000|Overall Study|Adverse Event|1|||
160874946|NCT02379637|580935702|FG001|Overall Study|Adverse Event|0|||
160874947|NCT02379637|580935701|FG000|Overall Study|Withdrawal by Subject|1|||
160874948|NCT02379637|580935702|FG001|Overall Study|Withdrawal by Subject|0|||
160874949|NCT02447302|580935703|FG000|Overall Study|Physician Decision|1|||
160874950|NCT02447302|580935704|FG001|Overall Study|Physician Decision|0|||
160874951|NCT02447302|580935705|FG002|Overall Study|Physician Decision|0|||
160874952|NCT02447302|580935703|FG000|Overall Study|Adverse Event|4|||
160874953|NCT02447302|580935704|FG001|Overall Study|Adverse Event|3|||
160874954|NCT02447302|580935705|FG002|Overall Study|Adverse Event|0|||
160874955|NCT02447302|580935703|FG000|Overall Study|Withdrawal by Subject|0|||
160874956|NCT02447302|580935704|FG001|Overall Study|Withdrawal by Subject|1|||
160874957|NCT02447302|580935705|FG002|Overall Study|Withdrawal by Subject|5|||
160874958|NCT02447302|580935703|FG000|Overall Study|Sponsor Decision|0|||
160874959|NCT02447302|580935704|FG001|Overall Study|Sponsor Decision|0|||
160874960|NCT02447302|580935705|FG002|Overall Study|Sponsor Decision|1|||
160874961|NCT01742286|580935715|FG000|Escalation Phase|Administrative problems|1|||
160874962|NCT01742286|580935716|FG001|Escalation Phase|Administrative problems|1|||
160874963|NCT01742286|580935717|FG002|Escalation Phase|Administrative problems|0|||
160874964|NCT01742286|580935718|FG003|Escalation Phase|Administrative problems|0|||
160874965|NCT01742286|580935719|FG004|Escalation Phase|Administrative problems|0|||
160874966|NCT01742286|580935720|FG005|Escalation Phase|Administrative problems|0|||
160874967|NCT01742286|580935721|FG006|Escalation Phase|Administrative problems|2|||
160874968|NCT01742286|580935715|FG000|Escalation Phase|Adverse Event|0|||
160874969|NCT01742286|580935716|FG001|Escalation Phase|Adverse Event|1|||
160874970|NCT01742286|580935717|FG002|Escalation Phase|Adverse Event|2|||
160874971|NCT01742286|580935718|FG003|Escalation Phase|Adverse Event|0|||
160874972|NCT01742286|580935719|FG004|Escalation Phase|Adverse Event|0|||
160874973|NCT01742286|580935720|FG005|Escalation Phase|Adverse Event|1|||
160874974|NCT01742286|580935721|FG006|Escalation Phase|Adverse Event|0|||
161224606|NCT02750761|582203453|FG004|Overall Study|Lost to Follow-up|0|||
161224607|NCT02750761|582203454|FG005|Overall Study|Lost to Follow-up|0|||
161224608|NCT01860976|582203455|FG000|Blinded Treatment|Adverse Event|1|||
161224609|NCT01860976|582203456|FG001|Blinded Treatment|Adverse Event|3|||
161224610|NCT01860976|582203455|FG000|Blinded Treatment|Lack of Efficacy|5|||
161224611|NCT01860976|582203456|FG001|Blinded Treatment|Lack of Efficacy|12|||
161224612|NCT01860976|582203455|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
161224613|NCT01860976|582203456|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
161224614|NCT01860976|582203455|FG000|Blinded Treatment|Withdrawal by Subject|3|||
161224615|NCT01860976|582203456|FG001|Blinded Treatment|Withdrawal by Subject|5|||
161224616|NCT01860976|582203455|FG000|Blinded Treatment|Subject no longer met criteria|1|||
161224617|NCT01860976|582203456|FG001|Blinded Treatment|Subject no longer met criteria|0|||
161224618|NCT01860976|582203455|FG000|Blinded Treatment|Entered Open-Label in error|0|||
161224619|NCT01860976|582203456|FG001|Blinded Treatment|Entered Open-Label in error|1|||
161224620|NCT01860976|582203455|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
161224621|NCT01860976|582203456|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
161224622|NCT01860976|582203455|FG000|Open-Label|Adverse Event|2|||
161224623|NCT01860976|582203456|FG001|Open-Label|Adverse Event|4|||
160874975|NCT01742286|580935715|FG000|Escalation Phase|Disease progression|3|||
160874976|NCT01742286|580935716|FG001|Escalation Phase|Disease progression|7|||
160874977|NCT01742286|580935717|FG002|Escalation Phase|Disease progression|4|||
160874978|NCT01742286|580935718|FG003|Escalation Phase|Disease progression|1|||
160874979|NCT01742286|580935719|FG004|Escalation Phase|Disease progression|4|||
160874980|NCT01742286|580935720|FG005|Escalation Phase|Disease progression|3|||
160874981|NCT01742286|580935721|FG006|Escalation Phase|Disease progression|2|||
160874982|NCT01742286|580935715|FG000|Escalation Phase|Death|0|||
160874983|NCT01742286|580935716|FG001|Escalation Phase|Death|0|||
160874984|NCT01742286|580935717|FG002|Escalation Phase|Death|0|||
160874985|NCT01742286|580935718|FG003|Escalation Phase|Death|0|||
160874986|NCT01742286|580935719|FG004|Escalation Phase|Death|0|||
160874987|NCT01742286|580935720|FG005|Escalation Phase|Death|1|||
161224624|NCT01860976|582203455|FG000|Open-Label|Lack of Efficacy|16|||
161224625|NCT01860976|582203456|FG001|Open-Label|Lack of Efficacy|8|||
161224626|NCT01860976|582203455|FG000|Open-Label|Lost to Follow-up|1|||
161224627|NCT01860976|582203456|FG001|Open-Label|Lost to Follow-up|2|||
161224628|NCT01860976|582203455|FG000|Open-Label|Subject request discontinue treatment|4|||
161224629|NCT01860976|582203456|FG001|Open-Label|Subject request discontinue treatment|3|||
160874988|NCT01742286|580935721|FG006|Escalation Phase|Death|0|||
160874989|NCT01742286|580935715|FG000|Escalation Phase|Physician Decision|0|||
160874990|NCT01742286|580935716|FG001|Escalation Phase|Physician Decision|3|||
160874991|NCT01742286|580935717|FG002|Escalation Phase|Physician Decision|0|||
160874992|NCT01742286|580935718|FG003|Escalation Phase|Physician Decision|1|||
161224630|NCT01860976|582203455|FG000|Open-Label|Withdrawal by Subject|4|||
161224631|NCT01860976|582203456|FG001|Open-Label|Withdrawal by Subject|1|||
161224632|NCT01860976|582203455|FG000|Open-Label|Other Reasons|1|||
161224633|NCT01860976|582203456|FG001|Open-Label|Other Reasons|1|||
161224634|NCT01860976|582203455|FG000|Long Term Extension|Adverse Event|4|||
161224635|NCT01860976|582203456|FG001|Long Term Extension|Adverse Event|0|||
161224636|NCT01860976|582203455|FG000|Long Term Extension|Lack of Efficacy|2|||
160874993|NCT01742286|580935719|FG004|Escalation Phase|Physician Decision|0|||
161224637|NCT01860976|582203456|FG001|Long Term Extension|Lack of Efficacy|0|||
161224638|NCT01860976|582203455|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
161324556|NCT00452439|582575625|FG001|Overall Study|Too Ill to Continue|1|||
160874994|NCT01742286|580935720|FG005|Escalation Phase|Physician Decision|0|||
160874995|NCT01742286|580935721|FG006|Escalation Phase|Physician Decision|2|||
160874996|NCT01742286|580935715|FG000|Escalation Phase|Subject/guardian decision|1|||
160874997|NCT01742286|580935716|FG001|Escalation Phase|Subject/guardian decision|0|||
160874998|NCT01742286|580935717|FG002|Escalation Phase|Subject/guardian decision|0|||
160874999|NCT01742286|580935718|FG003|Escalation Phase|Subject/guardian decision|0|||
160875000|NCT01742286|580935719|FG004|Escalation Phase|Subject/guardian decision|0|||
161224639|NCT01860976|582203456|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
161224640|NCT01860976|582203455|FG000|Long Term Extension|Lost to Follow-up|2|||
160875001|NCT01742286|580935720|FG005|Escalation Phase|Subject/guardian decision|0|||
160875002|NCT01742286|580935721|FG006|Escalation Phase|Subject/guardian decision|0|||
160875003|NCT01742286|580935715|FG000|Expansion Phase|Administrative problems|0|||
160875004|NCT01742286|580935716|FG001|Expansion Phase|Administrative problems|0|||
160875005|NCT01742286|580935717|FG002|Expansion Phase|Administrative problems|0|||
160875006|NCT01742286|580935718|FG003|Expansion Phase|Administrative problems|0|||
160875007|NCT01742286|580935719|FG004|Expansion Phase|Administrative problems|0|||
160875008|NCT01742286|580935720|FG005|Expansion Phase|Administrative problems|0|||
160875009|NCT01742286|580935721|FG006|Expansion Phase|Administrative problems|5|||
160875010|NCT01742286|580935715|FG000|Expansion Phase|Physician Decision|0|||
160875011|NCT01742286|580935716|FG001|Expansion Phase|Physician Decision|0|||
160875012|NCT01742286|580935717|FG002|Expansion Phase|Physician Decision|4|||
160875013|NCT01742286|580935718|FG003|Expansion Phase|Physician Decision|0|||
160875014|NCT01742286|580935719|FG004|Expansion Phase|Physician Decision|0|||
160875015|NCT01742286|580935720|FG005|Expansion Phase|Physician Decision|0|||
160875016|NCT01742286|580935721|FG006|Expansion Phase|Physician Decision|9|||
160875017|NCT01742286|580935715|FG000|Expansion Phase|Adverse Event|0|||
160875018|NCT01742286|580935716|FG001|Expansion Phase|Adverse Event|0|||
160875019|NCT01742286|580935717|FG002|Expansion Phase|Adverse Event|0|||
160875020|NCT01742286|580935718|FG003|Expansion Phase|Adverse Event|0|||
160875021|NCT01742286|580935719|FG004|Expansion Phase|Adverse Event|0|||
160875022|NCT01742286|580935720|FG005|Expansion Phase|Adverse Event|0|||
160875023|NCT01742286|580935721|FG006|Expansion Phase|Adverse Event|6|||
160875024|NCT01742286|580935715|FG000|Expansion Phase|Disease progression|0|||
160875025|NCT01742286|580935716|FG001|Expansion Phase|Disease progression|0|||
160875026|NCT01742286|580935717|FG002|Expansion Phase|Disease progression|3|||
160875027|NCT01742286|580935718|FG003|Expansion Phase|Disease progression|0|||
160875028|NCT01742286|580935719|FG004|Expansion Phase|Disease progression|0|||
160875029|NCT01742286|580935720|FG005|Expansion Phase|Disease progression|0|||
160875030|NCT01742286|580935721|FG006|Expansion Phase|Disease progression|15|||
160875031|NCT01742286|580935715|FG000|Expansion Phase|Withdrawal by Subject|0|||
160875032|NCT01742286|580935716|FG001|Expansion Phase|Withdrawal by Subject|0|||
160875033|NCT01742286|580935717|FG002|Expansion Phase|Withdrawal by Subject|0|||
160875034|NCT01742286|580935718|FG003|Expansion Phase|Withdrawal by Subject|0|||
160875035|NCT01742286|580935719|FG004|Expansion Phase|Withdrawal by Subject|0|||
161224641|NCT01860976|582203456|FG001|Long Term Extension|Lost to Follow-up|0|||
161224642|NCT01860976|582203455|FG000|Long Term Extension|subject withdrew consent|7|||
161224643|NCT01860976|582203456|FG001|Long Term Extension|subject withdrew consent|0|||
161224644|NCT02153398|582203457|FG000|Overall Study|Withdrawal by Subject|1|||
161224645|NCT02153398|582203458|FG001|Overall Study|Withdrawal by Subject|0|||
161224646|NCT02153398|582203459|FG002|Overall Study|Withdrawal by Subject|0|||
161224647|NCT02153398|582203460|FG003|Overall Study|Withdrawal by Subject|0|||
161224648|NCT02153398|582203461|FG004|Overall Study|Withdrawal by Subject|0|||
161224649|NCT02153398|582203457|FG000|Overall Study|Adverse Event|0|||
161224650|NCT02153398|582203458|FG001|Overall Study|Adverse Event|0|||
161224651|NCT02153398|582203459|FG002|Overall Study|Adverse Event|1|||
161224652|NCT02153398|582203460|FG003|Overall Study|Adverse Event|1|||
161224653|NCT02153398|582203461|FG004|Overall Study|Adverse Event|0|||
161224654|NCT02204371|582203462|FG000|Overall Study|Adverse Event|1|||
161224655|NCT01506947|582203463|FG000|Overall Study|Lost to Follow-up|7|||
161224656|NCT01506947|582203463|FG000|Overall Study|Adverse Event|5|||
161224657|NCT01506947|582203463|FG000|Overall Study|Death|1|||
161224658|NCT01506947|582203463|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
161224659|NCT03803943|582203466|FG000|Overall Study|Withdrawal by Subject|2|||
161224660|NCT03803943|582203467|FG001|Overall Study|Withdrawal by Subject|2|||
161224661|NCT03803943|582203468|FG002|Overall Study|Withdrawal by Subject|2|||
161224662|NCT03803943|582203469|FG003|Overall Study|Withdrawal by Subject|2|||
161224663|NCT01781286|582203472|FG000|Overall Study|Lost to Follow-up|0|||
161224664|NCT01781286|582203473|FG001|Overall Study|Lost to Follow-up|0|||
161224665|NCT01781286|582203474|FG002|Overall Study|Lost to Follow-up|0|||
161224666|NCT01781286|582203475|FG003|Overall Study|Lost to Follow-up|0|||
160875036|NCT01742286|580935720|FG005|Expansion Phase|Withdrawal by Subject|0|||
160875037|NCT01742286|580935721|FG006|Expansion Phase|Withdrawal by Subject|1|||
160875038|NCT01233232|580935722|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
160875039|NCT01233232|580935723|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
160875040|NCT01233232|580935724|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
160875041|NCT01217307|580939029|FG000|Overall Study|Withdrawal by Subject|0|||
160875042|NCT01217307|580939030|FG001|Overall Study|Withdrawal by Subject|1|||
160875043|NCT00843284|580939033|FG000|Overall Study|Adverse Event|39|||
160875044|NCT00843284|580939033|FG000|Overall Study|Lack of Efficacy|5|||
161224667|NCT01781286|582203476|FG004|Overall Study|Lost to Follow-up|0|||
161224668|NCT01781286|582203477|FG005|Overall Study|Lost to Follow-up|1|||
161224669|NCT01781286|582203472|FG000|Overall Study|Time Constraints|2|||
161224670|NCT01781286|582203473|FG001|Overall Study|Time Constraints|0|||
160875045|NCT00843284|580939033|FG000|Overall Study|Lost to Follow-up|11|||
160875046|NCT00843284|580939033|FG000|Overall Study|Other|10|||
160875047|NCT00843284|580939033|FG000|Overall Study|Withdrawal by Subject|4|||
160875048|NCT00843284|580939033|FG000|Overall Study|Death|3|||
160875049|NCT01794338|580939037|FG000|Overall Study|Death|2|||
160875050|NCT01794338|580939038|FG001|Overall Study|Death|0|||
160875051|NCT01794338|580939037|FG000|Overall Study|Lost to Follow-up|6|||
160875052|NCT01794338|580939038|FG001|Overall Study|Lost to Follow-up|9|||
160875053|NCT01282463|580939039|FG000|Overall Study|Lost to Follow-up|1|||
160875054|NCT01282463|580939040|FG001|Overall Study|Lost to Follow-up|0|||
161119560|NCT04232696|581825943|FG000|Overall Study|Not satisfied with therapy outcome|0|||
161119561|NCT04232696|581825944|FG001|Overall Study|Not satisfied with therapy outcome|8|||
161119562|NCT04232696|581825943|FG000|Overall Study|Adverse Event|0|||
161119563|NCT04232696|581825944|FG001|Overall Study|Adverse Event|3|||
161119564|NCT04232696|581825943|FG000|Overall Study|Withdrawal by Subject|0|||
161119565|NCT04232696|581825944|FG001|Overall Study|Withdrawal by Subject|3|||
161119566|NCT04232696|581825943|FG000|Overall Study|Missed Visit|0|||
161119567|NCT04232696|581825944|FG001|Overall Study|Missed Visit|2|||
161119568|NCT04232696|581825943|FG000|Overall Study|Other reason|0|||
161119569|NCT04232696|581825944|FG001|Overall Study|Other reason|1|||
161119570|NCT03118297|581825945|FG000|Overall Study|Lost to Follow-up|0|||
161119571|NCT03118297|581825946|FG001|Overall Study|Lost to Follow-up|2|||
161119572|NCT02363686|581825952|FG000|Overall Study|Withdrawal by Subject|22|||
161119573|NCT02363686|581825952|FG000|Overall Study|incomplete FEES examinations|13|||
161119574|NCT05617911|581825954|FG000|Overall Study|Withdrawal by Subject|1|||
161119575|NCT05617911|581825955|FG001|Overall Study|Withdrawal by Subject|0|||
161119576|NCT03975647|581825956|FG000|Overall Study|Death|71|||
161119577|NCT03975647|581825957|FG001|Overall Study|Death|63|||
161119578|NCT03975647|581825956|FG000|Overall Study|Lost to Follow-up|2|||
161119579|NCT03975647|581825957|FG001|Overall Study|Lost to Follow-up|2|||
161119580|NCT03975647|581825956|FG000|Overall Study|Subject withdrawal of consent|7|||
161119581|NCT03975647|581825957|FG001|Overall Study|Subject withdrawal of consent|11|||
161119582|NCT04868903|581825958|FG000|Overall Study|Adverse Event|0|||
161119583|NCT04868903|581825959|FG001|Overall Study|Adverse Event|0|||
161119584|NCT04868903|581825960|FG002|Overall Study|Adverse Event|0|||
161119585|NCT04868903|581825961|FG003|Overall Study|Adverse Event|1|||
161119586|NCT04868903|581825958|FG000|Overall Study|Withdrawal by Subject|29|||
161119587|NCT04868903|581825959|FG001|Overall Study|Withdrawal by Subject|44|||
161119588|NCT04868903|581825960|FG002|Overall Study|Withdrawal by Subject|17|||
161119589|NCT04868903|581825961|FG003|Overall Study|Withdrawal by Subject|12|||
161119590|NCT04868903|581825958|FG000|Overall Study|Hyperparathyroidism|3|||
161119591|NCT04868903|581825959|FG001|Overall Study|Hyperparathyroidism|5|||
161119592|NCT04868903|581825960|FG002|Overall Study|Hyperparathyroidism|2|||
161119593|NCT04868903|581825961|FG003|Overall Study|Hyperparathyroidism|3|||
161119594|NCT03735667|581825962|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
161119595|NCT03735667|581825963|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
161119596|NCT03735667|581825964|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
161119597|NCT03735667|581825962|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
161119598|NCT03735667|581825963|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
161119599|NCT03735667|581825964|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
161119600|NCT03735667|581825962|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
161119601|NCT03735667|581825963|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
161119602|NCT03735667|581825964|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
161119603|NCT03735667|581825962|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
161119604|NCT03735667|581825963|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
161119605|NCT03735667|581825964|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
161119606|NCT03735667|581825962|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
161119607|NCT03735667|581825963|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
161119608|NCT03735667|581825964|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
161119609|NCT03735667|581825962|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
161119610|NCT03735667|581825963|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
161119611|NCT03735667|581825964|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
161119612|NCT03735667|581825962|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
161119613|NCT03735667|581825963|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
161119614|NCT03735667|581825964|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
161119615|NCT03735667|581825962|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
161119616|NCT03735667|581825963|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
160875055|NCT01282463|580939041|FG002|Overall Study|Lost to Follow-up|0|||
161119617|NCT03735667|581825964|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
160875056|NCT01282463|580939039|FG000|Overall Study|Withdrawal by Subject|6|||
161119618|NCT03735667|581825962|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
161119619|NCT03735667|581825963|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
161119620|NCT03735667|581825964|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
161119621|NCT03735667|581825962|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
160875057|NCT01282463|580939040|FG001|Overall Study|Withdrawal by Subject|2|||
160875058|NCT01282463|580939041|FG002|Overall Study|Withdrawal by Subject|3|||
160875059|NCT01282463|580939039|FG000|Overall Study|"Never Treated Death"|0|||
160875060|NCT01282463|580939040|FG001|Overall Study|"Never Treated Death"|1|||
160875061|NCT01282463|580939041|FG002|Overall Study|"Never Treated Death"|0|||
160875062|NCT01282463|580939039|FG000|Overall Study|"Never Treated PD"|0|||
160875063|NCT01282463|580939040|FG001|Overall Study|"Never Treated PD"|1|||
160875064|NCT01282463|580939041|FG002|Overall Study|"Never Treated PD"|0|||
160875065|NCT01282463|580939039|FG000|Overall Study|Protocol Violation|0|||
160875066|NCT01282463|580939040|FG001|Overall Study|Protocol Violation|0|||
160875067|NCT01282463|580939041|FG002|Overall Study|Protocol Violation|1|||
160875068|NCT01282463|580939039|FG000|Overall Study|Physician Decision|1|||
160875069|NCT01282463|580939040|FG001|Overall Study|Physician Decision|0|||
160875070|NCT01282463|580939041|FG002|Overall Study|Physician Decision|0|||
160875071|NCT03320824|580939042|FG000|Overall Study|Withdrawal by Subject|8|||
160875072|NCT03320824|580939043|FG001|Overall Study|Withdrawal by Subject|1|||
160875073|NCT03320824|580939042|FG000|Overall Study|Lost to Follow-up|10|||
160875074|NCT03320824|580939043|FG001|Overall Study|Lost to Follow-up|1|||
160875075|NCT03320824|580939042|FG000|Overall Study|moved out of state|0|||
160875076|NCT03320824|580939043|FG001|Overall Study|moved out of state|1|||
160875077|NCT03320824|580939042|FG000|Overall Study|could not complete final visit|0|||
161224671|NCT01781286|582203474|FG002|Overall Study|Time Constraints|2|||
161224672|NCT01781286|582203475|FG003|Overall Study|Time Constraints|0|||
160875078|NCT03320824|580939043|FG001|Overall Study|could not complete final visit|1|||
160875079|NCT00955305|580939044|FG000|Overall Study|Disease progression|39|||
160875080|NCT00955305|580939045|FG001|Overall Study|Disease progression|41|||
160875081|NCT00955305|580939044|FG000|Overall Study|Adverse Event|22|||
160875082|NCT00955305|580939045|FG001|Overall Study|Adverse Event|22|||
160875083|NCT00955305|580939044|FG000|Overall Study|Death|2|||
160875084|NCT00955305|580939045|FG001|Overall Study|Death|1|||
160875085|NCT00955305|580939044|FG000|Overall Study|Withdrawal by Subject|5|||
160875086|NCT00955305|580939045|FG001|Overall Study|Withdrawal by Subject|4|||
160875087|NCT00955305|580939044|FG000|Overall Study|Alternative therapy|4|||
160875088|NCT00955305|580939045|FG001|Overall Study|Alternative therapy|0|||
160875089|NCT00955305|580939044|FG000|Overall Study|Other complicating disease|2|||
160875090|NCT00955305|580939045|FG001|Overall Study|Other complicating disease|4|||
160875091|NCT00955305|580939044|FG000|Overall Study|Physician Decision|1|||
160875092|NCT00955305|580939045|FG001|Overall Study|Physician Decision|0|||
160875093|NCT00955305|580939044|FG000|Overall Study|Continued presence of residual disease|0|||
160875094|NCT00955305|580939045|FG001|Overall Study|Continued presence of residual disease|1|||
160875095|NCT00955305|580939044|FG000|Overall Study|Functional decline|2|||
160875096|NCT00955305|580939045|FG001|Overall Study|Functional decline|0|||
160875097|NCT00955305|580939044|FG000|Overall Study|Maximum response achieved|0|||
160875098|NCT00955305|580939045|FG001|Overall Study|Maximum response achieved|1|||
160875099|NCT00955305|580939044|FG000|Overall Study|Lost to Follow-up|0|||
160875100|NCT00955305|580939045|FG001|Overall Study|Lost to Follow-up|1|||
160875101|NCT00955305|580939044|FG000|Overall Study|No off-treatment reason submitted|1|||
160875102|NCT00955305|580939045|FG001|Overall Study|No off-treatment reason submitted|0|||
160875103|NCT00955305|580939044|FG000|Overall Study|Never started protocol treatment|5|||
160875104|NCT00955305|580939045|FG001|Overall Study|Never started protocol treatment|5|||
160875105|NCT00955305|580939044|FG000|Overall Study|Ineligible|5|||
160875106|NCT00955305|580939045|FG001|Overall Study|Ineligible|7|||
160875107|NCT00109590|580939046|FG000|Overall Study|Lost to Follow-up|1|||
160875108|NCT00109590|580939047|FG001|Overall Study|Lost to Follow-up|0|||
161224673|NCT01781286|582203476|FG004|Overall Study|Time Constraints|0|||
161224674|NCT01781286|582203477|FG005|Overall Study|Time Constraints|0|||
161224675|NCT01781286|582203472|FG000|Overall Study|Noncompliance|0|||
160875109|NCT00109590|580939048|FG002|Overall Study|Lost to Follow-up|1|||
160875110|NCT00109590|580939046|FG000|Overall Study|Never Started Treatment|1|||
161224676|NCT01781286|582203473|FG001|Overall Study|Noncompliance|0|||
161224677|NCT01781286|582203474|FG002|Overall Study|Noncompliance|0|||
160875111|NCT00109590|580939047|FG001|Overall Study|Never Started Treatment|2|||
160875112|NCT00109590|580939048|FG002|Overall Study|Never Started Treatment|3|||
160875113|NCT01221285|580939049|FG000|Overall Study|Withdrawal by Subject|1|||
160875114|NCT00588861|580939050|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
160875115|NCT00588861|580939051|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
161224678|NCT01781286|582203475|FG003|Overall Study|Noncompliance|1|||
161224679|NCT01781286|582203476|FG004|Overall Study|Noncompliance|0|||
161119622|NCT03735667|581825963|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
161119623|NCT03735667|581825964|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
161119624|NCT03735667|581825962|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
161119625|NCT03735667|581825963|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
161119626|NCT03735667|581825964|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
161119627|NCT03735667|581825962|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
161119628|NCT03735667|581825963|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
161224680|NCT01781286|582203477|FG005|Overall Study|Noncompliance|0|||
161224681|NCT00995410|582203478|FG000|Overall Study|Adverse Event|51|||
160875116|NCT00588861|580939050|FG000|6 Months|Patients did not return for follow-up|98|||
160875117|NCT00588861|580939051|FG001|6 Months|Patients did not return for follow-up|73|||
160875118|NCT00588861|580939050|FG000|1 Year|Patients did not return for follow-up|89|||
160875119|NCT00588861|580939051|FG001|1 Year|Patients did not return for follow-up|82|||
160875120|NCT00588861|580939050|FG000|2 Years|Patients did not return for follow-up|92|||
160875121|NCT00588861|580939051|FG001|2 Years|Patients did not return for follow-up|87|||
160875122|NCT00588861|580939050|FG000|4 Years|Patients did not return for follow-up|91|||
160875123|NCT00588861|580939051|FG001|4 Years|Patients did not return for follow-up|103|||
160875124|NCT00588861|580939050|FG000|6 Years|Patients did not return for follow-up|104|||
160875125|NCT00588861|580939051|FG001|6 Years|Patients did not return for follow-up|109|||
160875126|NCT00588861|580939050|FG000|8 Years|Patients did not return for follow-up|105|||
160875127|NCT00588861|580939051|FG001|8 Years|Patients did not return for follow-up|114|||
160875128|NCT00588861|580939050|FG000|10 Years|Incomplete due to study termination|107|||
161224682|NCT00995410|582203478|FG000|Overall Study|Withdrawal by Subject|7|||
161224683|NCT00995410|582203478|FG000|Overall Study|Lost to Follow-up|2|||
161224684|NCT00995410|582203478|FG000|Overall Study|Misc|28|||
161224685|NCT03594123|582203479|FG000|Overall Study|Lost to Follow-up|0|||
161224686|NCT03594123|582203480|FG001|Overall Study|Lost to Follow-up|1|||
161224687|NCT03594123|582203479|FG000|Overall Study|Adverse Event|8|||
161224688|NCT03594123|582203480|FG001|Overall Study|Adverse Event|5|||
161224689|NCT03594123|582203479|FG000|Overall Study|Site Terminated by Sponsor|4|||
161224690|NCT03594123|582203480|FG001|Overall Study|Site Terminated by Sponsor|1|||
161224691|NCT03594123|582203479|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
161224692|NCT03594123|582203480|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
161224693|NCT03594123|582203479|FG000|Overall Study|Lack of Efficacy|1|||
161224694|NCT03594123|582203480|FG001|Overall Study|Lack of Efficacy|0|||
161224695|NCT03594123|582203479|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
161224696|NCT03594123|582203480|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
161224697|NCT01901055|582203481|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
161224698|NCT01901055|582203482|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
161224699|NCT01901055|582203481|FG000|Randomization But Not Titrated|Physician Decision|0|||
161224700|NCT01901055|582203482|FG001|Randomization But Not Titrated|Physician Decision|1|||
161224701|NCT01901055|582203481|FG000|Started Protocol to Week 6|Physician Decision|2|||
161224702|NCT01901055|582203482|FG001|Started Protocol to Week 6|Physician Decision|1|||
161224703|NCT01901055|582203481|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
161224704|NCT01901055|582203482|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
161224705|NCT01901055|582203481|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
161224706|NCT01901055|582203482|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
161224707|NCT01901055|582203481|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
161224708|NCT01901055|582203482|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
161224709|NCT01901055|582203481|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
161224710|NCT01901055|582203482|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
161224711|NCT01901055|582203481|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
161224712|NCT01901055|582203482|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
161224713|NCT01901055|582203481|FG000|Week 24|Withdrawal by Subject|13|||
161224714|NCT01901055|582203482|FG001|Week 24|Withdrawal by Subject|19|||
161224715|NCT01901055|582203481|FG000|Week 24|Physician Decision|1|||
161224716|NCT01901055|582203482|FG001|Week 24|Physician Decision|0|||
161224717|NCT01901055|582203481|FG000|Week 36|Withdrawal by Subject|0|||
161224718|NCT01901055|582203482|FG001|Week 36|Withdrawal by Subject|5|||
161224719|NCT03019965|582203485|FG000|Overall Study|Withdrawal by Subject|1|||
161224720|NCT03019965|582203486|FG001|Overall Study|Withdrawal by Subject|0|||
161224721|NCT03019965|582203485|FG000|Overall Study|Protocol Violation|1|||
161224722|NCT03019965|582203486|FG001|Overall Study|Protocol Violation|3|||
161224723|NCT03019965|582203485|FG000|Overall Study|viral or fungal infection|3|||
161224724|NCT03019965|582203486|FG001|Overall Study|viral or fungal infection|4|||
161224725|NCT03019965|582203485|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
161224726|NCT03019965|582203486|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
161224727|NCT03019965|582203485|FG000|Overall Study|Physician Decision|1|||
160875129|NCT00588861|580939051|FG001|10 Years|Incomplete due to study termination|114|||
160875130|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
160875131|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
161224728|NCT03019965|582203486|FG001|Overall Study|Physician Decision|1|||
161224729|NCT01513148|582203492|FG000|Overall Study|Protocol Violation|2|||
160875132|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
160875133|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
160875134|NCT00490529|580939056|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
160875135|NCT00490529|580939056|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
161224730|NCT01513148|582203493|FG001|Overall Study|Protocol Violation|2|||
161224731|NCT03552757|582203494|FG000|Overall Study|Withdrawal by Subject|10|||
161224732|NCT03552757|582203495|FG001|Overall Study|Withdrawal by Subject|5|||
161224733|NCT03552757|582203496|FG002|Overall Study|Withdrawal by Subject|12|||
161224734|NCT03552757|582203494|FG000|Overall Study|Lost to Follow-up|2|||
161224735|NCT03552757|582203495|FG001|Overall Study|Lost to Follow-up|7|||
161224736|NCT03552757|582203496|FG002|Overall Study|Lost to Follow-up|7|||
161224737|NCT03552757|582203494|FG000|Overall Study|Death|1|||
161224738|NCT03552757|582203495|FG001|Overall Study|Death|1|||
161224739|NCT03552757|582203496|FG002|Overall Study|Death|1|||
161224740|NCT02192099|582203499|FG000|Overall Study|Adverse Event|1|||
161224741|NCT02192099|582203499|FG000|Overall Study|Lost to Follow-up|2|||
161224742|NCT02192099|582203499|FG000|Overall Study|Physician Decision|1|||
161224743|NCT02192099|582203499|FG000|Overall Study|Pregnancy|1|||
161224744|NCT02192099|582203499|FG000|Overall Study|Protocol Violation|8|||
161224745|NCT02192099|582203499|FG000|Overall Study|Study Terminated by Sponsor|32|||
161224746|NCT02192099|582203499|FG000|Overall Study|Withdrawal by Subject|11|||
161224747|NCT02192099|582203499|FG000|Overall Study|Miscellaneous Reasons|5|||
161224748|NCT01862328|582203504|FG000|Overall Study|Progressive Disease|3|||
161224749|NCT01862328|582203505|FG001|Overall Study|Progressive Disease|11|||
161224750|NCT01862328|582203506|FG002|Overall Study|Progressive Disease|5|||
161224751|NCT01862328|582203507|FG003|Overall Study|Progressive Disease|6|||
161224752|NCT01862328|582203508|FG004|Overall Study|Progressive Disease|7|||
161224753|NCT01862328|582203509|FG005|Overall Study|Progressive Disease|4|||
161224754|NCT01862328|582203510|FG006|Overall Study|Progressive Disease|3|||
161224755|NCT01862328|582203504|FG000|Overall Study|Adverse Event|0|||
161224756|NCT01862328|582203505|FG001|Overall Study|Adverse Event|4|||
161224757|NCT01862328|582203506|FG002|Overall Study|Adverse Event|0|||
161224758|NCT01862328|582203507|FG003|Overall Study|Adverse Event|1|||
161224759|NCT01862328|582203508|FG004|Overall Study|Adverse Event|0|||
161224760|NCT01862328|582203509|FG005|Overall Study|Adverse Event|2|||
161119629|NCT03735667|581825964|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
161119630|NCT03092726|581825965|FG000|Overall Study|Adverse Event|3|||
161119631|NCT03092726|581825966|FG001|Overall Study|Adverse Event|10|||
161119632|NCT03092726|581825965|FG000|Overall Study|Lack of Efficacy|0|||
161119633|NCT03092726|581825966|FG001|Overall Study|Lack of Efficacy|1|||
161119634|NCT03092726|581825965|FG000|Overall Study|Lost to Follow-up|1|||
161119635|NCT03092726|581825966|FG001|Overall Study|Lost to Follow-up|0|||
161119636|NCT03092726|581825965|FG000|Overall Study|Withdrawal by Subject|5|||
161119637|NCT03092726|581825966|FG001|Overall Study|Withdrawal by Subject|3|||
161119638|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
161119639|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
161119640|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
161119641|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
161119642|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
161119643|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
161119644|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
161119645|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
161119646|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
161119647|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
161119648|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
161119649|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
161119650|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
161119651|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
161119652|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
161119653|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
161119654|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
161119655|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
161119656|NCT04418765|581825971|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
161119657|NCT04418765|581825972|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
161119658|NCT04418765|581825973|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
161119659|NCT04418765|581825971|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
161119660|NCT04418765|581825972|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
161119661|NCT04418765|581825973|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
161119662|NCT04418765|581825971|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
161119663|NCT04418765|581825972|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
161119664|NCT04418765|581825973|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
161119665|NCT04418765|581825971|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
161224761|NCT01862328|582203510|FG006|Overall Study|Adverse Event|4|||
161224762|NCT01862328|582203504|FG000|Overall Study|Other|0|||
161224763|NCT01862328|582203505|FG001|Overall Study|Other|2|||
161224764|NCT01862328|582203506|FG002|Overall Study|Other|1|||
161224765|NCT01862328|582203507|FG003|Overall Study|Other|0|||
161224766|NCT01862328|582203508|FG004|Overall Study|Other|4|||
161224767|NCT01862328|582203509|FG005|Overall Study|Other|0|||
161224768|NCT01862328|582203510|FG006|Overall Study|Other|1|||
161224769|NCT01862328|582203504|FG000|Overall Study|Withdrawal by Subject|1|||
160875136|NCT02617485|580939069|FG000|Treatment and Observation Period|Adverse Event|9|||
160875137|NCT02617485|580939070|FG001|Treatment and Observation Period|Adverse Event|1|||
160875138|NCT02617485|580939069|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
160875139|NCT02617485|580939070|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
160875140|NCT02617485|580939069|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
160875141|NCT02617485|580939070|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
160875142|NCT02617485|580939069|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
160875143|NCT02617485|580939070|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
160875144|NCT02617485|580939069|FG000|Treatment and Observation Period|Physician Decision|0|||
160875145|NCT02617485|580939070|FG001|Treatment and Observation Period|Physician Decision|1|||
160875146|NCT02617485|580939069|FG000|Follow-up Period|Adverse Event|1|||
160875147|NCT02617485|580939070|FG001|Follow-up Period|Adverse Event|0|||
160875148|NCT02617485|580939069|FG000|Follow-up Period|Withdrawal by Subject|1|||
160875149|NCT02617485|580939070|FG001|Follow-up Period|Withdrawal by Subject|0|||
160875150|NCT02617485|580939069|FG000|Follow-up Period|Disease progression|2|||
160875151|NCT02617485|580939070|FG001|Follow-up Period|Disease progression|1|||
160875152|NCT02617485|580939069|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
160875153|NCT02617485|580939070|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
160875154|NCT02617485|580939069|FG000|Follow-up Period|Patient needed radiotherapy|9|||
161224770|NCT01862328|582203505|FG001|Overall Study|Withdrawal by Subject|1|||
161224771|NCT01862328|582203506|FG002|Overall Study|Withdrawal by Subject|0|||
161224772|NCT01862328|582203507|FG003|Overall Study|Withdrawal by Subject|0|||
161224773|NCT01862328|582203508|FG004|Overall Study|Withdrawal by Subject|1|||
161224774|NCT01862328|582203509|FG005|Overall Study|Withdrawal by Subject|1|||
161224775|NCT01862328|582203510|FG006|Overall Study|Withdrawal by Subject|1|||
161224776|NCT01862328|582203504|FG000|Overall Study|Symptomatic Deterioration|0|||
161224777|NCT01862328|582203505|FG001|Overall Study|Symptomatic Deterioration|0|||
161224778|NCT01862328|582203506|FG002|Overall Study|Symptomatic Deterioration|0|||
161224779|NCT01862328|582203507|FG003|Overall Study|Symptomatic Deterioration|0|||
161224780|NCT01862328|582203508|FG004|Overall Study|Symptomatic Deterioration|0|||
161224781|NCT01862328|582203509|FG005|Overall Study|Symptomatic Deterioration|0|||
161224782|NCT01862328|582203510|FG006|Overall Study|Symptomatic Deterioration|1|||
161224783|NCT00936975|582203511|FG000|Overall Study|Withdrawal by Subject|1|||
161224784|NCT00936975|582203511|FG000|Overall Study|Disease progression|3|||
161224785|NCT00936975|582203511|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
161224786|NCT01656889|582203515|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
161224787|NCT01656889|582203516|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
161224788|NCT01656889|582203515|FG000|Treatment Period, 12 Weeks|Death|0|||
161224789|NCT01656889|582203516|FG001|Treatment Period, 12 Weeks|Death|1|||
161224790|NCT01656889|582203515|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
161224791|NCT01656889|582203516|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
161224792|NCT01656889|582203515|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
161224793|NCT01656889|582203516|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
161224794|NCT01656889|582203515|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
161224795|NCT01656889|582203516|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
161224796|NCT01656889|582203515|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
161224797|NCT01656889|582203516|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
161224798|NCT01656889|582203515|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
161224799|NCT01656889|582203516|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
161224800|NCT01656889|582203515|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
161224801|NCT01656889|582203516|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
161224802|NCT01656889|582203515|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
161224803|NCT01656889|582203516|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
161224804|NCT01656889|582203515|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
161224805|NCT01656889|582203516|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
161224806|NCT02486796|582203517|FG000|Overall Study|Withdrawal by Subject|1|||
161224807|NCT02486796|582203518|FG001|Overall Study|Withdrawal by Subject|1|||
161224808|NCT02486796|582203517|FG000|Overall Study|Physician Decision|1|||
161224809|NCT02486796|582203518|FG001|Overall Study|Physician Decision|0|||
161224810|NCT03276975|582203519|FG000|Overall Study|Withdrawal by Subject|1|||
161224811|NCT03276975|582203520|FG001|Overall Study|Withdrawal by Subject|0|||
161224812|NCT00306384|582203523|FG000|Overall Study|Adverse Event|103|||
161224813|NCT00306384|582203524|FG001|Overall Study|Adverse Event|87|||
161224814|NCT00306384|582203525|FG002|Overall Study|Adverse Event|40|||
161224815|NCT00306384|582203523|FG000|Overall Study|Major protocol deviation|43|||
161224816|NCT00306384|582203524|FG001|Overall Study|Major protocol deviation|51|||
161224817|NCT00306384|582203525|FG002|Overall Study|Major protocol deviation|18|||
161224818|NCT00306384|582203523|FG000|Overall Study|Lost to Follow-up|57|||
161224819|NCT00306384|582203524|FG001|Overall Study|Lost to Follow-up|41|||
161224820|NCT00306384|582203525|FG002|Overall Study|Lost to Follow-up|35|||
161324557|NCT00452439|582575624|FG000|Overall Study|Failed to achieve complete response|2|||
161224821|NCT00306384|582203523|FG000|Overall Study|Voluntary withdrawal|199|||
161224822|NCT00306384|582203524|FG001|Overall Study|Voluntary withdrawal|187|||
160875155|NCT02617485|580939070|FG001|Follow-up Period|Patient needed radiotherapy|5|||
161224823|NCT00306384|582203525|FG002|Overall Study|Voluntary withdrawal|91|||
161224824|NCT00306384|582203523|FG000|Overall Study|Study termination|1|||
160875156|NCT02617485|580939069|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
161224825|NCT00306384|582203524|FG001|Overall Study|Study termination|0|||
161224826|NCT00306384|582203525|FG002|Overall Study|Study termination|1|||
161224827|NCT00306384|582203523|FG000|Overall Study|Pregnancy|3|||
161224828|NCT00306384|582203524|FG001|Overall Study|Pregnancy|1|||
161224829|NCT00306384|582203525|FG002|Overall Study|Pregnancy|1|||
161224830|NCT00306384|582203523|FG000|Overall Study|Lack of Efficacy|26|||
161224831|NCT00306384|582203524|FG001|Overall Study|Lack of Efficacy|40|||
161224832|NCT00306384|582203525|FG002|Overall Study|Lack of Efficacy|38|||
161224833|NCT00306384|582203523|FG000|Overall Study|Investigator discretion|28|||
161224834|NCT00306384|582203524|FG001|Overall Study|Investigator discretion|31|||
161224835|NCT00306384|582203525|FG002|Overall Study|Investigator discretion|21|||
161224836|NCT00306384|582203523|FG000|Overall Study|Other|80|||
161224837|NCT00306384|582203524|FG001|Overall Study|Other|70|||
161224838|NCT00306384|582203525|FG002|Overall Study|Other|32|||
161224839|NCT00306384|582203523|FG000|Overall Study|Site closure|2|||
161224840|NCT00306384|582203524|FG001|Overall Study|Site closure|0|||
161224841|NCT00306384|582203525|FG002|Overall Study|Site closure|0|||
161224842|NCT02275364|582203526|FG000|Period 1|Withdrawal by Subject|1|||
161224843|NCT02275364|582203527|FG001|Period 1|Withdrawal by Subject|0|||
161224844|NCT02275364|582203526|FG000|Period 1|Other reason|1|||
161224845|NCT02275364|582203527|FG001|Period 1|Other reason|0|||
161224846|NCT01463683|582203530|FG000|Overall Study|Adverse Event|2|||
161224847|NCT01463683|582203531|FG001|Overall Study|Adverse Event|0|||
161224848|NCT01463683|582203532|FG002|Overall Study|Adverse Event|0|||
161224849|NCT01463683|582203530|FG000|Overall Study|Lost to Follow-up|10|||
161224850|NCT01463683|582203531|FG001|Overall Study|Lost to Follow-up|9|||
161224851|NCT01463683|582203532|FG002|Overall Study|Lost to Follow-up|7|||
160875157|NCT02617485|580939070|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
160875158|NCT00791076|580939071|FG000|Overall Study|Study was terminated,PI left institution|8|||
160875159|NCT00669409|580939072|FG000|Part 2|Withdrawal by Subject|0|||
160875160|NCT00669409|580939073|FG001|Part 2|Withdrawal by Subject|0|||
160875161|NCT00669409|580939074|FG002|Part 2|Withdrawal by Subject|0|||
160875162|NCT00669409|580939075|FG003|Part 2|Withdrawal by Subject|0|||
160875163|NCT00669409|580939076|FG004|Part 2|Withdrawal by Subject|0|||
161224852|NCT01463683|582203530|FG000|Overall Study|Physician Decision|0|||
161224853|NCT01463683|582203531|FG001|Overall Study|Physician Decision|3|||
161224854|NCT01463683|582203532|FG002|Overall Study|Physician Decision|1|||
161224855|NCT01463683|582203530|FG000|Overall Study|Pregnancy|2|||
161224856|NCT01463683|582203531|FG001|Overall Study|Pregnancy|2|||
161224857|NCT01463683|582203532|FG002|Overall Study|Pregnancy|1|||
161224858|NCT01463683|582203530|FG000|Overall Study|Withdrawal by Subject|5|||
161224859|NCT01463683|582203531|FG001|Overall Study|Withdrawal by Subject|17|||
161224860|NCT01463683|582203532|FG002|Overall Study|Withdrawal by Subject|2|||
161224861|NCT03111147|582203533|FG000|Overall Study|Lost to Follow-up|2|||
161224862|NCT03111147|582203534|FG001|Overall Study|Lost to Follow-up|5|||
161224863|NCT03111147|582203533|FG000|Overall Study|Withdrawal by Subject|4|||
161224864|NCT03111147|582203534|FG001|Overall Study|Withdrawal by Subject|3|||
161224865|NCT03111147|582203533|FG000|Overall Study|Protocol Violation|2|||
161224866|NCT03111147|582203534|FG001|Overall Study|Protocol Violation|1|||
161224867|NCT03111147|582203533|FG000|Overall Study|Death|1|||
161224868|NCT03111147|582203534|FG001|Overall Study|Death|1|||
161224869|NCT03384745|582203535|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161224870|NCT03384745|582203536|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161224871|NCT03384745|582203537|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
161224872|NCT03384745|582203538|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
161224873|NCT03384745|582203539|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
161224874|NCT03384745|582203540|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
160875164|NCT00669409|580939077|FG005|Part 2|Withdrawal by Subject|0|||
160875165|NCT00669409|580939078|FG006|Part 2|Withdrawal by Subject|0|||
160875166|NCT00669409|580939079|FG007|Part 2|Withdrawal by Subject|0|||
161224875|NCT03384745|582203535|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161224876|NCT03384745|582203536|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161324558|NCT00452439|582575625|FG001|Overall Study|Failed to achieve complete response|0|||
160875167|NCT00669409|580939080|FG008|Part 2|Withdrawal by Subject|0|||
161224877|NCT03384745|582203537|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161224878|NCT03384745|582203538|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
161224879|NCT03384745|582203539|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
161224880|NCT03384745|582203540|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
161224881|NCT03384745|582203535|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161224882|NCT03384745|582203536|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161224883|NCT03384745|582203537|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
161224884|NCT03384745|582203538|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161119666|NCT04418765|581825972|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
161119667|NCT04418765|581825973|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
161119668|NCT04418765|581825971|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
161119669|NCT04418765|581825972|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
161119670|NCT04418765|581825973|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
161119671|NCT04418765|581825971|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
161119672|NCT04418765|581825972|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
161119673|NCT04418765|581825973|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
161119674|NCT04418765|581825971|FG000|Extension Period (48 Weeks)|Other than specified|0|||
161119675|NCT04418765|581825972|FG001|Extension Period (48 Weeks)|Other than specified|5|||
161119676|NCT04418765|581825973|FG002|Extension Period (48 Weeks)|Other than specified|2|||
161119677|NCT01121393|581825977|FG000|Overall Study|Progressive disease|201|||
161119678|NCT01121393|581825978|FG001|Overall Study|Progressive disease|20|||
161119679|NCT01121393|581825977|FG000|Overall Study|Other Adverse events|24|||
161119680|NCT01121393|581825978|FG001|Overall Study|Other Adverse events|45|||
161119681|NCT01121393|581825977|FG000|Overall Study|Non-compliant with protocol|0|||
161119682|NCT01121393|581825978|FG001|Overall Study|Non-compliant with protocol|3|||
161119683|NCT01121393|581825977|FG000|Overall Study|Lost to Follow-up|1|||
161119684|NCT01121393|581825978|FG001|Overall Study|Lost to Follow-up|0|||
161119685|NCT01121393|581825977|FG000|Overall Study|Refused cont. medication|7|||
161119686|NCT01121393|581825978|FG001|Overall Study|Refused cont. medication|7|||
161119687|NCT01121393|581825977|FG000|Overall Study|Not treated|3|||
161119688|NCT01121393|581825978|FG001|Overall Study|Not treated|9|||
161119689|NCT01121393|581825977|FG000|Overall Study|Other than listed|6|||
161119690|NCT01121393|581825978|FG001|Overall Study|Other than listed|0|||
161224885|NCT03384745|582203539|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
161119691|NCT01926782|581825979|FG000|Overall Study|Participant moved|2|||
161119692|NCT01926782|581825980|FG001|Overall Study|Participant moved|0|||
161119693|NCT01926782|581825981|FG002|Overall Study|Participant moved|1|||
161119694|NCT01926782|581825982|FG003|Overall Study|Participant moved|1|||
161119695|NCT01926782|581825983|FG004|Overall Study|Participant moved|0|||
161119696|NCT01926782|581825984|FG005|Overall Study|Participant moved|3|||
161119697|NCT01926782|581825979|FG000|Overall Study|Physician Decision|0|||
161119698|NCT01926782|581825980|FG001|Overall Study|Physician Decision|2|||
161119699|NCT01926782|581825981|FG002|Overall Study|Physician Decision|1|||
161119700|NCT01926782|581825982|FG003|Overall Study|Physician Decision|1|||
161119701|NCT01926782|581825983|FG004|Overall Study|Physician Decision|0|||
161119702|NCT01926782|581825984|FG005|Overall Study|Physician Decision|0|||
161119703|NCT01926782|581825979|FG000|Overall Study|Other than specified|2|||
161119704|NCT01926782|581825980|FG001|Overall Study|Other than specified|3|||
161119705|NCT01926782|581825981|FG002|Overall Study|Other than specified|5|||
161119706|NCT01926782|581825982|FG003|Overall Study|Other than specified|12|||
161119707|NCT01926782|581825983|FG004|Overall Study|Other than specified|4|||
161119708|NCT01926782|581825984|FG005|Overall Study|Other than specified|11|||
161119709|NCT01926782|581825979|FG000|Overall Study|Adverse Event|13|||
161119710|NCT01926782|581825980|FG001|Overall Study|Adverse Event|4|||
161119711|NCT01926782|581825981|FG002|Overall Study|Adverse Event|17|||
161224886|NCT03384745|582203540|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
160875168|NCT00669409|580939081|FG009|Part 2|Withdrawal by Subject|1|||
161119712|NCT01926782|581825982|FG003|Overall Study|Adverse Event|4|||
161119713|NCT01926782|581825983|FG004|Overall Study|Adverse Event|3|||
161119714|NCT01926782|581825984|FG005|Overall Study|Adverse Event|14|||
161324559|NCT00452439|582575624|FG000|Overall Study|Relapse|3|||
161224887|NCT03384745|582203535|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161224888|NCT03384745|582203536|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
161224889|NCT03384745|582203537|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
161119715|NCT01926782|581825979|FG000|Overall Study|Poor compliance to protocol|5|||
161119716|NCT01926782|581825980|FG001|Overall Study|Poor compliance to protocol|3|||
161119717|NCT01926782|581825981|FG002|Overall Study|Poor compliance to protocol|8|||
161119718|NCT01926782|581825982|FG003|Overall Study|Poor compliance to protocol|0|||
161119719|NCT01926782|581825983|FG004|Overall Study|Poor compliance to protocol|1|||
161119720|NCT01926782|581825984|FG005|Overall Study|Poor compliance to protocol|6|||
161119721|NCT01926782|581825979|FG000|Overall Study|Randomized and not treated|0|||
161119722|NCT01926782|581825980|FG001|Overall Study|Randomized and not treated|0|||
161119723|NCT01926782|581825981|FG002|Overall Study|Randomized and not treated|0|||
161119724|NCT01926782|581825982|FG003|Overall Study|Randomized and not treated|1|||
161119725|NCT01926782|581825983|FG004|Overall Study|Randomized and not treated|0|||
161119726|NCT01926782|581825984|FG005|Overall Study|Randomized and not treated|0|||
161119727|NCT01926782|581825979|FG000|Overall Study|Withdrawal by Subject|6|||
161119728|NCT01926782|581825980|FG001|Overall Study|Withdrawal by Subject|1|||
161119729|NCT01926782|581825981|FG002|Overall Study|Withdrawal by Subject|8|||
161119730|NCT01926782|581825982|FG003|Overall Study|Withdrawal by Subject|1|||
161119731|NCT01926782|581825983|FG004|Overall Study|Withdrawal by Subject|0|||
161119732|NCT01926782|581825984|FG005|Overall Study|Withdrawal by Subject|5|||
161119733|NCT01926782|581825979|FG000|Overall Study|Related to study drug administration|0|||
161119734|NCT01926782|581825980|FG001|Overall Study|Related to study drug administration|0|||
161119735|NCT01926782|581825981|FG002|Overall Study|Related to study drug administration|0|||
161119736|NCT01926782|581825982|FG003|Overall Study|Related to study drug administration|0|||
161119737|NCT01926782|581825983|FG004|Overall Study|Related to study drug administration|0|||
161119738|NCT01926782|581825984|FG005|Overall Study|Related to study drug administration|2|||
161119739|NCT00577993|581825990|FG000|Overall Study|Adverse Event|1|||
161119740|NCT00577993|581825991|FG001|Overall Study|Adverse Event|0|||
161119741|NCT00577993|581825992|FG002|Overall Study|Adverse Event|0|||
161119742|NCT00577993|581825990|FG000|Overall Study|Death|0|||
161119743|NCT00577993|581825991|FG001|Overall Study|Death|1|||
161119744|NCT00577993|581825992|FG002|Overall Study|Death|1|||
161224890|NCT03384745|582203538|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160875169|NCT00669409|580939082|FG010|Part 2|Withdrawal by Subject|0|||
160875170|NCT00095940|580939085|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
160875171|NCT00095940|580939086|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
160875172|NCT00095940|580939087|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
160875173|NCT00095940|580939088|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
160875174|NCT00095940|580939089|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
160875175|NCT00095940|580939090|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
160875176|NCT00095940|580939091|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
160875177|NCT00095940|580939092|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
160875178|NCT00095940|580939093|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
160875179|NCT00095940|580939085|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875180|NCT00095940|580939086|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875181|NCT00095940|580939087|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875182|NCT00095940|580939088|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875183|NCT00095940|580939089|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875184|NCT00095940|580939090|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875185|NCT00095940|580939091|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875186|NCT00095940|580939092|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
160875187|NCT00095940|580939093|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
160875188|NCT00095940|580939085|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875189|NCT00095940|580939086|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
161119745|NCT00577993|581825990|FG000|Overall Study|Lack of Efficacy|0|||
161119746|NCT00577993|581825991|FG001|Overall Study|Lack of Efficacy|1|||
161119747|NCT00577993|581825992|FG002|Overall Study|Lack of Efficacy|0|||
161224891|NCT03384745|582203539|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160875190|NCT00095940|580939087|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875191|NCT00095940|580939088|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875192|NCT00095940|580939089|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875193|NCT00095940|580939090|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875194|NCT00095940|580939091|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875195|NCT00095940|580939092|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
160875196|NCT00095940|580939093|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
160875197|NCT01716052|580939094|FG000|Overall Study|Withdrawal of funding|1|||
160875198|NCT01716052|580939095|FG001|Overall Study|Withdrawal of funding|1|||
160875199|NCT02864862|580939101|FG000|Overall Study|Lost to Follow-up|1|||
160875200|NCT02864862|580939102|FG001|Overall Study|Lost to Follow-up|0|||
160875201|NCT02864862|580939103|FG002|Overall Study|Lost to Follow-up|1|||
160875202|NCT02864862|580939101|FG000|Overall Study|Protocol Violation|0|||
160875203|NCT02864862|580939102|FG001|Overall Study|Protocol Violation|0|||
160875204|NCT02864862|580939103|FG002|Overall Study|Protocol Violation|1|||
160875205|NCT01523275|580939107|FG000|Overall Study|Lost to Follow-up|1|||
160875206|NCT01523275|580939108|FG001|Overall Study|Lost to Follow-up|2|||
160875207|NCT01523275|580939107|FG000|Overall Study|Withdrawal by Subject|1|||
160875208|NCT01523275|580939108|FG001|Overall Study|Withdrawal by Subject|0|||
160875209|NCT03263702|580939109|FG000|Overall Study|Lost to Follow-up|2|||
160875210|NCT03263702|580939110|FG001|Overall Study|Lost to Follow-up|2|||
160875211|NCT03263702|580939109|FG000|Overall Study|Withdrawal by Subject|1|||
160875212|NCT03263702|580939110|FG001|Overall Study|Withdrawal by Subject|2|||
160875213|NCT03598114|580939111|FG000|Overall Study|Staff turnover/left the program|3|||
160875214|NCT03598114|580939112|FG001|Overall Study|Staff turnover/left the program|39|||
160875215|NCT02527200|580939113|FG000|Overall Study|Withdrawal by Subject|3|||
160875216|NCT02527200|580939114|FG001|Overall Study|Withdrawal by Subject|2|||
160875217|NCT02527200|580939115|FG002|Overall Study|Withdrawal by Subject|1|||
160875218|NCT02527200|580939116|FG003|Overall Study|Withdrawal by Subject|0|||
160875219|NCT02527200|580939113|FG000|Overall Study|Unclassified|0|||
160875220|NCT02527200|580939114|FG001|Overall Study|Unclassified|1|||
160875221|NCT02527200|580939115|FG002|Overall Study|Unclassified|0|||
160875222|NCT02527200|580939116|FG003|Overall Study|Unclassified|0|||
160875223|NCT02527200|580939113|FG000|Overall Study|Lost to Follow-up|0|||
160875224|NCT02527200|580939114|FG001|Overall Study|Lost to Follow-up|0|||
160875225|NCT02527200|580939115|FG002|Overall Study|Lost to Follow-up|1|||
160875226|NCT02527200|580939116|FG003|Overall Study|Lost to Follow-up|0|||
160875227|NCT00966875|580939117|FG000|Part A|Adverse Event|2|||
160875228|NCT00966875|580939118|FG001|Part A|Adverse Event|1|||
160875229|NCT00966875|580939119|FG002|Part A|Adverse Event|0|||
160875230|NCT00966875|580939120|FG003|Part A|Adverse Event|1|||
160875231|NCT00966875|580939121|FG004|Part A|Adverse Event|0|||
160875232|NCT00966875|580939122|FG005|Part A|Adverse Event|1|||
160875233|NCT00966875|580939123|FG006|Part A|Adverse Event|0|||
161224892|NCT03384745|582203540|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
160875234|NCT00966875|580939124|FG007|Part A|Adverse Event|3|||
160875235|NCT00966875|580939125|FG008|Part A|Adverse Event|3|||
160875236|NCT00966875|580939117|FG000|Part A|Entry Criteria|0|||
160875237|NCT00966875|580939118|FG001|Part A|Entry Criteria|0|||
160875238|NCT00966875|580939119|FG002|Part A|Entry Criteria|0|||
160875239|NCT00966875|580939120|FG003|Part A|Entry Criteria|0|||
161224893|NCT03384745|582203535|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161224894|NCT03384745|582203536|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161224895|NCT03384745|582203537|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161224896|NCT03384745|582203538|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
161224897|NCT03384745|582203539|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
161224898|NCT03384745|582203540|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
161224899|NCT03384745|582203535|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161224900|NCT03384745|582203536|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161224901|NCT03384745|582203537|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161224902|NCT03384745|582203538|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161224903|NCT03384745|582203539|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
161224904|NCT03384745|582203540|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
161224905|NCT03384745|582203535|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161224906|NCT03384745|582203536|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161224907|NCT03384745|582203537|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
161224908|NCT03384745|582203538|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
161224909|NCT03384745|582203539|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161224910|NCT03384745|582203540|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
161224911|NCT03384745|582203535|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161224912|NCT03384745|582203536|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161224913|NCT03384745|582203537|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
161224914|NCT03384745|582203538|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
161224915|NCT03384745|582203539|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
161224916|NCT03384745|582203540|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
161224917|NCT03384745|582203535|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
161224918|NCT03384745|582203536|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
161224919|NCT03384745|582203537|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
161224920|NCT03384745|582203538|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
161224921|NCT03384745|582203539|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
161224922|NCT03384745|582203540|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
161224923|NCT03384745|582203535|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161224924|NCT03384745|582203536|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161224925|NCT03384745|582203537|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161224926|NCT03384745|582203538|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
161224927|NCT03384745|582203539|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161224928|NCT03384745|582203540|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
161224929|NCT03384745|582203535|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
161224930|NCT03384745|582203536|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
161224931|NCT03384745|582203537|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
161224932|NCT03384745|582203538|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
161224933|NCT03384745|582203539|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
161224934|NCT03384745|582203540|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
161224935|NCT01058421|582203543|FG000|1 Month Outcomes|Death|10|||
161224936|NCT01058421|582203544|FG001|1 Month Outcomes|Death|6|||
161224937|NCT01058421|582203543|FG000|1 Month Outcomes|Lost to Follow-up|8|||
161224938|NCT01058421|582203544|FG001|1 Month Outcomes|Lost to Follow-up|7|||
161224939|NCT01058421|582203543|FG000|1 Month Outcomes|Remained in Hospital|5|||
160875240|NCT00966875|580939121|FG004|Part A|Entry Criteria|0|||
160875241|NCT00966875|580939122|FG005|Part A|Entry Criteria|2|||
160875242|NCT00966875|580939123|FG006|Part A|Entry Criteria|0|||
160875243|NCT00966875|580939124|FG007|Part A|Entry Criteria|0|||
160875244|NCT00966875|580939125|FG008|Part A|Entry Criteria|0|||
160875245|NCT00966875|580939117|FG000|Part A|Lack of Efficacy|0|||
160875246|NCT00966875|580939118|FG001|Part A|Lack of Efficacy|1|||
160875247|NCT00966875|580939119|FG002|Part A|Lack of Efficacy|0|||
160875248|NCT00966875|580939120|FG003|Part A|Lack of Efficacy|0|||
160875249|NCT00966875|580939121|FG004|Part A|Lack of Efficacy|0|||
160875250|NCT00966875|580939122|FG005|Part A|Lack of Efficacy|0|||
160875251|NCT00966875|580939123|FG006|Part A|Lack of Efficacy|4|||
160875252|NCT00966875|580939124|FG007|Part A|Lack of Efficacy|0|||
160875253|NCT00966875|580939125|FG008|Part A|Lack of Efficacy|0|||
160875254|NCT00966875|580939117|FG000|Part A|Lost to Follow-up|2|||
160875255|NCT00966875|580939118|FG001|Part A|Lost to Follow-up|0|||
160875256|NCT00966875|580939119|FG002|Part A|Lost to Follow-up|0|||
160875257|NCT00966875|580939120|FG003|Part A|Lost to Follow-up|0|||
161119748|NCT00577993|581825990|FG000|Overall Study|Protocol Violation|2|||
161119749|NCT00577993|581825991|FG001|Overall Study|Protocol Violation|3|||
161119750|NCT00577993|581825992|FG002|Overall Study|Protocol Violation|0|||
161119751|NCT00577993|581825990|FG000|Overall Study|Withdrawal by Subject|1|||
161119752|NCT00577993|581825991|FG001|Overall Study|Withdrawal by Subject|0|||
161119753|NCT00577993|581825992|FG002|Overall Study|Withdrawal by Subject|2|||
161119754|NCT00577993|581825990|FG000|Overall Study|Conversion|2|||
161119755|NCT00577993|581825991|FG001|Overall Study|Conversion|5|||
161119756|NCT00577993|581825992|FG002|Overall Study|Conversion|0|||
161119757|NCT00577993|581825990|FG000|Overall Study|Uninsured|1|||
161119758|NCT00577993|581825991|FG001|Overall Study|Uninsured|0|||
161119759|NCT00577993|581825992|FG002|Overall Study|Uninsured|0|||
161119760|NCT02217566|581825993|FG000|Overall Study|Lost to Follow-up|2|||
161119761|NCT02217566|581825993|FG000|Overall Study|Death|3|||
161119762|NCT02217566|581825993|FG000|Overall Study|Early study termination|6|||
161119763|NCT02064387|581825998|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119764|NCT02064387|581825999|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119765|NCT02064387|581826000|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119766|NCT02064387|581826001|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119767|NCT02064387|581826002|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119768|NCT02064387|581826003|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119769|NCT02064387|581826004|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119770|NCT02064387|581826005|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
161119771|NCT02064387|581826006|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119772|NCT02064387|581826007|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
161119773|NCT02064387|581826008|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119774|NCT02064387|581826009|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
161119775|NCT02064387|581825998|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119776|NCT02064387|581825999|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119777|NCT02064387|581826000|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119778|NCT02064387|581826001|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119779|NCT02064387|581826002|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119780|NCT02064387|581826003|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119781|NCT02064387|581826004|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119782|NCT02064387|581826005|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
161119783|NCT02064387|581826006|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119784|NCT02064387|581826007|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119785|NCT02064387|581826008|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119786|NCT02064387|581826009|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
161119787|NCT02064387|581825998|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119788|NCT02064387|581825999|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119789|NCT02064387|581826000|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119790|NCT02064387|581826001|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119791|NCT02064387|581826002|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119792|NCT02064387|581826003|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119793|NCT02064387|581826004|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119794|NCT02064387|581826005|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119795|NCT02064387|581826006|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
161119796|NCT02064387|581826007|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160875258|NCT00966875|580939121|FG004|Part A|Lost to Follow-up|0|||
160875259|NCT00966875|580939122|FG005|Part A|Lost to Follow-up|1|||
160875260|NCT00966875|580939123|FG006|Part A|Lost to Follow-up|0|||
161119797|NCT02064387|581826008|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
160875261|NCT00966875|580939124|FG007|Part A|Lost to Follow-up|0|||
160875262|NCT00966875|580939125|FG008|Part A|Lost to Follow-up|0|||
160875263|NCT00966875|580939117|FG000|Part A|Parent/Caregiver Decision|0|||
160875264|NCT00966875|580939118|FG001|Part A|Parent/Caregiver Decision|0|||
160875265|NCT00966875|580939119|FG002|Part A|Parent/Caregiver Decision|0|||
160875266|NCT00966875|580939120|FG003|Part A|Parent/Caregiver Decision|1|||
160875267|NCT00966875|580939121|FG004|Part A|Parent/Caregiver Decision|0|||
160875268|NCT00966875|580939122|FG005|Part A|Parent/Caregiver Decision|0|||
160875269|NCT00966875|580939123|FG006|Part A|Parent/Caregiver Decision|0|||
160875270|NCT00966875|580939124|FG007|Part A|Parent/Caregiver Decision|0|||
160875271|NCT00966875|580939125|FG008|Part A|Parent/Caregiver Decision|0|||
160875272|NCT00966875|580939117|FG000|Part A|Physician Decision|0|||
160875273|NCT00966875|580939118|FG001|Part A|Physician Decision|0|||
160875274|NCT00966875|580939119|FG002|Part A|Physician Decision|0|||
160875275|NCT00966875|580939120|FG003|Part A|Physician Decision|0|||
160875276|NCT00966875|580939121|FG004|Part A|Physician Decision|1|||
160875277|NCT00966875|580939122|FG005|Part A|Physician Decision|0|||
160875278|NCT00966875|580939123|FG006|Part A|Physician Decision|1|||
160875279|NCT00966875|580939124|FG007|Part A|Physician Decision|0|||
160875280|NCT00966875|580939125|FG008|Part A|Physician Decision|2|||
160875281|NCT00966875|580939117|FG000|Part A|Sponsor Decision|0|||
160875282|NCT00966875|580939118|FG001|Part A|Sponsor Decision|0|||
160875283|NCT00966875|580939119|FG002|Part A|Sponsor Decision|1|||
160875284|NCT00966875|580939120|FG003|Part A|Sponsor Decision|0|||
160875285|NCT00966875|580939121|FG004|Part A|Sponsor Decision|1|||
160875286|NCT00966875|580939122|FG005|Part A|Sponsor Decision|0|||
160875287|NCT00966875|580939123|FG006|Part A|Sponsor Decision|0|||
160875288|NCT00966875|580939124|FG007|Part A|Sponsor Decision|2|||
160875289|NCT00966875|580939125|FG008|Part A|Sponsor Decision|1|||
160875290|NCT00966875|580939117|FG000|Part A|Withdrawal by Subject|2|||
160875291|NCT00966875|580939118|FG001|Part A|Withdrawal by Subject|2|||
160875292|NCT00966875|580939119|FG002|Part A|Withdrawal by Subject|1|||
160875293|NCT00966875|580939120|FG003|Part A|Withdrawal by Subject|1|||
160875294|NCT00966875|580939121|FG004|Part A|Withdrawal by Subject|3|||
160875295|NCT00966875|580939122|FG005|Part A|Withdrawal by Subject|0|||
160875296|NCT00966875|580939123|FG006|Part A|Withdrawal by Subject|5|||
160875297|NCT00966875|580939124|FG007|Part A|Withdrawal by Subject|1|||
160875298|NCT00966875|580939125|FG008|Part A|Withdrawal by Subject|1|||
160875299|NCT00966875|580939117|FG000|Part A|Protocol Violation|0|||
160875300|NCT00966875|580939118|FG001|Part A|Protocol Violation|0|||
160875301|NCT00966875|580939119|FG002|Part A|Protocol Violation|0|||
160875302|NCT00966875|580939120|FG003|Part A|Protocol Violation|0|||
160875303|NCT00966875|580939121|FG004|Part A|Protocol Violation|0|||
160875304|NCT00966875|580939122|FG005|Part A|Protocol Violation|0|||
160875305|NCT00966875|580939123|FG006|Part A|Protocol Violation|2|||
160875306|NCT00966875|580939124|FG007|Part A|Protocol Violation|1|||
160875307|NCT00966875|580939125|FG008|Part A|Protocol Violation|1|||
160875308|NCT00966875|580939117|FG000|Part B|Adverse Event|0|||
160875309|NCT00966875|580939118|FG001|Part B|Adverse Event|1|||
160875310|NCT00966875|580939119|FG002|Part B|Adverse Event|1|||
160875311|NCT00966875|580939120|FG003|Part B|Adverse Event|0|||
160875312|NCT00966875|580939121|FG004|Part B|Adverse Event|1|||
160875313|NCT00966875|580939122|FG005|Part B|Adverse Event|0|||
160875314|NCT00966875|580939123|FG006|Part B|Adverse Event|5|||
160875315|NCT00966875|580939124|FG007|Part B|Adverse Event|2|||
160875316|NCT00966875|580939125|FG008|Part B|Adverse Event|2|||
160875317|NCT00966875|580939117|FG000|Part B|Death|0|||
160875318|NCT00966875|580939118|FG001|Part B|Death|0|||
160875319|NCT00966875|580939119|FG002|Part B|Death|1|||
160875320|NCT00966875|580939120|FG003|Part B|Death|0|||
160875321|NCT00966875|580939121|FG004|Part B|Death|0|||
160875322|NCT00966875|580939122|FG005|Part B|Death|0|||
160875323|NCT00966875|580939123|FG006|Part B|Death|0|||
160875324|NCT00966875|580939124|FG007|Part B|Death|1|||
160875325|NCT00966875|580939125|FG008|Part B|Death|0|||
160875326|NCT00966875|580939117|FG000|Part B|Lack of Efficacy|2|||
160875327|NCT00966875|580939118|FG001|Part B|Lack of Efficacy|1|||
160875328|NCT00966875|580939119|FG002|Part B|Lack of Efficacy|1|||
160875329|NCT00966875|580939120|FG003|Part B|Lack of Efficacy|1|||
160875330|NCT00966875|580939121|FG004|Part B|Lack of Efficacy|2|||
160875331|NCT00966875|580939122|FG005|Part B|Lack of Efficacy|3|||
160875332|NCT00966875|580939123|FG006|Part B|Lack of Efficacy|12|||
160875333|NCT00966875|580939124|FG007|Part B|Lack of Efficacy|9|||
160875334|NCT00966875|580939125|FG008|Part B|Lack of Efficacy|6|||
160875335|NCT00966875|580939117|FG000|Part B|Lost to Follow-up|0|||
160875336|NCT00966875|580939118|FG001|Part B|Lost to Follow-up|0|||
160875337|NCT00966875|580939119|FG002|Part B|Lost to Follow-up|0|||
160875338|NCT00966875|580939120|FG003|Part B|Lost to Follow-up|1|||
160875339|NCT00966875|580939121|FG004|Part B|Lost to Follow-up|0|||
160875340|NCT00966875|580939122|FG005|Part B|Lost to Follow-up|0|||
160875341|NCT00966875|580939123|FG006|Part B|Lost to Follow-up|0|||
160875342|NCT00966875|580939124|FG007|Part B|Lost to Follow-up|0|||
160875343|NCT00966875|580939125|FG008|Part B|Lost to Follow-up|1|||
160875344|NCT00966875|580939117|FG000|Part B|Physician Decision|0|||
160875345|NCT00966875|580939118|FG001|Part B|Physician Decision|0|||
160875346|NCT00966875|580939119|FG002|Part B|Physician Decision|1|||
160875347|NCT00966875|580939120|FG003|Part B|Physician Decision|0|||
160875348|NCT00966875|580939121|FG004|Part B|Physician Decision|2|||
160875349|NCT00966875|580939122|FG005|Part B|Physician Decision|1|||
160875350|NCT00966875|580939123|FG006|Part B|Physician Decision|0|||
160875351|NCT00966875|580939124|FG007|Part B|Physician Decision|0|||
161224940|NCT01058421|582203544|FG001|1 Month Outcomes|Remained in Hospital|12|||
161224941|NCT01058421|582203543|FG000|1 Month Outcomes|Remained in Other Facility|16|||
160875352|NCT00966875|580939125|FG008|Part B|Physician Decision|2|||
160875353|NCT00966875|580939117|FG000|Part B|Sponsor Decision|1|||
161224942|NCT01058421|582203544|FG001|1 Month Outcomes|Remained in Other Facility|17|||
161224943|NCT01058421|582203543|FG000|3 Month Outcomes|Death|3|||
161224944|NCT01058421|582203544|FG001|3 Month Outcomes|Death|5|||
161224945|NCT01058421|582203543|FG000|3 Month Outcomes|Lost to Follow-up|12|||
161224946|NCT01058421|582203544|FG001|3 Month Outcomes|Lost to Follow-up|11|||
161224947|NCT01058421|582203543|FG000|3 Month Outcomes|Remained in Hospital|0|||
161224948|NCT01058421|582203544|FG001|3 Month Outcomes|Remained in Hospital|2|||
161224949|NCT01058421|582203543|FG000|3 Month Outcomes|Remained in Other Facility|5|||
161224950|NCT01058421|582203544|FG001|3 Month Outcomes|Remained in Other Facility|8|||
161224951|NCT01058421|582203543|FG000|6 Month Outcomes|Death|2|||
161224952|NCT01058421|582203544|FG001|6 Month Outcomes|Death|2|||
161224953|NCT01058421|582203543|FG000|6 Month Outcomes|Lost to Follow-up|16|||
161224954|NCT01058421|582203544|FG001|6 Month Outcomes|Lost to Follow-up|21|||
161224955|NCT01058421|582203543|FG000|6 Month Outcomes|Remained in Other Facility|1|||
161224956|NCT01058421|582203544|FG001|6 Month Outcomes|Remained in Other Facility|3|||
161224957|NCT02984683|582203545|FG000|Overall Study|Adverse Event|3|||
161224958|NCT02984683|582203546|FG001|Overall Study|Adverse Event|3|||
161224959|NCT02984683|582203545|FG000|Overall Study|Withdrawal by Subject|1|||
161224960|NCT02984683|582203546|FG001|Overall Study|Withdrawal by Subject|0|||
161224961|NCT02984683|582203545|FG000|Overall Study|Disease progression|7|||
161224962|NCT02984683|582203546|FG001|Overall Study|Disease progression|9|||
161224963|NCT02260492|582203547|FG000|Overall Study|Adverse Event|6|||
161224964|NCT02260492|582203548|FG001|Overall Study|Adverse Event|1|||
161224965|NCT02260492|582203549|FG002|Overall Study|Adverse Event|2|||
161224966|NCT02260492|582203547|FG000|Overall Study|Death|0|||
161224967|NCT02260492|582203548|FG001|Overall Study|Death|1|||
161224968|NCT02260492|582203549|FG002|Overall Study|Death|0|||
161224969|NCT02260492|582203547|FG000|Overall Study|Lost to Follow-up|12|||
161224970|NCT02260492|582203548|FG001|Overall Study|Lost to Follow-up|9|||
161224971|NCT02260492|582203549|FG002|Overall Study|Lost to Follow-up|0|||
161224972|NCT02260492|582203547|FG000|Overall Study|Physician Decision|2|||
161224973|NCT02260492|582203548|FG001|Overall Study|Physician Decision|0|||
161224974|NCT02260492|582203549|FG002|Overall Study|Physician Decision|1|||
161224975|NCT02260492|582203547|FG000|Overall Study|Withdrawal by Subject|3|||
161224976|NCT02260492|582203548|FG001|Overall Study|Withdrawal by Subject|2|||
161224977|NCT02260492|582203549|FG002|Overall Study|Withdrawal by Subject|2|||
161224978|NCT03131999|582203550|FG000|Overall Study|Withdrawal by Subject|0|||
161224979|NCT03131999|582203551|FG001|Overall Study|Withdrawal by Subject|1|||
161224980|NCT04634409|582203552|FG000|Overall Study|Death|0|||
161224981|NCT04634409|582203553|FG001|Overall Study|Death|0|||
161224982|NCT04634409|582203554|FG002|Overall Study|Death|0|||
161224983|NCT04634409|582203555|FG003|Overall Study|Death|0|||
161224984|NCT04634409|582203556|FG004|Overall Study|Death|0|||
161224985|NCT04634409|582203557|FG005|Overall Study|Death|0|||
161224986|NCT04634409|582203558|FG006|Overall Study|Death|0|||
161224987|NCT04634409|582203559|FG007|Overall Study|Death|0|||
161224988|NCT04634409|582203560|FG008|Overall Study|Death|0|||
161224989|NCT04634409|582203561|FG009|Overall Study|Death|0|||
161224990|NCT04634409|582203562|FG010|Overall Study|Death|1|||
161224991|NCT04634409|582203563|FG011|Overall Study|Death|0|||
160875354|NCT00966875|580939118|FG001|Part B|Sponsor Decision|0|||
160875355|NCT00966875|580939119|FG002|Part B|Sponsor Decision|0|||
160875356|NCT00966875|580939120|FG003|Part B|Sponsor Decision|0|||
160875357|NCT00966875|580939121|FG004|Part B|Sponsor Decision|0|||
160875358|NCT00966875|580939122|FG005|Part B|Sponsor Decision|1|||
160875359|NCT00966875|580939123|FG006|Part B|Sponsor Decision|0|||
160875360|NCT00966875|580939124|FG007|Part B|Sponsor Decision|2|||
160875361|NCT00966875|580939125|FG008|Part B|Sponsor Decision|1|||
160875362|NCT00966875|580939117|FG000|Part B|Withdrawal by Subject|2|||
160875363|NCT00966875|580939118|FG001|Part B|Withdrawal by Subject|1|||
160875364|NCT00966875|580939119|FG002|Part B|Withdrawal by Subject|2|||
160875365|NCT00966875|580939120|FG003|Part B|Withdrawal by Subject|1|||
160875366|NCT00966875|580939121|FG004|Part B|Withdrawal by Subject|2|||
160875367|NCT00966875|580939122|FG005|Part B|Withdrawal by Subject|1|||
160875368|NCT00966875|580939123|FG006|Part B|Withdrawal by Subject|4|||
160875369|NCT00966875|580939124|FG007|Part B|Withdrawal by Subject|5|||
160875370|NCT00966875|580939125|FG008|Part B|Withdrawal by Subject|5|||
160875371|NCT00966875|580939117|FG000|Part B|Entry Criteria|0|||
160875372|NCT00966875|580939118|FG001|Part B|Entry Criteria|0|||
160875373|NCT00966875|580939119|FG002|Part B|Entry Criteria|0|||
160875374|NCT00966875|580939120|FG003|Part B|Entry Criteria|0|||
160875375|NCT00966875|580939121|FG004|Part B|Entry Criteria|0|||
160875376|NCT00966875|580939122|FG005|Part B|Entry Criteria|0|||
160875377|NCT00966875|580939123|FG006|Part B|Entry Criteria|1|||
160875378|NCT00966875|580939124|FG007|Part B|Entry Criteria|0|||
160875379|NCT00966875|580939125|FG008|Part B|Entry Criteria|1|||
160875380|NCT00444678|580939126|FG000|Overall Study|Toxicity|11|||
160875381|NCT00444678|580939126|FG000|Overall Study|Disease Progression|12|||
160875382|NCT00444678|580939126|FG000|Overall Study|Death|3|||
160875383|NCT00444678|580939126|FG000|Overall Study|Physician Decision|3|||
160875384|NCT00444678|580939126|FG000|Overall Study|Withdrawal by Subject|2|||
160875385|NCT01305577|580939129|FG000|Overall Study|Adverse Event|2|||
160875386|NCT01305577|580939130|FG001|Overall Study|Adverse Event|2|||
160875387|NCT01305577|580939131|FG002|Overall Study|Adverse Event|1|||
160875388|NCT01305577|580939129|FG000|Overall Study|Withdrawal by Subject|7|||
160875389|NCT01305577|580939130|FG001|Overall Study|Withdrawal by Subject|5|||
160875390|NCT01305577|580939131|FG002|Overall Study|Withdrawal by Subject|6|||
160875391|NCT01305577|580939129|FG000|Overall Study|Lost to Follow-up|4|||
160875392|NCT01305577|580939130|FG001|Overall Study|Lost to Follow-up|3|||
160875393|NCT01305577|580939131|FG002|Overall Study|Lost to Follow-up|2|||
160875394|NCT01305577|580939129|FG000|Overall Study|Protocol Deviation|0|||
160875395|NCT01305577|580939130|FG001|Overall Study|Protocol Deviation|1|||
160875396|NCT01305577|580939131|FG002|Overall Study|Protocol Deviation|1|||
160875397|NCT00796978|580939132|FG000|Overall Study|Cardiac adverse event|5|||
160875398|NCT00796978|580939132|FG000|Overall Study|Adverse Event|4|||
160875399|NCT00796978|580939132|FG000|Overall Study|Withdrawal by Subject|3|||
160875400|NCT01256190|580939133|FG000|Overall Study|Lost to Follow-up|2|||
160875401|NCT01256190|580939134|FG001|Overall Study|Lost to Follow-up|0|||
160875402|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
160875403|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
161119798|NCT02064387|581826009|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
161119799|NCT02064387|581825998|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
161119800|NCT02064387|581825999|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
161119801|NCT02064387|581826000|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
161119802|NCT02064387|581826001|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
161119803|NCT02064387|581826002|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
161119804|NCT02064387|581826003|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
160875404|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
160875405|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
160875406|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
160875407|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
160875408|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
160875409|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
160875410|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
160875411|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
160875412|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
160875413|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
160875414|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
160875415|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
161119805|NCT02064387|581826004|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
160875416|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
160875417|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
160875418|NCT02834793|580939135|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
160875419|NCT02834793|580939136|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
160875420|NCT02834793|580939137|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
160875421|NCT02834793|580939138|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
160875422|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
160875423|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
160875424|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
160875425|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
160875426|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
160875427|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
160875428|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
160875429|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
160875430|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
160875431|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
160875432|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
160875433|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
160875434|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
160875435|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
160875436|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
160875437|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
160875438|NCT02834793|580939135|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
160875439|NCT02834793|580939136|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
160875440|NCT02834793|580939137|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
160875441|NCT02834793|580939138|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
160875442|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
160875443|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
160875444|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
160875445|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
160875446|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
160875447|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
160875448|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
160875449|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
160875450|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
160875451|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
160875452|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
160875453|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
160875454|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
160875455|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
160875456|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
160875457|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
160875458|NCT02834793|580939135|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
160875459|NCT02834793|580939136|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
160875460|NCT02834793|580939137|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
160875461|NCT02834793|580939138|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
160875462|NCT02364336|580939139|FG000|Overall Study|Adverse Event|0|||
160875463|NCT02364336|580939140|FG001|Overall Study|Adverse Event|1|||
160875464|NCT01731938|580939141|FG000|Preliminary Part I|Withdrawal by Subject|2|||
160875465|NCT01731938|580939142|FG001|Preliminary Part I|Withdrawal by Subject|2|||
160875466|NCT01731938|580939141|FG000|Preliminary Part I|Physician Decision|1|||
160875467|NCT01731938|580939142|FG001|Preliminary Part I|Physician Decision|0|||
160875468|NCT01731938|580939141|FG000|Preliminary Part I|Lost to Follow-up|0|||
160875469|NCT01731938|580939142|FG001|Preliminary Part I|Lost to Follow-up|3|||
160875470|NCT01731938|580939141|FG000|Preliminary Part I|Missed Week 6 visit|0|||
160875471|NCT01731938|580939142|FG001|Preliminary Part I|Missed Week 6 visit|3|||
160875472|NCT01731938|580939141|FG000|Primary Part II|Withdrawal by Subject|5|||
160875473|NCT01731938|580939142|FG001|Primary Part II|Withdrawal by Subject|4|||
160875474|NCT01731938|580939141|FG000|Primary Part II|Lost to Follow-up|4|||
160875475|NCT01731938|580939142|FG001|Primary Part II|Lost to Follow-up|5|||
160875476|NCT01731938|580939141|FG000|Primary Part II|Death|2|||
160875477|NCT01731938|580939142|FG001|Primary Part II|Death|1|||
160875478|NCT01731938|580939141|FG000|Primary Part II|Missed Week 6 visit|2|||
160875479|NCT01731938|580939142|FG001|Primary Part II|Missed Week 6 visit|3|||
160875480|NCT03319745|580939143|FG000|Overall Study|Death|1|||
160875481|NCT03319745|580939143|FG000|Overall Study|Toxicity Precluding Surgery|1|||
160875482|NCT01317550|580939144|FG000|Overall Study|Withdrawal by Subject|1|||
160875483|NCT01317550|580939145|FG001|Overall Study|Withdrawal by Subject|0|||
160875484|NCT01317550|580939146|FG002|Overall Study|Withdrawal by Subject|0|||
160875485|NCT01317550|580939147|FG003|Overall Study|Withdrawal by Subject|0|||
161224992|NCT04634409|582203564|FG012|Overall Study|Death|1|||
160875486|NCT01317550|580939144|FG000|Overall Study|Lack of compliance study med|1|||
160875487|NCT01317550|580939145|FG001|Overall Study|Lack of compliance study med|0|||
160875488|NCT01317550|580939146|FG002|Overall Study|Lack of compliance study med|0|||
160875489|NCT01317550|580939147|FG003|Overall Study|Lack of compliance study med|0|||
160875490|NCT00870103|580939148|FG000|Overall Study|Physician Decision|2|||
160875491|NCT00870103|580939148|FG000|Overall Study|Lost to Follow-up|2|||
160875492|NCT03179202|580939149|FG000|Overall Study|Screen Failure|67|||
160875493|NCT03179202|580939149|FG000|Overall Study|Subject Lost to Follow Up|12|||
160875494|NCT03179202|580939149|FG000|Overall Study|Withdrawal by Subject|7|||
160875495|NCT03179202|580939149|FG000|Overall Study|Adverse Event|3|||
160875496|NCT03179202|580939149|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
160875497|NCT03179202|580939149|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
160875498|NCT03255629|580939150|FG000|Overall Study|Adverse Event|1|||
160875499|NCT03255629|580939151|FG001|Overall Study|Adverse Event|0|||
160875500|NCT03255629|580939150|FG000|Overall Study|did not experience hypoglycemia|2|||
160875501|NCT03255629|580939151|FG001|Overall Study|did not experience hypoglycemia|1|||
160875502|NCT02082340|580939153|FG000|Overall Study|Lost to Follow-up|1|||
160875503|NCT02082340|580939154|FG001|Overall Study|Lost to Follow-up|1|||
160875504|NCT03899805|580939155|FG000|Overall Study|Physician Decision|3|||
160875505|NCT03899805|580939156|FG001|Overall Study|Physician Decision|0|||
160875506|NCT03899805|580939157|FG002|Overall Study|Physician Decision|2|||
160875507|NCT03899805|580939155|FG000|Overall Study|Withdrawal by Subject|1|||
160875508|NCT03899805|580939156|FG001|Overall Study|Withdrawal by Subject|0|||
160875509|NCT03899805|580939157|FG002|Overall Study|Withdrawal by Subject|2|||
160875510|NCT03899805|580939155|FG000|Overall Study|Progressive Disease|10|||
160875511|NCT03899805|580939156|FG001|Overall Study|Progressive Disease|18|||
160875512|NCT03899805|580939157|FG002|Overall Study|Progressive Disease|12|||
160875513|NCT03899805|580939155|FG000|Overall Study|Adverse Event|3|||
160875514|NCT03899805|580939156|FG001|Overall Study|Adverse Event|1|||
160875515|NCT03899805|580939157|FG002|Overall Study|Adverse Event|0|||
160875516|NCT03899805|580939155|FG000|Overall Study|Death|2|||
160875517|NCT03899805|580939156|FG001|Overall Study|Death|0|||
160875518|NCT03899805|580939157|FG002|Overall Study|Death|0|||
160875519|NCT03899805|580939155|FG000|Overall Study|Came off for surgery|0|||
160875520|NCT03899805|580939156|FG001|Overall Study|Came off for surgery|0|||
160875521|NCT03899805|580939157|FG002|Overall Study|Came off for surgery|1|||
160875522|NCT05246514|580939158|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
160875523|NCT05246514|580939158|FG000|Overall Study|Withdrawal by Subject|1|||
160875524|NCT05246514|580939158|FG000|Overall Study|Death|13|||
160875525|NCT04195893|580939159|FG000|Second Intervention|Withdrawal by Subject|1|||
160875526|NCT04195893|580939160|FG001|Second Intervention|Withdrawal by Subject|0|||
160875527|NCT01802073|580939161|FG000|Overall Study|Lost to Follow-up|0|||
160875528|NCT01802073|580939162|FG001|Overall Study|Lost to Follow-up|1|||
160875529|NCT01802073|580939161|FG000|Overall Study|Non-compliant|4|||
160875530|NCT01802073|580939162|FG001|Overall Study|Non-compliant|2|||
160875531|NCT01802073|580939161|FG000|Overall Study|Withdrawal by Subject|1|||
160875532|NCT01802073|580939162|FG001|Overall Study|Withdrawal by Subject|1|||
160875533|NCT01802073|580939161|FG000|Overall Study|Physician Decision|0|||
160875534|NCT01802073|580939162|FG001|Overall Study|Physician Decision|7|||
160875535|NCT01137604|580939163|FG000|Overall Study|Adverse Event|3|||
160875536|NCT01137604|580939164|FG001|Overall Study|Adverse Event|6|||
160875537|NCT01137604|580939165|FG002|Overall Study|Adverse Event|9|||
160875538|NCT01137604|580939166|FG003|Overall Study|Adverse Event|9|||
160875539|NCT01137604|580939163|FG000|Overall Study|Participant Choice|0|||
160875540|NCT01137604|580939164|FG001|Overall Study|Participant Choice|2|||
160875541|NCT01137604|580939165|FG002|Overall Study|Participant Choice|2|||
160875542|NCT01137604|580939166|FG003|Overall Study|Participant Choice|0|||
160875543|NCT01137604|580939163|FG000|Overall Study|Withdrawal of consent|0|||
160875544|NCT01137604|580939164|FG001|Overall Study|Withdrawal of consent|0|||
160875545|NCT01137604|580939165|FG002|Overall Study|Withdrawal of consent|0|||
160875546|NCT01137604|580939166|FG003|Overall Study|Withdrawal of consent|2|||
160875547|NCT01137604|580939163|FG000|Overall Study|Clinical progression/deterioration|1|||
160875548|NCT01137604|580939164|FG001|Overall Study|Clinical progression/deterioration|2|||
160875549|NCT01137604|580939165|FG002|Overall Study|Clinical progression/deterioration|2|||
160875550|NCT01137604|580939166|FG003|Overall Study|Clinical progression/deterioration|0|||
160875551|NCT01327482|580939167|FG000|Overall Study|Adverse Event|1|||
160875552|NCT00312195|580939168|FG000|Overall Study|Adverse Event|4|||
160875553|NCT00312195|580939169|FG001|Overall Study|Adverse Event|6|||
160875554|NCT00312195|580939168|FG000|Overall Study|Lost to Follow-up|1|||
160875555|NCT00312195|580939169|FG001|Overall Study|Lost to Follow-up|0|||
160875556|NCT00312195|580939168|FG000|Overall Study|Protocol Violation|1|||
160875557|NCT00312195|580939169|FG001|Overall Study|Protocol Violation|0|||
160875558|NCT01018810|580939170|FG000|Overall Study|Withdrawal by Subject|0|||
160875559|NCT01018810|580939171|FG001|Overall Study|Withdrawal by Subject|1|||
160875560|NCT01018810|580939172|FG002|Overall Study|Withdrawal by Subject|0|||
160875561|NCT01018810|580939173|FG003|Overall Study|Withdrawal by Subject|0|||
160875562|NCT01018810|580939174|FG004|Overall Study|Withdrawal by Subject|0|||
160875563|NCT01018810|580939170|FG000|Overall Study|Sponsor Decision|2|||
160875564|NCT01018810|580939171|FG001|Overall Study|Sponsor Decision|0|||
160875565|NCT01018810|580939172|FG002|Overall Study|Sponsor Decision|1|||
160875566|NCT01018810|580939173|FG003|Overall Study|Sponsor Decision|1|||
160875567|NCT01018810|580939174|FG004|Overall Study|Sponsor Decision|1|||
160875568|NCT04145219|580939175|FG000|Overall Study|Adverse Event|18|||
160875569|NCT04145219|580939176|FG001|Overall Study|Adverse Event|6|||
160875570|NCT04145219|580939175|FG000|Overall Study|Lost to Follow-up|2|||
160875571|NCT04145219|580939176|FG001|Overall Study|Lost to Follow-up|3|||
160875572|NCT04145219|580939175|FG000|Overall Study|Physician Decision|0|||
160875573|NCT04145219|580939176|FG001|Overall Study|Physician Decision|2|||
160875574|NCT04145219|580939175|FG000|Overall Study|Withdrawal by Subject|12|||
160875575|NCT04145219|580939176|FG001|Overall Study|Withdrawal by Subject|8|||
160875576|NCT04145219|580939175|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
160875577|NCT04145219|580939176|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
160875578|NCT01459497|580939182|FG000|Overall Study|Inability to meet trial constraints.|1|||
160875579|NCT01459497|580939183|FG001|Overall Study|Inability to meet trial constraints.|0|||
160875580|NCT01459497|580939182|FG000|Overall Study|Physician Decision|1|||
160875581|NCT01459497|580939183|FG001|Overall Study|Physician Decision|1|||
160875582|NCT01459497|580939182|FG000|Overall Study|Hospitalization.|0|||
160875583|NCT01459497|580939183|FG001|Overall Study|Hospitalization.|3|||
160875584|NCT01459497|580939182|FG000|Overall Study|Disease progression.|0|||
160875585|NCT01459497|580939183|FG001|Overall Study|Disease progression.|1|||
160875586|NCT00862082|580939184|FG000|Overall Study|Sponsor decision to terminate the study|5|||
160875587|NCT00862082|580939185|FG001|Overall Study|Sponsor decision to terminate the study|0|||
160875588|NCT00862082|580939184|FG000|Overall Study|Withdrawal by Subject|0|||
160875589|NCT00862082|580939185|FG001|Overall Study|Withdrawal by Subject|1|||
160875590|NCT00947882|580939186|FG000|Overall Study|Adverse Event|0|||
160875591|NCT00947882|580939187|FG001|Overall Study|Adverse Event|1|||
160875592|NCT00947882|580939188|FG002|Overall Study|Adverse Event|4|||
160875593|NCT00947882|580939189|FG003|Overall Study|Adverse Event|4|||
160875594|NCT00947882|580939186|FG000|Overall Study|Withdrawal by Subject|2|||
160875595|NCT00947882|580939187|FG001|Overall Study|Withdrawal by Subject|0|||
160875596|NCT00947882|580939188|FG002|Overall Study|Withdrawal by Subject|8|||
160875597|NCT00947882|580939189|FG003|Overall Study|Withdrawal by Subject|2|||
160875598|NCT00947882|580939186|FG000|Overall Study|Protocol Violation|0|||
160875599|NCT00947882|580939187|FG001|Overall Study|Protocol Violation|0|||
160875600|NCT00947882|580939188|FG002|Overall Study|Protocol Violation|1|||
160875601|NCT00947882|580939189|FG003|Overall Study|Protocol Violation|0|||
160875602|NCT00947882|580939186|FG000|Overall Study|Lost to Follow-up|0|||
160875603|NCT00947882|580939187|FG001|Overall Study|Lost to Follow-up|2|||
160875604|NCT00947882|580939188|FG002|Overall Study|Lost to Follow-up|1|||
160875605|NCT00947882|580939189|FG003|Overall Study|Lost to Follow-up|0|||
160875606|NCT00947882|580939186|FG000|Overall Study|Other/Unknown|10|||
160875607|NCT00947882|580939187|FG001|Overall Study|Other/Unknown|13|||
160875608|NCT00947882|580939188|FG002|Overall Study|Other/Unknown|3|||
160875609|NCT00947882|580939189|FG003|Overall Study|Other/Unknown|6|||
160875610|NCT00947882|580939186|FG000|Overall Study|Trial Terminated by Sponsor|62|||
160875611|NCT00947882|580939187|FG001|Overall Study|Trial Terminated by Sponsor|61|||
160875612|NCT00947882|580939188|FG002|Overall Study|Trial Terminated by Sponsor|62|||
160875613|NCT00947882|580939189|FG003|Overall Study|Trial Terminated by Sponsor|70|||
160875614|NCT02791763|580939192|FG000|Overall Study|Protocol Violation|0|||
160875615|NCT02791763|580939193|FG001|Overall Study|Protocol Violation|0|||
160875616|NCT02791763|580939194|FG002|Overall Study|Protocol Violation|1|||
160875617|NCT02791763|580939192|FG000|Overall Study|Withdrawal by Subject|5|||
160875618|NCT02791763|580939193|FG001|Overall Study|Withdrawal by Subject|1|||
160875619|NCT02791763|580939194|FG002|Overall Study|Withdrawal by Subject|0|||
160875620|NCT02791763|580939192|FG000|Overall Study|Physician Decision|0|||
160875621|NCT02791763|580939193|FG001|Overall Study|Physician Decision|1|||
160875622|NCT02791763|580939194|FG002|Overall Study|Physician Decision|0|||
160875623|NCT02791763|580939192|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
160875624|NCT02791763|580939193|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
160875625|NCT02791763|580939194|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
160875626|NCT02791763|580939192|FG000|Overall Study|Cancer event|1|||
160875627|NCT02791763|580939193|FG001|Overall Study|Cancer event|3|||
160875628|NCT02791763|580939194|FG002|Overall Study|Cancer event|0|||
160875629|NCT02791763|580939192|FG000|Overall Study|Participant had renal transplant|3|||
160875630|NCT02791763|580939193|FG001|Overall Study|Participant had renal transplant|0|||
160875631|NCT02791763|580939194|FG002|Overall Study|Participant had renal transplant|0|||
160875632|NCT02791763|580939192|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
160875633|NCT02791763|580939193|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
160875634|NCT02791763|580939194|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
160875635|NCT02791763|580939192|FG000|Overall Study|Adverse Event|12|||
160875636|NCT02791763|580939193|FG001|Overall Study|Adverse Event|13|||
160875637|NCT02791763|580939194|FG002|Overall Study|Adverse Event|7|||
160875638|NCT05334212|580939195|FG000|Overall Study|Study terminated prematurely|7|||
160875639|NCT00910299|580939196|FG000|Overall Study|Withdrawal by Subject|16|||
160875640|NCT00910299|580939197|FG001|Overall Study|Withdrawal by Subject|13|||
160875641|NCT00910299|580939196|FG000|Overall Study|Sponsor Decision|58|||
160875642|NCT00910299|580939197|FG001|Overall Study|Sponsor Decision|60|||
160875643|NCT00910299|580939196|FG000|Overall Study|Didn't receive any study drug|2|||
160875644|NCT00910299|580939197|FG001|Overall Study|Didn't receive any study drug|1|||
160875645|NCT01456897|580939198|FG000|Overall Study|Adverse Event|19|||
160875646|NCT01456897|580939199|FG001|Overall Study|Adverse Event|22|||
160875647|NCT01456897|580939198|FG000|Overall Study|Protocol Violation|3|||
160875648|NCT01456897|580939199|FG001|Overall Study|Protocol Violation|4|||
160875649|NCT01456897|580939198|FG000|Overall Study|Physician Decision|5|||
160875650|NCT01456897|580939199|FG001|Overall Study|Physician Decision|3|||
160875651|NCT01456897|580939198|FG000|Overall Study|Withdrawal by Subject|44|||
160875652|NCT01456897|580939199|FG001|Overall Study|Withdrawal by Subject|17|||
160875653|NCT01456897|580939198|FG000|Overall Study|Lack of Efficacy|4|||
160875654|NCT01456897|580939199|FG001|Overall Study|Lack of Efficacy|11|||
160875655|NCT04535453|580939200|FG000|Overall Study|Death|0|||
160875656|NCT04535453|580939201|FG001|Overall Study|Death|1|||
160875657|NCT04535453|580939202|FG002|Overall Study|Death|0|||
160875658|NCT04535453|580939203|FG003|Overall Study|Death|0|||
160875659|NCT04535453|580939204|FG004|Overall Study|Death|0|||
160875660|NCT04535453|580939205|FG005|Overall Study|Death|0|||
160875661|NCT04535453|580939206|FG006|Overall Study|Death|0|||
160875662|NCT04535453|580939207|FG007|Overall Study|Death|0|||
160875663|NCT04535453|580939208|FG008|Overall Study|Death|0|||
160875664|NCT04535453|580939209|FG009|Overall Study|Death|0|||
160875665|NCT04535453|580939210|FG010|Overall Study|Death|0|||
160875666|NCT04535453|580939211|FG011|Overall Study|Death|0|||
160875667|NCT04535453|580939200|FG000|Overall Study|Lost to Follow-up|1|||
160875668|NCT04535453|580939201|FG001|Overall Study|Lost to Follow-up|1|||
160875669|NCT04535453|580939202|FG002|Overall Study|Lost to Follow-up|1|||
160875670|NCT04535453|580939203|FG003|Overall Study|Lost to Follow-up|0|||
160875671|NCT04535453|580939204|FG004|Overall Study|Lost to Follow-up|3|||
160875672|NCT04535453|580939205|FG005|Overall Study|Lost to Follow-up|1|||
160875673|NCT04535453|580939206|FG006|Overall Study|Lost to Follow-up|0|||
160875674|NCT04535453|580939207|FG007|Overall Study|Lost to Follow-up|0|||
160875675|NCT04535453|580939208|FG008|Overall Study|Lost to Follow-up|1|||
160875676|NCT04535453|580939209|FG009|Overall Study|Lost to Follow-up|1|||
160875677|NCT04535453|580939210|FG010|Overall Study|Lost to Follow-up|0|||
160875678|NCT04535453|580939211|FG011|Overall Study|Lost to Follow-up|0|||
160875679|NCT04535453|580939200|FG000|Overall Study|Physician Decision|0|||
160875680|NCT04535453|580939201|FG001|Overall Study|Physician Decision|0|||
160875681|NCT04535453|580939202|FG002|Overall Study|Physician Decision|0|||
160875682|NCT04535453|580939203|FG003|Overall Study|Physician Decision|1|||
160875683|NCT04535453|580939204|FG004|Overall Study|Physician Decision|0|||
160875684|NCT04535453|580939205|FG005|Overall Study|Physician Decision|0|||
160875685|NCT04535453|580939206|FG006|Overall Study|Physician Decision|0|||
160875686|NCT04535453|580939207|FG007|Overall Study|Physician Decision|0|||
160875687|NCT04535453|580939208|FG008|Overall Study|Physician Decision|0|||
160875688|NCT04535453|580939209|FG009|Overall Study|Physician Decision|0|||
160875689|NCT04535453|580939210|FG010|Overall Study|Physician Decision|0|||
160875690|NCT04535453|580939211|FG011|Overall Study|Physician Decision|0|||
160875691|NCT04535453|580939200|FG000|Overall Study|Withdrawal by Subject|3|||
161119806|NCT02064387|581826005|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
161119807|NCT02064387|581826006|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
161119808|NCT02064387|581826007|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
161119809|NCT02064387|581826008|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
161119810|NCT02064387|581826009|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
161119811|NCT02064387|581825998|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119812|NCT02064387|581825999|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119813|NCT02064387|581826000|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119814|NCT02064387|581826001|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119815|NCT02064387|581826002|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119816|NCT02064387|581826003|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119817|NCT02064387|581826004|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119818|NCT02064387|581826005|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119819|NCT02064387|581826006|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119820|NCT02064387|581826007|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
160875692|NCT04535453|580939201|FG001|Overall Study|Withdrawal by Subject|6|||
160875693|NCT04535453|580939202|FG002|Overall Study|Withdrawal by Subject|3|||
160875694|NCT04535453|580939203|FG003|Overall Study|Withdrawal by Subject|3|||
160875695|NCT04535453|580939204|FG004|Overall Study|Withdrawal by Subject|2|||
160875696|NCT04535453|580939205|FG005|Overall Study|Withdrawal by Subject|1|||
161119821|NCT02064387|581826008|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
160875697|NCT04535453|580939206|FG006|Overall Study|Withdrawal by Subject|1|||
160875698|NCT04535453|580939207|FG007|Overall Study|Withdrawal by Subject|1|||
160875699|NCT04535453|580939208|FG008|Overall Study|Withdrawal by Subject|1|||
160875700|NCT04535453|580939209|FG009|Overall Study|Withdrawal by Subject|1|||
160875701|NCT04535453|580939210|FG010|Overall Study|Withdrawal by Subject|0|||
160875702|NCT04535453|580939211|FG011|Overall Study|Withdrawal by Subject|1|||
160875703|NCT04535453|580939200|FG000|Overall Study|Other|0|||
160875704|NCT04535453|580939201|FG001|Overall Study|Other|0|||
160875705|NCT04535453|580939202|FG002|Overall Study|Other|1|||
160875706|NCT04535453|580939203|FG003|Overall Study|Other|0|||
160875707|NCT04535453|580939204|FG004|Overall Study|Other|1|||
160875708|NCT04535453|580939205|FG005|Overall Study|Other|0|||
160875709|NCT04535453|580939206|FG006|Overall Study|Other|1|||
160875710|NCT04535453|580939207|FG007|Overall Study|Other|1|||
160875711|NCT04535453|580939208|FG008|Overall Study|Other|1|||
160875712|NCT04535453|580939209|FG009|Overall Study|Other|0|||
160875713|NCT04535453|580939210|FG010|Overall Study|Other|0|||
160875714|NCT04535453|580939211|FG011|Overall Study|Other|0|||
160875715|NCT00916929|580939212|FG000|Overall Study|Lost to Follow-up|1|||
160875716|NCT00916929|580939213|FG001|Overall Study|Lost to Follow-up|3|||
160875717|NCT00916929|580939212|FG000|Overall Study|Death|5|||
160875718|NCT00916929|580939213|FG001|Overall Study|Death|10|||
160875719|NCT00916929|580939212|FG000|Overall Study|Withdrawal by Subject|1|||
160875720|NCT00916929|580939213|FG001|Overall Study|Withdrawal by Subject|5|||
160875721|NCT00916929|580939212|FG000|Overall Study|Left ventricular epicardial lead|1|||
160875722|NCT00916929|580939213|FG001|Overall Study|Left ventricular epicardial lead|2|||
160875723|NCT00916929|580939212|FG000|Overall Study|Transferred to hospice care|1|||
160875724|NCT00916929|580939213|FG001|Overall Study|Transferred to hospice care|1|||
160875725|NCT00916929|580939212|FG000|Overall Study|System explant|1|||
160875726|NCT00916929|580939213|FG001|Overall Study|System explant|0|||
160875727|NCT00916929|580939212|FG000|Overall Study|Moved to another state|0|||
160875728|NCT00916929|580939213|FG001|Overall Study|Moved to another state|1|||
160875729|NCT00916929|580939212|FG000|Overall Study|Device unable to process impedance data|0|||
160875730|NCT00916929|580939213|FG001|Overall Study|Device unable to process impedance data|7|||
160875731|NCT02929407|580939214|FG000|Overall Study|Adverse Event|1|||
160875732|NCT02878798|580939215|FG000|Overall Study|Withdrawal by Subject|5|||
160875733|NCT02878798|580939216|FG001|Overall Study|Withdrawal by Subject|4|||
160875734|NCT02878798|580939215|FG000|Overall Study|Lost to Follow-up|2|||
160875735|NCT02878798|580939216|FG001|Overall Study|Lost to Follow-up|2|||
160875736|NCT02878798|580939215|FG000|Overall Study|Protocol Violation|0|||
160875737|NCT02878798|580939216|FG001|Overall Study|Protocol Violation|1|||
160875738|NCT01309282|580939217|FG000|Overall Study|Lost to Follow-up|1|||
160875739|NCT01708902|580939221|FG000|Overall Study|Adverse Event|3|||
160875740|NCT01708902|580939222|FG001|Overall Study|Adverse Event|4|||
160875741|NCT01708902|580939223|FG002|Overall Study|Adverse Event|9|||
160875742|NCT01708902|580939224|FG003|Overall Study|Adverse Event|2|||
160875743|NCT01708902|580939225|FG004|Overall Study|Adverse Event|7|||
160875744|NCT01708902|580939226|FG005|Overall Study|Adverse Event|3|||
160875745|NCT01708902|580939227|FG006|Overall Study|Adverse Event|5|||
160875746|NCT01708902|580939221|FG000|Overall Study|Lack of Efficacy|3|||
160875747|NCT01708902|580939222|FG001|Overall Study|Lack of Efficacy|1|||
160875748|NCT01708902|580939223|FG002|Overall Study|Lack of Efficacy|0|||
160875749|NCT01708902|580939224|FG003|Overall Study|Lack of Efficacy|0|||
160875750|NCT01708902|580939225|FG004|Overall Study|Lack of Efficacy|0|||
160875751|NCT01708902|580939226|FG005|Overall Study|Lack of Efficacy|1|||
160875752|NCT01708902|580939227|FG006|Overall Study|Lack of Efficacy|0|||
160875753|NCT01708902|580939221|FG000|Overall Study|Non compliance with protocol|0|||
161119822|NCT02064387|581826009|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
161119823|NCT02436876|581826013|FG000|Overall Study|Lost to Follow-up|0|||
161119824|NCT02436876|581826014|FG001|Overall Study|Lost to Follow-up|1|||
161119825|NCT02436876|581826015|FG002|Overall Study|Lost to Follow-up|1|||
161119826|NCT02436876|581826016|FG003|Overall Study|Lost to Follow-up|1|||
161119827|NCT02436876|581826013|FG000|Overall Study|Withdrawal by Subject|1|||
161119828|NCT02436876|581826014|FG001|Overall Study|Withdrawal by Subject|0|||
161119829|NCT02436876|581826015|FG002|Overall Study|Withdrawal by Subject|0|||
161119830|NCT02436876|581826016|FG003|Overall Study|Withdrawal by Subject|1|||
160875754|NCT01708902|580939222|FG001|Overall Study|Non compliance with protocol|2|||
160875755|NCT01708902|580939223|FG002|Overall Study|Non compliance with protocol|1|||
160875756|NCT01708902|580939224|FG003|Overall Study|Non compliance with protocol|3|||
160875757|NCT01708902|580939225|FG004|Overall Study|Non compliance with protocol|0|||
160875758|NCT01708902|580939226|FG005|Overall Study|Non compliance with protocol|0|||
160875759|NCT01708902|580939227|FG006|Overall Study|Non compliance with protocol|0|||
161119831|NCT02436876|581826013|FG000|Overall Study|Physician Decision|0|||
161119832|NCT02436876|581826014|FG001|Overall Study|Physician Decision|2|||
160875760|NCT01708902|580939221|FG000|Overall Study|Lost to Follow-up|2|||
160875761|NCT01708902|580939222|FG001|Overall Study|Lost to Follow-up|1|||
160875762|NCT01708902|580939223|FG002|Overall Study|Lost to Follow-up|2|||
160875763|NCT01708902|580939224|FG003|Overall Study|Lost to Follow-up|2|||
160875764|NCT01708902|580939225|FG004|Overall Study|Lost to Follow-up|0|||
160875765|NCT01708902|580939226|FG005|Overall Study|Lost to Follow-up|0|||
161119833|NCT02436876|581826015|FG002|Overall Study|Physician Decision|1|||
161224993|NCT04634409|582203565|FG013|Overall Study|Death|0|||
161224994|NCT04634409|582203566|FG014|Overall Study|Death|0|||
161224995|NCT04634409|582203567|FG015|Overall Study|Death|0|||
161224996|NCT04634409|582203568|FG016|Overall Study|Death|0|||
161224997|NCT04634409|582203569|FG017|Overall Study|Death|0|||
161224998|NCT04634409|582203570|FG018|Overall Study|Death|0|||
161224999|NCT04634409|582203571|FG019|Overall Study|Death|0|||
161225000|NCT04634409|582203572|FG020|Overall Study|Death|0|||
161225001|NCT04634409|582203573|FG021|Overall Study|Death|0|||
160875766|NCT01708902|580939227|FG006|Overall Study|Lost to Follow-up|1|||
160875767|NCT01708902|580939221|FG000|Overall Study|Refused to continue trial medication|8|||
160875768|NCT01708902|580939222|FG001|Overall Study|Refused to continue trial medication|0|||
160875769|NCT01708902|580939223|FG002|Overall Study|Refused to continue trial medication|4|||
160875770|NCT01708902|580939224|FG003|Overall Study|Refused to continue trial medication|2|||
160875771|NCT01708902|580939225|FG004|Overall Study|Refused to continue trial medication|8|||
160875772|NCT01708902|580939226|FG005|Overall Study|Refused to continue trial medication|1|||
160875773|NCT01708902|580939227|FG006|Overall Study|Refused to continue trial medication|1|||
160875774|NCT01708902|580939221|FG000|Overall Study|Other Reason|1|||
160875775|NCT01708902|580939222|FG001|Overall Study|Other Reason|0|||
160875776|NCT01708902|580939223|FG002|Overall Study|Other Reason|1|||
160875777|NCT01708902|580939224|FG003|Overall Study|Other Reason|1|||
160875778|NCT01708902|580939225|FG004|Overall Study|Other Reason|1|||
160875779|NCT01708902|580939226|FG005|Overall Study|Other Reason|2|||
160875780|NCT01708902|580939227|FG006|Overall Study|Other Reason|0|||
160875781|NCT02445794|580939231|FG000|Overall Study|Adverse Event|0|||
160875782|NCT02445794|580939232|FG001|Overall Study|Adverse Event|0|||
160875783|NCT02445794|580939233|FG002|Overall Study|Adverse Event|2|||
160875784|NCT02445794|580939234|FG003|Overall Study|Adverse Event|0|||
160875785|NCT01388985|580939235|FG000|Overall Study|Death|0|||
160875786|NCT01388985|580939236|FG001|Overall Study|Death|1|||
160875787|NCT01388985|580939235|FG000|Overall Study|Lost to Follow-up|30|||
160875788|NCT01388985|580939236|FG001|Overall Study|Lost to Follow-up|30|||
160875789|NCT01388985|580939235|FG000|Overall Study|Withdrawal by Subject|13|||
160875790|NCT01388985|580939236|FG001|Overall Study|Withdrawal by Subject|4|||
160875791|NCT01388985|580939235|FG000|Overall Study|Subject unavailable|1|||
160875792|NCT01388985|580939236|FG001|Overall Study|Subject unavailable|1|||
160875793|NCT01388985|580939235|FG000|Overall Study|Other (no reason)|0|||
160875794|NCT01388985|580939236|FG001|Overall Study|Other (no reason)|1|||
160875795|NCT01388985|580939235|FG000|Overall Study|Error of nurse|5|||
160875796|NCT01388985|580939236|FG001|Overall Study|Error of nurse|1|||
160875797|NCT01057589|580939237|FG000|Overall Study|Disease Progression|35|||
160875798|NCT01057589|580939237|FG000|Overall Study|Adverse Event|10|||
160875799|NCT01057589|580939237|FG000|Overall Study|Physician Decision|8|||
160875800|NCT01057589|580939237|FG000|Overall Study|Withdrawal by Subject|3|||
160875801|NCT01057589|580939237|FG000|Overall Study|Sponsor Decision|1|||
160875802|NCT01057589|580939237|FG000|Overall Study|Death|8|||
160875803|NCT01057589|580939237|FG000|Overall Study|Lost to Follow-up|1|||
160875804|NCT01519167|580939240|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
160875805|NCT01519167|580939241|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
160875806|NCT01519167|580939240|FG000|Overall Study|Adverse Event|0|||
160875807|NCT01519167|580939241|FG001|Overall Study|Adverse Event|1|||
160875808|NCT01519167|580939240|FG000|Overall Study|Lack of Efficacy|0|||
160875809|NCT01519167|580939241|FG001|Overall Study|Lack of Efficacy|1|||
160875810|NCT01519167|580939240|FG000|Overall Study|Medical condition changes&deep sedation|0|||
160875811|NCT01519167|580939241|FG001|Overall Study|Medical condition changes&deep sedation|2|||
160875812|NCT01519167|580939240|FG000|Overall Study|Physician Decision|0|||
160875813|NCT01519167|580939241|FG001|Overall Study|Physician Decision|1|||
160875814|NCT01031836|580940537|FG000|Stage I|Adverse Event|1|||
160875815|NCT01031836|580940538|FG001|Stage I|Adverse Event|1|||
160875816|NCT01031836|580940539|FG002|Stage I|Adverse Event|0|||
160875817|NCT01031836|580940540|FG003|Stage I|Adverse Event|0|||
160875818|NCT01031836|580940541|FG004|Stage I|Adverse Event|0|||
160875819|NCT01031836|580940542|FG005|Stage I|Adverse Event|0|||
160875820|NCT01031836|580940537|FG000|Stage I|Other|0|||
160875821|NCT01031836|580940538|FG001|Stage I|Other|1|||
161225002|NCT04634409|582203574|FG022|Overall Study|Death|0|||
161225003|NCT04634409|582203575|FG023|Overall Study|Death|0|||
161225004|NCT04634409|582203576|FG024|Overall Study|Death|0|||
161225005|NCT04634409|582203577|FG025|Overall Study|Death|0|||
161225006|NCT04634409|582203578|FG026|Overall Study|Death|0|||
161324560|NCT00452439|582575625|FG001|Overall Study|Relapse|0|||
160875822|NCT01031836|580940539|FG002|Stage I|Other|0|||
160875823|NCT01031836|580940540|FG003|Stage I|Other|0|||
160875824|NCT01031836|580940541|FG004|Stage I|Other|0|||
160875825|NCT01031836|580940542|FG005|Stage I|Other|1|||
160875826|NCT01031836|580940537|FG000|Stage II|Adverse Event|0|||
160875827|NCT01031836|580940538|FG001|Stage II|Adverse Event|0|||
160875828|NCT01031836|580940539|FG002|Stage II|Adverse Event|2|||
160875829|NCT01031836|580940540|FG003|Stage II|Adverse Event|2|||
160875830|NCT01031836|580940541|FG004|Stage II|Adverse Event|1|||
161225007|NCT04634409|582203552|FG000|Overall Study|Adverse Event|0|||
161324561|NCT00452439|582575624|FG000|Overall Study|Fracture|1|||
160875831|NCT01031836|580940542|FG005|Stage II|Adverse Event|1|||
160875832|NCT01031836|580940537|FG000|Stage II|Other|2|||
160875833|NCT01031836|580940538|FG001|Stage II|Other|0|||
160875834|NCT01031836|580940539|FG002|Stage II|Other|0|||
160875835|NCT01031836|580940540|FG003|Stage II|Other|1|||
160875836|NCT01031836|580940541|FG004|Stage II|Other|1|||
160875837|NCT01031836|580940542|FG005|Stage II|Other|0|||
160875838|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
160875839|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
160875840|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Physician Decision|1|||
160875841|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Physician Decision|1|||
160875842|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
160875843|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
160875844|NCT01888432|580940547|FG000|12-month Analysis (FAS)|Death|4|||
160875845|NCT01888432|580940548|FG001|12-month Analysis (FAS)|Death|3|||
160875846|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Graft loss|0|||
160875847|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Graft loss|1|||
160875848|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
160875849|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
160875850|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Physician Decision|2|||
160875851|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Physician Decision|4|||
160875852|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
160875853|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
160875854|NCT01888432|580940547|FG000|24-month Analysis (FAS)|Death|8|||
160875855|NCT01888432|580940548|FG001|24-month Analysis (FAS)|Death|4|||
160875856|NCT01888432|580940547|FG000|36-month Analysis (Extension)|Death|1|||
160875857|NCT01888432|580940548|FG001|36-month Analysis (Extension)|Death|0|||
160875858|NCT01754402|580940552|FG000|Overall Study|Death|0|||
160875859|NCT01754402|580940553|FG001|Overall Study|Death|0|||
160875860|NCT01754402|580940554|FG002|Overall Study|Death|1|||
160875861|NCT01754402|580940552|FG000|Overall Study|Adverse Event|2|||
160875862|NCT01754402|580940553|FG001|Overall Study|Adverse Event|2|||
160875863|NCT01754402|580940554|FG002|Overall Study|Adverse Event|1|||
160875864|NCT01754402|580940552|FG000|Overall Study|Withdrawal by Subject|0|||
160875865|NCT01754402|580940553|FG001|Overall Study|Withdrawal by Subject|0|||
160875866|NCT01754402|580940554|FG002|Overall Study|Withdrawal by Subject|1|||
160875867|NCT01754402|580940552|FG000|Overall Study|Lack of Efficacy|0|||
160875868|NCT01754402|580940553|FG001|Overall Study|Lack of Efficacy|0|||
160875869|NCT01754402|580940554|FG002|Overall Study|Lack of Efficacy|1|||
160875870|NCT02051933|580940555|FG000|Overall Study|Physician Decision|0|||
160875871|NCT02051933|580940556|FG001|Overall Study|Physician Decision|1|||
160875872|NCT01954927|580940557|FG000|Overall Study|Withdrawal by Subject|3|||
160875873|NCT01954927|580940558|FG001|Overall Study|Withdrawal by Subject|1|||
160875874|NCT02156271|580940559|FG000|Overall Study|Physician Decision|4|||
160875875|NCT02156271|580940560|FG001|Overall Study|Physician Decision|3|||
160875876|NCT02123251|580940561|FG000|Overall Study|Death|1|||
160875877|NCT02123251|580940562|FG001|Overall Study|Death|1|||
160875878|NCT02123251|580940561|FG000|Overall Study|Withdrawal by Subject|0|||
160875879|NCT02123251|580940562|FG001|Overall Study|Withdrawal by Subject|3|||
160875880|NCT02123251|580940561|FG000|Overall Study|Lost Medicaid eligibility|29|||
160875881|NCT02123251|580940562|FG001|Overall Study|Lost Medicaid eligibility|22|||
160875882|NCT02123251|580940561|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
160875883|NCT02123251|580940562|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
160875884|NCT00375609|580940569|FG000|Overall Study|Did not receive treatment|1|||
160875885|NCT00375609|580940570|FG001|Overall Study|Did not receive treatment|0|||
160875886|NCT00375609|580940571|FG002|Overall Study|Did not receive treatment|0|||
161119834|NCT02436876|581826016|FG003|Overall Study|Physician Decision|0|||
161119835|NCT02436876|581826013|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
161119836|NCT02436876|581826014|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
161119837|NCT02436876|581826015|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
161119838|NCT02436876|581826016|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
161225008|NCT04634409|582203553|FG001|Overall Study|Adverse Event|0|||
160875887|NCT00375609|580940569|FG000|Overall Study|Adverse Event|0|||
160875888|NCT00375609|580940570|FG001|Overall Study|Adverse Event|3|||
160875889|NCT00375609|580940571|FG002|Overall Study|Adverse Event|0|||
160875890|NCT00375609|580940569|FG000|Overall Study|Lost to Follow-up|1|||
160875891|NCT00375609|580940570|FG001|Overall Study|Lost to Follow-up|0|||
160875892|NCT00375609|580940571|FG002|Overall Study|Lost to Follow-up|0|||
160875893|NCT00375609|580940569|FG000|Overall Study|Physician Decision|0|||
160875894|NCT00375609|580940570|FG001|Overall Study|Physician Decision|0|||
160875895|NCT00375609|580940571|FG002|Overall Study|Physician Decision|1|||
160875896|NCT00375609|580940569|FG000|Overall Study|Withdrawal by Subject|1|||
160875897|NCT00375609|580940570|FG001|Overall Study|Withdrawal by Subject|4|||
160875898|NCT00375609|580940571|FG002|Overall Study|Withdrawal by Subject|0|||
160875899|NCT00375609|580940569|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
160875900|NCT00375609|580940570|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
160875901|NCT00375609|580940571|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
160875902|NCT02338882|580940572|FG000|Overall Study|Death|1|||
160875903|NCT02338882|580940573|FG001|Overall Study|Death|0|||
160875904|NCT02338882|580940572|FG000|Overall Study|Lost to Follow-up|6|||
160875905|NCT02338882|580940573|FG001|Overall Study|Lost to Follow-up|3|||
160875906|NCT02184455|580940576|FG000|Overall Study|Lost to Follow-up|1|||
160875907|NCT02248675|580940583|FG000|Overall Study|Lost to Follow-up|3|||
160875908|NCT02248675|580940584|FG001|Overall Study|Lost to Follow-up|1|||
160875909|NCT00617669|580940585|FG000|Overall Study|Withdrawal by Subject|71|||
160875910|NCT00617669|580940586|FG001|Overall Study|Withdrawal by Subject|77|||
160875911|NCT00617669|580940585|FG000|Overall Study|Lost to Follow-up|3|||
160875912|NCT00617669|580940586|FG001|Overall Study|Lost to Follow-up|2|||
160875913|NCT00617669|580940585|FG000|Overall Study|Adverse Event|87|||
160875914|NCT00617669|580940586|FG001|Overall Study|Adverse Event|76|||
160875915|NCT00617669|580940585|FG000|Overall Study|Protocol Violation|2|||
160875916|NCT00617669|580940586|FG001|Overall Study|Protocol Violation|3|||
160875917|NCT00617669|580940585|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
160875918|NCT00617669|580940586|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
160875919|NCT00617669|580940585|FG000|Overall Study|Patients randomized but not treated|2|||
160875920|NCT00617669|580940586|FG001|Overall Study|Patients randomized but not treated|3|||
160875921|NCT03745820|580940589|FG000|Overall Study|Adverse Event|0|||
160875922|NCT03745820|580940590|FG001|Overall Study|Adverse Event|3|||
160875923|NCT03745820|580940591|FG002|Overall Study|Adverse Event|2|||
160875924|NCT03745820|580940589|FG000|Overall Study|Non-Compliance with Study Drug|4|||
160875925|NCT03745820|580940590|FG001|Overall Study|Non-Compliance with Study Drug|3|||
160875926|NCT03745820|580940591|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160875927|NCT03745820|580940589|FG000|Overall Study|Withdrawal by Subject|4|||
160875928|NCT03745820|580940590|FG001|Overall Study|Withdrawal by Subject|4|||
160875929|NCT03745820|580940591|FG002|Overall Study|Withdrawal by Subject|4|||
160875930|NCT03745820|580940589|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
160875931|NCT03745820|580940590|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
160875932|NCT03745820|580940591|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
160875933|NCT03745820|580940589|FG000|Overall Study|Lost to Follow-up|2|||
160875934|NCT03745820|580940590|FG001|Overall Study|Lost to Follow-up|0|||
160875935|NCT03745820|580940591|FG002|Overall Study|Lost to Follow-up|3|||
160875936|NCT03745820|580940589|FG000|Overall Study|Reason not Specified|2|||
160875937|NCT03745820|580940590|FG001|Overall Study|Reason not Specified|4|||
160875938|NCT03745820|580940591|FG002|Overall Study|Reason not Specified|1|||
160875939|NCT04250077|580940600|FG000|Overall Study|Withdrawal by Subject|0|||
160875940|NCT04250077|580940601|FG001|Overall Study|Withdrawal by Subject|1|||
160875941|NCT04250077|580940602|FG002|Overall Study|Withdrawal by Subject|0|||
160875942|NCT04250077|580940600|FG000|Overall Study|Lost to Follow-up|2|||
160875943|NCT04250077|580940601|FG001|Overall Study|Lost to Follow-up|3|||
160875944|NCT04250077|580940602|FG002|Overall Study|Lost to Follow-up|0|||
160875945|NCT00926029|580940603|FG000|Overall Study|Lost to Follow-up|2|||
160875946|NCT00926029|580940604|FG001|Overall Study|Lost to Follow-up|1|||
160875947|NCT00926029|580940605|FG002|Overall Study|Lost to Follow-up|1|||
160875948|NCT03206788|580940606|FG000|Overall Study|Withdrawal by Subject|0|||
160875949|NCT03206788|580940607|FG001|Overall Study|Withdrawal by Subject|1|||
160875950|NCT03206788|580940606|FG000|Overall Study|Adverse Event|0|||
160875951|NCT03206788|580940607|FG001|Overall Study|Adverse Event|1|||
160875952|NCT03206788|580940606|FG000|Overall Study|Physician Decision|0|||
160875953|NCT03206788|580940607|FG001|Overall Study|Physician Decision|1|||
160875954|NCT02471612|580940608|FG000|Overall Study|Lost to Follow-up|2|||
160875955|NCT01598129|580940609|FG000|Overall Study|Disease progression|6|||
160875956|NCT01598129|580940609|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
160875957|NCT01598129|580940609|FG000|Overall Study|Withdrawal by Subject|1|||
160875958|NCT00591318|580940610|FG000|Overall Study|Lack of Efficacy|2|||
161225009|NCT04634409|582203554|FG002|Overall Study|Adverse Event|1|||
161225010|NCT04634409|582203555|FG003|Overall Study|Adverse Event|0|||
161225011|NCT04634409|582203556|FG004|Overall Study|Adverse Event|0|||
160875959|NCT00591318|580940611|FG001|Overall Study|Lack of Efficacy|0|||
160875960|NCT00591318|580940610|FG000|Overall Study|Adverse Event|2|||
160875961|NCT00591318|580940611|FG001|Overall Study|Adverse Event|0|||
160875962|NCT03615040|580940612|FG000|Overall Study|Withdrawal by Subject|2|||
160875963|NCT03615040|580940613|FG001|Overall Study|Withdrawal by Subject|1|||
160875964|NCT03615040|580940612|FG000|Overall Study|Physician Decision|2|||
160875965|NCT03615040|580940613|FG001|Overall Study|Physician Decision|2|||
160875966|NCT03615040|580940612|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
161225012|NCT04634409|582203557|FG005|Overall Study|Adverse Event|1|||
160875967|NCT03615040|580940613|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
160875968|NCT03615040|580940612|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
160875969|NCT03615040|580940613|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
160875970|NCT03615040|580940612|FG000|Overall Study|Death|0|||
160875971|NCT03615040|580940613|FG001|Overall Study|Death|2|||
160875972|NCT01024309|580940616|FG000|Overall Study|Physician Decision|4|||
160875973|NCT01024309|580940617|FG001|Overall Study|Physician Decision|0|||
160875974|NCT01024309|580940616|FG000|Overall Study|Withdrawal by Subject|4|||
160875975|NCT01024309|580940617|FG001|Overall Study|Withdrawal by Subject|4|||
160875976|NCT00567255|580940618|FG000|Overall Study|Adverse Event|241|||
160875977|NCT00567255|580940619|FG001|Overall Study|Adverse Event|68|||
160875978|NCT00567255|580940618|FG000|Overall Study|Lost to Follow-up|77|||
160875979|NCT00567255|580940619|FG001|Overall Study|Lost to Follow-up|48|||
160875980|NCT00567255|580940618|FG000|Overall Study|Withdrawal by Subject|75|||
160875981|NCT00567255|580940619|FG001|Overall Study|Withdrawal by Subject|56|||
160875982|NCT00567255|580940618|FG000|Overall Study|Lack of Efficacy|19|||
160875983|NCT00567255|580940619|FG001|Overall Study|Lack of Efficacy|33|||
160875984|NCT00567255|580940618|FG000|Overall Study|Protocol Violation|20|||
160875985|NCT00567255|580940619|FG001|Overall Study|Protocol Violation|8|||
160875986|NCT00567255|580940618|FG000|Overall Study|Pregnancy|6|||
160875987|NCT00567255|580940619|FG001|Overall Study|Pregnancy|0|||
160875988|NCT00567255|580940618|FG000|Overall Study|Drug noncompliance,moved,other|25|||
160875989|NCT00567255|580940619|FG001|Overall Study|Drug noncompliance,moved,other|15|||
160875990|NCT03672097|580940624|FG000|Period 1|Withdrawal by Subject|2|||
160875991|NCT03672097|580940624|FG000|Period 1|Adverse Event|1|||
160875992|NCT03672097|580940624|FG000|Period 1|Did not receive treatment|1|||
160875993|NCT03672097|580940624|FG000|Period 2|Withdrawal by Subject|3|||
160875994|NCT03672097|580940624|FG000|Period 2|Other|1|||
160875995|NCT02657408|580940625|FG000|Overall Study|Adverse Event|3|||
160875996|NCT02657408|580940626|FG001|Overall Study|Adverse Event|7|||
160875997|NCT01403948|580940627|FG000|Overall Study|Progressive disease|0|||
160875998|NCT01403948|580940628|FG001|Overall Study|Progressive disease|2|||
160875999|NCT01403948|580940629|FG002|Overall Study|Progressive disease|2|||
160876000|NCT01403948|580940630|FG003|Overall Study|Progressive disease|4|||
160876001|NCT01403948|580940631|FG004|Overall Study|Progressive disease|2|||
160876002|NCT01403948|580940632|FG005|Overall Study|Progressive disease|6|||
160876003|NCT01403948|580940633|FG006|Overall Study|Progressive disease|2|||
160876004|NCT01403948|580940634|FG007|Overall Study|Progressive disease|4|||
160876005|NCT01403948|580940635|FG008|Overall Study|Progressive disease|5|||
160876006|NCT01403948|580940636|FG009|Overall Study|Progressive disease|5|||
160876007|NCT01403948|580940627|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876008|NCT01403948|580940628|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876009|NCT01403948|580940629|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876010|NCT01403948|580940630|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876011|NCT01403948|580940631|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
160876012|NCT01403948|580940632|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876013|NCT01403948|580940633|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
160876014|NCT01403948|580940634|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876015|NCT01403948|580940635|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
160876016|NCT01403948|580940636|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
160876017|NCT01403948|580940627|FG000|Overall Study|Lost to Follow-up|0|||
160876018|NCT01403948|580940628|FG001|Overall Study|Lost to Follow-up|0|||
160876019|NCT01403948|580940629|FG002|Overall Study|Lost to Follow-up|0|||
160876020|NCT01403948|580940630|FG003|Overall Study|Lost to Follow-up|0|||
160876021|NCT01403948|580940631|FG004|Overall Study|Lost to Follow-up|0|||
160876022|NCT01403948|580940632|FG005|Overall Study|Lost to Follow-up|0|||
160876023|NCT01403948|580940633|FG006|Overall Study|Lost to Follow-up|0|||
160876024|NCT01403948|580940634|FG007|Overall Study|Lost to Follow-up|0|||
160876025|NCT01403948|580940635|FG008|Overall Study|Lost to Follow-up|0|||
160876026|NCT01403948|580940636|FG009|Overall Study|Lost to Follow-up|1|||
160876027|NCT01403948|580940627|FG000|Overall Study|Refused cont. medication|0|||
160876028|NCT01403948|580940628|FG001|Overall Study|Refused cont. medication|0|||
160876029|NCT01403948|580940629|FG002|Overall Study|Refused cont. medication|0|||
160876030|NCT01403948|580940630|FG003|Overall Study|Refused cont. medication|0|||
160876031|NCT01403948|580940631|FG004|Overall Study|Refused cont. medication|1|||
160876032|NCT01403948|580940632|FG005|Overall Study|Refused cont. medication|0|||
160876033|NCT01403948|580940633|FG006|Overall Study|Refused cont. medication|0|||
160876034|NCT01403948|580940634|FG007|Overall Study|Refused cont. medication|0|||
160876035|NCT01403948|580940635|FG008|Overall Study|Refused cont. medication|0|||
160876036|NCT01403948|580940636|FG009|Overall Study|Refused cont. medication|1|||
160876037|NCT01403948|580940627|FG000|Overall Study|other than above|1|||
160876038|NCT01403948|580940628|FG001|Overall Study|other than above|2|||
160876039|NCT01403948|580940629|FG002|Overall Study|other than above|1|||
160876040|NCT01403948|580940630|FG003|Overall Study|other than above|0|||
161119839|NCT00999908|581826017|FG000|Treatment Period 1|Subject withdrew consent|2|||
161119840|NCT00999908|581826018|FG001|Treatment Period 1|Subject withdrew consent|0|||
161119841|NCT00999908|581826019|FG002|Treatment Period 1|Subject withdrew consent|0|||
161119842|NCT00999908|581826017|FG000|Treatment Period 2|Protocol Violation|1|||
160876041|NCT01403948|580940631|FG004|Overall Study|other than above|1|||
160876042|NCT01403948|580940632|FG005|Overall Study|other than above|1|||
160876043|NCT01403948|580940633|FG006|Overall Study|other than above|2|||
160876044|NCT01403948|580940634|FG007|Overall Study|other than above|0|||
160876045|NCT01403948|580940635|FG008|Overall Study|other than above|0|||
160876046|NCT01403948|580940636|FG009|Overall Study|other than above|0|||
160876047|NCT01090323|580940637|FG000|Overall Study|Adverse Event|12|||
160876048|NCT01090323|580940638|FG001|Overall Study|Adverse Event|2|||
160876049|NCT01090323|580940637|FG000|Overall Study|Abnormal Lab Values|3|||
160876050|NCT01090323|580940638|FG001|Overall Study|Abnormal Lab Values|1|||
160876051|NCT01090323|580940637|FG000|Overall Study|Abnormal Test Procedure Results|2|||
160876052|NCT01090323|580940638|FG001|Overall Study|Abnormal Test Procedure Results|0|||
160876053|NCT01090323|580940637|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160876054|NCT01090323|580940638|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160876055|NCT01090323|580940637|FG000|Overall Study|Condition no longer requires drug|5|||
160876056|NCT01090323|580940638|FG001|Overall Study|Condition no longer requires drug|4|||
160876057|NCT01090323|580940637|FG000|Overall Study|Protocol Violation|2|||
160876058|NCT01090323|580940638|FG001|Overall Study|Protocol Violation|1|||
160876059|NCT01090323|580940637|FG000|Overall Study|Withdrew consent|33|||
160876060|NCT01090323|580940638|FG001|Overall Study|Withdrew consent|11|||
160876061|NCT01090323|580940637|FG000|Overall Study|Lost to Follow-up|11|||
160876062|NCT01090323|580940638|FG001|Overall Study|Lost to Follow-up|6|||
160876063|NCT01090323|580940637|FG000|Overall Study|Administrative problems|6|||
160876064|NCT01090323|580940638|FG001|Overall Study|Administrative problems|4|||
160876065|NCT01090323|580940637|FG000|Overall Study|Death|1|||
160876066|NCT01090323|580940638|FG001|Overall Study|Death|2|||
160876067|NCT01090323|580940637|FG000|Overall Study|Stopped end of core|7|||
160876068|NCT01090323|580940638|FG001|Overall Study|Stopped end of core|0|||
160876069|NCT01090323|580940637|FG000|Overall Study|Stopped end of extension 1#|3|||
160876070|NCT01090323|580940638|FG001|Overall Study|Stopped end of extension 1#|1|||
160876071|NCT05498701|580940639|FG000|Period 3|Adverse Event|1|||
160876072|NCT05498701|580940640|FG001|Period 3|Adverse Event|0|||
160876073|NCT02424578|580940641|FG000|Overall Study|Withdrawal by Subject|0|||
160876074|NCT02424578|580940642|FG001|Overall Study|Withdrawal by Subject|1|||
160876075|NCT05343624|580940643|FG000|Overall Study|Chart review not completed|1|||
160876076|NCT00711477|580940645|FG000|Overall Study|Adverse Event|3|||
160876077|NCT00711477|580940646|FG001|Overall Study|Adverse Event|1|||
160876078|NCT00711477|580940645|FG000|Overall Study|Lost to Follow-up|0|||
160876079|NCT00711477|580940646|FG001|Overall Study|Lost to Follow-up|1|||
160876080|NCT00711477|580940645|FG000|Overall Study|Noncompliance|0|||
160876081|NCT00711477|580940646|FG001|Overall Study|Noncompliance|1|||
160876082|NCT02695420|580940647|FG000|Overall Study|Death|0|||
160876083|NCT02695420|580940648|FG001|Overall Study|Death|1|||
160876084|NCT02695420|580940649|FG002|Overall Study|Death|0|||
160876085|NCT02695420|580940650|FG003|Overall Study|Death|0|||
160876086|NCT02087423|580940651|FG000|Overall Study|Withdrawal by Subject|20|||
160876087|NCT02087423|580940652|FG001|Overall Study|Withdrawal by Subject|20|||
160876088|NCT02087423|580940653|FG002|Overall Study|Withdrawal by Subject|3|||
160876089|NCT02087423|580940651|FG000|Overall Study|Death|68|||
160876090|NCT02087423|580940652|FG001|Overall Study|Death|207|||
160876091|NCT02087423|580940653|FG002|Overall Study|Death|40|||
160876092|NCT02087423|580940651|FG000|Overall Study|Lost to Follow-up|0|||
160876093|NCT02087423|580940652|FG001|Overall Study|Lost to Follow-up|2|||
160876094|NCT02087423|580940653|FG002|Overall Study|Lost to Follow-up|0|||
160876095|NCT02087423|580940651|FG000|Overall Study|Terminated from study at final DCO|23|||
160876096|NCT02087423|580940652|FG001|Overall Study|Terminated from study at final DCO|36|||
160876097|NCT02087423|580940653|FG002|Overall Study|Terminated from study at final DCO|25|||
160876098|NCT02762370|580940654|FG000|Overall Study|Protocol Violation|1|||
160876099|NCT02762370|580940655|FG001|Overall Study|Protocol Violation|0|||
160876100|NCT00530816|580940659|FG000|Overall Study|Progressive Disease|16|||
160876101|NCT00530816|580940660|FG001|Overall Study|Progressive Disease|24|||
160876102|NCT00530816|580940661|FG002|Overall Study|Progressive Disease|24|||
160876103|NCT00530816|580940659|FG000|Overall Study|Adverse Event|6|||
160876104|NCT00530816|580940660|FG001|Overall Study|Adverse Event|13|||
160876105|NCT00530816|580940661|FG002|Overall Study|Adverse Event|7|||
160876106|NCT00530816|580940659|FG000|Overall Study|Other|3|||
160876107|NCT00530816|580940660|FG001|Overall Study|Other|3|||
160876108|NCT00530816|580940661|FG002|Overall Study|Other|4|||
160876109|NCT00530816|580940659|FG000|Overall Study|Withdrawal by Subject|1|||
160876110|NCT00530816|580940660|FG001|Overall Study|Withdrawal by Subject|2|||
160876111|NCT00530816|580940661|FG002|Overall Study|Withdrawal by Subject|6|||
160876112|NCT01516034|580940662|FG000|Overall Study|Physician Decision|1|||
160876113|NCT01516034|580940662|FG000|Overall Study|Lack of Efficacy|7|||
160876114|NCT01033448|580940663|FG000|Overall Study|Withdrawal by Subject|4|||
160876115|NCT01033448|580940663|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
160876116|NCT01033448|580940663|FG000|Overall Study|Lost to Follow-up|3|||
160876117|NCT01033448|580940663|FG000|Overall Study|Withdrew due to other reasons|3|||
160876118|NCT01033448|580940663|FG000|Overall Study|Unknown disposition|1|||
160876119|NCT00870584|580940667|FG000|Overall Study|Adverse Event|3|||
160876120|NCT00870584|580940668|FG001|Overall Study|Adverse Event|3|||
160876121|NCT00870584|580940667|FG000|Overall Study|Withdrawal by Subject|6|||
160876122|NCT00870584|580940668|FG001|Overall Study|Withdrawal by Subject|7|||
160876123|NCT00870584|580940667|FG000|Overall Study|Lost to Follow-up|5|||
160876124|NCT00870584|580940668|FG001|Overall Study|Lost to Follow-up|1|||
160876125|NCT00870584|580940667|FG000|Overall Study|Protocol Deviation|2|||
160876126|NCT00870584|580940668|FG001|Overall Study|Protocol Deviation|2|||
161119843|NCT00999908|581826018|FG001|Treatment Period 2|Protocol Violation|0|||
161119844|NCT00999908|581826019|FG002|Treatment Period 2|Protocol Violation|0|||
161119845|NCT00075504|581826020|FG000|Overall Study|Withdrawal by Subject|9|||
161119846|NCT00075504|581826021|FG001|Overall Study|Withdrawal by Subject|7|||
161119847|NCT05103332|581826031|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119848|NCT05103332|581826032|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
161119849|NCT05103332|581826033|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
161119850|NCT05103332|581826034|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119851|NCT05103332|581826035|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
160876127|NCT02560025|580940669|FG000|Overall Study|Ineligible after consent/ registration|3|||
160876128|NCT01497366|580940670|FG000|Overall Study|Virologic failure|2|||
160876129|NCT01497366|580940671|FG001|Overall Study|Virologic failure|50|||
160876130|NCT01497366|580940670|FG000|Overall Study|Lost to Follow-up|11|||
160876131|NCT01497366|580940671|FG001|Overall Study|Lost to Follow-up|10|||
160876132|NCT01497366|580940670|FG000|Overall Study|Withdrawal by Subject|6|||
160876133|NCT01497366|580940671|FG001|Overall Study|Withdrawal by Subject|6|||
160876134|NCT01497366|580940670|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
160876135|NCT01497366|580940671|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
160876136|NCT01497366|580940670|FG000|Overall Study|Other|5|||
160876137|NCT01497366|580940671|FG001|Overall Study|Other|0|||
160876138|NCT01497366|580940670|FG000|Overall Study|Death|1|||
160876139|NCT01497366|580940671|FG001|Overall Study|Death|1|||
160876140|NCT01497366|580940670|FG000|Overall Study|Randomized but not treated|7|||
160876141|NCT01497366|580940671|FG001|Overall Study|Randomized but not treated|21|||
160876142|NCT02745080|580940681|FG000|Overall Study|Adverse Event|13|||
160876143|NCT02745080|580940682|FG001|Overall Study|Adverse Event|21|||
160876144|NCT02745080|580940681|FG000|Overall Study|Lack of Efficacy|11|||
160876145|NCT02745080|580940682|FG001|Overall Study|Lack of Efficacy|23|||
160876146|NCT02745080|580940681|FG000|Overall Study|Lost to Follow-up|3|||
160876147|NCT02745080|580940682|FG001|Overall Study|Lost to Follow-up|3|||
160876148|NCT02745080|580940681|FG000|Overall Study|Physician Decision|3|||
160876149|NCT02745080|580940682|FG001|Overall Study|Physician Decision|0|||
160876150|NCT02745080|580940681|FG000|Overall Study|Protocol Violation|3|||
160876151|NCT02745080|580940682|FG001|Overall Study|Protocol Violation|1|||
160876152|NCT02745080|580940681|FG000|Overall Study|Withdrawal by Subject|22|||
160876153|NCT02745080|580940682|FG001|Overall Study|Withdrawal by Subject|41|||
160876154|NCT00472030|580940686|FG000|Overall Study|Physician Decision|1|||
160876155|NCT00472030|580940687|FG001|Overall Study|Physician Decision|0|||
160876156|NCT00829504|580940688|FG000|First Intervention|Adverse Event|1|||
160876157|NCT00829504|580940689|FG001|First Intervention|Adverse Event|0|||
160876158|NCT00829504|580940688|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160876159|NCT00829504|580940689|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160876160|NCT00829504|580940688|FG000|Second Intervention|Physician Decision|1|||
160876161|NCT00829504|580940689|FG001|Second Intervention|Physician Decision|0|||
160876162|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
160876163|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
160876164|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
160876165|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
160876166|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
160876167|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
160876168|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
160876169|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
160876170|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
160876171|NCT00647270|580942013|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
160876172|NCT00647270|580942014|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
160876173|NCT00647270|580942015|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
160876174|NCT00647270|580942013|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
160876175|NCT00647270|580942014|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
160876176|NCT00647270|580942015|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
161119852|NCT05103332|581826036|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
161119853|NCT05103332|581826037|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119854|NCT05103332|581826038|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119855|NCT05103332|581826039|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119856|NCT05103332|581826040|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119857|NCT05103332|581826041|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119858|NCT05103332|581826042|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119859|NCT05103332|581826043|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119860|NCT05103332|581826044|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119861|NCT05103332|581826045|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119862|NCT05103332|581826046|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119863|NCT05103332|581826047|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119864|NCT05103332|581826048|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119865|NCT05103332|581826031|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119866|NCT05103332|581826032|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
161119867|NCT05103332|581826033|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
160876177|NCT00647270|580942013|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
160876178|NCT00647270|580942014|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
160876179|NCT00647270|580942015|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
160876180|NCT00647270|580942013|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
160876181|NCT00647270|580942014|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
160876182|NCT00647270|580942015|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
160876183|NCT01743001|580942016|FG000|Overall Study|Physician Decision|1|||
160876184|NCT01743001|580942017|FG001|Overall Study|Physician Decision|0|||
160876185|NCT01743001|580942016|FG000|Overall Study|Pregnancy|1|||
160876186|NCT01743001|580942017|FG001|Overall Study|Pregnancy|0|||
160876187|NCT01743001|580942016|FG000|Overall Study|Death|1|||
160876188|NCT01743001|580942017|FG001|Overall Study|Death|0|||
160876189|NCT01864005|580942018|FG000|Overall Study|Protocol Violation|0|||
160876190|NCT01864005|580942019|FG001|Overall Study|Protocol Violation|1|||
161119868|NCT05103332|581826034|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
161119869|NCT05103332|581826035|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119870|NCT05103332|581826036|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119871|NCT05103332|581826037|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119872|NCT05103332|581826038|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119873|NCT05103332|581826039|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119874|NCT05103332|581826040|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119875|NCT05103332|581826041|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119876|NCT05103332|581826042|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119877|NCT05103332|581826043|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119878|NCT05103332|581826044|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119879|NCT05103332|581826045|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119880|NCT05103332|581826046|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119881|NCT05103332|581826047|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119882|NCT05103332|581826048|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
161119883|NCT05103332|581826031|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
161119884|NCT05103332|581826032|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161119885|NCT05103332|581826033|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
161119886|NCT05103332|581826034|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161119887|NCT05103332|581826035|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161119888|NCT05103332|581826036|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
161119889|NCT05103332|581826037|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119890|NCT05103332|581826038|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119891|NCT05103332|581826039|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119892|NCT05103332|581826040|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119893|NCT05103332|581826041|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119894|NCT05103332|581826042|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119895|NCT05103332|581826043|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119896|NCT05103332|581826044|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119897|NCT05103332|581826045|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119898|NCT05103332|581826046|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119899|NCT05103332|581826047|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119900|NCT05103332|581826048|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161119901|NCT05103332|581826031|FG000|DB Period (6 Months=168 Days)|Other|0|||
161119902|NCT05103332|581826032|FG001|DB Period (6 Months=168 Days)|Other|0|||
161119903|NCT05103332|581826033|FG002|DB Period (6 Months=168 Days)|Other|0|||
161119904|NCT05103332|581826034|FG003|DB Period (6 Months=168 Days)|Other|1|||
161119905|NCT05103332|581826035|FG004|DB Period (6 Months=168 Days)|Other|0|||
161119906|NCT05103332|581826036|FG005|DB Period (6 Months=168 Days)|Other|0|||
161119907|NCT05103332|581826037|FG006|DB Period (6 Months=168 Days)|Other|0|||
161119908|NCT05103332|581826038|FG007|DB Period (6 Months=168 Days)|Other|0|||
161119909|NCT05103332|581826039|FG008|DB Period (6 Months=168 Days)|Other|0|||
161119910|NCT05103332|581826040|FG009|DB Period (6 Months=168 Days)|Other|0|||
161119911|NCT05103332|581826041|FG010|DB Period (6 Months=168 Days)|Other|0|||
161119912|NCT05103332|581826042|FG011|DB Period (6 Months=168 Days)|Other|0|||
161119913|NCT05103332|581826043|FG012|DB Period (6 Months=168 Days)|Other|0|||
161119914|NCT05103332|581826044|FG013|DB Period (6 Months=168 Days)|Other|0|||
161119915|NCT05103332|581826045|FG014|DB Period (6 Months=168 Days)|Other|0|||
161119916|NCT05103332|581826046|FG015|DB Period (6 Months=168 Days)|Other|0|||
161119917|NCT05103332|581826047|FG016|DB Period (6 Months=168 Days)|Other|0|||
161119918|NCT05103332|581826048|FG017|DB Period (6 Months=168 Days)|Other|0|||
161119919|NCT05103332|581826031|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119920|NCT05103332|581826032|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119921|NCT05103332|581826033|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119922|NCT05103332|581826034|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
160876191|NCT01864005|580942018|FG000|Overall Study|Withdrawal by Subject|0|||
160876192|NCT01864005|580942019|FG001|Overall Study|Withdrawal by Subject|1|||
160876193|NCT01864005|580942018|FG000|Overall Study|Incorrect enrolment|1|||
160876194|NCT01864005|580942019|FG001|Overall Study|Incorrect enrolment|0|||
160876195|NCT01864005|580942018|FG000|Overall Study|Disease need|1|||
161119923|NCT05103332|581826035|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119924|NCT05103332|581826036|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119925|NCT05103332|581826037|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119926|NCT05103332|581826038|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119927|NCT05103332|581826039|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119928|NCT05103332|581826040|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119929|NCT05103332|581826041|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
161119930|NCT05103332|581826042|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119931|NCT05103332|581826043|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119932|NCT05103332|581826044|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119933|NCT05103332|581826045|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119934|NCT05103332|581826046|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119935|NCT05103332|581826047|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119936|NCT05103332|581826048|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
161119937|NCT05103332|581826031|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119938|NCT05103332|581826032|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119939|NCT05103332|581826033|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119940|NCT05103332|581826034|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119941|NCT05103332|581826035|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119942|NCT05103332|581826036|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119943|NCT05103332|581826037|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119944|NCT05103332|581826038|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119945|NCT05103332|581826039|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
161119946|NCT05103332|581826040|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119947|NCT05103332|581826041|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119948|NCT05103332|581826042|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119949|NCT05103332|581826043|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119950|NCT05103332|581826044|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119951|NCT05103332|581826045|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119952|NCT05103332|581826046|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119953|NCT05103332|581826047|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119954|NCT05103332|581826048|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
161119955|NCT05103332|581826031|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119956|NCT05103332|581826032|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119957|NCT05103332|581826033|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119958|NCT05103332|581826034|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119959|NCT05103332|581826035|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119960|NCT05103332|581826036|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119961|NCT05103332|581826037|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119962|NCT05103332|581826038|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119963|NCT05103332|581826039|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119964|NCT05103332|581826040|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119965|NCT05103332|581826041|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119966|NCT05103332|581826042|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
160876196|NCT01864005|580942019|FG001|Overall Study|Disease need|1|||
160876197|NCT01864005|580942018|FG000|Overall Study|Need GP IIb/IIIa|1|||
160876198|NCT01864005|580942019|FG001|Overall Study|Need GP IIb/IIIa|3|||
160876199|NCT02184572|580942020|FG000|Overall Study|Lost to Follow-up|29|||
160876200|NCT02184572|580942021|FG001|Overall Study|Lost to Follow-up|21|||
160876201|NCT02184572|580942020|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
160876202|NCT02184572|580942021|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
160876203|NCT02184572|580942020|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
160876204|NCT02184572|580942021|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
160876205|NCT02184572|580942020|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
160876206|NCT02184572|580942021|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
160876207|NCT02184572|580942020|FG000|Overall Study|Traveling Outside The Country|1|||
160876208|NCT02184572|580942021|FG001|Overall Study|Traveling Outside The Country|0|||
160876209|NCT02184572|580942020|FG000|Overall Study|Withdrawal by Subject|14|||
160876210|NCT02184572|580942021|FG001|Overall Study|Withdrawal by Subject|9|||
160876211|NCT03679754|580942025|FG000|Overall Study|Investigator request|1|||
160876212|NCT00964171|580942026|FG000|Overall Study|Death|5|||
160876213|NCT00080899|580942027|FG000|Overall Study|Adverse Event|1|||
160876214|NCT02872935|580942028|FG000|Overall Study|Other|0|||
160876215|NCT02872935|580942029|FG001|Overall Study|Other|1|||
160876216|NCT03179319|580942030|FG000|Overall Study|Lost to Follow-up|6|||
160876217|NCT03179319|580942031|FG001|Overall Study|Lost to Follow-up|0|||
160876218|NCT01120717|580942032|FG000|Overall Study|Withdrawal by Subject|11|||
160876219|NCT01120717|580942033|FG001|Overall Study|Withdrawal by Subject|6|||
160876220|NCT01120717|580942032|FG000|Overall Study|Adverse Event|10|||
160876221|NCT01120717|580942033|FG001|Overall Study|Adverse Event|6|||
160876222|NCT01120717|580942032|FG000|Overall Study|Protocol Deviation|2|||
160876223|NCT01120717|580942033|FG001|Overall Study|Protocol Deviation|5|||
160876224|NCT01120717|580942032|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160876225|NCT01120717|580942033|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160876226|NCT01120717|580942032|FG000|Overall Study|Lost to Follow-up|2|||
160876227|NCT01120717|580942033|FG001|Overall Study|Lost to Follow-up|3|||
160876228|NCT01120717|580942032|FG000|Overall Study|Death|3|||
160876229|NCT01120717|580942033|FG001|Overall Study|Death|1|||
160876230|NCT01120717|580942032|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160876231|NCT01120717|580942033|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160876232|NCT02640508|580942038|FG000|Overall Study|Death|19|||
160876233|NCT02640508|580942038|FG000|Overall Study|Withdrawal by Subject|8|||
161119967|NCT05103332|581826043|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119968|NCT05103332|581826044|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119969|NCT05103332|581826045|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119970|NCT05103332|581826046|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119971|NCT05103332|581826047|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119972|NCT05103332|581826048|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
161119973|NCT05103332|581826031|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119974|NCT05103332|581826032|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119975|NCT05103332|581826033|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119976|NCT05103332|581826034|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119977|NCT05103332|581826035|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119978|NCT05103332|581826036|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119979|NCT05103332|581826037|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
161119980|NCT05103332|581826038|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
161119981|NCT05103332|581826039|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119982|NCT05103332|581826040|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
161119983|NCT05103332|581826041|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
160876234|NCT02640508|580942038|FG000|Overall Study|Physician Decision|1|||
160876235|NCT02640508|580942038|FG000|Overall Study|Lost to Follow-up|1|||
160876236|NCT00865280|580942039|FG000|Overall Study|Withdrawal by Subject|4|||
160876237|NCT00865280|580942040|FG001|Overall Study|Withdrawal by Subject|1|||
160876238|NCT00865280|580942039|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
160876239|NCT00865280|580942040|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
160876240|NCT00865280|580942039|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
160876241|NCT00865280|580942040|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
160876242|NCT00865280|580942039|FG000|Overall Study|Exclusion Condition|1|||
160876243|NCT00865280|580942040|FG001|Overall Study|Exclusion Condition|0|||
160876244|NCT00865280|580942039|FG000|Overall Study|Adverse Event|0|||
160876245|NCT00865280|580942040|FG001|Overall Study|Adverse Event|1|||
160876246|NCT00329797|580942041|FG000|Overall Study|Protocol Violation|1|||
160876247|NCT00329797|580942042|FG001|Overall Study|Protocol Violation|0|||
160876248|NCT00329797|580942041|FG000|Overall Study|Withdrawal by Subject|6|||
160876249|NCT00329797|580942042|FG001|Overall Study|Withdrawal by Subject|6|||
160876250|NCT03091348|580942049|FG000|Overall Study|Lost to Follow-up|2|||
160876251|NCT03091348|580942050|FG001|Overall Study|Lost to Follow-up|1|||
160876252|NCT04534686|580942051|FG000|Baseline Measurement|Lost to Follow-up|4|||
160876253|NCT04534686|580942052|FG001|Baseline Measurement|Lost to Follow-up|6|||
160876254|NCT04534686|580942051|FG000|Baseline Measurement|Withdrawal by Subject|3|||
160876255|NCT04534686|580942052|FG001|Baseline Measurement|Withdrawal by Subject|1|||
160876256|NCT04534686|580942051|FG000|Intervention|Withdrawal by Subject|2|||
160876257|NCT04534686|580942052|FG001|Intervention|Withdrawal by Subject|2|||
160876258|NCT03179605|580942053|FG000|Overall Study|Withdrawal by Subject|1|||
160876259|NCT00635999|580942054|FG000|Overall Study|Withdrawal by Subject|4|||
160876260|NCT00635999|580942055|FG001|Overall Study|Withdrawal by Subject|2|||
160876261|NCT00635999|580942056|FG002|Overall Study|Withdrawal by Subject|1|||
160876262|NCT01396070|580942058|FG000|Overall Study|Withdrawal by Subject|2|||
160876263|NCT01396070|580942058|FG000|Overall Study|Death|2|||
160876264|NCT01396070|580942058|FG000|Overall Study|Adverse Event|8|||
160876265|NCT01396070|580942058|FG000|Overall Study|Physician Decision|3|||
160876266|NCT01396070|580942058|FG000|Overall Study|Lack of Efficacy|4|||
160876267|NCT02636361|580942059|FG000|Period 4|Physician Decision|0|||
160876268|NCT02636361|580942060|FG001|Period 4|Physician Decision|0|||
160876269|NCT02636361|580942061|FG002|Period 4|Physician Decision|0|||
160876270|NCT02636361|580942062|FG003|Period 4|Physician Decision|1|||
160876271|NCT02636361|580942063|FG004|Period 4|Physician Decision|0|||
160876272|NCT03037580|580942068|FG000|Overall Study|Withdrawal by Subject|3|||
160876273|NCT03037580|580942069|FG001|Overall Study|Withdrawal by Subject|0|||
160876274|NCT03037580|580942068|FG000|Overall Study|Adverse Event|1|||
160876275|NCT03037580|580942069|FG001|Overall Study|Adverse Event|0|||
160876276|NCT03037580|580942068|FG000|Overall Study|Study Terminated by Sponsor|12|||
160876277|NCT03037580|580942069|FG001|Overall Study|Study Terminated by Sponsor|15|||
160876278|NCT03037580|580942068|FG000|Overall Study|Death|0|||
160876279|NCT03037580|580942069|FG001|Overall Study|Death|1|||
160876280|NCT02036853|580942070|FG000|Overall Study|Adverse Event|0|||
160876281|NCT02036853|580942071|FG001|Overall Study|Adverse Event|2|||
160876282|NCT02036853|580942070|FG000|Overall Study|Lack of Efficacy|0|||
160876283|NCT02036853|580942071|FG001|Overall Study|Lack of Efficacy|2|||
160876284|NCT02036853|580942070|FG000|Overall Study|Physician Decision|0|||
160876285|NCT02036853|580942071|FG001|Overall Study|Physician Decision|1|||
160876286|NCT02036853|580942070|FG000|Overall Study|Withdrawal by Subject|0|||
160876287|NCT02036853|580942071|FG001|Overall Study|Withdrawal by Subject|1|||
160876288|NCT00228553|580942072|FG000|Overall Study|Adverse Event|112|||
160876289|NCT00228553|580942072|FG000|Overall Study|Lack of Efficacy|34|||
160876290|NCT00228553|580942072|FG000|Overall Study|Lost to Follow-up|67|||
160876291|NCT00228553|580942072|FG000|Overall Study|Physician Decision|48|||
160876292|NCT00228553|580942072|FG000|Overall Study|Protocol Violation|6|||
160876293|NCT00228553|580942072|FG000|Overall Study|Withdrawal by Subject|115|||
160876294|NCT00228553|580942072|FG000|Overall Study|Pregnancy|2|||
160876295|NCT00228553|580942072|FG000|Overall Study|Miscellaneous|46|||
160876296|NCT04530136|580942073|FG000|Overall Study|Lost to Follow-up|2|||
160876297|NCT04530136|580942074|FG001|Overall Study|Lost to Follow-up|3|||
160876298|NCT04530136|580942073|FG000|Overall Study|Withdrawal by Subject|1|||
160876299|NCT04530136|580942074|FG001|Overall Study|Withdrawal by Subject|0|||
160876300|NCT04530136|580942073|FG000|Overall Study|Death|0|||
160876301|NCT04530136|580942074|FG001|Overall Study|Death|1|||
160876302|NCT00499590|580942078|FG000|Overall Study|Study Terminated|112|||
160876303|NCT00499590|580942079|FG001|Overall Study|Study Terminated|112|||
160876304|NCT00499590|580942080|FG002|Overall Study|Study Terminated|112|||
161119984|NCT05103332|581826042|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
161119985|NCT05103332|581826043|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119986|NCT05103332|581826044|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119987|NCT05103332|581826045|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119988|NCT05103332|581826046|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119989|NCT05103332|581826047|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119990|NCT05103332|581826048|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
161119991|NCT05103332|581826031|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119992|NCT05103332|581826032|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119993|NCT05103332|581826033|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161225013|NCT04634409|582203558|FG006|Overall Study|Adverse Event|0|||
161225014|NCT04634409|582203559|FG007|Overall Study|Adverse Event|0|||
161225015|NCT04634409|582203560|FG008|Overall Study|Adverse Event|0|||
161225016|NCT04634409|582203561|FG009|Overall Study|Adverse Event|0|||
161225017|NCT04634409|582203562|FG010|Overall Study|Adverse Event|0|||
161225018|NCT04634409|582203563|FG011|Overall Study|Adverse Event|0|||
161119994|NCT05103332|581826034|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119995|NCT05103332|581826035|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119996|NCT05103332|581826036|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119997|NCT05103332|581826037|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119998|NCT05103332|581826038|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161119999|NCT05103332|581826039|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161120000|NCT05103332|581826040|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161120001|NCT05103332|581826041|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161120002|NCT05103332|581826042|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
161120003|NCT05103332|581826043|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
161120004|NCT05103332|581826044|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
161120005|NCT05103332|581826045|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
161120006|NCT05103332|581826046|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
161120007|NCT05103332|581826047|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
161120008|NCT05103332|581826048|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
161120009|NCT05103332|581826031|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120010|NCT05103332|581826032|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120011|NCT05103332|581826033|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120012|NCT05103332|581826034|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120013|NCT05103332|581826035|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120014|NCT05103332|581826036|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120015|NCT05103332|581826037|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120016|NCT05103332|581826038|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120017|NCT05103332|581826039|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120018|NCT05103332|581826040|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120019|NCT05103332|581826041|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120020|NCT05103332|581826042|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120021|NCT05103332|581826043|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120022|NCT05103332|581826044|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120023|NCT05103332|581826045|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120024|NCT05103332|581826046|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120025|NCT05103332|581826047|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
161120026|NCT05103332|581826048|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
161120027|NCT05103332|581826031|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120028|NCT05103332|581826032|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160876305|NCT00499590|580942078|FG000|Overall Study|Not treated|1|||
160876306|NCT00499590|580942079|FG001|Overall Study|Not treated|0|||
160876307|NCT00499590|580942080|FG002|Overall Study|Not treated|1|||
160876308|NCT02633020|580942084|FG000|Overall Study|Adverse Event|1|||
160876309|NCT02633020|580942085|FG001|Overall Study|Adverse Event|0|||
160876310|NCT00934440|580942086|FG000|Overall Study|Lost to Follow-up|1|||
160876311|NCT05661851|580942087|FG000|Overall Study|Protocol Violation|1|||
160876312|NCT05661851|580942088|FG001|Overall Study|Protocol Violation|1|||
160876313|NCT05661851|580942087|FG000|Overall Study|Covid-19 Related|3|||
160876314|NCT05661851|580942088|FG001|Overall Study|Covid-19 Related|4|||
160876315|NCT05661851|580942087|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
160876316|NCT05661851|580942088|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
160876317|NCT05661851|580942087|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
160876318|NCT05661851|580942088|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
161120029|NCT05103332|581826033|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120030|NCT05103332|581826034|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160876319|NCT02152956|580942089|FG000|Overall Study|Adverse Event|0|||
160876320|NCT02152956|580942090|FG001|Overall Study|Adverse Event|0|||
160876321|NCT02152956|580942091|FG002|Overall Study|Adverse Event|0|||
160876322|NCT02152956|580942092|FG003|Overall Study|Adverse Event|0|||
160876323|NCT02152956|580942093|FG004|Overall Study|Adverse Event|0|||
160876324|NCT02152956|580942094|FG005|Overall Study|Adverse Event|0|||
160876325|NCT02152956|580942095|FG006|Overall Study|Adverse Event|0|||
160876326|NCT02152956|580942096|FG007|Overall Study|Adverse Event|0|||
160876327|NCT02152956|580942097|FG008|Overall Study|Adverse Event|0|||
160876328|NCT02152956|580942098|FG009|Overall Study|Adverse Event|0|||
160876329|NCT02152956|580942099|FG010|Overall Study|Adverse Event|0|||
160876330|NCT02152956|580942100|FG011|Overall Study|Adverse Event|4|||
160876331|NCT02152956|580942101|FG012|Overall Study|Adverse Event|0|||
160876332|NCT02152956|580942089|FG000|Overall Study|Death|0|||
160876333|NCT02152956|580942090|FG001|Overall Study|Death|3|||
160876334|NCT02152956|580942091|FG002|Overall Study|Death|3|||
160876335|NCT02152956|580942092|FG003|Overall Study|Death|4|||
160876336|NCT02152956|580942093|FG004|Overall Study|Death|1|||
160876337|NCT02152956|580942094|FG005|Overall Study|Death|2|||
160876338|NCT02152956|580942095|FG006|Overall Study|Death|6|||
160876339|NCT02152956|580942096|FG007|Overall Study|Death|6|||
160876340|NCT02152956|580942097|FG008|Overall Study|Death|4|||
160876341|NCT02152956|580942098|FG009|Overall Study|Death|5|||
160876342|NCT02152956|580942099|FG010|Overall Study|Death|3|||
160876343|NCT02152956|580942100|FG011|Overall Study|Death|143|||
160876344|NCT02152956|580942101|FG012|Overall Study|Death|12|||
160876345|NCT02152956|580942089|FG000|Overall Study|Lost to Follow-up|0|||
160876346|NCT02152956|580942090|FG001|Overall Study|Lost to Follow-up|1|||
160876347|NCT02152956|580942091|FG002|Overall Study|Lost to Follow-up|0|||
160876348|NCT02152956|580942092|FG003|Overall Study|Lost to Follow-up|0|||
160876349|NCT02152956|580942093|FG004|Overall Study|Lost to Follow-up|0|||
160876350|NCT02152956|580942094|FG005|Overall Study|Lost to Follow-up|0|||
160876351|NCT02152956|580942095|FG006|Overall Study|Lost to Follow-up|0|||
160876352|NCT02152956|580942096|FG007|Overall Study|Lost to Follow-up|0|||
160876353|NCT02152956|580942097|FG008|Overall Study|Lost to Follow-up|0|||
161120031|NCT05103332|581826035|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160876354|NCT02152956|580942098|FG009|Overall Study|Lost to Follow-up|0|||
160876355|NCT02152956|580942099|FG010|Overall Study|Lost to Follow-up|0|||
160876356|NCT02152956|580942100|FG011|Overall Study|Lost to Follow-up|3|||
160876357|NCT02152956|580942101|FG012|Overall Study|Lost to Follow-up|0|||
160876358|NCT02152956|580942089|FG000|Overall Study|Withdrawal by Subject|1|||
160876359|NCT02152956|580942090|FG001|Overall Study|Withdrawal by Subject|0|||
160876360|NCT02152956|580942091|FG002|Overall Study|Withdrawal by Subject|1|||
160876361|NCT02152956|580942092|FG003|Overall Study|Withdrawal by Subject|0|||
160876362|NCT02152956|580942093|FG004|Overall Study|Withdrawal by Subject|2|||
160876363|NCT02152956|580942094|FG005|Overall Study|Withdrawal by Subject|2|||
160876364|NCT02152956|580942095|FG006|Overall Study|Withdrawal by Subject|0|||
160876365|NCT02152956|580942096|FG007|Overall Study|Withdrawal by Subject|0|||
160876366|NCT02152956|580942097|FG008|Overall Study|Withdrawal by Subject|1|||
160876367|NCT02152956|580942098|FG009|Overall Study|Withdrawal by Subject|0|||
160876368|NCT02152956|580942099|FG010|Overall Study|Withdrawal by Subject|0|||
160876369|NCT02152956|580942100|FG011|Overall Study|Withdrawal by Subject|4|||
160876370|NCT02152956|580942101|FG012|Overall Study|Withdrawal by Subject|0|||
161142576|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Physician Decision|4|||
160876371|NCT02152956|580942089|FG000|Overall Study|Physician Decision|0|||
160876372|NCT02152956|580942090|FG001|Overall Study|Physician Decision|0|||
160876373|NCT02152956|580942091|FG002|Overall Study|Physician Decision|0|||
160876374|NCT02152956|580942092|FG003|Overall Study|Physician Decision|0|||
160876375|NCT02152956|580942093|FG004|Overall Study|Physician Decision|0|||
160876376|NCT02152956|580942094|FG005|Overall Study|Physician Decision|0|||
160876377|NCT02152956|580942095|FG006|Overall Study|Physician Decision|0|||
160876378|NCT02152956|580942096|FG007|Overall Study|Physician Decision|0|||
160876379|NCT02152956|580942097|FG008|Overall Study|Physician Decision|0|||
160876380|NCT02152956|580942098|FG009|Overall Study|Physician Decision|0|||
160876381|NCT02152956|580942099|FG010|Overall Study|Physician Decision|0|||
160876382|NCT02152956|580942100|FG011|Overall Study|Physician Decision|1|||
160876383|NCT02152956|580942101|FG012|Overall Study|Physician Decision|0|||
160876384|NCT02152956|580942089|FG000|Overall Study|Study terminated by sponsor|0|||
160876385|NCT02152956|580942090|FG001|Overall Study|Study terminated by sponsor|0|||
160876386|NCT02152956|580942091|FG002|Overall Study|Study terminated by sponsor|0|||
160876387|NCT02152956|580942092|FG003|Overall Study|Study terminated by sponsor|0|||
160876388|NCT02152956|580942093|FG004|Overall Study|Study terminated by sponsor|0|||
160876389|NCT02152956|580942094|FG005|Overall Study|Study terminated by sponsor|0|||
160876390|NCT02152956|580942095|FG006|Overall Study|Study terminated by sponsor|0|||
160876391|NCT02152956|580942096|FG007|Overall Study|Study terminated by sponsor|0|||
160876392|NCT02152956|580942097|FG008|Overall Study|Study terminated by sponsor|0|||
160876393|NCT02152956|580942098|FG009|Overall Study|Study terminated by sponsor|0|||
160876394|NCT02152956|580942099|FG010|Overall Study|Study terminated by sponsor|0|||
160876395|NCT02152956|580942100|FG011|Overall Study|Study terminated by sponsor|29|||
160876396|NCT02152956|580942101|FG012|Overall Study|Study terminated by sponsor|0|||
160876397|NCT02152956|580942089|FG000|Overall Study|progressive disease|0|||
160876398|NCT02152956|580942090|FG001|Overall Study|progressive disease|0|||
161120032|NCT05103332|581826036|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
160876399|NCT02152956|580942091|FG002|Overall Study|progressive disease|0|||
160876400|NCT02152956|580942092|FG003|Overall Study|progressive disease|0|||
160876401|NCT02152956|580942093|FG004|Overall Study|progressive disease|0|||
160876402|NCT02152956|580942094|FG005|Overall Study|progressive disease|0|||
161142577|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Physician Decision|2|||
160876403|NCT02152956|580942095|FG006|Overall Study|progressive disease|0|||
160876404|NCT02152956|580942096|FG007|Overall Study|progressive disease|0|||
160876405|NCT02152956|580942097|FG008|Overall Study|progressive disease|1|||
160876406|NCT02152956|580942098|FG009|Overall Study|progressive disease|0|||
160876407|NCT02152956|580942099|FG010|Overall Study|progressive disease|0|||
160876408|NCT02152956|580942100|FG011|Overall Study|progressive disease|1|||
160876409|NCT02152956|580942101|FG012|Overall Study|progressive disease|0|||
160876410|NCT01014910|580942102|FG000|Overall Study|Withdrawal by Subject|0|||
160876411|NCT01014910|580942103|FG001|Overall Study|Withdrawal by Subject|2|||
160876412|NCT03753789|580942104|FG000|Overall Study|Withdrawal by Subject|2|||
160876413|NCT01136785|580942106|FG000|Overall Study|Protocol Violation|2|||
160876414|NCT01136785|580942107|FG001|Overall Study|Protocol Violation|1|||
160876415|NCT02873429|580942108|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
160876416|NCT02873429|580942109|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
160876417|NCT02873429|580942108|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
160876418|NCT02873429|580942109|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
160876419|NCT02873429|580942108|FG000|16 Weeks|Lost to Follow-up|3|||
160876420|NCT02873429|580942109|FG001|16 Weeks|Lost to Follow-up|0|||
160876421|NCT00612807|580942110|FG000|Overall Study|Withdrawal by Subject|2|||
160876422|NCT00612807|580942111|FG001|Overall Study|Withdrawal by Subject|0|||
160876423|NCT00744042|580942114|FG000|Overall Study|Withdrawal by Subject|1|||
160876424|NCT00853567|580942115|FG000|Overall Study|Study prematurely terminated|71|||
160876425|NCT02055118|580942119|FG000|Overall Study|Withdrawal by Subject|0|||
160876426|NCT02055118|580942120|FG001|Overall Study|Withdrawal by Subject|2|||
160876427|NCT02055118|580942121|FG002|Overall Study|Withdrawal by Subject|0|||
160876428|NCT02281383|580942123|FG000|Overall Study|Progressive Disease|1|||
160876429|NCT02281383|580942123|FG000|Overall Study|Withdrawal by Subject|6|||
160876430|NCT02281383|580942123|FG000|Overall Study|Protocol Violation|2|||
160876431|NCT02281383|580942123|FG000|Overall Study|Death|1|||
160876432|NCT02281383|580942123|FG000|Overall Study|Adverse Event|2|||
160876433|NCT00599339|580942126|FG000|Overall Study|Adverse Event|79|||
160876434|NCT00599339|580942126|FG000|Overall Study|Withdrawal by Subject|137|||
160876435|NCT00599339|580942126|FG000|Overall Study|Other Reason|179|||
160876436|NCT00599339|580942126|FG000|Overall Study|Lost to Follow-up|221|||
160876437|NCT00599339|580942126|FG000|Overall Study|No valid data consent|36|||
160876438|NCT00599339|580942126|FG000|Overall Study|Study Termination Status Unknown|12|||
160876439|NCT05564052|580942127|FG000|Overall Study|Withdrawal by Subject|0|||
160876440|NCT05564052|580942128|FG001|Overall Study|Withdrawal by Subject|0|||
160876441|NCT05564052|580942129|FG002|Overall Study|Withdrawal by Subject|0|||
160876442|NCT05564052|580942130|FG003|Overall Study|Withdrawal by Subject|1|||
160876443|NCT01821560|580942131|FG000|Overall Study|Lost to Follow-up|5|||
160876444|NCT01821560|580942132|FG001|Overall Study|Lost to Follow-up|5|||
160876445|NCT01821560|580942131|FG000|Overall Study|Withdrawal by Subject|1|||
160876446|NCT01821560|580942132|FG001|Overall Study|Withdrawal by Subject|1|||
160876447|NCT01821560|580942131|FG000|Overall Study|Protocol Violation|0|||
160876448|NCT01821560|580942132|FG001|Overall Study|Protocol Violation|1|||
160876449|NCT04189224|580942134|FG000|Period 2|Adverse Event|0|||
161120033|NCT05103332|581826037|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120034|NCT05103332|581826038|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120035|NCT05103332|581826039|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120036|NCT05103332|581826040|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120037|NCT05103332|581826041|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120038|NCT05103332|581826042|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
161120039|NCT05103332|581826043|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
161120040|NCT05103332|581826044|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
161120041|NCT05103332|581826045|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
161120042|NCT05103332|581826046|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
161120043|NCT05103332|581826047|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
161120044|NCT05103332|581826048|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
161225019|NCT04634409|582203564|FG012|Overall Study|Adverse Event|0|||
161225020|NCT04634409|582203565|FG013|Overall Study|Adverse Event|0|||
161225021|NCT04634409|582203566|FG014|Overall Study|Adverse Event|0|||
160876450|NCT04189224|580942135|FG001|Period 2|Adverse Event|1|||
160876451|NCT03338959|580943545|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
160876452|NCT03338959|580943545|FG000|Overall Study|Physician Decision|1|||
160876453|NCT00409331|580943547|FG000|Overall Study|Physician Decision|1|||
160876454|NCT00281658|580943548|FG000|Randomized Phase|Adverse Event|0|||
160876455|NCT00281658|580943549|FG001|Randomized Phase|Adverse Event|2|||
160876456|NCT00281658|580943550|FG002|Randomized Phase|Adverse Event|0|||
160876457|NCT00281658|580943551|FG003|Randomized Phase|Adverse Event|0|||
160876458|NCT00281658|580943548|FG000|Randomized Phase|Lost to Follow-up|34|||
160876459|NCT00281658|580943549|FG001|Randomized Phase|Lost to Follow-up|27|||
160876460|NCT00281658|580943550|FG002|Randomized Phase|Lost to Follow-up|0|||
160876461|NCT00281658|580943551|FG003|Randomized Phase|Lost to Follow-up|0|||
160876462|NCT00281658|580943548|FG000|Randomized Phase|Withdrawal by Subject|8|||
160876463|NCT00281658|580943549|FG001|Randomized Phase|Withdrawal by Subject|7|||
160876464|NCT00281658|580943550|FG002|Randomized Phase|Withdrawal by Subject|0|||
160876465|NCT00281658|580943551|FG003|Randomized Phase|Withdrawal by Subject|0|||
160876466|NCT00281658|580943548|FG000|Randomized Phase|Study closed/terminated|1|||
160876467|NCT00281658|580943549|FG001|Randomized Phase|Study closed/terminated|1|||
160876468|NCT00281658|580943550|FG002|Randomized Phase|Study closed/terminated|0|||
160876469|NCT00281658|580943551|FG003|Randomized Phase|Study closed/terminated|0|||
160876470|NCT00281658|580943548|FG000|Randomized Phase|Disease progression|36|||
160876471|NCT00281658|580943549|FG001|Randomized Phase|Disease progression|27|||
160876472|NCT00281658|580943550|FG002|Randomized Phase|Disease progression|0|||
160876473|NCT00281658|580943551|FG003|Randomized Phase|Disease progression|0|||
160876474|NCT00281658|580943548|FG000|Randomized Phase|Physician Decision|1|||
160876475|NCT00281658|580943549|FG001|Randomized Phase|Physician Decision|1|||
160876476|NCT00281658|580943550|FG002|Randomized Phase|Physician Decision|0|||
160876477|NCT00281658|580943551|FG003|Randomized Phase|Physician Decision|0|||
160876478|NCT00281658|580943548|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
160876479|NCT00281658|580943549|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
160876480|NCT00281658|580943550|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
160876481|NCT00281658|580943551|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
160876482|NCT00281658|580943548|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
160876483|NCT00281658|580943549|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
160876484|NCT00281658|580943550|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
160876485|NCT00281658|580943551|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
160876486|NCT00281658|580943548|FG000|Randomized Phase|Treatment ongoing|1|||
160876487|NCT00281658|580943549|FG001|Randomized Phase|Treatment ongoing|0|||
160876488|NCT00281658|580943550|FG002|Randomized Phase|Treatment ongoing|0|||
160876489|NCT00281658|580943551|FG003|Randomized Phase|Treatment ongoing|0|||
160876490|NCT00281658|580943548|FG000|Open Label Phase|Adverse Event|0|||
160876491|NCT00281658|580943549|FG001|Open Label Phase|Adverse Event|0|||
160876492|NCT00281658|580943550|FG002|Open Label Phase|Adverse Event|1|||
160876493|NCT00281658|580943551|FG003|Open Label Phase|Adverse Event|0|||
160876494|NCT00281658|580943548|FG000|Open Label Phase|Lost to Follow-up|0|||
160876495|NCT00281658|580943549|FG001|Open Label Phase|Lost to Follow-up|0|||
160876496|NCT00281658|580943550|FG002|Open Label Phase|Lost to Follow-up|16|||
160876497|NCT00281658|580943551|FG003|Open Label Phase|Lost to Follow-up|2|||
160876498|NCT00281658|580943548|FG000|Open Label Phase|Withdrawal by Subject|0|||
160876499|NCT00281658|580943549|FG001|Open Label Phase|Withdrawal by Subject|0|||
160876500|NCT00281658|580943550|FG002|Open Label Phase|Withdrawal by Subject|3|||
160876501|NCT00281658|580943551|FG003|Open Label Phase|Withdrawal by Subject|2|||
160876502|NCT00281658|580943548|FG000|Open Label Phase|Disease progression|0|||
160876503|NCT00281658|580943549|FG001|Open Label Phase|Disease progression|0|||
160876504|NCT00281658|580943550|FG002|Open Label Phase|Disease progression|18|||
160876505|NCT00281658|580943551|FG003|Open Label Phase|Disease progression|0|||
160876506|NCT00281658|580943548|FG000|Open Label Phase|Physician Decision|0|||
160876507|NCT00281658|580943549|FG001|Open Label Phase|Physician Decision|0|||
160876508|NCT00281658|580943550|FG002|Open Label Phase|Physician Decision|1|||
160876509|NCT00281658|580943551|FG003|Open Label Phase|Physician Decision|0|||
160876510|NCT00281658|580943548|FG000|Open Label Phase|Relocation of patient|0|||
160876511|NCT00281658|580943549|FG001|Open Label Phase|Relocation of patient|0|||
160876512|NCT00281658|580943550|FG002|Open Label Phase|Relocation of patient|1|||
160876513|NCT00281658|580943551|FG003|Open Label Phase|Relocation of patient|0|||
160876514|NCT00281658|580943548|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
160876515|NCT00281658|580943549|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
160876516|NCT00281658|580943550|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
160876517|NCT00281658|580943551|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
160876518|NCT02151773|580943552|FG000|Overall Study|Protocol Deviation|64|||
160876519|NCT03680742|580943553|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
160876520|NCT02894502|580943556|FG000|Baseline|Withdrawal by Subject|24|||
160876521|NCT02894502|580943557|FG001|Baseline|Withdrawal by Subject|31|||
160876522|NCT02894502|580943558|FG002|Baseline|Withdrawal by Subject|36|||
160876523|NCT02894502|580943556|FG000|Baseline|Death|3|||
160876524|NCT02894502|580943557|FG001|Baseline|Death|1|||
160876525|NCT02894502|580943558|FG002|Baseline|Death|9|||
160876526|NCT02894502|580943556|FG000|First Follow up|Withdrawal by Subject|32|||
160876527|NCT02894502|580943557|FG001|First Follow up|Withdrawal by Subject|29|||
160876528|NCT02894502|580943558|FG002|First Follow up|Withdrawal by Subject|37|||
160876529|NCT02894502|580943556|FG000|First Follow up|Death|2|||
160876530|NCT02894502|580943557|FG001|First Follow up|Death|2|||
160876531|NCT02894502|580943558|FG002|First Follow up|Death|3|||
160876532|NCT02894502|580943556|FG000|Second Follow up|Withdrawal by Subject|13|||
160876533|NCT02894502|580943557|FG001|Second Follow up|Withdrawal by Subject|15|||
160876534|NCT02894502|580943558|FG002|Second Follow up|Withdrawal by Subject|13|||
160876535|NCT02894502|580943556|FG000|Second Follow up|Death|2|||
160876536|NCT02894502|580943557|FG001|Second Follow up|Death|3|||
160876537|NCT02894502|580943558|FG002|Second Follow up|Death|1|||
160876538|NCT02894502|580943556|FG000|Third Follow up|Withdrawal by Subject|5|||
160876539|NCT02894502|580943557|FG001|Third Follow up|Withdrawal by Subject|6|||
160876540|NCT02894502|580943558|FG002|Third Follow up|Withdrawal by Subject|3|||
160876541|NCT02894502|580943556|FG000|Third Follow up|Death|1|||
160876542|NCT02894502|580943557|FG001|Third Follow up|Death|1|||
160876543|NCT02894502|580943558|FG002|Third Follow up|Death|0|||
160876544|NCT01410357|580943559|FG000|Overall Study|Death|2|||
160876545|NCT01410357|580943560|FG001|Overall Study|Death|1|||
160876546|NCT01410357|580943559|FG000|Overall Study|Withdrawal by Subject|1|||
160876547|NCT01410357|580943560|FG001|Overall Study|Withdrawal by Subject|2|||
160876548|NCT01410357|580943559|FG000|Overall Study|Lost to Follow-up|23|||
160876549|NCT01410357|580943560|FG001|Overall Study|Lost to Follow-up|21|||
160876550|NCT01206322|580943562|FG000|Overall Study|Adverse Event|0|||
160876551|NCT01206322|580943563|FG001|Overall Study|Adverse Event|0|||
160876552|NCT01206322|580943564|FG002|Overall Study|Adverse Event|0|||
160876553|NCT01206322|580943565|FG003|Overall Study|Adverse Event|1|||
160876554|NCT01589653|580943571|FG000|Overall Study|Protocol Violation|3|||
160876555|NCT01589653|580943572|FG001|Overall Study|Protocol Violation|1|||
160876556|NCT01589653|580943571|FG000|Overall Study|Withdrawal criteria|4|||
160876557|NCT01589653|580943572|FG001|Overall Study|Withdrawal criteria|7|||
160876558|NCT01589653|580943571|FG000|Overall Study|Unclassified|0|||
160876559|NCT01589653|580943572|FG001|Overall Study|Unclassified|3|||
160876560|NCT03700684|580943573|FG000|Overall Study|COVID-19|0|||
160876561|NCT03700684|580943574|FG001|Overall Study|COVID-19|0|||
160876562|NCT03700684|580943575|FG002|Overall Study|COVID-19|2|||
160876563|NCT01120782|580943576|FG000|Overall Study|Test article shipping error|11|||
160876564|NCT04140227|580943577|FG000|Overall Study|Withdrawal by Subject|26|||
160876565|NCT04140227|580943577|FG000|Overall Study|Lost to Follow-up|8|||
160876566|NCT04140227|580943577|FG000|Overall Study|Adverse Event|8|||
160876567|NCT04140227|580943577|FG000|Overall Study|Death|1|||
160876568|NCT04140227|580943577|FG000|Overall Study|Other|3|||
160876569|NCT04140227|580943577|FG000|Overall Study|Protocol Violation|2|||
160876570|NCT00538785|580943578|FG000|Overall Study|Death|9|||
160876571|NCT00538785|580943579|FG001|Overall Study|Death|10|||
160876572|NCT00538785|580943578|FG000|Overall Study|Withdrawal of consent|9|||
160876573|NCT00538785|580943579|FG001|Overall Study|Withdrawal of consent|7|||
160876574|NCT00538785|580943578|FG000|Overall Study|Lost to Follow-up|1|||
160876575|NCT00538785|580943579|FG001|Overall Study|Lost to Follow-up|0|||
160876576|NCT01767142|580943581|FG000|Overall Study|Lost to Follow-up|3|||
160876577|NCT03317405|580943582|FG000|Overall Study|Withdrawal by Subject|1|||
160876578|NCT03317405|580943583|FG001|Overall Study|Withdrawal by Subject|0|||
160876579|NCT03317405|580943584|FG002|Overall Study|Withdrawal by Subject|0|||
160876580|NCT03317405|580943582|FG000|Overall Study|Physician Decision|0|||
160876581|NCT03317405|580943583|FG001|Overall Study|Physician Decision|0|||
161120045|NCT05103332|581826031|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120046|NCT05103332|581826032|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120047|NCT05103332|581826033|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120048|NCT05103332|581826034|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120049|NCT05103332|581826035|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120050|NCT05103332|581826036|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120051|NCT05103332|581826037|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120052|NCT05103332|581826038|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120053|NCT05103332|581826039|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120054|NCT05103332|581826040|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120055|NCT05103332|581826041|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120056|NCT05103332|581826042|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120057|NCT05103332|581826043|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120058|NCT05103332|581826044|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120059|NCT05103332|581826045|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
161120060|NCT05103332|581826046|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
161225022|NCT04634409|582203567|FG015|Overall Study|Adverse Event|0|||
160876582|NCT03317405|580943584|FG002|Overall Study|Physician Decision|1|||
160876583|NCT03317405|580943582|FG000|Overall Study|Surgery Rescheduled|0|||
160876584|NCT03317405|580943583|FG001|Overall Study|Surgery Rescheduled|1|||
160876585|NCT03317405|580943584|FG002|Overall Study|Surgery Rescheduled|0|||
160876586|NCT00635219|580943585|FG000|Overall Study|Adverse Event|12|||
160876587|NCT00635219|580943586|FG001|Overall Study|Adverse Event|10|||
160876588|NCT00635219|580943587|FG002|Overall Study|Adverse Event|18|||
160876589|NCT00635219|580943588|FG003|Overall Study|Adverse Event|15|||
160876590|NCT00635219|580943589|FG004|Overall Study|Adverse Event|19|||
160876591|NCT00635219|580943585|FG000|Overall Study|Lack of Efficacy|5|||
160876592|NCT00635219|580943586|FG001|Overall Study|Lack of Efficacy|6|||
160876593|NCT00635219|580943587|FG002|Overall Study|Lack of Efficacy|3|||
160876594|NCT00635219|580943588|FG003|Overall Study|Lack of Efficacy|4|||
160876595|NCT00635219|580943589|FG004|Overall Study|Lack of Efficacy|6|||
160876596|NCT00635219|580943585|FG000|Overall Study|Non-compliance With Study Product|0|||
160876597|NCT00635219|580943586|FG001|Overall Study|Non-compliance With Study Product|0|||
161120061|NCT05103332|581826047|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
161120062|NCT05103332|581826048|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
161120063|NCT05103332|581826031|FG000|SFU Period (6 Months=168 Days)|Death|0|||
161120064|NCT05103332|581826032|FG001|SFU Period (6 Months=168 Days)|Death|0|||
161120065|NCT05103332|581826033|FG002|SFU Period (6 Months=168 Days)|Death|0|||
161120066|NCT05103332|581826034|FG003|SFU Period (6 Months=168 Days)|Death|0|||
161120067|NCT05103332|581826035|FG004|SFU Period (6 Months=168 Days)|Death|0|||
161120068|NCT05103332|581826036|FG005|SFU Period (6 Months=168 Days)|Death|0|||
161120069|NCT05103332|581826037|FG006|SFU Period (6 Months=168 Days)|Death|0|||
161120070|NCT05103332|581826038|FG007|SFU Period (6 Months=168 Days)|Death|0|||
161120071|NCT05103332|581826039|FG008|SFU Period (6 Months=168 Days)|Death|0|||
161120072|NCT05103332|581826040|FG009|SFU Period (6 Months=168 Days)|Death|0|||
161120073|NCT05103332|581826041|FG010|SFU Period (6 Months=168 Days)|Death|0|||
161120074|NCT05103332|581826042|FG011|SFU Period (6 Months=168 Days)|Death|0|||
161120075|NCT05103332|581826043|FG012|SFU Period (6 Months=168 Days)|Death|0|||
161120076|NCT05103332|581826044|FG013|SFU Period (6 Months=168 Days)|Death|0|||
161120077|NCT05103332|581826045|FG014|SFU Period (6 Months=168 Days)|Death|1|||
161120078|NCT05103332|581826046|FG015|SFU Period (6 Months=168 Days)|Death|0|||
161120079|NCT05103332|581826047|FG016|SFU Period (6 Months=168 Days)|Death|0|||
161120080|NCT05103332|581826048|FG017|SFU Period (6 Months=168 Days)|Death|1|||
161120081|NCT02043548|581826049|FG000|Overall Study|Lack of Efficacy|1|||
161120082|NCT02043548|581826050|FG001|Overall Study|Lack of Efficacy|0|||
161120083|NCT02043548|581826049|FG000|Overall Study|Adverse Event|0|||
161120084|NCT02043548|581826050|FG001|Overall Study|Adverse Event|1|||
161120085|NCT00264238|581826052|FG000|Overall Study|Protocol Violation|1|||
161120086|NCT04316585|581827081|FG000|Overall Study|Adverse Event|2|||
161120087|NCT04316585|581827082|FG001|Overall Study|Adverse Event|1|||
161120088|NCT04316585|581827081|FG000|Overall Study|Lost to Follow-up|1|||
161120089|NCT04316585|581827082|FG001|Overall Study|Lost to Follow-up|0|||
161120090|NCT04316585|581827081|FG000|Overall Study|Withdrawal by Subject|2|||
161120091|NCT04316585|581827082|FG001|Overall Study|Withdrawal by Subject|3|||
161120092|NCT04316585|581827081|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161120093|NCT04316585|581827082|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
161120094|NCT04316585|581827081|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
161120095|NCT04316585|581827082|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
161120096|NCT03269344|581827084|FG000|Overall Study|Protocol Violation|4|||
161120097|NCT03269344|581827085|FG001|Overall Study|Protocol Violation|3|||
161120098|NCT02770326|581827086|FG000|Overall Study|Death|3|||
161120099|NCT02770326|581827086|FG000|Overall Study|Lost to Follow-up|1|||
161120100|NCT05289830|581827091|FG000|Overall Study|Lost to Follow-up|1|||
161120101|NCT05289830|581827092|FG001|Overall Study|Lost to Follow-up|1|||
161120102|NCT05289830|581827091|FG000|Overall Study|Physician Decision|0|||
161120103|NCT05289830|581827092|FG001|Overall Study|Physician Decision|1|||
161120104|NCT01046825|581827093|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161120105|NCT01046825|581827094|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
161120106|NCT01046825|581827095|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161120107|NCT01046825|581827096|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161120108|NCT01046825|581827097|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
161120109|NCT01046825|581827093|FG000|Overall Study|Physician Decision|0|||
161120110|NCT01046825|581827094|FG001|Overall Study|Physician Decision|1|||
161120111|NCT01046825|581827095|FG002|Overall Study|Physician Decision|2|||
161120112|NCT01046825|581827096|FG003|Overall Study|Physician Decision|0|||
161120113|NCT01046825|581827097|FG004|Overall Study|Physician Decision|0|||
161120114|NCT01046825|581827093|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161120115|NCT01046825|581827094|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161120116|NCT01046825|581827095|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
161120117|NCT01046825|581827096|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161120118|NCT01046825|581827097|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
161120119|NCT01046825|581827093|FG000|Overall Study|Found to be ineligible|0|||
161225023|NCT04634409|582203568|FG016|Overall Study|Adverse Event|0|||
161225024|NCT04634409|582203569|FG017|Overall Study|Adverse Event|0|||
161120120|NCT01046825|581827094|FG001|Overall Study|Found to be ineligible|1|||
161120121|NCT01046825|581827095|FG002|Overall Study|Found to be ineligible|0|||
161120122|NCT01046825|581827096|FG003|Overall Study|Found to be ineligible|0|||
161120123|NCT01046825|581827097|FG004|Overall Study|Found to be ineligible|0|||
161120124|NCT01046825|581827093|FG000|Overall Study|Death|0|||
161120125|NCT01046825|581827094|FG001|Overall Study|Death|0|||
161120126|NCT01046825|581827095|FG002|Overall Study|Death|0|||
161120127|NCT01046825|581827096|FG003|Overall Study|Death|1|||
161120128|NCT01046825|581827097|FG004|Overall Study|Death|0|||
161120129|NCT01046825|581827093|FG000|Overall Study|Did not submit biology samples|0|||
161225025|NCT04634409|582203570|FG018|Overall Study|Adverse Event|0|||
161120130|NCT01046825|581827094|FG001|Overall Study|Did not submit biology samples|0|||
161120131|NCT01046825|581827095|FG002|Overall Study|Did not submit biology samples|0|||
161120132|NCT01046825|581827096|FG003|Overall Study|Did not submit biology samples|0|||
161225026|NCT04634409|582203571|FG019|Overall Study|Adverse Event|0|||
161225027|NCT04634409|582203572|FG020|Overall Study|Adverse Event|0|||
161225028|NCT04634409|582203573|FG021|Overall Study|Adverse Event|0|||
161225029|NCT04634409|582203574|FG022|Overall Study|Adverse Event|0|||
161225030|NCT04634409|582203575|FG023|Overall Study|Adverse Event|0|||
161225031|NCT04634409|582203576|FG024|Overall Study|Adverse Event|0|||
160876598|NCT00635219|580943587|FG002|Overall Study|Non-compliance With Study Product|0|||
160876599|NCT00635219|580943588|FG003|Overall Study|Non-compliance With Study Product|2|||
160876600|NCT00635219|580943589|FG004|Overall Study|Non-compliance With Study Product|1|||
160876601|NCT00635219|580943585|FG000|Overall Study|Protocol Violation|0|||
160876602|NCT00635219|580943586|FG001|Overall Study|Protocol Violation|2|||
160876603|NCT00635219|580943587|FG002|Overall Study|Protocol Violation|3|||
160876604|NCT00635219|580943588|FG003|Overall Study|Protocol Violation|2|||
160876605|NCT00635219|580943589|FG004|Overall Study|Protocol Violation|4|||
160876606|NCT00635219|580943585|FG000|Overall Study|Withdrawal of Consent|8|||
160876607|NCT00635219|580943586|FG001|Overall Study|Withdrawal of Consent|6|||
160876608|NCT00635219|580943587|FG002|Overall Study|Withdrawal of Consent|8|||
160876609|NCT00635219|580943588|FG003|Overall Study|Withdrawal of Consent|11|||
160876610|NCT00635219|580943589|FG004|Overall Study|Withdrawal of Consent|8|||
160876611|NCT00635219|580943585|FG000|Overall Study|Lost to Follow-up|0|||
160876612|NCT00635219|580943586|FG001|Overall Study|Lost to Follow-up|0|||
160876613|NCT00635219|580943587|FG002|Overall Study|Lost to Follow-up|2|||
160876614|NCT00635219|580943588|FG003|Overall Study|Lost to Follow-up|0|||
160876615|NCT00635219|580943589|FG004|Overall Study|Lost to Follow-up|3|||
160876616|NCT00635219|580943585|FG000|Overall Study|Administrative or Other Reasons|0|||
160876617|NCT00635219|580943586|FG001|Overall Study|Administrative or Other Reasons|1|||
160876618|NCT00635219|580943587|FG002|Overall Study|Administrative or Other Reasons|1|||
160876619|NCT00635219|580943588|FG003|Overall Study|Administrative or Other Reasons|0|||
160876620|NCT00635219|580943589|FG004|Overall Study|Administrative or Other Reasons|1|||
160876621|NCT04093024|580943592|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
160876622|NCT04093024|580943593|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
160876623|NCT04093024|580943592|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
160876624|NCT04093024|580943593|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
160876625|NCT04093024|580943592|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
160876626|NCT04093024|580943593|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
160876627|NCT04093024|580943592|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
160876628|NCT04093024|580943593|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
160876629|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
160876630|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
160876631|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
160876632|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
160876633|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
160876634|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
160876635|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
160876636|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
160876637|NCT00435045|580943600|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
160876638|NCT00435045|580943601|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
160876639|NCT00435045|580943600|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
160876640|NCT00435045|580943601|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
160876641|NCT00435045|580943600|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
160876642|NCT00435045|580943601|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
160876643|NCT00435045|580943600|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
160876644|NCT00435045|580943601|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
160876645|NCT00435045|580943600|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
160876646|NCT00435045|580943601|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
160876647|NCT00435045|580943600|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
160876648|NCT00435045|580943601|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
160876649|NCT00435045|580943600|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
160876650|NCT00435045|580943601|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
160876651|NCT03052426|580943602|FG000|Overall Study|Withdrawal by Subject|0|||
160876652|NCT03052426|580943603|FG001|Overall Study|Withdrawal by Subject|1|||
160876653|NCT03052426|580943604|FG002|Overall Study|Withdrawal by Subject|0|||
160876654|NCT03052426|580943602|FG000|Overall Study|Lost to Follow-up|2|||
160876655|NCT03052426|580943603|FG001|Overall Study|Lost to Follow-up|0|||
160876656|NCT03052426|580943604|FG002|Overall Study|Lost to Follow-up|1|||
160876657|NCT01853839|580943611|FG000|Overall Study|Violated inclusion criteria|2|||
160876658|NCT01853839|580943611|FG000|Overall Study|Not meet ITT population definition|58|||
160876659|NCT01853839|580943611|FG000|Overall Study|End of treatment visit too early|33|||
160876660|NCT01853839|580943611|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
160876661|NCT01640314|580943612|FG000|Overall Study|Protocol Violation|0|||
160876662|NCT01640314|580943613|FG001|Overall Study|Protocol Violation|1|||
160876663|NCT01290796|580943614|FG000|Overall Study|Lost to Follow-up|21|||
160876664|NCT01290796|580943614|FG000|Overall Study|Withdrawal by Subject|4|||
160876665|NCT01290796|580943614|FG000|Overall Study|Physician Decision|2|||
160876666|NCT01290796|580943614|FG000|Overall Study|Secondary Surgical Intervention|2|||
160876667|NCT01290796|580943614|FG000|Overall Study|Withdrawal by Sponsor|1|||
160876668|NCT02709538|580943616|FG000|Overall Study|Adverse Event|13|||
160876669|NCT02709538|580943617|FG001|Overall Study|Adverse Event|2|||
160876670|NCT02709538|580943618|FG002|Overall Study|Adverse Event|3|||
160876671|NCT02709538|580943616|FG000|Overall Study|Lack of Efficacy|1|||
160876672|NCT02709538|580943617|FG001|Overall Study|Lack of Efficacy|0|||
160876673|NCT02709538|580943618|FG002|Overall Study|Lack of Efficacy|0|||
160876674|NCT02709538|580943616|FG000|Overall Study|Lost to Follow-up|24|||
160876675|NCT02709538|580943617|FG001|Overall Study|Lost to Follow-up|8|||
160876676|NCT02709538|580943618|FG002|Overall Study|Lost to Follow-up|4|||
160876677|NCT02709538|580943616|FG000|Overall Study|Physician Decision|1|||
160876678|NCT02709538|580943617|FG001|Overall Study|Physician Decision|0|||
160876679|NCT02709538|580943618|FG002|Overall Study|Physician Decision|0|||
160876680|NCT02709538|580943616|FG000|Overall Study|Withdrawal by Subject|40|||
160876681|NCT02709538|580943617|FG001|Overall Study|Withdrawal by Subject|7|||
160876682|NCT02709538|580943618|FG002|Overall Study|Withdrawal by Subject|4|||
160876683|NCT02709538|580943616|FG000|Overall Study|Non-compliance with study procedures|5|||
160876684|NCT02709538|580943617|FG001|Overall Study|Non-compliance with study procedures|0|||
160876685|NCT02709538|580943618|FG002|Overall Study|Non-compliance with study procedures|0|||
160876686|NCT02709538|580943616|FG000|Overall Study|Non-compliance with study drug|2|||
160876687|NCT02709538|580943617|FG001|Overall Study|Non-compliance with study drug|0|||
160876688|NCT02709538|580943618|FG002|Overall Study|Non-compliance with study drug|0|||
160876689|NCT02709538|580943616|FG000|Overall Study|Protocol deviation|10|||
160876690|NCT02709538|580943617|FG001|Overall Study|Protocol deviation|4|||
160876691|NCT02709538|580943618|FG002|Overall Study|Protocol deviation|4|||
160876692|NCT02709538|580943616|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
160876693|NCT02709538|580943617|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
160876694|NCT02709538|580943618|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
160876695|NCT02709538|580943616|FG000|Overall Study|Other|16|||
160876696|NCT02709538|580943617|FG001|Overall Study|Other|7|||
160876697|NCT02709538|580943618|FG002|Overall Study|Other|5|||
160876698|NCT00835211|580943620|FG000|First Intervention|Withdrawal by Subject|0|||
160876699|NCT00835211|580943621|FG001|First Intervention|Withdrawal by Subject|1|||
160876700|NCT00835211|580943620|FG000|Washout: 7 Days|Adverse Event|2|||
160876701|NCT00835211|580943621|FG001|Washout: 7 Days|Adverse Event|1|||
160876702|NCT00835211|580943620|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160876703|NCT00835211|580943621|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160876704|NCT02343549|580943622|FG000|Overall Study|Death|11|||
160876705|NCT02343549|580943622|FG000|Overall Study|Withdrawal by Subject|2|||
160876706|NCT03087617|580943623|FG000|Overall Study|Lost to Follow-up|32|||
160876707|NCT03087617|580943624|FG001|Overall Study|Lost to Follow-up|30|||
160876708|NCT03087617|580943625|FG002|Overall Study|Lost to Follow-up|30|||
160876709|NCT03087617|580943626|FG003|Overall Study|Lost to Follow-up|39|||
160876710|NCT02160041|580943628|FG000|Overall Study|Adverse Event|11|||
160876711|NCT02160041|580943628|FG000|Overall Study|Death|2|||
160876712|NCT02160041|580943628|FG000|Overall Study|disease progression|57|||
160876713|NCT02160041|580943628|FG000|Overall Study|Protocol Violation|1|||
160876714|NCT02160041|580943628|FG000|Overall Study|non-compliance with study|1|||
160876715|NCT02160041|580943628|FG000|Overall Study|Physician Decision|3|||
160876716|NCT02160041|580943628|FG000|Overall Study|Withdrawal by Subject|8|||
160876717|NCT02160041|580943628|FG000|Overall Study|study terminated by by sponsor|1|||
160876718|NCT04450381|580943629|FG000|Overall Study|Protocol Violation|4|||
160876719|NCT04450381|580943629|FG000|Overall Study|Wrong device setting|2|||
160876720|NCT00763698|580943635|FG000|Overall Study|Unsuccessful Implant|5|||
160876721|NCT00763698|580943635|FG000|Overall Study|Death|4|||
160876722|NCT00763698|580943635|FG000|Overall Study|Withdrawal by Subject|1|||
160876723|NCT00782834|580943644|FG000|Treatment Phase|fibrous tumor not GIST|1|||
160876724|NCT02252939|580943645|FG000|Overall Study|Lost to Follow-up|3|||
160876725|NCT04270370|580943646|FG000|Overall Study|Lost to Follow-up|1|||
160876726|NCT04270370|580943647|FG001|Overall Study|Lost to Follow-up|0|||
160876727|NCT04270370|580943648|FG002|Overall Study|Lost to Follow-up|0|||
160876728|NCT04270370|580943649|FG003|Overall Study|Lost to Follow-up|0|||
160876729|NCT04270370|580943650|FG004|Overall Study|Lost to Follow-up|0|||
160876730|NCT04270370|580943651|FG005|Overall Study|Lost to Follow-up|0|||
160876731|NCT04270370|580943652|FG006|Overall Study|Lost to Follow-up|0|||
160876732|NCT04270370|580943653|FG007|Overall Study|Lost to Follow-up|0|||
160876733|NCT04270370|580943654|FG008|Overall Study|Lost to Follow-up|1|||
160876734|NCT04270370|580943655|FG009|Overall Study|Lost to Follow-up|0|||
160876735|NCT04270370|580943656|FG010|Overall Study|Lost to Follow-up|0|||
160876736|NCT04270370|580943657|FG011|Overall Study|Lost to Follow-up|0|||
160876737|NCT01324141|580943658|FG000|Overall Study|Declined to participate before treatment started|1|||
160876738|NCT01324141|580943658|FG000|Overall Study|Disease progression on study|1|||
160876739|NCT02703337|580943659|FG000|Period One (Part A)|Withdrawal by Subject|0|||
160876740|NCT02703337|580943660|FG001|Period One (Part A)|Withdrawal by Subject|0|||
160876741|NCT02703337|580943661|FG002|Period One (Part A)|Withdrawal by Subject|0|||
160876742|NCT02703337|580943662|FG003|Period One (Part A)|Withdrawal by Subject|0|||
160876743|NCT02703337|580943663|FG004|Period One (Part A)|Withdrawal by Subject|1|||
161225032|NCT04634409|582203577|FG025|Overall Study|Adverse Event|0|||
161120133|NCT01046825|581827097|FG004|Overall Study|Did not submit biology samples|13|||
161120134|NCT02872311|581827098|FG000|Overall Study|Death|2|||
161120135|NCT02872311|581827099|FG001|Overall Study|Death|0|||
161120136|NCT02872311|581827100|FG002|Overall Study|Death|0|||
161120137|NCT02872311|581827101|FG003|Overall Study|Death|0|||
161120138|NCT02872311|581827102|FG004|Overall Study|Death|0|||
161120139|NCT02872311|581827098|FG000|Overall Study|Lost to Follow-up|2|||
161120140|NCT02872311|581827099|FG001|Overall Study|Lost to Follow-up|0|||
161120141|NCT02872311|581827100|FG002|Overall Study|Lost to Follow-up|0|||
161120142|NCT02872311|581827101|FG003|Overall Study|Lost to Follow-up|0|||
161120143|NCT02872311|581827102|FG004|Overall Study|Lost to Follow-up|0|||
161120144|NCT02872311|581827098|FG000|Overall Study|Protocol Violation|0|||
161120145|NCT02872311|581827099|FG001|Overall Study|Protocol Violation|2|||
161120146|NCT02872311|581827100|FG002|Overall Study|Protocol Violation|1|||
161120147|NCT02872311|581827101|FG003|Overall Study|Protocol Violation|0|||
161120148|NCT02872311|581827102|FG004|Overall Study|Protocol Violation|0|||
161225033|NCT04634409|582203578|FG026|Overall Study|Adverse Event|0|||
161225034|NCT04634409|582203552|FG000|Overall Study|Lost to Follow-up|3|||
161225035|NCT04634409|582203553|FG001|Overall Study|Lost to Follow-up|1|||
161225036|NCT04634409|582203554|FG002|Overall Study|Lost to Follow-up|1|||
160876744|NCT02703337|580943664|FG005|Period One (Part A)|Withdrawal by Subject|0|||
160876745|NCT02703337|580943665|FG006|Period One (Part A)|Withdrawal by Subject|0|||
160876746|NCT02703337|580943666|FG007|Period One (Part A)|Withdrawal by Subject|0|||
160876747|NCT01001325|580943676|FG000|Overall Study|Lost to Follow-up|16|||
160876748|NCT01001325|580943677|FG001|Overall Study|Lost to Follow-up|10|||
160876749|NCT01001325|580943676|FG000|Overall Study|Protocol Violation|2|||
160876750|NCT01001325|580943677|FG001|Overall Study|Protocol Violation|0|||
160876751|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
160876752|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876753|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876754|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876755|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
160876756|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
160876757|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
160876758|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
160876759|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
160876760|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
160876761|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
160876762|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876763|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876764|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876765|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
160876766|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
160876767|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
160876768|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
160876769|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
160876770|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
160876771|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
160876772|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876773|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876774|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876775|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
160876776|NCT01584440|580943680|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876777|NCT01584440|580943681|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
160876778|NCT01584440|580943682|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876779|NCT01584440|580943683|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876780|NCT01584440|580943684|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
160876781|NCT01584440|580943680|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
160876782|NCT01584440|580943681|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
160876783|NCT01584440|580943682|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
160876784|NCT01584440|580943683|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
160876785|NCT01584440|580943684|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
160876786|NCT01584440|580943680|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
160876787|NCT01584440|580943681|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
160876788|NCT01584440|580943682|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
160876789|NCT01584440|580943683|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
160876790|NCT01584440|580943684|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
160876791|NCT01584440|580943680|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876792|NCT01584440|580943681|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876793|NCT01584440|580943682|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
160876794|NCT01584440|580943683|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876795|NCT01584440|580943684|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
160876796|NCT04237116|580943685|FG000|Overall Study|Adverse Event|0|||
160876797|NCT04237116|580943686|FG001|Overall Study|Adverse Event|1|||
160876798|NCT04237116|580943685|FG000|Overall Study|Study terminated by Sponsor|4|||
160876799|NCT04237116|580943686|FG001|Overall Study|Study terminated by Sponsor|1|||
160876800|NCT00899431|580943687|FG000|Overall Study|Physician Decision|1|||
160876801|NCT00899431|580943688|FG001|Overall Study|Physician Decision|0|||
160876802|NCT00899431|580943689|FG002|Overall Study|Physician Decision|0|||
160876803|NCT03212144|580943690|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
160876804|NCT03212144|580943691|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
160876805|NCT03212144|580943690|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
160876806|NCT03212144|580943691|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
160876807|NCT00661427|580943695|FG000|Overall Study|Adverse Event|5|||
160876808|NCT00661427|580943696|FG001|Overall Study|Adverse Event|5|||
160876809|NCT00661427|580943695|FG000|Overall Study|Patient not treated|0|||
160876810|NCT00661427|580943696|FG001|Overall Study|Patient not treated|2|||
160876811|NCT01338298|580943697|FG000|Overall Study|Withdrawal by Subject|1|||
160876812|NCT01338298|580943698|FG001|Overall Study|Withdrawal by Subject|1|||
160876813|NCT01338298|580943697|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
160876814|NCT01338298|580943698|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
160876815|NCT01338298|580943697|FG000|Overall Study|Administrative error|0|||
160876816|NCT01338298|580943698|FG001|Overall Study|Administrative error|1|||
160876817|NCT01338298|580943697|FG000|Overall Study|Positive symptom worsening|1|||
161120149|NCT01290692|581827103|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
161120150|NCT02780648|581827105|FG000|Overall Study|Disease Progression|1|||
161120151|NCT02780648|581827106|FG001|Overall Study|Disease Progression|0|||
161120152|NCT00293579|581827107|FG000|Overall Study|Withdrawal by Subject|1|||
160876818|NCT01338298|580943698|FG001|Overall Study|Positive symptom worsening|0|||
160876819|NCT01338298|580943697|FG000|Overall Study|Depressive symptoms and nausea|1|||
160876820|NCT01338298|580943698|FG001|Overall Study|Depressive symptoms and nausea|0|||
160876821|NCT01338298|580943697|FG000|Overall Study|Non-adherence|1|||
160876822|NCT01338298|580943698|FG001|Overall Study|Non-adherence|0|||
160876823|NCT02872285|580943699|FG000|Overall Study|Withdrawal by Subject|2|||
160876824|NCT02872285|580943700|FG001|Overall Study|Withdrawal by Subject|0|||
160876825|NCT02872285|580943699|FG000|Overall Study|Lost to Follow-up|2|||
160876826|NCT02872285|580943700|FG001|Overall Study|Lost to Follow-up|2|||
160876827|NCT02872285|580943699|FG000|Overall Study|Discontinued due to back surgery|1|||
160876828|NCT02872285|580943700|FG001|Overall Study|Discontinued due to back surgery|0|||
160876829|NCT00531427|580943701|FG000|Overall Study|Withdrawal by Subject|7|||
160876830|NCT00531427|580943702|FG001|Overall Study|Withdrawal by Subject|13|||
160876831|NCT00531427|580943701|FG000|Overall Study|Adverse Event|44|||
160876832|NCT00531427|580943702|FG001|Overall Study|Adverse Event|30|||
160876833|NCT00531427|580943701|FG000|Overall Study|Lost to Follow-up|4|||
160876834|NCT00531427|580943702|FG001|Overall Study|Lost to Follow-up|3|||
160876835|NCT00531427|580943701|FG000|Overall Study|Lack of Efficacy|14|||
160876836|NCT00531427|580943702|FG001|Overall Study|Lack of Efficacy|39|||
160876837|NCT00531427|580943701|FG000|Overall Study|Administrative|4|||
160876838|NCT00531427|580943702|FG001|Overall Study|Administrative|9|||
160876839|NCT05477108|580943703|FG000|Overall Study|Participants randomized, not treated|1|||
160876840|NCT05477108|580943704|FG001|Overall Study|Participants randomized, not treated|1|||
160876841|NCT05477108|580943705|FG002|Overall Study|Participants randomized, not treated|1|||
160876842|NCT05477108|580943703|FG000|Overall Study|Physician Decision|0|||
160876843|NCT05477108|580943704|FG001|Overall Study|Physician Decision|0|||
160876844|NCT05477108|580943705|FG002|Overall Study|Physician Decision|1|||
160876845|NCT05477108|580943703|FG000|Overall Study|withdrawn from study|0|||
160876846|NCT05477108|580943704|FG001|Overall Study|withdrawn from study|0|||
160876847|NCT05477108|580943705|FG002|Overall Study|withdrawn from study|1|||
160876848|NCT01253577|580943706|FG000|Overall Study|Lost to Follow-up|3|||
160876849|NCT05688670|580943707|FG000|Overall Study|Change in surgery plan|1|||
160876850|NCT05688670|580943708|FG001|Overall Study|Change in surgery plan|4|||
160876851|NCT05688670|580943707|FG000|Overall Study|Inability to extubate|1|||
160876852|NCT05688670|580943708|FG001|Overall Study|Inability to extubate|2|||
160876853|NCT05688670|580943707|FG000|Overall Study|Day of surgery cancellation|0|||
160876854|NCT05688670|580943708|FG001|Overall Study|Day of surgery cancellation|1|||
160876855|NCT05688670|580943707|FG000|Overall Study|Reintubated on PCICU arrival|0|||
160876856|NCT05688670|580943708|FG001|Overall Study|Reintubated on PCICU arrival|1|||
160876857|NCT00488683|580943709|FG000|Overall Study|Withdrawal by Subject|1|||
160876858|NCT00488683|580943710|FG001|Overall Study|Withdrawal by Subject|2|||
160876859|NCT00488683|580943711|FG002|Overall Study|Withdrawal by Subject|2|||
160876860|NCT00488683|580943709|FG000|Overall Study|Lost to Follow-up|5|||
160876861|NCT00488683|580943710|FG001|Overall Study|Lost to Follow-up|3|||
160876862|NCT00488683|580943711|FG002|Overall Study|Lost to Follow-up|0|||
160876863|NCT00488683|580943709|FG000|Overall Study|Protocol Violation|5|||
160876864|NCT00488683|580943710|FG001|Overall Study|Protocol Violation|1|||
160876865|NCT00488683|580943711|FG002|Overall Study|Protocol Violation|0|||
160876866|NCT00488683|580943709|FG000|Overall Study|Unable to Classify|1|||
160876867|NCT00488683|580943710|FG001|Overall Study|Unable to Classify|0|||
160876868|NCT00488683|580943711|FG002|Overall Study|Unable to Classify|0|||
160876869|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
160876870|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
160876871|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
160876872|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
160876873|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
160876874|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
160876875|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
160876876|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
160876877|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
160876878|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
160876879|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
160876880|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
160876881|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
160876882|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
160876883|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
160876884|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
160876885|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
160876886|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
160876887|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
160876888|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
160876889|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
160876890|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
160876891|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
160876892|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
160876893|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
160876894|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
160876895|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
160876896|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
160876897|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
160876898|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
160876899|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
160876900|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
160876901|NCT03818035|580943712|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
160876902|NCT03818035|580943713|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
160876903|NCT03818035|580943714|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
160876904|NCT03818035|580943715|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
160876905|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
160876906|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
160876907|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
160876908|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
160876909|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
160876910|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
160876911|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
160876912|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
160876913|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
160876914|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
160876915|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
160876916|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
160876917|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
160876918|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
160876919|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
160876920|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
160876921|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
160876922|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
160876923|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
160876924|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
160876925|NCT03818035|580943712|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
160876926|NCT03818035|580943713|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
160876927|NCT03818035|580943714|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
160876928|NCT03818035|580943715|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
160876929|NCT00336856|580945254|FG000|Overall Study|Withdrawal by Subject|3|||
160876930|NCT00336856|580945254|FG000|Overall Study|Found ineligible at time of analysis|1|||
160876931|NCT00843778|580945267|FG000|Overall Study|Adverse Event|15|||
160876932|NCT00843778|580945267|FG000|Overall Study|Lack of Efficacy|14|||
160876933|NCT00843778|580945267|FG000|Overall Study|Loss of efficacy|2|||
160876934|NCT00843778|580945267|FG000|Overall Study|Withdrawal by Subject|4|||
160876935|NCT00830869|580945270|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
160876936|NCT00830869|580945271|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
160876937|NCT00830869|580945272|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
160876938|NCT00830869|580945273|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
160876939|NCT00830869|580945274|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
160876940|NCT00830869|580945275|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
160876941|NCT00830869|580945276|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
160876942|NCT00830869|580945277|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
160876943|NCT00830869|580945278|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
160876944|NCT00830869|580945279|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
160876945|NCT00830869|580945280|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
160876946|NCT00830869|580945281|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
160876947|NCT00830869|580945270|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
160876948|NCT00830869|580945271|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
160876949|NCT00830869|580945272|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
160876950|NCT00830869|580945273|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
160876951|NCT00830869|580945274|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
160876952|NCT00830869|580945275|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
161120153|NCT03215771|581827108|FG000|Overall Study|Withdrawal by Subject|2|||
161120154|NCT03215771|581827108|FG000|Overall Study|Physician Decision|1|||
161120155|NCT03127384|581827113|FG000|Overall Study|Lost to Follow-up|4|||
161120156|NCT03127384|581827113|FG000|Overall Study|Subject request|2|||
161120157|NCT02703311|581827114|FG000|Overall Study|Death|5|||
160876953|NCT00830869|580945276|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
160876954|NCT00830869|580945277|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
161120158|NCT02703311|581827114|FG000|Overall Study|Withdrawal by Subject|3|||
161120159|NCT00689871|581827115|FG000|Overall Study|Lost to Follow-up|123|||
160876955|NCT00830869|580945278|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
161120160|NCT00689871|581827116|FG001|Overall Study|Lost to Follow-up|13|||
161120161|NCT00689871|581827117|FG002|Overall Study|Lost to Follow-up|37|||
160876956|NCT00830869|580945279|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
160876957|NCT00830869|580945280|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
160876958|NCT00830869|580945281|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
160876959|NCT00830869|580945270|FG000|Period 1: Part 1|Adverse Event|0|||
160876960|NCT00830869|580945271|FG001|Period 1: Part 1|Adverse Event|0|||
160876961|NCT00830869|580945272|FG002|Period 1: Part 1|Adverse Event|0|||
160876962|NCT00830869|580945273|FG003|Period 1: Part 1|Adverse Event|0|||
160876963|NCT00830869|580945274|FG004|Period 1: Part 1|Adverse Event|0|||
160876964|NCT00830869|580945275|FG005|Period 1: Part 1|Adverse Event|1|||
160876965|NCT00830869|580945276|FG006|Period 1: Part 1|Adverse Event|1|||
160876966|NCT00830869|580945277|FG007|Period 1: Part 1|Adverse Event|0|||
160876967|NCT00830869|580945278|FG008|Period 1: Part 1|Adverse Event|0|||
160876968|NCT00830869|580945279|FG009|Period 1: Part 1|Adverse Event|0|||
160876969|NCT00830869|580945280|FG010|Period 1: Part 1|Adverse Event|0|||
160876970|NCT00830869|580945281|FG011|Period 1: Part 1|Adverse Event|0|||
160876971|NCT00830869|580945270|FG000|Period 1: Part 1|Progressive disease|1|||
160876972|NCT00830869|580945271|FG001|Period 1: Part 1|Progressive disease|0|||
160876973|NCT00830869|580945272|FG002|Period 1: Part 1|Progressive disease|1|||
160876974|NCT00830869|580945273|FG003|Period 1: Part 1|Progressive disease|6|||
160876975|NCT00830869|580945274|FG004|Period 1: Part 1|Progressive disease|4|||
160876976|NCT00830869|580945275|FG005|Period 1: Part 1|Progressive disease|4|||
160876977|NCT00830869|580945276|FG006|Period 1: Part 1|Progressive disease|1|||
160876978|NCT00830869|580945277|FG007|Period 1: Part 1|Progressive disease|0|||
160876979|NCT00830869|580945278|FG008|Period 1: Part 1|Progressive disease|0|||
160876980|NCT00830869|580945279|FG009|Period 1: Part 1|Progressive disease|0|||
160876981|NCT00830869|580945280|FG010|Period 1: Part 1|Progressive disease|0|||
160876982|NCT00830869|580945281|FG011|Period 1: Part 1|Progressive disease|0|||
160876983|NCT00830869|580945270|FG000|Period 2: Part 2|Protocol Violation|0|||
160876984|NCT00830869|580945271|FG001|Period 2: Part 2|Protocol Violation|0|||
160876985|NCT00830869|580945272|FG002|Period 2: Part 2|Protocol Violation|0|||
160876986|NCT00830869|580945273|FG003|Period 2: Part 2|Protocol Violation|0|||
160876987|NCT00830869|580945274|FG004|Period 2: Part 2|Protocol Violation|0|||
160876988|NCT00830869|580945275|FG005|Period 2: Part 2|Protocol Violation|0|||
160876989|NCT00830869|580945276|FG006|Period 2: Part 2|Protocol Violation|0|||
160876990|NCT00830869|580945277|FG007|Period 2: Part 2|Protocol Violation|1|||
160876991|NCT00830869|580945278|FG008|Period 2: Part 2|Protocol Violation|0|||
160876992|NCT00830869|580945279|FG009|Period 2: Part 2|Protocol Violation|1|||
160876993|NCT00830869|580945280|FG010|Period 2: Part 2|Protocol Violation|0|||
160876994|NCT00830869|580945281|FG011|Period 2: Part 2|Protocol Violation|0|||
160876995|NCT00830869|580945270|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
160876996|NCT00830869|580945271|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
160876997|NCT00830869|580945272|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
160876998|NCT00830869|580945273|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
160876999|NCT00830869|580945274|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
160877000|NCT00830869|580945275|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
160877001|NCT00830869|580945276|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
160877002|NCT00830869|580945277|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
160877003|NCT00830869|580945278|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
160877004|NCT00830869|580945279|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
160877005|NCT00830869|580945280|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
160877006|NCT00830869|580945281|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
160877007|NCT00830869|580945270|FG000|Period 2: Part 2|Adverse Event|0|||
160877008|NCT00830869|580945271|FG001|Period 2: Part 2|Adverse Event|0|||
160877009|NCT00830869|580945272|FG002|Period 2: Part 2|Adverse Event|0|||
160877010|NCT00830869|580945273|FG003|Period 2: Part 2|Adverse Event|0|||
160877011|NCT00830869|580945274|FG004|Period 2: Part 2|Adverse Event|0|||
160877012|NCT00830869|580945275|FG005|Period 2: Part 2|Adverse Event|0|||
160877013|NCT00830869|580945276|FG006|Period 2: Part 2|Adverse Event|0|||
160877014|NCT00830869|580945277|FG007|Period 2: Part 2|Adverse Event|4|||
160877015|NCT00830869|580945278|FG008|Period 2: Part 2|Adverse Event|3|||
160877016|NCT00830869|580945279|FG009|Period 2: Part 2|Adverse Event|2|||
160877017|NCT00830869|580945280|FG010|Period 2: Part 2|Adverse Event|2|||
160877018|NCT00830869|580945281|FG011|Period 2: Part 2|Adverse Event|0|||
160877019|NCT00830869|580945270|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
160877020|NCT00830869|580945271|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
160877021|NCT00830869|580945272|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
160877022|NCT00830869|580945273|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
160877023|NCT00830869|580945274|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
160877024|NCT00830869|580945275|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
160877025|NCT00830869|580945276|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
160877026|NCT00830869|580945277|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
160877027|NCT00830869|580945278|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
160877028|NCT00830869|580945279|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
160877029|NCT00830869|580945280|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
160877030|NCT00830869|580945281|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
160877031|NCT00830869|580945270|FG000|Period 2: Part 2|Progressive disease|0|||
160877032|NCT00830869|580945271|FG001|Period 2: Part 2|Progressive disease|0|||
160877033|NCT00830869|580945272|FG002|Period 2: Part 2|Progressive disease|0|||
160877034|NCT00830869|580945273|FG003|Period 2: Part 2|Progressive disease|0|||
160877035|NCT00830869|580945274|FG004|Period 2: Part 2|Progressive disease|0|||
160877036|NCT00830869|580945275|FG005|Period 2: Part 2|Progressive disease|0|||
160877037|NCT00830869|580945276|FG006|Period 2: Part 2|Progressive disease|0|||
160877038|NCT00830869|580945277|FG007|Period 2: Part 2|Progressive disease|14|||
160877039|NCT00830869|580945278|FG008|Period 2: Part 2|Progressive disease|11|||
160877040|NCT00830869|580945279|FG009|Period 2: Part 2|Progressive disease|12|||
160877041|NCT00830869|580945280|FG010|Period 2: Part 2|Progressive disease|8|||
160877042|NCT00830869|580945281|FG011|Period 2: Part 2|Progressive disease|15|||
160877043|NCT00830869|580945270|FG000|Period 2: Part 2|Other|0|||
160877044|NCT00830869|580945271|FG001|Period 2: Part 2|Other|0|||
160877045|NCT00830869|580945272|FG002|Period 2: Part 2|Other|0|||
160877046|NCT00830869|580945273|FG003|Period 2: Part 2|Other|0|||
160877047|NCT00830869|580945274|FG004|Period 2: Part 2|Other|0|||
160877048|NCT00830869|580945275|FG005|Period 2: Part 2|Other|0|||
160877049|NCT00830869|580945276|FG006|Period 2: Part 2|Other|0|||
160877050|NCT00830869|580945277|FG007|Period 2: Part 2|Other|0|||
160877051|NCT00830869|580945278|FG008|Period 2: Part 2|Other|0|||
160877052|NCT00830869|580945279|FG009|Period 2: Part 2|Other|1|||
160877053|NCT00830869|580945280|FG010|Period 2: Part 2|Other|0|||
160877054|NCT00830869|580945281|FG011|Period 2: Part 2|Other|0|||
160877055|NCT00507728|580945282|FG000|Randomization to Month 3|Lost to Follow-up|15|||
160877056|NCT00507728|580945283|FG001|Randomization to Month 3|Lost to Follow-up|14|||
160877057|NCT00507728|580945284|FG002|Randomization to Month 3|Lost to Follow-up|20|||
160877058|NCT00507728|580945282|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
160877059|NCT00507728|580945283|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
160877060|NCT00507728|580945284|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
160877061|NCT00730028|580945286|FG000|Overall Study|Adverse Event|23|||
160877062|NCT00730028|580945287|FG001|Overall Study|Adverse Event|26|||
160877063|NCT00730028|580945288|FG002|Overall Study|Adverse Event|16|||
160877064|NCT00730028|580945289|FG003|Overall Study|Adverse Event|20|||
160877065|NCT00730028|580945290|FG004|Overall Study|Adverse Event|43|||
160877066|NCT00730028|580945286|FG000|Overall Study|Lost to Follow-up|13|||
160877067|NCT00730028|580945287|FG001|Overall Study|Lost to Follow-up|26|||
160877068|NCT00730028|580945288|FG002|Overall Study|Lost to Follow-up|22|||
160877069|NCT00730028|580945289|FG003|Overall Study|Lost to Follow-up|26|||
160877070|NCT00730028|580945290|FG004|Overall Study|Lost to Follow-up|25|||
160877071|NCT00730028|580945286|FG000|Overall Study|Protocol Violation|6|||
160877072|NCT00730028|580945287|FG001|Overall Study|Protocol Violation|1|||
160877073|NCT00730028|580945288|FG002|Overall Study|Protocol Violation|1|||
160877074|NCT00730028|580945289|FG003|Overall Study|Protocol Violation|2|||
160877075|NCT00730028|580945290|FG004|Overall Study|Protocol Violation|0|||
160877076|NCT00730028|580945286|FG000|Overall Study|Withdrawal by Subject|9|||
160877077|NCT00730028|580945287|FG001|Overall Study|Withdrawal by Subject|5|||
160877078|NCT00730028|580945288|FG002|Overall Study|Withdrawal by Subject|4|||
160877079|NCT00730028|580945289|FG003|Overall Study|Withdrawal by Subject|5|||
160877080|NCT00730028|580945290|FG004|Overall Study|Withdrawal by Subject|9|||
160877081|NCT00730028|580945286|FG000|Overall Study|Physician Decision|3|||
160877082|NCT00730028|580945287|FG001|Overall Study|Physician Decision|3|||
160877083|NCT00730028|580945288|FG002|Overall Study|Physician Decision|2|||
160877084|NCT00730028|580945289|FG003|Overall Study|Physician Decision|3|||
160877085|NCT00730028|580945290|FG004|Overall Study|Physician Decision|2|||
160877086|NCT00730028|580945286|FG000|Overall Study|Treatment Failure|5|||
160877087|NCT00730028|580945287|FG001|Overall Study|Treatment Failure|5|||
160877088|NCT00730028|580945288|FG002|Overall Study|Treatment Failure|0|||
160877089|NCT00730028|580945289|FG003|Overall Study|Treatment Failure|0|||
160877090|NCT00730028|580945290|FG004|Overall Study|Treatment Failure|1|||
160877091|NCT00730028|580945286|FG000|Overall Study|Randomization Error|1|||
160877092|NCT00730028|580945287|FG001|Overall Study|Randomization Error|0|||
160877093|NCT00730028|580945288|FG002|Overall Study|Randomization Error|0|||
160877094|NCT00730028|580945289|FG003|Overall Study|Randomization Error|0|||
160877095|NCT00730028|580945290|FG004|Overall Study|Randomization Error|2|||
160877096|NCT00615901|580945291|FG000|Overall Study|Withdrawal by Subject|2|||
160877097|NCT00615901|580945291|FG000|Overall Study|Adverse Event|7|||
160877098|NCT01250496|580945294|FG000|Overall Study|Study terminated|124|||
160877099|NCT01250496|580945295|FG001|Overall Study|Study terminated|124|||
160877100|NCT00003590|580945296|FG000|Overall Study|Ineligible Patient|1|||
160877101|NCT00003590|580945296|FG000|Overall Study|Adverse Event|7|||
160877102|NCT00003590|580945296|FG000|Overall Study|Withdrawal by Subject|1|||
160877103|NCT00003590|580945296|FG000|Overall Study|Lack of Efficacy|11|||
160877104|NCT00003590|580945296|FG000|Overall Study|Death|1|||
160877105|NCT00003590|580945296|FG000|Overall Study|Physician Decision|1|||
160877106|NCT01425463|580945302|FG000|Overall Study|Adverse Event|5|||
160877107|NCT01425463|580945303|FG001|Overall Study|Adverse Event|7|||
160877108|NCT01425463|580945302|FG000|Overall Study|Lack of Efficacy|1|||
160877109|NCT01425463|580945303|FG001|Overall Study|Lack of Efficacy|1|||
160877110|NCT01425463|580945302|FG000|Overall Study|Protocol Violation|2|||
160877111|NCT01425463|580945303|FG001|Overall Study|Protocol Violation|2|||
160877112|NCT01425463|580945302|FG000|Overall Study|Lost to Follow-up|5|||
160877113|NCT01425463|580945303|FG001|Overall Study|Lost to Follow-up|2|||
160877114|NCT01425463|580945302|FG000|Overall Study|Withdrawal by Subject|7|||
160877115|NCT01425463|580945303|FG001|Overall Study|Withdrawal by Subject|5|||
160877116|NCT01425463|580945302|FG000|Overall Study|Unknown Reason|4|||
160877117|NCT01425463|580945303|FG001|Overall Study|Unknown Reason|7|||
160877118|NCT01332799|580945306|FG000|Overall Study|Insufficient funding|10|||
160877119|NCT01332799|580945307|FG001|Overall Study|Insufficient funding|10|||
160877120|NCT03467152|580945308|FG000|Overall Study|Adverse Event|4|||
160877121|NCT03467152|580945309|FG001|Overall Study|Adverse Event|5|||
160877122|NCT03467152|580945310|FG002|Overall Study|Adverse Event|0|||
160877123|NCT03467152|580945308|FG000|Overall Study|Subject Choice|1|||
160877124|NCT03467152|580945309|FG001|Overall Study|Subject Choice|3|||
160877125|NCT03467152|580945310|FG002|Overall Study|Subject Choice|0|||
160877126|NCT03467152|580945308|FG000|Overall Study|Lost to Follow-up|1|||
160877127|NCT03467152|580945309|FG001|Overall Study|Lost to Follow-up|0|||
160877128|NCT03467152|580945310|FG002|Overall Study|Lost to Follow-up|0|||
160877129|NCT03467152|580945308|FG000|Overall Study|Withdrawal by Subject|4|||
160877130|NCT03467152|580945309|FG001|Overall Study|Withdrawal by Subject|2|||
160877131|NCT03467152|580945310|FG002|Overall Study|Withdrawal by Subject|0|||
160877132|NCT03467152|580945308|FG000|Overall Study|Others|3|||
160877133|NCT03467152|580945309|FG001|Overall Study|Others|0|||
160877134|NCT03467152|580945310|FG002|Overall Study|Others|0|||
160877135|NCT03467152|580945308|FG000|Overall Study|Not treated|3|||
160877136|NCT03467152|580945309|FG001|Overall Study|Not treated|1|||
160877137|NCT03467152|580945310|FG002|Overall Study|Not treated|6|||
160877138|NCT00945906|580945312|FG000|Overall Study|Withdrawal by Subject|1|||
160877139|NCT00945906|580945312|FG000|Overall Study|Did not want to return for last visit|2|||
160877140|NCT00945906|580945312|FG000|Overall Study|Unable to return for last visit|2|||
160877141|NCT00945906|580945312|FG000|Overall Study|Moved to another country|2|||
160877142|NCT01236547|580945313|FG000|Overall Study|Protocol Violation|0|||
160877143|NCT01236547|580945314|FG001|Overall Study|Protocol Violation|1|||
160877144|NCT01236547|580945315|FG002|Overall Study|Protocol Violation|1|||
160877145|NCT01236547|580945316|FG003|Overall Study|Protocol Violation|6|||
160877146|NCT01236547|580945317|FG004|Overall Study|Protocol Violation|12|||
160877147|NCT04022733|580945318|FG000|Overall Study|conversion to open surgery|3|||
160877148|NCT04022733|580945319|FG001|Overall Study|conversion to open surgery|2|||
160877149|NCT04022733|580945318|FG000|Overall Study|bradycardia|0|||
160877150|NCT04022733|580945319|FG001|Overall Study|bradycardia|1|||
160877151|NCT03083990|580945320|FG000|Overall Study|Adverse Event|1|||
160877152|NCT03083990|580945321|FG001|Overall Study|Adverse Event|0|||
160877153|NCT00006409|580945322|FG000|Baseline|Protocol Violation|48|||
160877154|NCT00006409|580945323|FG001|Baseline|Protocol Violation|70|||
160877155|NCT00006409|580945324|FG002|Baseline|Protocol Violation|0|||
160877156|NCT00006409|580945325|FG003|Baseline|Protocol Violation|0|||
160877157|NCT00006409|580945326|FG004|Baseline|Protocol Violation|0|||
160877158|NCT00006409|580945327|FG005|Baseline|Protocol Violation|0|||
160877159|NCT00006409|580945322|FG000|Post-2 Year Intervention|Protocol Violation|0|||
160877160|NCT00006409|580945323|FG001|Post-2 Year Intervention|Protocol Violation|0|||
160877161|NCT00006409|580945324|FG002|Post-2 Year Intervention|Protocol Violation|251|||
160877162|NCT00006409|580945325|FG003|Post-2 Year Intervention|Protocol Violation|168|||
160877163|NCT00006409|580945326|FG004|Post-2 Year Intervention|Protocol Violation|0|||
160877164|NCT00006409|580945327|FG005|Post-2 Year Intervention|Protocol Violation|0|||
160877165|NCT00006409|580945322|FG000|Post-3 Year Intervention|Protocol Violation|0|||
160877166|NCT00006409|580945323|FG001|Post-3 Year Intervention|Protocol Violation|0|||
160877167|NCT00006409|580945324|FG002|Post-3 Year Intervention|Protocol Violation|0|||
160877168|NCT00006409|580945325|FG003|Post-3 Year Intervention|Protocol Violation|0|||
160877169|NCT00006409|580945326|FG004|Post-3 Year Intervention|Protocol Violation|62|||
160877170|NCT00006409|580945327|FG005|Post-3 Year Intervention|Protocol Violation|62|||
160877171|NCT02059291|580945328|FG000|Epoch 2|Lack of Efficacy|0|||
160877172|NCT02059291|580945329|FG001|Epoch 2|Lack of Efficacy|0|||
160877173|NCT02059291|580945330|FG002|Epoch 2|Lack of Efficacy|0|||
160877174|NCT02059291|580945331|FG003|Epoch 2|Lack of Efficacy|1|||
160877175|NCT02059291|580945332|FG004|Epoch 2|Lack of Efficacy|0|||
160877176|NCT02059291|580945333|FG005|Epoch 2|Lack of Efficacy|1|||
160877177|NCT02059291|580945334|FG006|Epoch 2|Lack of Efficacy|0|||
160877178|NCT02059291|580945335|FG007|Epoch 2|Lack of Efficacy|0|||
160877179|NCT02059291|580945336|FG008|Epoch 2|Lack of Efficacy|0|||
160877180|NCT02059291|580945337|FG009|Epoch 2|Lack of Efficacy|0|||
160877181|NCT02059291|580945338|FG010|Epoch 2|Lack of Efficacy|0|||
160877182|NCT02059291|580945339|FG011|Epoch 2|Lack of Efficacy|0|||
160877183|NCT02059291|580945340|FG012|Epoch 2|Lack of Efficacy|0|||
160877184|NCT02059291|580945341|FG013|Epoch 2|Lack of Efficacy|0|||
160877185|NCT02059291|580945342|FG014|Epoch 2|Lack of Efficacy|0|||
160877186|NCT02059291|580945343|FG015|Epoch 2|Lack of Efficacy|0|||
160877187|NCT02059291|580945344|FG016|Epoch 2|Lack of Efficacy|0|||
160877188|NCT02059291|580945345|FG017|Epoch 2|Lack of Efficacy|0|||
160877189|NCT02059291|580945346|FG018|Epoch 2|Lack of Efficacy|0|||
160877190|NCT02059291|580945347|FG019|Epoch 2|Lack of Efficacy|0|||
160877191|NCT02059291|580945348|FG020|Epoch 2|Lack of Efficacy|0|||
160877192|NCT02059291|580945349|FG021|Epoch 2|Lack of Efficacy|0|||
160877193|NCT02059291|580945350|FG022|Epoch 2|Lack of Efficacy|0|||
160877194|NCT02059291|580945351|FG023|Epoch 2|Lack of Efficacy|0|||
160877195|NCT02059291|580945352|FG024|Epoch 2|Lack of Efficacy|0|||
160877196|NCT02059291|580945328|FG000|Epoch 2|Adverse Event|0|||
160877197|NCT02059291|580945329|FG001|Epoch 2|Adverse Event|0|||
160877198|NCT02059291|580945330|FG002|Epoch 2|Adverse Event|1|||
160877199|NCT02059291|580945331|FG003|Epoch 2|Adverse Event|1|||
160877200|NCT02059291|580945332|FG004|Epoch 2|Adverse Event|0|||
160877201|NCT02059291|580945333|FG005|Epoch 2|Adverse Event|0|||
160877202|NCT02059291|580945334|FG006|Epoch 2|Adverse Event|0|||
160877203|NCT02059291|580945335|FG007|Epoch 2|Adverse Event|1|||
160877204|NCT02059291|580945336|FG008|Epoch 2|Adverse Event|1|||
160877205|NCT02059291|580945337|FG009|Epoch 2|Adverse Event|0|||
160877206|NCT02059291|580945338|FG010|Epoch 2|Adverse Event|0|||
160877207|NCT02059291|580945339|FG011|Epoch 2|Adverse Event|0|||
160877208|NCT02059291|580945340|FG012|Epoch 2|Adverse Event|0|||
160877209|NCT02059291|580945341|FG013|Epoch 2|Adverse Event|0|||
160877210|NCT02059291|580945342|FG014|Epoch 2|Adverse Event|0|||
160877211|NCT02059291|580945343|FG015|Epoch 2|Adverse Event|0|||
160877212|NCT02059291|580945344|FG016|Epoch 2|Adverse Event|0|||
160877213|NCT02059291|580945345|FG017|Epoch 2|Adverse Event|0|||
160877214|NCT02059291|580945346|FG018|Epoch 2|Adverse Event|0|||
160877215|NCT02059291|580945347|FG019|Epoch 2|Adverse Event|0|||
160877216|NCT02059291|580945348|FG020|Epoch 2|Adverse Event|0|||
160877217|NCT02059291|580945349|FG021|Epoch 2|Adverse Event|0|||
160877218|NCT02059291|580945350|FG022|Epoch 2|Adverse Event|0|||
160877219|NCT02059291|580945351|FG023|Epoch 2|Adverse Event|0|||
160877220|NCT02059291|580945352|FG024|Epoch 2|Adverse Event|0|||
160877221|NCT02059291|580945328|FG000|Epoch 2|Withdrawal by Subject|0|||
160877222|NCT02059291|580945329|FG001|Epoch 2|Withdrawal by Subject|1|||
160877223|NCT02059291|580945330|FG002|Epoch 2|Withdrawal by Subject|0|||
160877224|NCT02059291|580945331|FG003|Epoch 2|Withdrawal by Subject|0|||
160877225|NCT02059291|580945332|FG004|Epoch 2|Withdrawal by Subject|0|||
160877226|NCT02059291|580945333|FG005|Epoch 2|Withdrawal by Subject|1|||
160877227|NCT02059291|580945334|FG006|Epoch 2|Withdrawal by Subject|0|||
160877228|NCT02059291|580945335|FG007|Epoch 2|Withdrawal by Subject|0|||
160877229|NCT02059291|580945336|FG008|Epoch 2|Withdrawal by Subject|1|||
160877230|NCT02059291|580945337|FG009|Epoch 2|Withdrawal by Subject|0|||
160877231|NCT02059291|580945338|FG010|Epoch 2|Withdrawal by Subject|0|||
160877232|NCT02059291|580945339|FG011|Epoch 2|Withdrawal by Subject|0|||
160877233|NCT02059291|580945340|FG012|Epoch 2|Withdrawal by Subject|0|||
160877234|NCT02059291|580945341|FG013|Epoch 2|Withdrawal by Subject|0|||
160877235|NCT02059291|580945342|FG014|Epoch 2|Withdrawal by Subject|0|||
160877236|NCT02059291|580945343|FG015|Epoch 2|Withdrawal by Subject|0|||
160877237|NCT02059291|580945344|FG016|Epoch 2|Withdrawal by Subject|0|||
160877238|NCT02059291|580945345|FG017|Epoch 2|Withdrawal by Subject|0|||
160877239|NCT02059291|580945346|FG018|Epoch 2|Withdrawal by Subject|0|||
160877240|NCT02059291|580945347|FG019|Epoch 2|Withdrawal by Subject|0|||
160877241|NCT02059291|580945348|FG020|Epoch 2|Withdrawal by Subject|0|||
160877242|NCT02059291|580945349|FG021|Epoch 2|Withdrawal by Subject|0|||
160877243|NCT02059291|580945350|FG022|Epoch 2|Withdrawal by Subject|0|||
160877244|NCT02059291|580945351|FG023|Epoch 2|Withdrawal by Subject|0|||
160877245|NCT02059291|580945352|FG024|Epoch 2|Withdrawal by Subject|0|||
160877246|NCT02059291|580945328|FG000|Epoch 3|Physician Decision|0|||
160877247|NCT02059291|580945329|FG001|Epoch 3|Physician Decision|0|||
160877248|NCT02059291|580945330|FG002|Epoch 3|Physician Decision|0|||
160877249|NCT02059291|580945331|FG003|Epoch 3|Physician Decision|0|||
160877250|NCT02059291|580945332|FG004|Epoch 3|Physician Decision|0|||
161120162|NCT00689871|581827118|FG003|Overall Study|Lost to Follow-up|1|||
161120163|NCT00689871|581827115|FG000|Overall Study|Explanted of All Study Devices|36|||
161120164|NCT00689871|581827116|FG001|Overall Study|Explanted of All Study Devices|25|||
161120165|NCT00689871|581827117|FG002|Overall Study|Explanted of All Study Devices|29|||
161120166|NCT00689871|581827118|FG003|Overall Study|Explanted of All Study Devices|3|||
161120167|NCT00689871|581827115|FG000|Overall Study|Withdrawal by Subject|13|||
161120168|NCT00689871|581827116|FG001|Overall Study|Withdrawal by Subject|3|||
161120169|NCT00689871|581827117|FG002|Overall Study|Withdrawal by Subject|4|||
161120170|NCT00689871|581827118|FG003|Overall Study|Withdrawal by Subject|1|||
161120171|NCT00689871|581827115|FG000|Overall Study|Death|1|||
160877251|NCT02059291|580945333|FG005|Epoch 3|Physician Decision|0|||
160877252|NCT02059291|580945334|FG006|Epoch 3|Physician Decision|0|||
160877253|NCT02059291|580945335|FG007|Epoch 3|Physician Decision|0|||
160877254|NCT02059291|580945336|FG008|Epoch 3|Physician Decision|0|||
160877255|NCT02059291|580945337|FG009|Epoch 3|Physician Decision|0|||
160877256|NCT02059291|580945338|FG010|Epoch 3|Physician Decision|0|||
160877257|NCT02059291|580945339|FG011|Epoch 3|Physician Decision|0|||
160877258|NCT02059291|580945340|FG012|Epoch 3|Physician Decision|0|||
160877259|NCT02059291|580945341|FG013|Epoch 3|Physician Decision|1|||
160877260|NCT02059291|580945342|FG014|Epoch 3|Physician Decision|0|||
160877261|NCT02059291|580945343|FG015|Epoch 3|Physician Decision|1|||
160877262|NCT02059291|580945344|FG016|Epoch 3|Physician Decision|0|||
161120172|NCT00689871|581827116|FG001|Overall Study|Death|10|||
161120173|NCT00689871|581827117|FG002|Overall Study|Death|2|||
161225037|NCT04634409|582203555|FG003|Overall Study|Lost to Follow-up|3|||
161225038|NCT04634409|582203556|FG004|Overall Study|Lost to Follow-up|1|||
161225039|NCT04634409|582203557|FG005|Overall Study|Lost to Follow-up|1|||
160877263|NCT02059291|580945345|FG017|Epoch 3|Physician Decision|0|||
161225040|NCT04634409|582203558|FG006|Overall Study|Lost to Follow-up|1|||
161225041|NCT04634409|582203559|FG007|Overall Study|Lost to Follow-up|3|||
161225042|NCT04634409|582203560|FG008|Overall Study|Lost to Follow-up|3|||
161225043|NCT04634409|582203561|FG009|Overall Study|Lost to Follow-up|11|||
161225044|NCT04634409|582203562|FG010|Overall Study|Lost to Follow-up|8|||
161225045|NCT04634409|582203563|FG011|Overall Study|Lost to Follow-up|15|||
161225046|NCT04634409|582203564|FG012|Overall Study|Lost to Follow-up|3|||
161225047|NCT04634409|582203565|FG013|Overall Study|Lost to Follow-up|2|||
161225048|NCT04634409|582203566|FG014|Overall Study|Lost to Follow-up|7|||
161225049|NCT04634409|582203567|FG015|Overall Study|Lost to Follow-up|0|||
161225050|NCT04634409|582203568|FG016|Overall Study|Lost to Follow-up|0|||
161225051|NCT04634409|582203569|FG017|Overall Study|Lost to Follow-up|0|||
161225052|NCT04634409|582203570|FG018|Overall Study|Lost to Follow-up|0|||
161225053|NCT04634409|582203571|FG019|Overall Study|Lost to Follow-up|0|||
161225054|NCT04634409|582203572|FG020|Overall Study|Lost to Follow-up|0|||
161225055|NCT04634409|582203573|FG021|Overall Study|Lost to Follow-up|0|||
160877264|NCT02059291|580945346|FG018|Epoch 3|Physician Decision|0|||
160877265|NCT02059291|580945347|FG019|Epoch 3|Physician Decision|0|||
160877266|NCT02059291|580945348|FG020|Epoch 3|Physician Decision|0|||
160877267|NCT02059291|580945349|FG021|Epoch 3|Physician Decision|0|||
160877268|NCT02059291|580945350|FG022|Epoch 3|Physician Decision|0|||
160877269|NCT02059291|580945351|FG023|Epoch 3|Physician Decision|0|||
160877270|NCT02059291|580945352|FG024|Epoch 3|Physician Decision|0|||
160877271|NCT02059291|580945328|FG000|Epoch 3|Adverse Event|0|||
160877272|NCT02059291|580945329|FG001|Epoch 3|Adverse Event|0|||
160877273|NCT02059291|580945330|FG002|Epoch 3|Adverse Event|0|||
160877274|NCT02059291|580945331|FG003|Epoch 3|Adverse Event|0|||
160877275|NCT02059291|580945332|FG004|Epoch 3|Adverse Event|0|||
160877276|NCT02059291|580945333|FG005|Epoch 3|Adverse Event|0|||
160877277|NCT02059291|580945334|FG006|Epoch 3|Adverse Event|0|||
160877278|NCT02059291|580945335|FG007|Epoch 3|Adverse Event|0|||
160877279|NCT02059291|580945336|FG008|Epoch 3|Adverse Event|0|||
160877280|NCT02059291|580945337|FG009|Epoch 3|Adverse Event|0|||
160877281|NCT02059291|580945338|FG010|Epoch 3|Adverse Event|0|||
160877282|NCT02059291|580945339|FG011|Epoch 3|Adverse Event|0|||
160877283|NCT02059291|580945340|FG012|Epoch 3|Adverse Event|0|||
160877284|NCT02059291|580945341|FG013|Epoch 3|Adverse Event|0|||
160877285|NCT02059291|580945342|FG014|Epoch 3|Adverse Event|0|||
160877286|NCT02059291|580945343|FG015|Epoch 3|Adverse Event|1|||
160877287|NCT02059291|580945344|FG016|Epoch 3|Adverse Event|0|||
160877288|NCT02059291|580945345|FG017|Epoch 3|Adverse Event|0|||
160877289|NCT02059291|580945346|FG018|Epoch 3|Adverse Event|0|||
160877290|NCT02059291|580945347|FG019|Epoch 3|Adverse Event|0|||
160877291|NCT02059291|580945348|FG020|Epoch 3|Adverse Event|0|||
160877292|NCT02059291|580945349|FG021|Epoch 3|Adverse Event|0|||
160877293|NCT02059291|580945350|FG022|Epoch 3|Adverse Event|0|||
161225056|NCT04634409|582203574|FG022|Overall Study|Lost to Follow-up|0|||
161225057|NCT04634409|582203575|FG023|Overall Study|Lost to Follow-up|0|||
161225058|NCT04634409|582203576|FG024|Overall Study|Lost to Follow-up|0|||
161225059|NCT04634409|582203577|FG025|Overall Study|Lost to Follow-up|0|||
161225060|NCT04634409|582203578|FG026|Overall Study|Lost to Follow-up|0|||
161225061|NCT04634409|582203552|FG000|Overall Study|Withdrawal by Subject|3|||
161225062|NCT04634409|582203553|FG001|Overall Study|Withdrawal by Subject|1|||
161225063|NCT04634409|582203554|FG002|Overall Study|Withdrawal by Subject|6|||
161225064|NCT04634409|582203555|FG003|Overall Study|Withdrawal by Subject|4|||
161225065|NCT04634409|582203556|FG004|Overall Study|Withdrawal by Subject|2|||
161225066|NCT04634409|582203557|FG005|Overall Study|Withdrawal by Subject|0|||
160877294|NCT02059291|580945351|FG023|Epoch 3|Adverse Event|0|||
160877295|NCT02059291|580945352|FG024|Epoch 3|Adverse Event|0|||
160877296|NCT02059291|580945328|FG000|Epoch 3|Lack of Efficacy|0|||
161225067|NCT04634409|582203558|FG006|Overall Study|Withdrawal by Subject|0|||
160877297|NCT02059291|580945329|FG001|Epoch 3|Lack of Efficacy|0|||
160877298|NCT02059291|580945330|FG002|Epoch 3|Lack of Efficacy|0|||
160877299|NCT02059291|580945331|FG003|Epoch 3|Lack of Efficacy|0|||
160877300|NCT02059291|580945332|FG004|Epoch 3|Lack of Efficacy|0|||
160877301|NCT02059291|580945333|FG005|Epoch 3|Lack of Efficacy|0|||
160877302|NCT02059291|580945334|FG006|Epoch 3|Lack of Efficacy|0|||
161225068|NCT04634409|582203559|FG007|Overall Study|Withdrawal by Subject|2|||
161225069|NCT04634409|582203560|FG008|Overall Study|Withdrawal by Subject|3|||
161225070|NCT04634409|582203561|FG009|Overall Study|Withdrawal by Subject|2|||
160877303|NCT02059291|580945335|FG007|Epoch 3|Lack of Efficacy|0|||
160877304|NCT02059291|580945336|FG008|Epoch 3|Lack of Efficacy|0|||
160877305|NCT02059291|580945337|FG009|Epoch 3|Lack of Efficacy|0|||
160877306|NCT02059291|580945338|FG010|Epoch 3|Lack of Efficacy|0|||
161225071|NCT04634409|582203562|FG010|Overall Study|Withdrawal by Subject|3|||
160877307|NCT02059291|580945339|FG011|Epoch 3|Lack of Efficacy|0|||
160877308|NCT02059291|580945340|FG012|Epoch 3|Lack of Efficacy|0|||
160877309|NCT02059291|580945341|FG013|Epoch 3|Lack of Efficacy|0|||
160877310|NCT02059291|580945342|FG014|Epoch 3|Lack of Efficacy|0|||
161324562|NCT00452439|582575625|FG001|Overall Study|Fracture|0|||
161225072|NCT04634409|582203563|FG011|Overall Study|Withdrawal by Subject|2|||
161225073|NCT04634409|582203564|FG012|Overall Study|Withdrawal by Subject|2|||
161225074|NCT04634409|582203565|FG013|Overall Study|Withdrawal by Subject|1|||
161225075|NCT04634409|582203566|FG014|Overall Study|Withdrawal by Subject|5|||
161225076|NCT04634409|582203567|FG015|Overall Study|Withdrawal by Subject|0|||
161225077|NCT04634409|582203568|FG016|Overall Study|Withdrawal by Subject|0|||
161225078|NCT04634409|582203569|FG017|Overall Study|Withdrawal by Subject|1|||
161225079|NCT04634409|582203570|FG018|Overall Study|Withdrawal by Subject|0|||
161225080|NCT04634409|582203571|FG019|Overall Study|Withdrawal by Subject|0|||
161225081|NCT04634409|582203572|FG020|Overall Study|Withdrawal by Subject|0|||
161225082|NCT04634409|582203573|FG021|Overall Study|Withdrawal by Subject|0|||
161225083|NCT04634409|582203574|FG022|Overall Study|Withdrawal by Subject|0|||
161225084|NCT04634409|582203575|FG023|Overall Study|Withdrawal by Subject|1|||
161225085|NCT04634409|582203576|FG024|Overall Study|Withdrawal by Subject|0|||
161225086|NCT04634409|582203577|FG025|Overall Study|Withdrawal by Subject|0|||
161225087|NCT04634409|582203578|FG026|Overall Study|Withdrawal by Subject|0|||
161225088|NCT04634409|582203552|FG000|Overall Study|Other - As reported by Investigator|1|||
161225089|NCT04634409|582203553|FG001|Overall Study|Other - As reported by Investigator|0|||
161225090|NCT04634409|582203554|FG002|Overall Study|Other - As reported by Investigator|0|||
161225091|NCT04634409|582203555|FG003|Overall Study|Other - As reported by Investigator|0|||
161225092|NCT04634409|582203556|FG004|Overall Study|Other - As reported by Investigator|0|||
161225093|NCT04634409|582203557|FG005|Overall Study|Other - As reported by Investigator|0|||
161225094|NCT04634409|582203558|FG006|Overall Study|Other - As reported by Investigator|0|||
161225095|NCT04634409|582203559|FG007|Overall Study|Other - As reported by Investigator|6|||
161225096|NCT04634409|582203560|FG008|Overall Study|Other - As reported by Investigator|4|||
161225097|NCT04634409|582203561|FG009|Overall Study|Other - As reported by Investigator|0|||
161225098|NCT04634409|582203562|FG010|Overall Study|Other - As reported by Investigator|1|||
161225099|NCT04634409|582203563|FG011|Overall Study|Other - As reported by Investigator|2|||
161225100|NCT04634409|582203564|FG012|Overall Study|Other - As reported by Investigator|2|||
161225101|NCT04634409|582203565|FG013|Overall Study|Other - As reported by Investigator|1|||
161225102|NCT04634409|582203566|FG014|Overall Study|Other - As reported by Investigator|0|||
161225103|NCT04634409|582203567|FG015|Overall Study|Other - As reported by Investigator|0|||
161225104|NCT04634409|582203568|FG016|Overall Study|Other - As reported by Investigator|0|||
161225105|NCT04634409|582203569|FG017|Overall Study|Other - As reported by Investigator|0|||
161225106|NCT04634409|582203570|FG018|Overall Study|Other - As reported by Investigator|0|||
161225107|NCT04634409|582203571|FG019|Overall Study|Other - As reported by Investigator|0|||
161225108|NCT04634409|582203572|FG020|Overall Study|Other - As reported by Investigator|0|||
161225109|NCT04634409|582203573|FG021|Overall Study|Other - As reported by Investigator|0|||
161225110|NCT04634409|582203574|FG022|Overall Study|Other - As reported by Investigator|0|||
161225111|NCT04634409|582203575|FG023|Overall Study|Other - As reported by Investigator|0|||
161225112|NCT04634409|582203576|FG024|Overall Study|Other - As reported by Investigator|0|||
161225113|NCT04634409|582203577|FG025|Overall Study|Other - As reported by Investigator|0|||
161225114|NCT04634409|582203578|FG026|Overall Study|Other - As reported by Investigator|0|||
161225115|NCT02683187|582203579|FG000|Overall Study|Failed IV access|3|||
161225116|NCT02683187|582203579|FG000|Overall Study|Withdrawal by Subject|5|||
161225117|NCT02742090|582205148|FG000|Overall Study|Adverse Event|10|||
161225118|NCT02742090|582205148|FG000|Overall Study|Death|3|||
161225119|NCT02742090|582205148|FG000|Overall Study|Disease Progression|25|||
161225120|NCT02742090|582205148|FG000|Overall Study|Investigator's Decision|1|||
161225121|NCT02742090|582205148|FG000|Overall Study|Lost to Follow-up|1|||
161225122|NCT02742090|582205148|FG000|Overall Study|Non-compliance with Study|1|||
161225123|NCT02742090|582205148|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
161225124|NCT02742090|582205148|FG000|Overall Study|Withdrawal by Subject|4|||
161225125|NCT02742090|582205148|FG000|Overall Study|Reason Not Specified|1|||
161225126|NCT02710123|582205149|FG000|Overall Study|Lost to Follow-up|3|||
161120174|NCT00689871|581827118|FG003|Overall Study|Death|2|||
161120175|NCT00689871|581827115|FG000|Overall Study|Physician Decision|2|||
161120176|NCT00689871|581827116|FG001|Overall Study|Physician Decision|1|||
161120177|NCT00689871|581827117|FG002|Overall Study|Physician Decision|1|||
161120178|NCT00689871|581827118|FG003|Overall Study|Physician Decision|0|||
161120179|NCT00343889|581827126|FG000|Overall Study|Lost to Follow-up|2|||
161120180|NCT00343889|581827127|FG001|Overall Study|Lost to Follow-up|0|||
161120181|NCT00343889|581827126|FG000|Overall Study|Withdrawal by Subject|0|||
161120182|NCT00343889|581827127|FG001|Overall Study|Withdrawal by Subject|1|||
161120183|NCT00343889|581827126|FG000|Overall Study|Protocol Violation|1|||
161120184|NCT00343889|581827127|FG001|Overall Study|Protocol Violation|0|||
161120185|NCT00137111|581827128|FG000|Total Therapy|Death|35|||
161120186|NCT00137111|581827129|FG001|Total Therapy|Death|0|||
161225127|NCT02710123|582205150|FG001|Overall Study|Lost to Follow-up|4|||
161225128|NCT02710123|582205149|FG000|Overall Study|Withdrawal by Subject|1|||
161120187|NCT00137111|581827130|FG002|Total Therapy|Death|0|||
161120188|NCT00137111|581827131|FG003|Total Therapy|Death|0|||
161120189|NCT00137111|581827128|FG000|Total Therapy|Non Compliance|5|||
161120190|NCT00137111|581827129|FG001|Total Therapy|Non Compliance|0|||
161225129|NCT02710123|582205150|FG001|Overall Study|Withdrawal by Subject|1|||
161225130|NCT02710123|582205149|FG000|Overall Study|Illness unrelated to study intervention|1|||
161225131|NCT02710123|582205150|FG001|Overall Study|Illness unrelated to study intervention|0|||
161225132|NCT00419926|582205151|FG000|Overall Study|Withdrawal by Subject|7|||
161225133|NCT00419926|582205152|FG001|Overall Study|Withdrawal by Subject|3|||
161225134|NCT00419926|582205151|FG000|Overall Study|Administrative Problem|4|||
161225135|NCT00419926|582205152|FG001|Overall Study|Administrative Problem|4|||
161225136|NCT00419926|582205151|FG000|Overall Study|Lost to Follow-up|1|||
161225137|NCT00419926|582205152|FG001|Overall Study|Lost to Follow-up|2|||
161225138|NCT00419926|582205151|FG000|Overall Study|Death|2|||
161225139|NCT00419926|582205152|FG001|Overall Study|Death|1|||
161225140|NCT02374918|582205154|FG000|Overall Study|Protocol Violation|2|||
161225141|NCT02374918|582205155|FG001|Overall Study|Protocol Violation|0|||
161225142|NCT02374918|582205156|FG002|Overall Study|Protocol Violation|2|||
161225143|NCT02374918|582205157|FG003|Overall Study|Protocol Violation|1|||
161225144|NCT02374918|582205154|FG000|Overall Study|Withdrawal by Subject|1|||
160877311|NCT02059291|580945343|FG015|Epoch 3|Lack of Efficacy|3|||
160877312|NCT02059291|580945344|FG016|Epoch 3|Lack of Efficacy|0|||
160877313|NCT02059291|580945345|FG017|Epoch 3|Lack of Efficacy|0|||
160877314|NCT02059291|580945346|FG018|Epoch 3|Lack of Efficacy|0|||
160877315|NCT02059291|580945347|FG019|Epoch 3|Lack of Efficacy|0|||
160877316|NCT02059291|580945348|FG020|Epoch 3|Lack of Efficacy|0|||
160877317|NCT02059291|580945349|FG021|Epoch 3|Lack of Efficacy|0|||
160877318|NCT02059291|580945350|FG022|Epoch 3|Lack of Efficacy|0|||
160877319|NCT02059291|580945351|FG023|Epoch 3|Lack of Efficacy|0|||
160877320|NCT02059291|580945352|FG024|Epoch 3|Lack of Efficacy|0|||
160877321|NCT02059291|580945328|FG000|Epoch 3|Withdrawal by Subject|0|||
160877322|NCT02059291|580945329|FG001|Epoch 3|Withdrawal by Subject|0|||
160877323|NCT02059291|580945330|FG002|Epoch 3|Withdrawal by Subject|0|||
160877324|NCT02059291|580945331|FG003|Epoch 3|Withdrawal by Subject|0|||
160877325|NCT02059291|580945332|FG004|Epoch 3|Withdrawal by Subject|0|||
160877326|NCT02059291|580945333|FG005|Epoch 3|Withdrawal by Subject|0|||
160877327|NCT02059291|580945334|FG006|Epoch 3|Withdrawal by Subject|0|||
160877328|NCT02059291|580945335|FG007|Epoch 3|Withdrawal by Subject|0|||
160877329|NCT02059291|580945336|FG008|Epoch 3|Withdrawal by Subject|0|||
160877330|NCT02059291|580945337|FG009|Epoch 3|Withdrawal by Subject|0|||
160877331|NCT02059291|580945338|FG010|Epoch 3|Withdrawal by Subject|0|||
160877332|NCT02059291|580945339|FG011|Epoch 3|Withdrawal by Subject|0|||
160877333|NCT02059291|580945340|FG012|Epoch 3|Withdrawal by Subject|0|||
160877334|NCT02059291|580945341|FG013|Epoch 3|Withdrawal by Subject|0|||
160877335|NCT02059291|580945342|FG014|Epoch 3|Withdrawal by Subject|0|||
160877336|NCT02059291|580945343|FG015|Epoch 3|Withdrawal by Subject|1|||
160877337|NCT02059291|580945344|FG016|Epoch 3|Withdrawal by Subject|0|||
160877338|NCT02059291|580945345|FG017|Epoch 3|Withdrawal by Subject|0|||
160877339|NCT02059291|580945346|FG018|Epoch 3|Withdrawal by Subject|0|||
160877340|NCT02059291|580945347|FG019|Epoch 3|Withdrawal by Subject|0|||
160877341|NCT02059291|580945348|FG020|Epoch 3|Withdrawal by Subject|0|||
160877342|NCT02059291|580945349|FG021|Epoch 3|Withdrawal by Subject|0|||
160877343|NCT02059291|580945350|FG022|Epoch 3|Withdrawal by Subject|0|||
160877344|NCT02059291|580945351|FG023|Epoch 3|Withdrawal by Subject|0|||
160877345|NCT02059291|580945352|FG024|Epoch 3|Withdrawal by Subject|0|||
160877346|NCT02059291|580945328|FG000|Epoch 4|Adverse Event|0|||
160877347|NCT02059291|580945329|FG001|Epoch 4|Adverse Event|0|||
160877348|NCT02059291|580945330|FG002|Epoch 4|Adverse Event|0|||
160877349|NCT02059291|580945331|FG003|Epoch 4|Adverse Event|0|||
160877350|NCT02059291|580945332|FG004|Epoch 4|Adverse Event|0|||
160877351|NCT02059291|580945333|FG005|Epoch 4|Adverse Event|0|||
160877352|NCT02059291|580945334|FG006|Epoch 4|Adverse Event|0|||
160877353|NCT02059291|580945335|FG007|Epoch 4|Adverse Event|0|||
160877354|NCT02059291|580945336|FG008|Epoch 4|Adverse Event|0|||
160877355|NCT02059291|580945337|FG009|Epoch 4|Adverse Event|0|||
160877356|NCT02059291|580945338|FG010|Epoch 4|Adverse Event|0|||
160877357|NCT02059291|580945339|FG011|Epoch 4|Adverse Event|0|||
160877358|NCT02059291|580945340|FG012|Epoch 4|Adverse Event|0|||
160877359|NCT02059291|580945341|FG013|Epoch 4|Adverse Event|0|||
160877360|NCT02059291|580945342|FG014|Epoch 4|Adverse Event|0|||
160877361|NCT02059291|580945343|FG015|Epoch 4|Adverse Event|0|||
160877362|NCT02059291|580945344|FG016|Epoch 4|Adverse Event|1|||
160877363|NCT02059291|580945345|FG017|Epoch 4|Adverse Event|0|||
160877364|NCT02059291|580945346|FG018|Epoch 4|Adverse Event|0|||
160877365|NCT02059291|580945347|FG019|Epoch 4|Adverse Event|0|||
160877366|NCT02059291|580945348|FG020|Epoch 4|Adverse Event|0|||
160877367|NCT02059291|580945349|FG021|Epoch 4|Adverse Event|0|||
160877368|NCT02059291|580945350|FG022|Epoch 4|Adverse Event|1|||
160877369|NCT02059291|580945351|FG023|Epoch 4|Adverse Event|0|||
160877370|NCT02059291|580945352|FG024|Epoch 4|Adverse Event|0|||
160877371|NCT02059291|580945328|FG000|Epoch 4|Pregnancy|0|||
160877372|NCT02059291|580945329|FG001|Epoch 4|Pregnancy|0|||
160877373|NCT02059291|580945330|FG002|Epoch 4|Pregnancy|0|||
160877374|NCT02059291|580945331|FG003|Epoch 4|Pregnancy|0|||
160877375|NCT02059291|580945332|FG004|Epoch 4|Pregnancy|0|||
160877376|NCT02059291|580945333|FG005|Epoch 4|Pregnancy|0|||
160877377|NCT02059291|580945334|FG006|Epoch 4|Pregnancy|0|||
160877378|NCT02059291|580945335|FG007|Epoch 4|Pregnancy|0|||
160877379|NCT02059291|580945336|FG008|Epoch 4|Pregnancy|0|||
160877380|NCT02059291|580945337|FG009|Epoch 4|Pregnancy|0|||
160877381|NCT02059291|580945338|FG010|Epoch 4|Pregnancy|0|||
160877382|NCT02059291|580945339|FG011|Epoch 4|Pregnancy|0|||
160877383|NCT02059291|580945340|FG012|Epoch 4|Pregnancy|0|||
160877384|NCT02059291|580945341|FG013|Epoch 4|Pregnancy|0|||
160877385|NCT02059291|580945342|FG014|Epoch 4|Pregnancy|0|||
160877386|NCT02059291|580945343|FG015|Epoch 4|Pregnancy|0|||
160877387|NCT02059291|580945344|FG016|Epoch 4|Pregnancy|1|||
160877388|NCT02059291|580945345|FG017|Epoch 4|Pregnancy|0|||
160877389|NCT02059291|580945346|FG018|Epoch 4|Pregnancy|0|||
160877390|NCT02059291|580945347|FG019|Epoch 4|Pregnancy|0|||
160877391|NCT02059291|580945348|FG020|Epoch 4|Pregnancy|0|||
160877392|NCT02059291|580945349|FG021|Epoch 4|Pregnancy|0|||
160877393|NCT02059291|580945350|FG022|Epoch 4|Pregnancy|0|||
160877394|NCT02059291|580945351|FG023|Epoch 4|Pregnancy|0|||
160877395|NCT02059291|580945352|FG024|Epoch 4|Pregnancy|0|||
160877396|NCT02059291|580945328|FG000|Epoch 4|Withdrawal by Subject|0|||
160877397|NCT02059291|580945329|FG001|Epoch 4|Withdrawal by Subject|0|||
160877398|NCT02059291|580945330|FG002|Epoch 4|Withdrawal by Subject|0|||
160877399|NCT02059291|580945331|FG003|Epoch 4|Withdrawal by Subject|0|||
160877400|NCT02059291|580945332|FG004|Epoch 4|Withdrawal by Subject|0|||
160877401|NCT02059291|580945333|FG005|Epoch 4|Withdrawal by Subject|0|||
160877402|NCT02059291|580945334|FG006|Epoch 4|Withdrawal by Subject|0|||
160877403|NCT02059291|580945335|FG007|Epoch 4|Withdrawal by Subject|0|||
160877404|NCT02059291|580945336|FG008|Epoch 4|Withdrawal by Subject|0|||
160877405|NCT02059291|580945337|FG009|Epoch 4|Withdrawal by Subject|0|||
160877406|NCT02059291|580945338|FG010|Epoch 4|Withdrawal by Subject|0|||
160877407|NCT02059291|580945339|FG011|Epoch 4|Withdrawal by Subject|0|||
160877408|NCT02059291|580945340|FG012|Epoch 4|Withdrawal by Subject|0|||
160877409|NCT02059291|580945341|FG013|Epoch 4|Withdrawal by Subject|0|||
160877410|NCT02059291|580945342|FG014|Epoch 4|Withdrawal by Subject|0|||
160877411|NCT02059291|580945343|FG015|Epoch 4|Withdrawal by Subject|0|||
160877412|NCT02059291|580945344|FG016|Epoch 4|Withdrawal by Subject|0|||
160877413|NCT02059291|580945345|FG017|Epoch 4|Withdrawal by Subject|0|||
160877414|NCT02059291|580945346|FG018|Epoch 4|Withdrawal by Subject|0|||
160877415|NCT02059291|580945347|FG019|Epoch 4|Withdrawal by Subject|0|||
160877416|NCT02059291|580945348|FG020|Epoch 4|Withdrawal by Subject|1|||
160877417|NCT02059291|580945349|FG021|Epoch 4|Withdrawal by Subject|0|||
160877418|NCT02059291|580945350|FG022|Epoch 4|Withdrawal by Subject|0|||
160877419|NCT02059291|580945351|FG023|Epoch 4|Withdrawal by Subject|0|||
160877420|NCT02059291|580945352|FG024|Epoch 4|Withdrawal by Subject|0|||
160877421|NCT02059291|580945328|FG000|Epoch 4|Lack of Efficacy|0|||
160877422|NCT02059291|580945329|FG001|Epoch 4|Lack of Efficacy|0|||
160877423|NCT02059291|580945330|FG002|Epoch 4|Lack of Efficacy|0|||
160877424|NCT02059291|580945331|FG003|Epoch 4|Lack of Efficacy|0|||
160877425|NCT02059291|580945332|FG004|Epoch 4|Lack of Efficacy|0|||
160877426|NCT02059291|580945333|FG005|Epoch 4|Lack of Efficacy|0|||
160877427|NCT02059291|580945334|FG006|Epoch 4|Lack of Efficacy|0|||
160877428|NCT02059291|580945335|FG007|Epoch 4|Lack of Efficacy|0|||
160877429|NCT02059291|580945336|FG008|Epoch 4|Lack of Efficacy|0|||
160877430|NCT02059291|580945337|FG009|Epoch 4|Lack of Efficacy|0|||
160877431|NCT02059291|580945338|FG010|Epoch 4|Lack of Efficacy|0|||
160877432|NCT02059291|580945339|FG011|Epoch 4|Lack of Efficacy|0|||
160877433|NCT02059291|580945340|FG012|Epoch 4|Lack of Efficacy|0|||
160877434|NCT02059291|580945341|FG013|Epoch 4|Lack of Efficacy|0|||
160877435|NCT02059291|580945342|FG014|Epoch 4|Lack of Efficacy|0|||
160877436|NCT02059291|580945343|FG015|Epoch 4|Lack of Efficacy|0|||
160877437|NCT02059291|580945344|FG016|Epoch 4|Lack of Efficacy|0|||
160877438|NCT02059291|580945345|FG017|Epoch 4|Lack of Efficacy|0|||
160877439|NCT02059291|580945346|FG018|Epoch 4|Lack of Efficacy|0|||
160877440|NCT02059291|580945347|FG019|Epoch 4|Lack of Efficacy|0|||
160877441|NCT02059291|580945348|FG020|Epoch 4|Lack of Efficacy|0|||
160877442|NCT02059291|580945349|FG021|Epoch 4|Lack of Efficacy|0|||
160877443|NCT02059291|580945350|FG022|Epoch 4|Lack of Efficacy|0|||
160877444|NCT02059291|580945351|FG023|Epoch 4|Lack of Efficacy|1|||
160877445|NCT02059291|580945352|FG024|Epoch 4|Lack of Efficacy|0|||
160877446|NCT01276054|580945357|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
160877447|NCT01276054|580945358|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
160877448|NCT00787267|580945359|FG000|Overall Study|Screen failure/Ineligible|10|||
160877449|NCT00787267|580945359|FG000|Overall Study|No Reason Provided|1|||
160877450|NCT00787267|580945359|FG000|Overall Study|Withdrawal by Subject|1|||
160877451|NCT04343235|580945360|FG000|Overall Study|Lost to Follow-up|3|||
160877452|NCT04343235|580945361|FG001|Overall Study|Lost to Follow-up|2|||
160877453|NCT01763996|580945362|FG000|Treatment Period 2|Adverse Event|0|||
160877454|NCT01763996|580945363|FG001|Treatment Period 2|Adverse Event|1|||
160877455|NCT05405257|580945367|FG000|Overall Study|Withdrawal by Subject|1|||
160877456|NCT00776919|580945370|FG000|Overall Study|Withdrawal by Subject|16|||
160877457|NCT00776919|580945371|FG001|Overall Study|Withdrawal by Subject|14|||
160877458|NCT00776919|580945372|FG002|Overall Study|Withdrawal by Subject|15|||
160877459|NCT00776919|580945373|FG003|Overall Study|Withdrawal by Subject|26|||
160877460|NCT00776919|580945370|FG000|Overall Study|Lost to Follow-up|8|||
160877461|NCT00776919|580945371|FG001|Overall Study|Lost to Follow-up|12|||
160877462|NCT00776919|580945372|FG002|Overall Study|Lost to Follow-up|11|||
160877463|NCT00776919|580945373|FG003|Overall Study|Lost to Follow-up|8|||
160877464|NCT00776919|580945370|FG000|Overall Study|Adverse Event|1|||
160877465|NCT00776919|580945371|FG001|Overall Study|Adverse Event|0|||
160877466|NCT00776919|580945372|FG002|Overall Study|Adverse Event|2|||
160877467|NCT00776919|580945373|FG003|Overall Study|Adverse Event|2|||
160877468|NCT00776919|580945370|FG000|Overall Study|Protocol Violation|1|||
160877469|NCT00776919|580945371|FG001|Overall Study|Protocol Violation|2|||
160877470|NCT00776919|580945372|FG002|Overall Study|Protocol Violation|0|||
160877471|NCT00776919|580945373|FG003|Overall Study|Protocol Violation|1|||
160877472|NCT00776919|580945370|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
160877473|NCT00776919|580945371|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
160877474|NCT00776919|580945372|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
160877475|NCT00776919|580945373|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
160877476|NCT01788215|580945374|FG000|Overall Study|Withdrawal by Subject|0|||
160877477|NCT01788215|580945375|FG001|Overall Study|Withdrawal by Subject|1|||
160877478|NCT01788215|580945374|FG000|Overall Study|Lost to Follow-up|2|||
160877479|NCT01788215|580945375|FG001|Overall Study|Lost to Follow-up|0|||
160877480|NCT03116152|580945376|FG000|Overall Study|Disease Progression|49|||
160877481|NCT03116152|580945377|FG001|Overall Study|Disease Progression|47|||
160877482|NCT03116152|580945376|FG000|Overall Study|Death|5|||
160877483|NCT03116152|580945377|FG001|Overall Study|Death|2|||
160877484|NCT03116152|580945376|FG000|Overall Study|Adverse Event|21|||
160877485|NCT03116152|580945377|FG001|Overall Study|Adverse Event|7|||
160877486|NCT03116152|580945376|FG000|Overall Study|Protocol Violation|2|||
160877487|NCT03116152|580945377|FG001|Overall Study|Protocol Violation|2|||
160877488|NCT03116152|580945376|FG000|Overall Study|Withdrawal by Subject|0|||
160877489|NCT03116152|580945377|FG001|Overall Study|Withdrawal by Subject|1|||
160877490|NCT03116152|580945376|FG000|Overall Study|Physician Decision|3|||
160877491|NCT03116152|580945377|FG001|Overall Study|Physician Decision|2|||
160877492|NCT03116152|580945376|FG000|Overall Study|other|11|||
160877493|NCT03116152|580945377|FG001|Overall Study|other|34|||
160877494|NCT01396057|580945386|FG000|Overall Study|Adverse Event|2|||
160877495|NCT01396057|580945387|FG001|Overall Study|Adverse Event|6|||
160877496|NCT01396057|580945386|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160877497|NCT01396057|580945387|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160877498|NCT01396057|580945386|FG000|Overall Study|Protocol deviation|4|||
160877499|NCT01396057|580945387|FG001|Overall Study|Protocol deviation|4|||
160877500|NCT01396057|580945386|FG000|Overall Study|Consent withdrawn|3|||
160877501|NCT01396057|580945387|FG001|Overall Study|Consent withdrawn|2|||
160877502|NCT01324401|580945390|FG000|Overall Study|Withdrawn before any treatment|0|||
160877503|NCT01324401|580945391|FG001|Overall Study|Withdrawn before any treatment|3|||
160877504|NCT01324401|580945390|FG000|Overall Study|Adverse Event|1|||
160877505|NCT01324401|580945391|FG001|Overall Study|Adverse Event|3|||
160877506|NCT00335764|580945392|FG000|Overall Study|wrong histology|1|||
160877507|NCT00335764|580945393|FG001|Overall Study|wrong histology|0|||
160877508|NCT00335764|580945394|FG002|Overall Study|wrong histology|0|||
160877509|NCT00335764|580945395|FG003|Overall Study|wrong histology|0|||
160877510|NCT00335764|580945396|FG004|Overall Study|wrong histology|1|||
160877511|NCT01578850|580945398|FG000|Period 1|Insufficient Clinical Response|1|||
160877512|NCT01578850|580945399|FG001|Period 1|Insufficient Clinical Response|0|||
160877513|NCT01578850|580945400|FG002|Period 1|Insufficient Clinical Response|0|||
160877514|NCT01578850|580945398|FG000|Period 1|Adverse Event|11|||
160877515|NCT01578850|580945399|FG001|Period 1|Adverse Event|0|||
160877516|NCT01578850|580945400|FG002|Period 1|Adverse Event|0|||
160877517|NCT01578850|580945398|FG000|Period 1|Death|1|||
160877518|NCT01578850|580945399|FG001|Period 1|Death|0|||
160877519|NCT01578850|580945400|FG002|Period 1|Death|0|||
160877520|NCT01578850|580945398|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
160877521|NCT01578850|580945399|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
160877522|NCT01578850|580945400|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
160877523|NCT01578850|580945398|FG000|Period 1|Withdrawal by Subject|9|||
160877524|NCT01578850|580945399|FG001|Period 1|Withdrawal by Subject|0|||
160877525|NCT01578850|580945400|FG002|Period 1|Withdrawal by Subject|0|||
160877526|NCT01578850|580945398|FG000|Period 1|Study Terminated by Sponsor|3|||
160877527|NCT01578850|580945399|FG001|Period 1|Study Terminated by Sponsor|0|||
160877528|NCT01578850|580945400|FG002|Period 1|Study Terminated by Sponsor|0|||
160877529|NCT01578850|580945398|FG000|Period 2|Insufficient Clinical Response|0|||
160877530|NCT01578850|580945399|FG001|Period 2|Insufficient Clinical Response|1|||
160877531|NCT01578850|580945400|FG002|Period 2|Insufficient Clinical Response|0|||
160877532|NCT01578850|580945398|FG000|Period 2|Adverse Event|0|||
160877533|NCT01578850|580945399|FG001|Period 2|Adverse Event|3|||
160877534|NCT01578850|580945400|FG002|Period 2|Adverse Event|6|||
160877535|NCT01578850|580945398|FG000|Period 2|Lost to Follow-up|0|||
160877536|NCT01578850|580945399|FG001|Period 2|Lost to Follow-up|1|||
160877537|NCT01578850|580945400|FG002|Period 2|Lost to Follow-up|2|||
160877538|NCT01578850|580945398|FG000|Period 2|Withdrawal by Subject|0|||
160877539|NCT01578850|580945399|FG001|Period 2|Withdrawal by Subject|2|||
160877540|NCT01578850|580945400|FG002|Period 2|Withdrawal by Subject|2|||
160877541|NCT01578850|580945398|FG000|Period 2|Study Terminated by Sponsor|0|||
160877542|NCT01578850|580945399|FG001|Period 2|Study Terminated by Sponsor|5|||
160877543|NCT01578850|580945400|FG002|Period 2|Study Terminated by Sponsor|4|||
160877544|NCT01578850|580945398|FG000|Period 2|Unspecified Reasons|0|||
160877545|NCT01578850|580945399|FG001|Period 2|Unspecified Reasons|1|||
160877546|NCT01578850|580945400|FG002|Period 2|Unspecified Reasons|0|||
160877547|NCT01215097|580945412|FG000|Overall Study|Adverse Event|1|||
160877548|NCT01215097|580945413|FG001|Overall Study|Adverse Event|3|||
160877549|NCT01215097|580945412|FG000|Overall Study|Protocol Violation|0|||
160877550|NCT01215097|580945413|FG001|Overall Study|Protocol Violation|2|||
160877551|NCT01215097|580945412|FG000|Overall Study|Lost to Follow-up|2|||
161324563|NCT01381926|582575626|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
160877552|NCT01215097|580945413|FG001|Overall Study|Lost to Follow-up|0|||
160877553|NCT01215097|580945412|FG000|Overall Study|Withdrawal by Subject|6|||
160877554|NCT01215097|580945413|FG001|Overall Study|Withdrawal by Subject|3|||
160877555|NCT01215097|580945412|FG000|Overall Study|Lack of Efficacy|0|||
160877556|NCT01215097|580945413|FG001|Overall Study|Lack of Efficacy|3|||
160877557|NCT01215097|580945412|FG000|Overall Study|patient's refusal to come|2|||
160877558|NCT01215097|580945413|FG001|Overall Study|patient's refusal to come|2|||
160877559|NCT01215097|580945412|FG000|Overall Study|patient's private reason|1|||
160877560|NCT01215097|580945413|FG001|Overall Study|patient's private reason|1|||
160877561|NCT02259088|580945414|FG000|Overall Study|Adverse Event|6|||
160877562|NCT02259088|580945415|FG001|Overall Study|Adverse Event|4|||
160877563|NCT02259088|580945414|FG000|Overall Study|Lost to Follow-up|2|||
160877564|NCT02259088|580945415|FG001|Overall Study|Lost to Follow-up|0|||
160877565|NCT02259088|580945414|FG000|Overall Study|Death|2|||
160877566|NCT02259088|580945415|FG001|Overall Study|Death|0|||
160877567|NCT02259088|580945414|FG000|Overall Study|Physician Decision|5|||
160877568|NCT02259088|580945415|FG001|Overall Study|Physician Decision|2|||
160877569|NCT02259088|580945414|FG000|Overall Study|Protocol deviation|5|||
160877570|NCT02259088|580945415|FG001|Overall Study|Protocol deviation|0|||
160877571|NCT02259088|580945414|FG000|Overall Study|Subject/guardian decision|8|||
160877572|NCT02259088|580945415|FG001|Overall Study|Subject/guardian decision|8|||
160877573|NCT01818752|580945417|FG000|Overall Study|Adverse Event|64|||
161225145|NCT02374918|582205155|FG001|Overall Study|Withdrawal by Subject|1|||
161225146|NCT02374918|582205156|FG002|Overall Study|Withdrawal by Subject|1|||
161225147|NCT02374918|582205157|FG003|Overall Study|Withdrawal by Subject|0|||
161225148|NCT02374918|582205154|FG000|Overall Study|Lack of Efficacy|0|||
161225149|NCT02374918|582205155|FG001|Overall Study|Lack of Efficacy|0|||
161225150|NCT02374918|582205156|FG002|Overall Study|Lack of Efficacy|1|||
161225151|NCT02374918|582205157|FG003|Overall Study|Lack of Efficacy|1|||
161225152|NCT00810368|582205159|FG000|Overall Study|Lost to Follow-up|4|||
161225153|NCT00810368|582205160|FG001|Overall Study|Lost to Follow-up|2|||
161225154|NCT00810368|582205159|FG000|Overall Study|Lack of Efficacy|2|||
161225155|NCT00810368|582205160|FG001|Overall Study|Lack of Efficacy|0|||
161225156|NCT03365375|582205161|FG000|Overall Study|Withdrawal by Subject|0|||
161225157|NCT03365375|582205162|FG001|Overall Study|Withdrawal by Subject|1|||
161225158|NCT03365375|582205161|FG000|Overall Study|Lost to Follow-up|0|||
161225159|NCT03365375|582205162|FG001|Overall Study|Lost to Follow-up|4|||
161225160|NCT02483975|582205163|FG000|Overall Study|Adverse Event|0|||
161225161|NCT02483975|582205164|FG001|Overall Study|Adverse Event|1|||
161225162|NCT02483975|582205163|FG000|Overall Study|Lost to Follow-up|0|||
161225163|NCT02483975|582205164|FG001|Overall Study|Lost to Follow-up|1|||
161225164|NCT02483975|582205163|FG000|Overall Study|Physician Decision|2|||
161225165|NCT02483975|582205164|FG001|Overall Study|Physician Decision|0|||
161225166|NCT00818883|582205165|FG000|Overall Study|Adverse Event|28|||
161225167|NCT00818883|582205166|FG001|Overall Study|Adverse Event|19|||
161225168|NCT00818883|582205165|FG000|Overall Study|Protocol Violation|2|||
161225169|NCT00818883|582205166|FG001|Overall Study|Protocol Violation|2|||
161225170|NCT00818883|582205165|FG000|Overall Study|Lost to Follow-up|3|||
161225171|NCT00818883|582205166|FG001|Overall Study|Lost to Follow-up|2|||
161225172|NCT00818883|582205165|FG000|Overall Study|Withdrawal by Subject|16|||
161225173|NCT00818883|582205166|FG001|Overall Study|Withdrawal by Subject|14|||
161225174|NCT00818883|582205165|FG000|Overall Study|Lack of Efficacy|0|||
161225175|NCT00818883|582205166|FG001|Overall Study|Lack of Efficacy|2|||
161225176|NCT00818883|582205165|FG000|Overall Study|Other|2|||
161225177|NCT00818883|582205166|FG001|Overall Study|Other|7|||
161225178|NCT02166697|582205167|FG000|Overall Study|Protocol Violation|347|||
161225179|NCT02684578|582205169|FG000|Overall Study|Withdrawal by Subject|10|||
161225180|NCT02684578|582205170|FG001|Overall Study|Withdrawal by Subject|7|||
161225181|NCT02684578|582205169|FG000|Overall Study|Lost to Follow-up|0|||
161225182|NCT02684578|582205170|FG001|Overall Study|Lost to Follow-up|3|||
161225183|NCT02684578|582205169|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
161225184|NCT02684578|582205170|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
161225185|NCT02684578|582205169|FG000|Overall Study|Missing follow-up data|0|||
161225186|NCT02684578|582205170|FG001|Overall Study|Missing follow-up data|1|||
161225187|NCT01505530|582205171|FG000|Overall Study|Progressive Disease|19|||
161225188|NCT01505530|582205172|FG001|Overall Study|Progressive Disease|17|||
161225189|NCT01505530|582205173|FG002|Overall Study|Progressive Disease|18|||
161225190|NCT01505530|582205171|FG000|Overall Study|Adverse Event|1|||
161225191|NCT01505530|582205172|FG001|Overall Study|Adverse Event|1|||
161225192|NCT01505530|582205173|FG002|Overall Study|Adverse Event|0|||
161225193|NCT01505530|582205171|FG000|Overall Study|Withdrawal by Subject|7|||
161225194|NCT01505530|582205172|FG001|Overall Study|Withdrawal by Subject|8|||
161225195|NCT01505530|582205173|FG002|Overall Study|Withdrawal by Subject|6|||
161225196|NCT01505530|582205171|FG000|Overall Study|Physician Decision|6|||
161225197|NCT01505530|582205172|FG001|Overall Study|Physician Decision|2|||
161225198|NCT01505530|582205173|FG002|Overall Study|Physician Decision|5|||
161225199|NCT01505530|582205171|FG000|Overall Study|Sponsor Decision|1|||
160877574|NCT01818752|580945418|FG001|Overall Study|Adverse Event|74|||
161225200|NCT01505530|582205172|FG001|Overall Study|Sponsor Decision|8|||
161225201|NCT01505530|582205173|FG002|Overall Study|Sponsor Decision|7|||
161225202|NCT01505530|582205171|FG000|Overall Study|Death|7|||
160877575|NCT01818752|580945417|FG000|Overall Study|Death|14|||
160877576|NCT01818752|580945418|FG001|Overall Study|Death|18|||
161225203|NCT01505530|582205172|FG001|Overall Study|Death|6|||
161225204|NCT01505530|582205173|FG002|Overall Study|Death|5|||
161225205|NCT01505530|582205171|FG000|Overall Study|entry criteria not met|0|||
161225206|NCT01505530|582205172|FG001|Overall Study|entry criteria not met|1|||
160877577|NCT01818752|580945417|FG000|Overall Study|Non-compliance|16|||
160877578|NCT01818752|580945418|FG001|Overall Study|Non-compliance|20|||
160877579|NCT01818752|580945417|FG000|Overall Study|Withdrawal by Subject|15|||
160877580|NCT01818752|580945418|FG001|Overall Study|Withdrawal by Subject|14|||
160877581|NCT01818752|580945417|FG000|Overall Study|Physician Decision|9|||
160877582|NCT01818752|580945418|FG001|Overall Study|Physician Decision|8|||
160877583|NCT01818752|580945417|FG000|Overall Study|Disease Progression|54|||
160877584|NCT01818752|580945418|FG001|Overall Study|Disease Progression|48|||
160877585|NCT01818752|580945417|FG000|Overall Study|Other|7|||
160877586|NCT01818752|580945418|FG001|Overall Study|Other|8|||
160877587|NCT01818752|580945417|FG000|Overall Study|Continuing Treatment|1|||
160877588|NCT01818752|580945418|FG001|Overall Study|Continuing Treatment|4|||
160877589|NCT01818752|580945417|FG000|Overall Study|Randomized but not Dosed|7|||
160877590|NCT01818752|580945418|FG001|Overall Study|Randomized but not Dosed|4|||
160877591|NCT04629066|580945419|FG000|Overall Study|Lost to Follow-up|3|||
160877592|NCT04629066|580945420|FG001|Overall Study|Lost to Follow-up|2|||
160877593|NCT00282308|580945423|FG000|Treatment Period|Lost to Follow-up|1|||
160877594|NCT00282308|580945424|FG001|Treatment Period|Lost to Follow-up|0|||
160877595|NCT00282308|580945425|FG002|Treatment Period|Lost to Follow-up|0|||
160877596|NCT00282308|580945423|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
160877597|NCT00282308|580945424|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
160877598|NCT00282308|580945425|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
160877599|NCT00282308|580945423|FG000|Treatment Period|Adverse Event|0|||
160877600|NCT00282308|580945424|FG001|Treatment Period|Adverse Event|2|||
160877601|NCT00282308|580945425|FG002|Treatment Period|Adverse Event|0|||
160877602|NCT00282308|580945423|FG000|Treatment Period|Not Treated with Study Drug|1|||
160877603|NCT00282308|580945424|FG001|Treatment Period|Not Treated with Study Drug|0|||
160877604|NCT00282308|580945425|FG002|Treatment Period|Not Treated with Study Drug|0|||
160877605|NCT00282308|580945423|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
160877606|NCT00282308|580945424|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
160877607|NCT00282308|580945425|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
160877608|NCT00282308|580945423|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
160877609|NCT00282308|580945424|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
160877610|NCT00282308|580945425|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
160877611|NCT00282308|580945423|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
160877612|NCT00282308|580945424|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
160877613|NCT00282308|580945425|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
160877614|NCT00282308|580945423|FG000|Safety Follow-up Period|Adverse Event|0|||
160877615|NCT00282308|580945424|FG001|Safety Follow-up Period|Adverse Event|0|||
160877616|NCT00282308|580945425|FG002|Safety Follow-up Period|Adverse Event|1|||
160877617|NCT00282308|580945423|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
160877618|NCT00282308|580945424|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
160877619|NCT00282308|580945425|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
160877620|NCT00282308|580945423|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
160877621|NCT00282308|580945424|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
160877622|NCT00282308|580945425|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
160877623|NCT00282308|580945423|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
160877624|NCT00282308|580945424|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
160877625|NCT00282308|580945425|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
160877626|NCT02660983|580945426|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
160877627|NCT02660983|580945427|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
160877628|NCT02660983|580945426|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
160877629|NCT02660983|580945427|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
160877630|NCT02660983|580945426|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
160877631|NCT02660983|580945427|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
160877632|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
160877633|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
160877634|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
160877635|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
160877636|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
160877637|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
160877638|NCT02660983|580945426|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
160877639|NCT02660983|580945427|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
161120191|NCT00137111|581827130|FG002|Total Therapy|Non Compliance|0|||
161120192|NCT00137111|581827131|FG003|Total Therapy|Non Compliance|0|||
161120193|NCT00088374|581827132|FG000|Overall Study|patient did not receive any 17AAG|1|||
161120194|NCT00088374|581827132|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
161120195|NCT00852995|581827133|FG000|Overall Study|Adverse Event|1|||
161120196|NCT00852995|581827134|FG001|Overall Study|Adverse Event|0|||
161120197|NCT00852995|581827135|FG002|Overall Study|Adverse Event|4|||
160877640|NCT00721968|580945430|FG000|Overall Study|Lost to Follow-up|2|||
160877641|NCT00721968|580945431|FG001|Overall Study|Lost to Follow-up|0|||
160877642|NCT03374202|580945432|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
160877643|NCT03374202|580945433|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
160877644|NCT03374202|580945434|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
160877645|NCT03374202|580945432|FG000|Five Year Long Term Follow Up|Death|0|||
160877646|NCT03374202|580945433|FG001|Five Year Long Term Follow Up|Death|1|||
160877647|NCT03374202|580945434|FG002|Five Year Long Term Follow Up|Death|0|||
160877648|NCT00361634|580947285|FG000|Overall Study|Lost to Follow-up|1|||
160877649|NCT00361634|580947285|FG000|Overall Study|Withdrawal by Subject|1|||
160877650|NCT05315908|580947286|FG000|Overall Study|Lost to Follow-up|4477|||
160877651|NCT05315908|580947287|FG001|Overall Study|Lost to Follow-up|4606|||
160877652|NCT00505076|580947296|FG000|Overall Study|Adverse Event|1|||
160877653|NCT00505076|580947297|FG001|Overall Study|Adverse Event|0|||
160877654|NCT00505076|580947298|FG002|Overall Study|Adverse Event|1|||
160877655|NCT00505076|580947296|FG000|Overall Study|Protocol Violation|2|||
160877656|NCT00505076|580947297|FG001|Overall Study|Protocol Violation|1|||
160877657|NCT00505076|580947298|FG002|Overall Study|Protocol Violation|2|||
160877658|NCT00505076|580947296|FG000|Overall Study|Withdrawal by Subject|0|||
160877659|NCT00505076|580947297|FG001|Overall Study|Withdrawal by Subject|1|||
160877660|NCT00505076|580947298|FG002|Overall Study|Withdrawal by Subject|2|||
160877661|NCT01541397|580947299|FG000|Overall Study|Study ended prior to data collection|4|||
160877662|NCT01541397|580947300|FG001|Overall Study|Study ended prior to data collection|2|||
160877663|NCT00233454|580947303|FG000|Overall Study|Death|6|||
160877664|NCT04224688|580947304|FG000|Overall Study|Withdrawal by Subject|1|||
160877665|NCT04224688|580947305|FG001|Overall Study|Withdrawal by Subject|3|||
160877666|NCT04224688|580947304|FG000|Overall Study|Lack of Efficacy|1|||
160877667|NCT04224688|580947305|FG001|Overall Study|Lack of Efficacy|1|||
160877668|NCT04224688|580947304|FG000|Overall Study|Adverse event, not fatal|0|||
160877669|NCT04224688|580947305|FG001|Overall Study|Adverse event, not fatal|2|||
160877670|NCT04224688|580947304|FG000|Overall Study|COVID-19|0|||
160877671|NCT04224688|580947305|FG001|Overall Study|COVID-19|1|||
160877672|NCT03595228|580947306|FG000|Overall Study|Death|2|||
160877673|NCT03595228|580947306|FG000|Overall Study|Lack of Efficacy|13|||
160877674|NCT03595228|580947306|FG000|Overall Study|Withdrawal by Subject|3|||
160877675|NCT03595228|580947306|FG000|Overall Study|Withdrawal by Sponsor|1|||
160877676|NCT01639729|580947307|FG000|Overall Study|Withdrawal by Subject|1|||
160877677|NCT01639729|580947308|FG001|Overall Study|Withdrawal by Subject|0|||
160877678|NCT01639729|580947309|FG002|Overall Study|Withdrawal by Subject|1|||
160877679|NCT01639729|580947310|FG003|Overall Study|Withdrawal by Subject|1|||
160877680|NCT01639729|580947311|FG004|Overall Study|Withdrawal by Subject|0|||
160877681|NCT01639729|580947312|FG005|Overall Study|Withdrawal by Subject|0|||
160877682|NCT03232333|580947313|FG000|Overall Study|Infection or Osteomyelitis|9|||
160877683|NCT03232333|580947313|FG000|Overall Study|Lost to Follow-up|4|||
160877684|NCT03232333|580947313|FG000|Overall Study|Withdrawal by Subject|2|||
160877685|NCT01155011|580947314|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
160877686|NCT01155011|580947315|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
160877687|NCT01155011|580947314|FG000|Baseline to 6 Months|investigator decision, moved|4|||
160877688|NCT01155011|580947315|FG001|Baseline to 6 Months|investigator decision, moved|5|||
160877689|NCT01155011|580947314|FG000|Baseline to 6 Months|Death|0|||
160877690|NCT01155011|580947315|FG001|Baseline to 6 Months|Death|1|||
160877691|NCT01155011|580947314|FG000|6 to 12 Months|Withdrawal by Subject|8|||
160877692|NCT01155011|580947315|FG001|6 to 12 Months|Withdrawal by Subject|5|||
160877693|NCT01155011|580947314|FG000|6 to 12 Months|Death|1|||
160877694|NCT01155011|580947315|FG001|6 to 12 Months|Death|5|||
160877695|NCT01087736|580947316|FG000|Overall Study|Lost to Follow-up|1|||
160877696|NCT01087736|580947317|FG001|Overall Study|Lost to Follow-up|0|||
160877697|NCT01087736|580947316|FG000|Overall Study|Death|0|||
160877698|NCT01087736|580947317|FG001|Overall Study|Death|1|||
160877699|NCT01087736|580947316|FG000|Overall Study|Withdrawal by Subject|0|||
160877700|NCT01087736|580947317|FG001|Overall Study|Withdrawal by Subject|1|||
160877701|NCT01253811|580947318|FG000|Overall Study|Withdrawal criteria|1|||
160877702|NCT00759564|580947319|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877703|NCT00759564|580947320|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877704|NCT00759564|580947321|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877705|NCT00759564|580947322|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
160877706|NCT00759564|580947323|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
160877707|NCT01565343|580947324|FG000|Overall Study|Administrative decision/technical issues|1|||
160877708|NCT01565343|580947325|FG001|Overall Study|Administrative decision/technical issues|0|||
160877709|NCT01565343|580947326|FG002|Overall Study|Administrative decision/technical issues|0|||
160877710|NCT01989208|580947329|FG000|200 mg (7 Days)|Protocol Violation|0|||
160877711|NCT01989208|580947330|FG001|200 mg (7 Days)|Protocol Violation|1|||
160877712|NCT04975438|580947331|FG000|Overall Study|Lost to Follow-up|1|||
160877713|NCT04975438|580947332|FG001|Overall Study|Lost to Follow-up|0|||
160877714|NCT04975438|580947333|FG002|Overall Study|Lost to Follow-up|1|||
160877715|NCT04975438|580947334|FG003|Overall Study|Lost to Follow-up|0|||
161120198|NCT00852995|581827136|FG003|Overall Study|Adverse Event|0|||
161120199|NCT00852995|581827137|FG004|Overall Study|Adverse Event|0|||
161120200|NCT00852995|581827133|FG000|Overall Study|Lost to Follow-up|0|||
161120201|NCT00852995|581827134|FG001|Overall Study|Lost to Follow-up|1|||
161120202|NCT00852995|581827135|FG002|Overall Study|Lost to Follow-up|1|||
161120203|NCT00852995|581827136|FG003|Overall Study|Lost to Follow-up|0|||
161120204|NCT00852995|581827137|FG004|Overall Study|Lost to Follow-up|0|||
161120205|NCT00852995|581827133|FG000|Overall Study|Withdrawal by Subject|4|||
161120206|NCT00852995|581827134|FG001|Overall Study|Withdrawal by Subject|0|||
160877716|NCT04975438|580947331|FG000|Overall Study|Withdrawal by Subject|1|||
160877717|NCT04975438|580947332|FG001|Overall Study|Withdrawal by Subject|0|||
160877718|NCT04975438|580947333|FG002|Overall Study|Withdrawal by Subject|0|||
160877719|NCT04975438|580947334|FG003|Overall Study|Withdrawal by Subject|0|||
160877720|NCT04973436|580947335|FG000|Overall Study|Lost to Follow-up|3|||
160877721|NCT04973436|580947335|FG000|Overall Study|Withdrawal by Subject|1|||
160877722|NCT04973436|580947335|FG000|Overall Study|Death|2|||
160877723|NCT01798849|580947339|FG000|Overall Study|Physician Decision|0|||
160877724|NCT01798849|580947340|FG001|Overall Study|Physician Decision|0|||
160877725|NCT01798849|580947341|FG002|Overall Study|Physician Decision|1|||
160877726|NCT00743106|580947342|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
160877727|NCT00743106|580947343|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
160877728|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
160877729|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
160877730|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
160877731|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
160877732|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Death|3|||
160877733|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Death|0|||
160877734|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Death|0|||
160877735|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Death|0|||
161120207|NCT00852995|581827135|FG002|Overall Study|Withdrawal by Subject|0|||
161120208|NCT00852995|581827136|FG003|Overall Study|Withdrawal by Subject|1|||
161120209|NCT00852995|581827137|FG004|Overall Study|Withdrawal by Subject|2|||
161120210|NCT00852995|581827133|FG000|Overall Study|Non-Compliance|0|||
161120211|NCT00852995|581827134|FG001|Overall Study|Non-Compliance|0|||
161120212|NCT00852995|581827135|FG002|Overall Study|Non-Compliance|0|||
161120213|NCT00852995|581827136|FG003|Overall Study|Non-Compliance|2|||
161120214|NCT00852995|581827137|FG004|Overall Study|Non-Compliance|0|||
161120215|NCT00852995|581827133|FG000|Overall Study|Progressive Disease|1|||
161120216|NCT00852995|581827134|FG001|Overall Study|Progressive Disease|0|||
161120217|NCT00852995|581827135|FG002|Overall Study|Progressive Disease|0|||
161120218|NCT00852995|581827136|FG003|Overall Study|Progressive Disease|2|||
161120219|NCT00852995|581827137|FG004|Overall Study|Progressive Disease|1|||
161120220|NCT00852995|581827133|FG000|Overall Study|Physician Decision|1|||
161120221|NCT00852995|581827134|FG001|Overall Study|Physician Decision|0|||
161120222|NCT00852995|581827135|FG002|Overall Study|Physician Decision|0|||
161120223|NCT00852995|581827136|FG003|Overall Study|Physician Decision|0|||
161120224|NCT00852995|581827137|FG004|Overall Study|Physician Decision|0|||
161120225|NCT00852995|581827133|FG000|Overall Study|Protocol Violation|0|||
161120226|NCT00852995|581827134|FG001|Overall Study|Protocol Violation|0|||
161120227|NCT00852995|581827135|FG002|Overall Study|Protocol Violation|0|||
161120228|NCT00852995|581827136|FG003|Overall Study|Protocol Violation|0|||
161120229|NCT00852995|581827137|FG004|Overall Study|Protocol Violation|1|||
161120230|NCT00852995|581827133|FG000|Overall Study|Moved Out of Area|1|||
161120231|NCT00852995|581827134|FG001|Overall Study|Moved Out of Area|0|||
161120232|NCT00852995|581827135|FG002|Overall Study|Moved Out of Area|0|||
161120233|NCT00852995|581827136|FG003|Overall Study|Moved Out of Area|0|||
161120234|NCT00852995|581827137|FG004|Overall Study|Moved Out of Area|0|||
161120235|NCT01110200|581827138|FG000|Overall Study|Adverse Event|28|||
161120236|NCT01110200|581827139|FG001|Overall Study|Adverse Event|28|||
161225207|NCT01505530|582205173|FG002|Overall Study|entry criteria not met|0|||
161120237|NCT01110200|581827138|FG000|Overall Study|Withdrawal by Subject|25|||
161120238|NCT01110200|581827139|FG001|Overall Study|Withdrawal by Subject|32|||
161120239|NCT01110200|581827138|FG000|Overall Study|Lack of Efficacy|16|||
161120240|NCT01110200|581827139|FG001|Overall Study|Lack of Efficacy|25|||
161120241|NCT01110200|581827138|FG000|Overall Study|Protocol Violation|14|||
161120242|NCT01110200|581827139|FG001|Overall Study|Protocol Violation|12|||
161120243|NCT01110200|581827138|FG000|Overall Study|Physician Decision|13|||
161120244|NCT01110200|581827139|FG001|Overall Study|Physician Decision|17|||
161120245|NCT01110200|581827138|FG000|Overall Study|Lost to Follow-up|10|||
161120246|NCT01110200|581827139|FG001|Overall Study|Lost to Follow-up|7|||
161120247|NCT05913232|581827143|FG000|Overall Study|Adverse Event|0|||
161120248|NCT05913232|581827144|FG001|Overall Study|Adverse Event|2|||
161225208|NCT01153984|582205179|FG000|Overall Study|Withdrawal by Subject|1|||
161120249|NCT05913232|581827145|FG002|Overall Study|Adverse Event|1|||
161120250|NCT05913232|581827146|FG003|Overall Study|Adverse Event|1|||
161120251|NCT04428476|581827149|FG000|Overall Study|Withdrawal by Subject|1|||
161120252|NCT04428476|581827149|FG000|Overall Study|Still on treatment|12|||
161120253|NCT02289950|581827156|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
161225209|NCT01153984|582205179|FG000|Overall Study|Adverse Event|1|||
161225210|NCT00973700|582205180|FG000|Overall Study|Withdrawal by Subject|2|||
161225211|NCT00973700|582205181|FG001|Overall Study|Withdrawal by Subject|2|||
161225212|NCT00973700|582205182|FG002|Overall Study|Withdrawal by Subject|8|||
161225213|NCT00973700|582205183|FG003|Overall Study|Withdrawal by Subject|4|||
161225214|NCT00973700|582205184|FG004|Overall Study|Withdrawal by Subject|4|||
161225215|NCT00973700|582205180|FG000|Overall Study|Lost to Follow-up|5|||
161225216|NCT00973700|582205181|FG001|Overall Study|Lost to Follow-up|0|||
161225217|NCT00973700|582205182|FG002|Overall Study|Lost to Follow-up|1|||
161225218|NCT00973700|582205183|FG003|Overall Study|Lost to Follow-up|8|||
161225219|NCT00973700|582205184|FG004|Overall Study|Lost to Follow-up|5|||
161225220|NCT00973700|582205180|FG000|Overall Study|Inappropriate enrolment|0|||
161225221|NCT00973700|582205181|FG001|Overall Study|Inappropriate enrolment|0|||
161225222|NCT00973700|582205182|FG002|Overall Study|Inappropriate enrolment|0|||
161225223|NCT00973700|582205183|FG003|Overall Study|Inappropriate enrolment|4|||
161225224|NCT00973700|582205184|FG004|Overall Study|Inappropriate enrolment|0|||
161225225|NCT00973700|582205180|FG000|Overall Study|Unable to Classify|0|||
161225226|NCT00973700|582205181|FG001|Overall Study|Unable to Classify|0|||
161225227|NCT00973700|582205182|FG002|Overall Study|Unable to Classify|1|||
161225228|NCT00973700|582205183|FG003|Overall Study|Unable to Classify|2|||
161225229|NCT00973700|582205184|FG004|Overall Study|Unable to Classify|1|||
161225230|NCT00290745|582205194|FG000|Overall Study|Withdrawal by Subject|4|||
161225231|NCT00290745|582205194|FG000|Overall Study|Physician Decision|2|||
161225232|NCT00290745|582205194|FG000|Overall Study|Surgery after 3 months for progression|3|||
161225233|NCT00290745|582205194|FG000|Overall Study|Baseline MRI not available|3|||
161225234|NCT00626925|582205197|FG000|Overall Study|Lost to Follow-up|1|||
161225235|NCT00626925|582205198|FG001|Overall Study|Lost to Follow-up|2|||
161225236|NCT00626925|582205197|FG000|Overall Study|relapse|1|||
161225237|NCT00626925|582205198|FG001|Overall Study|relapse|0|||
161225238|NCT00626925|582205197|FG000|Overall Study|Adverse effect|6|||
161225239|NCT00626925|582205198|FG001|Overall Study|Adverse effect|2|||
161225240|NCT00626925|582205197|FG000|Overall Study|Lack of Efficacy|1|||
161225241|NCT00626925|582205198|FG001|Overall Study|Lack of Efficacy|4|||
161225242|NCT00626925|582205197|FG000|Overall Study|Time constraints|3|||
161225243|NCT00626925|582205198|FG001|Overall Study|Time constraints|1|||
161225244|NCT00625807|582205201|FG000|Overall Study|schedule conflict|2|||
161225245|NCT00625807|582205202|FG001|Overall Study|schedule conflict|8|||
161225246|NCT01802879|582205203|FG000|Overall Study|Administrative problems|2|||
161225247|NCT01802879|582205203|FG000|Overall Study|Disease progression|6|||
161225248|NCT00266409|582205204|FG000|Overall Study|Lack of Efficacy|2|||
161225249|NCT00266409|582205205|FG001|Overall Study|Lack of Efficacy|6|||
161225250|NCT00266409|582205206|FG002|Overall Study|Lack of Efficacy|1|||
161225251|NCT00266409|582205207|FG003|Overall Study|Lack of Efficacy|2|||
161225252|NCT00266409|582205204|FG000|Overall Study|Adverse Event|7|||
161225253|NCT00266409|582205205|FG001|Overall Study|Adverse Event|2|||
161225254|NCT00266409|582205206|FG002|Overall Study|Adverse Event|1|||
161225255|NCT00266409|582205207|FG003|Overall Study|Adverse Event|1|||
161225256|NCT00266409|582205204|FG000|Overall Study|Lost to Follow-up|18|||
161225257|NCT00266409|582205205|FG001|Overall Study|Lost to Follow-up|21|||
161225258|NCT00266409|582205206|FG002|Overall Study|Lost to Follow-up|6|||
161225259|NCT00266409|582205207|FG003|Overall Study|Lost to Follow-up|8|||
161225260|NCT00266409|582205204|FG000|Overall Study|Withdrawal by Subject|6|||
161225261|NCT00266409|582205205|FG001|Overall Study|Withdrawal by Subject|10|||
161225262|NCT00266409|582205206|FG002|Overall Study|Withdrawal by Subject|3|||
161225263|NCT00266409|582205207|FG003|Overall Study|Withdrawal by Subject|9|||
161225264|NCT00266409|582205204|FG000|Overall Study|Protocol Violation|5|||
161225265|NCT00266409|582205205|FG001|Overall Study|Protocol Violation|3|||
161225266|NCT00266409|582205206|FG002|Overall Study|Protocol Violation|4|||
161225267|NCT00266409|582205207|FG003|Overall Study|Protocol Violation|2|||
161225268|NCT00266409|582205204|FG000|Overall Study|Other|7|||
161225269|NCT00266409|582205205|FG001|Overall Study|Other|4|||
161225270|NCT00266409|582205206|FG002|Overall Study|Other|2|||
161225271|NCT00266409|582205207|FG003|Overall Study|Other|0|||
161225272|NCT00108732|582205210|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
161225273|NCT00108732|582205210|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
161225274|NCT00108732|582205210|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
160877736|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
160877737|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
160877738|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
160877739|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
160877740|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
160877741|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
160877742|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
160877743|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
160877744|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
160877745|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
160877746|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
160877747|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
160877748|NCT00884741|580947355|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
160877749|NCT00884741|580947356|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
160877750|NCT00884741|580947357|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
160877751|NCT00884741|580947358|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
160877752|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
161120254|NCT02289950|581827157|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
161120255|NCT02289950|581827156|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
161120256|NCT02289950|581827157|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
161120257|NCT02289950|581827156|FG000|Overall Study|Lost to Follow-up|1|||
161120258|NCT02289950|581827157|FG001|Overall Study|Lost to Follow-up|0|||
161120259|NCT02289950|581827156|FG000|Overall Study|Physician Decision|9|||
161120260|NCT02289950|581827157|FG001|Overall Study|Physician Decision|3|||
161120261|NCT02289950|581827156|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
161120262|NCT02289950|581827157|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
161120263|NCT02289950|581827156|FG000|Overall Study|Withdrawal by Subject|1|||
161120264|NCT02289950|581827157|FG001|Overall Study|Withdrawal by Subject|3|||
161120265|NCT02289950|581827156|FG000|Overall Study|Test article held for greater than 28 days|0|||
161120266|NCT02289950|581827157|FG001|Overall Study|Test article held for greater than 28 days|1|||
161120267|NCT02289950|581827156|FG000|Overall Study|Adverse Event|11|||
161120268|NCT02289950|581827157|FG001|Overall Study|Adverse Event|3|||
161120269|NCT02289950|581827156|FG000|Overall Study|Death|1|||
161120270|NCT02289950|581827157|FG001|Overall Study|Death|1|||
161120271|NCT02289950|581827156|FG000|Overall Study|Other|5|||
161120272|NCT02289950|581827157|FG001|Overall Study|Other|2|||
161120273|NCT02289950|581827156|FG000|Overall Study|Not Treated|2|||
161120274|NCT02289950|581827157|FG001|Overall Study|Not Treated|1|||
161120275|NCT04518462|581827158|FG000|Overall Study|Withdrawal by Subject|0|||
161120276|NCT04518462|581827159|FG001|Overall Study|Withdrawal by Subject|0|||
161120277|NCT04518462|581827160|FG002|Overall Study|Withdrawal by Subject|1|||
161120278|NCT04518462|581827158|FG000|Overall Study|Physician Decision|1|||
161120279|NCT04518462|581827159|FG001|Overall Study|Physician Decision|1|||
161120280|NCT04518462|581827160|FG002|Overall Study|Physician Decision|0|||
161120281|NCT00271817|581827161|FG000|Part 1|Adverse Event|68|||
161120282|NCT00271817|581827162|FG001|Part 1|Adverse Event|25|||
161120283|NCT00271817|581827163|FG002|Part 1|Adverse Event|156|||
161120284|NCT00271817|581827161|FG000|Part 1|Lost to Follow-up|6|||
161120285|NCT00271817|581827162|FG001|Part 1|Lost to Follow-up|8|||
161120286|NCT00271817|581827163|FG002|Part 1|Lost to Follow-up|24|||
161120287|NCT00271817|581827161|FG000|Part 1|Protocol Violation|5|||
161120288|NCT00271817|581827162|FG001|Part 1|Protocol Violation|4|||
161120289|NCT00271817|581827163|FG002|Part 1|Protocol Violation|7|||
161120290|NCT00271817|581827161|FG000|Part 1|Patient Moved|3|||
161225275|NCT00108732|582205210|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
161225276|NCT00108732|582205210|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
161225277|NCT00108732|582205210|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
160877753|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
160877754|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
160877755|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
160877756|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
160877757|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
160877758|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
160877759|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
160877760|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
160877761|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
160877762|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
160877763|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
161225278|NCT00108732|582205210|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
161225279|NCT01946165|582205212|FG000|Overall Study|Physician Decision|2|||
161225280|NCT01946165|582205213|FG001|Overall Study|Physician Decision|0|||
161225281|NCT01946165|582205212|FG000|Overall Study|Withdrawal by Subject|0|||
161225282|NCT01946165|582205213|FG001|Overall Study|Withdrawal by Subject|2|||
161225283|NCT01659567|582205214|FG000|Overall Study|Lack of Efficacy|22|||
161225284|NCT01659567|582205214|FG000|Overall Study|Switched to Pegferon|6|||
161225285|NCT01659567|582205214|FG000|Overall Study|Adverse Event|12|||
161225286|NCT01659567|582205214|FG000|Overall Study|Good result at early stage of treatment|5|||
160877764|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
161225287|NCT01659567|582205214|FG000|Overall Study|Withdrawal by Subject|64|||
161225288|NCT01659567|582205214|FG000|Overall Study|Progression of the main disease|1|||
161225289|NCT01659567|582205214|FG000|Overall Study|Other|13|||
161225290|NCT01179919|582205217|FG000|Overall Study|Protocol Violation|1|||
161225291|NCT01179919|582205217|FG000|Overall Study|Adverse Event|1|||
161225292|NCT01915732|582205223|FG000|Overall Study|Withdrawal by Subject|18|||
161225293|NCT01915732|582205224|FG001|Overall Study|Withdrawal by Subject|18|||
161225294|NCT01915732|582205223|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161225295|NCT01915732|582205224|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161225296|NCT01915732|582205223|FG000|Overall Study|Adverse Event|12|||
161225297|NCT01915732|582205224|FG001|Overall Study|Adverse Event|4|||
161225298|NCT01915732|582205223|FG000|Overall Study|Protocol Violation|5|||
161225299|NCT01915732|582205224|FG001|Overall Study|Protocol Violation|5|||
161225300|NCT01915732|582205223|FG000|Overall Study|Lack of Efficacy|6|||
161225301|NCT01915732|582205224|FG001|Overall Study|Lack of Efficacy|11|||
161225302|NCT01915732|582205223|FG000|Overall Study|Lost to Follow-up|22|||
161225303|NCT01915732|582205224|FG001|Overall Study|Lost to Follow-up|26|||
161225304|NCT01915732|582205223|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
161225305|NCT01915732|582205224|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
161225306|NCT01915732|582205223|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
161225307|NCT01915732|582205224|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
161225308|NCT01915732|582205223|FG000|Overall Study|Drug Release Error|1|||
161225309|NCT01915732|582205224|FG001|Overall Study|Drug Release Error|0|||
161225310|NCT01915732|582205223|FG000|Overall Study|Recovered|1|||
161225311|NCT01915732|582205224|FG001|Overall Study|Recovered|0|||
161225312|NCT01915732|582205223|FG000|Overall Study|Pregnancy|1|||
161225313|NCT01915732|582205224|FG001|Overall Study|Pregnancy|0|||
161225314|NCT01915732|582205223|FG000|Overall Study|Poor Perceived Efficacy|1|||
161225315|NCT01915732|582205224|FG001|Overall Study|Poor Perceived Efficacy|0|||
161225316|NCT01915732|582205223|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
161225317|NCT01915732|582205224|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
161225318|NCT01915732|582205223|FG000|Overall Study|Got Well|0|||
161225319|NCT01915732|582205224|FG001|Overall Study|Got Well|1|||
161225320|NCT01915732|582205223|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
160877765|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
160877766|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
160877767|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
160877768|NCT00884741|580947355|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
160877769|NCT00884741|580947356|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
160877770|NCT00884741|580947357|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
161225321|NCT01915732|582205224|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
161225322|NCT01915732|582205223|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
161225323|NCT01915732|582205224|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
161225324|NCT01915732|582205223|FG000|Overall Study|Job Transfer|0|||
161225325|NCT01915732|582205224|FG001|Overall Study|Job Transfer|1|||
160877771|NCT00884741|580947358|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
160877772|NCT00884741|580947355|FG000|Randomization|Protocol Violation|0|||
160877773|NCT00884741|580947356|FG001|Randomization|Protocol Violation|0|||
160877774|NCT00884741|580947357|FG002|Randomization|Protocol Violation|8|||
160877775|NCT00884741|580947358|FG003|Randomization|Protocol Violation|8|||
161225326|NCT01915732|582205223|FG000|Overall Study|Improper Facial Procedure|0|||
161225327|NCT01915732|582205224|FG001|Overall Study|Improper Facial Procedure|1|||
161225328|NCT01915732|582205223|FG000|Overall Study|Poor Conscious Effect|0|||
161225329|NCT01915732|582205224|FG001|Overall Study|Poor Conscious Effect|1|||
161225330|NCT00698685|582205225|FG000|Overall Study|Sister withdrew as donor|1|||
161225331|NCT00698685|582205225|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
161225332|NCT01325207|582205226|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161225333|NCT01325207|582205227|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161225334|NCT01325207|582205228|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161225335|NCT01325207|582205229|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
161225336|NCT01325207|582205230|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
161225337|NCT01325207|582205231|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
160877776|NCT04784442|580947359|FG000|Overall Study|Adverse Event|1|||
160877777|NCT04784442|580947360|FG001|Overall Study|Adverse Event|0|||
160877778|NCT04784442|580947361|FG002|Overall Study|Adverse Event|2|||
160877779|NCT04784442|580947362|FG003|Overall Study|Adverse Event|1|||
160877780|NCT04784442|580947359|FG000|Overall Study|Protocol Violation|1|||
160877781|NCT04784442|580947360|FG001|Overall Study|Protocol Violation|0|||
160877782|NCT04784442|580947361|FG002|Overall Study|Protocol Violation|0|||
160877783|NCT04784442|580947362|FG003|Overall Study|Protocol Violation|0|||
160877784|NCT04784442|580947359|FG000|Overall Study|Non-compliance with study drug|1|||
160877785|NCT04784442|580947360|FG001|Overall Study|Non-compliance with study drug|0|||
160877786|NCT04784442|580947361|FG002|Overall Study|Non-compliance with study drug|0|||
160877787|NCT04784442|580947362|FG003|Overall Study|Non-compliance with study drug|0|||
160877788|NCT03500224|580947363|FG000|Overall Study|Withdrawal by Subject|2|||
160877789|NCT02969655|580947364|FG000|Overall Study|Withdrawal by Subject|3|||
160877790|NCT02969655|580947365|FG001|Overall Study|Withdrawal by Subject|2|||
160877791|NCT02969655|580947364|FG000|Overall Study|Physician Decision|4|||
160877792|NCT02969655|580947365|FG001|Overall Study|Physician Decision|3|||
160877793|NCT02969655|580947364|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
160877794|NCT02969655|580947365|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
160877795|NCT02969655|580947364|FG000|Overall Study|Adverse Event|10|||
160877796|NCT02969655|580947365|FG001|Overall Study|Adverse Event|8|||
160877797|NCT00929643|580947366|FG000|Overall Study|Protocol Violation|2|||
160877798|NCT00145977|580947370|FG000|Overall Study|Lack of Efficacy|0|||
160877799|NCT00145977|580947371|FG001|Overall Study|Lack of Efficacy|4|||
160877800|NCT00145977|580947370|FG000|Overall Study|Lost to Follow-up|1|||
160877801|NCT00145977|580947371|FG001|Overall Study|Lost to Follow-up|0|||
161225338|NCT01325207|582205226|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
161225339|NCT01325207|582205227|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
161225340|NCT01325207|582205228|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
161225341|NCT01325207|582205229|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
161225342|NCT01325207|582205230|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
161225343|NCT01325207|582205231|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
161225344|NCT01325207|582205226|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161225345|NCT01325207|582205227|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161225346|NCT01325207|582205228|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161225347|NCT01325207|582205229|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
161225348|NCT01325207|582205230|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
161225349|NCT01325207|582205231|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
161225350|NCT01325207|582205226|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161225351|NCT01325207|582205227|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
161225352|NCT01325207|582205228|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161225353|NCT01325207|582205229|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161225354|NCT01325207|582205230|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161225355|NCT01325207|582205231|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
161225356|NCT01325207|582205226|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161225357|NCT01325207|582205227|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161225358|NCT01325207|582205228|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161225359|NCT01325207|582205229|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161225360|NCT01325207|582205230|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
161225361|NCT01325207|582205231|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
161225362|NCT01325207|582205226|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161225363|NCT01325207|582205227|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161225364|NCT01325207|582205228|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161225365|NCT01325207|582205229|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161225366|NCT01325207|582205230|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
161225367|NCT01325207|582205231|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
161225368|NCT01325207|582205226|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161225369|NCT01325207|582205227|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161225370|NCT01325207|582205228|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161225371|NCT01325207|582205229|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
161225372|NCT01325207|582205230|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
161225373|NCT01325207|582205231|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
160877802|NCT00145977|580947370|FG000|Overall Study|Withdrawal by Subject|1|||
160877803|NCT00145977|580947371|FG001|Overall Study|Withdrawal by Subject|0|||
160877804|NCT02717832|580947374|FG000|Overall Study|Inability to place IV|3|||
160877805|NCT01711216|580947375|FG000|Overall Study|Adverse Event|4|||
160877806|NCT01711216|580947375|FG000|Overall Study|Pregnancy|56|||
160877807|NCT01711216|580947375|FG000|Overall Study|Withdrawal by Subject|6|||
160877808|NCT01711216|580947375|FG000|Overall Study|Lost to Follow-up|46|||
160877809|NCT01711216|580947375|FG000|Overall Study|variety of other minor reasons|83|||
160877810|NCT01711216|580947375|FG000|Overall Study|no reason specified|22|||
160877811|NCT03060551|580947376|FG000|Overall Study|Withdrawal by Subject|1|||
160877812|NCT03060551|580947376|FG000|Overall Study|Adverse Event|1|||
160877813|NCT03698591|580947379|FG000|Overall Study|Withdrawal by Subject|2|||
160877814|NCT03698591|580947380|FG001|Overall Study|Withdrawal by Subject|2|||
160877815|NCT03698591|580947379|FG000|Overall Study|Failed drug screen|1|||
160877816|NCT03698591|580947380|FG001|Overall Study|Failed drug screen|1|||
161225374|NCT00708422|582205232|FG000|Overall Study|Adverse Event|3|||
161225375|NCT00708422|582205233|FG001|Overall Study|Adverse Event|1|||
161225376|NCT00708422|582205232|FG000|Overall Study|Withdrawal by Subject|1|||
161225377|NCT00708422|582205233|FG001|Overall Study|Withdrawal by Subject|0|||
161225378|NCT01254409|582205234|FG000|Overall Study|Adverse Event|0|||
161225379|NCT01254409|582205235|FG001|Overall Study|Adverse Event|1|||
161225380|NCT01254409|582205236|FG002|Overall Study|Adverse Event|0|||
161225381|NCT01254409|582205237|FG003|Overall Study|Adverse Event|0|||
161225382|NCT00337571|582205243|FG000|Overall Study|Lack of Efficacy|3|||
161225383|NCT00337571|582205244|FG001|Overall Study|Lack of Efficacy|0|||
161225384|NCT00337571|582205245|FG002|Overall Study|Lack of Efficacy|0|||
161225385|NCT00337571|582205246|FG003|Overall Study|Lack of Efficacy|0|||
161225386|NCT00337571|582205243|FG000|Overall Study|Adverse Event|4|||
161225387|NCT00337571|582205244|FG001|Overall Study|Adverse Event|5|||
160877817|NCT03698591|580947379|FG000|Overall Study|Failed health screen|0|||
160877818|NCT03698591|580947380|FG001|Overall Study|Failed health screen|1|||
160877819|NCT03698591|580947379|FG000|Overall Study|Ineligible for financial compensation|1|||
160877820|NCT03698591|580947380|FG001|Overall Study|Ineligible for financial compensation|0|||
160877821|NCT03698591|580947379|FG000|Overall Study|Equipment Error|1|||
160877822|NCT03698591|580947380|FG001|Overall Study|Equipment Error|0|||
160877823|NCT03698591|580947379|FG000|Overall Study|Could not establish TMS dosage|0|||
160877824|NCT03698591|580947380|FG001|Overall Study|Could not establish TMS dosage|1|||
160877825|NCT04303195|580947387|FG000|Overall Study|Adverse Event|1|||
160877826|NCT04303195|580947388|FG001|Overall Study|Adverse Event|3|||
160877827|NCT04303195|580947389|FG002|Overall Study|Adverse Event|7|||
160877828|NCT04303195|580947390|FG003|Overall Study|Adverse Event|0|||
160877829|NCT04303195|580947387|FG000|Overall Study|Lost to Follow-up|1|||
160877830|NCT04303195|580947388|FG001|Overall Study|Lost to Follow-up|0|||
160877831|NCT04303195|580947389|FG002|Overall Study|Lost to Follow-up|1|||
160877832|NCT04303195|580947390|FG003|Overall Study|Lost to Follow-up|4|||
160877833|NCT04303195|580947387|FG000|Overall Study|Withdrawal by Subject|3|||
160877834|NCT04303195|580947388|FG001|Overall Study|Withdrawal by Subject|1|||
160877835|NCT04303195|580947389|FG002|Overall Study|Withdrawal by Subject|1|||
160877836|NCT04303195|580947390|FG003|Overall Study|Withdrawal by Subject|1|||
160877837|NCT04303195|580947387|FG000|Overall Study|No study drug administered or protocol deviation|0|||
160877838|NCT04303195|580947388|FG001|Overall Study|No study drug administered or protocol deviation|2|||
160877839|NCT04303195|580947389|FG002|Overall Study|No study drug administered or protocol deviation|0|||
160877840|NCT04303195|580947390|FG003|Overall Study|No study drug administered or protocol deviation|2|||
160877841|NCT01064947|580947391|FG000|Overall Study|negative culture|41|||
160877842|NCT02970942|580947394|FG000|Overall Study|Death|0|||
160877843|NCT02970942|580947395|FG001|Overall Study|Death|1|||
160877844|NCT02970942|580947396|FG002|Overall Study|Death|0|||
160877845|NCT02970942|580947397|FG003|Overall Study|Death|0|||
160877846|NCT02970942|580947394|FG000|Overall Study|Lost to Follow-up|1|||
160877847|NCT02970942|580947395|FG001|Overall Study|Lost to Follow-up|0|||
160877848|NCT02970942|580947396|FG002|Overall Study|Lost to Follow-up|2|||
160877849|NCT02970942|580947397|FG003|Overall Study|Lost to Follow-up|1|||
160877850|NCT02970942|580947394|FG000|Overall Study|Withdrawal by Subject|3|||
160877851|NCT02970942|580947395|FG001|Overall Study|Withdrawal by Subject|5|||
160877852|NCT02970942|580947396|FG002|Overall Study|Withdrawal by Subject|3|||
160877853|NCT02970942|580947397|FG003|Overall Study|Withdrawal by Subject|2|||
160877854|NCT06457204|580947400|FG000|Washout|Adverse Event|0|||
160877855|NCT06457204|580947401|FG001|Washout|Adverse Event|2|||
160877856|NCT01457352|580947404|FG000|Period 1|Adverse Event|2|||
160877857|NCT01457352|580947405|FG001|Period 1|Adverse Event|0|||
160877858|NCT01457352|580947404|FG000|Period 1|Withdrawal by Subject|2|||
160877859|NCT01457352|580947405|FG001|Period 1|Withdrawal by Subject|0|||
160877860|NCT01457352|580947404|FG000|Period 1|Physician Decision|2|||
160877861|NCT01457352|580947405|FG001|Period 1|Physician Decision|0|||
161225388|NCT00337571|582205245|FG002|Overall Study|Adverse Event|8|||
161324564|NCT01381926|582575627|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
160877862|NCT01457352|580947404|FG000|Period 1|MS related disease progression|1|||
160877863|NCT01457352|580947405|FG001|Period 1|MS related disease progression|0|||
160877864|NCT01457352|580947404|FG000|Period 1|Withdrawn|1|||
160877865|NCT01457352|580947405|FG001|Period 1|Withdrawn|0|||
160877866|NCT01457352|580947404|FG000|Period 1|withdrew per sponsor|1|||
160877867|NCT01457352|580947405|FG001|Period 1|withdrew per sponsor|0|||
161225389|NCT00337571|582205246|FG003|Overall Study|Adverse Event|4|||
161225390|NCT00337571|582205243|FG000|Overall Study|Withdrawal by Subject|2|||
161225391|NCT00337571|582205244|FG001|Overall Study|Withdrawal by Subject|2|||
161225392|NCT00337571|582205245|FG002|Overall Study|Withdrawal by Subject|1|||
161225393|NCT00337571|582205246|FG003|Overall Study|Withdrawal by Subject|0|||
161225394|NCT00337571|582205243|FG000|Overall Study|Lost to Follow-up|3|||
161225395|NCT00337571|582205244|FG001|Overall Study|Lost to Follow-up|1|||
161225396|NCT00337571|582205245|FG002|Overall Study|Lost to Follow-up|0|||
160877868|NCT01457352|580947404|FG000|Period 1|Protocol Violation|4|||
160877869|NCT01457352|580947405|FG001|Period 1|Protocol Violation|0|||
160877870|NCT01457352|580947404|FG000|Period 1|Did not meet eligibility criteria|3|||
160877871|NCT01457352|580947405|FG001|Period 1|Did not meet eligibility criteria|0|||
160877872|NCT01457352|580947404|FG000|Period 2|Withdrawal by Subject|23|||
160877873|NCT01457352|580947405|FG001|Period 2|Withdrawal by Subject|0|||
160877874|NCT01457352|580947404|FG000|Period 2|Adverse Event|22|||
160877875|NCT01457352|580947405|FG001|Period 2|Adverse Event|0|||
160877876|NCT01457352|580947404|FG000|Period 2|no analysis|10|||
160877877|NCT01457352|580947405|FG001|Period 2|no analysis|0|||
160877878|NCT01457352|580947404|FG000|Period 2|Lack of Efficacy|8|||
161120291|NCT00271817|581827162|FG001|Part 1|Patient Moved|1|||
161120292|NCT00271817|581827163|FG002|Part 1|Patient Moved|5|||
161120293|NCT00271817|581827161|FG000|Part 1|Withdrawal by Subject|23|||
161120294|NCT00271817|581827162|FG001|Part 1|Withdrawal by Subject|17|||
161120295|NCT00271817|581827163|FG002|Part 1|Withdrawal by Subject|45|||
161120296|NCT00271817|581827161|FG000|Part 1|LDL < 50 mg/dL|1|||
161120297|NCT00271817|581827162|FG001|Part 1|LDL < 50 mg/dL|4|||
161120298|NCT00271817|581827163|FG002|Part 1|LDL < 50 mg/dL|48|||
161120299|NCT00271817|581827161|FG000|Part 2|Adverse Event|0|||
161120300|NCT00271817|581827162|FG001|Part 2|Adverse Event|17|||
161120301|NCT00271817|581827163|FG002|Part 2|Adverse Event|33|||
161120302|NCT00271817|581827161|FG000|Part 2|Lack of Efficacy|0|||
161120303|NCT00271817|581827162|FG001|Part 2|Lack of Efficacy|1|||
161120304|NCT00271817|581827163|FG002|Part 2|Lack of Efficacy|6|||
161120305|NCT00271817|581827161|FG000|Part 2|Lost to Follow-up|0|||
161120306|NCT00271817|581827162|FG001|Part 2|Lost to Follow-up|6|||
161120307|NCT00271817|581827163|FG002|Part 2|Lost to Follow-up|18|||
161120308|NCT00271817|581827161|FG000|Part 2|Protocol Violation|0|||
161120309|NCT00271817|581827162|FG001|Part 2|Protocol Violation|3|||
161120310|NCT00271817|581827163|FG002|Part 2|Protocol Violation|5|||
161120311|NCT00271817|581827161|FG000|Part 2|Patient Moved|0|||
161120312|NCT00271817|581827162|FG001|Part 2|Patient Moved|0|||
161120313|NCT00271817|581827163|FG002|Part 2|Patient Moved|5|||
161120314|NCT00271817|581827161|FG000|Part 2|Withdrawal by Subject|0|||
161120315|NCT00271817|581827162|FG001|Part 2|Withdrawal by Subject|2|||
161120316|NCT00271817|581827163|FG002|Part 2|Withdrawal by Subject|13|||
161120317|NCT00271817|581827161|FG000|Part 2|LDL < 50 mg/dL|0|||
161120318|NCT00271817|581827162|FG001|Part 2|LDL < 50 mg/dL|3|||
161120319|NCT00271817|581827163|FG002|Part 2|LDL < 50 mg/dL|4|||
161225397|NCT00337571|582205246|FG003|Overall Study|Lost to Follow-up|1|||
161225398|NCT00337571|582205243|FG000|Overall Study|Poor/noncompliance|1|||
161225399|NCT00337571|582205244|FG001|Overall Study|Poor/noncompliance|1|||
161225400|NCT00337571|582205245|FG002|Overall Study|Poor/noncompliance|1|||
161225401|NCT00337571|582205246|FG003|Overall Study|Poor/noncompliance|1|||
161225402|NCT00337571|582205243|FG000|Overall Study|No longer met study criteria|1|||
161225403|NCT00337571|582205244|FG001|Overall Study|No longer met study criteria|0|||
161225404|NCT00337571|582205245|FG002|Overall Study|No longer met study criteria|0|||
161225405|NCT00337571|582205246|FG003|Overall Study|No longer met study criteria|0|||
161225406|NCT00337571|582205243|FG000|Overall Study|High Potassium level|0|||
161225407|NCT00337571|582205244|FG001|Overall Study|High Potassium level|0|||
161225408|NCT00337571|582205245|FG002|Overall Study|High Potassium level|0|||
161225409|NCT00337571|582205246|FG003|Overall Study|High Potassium level|1|||
161225410|NCT01890915|582205248|FG000|Overall Study|Adverse Event|1|||
161225411|NCT01890915|582205249|FG001|Overall Study|Adverse Event|0|||
161225412|NCT01890915|582205248|FG000|Overall Study|Protocol Violation|2|||
161225413|NCT01890915|582205249|FG001|Overall Study|Protocol Violation|0|||
161225414|NCT01890915|582205248|FG000|Overall Study|Equipment Malfunction|0|||
161225415|NCT01890915|582205249|FG001|Overall Study|Equipment Malfunction|1|||
161225416|NCT01974895|582205251|FG000|Overall Study|Protocol Violation|1|||
161225417|NCT01974895|582205252|FG001|Overall Study|Protocol Violation|0|||
161225418|NCT01974895|582205251|FG000|Overall Study|Lost to Follow-up|4|||
161225419|NCT01974895|582205252|FG001|Overall Study|Lost to Follow-up|6|||
161225420|NCT01974895|582205251|FG000|Overall Study|Withdrawal by Subject|0|||
161225421|NCT01974895|582205252|FG001|Overall Study|Withdrawal by Subject|1|||
161225422|NCT01974895|582205251|FG000|Overall Study|Other (Missed Visit)|1|||
161120320|NCT01471782|581827167|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
161120321|NCT01471782|581827168|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
161120322|NCT01471782|581827169|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
161120323|NCT01471782|581827170|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
161225423|NCT01974895|582205252|FG001|Overall Study|Other (Missed Visit)|0|||
161225424|NCT01974895|582205251|FG000|Overall Study|Other (Reason unknown)|9|||
160877879|NCT01457352|580947405|FG001|Period 2|Lack of Efficacy|0|||
160877880|NCT01457352|580947404|FG000|Period 2|Protocol Violation|4|||
160877881|NCT01457352|580947405|FG001|Period 2|Protocol Violation|0|||
161120324|NCT01471782|581827171|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
161120325|NCT01471782|581827172|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
161120326|NCT01471782|581827167|FG000|Overall Study|Lack of Efficacy|1|||
161120327|NCT01471782|581827168|FG001|Overall Study|Lack of Efficacy|2|||
161120328|NCT01471782|581827169|FG002|Overall Study|Lack of Efficacy|1|||
161120329|NCT01471782|581827170|FG003|Overall Study|Lack of Efficacy|1|||
161120330|NCT01471782|581827171|FG004|Overall Study|Lack of Efficacy|5|||
161120331|NCT01471782|581827172|FG005|Overall Study|Lack of Efficacy|18|||
161120332|NCT01471782|581827167|FG000|Overall Study|Adverse Event|1|||
161120333|NCT01471782|581827168|FG001|Overall Study|Adverse Event|1|||
161120334|NCT01471782|581827169|FG002|Overall Study|Adverse Event|2|||
161120335|NCT01471782|581827170|FG003|Overall Study|Adverse Event|2|||
161120336|NCT01471782|581827171|FG004|Overall Study|Adverse Event|3|||
161120337|NCT01471782|581827172|FG005|Overall Study|Adverse Event|1|||
161120338|NCT01471782|581827167|FG000|Overall Study|Other|0|||
161120339|NCT01471782|581827168|FG001|Overall Study|Other|0|||
161120340|NCT01471782|581827169|FG002|Overall Study|Other|1|||
161120341|NCT01471782|581827170|FG003|Overall Study|Other|1|||
161120342|NCT01471782|581827171|FG004|Overall Study|Other|6|||
161120343|NCT01471782|581827172|FG005|Overall Study|Other|5|||
161120344|NCT01471782|581827167|FG000|Overall Study|Change of Chemotherapy|1|||
161120345|NCT01471782|581827168|FG001|Overall Study|Change of Chemotherapy|1|||
161120346|NCT01471782|581827169|FG002|Overall Study|Change of Chemotherapy|0|||
161120347|NCT01471782|581827170|FG003|Overall Study|Change of Chemotherapy|0|||
161120348|NCT01471782|581827171|FG004|Overall Study|Change of Chemotherapy|1|||
161120349|NCT01471782|581827172|FG005|Overall Study|Change of Chemotherapy|4|||
161120350|NCT01471782|581827167|FG000|Overall Study|Disease Relapse|0|||
161120351|NCT01471782|581827168|FG001|Overall Study|Disease Relapse|0|||
161120352|NCT01471782|581827169|FG002|Overall Study|Disease Relapse|0|||
161120353|NCT01471782|581827170|FG003|Overall Study|Disease Relapse|1|||
161120354|NCT01471782|581827171|FG004|Overall Study|Disease Relapse|2|||
161120355|NCT01471782|581827172|FG005|Overall Study|Disease Relapse|1|||
161120356|NCT01471782|581827167|FG000|Overall Study|Physician Decision|0|||
161120357|NCT01471782|581827168|FG001|Overall Study|Physician Decision|0|||
161120358|NCT01471782|581827169|FG002|Overall Study|Physician Decision|0|||
161120359|NCT01471782|581827170|FG003|Overall Study|Physician Decision|0|||
161120360|NCT01471782|581827171|FG004|Overall Study|Physician Decision|3|||
161120361|NCT01471782|581827172|FG005|Overall Study|Physician Decision|8|||
161120362|NCT01471782|581827167|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161120363|NCT01471782|581827168|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161120364|NCT01471782|581827169|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161120365|NCT01471782|581827170|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161120366|NCT01471782|581827171|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
161120367|NCT01471782|581827172|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161120368|NCT01471782|581827167|FG000|Overall Study|Death|0|||
161120369|NCT01471782|581827168|FG001|Overall Study|Death|0|||
161120370|NCT01471782|581827169|FG002|Overall Study|Death|0|||
161120371|NCT01471782|581827170|FG003|Overall Study|Death|0|||
161120372|NCT01471782|581827171|FG004|Overall Study|Death|0|||
161120373|NCT01471782|581827172|FG005|Overall Study|Death|1|||
161120374|NCT00936208|581827173|FG000|Overall Study|Protocol Violation|37|||
161120375|NCT00936208|581827174|FG001|Overall Study|Protocol Violation|22|||
161120376|NCT04428424|581827175|FG000|Overall Study|Does not meet entrance criteria|132|||
161120377|NCT04428424|581827175|FG000|Overall Study|Lost to Follow-up|115|||
161120378|NCT03359759|581827176|FG000|Overall Study|Death|3|||
161120379|NCT03359759|581827176|FG000|Overall Study|Lost to Follow-up|2|||
161120380|NCT01564862|581827177|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
161120381|NCT01564862|581827178|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
161120382|NCT01564862|581827179|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161120383|NCT01564862|581827177|FG000|Overall Study|Major Protocol Deviation|3|||
161120384|NCT01564862|581827178|FG001|Overall Study|Major Protocol Deviation|3|||
161120385|NCT01564862|581827179|FG002|Overall Study|Major Protocol Deviation|4|||
161120386|NCT01564862|581827177|FG000|Overall Study|Lost to Follow-up|10|||
161120387|NCT01564862|581827178|FG001|Overall Study|Lost to Follow-up|8|||
161120388|NCT01564862|581827179|FG002|Overall Study|Lost to Follow-up|6|||
161120389|NCT01564862|581827177|FG000|Overall Study|Voluntary Withdrawal|9|||
161120390|NCT01564862|581827178|FG001|Overall Study|Voluntary Withdrawal|6|||
161120391|NCT01564862|581827179|FG002|Overall Study|Voluntary Withdrawal|8|||
161120392|NCT01564862|581827177|FG000|Overall Study|Lack of Efficacy|1|||
161120393|NCT01564862|581827178|FG001|Overall Study|Lack of Efficacy|5|||
161120394|NCT01564862|581827179|FG002|Overall Study|Lack of Efficacy|6|||
161120395|NCT01564862|581827177|FG000|Overall Study|Other reason(s)|1|||
161120396|NCT01564862|581827178|FG001|Overall Study|Other reason(s)|0|||
161120397|NCT01564862|581827179|FG002|Overall Study|Other reason(s)|0|||
161120398|NCT03809611|581827180|FG000|Overall Study|Withdrawal by Subject|1|||
161120399|NCT03809611|581827181|FG001|Overall Study|Withdrawal by Subject|1|||
161120400|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
161120401|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
160877882|NCT01457352|580947404|FG000|Period 2|Sponsor's withdrawal|7|||
160877883|NCT01457352|580947405|FG001|Period 2|Sponsor's withdrawal|0|||
160877884|NCT01457352|580947404|FG000|Period 2|Lost to Follow-up|1|||
160877885|NCT01457352|580947405|FG001|Period 2|Lost to Follow-up|0|||
160877886|NCT01457352|580947404|FG000|Period 2|dose change|1|||
160877887|NCT01457352|580947405|FG001|Period 2|dose change|0|||
160877888|NCT01457352|580947404|FG000|Period 2|Physician Decision|1|||
160877889|NCT01457352|580947405|FG001|Period 2|Physician Decision|0|||
160877890|NCT01457352|580947404|FG000|Period 2|Did not meet eligibility criteria|3|||
160877891|NCT01457352|580947405|FG001|Period 2|Did not meet eligibility criteria|0|||
160877892|NCT01457352|580947404|FG000|Period 3|Adverse Event|1|||
160877893|NCT01457352|580947405|FG001|Period 3|Adverse Event|1|||
160877894|NCT01457352|580947404|FG000|Period 3|Withdrawal by Subject|0|||
160877895|NCT01457352|580947405|FG001|Period 3|Withdrawal by Subject|2|||
160877896|NCT01457352|580947404|FG000|Period 3|incorrect treatment|0|||
160877897|NCT01457352|580947405|FG001|Period 3|incorrect treatment|1|||
160877898|NCT01457352|580947404|FG000|Period 3|Sponsor's withdrawal|0|||
160877899|NCT01457352|580947405|FG001|Period 3|Sponsor's withdrawal|1|||
160877900|NCT01065454|580947406|FG000|Treatment|Adverse Event|7|||
160877901|NCT01065454|580947407|FG001|Treatment|Adverse Event|4|||
160877902|NCT01065454|580947408|FG002|Treatment|Adverse Event|3|||
160877903|NCT01065454|580947409|FG003|Treatment|Adverse Event|6|||
160877904|NCT01065454|580947406|FG000|Treatment|Death|1|||
160877905|NCT01065454|580947407|FG001|Treatment|Death|0|||
160877906|NCT01065454|580947408|FG002|Treatment|Death|0|||
160877907|NCT01065454|580947409|FG003|Treatment|Death|0|||
160877908|NCT01065454|580947406|FG000|Treatment|Non-compliance|1|||
160877909|NCT01065454|580947407|FG001|Treatment|Non-compliance|0|||
160877910|NCT01065454|580947408|FG002|Treatment|Non-compliance|0|||
160877911|NCT01065454|580947409|FG003|Treatment|Non-compliance|1|||
160877912|NCT01065454|580947406|FG000|Treatment|Protocol Decision|0|||
160877913|NCT01065454|580947407|FG001|Treatment|Protocol Decision|0|||
160877914|NCT01065454|580947408|FG002|Treatment|Protocol Decision|3|||
160877915|NCT01065454|580947409|FG003|Treatment|Protocol Decision|2|||
160877916|NCT01065454|580947406|FG000|Treatment|Protocol Violation|1|||
160877917|NCT01065454|580947407|FG001|Treatment|Protocol Violation|0|||
160877918|NCT01065454|580947408|FG002|Treatment|Protocol Violation|1|||
160877919|NCT01065454|580947409|FG003|Treatment|Protocol Violation|0|||
160877920|NCT01065454|580947406|FG000|Treatment|Withdrawal by Subject|3|||
160877921|NCT01065454|580947407|FG001|Treatment|Withdrawal by Subject|1|||
160877922|NCT01065454|580947408|FG002|Treatment|Withdrawal by Subject|2|||
160877923|NCT01065454|580947409|FG003|Treatment|Withdrawal by Subject|3|||
160877924|NCT01065454|580947406|FG000|Follow up|Adverse Event|1|||
160877925|NCT01065454|580947407|FG001|Follow up|Adverse Event|0|||
160877926|NCT01065454|580947408|FG002|Follow up|Adverse Event|0|||
160877927|NCT01065454|580947409|FG003|Follow up|Adverse Event|1|||
160877928|NCT01065454|580947406|FG000|Follow up|Death|0|||
160877929|NCT01065454|580947407|FG001|Follow up|Death|1|||
160877930|NCT01065454|580947408|FG002|Follow up|Death|1|||
160877931|NCT01065454|580947409|FG003|Follow up|Death|0|||
160877932|NCT01065454|580947406|FG000|Follow up|Lost to Follow-up|0|||
160877933|NCT01065454|580947407|FG001|Follow up|Lost to Follow-up|0|||
160877934|NCT01065454|580947408|FG002|Follow up|Lost to Follow-up|0|||
160877935|NCT01065454|580947409|FG003|Follow up|Lost to Follow-up|1|||
160877936|NCT01065454|580947406|FG000|Follow up|Progressive disease|0|||
160877937|NCT01065454|580947407|FG001|Follow up|Progressive disease|0|||
160877938|NCT01065454|580947408|FG002|Follow up|Progressive disease|0|||
160877939|NCT01065454|580947409|FG003|Follow up|Progressive disease|1|||
160877940|NCT01065454|580947406|FG000|Follow up|Withdrawal by Subject|1|||
160877941|NCT01065454|580947407|FG001|Follow up|Withdrawal by Subject|1|||
160877942|NCT01065454|580947408|FG002|Follow up|Withdrawal by Subject|1|||
160877943|NCT01065454|580947409|FG003|Follow up|Withdrawal by Subject|0|||
160877944|NCT01065454|580947406|FG000|Follow up|study ongoing|37|||
160877945|NCT01065454|580947407|FG001|Follow up|study ongoing|22|||
160877946|NCT01065454|580947408|FG002|Follow up|study ongoing|15|||
160877947|NCT01065454|580947409|FG003|Follow up|study ongoing|41|||
160877948|NCT04614324|580947410|FG000|Overall Study|Lost to Follow-up|3|||
160877949|NCT04614324|580947410|FG000|Overall Study|Physician Decision|1|||
160877950|NCT04614324|580947410|FG000|Overall Study|Withdrawal by Subject|2|||
160877951|NCT04614324|580947410|FG000|Overall Study|Remaining in Follow up|123|||
160877952|NCT03472547|580947411|FG000|Overall Study|Withdrawal by Subject|30|||
160877953|NCT05141448|580947412|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877954|NCT05141448|580947413|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
160877955|NCT05141448|580947414|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877956|NCT05141448|580947415|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877957|NCT05141448|580947416|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877958|NCT05141448|580947417|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160877959|NCT05141448|580947412|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877960|NCT05141448|580947413|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877961|NCT05141448|580947414|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877962|NCT05141448|580947415|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877963|NCT05141448|580947416|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
160877964|NCT05141448|580947417|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160877965|NCT05141448|580947412|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877966|NCT05141448|580947413|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
160877967|NCT05141448|580947414|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877968|NCT05141448|580947415|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877969|NCT05141448|580947416|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877970|NCT05141448|580947417|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160877971|NCT05141448|580947412|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877972|NCT05141448|580947413|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877973|NCT05141448|580947414|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877974|NCT05141448|580947415|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877975|NCT05141448|580947416|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160877976|NCT05141448|580947417|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
160877977|NCT05141448|580947412|FG000|Period 2|COVID-19 Related|0|||
160877978|NCT05141448|580947413|FG001|Period 2|COVID-19 Related|0|||
160877979|NCT05141448|580947414|FG002|Period 2|COVID-19 Related|0|||
160877980|NCT05141448|580947415|FG003|Period 2|COVID-19 Related|1|||
160877981|NCT05141448|580947416|FG004|Period 2|COVID-19 Related|0|||
160877982|NCT05141448|580947417|FG005|Period 2|COVID-19 Related|1|||
160877983|NCT05141448|580947412|FG000|3|Covid-19 related|2|||
160877984|NCT05141448|580947413|FG001|3|Covid-19 related|0|||
160877985|NCT05141448|580947414|FG002|3|Covid-19 related|0|||
160877986|NCT05141448|580947415|FG003|3|Covid-19 related|0|||
160877987|NCT05141448|580947416|FG004|3|Covid-19 related|0|||
160877988|NCT05141448|580947417|FG005|3|Covid-19 related|1|||
160877989|NCT05141448|580947412|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
160877990|NCT05141448|580947413|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
160877991|NCT05141448|580947414|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
160877992|NCT05141448|580947415|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
160877993|NCT05141448|580947416|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
160877994|NCT05141448|580947417|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
160877995|NCT01948193|580949732|FG000|Overall Study|Serious event|2|||
160877996|NCT01948193|580949732|FG000|Overall Study|Lost to Follow-up|7|||
160877997|NCT01325337|580949733|FG000|Overall Study|Adverse Event|0|||
160877998|NCT01325337|580949734|FG001|Overall Study|Adverse Event|2|||
160877999|NCT01325337|580949735|FG002|Overall Study|Adverse Event|2|||
160878000|NCT01325337|580949736|FG003|Overall Study|Adverse Event|1|||
160878001|NCT01325337|580949737|FG004|Overall Study|Adverse Event|2|||
160878002|NCT01325337|580949733|FG000|Overall Study|Lost to Follow-up|2|||
160878003|NCT01325337|580949734|FG001|Overall Study|Lost to Follow-up|2|||
160878004|NCT01325337|580949735|FG002|Overall Study|Lost to Follow-up|2|||
160878005|NCT01325337|580949736|FG003|Overall Study|Lost to Follow-up|1|||
160878006|NCT01325337|580949737|FG004|Overall Study|Lost to Follow-up|2|||
160878007|NCT01325337|580949733|FG000|Overall Study|Personal Reasons|2|||
160878008|NCT01325337|580949734|FG001|Overall Study|Personal Reasons|5|||
160878009|NCT01325337|580949735|FG002|Overall Study|Personal Reasons|4|||
160878010|NCT01325337|580949736|FG003|Overall Study|Personal Reasons|8|||
160878011|NCT01325337|580949737|FG004|Overall Study|Personal Reasons|3|||
160878012|NCT01325337|580949733|FG000|Overall Study|Withdrawal by Subject|1|||
160878013|NCT01325337|580949734|FG001|Overall Study|Withdrawal by Subject|0|||
160878014|NCT01325337|580949735|FG002|Overall Study|Withdrawal by Subject|1|||
160878015|NCT01325337|580949736|FG003|Overall Study|Withdrawal by Subject|0|||
160878016|NCT01325337|580949737|FG004|Overall Study|Withdrawal by Subject|1|||
160878017|NCT01604278|580949744|FG000|Overall Study|Lack of Efficacy|0|||
160878018|NCT01604278|580949745|FG001|Overall Study|Lack of Efficacy|1|||
160878019|NCT01604278|580949744|FG000|Overall Study|Lost to Follow-up|1|||
160878020|NCT01604278|580949745|FG001|Overall Study|Lost to Follow-up|0|||
160878021|NCT01604278|580949744|FG000|Overall Study|Administrative problems|2|||
160878022|NCT01604278|580949745|FG001|Overall Study|Administrative problems|1|||
160878023|NCT01604278|580949744|FG000|Overall Study|Withdrawal by Subject|3|||
160878024|NCT01604278|580949745|FG001|Overall Study|Withdrawal by Subject|3|||
160878025|NCT01604278|580949744|FG000|Overall Study|Adverse Event|3|||
160878026|NCT01604278|580949745|FG001|Overall Study|Adverse Event|5|||
160878027|NCT01604278|580949744|FG000|Overall Study|Protocol Deviation|5|||
160878028|NCT01604278|580949745|FG001|Overall Study|Protocol Deviation|3|||
160878029|NCT00668733|580949753|FG000|Overall Study|Lost to Follow-up|2|||
160878030|NCT00668733|580949754|FG001|Overall Study|Lost to Follow-up|3|||
160878031|NCT00668733|580949753|FG000|Overall Study|Withdrawal by Subject|0|||
160878032|NCT00668733|580949754|FG001|Overall Study|Withdrawal by Subject|4|||
160878033|NCT01122264|580949757|FG000|Overall Study|Adverse Event|6|||
160878034|NCT01122264|580949758|FG001|Overall Study|Adverse Event|5|||
160878035|NCT01122264|580949759|FG002|Overall Study|Adverse Event|7|||
160878036|NCT01122264|580949757|FG000|Overall Study|Death|1|||
161225425|NCT01974895|582205252|FG001|Overall Study|Other (Reason unknown)|8|||
160878037|NCT01122264|580949758|FG001|Overall Study|Death|0|||
160878038|NCT01122264|580949759|FG002|Overall Study|Death|0|||
160878039|NCT01122264|580949757|FG000|Overall Study|Lost to Follow-up|5|||
160878040|NCT01122264|580949758|FG001|Overall Study|Lost to Follow-up|9|||
160878041|NCT01122264|580949759|FG002|Overall Study|Lost to Follow-up|13|||
160878042|NCT01122264|580949757|FG000|Overall Study|Entry Criteria Not Met|1|||
160878043|NCT01122264|580949758|FG001|Overall Study|Entry Criteria Not Met|0|||
160878044|NCT01122264|580949759|FG002|Overall Study|Entry Criteria Not Met|0|||
160878045|NCT01122264|580949757|FG000|Overall Study|Protocol Violation|7|||
160878046|NCT01122264|580949758|FG001|Overall Study|Protocol Violation|7|||
160878047|NCT01122264|580949759|FG002|Overall Study|Protocol Violation|9|||
160878048|NCT01122264|580949757|FG000|Overall Study|Withdrawal by Subject|6|||
160878049|NCT01122264|580949758|FG001|Overall Study|Withdrawal by Subject|6|||
160878050|NCT01122264|580949759|FG002|Overall Study|Withdrawal by Subject|16|||
160878051|NCT01122264|580949757|FG000|Overall Study|Physician Decision|3|||
160878052|NCT01122264|580949758|FG001|Overall Study|Physician Decision|1|||
160878053|NCT01122264|580949759|FG002|Overall Study|Physician Decision|1|||
160878054|NCT01122264|580949757|FG000|Overall Study|Lack of Efficacy|3|||
160878055|NCT01122264|580949758|FG001|Overall Study|Lack of Efficacy|1|||
160878056|NCT01122264|580949759|FG002|Overall Study|Lack of Efficacy|1|||
160878057|NCT00097981|580949768|FG000|Overall Study|Adverse Event|31|||
160878058|NCT00097981|580949769|FG001|Overall Study|Adverse Event|44|||
160878059|NCT00097981|580949768|FG000|Overall Study|Withdrawal by Subject|10|||
160878060|NCT00097981|580949769|FG001|Overall Study|Withdrawal by Subject|8|||
160878061|NCT00097981|580949768|FG000|Overall Study|Protocol Violation|1|||
160878062|NCT00097981|580949769|FG001|Overall Study|Protocol Violation|1|||
160878063|NCT00097981|580949768|FG000|Overall Study|Death|2|||
160878064|NCT00097981|580949769|FG001|Overall Study|Death|4|||
160878065|NCT00097981|580949768|FG000|Overall Study|Physician Decision|7|||
160878066|NCT00097981|580949769|FG001|Overall Study|Physician Decision|1|||
160878067|NCT00097981|580949768|FG000|Overall Study|Disease Progression|8|||
160878068|NCT00097981|580949769|FG001|Overall Study|Disease Progression|2|||
160878069|NCT00097981|580949768|FG000|Overall Study|Transplant planned|28|||
160878070|NCT00097981|580949769|FG001|Overall Study|Transplant planned|27|||
160878071|NCT00097981|580949768|FG000|Overall Study|Other|19|||
160878072|NCT00097981|580949769|FG001|Overall Study|Other|13|||
160878073|NCT01128621|580949782|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
160878074|NCT01128621|580949783|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
160878075|NCT04074161|580949784|FG000|Overall Study|Withdrawal by Subject|2|||
160878076|NCT04074161|580949785|FG001|Overall Study|Withdrawal by Subject|4|||
160878077|NCT04074161|580949786|FG002|Overall Study|Withdrawal by Subject|1|||
160878078|NCT04074161|580949784|FG000|Overall Study|Lost to Follow-up|4|||
160878079|NCT04074161|580949785|FG001|Overall Study|Lost to Follow-up|5|||
160878080|NCT04074161|580949786|FG002|Overall Study|Lost to Follow-up|3|||
160878081|NCT00796445|580949789|FG000|Overall Study|Protocol Violation|5|||
160878082|NCT00796445|580949790|FG001|Overall Study|Protocol Violation|3|||
160878083|NCT00796445|580949789|FG000|Overall Study|Adverse event, serious fatal|10|||
160878084|NCT00796445|580949790|FG001|Overall Study|Adverse event, serious fatal|5|||
160878085|NCT00796445|580949789|FG000|Overall Study|Adverse event, non-fatal|4|||
160878086|NCT00796445|580949790|FG001|Overall Study|Adverse event, non-fatal|0|||
160878087|NCT00796445|580949789|FG000|Overall Study|Disease progression/recurrence|537|||
160878088|NCT00796445|580949790|FG001|Overall Study|Disease progression/recurrence|268|||
160878089|NCT00796445|580949789|FG000|Overall Study|Other|10|||
160878090|NCT00796445|580949790|FG001|Overall Study|Other|7|||
160878091|NCT00796445|580949789|FG000|Overall Study|Withdrawal by Subject|18|||
160878092|NCT00796445|580949790|FG001|Overall Study|Withdrawal by Subject|9|||
160878093|NCT00796445|580949789|FG000|Overall Study|Invalid Informed Consent Form|1|||
160878094|NCT00796445|580949790|FG001|Overall Study|Invalid Informed Consent Form|0|||
160878095|NCT00388583|580949793|FG000|Overall Study|Protocol Violation|1|||
160878096|NCT00388583|580949794|FG001|Overall Study|Protocol Violation|0|||
160878097|NCT00388583|580949793|FG000|Overall Study|Withdrawal by Subject|3|||
160878098|NCT00388583|580949794|FG001|Overall Study|Withdrawal by Subject|3|||
160878099|NCT00388583|580949793|FG000|Overall Study|Serious Adverse Event|2|||
160878100|NCT00388583|580949794|FG001|Overall Study|Serious Adverse Event|0|||
160878101|NCT00388583|580949793|FG000|Overall Study|Did not receive vaccine|0|||
160878102|NCT00388583|580949794|FG001|Overall Study|Did not receive vaccine|1|||
160878103|NCT05194579|580949795|FG000|Overall Study|Lost to Follow-up|2|||
160878104|NCT05194579|580949796|FG001|Overall Study|Lost to Follow-up|3|||
160878105|NCT05194579|580949795|FG000|Overall Study|Withdrawal by Subject|3|||
160878106|NCT05194579|580949796|FG001|Overall Study|Withdrawal by Subject|4|||
160878107|NCT05194579|580949795|FG000|Overall Study|Refused further study procedures|0|||
160878108|NCT05194579|580949796|FG001|Overall Study|Refused further study procedures|1|||
160878109|NCT05194579|580949795|FG000|Overall Study|Protocol deviation|1|||
160878110|NCT05194579|580949796|FG001|Overall Study|Protocol deviation|0|||
160878111|NCT02500056|580949801|FG000|Overall Study|Lost to Follow-up|3|||
160878112|NCT02500056|580949802|FG001|Overall Study|Lost to Follow-up|7|||
160878113|NCT02500056|580949801|FG000|Overall Study|Recurrence|1|||
160878114|NCT02500056|580949802|FG001|Overall Study|Recurrence|0|||
160878115|NCT02500056|580949801|FG000|Overall Study|Death|3|||
160878116|NCT02500056|580949802|FG001|Overall Study|Death|1|||
160878117|NCT00638183|580949807|FG000|Overall Study|Adverse Event|23|||
160878118|NCT00638183|580949807|FG000|Overall Study|Lack of Efficacy|14|||
160878119|NCT00638183|580949807|FG000|Overall Study|Physician Decision|9|||
160878120|NCT00638183|580949807|FG000|Overall Study|Lost to Follow-up|46|||
160878121|NCT00638183|580949807|FG000|Overall Study|Other reason not defined above|27|||
160878122|NCT03180619|580949808|FG000|Overall Study|Withdrew Consent|5|||
160878123|NCT03180619|580949809|FG001|Overall Study|Withdrew Consent|0|||
160878124|NCT03180619|580949810|FG002|Overall Study|Withdrew Consent|2|||
160878125|NCT03180619|580949808|FG000|Overall Study|Death|2|||
160878126|NCT03180619|580949809|FG001|Overall Study|Death|1|||
160878127|NCT03180619|580949810|FG002|Overall Study|Death|2|||
160878128|NCT03180619|580949808|FG000|Overall Study|Adverse Event|2|||
160878129|NCT03180619|580949809|FG001|Overall Study|Adverse Event|0|||
160878130|NCT03180619|580949810|FG002|Overall Study|Adverse Event|1|||
160878131|NCT03180619|580949808|FG000|Overall Study|Investigator's discretion|2|||
160878132|NCT03180619|580949809|FG001|Overall Study|Investigator's discretion|0|||
160878133|NCT03180619|580949810|FG002|Overall Study|Investigator's discretion|1|||
160878134|NCT00275340|580949813|FG000|Overall Study|Lost to Follow-up|2|||
160878135|NCT00275340|580949814|FG001|Overall Study|Lost to Follow-up|4|||
160878136|NCT00862641|580949817|FG000|Overall Study|Randomized, but drug not received|1|||
161225426|NCT00635154|582205253|FG000|Overall Study|Alternative Treatment|8|||
161225427|NCT00635154|582205253|FG000|Overall Study|Other|4|||
161225428|NCT00635154|582205253|FG000|Overall Study|Still on treatment|21|||
161225429|NCT02114697|582205254|FG000|Overall Study|Study terminated|5|||
161225430|NCT02114697|582205255|FG001|Overall Study|Study terminated|4|||
161225431|NCT00424489|582205256|FG000|Overall Study|Death|3|||
161225432|NCT01984242|582205257|FG000|Overall Study|Death|52|||
161225433|NCT01984242|582205258|FG001|Overall Study|Death|50|||
161225434|NCT01984242|582205259|FG002|Overall Study|Death|52|||
161225435|NCT01984242|582205257|FG000|Overall Study|Withdrawal by Subject|5|||
161225436|NCT01984242|582205258|FG001|Overall Study|Withdrawal by Subject|3|||
161225437|NCT01984242|582205259|FG002|Overall Study|Withdrawal by Subject|10|||
161225438|NCT01984242|582205257|FG000|Overall Study|Physician Decision|0|||
161225439|NCT01984242|582205258|FG001|Overall Study|Physician Decision|0|||
161225440|NCT01984242|582205259|FG002|Overall Study|Physician Decision|1|||
161225441|NCT01984242|582205257|FG000|Overall Study|Lost to Follow-up|4|||
161225442|NCT01984242|582205258|FG001|Overall Study|Lost to Follow-up|0|||
161225443|NCT01984242|582205259|FG002|Overall Study|Lost to Follow-up|3|||
161225444|NCT01984242|582205257|FG000|Overall Study|Sponsor Decision|1|||
161225445|NCT01984242|582205258|FG001|Overall Study|Sponsor Decision|0|||
161225446|NCT01984242|582205259|FG002|Overall Study|Sponsor Decision|0|||
161225447|NCT01984242|582205257|FG000|Overall Study|Non-Compliance|1|||
161225448|NCT01984242|582205258|FG001|Overall Study|Non-Compliance|0|||
161225449|NCT01984242|582205259|FG002|Overall Study|Non-Compliance|0|||
161225450|NCT01984242|582205257|FG000|Overall Study|Study terminated by Sponsor|38|||
161225451|NCT01984242|582205258|FG001|Overall Study|Study terminated by Sponsor|50|||
161225452|NCT01984242|582205259|FG002|Overall Study|Study terminated by Sponsor|34|||
161225453|NCT01984242|582205257|FG000|Overall Study|Disease Progression|0|||
161225454|NCT01984242|582205258|FG001|Overall Study|Disease Progression|0|||
161225455|NCT01984242|582205259|FG002|Overall Study|Disease Progression|1|||
161225456|NCT02660242|582205264|FG000|Glucose Tabs|Lost to Follow-up|1|||
161225457|NCT02660242|582205264|FG000|Glucagon Injection|Lost to Follow-up|1|||
161225458|NCT02796664|582205266|FG000|Overall Study|Withdrawal by Subject|0|||
161225459|NCT02796664|582205267|FG001|Overall Study|Withdrawal by Subject|3|||
161225460|NCT02796664|582205266|FG000|Overall Study|Noncompliance|1|||
161120402|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
161120403|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
161120404|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
161120405|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
161120406|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
161120407|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
161225461|NCT02796664|582205267|FG001|Overall Study|Noncompliance|1|||
160878137|NCT00862641|580949818|FG001|Overall Study|Randomized, but drug not received|4|||
160878138|NCT00862641|580949819|FG002|Overall Study|Randomized, but drug not received|1|||
160878139|NCT00862641|580949820|FG003|Overall Study|Randomized, but drug not received|4|||
160878140|NCT02365480|580949821|FG000|Overall Study|Withdrawal by Subject|2|||
161120408|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
161120409|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
161120410|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
161225462|NCT02796664|582205266|FG000|Overall Study|Death|0|||
161225463|NCT02796664|582205267|FG001|Overall Study|Death|1|||
161225464|NCT02246478|582205268|FG000|Multiple-dose Phase|Protocol Violation|1|||
161225465|NCT02246478|582205269|FG001|Multiple-dose Phase|Protocol Violation|0|||
161225466|NCT02246478|582205270|FG002|Multiple-dose Phase|Protocol Violation|0|||
160878141|NCT02365480|580949822|FG001|Overall Study|Withdrawal by Subject|0|||
160878142|NCT01419197|580949827|FG000|Overall Study|Death|247|||
161225467|NCT02246478|582205271|FG003|Multiple-dose Phase|Protocol Violation|1|||
161225468|NCT00536575|582205272|FG000|Overall Study|Withdrawal by Subject|1|||
161225469|NCT00536575|582205272|FG000|Overall Study|Death|1|||
160878143|NCT01419197|580949828|FG001|Overall Study|Death|122|||
160878144|NCT01419197|580949827|FG000|Overall Study|Physician Decision|4|||
160878145|NCT01419197|580949828|FG001|Overall Study|Physician Decision|4|||
160878146|NCT01419197|580949827|FG000|Overall Study|Non-compliance|3|||
160878147|NCT01419197|580949828|FG001|Overall Study|Non-compliance|1|||
160878148|NCT01419197|580949827|FG000|Overall Study|Withdrawal by Subject|33|||
161225470|NCT00198029|582205276|FG000|Overall Study|Withdrawal by Subject|4|||
161225471|NCT02785913|582207845|FG000|Overall Study|Adverse Event|5|||
161225472|NCT02785913|582207845|FG000|Overall Study|Death|2|||
161225473|NCT02785913|582207845|FG000|Overall Study|Progression|18|||
161225474|NCT02785913|582207845|FG000|Overall Study|Not protocol specified|1|||
161225475|NCT01298570|582207846|FG000|Overall Study|Disease progression, relapse during acti|64|||
161225476|NCT01298570|582207847|FG001|Overall Study|Disease progression, relapse during acti|40|||
161225477|NCT01298570|582207846|FG000|Overall Study|Adverse Event|20|||
161225478|NCT01298570|582207847|FG001|Overall Study|Adverse Event|2|||
161225479|NCT01298570|582207846|FG000|Overall Study|Withdrawal by Subject|21|||
161225480|NCT01298570|582207847|FG001|Overall Study|Withdrawal by Subject|6|||
161225481|NCT01298570|582207846|FG000|Overall Study|Treatment delay > 4 weeks|4|||
161225482|NCT01298570|582207847|FG001|Overall Study|Treatment delay > 4 weeks|5|||
161225483|NCT01298570|582207846|FG000|Overall Study|Physician Decision|4|||
161225484|NCT01298570|582207847|FG001|Overall Study|Physician Decision|2|||
161225485|NCT01298570|582207846|FG000|Overall Study|Other complicating disease|2|||
161225486|NCT01298570|582207847|FG001|Overall Study|Other complicating disease|1|||
161225487|NCT01298570|582207846|FG000|Overall Study|Surgery|2|||
161225488|NCT01298570|582207847|FG001|Overall Study|Surgery|1|||
161225489|NCT01298570|582207846|FG000|Overall Study|Symptomatic progression/deterioration|3|||
161225490|NCT01298570|582207847|FG001|Overall Study|Symptomatic progression/deterioration|2|||
161225491|NCT01298570|582207846|FG000|Overall Study|Death|0|||
161225492|NCT01298570|582207847|FG001|Overall Study|Death|1|||
161225493|NCT01298570|582207846|FG000|Overall Study|Ineligibility|0|||
161225494|NCT01298570|582207847|FG001|Overall Study|Ineligibility|1|||
161225495|NCT00076102|582207848|FG000|Overall Study|Clinical progression|1|||
161225496|NCT00076102|582207848|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
161225497|NCT00076102|582207848|FG000|Overall Study|plexiform neurofibroma surgery|1|||
161225498|NCT00076102|582207848|FG000|Overall Study|refusal of further therapy|2|||
160878149|NCT01419197|580949828|FG001|Overall Study|Withdrawal by Subject|32|||
160878150|NCT01419197|580949827|FG000|Overall Study|Study Completed by Sponsor|103|||
161225499|NCT01052116|582207849|FG000|Overall Study|Lost to Follow-up|11|||
161225500|NCT01052116|582207850|FG001|Overall Study|Lost to Follow-up|17|||
161225501|NCT01052116|582207849|FG000|Overall Study|Withdrawal by Subject|3|||
161225502|NCT01052116|582207850|FG001|Overall Study|Withdrawal by Subject|6|||
161225503|NCT01052116|582207849|FG000|Overall Study|Spirometry not performed|0|||
161225504|NCT01052116|582207850|FG001|Overall Study|Spirometry not performed|4|||
161225505|NCT02180711|582207851|FG000|Overall Study|Death|0|||
161225506|NCT02180711|582207852|FG001|Overall Study|Death|1|||
160878151|NCT01419197|580949828|FG001|Overall Study|Study Completed by Sponsor|34|||
160878152|NCT01419197|580949827|FG000|Overall Study|Reason Not Specified|0|||
160878153|NCT01419197|580949828|FG001|Overall Study|Reason Not Specified|1|||
160878154|NCT01419197|580949827|FG000|Overall Study|Lost to Follow-up|14|||
160878155|NCT01419197|580949828|FG001|Overall Study|Lost to Follow-up|4|||
160878156|NCT01781299|580949829|FG000|Overall Study|Withdrawal by Subject|0|||
160878157|NCT01781299|580949830|FG001|Overall Study|Withdrawal by Subject|1|||
160878158|NCT00146848|580949834|FG000|Pre-randomization|Death|19|||
160878159|NCT00146848|580949835|FG001|Pre-randomization|Death|0|||
160878160|NCT00146848|580949836|FG002|Pre-randomization|Death|0|||
160878161|NCT00146848|580949834|FG000|Pre-randomization|Lost to Follow-up|70|||
160878162|NCT00146848|580949835|FG001|Pre-randomization|Lost to Follow-up|0|||
160878163|NCT00146848|580949836|FG002|Pre-randomization|Lost to Follow-up|0|||
160878164|NCT00146848|580949834|FG000|Pre-randomization|Physician Decision|8|||
160878165|NCT00146848|580949835|FG001|Pre-randomization|Physician Decision|0|||
161225507|NCT02180711|582207853|FG002|Overall Study|Death|0|||
161225508|NCT02180711|582207854|FG003|Overall Study|Death|0|||
160878166|NCT00146848|580949836|FG002|Pre-randomization|Physician Decision|0|||
161225509|NCT02180711|582207855|FG004|Overall Study|Death|7|||
161225510|NCT02180711|582207856|FG005|Overall Study|Death|0|||
161225511|NCT02180711|582207857|FG006|Overall Study|Death|1|||
160878167|NCT00146848|580949834|FG000|Pre-randomization|Protocol Violation|172|||
160878168|NCT00146848|580949835|FG001|Pre-randomization|Protocol Violation|0|||
160878169|NCT00146848|580949836|FG002|Pre-randomization|Protocol Violation|0|||
160878170|NCT00146848|580949834|FG000|Pre-randomization|Withdrawal by Subject|40|||
160878171|NCT00146848|580949835|FG001|Pre-randomization|Withdrawal by Subject|0|||
161225512|NCT02180711|582207858|FG007|Overall Study|Death|3|||
161225513|NCT02180711|582207851|FG000|Overall Study|Lost to Follow-up|0|||
161225514|NCT02180711|582207852|FG001|Overall Study|Lost to Follow-up|1|||
161225515|NCT02180711|582207853|FG002|Overall Study|Lost to Follow-up|0|||
161225516|NCT02180711|582207854|FG003|Overall Study|Lost to Follow-up|0|||
160878172|NCT00146848|580949836|FG002|Pre-randomization|Withdrawal by Subject|0|||
160878173|NCT00146848|580949834|FG000|Post-randomization|Lost to Follow-up|12|||
160878174|NCT00146848|580949835|FG001|Post-randomization|Lost to Follow-up|15|||
160878175|NCT00146848|580949836|FG002|Post-randomization|Lost to Follow-up|12|||
160878176|NCT00146848|580949834|FG000|Post-randomization|Withdrawn|26|||
160878177|NCT00146848|580949835|FG001|Post-randomization|Withdrawn|32|||
160878178|NCT00146848|580949836|FG002|Post-randomization|Withdrawn|27|||
160878179|NCT02395172|580949837|FG000|Overall Study|Participants randomized but not treated|3|||
160878180|NCT02395172|580949838|FG001|Overall Study|Participants randomized but not treated|31|||
160878181|NCT02032238|580949839|FG000|Overall Study|Lost to Follow-up|2|||
160878182|NCT02032238|580949840|FG001|Overall Study|Lost to Follow-up|0|||
160878183|NCT00653939|580949841|FG000|Overall Study|Adverse Event|1|||
160878184|NCT00653939|580949842|FG001|Overall Study|Adverse Event|3|||
160878185|NCT00653939|580949841|FG000|Overall Study|Withdrawal by Subject|3|||
160878186|NCT00653939|580949842|FG001|Overall Study|Withdrawal by Subject|3|||
160878187|NCT00653939|580949841|FG000|Overall Study|Physician Decision|4|||
160878188|NCT00653939|580949842|FG001|Overall Study|Physician Decision|0|||
160878189|NCT00653939|580949841|FG000|Overall Study|Disease Progression|2|||
160878190|NCT00653939|580949842|FG001|Overall Study|Disease Progression|3|||
160878191|NCT00653939|580949841|FG000|Overall Study|Other|2|||
160878192|NCT00653939|580949842|FG001|Overall Study|Other|6|||
160878193|NCT00717236|580949843|FG000|Double-Blind Period|Adverse Event|33|||
160878194|NCT00717236|580949844|FG001|Double-Blind Period|Adverse Event|6|||
160878195|NCT00717236|580949843|FG000|Double-Blind Period|Lack of Efficacy|6|||
160878196|NCT00717236|580949844|FG001|Double-Blind Period|Lack of Efficacy|6|||
160878197|NCT00717236|580949843|FG000|Double-Blind Period|Lost to Follow-up|3|||
160878198|NCT00717236|580949844|FG001|Double-Blind Period|Lost to Follow-up|5|||
160878199|NCT00717236|580949843|FG000|Double-Blind Period|Withdrawal by Subject|10|||
160878200|NCT00717236|580949844|FG001|Double-Blind Period|Withdrawal by Subject|2|||
160878201|NCT00717236|580949843|FG000|Double-Blind Period|Loss of efficacy|3|||
160878202|NCT00717236|580949844|FG001|Double-Blind Period|Loss of efficacy|0|||
161225517|NCT02180711|582207855|FG004|Overall Study|Lost to Follow-up|1|||
161225518|NCT02180711|582207856|FG005|Overall Study|Lost to Follow-up|1|||
161225519|NCT02180711|582207857|FG006|Overall Study|Lost to Follow-up|0|||
161225520|NCT02180711|582207858|FG007|Overall Study|Lost to Follow-up|3|||
161225521|NCT02180711|582207851|FG000|Overall Study|Withdrawal by Subject|2|||
161225522|NCT02180711|582207852|FG001|Overall Study|Withdrawal by Subject|1|||
160878203|NCT00717236|580949843|FG000|Double-Blind Period|Other: Death|1|||
160878204|NCT00717236|580949844|FG001|Double-Blind Period|Other: Death|0|||
160878205|NCT00717236|580949843|FG000|Double-Blind Period|Other: Pregnancy|1|||
160878206|NCT00717236|580949844|FG001|Double-Blind Period|Other: Pregnancy|0|||
160878207|NCT00717236|580949843|FG000|Double-Blind Period|Other: Protocol Violation|2|||
160878208|NCT00717236|580949844|FG001|Double-Blind Period|Other: Protocol Violation|0|||
160878209|NCT00717236|580949843|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
160878210|NCT00717236|580949844|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
160878211|NCT00717236|580949843|FG000|Double-Blind Period|Other: Site withdrew|2|||
160878212|NCT00717236|580949844|FG001|Double-Blind Period|Other: Site withdrew|0|||
160878213|NCT00717236|580949843|FG000|Double-Blind Period|Other: Screening failure|1|||
160878214|NCT00717236|580949844|FG001|Double-Blind Period|Other: Screening failure|0|||
160878215|NCT00717236|580949843|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
160878216|NCT00717236|580949844|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
161225523|NCT02180711|582207853|FG002|Overall Study|Withdrawal by Subject|0|||
161225524|NCT02180711|582207854|FG003|Overall Study|Withdrawal by Subject|4|||
161324565|NCT01381926|582575626|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
161324566|NCT01381926|582575627|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
161324567|NCT02624947|582575631|FG000|Maternal Participants|Adverse Event|5|||
161324568|NCT02624947|582575632|FG001|Maternal Participants|Adverse Event|0|||
161324569|NCT02624947|582575631|FG000|Maternal Participants|Investigator Decision|5|||
161324570|NCT02624947|582575632|FG001|Maternal Participants|Investigator Decision|3|||
161324571|NCT02624947|582575631|FG000|Maternal Participants|Lost to Follow-up|54|||
161324572|NCT02624947|582575632|FG001|Maternal Participants|Lost to Follow-up|24|||
161324573|NCT02624947|582575631|FG000|Maternal Participants|Non Compliance|8|||
161324574|NCT02624947|582575632|FG001|Maternal Participants|Non Compliance|5|||
161324575|NCT02624947|582575631|FG000|Maternal Participants|Sponsor Request|1|||
161324576|NCT02624947|582575632|FG001|Maternal Participants|Sponsor Request|1|||
161324577|NCT02624947|582575631|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
161324578|NCT02624947|582575632|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
161324579|NCT02624947|582575631|FG000|Maternal Participants|Miscellaneous|23|||
161324580|NCT02624947|582575632|FG001|Maternal Participants|Miscellaneous|15|||
161324581|NCT02624947|582575631|FG000|Infant Participants|Adverse Event|18|||
161324582|NCT02624947|582575632|FG001|Infant Participants|Adverse Event|11|||
161324583|NCT02624947|582575631|FG000|Infant Participants|Investigator Decision|5|||
160878217|NCT00717236|580949843|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
160878218|NCT00717236|580949844|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
160878219|NCT00717236|580949843|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
160878220|NCT00717236|580949844|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
160878221|NCT00717236|580949843|FG000|Double-Blind Period|Other: History of cancer|1|||
160878222|NCT00717236|580949844|FG001|Double-Blind Period|Other: History of cancer|0|||
160878223|NCT00717236|580949843|FG000|Double-Blind Period|Other: Sponsor request|1|||
160878224|NCT00717236|580949844|FG001|Double-Blind Period|Other: Sponsor request|0|||
160878225|NCT00717236|580949843|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
160878226|NCT00717236|580949844|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
160878227|NCT00717236|580949843|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
160878228|NCT00717236|580949844|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
160878229|NCT00717236|580949843|FG000|Double-Blind Period|Other: Subject moved|1|||
160878230|NCT00717236|580949844|FG001|Double-Blind Period|Other: Subject moved|1|||
160878231|NCT00717236|580949843|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
160878232|NCT00717236|580949844|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
160878233|NCT00717236|580949843|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
160878234|NCT00717236|580949844|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
160878235|NCT00717236|580949843|FG000|Double-Blind Period|Other: Transportation problems|0|||
160878236|NCT00717236|580949844|FG001|Double-Blind Period|Other: Transportation problems|1|||
160878237|NCT00717236|580949843|FG000|Double-Blind Period|Other: Investigator Decision|0|||
160878238|NCT00717236|580949844|FG001|Double-Blind Period|Other: Investigator Decision|1|||
160878239|NCT00717236|580949843|FG000|Open-Label Period|Adverse Event|29|||
160878240|NCT00717236|580949844|FG001|Open-Label Period|Adverse Event|4|||
160878241|NCT00717236|580949843|FG000|Open-Label Period|Lack of Efficacy|30|||
160878242|NCT00717236|580949844|FG001|Open-Label Period|Lack of Efficacy|8|||
160878243|NCT00717236|580949843|FG000|Open-Label Period|Lost to Follow-up|28|||
160878244|NCT00717236|580949844|FG001|Open-Label Period|Lost to Follow-up|4|||
160878245|NCT00717236|580949843|FG000|Open-Label Period|Withdrawal by Subject|20|||
160878246|NCT00717236|580949844|FG001|Open-Label Period|Withdrawal by Subject|2|||
160878247|NCT00717236|580949843|FG000|Open-Label Period|Loss of Efficacy|6|||
160878248|NCT00717236|580949844|FG001|Open-Label Period|Loss of Efficacy|1|||
160878249|NCT00717236|580949843|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
160878250|NCT00717236|580949844|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
160878251|NCT00717236|580949843|FG000|Open-Label Period|Other: Lack of Compliance|1|||
160878252|NCT00717236|580949844|FG001|Open-Label Period|Other: Lack of Compliance|1|||
160878253|NCT00717236|580949843|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
160878254|NCT00717236|580949844|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
160878255|NCT00717236|580949843|FG000|Open-Label Period|Other: Moved|1|||
160878256|NCT00717236|580949844|FG001|Open-Label Period|Other: Moved|0|||
160878257|NCT00717236|580949843|FG000|Open-Label Period|Other: Investigator Decision|1|||
161120411|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
161120412|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
161120413|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
161120414|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
161120415|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
161120416|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
161120417|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
161120418|NCT02600494|581827184|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
161120419|NCT02600494|581827185|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
161120420|NCT02600494|581827186|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
161120421|NCT02600494|581827184|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
161120422|NCT02600494|581827185|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
161120423|NCT02600494|581827186|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
161120424|NCT02600494|581827184|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
161120425|NCT02600494|581827185|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
161120426|NCT02600494|581827186|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
161120427|NCT02600494|581827184|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
161120428|NCT02600494|581827185|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
161120429|NCT02600494|581827186|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
161120430|NCT02600494|581827184|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
161120431|NCT02600494|581827185|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
161120432|NCT02600494|581827186|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
161120433|NCT02600494|581827184|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
161120434|NCT02600494|581827185|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
161120435|NCT02600494|581827186|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
161120436|NCT02600494|581827184|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
161120437|NCT02600494|581827185|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
160878258|NCT00717236|580949844|FG001|Open-Label Period|Other: Investigator Decision|0|||
160878259|NCT00717236|580949843|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
160878260|NCT00717236|580949844|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
160878261|NCT00717236|580949843|FG000|Open-Label Period|Other: Sponsor Request|3|||
160878262|NCT00717236|580949844|FG001|Open-Label Period|Other: Sponsor Request|0|||
160878263|NCT00717236|580949843|FG000|Open-Label Period|Other: Cataract Surgery|1|||
161225525|NCT02180711|582207855|FG004|Overall Study|Withdrawal by Subject|3|||
161225526|NCT02180711|582207856|FG005|Overall Study|Withdrawal by Subject|0|||
161225527|NCT02180711|582207857|FG006|Overall Study|Withdrawal by Subject|3|||
161225528|NCT02180711|582207858|FG007|Overall Study|Withdrawal by Subject|2|||
161225529|NCT02180711|582207851|FG000|Overall Study|- Disease Progression|0|||
161225530|NCT02180711|582207852|FG001|Overall Study|- Disease Progression|1|||
161225531|NCT02180711|582207853|FG002|Overall Study|- Disease Progression|0|||
161225532|NCT02180711|582207854|FG003|Overall Study|- Disease Progression|0|||
161225533|NCT02180711|582207855|FG004|Overall Study|- Disease Progression|0|||
161225534|NCT02180711|582207856|FG005|Overall Study|- Disease Progression|0|||
161225535|NCT02180711|582207857|FG006|Overall Study|- Disease Progression|0|||
161225536|NCT02180711|582207858|FG007|Overall Study|- Disease Progression|0|||
161225537|NCT02180711|582207851|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
161225538|NCT02180711|582207852|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
161225539|NCT02180711|582207853|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
161225540|NCT02180711|582207854|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
161225541|NCT02180711|582207855|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161225542|NCT02180711|582207856|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161225543|NCT02180711|582207857|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161225544|NCT02180711|582207858|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
161225545|NCT02180711|582207851|FG000|Overall Study|- Study Terminated by Sponsor|2|||
161225546|NCT02180711|582207852|FG001|Overall Study|- Study Terminated by Sponsor|3|||
161225547|NCT02180711|582207853|FG002|Overall Study|- Study Terminated by Sponsor|0|||
161225548|NCT02180711|582207854|FG003|Overall Study|- Study Terminated by Sponsor|5|||
161225549|NCT02180711|582207855|FG004|Overall Study|- Study Terminated by Sponsor|32|||
161225550|NCT02180711|582207856|FG005|Overall Study|- Study Terminated by Sponsor|0|||
161225551|NCT02180711|582207857|FG006|Overall Study|- Study Terminated by Sponsor|4|||
160878264|NCT00717236|580949844|FG001|Open-Label Period|Other: Cataract Surgery|0|||
160878265|NCT00717236|580949843|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
160878266|NCT00717236|580949844|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
160878267|NCT00717236|580949843|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
160878268|NCT00717236|580949844|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
160878269|NCT00717236|580949843|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
161225552|NCT02180711|582207858|FG007|Overall Study|- Study Terminated by Sponsor|13|||
161225553|NCT02180711|582207851|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
161225554|NCT02180711|582207852|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
161225555|NCT02180711|582207853|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
161225556|NCT02180711|582207854|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
161225557|NCT02180711|582207855|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
161225558|NCT02180711|582207856|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
161225559|NCT02180711|582207857|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
161225560|NCT02180711|582207858|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
161225561|NCT02180711|582207851|FG000|Overall Study|- Other|1|||
161225562|NCT02180711|582207852|FG001|Overall Study|- Other|0|||
161225563|NCT02180711|582207853|FG002|Overall Study|- Other|0|||
161225564|NCT02180711|582207854|FG003|Overall Study|- Other|1|||
161225565|NCT02180711|582207855|FG004|Overall Study|- Other|0|||
161225566|NCT02180711|582207856|FG005|Overall Study|- Other|0|||
161225567|NCT02180711|582207857|FG006|Overall Study|- Other|0|||
161225568|NCT02180711|582207858|FG007|Overall Study|- Other|0|||
161225569|NCT00444145|582207859|FG000|Overall Study|Withdrawal by Subject|2|||
161225570|NCT00444145|582207859|FG000|Overall Study|Lost to Follow-up|1|||
161225571|NCT00444145|582207859|FG000|Overall Study|non-compliant|11|||
161225572|NCT00444145|582207859|FG000|Overall Study|Screen Failures|5|||
161225573|NCT01619800|582207860|FG000|Overall Study|study terminated|2|||
161225574|NCT01619800|582207861|FG001|Overall Study|study terminated|0|||
161225575|NCT00414466|582207863|FG000|Overall Study|Adverse Event|0|||
160878270|NCT00717236|580949844|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
161225576|NCT00414466|582207864|FG001|Overall Study|Adverse Event|0|||
161225577|NCT00414466|582207865|FG002|Overall Study|Adverse Event|1|||
161225578|NCT00414466|582207866|FG003|Overall Study|Adverse Event|1|||
161225579|NCT00414466|582207863|FG000|Overall Study|Lack of Efficacy|1|||
161225580|NCT00414466|582207864|FG001|Overall Study|Lack of Efficacy|0|||
161225581|NCT00414466|582207865|FG002|Overall Study|Lack of Efficacy|0|||
161225582|NCT00414466|582207866|FG003|Overall Study|Lack of Efficacy|0|||
161225583|NCT00414466|582207863|FG000|Overall Study|Withdrawn by Sponsor|1|||
161225584|NCT00414466|582207864|FG001|Overall Study|Withdrawn by Sponsor|0|||
160878271|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
160878272|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
160878273|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
160878274|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
160878275|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
160878276|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
160878277|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
160878278|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
160878279|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
160878280|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
160878281|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
160878282|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
160878283|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
160878284|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
160878285|NCT00612105|580949845|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
160878286|NCT00612105|580949846|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
160878287|NCT00612105|580949845|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
160878288|NCT00612105|580949846|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
160878289|NCT00612105|580949845|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
160878290|NCT00612105|580949846|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
160878291|NCT00612105|580949845|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
160878292|NCT00612105|580949846|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
160878293|NCT00612105|580949845|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
160878294|NCT00612105|580949846|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
160878295|NCT01105767|580949847|FG000|Overall Study|Lost to Follow-up|1160|||
160878296|NCT01105767|580949848|FG001|Overall Study|Lost to Follow-up|1614|||
160878297|NCT01105767|580949849|FG002|Overall Study|Lost to Follow-up|1184|||
160878298|NCT00475982|580949850|FG000|Overall Study|surgery rescheduled|7|||
160878299|NCT00475982|580949851|FG001|Overall Study|surgery rescheduled|3|||
160878300|NCT02410343|580949856|FG000|Core Period (24 Weeks)|Adverse Event|1|||
160878301|NCT02410343|580949857|FG001|Core Period (24 Weeks)|Adverse Event|0|||
160878302|NCT02410343|580949856|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
160878303|NCT02410343|580949857|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
160878304|NCT02410343|580949856|FG000|Extension Period (12 Months)|Adverse Event|1|||
160878305|NCT02410343|580949857|FG001|Extension Period (12 Months)|Adverse Event|0|||
160878306|NCT02410343|580949856|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
160878307|NCT02410343|580949857|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
160878308|NCT00029146|580949858|FG000|Overall Study|Lost to Follow-up|2|||
160878309|NCT00029146|580949859|FG001|Overall Study|Lost to Follow-up|1|||
160878310|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
160878311|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
160878312|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
160878313|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
160878314|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
160878315|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
160878316|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
160878317|NCT00946985|580949860|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
160878318|NCT00946985|580949860|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
160878319|NCT00271505|580949861|FG000|Overall Study|Screen Failure|3|||
160878320|NCT00271505|580949861|FG000|Overall Study|Adverse Event|1|||
160878321|NCT00271505|580949861|FG000|Overall Study|Death|1|||
160878322|NCT04556383|580949862|FG000|PCP|Lack of Efficacy|28|||
160878323|NCT04556383|580949863|FG001|PCP|Lack of Efficacy|23|||
161225585|NCT00414466|582207865|FG002|Overall Study|Withdrawn by Sponsor|0|||
160878324|NCT04556383|580949864|FG002|PCP|Lack of Efficacy|23|||
160878325|NCT04556383|580949865|FG003|PCP|Lack of Efficacy|0|||
160878326|NCT04556383|580949862|FG000|PCP|Study terminated by sponsor|15|||
160878327|NCT04556383|580949863|FG001|PCP|Study terminated by sponsor|13|||
160878328|NCT04556383|580949864|FG002|PCP|Study terminated by sponsor|16|||
160878329|NCT04556383|580949865|FG003|PCP|Study terminated by sponsor|0|||
160878330|NCT04556383|580949862|FG000|PCP|Withdrawal by Subject|8|||
161225586|NCT00414466|582207866|FG003|Overall Study|Withdrawn by Sponsor|0|||
160878331|NCT04556383|580949863|FG001|PCP|Withdrawal by Subject|6|||
160878332|NCT04556383|580949864|FG002|PCP|Withdrawal by Subject|6|||
160878333|NCT04556383|580949865|FG003|PCP|Withdrawal by Subject|0|||
160878334|NCT04556383|580949862|FG000|PCP|Adverse Event|1|||
160878335|NCT04556383|580949863|FG001|PCP|Adverse Event|7|||
160878336|NCT04556383|580949864|FG002|PCP|Adverse Event|7|||
160878337|NCT04556383|580949865|FG003|PCP|Adverse Event|0|||
160878338|NCT04556383|580949862|FG000|PCP|Other, Not Specified|1|||
160878339|NCT04556383|580949863|FG001|PCP|Other, Not Specified|2|||
160878340|NCT04556383|580949864|FG002|PCP|Other, Not Specified|1|||
160878341|NCT04556383|580949865|FG003|PCP|Other, Not Specified|0|||
160878342|NCT04556383|580949862|FG000|PCP|Protocol Violation|1|||
160878343|NCT04556383|580949863|FG001|PCP|Protocol Violation|0|||
160878344|NCT04556383|580949864|FG002|PCP|Protocol Violation|1|||
160878345|NCT04556383|580949865|FG003|PCP|Protocol Violation|0|||
160878346|NCT04556383|580949862|FG000|PCP|Lost to Follow-up|1|||
161225587|NCT02016300|582207869|FG000|Overall Study|Lost to Follow-up|0|||
161225588|NCT02016300|582207870|FG001|Overall Study|Lost to Follow-up|3|||
161225589|NCT05301751|582207875|FG000|Overall Study|Withdrawal by Subject|0|||
161225590|NCT05301751|582207876|FG001|Overall Study|Withdrawal by Subject|0|||
161225591|NCT05301751|582207877|FG002|Overall Study|Withdrawal by Subject|1|||
161225592|NCT05301751|582207878|FG003|Overall Study|Withdrawal by Subject|0|||
161225593|NCT06165744|582207881|FG000|Overall Study|Non device-related adverse event|1|||
161225594|NCT01546987|582207882|FG000|Overall Study|Protocol Violation|3|||
161225595|NCT01546987|582207883|FG001|Overall Study|Protocol Violation|4|||
161225596|NCT02270736|582207884|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161225597|NCT02270736|582207885|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
161225598|NCT02270736|582207886|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161225599|NCT02270736|582207887|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161225600|NCT02270736|582207888|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
161225601|NCT02270736|582207884|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
161225602|NCT02270736|582207885|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161225603|NCT02270736|582207886|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
161225604|NCT02270736|582207887|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161225605|NCT02270736|582207888|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
161225606|NCT02270736|582207884|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161225607|NCT02270736|582207885|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
161225608|NCT02270736|582207886|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161225609|NCT02270736|582207887|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161225610|NCT02270736|582207888|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
161225611|NCT02270736|582207884|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161225612|NCT02270736|582207885|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161225613|NCT02270736|582207886|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
161225614|NCT02270736|582207887|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161225615|NCT02270736|582207888|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
161225616|NCT02270736|582207884|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161225617|NCT02270736|582207885|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161225618|NCT02270736|582207886|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161225619|NCT02270736|582207887|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
161225620|NCT02270736|582207888|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
161225621|NCT02270736|582207884|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161225622|NCT02270736|582207885|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161225623|NCT02270736|582207886|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161225624|NCT02270736|582207887|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
161225625|NCT02270736|582207888|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
161225626|NCT02270736|582207884|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161225627|NCT02270736|582207885|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161225628|NCT02270736|582207886|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161225629|NCT02270736|582207887|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
161225630|NCT02270736|582207888|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
161225631|NCT02270736|582207884|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161225632|NCT02270736|582207885|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161225633|NCT02270736|582207886|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161225634|NCT02270736|582207887|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
161225635|NCT02270736|582207888|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
161225636|NCT02270736|582207884|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161225637|NCT02270736|582207885|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161225638|NCT02270736|582207886|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161225639|NCT02270736|582207887|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
161225640|NCT02270736|582207888|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
161225641|NCT00262600|582207889|FG000|Overall Study|Lost to Follow-up|17|||
161225642|NCT00262600|582207890|FG001|Overall Study|Lost to Follow-up|31|||
161225643|NCT00262600|582207891|FG002|Overall Study|Lost to Follow-up|41|||
161225644|NCT00262600|582207889|FG000|Overall Study|Withdrawal by Subject|128|||
161225645|NCT00262600|582207890|FG001|Overall Study|Withdrawal by Subject|145|||
161225646|NCT00262600|582207891|FG002|Overall Study|Withdrawal by Subject|139|||
160878347|NCT04556383|580949863|FG001|PCP|Lost to Follow-up|0|||
160878348|NCT04556383|580949864|FG002|PCP|Lost to Follow-up|0|||
160878349|NCT04556383|580949865|FG003|PCP|Lost to Follow-up|0|||
160878350|NCT04556383|580949862|FG000|PCP|Physician Decision|0|||
160878351|NCT04556383|580949863|FG001|PCP|Physician Decision|1|||
160878352|NCT04556383|580949864|FG002|PCP|Physician Decision|0|||
160878353|NCT04556383|580949865|FG003|PCP|Physician Decision|0|||
160878354|NCT04556383|580949862|FG000|PCP|Site terminated by sponsor|0|||
160878355|NCT04556383|580949863|FG001|PCP|Site terminated by sponsor|1|||
160878356|NCT04556383|580949864|FG002|PCP|Site terminated by sponsor|0|||
160878357|NCT04556383|580949865|FG003|PCP|Site terminated by sponsor|0|||
160878358|NCT04556383|580949862|FG000|OLE|Study terminated by sponsor|0|||
160878359|NCT04556383|580949863|FG001|OLE|Study terminated by sponsor|0|||
160878360|NCT04556383|580949864|FG002|OLE|Study terminated by sponsor|0|||
160878361|NCT04556383|580949865|FG003|OLE|Study terminated by sponsor|68|||
160878362|NCT04556383|580949862|FG000|OLE|Withdrawal by Subject|0|||
160878363|NCT04556383|580949863|FG001|OLE|Withdrawal by Subject|0|||
160878364|NCT04556383|580949864|FG002|OLE|Withdrawal by Subject|0|||
160878365|NCT04556383|580949865|FG003|OLE|Withdrawal by Subject|10|||
160878366|NCT04556383|580949862|FG000|OLE|Lack of Efficacy|0|||
160878367|NCT04556383|580949863|FG001|OLE|Lack of Efficacy|0|||
160878368|NCT04556383|580949864|FG002|OLE|Lack of Efficacy|0|||
160878369|NCT04556383|580949865|FG003|OLE|Lack of Efficacy|7|||
160878370|NCT04556383|580949862|FG000|OLE|Adverse Event|0|||
160878371|NCT04556383|580949863|FG001|OLE|Adverse Event|0|||
160878372|NCT04556383|580949864|FG002|OLE|Adverse Event|0|||
160878373|NCT04556383|580949865|FG003|OLE|Adverse Event|2|||
160878374|NCT04556383|580949862|FG000|OLE|Other, Not Specified|0|||
160878375|NCT04556383|580949863|FG001|OLE|Other, Not Specified|0|||
160878376|NCT04556383|580949864|FG002|OLE|Other, Not Specified|0|||
160878377|NCT04556383|580949865|FG003|OLE|Other, Not Specified|2|||
160878378|NCT04556383|580949862|FG000|OLE|Death|0|||
160878379|NCT04556383|580949863|FG001|OLE|Death|0|||
160878380|NCT04556383|580949864|FG002|OLE|Death|0|||
160878381|NCT04556383|580949865|FG003|OLE|Death|1|||
160878382|NCT04556383|580949862|FG000|OLE|Lost to Follow-up|0|||
160878383|NCT04556383|580949863|FG001|OLE|Lost to Follow-up|0|||
160878384|NCT04556383|580949864|FG002|OLE|Lost to Follow-up|0|||
160878385|NCT04556383|580949865|FG003|OLE|Lost to Follow-up|1|||
160878386|NCT03704636|580949866|FG000|Overall Study|Inadequate Venous Flow|3|||
160878387|NCT02720042|580949867|FG000|Overall Study|Death|3|||
160878388|NCT02720042|580949867|FG000|Overall Study|Lost to Follow-up|4|||
160878389|NCT02720042|580949867|FG000|Overall Study|Withdrawal by Subject|1|||
160878390|NCT02720042|580949867|FG000|Overall Study|Physician Decision|3|||
160878391|NCT02720042|580949867|FG000|Overall Study|Phasix Mesh explanted|1|||
160878392|NCT02720042|580949867|FG000|Overall Study|unable due to non-study-related illness|3|||
160878393|NCT00539188|580949868|FG000|Overall Study|Withdrawal by Subject|1|||
160878394|NCT00539188|580949869|FG001|Overall Study|Withdrawal by Subject|0|||
160878395|NCT00539188|580949868|FG000|Overall Study|Lost to Follow-up|2|||
160878396|NCT00539188|580949869|FG001|Overall Study|Lost to Follow-up|1|||
160878397|NCT00509145|580949870|FG000|Overall Study|Death|0|||
160878398|NCT00509145|580949871|FG001|Overall Study|Death|2|||
161225647|NCT00262600|582207889|FG000|Overall Study|Not Treated|32|||
161225648|NCT00262600|582207890|FG001|Overall Study|Not Treated|17|||
160878399|NCT00509145|580949870|FG000|Overall Study|Adverse Event|42|||
160878400|NCT00509145|580949871|FG001|Overall Study|Adverse Event|28|||
160878401|NCT00509145|580949870|FG000|Overall Study|Withdrawal by Subject|32|||
160878402|NCT00509145|580949871|FG001|Overall Study|Withdrawal by Subject|38|||
160878403|NCT00509145|580949870|FG000|Overall Study|Physician Decision|11|||
160878404|NCT00509145|580949871|FG001|Overall Study|Physician Decision|14|||
161225649|NCT00262600|582207891|FG002|Overall Study|Not Treated|24|||
160878405|NCT00509145|580949870|FG000|Overall Study|Protocol Violation|1|||
160878406|NCT00509145|580949871|FG001|Overall Study|Protocol Violation|6|||
160878407|NCT00509145|580949870|FG000|Overall Study|Pregnancy|3|||
160878408|NCT00509145|580949871|FG001|Overall Study|Pregnancy|8|||
160878409|NCT00509145|580949870|FG000|Overall Study|Lost to Follow-up|6|||
160878410|NCT00509145|580949871|FG001|Overall Study|Lost to Follow-up|5|||
160878411|NCT00509145|580949870|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
160878412|NCT00509145|580949871|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
160878413|NCT00509145|580949870|FG000|Overall Study|Other|6|||
160878414|NCT00509145|580949871|FG001|Overall Study|Other|6|||
160878415|NCT01994889|580949874|FG000|Overall Study|Adverse Event|5|||
160878416|NCT01994889|580949875|FG001|Overall Study|Adverse Event|12|||
160878417|NCT01994889|580949876|FG002|Overall Study|Adverse Event|11|||
160878418|NCT01994889|580949874|FG000|Overall Study|Cardiac Device Implantation|0|||
160878419|NCT01994889|580949875|FG001|Overall Study|Cardiac Device Implantation|2|||
161120438|NCT02600494|581827186|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
161120439|NCT03124563|581827188|FG000|Overall Study|Lost to Follow-up|1|||
161120440|NCT03124563|581827189|FG001|Overall Study|Lost to Follow-up|1|||
161120441|NCT03124563|581827188|FG000|Overall Study|Withdrawal by Subject|1|||
161120442|NCT03124563|581827189|FG001|Overall Study|Withdrawal by Subject|1|||
161120443|NCT02396589|581827194|FG000|Intervention|Lost to Follow-up|1|||
161120444|NCT02396589|581827195|FG001|Intervention|Lost to Follow-up|0|||
161120445|NCT02396589|581827194|FG000|6 Month Follow-up|change in health status|0|||
161120446|NCT02396589|581827195|FG001|6 Month Follow-up|change in health status|1|||
161120447|NCT02396589|581827194|FG000|9 Month Follow-up|Death|0|||
161120448|NCT02396589|581827195|FG001|9 Month Follow-up|Death|1|||
161120449|NCT02396589|581827194|FG000|12 Month Follow up|Lost to Follow-up|0|||
161120450|NCT02396589|581827195|FG001|12 Month Follow up|Lost to Follow-up|2|||
161120451|NCT05593016|581829424|FG000|Overall Study|Death|1|||
161120452|NCT05593016|581829425|FG001|Overall Study|Death|1|||
161120453|NCT05593016|581829426|FG002|Overall Study|Death|1|||
161120454|NCT05593016|581829427|FG003|Overall Study|Death|0|||
161120455|NCT05593016|581829428|FG004|Overall Study|Death|0|||
161120456|NCT05593016|581829424|FG000|Overall Study|Lost to Follow-up|1|||
161120457|NCT05593016|581829425|FG001|Overall Study|Lost to Follow-up|1|||
161120458|NCT05593016|581829426|FG002|Overall Study|Lost to Follow-up|1|||
161120459|NCT05593016|581829427|FG003|Overall Study|Lost to Follow-up|2|||
161120460|NCT05593016|581829428|FG004|Overall Study|Lost to Follow-up|0|||
161120461|NCT05416138|581829429|FG000|Overall Study|Withdrawal by Subject|2|||
161120462|NCT05416138|581829430|FG001|Overall Study|Withdrawal by Subject|1|||
161120463|NCT04705051|581829431|FG000|Overall Study|Enrolled but not treated|1|||
161120464|NCT04705051|581829431|FG000|Overall Study|Study terminated by sponsor|23|||
161120465|NCT03686397|581829432|FG000|Overall Study|Lack of Efficacy|3|||
161120466|NCT03686397|581829433|FG001|Overall Study|Lack of Efficacy|5|||
161120467|NCT03686397|581829432|FG000|Overall Study|Adverse Event|0|||
161120468|NCT03686397|581829433|FG001|Overall Study|Adverse Event|1|||
161120469|NCT03686397|581829432|FG000|Overall Study|Protocol Violation|0|||
161120470|NCT03686397|581829433|FG001|Overall Study|Protocol Violation|1|||
161120471|NCT03686397|581829432|FG000|Overall Study|Withdrawal by Subject|0|||
161120472|NCT03686397|581829433|FG001|Overall Study|Withdrawal by Subject|1|||
161120473|NCT03686397|581829432|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
161120474|NCT03686397|581829433|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
161120475|NCT02814565|581829435|FG000|Overall Study|Lack of Efficacy|0|||
161120476|NCT02814565|581829436|FG001|Overall Study|Lack of Efficacy|1|||
161120477|NCT02814565|581829435|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
161120478|NCT02814565|581829436|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
161120479|NCT04735653|581829437|FG000|Overall Study|Lost to Follow-up|17|||
161120480|NCT04735653|581829438|FG001|Overall Study|Lost to Follow-up|7|||
161120481|NCT04735653|581829437|FG000|Overall Study|Withdrawal by Subject|8|||
161120482|NCT04735653|581829438|FG001|Overall Study|Withdrawal by Subject|2|||
161120483|NCT04735653|581829437|FG000|Overall Study|Death|0|||
161120484|NCT04735653|581829438|FG001|Overall Study|Death|2|||
161120485|NCT04735653|581829437|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
161120486|NCT04735653|581829438|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
161120487|NCT00608985|581829443|FG000|Overall Study|Adverse Event|2|||
160878420|NCT01994889|580949876|FG002|Overall Study|Cardiac Device Implantation|0|||
160878421|NCT01994889|580949874|FG000|Overall Study|Organ Transplantation|1|||
161120488|NCT00608985|581829444|FG001|Overall Study|Adverse Event|7|||
161120489|NCT00608985|581829445|FG002|Overall Study|Adverse Event|4|||
161120490|NCT00608985|581829446|FG003|Overall Study|Adverse Event|6|||
161120491|NCT00608985|581829443|FG000|Overall Study|Administrative/Other|7|||
161120492|NCT00608985|581829444|FG001|Overall Study|Administrative/Other|4|||
161120493|NCT00608985|581829445|FG002|Overall Study|Administrative/Other|1|||
161120494|NCT00608985|581829446|FG003|Overall Study|Administrative/Other|2|||
161120495|NCT00608985|581829443|FG000|Overall Study|Withdrawal of Consent|5|||
161120496|NCT00608985|581829444|FG001|Overall Study|Withdrawal of Consent|1|||
161120497|NCT00608985|581829445|FG002|Overall Study|Withdrawal of Consent|1|||
161120498|NCT00608985|581829446|FG003|Overall Study|Withdrawal of Consent|1|||
161225650|NCT00262600|582207889|FG000|Overall Study|Other|58|||
161225651|NCT00262600|582207890|FG001|Overall Study|Other|59|||
161225652|NCT00262600|582207891|FG002|Overall Study|Other|62|||
161225653|NCT05381948|582207896|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
161225654|NCT05381948|582207897|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
161225655|NCT05381948|582207898|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
161225656|NCT05381948|582207896|FG000|Overall Study|Adverse Event: Non-ocular|0|||
161225657|NCT05381948|582207897|FG001|Overall Study|Adverse Event: Non-ocular|1|||
161225658|NCT05381948|582207898|FG002|Overall Study|Adverse Event: Non-ocular|0|||
161225659|NCT05381948|582207896|FG000|Overall Study|Lost to Follow-up|1|||
161225660|NCT05381948|582207897|FG001|Overall Study|Lost to Follow-up|0|||
161225661|NCT05381948|582207898|FG002|Overall Study|Lost to Follow-up|0|||
161225662|NCT05381948|582207896|FG000|Overall Study|Protocol Deviation|0|||
161225663|NCT05381948|582207897|FG001|Overall Study|Protocol Deviation|2|||
161225664|NCT05381948|582207898|FG002|Overall Study|Protocol Deviation|0|||
161225665|NCT05381948|582207896|FG000|Overall Study|Withdrawal by Subject|1|||
161225666|NCT05381948|582207897|FG001|Overall Study|Withdrawal by Subject|0|||
161225667|NCT05381948|582207898|FG002|Overall Study|Withdrawal by Subject|1|||
161225668|NCT05381948|582207896|FG000|Overall Study|Death|0|||
161225669|NCT05381948|582207897|FG001|Overall Study|Death|2|||
161225670|NCT05381948|582207898|FG002|Overall Study|Death|0|||
161225671|NCT05381948|582207896|FG000|Overall Study|Discontinued study without receiving study drug|0|||
161225672|NCT05381948|582207897|FG001|Overall Study|Discontinued study without receiving study drug|0|||
161225673|NCT05381948|582207898|FG002|Overall Study|Discontinued study without receiving study drug|1|||
161225674|NCT04471207|582207899|FG000|Overall Study|Lost to Follow-up|4|||
161225675|NCT04471207|582207900|FG001|Overall Study|Lost to Follow-up|1|||
161225676|NCT04471207|582207899|FG000|Overall Study|Medication Contraindication|0|||
161225677|NCT04471207|582207900|FG001|Overall Study|Medication Contraindication|1|||
161225678|NCT04471207|582207899|FG000|Overall Study|Loss of Interest|2|||
161225679|NCT04471207|582207900|FG001|Overall Study|Loss of Interest|1|||
161225680|NCT04471207|582207899|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
161225681|NCT04471207|582207900|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
161225682|NCT04471207|582207899|FG000|Overall Study|Scheduling Conflicts|3|||
161225683|NCT04471207|582207900|FG001|Overall Study|Scheduling Conflicts|1|||
161225684|NCT04471207|582207899|FG000|Overall Study|Physician Decision|1|||
161225685|NCT04471207|582207900|FG001|Overall Study|Physician Decision|0|||
161225686|NCT04471207|582207899|FG000|Overall Study|Unwilling to Use System|0|||
161225687|NCT04471207|582207900|FG001|Overall Study|Unwilling to Use System|1|||
161225688|NCT02132247|582207905|FG000|Overall Study|Protocol Violation|1|||
161225689|NCT02132247|582207906|FG001|Overall Study|Protocol Violation|0|||
161225690|NCT00520741|582207909|FG000|Overall Study|Adverse Event|16|||
161225691|NCT00520741|582207910|FG001|Overall Study|Adverse Event|56|||
161225692|NCT00520741|582207909|FG000|Overall Study|Lack of Efficacy|11|||
161225693|NCT00520741|582207910|FG001|Overall Study|Lack of Efficacy|30|||
161225694|NCT00520741|582207909|FG000|Overall Study|Withdrawal by Subject|0|||
161225695|NCT00520741|582207910|FG001|Overall Study|Withdrawal by Subject|11|||
161225696|NCT00520741|582207909|FG000|Overall Study|Protocol Violation|2|||
161225697|NCT00520741|582207910|FG001|Overall Study|Protocol Violation|15|||
161225698|NCT00520741|582207909|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
161225699|NCT00520741|582207910|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
161225700|NCT00520741|582207909|FG000|Overall Study|Lost to Follow-up|4|||
161225701|NCT00520741|582207910|FG001|Overall Study|Lost to Follow-up|4|||
161225702|NCT00520741|582207909|FG000|Overall Study|Other reasons for premature termination|0|||
161120499|NCT00608985|581829443|FG000|Overall Study|Lost to Follow-up|2|||
161120500|NCT00608985|581829444|FG001|Overall Study|Lost to Follow-up|1|||
161120501|NCT00608985|581829445|FG002|Overall Study|Lost to Follow-up|0|||
161120502|NCT00608985|581829446|FG003|Overall Study|Lost to Follow-up|0|||
161120503|NCT00661271|581829447|FG000|Overall Study|Lost to Follow-up|28|||
161120504|NCT00661271|581829448|FG001|Overall Study|Lost to Follow-up|25|||
161120505|NCT00953758|581829449|FG000|Overall Study|Death|2|||
161120506|NCT00953758|581829450|FG001|Overall Study|Death|0|||
161225703|NCT00520741|582207910|FG001|Overall Study|Other reasons for premature termination|6|||
161225704|NCT03702621|582207911|FG000|Overall Study|Physician Decision|6|||
161225705|NCT03702621|582207912|FG001|Overall Study|Physician Decision|6|||
161225706|NCT03444038|582207913|FG000|Overall Study|Adverse Event|12|||
161225707|NCT03444038|582207913|FG000|Overall Study|Withdrawal by Subject|7|||
161225708|NCT03444038|582207913|FG000|Overall Study|Lost to Follow-up|1|||
161225709|NCT03444038|582207913|FG000|Overall Study|Physician Decision|2|||
161225710|NCT03444038|582207913|FG000|Overall Study|Lack of Efficacy|7|||
161120507|NCT00953758|581829451|FG002|Overall Study|Death|1|||
161120508|NCT00953758|581829452|FG003|Overall Study|Death|1|||
161120509|NCT00953758|581829453|FG004|Overall Study|Death|1|||
161225711|NCT02354586|582207915|FG000|Overall Study|Death|230|||
161225712|NCT02354586|582207915|FG000|Overall Study|Withdrawal by Subject|59|||
161225713|NCT02354586|582207915|FG000|Overall Study|Lost to Follow-up|11|||
161225714|NCT02354586|582207915|FG000|Overall Study|Sponsor decision|51|||
161225715|NCT02354586|582207915|FG000|Overall Study|Site closure|2|||
161225716|NCT02354586|582207915|FG000|Overall Study|Intercurrent illness|1|||
161225717|NCT02354586|582207915|FG000|Overall Study|Protocol Violation|3|||
161225718|NCT02354586|582207915|FG000|Overall Study|Physician Decision|13|||
161225719|NCT02354586|582207915|FG000|Overall Study|Lack of Efficacy|86|||
161225720|NCT02354586|582207915|FG000|Overall Study|Adverse Event|7|||
161225721|NCT00721409|582207916|FG000|Overall Study|Global deterioration of health status|2|||
161225722|NCT00721409|582207917|FG001|Overall Study|Global deterioration of health status|6|||
161225723|NCT00721409|582207918|FG002|Overall Study|Global deterioration of health status|3|||
161225724|NCT00721409|582207916|FG000|Overall Study|Death|0|||
161225725|NCT00721409|582207917|FG001|Overall Study|Death|1|||
161225726|NCT00721409|582207918|FG002|Overall Study|Death|0|||
161225727|NCT00721409|582207916|FG000|Overall Study|Randomized not Treated|0|||
161225728|NCT00721409|582207917|FG001|Overall Study|Randomized not Treated|1|||
161225729|NCT00721409|582207918|FG002|Overall Study|Randomized not Treated|4|||
161225730|NCT00721409|582207916|FG000|Overall Study|Reason not specified|1|||
161225731|NCT00721409|582207917|FG001|Overall Study|Reason not specified|0|||
161225732|NCT00721409|582207918|FG002|Overall Study|Reason not specified|2|||
161225733|NCT00721409|582207916|FG000|Overall Study|Adverse Event|0|||
161225734|NCT00721409|582207917|FG001|Overall Study|Adverse Event|13|||
161225735|NCT00721409|582207918|FG002|Overall Study|Adverse Event|2|||
161225736|NCT00721409|582207916|FG000|Overall Study|Lost to Follow-up|0|||
161225737|NCT00721409|582207917|FG001|Overall Study|Lost to Follow-up|0|||
161225738|NCT00721409|582207918|FG002|Overall Study|Lost to Follow-up|1|||
161225739|NCT00721409|582207916|FG000|Overall Study|Withdrawal by Subject|1|||
161225740|NCT00721409|582207917|FG001|Overall Study|Withdrawal by Subject|6|||
161225741|NCT00721409|582207918|FG002|Overall Study|Withdrawal by Subject|5|||
161225742|NCT00721409|582207916|FG000|Overall Study|Objective progression or relapse|8|||
161225743|NCT00721409|582207917|FG001|Overall Study|Objective progression or relapse|55|||
161225744|NCT00721409|582207918|FG002|Overall Study|Objective progression or relapse|62|||
161225745|NCT01957488|582207919|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
161225746|NCT01957488|582207920|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161225747|NCT01957488|582207921|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
161225748|NCT01957488|582207922|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
161225749|NCT01957488|582207923|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161225750|NCT01957488|582207924|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
161225751|NCT01957488|582207919|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
161225752|NCT01957488|582207920|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
161225753|NCT01957488|582207921|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
161225754|NCT01957488|582207922|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
161225755|NCT01957488|582207923|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
161225756|NCT01957488|582207924|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
161225757|NCT01957488|582207919|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
161225758|NCT01957488|582207920|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
161225759|NCT01957488|582207921|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
161225760|NCT01957488|582207922|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
161225761|NCT01957488|582207923|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
161225762|NCT01957488|582207924|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
161225763|NCT01957488|582207919|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161225764|NCT01957488|582207920|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161225765|NCT01957488|582207921|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
161225766|NCT01957488|582207922|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161225767|NCT01957488|582207923|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
161225768|NCT01957488|582207924|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
161225769|NCT01957488|582207919|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161225770|NCT01957488|582207920|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161225771|NCT01957488|582207921|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161225772|NCT01957488|582207922|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161225773|NCT01957488|582207923|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
161225774|NCT01957488|582207924|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
161225775|NCT01957488|582207919|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
161225776|NCT01957488|582207920|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
161225777|NCT01957488|582207921|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
161225778|NCT01957488|582207922|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
160878422|NCT01994889|580949875|FG001|Overall Study|Organ Transplantation|5|||
160878423|NCT01994889|580949876|FG002|Overall Study|Organ Transplantation|5|||
160878424|NCT01994889|580949874|FG000|Overall Study|No longer willing to participate|8|||
160878425|NCT01994889|580949875|FG001|Overall Study|No longer willing to participate|17|||
160878426|NCT01994889|580949876|FG002|Overall Study|No longer willing to participate|37|||
160878427|NCT01994889|580949874|FG000|Overall Study|Lost to Follow-up|0|||
160878428|NCT01994889|580949875|FG001|Overall Study|Lost to Follow-up|1|||
160878429|NCT01994889|580949876|FG002|Overall Study|Lost to Follow-up|0|||
160878430|NCT01994889|580949874|FG000|Overall Study|Protocol Violation|0|||
160878431|NCT01994889|580949875|FG001|Overall Study|Protocol Violation|1|||
160878432|NCT01994889|580949876|FG002|Overall Study|Protocol Violation|1|||
160878433|NCT01994889|580949874|FG000|Overall Study|Death|14|||
160878434|NCT01994889|580949875|FG001|Overall Study|Death|25|||
160878435|NCT01994889|580949876|FG002|Overall Study|Death|38|||
160878436|NCT00334113|580949881|FG000|Overall Study|Lost to Follow-up|2|||
160878437|NCT00334113|580949882|FG001|Overall Study|Lost to Follow-up|2|||
160878438|NCT00334113|580949881|FG000|Overall Study|Withdrawal by Subject|0|||
160878439|NCT00334113|580949882|FG001|Overall Study|Withdrawal by Subject|1|||
160878440|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
160878441|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
160878442|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
160878443|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
160878444|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Other|2|||
160878445|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
160878446|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
160878447|NCT02509026|580949887|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
160878448|NCT02509026|580949887|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
160878449|NCT02509026|580949887|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
160878450|NCT02509026|580949887|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
160878451|NCT02509026|580949887|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
160878452|NCT02509026|580949887|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
160878453|NCT01165216|580949888|FG000|Overall Study|Adverse Event|6|||
160878454|NCT01165216|580949889|FG001|Overall Study|Adverse Event|3|||
160878455|NCT01165216|580949888|FG000|Overall Study|Withdrawal by Subject|1|||
160878456|NCT01165216|580949889|FG001|Overall Study|Withdrawal by Subject|1|||
160878457|NCT01165216|580949888|FG000|Overall Study|Disease progression|1|||
160878458|NCT01165216|580949889|FG001|Overall Study|Disease progression|3|||
160878459|NCT00243841|580949893|FG000|Overall Study|Physician Decision|0|||
160878460|NCT00243841|580949894|FG001|Overall Study|Physician Decision|0|||
160878461|NCT00243841|580949895|FG002|Overall Study|Physician Decision|1|||
160878462|NCT00243841|580949896|FG003|Overall Study|Physician Decision|0|||
160878463|NCT00243841|580949897|FG004|Overall Study|Physician Decision|0|||
160878464|NCT00243841|580949898|FG005|Overall Study|Physician Decision|2|||
160878465|NCT05601544|580949899|FG000|Phase 2 Period 1|Adverse Event|0|||
160878466|NCT05601544|580949900|FG001|Phase 2 Period 1|Adverse Event|1|||
160878467|NCT05601544|580949901|FG002|Phase 2 Period 1|Adverse Event|0|||
160878468|NCT05601544|580949902|FG003|Phase 2 Period 1|Adverse Event|0|||
160878469|NCT05601544|580949903|FG004|Phase 2 Period 1|Adverse Event|0|||
160878470|NCT05601544|580949904|FG005|Phase 2 Period 1|Adverse Event|0|||
160878471|NCT01601652|580949906|FG000|Overall Study|Death|1|||
160878472|NCT02537015|580949907|FG000|Overall Study|Adverse Event|3|||
160878473|NCT02537015|580949907|FG000|Overall Study|Withdrawal by Subject|2|||
160878474|NCT02537015|580949907|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160878475|NCT01808092|580949914|FG000|Overall Study|Death|39|||
160878476|NCT01808092|580949915|FG001|Overall Study|Death|29|||
160878477|NCT01808092|580949914|FG000|Overall Study|Lost to Follow-up|3|||
160878478|NCT01808092|580949915|FG001|Overall Study|Lost to Follow-up|7|||
160878479|NCT01808092|580949914|FG000|Overall Study|Withdrawal by Subject|9|||
160878480|NCT01808092|580949915|FG001|Overall Study|Withdrawal by Subject|4|||
160878481|NCT01808092|580949914|FG000|Overall Study|Other Eligibility criteria|3|||
160878482|NCT01808092|580949915|FG001|Overall Study|Other Eligibility criteria|5|||
160878483|NCT03865316|580952141|FG000|Overall Study|Procedure Cancelled|4|||
160878484|NCT03865316|580952141|FG000|Overall Study|Equipment failure|4|||
160878485|NCT01836276|580952145|FG000|Overall Study|Lost to Follow-up|28|||
160878486|NCT01836276|580952146|FG001|Overall Study|Lost to Follow-up|51|||
160878487|NCT02208063|580952153|FG000|Overall Study|Death|3|||
160878488|NCT02208063|580952154|FG001|Overall Study|Death|5|||
160878489|NCT02208063|580952153|FG000|Overall Study|Not Specified in report|3|||
160878490|NCT02208063|580952154|FG001|Overall Study|Not Specified in report|4|||
160878491|NCT02208063|580952153|FG000|Overall Study|Withdrawal by Subject|5|||
160878492|NCT02208063|580952154|FG001|Overall Study|Withdrawal by Subject|2|||
160878493|NCT02208063|580952153|FG000|Overall Study|Lost to Follow-up|1|||
160878494|NCT02208063|580952154|FG001|Overall Study|Lost to Follow-up|0|||
160878495|NCT00913458|580952155|FG000|Phase 1|Non-Responder|54|||
160878496|NCT00913458|580952156|FG001|Phase 1|Non-Responder|0|||
160878497|NCT00913458|580952157|FG002|Phase 1|Non-Responder|0|||
160878498|NCT00913458|580952158|FG003|Phase 1|Non-Responder|0|||
160878499|NCT00913458|580952159|FG004|Phase 1|Non-Responder|0|||
161225779|NCT01957488|582207923|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
161225780|NCT01957488|582207924|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
161225781|NCT01957488|582207919|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
161225782|NCT01957488|582207920|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161225783|NCT01957488|582207921|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
161225784|NCT01957488|582207922|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
161225785|NCT01957488|582207923|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161225786|NCT01957488|582207924|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
161225787|NCT01957488|582207919|FG000|Test Period 2 (2 Weeks)|Other|1|||
161225788|NCT01957488|582207920|FG001|Test Period 2 (2 Weeks)|Other|0|||
161225789|NCT01957488|582207921|FG002|Test Period 2 (2 Weeks)|Other|0|||
161225790|NCT01957488|582207922|FG003|Test Period 2 (2 Weeks)|Other|0|||
161225791|NCT01957488|582207923|FG004|Test Period 2 (2 Weeks)|Other|0|||
161225792|NCT01957488|582207924|FG005|Test Period 2 (2 Weeks)|Other|0|||
161225793|NCT01957488|582207919|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161225794|NCT01957488|582207920|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
161225795|NCT01957488|582207921|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161225796|NCT01957488|582207922|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161225797|NCT01957488|582207923|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161225798|NCT01957488|582207924|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
161225799|NCT01957488|582207919|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
161225800|NCT01957488|582207920|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
161225801|NCT01957488|582207921|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
161225802|NCT01957488|582207922|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
161225803|NCT01957488|582207923|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
161225804|NCT01957488|582207924|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
161225805|NCT01957488|582207919|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161225806|NCT01957488|582207920|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161225807|NCT01957488|582207921|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161225808|NCT01957488|582207922|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161225809|NCT01957488|582207923|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
161225810|NCT01957488|582207924|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
161225811|NCT01957488|582207919|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
161225812|NCT01957488|582207920|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161225813|NCT01957488|582207921|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161225814|NCT01957488|582207922|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161225815|NCT01957488|582207923|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161225816|NCT01957488|582207924|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
161225817|NCT01957488|582207919|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161225818|NCT01957488|582207920|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
161225819|NCT01957488|582207921|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161225820|NCT01957488|582207922|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161225821|NCT01957488|582207923|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161225822|NCT01957488|582207924|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
161225823|NCT02402166|582207925|FG000|Overall Study|Adverse Event|2|||
160878500|NCT00913458|580952160|FG005|Phase 1|Non-Responder|0|||
160878501|NCT00913458|580952161|FG006|Phase 1|Non-Responder|0|||
160878502|NCT00913458|580952155|FG000|Phase 1|Subject Request|17|||
160878503|NCT00913458|580952156|FG001|Phase 1|Subject Request|0|||
160878504|NCT00913458|580952157|FG002|Phase 1|Subject Request|0|||
160878505|NCT00913458|580952158|FG003|Phase 1|Subject Request|0|||
160878506|NCT00913458|580952159|FG004|Phase 1|Subject Request|0|||
160878507|NCT00913458|580952160|FG005|Phase 1|Subject Request|0|||
160878508|NCT00913458|580952161|FG006|Phase 1|Subject Request|0|||
160878509|NCT00913458|580952155|FG000|Phase 1|Adverse Event|20|||
160878510|NCT00913458|580952156|FG001|Phase 1|Adverse Event|0|||
160878511|NCT00913458|580952157|FG002|Phase 1|Adverse Event|0|||
160878512|NCT00913458|580952158|FG003|Phase 1|Adverse Event|0|||
161225824|NCT02402166|582207925|FG000|Overall Study|Withdrawal by Subject|2|||
161225825|NCT02402166|582207925|FG000|Overall Study|Lost to Follow-up|1|||
161225826|NCT00623103|582207926|FG000|Overall Study|Adverse Event|70|||
161225827|NCT00623103|582207927|FG001|Overall Study|Adverse Event|60|||
161225828|NCT00623103|582207926|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161225829|NCT00623103|582207927|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
161225830|NCT00623103|582207926|FG000|Overall Study|Withdrawal by Subject|18|||
161225831|NCT00623103|582207927|FG001|Overall Study|Withdrawal by Subject|24|||
161225832|NCT00623103|582207926|FG000|Overall Study|Lost to Follow-up|4|||
161225833|NCT00623103|582207927|FG001|Overall Study|Lost to Follow-up|1|||
161225834|NCT00623103|582207926|FG000|Overall Study|Administrative problems|2|||
161225835|NCT00623103|582207927|FG001|Overall Study|Administrative problems|4|||
161225836|NCT00623103|582207926|FG000|Overall Study|Death|11|||
161225837|NCT00623103|582207927|FG001|Overall Study|Death|11|||
161225838|NCT00623103|582207926|FG000|Overall Study|Protocol deviation|2|||
161225839|NCT00623103|582207927|FG001|Overall Study|Protocol deviation|1|||
161225840|NCT02433678|582207932|FG000|Overall Study|Lost to Follow-up|1|||
161225841|NCT02433678|582207933|FG001|Overall Study|Lost to Follow-up|2|||
161225842|NCT01424722|582207937|FG000|Overall Study|Sponsor terminated investigation|2258|||
161225843|NCT01618266|582207940|FG000|Overall Study|Lost to Follow-up|9|||
161225844|NCT01618266|582207940|FG000|Overall Study|Treatment satisfaction|10|||
161225845|NCT01618266|582207940|FG000|Overall Study|Other reasons|11|||
161225846|NCT01618266|582207940|FG000|Overall Study|Lack of Efficacy|23|||
161225847|NCT01618266|582207940|FG000|Overall Study|Protocol Violation|43|||
161225848|NCT01966042|582207941|FG000|Overall Study|Death|2|||
161225849|NCT03267264|582207942|FG000|Overall Study|Withdrawal by Subject|1|||
161225850|NCT03267264|582207943|FG001|Overall Study|Withdrawal by Subject|0|||
161225851|NCT03267264|582207944|FG002|Overall Study|Withdrawal by Subject|2|||
161225852|NCT03267264|582207945|FG003|Overall Study|Withdrawal by Subject|4|||
161225853|NCT02224391|582207946|FG000|Overall Study|Lost to Follow-up|26|||
161225854|NCT02224391|582207947|FG001|Overall Study|Lost to Follow-up|19|||
161225855|NCT02224391|582207946|FG000|Overall Study|Withdrawal by Subject|6|||
161225856|NCT02224391|582207947|FG001|Overall Study|Withdrawal by Subject|5|||
161225857|NCT02492958|582207948|FG000|Overall Study|Withdrawal by Subject|0|||
161225858|NCT02492958|582207949|FG001|Overall Study|Withdrawal by Subject|0|||
161225859|NCT02492958|582207950|FG002|Overall Study|Withdrawal by Subject|1|||
161225860|NCT02492958|582207951|FG003|Overall Study|Withdrawal by Subject|0|||
161225861|NCT02492958|582207948|FG000|Overall Study|Adverse Event|1|||
161225862|NCT02492958|582207949|FG001|Overall Study|Adverse Event|0|||
161225863|NCT02492958|582207950|FG002|Overall Study|Adverse Event|1|||
161225864|NCT02492958|582207951|FG003|Overall Study|Adverse Event|0|||
161225865|NCT03522948|582207952|FG000|Overall Study|Lost to Follow-up|1|||
161225866|NCT02236130|582207957|FG000|Overall Study|Lost to Follow-up|7|||
161225867|NCT02236130|582207958|FG001|Overall Study|Lost to Follow-up|12|||
161225868|NCT00449150|582207970|FG000|Overall Study|Adverse Event|11|||
161225869|NCT00449150|582207971|FG001|Overall Study|Adverse Event|18|||
161225870|NCT00449150|582207972|FG002|Overall Study|Adverse Event|9|||
161225871|NCT00449150|582207970|FG000|Overall Study|Lack of Efficacy|1|||
161225872|NCT00449150|582207971|FG001|Overall Study|Lack of Efficacy|2|||
160878513|NCT00913458|580952159|FG004|Phase 1|Adverse Event|0|||
160878514|NCT00913458|580952160|FG005|Phase 1|Adverse Event|0|||
161225873|NCT00449150|582207972|FG002|Overall Study|Lack of Efficacy|2|||
161225874|NCT00449150|582207970|FG000|Overall Study|Other|16|||
161225875|NCT00449150|582207971|FG001|Overall Study|Other|13|||
161225876|NCT00449150|582207972|FG002|Overall Study|Other|14|||
161225877|NCT00449150|582207970|FG000|Overall Study|Withdrawal by Subject|17|||
161225878|NCT00449150|582207971|FG001|Overall Study|Withdrawal by Subject|18|||
161225879|NCT00449150|582207972|FG002|Overall Study|Withdrawal by Subject|21|||
161225880|NCT00449150|582207970|FG000|Overall Study|Protocol Violation|1|||
161225881|NCT00449150|582207971|FG001|Overall Study|Protocol Violation|2|||
161225882|NCT00449150|582207972|FG002|Overall Study|Protocol Violation|1|||
161225883|NCT00770510|582207973|FG000|Overall Study|Lost to Follow-up|2|||
161225884|NCT00770510|582207973|FG000|Overall Study|Pregnancy|1|||
161225885|NCT00770510|582207973|FG000|Overall Study|Withdrawal by Subject|2|||
161225886|NCT01531205|582207980|FG000|Overall Study|Did not proceed to surgery|1|||
161225887|NCT01089647|582207981|FG000|Overall Study|Lost to Follow-up|2|||
161225888|NCT01089647|582207982|FG001|Overall Study|Lost to Follow-up|2|||
161225889|NCT01089647|582207981|FG000|Overall Study|Withdrawal by Subject|2|||
161225890|NCT01089647|582207982|FG001|Overall Study|Withdrawal by Subject|1|||
161225891|NCT01089647|582207981|FG000|Overall Study|Adverse Event|0|||
161225892|NCT01089647|582207982|FG001|Overall Study|Adverse Event|1|||
161225893|NCT02001558|582207985|FG000|Overall Study|Lost to Follow-up|8|||
161225894|NCT02001558|582207986|FG001|Overall Study|Lost to Follow-up|14|||
161225895|NCT04117607|582207987|FG000|Overall Study|Early Termination|0|||
161225896|NCT04117607|582207988|FG001|Overall Study|Early Termination|1|||
160878515|NCT00913458|580952161|FG006|Phase 1|Adverse Event|0|||
160878516|NCT00913458|580952155|FG000|Phase 1|Lost to Follow-up|2|||
160878517|NCT00913458|580952156|FG001|Phase 1|Lost to Follow-up|0|||
160878518|NCT00913458|580952157|FG002|Phase 1|Lost to Follow-up|0|||
160878519|NCT00913458|580952158|FG003|Phase 1|Lost to Follow-up|0|||
160878520|NCT00913458|580952159|FG004|Phase 1|Lost to Follow-up|0|||
160878521|NCT00913458|580952160|FG005|Phase 1|Lost to Follow-up|0|||
160878522|NCT00913458|580952161|FG006|Phase 1|Lost to Follow-up|0|||
160878523|NCT00913458|580952155|FG000|Phase 1|Protocol Violation|10|||
160878524|NCT00913458|580952156|FG001|Phase 1|Protocol Violation|0|||
160878525|NCT00913458|580952157|FG002|Phase 1|Protocol Violation|0|||
160878526|NCT00913458|580952158|FG003|Phase 1|Protocol Violation|0|||
160878527|NCT00913458|580952159|FG004|Phase 1|Protocol Violation|0|||
160878528|NCT00913458|580952160|FG005|Phase 1|Protocol Violation|0|||
160878529|NCT00913458|580952161|FG006|Phase 1|Protocol Violation|0|||
160878530|NCT00913458|580952155|FG000|Phase 1|Sponsor|2|||
160878531|NCT00913458|580952156|FG001|Phase 1|Sponsor|0|||
160878532|NCT00913458|580952157|FG002|Phase 1|Sponsor|0|||
160878533|NCT00913458|580952158|FG003|Phase 1|Sponsor|0|||
160878534|NCT00913458|580952159|FG004|Phase 1|Sponsor|0|||
160878535|NCT00913458|580952160|FG005|Phase 1|Sponsor|0|||
160878536|NCT00913458|580952161|FG006|Phase 1|Sponsor|0|||
160878537|NCT00913458|580952155|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
160878538|NCT00913458|580952156|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
160878539|NCT00913458|580952157|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
160878540|NCT00913458|580952158|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
160878541|NCT00913458|580952159|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
160878542|NCT00913458|580952160|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
160878543|NCT00913458|580952161|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
160878544|NCT00913458|580952155|FG000|Phase 2|Non-Responder|0|||
160878545|NCT00913458|580952156|FG001|Phase 2|Non-Responder|5|||
160878546|NCT00913458|580952157|FG002|Phase 2|Non-Responder|7|||
160878547|NCT00913458|580952158|FG003|Phase 2|Non-Responder|12|||
160878548|NCT00913458|580952159|FG004|Phase 2|Non-Responder|0|||
160878549|NCT00913458|580952160|FG005|Phase 2|Non-Responder|0|||
160878550|NCT00913458|580952161|FG006|Phase 2|Non-Responder|0|||
160878551|NCT00913458|580952155|FG000|Phase 2|Subject Request|0|||
160878552|NCT00913458|580952156|FG001|Phase 2|Subject Request|0|||
160878553|NCT00913458|580952157|FG002|Phase 2|Subject Request|1|||
160878554|NCT00913458|580952158|FG003|Phase 2|Subject Request|2|||
160878555|NCT00913458|580952159|FG004|Phase 2|Subject Request|0|||
160878556|NCT00913458|580952160|FG005|Phase 2|Subject Request|0|||
160878557|NCT00913458|580952161|FG006|Phase 2|Subject Request|0|||
160878558|NCT00913458|580952155|FG000|Phase 2|Adverse Event|0|||
160878559|NCT00913458|580952156|FG001|Phase 2|Adverse Event|3|||
160878560|NCT00913458|580952157|FG002|Phase 2|Adverse Event|0|||
160878561|NCT00913458|580952158|FG003|Phase 2|Adverse Event|1|||
160878562|NCT00913458|580952159|FG004|Phase 2|Adverse Event|0|||
160878563|NCT00913458|580952160|FG005|Phase 2|Adverse Event|0|||
160878564|NCT00913458|580952161|FG006|Phase 2|Adverse Event|0|||
160878565|NCT00913458|580952155|FG000|Phase 2|Lost to Follow-up|0|||
160878566|NCT00913458|580952156|FG001|Phase 2|Lost to Follow-up|0|||
160878567|NCT00913458|580952157|FG002|Phase 2|Lost to Follow-up|0|||
160878568|NCT00913458|580952158|FG003|Phase 2|Lost to Follow-up|1|||
160878569|NCT00913458|580952159|FG004|Phase 2|Lost to Follow-up|0|||
160878570|NCT00913458|580952160|FG005|Phase 2|Lost to Follow-up|0|||
160878571|NCT00913458|580952161|FG006|Phase 2|Lost to Follow-up|0|||
160878572|NCT00913458|580952155|FG000|Phase 2|Protocol Violation|0|||
160878573|NCT00913458|580952156|FG001|Phase 2|Protocol Violation|2|||
160878574|NCT00913458|580952157|FG002|Phase 2|Protocol Violation|0|||
160878575|NCT00913458|580952158|FG003|Phase 2|Protocol Violation|0|||
160878576|NCT00913458|580952159|FG004|Phase 2|Protocol Violation|0|||
160878577|NCT00913458|580952160|FG005|Phase 2|Protocol Violation|0|||
160878578|NCT00913458|580952161|FG006|Phase 2|Protocol Violation|0|||
160878579|NCT00913458|580952155|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
160878580|NCT00913458|580952156|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
160878581|NCT00913458|580952157|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
160878582|NCT00913458|580952158|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
161120510|NCT00953758|581829454|FG005|Overall Study|Death|1|||
161120511|NCT00953758|581829455|FG006|Overall Study|Death|1|||
161120512|NCT00953758|581829456|FG007|Overall Study|Death|3|||
161120513|NCT00953758|581829457|FG008|Overall Study|Death|1|||
160878583|NCT00913458|580952159|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
160878584|NCT00913458|580952160|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
160878585|NCT00913458|580952161|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
160878586|NCT00913458|580952155|FG000|Phase 3|Adverse Event|0|||
160878587|NCT00913458|580952156|FG001|Phase 3|Adverse Event|0|||
160878588|NCT00913458|580952157|FG002|Phase 3|Adverse Event|0|||
160878589|NCT00913458|580952158|FG003|Phase 3|Adverse Event|0|||
160878590|NCT00913458|580952159|FG004|Phase 3|Adverse Event|5|||
160878591|NCT00913458|580952160|FG005|Phase 3|Adverse Event|4|||
160878592|NCT00913458|580952161|FG006|Phase 3|Adverse Event|1|||
160878593|NCT00913458|580952155|FG000|Phase 3|Lost to Follow-up|0|||
161120514|NCT00953758|581829458|FG009|Overall Study|Death|0|||
160878594|NCT00913458|580952156|FG001|Phase 3|Lost to Follow-up|0|||
160878595|NCT00913458|580952157|FG002|Phase 3|Lost to Follow-up|0|||
160878596|NCT00913458|580952158|FG003|Phase 3|Lost to Follow-up|0|||
160878597|NCT00913458|580952159|FG004|Phase 3|Lost to Follow-up|2|||
160878598|NCT00913458|580952160|FG005|Phase 3|Lost to Follow-up|0|||
160878599|NCT00913458|580952161|FG006|Phase 3|Lost to Follow-up|0|||
160878600|NCT00913458|580952155|FG000|Phase 3|Non-Responder|0|||
160878601|NCT00913458|580952156|FG001|Phase 3|Non-Responder|0|||
160878602|NCT00913458|580952157|FG002|Phase 3|Non-Responder|0|||
160878603|NCT00913458|580952158|FG003|Phase 3|Non-Responder|0|||
160878604|NCT00913458|580952159|FG004|Phase 3|Non-Responder|0|||
160878605|NCT00913458|580952160|FG005|Phase 3|Non-Responder|1|||
160878606|NCT00913458|580952161|FG006|Phase 3|Non-Responder|3|||
160878607|NCT00913458|580952155|FG000|Phase 3|Withdrawal by Subject|0|||
160878608|NCT00913458|580952156|FG001|Phase 3|Withdrawal by Subject|0|||
160878609|NCT00913458|580952157|FG002|Phase 3|Withdrawal by Subject|0|||
160878610|NCT00913458|580952158|FG003|Phase 3|Withdrawal by Subject|0|||
160878611|NCT00913458|580952159|FG004|Phase 3|Withdrawal by Subject|1|||
160878612|NCT00913458|580952160|FG005|Phase 3|Withdrawal by Subject|2|||
160878613|NCT00913458|580952161|FG006|Phase 3|Withdrawal by Subject|0|||
160878614|NCT00913458|580952155|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
160878615|NCT00913458|580952156|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
160878616|NCT00913458|580952157|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
160878617|NCT00913458|580952158|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
160878618|NCT00913458|580952159|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
160878619|NCT00913458|580952160|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
160878620|NCT00913458|580952161|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
160878621|NCT02366091|580952162|FG000|Overall Study|Withdrawal by Subject|3|||
160878622|NCT02366091|580952163|FG001|Overall Study|Withdrawal by Subject|7|||
160878623|NCT02366091|580952164|FG002|Overall Study|Withdrawal by Subject|3|||
160878624|NCT02366091|580952165|FG003|Overall Study|Withdrawal by Subject|1|||
160878625|NCT02338232|580952166|FG000|Overall Study|Screen Failure|3|||
160878626|NCT02338232|580952166|FG000|Overall Study|Withdrawal by Subject|6|||
160878627|NCT02338232|580952166|FG000|Overall Study|Adverse Event|2|||
160878628|NCT03890666|580952167|FG000|Overall Study|Withdrawal by Subject|0|||
160878629|NCT03890666|580952168|FG001|Overall Study|Withdrawal by Subject|1|||
160878630|NCT03890666|580952167|FG000|Overall Study|Protocol deviation|1|||
160878631|NCT03890666|580952168|FG001|Overall Study|Protocol deviation|4|||
160878632|NCT03890666|580952167|FG000|Overall Study|Lost to Follow-up|2|||
160878633|NCT03890666|580952168|FG001|Overall Study|Lost to Follow-up|5|||
160878634|NCT03890666|580952167|FG000|Overall Study|Other than specified|1|||
160878635|NCT03890666|580952168|FG001|Overall Study|Other than specified|8|||
160878636|NCT01105065|580952169|FG000|Overall Study|Adverse Event|5|||
160878637|NCT01105065|580952169|FG000|Overall Study|Technical Problems|1|||
160878638|NCT02122783|580952173|FG000|Overall Study|Adverse Event|0|||
160878639|NCT02122783|580952174|FG001|Overall Study|Adverse Event|1|||
160878640|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
160878641|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
160878642|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
160878643|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
160878644|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
160878645|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
160878646|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
160878647|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
160878648|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
160878649|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
160878650|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
160878651|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
160878652|NCT00322621|580952175|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
160878653|NCT00322621|580952176|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
161120515|NCT00953758|581829449|FG000|Overall Study|Participant refused further follow-up|0|||
160878654|NCT00322621|580952177|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
160878655|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
160878656|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
160878657|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
160878658|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
160878659|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
160878660|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
160878661|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
160878662|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
160878663|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
160878664|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
160878665|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
160878666|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
161225897|NCT04117607|582207989|FG002|Overall Study|Early Termination|0|||
161225898|NCT04117607|582207990|FG003|Overall Study|Early Termination|0|||
161225899|NCT04117607|582207991|FG004|Overall Study|Early Termination|0|||
161225900|NCT04117607|582207992|FG005|Overall Study|Early Termination|0|||
161225901|NCT04117607|582207993|FG006|Overall Study|Early Termination|1|||
160878667|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
160878668|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
160878669|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
160878670|NCT00322621|580952175|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
160878671|NCT00322621|580952176|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
160878672|NCT00322621|580952177|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
160878673|NCT02238067|580952180|FG000|Overall Study|Not completed survey at Month 6|45|||
160878674|NCT02213133|580952184|FG000|Overall Study|Participant discontinued study therapy|2|||
160878675|NCT02213133|580952185|FG001|Overall Study|Participant discontinued study therapy|0|||
160878676|NCT02213133|580952186|FG002|Overall Study|Participant discontinued study therapy|0|||
160878677|NCT02213133|580952184|FG000|Overall Study|Participant withdrew informed consent|2|||
160878678|NCT02213133|580952185|FG001|Overall Study|Participant withdrew informed consent|1|||
160878679|NCT02213133|580952186|FG002|Overall Study|Participant withdrew informed consent|2|||
160878680|NCT02213133|580952184|FG000|Overall Study|Disease progression|11|||
160878681|NCT02213133|580952185|FG001|Overall Study|Disease progression|2|||
160878682|NCT02213133|580952186|FG002|Overall Study|Disease progression|0|||
160878683|NCT02213133|580952184|FG000|Overall Study|Adverse Event (AE)|1|||
160878684|NCT02213133|580952185|FG001|Overall Study|Adverse Event (AE)|0|||
160878685|NCT02213133|580952186|FG002|Overall Study|Adverse Event (AE)|0|||
160878686|NCT02213133|580952184|FG000|Overall Study|Death|16|||
160878687|NCT02213133|580952185|FG001|Overall Study|Death|2|||
160878688|NCT02213133|580952186|FG002|Overall Study|Death|1|||
160878689|NCT02213133|580952184|FG000|Overall Study|Other|5|||
160878690|NCT02213133|580952185|FG001|Overall Study|Other|0|||
160878691|NCT02213133|580952186|FG002|Overall Study|Other|0|||
160878692|NCT02350764|580952187|FG000|Overall Study|Adverse Event|4|||
160878693|NCT02350764|580952187|FG000|Overall Study|Death|3|||
160878694|NCT02350764|580952187|FG000|Overall Study|Physician Decision|2|||
160878695|NCT02350764|580952187|FG000|Overall Study|Withdrawal by Subject|2|||
160878696|NCT02743611|580952188|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
160878697|NCT02743611|580952189|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
160878698|NCT02743611|580952190|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
160878699|NCT02743611|580952191|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
160878700|NCT01433289|580952192|FG000|Overall Study|Pregnancy|0|||
160878701|NCT01433289|580952193|FG001|Overall Study|Pregnancy|1|||
160878702|NCT01433289|580952194|FG002|Overall Study|Pregnancy|0|||
160878703|NCT01433289|580952195|FG003|Overall Study|Pregnancy|0|||
160878704|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
160878705|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
160878706|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
160878707|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
160878708|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
160878709|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
160878710|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878711|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
161225902|NCT04117607|582207994|FG007|Overall Study|Early Termination|0|||
161225903|NCT04117607|582207995|FG008|Overall Study|Early Termination|0|||
161225904|NCT04117607|582207996|FG009|Overall Study|Early Termination|0|||
161225905|NCT04117607|582207997|FG010|Overall Study|Early Termination|0|||
161225906|NCT04117607|582207998|FG011|Overall Study|Early Termination|0|||
161225907|NCT04117607|582207999|FG012|Overall Study|Early Termination|0|||
161225908|NCT04117607|582208000|FG013|Overall Study|Early Termination|0|||
161225909|NCT01626079|582208001|FG000|Overall Study|Death|167|||
161225910|NCT01626079|582208002|FG001|Overall Study|Death|192|||
161225911|NCT01626079|582208003|FG002|Overall Study|Death|39|||
161225912|NCT01626079|582208001|FG000|Overall Study|Withdrawal by Subject|23|||
160878712|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
160878713|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878714|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878715|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160878716|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878717|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878718|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
161225913|NCT01626079|582208002|FG001|Overall Study|Withdrawal by Subject|37|||
161225914|NCT01626079|582208003|FG002|Overall Study|Withdrawal by Subject|5|||
161225915|NCT01626079|582208001|FG000|Overall Study|Lost to Follow-up|7|||
161225916|NCT01626079|582208002|FG001|Overall Study|Lost to Follow-up|4|||
161225917|NCT01626079|582208003|FG002|Overall Study|Lost to Follow-up|2|||
161225918|NCT01626079|582208001|FG000|Overall Study|Missed Visits|1|||
161225919|NCT01626079|582208002|FG001|Overall Study|Missed Visits|4|||
161225920|NCT01626079|582208003|FG002|Overall Study|Missed Visits|6|||
161225921|NCT02073643|582208005|FG000|Overall Study|Lost to Follow-up|24|||
161324584|NCT02624947|582575632|FG001|Infant Participants|Investigator Decision|4|||
160878719|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878720|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
160878721|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
160878722|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
160878723|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878724|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878725|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878726|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878727|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
160878728|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
160878729|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
160878730|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
160878731|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
160878732|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
160878733|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
160878734|NCT00600119|580952196|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
160878735|NCT00600119|580952197|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
160878736|NCT00600119|580952198|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878737|NCT00600119|580952199|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878738|NCT00600119|580952200|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878739|NCT00600119|580952201|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
160878740|NCT00600119|580952196|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
160878741|NCT00600119|580952197|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
160878742|NCT00600119|580952198|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160878743|NCT00600119|580952199|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
160878744|NCT00600119|580952200|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
160878745|NCT00600119|580952201|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
160878746|NCT00600119|580952196|FG000|Double-blind Treatment Period|Other|0|||
160878747|NCT00600119|580952197|FG001|Double-blind Treatment Period|Other|0|||
160878748|NCT00600119|580952198|FG002|Double-blind Treatment Period|Other|0|||
160878749|NCT00600119|580952199|FG003|Double-blind Treatment Period|Other|0|||
160878750|NCT00600119|580952200|FG004|Double-blind Treatment Period|Other|2|||
160878751|NCT00600119|580952201|FG005|Double-blind Treatment Period|Other|1|||
160878752|NCT00600119|580952196|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878753|NCT00600119|580952197|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
160878754|NCT00600119|580952198|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878755|NCT00600119|580952199|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878756|NCT00600119|580952200|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
160878757|NCT00600119|580952201|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
160878758|NCT00600119|580952196|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878759|NCT00600119|580952197|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
160878760|NCT00600119|580952198|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878761|NCT00600119|580952199|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878762|NCT00600119|580952200|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878763|NCT00600119|580952201|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
160878764|NCT00600119|580952196|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
160878765|NCT00600119|580952197|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
160878766|NCT00600119|580952198|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
160878767|NCT00600119|580952199|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
160878768|NCT00600119|580952200|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
160878769|NCT00600119|580952201|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
160878770|NCT00600119|580952196|FG000|Double-blind Treatment Period|Physician Decision|2|||
160878771|NCT00600119|580952197|FG001|Double-blind Treatment Period|Physician Decision|0|||
160878772|NCT00600119|580952198|FG002|Double-blind Treatment Period|Physician Decision|0|||
160878773|NCT00600119|580952199|FG003|Double-blind Treatment Period|Physician Decision|0|||
160878774|NCT00600119|580952200|FG004|Double-blind Treatment Period|Physician Decision|0|||
160878775|NCT00600119|580952201|FG005|Double-blind Treatment Period|Physician Decision|0|||
160878776|NCT00600119|580952196|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160878777|NCT00600119|580952197|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
160878778|NCT00600119|580952198|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
160878779|NCT00600119|580952199|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
160878780|NCT00600119|580952200|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
160878781|NCT00600119|580952201|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
160878782|NCT00600119|580952196|FG000|Double-blind Treatment Period|Adverse Event|1|||
160878783|NCT00600119|580952197|FG001|Double-blind Treatment Period|Adverse Event|1|||
161120516|NCT00953758|581829450|FG001|Overall Study|Participant refused further follow-up|0|||
160878784|NCT00600119|580952198|FG002|Double-blind Treatment Period|Adverse Event|0|||
160878785|NCT00600119|580952199|FG003|Double-blind Treatment Period|Adverse Event|1|||
160878786|NCT00600119|580952200|FG004|Double-blind Treatment Period|Adverse Event|2|||
160878787|NCT00600119|580952201|FG005|Double-blind Treatment Period|Adverse Event|10|||
160878788|NCT00600119|580952196|FG000|Follow-up Period|Adverse Event|0|||
160878789|NCT00600119|580952197|FG001|Follow-up Period|Adverse Event|0|||
160878790|NCT00600119|580952198|FG002|Follow-up Period|Adverse Event|0|||
160878791|NCT00600119|580952199|FG003|Follow-up Period|Adverse Event|0|||
160878792|NCT00600119|580952200|FG004|Follow-up Period|Adverse Event|0|||
160878793|NCT00600119|580952201|FG005|Follow-up Period|Adverse Event|1|||
160878794|NCT00600119|580952196|FG000|Follow-up Period|Other|1|||
160878795|NCT00600119|580952197|FG001|Follow-up Period|Other|0|||
160878796|NCT00600119|580952198|FG002|Follow-up Period|Other|0|||
160878797|NCT00600119|580952199|FG003|Follow-up Period|Other|0|||
160878798|NCT00600119|580952200|FG004|Follow-up Period|Other|0|||
160878799|NCT00600119|580952201|FG005|Follow-up Period|Other|0|||
160878800|NCT00729469|580952202|FG000|Overall Study|Adverse Event|14|||
160878801|NCT00729469|580952203|FG001|Overall Study|Adverse Event|25|||
160878802|NCT00729469|580952202|FG000|Overall Study|Lost to Follow-up|9|||
160878803|NCT00729469|580952203|FG001|Overall Study|Lost to Follow-up|9|||
160878804|NCT00729469|580952202|FG000|Overall Study|Protocol Violation|2|||
160878805|NCT00729469|580952203|FG001|Overall Study|Protocol Violation|1|||
160878806|NCT00729469|580952202|FG000|Overall Study|Withdrawal by Subject|19|||
160878807|NCT00729469|580952203|FG001|Overall Study|Withdrawal by Subject|8|||
160878808|NCT00729469|580952202|FG000|Overall Study|Other-Not mentioned|9|||
160878809|NCT00729469|580952203|FG001|Overall Study|Other-Not mentioned|4|||
160878810|NCT00561977|580952204|FG000|Overall Study|Withdrawal by Subject|0|||
160878811|NCT00561977|580952205|FG001|Overall Study|Withdrawal by Subject|2|||
160878812|NCT00561977|580952206|FG002|Overall Study|Withdrawal by Subject|1|||
160878813|NCT00561977|580952204|FG000|Overall Study|Pregnancy|0|||
160878814|NCT00561977|580952205|FG001|Overall Study|Pregnancy|1|||
160878815|NCT00561977|580952206|FG002|Overall Study|Pregnancy|1|||
160878816|NCT00566696|580952207|FG000|Overall Study|Met Exclusion Criteria|2|||
160878817|NCT00566696|580952207|FG000|Overall Study|Muromonab not available|1|||
160878818|NCT00566696|580952207|FG000|Overall Study|Health Status Change|1|||
160878819|NCT00566696|580952207|FG000|Overall Study|Physician Decision|1|||
160878820|NCT00566696|580952207|FG000|Overall Study|Non-Patient Donors|37|||
160878821|NCT00706342|580952209|FG000|Overall Study|Adverse Event|3|||
160878822|NCT00706342|580952209|FG000|Overall Study|Not responding to treatment|2|||
160878823|NCT00706342|580952209|FG000|Overall Study|Withdrawn due to failure to respond|1|||
160878824|NCT00706342|580952209|FG000|Overall Study|Death|1|||
160878825|NCT00706342|580952209|FG000|Overall Study|Withdrew from the study on his own.|1|||
160878826|NCT00706342|580952209|FG000|Overall Study|Investigator discretion|2|||
160878827|NCT00706342|580952209|FG000|Overall Study|Non-responder Week 12|1|||
160878828|NCT00706342|580952209|FG000|Overall Study|Ongoing|6|||
160878829|NCT00706342|580952209|FG000|Overall Study|WIthdrawal of consent|1|||
160878830|NCT00119678|580952211|FG000|Double-blind Treatment Period|Death|1|||
160878831|NCT00119678|580952212|FG001|Double-blind Treatment Period|Death|0|||
160878832|NCT00119678|580952211|FG000|Double-blind Treatment Period|Adverse Event|7|||
160878833|NCT00119678|580952212|FG001|Double-blind Treatment Period|Adverse Event|1|||
160878834|NCT00119678|580952211|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
160878835|NCT00119678|580952212|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
160878836|NCT00119678|580952211|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
160878837|NCT00119678|580952212|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
160878838|NCT00119678|580952211|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
160878839|NCT00119678|580952212|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
160878840|NCT00119678|580952211|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
160878841|NCT00119678|580952212|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
160878842|NCT00119678|580952211|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
160878843|NCT00119678|580952212|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
160878844|NCT00119678|580952211|FG000|Double-blind Treatment Period|Pregnancy|0|||
160878845|NCT00119678|580952212|FG001|Double-blind Treatment Period|Pregnancy|2|||
160878846|NCT00119678|580952211|FG000|Double-blind Treatment Period|Not treated|1|||
160878847|NCT00119678|580952212|FG001|Double-blind Treatment Period|Not treated|2|||
161120517|NCT00953758|581829451|FG002|Overall Study|Participant refused further follow-up|1|||
161120518|NCT00953758|581829452|FG003|Overall Study|Participant refused further follow-up|0|||
161120519|NCT00953758|581829453|FG004|Overall Study|Participant refused further follow-up|3|||
161120520|NCT00953758|581829454|FG005|Overall Study|Participant refused further follow-up|0|||
161120521|NCT00953758|581829455|FG006|Overall Study|Participant refused further follow-up|0|||
161120522|NCT00953758|581829456|FG007|Overall Study|Participant refused further follow-up|0|||
161120523|NCT00953758|581829457|FG008|Overall Study|Participant refused further follow-up|1|||
161120524|NCT00953758|581829458|FG009|Overall Study|Participant refused further follow-up|0|||
161120525|NCT00953758|581829449|FG000|Overall Study|Lost to Follow-up|0|||
161120526|NCT00953758|581829450|FG001|Overall Study|Lost to Follow-up|0|||
161120527|NCT00953758|581829451|FG002|Overall Study|Lost to Follow-up|0|||
161120528|NCT00953758|581829452|FG003|Overall Study|Lost to Follow-up|1|||
161120529|NCT00953758|581829453|FG004|Overall Study|Lost to Follow-up|0|||
161120530|NCT00953758|581829454|FG005|Overall Study|Lost to Follow-up|0|||
161120531|NCT00953758|581829455|FG006|Overall Study|Lost to Follow-up|0|||
161120532|NCT00953758|581829456|FG007|Overall Study|Lost to Follow-up|1|||
161120533|NCT00953758|581829457|FG008|Overall Study|Lost to Follow-up|0|||
161120534|NCT00953758|581829458|FG009|Overall Study|Lost to Follow-up|1|||
161120535|NCT00953758|581829449|FG000|Overall Study|Physician Decision|0|||
161120536|NCT00953758|581829450|FG001|Overall Study|Physician Decision|0|||
161120537|NCT00953758|581829451|FG002|Overall Study|Physician Decision|0|||
161225922|NCT02430870|582208006|FG000|Part 2|Voluntary Withdrawal|0|||
161225923|NCT02430870|582208007|FG001|Part 2|Voluntary Withdrawal|0|||
161225924|NCT02430870|582208008|FG002|Part 2|Voluntary Withdrawal|0|||
161225925|NCT02430870|582208009|FG003|Part 2|Voluntary Withdrawal|0|||
161225926|NCT02430870|582208010|FG004|Part 2|Voluntary Withdrawal|0|||
161225927|NCT02430870|582208011|FG005|Part 2|Voluntary Withdrawal|0|||
161225928|NCT02430870|582208012|FG006|Part 2|Voluntary Withdrawal|1|||
161225929|NCT02430870|582208013|FG007|Part 2|Voluntary Withdrawal|0|||
161225930|NCT02430870|582208006|FG000|Part 2|Other Reason Not Specified|0|||
161225931|NCT02430870|582208007|FG001|Part 2|Other Reason Not Specified|0|||
161225932|NCT02430870|582208008|FG002|Part 2|Other Reason Not Specified|0|||
161225933|NCT02430870|582208009|FG003|Part 2|Other Reason Not Specified|0|||
161225934|NCT02430870|582208010|FG004|Part 2|Other Reason Not Specified|0|||
161225935|NCT02430870|582208011|FG005|Part 2|Other Reason Not Specified|0|||
161225936|NCT02430870|582208012|FG006|Part 2|Other Reason Not Specified|0|||
161120538|NCT00953758|581829452|FG003|Overall Study|Physician Decision|0|||
161120539|NCT00953758|581829453|FG004|Overall Study|Physician Decision|1|||
161120540|NCT00953758|581829454|FG005|Overall Study|Physician Decision|0|||
161120541|NCT00953758|581829455|FG006|Overall Study|Physician Decision|0|||
161120542|NCT00953758|581829456|FG007|Overall Study|Physician Decision|0|||
161120543|NCT00953758|581829457|FG008|Overall Study|Physician Decision|0|||
161120544|NCT00953758|581829458|FG009|Overall Study|Physician Decision|0|||
161120545|NCT00953758|581829449|FG000|Overall Study|Disease progression|0|||
161120546|NCT00953758|581829450|FG001|Overall Study|Disease progression|0|||
161120547|NCT00953758|581829451|FG002|Overall Study|Disease progression|0|||
161225937|NCT02430870|582208013|FG007|Part 2|Other Reason Not Specified|1|||
161324585|NCT02624947|582575631|FG000|Infant Participants|Lost to Follow-up|93|||
161120548|NCT00953758|581829452|FG003|Overall Study|Disease progression|0|||
161120549|NCT00953758|581829453|FG004|Overall Study|Disease progression|1|||
161120550|NCT00953758|581829454|FG005|Overall Study|Disease progression|0|||
161120551|NCT00953758|581829455|FG006|Overall Study|Disease progression|0|||
161120552|NCT00953758|581829456|FG007|Overall Study|Disease progression|0|||
161225938|NCT00865709|582208015|FG000|Treatment|Adverse Event|9|||
161225939|NCT00865709|582208016|FG001|Treatment|Adverse Event|6|||
161225940|NCT00865709|582208015|FG000|Treatment|Withdrawal by Subject|10|||
161225941|NCT00865709|582208016|FG001|Treatment|Withdrawal by Subject|7|||
161225942|NCT00865709|582208015|FG000|Treatment|Physician Decision|3|||
161225943|NCT00865709|582208016|FG001|Treatment|Physician Decision|2|||
161225944|NCT00865709|582208015|FG000|Treatment|Surgery|8|||
161225945|NCT00865709|582208016|FG001|Treatment|Surgery|3|||
161225946|NCT00429923|582208017|FG000|Overall Study|Adverse Event|0|||
161225947|NCT00429923|582208018|FG001|Overall Study|Adverse Event|2|||
161225948|NCT00429923|582208019|FG002|Overall Study|Adverse Event|3|||
161225949|NCT00429923|582208017|FG000|Overall Study|Lack of Efficacy|4|||
161225950|NCT00429923|582208018|FG001|Overall Study|Lack of Efficacy|1|||
161225951|NCT00429923|582208019|FG002|Overall Study|Lack of Efficacy|33|||
161225952|NCT00429923|582208017|FG000|Overall Study|Lost to Follow-up|0|||
161225953|NCT00429923|582208018|FG001|Overall Study|Lost to Follow-up|0|||
161225954|NCT00429923|582208019|FG002|Overall Study|Lost to Follow-up|2|||
161225955|NCT00429923|582208017|FG000|Overall Study|Withdrew Consent|1|||
161225956|NCT00429923|582208018|FG001|Overall Study|Withdrew Consent|0|||
161225957|NCT00429923|582208019|FG002|Overall Study|Withdrew Consent|1|||
161225958|NCT00429923|582208017|FG000|Overall Study|Early Termination|0|||
161225959|NCT00429923|582208018|FG001|Overall Study|Early Termination|1|||
161225960|NCT00429923|582208019|FG002|Overall Study|Early Termination|0|||
161225961|NCT01265784|582208020|FG000|Overall Study|Lost to Follow-up|5|||
161324586|NCT02624947|582575632|FG001|Infant Participants|Lost to Follow-up|58|||
160878848|NCT00119678|580952211|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
160878849|NCT00119678|580952212|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
160878850|NCT00119678|580952211|FG000|Open-label Treatment Period|Death|1|||
160878851|NCT00119678|580952212|FG001|Open-label Treatment Period|Death|0|||
160878852|NCT00119678|580952211|FG000|Open-label Treatment Period|Adverse Event|3|||
160878853|NCT00119678|580952212|FG001|Open-label Treatment Period|Adverse Event|0|||
160878854|NCT00119678|580952211|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
160878855|NCT00119678|580952212|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
160878856|NCT00119678|580952211|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
160878857|NCT00119678|580952212|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
160878858|NCT00119678|580952211|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
160878859|NCT00119678|580952212|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
160878860|NCT00119678|580952211|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
160878861|NCT00119678|580952212|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
160878862|NCT00119678|580952211|FG000|Open-label Treatment Period|Pregnancy|1|||
160878863|NCT00119678|580952212|FG001|Open-label Treatment Period|Pregnancy|0|||
160878864|NCT00119678|580952211|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
160878865|NCT00119678|580952212|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
160878866|NCT01546623|580952215|FG000|Overall Study|Adverse Event|2|||
160878867|NCT01546623|580952216|FG001|Overall Study|Adverse Event|3|||
160878868|NCT01546623|580952215|FG000|Overall Study|Major Protocol Deviation|1|||
160878869|NCT01546623|580952216|FG001|Overall Study|Major Protocol Deviation|1|||
160878870|NCT01546623|580952215|FG000|Overall Study|High Prostate specific antigen|2|||
160878871|NCT01546623|580952216|FG001|Overall Study|High Prostate specific antigen|1|||
160878872|NCT01546623|580952215|FG000|Overall Study|Did Not Receive Study Drug|1|||
160878873|NCT01546623|580952216|FG001|Overall Study|Did Not Receive Study Drug|1|||
160878874|NCT03567343|580952217|FG000|Overall Study|Lost to Follow-up|2|||
160878875|NCT03567343|580952218|FG001|Overall Study|Lost to Follow-up|1|||
160878876|NCT03567343|580952217|FG000|Overall Study|No longer eligible|2|||
160878877|NCT03567343|580952218|FG001|Overall Study|No longer eligible|1|||
160878878|NCT03567343|580952217|FG000|Overall Study|Adverse Event|1|||
160878879|NCT03567343|580952218|FG001|Overall Study|Adverse Event|0|||
160878880|NCT03567343|580952217|FG000|Overall Study|Protocol Violation|1|||
160878881|NCT03567343|580952218|FG001|Overall Study|Protocol Violation|1|||
160878882|NCT01134705|580952219|FG000|Overall Study|Adverse Event|1|||
160878883|NCT01134705|580952220|FG001|Overall Study|Adverse Event|7|||
160878884|NCT01134705|580952219|FG000|Overall Study|Withdrawal by Subject|6|||
160878885|NCT01134705|580952220|FG001|Overall Study|Withdrawal by Subject|6|||
160878886|NCT01134705|580952219|FG000|Overall Study|Pregnancy|1|||
160878887|NCT01134705|580952220|FG001|Overall Study|Pregnancy|0|||
160878888|NCT01134705|580952219|FG000|Overall Study|Lost to Follow-up|5|||
160878889|NCT01134705|580952220|FG001|Overall Study|Lost to Follow-up|2|||
160878890|NCT01134705|580952219|FG000|Overall Study|Protocol Violation|1|||
160878891|NCT01134705|580952220|FG001|Overall Study|Protocol Violation|1|||
160878892|NCT01134705|580952219|FG000|Overall Study|Other|1|||
160878893|NCT01134705|580952220|FG001|Overall Study|Other|6|||
160878894|NCT00246740|580952221|FG000|Initial Enrollment|Death|1|||
160878895|NCT00246740|580952222|FG001|Initial Enrollment|Death|0|||
160878896|NCT00246740|580952221|FG000|Initial Enrollment|Additional surgery scheduled|0|||
161225962|NCT01265784|582208021|FG001|Overall Study|Lost to Follow-up|3|||
161225963|NCT01265784|582208022|FG002|Overall Study|Lost to Follow-up|2|||
161225964|NCT01265784|582208020|FG000|Overall Study|Withdrawal by Subject|0|||
161225965|NCT01265784|582208021|FG001|Overall Study|Withdrawal by Subject|5|||
161225966|NCT01265784|582208022|FG002|Overall Study|Withdrawal by Subject|0|||
161225967|NCT01265784|582208020|FG000|Overall Study|Physician Decision|1|||
161225968|NCT01265784|582208021|FG001|Overall Study|Physician Decision|0|||
161324587|NCT02624947|582575631|FG000|Infant Participants|Non Compliance|17|||
161324588|NCT02624947|582575632|FG001|Infant Participants|Non Compliance|7|||
161324589|NCT02624947|582575631|FG000|Infant Participants|Sponsor Request|0|||
161324590|NCT02624947|582575632|FG001|Infant Participants|Sponsor Request|1|||
161324591|NCT02624947|582575631|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
161324592|NCT02624947|582575632|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
161324593|NCT02624947|582575631|FG000|Infant Participants|Miscellaneous|50|||
161324594|NCT02624947|582575632|FG001|Infant Participants|Miscellaneous|26|||
161324595|NCT00215644|582575635|FG000|Overall Study|Disease Progression|28|||
161324596|NCT00215644|582575636|FG001|Overall Study|Disease Progression|10|||
161324597|NCT00215644|582575635|FG000|Overall Study|Adverse Event|2|||
161120553|NCT00953758|581829457|FG008|Overall Study|Disease progression|0|||
161120554|NCT00953758|581829458|FG009|Overall Study|Disease progression|0|||
161120555|NCT00953758|581829449|FG000|Overall Study|Participant went for transplant|0|||
161120556|NCT00953758|581829450|FG001|Overall Study|Participant went for transplant|0|||
161120557|NCT00953758|581829451|FG002|Overall Study|Participant went for transplant|0|||
161120558|NCT00953758|581829452|FG003|Overall Study|Participant went for transplant|0|||
161120559|NCT00953758|581829453|FG004|Overall Study|Participant went for transplant|0|||
161120560|NCT00953758|581829454|FG005|Overall Study|Participant went for transplant|0|||
161120561|NCT00953758|581829455|FG006|Overall Study|Participant went for transplant|0|||
161120562|NCT00953758|581829456|FG007|Overall Study|Participant went for transplant|0|||
161120563|NCT00953758|581829457|FG008|Overall Study|Participant went for transplant|1|||
161225969|NCT01265784|582208022|FG002|Overall Study|Physician Decision|1|||
161225970|NCT01265784|582208020|FG000|Overall Study|Adverse Event|1|||
161225971|NCT01265784|582208021|FG001|Overall Study|Adverse Event|0|||
161225972|NCT01265784|582208022|FG002|Overall Study|Adverse Event|0|||
161225973|NCT01265784|582208020|FG000|Overall Study|Death|3|||
161225974|NCT01265784|582208021|FG001|Overall Study|Death|0|||
161225975|NCT01265784|582208022|FG002|Overall Study|Death|0|||
161225976|NCT01265784|582208020|FG000|Overall Study|Protocol Violation|2|||
161225977|NCT01265784|582208021|FG001|Overall Study|Protocol Violation|0|||
161225978|NCT01265784|582208022|FG002|Overall Study|Protocol Violation|0|||
161225979|NCT01265784|582208020|FG000|Overall Study|Incorrectly Randomized|0|||
161225980|NCT01265784|582208021|FG001|Overall Study|Incorrectly Randomized|0|||
161225981|NCT01265784|582208022|FG002|Overall Study|Incorrectly Randomized|1|||
161225982|NCT04333095|582208027|FG000|Overall Study|Protocol Violation|4|||
161225983|NCT04333095|582208028|FG001|Overall Study|Protocol Violation|0|||
161225984|NCT04333095|582208027|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
161225985|NCT04333095|582208028|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
161225986|NCT04333095|582208027|FG000|Overall Study|Mini Sternotomy|4|||
161225987|NCT04333095|582208028|FG001|Overall Study|Mini Sternotomy|5|||
161225988|NCT00984295|582208029|FG000|Overall Study|Lost to Follow-up|31|||
161225989|NCT00984295|582208030|FG001|Overall Study|Lost to Follow-up|12|||
161225990|NCT00984295|582208031|FG002|Overall Study|Lost to Follow-up|13|||
161225991|NCT00984295|582208029|FG000|Overall Study|Protocol Violation|2|||
161225992|NCT00984295|582208030|FG001|Overall Study|Protocol Violation|1|||
161225993|NCT00984295|582208031|FG002|Overall Study|Protocol Violation|4|||
161225994|NCT00984295|582208029|FG000|Overall Study|Withdrawal by Subject|18|||
161225995|NCT00984295|582208030|FG001|Overall Study|Withdrawal by Subject|9|||
161225996|NCT00984295|582208031|FG002|Overall Study|Withdrawal by Subject|12|||
161225997|NCT00984295|582208029|FG000|Overall Study|CAE - discontinued test vaccine|0|||
161225998|NCT00984295|582208030|FG001|Overall Study|CAE - discontinued test vaccine|1|||
161225999|NCT00984295|582208031|FG002|Overall Study|CAE - discontinued test vaccine|3|||
161226000|NCT00984295|582208029|FG000|Overall Study|Missed one or more blood samplings|3|||
161226001|NCT00984295|582208030|FG001|Overall Study|Missed one or more blood samplings|7|||
161226002|NCT00984295|582208031|FG002|Overall Study|Missed one or more blood samplings|2|||
161226003|NCT00984295|582208029|FG000|Overall Study|Incomplete safety follow-up|11|||
161226004|NCT00984295|582208030|FG001|Overall Study|Incomplete safety follow-up|2|||
161226005|NCT00984295|582208031|FG002|Overall Study|Incomplete safety follow-up|3|||
161226006|NCT02364557|582208032|FG000|Overall Study|Protocol Violation|3|||
161226007|NCT02364557|582208033|FG001|Overall Study|Protocol Violation|1|||
160878897|NCT00246740|580952222|FG001|Initial Enrollment|Additional surgery scheduled|2|||
160878898|NCT00246740|580952221|FG000|Initial Enrollment|Surgery schedule change|4|||
160878899|NCT00246740|580952222|FG001|Initial Enrollment|Surgery schedule change|4|||
160878900|NCT00246740|580952221|FG000|Initial Enrollment|Other|1|||
160878901|NCT00246740|580952222|FG001|Initial Enrollment|Other|2|||
160878902|NCT00101452|580952223|FG000|Overall Study|Adverse Event|2|||
160878903|NCT00101452|580952224|FG001|Overall Study|Adverse Event|0|||
160878904|NCT00101452|580952225|FG002|Overall Study|Adverse Event|1|||
160878905|NCT00101452|580952223|FG000|Overall Study|Lost to Follow-up|13|||
160878906|NCT00101452|580952224|FG001|Overall Study|Lost to Follow-up|8|||
160878907|NCT00101452|580952225|FG002|Overall Study|Lost to Follow-up|14|||
160878908|NCT00101452|580952223|FG000|Overall Study|Withdrawal by Subject|10|||
160878909|NCT00101452|580952224|FG001|Overall Study|Withdrawal by Subject|14|||
160878910|NCT00101452|580952225|FG002|Overall Study|Withdrawal by Subject|9|||
161226008|NCT03740165|582208034|FG000|Overall Study|Death|232|||
160878911|NCT00101452|580952223|FG000|Overall Study|Baseline Fail|2|||
160878912|NCT00101452|580952224|FG001|Overall Study|Baseline Fail|1|||
160878913|NCT00101452|580952225|FG002|Overall Study|Baseline Fail|2|||
160878914|NCT00101452|580952223|FG000|Overall Study|Physician Decision|0|||
160878915|NCT00101452|580952224|FG001|Overall Study|Physician Decision|3|||
160878916|NCT00101452|580952225|FG002|Overall Study|Physician Decision|2|||
160878917|NCT00101452|580952223|FG000|Overall Study|Protocol Violation|2|||
160878918|NCT00101452|580952224|FG001|Overall Study|Protocol Violation|1|||
160878919|NCT00101452|580952225|FG002|Overall Study|Protocol Violation|3|||
160878920|NCT00101452|580952223|FG000|Overall Study|Other|15|||
160878921|NCT00101452|580952224|FG001|Overall Study|Other|16|||
160878922|NCT00101452|580952225|FG002|Overall Study|Other|12|||
160878923|NCT01510769|580952226|FG000|Overall Study|Adverse Event|7|||
160878924|NCT01510769|580952227|FG001|Overall Study|Adverse Event|6|||
160878925|NCT01510769|580952228|FG002|Overall Study|Adverse Event|4|||
160878926|NCT01510769|580952226|FG000|Overall Study|Gout Flare|0|||
160878927|NCT01510769|580952227|FG001|Overall Study|Gout Flare|3|||
160878928|NCT01510769|580952228|FG002|Overall Study|Gout Flare|1|||
160878929|NCT01510769|580952226|FG000|Overall Study|Protocol Violation|11|||
160878930|NCT01510769|580952227|FG001|Overall Study|Protocol Violation|10|||
160878931|NCT01510769|580952228|FG002|Overall Study|Protocol Violation|9|||
160878932|NCT01510769|580952226|FG000|Overall Study|Lost to Follow-up|5|||
160878933|NCT01510769|580952227|FG001|Overall Study|Lost to Follow-up|1|||
160878934|NCT01510769|580952228|FG002|Overall Study|Lost to Follow-up|5|||
160878935|NCT01510769|580952226|FG000|Overall Study|Withdrawal by Subject|3|||
160878936|NCT01510769|580952227|FG001|Overall Study|Withdrawal by Subject|4|||
160878937|NCT01510769|580952228|FG002|Overall Study|Withdrawal by Subject|3|||
160878938|NCT01510769|580952226|FG000|Overall Study|Death|1|||
160878939|NCT01510769|580952227|FG001|Overall Study|Death|1|||
160878940|NCT01510769|580952228|FG002|Overall Study|Death|0|||
160878941|NCT02674204|580952229|FG000|Overall Study|Adverse Event|1|||
160878942|NCT02674204|580952230|FG001|Overall Study|Adverse Event|0|||
160878943|NCT02466659|580952233|FG000|Overall Study|Lost to Follow-up|5|||
160878944|NCT02466659|580952234|FG001|Overall Study|Lost to Follow-up|2|||
160878945|NCT01536392|580952235|FG000|Overall Study|Adverse Event|2|||
160878946|NCT01536392|580952236|FG001|Overall Study|Adverse Event|2|||
160878947|NCT01536392|580952235|FG000|Overall Study|Physician Decision|2|||
160878948|NCT01536392|580952236|FG001|Overall Study|Physician Decision|3|||
160878949|NCT01536392|580952235|FG000|Overall Study|Withdrawal by Subject|3|||
160878950|NCT01536392|580952236|FG001|Overall Study|Withdrawal by Subject|6|||
160878951|NCT01536392|580952235|FG000|Overall Study|Non Compliance|3|||
160878952|NCT01536392|580952236|FG001|Overall Study|Non Compliance|4|||
160878953|NCT01536392|580952235|FG000|Overall Study|Completed therapy early|3|||
160878954|NCT01536392|580952236|FG001|Overall Study|Completed therapy early|0|||
161226009|NCT03740165|582208035|FG001|Overall Study|Death|242|||
161226010|NCT03740165|582208036|FG002|Overall Study|Death|229|||
160878955|NCT02874144|580952237|FG000|Overall Study|Lost to Follow-up|3|||
160878956|NCT02874144|580952238|FG001|Overall Study|Lost to Follow-up|5|||
160878957|NCT00486811|580952240|FG000|Overall Study|Adverse Event|28|||
160878958|NCT00486811|580952241|FG001|Overall Study|Adverse Event|60|||
160878959|NCT00486811|580952242|FG002|Overall Study|Adverse Event|135|||
160878960|NCT00486811|580952240|FG000|Overall Study|Lack of Efficacy|34|||
160878961|NCT00486811|580952241|FG001|Overall Study|Lack of Efficacy|14|||
160878962|NCT00486811|580952242|FG002|Overall Study|Lack of Efficacy|7|||
160878963|NCT00486811|580952240|FG000|Overall Study|Lost to Follow-up|4|||
160878964|NCT00486811|580952241|FG001|Overall Study|Lost to Follow-up|6|||
160878965|NCT00486811|580952242|FG002|Overall Study|Lost to Follow-up|4|||
160878966|NCT00486811|580952240|FG000|Overall Study|Withdrawal by Subject|33|||
160878967|NCT00486811|580952241|FG001|Overall Study|Withdrawal by Subject|44|||
160878968|NCT00486811|580952242|FG002|Overall Study|Withdrawal by Subject|58|||
160878969|NCT00486811|580952240|FG000|Overall Study|Study drug non-compliant|5|||
161226011|NCT03740165|582208034|FG000|Overall Study|Lost to Follow-up|0|||
160878970|NCT00486811|580952241|FG001|Overall Study|Study drug non-compliant|6|||
160878971|NCT00486811|580952242|FG002|Overall Study|Study drug non-compliant|3|||
160878972|NCT00486811|580952240|FG000|Overall Study|All other|18|||
160878973|NCT00486811|580952241|FG001|Overall Study|All other|11|||
160878974|NCT00486811|580952242|FG002|Overall Study|All other|7|||
160878975|NCT00852371|580952248|FG000|Overall Study|Lost to Follow-up|2|||
160878976|NCT00852371|580952249|FG001|Overall Study|Lost to Follow-up|3|||
160878977|NCT00852371|580952250|FG002|Overall Study|Lost to Follow-up|4|||
160878978|NCT00852371|580952251|FG003|Overall Study|Lost to Follow-up|2|||
160878979|NCT04525885|580952252|FG000|Overall Study|Screen Failure|1|||
160878980|NCT04525885|580952253|FG001|Overall Study|Screen Failure|0|||
160878981|NCT04525885|580952254|FG002|Overall Study|Screen Failure|0|||
160878982|NCT04525885|580952252|FG000|Overall Study|Withdrawal by Subject|14|||
160878983|NCT04525885|580952253|FG001|Overall Study|Withdrawal by Subject|6|||
160878984|NCT04525885|580952254|FG002|Overall Study|Withdrawal by Subject|20|||
160878985|NCT04525885|580952252|FG000|Overall Study|Physician Decision|1|||
160878986|NCT04525885|580952253|FG001|Overall Study|Physician Decision|0|||
160878987|NCT04525885|580952254|FG002|Overall Study|Physician Decision|1|||
160878988|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
160878989|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
160878990|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
160878991|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
160878992|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
160878993|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
160878994|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
160878995|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
160878996|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
160878997|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160878998|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
161226012|NCT03740165|582208035|FG001|Overall Study|Lost to Follow-up|0|||
161226013|NCT03740165|582208036|FG002|Overall Study|Lost to Follow-up|1|||
160878999|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160879000|NCT03158285|580952255|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
160879001|NCT03158285|580952256|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
160879002|NCT03158285|580952257|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
161226014|NCT03740165|582208034|FG000|Overall Study|Withdrawal by Subject|7|||
161226015|NCT03740165|582208035|FG001|Overall Study|Withdrawal by Subject|4|||
161226016|NCT03740165|582208036|FG002|Overall Study|Withdrawal by Subject|3|||
161226017|NCT03740165|582208034|FG000|Overall Study|Ongoing in Study|216|||
161226018|NCT03740165|582208035|FG001|Overall Study|Ongoing in Study|212|||
161226019|NCT03740165|582208036|FG002|Overall Study|Ongoing in Study|221|||
161120564|NCT00953758|581829458|FG009|Overall Study|Participant went for transplant|0|||
161120565|NCT03847610|581829459|FG000|Overall Study|Withdrawal by Subject|1|||
161120566|NCT02004873|581829460|FG000|Overall Study|Implant unsuccessful|6|||
161120567|NCT02004873|581829460|FG000|Overall Study|Awaiting 6-month visit|390|||
161120568|NCT02004873|581829460|FG000|Overall Study|Missed 6-month visit|4|||
161120569|NCT02004873|581829460|FG000|Overall Study|Death|23|||
161120570|NCT02004873|581829460|FG000|Overall Study|Withdrawal by Subject|1|||
161120571|NCT01276236|581829462|FG000|Overall Study|Lack of Efficacy|2|||
161120572|NCT01276236|581829462|FG000|Overall Study|Withdrawal by Subject|4|||
161120573|NCT02799069|581829463|FG000|Overall Study|Adverse Event|0|||
161120574|NCT02799069|581829464|FG001|Overall Study|Adverse Event|2|||
161120575|NCT02799069|581829465|FG002|Overall Study|Adverse Event|2|||
161120576|NCT02799069|581829463|FG000|Overall Study|Lack of Efficacy|2|||
161120577|NCT02799069|581829464|FG001|Overall Study|Lack of Efficacy|0|||
161120578|NCT02799069|581829465|FG002|Overall Study|Lack of Efficacy|0|||
161120579|NCT02799069|581829463|FG000|Overall Study|Lost to Follow-up|1|||
161120580|NCT02799069|581829464|FG001|Overall Study|Lost to Follow-up|1|||
161120581|NCT02799069|581829465|FG002|Overall Study|Lost to Follow-up|0|||
161120582|NCT02799069|581829463|FG000|Overall Study|Withdrawal by Subject|4|||
161120583|NCT02799069|581829464|FG001|Overall Study|Withdrawal by Subject|4|||
161120584|NCT02799069|581829465|FG002|Overall Study|Withdrawal by Subject|3|||
161120585|NCT02799069|581829463|FG000|Overall Study|Protocol Violation|1|||
161120586|NCT02799069|581829464|FG001|Overall Study|Protocol Violation|0|||
161120587|NCT02799069|581829465|FG002|Overall Study|Protocol Violation|2|||
160879003|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
160879004|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
161226020|NCT04347239|582208037|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
161226021|NCT04347239|582208038|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
161226022|NCT04347239|582208039|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
161226023|NCT04347239|582208037|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
161226024|NCT04347239|582208038|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
161226025|NCT04347239|582208039|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
161226026|NCT03049618|582208040|FG000|Overall Study|Death|1|||
161226027|NCT03049618|582208041|FG001|Overall Study|Death|0|||
161226028|NCT03049618|582208040|FG000|Overall Study|Lack of Efficacy|1|||
161226029|NCT03049618|582208041|FG001|Overall Study|Lack of Efficacy|2|||
160879005|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
160879006|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
160879007|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
160879008|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
160879009|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
160879010|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
160879011|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
160879012|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
160879013|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
160879014|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
160879015|NCT03158285|580952255|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
160879016|NCT03158285|580952256|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
160879017|NCT03158285|580952257|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
160879018|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
160879019|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
160879020|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
160879021|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
160879022|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
160879023|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
160879024|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
160879025|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
160879026|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
160879027|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
161226030|NCT04582539|582208042|FG000|Overall Study|Death|1|||
161226031|NCT04582539|582208043|FG001|Overall Study|Death|1|||
160879028|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
160879029|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
160879030|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Death|1|||
160879031|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Death|0|||
160879032|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Death|0|||
160879033|NCT03158285|580952255|FG000|Active Treatment Period: Week 52-100|Other|4|||
160879034|NCT03158285|580952256|FG001|Active Treatment Period: Week 52-100|Other|1|||
160879035|NCT03158285|580952257|FG002|Active Treatment Period: Week 52-100|Other|0|||
160879036|NCT02228980|580952258|FG000|Overall Study|Adverse Event|14|||
160879037|NCT02228980|580952259|FG001|Overall Study|Adverse Event|0|||
160879038|NCT02228980|580952260|FG002|Overall Study|Adverse Event|0|||
160879039|NCT02228980|580952261|FG003|Overall Study|Adverse Event|0|||
160879040|NCT02228980|580952258|FG000|Overall Study|Protocol Violation|7|||
160879041|NCT02228980|580952259|FG001|Overall Study|Protocol Violation|0|||
160879042|NCT02228980|580952260|FG002|Overall Study|Protocol Violation|0|||
160879043|NCT02228980|580952261|FG003|Overall Study|Protocol Violation|0|||
160879044|NCT02228980|580952258|FG000|Overall Study|Withdrawal by Subject|3|||
160879045|NCT02228980|580952259|FG001|Overall Study|Withdrawal by Subject|3|||
160879046|NCT02228980|580952260|FG002|Overall Study|Withdrawal by Subject|2|||
160879047|NCT02228980|580952261|FG003|Overall Study|Withdrawal by Subject|3|||
160879048|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
160879049|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879050|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879051|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
160879052|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
160879053|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
160879054|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
160879055|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
160879056|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
160879057|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
160879058|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
160879059|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
160879060|NCT01642615|580952262|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
160879061|NCT01642615|580952263|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
160879062|NCT01642615|580952264|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
160879063|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
160879064|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
160879065|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
160879066|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
160879067|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
160879068|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
160879069|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879070|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
160879071|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160879072|NCT01642615|580952262|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
160879073|NCT01642615|580952263|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
160879074|NCT01642615|580952264|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
160879075|NCT02744040|580952265|FG000|Overall Study|Withdrawal by Subject|3|||
160879076|NCT02744040|580952266|FG001|Overall Study|Withdrawal by Subject|2|||
160879077|NCT02744040|580952267|FG002|Overall Study|Withdrawal by Subject|2|||
161120588|NCT03440814|581829474|FG000|Overall Study|Adverse Event|2|||
161120589|NCT03440814|581829475|FG001|Overall Study|Adverse Event|1|||
161120590|NCT03440814|581829474|FG000|Overall Study|Lost to Follow-up|2|||
161120591|NCT03440814|581829475|FG001|Overall Study|Lost to Follow-up|0|||
161120592|NCT03440814|581829474|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
161120593|NCT03440814|581829475|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
161120594|NCT00626093|581829478|FG000|Overall Study|Lost to Follow-up|5|||
161120595|NCT00626093|581829478|FG000|Overall Study|Death|1|||
161120596|NCT00626093|581829478|FG000|Overall Study|Physician Decision|4|||
161120597|NCT00626093|581829478|FG000|Overall Study|Withdrawal by Subject|6|||
161120598|NCT00626093|581829478|FG000|Overall Study|Protocol Violation|1|||
161120599|NCT00626093|581829478|FG000|Overall Study|One of the required devices not implante|6|||
161120600|NCT00511355|581829479|FG000|Overall Study|Adverse Event|4|||
161120601|NCT00511355|581829480|FG001|Overall Study|Adverse Event|4|||
161120602|NCT00511355|581829479|FG000|Overall Study|Pregnancy Wish|1|||
160879078|NCT02744040|580952265|FG000|Overall Study|Physician Decision|0|||
161120603|NCT00511355|581829480|FG001|Overall Study|Pregnancy Wish|0|||
161120604|NCT00511355|581829479|FG000|Overall Study|Lost to Follow-up|2|||
161226032|NCT04582539|582208044|FG002|Overall Study|Death|0|||
161226033|NCT04582539|582208045|FG003|Overall Study|Death|1|||
161226034|NCT04582539|582208046|FG004|Overall Study|Death|0|||
161120605|NCT00511355|581829480|FG001|Overall Study|Lost to Follow-up|1|||
161120606|NCT00511355|581829479|FG000|Overall Study|Other Reason|0|||
161120607|NCT00511355|581829480|FG001|Overall Study|Other Reason|1|||
161120608|NCT00511355|581829479|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
161120609|NCT00511355|581829480|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
161120610|NCT00511355|581829479|FG000|Overall Study|Withdrawal of informed consent|0|||
161120611|NCT00511355|581829480|FG001|Overall Study|Withdrawal of informed consent|1|||
161120612|NCT00511355|581829479|FG000|Overall Study|Other reason pre-treatment|0|||
161120613|NCT00511355|581829480|FG001|Overall Study|Other reason pre-treatment|1|||
161120614|NCT01632566|581829482|FG000|Overall Study|Withdrawal by Subject|0|||
161120615|NCT01632566|581829483|FG001|Overall Study|Withdrawal by Subject|1|||
161120616|NCT01632566|581829484|FG002|Overall Study|Withdrawal by Subject|0|||
161120617|NCT01632566|581829485|FG003|Overall Study|Withdrawal by Subject|0|||
161120618|NCT01632566|581829486|FG004|Overall Study|Withdrawal by Subject|0|||
161120619|NCT01632566|581829482|FG000|Overall Study|Sponsor Decision|0|||
161120620|NCT01632566|581829483|FG001|Overall Study|Sponsor Decision|2|||
161120621|NCT01632566|581829484|FG002|Overall Study|Sponsor Decision|9|||
161120622|NCT01632566|581829485|FG003|Overall Study|Sponsor Decision|2|||
161120623|NCT01632566|581829486|FG004|Overall Study|Sponsor Decision|2|||
161120624|NCT00454805|581829487|FG000|Overall Study|Withdrawal by Subject|9|||
161120625|NCT00454805|581829488|FG001|Overall Study|Withdrawal by Subject|2|||
161120626|NCT00454805|581829487|FG000|Overall Study|Death|0|||
161120627|NCT00454805|581829488|FG001|Overall Study|Death|2|||
161120628|NCT00454805|581829487|FG000|Overall Study|Disease progression|16|||
161120629|NCT00454805|581829488|FG001|Overall Study|Disease progression|19|||
161120630|NCT00454805|581829487|FG000|Overall Study|In order to begin radiotherapy|1|||
161120631|NCT00454805|581829488|FG001|Overall Study|In order to begin radiotherapy|0|||
161120632|NCT00217087|581829489|FG000|Overall Study|decided to have esophagectomy|1|||
161120633|NCT00217087|581829490|FG001|Overall Study|decided to have esophagectomy|2|||
161120634|NCT00217087|581829489|FG000|Overall Study|completed less than 12 months return|10|||
161120635|NCT00217087|581829490|FG001|Overall Study|completed less than 12 months return|18|||
161120636|NCT03208231|581829493|FG000|Overall Study|Death|1|||
161120637|NCT03208231|581829494|FG001|Overall Study|Death|2|||
161120638|NCT03208231|581829493|FG000|Overall Study|Moved and unable to get to clinic|1|||
161120639|NCT03208231|581829494|FG001|Overall Study|Moved and unable to get to clinic|0|||
161120640|NCT03208231|581829493|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
161120641|NCT03208231|581829494|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
161120642|NCT03205995|581829495|FG000|Overall Study|Adverse Event|1|||
161120643|NCT03205995|581829495|FG000|Overall Study|Death|1|||
161120644|NCT03205995|581829495|FG000|Overall Study|Physician Decision|2|||
161120645|NCT03205995|581829495|FG000|Overall Study|Protocol Violation|2|||
161120646|NCT04947800|581829496|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
161120647|NCT04947800|581829497|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
161120648|NCT04947800|581829498|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
161120649|NCT03892746|581829499|FG000|Overall Study|Withdrawal by Subject|2|||
161120650|NCT03892746|581829500|FG001|Overall Study|Withdrawal by Subject|1|||
161120651|NCT03892746|581829499|FG000|Overall Study|Lost to Follow-up|2|||
161120652|NCT03892746|581829500|FG001|Overall Study|Lost to Follow-up|0|||
161120653|NCT03977467|581829501|FG000|Overall Study|Disease Progression|1|||
161120654|NCT03977467|581829502|FG001|Overall Study|Disease Progression|1|||
161120655|NCT03977467|581829503|FG002|Overall Study|Disease Progression|30|||
161120656|NCT03977467|581829504|FG003|Overall Study|Disease Progression|0|||
161120657|NCT03977467|581829501|FG000|Overall Study|Adverse Event|0|||
161120658|NCT03977467|581829502|FG001|Overall Study|Adverse Event|1|||
161120659|NCT03977467|581829503|FG002|Overall Study|Adverse Event|0|||
161120660|NCT03977467|581829504|FG003|Overall Study|Adverse Event|0|||
161120661|NCT03977467|581829501|FG000|Overall Study|Death|0|||
161120662|NCT03977467|581829502|FG001|Overall Study|Death|0|||
161120663|NCT03977467|581829503|FG002|Overall Study|Death|3|||
161120664|NCT03977467|581829504|FG003|Overall Study|Death|0|||
161120665|NCT03977467|581829501|FG000|Overall Study|Lack of Efficacy|0|||
161120666|NCT03977467|581829502|FG001|Overall Study|Lack of Efficacy|0|||
161120667|NCT03977467|581829503|FG002|Overall Study|Lack of Efficacy|1|||
161120668|NCT03977467|581829504|FG003|Overall Study|Lack of Efficacy|0|||
161120669|NCT03977467|581829501|FG000|Overall Study|Withdrawal by Subject|2|||
161120670|NCT03977467|581829502|FG001|Overall Study|Withdrawal by Subject|1|||
161120671|NCT03977467|581829503|FG002|Overall Study|Withdrawal by Subject|4|||
161324598|NCT00215644|582575636|FG001|Overall Study|Adverse Event|9|||
161324599|NCT00215644|582575635|FG000|Overall Study|Death|1|||
161324600|NCT00215644|582575636|FG001|Overall Study|Death|2|||
160879079|NCT02744040|580952266|FG001|Overall Study|Physician Decision|8|||
161120672|NCT03977467|581829504|FG003|Overall Study|Withdrawal by Subject|0|||
161120673|NCT03977467|581829501|FG000|Overall Study|Study Terminated|1|||
161120674|NCT03977467|581829502|FG001|Overall Study|Study Terminated|0|||
161120675|NCT03977467|581829503|FG002|Overall Study|Study Terminated|0|||
161120676|NCT03977467|581829504|FG003|Overall Study|Study Terminated|1|||
161120677|NCT01318109|581829505|FG000|Overall Study|Adverse Event|0|||
161120678|NCT01318109|581829506|FG001|Overall Study|Adverse Event|2|||
160879080|NCT02744040|580952267|FG002|Overall Study|Physician Decision|13|||
160879081|NCT02744040|580952265|FG000|Overall Study|Lost to Follow-up|3|||
160879082|NCT02744040|580952266|FG001|Overall Study|Lost to Follow-up|1|||
160879083|NCT02744040|580952267|FG002|Overall Study|Lost to Follow-up|7|||
160879084|NCT00750152|580952268|FG000|Overall Study|Adverse Event|2|||
161120679|NCT01318109|581829507|FG002|Overall Study|Adverse Event|0|||
161120680|NCT01318109|581829505|FG000|Overall Study|Withdrawal by Subject|1|||
161120681|NCT01318109|581829506|FG001|Overall Study|Withdrawal by Subject|0|||
161120682|NCT01318109|581829507|FG002|Overall Study|Withdrawal by Subject|0|||
161120683|NCT01318109|581829505|FG000|Overall Study|Schedule Conflict|0|||
161120684|NCT01318109|581829506|FG001|Overall Study|Schedule Conflict|1|||
161120685|NCT01318109|581829507|FG002|Overall Study|Schedule Conflict|0|||
161120686|NCT01328951|581829508|FG000|Overall Study|Disease Progression|17|||
161120687|NCT01328951|581829509|FG001|Overall Study|Disease Progression|14|||
160879085|NCT00750152|580952269|FG001|Overall Study|Adverse Event|1|||
160879086|NCT00750152|580952268|FG000|Overall Study|Lost to Follow-up|8|||
160879087|NCT00750152|580952269|FG001|Overall Study|Lost to Follow-up|13|||
160879088|NCT00750152|580952268|FG000|Overall Study|Withdrawal by Subject|3|||
161120688|NCT01328951|581829508|FG000|Overall Study|Adverse Event|2|||
161120689|NCT01328951|581829509|FG001|Overall Study|Adverse Event|0|||
160879089|NCT00750152|580952269|FG001|Overall Study|Withdrawal by Subject|3|||
161120690|NCT01328951|581829508|FG000|Overall Study|Death|243|||
161226035|NCT04582539|582208042|FG000|Overall Study|Lost to Follow-up|1|||
161226036|NCT04582539|582208043|FG001|Overall Study|Lost to Follow-up|0|||
160879090|NCT00750152|580952268|FG000|Overall Study|Physician Decision|1|||
160879091|NCT00750152|580952269|FG001|Overall Study|Physician Decision|1|||
160879092|NCT00750152|580952268|FG000|Overall Study|Non-compliance|0|||
160879093|NCT00750152|580952269|FG001|Overall Study|Non-compliance|1|||
160879094|NCT00750152|580952268|FG000|Overall Study|Termination by sponsor|1|||
160879095|NCT00750152|580952269|FG001|Overall Study|Termination by sponsor|0|||
160879096|NCT00750152|580952268|FG000|Overall Study|Other|7|||
160879097|NCT00750152|580952269|FG001|Overall Study|Other|8|||
160879098|NCT00402740|580952275|FG000|Overall Study|Withdrawal by Subject|18|||
160879099|NCT00402740|580952275|FG000|Overall Study|Death|50|||
160879100|NCT00402740|580952275|FG000|Overall Study|Lost to Follow-up|6|||
160879101|NCT00402740|580952275|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
160879102|NCT00402740|580952275|FG000|Overall Study|Subject disposition unknown.|1|||
160879103|NCT01214395|580952276|FG000|Overall Study|All patients had infection|5|||
160879104|NCT00715910|580952277|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
160879105|NCT00715910|580952278|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
160879106|NCT00715910|580952279|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
160879107|NCT00715910|580952280|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
160879108|NCT00715910|580952281|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
160879109|NCT00715910|580952282|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
160879110|NCT00715910|580952277|FG000|Booster and ESFU Phase|Other|0|||
160879111|NCT00715910|580952278|FG001|Booster and ESFU Phase|Other|0|||
160879112|NCT00715910|580952279|FG002|Booster and ESFU Phase|Other|0|||
160879113|NCT00715910|580952280|FG003|Booster and ESFU Phase|Other|5|||
160879114|NCT00715910|580952281|FG004|Booster and ESFU Phase|Other|1|||
160879115|NCT00715910|580952282|FG005|Booster and ESFU Phase|Other|0|||
160879116|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879117|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879118|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879119|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
160879120|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
160879121|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879122|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879123|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879124|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879125|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
160879126|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879127|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879128|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879129|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879130|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
160879131|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879132|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879133|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879134|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879135|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
160879136|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
160879137|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879138|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879139|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879140|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
160879141|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879142|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879143|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879144|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
160879145|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
161226037|NCT04582539|582208044|FG002|Overall Study|Lost to Follow-up|0|||
161226038|NCT04582539|582208045|FG003|Overall Study|Lost to Follow-up|0|||
161226039|NCT04582539|582208046|FG004|Overall Study|Lost to Follow-up|0|||
161226040|NCT04582539|582208042|FG000|Overall Study|Study Terminated by Sponsor|1|||
161226041|NCT04582539|582208043|FG001|Overall Study|Study Terminated by Sponsor|3|||
161226042|NCT04582539|582208044|FG002|Overall Study|Study Terminated by Sponsor|2|||
161226043|NCT04582539|582208045|FG003|Overall Study|Study Terminated by Sponsor|2|||
161226044|NCT04582539|582208046|FG004|Overall Study|Study Terminated by Sponsor|3|||
161226045|NCT04582539|582208042|FG000|Overall Study|Physician Decision|0|||
161226046|NCT04582539|582208043|FG001|Overall Study|Physician Decision|1|||
161226047|NCT04582539|582208044|FG002|Overall Study|Physician Decision|0|||
160879146|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879147|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879148|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
160879149|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
161226048|NCT04582539|582208045|FG003|Overall Study|Physician Decision|0|||
160879150|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
160879151|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879152|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879153|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879154|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879155|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
160879156|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879157|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879158|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879159|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879160|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
160879161|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879162|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879163|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879164|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879165|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
160879166|NCT01185353|580952286|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
160879167|NCT01185353|580952287|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879168|NCT01185353|580952288|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879169|NCT01185353|580952289|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879170|NCT01185353|580952290|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
160879171|NCT01185353|580952291|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879172|NCT01185353|580952292|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879173|NCT01185353|580952293|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879174|NCT01185353|580952294|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879175|NCT01185353|580952295|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
160879176|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879177|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879178|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
160879179|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879180|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879181|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
160879182|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879183|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879184|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879185|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
160879186|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879187|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
160879188|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879189|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
161226049|NCT04582539|582208046|FG004|Overall Study|Physician Decision|0|||
160879190|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879191|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879192|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879193|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879194|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879195|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
160879196|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879197|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879198|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879199|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
160879200|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879201|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879202|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
160879203|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879204|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879205|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
160879206|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879207|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879208|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
160879209|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
160879210|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879211|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
160879212|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
160879213|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879214|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879215|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
160879216|NCT01185353|580952286|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879217|NCT01185353|580952287|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879218|NCT01185353|580952288|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879219|NCT01185353|580952289|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879220|NCT01185353|580952290|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879221|NCT01185353|580952291|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879222|NCT01185353|580952292|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
160879223|NCT01185353|580952293|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879224|NCT01185353|580952294|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879225|NCT01185353|580952295|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
160879226|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879227|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879228|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879229|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879230|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
161226050|NCT04582539|582208042|FG000|Overall Study|Withdrawal by Subject|1|||
161226051|NCT04582539|582208043|FG001|Overall Study|Withdrawal by Subject|0|||
161226052|NCT04582539|582208044|FG002|Overall Study|Withdrawal by Subject|2|||
160879231|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879232|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
160879233|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
160879234|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
160879235|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
160879236|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879237|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879238|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879239|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879240|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879241|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879242|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
160879243|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
160879244|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
160879245|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
160879246|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879247|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879248|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879249|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879250|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879251|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879252|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
160879253|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
160879254|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
160879255|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
160879256|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879257|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879258|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879259|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879260|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879261|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879262|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879263|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879264|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
160879265|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
160879266|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Death|0|||
160879267|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Death|0|||
160879268|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Death|0|||
160879269|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Death|0|||
160879270|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Death|0|||
160879271|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Death|0|||
160879272|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Death|0|||
160879273|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Death|0|||
160879274|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Death|0|||
160879275|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Death|1|||
160879276|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879277|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879278|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879279|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879280|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879281|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879282|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879283|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879284|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
160879285|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
160879286|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879287|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879288|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879289|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879290|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879291|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879292|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879293|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879294|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
160879295|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
160879296|NCT01185353|580952286|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879297|NCT01185353|580952287|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879298|NCT01185353|580952288|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879299|NCT01185353|580952289|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879300|NCT01185353|580952290|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879301|NCT01185353|580952291|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879302|NCT01185353|580952292|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879303|NCT01185353|580952293|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879304|NCT01185353|580952294|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
160879305|NCT01185353|580952295|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
160879306|NCT01185353|580952286|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879307|NCT01185353|580952287|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879308|NCT01185353|580952288|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879309|NCT01185353|580952289|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879310|NCT01185353|580952290|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879311|NCT01185353|580952291|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879312|NCT01185353|580952292|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879313|NCT01185353|580952293|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
160879314|NCT01185353|580952294|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
160879315|NCT01185353|580952295|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
160879316|NCT01185353|580952286|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879317|NCT01185353|580952287|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879318|NCT01185353|580952288|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879319|NCT01185353|580952289|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879320|NCT01185353|580952290|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879321|NCT01185353|580952291|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879322|NCT01185353|580952292|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
160879323|NCT01185353|580952293|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
160879324|NCT01185353|580952294|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
160879325|NCT01185353|580952295|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
160879326|NCT01185353|580952286|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879327|NCT01185353|580952287|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879328|NCT01185353|580952288|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879329|NCT01185353|580952289|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879330|NCT01185353|580952290|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879331|NCT01185353|580952291|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879332|NCT01185353|580952292|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879333|NCT01185353|580952293|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
160879334|NCT01185353|580952294|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
160879335|NCT01185353|580952295|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
160879336|NCT02626624|580952307|FG000|Overall Study|Adverse Event|1|||
160879337|NCT02626624|580952307|FG000|Overall Study|Lost to Follow-up|3|||
160879338|NCT02626624|580952307|FG000|Overall Study|Protocol Violation|4|||
160879339|NCT02626624|580952307|FG000|Overall Study|Death|2|||
160879340|NCT01097005|580952308|FG000|Overall Study|Case Report Form not collected|18|||
161120691|NCT01328951|581829509|FG001|Overall Study|Death|258|||
161120692|NCT01328951|581829508|FG000|Overall Study|Lost to Follow-up|6|||
160879341|NCT01097005|580952308|FG000|Overall Study|Subjects cannot visit the hospital|1|||
160879342|NCT01097005|580952308|FG000|Overall Study|Poor medication compliance|1|||
160879343|NCT01097005|580952308|FG000|Overall Study|No examination data available|244|||
160879344|NCT01097005|580952308|FG000|Overall Study|Deviation from exclusion criteria|37|||
161120693|NCT01328951|581829509|FG001|Overall Study|Lost to Follow-up|7|||
161120694|NCT01328951|581829508|FG000|Overall Study|Withdrawal by Subject|6|||
161120695|NCT01328951|581829509|FG001|Overall Study|Withdrawal by Subject|6|||
161120696|NCT01328951|581829508|FG000|Overall Study|Study Closed by the Sponsor|36|||
161120697|NCT01328951|581829509|FG001|Overall Study|Study Closed by the Sponsor|31|||
161120698|NCT01328951|581829508|FG000|Overall Study|Other|11|||
161120699|NCT01328951|581829509|FG001|Overall Study|Other|6|||
161120700|NCT01358864|581829524|FG000|Overall Study|Adverse Event|0|||
161120701|NCT01358864|581829525|FG001|Overall Study|Adverse Event|6|||
161120702|NCT01358864|581829526|FG002|Overall Study|Adverse Event|9|||
161120703|NCT01358864|581829527|FG003|Overall Study|Adverse Event|0|||
161120704|NCT01358864|581829528|FG004|Overall Study|Adverse Event|4|||
161120705|NCT01358864|581829529|FG005|Overall Study|Adverse Event|8|||
161120706|NCT01358864|581829530|FG006|Overall Study|Adverse Event|12|||
161120707|NCT01358864|581829531|FG007|Overall Study|Adverse Event|7|||
161120708|NCT01358864|581829524|FG000|Overall Study|Lack of Efficacy|26|||
161120709|NCT01358864|581829525|FG001|Overall Study|Lack of Efficacy|3|||
161120710|NCT01358864|581829526|FG002|Overall Study|Lack of Efficacy|4|||
161120711|NCT01358864|581829527|FG003|Overall Study|Lack of Efficacy|19|||
161120712|NCT01358864|581829528|FG004|Overall Study|Lack of Efficacy|7|||
161120713|NCT01358864|581829529|FG005|Overall Study|Lack of Efficacy|4|||
161120714|NCT01358864|581829530|FG006|Overall Study|Lack of Efficacy|49|||
161120715|NCT01358864|581829531|FG007|Overall Study|Lack of Efficacy|44|||
161120716|NCT01358864|581829524|FG000|Overall Study|Lost to Follow-up|0|||
161120717|NCT01358864|581829525|FG001|Overall Study|Lost to Follow-up|0|||
161120718|NCT01358864|581829526|FG002|Overall Study|Lost to Follow-up|1|||
161120719|NCT01358864|581829527|FG003|Overall Study|Lost to Follow-up|0|||
161120720|NCT01358864|581829528|FG004|Overall Study|Lost to Follow-up|0|||
161120721|NCT01358864|581829529|FG005|Overall Study|Lost to Follow-up|0|||
161120722|NCT01358864|581829530|FG006|Overall Study|Lost to Follow-up|0|||
161120723|NCT01358864|581829531|FG007|Overall Study|Lost to Follow-up|1|||
161120724|NCT01358864|581829524|FG000|Overall Study|Withdrawal by Subject|3|||
161120725|NCT01358864|581829525|FG001|Overall Study|Withdrawal by Subject|4|||
161120726|NCT01358864|581829526|FG002|Overall Study|Withdrawal by Subject|2|||
161120727|NCT01358864|581829527|FG003|Overall Study|Withdrawal by Subject|0|||
161120728|NCT01358864|581829528|FG004|Overall Study|Withdrawal by Subject|0|||
161120729|NCT01358864|581829529|FG005|Overall Study|Withdrawal by Subject|1|||
161120730|NCT01358864|581829530|FG006|Overall Study|Withdrawal by Subject|1|||
161120731|NCT01358864|581829531|FG007|Overall Study|Withdrawal by Subject|3|||
161120732|NCT01358864|581829524|FG000|Overall Study|Other reason not defined above|2|||
161120733|NCT01358864|581829525|FG001|Overall Study|Other reason not defined above|0|||
161120734|NCT01358864|581829526|FG002|Overall Study|Other reason not defined above|0|||
161120735|NCT01358864|581829527|FG003|Overall Study|Other reason not defined above|0|||
161120736|NCT01358864|581829528|FG004|Overall Study|Other reason not defined above|0|||
161120737|NCT01358864|581829529|FG005|Overall Study|Other reason not defined above|0|||
161120738|NCT01358864|581829530|FG006|Overall Study|Other reason not defined above|2|||
161120739|NCT01358864|581829531|FG007|Overall Study|Other reason not defined above|0|||
161120740|NCT01358864|581829524|FG000|Overall Study|Not treated|0|||
161120741|NCT01358864|581829525|FG001|Overall Study|Not treated|0|||
161120742|NCT01358864|581829526|FG002|Overall Study|Not treated|0|||
161120743|NCT01358864|581829527|FG003|Overall Study|Not treated|0|||
161120744|NCT01358864|581829528|FG004|Overall Study|Not treated|0|||
161120745|NCT01358864|581829529|FG005|Overall Study|Not treated|0|||
161120746|NCT01358864|581829530|FG006|Overall Study|Not treated|1|||
161120747|NCT01358864|581829531|FG007|Overall Study|Not treated|0|||
161120748|NCT04042103|581829537|FG000|Overall Study|Lost to Follow-up|1|||
161120749|NCT04042103|581829537|FG000|Overall Study|Withdrawal by Subject|1|||
161226053|NCT04582539|582208045|FG003|Overall Study|Withdrawal by Subject|1|||
161226054|NCT04582539|582208046|FG004|Overall Study|Withdrawal by Subject|0|||
161226055|NCT04582539|582208042|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161226056|NCT04582539|582208043|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161226057|NCT04582539|582208044|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
160879345|NCT01097005|580952308|FG000|Overall Study|Adverse Event|14|||
161120750|NCT04209855|581829538|FG000|Overall Study|Death|161|||
161120751|NCT04209855|581829539|FG001|Overall Study|Death|177|||
161120752|NCT04209855|581829538|FG000|Overall Study|PI Discretion|1|||
161120753|NCT04209855|581829539|FG001|Overall Study|PI Discretion|1|||
161120754|NCT04209855|581829538|FG000|Overall Study|Lost to Follow-up|5|||
161120755|NCT04209855|581829539|FG001|Overall Study|Lost to Follow-up|2|||
161120756|NCT04209855|581829538|FG000|Overall Study|Withdrew consent|10|||
161120757|NCT04209855|581829539|FG001|Overall Study|Withdrew consent|24|||
161120758|NCT04209855|581829538|FG000|Overall Study|Sponsor decision|44|||
161120759|NCT04209855|581829539|FG001|Overall Study|Sponsor decision|18|||
161120760|NCT04209855|581829538|FG000|Overall Study|Other than specified|6|||
161120761|NCT04209855|581829539|FG001|Overall Study|Other than specified|4|||
161120762|NCT01003210|581829540|FG000|Overall Study|Lost to Follow-up|1|||
161120763|NCT01003210|581829541|FG001|Overall Study|Lost to Follow-up|3|||
161120764|NCT00861744|581829542|FG000|Overall Study|Adverse Event|0|||
161120765|NCT00861744|581829543|FG001|Overall Study|Adverse Event|0|||
161120766|NCT00861744|581829544|FG002|Overall Study|Adverse Event|0|||
161120767|NCT00861744|581829545|FG003|Overall Study|Adverse Event|1|||
161120768|NCT00861744|581829542|FG000|Overall Study|Lost to Follow-up|7|||
161120769|NCT00861744|581829543|FG001|Overall Study|Lost to Follow-up|19|||
161120770|NCT00861744|581829544|FG002|Overall Study|Lost to Follow-up|17|||
161120771|NCT00861744|581829545|FG003|Overall Study|Lost to Follow-up|12|||
161120772|NCT00861744|581829542|FG000|Overall Study|Withdrawal by Subject|10|||
161120773|NCT00861744|581829543|FG001|Overall Study|Withdrawal by Subject|6|||
161120774|NCT00861744|581829544|FG002|Overall Study|Withdrawal by Subject|6|||
161120775|NCT00861744|581829545|FG003|Overall Study|Withdrawal by Subject|19|||
161120776|NCT00861744|581829542|FG000|Overall Study|Protocol Violation|0|||
161120777|NCT00861744|581829543|FG001|Overall Study|Protocol Violation|1|||
161120778|NCT00861744|581829544|FG002|Overall Study|Protocol Violation|0|||
161120779|NCT00861744|581829545|FG003|Overall Study|Protocol Violation|0|||
161120780|NCT00861744|581829542|FG000|Overall Study|Migration from study area|0|||
161120781|NCT00861744|581829543|FG001|Overall Study|Migration from study area|3|||
161120782|NCT00861744|581829544|FG002|Overall Study|Migration from study area|1|||
161120783|NCT00861744|581829545|FG003|Overall Study|Migration from study area|0|||
161120784|NCT00861744|581829542|FG000|Overall Study|Blood draws|0|||
161120785|NCT00861744|581829543|FG001|Overall Study|Blood draws|0|||
161120786|NCT00861744|581829544|FG002|Overall Study|Blood draws|0|||
161120787|NCT00861744|581829545|FG003|Overall Study|Blood draws|1|||
161120788|NCT01411085|581829546|FG000|Overall Study|Physician Decision|1|||
161120789|NCT01411085|581829546|FG000|Overall Study|Protocol Violation|1|||
161120790|NCT01411085|581829546|FG000|Overall Study|Adverse Event|1|||
161120791|NCT02193074|581829547|FG000|Overall Study|Withdrawal by Subject|1|||
161120792|NCT02193074|581829548|FG001|Overall Study|Withdrawal by Subject|2|||
161120793|NCT02193074|581829547|FG000|Overall Study|Adverse Event|16|||
161120794|NCT02193074|581829548|FG001|Overall Study|Adverse Event|13|||
161120795|NCT05036083|581829556|FG000|Overall Study|Physician Decision|1|||
161120796|NCT05036083|581829556|FG000|Overall Study|Withdrawal by Subject|1|||
161120797|NCT05036083|581829556|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
161120798|NCT05036083|581829556|FG000|Overall Study|IV not sustainable|1|||
161120799|NCT04745689|581829557|FG000|Overall Study|Death|9|||
161120800|NCT04745689|581829558|FG001|Overall Study|Death|6|||
160879346|NCT01097005|580952308|FG000|Overall Study|Discontinuance by complication|50|||
160879347|NCT03425253|580952312|FG000|Overall Study|Adverse Event|2|||
160879348|NCT03425253|580952312|FG000|Overall Study|Lost to Follow-up|3|||
160879349|NCT03425253|580952312|FG000|Overall Study|Withdrew Consent|6|||
160879350|NCT03425253|580952312|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
160879351|NCT04627285|580952317|FG000|Overall Study|Adverse Event|0|||
160879352|NCT04627285|580952318|FG001|Overall Study|Adverse Event|2|||
160879353|NCT04627285|580952317|FG000|Overall Study|Lost to Follow-up|1|||
160879354|NCT04627285|580952318|FG001|Overall Study|Lost to Follow-up|0|||
160879355|NCT04627285|580952317|FG000|Overall Study|Withdrawal by Subject|1|||
160879356|NCT04627285|580952318|FG001|Overall Study|Withdrawal by Subject|1|||
160879357|NCT04627285|580952317|FG000|Overall Study|Sponsor decision|5|||
160879358|NCT04627285|580952318|FG001|Overall Study|Sponsor decision|0|||
160879359|NCT04627285|580952317|FG000|Overall Study|Participant left country; aunt informed the site|0|||
160879360|NCT04627285|580952318|FG001|Overall Study|Participant left country; aunt informed the site|1|||
160879361|NCT03658876|580953865|FG000|Overall Study|Protocol Violation|3|||
160879362|NCT03658876|580953866|FG001|Overall Study|Protocol Violation|2|||
161120801|NCT04745689|581829557|FG000|Overall Study|Lost to Follow-up|1|||
161120802|NCT04745689|581829558|FG001|Overall Study|Lost to Follow-up|0|||
161120803|NCT04745689|581829557|FG000|Overall Study|Withdrawal by Subject|2|||
161120804|NCT04745689|581829558|FG001|Overall Study|Withdrawal by Subject|0|||
161120805|NCT04745689|581829557|FG000|Overall Study|Study terminated by sponsor|10|||
161120806|NCT04745689|581829558|FG001|Overall Study|Study terminated by sponsor|3|||
161120807|NCT02028455|581829561|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161142578|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Progressive disease|0|||
161142579|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Progressive disease|0|||
160879363|NCT03658876|580953865|FG000|Overall Study|Withdrawal by Subject|2|||
160879364|NCT03658876|580953866|FG001|Overall Study|Withdrawal by Subject|0|||
160879365|NCT03658876|580953865|FG000|Overall Study|Death|0|||
160879366|NCT03658876|580953866|FG001|Overall Study|Death|1|||
160879367|NCT03658876|580953865|FG000|Overall Study|Intercurrent illness|6|||
160879368|NCT03658876|580953866|FG001|Overall Study|Intercurrent illness|4|||
160879369|NCT03658876|580953865|FG000|Overall Study|Transplantation/other operation|1|||
160879370|NCT03658876|580953866|FG001|Overall Study|Transplantation/other operation|5|||
160879371|NCT01330017|580953867|FG000|Overall Study|Adverse Event|0|||
160879372|NCT01330017|580953868|FG001|Overall Study|Adverse Event|1|||
160879373|NCT01330017|580953869|FG002|Overall Study|Adverse Event|1|||
160879374|NCT01330017|580953870|FG003|Overall Study|Adverse Event|4|||
160879375|NCT01330017|580953871|FG004|Overall Study|Adverse Event|0|||
160879376|NCT01330017|580953867|FG000|Overall Study|Withdrawal by Subject|0|||
160879377|NCT01330017|580953868|FG001|Overall Study|Withdrawal by Subject|0|||
161120808|NCT02028455|581829562|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161120809|NCT02028455|581829563|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161120810|NCT02028455|581829564|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161120811|NCT02028455|581829565|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161120812|NCT02028455|581829566|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
161120813|NCT02028455|581829567|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
161120814|NCT02028455|581829568|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
161120815|NCT02028455|581829561|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
161120816|NCT02028455|581829562|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
161120817|NCT02028455|581829563|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
161120818|NCT02028455|581829564|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
161120819|NCT02028455|581829565|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
161120820|NCT02028455|581829566|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
161120821|NCT02028455|581829567|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
161120822|NCT02028455|581829568|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
161120823|NCT02028455|581829561|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161120824|NCT02028455|581829562|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161120825|NCT02028455|581829563|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
160879378|NCT01330017|580953869|FG002|Overall Study|Withdrawal by Subject|1|||
160879379|NCT01330017|580953870|FG003|Overall Study|Withdrawal by Subject|0|||
161120826|NCT02028455|581829564|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161120827|NCT02028455|581829565|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161120828|NCT02028455|581829566|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
161120829|NCT02028455|581829567|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
161120830|NCT02028455|581829568|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
161120831|NCT02028455|581829561|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161120832|NCT02028455|581829562|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161120833|NCT02028455|581829563|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
161120834|NCT02028455|581829564|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
161226058|NCT04582539|582208045|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
161226059|NCT04582539|582208046|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
161226060|NCT00770315|582208053|FG000|Overall Study|Adverse Event|11|||
161226061|NCT00770315|582208054|FG001|Overall Study|Adverse Event|17|||
161226062|NCT00770315|582208055|FG002|Overall Study|Adverse Event|16|||
161226063|NCT00770315|582208056|FG003|Overall Study|Adverse Event|6|||
161226064|NCT00770315|582208053|FG000|Overall Study|Lost to Follow-up|9|||
161226065|NCT00770315|582208054|FG001|Overall Study|Lost to Follow-up|5|||
161226066|NCT00770315|582208055|FG002|Overall Study|Lost to Follow-up|10|||
161226067|NCT00770315|582208056|FG003|Overall Study|Lost to Follow-up|3|||
161226068|NCT00770315|582208053|FG000|Overall Study|Withdrawal by Subject|13|||
161226069|NCT00770315|582208054|FG001|Overall Study|Withdrawal by Subject|17|||
161226070|NCT00770315|582208055|FG002|Overall Study|Withdrawal by Subject|24|||
161226071|NCT00770315|582208056|FG003|Overall Study|Withdrawal by Subject|20|||
161226072|NCT00770315|582208053|FG000|Overall Study|Noncompliance with Protocol|7|||
161226073|NCT00770315|582208054|FG001|Overall Study|Noncompliance with Protocol|4|||
160879380|NCT01330017|580953871|FG004|Overall Study|Withdrawal by Subject|1|||
160879381|NCT01330017|580953867|FG000|Overall Study|Lost to Follow-up|0|||
160879382|NCT01330017|580953868|FG001|Overall Study|Lost to Follow-up|0|||
160879383|NCT01330017|580953869|FG002|Overall Study|Lost to Follow-up|1|||
160879384|NCT01330017|580953870|FG003|Overall Study|Lost to Follow-up|0|||
160879385|NCT01330017|580953871|FG004|Overall Study|Lost to Follow-up|0|||
160879386|NCT01330017|580953867|FG000|Overall Study|Protocol Violation|0|||
160879387|NCT01330017|580953868|FG001|Overall Study|Protocol Violation|0|||
160879388|NCT01330017|580953869|FG002|Overall Study|Protocol Violation|0|||
160879389|NCT01330017|580953870|FG003|Overall Study|Protocol Violation|1|||
160879390|NCT01330017|580953871|FG004|Overall Study|Protocol Violation|0|||
160879391|NCT01330017|580953867|FG000|Overall Study|Unknown Reason|5|||
160879392|NCT01330017|580953868|FG001|Overall Study|Unknown Reason|3|||
160879393|NCT01330017|580953869|FG002|Overall Study|Unknown Reason|5|||
160879394|NCT01330017|580953870|FG003|Overall Study|Unknown Reason|7|||
160879395|NCT01330017|580953871|FG004|Overall Study|Unknown Reason|2|||
160879396|NCT03137069|580953875|FG000|Overall Study|Withdrawal by Subject|1|||
160879397|NCT03137069|580953876|FG001|Overall Study|Withdrawal by Subject|2|||
160879398|NCT03137069|580953877|FG002|Overall Study|Withdrawal by Subject|2|||
160879399|NCT03137069|580953878|FG003|Overall Study|Withdrawal by Subject|2|||
160879400|NCT03137069|580953879|FG004|Overall Study|Withdrawal by Subject|0|||
160879401|NCT03137069|580953880|FG005|Overall Study|Withdrawal by Subject|0|||
160879402|NCT03137069|580953875|FG000|Overall Study|Adverse Event|0|||
160879403|NCT03137069|580953876|FG001|Overall Study|Adverse Event|3|||
160879404|NCT03137069|580953877|FG002|Overall Study|Adverse Event|1|||
161226074|NCT00770315|582208055|FG002|Overall Study|Noncompliance with Protocol|7|||
161226075|NCT00770315|582208056|FG003|Overall Study|Noncompliance with Protocol|9|||
161226076|NCT03717064|582209859|FG000|Period 2|Adverse Event|1|||
160879405|NCT03137069|580953878|FG003|Overall Study|Adverse Event|1|||
161226077|NCT02841709|582209860|FG000|5th Intervention|Adverse Event|2|||
161226078|NCT02841709|582209861|FG001|5th Intervention|Adverse Event|0|||
161226079|NCT02841709|582209862|FG002|5th Intervention|Adverse Event|0|||
161226080|NCT02841709|582209863|FG003|5th Intervention|Adverse Event|0|||
161226081|NCT02841709|582209864|FG004|5th Intervention|Adverse Event|2|||
161226082|NCT01929109|582209865|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
160879406|NCT03137069|580953879|FG004|Overall Study|Adverse Event|0|||
160879407|NCT03137069|580953880|FG005|Overall Study|Adverse Event|1|||
160879408|NCT03137069|580953875|FG000|Overall Study|Protocol Violation|0|||
160879409|NCT03137069|580953876|FG001|Overall Study|Protocol Violation|1|||
160879410|NCT03137069|580953877|FG002|Overall Study|Protocol Violation|0|||
160879411|NCT03137069|580953878|FG003|Overall Study|Protocol Violation|1|||
161120835|NCT02028455|581829565|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161226083|NCT01929109|582209866|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
161226084|NCT01929109|582209867|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
161226085|NCT01929109|582209868|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
161226086|NCT01929109|582209869|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
160879412|NCT03137069|580953879|FG004|Overall Study|Protocol Violation|1|||
160879413|NCT03137069|580953880|FG005|Overall Study|Protocol Violation|1|||
161120836|NCT02028455|581829566|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
161120837|NCT02028455|581829567|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
161120838|NCT02028455|581829568|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
161120839|NCT07099521|581829569|FG000|Overall Study|Incompeleted stimulus program|1|||
161120840|NCT07099521|581829570|FG001|Overall Study|Incompeleted stimulus program|0|||
161120841|NCT07099521|581829569|FG000|Overall Study|Non-social anxiety symtpoms|0|||
161120842|NCT07099521|581829570|FG001|Overall Study|Non-social anxiety symtpoms|1|||
161120843|NCT07099521|581829569|FG000|Overall Study|Extreme values|2|||
161120844|NCT07099521|581829570|FG001|Overall Study|Extreme values|4|||
161120845|NCT04381650|581829571|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120846|NCT04381650|581829572|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120847|NCT04381650|581829573|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120848|NCT04381650|581829574|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
161120849|NCT04381650|581829575|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120850|NCT04381650|581829576|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120851|NCT04381650|581829577|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120852|NCT04381650|581829578|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120853|NCT04381650|581829579|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120854|NCT04381650|581829580|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120855|NCT04381650|581829581|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
161120856|NCT04381650|581829571|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120857|NCT04381650|581829572|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120858|NCT04381650|581829573|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120859|NCT04381650|581829574|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
161120860|NCT04381650|581829575|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120861|NCT04381650|581829576|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120862|NCT04381650|581829577|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120863|NCT04381650|581829578|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120864|NCT04381650|581829579|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120865|NCT04381650|581829580|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120866|NCT04381650|581829581|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
161120867|NCT04381650|581829571|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
161120868|NCT04381650|581829572|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
161120869|NCT04381650|581829573|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
161120870|NCT04381650|581829574|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
161120871|NCT04381650|581829575|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120872|NCT04381650|581829576|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120873|NCT04381650|581829577|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120874|NCT04381650|581829578|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120875|NCT04381650|581829579|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120876|NCT04381650|581829580|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120877|NCT04381650|581829581|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
161120878|NCT04381650|581829571|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120879|NCT04381650|581829572|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120880|NCT04381650|581829573|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
161120881|NCT04381650|581829574|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
161226087|NCT04526210|582209874|FG000|Overall Study|Sponsor decision|7|||
161226088|NCT04526210|582209875|FG001|Overall Study|Sponsor decision|5|||
160879414|NCT03137069|580953875|FG000|Overall Study|Physician Decision|0|||
160879415|NCT03137069|580953876|FG001|Overall Study|Physician Decision|0|||
160879416|NCT03137069|580953877|FG002|Overall Study|Physician Decision|0|||
160879417|NCT03137069|580953878|FG003|Overall Study|Physician Decision|1|||
160879418|NCT03137069|580953879|FG004|Overall Study|Physician Decision|0|||
160879419|NCT03137069|580953880|FG005|Overall Study|Physician Decision|0|||
160879420|NCT03137069|580953875|FG000|Overall Study|Study Terminated by Sponsor|0|||
160879421|NCT03137069|580953876|FG001|Overall Study|Study Terminated by Sponsor|0|||
160879422|NCT03137069|580953877|FG002|Overall Study|Study Terminated by Sponsor|0|||
160879423|NCT03137069|580953878|FG003|Overall Study|Study Terminated by Sponsor|0|||
160879424|NCT03137069|580953879|FG004|Overall Study|Study Terminated by Sponsor|1|||
160879425|NCT03137069|580953880|FG005|Overall Study|Study Terminated by Sponsor|0|||
160879426|NCT03137069|580953875|FG000|Overall Study|Data Entry Error|0|||
160879427|NCT03137069|580953876|FG001|Overall Study|Data Entry Error|0|||
160879428|NCT03137069|580953877|FG002|Overall Study|Data Entry Error|0|||
160879429|NCT03137069|580953878|FG003|Overall Study|Data Entry Error|1|||
160879430|NCT03137069|580953879|FG004|Overall Study|Data Entry Error|0|||
160879431|NCT03137069|580953880|FG005|Overall Study|Data Entry Error|0|||
160879432|NCT02043899|580953882|FG000|Overall Study|Adverse Event|3|||
160879433|NCT02043899|580953882|FG000|Overall Study|Physician Decision|1|||
160879434|NCT02043899|580953882|FG000|Overall Study|Withdrawal by Subject|2|||
160879435|NCT02043899|580953882|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
160879436|NCT02043899|580953882|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
160879437|NCT02043899|580953882|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
160879438|NCT02043899|580953882|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
160879439|NCT02043899|580953882|FG000|Overall Study|Treatment delayed|1|||
160879440|NCT01771809|580953883|FG000|Overall Study|Adverse Event|4|||
160879441|NCT01771809|580953884|FG001|Overall Study|Adverse Event|12|||
160879442|NCT01771809|580953883|FG000|Overall Study|Protocol Violation|0|||
160879443|NCT01771809|580953884|FG001|Overall Study|Protocol Violation|1|||
160879444|NCT01771809|580953883|FG000|Overall Study|Withdrawal by Subject|34|||
160879445|NCT01771809|580953884|FG001|Overall Study|Withdrawal by Subject|42|||
160879446|NCT01771809|580953883|FG000|Overall Study|Lost to Follow-up|1|||
160879447|NCT01771809|580953884|FG001|Overall Study|Lost to Follow-up|3|||
160879448|NCT01771809|580953883|FG000|Overall Study|Other (Insufficient clinical response)|22|||
160879449|NCT01771809|580953884|FG001|Overall Study|Other (Insufficient clinical response)|20|||
160879450|NCT01771809|580953883|FG000|Overall Study|Death|1|||
160879451|NCT01771809|580953884|FG001|Overall Study|Death|0|||
160879452|NCT01771809|580953883|FG000|Overall Study|Other (other)|9|||
160879453|NCT01771809|580953884|FG001|Overall Study|Other (other)|5|||
160879454|NCT01106092|580953885|FG000|Overall Study|Withdrawal by Subject|0|||
160879455|NCT01106092|580953886|FG001|Overall Study|Withdrawal by Subject|0|||
160879456|NCT01106092|580953887|FG002|Overall Study|Withdrawal by Subject|0|||
160879457|NCT01106092|580953888|FG003|Overall Study|Withdrawal by Subject|1|||
160879458|NCT02434471|580953889|FG000|Overall Study|Physician Decision|9|||
160879459|NCT00369629|580953894|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
160879460|NCT00369629|580953895|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
160879461|NCT00369629|580953896|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
160879462|NCT00369629|580953897|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
160879463|NCT00369629|580953894|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
160879464|NCT00369629|580953895|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
160879465|NCT00369629|580953896|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
160879466|NCT00369629|580953897|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
160879467|NCT00369629|580953894|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
160879468|NCT00369629|580953895|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
160879469|NCT00369629|580953896|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
160879470|NCT00369629|580953897|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
160879471|NCT00369629|580953894|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
160879472|NCT00369629|580953895|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
160879473|NCT00369629|580953896|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
160879474|NCT00369629|580953897|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
160879475|NCT00369629|580953894|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
160879476|NCT00369629|580953895|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
160879477|NCT00369629|580953896|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
160879478|NCT00369629|580953897|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
160879479|NCT00369629|580953894|FG000|Completed 4 More Cycles|Progressive disease|2|||
160879480|NCT00369629|580953895|FG001|Completed 4 More Cycles|Progressive disease|1|||
160879481|NCT00369629|580953896|FG002|Completed 4 More Cycles|Progressive disease|2|||
160879482|NCT00369629|580953897|FG003|Completed 4 More Cycles|Progressive disease|0|||
161324601|NCT00215644|582575635|FG000|Overall Study|Withdrawal by Subject|1|||
160879483|NCT00369629|580953894|FG000|Follow up for 1 Year|Death|2|||
160879484|NCT00369629|580953895|FG001|Follow up for 1 Year|Death|1|||
160879485|NCT00369629|580953896|FG002|Follow up for 1 Year|Death|1|||
161226089|NCT04526210|582209874|FG000|Overall Study|Withdrawal by Subject|3|||
161226090|NCT04526210|582209875|FG001|Overall Study|Withdrawal by Subject|2|||
161226091|NCT02637232|582209876|FG000|Overall Study|Lost to Follow-up|42|||
161226092|NCT02637232|582209876|FG000|Overall Study|Adverse Event|11|||
161226093|NCT02637232|582209876|FG000|Overall Study|patient 's decision|2|||
161226094|NCT01781637|582209877|FG000|Overall Study|Adverse Event|1|||
161226095|NCT01781637|582209878|FG001|Overall Study|Adverse Event|0|||
161226096|NCT01781637|582209877|FG000|Overall Study|Lack of Efficacy|2|||
161226097|NCT01781637|582209878|FG001|Overall Study|Lack of Efficacy|6|||
161226098|NCT01781637|582209877|FG000|Overall Study|Withdrawal by Subject|1|||
161226099|NCT01781637|582209878|FG001|Overall Study|Withdrawal by Subject|0|||
161226100|NCT00090857|582209880|FG000|Overall Study|Lost to Follow-up|0|||
161226101|NCT00090857|582209881|FG001|Overall Study|Lost to Follow-up|1|||
161226102|NCT00090857|582209880|FG000|Overall Study|Withdrawal by Subject|2|||
161226103|NCT00090857|582209881|FG001|Overall Study|Withdrawal by Subject|0|||
161120882|NCT04381650|581829575|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120883|NCT04381650|581829576|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120884|NCT04381650|581829577|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120885|NCT04381650|581829578|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120886|NCT04381650|581829579|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120887|NCT04381650|581829580|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120888|NCT04381650|581829581|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
161120889|NCT04381650|581829571|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120890|NCT04381650|581829572|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161120891|NCT04381650|581829573|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
161120892|NCT04381650|581829574|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
160879486|NCT00369629|580953897|FG003|Follow up for 1 Year|Death|0|||
160879487|NCT00369629|580953894|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
160879488|NCT00369629|580953895|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
160879489|NCT00369629|580953896|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
160879490|NCT00369629|580953897|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
160879491|NCT00369629|580953894|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
160879492|NCT00369629|580953895|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
160879493|NCT00369629|580953896|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
160879494|NCT00369629|580953897|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
160879495|NCT04839562|580953898|FG000|Overall Study|Withdrawal by Subject|0|||
160879496|NCT04839562|580953899|FG001|Overall Study|Withdrawal by Subject|1|||
160879497|NCT04839562|580953898|FG000|Overall Study|Physician Decision|0|||
160879498|NCT04839562|580953899|FG001|Overall Study|Physician Decision|1|||
160879499|NCT00877773|580953900|FG000|Overall Study|Disease Progression|44|||
160879500|NCT02907892|580953908|FG000|Overall Study|Lost to Follow-up|27|||
160879501|NCT02907892|580953909|FG001|Overall Study|Lost to Follow-up|40|||
160879502|NCT01974765|580953910|FG000|Overall Study|Withdrawal by Subject|1|||
160879503|NCT01974765|580953910|FG000|Overall Study|Death|1|||
160879504|NCT01974765|580953910|FG000|Overall Study|Adverse Event|2|||
160879505|NCT01347580|580953911|FG000|Overall Study|Withdrawal by Subject|13|||
160879506|NCT01347580|580953912|FG001|Overall Study|Withdrawal by Subject|23|||
160879507|NCT01347580|580953911|FG000|Overall Study|Death|30|||
160879508|NCT01347580|580953912|FG001|Overall Study|Death|19|||
160879509|NCT01347580|580953911|FG000|Overall Study|Protocol Violation|10|||
161120893|NCT04381650|581829575|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161226104|NCT00090857|582209880|FG000|Overall Study|Adverse Event|2|||
161226105|NCT00090857|582209881|FG001|Overall Study|Adverse Event|2|||
161226106|NCT05097326|582209882|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
161226107|NCT05097326|582209883|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
161120894|NCT04381650|581829576|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120895|NCT04381650|581829577|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120896|NCT04381650|581829578|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120897|NCT04381650|581829579|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120898|NCT04381650|581829580|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120899|NCT04381650|581829581|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
161120900|NCT04381650|581829571|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120901|NCT04381650|581829572|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120902|NCT04381650|581829573|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120903|NCT04381650|581829574|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120904|NCT04381650|581829575|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
161120905|NCT04381650|581829576|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
161120906|NCT04381650|581829577|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120907|NCT04381650|581829578|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120908|NCT04381650|581829579|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
160879510|NCT01347580|580953912|FG001|Overall Study|Protocol Violation|7|||
161120909|NCT04381650|581829580|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
161120910|NCT04381650|581829581|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
161120911|NCT04381650|581829571|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120912|NCT04381650|581829572|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120913|NCT04381650|581829573|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120914|NCT04381650|581829574|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120915|NCT04381650|581829575|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120916|NCT04381650|581829576|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120917|NCT04381650|581829577|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161120918|NCT04381650|581829578|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161120919|NCT04381650|581829579|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161120920|NCT04381650|581829580|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161120921|NCT04381650|581829581|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
160879511|NCT01347580|580953911|FG000|Overall Study|Lost to Follow-up|3|||
160879512|NCT01347580|580953912|FG001|Overall Study|Lost to Follow-up|1|||
160879513|NCT01347580|580953911|FG000|Overall Study|Had other reason|9|||
160879514|NCT01347580|580953912|FG001|Overall Study|Had other reason|6|||
160879515|NCT01964755|580953915|FG000|Overall Study|Death|2|||
160879516|NCT02870933|580953916|FG000|Overall Study|Death|2|||
160879517|NCT02870933|580953917|FG001|Overall Study|Death|1|||
160879518|NCT02870933|580953916|FG000|Overall Study|Withdrawal by Subject|0|||
160879519|NCT02870933|580953917|FG001|Overall Study|Withdrawal by Subject|1|||
160879520|NCT02168387|580953918|FG000|Overall Study|Planned exubation|6|||
160879521|NCT02168387|580953919|FG001|Overall Study|Planned exubation|3|||
160879522|NCT02168387|580953918|FG000|Overall Study|Death|1|||
160879523|NCT02168387|580953919|FG001|Overall Study|Death|0|||
160879524|NCT01659554|580953920|FG000|Overall Study|Study Termination|4|||
160879525|NCT00412373|580953921|FG000|Overall Study|Adverse Event|8|||
161120922|NCT04381650|581829571|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161120923|NCT04381650|581829572|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161120924|NCT04381650|581829573|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161120925|NCT04381650|581829574|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161120926|NCT04381650|581829575|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
161120927|NCT04381650|581829576|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
161120928|NCT04381650|581829577|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
161120929|NCT04381650|581829578|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
161120930|NCT04381650|581829579|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
161120931|NCT04381650|581829580|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
161120932|NCT04381650|581829581|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
161120933|NCT04381650|581829571|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161120934|NCT04381650|581829572|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161120935|NCT04381650|581829573|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161120936|NCT04381650|581829574|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
161120937|NCT04381650|581829575|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161120938|NCT04381650|581829576|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
161120939|NCT04381650|581829577|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
161120940|NCT04381650|581829578|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
161120941|NCT04381650|581829579|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161120942|NCT04381650|581829580|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
161120943|NCT04381650|581829581|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
161120944|NCT04381650|581829571|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120945|NCT04381650|581829572|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120946|NCT04381650|581829573|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120947|NCT04381650|581829574|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120948|NCT04381650|581829575|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120949|NCT04381650|581829576|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120950|NCT04381650|581829577|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120951|NCT04381650|581829578|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
161120952|NCT04381650|581829579|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120953|NCT04381650|581829580|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120954|NCT04381650|581829581|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
161120955|NCT00482014|581831273|FG000|Overall Study|Withdrawal by Subject|1|||
161120956|NCT00482014|581831274|FG001|Overall Study|Withdrawal by Subject|2|||
161120957|NCT00482014|581831275|FG002|Overall Study|Withdrawal by Subject|3|||
161120958|NCT00482014|581831276|FG003|Overall Study|Withdrawal by Subject|4|||
161120959|NCT00482014|581831273|FG000|Overall Study|Adverse Event|3|||
161120960|NCT00482014|581831274|FG001|Overall Study|Adverse Event|0|||
161120961|NCT00482014|581831275|FG002|Overall Study|Adverse Event|2|||
161120962|NCT00482014|581831276|FG003|Overall Study|Adverse Event|8|||
161120963|NCT00482014|581831273|FG000|Overall Study|Death|1|||
161120964|NCT00482014|581831274|FG001|Overall Study|Death|2|||
161120965|NCT00482014|581831275|FG002|Overall Study|Death|1|||
161120966|NCT00482014|581831276|FG003|Overall Study|Death|4|||
161120967|NCT00482014|581831273|FG000|Overall Study|Lack of Efficacy|1|||
161120968|NCT00482014|581831274|FG001|Overall Study|Lack of Efficacy|0|||
161120969|NCT00482014|581831275|FG002|Overall Study|Lack of Efficacy|4|||
161120970|NCT00482014|581831276|FG003|Overall Study|Lack of Efficacy|6|||
161226108|NCT03480425|582209885|FG000|Overall Study|Force transducer technical failure|1|||
161226109|NCT01244126|582209886|FG000|Overall Study|Protocol Violation|3|||
160879526|NCT00412373|580953922|FG001|Overall Study|Adverse Event|13|||
160879527|NCT00412373|580953921|FG000|Overall Study|Lack of Efficacy|16|||
160879528|NCT00412373|580953922|FG001|Overall Study|Lack of Efficacy|22|||
160879529|NCT00412373|580953921|FG000|Overall Study|Lost to Follow-up|7|||
160879530|NCT00412373|580953922|FG001|Overall Study|Lost to Follow-up|13|||
160879531|NCT00412373|580953921|FG000|Overall Study|Withdrawal by Subject|8|||
161120971|NCT00482014|581831273|FG000|Overall Study|Sponsor Decision|1|||
161120972|NCT00482014|581831274|FG001|Overall Study|Sponsor Decision|2|||
161120973|NCT00482014|581831275|FG002|Overall Study|Sponsor Decision|1|||
161120974|NCT00482014|581831276|FG003|Overall Study|Sponsor Decision|1|||
160879532|NCT00412373|580953922|FG001|Overall Study|Withdrawal by Subject|27|||
160879533|NCT00412373|580953921|FG000|Overall Study|Other|2|||
160879534|NCT00412373|580953922|FG001|Overall Study|Other|2|||
160879535|NCT00640224|580953923|FG000|Overall Study|Lost to Follow-up|5|||
160879536|NCT00640224|580953924|FG001|Overall Study|Lost to Follow-up|2|||
160879537|NCT00640224|580953925|FG002|Overall Study|Lost to Follow-up|0|||
160879538|NCT00640224|580953926|FG003|Overall Study|Lost to Follow-up|0|||
160879539|NCT00640224|580953923|FG000|Overall Study|Withdrawal by Subject|1|||
160879540|NCT00640224|580953924|FG001|Overall Study|Withdrawal by Subject|0|||
160879541|NCT00640224|580953925|FG002|Overall Study|Withdrawal by Subject|0|||
160879542|NCT00640224|580953926|FG003|Overall Study|Withdrawal by Subject|0|||
160879543|NCT00640224|580953923|FG000|Overall Study|Headaches|0|||
160879544|NCT00640224|580953924|FG001|Overall Study|Headaches|1|||
160879545|NCT00640224|580953925|FG002|Overall Study|Headaches|0|||
160879546|NCT00640224|580953926|FG003|Overall Study|Headaches|0|||
160879547|NCT00422513|580953927|FG000|Overall Study|Lack of Efficacy|4|||
160879548|NCT00422513|580953928|FG001|Overall Study|Lack of Efficacy|5|||
160879549|NCT00422513|580953927|FG000|Overall Study|Protocol Violation|23|||
160879550|NCT00422513|580953928|FG001|Overall Study|Protocol Violation|7|||
160879551|NCT00422513|580953927|FG000|Overall Study|Refused Treatment|4|||
160879552|NCT00422513|580953928|FG001|Overall Study|Refused Treatment|2|||
160879553|NCT00422513|580953927|FG000|Overall Study|Withdrawal by Subject|2|||
161120975|NCT00542997|581831279|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
161120976|NCT00542997|581831279|FG000|Wash in / Wash Out Period|Adverse Event|3|||
161120977|NCT00542997|581831279|FG000|Efficacy Period|Adverse Event|3|||
161120978|NCT01284114|581831282|FG000|Overall Study|viral infection|1|||
160879554|NCT00422513|580953928|FG001|Overall Study|Withdrawal by Subject|1|||
160879555|NCT00422513|580953927|FG000|Overall Study|early termination of the study|67|||
160879556|NCT00422513|580953928|FG001|Overall Study|early termination of the study|80|||
160879557|NCT00422513|580953927|FG000|Overall Study|Adverse Event|4|||
160879558|NCT00422513|580953928|FG001|Overall Study|Adverse Event|4|||
160879559|NCT00422513|580953927|FG000|Overall Study|Death|3|||
160879560|NCT00422513|580953928|FG001|Overall Study|Death|7|||
160879561|NCT03135119|580953929|FG000|Overall Study|Lost to Follow-up|2|||
160879562|NCT03135119|580953930|FG001|Overall Study|Lost to Follow-up|0|||
160879563|NCT03135119|580953929|FG000|Overall Study|Physician Decision|1|||
160879564|NCT03135119|580953930|FG001|Overall Study|Physician Decision|1|||
160879565|NCT03135119|580953929|FG000|Overall Study|COVID-19 Shutdown|2|||
160879566|NCT03135119|580953930|FG001|Overall Study|COVID-19 Shutdown|2|||
160879567|NCT01478048|580953931|FG000|Overall Study|Disease Progression|52|||
160879568|NCT01478048|580953932|FG001|Overall Study|Disease Progression|35|||
160879569|NCT01478048|580953931|FG000|Overall Study|study drug toxicity|11|||
160879570|NCT01478048|580953932|FG001|Overall Study|study drug toxicity|14|||
160879571|NCT01478048|580953931|FG000|Overall Study|Adverse Event|2|||
160879572|NCT01478048|580953932|FG001|Overall Study|Adverse Event|11|||
160879573|NCT01478048|580953931|FG000|Overall Study|subject request to discontinue treatment|3|||
160879574|NCT01478048|580953932|FG001|Overall Study|subject request to discontinue treatment|5|||
160879575|NCT01478048|580953931|FG000|Overall Study|Withdrawal by Subject|2|||
160879576|NCT01478048|580953932|FG001|Overall Study|Withdrawal by Subject|5|||
160879577|NCT01478048|580953931|FG000|Overall Study|non-specified|6|||
160879578|NCT01478048|580953932|FG001|Overall Study|non-specified|4|||
160879579|NCT01478048|580953931|FG000|Overall Study|poor/non-compliance|0|||
160879580|NCT01478048|580953932|FG001|Overall Study|poor/non-compliance|1|||
160879581|NCT01478048|580953931|FG000|Overall Study|no longer meets study criteria|1|||
160879582|NCT01478048|580953932|FG001|Overall Study|no longer meets study criteria|0|||
160879583|NCT01369329|580953934|FG000|Overall Study|Withdrawal by Subject|8|||
160879584|NCT01369329|580953935|FG001|Overall Study|Withdrawal by Subject|6|||
160879585|NCT01369329|580953936|FG002|Overall Study|Withdrawal by Subject|10|||
160879586|NCT01369329|580953934|FG000|Overall Study|Lost to Follow-up|2|||
160879587|NCT01369329|580953935|FG001|Overall Study|Lost to Follow-up|2|||
160879588|NCT01369329|580953936|FG002|Overall Study|Lost to Follow-up|2|||
160879589|NCT01369329|580953934|FG000|Overall Study|Other|2|||
160879590|NCT01369329|580953935|FG001|Overall Study|Other|3|||
160879591|NCT01369329|580953936|FG002|Overall Study|Other|2|||
160879592|NCT01252667|580953937|FG000|Overall Study|Transplant aborted post-conditioning|0|||
160879593|NCT01252667|580953938|FG001|Overall Study|Transplant aborted post-conditioning|0|||
160879594|NCT01252667|580953939|FG002|Overall Study|Transplant aborted post-conditioning|0|||
160879595|NCT01252667|580953940|FG003|Overall Study|Transplant aborted post-conditioning|0|||
160879596|NCT01252667|580953941|FG004|Overall Study|Transplant aborted post-conditioning|0|||
160879597|NCT01252667|580953942|FG005|Overall Study|Transplant aborted post-conditioning|1|||
160879598|NCT04644315|580953943|FG000|Overall Study|Subject withdrawal of consent|1|||
160879599|NCT03032380|580953944|FG000|Overall Study|Adverse Event|0|||
160879600|NCT03032380|580953945|FG001|Overall Study|Adverse Event|1|||
160879601|NCT03032380|580953944|FG000|Overall Study|Lack of Efficacy|1|||
160879602|NCT03032380|580953945|FG001|Overall Study|Lack of Efficacy|0|||
160879603|NCT03032380|580953944|FG000|Overall Study|Withdrawal by Subject|2|||
160879604|NCT03032380|580953945|FG001|Overall Study|Withdrawal by Subject|3|||
160879605|NCT03032380|580953944|FG000|Overall Study|Recovery|0|||
160879606|NCT03032380|580953945|FG001|Overall Study|Recovery|1|||
160879607|NCT03032380|580953944|FG000|Overall Study|Death|39|||
160879608|NCT03032380|580953945|FG001|Overall Study|Death|34|||
160879609|NCT03032380|580953944|FG000|Overall Study|Other - Miscellaneous|0|||
160879610|NCT03032380|580953945|FG001|Overall Study|Other - Miscellaneous|1|||
160879611|NCT02937584|580953946|FG000|Period 1|Adverse Event|1|||
160879612|NCT02937584|580953947|FG001|Period 1|Adverse Event|2|||
160879613|NCT02937584|580953946|FG000|Washout|Adverse Event|0|||
160879614|NCT02937584|580953947|FG001|Washout|Adverse Event|1|||
160879615|NCT01883453|580953948|FG000|Overall Study|No episode of common cold|25|||
160879616|NCT01883453|580953949|FG001|Overall Study|No episode of common cold|23|||
160879617|NCT02238080|580953950|FG000|Overall Study|Death|13|||
160879618|NCT02238080|580953950|FG000|Overall Study|Treatment interrupted|6|||
160879619|NCT02238080|580953950|FG000|Overall Study|Withdrawal by Subject|2|||
160879620|NCT02238080|580953950|FG000|Overall Study|Other|4|||
160879621|NCT00864916|580953951|FG000|Overall Study|Lost to Follow-up|4|||
160879622|NCT00864916|580953952|FG001|Overall Study|Lost to Follow-up|4|||
160879623|NCT00864916|580953951|FG000|Overall Study|Protocol Violation|1|||
160879624|NCT00864916|580953952|FG001|Overall Study|Protocol Violation|0|||
160879625|NCT00864916|580953951|FG000|Overall Study|Withdrawal by Subject|1|||
160879626|NCT00864916|580953952|FG001|Overall Study|Withdrawal by Subject|0|||
160879627|NCT01038869|580953954|FG000|Overall Study|Withdrawal by Subject|1|||
160879628|NCT01038869|580953954|FG000|Overall Study|Lost to Follow-up|6|||
160879629|NCT04136444|580953955|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
160879630|NCT04136444|580953956|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
160879631|NCT01950013|580953957|FG000|Overall Study|Withdrawal by Subject|0|||
160879632|NCT01950013|580953958|FG001|Overall Study|Withdrawal by Subject|2|||
160879633|NCT01950013|580953959|FG002|Overall Study|Withdrawal by Subject|0|||
160879634|NCT00783198|580953964|FG000|Overall Study|Adverse Event|15|||
160879635|NCT00783198|580953965|FG001|Overall Study|Adverse Event|19|||
160879636|NCT00783198|580953966|FG002|Overall Study|Adverse Event|3|||
160879637|NCT00783198|580953964|FG000|Overall Study|Lost to Follow-up|11|||
160879638|NCT00783198|580953965|FG001|Overall Study|Lost to Follow-up|1|||
160879639|NCT00783198|580953966|FG002|Overall Study|Lost to Follow-up|7|||
160879640|NCT00783198|580953964|FG000|Overall Study|Withdrawal by Subject|22|||
160879641|NCT00783198|580953965|FG001|Overall Study|Withdrawal by Subject|14|||
160879642|NCT00783198|580953966|FG002|Overall Study|Withdrawal by Subject|20|||
160879643|NCT00783198|580953964|FG000|Overall Study|Noncompliance with protocol|7|||
160879644|NCT00783198|580953965|FG001|Overall Study|Noncompliance with protocol|7|||
160879645|NCT00783198|580953966|FG002|Overall Study|Noncompliance with protocol|10|||
160879646|NCT00783198|580953964|FG000|Overall Study|Did not meet protocol eligibility|0|||
160879647|NCT00783198|580953965|FG001|Overall Study|Did not meet protocol eligibility|1|||
160879648|NCT00783198|580953966|FG002|Overall Study|Did not meet protocol eligibility|0|||
160879649|NCT00783198|580953964|FG000|Overall Study|Administrative|2|||
160879650|NCT00783198|580953965|FG001|Overall Study|Administrative|1|||
160879651|NCT00783198|580953966|FG002|Overall Study|Administrative|2|||
161120979|NCT01284114|581831282|FG000|Overall Study|From the results of ALLTITUDE study|1|||
161120980|NCT01284114|581831282|FG000|Overall Study|Symptomatic hypotension|1|||
161120981|NCT01284114|581831282|FG000|Overall Study|dizziness|1|||
161120982|NCT00598975|581831283|FG000|Overall Study|Adverse Event|1|||
161120983|NCT00598975|581831284|FG001|Overall Study|Adverse Event|1|||
161120984|NCT00598975|581831283|FG000|Overall Study|Brain metastases|1|||
161120985|NCT00598975|581831284|FG001|Overall Study|Brain metastases|0|||
161120986|NCT00598975|581831283|FG000|Overall Study|Withdrawal by Subject|1|||
161120987|NCT00598975|581831284|FG001|Overall Study|Withdrawal by Subject|1|||
161120988|NCT00598975|581831283|FG000|Overall Study|Withdrawal of consent|0|||
161120989|NCT00598975|581831284|FG001|Overall Study|Withdrawal of consent|1|||
161120990|NCT00598975|581831283|FG000|Overall Study|Disease progression|8|||
161120991|NCT00598975|581831284|FG001|Overall Study|Disease progression|3|||
161120992|NCT00598975|581831283|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
161120993|NCT00598975|581831284|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
161120994|NCT03160560|581831285|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
161120995|NCT03160560|581831286|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161120996|NCT03160560|581831287|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161120997|NCT03160560|581831288|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161120998|NCT03160560|581831285|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161120999|NCT03160560|581831286|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161121000|NCT03160560|581831287|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161121001|NCT03160560|581831288|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161121002|NCT04137887|581831295|FG000|Overall Study|Death|102|||
161121003|NCT04137887|581831296|FG001|Overall Study|Death|92|||
161121004|NCT04137887|581831295|FG000|Overall Study|Withdrawal by Subject|2|||
161121005|NCT04137887|581831296|FG001|Overall Study|Withdrawal by Subject|3|||
161121006|NCT04137887|581831295|FG000|Overall Study|Randomized but not treated|0|||
161121007|NCT04137887|581831296|FG001|Overall Study|Randomized but not treated|1|||
161121008|NCT04183335|581831297|FG000|Overall Study|Adverse Event|1|||
161121009|NCT04183335|581831298|FG001|Overall Study|Adverse Event|0|||
161121010|NCT04183335|581831297|FG000|Overall Study|Withdrawal by Subject|12|||
161121011|NCT04183335|581831298|FG001|Overall Study|Withdrawal by Subject|3|||
161121012|NCT03733392|581831301|FG000|Overall Study|Withdrawal by Subject|11|||
161121013|NCT03733392|581831302|FG001|Overall Study|Withdrawal by Subject|1|||
161121014|NCT03733392|581831301|FG000|Overall Study|Death|1|||
161121015|NCT03733392|581831302|FG001|Overall Study|Death|0|||
161121016|NCT03733392|581831301|FG000|Overall Study|Lost to Follow-up|5|||
161121017|NCT03733392|581831302|FG001|Overall Study|Lost to Follow-up|0|||
161121018|NCT03733392|581831301|FG000|Overall Study|Protocol Violation|0|||
161121019|NCT03733392|581831302|FG001|Overall Study|Protocol Violation|1|||
161121020|NCT03733392|581831301|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
161121021|NCT03733392|581831302|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
161121022|NCT03733392|581831301|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
161121023|NCT03733392|581831302|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
161121024|NCT03733392|581831301|FG000|Overall Study|Patient Non-Compliance|2|||
161121025|NCT03733392|581831302|FG001|Overall Study|Patient Non-Compliance|1|||
161121026|NCT03733392|581831301|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
161121027|NCT03733392|581831302|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
161121028|NCT03733392|581831301|FG000|Overall Study|Withdrawal prior to procedure|5|||
161121029|NCT03733392|581831302|FG001|Overall Study|Withdrawal prior to procedure|2|||
161121030|NCT02740478|581831303|FG000|Overall Study|Withdrawal by Subject|1|||
161121031|NCT00618748|581831310|FG000|Overall Study|Adverse Event|4|||
161121032|NCT00618748|581831311|FG001|Overall Study|Adverse Event|3|||
161121033|NCT00618748|581831312|FG002|Overall Study|Adverse Event|8|||
161121034|NCT00618748|581831310|FG000|Overall Study|Physician Decision|3|||
161121035|NCT00618748|581831311|FG001|Overall Study|Physician Decision|1|||
161121036|NCT00618748|581831312|FG002|Overall Study|Physician Decision|1|||
161121037|NCT00618748|581831310|FG000|Overall Study|Withdrawal by Subject|4|||
161226110|NCT01244126|582209887|FG001|Overall Study|Protocol Violation|3|||
160879652|NCT02756806|580953967|FG000|Overall Study|Study terminated early|5|||
160879653|NCT00978757|580953972|FG000|Overall Study|Physician Decision|1|||
160879654|NCT00978757|580953973|FG001|Overall Study|Physician Decision|3|||
160879655|NCT01028300|580953974|FG000|Overall Study|Study Terminated|4|||
160879656|NCT00946153|580953977|FG000|Phase 2|Adverse Event|0|||
160879657|NCT00946153|580953978|FG001|Phase 2|Adverse Event|0|||
160879658|NCT00946153|580953979|FG002|Phase 2|Adverse Event|0|||
160879659|NCT00946153|580953980|FG003|Phase 2|Adverse Event|0|||
160879660|NCT00946153|580953981|FG004|Phase 2|Adverse Event|6|||
160879661|NCT00946153|580953977|FG000|Phase 2|Need more reduction of dose|0|||
160879662|NCT00946153|580953978|FG001|Phase 2|Need more reduction of dose|0|||
160879663|NCT00946153|580953979|FG002|Phase 2|Need more reduction of dose|0|||
160879664|NCT00946153|580953980|FG003|Phase 2|Need more reduction of dose|0|||
160879665|NCT00946153|580953981|FG004|Phase 2|Need more reduction of dose|2|||
160879666|NCT00946153|580953977|FG000|Phase 2|Physician Decision|0|||
160879667|NCT00946153|580953978|FG001|Phase 2|Physician Decision|0|||
160879668|NCT00946153|580953979|FG002|Phase 2|Physician Decision|0|||
160879669|NCT00946153|580953980|FG003|Phase 2|Physician Decision|0|||
160879670|NCT00946153|580953981|FG004|Phase 2|Physician Decision|1|||
160879671|NCT00946153|580953977|FG000|Phase 2|14 days washout for recovery due to AE|0|||
160879672|NCT00946153|580953978|FG001|Phase 2|14 days washout for recovery due to AE|0|||
160879673|NCT00946153|580953979|FG002|Phase 2|14 days washout for recovery due to AE|0|||
160879674|NCT00946153|580953980|FG003|Phase 2|14 days washout for recovery due to AE|0|||
160879675|NCT00946153|580953981|FG004|Phase 2|14 days washout for recovery due to AE|4|||
160879676|NCT01030666|580953982|FG000|Overall Study|Lost to Follow-up|3|||
160879677|NCT01030666|580953983|FG001|Overall Study|Lost to Follow-up|2|||
160879678|NCT01144299|580953984|FG000|Overall Study|Lost to Follow-up|1|||
160879679|NCT01144299|580953985|FG001|Overall Study|Lost to Follow-up|0|||
160879680|NCT01144299|580953984|FG000|Overall Study|Withdrawal by Subject|1|||
160879681|NCT01144299|580953985|FG001|Overall Study|Withdrawal by Subject|0|||
160879682|NCT04002908|580953994|FG000|Overall Study|Death|41|||
160879683|NCT04002908|580953995|FG001|Overall Study|Death|0|||
160879684|NCT04002908|580953996|FG002|Overall Study|Death|0|||
160879685|NCT04002908|580953997|FG003|Overall Study|Death|0|||
160879686|NCT04002908|580953994|FG000|Overall Study|Withdrawal by Subject|112|||
160879687|NCT04002908|580953995|FG001|Overall Study|Withdrawal by Subject|0|||
160879688|NCT04002908|580953996|FG002|Overall Study|Withdrawal by Subject|0|||
160879689|NCT04002908|580953997|FG003|Overall Study|Withdrawal by Subject|0|||
160879690|NCT04002908|580953994|FG000|Overall Study|Lost to Follow-up|72|||
160879691|NCT04002908|580953995|FG001|Overall Study|Lost to Follow-up|0|||
160879692|NCT04002908|580953996|FG002|Overall Study|Lost to Follow-up|0|||
160879693|NCT04002908|580953997|FG003|Overall Study|Lost to Follow-up|0|||
160879694|NCT04002908|580953994|FG000|Overall Study|Infant died, so mother withdrawn|34|||
160879695|NCT04002908|580953995|FG001|Overall Study|Infant died, so mother withdrawn|0|||
160879696|NCT04002908|580953996|FG002|Overall Study|Infant died, so mother withdrawn|0|||
160879697|NCT04002908|580953997|FG003|Overall Study|Infant died, so mother withdrawn|0|||
160879698|NCT04359901|580954002|FG000|Overall Study|Withdrawal by Subject|0|||
160879699|NCT04359901|580954003|FG001|Overall Study|Withdrawal by Subject|1|||
160879700|NCT04359901|580954002|FG000|Overall Study|Death|6|||
160879701|NCT04359901|580954003|FG001|Overall Study|Death|2|||
160879702|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879703|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
160879704|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879705|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
160879706|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879707|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
160879708|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
160879709|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
160879710|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
160879711|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
160879712|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161226111|NCT01244126|582209888|FG002|Overall Study|Protocol Violation|9|||
161226112|NCT00863746|582209902|FG000|Treatment|Not treated|4|||
160879713|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
160879714|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
161226113|NCT00863746|582209903|FG001|Treatment|Not treated|2|||
161226114|NCT00863746|582209902|FG000|Treatment|Adverse Event|41|||
160879715|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879716|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879717|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879718|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879719|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
160879720|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879721|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
160879722|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879723|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
161121038|NCT00618748|581831311|FG001|Overall Study|Withdrawal by Subject|1|||
161121039|NCT00618748|581831312|FG002|Overall Study|Withdrawal by Subject|5|||
161121040|NCT02479802|581831313|FG000|Overall Study|Lost to Follow-up|1|||
161121041|NCT02479802|581831313|FG000|Overall Study|Adverse Event|1|||
161121042|NCT02421887|581831314|FG000|Overall Study|Lost to Follow-up|5|||
161121043|NCT02421887|581831315|FG001|Overall Study|Lost to Follow-up|0|||
161121044|NCT02421887|581831314|FG000|Overall Study|Withdrawal by Subject|8|||
161121045|NCT02421887|581831315|FG001|Overall Study|Withdrawal by Subject|5|||
161121046|NCT02421887|581831314|FG000|Overall Study|Physician Decision|2|||
161121047|NCT02421887|581831315|FG001|Overall Study|Physician Decision|4|||
161121048|NCT02421887|581831314|FG000|Overall Study|Adverse Event|2|||
161121049|NCT02421887|581831315|FG001|Overall Study|Adverse Event|0|||
161121050|NCT01882907|581831316|FG000|Overall Study|Adverse Event|3|||
161121051|NCT01882907|581831317|FG001|Overall Study|Adverse Event|1|||
161121052|NCT01882907|581831316|FG000|Overall Study|Lack of Efficacy|0|||
161121053|NCT01882907|581831317|FG001|Overall Study|Lack of Efficacy|3|||
161121054|NCT01882907|581831316|FG000|Overall Study|Lost to Follow-up|1|||
161121055|NCT01882907|581831317|FG001|Overall Study|Lost to Follow-up|4|||
161121056|NCT01882907|581831316|FG000|Overall Study|Protocol Violation|10|||
161121057|NCT01882907|581831317|FG001|Overall Study|Protocol Violation|14|||
161121058|NCT01882907|581831316|FG000|Overall Study|Withdrawal by Subject|0|||
161121059|NCT01882907|581831317|FG001|Overall Study|Withdrawal by Subject|6|||
161121060|NCT01978093|581831318|FG000|Overall Study|Death|1|||
161121061|NCT01978093|581831319|FG001|Overall Study|Death|0|||
161121062|NCT01978093|581831318|FG000|Overall Study|Adverse Event|0|||
161121063|NCT01978093|581831319|FG001|Overall Study|Adverse Event|5|||
161121064|NCT01978093|581831318|FG000|Overall Study|Protocol Violation|8|||
161121065|NCT01978093|581831319|FG001|Overall Study|Protocol Violation|2|||
161121066|NCT01978093|581831318|FG000|Overall Study|Withdrawal by Subject|29|||
161121067|NCT01978093|581831319|FG001|Overall Study|Withdrawal by Subject|25|||
161121068|NCT01978093|581831318|FG000|Overall Study|Lost to Follow-up|11|||
161121069|NCT01978093|581831319|FG001|Overall Study|Lost to Follow-up|15|||
161121070|NCT01978093|581831318|FG000|Overall Study|Migrated/moved from study area|11|||
161121071|NCT01978093|581831319|FG001|Overall Study|Migrated/moved from study area|13|||
161121072|NCT01978093|581831318|FG000|Overall Study|Loss of kaiser coverage|4|||
161121073|NCT01978093|581831319|FG001|Overall Study|Loss of kaiser coverage|10|||
161121074|NCT01978093|581831318|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
161121075|NCT01978093|581831319|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
161121076|NCT01978093|581831318|FG000|Overall Study|Mother lost custody of child|0|||
161121077|NCT01978093|581831319|FG001|Overall Study|Mother lost custody of child|1|||
161121078|NCT01978093|581831318|FG000|Overall Study|Child was in care of grandmother|0|||
161121079|NCT01978093|581831319|FG001|Overall Study|Child was in care of grandmother|1|||
161121080|NCT01978093|581831318|FG000|Overall Study|N/A for vaccine administration|0|||
161121081|NCT01978093|581831319|FG001|Overall Study|N/A for vaccine administration|1|||
161121082|NCT03124784|581831324|FG000|Overall Study|Adverse Event|1|||
161121083|NCT03124784|581831324|FG000|Overall Study|Computer/Equip Malfunction|1|||
161121084|NCT05702515|581831325|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
161121085|NCT02162732|581831326|FG000|Overall Study|Biopsy not performed.|18|||
160879724|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879725|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
160879726|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
160879727|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
160879728|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
160879729|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Other|0|||
160879730|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Other|0|||
160879731|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Other|1|||
161121086|NCT01784965|581831327|FG000|Overall Study|Withdrawal by Subject|6|||
161121087|NCT01784965|581831328|FG001|Overall Study|Withdrawal by Subject|3|||
161121088|NCT01784965|581831327|FG000|Overall Study|Adverse Event|0|||
161121089|NCT01784965|581831328|FG001|Overall Study|Adverse Event|8|||
161121090|NCT03757988|581831331|FG000|Overall Study|Withdrawal by Subject|1|||
161121091|NCT05587296|581831332|FG000|Overall Study|Adverse Event|15|||
161121092|NCT05587296|581831333|FG001|Overall Study|Adverse Event|7|||
161121093|NCT05587296|581831332|FG000|Overall Study|Lack of Efficacy|2|||
161121094|NCT05587296|581831333|FG001|Overall Study|Lack of Efficacy|0|||
161121095|NCT05587296|581831332|FG000|Overall Study|Lost to Follow-up|1|||
161121096|NCT05587296|581831333|FG001|Overall Study|Lost to Follow-up|0|||
161121097|NCT05587296|581831332|FG000|Overall Study|Withdrawal by Subject|14|||
161121098|NCT05587296|581831333|FG001|Overall Study|Withdrawal by Subject|4|||
161121099|NCT05587296|581831332|FG000|Overall Study|miscellaneous|3|||
161121100|NCT05587296|581831333|FG001|Overall Study|miscellaneous|6|||
161121101|NCT05587296|581831332|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
161121102|NCT05587296|581831333|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
161121103|NCT02847624|581831336|FG000|Overall Study|Lost to Follow-up|28|||
161121104|NCT02847624|581831336|FG000|Overall Study|Protocol Violation|98|||
161121105|NCT02847624|581831336|FG000|Overall Study|Case report failures|4|||
161121106|NCT04142983|581831347|FG000|Overall Study|Lost to Follow-up|73|||
161121107|NCT04142983|581831347|FG000|Overall Study|Withdrawal by Subject|10|||
161121108|NCT04142983|581831347|FG000|Overall Study|Physician Decision|1|||
161121109|NCT04142983|581831347|FG000|Overall Study|Adverse Event|1|||
161121110|NCT04142983|581831347|FG000|Overall Study|No longer eligible|4|||
161121111|NCT04142983|581831347|FG000|Overall Study|Screen Failure|10|||
161121112|NCT04372927|581831348|FG000|Overall Study|Death|1|||
161121113|NCT03033745|581831349|FG000|Overall Study|Protocol Violation|0|||
161121114|NCT03033745|581831350|FG001|Overall Study|Protocol Violation|0|||
161121115|NCT03033745|581831351|FG002|Overall Study|Protocol Violation|1|||
161121116|NCT03033745|581831349|FG000|Overall Study|Adverse Event|1|||
161121117|NCT03033745|581831350|FG001|Overall Study|Adverse Event|0|||
161121118|NCT03033745|581831351|FG002|Overall Study|Adverse Event|1|||
161121119|NCT03033745|581831349|FG000|Overall Study|Withdrawal by Subject|0|||
161121120|NCT03033745|581831350|FG001|Overall Study|Withdrawal by Subject|1|||
161121121|NCT03033745|581831351|FG002|Overall Study|Withdrawal by Subject|0|||
161121122|NCT01999582|581831352|FG000|Overall Study|Withdrawal by Subject|0|||
161121123|NCT01999582|581831353|FG001|Overall Study|Withdrawal by Subject|0|||
161121124|NCT01999582|581831354|FG002|Overall Study|Withdrawal by Subject|0|||
161324602|NCT00215644|582575636|FG001|Overall Study|Withdrawal by Subject|0|||
161324603|NCT00215644|582575635|FG000|Overall Study|Other|3|||
161324604|NCT00215644|582575636|FG001|Overall Study|Other|15|||
161324605|NCT00215644|582575635|FG000|Overall Study|Randomized but Not Treated|1|||
161324606|NCT00215644|582575636|FG001|Overall Study|Randomized but Not Treated|0|||
161324607|NCT02861664|582575639|FG000|Overall Study|Withdrawal of Consent|0|||
161324608|NCT02861664|582575640|FG001|Overall Study|Withdrawal of Consent|1|||
161324609|NCT03512353|582575641|FG000|Overall Study|Sponsor Decision|3|||
161324610|NCT03512353|582575641|FG000|Overall Study|Death|1|||
161324611|NCT01000974|582575642|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
161324612|NCT01000974|582575643|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
161324613|NCT01000974|582575644|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
161324614|NCT01000974|582575642|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
161324615|NCT01000974|582575643|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
161121125|NCT01999582|581831355|FG003|Overall Study|Withdrawal by Subject|1|||
160879732|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Other|1|||
160879733|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Other|0|||
160879734|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Other|0|||
160879735|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Other|0|||
160879736|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Other|1|||
160879737|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Other|0|||
160879738|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|Death|0|||
160879739|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|Death|0|||
160879740|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|Death|0|||
160879741|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|Death|0|||
160879742|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|Death|0|||
160879743|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|Death|1|||
160879744|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|Death|0|||
160879745|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|Death|0|||
160879746|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|Death|0|||
160879747|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879748|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879749|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879750|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879751|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879752|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
160879753|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
160879754|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879755|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
160879756|NCT00557856|580954004|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
160879757|NCT00557856|580954005|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879758|NCT00557856|580954006|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879759|NCT00557856|580954007|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879760|NCT00557856|580954008|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879761|NCT00557856|580954009|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879762|NCT00557856|580954010|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879763|NCT00557856|580954011|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879764|NCT00557856|580954012|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
160879765|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879766|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879767|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879768|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879769|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879770|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879771|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879772|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
160879773|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
160879774|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879775|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
161121126|NCT01999582|581831356|FG004|Overall Study|Withdrawal by Subject|0|||
161121127|NCT01999582|581831357|FG005|Overall Study|Withdrawal by Subject|0|||
161121128|NCT01999582|581831352|FG000|Overall Study|Adverse Event|0|||
161121129|NCT01999582|581831353|FG001|Overall Study|Adverse Event|0|||
161121130|NCT01999582|581831354|FG002|Overall Study|Adverse Event|3|||
161121131|NCT01999582|581831355|FG003|Overall Study|Adverse Event|0|||
161121132|NCT01999582|581831356|FG004|Overall Study|Adverse Event|1|||
161121133|NCT01999582|581831357|FG005|Overall Study|Adverse Event|0|||
161121134|NCT01999582|581831352|FG000|Overall Study|Other Reasons|1|||
161121135|NCT01999582|581831353|FG001|Overall Study|Other Reasons|0|||
161121136|NCT01999582|581831354|FG002|Overall Study|Other Reasons|3|||
161121137|NCT01999582|581831355|FG003|Overall Study|Other Reasons|1|||
161121138|NCT01999582|581831356|FG004|Overall Study|Other Reasons|1|||
161121139|NCT01999582|581831357|FG005|Overall Study|Other Reasons|2|||
161226115|NCT00863746|582209903|FG001|Treatment|Adverse Event|16|||
160879776|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879777|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879778|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879779|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879780|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879781|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
160879782|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
160879783|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
161121140|NCT01999582|581831352|FG000|Overall Study|Protocol Violation|1|||
161121141|NCT01999582|581831353|FG001|Overall Study|Protocol Violation|0|||
161121142|NCT01999582|581831354|FG002|Overall Study|Protocol Violation|0|||
161226116|NCT00863746|582209902|FG000|Treatment|non-compliant with study medication|4|||
160879784|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
160879785|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
160879786|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
160879787|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
160879788|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
160879789|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
160879790|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
160879791|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
160879792|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Other|0|||
160879793|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Other|0|||
160879794|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Other|0|||
160879795|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Other|0|||
160879796|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Other|0|||
160879797|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Other|0|||
160879798|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Other|0|||
160879799|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Other|0|||
160879800|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Other|1|||
160879801|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|Death|0|||
160879802|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|Death|0|||
160879803|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|Death|0|||
160879804|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|Death|0|||
160879805|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|Death|0|||
160879806|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|Death|0|||
160879807|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|Death|0|||
160879808|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|Death|0|||
160879809|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|Death|2|||
160879810|NCT00557856|580954004|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879811|NCT00557856|580954005|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879812|NCT00557856|580954006|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879813|NCT00557856|580954007|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879814|NCT00557856|580954008|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879815|NCT00557856|580954009|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879816|NCT00557856|580954010|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879817|NCT00557856|580954011|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
160879818|NCT00557856|580954012|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
160879819|NCT03255083|580954013|FG000|Overall Study|Clinical progression|1|||
160879820|NCT03255083|580954014|FG001|Overall Study|Clinical progression|0|||
161226117|NCT00863746|582209903|FG001|Treatment|non-compliant with study medication|0|||
160879821|NCT03255083|580954015|FG002|Overall Study|Clinical progression|0|||
160879822|NCT03255083|580954016|FG003|Overall Study|Clinical progression|0|||
160879823|NCT03255083|580954013|FG000|Overall Study|Adverse Event|0|||
160879824|NCT03255083|580954014|FG001|Overall Study|Adverse Event|1|||
160879825|NCT03255083|580954015|FG002|Overall Study|Adverse Event|0|||
160879826|NCT03255083|580954016|FG003|Overall Study|Adverse Event|0|||
160879827|NCT03255083|580954013|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
160879828|NCT03255083|580954014|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
160879829|NCT03255083|580954015|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
160879830|NCT03255083|580954016|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
160879831|NCT03255083|580954013|FG000|Overall Study|Withdrawal by Subject|1|||
160879832|NCT03255083|580954014|FG001|Overall Study|Withdrawal by Subject|1|||
160879833|NCT03255083|580954015|FG002|Overall Study|Withdrawal by Subject|1|||
160879834|NCT03255083|580954016|FG003|Overall Study|Withdrawal by Subject|0|||
160879835|NCT00363545|580954017|FG000|Overall Study|Serious Adverse Event|0|||
160879836|NCT00363545|580954018|FG001|Overall Study|Serious Adverse Event|1|||
160879837|NCT00363545|580954017|FG000|Overall Study|Withdrawal by Subject|12|||
160879838|NCT00363545|580954018|FG001|Overall Study|Withdrawal by Subject|15|||
160879839|NCT00363545|580954017|FG000|Overall Study|Migrated/moved from study area|3|||
160879840|NCT00363545|580954018|FG001|Overall Study|Migrated/moved from study area|6|||
160879841|NCT00363545|580954017|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
161226118|NCT00863746|582209902|FG000|Treatment|Consent withdrawn|15|||
160879842|NCT00363545|580954018|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
160879843|NCT00363545|580954017|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
160879844|NCT00363545|580954018|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
160879845|NCT00363545|580954017|FG000|Overall Study|Others|1|||
160879846|NCT00363545|580954018|FG001|Overall Study|Others|0|||
160879847|NCT05009979|580954019|FG000|Overall Study|Withdrawal by Subject|1|||
160879848|NCT04174365|580954020|FG000|Overall Study|Lost to Follow-up|1|||
160879849|NCT04174365|580954021|FG001|Overall Study|Lost to Follow-up|2|||
160879850|NCT04174365|580954020|FG000|Overall Study|Adverse Event|2|||
160879851|NCT04174365|580954021|FG001|Overall Study|Adverse Event|1|||
161226119|NCT00863746|582209903|FG001|Treatment|Consent withdrawn|14|||
161226120|NCT00863746|582209902|FG000|Treatment|Lost to Follow-up|1|||
161226121|NCT00863746|582209903|FG001|Treatment|Lost to Follow-up|0|||
160879852|NCT04174365|580954020|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
160879853|NCT04174365|580954021|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
160879854|NCT04174365|580954020|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
160879855|NCT04174365|580954021|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
160879856|NCT04174365|580954020|FG000|Overall Study|Protocol Deviation|1|||
160879857|NCT04174365|580954021|FG001|Overall Study|Protocol Deviation|0|||
160879858|NCT04174365|580954020|FG000|Overall Study|Lack of Efficacy|0|||
160879859|NCT04174365|580954021|FG001|Overall Study|Lack of Efficacy|2|||
160879860|NCT04174365|580954020|FG000|Overall Study|Disease Relapse|1|||
160879861|NCT04174365|580954021|FG001|Overall Study|Disease Relapse|0|||
160879862|NCT04174365|580954020|FG000|Overall Study|Reason Not Specified|0|||
160879863|NCT04174365|580954021|FG001|Overall Study|Reason Not Specified|1|||
160879864|NCT02522624|580955238|FG000|Overall Study|Technical failure|1|||
160879865|NCT02522624|580955239|FG001|Overall Study|Technical failure|0|||
160879866|NCT00910624|580955241|FG000|Treatment Phase|Adverse Event|2|||
160879867|NCT00910624|580955242|FG001|Treatment Phase|Adverse Event|6|||
160879868|NCT00910624|580955243|FG002|Treatment Phase|Adverse Event|6|||
160879869|NCT00910624|580955244|FG003|Treatment Phase|Adverse Event|0|||
160879870|NCT00910624|580955241|FG000|Treatment Phase|Treatment Failure|23|||
160879871|NCT00910624|580955242|FG001|Treatment Phase|Treatment Failure|10|||
160879872|NCT00910624|580955243|FG002|Treatment Phase|Treatment Failure|0|||
160879873|NCT00910624|580955244|FG003|Treatment Phase|Treatment Failure|0|||
160879874|NCT00910624|580955241|FG000|Treatment Phase|Lost to Follow-up|0|||
160879875|NCT00910624|580955242|FG001|Treatment Phase|Lost to Follow-up|0|||
160879876|NCT00910624|580955243|FG002|Treatment Phase|Lost to Follow-up|1|||
160879877|NCT00910624|580955244|FG003|Treatment Phase|Lost to Follow-up|0|||
160879878|NCT00910624|580955241|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
160879879|NCT00910624|580955242|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
160879880|NCT00910624|580955243|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
160879881|NCT00910624|580955244|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
160879882|NCT00910624|580955241|FG000|Treatment Phase|Withdrawal by Subject|2|||
160879883|NCT00910624|580955242|FG001|Treatment Phase|Withdrawal by Subject|1|||
160879884|NCT00910624|580955243|FG002|Treatment Phase|Withdrawal by Subject|0|||
160879885|NCT00910624|580955244|FG003|Treatment Phase|Withdrawal by Subject|0|||
160879886|NCT00910624|580955241|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
160879887|NCT00910624|580955242|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
160879888|NCT00910624|580955243|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
160879889|NCT00910624|580955244|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
160879890|NCT00910624|580955241|FG000|Follow-Up Phase|Adverse Event|0|||
160879891|NCT00910624|580955242|FG001|Follow-Up Phase|Adverse Event|0|||
160879892|NCT00910624|580955243|FG002|Follow-Up Phase|Adverse Event|1|||
160879893|NCT00910624|580955244|FG003|Follow-Up Phase|Adverse Event|0|||
160879894|NCT00910624|580955241|FG000|Follow-Up Phase|Lost to Follow-up|3|||
160879895|NCT00910624|580955242|FG001|Follow-Up Phase|Lost to Follow-up|1|||
160879896|NCT00910624|580955243|FG002|Follow-Up Phase|Lost to Follow-up|2|||
160879897|NCT00910624|580955244|FG003|Follow-Up Phase|Lost to Follow-up|0|||
160879898|NCT00910624|580955241|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
160879899|NCT00910624|580955242|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
160879900|NCT00910624|580955243|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
160879901|NCT00910624|580955244|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
160879902|NCT00910624|580955241|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
160879903|NCT00910624|580955242|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
160879904|NCT00910624|580955243|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
160879905|NCT00910624|580955244|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
160879906|NCT00910624|580955241|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
160879907|NCT00910624|580955242|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
160879908|NCT00910624|580955243|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
160879909|NCT00910624|580955244|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
160879910|NCT00910624|580955241|FG000|Follow-Up Phase|Administrative|0|||
160879911|NCT00910624|580955242|FG001|Follow-Up Phase|Administrative|1|||
160879912|NCT00910624|580955243|FG002|Follow-Up Phase|Administrative|1|||
160879913|NCT00910624|580955244|FG003|Follow-Up Phase|Administrative|0|||
160879914|NCT00294762|580955245|FG000|Overall Study|Did not receive study treatment|3|||
160879915|NCT00294762|580955246|FG001|Overall Study|Did not receive study treatment|3|||
160879916|NCT01738646|580955247|FG000|Overall Study|Still Receiving Treatment|2|||
160879917|NCT00701662|580955249|FG000|Overall Study|Lack of Efficacy|1|||
160879918|NCT03642132|580955250|FG000|Chemotherapy Period|Adverse Event|1|||
161226122|NCT00863746|582209902|FG000|Treatment|Protocol Violation|5|||
160879919|NCT03642132|580955251|FG001|Chemotherapy Period|Adverse Event|1|||
160879920|NCT03642132|580955252|FG002|Chemotherapy Period|Adverse Event|0|||
160879921|NCT03642132|580955250|FG000|Chemotherapy Period|Physician's decision|4|||
160879922|NCT03642132|580955251|FG001|Chemotherapy Period|Physician's decision|1|||
160879923|NCT03642132|580955252|FG002|Chemotherapy Period|Physician's decision|0|||
160879924|NCT03642132|580955250|FG000|Chemotherapy Period|Progressive disease|0|||
160879925|NCT03642132|580955251|FG001|Chemotherapy Period|Progressive disease|0|||
161226123|NCT00863746|582209903|FG001|Treatment|Protocol Violation|3|||
160879926|NCT03642132|580955252|FG002|Chemotherapy Period|Progressive disease|1|||
160879927|NCT03642132|580955250|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
160879928|NCT03642132|580955251|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
160879929|NCT03642132|580955252|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
160879930|NCT03642132|580955250|FG000|Chemotherapy Period|Other|1|||
160879931|NCT03642132|580955251|FG001|Chemotherapy Period|Other|0|||
160879932|NCT03642132|580955252|FG002|Chemotherapy Period|Other|2|||
160879933|NCT03642132|580955250|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
160879934|NCT03642132|580955251|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
160879935|NCT03642132|580955252|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
161121143|NCT01999582|581831355|FG003|Overall Study|Protocol Violation|0|||
161121144|NCT01999582|581831356|FG004|Overall Study|Protocol Violation|0|||
161121145|NCT01999582|581831357|FG005|Overall Study|Protocol Violation|1|||
161121146|NCT01999582|581831352|FG000|Overall Study|Lack of Efficacy|1|||
161121147|NCT01999582|581831353|FG001|Overall Study|Lack of Efficacy|3|||
161121148|NCT01999582|581831354|FG002|Overall Study|Lack of Efficacy|0|||
161121149|NCT01999582|581831355|FG003|Overall Study|Lack of Efficacy|1|||
161121150|NCT01999582|581831356|FG004|Overall Study|Lack of Efficacy|0|||
161121151|NCT01999582|581831357|FG005|Overall Study|Lack of Efficacy|0|||
161121152|NCT03728309|581831362|FG000|Overall Study|Randomized but not Treated|0|||
161121153|NCT03728309|581831363|FG001|Overall Study|Randomized but not Treated|1|||
161121154|NCT03728309|581831362|FG000|Overall Study|Adverse Event|0|||
161121155|NCT03728309|581831363|FG001|Overall Study|Adverse Event|1|||
161121156|NCT03728309|581831362|FG000|Overall Study|Withdrawal by Subject|2|||
161121157|NCT03728309|581831363|FG001|Overall Study|Withdrawal by Subject|8|||
161121158|NCT03728309|581831362|FG000|Overall Study|Lost to Follow-up|9|||
161121159|NCT03728309|581831363|FG001|Overall Study|Lost to Follow-up|10|||
161121160|NCT03728309|581831362|FG000|Overall Study|Protocol Deviation|0|||
161121161|NCT03728309|581831363|FG001|Overall Study|Protocol Deviation|1|||
161121162|NCT03728309|581831362|FG000|Overall Study|Due to COVID|1|||
161121163|NCT03728309|581831363|FG001|Overall Study|Due to COVID|3|||
161121164|NCT00927095|581831366|FG000|Overall Study|Adverse Event|3|||
161121165|NCT00927095|581831367|FG001|Overall Study|Adverse Event|1|||
161121166|NCT00927095|581831368|FG002|Overall Study|Adverse Event|0|||
161121167|NCT00927095|581831366|FG000|Overall Study|Withdrawal by Subject|2|||
161121168|NCT00927095|581831367|FG001|Overall Study|Withdrawal by Subject|1|||
161121169|NCT00927095|581831368|FG002|Overall Study|Withdrawal by Subject|1|||
161121170|NCT00927095|581831366|FG000|Overall Study|Physician Decision|1|||
161121171|NCT00927095|581831367|FG001|Overall Study|Physician Decision|2|||
161121172|NCT00927095|581831368|FG002|Overall Study|Physician Decision|1|||
161121173|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
161121174|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
161121175|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
161121176|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
161121177|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161121178|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161121179|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
161121180|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161121181|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
161121182|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161121183|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161121184|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161121185|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
161121186|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
161121187|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
161121188|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
161121189|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
161121190|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
161121191|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
161121192|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
161121193|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161121194|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161121195|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161121196|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
161121197|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
160879936|NCT03642132|580955250|FG000|Maintenance Period|Adverse Event|1|||
160879937|NCT03642132|580955251|FG001|Maintenance Period|Adverse Event|2|||
161121198|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161121199|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161121200|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161121201|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161324616|NCT01000974|582575644|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
160879938|NCT03642132|580955252|FG002|Maintenance Period|Adverse Event|0|||
161121202|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
161121203|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161121204|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
161121205|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161121206|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161121207|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161121208|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
161121209|NCT03403205|581831375|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
161121210|NCT03403205|581831376|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161121211|NCT03403205|581831377|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
161121212|NCT03403205|581831378|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
161121213|NCT03403205|581831379|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161121214|NCT03403205|581831380|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
161121215|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
161121216|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
161121217|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
161121218|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
161121219|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
161121220|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
161121221|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
161121222|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
161121223|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
161121224|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
161121225|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
161121226|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
161121227|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Death|1|||
161121228|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Death|0|||
161121229|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Death|0|||
161121230|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Death|0|||
161121231|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Death|0|||
161121232|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Death|0|||
161121233|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
161121234|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161121235|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161121236|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161121237|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161121238|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
161121239|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
161121240|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
161121241|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
161121242|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
161121243|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
161121244|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
161121245|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
161121246|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161121247|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161121248|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161121249|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161121250|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
161121251|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
161121252|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
161121253|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
161121254|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
161121255|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
161121256|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
161121257|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
161121258|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
161121259|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
161121260|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
161121261|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
161121262|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
161121263|NCT03403205|581831375|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
161121264|NCT03403205|581831376|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
161121265|NCT03403205|581831377|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
161121266|NCT03403205|581831378|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
161121267|NCT03403205|581831379|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
161121268|NCT03403205|581831380|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
161121269|NCT00706030|581831381|FG000|Overall Study|Disease Progression|4|||
160879939|NCT03642132|580955250|FG000|Maintenance Period|Non-compliance with study drug|0|||
160879940|NCT03642132|580955251|FG001|Maintenance Period|Non-compliance with study drug|0|||
160879941|NCT03642132|580955252|FG002|Maintenance Period|Non-compliance with study drug|1|||
160879942|NCT03642132|580955250|FG000|Maintenance Period|Physician's decision|2|||
160879943|NCT03642132|580955251|FG001|Maintenance Period|Physician's decision|2|||
160879944|NCT03642132|580955252|FG002|Maintenance Period|Physician's decision|2|||
160879945|NCT03642132|580955250|FG000|Maintenance Period|Progressive disease|9|||
160879946|NCT03642132|580955251|FG001|Maintenance Period|Progressive disease|3|||
160879947|NCT03642132|580955252|FG002|Maintenance Period|Progressive disease|6|||
160879948|NCT03642132|580955250|FG000|Maintenance Period|Other|0|||
160879949|NCT03642132|580955251|FG001|Maintenance Period|Other|0|||
160879950|NCT03642132|580955252|FG002|Maintenance Period|Other|3|||
160879951|NCT03642132|580955250|FG000|Maintenance Period|Withdrawal by Subject|1|||
160879952|NCT03642132|580955251|FG001|Maintenance Period|Withdrawal by Subject|1|||
160879953|NCT03642132|580955252|FG002|Maintenance Period|Withdrawal by Subject|2|||
160879954|NCT03642132|580955250|FG000|Follow-up Period|Other|0|||
160879955|NCT03642132|580955251|FG001|Follow-up Period|Other|0|||
160879956|NCT03642132|580955252|FG002|Follow-up Period|Other|1|||
160879957|NCT03642132|580955250|FG000|Follow-up Period|Withdrawal by Subject|1|||
160879958|NCT03642132|580955251|FG001|Follow-up Period|Withdrawal by Subject|2|||
160879959|NCT03642132|580955252|FG002|Follow-up Period|Withdrawal by Subject|0|||
160879960|NCT03642132|580955250|FG000|Follow-up Period|Study terminated by sponsor|1|||
160879961|NCT03642132|580955251|FG001|Follow-up Period|Study terminated by sponsor|0|||
160879962|NCT03642132|580955252|FG002|Follow-up Period|Study terminated by sponsor|1|||
160879963|NCT03642132|580955250|FG000|Follow-up Period|Lack of Efficacy|1|||
160879964|NCT03642132|580955251|FG001|Follow-up Period|Lack of Efficacy|0|||
160879965|NCT03642132|580955252|FG002|Follow-up Period|Lack of Efficacy|0|||
160879966|NCT03642132|580955250|FG000|Follow-up Period|Death|1|||
160879967|NCT03642132|580955251|FG001|Follow-up Period|Death|0|||
160879968|NCT03642132|580955252|FG002|Follow-up Period|Death|2|||
160879969|NCT03642132|580955250|FG000|Follow-up Period|Adverse Event|1|||
160879970|NCT03642132|580955251|FG001|Follow-up Period|Adverse Event|0|||
160879971|NCT03642132|580955252|FG002|Follow-up Period|Adverse Event|0|||
160879972|NCT04493892|580955258|FG000|Overall Study|Withdrawal by Subject|15|||
160879973|NCT02577887|580955261|FG000|Overall Study|Death|93|||
160879974|NCT02577887|580955261|FG000|Overall Study|Protocol Violation|125|||
160879975|NCT02577887|580955261|FG000|Overall Study|Withdrawal by Subject|80|||
160879976|NCT02267317|580955262|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
160879977|NCT02267317|580955263|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879978|NCT02267317|580955264|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879979|NCT02267317|580955265|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879980|NCT02267317|580955266|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879981|NCT02267317|580955267|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
160879982|NCT02267317|580955262|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
160879983|NCT02267317|580955263|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879984|NCT02267317|580955264|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879985|NCT02267317|580955265|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879986|NCT02267317|580955266|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879987|NCT02267317|580955267|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
160879988|NCT03595618|580955270|FG000|Overall Study|Adverse Event|16|||
160879989|NCT03595618|580955271|FG001|Overall Study|Adverse Event|17|||
161121270|NCT00706030|581831382|FG001|Overall Study|Disease Progression|6|||
161121271|NCT00706030|581831383|FG002|Overall Study|Disease Progression|46|||
161121272|NCT00706030|581831384|FG003|Overall Study|Disease Progression|12|||
161121273|NCT00706030|581831381|FG000|Overall Study|Adverse Event|1|||
161121274|NCT00706030|581831382|FG001|Overall Study|Adverse Event|0|||
161121275|NCT00706030|581831383|FG002|Overall Study|Adverse Event|4|||
161121276|NCT00706030|581831384|FG003|Overall Study|Adverse Event|2|||
161121277|NCT00706030|581831381|FG000|Overall Study|Withdrawal by Subject|1|||
161226124|NCT00863746|582209902|FG000|Treatment|Other|1|||
160879990|NCT03595618|580955272|FG002|Overall Study|Adverse Event|20|||
160879991|NCT03595618|580955273|FG003|Overall Study|Adverse Event|8|||
160879992|NCT03595618|580955270|FG000|Overall Study|Withdrawal by Subject|12|||
160879993|NCT03595618|580955271|FG001|Overall Study|Withdrawal by Subject|14|||
161121278|NCT00706030|581831382|FG001|Overall Study|Withdrawal by Subject|0|||
161121279|NCT00706030|581831383|FG002|Overall Study|Withdrawal by Subject|2|||
160879994|NCT03595618|580955272|FG002|Overall Study|Withdrawal by Subject|14|||
160879995|NCT03595618|580955273|FG003|Overall Study|Withdrawal by Subject|10|||
160879996|NCT03595618|580955270|FG000|Overall Study|Lost to Follow-up|6|||
160879997|NCT03595618|580955271|FG001|Overall Study|Lost to Follow-up|4|||
160879998|NCT03595618|580955272|FG002|Overall Study|Lost to Follow-up|5|||
160879999|NCT03595618|580955273|FG003|Overall Study|Lost to Follow-up|6|||
160880000|NCT03595618|580955270|FG000|Overall Study|Protocol Violation|2|||
161226125|NCT00863746|582209903|FG001|Treatment|Other|0|||
160880001|NCT03595618|580955271|FG001|Overall Study|Protocol Violation|0|||
160880002|NCT03595618|580955272|FG002|Overall Study|Protocol Violation|6|||
160880003|NCT03595618|580955273|FG003|Overall Study|Protocol Violation|2|||
160880004|NCT03595618|580955270|FG000|Overall Study|Physician Decision|0|||
160880005|NCT03595618|580955271|FG001|Overall Study|Physician Decision|0|||
160880006|NCT03595618|580955272|FG002|Overall Study|Physician Decision|1|||
160880007|NCT03595618|580955273|FG003|Overall Study|Physician Decision|2|||
160880008|NCT03595618|580955270|FG000|Overall Study|Miscellaneous|7|||
160880009|NCT03595618|580955271|FG001|Overall Study|Miscellaneous|5|||
160880010|NCT03595618|580955272|FG002|Overall Study|Miscellaneous|10|||
160880011|NCT03595618|580955273|FG003|Overall Study|Miscellaneous|6|||
160880012|NCT02279407|580955276|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
160880013|NCT02279407|580955277|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
160880014|NCT02279407|580955278|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
160880015|NCT02279407|580955279|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
160880016|NCT02279407|580955276|FG000|Overall Study|Withdrawal by Subject|1|||
160880017|NCT02279407|580955277|FG001|Overall Study|Withdrawal by Subject|0|||
160880018|NCT02279407|580955278|FG002|Overall Study|Withdrawal by Subject|1|||
160880019|NCT02279407|580955279|FG003|Overall Study|Withdrawal by Subject|1|||
160880020|NCT02279407|580955276|FG000|Overall Study|Adverse Event|1|||
160880021|NCT02279407|580955277|FG001|Overall Study|Adverse Event|1|||
160880022|NCT02279407|580955278|FG002|Overall Study|Adverse Event|2|||
160880023|NCT02279407|580955279|FG003|Overall Study|Adverse Event|0|||
160880024|NCT00422084|580955280|FG000|Overall Study|Adverse Event|21|||
160880025|NCT00422084|580955281|FG001|Overall Study|Adverse Event|7|||
160880026|NCT00422084|580955280|FG000|Overall Study|Withdrawal by Subject|12|||
160880027|NCT00422084|580955281|FG001|Overall Study|Withdrawal by Subject|9|||
160880028|NCT00422084|580955280|FG000|Overall Study|Lost to Follow-up|14|||
160880029|NCT00422084|580955281|FG001|Overall Study|Lost to Follow-up|9|||
160880030|NCT00422084|580955280|FG000|Overall Study|Protocol Violation|4|||
160880031|NCT00422084|580955281|FG001|Overall Study|Protocol Violation|1|||
160880032|NCT00422084|580955280|FG000|Overall Study|Lack of Efficacy|40|||
160880033|NCT00422084|580955281|FG001|Overall Study|Lack of Efficacy|42|||
160880034|NCT00422084|580955280|FG000|Overall Study|P. vivax infection|3|||
160880035|NCT00422084|580955281|FG001|Overall Study|P. vivax infection|6|||
160880036|NCT00422084|580955280|FG000|Overall Study|Cyesis|1|||
160880037|NCT00422084|580955281|FG001|Overall Study|Cyesis|0|||
160880038|NCT00422084|580955280|FG000|Overall Study|Withdrawn from study accidentally|1|||
160880039|NCT00422084|580955281|FG001|Overall Study|Withdrawn from study accidentally|0|||
160880040|NCT00422084|580955280|FG000|Overall Study|Non-compliance|1|||
160880041|NCT00422084|580955281|FG001|Overall Study|Non-compliance|0|||
160880042|NCT00422084|580955280|FG000|Overall Study|Re-location|0|||
160880043|NCT00422084|580955281|FG001|Overall Study|Re-location|1|||
160880044|NCT00422084|580955280|FG000|Overall Study|Not defined|1|||
160880045|NCT00422084|580955281|FG001|Overall Study|Not defined|1|||
160880046|NCT03774823|580955284|FG000|Overall Study|Withdrawal by Subject|1|||
160880047|NCT03774823|580955285|FG001|Overall Study|Withdrawal by Subject|1|||
160880048|NCT03996369|580955292|FG000|Overall Study|Protocol deviation|1|||
160880049|NCT03996369|580955293|FG001|Overall Study|Protocol deviation|1|||
160880050|NCT03996369|580955292|FG000|Overall Study|Physician Decision|4|||
160880051|NCT03996369|580955293|FG001|Overall Study|Physician Decision|2|||
160880052|NCT03996369|580955292|FG000|Overall Study|Participant decision|0|||
160880053|NCT03996369|580955293|FG001|Overall Study|Participant decision|1|||
160880054|NCT03996369|580955292|FG000|Overall Study|Lack of Efficacy|4|||
160880055|NCT03996369|580955293|FG001|Overall Study|Lack of Efficacy|0|||
160880056|NCT03996369|580955292|FG000|Overall Study|Adverse Event|9|||
160880057|NCT03996369|580955293|FG001|Overall Study|Adverse Event|0|||
160880058|NCT03996369|580955292|FG000|Overall Study|Withdrawal by Subject|6|||
160880059|NCT03996369|580955293|FG001|Overall Study|Withdrawal by Subject|8|||
160880060|NCT03996369|580955292|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
160880061|NCT03996369|580955293|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
160880062|NCT03996369|580955292|FG000|Overall Study|Lost to Follow-up|0|||
160880063|NCT03996369|580955293|FG001|Overall Study|Lost to Follow-up|1|||
160880064|NCT01579812|580955294|FG000|Overall Study|Ineligible after treatment start|40|||
160880065|NCT01579812|580955294|FG000|Overall Study|Patient choice|3|||
160880066|NCT01579812|580955294|FG000|Overall Study|Noncompliance|3|||
160880067|NCT01579812|580955294|FG000|Overall Study|Withdrawal by Subject|6|||
160880068|NCT00653432|580955295|FG000|Overall Study|Adverse Event|4|||
160880069|NCT00653432|580955296|FG001|Overall Study|Adverse Event|1|||
160880070|NCT00653432|580955295|FG000|Overall Study|Withdrawal by Subject|4|||
160880071|NCT00653432|580955296|FG001|Overall Study|Withdrawal by Subject|5|||
160880072|NCT00653432|580955295|FG000|Overall Study|Lost to Follow-up|7|||
160880073|NCT00653432|580955296|FG001|Overall Study|Lost to Follow-up|6|||
160880074|NCT00653432|580955295|FG000|Overall Study|Use/Need of Con Therapy|2|||
160880075|NCT00653432|580955296|FG001|Overall Study|Use/Need of Con Therapy|1|||
160880076|NCT00653432|580955295|FG000|Overall Study|Other - Reason Not Provided|5|||
160880077|NCT00653432|580955296|FG001|Overall Study|Other - Reason Not Provided|3|||
160880078|NCT01782469|580955297|FG000|Overall Study|Lost to Follow-up|1|||
160880079|NCT00357760|580955298|FG000|Overall Study|Disease progression|44|||
160880080|NCT00357760|580955299|FG001|Overall Study|Disease progression|17|||
160880081|NCT00357760|580955298|FG000|Overall Study|Adverse Event|10|||
160880082|NCT00357760|580955299|FG001|Overall Study|Adverse Event|7|||
160880083|NCT00357760|580955298|FG000|Overall Study|Death|0|||
160880084|NCT00357760|580955299|FG001|Overall Study|Death|3|||
160880085|NCT00357760|580955298|FG000|Overall Study|Alternative therapy|1|||
160880086|NCT00357760|580955299|FG001|Overall Study|Alternative therapy|0|||
160880087|NCT00357760|580955298|FG000|Overall Study|Withdrawal by Subject|0|||
160880088|NCT00357760|580955299|FG001|Overall Study|Withdrawal by Subject|2|||
160880089|NCT00357760|580955298|FG000|Overall Study|Never started treatment|2|||
160880090|NCT00357760|580955299|FG001|Overall Study|Never started treatment|1|||
160880091|NCT00357760|580955298|FG000|Overall Study|Ineligible|0|||
160880092|NCT00357760|580955299|FG001|Overall Study|Ineligible|2|||
160880093|NCT00357760|580955298|FG000|Overall Study|Physician Decision|2|||
160880094|NCT00357760|580955299|FG001|Overall Study|Physician Decision|1|||
160880095|NCT00357760|580955298|FG000|Overall Study|Protocol Violation|0|||
160880096|NCT00357760|580955299|FG001|Overall Study|Protocol Violation|1|||
160880097|NCT00357760|580955298|FG000|Overall Study|To receive hospice care|0|||
160880098|NCT00357760|580955299|FG001|Overall Study|To receive hospice care|1|||
160880099|NCT02353143|580955300|FG000|Overall Study|Withdrawal by Subject|1|||
160880100|NCT02353143|580955301|FG001|Overall Study|Withdrawal by Subject|0|||
160880101|NCT02353143|580955302|FG002|Overall Study|Withdrawal by Subject|0|||
160880102|NCT02353143|580955303|FG003|Overall Study|Withdrawal by Subject|0|||
160880103|NCT02353143|580955304|FG004|Overall Study|Withdrawal by Subject|1|||
160880104|NCT02353143|580955305|FG005|Overall Study|Withdrawal by Subject|0|||
160880105|NCT02353143|580955306|FG006|Overall Study|Withdrawal by Subject|0|||
160880106|NCT02353143|580955307|FG007|Overall Study|Withdrawal by Subject|1|||
160880107|NCT02353143|580955308|FG008|Overall Study|Withdrawal by Subject|1|||
160880108|NCT02353143|580955300|FG000|Overall Study|Lack of Efficacy|2|||
160880109|NCT02353143|580955301|FG001|Overall Study|Lack of Efficacy|1|||
160880110|NCT02353143|580955302|FG002|Overall Study|Lack of Efficacy|2|||
160880111|NCT02353143|580955303|FG003|Overall Study|Lack of Efficacy|4|||
160880112|NCT02353143|580955304|FG004|Overall Study|Lack of Efficacy|13|||
160880113|NCT02353143|580955305|FG005|Overall Study|Lack of Efficacy|2|||
160880114|NCT02353143|580955306|FG006|Overall Study|Lack of Efficacy|2|||
160880115|NCT02353143|580955307|FG007|Overall Study|Lack of Efficacy|2|||
160880116|NCT02353143|580955308|FG008|Overall Study|Lack of Efficacy|1|||
160880117|NCT02353143|580955300|FG000|Overall Study|reason not specified|1|||
160880118|NCT02353143|580955301|FG001|Overall Study|reason not specified|2|||
160880119|NCT02353143|580955302|FG002|Overall Study|reason not specified|0|||
160880120|NCT02353143|580955303|FG003|Overall Study|reason not specified|0|||
160880121|NCT02353143|580955304|FG004|Overall Study|reason not specified|6|||
160880122|NCT02353143|580955305|FG005|Overall Study|reason not specified|1|||
160880123|NCT02353143|580955306|FG006|Overall Study|reason not specified|0|||
160880124|NCT02353143|580955307|FG007|Overall Study|reason not specified|3|||
160880125|NCT02353143|580955308|FG008|Overall Study|reason not specified|1|||
160880126|NCT02353143|580955300|FG000|Overall Study|Physician Decision|0|||
160880127|NCT02353143|580955301|FG001|Overall Study|Physician Decision|4|||
160880128|NCT02353143|580955302|FG002|Overall Study|Physician Decision|2|||
160880129|NCT02353143|580955303|FG003|Overall Study|Physician Decision|3|||
160880130|NCT02353143|580955304|FG004|Overall Study|Physician Decision|4|||
160880131|NCT02353143|580955305|FG005|Overall Study|Physician Decision|0|||
160880132|NCT02353143|580955306|FG006|Overall Study|Physician Decision|1|||
161121280|NCT00706030|581831384|FG003|Overall Study|Withdrawal by Subject|0|||
161121281|NCT00706030|581831381|FG000|Overall Study|Physician Decision|0|||
161121282|NCT00706030|581831382|FG001|Overall Study|Physician Decision|0|||
161121283|NCT00706030|581831383|FG002|Overall Study|Physician Decision|2|||
161121284|NCT00706030|581831384|FG003|Overall Study|Physician Decision|0|||
161121285|NCT00706030|581831381|FG000|Overall Study|Not recorded|0|||
161121286|NCT00706030|581831382|FG001|Overall Study|Not recorded|0|||
161121287|NCT00706030|581831383|FG002|Overall Study|Not recorded|2|||
161121288|NCT00706030|581831384|FG003|Overall Study|Not recorded|0|||
161121289|NCT00706030|581831381|FG000|Overall Study|Protocol Violation|0|||
161121290|NCT00706030|581831382|FG001|Overall Study|Protocol Violation|0|||
161121291|NCT00706030|581831383|FG002|Overall Study|Protocol Violation|1|||
161121292|NCT00706030|581831384|FG003|Overall Study|Protocol Violation|1|||
161121293|NCT00706030|581831381|FG000|Overall Study|Failed to return|0|||
161121294|NCT00706030|581831382|FG001|Overall Study|Failed to return|0|||
161121295|NCT00706030|581831383|FG002|Overall Study|Failed to return|1|||
161121296|NCT00706030|581831384|FG003|Overall Study|Failed to return|0|||
161121297|NCT00706030|581831381|FG000|Overall Study|Symptomatic Deterioration|0|||
161121298|NCT00706030|581831382|FG001|Overall Study|Symptomatic Deterioration|0|||
161121299|NCT00706030|581831383|FG002|Overall Study|Symptomatic Deterioration|1|||
161121300|NCT00706030|581831384|FG003|Overall Study|Symptomatic Deterioration|0|||
160880133|NCT02353143|580955307|FG007|Overall Study|Physician Decision|2|||
160880134|NCT02353143|580955308|FG008|Overall Study|Physician Decision|0|||
160880135|NCT02353143|580955300|FG000|Overall Study|Adverse Event|0|||
160880136|NCT02353143|580955301|FG001|Overall Study|Adverse Event|0|||
161121301|NCT00706030|581831381|FG000|Overall Study|No treatment received|0|||
160880137|NCT02353143|580955302|FG002|Overall Study|Adverse Event|1|||
160880138|NCT02353143|580955303|FG003|Overall Study|Adverse Event|0|||
160880139|NCT02353143|580955304|FG004|Overall Study|Adverse Event|1|||
160880140|NCT02353143|580955305|FG005|Overall Study|Adverse Event|1|||
160880141|NCT02353143|580955306|FG006|Overall Study|Adverse Event|0|||
160880142|NCT02353143|580955307|FG007|Overall Study|Adverse Event|0|||
160880143|NCT02353143|580955308|FG008|Overall Study|Adverse Event|0|||
160880144|NCT02353143|580955300|FG000|Overall Study|patient receiving other treatment for AML|0|||
160880145|NCT02353143|580955301|FG001|Overall Study|patient receiving other treatment for AML|0|||
160880146|NCT02353143|580955302|FG002|Overall Study|patient receiving other treatment for AML|1|||
160880147|NCT02353143|580955303|FG003|Overall Study|patient receiving other treatment for AML|0|||
160880148|NCT02353143|580955304|FG004|Overall Study|patient receiving other treatment for AML|0|||
160880149|NCT02353143|580955305|FG005|Overall Study|patient receiving other treatment for AML|0|||
160880150|NCT02353143|580955306|FG006|Overall Study|patient receiving other treatment for AML|0|||
160880151|NCT02353143|580955307|FG007|Overall Study|patient receiving other treatment for AML|0|||
160880152|NCT02353143|580955308|FG008|Overall Study|patient receiving other treatment for AML|0|||
160880153|NCT02353143|580955300|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
160880154|NCT02353143|580955301|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
160880155|NCT02353143|580955302|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
160880156|NCT02353143|580955303|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
160880157|NCT02353143|580955304|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
160880158|NCT02353143|580955305|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
160880159|NCT02353143|580955306|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
160880160|NCT02353143|580955307|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
160880161|NCT02353143|580955308|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
160880162|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
160880163|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
160880164|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
160880165|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
160880166|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
160880167|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
160880168|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
160880169|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
160880170|NCT04740905|580955309|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
160880171|NCT04740905|580955310|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
160880172|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
160880173|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
160880174|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
160880175|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
160880176|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
160880177|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
160880178|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
160880179|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
160880180|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
160880181|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
160880182|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
160880183|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
160880184|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
160880185|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
160880186|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
160880187|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
160880188|NCT04740905|580955309|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
160880189|NCT04740905|580955310|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
160880190|NCT01534182|580955314|FG000|Overall Study|Administrative problems|1|||
160880191|NCT01534182|580955315|FG001|Overall Study|Administrative problems|0|||
160880192|NCT01534182|580955314|FG000|Overall Study|Withdrawal by Subject|4|||
160880193|NCT01534182|580955315|FG001|Overall Study|Withdrawal by Subject|7|||
160880194|NCT01534182|580955314|FG000|Overall Study|Adverse Event|7|||
160880195|NCT01534182|580955315|FG001|Overall Study|Adverse Event|3|||
160880196|NCT03077087|580955316|FG000|Overall Study|Physician Decision|2|||
160880197|NCT01989468|580955317|FG000|Overall Study|Adverse Event|10|||
160880198|NCT01989468|580955318|FG001|Overall Study|Adverse Event|15|||
160880199|NCT01989468|580955319|FG002|Overall Study|Adverse Event|4|||
160880200|NCT01989468|580955320|FG003|Overall Study|Adverse Event|5|||
160880201|NCT01989468|580955321|FG004|Overall Study|Adverse Event|4|||
160880202|NCT01989468|580955317|FG000|Overall Study|Lack of Efficacy|11|||
160880203|NCT01989468|580955318|FG001|Overall Study|Lack of Efficacy|11|||
160880204|NCT01989468|580955319|FG002|Overall Study|Lack of Efficacy|7|||
160880205|NCT01989468|580955320|FG003|Overall Study|Lack of Efficacy|4|||
160880206|NCT01989468|580955321|FG004|Overall Study|Lack of Efficacy|2|||
160880207|NCT01989468|580955317|FG000|Overall Study|Lost to Follow-up|5|||
160880208|NCT01989468|580955318|FG001|Overall Study|Lost to Follow-up|2|||
160880209|NCT01989468|580955319|FG002|Overall Study|Lost to Follow-up|0|||
160880210|NCT01989468|580955320|FG003|Overall Study|Lost to Follow-up|1|||
160880211|NCT01989468|580955321|FG004|Overall Study|Lost to Follow-up|1|||
160880212|NCT01989468|580955317|FG000|Overall Study|Physician Decision|4|||
160880213|NCT01989468|580955318|FG001|Overall Study|Physician Decision|1|||
160880214|NCT01989468|580955319|FG002|Overall Study|Physician Decision|0|||
160880215|NCT01989468|580955320|FG003|Overall Study|Physician Decision|1|||
160880216|NCT01989468|580955321|FG004|Overall Study|Physician Decision|0|||
160880217|NCT01989468|580955317|FG000|Overall Study|Pregnancy|0|||
160880218|NCT01989468|580955318|FG001|Overall Study|Pregnancy|1|||
160880219|NCT01989468|580955319|FG002|Overall Study|Pregnancy|0|||
160880220|NCT01989468|580955320|FG003|Overall Study|Pregnancy|0|||
160880221|NCT01989468|580955321|FG004|Overall Study|Pregnancy|0|||
160880222|NCT01989468|580955317|FG000|Overall Study|Technical Problems|3|||
160880223|NCT01989468|580955318|FG001|Overall Study|Technical Problems|1|||
160880224|NCT01989468|580955319|FG002|Overall Study|Technical Problems|3|||
160880225|NCT01989468|580955320|FG003|Overall Study|Technical Problems|1|||
160880226|NCT01989468|580955321|FG004|Overall Study|Technical Problems|0|||
160880227|NCT01989468|580955317|FG000|Overall Study|Subject Guardian Decision|11|||
160880228|NCT01989468|580955318|FG001|Overall Study|Subject Guardian Decision|6|||
160880229|NCT01989468|580955319|FG002|Overall Study|Subject Guardian Decision|4|||
160880230|NCT01989468|580955320|FG003|Overall Study|Subject Guardian Decision|4|||
160880231|NCT01989468|580955321|FG004|Overall Study|Subject Guardian Decision|1|||
160880232|NCT01989468|580955317|FG000|Overall Study|Death|3|||
160880233|NCT01989468|580955318|FG001|Overall Study|Death|0|||
160880234|NCT01989468|580955319|FG002|Overall Study|Death|1|||
161226126|NCT00863746|582209902|FG000|Survival Follow up|Death|244|||
161226127|NCT00863746|582209903|FG001|Survival Follow up|Death|271|||
161226128|NCT00863746|582209902|FG000|Survival Follow up|Lost to Follow-up|2|||
161226129|NCT00863746|582209903|FG001|Survival Follow up|Lost to Follow-up|1|||
161226130|NCT00863746|582209902|FG000|Survival Follow up|Consent Withdrawn|7|||
161226131|NCT00863746|582209903|FG001|Survival Follow up|Consent Withdrawn|8|||
161226132|NCT03292653|582209904|FG000|Overall Study|Adverse Event|0|||
161226133|NCT03292653|582209905|FG001|Overall Study|Adverse Event|0|||
160880235|NCT01989468|580955320|FG003|Overall Study|Death|0|||
160880236|NCT01989468|580955321|FG004|Overall Study|Death|0|||
160880237|NCT01224782|580955324|FG000|Overall Study|Lost to Follow-up|177|||
160880238|NCT01224782|580955324|FG000|Overall Study|Withdrawal by Subject|16|||
160880239|NCT01224782|580955324|FG000|Overall Study|Death|14|||
160880240|NCT01224782|580955324|FG000|Overall Study|Improvement|13|||
160880241|NCT01224782|580955324|FG000|Overall Study|Adverse Event|12|||
160880242|NCT01224782|580955324|FG000|Overall Study|Adverse Reaction|11|||
160880243|NCT01224782|580955324|FG000|Overall Study|Noncompliance|10|||
160880244|NCT01224782|580955324|FG000|Overall Study|Other|4|||
160880245|NCT01224782|580955324|FG000|Overall Study|Start of Dialysis|3|||
160880246|NCT01224782|580955324|FG000|Overall Study|Change of Treatment|1|||
160880247|NCT01224782|580955324|FG000|Overall Study|Financial Reasons|1|||
160880248|NCT01224782|580955324|FG000|Overall Study|Deterioration|1|||
160880249|NCT01224782|580955324|FG000|Overall Study|Transplantation|1|||
160880250|NCT01960907|580955325|FG000|Overall Study|Death|4|||
160880251|NCT01960907|580955326|FG001|Overall Study|Death|3|||
160880252|NCT01960907|580955325|FG000|Overall Study|Withdrawal by Subject|32|||
160880253|NCT01960907|580955326|FG001|Overall Study|Withdrawal by Subject|42|||
161226134|NCT03292653|582209906|FG002|Overall Study|Adverse Event|1|||
161226135|NCT03292653|582209904|FG000|Overall Study|Did not Receive Treatment|1|||
161226136|NCT03292653|582209905|FG001|Overall Study|Did not Receive Treatment|0|||
161226137|NCT03292653|582209906|FG002|Overall Study|Did not Receive Treatment|0|||
161226138|NCT04373434|582209911|FG000|Overall Study|Lost to Follow-up|37|||
161226139|NCT04373434|582209912|FG001|Overall Study|Lost to Follow-up|32|||
161226140|NCT04373434|582209911|FG000|Overall Study|Refused at 9 months|1|||
161226141|NCT04373434|582209912|FG001|Overall Study|Refused at 9 months|2|||
161226142|NCT04373434|582209911|FG000|Overall Study|Refused at 4 months|7|||
161226143|NCT04373434|582209912|FG001|Overall Study|Refused at 4 months|3|||
160880254|NCT00977080|580955329|FG000|Overall Study|Adverse Event|2|||
160880255|NCT00977080|580955330|FG001|Overall Study|Adverse Event|7|||
160880256|NCT00977080|580955331|FG002|Overall Study|Adverse Event|7|||
160880257|NCT00977080|580955332|FG003|Overall Study|Adverse Event|7|||
160880258|NCT00977080|580955329|FG000|Overall Study|Withdrawal by Subject|1|||
160880259|NCT00977080|580955330|FG001|Overall Study|Withdrawal by Subject|5|||
160880260|NCT00977080|580955331|FG002|Overall Study|Withdrawal by Subject|1|||
160880261|NCT00977080|580955332|FG003|Overall Study|Withdrawal by Subject|5|||
161226144|NCT04373434|582209911|FG000|Overall Study|Excluded|2|||
161226145|NCT04373434|582209912|FG001|Overall Study|Excluded|0|||
160880262|NCT00977080|580955329|FG000|Overall Study|Protocol Violation|7|||
160880263|NCT00977080|580955330|FG001|Overall Study|Protocol Violation|3|||
160880264|NCT00977080|580955331|FG002|Overall Study|Protocol Violation|4|||
160880265|NCT00977080|580955332|FG003|Overall Study|Protocol Violation|3|||
160880266|NCT00977080|580955329|FG000|Overall Study|Noncompliance|0|||
160880267|NCT00977080|580955330|FG001|Overall Study|Noncompliance|2|||
160880268|NCT00977080|580955331|FG002|Overall Study|Noncompliance|1|||
161226146|NCT00527423|582209913|FG000|Overall Study|Protocol Violation|1|||
161226147|NCT00527423|582209913|FG000|Overall Study|Adverse Event|5|||
161226148|NCT00527423|582209913|FG000|Overall Study|Physician Decision|4|||
161226149|NCT00527423|582209913|FG000|Overall Study|Withdrawal by Subject|10|||
161226150|NCT00527423|582209913|FG000|Overall Study|Lost to Follow-up|4|||
161226151|NCT00527423|582209913|FG000|Overall Study|OTHER|4|||
161226152|NCT00527423|582209913|FG000|Overall Study|Death|9|||
161226153|NCT02446132|582209916|FG000|Overall Study|Adverse Event|10|||
161226154|NCT02446132|582209917|FG001|Overall Study|Adverse Event|27|||
161226155|NCT02446132|582209918|FG002|Overall Study|Adverse Event|27|||
161226156|NCT02446132|582209916|FG000|Overall Study|Death|2|||
161226157|NCT02446132|582209917|FG001|Overall Study|Death|13|||
161226158|NCT02446132|582209918|FG002|Overall Study|Death|10|||
161226159|NCT02446132|582209916|FG000|Overall Study|Lack of Efficacy|1|||
161226160|NCT02446132|582209917|FG001|Overall Study|Lack of Efficacy|10|||
161226161|NCT02446132|582209918|FG002|Overall Study|Lack of Efficacy|6|||
161226162|NCT02446132|582209916|FG000|Overall Study|Lost to Follow-up|2|||
161226163|NCT02446132|582209917|FG001|Overall Study|Lost to Follow-up|4|||
161226164|NCT02446132|582209918|FG002|Overall Study|Lost to Follow-up|5|||
161226165|NCT02446132|582209916|FG000|Overall Study|Non-compliance With Study Drug|2|||
161226166|NCT02446132|582209917|FG001|Overall Study|Non-compliance With Study Drug|2|||
161226167|NCT02446132|582209918|FG002|Overall Study|Non-compliance With Study Drug|3|||
161226168|NCT02446132|582209916|FG000|Overall Study|Physician Decision|1|||
161226169|NCT02446132|582209917|FG001|Overall Study|Physician Decision|8|||
161226170|NCT02446132|582209918|FG002|Overall Study|Physician Decision|13|||
161226171|NCT02446132|582209916|FG000|Overall Study|Protocol Deviation|0|||
161226172|NCT02446132|582209917|FG001|Overall Study|Protocol Deviation|0|||
161226173|NCT02446132|582209918|FG002|Overall Study|Protocol Deviation|1|||
161226174|NCT02446132|582209916|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
161226175|NCT02446132|582209917|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
161226176|NCT02446132|582209918|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
161226177|NCT02446132|582209916|FG000|Overall Study|Study Terminated by Sponsor|4|||
161226178|NCT02446132|582209917|FG001|Overall Study|Study Terminated by Sponsor|35|||
161226179|NCT02446132|582209918|FG002|Overall Study|Study Terminated by Sponsor|58|||
161226180|NCT02446132|582209916|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
161226181|NCT02446132|582209917|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
161226182|NCT02446132|582209918|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
161226183|NCT02446132|582209916|FG000|Overall Study|Withdrawal by Subject|11|||
161226184|NCT02446132|582209917|FG001|Overall Study|Withdrawal by Subject|29|||
161226185|NCT02446132|582209918|FG002|Overall Study|Withdrawal by Subject|25|||
161226186|NCT02446132|582209916|FG000|Overall Study|Reason not Specified|4|||
161226187|NCT02446132|582209917|FG001|Overall Study|Reason not Specified|16|||
161226188|NCT02446132|582209918|FG002|Overall Study|Reason not Specified|10|||
161226189|NCT02446132|582209916|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
161226190|NCT02446132|582209917|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
161226191|NCT02446132|582209918|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
161226192|NCT00436007|582209922|FG000|Overall Study|Withdrawal by Subject|5|||
161226193|NCT00436007|582209923|FG001|Overall Study|Withdrawal by Subject|3|||
161226194|NCT00436007|582209924|FG002|Overall Study|Withdrawal by Subject|4|||
161226195|NCT00436007|582209922|FG000|Overall Study|Lost to Follow-up|14|||
161226196|NCT00436007|582209923|FG001|Overall Study|Lost to Follow-up|10|||
161226197|NCT00436007|582209924|FG002|Overall Study|Lost to Follow-up|13|||
161226198|NCT00436007|582209922|FG000|Overall Study|Physician Decision|0|||
161226199|NCT00436007|582209923|FG001|Overall Study|Physician Decision|0|||
161226200|NCT00436007|582209924|FG002|Overall Study|Physician Decision|2|||
161226201|NCT00436007|582209922|FG000|Overall Study|Death|0|||
161226202|NCT00436007|582209923|FG001|Overall Study|Death|1|||
161226203|NCT00436007|582209924|FG002|Overall Study|Death|3|||
161226204|NCT00436007|582209922|FG000|Overall Study|Other|0|||
161226205|NCT00436007|582209923|FG001|Overall Study|Other|0|||
161226206|NCT00436007|582209924|FG002|Overall Study|Other|1|||
161226207|NCT01439165|582209926|FG000|Overall Study|Protocol Violation|3|||
161226208|NCT01439165|582209927|FG001|Overall Study|Protocol Violation|0|||
161226209|NCT01439165|582209926|FG000|Overall Study|Lost to Follow-up|11|||
161226210|NCT01439165|582209927|FG001|Overall Study|Lost to Follow-up|1|||
161226211|NCT01439165|582209926|FG000|Overall Study|Withdrawal by Subject|7|||
161226212|NCT01439165|582209927|FG001|Overall Study|Withdrawal by Subject|1|||
161226213|NCT03331042|582209928|FG000|Overall Study|Protocol Violation|1|||
161226214|NCT03331042|582209929|FG001|Overall Study|Protocol Violation|0|||
161226215|NCT03331042|582209930|FG002|Overall Study|Protocol Violation|0|||
161226216|NCT03331042|582209931|FG003|Overall Study|Protocol Violation|0|||
161226217|NCT03331042|582209928|FG000|Overall Study|Physician Decision|0|||
161226218|NCT03331042|582209929|FG001|Overall Study|Physician Decision|0|||
161226219|NCT03331042|582209930|FG002|Overall Study|Physician Decision|1|||
161226220|NCT03331042|582209931|FG003|Overall Study|Physician Decision|0|||
161226221|NCT03331042|582209928|FG000|Overall Study|Lost to Follow-up|0|||
161226222|NCT03331042|582209929|FG001|Overall Study|Lost to Follow-up|0|||
161226223|NCT03331042|582209930|FG002|Overall Study|Lost to Follow-up|0|||
160880269|NCT00977080|580955332|FG003|Overall Study|Noncompliance|0|||
160880270|NCT00977080|580955329|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
160880271|NCT00977080|580955330|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
160880272|NCT00977080|580955331|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
160880273|NCT00977080|580955332|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
160880274|NCT00977080|580955329|FG000|Overall Study|Required kidney transplantation|1|||
160880275|NCT00977080|580955330|FG001|Overall Study|Required kidney transplantation|3|||
160880276|NCT00977080|580955331|FG002|Overall Study|Required kidney transplantation|3|||
160880277|NCT00977080|580955332|FG003|Overall Study|Required kidney transplantation|1|||
160880278|NCT00977080|580955329|FG000|Overall Study|Travel for family reasons|1|||
160880279|NCT00977080|580955330|FG001|Overall Study|Travel for family reasons|0|||
160880280|NCT00977080|580955331|FG002|Overall Study|Travel for family reasons|0|||
160880281|NCT00977080|580955332|FG003|Overall Study|Travel for family reasons|0|||
160880282|NCT01765218|580955335|FG000|Overall Study|Protocol Violation|1|||
160880283|NCT01765218|580955336|FG001|Overall Study|Protocol Violation|2|||
160880284|NCT00313781|580955337|FG000|Before Crossover|Death|22|||
160880285|NCT00313781|580955338|FG001|Before Crossover|Death|8|||
160880286|NCT00313781|580955339|FG002|Before Crossover|Death|0|||
160880287|NCT00313781|580955337|FG000|Before Crossover|Lost to Follow-up|0|||
160880288|NCT00313781|580955338|FG001|Before Crossover|Lost to Follow-up|3|||
160880289|NCT00313781|580955339|FG002|Before Crossover|Lost to Follow-up|0|||
160880290|NCT00313781|580955337|FG000|Before Crossover|Withdrawal by Subject|3|||
160880291|NCT00313781|580955338|FG001|Before Crossover|Withdrawal by Subject|1|||
160880292|NCT00313781|580955339|FG002|Before Crossover|Withdrawal by Subject|0|||
160880293|NCT00313781|580955337|FG000|Before Crossover|Other|45|||
160880294|NCT00313781|580955338|FG001|Before Crossover|Other|30|||
160880295|NCT00313781|580955339|FG002|Before Crossover|Other|0|||
160880296|NCT00313781|580955337|FG000|Before Crossover|Crossover|0|||
160880297|NCT00313781|580955338|FG001|Before Crossover|Crossover|37|||
160880298|NCT00313781|580955339|FG002|Before Crossover|Crossover|0|||
160880299|NCT00313781|580955337|FG000|Before Crossover|Randomized, not treated|5|||
160880300|NCT00313781|580955338|FG001|Before Crossover|Randomized, not treated|0|||
160880301|NCT00313781|580955339|FG002|Before Crossover|Randomized, not treated|0|||
160880302|NCT00313781|580955337|FG000|After Crossover|Death|0|||
160880303|NCT00313781|580955338|FG001|After Crossover|Death|0|||
160880304|NCT00313781|580955339|FG002|After Crossover|Death|6|||
160880305|NCT00313781|580955337|FG000|After Crossover|Withdrawal by Subject|0|||
160880306|NCT00313781|580955338|FG001|After Crossover|Withdrawal by Subject|0|||
160880307|NCT00313781|580955339|FG002|After Crossover|Withdrawal by Subject|3|||
160880308|NCT00313781|580955337|FG000|After Crossover|Other|0|||
160880309|NCT00313781|580955338|FG001|After Crossover|Other|0|||
160880310|NCT00313781|580955339|FG002|After Crossover|Other|18|||
160880311|NCT01590758|580955340|FG000|Overall Study|Withdrawal by Subject|0|||
160880312|NCT01590758|580955341|FG001|Overall Study|Withdrawal by Subject|3|||
160880313|NCT01590758|580955340|FG000|Overall Study|Physician Decision|1|||
160880314|NCT01590758|580955341|FG001|Overall Study|Physician Decision|2|||
160880315|NCT01590758|580955340|FG000|Overall Study|Lost to Follow-up|4|||
160880316|NCT01590758|580955341|FG001|Overall Study|Lost to Follow-up|2|||
160880317|NCT02929498|580955342|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
160880318|NCT02929498|580955343|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
160880319|NCT02929498|580955344|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
160880320|NCT02929498|580955342|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
161121302|NCT00706030|581831382|FG001|Overall Study|No treatment received|0|||
161121303|NCT00706030|581831383|FG002|Overall Study|No treatment received|0|||
161121304|NCT00706030|581831384|FG003|Overall Study|No treatment received|1|||
161121305|NCT00706030|581831381|FG000|Overall Study|Death|0|||
161121306|NCT00706030|581831382|FG001|Overall Study|Death|0|||
161121307|NCT00706030|581831383|FG002|Overall Study|Death|1|||
161121308|NCT00706030|581831384|FG003|Overall Study|Death|0|||
161226224|NCT03331042|582209931|FG003|Overall Study|Lost to Follow-up|1|||
161121309|NCT05779072|581831385|FG000|Overall Study|Lost to Follow-up|0|||
161121310|NCT05779072|581831386|FG001|Overall Study|Lost to Follow-up|1|||
161226225|NCT00712010|582209932|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
161121311|NCT05779072|581831385|FG000|Overall Study|Withdrawal by Subject|1|||
161226226|NCT00995553|582209933|FG000|Overall Study|Withdrawal by Subject|2|||
161226227|NCT00995553|582209934|FG001|Overall Study|Withdrawal by Subject|6|||
160880321|NCT02929498|580955343|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
160880322|NCT02929498|580955344|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
160880323|NCT01011309|580955349|FG000|Overall Study|Adverse Event|2|||
160880324|NCT01011309|580955350|FG001|Overall Study|Adverse Event|1|||
160880325|NCT01011309|580955351|FG002|Overall Study|Adverse Event|2|||
160880326|NCT01011309|580955349|FG000|Overall Study|Lack of Efficacy|0|||
160880327|NCT01011309|580955350|FG001|Overall Study|Lack of Efficacy|1|||
160880328|NCT01011309|580955351|FG002|Overall Study|Lack of Efficacy|0|||
160880329|NCT01011309|580955349|FG000|Overall Study|Protocol Violation|0|||
160880330|NCT01011309|580955350|FG001|Overall Study|Protocol Violation|1|||
160880331|NCT01011309|580955351|FG002|Overall Study|Protocol Violation|3|||
160880332|NCT00530504|580955354|FG000|Overall Study|Death|54|||
161226228|NCT00927810|582209935|FG000|Overall Study|Withdrawal by Subject|0|||
161226229|NCT00927810|582209936|FG001|Overall Study|Withdrawal by Subject|3|||
161226230|NCT00927810|582209937|FG002|Overall Study|Withdrawal by Subject|0|||
161226231|NCT00927810|582209938|FG003|Overall Study|Withdrawal by Subject|1|||
161226232|NCT00927810|582209935|FG000|Overall Study|Lost to Follow-up|0|||
161226233|NCT00927810|582209936|FG001|Overall Study|Lost to Follow-up|2|||
161226234|NCT00927810|582209937|FG002|Overall Study|Lost to Follow-up|1|||
161226235|NCT00927810|582209938|FG003|Overall Study|Lost to Follow-up|1|||
161226236|NCT00927810|582209935|FG000|Overall Study|Death|0|||
161226237|NCT00927810|582209936|FG001|Overall Study|Death|2|||
161226238|NCT00927810|582209937|FG002|Overall Study|Death|0|||
161226239|NCT00927810|582209938|FG003|Overall Study|Death|0|||
161226240|NCT00927810|582209935|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161226241|NCT00927810|582209936|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161226242|NCT00927810|582209937|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161226243|NCT00927810|582209938|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161226244|NCT01457053|582209941|FG000|Overall Study|Unable to undergo selected treatment|1|||
161226245|NCT01457053|582209942|FG001|Overall Study|Unable to undergo selected treatment|1|||
161226246|NCT00788957|582209946|FG000|Part 1|Death|8|||
161226247|NCT00788957|582209947|FG001|Part 1|Death|0|||
161226248|NCT00788957|582209948|FG002|Part 1|Death|0|||
161226249|NCT00788957|582209949|FG003|Part 1|Death|0|||
161226250|NCT00788957|582209950|FG004|Part 1|Death|0|||
161226251|NCT00788957|582209951|FG005|Part 1|Death|0|||
161226252|NCT00788957|582209946|FG000|Part 1|Lost to Follow-up|1|||
161226253|NCT00788957|582209947|FG001|Part 1|Lost to Follow-up|0|||
161226254|NCT00788957|582209948|FG002|Part 1|Lost to Follow-up|0|||
161226255|NCT00788957|582209949|FG003|Part 1|Lost to Follow-up|0|||
161226256|NCT00788957|582209950|FG004|Part 1|Lost to Follow-up|0|||
161226257|NCT00788957|582209951|FG005|Part 1|Lost to Follow-up|0|||
161226258|NCT00788957|582209946|FG000|Part 2|Withdrawal by Subject|0|||
161226259|NCT00788957|582209947|FG001|Part 2|Withdrawal by Subject|9|||
161226260|NCT00788957|582209948|FG002|Part 2|Withdrawal by Subject|5|||
161226261|NCT00788957|582209949|FG003|Part 2|Withdrawal by Subject|3|||
161226262|NCT00788957|582209950|FG004|Part 2|Withdrawal by Subject|0|||
161226263|NCT00788957|582209951|FG005|Part 2|Withdrawal by Subject|0|||
161226264|NCT00788957|582209946|FG000|Part 2|Death|0|||
160880333|NCT00530504|580955354|FG000|Overall Study|Lost to Follow-up|26|||
160880334|NCT00530504|580955354|FG000|Overall Study|Withdrawal by Subject|39|||
160880335|NCT00530504|580955354|FG000|Overall Study|Exited study due to other reasons|33|||
161226265|NCT00788957|582209947|FG001|Part 2|Death|32|||
161226266|NCT00788957|582209948|FG002|Part 2|Death|35|||
161226267|NCT00788957|582209949|FG003|Part 2|Death|37|||
161226268|NCT00788957|582209950|FG004|Part 2|Death|0|||
161226269|NCT00788957|582209951|FG005|Part 2|Death|0|||
161226270|NCT00788957|582209946|FG000|Part 2|Lost to Follow-up|0|||
161226271|NCT00788957|582209947|FG001|Part 2|Lost to Follow-up|0|||
161226272|NCT00788957|582209948|FG002|Part 2|Lost to Follow-up|3|||
161226273|NCT00788957|582209949|FG003|Part 2|Lost to Follow-up|0|||
161226274|NCT00788957|582209950|FG004|Part 2|Lost to Follow-up|0|||
161226275|NCT00788957|582209951|FG005|Part 2|Lost to Follow-up|0|||
161226276|NCT00788957|582209946|FG000|Part 2|On-study at time of data cut-off|0|||
161226277|NCT00788957|582209947|FG001|Part 2|On-study at time of data cut-off|1|||
161226278|NCT00788957|582209948|FG002|Part 2|On-study at time of data cut-off|1|||
161226279|NCT00788957|582209949|FG003|Part 2|On-study at time of data cut-off|1|||
161226280|NCT00788957|582209950|FG004|Part 2|On-study at time of data cut-off|0|||
161226281|NCT00788957|582209951|FG005|Part 2|On-study at time of data cut-off|0|||
161226282|NCT00788957|582209946|FG000|Part 3|Withdrawal by Subject|0|||
161226283|NCT00788957|582209947|FG001|Part 3|Withdrawal by Subject|0|||
161226284|NCT00788957|582209948|FG002|Part 3|Withdrawal by Subject|0|||
161226285|NCT00788957|582209949|FG003|Part 3|Withdrawal by Subject|0|||
161226286|NCT00788957|582209950|FG004|Part 3|Withdrawal by Subject|0|||
161226287|NCT00788957|582209951|FG005|Part 3|Withdrawal by Subject|2|||
161226288|NCT00788957|582209946|FG000|Part 3|Death|0|||
160880336|NCT00006289|580955355|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
160880337|NCT00006289|580955356|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
161226289|NCT00788957|582209947|FG001|Part 3|Death|0|||
161226290|NCT00788957|582209948|FG002|Part 3|Death|0|||
161226291|NCT00788957|582209949|FG003|Part 3|Death|0|||
161226292|NCT00788957|582209950|FG004|Part 3|Death|8|||
161226293|NCT00788957|582209951|FG005|Part 3|Death|8|||
161226294|NCT00788957|582209946|FG000|Part 3|On-study at time of data cut-off|0|||
161226295|NCT00788957|582209947|FG001|Part 3|On-study at time of data cut-off|0|||
161226296|NCT00788957|582209948|FG002|Part 3|On-study at time of data cut-off|0|||
161226297|NCT00788957|582209949|FG003|Part 3|On-study at time of data cut-off|0|||
161226298|NCT00788957|582209950|FG004|Part 3|On-study at time of data cut-off|1|||
161226299|NCT00788957|582209951|FG005|Part 3|On-study at time of data cut-off|0|||
160880338|NCT00006289|580955355|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
161226300|NCT00662129|582209952|FG000|Overall Study|Protocol Violation|1|||
161226301|NCT00662129|582209952|FG000|Overall Study|Cancel prior to beginning treatment|1|||
161226302|NCT00662129|582209952|FG000|Overall Study|Ineligible|1|||
161226303|NCT00796510|582209965|FG000|Overall Study|Death|1|||
160880339|NCT00006289|580955356|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
160880340|NCT00576420|580956946|FG000|Overall Study|Death|0|||
160880341|NCT00576420|580956947|FG001|Overall Study|Death|0|||
160880342|NCT00576420|580956948|FG002|Overall Study|Death|1|||
160880343|NCT02616146|580956949|FG000|Overall Study|Adverse Event|64|||
160880344|NCT02616146|580956950|FG001|Overall Study|Adverse Event|24|||
160880345|NCT02616146|580956949|FG000|Overall Study|Lost to Follow-up|23|||
160880346|NCT02616146|580956950|FG001|Overall Study|Lost to Follow-up|13|||
160880347|NCT02616146|580956949|FG000|Overall Study|Non-compliance with study protocol|2|||
160880348|NCT02616146|580956950|FG001|Overall Study|Non-compliance with study protocol|0|||
160880349|NCT02616146|580956949|FG000|Overall Study|Non-compliance with study drug|4|||
160880350|NCT02616146|580956950|FG001|Overall Study|Non-compliance with study drug|2|||
160880351|NCT02616146|580956949|FG000|Overall Study|Pregnancy|2|||
160880352|NCT02616146|580956950|FG001|Overall Study|Pregnancy|2|||
160880353|NCT02616146|580956949|FG000|Overall Study|Pregnancy wish|3|||
160880354|NCT02616146|580956950|FG001|Overall Study|Pregnancy wish|0|||
160880355|NCT02616146|580956949|FG000|Overall Study|Protocol Violation|6|||
160880356|NCT02616146|580956950|FG001|Overall Study|Protocol Violation|3|||
160880357|NCT02616146|580956949|FG000|Overall Study|Study terminated by sponsor|1372|||
160880358|NCT02616146|580956950|FG001|Overall Study|Study terminated by sponsor|432|||
160880359|NCT02616146|580956949|FG000|Overall Study|Participant moved|4|||
160880360|NCT02616146|580956950|FG001|Overall Study|Participant moved|3|||
160880361|NCT02616146|580956949|FG000|Overall Study|Withdrawal by Subject|30|||
160880362|NCT02616146|580956950|FG001|Overall Study|Withdrawal by Subject|24|||
160880363|NCT02616146|580956949|FG000|Overall Study|Physician Decision|2|||
160880364|NCT02616146|580956950|FG001|Overall Study|Physician Decision|1|||
160880365|NCT01221272|580956951|FG000|Period 1|Adverse Event|2|||
161121312|NCT05779072|581831386|FG001|Overall Study|Withdrawal by Subject|5|||
161121313|NCT03870555|581831387|FG000|Period 3 (2 Days)|Adverse Event|1|||
161121314|NCT03870555|581831388|FG001|Period 3 (2 Days)|Adverse Event|0|||
161121315|NCT03870555|581831389|FG002|Period 3 (2 Days)|Adverse Event|0|||
161121316|NCT01445769|581831390|FG000|Overall Study|Consent Withdrawn|2|||
161121317|NCT01445769|581831390|FG000|Overall Study|Disease Progression|1|||
161121318|NCT01445769|581831390|FG000|Overall Study|Lost to Follow-up|5|||
161121319|NCT00044512|581831393|FG000|Follow Up|Lost to Follow-up|2|||
161121320|NCT05130463|581831398|FG000|Overall Study|Unspecified reasons|2|||
161121321|NCT05130463|581831398|FG000|Overall Study|off-label indication dose|435|||
161121322|NCT03652662|581831402|FG000|Overall Study|Withdrawal by Subject|2|||
161121323|NCT03652662|581831403|FG001|Overall Study|Withdrawal by Subject|1|||
161121324|NCT03652662|581831402|FG000|Overall Study|Lost to Follow-up|1|||
161121325|NCT03652662|581831403|FG001|Overall Study|Lost to Follow-up|0|||
161121326|NCT00487539|581831404|FG000|Overall Study|Adverse Event|3|||
161121327|NCT00487539|581831405|FG001|Overall Study|Adverse Event|2|||
161121328|NCT00487539|581831406|FG002|Overall Study|Adverse Event|1|||
161121329|NCT00487539|581831407|FG003|Overall Study|Adverse Event|1|||
161121330|NCT00487539|581831404|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161121331|NCT00487539|581831405|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161121332|NCT00487539|581831406|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161121333|NCT00487539|581831407|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
161121334|NCT00487539|581831404|FG000|Overall Study|Other|3|||
161121335|NCT00487539|581831405|FG001|Overall Study|Other|1|||
161121336|NCT00487539|581831406|FG002|Overall Study|Other|2|||
161121337|NCT00487539|581831407|FG003|Overall Study|Other|2|||
161121338|NCT02695628|581831408|FG000|Overall Study|Withdrawal by Subject|1|||
161121339|NCT02751502|581831409|FG000|Overall Study|Lack of funding|4|||
161121340|NCT02678390|581831410|FG000|AE (1 Day)|Withdrawal by Subject|0|||
161121341|NCT02678390|581831411|FG001|AE (1 Day)|Withdrawal by Subject|1|||
161121342|NCT03499028|581831412|FG000|Overall Study|Lost to Follow-up|12|||
161121343|NCT03499028|581831413|FG001|Overall Study|Lost to Follow-up|9|||
161121344|NCT03499028|581831412|FG000|Overall Study|Withdrawal by Subject|5|||
161121345|NCT03499028|581831413|FG001|Overall Study|Withdrawal by Subject|8|||
161121346|NCT03499028|581831412|FG000|Overall Study|Unplanned SNF discharge|5|||
161121347|NCT03499028|581831413|FG001|Overall Study|Unplanned SNF discharge|8|||
161121348|NCT01437397|581831414|FG000|Overall Study|Lost to Follow-up|9|||
161226304|NCT00796510|582209966|FG001|Overall Study|Death|0|||
160880366|NCT01221272|580956952|FG001|Period 1|Adverse Event|0|||
161121349|NCT01437397|581831415|FG001|Overall Study|Lost to Follow-up|4|||
161121350|NCT01437397|581831416|FG002|Overall Study|Lost to Follow-up|2|||
161121351|NCT01437397|581831417|FG003|Overall Study|Lost to Follow-up|4|||
161226305|NCT00796510|582209965|FG000|Overall Study|Study Terminated|2|||
161226306|NCT00796510|582209966|FG001|Overall Study|Study Terminated|0|||
160880367|NCT01221272|580956951|FG000|Period 1|Consent Withdrawal|0|||
160880368|NCT01221272|580956952|FG001|Period 1|Consent Withdrawal|1|||
160880369|NCT01221272|580956951|FG000|Period 1|Significant Dosing Noncompliance|0|||
160880370|NCT01221272|580956952|FG001|Period 1|Significant Dosing Noncompliance|1|||
160880371|NCT01221272|580956951|FG000|Period 2|Adverse Event|0|||
160880372|NCT01221272|580956952|FG001|Period 2|Adverse Event|2|||
160880373|NCT01340872|580956953|FG000|Double-blind Phase|Adverse Event|6|||
160880374|NCT01340872|580956954|FG001|Double-blind Phase|Adverse Event|4|||
160880375|NCT01340872|580956955|FG002|Double-blind Phase|Adverse Event|0|||
161226307|NCT05030753|582209967|FG000|9-week|Lost to Follow-up|10|||
161226308|NCT05030753|582209968|FG001|9-week|Lost to Follow-up|7|||
161226309|NCT05030753|582209967|FG000|9-week|Withdrawal by Subject|1|||
161226310|NCT05030753|582209968|FG001|9-week|Withdrawal by Subject|0|||
161226311|NCT05030753|582209967|FG000|9-week|Excluded from analysis due to missing covariates|2|||
161226312|NCT05030753|582209968|FG001|9-week|Excluded from analysis due to missing covariates|1|||
161226313|NCT05030753|582209967|FG000|6-month post intervention|Lost to Follow-up|5|||
161226314|NCT05030753|582209968|FG001|6-month post intervention|Lost to Follow-up|4|||
161226315|NCT05030753|582209967|FG000|6-month post intervention|Withdrawal by Subject|4|||
161226316|NCT05030753|582209968|FG001|6-month post intervention|Withdrawal by Subject|0|||
161226317|NCT05030753|582209967|FG000|18-month post intervention|Lost to Follow-up|3|||
161226318|NCT05030753|582209968|FG001|18-month post intervention|Lost to Follow-up|1|||
161226319|NCT03072459|582209973|FG000|Overall Study|Device revised/removed|1|||
161226320|NCT03072459|582209973|FG000|Overall Study|Subject not able to return|1|||
161226321|NCT00329602|582209974|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
161226322|NCT00329602|582209975|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
161226323|NCT00329602|582209976|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
161226324|NCT00329602|582209974|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
161226325|NCT00329602|582209975|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
161226326|NCT00329602|582209976|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
161226327|NCT00329602|582209974|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
161226328|NCT00329602|582209975|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
161226329|NCT00329602|582209976|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
161226330|NCT00329602|582209974|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
161226331|NCT00329602|582209975|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
161226332|NCT00329602|582209976|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
161226333|NCT00329602|582209974|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
161226334|NCT00329602|582209975|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
161226335|NCT00329602|582209976|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
161226336|NCT00329602|582209974|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
161226337|NCT00329602|582209975|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
161226338|NCT00329602|582209976|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
161226339|NCT02579096|582209977|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
161226340|NCT02579096|582209978|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
161226341|NCT02579096|582209977|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
161226342|NCT02579096|582209978|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
161226343|NCT02579096|582209977|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
161226344|NCT02579096|582209978|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
161226345|NCT02579096|582209977|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
161226346|NCT02579096|582209978|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
161226347|NCT02579096|582209977|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
161226348|NCT02579096|582209978|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
161226349|NCT02579096|582209977|FG000|Phase 2, Weeks 25 - 48|Death|2|||
161226350|NCT02579096|582209978|FG001|Phase 2, Weeks 25 - 48|Death|4|||
161226351|NCT02579096|582209977|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
161226352|NCT02579096|582209978|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
161226353|NCT02579096|582209977|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
161226354|NCT02579096|582209978|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
161226355|NCT02579096|582209977|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
161226356|NCT02579096|582209978|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
161226357|NCT02579096|582209977|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
161226358|NCT02579096|582209978|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
161226359|NCT02579096|582209977|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
161226360|NCT02579096|582209978|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
161226361|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Death|3|||
161226362|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Death|2|||
160880376|NCT01340872|580956956|FG003|Double-blind Phase|Adverse Event|0|||
160880377|NCT01340872|580956953|FG000|Double-blind Phase|Withdrawal by Subject|3|||
160880378|NCT01340872|580956954|FG001|Double-blind Phase|Withdrawal by Subject|5|||
161226363|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
161226364|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
161226365|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
161226366|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
161226367|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
161226368|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
161226369|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
161226370|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
161226371|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
161257863|NCT01197417|582323505|FG001|Overall Study|Withdrawal by Subject|4|||
160880379|NCT01340872|580956955|FG002|Double-blind Phase|Withdrawal by Subject|0|||
161121352|NCT01437397|581831418|FG004|Overall Study|Lost to Follow-up|5|||
161121353|NCT01437397|581831414|FG000|Overall Study|Withdrawal by Subject|11|||
161121354|NCT01437397|581831415|FG001|Overall Study|Withdrawal by Subject|12|||
161121355|NCT01437397|581831416|FG002|Overall Study|Withdrawal by Subject|24|||
161121356|NCT01437397|581831417|FG003|Overall Study|Withdrawal by Subject|11|||
161121357|NCT01437397|581831418|FG004|Overall Study|Withdrawal by Subject|22|||
161121358|NCT01437397|581831414|FG000|Overall Study|Protocol Violation|10|||
161121359|NCT01437397|581831415|FG001|Overall Study|Protocol Violation|12|||
161121360|NCT01437397|581831416|FG002|Overall Study|Protocol Violation|13|||
161121361|NCT01437397|581831417|FG003|Overall Study|Protocol Violation|21|||
161121362|NCT01437397|581831418|FG004|Overall Study|Protocol Violation|19|||
161121363|NCT01437397|581831414|FG000|Overall Study|Lack of Efficacy|5|||
161121364|NCT01437397|581831415|FG001|Overall Study|Lack of Efficacy|4|||
161121365|NCT01437397|581831416|FG002|Overall Study|Lack of Efficacy|8|||
161121366|NCT01437397|581831417|FG003|Overall Study|Lack of Efficacy|10|||
161121367|NCT01437397|581831418|FG004|Overall Study|Lack of Efficacy|20|||
161121368|NCT01437397|581831414|FG000|Overall Study|Adverse Event|21|||
161121369|NCT01437397|581831415|FG001|Overall Study|Adverse Event|22|||
161121370|NCT01437397|581831416|FG002|Overall Study|Adverse Event|16|||
161121371|NCT01437397|581831417|FG003|Overall Study|Adverse Event|14|||
161121372|NCT01437397|581831418|FG004|Overall Study|Adverse Event|21|||
161121373|NCT01437397|581831414|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
161121374|NCT01437397|581831415|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
161121375|NCT01437397|581831416|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
161121376|NCT01437397|581831417|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
161121377|NCT01437397|581831418|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
161121378|NCT02925156|581831420|FG000|Overall Study|Lost to Follow-up|27|||
161226372|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
161121379|NCT02925156|581831421|FG001|Overall Study|Lost to Follow-up|53|||
161121380|NCT02925156|581831422|FG002|Overall Study|Lost to Follow-up|51|||
161121381|NCT02925156|581831423|FG003|Overall Study|Lost to Follow-up|59|||
161121382|NCT02925156|581831424|FG004|Overall Study|Lost to Follow-up|89|||
161121383|NCT02925156|581831425|FG005|Overall Study|Lost to Follow-up|107|||
161121384|NCT02925156|581831426|FG006|Overall Study|Lost to Follow-up|34|||
161121385|NCT02925156|581831427|FG007|Overall Study|Lost to Follow-up|36|||
161121386|NCT02925156|581831428|FG008|Overall Study|Lost to Follow-up|73|||
161121387|NCT02925156|581831429|FG009|Overall Study|Lost to Follow-up|34|||
161121388|NCT00866307|581831430|FG000|Induction|Adverse Event|5|||
161121389|NCT00866307|581831431|FG001|Induction|Adverse Event|0|||
161121390|NCT00866307|581831432|FG002|Induction|Adverse Event|0|||
161121391|NCT00866307|581831430|FG000|Induction|Death|2|||
161121392|NCT00866307|581831431|FG001|Induction|Death|0|||
161121393|NCT00866307|581831432|FG002|Induction|Death|0|||
161121394|NCT00866307|581831430|FG000|Induction|Physician Decision|5|||
161121395|NCT00866307|581831431|FG001|Induction|Physician Decision|0|||
161121396|NCT00866307|581831432|FG002|Induction|Physician Decision|0|||
161121397|NCT00866307|581831430|FG000|Induction|Progressive Disease|1|||
161121398|NCT00866307|581831431|FG001|Induction|Progressive Disease|0|||
161121399|NCT00866307|581831432|FG002|Induction|Progressive Disease|0|||
161121400|NCT00866307|581831430|FG000|Induction|Identification of Patients with Day 29 M|3|||
161121401|NCT00866307|581831431|FG001|Induction|Identification of Patients with Day 29 M|0|||
161121402|NCT00866307|581831432|FG002|Induction|Identification of Patients with Day 29 M|0|||
161121403|NCT00866307|581831430|FG000|Induction|Inadequate cytognetic samples th|1|||
161121404|NCT00866307|581831431|FG001|Induction|Inadequate cytognetic samples th|0|||
161121405|NCT00866307|581831432|FG002|Induction|Inadequate cytognetic samples th|0|||
161121406|NCT00866307|581831430|FG000|Induction|Improper post-induction consent|2|||
161121407|NCT00866307|581831431|FG001|Induction|Improper post-induction consent|0|||
161121408|NCT00866307|581831432|FG002|Induction|Improper post-induction consent|0|||
161121409|NCT00866307|581831430|FG000|Induction|Study was closed at the time|1|||
161121410|NCT00866307|581831431|FG001|Induction|Study was closed at the time|0|||
161121411|NCT00866307|581831432|FG002|Induction|Study was closed at the time|0|||
161121412|NCT00866307|581831430|FG000|Consolidation/Maintenance|Adverse Event|0|||
161121413|NCT00866307|581831431|FG001|Consolidation/Maintenance|Adverse Event|0|||
161121414|NCT00866307|581831432|FG002|Consolidation/Maintenance|Adverse Event|8|||
161121415|NCT00866307|581831430|FG000|Consolidation/Maintenance|Death|0|||
161121416|NCT00866307|581831431|FG001|Consolidation/Maintenance|Death|0|||
161121417|NCT00866307|581831432|FG002|Consolidation/Maintenance|Death|1|||
161121418|NCT00866307|581831430|FG000|Consolidation/Maintenance|Physician Decision|0|||
161121419|NCT00866307|581831431|FG001|Consolidation/Maintenance|Physician Decision|3|||
161121420|NCT00866307|581831432|FG002|Consolidation/Maintenance|Physician Decision|2|||
161121421|NCT00866307|581831430|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
161121422|NCT00866307|581831431|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
161121423|NCT00866307|581831432|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
161121424|NCT00866307|581831430|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
161121425|NCT00866307|581831431|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
161121426|NCT00866307|581831432|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
161121427|NCT00866307|581831430|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
161121428|NCT00866307|581831431|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
161121429|NCT00866307|581831432|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
161121430|NCT00866307|581831430|FG000|Consolidation/Maintenance|Therapy error|0|||
161121431|NCT00866307|581831431|FG001|Consolidation/Maintenance|Therapy error|1|||
161121432|NCT00866307|581831432|FG002|Consolidation/Maintenance|Therapy error|0|||
161226373|NCT02579096|582209977|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
161226374|NCT02579096|582209978|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
161226375|NCT02097121|582209983|FG000|Overall Study|Other, not specified|4|||
161226376|NCT02097121|582209984|FG001|Overall Study|Other, not specified|2|||
161226377|NCT02097121|582209985|FG002|Overall Study|Other, not specified|3|||
161226378|NCT02097121|582209983|FG000|Overall Study|Lack of Efficacy|2|||
161226379|NCT02097121|582209984|FG001|Overall Study|Lack of Efficacy|1|||
161226380|NCT02097121|582209985|FG002|Overall Study|Lack of Efficacy|3|||
161226381|NCT02097121|582209983|FG000|Overall Study|Withdrawal by Subject|0|||
161226382|NCT02097121|582209984|FG001|Overall Study|Withdrawal by Subject|1|||
161226383|NCT02097121|582209985|FG002|Overall Study|Withdrawal by Subject|2|||
161226384|NCT02097121|582209983|FG000|Overall Study|Adverse Event|0|||
161226385|NCT02097121|582209984|FG001|Overall Study|Adverse Event|1|||
161226386|NCT02097121|582209985|FG002|Overall Study|Adverse Event|0|||
161226387|NCT02097121|582209983|FG000|Overall Study|Lost to Follow-up|1|||
161226388|NCT02097121|582209984|FG001|Overall Study|Lost to Follow-up|1|||
161226389|NCT02097121|582209985|FG002|Overall Study|Lost to Follow-up|2|||
161226390|NCT00510510|582209986|FG000|Overall Study|Adverse Event|4|||
161226391|NCT00510510|582209987|FG001|Overall Study|Adverse Event|3|||
161226392|NCT00510510|582209988|FG002|Overall Study|Adverse Event|6|||
161226393|NCT00510510|582209986|FG000|Overall Study|Lack of Efficacy|0|||
161226394|NCT00510510|582209987|FG001|Overall Study|Lack of Efficacy|1|||
161226395|NCT00510510|582209988|FG002|Overall Study|Lack of Efficacy|1|||
161226396|NCT00510510|582209986|FG000|Overall Study|Subjects no longer requires study drug|0|||
161226397|NCT00510510|582209987|FG001|Overall Study|Subjects no longer requires study drug|0|||
161226398|NCT00510510|582209988|FG002|Overall Study|Subjects no longer requires study drug|2|||
161226399|NCT00510510|582209986|FG000|Overall Study|Withdrawal by Subject|1|||
161226400|NCT00510510|582209987|FG001|Overall Study|Withdrawal by Subject|2|||
161226401|NCT00510510|582209988|FG002|Overall Study|Withdrawal by Subject|3|||
161226402|NCT00510510|582209986|FG000|Overall Study|Lost to Follow-up|0|||
161226403|NCT00510510|582209987|FG001|Overall Study|Lost to Follow-up|0|||
161226404|NCT00510510|582209988|FG002|Overall Study|Lost to Follow-up|1|||
161226405|NCT00510510|582209986|FG000|Overall Study|Protocol Violation|0|||
161226406|NCT00510510|582209987|FG001|Overall Study|Protocol Violation|3|||
160880380|NCT01340872|580956956|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160880381|NCT01340872|580956953|FG000|Double-blind Phase|Lost to Follow-up|0|||
160880382|NCT01340872|580956954|FG001|Double-blind Phase|Lost to Follow-up|1|||
160880383|NCT01340872|580956955|FG002|Double-blind Phase|Lost to Follow-up|0|||
160880384|NCT01340872|580956956|FG003|Double-blind Phase|Lost to Follow-up|0|||
160880385|NCT01340872|580956953|FG000|Double-blind Phase|Protocol Violation|0|||
160880386|NCT01340872|580956954|FG001|Double-blind Phase|Protocol Violation|1|||
160880387|NCT01340872|580956955|FG002|Double-blind Phase|Protocol Violation|0|||
160880388|NCT01340872|580956956|FG003|Double-blind Phase|Protocol Violation|0|||
160880389|NCT01340872|580956953|FG000|Open-label Phase|Physician Decision|0|||
160880390|NCT01340872|580956954|FG001|Open-label Phase|Physician Decision|0|||
160880391|NCT01340872|580956955|FG002|Open-label Phase|Physician Decision|2|||
160880392|NCT01340872|580956956|FG003|Open-label Phase|Physician Decision|1|||
160880393|NCT01340872|580956953|FG000|Open-label Phase|Pregnancy|0|||
160880394|NCT01340872|580956954|FG001|Open-label Phase|Pregnancy|0|||
160880395|NCT01340872|580956955|FG002|Open-label Phase|Pregnancy|1|||
160880396|NCT01340872|580956956|FG003|Open-label Phase|Pregnancy|0|||
160880397|NCT01340872|580956953|FG000|Open-label Phase|Adverse Event|0|||
160880398|NCT01340872|580956954|FG001|Open-label Phase|Adverse Event|0|||
160880399|NCT01340872|580956955|FG002|Open-label Phase|Adverse Event|8|||
160880400|NCT01340872|580956956|FG003|Open-label Phase|Adverse Event|4|||
160880401|NCT01340872|580956953|FG000|Open-label Phase|Withdrawal by Subject|0|||
160880402|NCT01340872|580956954|FG001|Open-label Phase|Withdrawal by Subject|0|||
160880403|NCT01340872|580956955|FG002|Open-label Phase|Withdrawal by Subject|1|||
160880404|NCT01340872|580956956|FG003|Open-label Phase|Withdrawal by Subject|6|||
161226407|NCT00510510|582209988|FG002|Overall Study|Protocol Violation|4|||
161226408|NCT03595657|582209989|FG000|Overall Study|Adverse Event|14|||
161226409|NCT03595657|582209989|FG000|Overall Study|Death|1|||
161226410|NCT03595657|582209989|FG000|Overall Study|Lack of Efficacy|40|||
160880405|NCT01340872|580956953|FG000|Open-label Phase|Worsening of IBD|0|||
160880406|NCT01340872|580956954|FG001|Open-label Phase|Worsening of IBD|0|||
160880407|NCT01340872|580956955|FG002|Open-label Phase|Worsening of IBD|1|||
161226411|NCT03595657|582209989|FG000|Overall Study|Withdrawal by Subject|10|||
161226412|NCT03595657|582209989|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
161226413|NCT03595657|582209989|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
161226414|NCT01066052|582209990|FG000|Overall Study|Enrolled But Not Treated|3|||
160880408|NCT01340872|580956956|FG003|Open-label Phase|Worsening of IBD|0|||
160880409|NCT03039621|580956961|FG000|Overall Study|Violation of inclusion criteria|3|||
160880410|NCT03039621|580956962|FG001|Overall Study|Violation of inclusion criteria|2|||
160880411|NCT03039621|580956961|FG000|Overall Study|Non-compliance with protocol requirement|4|||
160880412|NCT03039621|580956962|FG001|Overall Study|Non-compliance with protocol requirement|5|||
161226415|NCT01066052|582209991|FG001|Overall Study|Enrolled But Not Treated|0|||
161226416|NCT01200394|582209992|FG000|Overall Study|Adverse Event|0|||
161226417|NCT01200394|582209993|FG001|Overall Study|Adverse Event|14|||
161226418|NCT01200394|582209992|FG000|Overall Study|Death|1|||
161226419|NCT01200394|582209993|FG001|Overall Study|Death|0|||
161226420|NCT01200394|582209992|FG000|Overall Study|Lost to Follow-up|0|||
161226421|NCT01200394|582209993|FG001|Overall Study|Lost to Follow-up|1|||
161226422|NCT01200394|582209992|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161226423|NCT01200394|582209993|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
161226424|NCT01200394|582209992|FG000|Overall Study|Protocol Violation|0|||
161226425|NCT01200394|582209993|FG001|Overall Study|Protocol Violation|3|||
161226426|NCT01200394|582209992|FG000|Overall Study|Withdrawal by Subject|0|||
161226427|NCT01200394|582209993|FG001|Overall Study|Withdrawal by Subject|5|||
161226428|NCT01200394|582209992|FG000|Overall Study|Other|0|||
161226429|NCT01200394|582209993|FG001|Overall Study|Other|1|||
161226430|NCT02729896|582209996|FG000|Overall Study|Death|0|||
161226431|NCT02729896|582209997|FG001|Overall Study|Death|2|||
161226432|NCT02729896|582209998|FG002|Overall Study|Death|13|||
161226433|NCT02729896|582209996|FG000|Overall Study|Lost to Follow-up|0|||
160880413|NCT03039621|580956961|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
160880414|NCT03039621|580956962|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
160880415|NCT03039621|580956961|FG000|Overall Study|Violation of non-inclusion criteria|1|||
160880416|NCT03039621|580956962|FG001|Overall Study|Violation of non-inclusion criteria|2|||
160880417|NCT03254108|580956963|FG000|Overall Study|Adverse Event|0|||
160880418|NCT03254108|580956964|FG001|Overall Study|Adverse Event|2|||
160880419|NCT03254108|580956965|FG002|Overall Study|Adverse Event|0|||
160880420|NCT03254108|580956966|FG003|Overall Study|Adverse Event|1|||
160880421|NCT03254108|580956967|FG004|Overall Study|Adverse Event|1|||
160880422|NCT03254108|580956963|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160880423|NCT03254108|580956964|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160880424|NCT03254108|580956965|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
160880425|NCT03254108|580956966|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
161226434|NCT02729896|582209997|FG001|Overall Study|Lost to Follow-up|2|||
161226435|NCT02729896|582209998|FG002|Overall Study|Lost to Follow-up|3|||
161226436|NCT02729896|582209996|FG000|Overall Study|Other|0|||
161226437|NCT02729896|582209997|FG001|Overall Study|Other|2|||
161226438|NCT02729896|582209998|FG002|Overall Study|Other|0|||
161226439|NCT02729896|582209996|FG000|Overall Study|Physician Decision|1|||
161226440|NCT02729896|582209997|FG001|Overall Study|Physician Decision|2|||
161226441|NCT02729896|582209998|FG002|Overall Study|Physician Decision|3|||
161226442|NCT02729896|582209996|FG000|Overall Study|Progressive Disease|0|||
161226443|NCT02729896|582209997|FG001|Overall Study|Progressive Disease|1|||
161226444|NCT02729896|582209998|FG002|Overall Study|Progressive Disease|0|||
161226445|NCT02729896|582209996|FG000|Overall Study|Withdrawal by Subject|1|||
161226446|NCT02729896|582209997|FG001|Overall Study|Withdrawal by Subject|0|||
161226447|NCT02729896|582209998|FG002|Overall Study|Withdrawal by Subject|3|||
161226448|NCT01835145|582209999|FG000|Overall Study|Ineligible prior to treatment|1|||
161226449|NCT01835145|582210000|FG001|Overall Study|Ineligible prior to treatment|0|||
161226450|NCT04094870|582210001|FG000|Overall Study|Lost to Follow-up|1|||
161226451|NCT04094870|582210002|FG001|Overall Study|Lost to Follow-up|1|||
161226452|NCT02708277|582210004|FG000|Overall Study|Lost to Follow-up|7|||
161226453|NCT02708277|582210005|FG001|Overall Study|Lost to Follow-up|4|||
161226454|NCT01592370|582210008|FG000|Overall Study|Disease Progression|62|||
161226455|NCT01592370|582210009|FG001|Overall Study|Disease Progression|16|||
161226456|NCT01592370|582210010|FG002|Overall Study|Disease Progression|52|||
161226457|NCT01592370|582210011|FG003|Overall Study|Disease Progression|3|||
161226458|NCT01592370|582210012|FG004|Overall Study|Disease Progression|3|||
161226459|NCT01592370|582210013|FG005|Overall Study|Disease Progression|31|||
161226460|NCT01592370|582210014|FG006|Overall Study|Disease Progression|14|||
161226461|NCT01592370|582210008|FG000|Overall Study|Study Drug Toxicity|14|||
161226462|NCT01592370|582210009|FG001|Overall Study|Study Drug Toxicity|3|||
161226463|NCT01592370|582210010|FG002|Overall Study|Study Drug Toxicity|0|||
161226464|NCT01592370|582210011|FG003|Overall Study|Study Drug Toxicity|0|||
161226465|NCT01592370|582210012|FG004|Overall Study|Study Drug Toxicity|0|||
161226466|NCT01592370|582210013|FG005|Overall Study|Study Drug Toxicity|0|||
160880426|NCT03254108|580956967|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
160880427|NCT00362180|580956968|FG000|Treated Period|Withdrawal by Subject|1|||
160880428|NCT00362180|580956969|FG001|Treated Period|Withdrawal by Subject|0|||
160880429|NCT00362180|580956970|FG002|Treated Period|Withdrawal by Subject|0|||
160880430|NCT00362180|580956971|FG003|Treated Period|Withdrawal by Subject|0|||
160880431|NCT00362180|580956972|FG004|Treated Period|Withdrawal by Subject|0|||
161226467|NCT01592370|582210014|FG006|Overall Study|Study Drug Toxicity|1|||
161226468|NCT01592370|582210008|FG000|Overall Study|AE unrelated to study drug|4|||
161226469|NCT01592370|582210009|FG001|Overall Study|AE unrelated to study drug|3|||
161226470|NCT01592370|582210010|FG002|Overall Study|AE unrelated to study drug|0|||
161226471|NCT01592370|582210011|FG003|Overall Study|AE unrelated to study drug|0|||
161226472|NCT01592370|582210012|FG004|Overall Study|AE unrelated to study drug|0|||
161226473|NCT01592370|582210013|FG005|Overall Study|AE unrelated to study drug|0|||
161226474|NCT01592370|582210014|FG006|Overall Study|AE unrelated to study drug|1|||
160880432|NCT00362180|580956973|FG005|Treated Period|Withdrawal by Subject|0|||
160880433|NCT00362180|580956974|FG006|Treated Period|Withdrawal by Subject|0|||
160880434|NCT00362180|580956975|FG007|Treated Period|Withdrawal by Subject|0|||
160880435|NCT00362180|580956976|FG008|Treated Period|Withdrawal by Subject|0|||
160880436|NCT00362180|580956968|FG000|Treated Period|Adverse Event|0|||
160880437|NCT00362180|580956969|FG001|Treated Period|Adverse Event|0|||
160880438|NCT00362180|580956970|FG002|Treated Period|Adverse Event|0|||
160880439|NCT00362180|580956971|FG003|Treated Period|Adverse Event|0|||
160880440|NCT00362180|580956972|FG004|Treated Period|Adverse Event|0|||
160880441|NCT00362180|580956973|FG005|Treated Period|Adverse Event|1|||
160880442|NCT00362180|580956974|FG006|Treated Period|Adverse Event|0|||
160880443|NCT00362180|580956975|FG007|Treated Period|Adverse Event|1|||
160880444|NCT00362180|580956976|FG008|Treated Period|Adverse Event|0|||
160880445|NCT02600871|580956979|FG000|Overall Study|Lost to Follow-up|13|||
160880446|NCT02600871|580956980|FG001|Overall Study|Lost to Follow-up|10|||
160880447|NCT01246466|580956984|FG000|Overall Study|Death|1|||
160880448|NCT01246466|580956984|FG000|Overall Study|Withdrawal by Subject|1|||
160880449|NCT01142089|580956985|FG000|Overall Study|Physician Decision|1|||
160880450|NCT01142089|580956986|FG001|Overall Study|Physician Decision|0|||
160880451|NCT01142089|580956985|FG000|Overall Study|Withdrawal by Subject|1|||
160880452|NCT01142089|580956986|FG001|Overall Study|Withdrawal by Subject|2|||
160880453|NCT01142089|580956985|FG000|Overall Study|Use of prohibited medications|0|||
160880454|NCT01142089|580956986|FG001|Overall Study|Use of prohibited medications|1|||
160880455|NCT01142089|580956985|FG000|Overall Study|Noncompliance with study procedures|2|||
160880456|NCT01142089|580956986|FG001|Overall Study|Noncompliance with study procedures|1|||
160880457|NCT01142089|580956985|FG000|Overall Study|Patient required rescue medication|8|||
160880458|NCT01142089|580956986|FG001|Overall Study|Patient required rescue medication|17|||
160880459|NCT00348933|580956989|FG000|Overall Study|Withdrawal by Subject|10|||
160880460|NCT00348933|580956989|FG000|Overall Study|Lost to Follow-up|6|||
160880461|NCT00348933|580956989|FG000|Overall Study|Protocol Violation|2|||
160880462|NCT00348933|580956989|FG000|Overall Study|Adverse Event|7|||
160880463|NCT01489111|580956990|FG000|Overall Study|Withdrawal criterion|1|||
160880464|NCT00003472|580956995|FG000|Overall Study|Not evaluable|3|||
160880465|NCT00874939|580956996|FG000|Overall Study|Study terminated|4|||
160880466|NCT01350544|580956997|FG000|Overall Study|Administrative Withdrawal|0|||
160880467|NCT01350544|580956998|FG001|Overall Study|Administrative Withdrawal|1|||
160880468|NCT01350544|580956997|FG000|Overall Study|Death|1|||
160880469|NCT01350544|580956998|FG001|Overall Study|Death|2|||
160880470|NCT01350544|580956997|FG000|Overall Study|Moved out of LA County|2|||
160880471|NCT01350544|580956998|FG001|Overall Study|Moved out of LA County|2|||
160880472|NCT01350544|580956997|FG000|Overall Study|Medical Issues|1|||
160880473|NCT01350544|580956998|FG001|Overall Study|Medical Issues|1|||
160880474|NCT01350544|580956997|FG000|Overall Study|Withdrawal by Subject|0|||
160880475|NCT01350544|580956998|FG001|Overall Study|Withdrawal by Subject|1|||
160880476|NCT01350544|580956997|FG000|Overall Study|Incarceration|1|||
160880477|NCT01350544|580956998|FG001|Overall Study|Incarceration|0|||
160880478|NCT01350544|580956997|FG000|Overall Study|Lost to Follow-up|18|||
160880479|NCT01350544|580956998|FG001|Overall Study|Lost to Follow-up|15|||
160880480|NCT01444092|580956999|FG000|Overall Study|Adverse Event|8|||
160880481|NCT01444092|580956999|FG000|Overall Study|Protocol Violation|1|||
160880482|NCT01444092|580956999|FG000|Overall Study|Withdrawal by Subject|1|||
160880483|NCT01444092|580956999|FG000|Overall Study|Other Eligibility criteria|7|||
160880484|NCT00603590|580957000|FG000|Overall Study|Did not attend study clinic|39|||
161121433|NCT00866307|581831430|FG000|Consolidation/Maintenance|Non-compliance|0|||
161121434|NCT00866307|581831431|FG001|Consolidation/Maintenance|Non-compliance|0|||
161121435|NCT00866307|581831432|FG002|Consolidation/Maintenance|Non-compliance|1|||
161121436|NCT00866307|581831430|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
161121437|NCT00866307|581831431|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
161121438|NCT00866307|581831432|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
161121439|NCT02573155|581831435|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
161121440|NCT02573155|581831436|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
161121441|NCT02573155|581831435|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
161121442|NCT02573155|581831436|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
161121443|NCT02573155|581831435|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
160880485|NCT00603590|580957001|FG001|Overall Study|Did not attend study clinic|30|||
160880486|NCT00603590|580957000|FG000|Overall Study|Refused blood test|5|||
160880487|NCT00603590|580957001|FG001|Overall Study|Refused blood test|1|||
160880488|NCT00603590|580957000|FG000|Overall Study|Patient discontinued study drug|22|||
160880489|NCT00603590|580957001|FG001|Overall Study|Patient discontinued study drug|15|||
160880490|NCT00603590|580957000|FG000|Overall Study|Adverse Event|2|||
160880491|NCT00603590|580957001|FG001|Overall Study|Adverse Event|0|||
160880492|NCT00603590|580957000|FG000|Overall Study|Lost to Follow-up|8|||
160880493|NCT00603590|580957001|FG001|Overall Study|Lost to Follow-up|4|||
160880494|NCT00603590|580957000|FG000|Overall Study|Cardiovascular event|0|||
160880495|NCT00603590|580957001|FG001|Overall Study|Cardiovascular event|1|||
160880496|NCT03005873|580957005|FG000|Overall Study|Prohibited medication use post radnomization|1|||
160880497|NCT03005873|580957006|FG001|Overall Study|Prohibited medication use post radnomization|1|||
160880498|NCT03005873|580957007|FG002|Overall Study|Prohibited medication use post radnomization|1|||
160880499|NCT03005873|580957005|FG000|Overall Study|Withdrew consent|0|||
160880500|NCT03005873|580957006|FG001|Overall Study|Withdrew consent|1|||
160880501|NCT03005873|580957007|FG002|Overall Study|Withdrew consent|2|||
160880502|NCT03005873|580957005|FG000|Overall Study|Lost to Follow-up|0|||
160880503|NCT03005873|580957006|FG001|Overall Study|Lost to Follow-up|1|||
160880504|NCT03005873|580957007|FG002|Overall Study|Lost to Follow-up|0|||
160880505|NCT03005873|580957005|FG000|Overall Study|Ineligible post randomization|0|||
160880506|NCT03005873|580957006|FG001|Overall Study|Ineligible post randomization|0|||
160880507|NCT03005873|580957007|FG002|Overall Study|Ineligible post randomization|1|||
160880508|NCT04585009|580957008|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
160880509|NCT04585009|580957009|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880510|NCT04585009|580957010|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880511|NCT04585009|580957011|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880512|NCT04585009|580957012|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880513|NCT04585009|580957013|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161121444|NCT02573155|581831436|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
161121445|NCT02573155|581831435|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
161121446|NCT02573155|581831436|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
161121447|NCT02573155|581831435|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
161121448|NCT02573155|581831436|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
161121449|NCT02573155|581831435|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
161121450|NCT02573155|581831436|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
161121451|NCT02573155|581831435|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
161121452|NCT02573155|581831436|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
161121453|NCT02573155|581831435|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
161121454|NCT02573155|581831436|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
161121455|NCT01681433|581831437|FG000|Overall Study|Lack of Efficacy|23|||
161121456|NCT01681433|581831438|FG001|Overall Study|Lack of Efficacy|23|||
161121457|NCT01681433|581831437|FG000|Overall Study|Withdrawal by Subject|5|||
161121458|NCT01681433|581831438|FG001|Overall Study|Withdrawal by Subject|5|||
161121459|NCT01681433|581831437|FG000|Overall Study|Protocol Violation|2|||
161121460|NCT01681433|581831438|FG001|Overall Study|Protocol Violation|0|||
161121461|NCT01681433|581831437|FG000|Overall Study|Adverse Event|2|||
161121462|NCT01681433|581831438|FG001|Overall Study|Adverse Event|4|||
161121463|NCT01681433|581831437|FG000|Overall Study|Lost to Follow-up|0|||
161121464|NCT01681433|581831438|FG001|Overall Study|Lost to Follow-up|1|||
161121465|NCT00903929|581831439|FG000|Overall Study|Withdrawal by Subject|0|||
161121466|NCT00903929|581831440|FG001|Overall Study|Withdrawal by Subject|0|||
161121467|NCT00903929|581831441|FG002|Overall Study|Withdrawal by Subject|1|||
161121468|NCT00903929|581831442|FG003|Overall Study|Withdrawal by Subject|2|||
161121469|NCT00903929|581831439|FG000|Overall Study|Adverse Event|0|||
161121470|NCT00903929|581831440|FG001|Overall Study|Adverse Event|0|||
161121471|NCT00903929|581831441|FG002|Overall Study|Adverse Event|0|||
161121472|NCT00903929|581831442|FG003|Overall Study|Adverse Event|1|||
161121473|NCT01844895|581831444|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
161121474|NCT01844895|581831444|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
161121475|NCT01844895|581831444|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
161121476|NCT01844895|581831444|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
161121477|NCT01844895|581831444|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
161121478|NCT01844895|581831444|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
161121479|NCT01844895|581831444|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
161121480|NCT02508194|581831447|FG000|Overall Study|Death|5|||
161121481|NCT02508194|581831448|FG001|Overall Study|Death|3|||
161121482|NCT02508194|581831447|FG000|Overall Study|Lost to Follow-up|25|||
161121483|NCT02508194|581831448|FG001|Overall Study|Lost to Follow-up|18|||
161121484|NCT02508194|581831447|FG000|Overall Study|Withdrawal by Subject|20|||
161121485|NCT02508194|581831448|FG001|Overall Study|Withdrawal by Subject|18|||
161121486|NCT02508194|581831447|FG000|Overall Study|Error in Randomization|1|||
161121487|NCT02508194|581831448|FG001|Overall Study|Error in Randomization|3|||
161121488|NCT02508194|581831447|FG000|Overall Study|Principal Investigator Decision|1|||
161121489|NCT02508194|581831448|FG001|Overall Study|Principal Investigator Decision|2|||
161121490|NCT02158091|581831453|FG000|Overall Study|DLT|2|||
161121491|NCT02158091|581831454|FG001|Overall Study|DLT|1|||
161121492|NCT02158091|581831455|FG002|Overall Study|DLT|0|||
161121493|NCT04982250|581831456|FG000|Overall Study|Lost to Follow-up|0|||
161121494|NCT04982250|581831457|FG001|Overall Study|Lost to Follow-up|26|||
161121495|NCT04982250|581831458|FG002|Overall Study|Lost to Follow-up|0|||
160880514|NCT04585009|580957014|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
161121496|NCT04982250|581831459|FG003|Overall Study|Lost to Follow-up|0|||
160880515|NCT04585009|580957015|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880516|NCT04585009|580957016|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880517|NCT04585009|580957017|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880518|NCT04585009|580957018|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880519|NCT04585009|580957019|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
160880520|NCT04585009|580957008|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
160880521|NCT04585009|580957009|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880522|NCT04585009|580957010|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880523|NCT04585009|580957011|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880524|NCT04585009|580957012|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880525|NCT04585009|580957013|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880526|NCT04585009|580957014|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880527|NCT04585009|580957015|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880528|NCT04585009|580957016|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880529|NCT04585009|580957017|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880530|NCT04585009|580957018|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880531|NCT04585009|580957019|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
160880532|NCT04585009|580957008|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880533|NCT04585009|580957009|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880534|NCT04585009|580957010|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880535|NCT04585009|580957011|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880536|NCT04585009|580957012|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880537|NCT04585009|580957013|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880538|NCT04585009|580957014|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880539|NCT04585009|580957015|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
160880540|NCT04585009|580957016|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880541|NCT04585009|580957017|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880542|NCT04585009|580957018|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880543|NCT04585009|580957019|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
160880544|NCT04585009|580957008|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880545|NCT04585009|580957009|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880546|NCT04585009|580957010|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880547|NCT04585009|580957011|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880548|NCT04585009|580957012|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
160880549|NCT04585009|580957013|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880550|NCT04585009|580957014|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880551|NCT04585009|580957015|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880552|NCT04585009|580957016|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880553|NCT04585009|580957017|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880554|NCT04585009|580957018|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880555|NCT04585009|580957019|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
160880556|NCT04585009|580957008|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880557|NCT04585009|580957009|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880558|NCT04585009|580957010|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880559|NCT04585009|580957011|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880560|NCT04585009|580957012|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880561|NCT04585009|580957013|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880562|NCT04585009|580957014|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880563|NCT04585009|580957015|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880564|NCT04585009|580957016|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880565|NCT04585009|580957017|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
160880566|NCT04585009|580957018|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880567|NCT04585009|580957019|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
160880568|NCT04585009|580957008|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880569|NCT04585009|580957009|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880570|NCT04585009|580957010|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880571|NCT04585009|580957011|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
161121497|NCT04982250|581831460|FG004|Overall Study|Lost to Follow-up|72|||
161121498|NCT04982250|581831461|FG005|Overall Study|Lost to Follow-up|69|||
161121499|NCT04982250|581831456|FG000|Overall Study|Not Eligible to Enroll|0|||
161121500|NCT04982250|581831457|FG001|Overall Study|Not Eligible to Enroll|0|||
161121501|NCT04982250|581831458|FG002|Overall Study|Not Eligible to Enroll|0|||
161121502|NCT04982250|581831459|FG003|Overall Study|Not Eligible to Enroll|0|||
161121503|NCT04982250|581831460|FG004|Overall Study|Not Eligible to Enroll|10|||
161121504|NCT04982250|581831461|FG005|Overall Study|Not Eligible to Enroll|7|||
160880572|NCT04585009|580957012|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880573|NCT04585009|580957013|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880574|NCT04585009|580957014|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880575|NCT04585009|580957015|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880576|NCT04585009|580957016|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880577|NCT04585009|580957017|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880578|NCT04585009|580957018|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
160880579|NCT04585009|580957019|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
160880580|NCT03699475|580957020|FG000|Overall Study|Death|1|||
160880581|NCT04618770|580957032|FG000|Overall Study|Censored from Analysis|12|||
160880582|NCT04618770|580957032|FG000|Overall Study|Early Termination|25|||
160880583|NCT05338671|580957033|FG000|Overall Study|Lost to Follow-up|2|||
160880584|NCT05338671|580957034|FG001|Overall Study|Lost to Follow-up|2|||
160880585|NCT05338671|580957033|FG000|Overall Study|Root canal completed in a single visit|1|||
160880586|NCT05338671|580957034|FG001|Overall Study|Root canal completed in a single visit|0|||
160880587|NCT03859973|580957037|FG000|Overall Study|Other reason than listed|3|||
160880588|NCT03859973|580957038|FG001|Overall Study|Other reason than listed|2|||
160880589|NCT03859973|580957037|FG000|Overall Study|COVID-19 related, not due to AE|3|||
160880590|NCT03859973|580957038|FG001|Overall Study|COVID-19 related, not due to AE|4|||
160880591|NCT03859973|580957037|FG000|Overall Study|Withdrawal by Subject|8|||
160880592|NCT03859973|580957038|FG001|Overall Study|Withdrawal by Subject|9|||
160880593|NCT03859973|580957037|FG000|Overall Study|Lost to Follow-up|2|||
160880594|NCT03859973|580957038|FG001|Overall Study|Lost to Follow-up|3|||
160880595|NCT03859973|580957037|FG000|Overall Study|Protocol Violation|1|||
160880596|NCT03859973|580957038|FG001|Overall Study|Protocol Violation|3|||
160880597|NCT03859973|580957037|FG000|Overall Study|Adverse Event|3|||
160880598|NCT03859973|580957038|FG001|Overall Study|Adverse Event|5|||
160880599|NCT02855541|580957039|FG000|Overall Study|Change in health status|2|||
160880600|NCT02855541|580957039|FG000|Overall Study|Withdrawal by Subject|2|||
160880601|NCT03085914|580957040|FG000|Overall Study|Death|6|||
160880602|NCT03085914|580957041|FG001|Overall Study|Death|6|||
160880603|NCT03085914|580957042|FG002|Overall Study|Death|4|||
160880604|NCT03085914|580957043|FG003|Overall Study|Death|1|||
160880605|NCT03085914|580957044|FG004|Overall Study|Death|5|||
160880606|NCT03085914|580957045|FG005|Overall Study|Death|2|||
160880607|NCT03085914|580957046|FG006|Overall Study|Death|2|||
160880608|NCT03085914|580957040|FG000|Overall Study|Withdrawal by Subject|1|||
160880609|NCT03085914|580957041|FG001|Overall Study|Withdrawal by Subject|1|||
160880610|NCT03085914|580957042|FG002|Overall Study|Withdrawal by Subject|2|||
160880611|NCT03085914|580957043|FG003|Overall Study|Withdrawal by Subject|2|||
160880612|NCT03085914|580957044|FG004|Overall Study|Withdrawal by Subject|2|||
160880613|NCT03085914|580957045|FG005|Overall Study|Withdrawal by Subject|0|||
160880614|NCT03085914|580957046|FG006|Overall Study|Withdrawal by Subject|1|||
160880615|NCT03085914|580957040|FG000|Overall Study|Lost to Follow-up|0|||
160880616|NCT03085914|580957041|FG001|Overall Study|Lost to Follow-up|0|||
160880617|NCT03085914|580957042|FG002|Overall Study|Lost to Follow-up|1|||
160880618|NCT03085914|580957043|FG003|Overall Study|Lost to Follow-up|0|||
160880619|NCT03085914|580957044|FG004|Overall Study|Lost to Follow-up|0|||
160880620|NCT03085914|580957045|FG005|Overall Study|Lost to Follow-up|1|||
160880621|NCT03085914|580957046|FG006|Overall Study|Lost to Follow-up|1|||
160880622|NCT03085914|580957040|FG000|Overall Study|Reason was not specified,|2|||
160880623|NCT03085914|580957041|FG001|Overall Study|Reason was not specified,|2|||
160880624|NCT03085914|580957042|FG002|Overall Study|Reason was not specified,|2|||
160880625|NCT03085914|580957043|FG003|Overall Study|Reason was not specified,|3|||
160880626|NCT03085914|580957044|FG004|Overall Study|Reason was not specified,|3|||
160880627|NCT03085914|580957045|FG005|Overall Study|Reason was not specified,|3|||
160880628|NCT03085914|580957046|FG006|Overall Study|Reason was not specified,|6|||
160880629|NCT03085914|580957040|FG000|Overall Study|Progressive Disease|0|||
160880630|NCT03085914|580957041|FG001|Overall Study|Progressive Disease|0|||
160880631|NCT03085914|580957042|FG002|Overall Study|Progressive Disease|2|||
160880632|NCT03085914|580957043|FG003|Overall Study|Progressive Disease|2|||
160880633|NCT03085914|580957044|FG004|Overall Study|Progressive Disease|1|||
160880634|NCT03085914|580957045|FG005|Overall Study|Progressive Disease|1|||
160880635|NCT03085914|580957046|FG006|Overall Study|Progressive Disease|1|||
160880636|NCT03085914|580957040|FG000|Overall Study|Study Terminated by the Sponsor|0|||
160880637|NCT03085914|580957041|FG001|Overall Study|Study Terminated by the Sponsor|0|||
160880638|NCT03085914|580957042|FG002|Overall Study|Study Terminated by the Sponsor|0|||
161121505|NCT05568888|581831464|FG000|Overall Study|Physician Decision|1|||
161121506|NCT05568888|581831465|FG001|Overall Study|Physician Decision|0|||
161121507|NCT05568888|581831464|FG000|Overall Study|Protocol Deviation|2|||
161121508|NCT05568888|581831465|FG001|Overall Study|Protocol Deviation|1|||
161121509|NCT05568888|581831464|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
161121510|NCT05568888|581831465|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
161121511|NCT05568888|581831464|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
161121512|NCT05568888|581831465|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
161121513|NCT05568888|581831464|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
161226475|NCT01592370|582210008|FG000|Overall Study|Request to discontinue study treatment|5|||
160880639|NCT03085914|580957043|FG003|Overall Study|Study Terminated by the Sponsor|1|||
160880640|NCT03085914|580957044|FG004|Overall Study|Study Terminated by the Sponsor|2|||
160880641|NCT03085914|580957045|FG005|Overall Study|Study Terminated by the Sponsor|1|||
161121514|NCT05568888|581831465|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
161121515|NCT01844986|581831466|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
161121516|NCT01844986|581831467|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
161121517|NCT01844986|581831466|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
161121518|NCT01844986|581831467|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
161121519|NCT01844986|581831466|FG000|Overall Study (Global Cohort)|Death|55|||
161121520|NCT01844986|581831467|FG001|Overall Study (Global Cohort)|Death|26|||
161121521|NCT01844986|581831466|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
161121522|NCT01844986|581831467|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
161121523|NCT01844986|581831466|FG000|Overall Study (China Cohort)|Death|10|||
161121524|NCT01844986|581831467|FG001|Overall Study (China Cohort)|Death|6|||
161142580|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Progressive disease|0|||
161142581|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Progressive disease|0|||
161142582|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Progressive disease|0|||
161142583|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Progressive disease|0|||
161142584|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Progressive disease|0|||
161142585|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Progressive disease|0|||
161142586|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Progressive disease|0|||
161142587|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Progressive disease|5|||
161142588|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Progressive disease|0|||
161142589|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Progressive disease|0|||
161142590|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Progressive disease|0|||
161142591|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Progressive disease|30|||
161142592|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Progressive disease|8|||
161142593|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142594|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142595|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142596|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142597|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142598|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142599|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142600|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142601|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142602|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142603|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142604|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142605|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
161142606|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
161142607|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
161142608|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142609|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142610|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142611|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142612|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142613|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142614|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142615|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142616|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142617|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
161142618|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142619|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142620|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
161142621|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
161142622|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
161142623|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142624|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142625|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142626|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142627|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
161226476|NCT01592370|582210009|FG001|Overall Study|Request to discontinue study treatment|0|||
161226477|NCT01592370|582210010|FG002|Overall Study|Request to discontinue study treatment|2|||
160880642|NCT03085914|580957046|FG006|Overall Study|Study Terminated by the Sponsor|0|||
161142628|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
161226478|NCT01592370|582210011|FG003|Overall Study|Request to discontinue study treatment|0|||
160880643|NCT03874429|580957048|FG000|Overall Study|Adverse Event|2|||
160880644|NCT03874429|580957049|FG001|Overall Study|Adverse Event|2|||
160880645|NCT03874429|580957048|FG000|Overall Study|Lack of Efficacy|0|||
160880646|NCT03874429|580957049|FG001|Overall Study|Lack of Efficacy|1|||
160880647|NCT03874429|580957048|FG000|Overall Study|Covid-19 pandemic|4|||
160880648|NCT03874429|580957049|FG001|Overall Study|Covid-19 pandemic|2|||
160880649|NCT01561898|580957052|FG000|Overall Study|Withdrawal by Subject|0|||
160880650|NCT01561898|580957053|FG001|Overall Study|Withdrawal by Subject|8|||
160880651|NCT01561898|580957054|FG002|Overall Study|Withdrawal by Subject|12|||
160880652|NCT01561898|580957055|FG003|Overall Study|Withdrawal by Subject|5|||
160880653|NCT01561898|580957052|FG000|Overall Study|Lack of Efficacy|0|||
160880654|NCT01561898|580957053|FG001|Overall Study|Lack of Efficacy|8|||
160880655|NCT01561898|580957054|FG002|Overall Study|Lack of Efficacy|10|||
160880656|NCT01561898|580957055|FG003|Overall Study|Lack of Efficacy|5|||
160880657|NCT01561898|580957052|FG000|Overall Study|Worsening of complications|0|||
160880658|NCT01561898|580957053|FG001|Overall Study|Worsening of complications|1|||
160880659|NCT01561898|580957054|FG002|Overall Study|Worsening of complications|0|||
160880660|NCT01561898|580957055|FG003|Overall Study|Worsening of complications|0|||
160880661|NCT01561898|580957052|FG000|Overall Study|Lost to Follow-up|0|||
160880662|NCT01561898|580957053|FG001|Overall Study|Lost to Follow-up|0|||
160880663|NCT01561898|580957054|FG002|Overall Study|Lost to Follow-up|1|||
160880664|NCT01561898|580957055|FG003|Overall Study|Lost to Follow-up|0|||
160880665|NCT01561898|580957052|FG000|Overall Study|Adverse Event|1|||
160880666|NCT01561898|580957053|FG001|Overall Study|Adverse Event|19|||
160880667|NCT01561898|580957054|FG002|Overall Study|Adverse Event|14|||
160880668|NCT01561898|580957055|FG003|Overall Study|Adverse Event|9|||
160880669|NCT01561898|580957052|FG000|Overall Study|Physician Decision|1|||
160880670|NCT01561898|580957053|FG001|Overall Study|Physician Decision|5|||
160880671|NCT01561898|580957054|FG002|Overall Study|Physician Decision|7|||
160880672|NCT01561898|580957055|FG003|Overall Study|Physician Decision|1|||
160880673|NCT00331552|580957056|FG000|Period 3: Phase II|Neurological Symptoms|1|||
160880674|NCT00331552|580957057|FG001|Period 3: Phase II|Neurological Symptoms|0|||
160880675|NCT00331552|580957056|FG000|Period 3: Phase II|Severe Nausea|1|||
160880676|NCT00331552|580957057|FG001|Period 3: Phase II|Severe Nausea|0|||
160880677|NCT01445548|580957058|FG000|Overall Study|Adverse Event|1|||
160880678|NCT03560518|580957059|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
160880679|NCT03560518|580957060|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
160880680|NCT03560518|580957061|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
160880681|NCT03560518|580957059|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
160880682|NCT03560518|580957060|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
160880683|NCT03560518|580957061|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
160880684|NCT03560518|580957059|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160880685|NCT03560518|580957060|FG001|Double Blind Treatment Period|Protocol Violation|2|||
160880686|NCT03560518|580957061|FG002|Double Blind Treatment Period|Protocol Violation|0|||
160880687|NCT03560518|580957059|FG000|Double Blind Treatment Period|Pregnancy|0|||
160880688|NCT03560518|580957060|FG001|Double Blind Treatment Period|Pregnancy|2|||
160880689|NCT03560518|580957061|FG002|Double Blind Treatment Period|Pregnancy|0|||
160880690|NCT03560518|580957059|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
160880691|NCT03560518|580957060|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
160880692|NCT03560518|580957061|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
160880693|NCT03560518|580957059|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
160880694|NCT03560518|580957060|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
160880695|NCT03560518|580957061|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
160880696|NCT03560518|580957059|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
160880697|NCT03560518|580957060|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
160880698|NCT03560518|580957061|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
160880699|NCT03560518|580957059|FG000|Double Blind Treatment Period|Adverse Event|0|||
160880700|NCT03560518|580957060|FG001|Double Blind Treatment Period|Adverse Event|3|||
160880701|NCT03560518|580957061|FG002|Double Blind Treatment Period|Adverse Event|1|||
160880702|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
160880703|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Adverse Event|9|||
160880704|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Death|4|||
160880705|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
160880706|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
160880707|NCT00159822|580957062|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
160880708|NCT00159822|580957062|FG000|Post-treatment Follow-up Period|Death|1|||
160880709|NCT00159822|580957062|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
160880710|NCT00159822|580957062|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
160880711|NCT01215916|580957064|FG000|Overall Study|Progressive Disease|0|||
160880712|NCT01215916|580957065|FG001|Overall Study|Progressive Disease|2|||
160880713|NCT01215916|580957066|FG002|Overall Study|Progressive Disease|1|||
160880714|NCT01215916|580957067|FG003|Overall Study|Progressive Disease|2|||
160880715|NCT01215916|580957068|FG004|Overall Study|Progressive Disease|5|||
160880716|NCT01215916|580957069|FG005|Overall Study|Progressive Disease|4|||
160880717|NCT01215916|580957070|FG006|Overall Study|Progressive Disease|5|||
160880718|NCT01215916|580957071|FG007|Overall Study|Progressive Disease|3|||
160880719|NCT01215916|580957072|FG008|Overall Study|Progressive Disease|1|||
160880720|NCT01215916|580957064|FG000|Overall Study|Adverse Event|1|||
161226479|NCT01592370|582210012|FG004|Overall Study|Request to discontinue study treatment|1|||
161226480|NCT01592370|582210013|FG005|Overall Study|Request to discontinue study treatment|2|||
161226481|NCT01592370|582210014|FG006|Overall Study|Request to discontinue study treatment|0|||
161226482|NCT01592370|582210008|FG000|Overall Study|Withdrew consent|1|||
161226483|NCT01592370|582210009|FG001|Overall Study|Withdrew consent|2|||
161226484|NCT01592370|582210010|FG002|Overall Study|Withdrew consent|1|||
161226485|NCT01592370|582210011|FG003|Overall Study|Withdrew consent|1|||
161226486|NCT01592370|582210012|FG004|Overall Study|Withdrew consent|0|||
161226487|NCT01592370|582210013|FG005|Overall Study|Withdrew consent|0|||
161226488|NCT01592370|582210014|FG006|Overall Study|Withdrew consent|0|||
161226489|NCT01592370|582210008|FG000|Overall Study|Maximum clinical benefit|11|||
161226490|NCT01592370|582210009|FG001|Overall Study|Maximum clinical benefit|1|||
161226491|NCT01592370|582210010|FG002|Overall Study|Maximum clinical benefit|7|||
161226492|NCT01592370|582210011|FG003|Overall Study|Maximum clinical benefit|1|||
161226493|NCT01592370|582210012|FG004|Overall Study|Maximum clinical benefit|0|||
161226494|NCT01592370|582210013|FG005|Overall Study|Maximum clinical benefit|0|||
161226495|NCT01592370|582210014|FG006|Overall Study|Maximum clinical benefit|0|||
161226496|NCT01592370|582210008|FG000|Overall Study|No longer meets study criteria|1|||
161226497|NCT01592370|582210009|FG001|Overall Study|No longer meets study criteria|0|||
161226498|NCT01592370|582210010|FG002|Overall Study|No longer meets study criteria|0|||
161226499|NCT01592370|582210011|FG003|Overall Study|No longer meets study criteria|0|||
161226500|NCT01592370|582210012|FG004|Overall Study|No longer meets study criteria|0|||
161226501|NCT01592370|582210013|FG005|Overall Study|No longer meets study criteria|0|||
161226502|NCT01592370|582210014|FG006|Overall Study|No longer meets study criteria|0|||
161226503|NCT01592370|582210008|FG000|Overall Study|Other Reasons|6|||
161226504|NCT01592370|582210009|FG001|Overall Study|Other Reasons|0|||
161226505|NCT01592370|582210010|FG002|Overall Study|Other Reasons|10|||
161226506|NCT01592370|582210011|FG003|Overall Study|Other Reasons|0|||
161226507|NCT01592370|582210012|FG004|Overall Study|Other Reasons|0|||
161226508|NCT01592370|582210013|FG005|Overall Study|Other Reasons|1|||
161226509|NCT01592370|582210014|FG006|Overall Study|Other Reasons|0|||
161226510|NCT01592370|582210008|FG000|Overall Study|Not Treated|0|||
161226511|NCT01592370|582210009|FG001|Overall Study|Not Treated|0|||
161226512|NCT01592370|582210010|FG002|Overall Study|Not Treated|0|||
161226513|NCT01592370|582210011|FG003|Overall Study|Not Treated|0|||
161226514|NCT01592370|582210012|FG004|Overall Study|Not Treated|2|||
161226515|NCT01592370|582210013|FG005|Overall Study|Not Treated|2|||
161226516|NCT01592370|582210014|FG006|Overall Study|Not Treated|0|||
161226517|NCT02742181|582210015|FG000|Overall Study|Physician Decision|1|||
161226518|NCT02742181|582210016|FG001|Overall Study|Physician Decision|0|||
161226519|NCT02739984|582210017|FG000|Overall Study|Sponsor Decision|1|||
161226520|NCT02739984|582210018|FG001|Overall Study|Sponsor Decision|0|||
161226521|NCT02739984|582210017|FG000|Overall Study|Withdrawal by Subject|1|||
161226522|NCT02739984|582210018|FG001|Overall Study|Withdrawal by Subject|1|||
161226523|NCT02739984|582210017|FG000|Overall Study|Death|0|||
161226524|NCT02739984|582210018|FG001|Overall Study|Death|1|||
161226525|NCT02739984|582210017|FG000|Overall Study|Lost to Follow-up|3|||
161226526|NCT02739984|582210018|FG001|Overall Study|Lost to Follow-up|0|||
161226527|NCT01048333|582210023|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161226528|NCT01048333|582210024|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
161226529|NCT01048333|582210025|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161226530|NCT01048333|582210026|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161226531|NCT01048333|582210027|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161226532|NCT01048333|582210028|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
161226533|NCT00996736|582210030|FG000|Overall Study|Death|1|||
161226534|NCT00996736|582210031|FG001|Overall Study|Death|1|||
161226535|NCT00996736|582210030|FG000|Overall Study|Lost to Follow-up|15|||
161226536|NCT00996736|582210031|FG001|Overall Study|Lost to Follow-up|14|||
161226537|NCT00996736|582210030|FG000|Overall Study|Visit not within 3-month window|5|||
161226538|NCT00996736|582210031|FG001|Overall Study|Visit not within 3-month window|3|||
161226539|NCT02346201|582210032|FG000|Overall Study|Adverse Event|3|||
161226540|NCT02346201|582210033|FG001|Overall Study|Adverse Event|2|||
161226541|NCT02346201|582210032|FG000|Overall Study|Lost to Follow-up|1|||
161226542|NCT02346201|582210033|FG001|Overall Study|Lost to Follow-up|0|||
161226543|NCT02346201|582210032|FG000|Overall Study|Withdrawal by Subject|6|||
161226544|NCT02346201|582210033|FG001|Overall Study|Withdrawal by Subject|3|||
161226545|NCT02346201|582210032|FG000|Overall Study|Unavailable for future follow-up|0|||
161226546|NCT02346201|582210033|FG001|Overall Study|Unavailable for future follow-up|1|||
161226547|NCT02346201|582210032|FG000|Overall Study|Physician Decision|0|||
160880721|NCT01215916|580957065|FG001|Overall Study|Adverse Event|1|||
160880722|NCT01215916|580957066|FG002|Overall Study|Adverse Event|0|||
161226548|NCT02346201|582210033|FG001|Overall Study|Physician Decision|1|||
161226549|NCT02346201|582210032|FG000|Overall Study|Missed final visit|0|||
161226550|NCT02346201|582210033|FG001|Overall Study|Missed final visit|2|||
160880723|NCT01215916|580957067|FG003|Overall Study|Adverse Event|1|||
161226551|NCT02109133|582210036|FG000|Overall Study|Lost to Follow-up|1|||
161226552|NCT02109133|582210037|FG001|Overall Study|Lost to Follow-up|0|||
161226553|NCT05200858|582210038|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
160880724|NCT01215916|580957068|FG004|Overall Study|Adverse Event|0|||
160880725|NCT01215916|580957069|FG005|Overall Study|Adverse Event|0|||
160880726|NCT01215916|580957070|FG006|Overall Study|Adverse Event|3|||
160880727|NCT01215916|580957071|FG007|Overall Study|Adverse Event|0|||
160880728|NCT01215916|580957072|FG008|Overall Study|Adverse Event|0|||
160880729|NCT01215916|580957064|FG000|Overall Study|Withdrawal by Subject|0|||
160880730|NCT01215916|580957065|FG001|Overall Study|Withdrawal by Subject|1|||
160880731|NCT01215916|580957066|FG002|Overall Study|Withdrawal by Subject|1|||
160880732|NCT01215916|580957067|FG003|Overall Study|Withdrawal by Subject|2|||
160880733|NCT01215916|580957068|FG004|Overall Study|Withdrawal by Subject|0|||
160880734|NCT01215916|580957069|FG005|Overall Study|Withdrawal by Subject|0|||
160880735|NCT01215916|580957070|FG006|Overall Study|Withdrawal by Subject|1|||
160880736|NCT01215916|580957071|FG007|Overall Study|Withdrawal by Subject|0|||
160880737|NCT01215916|580957072|FG008|Overall Study|Withdrawal by Subject|0|||
160880738|NCT01215916|580957064|FG000|Overall Study|Death|0|||
160880739|NCT01215916|580957065|FG001|Overall Study|Death|1|||
160880740|NCT01215916|580957066|FG002|Overall Study|Death|0|||
160880741|NCT01215916|580957067|FG003|Overall Study|Death|0|||
160880742|NCT01215916|580957068|FG004|Overall Study|Death|1|||
160880743|NCT01215916|580957069|FG005|Overall Study|Death|0|||
160880744|NCT01215916|580957070|FG006|Overall Study|Death|0|||
160880745|NCT01215916|580957071|FG007|Overall Study|Death|0|||
160880746|NCT01215916|580957072|FG008|Overall Study|Death|1|||
160880747|NCT01215916|580957064|FG000|Overall Study|Physician Decision|0|||
160880748|NCT01215916|580957065|FG001|Overall Study|Physician Decision|0|||
160880749|NCT01215916|580957066|FG002|Overall Study|Physician Decision|1|||
160880750|NCT01215916|580957067|FG003|Overall Study|Physician Decision|1|||
160880751|NCT01215916|580957068|FG004|Overall Study|Physician Decision|0|||
160880752|NCT01215916|580957069|FG005|Overall Study|Physician Decision|0|||
160880753|NCT01215916|580957070|FG006|Overall Study|Physician Decision|0|||
160880754|NCT01215916|580957071|FG007|Overall Study|Physician Decision|0|||
160880755|NCT01215916|580957072|FG008|Overall Study|Physician Decision|0|||
160880756|NCT01185301|580957073|FG000|Overall Study|Adverse Event|3|||
160880757|NCT01185301|580957074|FG001|Overall Study|Adverse Event|0|||
160880758|NCT01185301|580957075|FG002|Overall Study|Adverse Event|2|||
160880759|NCT01185301|580957076|FG003|Overall Study|Adverse Event|3|||
160880760|NCT01185301|580957073|FG000|Overall Study|Withdrawal by Subject|7|||
160880761|NCT01185301|580957074|FG001|Overall Study|Withdrawal by Subject|5|||
160880762|NCT01185301|580957075|FG002|Overall Study|Withdrawal by Subject|2|||
160880763|NCT01185301|580957076|FG003|Overall Study|Withdrawal by Subject|3|||
160880764|NCT01185301|580957073|FG000|Overall Study|Lost to Follow-up|2|||
160880765|NCT01185301|580957074|FG001|Overall Study|Lost to Follow-up|0|||
160880766|NCT01185301|580957075|FG002|Overall Study|Lost to Follow-up|0|||
160880767|NCT01185301|580957076|FG003|Overall Study|Lost to Follow-up|1|||
160880768|NCT01185301|580957073|FG000|Overall Study|Other Reason|3|||
160880769|NCT01185301|580957074|FG001|Overall Study|Other Reason|2|||
160880770|NCT01185301|580957075|FG002|Overall Study|Other Reason|2|||
161226554|NCT05200858|582210039|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
161226555|NCT05200858|582210040|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
161226556|NCT05200858|582210041|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
161226557|NCT00409578|582210042|FG000|Overall Study|Adverse Event|27|||
161226558|NCT00409578|582210043|FG001|Overall Study|Adverse Event|37|||
161226559|NCT00409578|582210044|FG002|Overall Study|Adverse Event|25|||
161226560|NCT00409578|582210045|FG003|Overall Study|Adverse Event|33|||
160880771|NCT01185301|580957076|FG003|Overall Study|Other Reason|2|||
161226561|NCT00409578|582210042|FG000|Overall Study|Abnormal laboratory value(s)|2|||
160880772|NCT02683746|580957077|FG000|Overall Study|Adverse Event|3|||
160880773|NCT02683746|580957078|FG001|Overall Study|Adverse Event|2|||
160880774|NCT02683746|580957077|FG000|Overall Study|Lost to Follow-up|5|||
161226562|NCT00409578|582210043|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160880775|NCT02683746|580957078|FG001|Overall Study|Lost to Follow-up|6|||
160880776|NCT02683746|580957077|FG000|Overall Study|Withdrawal by Subject|6|||
161226563|NCT00409578|582210044|FG002|Overall Study|Abnormal laboratory value(s)|2|||
161226564|NCT00409578|582210045|FG003|Overall Study|Abnormal laboratory value(s)|4|||
161226565|NCT00409578|582210042|FG000|Overall Study|Lack of Efficacy|0|||
161226566|NCT00409578|582210043|FG001|Overall Study|Lack of Efficacy|0|||
160880777|NCT02683746|580957078|FG001|Overall Study|Withdrawal by Subject|5|||
160880778|NCT02683746|580957077|FG000|Overall Study|Physician Decision|2|||
160880779|NCT02683746|580957078|FG001|Overall Study|Physician Decision|1|||
160880780|NCT03726996|580957082|FG000|Overall Study|Parent's decision|2|||
160880781|NCT03726996|580957082|FG000|Overall Study|Study early termination|2|||
160880782|NCT03531632|580957087|FG000|Overall Study|Adverse Event|0|||
160880783|NCT03531632|580957088|FG001|Overall Study|Adverse Event|0|||
160880784|NCT03531632|580957089|FG002|Overall Study|Adverse Event|1|||
160880785|NCT03531632|580957087|FG000|Overall Study|Death|4|||
160880786|NCT03531632|580957088|FG001|Overall Study|Death|0|||
161226567|NCT00409578|582210044|FG002|Overall Study|Lack of Efficacy|0|||
161226568|NCT00409578|582210045|FG003|Overall Study|Lack of Efficacy|2|||
161226569|NCT00409578|582210042|FG000|Overall Study|Subject no longer requires study drug|0|||
161226570|NCT00409578|582210043|FG001|Overall Study|Subject no longer requires study drug|0|||
161226571|NCT00409578|582210044|FG002|Overall Study|Subject no longer requires study drug|0|||
161226572|NCT00409578|582210045|FG003|Overall Study|Subject no longer requires study drug|1|||
161226573|NCT00409578|582210042|FG000|Overall Study|Withdrawal by Subject|8|||
161226574|NCT00409578|582210043|FG001|Overall Study|Withdrawal by Subject|15|||
161226575|NCT00409578|582210044|FG002|Overall Study|Withdrawal by Subject|16|||
161226576|NCT00409578|582210045|FG003|Overall Study|Withdrawal by Subject|17|||
161226577|NCT00409578|582210042|FG000|Overall Study|Lost to Follow-up|2|||
161226578|NCT00409578|582210043|FG001|Overall Study|Lost to Follow-up|0|||
161226579|NCT00409578|582210044|FG002|Overall Study|Lost to Follow-up|2|||
161226580|NCT00409578|582210045|FG003|Overall Study|Lost to Follow-up|2|||
161226581|NCT00409578|582210042|FG000|Overall Study|Administrative problems|8|||
161226582|NCT00409578|582210043|FG001|Overall Study|Administrative problems|9|||
161226583|NCT00409578|582210044|FG002|Overall Study|Administrative problems|2|||
161226584|NCT00409578|582210045|FG003|Overall Study|Administrative problems|4|||
161226585|NCT00409578|582210042|FG000|Overall Study|Death|2|||
161226586|NCT00409578|582210043|FG001|Overall Study|Death|4|||
161226587|NCT00409578|582210044|FG002|Overall Study|Death|4|||
161226588|NCT00409578|582210045|FG003|Overall Study|Death|2|||
161226589|NCT00409578|582210042|FG000|Overall Study|Protocol Violation|3|||
161226590|NCT00409578|582210043|FG001|Overall Study|Protocol Violation|2|||
161226591|NCT00409578|582210044|FG002|Overall Study|Protocol Violation|3|||
161226592|NCT00409578|582210045|FG003|Overall Study|Protocol Violation|1|||
161226593|NCT00409578|582210042|FG000|Overall Study|Missing|0|||
161226594|NCT00409578|582210043|FG001|Overall Study|Missing|1|||
161226595|NCT00409578|582210044|FG002|Overall Study|Missing|0|||
161226596|NCT00409578|582210045|FG003|Overall Study|Missing|1|||
161226597|NCT02448771|582210046|FG000|Overall Study|Disease Progression|30|||
161226598|NCT02448771|582210046|FG000|Overall Study|Unacceptable Toxicity|1|||
161226599|NCT02448771|582210046|FG000|Overall Study|Physician Decision|3|||
161226600|NCT02448771|582210046|FG000|Overall Study|Started new therapy|2|||
161226601|NCT01210001|582211517|FG000|Overall Study|Not treated|1|||
161226602|NCT01210001|582211518|FG001|Overall Study|Not treated|0|||
161226603|NCT01210001|582211519|FG002|Overall Study|Not treated|0|||
161226604|NCT01210001|582211517|FG000|Overall Study|Adverse Event|4|||
161226605|NCT01210001|582211518|FG001|Overall Study|Adverse Event|2|||
161226606|NCT01210001|582211519|FG002|Overall Study|Adverse Event|5|||
161226607|NCT01210001|582211517|FG000|Overall Study|Non compliant with protocol|2|||
161226608|NCT01210001|582211518|FG001|Overall Study|Non compliant with protocol|2|||
161226609|NCT01210001|582211519|FG002|Overall Study|Non compliant with protocol|3|||
161226610|NCT01210001|582211517|FG000|Overall Study|Lost to Follow-up|4|||
161226611|NCT01210001|582211518|FG001|Overall Study|Lost to Follow-up|3|||
161226612|NCT01210001|582211519|FG002|Overall Study|Lost to Follow-up|2|||
161226613|NCT01210001|582211517|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
161226614|NCT01210001|582211518|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
161226615|NCT01210001|582211519|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
161226616|NCT01210001|582211517|FG000|Overall Study|Other reason not defined above|2|||
161226617|NCT01210001|582211518|FG001|Overall Study|Other reason not defined above|2|||
161226618|NCT01210001|582211519|FG002|Overall Study|Other reason not defined above|1|||
161226619|NCT00788125|582211520|FG000|Overall Study|Death|6|||
161226620|NCT01374919|582211530|FG000|Overall Study|Withdrawal by Subject|2|||
161226621|NCT02999178|582211531|FG000|Overall Study|Adverse Event|85|||
161226622|NCT02999178|582211532|FG001|Overall Study|Adverse Event|62|||
161226623|NCT02999178|582211531|FG000|Overall Study|Protocol Violation|1|||
161226624|NCT02999178|582211532|FG001|Overall Study|Protocol Violation|2|||
161226625|NCT02999178|582211531|FG000|Overall Study|Lost to Follow-up|0|||
161226626|NCT02999178|582211532|FG001|Overall Study|Lost to Follow-up|2|||
161226627|NCT02999178|582211531|FG000|Overall Study|Withdrawal by Subject|21|||
161226628|NCT02999178|582211532|FG001|Overall Study|Withdrawal by Subject|21|||
161226629|NCT02999178|582211531|FG000|Overall Study|Other reason not defined above|7|||
161226630|NCT02999178|582211532|FG001|Overall Study|Other reason not defined above|13|||
161226631|NCT00630305|582211533|FG000|Overall Study|Withdrawal by Subject|1|||
161226632|NCT00630305|582211533|FG000|Overall Study|Inability to insert contact lens|1|||
161226633|NCT01085045|582211534|FG000|Part A|Withdrawal by Subject|4|||
161226634|NCT01085045|582211534|FG000|Part A|Adverse Event|6|||
161226635|NCT01085045|582211534|FG000|Part A|Protocol Violation|1|||
161226636|NCT01085045|582211534|FG000|Part A|Protocol Specified Criteria|7|||
161226637|NCT01085045|582211534|FG000|Part B|Withdrawal by Subject|2|||
161226638|NCT01085045|582211534|FG000|Part B|Protocol Specified Criteria|6|||
161226639|NCT01085045|582211534|FG000|Part B|Lost to Follow-up|1|||
161226640|NCT01085045|582211534|FG000|Part B|Adverse Event|6|||
161226641|NCT02924038|582211535|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
161226642|NCT02924038|582211536|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
161226643|NCT02473640|582211537|FG000|Treatment Period 1|Adverse Event|1|||
161226644|NCT02395822|582211538|FG000|Overall Study|Withdrawal by Subject|1|||
161226645|NCT02395822|582211538|FG000|Overall Study|Death|1|||
161226646|NCT04720664|582211541|FG000|Overall Study|Adverse Event|2|||
161226647|NCT04720664|582211541|FG000|Overall Study|Lack of Efficacy|9|||
161226648|NCT03311646|582211546|FG000|Overall Study|Physician Decision|1|||
161226649|NCT03311646|582211546|FG000|Overall Study|Withdrawal by Subject|5|||
161226650|NCT03311646|582211546|FG000|Overall Study|Lost to Follow-up|5|||
161226651|NCT03311646|582211546|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
161226652|NCT03103100|582211547|FG000|Overall Study|Adverse Event|1|||
161226653|NCT03103100|582211548|FG001|Overall Study|Adverse Event|0|||
161226654|NCT03103100|582211549|FG002|Overall Study|Adverse Event|0|||
161226655|NCT03103100|582211547|FG000|Overall Study|Physician Decision|1|||
161226656|NCT03103100|582211548|FG001|Overall Study|Physician Decision|0|||
161226657|NCT03103100|582211549|FG002|Overall Study|Physician Decision|2|||
161226658|NCT00531206|582211550|FG000|Overall Study|Adverse Event related|5|||
161226659|NCT00531206|582211550|FG000|Overall Study|Lack of Efficacy|2|||
161226660|NCT00531206|582211550|FG000|Overall Study|Lost to Follow-up|5|||
161226661|NCT00531206|582211550|FG000|Overall Study|including non-related adverse events|8|||
161226662|NCT02720510|582211568|FG000|Overall Study|Study Terminated by the sponsor|2|||
161226663|NCT02720510|582211569|FG001|Overall Study|Study Terminated by the sponsor|0|||
161226664|NCT02720510|582211568|FG000|Overall Study|Adverse Event|0|||
161226665|NCT02720510|582211569|FG001|Overall Study|Adverse Event|1|||
161226666|NCT02720510|582211568|FG000|Overall Study|Physician Decision|1|||
161226667|NCT02720510|582211569|FG001|Overall Study|Physician Decision|2|||
161226668|NCT02460159|582211570|FG000|Overall Study|Adverse Event|4|||
161226669|NCT02460159|582211571|FG001|Overall Study|Adverse Event|1|||
161226670|NCT02460159|582211570|FG000|Overall Study|Withdrawal by Subject|2|||
161226671|NCT02460159|582211571|FG001|Overall Study|Withdrawal by Subject|0|||
161226672|NCT03499964|582211572|FG000|Overall Study|Lack of Efficacy|6|||
161226673|NCT03499964|582211573|FG001|Overall Study|Lack of Efficacy|26|||
161226674|NCT03499964|582211572|FG000|Overall Study|Adverse Event|1|||
161226675|NCT03499964|582211573|FG001|Overall Study|Adverse Event|0|||
161226676|NCT03499964|582211572|FG000|Overall Study|Death|1|||
161226677|NCT03499964|582211573|FG001|Overall Study|Death|0|||
161226678|NCT03499964|582211572|FG000|Overall Study|Withdrawal by Subject|2|||
161226679|NCT03499964|582211573|FG001|Overall Study|Withdrawal by Subject|1|||
161226680|NCT03499964|582211572|FG000|Overall Study|Lost to Follow-up|1|||
161226681|NCT03499964|582211573|FG001|Overall Study|Lost to Follow-up|0|||
161226682|NCT00084084|582211574|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
161226683|NCT00084084|582211574|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
161226684|NCT01047345|582211575|FG000|Base Study|Adverse Event|3|||
161226685|NCT01047345|582211576|FG001|Base Study|Adverse Event|0|||
161226686|NCT01047345|582211577|FG002|Base Study|Adverse Event|0|||
161226687|NCT01047345|582211575|FG000|Base Study|Lost to Follow-up|4|||
161226688|NCT01047345|582211576|FG001|Base Study|Lost to Follow-up|1|||
161226689|NCT01047345|582211577|FG002|Base Study|Lost to Follow-up|0|||
161226690|NCT01047345|582211575|FG000|Base Study|Protocol Violation|3|||
161226691|NCT01047345|582211576|FG001|Base Study|Protocol Violation|1|||
161226692|NCT01047345|582211577|FG002|Base Study|Protocol Violation|0|||
161226693|NCT01047345|582211575|FG000|Base Study|Withdrawal by Subject|12|||
161226694|NCT01047345|582211576|FG001|Base Study|Withdrawal by Subject|4|||
161226695|NCT01047345|582211577|FG002|Base Study|Withdrawal by Subject|0|||
161226696|NCT01047345|582211575|FG000|Extension|Withdrawal by Subject|0|||
161226697|NCT01047345|582211576|FG001|Extension|Withdrawal by Subject|0|||
161226698|NCT01047345|582211577|FG002|Extension|Withdrawal by Subject|1|||
161226699|NCT01047345|582211575|FG000|Extension|Lost to Follow-up|0|||
161226700|NCT01047345|582211576|FG001|Extension|Lost to Follow-up|0|||
161226701|NCT01047345|582211577|FG002|Extension|Lost to Follow-up|5|||
161226702|NCT02465567|582211581|FG000|Overall Study|Adverse Event|118|||
161226703|NCT02465567|582211582|FG001|Overall Study|Adverse Event|113|||
161226704|NCT02465567|582211583|FG002|Overall Study|Adverse Event|147|||
161226705|NCT02465567|582211584|FG003|Overall Study|Adverse Event|138|||
161121525|NCT02392429|581833505|FG000|Screening|Screen failure|15|||
161121526|NCT02392429|581833505|FG000|Enrolled Participants|Ineligible due to disease|3|||
161121527|NCT02392429|581833505|FG000|Enrolled Participants|Withdrawal by Subject|4|||
161121528|NCT02392429|581833505|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
161121529|NCT02392429|581833505|FG000|Evaluable|Death|5|||
161121530|NCT02392429|581833505|FG000|Evaluable|Withdrawal by Subject|1|||
161121531|NCT02392429|581833505|FG000|Evaluable|Adverse Event|1|||
161121532|NCT02392429|581833505|FG000|Evaluable|remission bone marrow biopsy|3|||
161121533|NCT01178138|581833508|FG000|Overall Study|Lost to Follow-up|8|||
161121534|NCT01178138|581833508|FG000|Overall Study|Withdrawal by Subject|7|||
161121535|NCT01178138|581833508|FG000|Overall Study|Physician Decision|8|||
161121536|NCT00403260|581833509|FG000|Overall Study|Adverse Event|5|||
161121537|NCT00403260|581833510|FG001|Overall Study|Adverse Event|4|||
161121538|NCT00403260|581833509|FG000|Overall Study|Withdrawal by Subject|5|||
161121539|NCT00403260|581833510|FG001|Overall Study|Withdrawal by Subject|6|||
161121540|NCT00403260|581833509|FG000|Overall Study|Lost to Follow-up|49|||
161121541|NCT00403260|581833510|FG001|Overall Study|Lost to Follow-up|25|||
161121542|NCT00403260|581833509|FG000|Overall Study|Re-appearance of P. falciparum|34|||
161121543|NCT00403260|581833510|FG001|Overall Study|Re-appearance of P. falciparum|25|||
161121544|NCT00403260|581833509|FG000|Overall Study|P. vivax infection|26|||
161121545|NCT00403260|581833510|FG001|Overall Study|P. vivax infection|4|||
161121546|NCT00403260|581833509|FG000|Overall Study|Mixed infection with P. vivax|2|||
161121547|NCT00403260|581833510|FG001|Overall Study|Mixed infection with P. vivax|0|||
160880787|NCT03531632|580957089|FG002|Overall Study|Death|14|||
161121548|NCT00403260|581833509|FG000|Overall Study|Mixed infection with P. falciparum|1|||
161226706|NCT02465567|582211581|FG000|Overall Study|Lack of Efficacy|103|||
161226707|NCT02465567|582211582|FG001|Overall Study|Lack of Efficacy|102|||
161226708|NCT02465567|582211583|FG002|Overall Study|Lack of Efficacy|171|||
160880788|NCT03531632|580957087|FG000|Overall Study|Study Terminated|1|||
160880789|NCT03531632|580957088|FG001|Overall Study|Study Terminated|3|||
160880790|NCT03531632|580957089|FG002|Overall Study|Study Terminated|11|||
160880791|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
160880792|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
160880793|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Adverse Event|7|||
160880794|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Adverse Event|6|||
160880795|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
160880796|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
160880797|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Physician Decision|4|||
160880798|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Physician Decision|4|||
160880799|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
160880800|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
160880801|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
160880802|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
160880803|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
160880804|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
160880805|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Non-compliance|1|||
160880806|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Non-compliance|0|||
160880807|NCT00470834|580957090|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
160880808|NCT00470834|580957091|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
160880809|NCT00470834|580957090|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
160880810|NCT00470834|580957091|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
160880811|NCT00470834|580957090|FG000|Extension Period (24 Months)|Adverse Event|3|||
160880812|NCT00470834|580957091|FG001|Extension Period (24 Months)|Adverse Event|4|||
160880813|NCT00470834|580957090|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
160880814|NCT00470834|580957091|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
160880815|NCT00470834|580957090|FG000|Extension Period (24 Months)|Physician Decision|4|||
160880816|NCT00470834|580957091|FG001|Extension Period (24 Months)|Physician Decision|3|||
160880817|NCT00470834|580957090|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
160880818|NCT00470834|580957091|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
160880819|NCT00470834|580957090|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
160880820|NCT00470834|580957091|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
160880821|NCT00470834|580957090|FG000|Extension Period (24 Months)|Non-compliance|0|||
160880822|NCT00470834|580957091|FG001|Extension Period (24 Months)|Non-compliance|1|||
160880823|NCT00470834|580957090|FG000|Extension Period (24 Months)|Disease Progression|0|||
160880824|NCT00470834|580957091|FG001|Extension Period (24 Months)|Disease Progression|1|||
160880825|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880826|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880827|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880828|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880829|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880830|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
160880831|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
160880832|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880833|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880834|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
160880835|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880836|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880837|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880838|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
160880839|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
160880840|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880841|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880842|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880843|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880844|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880845|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
160880846|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
160880847|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
160880848|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
160880849|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
160880850|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
160880851|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
161226709|NCT02465567|582211584|FG003|Overall Study|Lack of Efficacy|135|||
160880852|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
160880853|NCT00065429|580957092|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160880854|NCT00065429|580957093|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
161226710|NCT02465567|582211581|FG000|Overall Study|Withdrawal by Subject|104|||
161226711|NCT02465567|582211582|FG001|Overall Study|Withdrawal by Subject|94|||
160880855|NCT00065429|580957094|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160880856|NCT00065429|580957095|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
160880857|NCT00065429|580957096|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
160880858|NCT00065429|580957097|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
160880859|NCT00065429|580957098|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
160880860|NCT00065429|580957092|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880861|NCT00065429|580957093|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880862|NCT00065429|580957094|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880863|NCT00065429|580957095|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880864|NCT00065429|580957096|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
160880865|NCT00065429|580957097|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880866|NCT00065429|580957098|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
160880867|NCT00065429|580957092|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880868|NCT00065429|580957093|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880869|NCT00065429|580957094|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880870|NCT00065429|580957095|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880871|NCT00065429|580957096|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
160880872|NCT00065429|580957097|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880873|NCT00065429|580957098|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
160880874|NCT01616693|580957100|FG000|Evaluated for Safety|Physician Decision|1|||
160880875|NCT01616693|580957101|FG001|Evaluated for Safety|Physician Decision|0|||
160880876|NCT01616693|580957102|FG002|Evaluated for Safety|Physician Decision|1|||
160880877|NCT01616693|580957103|FG003|Evaluated for Safety|Physician Decision|0|||
160880878|NCT01616693|580957100|FG000|Received Both Vaccines|Adverse Event|2|||
160880879|NCT01616693|580957101|FG001|Received Both Vaccines|Adverse Event|0|||
160880880|NCT01616693|580957102|FG002|Received Both Vaccines|Adverse Event|0|||
160880881|NCT01616693|580957103|FG003|Received Both Vaccines|Adverse Event|0|||
160880882|NCT01616693|580957100|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
160880883|NCT01616693|580957101|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
160880884|NCT01616693|580957102|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
160880885|NCT01616693|580957103|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
160880886|NCT01616693|580957100|FG000|Received Both Vaccines|Lost to Follow-up|4|||
160880887|NCT01616693|580957101|FG001|Received Both Vaccines|Lost to Follow-up|3|||
160880888|NCT01616693|580957102|FG002|Received Both Vaccines|Lost to Follow-up|4|||
160880889|NCT01616693|580957103|FG003|Received Both Vaccines|Lost to Follow-up|4|||
160880890|NCT01616693|580957100|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
160880891|NCT01616693|580957101|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
160880892|NCT01616693|580957102|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
160880893|NCT01616693|580957103|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
160880894|NCT00441116|580957107|FG000|Overall Study|Adverse Event|1|||
160880895|NCT00441116|580957108|FG001|Overall Study|Adverse Event|1|||
160880896|NCT00441116|580957107|FG000|Overall Study|Withdrawal by Subject|1|||
160880897|NCT00441116|580957108|FG001|Overall Study|Withdrawal by Subject|0|||
160880898|NCT00441116|580957107|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
160880899|NCT00441116|580957108|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
160880900|NCT02925338|580957109|FG000|Overall Study|Death|0|||
160880901|NCT02925338|580957110|FG001|Overall Study|Death|2|||
160880902|NCT02925338|580957111|FG002|Overall Study|Death|1|||
160880903|NCT02925338|580957112|FG003|Overall Study|Death|0|||
160880904|NCT02925338|580957113|FG004|Overall Study|Death|0|||
160880905|NCT02925338|580957109|FG000|Overall Study|Lost to Follow-up|30|||
160880906|NCT02925338|580957110|FG001|Overall Study|Lost to Follow-up|10|||
160880907|NCT02925338|580957111|FG002|Overall Study|Lost to Follow-up|1|||
160880908|NCT02925338|580957112|FG003|Overall Study|Lost to Follow-up|16|||
160880909|NCT02925338|580957113|FG004|Overall Study|Lost to Follow-up|3|||
160880910|NCT02925338|580957109|FG000|Overall Study|Withdrawal by Subject|3|||
160880911|NCT02925338|580957110|FG001|Overall Study|Withdrawal by Subject|0|||
160880912|NCT02925338|580957111|FG002|Overall Study|Withdrawal by Subject|3|||
160880913|NCT02925338|580957112|FG003|Overall Study|Withdrawal by Subject|2|||
160880914|NCT02925338|580957113|FG004|Overall Study|Withdrawal by Subject|2|||
160880915|NCT02925338|580957109|FG000|Overall Study|Missing|38|||
160880916|NCT02925338|580957110|FG001|Overall Study|Missing|27|||
160880917|NCT02925338|580957111|FG002|Overall Study|Missing|0|||
160880918|NCT02925338|580957112|FG003|Overall Study|Missing|3|||
160880919|NCT02925338|580957113|FG004|Overall Study|Missing|2|||
160880920|NCT02925338|580957109|FG000|Overall Study|Participant's Decision|11|||
160880921|NCT02925338|580957110|FG001|Overall Study|Participant's Decision|7|||
160880922|NCT02925338|580957111|FG002|Overall Study|Participant's Decision|3|||
160880923|NCT02925338|580957112|FG003|Overall Study|Participant's Decision|8|||
160880924|NCT02925338|580957113|FG004|Overall Study|Participant's Decision|1|||
160880925|NCT02925338|580957109|FG000|Overall Study|Treatment Discontinuation|144|||
160880926|NCT02925338|580957110|FG001|Overall Study|Treatment Discontinuation|65|||
160880927|NCT02925338|580957111|FG002|Overall Study|Treatment Discontinuation|56|||
160880928|NCT02925338|580957112|FG003|Overall Study|Treatment Discontinuation|131|||
160880929|NCT02925338|580957113|FG004|Overall Study|Treatment Discontinuation|22|||
160880930|NCT00636363|580957116|FG000|Overall Study|Conjunctivitis|0|||
160880931|NCT00636363|580957117|FG001|Overall Study|Conjunctivitis|0|||
160880932|NCT00636363|580957118|FG002|Overall Study|Conjunctivitis|1|||
160880933|NCT00636363|580957116|FG000|Overall Study|Adverse Event|0|||
160880934|NCT00636363|580957117|FG001|Overall Study|Adverse Event|0|||
160880935|NCT00636363|580957118|FG002|Overall Study|Adverse Event|1|||
160880936|NCT00636363|580957116|FG000|Overall Study|Positive slit lamp finding|0|||
160880937|NCT00636363|580957117|FG001|Overall Study|Positive slit lamp finding|2|||
160880938|NCT00636363|580957118|FG002|Overall Study|Positive slit lamp finding|1|||
160880939|NCT00636363|580957116|FG000|Overall Study|Study related symptoms/complaints|8|||
160880940|NCT00636363|580957117|FG001|Overall Study|Study related symptoms/complaints|7|||
160880941|NCT00636363|580957118|FG002|Overall Study|Study related symptoms/complaints|4|||
160880942|NCT00636363|580957116|FG000|Overall Study|Met ineligibility criteria|0|||
160880943|NCT00636363|580957117|FG001|Overall Study|Met ineligibility criteria|0|||
160880944|NCT00636363|580957118|FG002|Overall Study|Met ineligibility criteria|3|||
160880945|NCT00636363|580957116|FG000|Overall Study|Missed > 1 visit|0|||
160880946|NCT00636363|580957117|FG001|Overall Study|Missed > 1 visit|1|||
160880947|NCT00636363|580957118|FG002|Overall Study|Missed > 1 visit|3|||
160880948|NCT00636363|580957116|FG000|Overall Study|Lack of motivation|1|||
160880949|NCT00636363|580957117|FG001|Overall Study|Lack of motivation|0|||
160880950|NCT00636363|580957118|FG002|Overall Study|Lack of motivation|1|||
160880951|NCT00636363|580957116|FG000|Overall Study|Protocol Violation|0|||
160880952|NCT00636363|580957117|FG001|Overall Study|Protocol Violation|3|||
160880953|NCT00636363|580957118|FG002|Overall Study|Protocol Violation|0|||
160880954|NCT00636363|580957116|FG000|Overall Study|Lost to Follow-up|3|||
160880955|NCT00636363|580957117|FG001|Overall Study|Lost to Follow-up|4|||
160880956|NCT00636363|580957118|FG002|Overall Study|Lost to Follow-up|2|||
160880957|NCT00636363|580957116|FG000|Overall Study|Withdrawal by Subject|1|||
160880958|NCT00636363|580957117|FG001|Overall Study|Withdrawal by Subject|3|||
160880959|NCT00636363|580957118|FG002|Overall Study|Withdrawal by Subject|2|||
160880960|NCT03148691|580957121|FG000|Overall Study|Protocol Violation|1|||
160880961|NCT03148691|580957122|FG001|Overall Study|Protocol Violation|2|||
160880962|NCT03148691|580957123|FG002|Overall Study|Protocol Violation|7|||
160880963|NCT03148691|580957121|FG000|Overall Study|Lost to Follow-up|0|||
160880964|NCT03148691|580957122|FG001|Overall Study|Lost to Follow-up|0|||
160880965|NCT03148691|580957123|FG002|Overall Study|Lost to Follow-up|1|||
160880966|NCT03148691|580957121|FG000|Overall Study|Other|1|||
160880967|NCT03148691|580957122|FG001|Overall Study|Other|0|||
160880968|NCT03148691|580957123|FG002|Overall Study|Other|0|||
160880969|NCT03148691|580957121|FG000|Overall Study|Withdrawal by Subject|1|||
160880970|NCT03148691|580957122|FG001|Overall Study|Withdrawal by Subject|0|||
160880971|NCT03148691|580957123|FG002|Overall Study|Withdrawal by Subject|0|||
160880972|NCT00096356|580957124|FG000|Overall Study|Adverse Event|11|||
160880973|NCT00096356|580957125|FG001|Overall Study|Adverse Event|9|||
160880974|NCT00096356|580957124|FG000|Overall Study|Physician Decision|5|||
160880975|NCT00096356|580957125|FG001|Overall Study|Physician Decision|3|||
160880976|NCT00096356|580957124|FG000|Overall Study|Withdrawal by Subject|17|||
160880977|NCT00096356|580957125|FG001|Overall Study|Withdrawal by Subject|23|||
160880978|NCT00096356|580957124|FG000|Overall Study|Lack of Efficacy|1|||
160880979|NCT00096356|580957125|FG001|Overall Study|Lack of Efficacy|0|||
160880980|NCT00096356|580957124|FG000|Overall Study|multiple reasons|10|||
160880981|NCT00096356|580957125|FG001|Overall Study|multiple reasons|18|||
161121549|NCT00403260|581833510|FG001|Overall Study|Mixed infection with P. falciparum|0|||
161121550|NCT00403260|581833509|FG000|Overall Study|P. vivax infection at screening|1|||
161121551|NCT00403260|581833510|FG001|Overall Study|P. vivax infection at screening|0|||
161121552|NCT00403260|581833509|FG000|Overall Study|P. ovale infection|1|||
161121553|NCT00403260|581833510|FG001|Overall Study|P. ovale infection|0|||
161121554|NCT00403260|581833509|FG000|Overall Study|Gametocyte re-appearance|1|||
161121555|NCT00403260|581833510|FG001|Overall Study|Gametocyte re-appearance|1|||
161121556|NCT00403260|581833509|FG000|Overall Study|Withdrawn from study accidentally|0|||
161121557|NCT00403260|581833510|FG001|Overall Study|Withdrawn from study accidentally|1|||
161226712|NCT02465567|582211583|FG002|Overall Study|Withdrawal by Subject|123|||
161226713|NCT02465567|582211584|FG003|Overall Study|Withdrawal by Subject|130|||
161226714|NCT02465567|582211581|FG000|Overall Study|Physician Decision|23|||
161226715|NCT02465567|582211582|FG001|Overall Study|Physician Decision|33|||
160880982|NCT01008423|580957126|FG000|Overall Study|Adverse Event|13|||
160880983|NCT01008423|580957127|FG001|Overall Study|Adverse Event|6|||
160880984|NCT01008423|580957126|FG000|Overall Study|Withdrawal by Subject|4|||
160880985|NCT01008423|580957127|FG001|Overall Study|Withdrawal by Subject|7|||
160880986|NCT01008423|580957126|FG000|Overall Study|Lost to Follow-up|0|||
160880987|NCT01008423|580957127|FG001|Overall Study|Lost to Follow-up|2|||
160880988|NCT01008423|580957126|FG000|Overall Study|Low Cortisol|0|||
160880989|NCT01008423|580957127|FG001|Overall Study|Low Cortisol|1|||
160880990|NCT01008423|580957126|FG000|Overall Study|Lack of Efficacy|0|||
160880991|NCT01008423|580957127|FG001|Overall Study|Lack of Efficacy|5|||
161121558|NCT01241708|581833511|FG000|Overall Study|Withdrawal by Subject|6|||
161226716|NCT02465567|582211583|FG002|Overall Study|Physician Decision|38|||
160880992|NCT01008423|580957126|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
160880993|NCT01008423|580957127|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
160880994|NCT01008423|580957126|FG000|Overall Study|Personal Conflict|1|||
160880995|NCT01008423|580957127|FG001|Overall Study|Personal Conflict|0|||
160880996|NCT01008423|580957126|FG000|Overall Study|Other|0|||
160880997|NCT01008423|580957127|FG001|Overall Study|Other|1|||
160880998|NCT04391049|580958091|FG000|Overall Study|Protocol Violation|1|||
160880999|NCT01242813|580958092|FG000|Overall Study|Lost to Follow-up|2|||
160881000|NCT00958438|580958094|FG000|Overall Study|Protocol Violation|3|||
160881001|NCT00958438|580958095|FG001|Overall Study|Protocol Violation|2|||
160881002|NCT00958438|580958096|FG002|Overall Study|Protocol Violation|2|||
160881003|NCT00958438|580958094|FG000|Overall Study|Withdrawal by Subject|4|||
160881004|NCT00958438|580958095|FG001|Overall Study|Withdrawal by Subject|2|||
160881005|NCT00958438|580958096|FG002|Overall Study|Withdrawal by Subject|1|||
160881006|NCT00958438|580958094|FG000|Overall Study|Adverse Event|0|||
160881007|NCT00958438|580958095|FG001|Overall Study|Adverse Event|3|||
160881008|NCT00958438|580958096|FG002|Overall Study|Adverse Event|0|||
160881009|NCT00958438|580958094|FG000|Overall Study|Physician Decision|1|||
160881010|NCT00958438|580958095|FG001|Overall Study|Physician Decision|0|||
160881011|NCT00958438|580958096|FG002|Overall Study|Physician Decision|1|||
160881012|NCT00958438|580958094|FG000|Overall Study|Other than specified above|2|||
160881013|NCT00958438|580958095|FG001|Overall Study|Other than specified above|3|||
160881014|NCT00958438|580958096|FG002|Overall Study|Other than specified above|2|||
160881015|NCT02788279|580958097|FG000|Overall Study|Death|62|||
160881016|NCT02788279|580958098|FG001|Overall Study|Death|136|||
160881017|NCT02788279|580958099|FG002|Overall Study|Death|72|||
160881018|NCT02788279|580958097|FG000|Overall Study|Withdrawal by Subject|10|||
160881019|NCT02788279|580958098|FG001|Overall Study|Withdrawal by Subject|15|||
160881020|NCT02788279|580958099|FG002|Overall Study|Withdrawal by Subject|5|||
160881021|NCT02788279|580958097|FG000|Overall Study|Lost to Follow-up|0|||
160881022|NCT02788279|580958098|FG001|Overall Study|Lost to Follow-up|3|||
160881023|NCT02788279|580958099|FG002|Overall Study|Lost to Follow-up|2|||
160881024|NCT02788279|580958097|FG000|Overall Study|Sponsor decision|18|||
160881025|NCT02788279|580958098|FG001|Overall Study|Sponsor decision|29|||
160881026|NCT02788279|580958099|FG002|Overall Study|Sponsor decision|11|||
160881027|NCT00329849|580958101|FG000|Overall Study|Withdrawal by Subject|6|||
160881028|NCT00329849|580958102|FG001|Overall Study|Withdrawal by Subject|4|||
160881029|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
160881030|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881031|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881032|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881033|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160881034|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
161121559|NCT01241708|581833511|FG000|Overall Study|Screen Failure|6|||
161121560|NCT01241708|581833511|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
161121561|NCT01241708|581833511|FG000|Overall Study|Lost to Follow-up|5|||
161121562|NCT01790503|581833516|FG000|Overall Study|Adverse Event|1|||
161121563|NCT01790503|581833517|FG001|Overall Study|Adverse Event|0|||
161121564|NCT01790503|581833518|FG002|Overall Study|Adverse Event|0|||
161121565|NCT01790503|581833519|FG003|Overall Study|Adverse Event|0|||
161121566|NCT01790503|581833520|FG004|Overall Study|Adverse Event|0|||
161121567|NCT01790503|581833521|FG005|Overall Study|Adverse Event|2|||
161121568|NCT01790503|581833522|FG006|Overall Study|Adverse Event|0|||
161121569|NCT01790503|581833523|FG007|Overall Study|Adverse Event|0|||
161121570|NCT01790503|581833524|FG008|Overall Study|Adverse Event|2|||
161121571|NCT01790503|581833525|FG009|Overall Study|Adverse Event|4|||
161121572|NCT01790503|581833526|FG010|Overall Study|Adverse Event|7|||
160881035|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
160881036|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881037|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881038|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881039|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881040|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
160881041|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160881042|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881043|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881044|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881045|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881046|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160881047|NCT01133990|580958107|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
160881048|NCT01133990|580958108|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881049|NCT01133990|580958109|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881050|NCT01133990|580958110|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881051|NCT01133990|580958111|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881052|NCT01133990|580958112|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
160881053|NCT05277337|580958113|FG000|Overall Study|Lost to Follow-up|2|||
160881054|NCT05277337|580958114|FG001|Overall Study|Lost to Follow-up|0|||
160881055|NCT05277337|580958113|FG000|Overall Study|Withdrawal by Subject|1|||
160881056|NCT05277337|580958114|FG001|Overall Study|Withdrawal by Subject|0|||
160881057|NCT04987944|580958119|FG000|Overall Study|Adverse Event|0|||
160881058|NCT04987944|580958120|FG001|Overall Study|Adverse Event|1|||
160881059|NCT04987944|580958119|FG000|Overall Study|Withdrawal by Subject|0|||
160881060|NCT04987944|580958120|FG001|Overall Study|Withdrawal by Subject|1|||
160881061|NCT02946931|580958130|FG000|Overall Study|Did not require collection of CRFs|588|||
160881062|NCT02946931|580958130|FG000|Overall Study|Other than listed|37|||
160881063|NCT02946931|580958130|FG000|Overall Study|Discharge from hospital|118|||
160881064|NCT02946931|580958130|FG000|Overall Study|Adverse Event|81|||
160881065|NCT02946931|580958130|FG000|Overall Study|CRFs not valid|1|||
160881066|NCT02946931|580958130|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
160881067|NCT00869778|580958131|FG000|Overall Study|Adverse Event|2|||
160881068|NCT00869778|580958132|FG001|Overall Study|Adverse Event|0|||
160881069|NCT00869778|580958133|FG002|Overall Study|Adverse Event|0|||
160881070|NCT00869778|580958131|FG000|Overall Study|Withdrawal by Subject|3|||
160881071|NCT00869778|580958132|FG001|Overall Study|Withdrawal by Subject|4|||
160881072|NCT00869778|580958133|FG002|Overall Study|Withdrawal by Subject|5|||
160881073|NCT00869778|580958131|FG000|Overall Study|Pregnancy|1|||
160881074|NCT00869778|580958132|FG001|Overall Study|Pregnancy|0|||
160881075|NCT00869778|580958133|FG002|Overall Study|Pregnancy|0|||
160881076|NCT00869778|580958131|FG000|Overall Study|Protocol Violation|5|||
160881077|NCT00869778|580958132|FG001|Overall Study|Protocol Violation|3|||
160881078|NCT00869778|580958133|FG002|Overall Study|Protocol Violation|5|||
160881079|NCT00869778|580958131|FG000|Overall Study|Unblinding|1|||
160881080|NCT00869778|580958132|FG001|Overall Study|Unblinding|0|||
160881081|NCT00869778|580958133|FG002|Overall Study|Unblinding|0|||
160881082|NCT03339297|580958134|FG000|Overall Study|Relapse of Hematologic Disease|1|||
160881083|NCT03339297|580958135|FG001|Overall Study|Relapse of Hematologic Disease|0|||
160881084|NCT03339297|580958134|FG000|Overall Study|Death|10|||
160881085|NCT03339297|580958135|FG001|Overall Study|Death|7|||
160881086|NCT03339297|580958134|FG000|Overall Study|Hepatic Candidosis|1|||
160881087|NCT03339297|580958135|FG001|Overall Study|Hepatic Candidosis|0|||
161121573|NCT01790503|581833516|FG000|Overall Study|Withdrawal by Subject|0|||
161121574|NCT01790503|581833517|FG001|Overall Study|Withdrawal by Subject|0|||
161121575|NCT01790503|581833518|FG002|Overall Study|Withdrawal by Subject|1|||
161121576|NCT01790503|581833519|FG003|Overall Study|Withdrawal by Subject|1|||
160881088|NCT03339297|580958134|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
160881089|NCT03339297|580958135|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
160881090|NCT03339297|580958134|FG000|Overall Study|Consent Withdrawn by Participant|3|||
160881091|NCT03339297|580958135|FG001|Overall Study|Consent Withdrawn by Participant|3|||
160881092|NCT03339297|580958134|FG000|Overall Study|Disease Relapse|2|||
160881093|NCT03339297|580958135|FG001|Overall Study|Disease Relapse|0|||
160881094|NCT03339297|580958134|FG000|Overall Study|Physician Decision|1|||
160881095|NCT03339297|580958135|FG001|Overall Study|Physician Decision|1|||
161121577|NCT01790503|581833520|FG004|Overall Study|Withdrawal by Subject|1|||
161121578|NCT01790503|581833521|FG005|Overall Study|Withdrawal by Subject|2|||
161226717|NCT02465567|582211584|FG003|Overall Study|Physician Decision|28|||
160881096|NCT03339297|580958134|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
160881097|NCT03339297|580958135|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
160881098|NCT03339297|580958134|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
160881099|NCT03339297|580958135|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
160881100|NCT03339297|580958134|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
160881101|NCT03339297|580958135|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
160881102|NCT03339297|580958134|FG000|Overall Study|Adverse Event, Non-fatal|1|||
161121579|NCT01790503|581833522|FG006|Overall Study|Withdrawal by Subject|1|||
161121580|NCT01790503|581833523|FG007|Overall Study|Withdrawal by Subject|0|||
161121581|NCT01790503|581833524|FG008|Overall Study|Withdrawal by Subject|0|||
161121582|NCT01790503|581833525|FG009|Overall Study|Withdrawal by Subject|0|||
161121583|NCT01790503|581833526|FG010|Overall Study|Withdrawal by Subject|1|||
161121584|NCT01790503|581833516|FG000|Overall Study|Disease progression|2|||
161121585|NCT01790503|581833517|FG001|Overall Study|Disease progression|1|||
161121586|NCT01790503|581833518|FG002|Overall Study|Disease progression|0|||
161121587|NCT01790503|581833519|FG003|Overall Study|Disease progression|1|||
161121588|NCT01790503|581833520|FG004|Overall Study|Disease progression|2|||
161121589|NCT01790503|581833521|FG005|Overall Study|Disease progression|1|||
161121590|NCT01790503|581833522|FG006|Overall Study|Disease progression|0|||
161121591|NCT01790503|581833523|FG007|Overall Study|Disease progression|1|||
161121592|NCT01790503|581833524|FG008|Overall Study|Disease progression|0|||
161121593|NCT01790503|581833525|FG009|Overall Study|Disease progression|17|||
161121594|NCT01790503|581833526|FG010|Overall Study|Disease progression|7|||
161121595|NCT01790503|581833516|FG000|Overall Study|Protocol Violation|0|||
161121596|NCT01790503|581833517|FG001|Overall Study|Protocol Violation|0|||
161121597|NCT01790503|581833518|FG002|Overall Study|Protocol Violation|0|||
161121598|NCT01790503|581833519|FG003|Overall Study|Protocol Violation|0|||
161121599|NCT01790503|581833520|FG004|Overall Study|Protocol Violation|0|||
161121600|NCT01790503|581833521|FG005|Overall Study|Protocol Violation|0|||
161121601|NCT01790503|581833522|FG006|Overall Study|Protocol Violation|0|||
161121602|NCT01790503|581833523|FG007|Overall Study|Protocol Violation|0|||
161121603|NCT01790503|581833524|FG008|Overall Study|Protocol Violation|0|||
161121604|NCT01790503|581833525|FG009|Overall Study|Protocol Violation|1|||
161121605|NCT01790503|581833526|FG010|Overall Study|Protocol Violation|0|||
161121606|NCT01790503|581833516|FG000|Overall Study|Physician Decision|0|||
161121607|NCT01790503|581833517|FG001|Overall Study|Physician Decision|0|||
161121608|NCT01790503|581833518|FG002|Overall Study|Physician Decision|0|||
161121609|NCT01790503|581833519|FG003|Overall Study|Physician Decision|0|||
161121610|NCT01790503|581833520|FG004|Overall Study|Physician Decision|0|||
161121611|NCT01790503|581833521|FG005|Overall Study|Physician Decision|0|||
161121612|NCT01790503|581833522|FG006|Overall Study|Physician Decision|0|||
161121613|NCT01790503|581833523|FG007|Overall Study|Physician Decision|0|||
161121614|NCT01790503|581833524|FG008|Overall Study|Physician Decision|0|||
161121615|NCT01790503|581833525|FG009|Overall Study|Physician Decision|1|||
161121616|NCT01790503|581833526|FG010|Overall Study|Physician Decision|1|||
161121617|NCT01790503|581833516|FG000|Overall Study|Death|0|||
161121618|NCT01790503|581833517|FG001|Overall Study|Death|0|||
161121619|NCT01790503|581833518|FG002|Overall Study|Death|0|||
161121620|NCT01790503|581833519|FG003|Overall Study|Death|0|||
161121621|NCT01790503|581833520|FG004|Overall Study|Death|0|||
161121622|NCT01790503|581833521|FG005|Overall Study|Death|0|||
161121623|NCT01790503|581833522|FG006|Overall Study|Death|0|||
161121624|NCT01790503|581833523|FG007|Overall Study|Death|0|||
161121625|NCT01790503|581833524|FG008|Overall Study|Death|0|||
161121626|NCT01790503|581833525|FG009|Overall Study|Death|1|||
161121627|NCT01790503|581833526|FG010|Overall Study|Death|0|||
161121628|NCT01790503|581833516|FG000|Overall Study|Non Compliance|0|||
161121629|NCT01790503|581833517|FG001|Overall Study|Non Compliance|0|||
161121630|NCT01790503|581833518|FG002|Overall Study|Non Compliance|0|||
161121631|NCT01790503|581833519|FG003|Overall Study|Non Compliance|0|||
161121632|NCT01790503|581833520|FG004|Overall Study|Non Compliance|1|||
161121633|NCT01790503|581833521|FG005|Overall Study|Non Compliance|0|||
161121634|NCT01790503|581833522|FG006|Overall Study|Non Compliance|0|||
161121635|NCT01790503|581833523|FG007|Overall Study|Non Compliance|0|||
161121636|NCT01790503|581833524|FG008|Overall Study|Non Compliance|0|||
161121637|NCT01790503|581833525|FG009|Overall Study|Non Compliance|0|||
161121638|NCT01790503|581833526|FG010|Overall Study|Non Compliance|0|||
161121639|NCT01790503|581833516|FG000|Overall Study|Other|0|||
161121640|NCT01790503|581833517|FG001|Overall Study|Other|0|||
161121641|NCT01790503|581833518|FG002|Overall Study|Other|0|||
161121642|NCT01790503|581833519|FG003|Overall Study|Other|0|||
161121643|NCT01790503|581833520|FG004|Overall Study|Other|1|||
161121644|NCT01790503|581833521|FG005|Overall Study|Other|0|||
161121645|NCT01790503|581833522|FG006|Overall Study|Other|0|||
161121646|NCT01790503|581833523|FG007|Overall Study|Other|0|||
161121647|NCT01790503|581833524|FG008|Overall Study|Other|1|||
161121648|NCT01790503|581833525|FG009|Overall Study|Other|2|||
161121649|NCT01790503|581833526|FG010|Overall Study|Other|0|||
161121650|NCT00049673|581833527|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
161226718|NCT02465567|582211581|FG000|Overall Study|Major Protocol Deviation|24|||
161226719|NCT02465567|582211582|FG001|Overall Study|Major Protocol Deviation|26|||
161226720|NCT02465567|582211583|FG002|Overall Study|Major Protocol Deviation|22|||
161226721|NCT02465567|582211584|FG003|Overall Study|Major Protocol Deviation|25|||
160881103|NCT03339297|580958135|FG001|Overall Study|Adverse Event, Non-fatal|0|||
160881104|NCT03339297|580958134|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
160881105|NCT03339297|580958135|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
160881106|NCT03339297|580958134|FG000|Overall Study|Patient Was Not Eligible|1|||
160881107|NCT03339297|580958135|FG001|Overall Study|Patient Was Not Eligible|0|||
160881108|NCT03051620|580958138|FG000|Overall Study|Lost to Follow-up|6|||
160881109|NCT03051620|580958138|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
160881110|NCT00393510|580958139|FG000|Overall Study|Physician Decision|3|||
160881111|NCT00393510|580958140|FG001|Overall Study|Physician Decision|9|||
160881112|NCT02412488|580958141|FG000|Overall Study|Lost to Follow-up|10|||
160881113|NCT02412488|580958141|FG000|Overall Study|Withdrawal by Subject|5|||
160881114|NCT02412488|580958141|FG000|Overall Study|Physician Decision|1|||
160881115|NCT02412488|580958141|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
160881116|NCT02412488|580958141|FG000|Overall Study|Reveal LINQ explant|1|||
160881117|NCT00674154|580958142|FG000|Overall Study|Withdrawal by Subject|3|||
160881118|NCT00674154|580958143|FG001|Overall Study|Withdrawal by Subject|1|||
160881119|NCT00674154|580958142|FG000|Overall Study|Did not want parathyroidectomy|0|||
160881120|NCT00674154|580958143|FG001|Overall Study|Did not want parathyroidectomy|2|||
160881121|NCT00816023|580958144|FG000|Overall Study|Lost to Follow-up|1|||
160881122|NCT00816023|580958145|FG001|Overall Study|Lost to Follow-up|1|||
160881123|NCT00816023|580958146|FG002|Overall Study|Lost to Follow-up|0|||
160881124|NCT00816023|580958147|FG003|Overall Study|Lost to Follow-up|0|||
160881125|NCT00816023|580958144|FG000|Overall Study|Withdrawal by Subject|1|||
160881126|NCT00816023|580958145|FG001|Overall Study|Withdrawal by Subject|0|||
160881127|NCT00816023|580958146|FG002|Overall Study|Withdrawal by Subject|0|||
160881128|NCT00816023|580958147|FG003|Overall Study|Withdrawal by Subject|0|||
160881129|NCT00816023|580958144|FG000|Overall Study|Physician Decision|0|||
160881130|NCT00816023|580958145|FG001|Overall Study|Physician Decision|0|||
160881131|NCT00816023|580958146|FG002|Overall Study|Physician Decision|1|||
160881132|NCT00816023|580958147|FG003|Overall Study|Physician Decision|0|||
160881133|NCT00816023|580958144|FG000|Overall Study|assessments complete prior to window|1|||
160881134|NCT00816023|580958145|FG001|Overall Study|assessments complete prior to window|1|||
160881135|NCT00816023|580958146|FG002|Overall Study|assessments complete prior to window|2|||
160881136|NCT00816023|580958147|FG003|Overall Study|assessments complete prior to window|1|||
160881137|NCT00816023|580958144|FG000|Overall Study|Randomized Not Treated|6|||
160881138|NCT00816023|580958145|FG001|Overall Study|Randomized Not Treated|4|||
160881139|NCT00816023|580958146|FG002|Overall Study|Randomized Not Treated|6|||
160881140|NCT00816023|580958147|FG003|Overall Study|Randomized Not Treated|11|||
160881141|NCT03554486|580958148|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
160881142|NCT03554486|580958149|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
160881143|NCT03554486|580958150|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
160881144|NCT03554486|580958148|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
160881145|NCT03554486|580958149|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
160881146|NCT03554486|580958150|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
160881147|NCT03554486|580958148|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160881148|NCT03554486|580958149|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
160881149|NCT03554486|580958150|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
160881150|NCT03288142|580958151|FG000|Overall Study|Lost to Follow-up|22|||
160881151|NCT03288142|580958152|FG001|Overall Study|Lost to Follow-up|15|||
160881152|NCT02034409|580958153|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
160881153|NCT02034409|580958154|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
160881154|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
160881155|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
160881156|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
160881157|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
160881158|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
160881159|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
160881160|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
160881161|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
160881162|NCT02034409|580958153|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
160881163|NCT02034409|580958154|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
160881164|NCT02270944|580958158|FG000|Overall Study|Lost to Follow-up|9|||
160881165|NCT02270944|580958159|FG001|Overall Study|Lost to Follow-up|4|||
160881166|NCT02270944|580958158|FG000|Overall Study|Withdrawal by Subject|2|||
160881167|NCT02270944|580958159|FG001|Overall Study|Withdrawal by Subject|1|||
161226722|NCT02465567|582211581|FG000|Overall Study|Lost to Follow-up|25|||
161226723|NCT02465567|582211582|FG001|Overall Study|Lost to Follow-up|21|||
161226724|NCT02465567|582211583|FG002|Overall Study|Lost to Follow-up|19|||
160881168|NCT02342418|580958160|FG000|Overall Study|Adverse Event|0|||
160881169|NCT02342418|580958161|FG001|Overall Study|Adverse Event|1|||
160881170|NCT01699867|580958162|FG000|Overall Study|Screening Failure|3|||
160881171|NCT04255394|580958163|FG000|Overall Study|Death|35|||
160881172|NCT04255394|580958164|FG001|Overall Study|Death|25|||
160881173|NCT04255394|580958163|FG000|Overall Study|Device removed|2|||
160881174|NCT04255394|580958164|FG001|Overall Study|Device removed|10|||
160881175|NCT04255394|580958163|FG000|Overall Study|Withdrawal by Subject|9|||
160881176|NCT04255394|580958164|FG001|Overall Study|Withdrawal by Subject|8|||
160881177|NCT04255394|580958163|FG000|Overall Study|Screen Failure/Not treated|12|||
160881178|NCT04255394|580958164|FG001|Overall Study|Screen Failure/Not treated|8|||
161226725|NCT02465567|582211584|FG003|Overall Study|Lost to Follow-up|15|||
161226726|NCT02465567|582211581|FG000|Overall Study|Protocol Specified Criteria|20|||
161226727|NCT02465567|582211582|FG001|Overall Study|Protocol Specified Criteria|10|||
161226728|NCT02465567|582211583|FG002|Overall Study|Protocol Specified Criteria|9|||
160881179|NCT04255394|580958163|FG000|Overall Study|Lost to Follow-up|123|||
160881180|NCT04255394|580958164|FG001|Overall Study|Lost to Follow-up|265|||
160881181|NCT04255394|580958163|FG000|Overall Study|Adverse Event|1|||
160881182|NCT04255394|580958164|FG001|Overall Study|Adverse Event|3|||
160881183|NCT01181986|580958169|FG000|Phase 1|Lost to Follow-up|0|||
160881184|NCT01181986|580958170|FG001|Phase 1|Lost to Follow-up|1|||
160881185|NCT01181986|580958171|FG002|Phase 1|Lost to Follow-up|1|||
160881186|NCT01181986|580958169|FG000|Phase 1|Adverse Event|0|||
160881187|NCT01181986|580958170|FG001|Phase 1|Adverse Event|0|||
160881188|NCT01181986|580958171|FG002|Phase 1|Adverse Event|1|||
160881189|NCT01181986|580958169|FG000|Phase 1|Protocol Violation|1|||
160881190|NCT01181986|580958170|FG001|Phase 1|Protocol Violation|0|||
160881191|NCT01181986|580958171|FG002|Phase 1|Protocol Violation|0|||
160881192|NCT01181986|580958169|FG000|Phase 2|Adverse Event|0|||
160881193|NCT01181986|580958170|FG001|Phase 2|Adverse Event|3|||
160881194|NCT01181986|580958171|FG002|Phase 2|Adverse Event|0|||
160881195|NCT01181986|580958169|FG000|Phase 2|Medical condition|0|||
160881196|NCT01181986|580958170|FG001|Phase 2|Medical condition|1|||
160881197|NCT01181986|580958171|FG002|Phase 2|Medical condition|0|||
160881198|NCT00831493|580958172|FG000|Overall Study|Intractable nausea and vomiting|1|||
160881199|NCT00835731|580958175|FG000|Overall Study|Withdrawal by Subject|1|||
160881200|NCT00835731|580958176|FG001|Overall Study|Withdrawal by Subject|0|||
160881201|NCT00835731|580958175|FG000|Overall Study|Physician Decision|1|||
160881202|NCT00835731|580958176|FG001|Overall Study|Physician Decision|1|||
160881203|NCT00348881|580958177|FG000|Overall Study|Lost to Follow-up|12|||
160881204|NCT00348881|580958178|FG001|Overall Study|Lost to Follow-up|6|||
160881205|NCT00348881|580958177|FG000|Overall Study|Withdrawal by Subject|3|||
160881206|NCT00348881|580958178|FG001|Overall Study|Withdrawal by Subject|4|||
160881207|NCT00348881|580958177|FG000|Overall Study|Adverse Event|2|||
160881208|NCT00348881|580958178|FG001|Overall Study|Adverse Event|0|||
160881209|NCT00348881|580958177|FG000|Overall Study|Serious Adverse Event|0|||
160881210|NCT00348881|580958178|FG001|Overall Study|Serious Adverse Event|2|||
160881211|NCT05092360|580958186|FG000|Overall Study|Withdrawal by Subject|21|||
160881212|NCT05092360|580958187|FG001|Overall Study|Withdrawal by Subject|4|||
160881213|NCT05092360|580958188|FG002|Overall Study|Withdrawal by Subject|9|||
160881214|NCT05092360|580958189|FG003|Overall Study|Withdrawal by Subject|26|||
160881215|NCT05092360|580958186|FG000|Overall Study|Death|97|||
160881216|NCT05092360|580958187|FG001|Overall Study|Death|14|||
160881217|NCT05092360|580958188|FG002|Overall Study|Death|31|||
160881218|NCT05092360|580958189|FG003|Overall Study|Death|101|||
160881219|NCT05092360|580958186|FG000|Overall Study|Lost to Follow-up|1|||
160881220|NCT05092360|580958187|FG001|Overall Study|Lost to Follow-up|2|||
160881221|NCT05092360|580958188|FG002|Overall Study|Lost to Follow-up|2|||
160881222|NCT05092360|580958189|FG003|Overall Study|Lost to Follow-up|2|||
160881223|NCT05092360|580958186|FG000|Overall Study|Study terminated by sponsor|65|||
160881224|NCT05092360|580958187|FG001|Overall Study|Study terminated by sponsor|7|||
161226729|NCT02465567|582211584|FG003|Overall Study|Protocol Specified Criteria|12|||
160881225|NCT05092360|580958188|FG002|Overall Study|Study terminated by sponsor|13|||
160881226|NCT05092360|580958189|FG003|Overall Study|Study terminated by sponsor|61|||
160881227|NCT01675167|580958190|FG000|Open-label Titration Phase|Adverse Event|81|||
160881228|NCT01675167|580958191|FG001|Open-label Titration Phase|Adverse Event|0|||
160881229|NCT01675167|580958192|FG002|Open-label Titration Phase|Adverse Event|0|||
160881230|NCT01675167|580958190|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
160881231|NCT01675167|580958191|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
160881232|NCT01675167|580958192|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
160881233|NCT01675167|580958190|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
160881234|NCT01675167|580958191|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
160881235|NCT01675167|580958192|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
160881236|NCT01675167|580958190|FG000|Open-label Titration Phase|Protocol Violation|43|||
160881237|NCT01675167|580958191|FG001|Open-label Titration Phase|Protocol Violation|0|||
160881238|NCT01675167|580958192|FG002|Open-label Titration Phase|Protocol Violation|0|||
160881239|NCT01675167|580958190|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
161226730|NCT02465567|582211581|FG000|Overall Study|Administrative Reasons|12|||
161226731|NCT02465567|582211582|FG001|Overall Study|Administrative Reasons|9|||
161226732|NCT02465567|582211583|FG002|Overall Study|Administrative Reasons|11|||
161226733|NCT02465567|582211584|FG003|Overall Study|Administrative Reasons|5|||
161226734|NCT02465567|582211581|FG000|Overall Study|Randomized but not treated|1|||
161226735|NCT02465567|582211582|FG001|Overall Study|Randomized but not treated|5|||
161226736|NCT02465567|582211583|FG002|Overall Study|Randomized but not treated|4|||
161226737|NCT02465567|582211584|FG003|Overall Study|Randomized but not treated|5|||
161226738|NCT02465567|582211581|FG000|Overall Study|enrolled in >1 studies|18|||
161226739|NCT02465567|582211582|FG001|Overall Study|enrolled in >1 studies|11|||
161226740|NCT02465567|582211583|FG002|Overall Study|enrolled in >1 studies|19|||
161226741|NCT02465567|582211584|FG003|Overall Study|enrolled in >1 studies|15|||
161226742|NCT02465567|582211581|FG000|Overall Study|missing PI Signature|1|||
161226743|NCT02465567|582211582|FG001|Overall Study|missing PI Signature|0|||
161226744|NCT02465567|582211583|FG002|Overall Study|missing PI Signature|0|||
161226745|NCT02465567|582211584|FG003|Overall Study|missing PI Signature|0|||
161226746|NCT00950807|582211586|FG000|Treatment Period 1|Lack of Efficacy|1|||
161226747|NCT00950807|582211587|FG001|Treatment Period 1|Lack of Efficacy|0|||
161226748|NCT00950807|582211588|FG002|Treatment Period 1|Lack of Efficacy|0|||
161226749|NCT00950807|582211589|FG003|Treatment Period 1|Lack of Efficacy|0|||
161226750|NCT00950807|582211590|FG004|Treatment Period 1|Lack of Efficacy|0|||
161226751|NCT00950807|582211591|FG005|Treatment Period 1|Lack of Efficacy|1|||
161226752|NCT00950807|582211592|FG006|Treatment Period 1|Lack of Efficacy|0|||
161226753|NCT00950807|582211593|FG007|Treatment Period 1|Lack of Efficacy|0|||
161226754|NCT00950807|582211594|FG008|Treatment Period 1|Lack of Efficacy|0|||
161226755|NCT00950807|582211595|FG009|Treatment Period 1|Lack of Efficacy|0|||
161226756|NCT00950807|582211586|FG000|Treatment Period 1|Protocol Violation|1|||
161226757|NCT00950807|582211587|FG001|Treatment Period 1|Protocol Violation|0|||
161226758|NCT00950807|582211588|FG002|Treatment Period 1|Protocol Violation|0|||
161226759|NCT00950807|582211589|FG003|Treatment Period 1|Protocol Violation|0|||
161226760|NCT00950807|582211590|FG004|Treatment Period 1|Protocol Violation|0|||
161226761|NCT00950807|582211591|FG005|Treatment Period 1|Protocol Violation|0|||
161226762|NCT00950807|582211592|FG006|Treatment Period 1|Protocol Violation|0|||
161226763|NCT00950807|582211593|FG007|Treatment Period 1|Protocol Violation|0|||
161226764|NCT00950807|582211594|FG008|Treatment Period 1|Protocol Violation|0|||
161226765|NCT00950807|582211595|FG009|Treatment Period 1|Protocol Violation|0|||
161226766|NCT00950807|582211586|FG000|Treatment Period 1|Lost to Follow-up|0|||
161226767|NCT00950807|582211587|FG001|Treatment Period 1|Lost to Follow-up|0|||
160881240|NCT01675167|580958191|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
160881241|NCT01675167|580958192|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
160881242|NCT01675167|580958190|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
160881243|NCT01675167|580958191|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
160881244|NCT01675167|580958192|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
160881245|NCT01675167|580958190|FG000|Open-label Titration Phase|Other|55|||
160881246|NCT01675167|580958191|FG001|Open-label Titration Phase|Other|0|||
160881247|NCT01675167|580958192|FG002|Open-label Titration Phase|Other|0|||
160881248|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
160881249|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
160881250|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
160881251|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160881252|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
160881253|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
160881254|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160881255|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Adverse Event|5|||
160881256|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Adverse Event|13|||
160881257|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
160881258|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
160881259|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
160881260|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160881261|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
160881262|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
161226768|NCT00950807|582211588|FG002|Treatment Period 1|Lost to Follow-up|1|||
161226769|NCT00950807|582211589|FG003|Treatment Period 1|Lost to Follow-up|0|||
161226770|NCT00950807|582211590|FG004|Treatment Period 1|Lost to Follow-up|0|||
161226771|NCT00950807|582211591|FG005|Treatment Period 1|Lost to Follow-up|0|||
161226772|NCT00950807|582211592|FG006|Treatment Period 1|Lost to Follow-up|0|||
161226773|NCT00950807|582211593|FG007|Treatment Period 1|Lost to Follow-up|0|||
160881263|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
160881264|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
161226774|NCT00950807|582211594|FG008|Treatment Period 1|Lost to Follow-up|0|||
161226775|NCT00950807|582211595|FG009|Treatment Period 1|Lost to Follow-up|0|||
161226776|NCT00950807|582211586|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161226777|NCT00950807|582211587|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161226778|NCT00950807|582211588|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160881265|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
160881266|NCT01675167|580958190|FG000|Double-blind Treatment Phase|Other|0|||
160881267|NCT01675167|580958191|FG001|Double-blind Treatment Phase|Other|7|||
160881268|NCT01675167|580958192|FG002|Double-blind Treatment Phase|Other|5|||
160881269|NCT01525225|580958195|FG000|Enrollment|No longer met study criteria|1|||
160881270|NCT01525225|580958195|FG000|Enrollment|Other|1|||
160881271|NCT01379508|580958196|FG000|Treatment to Week 104|Adverse Event|2|||
160881272|NCT01379508|580958197|FG001|Treatment to Week 104|Adverse Event|0|||
160881273|NCT01379508|580958198|FG002|Treatment to Week 104|Adverse Event|5|||
160881274|NCT01379508|580958199|FG003|Treatment to Week 104|Adverse Event|0|||
160881275|NCT01379508|580958196|FG000|Treatment to Week 104|Abnormal lab value|1|||
160881276|NCT01379508|580958197|FG001|Treatment to Week 104|Abnormal lab value|0|||
160881277|NCT01379508|580958198|FG002|Treatment to Week 104|Abnormal lab value|0|||
160881278|NCT01379508|580958199|FG003|Treatment to Week 104|Abnormal lab value|0|||
160881279|NCT01379508|580958196|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
160881280|NCT01379508|580958197|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
160881281|NCT01379508|580958198|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
160881282|NCT01379508|580958199|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
160881283|NCT01379508|580958196|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
160881284|NCT01379508|580958197|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
160881285|NCT01379508|580958198|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
160881286|NCT01379508|580958199|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
160881287|NCT01379508|580958196|FG000|Treatment to Week 104|Lost to Follow-up|5|||
160881288|NCT01379508|580958197|FG001|Treatment to Week 104|Lost to Follow-up|0|||
160881289|NCT01379508|580958198|FG002|Treatment to Week 104|Lost to Follow-up|3|||
160881290|NCT01379508|580958199|FG003|Treatment to Week 104|Lost to Follow-up|0|||
160881291|NCT01379508|580958196|FG000|Treatment to Week 104|Administrative problems|3|||
160881292|NCT01379508|580958197|FG001|Treatment to Week 104|Administrative problems|1|||
160881293|NCT01379508|580958198|FG002|Treatment to Week 104|Administrative problems|0|||
160881294|NCT01379508|580958199|FG003|Treatment to Week 104|Administrative problems|0|||
160881295|NCT01379508|580958196|FG000|Treatment to Week 104|Protocol Violation|1|||
160881296|NCT01379508|580958197|FG001|Treatment to Week 104|Protocol Violation|1|||
160881297|NCT01379508|580958198|FG002|Treatment to Week 104|Protocol Violation|1|||
160881298|NCT01379508|580958199|FG003|Treatment to Week 104|Protocol Violation|0|||
160881299|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
160881300|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
160881301|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
160881302|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
160881303|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
160881304|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
160881305|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
160881306|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
160881307|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
160881308|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
160881309|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
160881310|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
160881311|NCT01379508|580958196|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
160881312|NCT01379508|580958197|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
160881313|NCT01379508|580958198|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
160881314|NCT01379508|580958199|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
160881315|NCT01182844|580958200|FG000|Overall Study|Withdrawal by Subject|0|||
160881316|NCT01182844|580958201|FG001|Overall Study|Withdrawal by Subject|2|||
160881317|NCT03952039|580958204|FG000|Overall Study|Adverse Event|22|||
160881318|NCT03952039|580958205|FG001|Overall Study|Adverse Event|8|||
160881319|NCT03952039|580958204|FG000|Overall Study|Withdrawal by Participant|17|||
160881320|NCT03952039|580958205|FG001|Overall Study|Withdrawal by Participant|12|||
160881321|NCT03952039|580958204|FG000|Overall Study|Death|13|||
160881322|NCT03952039|580958205|FG001|Overall Study|Death|6|||
160881323|NCT03952039|580958204|FG000|Overall Study|Lack of Efficacy|12|||
160881324|NCT03952039|580958205|FG001|Overall Study|Lack of Efficacy|2|||
160881325|NCT03952039|580958204|FG000|Overall Study|Physician Decision|9|||
160881326|NCT03952039|580958205|FG001|Overall Study|Physician Decision|3|||
160881327|NCT03952039|580958204|FG000|Overall Study|Progressive Disease|6|||
160881328|NCT03952039|580958205|FG001|Overall Study|Progressive Disease|4|||
160881329|NCT03952039|580958204|FG000|Overall Study|Other Reasons|12|||
160881330|NCT03952039|580958205|FG001|Overall Study|Other Reasons|4|||
160881331|NCT02055365|580960504|FG000|Overall Study|Prematurely Withdrawn|1|||
160881332|NCT03603509|580960508|FG000|Overall Study|Lost to Follow-up|3|||
160881333|NCT03603509|580960509|FG001|Overall Study|Lost to Follow-up|4|||
160881334|NCT02656680|580960512|FG000|Overall Study|Lost to Follow-up|0|||
160881335|NCT02656680|580960513|FG001|Overall Study|Lost to Follow-up|1|||
160881336|NCT02656680|580960514|FG002|Overall Study|Lost to Follow-up|7|||
160881337|NCT01258998|580960515|FG000|Overall Study|Ineligible|1|||
160881338|NCT01143389|580960516|FG000|Overall Study|Lost to Follow-up|26|||
160881339|NCT01143389|580960517|FG001|Overall Study|Lost to Follow-up|25|||
160881340|NCT04966910|580960520|FG000|Baseline|Participant did not complete measure|0|||
160881341|NCT04966910|580960521|FG001|Baseline|Participant did not complete measure|0|||
160881342|NCT04966910|580960522|FG002|Baseline|Participant did not complete measure|1|||
160881343|NCT04966910|580960523|FG003|Baseline|Participant did not complete measure|0|||
160881344|NCT04966910|580960520|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
160881345|NCT04966910|580960521|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
160881346|NCT04966910|580960522|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
160881347|NCT04966910|580960523|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
160881348|NCT04966910|580960520|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
160881349|NCT04966910|580960521|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
160881350|NCT04966910|580960522|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
160881351|NCT04966910|580960523|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
160881352|NCT04966910|580960520|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
160881353|NCT04966910|580960521|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
160881354|NCT04966910|580960522|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
160881355|NCT04966910|580960523|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
160881356|NCT00002931|580960524|FG000|Overall Study|rapidly progressing disease during|2|||
160881357|NCT04531462|580960533|FG000|Overall Study|Withdrawal by Subject|3|||
160881358|NCT04531462|580960534|FG001|Overall Study|Withdrawal by Subject|1|||
160881359|NCT04531462|580960533|FG000|Overall Study|Adverse Event|3|||
160881360|NCT04531462|580960534|FG001|Overall Study|Adverse Event|3|||
160881361|NCT00504582|580960535|FG000|Overall Study|Lost to Follow-up|1|||
160881362|NCT00504582|580960536|FG001|Overall Study|Lost to Follow-up|0|||
160881363|NCT00504582|580960537|FG002|Overall Study|Lost to Follow-up|0|||
160881364|NCT01264081|580960540|FG000|Participants Screened|Screening failures|30|||
160881365|NCT01264081|580960540|FG000|Started Treatment|Withdrawal by Subject|1|||
160881366|NCT01264081|580960540|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
160881367|NCT02716896|580960541|FG000|Overall Study|Physician Decision|0|||
160881368|NCT02716896|580960542|FG001|Overall Study|Physician Decision|1|||
160881369|NCT01727700|580960543|FG000|Overall Study|Adverse Event|0|||
160881370|NCT01727700|580960544|FG001|Overall Study|Adverse Event|7|||
160881371|NCT01727700|580960545|FG002|Overall Study|Adverse Event|1|||
160881372|NCT01727700|580960543|FG000|Overall Study|Particpant withdrew consent|0|||
160881373|NCT01727700|580960544|FG001|Overall Study|Particpant withdrew consent|3|||
160881374|NCT01727700|580960545|FG002|Overall Study|Particpant withdrew consent|1|||
160881375|NCT01727700|580960543|FG000|Overall Study|Protocol Violation|2|||
160881376|NCT01727700|580960544|FG001|Overall Study|Protocol Violation|0|||
160881377|NCT01727700|580960545|FG002|Overall Study|Protocol Violation|0|||
160881378|NCT01757691|580960547|FG000|Overall Study|Administrative problems|2|||
160881379|NCT01757691|580960548|FG001|Overall Study|Administrative problems|0|||
160881380|NCT02054481|580960552|FG000|Overall Study|Adverse Event|1|||
160881381|NCT02054481|580960553|FG001|Overall Study|Adverse Event|1|||
160881382|NCT02054481|580960554|FG002|Overall Study|Adverse Event|0|||
160881383|NCT02054481|580960555|FG003|Overall Study|Adverse Event|1|||
160881384|NCT02054481|580960552|FG000|Overall Study|Lost to Follow-up|1|||
160881385|NCT02054481|580960553|FG001|Overall Study|Lost to Follow-up|0|||
160881386|NCT02054481|580960554|FG002|Overall Study|Lost to Follow-up|0|||
160881387|NCT02054481|580960555|FG003|Overall Study|Lost to Follow-up|0|||
160881388|NCT02054481|580960552|FG000|Overall Study|Other reason|2|||
160881389|NCT02054481|580960553|FG001|Overall Study|Other reason|1|||
160881390|NCT02054481|580960554|FG002|Overall Study|Other reason|2|||
160881391|NCT02054481|580960555|FG003|Overall Study|Other reason|0|||
160881392|NCT01012219|580960557|FG000|Period 1|Withdrawal by Subject|1|||
160881393|NCT01012219|580960557|FG000|Period 2|Withdrawal by Subject|1|||
160881394|NCT01909791|580960558|FG000|Overall Study|Death|9|||
160881395|NCT01909791|580960559|FG001|Overall Study|Death|8|||
160881396|NCT01909791|580960560|FG002|Overall Study|Death|4|||
160881397|NCT01909791|580960558|FG000|Overall Study|Withdrawal by Subject|5|||
160881398|NCT01909791|580960559|FG001|Overall Study|Withdrawal by Subject|9|||
160881399|NCT01909791|580960560|FG002|Overall Study|Withdrawal by Subject|13|||
160881400|NCT01909791|580960558|FG000|Overall Study|Lost to Follow-up|5|||
160881401|NCT01909791|580960559|FG001|Overall Study|Lost to Follow-up|11|||
160881402|NCT01909791|580960560|FG002|Overall Study|Lost to Follow-up|10|||
160881403|NCT01909791|580960558|FG000|Overall Study|Missed Visit|2|||
160881404|NCT01909791|580960559|FG001|Overall Study|Missed Visit|0|||
160881405|NCT01909791|580960560|FG002|Overall Study|Missed Visit|1|||
160881406|NCT01328366|580960563|FG000|Overall Study|Death|1|||
160881407|NCT01328366|580960563|FG000|Overall Study|Withdrawal by Subject|2|||
160881408|NCT01328366|580960563|FG000|Overall Study|Lost to Follow-up|7|||
160881409|NCT01713933|580960564|FG000|Overall Study|Lost to Follow-up|2|||
160881410|NCT01713933|580960564|FG000|Overall Study|Withdrawal by Subject|3|||
160881411|NCT01713933|580960564|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
160881412|NCT00528970|580960565|FG000|Overall Study|Adverse Event|6|||
160881413|NCT00528970|580960566|FG001|Overall Study|Adverse Event|8|||
160881414|NCT00528970|580960567|FG002|Overall Study|Adverse Event|5|||
160881415|NCT00528970|580960565|FG000|Overall Study|Lost to Follow-up|0|||
160881416|NCT00528970|580960566|FG001|Overall Study|Lost to Follow-up|0|||
160881417|NCT00528970|580960567|FG002|Overall Study|Lost to Follow-up|1|||
160881418|NCT00528970|580960565|FG000|Overall Study|Other than specified|2|||
160881419|NCT00528970|580960566|FG001|Overall Study|Other than specified|3|||
160881420|NCT00528970|580960567|FG002|Overall Study|Other than specified|3|||
160881421|NCT00528970|580960565|FG000|Overall Study|Protocol Violation|2|||
160881422|NCT00528970|580960566|FG001|Overall Study|Protocol Violation|1|||
160881423|NCT00528970|580960567|FG002|Overall Study|Protocol Violation|4|||
160881424|NCT00528970|580960565|FG000|Overall Study|Lack of Efficacy|0|||
160881425|NCT00528970|580960566|FG001|Overall Study|Lack of Efficacy|0|||
160881426|NCT00528970|580960567|FG002|Overall Study|Lack of Efficacy|1|||
160881427|NCT00528970|580960565|FG000|Overall Study|Withdrawal by Subject|4|||
160881428|NCT00528970|580960566|FG001|Overall Study|Withdrawal by Subject|3|||
160881429|NCT00528970|580960567|FG002|Overall Study|Withdrawal by Subject|5|||
160881430|NCT00528970|580960565|FG000|Overall Study|Randomized but not treated|0|||
160881431|NCT00528970|580960566|FG001|Overall Study|Randomized but not treated|0|||
160881432|NCT00528970|580960567|FG002|Overall Study|Randomized but not treated|1|||
160881433|NCT02882152|580960568|FG000|Overall Study|Lost to Follow-up|1|||
160881434|NCT02882152|580960569|FG001|Overall Study|Lost to Follow-up|0|||
160881435|NCT01009840|580960570|FG000|Overall Study|Lost to Follow-up|1|||
160881436|NCT01009840|580960570|FG000|Overall Study|Adverse Event|4|||
160881437|NCT01009840|580960570|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
160881438|NCT01009840|580960570|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
160881439|NCT01009840|580960570|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
160881440|NCT01104376|580960573|FG000|Overall Study|Withdrawal by Subject|15|||
160881441|NCT01104376|580960573|FG000|Overall Study|Consented but excluded after labs|13|||
160881442|NCT00797966|580960576|FG000|Phase A|Lost to Follow-up|0|||
160881443|NCT00797966|580960577|FG001|Phase A|Lost to Follow-up|0|||
160881444|NCT00797966|580960578|FG002|Phase A|Lost to Follow-up|0|||
160881445|NCT00797966|580960579|FG003|Phase A|Lost to Follow-up|0|||
160881446|NCT00797966|580960580|FG004|Phase A|Lost to Follow-up|33|||
160881447|NCT00797966|580960581|FG005|Phase A|Lost to Follow-up|0|||
160881448|NCT00797966|580960576|FG000|Phase A|Adverse Event|0|||
160881449|NCT00797966|580960577|FG001|Phase A|Adverse Event|0|||
160881450|NCT00797966|580960578|FG002|Phase A|Adverse Event|0|||
160881451|NCT00797966|580960579|FG003|Phase A|Adverse Event|0|||
160881452|NCT00797966|580960580|FG004|Phase A|Adverse Event|46|||
160881453|NCT00797966|580960581|FG005|Phase A|Adverse Event|0|||
160881454|NCT00797966|580960576|FG000|Phase A|Met withdrawal criteria|0|||
160881455|NCT00797966|580960577|FG001|Phase A|Met withdrawal criteria|0|||
160881456|NCT00797966|580960578|FG002|Phase A|Met withdrawal criteria|0|||
160881457|NCT00797966|580960579|FG003|Phase A|Met withdrawal criteria|0|||
160881458|NCT00797966|580960580|FG004|Phase A|Met withdrawal criteria|4|||
160881459|NCT00797966|580960581|FG005|Phase A|Met withdrawal criteria|0|||
160881460|NCT00797966|580960576|FG000|Phase A|Physician Decision|0|||
160881461|NCT00797966|580960577|FG001|Phase A|Physician Decision|0|||
160881462|NCT00797966|580960578|FG002|Phase A|Physician Decision|0|||
160881463|NCT00797966|580960579|FG003|Phase A|Physician Decision|0|||
160881464|NCT00797966|580960580|FG004|Phase A|Physician Decision|13|||
160881465|NCT00797966|580960581|FG005|Phase A|Physician Decision|0|||
160881466|NCT00797966|580960576|FG000|Phase A|Withdrawal by Subject|0|||
160881467|NCT00797966|580960577|FG001|Phase A|Withdrawal by Subject|0|||
160881468|NCT00797966|580960578|FG002|Phase A|Withdrawal by Subject|0|||
160881469|NCT00797966|580960579|FG003|Phase A|Withdrawal by Subject|0|||
160881470|NCT00797966|580960580|FG004|Phase A|Withdrawal by Subject|33|||
160881471|NCT00797966|580960581|FG005|Phase A|Withdrawal by Subject|0|||
160881472|NCT00797966|580960576|FG000|Phase A|Protocol deviation|0|||
160881473|NCT00797966|580960577|FG001|Phase A|Protocol deviation|0|||
160881474|NCT00797966|580960578|FG002|Phase A|Protocol deviation|0|||
160881475|NCT00797966|580960579|FG003|Phase A|Protocol deviation|0|||
160881476|NCT00797966|580960580|FG004|Phase A|Protocol deviation|56|||
160881477|NCT00797966|580960581|FG005|Phase A|Protocol deviation|0|||
160881478|NCT00797966|580960576|FG000|Phase B|Lost to Follow-up|0|||
160881479|NCT00797966|580960577|FG001|Phase B|Lost to Follow-up|1|||
160881480|NCT00797966|580960578|FG002|Phase B|Lost to Follow-up|3|||
160881481|NCT00797966|580960579|FG003|Phase B|Lost to Follow-up|0|||
160881482|NCT00797966|580960580|FG004|Phase B|Lost to Follow-up|0|||
160881483|NCT00797966|580960581|FG005|Phase B|Lost to Follow-up|0|||
160881484|NCT00797966|580960576|FG000|Phase B|Adverse Event|2|||
160881485|NCT00797966|580960577|FG001|Phase B|Adverse Event|1|||
160881486|NCT00797966|580960578|FG002|Phase B|Adverse Event|3|||
160881487|NCT00797966|580960579|FG003|Phase B|Adverse Event|1|||
160881488|NCT00797966|580960580|FG004|Phase B|Adverse Event|0|||
160881489|NCT00797966|580960581|FG005|Phase B|Adverse Event|0|||
160881490|NCT00797966|580960576|FG000|Phase B|Met Withdrawal Criteria|3|||
160881491|NCT00797966|580960577|FG001|Phase B|Met Withdrawal Criteria|3|||
160881492|NCT00797966|580960578|FG002|Phase B|Met Withdrawal Criteria|6|||
160881493|NCT00797966|580960579|FG003|Phase B|Met Withdrawal Criteria|1|||
160881494|NCT00797966|580960580|FG004|Phase B|Met Withdrawal Criteria|0|||
160881495|NCT00797966|580960581|FG005|Phase B|Met Withdrawal Criteria|0|||
160881496|NCT00797966|580960576|FG000|Phase B|Physician Decision|1|||
160881497|NCT00797966|580960577|FG001|Phase B|Physician Decision|0|||
160881498|NCT00797966|580960578|FG002|Phase B|Physician Decision|3|||
160881499|NCT00797966|580960579|FG003|Phase B|Physician Decision|1|||
160881500|NCT00797966|580960580|FG004|Phase B|Physician Decision|0|||
160881501|NCT00797966|580960581|FG005|Phase B|Physician Decision|0|||
160881502|NCT00797966|580960576|FG000|Phase B|Withdrawal by Subject|1|||
160881503|NCT00797966|580960577|FG001|Phase B|Withdrawal by Subject|4|||
160881504|NCT00797966|580960578|FG002|Phase B|Withdrawal by Subject|3|||
160881505|NCT00797966|580960579|FG003|Phase B|Withdrawal by Subject|3|||
160881506|NCT00797966|580960580|FG004|Phase B|Withdrawal by Subject|0|||
160881507|NCT00797966|580960581|FG005|Phase B|Withdrawal by Subject|0|||
160881508|NCT00797966|580960576|FG000|Phase B|Protocol Deviation|4|||
161121651|NCT00049673|581833528|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
161121652|NCT01535729|581833529|FG000|Overall Study|Withdrawal by Subject|2|||
161121653|NCT01535729|581833529|FG000|Overall Study|Disease progression|230|||
160881509|NCT00797966|580960577|FG001|Phase B|Protocol Deviation|8|||
160881510|NCT00797966|580960578|FG002|Phase B|Protocol Deviation|2|||
160881511|NCT00797966|580960579|FG003|Phase B|Protocol Deviation|6|||
160881512|NCT00797966|580960580|FG004|Phase B|Protocol Deviation|0|||
160881513|NCT00797966|580960581|FG005|Phase B|Protocol Deviation|0|||
160881514|NCT00797966|580960576|FG000|Phase B|Lack of Efficacy|0|||
160881515|NCT00797966|580960577|FG001|Phase B|Lack of Efficacy|1|||
160881516|NCT00797966|580960578|FG002|Phase B|Lack of Efficacy|1|||
160881517|NCT00797966|580960579|FG003|Phase B|Lack of Efficacy|4|||
160881518|NCT00797966|580960580|FG004|Phase B|Lack of Efficacy|0|||
160881519|NCT00797966|580960581|FG005|Phase B|Lack of Efficacy|0|||
160881520|NCT00797966|580960576|FG000|Phase A+|Lost to Follow-up|0|||
160881521|NCT00797966|580960577|FG001|Phase A+|Lost to Follow-up|0|||
160881522|NCT00797966|580960578|FG002|Phase A+|Lost to Follow-up|0|||
160881523|NCT00797966|580960579|FG003|Phase A+|Lost to Follow-up|0|||
160881524|NCT00797966|580960580|FG004|Phase A+|Lost to Follow-up|0|||
160881525|NCT00797966|580960581|FG005|Phase A+|Lost to Follow-up|9|||
160881526|NCT00797966|580960576|FG000|Phase A+|Met withdrawal criteria|0|||
160881527|NCT00797966|580960577|FG001|Phase A+|Met withdrawal criteria|0|||
160881528|NCT00797966|580960578|FG002|Phase A+|Met withdrawal criteria|0|||
160881529|NCT00797966|580960579|FG003|Phase A+|Met withdrawal criteria|0|||
160881530|NCT00797966|580960580|FG004|Phase A+|Met withdrawal criteria|0|||
160881531|NCT00797966|580960581|FG005|Phase A+|Met withdrawal criteria|5|||
160881532|NCT00797966|580960576|FG000|Phase A+|Withdrawal by Subject|0|||
160881533|NCT00797966|580960577|FG001|Phase A+|Withdrawal by Subject|0|||
160881534|NCT00797966|580960578|FG002|Phase A+|Withdrawal by Subject|0|||
160881535|NCT00797966|580960579|FG003|Phase A+|Withdrawal by Subject|0|||
160881536|NCT00797966|580960580|FG004|Phase A+|Withdrawal by Subject|0|||
160881537|NCT00797966|580960581|FG005|Phase A+|Withdrawal by Subject|6|||
160881538|NCT00797966|580960576|FG000|Phase A+|Adverse Event|0|||
160881539|NCT00797966|580960577|FG001|Phase A+|Adverse Event|0|||
160881540|NCT00797966|580960578|FG002|Phase A+|Adverse Event|0|||
160881541|NCT00797966|580960579|FG003|Phase A+|Adverse Event|0|||
160881542|NCT00797966|580960580|FG004|Phase A+|Adverse Event|0|||
160881543|NCT00797966|580960581|FG005|Phase A+|Adverse Event|4|||
161121654|NCT01535729|581833529|FG000|Overall Study|Discontinued treatment|25|||
161121655|NCT01535729|581833529|FG000|Overall Study|Lost to Follow-up|8|||
161121656|NCT01535729|581833529|FG000|Overall Study|Death|52|||
161324617|NCT01000974|582575642|FG000|Primary Vaccination Phase|Protocol Violation|40|||
161324618|NCT01000974|582575643|FG001|Primary Vaccination Phase|Protocol Violation|3|||
161324619|NCT01000974|582575644|FG002|Primary Vaccination Phase|Protocol Violation|2|||
161324620|NCT01000974|582575642|FG000|Primary Vaccination Phase|Adverse Event|14|||
161324621|NCT01000974|582575643|FG001|Primary Vaccination Phase|Adverse Event|2|||
161324622|NCT01000974|582575644|FG002|Primary Vaccination Phase|Adverse Event|2|||
161324623|NCT01000974|582575642|FG000|Primary Vaccination Phase|Other|4|||
161324624|NCT01000974|582575643|FG001|Primary Vaccination Phase|Other|9|||
161324625|NCT01000974|582575644|FG002|Primary Vaccination Phase|Other|12|||
161324626|NCT01000974|582575642|FG000|Booster Vaccination Phase|Protocol Violation|0|||
161324627|NCT01000974|582575643|FG001|Booster Vaccination Phase|Protocol Violation|0|||
161324628|NCT01000974|582575644|FG002|Booster Vaccination Phase|Protocol Violation|2|||
161324629|NCT01000974|582575642|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
161324630|NCT01000974|582575643|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
161324631|NCT01000974|582575644|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
161324632|NCT01000974|582575642|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
161324633|NCT01000974|582575643|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
161324634|NCT01000974|582575644|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
161324635|NCT01000974|582575642|FG000|Booster Vaccination Phase|Other|24|||
161324636|NCT01000974|582575643|FG001|Booster Vaccination Phase|Other|6|||
161324637|NCT01000974|582575644|FG002|Booster Vaccination Phase|Other|4|||
161324638|NCT01639144|582575646|FG000|Overall Study|Withdrawal by Subject|4|||
161324639|NCT01639144|582575647|FG001|Overall Study|Withdrawal by Subject|2|||
161324640|NCT01639144|582575646|FG000|Overall Study|Physician Decision|2|||
161324641|NCT01639144|582575647|FG001|Overall Study|Physician Decision|0|||
161324642|NCT01639144|582575646|FG000|Overall Study|Met postoperative exclusion criteria|4|||
161324643|NCT01639144|582575647|FG001|Overall Study|Met postoperative exclusion criteria|3|||
161324644|NCT01307891|582575650|FG000|Overall Study|Progressive Disease|3|||
161324645|NCT01307891|582575651|FG001|Overall Study|Progressive Disease|1|||
161324646|NCT03365934|582575652|FG000|Overall Study|Adverse Event|1|||
161324647|NCT03365934|582575652|FG000|Overall Study|Withdrawal by Subject|1|||
161324648|NCT02937740|582575653|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
161324649|NCT02937740|582575654|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
161324650|NCT02937740|582575653|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
161324651|NCT02937740|582575654|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
161324652|NCT02937740|582575653|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
161324653|NCT02937740|582575654|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
161324654|NCT02937740|582575653|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
161324655|NCT02937740|582575654|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
161324656|NCT02937740|582575653|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
161324657|NCT02937740|582575654|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
161324658|NCT02937740|582575653|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
161324659|NCT02937740|582575654|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
161324660|NCT02964338|582575659|FG000|Overall Study|Sponsor terminated study for futility|12|||
161324661|NCT02964338|582575660|FG001|Overall Study|Sponsor terminated study for futility|15|||
161324662|NCT02964338|582575661|FG002|Overall Study|Sponsor terminated study for futility|14|||
161324663|NCT02964338|582575659|FG000|Overall Study|Lack of Efficacy|0|||
161324664|NCT02964338|582575660|FG001|Overall Study|Lack of Efficacy|3|||
161324665|NCT02964338|582575661|FG002|Overall Study|Lack of Efficacy|0|||
161324666|NCT02964338|582575659|FG000|Overall Study|Lost to Follow-up|1|||
161324667|NCT02964338|582575660|FG001|Overall Study|Lost to Follow-up|0|||
160881544|NCT00797966|580960576|FG000|Phase A+|Protocol deviation|0|||
160881545|NCT00797966|580960577|FG001|Phase A+|Protocol deviation|0|||
160881546|NCT00797966|580960578|FG002|Phase A+|Protocol deviation|0|||
160881547|NCT00797966|580960579|FG003|Phase A+|Protocol deviation|0|||
160881548|NCT00797966|580960580|FG004|Phase A+|Protocol deviation|0|||
160881549|NCT00797966|580960581|FG005|Phase A+|Protocol deviation|4|||
160881550|NCT01002820|580960585|FG000|Overall Study|Adverse Event|1|||
160881551|NCT01002820|580960585|FG000|Overall Study|Withdrawal by Subject|2|||
160881552|NCT01002820|580960585|FG000|Overall Study|Lack of Efficacy|1|||
160881553|NCT01673347|580960586|FG000|Overall Study|failure of allograft|7|||
160881554|NCT01430754|580960590|FG000|Run-In Phase|Circadian Period Ineligible|24|||
160881555|NCT01430754|580960591|FG001|Run-In Phase|Circadian Period Ineligible|0|||
160881556|NCT01430754|580960590|FG000|Run-In Phase|Protocol Violation|6|||
160881557|NCT01430754|580960591|FG001|Run-In Phase|Protocol Violation|0|||
160881558|NCT01430754|580960590|FG000|Run-In Phase|Adverse Event|2|||
160881559|NCT01430754|580960591|FG001|Run-In Phase|Adverse Event|0|||
160881560|NCT01430754|580960590|FG000|Run-In Phase|Other|2|||
160881561|NCT01430754|580960591|FG001|Run-In Phase|Other|0|||
160881562|NCT01430754|580960590|FG000|Run-In Phase|Withdrawal by Subject|2|||
160881563|NCT01430754|580960591|FG001|Run-In Phase|Withdrawal by Subject|0|||
160881564|NCT01430754|580960590|FG000|Run-In Phase|Lost to Follow-up|1|||
160881565|NCT01430754|580960591|FG001|Run-In Phase|Lost to Follow-up|0|||
160881566|NCT00895011|580960592|FG000|Overall Study|Withdrawal by Subject|14|||
160881567|NCT00895011|580960593|FG001|Overall Study|Withdrawal by Subject|7|||
160881568|NCT00895011|580960594|FG002|Overall Study|Withdrawal by Subject|2|||
160881569|NCT00895011|580960592|FG000|Overall Study|Lost to Follow-up|5|||
160881570|NCT00895011|580960593|FG001|Overall Study|Lost to Follow-up|4|||
160881571|NCT00895011|580960594|FG002|Overall Study|Lost to Follow-up|1|||
160881572|NCT00895011|580960592|FG000|Overall Study|Protocol Violation|3|||
160881573|NCT00895011|580960593|FG001|Overall Study|Protocol Violation|1|||
160881574|NCT00895011|580960594|FG002|Overall Study|Protocol Violation|3|||
160881575|NCT00895011|580960592|FG000|Overall Study|Adverse Event|1|||
160881576|NCT00895011|580960593|FG001|Overall Study|Adverse Event|2|||
160881577|NCT00895011|580960594|FG002|Overall Study|Adverse Event|2|||
160881578|NCT00895011|580960592|FG000|Overall Study|schedule conflict|1|||
160881579|NCT00895011|580960593|FG001|Overall Study|schedule conflict|0|||
160881580|NCT00895011|580960594|FG002|Overall Study|schedule conflict|0|||
160881581|NCT02661178|580960601|FG000|Part 1|Protocol Violation|1|||
160881582|NCT02661178|580960602|FG001|Part 1|Protocol Violation|0|||
160881583|NCT02661178|580960603|FG002|Part 1|Protocol Violation|0|||
160881584|NCT02661178|580960604|FG003|Part 1|Protocol Violation|0|||
160881585|NCT02661178|580960605|FG004|Part 1|Protocol Violation|0|||
160881586|NCT02661178|580960606|FG005|Part 1|Protocol Violation|0|||
160881587|NCT02661178|580960607|FG006|Part 1|Protocol Violation|0|||
160881588|NCT02661178|580960608|FG007|Part 1|Protocol Violation|0|||
160881589|NCT02661178|580960609|FG008|Part 1|Protocol Violation|0|||
160881590|NCT02661178|580960610|FG009|Part 1|Protocol Violation|0|||
160881591|NCT02661178|580960611|FG010|Part 1|Protocol Violation|0|||
160881592|NCT02661178|580960612|FG011|Part 1|Protocol Violation|0|||
160881593|NCT02661178|580960613|FG012|Part 1|Protocol Violation|0|||
160881594|NCT02661178|580960614|FG013|Part 1|Protocol Violation|0|||
160881595|NCT02661178|580960615|FG014|Part 1|Protocol Violation|0|||
160881596|NCT02278471|580960616|FG000|Overall Study|Lost to Follow-up|6|||
160881597|NCT02278471|580960617|FG001|Overall Study|Lost to Follow-up|15|||
160881598|NCT02278471|580960616|FG000|Overall Study|Death|2|||
160881599|NCT02278471|580960617|FG001|Overall Study|Death|2|||
160881600|NCT02278471|580960616|FG000|Overall Study|Withdrawal by Subject|0|||
160881601|NCT02278471|580960617|FG001|Overall Study|Withdrawal by Subject|3|||
160881602|NCT00275821|580960618|FG000|Overall Study|Adverse Event|4|||
160881603|NCT00275821|580960619|FG001|Overall Study|Adverse Event|12|||
160881604|NCT00275821|580960620|FG002|Overall Study|Adverse Event|5|||
160881605|NCT00275821|580960618|FG000|Overall Study|Administrative problems|3|||
160881606|NCT00275821|580960619|FG001|Overall Study|Administrative problems|4|||
160881607|NCT00275821|580960620|FG002|Overall Study|Administrative problems|4|||
160881608|NCT00275821|580960618|FG000|Overall Study|Withdrawal by Subject|0|||
160881609|NCT00275821|580960619|FG001|Overall Study|Withdrawal by Subject|2|||
160881610|NCT00275821|580960620|FG002|Overall Study|Withdrawal by Subject|1|||
160881611|NCT00275821|580960618|FG000|Overall Study|Lost to Follow-up|0|||
160881612|NCT00275821|580960619|FG001|Overall Study|Lost to Follow-up|1|||
160881613|NCT00275821|580960620|FG002|Overall Study|Lost to Follow-up|1|||
160881614|NCT00275821|580960618|FG000|Overall Study|Death|0|||
160881615|NCT00275821|580960619|FG001|Overall Study|Death|2|||
160881616|NCT00275821|580960620|FG002|Overall Study|Death|1|||
160881617|NCT00275821|580960618|FG000|Overall Study|Lack of Efficacy|2|||
160881618|NCT00275821|580960619|FG001|Overall Study|Lack of Efficacy|1|||
160881619|NCT00275821|580960620|FG002|Overall Study|Lack of Efficacy|0|||
160881620|NCT00275821|580960618|FG000|Overall Study|Protocol Violation|5|||
160881621|NCT00275821|580960619|FG001|Overall Study|Protocol Violation|1|||
160881622|NCT00275821|580960620|FG002|Overall Study|Protocol Violation|0|||
160881623|NCT00409175|580960621|FG000|Overall Study|Adverse Event|4|||
160881624|NCT00409175|580960622|FG001|Overall Study|Adverse Event|3|||
160881625|NCT00409175|580960621|FG000|Overall Study|Withdrawal by Subject|1|||
160881626|NCT00409175|580960622|FG001|Overall Study|Withdrawal by Subject|2|||
160881627|NCT00409175|580960621|FG000|Overall Study|Negative genotype|0|||
160881628|NCT00409175|580960622|FG001|Overall Study|Negative genotype|1|||
160881629|NCT00409175|580960621|FG000|Overall Study|Liver transplantation|13|||
160881630|NCT00409175|580960622|FG001|Overall Study|Liver transplantation|13|||
160881631|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160881632|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160881633|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160881634|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160881635|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
160881636|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
160881637|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
160881638|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160881639|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160881640|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160881641|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
160881642|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
160881643|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881644|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881645|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881646|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160881647|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160881648|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160881649|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881650|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
160881651|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881652|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881653|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
160881654|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
160881655|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
160881656|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160881657|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160881658|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160881659|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160881660|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160881661|NCT01328444|580960625|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160881662|NCT01328444|580960626|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
160881663|NCT01328444|580960627|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160881664|NCT01328444|580960628|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
160881665|NCT01328444|580960629|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160881666|NCT01328444|580960630|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160881667|NCT01328444|580960625|FG000|Washout Period (14 Days)|Adverse Event|1|||
160881668|NCT01328444|580960626|FG001|Washout Period (14 Days)|Adverse Event|1|||
160881669|NCT01328444|580960627|FG002|Washout Period (14 Days)|Adverse Event|0|||
160881670|NCT01328444|580960628|FG003|Washout Period (14 Days)|Adverse Event|1|||
160881671|NCT01328444|580960629|FG004|Washout Period (14 Days)|Adverse Event|1|||
160881672|NCT01328444|580960630|FG005|Washout Period (14 Days)|Adverse Event|2|||
160881673|NCT01328444|580960625|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
160881674|NCT01328444|580960626|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
160881675|NCT01328444|580960627|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
160881676|NCT01328444|580960628|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
160881677|NCT01328444|580960629|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
160881678|NCT01328444|580960630|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
160881679|NCT01328444|580960625|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881680|NCT01328444|580960626|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881681|NCT01328444|580960627|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881682|NCT01328444|580960628|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881683|NCT01328444|580960629|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
160881684|NCT01328444|580960630|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
160881685|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
160881686|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160881687|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160881688|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160881689|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160881690|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160881691|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
160881692|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160881693|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160881694|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
160881695|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
160881696|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
160881697|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
161324668|NCT02964338|582575661|FG002|Overall Study|Lost to Follow-up|3|||
161324669|NCT02964338|582575659|FG000|Overall Study|Protocol Violation|0|||
161324670|NCT02964338|582575660|FG001|Overall Study|Protocol Violation|1|||
161324671|NCT02964338|582575661|FG002|Overall Study|Protocol Violation|0|||
161324672|NCT02964338|582575659|FG000|Overall Study|Withdrawal by Subject|1|||
161324673|NCT02964338|582575660|FG001|Overall Study|Withdrawal by Subject|3|||
161324674|NCT02964338|582575661|FG002|Overall Study|Withdrawal by Subject|1|||
161324675|NCT02964338|582575659|FG000|Overall Study|Adverse Event|2|||
161324676|NCT02964338|582575660|FG001|Overall Study|Adverse Event|1|||
161324677|NCT02964338|582575661|FG002|Overall Study|Adverse Event|1|||
161324678|NCT02964338|582575659|FG000|Overall Study|Non-compliant with e-diary|0|||
161324679|NCT02964338|582575660|FG001|Overall Study|Non-compliant with e-diary|1|||
161324680|NCT02964338|582575661|FG002|Overall Study|Non-compliant with e-diary|0|||
161324681|NCT02964338|582575659|FG000|Overall Study|Did not meet criteria|1|||
161324682|NCT02964338|582575660|FG001|Overall Study|Did not meet criteria|0|||
161324683|NCT02964338|582575661|FG002|Overall Study|Did not meet criteria|0|||
161324684|NCT02239640|582575664|FG000|Overall Study|Withdrawal by Subject|3|||
161324685|NCT02239640|582575664|FG000|Overall Study|Lost to Follow-up|72|||
161324686|NCT02239640|582575664|FG000|Overall Study|Death|142|||
161324687|NCT02291029|582575671|FG000|Overall Study|Withdrawal by Subject|0|||
161324688|NCT02291029|582575672|FG001|Overall Study|Withdrawal by Subject|0|||
161324689|NCT02291029|582575673|FG002|Overall Study|Withdrawal by Subject|1|||
161324690|NCT02291029|582575674|FG003|Overall Study|Withdrawal by Subject|0|||
161324691|NCT02291029|582575675|FG004|Overall Study|Withdrawal by Subject|0|||
161324692|NCT02291029|582575676|FG005|Overall Study|Withdrawal by Subject|0|||
160881698|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881699|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881700|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881701|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
160881702|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
160881703|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881704|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881705|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881706|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
160881707|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
160881708|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
160881709|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160881710|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160881711|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160881712|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160881713|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160881714|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
160881715|NCT01328444|580960625|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881716|NCT01328444|580960626|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881717|NCT01328444|580960627|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881718|NCT01328444|580960628|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160881719|NCT01328444|580960629|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160881720|NCT01328444|580960630|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160881721|NCT03241368|580960635|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
160881722|NCT03241368|580960635|FG000|Overall Study|Lost to Follow-up|1|||
160881723|NCT03241368|580960635|FG000|Overall Study|Physician Decision|6|||
160881724|NCT03241368|580960635|FG000|Overall Study|Withdrawal by Subject|6|||
160881725|NCT03241368|580960635|FG000|Overall Study|Protocol Violation|1|||
160881726|NCT03316911|580960636|FG000|Overall Study|Lost to Follow-up|33|||
160881727|NCT03316911|580960637|FG001|Overall Study|Lost to Follow-up|29|||
160881728|NCT01119937|580960638|FG000|Overall Study|Adverse Event|11|||
160881729|NCT01119937|580960639|FG001|Overall Study|Adverse Event|5|||
160881730|NCT01119937|580960638|FG000|Overall Study|Protocol deviation|3|||
160881731|NCT01119937|580960639|FG001|Overall Study|Protocol deviation|1|||
160881732|NCT01119937|580960638|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160881733|NCT01119937|580960639|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160881734|NCT01119937|580960638|FG000|Overall Study|Withdrawal by Subject|2|||
160881735|NCT01119937|580960639|FG001|Overall Study|Withdrawal by Subject|1|||
160881736|NCT01270802|580960640|FG000|Overall Study|Withdrawal by Subject|1|||
160881737|NCT01270802|580960641|FG001|Overall Study|Withdrawal by Subject|0|||
160881738|NCT01270802|580960640|FG000|Overall Study|Adverse Event|1|||
160881739|NCT01270802|580960641|FG001|Overall Study|Adverse Event|0|||
160881740|NCT01270802|580960640|FG000|Overall Study|Lost to Follow-up|0|||
160881741|NCT01270802|580960641|FG001|Overall Study|Lost to Follow-up|1|||
161226779|NCT00950807|582211589|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160881742|NCT01566214|580960642|FG000|Overall Study|Lost to Follow-up|3|||
160881743|NCT01566214|580960643|FG001|Overall Study|Lost to Follow-up|0|||
160881744|NCT04620798|580960646|FG000|Overall Study|Lost to Follow-up|126|||
160881745|NCT04620798|580960647|FG001|Overall Study|Lost to Follow-up|138|||
160881746|NCT03222492|580960653|FG000|Overall Study|Withdrawal by Subject|0|||
160881747|NCT03222492|580960654|FG001|Overall Study|Withdrawal by Subject|0|||
160881748|NCT03222492|580960655|FG002|Overall Study|Withdrawal by Subject|1|||
160881749|NCT03222492|580960656|FG003|Overall Study|Withdrawal by Subject|0|||
160881750|NCT03222492|580960653|FG000|Overall Study|COVID-19 related|0|||
160881751|NCT03222492|580960654|FG001|Overall Study|COVID-19 related|0|||
160881752|NCT03222492|580960655|FG002|Overall Study|COVID-19 related|1|||
160881753|NCT03222492|580960656|FG003|Overall Study|COVID-19 related|0|||
160881754|NCT01375075|580960663|FG000|Overall Study|Adverse Event|0|||
160881755|NCT01375075|580960664|FG001|Overall Study|Adverse Event|0|||
160881756|NCT01375075|580960665|FG002|Overall Study|Adverse Event|3|||
161226780|NCT00950807|582211590|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161226781|NCT00950807|582211591|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161226782|NCT00950807|582211592|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161226783|NCT00950807|582211593|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161226784|NCT00950807|582211594|FG008|Treatment Period 1|Withdrawal by Subject|1|||
160881757|NCT01375075|580960666|FG003|Overall Study|Adverse Event|1|||
160881758|NCT01375075|580960667|FG004|Overall Study|Adverse Event|0|||
160881759|NCT01375075|580960668|FG005|Overall Study|Adverse Event|1|||
160881760|NCT01375075|580960663|FG000|Overall Study|Entry Criterion Not Met|1|||
160881761|NCT01375075|580960664|FG001|Overall Study|Entry Criterion Not Met|0|||
160881762|NCT01375075|580960665|FG002|Overall Study|Entry Criterion Not Met|0|||
160881763|NCT01375075|580960666|FG003|Overall Study|Entry Criterion Not Met|0|||
160881764|NCT01375075|580960667|FG004|Overall Study|Entry Criterion Not Met|0|||
160881765|NCT01375075|580960668|FG005|Overall Study|Entry Criterion Not Met|1|||
160881766|NCT01375075|580960663|FG000|Overall Study|Withdrawal by Subject|0|||
160881767|NCT01375075|580960664|FG001|Overall Study|Withdrawal by Subject|1|||
160881768|NCT01375075|580960665|FG002|Overall Study|Withdrawal by Subject|0|||
160881769|NCT01375075|580960666|FG003|Overall Study|Withdrawal by Subject|0|||
160881770|NCT01375075|580960667|FG004|Overall Study|Withdrawal by Subject|0|||
160881771|NCT01375075|580960668|FG005|Overall Study|Withdrawal by Subject|1|||
160881772|NCT00384111|580960669|FG000|Overall Study|Disease Progression|3|||
160881773|NCT00384111|580960669|FG000|Overall Study|Adverse Event|1|||
160881774|NCT00384111|580960669|FG000|Overall Study|Investigator Decision|3|||
160881775|NCT00384111|580960669|FG000|Overall Study|Study Terminated by the Sponsor|19|||
160881776|NCT00821509|580960670|FG000|Overall Study|Withdrawal by Subject|12|||
160881777|NCT00821509|580960671|FG001|Overall Study|Withdrawal by Subject|11|||
160881778|NCT00821509|580960672|FG002|Overall Study|Withdrawal by Subject|34|||
160881779|NCT01551420|580960673|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
160881780|NCT01551420|580960674|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
160881781|NCT01551420|580960673|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
160881782|NCT01551420|580960674|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
160881783|NCT01551420|580960673|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
160881784|NCT01551420|580960674|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
160881785|NCT01551420|580960673|FG000|Screened for Part B Eligibility|Declined participation|8|||
160881786|NCT01551420|580960674|FG001|Screened for Part B Eligibility|Declined participation|1|||
160881787|NCT01551420|580960673|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
160881788|NCT01551420|580960674|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
160881789|NCT01551420|580960673|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
160881790|NCT01551420|580960674|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
160881791|NCT01551420|580960673|FG000|Home Use (Part B)|Withdrawal by staff|0|||
160881792|NCT01551420|580960674|FG001|Home Use (Part B)|Withdrawal by staff|1|||
160881793|NCT03612856|580960675|FG000|Pre-dose Period|Physician Decision|0|||
160881794|NCT03612856|580960676|FG001|Pre-dose Period|Physician Decision|1|||
160881795|NCT03612856|580960677|FG002|Pre-dose Period|Physician Decision|1|||
160881796|NCT03612856|580960675|FG000|Pre-dose Period|Withdrawal by Subject|0|||
160881797|NCT03612856|580960676|FG001|Pre-dose Period|Withdrawal by Subject|1|||
161121657|NCT01535729|581833529|FG000|Overall Study|Other|19|||
161121658|NCT01535729|581833529|FG000|Overall Study|Did not sign informed consent|1|||
161121659|NCT01535729|581833529|FG000|Overall Study|No previous chemotherapy|33|||
161121660|NCT01535729|581833529|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
161121661|NCT01535729|581833529|FG000|Overall Study|Protocol Violation|11|||
161121662|NCT01535729|581833529|FG000|Overall Study|Screening failure|1|||
161121663|NCT01535729|581833529|FG000|Overall Study|Not treated|9|||
161121664|NCT01535729|581833529|FG000|Overall Study|No participant record available|5|||
161121665|NCT02322710|581833533|FG000|Overall Study|No efficacy assessment post-baseline|0|||
161121666|NCT02322710|581833534|FG001|Overall Study|No efficacy assessment post-baseline|1|||
161121667|NCT02322710|581833533|FG000|Overall Study|Protocol Violation|20|||
161121668|NCT02322710|581833534|FG001|Overall Study|Protocol Violation|25|||
161121669|NCT04161131|581833535|FG000|Overall Study|Ineligible|2|||
161121670|NCT04161131|581833535|FG000|Overall Study|Lost to Follow-up|4|||
161121671|NCT05064059|581833536|FG000|Overall Study|Death|199|||
161121672|NCT05064059|581833537|FG001|Overall Study|Death|196|||
161121673|NCT05064059|581833536|FG000|Overall Study|Physician Decision|4|||
161121674|NCT05064059|581833537|FG001|Overall Study|Physician Decision|2|||
161121675|NCT05064059|581833536|FG000|Overall Study|Sponsor Decision|14|||
161121676|NCT05064059|581833537|FG001|Overall Study|Sponsor Decision|11|||
160881798|NCT03612856|580960677|FG002|Pre-dose Period|Withdrawal by Subject|0|||
161226785|NCT00950807|582211595|FG009|Treatment Period 1|Withdrawal by Subject|0|||
161226786|NCT00950807|582211586|FG000|Treatment Period 1|Adverse Event|0|||
161226787|NCT00950807|582211587|FG001|Treatment Period 1|Adverse Event|0|||
161226788|NCT00950807|582211588|FG002|Treatment Period 1|Adverse Event|0|||
161226789|NCT00950807|582211589|FG003|Treatment Period 1|Adverse Event|0|||
161226790|NCT00950807|582211590|FG004|Treatment Period 1|Adverse Event|0|||
161226791|NCT00950807|582211591|FG005|Treatment Period 1|Adverse Event|1|||
161226792|NCT00950807|582211592|FG006|Treatment Period 1|Adverse Event|0|||
161226793|NCT00950807|582211593|FG007|Treatment Period 1|Adverse Event|0|||
161226794|NCT00950807|582211594|FG008|Treatment Period 1|Adverse Event|0|||
161226795|NCT00950807|582211595|FG009|Treatment Period 1|Adverse Event|0|||
161226796|NCT00950807|582211586|FG000|Washout Period 1|Lack of Efficacy|0|||
161226797|NCT00950807|582211587|FG001|Washout Period 1|Lack of Efficacy|0|||
161226798|NCT00950807|582211588|FG002|Washout Period 1|Lack of Efficacy|0|||
161226799|NCT00950807|582211589|FG003|Washout Period 1|Lack of Efficacy|0|||
161226800|NCT00950807|582211590|FG004|Washout Period 1|Lack of Efficacy|0|||
161226801|NCT00950807|582211591|FG005|Washout Period 1|Lack of Efficacy|0|||
161226802|NCT00950807|582211592|FG006|Washout Period 1|Lack of Efficacy|1|||
161226803|NCT00950807|582211593|FG007|Washout Period 1|Lack of Efficacy|0|||
161226804|NCT00950807|582211594|FG008|Washout Period 1|Lack of Efficacy|0|||
161226805|NCT00950807|582211595|FG009|Washout Period 1|Lack of Efficacy|0|||
161226806|NCT00950807|582211586|FG000|Washout Period 1|Withdrawal by Subject|0|||
161226807|NCT00950807|582211587|FG001|Washout Period 1|Withdrawal by Subject|0|||
161226808|NCT00950807|582211588|FG002|Washout Period 1|Withdrawal by Subject|0|||
161226809|NCT00950807|582211589|FG003|Washout Period 1|Withdrawal by Subject|0|||
161226810|NCT00950807|582211590|FG004|Washout Period 1|Withdrawal by Subject|0|||
161226811|NCT00950807|582211591|FG005|Washout Period 1|Withdrawal by Subject|0|||
161226812|NCT00950807|582211592|FG006|Washout Period 1|Withdrawal by Subject|0|||
161226813|NCT00950807|582211593|FG007|Washout Period 1|Withdrawal by Subject|0|||
161226814|NCT00950807|582211594|FG008|Washout Period 1|Withdrawal by Subject|1|||
161226815|NCT00950807|582211595|FG009|Washout Period 1|Withdrawal by Subject|0|||
161226816|NCT00950807|582211586|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
161226817|NCT00950807|582211587|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226818|NCT00950807|582211588|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226819|NCT00950807|582211589|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226820|NCT00950807|582211590|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226821|NCT00950807|582211591|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226822|NCT00950807|582211592|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
161226823|NCT00950807|582211593|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
161226824|NCT00950807|582211594|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226825|NCT00950807|582211595|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
161226826|NCT00950807|582211586|FG000|Washout Period 1|Adverse Event|2|||
161226827|NCT00950807|582211587|FG001|Washout Period 1|Adverse Event|0|||
161226828|NCT00950807|582211588|FG002|Washout Period 1|Adverse Event|0|||
161226829|NCT00950807|582211589|FG003|Washout Period 1|Adverse Event|1|||
161226830|NCT00950807|582211590|FG004|Washout Period 1|Adverse Event|1|||
161226831|NCT00950807|582211591|FG005|Washout Period 1|Adverse Event|0|||
161226832|NCT00950807|582211592|FG006|Washout Period 1|Adverse Event|0|||
161226833|NCT00950807|582211593|FG007|Washout Period 1|Adverse Event|0|||
161226834|NCT00950807|582211594|FG008|Washout Period 1|Adverse Event|0|||
161226835|NCT00950807|582211595|FG009|Washout Period 1|Adverse Event|0|||
161226836|NCT00950807|582211586|FG000|Treatment Period 2|Lack of Efficacy|1|||
161226837|NCT00950807|582211587|FG001|Treatment Period 2|Lack of Efficacy|0|||
161226838|NCT00950807|582211588|FG002|Treatment Period 2|Lack of Efficacy|0|||
161226839|NCT00950807|582211589|FG003|Treatment Period 2|Lack of Efficacy|0|||
161226840|NCT00950807|582211590|FG004|Treatment Period 2|Lack of Efficacy|0|||
161121677|NCT05064059|581833536|FG000|Overall Study|Withdrawal by Subject|4|||
161121678|NCT05064059|581833537|FG001|Overall Study|Withdrawal by Subject|11|||
161121679|NCT02615990|581833538|FG000|Overall Study|study terminated|1|||
161121680|NCT02615990|581833539|FG001|Overall Study|study terminated|1|||
161121681|NCT01934140|581833540|FG000|Persistence Phase (Year 6-10)|Other|24|||
161121682|NCT01934140|581833541|FG001|Persistence Phase (Year 6-10)|Other|6|||
161121683|NCT01934140|581833540|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
161121684|NCT01934140|581833541|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
161121685|NCT01934140|581833540|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
161121686|NCT01934140|581833541|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
161121687|NCT01934140|581833540|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
161121688|NCT01934140|581833541|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
161226841|NCT00950807|582211591|FG005|Treatment Period 2|Lack of Efficacy|0|||
161226842|NCT00950807|582211592|FG006|Treatment Period 2|Lack of Efficacy|0|||
161226843|NCT00950807|582211593|FG007|Treatment Period 2|Lack of Efficacy|0|||
161226844|NCT00950807|582211594|FG008|Treatment Period 2|Lack of Efficacy|0|||
161226845|NCT00950807|582211595|FG009|Treatment Period 2|Lack of Efficacy|0|||
161226846|NCT00950807|582211586|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161226847|NCT00950807|582211587|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161226848|NCT00950807|582211588|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161226849|NCT00950807|582211589|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161226850|NCT00950807|582211590|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161226851|NCT00950807|582211591|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161226852|NCT00950807|582211592|FG006|Treatment Period 2|Withdrawal by Subject|1|||
161226853|NCT00950807|582211593|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161226854|NCT00950807|582211594|FG008|Treatment Period 2|Withdrawal by Subject|0|||
161226855|NCT00950807|582211595|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161226856|NCT00950807|582211586|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
161226857|NCT00950807|582211587|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226858|NCT00950807|582211588|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226859|NCT00950807|582211589|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226860|NCT00950807|582211590|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226861|NCT00950807|582211591|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226862|NCT00950807|582211592|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226863|NCT00950807|582211593|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226864|NCT00950807|582211594|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226865|NCT00950807|582211595|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161226866|NCT00950807|582211586|FG000|Treatment Period 2|Adverse Event|0|||
161226867|NCT00950807|582211587|FG001|Treatment Period 2|Adverse Event|1|||
161226868|NCT00950807|582211588|FG002|Treatment Period 2|Adverse Event|0|||
161226869|NCT00950807|582211589|FG003|Treatment Period 2|Adverse Event|1|||
161226870|NCT00950807|582211590|FG004|Treatment Period 2|Adverse Event|0|||
161226871|NCT00950807|582211591|FG005|Treatment Period 2|Adverse Event|1|||
161226872|NCT00950807|582211592|FG006|Treatment Period 2|Adverse Event|0|||
161226873|NCT00950807|582211593|FG007|Treatment Period 2|Adverse Event|1|||
161226874|NCT00950807|582211594|FG008|Treatment Period 2|Adverse Event|0|||
161226875|NCT00950807|582211595|FG009|Treatment Period 2|Adverse Event|0|||
161226876|NCT00950807|582211586|FG000|Washout Period 2|Lack of Efficacy|1|||
161226877|NCT00950807|582211587|FG001|Washout Period 2|Lack of Efficacy|0|||
161226878|NCT00950807|582211588|FG002|Washout Period 2|Lack of Efficacy|0|||
161226879|NCT00950807|582211589|FG003|Washout Period 2|Lack of Efficacy|0|||
161226880|NCT00950807|582211590|FG004|Washout Period 2|Lack of Efficacy|0|||
161226881|NCT00950807|582211591|FG005|Washout Period 2|Lack of Efficacy|0|||
161226882|NCT00950807|582211592|FG006|Washout Period 2|Lack of Efficacy|0|||
161226883|NCT00950807|582211593|FG007|Washout Period 2|Lack of Efficacy|0|||
161226884|NCT00950807|582211594|FG008|Washout Period 2|Lack of Efficacy|0|||
161226885|NCT00950807|582211595|FG009|Washout Period 2|Lack of Efficacy|0|||
161226886|NCT00950807|582211586|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161226887|NCT00950807|582211587|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161226888|NCT00950807|582211588|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161226889|NCT00950807|582211589|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161226890|NCT00950807|582211590|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161226891|NCT00950807|582211591|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161226892|NCT00950807|582211592|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161226893|NCT00950807|582211593|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
161226894|NCT00950807|582211594|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161226895|NCT00950807|582211595|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
161226896|NCT00950807|582211586|FG000|Washout Period 2|Adverse Event|3|||
161226897|NCT00950807|582211587|FG001|Washout Period 2|Adverse Event|0|||
161226898|NCT00950807|582211588|FG002|Washout Period 2|Adverse Event|0|||
161226899|NCT00950807|582211589|FG003|Washout Period 2|Adverse Event|1|||
161226900|NCT00950807|582211590|FG004|Washout Period 2|Adverse Event|0|||
161226901|NCT00950807|582211591|FG005|Washout Period 2|Adverse Event|0|||
161226902|NCT00950807|582211592|FG006|Washout Period 2|Adverse Event|0|||
161226903|NCT00950807|582211593|FG007|Washout Period 2|Adverse Event|0|||
161226904|NCT00950807|582211594|FG008|Washout Period 2|Adverse Event|0|||
161226905|NCT00950807|582211595|FG009|Washout Period 2|Adverse Event|0|||
161226906|NCT00950807|582211586|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161226907|NCT00950807|582211587|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161226908|NCT00950807|582211588|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161226909|NCT00950807|582211589|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161226910|NCT00950807|582211590|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161226911|NCT00950807|582211591|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161226912|NCT00950807|582211592|FG006|Treatment Period 3|Withdrawal by Subject|0|||
161226913|NCT00950807|582211593|FG007|Treatment Period 3|Withdrawal by Subject|0|||
161226914|NCT00950807|582211594|FG008|Treatment Period 3|Withdrawal by Subject|0|||
161226915|NCT00950807|582211595|FG009|Treatment Period 3|Withdrawal by Subject|1|||
161226916|NCT00950807|582211586|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161226917|NCT00950807|582211587|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226918|NCT00950807|582211588|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226919|NCT00950807|582211589|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226920|NCT00950807|582211590|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226921|NCT00950807|582211591|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226922|NCT00950807|582211592|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226923|NCT00950807|582211593|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
161226924|NCT00950807|582211594|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226925|NCT00950807|582211595|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
161226926|NCT00950807|582211586|FG000|Treatment Period 3|Adverse Event|0|||
161226927|NCT00950807|582211587|FG001|Treatment Period 3|Adverse Event|0|||
161226928|NCT00950807|582211588|FG002|Treatment Period 3|Adverse Event|0|||
161226929|NCT00950807|582211589|FG003|Treatment Period 3|Adverse Event|0|||
161226930|NCT00950807|582211590|FG004|Treatment Period 3|Adverse Event|0|||
161226931|NCT00950807|582211591|FG005|Treatment Period 3|Adverse Event|0|||
161226932|NCT00950807|582211592|FG006|Treatment Period 3|Adverse Event|1|||
161226933|NCT00950807|582211593|FG007|Treatment Period 3|Adverse Event|0|||
161226934|NCT00950807|582211594|FG008|Treatment Period 3|Adverse Event|0|||
161226935|NCT00950807|582211595|FG009|Treatment Period 3|Adverse Event|0|||
161226936|NCT00337077|582211596|FG000|Overall Study|Progressive disease|25|||
161226937|NCT00337077|582211597|FG001|Overall Study|Progressive disease|37|||
161226938|NCT00337077|582211598|FG002|Overall Study|Progressive disease|19|||
161226939|NCT00337077|582211596|FG000|Overall Study|Adverse Event|7|||
161226940|NCT00337077|582211597|FG001|Overall Study|Adverse Event|7|||
161226941|NCT00337077|582211598|FG002|Overall Study|Adverse Event|1|||
161226942|NCT00337077|582211596|FG000|Overall Study|Death|0|||
161226943|NCT00337077|582211597|FG001|Overall Study|Death|1|||
161226944|NCT00337077|582211598|FG002|Overall Study|Death|0|||
161226945|NCT00337077|582211596|FG000|Overall Study|Withdrawal by Subject|7|||
161226946|NCT00337077|582211597|FG001|Overall Study|Withdrawal by Subject|2|||
161226947|NCT00337077|582211598|FG002|Overall Study|Withdrawal by Subject|2|||
161226948|NCT00337077|582211596|FG000|Overall Study|Alternative therapy|1|||
161226949|NCT00337077|582211597|FG001|Overall Study|Alternative therapy|0|||
161226950|NCT00337077|582211598|FG002|Overall Study|Alternative therapy|0|||
161226951|NCT00337077|582211596|FG000|Overall Study|Physician Decision|1|||
161226952|NCT00337077|582211597|FG001|Overall Study|Physician Decision|4|||
161226953|NCT00337077|582211598|FG002|Overall Study|Physician Decision|2|||
161226954|NCT00337077|582211596|FG000|Overall Study|Never started treatment|1|||
161226955|NCT00337077|582211597|FG001|Overall Study|Never started treatment|1|||
161226956|NCT00337077|582211598|FG002|Overall Study|Never started treatment|0|||
161226957|NCT00337077|582211596|FG000|Overall Study|Ineligible|1|||
161226958|NCT00337077|582211597|FG001|Overall Study|Ineligible|1|||
161226959|NCT00337077|582211598|FG002|Overall Study|Ineligible|1|||
161226960|NCT01492400|582211602|FG000|Overall Study|Miscellaneous Reasons|2|||
161226961|NCT01492400|582211603|FG001|Overall Study|Miscellaneous Reasons|3|||
161226962|NCT01492400|582211602|FG000|Overall Study|Personal Reasons|0|||
161226963|NCT01492400|582211603|FG001|Overall Study|Personal Reasons|5|||
161226964|NCT01492400|582211602|FG000|Overall Study|Lost to Follow-up|3|||
161226965|NCT01492400|582211603|FG001|Overall Study|Lost to Follow-up|1|||
161226966|NCT01492400|582211602|FG000|Overall Study|Pregnancy|0|||
161226967|NCT01492400|582211603|FG001|Overall Study|Pregnancy|1|||
161226968|NCT01492400|582211602|FG000|Overall Study|Lack of Efficacy|1|||
161226969|NCT01492400|582211603|FG001|Overall Study|Lack of Efficacy|1|||
161226970|NCT01492400|582211602|FG000|Overall Study|Adverse Event|10|||
161226971|NCT01492400|582211603|FG001|Overall Study|Adverse Event|5|||
161226972|NCT00659607|582211604|FG000|Overall Study|No blood pressure recorded|147|||
161226973|NCT00659607|582211604|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
161226974|NCT00659607|582211604|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
161226975|NCT00659607|582211604|FG000|Overall Study|No recorded efficacy data|15|||
161226976|NCT00659607|582211604|FG000|Overall Study|Inconsistent BP measuring date|2|||
161226977|NCT02568384|582211610|FG000|Overall Study|Mobile devices incompatible with App|2|||
161226978|NCT03184441|582211611|FG000|Overall Study|Withdrawal by Subject|1|||
161226979|NCT00264810|582211612|FG000|Baseline|Withdrawal by Subject|10|||
161226980|NCT00264810|582211613|FG001|Baseline|Withdrawal by Subject|10|||
161226981|NCT00264810|582211612|FG000|Baseline|Physician Decision|7|||
161226982|NCT00264810|582211613|FG001|Baseline|Physician Decision|8|||
161226983|NCT00264810|582211612|FG000|Baseline|Subject Compliance Failure|3|||
161226984|NCT00264810|582211613|FG001|Baseline|Subject Compliance Failure|3|||
161226985|NCT00264810|582211612|FG000|Baseline|Insufficient Seizure Frequency|2|||
161226986|NCT00264810|582211613|FG001|Baseline|Insufficient Seizure Frequency|2|||
161226987|NCT00264810|582211612|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
161226988|NCT00264810|582211613|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
161226989|NCT00264810|582211612|FG000|Baseline|Other|0|||
161226990|NCT00264810|582211613|FG001|Baseline|Other|1|||
161226991|NCT00264810|582211612|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
161226992|NCT00264810|582211613|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
161226993|NCT00264810|582211612|FG000|Stimulation Optimization Period|Death|0|||
161226994|NCT00264810|582211613|FG001|Stimulation Optimization Period|Death|1|||
161226995|NCT00264810|582211612|FG000|Blinded Evaluation Period|Explant due to infection|1|||
161226996|NCT00264810|582211613|FG001|Blinded Evaluation Period|Explant due to infection|1|||
161226997|NCT00264810|582211612|FG000|Open Label Evaluation Period|Explant due to infection|1|||
161324693|NCT02291029|582575671|FG000|Overall Study|Adverse Event|0|||
161226998|NCT00264810|582211613|FG001|Open Label Evaluation Period|Explant due to infection|1|||
161226999|NCT00264810|582211612|FG000|Open Label Evaluation Period|Death|3|||
161227000|NCT00264810|582211613|FG001|Open Label Evaluation Period|Death|2|||
161227001|NCT00264810|582211612|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
161227002|NCT00264810|582211613|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
161227003|NCT02994056|582211614|FG000|Overall Study|Death|8|||
161227004|NCT02994056|582211614|FG000|Overall Study|Withdrew Consent|1|||
161227005|NCT02199509|582211617|FG000|Overall Study|Suicidal Ideation|0|||
161227006|NCT02199509|582211618|FG001|Overall Study|Suicidal Ideation|1|||
161227007|NCT02199509|582211617|FG000|Overall Study|Misunderstood titration schedule|1|||
161227008|NCT02199509|582211618|FG001|Overall Study|Misunderstood titration schedule|0|||
161227009|NCT01346410|582211620|FG000|Overall Study|Death|1|||
161227010|NCT00979628|582211621|FG000|Overall Study|received regimen < 24 hours|7|||
161227011|NCT00979628|582211622|FG001|Overall Study|received regimen < 24 hours|6|||
161227012|NCT00979628|582211623|FG002|Overall Study|received regimen < 24 hours|5|||
161227013|NCT00979628|582211621|FG000|Overall Study|received steroids|1|||
161227014|NCT00979628|582211622|FG001|Overall Study|received steroids|1|||
161227015|NCT00979628|582211623|FG002|Overall Study|received steroids|0|||
161227016|NCT00979628|582211621|FG000|Overall Study|transferred to ICU|1|||
161227017|NCT00979628|582211622|FG001|Overall Study|transferred to ICU|2|||
161227018|NCT00979628|582211623|FG002|Overall Study|transferred to ICU|1|||
161227019|NCT05905783|582211624|FG000|Overall Study|Lost to Follow-up|12|||
161227020|NCT05905783|582211625|FG001|Overall Study|Lost to Follow-up|18|||
161227021|NCT05905783|582211624|FG000|Overall Study|Withdrawal by Subject|29|||
161227022|NCT05905783|582211625|FG001|Overall Study|Withdrawal by Subject|37|||
161227023|NCT05905783|582211624|FG000|Overall Study|Decision by sponsor|69|||
160881799|NCT01576159|580960678|FG000|Overall Study|Withdrawal by Subject|0|||
160881800|NCT01576159|580960679|FG001|Overall Study|Withdrawal by Subject|1|||
160881801|NCT01576159|580960680|FG002|Overall Study|Withdrawal by Subject|0|||
161227024|NCT05905783|582211625|FG001|Overall Study|Decision by sponsor|65|||
161227025|NCT00911859|582211626|FG000|Treatment Period|Adverse Event|3|||
161227026|NCT00911859|582211627|FG001|Treatment Period|Adverse Event|3|||
161227027|NCT00911859|582211628|FG002|Treatment Period|Adverse Event|7|||
161227028|NCT00911859|582211626|FG000|Treatment Period|Death|1|||
161227029|NCT00911859|582211627|FG001|Treatment Period|Death|3|||
161227030|NCT00911859|582211628|FG002|Treatment Period|Death|5|||
161227031|NCT00911859|582211626|FG000|Treatment Period|Lack of Efficacy|1|||
161227032|NCT00911859|582211627|FG001|Treatment Period|Lack of Efficacy|7|||
161227033|NCT00911859|582211628|FG002|Treatment Period|Lack of Efficacy|5|||
161227034|NCT00911859|582211626|FG000|Treatment Period|Physician Decision|3|||
161227035|NCT00911859|582211627|FG001|Treatment Period|Physician Decision|3|||
161227036|NCT00911859|582211628|FG002|Treatment Period|Physician Decision|3|||
161227037|NCT00911859|582211626|FG000|Treatment Period|Withdrawal by Subject|0|||
161227038|NCT00911859|582211627|FG001|Treatment Period|Withdrawal by Subject|4|||
161227039|NCT00911859|582211628|FG002|Treatment Period|Withdrawal by Subject|5|||
161227040|NCT00911859|582211626|FG000|Treatment Period|Did not receive study treatment|0|||
161227041|NCT00911859|582211627|FG001|Treatment Period|Did not receive study treatment|1|||
161227042|NCT00911859|582211628|FG002|Treatment Period|Did not receive study treatment|0|||
161227043|NCT00911859|582211626|FG000|Maintainance Period|Lack of Efficacy|0|||
161227044|NCT00911859|582211627|FG001|Maintainance Period|Lack of Efficacy|0|||
161227045|NCT00911859|582211628|FG002|Maintainance Period|Lack of Efficacy|9|||
161227046|NCT00911859|582211626|FG000|Maintainance Period|Physician Decision|0|||
161227047|NCT00911859|582211627|FG001|Maintainance Period|Physician Decision|0|||
161227048|NCT00911859|582211628|FG002|Maintainance Period|Physician Decision|9|||
161227049|NCT00911859|582211626|FG000|Maintainance Period|Withdrawal by Subject|0|||
161227050|NCT00911859|582211627|FG001|Maintainance Period|Withdrawal by Subject|0|||
161227051|NCT00911859|582211628|FG002|Maintainance Period|Withdrawal by Subject|3|||
161227052|NCT00911859|582211626|FG000|Follow-up Period|Death|5|||
161227053|NCT00911859|582211627|FG001|Follow-up Period|Death|8|||
161227054|NCT00911859|582211628|FG002|Follow-up Period|Death|10|||
161227055|NCT00911859|582211626|FG000|Follow-up Period|Lost to Follow-up|1|||
161227056|NCT00911859|582211627|FG001|Follow-up Period|Lost to Follow-up|1|||
161227057|NCT00911859|582211628|FG002|Follow-up Period|Lost to Follow-up|0|||
160881802|NCT01576159|580960681|FG003|Overall Study|Withdrawal by Subject|0|||
160881803|NCT01576159|580960678|FG000|Overall Study|Physician Decision|0|||
160881804|NCT01576159|580960679|FG001|Overall Study|Physician Decision|0|||
161227058|NCT00911859|582211626|FG000|Follow-up Period|Withdrawal by Subject|0|||
160881805|NCT01576159|580960680|FG002|Overall Study|Physician Decision|1|||
160881806|NCT01576159|580960681|FG003|Overall Study|Physician Decision|0|||
161227059|NCT00911859|582211627|FG001|Follow-up Period|Withdrawal by Subject|4|||
161227060|NCT00911859|582211628|FG002|Follow-up Period|Withdrawal by Subject|4|||
161227061|NCT00911859|582211626|FG000|Follow-up Period|Study terminated by sponsor|5|||
161227062|NCT00911859|582211627|FG001|Follow-up Period|Study terminated by sponsor|33|||
161227063|NCT00911859|582211628|FG002|Follow-up Period|Study terminated by sponsor|27|||
161227064|NCT03008460|582211633|FG000|Overall Study|Protocol deviation|0|||
161227065|NCT03008460|582211634|FG001|Overall Study|Protocol deviation|2|||
161227066|NCT03008460|582211633|FG000|Overall Study|Study drug not dispensed|0|||
161227067|NCT03008460|582211634|FG001|Overall Study|Study drug not dispensed|1|||
161227068|NCT03008460|582211633|FG000|Overall Study|Adverse Event|0|||
161227069|NCT03008460|582211634|FG001|Overall Study|Adverse Event|1|||
161227070|NCT03008460|582211633|FG000|Overall Study|Withdrawal by Subject|5|||
161227071|NCT03008460|582211634|FG001|Overall Study|Withdrawal by Subject|6|||
161227072|NCT03008460|582211633|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
161227073|NCT03008460|582211634|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
161227074|NCT03008460|582211633|FG000|Overall Study|End of study visit outside permitted time window|0|||
161227075|NCT03008460|582211634|FG001|Overall Study|End of study visit outside permitted time window|1|||
161227076|NCT03008460|582211633|FG000|Overall Study|Lost to Follow-up|1|||
161227077|NCT03008460|582211634|FG001|Overall Study|Lost to Follow-up|3|||
161227078|NCT00634179|582211638|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
161227079|NCT04947579|582211639|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161227080|NCT04947579|582211640|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161227081|NCT04947579|582211641|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161227082|NCT04947579|582211642|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
161227083|NCT04947579|582211643|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161227084|NCT04947579|582211644|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
161227085|NCT04947579|582211639|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161227086|NCT04947579|582211640|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161227087|NCT04947579|582211641|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
161227088|NCT04947579|582211642|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161227089|NCT04947579|582211643|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161227090|NCT04947579|582211644|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
161227091|NCT04947579|582211639|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
161227092|NCT04947579|582211640|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
161227093|NCT04947579|582211641|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
161227094|NCT04947579|582211642|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
161227095|NCT04947579|582211643|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
161227096|NCT04947579|582211644|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
161227097|NCT04947579|582211639|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
161227098|NCT04947579|582211640|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
161227099|NCT04947579|582211641|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
161227100|NCT04947579|582211642|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
161227101|NCT04947579|582211643|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
161227102|NCT04947579|582211644|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
161227103|NCT04947579|582211639|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
161227104|NCT04947579|582211640|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161227105|NCT04947579|582211641|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161227106|NCT04947579|582211642|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161227107|NCT04947579|582211643|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161227108|NCT04947579|582211644|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
161227109|NCT04947579|582211639|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161227110|NCT04947579|582211640|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161227111|NCT04947579|582211641|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
161227112|NCT04947579|582211642|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161227113|NCT04947579|582211643|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161227114|NCT04947579|582211644|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
161227115|NCT04947579|582211639|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161227116|NCT04947579|582211640|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
161227117|NCT04947579|582211641|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161227118|NCT04947579|582211642|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161227119|NCT04947579|582211643|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
161227120|NCT04947579|582211644|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
161227121|NCT04947579|582211639|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161227122|NCT04947579|582211640|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161227123|NCT04947579|582211641|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
161227124|NCT04947579|582211642|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161227125|NCT04947579|582211643|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161227126|NCT04947579|582211644|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
161227127|NCT04947579|582211639|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
161227128|NCT04947579|582211640|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
161227129|NCT04947579|582211641|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
161227130|NCT04947579|582211642|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
161227131|NCT04947579|582211643|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
161324694|NCT02291029|582575672|FG001|Overall Study|Adverse Event|1|||
161227132|NCT04947579|582211644|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
161227133|NCT04947579|582211639|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
161227134|NCT04947579|582211640|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
161227135|NCT04947579|582211641|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
161227136|NCT04947579|582211642|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
161227137|NCT04947579|582211643|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
161227138|NCT04947579|582211644|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
161227139|NCT04947579|582211639|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161227140|NCT04947579|582211640|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
161227141|NCT04947579|582211641|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
161227142|NCT04947579|582211642|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161227143|NCT04947579|582211643|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
161227144|NCT04947579|582211644|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
161227145|NCT00767325|582211645|FG000|Overall Study|Lack of Efficacy|2|||
161227146|NCT00767325|582211645|FG000|Overall Study|Adverse Event|7|||
161227147|NCT00767325|582211645|FG000|Overall Study|Lost to Follow-up|3|||
161227148|NCT00767325|582211645|FG000|Overall Study|No longer met study criteria|2|||
161227149|NCT00767325|582211645|FG000|Overall Study|Missed visit due to family reasons|1|||
161227150|NCT03538756|582211646|FG000|Long-Term Follow-up|Adverse Event|0|||
161227151|NCT03538756|582211647|FG001|Long-Term Follow-up|Adverse Event|0|||
161227152|NCT03538756|582211648|FG002|Long-Term Follow-up|Adverse Event|6|||
161227153|NCT03538756|582211646|FG000|Long-Term Follow-up|Death|0|||
161227154|NCT03538756|582211647|FG001|Long-Term Follow-up|Death|0|||
161227155|NCT03538756|582211648|FG002|Long-Term Follow-up|Death|1|||
161227156|NCT03538756|582211646|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
161227157|NCT03538756|582211647|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
161227158|NCT03538756|582211648|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
161227159|NCT03538756|582211646|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
161227160|NCT03538756|582211647|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
161227161|NCT03538756|582211648|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
161227162|NCT03538756|582211646|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
161227163|NCT03538756|582211647|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
161227164|NCT03538756|582211648|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
161227165|NCT00752856|582211649|FG000|Overall Study|randomized but did not do viral kinetics|0|||
161227166|NCT00752856|582211650|FG001|Overall Study|randomized but did not do viral kinetics|1|||
161227167|NCT02688608|582211651|FG000|Overall Study|Lost to Follow-up|1|||
161227168|NCT04529109|582211653|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161227169|NCT04529109|582211654|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161227170|NCT01508936|582211656|FG000|Overall Study|Adverse Event|11|||
161227171|NCT01508936|582211657|FG001|Overall Study|Adverse Event|32|||
161227172|NCT01508936|582211656|FG000|Overall Study|Lack of Efficacy|0|||
161227173|NCT01508936|582211657|FG001|Overall Study|Lack of Efficacy|1|||
161227174|NCT01508936|582211656|FG000|Overall Study|Withdrawal by Subject|4|||
161227175|NCT01508936|582211657|FG001|Overall Study|Withdrawal by Subject|18|||
161227176|NCT01508936|582211656|FG000|Overall Study|Protocol Violation|2|||
161227177|NCT01508936|582211657|FG001|Overall Study|Protocol Violation|3|||
161227178|NCT01508936|582211656|FG000|Overall Study|Lost to Follow-up|2|||
161227179|NCT01508936|582211657|FG001|Overall Study|Lost to Follow-up|9|||
161227180|NCT01508936|582211656|FG000|Overall Study|Other|0|||
161227181|NCT01508936|582211657|FG001|Overall Study|Other|5|||
161227182|NCT01508936|582211656|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
161227183|NCT01508936|582211657|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
161227184|NCT00679367|582211658|FG000|Overall Study|Adverse Event|7|||
161227185|NCT00679367|582211658|FG000|Overall Study|inability to swallow oral drugs|1|||
161227186|NCT00679367|582211658|FG000|Overall Study|Lack of Efficacy|3|||
161227187|NCT00679367|582211658|FG000|Overall Study|Withdrawal by Subject|1|||
161227188|NCT00922779|582211659|FG000|Overall Study|Adverse Event|67|||
161227189|NCT00922779|582211659|FG000|Overall Study|Pregnancy|7|||
161227190|NCT00922779|582211659|FG000|Overall Study|Withdrawal by Subject|308|||
161227191|NCT00922779|582211659|FG000|Overall Study|Lost to Follow-up|44|||
161227192|NCT00922779|582211659|FG000|Overall Study|Other|27|||
161227193|NCT00922779|582211659|FG000|Overall Study|Missing|1874|||
161227194|NCT01611090|582211660|FG000|Randomized Period|Lost to Follow-up|8|||
161227195|NCT01611090|582211661|FG001|Randomized Period|Lost to Follow-up|3|||
161227196|NCT01611090|582211662|FG002|Randomized Period|Lost to Follow-up|0|||
161227197|NCT01611090|582211660|FG000|Randomized Period|Withdrawal by Subject|22|||
161227198|NCT01611090|582211661|FG001|Randomized Period|Withdrawal by Subject|26|||
161227199|NCT01611090|582211662|FG002|Randomized Period|Withdrawal by Subject|0|||
161227200|NCT01611090|582211660|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
160881807|NCT01576159|580960678|FG000|Overall Study|Lost to Follow-up|0|||
161227201|NCT01611090|582211661|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
161227202|NCT01611090|582211662|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
160881808|NCT01576159|580960679|FG001|Overall Study|Lost to Follow-up|0|||
161324695|NCT02291029|582575673|FG002|Overall Study|Adverse Event|0|||
161227203|NCT01611090|582211660|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
161227204|NCT01611090|582211661|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
161227205|NCT01611090|582211662|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
161227206|NCT03968224|582211663|FG000|Overall Study|Lost to Follow-up|11|||
161227207|NCT03968224|582211664|FG001|Overall Study|Lost to Follow-up|18|||
161227208|NCT04256421|582211666|FG000|Overall Study|Death|171|||
161227209|NCT04256421|582211667|FG001|Overall Study|Death|180|||
161227210|NCT04256421|582211666|FG000|Overall Study|Lost to Follow-up|1|||
161227211|NCT04256421|582211667|FG001|Overall Study|Lost to Follow-up|1|||
161227212|NCT04256421|582211666|FG000|Overall Study|Withdrawal by Subject|9|||
161227213|NCT04256421|582211667|FG001|Overall Study|Withdrawal by Subject|10|||
161227214|NCT04256421|582211666|FG000|Overall Study|Ongoing in Study|66|||
161227215|NCT04256421|582211667|FG001|Overall Study|Ongoing in Study|52|||
161227216|NCT00454636|582212881|FG000|Overall Study|Adverse Event|10|||
161227217|NCT00454636|582212882|FG001|Overall Study|Adverse Event|6|||
161227218|NCT00454636|582212883|FG002|Overall Study|Adverse Event|9|||
161227219|NCT00454636|582212884|FG003|Overall Study|Adverse Event|15|||
161227220|NCT00454636|582212881|FG000|Overall Study|Disease Progression|11|||
161227221|NCT00454636|582212882|FG001|Overall Study|Disease Progression|12|||
161227222|NCT00454636|582212883|FG002|Overall Study|Disease Progression|4|||
161227223|NCT00454636|582212884|FG003|Overall Study|Disease Progression|11|||
161227224|NCT00454636|582212881|FG000|Overall Study|Protocol Violation|3|||
161227225|NCT00454636|582212882|FG001|Overall Study|Protocol Violation|2|||
161227226|NCT00454636|582212883|FG002|Overall Study|Protocol Violation|3|||
161227227|NCT00454636|582212884|FG003|Overall Study|Protocol Violation|3|||
161227228|NCT00454636|582212881|FG000|Overall Study|Death|6|||
161227229|NCT00454636|582212882|FG001|Overall Study|Death|1|||
161227230|NCT00454636|582212883|FG002|Overall Study|Death|1|||
161227231|NCT00454636|582212884|FG003|Overall Study|Death|1|||
161227232|NCT00454636|582212881|FG000|Overall Study|Patient refusal|1|||
161227233|NCT00454636|582212882|FG001|Overall Study|Patient refusal|1|||
161227234|NCT00454636|582212883|FG002|Overall Study|Patient refusal|3|||
161227235|NCT00454636|582212884|FG003|Overall Study|Patient refusal|2|||
161227236|NCT00454636|582212881|FG000|Overall Study|Lost to Follow-up|0|||
161227237|NCT00454636|582212882|FG001|Overall Study|Lost to Follow-up|1|||
161227238|NCT00454636|582212883|FG002|Overall Study|Lost to Follow-up|0|||
161227239|NCT00454636|582212884|FG003|Overall Study|Lost to Follow-up|0|||
161227240|NCT00806156|582212885|FG000|Overall Study|Death|35|||
161227241|NCT00806156|582212886|FG001|Overall Study|Death|95|||
161227242|NCT00806156|582212885|FG000|Overall Study|Did not meet eligibility criteria|1|||
161227243|NCT00806156|582212886|FG001|Overall Study|Did not meet eligibility criteria|0|||
161227244|NCT00806156|582212885|FG000|Overall Study|Study terminated by Sponsor|2|||
161227245|NCT00806156|582212886|FG001|Overall Study|Study terminated by Sponsor|40|||
161227246|NCT00806156|582212885|FG000|Overall Study|Consent withdrawn by subject|1|||
161227247|NCT00806156|582212886|FG001|Overall Study|Consent withdrawn by subject|3|||
161227248|NCT00806156|582212885|FG000|Overall Study|Lost to Follow-up|0|||
161227249|NCT00806156|582212886|FG001|Overall Study|Lost to Follow-up|1|||
161227250|NCT02674334|582212891|FG000|Overall Study|Lost to Follow-up|5|||
161227251|NCT02674334|582212892|FG001|Overall Study|Lost to Follow-up|3|||
161227252|NCT02674334|582212891|FG000|Overall Study|participant difficulty breathing|1|||
161227253|NCT02674334|582212892|FG001|Overall Study|participant difficulty breathing|0|||
161227254|NCT02674334|582212891|FG000|Overall Study|NIRS not recording|1|||
161227255|NCT02674334|582212892|FG001|Overall Study|NIRS not recording|0|||
161227256|NCT00860405|582212903|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
161227257|NCT00860405|582212904|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
161227258|NCT00864097|582212905|FG000|Overall Study|Death|0|||
161227259|NCT00864097|582212906|FG001|Overall Study|Death|1|||
161227260|NCT00864097|582212907|FG002|Overall Study|Death|0|||
161227261|NCT00864097|582212908|FG003|Overall Study|Death|0|||
161227262|NCT00864097|582212905|FG000|Overall Study|Adverse Event|6|||
161227263|NCT00864097|582212906|FG001|Overall Study|Adverse Event|8|||
161227264|NCT00864097|582212907|FG002|Overall Study|Adverse Event|11|||
161227265|NCT00864097|582212908|FG003|Overall Study|Adverse Event|9|||
161227266|NCT00864097|582212905|FG000|Overall Study|Lack of Efficacy|9|||
161227267|NCT00864097|582212906|FG001|Overall Study|Lack of Efficacy|3|||
161227268|NCT00864097|582212907|FG002|Overall Study|Lack of Efficacy|7|||
161227269|NCT00864097|582212908|FG003|Overall Study|Lack of Efficacy|2|||
161227270|NCT00864097|582212905|FG000|Overall Study|Lost to Follow-up|0|||
161227271|NCT00864097|582212906|FG001|Overall Study|Lost to Follow-up|1|||
161227272|NCT00864097|582212907|FG002|Overall Study|Lost to Follow-up|0|||
161227273|NCT00864097|582212908|FG003|Overall Study|Lost to Follow-up|1|||
161227274|NCT00864097|582212905|FG000|Overall Study|Withdrawal by Subject|15|||
161227275|NCT00864097|582212906|FG001|Overall Study|Withdrawal by Subject|11|||
161227276|NCT00864097|582212907|FG002|Overall Study|Withdrawal by Subject|11|||
161227277|NCT00864097|582212908|FG003|Overall Study|Withdrawal by Subject|12|||
161227278|NCT00864097|582212905|FG000|Overall Study|Protocol Violation|2|||
161227279|NCT00864097|582212906|FG001|Overall Study|Protocol Violation|1|||
161227280|NCT00864097|582212907|FG002|Overall Study|Protocol Violation|0|||
161227281|NCT00864097|582212908|FG003|Overall Study|Protocol Violation|1|||
161227282|NCT00864097|582212905|FG000|Overall Study|Terminated by sponsor|105|||
161227283|NCT00864097|582212906|FG001|Overall Study|Terminated by sponsor|112|||
161227284|NCT00864097|582212907|FG002|Overall Study|Terminated by sponsor|102|||
161227285|NCT00864097|582212908|FG003|Overall Study|Terminated by sponsor|99|||
161227286|NCT00864097|582212905|FG000|Overall Study|Randomized but not treated|2|||
161227287|NCT00864097|582212906|FG001|Overall Study|Randomized but not treated|0|||
161227288|NCT00864097|582212907|FG002|Overall Study|Randomized but not treated|1|||
161227289|NCT00864097|582212908|FG003|Overall Study|Randomized but not treated|0|||
161227290|NCT00864097|582212905|FG000|Overall Study|Other|0|||
161227291|NCT00864097|582212906|FG001|Overall Study|Other|0|||
161227292|NCT00864097|582212907|FG002|Overall Study|Other|0|||
161227293|NCT00864097|582212908|FG003|Overall Study|Other|1|||
161227294|NCT00320112|582212911|FG000|Overall Study|Lost to Follow-up|3|||
161227295|NCT00320112|582212912|FG001|Overall Study|Lost to Follow-up|4|||
161227296|NCT00320112|582212911|FG000|Overall Study|Withdrawal by Subject|3|||
161227297|NCT00320112|582212912|FG001|Overall Study|Withdrawal by Subject|0|||
161227298|NCT00320112|582212911|FG000|Overall Study|Death|2|||
161227299|NCT00320112|582212912|FG001|Overall Study|Death|1|||
161227300|NCT02899338|582212913|FG000|Overall Study|Adverse Event|1|||
161227301|NCT02899338|582212914|FG001|Overall Study|Adverse Event|2|||
161227302|NCT02899338|582212913|FG000|Overall Study|Withdrawal by Subject|2|||
161227303|NCT02899338|582212914|FG001|Overall Study|Withdrawal by Subject|0|||
161227304|NCT06179108|582212915|FG000|Overall Study|Withdrawal by Subject|16|||
161227305|NCT06179108|582212916|FG001|Overall Study|Withdrawal by Subject|19|||
161227306|NCT06179108|582212917|FG002|Overall Study|Withdrawal by Subject|10|||
161227307|NCT06179108|582212918|FG003|Overall Study|Withdrawal by Subject|11|||
161227308|NCT06179108|582212915|FG000|Overall Study|Lost to Follow-up|12|||
161227309|NCT06179108|582212916|FG001|Overall Study|Lost to Follow-up|4|||
161227310|NCT06179108|582212917|FG002|Overall Study|Lost to Follow-up|1|||
161227311|NCT06179108|582212918|FG003|Overall Study|Lost to Follow-up|9|||
161227312|NCT06179108|582212915|FG000|Overall Study|Adverse Event|2|||
161227313|NCT06179108|582212916|FG001|Overall Study|Adverse Event|3|||
161227314|NCT06179108|582212917|FG002|Overall Study|Adverse Event|3|||
161227315|NCT06179108|582212918|FG003|Overall Study|Adverse Event|2|||
161227316|NCT06179108|582212915|FG000|Overall Study|Protocol Violation|0|||
161227317|NCT06179108|582212916|FG001|Overall Study|Protocol Violation|1|||
161227318|NCT06179108|582212917|FG002|Overall Study|Protocol Violation|0|||
161227319|NCT06179108|582212918|FG003|Overall Study|Protocol Violation|1|||
161227320|NCT06179108|582212915|FG000|Overall Study|Physician Decision|1|||
161227321|NCT06179108|582212916|FG001|Overall Study|Physician Decision|1|||
161227322|NCT06179108|582212917|FG002|Overall Study|Physician Decision|0|||
161227323|NCT06179108|582212918|FG003|Overall Study|Physician Decision|0|||
161227324|NCT06179108|582212915|FG000|Overall Study|Lack of Efficacy|0|||
161227325|NCT06179108|582212916|FG001|Overall Study|Lack of Efficacy|0|||
161227326|NCT06179108|582212917|FG002|Overall Study|Lack of Efficacy|0|||
161227327|NCT06179108|582212918|FG003|Overall Study|Lack of Efficacy|1|||
161227328|NCT06179108|582212915|FG000|Overall Study|Death|0|||
161227329|NCT06179108|582212916|FG001|Overall Study|Death|0|||
161227330|NCT06179108|582212917|FG002|Overall Study|Death|0|||
161227331|NCT06179108|582212918|FG003|Overall Study|Death|1|||
161227332|NCT00814463|582212920|FG000|Overall Study|Lost to Follow-up|1|||
161227333|NCT01370408|582212921|FG000|Overall Study|treatment failure|9|||
161227334|NCT02780687|582212926|FG000|Overall Study|Adverse Event|1|||
161227335|NCT02780687|582212927|FG001|Overall Study|Adverse Event|1|||
161227336|NCT02780687|582212926|FG000|Overall Study|Withdrawal by Subject|2|||
161227337|NCT02780687|582212927|FG001|Overall Study|Withdrawal by Subject|1|||
161227338|NCT02780687|582212926|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
161227339|NCT02780687|582212927|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
161227340|NCT02780687|582212926|FG000|Overall Study|progressive disease|29|||
161227341|NCT02780687|582212927|FG001|Overall Study|progressive disease|6|||
161227342|NCT05014412|582212928|FG000|Overall Study|Death|11|||
161227343|NCT05014412|582212929|FG001|Overall Study|Death|7|||
161227344|NCT05014412|582212930|FG002|Overall Study|Death|4|||
161227345|NCT05014412|582212931|FG003|Overall Study|Death|7|||
161227346|NCT05014412|582212928|FG000|Overall Study|Withdrawal by Subject|1|||
161227347|NCT05014412|582212929|FG001|Overall Study|Withdrawal by Subject|1|||
161227348|NCT05014412|582212930|FG002|Overall Study|Withdrawal by Subject|1|||
161227349|NCT05014412|582212931|FG003|Overall Study|Withdrawal by Subject|2|||
161227350|NCT05014412|582212928|FG000|Overall Study|Ongoing|21|||
161227351|NCT05014412|582212929|FG001|Overall Study|Ongoing|4|||
161227352|NCT05014412|582212930|FG002|Overall Study|Ongoing|6|||
161227353|NCT05014412|582212931|FG003|Overall Study|Ongoing|20|||
161227354|NCT02353169|582212932|FG000|Overall Study|QTc > 450 msec|1|||
161227355|NCT02353169|582212933|FG001|Overall Study|QTc > 450 msec|1|||
161227356|NCT02353169|582212934|FG002|Overall Study|QTc > 450 msec|1|||
161227357|NCT02353169|582212935|FG003|Overall Study|QTc > 450 msec|1|||
161227358|NCT02353169|582212932|FG000|Overall Study|OR team declined|2|||
161227359|NCT02353169|582212933|FG001|Overall Study|OR team declined|0|||
161227360|NCT02353169|582212934|FG002|Overall Study|OR team declined|0|||
161227361|NCT02353169|582212935|FG003|Overall Study|OR team declined|0|||
161227362|NCT02353169|582212932|FG000|Overall Study|Inhalational induction|0|||
161227363|NCT02353169|582212933|FG001|Overall Study|Inhalational induction|2|||
161227364|NCT02353169|582212934|FG002|Overall Study|Inhalational induction|0|||
161227365|NCT02353169|582212935|FG003|Overall Study|Inhalational induction|0|||
161227366|NCT02353169|582212932|FG000|Overall Study|ECG data error|0|||
161227367|NCT02353169|582212933|FG001|Overall Study|ECG data error|3|||
161227368|NCT02353169|582212934|FG002|Overall Study|ECG data error|2|||
161227369|NCT02353169|582212935|FG003|Overall Study|ECG data error|2|||
161227370|NCT02353169|582212932|FG000|Overall Study|Pre-op medication|0|||
161227371|NCT02353169|582212933|FG001|Overall Study|Pre-op medication|0|||
161227372|NCT02353169|582212934|FG002|Overall Study|Pre-op medication|1|||
161227373|NCT02353169|582212935|FG003|Overall Study|Pre-op medication|0|||
161227374|NCT00486837|582212937|FG000|Overall Study|Withdrawal by Subject|1|||
161227375|NCT00486837|582212938|FG001|Overall Study|Withdrawal by Subject|0|||
161227376|NCT00486837|582212937|FG000|Overall Study|Adverse Event|1|||
161227377|NCT00486837|582212938|FG001|Overall Study|Adverse Event|1|||
161227378|NCT00486837|582212937|FG000|Overall Study|Protocol Violation|4|||
161227379|NCT00486837|582212938|FG001|Overall Study|Protocol Violation|2|||
161227380|NCT00486837|582212937|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
161227381|NCT00486837|582212938|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
161227382|NCT00414765|582212939|FG000|Overall Study|Adverse Event|5|||
161227383|NCT00414765|582212940|FG001|Overall Study|Adverse Event|9|||
161227384|NCT00414765|582212939|FG000|Overall Study|Withdrawal by Subject|1|||
161227385|NCT00414765|582212940|FG001|Overall Study|Withdrawal by Subject|1|||
161227386|NCT00414765|582212939|FG000|Overall Study|Disease Progression|0|||
161227387|NCT00414765|582212940|FG001|Overall Study|Disease Progression|1|||
161227388|NCT05295953|582212942|FG000|Overall Study|Withdrawal by Subject|0|||
161227389|NCT05295953|582212943|FG001|Overall Study|Withdrawal by Subject|1|||
161227390|NCT05694013|582212945|FG000|Overall Study|Death|6|||
161227391|NCT05694013|582212946|FG001|Overall Study|Death|2|||
161227392|NCT05694013|582212945|FG000|Overall Study|Participant Decision|0|||
161227393|NCT05694013|582212946|FG001|Overall Study|Participant Decision|1|||
161227394|NCT05694013|582212945|FG000|Overall Study|Physician Decision|1|||
161227395|NCT05694013|582212946|FG001|Overall Study|Physician Decision|0|||
161227396|NCT05694013|582212945|FG000|Overall Study|Progressive Disease|0|||
161227397|NCT05694013|582212946|FG001|Overall Study|Progressive Disease|1|||
161324696|NCT02291029|582575674|FG003|Overall Study|Adverse Event|0|||
161324697|NCT02291029|582575675|FG004|Overall Study|Adverse Event|0|||
161324698|NCT02291029|582575676|FG005|Overall Study|Adverse Event|0|||
161324699|NCT02171429|582575677|FG000|Overall Study|Other|0|||
161324700|NCT02171429|582575678|FG001|Overall Study|Other|1|||
160881809|NCT01576159|580960680|FG002|Overall Study|Lost to Follow-up|0|||
160881810|NCT01576159|580960681|FG003|Overall Study|Lost to Follow-up|1|||
161227398|NCT05694013|582212945|FG000|Overall Study|Study Terminated by Sponsor|12|||
161227399|NCT05694013|582212946|FG001|Overall Study|Study Terminated by Sponsor|17|||
161227400|NCT05694013|582212945|FG000|Overall Study|Withdrawal by Subject|3|||
161227401|NCT05694013|582212946|FG001|Overall Study|Withdrawal by Subject|0|||
161227402|NCT01199861|582212947|FG000|Overall Study|Administrative problems|1|||
161324701|NCT02171429|582575679|FG002|Overall Study|Other|1|||
161324702|NCT02171429|582575677|FG000|Overall Study|Non-Compliance|0|||
161227403|NCT01199861|582212948|FG001|Overall Study|Administrative problems|0|||
161227404|NCT01199861|582212947|FG000|Overall Study|Adverse Event|1|||
161227405|NCT01199861|582212948|FG001|Overall Study|Adverse Event|0|||
161227406|NCT04817891|582212949|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
161227407|NCT04817891|582212949|FG000|Overall Study|Adverse Event|1|||
161227408|NCT04817891|582212949|FG000|Overall Study|Withdrawal by Subject|1|||
161227409|NCT03982433|582212950|FG000|Overall Study|Lost to Follow-up|1|||
161227410|NCT04981912|582212951|FG000|Overall Study|Physician Decision|2|||
161227423|NCT05630547|582212955|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161227424|NCT05630547|582212956|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
161227425|NCT05630547|582212957|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161227426|NCT05630547|582212958|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
161227427|NCT05630547|582212955|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
161227428|NCT05630547|582212956|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
161227429|NCT05630547|582212957|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
161227430|NCT05630547|582212958|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
161227431|NCT05630547|582212955|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161227432|NCT05630547|582212956|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
161227433|NCT05630547|582212957|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161227434|NCT05630547|582212958|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
161227435|NCT05630547|582212955|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
161227436|NCT05630547|582212956|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
161227437|NCT05630547|582212957|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
161227438|NCT05630547|582212958|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
161227439|NCT05630547|582212955|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161227440|NCT05630547|582212956|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
161227441|NCT05630547|582212957|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161227442|NCT05630547|582212958|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
161227443|NCT05630547|582212955|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
161227444|NCT05630547|582212956|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
161227445|NCT05630547|582212957|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
161227446|NCT05630547|582212958|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
161227447|NCT05630547|582212955|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161227448|NCT05630547|582212956|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161227449|NCT05630547|582212957|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
161227450|NCT05630547|582212958|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
161227451|NCT05630547|582212955|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
161227452|NCT05630547|582212956|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
161227453|NCT05630547|582212957|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
161227454|NCT05630547|582212958|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
161227455|NCT05630547|582212955|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
161227456|NCT05630547|582212956|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
161227457|NCT05630547|582212957|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
161227458|NCT05630547|582212958|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
161227459|NCT05630547|582212955|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
161227460|NCT05630547|582212956|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
161227461|NCT05630547|582212957|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
161227462|NCT05630547|582212958|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
161227463|NCT02153736|582212965|FG000|Overall Study|Lost to Follow-up|1|||
161227464|NCT02153736|582212966|FG001|Overall Study|Lost to Follow-up|0|||
161227465|NCT02153736|582212965|FG000|Overall Study|Medical status change made ineligible|1|||
161227466|NCT02153736|582212966|FG001|Overall Study|Medical status change made ineligible|0|||
161227467|NCT02153736|582212965|FG000|Overall Study|Death|0|||
161227468|NCT02153736|582212966|FG001|Overall Study|Death|1|||
161227469|NCT02153736|582212965|FG000|Overall Study|Withdrawal by Subject|0|||
161227470|NCT02153736|582212966|FG001|Overall Study|Withdrawal by Subject|1|||
161227471|NCT01734772|582212967|FG000|Overall Study|Adverse Event|1|||
161227472|NCT01734772|582212968|FG001|Overall Study|Adverse Event|2|||
161227473|NCT01734772|582212967|FG000|Overall Study|Withdrawal by Subject|0|||
161227474|NCT01734772|582212968|FG001|Overall Study|Withdrawal by Subject|1|||
161227475|NCT00720122|582212975|FG000|Overall Study|Lost to Follow-up|1|||
161324703|NCT02171429|582575678|FG001|Overall Study|Non-Compliance|0|||
161324704|NCT02171429|582575679|FG002|Overall Study|Non-Compliance|1|||
161324705|NCT02171429|582575677|FG000|Overall Study|Physician Decision|0|||
161324706|NCT02171429|582575678|FG001|Overall Study|Physician Decision|0|||
161324707|NCT02171429|582575679|FG002|Overall Study|Physician Decision|1|||
161324708|NCT02171429|582575677|FG000|Overall Study|Withdrawal by Subject|1|||
161324709|NCT02171429|582575678|FG001|Overall Study|Withdrawal by Subject|1|||
161324710|NCT02171429|582575679|FG002|Overall Study|Withdrawal by Subject|1|||
161324711|NCT02171429|582575677|FG000|Overall Study|Lost to Follow-up|0|||
161324712|NCT02171429|582575678|FG001|Overall Study|Lost to Follow-up|1|||
161324713|NCT02171429|582575679|FG002|Overall Study|Lost to Follow-up|0|||
161324714|NCT02171429|582575677|FG000|Overall Study|Death|0|||
161324715|NCT02171429|582575678|FG001|Overall Study|Death|0|||
161324716|NCT02171429|582575679|FG002|Overall Study|Death|1|||
161324717|NCT00493012|582575680|FG000|Overall Study|Lost to Follow-up|18|||
161324718|NCT00493012|582575681|FG001|Overall Study|Lost to Follow-up|17|||
161324719|NCT04147247|582575682|FG000|Overall Study|Progressive disease|3|||
161324720|NCT04147247|582575683|FG001|Overall Study|Progressive disease|3|||
161324721|NCT04147247|582575684|FG002|Overall Study|Progressive disease|4|||
161324722|NCT04147247|582575685|FG003|Overall Study|Progressive disease|4|||
161324723|NCT04147247|582575686|FG004|Overall Study|Progressive disease|3|||
161324724|NCT04147247|582575682|FG000|Overall Study|Physician Decision|0|||
161324725|NCT04147247|582575683|FG001|Overall Study|Physician Decision|1|||
161324726|NCT04147247|582575684|FG002|Overall Study|Physician Decision|0|||
161324727|NCT04147247|582575685|FG003|Overall Study|Physician Decision|0|||
161324728|NCT04147247|582575686|FG004|Overall Study|Physician Decision|0|||
161324729|NCT04147247|582575682|FG000|Overall Study|Clinical Disease Progression|0|||
161324730|NCT04147247|582575683|FG001|Overall Study|Clinical Disease Progression|0|||
161324731|NCT04147247|582575684|FG002|Overall Study|Clinical Disease Progression|0|||
161324732|NCT04147247|582575685|FG003|Overall Study|Clinical Disease Progression|0|||
161324733|NCT04147247|582575686|FG004|Overall Study|Clinical Disease Progression|1|||
161324734|NCT04147247|582575682|FG000|Overall Study|Adverse Event|0|||
161324735|NCT04147247|582575683|FG001|Overall Study|Adverse Event|0|||
161324736|NCT04147247|582575684|FG002|Overall Study|Adverse Event|1|||
161121689|NCT01934140|581833540|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
161121690|NCT01934140|581833541|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
161121691|NCT01934140|581833540|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
161121692|NCT01934140|581833541|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
161121693|NCT01934140|581833540|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
161121694|NCT01934140|581833541|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
161121695|NCT01934140|581833540|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
161121696|NCT01934140|581833541|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
161121697|NCT00808444|581833547|FG000|Overall Study|Withdrawal by Subject|1|||
161121698|NCT00808444|581833548|FG001|Overall Study|Withdrawal by Subject|0|||
161121699|NCT00808444|581833547|FG000|Overall Study|Lost to Follow-up|0|||
161121700|NCT00808444|581833548|FG001|Overall Study|Lost to Follow-up|1|||
161121701|NCT01461044|581833549|FG000|Overall Study|Death|58|||
161227476|NCT00720122|582212975|FG000|Overall Study|Physician Decision|1|||
161227477|NCT00720122|582212975|FG000|Overall Study|Withdrawal by Subject|7|||
161227478|NCT01867242|582212976|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
161227479|NCT01867242|582212977|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
161227480|NCT01867242|582212978|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
161227481|NCT00661999|582212979|FG000|Overall Study|Adverse Event|11|||
161227482|NCT00661999|582212980|FG001|Overall Study|Adverse Event|5|||
161227483|NCT00661999|582212981|FG002|Overall Study|Adverse Event|8|||
161227484|NCT00661999|582212979|FG000|Overall Study|Death|8|||
161227485|NCT00661999|582212980|FG001|Overall Study|Death|6|||
161227486|NCT00661999|582212981|FG002|Overall Study|Death|3|||
161227487|NCT00661999|582212979|FG000|Overall Study|Other Reasons|5|||
161227488|NCT00661999|582212980|FG001|Overall Study|Other Reasons|12|||
161227489|NCT00661999|582212981|FG002|Overall Study|Other Reasons|23|||
161227490|NCT00661999|582212979|FG000|Overall Study|Withdrawal by Subject|30|||
161227491|NCT00661999|582212980|FG001|Overall Study|Withdrawal by Subject|23|||
161227492|NCT00661999|582212981|FG002|Overall Study|Withdrawal by Subject|14|||
161227493|NCT00661999|582212979|FG000|Overall Study|Alternative Treatment|1|||
161227494|NCT00661999|582212980|FG001|Overall Study|Alternative Treatment|0|||
161227495|NCT00661999|582212981|FG002|Overall Study|Alternative Treatment|0|||
161227496|NCT00661999|582212979|FG000|Overall Study|Other Medical Problems|4|||
161227497|NCT00661999|582212980|FG001|Overall Study|Other Medical Problems|4|||
161227498|NCT00661999|582212981|FG002|Overall Study|Other Medical Problems|9|||
161227499|NCT03066999|582212982|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
161227500|NCT03066999|582212983|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
161227501|NCT01139164|582212986|FG000|Overall Study|Withdrawn prior to study start|0|||
161227502|NCT01139164|582212987|FG001|Overall Study|Withdrawn prior to study start|2|||
161227503|NCT01139164|582212988|FG002|Overall Study|Withdrawn prior to study start|0|||
161324737|NCT04147247|582575685|FG003|Overall Study|Adverse Event|0|||
161227504|NCT01790568|582212989|FG000|Overall Study|Progression prior to transplant|0|||
161227505|NCT01790568|582212990|FG001|Overall Study|Progression prior to transplant|1|||
161227506|NCT01361126|582212991|FG000|Overall Study|Sponsor decision|0|||
161227507|NCT01361126|582212992|FG001|Overall Study|Sponsor decision|2|||
161227508|NCT01658943|582212995|FG000|Overall Study|Adverse Event|6|||
161227509|NCT01658943|582212996|FG001|Overall Study|Adverse Event|13|||
161227510|NCT01658943|582212995|FG000|Overall Study|Withdrawal by Subject|9|||
161227511|NCT01658943|582212996|FG001|Overall Study|Withdrawal by Subject|2|||
161227512|NCT01658943|582212995|FG000|Overall Study|Progression/Relapse|39|||
161227513|NCT01658943|582212996|FG001|Overall Study|Progression/Relapse|40|||
161227514|NCT01658943|582212995|FG000|Overall Study|Death|4|||
161227515|NCT01658943|582212996|FG001|Overall Study|Death|2|||
161227516|NCT01658943|582212995|FG000|Overall Study|not protocol specified|4|||
161227517|NCT01658943|582212996|FG001|Overall Study|not protocol specified|1|||
161227518|NCT01658943|582212995|FG000|Overall Study|Not eligible|7|||
161227519|NCT01658943|582212996|FG001|Overall Study|Not eligible|9|||
161227520|NCT01658943|582212995|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
161227521|NCT01658943|582212996|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
161227522|NCT04272801|582212999|FG000|Overall Study|Withdrawal by Subject|4|||
161227523|NCT04272801|582212999|FG000|Overall Study|Lost to Follow-up|4|||
161227524|NCT04272801|582212999|FG000|Overall Study|Ineligible|1|||
161227525|NCT02456909|582213000|FG000|Overall Study|Did not receive allocated intervention|24|||
161227526|NCT02456909|582213001|FG001|Overall Study|Did not receive allocated intervention|26|||
161227527|NCT02456909|582213000|FG000|Overall Study|Did not complete the primary outcome|0|||
161227528|NCT02456909|582213001|FG001|Overall Study|Did not complete the primary outcome|1|||
161227529|NCT02768298|582213002|FG000|Overall Study|Adverse Event|1|||
161227530|NCT02768298|582213003|FG001|Overall Study|Adverse Event|4|||
161227531|NCT02768298|582213002|FG000|Overall Study|Death|2|||
161227532|NCT02768298|582213003|FG001|Overall Study|Death|1|||
161227533|NCT02768298|582213002|FG000|Overall Study|Non-compliance with study treatment|0|||
160881811|NCT01576159|580960678|FG000|Overall Study|Protocol Violation|1|||
160881812|NCT01576159|580960679|FG001|Overall Study|Protocol Violation|0|||
160881813|NCT01576159|580960680|FG002|Overall Study|Protocol Violation|0|||
160881814|NCT01576159|580960681|FG003|Overall Study|Protocol Violation|0|||
160881815|NCT04463069|580960682|FG000|Overall Study|Withdrawal by Subject|2|||
160881816|NCT04463069|580960683|FG001|Overall Study|Withdrawal by Subject|10|||
160881817|NCT04463069|580960682|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
160881818|NCT04463069|580960683|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
160881819|NCT00311584|580960685|FG000|Overall Study|Death|1|||
160881820|NCT00311584|580960686|FG001|Overall Study|Death|0|||
160881821|NCT00311584|580960685|FG000|Overall Study|Lack of Efficacy|12|||
160881822|NCT00311584|580960686|FG001|Overall Study|Lack of Efficacy|15|||
160881823|NCT00311584|580960685|FG000|Overall Study|Physician Decision|4|||
160881824|NCT00311584|580960686|FG001|Overall Study|Physician Decision|5|||
160881825|NCT00311584|580960685|FG000|Overall Study|Withdrawal by Subject|1|||
160881826|NCT00311584|580960686|FG001|Overall Study|Withdrawal by Subject|1|||
160881827|NCT00311584|580960685|FG000|Overall Study|ineligible|2|||
160881828|NCT00311584|580960686|FG001|Overall Study|ineligible|2|||
160881829|NCT03073733|580960693|FG000|Overall Study|Lost to Follow-up|1|||
160881830|NCT03073733|580960694|FG001|Overall Study|Lost to Follow-up|0|||
160881831|NCT03073733|580960695|FG002|Overall Study|Lost to Follow-up|0|||
160881832|NCT03073733|580960693|FG000|Overall Study|Physician Decision|0|||
160881833|NCT03073733|580960694|FG001|Overall Study|Physician Decision|1|||
160881834|NCT03073733|580960695|FG002|Overall Study|Physician Decision|0|||
160881835|NCT03073733|580960693|FG000|Overall Study|Withdrawal by Subject|0|||
160881836|NCT03073733|580960694|FG001|Overall Study|Withdrawal by Subject|0|||
160881837|NCT03073733|580960695|FG002|Overall Study|Withdrawal by Subject|1|||
160881838|NCT01454778|580960696|FG000|Overall Study|Lost to Follow-up|2|||
160881839|NCT01454778|580960696|FG000|Overall Study|Death|1|||
160881840|NCT01227629|580960698|FG000|Overall Study|Adverse Event|2|||
160881841|NCT01227629|580960699|FG001|Overall Study|Adverse Event|2|||
160881842|NCT01227629|580960700|FG002|Overall Study|Adverse Event|1|||
161121702|NCT01461044|581833550|FG001|Overall Study|Death|35|||
161121703|NCT01461044|581833549|FG000|Overall Study|Lost to Follow-up|12|||
161121704|NCT01461044|581833550|FG001|Overall Study|Lost to Follow-up|5|||
161121705|NCT04401267|581833551|FG000|Overall Study|Death|0|||
161121706|NCT04401267|581833552|FG001|Overall Study|Death|1|||
161121707|NCT04401267|581833551|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
161121708|NCT04401267|581833552|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
161121709|NCT04401267|581833551|FG000|Overall Study|Found to be Ineligible|1|||
161121710|NCT04401267|581833552|FG001|Overall Study|Found to be Ineligible|0|||
161121711|NCT00200850|581833558|FG000|Overall Study|relocation|1|||
161121712|NCT00200850|581833559|FG001|Overall Study|relocation|0|||
161121713|NCT00200850|581833560|FG002|Overall Study|relocation|1|||
161121714|NCT00200850|581833558|FG000|Overall Study|too busy|1|||
161121715|NCT00200850|581833559|FG001|Overall Study|too busy|0|||
161121716|NCT00200850|581833560|FG002|Overall Study|too busy|0|||
161121717|NCT00200850|581833558|FG000|Overall Study|Pregnancy|0|||
161121718|NCT00200850|581833559|FG001|Overall Study|Pregnancy|0|||
161121719|NCT00200850|581833560|FG002|Overall Study|Pregnancy|1|||
161121720|NCT00200850|581833558|FG000|Overall Study|Poor adherence|0|||
161121721|NCT00200850|581833559|FG001|Overall Study|Poor adherence|0|||
161121722|NCT00200850|581833560|FG002|Overall Study|Poor adherence|1|||
161121723|NCT00200850|581833558|FG000|Overall Study|optic neuritis|0|||
161121724|NCT00200850|581833559|FG001|Overall Study|optic neuritis|0|||
161121725|NCT00200850|581833560|FG002|Overall Study|optic neuritis|1|||
161121726|NCT00200850|581833558|FG000|Overall Study|Adverse Event|1|||
161121727|NCT00200850|581833559|FG001|Overall Study|Adverse Event|1|||
161121728|NCT00200850|581833560|FG002|Overall Study|Adverse Event|2|||
161121729|NCT02889796|581833563|FG000|Overall Study|Withdrew Consent|18|||
161121730|NCT02889796|581833564|FG001|Overall Study|Withdrew Consent|29|||
161121731|NCT02889796|581833565|FG002|Overall Study|Withdrew Consent|20|||
161121732|NCT02889796|581833566|FG003|Overall Study|Withdrew Consent|1|||
161121733|NCT02889796|581833567|FG004|Overall Study|Withdrew Consent|2|||
161121734|NCT02889796|581833568|FG005|Overall Study|Withdrew Consent|35|||
161227534|NCT02768298|582213003|FG001|Overall Study|Non-compliance with study treatment|1|||
161121735|NCT02889796|581833563|FG000|Overall Study|Investigator's Discretion|10|||
161121736|NCT02889796|581833564|FG001|Overall Study|Investigator's Discretion|9|||
161121737|NCT02889796|581833565|FG002|Overall Study|Investigator's Discretion|10|||
161121738|NCT02889796|581833566|FG003|Overall Study|Investigator's Discretion|3|||
161121739|NCT02889796|581833567|FG004|Overall Study|Investigator's Discretion|0|||
161121740|NCT02889796|581833568|FG005|Overall Study|Investigator's Discretion|15|||
161227535|NCT02768298|582213002|FG000|Overall Study|Subject/guardian decision|1|||
160881843|NCT01227629|580960701|FG003|Overall Study|Adverse Event|6|||
161121741|NCT02889796|581833563|FG000|Overall Study|Adverse Event|17|||
161121742|NCT02889796|581833564|FG001|Overall Study|Adverse Event|8|||
161121743|NCT02889796|581833565|FG002|Overall Study|Adverse Event|8|||
161121744|NCT02889796|581833566|FG003|Overall Study|Adverse Event|4|||
161121745|NCT02889796|581833567|FG004|Overall Study|Adverse Event|1|||
161324738|NCT04147247|582575686|FG004|Overall Study|Adverse Event|1|||
160881844|NCT01227629|580960702|FG004|Overall Study|Adverse Event|1|||
161121746|NCT02889796|581833568|FG005|Overall Study|Adverse Event|7|||
161121747|NCT02889796|581833563|FG000|Overall Study|Lost to Follow-up|5|||
161324739|NCT01724177|582575687|FG000|Overall Study|Adverse Event|8|||
161324740|NCT01724177|582575687|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
161324741|NCT01724177|582575687|FG000|Overall Study|Nervous participant|1|||
161324742|NCT01724177|582575687|FG000|Overall Study|Serious Adverse Event Related|1|||
160881845|NCT01227629|580960703|FG005|Overall Study|Adverse Event|1|||
160881846|NCT01227629|580960704|FG006|Overall Study|Adverse Event|6|||
160881847|NCT01227629|580960705|FG007|Overall Study|Adverse Event|6|||
160881848|NCT01227629|580960706|FG008|Overall Study|Adverse Event|4|||
160881849|NCT01227629|580960707|FG009|Overall Study|Adverse Event|0|||
160881850|NCT01227629|580960698|FG000|Overall Study|Protocol Violation|0|||
160881851|NCT01227629|580960699|FG001|Overall Study|Protocol Violation|0|||
160881852|NCT01227629|580960700|FG002|Overall Study|Protocol Violation|0|||
160881853|NCT01227629|580960701|FG003|Overall Study|Protocol Violation|1|||
160881854|NCT01227629|580960702|FG004|Overall Study|Protocol Violation|0|||
160881855|NCT01227629|580960703|FG005|Overall Study|Protocol Violation|0|||
160881856|NCT01227629|580960704|FG006|Overall Study|Protocol Violation|0|||
160881857|NCT01227629|580960705|FG007|Overall Study|Protocol Violation|0|||
160881858|NCT01227629|580960706|FG008|Overall Study|Protocol Violation|0|||
160881859|NCT01227629|580960707|FG009|Overall Study|Protocol Violation|0|||
160881860|NCT01227629|580960698|FG000|Overall Study|Lost to Follow-up|0|||
160881861|NCT01227629|580960699|FG001|Overall Study|Lost to Follow-up|0|||
160881862|NCT01227629|580960700|FG002|Overall Study|Lost to Follow-up|0|||
160881863|NCT01227629|580960701|FG003|Overall Study|Lost to Follow-up|0|||
160881864|NCT01227629|580960702|FG004|Overall Study|Lost to Follow-up|1|||
160881865|NCT01227629|580960703|FG005|Overall Study|Lost to Follow-up|0|||
160881866|NCT01227629|580960704|FG006|Overall Study|Lost to Follow-up|0|||
160881867|NCT01227629|580960705|FG007|Overall Study|Lost to Follow-up|0|||
160881868|NCT01227629|580960706|FG008|Overall Study|Lost to Follow-up|0|||
160881869|NCT01227629|580960707|FG009|Overall Study|Lost to Follow-up|0|||
160881870|NCT01227629|580960698|FG000|Overall Study|Withdrawal by Subject|0|||
160881871|NCT01227629|580960699|FG001|Overall Study|Withdrawal by Subject|0|||
160881872|NCT01227629|580960700|FG002|Overall Study|Withdrawal by Subject|0|||
160881873|NCT01227629|580960701|FG003|Overall Study|Withdrawal by Subject|0|||
160881874|NCT01227629|580960702|FG004|Overall Study|Withdrawal by Subject|0|||
160881875|NCT01227629|580960703|FG005|Overall Study|Withdrawal by Subject|0|||
160881876|NCT01227629|580960704|FG006|Overall Study|Withdrawal by Subject|2|||
160881877|NCT01227629|580960705|FG007|Overall Study|Withdrawal by Subject|0|||
160881878|NCT01227629|580960706|FG008|Overall Study|Withdrawal by Subject|0|||
160881879|NCT01227629|580960707|FG009|Overall Study|Withdrawal by Subject|1|||
160881880|NCT01227629|580960698|FG000|Overall Study|Other|0|||
160881881|NCT01227629|580960699|FG001|Overall Study|Other|0|||
160881882|NCT01227629|580960700|FG002|Overall Study|Other|0|||
160881883|NCT01227629|580960701|FG003|Overall Study|Other|1|||
160881884|NCT01227629|580960702|FG004|Overall Study|Other|0|||
160881885|NCT01227629|580960703|FG005|Overall Study|Other|0|||
160881886|NCT01227629|580960704|FG006|Overall Study|Other|0|||
160881887|NCT01227629|580960705|FG007|Overall Study|Other|0|||
160881888|NCT01227629|580960706|FG008|Overall Study|Other|2|||
160881889|NCT01227629|580960707|FG009|Overall Study|Other|1|||
160881890|NCT00129311|580960708|FG000|Overall Study|Withdrawal by Subject|12|||
160881891|NCT00129311|580960709|FG001|Overall Study|Withdrawal by Subject|19|||
160881892|NCT02446171|580962878|FG000|Overall Study|Withdrawal by Subject|0|||
160881893|NCT02446171|580962879|FG001|Overall Study|Withdrawal by Subject|0|||
160881894|NCT02446171|580962880|FG002|Overall Study|Withdrawal by Subject|2|||
160881895|NCT02446171|580962881|FG003|Overall Study|Withdrawal by Subject|0|||
160881896|NCT02320903|580962884|FG000|Overall Study|Withdrawal by Subject|0|||
160881897|NCT02320903|580962885|FG001|Overall Study|Withdrawal by Subject|9|||
160881898|NCT02320903|580962886|FG002|Overall Study|Withdrawal by Subject|9|||
160881899|NCT02320903|580962884|FG000|Overall Study|Exited therapy; no longer eligible|8|||
160881900|NCT02320903|580962885|FG001|Overall Study|Exited therapy; no longer eligible|2|||
160881901|NCT02320903|580962886|FG002|Overall Study|Exited therapy; no longer eligible|2|||
160881902|NCT02320903|580962884|FG000|Overall Study|Lost to Follow-up|0|||
160881903|NCT02320903|580962885|FG001|Overall Study|Lost to Follow-up|5|||
160881904|NCT02320903|580962886|FG002|Overall Study|Lost to Follow-up|5|||
160881905|NCT00773383|580962887|FG000|Overall Study|Adverse Event|4|||
160881906|NCT00773383|580962887|FG000|Overall Study|Death|1|||
160881907|NCT00773383|580962887|FG000|Overall Study|Progression of Disease|23|||
160881908|NCT00773383|580962887|FG000|Overall Study|Other|2|||
160881909|NCT00773383|580962887|FG000|Overall Study|No study dose received|1|||
160881910|NCT03811093|580962905|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
160881911|NCT03811093|580962906|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
160881912|NCT03811093|580962905|FG000|Overall Study|Unable to measure body fat percentage|2|||
160881913|NCT03811093|580962906|FG001|Overall Study|Unable to measure body fat percentage|0|||
160881914|NCT00464490|580962908|FG000|Overall Study|Physician Decision|11|||
160881915|NCT00464490|580962909|FG001|Overall Study|Physician Decision|11|||
160881916|NCT03188042|580962912|FG000|Overall Study|Withdrawal by Subject|1|||
160881917|NCT03188042|580962913|FG001|Overall Study|Withdrawal by Subject|1|||
160881918|NCT00039871|580962921|FG000|Overall Study|Adverse Event|165|||
160881919|NCT00039871|580962921|FG000|Overall Study|Lost to Follow-up|18|||
160881920|NCT00039871|580962921|FG000|Overall Study|Protocol Violation|24|||
160881921|NCT00039871|580962921|FG000|Overall Study|Withdrawal by Subject|97|||
160881922|NCT00039871|580962921|FG000|Overall Study|Did not meet eligibility criteria|11|||
160881923|NCT00039871|580962921|FG000|Overall Study|Administrative|1|||
161121748|NCT02889796|581833564|FG001|Overall Study|Lost to Follow-up|7|||
160881924|NCT00039871|580962921|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
160881925|NCT00039871|580962921|FG000|Overall Study|Never entered follow-up|7|||
160881926|NCT02446743|580962922|FG000|Overall Study|Withdrawal by Subject|1|||
160881927|NCT02446743|580962923|FG001|Overall Study|Withdrawal by Subject|1|||
160881928|NCT02446743|580962922|FG000|Overall Study|Lost to Follow-up|1|||
160881929|NCT02446743|580962923|FG001|Overall Study|Lost to Follow-up|0|||
161324743|NCT00327340|582575692|FG000|Overall Study|Withdrawal by Subject|1|||
161324744|NCT00327340|582575693|FG001|Overall Study|Withdrawal by Subject|5|||
160881930|NCT02446743|580962922|FG000|Overall Study|Adverse Event|1|||
160881931|NCT02446743|580962923|FG001|Overall Study|Adverse Event|1|||
160881932|NCT02446743|580962922|FG000|Overall Study|Other|2|||
160881933|NCT02446743|580962923|FG001|Overall Study|Other|3|||
160881934|NCT02478398|580962924|FG000|Overall Study|Adverse Event|20|||
160881935|NCT02478398|580962925|FG001|Overall Study|Adverse Event|5|||
160881936|NCT02478398|580962924|FG000|Overall Study|Lost to Follow-up|5|||
160881937|NCT02478398|580962925|FG001|Overall Study|Lost to Follow-up|4|||
160881938|NCT02478398|580962924|FG000|Overall Study|Non-Compliance With Study Drug|5|||
160881939|NCT02478398|580962925|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160881940|NCT02478398|580962924|FG000|Overall Study|Protocol Violation|3|||
160881941|NCT02478398|580962925|FG001|Overall Study|Protocol Violation|1|||
160881942|NCT02478398|580962924|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
160881943|NCT02478398|580962925|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
160881944|NCT02478398|580962924|FG000|Overall Study|Withdrawal By Participant|10|||
160881945|NCT02478398|580962925|FG001|Overall Study|Withdrawal By Participant|4|||
160881946|NCT01475071|580962929|FG000|Overall Study|Physician Decision|1|||
160881947|NCT01475071|580962929|FG000|Overall Study|Withdrawal by Subject|6|||
160881948|NCT01475071|580962929|FG000|Overall Study|Lost to Follow-up|1|||
160881949|NCT01205581|580962933|FG000|Overall Study|Withdrawal by Subject|1|||
160881950|NCT01205581|580962934|FG001|Overall Study|Withdrawal by Subject|0|||
160881951|NCT01205581|580962935|FG002|Overall Study|Withdrawal by Subject|0|||
160881952|NCT01205581|580962936|FG003|Overall Study|Withdrawal by Subject|0|||
160881953|NCT01205581|580962937|FG004|Overall Study|Withdrawal by Subject|0|||
160881954|NCT01205581|580962938|FG005|Overall Study|Withdrawal by Subject|0|||
160881955|NCT00770146|580962950|FG000|Treatment Period|Withdrawal by Subject|6|||
160881956|NCT00770146|580962951|FG001|Treatment Period|Withdrawal by Subject|13|||
160881957|NCT00770146|580962950|FG000|Treatment Period|Adverse Event|2|||
160881958|NCT00770146|580962951|FG001|Treatment Period|Adverse Event|26|||
160881959|NCT00770146|580962950|FG000|Treatment Period|Other|1|||
160881960|NCT00770146|580962951|FG001|Treatment Period|Other|5|||
160881961|NCT00770146|580962950|FG000|Treatment Period|Protocol non-compliance|0|||
160881962|NCT00770146|580962951|FG001|Treatment Period|Protocol non-compliance|1|||
160881963|NCT00770146|580962950|FG000|Follow-up Period|Withdrawal by Subject|7|||
161121749|NCT02889796|581833565|FG002|Overall Study|Lost to Follow-up|2|||
161324745|NCT00327340|582575692|FG000|Overall Study|Physician Decision|1|||
161324746|NCT00327340|582575693|FG001|Overall Study|Physician Decision|1|||
160881964|NCT00770146|580962951|FG001|Follow-up Period|Withdrawal by Subject|13|||
160881965|NCT00770146|580962950|FG000|Follow-up Period|Adverse Event|0|||
160881966|NCT00770146|580962951|FG001|Follow-up Period|Adverse Event|2|||
160881967|NCT00770146|580962950|FG000|Follow-up Period|Other|4|||
160881968|NCT00770146|580962951|FG001|Follow-up Period|Other|5|||
160881969|NCT01525901|580962953|FG000|Period 2: 12 Weeks|Adverse Event|0|||
161324747|NCT00327340|582575692|FG000|Overall Study|Disease Progression|10|||
161324748|NCT00327340|582575693|FG001|Overall Study|Disease Progression|19|||
161324749|NCT00327340|582575692|FG000|Overall Study|Symptomatic Disease|0|||
161324750|NCT00327340|582575693|FG001|Overall Study|Symptomatic Disease|2|||
160881970|NCT01525901|580962954|FG001|Period 2: 12 Weeks|Adverse Event|1|||
160881971|NCT01525901|580962955|FG002|Period 2: 12 Weeks|Adverse Event|0|||
160881972|NCT01525901|580962956|FG003|Period 2: 12 Weeks|Adverse Event|0|||
160881973|NCT04449029|580962958|FG000|Overall Study|Adverse Event|0|||
160881974|NCT04449029|580962959|FG001|Overall Study|Adverse Event|1|||
160881975|NCT04449029|580962960|FG002|Overall Study|Adverse Event|1|||
160881976|NCT04449029|580962961|FG003|Overall Study|Adverse Event|0|||
160881977|NCT04449029|580962962|FG004|Overall Study|Adverse Event|1|||
160881978|NCT04449029|580962963|FG005|Overall Study|Adverse Event|0|||
160881979|NCT04449029|580962964|FG006|Overall Study|Adverse Event|1|||
160881980|NCT04449029|580962965|FG007|Overall Study|Adverse Event|0|||
160881981|NCT04449029|580962958|FG000|Overall Study|Lost to Follow-up|0|||
160881982|NCT04449029|580962959|FG001|Overall Study|Lost to Follow-up|1|||
160881983|NCT04449029|580962960|FG002|Overall Study|Lost to Follow-up|0|||
160881984|NCT04449029|580962961|FG003|Overall Study|Lost to Follow-up|0|||
160881985|NCT04449029|580962962|FG004|Overall Study|Lost to Follow-up|0|||
160881986|NCT04449029|580962963|FG005|Overall Study|Lost to Follow-up|0|||
160881987|NCT04449029|580962964|FG006|Overall Study|Lost to Follow-up|0|||
160881988|NCT04449029|580962965|FG007|Overall Study|Lost to Follow-up|0|||
161121750|NCT02889796|581833566|FG003|Overall Study|Lost to Follow-up|0|||
161121751|NCT02889796|581833567|FG004|Overall Study|Lost to Follow-up|2|||
161324751|NCT00327340|582575692|FG000|Overall Study|Adverse Event|3|||
161324752|NCT00327340|582575693|FG001|Overall Study|Adverse Event|3|||
161324753|NCT00206427|582575696|FG000|Overall Study|Adverse Event|2|||
161324754|NCT04085601|582575697|FG000|Overall Study|Lost to Follow-up|1|||
161324755|NCT04085601|582575698|FG001|Overall Study|Lost to Follow-up|0|||
161324756|NCT04085601|582575697|FG000|Overall Study|Death|1|||
161324757|NCT04085601|582575698|FG001|Overall Study|Death|1|||
161324758|NCT03492437|582575699|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161324759|NCT03492437|582575700|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161324760|NCT03280056|582575702|FG000|Overall Study|Withdrawal by Subject|12|||
160881989|NCT04449029|580962958|FG000|Overall Study|Protocol Violation|0|||
160881990|NCT04449029|580962959|FG001|Overall Study|Protocol Violation|1|||
160881991|NCT04449029|580962960|FG002|Overall Study|Protocol Violation|0|||
160881992|NCT04449029|580962961|FG003|Overall Study|Protocol Violation|0|||
161121752|NCT02889796|581833568|FG005|Overall Study|Lost to Follow-up|6|||
161324761|NCT03280056|582575703|FG001|Overall Study|Withdrawal by Subject|14|||
161324762|NCT03280056|582575702|FG000|Overall Study|Death|9|||
161324763|NCT03280056|582575703|FG001|Overall Study|Death|2|||
161121753|NCT02889796|581833563|FG000|Overall Study|Protocol Violation|0|||
161324764|NCT03280056|582575702|FG000|Overall Study|Adverse Event|1|||
161324765|NCT03280056|582575703|FG001|Overall Study|Adverse Event|3|||
161324766|NCT03280056|582575702|FG000|Overall Study|Lost to Follow-up|1|||
161121754|NCT02889796|581833564|FG001|Overall Study|Protocol Violation|1|||
161324767|NCT03280056|582575703|FG001|Overall Study|Lost to Follow-up|1|||
161324768|NCT03280056|582575702|FG000|Overall Study|Physician Decision|0|||
161324769|NCT03280056|582575703|FG001|Overall Study|Physician Decision|1|||
161324770|NCT03280056|582575702|FG000|Overall Study|Early Discontinuation|1|||
161324771|NCT03280056|582575703|FG001|Overall Study|Early Discontinuation|0|||
161324772|NCT00613821|582575704|FG000|Overall Study|Withdrawal by Subject|1|||
161324773|NCT00613821|582575705|FG001|Overall Study|Withdrawal by Subject|0|||
161324774|NCT00613821|582575704|FG000|Overall Study|Physician Decision|1|||
161324775|NCT00613821|582575705|FG001|Overall Study|Physician Decision|1|||
161324776|NCT00397189|582575706|FG000|3 Weeks Period|Lost to Follow-up|5|||
161324777|NCT00397189|582575707|FG001|3 Weeks Period|Lost to Follow-up|4|||
161324778|NCT00397189|582575706|FG000|3 Weeks Period|Adverse Event|3|||
161324779|NCT00397189|582575707|FG001|3 Weeks Period|Adverse Event|2|||
161324780|NCT00397189|582575706|FG000|3 Weeks Period|Withdrawal by Subject|13|||
161324781|NCT00397189|582575707|FG001|3 Weeks Period|Withdrawal by Subject|9|||
161324782|NCT00397189|582575706|FG000|3 Weeks Period|Physician Decision|0|||
160881993|NCT04449029|580962962|FG004|Overall Study|Protocol Violation|0|||
160881994|NCT04449029|580962963|FG005|Overall Study|Protocol Violation|0|||
160881995|NCT04449029|580962964|FG006|Overall Study|Protocol Violation|0|||
160881996|NCT04449029|580962965|FG007|Overall Study|Protocol Violation|0|||
160881997|NCT04449029|580962958|FG000|Overall Study|Physician Decision|0|||
160881998|NCT04449029|580962959|FG001|Overall Study|Physician Decision|0|||
160881999|NCT04449029|580962960|FG002|Overall Study|Physician Decision|0|||
160882000|NCT04449029|580962961|FG003|Overall Study|Physician Decision|0|||
160882001|NCT04449029|580962962|FG004|Overall Study|Physician Decision|0|||
160882002|NCT04449029|580962963|FG005|Overall Study|Physician Decision|1|||
160882003|NCT04449029|580962964|FG006|Overall Study|Physician Decision|0|||
160882004|NCT04449029|580962965|FG007|Overall Study|Physician Decision|0|||
160882005|NCT04449029|580962958|FG000|Overall Study|Withdrawal by Subject|3|||
160882006|NCT04449029|580962959|FG001|Overall Study|Withdrawal by Subject|0|||
160882007|NCT04449029|580962960|FG002|Overall Study|Withdrawal by Subject|1|||
160882008|NCT04449029|580962961|FG003|Overall Study|Withdrawal by Subject|1|||
160882009|NCT04449029|580962962|FG004|Overall Study|Withdrawal by Subject|5|||
160882010|NCT04449029|580962963|FG005|Overall Study|Withdrawal by Subject|1|||
160882011|NCT04449029|580962964|FG006|Overall Study|Withdrawal by Subject|4|||
160882012|NCT04449029|580962965|FG007|Overall Study|Withdrawal by Subject|0|||
160882013|NCT02486627|580962968|FG000|Overall Study|Death|1|||
160882014|NCT02486627|580962969|FG001|Overall Study|Death|0|||
160882015|NCT02486627|580962968|FG000|Overall Study|Other Unspecified|0|||
160882016|NCT02486627|580962969|FG001|Overall Study|Other Unspecified|2|||
160882017|NCT02486627|580962968|FG000|Overall Study|Consent Withdrawn by Participant|4|||
160882018|NCT02486627|580962969|FG001|Overall Study|Consent Withdrawn by Participant|3|||
160882019|NCT02486627|580962968|FG000|Overall Study|Significant Participant Noncompliance|1|||
160882020|NCT02486627|580962969|FG001|Overall Study|Significant Participant Noncompliance|1|||
160882021|NCT02486627|580962968|FG000|Overall Study|Lost to Follow-up|1|||
160882022|NCT02486627|580962969|FG001|Overall Study|Lost to Follow-up|3|||
160882023|NCT02112045|580962973|FG000|Overall Study|Withdrawal by Subject|1|||
160882024|NCT02112045|580962974|FG001|Overall Study|Withdrawal by Subject|0|||
160882025|NCT00627445|580962975|FG000|Overall Study|Adverse Event|3|||
160882026|NCT00627445|580962976|FG001|Overall Study|Adverse Event|3|||
160882027|NCT00627445|580962975|FG000|Overall Study|Lack of Efficacy|0|||
160882028|NCT00627445|580962976|FG001|Overall Study|Lack of Efficacy|1|||
160882029|NCT00627445|580962975|FG000|Overall Study|Other|6|||
160882030|NCT00627445|580962976|FG001|Overall Study|Other|8|||
160882031|NCT01073462|580962977|FG000|Overall Study|Death|14|||
160882032|NCT01073462|580962977|FG000|Overall Study|Kidney transplant|10|||
160882033|NCT01073462|580962977|FG000|Overall Study|Low parathyroid hormone levels|8|||
160882034|NCT01073462|580962977|FG000|Overall Study|Serious adverse event|2|||
161121755|NCT02889796|581833565|FG002|Overall Study|Protocol Violation|3|||
161324783|NCT00397189|582575707|FG001|3 Weeks Period|Physician Decision|2|||
161324784|NCT00397189|582575706|FG000|3 Weeks Period|Protocol Violation|0|||
161324785|NCT00397189|582575707|FG001|3 Weeks Period|Protocol Violation|3|||
161324786|NCT00397189|582575706|FG000|3 Weeks Period|Other|0|||
161324787|NCT00397189|582575707|FG001|3 Weeks Period|Other|2|||
160882035|NCT01073462|580962977|FG000|Overall Study|Lost to Follow-up|7|||
160882036|NCT01238588|580962979|FG000|Overall Study|Withdrawal by Subject|1|||
160882037|NCT01238588|580962979|FG000|Overall Study|Physician Decision|2|||
160882038|NCT00247611|580962984|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
160882039|NCT00247611|580962985|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
160882040|NCT00247611|580962984|FG000|Baselined|Completed baseline only|9|||
160882041|NCT00247611|580962985|FG001|Baselined|Completed baseline only|8|||
160882042|NCT05395091|580962986|FG000|Baseline to Month 12|Adverse Event|7|||
161324788|NCT00141518|582575710|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
160882043|NCT05395091|580962987|FG001|Baseline to Month 12|Adverse Event|2|||
160882044|NCT05395091|580962988|FG002|Baseline to Month 12|Adverse Event|0|||
160882045|NCT05395091|580962986|FG000|Baseline to Month 12|Death|3|||
160882046|NCT05395091|580962987|FG001|Baseline to Month 12|Death|1|||
160882047|NCT05395091|580962988|FG002|Baseline to Month 12|Death|0|||
160882048|NCT05395091|580962986|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
160882049|NCT05395091|580962987|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
160882050|NCT05395091|580962988|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
160882051|NCT05395091|580962986|FG000|Baseline to Month 12|Protocol Violation|2|||
160882052|NCT05395091|580962987|FG001|Baseline to Month 12|Protocol Violation|3|||
160882053|NCT05395091|580962988|FG002|Baseline to Month 12|Protocol Violation|0|||
160882054|NCT05395091|580962986|FG000|Baseline to Month 12|Physician Decision|1|||
160882055|NCT05395091|580962987|FG001|Baseline to Month 12|Physician Decision|0|||
160882056|NCT05395091|580962988|FG002|Baseline to Month 12|Physician Decision|0|||
160882057|NCT05395091|580962986|FG000|Month 12 to Month 18|Death|1|||
160882058|NCT05395091|580962987|FG001|Month 12 to Month 18|Death|0|||
160882059|NCT05395091|580962988|FG002|Month 12 to Month 18|Death|0|||
160882060|NCT05395091|580962986|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
160882061|NCT05395091|580962987|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
160882062|NCT05395091|580962988|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
160882063|NCT05395091|580962986|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
160882064|NCT05395091|580962987|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
160882065|NCT05395091|580962988|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
160882066|NCT05395091|580962986|FG000|Month 12 to Month 18|Other reasons|0|||
160882067|NCT05395091|580962987|FG001|Month 12 to Month 18|Other reasons|0|||
160882068|NCT05395091|580962988|FG002|Month 12 to Month 18|Other reasons|1|||
160882069|NCT01509053|580962990|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
160882070|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
160882071|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
160882072|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
160882073|NCT01509053|580962990|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
160882074|NCT01509053|580962990|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
160882075|NCT01915303|580962996|FG000|Core Phase|Adverse Event|7|||
160882076|NCT01915303|580962996|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
160882077|NCT01915303|580962996|FG000|Core Phase|Death|2|||
160882078|NCT01915303|580962996|FG000|Core Phase|Protocol Violation|2|||
160882079|NCT01915303|580962996|FG000|Core Phase|Abnormal lab value|1|||
160882080|NCT01915303|580962996|FG000|Core Phase|Withdrawal by Subject|1|||
160882081|NCT01915303|580962996|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
160882082|NCT01915303|580962996|FG000|Extension Phase|Withdrawal by Subject|4|||
160882083|NCT01915303|580962996|FG000|Extension Phase|Adverse Event|3|||
160882084|NCT01915303|580962996|FG000|Extension Phase|Death|1|||
160882085|NCT01915303|580962996|FG000|Extension Phase|Protocol Violation|1|||
160882086|NCT02509117|580962998|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882087|NCT02509117|580962999|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
160882088|NCT02509117|580963000|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882089|NCT02509117|580963001|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882090|NCT02509117|580963002|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882091|NCT02509117|580963003|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882092|NCT02509117|580963004|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882093|NCT02509117|580963005|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882094|NCT02509117|580963006|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882095|NCT02509117|580963007|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
160882096|NCT02509117|580962998|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882097|NCT02509117|580962999|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882098|NCT02509117|580963000|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882099|NCT02509117|580963001|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882100|NCT02509117|580963002|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882101|NCT02509117|580963003|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
161121756|NCT02889796|581833566|FG003|Overall Study|Protocol Violation|0|||
161121757|NCT02889796|581833567|FG004|Overall Study|Protocol Violation|0|||
160882102|NCT02509117|580963004|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882103|NCT02509117|580963005|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882104|NCT02509117|580963006|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
160882105|NCT02509117|580963007|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
160882106|NCT02509117|580962998|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882107|NCT02509117|580962999|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882108|NCT02509117|580963000|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
161121758|NCT02889796|581833568|FG005|Overall Study|Protocol Violation|4|||
160882109|NCT02509117|580963001|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882110|NCT02509117|580963002|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882111|NCT02509117|580963003|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882112|NCT02509117|580963004|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882113|NCT02509117|580963005|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882114|NCT02509117|580963006|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
160882115|NCT02509117|580963007|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
160882116|NCT00832624|580963008|FG000|Overall Study|Study Terminated|10|||
160882117|NCT00548184|580963011|FG000|Overall Study|Adverse Event|3|||
160882118|NCT00548184|580963011|FG000|Overall Study|took other drug|1|||
160882119|NCT00548184|580963011|FG000|Overall Study|Found Her2 negative|1|||
160882120|NCT00280748|580963018|FG000|Overall Study|Decline in performance|3|||
160882121|NCT00280748|580963018|FG000|Overall Study|Extra-cranial disease progression|1|||
160882122|NCT01433250|580963019|FG000|Overall Study|Protocol Violation|0|||
160882123|NCT01433250|580963020|FG001|Overall Study|Protocol Violation|1|||
160882124|NCT01433250|580963019|FG000|Overall Study|Withdrawal by Subject|3|||
160882125|NCT01433250|580963020|FG001|Overall Study|Withdrawal by Subject|2|||
160882126|NCT00796523|580963023|FG000|Overall Study|Lost to Follow-up|9|||
160882127|NCT00796523|580963024|FG001|Overall Study|Lost to Follow-up|7|||
160882128|NCT02431260|580963029|FG000|Overall Study|Subject Decision|0|||
160882129|NCT02431260|580963030|FG001|Overall Study|Subject Decision|1|||
160882130|NCT02431260|580963031|FG002|Overall Study|Subject Decision|1|||
160882131|NCT02431260|580963032|FG003|Overall Study|Subject Decision|0|||
160882132|NCT02431260|580963033|FG004|Overall Study|Subject Decision|0|||
160882133|NCT02431260|580963034|FG005|Overall Study|Subject Decision|0|||
160882134|NCT02431260|580963035|FG006|Overall Study|Subject Decision|0|||
160882135|NCT02431260|580963036|FG007|Overall Study|Subject Decision|0|||
160882136|NCT02431260|580963037|FG008|Overall Study|Subject Decision|1|||
160882137|NCT02431260|580963038|FG009|Overall Study|Subject Decision|1|||
160882138|NCT02431260|580963039|FG010|Overall Study|Subject Decision|0|||
160882139|NCT02431260|580963040|FG011|Overall Study|Subject Decision|1|||
160882140|NCT02431260|580963041|FG012|Overall Study|Subject Decision|0|||
160882141|NCT02431260|580963042|FG013|Overall Study|Subject Decision|0|||
160882142|NCT02431260|580963029|FG000|Overall Study|Death|4|||
160882143|NCT02431260|580963030|FG001|Overall Study|Death|4|||
160882144|NCT02431260|580963031|FG002|Overall Study|Death|3|||
160882145|NCT02431260|580963032|FG003|Overall Study|Death|4|||
160882146|NCT02431260|580963033|FG004|Overall Study|Death|2|||
160882147|NCT02431260|580963034|FG005|Overall Study|Death|2|||
160882148|NCT02431260|580963035|FG006|Overall Study|Death|3|||
160882149|NCT02431260|580963036|FG007|Overall Study|Death|1|||
160882150|NCT02431260|580963037|FG008|Overall Study|Death|6|||
160882151|NCT02431260|580963038|FG009|Overall Study|Death|6|||
160882152|NCT02431260|580963039|FG010|Overall Study|Death|3|||
160882153|NCT02431260|580963040|FG011|Overall Study|Death|2|||
160882154|NCT02431260|580963041|FG012|Overall Study|Death|5|||
160882155|NCT02431260|580963042|FG013|Overall Study|Death|1|||
160882156|NCT02431260|580963029|FG000|Overall Study|Lost to Follow-up|0|||
160882157|NCT02431260|580963030|FG001|Overall Study|Lost to Follow-up|0|||
160882158|NCT02431260|580963031|FG002|Overall Study|Lost to Follow-up|0|||
160882159|NCT02431260|580963032|FG003|Overall Study|Lost to Follow-up|0|||
160882160|NCT02431260|580963033|FG004|Overall Study|Lost to Follow-up|0|||
160882161|NCT02431260|580963034|FG005|Overall Study|Lost to Follow-up|1|||
160882162|NCT02431260|580963035|FG006|Overall Study|Lost to Follow-up|0|||
160882163|NCT02431260|580963036|FG007|Overall Study|Lost to Follow-up|0|||
160882164|NCT02431260|580963037|FG008|Overall Study|Lost to Follow-up|0|||
161121759|NCT02889796|581833563|FG000|Overall Study|Non-compliance With Study Drug|0|||
161121760|NCT02889796|581833564|FG001|Overall Study|Non-compliance With Study Drug|2|||
161121761|NCT02889796|581833565|FG002|Overall Study|Non-compliance With Study Drug|0|||
160882165|NCT02431260|580963038|FG009|Overall Study|Lost to Follow-up|0|||
160882166|NCT02431260|580963039|FG010|Overall Study|Lost to Follow-up|0|||
160882167|NCT02431260|580963040|FG011|Overall Study|Lost to Follow-up|0|||
160882168|NCT02431260|580963041|FG012|Overall Study|Lost to Follow-up|0|||
160882169|NCT02431260|580963042|FG013|Overall Study|Lost to Follow-up|0|||
160882170|NCT02431260|580963029|FG000|Overall Study|Study Terminated by the Sponsor|0|||
160882171|NCT02431260|580963030|FG001|Overall Study|Study Terminated by the Sponsor|0|||
160882172|NCT02431260|580963031|FG002|Overall Study|Study Terminated by the Sponsor|2|||
160882173|NCT02431260|580963032|FG003|Overall Study|Study Terminated by the Sponsor|1|||
160882174|NCT02431260|580963033|FG004|Overall Study|Study Terminated by the Sponsor|1|||
160882175|NCT02431260|580963034|FG005|Overall Study|Study Terminated by the Sponsor|0|||
160882176|NCT02431260|580963035|FG006|Overall Study|Study Terminated by the Sponsor|1|||
160882177|NCT02431260|580963036|FG007|Overall Study|Study Terminated by the Sponsor|2|||
160882178|NCT02431260|580963037|FG008|Overall Study|Study Terminated by the Sponsor|1|||
160882179|NCT02431260|580963038|FG009|Overall Study|Study Terminated by the Sponsor|1|||
160882180|NCT02431260|580963039|FG010|Overall Study|Study Terminated by the Sponsor|1|||
160882181|NCT02431260|580963040|FG011|Overall Study|Study Terminated by the Sponsor|0|||
160882182|NCT02431260|580963041|FG012|Overall Study|Study Terminated by the Sponsor|4|||
160882183|NCT02431260|580963042|FG013|Overall Study|Study Terminated by the Sponsor|0|||
160882184|NCT02431260|580963029|FG000|Overall Study|Physician Decision|0|||
160882185|NCT02431260|580963030|FG001|Overall Study|Physician Decision|0|||
160882186|NCT02431260|580963031|FG002|Overall Study|Physician Decision|0|||
160882187|NCT02431260|580963032|FG003|Overall Study|Physician Decision|0|||
160882188|NCT02431260|580963033|FG004|Overall Study|Physician Decision|0|||
160882189|NCT02431260|580963034|FG005|Overall Study|Physician Decision|1|||
160882190|NCT02431260|580963035|FG006|Overall Study|Physician Decision|0|||
160882191|NCT02431260|580963036|FG007|Overall Study|Physician Decision|0|||
160882192|NCT02431260|580963037|FG008|Overall Study|Physician Decision|0|||
160882193|NCT02431260|580963038|FG009|Overall Study|Physician Decision|0|||
160882194|NCT02431260|580963039|FG010|Overall Study|Physician Decision|0|||
160882195|NCT02431260|580963040|FG011|Overall Study|Physician Decision|0|||
160882196|NCT02431260|580963041|FG012|Overall Study|Physician Decision|0|||
160882197|NCT02431260|580963042|FG013|Overall Study|Physician Decision|0|||
160882198|NCT02431260|580963029|FG000|Overall Study|Other Unspecified|0|||
160882199|NCT02431260|580963030|FG001|Overall Study|Other Unspecified|0|||
160882200|NCT02431260|580963031|FG002|Overall Study|Other Unspecified|0|||
160882201|NCT02431260|580963032|FG003|Overall Study|Other Unspecified|0|||
160882202|NCT02431260|580963033|FG004|Overall Study|Other Unspecified|0|||
160882203|NCT02431260|580963034|FG005|Overall Study|Other Unspecified|0|||
160882204|NCT02431260|580963035|FG006|Overall Study|Other Unspecified|0|||
160882205|NCT02431260|580963036|FG007|Overall Study|Other Unspecified|0|||
160882206|NCT02431260|580963037|FG008|Overall Study|Other Unspecified|0|||
160882207|NCT02431260|580963038|FG009|Overall Study|Other Unspecified|0|||
160882208|NCT02431260|580963039|FG010|Overall Study|Other Unspecified|0|||
160882209|NCT02431260|580963040|FG011|Overall Study|Other Unspecified|1|||
160882210|NCT02431260|580963041|FG012|Overall Study|Other Unspecified|1|||
160882211|NCT02431260|580963042|FG013|Overall Study|Other Unspecified|0|||
161121762|NCT02889796|581833566|FG003|Overall Study|Non-compliance With Study Drug|0|||
161121763|NCT02889796|581833567|FG004|Overall Study|Non-compliance With Study Drug|1|||
161121764|NCT02889796|581833568|FG005|Overall Study|Non-compliance With Study Drug|2|||
161121765|NCT02889796|581833563|FG000|Overall Study|Death|1|||
161121766|NCT02889796|581833564|FG001|Overall Study|Death|1|||
161121767|NCT02889796|581833565|FG002|Overall Study|Death|0|||
161121768|NCT02889796|581833566|FG003|Overall Study|Death|1|||
161121769|NCT02889796|581833567|FG004|Overall Study|Death|0|||
161121770|NCT02889796|581833568|FG005|Overall Study|Death|1|||
161121771|NCT02889796|581833563|FG000|Overall Study|Pregnancy|0|||
161121772|NCT02889796|581833564|FG001|Overall Study|Pregnancy|1|||
161121773|NCT02889796|581833565|FG002|Overall Study|Pregnancy|1|||
161121774|NCT02889796|581833566|FG003|Overall Study|Pregnancy|0|||
161121775|NCT02889796|581833567|FG004|Overall Study|Pregnancy|0|||
161121776|NCT02889796|581833568|FG005|Overall Study|Pregnancy|0|||
161121777|NCT02889796|581833563|FG000|Overall Study|Randomized but not Dosed|2|||
161121778|NCT02889796|581833564|FG001|Overall Study|Randomized but not Dosed|0|||
161121779|NCT02889796|581833565|FG002|Overall Study|Randomized but not Dosed|0|||
161121780|NCT02889796|581833566|FG003|Overall Study|Randomized but not Dosed|0|||
161121781|NCT02889796|581833567|FG004|Overall Study|Randomized but not Dosed|0|||
161121782|NCT02889796|581833568|FG005|Overall Study|Randomized but not Dosed|2|||
161121783|NCT04294459|581833569|FG000|Overall Study|Adverse Event|0|||
161121784|NCT04294459|581833570|FG001|Overall Study|Adverse Event|1|||
161121785|NCT02787863|581833571|FG000|Overall Study|Death|1|||
161121786|NCT02787863|581833572|FG001|Overall Study|Death|0|||
161121787|NCT02787863|581833573|FG002|Overall Study|Death|1|||
161121788|NCT02787863|581833574|FG003|Overall Study|Death|0|||
161121789|NCT02787863|581833575|FG004|Overall Study|Death|0|||
161121790|NCT02787863|581833576|FG005|Overall Study|Death|0|||
161121791|NCT02787863|581833577|FG006|Overall Study|Death|0|||
161121792|NCT02787863|581833578|FG007|Overall Study|Death|0|||
161121793|NCT02787863|581833571|FG000|Overall Study|Withdrawal by Subject|0|||
161121794|NCT02787863|581833572|FG001|Overall Study|Withdrawal by Subject|1|||
161121795|NCT02787863|581833573|FG002|Overall Study|Withdrawal by Subject|1|||
161121796|NCT02787863|581833574|FG003|Overall Study|Withdrawal by Subject|0|||
161121797|NCT02787863|581833575|FG004|Overall Study|Withdrawal by Subject|0|||
161121798|NCT02787863|581833576|FG005|Overall Study|Withdrawal by Subject|0|||
161227536|NCT02768298|582213003|FG001|Overall Study|Subject/guardian decision|0|||
161227537|NCT02768298|582213002|FG000|Overall Study|Withdrawal of informed consent|0|||
160882212|NCT00321646|580963043|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
160882213|NCT00321646|580963043|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
160882214|NCT00321646|580963043|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
160882215|NCT00336583|580964332|FG000|Overall Study|Lost to Follow-up|1|||
160882216|NCT00336583|580964332|FG000|Overall Study|Death|1|||
160882217|NCT02276027|580964335|FG000|Overall Study|Death|1|||
160882218|NCT02276027|580964336|FG001|Overall Study|Death|0|||
160882219|NCT02276027|580964337|FG002|Overall Study|Death|0|||
161121799|NCT02787863|581833577|FG006|Overall Study|Withdrawal by Subject|0|||
161121800|NCT02787863|581833578|FG007|Overall Study|Withdrawal by Subject|0|||
161121801|NCT01414257|581833579|FG000|Overall Study|No Visit After First Day of Treatment|12|||
161121802|NCT01414257|581833579|FG000|Overall Study|Protocol Violation|10|||
160882220|NCT02276027|580964338|FG003|Overall Study|Death|2|||
160882221|NCT02276027|580964335|FG000|Overall Study|Physician Decision|0|||
160882222|NCT02276027|580964336|FG001|Overall Study|Physician Decision|0|||
160882223|NCT02276027|580964337|FG002|Overall Study|Physician Decision|0|||
160882224|NCT02276027|580964338|FG003|Overall Study|Physician Decision|1|||
160882225|NCT02276027|580964335|FG000|Overall Study|Progressive disease|1|||
160882226|NCT02276027|580964336|FG001|Overall Study|Progressive disease|13|||
160882227|NCT02276027|580964337|FG002|Overall Study|Progressive disease|12|||
160882228|NCT02276027|580964338|FG003|Overall Study|Progressive disease|14|||
160882229|NCT02276027|580964335|FG000|Overall Study|Subject/guardian decision|0|||
160882230|NCT02276027|580964336|FG001|Overall Study|Subject/guardian decision|1|||
160882231|NCT02276027|580964337|FG002|Overall Study|Subject/guardian decision|0|||
160882232|NCT02276027|580964338|FG003|Overall Study|Subject/guardian decision|3|||
160882233|NCT02276027|580964335|FG000|Overall Study|Adverse Event|0|||
160882234|NCT02276027|580964336|FG001|Overall Study|Adverse Event|2|||
160882235|NCT02276027|580964337|FG002|Overall Study|Adverse Event|8|||
160882236|NCT02276027|580964338|FG003|Overall Study|Adverse Event|2|||
160882237|NCT03224598|580964339|FG000|Overall Study|Lost to Follow-up|0|||
160882238|NCT03224598|580964340|FG001|Overall Study|Lost to Follow-up|2|||
161121803|NCT02450487|581833580|FG000|Overall Study|Lost to Follow-up|3|||
160882239|NCT03224598|580964341|FG002|Overall Study|Lost to Follow-up|0|||
160882240|NCT03224598|580964339|FG000|Overall Study|Other|0|||
160882241|NCT03224598|580964340|FG001|Overall Study|Other|1|||
160882242|NCT03224598|580964341|FG002|Overall Study|Other|0|||
160882243|NCT03328182|580964344|FG000|Overall Study|Withdrawal by Subject|1|||
160882244|NCT03328182|580964344|FG000|Overall Study|Protocol Violation|2|||
160882245|NCT03328182|580964344|FG000|Overall Study|No Product Evaluated|1|||
160882246|NCT00003830|580964345|FG000|Overall Study|No follow up data|3|||
160882247|NCT00003830|580964346|FG001|Overall Study|No follow up data|0|||
160882248|NCT00003830|580964345|FG000|Overall Study|Sentinel node positive patients|829|||
160882249|NCT00003830|580964346|FG001|Overall Study|Sentinel node positive patients|793|||
160882250|NCT01095094|580964347|FG000|Overall Study|Withdrawal by Subject|1|||
160882251|NCT01095094|580964347|FG000|Overall Study|Death|1|||
160882252|NCT01095094|580964347|FG000|Overall Study|Physician Decision|1|||
160882253|NCT05347147|580964348|FG000|Overall Study|Lost to Follow-up|0|||
160882254|NCT05347147|580964349|FG001|Overall Study|Lost to Follow-up|1|||
160882255|NCT05347147|580964348|FG000|Overall Study|Sponsor request|3|||
160882256|NCT05347147|580964349|FG001|Overall Study|Sponsor request|3|||
160882257|NCT05347147|580964348|FG000|Overall Study|Study termination|2|||
160882258|NCT05347147|580964349|FG001|Overall Study|Study termination|1|||
160882259|NCT00137839|580964351|FG000|Overall Study|Adverse Event|7|||
160882260|NCT00137839|580964351|FG000|Overall Study|Physician Decision|7|||
160882261|NCT00137839|580964351|FG000|Overall Study|Death|8|||
160882262|NCT00137839|580964351|FG000|Overall Study|Disease Progression|60|||
160882263|NCT00137839|580964351|FG000|Overall Study|Not Start Treatment|1|||
160882264|NCT00137839|580964351|FG000|Overall Study|Prolonged Treatment Delay|1|||
160882265|NCT01122394|580964352|FG000|Overall Study|Withdrawal by Subject|1|||
160882266|NCT01122394|580964353|FG001|Overall Study|Withdrawal by Subject|1|||
160882267|NCT01122394|580964352|FG000|Overall Study|Lost to Follow-up|2|||
160882268|NCT01122394|580964353|FG001|Overall Study|Lost to Follow-up|2|||
160882269|NCT01122394|580964352|FG000|Overall Study|Adverse Event|0|||
160882270|NCT01122394|580964353|FG001|Overall Study|Adverse Event|1|||
160882271|NCT03739242|580964354|FG000|Overall Study|Withdrawal by Subject|1|||
160882272|NCT03739242|580964355|FG001|Overall Study|Withdrawal by Subject|1|||
160882273|NCT03739242|580964354|FG000|Overall Study|Protocol Violation|0|||
160882274|NCT03739242|580964355|FG001|Overall Study|Protocol Violation|1|||
160882275|NCT03086967|580964356|FG000|Overall Study|Screen Failure|2|||
160882276|NCT03086967|580964357|FG001|Overall Study|Screen Failure|2|||
160882277|NCT03361176|580964358|FG000|Overall Study|Lost to Follow-up|1|||
160882278|NCT03361176|580964359|FG001|Overall Study|Lost to Follow-up|2|||
160882279|NCT03361176|580964358|FG000|Overall Study|Adverse Event|0|||
160882280|NCT03361176|580964359|FG001|Overall Study|Adverse Event|2|||
160882281|NCT03361176|580964358|FG000|Overall Study|Withdrawal by Subject|0|||
160882282|NCT03361176|580964359|FG001|Overall Study|Withdrawal by Subject|1|||
160882283|NCT02230527|580964363|FG000|Overall Study|Withdrawal by Subject|1|||
160882284|NCT02230527|580964364|FG001|Overall Study|Withdrawal by Subject|1|||
160882285|NCT02230527|580964363|FG000|Overall Study|Death|1|||
160882286|NCT02230527|580964364|FG001|Overall Study|Death|0|||
160882287|NCT02230527|580964363|FG000|Overall Study|Lost to Follow-up|2|||
161121804|NCT04269395|581833581|FG000|Overall Study|Lost to Follow-up|1|||
161121805|NCT04269395|581833582|FG001|Overall Study|Lost to Follow-up|0|||
161121806|NCT04269395|581833581|FG000|Overall Study|Study terminated by Sponsor|13|||
161121807|NCT04269395|581833582|FG001|Overall Study|Study terminated by Sponsor|10|||
160882288|NCT02230527|580964364|FG001|Overall Study|Lost to Follow-up|1|||
160882289|NCT02230527|580964363|FG000|Overall Study|Other|1|||
160882290|NCT02230527|580964364|FG001|Overall Study|Other|0|||
160882291|NCT01752036|580964365|FG000|Overall Study|Death|2|||
160882292|NCT01011478|580964366|FG000|Overall Study|No follow up data|12|||
160882293|NCT01011478|580964367|FG001|Overall Study|No follow up data|7|||
160882294|NCT01437995|580964371|FG000|Overall Study|Lost to Follow-up|11|||
161121808|NCT04161495|581833583|FG000|Overall Study|Withdrawal by Subject|3|||
161121809|NCT04161495|581833584|FG001|Overall Study|Withdrawal by Subject|0|||
161121810|NCT04161495|581833583|FG000|Overall Study|Protocol Violation|1|||
161121811|NCT04161495|581833584|FG001|Overall Study|Protocol Violation|0|||
161121812|NCT04161495|581833583|FG000|Overall Study|Prohibited concomitant medication|3|||
161121813|NCT04161495|581833584|FG001|Overall Study|Prohibited concomitant medication|0|||
161121814|NCT04161495|581833583|FG000|Overall Study|Adverse Event|1|||
161121815|NCT04161495|581833584|FG001|Overall Study|Adverse Event|0|||
161121816|NCT04161495|581833583|FG000|Overall Study|Other - Unspecified|1|||
161121817|NCT04161495|581833584|FG001|Overall Study|Other - Unspecified|0|||
161121818|NCT04161495|581833583|FG000|Overall Study|Death|0|||
161121819|NCT04161495|581833584|FG001|Overall Study|Death|1|||
161121820|NCT00252057|581833587|FG000|Overall Study|Withdrawal by Subject|2|||
161121821|NCT00252057|581833588|FG001|Overall Study|Withdrawal by Subject|5|||
161121822|NCT00252057|581833587|FG000|Overall Study|Death|1|||
161121823|NCT00252057|581833588|FG001|Overall Study|Death|2|||
161121824|NCT00252057|581833587|FG000|Overall Study|Participant previously enrolled|0|||
161121825|NCT00252057|581833588|FG001|Overall Study|Participant previously enrolled|1|||
161121826|NCT01340209|581833589|FG000|Overall Study|Adverse Event|1|||
161121827|NCT01340209|581833590|FG001|Overall Study|Adverse Event|1|||
161121828|NCT01340209|581833591|FG002|Overall Study|Adverse Event|2|||
161121829|NCT01340209|581833589|FG000|Overall Study|Protocol Violation|1|||
161121830|NCT01340209|581833590|FG001|Overall Study|Protocol Violation|2|||
161121831|NCT01340209|581833591|FG002|Overall Study|Protocol Violation|1|||
161121832|NCT01340209|581833589|FG000|Overall Study|Withdrawal by Subject|0|||
161121833|NCT01340209|581833590|FG001|Overall Study|Withdrawal by Subject|0|||
161121834|NCT01340209|581833591|FG002|Overall Study|Withdrawal by Subject|1|||
161121835|NCT01340209|581833589|FG000|Overall Study|Other reason not defined above|3|||
161121836|NCT01340209|581833590|FG001|Overall Study|Other reason not defined above|5|||
161121837|NCT01340209|581833591|FG002|Overall Study|Other reason not defined above|4|||
161121838|NCT02926209|581833592|FG000|Study Cohort|Poor Bowel Preparation|1|||
161121839|NCT02926209|581833593|FG001|Study Cohort|Poor Bowel Preparation|0|||
161121840|NCT00429858|581833594|FG000|Overall Study|Withdrawal by Subject|1|||
161121841|NCT00429858|581833594|FG000|Overall Study|Study Termination|1|||
161121842|NCT01587079|581833595|FG000|Overall Study|Protocol-specified criteria|9|||
161121843|NCT01587079|581833595|FG000|Overall Study|Protocol Violation|5|||
161121844|NCT01587079|581833595|FG000|Overall Study|Lost to Follow-up|2|||
161121845|NCT01587079|581833595|FG000|Overall Study|Physician Decision|2|||
161121846|NCT01587079|581833595|FG000|Overall Study|Withdrawal by Subject|7|||
161121847|NCT01587079|581833595|FG000|Overall Study|Adverse Event|14|||
161121848|NCT01239160|581833596|FG000|Overall Study|Lost to Follow-up|3|||
161324789|NCT00141518|582575711|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
161324790|NCT00141518|582575712|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
161324791|NCT00141518|582575710|FG000|Overall Study|Adverse Event|7|||
161324792|NCT00141518|582575711|FG001|Overall Study|Adverse Event|5|||
161324793|NCT00141518|582575712|FG002|Overall Study|Adverse Event|2|||
161121849|NCT01239160|581833597|FG001|Overall Study|Lost to Follow-up|5|||
161121850|NCT01239160|581833598|FG002|Overall Study|Lost to Follow-up|0|||
161121851|NCT01239160|581833596|FG000|Overall Study|Withdrawal by Subject|17|||
161121852|NCT01239160|581833597|FG001|Overall Study|Withdrawal by Subject|6|||
161121853|NCT01239160|581833598|FG002|Overall Study|Withdrawal by Subject|2|||
161121854|NCT01239160|581833596|FG000|Overall Study|Physician Decision|5|||
161121855|NCT01239160|581833597|FG001|Overall Study|Physician Decision|7|||
161324794|NCT00141518|582575710|FG000|Overall Study|Withdrawal by Subject|2|||
160882295|NCT01437995|580964372|FG001|Overall Study|Lost to Follow-up|18|||
160882296|NCT01437995|580964373|FG002|Overall Study|Lost to Follow-up|20|||
160882297|NCT04456673|580964374|FG000|Overall Study|Adverse Event|7|||
160882298|NCT04456673|580964375|FG001|Overall Study|Adverse Event|14|||
160882299|NCT04456673|580964374|FG000|Overall Study|Poor compliance to protocol|1|||
160882300|NCT04456673|580964375|FG001|Overall Study|Poor compliance to protocol|0|||
160882301|NCT04456673|580964374|FG000|Overall Study|Withdrawal by Subject|31|||
160882302|NCT04456673|580964375|FG001|Overall Study|Withdrawal by Subject|23|||
160882303|NCT04456673|580964374|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
160882304|NCT04456673|580964375|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
161324795|NCT00141518|582575711|FG001|Overall Study|Withdrawal by Subject|0|||
161324796|NCT00141518|582575712|FG002|Overall Study|Withdrawal by Subject|2|||
161324797|NCT00141518|582575710|FG000|Overall Study|Protocol Violation|1|||
161324798|NCT00141518|582575711|FG001|Overall Study|Protocol Violation|1|||
161324799|NCT00141518|582575712|FG002|Overall Study|Protocol Violation|2|||
161324800|NCT00141518|582575710|FG000|Overall Study|Lack of Efficacy|5|||
161324801|NCT00141518|582575711|FG001|Overall Study|Lack of Efficacy|0|||
161324802|NCT00141518|582575712|FG002|Overall Study|Lack of Efficacy|0|||
161324803|NCT02896569|582575717|FG000|Overall Study|Lost to Follow-up|2|||
161324804|NCT02896569|582575718|FG001|Overall Study|Lost to Follow-up|1|||
161324805|NCT02896569|582575717|FG000|Overall Study|Physician Decision|1|||
161324806|NCT02896569|582575718|FG001|Overall Study|Physician Decision|3|||
161324807|NCT02896569|582575717|FG000|Overall Study|Adverse Event|0|||
161324808|NCT02896569|582575718|FG001|Overall Study|Adverse Event|1|||
161324809|NCT02896569|582575717|FG000|Overall Study|Withdrawal by Subject|1|||
161324810|NCT02896569|582575718|FG001|Overall Study|Withdrawal by Subject|0|||
161324811|NCT01462630|582575719|FG000|Overall Study|Did not initiate therapy|3|||
161324812|NCT01462630|582575719|FG000|Overall Study|Death|1|||
161324813|NCT01462630|582575719|FG000|Overall Study|Protocol Violation|2|||
161324814|NCT01462630|582575719|FG000|Overall Study|Adverse Event|1|||
161324815|NCT01411852|582575725|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
161324816|NCT01411852|582575726|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
161324817|NCT01411852|582575725|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
161324818|NCT01411852|582575726|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
161324819|NCT01411852|582575725|FG000|Prehospital Intervention Phase|Found to be under age|0|||
161324820|NCT01411852|582575726|FG001|Prehospital Intervention Phase|Found to be under age|1|||
161324821|NCT01411852|582575725|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
161324822|NCT01411852|582575726|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
161324823|NCT01411852|582575725|FG000|Hospital Intervention Phase|Severe head injury|5|||
161324824|NCT01411852|582575726|FG001|Hospital Intervention Phase|Severe head injury|4|||
161324825|NCT01411852|582575725|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
161324826|NCT01411852|582575726|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
161324827|NCT01411852|582575725|FG000|Hospital Intervention Phase|Miscommunication error|1|||
161324828|NCT01411852|582575726|FG001|Hospital Intervention Phase|Miscommunication error|2|||
161324829|NCT01411852|582575725|FG000|Hospital Intervention Phase|CPR administered|3|||
161324830|NCT01411852|582575726|FG001|Hospital Intervention Phase|CPR administered|1|||
161324831|NCT01411852|582575725|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
160882305|NCT02160002|580964376|FG000|Overall Study|Withdrawal by Subject|2|||
160882306|NCT02160002|580964377|FG001|Overall Study|Withdrawal by Subject|1|||
160882307|NCT04395001|580964379|FG000|Overall Study|Lost to Follow-up|8|||
160882308|NCT04395001|580964380|FG001|Overall Study|Lost to Follow-up|9|||
160882309|NCT04395001|580964381|FG002|Overall Study|Lost to Follow-up|5|||
160882310|NCT04395001|580964379|FG000|Overall Study|Withdrawal by Subject|3|||
160882311|NCT04395001|580964380|FG001|Overall Study|Withdrawal by Subject|1|||
160882312|NCT04395001|580964381|FG002|Overall Study|Withdrawal by Subject|3|||
160882313|NCT04395001|580964379|FG000|Overall Study|missed appointment|7|||
160882314|NCT04395001|580964380|FG001|Overall Study|missed appointment|4|||
160882315|NCT04395001|580964381|FG002|Overall Study|missed appointment|1|||
160882316|NCT04418661|580964382|FG000|Overall Study|Adverse Event|0|||
160882317|NCT04418661|580964383|FG001|Overall Study|Adverse Event|1|||
160882318|NCT04418661|580964384|FG002|Overall Study|Adverse Event|5|||
160882319|NCT04418661|580964385|FG003|Overall Study|Adverse Event|3|||
160882320|NCT04418661|580964386|FG004|Overall Study|Adverse Event|0|||
160882321|NCT04418661|580964387|FG005|Overall Study|Adverse Event|2|||
160882322|NCT04418661|580964382|FG000|Overall Study|Progressive disease|4|||
160882323|NCT04418661|580964383|FG001|Overall Study|Progressive disease|11|||
160882324|NCT04418661|580964384|FG002|Overall Study|Progressive disease|6|||
160882325|NCT04418661|580964385|FG003|Overall Study|Progressive disease|11|||
160882326|NCT04418661|580964386|FG004|Overall Study|Progressive disease|1|||
160882327|NCT04418661|580964387|FG005|Overall Study|Progressive disease|12|||
160882328|NCT04418661|580964382|FG000|Overall Study|Withdrawal by Subject|0|||
160882329|NCT04418661|580964383|FG001|Overall Study|Withdrawal by Subject|1|||
160882330|NCT04418661|580964384|FG002|Overall Study|Withdrawal by Subject|0|||
160882331|NCT04418661|580964385|FG003|Overall Study|Withdrawal by Subject|1|||
160882332|NCT04418661|580964386|FG004|Overall Study|Withdrawal by Subject|0|||
161324832|NCT01411852|582575726|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
161324833|NCT01411852|582575725|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
161324834|NCT01411852|582575726|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
161324835|NCT01411852|582575725|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
161324836|NCT01411852|582575726|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
161324837|NCT01411852|582575725|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
161324838|NCT01411852|582575726|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
161324839|NCT01411852|582575725|FG000|Hospital Intervention Phase|Other ineligible|2|||
161324840|NCT01411852|582575726|FG001|Hospital Intervention Phase|Other ineligible|2|||
161324841|NCT01411852|582575725|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
161324842|NCT01411852|582575726|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
161324843|NCT01411852|582575725|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
161324844|NCT01411852|582575726|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
161324845|NCT01411852|582575725|FG000|Hospital Intervention Phase|Vascular access failed|1|||
161324846|NCT01411852|582575726|FG001|Hospital Intervention Phase|Vascular access failed|0|||
161324847|NCT02360280|582575730|FG000|Overall Study|Withdrawal by Subject|2|||
161324848|NCT02360280|582575731|FG001|Overall Study|Withdrawal by Subject|0|||
161324849|NCT02360280|582575730|FG000|Overall Study|Adverse Event|0|||
161324850|NCT02360280|582575731|FG001|Overall Study|Adverse Event|1|||
161324851|NCT02360280|582575730|FG000|Overall Study|Lost to Follow-up|1|||
161324852|NCT02360280|582575731|FG001|Overall Study|Lost to Follow-up|0|||
161324853|NCT01903993|582575734|FG000|Overall Study|Death|118|||
161324854|NCT01903993|582575735|FG001|Overall Study|Death|121|||
161324855|NCT01903993|582575734|FG000|Overall Study|Withdrawal by Subject|15|||
161324856|NCT01903993|582575735|FG001|Overall Study|Withdrawal by Subject|4|||
161324857|NCT01903993|582575734|FG000|Overall Study|Lost to Follow-up|2|||
161324858|NCT01903993|582575735|FG001|Overall Study|Lost to Follow-up|3|||
161324859|NCT01903993|582575734|FG000|Overall Study|Study Terminated by Sponsor|8|||
161324860|NCT01903993|582575735|FG001|Overall Study|Study Terminated by Sponsor|14|||
161324861|NCT01903993|582575734|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
160882333|NCT04418661|580964387|FG005|Overall Study|Withdrawal by Subject|0|||
160882334|NCT04418661|580964382|FG000|Overall Study|Other|0|||
160882335|NCT04418661|580964383|FG001|Overall Study|Other|0|||
160882336|NCT04418661|580964384|FG002|Overall Study|Other|1|||
160882337|NCT04418661|580964385|FG003|Overall Study|Other|3|||
160882338|NCT04418661|580964386|FG004|Overall Study|Other|0|||
160882339|NCT04418661|580964387|FG005|Overall Study|Other|1|||
160882340|NCT03337490|580964388|FG000|Overall Study|Withdrawal by Subject|1|||
160882341|NCT03337490|580964389|FG001|Overall Study|Withdrawal by Subject|0|||
160882342|NCT03337490|580964390|FG002|Overall Study|Withdrawal by Subject|0|||
160882343|NCT03337490|580964388|FG000|Overall Study|Lack of Efficacy|10|||
160882344|NCT03337490|580964389|FG001|Overall Study|Lack of Efficacy|12|||
160882345|NCT03337490|580964390|FG002|Overall Study|Lack of Efficacy|35|||
160882346|NCT03337490|580964388|FG000|Overall Study|Physician Decision|0|||
160882347|NCT03337490|580964389|FG001|Overall Study|Physician Decision|1|||
161227538|NCT02768298|582213003|FG001|Overall Study|Withdrawal of informed consent|1|||
161227539|NCT02130466|582213004|FG000|Overall Study|Death|4|||
161227540|NCT02130466|582213005|FG001|Overall Study|Death|1|||
161227541|NCT02130466|582213006|FG002|Overall Study|Death|1|||
161227542|NCT02130466|582213007|FG003|Overall Study|Death|3|||
161227543|NCT02130466|582213008|FG004|Overall Study|Death|2|||
161227544|NCT02130466|582213009|FG005|Overall Study|Death|30|||
161227545|NCT02130466|582213010|FG006|Overall Study|Death|45|||
161227546|NCT02130466|582213011|FG007|Overall Study|Death|2|||
161227547|NCT02130466|582213012|FG008|Overall Study|Death|3|||
161227548|NCT02130466|582213013|FG009|Overall Study|Death|4|||
161227549|NCT02130466|582213014|FG010|Overall Study|Death|5|||
161227550|NCT02130466|582213015|FG011|Overall Study|Death|3|||
161227551|NCT02130466|582213016|FG012|Overall Study|Death|11|||
161227552|NCT02130466|582213017|FG013|Overall Study|Death|7|||
161227553|NCT02130466|582213004|FG000|Overall Study|Lost to Follow-up|1|||
161227554|NCT02130466|582213005|FG001|Overall Study|Lost to Follow-up|0|||
161227555|NCT02130466|582213006|FG002|Overall Study|Lost to Follow-up|0|||
161227556|NCT02130466|582213007|FG003|Overall Study|Lost to Follow-up|0|||
161227557|NCT02130466|582213008|FG004|Overall Study|Lost to Follow-up|0|||
161227558|NCT02130466|582213009|FG005|Overall Study|Lost to Follow-up|1|||
161227559|NCT02130466|582213010|FG006|Overall Study|Lost to Follow-up|0|||
161227560|NCT02130466|582213011|FG007|Overall Study|Lost to Follow-up|0|||
161227561|NCT02130466|582213012|FG008|Overall Study|Lost to Follow-up|0|||
161227562|NCT02130466|582213013|FG009|Overall Study|Lost to Follow-up|0|||
161227563|NCT02130466|582213014|FG010|Overall Study|Lost to Follow-up|0|||
161227564|NCT02130466|582213015|FG011|Overall Study|Lost to Follow-up|0|||
161227565|NCT02130466|582213016|FG012|Overall Study|Lost to Follow-up|1|||
161227566|NCT02130466|582213017|FG013|Overall Study|Lost to Follow-up|0|||
161227567|NCT02130466|582213004|FG000|Overall Study|Physician Decision|0|||
161227568|NCT02130466|582213005|FG001|Overall Study|Physician Decision|0|||
161227569|NCT02130466|582213006|FG002|Overall Study|Physician Decision|0|||
161227570|NCT02130466|582213007|FG003|Overall Study|Physician Decision|0|||
161227571|NCT02130466|582213008|FG004|Overall Study|Physician Decision|0|||
161227572|NCT02130466|582213009|FG005|Overall Study|Physician Decision|1|||
161227573|NCT02130466|582213010|FG006|Overall Study|Physician Decision|1|||
161227574|NCT02130466|582213011|FG007|Overall Study|Physician Decision|0|||
161227575|NCT02130466|582213012|FG008|Overall Study|Physician Decision|0|||
161227576|NCT02130466|582213013|FG009|Overall Study|Physician Decision|0|||
161227577|NCT02130466|582213014|FG010|Overall Study|Physician Decision|0|||
161227578|NCT02130466|582213015|FG011|Overall Study|Physician Decision|0|||
161227579|NCT02130466|582213016|FG012|Overall Study|Physician Decision|0|||
161227580|NCT02130466|582213017|FG013|Overall Study|Physician Decision|0|||
161227581|NCT02130466|582213004|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161227582|NCT02130466|582213005|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
161227583|NCT02130466|582213006|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161227584|NCT02130466|582213007|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
161227585|NCT02130466|582213008|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
160882348|NCT03337490|580964390|FG002|Overall Study|Physician Decision|0|||
161227586|NCT02130466|582213009|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
160882349|NCT03337490|580964388|FG000|Overall Study|Lost to Follow-up|0|||
160882350|NCT03337490|580964389|FG001|Overall Study|Lost to Follow-up|1|||
160882351|NCT03337490|580964390|FG002|Overall Study|Lost to Follow-up|0|||
160882352|NCT01689532|580964391|FG000|Overall Study|Adverse Event|9|||
160882353|NCT01689532|580964392|FG001|Overall Study|Adverse Event|5|||
160882354|NCT01689532|580964391|FG000|Overall Study|Lack of Efficacy|2|||
160882355|NCT01689532|580964392|FG001|Overall Study|Lack of Efficacy|2|||
160882356|NCT01689532|580964391|FG000|Overall Study|Withdrawal by Subject|1|||
160882357|NCT01689532|580964392|FG001|Overall Study|Withdrawal by Subject|2|||
160882358|NCT01689532|580964391|FG000|Overall Study|Physician Decision|2|||
160882359|NCT01689532|580964392|FG001|Overall Study|Physician Decision|0|||
160882360|NCT01363349|580964393|FG000|Overall Study|Adverse Event|6|||
160882361|NCT01363349|580964394|FG001|Overall Study|Adverse Event|7|||
160882362|NCT01363349|580964393|FG000|Overall Study|Lack of Efficacy|3|||
160882363|NCT01363349|580964394|FG001|Overall Study|Lack of Efficacy|10|||
160882364|NCT01363349|580964393|FG000|Overall Study|Non compliance/Protocol deviations|2|||
160882365|NCT01363349|580964394|FG001|Overall Study|Non compliance/Protocol deviations|2|||
160882366|NCT01363349|580964393|FG000|Overall Study|Withdrawal by Subject|14|||
160882367|NCT01363349|580964394|FG001|Overall Study|Withdrawal by Subject|6|||
160882368|NCT01363349|580964393|FG000|Overall Study|Lost to Follow-up|5|||
160882369|NCT01363349|580964394|FG001|Overall Study|Lost to Follow-up|6|||
160882370|NCT01363349|580964393|FG000|Overall Study|Not reported|36|||
160882371|NCT01363349|580964394|FG001|Overall Study|Not reported|37|||
160882372|NCT01363349|580964393|FG000|Overall Study|missing|1|||
160882373|NCT01363349|580964394|FG001|Overall Study|missing|2|||
160882374|NCT00917644|580964396|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
160882375|NCT00917644|580964397|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
160882376|NCT00917644|580964396|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
160882377|NCT00917644|580964397|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
160882378|NCT00917644|580964396|FG000|Period 2: Second Intervention|family emergency|1|||
160882379|NCT00917644|580964397|FG001|Period 2: Second Intervention|family emergency|0|||
160882380|NCT02108262|580964407|FG000|Overall Study|Non-compliance|0|||
161324862|NCT01903993|582575735|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
161324863|NCT00184093|582575736|FG000|Overall Study|Adverse Event|3|||
161324864|NCT00184093|582575736|FG000|Overall Study|Lost to Follow-up|3|||
161324865|NCT00184093|582575736|FG000|Overall Study|Physician Decision|1|||
161324866|NCT00184093|582575736|FG000|Overall Study|Withdrawal by Subject|2|||
161324867|NCT05095311|582575739|FG000|Overall Study|Lost to Follow-up|7|||
161324868|NCT05095311|582575740|FG001|Overall Study|Lost to Follow-up|0|||
161324869|NCT05095311|582575741|FG002|Overall Study|Lost to Follow-up|0|||
160882381|NCT02108262|580964408|FG001|Overall Study|Non-compliance|2|||
160882382|NCT02108262|580964409|FG002|Overall Study|Non-compliance|1|||
160882383|NCT02108262|580964410|FG003|Overall Study|Non-compliance|1|||
160882384|NCT02108262|580964407|FG000|Overall Study|Randomized by error/screen failure|0|||
160882385|NCT02108262|580964408|FG001|Overall Study|Randomized by error/screen failure|0|||
160882386|NCT02108262|580964409|FG002|Overall Study|Randomized by error/screen failure|1|||
160882387|NCT02108262|580964410|FG003|Overall Study|Randomized by error/screen failure|0|||
160882388|NCT02108262|580964407|FG000|Overall Study|Distance to center|0|||
161324870|NCT03283930|582575743|FG000|Overall Study|Scheduling conflict|8|||
161324871|NCT03283930|582575744|FG001|Overall Study|Scheduling conflict|10|||
161324872|NCT03283930|582575743|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
161324873|NCT03283930|582575744|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
161324874|NCT03283930|582575743|FG000|Overall Study|Technical software issue|2|||
161324875|NCT03283930|582575744|FG001|Overall Study|Technical software issue|2|||
161324876|NCT00805129|582575748|FG000|Overall Study|Not treated|1|||
161324877|NCT00571662|582575749|FG000|Overall Study|Withdrawal by Subject|2|||
161324878|NCT00571662|582575749|FG000|Overall Study|psychiatric instability|1|||
161324879|NCT00571662|582575749|FG000|Overall Study|Adverse Event|5|||
161324880|NCT02588664|582575752|FG000|Overall Study|Death|56|||
161324881|NCT02588664|582575753|FG001|Overall Study|Death|55|||
161324882|NCT02588664|582575752|FG000|Overall Study|Lost to Follow-up|1305|||
161324883|NCT02588664|582575753|FG001|Overall Study|Lost to Follow-up|990|||
161324884|NCT03681184|582575754|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
161324885|NCT03681184|582575755|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
160882389|NCT02108262|580964408|FG001|Overall Study|Distance to center|1|||
160882390|NCT02108262|580964409|FG002|Overall Study|Distance to center|1|||
160882391|NCT02108262|580964410|FG003|Overall Study|Distance to center|0|||
160882392|NCT02108262|580964407|FG000|Overall Study|Adverse Event|0|||
160882393|NCT02108262|580964408|FG001|Overall Study|Adverse Event|11|||
160882394|NCT02108262|580964409|FG002|Overall Study|Adverse Event|6|||
160882395|NCT02108262|580964410|FG003|Overall Study|Adverse Event|12|||
160882396|NCT02108262|580964407|FG000|Overall Study|Death|0|||
161324886|NCT02500719|582575758|FG000|Overall Study|Lost to Follow-up|2|||
161324887|NCT02500719|582575759|FG001|Overall Study|Lost to Follow-up|3|||
160882397|NCT02108262|580964408|FG001|Overall Study|Death|2|||
160882398|NCT02108262|580964409|FG002|Overall Study|Death|2|||
160882399|NCT02108262|580964410|FG003|Overall Study|Death|1|||
161227587|NCT02130466|582213010|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
161227588|NCT02130466|582213011|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161227589|NCT02130466|582213012|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161227590|NCT02130466|582213013|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161227591|NCT02130466|582213014|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
161227592|NCT02130466|582213015|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161227593|NCT02130466|582213016|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
161227594|NCT02130466|582213017|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
161227595|NCT02130466|582213004|FG000|Overall Study|Withdrawal by Subject|1|||
161227596|NCT02130466|582213005|FG001|Overall Study|Withdrawal by Subject|0|||
161227597|NCT02130466|582213006|FG002|Overall Study|Withdrawal by Subject|0|||
161227598|NCT02130466|582213007|FG003|Overall Study|Withdrawal by Subject|0|||
161227599|NCT02130466|582213008|FG004|Overall Study|Withdrawal by Subject|0|||
161227600|NCT02130466|582213009|FG005|Overall Study|Withdrawal by Subject|1|||
161227601|NCT02130466|582213010|FG006|Overall Study|Withdrawal by Subject|0|||
161227602|NCT02130466|582213011|FG007|Overall Study|Withdrawal by Subject|0|||
161227603|NCT02130466|582213012|FG008|Overall Study|Withdrawal by Subject|1|||
161227604|NCT02130466|582213013|FG009|Overall Study|Withdrawal by Subject|0|||
161227605|NCT02130466|582213014|FG010|Overall Study|Withdrawal by Subject|0|||
161227606|NCT02130466|582213015|FG011|Overall Study|Withdrawal by Subject|0|||
161227607|NCT02130466|582213016|FG012|Overall Study|Withdrawal by Subject|0|||
161227608|NCT02130466|582213017|FG013|Overall Study|Withdrawal by Subject|0|||
161227609|NCT00336024|582213018|FG000|Overall Study|Death|2|||
161227610|NCT00336024|582213019|FG001|Overall Study|Death|1|||
161227611|NCT00336024|582213018|FG000|Overall Study|Physician Decision|4|||
161227612|NCT00336024|582213019|FG001|Overall Study|Physician Decision|1|||
161227613|NCT00336024|582213018|FG000|Overall Study|Protocol Violation|1|||
161227614|NCT00336024|582213019|FG001|Overall Study|Protocol Violation|0|||
161227615|NCT00336024|582213018|FG000|Overall Study|Withdrawal by Subject|1|||
161227616|NCT00336024|582213019|FG001|Overall Study|Withdrawal by Subject|2|||
161227617|NCT00336024|582213018|FG000|Overall Study|Failure to fulfill consolidation|1|||
161227618|NCT00336024|582213019|FG001|Overall Study|Failure to fulfill consolidation|1|||
161227619|NCT00336024|582213018|FG000|Overall Study|Progressive Disease|4|||
161227620|NCT00336024|582213019|FG001|Overall Study|Progressive Disease|7|||
161227621|NCT00336024|582213018|FG000|Overall Study|Ineligible|7|||
161227622|NCT00336024|582213019|FG001|Overall Study|Ineligible|7|||
161227623|NCT05067504|582213020|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
161227624|NCT05067504|582213021|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
161227625|NCT05067504|582213020|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
161227626|NCT05067504|582213021|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
161227627|NCT05067504|582213020|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
161227628|NCT05067504|582213021|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
161227629|NCT05771428|582215161|FG000|Overall Study|Adverse Event|0|||
161227630|NCT05771428|582215162|FG001|Overall Study|Adverse Event|1|||
161227631|NCT05771428|582215163|FG002|Overall Study|Adverse Event|1|||
161227632|NCT05771428|582215164|FG003|Overall Study|Adverse Event|1|||
161227633|NCT05771428|582215161|FG000|Overall Study|Withdrawal by Subject|3|||
161227634|NCT05771428|582215162|FG001|Overall Study|Withdrawal by Subject|2|||
161227635|NCT05771428|582215163|FG002|Overall Study|Withdrawal by Subject|1|||
161227636|NCT05771428|582215164|FG003|Overall Study|Withdrawal by Subject|4|||
161227637|NCT05771428|582215161|FG000|Overall Study|Other|0|||
161227638|NCT05771428|582215162|FG001|Overall Study|Other|1|||
161227639|NCT05771428|582215163|FG002|Overall Study|Other|2|||
161227640|NCT05771428|582215164|FG003|Overall Study|Other|1|||
161227641|NCT05771428|582215161|FG000|Overall Study|Randomized but Not Treated|0|||
161227642|NCT05771428|582215162|FG001|Overall Study|Randomized but Not Treated|0|||
161227643|NCT05771428|582215163|FG002|Overall Study|Randomized but Not Treated|1|||
161227644|NCT05771428|582215164|FG003|Overall Study|Randomized but Not Treated|0|||
161227645|NCT04025229|582215165|FG000|Overall Study|Adverse Event|1|||
161227646|NCT04025229|582215166|FG001|Overall Study|Adverse Event|0|||
161227647|NCT04025229|582215165|FG000|Overall Study|Withdrawal by Subject|0|||
161227648|NCT04025229|582215166|FG001|Overall Study|Withdrawal by Subject|2|||
161227649|NCT04025229|582215165|FG000|Overall Study|Death|0|||
161227650|NCT04025229|582215166|FG001|Overall Study|Death|1|||
160882400|NCT02108262|580964407|FG000|Overall Study|Lost to Follow-up|0|||
161324888|NCT02500719|582575758|FG000|Overall Study|Trauma history|1|||
160882401|NCT02108262|580964408|FG001|Overall Study|Lost to Follow-up|0|||
160882402|NCT02108262|580964409|FG002|Overall Study|Lost to Follow-up|1|||
160882403|NCT02108262|580964410|FG003|Overall Study|Lost to Follow-up|0|||
160882404|NCT02108262|580964407|FG000|Overall Study|Physician Decision|0|||
160882405|NCT02108262|580964408|FG001|Overall Study|Physician Decision|0|||
160882406|NCT02108262|580964409|FG002|Overall Study|Physician Decision|2|||
160882407|NCT02108262|580964410|FG003|Overall Study|Physician Decision|0|||
160882408|NCT02108262|580964407|FG000|Overall Study|Withdrawal by Subject|0|||
160882409|NCT02108262|580964408|FG001|Overall Study|Withdrawal by Subject|7|||
160882410|NCT02108262|580964409|FG002|Overall Study|Withdrawal by Subject|3|||
160882411|NCT02108262|580964410|FG003|Overall Study|Withdrawal by Subject|4|||
160882412|NCT02108262|580964407|FG000|Overall Study|Due to key hepatic values|0|||
160882413|NCT02108262|580964408|FG001|Overall Study|Due to key hepatic values|1|||
160882414|NCT02108262|580964409|FG002|Overall Study|Due to key hepatic values|0|||
160882415|NCT02108262|580964410|FG003|Overall Study|Due to key hepatic values|0|||
160882416|NCT02108262|580964407|FG000|Overall Study|Unable to contact patient|0|||
160882417|NCT02108262|580964408|FG001|Overall Study|Unable to contact patient|3|||
160882418|NCT02108262|580964409|FG002|Overall Study|Unable to contact patient|1|||
160882419|NCT02108262|580964410|FG003|Overall Study|Unable to contact patient|2|||
160882420|NCT02108262|580964407|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
160882421|NCT02108262|580964408|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
160882422|NCT02108262|580964409|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
160882423|NCT02108262|580964410|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
160882424|NCT02108262|580964407|FG000|Overall Study|Patient did not want another infusion|0|||
160882425|NCT02108262|580964408|FG001|Overall Study|Patient did not want another infusion|3|||
160882426|NCT02108262|580964409|FG002|Overall Study|Patient did not want another infusion|3|||
160882427|NCT02108262|580964410|FG003|Overall Study|Patient did not want another infusion|2|||
160882428|NCT02108262|580964407|FG000|Overall Study|Vacation|0|||
160882429|NCT02108262|580964408|FG001|Overall Study|Vacation|1|||
160882430|NCT02108262|580964409|FG002|Overall Study|Vacation|0|||
160882431|NCT02108262|580964410|FG003|Overall Study|Vacation|0|||
160882432|NCT02108262|580964407|FG000|Overall Study|Patient decision|0|||
160882433|NCT02108262|580964408|FG001|Overall Study|Patient decision|7|||
160882434|NCT02108262|580964409|FG002|Overall Study|Patient decision|9|||
160882435|NCT02108262|580964410|FG003|Overall Study|Patient decision|14|||
160882436|NCT02108262|580964407|FG000|Overall Study|Missed IV due to pharmacy error|0|||
160882437|NCT02108262|580964408|FG001|Overall Study|Missed IV due to pharmacy error|0|||
160882438|NCT02108262|580964409|FG002|Overall Study|Missed IV due to pharmacy error|1|||
160882439|NCT02108262|580964410|FG003|Overall Study|Missed IV due to pharmacy error|0|||
160882440|NCT02576145|580964418|FG000|Overall Study|Adverse Event|1|||
160882441|NCT02576145|580964419|FG001|Overall Study|Adverse Event|0|||
160882442|NCT02576145|580964418|FG000|Overall Study|Withdrawal by Subject|1|||
160882443|NCT02576145|580964419|FG001|Overall Study|Withdrawal by Subject|0|||
160882444|NCT02576145|580964418|FG000|Overall Study|Acute rejection|1|||
160882445|NCT02576145|580964419|FG001|Overall Study|Acute rejection|0|||
160882446|NCT02576145|580964418|FG000|Overall Study|Tetanus Titers Decreased|0|||
160882447|NCT02576145|580964419|FG001|Overall Study|Tetanus Titers Decreased|1|||
160882448|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
160882449|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
160882450|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
160882451|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
160882452|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
160882453|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
160882454|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
160882455|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
160882456|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
160882457|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
160882458|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
160882459|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
160882460|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
160882461|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
160882462|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
160882463|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
160882464|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
160882465|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
160882466|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
160882467|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
160882468|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
160882469|NCT01227824|580964420|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
160882470|NCT01227824|580964421|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
160882471|NCT01227824|580964422|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
160882472|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
160882473|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
160882474|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
160882475|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
160882476|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
160882477|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
160882478|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
161324889|NCT02500719|582575759|FG001|Overall Study|Trauma history|0|||
161324890|NCT02500719|582575758|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
161324891|NCT02500719|582575759|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
161324892|NCT02500719|582575758|FG000|Overall Study|Did not meet criteria for PTSD|0|||
161324893|NCT02500719|582575759|FG001|Overall Study|Did not meet criteria for PTSD|1|||
161324894|NCT02500719|582575758|FG000|Overall Study|Claustrophobia|0|||
161324895|NCT02500719|582575759|FG001|Overall Study|Claustrophobia|1|||
161324896|NCT02500719|582575758|FG000|Overall Study|History of head trauma|0|||
161324897|NCT02500719|582575759|FG001|Overall Study|History of head trauma|1|||
161324898|NCT02787083|582575760|FG000|Overall Study|Adverse Event|1|||
161324899|NCT02787083|582575761|FG001|Overall Study|Adverse Event|0|||
161324900|NCT02787083|582575760|FG000|Overall Study|Withdrawal by Subject|2|||
161324901|NCT02787083|582575761|FG001|Overall Study|Withdrawal by Subject|2|||
161324902|NCT02710084|582575762|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
161324903|NCT02710084|582575763|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
161324904|NCT00154375|582575764|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
161324905|NCT00154375|582575765|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
161324906|NCT00154375|582575764|FG000|Overall Study|Adverse Event|18|||
161324907|NCT00154375|582575765|FG001|Overall Study|Adverse Event|20|||
161324908|NCT00154375|582575764|FG000|Overall Study|Withdrawal by Subject|14|||
160882479|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
160882480|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
160882481|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
160882482|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
160882483|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
160882484|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
160882485|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
160882486|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
160882487|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
160882488|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
160882489|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
160882490|NCT01227824|580964420|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
160882491|NCT01227824|580964421|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
160882492|NCT01227824|580964422|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
160882493|NCT00392379|580964425|FG000|Overall Study|Withdrawal by Subject|17|||
160882494|NCT00392379|580964426|FG001|Overall Study|Withdrawal by Subject|28|||
160882495|NCT00392379|580964425|FG000|Overall Study|Lost to Follow-up|4|||
160882496|NCT00392379|580964426|FG001|Overall Study|Lost to Follow-up|9|||
160882497|NCT00392379|580964425|FG000|Overall Study|Adverse Event|1|||
160882498|NCT00392379|580964426|FG001|Overall Study|Adverse Event|1|||
160882499|NCT01700387|580964432|FG000|Overall Study|Withdrawal by Subject|1|||
160882500|NCT01700387|580964433|FG001|Overall Study|Withdrawal by Subject|2|||
160882501|NCT01700387|580964432|FG000|Overall Study|Adverse Event|1|||
160882502|NCT01700387|580964433|FG001|Overall Study|Adverse Event|1|||
160882503|NCT01700387|580964432|FG000|Overall Study|Lost to Follow-up|2|||
160882504|NCT01700387|580964433|FG001|Overall Study|Lost to Follow-up|1|||
160882505|NCT02730793|580964436|FG000|Overall Study|Physician Decision|0|||
160882506|NCT02730793|580964437|FG001|Overall Study|Physician Decision|1|||
160882507|NCT02730793|580964436|FG000|Overall Study|Withdrawal by Subject|0|||
160882508|NCT02730793|580964437|FG001|Overall Study|Withdrawal by Subject|1|||
160882509|NCT02365233|580964438|FG000|Overall Study|IRB withheld the data|1|||
161121856|NCT01239160|581833598|FG002|Overall Study|Physician Decision|2|||
161121857|NCT01239160|581833596|FG000|Overall Study|Early Termination Due to Study Closure|0|||
160882510|NCT02365233|580964439|FG001|Overall Study|IRB withheld the data|2|||
160882511|NCT02365233|580964440|FG002|Overall Study|IRB withheld the data|2|||
160882512|NCT00934843|580964441|FG000|Overall Study|Protocol Violation|0|||
160882513|NCT00934843|580964442|FG001|Overall Study|Protocol Violation|1|||
160882514|NCT00160667|580964443|FG000|Overall Study|Adverse Event|3|||
160882515|NCT00160667|580964444|FG001|Overall Study|Adverse Event|1|||
160882516|NCT00160667|580964445|FG002|Overall Study|Adverse Event|4|||
160882517|NCT00160667|580964443|FG000|Overall Study|Withdrawal by Subject|2|||
160882518|NCT00160667|580964444|FG001|Overall Study|Withdrawal by Subject|0|||
161121858|NCT01239160|581833597|FG001|Overall Study|Early Termination Due to Study Closure|1|||
160882519|NCT00160667|580964445|FG002|Overall Study|Withdrawal by Subject|1|||
160882520|NCT00160667|580964443|FG000|Overall Study|Lack of Efficacy|0|||
160882521|NCT00160667|580964444|FG001|Overall Study|Lack of Efficacy|1|||
160882522|NCT00160667|580964445|FG002|Overall Study|Lack of Efficacy|0|||
160882523|NCT00160667|580964443|FG000|Overall Study|Protocol Violation|0|||
160882524|NCT00160667|580964444|FG001|Overall Study|Protocol Violation|1|||
160882525|NCT00160667|580964445|FG002|Overall Study|Protocol Violation|0|||
160882526|NCT00160667|580964443|FG000|Overall Study|Patient decision|0|||
160882527|NCT00160667|580964444|FG001|Overall Study|Patient decision|0|||
160882528|NCT00160667|580964445|FG002|Overall Study|Patient decision|1|||
160882529|NCT00995566|580964453|FG000|Overall Study|Adverse Event|2|||
160882530|NCT00995566|580964453|FG000|Overall Study|Early study termination|52|||
160882531|NCT01426789|580964454|FG000|Part 1|Protocol deviation|0|||
160882532|NCT01426789|580964455|FG001|Part 1|Protocol deviation|1|||
160882533|NCT01426789|580964456|FG002|Part 1|Protocol deviation|0|||
160882534|NCT01426789|580964457|FG003|Part 1|Protocol deviation|0|||
160882535|NCT01426789|580964458|FG004|Part 1|Protocol deviation|0|||
160882536|NCT01426789|580964459|FG005|Part 1|Protocol deviation|0|||
160882537|NCT01426789|580964454|FG000|Part 1|Lost to Follow-up|1|||
160882538|NCT01426789|580964455|FG001|Part 1|Lost to Follow-up|2|||
160882539|NCT01426789|580964456|FG002|Part 1|Lost to Follow-up|0|||
160882540|NCT01426789|580964457|FG003|Part 1|Lost to Follow-up|0|||
160882541|NCT01426789|580964458|FG004|Part 1|Lost to Follow-up|0|||
160882542|NCT01426789|580964459|FG005|Part 1|Lost to Follow-up|0|||
160882543|NCT01426789|580964454|FG000|Part 1|Lack of Efficacy|2|||
160882544|NCT01426789|580964455|FG001|Part 1|Lack of Efficacy|1|||
160882545|NCT01426789|580964456|FG002|Part 1|Lack of Efficacy|0|||
160882546|NCT01426789|580964457|FG003|Part 1|Lack of Efficacy|0|||
160882547|NCT01426789|580964458|FG004|Part 1|Lack of Efficacy|0|||
160882548|NCT01426789|580964459|FG005|Part 1|Lack of Efficacy|0|||
160882549|NCT01426789|580964454|FG000|Part 1|Adverse Event|3|||
160882550|NCT01426789|580964455|FG001|Part 1|Adverse Event|0|||
160882551|NCT01426789|580964456|FG002|Part 1|Adverse Event|0|||
160882552|NCT01426789|580964457|FG003|Part 1|Adverse Event|0|||
160882553|NCT01426789|580964458|FG004|Part 1|Adverse Event|0|||
160882554|NCT01426789|580964459|FG005|Part 1|Adverse Event|0|||
160882555|NCT01426789|580964454|FG000|Part 2|Protocol deviation|0|||
160882556|NCT01426789|580964455|FG001|Part 2|Protocol deviation|0|||
160882557|NCT01426789|580964456|FG002|Part 2|Protocol deviation|1|||
160882558|NCT01426789|580964457|FG003|Part 2|Protocol deviation|0|||
160882559|NCT01426789|580964458|FG004|Part 2|Protocol deviation|0|||
160882560|NCT01426789|580964459|FG005|Part 2|Protocol deviation|0|||
160882561|NCT01426789|580964454|FG000|Part 2|Death|0|||
160882562|NCT01426789|580964455|FG001|Part 2|Death|0|||
160882563|NCT01426789|580964456|FG002|Part 2|Death|1|||
160882564|NCT01426789|580964457|FG003|Part 2|Death|0|||
160882565|NCT01426789|580964458|FG004|Part 2|Death|1|||
160882566|NCT01426789|580964459|FG005|Part 2|Death|0|||
160882567|NCT01426789|580964454|FG000|Part 2|Administrative problems|0|||
160882568|NCT01426789|580964455|FG001|Part 2|Administrative problems|0|||
160882569|NCT01426789|580964456|FG002|Part 2|Administrative problems|2|||
160882570|NCT01426789|580964457|FG003|Part 2|Administrative problems|0|||
160882571|NCT01426789|580964458|FG004|Part 2|Administrative problems|1|||
160882572|NCT01426789|580964459|FG005|Part 2|Administrative problems|0|||
160882573|NCT01426789|580964454|FG000|Part 2|Lost to Follow-up|0|||
160882574|NCT01426789|580964455|FG001|Part 2|Lost to Follow-up|0|||
160882575|NCT01426789|580964456|FG002|Part 2|Lost to Follow-up|4|||
160882576|NCT01426789|580964457|FG003|Part 2|Lost to Follow-up|0|||
160882577|NCT01426789|580964458|FG004|Part 2|Lost to Follow-up|1|||
160882578|NCT01426789|580964459|FG005|Part 2|Lost to Follow-up|0|||
160882579|NCT01426789|580964454|FG000|Part 2|Withdrawal by Subject|0|||
160882580|NCT01426789|580964455|FG001|Part 2|Withdrawal by Subject|0|||
160882581|NCT01426789|580964456|FG002|Part 2|Withdrawal by Subject|0|||
160882582|NCT01426789|580964457|FG003|Part 2|Withdrawal by Subject|1|||
160882583|NCT01426789|580964458|FG004|Part 2|Withdrawal by Subject|2|||
160882584|NCT01426789|580964459|FG005|Part 2|Withdrawal by Subject|0|||
160882585|NCT01426789|580964454|FG000|Part 2|Lack of Efficacy|0|||
161324909|NCT00154375|582575765|FG001|Overall Study|Withdrawal by Subject|10|||
160882586|NCT01426789|580964455|FG001|Part 2|Lack of Efficacy|0|||
160882587|NCT01426789|580964456|FG002|Part 2|Lack of Efficacy|5|||
160882588|NCT01426789|580964457|FG003|Part 2|Lack of Efficacy|0|||
160882589|NCT01426789|580964458|FG004|Part 2|Lack of Efficacy|2|||
160882590|NCT01426789|580964459|FG005|Part 2|Lack of Efficacy|0|||
160882591|NCT01426789|580964454|FG000|Part 2|Adverse Event|0|||
160882592|NCT01426789|580964455|FG001|Part 2|Adverse Event|0|||
160882593|NCT01426789|580964456|FG002|Part 2|Adverse Event|2|||
160882594|NCT01426789|580964457|FG003|Part 2|Adverse Event|0|||
160882595|NCT01426789|580964458|FG004|Part 2|Adverse Event|1|||
160882596|NCT01426789|580964459|FG005|Part 2|Adverse Event|0|||
160882597|NCT00883688|580966471|FG000|Overall Study|Ineligible|2|||
160882598|NCT03860935|580966478|FG000|Overall Study|Withdrawal of Consent|15|||
160882599|NCT03860935|580966479|FG001|Overall Study|Withdrawal of Consent|6|||
160882600|NCT03860935|580966478|FG000|Overall Study|Death|75|||
160882601|NCT03860935|580966479|FG001|Overall Study|Death|51|||
160882602|NCT04461600|580966483|FG000|Overall Study|Death|6|||
160882603|NCT04461600|580966484|FG001|Overall Study|Death|5|||
160882604|NCT04461600|580966483|FG000|Overall Study|Withdrawal by Subject|0|||
160882605|NCT04461600|580966484|FG001|Overall Study|Withdrawal by Subject|1|||
160882606|NCT00704522|580966485|FG000|Overall Study|Lack of Efficacy|65|||
160882607|NCT00704522|580966486|FG001|Overall Study|Lack of Efficacy|17|||
160882608|NCT00704522|580966485|FG000|Overall Study|Failure to appear again at hospital|56|||
160882609|NCT00704522|580966486|FG001|Overall Study|Failure to appear again at hospital|10|||
160882610|NCT00704522|580966485|FG000|Overall Study|Withdrawal by Subject|17|||
160882611|NCT00704522|580966486|FG001|Overall Study|Withdrawal by Subject|8|||
160882612|NCT00704522|580966485|FG000|Overall Study|Adverse Event|9|||
160882613|NCT00704522|580966486|FG001|Overall Study|Adverse Event|1|||
160882614|NCT00704522|580966485|FG000|Overall Study|Undefined causes|9|||
160882615|NCT00704522|580966486|FG001|Overall Study|Undefined causes|7|||
160882616|NCT00704522|580966485|FG000|Overall Study|No information on therapy end|27|||
160882617|NCT00704522|580966486|FG001|Overall Study|No information on therapy end|2|||
160882618|NCT01958489|580966487|FG000|Period 2|Adverse Event|0|||
160882619|NCT01958489|580966488|FG001|Period 2|Adverse Event|1|||
160882620|NCT00992589|580966489|FG000|Open-Label Phase|Adverse Event|4|||
160882621|NCT00992589|580966490|FG001|Open-Label Phase|Adverse Event|0|||
160882622|NCT00992589|580966491|FG002|Open-Label Phase|Adverse Event|0|||
160882623|NCT00992589|580966492|FG003|Open-Label Phase|Adverse Event|0|||
160882624|NCT00992589|580966489|FG000|Open-Label Phase|Withdrawal by Subject|20|||
160882625|NCT00992589|580966490|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160882626|NCT00992589|580966491|FG002|Open-Label Phase|Withdrawal by Subject|0|||
160882627|NCT00992589|580966492|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160882628|NCT00992589|580966489|FG000|Open-Label Phase|Lost to Follow-up|1|||
160882629|NCT00992589|580966490|FG001|Open-Label Phase|Lost to Follow-up|0|||
160882630|NCT00992589|580966491|FG002|Open-Label Phase|Lost to Follow-up|0|||
160882631|NCT00992589|580966492|FG003|Open-Label Phase|Lost to Follow-up|0|||
160882632|NCT00992589|580966489|FG000|Open-Label Phase|Protocol Violation|3|||
160882633|NCT00992589|580966490|FG001|Open-Label Phase|Protocol Violation|0|||
160882634|NCT00992589|580966491|FG002|Open-Label Phase|Protocol Violation|0|||
160882635|NCT00992589|580966492|FG003|Open-Label Phase|Protocol Violation|0|||
160882636|NCT00992589|580966489|FG000|Open-Label Phase|Physician Decision|4|||
160882637|NCT00992589|580966490|FG001|Open-Label Phase|Physician Decision|0|||
160882638|NCT00992589|580966491|FG002|Open-Label Phase|Physician Decision|0|||
160882639|NCT00992589|580966492|FG003|Open-Label Phase|Physician Decision|0|||
160882640|NCT00992589|580966489|FG000|Open-Label Phase|Other|45|||
160882641|NCT00992589|580966490|FG001|Open-Label Phase|Other|0|||
160882642|NCT00992589|580966491|FG002|Open-Label Phase|Other|0|||
160882643|NCT00992589|580966492|FG003|Open-Label Phase|Other|0|||
160882644|NCT00992589|580966489|FG000|Double-Blind Phase|Adverse Event|0|||
160882645|NCT00992589|580966490|FG001|Double-Blind Phase|Adverse Event|6|||
160882646|NCT00992589|580966491|FG002|Double-Blind Phase|Adverse Event|2|||
160882647|NCT00992589|580966492|FG003|Double-Blind Phase|Adverse Event|3|||
160882648|NCT00992589|580966489|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160882649|NCT00992589|580966490|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
160882650|NCT00992589|580966491|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
160882651|NCT00992589|580966492|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
160882652|NCT00992589|580966489|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160882653|NCT00992589|580966490|FG001|Double-Blind Phase|Lost to Follow-up|0|||
160882654|NCT00992589|580966491|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160882655|NCT00992589|580966492|FG003|Double-Blind Phase|Lost to Follow-up|2|||
160882656|NCT00992589|580966489|FG000|Double-Blind Phase|Other|0|||
160882657|NCT00992589|580966490|FG001|Double-Blind Phase|Other|1|||
160882658|NCT00992589|580966491|FG002|Double-Blind Phase|Other|6|||
160882659|NCT00992589|580966492|FG003|Double-Blind Phase|Other|3|||
160882660|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
160882661|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882662|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882663|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882664|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882665|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882666|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882667|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882668|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
160882669|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Adverse Event|5|||
160882670|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Adverse Event|0|||
160882671|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Adverse Event|0|||
160882672|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Adverse Event|0|||
160882673|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Adverse Event|0|||
160882674|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Adverse Event|0|||
160882675|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Adverse Event|0|||
160882676|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Adverse Event|0|||
160882677|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Adverse Event|0|||
160882678|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
160882679|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882680|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882681|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882682|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882683|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882684|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882685|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882686|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
160882687|NCT00045942|580966493|FG000|PKC412A2104 (Core)|Death|1|||
160882688|NCT00045942|580966494|FG001|PKC412A2104 (Core)|Death|0|||
160882689|NCT00045942|580966495|FG002|PKC412A2104 (Core)|Death|0|||
160882690|NCT00045942|580966496|FG003|PKC412A2104 (Core)|Death|0|||
160882691|NCT00045942|580966497|FG004|PKC412A2104 (Core)|Death|0|||
160882692|NCT00045942|580966498|FG005|PKC412A2104 (Core)|Death|0|||
160882693|NCT00045942|580966499|FG006|PKC412A2104 (Core)|Death|0|||
160882694|NCT00045942|580966500|FG007|PKC412A2104 (Core)|Death|0|||
160882695|NCT00045942|580966501|FG008|PKC412A2104 (Core)|Death|0|||
160882696|NCT00045942|580966493|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
160882697|NCT00045942|580966494|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
160882698|NCT00045942|580966495|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
160882699|NCT00045942|580966496|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
160882700|NCT00045942|580966497|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
160882701|NCT00045942|580966498|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
160882702|NCT00045942|580966499|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
160882703|NCT00045942|580966500|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
160882704|NCT00045942|580966501|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
160882705|NCT00045942|580966493|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
160882706|NCT00045942|580966494|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
160882707|NCT00045942|580966495|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
160882708|NCT00045942|580966496|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
160882709|NCT00045942|580966497|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
160882710|NCT00045942|580966498|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
160882711|NCT00045942|580966499|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
160882712|NCT00045942|580966500|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
160882713|NCT00045942|580966501|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
160882714|NCT00045942|580966493|FG000|PKC412A2104E1|Lack of Efficacy|0|||
160882715|NCT00045942|580966494|FG001|PKC412A2104E1|Lack of Efficacy|11|||
160882716|NCT00045942|580966495|FG002|PKC412A2104E1|Lack of Efficacy|11|||
160882717|NCT00045942|580966496|FG003|PKC412A2104E1|Lack of Efficacy|23|||
160882718|NCT00045942|580966497|FG004|PKC412A2104E1|Lack of Efficacy|17|||
160882719|NCT00045942|580966498|FG005|PKC412A2104E1|Lack of Efficacy|0|||
160882720|NCT00045942|580966499|FG006|PKC412A2104E1|Lack of Efficacy|0|||
160882721|NCT00045942|580966500|FG007|PKC412A2104E1|Lack of Efficacy|0|||
160882722|NCT00045942|580966501|FG008|PKC412A2104E1|Lack of Efficacy|0|||
160882723|NCT00045942|580966493|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
160882724|NCT00045942|580966494|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
160882725|NCT00045942|580966495|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
160882726|NCT00045942|580966496|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
160882727|NCT00045942|580966497|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
160882728|NCT00045942|580966498|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
160882729|NCT00045942|580966499|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
160882730|NCT00045942|580966500|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
160882731|NCT00045942|580966501|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
160882732|NCT00045942|580966493|FG000|PKC412A2104E1|Adverse Event|0|||
160882733|NCT00045942|580966494|FG001|PKC412A2104E1|Adverse Event|1|||
160882734|NCT00045942|580966495|FG002|PKC412A2104E1|Adverse Event|1|||
160882735|NCT00045942|580966496|FG003|PKC412A2104E1|Adverse Event|3|||
160882736|NCT00045942|580966497|FG004|PKC412A2104E1|Adverse Event|6|||
160882737|NCT00045942|580966498|FG005|PKC412A2104E1|Adverse Event|0|||
160882738|NCT00045942|580966499|FG006|PKC412A2104E1|Adverse Event|0|||
160882739|NCT00045942|580966500|FG007|PKC412A2104E1|Adverse Event|0|||
160882740|NCT00045942|580966501|FG008|PKC412A2104E1|Adverse Event|0|||
160882741|NCT00045942|580966493|FG000|PKC412A2104E1|Death|0|||
160882742|NCT00045942|580966494|FG001|PKC412A2104E1|Death|4|||
160882743|NCT00045942|580966495|FG002|PKC412A2104E1|Death|1|||
160882744|NCT00045942|580966496|FG003|PKC412A2104E1|Death|1|||
160882745|NCT00045942|580966497|FG004|PKC412A2104E1|Death|1|||
160882746|NCT00045942|580966498|FG005|PKC412A2104E1|Death|0|||
160882747|NCT00045942|580966499|FG006|PKC412A2104E1|Death|0|||
160882748|NCT00045942|580966500|FG007|PKC412A2104E1|Death|0|||
160882749|NCT00045942|580966501|FG008|PKC412A2104E1|Death|0|||
160882750|NCT00045942|580966493|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882751|NCT00045942|580966494|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882752|NCT00045942|580966495|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
160882753|NCT00045942|580966496|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
160882754|NCT00045942|580966497|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882755|NCT00045942|580966498|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882756|NCT00045942|580966499|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882757|NCT00045942|580966500|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882758|NCT00045942|580966501|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
160882759|NCT00045942|580966493|FG000|PKC412A2104E2|Lost to Follow-up|0|||
160882760|NCT00045942|580966494|FG001|PKC412A2104E2|Lost to Follow-up|0|||
160882761|NCT00045942|580966495|FG002|PKC412A2104E2|Lost to Follow-up|0|||
160882762|NCT00045942|580966496|FG003|PKC412A2104E2|Lost to Follow-up|0|||
160882763|NCT00045942|580966497|FG004|PKC412A2104E2|Lost to Follow-up|0|||
160882764|NCT00045942|580966498|FG005|PKC412A2104E2|Lost to Follow-up|0|||
160882765|NCT00045942|580966499|FG006|PKC412A2104E2|Lost to Follow-up|0|||
160882766|NCT00045942|580966500|FG007|PKC412A2104E2|Lost to Follow-up|3|||
160882767|NCT00045942|580966501|FG008|PKC412A2104E2|Lost to Follow-up|0|||
160882768|NCT00045942|580966493|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
160882769|NCT00045942|580966494|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
160882770|NCT00045942|580966495|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
160882771|NCT00045942|580966496|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
160882772|NCT00045942|580966497|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
160882773|NCT00045942|580966498|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
160882774|NCT00045942|580966499|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
160882775|NCT00045942|580966500|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
160882776|NCT00045942|580966501|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
160882777|NCT00045942|580966493|FG000|PKC412A2104E2|Lack of Efficacy|0|||
160882778|NCT00045942|580966494|FG001|PKC412A2104E2|Lack of Efficacy|0|||
160882779|NCT00045942|580966495|FG002|PKC412A2104E2|Lack of Efficacy|0|||
160882780|NCT00045942|580966496|FG003|PKC412A2104E2|Lack of Efficacy|0|||
160882781|NCT00045942|580966497|FG004|PKC412A2104E2|Lack of Efficacy|0|||
160882782|NCT00045942|580966498|FG005|PKC412A2104E2|Lack of Efficacy|3|||
160882783|NCT00045942|580966499|FG006|PKC412A2104E2|Lack of Efficacy|2|||
160882784|NCT00045942|580966500|FG007|PKC412A2104E2|Lack of Efficacy|2|||
160882785|NCT00045942|580966501|FG008|PKC412A2104E2|Lack of Efficacy|6|||
160882786|NCT00045942|580966493|FG000|PKC412A2104E2|Adverse Event|0|||
160882787|NCT00045942|580966494|FG001|PKC412A2104E2|Adverse Event|0|||
160882788|NCT00045942|580966495|FG002|PKC412A2104E2|Adverse Event|0|||
160882789|NCT00045942|580966496|FG003|PKC412A2104E2|Adverse Event|0|||
160882790|NCT00045942|580966497|FG004|PKC412A2104E2|Adverse Event|0|||
160882791|NCT00045942|580966498|FG005|PKC412A2104E2|Adverse Event|4|||
160882792|NCT00045942|580966499|FG006|PKC412A2104E2|Adverse Event|3|||
160882793|NCT00045942|580966500|FG007|PKC412A2104E2|Adverse Event|1|||
160882794|NCT00045942|580966501|FG008|PKC412A2104E2|Adverse Event|0|||
160882795|NCT00045942|580966493|FG000|PKC412A2104E2|Death|0|||
160882796|NCT00045942|580966494|FG001|PKC412A2104E2|Death|0|||
160882797|NCT00045942|580966495|FG002|PKC412A2104E2|Death|0|||
160882798|NCT00045942|580966496|FG003|PKC412A2104E2|Death|0|||
160882799|NCT00045942|580966497|FG004|PKC412A2104E2|Death|0|||
160882800|NCT00045942|580966498|FG005|PKC412A2104E2|Death|1|||
160882801|NCT00045942|580966499|FG006|PKC412A2104E2|Death|2|||
160882802|NCT00045942|580966500|FG007|PKC412A2104E2|Death|0|||
160882803|NCT00045942|580966501|FG008|PKC412A2104E2|Death|0|||
160882804|NCT05508074|580966502|FG000|Overall Study|Death|2|||
160882805|NCT05508074|580966503|FG001|Overall Study|Death|5|||
160882806|NCT05508074|580966502|FG000|Overall Study|Withdrawal by Subject|1|||
160882807|NCT05508074|580966503|FG001|Overall Study|Withdrawal by Subject|2|||
160882808|NCT05508074|580966502|FG000|Overall Study|Adverse Event|0|||
160882809|NCT05508074|580966503|FG001|Overall Study|Adverse Event|1|||
160882810|NCT05508074|580966502|FG000|Overall Study|Physician Decision|0|||
160882811|NCT05508074|580966503|FG001|Overall Study|Physician Decision|1|||
160882812|NCT05508074|580966502|FG000|Overall Study|wrongly randomized|0|||
160882813|NCT05508074|580966503|FG001|Overall Study|wrongly randomized|1|||
160882814|NCT05508074|580966502|FG000|Overall Study|non-compliance|0|||
160882815|NCT05508074|580966503|FG001|Overall Study|non-compliance|1|||
160882816|NCT01101308|580966504|FG000|Period 1|Adverse Event|2|||
160882817|NCT01101308|580966505|FG001|Period 1|Adverse Event|1|||
160882818|NCT01101308|580966504|FG000|Period 1|Positive for cotinine|1|||
160882819|NCT01101308|580966505|FG001|Period 1|Positive for cotinine|0|||
160882820|NCT00711516|580966506|FG000|Overall Study|Adverse Event|1|||
160882821|NCT00711516|580966507|FG001|Overall Study|Adverse Event|1|||
161324910|NCT00154375|582575764|FG000|Overall Study|Death|5|||
160882822|NCT00711516|580966506|FG000|Overall Study|Withdrawal by Subject|0|||
160882823|NCT00711516|580966507|FG001|Overall Study|Withdrawal by Subject|1|||
160882824|NCT00711516|580966506|FG000|Overall Study|Protocol Violation|0|||
160882825|NCT00711516|580966507|FG001|Overall Study|Protocol Violation|1|||
160882826|NCT04575597|580966508|FG000|Overall Study|Death|0|||
160882827|NCT04575597|580966509|FG001|Overall Study|Death|0|||
160882828|NCT04575597|580966510|FG002|Overall Study|Death|0|||
160882829|NCT04575597|580966511|FG003|Overall Study|Death|1|||
160882830|NCT04575597|580966512|FG004|Overall Study|Death|3|||
160882831|NCT04575597|580966513|FG005|Overall Study|Death|14|||
160882832|NCT04575597|580966508|FG000|Overall Study|Lost to Follow-up|2|||
160882833|NCT04575597|580966509|FG001|Overall Study|Lost to Follow-up|1|||
160882834|NCT04575597|580966510|FG002|Overall Study|Lost to Follow-up|1|||
160882835|NCT04575597|580966511|FG003|Overall Study|Lost to Follow-up|2|||
160882836|NCT04575597|580966512|FG004|Overall Study|Lost to Follow-up|10|||
160882837|NCT04575597|580966513|FG005|Overall Study|Lost to Follow-up|8|||
160882838|NCT04575597|580966508|FG000|Overall Study|Withdrawal by Subject|2|||
160882839|NCT04575597|580966509|FG001|Overall Study|Withdrawal by Subject|2|||
161324911|NCT00154375|582575765|FG001|Overall Study|Death|13|||
160882840|NCT04575597|580966510|FG002|Overall Study|Withdrawal by Subject|4|||
160882841|NCT04575597|580966511|FG003|Overall Study|Withdrawal by Subject|2|||
160882842|NCT04575597|580966512|FG004|Overall Study|Withdrawal by Subject|25|||
160882843|NCT04575597|580966513|FG005|Overall Study|Withdrawal by Subject|28|||
160882844|NCT04575597|580966508|FG000|Overall Study|Not Recorded|0|||
160882845|NCT04575597|580966509|FG001|Overall Study|Not Recorded|0|||
160882846|NCT04575597|580966510|FG002|Overall Study|Not Recorded|0|||
160882847|NCT04575597|580966511|FG003|Overall Study|Not Recorded|0|||
160882848|NCT04575597|580966512|FG004|Overall Study|Not Recorded|0|||
160882849|NCT04575597|580966513|FG005|Overall Study|Not Recorded|2|||
160882850|NCT04575597|580966508|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882851|NCT04575597|580966509|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882852|NCT04575597|580966510|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882853|NCT04575597|580966511|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160882854|NCT04575597|580966512|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
160882855|NCT04575597|580966513|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160882856|NCT02095132|580966515|FG000|Overall Study|Adverse Event|0|||
160882857|NCT02095132|580966516|FG001|Overall Study|Adverse Event|0|||
160882858|NCT02095132|580966517|FG002|Overall Study|Adverse Event|0|||
160882859|NCT02095132|580966518|FG003|Overall Study|Adverse Event|0|||
160882860|NCT02095132|580966519|FG004|Overall Study|Adverse Event|1|||
160882861|NCT02095132|580966520|FG005|Overall Study|Adverse Event|0|||
160882862|NCT02095132|580966521|FG006|Overall Study|Adverse Event|1|||
160882863|NCT02095132|580966522|FG007|Overall Study|Adverse Event|0|||
160882864|NCT02095132|580966523|FG008|Overall Study|Adverse Event|0|||
160882865|NCT02095132|580966515|FG000|Overall Study|Death|0|||
160882866|NCT02095132|580966516|FG001|Overall Study|Death|0|||
160882867|NCT02095132|580966517|FG002|Overall Study|Death|0|||
160882868|NCT02095132|580966518|FG003|Overall Study|Death|0|||
160882869|NCT02095132|580966519|FG004|Overall Study|Death|0|||
160882870|NCT02095132|580966520|FG005|Overall Study|Death|0|||
160882871|NCT02095132|580966521|FG006|Overall Study|Death|1|||
160882872|NCT02095132|580966522|FG007|Overall Study|Death|0|||
160882873|NCT02095132|580966523|FG008|Overall Study|Death|0|||
160882874|NCT02095132|580966515|FG000|Overall Study|Lack of Efficacy|3|||
160882875|NCT02095132|580966516|FG001|Overall Study|Lack of Efficacy|5|||
160882876|NCT02095132|580966517|FG002|Overall Study|Lack of Efficacy|2|||
160882877|NCT02095132|580966518|FG003|Overall Study|Lack of Efficacy|8|||
160882878|NCT02095132|580966519|FG004|Overall Study|Lack of Efficacy|3|||
160882879|NCT02095132|580966520|FG005|Overall Study|Lack of Efficacy|6|||
160882880|NCT02095132|580966521|FG006|Overall Study|Lack of Efficacy|10|||
160882881|NCT02095132|580966522|FG007|Overall Study|Lack of Efficacy|9|||
160882882|NCT02095132|580966523|FG008|Overall Study|Lack of Efficacy|8|||
160882883|NCT02095132|580966515|FG000|Overall Study|Physician Decision|1|||
160882884|NCT02095132|580966516|FG001|Overall Study|Physician Decision|0|||
160882885|NCT02095132|580966517|FG002|Overall Study|Physician Decision|0|||
160882886|NCT02095132|580966518|FG003|Overall Study|Physician Decision|0|||
160882887|NCT02095132|580966519|FG004|Overall Study|Physician Decision|0|||
160882888|NCT02095132|580966520|FG005|Overall Study|Physician Decision|0|||
160882889|NCT02095132|580966521|FG006|Overall Study|Physician Decision|1|||
160882890|NCT02095132|580966522|FG007|Overall Study|Physician Decision|0|||
160882891|NCT02095132|580966523|FG008|Overall Study|Physician Decision|2|||
160882892|NCT02095132|580966515|FG000|Overall Study|Withdrawal by Subject|0|||
160882893|NCT02095132|580966516|FG001|Overall Study|Withdrawal by Subject|0|||
160882894|NCT02095132|580966517|FG002|Overall Study|Withdrawal by Subject|2|||
160882895|NCT02095132|580966518|FG003|Overall Study|Withdrawal by Subject|2|||
160882896|NCT02095132|580966519|FG004|Overall Study|Withdrawal by Subject|3|||
160882897|NCT02095132|580966520|FG005|Overall Study|Withdrawal by Subject|0|||
160882898|NCT02095132|580966521|FG006|Overall Study|Withdrawal by Subject|5|||
160882899|NCT02095132|580966522|FG007|Overall Study|Withdrawal by Subject|0|||
160882900|NCT02095132|580966523|FG008|Overall Study|Withdrawal by Subject|0|||
160882901|NCT04905498|580966526|FG000|Overall Study|Lost to Follow-up|0|||
160882902|NCT04905498|580966527|FG001|Overall Study|Lost to Follow-up|2|||
160882903|NCT04905498|580966526|FG000|Overall Study|COVID lockdown|1|||
160882904|NCT04905498|580966527|FG001|Overall Study|COVID lockdown|0|||
160882905|NCT01029405|580966528|FG000|Overall Study|Withdrawal by Subject|0|||
160882906|NCT01029405|580966529|FG001|Overall Study|Withdrawal by Subject|1|||
160882907|NCT01029405|580966530|FG002|Overall Study|Withdrawal by Subject|2|||
160882908|NCT01029405|580966531|FG003|Overall Study|Withdrawal by Subject|0|||
160882909|NCT01029405|580966528|FG000|Overall Study|Protocol Violation|0|||
160882910|NCT01029405|580966529|FG001|Overall Study|Protocol Violation|0|||
160882911|NCT01029405|580966530|FG002|Overall Study|Protocol Violation|0|||
160882912|NCT01029405|580966531|FG003|Overall Study|Protocol Violation|1|||
160882913|NCT01029405|580966528|FG000|Overall Study|Adverse Event|0|||
160882914|NCT01029405|580966529|FG001|Overall Study|Adverse Event|0|||
160882915|NCT01029405|580966530|FG002|Overall Study|Adverse Event|1|||
160882916|NCT01029405|580966531|FG003|Overall Study|Adverse Event|1|||
160882917|NCT01029405|580966528|FG000|Overall Study|Lost to Follow-up|2|||
160882918|NCT01029405|580966529|FG001|Overall Study|Lost to Follow-up|1|||
160882919|NCT01029405|580966530|FG002|Overall Study|Lost to Follow-up|1|||
160882920|NCT01029405|580966531|FG003|Overall Study|Lost to Follow-up|2|||
160882921|NCT01029405|580966528|FG000|Overall Study|Other|0|||
160882922|NCT01029405|580966529|FG001|Overall Study|Other|1|||
160882923|NCT01029405|580966530|FG002|Overall Study|Other|0|||
160882924|NCT01029405|580966531|FG003|Overall Study|Other|1|||
160882925|NCT02692651|580966532|FG000|Study Treatment|Death|7|||
160882926|NCT02692651|580966533|FG001|Study Treatment|Death|3|||
160882927|NCT02692651|580966532|FG000|Study Treatment|comfort care|1|||
160882928|NCT02692651|580966533|FG001|Study Treatment|comfort care|1|||
160882929|NCT02692651|580966532|FG000|Study Treatment|Protocol violation per treating team preference|8|||
160882930|NCT02692651|580966533|FG001|Study Treatment|Protocol violation per treating team preference|6|||
160882931|NCT02692651|580966532|FG000|Post Study Treatment Follow-up|Death|4|||
160882932|NCT02692651|580966533|FG001|Post Study Treatment Follow-up|Death|4|||
160882933|NCT03490981|580966534|FG000|Overall Study|Lost to Follow-up|1|||
160882934|NCT03490981|580966535|FG001|Overall Study|Lost to Follow-up|2|||
160882935|NCT02480712|580966542|FG000|Overall Study|Enrolled but Never Treated|1|||
160882936|NCT02480712|580966542|FG000|Overall Study|Lost to Follow-up|5|||
160882937|NCT02480712|580966542|FG000|Overall Study|Withdrew Consent|3|||
160882938|NCT02480712|580966542|FG000|Overall Study|Death|1|||
160882939|NCT02480712|580966542|FG000|Overall Study|Lack of Efficacy|1|||
160882940|NCT01860846|580966543|FG000|Overall Study|Lost to Follow-up|33|||
160882941|NCT00466687|580966544|FG000|Overall Study|Adverse Event|1|||
160882942|NCT00466687|580966544|FG000|Overall Study|Other complicating illness|3|||
160882943|NCT00466687|580966544|FG000|Overall Study|Withdrawal by Subject|1|||
160882944|NCT00466687|580966544|FG000|Overall Study|Disease progression|29|||
160882945|NCT02586506|580966545|FG000|Overall Study|Protocol Violation|6|||
160882946|NCT02586506|580966545|FG000|Overall Study|Lost to Follow-up|1|||
160882947|NCT02586506|580966545|FG000|Overall Study|Other Reason|2|||
160882948|NCT05027971|580966555|FG000|Overall Study|Physician Decision|7|||
160882949|NCT05027971|580966556|FG001|Overall Study|Physician Decision|3|||
160882950|NCT05027971|580966555|FG000|Overall Study|Lost to Follow-up|1|||
160882951|NCT05027971|580966556|FG001|Overall Study|Lost to Follow-up|1|||
160882952|NCT05027971|580966555|FG000|Overall Study|Withdrawal by Subject|0|||
160882953|NCT05027971|580966556|FG001|Overall Study|Withdrawal by Subject|2|||
160882954|NCT05027971|580966555|FG000|Overall Study|Non-study fiber used.|0|||
160882955|NCT05027971|580966556|FG001|Overall Study|Non-study fiber used.|1|||
160882956|NCT05027971|580966555|FG000|Overall Study|Protocol Violation|0|||
160882957|NCT05027971|580966556|FG001|Overall Study|Protocol Violation|2|||
160882958|NCT02025556|580966557|FG000|Overall Study|Adverse Event|0|||
160882959|NCT02025556|580966558|FG001|Overall Study|Adverse Event|4|||
160882960|NCT02025556|580966559|FG002|Overall Study|Adverse Event|2|||
160882961|NCT02025556|580966557|FG000|Overall Study|Lack of Efficacy|2|||
160882962|NCT02025556|580966558|FG001|Overall Study|Lack of Efficacy|1|||
160882963|NCT02025556|580966559|FG002|Overall Study|Lack of Efficacy|0|||
160882964|NCT02025556|580966557|FG000|Overall Study|Protocol Violation|2|||
160882965|NCT02025556|580966558|FG001|Overall Study|Protocol Violation|1|||
160882966|NCT02025556|580966559|FG002|Overall Study|Protocol Violation|0|||
160882967|NCT02025556|580966557|FG000|Overall Study|Withdrawal by Subject|0|||
160882968|NCT02025556|580966558|FG001|Overall Study|Withdrawal by Subject|3|||
160882969|NCT02025556|580966559|FG002|Overall Study|Withdrawal by Subject|6|||
160882970|NCT02025556|580966557|FG000|Overall Study|Lost to Follow-up|2|||
160882971|NCT02025556|580966558|FG001|Overall Study|Lost to Follow-up|4|||
160882972|NCT02025556|580966559|FG002|Overall Study|Lost to Follow-up|0|||
160882973|NCT02025556|580966557|FG000|Overall Study|Reason not reported|0|||
160882974|NCT02025556|580966558|FG001|Overall Study|Reason not reported|0|||
160882975|NCT02025556|580966559|FG002|Overall Study|Reason not reported|1|||
160882976|NCT00796991|580966562|FG000|Overall Study|Adverse Event|0|||
160882977|NCT00796991|580966563|FG001|Overall Study|Adverse Event|0|||
160882978|NCT00796991|580966564|FG002|Overall Study|Adverse Event|1|||
160882979|NCT00796991|580966562|FG000|Overall Study|Death|2|||
160882980|NCT00796991|580966563|FG001|Overall Study|Death|0|||
160882981|NCT00796991|580966564|FG002|Overall Study|Death|0|||
160882982|NCT00796991|580966562|FG000|Overall Study|Disease Progression|10|||
160882983|NCT00796991|580966563|FG001|Overall Study|Disease Progression|9|||
161324912|NCT00154375|582575764|FG000|Overall Study|Study drug no longer required|5|||
160882984|NCT00796991|580966564|FG002|Overall Study|Disease Progression|7|||
160882985|NCT00796991|580966562|FG000|Overall Study|Study Drug Toxicity|3|||
160882986|NCT00796991|580966563|FG001|Overall Study|Study Drug Toxicity|3|||
160882987|NCT00796991|580966564|FG002|Overall Study|Study Drug Toxicity|5|||
160882988|NCT00796991|580966562|FG000|Overall Study|Withdrawal by Subject|0|||
160882989|NCT00796991|580966563|FG001|Overall Study|Withdrawal by Subject|0|||
160882990|NCT00796991|580966564|FG002|Overall Study|Withdrawal by Subject|1|||
160882991|NCT00171834|580966566|FG000|Overall Study|Adverse Event|2|||
160882992|NCT00171834|580966567|FG001|Overall Study|Adverse Event|1|||
160882993|NCT00171834|580966568|FG002|Overall Study|Adverse Event|3|||
160882994|NCT00171834|580966569|FG003|Overall Study|Adverse Event|2|||
160882995|NCT00171834|580966570|FG004|Overall Study|Adverse Event|2|||
160882996|NCT00171834|580966571|FG005|Overall Study|Adverse Event|15|||
161324913|NCT00154375|582575765|FG001|Overall Study|Study drug no longer required|3|||
161324914|NCT00154375|582575764|FG000|Overall Study|Lost to Follow-up|2|||
161324915|NCT00154375|582575765|FG001|Overall Study|Lost to Follow-up|1|||
161324916|NCT00154375|582575764|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160882997|NCT00171834|580966572|FG006|Overall Study|Adverse Event|1|||
160882998|NCT00171834|580966566|FG000|Overall Study|Withdrawal by Subject|0|||
160882999|NCT00171834|580966567|FG001|Overall Study|Withdrawal by Subject|2|||
160883000|NCT00171834|580966568|FG002|Overall Study|Withdrawal by Subject|0|||
160883001|NCT00171834|580966569|FG003|Overall Study|Withdrawal by Subject|1|||
160883002|NCT00171834|580966570|FG004|Overall Study|Withdrawal by Subject|1|||
160883003|NCT00171834|580966571|FG005|Overall Study|Withdrawal by Subject|1|||
160883004|NCT00171834|580966572|FG006|Overall Study|Withdrawal by Subject|0|||
160883005|NCT00171834|580966566|FG000|Overall Study|Death from study indication|0|||
160883006|NCT00171834|580966567|FG001|Overall Study|Death from study indication|1|||
160883007|NCT00171834|580966568|FG002|Overall Study|Death from study indication|0|||
160883008|NCT00171834|580966569|FG003|Overall Study|Death from study indication|0|||
160883009|NCT00171834|580966570|FG004|Overall Study|Death from study indication|1|||
160883010|NCT00171834|580966571|FG005|Overall Study|Death from study indication|0|||
160883011|NCT00171834|580966572|FG006|Overall Study|Death from study indication|0|||
160883012|NCT00171834|580966566|FG000|Overall Study|Disease Progression|4|||
160883013|NCT00171834|580966567|FG001|Overall Study|Disease Progression|8|||
160883014|NCT00171834|580966568|FG002|Overall Study|Disease Progression|8|||
160883015|NCT00171834|580966569|FG003|Overall Study|Disease Progression|9|||
160883016|NCT00171834|580966570|FG004|Overall Study|Disease Progression|2|||
160883017|NCT00171834|580966571|FG005|Overall Study|Disease Progression|18|||
160883018|NCT00171834|580966572|FG006|Overall Study|Disease Progression|3|||
160883019|NCT00171834|580966566|FG000|Overall Study|Treatment Duration Completed|0|||
160883020|NCT00171834|580966567|FG001|Overall Study|Treatment Duration Completed|0|||
160883021|NCT00171834|580966568|FG002|Overall Study|Treatment Duration Completed|1|||
160883022|NCT00171834|580966569|FG003|Overall Study|Treatment Duration Completed|0|||
160883023|NCT00171834|580966570|FG004|Overall Study|Treatment Duration Completed|2|||
160883024|NCT00171834|580966571|FG005|Overall Study|Treatment Duration Completed|1|||
160883025|NCT00171834|580966572|FG006|Overall Study|Treatment Duration Completed|0|||
160883026|NCT00834080|580966573|FG000|Overall Study|Adverse Event|7|||
160883027|NCT00834080|580966573|FG000|Overall Study|Lost to Follow-up|7|||
160883028|NCT00834080|580966573|FG000|Overall Study|Withdrawal by Subject|5|||
160883029|NCT00834080|580966573|FG000|Overall Study|Other - Pregnancy|1|||
160883030|NCT00834080|580966573|FG000|Overall Study|Other - False positive tests of the UDS|1|||
160883031|NCT00834080|580966573|FG000|Overall Study|Physician Decision|1|||
160883032|NCT00834080|580966573|FG000|Overall Study|Subject Relocated|1|||
160883033|NCT04345367|580966575|FG000|Overall Study|Other|3|||
160883034|NCT04345367|580966576|FG001|Overall Study|Other|4|||
160883035|NCT04345367|580966575|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
160883036|NCT04345367|580966576|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
160883037|NCT04345367|580966575|FG000|Overall Study|Withdrawal by Subject|11|||
160883038|NCT04345367|580966576|FG001|Overall Study|Withdrawal by Subject|11|||
160883039|NCT04345367|580966575|FG000|Overall Study|Protocol Violation|4|||
160883040|NCT04345367|580966576|FG001|Overall Study|Protocol Violation|3|||
160883041|NCT04345367|580966575|FG000|Overall Study|Lost to Follow-up|2|||
160883042|NCT04345367|580966576|FG001|Overall Study|Lost to Follow-up|4|||
160883043|NCT04345367|580966575|FG000|Overall Study|Lack of Efficacy|2|||
160883044|NCT04345367|580966576|FG001|Overall Study|Lack of Efficacy|0|||
160883045|NCT04345367|580966575|FG000|Overall Study|Death|2|||
160883046|NCT04345367|580966576|FG001|Overall Study|Death|0|||
160883047|NCT04345367|580966575|FG000|Overall Study|Adverse Event|10|||
160883048|NCT04345367|580966576|FG001|Overall Study|Adverse Event|9|||
160883049|NCT00439738|580966579|FG000|Overall Study|Withdrawal by Subject|16|||
160883050|NCT00439738|580966580|FG001|Overall Study|Withdrawal by Subject|13|||
160883051|NCT00439738|580966579|FG000|Overall Study|Adverse Event|6|||
160883052|NCT00439738|580966580|FG001|Overall Study|Adverse Event|4|||
160883053|NCT00439738|580966579|FG000|Overall Study|Lost to Follow-up|5|||
160883054|NCT00439738|580966580|FG001|Overall Study|Lost to Follow-up|6|||
160883055|NCT00439738|580966579|FG000|Overall Study|Protocol Violation|6|||
160883056|NCT00439738|580966580|FG001|Overall Study|Protocol Violation|3|||
160883057|NCT00439738|580966579|FG000|Overall Study|Lack of Efficacy|2|||
160883058|NCT00439738|580966580|FG001|Overall Study|Lack of Efficacy|2|||
160883059|NCT00439738|580966579|FG000|Overall Study|Abnormal Lab Values|1|||
160883060|NCT00439738|580966580|FG001|Overall Study|Abnormal Lab Values|0|||
160883061|NCT00781885|580966583|FG000|Overall Study|Physician Decision|1|||
160883062|NCT01755026|580966584|FG000|Overall Study|Adverse Event|1|||
160883063|NCT01755026|580966585|FG001|Overall Study|Adverse Event|0|||
160883064|NCT01755026|580966584|FG000|Overall Study|Withdrawal by Subject|1|||
160883065|NCT01755026|580966585|FG001|Overall Study|Withdrawal by Subject|1|||
160883066|NCT03836001|580966586|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
160883067|NCT03836001|580966587|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
160883068|NCT03836001|580966588|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
161324917|NCT00154375|582575765|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160883069|NCT03836001|580966586|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
160883070|NCT03836001|580966587|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
160883071|NCT03836001|580966588|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
160883072|NCT03836001|580966586|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
160883073|NCT03836001|580966587|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
160883074|NCT03836001|580966588|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
160883075|NCT03836001|580966586|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
160883076|NCT03836001|580966587|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
160883077|NCT03836001|580966588|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
160883078|NCT01284491|580966589|FG000|Overall Study|Study termination|13|||
160883079|NCT01978938|580966590|FG000|Overall Study|Lost to Follow-up|12|||
160883080|NCT01978938|580966591|FG001|Overall Study|Lost to Follow-up|6|||
160883081|NCT01978938|580966590|FG000|Overall Study|Withdrawal by Subject|8|||
160883082|NCT01978938|580966591|FG001|Overall Study|Withdrawal by Subject|4|||
160883083|NCT01978938|580966590|FG000|Overall Study|Adverse Event, non-fatal|2|||
160883084|NCT01978938|580966591|FG001|Overall Study|Adverse Event, non-fatal|1|||
160883085|NCT01978938|580966590|FG000|Overall Study|Participant noncompliance|1|||
160883086|NCT01978938|580966591|FG001|Overall Study|Participant noncompliance|1|||
160883087|NCT01978938|580966590|FG000|Overall Study|Did not meet inclusion criteria|0|||
160883088|NCT01978938|580966591|FG001|Overall Study|Did not meet inclusion criteria|1|||
160883089|NCT01978938|580966590|FG000|Overall Study|Previously scheduled procedure|0|||
160883090|NCT01978938|580966591|FG001|Overall Study|Previously scheduled procedure|1|||
160883091|NCT02694757|580966592|FG000|Overall Study|Lack of Efficacy|3|||
160883092|NCT02650921|580966593|FG000|Overall Study|Withdrawal by Subject|4|||
160883093|NCT02650921|580966593|FG000|Overall Study|Lost to Follow-up|2|||
160883094|NCT02650921|580966593|FG000|Overall Study|Adverse Event|1|||
160883095|NCT02650921|580966593|FG000|Overall Study|Due to Medical Condition|1|||
160883096|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
160883097|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
160883098|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
160883099|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
160883100|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
160883101|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
160883102|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
160883103|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
160883104|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
160883105|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
160883106|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
160883107|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
160883108|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
160883109|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
160883110|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
160883111|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
160883112|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
160883113|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
161227651|NCT04025229|582215165|FG000|Overall Study|Physician Decision|0|||
161227652|NCT04025229|582215166|FG001|Overall Study|Physician Decision|1|||
161227653|NCT03815942|582215167|FG000|Overall Study|Withdrawal by Subject|0|||
161227654|NCT03815942|582215168|FG001|Overall Study|Withdrawal by Subject|17|||
161227655|NCT00366899|582215169|FG000|Infant Series|Withdrawal by Subject|4|||
161227656|NCT00366899|582215170|FG001|Infant Series|Withdrawal by Subject|7|||
161227657|NCT00366899|582215169|FG000|Infant Series|Protocol Violation|2|||
161227658|NCT00366899|582215170|FG001|Infant Series|Protocol Violation|1|||
161227659|NCT00366899|582215169|FG000|Infant Series|Failed to return|1|||
161227660|NCT00366899|582215170|FG001|Infant Series|Failed to return|1|||
161227661|NCT00366899|582215169|FG000|Infant Series|Lost to Follow-up|0|||
161227662|NCT00366899|582215170|FG001|Infant Series|Lost to Follow-up|2|||
161227663|NCT00366899|582215169|FG000|Infant Series|Adverse Event|0|||
161227664|NCT00366899|582215170|FG001|Infant Series|Adverse Event|1|||
161227665|NCT00366899|582215169|FG000|Infant Series|Physician Decision|1|||
161227666|NCT00366899|582215170|FG001|Infant Series|Physician Decision|0|||
161227667|NCT00366899|582215169|FG000|Infant Series|Randomized but not consented|1|||
161227668|NCT00366899|582215170|FG001|Infant Series|Randomized but not consented|0|||
161227669|NCT00366899|582215169|FG000|After Infant Series|Lost to Follow-up|4|||
161227670|NCT00366899|582215170|FG001|After Infant Series|Lost to Follow-up|3|||
161227671|NCT00366899|582215169|FG000|After Infant Series|Withdrawal by Subject|1|||
161227672|NCT00366899|582215170|FG001|After Infant Series|Withdrawal by Subject|4|||
161227673|NCT00366899|582215169|FG000|After Infant Series|Adverse Event|1|||
161227674|NCT00366899|582215170|FG001|After Infant Series|Adverse Event|2|||
161227675|NCT00366899|582215169|FG000|After Infant Series|Protocol Violation|1|||
161227676|NCT00366899|582215170|FG001|After Infant Series|Protocol Violation|0|||
161227677|NCT00366899|582215169|FG000|Toddler Dose|Withdrawal by Subject|1|||
161324918|NCT00154375|582575764|FG000|Overall Study|Protocol Violation|0|||
161324919|NCT00154375|582575765|FG001|Overall Study|Protocol Violation|1|||
161324920|NCT00154375|582575764|FG000|Overall Study|Suspected progression of disease|44|||
161324921|NCT00154375|582575765|FG001|Overall Study|Suspected progression of disease|30|||
161324922|NCT00792116|582575770|FG000|Overall Study|Lost to Follow-up|0|||
161324923|NCT00792116|582575771|FG001|Overall Study|Lost to Follow-up|1|||
161324924|NCT00792116|582575770|FG000|Overall Study|Discontnued intervention|1|||
161324925|NCT00792116|582575771|FG001|Overall Study|Discontnued intervention|0|||
161324926|NCT02453256|582575772|FG000|Double Blind Period|Death|1|||
161324927|NCT02453256|582575773|FG001|Double Blind Period|Death|1|||
161324928|NCT02453256|582575772|FG000|Double Blind Period|Adverse Event|3|||
161324929|NCT02453256|582575773|FG001|Double Blind Period|Adverse Event|2|||
161324930|NCT02453256|582575772|FG000|Double Blind Period|Withdrawal by Subject|9|||
161324931|NCT02453256|582575773|FG001|Double Blind Period|Withdrawal by Subject|5|||
161324932|NCT02453256|582575772|FG000|Double Blind Period|Other|0|||
161324933|NCT02453256|582575773|FG001|Double Blind Period|Other|1|||
161324934|NCT02453256|582575772|FG000|Open Label Period|Adverse Event|1|||
161324935|NCT02453256|582575773|FG001|Open Label Period|Adverse Event|3|||
161324936|NCT02453256|582575772|FG000|Open Label Period|Death|0|||
161324937|NCT02453256|582575773|FG001|Open Label Period|Death|1|||
161324938|NCT02453256|582575772|FG000|Open Label Period|Lost to Follow-up|1|||
161324939|NCT02453256|582575773|FG001|Open Label Period|Lost to Follow-up|0|||
161324940|NCT02453256|582575772|FG000|Open Label Period|Other|0|||
161324941|NCT02453256|582575773|FG001|Open Label Period|Other|2|||
161324942|NCT02453256|582575772|FG000|Open Label Period|Withdrawal by Subject|5|||
161324943|NCT02453256|582575773|FG001|Open Label Period|Withdrawal by Subject|1|||
161324944|NCT03654729|582578039|FG000|Overall Study|Death|9|||
161324945|NCT03654729|582578040|FG001|Overall Study|Death|9|||
161324946|NCT03654729|582578041|FG002|Overall Study|Death|16|||
161324947|NCT03654729|582578039|FG000|Overall Study|Withdrawal by Subject|8|||
161324948|NCT03654729|582578040|FG001|Overall Study|Withdrawal by Subject|6|||
161324949|NCT03654729|582578041|FG002|Overall Study|Withdrawal by Subject|4|||
161324950|NCT03654729|582578039|FG000|Overall Study|Study terminated by Sponsor|3|||
161324951|NCT03654729|582578040|FG001|Overall Study|Study terminated by Sponsor|5|||
161324952|NCT03654729|582578041|FG002|Overall Study|Study terminated by Sponsor|4|||
161324953|NCT03654729|582578039|FG000|Overall Study|Not reported|2|||
161324954|NCT03654729|582578040|FG001|Overall Study|Not reported|4|||
161324955|NCT03654729|582578041|FG002|Overall Study|Not reported|5|||
161324956|NCT03654729|582578039|FG000|Overall Study|Progressive disease|3|||
161324957|NCT03654729|582578040|FG001|Overall Study|Progressive disease|0|||
161324958|NCT03654729|582578041|FG002|Overall Study|Progressive disease|0|||
161324959|NCT03654729|582578039|FG000|Overall Study|Lost to Follow-up|2|||
161324960|NCT03654729|582578040|FG001|Overall Study|Lost to Follow-up|0|||
161324961|NCT03654729|582578041|FG002|Overall Study|Lost to Follow-up|0|||
161324962|NCT03654729|582578039|FG000|Overall Study|Physician Decision|2|||
161324963|NCT03654729|582578040|FG001|Overall Study|Physician Decision|0|||
161324964|NCT03654729|582578041|FG002|Overall Study|Physician Decision|0|||
161324965|NCT03654729|582578039|FG000|Overall Study|Protocol Violation|1|||
161324966|NCT03654729|582578040|FG001|Overall Study|Protocol Violation|1|||
161324967|NCT03654729|582578041|FG002|Overall Study|Protocol Violation|0|||
161324968|NCT03654729|582578039|FG000|Overall Study|Non-compliance with study drug|0|||
160883114|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
160883115|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
160883116|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
160883117|NCT01087788|580966594|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
160883118|NCT01087788|580966595|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
160883119|NCT01087788|580966596|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
160883120|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
161121859|NCT01239160|581833598|FG002|Overall Study|Early Termination Due to Study Closure|6|||
161121860|NCT01764633|581833599|FG000|Overall Study|Withdrawal by Subject|105|||
161121861|NCT01764633|581833600|FG001|Overall Study|Withdrawal by Subject|88|||
161121862|NCT01764633|581833599|FG000|Overall Study|Lost to Follow-up|13|||
161324969|NCT03654729|582578040|FG001|Overall Study|Non-compliance with study drug|1|||
161324970|NCT03654729|582578041|FG002|Overall Study|Non-compliance with study drug|0|||
161324971|NCT03654729|582578039|FG000|Overall Study|Site terminated by Sponsor|1|||
161324972|NCT03654729|582578040|FG001|Overall Study|Site terminated by Sponsor|0|||
161324973|NCT03654729|582578041|FG002|Overall Study|Site terminated by Sponsor|0|||
161324974|NCT00588146|582578048|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
161324975|NCT00588146|582578049|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
161324976|NCT01239394|582578051|FG000|Overall Study|Adverse Event|1|||
161324977|NCT00905632|582578053|FG000|Overall Study|Adverse Event|0|||
161324978|NCT00905632|582578054|FG001|Overall Study|Adverse Event|0|||
161324979|NCT00905632|582578055|FG002|Overall Study|Adverse Event|0|||
161324980|NCT00905632|582578056|FG003|Overall Study|Adverse Event|0|||
161324981|NCT00905632|582578057|FG004|Overall Study|Adverse Event|0|||
161324982|NCT00905632|582578058|FG005|Overall Study|Adverse Event|1|||
161324983|NCT00905632|582578059|FG006|Overall Study|Adverse Event|4|||
160883121|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
160883122|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
160883123|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
160883124|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
160883125|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
160883126|NCT01087788|580966594|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
160883127|NCT01087788|580966595|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
160883128|NCT01087788|580966596|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
160883129|NCT01087788|580966594|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
160883130|NCT01087788|580966595|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
160883131|NCT01087788|580966596|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
160883132|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
160883133|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
160883134|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
160883135|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
160883136|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
160883137|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
160883138|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
160883139|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
160883140|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
160883141|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
160883142|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
160883143|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
160883144|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
160883145|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
160883146|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
160883147|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
160883148|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
160883149|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
160883150|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
160883151|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
160883152|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
160883153|NCT01087788|580966594|FG000|24-weeks Dose-blind Period|Patient moved|0|||
160883154|NCT01087788|580966595|FG001|24-weeks Dose-blind Period|Patient moved|0|||
160883155|NCT01087788|580966596|FG002|24-weeks Dose-blind Period|Patient moved|1|||
160883156|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
160883157|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
160883158|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
160883159|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
160883160|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
160883161|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
161121863|NCT01764633|581833600|FG001|Overall Study|Lost to Follow-up|5|||
161121864|NCT02268058|581833601|FG000|Overall Study|Protocol Violation|1|||
161121865|NCT02268058|581833602|FG001|Overall Study|Protocol Violation|0|||
161121866|NCT02268058|581833603|FG002|Overall Study|Protocol Violation|0|||
161121867|NCT02268058|581833604|FG003|Overall Study|Protocol Violation|0|||
161121868|NCT04781816|581833609|FG000|Overall Study|Adverse Event|0|||
161121869|NCT04781816|581833610|FG001|Overall Study|Adverse Event|1|||
161121870|NCT04781816|581833609|FG000|Overall Study|Withdrawal by Subject|1|||
161121871|NCT04781816|581833610|FG001|Overall Study|Withdrawal by Subject|1|||
161121872|NCT04781816|581833609|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
161121873|NCT04781816|581833610|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
161121874|NCT01789970|581833611|FG000|Open-label Titration Period|Adverse Event|68|||
161121875|NCT01789970|581833612|FG001|Open-label Titration Period|Adverse Event|0|||
161121876|NCT01789970|581833613|FG002|Open-label Titration Period|Adverse Event|0|||
161121877|NCT01789970|581833611|FG000|Open-label Titration Period|Lack of Efficacy|31|||
161121878|NCT01789970|581833612|FG001|Open-label Titration Period|Lack of Efficacy|0|||
161121879|NCT01789970|581833613|FG002|Open-label Titration Period|Lack of Efficacy|0|||
161121880|NCT01789970|581833611|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
161121881|NCT01789970|581833612|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
161121882|NCT01789970|581833613|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
160883162|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
160883163|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
160883164|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
160883165|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
160883166|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
161121883|NCT01789970|581833611|FG000|Open-label Titration Period|Protocol Violation|18|||
161121884|NCT01789970|581833612|FG001|Open-label Titration Period|Protocol Violation|0|||
161121885|NCT01789970|581833613|FG002|Open-label Titration Period|Protocol Violation|0|||
161227678|NCT00366899|582215170|FG001|Toddler Dose|Withdrawal by Subject|1|||
160883167|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
160883168|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
160883169|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
160883170|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
160883171|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
160883172|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
160883173|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
160883174|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
160883175|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
160883176|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
160883177|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
160883178|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
160883179|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
160883180|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
160883181|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
160883182|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
160883183|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
160883184|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
160883185|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
160883186|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
160883187|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
160883188|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
160883189|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
160883190|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
160883191|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
160883192|NCT01087788|580966594|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
160883193|NCT01087788|580966595|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
160883194|NCT01087788|580966596|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
160883195|NCT00783302|580966597|FG000|Overall Study|Lost to Follow-up|17|||
160883196|NCT00783302|580966597|FG000|Overall Study|Technical Problems|11|||
160883197|NCT00783302|580966597|FG000|Overall Study|Protocol Violation|3|||
160883198|NCT00783302|580966597|FG000|Overall Study|Physician Decision|1|||
160883199|NCT00783302|580966597|FG000|Overall Study|Withdrawal by Subject|3|||
160883200|NCT01806662|580966598|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
160883201|NCT01806662|580966599|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
160883202|NCT01806662|580966598|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
160883203|NCT01806662|580966599|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
160883204|NCT01806662|580966598|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
160883205|NCT01806662|580966599|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
160883206|NCT01806662|580966598|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
160883207|NCT01806662|580966599|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
160883208|NCT00043550|580966600|FG000|Overall Study|Withdrawal by Subject|22|||
160883209|NCT00043550|580966601|FG001|Overall Study|Withdrawal by Subject|12|||
160883210|NCT00043550|580966602|FG002|Overall Study|Withdrawal by Subject|20|||
160883211|NCT01917656|580966603|FG000|Overall Study|Adverse Event|11|||
160883212|NCT01917656|580966604|FG001|Overall Study|Adverse Event|0|||
160883213|NCT01917656|580966603|FG000|Overall Study|Withdrawal criteria|8|||
160883214|NCT01917656|580966604|FG001|Overall Study|Withdrawal criteria|14|||
160883215|NCT01917656|580966603|FG000|Overall Study|Unclassified|0|||
160883216|NCT01917656|580966604|FG001|Overall Study|Unclassified|3|||
160883217|NCT01917656|580966603|FG000|Overall Study|Withdrawal by Subject|4|||
160883218|NCT01917656|580966604|FG001|Overall Study|Withdrawal by Subject|3|||
160883219|NCT01917656|580966603|FG000|Overall Study|Lost to Follow-up|3|||
160883220|NCT01917656|580966604|FG001|Overall Study|Lost to Follow-up|4|||
160883221|NCT02285062|580966605|FG000|Pre-Treatment Period|Protocol Violation|0|||
160883222|NCT02285062|580966606|FG001|Pre-Treatment Period|Protocol Violation|2|||
160883223|NCT02285062|580966605|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
160883224|NCT02285062|580966606|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160883225|NCT02015221|580966607|FG000|Overall Study|Withdrawal by Subject|8|||
160883226|NCT02015221|580966608|FG001|Overall Study|Withdrawal by Subject|6|||
160883227|NCT02015221|580966607|FG000|Overall Study|Lost to Follow-up|1|||
160883228|NCT02015221|580966608|FG001|Overall Study|Lost to Follow-up|0|||
160883229|NCT01306929|580966609|FG000|Overall Study|Withdrawal by Subject|23|||
160883230|NCT01306929|580966609|FG000|Overall Study|Adverse Event|21|||
160883231|NCT01306929|580966609|FG000|Overall Study|Physician Decision|13|||
160883232|NCT01306929|580966609|FG000|Overall Study|Death|8|||
160883233|NCT01306929|580966609|FG000|Overall Study|Withdrawal by parent/guardian|5|||
160883234|NCT01306929|580966609|FG000|Overall Study|Protocol Violation|3|||
160883235|NCT01306929|580966609|FG000|Overall Study|Non-compliance with study drug|2|||
160883236|NCT01306929|580966609|FG000|Overall Study|Lost to Follow-up|2|||
160883237|NCT01306929|580966609|FG000|Overall Study|Various|17|||
160883238|NCT00483756|580966612|FG000|Overall Study|Death|2|||
161227679|NCT00366899|582215169|FG000|Toddler Dose|Protocol Violation|1|||
160883239|NCT00483756|580966613|FG001|Overall Study|Death|0|||
160883240|NCT00483756|580966614|FG002|Overall Study|Death|1|||
160883241|NCT00483756|580966612|FG000|Overall Study|Adverse Event|19|||
160883242|NCT00483756|580966613|FG001|Overall Study|Adverse Event|38|||
160883243|NCT00483756|580966614|FG002|Overall Study|Adverse Event|40|||
160883244|NCT00483756|580966612|FG000|Overall Study|Lack of Efficacy|1|||
160883245|NCT00483756|580966613|FG001|Overall Study|Lack of Efficacy|0|||
160883246|NCT00483756|580966614|FG002|Overall Study|Lack of Efficacy|0|||
160883247|NCT00483756|580966612|FG000|Overall Study|Lost to Follow-up|3|||
160883248|NCT00483756|580966613|FG001|Overall Study|Lost to Follow-up|1|||
160883249|NCT00483756|580966614|FG002|Overall Study|Lost to Follow-up|0|||
160883250|NCT00483756|580966612|FG000|Overall Study|Withdrawal by Subject|5|||
160883251|NCT00483756|580966613|FG001|Overall Study|Withdrawal by Subject|3|||
160883252|NCT00483756|580966614|FG002|Overall Study|Withdrawal by Subject|4|||
160883253|NCT00483756|580966612|FG000|Overall Study|Other|2|||
160883254|NCT00483756|580966613|FG001|Overall Study|Other|4|||
160883255|NCT00483756|580966614|FG002|Overall Study|Other|3|||
160883256|NCT00483756|580966612|FG000|Overall Study|Randomized, Not Treated|1|||
160883257|NCT00483756|580966613|FG001|Overall Study|Randomized, Not Treated|4|||
160883258|NCT00483756|580966614|FG002|Overall Study|Randomized, Not Treated|4|||
160883259|NCT01829243|580966615|FG000|First Intervention|Screen Failure|4|||
160883260|NCT01829243|580966616|FG001|First Intervention|Screen Failure|2|||
160883261|NCT02282293|580966621|FG000|Overall Study|Lost to Follow-up|2|||
160883262|NCT02282293|580966622|FG001|Overall Study|Lost to Follow-up|2|||
160883263|NCT02282293|580966621|FG000|Overall Study|Unable to comply with study procedures|1|||
160883264|NCT02282293|580966622|FG001|Overall Study|Unable to comply with study procedures|0|||
160883265|NCT02282293|580966621|FG000|Overall Study|Moved out of study area|0|||
160883266|NCT02282293|580966622|FG001|Overall Study|Moved out of study area|1|||
160883267|NCT03011892|580966623|FG000|Double Blind (DB) Period|Adverse Event|0|||
160883268|NCT03011892|580966624|FG001|Double Blind (DB) Period|Adverse Event|1|||
160883269|NCT03011892|580966625|FG002|Double Blind (DB) Period|Adverse Event|1|||
160883270|NCT03011892|580966626|FG003|Double Blind (DB) Period|Adverse Event|0|||
160883271|NCT03011892|580966627|FG004|Double Blind (DB) Period|Adverse Event|0|||
160883272|NCT03011892|580966628|FG005|Double Blind (DB) Period|Adverse Event|0|||
160883273|NCT03011892|580966629|FG006|Double Blind (DB) Period|Adverse Event|0|||
160883274|NCT03011892|580966630|FG007|Double Blind (DB) Period|Adverse Event|0|||
160883275|NCT03011892|580966631|FG008|Double Blind (DB) Period|Adverse Event|0|||
160883276|NCT03011892|580966632|FG009|Double Blind (DB) Period|Adverse Event|0|||
160883277|NCT03011892|580966633|FG010|Double Blind (DB) Period|Adverse Event|0|||
160883278|NCT03011892|580966634|FG011|Double Blind (DB) Period|Adverse Event|0|||
160883279|NCT03011892|580966623|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
160883280|NCT03011892|580966624|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
160883281|NCT03011892|580966625|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
160883282|NCT03011892|580966626|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
160883283|NCT03011892|580966627|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
160883284|NCT03011892|580966628|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
160883285|NCT03011892|580966629|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
160883286|NCT03011892|580966630|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
160883287|NCT03011892|580966631|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
160883288|NCT03011892|580966632|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
160883289|NCT03011892|580966633|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
160883290|NCT03011892|580966634|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
160883291|NCT03011892|580966623|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
160883292|NCT03011892|580966624|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
160883293|NCT03011892|580966625|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
160883294|NCT03011892|580966626|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
160883295|NCT03011892|580966627|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
160883296|NCT03011892|580966628|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
160883297|NCT03011892|580966629|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
160883298|NCT03011892|580966630|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
160883299|NCT03011892|580966631|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
160883300|NCT03011892|580966632|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
160883301|NCT03011892|580966633|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
161121886|NCT01789970|581833611|FG000|Open-label Titration Period|Lost to Follow-up|5|||
161121887|NCT01789970|581833612|FG001|Open-label Titration Period|Lost to Follow-up|0|||
160883302|NCT03011892|580966634|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
160883303|NCT03011892|580966623|FG000|Double Blind (DB) Period|Other|1|||
161121888|NCT01789970|581833613|FG002|Open-label Titration Period|Lost to Follow-up|0|||
161121889|NCT01789970|581833611|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
161121890|NCT01789970|581833612|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
160883304|NCT03011892|580966624|FG001|Double Blind (DB) Period|Other|1|||
160883305|NCT03011892|580966625|FG002|Double Blind (DB) Period|Other|1|||
160883306|NCT03011892|580966626|FG003|Double Blind (DB) Period|Other|0|||
160883307|NCT03011892|580966627|FG004|Double Blind (DB) Period|Other|1|||
160883308|NCT03011892|580966628|FG005|Double Blind (DB) Period|Other|0|||
160883309|NCT03011892|580966629|FG006|Double Blind (DB) Period|Other|0|||
160883310|NCT03011892|580966630|FG007|Double Blind (DB) Period|Other|0|||
160883311|NCT03011892|580966631|FG008|Double Blind (DB) Period|Other|0|||
160883312|NCT03011892|580966632|FG009|Double Blind (DB) Period|Other|0|||
160883313|NCT03011892|580966633|FG010|Double Blind (DB) Period|Other|0|||
160883314|NCT03011892|580966634|FG011|Double Blind (DB) Period|Other|0|||
160883315|NCT03011892|580966623|FG000|Double Blind (DB) Period|Physician Decision|1|||
160883316|NCT03011892|580966624|FG001|Double Blind (DB) Period|Physician Decision|0|||
160883317|NCT03011892|580966625|FG002|Double Blind (DB) Period|Physician Decision|1|||
160883318|NCT03011892|580966626|FG003|Double Blind (DB) Period|Physician Decision|0|||
160883319|NCT03011892|580966627|FG004|Double Blind (DB) Period|Physician Decision|0|||
160883320|NCT03011892|580966628|FG005|Double Blind (DB) Period|Physician Decision|0|||
160883321|NCT03011892|580966629|FG006|Double Blind (DB) Period|Physician Decision|0|||
160883322|NCT03011892|580966630|FG007|Double Blind (DB) Period|Physician Decision|0|||
160883323|NCT03011892|580966631|FG008|Double Blind (DB) Period|Physician Decision|0|||
160883324|NCT03011892|580966632|FG009|Double Blind (DB) Period|Physician Decision|0|||
160883325|NCT03011892|580966633|FG010|Double Blind (DB) Period|Physician Decision|0|||
160883326|NCT03011892|580966634|FG011|Double Blind (DB) Period|Physician Decision|0|||
160883327|NCT03011892|580966623|FG000|Double Blind (DB) Period|Pregnancy|0|||
160883328|NCT03011892|580966624|FG001|Double Blind (DB) Period|Pregnancy|0|||
160883329|NCT03011892|580966625|FG002|Double Blind (DB) Period|Pregnancy|0|||
160883330|NCT03011892|580966626|FG003|Double Blind (DB) Period|Pregnancy|0|||
160883331|NCT03011892|580966627|FG004|Double Blind (DB) Period|Pregnancy|1|||
160883332|NCT03011892|580966628|FG005|Double Blind (DB) Period|Pregnancy|0|||
160883333|NCT03011892|580966629|FG006|Double Blind (DB) Period|Pregnancy|0|||
160883334|NCT03011892|580966630|FG007|Double Blind (DB) Period|Pregnancy|0|||
160883335|NCT03011892|580966631|FG008|Double Blind (DB) Period|Pregnancy|0|||
160883336|NCT03011892|580966632|FG009|Double Blind (DB) Period|Pregnancy|0|||
160883337|NCT03011892|580966633|FG010|Double Blind (DB) Period|Pregnancy|0|||
160883338|NCT03011892|580966634|FG011|Double Blind (DB) Period|Pregnancy|0|||
160883339|NCT03011892|580966623|FG000|Double Blind (DB) Period|Protocol Violation|1|||
160883340|NCT03011892|580966624|FG001|Double Blind (DB) Period|Protocol Violation|0|||
160883341|NCT03011892|580966625|FG002|Double Blind (DB) Period|Protocol Violation|0|||
160883342|NCT03011892|580966626|FG003|Double Blind (DB) Period|Protocol Violation|0|||
160883343|NCT03011892|580966627|FG004|Double Blind (DB) Period|Protocol Violation|0|||
160883344|NCT03011892|580966628|FG005|Double Blind (DB) Period|Protocol Violation|0|||
160883345|NCT03011892|580966629|FG006|Double Blind (DB) Period|Protocol Violation|0|||
160883346|NCT03011892|580966630|FG007|Double Blind (DB) Period|Protocol Violation|0|||
160883347|NCT03011892|580966631|FG008|Double Blind (DB) Period|Protocol Violation|0|||
160883348|NCT03011892|580966632|FG009|Double Blind (DB) Period|Protocol Violation|0|||
160883349|NCT03011892|580966633|FG010|Double Blind (DB) Period|Protocol Violation|0|||
160883350|NCT03011892|580966634|FG011|Double Blind (DB) Period|Protocol Violation|0|||
160883351|NCT03011892|580966623|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
160883352|NCT03011892|580966624|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
160883353|NCT03011892|580966625|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
160883354|NCT03011892|580966626|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
160883355|NCT03011892|580966627|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
160883356|NCT03011892|580966628|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
160883357|NCT03011892|580966629|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883358|NCT03011892|580966630|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883359|NCT03011892|580966631|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883360|NCT03011892|580966632|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883361|NCT03011892|580966633|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883362|NCT03011892|580966634|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
160883363|NCT03011892|580966623|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
160883364|NCT03011892|580966624|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
160883365|NCT03011892|580966625|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
160883366|NCT03011892|580966626|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
160883367|NCT03011892|580966627|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
160883368|NCT03011892|580966628|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
160883369|NCT03011892|580966629|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
160883370|NCT03011892|580966630|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
160883371|NCT03011892|580966631|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
160883372|NCT03011892|580966632|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
160883373|NCT03011892|580966633|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
160883374|NCT03011892|580966634|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
161227680|NCT00366899|582215170|FG001|Toddler Dose|Protocol Violation|0|||
160883375|NCT03011892|580966623|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
161227681|NCT03601637|582215172|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
161227682|NCT03601637|582215173|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
161227683|NCT03601637|582215172|FG000|Overall Study|Adverse Event|1|||
160883376|NCT03011892|580966624|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
160883377|NCT03011892|580966625|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
160883378|NCT03011892|580966626|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
160883379|NCT03011892|580966627|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
160883380|NCT03011892|580966628|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
160883381|NCT03011892|580966629|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
160883382|NCT03011892|580966630|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
160883383|NCT03011892|580966631|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
160883384|NCT03011892|580966632|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
160883385|NCT03011892|580966633|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
160883386|NCT03011892|580966634|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
160883387|NCT03011892|580966623|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
160883388|NCT03011892|580966624|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
160883389|NCT03011892|580966625|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
160883390|NCT03011892|580966626|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
160883391|NCT03011892|580966627|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
160883392|NCT03011892|580966628|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
160883393|NCT03011892|580966629|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
160883394|NCT03011892|580966630|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
160883395|NCT03011892|580966631|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
160883396|NCT03011892|580966632|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
160883397|NCT03011892|580966633|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
160883398|NCT03011892|580966634|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
160883399|NCT03011892|580966623|FG000|Open Label (OL) Period|Reason not specified|0|||
160883400|NCT03011892|580966624|FG001|Open Label (OL) Period|Reason not specified|0|||
160883401|NCT03011892|580966625|FG002|Open Label (OL) Period|Reason not specified|0|||
160883402|NCT03011892|580966626|FG003|Open Label (OL) Period|Reason not specified|0|||
160883403|NCT03011892|580966627|FG004|Open Label (OL) Period|Reason not specified|0|||
160883404|NCT03011892|580966628|FG005|Open Label (OL) Period|Reason not specified|0|||
160883405|NCT03011892|580966629|FG006|Open Label (OL) Period|Reason not specified|0|||
160883406|NCT03011892|580966630|FG007|Open Label (OL) Period|Reason not specified|1|||
160883407|NCT03011892|580966631|FG008|Open Label (OL) Period|Reason not specified|0|||
160883408|NCT03011892|580966632|FG009|Open Label (OL) Period|Reason not specified|0|||
160883409|NCT03011892|580966633|FG010|Open Label (OL) Period|Reason not specified|0|||
160883410|NCT03011892|580966634|FG011|Open Label (OL) Period|Reason not specified|0|||
160883411|NCT00608569|580966635|FG000|Overall Study|Death|4|||
160883412|NCT00608569|580966636|FG001|Overall Study|Death|3|||
160883413|NCT00608569|580966635|FG000|Overall Study|Lost to Follow-up|4|||
160883414|NCT00608569|580966636|FG001|Overall Study|Lost to Follow-up|5|||
160883415|NCT00608569|580966635|FG000|Overall Study|Withdrawal by Subject|1|||
160883416|NCT00608569|580966636|FG001|Overall Study|Withdrawal by Subject|0|||
160883417|NCT00608569|580966635|FG000|Overall Study|Adverse Event|1|||
160883418|NCT00608569|580966636|FG001|Overall Study|Adverse Event|0|||
160883419|NCT00608569|580966635|FG000|Overall Study|Unable to adhere with study requirements|0|||
160883420|NCT00608569|580966636|FG001|Overall Study|Unable to adhere with study requirements|1|||
160883421|NCT02312687|580966651|FG000|Overall Study|Other, Not Specified|1|||
160883422|NCT00906971|580966652|FG000|Overall Study|Withdrawal by Subject|8|||
160883423|NCT00906971|580966653|FG001|Overall Study|Withdrawal by Subject|2|||
160883424|NCT00906971|580966652|FG000|Overall Study|Lost to Follow-up|0|||
160883425|NCT00906971|580966653|FG001|Overall Study|Lost to Follow-up|1|||
160883426|NCT00545129|580966656|FG000|Overall Study|Lack of Efficacy|2|||
160883427|NCT00545129|580966657|FG001|Overall Study|Lack of Efficacy|5|||
160883428|NCT00545129|580966656|FG000|Overall Study|Death|2|||
160883429|NCT00545129|580966657|FG001|Overall Study|Death|1|||
160883430|NCT00545129|580966656|FG000|Overall Study|Adverse Event|1|||
160883431|NCT00545129|580966657|FG001|Overall Study|Adverse Event|1|||
160883432|NCT00545129|580966656|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
160883433|NCT00545129|580966657|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
160883434|NCT00545129|580966656|FG000|Overall Study|Other|3|||
160883435|NCT00545129|580966657|FG001|Overall Study|Other|3|||
160883436|NCT03678870|580966658|FG000|Overall Study|prescribed non- protocol medications|10|||
160883437|NCT03678870|580966659|FG001|Overall Study|prescribed non- protocol medications|6|||
160883438|NCT03678870|580966658|FG000|Overall Study|Lost to Follow-up|3|||
160883439|NCT03678870|580966659|FG001|Overall Study|Lost to Follow-up|2|||
160883440|NCT03104816|580966661|FG000|Overall Study|Lack of Efficacy|0|||
160883441|NCT03104816|580966662|FG001|Overall Study|Lack of Efficacy|2|||
160883442|NCT03104816|580966663|FG002|Overall Study|Lack of Efficacy|0|||
160883443|NCT03104816|580966661|FG000|Overall Study|Protocol Violation|2|||
160883444|NCT03104816|580966662|FG001|Overall Study|Protocol Violation|0|||
160883445|NCT03104816|580966663|FG002|Overall Study|Protocol Violation|2|||
160883446|NCT01007253|580966668|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
160883447|NCT01007253|580966669|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
160883448|NCT01007253|580966670|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
160883449|NCT01007253|580966671|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
160883450|NCT04896229|580968416|FG000|Overall Study|Lost to Follow-up|113|||
160883451|NCT04896229|580968417|FG001|Overall Study|Lost to Follow-up|113|||
160883452|NCT00635024|580968418|FG000|Overall Study|Adverse Event|1|||
160883453|NCT02142387|580968419|FG000|Overall Study|<19 years old|49|||
160883454|NCT02142387|580968420|FG001|Overall Study|<19 years old|326|||
160883455|NCT02142387|580968419|FG000|Overall Study|non-cardiac etiology|504|||
160883456|NCT02142387|580968420|FG001|Overall Study|non-cardiac etiology|3431|||
160883457|NCT02142387|580968419|FG000|Overall Study|CPR not performed|74|||
160883458|NCT02142387|580968420|FG001|Overall Study|CPR not performed|473|||
160883459|NCT02142387|580968419|FG000|Overall Study|witnessed by paramedic|139|||
160883460|NCT02142387|580968420|FG001|Overall Study|witnessed by paramedic|917|||
160883461|NCT02142387|580968419|FG000|Overall Study|incomplete data|1|||
160883462|NCT02142387|580968420|FG001|Overall Study|incomplete data|9|||
160883463|NCT02142387|580968419|FG000|Overall Study|occurred not at home|298|||
160883464|NCT02142387|580968420|FG001|Overall Study|occurred not at home|2474|||
160883465|NCT02984943|580968421|FG000|Overall Study|Withdrawal by Subject|3|||
160883466|NCT02984943|580968421|FG000|Overall Study|Physician Decision|1|||
160883467|NCT02282345|580968424|FG000|Overall Study|Progression|0|||
160883468|NCT02282345|580968425|FG001|Overall Study|Progression|1|||
160883469|NCT02296138|580968426|FG000|Overall Study|Adverse Event|348|||
160883470|NCT02296138|580968427|FG001|Overall Study|Adverse Event|259|||
160883471|NCT02296138|580968426|FG000|Overall Study|Lack of Efficacy|59|||
160883472|NCT02296138|580968427|FG001|Overall Study|Lack of Efficacy|37|||
160883473|NCT02296138|580968426|FG000|Overall Study|Protocol Violation|35|||
160883474|NCT02296138|580968427|FG001|Overall Study|Protocol Violation|36|||
160883475|NCT02296138|580968426|FG000|Overall Study|Lost to Follow-up|9|||
160883476|NCT02296138|580968427|FG001|Overall Study|Lost to Follow-up|12|||
160883477|NCT02296138|580968426|FG000|Overall Study|Withdrawal by Subject|184|||
160883478|NCT02296138|580968427|FG001|Overall Study|Withdrawal by Subject|131|||
160883479|NCT02296138|580968426|FG000|Overall Study|Not Treated|1|||
160883480|NCT02296138|580968427|FG001|Overall Study|Not Treated|1|||
160883481|NCT02296138|580968426|FG000|Overall Study|Patients with data irregularities|10|||
161227684|NCT03601637|582215173|FG001|Overall Study|Adverse Event|1|||
161227685|NCT03601637|582215172|FG000|Overall Study|Other|0|||
161227686|NCT03601637|582215173|FG001|Overall Study|Other|1|||
161227687|NCT02322047|582215174|FG000|Overall Study|Physician Decision|1|||
161227688|NCT02322047|582215175|FG001|Overall Study|Physician Decision|0|||
161227689|NCT02322047|582215176|FG002|Overall Study|Physician Decision|0|||
161227690|NCT02322047|582215177|FG003|Overall Study|Physician Decision|0|||
161227691|NCT02322047|582215174|FG000|Overall Study|Withdrawal by Subject|1|||
161227692|NCT02322047|582215175|FG001|Overall Study|Withdrawal by Subject|0|||
161227693|NCT02322047|582215176|FG002|Overall Study|Withdrawal by Subject|0|||
161227694|NCT02322047|582215177|FG003|Overall Study|Withdrawal by Subject|1|||
161227695|NCT02322047|582215174|FG000|Overall Study|Adverse Event|0|||
161227696|NCT02322047|582215175|FG001|Overall Study|Adverse Event|1|||
161227697|NCT02322047|582215176|FG002|Overall Study|Adverse Event|0|||
161227698|NCT02322047|582215177|FG003|Overall Study|Adverse Event|0|||
161227699|NCT02322047|582215174|FG000|Overall Study|Lost to Follow-up|0|||
161227700|NCT02322047|582215175|FG001|Overall Study|Lost to Follow-up|0|||
161227701|NCT02322047|582215176|FG002|Overall Study|Lost to Follow-up|1|||
161227702|NCT02322047|582215177|FG003|Overall Study|Lost to Follow-up|1|||
161227703|NCT00920140|582215180|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
161324984|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
160883482|NCT02296138|580968427|FG001|Overall Study|Patients with data irregularities|11|||
160883483|NCT02296138|580968426|FG000|Overall Study|Other than specified|15|||
160883484|NCT02296138|580968427|FG001|Overall Study|Other than specified|13|||
160883485|NCT01895361|580968431|FG000|Overall Study|Adverse Event|1|||
160883486|NCT01895361|580968432|FG001|Overall Study|Adverse Event|1|||
160883487|NCT01895361|580968433|FG002|Overall Study|Adverse Event|3|||
160883488|NCT01895361|580968431|FG000|Overall Study|Death|2|||
160883489|NCT01895361|580968432|FG001|Overall Study|Death|1|||
160883490|NCT01895361|580968433|FG002|Overall Study|Death|2|||
160883491|NCT01895361|580968431|FG000|Overall Study|Lost to Follow-up|4|||
160883492|NCT01895361|580968432|FG001|Overall Study|Lost to Follow-up|4|||
161324985|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
160883493|NCT01895361|580968433|FG002|Overall Study|Lost to Follow-up|6|||
160883494|NCT01895361|580968431|FG000|Overall Study|Non-compliance with study|1|||
160883495|NCT01895361|580968432|FG001|Overall Study|Non-compliance with study|3|||
160883496|NCT01895361|580968433|FG002|Overall Study|Non-compliance with study|1|||
160883497|NCT01895361|580968431|FG000|Overall Study|Physician Decision|2|||
160883498|NCT01895361|580968432|FG001|Overall Study|Physician Decision|2|||
160883499|NCT01895361|580968433|FG002|Overall Study|Physician Decision|2|||
160883500|NCT01895361|580968431|FG000|Overall Study|Withdrawal by Subject|7|||
160883501|NCT01895361|580968432|FG001|Overall Study|Withdrawal by Subject|6|||
161227704|NCT00920140|582215181|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
161227705|NCT00920140|582215182|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
161227706|NCT00920140|582215183|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
161227707|NCT00920140|582215184|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
161227708|NCT00920140|582215180|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
160883502|NCT01895361|580968433|FG002|Overall Study|Withdrawal by Subject|6|||
160883503|NCT01895361|580968431|FG000|Overall Study|Lack of Efficacy|0|||
160883504|NCT01895361|580968432|FG001|Overall Study|Lack of Efficacy|1|||
160883505|NCT01895361|580968433|FG002|Overall Study|Lack of Efficacy|0|||
160883506|NCT01895361|580968431|FG000|Overall Study|Reasons different from categories above|7|||
160883507|NCT01895361|580968432|FG001|Overall Study|Reasons different from categories above|3|||
160883508|NCT01895361|580968433|FG002|Overall Study|Reasons different from categories above|4|||
160883509|NCT02677324|580968434|FG000|Overall Study|Disease Progression|6|||
160883510|NCT02677324|580968434|FG000|Overall Study|Inability to Swallow pills|1|||
160883511|NCT02677324|580968434|FG000|Overall Study|Non-compliance|1|||
160883512|NCT02677324|580968434|FG000|Overall Study|Lack of Efficacy|1|||
160883513|NCT02677324|580968434|FG000|Overall Study|Medical insurance coverage|1|||
160883514|NCT02677324|580968434|FG000|Overall Study|Adverse Event|1|||
160883515|NCT02677324|580968434|FG000|Overall Study|IgM Myeloma diagnosis|1|||
160883516|NCT01268579|580968435|FG000|Overall Study|Adverse Event|1|||
160883517|NCT01268579|580968435|FG000|Overall Study|Withdrawal by Subject|2|||
160883518|NCT03312751|580968436|FG000|Overall Study|Death|7|||
160883519|NCT03312751|580968437|FG001|Overall Study|Death|9|||
160883520|NCT03312751|580968436|FG000|Overall Study|Study discontinuation due to other reason|0|||
160883521|NCT03312751|580968437|FG001|Overall Study|Study discontinuation due to other reason|1|||
160883522|NCT05463198|580968438|FG000|Overall Study|Withdrawal by Subject|19|||
160883523|NCT05463198|580968438|FG000|Overall Study|Procedure Notes Missing|18|||
160883524|NCT02239120|580968441|FG000|Overall Study|Death|56|||
160883525|NCT02239120|580968442|FG001|Overall Study|Death|58|||
160883526|NCT02239120|580968441|FG000|Overall Study|Lost to Follow-up|19|||
160883527|NCT02239120|580968442|FG001|Overall Study|Lost to Follow-up|14|||
160883528|NCT00046891|580968448|FG000|Overall Study|Cancels|5|||
160883529|NCT00046891|580968449|FG001|Overall Study|Cancels|9|||
160883530|NCT00046891|580968448|FG000|Overall Study|Ineligible|1|||
160883531|NCT00046891|580968449|FG001|Overall Study|Ineligible|1|||
160883532|NCT00046891|580968448|FG000|Overall Study|Withdrawal by Subject|18|||
160883533|NCT00046891|580968449|FG001|Overall Study|Withdrawal by Subject|15|||
160883534|NCT00046891|580968448|FG000|Overall Study|Adverse Event|5|||
160883535|NCT00046891|580968449|FG001|Overall Study|Adverse Event|5|||
160883536|NCT00420641|580968452|FG000|Overall Study|Adverse Event|3|||
160883537|NCT00420641|580968453|FG001|Overall Study|Adverse Event|25|||
160883538|NCT00420641|580968454|FG002|Overall Study|Adverse Event|10|||
160883539|NCT00420641|580968452|FG000|Overall Study|Lost to Follow-up|2|||
160883540|NCT00420641|580968453|FG001|Overall Study|Lost to Follow-up|4|||
160883541|NCT00420641|580968454|FG002|Overall Study|Lost to Follow-up|2|||
160883542|NCT00420641|580968452|FG000|Overall Study|Protocol Violation|8|||
160883543|NCT00420641|580968453|FG001|Overall Study|Protocol Violation|8|||
160883544|NCT00420641|580968454|FG002|Overall Study|Protocol Violation|7|||
160883545|NCT00420641|580968452|FG000|Overall Study|Withdrawal by Subject|15|||
160883546|NCT00420641|580968453|FG001|Overall Study|Withdrawal by Subject|21|||
160883547|NCT00420641|580968454|FG002|Overall Study|Withdrawal by Subject|14|||
160883548|NCT00420641|580968452|FG000|Overall Study|Lack of Efficacy|6|||
160883549|NCT00420641|580968453|FG001|Overall Study|Lack of Efficacy|5|||
160883550|NCT00420641|580968454|FG002|Overall Study|Lack of Efficacy|4|||
160883551|NCT00420641|580968452|FG000|Overall Study|Non-compliance|7|||
160883552|NCT00420641|580968453|FG001|Overall Study|Non-compliance|5|||
160883553|NCT00420641|580968454|FG002|Overall Study|Non-compliance|4|||
160883554|NCT00420641|580968452|FG000|Overall Study|Other|4|||
160883555|NCT00420641|580968453|FG001|Overall Study|Other|4|||
160883556|NCT00420641|580968454|FG002|Overall Study|Other|3|||
160883557|NCT02815280|580968466|FG000|Double-Blind Phase|Adverse Event|1|||
160883558|NCT02815280|580968467|FG001|Double-Blind Phase|Adverse Event|1|||
160883559|NCT02815280|580968466|FG000|Double-Blind Phase|Lost to Follow-up|10|||
160883560|NCT02815280|580968467|FG001|Double-Blind Phase|Lost to Follow-up|9|||
160883561|NCT02815280|580968466|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
160883562|NCT02815280|580968467|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
160883563|NCT02815280|580968466|FG000|Double-Blind Phase|Protocol Violation|2|||
160883564|NCT02815280|580968467|FG001|Double-Blind Phase|Protocol Violation|2|||
161121891|NCT01789970|581833613|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
161121892|NCT01789970|581833611|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
161121893|NCT01789970|581833612|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
161121894|NCT01789970|581833613|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
160883565|NCT02815280|580968466|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
160883566|NCT02815280|580968467|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
160883567|NCT02815280|580968466|FG000|Open-Label Phase|Adverse Event|2|||
160883568|NCT02815280|580968467|FG001|Open-Label Phase|Adverse Event|3|||
160883569|NCT02815280|580968466|FG000|Open-Label Phase|Lost to Follow-up|18|||
160883570|NCT02815280|580968467|FG001|Open-Label Phase|Lost to Follow-up|9|||
160883571|NCT02815280|580968466|FG000|Open-Label Phase|Withdrawal by Subject|33|||
160883572|NCT02815280|580968467|FG001|Open-Label Phase|Withdrawal by Subject|18|||
160883573|NCT02815280|580968466|FG000|Open-Label Phase|Protocol Violation|3|||
160883574|NCT02815280|580968467|FG001|Open-Label Phase|Protocol Violation|0|||
160883575|NCT02815280|580968466|FG000|Open-Label Phase|Administrative|26|||
160883576|NCT02815280|580968467|FG001|Open-Label Phase|Administrative|12|||
160883577|NCT02815280|580968466|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
160883578|NCT02815280|580968467|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
160883579|NCT01944839|580968483|FG000|Overall Study|Physician Decision|2|||
160883580|NCT01944839|580968484|FG001|Overall Study|Physician Decision|2|||
160883581|NCT01944839|580968483|FG000|Overall Study|Protocol Violation|0|||
160883582|NCT01944839|580968484|FG001|Overall Study|Protocol Violation|1|||
160883583|NCT01944839|580968483|FG000|Overall Study|Adverse Event|10|||
160883584|NCT01944839|580968484|FG001|Overall Study|Adverse Event|5|||
160883585|NCT01944839|580968483|FG000|Overall Study|Withdrawal by Subject|9|||
160883586|NCT01944839|580968484|FG001|Overall Study|Withdrawal by Subject|17|||
160883587|NCT01944839|580968483|FG000|Overall Study|Lost to Follow-up|1|||
160883588|NCT01944839|580968484|FG001|Overall Study|Lost to Follow-up|0|||
160883589|NCT01944839|580968483|FG000|Overall Study|Subject non-compliance|0|||
160883590|NCT01944839|580968484|FG001|Overall Study|Subject non-compliance|3|||
160883591|NCT00609362|580968485|FG000|Overall Study|Withdrawal by Subject|2|||
160883592|NCT00609362|580968486|FG001|Overall Study|Withdrawal by Subject|1|||
160883593|NCT00609362|580968485|FG000|Overall Study|Adverse Event|1|||
160883594|NCT00609362|580968486|FG001|Overall Study|Adverse Event|0|||
160883595|NCT05093790|580968487|FG000|Overall Study|Failure to meet continuation criteria|0|||
160883596|NCT05093790|580968488|FG001|Overall Study|Failure to meet continuation criteria|0|||
160883597|NCT05093790|580968489|FG002|Overall Study|Failure to meet continuation criteria|1|||
160883598|NCT05093790|580968490|FG003|Overall Study|Failure to meet continuation criteria|0|||
160883599|NCT05093790|580968487|FG000|Overall Study|Adverse Event|1|||
160883600|NCT05093790|580968488|FG001|Overall Study|Adverse Event|0|||
160883601|NCT05093790|580968489|FG002|Overall Study|Adverse Event|0|||
160883602|NCT05093790|580968490|FG003|Overall Study|Adverse Event|0|||
160883603|NCT02582684|580968491|FG000|Overall Study|Unable to contact subject/parent|4|||
160883604|NCT02582684|580968491|FG000|Overall Study|Subject not able to get to clinic|10|||
160883605|NCT02582684|580968491|FG000|Overall Study|Subject withdrew consent|1|||
160883606|NCT02582684|580968491|FG000|Overall Study|Found to be ineligible after enrollment|2|||
160883607|NCT01587898|580968499|FG000|Overall Study|Adverse Event|1|||
160883608|NCT01587898|580968500|FG001|Overall Study|Adverse Event|1|||
160883609|NCT01587898|580968501|FG002|Overall Study|Adverse Event|0|||
160883610|NCT01587898|580968502|FG003|Overall Study|Adverse Event|0|||
160883611|NCT01587898|580968499|FG000|Overall Study|Protocol Violation|0|||
160883612|NCT01587898|580968500|FG001|Overall Study|Protocol Violation|2|||
160883613|NCT01587898|580968501|FG002|Overall Study|Protocol Violation|1|||
160883614|NCT01587898|580968502|FG003|Overall Study|Protocol Violation|1|||
160883615|NCT01587898|580968499|FG000|Overall Study|Lost to Follow-up|0|||
160883616|NCT01587898|580968500|FG001|Overall Study|Lost to Follow-up|0|||
160883617|NCT01587898|580968501|FG002|Overall Study|Lost to Follow-up|0|||
160883618|NCT01587898|580968502|FG003|Overall Study|Lost to Follow-up|1|||
160883619|NCT01587898|580968499|FG000|Overall Study|Withdrawal by Subject|2|||
160883620|NCT01587898|580968500|FG001|Overall Study|Withdrawal by Subject|1|||
160883621|NCT01587898|580968501|FG002|Overall Study|Withdrawal by Subject|0|||
160883622|NCT01587898|580968502|FG003|Overall Study|Withdrawal by Subject|0|||
160883623|NCT01587898|580968499|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
160883624|NCT01587898|580968500|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
160883625|NCT01587898|580968501|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
160883626|NCT01587898|580968502|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
160883627|NCT02720094|580968503|FG000|Overall Study|Ongoing|2210|||
160883628|NCT02720094|580968504|FG001|Overall Study|Ongoing|2203|||
160883629|NCT02720094|580968503|FG000|Overall Study|Scheduled exit visit/end of study|2|||
160883630|NCT02720094|580968504|FG001|Overall Study|Scheduled exit visit/end of study|1|||
160883631|NCT02720094|580968503|FG000|Overall Study|Death|4|||
160883632|NCT02720094|580968504|FG001|Overall Study|Death|7|||
160883633|NCT02720094|580968503|FG000|Overall Study|Withdrawal by Subject|55|||
160883634|NCT02720094|580968504|FG001|Overall Study|Withdrawal by Subject|56|||
160883635|NCT02720094|580968503|FG000|Overall Study|Lost to Follow-up|2|||
160883636|NCT02720094|580968504|FG001|Overall Study|Lost to Follow-up|7|||
160883637|NCT02720094|580968503|FG000|Overall Study|Physician Decision|1|||
161121895|NCT01789970|581833611|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
160883638|NCT02720094|580968504|FG001|Overall Study|Physician Decision|3|||
160883639|NCT02720094|580968503|FG000|Overall Study|Inappropriate enrollment|1|||
160883640|NCT02720094|580968504|FG001|Overall Study|Inappropriate enrollment|3|||
160883641|NCT02720094|580968503|FG000|Overall Study|Relocation|1|||
160883642|NCT02720094|580968504|FG001|Overall Study|Relocation|1|||
160883643|NCT02437110|580968507|FG000|Screening|Lost to Follow-up|3|||
160883644|NCT02437110|580968507|FG000|Screening|Physician Decision|1|||
160883645|NCT02437110|580968507|FG000|ART|Adverse Event|3|||
160883646|NCT02437110|580968507|FG000|ART|Protocol Violation|3|||
160883647|NCT02437110|580968507|FG000|ART|Withdrawal by Subject|4|||
160883648|NCT02437110|580968507|FG000|ART|Lost to follow-up prior to start of intervention|1|||
160883649|NCT02437110|580968507|FG000|ART|Physician decision prior to start of intervention|2|||
160883650|NCT02437110|580968507|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
160883651|NCT02437110|580968507|FG000|Post-ART|Lost to Follow-up|3|||
160883652|NCT02437110|580968507|FG000|Post-ART|Protocol Violation|4|||
160883653|NCT02437110|580968507|FG000|Post-ART|Withdrawal by Subject|3|||
160883654|NCT03735238|580968508|FG000|Overall Study|Did not want to participate in research|3|||
160883655|NCT03735238|580968508|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
160883656|NCT01261780|580968509|FG000|Overall Study|Withdrawal by Subject|1|||
160883657|NCT01261780|580968510|FG001|Overall Study|Withdrawal by Subject|0|||
160883658|NCT01261780|580968509|FG000|Overall Study|Event not related to subject|1|||
160883659|NCT01261780|580968510|FG001|Overall Study|Event not related to subject|2|||
160883660|NCT01239732|580968511|FG000|Overall Study|Termination of study per protocol|667|||
160883661|NCT01239732|580968511|FG000|Overall Study|Death|226|||
160883662|NCT01239732|580968511|FG000|Overall Study|Withdrawal by Subject|87|||
160883663|NCT01239732|580968511|FG000|Overall Study|Adverse Event|6|||
160883664|NCT01239732|580968511|FG000|Overall Study|Protocol Violation|3|||
160883665|NCT01239732|580968511|FG000|Overall Study|Participant non compliance|5|||
160883666|NCT01239732|580968511|FG000|Overall Study|Study termination by sponsor|2|||
160883667|NCT01239732|580968511|FG000|Overall Study|Investigator's decision|4|||
160883668|NCT01239732|580968511|FG000|Overall Study|Treatment failure|2|||
160883669|NCT01239732|580968511|FG000|Overall Study|Other|19|||
160883670|NCT02395302|580968512|FG000|Overall Study|Screen Failure|3|||
160883671|NCT02395302|580968512|FG000|Overall Study|Run In Failure|7|||
160883672|NCT02395302|580968512|FG000|Overall Study|Withdrawal by Subject|2|||
160883673|NCT02395302|580968512|FG000|Overall Study|Physician Decision|2|||
160883674|NCT03041129|580968518|FG000|Overall Study|Withdrawal by Subject|2|||
160883675|NCT03041129|580968519|FG001|Overall Study|Withdrawal by Subject|0|||
160883676|NCT03041129|580968520|FG002|Overall Study|Withdrawal by Subject|0|||
160883677|NCT03041129|580968521|FG003|Overall Study|Withdrawal by Subject|0|||
160883678|NCT00436501|580968524|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
160883679|NCT00436501|580968525|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
160883680|NCT00436501|580968524|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
160883681|NCT00436501|580968525|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
160883682|NCT00169442|580968537|FG000|Overall Study|Withdrawal by Subject|0|||
160883683|NCT00169442|580968538|FG001|Overall Study|Withdrawal by Subject|0|||
160883684|NCT00169442|580968539|FG002|Overall Study|Withdrawal by Subject|1|||
160883685|NCT00169442|580968540|FG003|Overall Study|Withdrawal by Subject|0|||
160883686|NCT00169442|580968541|FG004|Overall Study|Withdrawal by Subject|0|||
160883687|NCT00169442|580968542|FG005|Overall Study|Withdrawal by Subject|0|||
160883688|NCT00169442|580968537|FG000|Overall Study|Migrated/moved from study area|0|||
160883689|NCT00169442|580968538|FG001|Overall Study|Migrated/moved from study area|0|||
160883690|NCT00169442|580968539|FG002|Overall Study|Migrated/moved from study area|0|||
160883691|NCT00169442|580968540|FG003|Overall Study|Migrated/moved from study area|0|||
160883692|NCT00169442|580968541|FG004|Overall Study|Migrated/moved from study area|0|||
160883693|NCT00169442|580968542|FG005|Overall Study|Migrated/moved from study area|2|||
160883694|NCT00169442|580968537|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883695|NCT00169442|580968538|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883696|NCT00169442|580968539|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883697|NCT00169442|580968540|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883698|NCT00169442|580968541|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
160883699|NCT00169442|580968542|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
160883700|NCT00169442|580968537|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883701|NCT00169442|580968538|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
160883702|NCT00169442|580968539|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883703|NCT00169442|580968540|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883704|NCT00169442|580968541|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883705|NCT00169442|580968542|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
160883706|NCT01159431|580968543|FG000|Overall Study|Adverse Event|1|||
160883707|NCT01159431|580968544|FG001|Overall Study|Adverse Event|2|||
161121896|NCT01789970|581833612|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
160883708|NCT01159431|580968543|FG000|Overall Study|non-compliance|1|||
160883709|NCT01159431|580968544|FG001|Overall Study|non-compliance|1|||
160883710|NCT01159431|580968543|FG000|Overall Study|Lack of Efficacy|0|||
160883711|NCT01159431|580968544|FG001|Overall Study|Lack of Efficacy|3|||
160883712|NCT03353740|580968547|FG000|Overall Study|Images for these participants not viable|52|||
160883713|NCT03976648|580968550|FG000|Overall Study|Adverse Event|0|||
160883714|NCT03976648|580968551|FG001|Overall Study|Adverse Event|2|||
160883715|NCT03976648|580968550|FG000|Overall Study|Study terminated by sponsor|21|||
160883716|NCT03976648|580968551|FG001|Overall Study|Study terminated by sponsor|8|||
160883717|NCT03645434|580968552|FG000|Period 1|Adverse Event|0|||
160883718|NCT03645434|580968553|FG001|Period 1|Adverse Event|0|||
160883719|NCT03645434|580968554|FG002|Period 1|Adverse Event|0|||
160883720|NCT03645434|580968555|FG003|Period 1|Adverse Event|1|||
160883721|NCT03645434|580968556|FG004|Period 1|Adverse Event|0|||
160883722|NCT03645434|580968557|FG005|Period 1|Adverse Event|0|||
160883723|NCT03645434|580968552|FG000|Period 1|COPD exacerbation|0|||
160883724|NCT03645434|580968553|FG001|Period 1|COPD exacerbation|0|||
160883725|NCT03645434|580968554|FG002|Period 1|COPD exacerbation|0|||
160883726|NCT03645434|580968555|FG003|Period 1|COPD exacerbation|0|||
160883727|NCT03645434|580968556|FG004|Period 1|COPD exacerbation|1|||
160883728|NCT03645434|580968557|FG005|Period 1|COPD exacerbation|0|||
160883729|NCT00881868|580968558|FG000|Overall Study|Adverse Event|0|||
160883730|NCT00881868|580968559|FG001|Overall Study|Adverse Event|1|||
160883731|NCT00881868|580968558|FG000|Overall Study|Lost to Follow-up|2|||
160883732|NCT00881868|580968559|FG001|Overall Study|Lost to Follow-up|1|||
160883733|NCT00881868|580968558|FG000|Overall Study|Physician Decision|4|||
160883734|NCT00881868|580968559|FG001|Overall Study|Physician Decision|0|||
160883735|NCT00881868|580968558|FG000|Overall Study|Protocol Violation|2|||
160883736|NCT00881868|580968559|FG001|Overall Study|Protocol Violation|0|||
160883737|NCT02880956|580968562|FG000|Overall Study|Adverse Event|3|||
160883738|NCT02880956|580968563|FG001|Overall Study|Adverse Event|6|||
160883739|NCT02880956|580968564|FG002|Overall Study|Adverse Event|5|||
160883740|NCT02880956|580968565|FG003|Overall Study|Adverse Event|4|||
160883741|NCT02880956|580968562|FG000|Overall Study|Withdrawal by Subject|9|||
160883742|NCT02880956|580968563|FG001|Overall Study|Withdrawal by Subject|4|||
160883743|NCT02880956|580968564|FG002|Overall Study|Withdrawal by Subject|6|||
160883744|NCT02880956|580968565|FG003|Overall Study|Withdrawal by Subject|11|||
160883745|NCT02880956|580968562|FG000|Overall Study|Lost to Follow-up|0|||
160883746|NCT02880956|580968563|FG001|Overall Study|Lost to Follow-up|1|||
160883747|NCT02880956|580968564|FG002|Overall Study|Lost to Follow-up|0|||
160883748|NCT02880956|580968565|FG003|Overall Study|Lost to Follow-up|0|||
160883749|NCT02880956|580968562|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
160883750|NCT02880956|580968563|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
160883751|NCT02880956|580968564|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
160883752|NCT02880956|580968565|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
160883753|NCT02880956|580968562|FG000|Overall Study|Other, Not Specified|4|||
160883754|NCT02880956|580968563|FG001|Overall Study|Other, Not Specified|2|||
160883755|NCT02880956|580968564|FG002|Overall Study|Other, Not Specified|0|||
160883756|NCT02880956|580968565|FG003|Overall Study|Other, Not Specified|3|||
160883757|NCT02081859|580968566|FG000|Overall Study|No fertilization|2|||
160883758|NCT02081859|580968567|FG001|Overall Study|No fertilization|2|||
160883759|NCT02081859|580968566|FG000|Overall Study|No sperm|1|||
160883760|NCT02081859|580968567|FG001|Overall Study|No sperm|0|||
160883761|NCT02081859|580968566|FG000|Overall Study|Unanticipated freeze all cycle|2|||
160883762|NCT02081859|580968567|FG001|Overall Study|Unanticipated freeze all cycle|6|||
160883763|NCT02081859|580968566|FG000|Overall Study|< 4 embryos|27|||
160883764|NCT02081859|580968567|FG001|Overall Study|< 4 embryos|23|||
160883765|NCT02081859|580968566|FG000|Overall Study|Other reasons|2|||
160883766|NCT02081859|580968567|FG001|Overall Study|Other reasons|0|||
160883767|NCT00282464|580970362|FG000|Overall Study|Adverse Event|26|||
160883768|NCT00282464|580970363|FG001|Overall Study|Adverse Event|20|||
160883769|NCT00282464|580970362|FG000|Overall Study|Lack of Efficacy|8|||
160883770|NCT00282464|580970363|FG001|Overall Study|Lack of Efficacy|8|||
160883771|NCT00282464|580970362|FG000|Overall Study|Lost to Follow-up|10|||
160883772|NCT00282464|580970363|FG001|Overall Study|Lost to Follow-up|10|||
160883773|NCT00282464|580970362|FG000|Overall Study|Withdrawal by Subject|24|||
160883774|NCT00282464|580970363|FG001|Overall Study|Withdrawal by Subject|10|||
160883775|NCT00282464|580970362|FG000|Overall Study|laboratory abnormality|1|||
160883776|NCT00282464|580970363|FG001|Overall Study|laboratory abnormality|2|||
160883777|NCT00282464|580970362|FG000|Overall Study|Protocol Violation|0|||
160883778|NCT00282464|580970363|FG001|Overall Study|Protocol Violation|7|||
160883779|NCT00282464|580970362|FG000|Overall Study|Patient moved|1|||
160883780|NCT00282464|580970363|FG001|Overall Study|Patient moved|0|||
160883781|NCT00282464|580970362|FG000|Overall Study|patient non-compliant|3|||
160883782|NCT00282464|580970363|FG001|Overall Study|patient non-compliant|0|||
160883783|NCT00282464|580970362|FG000|Overall Study|patient no show|0|||
160883784|NCT00282464|580970363|FG001|Overall Study|patient no show|1|||
160883785|NCT00282464|580970362|FG000|Overall Study|patient incarcerated|0|||
160883786|NCT00282464|580970363|FG001|Overall Study|patient incarcerated|1|||
160883787|NCT00282464|580970362|FG000|Overall Study|family crisis|0|||
160883788|NCT00282464|580970363|FG001|Overall Study|family crisis|1|||
160883789|NCT00282464|580970362|FG000|Overall Study|dispensed wrong kit|0|||
160883790|NCT00282464|580970363|FG001|Overall Study|dispensed wrong kit|1|||
160883791|NCT00282464|580970362|FG000|Overall Study|dropped due to missed visits|0|||
160883792|NCT00282464|580970363|FG001|Overall Study|dropped due to missed visits|1|||
160883793|NCT00475423|580970364|FG000|Overall Study|Protocol Violation|5|||
160883794|NCT00475423|580970364|FG000|Overall Study|Adverse Event|4|||
160883795|NCT00475423|580970364|FG000|Overall Study|Withdrawal by Subject|6|||
160883796|NCT00475423|580970364|FG000|Overall Study|Lack of Efficacy|8|||
160883797|NCT00475423|580970364|FG000|Overall Study|Death|1|||
160883798|NCT00475423|580970364|FG000|Overall Study|Reason not specified|1|||
160883799|NCT00475423|580970364|FG000|Overall Study|Lost to Follow-up|7|||
160883800|NCT01214174|580970365|FG000|Overall Study|Withdrawal by Subject|0|||
160883801|NCT01214174|580970366|FG001|Overall Study|Withdrawal by Subject|0|||
160883802|NCT01214174|580970367|FG002|Overall Study|Withdrawal by Subject|1|||
160883803|NCT00548405|580970368|FG000|Overall Study|Adverse Event|6|||
160883804|NCT00548405|580970369|FG001|Overall Study|Adverse Event|2|||
160883805|NCT00548405|580970370|FG002|Overall Study|Adverse Event|0|||
160883806|NCT00548405|580970368|FG000|Overall Study|Lack of Efficacy|6|||
160883807|NCT00548405|580970369|FG001|Overall Study|Lack of Efficacy|0|||
160883808|NCT00548405|580970370|FG002|Overall Study|Lack of Efficacy|0|||
160883809|NCT00548405|580970368|FG000|Overall Study|Physician Decision|3|||
160883810|NCT00548405|580970369|FG001|Overall Study|Physician Decision|4|||
160883811|NCT00548405|580970370|FG002|Overall Study|Physician Decision|1|||
160883812|NCT00548405|580970368|FG000|Overall Study|Pregnancy|1|||
160883813|NCT00548405|580970369|FG001|Overall Study|Pregnancy|0|||
160883814|NCT00548405|580970370|FG002|Overall Study|Pregnancy|0|||
160883815|NCT00548405|580970368|FG000|Overall Study|Protocol Violation|1|||
160883816|NCT00548405|580970369|FG001|Overall Study|Protocol Violation|0|||
160883817|NCT00548405|580970370|FG002|Overall Study|Protocol Violation|0|||
160883818|NCT00548405|580970368|FG000|Overall Study|Withdrawal by Subject|36|||
160883819|NCT00548405|580970369|FG001|Overall Study|Withdrawal by Subject|12|||
160883820|NCT00548405|580970370|FG002|Overall Study|Withdrawal by Subject|5|||
160883821|NCT00548405|580970368|FG000|Overall Study|Lost to Follow-up|1|||
160883822|NCT00548405|580970369|FG001|Overall Study|Lost to Follow-up|1|||
160883823|NCT00548405|580970370|FG002|Overall Study|Lost to Follow-up|2|||
160883824|NCT00548405|580970368|FG000|Overall Study|Death|0|||
160883825|NCT00548405|580970369|FG001|Overall Study|Death|1|||
160883826|NCT00548405|580970370|FG002|Overall Study|Death|1|||
160883827|NCT00548405|580970368|FG000|Overall Study|Sponsor decision|1|||
160883828|NCT00548405|580970369|FG001|Overall Study|Sponsor decision|0|||
160883829|NCT00548405|580970370|FG002|Overall Study|Sponsor decision|0|||
160883830|NCT00548405|580970368|FG000|Overall Study|Randomized but not treated|1|||
160883831|NCT00548405|580970369|FG001|Overall Study|Randomized but not treated|0|||
160883832|NCT00548405|580970370|FG002|Overall Study|Randomized but not treated|0|||
160883833|NCT01624870|580970371|FG000|Overall Study|Death|19|||
160883834|NCT01624870|580970371|FG000|Overall Study|Withdrawal by Subject|1|||
160883835|NCT01624870|580970371|FG000|Overall Study|CoreValve not implanted|6|||
160883836|NCT01624870|580970371|FG000|Overall Study|Lost to follow up|1|||
160883837|NCT01381562|580970374|FG000|Overall Study|Adverse Event|0|||
160883838|NCT01381562|580970375|FG001|Overall Study|Adverse Event|1|||
160883839|NCT01381562|580970376|FG002|Overall Study|Adverse Event|0|||
160883840|NCT02660138|580970378|FG000|Overall Study|Adverse Event|0|||
160883841|NCT02660138|580970379|FG001|Overall Study|Adverse Event|3|||
160883842|NCT02660138|580970380|FG002|Overall Study|Adverse Event|2|||
160883843|NCT02660138|580970378|FG000|Overall Study|Lack of Efficacy|1|||
160883844|NCT02660138|580970379|FG001|Overall Study|Lack of Efficacy|2|||
160883845|NCT02660138|580970380|FG002|Overall Study|Lack of Efficacy|1|||
160883846|NCT02660138|580970378|FG000|Overall Study|Withdrawal by Subject|7|||
160883847|NCT02660138|580970379|FG001|Overall Study|Withdrawal by Subject|6|||
160883848|NCT02660138|580970380|FG002|Overall Study|Withdrawal by Subject|6|||
160883849|NCT02660138|580970378|FG000|Overall Study|Lost to Follow-up|4|||
160883850|NCT02660138|580970379|FG001|Overall Study|Lost to Follow-up|4|||
160883851|NCT02660138|580970380|FG002|Overall Study|Lost to Follow-up|1|||
160883852|NCT02660138|580970378|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
161121897|NCT01789970|581833613|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
160883853|NCT02660138|580970379|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
160883854|NCT02660138|580970380|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
160883855|NCT02660138|580970378|FG000|Overall Study|Other|1|||
160883856|NCT02660138|580970379|FG001|Overall Study|Other|1|||
160883857|NCT02660138|580970380|FG002|Overall Study|Other|0|||
160883858|NCT02660138|580970378|FG000|Overall Study|Not treated|0|||
160883859|NCT02660138|580970379|FG001|Overall Study|Not treated|1|||
160883860|NCT02660138|580970380|FG002|Overall Study|Not treated|0|||
160883861|NCT00308581|580970381|FG000|Induction Phase|Adverse Event|0|||
160883862|NCT00308581|580970382|FG001|Induction Phase|Adverse Event|0|||
160883863|NCT00308581|580970383|FG002|Induction Phase|Adverse Event|37|||
160883864|NCT00308581|580970381|FG000|Induction Phase|Lack of Efficacy|0|||
160883865|NCT00308581|580970382|FG001|Induction Phase|Lack of Efficacy|0|||
160883866|NCT00308581|580970383|FG002|Induction Phase|Lack of Efficacy|121|||
160883867|NCT00308581|580970381|FG000|Induction Phase|Withdrawal by Subject|0|||
161121898|NCT01789970|581833611|FG000|Open-label Titration Period|Pregnancy|2|||
160883868|NCT00308581|580970382|FG001|Induction Phase|Withdrawal by Subject|0|||
160883869|NCT00308581|580970383|FG002|Induction Phase|Withdrawal by Subject|5|||
160883870|NCT00308581|580970381|FG000|Induction Phase|Unknown reason|0|||
160883871|NCT00308581|580970382|FG001|Induction Phase|Unknown reason|0|||
160883872|NCT00308581|580970383|FG002|Induction Phase|Unknown reason|3|||
160883873|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Adverse Event|10|||
160883874|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Adverse Event|17|||
160883875|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Adverse Event|0|||
160883876|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
160883877|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
160883878|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
160883879|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
160883880|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
160883881|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
160883882|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
160883883|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
160883884|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
160883885|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
160883886|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
160883887|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
160883888|NCT00308581|580970381|FG000|Randomized Maintenance Phase|Unknown reason|3|||
160883889|NCT00308581|580970382|FG001|Randomized Maintenance Phase|Unknown reason|0|||
160883890|NCT00308581|580970383|FG002|Randomized Maintenance Phase|Unknown reason|0|||
160883891|NCT00899353|580970386|FG000|Overall Study|Adverse Event|2|||
160883892|NCT00899353|580970386|FG000|Overall Study|Lost to Follow-up|1|||
160883893|NCT00899353|580970386|FG000|Overall Study|Withdrawal by Subject|2|||
160883894|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
160883895|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
160883896|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
160883897|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
160883898|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
160883899|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
160883900|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
160883901|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
160883902|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
160883903|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
160883904|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
160883905|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
160883906|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
160883907|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
160883908|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
160883909|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
160883910|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
160883911|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
160883912|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
160883913|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
160883914|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
160883915|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
160883916|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
160883917|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
160883918|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
160883919|NCT00095147|580970392|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
160883920|NCT00095147|580970393|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
160883921|NCT00095147|580970394|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
160883922|NCT00095147|580970395|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
160883923|NCT00095147|580970396|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
160883924|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
160883925|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
160883926|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
160883927|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
160883928|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
160883929|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
160883930|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
160883931|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
160883932|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
160883933|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
160883934|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
160883935|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
161227709|NCT00920140|582215181|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
160883936|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
160883937|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
160883938|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
160883939|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
160883940|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
160883941|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
160883942|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
160883943|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
160883944|NCT00095147|580970392|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
160883945|NCT00095147|580970393|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
160883946|NCT00095147|580970394|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
160883947|NCT00095147|580970395|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
160883948|NCT00095147|580970396|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
160883949|NCT00095147|580970392|FG000|Long-term Extension Period|Death|0|||
160883950|NCT00095147|580970393|FG001|Long-term Extension Period|Death|0|||
160883951|NCT00095147|580970394|FG002|Long-term Extension Period|Death|0|||
160883952|NCT00095147|580970395|FG003|Long-term Extension Period|Death|0|||
160883953|NCT00095147|580970396|FG004|Long-term Extension Period|Death|3|||
160883954|NCT00095147|580970392|FG000|Long-term Extension Period|Adverse Event|0|||
160883955|NCT00095147|580970393|FG001|Long-term Extension Period|Adverse Event|0|||
160883956|NCT00095147|580970394|FG002|Long-term Extension Period|Adverse Event|0|||
160883957|NCT00095147|580970395|FG003|Long-term Extension Period|Adverse Event|0|||
160883958|NCT00095147|580970396|FG004|Long-term Extension Period|Adverse Event|11|||
160883959|NCT00095147|580970392|FG000|Long-term Extension Period|Lack of Efficacy|0|||
160883960|NCT00095147|580970393|FG001|Long-term Extension Period|Lack of Efficacy|0|||
160883961|NCT00095147|580970394|FG002|Long-term Extension Period|Lack of Efficacy|0|||
160883962|NCT00095147|580970395|FG003|Long-term Extension Period|Lack of Efficacy|0|||
160883963|NCT00095147|580970396|FG004|Long-term Extension Period|Lack of Efficacy|9|||
160883964|NCT00095147|580970392|FG000|Long-term Extension Period|Lost to Follow-up|0|||
160883965|NCT00095147|580970393|FG001|Long-term Extension Period|Lost to Follow-up|0|||
160883966|NCT00095147|580970394|FG002|Long-term Extension Period|Lost to Follow-up|0|||
160883967|NCT00095147|580970395|FG003|Long-term Extension Period|Lost to Follow-up|0|||
160883968|NCT00095147|580970396|FG004|Long-term Extension Period|Lost to Follow-up|6|||
160883969|NCT00095147|580970392|FG000|Long-term Extension Period|Withdrawal of consent|0|||
160883970|NCT00095147|580970393|FG001|Long-term Extension Period|Withdrawal of consent|0|||
160883971|NCT00095147|580970394|FG002|Long-term Extension Period|Withdrawal of consent|0|||
160883972|NCT00095147|580970395|FG003|Long-term Extension Period|Withdrawal of consent|0|||
160883973|NCT00095147|580970396|FG004|Long-term Extension Period|Withdrawal of consent|12|||
160883974|NCT00095147|580970392|FG000|Long-term Extension Period|Pregnancy|0|||
160883975|NCT00095147|580970393|FG001|Long-term Extension Period|Pregnancy|0|||
160883976|NCT00095147|580970394|FG002|Long-term Extension Period|Pregnancy|0|||
160883977|NCT00095147|580970395|FG003|Long-term Extension Period|Pregnancy|0|||
160883978|NCT00095147|580970396|FG004|Long-term Extension Period|Pregnancy|1|||
160883979|NCT00095147|580970392|FG000|Long-term Extension Period|No longer meets study criteria|0|||
160883980|NCT00095147|580970393|FG001|Long-term Extension Period|No longer meets study criteria|0|||
160883981|NCT00095147|580970394|FG002|Long-term Extension Period|No longer meets study criteria|0|||
160883982|NCT00095147|580970395|FG003|Long-term Extension Period|No longer meets study criteria|0|||
160883983|NCT00095147|580970396|FG004|Long-term Extension Period|No longer meets study criteria|1|||
160883984|NCT00095147|580970392|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
160883985|NCT00095147|580970393|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
160883986|NCT00095147|580970394|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
160883987|NCT00095147|580970395|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
160883988|NCT00095147|580970396|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
160883989|NCT00095147|580970392|FG000|Long-term Extension Period|Leaving country|0|||
160883990|NCT00095147|580970393|FG001|Long-term Extension Period|Leaving country|0|||
160883991|NCT00095147|580970394|FG002|Long-term Extension Period|Leaving country|0|||
160883992|NCT00095147|580970395|FG003|Long-term Extension Period|Leaving country|0|||
160883993|NCT00095147|580970396|FG004|Long-term Extension Period|Leaving country|1|||
160883994|NCT04604132|580970397|FG000|Overall Study|Adverse Event|2|||
161227710|NCT00920140|582215182|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
160883995|NCT04604132|580970398|FG001|Overall Study|Adverse Event|0|||
160883996|NCT04604132|580970399|FG002|Overall Study|Adverse Event|0|||
160883997|NCT04604132|580970400|FG003|Overall Study|Adverse Event|1|||
160883998|NCT04604132|580970401|FG004|Overall Study|Adverse Event|2|||
160883999|NCT04604132|580970397|FG000|Overall Study|Study terminated by sponsor|0|||
160884000|NCT04604132|580970398|FG001|Overall Study|Study terminated by sponsor|0|||
160884001|NCT04604132|580970399|FG002|Overall Study|Study terminated by sponsor|0|||
160884002|NCT04604132|580970400|FG003|Overall Study|Study terminated by sponsor|0|||
161227711|NCT00920140|582215183|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
161227712|NCT00920140|582215184|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
160884003|NCT04604132|580970401|FG004|Overall Study|Study terminated by sponsor|1|||
160884004|NCT04604132|580970397|FG000|Overall Study|Progressive disease: Clinical progression|0|||
160884005|NCT04604132|580970398|FG001|Overall Study|Progressive disease: Clinical progression|0|||
160884006|NCT04604132|580970399|FG002|Overall Study|Progressive disease: Clinical progression|1|||
160884007|NCT04604132|580970400|FG003|Overall Study|Progressive disease: Clinical progression|0|||
160884008|NCT04604132|580970401|FG004|Overall Study|Progressive disease: Clinical progression|0|||
160884009|NCT04604132|580970397|FG000|Overall Study|Progressive disease: Radiological progression|8|||
160884010|NCT04604132|580970398|FG001|Overall Study|Progressive disease: Radiological progression|7|||
160884011|NCT04604132|580970399|FG002|Overall Study|Progressive disease: Radiological progression|10|||
160884012|NCT04604132|580970400|FG003|Overall Study|Progressive disease: Radiological progression|4|||
160884013|NCT04604132|580970401|FG004|Overall Study|Progressive disease: Radiological progression|3|||
160884014|NCT04604132|580970397|FG000|Overall Study|Death|3|||
160884015|NCT04604132|580970398|FG001|Overall Study|Death|1|||
160884016|NCT04604132|580970399|FG002|Overall Study|Death|2|||
160884017|NCT04604132|580970400|FG003|Overall Study|Death|1|||
161121899|NCT01789970|581833612|FG001|Open-label Titration Period|Pregnancy|0|||
160884018|NCT04604132|580970401|FG004|Overall Study|Death|0|||
160884019|NCT00952380|580970402|FG000|Overall Study|Other|0|||
160884020|NCT00952380|580970403|FG001|Overall Study|Other|0|||
160884021|NCT00952380|580970404|FG002|Overall Study|Other|0|||
160884022|NCT00952380|580970405|FG003|Overall Study|Other|0|||
160884023|NCT00952380|580970406|FG004|Overall Study|Other|1|||
160884024|NCT00952380|580970402|FG000|Overall Study|Withdrawal by Subject|0|||
160884025|NCT00952380|580970403|FG001|Overall Study|Withdrawal by Subject|0|||
160884026|NCT00952380|580970404|FG002|Overall Study|Withdrawal by Subject|1|||
160884027|NCT00952380|580970405|FG003|Overall Study|Withdrawal by Subject|0|||
160884028|NCT00952380|580970406|FG004|Overall Study|Withdrawal by Subject|2|||
160884029|NCT00952380|580970402|FG000|Overall Study|Adverse Event|0|||
160884030|NCT00952380|580970403|FG001|Overall Study|Adverse Event|1|||
160884031|NCT00952380|580970404|FG002|Overall Study|Adverse Event|0|||
160884032|NCT00952380|580970405|FG003|Overall Study|Adverse Event|0|||
160884033|NCT00952380|580970406|FG004|Overall Study|Adverse Event|3|||
160884034|NCT00952380|580970402|FG000|Overall Study|Physician Decision|0|||
160884035|NCT00952380|580970403|FG001|Overall Study|Physician Decision|0|||
160884036|NCT00952380|580970404|FG002|Overall Study|Physician Decision|1|||
160884037|NCT00952380|580970405|FG003|Overall Study|Physician Decision|2|||
160884038|NCT00952380|580970406|FG004|Overall Study|Physician Decision|0|||
160884039|NCT00952380|580970402|FG000|Overall Study|Non-compliant to protocol|0|||
160884040|NCT00952380|580970403|FG001|Overall Study|Non-compliant to protocol|0|||
160884041|NCT00952380|580970404|FG002|Overall Study|Non-compliant to protocol|0|||
160884042|NCT00952380|580970405|FG003|Overall Study|Non-compliant to protocol|1|||
160884043|NCT00952380|580970406|FG004|Overall Study|Non-compliant to protocol|0|||
160884044|NCT03400956|580970407|FG000|Treatment Period 1|Adverse Event|0|||
160884045|NCT03400956|580970408|FG001|Treatment Period 1|Adverse Event|1|||
160884046|NCT03400956|580970409|FG002|Treatment Period 1|Adverse Event|0|||
160884047|NCT03400956|580970407|FG000|Treatment Period 1|Lost to Follow-up|0|||
160884048|NCT03400956|580970408|FG001|Treatment Period 1|Lost to Follow-up|0|||
160884049|NCT03400956|580970409|FG002|Treatment Period 1|Lost to Follow-up|1|||
160884050|NCT03400956|580970407|FG000|Treatment Period 1|Protocol Violation|0|||
160884051|NCT03400956|580970408|FG001|Treatment Period 1|Protocol Violation|2|||
160884052|NCT03400956|580970409|FG002|Treatment Period 1|Protocol Violation|0|||
160884053|NCT03400956|580970407|FG000|Treatment Period 1|Study terminated by sponsor|3|||
160884054|NCT03400956|580970408|FG001|Treatment Period 1|Study terminated by sponsor|1|||
160884055|NCT03400956|580970409|FG002|Treatment Period 1|Study terminated by sponsor|1|||
160884056|NCT03400956|580970407|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160884057|NCT03400956|580970408|FG001|Treatment Period 1|Withdrawal by Subject|2|||
160884058|NCT03400956|580970409|FG002|Treatment Period 1|Withdrawal by Subject|4|||
160884059|NCT03400956|580970407|FG000|Treatment Period 1|Other|1|||
160884060|NCT03400956|580970408|FG001|Treatment Period 1|Other|2|||
160884061|NCT03400956|580970409|FG002|Treatment Period 1|Other|3|||
160884062|NCT03400956|580970407|FG000|Post-treatment Period 1|Adverse Event|0|||
160884063|NCT03400956|580970408|FG001|Post-treatment Period 1|Adverse Event|0|||
160884064|NCT03400956|580970409|FG002|Post-treatment Period 1|Adverse Event|1|||
160884065|NCT03400956|580970407|FG000|Post-treatment Period 1|Physician Decision|2|||
160884066|NCT03400956|580970408|FG001|Post-treatment Period 1|Physician Decision|3|||
160884067|NCT03400956|580970409|FG002|Post-treatment Period 1|Physician Decision|0|||
161121900|NCT01789970|581833613|FG002|Open-label Titration Period|Pregnancy|0|||
160884068|NCT03400956|580970407|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
160884069|NCT03400956|580970408|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
160884070|NCT03400956|580970409|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
160884071|NCT03400956|580970407|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
161121901|NCT01789970|581833611|FG000|Open-label Titration Period|Other|76|||
160884072|NCT03400956|580970408|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
160884073|NCT03400956|580970409|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
160884074|NCT03400956|580970407|FG000|Post-treatment Period 1|Other|4|||
160884075|NCT03400956|580970408|FG001|Post-treatment Period 1|Other|3|||
160884076|NCT03400956|580970409|FG002|Post-treatment Period 1|Other|4|||
160884077|NCT03400956|580970407|FG000|Treatment Period 2|Adverse Event|2|||
160884078|NCT03400956|580970408|FG001|Treatment Period 2|Adverse Event|1|||
160884079|NCT03400956|580970409|FG002|Treatment Period 2|Adverse Event|1|||
160884080|NCT03400956|580970407|FG000|Treatment Period 2|Lost to Follow-up|1|||
160884081|NCT03400956|580970408|FG001|Treatment Period 2|Lost to Follow-up|1|||
160884082|NCT03400956|580970409|FG002|Treatment Period 2|Lost to Follow-up|0|||
160884083|NCT03400956|580970407|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160884084|NCT03400956|580970408|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160884085|NCT03400956|580970409|FG002|Treatment Period 2|Withdrawal by Subject|3|||
160884086|NCT03400956|580970407|FG000|Treatment Period 2|Other|1|||
160884087|NCT03400956|580970408|FG001|Treatment Period 2|Other|1|||
160884088|NCT03400956|580970409|FG002|Treatment Period 2|Other|0|||
160884089|NCT03400956|580970407|FG000|Follow-up Period|Withdrawal by Subject|0|||
160884090|NCT03400956|580970408|FG001|Follow-up Period|Withdrawal by Subject|0|||
160884091|NCT03400956|580970409|FG002|Follow-up Period|Withdrawal by Subject|1|||
160884092|NCT03400956|580970407|FG000|Follow-up Period|Other|0|||
160884093|NCT03400956|580970408|FG001|Follow-up Period|Other|0|||
160884094|NCT03400956|580970409|FG002|Follow-up Period|Other|1|||
160884095|NCT02048241|580970411|FG000|Overall Study|Withdrawal by Subject|0|||
160884096|NCT02048241|580970412|FG001|Overall Study|Withdrawal by Subject|1|||
160884097|NCT00534313|580970413|FG000|Short-term Period|Adverse Event|1|||
160884098|NCT00534313|580970414|FG001|Short-term Period|Adverse Event|2|||
160884099|NCT00534313|580970415|FG002|Short-term Period|Adverse Event|1|||
160884100|NCT00534313|580970416|FG003|Short-term Period|Adverse Event|3|||
160884101|NCT00534313|580970413|FG000|Short-term Period|Lack of Efficacy|3|||
160884102|NCT00534313|580970414|FG001|Short-term Period|Lack of Efficacy|4|||
160884103|NCT00534313|580970415|FG002|Short-term Period|Lack of Efficacy|0|||
160884104|NCT00534313|580970416|FG003|Short-term Period|Lack of Efficacy|3|||
160884105|NCT00534313|580970413|FG000|Short-term Period|Participant not meeting study criteria|0|||
160884106|NCT00534313|580970414|FG001|Short-term Period|Participant not meeting study criteria|0|||
160884107|NCT00534313|580970415|FG002|Short-term Period|Participant not meeting study criteria|0|||
160884108|NCT00534313|580970416|FG003|Short-term Period|Participant not meeting study criteria|1|||
160884109|NCT00534313|580970413|FG000|Short-term Period|Participant withdrew consent|2|||
160884110|NCT00534313|580970414|FG001|Short-term Period|Participant withdrew consent|0|||
160884111|NCT00534313|580970415|FG002|Short-term Period|Participant withdrew consent|0|||
160884112|NCT00534313|580970416|FG003|Short-term Period|Participant withdrew consent|2|||
160884113|NCT00534313|580970413|FG000|Short-term Period|Pregnancy|0|||
160884114|NCT00534313|580970414|FG001|Short-term Period|Pregnancy|0|||
160884115|NCT00534313|580970415|FG002|Short-term Period|Pregnancy|1|||
160884116|NCT00534313|580970416|FG003|Short-term Period|Pregnancy|0|||
160884117|NCT00534313|580970413|FG000|Long-term Period|Adverse Event|2|||
160884118|NCT00534313|580970414|FG001|Long-term Period|Adverse Event|1|||
160884119|NCT00534313|580970415|FG002|Long-term Period|Adverse Event|0|||
160884120|NCT00534313|580970416|FG003|Long-term Period|Adverse Event|1|||
160884121|NCT00534313|580970413|FG000|Long-term Period|Lack of Efficacy|14|||
160884122|NCT00534313|580970414|FG001|Long-term Period|Lack of Efficacy|10|||
160884123|NCT00534313|580970415|FG002|Long-term Period|Lack of Efficacy|14|||
160884124|NCT00534313|580970416|FG003|Long-term Period|Lack of Efficacy|12|||
160884125|NCT00534313|580970413|FG000|Long-term Period|Lost to Follow-up|1|||
160884126|NCT00534313|580970414|FG001|Long-term Period|Lost to Follow-up|2|||
160884127|NCT00534313|580970415|FG002|Long-term Period|Lost to Follow-up|0|||
160884128|NCT00534313|580970416|FG003|Long-term Period|Lost to Follow-up|0|||
160884129|NCT00534313|580970413|FG000|Long-term Period|Withdrawal by Subject|2|||
160884130|NCT00534313|580970414|FG001|Long-term Period|Withdrawal by Subject|2|||
160884131|NCT00534313|580970415|FG002|Long-term Period|Withdrawal by Subject|0|||
160884132|NCT00534313|580970416|FG003|Long-term Period|Withdrawal by Subject|0|||
160884133|NCT00534313|580970413|FG000|Long-term Period|No longer meets study criteria|0|||
160884134|NCT00534313|580970414|FG001|Long-term Period|No longer meets study criteria|1|||
160884135|NCT00534313|580970415|FG002|Long-term Period|No longer meets study criteria|0|||
160884136|NCT00534313|580970416|FG003|Long-term Period|No longer meets study criteria|0|||
160884137|NCT00534313|580970413|FG000|Long-term Period|Poor compliance/noncompliance|0|||
160884138|NCT00534313|580970414|FG001|Long-term Period|Poor compliance/noncompliance|1|||
160884139|NCT00534313|580970415|FG002|Long-term Period|Poor compliance/noncompliance|1|||
160884140|NCT00534313|580970416|FG003|Long-term Period|Poor compliance/noncompliance|0|||
160884141|NCT00534313|580970413|FG000|Long-term Period|Administrative reason by sponsor|17|||
160884142|NCT00534313|580970414|FG001|Long-term Period|Administrative reason by sponsor|15|||
160884143|NCT00534313|580970415|FG002|Long-term Period|Administrative reason by sponsor|26|||
160884144|NCT00534313|580970416|FG003|Long-term Period|Administrative reason by sponsor|18|||
160884145|NCT00534313|580970413|FG000|Long-term Period|Other|1|||
160884146|NCT00534313|580970414|FG001|Long-term Period|Other|2|||
160884147|NCT00534313|580970415|FG002|Long-term Period|Other|2|||
160884148|NCT00534313|580970416|FG003|Long-term Period|Other|2|||
160884149|NCT00402233|580970417|FG000|Overall Study|Adverse Event|1|||
160884150|NCT00402233|580970418|FG001|Overall Study|Adverse Event|7|||
160884151|NCT00402233|580970419|FG002|Overall Study|Adverse Event|9|||
160884152|NCT00402233|580970420|FG003|Overall Study|Adverse Event|9|||
160884153|NCT00402233|580970417|FG000|Overall Study|Protocol Violation|0|||
160884154|NCT00402233|580970418|FG001|Overall Study|Protocol Violation|1|||
160884155|NCT00402233|580970419|FG002|Overall Study|Protocol Violation|0|||
160884156|NCT00402233|580970420|FG003|Overall Study|Protocol Violation|0|||
160884157|NCT00402233|580970417|FG000|Overall Study|Withdrawal by Subject|2|||
160884158|NCT00402233|580970418|FG001|Overall Study|Withdrawal by Subject|1|||
160884159|NCT00402233|580970419|FG002|Overall Study|Withdrawal by Subject|2|||
160884160|NCT00402233|580970420|FG003|Overall Study|Withdrawal by Subject|2|||
160884161|NCT00402233|580970417|FG000|Overall Study|Worsening of disease under study|2|||
160884162|NCT00402233|580970418|FG001|Overall Study|Worsening of disease under study|0|||
160884163|NCT00402233|580970419|FG002|Overall Study|Worsening of disease under study|0|||
160884164|NCT00402233|580970420|FG003|Overall Study|Worsening of disease under study|0|||
160884165|NCT00402233|580970417|FG000|Overall Study|Worsening of other pre-existing disease|0|||
160884166|NCT00402233|580970418|FG001|Overall Study|Worsening of other pre-existing disease|1|||
160884167|NCT00402233|580970419|FG002|Overall Study|Worsening of other pre-existing disease|0|||
160884168|NCT00402233|580970420|FG003|Overall Study|Worsening of other pre-existing disease|0|||
160884169|NCT00927940|580970421|FG000|Overall Study|Death|1|||
160884170|NCT03007888|580970422|FG000|First Intervention (14 Days)|Adverse Event|1|||
160884171|NCT03007888|580970423|FG001|First Intervention (14 Days)|Adverse Event|0|||
160884172|NCT04658940|580970425|FG000|Overall Study|Withdrawal by Subject|1|||
160884173|NCT00827931|580970427|FG000|Overall Study|Death|3|||
160884174|NCT00827931|580970428|FG001|Overall Study|Death|5|||
160884175|NCT00827931|580970427|FG000|Overall Study|Adverse Event|1|||
160884176|NCT00827931|580970428|FG001|Overall Study|Adverse Event|0|||
160884177|NCT00827931|580970427|FG000|Overall Study|Lost to Follow-up|1|||
160884178|NCT00827931|580970428|FG001|Overall Study|Lost to Follow-up|0|||
160884179|NCT00827931|580970427|FG000|Overall Study|Withdrawal by Subject|0|||
160884180|NCT00827931|580970428|FG001|Overall Study|Withdrawal by Subject|1|||
160884181|NCT00827931|580970427|FG000|Overall Study|Other|1|||
160884182|NCT00827931|580970428|FG001|Overall Study|Other|0|||
160884183|NCT03579602|580970429|FG000|Overall Study|Subject unable to receive study drug|0|||
160884184|NCT03579602|580970430|FG001|Overall Study|Subject unable to receive study drug|2|||
160884185|NCT03579602|580970429|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
160884186|NCT03579602|580970430|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
160884187|NCT01870076|580970431|FG000|Overall Study|Withdrawal by Subject|1|||
160884188|NCT01870076|580970432|FG001|Overall Study|Withdrawal by Subject|0|||
160884189|NCT01870076|580970433|FG002|Overall Study|Withdrawal by Subject|1|||
160884190|NCT01870076|580970434|FG003|Overall Study|Withdrawal by Subject|0|||
160884191|NCT00492063|580970435|FG000|Overall Study|Death|0|||
160884192|NCT00492063|580970436|FG001|Overall Study|Death|0|||
160884193|NCT00492063|580970437|FG002|Overall Study|Death|1|||
160884194|NCT00492063|580970438|FG003|Overall Study|Death|2|||
160884195|NCT00492063|580970435|FG000|Overall Study|Withdrawal by Subject|4|||
160884196|NCT00492063|580970436|FG001|Overall Study|Withdrawal by Subject|3|||
160884197|NCT00492063|580970437|FG002|Overall Study|Withdrawal by Subject|5|||
160884198|NCT00492063|580970438|FG003|Overall Study|Withdrawal by Subject|4|||
160884199|NCT00492063|580970435|FG000|Overall Study|Lost to Follow-up|6|||
160884200|NCT00492063|580970436|FG001|Overall Study|Lost to Follow-up|11|||
160884201|NCT00492063|580970437|FG002|Overall Study|Lost to Follow-up|5|||
160884202|NCT00492063|580970438|FG003|Overall Study|Lost to Follow-up|3|||
160884203|NCT00492063|580970435|FG000|Overall Study|Protocol Violation|0|||
160884204|NCT00492063|580970436|FG001|Overall Study|Protocol Violation|0|||
160884205|NCT00492063|580970437|FG002|Overall Study|Protocol Violation|0|||
160884206|NCT00492063|580970438|FG003|Overall Study|Protocol Violation|1|||
160884207|NCT00495040|580970439|FG000|Overall Study|Withdrawal by Subject|3|||
160884208|NCT01894568|580970440|FG000|Overall Study|Adverse Event|2|||
160884209|NCT01894568|580970441|FG001|Overall Study|Adverse Event|3|||
160884210|NCT01894568|580970440|FG000|Overall Study|Protocol required discontinuation|2|||
160884211|NCT01894568|580970441|FG001|Overall Study|Protocol required discontinuation|1|||
160884212|NCT01894568|580970440|FG000|Overall Study|Withdrawal by Subject|5|||
160884213|NCT01894568|580970441|FG001|Overall Study|Withdrawal by Subject|5|||
160884214|NCT01894568|580970440|FG000|Overall Study|Physician Decision|1|||
160884215|NCT01894568|580970441|FG001|Overall Study|Physician Decision|0|||
160884216|NCT01894568|580970440|FG000|Overall Study|Lost to Follow-up|0|||
160884217|NCT01894568|580970441|FG001|Overall Study|Lost to Follow-up|1|||
160884218|NCT00807573|580970442|FG000|Overall Study|Withdrawal by Subject|1|||
160884219|NCT00807573|580970442|FG000|Overall Study|Adverse Event|1|||
160884220|NCT01514370|580970445|FG000|Overall Study|Protocol Violation|2|||
160884221|NCT01514370|580970446|FG001|Overall Study|Protocol Violation|3|||
160884222|NCT01514370|580970445|FG000|Overall Study|Lost to Follow-up|0|||
160884223|NCT01514370|580970446|FG001|Overall Study|Lost to Follow-up|2|||
160884224|NCT01514370|580970445|FG000|Overall Study|Withdrawal by Subject|2|||
160884225|NCT01514370|580970446|FG001|Overall Study|Withdrawal by Subject|1|||
160884226|NCT01514370|580970445|FG000|Overall Study|Adverse Event|1|||
160884227|NCT01514370|580970446|FG001|Overall Study|Adverse Event|3|||
160884228|NCT01514370|580970445|FG000|Overall Study|Other|6|||
160884229|NCT01514370|580970446|FG001|Overall Study|Other|7|||
160884230|NCT01089361|580970447|FG000|Overall Study|Death|1|||
160884231|NCT01089361|580970448|FG001|Overall Study|Death|0|||
160884232|NCT04054947|580970449|FG000|Overall Study|Withdrawal by Subject|1|||
160884233|NCT04054947|580970450|FG001|Overall Study|Withdrawal by Subject|0|||
160884234|NCT04054947|580970449|FG000|Overall Study|Lost to Follow-up|2|||
160884235|NCT04054947|580970450|FG001|Overall Study|Lost to Follow-up|5|||
160884236|NCT01606878|580970453|FG000|Overall Study|Adverse Event|1|||
160884237|NCT01606878|580970454|FG001|Overall Study|Adverse Event|1|||
160884238|NCT01606878|580970455|FG002|Overall Study|Adverse Event|0|||
160884239|NCT01606878|580970456|FG003|Overall Study|Adverse Event|0|||
160884240|NCT01606878|580970457|FG004|Overall Study|Adverse Event|0|||
160884241|NCT01606878|580970458|FG005|Overall Study|Adverse Event|0|||
160884242|NCT01606878|580970459|FG006|Overall Study|Adverse Event|1|||
160884243|NCT01606878|580970460|FG007|Overall Study|Adverse Event|0|||
160884244|NCT01606878|580970461|FG008|Overall Study|Adverse Event|1|||
160884245|NCT01606878|580970462|FG009|Overall Study|Adverse Event|3|||
160884246|NCT01606878|580970463|FG010|Overall Study|Adverse Event|0|||
160884247|NCT01606878|580970453|FG000|Overall Study|Lack of Efficacy|1|||
160884248|NCT01606878|580970454|FG001|Overall Study|Lack of Efficacy|1|||
160884249|NCT01606878|580970455|FG002|Overall Study|Lack of Efficacy|1|||
160884250|NCT01606878|580970456|FG003|Overall Study|Lack of Efficacy|2|||
160884251|NCT01606878|580970457|FG004|Overall Study|Lack of Efficacy|1|||
160884252|NCT01606878|580970458|FG005|Overall Study|Lack of Efficacy|2|||
160884253|NCT01606878|580970459|FG006|Overall Study|Lack of Efficacy|1|||
160884254|NCT01606878|580970460|FG007|Overall Study|Lack of Efficacy|2|||
160884255|NCT01606878|580970461|FG008|Overall Study|Lack of Efficacy|2|||
160884256|NCT01606878|580970462|FG009|Overall Study|Lack of Efficacy|0|||
160884257|NCT01606878|580970463|FG010|Overall Study|Lack of Efficacy|1|||
160884258|NCT01606878|580970453|FG000|Overall Study|Physician Decision|1|||
160884259|NCT01606878|580970454|FG001|Overall Study|Physician Decision|0|||
160884260|NCT01606878|580970455|FG002|Overall Study|Physician Decision|2|||
160884261|NCT01606878|580970456|FG003|Overall Study|Physician Decision|1|||
160884262|NCT01606878|580970457|FG004|Overall Study|Physician Decision|1|||
160884263|NCT01606878|580970458|FG005|Overall Study|Physician Decision|1|||
160884264|NCT01606878|580970459|FG006|Overall Study|Physician Decision|2|||
160884265|NCT01606878|580970460|FG007|Overall Study|Physician Decision|0|||
160884266|NCT01606878|580970461|FG008|Overall Study|Physician Decision|1|||
160884267|NCT01606878|580970462|FG009|Overall Study|Physician Decision|0|||
160884268|NCT01606878|580970463|FG010|Overall Study|Physician Decision|0|||
160884269|NCT01606878|580970453|FG000|Overall Study|Withdrawal by Subject|3|||
160884270|NCT01606878|580970454|FG001|Overall Study|Withdrawal by Subject|2|||
160884271|NCT01606878|580970455|FG002|Overall Study|Withdrawal by Subject|2|||
160884272|NCT01606878|580970456|FG003|Overall Study|Withdrawal by Subject|0|||
160884273|NCT01606878|580970457|FG004|Overall Study|Withdrawal by Subject|1|||
160884274|NCT01606878|580970458|FG005|Overall Study|Withdrawal by Subject|1|||
160884275|NCT01606878|580970459|FG006|Overall Study|Withdrawal by Subject|2|||
160884276|NCT01606878|580970460|FG007|Overall Study|Withdrawal by Subject|1|||
160884277|NCT01606878|580970461|FG008|Overall Study|Withdrawal by Subject|2|||
160884278|NCT01606878|580970462|FG009|Overall Study|Withdrawal by Subject|0|||
160884279|NCT01606878|580970463|FG010|Overall Study|Withdrawal by Subject|2|||
160884280|NCT03720652|580970466|FG000|Overall Study|Withdrawal by Subject|2|||
160884281|NCT03720652|580970467|FG001|Overall Study|Withdrawal by Subject|7|||
160884282|NCT03720652|580970466|FG000|Overall Study|Lost to Follow-up|0|||
160884283|NCT03720652|580970467|FG001|Overall Study|Lost to Follow-up|4|||
160884284|NCT02232880|580970471|FG000|Overall Study|study stopped prior to randomization|1|||
160884285|NCT00604214|580970472|FG000|Baseline to Day 28|Death|223|||
160884286|NCT00604214|580970473|FG001|Baseline to Day 28|Death|202|||
160884287|NCT00604214|580970472|FG000|Baseline to Day 28|Lost to Follow-up|2|||
160884288|NCT00604214|580970473|FG001|Baseline to Day 28|Lost to Follow-up|4|||
160884289|NCT00604214|580970472|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
160884290|NCT00604214|580970473|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
160884291|NCT00604214|580970472|FG000|Day 29 to Day 90|Death|64|||
160884292|NCT00604214|580970473|FG001|Day 29 to Day 90|Death|67|||
160884293|NCT00604214|580970472|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
160884294|NCT00604214|580970473|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
160884295|NCT00604214|580970472|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
160884296|NCT00604214|580970473|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
160884297|NCT00604214|580970472|FG000|Day 91 to Day 180|Death|19|||
160884298|NCT00604214|580970473|FG001|Day 91 to Day 180|Death|23|||
160884299|NCT00604214|580970472|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
160884300|NCT00604214|580970473|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
160884301|NCT00604214|580970472|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
160884302|NCT00604214|580970473|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
160884303|NCT00534599|580970474|FG000|Overall Study|Adverse Event|25|||
160884304|NCT00534599|580970475|FG001|Overall Study|Adverse Event|4|||
160884305|NCT00534599|580970474|FG000|Overall Study|Incorrect enrollment|2|||
160884306|NCT00534599|580970475|FG001|Overall Study|Incorrect enrollment|1|||
160884307|NCT00534599|580970474|FG000|Overall Study|Mis-randomization|2|||
160884308|NCT00534599|580970475|FG001|Overall Study|Mis-randomization|2|||
160884309|NCT00534599|580970474|FG000|Overall Study|Developed study-specific d/c criteria|5|||
160884310|NCT00534599|580970475|FG001|Overall Study|Developed study-specific d/c criteria|0|||
160884311|NCT00534599|580970474|FG000|Overall Study|Lack of Efficacy|0|||
160884312|NCT00534599|580970475|FG001|Overall Study|Lack of Efficacy|1|||
160884313|NCT00534599|580970474|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
160884314|NCT00534599|580970475|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
160884315|NCT00534599|580970474|FG000|Overall Study|Protocol Violation|1|||
160884316|NCT00534599|580970475|FG001|Overall Study|Protocol Violation|3|||
160884317|NCT00534599|580970474|FG000|Overall Study|Lost to Follow-up|11|||
160884318|NCT00534599|580970475|FG001|Overall Study|Lost to Follow-up|14|||
160884319|NCT00534599|580970474|FG000|Overall Study|Withdrawal by Subject|4|||
160884320|NCT00534599|580970475|FG001|Overall Study|Withdrawal by Subject|6|||
160884321|NCT00534599|580970474|FG000|Overall Study|Other|7|||
160884322|NCT00534599|580970475|FG001|Overall Study|Other|0|||
160884323|NCT01155167|580970480|FG000|Overall Study|Insufficient ultrasound data|2|||
160884324|NCT01155167|580970481|FG001|Overall Study|Insufficient ultrasound data|0|||
160884325|NCT01155167|580970480|FG000|Overall Study|Access site changed to femoral artery|1|||
160884326|NCT01155167|580970481|FG001|Overall Study|Access site changed to femoral artery|0|||
160884327|NCT01981551|580970482|FG000|Overall Study|Refused further treatment|8|||
160884328|NCT01981551|580970482|FG000|Overall Study|Adverse Event|1|||
160884329|NCT00167778|580970483|FG000|Overall Study|Withdrawal by Subject|1|||
160884330|NCT02654717|580970484|FG000|Overall Study|Adverse Event|2|||
160884331|NCT02654717|580970485|FG001|Overall Study|Adverse Event|2|||
160884332|NCT02654717|580970484|FG000|Overall Study|Protocol Violation|1|||
160884333|NCT02654717|580970485|FG001|Overall Study|Protocol Violation|2|||
160884334|NCT02654717|580970484|FG000|Overall Study|Withdrawal by Subject|0|||
160884335|NCT02654717|580970485|FG001|Overall Study|Withdrawal by Subject|1|||
160884336|NCT02654717|580970484|FG000|Overall Study|Non-permitted medication|3|||
160884337|NCT02654717|580970485|FG001|Overall Study|Non-permitted medication|0|||
160884338|NCT01451437|580970486|FG000|Overall Study|Adverse Event|0|||
160884339|NCT01451437|580970487|FG001|Overall Study|Adverse Event|0|||
160884340|NCT01451437|580970488|FG002|Overall Study|Adverse Event|0|||
160884341|NCT01451437|580970489|FG003|Overall Study|Adverse Event|0|||
160884342|NCT01451437|580970490|FG004|Overall Study|Adverse Event|0|||
160884343|NCT01451437|580970491|FG005|Overall Study|Adverse Event|1|||
160884344|NCT01451437|580970492|FG006|Overall Study|Adverse Event|1|||
160884345|NCT01451437|580970493|FG007|Overall Study|Adverse Event|2|||
160884346|NCT01451437|580970494|FG008|Overall Study|Adverse Event|1|||
160884347|NCT01451437|580970486|FG000|Overall Study|Physician Decision|1|||
160884348|NCT01451437|580970487|FG001|Overall Study|Physician Decision|1|||
160884349|NCT01451437|580970488|FG002|Overall Study|Physician Decision|2|||
160884350|NCT01451437|580970489|FG003|Overall Study|Physician Decision|0|||
160884351|NCT01451437|580970490|FG004|Overall Study|Physician Decision|0|||
160884352|NCT01451437|580970491|FG005|Overall Study|Physician Decision|0|||
160884353|NCT01451437|580970492|FG006|Overall Study|Physician Decision|0|||
160884354|NCT01451437|580970493|FG007|Overall Study|Physician Decision|0|||
160884355|NCT01451437|580970494|FG008|Overall Study|Physician Decision|0|||
160884356|NCT01451437|580970486|FG000|Overall Study|Disease Progression|0|||
160884357|NCT01451437|580970487|FG001|Overall Study|Disease Progression|0|||
160884358|NCT01451437|580970488|FG002|Overall Study|Disease Progression|1|||
160884359|NCT01451437|580970489|FG003|Overall Study|Disease Progression|1|||
160884360|NCT01451437|580970490|FG004|Overall Study|Disease Progression|3|||
160884361|NCT01451437|580970491|FG005|Overall Study|Disease Progression|2|||
160884362|NCT01451437|580970492|FG006|Overall Study|Disease Progression|3|||
160884363|NCT01451437|580970493|FG007|Overall Study|Disease Progression|1|||
160884364|NCT01451437|580970494|FG008|Overall Study|Disease Progression|3|||
160884365|NCT01451437|580970486|FG000|Overall Study|Protocol Violation|0|||
160884366|NCT01451437|580970487|FG001|Overall Study|Protocol Violation|0|||
160884367|NCT01451437|580970488|FG002|Overall Study|Protocol Violation|0|||
160884368|NCT01451437|580970489|FG003|Overall Study|Protocol Violation|0|||
160884369|NCT01451437|580970490|FG004|Overall Study|Protocol Violation|0|||
160884370|NCT01451437|580970491|FG005|Overall Study|Protocol Violation|0|||
160884371|NCT01451437|580970492|FG006|Overall Study|Protocol Violation|1|||
160884372|NCT01451437|580970493|FG007|Overall Study|Protocol Violation|0|||
161121902|NCT01789970|581833612|FG001|Open-label Titration Period|Other|0|||
160884373|NCT01451437|580970494|FG008|Overall Study|Protocol Violation|0|||
160884374|NCT01451437|580970486|FG000|Overall Study|Withdrawal by Subject|0|||
160884375|NCT01451437|580970487|FG001|Overall Study|Withdrawal by Subject|0|||
160884376|NCT01451437|580970488|FG002|Overall Study|Withdrawal by Subject|0|||
160884377|NCT01451437|580970489|FG003|Overall Study|Withdrawal by Subject|0|||
160884378|NCT01451437|580970490|FG004|Overall Study|Withdrawal by Subject|1|||
160884379|NCT01451437|580970491|FG005|Overall Study|Withdrawal by Subject|0|||
160884380|NCT01451437|580970492|FG006|Overall Study|Withdrawal by Subject|1|||
160884381|NCT01451437|580970493|FG007|Overall Study|Withdrawal by Subject|0|||
160884382|NCT01451437|580970494|FG008|Overall Study|Withdrawal by Subject|0|||
160884383|NCT00853970|580970497|FG000|Overall Study|Withdrawal by Subject|2|||
160861861|NCT02531802|580887857|FG012|Received Vaccination 2|Adverse Event|0|||
160884384|NCT00853970|580970498|FG001|Overall Study|Withdrawal by Subject|1|||
160884385|NCT00853970|580970497|FG000|Overall Study|Cancelled surgery|4|||
160884386|NCT00853970|580970498|FG001|Overall Study|Cancelled surgery|2|||
160884387|NCT00884377|580971778|FG000|Overall Study|Withdrawal by Subject|1|||
160884388|NCT00884377|580971779|FG001|Overall Study|Withdrawal by Subject|0|||
160884389|NCT00884377|580971778|FG000|Overall Study|Could not confirm diagnosis|1|||
160884390|NCT00884377|580971779|FG001|Overall Study|Could not confirm diagnosis|0|||
160884391|NCT00884377|580971778|FG000|Overall Study|Physician Decision|0|||
160884392|NCT00884377|580971779|FG001|Overall Study|Physician Decision|1|||
160884393|NCT00706849|580971782|FG000|Treatment Period|Adverse Event|0|||
160884394|NCT00706849|580971783|FG001|Treatment Period|Adverse Event|9|||
160884395|NCT00706849|580971782|FG000|Treatment Period|Other|0|||
160884396|NCT00706849|580971783|FG001|Treatment Period|Other|1|||
160884397|NCT00706849|580971782|FG000|Follow-up Period|Withdrawal by Subject|0|||
160884398|NCT00706849|580971783|FG001|Follow-up Period|Withdrawal by Subject|2|||
160884399|NCT00706849|580971782|FG000|Follow-up Period|Protocol non-compliance|0|||
160884400|NCT00706849|580971783|FG001|Follow-up Period|Protocol non-compliance|1|||
160884401|NCT01611454|580971785|FG000|Overall Study|Lack of Efficacy|18|||
160884402|NCT01611454|580971786|FG001|Overall Study|Lack of Efficacy|10|||
160884403|NCT01275339|580971789|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
160884404|NCT01275339|580971790|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
160884405|NCT01275339|580971791|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
160884406|NCT01275339|580971792|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
160884407|NCT01275339|580971789|FG000|Overall Study|Withdrawal by Subject|0|||
160884408|NCT01275339|580971790|FG001|Overall Study|Withdrawal by Subject|0|||
160884409|NCT01275339|580971791|FG002|Overall Study|Withdrawal by Subject|1|||
160884410|NCT01275339|580971792|FG003|Overall Study|Withdrawal by Subject|0|||
160884411|NCT03718299|580971793|FG000|Overall Study|Adverse Event|1|||
160884412|NCT03718299|580971793|FG000|Overall Study|Withdrawal by Subject|6|||
160884413|NCT03718299|580971793|FG000|Overall Study|Physician Decision|2|||
160884414|NCT03718299|580971793|FG000|Overall Study|Lost to Follow-up|1|||
160884415|NCT04389970|580971795|FG000|Overall Study|Lost to Follow-up|1|||
160884416|NCT03123185|580971796|FG000|Overall Study|Withdrawal by Subject|0|||
160884417|NCT03123185|580971797|FG001|Overall Study|Withdrawal by Subject|0|||
160884418|NCT03123185|580971798|FG002|Overall Study|Withdrawal by Subject|0|||
160884419|NCT03123185|580971799|FG003|Overall Study|Withdrawal by Subject|0|||
160884420|NCT03123185|580971800|FG004|Overall Study|Withdrawal by Subject|0|||
160884421|NCT03123185|580971801|FG005|Overall Study|Withdrawal by Subject|0|||
160884422|NCT03123185|580971802|FG006|Overall Study|Withdrawal by Subject|0|||
160884423|NCT03123185|580971803|FG007|Overall Study|Withdrawal by Subject|0|||
160884424|NCT03123185|580971804|FG008|Overall Study|Withdrawal by Subject|0|||
160884425|NCT03123185|580971805|FG009|Overall Study|Withdrawal by Subject|0|||
160884426|NCT03123185|580971806|FG010|Overall Study|Withdrawal by Subject|0|||
160884427|NCT03123185|580971807|FG011|Overall Study|Withdrawal by Subject|0|||
160884428|NCT03123185|580971808|FG012|Overall Study|Withdrawal by Subject|1|||
160884429|NCT03123185|580971809|FG013|Overall Study|Withdrawal by Subject|0|||
160884430|NCT00713310|580971814|FG000|Overall Study|Adverse Event|5|||
160884431|NCT00713310|580971815|FG001|Overall Study|Adverse Event|2|||
160884432|NCT00713310|580971814|FG000|Overall Study|Lack of Efficacy|0|||
160884433|NCT00713310|580971815|FG001|Overall Study|Lack of Efficacy|2|||
160884434|NCT00713310|580971814|FG000|Overall Study|Withdrawal by Subject|0|||
160884435|NCT00713310|580971815|FG001|Overall Study|Withdrawal by Subject|2|||
160884436|NCT00329901|580971816|FG000|Overall Study|Withdrawal by Subject|4|||
160884437|NCT00329901|580971817|FG001|Overall Study|Withdrawal by Subject|3|||
160884438|NCT00329901|580971818|FG002|Overall Study|Withdrawal by Subject|2|||
160884439|NCT00329901|580971816|FG000|Overall Study|Lost to Follow-up|2|||
160884440|NCT00329901|580971817|FG001|Overall Study|Lost to Follow-up|0|||
160884441|NCT00329901|580971818|FG002|Overall Study|Lost to Follow-up|1|||
160884442|NCT00329901|580971816|FG000|Overall Study|Protocol Violation|1|||
160884443|NCT00329901|580971817|FG001|Overall Study|Protocol Violation|0|||
160884444|NCT00329901|580971818|FG002|Overall Study|Protocol Violation|1|||
160884445|NCT00329901|580971816|FG000|Overall Study|Unable to classify|2|||
160884446|NCT00329901|580971817|FG001|Overall Study|Unable to classify|2|||
160884447|NCT00329901|580971818|FG002|Overall Study|Unable to classify|0|||
160884448|NCT05028361|580971819|FG000|Overall Study|Withdrawal by Subject|1|||
160884449|NCT05028361|580971820|FG001|Overall Study|Withdrawal by Subject|0|||
160884450|NCT01993836|580971821|FG000|Overall Study|Surgery Cancelled|3|||
160884451|NCT01993836|580971822|FG001|Overall Study|Surgery Cancelled|0|||
160884452|NCT01993836|580971823|FG002|Overall Study|Surgery Cancelled|0|||
160884453|NCT01993836|580971821|FG000|Overall Study|Physician Decision|2|||
160884454|NCT01993836|580971822|FG001|Overall Study|Physician Decision|1|||
160884455|NCT01993836|580971823|FG002|Overall Study|Physician Decision|0|||
160884456|NCT01993836|580971821|FG000|Overall Study|Death|0|||
160884457|NCT01993836|580971822|FG001|Overall Study|Death|2|||
160884458|NCT01993836|580971823|FG002|Overall Study|Death|0|||
160884459|NCT01993836|580971821|FG000|Overall Study|Withdrawal by Subject|12|||
160884460|NCT01993836|580971822|FG001|Overall Study|Withdrawal by Subject|10|||
160884461|NCT01993836|580971823|FG002|Overall Study|Withdrawal by Subject|5|||
160884462|NCT02195687|580971824|FG000|Overall Study|Personal Reasons|1|||
160884463|NCT02195687|580971825|FG001|Overall Study|Personal Reasons|1|||
160884464|NCT02195687|580971824|FG000|Overall Study|Lost to Follow-up|4|||
160884465|NCT02195687|580971825|FG001|Overall Study|Lost to Follow-up|1|||
160884466|NCT00779259|580971826|FG000|Quinine Alone|Adverse Event|2|||
160884467|NCT00686634|580971827|FG000|Overall Study|Protocol Violation|6|||
160884468|NCT04369924|580971831|FG000|Overall Study|Lost to Follow-up|302|||
160884469|NCT04369924|580971832|FG001|Overall Study|Lost to Follow-up|339|||
160884470|NCT01653132|580971835|FG000|First Intervention|Protocol Violation|1|||
160884471|NCT01653132|580971836|FG001|First Intervention|Protocol Violation|0|||
160884472|NCT03828370|580971837|FG000|3 Month Follow-up|Lost to Follow-up|4|||
160884473|NCT03828370|580971838|FG001|3 Month Follow-up|Lost to Follow-up|12|||
160884474|NCT03828370|580971837|FG000|9 Month Follow up|Lost to Follow-up|12|||
160884475|NCT03828370|580971838|FG001|9 Month Follow up|Lost to Follow-up|20|||
160884476|NCT01209832|580971842|FG000|Period 1|Sponsor Decision and was not dosed|1|||
160884477|NCT01209832|580971842|FG000|Period 2|Sponsor Decision|1|||
160884478|NCT00761150|580971843|FG000|Open-label Period|Adverse Event|36|||
160884479|NCT00761150|580971844|FG001|Open-label Period|Adverse Event|0|||
160884480|NCT00761150|580971845|FG002|Open-label Period|Adverse Event|0|||
160884481|NCT00761150|580971843|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
160884482|NCT00761150|580971844|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
160884483|NCT00761150|580971845|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
160884484|NCT00761150|580971843|FG000|Open-label Period|Lost to Follow-up|7|||
160884485|NCT00761150|580971844|FG001|Open-label Period|Lost to Follow-up|0|||
160884486|NCT00761150|580971845|FG002|Open-label Period|Lost to Follow-up|0|||
160884487|NCT00761150|580971843|FG000|Open-label Period|Lack of Efficacy|4|||
160884488|NCT00761150|580971844|FG001|Open-label Period|Lack of Efficacy|0|||
160884489|NCT00761150|580971845|FG002|Open-label Period|Lack of Efficacy|0|||
160884490|NCT00761150|580971843|FG000|Open-label Period|Withdrawal by Subject|5|||
160884491|NCT00761150|580971844|FG001|Open-label Period|Withdrawal by Subject|0|||
160884492|NCT00761150|580971845|FG002|Open-label Period|Withdrawal by Subject|0|||
160884493|NCT00761150|580971843|FG000|Open-label Period|Noncompliance|2|||
160884494|NCT00761150|580971844|FG001|Open-label Period|Noncompliance|0|||
160884495|NCT00761150|580971845|FG002|Open-label Period|Noncompliance|0|||
160884496|NCT00761150|580971843|FG000|Open-label Period|Other|5|||
160884497|NCT00761150|580971844|FG001|Open-label Period|Other|0|||
160884498|NCT00761150|580971845|FG002|Open-label Period|Other|0|||
160884499|NCT00761150|580971843|FG000|Double-blind Period|Lack of Efficacy|0|||
160884500|NCT00761150|580971844|FG001|Double-blind Period|Lack of Efficacy|2|||
160884501|NCT00761150|580971845|FG002|Double-blind Period|Lack of Efficacy|19|||
160884502|NCT00761150|580971843|FG000|Double-blind Period|Adverse Event|0|||
160884503|NCT00761150|580971844|FG001|Double-blind Period|Adverse Event|3|||
160884504|NCT00761150|580971845|FG002|Double-blind Period|Adverse Event|3|||
160884505|NCT00761150|580971843|FG000|Double-blind Period|Withdrawal by Subject|0|||
160884506|NCT00761150|580971844|FG001|Double-blind Period|Withdrawal by Subject|3|||
160884507|NCT00761150|580971845|FG002|Double-blind Period|Withdrawal by Subject|2|||
160884508|NCT00761150|580971843|FG000|Double-blind Period|Lost to Follow-up|0|||
160884509|NCT00761150|580971844|FG001|Double-blind Period|Lost to Follow-up|2|||
160884510|NCT00761150|580971845|FG002|Double-blind Period|Lost to Follow-up|1|||
160884511|NCT00761150|580971843|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
160884512|NCT00761150|580971844|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
160884513|NCT00761150|580971845|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
160884514|NCT00761150|580971843|FG000|Double-blind Period|Noncompliance|0|||
160884515|NCT00761150|580971844|FG001|Double-blind Period|Noncompliance|1|||
160884516|NCT00761150|580971845|FG002|Double-blind Period|Noncompliance|0|||
160884517|NCT00761150|580971843|FG000|Double-blind Period|Other|0|||
160884518|NCT00761150|580971844|FG001|Double-blind Period|Other|3|||
160884519|NCT00761150|580971845|FG002|Double-blind Period|Other|3|||
160884520|NCT01925989|580971846|FG000|Period 1|Sponsor Decision|1|||
160884521|NCT01925989|580971847|FG001|Period 1|Sponsor Decision|1|||
160884522|NCT01925989|580971848|FG002|Period 1|Sponsor Decision|0|||
160884523|NCT01925989|580971846|FG000|Period 1|Withdrawal by Subject|0|||
160884524|NCT01925989|580971847|FG001|Period 1|Withdrawal by Subject|1|||
160884525|NCT01925989|580971848|FG002|Period 1|Withdrawal by Subject|0|||
160884526|NCT03901456|580971849|FG000|Overall Study|Withdrawal by Subject|0|||
160884527|NCT03901456|580971850|FG001|Overall Study|Withdrawal by Subject|0|||
160884528|NCT03901456|580971851|FG002|Overall Study|Withdrawal by Subject|1|||
160884529|NCT03901456|580971849|FG000|Overall Study|Lost to Follow-up|0|||
160884530|NCT03901456|580971850|FG001|Overall Study|Lost to Follow-up|1|||
160884531|NCT03901456|580971851|FG002|Overall Study|Lost to Follow-up|0|||
160884532|NCT05318183|580971853|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161121903|NCT01789970|581833613|FG002|Open-label Titration Period|Other|0|||
161121904|NCT01789970|581833611|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
161121905|NCT01789970|581833612|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
161121906|NCT01789970|581833613|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
161121907|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
160884533|NCT05318183|580971854|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
160884534|NCT05318183|580971853|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
160884535|NCT05318183|580971854|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160884536|NCT05318183|580971853|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
160884537|NCT05318183|580971854|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
160884538|NCT05318183|580971853|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
160884539|NCT05318183|580971854|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
160884540|NCT06400251|580971855|FG000|Overall Study|Never Start Protocol Therapy|1|||
160884541|NCT06400251|580971855|FG000|Overall Study|Ineligible|2|||
160884542|NCT06400251|580971855|FG000|Overall Study|Mutation Status Not Confirmed|3|||
160884543|NCT06400251|580971855|FG000|Overall Study|Disease Progression|25|||
160884544|NCT06400251|580971855|FG000|Overall Study|Adverse Event|1|||
160884545|NCT06400251|580971855|FG000|Overall Study|Complicating Disease|1|||
160884546|NCT06400251|580971855|FG000|Overall Study|Physician Decision|2|||
160884547|NCT04098224|580971856|FG000|Overall Study|Adverse Event|1|||
160884548|NCT04098224|580971857|FG001|Overall Study|Adverse Event|0|||
160884549|NCT04098224|580971856|FG000|Overall Study|Physician Decision|1|||
160884550|NCT04098224|580971857|FG001|Overall Study|Physician Decision|0|||
160884551|NCT04098224|580971856|FG000|Overall Study|Patient not required enteral feeding|1|||
160884552|NCT04098224|580971857|FG001|Overall Study|Patient not required enteral feeding|0|||
160884553|NCT04098224|580971856|FG000|Overall Study|Patient failure nasogastric tube|1|||
160884554|NCT04098224|580971857|FG001|Overall Study|Patient failure nasogastric tube|0|||
160884555|NCT04098224|580971856|FG000|Overall Study|Patient early extubation|1|||
160884556|NCT04098224|580971857|FG001|Overall Study|Patient early extubation|3|||
160884557|NCT02217527|580971858|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
160884558|NCT02217527|580971859|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
160884559|NCT02217527|580971858|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
160884560|NCT02217527|580971859|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
160884561|NCT01203852|580971863|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
160884562|NCT01203852|580971863|FG000|Washout 2 Weeks|Physician Decision|46|||
160884563|NCT01878149|580971866|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
160884564|NCT01878149|580971867|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
160884565|NCT04672252|580971868|FG000|Overall Study|Protocol Violation|1|||
160884566|NCT04672252|580971869|FG001|Overall Study|Protocol Violation|0|||
160884567|NCT06390839|580971871|FG000|Overall Study|Ineligible|2|||
160884568|NCT06390839|580971871|FG000|Overall Study|Never start protocol therapy|3|||
160884569|NCT06390839|580971871|FG000|Overall Study|Adverse Event|1|||
160884570|NCT06390839|580971871|FG000|Overall Study|Alternative therapy|2|||
160884571|NCT06390839|580971871|FG000|Overall Study|Death|3|||
160884572|NCT06390839|580971871|FG000|Overall Study|Disease progression|28|||
160884573|NCT06390839|580971871|FG000|Overall Study|Withdrawal by Subject|2|||
160884574|NCT06390839|580971871|FG000|Overall Study|Complicating disease|1|||
160884575|NCT06390839|580971871|FG000|Overall Study|Noncompliance|1|||
160884576|NCT01738477|580971872|FG000|Overall Study|Lost to Follow-up|1|||
160884577|NCT01738477|580971873|FG001|Overall Study|Lost to Follow-up|4|||
160884578|NCT00502203|580971874|FG000|Overall Study|Inevaluable|1|||
160884579|NCT01431638|580971877|FG000|Overall Study|Adverse Event|1|||
160884580|NCT01431638|580971878|FG001|Overall Study|Adverse Event|3|||
160884581|NCT01431638|580971879|FG002|Overall Study|Adverse Event|1|||
160884582|NCT01431638|580971877|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160884583|NCT01431638|580971878|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160884584|NCT01431638|580971879|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
160884585|NCT01431638|580971877|FG000|Overall Study|Participants condition no longer requires study drug|0|||
160884586|NCT01431638|580971878|FG001|Overall Study|Participants condition no longer requires study drug|1|||
160884587|NCT01431638|580971879|FG002|Overall Study|Participants condition no longer requires study drug|0|||
160884588|NCT01431638|580971877|FG000|Overall Study|Participant withdrew consent|14|||
160884589|NCT01431638|580971878|FG001|Overall Study|Participant withdrew consent|5|||
160884590|NCT01431638|580971879|FG002|Overall Study|Participant withdrew consent|8|||
160884591|NCT01431638|580971877|FG000|Overall Study|Lost to Follow-up|7|||
160884592|NCT01431638|580971878|FG001|Overall Study|Lost to Follow-up|9|||
160884593|NCT01431638|580971879|FG002|Overall Study|Lost to Follow-up|7|||
160884594|NCT01431638|580971877|FG000|Overall Study|Administrative problems|1|||
160884595|NCT01431638|580971878|FG001|Overall Study|Administrative problems|4|||
160884596|NCT01431638|580971879|FG002|Overall Study|Administrative problems|6|||
160884597|NCT01431638|580971877|FG000|Overall Study|Death|1|||
160884598|NCT01431638|580971878|FG001|Overall Study|Death|0|||
160884599|NCT01431638|580971879|FG002|Overall Study|Death|0|||
160884600|NCT01431638|580971877|FG000|Overall Study|Protocol deviation|1|||
161324986|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
160884601|NCT01431638|580971878|FG001|Overall Study|Protocol deviation|1|||
160884602|NCT01431638|580971879|FG002|Overall Study|Protocol deviation|4|||
160884603|NCT01431638|580971877|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
160884604|NCT01431638|580971878|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
160884605|NCT01431638|580971879|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
160884606|NCT03709576|580971893|FG000|Overall Study|progression prior to enrollment|1|||
160884607|NCT00890045|580971901|FG000|Overall Study|Death|0|||
160884608|NCT00890045|580971902|FG001|Overall Study|Death|1|||
160884609|NCT00890045|580971901|FG000|Overall Study|Did not receive HeRO Graft|0|||
160884610|NCT00890045|580971902|FG001|Overall Study|Did not receive HeRO Graft|2|||
160884611|NCT00890045|580971901|FG000|Overall Study|Lost to Follow-up|5|||
160884612|NCT00890045|580971902|FG001|Overall Study|Lost to Follow-up|7|||
160884613|NCT00510653|580971903|FG000|Overall Study|Withdrawal by Subject|8|||
160884614|NCT00510653|580971903|FG000|Overall Study|Monetary|3|||
160884615|NCT00710762|580971906|FG000|Overall Study|Progressive disease|27|||
160884616|NCT00710762|580971907|FG001|Overall Study|Progressive disease|30|||
160884617|NCT00710762|580971906|FG000|Overall Study|Adverse Event other disease worsening|2|||
160884618|NCT00710762|580971907|FG001|Overall Study|Adverse Event other disease worsening|1|||
160884619|NCT00710762|580971906|FG000|Overall Study|Other Adverse Event|7|||
160884620|NCT00710762|580971907|FG001|Overall Study|Other Adverse Event|7|||
160884621|NCT00710762|580971906|FG000|Overall Study|Lost to Follow-up|1|||
160884622|NCT00710762|580971907|FG001|Overall Study|Lost to Follow-up|0|||
160884623|NCT00710762|580971906|FG000|Overall Study|Reason other than listed above|2|||
160884624|NCT00710762|580971907|FG001|Overall Study|Reason other than listed above|2|||
160884625|NCT01947855|580971908|FG000|Overall Study|Withdrawal by Subject|1|||
160884626|NCT01947855|580971909|FG001|Overall Study|Withdrawal by Subject|0|||
160884627|NCT01947855|580971910|FG002|Overall Study|Withdrawal by Subject|0|||
160884628|NCT00592774|580971914|FG000|Overall Study|Adverse Event|5|||
160884629|NCT00592774|580971915|FG001|Overall Study|Adverse Event|19|||
160884630|NCT00592774|580971916|FG002|Overall Study|Adverse Event|2|||
160884631|NCT00592774|580971917|FG003|Overall Study|Adverse Event|14|||
160884632|NCT00592774|580971918|FG004|Overall Study|Adverse Event|8|||
160884633|NCT00592774|580971914|FG000|Overall Study|Protocol Violation|0|||
160884634|NCT00592774|580971915|FG001|Overall Study|Protocol Violation|1|||
160884635|NCT00592774|580971916|FG002|Overall Study|Protocol Violation|0|||
160884636|NCT00592774|580971917|FG003|Overall Study|Protocol Violation|0|||
160884637|NCT00592774|580971918|FG004|Overall Study|Protocol Violation|1|||
160884638|NCT00592774|580971914|FG000|Overall Study|Withdrawal by Subject|3|||
160884639|NCT00592774|580971915|FG001|Overall Study|Withdrawal by Subject|7|||
160884640|NCT00592774|580971916|FG002|Overall Study|Withdrawal by Subject|0|||
160884641|NCT00592774|580971917|FG003|Overall Study|Withdrawal by Subject|0|||
160884642|NCT00592774|580971918|FG004|Overall Study|Withdrawal by Subject|0|||
160884643|NCT00592774|580971914|FG000|Overall Study|Lack of Efficacy|3|||
160884644|NCT00592774|580971915|FG001|Overall Study|Lack of Efficacy|3|||
160884645|NCT00592774|580971916|FG002|Overall Study|Lack of Efficacy|0|||
160884646|NCT00592774|580971917|FG003|Overall Study|Lack of Efficacy|0|||
160884647|NCT00592774|580971918|FG004|Overall Study|Lack of Efficacy|2|||
160884648|NCT00592774|580971914|FG000|Overall Study|Physician Decision|0|||
160884649|NCT00592774|580971915|FG001|Overall Study|Physician Decision|1|||
160884650|NCT00592774|580971916|FG002|Overall Study|Physician Decision|1|||
160884651|NCT00592774|580971917|FG003|Overall Study|Physician Decision|0|||
160884652|NCT00592774|580971918|FG004|Overall Study|Physician Decision|1|||
160884653|NCT00592774|580971914|FG000|Overall Study|Other|0|||
160884654|NCT00592774|580971915|FG001|Overall Study|Other|1|||
160884655|NCT00592774|580971916|FG002|Overall Study|Other|1|||
160884656|NCT00592774|580971917|FG003|Overall Study|Other|0|||
160884657|NCT00592774|580971918|FG004|Overall Study|Other|2|||
160884658|NCT01700439|580971919|FG000|Overall Study|Lost to Follow-up|47|||
160884659|NCT01700439|580971919|FG000|Overall Study|Withdrawal by Subject|183|||
160884660|NCT01700439|580971919|FG000|Overall Study|Death|186|||
160884661|NCT01892384|580971920|FG000|Overall Study|Withdrawal by Subject|1|||
160884662|NCT01892384|580971921|FG001|Overall Study|Withdrawal by Subject|1|||
160884663|NCT01892384|580971922|FG002|Overall Study|Withdrawal by Subject|0|||
160884664|NCT01892384|580971923|FG003|Overall Study|Withdrawal by Subject|0|||
160884665|NCT00621621|580971924|FG000|Overall Study|Subjects were exited at EP study|30|||
160884666|NCT00621621|580971925|FG001|Overall Study|Subjects were exited at EP study|0|||
160884667|NCT00053898|580971929|FG000|Overall Study|No follow-up data from any source|9|||
160884668|NCT00053898|580971930|FG001|Overall Study|No follow-up data from any source|12|||
160884669|NCT00053898|580971929|FG000|Overall Study|Follow-up from telephone contact only|5|||
160884670|NCT00053898|580971930|FG001|Overall Study|Follow-up from telephone contact only|1|||
160884671|NCT03985878|580971934|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
160884672|NCT03985878|580971934|FG000|Overall Study|Study Terminated by Sponsor|12|||
160884673|NCT03985878|580971934|FG000|Overall Study|Withdrawal by Subject|1|||
160884674|NCT02889562|580971935|FG000|Overall Study|Physician Decision|0|||
160884675|NCT02889562|580971936|FG001|Overall Study|Physician Decision|1|||
160884676|NCT02889562|580971935|FG000|Overall Study|Withdrawal by Subject|0|||
160884677|NCT02889562|580971936|FG001|Overall Study|Withdrawal by Subject|1|||
160884678|NCT00960570|580971942|FG000|21 Day Washout Period|Adverse Event|1|||
160884679|NCT00960570|580971942|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
160884680|NCT00960570|580971942|FG000|1 Day Period Between Dosing|Adverse Event|2|||
160884681|NCT00960570|580971942|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
161227713|NCT00920140|582215180|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161227714|NCT00920140|582215181|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
161227715|NCT00920140|582215182|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161227716|NCT00920140|582215183|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161227717|NCT00920140|582215184|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161227718|NCT00920140|582215180|FG000|Phase 2|Adverse Event|0|||
161227719|NCT00920140|582215181|FG001|Phase 2|Adverse Event|0|||
161227720|NCT00920140|582215182|FG002|Phase 2|Adverse Event|14|||
161227721|NCT00920140|582215183|FG003|Phase 2|Adverse Event|2|||
161227722|NCT00920140|582215184|FG004|Phase 2|Adverse Event|3|||
161227723|NCT00920140|582215180|FG000|Phase 2|Lack of Efficacy|0|||
161227724|NCT00920140|582215181|FG001|Phase 2|Lack of Efficacy|0|||
161227725|NCT00920140|582215182|FG002|Phase 2|Lack of Efficacy|29|||
161227726|NCT00920140|582215183|FG003|Phase 2|Lack of Efficacy|14|||
161227727|NCT00920140|582215184|FG004|Phase 2|Lack of Efficacy|5|||
161227728|NCT00920140|582215180|FG000|Phase 2|Lost to Follow-up|0|||
161227729|NCT00920140|582215181|FG001|Phase 2|Lost to Follow-up|0|||
161227730|NCT00920140|582215182|FG002|Phase 2|Lost to Follow-up|0|||
161227731|NCT00920140|582215183|FG003|Phase 2|Lost to Follow-up|1|||
161227732|NCT00920140|582215184|FG004|Phase 2|Lost to Follow-up|0|||
161227733|NCT00920140|582215180|FG000|Phase 2|Physician Decision|0|||
161227734|NCT00920140|582215181|FG001|Phase 2|Physician Decision|0|||
161227735|NCT00920140|582215182|FG002|Phase 2|Physician Decision|3|||
161227736|NCT00920140|582215183|FG003|Phase 2|Physician Decision|3|||
161227737|NCT00920140|582215184|FG004|Phase 2|Physician Decision|2|||
161227738|NCT00920140|582215180|FG000|Phase 2|Withdrawal by Subject|0|||
161227739|NCT00920140|582215181|FG001|Phase 2|Withdrawal by Subject|0|||
161227740|NCT00920140|582215182|FG002|Phase 2|Withdrawal by Subject|4|||
161227741|NCT00920140|582215183|FG003|Phase 2|Withdrawal by Subject|2|||
161227742|NCT00920140|582215184|FG004|Phase 2|Withdrawal by Subject|1|||
161227743|NCT01400425|582215185|FG000|Overall Study|Withdrawal by Subject|10|||
161227744|NCT00720096|582215187|FG000|Overall Study|Withdrawal by Subject|0|||
161227745|NCT00720096|582215188|FG001|Overall Study|Withdrawal by Subject|2|||
161227746|NCT04557124|582215189|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
161227747|NCT04557124|582215190|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
161227748|NCT04557124|582215189|FG000|Mid-point (1 Month)|Missed testing|5|||
161227749|NCT04557124|582215190|FG001|Mid-point (1 Month)|Missed testing|4|||
161227750|NCT04557124|582215189|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
161227751|NCT04557124|582215190|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
161227752|NCT04557124|582215189|FG000|Post-testing (2 Months)|Missed testing|1|||
161227753|NCT04557124|582215190|FG001|Post-testing (2 Months)|Missed testing|5|||
161227754|NCT04557124|582215189|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
161227755|NCT04557124|582215190|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
161227756|NCT04557124|582215189|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
161227757|NCT04557124|582215190|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
161227758|NCT00001849|582215191|FG000|Overall Study|Death|4|||
160884682|NCT04085367|580973043|FG000|Overall Study|Adverse Event|1|||
160884683|NCT04085367|580973044|FG001|Overall Study|Adverse Event|1|||
160884684|NCT04085367|580973043|FG000|Overall Study|Withdrawal by Subject|13|||
161227759|NCT00001849|582215191|FG000|Overall Study|Lost to Follow-up|2|||
161227760|NCT00001849|582215191|FG000|Overall Study|Withdrawal by Subject|2|||
161227761|NCT00001849|582215191|FG000|Overall Study|tumor remained occult|6|||
161227762|NCT00442936|582215192|FG000|Overall Study|Protocol Violation|1|||
161227763|NCT00442936|582215193|FG001|Overall Study|Protocol Violation|0|||
161227764|NCT00442936|582215194|FG002|Overall Study|Protocol Violation|1|||
161227765|NCT00442936|582215195|FG003|Overall Study|Protocol Violation|1|||
161227766|NCT02428699|582215196|FG000|Washout Period 1|Screen Failure|1|||
161227767|NCT02428699|582215197|FG001|Washout Period 1|Screen Failure|2|||
161227768|NCT03127137|582215198|FG000|Overall Study|Requested sedation after consent|1|||
161227769|NCT03127137|582215199|FG001|Overall Study|Requested sedation after consent|0|||
161227770|NCT03127137|582215198|FG000|Overall Study|Malfunction in electronic data collection|1|||
161227771|NCT03127137|582215199|FG001|Overall Study|Malfunction in electronic data collection|0|||
161227772|NCT03127137|582215198|FG000|Overall Study|Post procedure testing could not be obtained|0|||
160884685|NCT04085367|580973044|FG001|Overall Study|Withdrawal by Subject|4|||
160884686|NCT04085367|580973043|FG000|Overall Study|Lost to Follow-up|3|||
161227773|NCT03127137|582215199|FG001|Overall Study|Post procedure testing could not be obtained|1|||
161227774|NCT04424407|582215200|FG000|Overall Study|Withdrawal by Subject|2|||
160884687|NCT04085367|580973044|FG001|Overall Study|Lost to Follow-up|1|||
160884688|NCT04085367|580973043|FG000|Overall Study|Other unspecified|2|||
160884689|NCT04085367|580973044|FG001|Overall Study|Other unspecified|1|||
161227775|NCT04424407|582215200|FG000|Overall Study|Lost to Follow-up|1|||
161227776|NCT00264797|582215201|FG000|Overall Study|Withdrawal by Subject|11|||
161227777|NCT00264797|582215202|FG001|Overall Study|Withdrawal by Subject|11|||
161227778|NCT00264797|582215201|FG000|Overall Study|Lost to Follow-up|9|||
161227779|NCT00264797|582215202|FG001|Overall Study|Lost to Follow-up|17|||
161227780|NCT00264797|582215201|FG000|Overall Study|Moved from area|3|||
161227781|NCT00264797|582215202|FG001|Overall Study|Moved from area|1|||
161227782|NCT00264797|582215201|FG000|Overall Study|Practical Problems|2|||
161227783|NCT00264797|582215202|FG001|Overall Study|Practical Problems|3|||
161227784|NCT00264797|582215201|FG000|Overall Study|Incarceration|4|||
161227785|NCT00264797|582215202|FG001|Overall Study|Incarceration|5|||
161227786|NCT00264797|582215201|FG000|Overall Study|Pressure/advice from Outsiders|1|||
161227787|NCT00264797|582215202|FG001|Overall Study|Pressure/advice from Outsiders|1|||
161227788|NCT00264797|582215201|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
161227789|NCT00264797|582215202|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
161227790|NCT00264797|582215201|FG000|Overall Study|Other|3|||
161227791|NCT00264797|582215202|FG001|Overall Study|Other|4|||
160884690|NCT04085367|580973043|FG000|Overall Study|Status Unknown|1|||
160884691|NCT04085367|580973044|FG001|Overall Study|Status Unknown|1|||
161227792|NCT03992196|582215203|FG000|Enrollment|lost to follow-up prior dosing|1|||
161227793|NCT03992196|582215204|FG001|Enrollment|lost to follow-up prior dosing|0|||
161227794|NCT03992196|582215205|FG002|Enrollment|lost to follow-up prior dosing|0|||
161227795|NCT03992196|582215203|FG000|Treatment|Protocol Violation|0|||
161227796|NCT03992196|582215204|FG001|Treatment|Protocol Violation|0|||
161227797|NCT03992196|582215205|FG002|Treatment|Protocol Violation|1|||
161227798|NCT03992196|582215203|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
161227799|NCT03992196|582215204|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
161227800|NCT03992196|582215205|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
161227801|NCT03992196|582215203|FG000|Treatment|Withdrawal due to non-compliance|0|||
161227802|NCT03992196|582215204|FG001|Treatment|Withdrawal due to non-compliance|0|||
161227803|NCT03992196|582215205|FG002|Treatment|Withdrawal due to non-compliance|1|||
161227804|NCT03992196|582215203|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
161227805|NCT03992196|582215204|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
161227806|NCT03992196|582215205|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
161227807|NCT03992196|582215203|FG000|Treatment|Withdrawal by parent/guardian|0|||
160884692|NCT00130442|580973048|FG000|Overall Study|Withdrawal by Subject|0|||
160884693|NCT00130442|580973049|FG001|Overall Study|Withdrawal by Subject|1|||
160884694|NCT00130442|580973048|FG000|Overall Study|did not meet criteria|1|||
160884695|NCT00130442|580973049|FG001|Overall Study|did not meet criteria|1|||
160884696|NCT00814333|580973050|FG000|Enrollment|Lost to Follow-up|1|||
160884697|NCT00814333|580973051|FG001|Enrollment|Lost to Follow-up|0|||
160884698|NCT01527357|580973052|FG000|Overall Study|Death|8|||
160884699|NCT01527357|580973053|FG001|Overall Study|Death|2|||
160884700|NCT01527357|580973052|FG000|Overall Study|Lost to Follow-up|6|||
161121908|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
161227808|NCT03992196|582215204|FG001|Treatment|Withdrawal by parent/guardian|0|||
161121909|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
161121910|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
161121911|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
161121912|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
161121913|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
161121914|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
161121915|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
161121916|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
161121917|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
161121918|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
161121919|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
161121920|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
161121921|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
161121922|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
161121923|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
161121924|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
161121925|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161121926|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161121927|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
161121928|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
161121929|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
161121930|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
161121931|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
160884701|NCT01527357|580973053|FG001|Overall Study|Lost to Follow-up|4|||
160884702|NCT01527357|580973052|FG000|Overall Study|Withdrew Consent|1|||
160884703|NCT01527357|580973053|FG001|Overall Study|Withdrew Consent|1|||
160884704|NCT01527357|580973052|FG000|Overall Study|Non-compliance|0|||
161121932|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
160884705|NCT01527357|580973053|FG001|Overall Study|Non-compliance|1|||
160884706|NCT01527357|580973052|FG000|Overall Study|No Day 29 Visit|0|||
160884707|NCT01527357|580973053|FG001|Overall Study|No Day 29 Visit|1|||
161121933|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
161121934|NCT01789970|581833611|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
161121935|NCT01789970|581833612|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
161121936|NCT01789970|581833613|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
161121937|NCT00643994|581833614|FG000|Overall Study|Death|24|||
161121938|NCT00643994|581833614|FG000|Overall Study|Lost to Follow-up|72|||
161121939|NCT01847885|581833624|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
161121940|NCT01847885|581833625|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
161121941|NCT01847885|581833626|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
161121942|NCT01847885|581833624|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
161121943|NCT01847885|581833625|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
161121944|NCT01847885|581833626|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
161121945|NCT01847885|581833624|FG000|Initial Enrollment (Consented)|Screen failure|39|||
161121946|NCT01847885|581833625|FG001|Initial Enrollment (Consented)|Screen failure|0|||
161121947|NCT01847885|581833626|FG002|Initial Enrollment (Consented)|Screen failure|0|||
161121948|NCT01847885|581833624|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
161121949|NCT01847885|581833625|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
161121950|NCT01847885|581833626|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
161121951|NCT01847885|581833624|FG000|Randomization|Protocol Violation|0|||
161121952|NCT01847885|581833625|FG001|Randomization|Protocol Violation|1|||
161121953|NCT01847885|581833626|FG002|Randomization|Protocol Violation|0|||
161121954|NCT01847885|581833624|FG000|Randomization|Withdrawal by Subject|0|||
161121955|NCT01847885|581833625|FG001|Randomization|Withdrawal by Subject|0|||
161121956|NCT01847885|581833626|FG002|Randomization|Withdrawal by Subject|2|||
161121957|NCT01847885|581833624|FG000|Randomization|Screen Failure|0|||
161121958|NCT01847885|581833625|FG001|Randomization|Screen Failure|3|||
161121959|NCT01847885|581833626|FG002|Randomization|Screen Failure|0|||
161121960|NCT04016311|581833630|FG000|Overall Study|Withdrawal by Subject|1|||
161121961|NCT04016311|581833631|FG001|Overall Study|Withdrawal by Subject|0|||
161121962|NCT02706730|581833636|FG000|Overall Study|Adverse Event|3|||
161121963|NCT02706730|581833636|FG000|Overall Study|Lack of Efficacy|5|||
161121964|NCT02706730|581833636|FG000|Overall Study|Withdrawal by Subject|11|||
161121965|NCT02706730|581833636|FG000|Overall Study|Study Terminated by Sponsor|11|||
161121966|NCT02706730|581833636|FG000|Overall Study|Subject chose not to receive injection|3|||
161121967|NCT02499029|581833637|FG000|Overall Study|Lost to Follow-up|2|||
161121968|NCT02499029|581833638|FG001|Overall Study|Lost to Follow-up|2|||
161121969|NCT02499029|581833637|FG000|Overall Study|Physician Decision|2|||
161121970|NCT02499029|581833638|FG001|Overall Study|Physician Decision|1|||
161121971|NCT02499029|581833637|FG000|Overall Study|Death|1|||
161121972|NCT02499029|581833638|FG001|Overall Study|Death|0|||
161121973|NCT00094055|581833639|FG000|Overall Study|Adverse Event|11|||
161121974|NCT00094055|581833639|FG000|Overall Study|Death|4|||
161121975|NCT00094055|581833639|FG000|Overall Study|Lack of Efficacy|17|||
161121976|NCT00094055|581833639|FG000|Overall Study|Lost to Follow-up|2|||
161121977|NCT00094055|581833639|FG000|Overall Study|progressive disease|2|||
161121978|NCT00094055|581833639|FG000|Overall Study|clinical progression|1|||
161121979|NCT00094055|581833639|FG000|Overall Study|roll-over to another study|14|||
161121980|NCT00094055|581833639|FG000|Overall Study|Withdrawal by Subject|9|||
161121981|NCT00441545|581833640|FG000|First Intervention|Adverse Event|6|||
161121982|NCT00441545|581833641|FG001|First Intervention|Adverse Event|5|||
161121983|NCT00441545|581833640|FG000|First Intervention|Protocol Violation|2|||
161121984|NCT00441545|581833641|FG001|First Intervention|Protocol Violation|2|||
161121985|NCT00441545|581833640|FG000|First Intervention|Withdrawal by Subject|3|||
161121986|NCT00441545|581833641|FG001|First Intervention|Withdrawal by Subject|3|||
161121987|NCT00441545|581833640|FG000|First Intervention|Kidney transplant|1|||
161121988|NCT00441545|581833641|FG001|First Intervention|Kidney transplant|1|||
161121989|NCT00441545|581833640|FG000|First Intervention|Lack of Efficacy|2|||
161121990|NCT00441545|581833641|FG001|First Intervention|Lack of Efficacy|0|||
161121991|NCT00441545|581833640|FG000|First Intervention|Subject exceeded safety criteria|0|||
161121992|NCT00441545|581833641|FG001|First Intervention|Subject exceeded safety criteria|1|||
161121993|NCT00441545|581833640|FG000|First Intervention|Subject met an exclusionary criteria|1|||
161121994|NCT00441545|581833641|FG001|First Intervention|Subject met an exclusionary criteria|0|||
161121995|NCT00441545|581833640|FG000|First Intervention|Extended hospitalization|1|||
161121996|NCT00441545|581833641|FG001|First Intervention|Extended hospitalization|0|||
161121997|NCT00441545|581833640|FG000|First Intervention|Site error|1|||
161121998|NCT00441545|581833641|FG001|First Intervention|Site error|0|||
161121999|NCT00441545|581833640|FG000|First Intervention|Sponsor's request|1|||
161122000|NCT00441545|581833641|FG001|First Intervention|Sponsor's request|0|||
161122001|NCT00441545|581833640|FG000|Second Intervention|Adverse Event|5|||
161122002|NCT00441545|581833641|FG001|Second Intervention|Adverse Event|2|||
161122003|NCT00441545|581833640|FG000|Second Intervention|Protocol Violation|4|||
161122004|NCT00441545|581833641|FG001|Second Intervention|Protocol Violation|1|||
161122005|NCT00441545|581833640|FG000|Second Intervention|Withdrawal by Subject|1|||
161324987|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
160884708|NCT01527357|580973052|FG000|Overall Study|Did Not Receive Treatment|2|||
160884709|NCT01527357|580973053|FG001|Overall Study|Did Not Receive Treatment|0|||
160884710|NCT02233946|580973054|FG000|Baseline|Withdrawal by Subject|2|||
160884711|NCT02233946|580973055|FG001|Baseline|Withdrawal by Subject|0|||
160884712|NCT02233946|580973054|FG000|3-months Follow-up|Lost to Follow-up|53|||
160884713|NCT02233946|580973055|FG001|3-months Follow-up|Lost to Follow-up|29|||
160884714|NCT02233946|580973054|FG000|6-months Follow-up|Lost to Follow-up|21|||
160884715|NCT02233946|580973055|FG001|6-months Follow-up|Lost to Follow-up|2|||
160884716|NCT02233946|580973054|FG000|9-month Follow-up|Lost to Follow-up|20|||
160884717|NCT02233946|580973055|FG001|9-month Follow-up|Lost to Follow-up|11|||
160884718|NCT02233946|580973054|FG000|12-month Follow-up|Lost to Follow-up|28|||
160884719|NCT02233946|580973055|FG001|12-month Follow-up|Lost to Follow-up|11|||
160884720|NCT00910247|580973056|FG000|Overall Study|Adverse Event|15|||
160884721|NCT00910247|580973056|FG000|Overall Study|Death|2|||
160884722|NCT00910247|580973056|FG000|Overall Study|Lost to Follow-up|10|||
160884723|NCT00910247|580973056|FG000|Overall Study|Physician Decision|3|||
160884724|NCT00910247|580973056|FG000|Overall Study|Protocol Violation|10|||
160884725|NCT00910247|580973056|FG000|Overall Study|Withdrawal by Subject|25|||
160884726|NCT00910247|580973056|FG000|Overall Study|Not collected|4|||
160884727|NCT01879579|580973057|FG000|Overall Study|Phone incompatible with texting platform|3|||
160884728|NCT01879579|580973058|FG001|Overall Study|Phone incompatible with texting platform|0|||
160884729|NCT01879579|580973057|FG000|Overall Study|Did not enroll in texting platform|1|||
160884730|NCT01879579|580973058|FG001|Overall Study|Did not enroll in texting platform|0|||
160884731|NCT01879579|580973057|FG000|Overall Study|Did not initiate insulin treatment|1|||
160884732|NCT01879579|580973058|FG001|Overall Study|Did not initiate insulin treatment|0|||
160884733|NCT01879579|580973057|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
160884734|NCT01879579|580973058|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
160884735|NCT01879579|580973057|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
160884736|NCT01879579|580973058|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
160884737|NCT02927067|580973059|FG000|Overall Study|Withdrawn Consent|20|||
160884738|NCT02927067|580973060|FG001|Overall Study|Withdrawn Consent|12|||
160884739|NCT02927067|580973059|FG000|Overall Study|Death|18|||
160884740|NCT02927067|580973060|FG001|Overall Study|Death|31|||
160884741|NCT02927067|580973059|FG000|Overall Study|Adverse Event|13|||
160884742|NCT02927067|580973060|FG001|Overall Study|Adverse Event|10|||
160884743|NCT02927067|580973059|FG000|Overall Study|Noncompliance|5|||
160884744|NCT02927067|580973060|FG001|Overall Study|Noncompliance|2|||
160884745|NCT02927067|580973059|FG000|Overall Study|Reason not Specified|4|||
160884746|NCT02927067|580973060|FG001|Overall Study|Reason not Specified|6|||
160884747|NCT02292784|580973063|FG000|Overall Study|Lost to Follow-up|1|||
160884748|NCT02292784|580973064|FG001|Overall Study|Lost to Follow-up|17|||
160884749|NCT02292784|580973065|FG002|Overall Study|Lost to Follow-up|18|||
160884750|NCT02292784|580973063|FG000|Overall Study|Withdrawal by Subject|0|||
160884751|NCT02292784|580973064|FG001|Overall Study|Withdrawal by Subject|3|||
160884752|NCT02292784|580973065|FG002|Overall Study|Withdrawal by Subject|3|||
160884753|NCT02519855|580973066|FG000|Overall Study|Adverse Event|0|||
160884754|NCT02519855|580973067|FG001|Overall Study|Adverse Event|1|||
160884755|NCT02519855|580973066|FG000|Overall Study|Lost to Follow-up|3|||
160884756|NCT02519855|580973067|FG001|Overall Study|Lost to Follow-up|3|||
161122006|NCT00441545|581833641|FG001|Second Intervention|Withdrawal by Subject|1|||
161122007|NCT00441545|581833640|FG000|Second Intervention|Kidney Transplant|1|||
160884757|NCT02919969|580973068|FG000|Overall Study|Lack of Efficacy|22|||
161122008|NCT00441545|581833641|FG001|Second Intervention|Kidney Transplant|1|||
161122009|NCT00441545|581833640|FG000|Second Intervention|Lack of Efficacy|0|||
160884758|NCT02919969|580973068|FG000|Overall Study|Death|4|||
160884759|NCT02919969|580973068|FG000|Overall Study|Physician Decision|3|||
160884760|NCT02919969|580973068|FG000|Overall Study|Withdrawal by Subject|2|||
161122010|NCT00441545|581833641|FG001|Second Intervention|Lack of Efficacy|1|||
161122011|NCT00441545|581833640|FG000|Second Intervention|Subject exceeded safety criteria|1|||
161324988|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
161324989|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
161324990|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
161324991|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
161324992|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
161324993|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
160884761|NCT03621475|580973069|FG000|Overall Study|No longer required restraints at initiation|0|||
160884762|NCT03621475|580973070|FG001|Overall Study|No longer required restraints at initiation|1|||
160884763|NCT01842633|580973071|FG000|Overall Study|Screen Failure|1|||
160884764|NCT01842633|580973072|FG001|Overall Study|Screen Failure|0|||
160884765|NCT01842633|580973073|FG002|Overall Study|Screen Failure|0|||
160884766|NCT01842633|580973071|FG000|Overall Study|Adverse Event|1|||
160884767|NCT01842633|580973072|FG001|Overall Study|Adverse Event|1|||
160884768|NCT01842633|580973073|FG002|Overall Study|Adverse Event|0|||
160884769|NCT01842633|580973071|FG000|Overall Study|Withdrawal by Subject|0|||
160884770|NCT01842633|580973072|FG001|Overall Study|Withdrawal by Subject|1|||
160884771|NCT01842633|580973073|FG002|Overall Study|Withdrawal by Subject|0|||
160884772|NCT01842633|580973071|FG000|Overall Study|Technical issues|1|||
160884773|NCT01842633|580973072|FG001|Overall Study|Technical issues|0|||
161122012|NCT00441545|581833641|FG001|Second Intervention|Subject exceeded safety criteria|0|||
161122013|NCT00441545|581833640|FG000|Second Intervention|Subject moved|0|||
161122014|NCT00441545|581833641|FG001|Second Intervention|Subject moved|1|||
161122015|NCT00411554|581833644|FG000|Overall Study|Adverse Event|2|||
161122016|NCT00411554|581833645|FG001|Overall Study|Adverse Event|4|||
161122017|NCT00411554|581833644|FG000|Overall Study|Lack of Efficacy|2|||
161122018|NCT00411554|581833645|FG001|Overall Study|Lack of Efficacy|5|||
161122019|NCT00411554|581833644|FG000|Overall Study|Withdrawal by Subject|3|||
161122020|NCT00411554|581833645|FG001|Overall Study|Withdrawal by Subject|0|||
161122021|NCT00411554|581833644|FG000|Overall Study|Patient Moved|1|||
161122022|NCT00411554|581833645|FG001|Overall Study|Patient Moved|0|||
161122023|NCT04153188|581833653|FG000|Overall Study|Lost to Follow-up|1|||
161122024|NCT04153188|581833654|FG001|Overall Study|Lost to Follow-up|1|||
161122025|NCT04153188|581833653|FG000|Overall Study|Withdrawal by Subject|2|||
161122026|NCT04153188|581833654|FG001|Overall Study|Withdrawal by Subject|0|||
161122027|NCT04153188|581833653|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
161122028|NCT04153188|581833654|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
161122029|NCT01489527|581833655|FG000|Overall Study|Pregnancy|9|||
161122030|NCT01489527|581833656|FG001|Overall Study|Pregnancy|14|||
161122031|NCT01489527|581833655|FG000|Overall Study|Participant moved|6|||
161122032|NCT01489527|581833656|FG001|Overall Study|Participant moved|7|||
161122033|NCT01489527|581833655|FG000|Overall Study|Withdrawal by Subject|0|||
161122034|NCT01489527|581833656|FG001|Overall Study|Withdrawal by Subject|4|||
161122035|NCT01489527|581833655|FG000|Overall Study|Lost to Follow-up|5|||
161122036|NCT01489527|581833656|FG001|Overall Study|Lost to Follow-up|1|||
161122037|NCT01489527|581833655|FG000|Overall Study|Procedures|1|||
161122038|NCT01489527|581833656|FG001|Overall Study|Procedures|0|||
161122039|NCT01489527|581833655|FG000|Overall Study|Not compliant|1|||
161122040|NCT01489527|581833656|FG001|Overall Study|Not compliant|0|||
161122041|NCT00700271|581833657|FG000|Overall Study|Adverse Event|4|||
161122042|NCT00700271|581833658|FG001|Overall Study|Adverse Event|6|||
161122043|NCT00700271|581833657|FG000|Overall Study|Protocol Violation|1|||
161122044|NCT00700271|581833658|FG001|Overall Study|Protocol Violation|0|||
161122045|NCT00700271|581833657|FG000|Overall Study|Administrative Reasons|1|||
161122046|NCT00700271|581833658|FG001|Overall Study|Administrative Reasons|0|||
161122047|NCT00700271|581833657|FG000|Overall Study|Withdrawal by Subject|6|||
161122048|NCT00700271|581833658|FG001|Overall Study|Withdrawal by Subject|4|||
161122049|NCT00700271|581833657|FG000|Overall Study|Lost to Follow-up|2|||
161122050|NCT00700271|581833658|FG001|Overall Study|Lost to Follow-up|2|||
161122051|NCT02926950|581833659|FG000|Overall Study|Adverse Event|4|||
161122052|NCT02926950|581833660|FG001|Overall Study|Adverse Event|6|||
161122053|NCT02926950|581833659|FG000|Overall Study|At the participant's own request|21|||
161122054|NCT02926950|581833660|FG001|Overall Study|At the participant's own request|25|||
161122055|NCT02926950|581833659|FG000|Overall Study|Reason not Specified|17|||
161122056|NCT02926950|581833660|FG001|Overall Study|Reason not Specified|9|||
161122057|NCT02926950|581833659|FG000|Overall Study|Lost to Follow-up|7|||
161122058|NCT02926950|581833660|FG001|Overall Study|Lost to Follow-up|8|||
161122059|NCT03087955|581835107|FG000|Overall Study|Death|4|||
161122060|NCT03087955|581835108|FG001|Overall Study|Death|0|||
161122061|NCT03087955|581835107|FG000|Overall Study|Lack of Efficacy|2|||
161122062|NCT03087955|581835108|FG001|Overall Study|Lack of Efficacy|0|||
161122063|NCT03087955|581835107|FG000|Overall Study|Lost to Follow-up|1|||
161122064|NCT03087955|581835108|FG001|Overall Study|Lost to Follow-up|0|||
161122065|NCT03266016|581835115|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
161122066|NCT03266016|581835116|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161122067|NCT03266016|581835117|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161122068|NCT03266016|581835118|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
161122069|NCT03266016|581835115|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
161122070|NCT03266016|581835116|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
161122071|NCT03266016|581835117|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
161122072|NCT03266016|581835118|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
161122073|NCT05280756|581835119|FG000|Overall Study|Lost to Follow-up|1|||
160884774|NCT01842633|580973073|FG002|Overall Study|Technical issues|0|||
160884775|NCT02093351|580973077|FG000|Part A|Adverse Event|0|||
160884776|NCT02093351|580973078|FG001|Part A|Adverse Event|1|||
160884777|NCT02093351|580973079|FG002|Part A|Adverse Event|1|||
160884778|NCT02093351|580973080|FG003|Part A|Adverse Event|0|||
160884779|NCT02093351|580973077|FG000|Part A|Condition under investigation worsened|2|||
160884780|NCT02093351|580973078|FG001|Part A|Condition under investigation worsened|0|||
160884781|NCT02093351|580973079|FG002|Part A|Condition under investigation worsened|2|||
160884782|NCT02093351|580973080|FG003|Part A|Condition under investigation worsened|0|||
160884783|NCT02093351|580973077|FG000|Part A|Death|0|||
160884784|NCT02093351|580973078|FG001|Part A|Death|1|||
160884785|NCT02093351|580973079|FG002|Part A|Death|0|||
160884786|NCT02093351|580973080|FG003|Part A|Death|0|||
160884787|NCT02093351|580973077|FG000|Part B|Patient decision|0|||
160884788|NCT02093351|580973078|FG001|Part B|Patient decision|0|||
160884789|NCT02093351|580973079|FG002|Part B|Patient decision|0|||
160884790|NCT02093351|580973080|FG003|Part B|Patient decision|3|||
160884791|NCT02093351|580973077|FG000|Part B|Disease progression|0|||
160884792|NCT02093351|580973078|FG001|Part B|Disease progression|0|||
160884793|NCT02093351|580973079|FG002|Part B|Disease progression|0|||
160884794|NCT02093351|580973080|FG003|Part B|Disease progression|4|||
160884795|NCT02093351|580973077|FG000|Part B|Complete response|0|||
160884796|NCT02093351|580973078|FG001|Part B|Complete response|0|||
160884797|NCT02093351|580973079|FG002|Part B|Complete response|0|||
160884798|NCT02093351|580973080|FG003|Part B|Complete response|1|||
160884799|NCT02093351|580973077|FG000|Part B|Adverse event + disease progression|0|||
160884800|NCT02093351|580973078|FG001|Part B|Adverse event + disease progression|0|||
160884801|NCT02093351|580973079|FG002|Part B|Adverse event + disease progression|0|||
160884802|NCT02093351|580973080|FG003|Part B|Adverse event + disease progression|1|||
160884803|NCT02093351|580973077|FG000|Part B|Lack of therapeutic response|0|||
160884804|NCT02093351|580973078|FG001|Part B|Lack of therapeutic response|0|||
160884805|NCT02093351|580973079|FG002|Part B|Lack of therapeutic response|0|||
160884806|NCT02093351|580973080|FG003|Part B|Lack of therapeutic response|12|||
160884807|NCT02093351|580973077|FG000|Part B|Condition under investigation worsened|0|||
160884808|NCT02093351|580973078|FG001|Part B|Condition under investigation worsened|0|||
160884809|NCT02093351|580973079|FG002|Part B|Condition under investigation worsened|0|||
160884810|NCT02093351|580973080|FG003|Part B|Condition under investigation worsened|39|||
160884811|NCT02093351|580973077|FG000|Part B|Adverse Event|0|||
160884812|NCT02093351|580973078|FG001|Part B|Adverse Event|0|||
160884813|NCT02093351|580973079|FG002|Part B|Adverse Event|0|||
160884814|NCT02093351|580973080|FG003|Part B|Adverse Event|2|||
160884815|NCT02093351|580973077|FG000|Part B|Death|0|||
160884816|NCT02093351|580973078|FG001|Part B|Death|0|||
160884817|NCT02093351|580973079|FG002|Part B|Death|0|||
161122074|NCT05280756|581835120|FG001|Overall Study|Lost to Follow-up|1|||
161122075|NCT00768898|581835121|FG000|Overall Study|Unrelated injury|1|||
161122076|NCT00768898|581835121|FG000|Overall Study|Headache|1|||
161122077|NCT01777763|581835134|FG000|Overall Study|Adverse Event|2|||
161122078|NCT01777763|581835135|FG001|Overall Study|Adverse Event|32|||
161122079|NCT01777763|581835134|FG000|Overall Study|Protocol Violation|1|||
161122080|NCT01777763|581835135|FG001|Overall Study|Protocol Violation|7|||
161122081|NCT01777763|581835134|FG000|Overall Study|Withdrawal by Subject|0|||
161122082|NCT01777763|581835135|FG001|Overall Study|Withdrawal by Subject|2|||
161122083|NCT01777763|581835134|FG000|Overall Study|Treatment Failure|1|||
161122084|NCT01777763|581835135|FG001|Overall Study|Treatment Failure|6|||
161122085|NCT02968810|581835139|FG000|Overall Study|Lost to Follow-up|1|||
161122086|NCT02968810|581835140|FG001|Overall Study|Lost to Follow-up|0|||
161122087|NCT02968810|581835139|FG000|Overall Study|Physician Decision|1|||
161122088|NCT02968810|581835140|FG001|Overall Study|Physician Decision|0|||
161122089|NCT02968810|581835139|FG000|Overall Study|Withdrawal by Subject|1|||
161122090|NCT02968810|581835140|FG001|Overall Study|Withdrawal by Subject|3|||
161122091|NCT02968810|581835139|FG000|Overall Study|Disease Progression|0|||
161122092|NCT02968810|581835140|FG001|Overall Study|Disease Progression|1|||
161122093|NCT02787850|581835142|FG000|Overall Study|Withdrawal by Subject|0|||
160884818|NCT02093351|580973080|FG003|Part B|Death|1|||
160884819|NCT03565367|580973081|FG000|Overall Study|No scan due to technical issues|4|||
160884820|NCT03565367|580973082|FG001|Overall Study|No scan due to technical issues|0|||
160884821|NCT01099709|580973085|FG000|Period 1|Withdrawal by Subject|0|||
160884822|NCT01099709|580973086|FG001|Period 1|Withdrawal by Subject|1|||
160884823|NCT01099709|580973085|FG000|Period 1|Positive cotinine test|0|||
160884824|NCT01099709|580973086|FG001|Period 1|Positive cotinine test|1|||
160884825|NCT01099709|580973085|FG000|Period 1|Adverse Event|1|||
160884826|NCT01099709|580973086|FG001|Period 1|Adverse Event|0|||
160884827|NCT00923364|580973088|FG000|Overall Study|Death|3|||
160884828|NCT00923364|580973089|FG001|Overall Study|Death|0|||
160884829|NCT00923364|580973088|FG000|Overall Study|Did not go to transplant|1|||
161122094|NCT02787850|581835143|FG001|Overall Study|Withdrawal by Subject|1|||
161122095|NCT03718143|581835144|FG000|Overall Study|Death|1|||
161122096|NCT03718143|581835145|FG001|Overall Study|Death|0|||
161122097|NCT03718143|581835146|FG002|Overall Study|Death|0|||
161122098|NCT03718143|581835144|FG000|Overall Study|Progression of Disease|1|||
160884830|NCT00923364|580973089|FG001|Overall Study|Did not go to transplant|0|||
160884831|NCT00976508|580973091|FG000|Overall Study|Death|7|||
161227809|NCT03992196|582215205|FG002|Treatment|Withdrawal by parent/guardian|2|||
161227810|NCT00755196|582215207|FG000|Overall Study|Lost to Follow-up|1|||
161227811|NCT00755196|582215207|FG000|Overall Study|Lack of Efficiency|1|||
161227812|NCT02388763|582215208|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
161227813|NCT02388763|582215209|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
161227814|NCT02388763|582215208|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
161227815|NCT02388763|582215209|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
161227816|NCT01604850|582215210|FG000|Overall Study|Enrolled but never treated|0|||
161227817|NCT01604850|582215211|FG001|Overall Study|Enrolled but never treated|1|||
161227818|NCT01604850|582215210|FG000|Overall Study|Efficacy Failure|50|||
161227819|NCT01604850|582215211|FG001|Overall Study|Efficacy Failure|29|||
161227820|NCT01604850|582215210|FG000|Overall Study|Lost to Follow-up|1|||
161227821|NCT01604850|582215211|FG001|Overall Study|Lost to Follow-up|0|||
161227822|NCT01604850|582215210|FG000|Overall Study|Subject withdrew consent|1|||
161227823|NCT01604850|582215211|FG001|Overall Study|Subject withdrew consent|0|||
161227824|NCT01703832|582215212|FG000|Overall Study|Withdrawal by Subject|1|||
161227825|NCT01703832|582215213|FG001|Overall Study|Withdrawal by Subject|0|||
161227826|NCT00243932|582215214|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
161227827|NCT00243932|582215215|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
161227828|NCT00243932|582215216|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
161227829|NCT01458405|582215222|FG000|Phase 1 (up to 12 Months)|Other|0|||
161227830|NCT01458405|582215223|FG001|Phase 1 (up to 12 Months)|Other|1|||
160884832|NCT00976508|580973092|FG001|Overall Study|Death|1|||
161227831|NCT01458405|582215224|FG002|Phase 1 (up to 12 Months)|Other|0|||
161122099|NCT03718143|581835145|FG001|Overall Study|Progression of Disease|0|||
161122100|NCT03718143|581835146|FG002|Overall Study|Progression of Disease|0|||
161122101|NCT03718143|581835144|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161122102|NCT03718143|581835145|FG001|Overall Study|Withdrawal of Informed Consent|2|||
161122103|NCT03718143|581835146|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161122104|NCT03905863|581835147|FG000|Overall Study|Adverse Event|2|||
161122105|NCT03905863|581835148|FG001|Overall Study|Adverse Event|4|||
161122106|NCT03905863|581835147|FG000|Overall Study|Withdrawal by Subject|2|||
161122107|NCT03905863|581835148|FG001|Overall Study|Withdrawal by Subject|2|||
161122108|NCT03905863|581835147|FG000|Overall Study|Physician Decision|0|||
161122109|NCT03905863|581835148|FG001|Overall Study|Physician Decision|3|||
161122110|NCT03905863|581835147|FG000|Overall Study|Lost to Follow-up|1|||
161122111|NCT03905863|581835148|FG001|Overall Study|Lost to Follow-up|0|||
161122112|NCT03905863|581835147|FG000|Overall Study|Protocol Violation|0|||
161122113|NCT03905863|581835148|FG001|Overall Study|Protocol Violation|2|||
161122114|NCT03905863|581835147|FG000|Overall Study|Death|0|||
161122115|NCT03905863|581835148|FG001|Overall Study|Death|1|||
161122116|NCT02944448|581835149|FG000|Overall Study|Adverse Event|37|||
161122117|NCT02944448|581835150|FG001|Overall Study|Adverse Event|6|||
161122118|NCT02944448|581835149|FG000|Overall Study|Lack of Efficacy|8|||
161122119|NCT02944448|581835150|FG001|Overall Study|Lack of Efficacy|5|||
161122120|NCT02944448|581835149|FG000|Overall Study|Lost to Follow-up|3|||
161122121|NCT02944448|581835150|FG001|Overall Study|Lost to Follow-up|1|||
161122122|NCT02944448|581835149|FG000|Overall Study|Protocol Violation|25|||
161122123|NCT02944448|581835150|FG001|Overall Study|Protocol Violation|7|||
161122124|NCT02944448|581835149|FG000|Overall Study|Withdrawal by Subject|14|||
161122125|NCT02944448|581835150|FG001|Overall Study|Withdrawal by Subject|4|||
161122126|NCT02944448|581835149|FG000|Overall Study|Sponsor did not supply drug in time|0|||
161122127|NCT02944448|581835150|FG001|Overall Study|Sponsor did not supply drug in time|1|||
161122128|NCT02944448|581835149|FG000|Overall Study|Noncompliant with dosing|1|||
161122129|NCT02944448|581835150|FG001|Overall Study|Noncompliant with dosing|0|||
161122130|NCT02944448|581835149|FG000|Overall Study|Abnormal laboratory values|1|||
161227832|NCT01458405|582215225|FG003|Phase 1 (up to 12 Months)|Other|0|||
161227833|NCT01458405|582215222|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
161227834|NCT01458405|582215223|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
161227835|NCT01458405|582215224|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
161227836|NCT01458405|582215225|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
161227837|NCT01458405|582215222|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161227838|NCT01458405|582215223|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161227839|NCT01458405|582215224|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
161227840|NCT01458405|582215225|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
161227841|NCT01458405|582215222|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161227842|NCT01458405|582215223|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161227843|NCT01458405|582215224|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
161227844|NCT01458405|582215225|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
161227845|NCT02497781|582215226|FG000|Overall Study|Withdrawal by Subject|2|||
161227846|NCT02497781|582215227|FG001|Overall Study|Withdrawal by Subject|0|||
161227847|NCT02497781|582215226|FG000|Overall Study|Lack of Efficacy|0|||
161227848|NCT02497781|582215227|FG001|Overall Study|Lack of Efficacy|1|||
161227849|NCT02497781|582215226|FG000|Overall Study|Randomised but not treated|1|||
161227850|NCT02497781|582215227|FG001|Overall Study|Randomised but not treated|1|||
161227851|NCT02497781|582215226|FG000|Overall Study|Lost to Follow-up|1|||
161227852|NCT02497781|582215227|FG001|Overall Study|Lost to Follow-up|1|||
161227853|NCT01193608|582215228|FG000|Overall Study|Other|0|||
161227854|NCT01193608|582215229|FG001|Overall Study|Other|1|||
161227855|NCT01193608|582215230|FG002|Overall Study|Other|0|||
161227856|NCT01193608|582215231|FG003|Overall Study|Other|0|||
161227857|NCT01193608|582215232|FG004|Overall Study|Other|0|||
161227858|NCT01193608|582215233|FG005|Overall Study|Other|0|||
161227859|NCT01193608|582215228|FG000|Overall Study|Withdrawal by Subject|0|||
161227860|NCT01193608|582215229|FG001|Overall Study|Withdrawal by Subject|1|||
161227861|NCT01193608|582215230|FG002|Overall Study|Withdrawal by Subject|2|||
161227862|NCT01193608|582215231|FG003|Overall Study|Withdrawal by Subject|3|||
161227863|NCT01193608|582215232|FG004|Overall Study|Withdrawal by Subject|3|||
161227864|NCT01193608|582215233|FG005|Overall Study|Withdrawal by Subject|0|||
161227865|NCT01193608|582215228|FG000|Overall Study|Lost to Follow-up|0|||
161227866|NCT01193608|582215229|FG001|Overall Study|Lost to Follow-up|0|||
161227867|NCT01193608|582215230|FG002|Overall Study|Lost to Follow-up|0|||
161227868|NCT01193608|582215231|FG003|Overall Study|Lost to Follow-up|0|||
161227869|NCT01193608|582215232|FG004|Overall Study|Lost to Follow-up|1|||
161227870|NCT01193608|582215233|FG005|Overall Study|Lost to Follow-up|2|||
161227871|NCT01193608|582215228|FG000|Overall Study|Adverse Event|0|||
161227872|NCT01193608|582215229|FG001|Overall Study|Adverse Event|0|||
161227873|NCT01193608|582215230|FG002|Overall Study|Adverse Event|0|||
161227874|NCT01193608|582215231|FG003|Overall Study|Adverse Event|0|||
161227875|NCT01193608|582215232|FG004|Overall Study|Adverse Event|1|||
161227876|NCT01193608|582215233|FG005|Overall Study|Adverse Event|0|||
161227877|NCT01249664|582215234|FG000|Overall Study|Withdrawal by Subject|5|||
161227878|NCT01249664|582215235|FG001|Overall Study|Withdrawal by Subject|0|||
161227879|NCT01249664|582215234|FG000|Overall Study|Adverse Event|1|||
161227880|NCT01249664|582215235|FG001|Overall Study|Adverse Event|0|||
161227881|NCT01400113|582215236|FG000|Overall Study|Withdrawal by Subject|1|||
161227882|NCT01400113|582215237|FG001|Overall Study|Withdrawal by Subject|1|||
161227883|NCT00282256|582215238|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
161227884|NCT00282256|582215238|FG000|Extension Treatment Period|Adverse Event|2|||
161227885|NCT01025037|582215243|FG000|Overall Study|Adverse Event|3|||
161227886|NCT01025037|582215243|FG000|Overall Study|Lost to Follow-up|7|||
161227887|NCT01025037|582215243|FG000|Overall Study|Withdrawal by Subject|1|||
161227888|NCT03661528|582215244|FG000|Overall Study|Death|1|||
161227889|NCT03661528|582215245|FG001|Overall Study|Death|0|||
161227890|NCT03661528|582215244|FG000|Overall Study|Physician Decision|3|||
161227891|NCT03661528|582215245|FG001|Overall Study|Physician Decision|1|||
161227892|NCT03661528|582215244|FG000|Overall Study|Other than Specified|5|||
161227893|NCT03661528|582215245|FG001|Overall Study|Other than Specified|2|||
161227894|NCT03661528|582215244|FG000|Overall Study|Withdrawal by Subject|5|||
161227895|NCT03661528|582215245|FG001|Overall Study|Withdrawal by Subject|3|||
161227896|NCT03661528|582215244|FG000|Overall Study|Disease Progression|8|||
161227897|NCT03661528|582215245|FG001|Overall Study|Disease Progression|13|||
161227898|NCT03661528|582215244|FG000|Overall Study|Adverse Event|61|||
161227899|NCT03661528|582215245|FG001|Overall Study|Adverse Event|55|||
161227900|NCT03130699|582215246|FG000|Overall Study|Lost to Follow-up|34|||
161227901|NCT03130699|582215247|FG001|Overall Study|Lost to Follow-up|37|||
161227902|NCT03130699|582215248|FG002|Overall Study|Lost to Follow-up|26|||
161227903|NCT03130699|582215246|FG000|Overall Study|Withdrawal by Subject|5|||
161227904|NCT03130699|582215247|FG001|Overall Study|Withdrawal by Subject|1|||
161227905|NCT03130699|582215248|FG002|Overall Study|Withdrawal by Subject|0|||
161227906|NCT03130699|582215246|FG000|Overall Study|Withdrawal by PI|1|||
161227907|NCT03130699|582215247|FG001|Overall Study|Withdrawal by PI|2|||
161227908|NCT03130699|582215248|FG002|Overall Study|Withdrawal by PI|5|||
161227909|NCT03130699|582215246|FG000|Overall Study|Death|0|||
161227910|NCT03130699|582215247|FG001|Overall Study|Death|0|||
161227911|NCT03130699|582215248|FG002|Overall Study|Death|1|||
161227912|NCT04534283|582215251|FG000|Overall Study|Physician Decision|2|||
161227913|NCT04534283|582215251|FG000|Overall Study|Withdrawal by Subject|1|||
160884833|NCT00976508|580973091|FG000|Overall Study|Lost to Follow-up|1|||
161227914|NCT04534283|582215251|FG000|Overall Study|Disease Progression|12|||
161122131|NCT02944448|581835150|FG001|Overall Study|Abnormal laboratory values|0|||
161122132|NCT01449708|581835160|FG000|Overall Study|Protocol Violation|0|||
161122133|NCT01449708|581835161|FG001|Overall Study|Protocol Violation|1|||
161122134|NCT01449708|581835160|FG000|Overall Study|surgical complication|1|||
161122135|NCT01449708|581835161|FG001|Overall Study|surgical complication|2|||
161122136|NCT01449708|581835160|FG000|Overall Study|respiratory failure|1|||
161122137|NCT01449708|581835161|FG001|Overall Study|respiratory failure|0|||
161122138|NCT01396005|581835164|FG000|Overall Study|Withdrawal by Subject|0|||
161122139|NCT01396005|581835165|FG001|Overall Study|Withdrawal by Subject|1|||
161122140|NCT01396005|581835164|FG000|Overall Study|Non-compliance with protocol|0|||
161122141|NCT01396005|581835165|FG001|Overall Study|Non-compliance with protocol|1|||
161122142|NCT01467492|581835166|FG000|Overall Study|Withdrawal by Subject|6|||
161122143|NCT01467492|581835167|FG001|Overall Study|Withdrawal by Subject|4|||
161122144|NCT01467492|581835166|FG000|Overall Study|Study Terminated by Sponsor|6|||
161122145|NCT01467492|581835167|FG001|Overall Study|Study Terminated by Sponsor|4|||
161122146|NCT01467492|581835166|FG000|Overall Study|Adverse Event|4|||
161122147|NCT01467492|581835167|FG001|Overall Study|Adverse Event|3|||
161122148|NCT01467492|581835166|FG000|Overall Study|Lost to Follow-up|3|||
161122149|NCT01467492|581835167|FG001|Overall Study|Lost to Follow-up|2|||
161122150|NCT01467492|581835166|FG000|Overall Study|Undefined|2|||
161122151|NCT01467492|581835167|FG001|Overall Study|Undefined|0|||
161122152|NCT01467492|581835166|FG000|Overall Study|Enrolled But Not Treated|1|||
161122153|NCT01467492|581835167|FG001|Overall Study|Enrolled But Not Treated|0|||
161122154|NCT03529773|581835171|FG000|Overall Study|Adverse Event|0|||
161122155|NCT03529773|581835172|FG001|Overall Study|Adverse Event|0|||
161122156|NCT03529773|581835173|FG002|Overall Study|Adverse Event|0|||
161122157|NCT03529773|581835174|FG003|Overall Study|Adverse Event|0|||
161122158|NCT03529773|581835175|FG004|Overall Study|Adverse Event|0|||
161122159|NCT03529773|581835176|FG005|Overall Study|Adverse Event|0|||
161122160|NCT03529773|581835177|FG006|Overall Study|Adverse Event|0|||
161122161|NCT03529773|581835178|FG007|Overall Study|Adverse Event|0|||
161122162|NCT03529773|581835179|FG008|Overall Study|Adverse Event|0|||
161122163|NCT03529773|581835180|FG009|Overall Study|Adverse Event|0|||
161122164|NCT03529773|581835181|FG010|Overall Study|Adverse Event|0|||
161122165|NCT03529773|581835182|FG011|Overall Study|Adverse Event|0|||
161122166|NCT03529773|581835183|FG012|Overall Study|Adverse Event|0|||
161122167|NCT03529773|581835184|FG013|Overall Study|Adverse Event|0|||
161122168|NCT03529773|581835185|FG014|Overall Study|Adverse Event|0|||
161122169|NCT03529773|581835186|FG015|Overall Study|Adverse Event|0|||
161122170|NCT03529773|581835187|FG016|Overall Study|Adverse Event|0|||
161122171|NCT03529773|581835188|FG017|Overall Study|Adverse Event|0|||
161122172|NCT03529773|581835189|FG018|Overall Study|Adverse Event|0|||
161122173|NCT03529773|581835190|FG019|Overall Study|Adverse Event|0|||
161122174|NCT03529773|581835191|FG020|Overall Study|Adverse Event|0|||
161122175|NCT03529773|581835192|FG021|Overall Study|Adverse Event|0|||
161122176|NCT03529773|581835193|FG022|Overall Study|Adverse Event|0|||
161122177|NCT03529773|581835194|FG023|Overall Study|Adverse Event|0|||
161122178|NCT03529773|581835195|FG024|Overall Study|Adverse Event|0|||
161122179|NCT03529773|581835196|FG025|Overall Study|Adverse Event|0|||
161122180|NCT03529773|581835197|FG026|Overall Study|Adverse Event|0|||
161122181|NCT03529773|581835198|FG027|Overall Study|Adverse Event|0|||
161122182|NCT03529773|581835199|FG028|Overall Study|Adverse Event|0|||
161122183|NCT03529773|581835200|FG029|Overall Study|Adverse Event|0|||
161122184|NCT03529773|581835201|FG030|Overall Study|Adverse Event|1|||
161122185|NCT03529773|581835202|FG031|Overall Study|Adverse Event|0|||
161122186|NCT03529773|581835203|FG032|Overall Study|Adverse Event|0|||
161122187|NCT03529773|581835204|FG033|Overall Study|Adverse Event|0|||
161122188|NCT03529773|581835205|FG034|Overall Study|Adverse Event|0|||
161122189|NCT03529773|581835206|FG035|Overall Study|Adverse Event|1|||
161122190|NCT03529773|581835207|FG036|Overall Study|Adverse Event|0|||
161122191|NCT03529773|581835208|FG037|Overall Study|Adverse Event|0|||
161122192|NCT03529773|581835209|FG038|Overall Study|Adverse Event|1|||
161122193|NCT03529773|581835210|FG039|Overall Study|Adverse Event|1|||
161122194|NCT03529773|581835171|FG000|Overall Study|Death|0|||
161122195|NCT03529773|581835172|FG001|Overall Study|Death|0|||
161122196|NCT03529773|581835173|FG002|Overall Study|Death|0|||
161122197|NCT03529773|581835174|FG003|Overall Study|Death|0|||
161122198|NCT03529773|581835175|FG004|Overall Study|Death|0|||
161122199|NCT03529773|581835176|FG005|Overall Study|Death|0|||
161122200|NCT03529773|581835177|FG006|Overall Study|Death|0|||
161227915|NCT04534283|582215251|FG000|Overall Study|Adverse Event|1|||
161227916|NCT05956665|582215252|FG000|Overall Study|Death|1|||
161227917|NCT05956665|582215252|FG000|Overall Study|Withdrawal by Subject|1|||
161227918|NCT05049460|582215253|FG000|Overall Study|Withdrawal by Subject|2|||
161227919|NCT05049460|582215254|FG001|Overall Study|Withdrawal by Subject|2|||
161227920|NCT05049460|582215253|FG000|Overall Study|Lost to Follow-up|2|||
161227921|NCT05049460|582215254|FG001|Overall Study|Lost to Follow-up|2|||
161227922|NCT00977470|582215255|FG000|Overall Study|Lack of Efficacy|32|||
161227923|NCT00977470|582215256|FG001|Overall Study|Lack of Efficacy|30|||
161227924|NCT00977470|582215255|FG000|Overall Study|Physician Decision|2|||
161227925|NCT00977470|582215256|FG001|Overall Study|Physician Decision|0|||
161227926|NCT00977470|582215255|FG000|Overall Study|Adverse Event|1|||
161324994|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
161324995|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
161324996|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
161324997|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
161324998|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
161227927|NCT00977470|582215256|FG001|Overall Study|Adverse Event|2|||
161227928|NCT00977470|582215255|FG000|Overall Study|Protocol Violation|1|||
161227929|NCT00977470|582215256|FG001|Overall Study|Protocol Violation|0|||
161227930|NCT00977470|582215255|FG000|Overall Study|Withdrawal by Subject|0|||
161227931|NCT00977470|582215256|FG001|Overall Study|Withdrawal by Subject|2|||
161227932|NCT00977470|582215255|FG000|Overall Study|Death|0|||
161227933|NCT00977470|582215256|FG001|Overall Study|Death|2|||
161227934|NCT00977470|582215255|FG000|Overall Study|clinical decline|0|||
161227935|NCT00977470|582215256|FG001|Overall Study|clinical decline|1|||
161227936|NCT00977470|582215255|FG000|Overall Study|prolonged recovery post-surgery|0|||
161227937|NCT00977470|582215256|FG001|Overall Study|prolonged recovery post-surgery|1|||
161227938|NCT00977470|582215255|FG000|Overall Study|Still on-study|2|||
161227939|NCT00977470|582215256|FG001|Overall Study|Still on-study|0|||
161227940|NCT03257462|582215259|FG000|Cohort A|Lost to Follow-up|1|||
161227941|NCT03257462|582215260|FG001|Cohort A|Lost to Follow-up|0|||
161227942|NCT03257462|582215261|FG002|Cohort A|Lost to Follow-up|0|||
161227943|NCT03257462|582215262|FG003|Cohort A|Lost to Follow-up|0|||
161227944|NCT03257462|582215259|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
161227945|NCT03257462|582215260|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
161227946|NCT03257462|582215261|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
161227947|NCT03257462|582215262|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
161227948|NCT00368277|582215263|FG000|Overall Study|Adverse Event|33|||
161122201|NCT03529773|581835178|FG007|Overall Study|Death|0|||
161122202|NCT03529773|581835179|FG008|Overall Study|Death|0|||
161122203|NCT03529773|581835180|FG009|Overall Study|Death|0|||
161122204|NCT03529773|581835181|FG010|Overall Study|Death|0|||
161122205|NCT03529773|581835182|FG011|Overall Study|Death|0|||
161122206|NCT03529773|581835183|FG012|Overall Study|Death|1|||
161122207|NCT03529773|581835184|FG013|Overall Study|Death|0|||
161122208|NCT03529773|581835185|FG014|Overall Study|Death|0|||
161122209|NCT03529773|581835186|FG015|Overall Study|Death|0|||
161122210|NCT03529773|581835187|FG016|Overall Study|Death|0|||
161122211|NCT03529773|581835188|FG017|Overall Study|Death|0|||
161122212|NCT03529773|581835189|FG018|Overall Study|Death|0|||
161122213|NCT03529773|581835190|FG019|Overall Study|Death|1|||
161122214|NCT03529773|581835191|FG020|Overall Study|Death|0|||
161122215|NCT03529773|581835192|FG021|Overall Study|Death|0|||
161122216|NCT03529773|581835193|FG022|Overall Study|Death|1|||
161122217|NCT03529773|581835194|FG023|Overall Study|Death|0|||
161122218|NCT03529773|581835195|FG024|Overall Study|Death|0|||
161122219|NCT03529773|581835196|FG025|Overall Study|Death|0|||
161122220|NCT03529773|581835197|FG026|Overall Study|Death|0|||
161122221|NCT03529773|581835198|FG027|Overall Study|Death|0|||
161122222|NCT03529773|581835199|FG028|Overall Study|Death|0|||
161122223|NCT03529773|581835200|FG029|Overall Study|Death|0|||
161227949|NCT00368277|582215264|FG001|Overall Study|Adverse Event|49|||
161227950|NCT00368277|582215263|FG000|Overall Study|Death|2|||
161227951|NCT00368277|582215264|FG001|Overall Study|Death|1|||
161227952|NCT00368277|582215263|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
161227953|NCT00368277|582215264|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
161227954|NCT00368277|582215263|FG000|Overall Study|Protocol deviation|7|||
161122224|NCT03529773|581835201|FG030|Overall Study|Death|0|||
161122225|NCT03529773|581835202|FG031|Overall Study|Death|0|||
161122226|NCT03529773|581835203|FG032|Overall Study|Death|0|||
161122227|NCT03529773|581835204|FG033|Overall Study|Death|1|||
161122228|NCT03529773|581835205|FG034|Overall Study|Death|1|||
161122229|NCT03529773|581835206|FG035|Overall Study|Death|0|||
161122230|NCT03529773|581835207|FG036|Overall Study|Death|1|||
161227955|NCT00368277|582215264|FG001|Overall Study|Protocol deviation|0|||
161324999|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
160884834|NCT00976508|580973092|FG001|Overall Study|Lost to Follow-up|0|||
160884835|NCT00976508|580973091|FG000|Overall Study|Withdrawal by Subject|1|||
161122231|NCT03529773|581835208|FG037|Overall Study|Death|0|||
161122232|NCT03529773|581835209|FG038|Overall Study|Death|0|||
161122233|NCT03529773|581835210|FG039|Overall Study|Death|0|||
161122234|NCT03529773|581835171|FG000|Overall Study|Lost to Follow-up|0|||
161122235|NCT03529773|581835172|FG001|Overall Study|Lost to Follow-up|0|||
161122236|NCT03529773|581835173|FG002|Overall Study|Lost to Follow-up|1|||
161122237|NCT03529773|581835174|FG003|Overall Study|Lost to Follow-up|0|||
161122238|NCT03529773|581835175|FG004|Overall Study|Lost to Follow-up|1|||
161122239|NCT03529773|581835176|FG005|Overall Study|Lost to Follow-up|1|||
161122240|NCT03529773|581835177|FG006|Overall Study|Lost to Follow-up|0|||
161122241|NCT03529773|581835178|FG007|Overall Study|Lost to Follow-up|0|||
161122242|NCT03529773|581835179|FG008|Overall Study|Lost to Follow-up|0|||
161122243|NCT03529773|581835180|FG009|Overall Study|Lost to Follow-up|0|||
161122244|NCT03529773|581835181|FG010|Overall Study|Lost to Follow-up|0|||
161122245|NCT03529773|581835182|FG011|Overall Study|Lost to Follow-up|0|||
161122246|NCT03529773|581835183|FG012|Overall Study|Lost to Follow-up|0|||
161122247|NCT03529773|581835184|FG013|Overall Study|Lost to Follow-up|1|||
161122248|NCT03529773|581835185|FG014|Overall Study|Lost to Follow-up|4|||
161122249|NCT03529773|581835186|FG015|Overall Study|Lost to Follow-up|1|||
161122250|NCT03529773|581835187|FG016|Overall Study|Lost to Follow-up|1|||
161122251|NCT03529773|581835188|FG017|Overall Study|Lost to Follow-up|0|||
161122252|NCT03529773|581835189|FG018|Overall Study|Lost to Follow-up|1|||
161122253|NCT03529773|581835190|FG019|Overall Study|Lost to Follow-up|1|||
161122254|NCT03529773|581835191|FG020|Overall Study|Lost to Follow-up|2|||
161122255|NCT03529773|581835192|FG021|Overall Study|Lost to Follow-up|4|||
161122256|NCT03529773|581835193|FG022|Overall Study|Lost to Follow-up|3|||
161122257|NCT03529773|581835194|FG023|Overall Study|Lost to Follow-up|4|||
161122258|NCT03529773|581835195|FG024|Overall Study|Lost to Follow-up|3|||
161122259|NCT03529773|581835196|FG025|Overall Study|Lost to Follow-up|5|||
161122260|NCT03529773|581835197|FG026|Overall Study|Lost to Follow-up|5|||
161122261|NCT03529773|581835198|FG027|Overall Study|Lost to Follow-up|0|||
161122262|NCT03529773|581835199|FG028|Overall Study|Lost to Follow-up|0|||
161122263|NCT03529773|581835200|FG029|Overall Study|Lost to Follow-up|0|||
161122264|NCT03529773|581835201|FG030|Overall Study|Lost to Follow-up|1|||
161122265|NCT03529773|581835202|FG031|Overall Study|Lost to Follow-up|0|||
161122266|NCT03529773|581835203|FG032|Overall Study|Lost to Follow-up|0|||
161122267|NCT03529773|581835204|FG033|Overall Study|Lost to Follow-up|1|||
161122268|NCT03529773|581835205|FG034|Overall Study|Lost to Follow-up|1|||
161122269|NCT03529773|581835206|FG035|Overall Study|Lost to Follow-up|0|||
161122270|NCT03529773|581835207|FG036|Overall Study|Lost to Follow-up|0|||
161122271|NCT03529773|581835208|FG037|Overall Study|Lost to Follow-up|3|||
161122272|NCT03529773|581835209|FG038|Overall Study|Lost to Follow-up|1|||
161122273|NCT03529773|581835210|FG039|Overall Study|Lost to Follow-up|1|||
161122274|NCT03529773|581835171|FG000|Overall Study|No longer meets eligibility criteria|0|||
161122275|NCT03529773|581835172|FG001|Overall Study|No longer meets eligibility criteria|0|||
161122276|NCT03529773|581835173|FG002|Overall Study|No longer meets eligibility criteria|0|||
161122277|NCT03529773|581835174|FG003|Overall Study|No longer meets eligibility criteria|0|||
161122278|NCT03529773|581835175|FG004|Overall Study|No longer meets eligibility criteria|0|||
161122279|NCT03529773|581835176|FG005|Overall Study|No longer meets eligibility criteria|0|||
161122280|NCT03529773|581835177|FG006|Overall Study|No longer meets eligibility criteria|0|||
161122281|NCT03529773|581835178|FG007|Overall Study|No longer meets eligibility criteria|0|||
161122282|NCT03529773|581835179|FG008|Overall Study|No longer meets eligibility criteria|0|||
161122283|NCT03529773|581835180|FG009|Overall Study|No longer meets eligibility criteria|0|||
161122284|NCT03529773|581835181|FG010|Overall Study|No longer meets eligibility criteria|0|||
161122285|NCT03529773|581835182|FG011|Overall Study|No longer meets eligibility criteria|0|||
161122286|NCT03529773|581835183|FG012|Overall Study|No longer meets eligibility criteria|0|||
161122287|NCT03529773|581835184|FG013|Overall Study|No longer meets eligibility criteria|0|||
161122288|NCT03529773|581835185|FG014|Overall Study|No longer meets eligibility criteria|0|||
161122289|NCT03529773|581835186|FG015|Overall Study|No longer meets eligibility criteria|0|||
161122290|NCT03529773|581835187|FG016|Overall Study|No longer meets eligibility criteria|0|||
161122291|NCT03529773|581835188|FG017|Overall Study|No longer meets eligibility criteria|0|||
161122292|NCT03529773|581835189|FG018|Overall Study|No longer meets eligibility criteria|0|||
161122293|NCT03529773|581835190|FG019|Overall Study|No longer meets eligibility criteria|0|||
161122294|NCT03529773|581835191|FG020|Overall Study|No longer meets eligibility criteria|0|||
161122295|NCT03529773|581835192|FG021|Overall Study|No longer meets eligibility criteria|0|||
161122296|NCT03529773|581835193|FG022|Overall Study|No longer meets eligibility criteria|1|||
161122297|NCT03529773|581835194|FG023|Overall Study|No longer meets eligibility criteria|0|||
161122298|NCT03529773|581835195|FG024|Overall Study|No longer meets eligibility criteria|0|||
161122299|NCT03529773|581835196|FG025|Overall Study|No longer meets eligibility criteria|0|||
161122300|NCT03529773|581835197|FG026|Overall Study|No longer meets eligibility criteria|0|||
161122301|NCT03529773|581835198|FG027|Overall Study|No longer meets eligibility criteria|0|||
161325000|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
160884836|NCT00976508|580973092|FG001|Overall Study|Withdrawal by Subject|0|||
160884837|NCT00976508|580973091|FG000|Overall Study|Disease Progression|4|||
160884838|NCT00976508|580973092|FG001|Overall Study|Disease Progression|4|||
160884839|NCT00976508|580973091|FG000|Overall Study|Subject Enrolled in Hospice|1|||
160884840|NCT00976508|580973092|FG001|Overall Study|Subject Enrolled in Hospice|0|||
160884841|NCT00976508|580973091|FG000|Overall Study|Terminated by the Sponsor|0|||
160884842|NCT00976508|580973092|FG001|Overall Study|Terminated by the Sponsor|1|||
160884843|NCT04352127|580973093|FG000|Overall Study|Unable to obtain readings|4|||
160884844|NCT04352127|580973094|FG001|Overall Study|Unable to obtain readings|1|||
160884845|NCT05954143|580973099|FG000|Overall Study|Progressive Disease|1|||
160884846|NCT05954143|580973100|FG001|Overall Study|Progressive Disease|0|||
160884847|NCT05954143|580973099|FG000|Overall Study|Physician Decision|1|||
160884848|NCT05954143|580973100|FG001|Overall Study|Physician Decision|0|||
160884849|NCT05954143|580973099|FG000|Overall Study|Study Terminated by Sponsor|2|||
160884850|NCT05954143|580973100|FG001|Overall Study|Study Terminated by Sponsor|4|||
160884851|NCT05954143|580973099|FG000|Overall Study|Death|1|||
161122302|NCT03529773|581835199|FG028|Overall Study|No longer meets eligibility criteria|0|||
160884852|NCT05954143|580973100|FG001|Overall Study|Death|0|||
160884853|NCT05954143|580973099|FG000|Overall Study|Withdrawal by Subject|0|||
161122303|NCT03529773|581835200|FG029|Overall Study|No longer meets eligibility criteria|0|||
161122304|NCT03529773|581835201|FG030|Overall Study|No longer meets eligibility criteria|0|||
161122305|NCT03529773|581835202|FG031|Overall Study|No longer meets eligibility criteria|0|||
161122306|NCT03529773|581835203|FG032|Overall Study|No longer meets eligibility criteria|0|||
161122307|NCT03529773|581835204|FG033|Overall Study|No longer meets eligibility criteria|0|||
161122308|NCT03529773|581835205|FG034|Overall Study|No longer meets eligibility criteria|0|||
161122309|NCT03529773|581835206|FG035|Overall Study|No longer meets eligibility criteria|0|||
161122310|NCT03529773|581835207|FG036|Overall Study|No longer meets eligibility criteria|0|||
161122311|NCT03529773|581835208|FG037|Overall Study|No longer meets eligibility criteria|0|||
161122312|NCT03529773|581835209|FG038|Overall Study|No longer meets eligibility criteria|1|||
161122313|NCT03529773|581835210|FG039|Overall Study|No longer meets eligibility criteria|0|||
161122314|NCT03529773|581835171|FG000|Overall Study|Other|0|||
161122315|NCT03529773|581835172|FG001|Overall Study|Other|0|||
161122316|NCT03529773|581835173|FG002|Overall Study|Other|0|||
161122317|NCT03529773|581835174|FG003|Overall Study|Other|0|||
161122318|NCT03529773|581835175|FG004|Overall Study|Other|0|||
161122319|NCT03529773|581835176|FG005|Overall Study|Other|0|||
161122320|NCT03529773|581835177|FG006|Overall Study|Other|0|||
161122321|NCT03529773|581835178|FG007|Overall Study|Other|0|||
161122322|NCT03529773|581835179|FG008|Overall Study|Other|0|||
161122323|NCT03529773|581835180|FG009|Overall Study|Other|0|||
161122324|NCT03529773|581835181|FG010|Overall Study|Other|0|||
161122325|NCT03529773|581835182|FG011|Overall Study|Other|0|||
161122326|NCT03529773|581835183|FG012|Overall Study|Other|1|||
161122327|NCT03529773|581835184|FG013|Overall Study|Other|0|||
161122328|NCT03529773|581835185|FG014|Overall Study|Other|2|||
161122329|NCT03529773|581835186|FG015|Overall Study|Other|0|||
161122330|NCT03529773|581835187|FG016|Overall Study|Other|0|||
161122331|NCT03529773|581835188|FG017|Overall Study|Other|3|||
161122332|NCT03529773|581835189|FG018|Overall Study|Other|0|||
161122333|NCT03529773|581835190|FG019|Overall Study|Other|0|||
161122334|NCT03529773|581835191|FG020|Overall Study|Other|1|||
161122335|NCT03529773|581835192|FG021|Overall Study|Other|0|||
161122336|NCT03529773|581835193|FG022|Overall Study|Other|1|||
161122337|NCT03529773|581835194|FG023|Overall Study|Other|0|||
161122338|NCT03529773|581835195|FG024|Overall Study|Other|3|||
161122339|NCT03529773|581835196|FG025|Overall Study|Other|2|||
161122340|NCT03529773|581835197|FG026|Overall Study|Other|2|||
161122341|NCT03529773|581835198|FG027|Overall Study|Other|0|||
161122342|NCT03529773|581835199|FG028|Overall Study|Other|0|||
161122343|NCT03529773|581835200|FG029|Overall Study|Other|0|||
161122344|NCT03529773|581835201|FG030|Overall Study|Other|0|||
161122345|NCT03529773|581835202|FG031|Overall Study|Other|0|||
161122346|NCT03529773|581835203|FG032|Overall Study|Other|0|||
160884854|NCT05954143|580973100|FG001|Overall Study|Withdrawal by Subject|1|||
161122347|NCT03529773|581835204|FG033|Overall Study|Other|0|||
161122348|NCT03529773|581835205|FG034|Overall Study|Other|1|||
161122349|NCT03529773|581835206|FG035|Overall Study|Other|1|||
161122350|NCT03529773|581835207|FG036|Overall Study|Other|0|||
161122351|NCT03529773|581835208|FG037|Overall Study|Other|0|||
161227956|NCT00368277|582215263|FG000|Overall Study|Patient withdrew consent|32|||
161227957|NCT00368277|582215264|FG001|Overall Study|Patient withdrew consent|28|||
160884855|NCT05954143|580973099|FG000|Overall Study|Other|1|||
160884856|NCT05954143|580973100|FG001|Overall Study|Other|0|||
160884857|NCT02496676|580973102|FG000|Phase 1 - Period 1|Adverse Event|0|||
161122352|NCT03529773|581835209|FG038|Overall Study|Other|0|||
161122353|NCT03529773|581835210|FG039|Overall Study|Other|0|||
161227958|NCT00368277|582215263|FG000|Overall Study|Lost to Follow-up|8|||
160884858|NCT02496676|580973103|FG001|Phase 1 - Period 1|Adverse Event|1|||
161122354|NCT03529773|581835171|FG000|Overall Study|Physician Decision|0|||
161122355|NCT03529773|581835172|FG001|Overall Study|Physician Decision|0|||
161122356|NCT03529773|581835173|FG002|Overall Study|Physician Decision|0|||
160884859|NCT02496676|580973102|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
160884860|NCT02496676|580973103|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
161122357|NCT03529773|581835174|FG003|Overall Study|Physician Decision|0|||
161122358|NCT03529773|581835175|FG004|Overall Study|Physician Decision|0|||
161122359|NCT03529773|581835176|FG005|Overall Study|Physician Decision|0|||
161122360|NCT03529773|581835177|FG006|Overall Study|Physician Decision|0|||
161122361|NCT03529773|581835178|FG007|Overall Study|Physician Decision|0|||
161122362|NCT03529773|581835179|FG008|Overall Study|Physician Decision|0|||
161122363|NCT03529773|581835180|FG009|Overall Study|Physician Decision|0|||
161122364|NCT03529773|581835181|FG010|Overall Study|Physician Decision|0|||
160884861|NCT05442775|580973104|FG000|Overall Study|Trial terminated|61|||
160884862|NCT05442775|580973104|FG000|Overall Study|Lack of Efficacy|4|||
160884863|NCT05442775|580973104|FG000|Overall Study|Withdrawal by Subject|4|||
160884864|NCT05442775|580973104|FG000|Overall Study|Death|1|||
160884865|NCT05442775|580973104|FG000|Overall Study|Participant removed at Sponsor request|1|||
160884866|NCT03459690|580973106|FG000|Overall Study|Lost to Follow-up|0|||
160884867|NCT03459690|580973107|FG001|Overall Study|Lost to Follow-up|1|||
160884868|NCT03459690|580973106|FG000|Overall Study|Withdrawal by Subject|1|||
160884869|NCT03459690|580973107|FG001|Overall Study|Withdrawal by Subject|1|||
160884870|NCT02963831|580973109|FG000|Overall Study|Progressive Disease|3|||
160884871|NCT02963831|580973110|FG001|Overall Study|Progressive Disease|3|||
160884872|NCT02963831|580973111|FG002|Overall Study|Progressive Disease|16|||
160884873|NCT02963831|580973112|FG003|Overall Study|Progressive Disease|27|||
161227959|NCT00368277|582215264|FG001|Overall Study|Lost to Follow-up|6|||
161227960|NCT06354270|582215265|FG000|Overall Study|Withdrawal by Subject|1|||
161227961|NCT06354270|582215266|FG001|Overall Study|Withdrawal by Subject|0|||
161227962|NCT05097989|582215267|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227963|NCT05097989|582215268|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227964|NCT05097989|582215269|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227965|NCT05097989|582215270|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227966|NCT05097989|582215271|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227967|NCT05097989|582215272|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
161227968|NCT05097989|582215273|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227969|NCT05097989|582215274|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161122365|NCT03529773|581835182|FG011|Overall Study|Physician Decision|0|||
161122366|NCT03529773|581835183|FG012|Overall Study|Physician Decision|0|||
161122367|NCT03529773|581835184|FG013|Overall Study|Physician Decision|0|||
161122368|NCT03529773|581835185|FG014|Overall Study|Physician Decision|0|||
161122369|NCT03529773|581835186|FG015|Overall Study|Physician Decision|0|||
161122370|NCT03529773|581835187|FG016|Overall Study|Physician Decision|0|||
161122371|NCT03529773|581835188|FG017|Overall Study|Physician Decision|0|||
161122372|NCT03529773|581835189|FG018|Overall Study|Physician Decision|0|||
161122373|NCT03529773|581835190|FG019|Overall Study|Physician Decision|1|||
161122374|NCT03529773|581835191|FG020|Overall Study|Physician Decision|1|||
161122375|NCT03529773|581835192|FG021|Overall Study|Physician Decision|0|||
161122376|NCT03529773|581835193|FG022|Overall Study|Physician Decision|0|||
161122377|NCT03529773|581835194|FG023|Overall Study|Physician Decision|0|||
161122378|NCT03529773|581835195|FG024|Overall Study|Physician Decision|0|||
161122379|NCT03529773|581835196|FG025|Overall Study|Physician Decision|0|||
161122380|NCT03529773|581835197|FG026|Overall Study|Physician Decision|0|||
161122381|NCT03529773|581835198|FG027|Overall Study|Physician Decision|0|||
161122382|NCT03529773|581835199|FG028|Overall Study|Physician Decision|0|||
161227970|NCT05097989|582215275|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
161227971|NCT05097989|582215267|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
161325001|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
161325002|NCT03569098|582578060|FG000|Double-Blind Treatment Cycle 1|Other|1|||
161325003|NCT03569098|582578061|FG001|Double-Blind Treatment Cycle 1|Other|0|||
161325004|NCT03569098|582578062|FG002|Double-Blind Treatment Cycle 1|Other|1|||
161325005|NCT03569098|582578060|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
161325006|NCT03569098|582578061|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
161325007|NCT03569098|582578062|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
161325008|NCT03569098|582578060|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
161325009|NCT03569098|582578061|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
161325010|NCT03569098|582578062|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
161325011|NCT03569098|582578060|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
161325012|NCT03569098|582578061|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
161325013|NCT03569098|582578062|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
161325014|NCT03569098|582578060|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
161325015|NCT03569098|582578061|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
161325016|NCT03569098|582578062|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
161325017|NCT03569098|582578060|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
161325018|NCT03569098|582578061|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
161325019|NCT03569098|582578062|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
161325020|NCT03569098|582578060|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
161325021|NCT03569098|582578061|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
161325022|NCT03569098|582578062|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
161325023|NCT02581488|582578067|FG000|Overall Study|Adverse Event|6|||
161325024|NCT02581488|582578068|FG001|Overall Study|Adverse Event|7|||
161325025|NCT02581488|582578067|FG000|Overall Study|Lost to Follow-up|1|||
161325026|NCT02581488|582578068|FG001|Overall Study|Lost to Follow-up|0|||
161325027|NCT02581488|582578067|FG000|Overall Study|Withdrawal by Subject|1|||
161325028|NCT02581488|582578068|FG001|Overall Study|Withdrawal by Subject|0|||
161325029|NCT02581488|582578067|FG000|Overall Study|Non-Compliance|1|||
161325030|NCT02581488|582578068|FG001|Overall Study|Non-Compliance|0|||
161325031|NCT02581488|582578067|FG000|Overall Study|Protocol Violation|0|||
161325032|NCT02581488|582578068|FG001|Overall Study|Protocol Violation|4|||
161325033|NCT02915159|582578071|FG000|Overall Study|Participant no longer meets criteria|2|||
161325034|NCT02915159|582578072|FG001|Overall Study|Participant no longer meets criteria|0|||
161325035|NCT02915159|582578071|FG000|Overall Study|poor/non-compliance|1|||
161325036|NCT02915159|582578072|FG001|Overall Study|poor/non-compliance|0|||
161325037|NCT02915159|582578071|FG000|Overall Study|Participant withdrew consent|5|||
161325038|NCT02915159|582578072|FG001|Overall Study|Participant withdrew consent|1|||
161325039|NCT02915159|582578071|FG000|Overall Study|Request to discontinue treatment|1|||
161325040|NCT02915159|582578072|FG001|Overall Study|Request to discontinue treatment|2|||
161325041|NCT02915159|582578071|FG000|Overall Study|Adverse Event|2|||
161325042|NCT02915159|582578072|FG001|Overall Study|Adverse Event|2|||
161325043|NCT02915159|582578071|FG000|Overall Study|Lack of Efficacy|0|||
161325044|NCT02915159|582578072|FG001|Overall Study|Lack of Efficacy|3|||
161325045|NCT04534517|582578073|FG000|Overall Study|Adverse Event|1|||
161325046|NCT04534517|582578073|FG000|Overall Study|Withdrawal by Subject|1|||
161325047|NCT04534517|582578073|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161325048|NCT04534517|582578073|FG000|Overall Study|COVID-19 Related|1|||
161325049|NCT02121795|582578074|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
161325050|NCT02121795|582578075|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
161325051|NCT02121795|582578074|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
161325052|NCT02121795|582578075|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
161325053|NCT02121795|582578074|FG000|Double-Blind Phase|Lost to Follow-up|7|||
161325054|NCT02121795|582578075|FG001|Double-Blind Phase|Lost to Follow-up|4|||
161325055|NCT02121795|582578074|FG000|Double-Blind Phase|Physician Decision|2|||
161325056|NCT02121795|582578075|FG001|Double-Blind Phase|Physician Decision|5|||
161325057|NCT02121795|582578074|FG000|Double-Blind Phase|Adverse Event|5|||
161325058|NCT02121795|582578075|FG001|Double-Blind Phase|Adverse Event|0|||
161325059|NCT02121795|582578074|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161325060|NCT02121795|582578075|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161325061|NCT02121795|582578074|FG000|Double-Blind Phase|Protocol Violation|0|||
161325062|NCT02121795|582578075|FG001|Double-Blind Phase|Protocol Violation|3|||
161325063|NCT02121795|582578074|FG000|Double-Blind Phase|Death|1|||
161325064|NCT02121795|582578075|FG001|Double-Blind Phase|Death|1|||
161325065|NCT02121795|582578074|FG000|Open-Label Phase|Physician Decision|8|||
161325066|NCT02121795|582578075|FG001|Open-Label Phase|Physician Decision|8|||
161325067|NCT02121795|582578074|FG000|Open-Label Phase|Withdrawal by Subject|3|||
161325068|NCT02121795|582578075|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161325069|NCT02121795|582578074|FG000|Open-Label Phase|Lost to Follow-up|1|||
161325070|NCT02121795|582578075|FG001|Open-Label Phase|Lost to Follow-up|0|||
161122383|NCT03529773|581835200|FG029|Overall Study|Physician Decision|0|||
161122384|NCT03529773|581835201|FG030|Overall Study|Physician Decision|0|||
161122385|NCT03529773|581835202|FG031|Overall Study|Physician Decision|0|||
161122386|NCT03529773|581835203|FG032|Overall Study|Physician Decision|0|||
161122387|NCT03529773|581835204|FG033|Overall Study|Physician Decision|0|||
161122388|NCT03529773|581835205|FG034|Overall Study|Physician Decision|0|||
161122389|NCT03529773|581835206|FG035|Overall Study|Physician Decision|0|||
161122390|NCT03529773|581835207|FG036|Overall Study|Physician Decision|0|||
161122391|NCT03529773|581835208|FG037|Overall Study|Physician Decision|0|||
161122392|NCT03529773|581835209|FG038|Overall Study|Physician Decision|0|||
161122393|NCT03529773|581835210|FG039|Overall Study|Physician Decision|0|||
161122394|NCT03529773|581835171|FG000|Overall Study|Protocol Violation|0|||
161122395|NCT03529773|581835172|FG001|Overall Study|Protocol Violation|0|||
161122396|NCT03529773|581835173|FG002|Overall Study|Protocol Violation|0|||
161122397|NCT03529773|581835174|FG003|Overall Study|Protocol Violation|0|||
161122398|NCT03529773|581835175|FG004|Overall Study|Protocol Violation|0|||
161325071|NCT00823264|582578076|FG000|Overall Study|Protocol Violation|2|||
161325072|NCT00823264|582578077|FG001|Overall Study|Protocol Violation|0|||
161325073|NCT01914393|582578078|FG000|Overall Study|Protocol Violation|11|||
161325074|NCT01914393|582578079|FG001|Overall Study|Protocol Violation|3|||
161325075|NCT01914393|582578080|FG002|Overall Study|Protocol Violation|19|||
161325076|NCT01914393|582578078|FG000|Overall Study|Lack of Efficacy|11|||
161325077|NCT01914393|582578079|FG001|Overall Study|Lack of Efficacy|16|||
161325078|NCT01914393|582578080|FG002|Overall Study|Lack of Efficacy|5|||
161325079|NCT01914393|582578078|FG000|Overall Study|no reason given|14|||
161325080|NCT01914393|582578079|FG001|Overall Study|no reason given|8|||
161325081|NCT01914393|582578080|FG002|Overall Study|no reason given|16|||
161325082|NCT01914393|582578078|FG000|Overall Study|Adverse Event|29|||
161325083|NCT01914393|582578079|FG001|Overall Study|Adverse Event|18|||
161325084|NCT01914393|582578080|FG002|Overall Study|Adverse Event|31|||
161325085|NCT01914393|582578078|FG000|Overall Study|Withdrawal by Subject|38|||
161325086|NCT01914393|582578079|FG001|Overall Study|Withdrawal by Subject|20|||
161325087|NCT01914393|582578080|FG002|Overall Study|Withdrawal by Subject|47|||
161325088|NCT01914393|582578078|FG000|Overall Study|Lost to Follow-up|12|||
161325089|NCT01914393|582578079|FG001|Overall Study|Lost to Follow-up|6|||
161325090|NCT01914393|582578080|FG002|Overall Study|Lost to Follow-up|19|||
161325091|NCT01914393|582578078|FG000|Overall Study|subject never dosed|0|||
161325092|NCT01914393|582578079|FG001|Overall Study|subject never dosed|0|||
161325093|NCT01914393|582578080|FG002|Overall Study|subject never dosed|1|||
161325094|NCT00572455|582578081|FG000|Stage I (14 Days)|Adverse Event|0|||
161325095|NCT00572455|582578082|FG001|Stage I (14 Days)|Adverse Event|0|||
161325096|NCT00572455|582578083|FG002|Stage I (14 Days)|Adverse Event|0|||
161325097|NCT00572455|582578084|FG003|Stage I (14 Days)|Adverse Event|0|||
161325098|NCT00572455|582578085|FG004|Stage I (14 Days)|Adverse Event|0|||
161325099|NCT00572455|582578086|FG005|Stage I (14 Days)|Adverse Event|3|||
161325100|NCT00572455|582578087|FG006|Stage I (14 Days)|Adverse Event|0|||
161325101|NCT00572455|582578088|FG007|Stage I (14 Days)|Adverse Event|0|||
161325102|NCT00572455|582578089|FG008|Stage I (14 Days)|Adverse Event|0|||
161325103|NCT00572455|582578090|FG009|Stage I (14 Days)|Adverse Event|0|||
161325104|NCT00572455|582578091|FG010|Stage I (14 Days)|Adverse Event|0|||
161325105|NCT00572455|582578092|FG011|Stage I (14 Days)|Adverse Event|0|||
161325106|NCT00572455|582578093|FG012|Stage I (14 Days)|Adverse Event|0|||
161325107|NCT00572455|582578094|FG013|Stage I (14 Days)|Adverse Event|0|||
161325108|NCT00572455|582578081|FG000|Stage I (14 Days)|Other|0|||
161325109|NCT00572455|582578082|FG001|Stage I (14 Days)|Other|0|||
161325110|NCT00572455|582578083|FG002|Stage I (14 Days)|Other|0|||
161325111|NCT00572455|582578084|FG003|Stage I (14 Days)|Other|0|||
161325112|NCT00572455|582578085|FG004|Stage I (14 Days)|Other|1|||
161325113|NCT00572455|582578086|FG005|Stage I (14 Days)|Other|0|||
161325114|NCT00572455|582578087|FG006|Stage I (14 Days)|Other|0|||
161325115|NCT00572455|582578088|FG007|Stage I (14 Days)|Other|0|||
161325116|NCT00572455|582578089|FG008|Stage I (14 Days)|Other|0|||
161325117|NCT00572455|582578090|FG009|Stage I (14 Days)|Other|0|||
161325118|NCT00572455|582578091|FG010|Stage I (14 Days)|Other|0|||
161325119|NCT00572455|582578092|FG011|Stage I (14 Days)|Other|0|||
161325120|NCT00572455|582578093|FG012|Stage I (14 Days)|Other|0|||
161325121|NCT00572455|582578094|FG013|Stage I (14 Days)|Other|0|||
161325122|NCT00572455|582578081|FG000|Stage II (28 Days)|Adverse Event|0|||
161325123|NCT00572455|582578082|FG001|Stage II (28 Days)|Adverse Event|0|||
161325124|NCT00572455|582578083|FG002|Stage II (28 Days)|Adverse Event|0|||
161325125|NCT00572455|582578084|FG003|Stage II (28 Days)|Adverse Event|0|||
161325126|NCT00572455|582578085|FG004|Stage II (28 Days)|Adverse Event|0|||
161325127|NCT00572455|582578086|FG005|Stage II (28 Days)|Adverse Event|0|||
161325128|NCT00572455|582578087|FG006|Stage II (28 Days)|Adverse Event|0|||
161325129|NCT00572455|582578088|FG007|Stage II (28 Days)|Adverse Event|0|||
161325130|NCT00572455|582578089|FG008|Stage II (28 Days)|Adverse Event|1|||
161325131|NCT00572455|582578090|FG009|Stage II (28 Days)|Adverse Event|3|||
161325132|NCT00572455|582578091|FG010|Stage II (28 Days)|Adverse Event|3|||
161325133|NCT00572455|582578092|FG011|Stage II (28 Days)|Adverse Event|4|||
161325134|NCT00572455|582578093|FG012|Stage II (28 Days)|Adverse Event|5|||
161325135|NCT00572455|582578094|FG013|Stage II (28 Days)|Adverse Event|1|||
161325136|NCT00572455|582578081|FG000|Stage II (28 Days)|Death|0|||
161325137|NCT00572455|582578082|FG001|Stage II (28 Days)|Death|0|||
161325138|NCT00572455|582578083|FG002|Stage II (28 Days)|Death|0|||
161325139|NCT00572455|582578084|FG003|Stage II (28 Days)|Death|0|||
161325140|NCT00572455|582578085|FG004|Stage II (28 Days)|Death|0|||
161325141|NCT00572455|582578086|FG005|Stage II (28 Days)|Death|0|||
161325142|NCT00572455|582578087|FG006|Stage II (28 Days)|Death|0|||
161325143|NCT00572455|582578088|FG007|Stage II (28 Days)|Death|0|||
161325144|NCT00572455|582578089|FG008|Stage II (28 Days)|Death|1|||
161325145|NCT00572455|582578090|FG009|Stage II (28 Days)|Death|0|||
161325146|NCT00572455|582578091|FG010|Stage II (28 Days)|Death|0|||
161325147|NCT00572455|582578092|FG011|Stage II (28 Days)|Death|0|||
161325148|NCT00572455|582578093|FG012|Stage II (28 Days)|Death|0|||
161325149|NCT00572455|582578094|FG013|Stage II (28 Days)|Death|0|||
161325150|NCT00572455|582578081|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
161325151|NCT00572455|582578082|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
161325152|NCT00572455|582578083|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
161227972|NCT05097989|582215268|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
161227973|NCT05097989|582215269|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
161227974|NCT05097989|582215270|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
161227975|NCT05097989|582215271|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
161227976|NCT05097989|582215272|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
161325153|NCT00572455|582578084|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
161325154|NCT00572455|582578085|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
161325155|NCT00572455|582578086|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
161325156|NCT00572455|582578087|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
161325157|NCT00572455|582578088|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
161325158|NCT00572455|582578089|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
161325159|NCT00572455|582578090|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
161325160|NCT00572455|582578091|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
161325161|NCT00572455|582578092|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
161325162|NCT00572455|582578093|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
161325163|NCT00572455|582578094|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
161325164|NCT00572455|582578081|FG000|Stage II (28 Days)|Other|0|||
161325165|NCT00572455|582578082|FG001|Stage II (28 Days)|Other|0|||
161325166|NCT00572455|582578083|FG002|Stage II (28 Days)|Other|0|||
161325167|NCT00572455|582578084|FG003|Stage II (28 Days)|Other|0|||
161325168|NCT00572455|582578085|FG004|Stage II (28 Days)|Other|0|||
161325169|NCT00572455|582578086|FG005|Stage II (28 Days)|Other|0|||
161325170|NCT00572455|582578087|FG006|Stage II (28 Days)|Other|0|||
161325171|NCT00572455|582578088|FG007|Stage II (28 Days)|Other|0|||
161325172|NCT00572455|582578089|FG008|Stage II (28 Days)|Other|1|||
161325173|NCT00572455|582578090|FG009|Stage II (28 Days)|Other|0|||
161325174|NCT00572455|582578091|FG010|Stage II (28 Days)|Other|0|||
161325175|NCT00572455|582578092|FG011|Stage II (28 Days)|Other|0|||
161325176|NCT00572455|582578093|FG012|Stage II (28 Days)|Other|0|||
161325177|NCT00572455|582578094|FG013|Stage II (28 Days)|Other|0|||
161325178|NCT00572455|582578081|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
161325179|NCT00572455|582578082|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
161325180|NCT00572455|582578083|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
161325181|NCT00572455|582578084|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
161325182|NCT00572455|582578085|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
161325183|NCT00572455|582578086|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
161325184|NCT00572455|582578087|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
161325185|NCT00572455|582578088|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
161325186|NCT00572455|582578089|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
161325187|NCT00572455|582578090|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
161325188|NCT00572455|582578091|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
161325189|NCT00572455|582578092|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
161325190|NCT00572455|582578093|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
161325191|NCT00572455|582578094|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
161325192|NCT00856999|582578095|FG000|Overall Study|Withdrawal by Subject|5|||
161325193|NCT02465437|582578096|FG000|Overall Study|Physician Decision|0|||
161325194|NCT02465437|582578097|FG001|Overall Study|Physician Decision|0|||
160884874|NCT02963831|580973109|FG000|Overall Study|Withdrawal by Subject|1|||
161122399|NCT03529773|581835176|FG005|Overall Study|Protocol Violation|0|||
161325195|NCT02465437|582578098|FG002|Overall Study|Physician Decision|1|||
161325196|NCT02465437|582578099|FG003|Overall Study|Physician Decision|0|||
161325197|NCT02465437|582578096|FG000|Overall Study|Withdrawal by Subject|1|||
161325198|NCT02465437|582578097|FG001|Overall Study|Withdrawal by Subject|0|||
161325199|NCT02465437|582578098|FG002|Overall Study|Withdrawal by Subject|0|||
161325200|NCT02465437|582578099|FG003|Overall Study|Withdrawal by Subject|1|||
161325201|NCT02465437|582578096|FG000|Overall Study|Adverse Event|0|||
160884875|NCT02963831|580973110|FG001|Overall Study|Withdrawal by Subject|0|||
160884876|NCT02963831|580973111|FG002|Overall Study|Withdrawal by Subject|2|||
160884877|NCT02963831|580973112|FG003|Overall Study|Withdrawal by Subject|4|||
161325202|NCT02465437|582578097|FG001|Overall Study|Adverse Event|1|||
161325203|NCT02465437|582578098|FG002|Overall Study|Adverse Event|0|||
161325204|NCT02465437|582578099|FG003|Overall Study|Adverse Event|0|||
161325205|NCT00003483|582578100|FG000|Overall Study|Not evaluable|1|||
161325206|NCT01308463|582578101|FG000|Overall Study|Study Discontinued|23|||
161325207|NCT01308463|582578101|FG000|Overall Study|Death|4|||
161325208|NCT01308463|582578101|FG000|Overall Study|Revision|2|||
161325209|NCT00103662|582578104|FG000|Overall Study|Entered Rescue Procedure|0|||
161325210|NCT00103662|582578105|FG001|Overall Study|Entered Rescue Procedure|7|||
161325211|NCT00103662|582578104|FG000|Overall Study|Death|7|||
161325212|NCT00103662|582578105|FG001|Overall Study|Death|7|||
161325213|NCT00103662|582578104|FG000|Overall Study|Elective Withdrawal|5|||
160884878|NCT02963831|580973109|FG000|Overall Study|Adverse Event|0|||
160884879|NCT02963831|580973110|FG001|Overall Study|Adverse Event|1|||
160884880|NCT02963831|580973111|FG002|Overall Study|Adverse Event|1|||
160884881|NCT02963831|580973112|FG003|Overall Study|Adverse Event|2|||
160884882|NCT02963831|580973109|FG000|Overall Study|Death|0|||
160884883|NCT02963831|580973110|FG001|Overall Study|Death|0|||
160884884|NCT02963831|580973111|FG002|Overall Study|Death|0|||
160884885|NCT02963831|580973112|FG003|Overall Study|Death|2|||
160884886|NCT01966432|580973113|FG000|Overall Study|Lost to Follow-up|3|||
160884887|NCT01966432|580973114|FG001|Overall Study|Lost to Follow-up|2|||
160884888|NCT01966432|580973115|FG002|Overall Study|Lost to Follow-up|5|||
160884889|NCT01966432|580973113|FG000|Overall Study|Withdrawal by Subject|1|||
160884890|NCT01966432|580973114|FG001|Overall Study|Withdrawal by Subject|3|||
160884891|NCT01966432|580973115|FG002|Overall Study|Withdrawal by Subject|0|||
160884892|NCT01966432|580973113|FG000|Overall Study|Subject Incarcerated|0|||
160884893|NCT01966432|580973114|FG001|Overall Study|Subject Incarcerated|0|||
160884894|NCT01966432|580973115|FG002|Overall Study|Subject Incarcerated|1|||
160884895|NCT01966432|580973113|FG000|Overall Study|SBIRT program ended|1|||
160884896|NCT01966432|580973114|FG001|Overall Study|SBIRT program ended|8|||
160884897|NCT01966432|580973115|FG002|Overall Study|SBIRT program ended|20|||
160884898|NCT02536404|580973120|FG000|Overall Study|Adverse Event|5|||
160884899|NCT02536404|580973121|FG001|Overall Study|Adverse Event|0|||
160884900|NCT02536404|580973120|FG000|Overall Study|Withdrawal by Subject|4|||
160884901|NCT02536404|580973121|FG001|Overall Study|Withdrawal by Subject|1|||
160884902|NCT02536404|580973120|FG000|Overall Study|Physician Decision|10|||
160884903|NCT02536404|580973121|FG001|Overall Study|Physician Decision|0|||
160884904|NCT02536404|580973120|FG000|Overall Study|Sponsor decision|1|||
160884905|NCT02536404|580973121|FG001|Overall Study|Sponsor decision|0|||
160884906|NCT02514473|580973122|FG000|Overall Study|Adverse Event|0|||
160884907|NCT02514473|580973123|FG001|Overall Study|Adverse Event|2|||
160884908|NCT02514473|580973122|FG000|Overall Study|Withdrawal by Subject|2|||
160884909|NCT02514473|580973123|FG001|Overall Study|Withdrawal by Subject|1|||
160884910|NCT02514473|580973122|FG000|Overall Study|Lost to Follow-up|0|||
160884911|NCT02514473|580973123|FG001|Overall Study|Lost to Follow-up|1|||
160884912|NCT02514473|580973122|FG000|Overall Study|Other|1|||
160884913|NCT02514473|580973123|FG001|Overall Study|Other|1|||
160884914|NCT04381988|580973124|FG000|Overall Study|The study was terminated|4|||
160884915|NCT04381988|580973125|FG001|Overall Study|The study was terminated|0|||
160884916|NCT02106923|580973126|FG000|Overall Study|Protocol Violation|0|||
160884917|NCT02106923|580973127|FG001|Overall Study|Protocol Violation|0|||
160884918|NCT02106923|580973128|FG002|Overall Study|Protocol Violation|0|||
160884919|NCT02106923|580973129|FG003|Overall Study|Protocol Violation|0|||
160884920|NCT02106923|580973130|FG004|Overall Study|Protocol Violation|0|||
160884921|NCT02106923|580973131|FG005|Overall Study|Protocol Violation|1|||
160884922|NCT03485495|580973132|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
160884923|NCT03485495|580973133|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
160884924|NCT03915860|580973134|FG000|Overall Study|Adverse Event|3|||
160884925|NCT03915860|580973134|FG000|Overall Study|Withdrawal by Subject|6|||
160884926|NCT03915860|580973134|FG000|Overall Study|Lost to Follow-up|2|||
160884927|NCT03915860|580973134|FG000|Overall Study|Other than specified|3|||
160884928|NCT01107379|580973138|FG000|Overall Study|Withdrawal by Subject|18|||
160884929|NCT01107379|580973138|FG000|Overall Study|Lost to Follow-up|3|||
160884930|NCT04559529|580973139|FG000|First Intervention (1 Day)|Adverse Event|0|||
160884931|NCT04559529|580973140|FG001|First Intervention (1 Day)|Adverse Event|0|||
161122400|NCT03529773|581835177|FG006|Overall Study|Protocol Violation|0|||
161122401|NCT03529773|581835178|FG007|Overall Study|Protocol Violation|0|||
161122402|NCT03529773|581835179|FG008|Overall Study|Protocol Violation|0|||
161122403|NCT03529773|581835180|FG009|Overall Study|Protocol Violation|0|||
161122404|NCT03529773|581835181|FG010|Overall Study|Protocol Violation|0|||
161122405|NCT03529773|581835182|FG011|Overall Study|Protocol Violation|0|||
161122406|NCT03529773|581835183|FG012|Overall Study|Protocol Violation|0|||
161122407|NCT03529773|581835184|FG013|Overall Study|Protocol Violation|0|||
161227977|NCT05097989|582215273|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
161227978|NCT05097989|582215274|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
161227979|NCT05097989|582215275|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
160884932|NCT04559529|580973141|FG002|First Intervention (1 Day)|Adverse Event|0|||
160884933|NCT04559529|580973142|FG003|First Intervention (1 Day)|Adverse Event|1|||
160884934|NCT04559529|580973139|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
160884935|NCT04559529|580973140|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
160884936|NCT04559529|580973141|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
160884937|NCT04559529|580973142|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
160884938|NCT04559529|580973139|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
160884939|NCT04559529|580973140|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
160884940|NCT04559529|580973141|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
160884941|NCT04559529|580973142|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
160884942|NCT01009281|580973143|FG000|Overall Study|Administrative problems|7|||
161122408|NCT03529773|581835185|FG014|Overall Study|Protocol Violation|0|||
160884943|NCT00924170|580973144|FG000|Overall Study|Refused further treatment|0|||
160884944|NCT00924170|580973145|FG001|Overall Study|Refused further treatment|1|||
160884945|NCT00924170|580973144|FG000|Overall Study|Physician Decision|0|||
160884946|NCT00924170|580973145|FG001|Overall Study|Physician Decision|1|||
161227980|NCT05097989|582215267|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161227981|NCT05097989|582215268|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161227982|NCT05097989|582215269|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161227983|NCT05097989|582215270|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161227984|NCT05097989|582215271|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161227985|NCT05097989|582215272|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
161227986|NCT05097989|582215273|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
161227987|NCT05097989|582215274|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
161227988|NCT05097989|582215275|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
161227989|NCT05097989|582215267|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161227990|NCT05097989|582215268|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161227991|NCT05097989|582215269|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
161227992|NCT05097989|582215270|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161227993|NCT05097989|582215271|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161227994|NCT05097989|582215272|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
161227995|NCT05097989|582215273|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161227996|NCT05097989|582215274|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
161227997|NCT05097989|582215275|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
161227998|NCT05097989|582215267|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161227999|NCT05097989|582215268|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228000|NCT05097989|582215269|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
161228001|NCT05097989|582215270|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228002|NCT05097989|582215271|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228003|NCT05097989|582215272|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228004|NCT05097989|582215273|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228005|NCT05097989|582215274|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228006|NCT05097989|582215275|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
161228007|NCT05097989|582215267|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228008|NCT05097989|582215268|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
161228009|NCT05097989|582215269|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228010|NCT05097989|582215270|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228011|NCT05097989|582215271|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228012|NCT05097989|582215272|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228013|NCT05097989|582215273|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228014|NCT05097989|582215274|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228015|NCT05097989|582215275|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
161228016|NCT05097989|582215267|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228017|NCT05097989|582215268|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228018|NCT05097989|582215269|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228019|NCT05097989|582215270|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
160884947|NCT00924170|580973144|FG000|Overall Study|Progressive disease|3|||
160884948|NCT00924170|580973145|FG001|Overall Study|Progressive disease|6|||
160884949|NCT00924170|580973144|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
160884950|NCT00924170|580973145|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
160884951|NCT00924170|580973144|FG000|Overall Study|Death|1|||
160884952|NCT00924170|580973145|FG001|Overall Study|Death|0|||
160884953|NCT00899392|580973148|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
160884954|NCT00899392|580973149|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
161122409|NCT03529773|581835186|FG015|Overall Study|Protocol Violation|0|||
161122410|NCT03529773|581835187|FG016|Overall Study|Protocol Violation|0|||
161122411|NCT03529773|581835188|FG017|Overall Study|Protocol Violation|0|||
161122412|NCT03529773|581835189|FG018|Overall Study|Protocol Violation|0|||
161122413|NCT03529773|581835190|FG019|Overall Study|Protocol Violation|0|||
161122414|NCT03529773|581835191|FG020|Overall Study|Protocol Violation|0|||
161122415|NCT03529773|581835192|FG021|Overall Study|Protocol Violation|0|||
161122416|NCT03529773|581835193|FG022|Overall Study|Protocol Violation|0|||
161122417|NCT03529773|581835194|FG023|Overall Study|Protocol Violation|0|||
161122418|NCT03529773|581835195|FG024|Overall Study|Protocol Violation|0|||
161122419|NCT03529773|581835196|FG025|Overall Study|Protocol Violation|0|||
161122420|NCT03529773|581835197|FG026|Overall Study|Protocol Violation|0|||
161122421|NCT03529773|581835198|FG027|Overall Study|Protocol Violation|0|||
161122422|NCT03529773|581835199|FG028|Overall Study|Protocol Violation|0|||
161122423|NCT03529773|581835200|FG029|Overall Study|Protocol Violation|0|||
161122424|NCT03529773|581835201|FG030|Overall Study|Protocol Violation|1|||
161122425|NCT03529773|581835202|FG031|Overall Study|Protocol Violation|0|||
161122426|NCT03529773|581835203|FG032|Overall Study|Protocol Violation|0|||
161122427|NCT03529773|581835204|FG033|Overall Study|Protocol Violation|0|||
161122428|NCT03529773|581835205|FG034|Overall Study|Protocol Violation|0|||
161228020|NCT05097989|582215271|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161122429|NCT03529773|581835206|FG035|Overall Study|Protocol Violation|0|||
161122430|NCT03529773|581835207|FG036|Overall Study|Protocol Violation|0|||
161122431|NCT03529773|581835208|FG037|Overall Study|Protocol Violation|0|||
161122432|NCT03529773|581835209|FG038|Overall Study|Protocol Violation|0|||
161122433|NCT03529773|581835210|FG039|Overall Study|Protocol Violation|0|||
161122434|NCT03529773|581835171|FG000|Overall Study|Withdrawal by Subject|0|||
161325214|NCT00103662|582578105|FG001|Overall Study|Elective Withdrawal|5|||
161325215|NCT00103662|582578104|FG000|Overall Study|Lost to Follow-up|0|||
161325216|NCT00103662|582578105|FG001|Overall Study|Lost to Follow-up|1|||
161325217|NCT00103662|582578104|FG000|Overall Study|Other|6|||
161325218|NCT00103662|582578105|FG001|Overall Study|Other|9|||
161325219|NCT00103662|582578104|FG000|Overall Study|Failed mobilization|0|||
161325220|NCT00103662|582578105|FG001|Overall Study|Failed mobilization|4|||
161325221|NCT00103662|582578104|FG000|Overall Study|Intercurrent illness|1|||
161325222|NCT00103662|582578105|FG001|Overall Study|Intercurrent illness|0|||
161325223|NCT03373760|582578108|FG000|Overall Study|Adverse Event|8|||
161325224|NCT03373760|582578108|FG000|Overall Study|Disease Progression|46|||
161325225|NCT03373760|582578108|FG000|Overall Study|Death|4|||
161325226|NCT01135524|582578121|FG000|Overall Study|Withdrawal by Subject|14|||
161325227|NCT01135524|582578121|FG000|Overall Study|Adverse Event|20|||
161325228|NCT01135524|582578121|FG000|Overall Study|Lost to Follow-up|3|||
161325229|NCT01135524|582578121|FG000|Overall Study|Administrative|151|||
161325230|NCT01135524|582578121|FG000|Overall Study|Lack of Efficacy|8|||
161325231|NCT02907463|582578123|FG000|Overall Study|Lost to Follow-up|17|||
161325232|NCT02907463|582578123|FG000|Overall Study|Death|10|||
161325233|NCT02907463|582578123|FG000|Overall Study|Withdrawal by Subject|4|||
161325234|NCT02907463|582578123|FG000|Overall Study|MIS Approach was not used|2|||
161325235|NCT02907463|582578123|FG000|Overall Study|Not Implanted with Study Device|2|||
161325236|NCT02907463|582578123|FG000|Overall Study|Device Explanted|1|||
161325237|NCT02907463|582578123|FG000|Overall Study|Missing Exit Form|1|||
161325238|NCT01266824|582578124|FG000|Overall Study|Study terminated prior to completion|2|||
161325239|NCT01266824|582578125|FG001|Overall Study|Study terminated prior to completion|3|||
161325240|NCT02302846|582578126|FG000|Overall Study|Withdrawal by Subject|1|||
161325241|NCT01447407|582578129|FG000|Overall Study|Withdrawal by Subject|2|||
161325242|NCT01447407|582578130|FG001|Overall Study|Withdrawal by Subject|0|||
161325243|NCT01447407|582578131|FG002|Overall Study|Withdrawal by Subject|0|||
161325244|NCT01447407|582578132|FG003|Overall Study|Withdrawal by Subject|1|||
161325245|NCT01447407|582578129|FG000|Overall Study|Physician Decision|0|||
161325246|NCT01447407|582578130|FG001|Overall Study|Physician Decision|0|||
161325247|NCT01447407|582578131|FG002|Overall Study|Physician Decision|1|||
161325248|NCT01447407|582578132|FG003|Overall Study|Physician Decision|1|||
161325249|NCT05225558|582578135|FG000|Overall Study|Withdrawal by Subject|4|||
161325250|NCT05225558|582578136|FG001|Overall Study|Withdrawal by Subject|3|||
161325251|NCT05225558|582578135|FG000|Overall Study|Adverse Event|1|||
161325252|NCT05225558|582578136|FG001|Overall Study|Adverse Event|0|||
161122435|NCT03529773|581835172|FG001|Overall Study|Withdrawal by Subject|0|||
161122436|NCT03529773|581835173|FG002|Overall Study|Withdrawal by Subject|0|||
161122437|NCT03529773|581835174|FG003|Overall Study|Withdrawal by Subject|0|||
161122438|NCT03529773|581835175|FG004|Overall Study|Withdrawal by Subject|0|||
161122439|NCT03529773|581835176|FG005|Overall Study|Withdrawal by Subject|0|||
161122440|NCT03529773|581835177|FG006|Overall Study|Withdrawal by Subject|0|||
161122441|NCT03529773|581835178|FG007|Overall Study|Withdrawal by Subject|1|||
161122442|NCT03529773|581835179|FG008|Overall Study|Withdrawal by Subject|0|||
161122443|NCT03529773|581835180|FG009|Overall Study|Withdrawal by Subject|1|||
161122444|NCT03529773|581835181|FG010|Overall Study|Withdrawal by Subject|1|||
161122445|NCT03529773|581835182|FG011|Overall Study|Withdrawal by Subject|0|||
161122446|NCT03529773|581835183|FG012|Overall Study|Withdrawal by Subject|0|||
161122447|NCT03529773|581835184|FG013|Overall Study|Withdrawal by Subject|0|||
161122448|NCT03529773|581835185|FG014|Overall Study|Withdrawal by Subject|0|||
161122449|NCT03529773|581835186|FG015|Overall Study|Withdrawal by Subject|3|||
161122450|NCT03529773|581835187|FG016|Overall Study|Withdrawal by Subject|0|||
161122451|NCT03529773|581835188|FG017|Overall Study|Withdrawal by Subject|2|||
161122452|NCT03529773|581835189|FG018|Overall Study|Withdrawal by Subject|3|||
161325253|NCT05225558|582578135|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
161325254|NCT05225558|582578136|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
161325255|NCT05225558|582578135|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
161325256|NCT05225558|582578136|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
161325257|NCT01001910|582578137|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
161325258|NCT03200548|582578138|FG000|Overall Study|Withdrawal by Subject|5|||
161325259|NCT03200548|582578139|FG001|Overall Study|Withdrawal by Subject|11|||
161325260|NCT03200548|582578140|FG002|Overall Study|Withdrawal by Subject|7|||
161325261|NCT03200548|582578141|FG003|Overall Study|Withdrawal by Subject|6|||
161325262|NCT00313846|582578142|FG000|Overall Study|Withdrawal by Subject|2|||
161325263|NCT00313846|582578143|FG001|Overall Study|Withdrawal by Subject|0|||
161325264|NCT00313846|582578142|FG000|Overall Study|Adverse Event|1|||
161325265|NCT00313846|582578143|FG001|Overall Study|Adverse Event|8|||
161325266|NCT00313846|582578142|FG000|Overall Study|Administrative|2|||
161325267|NCT00313846|582578143|FG001|Overall Study|Administrative|3|||
161325268|NCT01896193|582578144|FG000|Overall Study|Lack of Efficacy|20|||
161325269|NCT01896193|582578145|FG001|Overall Study|Lack of Efficacy|11|||
161325270|NCT01896193|582578144|FG000|Overall Study|Protocol Violation|0|||
161325271|NCT01896193|582578145|FG001|Overall Study|Protocol Violation|1|||
161325272|NCT01896193|582578144|FG000|Overall Study|Withdrew Consent|1|||
161325273|NCT01896193|582578145|FG001|Overall Study|Withdrew Consent|0|||
161325274|NCT02592447|582578148|FG000|Overall Study|Lost to Follow-up|1|||
161325275|NCT02592447|582578149|FG001|Overall Study|Lost to Follow-up|0|||
161325276|NCT02592447|582578148|FG000|Overall Study|Ineligible after randomization|1|||
161325277|NCT02592447|582578149|FG001|Overall Study|Ineligible after randomization|0|||
161325278|NCT02592447|582578148|FG000|Overall Study|Withdrawal by Subject|0|||
161325279|NCT02592447|582578149|FG001|Overall Study|Withdrawal by Subject|1|||
161325280|NCT03428100|582578150|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
161325281|NCT03428100|582578151|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325282|NCT03428100|582578152|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
161325283|NCT03428100|582578153|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
161325284|NCT03428100|582578154|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325285|NCT03428100|582578155|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325286|NCT03428100|582578156|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325287|NCT03428100|582578157|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325288|NCT03428100|582578158|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325289|NCT03428100|582578159|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325290|NCT03428100|582578160|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325291|NCT03428100|582578161|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161122453|NCT03529773|581835190|FG019|Overall Study|Withdrawal by Subject|1|||
161122454|NCT03529773|581835191|FG020|Overall Study|Withdrawal by Subject|3|||
161122455|NCT03529773|581835192|FG021|Overall Study|Withdrawal by Subject|1|||
161122456|NCT03529773|581835193|FG022|Overall Study|Withdrawal by Subject|1|||
161122457|NCT03529773|581835194|FG023|Overall Study|Withdrawal by Subject|2|||
161122458|NCT03529773|581835195|FG024|Overall Study|Withdrawal by Subject|2|||
161122459|NCT03529773|581835196|FG025|Overall Study|Withdrawal by Subject|4|||
161122460|NCT03529773|581835197|FG026|Overall Study|Withdrawal by Subject|2|||
161122461|NCT03529773|581835198|FG027|Overall Study|Withdrawal by Subject|1|||
161122462|NCT03529773|581835199|FG028|Overall Study|Withdrawal by Subject|1|||
161122463|NCT03529773|581835200|FG029|Overall Study|Withdrawal by Subject|0|||
161122464|NCT03529773|581835201|FG030|Overall Study|Withdrawal by Subject|0|||
161122465|NCT03529773|581835202|FG031|Overall Study|Withdrawal by Subject|0|||
161122466|NCT03529773|581835203|FG032|Overall Study|Withdrawal by Subject|0|||
161122467|NCT03529773|581835204|FG033|Overall Study|Withdrawal by Subject|0|||
161122468|NCT03529773|581835205|FG034|Overall Study|Withdrawal by Subject|1|||
161122469|NCT03529773|581835206|FG035|Overall Study|Withdrawal by Subject|2|||
161122470|NCT03529773|581835207|FG036|Overall Study|Withdrawal by Subject|0|||
161122471|NCT03529773|581835208|FG037|Overall Study|Withdrawal by Subject|2|||
161122472|NCT03529773|581835209|FG038|Overall Study|Withdrawal by Subject|1|||
161122473|NCT03529773|581835210|FG039|Overall Study|Withdrawal by Subject|1|||
161122474|NCT03529773|581835171|FG000|Overall Study|Screen Failure|0|||
161122475|NCT03529773|581835172|FG001|Overall Study|Screen Failure|0|||
161122476|NCT03529773|581835173|FG002|Overall Study|Screen Failure|0|||
161122477|NCT03529773|581835174|FG003|Overall Study|Screen Failure|0|||
160885003|NCT02520089|580973155|FG000|Overall Study|Lost to Follow-up|3|||
160885004|NCT02520089|580973156|FG001|Overall Study|Lost to Follow-up|4|||
160885005|NCT01397825|580974867|FG000|Overall Study|Progressive Disease|10|||
160885006|NCT01397825|580974868|FG001|Overall Study|Progressive Disease|3|||
161122478|NCT03529773|581835175|FG004|Overall Study|Screen Failure|0|||
161122479|NCT03529773|581835176|FG005|Overall Study|Screen Failure|0|||
161122480|NCT03529773|581835177|FG006|Overall Study|Screen Failure|0|||
161122481|NCT03529773|581835178|FG007|Overall Study|Screen Failure|0|||
161122482|NCT03529773|581835179|FG008|Overall Study|Screen Failure|0|||
161122483|NCT03529773|581835180|FG009|Overall Study|Screen Failure|0|||
161122484|NCT03529773|581835181|FG010|Overall Study|Screen Failure|0|||
161122485|NCT03529773|581835182|FG011|Overall Study|Screen Failure|0|||
161122486|NCT03529773|581835183|FG012|Overall Study|Screen Failure|0|||
161122487|NCT03529773|581835184|FG013|Overall Study|Screen Failure|0|||
160885007|NCT01397825|580974869|FG002|Overall Study|Progressive Disease|11|||
160885008|NCT01397825|580974870|FG003|Overall Study|Progressive Disease|1|||
161122488|NCT03529773|581835185|FG014|Overall Study|Screen Failure|0|||
161325292|NCT03428100|582578162|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325293|NCT03428100|582578163|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325294|NCT03428100|582578164|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325295|NCT03428100|582578165|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325296|NCT03428100|582578166|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325297|NCT03428100|582578167|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325298|NCT03428100|582578168|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
161325299|NCT03428100|582578150|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
161325300|NCT03428100|582578151|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
161325301|NCT03428100|582578152|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
161325302|NCT03428100|582578153|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
161325303|NCT03428100|582578154|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325304|NCT03428100|582578155|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325305|NCT03428100|582578156|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325306|NCT03428100|582578157|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325307|NCT03428100|582578158|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325308|NCT03428100|582578159|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325309|NCT03428100|582578160|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325310|NCT03428100|582578161|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325311|NCT03428100|582578162|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325312|NCT03428100|582578163|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325313|NCT03428100|582578164|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325314|NCT03428100|582578165|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325315|NCT03428100|582578166|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325316|NCT03428100|582578167|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325317|NCT03428100|582578168|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
161325318|NCT03428100|582578150|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325319|NCT03428100|582578151|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
161325320|NCT03428100|582578152|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
161325321|NCT03428100|582578153|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161122489|NCT03529773|581835186|FG015|Overall Study|Screen Failure|0|||
161122490|NCT03529773|581835187|FG016|Overall Study|Screen Failure|0|||
161122491|NCT03529773|581835188|FG017|Overall Study|Screen Failure|0|||
161122492|NCT03529773|581835189|FG018|Overall Study|Screen Failure|0|||
161122493|NCT03529773|581835190|FG019|Overall Study|Screen Failure|0|||
161122494|NCT03529773|581835191|FG020|Overall Study|Screen Failure|0|||
161122495|NCT03529773|581835192|FG021|Overall Study|Screen Failure|0|||
161122496|NCT03529773|581835193|FG022|Overall Study|Screen Failure|0|||
161122497|NCT03529773|581835194|FG023|Overall Study|Screen Failure|0|||
161122498|NCT03529773|581835195|FG024|Overall Study|Screen Failure|0|||
161122499|NCT03529773|581835196|FG025|Overall Study|Screen Failure|0|||
161122500|NCT03529773|581835197|FG026|Overall Study|Screen Failure|0|||
161122501|NCT03529773|581835198|FG027|Overall Study|Screen Failure|0|||
161122502|NCT03529773|581835199|FG028|Overall Study|Screen Failure|0|||
161122503|NCT03529773|581835200|FG029|Overall Study|Screen Failure|0|||
161122504|NCT03529773|581835201|FG030|Overall Study|Screen Failure|0|||
161122505|NCT03529773|581835202|FG031|Overall Study|Screen Failure|0|||
161122506|NCT03529773|581835203|FG032|Overall Study|Screen Failure|0|||
161122507|NCT03529773|581835204|FG033|Overall Study|Screen Failure|0|||
161122508|NCT03529773|581835205|FG034|Overall Study|Screen Failure|0|||
161122509|NCT03529773|581835206|FG035|Overall Study|Screen Failure|0|||
161122510|NCT03529773|581835207|FG036|Overall Study|Screen Failure|1|||
161122511|NCT03529773|581835208|FG037|Overall Study|Screen Failure|1|||
161122512|NCT03529773|581835209|FG038|Overall Study|Screen Failure|0|||
161122513|NCT03529773|581835210|FG039|Overall Study|Screen Failure|1|||
161122514|NCT03529773|581835171|FG000|Overall Study|Randomized but not vaccinated|0|||
161325322|NCT03428100|582578154|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325323|NCT03428100|582578155|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325324|NCT03428100|582578156|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325325|NCT03428100|582578157|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325326|NCT03428100|582578158|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325327|NCT03428100|582578159|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325328|NCT03428100|582578160|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325329|NCT03428100|582578161|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325330|NCT03428100|582578162|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325331|NCT03428100|582578163|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325332|NCT03428100|582578164|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325333|NCT03428100|582578165|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325334|NCT03428100|582578166|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325335|NCT03428100|582578167|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325336|NCT03428100|582578168|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
161325337|NCT03428100|582578150|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
161325338|NCT03428100|582578151|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325339|NCT03428100|582578152|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325340|NCT03428100|582578153|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325341|NCT03428100|582578154|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325342|NCT03428100|582578155|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325343|NCT03428100|582578156|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325344|NCT03428100|582578157|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325345|NCT03428100|582578158|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325346|NCT03428100|582578159|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325347|NCT03428100|582578160|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325348|NCT03428100|582578161|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325349|NCT03428100|582578162|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325350|NCT03428100|582578163|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325351|NCT03428100|582578164|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325352|NCT03428100|582578165|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325353|NCT03428100|582578166|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325354|NCT03428100|582578167|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325355|NCT03428100|582578168|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
161325356|NCT03428100|582578150|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325357|NCT03428100|582578151|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
161325358|NCT03428100|582578152|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325359|NCT03428100|582578153|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325360|NCT03428100|582578154|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325361|NCT03428100|582578155|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325362|NCT03428100|582578156|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325363|NCT03428100|582578157|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325364|NCT03428100|582578158|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325365|NCT03428100|582578159|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325366|NCT03428100|582578160|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325367|NCT03428100|582578161|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325368|NCT03428100|582578162|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325369|NCT03428100|582578163|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325370|NCT03428100|582578164|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325371|NCT03428100|582578165|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325372|NCT03428100|582578166|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161325373|NCT03428100|582578167|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161228021|NCT05097989|582215272|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228022|NCT05097989|582215273|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228023|NCT05097989|582215274|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228024|NCT05097989|582215275|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161228025|NCT05097989|582215267|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228026|NCT05097989|582215268|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228027|NCT05097989|582215269|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228028|NCT05097989|582215270|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228029|NCT05097989|582215271|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
161228030|NCT05097989|582215272|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228031|NCT05097989|582215273|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228032|NCT05097989|582215274|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228033|NCT05097989|582215275|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
161228034|NCT05097989|582215267|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228035|NCT05097989|582215268|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161228036|NCT05097989|582215269|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228037|NCT05097989|582215270|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161228038|NCT05097989|582215271|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228039|NCT05097989|582215272|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228040|NCT05097989|582215273|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228041|NCT05097989|582215274|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228042|NCT05097989|582215275|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161228043|NCT05097989|582215267|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
161228044|NCT05097989|582215268|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
161228045|NCT05097989|582215269|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161228046|NCT05097989|582215270|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
161228047|NCT05097989|582215271|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
161228048|NCT05097989|582215272|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161228049|NCT05097989|582215273|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
161228050|NCT05097989|582215274|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
161228051|NCT05097989|582215275|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
161228052|NCT05097989|582215267|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
161228053|NCT05097989|582215268|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
161228054|NCT05097989|582215269|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
161228055|NCT05097989|582215270|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
161228056|NCT05097989|582215271|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
161228057|NCT05097989|582215272|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
161228058|NCT05097989|582215273|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
161228059|NCT05097989|582215274|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
161228060|NCT05097989|582215275|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
161228061|NCT05097989|582215267|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228062|NCT05097989|582215268|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228063|NCT05097989|582215269|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
160885009|NCT01397825|580974871|FG004|Overall Study|Progressive Disease|0|||
161228064|NCT05097989|582215270|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228065|NCT05097989|582215271|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
161228066|NCT05097989|582215272|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228067|NCT05097989|582215273|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228068|NCT05097989|582215274|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228069|NCT05097989|582215275|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
161228070|NCT05097989|582215267|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
161228071|NCT05097989|582215268|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
161122515|NCT03529773|581835172|FG001|Overall Study|Randomized but not vaccinated|0|||
161122516|NCT03529773|581835173|FG002|Overall Study|Randomized but not vaccinated|0|||
161122517|NCT03529773|581835174|FG003|Overall Study|Randomized but not vaccinated|0|||
161122518|NCT03529773|581835175|FG004|Overall Study|Randomized but not vaccinated|0|||
161325374|NCT03428100|582578168|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
161122519|NCT03529773|581835176|FG005|Overall Study|Randomized but not vaccinated|0|||
161325375|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325376|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325377|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325378|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325379|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325380|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
161325381|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161325382|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
161325383|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161325384|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325385|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161325386|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325387|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
161325388|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161325389|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161325390|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
161325391|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
161325392|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325393|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
161325394|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
161325395|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
161325396|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
161325397|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
161325398|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
161325399|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
161325400|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
161325401|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
161325402|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
161325403|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
161325404|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
161325405|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
161325406|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
161325407|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
161325408|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
161325409|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
161325410|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
161325411|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
161325412|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
161325413|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161122520|NCT03529773|581835177|FG006|Overall Study|Randomized but not vaccinated|0|||
161325414|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161325415|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
160885010|NCT01397825|580974867|FG000|Overall Study|Symptomatic Deterioration|2|||
160885011|NCT01397825|580974868|FG001|Overall Study|Symptomatic Deterioration|0|||
160885012|NCT01397825|580974869|FG002|Overall Study|Symptomatic Deterioration|4|||
160885013|NCT01397825|580974870|FG003|Overall Study|Symptomatic Deterioration|0|||
160885014|NCT01397825|580974871|FG004|Overall Study|Symptomatic Deterioration|0|||
160885015|NCT01397825|580974867|FG000|Overall Study|Adverse Event|0|||
160885016|NCT01397825|580974868|FG001|Overall Study|Adverse Event|1|||
160885017|NCT01397825|580974869|FG002|Overall Study|Adverse Event|5|||
160885018|NCT01397825|580974870|FG003|Overall Study|Adverse Event|1|||
160885019|NCT01397825|580974871|FG004|Overall Study|Adverse Event|0|||
160885020|NCT01397825|580974867|FG000|Overall Study|Withdrawal by Subject|1|||
160885021|NCT01397825|580974868|FG001|Overall Study|Withdrawal by Subject|0|||
160885022|NCT01397825|580974869|FG002|Overall Study|Withdrawal by Subject|5|||
160885023|NCT01397825|580974870|FG003|Overall Study|Withdrawal by Subject|1|||
160885024|NCT01397825|580974871|FG004|Overall Study|Withdrawal by Subject|0|||
160885025|NCT01931670|580974872|FG000|Treatment Period|Exclusionary Medication Received|1|||
160885026|NCT01931670|580974873|FG001|Treatment Period|Exclusionary Medication Received|1|||
160885027|NCT01931670|580974874|FG002|Treatment Period|Exclusionary Medication Received|1|||
160885028|NCT01931670|580974872|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
160885029|NCT01931670|580974873|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
160885030|NCT01931670|580974874|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
160885031|NCT01931670|580974872|FG000|Treatment Period|Subject Noncompliant|4|||
160885032|NCT01931670|580974873|FG001|Treatment Period|Subject Noncompliant|9|||
160885033|NCT01931670|580974874|FG002|Treatment Period|Subject Noncompliant|5|||
160885034|NCT01931670|580974872|FG000|Treatment Period|Adverse Event|19|||
160885035|NCT01931670|580974873|FG001|Treatment Period|Adverse Event|8|||
160885036|NCT01931670|580974874|FG002|Treatment Period|Adverse Event|21|||
160885037|NCT01931670|580974872|FG000|Treatment Period|Lack of Efficacy|11|||
160885038|NCT01931670|580974873|FG001|Treatment Period|Lack of Efficacy|2|||
160885039|NCT01931670|580974874|FG002|Treatment Period|Lack of Efficacy|2|||
160885040|NCT01931670|580974872|FG000|Treatment Period|Pregnancy|7|||
160885041|NCT01931670|580974873|FG001|Treatment Period|Pregnancy|2|||
160885042|NCT01931670|580974874|FG002|Treatment Period|Pregnancy|0|||
160885043|NCT01931670|580974872|FG000|Treatment Period|Other|8|||
160885044|NCT01931670|580974873|FG001|Treatment Period|Other|7|||
160885045|NCT01931670|580974874|FG002|Treatment Period|Other|2|||
160885046|NCT01931670|580974872|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
160885047|NCT01931670|580974873|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
160885048|NCT01931670|580974874|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
160885049|NCT01931670|580974872|FG000|Treatment Period|Lost to Follow-up|19|||
160885050|NCT01931670|580974873|FG001|Treatment Period|Lost to Follow-up|5|||
160885051|NCT01931670|580974874|FG002|Treatment Period|Lost to Follow-up|7|||
160885052|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
160885053|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
160885054|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
160885055|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
160885056|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
161122521|NCT03529773|581835178|FG007|Overall Study|Randomized but not vaccinated|0|||
161122522|NCT03529773|581835179|FG008|Overall Study|Randomized but not vaccinated|0|||
161122523|NCT03529773|581835180|FG009|Overall Study|Randomized but not vaccinated|0|||
161122524|NCT03529773|581835181|FG010|Overall Study|Randomized but not vaccinated|0|||
161122525|NCT03529773|581835182|FG011|Overall Study|Randomized but not vaccinated|0|||
161122526|NCT03529773|581835183|FG012|Overall Study|Randomized but not vaccinated|0|||
161122527|NCT03529773|581835184|FG013|Overall Study|Randomized but not vaccinated|0|||
160885057|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
160885058|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
161122528|NCT03529773|581835185|FG014|Overall Study|Randomized but not vaccinated|0|||
161228072|NCT05097989|582215269|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
160885059|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
160885060|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
160885061|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
161122529|NCT03529773|581835186|FG015|Overall Study|Randomized but not vaccinated|0|||
160885062|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
160885063|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
161122530|NCT03529773|581835187|FG016|Overall Study|Randomized but not vaccinated|0|||
161228073|NCT05097989|582215270|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161228074|NCT05097989|582215271|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
160885064|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
161228075|NCT05097989|582215272|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161228076|NCT05097989|582215273|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161228077|NCT05097989|582215274|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161122531|NCT03529773|581835188|FG017|Overall Study|Randomized but not vaccinated|1|||
161122532|NCT03529773|581835189|FG018|Overall Study|Randomized but not vaccinated|0|||
161122533|NCT03529773|581835190|FG019|Overall Study|Randomized but not vaccinated|0|||
161122534|NCT03529773|581835191|FG020|Overall Study|Randomized but not vaccinated|0|||
161122535|NCT03529773|581835192|FG021|Overall Study|Randomized but not vaccinated|0|||
161122536|NCT03529773|581835193|FG022|Overall Study|Randomized but not vaccinated|0|||
161122537|NCT03529773|581835194|FG023|Overall Study|Randomized but not vaccinated|0|||
160885065|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
160885066|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
160885067|NCT01931670|580974872|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
161122538|NCT03529773|581835195|FG024|Overall Study|Randomized but not vaccinated|0|||
161122539|NCT03529773|581835196|FG025|Overall Study|Randomized but not vaccinated|0|||
161122540|NCT03529773|581835197|FG026|Overall Study|Randomized but not vaccinated|0|||
161122541|NCT03529773|581835198|FG027|Overall Study|Randomized but not vaccinated|1|||
161122542|NCT03529773|581835199|FG028|Overall Study|Randomized but not vaccinated|0|||
161122543|NCT03529773|581835200|FG029|Overall Study|Randomized but not vaccinated|0|||
161122544|NCT03529773|581835201|FG030|Overall Study|Randomized but not vaccinated|0|||
161122545|NCT03529773|581835202|FG031|Overall Study|Randomized but not vaccinated|0|||
161228078|NCT05097989|582215275|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
161228079|NCT05097989|582215267|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
160885068|NCT01931670|580974873|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
161228080|NCT05097989|582215268|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
161228081|NCT05097989|582215269|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161228082|NCT05097989|582215270|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
161228083|NCT05097989|582215271|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161228084|NCT05097989|582215272|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
161228085|NCT05097989|582215273|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
161228086|NCT05097989|582215274|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
161228087|NCT05097989|582215275|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
161228088|NCT00918567|582215284|FG000|Overall Study|Lack of Efficacy|3|||
161228089|NCT00918567|582215285|FG001|Overall Study|Lack of Efficacy|1|||
161228090|NCT00918567|582215284|FG000|Overall Study|Withdrawal by Subject|1|||
161228091|NCT00918567|582215285|FG001|Overall Study|Withdrawal by Subject|1|||
161228092|NCT00918567|582215284|FG000|Overall Study|Adverse Event|1|||
161228093|NCT00918567|582215285|FG001|Overall Study|Adverse Event|0|||
161228094|NCT00117949|582215286|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
161228095|NCT00117949|582215287|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
161228096|NCT00117949|582215288|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
161228097|NCT00117949|582215289|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
161228098|NCT00117949|582215286|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
161228099|NCT00117949|582215287|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
161228100|NCT00117949|582215288|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
161228101|NCT00117949|582215289|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
161228102|NCT00117949|582215286|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
161228103|NCT00117949|582215287|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
161228104|NCT00117949|582215288|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
161228105|NCT00117949|582215289|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
161228106|NCT00117949|582215286|FG000|Overall Study|PSA increase >=10ng/mL|0|||
161228107|NCT00117949|582215287|FG001|Overall Study|PSA increase >=10ng/mL|1|||
161228108|NCT00117949|582215288|FG002|Overall Study|PSA increase >=10ng/mL|1|||
161228109|NCT00117949|582215289|FG003|Overall Study|PSA increase >=10ng/mL|0|||
161228110|NCT00117949|582215286|FG000|Overall Study|PSA reduction <=50%|0|||
161228111|NCT00117949|582215287|FG001|Overall Study|PSA reduction <=50%|2|||
161228112|NCT00117949|582215288|FG002|Overall Study|PSA reduction <=50%|2|||
161228113|NCT00117949|582215289|FG003|Overall Study|PSA reduction <=50%|4|||
161228114|NCT00117949|582215286|FG000|Overall Study|Hepatic abnormalities|0|||
161228115|NCT00117949|582215287|FG001|Overall Study|Hepatic abnormalities|1|||
161228116|NCT00117949|582215288|FG002|Overall Study|Hepatic abnormalities|0|||
161228117|NCT00117949|582215289|FG003|Overall Study|Hepatic abnormalities|1|||
161228118|NCT05275998|582215290|FG000|Overall Study|Adverse Event|0|||
161228119|NCT05275998|582215291|FG001|Overall Study|Adverse Event|0|||
161228120|NCT05275998|582215292|FG002|Overall Study|Adverse Event|0|||
161228121|NCT05275998|582215293|FG003|Overall Study|Adverse Event|1|||
161228122|NCT05275998|582215290|FG000|Overall Study|Withdrawal by Subject|0|||
161228123|NCT05275998|582215291|FG001|Overall Study|Withdrawal by Subject|0|||
161228124|NCT05275998|582215292|FG002|Overall Study|Withdrawal by Subject|0|||
161228125|NCT05275998|582215293|FG003|Overall Study|Withdrawal by Subject|1|||
161228126|NCT05275998|582215290|FG000|Overall Study|Physician Decision|0|||
161228127|NCT05275998|582215291|FG001|Overall Study|Physician Decision|0|||
161228128|NCT05275998|582215292|FG002|Overall Study|Physician Decision|0|||
161228129|NCT05275998|582215293|FG003|Overall Study|Physician Decision|1|||
161228130|NCT05275998|582215290|FG000|Overall Study|Protocol Violation|0|||
161228131|NCT05275998|582215291|FG001|Overall Study|Protocol Violation|0|||
161228132|NCT05275998|582215292|FG002|Overall Study|Protocol Violation|1|||
161228133|NCT05275998|582215293|FG003|Overall Study|Protocol Violation|0|||
161228134|NCT01936948|582215294|FG000|Overall Study|no 30-day follow-up data|0|||
161228135|NCT01936948|582215295|FG001|Overall Study|no 30-day follow-up data|3|||
161228136|NCT01936948|582215296|FG002|Overall Study|no 30-day follow-up data|3|||
161122546|NCT03529773|581835203|FG032|Overall Study|Randomized but not vaccinated|0|||
161228137|NCT01936948|582215297|FG003|Overall Study|no 30-day follow-up data|3|||
160885069|NCT01931670|580974874|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
160885070|NCT03023046|580974880|FG000|Overall Study|Withdrawal by Subject|1|||
161228138|NCT01974141|582215298|FG000|Overall Study|Other Reasons|28|||
161228139|NCT01974141|582215299|FG001|Overall Study|Other Reasons|18|||
161228140|NCT01974141|582215298|FG000|Overall Study|Protocol Violation|2|||
161228141|NCT01974141|582215299|FG001|Overall Study|Protocol Violation|6|||
161228142|NCT01974141|582215298|FG000|Overall Study|Personal Reasons|21|||
161228143|NCT01974141|582215299|FG001|Overall Study|Personal Reasons|20|||
161228144|NCT01974141|582215298|FG000|Overall Study|Lost to Follow-up|38|||
161228145|NCT01974141|582215299|FG001|Overall Study|Lost to Follow-up|29|||
161228146|NCT01974141|582215298|FG000|Overall Study|Pregnancy|3|||
161325416|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161325417|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
161325418|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
160885071|NCT00640835|580974886|FG000|Overall Study|Adverse Event|5|||
160885072|NCT00640835|580974887|FG001|Overall Study|Adverse Event|3|||
160885073|NCT00640835|580974886|FG000|Overall Study|Withdrawal by Subject|12|||
160885074|NCT00640835|580974887|FG001|Overall Study|Withdrawal by Subject|14|||
160885075|NCT00640835|580974886|FG000|Overall Study|Physician Decision|10|||
160885076|NCT00640835|580974887|FG001|Overall Study|Physician Decision|14|||
160885077|NCT00640835|580974886|FG000|Overall Study|Sponsor's Decision|11|||
160885078|NCT00640835|580974887|FG001|Overall Study|Sponsor's Decision|7|||
160885079|NCT00640835|580974886|FG000|Overall Study|Protocol Violation|2|||
160885080|NCT00640835|580974887|FG001|Overall Study|Protocol Violation|2|||
160885081|NCT00640835|580974886|FG000|Overall Study|Lost to Follow-up|17|||
160885082|NCT00640835|580974887|FG001|Overall Study|Lost to Follow-up|13|||
160885083|NCT00640835|580974886|FG000|Overall Study|Other Reason|19|||
160885084|NCT00640835|580974887|FG001|Overall Study|Other Reason|4|||
160885085|NCT00470158|580974888|FG000|Overall Study|Death|0|||
160885086|NCT00470158|580974889|FG001|Overall Study|Death|0|||
160885087|NCT00470158|580974890|FG002|Overall Study|Death|0|||
161325419|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
161325420|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161325421|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161325422|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161325423|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161325424|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
161325425|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
161325426|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
160885088|NCT00470158|580974891|FG003|Overall Study|Death|0|||
160885089|NCT00470158|580974892|FG004|Overall Study|Death|2|||
160885090|NCT00470158|580974888|FG000|Overall Study|Lost to Follow-up|7|||
160885091|NCT00470158|580974889|FG001|Overall Study|Lost to Follow-up|8|||
160885092|NCT00470158|580974890|FG002|Overall Study|Lost to Follow-up|8|||
160885093|NCT00470158|580974891|FG003|Overall Study|Lost to Follow-up|5|||
160885094|NCT00470158|580974892|FG004|Overall Study|Lost to Follow-up|4|||
160885095|NCT00470158|580974888|FG000|Overall Study|Protocol Violation|1|||
160885096|NCT00470158|580974889|FG001|Overall Study|Protocol Violation|0|||
160885097|NCT00470158|580974890|FG002|Overall Study|Protocol Violation|0|||
160885098|NCT00470158|580974891|FG003|Overall Study|Protocol Violation|0|||
160885099|NCT00470158|580974892|FG004|Overall Study|Protocol Violation|0|||
160885100|NCT00880685|580974893|FG000|Memantine 10mg|Lost to Follow-up|2|||
160885101|NCT00880685|580974893|FG000|Memantine 20mg|Withdrawal by Subject|1|||
160885102|NCT04179890|580974894|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
160885103|NCT04179890|580974895|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
160885104|NCT04179890|580974894|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
160885105|NCT04179890|580974895|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
160885106|NCT04179890|580974894|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
160885107|NCT04179890|580974895|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
160885108|NCT04179890|580974894|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
160885109|NCT04179890|580974895|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
160885110|NCT04179890|580974894|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
160885111|NCT04179890|580974895|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
160885112|NCT04179890|580974894|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
160885113|NCT04179890|580974895|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
161325427|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
161325428|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
160917925|NCT02673489|581094148|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
161228147|NCT01974141|582215299|FG001|Overall Study|Pregnancy|3|||
161228148|NCT01974141|582215298|FG000|Overall Study|Lack of Efficacy|0|||
160885114|NCT04179890|580974894|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
160885115|NCT04179890|580974895|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
160885116|NCT04179890|580974894|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
160885117|NCT04179890|580974895|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
161228149|NCT01974141|582215299|FG001|Overall Study|Lack of Efficacy|1|||
161228150|NCT01974141|582215298|FG000|Overall Study|Adverse Event|4|||
161228151|NCT01974141|582215299|FG001|Overall Study|Adverse Event|5|||
161228152|NCT00406848|582215301|FG000|Overall Study|Withdrawal by Subject|27|||
161228153|NCT00406848|582215302|FG001|Overall Study|Withdrawal by Subject|22|||
161228154|NCT00406848|582215301|FG000|Overall Study|Adverse Event|38|||
161228155|NCT00406848|582215302|FG001|Overall Study|Adverse Event|7|||
161228156|NCT00406848|582215301|FG000|Overall Study|Lack of Efficacy|9|||
161228157|NCT00406848|582215302|FG001|Overall Study|Lack of Efficacy|14|||
161228158|NCT00406848|582215301|FG000|Overall Study|Protocol Violation|10|||
161228159|NCT00406848|582215302|FG001|Overall Study|Protocol Violation|6|||
161228160|NCT00406848|582215301|FG000|Overall Study|Lost to Follow-up|6|||
161228161|NCT00406848|582215302|FG001|Overall Study|Lost to Follow-up|2|||
161228162|NCT00406848|582215301|FG000|Overall Study|Physician Decision|2|||
161228163|NCT00406848|582215302|FG001|Overall Study|Physician Decision|2|||
161228164|NCT00406848|582215301|FG000|Overall Study|Sponsor Decision|1|||
161228165|NCT00406848|582215302|FG001|Overall Study|Sponsor Decision|1|||
161228166|NCT04803357|582215303|FG000|Overall Study|Withdrawal by Subject|31|||
161228167|NCT04803357|582215304|FG001|Overall Study|Withdrawal by Subject|5|||
161228168|NCT02879643|582215306|FG000|Overall Study|Adverse Event|0|||
161228169|NCT02879643|582215307|FG001|Overall Study|Adverse Event|0|||
161228170|NCT02879643|582215308|FG002|Overall Study|Adverse Event|1|||
161228171|NCT02879643|582215309|FG003|Overall Study|Adverse Event|1|||
161228172|NCT02879643|582215310|FG004|Overall Study|Adverse Event|0|||
161228173|NCT00182091|582215311|FG000|Overall Study|Withdrawal by Subject|1|||
161228174|NCT00182091|582215312|FG001|Overall Study|Withdrawal by Subject|0|||
161122547|NCT03529773|581835204|FG033|Overall Study|Randomized but not vaccinated|0|||
161122548|NCT03529773|581835205|FG034|Overall Study|Randomized but not vaccinated|0|||
161122549|NCT03529773|581835206|FG035|Overall Study|Randomized but not vaccinated|0|||
161122550|NCT03529773|581835207|FG036|Overall Study|Randomized but not vaccinated|0|||
161122551|NCT03529773|581835208|FG037|Overall Study|Randomized but not vaccinated|0|||
161122552|NCT03529773|581835209|FG038|Overall Study|Randomized but not vaccinated|0|||
161122553|NCT03529773|581835210|FG039|Overall Study|Randomized but not vaccinated|0|||
161122554|NCT01496066|581835212|FG000|Overall Study|Lost to Follow-up|8|||
161122555|NCT01496066|581835213|FG001|Overall Study|Lost to Follow-up|5|||
161122556|NCT01496066|581835212|FG000|Overall Study|Explant|3|||
161122557|NCT01496066|581835213|FG001|Overall Study|Explant|0|||
161122558|NCT01496066|581835212|FG000|Overall Study|Death|1|||
161122559|NCT01496066|581835213|FG001|Overall Study|Death|4|||
161122560|NCT00253630|581835214|FG000|Overall Study|ineligible|2|||
161122561|NCT00209339|581835215|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
161122562|NCT00209339|581835215|FG000|At 12 Months Follow-up|Death|1|||
161122563|NCT00209339|581835215|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
161122564|NCT00209339|581835215|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
161122565|NCT00209339|581835215|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
161122566|NCT00209339|581835215|FG000|At 24 Months Follow-up|Death|1|||
161122567|NCT00209339|581835215|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
161122568|NCT00209339|581835215|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
161122569|NCT00209339|581835215|FG000|At 4 Years Follow-up|Death|1|||
161122570|NCT00209339|581835215|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
161122571|NCT00209339|581835215|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
161122572|NCT00209339|581835215|FG000|At 5 Years Follow-up|Death|1|||
161122573|NCT02062658|581835217|FG000|Overall Study|Withdrawal by Subject|1|||
161122574|NCT02062658|581835217|FG000|Overall Study|Lack of Efficacy|1|||
161122575|NCT02574637|581835218|FG000|Double-blind Period|Adverse Event|1|||
161122576|NCT02574637|581835219|FG001|Double-blind Period|Adverse Event|0|||
161122577|NCT02574637|581835220|FG002|Double-blind Period|Adverse Event|0|||
161122578|NCT02574637|581835221|FG003|Double-blind Period|Adverse Event|0|||
161122579|NCT02574637|581835222|FG004|Double-blind Period|Adverse Event|0|||
161122580|NCT02574637|581835223|FG005|Double-blind Period|Adverse Event|0|||
161122581|NCT02574637|581835224|FG006|Double-blind Period|Adverse Event|0|||
161228175|NCT00182091|582215313|FG002|Overall Study|Withdrawal by Subject|0|||
161228176|NCT00182091|582215314|FG003|Overall Study|Withdrawal by Subject|0|||
161228177|NCT01046253|582215315|FG000|Second Intervention|Adverse Event|0|||
161122582|NCT02574637|581835225|FG007|Double-blind Period|Adverse Event|0|||
161228178|NCT01046253|582215316|FG001|Second Intervention|Adverse Event|1|||
161122583|NCT02574637|581835226|FG008|Double-blind Period|Adverse Event|0|||
161122584|NCT02574637|581835227|FG009|Double-blind Period|Adverse Event|0|||
161122585|NCT02574637|581835218|FG000|Double-blind Period|Lack of Efficacy|0|||
161122586|NCT02574637|581835219|FG001|Double-blind Period|Lack of Efficacy|0|||
161122587|NCT02574637|581835220|FG002|Double-blind Period|Lack of Efficacy|2|||
161122588|NCT02574637|581835221|FG003|Double-blind Period|Lack of Efficacy|0|||
161122589|NCT02574637|581835222|FG004|Double-blind Period|Lack of Efficacy|0|||
161122590|NCT02574637|581835223|FG005|Double-blind Period|Lack of Efficacy|0|||
161122591|NCT02574637|581835224|FG006|Double-blind Period|Lack of Efficacy|0|||
161122592|NCT02574637|581835225|FG007|Double-blind Period|Lack of Efficacy|0|||
161122593|NCT02574637|581835226|FG008|Double-blind Period|Lack of Efficacy|0|||
161122594|NCT02574637|581835227|FG009|Double-blind Period|Lack of Efficacy|0|||
161122595|NCT02574637|581835218|FG000|Double-blind Period|Protocol Deviation|1|||
161122596|NCT02574637|581835219|FG001|Double-blind Period|Protocol Deviation|0|||
161122597|NCT02574637|581835220|FG002|Double-blind Period|Protocol Deviation|0|||
161122598|NCT02574637|581835221|FG003|Double-blind Period|Protocol Deviation|0|||
161122599|NCT02574637|581835222|FG004|Double-blind Period|Protocol Deviation|0|||
161122600|NCT02574637|581835223|FG005|Double-blind Period|Protocol Deviation|0|||
160885118|NCT04179890|580974894|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
160885119|NCT04179890|580974895|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
160885120|NCT01236118|580974897|FG000|Overall Study|Adverse Event|2|||
161122601|NCT02574637|581835224|FG006|Double-blind Period|Protocol Deviation|0|||
161122602|NCT02574637|581835225|FG007|Double-blind Period|Protocol Deviation|0|||
160885121|NCT01236118|580974898|FG001|Overall Study|Adverse Event|0|||
160885122|NCT01236118|580974899|FG002|Overall Study|Adverse Event|2|||
161325429|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161325430|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
161325431|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
161325432|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325433|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160885123|NCT01236118|580974897|FG000|Overall Study|Physician Decision|0|||
160885124|NCT01236118|580974898|FG001|Overall Study|Physician Decision|1|||
160885125|NCT01236118|580974899|FG002|Overall Study|Physician Decision|0|||
160885126|NCT01236118|580974897|FG000|Overall Study|Withdrawal by Subject|0|||
160885127|NCT01236118|580974898|FG001|Overall Study|Withdrawal by Subject|0|||
160885128|NCT01236118|580974899|FG002|Overall Study|Withdrawal by Subject|1|||
160885129|NCT04535167|580974900|FG000|Treatment|Adverse Event|0|||
160885130|NCT04535167|580974901|FG001|Treatment|Adverse Event|0|||
160885131|NCT04535167|580974902|FG002|Treatment|Adverse Event|0|||
160885132|NCT04535167|580974903|FG003|Treatment|Adverse Event|0|||
160885133|NCT04535167|580974904|FG004|Treatment|Adverse Event|0|||
160885134|NCT04535167|580974905|FG005|Treatment|Adverse Event|0|||
160885135|NCT04535167|580974906|FG006|Treatment|Adverse Event|1|||
160885136|NCT04535167|580974900|FG000|Follow-Up|Death|0|||
160885137|NCT04535167|580974901|FG001|Follow-Up|Death|0|||
160885138|NCT04535167|580974902|FG002|Follow-Up|Death|0|||
161325434|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325435|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160885139|NCT04535167|580974903|FG003|Follow-Up|Death|0|||
160885140|NCT04535167|580974904|FG004|Follow-Up|Death|0|||
160885141|NCT04535167|580974905|FG005|Follow-Up|Death|0|||
160885142|NCT04535167|580974906|FG006|Follow-Up|Death|1|||
160885143|NCT04535167|580974900|FG000|Follow-Up|Lost to Follow-up|0|||
161228179|NCT01046253|582215315|FG000|Second Intervention|Protocol Violation|0|||
160885144|NCT04535167|580974901|FG001|Follow-Up|Lost to Follow-up|0|||
160885145|NCT04535167|580974902|FG002|Follow-Up|Lost to Follow-up|0|||
160885146|NCT04535167|580974903|FG003|Follow-Up|Lost to Follow-up|1|||
160885147|NCT04535167|580974904|FG004|Follow-Up|Lost to Follow-up|0|||
161228180|NCT01046253|582215316|FG001|Second Intervention|Protocol Violation|1|||
160885148|NCT04535167|580974905|FG005|Follow-Up|Lost to Follow-up|0|||
160885149|NCT04535167|580974906|FG006|Follow-Up|Lost to Follow-up|0|||
160885150|NCT00978432|580974907|FG000|Overall Study|Withdrawal by Subject|0|||
160885151|NCT00978432|580974908|FG001|Overall Study|Withdrawal by Subject|0|||
160885152|NCT00978432|580974909|FG002|Overall Study|Withdrawal by Subject|1|||
160885153|NCT00978432|580974907|FG000|Overall Study|Lack of Efficacy|1|||
160885154|NCT00978432|580974908|FG001|Overall Study|Lack of Efficacy|1|||
160885155|NCT00978432|580974909|FG002|Overall Study|Lack of Efficacy|3|||
160885156|NCT00978432|580974907|FG000|Overall Study|Adverse Event|2|||
160885157|NCT00978432|580974908|FG001|Overall Study|Adverse Event|0|||
160885158|NCT00978432|580974909|FG002|Overall Study|Adverse Event|1|||
160885159|NCT02579928|580974910|FG000|Overall Study|Withdrawal by Subject|1|||
160885160|NCT02579928|580974911|FG001|Overall Study|Withdrawal by Subject|0|||
160885161|NCT04300751|580974914|FG000|Overall Study|Withdrawal by Subject|1|||
160885162|NCT04656275|580974920|FG000|Overall Study|Study terminated by sponsor|2|||
160885163|NCT04656275|580974921|FG001|Overall Study|Study terminated by sponsor|4|||
160885164|NCT00924781|580974923|FG000|Overall Study|Study terminated by sponsor|12|||
160885165|NCT00924781|580974924|FG001|Overall Study|Study terminated by sponsor|10|||
160885166|NCT01155479|580974929|FG000|Part I|Adverse Event|13|||
160885167|NCT01155479|580974930|FG001|Part I|Adverse Event|8|||
160885168|NCT01155479|580974931|FG002|Part I|Adverse Event|18|||
161122603|NCT02574637|581835226|FG008|Double-blind Period|Protocol Deviation|0|||
161122604|NCT02574637|581835227|FG009|Double-blind Period|Protocol Deviation|0|||
161122605|NCT02574637|581835218|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
161122606|NCT02574637|581835219|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
161122607|NCT02574637|581835220|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
161122608|NCT02574637|581835221|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
161122609|NCT02574637|581835222|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
160885169|NCT01155479|580974932|FG003|Part I|Adverse Event|7|||
160885170|NCT01155479|580974933|FG004|Part I|Adverse Event|6|||
160885171|NCT01155479|580974929|FG000|Part I|Administrative|2|||
160885172|NCT01155479|580974930|FG001|Part I|Administrative|2|||
160885173|NCT01155479|580974931|FG002|Part I|Administrative|2|||
160885174|NCT01155479|580974932|FG003|Part I|Administrative|0|||
160885175|NCT01155479|580974933|FG004|Part I|Administrative|0|||
161122610|NCT02574637|581835223|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
161122611|NCT02574637|581835224|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
161325436|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160885176|NCT01155479|580974929|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
160885177|NCT01155479|580974930|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
160885178|NCT01155479|580974931|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
160885179|NCT01155479|580974932|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
160885180|NCT01155479|580974933|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
160885181|NCT01155479|580974929|FG000|Part I|Withdrawal by Subject|11|||
160885182|NCT01155479|580974930|FG001|Part I|Withdrawal by Subject|13|||
160885183|NCT01155479|580974931|FG002|Part I|Withdrawal by Subject|8|||
160885184|NCT01155479|580974932|FG003|Part I|Withdrawal by Subject|8|||
160885185|NCT01155479|580974933|FG004|Part I|Withdrawal by Subject|9|||
160885186|NCT01155479|580974929|FG000|Part I|Lost to Follow-up|0|||
160885187|NCT01155479|580974930|FG001|Part I|Lost to Follow-up|0|||
160885188|NCT01155479|580974931|FG002|Part I|Lost to Follow-up|1|||
160885189|NCT01155479|580974932|FG003|Part I|Lost to Follow-up|1|||
160885190|NCT01155479|580974933|FG004|Part I|Lost to Follow-up|0|||
160885191|NCT01155479|580974929|FG000|Part I|Treatment Failure|3|||
160885192|NCT01155479|580974930|FG001|Part I|Treatment Failure|0|||
160885193|NCT01155479|580974931|FG002|Part I|Treatment Failure|3|||
160885194|NCT01155479|580974932|FG003|Part I|Treatment Failure|1|||
160885195|NCT01155479|580974933|FG004|Part I|Treatment Failure|2|||
160885196|NCT01155479|580974929|FG000|Part I|Did Not Receive Treatment|4|||
160885197|NCT01155479|580974930|FG001|Part I|Did Not Receive Treatment|2|||
160885198|NCT01155479|580974931|FG002|Part I|Did Not Receive Treatment|2|||
160885199|NCT01155479|580974932|FG003|Part I|Did Not Receive Treatment|6|||
160885200|NCT01155479|580974933|FG004|Part I|Did Not Receive Treatment|1|||
160885201|NCT01155479|580974929|FG000|Part I|Non-Compliance with Protocol|2|||
160885202|NCT01155479|580974930|FG001|Part I|Non-Compliance with Protocol|1|||
160885203|NCT01155479|580974931|FG002|Part I|Non-Compliance with Protocol|3|||
160885204|NCT01155479|580974932|FG003|Part I|Non-Compliance with Protocol|3|||
160885205|NCT01155479|580974933|FG004|Part I|Non-Compliance with Protocol|2|||
160885206|NCT01155479|580974929|FG000|Part II|Adverse Event|7|||
160885207|NCT01155479|580974930|FG001|Part II|Adverse Event|6|||
160885208|NCT01155479|580974931|FG002|Part II|Adverse Event|8|||
160885209|NCT01155479|580974932|FG003|Part II|Adverse Event|3|||
160885210|NCT01155479|580974933|FG004|Part II|Adverse Event|4|||
161122612|NCT02574637|581835225|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
160885211|NCT01155479|580974929|FG000|Part II|Administrative|43|||
160885212|NCT01155479|580974930|FG001|Part II|Administrative|49|||
160885213|NCT01155479|580974931|FG002|Part II|Administrative|36|||
160885214|NCT01155479|580974932|FG003|Part II|Administrative|38|||
160885215|NCT01155479|580974933|FG004|Part II|Administrative|46|||
161122613|NCT02574637|581835226|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
161122614|NCT02574637|581835227|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
161122615|NCT02574637|581835218|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
161122616|NCT02574637|581835219|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
161122617|NCT02574637|581835220|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
160885216|NCT01155479|580974929|FG000|Part II|Withdrawal by Subject|8|||
160885217|NCT01155479|580974930|FG001|Part II|Withdrawal by Subject|4|||
160885218|NCT01155479|580974931|FG002|Part II|Withdrawal by Subject|12|||
160885219|NCT01155479|580974932|FG003|Part II|Withdrawal by Subject|7|||
160885220|NCT01155479|580974933|FG004|Part II|Withdrawal by Subject|3|||
160885221|NCT01155479|580974929|FG000|Part II|Lost to Follow-up|1|||
160885222|NCT01155479|580974930|FG001|Part II|Lost to Follow-up|0|||
160885223|NCT01155479|580974931|FG002|Part II|Lost to Follow-up|0|||
160885224|NCT01155479|580974932|FG003|Part II|Lost to Follow-up|0|||
160885225|NCT01155479|580974933|FG004|Part II|Lost to Follow-up|1|||
160885226|NCT01155479|580974929|FG000|Part II|Treatment Failure|0|||
160885227|NCT01155479|580974930|FG001|Part II|Treatment Failure|1|||
160885228|NCT01155479|580974931|FG002|Part II|Treatment Failure|2|||
160885229|NCT01155479|580974932|FG003|Part II|Treatment Failure|0|||
160885230|NCT01155479|580974933|FG004|Part II|Treatment Failure|1|||
160885231|NCT01155479|580974929|FG000|Part II|Non-Compliance with Protocol|0|||
160885232|NCT01155479|580974930|FG001|Part II|Non-Compliance with Protocol|1|||
160885233|NCT01155479|580974931|FG002|Part II|Non-Compliance with Protocol|0|||
160885234|NCT01155479|580974932|FG003|Part II|Non-Compliance with Protocol|2|||
160885235|NCT01155479|580974933|FG004|Part II|Non-Compliance with Protocol|0|||
160885236|NCT01857310|580974934|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
160885237|NCT01857310|580974935|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
160885238|NCT02360605|580974936|FG000|Overall Study|Withdrawal by Subject|4|||
160885239|NCT02360605|580974937|FG001|Overall Study|Withdrawal by Subject|9|||
160885240|NCT02360605|580974936|FG000|Overall Study|Lost to Follow-up|7|||
160885241|NCT02360605|580974937|FG001|Overall Study|Lost to Follow-up|8|||
160885242|NCT02360605|580974936|FG000|Overall Study|Death|0|||
160885243|NCT02360605|580974937|FG001|Overall Study|Death|1|||
160885244|NCT00290407|580974938|FG000|Overall Study|Physician Decision|2|||
160885245|NCT00868517|580974947|FG000|Overall Study|Withdrawal by Subject|3|||
161122618|NCT02574637|581835221|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
161122619|NCT02574637|581835222|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
161122620|NCT02574637|581835223|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
161122621|NCT02574637|581835224|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
160885246|NCT00868517|580974948|FG001|Overall Study|Withdrawal by Subject|3|||
160885247|NCT00868517|580974949|FG002|Overall Study|Withdrawal by Subject|2|||
160885248|NCT00868517|580974947|FG000|Overall Study|Protocol Violation|1|||
160885249|NCT00868517|580974948|FG001|Overall Study|Protocol Violation|1|||
160885250|NCT00868517|580974949|FG002|Overall Study|Protocol Violation|0|||
160885251|NCT01721577|580974950|FG000|Overall Study|Lack of Efficacy|1|||
160885252|NCT01721577|580974951|FG001|Overall Study|Lack of Efficacy|0|||
160885253|NCT01721577|580974950|FG000|Overall Study|Death|1|||
160885254|NCT01721577|580974951|FG001|Overall Study|Death|0|||
161122622|NCT02574637|581835225|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
161122623|NCT02574637|581835226|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
161122624|NCT02574637|581835227|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
161122625|NCT02574637|581835218|FG000|Double-blind Period|Reason Not Specified|0|||
161122626|NCT02574637|581835219|FG001|Double-blind Period|Reason Not Specified|0|||
161122627|NCT02574637|581835220|FG002|Double-blind Period|Reason Not Specified|0|||
161122628|NCT02574637|581835221|FG003|Double-blind Period|Reason Not Specified|1|||
161122629|NCT02574637|581835222|FG004|Double-blind Period|Reason Not Specified|0|||
161122630|NCT02574637|581835223|FG005|Double-blind Period|Reason Not Specified|0|||
161122631|NCT02574637|581835224|FG006|Double-blind Period|Reason Not Specified|0|||
161122632|NCT02574637|581835225|FG007|Double-blind Period|Reason Not Specified|0|||
161122633|NCT02574637|581835226|FG008|Double-blind Period|Reason Not Specified|0|||
161122634|NCT02574637|581835227|FG009|Double-blind Period|Reason Not Specified|0|||
161122635|NCT02574637|581835218|FG000|Open-label (OL) Period|Adverse Event|0|||
161122636|NCT02574637|581835219|FG001|Open-label (OL) Period|Adverse Event|0|||
161122637|NCT02574637|581835220|FG002|Open-label (OL) Period|Adverse Event|0|||
161122638|NCT02574637|581835221|FG003|Open-label (OL) Period|Adverse Event|0|||
161122639|NCT02574637|581835222|FG004|Open-label (OL) Period|Adverse Event|0|||
161122640|NCT02574637|581835223|FG005|Open-label (OL) Period|Adverse Event|0|||
161122641|NCT02574637|581835224|FG006|Open-label (OL) Period|Adverse Event|0|||
161122642|NCT02574637|581835225|FG007|Open-label (OL) Period|Adverse Event|0|||
160885255|NCT01721577|580974950|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
160885256|NCT01721577|580974951|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
160885257|NCT01721577|580974950|FG000|Overall Study|Adverse Event|0|||
160885258|NCT01721577|580974951|FG001|Overall Study|Adverse Event|2|||
160885259|NCT01055496|580974952|FG000|Overall Study|Withdrawal by Subject|2|||
160885260|NCT01055496|580974953|FG001|Overall Study|Withdrawal by Subject|4|||
160885261|NCT01055496|580974952|FG000|Overall Study|Death|13|||
160885262|NCT01055496|580974953|FG001|Overall Study|Death|23|||
160885263|NCT01055496|580974952|FG000|Overall Study|Lost to Follow-up|0|||
160885264|NCT01055496|580974953|FG001|Overall Study|Lost to Follow-up|2|||
160885265|NCT01055496|580974952|FG000|Overall Study|Other - Unspecified|0|||
160885266|NCT01055496|580974953|FG001|Overall Study|Other - Unspecified|1|||
160885267|NCT00584740|580974954|FG000|Overall Study|Adverse Event|1|||
160885268|NCT00584740|580974955|FG001|Overall Study|Adverse Event|1|||
160885269|NCT00584740|580974954|FG000|Overall Study|Lack of Efficacy|8|||
160885270|NCT00584740|580974955|FG001|Overall Study|Lack of Efficacy|2|||
160885271|NCT00584740|580974954|FG000|Overall Study|Withdrawal by Subject|3|||
160885272|NCT00584740|580974955|FG001|Overall Study|Withdrawal by Subject|2|||
160885273|NCT00584740|580974954|FG000|Overall Study|Lost to Follow-up|0|||
160885274|NCT00584740|580974955|FG001|Overall Study|Lost to Follow-up|1|||
160885275|NCT02158364|580974956|FG000|Overall Study|Case report forms uncollected|10|||
160885276|NCT02158364|580974956|FG000|Overall Study|Protocol Deviation|50|||
160885277|NCT00732940|580974960|FG000|Overall Study|Withdrawal by Subject|1|||
160885278|NCT00732940|580974961|FG001|Overall Study|Withdrawal by Subject|2|||
160885279|NCT00732940|580974960|FG000|Overall Study|Adverse Event|0|||
160885280|NCT00732940|580974961|FG001|Overall Study|Adverse Event|1|||
160885281|NCT00732940|580974960|FG000|Overall Study|Lost to Follow-up|1|||
160885282|NCT00732940|580974961|FG001|Overall Study|Lost to Follow-up|0|||
160885283|NCT01642732|580974962|FG000|Overall Study|Withdrawal by Subject|1|||
160885284|NCT01589770|580974967|FG000|Overall Study|EGFR <60ml/min|6|||
160885285|NCT01589770|580974968|FG001|Overall Study|EGFR <60ml/min|4|||
160885286|NCT01589770|580974967|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
160885287|NCT01589770|580974968|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
160885288|NCT01077375|580974972|FG000|Overall Study|Adverse Event|2|||
160885289|NCT01077375|580974973|FG001|Overall Study|Adverse Event|15|||
160885290|NCT01077375|580974972|FG000|Overall Study|Lack of Efficacy|6|||
160885291|NCT01077375|580974973|FG001|Overall Study|Lack of Efficacy|8|||
160885292|NCT01077375|580974972|FG000|Overall Study|Withdrawal by Subject|0|||
160885293|NCT01077375|580974973|FG001|Overall Study|Withdrawal by Subject|6|||
160885294|NCT01077375|580974972|FG000|Overall Study|Lost to Follow-up|2|||
160885295|NCT01077375|580974973|FG001|Overall Study|Lost to Follow-up|5|||
160885296|NCT01077375|580974972|FG000|Overall Study|Other Reason|0|||
160885297|NCT01077375|580974973|FG001|Overall Study|Other Reason|1|||
160885298|NCT03021564|580974977|FG000|Overall Study|Death|84|||
160885299|NCT03021564|580974978|FG001|Overall Study|Death|466|||
160885300|NCT03021564|580974977|FG000|Overall Study|Lost to Follow-up|0|||
160885301|NCT03021564|580974978|FG001|Overall Study|Lost to Follow-up|2|||
160885302|NCT00969280|580974979|FG000|Overall Study|Protocol Violation|2|||
160885303|NCT00969280|580974980|FG001|Overall Study|Protocol Violation|1|||
160885304|NCT00969280|580974979|FG000|Overall Study|Withdrawal by Subject|0|||
160885305|NCT00969280|580974980|FG001|Overall Study|Withdrawal by Subject|1|||
160885306|NCT00969280|580974979|FG000|Overall Study|infection of influenza A(H1N1)|0|||
160885307|NCT00969280|580974980|FG001|Overall Study|infection of influenza A(H1N1)|1|||
160885308|NCT00821327|580974981|FG000|Overall Study|Adverse Event|13|||
160885309|NCT00821327|580974981|FG000|Overall Study|Patient Request|1|||
160885310|NCT00821327|580974981|FG000|Overall Study|Investigator Request|2|||
160885311|NCT00821327|580974981|FG000|Overall Study|Sponsor Request|1|||
160885312|NCT00821327|580974981|FG000|Overall Study|Disease Progression|13|||
161228181|NCT02339909|582215317|FG000|Overall Study|Became ineligible after randomisation|89|||
161228182|NCT02339909|582215318|FG001|Overall Study|Became ineligible after randomisation|63|||
161228183|NCT02339909|582215319|FG002|Overall Study|Became ineligible after randomisation|71|||
161228184|NCT00860028|582215320|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
160885313|NCT00821327|580974981|FG000|Overall Study|Other/Unknown|5|||
160885314|NCT00217464|580974982|FG000|Overall Study|Progression|15|||
161228185|NCT00860028|582215321|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
161228186|NCT02576990|582215322|FG000|Overall Study|Death|29|||
160885315|NCT00217464|580974982|FG000|Overall Study|Other|2|||
160885316|NCT00459979|580974983|FG000|Overall Study|Withdrawal by Subject|1|||
160885317|NCT00459979|580974983|FG000|Overall Study|Protocol Violation|1|||
160885318|NCT00278915|580974984|FG000|Overall Study|Disease progression|1|||
160885319|NCT05214573|580974985|FG000|Overall Study|Physician Decision|5924|||
160885320|NCT05214573|580974986|FG001|Overall Study|Physician Decision|0|||
160885321|NCT00814801|580974987|FG000|Overall Study|Adverse Event|15|||
160885322|NCT00814801|580974988|FG001|Overall Study|Adverse Event|16|||
160885323|NCT00814801|580974989|FG002|Overall Study|Adverse Event|19|||
160885324|NCT00814801|580974987|FG000|Overall Study|Withdrawal by Subject|9|||
160885325|NCT00814801|580974988|FG001|Overall Study|Withdrawal by Subject|11|||
160885326|NCT00814801|580974989|FG002|Overall Study|Withdrawal by Subject|14|||
160885327|NCT00814801|580974987|FG000|Overall Study|Inappropriate as a subject|1|||
160885328|NCT00814801|580974988|FG001|Overall Study|Inappropriate as a subject|1|||
160885329|NCT00814801|580974989|FG002|Overall Study|Inappropriate as a subject|1|||
160885330|NCT00814801|580974987|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
160885331|NCT00814801|580974988|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
160885332|NCT00814801|580974989|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
160885333|NCT00814801|580974987|FG000|Overall Study|Missing or change of caregiver|6|||
160885334|NCT00814801|580974988|FG001|Overall Study|Missing or change of caregiver|2|||
160885335|NCT00814801|580974989|FG002|Overall Study|Missing or change of caregiver|4|||
160885336|NCT00814801|580974987|FG000|Overall Study|Non-compliance|0|||
160885337|NCT00814801|580974988|FG001|Overall Study|Non-compliance|1|||
160885338|NCT00814801|580974989|FG002|Overall Study|Non-compliance|1|||
160885339|NCT00814801|580974987|FG000|Overall Study|Other|2|||
160885340|NCT00814801|580974988|FG001|Overall Study|Other|6|||
160885341|NCT00814801|580974989|FG002|Overall Study|Other|4|||
160885342|NCT01037088|580974992|FG000|Overall Study|Withdrawal by Subject|3|||
160885343|NCT02216812|580974993|FG000|Overall Study|Lost to Follow-up|10|||
160885344|NCT02216812|580974994|FG001|Overall Study|Lost to Follow-up|5|||
160885345|NCT00527488|580974995|FG000|Overall Study|Withdrawn prior to dosing|0|||
160885346|NCT00527488|580974996|FG001|Overall Study|Withdrawn prior to dosing|1|||
160885347|NCT00527488|580974997|FG002|Overall Study|Withdrawn prior to dosing|1|||
160885348|NCT00527488|580974998|FG003|Overall Study|Withdrawn prior to dosing|0|||
160885349|NCT03036800|580974999|FG000|Overall Study|Protocol Violation|1|||
160885350|NCT03036800|580975000|FG001|Overall Study|Protocol Violation|0|||
160885351|NCT03036800|580974999|FG000|Overall Study|Non-compliance|1|||
160885352|NCT03036800|580975000|FG001|Overall Study|Non-compliance|0|||
160885353|NCT03036800|580974999|FG000|Overall Study|Lost to Follow-up|1|||
160885354|NCT03036800|580975000|FG001|Overall Study|Lost to Follow-up|0|||
160885355|NCT03036800|580974999|FG000|Overall Study|Death|1|||
160885356|NCT03036800|580975000|FG001|Overall Study|Death|0|||
160885357|NCT03036800|580974999|FG000|Overall Study|Tolerance|5|||
160885358|NCT03036800|580975000|FG001|Overall Study|Tolerance|0|||
160885359|NCT03036800|580974999|FG000|Overall Study|Unknown/no reason given|50|||
160885360|NCT03036800|580975000|FG001|Overall Study|Unknown/no reason given|39|||
160885361|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
160885362|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
160885363|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
160885364|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
160885365|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
160885366|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
160885367|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
160885368|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
160885369|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
160885370|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
160885371|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
160885372|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
160885373|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
160885374|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
160885375|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
160885376|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
160885377|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
160885378|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
160885379|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
160885380|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
160885381|NCT01986933|580975001|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885382|NCT01986933|580975002|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885383|NCT01986933|580975003|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885384|NCT01986933|580975004|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
160885385|NCT01986933|580975005|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
160885386|NCT01986933|580975001|FG000|Active-to-active (Part B)|Adverse Event|0|||
160885387|NCT01986933|580975002|FG001|Active-to-active (Part B)|Adverse Event|2|||
160885388|NCT01986933|580975003|FG002|Active-to-active (Part B)|Adverse Event|0|||
160885389|NCT01986933|580975004|FG003|Active-to-active (Part B)|Adverse Event|1|||
160885390|NCT01986933|580975005|FG004|Active-to-active (Part B)|Adverse Event|3|||
160885391|NCT01986933|580975001|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
160885392|NCT01986933|580975002|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
160885393|NCT01986933|580975003|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
160885394|NCT01986933|580975004|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
160885395|NCT01986933|580975005|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
160885396|NCT01986933|580975001|FG000|Active-to-active (Part B)|Pregnancy|0|||
160885397|NCT01986933|580975002|FG001|Active-to-active (Part B)|Pregnancy|0|||
160885398|NCT01986933|580975003|FG002|Active-to-active (Part B)|Pregnancy|0|||
160885399|NCT01986933|580975004|FG003|Active-to-active (Part B)|Pregnancy|0|||
160885400|NCT01986933|580975005|FG004|Active-to-active (Part B)|Pregnancy|1|||
160885401|NCT01986933|580975001|FG000|Active-to-active (Part B)|Physician Decision|0|||
160885402|NCT01986933|580975002|FG001|Active-to-active (Part B)|Physician Decision|0|||
160885403|NCT01986933|580975003|FG002|Active-to-active (Part B)|Physician Decision|1|||
160885404|NCT01986933|580975004|FG003|Active-to-active (Part B)|Physician Decision|1|||
160885405|NCT01986933|580975005|FG004|Active-to-active (Part B)|Physician Decision|0|||
160885406|NCT01986933|580975001|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
160885407|NCT01986933|580975002|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
160885408|NCT01986933|580975003|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
160885409|NCT01986933|580975004|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
160885410|NCT01986933|580975005|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
160885411|NCT01986933|580975001|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
160885412|NCT01986933|580975002|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
160885413|NCT01986933|580975003|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
160885414|NCT01986933|580975004|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
160885415|NCT01986933|580975005|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
160885416|NCT01986933|580975001|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
160885417|NCT01986933|580975002|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
160885418|NCT01986933|580975003|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
160885419|NCT01986933|580975004|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
160885420|NCT01986933|580975005|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
160885421|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
160885422|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
160885423|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
160885424|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
160885425|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
160885426|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885427|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885428|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885429|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
160885430|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
160885431|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
160885432|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
160885433|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
160885434|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
160885435|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
160885436|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
160885437|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
160885438|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
160885439|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
160885440|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
160885441|NCT01986933|580975001|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
160885442|NCT01986933|580975002|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
160885443|NCT01986933|580975003|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
161228187|NCT02576990|582215323|FG001|Overall Study|Death|18|||
161228188|NCT02576990|582215322|FG000|Overall Study|Physician Decision|1|||
161228189|NCT02576990|582215323|FG001|Overall Study|Physician Decision|0|||
161228190|NCT02576990|582215322|FG000|Overall Study|Screen failure|2|||
161228191|NCT02576990|582215323|FG001|Overall Study|Screen failure|0|||
161228192|NCT02576990|582215322|FG000|Overall Study|Sponsor's decision|24|||
161228193|NCT02576990|582215323|FG001|Overall Study|Sponsor's decision|4|||
161228194|NCT02576990|582215322|FG000|Overall Study|Withdrawal by Subject|0|||
161228195|NCT02576990|582215323|FG001|Overall Study|Withdrawal by Subject|2|||
161228196|NCT00936390|582215324|FG000|Overall Study|Protocol Violation|21|||
161228197|NCT00936390|582215325|FG001|Overall Study|Protocol Violation|25|||
161228198|NCT02093689|582215326|FG000|Overall Study|Physician Decision|4|||
161228199|NCT02093689|582215327|FG001|Overall Study|Physician Decision|0|||
161228200|NCT02093689|582215328|FG002|Overall Study|Physician Decision|0|||
161228201|NCT00475020|582215329|FG000|Overall Study|Physician Decision|3|||
161228202|NCT00475020|582215329|FG000|Overall Study|Insurance Denial|1|||
161228203|NCT00475020|582215329|FG000|Overall Study|Donor not able to donate the last minute|1|||
161228204|NCT01575054|582215330|FG000|Overall Study|Other Reasons|5|||
161228205|NCT01575054|582215331|FG001|Overall Study|Other Reasons|3|||
161228206|NCT01575054|582215330|FG000|Overall Study|Protocol Violation|2|||
161228207|NCT01575054|582215331|FG001|Overall Study|Protocol Violation|1|||
161228208|NCT01575054|582215330|FG000|Overall Study|Personal Reasons|10|||
161228209|NCT01575054|582215331|FG001|Overall Study|Personal Reasons|11|||
161228210|NCT01575054|582215330|FG000|Overall Study|Lost to Follow-up|3|||
161228211|NCT01575054|582215331|FG001|Overall Study|Lost to Follow-up|3|||
161228212|NCT01575054|582215330|FG000|Overall Study|Adverse Event|9|||
161325437|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
160885444|NCT01986933|580975004|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
161228213|NCT01575054|582215331|FG001|Overall Study|Adverse Event|8|||
161228214|NCT03481309|582215332|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
160885445|NCT01986933|580975005|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
160885446|NCT01077154|580975006|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
160885447|NCT01077154|580975007|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
160885448|NCT01077154|580975006|FG000|Overall Study|Withdrawal by Subject|369|||
160885449|NCT01077154|580975007|FG001|Overall Study|Withdrawal by Subject|385|||
160885450|NCT01077154|580975006|FG000|Overall Study|Death|215|||
160885451|NCT01077154|580975007|FG001|Overall Study|Death|214|||
160885452|NCT01077154|580975006|FG000|Overall Study|Lost to Follow-up|43|||
160885453|NCT01077154|580975007|FG001|Overall Study|Lost to Follow-up|35|||
160885454|NCT01077154|580975006|FG000|Overall Study|Noncompliance|22|||
160885455|NCT01077154|580975007|FG001|Overall Study|Noncompliance|20|||
160885456|NCT01077154|580975006|FG000|Overall Study|Disease Progression|18|||
160885457|NCT01077154|580975007|FG001|Overall Study|Disease Progression|20|||
160885458|NCT01077154|580975006|FG000|Overall Study|Ineligibility Determined|10|||
160885459|NCT01077154|580975007|FG001|Overall Study|Ineligibility Determined|14|||
160885460|NCT01077154|580975006|FG000|Overall Study|Other|14|||
160885461|NCT01077154|580975007|FG001|Overall Study|Other|11|||
160885462|NCT01077154|580975006|FG000|Overall Study|Adverse Event|9|||
160885463|NCT01077154|580975007|FG001|Overall Study|Adverse Event|9|||
160885464|NCT01077154|580975006|FG000|Overall Study|Administrative Decision|1|||
160885465|NCT01077154|580975007|FG001|Overall Study|Administrative Decision|6|||
160885466|NCT01077154|580975006|FG000|Overall Study|Protocol Deviation|1|||
160885467|NCT01077154|580975007|FG001|Overall Study|Protocol Deviation|0|||
160885468|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
160885469|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
160885470|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
160885471|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
160885472|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
160885473|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
160885474|NCT04030026|580975008|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
160885475|NCT04030026|580975009|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
160885476|NCT04030026|580975008|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
160885477|NCT04030026|580975009|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
160885478|NCT04030026|580975008|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
160885479|NCT04030026|580975009|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
160885480|NCT04030026|580975008|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
160885481|NCT04030026|580975009|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
160885482|NCT02545543|580975010|FG000|Overall Study|Lost to Follow-up|67|||
160885483|NCT02545543|580975011|FG001|Overall Study|Lost to Follow-up|25|||
160885484|NCT02545543|580975010|FG000|Overall Study|Physician Decision|3|||
160885485|NCT02545543|580975011|FG001|Overall Study|Physician Decision|0|||
160885486|NCT02545543|580975010|FG000|Overall Study|Withdrawal by Subject|9|||
160885487|NCT02545543|580975011|FG001|Overall Study|Withdrawal by Subject|8|||
160885488|NCT02545543|580975010|FG000|Overall Study|Noncomplaince|1|||
160885489|NCT02545543|580975011|FG001|Overall Study|Noncomplaince|0|||
160885490|NCT02545543|580975010|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
160885491|NCT02545543|580975011|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
160885492|NCT00811642|580975012|FG000|Overall Study|Adverse Event|3|||
160885493|NCT00811642|580975012|FG000|Overall Study|Protocol Violation|1|||
160885494|NCT00811642|580975012|FG000|Overall Study|Death|2|||
160885495|NCT00811642|580975012|FG000|Overall Study|Withdrawal by Subject|7|||
160885496|NCT00811642|580975012|FG000|Overall Study|Cumulative use of antifungal agent|2|||
160885497|NCT00622739|580976373|FG000|Overall Study|Physician Decision|1|||
160885498|NCT00622739|580976374|FG001|Overall Study|Physician Decision|0|||
160885499|NCT00622739|580976373|FG000|Overall Study|Adverse Event|1|||
160885500|NCT00622739|580976374|FG001|Overall Study|Adverse Event|2|||
160885501|NCT00622739|580976373|FG000|Overall Study|Lack of Efficacy|0|||
160885502|NCT00622739|580976374|FG001|Overall Study|Lack of Efficacy|2|||
160885503|NCT00622739|580976373|FG000|Overall Study|Withdrawal by Subject|0|||
160885504|NCT00622739|580976374|FG001|Overall Study|Withdrawal by Subject|1|||
160885505|NCT00622739|580976373|FG000|Overall Study|Lost to Follow-up|0|||
160885506|NCT00622739|580976374|FG001|Overall Study|Lost to Follow-up|1|||
160885507|NCT00134784|580976375|FG000|Overall Study|Withdrawal by Subject|2|||
160885508|NCT00134784|580976376|FG001|Overall Study|Withdrawal by Subject|2|||
160885509|NCT00134784|580976377|FG002|Overall Study|Withdrawal by Subject|2|||
160885510|NCT00134784|580976378|FG003|Overall Study|Withdrawal by Subject|1|||
160885511|NCT00625742|580976379|FG000|Overall Study|Disease Progression|2|||
160885512|NCT00625742|580976379|FG000|Overall Study|Withdrawal by Subject|1|||
160885513|NCT00625742|580976379|FG000|Overall Study|Adverse Event|4|||
160885514|NCT00625742|580976379|FG000|Overall Study|Lost to Follow-up|4|||
160885515|NCT00625742|580976379|FG000|Overall Study|Ineligible|1|||
160885516|NCT03384693|580976380|FG000|Overall Study|Adverse Event|3|||
160885517|NCT03387150|580976381|FG000|Overall Study|Withdrawal by Subject|3|||
160885518|NCT03387150|580976382|FG001|Overall Study|Withdrawal by Subject|0|||
160885519|NCT03387150|580976383|FG002|Overall Study|Withdrawal by Subject|3|||
160885520|NCT03387150|580976384|FG003|Overall Study|Withdrawal by Subject|4|||
160885521|NCT03387150|580976385|FG004|Overall Study|Withdrawal by Subject|1|||
160885522|NCT03387150|580976386|FG005|Overall Study|Withdrawal by Subject|2|||
160885523|NCT03387150|580976387|FG006|Overall Study|Withdrawal by Subject|0|||
160885524|NCT03387150|580976381|FG000|Overall Study|Lost to Follow-up|3|||
160885525|NCT03387150|580976382|FG001|Overall Study|Lost to Follow-up|2|||
160885526|NCT03387150|580976383|FG002|Overall Study|Lost to Follow-up|2|||
160885527|NCT03387150|580976384|FG003|Overall Study|Lost to Follow-up|3|||
160885528|NCT03387150|580976385|FG004|Overall Study|Lost to Follow-up|3|||
160885529|NCT03387150|580976386|FG005|Overall Study|Lost to Follow-up|3|||
161325438|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325439|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161325440|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325441|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325442|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325443|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
161325444|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161325445|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325446|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
161325447|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325448|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325449|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
161325450|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
161325451|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
160885530|NCT03387150|580976387|FG006|Overall Study|Lost to Follow-up|0|||
160885531|NCT03387150|580976381|FG000|Overall Study|Participant unable to adhere to visit|0|||
160885532|NCT03387150|580976382|FG001|Overall Study|Participant unable to adhere to visit|1|||
160885533|NCT03387150|580976383|FG002|Overall Study|Participant unable to adhere to visit|0|||
160885534|NCT03387150|580976384|FG003|Overall Study|Participant unable to adhere to visit|0|||
160885535|NCT03387150|580976385|FG004|Overall Study|Participant unable to adhere to visit|2|||
160885536|NCT03387150|580976386|FG005|Overall Study|Participant unable to adhere to visit|2|||
160885537|NCT03387150|580976387|FG006|Overall Study|Participant unable to adhere to visit|0|||
160885538|NCT04006119|580976388|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
160885539|NCT04006119|580976388|FG000|End of Treatment Veledimex|Adverse Event|2|||
160885540|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
160885541|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
160885542|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
161325452|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
161325453|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
161325454|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
161325455|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
161325456|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
161325457|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
161325458|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
161325459|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
161325460|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
161325461|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
161325462|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
161325463|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
161325464|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
161325465|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
161325466|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
160885543|NCT04006119|580976388|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
160885544|NCT00920907|580976393|FG000|Induction Period|Adverse Event|0|||
160885545|NCT00920907|580976394|FG001|Induction Period|Adverse Event|2|||
160885546|NCT00920907|580976393|FG000|Induction Period|Death|1|||
160885547|NCT00920907|580976394|FG001|Induction Period|Death|1|||
160885548|NCT00920907|580976393|FG000|Induction Period|Disease Progression|12|||
160885549|NCT00920907|580976394|FG001|Induction Period|Disease Progression|11|||
160885550|NCT00920907|580976393|FG000|Induction Period|Study Drug Toxicity|8|||
160885551|NCT00920907|580976394|FG001|Induction Period|Study Drug Toxicity|6|||
160885552|NCT00920907|580976393|FG000|Induction Period|No longer meets study criteria|0|||
160885553|NCT00920907|580976394|FG001|Induction Period|No longer meets study criteria|1|||
160885554|NCT00920907|580976393|FG000|Induction Period|Withdrawal by Subject|1|||
160885555|NCT00920907|580976394|FG001|Induction Period|Withdrawal by Subject|1|||
160885556|NCT00920907|580976393|FG000|Maintenance Period|Disease Progression|3|||
160885557|NCT00920907|580976394|FG001|Maintenance Period|Disease Progression|7|||
160885558|NCT00920907|580976393|FG000|Maintenance Period|Administrative (study closure)|7|||
161325467|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
161325468|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
161325469|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
161325470|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325471|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325472|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325473|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325474|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
160885559|NCT00920907|580976394|FG001|Maintenance Period|Administrative (study closure)|2|||
160885560|NCT00920907|580976393|FG000|Maintenance Period|Study Drug Toxicity|0|||
160885561|NCT00920907|580976394|FG001|Maintenance Period|Study Drug Toxicity|2|||
160885562|NCT00920907|580976393|FG000|Maintenance Period|Death|1|||
161325475|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325476|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
161325477|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325478|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325479|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325480|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325481|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325482|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325483|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325484|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325485|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325486|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325487|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
161325488|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
161325489|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161325490|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
160885563|NCT00920907|580976394|FG001|Maintenance Period|Death|1|||
160885564|NCT00920907|580976393|FG000|Maintenance Period|Withdrawal by Subject|1|||
160885565|NCT00920907|580976394|FG001|Maintenance Period|Withdrawal by Subject|0|||
160885566|NCT00920907|580976393|FG000|Maintenance Period|Adverse Event|0|||
160885567|NCT00920907|580976394|FG001|Maintenance Period|Adverse Event|1|||
160885568|NCT02616601|580976395|FG000|Overall Study|Withdrawal by Subject|4|||
160885569|NCT02616601|580976396|FG001|Overall Study|Withdrawal by Subject|4|||
160885570|NCT02616601|580976397|FG002|Overall Study|Withdrawal by Subject|3|||
160885571|NCT02616601|580976395|FG000|Overall Study|Adverse Event|2|||
160885572|NCT02616601|580976396|FG001|Overall Study|Adverse Event|0|||
160885573|NCT02616601|580976397|FG002|Overall Study|Adverse Event|2|||
160885574|NCT02616601|580976395|FG000|Overall Study|Death|1|||
160885575|NCT02616601|580976396|FG001|Overall Study|Death|0|||
160885576|NCT02616601|580976397|FG002|Overall Study|Death|0|||
160885577|NCT02616601|580976395|FG000|Overall Study|Lost to Follow-up|1|||
160885578|NCT02616601|580976396|FG001|Overall Study|Lost to Follow-up|0|||
160885579|NCT02616601|580976397|FG002|Overall Study|Lost to Follow-up|1|||
160885580|NCT02616601|580976395|FG000|Overall Study|Non-Compliance with Test Article|1|||
160885581|NCT02616601|580976396|FG001|Overall Study|Non-Compliance with Test Article|0|||
160885582|NCT02616601|580976397|FG002|Overall Study|Non-Compliance with Test Article|1|||
160885583|NCT00371761|580976398|FG000|Overall Study|Adverse Event|1|||
160885584|NCT00371761|580976399|FG001|Overall Study|Adverse Event|1|||
160885585|NCT00371761|580976398|FG000|Overall Study|Withdrawal by Subject|1|||
160885586|NCT00371761|580976399|FG001|Overall Study|Withdrawal by Subject|3|||
160885587|NCT00371761|580976398|FG000|Overall Study|Investigator Judgment|2|||
160885588|NCT00371761|580976399|FG001|Overall Study|Investigator Judgment|3|||
160885589|NCT00371761|580976398|FG000|Overall Study|Study termination|4|||
160885590|NCT00371761|580976399|FG001|Overall Study|Study termination|3|||
160885591|NCT00718081|580976400|FG000|Overall Study|Adverse Event|0|||
161325491|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161325492|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
161325493|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
160885592|NCT00718081|580976401|FG001|Overall Study|Adverse Event|1|||
160885593|NCT00718081|580976402|FG002|Overall Study|Adverse Event|0|||
160885594|NCT00718081|580976400|FG000|Overall Study|Lack of Efficacy|7|||
160885595|NCT00718081|580976401|FG001|Overall Study|Lack of Efficacy|3|||
160885596|NCT00718081|580976402|FG002|Overall Study|Lack of Efficacy|21|||
160885597|NCT00815516|580976403|FG000|Overall Study|Death|3|||
160885598|NCT00815516|580976404|FG001|Overall Study|Death|1|||
160885599|NCT00815516|580976403|FG000|Overall Study|Physician Decision|1|||
160885600|NCT00815516|580976404|FG001|Overall Study|Physician Decision|0|||
160885601|NCT01992159|580976411|FG000|Overall Study|Withdrawal by Subject|4|||
160885602|NCT01992159|580976412|FG001|Overall Study|Withdrawal by Subject|7|||
160885603|NCT01992159|580976413|FG002|Overall Study|Withdrawal by Subject|0|||
160885604|NCT01992159|580976414|FG003|Overall Study|Withdrawal by Subject|3|||
160885605|NCT01992159|580976411|FG000|Overall Study|Adverse Event|0|||
160885606|NCT01992159|580976412|FG001|Overall Study|Adverse Event|1|||
160885607|NCT01992159|580976413|FG002|Overall Study|Adverse Event|0|||
160885608|NCT01992159|580976414|FG003|Overall Study|Adverse Event|1|||
160885609|NCT01992159|580976411|FG000|Overall Study|Death|0|||
161228215|NCT03481309|582215333|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161228216|NCT03481309|582215334|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161228217|NCT03481309|582215335|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161228218|NCT03481309|582215336|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161228219|NCT03481309|582215337|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
161228220|NCT03309956|582215340|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
161228221|NCT03365947|582215341|FG000|Overall Study|Lost to Follow-up|0|||
161228222|NCT03365947|582215342|FG001|Overall Study|Lost to Follow-up|0|||
161228223|NCT03365947|582215343|FG002|Overall Study|Lost to Follow-up|0|||
161228224|NCT03365947|582215344|FG003|Overall Study|Lost to Follow-up|0|||
161228225|NCT03365947|582215345|FG004|Overall Study|Lost to Follow-up|0|||
161228226|NCT03365947|582215346|FG005|Overall Study|Lost to Follow-up|1|||
161228227|NCT03365947|582215347|FG006|Overall Study|Lost to Follow-up|0|||
161228228|NCT03365947|582215348|FG007|Overall Study|Lost to Follow-up|0|||
161228229|NCT03365947|582215349|FG008|Overall Study|Lost to Follow-up|0|||
161228230|NCT03365947|582215350|FG009|Overall Study|Lost to Follow-up|0|||
161228231|NCT03365947|582215351|FG010|Overall Study|Lost to Follow-up|0|||
161228232|NCT03365947|582215352|FG011|Overall Study|Lost to Follow-up|0|||
161228233|NCT03365947|582215353|FG012|Overall Study|Lost to Follow-up|0|||
161228234|NCT03365947|582215354|FG013|Overall Study|Lost to Follow-up|0|||
161228235|NCT03365947|582215355|FG014|Overall Study|Lost to Follow-up|0|||
161228236|NCT03365947|582215356|FG015|Overall Study|Lost to Follow-up|0|||
161228237|NCT03365947|582215357|FG016|Overall Study|Lost to Follow-up|0|||
161228238|NCT03365947|582215358|FG017|Overall Study|Lost to Follow-up|0|||
161228239|NCT03365947|582215359|FG018|Overall Study|Lost to Follow-up|0|||
161228240|NCT02518685|582215360|FG000|Overall Study|Adverse Event|29|||
161228241|NCT02518685|582215361|FG001|Overall Study|Adverse Event|1|||
161228242|NCT02518685|582215360|FG000|Overall Study|Withdrawal by Subject|10|||
161228243|NCT02518685|582215361|FG001|Overall Study|Withdrawal by Subject|3|||
161228244|NCT02518685|582215360|FG000|Overall Study|relocation, study fatigue|7|||
161228245|NCT02518685|582215361|FG001|Overall Study|relocation, study fatigue|2|||
161228246|NCT02518685|582215360|FG000|Overall Study|Pregnancy|1|||
161228247|NCT02518685|582215361|FG001|Overall Study|Pregnancy|0|||
161228248|NCT02518685|582215360|FG000|Overall Study|Physician Decision|1|||
161228249|NCT02518685|582215361|FG001|Overall Study|Physician Decision|0|||
161228250|NCT02518685|582215360|FG000|Overall Study|Lost to Follow-up|1|||
161228251|NCT02518685|582215361|FG001|Overall Study|Lost to Follow-up|4|||
161228252|NCT01922349|582215362|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161228253|NCT01922349|582215363|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161228254|NCT01922349|582215364|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
161228255|NCT01922349|582215365|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
161228256|NCT05109234|582215366|FG000|Overall Study|Adverse Event|2|||
161228257|NCT05109234|582215367|FG001|Overall Study|Adverse Event|2|||
161228258|NCT05109234|582215366|FG000|Overall Study|Lack of Efficacy|5|||
161228259|NCT05109234|582215367|FG001|Overall Study|Lack of Efficacy|0|||
161228260|NCT05109234|582215366|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
161228261|NCT05109234|582215367|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
161228262|NCT05109234|582215366|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
161228263|NCT05109234|582215367|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
161228264|NCT05109234|582215366|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
161228265|NCT05109234|582215367|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
161228266|NCT05109234|582215366|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
161228267|NCT05109234|582215367|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
161228268|NCT03805438|582216962|FG000|Overall Study|Lack of Efficacy|1|||
161228269|NCT03805438|582216962|FG000|Overall Study|Protocol Violation|1|||
161228270|NCT00419770|582216966|FG000|Overall Study|Withdrawal by Subject|5|||
161228271|NCT00419770|582216967|FG001|Overall Study|Withdrawal by Subject|1|||
161228272|NCT02684344|582216973|FG000|Overall Study|Withdrawal by Subject|0|||
161228273|NCT02684344|582216974|FG001|Overall Study|Withdrawal by Subject|1|||
161228274|NCT01451762|582216975|FG000|Overall Study|Lost to Follow-up|3|||
161228275|NCT01451762|582216976|FG001|Overall Study|Lost to Follow-up|6|||
161228276|NCT01451762|582216977|FG002|Overall Study|Lost to Follow-up|6|||
161228277|NCT02424188|582216981|FG000|Overall Study|Death|2|||
161228278|NCT02424188|582216982|FG001|Overall Study|Death|2|||
161228279|NCT02424188|582216981|FG000|Overall Study|Lost to Follow-up|1|||
161228280|NCT02424188|582216982|FG001|Overall Study|Lost to Follow-up|3|||
160885610|NCT01992159|580976412|FG001|Overall Study|Death|0|||
161228281|NCT02424188|582216981|FG000|Overall Study|Incarceration|1|||
161228282|NCT02424188|582216982|FG001|Overall Study|Incarceration|0|||
161228283|NCT01494506|582216987|FG000|Overall Study|Lack of Efficacy|77|||
161228284|NCT01494506|582216988|FG001|Overall Study|Lack of Efficacy|83|||
161228285|NCT01494506|582216989|FG002|Overall Study|Lack of Efficacy|57|||
161228286|NCT01494506|582216987|FG000|Overall Study|Adverse Event|17|||
161228287|NCT01494506|582216988|FG001|Overall Study|Adverse Event|10|||
161228288|NCT01494506|582216989|FG002|Overall Study|Adverse Event|11|||
161228289|NCT01494506|582216987|FG000|Overall Study|Death|9|||
161228290|NCT01494506|582216988|FG001|Overall Study|Death|5|||
161228291|NCT01494506|582216989|FG002|Overall Study|Death|2|||
161228292|NCT01494506|582216987|FG000|Overall Study|Physician Decision|7|||
161228293|NCT01494506|582216988|FG001|Overall Study|Physician Decision|5|||
161228294|NCT01494506|582216989|FG002|Overall Study|Physician Decision|4|||
161228295|NCT01494506|582216987|FG000|Overall Study|Withdrawal by Subject|17|||
161228296|NCT01494506|582216988|FG001|Overall Study|Withdrawal by Subject|20|||
161228297|NCT01494506|582216989|FG002|Overall Study|Withdrawal by Subject|14|||
161228298|NCT01494506|582216987|FG000|Overall Study|Clinical Deterioration|21|||
161228299|NCT01494506|582216988|FG001|Overall Study|Clinical Deterioration|17|||
161228300|NCT01494506|582216989|FG002|Overall Study|Clinical Deterioration|13|||
161228301|NCT01494506|582216987|FG000|Overall Study|Sponsor Decision|0|||
161228302|NCT01494506|582216988|FG001|Overall Study|Sponsor Decision|0|||
161228303|NCT01494506|582216989|FG002|Overall Study|Sponsor Decision|1|||
161228304|NCT01494506|582216987|FG000|Overall Study|Other|0|||
161228305|NCT01494506|582216988|FG001|Overall Study|Other|3|||
161325494|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
161325495|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161325496|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161325497|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
161325498|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
161325499|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
161325500|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
161325501|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
161325502|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
161325503|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
161325504|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
161325505|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
161325506|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
161325507|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
161325508|NCT03428100|582578150|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325509|NCT03428100|582578151|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325510|NCT03428100|582578152|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325511|NCT03428100|582578153|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325512|NCT03428100|582578154|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161325513|NCT03428100|582578155|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325514|NCT03428100|582578156|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161325515|NCT03428100|582578157|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161325516|NCT03428100|582578158|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325517|NCT03428100|582578159|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
161325518|NCT03428100|582578160|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
161325519|NCT03428100|582578161|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161325520|NCT03428100|582578162|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161325521|NCT03428100|582578163|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
161325522|NCT03428100|582578164|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
161325523|NCT03428100|582578165|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325524|NCT03428100|582578166|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
161325525|NCT03428100|582578167|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
161325526|NCT03428100|582578168|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
161325527|NCT01048541|582578171|FG000|Overall Study|Withdrawal by Subject|1|||
161325528|NCT01048541|582578172|FG001|Overall Study|Withdrawal by Subject|0|||
161325529|NCT01300247|582578173|FG000|Overall Study|Death|1|||
161325530|NCT01300247|582578174|FG001|Overall Study|Death|1|||
161325531|NCT01300247|582578173|FG000|Overall Study|Lost to Follow-up|2|||
161325532|NCT01300247|582578174|FG001|Overall Study|Lost to Follow-up|0|||
161325533|NCT01300247|582578173|FG000|Overall Study|Withdrawal by Subject|1|||
161325534|NCT01300247|582578174|FG001|Overall Study|Withdrawal by Subject|0|||
161325535|NCT01300247|582578173|FG000|Overall Study|Non-Compliance|0|||
161325536|NCT01300247|582578174|FG001|Overall Study|Non-Compliance|1|||
161325537|NCT00922116|582578175|FG000|Overall Study|Adverse Event|4|||
161228306|NCT01494506|582216989|FG002|Overall Study|Other|1|||
161228307|NCT02777528|582216993|FG000|Overall Study|Still in study|24|||
161228308|NCT02777528|582216994|FG001|Overall Study|Still in study|10|||
161228309|NCT02777528|582216995|FG002|Overall Study|Still in study|1|||
161228310|NCT02777528|582216993|FG000|Overall Study|Study Device Explanted|1|||
161228311|NCT02777528|582216994|FG001|Overall Study|Study Device Explanted|0|||
161228312|NCT02777528|582216995|FG002|Overall Study|Study Device Explanted|0|||
160885611|NCT01992159|580976413|FG002|Overall Study|Death|1|||
160885612|NCT01992159|580976414|FG003|Overall Study|Death|0|||
160885613|NCT01249118|580976415|FG000|First Washout Period|Physician Decision|0|||
160885614|NCT01249118|580976416|FG001|First Washout Period|Physician Decision|1|||
160885615|NCT01249118|580976417|FG002|First Washout Period|Physician Decision|0|||
160885616|NCT00997438|580976418|FG000|Overall Study|Blood draw difficulty|2|||
160885617|NCT00997438|580976419|FG001|Overall Study|Blood draw difficulty|0|||
160885618|NCT00997438|580976420|FG002|Overall Study|Blood draw difficulty|1|||
160885619|NCT00997438|580976418|FG000|Overall Study|Withdrawal by Subject|1|||
160885620|NCT00997438|580976419|FG001|Overall Study|Withdrawal by Subject|1|||
160885621|NCT00997438|580976420|FG002|Overall Study|Withdrawal by Subject|0|||
160885622|NCT00997438|580976418|FG000|Overall Study|Exclusion criteria at visit 1|2|||
160885623|NCT00997438|580976419|FG001|Overall Study|Exclusion criteria at visit 1|2|||
160885624|NCT00997438|580976420|FG002|Overall Study|Exclusion criteria at visit 1|3|||
160885625|NCT00095238|580976421|FG000|Overall Study|Lack of Efficacy|9|||
160885626|NCT00095238|580976422|FG001|Overall Study|Lack of Efficacy|9|||
160885627|NCT00095238|580976421|FG000|Overall Study|Adverse Event|331|||
160885628|NCT00095238|580976422|FG001|Overall Study|Adverse Event|287|||
160885629|NCT00095238|580976421|FG000|Overall Study|Subject Withdrew Consent|208|||
160885630|NCT00095238|580976422|FG001|Overall Study|Subject Withdrew Consent|223|||
160885631|NCT00095238|580976421|FG000|Overall Study|Death|154|||
160885632|NCT00095238|580976422|FG001|Overall Study|Death|170|||
160885633|NCT00095238|580976421|FG000|Overall Study|Lost to Follow-up|19|||
160885634|NCT00095238|580976422|FG001|Overall Study|Lost to Follow-up|24|||
160885635|NCT00095238|580976421|FG000|Overall Study|Noncompliance|44|||
160885636|NCT00095238|580976422|FG001|Overall Study|Noncompliance|45|||
160885637|NCT00095238|580976421|FG000|Overall Study|No longer met study criteria|4|||
160885638|NCT00095238|580976422|FG001|Overall Study|No longer met study criteria|5|||
160885639|NCT00095238|580976421|FG000|Overall Study|Study terminated by sponsor|0|||
160885640|NCT00095238|580976422|FG001|Overall Study|Study terminated by sponsor|1|||
160885641|NCT00095238|580976421|FG000|Overall Study|Missing|1|||
160885642|NCT00095238|580976422|FG001|Overall Study|Missing|0|||
160885643|NCT00095238|580976421|FG000|Overall Study|Other Reasons|87|||
160885644|NCT00095238|580976422|FG001|Overall Study|Other Reasons|88|||
160885645|NCT03754972|580976423|FG000|Overall Study|Protocol Violation|25|||
160885646|NCT02311582|580976424|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
160885647|NCT02311582|580976425|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
160885648|NCT02311582|580976426|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
160885649|NCT02311582|580976427|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
160885650|NCT02311582|580976428|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
160885651|NCT03404960|580976430|FG000|Overall Study|Adverse Event|0|||
160885652|NCT03404960|580976431|FG001|Overall Study|Adverse Event|2|||
160885653|NCT03404960|580976430|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
160885654|NCT03404960|580976431|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
160885655|NCT03404960|580976430|FG000|Overall Study|Bowel obstruction|0|||
160885656|NCT03404960|580976431|FG001|Overall Study|Bowel obstruction|1|||
160885657|NCT03404960|580976430|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
160885658|NCT03404960|580976431|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
160885659|NCT06460493|580976434|FG000|Overall Study|Withdrawal by Subject|2|||
160885660|NCT04972630|580976437|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
160885661|NCT04972630|580976438|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
160885662|NCT04972630|580976439|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
160885663|NCT00075270|580976444|FG000|Overall Study|Withdrawal by Subject|28|||
160885664|NCT00075270|580976445|FG001|Overall Study|Withdrawal by Subject|21|||
160885665|NCT00075270|580976444|FG000|Overall Study|Lost to Follow-up|25|||
160885666|NCT00075270|580976445|FG001|Overall Study|Lost to Follow-up|28|||
160885667|NCT00075270|580976444|FG000|Overall Study|Protocol Violation|0|||
160885668|NCT00075270|580976445|FG001|Overall Study|Protocol Violation|2|||
160885669|NCT00075270|580976444|FG000|Overall Study|Death|198|||
160885670|NCT00075270|580976445|FG001|Overall Study|Death|215|||
160885671|NCT00075270|580976444|FG000|Overall Study|Other/Unknown|9|||
161122643|NCT02574637|581835226|FG008|Open-label (OL) Period|Adverse Event|1|||
160885672|NCT00075270|580976445|FG001|Overall Study|Other/Unknown|5|||
161122644|NCT02574637|581835227|FG009|Open-label (OL) Period|Adverse Event|0|||
161122645|NCT02574637|581835218|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
160885673|NCT00075270|580976444|FG000|Overall Study|Missing|26|||
160885674|NCT00075270|580976445|FG001|Overall Study|Missing|13|||
160885675|NCT00246571|580976446|FG000|Overall Study|Adverse Event|7|||
160885676|NCT00246571|580976447|FG001|Overall Study|Adverse Event|0|||
160885677|NCT00246571|580976446|FG000|Overall Study|Protocol Violation|0|||
160885678|NCT00246571|580976447|FG001|Overall Study|Protocol Violation|1|||
160885679|NCT00246571|580976446|FG000|Overall Study|Withdrawal by Subject|2|||
160885680|NCT00246571|580976447|FG001|Overall Study|Withdrawal by Subject|3|||
160885681|NCT00246571|580976446|FG000|Overall Study|Lack of Efficacy|84|||
161228313|NCT02777528|582216993|FG000|Overall Study|Death|14|||
161228314|NCT02777528|582216994|FG001|Overall Study|Death|7|||
161228315|NCT02777528|582216995|FG002|Overall Study|Death|1|||
161228316|NCT02777528|582216993|FG000|Overall Study|Withdrawal by Subject|2|||
161228317|NCT02777528|582216994|FG001|Overall Study|Withdrawal by Subject|2|||
161228318|NCT02777528|582216995|FG002|Overall Study|Withdrawal by Subject|1|||
161228319|NCT02777528|582216993|FG000|Overall Study|Physician Decision|2|||
161228320|NCT02777528|582216994|FG001|Overall Study|Physician Decision|1|||
161228321|NCT02777528|582216995|FG002|Overall Study|Physician Decision|0|||
161228322|NCT02777528|582216993|FG000|Overall Study|Lost to Follow-up|2|||
161228323|NCT02777528|582216994|FG001|Overall Study|Lost to Follow-up|0|||
161228324|NCT02777528|582216995|FG002|Overall Study|Lost to Follow-up|0|||
161228325|NCT02777528|582216993|FG000|Overall Study|Discontinued due to Other|1|||
161228326|NCT02777528|582216994|FG001|Overall Study|Discontinued due to Other|0|||
161228327|NCT02777528|582216995|FG002|Overall Study|Discontinued due to Other|0|||
161228328|NCT00453362|582216996|FG000|Overall Study|Adverse Event|5|||
161228329|NCT00453362|582216996|FG000|Overall Study|Death|7|||
161228330|NCT00453362|582216996|FG000|Overall Study|Physician Decision|2|||
161228331|NCT00453362|582216996|FG000|Overall Study|Withdrawal by Subject|3|||
161228332|NCT00453362|582216996|FG000|Overall Study|Progression of disease|56|||
161228333|NCT00453362|582216996|FG000|Overall Study|Screening Failure|14|||
161228334|NCT02127281|582216997|FG000|Overall Study|Lost to Follow-up|1|||
161228335|NCT02127281|582216998|FG001|Overall Study|Lost to Follow-up|0|||
161228336|NCT04885296|582216999|FG000|Period 1|Covid-19 Related|1|||
161228337|NCT04885296|582217000|FG001|Period 1|Covid-19 Related|0|||
161228338|NCT04885296|582216999|FG000|Period 1|Adverse Event|0|||
161228339|NCT04885296|582217000|FG001|Period 1|Adverse Event|1|||
161228340|NCT04885296|582216999|FG000|Period 1|Withdrawal by Subject|1|||
161228341|NCT04885296|582217000|FG001|Period 1|Withdrawal by Subject|1|||
161228342|NCT04885296|582216999|FG000|Period 1|Test Article No Longer Available|1|||
161228343|NCT04885296|582217000|FG001|Period 1|Test Article No Longer Available|0|||
161228344|NCT04885296|582216999|FG000|Period 1|Dispensed Study lens in Error|1|||
161228345|NCT04885296|582217000|FG001|Period 1|Dispensed Study lens in Error|0|||
161228346|NCT04885296|582216999|FG000|Period 1|Lost to Follow-up|1|||
161228347|NCT04885296|582217000|FG001|Period 1|Lost to Follow-up|0|||
161228348|NCT04885296|582216999|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
161228349|NCT04885296|582217000|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
161228350|NCT00433147|582217002|FG000|Overall Study|Adverse Event|0|||
161228351|NCT00433147|582217003|FG001|Overall Study|Adverse Event|1|||
161228352|NCT00433147|582217004|FG002|Overall Study|Adverse Event|0|||
161228353|NCT00433147|582217005|FG003|Overall Study|Adverse Event|0|||
161228354|NCT01882647|582217006|FG000|Overall Study|Lost to Follow-up|2|||
161228355|NCT01882647|582217007|FG001|Overall Study|Lost to Follow-up|2|||
161228356|NCT01882647|582217006|FG000|Overall Study|Withdrawal by Subject|0|||
161228357|NCT01882647|582217007|FG001|Overall Study|Withdrawal by Subject|4|||
161228358|NCT01108094|582217009|FG000|Overall Study|Adverse Event|2|||
161228359|NCT01108094|582217010|FG001|Overall Study|Adverse Event|0|||
161228360|NCT01108094|582217011|FG002|Overall Study|Adverse Event|0|||
161228361|NCT01108094|582217012|FG003|Overall Study|Adverse Event|0|||
161228362|NCT01108094|582217009|FG000|Overall Study|Withdrawal by Subject|1|||
161228363|NCT01108094|582217010|FG001|Overall Study|Withdrawal by Subject|0|||
161228364|NCT01108094|582217011|FG002|Overall Study|Withdrawal by Subject|0|||
161228365|NCT01108094|582217012|FG003|Overall Study|Withdrawal by Subject|0|||
161228366|NCT05037097|582217016|FG000|Overall Study|Withdrawal by Subject|0|||
161228367|NCT05037097|582217017|FG001|Overall Study|Withdrawal by Subject|1|||
161228368|NCT05037097|582217018|FG002|Overall Study|Withdrawal by Subject|0|||
161228369|NCT05037097|582217019|FG003|Overall Study|Withdrawal by Subject|1|||
161228370|NCT05037097|582217020|FG004|Overall Study|Withdrawal by Subject|0|||
161228371|NCT05037097|582217021|FG005|Overall Study|Withdrawal by Subject|2|||
161228372|NCT05037097|582217022|FG006|Overall Study|Withdrawal by Subject|0|||
161228373|NCT05037097|582217023|FG007|Overall Study|Withdrawal by Subject|0|||
161325538|NCT00922116|582578175|FG000|Overall Study|Death|1|||
161325539|NCT00922116|582578175|FG000|Overall Study|Lost to Follow-up|1|||
161325540|NCT00922116|582578175|FG000|Overall Study|Withdrawal by Subject|4|||
161325541|NCT00922116|582578175|FG000|Overall Study|Other|5|||
161228374|NCT05037097|582217016|FG000|Overall Study|Lost to Follow-up|0|||
161228375|NCT05037097|582217017|FG001|Overall Study|Lost to Follow-up|1|||
161228376|NCT05037097|582217018|FG002|Overall Study|Lost to Follow-up|0|||
161228377|NCT05037097|582217019|FG003|Overall Study|Lost to Follow-up|0|||
161228378|NCT05037097|582217020|FG004|Overall Study|Lost to Follow-up|1|||
161228379|NCT05037097|582217021|FG005|Overall Study|Lost to Follow-up|1|||
161228380|NCT05037097|582217022|FG006|Overall Study|Lost to Follow-up|0|||
161228381|NCT05037097|582217023|FG007|Overall Study|Lost to Follow-up|0|||
161228382|NCT02918877|582217026|FG000|Overall Study|Withdrawal by Subject|2|||
161228383|NCT02918877|582217027|FG001|Overall Study|Withdrawal by Subject|2|||
161228384|NCT02918877|582217026|FG000|Overall Study|Surgery cancelled|1|||
161228385|NCT02918877|582217027|FG001|Overall Study|Surgery cancelled|0|||
161228386|NCT02918877|582217026|FG000|Overall Study|Physician Decision|1|||
161228387|NCT02918877|582217027|FG001|Overall Study|Physician Decision|0|||
161228388|NCT02918877|582217026|FG000|Overall Study|Received intraoperative steroids|1|||
161228389|NCT02918877|582217027|FG001|Overall Study|Received intraoperative steroids|0|||
161228390|NCT02918877|582217026|FG000|Overall Study|Unable to obtain lab samples|1|||
161228391|NCT02918877|582217027|FG001|Overall Study|Unable to obtain lab samples|0|||
161228392|NCT02918877|582217026|FG000|Overall Study|Unsafe to perform BAL|0|||
161228393|NCT02918877|582217027|FG001|Overall Study|Unsafe to perform BAL|1|||
161228394|NCT04510857|582217028|FG000|Overall Study|Withdrawal by Subject|1|||
161228395|NCT04510857|582217029|FG001|Overall Study|Withdrawal by Subject|2|||
161228396|NCT05346055|582217030|FG000|Overall Study|Withdrawal by Subject|1|||
161228397|NCT05346055|582217030|FG000|Overall Study|Protocol Violation|1|||
161228398|NCT05346055|582217030|FG000|Overall Study|Therapist decision|1|||
161228399|NCT00376220|582217033|FG000|Overall Study|Lost to Follow-up|7|||
161228400|NCT00376220|582217034|FG001|Overall Study|Lost to Follow-up|10|||
161228401|NCT00376220|582217033|FG000|Overall Study|Withdrawal by Subject|3|||
160885682|NCT00246571|580976447|FG001|Overall Study|Lack of Efficacy|21|||
160885683|NCT00246571|580976446|FG000|Overall Study|Death|17|||
160885684|NCT00246571|580976447|FG001|Overall Study|Death|3|||
160885685|NCT00246571|580976446|FG000|Overall Study|Sponsor|0|||
160885686|NCT00246571|580976447|FG001|Overall Study|Sponsor|1|||
160885687|NCT00246571|580976446|FG000|Overall Study|Did not meet entrance criteria|2|||
160885688|NCT00246571|580976447|FG001|Overall Study|Did not meet entrance criteria|1|||
160885689|NCT00246571|580976446|FG000|Overall Study|Laboratory abnormalities|1|||
160885690|NCT00246571|580976447|FG001|Overall Study|Laboratory abnormalities|0|||
160885691|NCT00246571|580976446|FG000|Overall Study|Crossover participants|0|||
160885692|NCT00246571|580976447|FG001|Overall Study|Crossover participants|74|||
160885693|NCT00775203|580976448|FG000|Overall Study|Adverse Event|25|||
160885694|NCT00775203|580976449|FG001|Overall Study|Adverse Event|6|||
160885695|NCT00775203|580976448|FG000|Overall Study|Lack of Efficacy|8|||
160885696|NCT00775203|580976449|FG001|Overall Study|Lack of Efficacy|9|||
160885697|NCT00775203|580976448|FG000|Overall Study|Withdrawal by Subject|11|||
160885698|NCT00775203|580976449|FG001|Overall Study|Withdrawal by Subject|9|||
160885699|NCT00775203|580976448|FG000|Overall Study|Lost to Follow-up|11|||
160885700|NCT00775203|580976449|FG001|Overall Study|Lost to Follow-up|15|||
160885701|NCT00775203|580976448|FG000|Overall Study|Administrative reason|2|||
160885702|NCT00775203|580976449|FG001|Overall Study|Administrative reason|0|||
160885703|NCT00775203|580976448|FG000|Overall Study|Noncompliance|4|||
160885704|NCT00775203|580976449|FG001|Overall Study|Noncompliance|2|||
160885705|NCT00775203|580976448|FG000|Overall Study|Protocol Violation|0|||
160885706|NCT00775203|580976449|FG001|Overall Study|Protocol Violation|1|||
160885707|NCT00775203|580976448|FG000|Overall Study|Entered other study|1|||
160885708|NCT00775203|580976449|FG001|Overall Study|Entered other study|0|||
160885709|NCT00775203|580976448|FG000|Overall Study|Physician Decision|0|||
160885710|NCT00775203|580976449|FG001|Overall Study|Physician Decision|1|||
160885711|NCT02987660|580976450|FG000|Overall Study|Study terminated by sponsor|10|||
160885712|NCT02987660|580976451|FG001|Overall Study|Study terminated by sponsor|10|||
160885713|NCT03422627|580976452|FG000|Overall Study|Protocol-specified Criteria|1|||
160885714|NCT03422627|580976453|FG001|Overall Study|Protocol-specified Criteria|1|||
160885715|NCT03422627|580976454|FG002|Overall Study|Protocol-specified Criteria|0|||
160885716|NCT03422627|580976455|FG003|Overall Study|Protocol-specified Criteria|0|||
160885717|NCT03422627|580976456|FG004|Overall Study|Protocol-specified Criteria|2|||
160885718|NCT03422627|580976452|FG000|Overall Study|Requirement for Alternative Therapy|1|||
160885719|NCT03422627|580976453|FG001|Overall Study|Requirement for Alternative Therapy|1|||
160885720|NCT03422627|580976454|FG002|Overall Study|Requirement for Alternative Therapy|2|||
160885721|NCT03422627|580976455|FG003|Overall Study|Requirement for Alternative Therapy|0|||
160885722|NCT03422627|580976456|FG004|Overall Study|Requirement for Alternative Therapy|0|||
160885723|NCT03422627|580976452|FG000|Overall Study|Disease Progression|1|||
160885724|NCT03422627|580976453|FG001|Overall Study|Disease Progression|0|||
160885725|NCT03422627|580976454|FG002|Overall Study|Disease Progression|1|||
160885726|NCT03422627|580976455|FG003|Overall Study|Disease Progression|2|||
160885727|NCT03422627|580976456|FG004|Overall Study|Disease Progression|0|||
160885728|NCT03422627|580976452|FG000|Overall Study|Adverse Event|2|||
160885729|NCT03422627|580976453|FG001|Overall Study|Adverse Event|1|||
160885730|NCT03422627|580976454|FG002|Overall Study|Adverse Event|0|||
160885731|NCT03422627|580976455|FG003|Overall Study|Adverse Event|0|||
160885732|NCT03422627|580976456|FG004|Overall Study|Adverse Event|2|||
160885733|NCT03422627|580976452|FG000|Overall Study|Ineligibility Determined|0|||
160885734|NCT03422627|580976453|FG001|Overall Study|Ineligibility Determined|1|||
160885735|NCT03422627|580976454|FG002|Overall Study|Ineligibility Determined|0|||
160885736|NCT03422627|580976455|FG003|Overall Study|Ineligibility Determined|0|||
160885737|NCT03422627|580976456|FG004|Overall Study|Ineligibility Determined|0|||
160885738|NCT03422627|580976452|FG000|Overall Study|Death|0|||
161122646|NCT02574637|581835219|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
161122647|NCT02574637|581835220|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
161122648|NCT02574637|581835221|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
161122649|NCT02574637|581835222|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
161122650|NCT02574637|581835223|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
160885739|NCT03422627|580976453|FG001|Overall Study|Death|1|||
160885740|NCT03422627|580976454|FG002|Overall Study|Death|1|||
160885741|NCT03422627|580976455|FG003|Overall Study|Death|0|||
160885742|NCT03422627|580976456|FG004|Overall Study|Death|0|||
160885743|NCT03422627|580976452|FG000|Overall Study|Withdrawal by Subject|0|||
160885744|NCT03422627|580976453|FG001|Overall Study|Withdrawal by Subject|0|||
160885745|NCT03422627|580976454|FG002|Overall Study|Withdrawal by Subject|0|||
160885746|NCT03422627|580976455|FG003|Overall Study|Withdrawal by Subject|1|||
160885747|NCT03422627|580976456|FG004|Overall Study|Withdrawal by Subject|0|||
160885748|NCT05247398|580976457|FG000|Overall Study|Withdrawal by Subject|1|||
160885749|NCT04251156|580976458|FG000|Overall Study|Lost to Follow-up|1|||
160885750|NCT04251156|580976459|FG001|Overall Study|Lost to Follow-up|1|||
160885751|NCT04251156|580976458|FG000|Overall Study|Withdrawal by Subject|4|||
160885752|NCT04251156|580976459|FG001|Overall Study|Withdrawal by Subject|4|||
160885753|NCT05171816|580976460|FG000|Overall Study|Death|18|||
161122651|NCT02574637|581835224|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
161325542|NCT02258659|582578176|FG000|Overall Study|Withdrawal by Subject|1|||
161325543|NCT03990051|582578177|FG000|Masked Period|Lost to Follow-up|1|||
161325544|NCT03990051|582578178|FG001|Masked Period|Lost to Follow-up|0|||
161325545|NCT03990051|582578177|FG000|Long Term Period|Death|1|||
161325546|NCT03990051|582578178|FG001|Long Term Period|Death|1|||
161325547|NCT03990051|582578177|FG000|Long Term Period|Lost to Follow-up|7|||
161325548|NCT03990051|582578178|FG001|Long Term Period|Lost to Follow-up|2|||
161325549|NCT00272844|582578179|FG000|Overall Study|Withdrawal by Subject|5|||
161325550|NCT03193047|582578180|FG000|Overall Study|Physician Decision|1|||
161325551|NCT03193047|582578181|FG001|Overall Study|Physician Decision|0|||
161325552|NCT03193047|582578180|FG000|Overall Study|Participant Left State|1|||
161325553|NCT03193047|582578181|FG001|Overall Study|Participant Left State|0|||
161325554|NCT03743025|582578185|FG000|Overall Study|Surgery was cancelled|2|||
161325555|NCT03743025|582578186|FG001|Overall Study|Surgery was cancelled|1|||
161325556|NCT00791700|582578187|FG000|Overall Study|Insufficient clinical response|1|||
161325557|NCT00791700|582578188|FG001|Overall Study|Insufficient clinical response|4|||
161325558|NCT00791700|582578189|FG002|Overall Study|Insufficient clinical response|1|||
161325559|NCT00791700|582578190|FG003|Overall Study|Insufficient clinical response|8|||
161325560|NCT00791700|582578187|FG000|Overall Study|No longer willing to participate|1|||
161325561|NCT00791700|582578188|FG001|Overall Study|No longer willing to participate|1|||
161325562|NCT00791700|582578189|FG002|Overall Study|No longer willing to participate|0|||
161325563|NCT00791700|582578190|FG003|Overall Study|No longer willing to participate|8|||
161325564|NCT00791700|582578187|FG000|Overall Study|Non-compliance with study treatment|0|||
161325565|NCT00791700|582578188|FG001|Overall Study|Non-compliance with study treatment|2|||
161325566|NCT00791700|582578189|FG002|Overall Study|Non-compliance with study treatment|0|||
161325567|NCT00791700|582578190|FG003|Overall Study|Non-compliance with study treatment|4|||
161325568|NCT00791700|582578187|FG000|Overall Study|Withdrawn due to pregnancy|0|||
161325569|NCT00791700|582578188|FG001|Overall Study|Withdrawn due to pregnancy|0|||
161325570|NCT00791700|582578189|FG002|Overall Study|Withdrawn due to pregnancy|0|||
161325571|NCT00791700|582578190|FG003|Overall Study|Withdrawn due to pregnancy|1|||
161325572|NCT00791700|582578187|FG000|Overall Study|Other|0|||
161325573|NCT00791700|582578188|FG001|Overall Study|Other|1|||
161325574|NCT00791700|582578189|FG002|Overall Study|Other|0|||
161325575|NCT00791700|582578190|FG003|Overall Study|Other|1|||
161325576|NCT00791700|582578187|FG000|Overall Study|Death|0|||
161325577|NCT00791700|582578188|FG001|Overall Study|Death|0|||
161325578|NCT00791700|582578189|FG002|Overall Study|Death|0|||
161325579|NCT00791700|582578190|FG003|Overall Study|Death|1|||
161325580|NCT00791700|582578187|FG000|Overall Study|Lost to Follow-up|4|||
161325581|NCT00791700|582578188|FG001|Overall Study|Lost to Follow-up|3|||
161325582|NCT00791700|582578189|FG002|Overall Study|Lost to Follow-up|4|||
161325583|NCT00791700|582578190|FG003|Overall Study|Lost to Follow-up|6|||
161325584|NCT00791700|582578187|FG000|Overall Study|Adverse Event|0|||
161325585|NCT00791700|582578188|FG001|Overall Study|Adverse Event|0|||
161325586|NCT00791700|582578189|FG002|Overall Study|Adverse Event|1|||
161325587|NCT00791700|582578190|FG003|Overall Study|Adverse Event|1|||
161325588|NCT00996034|582578191|FG000|Overall Study|Lost to Follow-up|2|||
161325589|NCT00996034|582578191|FG000|Overall Study|withdrawn by PI|1|||
161325590|NCT01720524|582578192|FG000|Part A|Insufficient Clinical Response|2|||
161325591|NCT01720524|582578193|FG001|Part A|Insufficient Clinical Response|4|||
161325592|NCT01720524|582578192|FG000|Part A|Adverse Event|2|||
161325593|NCT01720524|582578193|FG001|Part A|Adverse Event|2|||
161325594|NCT01720524|582578192|FG000|Part A|Death|2|||
161325595|NCT01720524|582578193|FG001|Part A|Death|1|||
161325596|NCT01720524|582578192|FG000|Part A|Lost to Follow-up|0|||
161325597|NCT01720524|582578193|FG001|Part A|Lost to Follow-up|1|||
161325598|NCT01720524|582578192|FG000|Part A|Missed 28 day follow-up visit|1|||
161325599|NCT01720524|582578193|FG001|Part A|Missed 28 day follow-up visit|1|||
160885754|NCT05171816|580976461|FG001|Overall Study|Death|16|||
160885755|NCT02937571|580976462|FG000|Overall Study|Adverse Event|0|||
160885756|NCT02937571|580976463|FG001|Overall Study|Adverse Event|0|||
160885757|NCT02937571|580976464|FG002|Overall Study|Adverse Event|4|||
160885758|NCT02937571|580976462|FG000|Overall Study|Withdrawal by Subject|0|||
160885759|NCT02937571|580976463|FG001|Overall Study|Withdrawal by Subject|0|||
161325600|NCT01720524|582578192|FG000|Part A|Withdrawal by Subject|0|||
161325601|NCT01720524|582578193|FG001|Part A|Withdrawal by Subject|1|||
161325602|NCT01720524|582578192|FG000|Part A|Other|0|||
161325603|NCT01720524|582578193|FG001|Part A|Other|1|||
161325604|NCT01720524|582578192|FG000|Part A|Lost to Follow-up|0|||
161325605|NCT01720524|582578193|FG001|Part A|Lost to Follow-up|1|||
160885760|NCT02937571|580976464|FG002|Overall Study|Withdrawal by Subject|3|||
161325606|NCT01720524|582578192|FG000|Part B|No longer willing to participate in study|1|||
161325607|NCT01720524|582578193|FG001|Part B|No longer willing to participate in study|4|||
160885761|NCT04214288|580976465|FG000|Overall Study|Ongoing in the study|41|||
161325608|NCT01720524|582578192|FG000|Part B|Other|2|||
161325609|NCT01720524|582578193|FG001|Part B|Other|0|||
161325610|NCT01720524|582578192|FG000|Part B|Lost to Follow-up|2|||
161325611|NCT01720524|582578193|FG001|Part B|Lost to Follow-up|3|||
161325612|NCT01720524|582578192|FG000|Part B|Death|0|||
161325613|NCT01720524|582578193|FG001|Part B|Death|2|||
161228402|NCT00376220|582217034|FG001|Overall Study|Withdrawal by Subject|2|||
161228403|NCT02564263|582217035|FG000|Overall Study|Adverse Event|31|||
161228404|NCT02564263|582217036|FG001|Overall Study|Adverse Event|29|||
161228405|NCT02564263|582217035|FG000|Overall Study|Death|270|||
161228406|NCT02564263|582217036|FG001|Overall Study|Death|262|||
161228407|NCT02564263|582217035|FG000|Overall Study|Withdrawal by Subject|4|||
161228408|NCT02564263|582217036|FG001|Overall Study|Withdrawal by Subject|19|||
161228409|NCT02564263|582217035|FG000|Overall Study|Sponsor's decision|9|||
161228410|NCT02564263|582217036|FG001|Overall Study|Sponsor's decision|4|||
161228411|NCT02906709|582217037|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
161228412|NCT02906709|582217038|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
161228413|NCT02906709|582217037|FG000|Phase A (Week 0 to Week 16)|Death|0|||
161228414|NCT02906709|582217038|FG001|Phase A (Week 0 to Week 16)|Death|1|||
161228415|NCT02906709|582217037|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
161228416|NCT02906709|582217038|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
161228417|NCT02906709|582217037|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
161228418|NCT02906709|582217038|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
161228419|NCT00977106|582217039|FG000|Overall Study|Adverse Event|5|||
161228420|NCT00977106|582217040|FG001|Overall Study|Adverse Event|6|||
160885762|NCT04214288|580976466|FG001|Overall Study|Ongoing in the study|51|||
161228421|NCT00977106|582217039|FG000|Overall Study|Withdrawal by Subject|2|||
161228422|NCT00977106|582217040|FG001|Overall Study|Withdrawal by Subject|2|||
161228423|NCT00977106|582217039|FG000|Overall Study|Lack of Efficacy|2|||
161228424|NCT00977106|582217040|FG001|Overall Study|Lack of Efficacy|2|||
161228425|NCT00977106|582217039|FG000|Overall Study|Protocol Violation|0|||
161228426|NCT00977106|582217040|FG001|Overall Study|Protocol Violation|1|||
161228427|NCT00977106|582217039|FG000|Overall Study|Other|1|||
161228428|NCT00977106|582217040|FG001|Overall Study|Other|0|||
161228429|NCT01124149|582217041|FG000|Acute Phase|Withdrawal by Subject|22|||
161228430|NCT01124149|582217041|FG000|Acute Phase|Adverse Event|21|||
161122652|NCT02574637|581835225|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
161122653|NCT02574637|581835226|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
161122654|NCT02574637|581835227|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
161122655|NCT02574637|581835218|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161122656|NCT02574637|581835219|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161122657|NCT02574637|581835220|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161122658|NCT02574637|581835221|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161122659|NCT02574637|581835222|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161122660|NCT02574637|581835223|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161122661|NCT02574637|581835224|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
161122662|NCT02574637|581835225|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161122663|NCT02574637|581835226|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
161122664|NCT02574637|581835227|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
161122665|NCT04029519|581835228|FG000|Overall Study|Protocol Violation|1|||
161122666|NCT04029519|581835228|FG000|Overall Study|Withdrawal by Subject|3|||
161122667|NCT04029519|581835228|FG000|Overall Study|Lost to Follow-up|1|||
161122668|NCT00756938|581835233|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
161122669|NCT00756938|581835234|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
161122670|NCT00756938|581835235|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
161122671|NCT00756938|581835236|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
161122672|NCT00756938|581835233|FG000|12-week Base Study|Protocol Violation|0|||
161122673|NCT00756938|581835234|FG001|12-week Base Study|Protocol Violation|0|||
161122674|NCT00756938|581835235|FG002|12-week Base Study|Protocol Violation|1|||
161122675|NCT00756938|581835236|FG003|12-week Base Study|Protocol Violation|0|||
161122676|NCT00756938|581835233|FG000|12-week Base Study|Lost to Follow-up|1|||
161122677|NCT00756938|581835234|FG001|12-week Base Study|Lost to Follow-up|0|||
161122678|NCT00756938|581835235|FG002|12-week Base Study|Lost to Follow-up|0|||
161122679|NCT00756938|581835236|FG003|12-week Base Study|Lost to Follow-up|0|||
161122680|NCT00756938|581835233|FG000|Optional Extension|Lack of Efficacy|0|||
161122681|NCT00756938|581835234|FG001|Optional Extension|Lack of Efficacy|0|||
161122682|NCT00756938|581835235|FG002|Optional Extension|Lack of Efficacy|0|||
161122683|NCT00756938|581835236|FG003|Optional Extension|Lack of Efficacy|1|||
161122684|NCT00756938|581835233|FG000|Optional Extension|End of Study|0|||
161122685|NCT00756938|581835234|FG001|Optional Extension|End of Study|0|||
161122686|NCT00756938|581835235|FG002|Optional Extension|End of Study|0|||
161122687|NCT00756938|581835236|FG003|Optional Extension|End of Study|11|||
161122688|NCT00756938|581835233|FG000|Optional Extension|Protocol-specific criteria met|0|||
161122689|NCT00756938|581835234|FG001|Optional Extension|Protocol-specific criteria met|0|||
161122690|NCT00756938|581835235|FG002|Optional Extension|Protocol-specific criteria met|0|||
161122691|NCT00756938|581835236|FG003|Optional Extension|Protocol-specific criteria met|9|||
161122692|NCT00756938|581835233|FG000|Optional Extension|Physician Decision|0|||
161122693|NCT00756938|581835234|FG001|Optional Extension|Physician Decision|0|||
161122694|NCT00756938|581835235|FG002|Optional Extension|Physician Decision|0|||
161122695|NCT00756938|581835236|FG003|Optional Extension|Physician Decision|3|||
161122696|NCT00756938|581835233|FG000|Optional Extension|Lost to Follow-up|0|||
161122697|NCT00756938|581835234|FG001|Optional Extension|Lost to Follow-up|0|||
161122698|NCT00756938|581835235|FG002|Optional Extension|Lost to Follow-up|0|||
161122699|NCT00756938|581835236|FG003|Optional Extension|Lost to Follow-up|1|||
161122700|NCT00756938|581835233|FG000|Optional Extension|Protocol Violation|0|||
161122701|NCT00756938|581835234|FG001|Optional Extension|Protocol Violation|0|||
160885763|NCT04214288|580976467|FG002|Overall Study|Ongoing in the study|12|||
160885764|NCT04214288|580976468|FG003|Overall Study|Ongoing in the study|39|||
160885765|NCT04214288|580976465|FG000|Overall Study|Adverse Event|1|||
160885766|NCT04214288|580976466|FG001|Overall Study|Adverse Event|0|||
160885767|NCT04214288|580976467|FG002|Overall Study|Adverse Event|0|||
160885768|NCT04214288|580976468|FG003|Overall Study|Adverse Event|0|||
160885769|NCT04214288|580976465|FG000|Overall Study|Death|22|||
160885770|NCT04214288|580976466|FG001|Overall Study|Death|13|||
160885771|NCT04214288|580976467|FG002|Overall Study|Death|7|||
160885772|NCT04214288|580976468|FG003|Overall Study|Death|19|||
160885773|NCT04214288|580976465|FG000|Overall Study|Lost to Follow-up|1|||
160885774|NCT04214288|580976466|FG001|Overall Study|Lost to Follow-up|2|||
160885775|NCT04214288|580976467|FG002|Overall Study|Lost to Follow-up|1|||
160885776|NCT04214288|580976468|FG003|Overall Study|Lost to Follow-up|0|||
160885777|NCT04214288|580976465|FG000|Overall Study|Other|1|||
160885778|NCT04214288|580976466|FG001|Overall Study|Other|2|||
160885779|NCT04214288|580976467|FG002|Overall Study|Other|0|||
160885780|NCT04214288|580976468|FG003|Overall Study|Other|6|||
160885781|NCT04214288|580976465|FG000|Overall Study|Protocol Violation|0|||
160885782|NCT04214288|580976466|FG001|Overall Study|Protocol Violation|1|||
160885783|NCT04214288|580976467|FG002|Overall Study|Protocol Violation|0|||
160885784|NCT04214288|580976468|FG003|Overall Study|Protocol Violation|0|||
160885785|NCT04214288|580976465|FG000|Overall Study|Withdrawal by Subject|8|||
160885786|NCT04214288|580976466|FG001|Overall Study|Withdrawal by Subject|4|||
160885787|NCT04214288|580976467|FG002|Overall Study|Withdrawal by Subject|0|||
160885788|NCT04214288|580976468|FG003|Overall Study|Withdrawal by Subject|9|||
160885789|NCT02455557|580976469|FG000|Overall Study|Withdrawal by Subject|2|||
160885790|NCT01129024|580976470|FG000|Overall Study|Physician Decision|5|||
160885791|NCT01129024|580976470|FG000|Overall Study|Study Terminated by Sponsor|8|||
160885792|NCT01129024|580976470|FG000|Overall Study|Withdrawal by Subject|2|||
160885793|NCT01129024|580976470|FG000|Overall Study|Lack of Efficacy|3|||
160885794|NCT01129024|580976470|FG000|Overall Study|Needed a Platelet Transfusion|1|||
160885795|NCT02207946|580976477|FG000|Overall Study|Lost to Follow-up|1|||
160885796|NCT02207946|580976478|FG001|Overall Study|Lost to Follow-up|0|||
160885797|NCT02207946|580976477|FG000|Overall Study|Adverse Event|0|||
160885798|NCT02207946|580976478|FG001|Overall Study|Adverse Event|1|||
160885799|NCT02829944|580976482|FG000|Overall Study|Physician Decision|0|||
160885800|NCT02829944|580976483|FG001|Overall Study|Physician Decision|1|||
160885801|NCT02829944|580976482|FG000|Overall Study|Screen Failure|2|||
160885802|NCT02829944|580976483|FG001|Overall Study|Screen Failure|2|||
160885803|NCT02829944|580976482|FG000|Overall Study|Inadequate Neuraxial Block|1|||
160885804|NCT02829944|580976483|FG001|Overall Study|Inadequate Neuraxial Block|1|||
160885805|NCT02829944|580976482|FG000|Overall Study|Withdrawal by Subject|2|||
160885806|NCT02829944|580976483|FG001|Overall Study|Withdrawal by Subject|1|||
160885807|NCT02829944|580976482|FG000|Overall Study|Catheter Displacement|1|||
160885808|NCT02829944|580976483|FG001|Overall Study|Catheter Displacement|0|||
160885809|NCT02829944|580976482|FG000|Overall Study|Catheter broke|0|||
160885810|NCT02829944|580976483|FG001|Overall Study|Catheter broke|1|||
160885811|NCT02829944|580976482|FG000|Overall Study|Staff unavailable|0|||
160885812|NCT02829944|580976483|FG001|Overall Study|Staff unavailable|1|||
160885813|NCT04675151|580976484|FG000|Overall Study|Protocol Violation|1|||
161228431|NCT01124149|582217041|FG000|Acute Phase|Lack of Efficacy|17|||
161228432|NCT01124149|582217041|FG000|Acute Phase|Protocol Violation|14|||
161228433|NCT01124149|582217041|FG000|Acute Phase|Lost to Follow-up|2|||
161228434|NCT01124149|582217041|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
161228435|NCT01124149|582217041|FG000|Acute Phase|Sponsor request|1|||
161228436|NCT01124149|582217041|FG000|Acute Phase|UC symptoms not ameliorated|1|||
161228437|NCT01124149|582217041|FG000|Acute Phase|Non-compliance|1|||
161228438|NCT01124149|582217041|FG000|Acute Phase|Low hemoglobin|1|||
161228439|NCT01124149|582217041|FG000|Acute Phase|Travelling to another country|1|||
161228440|NCT01124149|582217041|FG000|Acute Phase|Sponsor decision|1|||
160885814|NCT04675151|580976485|FG001|Overall Study|Protocol Violation|0|||
160885815|NCT04675151|580976486|FG002|Overall Study|Protocol Violation|0|||
160885816|NCT04675151|580976487|FG003|Overall Study|Protocol Violation|1|||
160885817|NCT01730937|580976488|FG000|Overall Study|Protocol Violation|5|||
161228441|NCT01124149|582217041|FG000|Maintenance Phase|Lack of Efficacy|40|||
160885818|NCT01730937|580976489|FG001|Overall Study|Protocol Violation|11|||
160885819|NCT03947684|580976490|FG000|Overall Study|Lost to Follow-up|13|||
161325614|NCT00527826|582578197|FG000|Overall Study|Adverse Event|10|||
161325615|NCT00527826|582578198|FG001|Overall Study|Adverse Event|10|||
160885820|NCT03947684|580976491|FG001|Overall Study|Lost to Follow-up|5|||
160885821|NCT03947684|580976492|FG002|Overall Study|Lost to Follow-up|1|||
160885822|NCT03947684|580976490|FG000|Overall Study|Withdrawal by Subject|11|||
160885823|NCT03947684|580976491|FG001|Overall Study|Withdrawal by Subject|4|||
160885824|NCT03947684|580976492|FG002|Overall Study|Withdrawal by Subject|0|||
160885825|NCT03947684|580976490|FG000|Overall Study|Physician Decision|1|||
161228442|NCT01124149|582217041|FG000|Maintenance Phase|Adverse Event|24|||
161228443|NCT01124149|582217041|FG000|Maintenance Phase|Lost to Follow-up|15|||
160885826|NCT03947684|580976491|FG001|Overall Study|Physician Decision|0|||
160885827|NCT03947684|580976492|FG002|Overall Study|Physician Decision|0|||
160885828|NCT03947684|580976490|FG000|Overall Study|Lack of adherence to study protocol|2|||
160885829|NCT03947684|580976491|FG001|Overall Study|Lack of adherence to study protocol|0|||
160885830|NCT03947684|580976492|FG002|Overall Study|Lack of adherence to study protocol|0|||
160885831|NCT01395784|580976498|FG000|Overall Study|Lost to Follow-up|7|||
160885832|NCT01395784|580976498|FG000|Overall Study|Withdrawal by Subject|3|||
160885833|NCT01395784|580976498|FG000|Overall Study|Physician Decision|5|||
160885834|NCT05772702|580976499|FG000|Overall Study|Adverse Event|1|||
160885835|NCT04285580|580978189|FG000|Overall Study|Protocol Violation|0|||
160885836|NCT04285580|580978190|FG001|Overall Study|Protocol Violation|1|||
160885837|NCT00562627|580978191|FG000|Overall Study|Protocol Violation|1|||
160885838|NCT00562627|580978192|FG001|Overall Study|Protocol Violation|1|||
160885839|NCT00562627|580978193|FG002|Overall Study|Protocol Violation|1|||
160885840|NCT02316548|580978195|FG000|Overall Study|Protocol Violation|0|||
160885841|NCT02316548|580978196|FG001|Overall Study|Protocol Violation|1|||
160885842|NCT05313009|580978197|FG000|Overall Study|Death|1|||
160885843|NCT05313009|580978198|FG001|Overall Study|Death|0|||
160885844|NCT03269552|580978199|FG000|Overall Study|Adverse Event|2|||
160885845|NCT03468543|580978200|FG000|Overall Study|Protocol stopping rules met|3|||
161228444|NCT01124149|582217041|FG000|Maintenance Phase|Withdrawal by Subject|10|||
161228445|NCT01124149|582217041|FG000|Maintenance Phase|Protocol Violation|5|||
161228446|NCT01124149|582217041|FG000|Maintenance Phase|Coordinator error|1|||
161228447|NCT01124149|582217041|FG000|Maintenance Phase|Non-compliance|1|||
161228448|NCT01644500|582217042|FG000|Overall Study|Adverse Event|6|||
161228449|NCT01644500|582217043|FG001|Overall Study|Adverse Event|1|||
161228450|NCT01644500|582217044|FG002|Overall Study|Adverse Event|2|||
161228451|NCT01644500|582217042|FG000|Overall Study|Death|0|||
161228452|NCT01644500|582217043|FG001|Overall Study|Death|1|||
161228453|NCT01644500|582217044|FG002|Overall Study|Death|0|||
161228454|NCT01644500|582217042|FG000|Overall Study|Lost to Follow-up|3|||
161228455|NCT01644500|582217043|FG001|Overall Study|Lost to Follow-up|8|||
161228456|NCT01644500|582217044|FG002|Overall Study|Lost to Follow-up|0|||
161228457|NCT01644500|582217042|FG000|Overall Study|Protocol Violation|1|||
161228458|NCT01644500|582217043|FG001|Overall Study|Protocol Violation|1|||
161228459|NCT01644500|582217044|FG002|Overall Study|Protocol Violation|0|||
161228460|NCT01644500|582217042|FG000|Overall Study|Withdrawal by Subject|11|||
161228461|NCT01644500|582217043|FG001|Overall Study|Withdrawal by Subject|12|||
161228462|NCT01644500|582217044|FG002|Overall Study|Withdrawal by Subject|12|||
161228463|NCT01644500|582217042|FG000|Overall Study|Physician Decision|1|||
161228464|NCT01644500|582217043|FG001|Overall Study|Physician Decision|1|||
161228465|NCT01644500|582217044|FG002|Overall Study|Physician Decision|1|||
161228466|NCT02419313|582217045|FG000|First Intervention|Lost to Follow-up|2|||
161228467|NCT02419313|582217046|FG001|First Intervention|Lost to Follow-up|0|||
161228468|NCT02419313|582217045|FG000|Second Intervention|Lost to Follow-up|1|||
161228469|NCT02419313|582217046|FG001|Second Intervention|Lost to Follow-up|0|||
161228470|NCT00322491|582217053|FG000|Overall Study|Adverse Event|1|||
161228471|NCT00322491|582217054|FG001|Overall Study|Adverse Event|0|||
161228472|NCT00322491|582217053|FG000|Overall Study|Death|1|||
161228473|NCT00322491|582217054|FG001|Overall Study|Death|2|||
161228474|NCT00688064|582217055|FG000|Overall Study|Protocol Violation|0|||
161228475|NCT00688064|582217056|FG001|Overall Study|Protocol Violation|1|||
161228476|NCT00688064|582217055|FG000|Overall Study|Adverse Event|2|||
161228477|NCT00688064|582217056|FG001|Overall Study|Adverse Event|4|||
161228478|NCT00688064|582217055|FG000|Overall Study|Withdrawal by Subject|7|||
161228479|NCT00688064|582217056|FG001|Overall Study|Withdrawal by Subject|7|||
161228480|NCT00688064|582217055|FG000|Overall Study|Lost to Follow-up|10|||
161228481|NCT00688064|582217056|FG001|Overall Study|Lost to Follow-up|10|||
161228482|NCT00688064|582217055|FG000|Overall Study|Lack of Efficacy|0|||
161228483|NCT00688064|582217056|FG001|Overall Study|Lack of Efficacy|1|||
161228484|NCT00688064|582217055|FG000|Overall Study|Pregnancy|1|||
161228485|NCT00688064|582217056|FG001|Overall Study|Pregnancy|0|||
161228486|NCT00688064|582217055|FG000|Overall Study|Any other reasons|1|||
161228487|NCT00688064|582217056|FG001|Overall Study|Any other reasons|3|||
161228488|NCT00524459|582217062|FG000|Overall Study|Withdrawal by Subject|1|||
161228489|NCT00524459|582217062|FG000|Overall Study|Other|1|||
161228490|NCT00728949|582217063|FG000|Overall Study|Adverse Event|8|||
161228491|NCT00728949|582217064|FG001|Overall Study|Adverse Event|0|||
161228492|NCT00728949|582217063|FG000|Overall Study|Withdrawal by Subject|2|||
161228493|NCT00728949|582217064|FG001|Overall Study|Withdrawal by Subject|2|||
161228494|NCT00728949|582217063|FG000|Overall Study|Abnormal Lab Results|0|||
161228495|NCT00728949|582217064|FG001|Overall Study|Abnormal Lab Results|2|||
161228496|NCT00728949|582217063|FG000|Overall Study|On treatment at cutoff date|1|||
161325616|NCT00527826|582578197|FG000|Overall Study|Lost to Follow-up|3|||
161325617|NCT00527826|582578198|FG001|Overall Study|Lost to Follow-up|2|||
161325618|NCT00527826|582578197|FG000|Overall Study|Withdrawal by Subject|5|||
161325619|NCT00527826|582578198|FG001|Overall Study|Withdrawal by Subject|8|||
161325620|NCT00527826|582578197|FG000|Overall Study|Inclusion Criteria Not Met|3|||
161325621|NCT00527826|582578198|FG001|Overall Study|Inclusion Criteria Not Met|3|||
161325622|NCT00527826|582578197|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
161325623|NCT00527826|582578198|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
161325624|NCT00527826|582578197|FG000|Overall Study|Additional Intake of Viani forte|0|||
161325625|NCT00527826|582578198|FG001|Overall Study|Additional Intake of Viani forte|1|||
161325626|NCT00527826|582578197|FG000|Overall Study|Participant moved away|0|||
161325627|NCT00527826|582578198|FG001|Overall Study|Participant moved away|1|||
161325628|NCT00158262|582578199|FG000|Overall Study|Lost to Follow-up|1|||
161325629|NCT00158262|582578200|FG001|Overall Study|Lost to Follow-up|1|||
161325630|NCT02080364|582578204|FG000|Baseline Period|Protocol Violation|2|||
161325631|NCT02080364|582578205|FG001|Baseline Period|Protocol Violation|1|||
161325632|NCT02080364|582578206|FG002|Baseline Period|Protocol Violation|0|||
161325633|NCT02080364|582578207|FG003|Baseline Period|Protocol Violation|0|||
161325634|NCT02080364|582578204|FG000|Baseline Period|Other|0|||
161325635|NCT02080364|582578205|FG001|Baseline Period|Other|1|||
161325636|NCT02080364|582578206|FG002|Baseline Period|Other|1|||
161325637|NCT02080364|582578207|FG003|Baseline Period|Other|0|||
161325638|NCT02080364|582578204|FG000|Treatment Period|Adverse Event|10|||
161325639|NCT02080364|582578205|FG001|Treatment Period|Adverse Event|15|||
161325640|NCT02080364|582578206|FG002|Treatment Period|Adverse Event|11|||
161325641|NCT02080364|582578207|FG003|Treatment Period|Adverse Event|14|||
161325642|NCT02080364|582578204|FG000|Treatment Period|Lost to Follow-up|2|||
161325643|NCT02080364|582578205|FG001|Treatment Period|Lost to Follow-up|3|||
161325644|NCT02080364|582578206|FG002|Treatment Period|Lost to Follow-up|5|||
161325645|NCT02080364|582578207|FG003|Treatment Period|Lost to Follow-up|0|||
161325646|NCT02080364|582578204|FG000|Treatment Period|Protocol Violation|5|||
161325647|NCT02080364|582578205|FG001|Treatment Period|Protocol Violation|3|||
161325648|NCT02080364|582578206|FG002|Treatment Period|Protocol Violation|5|||
161325649|NCT02080364|582578207|FG003|Treatment Period|Protocol Violation|1|||
161325650|NCT02080364|582578204|FG000|Treatment Period|Withdrawal by Subject|16|||
161325651|NCT02080364|582578205|FG001|Treatment Period|Withdrawal by Subject|16|||
161325652|NCT02080364|582578206|FG002|Treatment Period|Withdrawal by Subject|15|||
161325653|NCT02080364|582578207|FG003|Treatment Period|Withdrawal by Subject|10|||
161325654|NCT02080364|582578204|FG000|Treatment Period|Study Terminated by Sponsor|0|||
161325655|NCT02080364|582578205|FG001|Treatment Period|Study Terminated by Sponsor|0|||
161325656|NCT02080364|582578206|FG002|Treatment Period|Study Terminated by Sponsor|180|||
161325657|NCT02080364|582578207|FG003|Treatment Period|Study Terminated by Sponsor|183|||
161325658|NCT02080364|582578204|FG000|Treatment Period|Other|14|||
161325659|NCT02080364|582578205|FG001|Treatment Period|Other|12|||
161325660|NCT02080364|582578206|FG002|Treatment Period|Other|21|||
161325661|NCT02080364|582578207|FG003|Treatment Period|Other|16|||
161325662|NCT00784719|582578208|FG000|Overall Study|Adverse Event|0|||
161325663|NCT00784719|582578209|FG001|Overall Study|Adverse Event|2|||
161325664|NCT00784719|582578210|FG002|Overall Study|Adverse Event|0|||
161325665|NCT00784719|582578211|FG003|Overall Study|Adverse Event|0|||
161325666|NCT00784719|582578212|FG004|Overall Study|Adverse Event|1|||
161325667|NCT00784719|582578213|FG005|Overall Study|Adverse Event|1|||
161325668|NCT00784719|582578214|FG006|Overall Study|Adverse Event|1|||
161325669|NCT00784719|582578208|FG000|Overall Study|Lost to Follow-up|0|||
161325670|NCT00784719|582578209|FG001|Overall Study|Lost to Follow-up|0|||
161325671|NCT00784719|582578210|FG002|Overall Study|Lost to Follow-up|0|||
161325672|NCT00784719|582578211|FG003|Overall Study|Lost to Follow-up|0|||
161325673|NCT00784719|582578212|FG004|Overall Study|Lost to Follow-up|1|||
161122702|NCT00756938|581835235|FG002|Optional Extension|Protocol Violation|0|||
161325674|NCT00784719|582578213|FG005|Overall Study|Lost to Follow-up|1|||
161325675|NCT00784719|582578214|FG006|Overall Study|Lost to Follow-up|0|||
161325676|NCT00784719|582578208|FG000|Overall Study|Other|2|||
161325677|NCT00784719|582578209|FG001|Overall Study|Other|1|||
161325678|NCT00784719|582578210|FG002|Overall Study|Other|1|||
161325679|NCT00784719|582578211|FG003|Overall Study|Other|0|||
161325680|NCT00784719|582578212|FG004|Overall Study|Other|2|||
161325681|NCT00784719|582578213|FG005|Overall Study|Other|1|||
161325682|NCT00784719|582578214|FG006|Overall Study|Other|3|||
161325683|NCT00784719|582578208|FG000|Overall Study|Withdrawal by Subject|1|||
161325684|NCT00784719|582578209|FG001|Overall Study|Withdrawal by Subject|0|||
161325685|NCT00784719|582578210|FG002|Overall Study|Withdrawal by Subject|0|||
161325686|NCT00784719|582578211|FG003|Overall Study|Withdrawal by Subject|0|||
161325687|NCT00784719|582578212|FG004|Overall Study|Withdrawal by Subject|2|||
161325688|NCT00784719|582578213|FG005|Overall Study|Withdrawal by Subject|0|||
161325689|NCT00784719|582578214|FG006|Overall Study|Withdrawal by Subject|1|||
161325690|NCT01189461|582578218|FG000|Overall Study|Lack of Efficacy|13|||
161325691|NCT01189461|582578218|FG000|Overall Study|Lost to Follow-up|1|||
161325692|NCT01189461|582578218|FG000|Overall Study|Withdrawal by Subject|6|||
161325693|NCT01189461|582578218|FG000|Overall Study|Protocol Violation|1|||
160885846|NCT03675321|580978202|FG000|Overall Study|Lack of Efficacy|2|||
160885847|NCT03675321|580978203|FG001|Overall Study|Lack of Efficacy|2|||
160885848|NCT03675321|580978202|FG000|Overall Study|Withdrawal by Subject|1|||
160885849|NCT03675321|580978203|FG001|Overall Study|Withdrawal by Subject|3|||
160885850|NCT00807027|580978204|FG000|Overall Study|Withdrawal by Subject|13|||
160885851|NCT00807027|580978205|FG001|Overall Study|Withdrawal by Subject|14|||
160885852|NCT00807027|580978204|FG000|Overall Study|Protocol Violation|1|||
160885853|NCT00807027|580978205|FG001|Overall Study|Protocol Violation|1|||
160885854|NCT00807027|580978204|FG000|Overall Study|Adverse Event|2|||
161122703|NCT00756938|581835236|FG003|Optional Extension|Protocol Violation|1|||
161122704|NCT00756938|581835233|FG000|Optional Extension|Withdrawal by Subject|0|||
161122705|NCT00756938|581835234|FG001|Optional Extension|Withdrawal by Subject|0|||
161122706|NCT00756938|581835235|FG002|Optional Extension|Withdrawal by Subject|0|||
161122707|NCT00756938|581835236|FG003|Optional Extension|Withdrawal by Subject|10|||
161122708|NCT00756938|581835233|FG000|Optional Extension|Adverse Event|0|||
161122709|NCT00756938|581835234|FG001|Optional Extension|Adverse Event|0|||
161122710|NCT00756938|581835235|FG002|Optional Extension|Adverse Event|0|||
161122711|NCT00756938|581835236|FG003|Optional Extension|Adverse Event|1|||
161122712|NCT04823949|581835237|FG000|Overall Study|Withdrawal by Subject|0|||
161122713|NCT04823949|581835238|FG001|Overall Study|Withdrawal by Subject|4|||
161122714|NCT04823949|581835237|FG000|Overall Study|Physician Decision|0|||
161122715|NCT04823949|581835238|FG001|Overall Study|Physician Decision|1|||
161122716|NCT00939692|581835247|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
161122717|NCT00939692|581835248|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
161122718|NCT00939692|581835247|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
161122719|NCT00939692|581835248|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
161122720|NCT01081795|581835249|FG000|Overall Study|Adverse Event|18|||
161122721|NCT01081795|581835250|FG001|Overall Study|Adverse Event|23|||
161122722|NCT01081795|581835251|FG002|Overall Study|Adverse Event|6|||
161122723|NCT01081795|581835249|FG000|Overall Study|Lack of Efficacy|7|||
161122724|NCT01081795|581835250|FG001|Overall Study|Lack of Efficacy|5|||
161122725|NCT01081795|581835251|FG002|Overall Study|Lack of Efficacy|19|||
161122726|NCT01081795|581835249|FG000|Overall Study|Subject's schedule|1|||
161122727|NCT01081795|581835250|FG001|Overall Study|Subject's schedule|1|||
161122728|NCT01081795|581835251|FG002|Overall Study|Subject's schedule|2|||
161122729|NCT01081795|581835249|FG000|Overall Study|Revocation of informed consent|2|||
161122730|NCT01081795|581835250|FG001|Overall Study|Revocation of informed consent|0|||
161122731|NCT01081795|581835251|FG002|Overall Study|Revocation of informed consent|0|||
161122732|NCT01081795|581835249|FG000|Overall Study|Ineligible for participation|1|||
161122733|NCT01081795|581835250|FG001|Overall Study|Ineligible for participation|0|||
161122734|NCT01081795|581835251|FG002|Overall Study|Ineligible for participation|0|||
161122735|NCT01081795|581835249|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
161122736|NCT01081795|581835250|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
161122737|NCT01081795|581835251|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
161122738|NCT01081795|581835249|FG000|Overall Study|Using drug with restricted days of use|2|||
160885855|NCT00807027|580978205|FG001|Overall Study|Adverse Event|2|||
160885856|NCT02278341|580978206|FG000|Overall Study|Randomized but never received study drug|1|||
160885857|NCT02278341|580978207|FG001|Overall Study|Randomized but never received study drug|1|||
160885858|NCT02278341|580978206|FG000|Overall Study|Adverse Event|3|||
160885859|NCT02278341|580978207|FG001|Overall Study|Adverse Event|0|||
160885860|NCT02278341|580978206|FG000|Overall Study|Death|68|||
160885861|NCT02278341|580978207|FG001|Overall Study|Death|56|||
160885862|NCT02278341|580978206|FG000|Overall Study|Withdrawal by Subject|30|||
160885863|NCT02278341|580978207|FG001|Overall Study|Withdrawal by Subject|19|||
160885864|NCT02278341|580978206|FG000|Overall Study|Lost to Follow-up|0|||
160885865|NCT02278341|580978207|FG001|Overall Study|Lost to Follow-up|1|||
160885866|NCT02278341|580978206|FG000|Overall Study|Physician Decision|1|||
160885867|NCT02278341|580978207|FG001|Overall Study|Physician Decision|1|||
160885868|NCT02278341|580978206|FG000|Overall Study|Miscellaneous|15|||
160885869|NCT02278341|580978207|FG001|Overall Study|Miscellaneous|14|||
160885870|NCT04902326|580978210|FG000|Overall Study|Withdrawal by Subject|1|||
160885871|NCT04902326|580978211|FG001|Overall Study|Withdrawal by Subject|3|||
160885872|NCT04902326|580978212|FG002|Overall Study|Withdrawal by Subject|0|||
160885873|NCT04902326|580978213|FG003|Overall Study|Withdrawal by Subject|1|||
160885874|NCT04902326|580978210|FG000|Overall Study|Lost to Follow-up|14|||
160885875|NCT04902326|580978211|FG001|Overall Study|Lost to Follow-up|14|||
160885876|NCT04902326|580978212|FG002|Overall Study|Lost to Follow-up|14|||
160885877|NCT04902326|580978213|FG003|Overall Study|Lost to Follow-up|6|||
160885878|NCT00934648|580978216|FG000|Overall Study|Failure to return|8|||
160885879|NCT00934648|580978216|FG000|Overall Study|Withdrawal by Subject|1|||
160885880|NCT02361580|580978218|FG000|Overall Study|Lost to Follow-up|6|||
160885881|NCT02361580|580978219|FG001|Overall Study|Lost to Follow-up|3|||
160885882|NCT02047318|580978220|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
160885883|NCT02047318|580978220|FG000|Core Study Period|Adverse Event|1|||
160885884|NCT02047318|580978220|FG000|Core Study Period|Withdrawal by caregiver|3|||
160885885|NCT02047318|580978220|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
160885886|NCT01487577|580978221|FG000|Overall Study|Became ineligible after signing consent|1|||
160885887|NCT01479985|580978222|FG000|Overall Study|Tablet malfunction, no data saved|1|||
160885888|NCT01479985|580978223|FG001|Overall Study|Tablet malfunction, no data saved|1|||
160885889|NCT01479985|580978222|FG000|Overall Study|No decisional conflict scale responses|0|||
160885890|NCT01479985|580978223|FG001|Overall Study|No decisional conflict scale responses|2|||
160885891|NCT01479985|580978222|FG000|Overall Study|No post-visit survey|5|||
160885892|NCT01479985|580978223|FG001|Overall Study|No post-visit survey|3|||
160885893|NCT00708201|580978224|FG000|Overall Study|Adverse Event|4|||
160885894|NCT00708201|580978225|FG001|Overall Study|Adverse Event|4|||
160885895|NCT00708201|580978224|FG000|Overall Study|Withdrawal by Subject|1|||
160885896|NCT00708201|580978225|FG001|Overall Study|Withdrawal by Subject|1|||
160885897|NCT00708201|580978224|FG000|Overall Study|Lost to Follow-up|2|||
160885898|NCT00708201|580978225|FG001|Overall Study|Lost to Follow-up|0|||
160885899|NCT00708201|580978224|FG000|Overall Study|Protocol Violation|0|||
160885900|NCT00708201|580978225|FG001|Overall Study|Protocol Violation|1|||
160885901|NCT00761748|580978226|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
160885902|NCT00761748|580978227|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
160885903|NCT00761748|580978226|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
160885904|NCT00761748|580978227|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
160885905|NCT02554279|580978228|FG000|Overall Study|Adverse Event|2|||
160885906|NCT02554279|580978229|FG001|Overall Study|Adverse Event|5|||
160885907|NCT02554279|580978228|FG000|Overall Study|Lost to Follow-up|3|||
160885908|NCT02554279|580978229|FG001|Overall Study|Lost to Follow-up|2|||
160885909|NCT02554279|580978228|FG000|Overall Study|Withdrawal by Subject|6|||
160885910|NCT02554279|580978229|FG001|Overall Study|Withdrawal by Subject|4|||
160885911|NCT02554279|580978228|FG000|Overall Study|Protocol Violation|2|||
160885912|NCT02554279|580978229|FG001|Overall Study|Protocol Violation|1|||
160885913|NCT02554279|580978228|FG000|Overall Study|Other reason|19|||
160885914|NCT02554279|580978229|FG001|Overall Study|Other reason|6|||
160885915|NCT00812487|580978230|FG000|Overall Study|Lost to Follow-up|2|||
160885916|NCT00812487|580978231|FG001|Overall Study|Lost to Follow-up|0|||
160885917|NCT00812487|580978230|FG000|Overall Study|Withdrawal by Subject|3|||
161325694|NCT01189461|582578218|FG000|Overall Study|Adverse Event|2|||
160885918|NCT00812487|580978231|FG001|Overall Study|Withdrawal by Subject|2|||
160885919|NCT00812487|580978230|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
160885920|NCT00812487|580978231|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
160885921|NCT00812487|580978230|FG000|Overall Study|Protocol Violation|0|||
160885922|NCT00812487|580978231|FG001|Overall Study|Protocol Violation|1|||
160885923|NCT00998764|580978232|FG000|Overall Study|Lack of Efficacy|3|||
160885924|NCT00998764|580978233|FG001|Overall Study|Lack of Efficacy|6|||
160885925|NCT00998764|580978232|FG000|Overall Study|Adverse Event|17|||
160885926|NCT00998764|580978233|FG001|Overall Study|Adverse Event|12|||
160885927|NCT00998764|580978232|FG000|Overall Study|Withdrawal by Subject|19|||
160885928|NCT00998764|580978233|FG001|Overall Study|Withdrawal by Subject|25|||
160885929|NCT00998764|580978232|FG000|Overall Study|Physician Decision|3|||
160885930|NCT00998764|580978233|FG001|Overall Study|Physician Decision|3|||
160885931|NCT00998764|580978232|FG000|Overall Study|Death|3|||
160885932|NCT00998764|580978233|FG001|Overall Study|Death|1|||
160885933|NCT00998764|580978232|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
160885934|NCT00998764|580978233|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
160885935|NCT00998764|580978232|FG000|Overall Study|Protocol Violation|0|||
160885936|NCT00998764|580978233|FG001|Overall Study|Protocol Violation|1|||
161228497|NCT00728949|582217064|FG001|Overall Study|On treatment at cutoff date|0|||
160885937|NCT00998764|580978232|FG000|Overall Study|Failed to Return|1|||
160885938|NCT00998764|580978233|FG001|Overall Study|Failed to Return|1|||
160885939|NCT00998764|580978232|FG000|Overall Study|Lost to Follow-up|1|||
160885940|NCT00998764|580978233|FG001|Overall Study|Lost to Follow-up|1|||
160885941|NCT00998764|580978232|FG000|Overall Study|Loss of Caregiver|0|||
160885942|NCT00998764|580978233|FG001|Overall Study|Loss of Caregiver|3|||
160885943|NCT00998764|580978232|FG000|Overall Study|Other|4|||
160885944|NCT00998764|580978233|FG001|Overall Study|Other|4|||
160885945|NCT00998764|580978232|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
160885946|NCT00998764|580978233|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
160885947|NCT04761627|580978236|FG000|Run-in Period|Death|1|||
160885948|NCT04761627|580978237|FG001|Run-in Period|Death|0|||
160885949|NCT04761627|580978238|FG002|Run-in Period|Death|0|||
160885950|NCT04761627|580978236|FG000|Run-in Period|Required alternative therapy|2|||
160885951|NCT04761627|580978237|FG001|Run-in Period|Required alternative therapy|0|||
160885952|NCT04761627|580978238|FG002|Run-in Period|Required alternative therapy|0|||
160885953|NCT04761627|580978236|FG000|Run-in Period|Lost to Follow-up|2|||
160885954|NCT04761627|580978237|FG001|Run-in Period|Lost to Follow-up|0|||
160885955|NCT04761627|580978238|FG002|Run-in Period|Lost to Follow-up|0|||
160885956|NCT04761627|580978236|FG000|Run-in Period|Protocol Violation|3|||
160885957|NCT04761627|580978237|FG001|Run-in Period|Protocol Violation|0|||
160885958|NCT04761627|580978238|FG002|Run-in Period|Protocol Violation|0|||
160885959|NCT04761627|580978236|FG000|Run-in Period|Abnormal liver function|1|||
160885960|NCT04761627|580978237|FG001|Run-in Period|Abnormal liver function|0|||
160885961|NCT04761627|580978238|FG002|Run-in Period|Abnormal liver function|0|||
160885962|NCT04761627|580978236|FG000|Run-in Period|Adverse Event|6|||
160885963|NCT04761627|580978237|FG001|Run-in Period|Adverse Event|0|||
160885964|NCT04761627|580978238|FG002|Run-in Period|Adverse Event|0|||
161228498|NCT02319148|582217069|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
161228499|NCT02319148|582217070|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
161228500|NCT02319148|582217071|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
160885965|NCT04761627|580978236|FG000|Run-in Period|Withdrawal by Subject|7|||
160885966|NCT04761627|580978237|FG001|Run-in Period|Withdrawal by Subject|0|||
160885967|NCT04761627|580978238|FG002|Run-in Period|Withdrawal by Subject|0|||
160885968|NCT04761627|580978236|FG000|Run-in Period|Did not meet PASI 50|15|||
161228501|NCT02319148|582217072|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
160885969|NCT04761627|580978237|FG001|Run-in Period|Did not meet PASI 50|0|||
160885970|NCT04761627|580978238|FG002|Run-in Period|Did not meet PASI 50|0|||
160885971|NCT04761627|580978236|FG000|Run-in Period|Study site closure|2|||
160885972|NCT04761627|580978237|FG001|Run-in Period|Study site closure|0|||
160885973|NCT04761627|580978238|FG002|Run-in Period|Study site closure|0|||
160885974|NCT04761627|580978236|FG000|Run-in Period|Pregnancy|2|||
161325695|NCT01189461|582578218|FG000|Overall Study|Did not meet entrance criteria|3|||
161122739|NCT01081795|581835250|FG001|Overall Study|Using drug with restricted days of use|3|||
161325696|NCT01189461|582578218|FG000|Overall Study|Other|8|||
161325697|NCT00103285|582579584|FG000|Induction|Adverse Event|14|||
160885975|NCT04761627|580978237|FG001|Run-in Period|Pregnancy|0|||
160885976|NCT04761627|580978238|FG002|Run-in Period|Pregnancy|0|||
160885977|NCT04761627|580978236|FG000|Post-randomization Period|Military service|0|||
161122740|NCT01081795|581835251|FG002|Overall Study|Using drug with restricted days of use|2|||
161122741|NCT01081795|581835249|FG000|Overall Study|Other|1|||
160885978|NCT04761627|580978237|FG001|Post-randomization Period|Military service|1|||
161122742|NCT01081795|581835250|FG001|Overall Study|Other|2|||
161122743|NCT01081795|581835251|FG002|Overall Study|Other|0|||
160885979|NCT04761627|580978238|FG002|Post-randomization Period|Military service|0|||
160885980|NCT04761627|580978236|FG000|Post-randomization Period|Adverse Event|0|||
160885981|NCT04761627|580978237|FG001|Post-randomization Period|Adverse Event|4|||
160885982|NCT04761627|580978238|FG002|Post-randomization Period|Adverse Event|2|||
160885983|NCT04761627|580978236|FG000|Post-randomization Period|Lost to Follow-up|0|||
160885984|NCT04761627|580978237|FG001|Post-randomization Period|Lost to Follow-up|6|||
160885985|NCT04761627|580978238|FG002|Post-randomization Period|Lost to Follow-up|6|||
160885986|NCT04761627|580978236|FG000|Post-randomization Period|Withdrawal by Subject|0|||
160885987|NCT04761627|580978237|FG001|Post-randomization Period|Withdrawal by Subject|7|||
160885988|NCT04761627|580978238|FG002|Post-randomization Period|Withdrawal by Subject|6|||
160885989|NCT04761627|580978236|FG000|Post-randomization Period|Pregnancy|0|||
160885990|NCT04761627|580978237|FG001|Post-randomization Period|Pregnancy|0|||
160885991|NCT04761627|580978238|FG002|Post-randomization Period|Pregnancy|1|||
160885992|NCT04761627|580978236|FG000|Post-randomization Period|Study site closure|0|||
160885993|NCT04761627|580978237|FG001|Post-randomization Period|Study site closure|0|||
160885994|NCT04761627|580978238|FG002|Post-randomization Period|Study site closure|1|||
160885995|NCT04761627|580978236|FG000|Post-randomization Period|Family planning|0|||
160885996|NCT04761627|580978237|FG001|Post-randomization Period|Family planning|1|||
160885997|NCT04761627|580978238|FG002|Post-randomization Period|Family planning|0|||
160885998|NCT01634178|580978241|FG000|Treatment Period 1|Adverse Event|0|||
160885999|NCT01634178|580978242|FG001|Treatment Period 1|Adverse Event|1|||
160886000|NCT01634178|580978241|FG000|Treatment Period 2|Adverse Event|1|||
160886001|NCT01634178|580978242|FG001|Treatment Period 2|Adverse Event|0|||
160886002|NCT01933789|580978243|FG000|Overall Study|Death|0|||
160886003|NCT01933789|580978244|FG001|Overall Study|Death|0|||
160886004|NCT01933789|580978245|FG002|Overall Study|Death|0|||
160886005|NCT01933789|580978246|FG003|Overall Study|Death|0|||
160886006|NCT01933789|580978247|FG004|Overall Study|Death|21|||
160886007|NCT01933789|580978248|FG005|Overall Study|Death|32|||
160886008|NCT01933789|580978249|FG006|Overall Study|Death|0|||
160886009|NCT01933789|580978250|FG007|Overall Study|Death|0|||
160886010|NCT01933789|580978251|FG008|Overall Study|Death|0|||
160886011|NCT01933789|580978243|FG000|Overall Study|Lost to Follow-up|0|||
160886012|NCT01933789|580978244|FG001|Overall Study|Lost to Follow-up|0|||
160886013|NCT01933789|580978245|FG002|Overall Study|Lost to Follow-up|0|||
160886014|NCT01933789|580978246|FG003|Overall Study|Lost to Follow-up|1|||
160886015|NCT01933789|580978247|FG004|Overall Study|Lost to Follow-up|8|||
160886016|NCT01933789|580978248|FG005|Overall Study|Lost to Follow-up|9|||
160886017|NCT01933789|580978249|FG006|Overall Study|Lost to Follow-up|1|||
160886018|NCT01933789|580978250|FG007|Overall Study|Lost to Follow-up|4|||
160886019|NCT01933789|580978251|FG008|Overall Study|Lost to Follow-up|0|||
160886020|NCT01933789|580978243|FG000|Overall Study|Withdrawal by Subject|2|||
160886021|NCT01933789|580978244|FG001|Overall Study|Withdrawal by Subject|1|||
160886022|NCT01933789|580978245|FG002|Overall Study|Withdrawal by Subject|0|||
160886023|NCT01933789|580978246|FG003|Overall Study|Withdrawal by Subject|0|||
160886024|NCT01933789|580978247|FG004|Overall Study|Withdrawal by Subject|17|||
160886025|NCT01933789|580978248|FG005|Overall Study|Withdrawal by Subject|16|||
160886026|NCT01933789|580978249|FG006|Overall Study|Withdrawal by Subject|1|||
160886027|NCT01933789|580978250|FG007|Overall Study|Withdrawal by Subject|4|||
160886028|NCT01933789|580978251|FG008|Overall Study|Withdrawal by Subject|0|||
160886029|NCT01933789|580978243|FG000|Overall Study|Became Ineligible|4|||
160886030|NCT01933789|580978244|FG001|Overall Study|Became Ineligible|0|||
160886031|NCT01933789|580978245|FG002|Overall Study|Became Ineligible|0|||
160886032|NCT01933789|580978246|FG003|Overall Study|Became Ineligible|0|||
160886033|NCT01933789|580978247|FG004|Overall Study|Became Ineligible|13|||
160886034|NCT01933789|580978248|FG005|Overall Study|Became Ineligible|10|||
160886035|NCT01933789|580978249|FG006|Overall Study|Became Ineligible|13|||
160886036|NCT01933789|580978250|FG007|Overall Study|Became Ineligible|6|||
160886037|NCT01933789|580978251|FG008|Overall Study|Became Ineligible|0|||
160886038|NCT02915874|580978257|FG000|Overall Study|Lost to Follow-up|5|||
160886039|NCT02915874|580978258|FG001|Overall Study|Lost to Follow-up|4|||
160886040|NCT02915874|580978257|FG000|Overall Study|Withdrawal by Subject|1|||
160886041|NCT02915874|580978258|FG001|Overall Study|Withdrawal by Subject|1|||
160886042|NCT02915874|580978257|FG000|Overall Study|Started New Anxiety Medication|0|||
160886043|NCT02915874|580978258|FG001|Overall Study|Started New Anxiety Medication|1|||
160886044|NCT01903252|580978260|FG000|Double-Blind Induction|Adverse Event|20|||
160886045|NCT01903252|580978261|FG001|Double-Blind Induction|Adverse Event|18|||
160886046|NCT01903252|580978262|FG002|Double-Blind Induction|Adverse Event|0|||
160886047|NCT01903252|580978263|FG003|Double-Blind Induction|Adverse Event|0|||
160886048|NCT01903252|580978264|FG004|Double-Blind Induction|Adverse Event|0|||
160886049|NCT01903252|580978265|FG005|Double-Blind Induction|Adverse Event|0|||
160886050|NCT01903252|580978260|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
160886051|NCT01903252|580978261|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
160886052|NCT01903252|580978262|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
160886053|NCT01903252|580978263|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
160886054|NCT01903252|580978264|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
160886055|NCT01903252|580978265|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
160886056|NCT01903252|580978260|FG000|Double-Blind Induction|Physician Decision|2|||
160886057|NCT01903252|580978261|FG001|Double-Blind Induction|Physician Decision|3|||
160886058|NCT01903252|580978262|FG002|Double-Blind Induction|Physician Decision|0|||
160886059|NCT01903252|580978263|FG003|Double-Blind Induction|Physician Decision|0|||
161122744|NCT01707693|581835252|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
161122745|NCT01707693|581835253|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
161122746|NCT01707693|581835252|FG000|Overall Study Allocation|Protocol Violation|4|||
161122747|NCT01707693|581835253|FG001|Overall Study Allocation|Protocol Violation|3|||
161122748|NCT01707693|581835252|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
160886060|NCT01903252|580978264|FG004|Double-Blind Induction|Physician Decision|0|||
160886061|NCT01903252|580978265|FG005|Double-Blind Induction|Physician Decision|0|||
160886062|NCT01903252|580978260|FG000|Double-Blind Induction|non-compliance,|7|||
160886063|NCT01903252|580978261|FG001|Double-Blind Induction|non-compliance,|7|||
160886064|NCT01903252|580978262|FG002|Double-Blind Induction|non-compliance,|0|||
160886065|NCT01903252|580978263|FG003|Double-Blind Induction|non-compliance,|0|||
160886066|NCT01903252|580978264|FG004|Double-Blind Induction|non-compliance,|0|||
160886067|NCT01903252|580978265|FG005|Double-Blind Induction|non-compliance,|0|||
160886068|NCT01903252|580978260|FG000|Extended Induction, Open-Label|Adverse Event|0|||
160886069|NCT01903252|580978261|FG001|Extended Induction, Open-Label|Adverse Event|0|||
160886070|NCT01903252|580978262|FG002|Extended Induction, Open-Label|Adverse Event|17|||
160886071|NCT01903252|580978263|FG003|Extended Induction, Open-Label|Adverse Event|0|||
160886072|NCT01903252|580978264|FG004|Extended Induction, Open-Label|Adverse Event|0|||
160886073|NCT01903252|580978265|FG005|Extended Induction, Open-Label|Adverse Event|0|||
160886074|NCT01903252|580978260|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886075|NCT01903252|580978261|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886076|NCT01903252|580978262|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
160886077|NCT01903252|580978263|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886078|NCT01903252|580978264|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886079|NCT01903252|580978265|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
160886080|NCT01903252|580978260|FG000|Extended Induction, Open-Label|Physician Decision|0|||
160886081|NCT01903252|580978261|FG001|Extended Induction, Open-Label|Physician Decision|0|||
160886082|NCT01903252|580978262|FG002|Extended Induction, Open-Label|Physician Decision|1|||
160886083|NCT01903252|580978263|FG003|Extended Induction, Open-Label|Physician Decision|0|||
160886084|NCT01903252|580978264|FG004|Extended Induction, Open-Label|Physician Decision|0|||
160886085|NCT01903252|580978265|FG005|Extended Induction, Open-Label|Physician Decision|0|||
160886086|NCT01903252|580978260|FG000|Maintenance, Open-Label|Adverse Event|0|||
160886087|NCT01903252|580978261|FG001|Maintenance, Open-Label|Adverse Event|0|||
160886088|NCT01903252|580978262|FG002|Maintenance, Open-Label|Adverse Event|0|||
160886089|NCT01903252|580978263|FG003|Maintenance, Open-Label|Adverse Event|3|||
160886090|NCT01903252|580978264|FG004|Maintenance, Open-Label|Adverse Event|9|||
160886091|NCT01903252|580978265|FG005|Maintenance, Open-Label|Adverse Event|14|||
160886092|NCT01903252|580978260|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
160886093|NCT01903252|580978261|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
160886094|NCT01903252|580978262|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
160886095|NCT01903252|580978263|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
160886096|NCT01903252|580978264|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
160886097|NCT01903252|580978265|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
160886098|NCT01903252|580978260|FG000|Maintenance, Open-Label|Other|0|||
160886099|NCT01903252|580978261|FG001|Maintenance, Open-Label|Other|0|||
160886100|NCT01903252|580978262|FG002|Maintenance, Open-Label|Other|0|||
160886101|NCT01903252|580978263|FG003|Maintenance, Open-Label|Other|2|||
160886102|NCT01903252|580978264|FG004|Maintenance, Open-Label|Other|6|||
160886103|NCT01903252|580978265|FG005|Maintenance, Open-Label|Other|2|||
160886104|NCT03562767|580978266|FG000|Overall Study|Physician Decision|2|||
160886105|NCT03562767|580978267|FG001|Overall Study|Physician Decision|0|||
160886106|NCT03562767|580978268|FG002|Overall Study|Physician Decision|0|||
160886107|NCT03562767|580978266|FG000|Overall Study|Logistic Reason|1|||
160886108|NCT03562767|580978267|FG001|Overall Study|Logistic Reason|3|||
160886109|NCT03562767|580978268|FG002|Overall Study|Logistic Reason|0|||
160886110|NCT02518464|580978271|FG000|Overall Study|Adverse Event|2|||
160886111|NCT01120067|580978272|FG000|Overall Study|Lost to Follow-up|3|||
160886112|NCT01120067|580978273|FG001|Overall Study|Lost to Follow-up|1|||
160886113|NCT01120067|580978272|FG000|Overall Study|fail to engage >3 sessions|2|||
160886114|NCT01120067|580978273|FG001|Overall Study|fail to engage >3 sessions|0|||
160886115|NCT03761797|580978274|FG000|Overall Study|Changing hospital|11|||
160886116|NCT03761797|580978274|FG000|Overall Study|Improvement/remission|6|||
160886117|NCT03761797|580978274|FG000|Overall Study|Withdrawal by Subject|19|||
160886118|NCT03761797|580978274|FG000|Overall Study|Lost to Follow-up|33|||
160886119|NCT03761797|580978274|FG000|Overall Study|Adverse Event|37|||
160886120|NCT03761797|580978274|FG000|Overall Study|Case report form (CRF) not collected|5|||
160886121|NCT03761797|580978274|FG000|Overall Study|No patient visit after entry|13|||
160886122|NCT03761797|580978274|FG000|Overall Study|Switch to other diabetes medication|10|||
160886123|NCT03761797|580978274|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
160886124|NCT03761797|580978274|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
160886125|NCT03761797|580978274|FG000|Overall Study|Insufficient effectives|2|||
160886126|NCT03761797|580978274|FG000|Overall Study|Excessive alcohol intake|1|||
160886127|NCT00266877|580978275|FG000|Overall Study|Death|1|||
160886128|NCT00266877|580978276|FG001|Overall Study|Death|1|||
161122749|NCT01707693|581835253|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
161122750|NCT01707693|581835252|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
161122751|NCT01707693|581835253|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
161122752|NCT00143455|581835256|FG000|Cohort 1|Adverse Event|8|||
161122753|NCT00143455|581835257|FG001|Cohort 1|Adverse Event|4|||
161122754|NCT00143455|581835258|FG002|Cohort 1|Adverse Event|0|||
160886129|NCT00266877|580978277|FG002|Overall Study|Death|1|||
161122755|NCT00143455|581835259|FG003|Cohort 1|Adverse Event|0|||
161122756|NCT00143455|581835256|FG000|Cohort 1|Death|5|||
161122757|NCT00143455|581835257|FG001|Cohort 1|Death|2|||
161122758|NCT00143455|581835258|FG002|Cohort 1|Death|0|||
160886130|NCT00266877|580978275|FG000|Overall Study|Adverse Event|6|||
160886131|NCT00266877|580978276|FG001|Overall Study|Adverse Event|4|||
160886132|NCT00266877|580978277|FG002|Overall Study|Adverse Event|1|||
160886133|NCT00266877|580978275|FG000|Overall Study|Physician Decision|2|||
160886134|NCT00266877|580978276|FG001|Overall Study|Physician Decision|1|||
160886135|NCT00266877|580978277|FG002|Overall Study|Physician Decision|1|||
160886136|NCT00266877|580978275|FG000|Overall Study|Withdrawal by Subject|3|||
160886137|NCT00266877|580978276|FG001|Overall Study|Withdrawal by Subject|1|||
160886138|NCT00266877|580978277|FG002|Overall Study|Withdrawal by Subject|1|||
160886139|NCT00266877|580978275|FG000|Overall Study|Disease Progression|72|||
160886140|NCT00266877|580978276|FG001|Overall Study|Disease Progression|37|||
160886141|NCT00266877|580978277|FG002|Overall Study|Disease Progression|23|||
161325698|NCT00103285|582579585|FG001|Induction|Adverse Event|0|||
161325699|NCT00103285|582579586|FG002|Induction|Adverse Event|0|||
161325700|NCT00103285|582579587|FG003|Induction|Adverse Event|0|||
161325701|NCT00103285|582579588|FG004|Induction|Adverse Event|0|||
161325702|NCT00103285|582579589|FG005|Induction|Adverse Event|0|||
161325703|NCT00103285|582579590|FG006|Induction|Adverse Event|0|||
161325704|NCT00103285|582579591|FG007|Induction|Adverse Event|0|||
161325705|NCT00103285|582579584|FG000|Induction|Death|24|||
161325706|NCT00103285|582579585|FG001|Induction|Death|0|||
161325707|NCT00103285|582579586|FG002|Induction|Death|0|||
161325708|NCT00103285|582579587|FG003|Induction|Death|0|||
161325709|NCT00103285|582579588|FG004|Induction|Death|0|||
161325710|NCT00103285|582579589|FG005|Induction|Death|0|||
161325711|NCT00103285|582579590|FG006|Induction|Death|0|||
161325712|NCT00103285|582579591|FG007|Induction|Death|0|||
161325713|NCT00103285|582579584|FG000|Induction|Physician Decision|103|||
161325714|NCT00103285|582579585|FG001|Induction|Physician Decision|0|||
160886142|NCT00266877|580978275|FG000|Overall Study|Symptomatic Deterioration|6|||
160886143|NCT00266877|580978276|FG001|Overall Study|Symptomatic Deterioration|3|||
160886144|NCT00266877|580978277|FG002|Overall Study|Symptomatic Deterioration|1|||
160886145|NCT00266877|580978275|FG000|Overall Study|Hospitalization|1|||
160886146|NCT00266877|580978276|FG001|Overall Study|Hospitalization|0|||
160886147|NCT00266877|580978277|FG002|Overall Study|Hospitalization|0|||
160886148|NCT00266877|580978275|FG000|Overall Study|Concomitant Radiotherapy|0|||
160886149|NCT00266877|580978276|FG001|Overall Study|Concomitant Radiotherapy|1|||
160886150|NCT00266877|580978277|FG002|Overall Study|Concomitant Radiotherapy|0|||
160886151|NCT01924429|580978283|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
160886152|NCT01924429|580978284|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
160886153|NCT01150474|580978285|FG000|Overall Study|Withdrawal by Subject|5|||
160886154|NCT01150474|580978286|FG001|Overall Study|Withdrawal by Subject|2|||
160886155|NCT01150474|580978285|FG000|Overall Study|Cancer found|1|||
160886156|NCT01150474|580978286|FG001|Overall Study|Cancer found|0|||
160886157|NCT01150474|580978285|FG000|Overall Study|Multiple Studies|0|||
160886158|NCT01150474|580978286|FG001|Overall Study|Multiple Studies|1|||
160886159|NCT01150474|580978285|FG000|Overall Study|Rectotomy|1|||
160886160|NCT01150474|580978286|FG001|Overall Study|Rectotomy|0|||
160886161|NCT01150474|580978285|FG000|Overall Study|Drug did not arrive in time|1|||
160886162|NCT01150474|580978286|FG001|Overall Study|Drug did not arrive in time|0|||
160886163|NCT01150474|580978285|FG000|Overall Study|Drug not administered|1|||
160886164|NCT01150474|580978286|FG001|Overall Study|Drug not administered|0|||
160886165|NCT01150474|580978285|FG000|Overall Study|Surgery Changed|1|||
160886166|NCT01150474|580978286|FG001|Overall Study|Surgery Changed|0|||
160886167|NCT04231981|580978287|FG000|Overall Study|Adverse Event|1|||
160886168|NCT04231981|580978287|FG000|Overall Study|Death|16|||
160886169|NCT04231981|580978287|FG000|Overall Study|Lost to Follow-up|1|||
160886170|NCT02581943|580978288|FG000|Overall Study|Death|5|||
160886171|NCT02581943|580978289|FG001|Overall Study|Death|2|||
160886172|NCT02581943|580978288|FG000|Overall Study|Disease Progression|12|||
160886173|NCT02581943|580978289|FG001|Overall Study|Disease Progression|15|||
160886174|NCT02581943|580978288|FG000|Overall Study|Withdrawal by Subject|1|||
160886175|NCT02581943|580978289|FG001|Overall Study|Withdrawal by Subject|2|||
160886176|NCT01470989|580978290|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
160886177|NCT01470989|580978291|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
160886178|NCT01470989|580978290|FG000|Overall Study|Adverse Event|2|||
160886179|NCT01470989|580978291|FG001|Overall Study|Adverse Event|5|||
160886180|NCT01470989|580978290|FG000|Overall Study|Abnormal laboratory value|1|||
161325715|NCT00103285|582579586|FG002|Induction|Physician Decision|0|||
160886181|NCT01470989|580978291|FG001|Overall Study|Abnormal laboratory value|1|||
160886182|NCT01470989|580978290|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160886183|NCT01470989|580978291|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160886184|NCT01470989|580978290|FG000|Overall Study|Withdrawal by Subject|19|||
160886185|NCT01470989|580978291|FG001|Overall Study|Withdrawal by Subject|17|||
160886186|NCT01470989|580978290|FG000|Overall Study|Lost to Follow-up|18|||
160886187|NCT01470989|580978291|FG001|Overall Study|Lost to Follow-up|13|||
161325716|NCT00103285|582579587|FG003|Induction|Physician Decision|0|||
161325717|NCT00103285|582579588|FG004|Induction|Physician Decision|0|||
161325718|NCT00103285|582579589|FG005|Induction|Physician Decision|0|||
161325719|NCT00103285|582579590|FG006|Induction|Physician Decision|0|||
161122759|NCT00143455|581835259|FG003|Cohort 1|Death|0|||
161122760|NCT00143455|581835256|FG000|Cohort 1|Progressive Disease|0|||
161122761|NCT00143455|581835257|FG001|Cohort 1|Progressive Disease|6|||
161122762|NCT00143455|581835258|FG002|Cohort 1|Progressive Disease|0|||
161122763|NCT00143455|581835259|FG003|Cohort 1|Progressive Disease|0|||
161122764|NCT00143455|581835256|FG000|Cohort 1|Withdrawal by Subject|1|||
161122765|NCT00143455|581835257|FG001|Cohort 1|Withdrawal by Subject|4|||
161122766|NCT00143455|581835258|FG002|Cohort 1|Withdrawal by Subject|0|||
161122767|NCT00143455|581835259|FG003|Cohort 1|Withdrawal by Subject|0|||
161122768|NCT00143455|581835256|FG000|Cohort 1|Randomized But Not Treated|0|||
161122769|NCT00143455|581835257|FG001|Cohort 1|Randomized But Not Treated|1|||
161325720|NCT00103285|582579591|FG007|Induction|Physician Decision|0|||
161122770|NCT00143455|581835258|FG002|Cohort 1|Randomized But Not Treated|0|||
161325721|NCT00103285|582579584|FG000|Induction|Withdrawal by Subject|1|||
161325722|NCT00103285|582579585|FG001|Induction|Withdrawal by Subject|0|||
161325723|NCT00103285|582579586|FG002|Induction|Withdrawal by Subject|0|||
161325724|NCT00103285|582579587|FG003|Induction|Withdrawal by Subject|0|||
161325725|NCT00103285|582579588|FG004|Induction|Withdrawal by Subject|0|||
161325726|NCT00103285|582579589|FG005|Induction|Withdrawal by Subject|0|||
161325727|NCT00103285|582579590|FG006|Induction|Withdrawal by Subject|0|||
161325728|NCT00103285|582579591|FG007|Induction|Withdrawal by Subject|0|||
161325729|NCT00103285|582579584|FG000|Induction|Ineligible|43|||
161325730|NCT00103285|582579585|FG001|Induction|Ineligible|0|||
161325731|NCT00103285|582579586|FG002|Induction|Ineligible|0|||
161325732|NCT00103285|582579587|FG003|Induction|Ineligible|0|||
161325733|NCT00103285|582579588|FG004|Induction|Ineligible|0|||
161325734|NCT00103285|582579589|FG005|Induction|Ineligible|0|||
161325735|NCT00103285|582579590|FG006|Induction|Ineligible|0|||
161325736|NCT00103285|582579591|FG007|Induction|Ineligible|0|||
161325737|NCT00103285|582579584|FG000|Induction|Refusal|906|||
161325738|NCT00103285|582579585|FG001|Induction|Refusal|0|||
161325739|NCT00103285|582579586|FG002|Induction|Refusal|0|||
161325740|NCT00103285|582579587|FG003|Induction|Refusal|0|||
161325741|NCT00103285|582579588|FG004|Induction|Refusal|0|||
161325742|NCT00103285|582579589|FG005|Induction|Refusal|0|||
161325743|NCT00103285|582579590|FG006|Induction|Refusal|0|||
161325744|NCT00103285|582579591|FG007|Induction|Refusal|0|||
161325745|NCT00103285|582579584|FG000|Induction|Other|258|||
161325746|NCT00103285|582579585|FG001|Induction|Other|0|||
161325747|NCT00103285|582579586|FG002|Induction|Other|0|||
161325748|NCT00103285|582579587|FG003|Induction|Other|0|||
161325749|NCT00103285|582579588|FG004|Induction|Other|0|||
161325750|NCT00103285|582579589|FG005|Induction|Other|0|||
161325751|NCT00103285|582579590|FG006|Induction|Other|0|||
161325752|NCT00103285|582579591|FG007|Induction|Other|0|||
161325753|NCT00103285|582579584|FG000|Response Assignment|Adverse Event|0|||
161325754|NCT00103285|582579585|FG001|Response Assignment|Adverse Event|8|||
161325755|NCT00103285|582579586|FG002|Response Assignment|Adverse Event|3|||
161325756|NCT00103285|582579587|FG003|Response Assignment|Adverse Event|2|||
161325757|NCT00103285|582579588|FG004|Response Assignment|Adverse Event|3|||
161325758|NCT00103285|582579589|FG005|Response Assignment|Adverse Event|1|||
161325759|NCT00103285|582579590|FG006|Response Assignment|Adverse Event|1|||
161325760|NCT00103285|582579591|FG007|Response Assignment|Adverse Event|2|||
161325761|NCT00103285|582579584|FG000|Response Assignment|Death|0|||
161325762|NCT00103285|582579585|FG001|Response Assignment|Death|5|||
161325763|NCT00103285|582579586|FG002|Response Assignment|Death|2|||
161325764|NCT00103285|582579587|FG003|Response Assignment|Death|2|||
161325765|NCT00103285|582579588|FG004|Response Assignment|Death|3|||
161325766|NCT00103285|582579589|FG005|Response Assignment|Death|1|||
161325767|NCT00103285|582579590|FG006|Response Assignment|Death|0|||
161325768|NCT00103285|582579591|FG007|Response Assignment|Death|8|||
161325769|NCT00103285|582579584|FG000|Response Assignment|Lost to Follow-up|0|||
161325770|NCT00103285|582579585|FG001|Response Assignment|Lost to Follow-up|9|||
161325771|NCT00103285|582579586|FG002|Response Assignment|Lost to Follow-up|5|||
161325772|NCT00103285|582579587|FG003|Response Assignment|Lost to Follow-up|5|||
160886188|NCT01470989|580978290|FG000|Overall Study|Administrative problems|2|||
160886189|NCT01470989|580978291|FG001|Overall Study|Administrative problems|4|||
160886190|NCT01470989|580978290|FG000|Overall Study|Death|2|||
160886191|NCT01470989|580978291|FG001|Overall Study|Death|2|||
160886192|NCT01470989|580978290|FG000|Overall Study|Protocol deviation|1|||
160886193|NCT01470989|580978291|FG001|Overall Study|Protocol deviation|2|||
160886194|NCT01233687|580978292|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
160886195|NCT01233687|580978292|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
160886196|NCT01233687|580978292|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
160886197|NCT02197234|580978295|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
160886198|NCT02197234|580978295|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
160886199|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
160886200|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
160886201|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
160886202|NCT02197234|580978295|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
160886203|NCT03783702|580978296|FG000|Overall Study|Lost to Follow-up|6|||
160886204|NCT03783702|580978297|FG001|Overall Study|Lost to Follow-up|8|||
160886205|NCT03783702|580978296|FG000|Overall Study|Protocol Violation|1|||
160886206|NCT03783702|580978297|FG001|Overall Study|Protocol Violation|3|||
160886207|NCT02119676|580978298|FG000|Overall Study|Adverse Event|9|||
160886208|NCT02119676|580978299|FG001|Overall Study|Adverse Event|17|||
160886209|NCT02119676|580978300|FG002|Overall Study|Adverse Event|10|||
160886210|NCT02119676|580978301|FG003|Overall Study|Adverse Event|10|||
160886211|NCT02119676|580978298|FG000|Overall Study|Disease progression|53|||
160886212|NCT02119676|580978299|FG001|Overall Study|Disease progression|55|||
160886213|NCT02119676|580978300|FG002|Overall Study|Disease progression|68|||
160886214|NCT02119676|580978301|FG003|Overall Study|Disease progression|73|||
160886215|NCT02119676|580978298|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
161122771|NCT00143455|581835259|FG003|Cohort 1|Randomized But Not Treated|0|||
161122772|NCT00143455|581835256|FG000|Cohort 2|Adverse Event|0|||
160886216|NCT02119676|580978299|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
160886217|NCT02119676|580978300|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
160886218|NCT02119676|580978301|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
160886219|NCT02119676|580978298|FG000|Overall Study|Physician Decision|4|||
161325773|NCT00103285|582579588|FG004|Response Assignment|Lost to Follow-up|1|||
161325774|NCT00103285|582579589|FG005|Response Assignment|Lost to Follow-up|2|||
160886220|NCT02119676|580978299|FG001|Overall Study|Physician Decision|2|||
160886221|NCT02119676|580978300|FG002|Overall Study|Physician Decision|3|||
160886222|NCT02119676|580978301|FG003|Overall Study|Physician Decision|2|||
160886223|NCT02119676|580978298|FG000|Overall Study|Death|9|||
160886224|NCT02119676|580978299|FG001|Overall Study|Death|3|||
160886225|NCT02119676|580978300|FG002|Overall Study|Death|2|||
160886226|NCT02119676|580978301|FG003|Overall Study|Death|1|||
160886227|NCT02119676|580978298|FG000|Overall Study|Noncompliance|0|||
160886228|NCT02119676|580978299|FG001|Overall Study|Noncompliance|1|||
160886229|NCT02119676|580978300|FG002|Overall Study|Noncompliance|0|||
160886230|NCT02119676|580978301|FG003|Overall Study|Noncompliance|0|||
160886231|NCT02119676|580978298|FG000|Overall Study|Lost to Follow-up|0|||
160886232|NCT02119676|580978299|FG001|Overall Study|Lost to Follow-up|0|||
160886233|NCT02119676|580978300|FG002|Overall Study|Lost to Follow-up|1|||
160886234|NCT02119676|580978301|FG003|Overall Study|Lost to Follow-up|0|||
160886235|NCT02119676|580978298|FG000|Overall Study|Protocol deviation|0|||
160886236|NCT02119676|580978299|FG001|Overall Study|Protocol deviation|0|||
160886237|NCT02119676|580978300|FG002|Overall Study|Protocol deviation|1|||
160886238|NCT02119676|580978301|FG003|Overall Study|Protocol deviation|0|||
160886239|NCT02119676|580978298|FG000|Overall Study|Other, unspecified|2|||
160886240|NCT02119676|580978299|FG001|Overall Study|Other, unspecified|1|||
161325775|NCT00103285|582579590|FG006|Response Assignment|Lost to Follow-up|2|||
161325776|NCT00103285|582579591|FG007|Response Assignment|Lost to Follow-up|5|||
161325777|NCT00103285|582579584|FG000|Response Assignment|Physician Decision|0|||
161325778|NCT00103285|582579585|FG001|Response Assignment|Physician Decision|13|||
161325779|NCT00103285|582579586|FG002|Response Assignment|Physician Decision|14|||
161325780|NCT00103285|582579587|FG003|Response Assignment|Physician Decision|9|||
161325781|NCT00103285|582579588|FG004|Response Assignment|Physician Decision|13|||
161325782|NCT00103285|582579589|FG005|Response Assignment|Physician Decision|7|||
161325783|NCT00103285|582579590|FG006|Response Assignment|Physician Decision|4|||
161325784|NCT00103285|582579591|FG007|Response Assignment|Physician Decision|35|||
161325785|NCT00103285|582579584|FG000|Response Assignment|Protocol Violation|0|||
161325786|NCT00103285|582579585|FG001|Response Assignment|Protocol Violation|2|||
161325787|NCT00103285|582579586|FG002|Response Assignment|Protocol Violation|0|||
161325788|NCT00103285|582579587|FG003|Response Assignment|Protocol Violation|0|||
161325789|NCT00103285|582579588|FG004|Response Assignment|Protocol Violation|0|||
161325790|NCT00103285|582579589|FG005|Response Assignment|Protocol Violation|0|||
161325791|NCT00103285|582579590|FG006|Response Assignment|Protocol Violation|0|||
161325792|NCT00103285|582579591|FG007|Response Assignment|Protocol Violation|0|||
161325793|NCT00103285|582579584|FG000|Response Assignment|Withdrawal by Subject|0|||
161325794|NCT00103285|582579585|FG001|Response Assignment|Withdrawal by Subject|4|||
161325795|NCT00103285|582579586|FG002|Response Assignment|Withdrawal by Subject|1|||
161325796|NCT00103285|582579587|FG003|Response Assignment|Withdrawal by Subject|1|||
161325797|NCT00103285|582579588|FG004|Response Assignment|Withdrawal by Subject|2|||
161325798|NCT00103285|582579589|FG005|Response Assignment|Withdrawal by Subject|2|||
161325799|NCT00103285|582579590|FG006|Response Assignment|Withdrawal by Subject|0|||
161325800|NCT00103285|582579591|FG007|Response Assignment|Withdrawal by Subject|2|||
161325801|NCT00103285|582579584|FG000|Response Assignment|Ineligible|0|||
161325802|NCT00103285|582579585|FG001|Response Assignment|Ineligible|8|||
161325803|NCT00103285|582579586|FG002|Response Assignment|Ineligible|6|||
161325804|NCT00103285|582579587|FG003|Response Assignment|Ineligible|2|||
161325805|NCT00103285|582579588|FG004|Response Assignment|Ineligible|0|||
161325806|NCT00103285|582579589|FG005|Response Assignment|Ineligible|3|||
161325807|NCT00103285|582579590|FG006|Response Assignment|Ineligible|1|||
161325808|NCT00103285|582579591|FG007|Response Assignment|Ineligible|5|||
161325809|NCT00103285|582579584|FG000|Response Assignment|Refusal|0|||
161325810|NCT00103285|582579585|FG001|Response Assignment|Refusal|53|||
161325811|NCT00103285|582579586|FG002|Response Assignment|Refusal|5|||
161325812|NCT00103285|582579587|FG003|Response Assignment|Refusal|3|||
161325813|NCT00103285|582579588|FG004|Response Assignment|Refusal|25|||
161325814|NCT00103285|582579589|FG005|Response Assignment|Refusal|15|||
161325815|NCT00103285|582579590|FG006|Response Assignment|Refusal|30|||
161325816|NCT00103285|582579591|FG007|Response Assignment|Refusal|10|||
161325817|NCT00103285|582579584|FG000|Response Assignment|Other|0|||
161325818|NCT00103285|582579585|FG001|Response Assignment|Other|30|||
161325819|NCT00103285|582579586|FG002|Response Assignment|Other|48|||
161325820|NCT00103285|582579587|FG003|Response Assignment|Other|38|||
161325821|NCT00103285|582579588|FG004|Response Assignment|Other|37|||
161325822|NCT00103285|582579589|FG005|Response Assignment|Other|17|||
160886241|NCT02119676|580978300|FG002|Overall Study|Other, unspecified|3|||
160886242|NCT02119676|580978301|FG003|Overall Study|Other, unspecified|4|||
160886243|NCT02119676|580978298|FG000|Overall Study|Did not receive study med|2|||
160886244|NCT02119676|580978299|FG001|Overall Study|Did not receive study med|2|||
161325823|NCT00103285|582579590|FG006|Response Assignment|Other|11|||
161325824|NCT00103285|582579591|FG007|Response Assignment|Other|53|||
161325825|NCT02100839|582579596|FG000|Multiple Ascending Dose|Adverse Event|2|||
161325826|NCT02100839|582579597|FG001|Multiple Ascending Dose|Adverse Event|0|||
161325827|NCT02100839|582579596|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
161325828|NCT02100839|582579597|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
161325829|NCT03272347|582579598|FG000|Overall Study|Death|0|||
161325830|NCT03272347|582579599|FG001|Overall Study|Death|0|||
161325831|NCT03272347|582579600|FG002|Overall Study|Death|0|||
160886245|NCT02119676|580978300|FG002|Overall Study|Did not receive study med|4|||
161122773|NCT00143455|581835257|FG001|Cohort 2|Adverse Event|0|||
161122774|NCT00143455|581835258|FG002|Cohort 2|Adverse Event|42|||
161122775|NCT00143455|581835259|FG003|Cohort 2|Adverse Event|30|||
161122776|NCT00143455|581835256|FG000|Cohort 2|No Longer Required Study Treatment|0|||
161122777|NCT00143455|581835257|FG001|Cohort 2|No Longer Required Study Treatment|0|||
160886246|NCT02119676|580978301|FG003|Overall Study|Did not receive study med|5|||
160886247|NCT00219544|580978302|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
160886248|NCT00219544|580978303|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
160886249|NCT00219544|580978302|FG000|Single Blind Treatment Period|Adverse Event|9|||
160886250|NCT00219544|580978303|FG001|Single Blind Treatment Period|Adverse Event|0|||
160886251|NCT00219544|580978302|FG000|Single Blind Treatment Period|Protocol Violation|4|||
160886252|NCT00219544|580978303|FG001|Single Blind Treatment Period|Protocol Violation|0|||
160886253|NCT00219544|580978302|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
160886254|NCT00219544|580978303|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
160886255|NCT00219544|580978302|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
160886256|NCT00219544|580978303|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
160886257|NCT00219544|580978302|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
160886258|NCT00219544|580978303|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
160886259|NCT00989573|580978304|FG000|Overall Study|Adverse Event|8|||
160886260|NCT00989573|580978305|FG001|Overall Study|Adverse Event|12|||
160886261|NCT00989573|580978306|FG002|Overall Study|Adverse Event|4|||
160886262|NCT00989573|580978304|FG000|Overall Study|Physician Decision|0|||
160886263|NCT00989573|580978305|FG001|Overall Study|Physician Decision|2|||
160886264|NCT00989573|580978306|FG002|Overall Study|Physician Decision|0|||
160886265|NCT00989573|580978304|FG000|Overall Study|Protocol Violation|1|||
160886266|NCT00989573|580978305|FG001|Overall Study|Protocol Violation|1|||
160886267|NCT00989573|580978306|FG002|Overall Study|Protocol Violation|1|||
160886268|NCT00989573|580978304|FG000|Overall Study|Withdrawal by Subject|4|||
160886269|NCT00989573|580978305|FG001|Overall Study|Withdrawal by Subject|7|||
160886270|NCT00989573|580978306|FG002|Overall Study|Withdrawal by Subject|3|||
160886271|NCT01445886|580978308|FG000|Overall Study|Lost to Follow-up|2|||
160886272|NCT01445886|580978308|FG000|Overall Study|Protocol Violation|3|||
160886273|NCT03473548|580978309|FG000|Overall Study|Did not attempt HST testing|3|||
160886274|NCT03473548|580978310|FG001|Overall Study|Did not attempt HST testing|0|||
160886275|NCT05856760|580978321|FG000|Overall Study|Adverse Event|2|||
160886276|NCT05856760|580978321|FG000|Overall Study|Physician Decision|1|||
160886277|NCT05856760|580978321|FG000|Overall Study|Protocol Violation|1|||
160886278|NCT05856760|580978321|FG000|Overall Study|Withdrawal by Subject|3|||
160886279|NCT04035486|580978322|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
160886280|NCT04035486|580978323|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
160886281|NCT04035486|580978324|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
160886282|NCT04035486|580978325|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
160886283|NCT04035486|580978322|FG000|Overall Study|Death|6|||
160886284|NCT04035486|580978323|FG001|Overall Study|Death|3|||
160886285|NCT04035486|580978324|FG002|Overall Study|Death|70|||
160886286|NCT04035486|580978325|FG003|Overall Study|Death|77|||
160886287|NCT04035486|580978322|FG000|Overall Study|Screen Failure|0|||
160886288|NCT04035486|580978323|FG001|Overall Study|Screen Failure|0|||
160886289|NCT04035486|580978324|FG002|Overall Study|Screen Failure|1|||
160886290|NCT04035486|580978325|FG003|Overall Study|Screen Failure|1|||
160886291|NCT04035486|580978322|FG000|Overall Study|Withdrawal by Subject|1|||
160886292|NCT04035486|580978323|FG001|Overall Study|Withdrawal by Subject|1|||
160886293|NCT04035486|580978324|FG002|Overall Study|Withdrawal by Subject|11|||
160886294|NCT04035486|580978325|FG003|Overall Study|Withdrawal by Subject|9|||
160886295|NCT03875235|580978328|FG000|Overall Study|Ongoing study treatment|63|||
160886296|NCT03875235|580978329|FG001|Overall Study|Ongoing study treatment|20|||
160886297|NCT03875235|580978328|FG000|Overall Study|Off treatment|77|||
160886298|NCT03875235|580978329|FG001|Overall Study|Off treatment|91|||
160886299|NCT03875235|580978328|FG000|Overall Study|Withdrawal by Subject|3|||
160886300|NCT03875235|580978329|FG001|Overall Study|Withdrawal by Subject|10|||
160886301|NCT03875235|580978328|FG000|Overall Study|Death|198|||
160886302|NCT03875235|580978329|FG001|Overall Study|Death|223|||
160886303|NCT04268823|580978341|FG000|Overall Study|Adverse Event|1|||
160886304|NCT04268823|580978342|FG001|Overall Study|Adverse Event|0|||
160886305|NCT04268823|580978341|FG000|Overall Study|Participant Decision|1|||
160886306|NCT04268823|580978342|FG001|Overall Study|Participant Decision|0|||
160886307|NCT04078178|580979247|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
160886308|NCT04078178|580979248|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
160886309|NCT04078178|580979247|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
160886310|NCT04078178|580979248|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
160886311|NCT04078178|580979247|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
160886312|NCT04078178|580979248|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
160886313|NCT04078178|580979247|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
160886314|NCT04078178|580979248|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
160886315|NCT04078178|580979247|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
160886316|NCT04078178|580979248|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
160886317|NCT05710185|580979249|FG000|Overall Study|Adverse Event|1|||
160886318|NCT05710185|580979249|FG000|Overall Study|Lack of Efficacy|1|||
160886319|NCT02186301|580979254|FG000|Overall Study|Progressive Disease|7|||
160886320|NCT02186301|580979255|FG001|Overall Study|Progressive Disease|22|||
160886321|NCT02186301|580979256|FG002|Overall Study|Progressive Disease|27|||
161122778|NCT00143455|581835258|FG002|Cohort 2|No Longer Required Study Treatment|1|||
161122779|NCT00143455|581835259|FG003|Cohort 2|No Longer Required Study Treatment|0|||
160886322|NCT02186301|580979254|FG000|Overall Study|Adverse Event|5|||
161122780|NCT00143455|581835256|FG000|Cohort 2|Protocol Violation|0|||
161122781|NCT00143455|581835257|FG001|Cohort 2|Protocol Violation|0|||
161325832|NCT03272347|582579601|FG003|Overall Study|Death|1|||
161325833|NCT03272347|582579598|FG000|Overall Study|Lost to Follow-up|1|||
161325834|NCT03272347|582579599|FG001|Overall Study|Lost to Follow-up|3|||
161325835|NCT03272347|582579600|FG002|Overall Study|Lost to Follow-up|5|||
161325836|NCT03272347|582579601|FG003|Overall Study|Lost to Follow-up|1|||
161325837|NCT03272347|582579598|FG000|Overall Study|Physician Decision|4|||
161325838|NCT03272347|582579599|FG001|Overall Study|Physician Decision|2|||
161325839|NCT03272347|582579600|FG002|Overall Study|Physician Decision|5|||
161325840|NCT03272347|582579601|FG003|Overall Study|Physician Decision|4|||
161325841|NCT03272347|582579598|FG000|Overall Study|Screen Failure|1|||
161325842|NCT03272347|582579599|FG001|Overall Study|Screen Failure|0|||
161325843|NCT03272347|582579600|FG002|Overall Study|Screen Failure|0|||
161325844|NCT03272347|582579601|FG003|Overall Study|Screen Failure|0|||
161325845|NCT03272347|582579598|FG000|Overall Study|Withdrawal by Subject|5|||
161325846|NCT03272347|582579599|FG001|Overall Study|Withdrawal by Subject|1|||
161325847|NCT03272347|582579600|FG002|Overall Study|Withdrawal by Subject|2|||
161228502|NCT02319148|582217069|FG000|Second Intervention Period|No longer willing to participate|0|||
161228503|NCT02319148|582217070|FG001|Second Intervention Period|No longer willing to participate|1|||
161228504|NCT02319148|582217071|FG002|Second Intervention Period|No longer willing to participate|0|||
161228505|NCT02319148|582217072|FG003|Second Intervention Period|No longer willing to participate|0|||
161228506|NCT02319148|582217069|FG000|Second Intervention Period|Other|0|||
161228507|NCT02319148|582217070|FG001|Second Intervention Period|Other|0|||
161228508|NCT02319148|582217071|FG002|Second Intervention Period|Other|0|||
161228509|NCT02319148|582217072|FG003|Second Intervention Period|Other|1|||
161228510|NCT01574248|582217073|FG000|Overall Study|Withdrawal by Subject|2|||
161228511|NCT01574248|582217074|FG001|Overall Study|Withdrawal by Subject|0|||
161228512|NCT01574248|582217073|FG000|Overall Study|Missing primary endpoint data|1|||
161228513|NCT01574248|582217074|FG001|Overall Study|Missing primary endpoint data|0|||
161228514|NCT00048048|582217077|FG000|Core Treatment|Withdrawal by Subject|0|||
161228515|NCT00048048|582217078|FG001|Core Treatment|Withdrawal by Subject|0|||
161228516|NCT00048048|582217079|FG002|Core Treatment|Withdrawal by Subject|1|||
161228517|NCT00048048|582217080|FG003|Core Treatment|Withdrawal by Subject|0|||
161228518|NCT00048048|582217081|FG004|Core Treatment|Withdrawal by Subject|0|||
161228519|NCT00048048|582217082|FG005|Core Treatment|Withdrawal by Subject|0|||
161228520|NCT00048048|582217083|FG006|Core Treatment|Withdrawal by Subject|0|||
161228521|NCT00048048|582217084|FG007|Core Treatment|Withdrawal by Subject|0|||
161228522|NCT00048048|582217085|FG008|Core Treatment|Withdrawal by Subject|0|||
161228523|NCT00048048|582217086|FG009|Core Treatment|Withdrawal by Subject|0|||
161228524|NCT00048048|582217087|FG010|Core Treatment|Withdrawal by Subject|0|||
161228525|NCT00048048|582217088|FG011|Core Treatment|Withdrawal by Subject|0|||
161228526|NCT00048048|582217077|FG000|Core Treatment|Adverse Event|0|||
161228527|NCT00048048|582217078|FG001|Core Treatment|Adverse Event|0|||
161228528|NCT00048048|582217079|FG002|Core Treatment|Adverse Event|0|||
161228529|NCT00048048|582217080|FG003|Core Treatment|Adverse Event|0|||
161228530|NCT00048048|582217081|FG004|Core Treatment|Adverse Event|0|||
161228531|NCT00048048|582217082|FG005|Core Treatment|Adverse Event|0|||
161228532|NCT00048048|582217083|FG006|Core Treatment|Adverse Event|0|||
161228533|NCT00048048|582217084|FG007|Core Treatment|Adverse Event|1|||
161228534|NCT00048048|582217085|FG008|Core Treatment|Adverse Event|0|||
161228535|NCT00048048|582217086|FG009|Core Treatment|Adverse Event|0|||
161228536|NCT00048048|582217087|FG010|Core Treatment|Adverse Event|0|||
161228537|NCT00048048|582217088|FG011|Core Treatment|Adverse Event|0|||
161228538|NCT00048048|582217077|FG000|Extension Year 1|Early withdrawals|0|||
161228539|NCT00048048|582217078|FG001|Extension Year 1|Early withdrawals|0|||
161228540|NCT00048048|582217079|FG002|Extension Year 1|Early withdrawals|0|||
161228541|NCT00048048|582217080|FG003|Extension Year 1|Early withdrawals|0|||
161228542|NCT00048048|582217081|FG004|Extension Year 1|Early withdrawals|0|||
161228543|NCT00048048|582217082|FG005|Extension Year 1|Early withdrawals|0|||
161228544|NCT00048048|582217083|FG006|Extension Year 1|Early withdrawals|0|||
161228545|NCT00048048|582217084|FG007|Extension Year 1|Early withdrawals|0|||
161228546|NCT00048048|582217085|FG008|Extension Year 1|Early withdrawals|0|||
161228547|NCT00048048|582217086|FG009|Extension Year 1|Early withdrawals|2|||
161228548|NCT00048048|582217087|FG010|Extension Year 1|Early withdrawals|2|||
161228549|NCT00048048|582217088|FG011|Extension Year 1|Early withdrawals|4|||
161228550|NCT00048048|582217077|FG000|Extension Year 2|Early withdrawals|0|||
161228551|NCT00048048|582217078|FG001|Extension Year 2|Early withdrawals|0|||
161228552|NCT00048048|582217079|FG002|Extension Year 2|Early withdrawals|0|||
161228553|NCT00048048|582217080|FG003|Extension Year 2|Early withdrawals|0|||
161228554|NCT00048048|582217081|FG004|Extension Year 2|Early withdrawals|0|||
161228555|NCT00048048|582217082|FG005|Extension Year 2|Early withdrawals|0|||
161228556|NCT00048048|582217083|FG006|Extension Year 2|Early withdrawals|0|||
161228557|NCT00048048|582217084|FG007|Extension Year 2|Early withdrawals|0|||
161228558|NCT00048048|582217085|FG008|Extension Year 2|Early withdrawals|0|||
161228559|NCT00048048|582217086|FG009|Extension Year 2|Early withdrawals|0|||
161228560|NCT00048048|582217087|FG010|Extension Year 2|Early withdrawals|4|||
161228561|NCT00048048|582217088|FG011|Extension Year 2|Early withdrawals|2|||
161228562|NCT05518487|582217091|FG000|Overall Study|Withdrawal by Subject|3|||
161228563|NCT00543309|582217092|FG000|Overall Study|Physician Decision|0|||
161228564|NCT00543309|582217093|FG001|Overall Study|Physician Decision|1|||
161228565|NCT00543309|582217094|FG002|Overall Study|Physician Decision|0|||
161228566|NCT02194998|582217099|FG000|On-HCV Treatment|Did not pick up study medication|0|||
161228567|NCT02194998|582217100|FG001|On-HCV Treatment|Did not pick up study medication|1|||
161228568|NCT02194998|582217101|FG002|On-HCV Treatment|Did not pick up study medication|0|||
161228569|NCT02194998|582217102|FG003|On-HCV Treatment|Did not pick up study medication|0|||
161228570|NCT02194998|582217099|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
161228571|NCT02194998|582217100|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
161228572|NCT02194998|582217101|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
161228573|NCT02194998|582217102|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
161228574|NCT00525590|582217103|FG000|Overall Study|Adverse Event|3|||
161228575|NCT00525590|582217103|FG000|Overall Study|Physician Decision|3|||
160886323|NCT02186301|580979255|FG001|Overall Study|Adverse Event|5|||
160886324|NCT02186301|580979256|FG002|Overall Study|Adverse Event|5|||
160886325|NCT02186301|580979254|FG000|Overall Study|Death|1|||
160886326|NCT02186301|580979255|FG001|Overall Study|Death|0|||
160886327|NCT02186301|580979256|FG002|Overall Study|Death|0|||
160886328|NCT02186301|580979254|FG000|Overall Study|Withdrawal by Subject|5|||
160886329|NCT02186301|580979255|FG001|Overall Study|Withdrawal by Subject|1|||
160886330|NCT02186301|580979256|FG002|Overall Study|Withdrawal by Subject|3|||
160886331|NCT02186301|580979254|FG000|Overall Study|Physician Decision|1|||
160886332|NCT02186301|580979255|FG001|Overall Study|Physician Decision|0|||
160886333|NCT02186301|580979256|FG002|Overall Study|Physician Decision|1|||
160886334|NCT02186301|580979254|FG000|Overall Study|Study Terminated by Sponsor|1|||
160886335|NCT02186301|580979255|FG001|Overall Study|Study Terminated by Sponsor|0|||
160886336|NCT02186301|580979256|FG002|Overall Study|Study Terminated by Sponsor|11|||
160886337|NCT02186301|580979254|FG000|Overall Study|Protocol Deviation|0|||
160886338|NCT02186301|580979255|FG001|Overall Study|Protocol Deviation|2|||
160886339|NCT02186301|580979256|FG002|Overall Study|Protocol Deviation|0|||
160886340|NCT02186301|580979254|FG000|Overall Study|Missing|0|||
160886341|NCT02186301|580979255|FG001|Overall Study|Missing|0|||
160886342|NCT02186301|580979256|FG002|Overall Study|Missing|2|||
160886343|NCT02186301|580979254|FG000|Overall Study|Other|0|||
160886344|NCT02186301|580979255|FG001|Overall Study|Other|0|||
160886345|NCT02186301|580979256|FG002|Overall Study|Other|1|||
160886346|NCT01343823|580979257|FG000|Overall Study|Study Terminated|1|||
160886347|NCT01343823|580979258|FG001|Overall Study|Study Terminated|0|||
160886348|NCT01343823|580979259|FG002|Overall Study|Study Terminated|0|||
160886349|NCT01343823|580979260|FG003|Overall Study|Study Terminated|1|||
160886350|NCT01343823|580979257|FG000|Overall Study|Withdrawal by Subject|1|||
160886351|NCT01343823|580979258|FG001|Overall Study|Withdrawal by Subject|0|||
160886352|NCT01343823|580979259|FG002|Overall Study|Withdrawal by Subject|0|||
160886353|NCT01343823|580979260|FG003|Overall Study|Withdrawal by Subject|0|||
160886354|NCT01117792|580979263|FG000|Overall Study|Death|1|||
160886355|NCT01117792|580979263|FG000|Overall Study|Adverse Event|3|||
160886356|NCT05867342|580979264|FG000|Overall Study|Investigator Decision|3|||
160886357|NCT05867342|580979265|FG001|Overall Study|Investigator Decision|3|||
160886358|NCT00723203|580979266|FG000|Overall Study|Withdrawal by Subject|3|||
160886359|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
160886360|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
160886361|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
160886362|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
160886363|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
160886364|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
160886365|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
160886366|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
160886367|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
160886368|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
160886369|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
160886370|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
160886371|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
160886372|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
160886373|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
160886374|NCT00274924|580979267|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
160886375|NCT00274924|580979268|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
160886376|NCT00274924|580979269|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
160886377|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
160886378|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
160886379|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
160886380|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
160886381|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
160886382|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
160886383|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
160886384|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
160886385|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
160886386|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
160886387|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
160886388|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
160886389|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
160886390|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
160886391|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
160886392|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
160886393|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
160886394|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
160886395|NCT00274924|580979267|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
160886396|NCT00274924|580979268|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
160886397|NCT00274924|580979269|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
160886398|NCT01903525|580979272|FG000|Overall Study|Lost to Follow-up|5|||
160886399|NCT01903525|580979273|FG001|Overall Study|Lost to Follow-up|9|||
160886400|NCT01903525|580979272|FG000|Overall Study|Adverse Event|0|||
160886401|NCT01903525|580979273|FG001|Overall Study|Adverse Event|1|||
160886402|NCT01673282|580979275|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
160886403|NCT01673282|580979276|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
161122782|NCT00143455|581835258|FG002|Cohort 2|Protocol Violation|1|||
161122783|NCT00143455|581835259|FG003|Cohort 2|Protocol Violation|1|||
161122784|NCT00143455|581835256|FG000|Cohort 2|Lost to Follow-up|0|||
161122785|NCT00143455|581835257|FG001|Cohort 2|Lost to Follow-up|0|||
161122786|NCT00143455|581835258|FG002|Cohort 2|Lost to Follow-up|1|||
161122787|NCT00143455|581835259|FG003|Cohort 2|Lost to Follow-up|4|||
161122788|NCT00143455|581835256|FG000|Cohort 2|Death|0|||
161122789|NCT00143455|581835257|FG001|Cohort 2|Death|0|||
160886404|NCT01673282|580979275|FG000|Overall Study|Lack of Efficacy|9|||
160886405|NCT01673282|580979276|FG001|Overall Study|Lack of Efficacy|2|||
160886406|NCT01673282|580979275|FG000|Overall Study|Lost to Follow-up|11|||
160886407|NCT01673282|580979276|FG001|Overall Study|Lost to Follow-up|10|||
160886408|NCT01673282|580979275|FG000|Overall Study|Withdrawal by Subject|3|||
160886409|NCT01673282|580979276|FG001|Overall Study|Withdrawal by Subject|3|||
160886410|NCT01673282|580979275|FG000|Overall Study|Other|1|||
160886411|NCT01673282|580979276|FG001|Overall Study|Other|6|||
160886412|NCT04365257|580979277|FG000|Overall Study|Physician Decision|1|||
160886413|NCT04365257|580979278|FG001|Overall Study|Physician Decision|0|||
160886414|NCT04365257|580979277|FG000|Overall Study|Patient Noncompliance|1|||
160886415|NCT04365257|580979278|FG001|Overall Study|Patient Noncompliance|0|||
160886416|NCT04365257|580979277|FG000|Overall Study|Withdrawal by Subject|0|||
160886417|NCT04365257|580979278|FG001|Overall Study|Withdrawal by Subject|1|||
160886418|NCT02129777|580979283|FG000|Double-Blind Period|Adverse Event|0|||
160886419|NCT02129777|580979284|FG001|Double-Blind Period|Adverse Event|0|||
160886420|NCT02129777|580979285|FG002|Double-Blind Period|Adverse Event|0|||
160886421|NCT02129777|580979286|FG003|Double-Blind Period|Adverse Event|0|||
160886422|NCT02129777|580979287|FG004|Double-Blind Period|Adverse Event|1|||
160886423|NCT02129777|580979288|FG005|Double-Blind Period|Adverse Event|0|||
160886424|NCT02129777|580979289|FG006|Double-Blind Period|Adverse Event|0|||
160886425|NCT02129777|580979283|FG000|Double-Blind Period|Lost to Follow-up|1|||
160886426|NCT02129777|580979284|FG001|Double-Blind Period|Lost to Follow-up|1|||
160886427|NCT02129777|580979285|FG002|Double-Blind Period|Lost to Follow-up|1|||
160886428|NCT02129777|580979286|FG003|Double-Blind Period|Lost to Follow-up|2|||
160886429|NCT02129777|580979287|FG004|Double-Blind Period|Lost to Follow-up|0|||
160886430|NCT02129777|580979288|FG005|Double-Blind Period|Lost to Follow-up|0|||
160886431|NCT02129777|580979289|FG006|Double-Blind Period|Lost to Follow-up|0|||
160886432|NCT02129777|580979283|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160886433|NCT02129777|580979284|FG001|Double-Blind Period|Withdrawal by Subject|4|||
160886434|NCT02129777|580979285|FG002|Double-Blind Period|Withdrawal by Subject|3|||
160886435|NCT02129777|580979286|FG003|Double-Blind Period|Withdrawal by Subject|2|||
160886436|NCT02129777|580979287|FG004|Double-Blind Period|Withdrawal by Subject|3|||
160886437|NCT02129777|580979288|FG005|Double-Blind Period|Withdrawal by Subject|0|||
160886438|NCT02129777|580979289|FG006|Double-Blind Period|Withdrawal by Subject|0|||
160886439|NCT02129777|580979283|FG000|Double-Blind Period|Pregnancy|0|||
160886440|NCT02129777|580979284|FG001|Double-Blind Period|Pregnancy|0|||
160886441|NCT02129777|580979285|FG002|Double-Blind Period|Pregnancy|0|||
160886442|NCT02129777|580979286|FG003|Double-Blind Period|Pregnancy|0|||
160886443|NCT02129777|580979287|FG004|Double-Blind Period|Pregnancy|1|||
160886444|NCT02129777|580979288|FG005|Double-Blind Period|Pregnancy|0|||
160886445|NCT02129777|580979289|FG006|Double-Blind Period|Pregnancy|0|||
161122790|NCT00143455|581835258|FG002|Cohort 2|Death|20|||
161122791|NCT00143455|581835259|FG003|Cohort 2|Death|12|||
161122792|NCT00143455|581835256|FG000|Cohort 2|Progressive Disease|0|||
161122793|NCT00143455|581835257|FG001|Cohort 2|Progressive Disease|0|||
161122794|NCT00143455|581835258|FG002|Cohort 2|Progressive Disease|20|||
161122795|NCT00143455|581835259|FG003|Cohort 2|Progressive Disease|27|||
161122796|NCT00143455|581835256|FG000|Cohort 2|Withdrawal by Subject|0|||
161122797|NCT00143455|581835257|FG001|Cohort 2|Withdrawal by Subject|0|||
161122798|NCT00143455|581835258|FG002|Cohort 2|Withdrawal by Subject|13|||
161122799|NCT00143455|581835259|FG003|Cohort 2|Withdrawal by Subject|12|||
161122800|NCT00143455|581835256|FG000|Cohort 2|Other|0|||
161122801|NCT00143455|581835257|FG001|Cohort 2|Other|0|||
160886446|NCT02129777|580979283|FG000|Double-Blind Period|Lack of Efficacy|3|||
160886447|NCT02129777|580979284|FG001|Double-Blind Period|Lack of Efficacy|1|||
160886448|NCT02129777|580979285|FG002|Double-Blind Period|Lack of Efficacy|0|||
160886449|NCT02129777|580979286|FG003|Double-Blind Period|Lack of Efficacy|3|||
160886450|NCT02129777|580979287|FG004|Double-Blind Period|Lack of Efficacy|2|||
160886451|NCT02129777|580979288|FG005|Double-Blind Period|Lack of Efficacy|0|||
160886452|NCT02129777|580979289|FG006|Double-Blind Period|Lack of Efficacy|0|||
160886453|NCT02129777|580979283|FG000|Double-Blind Period|Other|1|||
160886454|NCT02129777|580979284|FG001|Double-Blind Period|Other|2|||
160886455|NCT02129777|580979285|FG002|Double-Blind Period|Other|0|||
160886456|NCT02129777|580979286|FG003|Double-Blind Period|Other|0|||
160886457|NCT02129777|580979287|FG004|Double-Blind Period|Other|0|||
160886458|NCT02129777|580979288|FG005|Double-Blind Period|Other|0|||
160886459|NCT02129777|580979289|FG006|Double-Blind Period|Other|0|||
160886460|NCT02129777|580979283|FG000|Open-Label Period|Lack of Efficacy|0|||
161122802|NCT00143455|581835258|FG002|Cohort 2|Other|7|||
161122803|NCT00143455|581835259|FG003|Cohort 2|Other|6|||
160886461|NCT02129777|580979284|FG001|Open-Label Period|Lack of Efficacy|0|||
160886462|NCT02129777|580979285|FG002|Open-Label Period|Lack of Efficacy|0|||
161122804|NCT00143455|581835256|FG000|Cohort 2|Randomized But Not Treated|0|||
160886463|NCT02129777|580979286|FG003|Open-Label Period|Lack of Efficacy|0|||
160886464|NCT02129777|580979287|FG004|Open-Label Period|Lack of Efficacy|0|||
161122805|NCT00143455|581835257|FG001|Cohort 2|Randomized But Not Treated|0|||
160886465|NCT02129777|580979288|FG005|Open-Label Period|Lack of Efficacy|0|||
161122806|NCT00143455|581835258|FG002|Cohort 2|Randomized But Not Treated|1|||
161122807|NCT00143455|581835259|FG003|Cohort 2|Randomized But Not Treated|1|||
160886466|NCT02129777|580979289|FG006|Open-Label Period|Lack of Efficacy|5|||
160886467|NCT02129777|580979283|FG000|Open-Label Period|Lost to Follow-up|0|||
160886468|NCT02129777|580979284|FG001|Open-Label Period|Lost to Follow-up|0|||
160886469|NCT02129777|580979285|FG002|Open-Label Period|Lost to Follow-up|0|||
160886470|NCT02129777|580979286|FG003|Open-Label Period|Lost to Follow-up|0|||
160886471|NCT02129777|580979287|FG004|Open-Label Period|Lost to Follow-up|0|||
160886472|NCT02129777|580979288|FG005|Open-Label Period|Lost to Follow-up|1|||
160886473|NCT02129777|580979289|FG006|Open-Label Period|Lost to Follow-up|1|||
160886474|NCT02129777|580979283|FG000|Open-Label Period|Withdrawal by Subject|0|||
160886475|NCT02129777|580979284|FG001|Open-Label Period|Withdrawal by Subject|0|||
160886476|NCT02129777|580979285|FG002|Open-Label Period|Withdrawal by Subject|0|||
160886477|NCT02129777|580979286|FG003|Open-Label Period|Withdrawal by Subject|0|||
160886478|NCT02129777|580979287|FG004|Open-Label Period|Withdrawal by Subject|0|||
160886479|NCT02129777|580979288|FG005|Open-Label Period|Withdrawal by Subject|1|||
160886480|NCT02129777|580979289|FG006|Open-Label Period|Withdrawal by Subject|3|||
160886481|NCT02129777|580979283|FG000|Open-Label Period|Study Termination|0|||
160886482|NCT02129777|580979284|FG001|Open-Label Period|Study Termination|0|||
160886483|NCT02129777|580979285|FG002|Open-Label Period|Study Termination|0|||
160886484|NCT02129777|580979286|FG003|Open-Label Period|Study Termination|0|||
160886485|NCT02129777|580979287|FG004|Open-Label Period|Study Termination|0|||
161228576|NCT00525590|582217103|FG000|Overall Study|Withdrawal by Subject|16|||
161228577|NCT00525590|582217103|FG000|Overall Study|Lost to Follow-up|1|||
161228578|NCT00525590|582217103|FG000|Overall Study|Death|9|||
161228579|NCT00525590|582217103|FG000|Overall Study|Other|13|||
161228580|NCT00762086|582217104|FG000|Overall Study|Adverse Event|2|||
161228581|NCT00762086|582217105|FG001|Overall Study|Adverse Event|0|||
161228582|NCT00762086|582217104|FG000|Overall Study|Lost to Follow-up|0|||
160886486|NCT02129777|580979288|FG005|Open-Label Period|Study Termination|10|||
160886487|NCT02129777|580979289|FG006|Open-Label Period|Study Termination|39|||
160886488|NCT01609478|580979297|FG000|Overall Study|Adverse Event|3|||
160886489|NCT01609478|580979298|FG001|Overall Study|Adverse Event|1|||
160886490|NCT01609478|580979299|FG002|Overall Study|Adverse Event|5|||
160886491|NCT01609478|580979297|FG000|Overall Study|Protocol Deviation|0|||
160886492|NCT01609478|580979298|FG001|Overall Study|Protocol Deviation|1|||
160886493|NCT01609478|580979299|FG002|Overall Study|Protocol Deviation|1|||
160886494|NCT01609478|580979297|FG000|Overall Study|Non-Compliance with study treatment|1|||
160886495|NCT01609478|580979298|FG001|Overall Study|Non-Compliance with study treatment|0|||
160886496|NCT01609478|580979299|FG002|Overall Study|Non-Compliance with study treatment|0|||
160886497|NCT01609478|580979297|FG000|Overall Study|Physician Decision|1|||
160886498|NCT01609478|580979298|FG001|Overall Study|Physician Decision|0|||
160886499|NCT01609478|580979299|FG002|Overall Study|Physician Decision|1|||
160886500|NCT01609478|580979297|FG000|Overall Study|Withdrawal by Subject|2|||
160886501|NCT01609478|580979298|FG001|Overall Study|Withdrawal by Subject|0|||
160886502|NCT01609478|580979299|FG002|Overall Study|Withdrawal by Subject|2|||
160886503|NCT04973137|580979300|FG000|Double Blind Phase|Adverse Event|4|||
160886504|NCT04973137|580979301|FG001|Double Blind Phase|Adverse Event|0|||
160886505|NCT04973137|580979300|FG000|Double Blind Phase|Death|25|||
160886506|NCT04973137|580979301|FG001|Double Blind Phase|Death|15|||
160886507|NCT04973137|580979300|FG000|Double Blind Phase|Physician Decision|5|||
160886508|NCT04973137|580979301|FG001|Double Blind Phase|Physician Decision|1|||
160886509|NCT04973137|580979300|FG000|Double Blind Phase|Withdrawal by Subject|6|||
160886510|NCT04973137|580979301|FG001|Double Blind Phase|Withdrawal by Subject|1|||
160886511|NCT04973137|580979300|FG000|Double Blind Phase|Other|2|||
160886512|NCT04973137|580979301|FG001|Double Blind Phase|Other|2|||
160886513|NCT04973137|580979300|FG000|Open Label Extension Phase|Death|3|||
160886514|NCT04973137|580979301|FG001|Open Label Extension Phase|Death|0|||
160886515|NCT04973137|580979300|FG000|Open Label Extension Phase|Physician Decision|0|||
160886516|NCT04973137|580979301|FG001|Open Label Extension Phase|Physician Decision|1|||
160886517|NCT04973137|580979300|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
160886518|NCT04973137|580979301|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
160886519|NCT04973137|580979300|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
160886520|NCT04973137|580979301|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
160886521|NCT04973137|580979300|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
160886522|NCT04973137|580979301|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
160886523|NCT05040971|580979302|FG000|Overall Study|Withdrawal by Subject|0|||
160886524|NCT05040971|580979303|FG001|Overall Study|Withdrawal by Subject|2|||
161228583|NCT00762086|582217105|FG001|Overall Study|Lost to Follow-up|2|||
161228584|NCT00762086|582217104|FG000|Overall Study|Non compliance|1|||
160886525|NCT05040971|580979302|FG000|Overall Study|Lost to Follow-up|8|||
160886526|NCT05040971|580979303|FG001|Overall Study|Lost to Follow-up|3|||
160886527|NCT05040971|580979302|FG000|Overall Study|Death|2|||
160886528|NCT05040971|580979303|FG001|Overall Study|Death|0|||
160886529|NCT04391569|580979306|FG000|Overall Study|Death|15|||
160886530|NCT04391569|580979307|FG001|Overall Study|Death|10|||
160886531|NCT04391569|580979306|FG000|Overall Study|Withdrawal by Subject|1|||
160886532|NCT04391569|580979307|FG001|Overall Study|Withdrawal by Subject|0|||
160886533|NCT04391569|580979306|FG000|Overall Study|Lost to Follow-up|3|||
160886534|NCT04391569|580979307|FG001|Overall Study|Lost to Follow-up|2|||
160886535|NCT04391569|580979306|FG000|Overall Study|Lack of Efficacy|0|||
160886536|NCT04391569|580979307|FG001|Overall Study|Lack of Efficacy|1|||
160886537|NCT04391569|580979306|FG000|Overall Study|Participant discharged to hospice facility|0|||
160886538|NCT04391569|580979307|FG001|Overall Study|Participant discharged to hospice facility|1|||
160886539|NCT04391569|580979306|FG000|Overall Study|Participant family decision|1|||
160886540|NCT04391569|580979307|FG001|Overall Study|Participant family decision|0|||
160886541|NCT04391569|580979306|FG000|Overall Study|Participant discharged prematurely|1|||
160886542|NCT04391569|580979307|FG001|Overall Study|Participant discharged prematurely|0|||
160886543|NCT00938886|580979338|FG000|Overall Study|Death|0|||
161122808|NCT02682901|581835260|FG000|Overall Study|Adverse Event|10|||
160886544|NCT00938886|580979339|FG001|Overall Study|Death|1|||
160886545|NCT00938886|580979338|FG000|Overall Study|Withdrawal by Subject|4|||
160886546|NCT00938886|580979339|FG001|Overall Study|Withdrawal by Subject|7|||
160886547|NCT00938886|580979338|FG000|Overall Study|Lost to Follow-up|3|||
160886548|NCT00938886|580979339|FG001|Overall Study|Lost to Follow-up|2|||
160886549|NCT03044574|580979340|FG000|Overall Study|Lost to Follow-up|37|||
160886550|NCT03044574|580979341|FG001|Overall Study|Lost to Follow-up|45|||
160886551|NCT00645788|580979342|FG000|Overall Study|Did not receive study drug|1|||
160886552|NCT00645788|580979343|FG001|Overall Study|Did not receive study drug|1|||
160886553|NCT00645788|580979344|FG002|Overall Study|Did not receive study drug|0|||
160886554|NCT00645788|580979345|FG003|Overall Study|Did not receive study drug|0|||
160886555|NCT00645788|580979342|FG000|Overall Study|Adverse Event|4|||
160886556|NCT00645788|580979343|FG001|Overall Study|Adverse Event|9|||
160886557|NCT00645788|580979344|FG002|Overall Study|Adverse Event|5|||
160886558|NCT00645788|580979345|FG003|Overall Study|Adverse Event|3|||
160886559|NCT00645788|580979342|FG000|Overall Study|Lost to Follow-up|1|||
160886560|NCT00645788|580979343|FG001|Overall Study|Lost to Follow-up|0|||
160886561|NCT00645788|580979344|FG002|Overall Study|Lost to Follow-up|0|||
160886562|NCT00645788|580979345|FG003|Overall Study|Lost to Follow-up|0|||
160886563|NCT00645788|580979342|FG000|Overall Study|Protocol Violation|1|||
160886564|NCT00645788|580979343|FG001|Overall Study|Protocol Violation|0|||
160886565|NCT00645788|580979344|FG002|Overall Study|Protocol Violation|2|||
160886566|NCT00645788|580979345|FG003|Overall Study|Protocol Violation|0|||
160886567|NCT00645788|580979342|FG000|Overall Study|Withdrawal by Subject|0|||
160886568|NCT00645788|580979343|FG001|Overall Study|Withdrawal by Subject|1|||
160886569|NCT00645788|580979344|FG002|Overall Study|Withdrawal by Subject|0|||
160886570|NCT00645788|580979345|FG003|Overall Study|Withdrawal by Subject|2|||
160886571|NCT00645788|580979342|FG000|Overall Study|Pulmonary exacerbation|13|||
160886572|NCT00645788|580979343|FG001|Overall Study|Pulmonary exacerbation|16|||
160886573|NCT00645788|580979344|FG002|Overall Study|Pulmonary exacerbation|11|||
160886574|NCT00645788|580979345|FG003|Overall Study|Pulmonary exacerbation|9|||
160886575|NCT03764033|580979348|FG000|Treatment Phase|Withdrawal by Subject|8|||
160886576|NCT03764033|580979349|FG001|Treatment Phase|Withdrawal by Subject|3|||
160886577|NCT03764033|580979348|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
160886578|NCT03764033|580979349|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
160886579|NCT03764033|580979348|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
160886580|NCT03764033|580979349|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
160886581|NCT01006603|580979350|FG000|Overall Study|Withdrawal by Subject|17|||
160886582|NCT01006603|580979351|FG001|Overall Study|Withdrawal by Subject|19|||
160886583|NCT01006603|580979350|FG000|Overall Study|Lost to Follow-up|0|||
160886584|NCT01006603|580979351|FG001|Overall Study|Lost to Follow-up|1|||
160886585|NCT01006603|580979350|FG000|Overall Study|Safety reason|1|||
160886586|NCT01006603|580979351|FG001|Overall Study|Safety reason|1|||
160886587|NCT01006603|580979350|FG000|Overall Study|Protocol Violation|1|||
160886588|NCT01006603|580979351|FG001|Overall Study|Protocol Violation|3|||
160886589|NCT01006603|580979350|FG000|Overall Study|Incorrect enrolment|0|||
160886590|NCT01006603|580979351|FG001|Overall Study|Incorrect enrolment|2|||
160886591|NCT01006603|580979350|FG000|Overall Study|Adverse Event|15|||
160886592|NCT01006603|580979351|FG001|Overall Study|Adverse Event|7|||
160886593|NCT01006603|580979350|FG000|Overall Study|Death|1|||
160886594|NCT01006603|580979351|FG001|Overall Study|Death|1|||
160886595|NCT01006603|580979350|FG000|Overall Study|Study specific discontinuation criteria|33|||
160886596|NCT01006603|580979351|FG001|Overall Study|Study specific discontinuation criteria|34|||
160886597|NCT01006603|580979350|FG000|Overall Study|Other|3|||
160886598|NCT01006603|580979351|FG001|Overall Study|Other|7|||
160886599|NCT01107418|580980536|FG000|Overall Study|Disease Progression|45|||
160886600|NCT01107418|580980536|FG000|Overall Study|Adverse Event|3|||
160886601|NCT01107418|580980536|FG000|Overall Study|Withdrawal by Subject|1|||
160886602|NCT01107418|580980536|FG000|Overall Study|Study Closing|1|||
160886603|NCT01107418|580980536|FG000|Overall Study|Started Other Therapy|1|||
160886604|NCT01107418|580980536|FG000|Overall Study|Entered Extension Study|1|||
161228585|NCT00762086|582217105|FG001|Overall Study|Non compliance|0|||
160886605|NCT03505671|580980537|FG000|Overall Study|Withdrawal by Subject|2|||
160886606|NCT03505671|580980538|FG001|Overall Study|Withdrawal by Subject|1|||
160886607|NCT03505671|580980537|FG000|Overall Study|Lost to Follow-up|1|||
160886608|NCT03505671|580980538|FG001|Overall Study|Lost to Follow-up|0|||
160886609|NCT02038829|580980539|FG000|Washout Period 1|Death|0|||
160886610|NCT02038829|580980540|FG001|Washout Period 1|Death|0|||
160886611|NCT02038829|580980541|FG002|Washout Period 1|Death|0|||
160886612|NCT02038829|580980542|FG003|Washout Period 1|Death|0|||
160886613|NCT02038829|580980543|FG004|Washout Period 1|Death|1|||
160886614|NCT02038829|580980544|FG005|Washout Period 1|Death|0|||
160886615|NCT02038829|580980545|FG006|Washout Period 1|Death|0|||
160886616|NCT02038829|580980546|FG007|Washout Period 1|Death|0|||
160886617|NCT02038829|580980547|FG008|Washout Period 1|Death|0|||
160886618|NCT02038829|580980548|FG009|Washout Period 1|Death|0|||
160886619|NCT02038829|580980549|FG010|Washout Period 1|Death|0|||
160886620|NCT02038829|580980550|FG011|Washout Period 1|Death|0|||
160886621|NCT02038829|580980539|FG000|Treatment Period 2|Adverse Event|0|||
161228586|NCT00762086|582217104|FG000|Overall Study|Withdrawal by Subject|2|||
161228587|NCT00762086|582217105|FG001|Overall Study|Withdrawal by Subject|2|||
161228588|NCT00762086|582217104|FG000|Overall Study|Ineligible to participate in the study|1|||
161228589|NCT00762086|582217105|FG001|Overall Study|Ineligible to participate in the study|0|||
161228590|NCT00796822|582217111|FG000|Overall Study|Lost to Follow-up|2|||
161228591|NCT00796822|582217112|FG001|Overall Study|Lost to Follow-up|0|||
161228592|NCT00796822|582217111|FG000|Overall Study|Adverse Event|1|||
161228593|NCT00796822|582217112|FG001|Overall Study|Adverse Event|0|||
161228594|NCT02327130|582217120|FG000|Overall Study|Discharged in less than 5 days|5|||
161228595|NCT02327130|582217120|FG000|Overall Study|Physician Decision|2|||
161228596|NCT02327130|582217120|FG000|Overall Study|Unable to provide breath sample|1|||
161228597|NCT02327130|582217120|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
161228598|NCT02327130|582217120|FG000|Overall Study|Met exclusion criteria|3|||
161228599|NCT04028843|582217121|FG000|Overall Study|Lost to Follow-up|32|||
161228600|NCT04028843|582217122|FG001|Overall Study|Lost to Follow-up|39|||
161228601|NCT04028843|582217121|FG000|Overall Study|Adverse Event|1|||
161228602|NCT04028843|582217122|FG001|Overall Study|Adverse Event|0|||
161228603|NCT04028843|582217121|FG000|Overall Study|Non-viable Pregnancy|0|||
161228604|NCT04028843|582217122|FG001|Overall Study|Non-viable Pregnancy|1|||
161228605|NCT04028843|582217121|FG000|Overall Study|Withdrawal by Subject|4|||
161228606|NCT04028843|582217122|FG001|Overall Study|Withdrawal by Subject|2|||
160886622|NCT02038829|580980540|FG001|Treatment Period 2|Adverse Event|0|||
160886623|NCT02038829|580980541|FG002|Treatment Period 2|Adverse Event|0|||
160886624|NCT02038829|580980542|FG003|Treatment Period 2|Adverse Event|0|||
160886625|NCT02038829|580980543|FG004|Treatment Period 2|Adverse Event|0|||
161228607|NCT01345019|582218598|FG000|Blinded Treatment Phase|Death|147|||
161228608|NCT01345019|582218599|FG001|Blinded Treatment Phase|Death|137|||
161228609|NCT01345019|582218598|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
161228610|NCT01345019|582218599|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
161228611|NCT01345019|582218598|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
161228612|NCT01345019|582218599|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
161228613|NCT01345019|582218598|FG000|Blinded Treatment Phase|Disease Progression|12|||
161228614|NCT01345019|582218599|FG001|Blinded Treatment Phase|Disease Progression|10|||
161228615|NCT01345019|582218598|FG000|Blinded Treatment Phase|Adverse Event|6|||
161228616|NCT01345019|582218599|FG001|Blinded Treatment Phase|Adverse Event|13|||
161228617|NCT01345019|582218598|FG000|Blinded Treatment Phase|Administrative Decision|10|||
161228618|NCT01345019|582218599|FG001|Blinded Treatment Phase|Administrative Decision|8|||
161228619|NCT01345019|582218598|FG000|Blinded Treatment Phase|Noncompliance|5|||
161228620|NCT01345019|582218599|FG001|Blinded Treatment Phase|Noncompliance|3|||
161228621|NCT01345019|582218598|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
161228622|NCT01345019|582218599|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
161228623|NCT01345019|582218598|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
161228624|NCT01345019|582218599|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
161228625|NCT01345019|582218598|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
161228626|NCT01345019|582218599|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
161228627|NCT01345019|582218598|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
161228628|NCT01345019|582218599|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
161228629|NCT01345019|582218598|FG000|Open Label Treatment Phase|Death|49|||
161228630|NCT01345019|582218599|FG001|Open Label Treatment Phase|Death|48|||
161228631|NCT01345019|582218598|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
161228632|NCT01345019|582218599|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
161228633|NCT01345019|582218598|FG000|Open Label Treatment Phase|Adverse Event|30|||
161228634|NCT01345019|582218599|FG001|Open Label Treatment Phase|Adverse Event|51|||
161228635|NCT01345019|582218598|FG000|Open Label Treatment Phase|Administrative Decision|30|||
161228636|NCT01345019|582218599|FG001|Open Label Treatment Phase|Administrative Decision|15|||
161228637|NCT01345019|582218598|FG000|Open Label Treatment Phase|Disease Progression|17|||
161228638|NCT01345019|582218599|FG001|Open Label Treatment Phase|Disease Progression|18|||
161228639|NCT01345019|582218598|FG000|Open Label Treatment Phase|Noncompliance|5|||
161228640|NCT01345019|582218599|FG001|Open Label Treatment Phase|Noncompliance|4|||
161228641|NCT01345019|582218598|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
161228642|NCT01345019|582218599|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
161228643|NCT01345019|582218598|FG000|Open Label Treatment Phase|Pregnancy|1|||
161228644|NCT01345019|582218599|FG001|Open Label Treatment Phase|Pregnancy|0|||
161228645|NCT01345019|582218598|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
161228646|NCT01345019|582218599|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
161228647|NCT01345019|582218598|FG000|Open Label Treatment Phase|Protocol Violation|0|||
161228648|NCT01345019|582218599|FG001|Open Label Treatment Phase|Protocol Violation|1|||
161228649|NCT02636907|582218600|FG000|Autoinjector Assessment Period|Adverse Event|2|||
161228650|NCT02636907|582218600|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
161228651|NCT02636907|582218600|FG000|Extension Phase|Adverse Event|2|||
161228652|NCT02636907|582218600|FG000|Extension Phase|Withdrawal by Subject|4|||
161228653|NCT02636907|582218600|FG000|Extension Phase|Physician Decision|1|||
161228654|NCT02636907|582218600|FG000|Extension Phase|Lost to Follow-up|2|||
161228655|NCT02636907|582218600|FG000|Extension Phase|Lack of Efficacy|1|||
161228656|NCT03830164|582218603|FG000|Overall Study|Adverse Event|0|||
161228657|NCT03830164|582218604|FG001|Overall Study|Adverse Event|2|||
161228658|NCT03830164|582218605|FG002|Overall Study|Adverse Event|0|||
161228659|NCT03830164|582218603|FG000|Overall Study|Lack of Efficacy|1|||
161228660|NCT03830164|582218604|FG001|Overall Study|Lack of Efficacy|5|||
161228661|NCT03830164|582218605|FG002|Overall Study|Lack of Efficacy|0|||
161228662|NCT03830164|582218603|FG000|Overall Study|Lost to Follow-up|0|||
161228663|NCT03830164|582218604|FG001|Overall Study|Lost to Follow-up|1|||
161228664|NCT03830164|582218605|FG002|Overall Study|Lost to Follow-up|0|||
161228665|NCT03830164|582218603|FG000|Overall Study|Withdrawal by Subject|1|||
161228666|NCT03830164|582218604|FG001|Overall Study|Withdrawal by Subject|0|||
161228667|NCT03830164|582218605|FG002|Overall Study|Withdrawal by Subject|0|||
161228668|NCT04099888|582218608|FG000|Overall Study|Study terminated by sponsor|9|||
161228669|NCT04099888|582218609|FG001|Overall Study|Study terminated by sponsor|11|||
161228670|NCT04099888|582218608|FG000|Overall Study|Lost to Follow-up|1|||
161325848|NCT03272347|582579601|FG003|Overall Study|Withdrawal by Subject|1|||
161228671|NCT04099888|582218609|FG001|Overall Study|Lost to Follow-up|1|||
161228672|NCT04099888|582218608|FG000|Overall Study|Withdrawal by Subject|5|||
161228673|NCT04099888|582218609|FG001|Overall Study|Withdrawal by Subject|6|||
161228674|NCT04099888|582218608|FG000|Overall Study|Death|5|||
161228675|NCT04099888|582218609|FG001|Overall Study|Death|2|||
161228676|NCT04099888|582218608|FG000|Overall Study|Other|1|||
160886626|NCT02038829|580980544|FG005|Treatment Period 2|Adverse Event|0|||
160886627|NCT02038829|580980545|FG006|Treatment Period 2|Adverse Event|0|||
160886628|NCT02038829|580980546|FG007|Treatment Period 2|Adverse Event|0|||
160886629|NCT02038829|580980547|FG008|Treatment Period 2|Adverse Event|0|||
160886630|NCT02038829|580980548|FG009|Treatment Period 2|Adverse Event|0|||
160886631|NCT02038829|580980549|FG010|Treatment Period 2|Adverse Event|1|||
160886632|NCT02038829|580980550|FG011|Treatment Period 2|Adverse Event|0|||
160886633|NCT02038829|580980539|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160886634|NCT02038829|580980540|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160886635|NCT02038829|580980541|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160886636|NCT02038829|580980542|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160886637|NCT02038829|580980543|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160886638|NCT02038829|580980544|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160886639|NCT02038829|580980545|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161228677|NCT04099888|582218609|FG001|Overall Study|Other|0|||
160886640|NCT02038829|580980546|FG007|Treatment Period 2|Withdrawal by Subject|0|||
160886641|NCT02038829|580980547|FG008|Treatment Period 2|Withdrawal by Subject|0|||
160886642|NCT02038829|580980548|FG009|Treatment Period 2|Withdrawal by Subject|0|||
161122809|NCT02682901|581835261|FG001|Overall Study|Adverse Event|3|||
161122810|NCT02682901|581835260|FG000|Overall Study|Lack of Efficacy|0|||
161122811|NCT02682901|581835261|FG001|Overall Study|Lack of Efficacy|1|||
161122812|NCT03713944|581835262|FG000|Study Treatment|Patient non-compliance|1|||
161122813|NCT03713944|581835262|FG000|Study Treatment|Alternative Cancer Therapy|3|||
161122814|NCT03713944|581835262|FG000|Study Treatment|Disease Progression|18|||
161122815|NCT03713944|581835262|FG000|Study Treatment|AE/Side Effects/Complications|2|||
161122816|NCT03713944|581835262|FG000|Study Treatment|Death|2|||
160886643|NCT02038829|580980549|FG010|Treatment Period 2|Withdrawal by Subject|0|||
160886644|NCT02038829|580980550|FG011|Treatment Period 2|Withdrawal by Subject|0|||
160886645|NCT02038829|580980539|FG000|Washout Period 2|Adverse Event|0|||
160886646|NCT02038829|580980540|FG001|Washout Period 2|Adverse Event|0|||
160886647|NCT02038829|580980541|FG002|Washout Period 2|Adverse Event|0|||
160886648|NCT02038829|580980542|FG003|Washout Period 2|Adverse Event|0|||
160886649|NCT02038829|580980543|FG004|Washout Period 2|Adverse Event|0|||
160886650|NCT02038829|580980544|FG005|Washout Period 2|Adverse Event|0|||
160886651|NCT02038829|580980545|FG006|Washout Period 2|Adverse Event|0|||
160886652|NCT02038829|580980546|FG007|Washout Period 2|Adverse Event|0|||
160886653|NCT02038829|580980547|FG008|Washout Period 2|Adverse Event|1|||
160886654|NCT02038829|580980548|FG009|Washout Period 2|Adverse Event|0|||
160886655|NCT02038829|580980549|FG010|Washout Period 2|Adverse Event|0|||
160886656|NCT02038829|580980550|FG011|Washout Period 2|Adverse Event|0|||
160886657|NCT02038829|580980539|FG000|Washout Period 2|Withdrawal by Subject|0|||
160886658|NCT02038829|580980540|FG001|Washout Period 2|Withdrawal by Subject|0|||
160886659|NCT02038829|580980541|FG002|Washout Period 2|Withdrawal by Subject|0|||
160886660|NCT02038829|580980542|FG003|Washout Period 2|Withdrawal by Subject|0|||
160886661|NCT02038829|580980543|FG004|Washout Period 2|Withdrawal by Subject|0|||
160886662|NCT02038829|580980544|FG005|Washout Period 2|Withdrawal by Subject|1|||
160886663|NCT02038829|580980545|FG006|Washout Period 2|Withdrawal by Subject|0|||
160886664|NCT02038829|580980546|FG007|Washout Period 2|Withdrawal by Subject|0|||
160886665|NCT02038829|580980547|FG008|Washout Period 2|Withdrawal by Subject|0|||
160886666|NCT02038829|580980548|FG009|Washout Period 2|Withdrawal by Subject|0|||
160886667|NCT02038829|580980549|FG010|Washout Period 2|Withdrawal by Subject|0|||
160886668|NCT02038829|580980550|FG011|Washout Period 2|Withdrawal by Subject|0|||
160886669|NCT02038829|580980539|FG000|Treatment Period 4|Adverse Event|0|||
160886670|NCT02038829|580980540|FG001|Treatment Period 4|Adverse Event|1|||
160886671|NCT02038829|580980541|FG002|Treatment Period 4|Adverse Event|0|||
160886672|NCT02038829|580980542|FG003|Treatment Period 4|Adverse Event|0|||
160886673|NCT02038829|580980543|FG004|Treatment Period 4|Adverse Event|0|||
160886674|NCT02038829|580980544|FG005|Treatment Period 4|Adverse Event|0|||
160886675|NCT02038829|580980545|FG006|Treatment Period 4|Adverse Event|0|||
160886676|NCT02038829|580980546|FG007|Treatment Period 4|Adverse Event|0|||
160886677|NCT02038829|580980547|FG008|Treatment Period 4|Adverse Event|0|||
160886678|NCT02038829|580980548|FG009|Treatment Period 4|Adverse Event|0|||
160886679|NCT02038829|580980549|FG010|Treatment Period 4|Adverse Event|0|||
160886680|NCT02038829|580980550|FG011|Treatment Period 4|Adverse Event|0|||
161122817|NCT03713944|581835262|FG000|Study Treatment|Withdrawal by Subject|1|||
161122818|NCT03713944|581835262|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
161122819|NCT03713944|581835262|FG000|Study Treatment|Symptomatic Deterioration|2|||
161122820|NCT03713944|581835262|FG000|Follow up|Withdrawal by Subject|2|||
160886681|NCT02038829|580980539|FG000|Washout Period 4|Adverse Event|0|||
160886682|NCT02038829|580980540|FG001|Washout Period 4|Adverse Event|0|||
160886683|NCT02038829|580980541|FG002|Washout Period 4|Adverse Event|0|||
160886684|NCT02038829|580980542|FG003|Washout Period 4|Adverse Event|0|||
160886685|NCT02038829|580980543|FG004|Washout Period 4|Adverse Event|0|||
160886686|NCT02038829|580980544|FG005|Washout Period 4|Adverse Event|0|||
160886687|NCT02038829|580980545|FG006|Washout Period 4|Adverse Event|1|||
160886688|NCT02038829|580980546|FG007|Washout Period 4|Adverse Event|0|||
160886689|NCT02038829|580980547|FG008|Washout Period 4|Adverse Event|0|||
160886690|NCT02038829|580980548|FG009|Washout Period 4|Adverse Event|0|||
160886691|NCT02038829|580980549|FG010|Washout Period 4|Adverse Event|0|||
160886692|NCT02038829|580980550|FG011|Washout Period 4|Adverse Event|0|||
160886693|NCT02038829|580980539|FG000|Treatment Period 6|Adverse Event|0|||
160886694|NCT02038829|580980540|FG001|Treatment Period 6|Adverse Event|0|||
160886695|NCT02038829|580980541|FG002|Treatment Period 6|Adverse Event|1|||
160886696|NCT02038829|580980542|FG003|Treatment Period 6|Adverse Event|0|||
160886697|NCT02038829|580980543|FG004|Treatment Period 6|Adverse Event|0|||
160886698|NCT02038829|580980544|FG005|Treatment Period 6|Adverse Event|0|||
160886699|NCT02038829|580980545|FG006|Treatment Period 6|Adverse Event|0|||
160886700|NCT02038829|580980546|FG007|Treatment Period 6|Adverse Event|0|||
160886701|NCT02038829|580980547|FG008|Treatment Period 6|Adverse Event|0|||
160886702|NCT02038829|580980548|FG009|Treatment Period 6|Adverse Event|0|||
160886703|NCT02038829|580980549|FG010|Treatment Period 6|Adverse Event|0|||
160886704|NCT02038829|580980550|FG011|Treatment Period 6|Adverse Event|0|||
160886705|NCT00749580|580980551|FG000|Overall Study|Lost to Follow-up|4|||
160886706|NCT00749580|580980552|FG001|Overall Study|Lost to Follow-up|8|||
160886707|NCT00749580|580980551|FG000|Overall Study|Adverse Event|0|||
160886708|NCT00749580|580980552|FG001|Overall Study|Adverse Event|1|||
160886709|NCT05128929|580980554|FG000|Overall Study|Adverse Event|0|||
160886710|NCT05128929|580980555|FG001|Overall Study|Adverse Event|1|||
160886711|NCT03553836|580980558|FG000|Overall Study|Ongoing in Study|460|||
160886712|NCT03553836|580980559|FG001|Overall Study|Ongoing in Study|459|||
160886713|NCT03553836|580980558|FG000|Overall Study|Withdrawal by Subject|9|||
160886714|NCT03553836|580980559|FG001|Overall Study|Withdrawal by Subject|10|||
161122821|NCT03713944|581835262|FG000|Follow up|Death|11|||
161122822|NCT03713944|581835262|FG000|Follow up|Study Terminated|3|||
160886715|NCT03553836|580980558|FG000|Overall Study|Lost to Follow-up|1|||
160886716|NCT03553836|580980559|FG001|Overall Study|Lost to Follow-up|3|||
160886717|NCT03553836|580980558|FG000|Overall Study|Death|17|||
160886718|NCT03553836|580980559|FG001|Overall Study|Death|17|||
161122823|NCT00720109|581835279|FG000|Induction Period|Did not meet eligibility criteria|3|||
160886719|NCT05660850|580980560|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
160886720|NCT05660850|580980561|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
160886721|NCT05660850|580980562|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
160886722|NCT05660850|580980563|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
161228678|NCT01074554|582218621|FG000|Overall Study|Adverse Event|3|||
160886723|NCT02604017|580980564|FG000|Overall Study|Withdrew Consent|0|||
160886724|NCT02604017|580980565|FG001|Overall Study|Withdrew Consent|2|||
160886725|NCT02604017|580980564|FG000|Overall Study|Lost to Follow-up|5|||
160886726|NCT02604017|580980565|FG001|Overall Study|Lost to Follow-up|6|||
160886727|NCT02604017|580980564|FG000|Overall Study|Other|1|||
160886728|NCT02604017|580980565|FG001|Overall Study|Other|0|||
160886729|NCT01653782|580980571|FG000|Overall Study|Withdrawal by Subject|9|||
160886730|NCT01653782|580980572|FG001|Overall Study|Withdrawal by Subject|15|||
160886731|NCT01653782|580980573|FG002|Overall Study|Withdrawal by Subject|4|||
160886732|NCT01653782|580980571|FG000|Overall Study|Lost to Follow-up|7|||
160886733|NCT01653782|580980572|FG001|Overall Study|Lost to Follow-up|3|||
160886734|NCT01653782|580980573|FG002|Overall Study|Lost to Follow-up|2|||
160886735|NCT01315236|580980577|FG000|Double-blind Phase|Death|1|||
160886736|NCT01315236|580980578|FG001|Double-blind Phase|Death|0|||
160886737|NCT01315236|580980577|FG000|Double-blind Phase|Adverse Event|1|||
160886738|NCT01315236|580980578|FG001|Double-blind Phase|Adverse Event|0|||
160886739|NCT01315236|580980577|FG000|Double-blind Phase|Withdrawal of Consent|1|||
160886740|NCT01315236|580980578|FG001|Double-blind Phase|Withdrawal of Consent|0|||
160886741|NCT01315236|580980577|FG000|Double-blind Phase|Lost to Follow-up|1|||
160886742|NCT01315236|580980578|FG001|Double-blind Phase|Lost to Follow-up|0|||
160886743|NCT01315236|580980577|FG000|Open-label Phase|Death|1|||
160886744|NCT01315236|580980578|FG001|Open-label Phase|Death|0|||
160886745|NCT01315236|580980577|FG000|Open-label Phase|Adverse Event|0|||
160886746|NCT01315236|580980578|FG001|Open-label Phase|Adverse Event|1|||
160886747|NCT01315236|580980577|FG000|Open-label Phase|Other|0|||
160886748|NCT01315236|580980578|FG001|Open-label Phase|Other|1|||
160886749|NCT01315236|580980577|FG000|12-Month Follow-up Period|Death|0|||
160886750|NCT01315236|580980578|FG001|12-Month Follow-up Period|Death|1|||
160886751|NCT01315236|580980577|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
160886752|NCT01315236|580980578|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
160886753|NCT02497976|580980581|FG000|Overall Study|Withdrawal by Subject|2|||
160886754|NCT02497976|580980582|FG001|Overall Study|Withdrawal by Subject|0|||
160886755|NCT02497976|580980581|FG000|Overall Study|Moved out of area|0|||
160886756|NCT02497976|580980582|FG001|Overall Study|Moved out of area|1|||
160886757|NCT00058539|580980586|FG000|Overall Study|Disease progression|24|||
160886758|NCT00058539|580980586|FG000|Overall Study|Adverse Event|3|||
160886759|NCT00058539|580980586|FG000|Overall Study|Withdrawal by Subject|5|||
160886760|NCT00058539|580980586|FG000|Overall Study|Physician Decision|9|||
160886761|NCT00058539|580980586|FG000|Overall Study|Death|1|||
160886762|NCT02483533|580980587|FG000|Overall Study|Lack of Efficacy|50|||
160886763|NCT02483533|580980588|FG001|Overall Study|Lack of Efficacy|50|||
160886764|NCT01323920|580980589|FG000|Overall Study|Death|5|||
160886765|NCT01323920|580980589|FG000|Overall Study|Withdrawal by Subject|1|||
160886766|NCT02283177|580980592|FG000|Overall Study|Withdrawal by Subject|1|||
160886767|NCT02283177|580980593|FG001|Overall Study|Withdrawal by Subject|1|||
160886768|NCT00327470|580980601|FG000|Overall Study|Randomized, but not treated|0|||
160886769|NCT00327470|580980602|FG001|Overall Study|Randomized, but not treated|2|||
160886770|NCT00327470|580980601|FG000|Overall Study|Adverse Event|9|||
160886771|NCT00327470|580980602|FG001|Overall Study|Adverse Event|14|||
160886772|NCT00327470|580980601|FG000|Overall Study|Lack of Efficacy|7|||
160886773|NCT00327470|580980602|FG001|Overall Study|Lack of Efficacy|19|||
160886774|NCT00327470|580980601|FG000|Overall Study|Other|5|||
160886775|NCT00327470|580980602|FG001|Overall Study|Other|9|||
160886776|NCT00327470|580980601|FG000|Overall Study|Lost to Follow-up|1|||
160886777|NCT00327470|580980602|FG001|Overall Study|Lost to Follow-up|3|||
160886778|NCT00327470|580980601|FG000|Overall Study|Withdrawal by Subject|6|||
160886779|NCT00327470|580980602|FG001|Overall Study|Withdrawal by Subject|12|||
160886780|NCT00327470|580980601|FG000|Overall Study|Death|1|||
160886781|NCT00327470|580980602|FG001|Overall Study|Death|4|||
160886782|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
160886783|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
160886784|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
160886785|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
160886786|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
160886787|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
160886788|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886789|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
160886790|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886791|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886792|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886793|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
160886794|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
160886795|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
160886796|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
160886797|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
160886798|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
161228679|NCT01074554|582218622|FG001|Overall Study|Adverse Event|3|||
160886799|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
160886800|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160886801|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
160886802|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160886803|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161122824|NCT00720109|581835280|FG001|Induction Period|Did not meet eligibility criteria|0|||
161122825|NCT00720109|581835281|FG002|Induction Period|Did not meet eligibility criteria|0|||
161122826|NCT00720109|581835279|FG000|Induction Period|Bone Marrow Transplant|2|||
161122827|NCT00720109|581835280|FG001|Induction Period|Bone Marrow Transplant|0|||
161122828|NCT00720109|581835281|FG002|Induction Period|Bone Marrow Transplant|0|||
161122829|NCT00720109|581835279|FG000|Induction Period|Physician Decision|1|||
161122830|NCT00720109|581835280|FG001|Induction Period|Physician Decision|0|||
161122831|NCT00720109|581835281|FG002|Induction Period|Physician Decision|0|||
161122832|NCT00720109|581835279|FG000|Risk Stratification Period|Adverse Event|0|||
161122833|NCT00720109|581835280|FG001|Risk Stratification Period|Adverse Event|1|||
161122834|NCT00720109|581835281|FG002|Risk Stratification Period|Adverse Event|0|||
161122835|NCT00720109|581835279|FG000|Risk Stratification Period|Physician Decision|0|||
161122836|NCT00720109|581835280|FG001|Risk Stratification Period|Physician Decision|2|||
161122837|NCT00720109|581835281|FG002|Risk Stratification Period|Physician Decision|1|||
161122838|NCT00720109|581835279|FG000|Risk Stratification Period|Bone marrow transplant|0|||
161122839|NCT00720109|581835280|FG001|Risk Stratification Period|Bone marrow transplant|9|||
161122840|NCT00720109|581835281|FG002|Risk Stratification Period|Bone marrow transplant|7|||
161122841|NCT00720109|581835279|FG000|Risk Stratification Period|Disease progression or relapse|0|||
161122842|NCT00720109|581835280|FG001|Risk Stratification Period|Disease progression or relapse|2|||
161122843|NCT00720109|581835281|FG002|Risk Stratification Period|Disease progression or relapse|0|||
161122844|NCT00720109|581835279|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
161122845|NCT00720109|581835280|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
161122846|NCT00720109|581835281|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
161122847|NCT02665286|581835284|FG000|Overall Study|Lost to Follow-up|3|||
161122848|NCT02665286|581835285|FG001|Overall Study|Lost to Follow-up|2|||
161122849|NCT02665286|581835286|FG002|Overall Study|Lost to Follow-up|1|||
161122850|NCT04899232|581835296|FG000|Screening Period|Physician Decision|1|||
161122851|NCT04899232|581835297|FG001|Screening Period|Physician Decision|0|||
161122852|NCT04899232|581835298|FG002|Screening Period|Physician Decision|0|||
161122853|NCT04899232|581835296|FG000|Screening Period|Withdrawal by Subject|1|||
161122854|NCT04899232|581835297|FG001|Screening Period|Withdrawal by Subject|0|||
161122855|NCT04899232|581835298|FG002|Screening Period|Withdrawal by Subject|0|||
161122856|NCT04899232|581835296|FG000|Screening Period|Participant discharged before receiving intervention|3|||
161142629|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
160886804|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
161122857|NCT04899232|581835297|FG001|Screening Period|Participant discharged before receiving intervention|0|||
160886805|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
160886806|NCT00745615|580980609|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
161228680|NCT01074554|582218621|FG000|Overall Study|Lost to Follow-up|0|||
160886807|NCT00745615|580980610|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
160886808|NCT00745615|580980611|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160886809|NCT00745615|580980612|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160886810|NCT00745615|580980613|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160886811|NCT00745615|580980614|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
160886812|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886813|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886814|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886815|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
160886816|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
160886817|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
160886818|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886819|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886820|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886821|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
160886822|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
160886823|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
160886824|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886825|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886826|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886827|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
160886828|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
161228681|NCT01074554|582218622|FG001|Overall Study|Lost to Follow-up|1|||
161228682|NCT00497796|582218623|FG000|Overall Study|Adverse event (not related)|9|||
161228683|NCT00497796|582218624|FG001|Overall Study|Adverse event (not related)|9|||
161122858|NCT04899232|581835298|FG002|Screening Period|Participant discharged before receiving intervention|0|||
161122859|NCT02553460|581835299|FG000|Overall Study|Death|3|||
161122860|NCT02553460|581835299|FG000|Overall Study|Withdrawal by Subject|1|||
161122861|NCT02553460|581835299|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
161122862|NCT02553460|581835299|FG000|Overall Study|Relapse or Transplant|14|||
161122863|NCT02553460|581835299|FG000|Overall Study|No response to treatment|2|||
161122864|NCT02553460|581835299|FG000|Overall Study|CAR T cells|2|||
161122865|NCT03505021|581835300|FG000|Overall Study|Protocol Violation|1|||
161122866|NCT03505021|581835301|FG001|Overall Study|Protocol Violation|0|||
161122867|NCT03505021|581835300|FG000|Overall Study|Death|9|||
161122868|NCT03505021|581835301|FG001|Overall Study|Death|8|||
161122869|NCT03505021|581835300|FG000|Overall Study|Consent withdrawn by subject|6|||
161122870|NCT03505021|581835301|FG001|Overall Study|Consent withdrawn by subject|1|||
161122871|NCT03505021|581835300|FG000|Overall Study|Lost to Follow-up|5|||
161122872|NCT03505021|581835301|FG001|Overall Study|Lost to Follow-up|3|||
161122873|NCT03505021|581835300|FG000|Overall Study|Adverse Event|26|||
161122874|NCT03505021|581835301|FG001|Overall Study|Adverse Event|9|||
161228684|NCT00497796|582218623|FG000|Overall Study|Adverse event (related)|5|||
161228685|NCT00497796|582218624|FG001|Overall Study|Adverse event (related)|4|||
161228686|NCT00497796|582218623|FG000|Overall Study|CMV infection or disease treatment|30|||
161228687|NCT00497796|582218624|FG001|Overall Study|CMV infection or disease treatment|4|||
161122875|NCT03505021|581835300|FG000|Overall Study|Disease progression|33|||
161122876|NCT03505021|581835301|FG001|Overall Study|Disease progression|17|||
161122877|NCT03505021|581835300|FG000|Overall Study|Other|11|||
161122878|NCT03505021|581835301|FG001|Overall Study|Other|5|||
161122879|NCT03505021|581835300|FG000|Overall Study|Personal reason|21|||
161228688|NCT00497796|582218623|FG000|Overall Study|Consent withdrawn|10|||
161228689|NCT00497796|582218624|FG001|Overall Study|Consent withdrawn|3|||
161228690|NCT00497796|582218623|FG000|Overall Study|Investigator/sponsor discretion|31|||
161228691|NCT00497796|582218624|FG001|Overall Study|Investigator/sponsor discretion|34|||
161228692|NCT00497796|582218623|FG000|Overall Study|Lost to Follow-up|0|||
161228693|NCT00497796|582218624|FG001|Overall Study|Lost to Follow-up|1|||
161228694|NCT00497796|582218623|FG000|Overall Study|Not applicable (randomized not treated)|0|||
161228695|NCT00497796|582218624|FG001|Overall Study|Not applicable (randomized not treated)|4|||
161228696|NCT01856309|582218628|FG000|Overall Study|Death|4|||
161228697|NCT01856309|582218629|FG001|Overall Study|Death|6|||
161228698|NCT01856309|582218630|FG002|Overall Study|Death|11|||
161228699|NCT01856309|582218631|FG003|Overall Study|Death|6|||
161228700|NCT01856309|582218628|FG000|Overall Study|Lost to Follow-up|6|||
161228701|NCT01856309|582218629|FG001|Overall Study|Lost to Follow-up|2|||
161228702|NCT01856309|582218630|FG002|Overall Study|Lost to Follow-up|4|||
161228703|NCT01856309|582218631|FG003|Overall Study|Lost to Follow-up|8|||
161228704|NCT01856309|582218628|FG000|Overall Study|Withdrawal by Subject|11|||
161228705|NCT01856309|582218629|FG001|Overall Study|Withdrawal by Subject|13|||
161228706|NCT01856309|582218630|FG002|Overall Study|Withdrawal by Subject|28|||
161228707|NCT01856309|582218631|FG003|Overall Study|Withdrawal by Subject|26|||
161228708|NCT01856309|582218628|FG000|Overall Study|Other|227|||
161228709|NCT01856309|582218629|FG001|Overall Study|Other|225|||
161228710|NCT01856309|582218630|FG002|Overall Study|Other|447|||
161228711|NCT01856309|582218631|FG003|Overall Study|Other|469|||
161228712|NCT01856309|582218628|FG000|Overall Study|Lack of Efficacy|14|||
161228713|NCT01856309|582218629|FG001|Overall Study|Lack of Efficacy|9|||
161228714|NCT01856309|582218630|FG002|Overall Study|Lack of Efficacy|40|||
161228715|NCT01856309|582218631|FG003|Overall Study|Lack of Efficacy|25|||
161228716|NCT01856309|582218628|FG000|Overall Study|Adverse Event|31|||
161228717|NCT01856309|582218629|FG001|Overall Study|Adverse Event|31|||
161228718|NCT01856309|582218630|FG002|Overall Study|Adverse Event|55|||
161228719|NCT01856309|582218631|FG003|Overall Study|Adverse Event|65|||
161228720|NCT01856309|582218628|FG000|Overall Study|Pregnancy|0|||
161228721|NCT01856309|582218629|FG001|Overall Study|Pregnancy|0|||
161228722|NCT01856309|582218630|FG002|Overall Study|Pregnancy|0|||
161228723|NCT01856309|582218631|FG003|Overall Study|Pregnancy|1|||
161228724|NCT01856309|582218628|FG000|Overall Study|Physician Decision|6|||
161122880|NCT03505021|581835301|FG001|Overall Study|Personal reason|12|||
161122881|NCT01191697|581837405|FG000|Overall Study|Death|1|||
161122882|NCT01191697|581837405|FG000|Overall Study|Physician Decision|2|||
161122883|NCT01191697|581837405|FG000|Overall Study|Pursue chemoradiation|2|||
161122884|NCT01191697|581837405|FG000|Overall Study|Break from chemotherapy|2|||
161122885|NCT01191697|581837405|FG000|Overall Study|Withdrawal by Subject|1|||
161122886|NCT01191697|581837405|FG000|Overall Study|Surveillance|1|||
161122887|NCT01191697|581837405|FG000|Overall Study|Adverse Event|2|||
161122888|NCT01191697|581837405|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
161122889|NCT01191697|581837405|FG000|Overall Study|Not completed but analyzed|25|||
161228725|NCT01856309|582218629|FG001|Overall Study|Physician Decision|1|||
161228726|NCT01856309|582218630|FG002|Overall Study|Physician Decision|6|||
161228727|NCT01856309|582218631|FG003|Overall Study|Physician Decision|8|||
161228728|NCT01856309|582218628|FG000|Overall Study|Noncompliance With Study Drug|0|||
161228729|NCT01856309|582218629|FG001|Overall Study|Noncompliance With Study Drug|1|||
161228730|NCT01856309|582218630|FG002|Overall Study|Noncompliance With Study Drug|4|||
161228731|NCT01856309|582218631|FG003|Overall Study|Noncompliance With Study Drug|1|||
161228732|NCT00832377|582218634|FG000|Overall Study|Protocol Violation|1|||
161228733|NCT00220337|582218635|FG000|Overall Study|Adverse Event|70|||
161228734|NCT00220337|582218635|FG000|Overall Study|Lack of Efficacy|17|||
161228735|NCT00220337|582218635|FG000|Overall Study|Withdrawal by Subject|68|||
161228736|NCT00220337|582218635|FG000|Overall Study|Protocol Violation|2|||
161228737|NCT00220337|582218635|FG000|Overall Study|Lost to Follow-up|5|||
161228738|NCT00220337|582218635|FG000|Overall Study|Other|12|||
161228739|NCT00220337|582218635|FG000|Overall Study|Unsatisfactory compliance|5|||
161228740|NCT01273181|582218636|FG000|Phase I, Dose 1|Study termination|1|||
161228741|NCT01273181|582218637|FG001|Phase I, Dose 1|Study termination|0|||
161228742|NCT01273181|582218638|FG002|Phase I, Dose 1|Study termination|0|||
161228743|NCT01273181|582218639|FG003|Phase I, Dose 1|Study termination|0|||
161228744|NCT01273181|582218636|FG000|Phase I, Dose 2|Death during treatment|0|||
161228745|NCT01273181|582218637|FG001|Phase I, Dose 2|Death during treatment|1|||
161228746|NCT01273181|582218638|FG002|Phase I, Dose 2|Death during treatment|0|||
161228747|NCT01273181|582218639|FG003|Phase I, Dose 2|Death during treatment|0|||
161228748|NCT01273181|582218636|FG000|Phase 2, Dose 1|Study termination|0|||
161228749|NCT01273181|582218637|FG001|Phase 2, Dose 1|Study termination|0|||
161228750|NCT01273181|582218638|FG002|Phase 2, Dose 1|Study termination|1|||
161228751|NCT01273181|582218639|FG003|Phase 2, Dose 1|Study termination|0|||
161228752|NCT01273181|582218636|FG000|Phase 2, Dose 2|Death during treatment|0|||
161228753|NCT01273181|582218637|FG001|Phase 2, Dose 2|Death during treatment|0|||
161228754|NCT01273181|582218638|FG002|Phase 2, Dose 2|Death during treatment|0|||
161228755|NCT01273181|582218639|FG003|Phase 2, Dose 2|Death during treatment|1|||
161228756|NCT00944697|582218640|FG000|Overall Study|Withdrawal by Subject|1|||
161228757|NCT00944697|582218641|FG001|Overall Study|Withdrawal by Subject|1|||
161228758|NCT00944697|582218640|FG000|Overall Study|Adverse Event|0|||
161228759|NCT00944697|582218641|FG001|Overall Study|Adverse Event|3|||
161228760|NCT00944697|582218640|FG000|Overall Study|Administrative|1|||
161228761|NCT00944697|582218641|FG001|Overall Study|Administrative|1|||
161228762|NCT04276883|582218642|FG000|Overall Study|Withdrawal by Subject|2|||
161228763|NCT04276883|582218643|FG001|Overall Study|Withdrawal by Subject|3|||
161228764|NCT04276883|582218644|FG002|Overall Study|Withdrawal by Subject|6|||
160886829|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
160886830|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
161228765|NCT04276883|582218642|FG000|Overall Study|Lost to Follow-up|1|||
161228766|NCT04276883|582218643|FG001|Overall Study|Lost to Follow-up|3|||
161228767|NCT04276883|582218644|FG002|Overall Study|Lost to Follow-up|0|||
161228768|NCT04276883|582218642|FG000|Overall Study|Adverse Event|0|||
161228769|NCT04276883|582218643|FG001|Overall Study|Adverse Event|1|||
161228770|NCT04276883|582218644|FG002|Overall Study|Adverse Event|0|||
161228771|NCT04276883|582218642|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
161228772|NCT04276883|582218643|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
161228773|NCT04276883|582218644|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
161228774|NCT01876706|582218645|FG000|Overall Study|BPH Intervention|9|||
161228775|NCT01876706|582218645|FG000|Overall Study|Lost to Follow-up|7|||
161228776|NCT01876706|582218645|FG000|Overall Study|Withdrawals|6|||
161228777|NCT01876706|582218645|FG000|Overall Study|Death|3|||
161228778|NCT00604500|582218646|FG000|Overall Study|Adverse Event|2|||
161228779|NCT00604500|582218646|FG000|Overall Study|Protocol Violation|2|||
161228780|NCT00604500|582218646|FG000|Overall Study|Treatment Failure|1|||
161122890|NCT01534676|581837406|FG000|Overall Study|Study closed due to poor enrollment|2|||
161122891|NCT01534676|581837407|FG001|Overall Study|Study closed due to poor enrollment|1|||
161122892|NCT02634580|581837408|FG000|Double-blind Treatment Period|Subject Request|1|||
161122893|NCT02634580|581837409|FG001|Double-blind Treatment Period|Subject Request|0|||
161122894|NCT02634580|581837410|FG002|Double-blind Treatment Period|Subject Request|1|||
161122895|NCT02634580|581837411|FG003|Double-blind Treatment Period|Subject Request|1|||
161122896|NCT02634580|581837408|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161122897|NCT02634580|581837409|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
161122898|NCT02634580|581837410|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161122899|NCT02634580|581837411|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
161122900|NCT00424827|581837414|FG000|Overall Study|Adverse Event|1|||
161122901|NCT02397473|581837417|FG000|Treatment Phase|Adverse Event|1|||
161122902|NCT02397473|581837418|FG001|Treatment Phase|Adverse Event|2|||
161122903|NCT02397473|581837417|FG000|Treatment Phase|Lack of Efficacy|8|||
161122904|NCT02397473|581837418|FG001|Treatment Phase|Lack of Efficacy|1|||
161122905|NCT02397473|581837417|FG000|Treatment Phase|Lost to Follow-up|1|||
161122906|NCT02397473|581837418|FG001|Treatment Phase|Lost to Follow-up|0|||
161122907|NCT02397473|581837417|FG000|Treatment Phase|Withdrawal by Subject|2|||
160886831|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
161122908|NCT02397473|581837418|FG001|Treatment Phase|Withdrawal by Subject|1|||
161122909|NCT02397473|581837417|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
161122910|NCT02397473|581837418|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
161122911|NCT02397473|581837417|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
161122912|NCT02397473|581837418|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
161122913|NCT02397473|581837417|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
161122914|NCT02397473|581837418|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161228781|NCT00604500|582218646|FG000|Overall Study|Withdrawal by Subject|4|||
161228782|NCT00604500|582218646|FG000|Overall Study|Administrative|1|||
161228783|NCT00604500|582218646|FG000|Overall Study|Did not meet protocol eligibility|1|||
161228784|NCT02468778|582218652|FG000|Overall Study|Death|2|||
161228785|NCT02468778|582218653|FG001|Overall Study|Death|1|||
161228786|NCT02468778|582218654|FG002|Overall Study|Death|0|||
161228787|NCT02468778|582218652|FG000|Overall Study|Lost to Follow-up|1|||
161228788|NCT02468778|582218653|FG001|Overall Study|Lost to Follow-up|2|||
161228789|NCT02468778|582218654|FG002|Overall Study|Lost to Follow-up|2|||
161228790|NCT02468778|582218652|FG000|Overall Study|Withdrawal by Subject|0|||
161228791|NCT02468778|582218653|FG001|Overall Study|Withdrawal by Subject|1|||
161228792|NCT02468778|582218654|FG002|Overall Study|Withdrawal by Subject|1|||
161228793|NCT02458469|582218658|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161228794|NCT02458469|582218659|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161228795|NCT02458469|582218660|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161228796|NCT02458469|582218661|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161228797|NCT02458469|582218662|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161228798|NCT02458469|582218663|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161228799|NCT02458469|582218658|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
161228800|NCT02458469|582218659|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
161228801|NCT02458469|582218660|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
161228802|NCT02458469|582218661|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
161228803|NCT02458469|582218662|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
161228804|NCT02458469|582218663|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
161228805|NCT02458469|582218658|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161228806|NCT02458469|582218659|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161228807|NCT02458469|582218660|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161228808|NCT02458469|582218661|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161228809|NCT02458469|582218662|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
161228810|NCT02458469|582218663|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
161228811|NCT00661505|582218665|FG000|Overall Study|Adverse Event|3|||
161228812|NCT00661505|582218665|FG000|Overall Study|Protocol Violation|14|||
161228813|NCT00661505|582218665|FG000|Overall Study|Withdrawal by Subject|8|||
161228814|NCT00661505|582218665|FG000|Overall Study|Lost to Follow-up|3|||
161228815|NCT00661505|582218665|FG000|Overall Study|Other|2|||
161228816|NCT02603952|582218677|FG000|Overall Study|Withdrawal by Subject|1|||
161228817|NCT02603952|582218678|FG001|Overall Study|Withdrawal by Subject|0|||
161228818|NCT02603952|582218679|FG002|Overall Study|Withdrawal by Subject|0|||
161228819|NCT02603952|582218680|FG003|Overall Study|Withdrawal by Subject|0|||
161228820|NCT02603952|582218677|FG000|Overall Study|Received oseltamivir by error|0|||
161228821|NCT02603952|582218678|FG001|Overall Study|Received oseltamivir by error|0|||
161228822|NCT02603952|582218679|FG002|Overall Study|Received oseltamivir by error|0|||
161228823|NCT02603952|582218680|FG003|Overall Study|Received oseltamivir by error|1|||
161228824|NCT03283709|582218691|FG000|Overall Study|trial terminated|0|||
161228825|NCT03283709|582218692|FG001|Overall Study|trial terminated|1|||
161228826|NCT01347710|582218696|FG000|Overall Study|Withdrawal by Subject|2|||
161228827|NCT01347710|582218696|FG000|Overall Study|Adverse Event|4|||
161228828|NCT01347710|582218696|FG000|Overall Study|Angio or SPECT not completed|18|||
161228829|NCT01347710|582218696|FG000|Overall Study|issue with vitals prior to dosing|1|||
161228830|NCT01347710|582218696|FG000|Overall Study|Lost to Follow-up|1|||
161228831|NCT01347710|582218696|FG000|Overall Study|Physician Decision|2|||
161228832|NCT01347710|582218696|FG000|Overall Study|Other|3|||
161325849|NCT01971567|582579602|FG000|Overall Study|Withdrawal by Subject|3|||
161228833|NCT04591626|582218698|FG000|Overall Study|Adverse Event|4|||
160886832|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
160886833|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
160886834|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
160886835|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
161122915|NCT02397473|581837417|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
161122916|NCT02397473|581837418|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
161122917|NCT02397473|581837417|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161122918|NCT02397473|581837418|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161122919|NCT00491179|581837419|FG000|Overall Study|Adverse Event|5|||
161122920|NCT00491179|581837420|FG001|Overall Study|Adverse Event|1|||
161122921|NCT00491179|581837419|FG000|Overall Study|Withdrawal by Subject|2|||
161122922|NCT00491179|581837420|FG001|Overall Study|Withdrawal by Subject|1|||
161122923|NCT02009878|581837422|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
161122924|NCT02009878|581837423|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
161122925|NCT02009878|581837424|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
161122926|NCT01790048|581837425|FG000|Overall Study|Incorrect Age|9|||
161122927|NCT01790048|581837426|FG001|Overall Study|Incorrect Age|14|||
161122928|NCT01790048|581837425|FG000|Overall Study|data entry error|0|||
161122929|NCT01790048|581837426|FG001|Overall Study|data entry error|1|||
161122930|NCT01790048|581837425|FG000|Overall Study|Other|0|||
161122931|NCT01790048|581837426|FG001|Overall Study|Other|2|||
161122932|NCT01790048|581837425|FG000|Overall Study|SAM at Enrollment|2|||
161122933|NCT01790048|581837426|FG001|Overall Study|SAM at Enrollment|0|||
161122934|NCT01790048|581837425|FG000|Overall Study|Measurement error|1|||
161122935|NCT01790048|581837426|FG001|Overall Study|Measurement error|0|||
161122936|NCT01491178|581837427|FG000|Overall Study|Adverse Event|1016|||
161122937|NCT01491178|581837427|FG000|Overall Study|Improvement of NVAF|210|||
161122938|NCT01491178|581837427|FG000|Overall Study|To conduct invasive treatment|59|||
161122939|NCT01491178|581837427|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
161122940|NCT01491178|581837427|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
160777121|NCT04766333|580568331|FG000|Overall Study|Lost to Follow-up|40|||
160777122|NCT04766333|580568332|FG001|Overall Study|Lost to Follow-up|826|||
160777123|NCT00639379|580568333|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
160777124|NCT00639379|580568334|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
160777125|NCT00639379|580568333|FG000|Period 1 - 2 Weeks|lens issue|3|||
160777126|NCT00639379|580568334|FG001|Period 1 - 2 Weeks|lens issue|0|||
160777138|NCT03600428|580568340|FG000|Overall Study|Not eligible|0|||
160777139|NCT03600428|580568341|FG001|Overall Study|Not eligible|1|||
160777140|NCT03600428|580568340|FG000|Overall Study|Lost to Follow-up|5|||
160777141|NCT03600428|580568341|FG001|Overall Study|Lost to Follow-up|4|||
160777142|NCT00770484|580568342|FG000|Overall Study|Withdrawal by Subject|1|||
160777143|NCT00770484|580568343|FG001|Overall Study|Withdrawal by Subject|0|||
160777144|NCT01666652|580568351|FG000|Overall Study|Serious Adverse Event|0|||
161122941|NCT01491178|581837427|FG000|Overall Study|To take a contraindication|20|||
161122942|NCT01491178|581837427|FG000|Overall Study|Other than specified above|657|||
160777145|NCT01666652|580568352|FG001|Overall Study|Serious Adverse Event|0|||
160777146|NCT01666652|580568353|FG002|Overall Study|Serious Adverse Event|0|||
160777147|NCT01666652|580568354|FG003|Overall Study|Serious Adverse Event|1|||
160777148|NCT01666652|580568355|FG004|Overall Study|Serious Adverse Event|0|||
160777149|NCT01666652|580568351|FG000|Overall Study|Withdrawal by Subject|0|||
160777150|NCT01666652|580568352|FG001|Overall Study|Withdrawal by Subject|0|||
160777151|NCT01666652|580568353|FG002|Overall Study|Withdrawal by Subject|0|||
160777152|NCT01666652|580568354|FG003|Overall Study|Withdrawal by Subject|0|||
160777153|NCT01666652|580568355|FG004|Overall Study|Withdrawal by Subject|1|||
160777154|NCT01666652|580568351|FG000|Overall Study|Moved from study area|1|||
160777155|NCT01666652|580568352|FG001|Overall Study|Moved from study area|0|||
160777156|NCT01666652|580568353|FG002|Overall Study|Moved from study area|0|||
160777157|NCT01666652|580568354|FG003|Overall Study|Moved from study area|2|||
160777158|NCT01666652|580568355|FG004|Overall Study|Moved from study area|0|||
160777159|NCT01666652|580568351|FG000|Overall Study|Lost to Follow-up|1|||
160777160|NCT01666652|580568352|FG001|Overall Study|Lost to Follow-up|1|||
160777161|NCT01666652|580568353|FG002|Overall Study|Lost to Follow-up|1|||
160777162|NCT01666652|580568354|FG003|Overall Study|Lost to Follow-up|1|||
160777163|NCT01666652|580568355|FG004|Overall Study|Lost to Follow-up|0|||
160777164|NCT00088153|580568356|FG000|Overall Study|Physician Decision|3|||
160777165|NCT00088153|580568357|FG001|Overall Study|Physician Decision|3|||
160777166|NCT00088153|580568356|FG000|Overall Study|Withdrawal by Subject|10|||
160777167|NCT00088153|580568357|FG001|Overall Study|Withdrawal by Subject|10|||
160777168|NCT00088153|580568356|FG000|Overall Study|Lost to Follow-up|11|||
160777169|NCT00088153|580568357|FG001|Overall Study|Lost to Follow-up|12|||
160777178|NCT01757847|580568365|FG000|Overall Study|Withdrawal by Subject|3|||
160777179|NCT01757847|580568366|FG001|Overall Study|Withdrawal by Subject|4|||
160777180|NCT01063114|580568367|FG000|Overall Study|Lost to Follow-up|1|||
160886836|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
160886837|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
160886838|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
161122943|NCT05689047|581837430|FG000|Overall Study|Lost to Follow-up|0|||
161122944|NCT05689047|581837431|FG001|Overall Study|Lost to Follow-up|1|||
161122945|NCT05689047|581837430|FG000|Overall Study|Protocol Deviation|1|||
161122946|NCT05689047|581837431|FG001|Overall Study|Protocol Deviation|0|||
161122947|NCT01604512|581837432|FG000|Overall Study|Withdrawal by Subject|3|||
161228834|NCT04591626|582218699|FG001|Overall Study|Adverse Event|0|||
161228835|NCT04591626|582218698|FG000|Overall Study|Withdrawal by Subject|5|||
161228836|NCT04591626|582218699|FG001|Overall Study|Withdrawal by Subject|3|||
161228837|NCT04591626|582218698|FG000|Overall Study|Physician Decision|0|||
161228838|NCT04591626|582218699|FG001|Overall Study|Physician Decision|1|||
161228839|NCT04591626|582218698|FG000|Overall Study|Death|0|||
161228840|NCT04591626|582218699|FG001|Overall Study|Death|1|||
161228841|NCT04591626|582218698|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161228842|NCT04591626|582218699|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161228843|NCT01004172|582218701|FG000|Overall Study|Progressive Disease in CNS Only|16|||
161228844|NCT01004172|582218701|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
161228845|NCT01004172|582218701|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
161228846|NCT01004172|582218701|FG000|Overall Study|Adverse Event|1|||
161228847|NCT01004172|582218701|FG000|Overall Study|Physician Decision|1|||
161228848|NCT01004172|582218701|FG000|Overall Study|Symptomatic Deterioration|2|||
161228849|NCT02003183|582218705|FG000|Overall Study|Lost to Follow-up|0|||
161228850|NCT02003183|582218706|FG001|Overall Study|Lost to Follow-up|2|||
161228851|NCT00841100|582218711|FG000|Phase 1 (28 Days)|Adverse Event|1|||
161228852|NCT00841100|582218711|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
161228853|NCT03338972|582218712|FG000|Overall Study|Death|1|||
161228854|NCT03338972|582218713|FG001|Overall Study|Death|1|||
161228855|NCT03338972|582218714|FG002|Overall Study|Death|0|||
161228856|NCT03338972|582218715|FG003|Overall Study|Death|0|||
161228857|NCT03338972|582218712|FG000|Overall Study|Withdrawal by Subject|1|||
161228858|NCT03338972|582218713|FG001|Overall Study|Withdrawal by Subject|0|||
161228859|NCT03338972|582218714|FG002|Overall Study|Withdrawal by Subject|0|||
161228860|NCT03338972|582218715|FG003|Overall Study|Withdrawal by Subject|0|||
161228861|NCT01355081|582218716|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
161228862|NCT01355081|582218717|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161228863|NCT01355081|582218718|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161228864|NCT01355081|582218716|FG000|Overall Study|Major Protocol Deviation|0|||
161228865|NCT01355081|582218717|FG001|Overall Study|Major Protocol Deviation|1|||
161228866|NCT01355081|582218718|FG002|Overall Study|Major Protocol Deviation|0|||
161228867|NCT01355081|582218716|FG000|Overall Study|Lost to Follow-up|0|||
161228868|NCT01355081|582218717|FG001|Overall Study|Lost to Follow-up|0|||
161228869|NCT01355081|582218718|FG002|Overall Study|Lost to Follow-up|1|||
161228870|NCT01355081|582218716|FG000|Overall Study|Withdrawal of Consent|2|||
161228871|NCT01355081|582218717|FG001|Overall Study|Withdrawal of Consent|3|||
161228872|NCT01355081|582218718|FG002|Overall Study|Withdrawal of Consent|3|||
161228873|NCT01355081|582218716|FG000|Overall Study|Lack of Efficacy|2|||
161228874|NCT01355081|582218717|FG001|Overall Study|Lack of Efficacy|1|||
161228875|NCT01355081|582218718|FG002|Overall Study|Lack of Efficacy|1|||
161228876|NCT01355081|582218716|FG000|Overall Study|Non Compliance with Study Medication|0|||
161228877|NCT01355081|582218717|FG001|Overall Study|Non Compliance with Study Medication|1|||
161122948|NCT01604512|581837432|FG000|Overall Study|Not treated|4|||
161122949|NCT03132636|581837433|FG000|Overall Study|Adverse Event|1|||
161122950|NCT03132636|581837434|FG001|Overall Study|Adverse Event|2|||
161228878|NCT01355081|582218718|FG002|Overall Study|Non Compliance with Study Medication|0|||
161228879|NCT02719522|582218721|FG000|Overall Study|Implant Failure|4|||
161228880|NCT02719522|582218721|FG000|Overall Study|Death|2|||
161228881|NCT02719522|582218721|FG000|Overall Study|Lost to Follow-up|5|||
161228882|NCT06096168|582218722|FG000|Overall Study|Death|30|||
161228883|NCT06096168|582218722|FG000|Overall Study|Revision|2|||
161228884|NCT01868009|582218723|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
161228885|NCT01868009|582218724|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
161228886|NCT01868009|582218723|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
161228887|NCT01868009|582218724|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
161228888|NCT01868009|582218723|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
161228889|NCT01868009|582218724|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
161228890|NCT04603937|582218725|FG000|Overall Study|Adverse Event|9|||
161228891|NCT04603937|582218726|FG001|Overall Study|Adverse Event|10|||
160886839|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
161122951|NCT03132636|581837433|FG000|Overall Study|Death|4|||
161228892|NCT04603937|582218725|FG000|Overall Study|Withdrawal by Subject|7|||
161228893|NCT04603937|582218726|FG001|Overall Study|Withdrawal by Subject|6|||
161228894|NCT04603937|582218725|FG000|Overall Study|Lost to Follow-up|5|||
161228895|NCT04603937|582218726|FG001|Overall Study|Lost to Follow-up|6|||
161228896|NCT04603937|582218725|FG000|Overall Study|Physician Decision|0|||
161228897|NCT04603937|582218726|FG001|Overall Study|Physician Decision|1|||
161122952|NCT03132636|581837434|FG001|Overall Study|Death|7|||
161257864|NCT01197417|582323504|FG000|Overall Study|Site miscommunication|0|||
161257865|NCT01197417|582323505|FG001|Overall Study|Site miscommunication|1|||
161257866|NCT01197417|582323504|FG000|Overall Study|Subject transferred to intensive care|0|||
161228898|NCT04603937|582218725|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
161228899|NCT04603937|582218726|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
161228900|NCT00993616|582218727|FG000|Overall Study|No tumor at entry|1|||
161228901|NCT00993616|582218727|FG000|Overall Study|Never treated|1|||
161228902|NCT02585258|582218728|FG000|Overall Study|Adverse Event|28|||
161228903|NCT02585258|582218729|FG001|Overall Study|Adverse Event|29|||
161228904|NCT02585258|582218728|FG000|Overall Study|Death|3|||
161228905|NCT02585258|582218729|FG001|Overall Study|Death|2|||
161228906|NCT02585258|582218728|FG000|Overall Study|Lack of Efficacy|7|||
161228907|NCT02585258|582218729|FG001|Overall Study|Lack of Efficacy|9|||
161228908|NCT02585258|582218728|FG000|Overall Study|includes covid-related access problems|42|||
161228909|NCT02585258|582218729|FG001|Overall Study|includes covid-related access problems|46|||
161228910|NCT02585258|582218728|FG000|Overall Study|Lost to Follow-up|5|||
161228911|NCT02585258|582218729|FG001|Overall Study|Lost to Follow-up|2|||
161228912|NCT05125952|582218730|FG000|Overall Study|Physician Decision|1|||
161228913|NCT03946449|582218731|FG000|Treatment Extension II|Rolled over to another study|0|||
161228914|NCT03946449|582218732|FG001|Treatment Extension II|Rolled over to another study|0|||
161228915|NCT03946449|582218733|FG002|Treatment Extension II|Rolled over to another study|2|||
161228916|NCT03946449|582218731|FG000|Treatment Extension II|Withdrawal by Subject|0|||
161228917|NCT03946449|582218732|FG001|Treatment Extension II|Withdrawal by Subject|0|||
160777270|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
160777271|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
160777272|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
160777273|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
160777274|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
160777275|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
160777276|NCT04633447|580569859|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
160777277|NCT04633447|580569860|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
161122953|NCT03132636|581837433|FG000|Overall Study|Lost to Follow-up|3|||
161122954|NCT03132636|581837434|FG001|Overall Study|Lost to Follow-up|2|||
161122955|NCT03132636|581837433|FG000|Overall Study|Non compliance with protocol by participant|1|||
161122956|NCT03132636|581837434|FG001|Overall Study|Non compliance with protocol by participant|1|||
161122957|NCT03132636|581837433|FG000|Overall Study|Subject decision|1|||
161122958|NCT03132636|581837434|FG001|Overall Study|Subject decision|9|||
160777278|NCT04633447|580569859|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
160777279|NCT04633447|580569860|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
160777280|NCT04633447|580569859|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
160777281|NCT04633447|580569860|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
160777282|NCT04333498|580569861|FG000|Overall Study|Lost to Follow-up|1|||
160777283|NCT04333498|580569862|FG001|Overall Study|Lost to Follow-up|0|||
160777284|NCT04333498|580569861|FG000|Overall Study|Lost to Follow-up|0|||
160777285|NCT04333498|580569862|FG001|Overall Study|Lost to Follow-up|1|||
160777286|NCT01565694|580569863|FG000|Dose-Titration Period|Adverse Event|4|||
160777287|NCT01565694|580569863|FG000|Dose-Titration Period|Protocol Violation|10|||
160777288|NCT01565694|580569863|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
160777289|NCT05399771|580569864|FG000|Overall Study|Physician Decision|3|||
160886840|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
160886841|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
160886842|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886843|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886844|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886845|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
160886846|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
160886847|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
160886848|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886849|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886850|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886851|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886852|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
160886853|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
160886854|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886855|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886856|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886857|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886858|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
160886859|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
160886860|NCT00745615|580980609|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
161122959|NCT03132636|581837433|FG000|Overall Study|Sponsor decision|0|||
161122960|NCT03132636|581837434|FG001|Overall Study|Sponsor decision|1|||
161122961|NCT03132636|581837433|FG000|Overall Study|Physician Decision|1|||
161122962|NCT03132636|581837434|FG001|Overall Study|Physician Decision|0|||
161122963|NCT03132636|581837433|FG000|Overall Study|Progressive disease|33|||
161122964|NCT03132636|581837434|FG001|Overall Study|Progressive disease|36|||
161122965|NCT03132636|581837433|FG000|Overall Study|Withdrawal of consent|2|||
161122966|NCT03132636|581837434|FG001|Overall Study|Withdrawal of consent|5|||
161122967|NCT03132636|581837433|FG000|Overall Study|Did not re-consent|1|||
161122968|NCT03132636|581837434|FG001|Overall Study|Did not re-consent|0|||
161122969|NCT03132636|581837433|FG000|Overall Study|Lost insurance coverage|1|||
161122970|NCT03132636|581837434|FG001|Overall Study|Lost insurance coverage|0|||
161122971|NCT03132636|581837433|FG000|Overall Study|Related to radiological outcomes|0|||
161122972|NCT03132636|581837434|FG001|Overall Study|Related to radiological outcomes|1|||
161122973|NCT03132636|581837433|FG000|Overall Study|Unable to come to site for continued visits|0|||
161122974|NCT03132636|581837434|FG001|Overall Study|Unable to come to site for continued visits|1|||
161122975|NCT01415752|581837437|FG000|Induction (Step 1)|Ineligible|4|||
161122976|NCT01415752|581837438|FG001|Induction (Step 1)|Ineligible|3|||
161122977|NCT01415752|581837439|FG002|Induction (Step 1)|Ineligible|4|||
161122978|NCT01415752|581837440|FG003|Induction (Step 1)|Ineligible|4|||
161122979|NCT01415752|581837437|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
161122980|NCT01415752|581837438|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
161122981|NCT01415752|581837439|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
161122982|NCT01415752|581837440|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
161122983|NCT01415752|581837437|FG000|Maintenance (Step 2)|Adverse Event|3|||
161122984|NCT01415752|581837438|FG001|Maintenance (Step 2)|Adverse Event|4|||
161122985|NCT01415752|581837439|FG002|Maintenance (Step 2)|Adverse Event|9|||
161122986|NCT01415752|581837440|FG003|Maintenance (Step 2)|Adverse Event|6|||
161122987|NCT01415752|581837437|FG000|Maintenance (Step 2)|Death|1|||
161122988|NCT01415752|581837438|FG001|Maintenance (Step 2)|Death|1|||
161122989|NCT01415752|581837439|FG002|Maintenance (Step 2)|Death|2|||
161122990|NCT01415752|581837440|FG003|Maintenance (Step 2)|Death|0|||
160777290|NCT05399771|580569864|FG000|Overall Study|Adverse Event|1|||
160777291|NCT00484159|580569871|FG000|Overall Study|Lost to Follow-up|1|||
160777292|NCT00484159|580569872|FG001|Overall Study|Lost to Follow-up|1|||
160777293|NCT00484159|580569873|FG002|Overall Study|Lost to Follow-up|0|||
160777294|NCT03234881|580569874|FG000|Overall Study|Lost to Follow-up|9|||
160777295|NCT03234881|580569875|FG001|Overall Study|Lost to Follow-up|3|||
160777296|NCT03807843|580569876|FG000|Overall Study|Lost to Follow-up|1|||
160777297|NCT03807843|580569877|FG001|Overall Study|Lost to Follow-up|0|||
160777298|NCT01312129|580569878|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
160777299|NCT01312129|580569879|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
160777300|NCT01239680|580569882|FG000|Overall Study|Withdrawal by Subject|2|||
160777301|NCT01239680|580569883|FG001|Overall Study|Withdrawal by Subject|0|||
160777302|NCT01797185|580569884|FG000|Overall Study|Adverse Event|5|||
160777303|NCT01797185|580569885|FG001|Overall Study|Adverse Event|15|||
160777304|NCT01797185|580569886|FG002|Overall Study|Adverse Event|6|||
160777305|NCT01797185|580569884|FG000|Overall Study|Withdrawal by Subject|6|||
160777306|NCT01797185|580569885|FG001|Overall Study|Withdrawal by Subject|9|||
160777307|NCT01797185|580569886|FG002|Overall Study|Withdrawal by Subject|5|||
160777308|NCT01797185|580569884|FG000|Overall Study|Site terminated|8|||
160777309|NCT01797185|580569885|FG001|Overall Study|Site terminated|4|||
160777310|NCT01797185|580569886|FG002|Overall Study|Site terminated|0|||
160777311|NCT01797185|580569884|FG000|Overall Study|Lost to Follow-up|2|||
160777312|NCT01797185|580569885|FG001|Overall Study|Lost to Follow-up|6|||
160777313|NCT01797185|580569886|FG002|Overall Study|Lost to Follow-up|1|||
160777314|NCT01797185|580569884|FG000|Overall Study|Withdrawn per sponsor|5|||
160777315|NCT01797185|580569885|FG001|Overall Study|Withdrawn per sponsor|0|||
160777316|NCT01797185|580569886|FG002|Overall Study|Withdrawn per sponsor|0|||
160777317|NCT01797185|580569884|FG000|Overall Study|Physician Decision|1|||
160777318|NCT01797185|580569885|FG001|Overall Study|Physician Decision|3|||
160777319|NCT01797185|580569886|FG002|Overall Study|Physician Decision|0|||
160777320|NCT01797185|580569884|FG000|Overall Study|Protocol Violation|1|||
160777321|NCT01797185|580569885|FG001|Overall Study|Protocol Violation|1|||
160777322|NCT01797185|580569886|FG002|Overall Study|Protocol Violation|0|||
160777323|NCT05177094|580569889|FG000|Overall Study|Adverse Event|5|||
160777324|NCT05177094|580569890|FG001|Overall Study|Adverse Event|5|||
160777325|NCT05177094|580569889|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
160777326|NCT05177094|580569890|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
160777327|NCT05177094|580569889|FG000|Overall Study|Protocol Deviation|3|||
160777328|NCT05177094|580569890|FG001|Overall Study|Protocol Deviation|0|||
160777329|NCT05177094|580569889|FG000|Overall Study|Withdrawal by Subject|6|||
160777330|NCT05177094|580569890|FG001|Overall Study|Withdrawal by Subject|3|||
160777331|NCT05177094|580569889|FG000|Overall Study|Participant could not tolerate long study visits|1|||
160777332|NCT05177094|580569890|FG001|Overall Study|Participant could not tolerate long study visits|0|||
160777333|NCT01033942|580569891|FG000|Overall Study|Withdrawal by Subject|1|||
160777334|NCT01033942|580569892|FG001|Overall Study|Withdrawal by Subject|1|||
160886861|NCT00745615|580980610|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160886862|NCT00745615|580980611|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160886863|NCT00745615|580980612|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
160886864|NCT00745615|580980613|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
160886865|NCT00745615|580980614|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
160886866|NCT00570232|580980615|FG000|Overall Study|Adverse Event|10|||
160886867|NCT00570232|580980615|FG000|Overall Study|discontinued due to medical condition|3|||
160886868|NCT00570232|580980615|FG000|Overall Study|discontinued due to recurrence|8|||
160886869|NCT00570232|580980615|FG000|Overall Study|discontinued due to noncompliance|2|||
160886870|NCT01076075|580980616|FG000|Overall Study|Adverse Event|3|||
160886871|NCT01076075|580980617|FG001|Overall Study|Adverse Event|9|||
160886872|NCT01076075|580980616|FG000|Overall Study|Lack of Efficacy|5|||
160886873|NCT01076075|580980617|FG001|Overall Study|Lack of Efficacy|4|||
160886874|NCT01076075|580980616|FG000|Overall Study|Lost to Follow-up|6|||
160886875|NCT01076075|580980617|FG001|Overall Study|Lost to Follow-up|5|||
160886876|NCT01076075|580980616|FG000|Overall Study|other|19|||
160886877|NCT01076075|580980617|FG001|Overall Study|other|9|||
160886878|NCT01076075|580980616|FG000|Overall Study|Protocol Violation|0|||
161228918|NCT03946449|582218733|FG002|Treatment Extension II|Withdrawal by Subject|1|||
160777335|NCT01033942|580569893|FG002|Overall Study|Withdrawal by Subject|1|||
160777336|NCT01033942|580569891|FG000|Overall Study|Lost to Follow-up|1|||
160777337|NCT01033942|580569892|FG001|Overall Study|Lost to Follow-up|0|||
160777338|NCT01033942|580569893|FG002|Overall Study|Lost to Follow-up|0|||
160886879|NCT01076075|580980617|FG001|Overall Study|Protocol Violation|1|||
160777339|NCT01033942|580569891|FG000|Overall Study|Enrolled in Extension Study|0|||
160777340|NCT01033942|580569892|FG001|Overall Study|Enrolled in Extension Study|3|||
160777341|NCT01033942|580569893|FG002|Overall Study|Enrolled in Extension Study|0|||
160777342|NCT02737618|580569894|FG000|Overall Study|Withdrawal by Subject|9|||
160777343|NCT05276804|580569903|FG000|Overall Study|screen failure|23|||
160777344|NCT05276804|580569904|FG001|Overall Study|screen failure|0|||
160777345|NCT02827708|580569905|FG000|Overall Study|Lost to Follow-up|3|||
160777346|NCT02827708|580569906|FG001|Overall Study|Lost to Follow-up|1|||
160777347|NCT02827708|580569905|FG000|Overall Study|Withdrawal by Subject|1|||
160777348|NCT02827708|580569906|FG001|Overall Study|Withdrawal by Subject|2|||
160777349|NCT02827708|580569905|FG000|Overall Study|Death|1|||
160777350|NCT02827708|580569906|FG001|Overall Study|Death|2|||
160777351|NCT02115386|580569908|FG000|Overall Study|Protocol Violation|1|||
160777352|NCT02115386|580569908|FG000|Overall Study|Administrative - trial was terminated|6|||
160777353|NCT02493855|580569909|FG000|Overall Study|Non-compliance|1|||
160777354|NCT02493855|580569910|FG001|Overall Study|Non-compliance|0|||
160777355|NCT02493855|580569911|FG002|Overall Study|Non-compliance|0|||
160777356|NCT02493855|580569909|FG000|Overall Study|Adverse Event|0|||
160777357|NCT02493855|580569910|FG001|Overall Study|Adverse Event|1|||
160777358|NCT02493855|580569911|FG002|Overall Study|Adverse Event|0|||
160777359|NCT02493855|580569909|FG000|Overall Study|Withdrawal by Subject|1|||
160777360|NCT02493855|580569910|FG001|Overall Study|Withdrawal by Subject|0|||
160777361|NCT02493855|580569911|FG002|Overall Study|Withdrawal by Subject|0|||
160777362|NCT05059080|580569912|FG000|Overall Study|Withdrawal by Subject|3|||
160777363|NCT05059080|580569912|FG000|Overall Study|Study Terminated by Sponsor|64|||
160777364|NCT01047501|580569913|FG000|Overall Study|Adverse Event|7|||
160777365|NCT01047501|580569914|FG001|Overall Study|Adverse Event|8|||
160777366|NCT01047501|580569915|FG002|Overall Study|Adverse Event|5|||
160777367|NCT01047501|580569913|FG000|Overall Study|Withdrew Consent|6|||
160777368|NCT01047501|580569914|FG001|Overall Study|Withdrew Consent|2|||
160777369|NCT01047501|580569915|FG002|Overall Study|Withdrew Consent|4|||
160777370|NCT01047501|580569913|FG000|Overall Study|Lost to Follow-up|0|||
160777371|NCT01047501|580569914|FG001|Overall Study|Lost to Follow-up|1|||
160777372|NCT01047501|580569915|FG002|Overall Study|Lost to Follow-up|1|||
160777373|NCT01047501|580569913|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
160777374|NCT01047501|580569914|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
160777375|NCT01047501|580569915|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
160777376|NCT01047501|580569913|FG000|Overall Study|Death|1|||
160777377|NCT01047501|580569914|FG001|Overall Study|Death|0|||
160777378|NCT01047501|580569915|FG002|Overall Study|Death|0|||
160777379|NCT01047501|580569913|FG000|Overall Study|Other discontinuation|1|||
160777380|NCT01047501|580569914|FG001|Overall Study|Other discontinuation|0|||
160777381|NCT01047501|580569915|FG002|Overall Study|Other discontinuation|1|||
160777382|NCT01047501|580569913|FG000|Overall Study|Investigator judgement|0|||
160777383|NCT01047501|580569914|FG001|Overall Study|Investigator judgement|0|||
160777384|NCT01047501|580569915|FG002|Overall Study|Investigator judgement|1|||
160777385|NCT00549328|580569919|FG000|Overall Study|Adverse Event|2|||
160777386|NCT00549328|580569919|FG000|Overall Study|Disease Progression|10|||
160777387|NCT00549328|580569919|FG000|Overall Study|Death|1|||
160777388|NCT00549328|580569919|FG000|Overall Study|Use of Prohibited Medication|1|||
160777389|NCT04868682|580569920|FG000|Post-treatment|Lost to Follow-up|1|||
160777390|NCT04868682|580569921|FG001|Post-treatment|Lost to Follow-up|1|||
160777391|NCT04868682|580569920|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
160777392|NCT04868682|580569921|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
160777393|NCT04868682|580569920|FG000|Six-month Assessment|Lost to Follow-up|1|||
160777394|NCT04868682|580569921|FG001|Six-month Assessment|Lost to Follow-up|0|||
160777395|NCT04868682|580569920|FG000|Six-month Assessment|Death|1|||
160777396|NCT04868682|580569921|FG001|Six-month Assessment|Death|0|||
160777397|NCT04868682|580569920|FG000|Six-month Assessment|Refused|0|||
160777398|NCT04868682|580569921|FG001|Six-month Assessment|Refused|1|||
160777399|NCT04868682|580569920|FG000|12-month Assessment|Lost to Follow-up|2|||
160886880|NCT01076075|580980616|FG000|Overall Study|Withdrawal by Subject|8|||
160777400|NCT04868682|580569921|FG001|12-month Assessment|Lost to Follow-up|1|||
160777401|NCT04868682|580569920|FG000|12-month Assessment|Death|0|||
160777402|NCT04868682|580569921|FG001|12-month Assessment|Death|1|||
160777403|NCT03384966|580569925|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
160777404|NCT03384966|580569926|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
160777405|NCT03384966|580569927|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
160777406|NCT03384966|580569925|FG000|Follow-up Period|Adverse Event|1|||
160777407|NCT03384966|580569926|FG001|Follow-up Period|Adverse Event|0|||
160777408|NCT03384966|580569927|FG002|Follow-up Period|Adverse Event|0|||
160886881|NCT01076075|580980617|FG001|Overall Study|Withdrawal by Subject|19|||
161325850|NCT01971567|582579603|FG001|Overall Study|Withdrawal by Subject|2|||
160777409|NCT03880565|580569928|FG000|Overall Study|Withdrawal by Subject|1|||
160777410|NCT03880565|580569929|FG001|Overall Study|Withdrawal by Subject|0|||
160777411|NCT02202616|580569930|FG000|Overall Study|Screen failed|24|||
160777412|NCT02202616|580569930|FG000|Overall Study|Adverse Event|32|||
160777413|NCT02202616|580569930|FG000|Overall Study|Protocol deviation|18|||
160777414|NCT02202616|580569930|FG000|Overall Study|Patient withdrew consent|12|||
160777415|NCT02202616|580569930|FG000|Overall Study|Lost to Follow-up|6|||
160777416|NCT02202616|580569930|FG000|Overall Study|Administrative problems|6|||
160777417|NCT02202616|580569930|FG000|Overall Study|Abnormal test procedure result|1|||
160777418|NCT02202616|580569930|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160777419|NCT04327271|580569931|FG000|Overall Study|Death|1|||
160777420|NCT04327271|580569932|FG001|Overall Study|Death|0|||
160777421|NCT04327271|580569931|FG000|Overall Study|Withdrawal by Subject|1|||
160777422|NCT04327271|580569932|FG001|Overall Study|Withdrawal by Subject|0|||
160777423|NCT04327271|580569931|FG000|Overall Study|randomization error (data capture)|4|||
160777424|NCT04327271|580569932|FG001|Overall Study|randomization error (data capture)|3|||
160777425|NCT01716156|580569934|FG000|Overall Study|Protocol Violation|1|||
160777426|NCT01716156|580569935|FG001|Overall Study|Protocol Violation|0|||
160777427|NCT01716156|580569936|FG002|Overall Study|Protocol Violation|0|||
160777428|NCT01716156|580569934|FG000|Overall Study|Withdrawal by Subject|0|||
160777429|NCT01716156|580569935|FG001|Overall Study|Withdrawal by Subject|1|||
160777430|NCT01716156|580569936|FG002|Overall Study|Withdrawal by Subject|2|||
160777431|NCT01716156|580569934|FG000|Overall Study|Lost to Follow-up|1|||
160777432|NCT01716156|580569935|FG001|Overall Study|Lost to Follow-up|0|||
160777433|NCT01716156|580569936|FG002|Overall Study|Lost to Follow-up|0|||
160777434|NCT05513950|580569939|FG000|Overall Study|Not treated due to technical reasons|0|||
160777435|NCT05513950|580569940|FG001|Overall Study|Not treated due to technical reasons|0|||
160777436|NCT05513950|580569941|FG002|Overall Study|Not treated due to technical reasons|1|||
160777437|NCT05513950|580569942|FG003|Overall Study|Not treated due to technical reasons|0|||
160777438|NCT05221866|580569943|FG000|Overall Study|Withdrawal by Subject|5|||
160777439|NCT05221866|580569944|FG001|Overall Study|Withdrawal by Subject|7|||
160777440|NCT05221866|580569945|FG002|Overall Study|Withdrawal by Subject|6|||
160777441|NCT05221866|580569946|FG003|Overall Study|Withdrawal by Subject|4|||
160777442|NCT05221866|580569943|FG000|Overall Study|Physician Decision|3|||
160777443|NCT05221866|580569944|FG001|Overall Study|Physician Decision|2|||
160777444|NCT05221866|580569945|FG002|Overall Study|Physician Decision|1|||
161228919|NCT02848326|582220260|FG000|Treatment Period|Adverse Event|5|||
161228920|NCT02848326|582220261|FG001|Treatment Period|Adverse Event|4|||
161228921|NCT02848326|582220262|FG002|Treatment Period|Adverse Event|11|||
161228922|NCT02848326|582220263|FG003|Treatment Period|Adverse Event|6|||
161228923|NCT02848326|582220264|FG004|Treatment Period|Adverse Event|5|||
161228924|NCT02848326|582220265|FG005|Treatment Period|Adverse Event|7|||
161228925|NCT02848326|582220260|FG000|Treatment Period|Withdrawal of Consent|20|||
161228926|NCT02848326|582220261|FG001|Treatment Period|Withdrawal of Consent|6|||
161228927|NCT02848326|582220262|FG002|Treatment Period|Withdrawal of Consent|9|||
161228928|NCT02848326|582220263|FG003|Treatment Period|Withdrawal of Consent|6|||
161228929|NCT02848326|582220264|FG004|Treatment Period|Withdrawal of Consent|9|||
161228930|NCT02848326|582220265|FG005|Treatment Period|Withdrawal of Consent|6|||
161228931|NCT02848326|582220260|FG000|Treatment Period|Lost to Follow-up|5|||
161228932|NCT02848326|582220261|FG001|Treatment Period|Lost to Follow-up|1|||
161228933|NCT02848326|582220262|FG002|Treatment Period|Lost to Follow-up|11|||
161228934|NCT02848326|582220263|FG003|Treatment Period|Lost to Follow-up|7|||
160777445|NCT05221866|580569946|FG003|Overall Study|Physician Decision|4|||
160777446|NCT05221866|580569943|FG000|Overall Study|Lost to Follow-up|12|||
160777447|NCT05221866|580569944|FG001|Overall Study|Lost to Follow-up|17|||
160777448|NCT05221866|580569945|FG002|Overall Study|Lost to Follow-up|14|||
160777449|NCT05221866|580569946|FG003|Overall Study|Lost to Follow-up|14|||
160777450|NCT05221866|580569943|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
160777451|NCT05221866|580569944|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
160777452|NCT05221866|580569945|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
160777453|NCT05221866|580569946|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
160777454|NCT00221104|580569947|FG000|Overall Study|Adverse Event|1|||
160777455|NCT00221104|580569948|FG001|Overall Study|Adverse Event|0|||
160777456|NCT00221104|580569947|FG000|Overall Study|Physician Decision|1|||
160777457|NCT00221104|580569948|FG001|Overall Study|Physician Decision|0|||
160777458|NCT00221104|580569947|FG000|Overall Study|Protocol Violation|2|||
160886882|NCT01163032|580980622|FG000|Randomization Phase|Withdrawal by Subject|2|||
161228935|NCT02848326|582220264|FG004|Treatment Period|Lost to Follow-up|2|||
161228936|NCT02848326|582220265|FG005|Treatment Period|Lost to Follow-up|3|||
161228937|NCT02848326|582220260|FG000|Treatment Period|Pregnancy|0|||
160777459|NCT00221104|580569948|FG001|Overall Study|Protocol Violation|0|||
160777460|NCT00221104|580569947|FG000|Overall Study|Withdrawal by Subject|42|||
160777461|NCT00221104|580569948|FG001|Overall Study|Withdrawal by Subject|29|||
160886883|NCT01163032|580980623|FG001|Randomization Phase|Withdrawal by Subject|3|||
161228938|NCT02848326|582220261|FG001|Treatment Period|Pregnancy|0|||
161228939|NCT02848326|582220262|FG002|Treatment Period|Pregnancy|1|||
161228940|NCT02848326|582220263|FG003|Treatment Period|Pregnancy|1|||
161228941|NCT02848326|582220264|FG004|Treatment Period|Pregnancy|0|||
161228942|NCT02848326|582220265|FG005|Treatment Period|Pregnancy|1|||
161228943|NCT02848326|582220260|FG000|Treatment Period|Protocol Violation|4|||
160777462|NCT00221104|580569947|FG000|Overall Study|Others|37|||
160777463|NCT00221104|580569948|FG001|Overall Study|Others|47|||
160777464|NCT02989389|580569949|FG000|Period 1|Lost to Follow-up|0|||
160777465|NCT02989389|580569950|FG001|Period 1|Lost to Follow-up|1|||
160777466|NCT02989389|580569951|FG002|Period 1|Lost to Follow-up|0|||
160777467|NCT02989389|580569952|FG003|Period 1|Lost to Follow-up|0|||
160777468|NCT02989389|580569953|FG004|Period 1|Lost to Follow-up|0|||
161228944|NCT02848326|582220261|FG001|Treatment Period|Protocol Violation|3|||
161228945|NCT02848326|582220262|FG002|Treatment Period|Protocol Violation|4|||
161228946|NCT02848326|582220263|FG003|Treatment Period|Protocol Violation|2|||
160777469|NCT02989389|580569954|FG005|Period 1|Lost to Follow-up|0|||
160777470|NCT02989389|580569955|FG006|Period 1|Lost to Follow-up|0|||
160777471|NCT02989389|580569956|FG007|Period 1|Lost to Follow-up|0|||
160777472|NCT02989389|580569957|FG008|Period 1|Lost to Follow-up|0|||
160777473|NCT02989389|580569958|FG009|Period 1|Lost to Follow-up|0|||
160777474|NCT02989389|580569949|FG000|Period 1|Physician Decision|0|||
160777475|NCT02989389|580569950|FG001|Period 1|Physician Decision|0|||
160777476|NCT02989389|580569951|FG002|Period 1|Physician Decision|0|||
160777477|NCT02989389|580569952|FG003|Period 1|Physician Decision|0|||
160777478|NCT02989389|580569953|FG004|Period 1|Physician Decision|0|||
160777479|NCT02989389|580569954|FG005|Period 1|Physician Decision|0|||
160777480|NCT02989389|580569955|FG006|Period 1|Physician Decision|0|||
160777481|NCT02989389|580569956|FG007|Period 1|Physician Decision|0|||
160777482|NCT02989389|580569957|FG008|Period 1|Physician Decision|1|||
160777483|NCT02989389|580569958|FG009|Period 1|Physician Decision|0|||
160777484|NCT01018979|580569959|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
161228947|NCT02848326|582220264|FG004|Treatment Period|Protocol Violation|3|||
161228948|NCT02848326|582220265|FG005|Treatment Period|Protocol Violation|3|||
161228949|NCT02848326|582220260|FG000|Treatment Period|Non-compliance with Study Drug|4|||
161228950|NCT02848326|582220261|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161228951|NCT02848326|582220262|FG002|Treatment Period|Non-compliance with Study Drug|0|||
161228952|NCT02848326|582220263|FG003|Treatment Period|Non-compliance with Study Drug|1|||
161228953|NCT02848326|582220264|FG004|Treatment Period|Non-compliance with Study Drug|0|||
161228954|NCT02848326|582220265|FG005|Treatment Period|Non-compliance with Study Drug|0|||
161228955|NCT02848326|582220260|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
161228956|NCT02848326|582220261|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
161228957|NCT02848326|582220262|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
161228958|NCT02848326|582220263|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
161228959|NCT02848326|582220264|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
161228960|NCT02848326|582220265|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
161228961|NCT02848326|582220260|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
161228962|NCT02848326|582220261|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161228963|NCT02848326|582220262|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
161228964|NCT02848326|582220263|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
161228965|NCT02848326|582220264|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
161228966|NCT02848326|582220265|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
161228967|NCT04349917|582220277|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
161228968|NCT04349917|582220278|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
161228969|NCT04349917|582220277|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
161228970|NCT04349917|582220278|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
161228971|NCT00441467|582220288|FG000|Overall Study|Adverse Event|6|||
161228972|NCT00441467|582220288|FG000|Overall Study|Withdrawal by Subject|3|||
161228973|NCT00441467|582220288|FG000|Overall Study|Progressive disease|9|||
161228974|NCT01042522|582220290|FG000|Overall Study|Adverse Event|1|||
161228975|NCT01042522|582220291|FG001|Overall Study|Adverse Event|2|||
161228976|NCT01042522|582220290|FG000|Overall Study|Disease Progression|5|||
161228977|NCT01042522|582220291|FG001|Overall Study|Disease Progression|0|||
161228978|NCT01042522|582220290|FG000|Overall Study|Death|1|||
161228979|NCT01042522|582220291|FG001|Overall Study|Death|0|||
161228980|NCT01042522|582220290|FG000|Overall Study|Patient Refused|0|||
161228981|NCT01042522|582220291|FG001|Overall Study|Patient Refused|3|||
161228982|NCT01042522|582220290|FG000|Overall Study|Withdrawal by Subject|1|||
161228983|NCT01042522|582220291|FG001|Overall Study|Withdrawal by Subject|1|||
161228984|NCT00745420|582220295|FG000|Overall Study|Ineligible|1|||
161228985|NCT00088829|582220305|FG000|Overall Study|PI left institution and study was close|22|||
160777485|NCT01018979|580569960|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
160777486|NCT01018979|580569959|FG000|Overall Study|Not received at least one dose|0|||
161228988|NCT01367275|582220307|FG000|Overall Study|Ineligible|1|||
161228989|NCT01367275|582220307|FG000|Overall Study|Disease Progression|2|||
161228990|NCT02532764|582220308|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161228991|NCT02532764|582220309|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161228992|NCT02532764|582220310|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161228993|NCT02532764|582220311|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161228994|NCT02532764|582220312|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
160777487|NCT01018979|580569960|FG001|Overall Study|Not received at least one dose|1|||
160777488|NCT04057365|580569961|FG000|Overall Study|Withdrawal by Subject|2|||
160777489|NCT04057365|580569962|FG001|Overall Study|Withdrawal by Subject|0|||
160777490|NCT04598828|580569963|FG000|Overall Study|Physician Decision|1|||
160777491|NCT04598828|580569964|FG001|Overall Study|Physician Decision|0|||
161228995|NCT02532764|582220313|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161228996|NCT02532764|582220314|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
161228997|NCT02532764|582220315|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161228998|NCT02532764|582220316|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161228999|NCT02532764|582220317|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
161229000|NCT00048568|582220319|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
160886884|NCT01163032|580980624|FG002|Randomization Phase|Withdrawal by Subject|0|||
160886885|NCT01163032|580980622|FG000|Randomization Phase|Adverse Event|3|||
161229001|NCT00048568|582220320|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
161325851|NCT01971567|582579602|FG000|Overall Study|Lost to Follow-up|1|||
161325852|NCT01971567|582579603|FG001|Overall Study|Lost to Follow-up|0|||
161325853|NCT00391872|582579604|FG000|Overall Study|Protocol Violation|7|||
161325854|NCT00391872|582579605|FG001|Overall Study|Protocol Violation|2|||
161325855|NCT00391872|582579604|FG000|Overall Study|Withdrawal by Subject|296|||
161325856|NCT00391872|582579605|FG001|Overall Study|Withdrawal by Subject|249|||
161325857|NCT00391872|582579604|FG000|Overall Study|Reason unknown|2|||
161325858|NCT00391872|582579605|FG001|Overall Study|Reason unknown|4|||
161325859|NCT00391872|582579604|FG000|Overall Study|Lost to Follow-up|2|||
161325860|NCT00391872|582579605|FG001|Overall Study|Lost to Follow-up|0|||
161325861|NCT04826484|582579606|FG000|Overall Study|Lost to Follow-up|2|||
161325862|NCT04826484|582579607|FG001|Overall Study|Lost to Follow-up|0|||
161325863|NCT00522548|582579608|FG000|Overall Study|Adverse Event|2|||
161325864|NCT00522548|582579609|FG001|Overall Study|Adverse Event|2|||
161325865|NCT00522548|582579608|FG000|Overall Study|Withdrawal by Subject|0|||
161325866|NCT00522548|582579609|FG001|Overall Study|Withdrawal by Subject|2|||
161325867|NCT00872521|582579610|FG000|Completed PAD Induction|Patient choice|0|||
161325868|NCT00872521|582579611|FG001|Completed PAD Induction|Patient choice|1|||
161325869|NCT00872521|582579612|FG002|Completed PAD Induction|Patient choice|0|||
161325870|NCT00872521|582579610|FG000|Completed PAD Induction|Disease progression|0|||
161325871|NCT00872521|582579611|FG001|Completed PAD Induction|Disease progression|2|||
161325872|NCT00872521|582579612|FG002|Completed PAD Induction|Disease progression|0|||
161325873|NCT00872521|582579610|FG000|Completed PAD Induction|Adverse Event|4|||
161325874|NCT00872521|582579611|FG001|Completed PAD Induction|Adverse Event|0|||
161325875|NCT00872521|582579612|FG002|Completed PAD Induction|Adverse Event|0|||
161325876|NCT00872521|582579610|FG000|Completed PAD Induction|Death|1|||
161325877|NCT00872521|582579611|FG001|Completed PAD Induction|Death|1|||
161325878|NCT00872521|582579612|FG002|Completed PAD Induction|Death|0|||
161325879|NCT00872521|582579610|FG000|Primary Endpoint Analysis|Other|1|||
161325880|NCT00872521|582579611|FG001|Primary Endpoint Analysis|Other|2|||
161325881|NCT00872521|582579612|FG002|Primary Endpoint Analysis|Other|0|||
161325882|NCT00872521|582579610|FG000|Primary Endpoint Analysis|Patient choice|0|||
161325883|NCT00872521|582579611|FG001|Primary Endpoint Analysis|Patient choice|1|||
161325884|NCT00872521|582579612|FG002|Primary Endpoint Analysis|Patient choice|0|||
161325885|NCT00872521|582579610|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
161325886|NCT00872521|582579611|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
161325887|NCT00872521|582579612|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
161325888|NCT00872521|582579610|FG000|Primary Endpoint Analysis|Patient response missing|0|||
161325889|NCT00872521|582579611|FG001|Primary Endpoint Analysis|Patient response missing|0|||
161325890|NCT00872521|582579612|FG002|Primary Endpoint Analysis|Patient response missing|1|||
161325891|NCT00872521|582579610|FG000|Completed 3-month Follow up|Other|0|||
161325892|NCT00872521|582579611|FG001|Completed 3-month Follow up|Other|2|||
161325893|NCT00872521|582579612|FG002|Completed 3-month Follow up|Other|0|||
161325894|NCT00872521|582579610|FG000|Completed 3-month Follow up|Physician Decision|0|||
161325895|NCT00872521|582579611|FG001|Completed 3-month Follow up|Physician Decision|1|||
161325896|NCT00872521|582579612|FG002|Completed 3-month Follow up|Physician Decision|0|||
161325897|NCT00872521|582579610|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
161325898|NCT00872521|582579611|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
161325899|NCT00872521|582579612|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
161325900|NCT01089127|582579613|FG000|Overall Study|Adverse Event|5|||
161325901|NCT01089127|582579614|FG001|Overall Study|Adverse Event|1|||
161325902|NCT01089127|582579615|FG002|Overall Study|Adverse Event|1|||
161325903|NCT01089127|582579616|FG003|Overall Study|Adverse Event|0|||
161325904|NCT01089127|582579617|FG004|Overall Study|Adverse Event|0|||
161325905|NCT01089127|582579618|FG005|Overall Study|Adverse Event|1|||
161325906|NCT01089127|582579613|FG000|Overall Study|Subject withdrew consent|0|||
161325907|NCT01089127|582579614|FG001|Overall Study|Subject withdrew consent|1|||
161325908|NCT01089127|582579615|FG002|Overall Study|Subject withdrew consent|1|||
161325909|NCT01089127|582579616|FG003|Overall Study|Subject withdrew consent|1|||
160886886|NCT01163032|580980623|FG001|Randomization Phase|Adverse Event|3|||
161325910|NCT01089127|582579617|FG004|Overall Study|Subject withdrew consent|0|||
161325911|NCT01089127|582579618|FG005|Overall Study|Subject withdrew consent|2|||
161325912|NCT01089127|582579613|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161325913|NCT01089127|582579614|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161325914|NCT01089127|582579615|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160777492|NCT04598828|580569963|FG000|Overall Study|Withdrawal by Subject|0|||
160777493|NCT04598828|580569964|FG001|Overall Study|Withdrawal by Subject|1|||
160777494|NCT04598828|580569963|FG000|Overall Study|Withdrawal by Subject|0|||
160777495|NCT04598828|580569964|FG001|Overall Study|Withdrawal by Subject|1|||
160777496|NCT02676973|580569965|FG000|Overall Study|Withdrawal by Subject|9|||
160777497|NCT02676973|580569966|FG001|Overall Study|Withdrawal by Subject|8|||
160777498|NCT02676973|580569967|FG002|Overall Study|Withdrawal by Subject|11|||
160777499|NCT02676973|580569965|FG000|Overall Study|Lost to Follow-up|8|||
160777500|NCT02676973|580569966|FG001|Overall Study|Lost to Follow-up|12|||
160777501|NCT02676973|580569967|FG002|Overall Study|Lost to Follow-up|8|||
160777502|NCT02676973|580569965|FG000|Overall Study|Death|2|||
160777503|NCT02676973|580569966|FG001|Overall Study|Death|1|||
160777504|NCT02676973|580569967|FG002|Overall Study|Death|5|||
160777505|NCT01078662|580569969|FG000|Overall Study|Death|41|||
160777506|NCT01078662|580569970|FG001|Overall Study|Death|103|||
160777507|NCT01078662|580569971|FG002|Overall Study|Death|18|||
160777508|NCT01078662|580569972|FG003|Overall Study|Death|5|||
160777509|NCT01078662|580569973|FG004|Overall Study|Death|8|||
160886887|NCT01163032|580980624|FG002|Randomization Phase|Adverse Event|0|||
160886888|NCT01163032|580980622|FG000|Randomization Phase|Protocol Violation|0|||
160886889|NCT01163032|580980623|FG001|Randomization Phase|Protocol Violation|1|||
160886890|NCT01163032|580980624|FG002|Randomization Phase|Protocol Violation|0|||
160886891|NCT01163032|580980622|FG000|Randomization Phase|Various*|5|||
160886892|NCT01163032|580980623|FG001|Randomization Phase|Various*|4|||
160886893|NCT01163032|580980624|FG002|Randomization Phase|Various*|0|||
160886894|NCT01163032|580980622|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
160886895|NCT01163032|580980623|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
160886896|NCT01163032|580980624|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
160886897|NCT01163032|580980622|FG000|Open Label Extension Phase|Adverse Event|0|||
160886898|NCT01163032|580980623|FG001|Open Label Extension Phase|Adverse Event|0|||
160886899|NCT01163032|580980624|FG002|Open Label Extension Phase|Adverse Event|3|||
161325915|NCT01089127|582579616|FG003|Overall Study|Abnormal test procedure result(s)|0|||
161325916|NCT01089127|582579617|FG004|Overall Study|Abnormal test procedure result(s)|0|||
161325917|NCT01089127|582579618|FG005|Overall Study|Abnormal test procedure result(s)|0|||
161325918|NCT01089127|582579613|FG000|Overall Study|Lost to Follow-up|1|||
161325919|NCT01089127|582579614|FG001|Overall Study|Lost to Follow-up|1|||
161325920|NCT01089127|582579615|FG002|Overall Study|Lost to Follow-up|0|||
161325921|NCT01089127|582579616|FG003|Overall Study|Lost to Follow-up|0|||
161325922|NCT01089127|582579617|FG004|Overall Study|Lost to Follow-up|1|||
161325923|NCT01089127|582579618|FG005|Overall Study|Lost to Follow-up|0|||
161325924|NCT01089127|582579613|FG000|Overall Study|Protocol deviation|0|||
161325925|NCT01089127|582579614|FG001|Overall Study|Protocol deviation|1|||
161325926|NCT01089127|582579615|FG002|Overall Study|Protocol deviation|0|||
161325927|NCT01089127|582579616|FG003|Overall Study|Protocol deviation|0|||
161325928|NCT01089127|582579617|FG004|Overall Study|Protocol deviation|1|||
161325929|NCT01089127|582579618|FG005|Overall Study|Protocol deviation|0|||
161325930|NCT00875563|582579620|FG000|Overall Study|Death|4|||
161325931|NCT00875563|582579620|FG000|Overall Study|Withdrawal by Subject|7|||
161325932|NCT00875563|582579620|FG000|Overall Study|No long-term (3-5 year) consent|6|||
161325933|NCT00875563|582579620|FG000|Overall Study|Still be eligible for follow-up|7|||
161325934|NCT00511810|582579623|FG000|Overall Study|Lost to Follow-up|1|||
161325935|NCT00511810|582579624|FG001|Overall Study|Lost to Follow-up|2|||
161325936|NCT00511810|582579623|FG000|Overall Study|Lack of Efficacy|0|||
161325937|NCT00511810|582579624|FG001|Overall Study|Lack of Efficacy|2|||
161325938|NCT00511810|582579623|FG000|Overall Study|Refused second scn|0|||
161325939|NCT00511810|582579624|FG001|Overall Study|Refused second scn|1|||
161325940|NCT00618826|582579626|FG000|Overall Study|Adverse Event|1|||
161325941|NCT03231306|582579629|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
161325942|NCT03231306|582579629|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
161325943|NCT03231306|582579629|FG000|Overall Study|Treatment delay > 21 days|2|||
161325944|NCT03231306|582579629|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
161325945|NCT03231306|582579629|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
161325946|NCT03231306|582579629|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
161325947|NCT03231306|582579629|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
161325948|NCT03231306|582579629|FG000|Overall Study|More than 1 Reason|2|||
161325949|NCT01808261|582579630|FG000|Overall Study|Physician Decision|0|||
161325950|NCT01808261|582579631|FG001|Overall Study|Physician Decision|2|||
161325951|NCT01808261|582579630|FG000|Overall Study|Study Closed/Terminated|25|||
161325952|NCT01808261|582579631|FG001|Overall Study|Study Closed/Terminated|23|||
161325953|NCT01808261|582579630|FG000|Overall Study|Adverse event, non-fatal|2|||
160777510|NCT01078662|580569969|FG000|Overall Study|Patients reached data cut-off|12|||
160777511|NCT01078662|580569970|FG001|Overall Study|Patients reached data cut-off|53|||
160777512|NCT01078662|580569971|FG002|Overall Study|Patients reached data cut-off|2|||
160777513|NCT01078662|580569972|FG003|Overall Study|Patients reached data cut-off|2|||
160777514|NCT01078662|580569973|FG004|Overall Study|Patients reached data cut-off|3|||
160777515|NCT01078662|580569969|FG000|Overall Study|Withdrawal by Subject|4|||
160777516|NCT01078662|580569970|FG001|Overall Study|Withdrawal by Subject|11|||
160777517|NCT01078662|580569971|FG002|Overall Study|Withdrawal by Subject|1|||
160777518|NCT01078662|580569972|FG003|Overall Study|Withdrawal by Subject|0|||
160777519|NCT01078662|580569973|FG004|Overall Study|Withdrawal by Subject|0|||
160777520|NCT01078662|580569969|FG000|Overall Study|Protocol Violation|0|||
160777521|NCT01078662|580569970|FG001|Overall Study|Protocol Violation|1|||
160777522|NCT01078662|580569971|FG002|Overall Study|Protocol Violation|0|||
160777523|NCT01078662|580569972|FG003|Overall Study|Protocol Violation|0|||
160777524|NCT01078662|580569973|FG004|Overall Study|Protocol Violation|0|||
160777525|NCT01078662|580569969|FG000|Overall Study|Lost to Follow-up|1|||
160777526|NCT01078662|580569970|FG001|Overall Study|Lost to Follow-up|0|||
160777527|NCT01078662|580569971|FG002|Overall Study|Lost to Follow-up|0|||
160777528|NCT01078662|580569972|FG003|Overall Study|Lost to Follow-up|0|||
160777529|NCT01078662|580569973|FG004|Overall Study|Lost to Follow-up|0|||
160777530|NCT01937299|580569977|FG000|Overall Study|Adverse Event|13|||
160777531|NCT01937299|580569978|FG001|Overall Study|Adverse Event|0|||
160777532|NCT01937299|580569977|FG000|Overall Study|Lack of Efficacy|0|||
160777533|NCT01937299|580569978|FG001|Overall Study|Lack of Efficacy|4|||
160777534|NCT01937299|580569977|FG000|Overall Study|Withdrawal by Subject|1|||
160777535|NCT01937299|580569978|FG001|Overall Study|Withdrawal by Subject|0|||
160777536|NCT01913353|580569979|FG000|Overall Study|Adverse Event|2|||
160777537|NCT01913353|580569980|FG001|Overall Study|Adverse Event|0|||
160777538|NCT01913353|580569979|FG000|Overall Study|Physician Decision|0|||
160777539|NCT01913353|580569980|FG001|Overall Study|Physician Decision|2|||
160777540|NCT01913353|580569979|FG000|Overall Study|Withdrawal by Subject|20|||
160777541|NCT01913353|580569980|FG001|Overall Study|Withdrawal by Subject|6|||
160777542|NCT01913353|580569979|FG000|Overall Study|multiple reasons|10|||
160777543|NCT01913353|580569980|FG001|Overall Study|multiple reasons|7|||
160777544|NCT00385840|580569981|FG000|Overall Study|Adverse Event|1|||
160777545|NCT00385840|580569982|FG001|Overall Study|Adverse Event|1|||
160777546|NCT00385840|580569981|FG000|Overall Study|Lost to Follow-up|3|||
160777547|NCT00385840|580569982|FG001|Overall Study|Lost to Follow-up|13|||
160777548|NCT01260948|580569983|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
160777549|NCT01260948|580569984|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
160777550|NCT01260948|580569983|FG000|Second Intervention|Emesis|0|||
160777551|NCT01260948|580569984|FG001|Second Intervention|Emesis|1|||
160777552|NCT01202591|580569985|FG000|Overall Study|Adverse Event|2|||
160777553|NCT01202591|580569986|FG001|Overall Study|Adverse Event|1|||
160777554|NCT01202591|580569987|FG002|Overall Study|Adverse Event|4|||
160777555|NCT01202591|580569988|FG003|Overall Study|Adverse Event|4|||
160777556|NCT01202591|580569989|FG004|Overall Study|Adverse Event|0|||
160777557|NCT01202591|580569990|FG005|Overall Study|Adverse Event|0|||
160777558|NCT01202591|580569985|FG000|Overall Study|Other reason as per investigator|3|||
160777559|NCT01202591|580569986|FG001|Overall Study|Other reason as per investigator|4|||
160777560|NCT01202591|580569987|FG002|Overall Study|Other reason as per investigator|7|||
160777561|NCT01202591|580569988|FG003|Overall Study|Other reason as per investigator|3|||
160777562|NCT01202591|580569989|FG004|Overall Study|Other reason as per investigator|1|||
160777563|NCT01202591|580569990|FG005|Overall Study|Other reason as per investigator|3|||
160777564|NCT01202591|580569985|FG000|Overall Study|Withdrawal by Subject|0|||
160777565|NCT01202591|580569986|FG001|Overall Study|Withdrawal by Subject|0|||
160777566|NCT01202591|580569987|FG002|Overall Study|Withdrawal by Subject|0|||
160777567|NCT01202591|580569988|FG003|Overall Study|Withdrawal by Subject|0|||
160777568|NCT01202591|580569989|FG004|Overall Study|Withdrawal by Subject|2|||
160777569|NCT01202591|580569990|FG005|Overall Study|Withdrawal by Subject|1|||
160777570|NCT01202591|580569985|FG000|Overall Study|Objective Disease Progression|0|||
160777571|NCT01202591|580569986|FG001|Overall Study|Objective Disease Progression|0|||
160777572|NCT01202591|580569987|FG002|Overall Study|Objective Disease Progression|0|||
160777573|NCT01202591|580569988|FG003|Overall Study|Objective Disease Progression|0|||
160777574|NCT01202591|580569989|FG004|Overall Study|Objective Disease Progression|2|||
160777575|NCT01202591|580569990|FG005|Overall Study|Objective Disease Progression|0|||
160777576|NCT00003456|580570969|FG000|Overall Study|Not evaluable|8|||
160886900|NCT01163032|580980622|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
160886901|NCT01163032|580980623|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
160777577|NCT00420407|580570971|FG000|Overall Study|Lost to Follow-up|0|||
160777578|NCT00420407|580570972|FG001|Overall Study|Lost to Follow-up|3|||
160777579|NCT00420407|580570971|FG000|Overall Study|Physician Decision|2|||
160886902|NCT01163032|580980624|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
160777580|NCT00420407|580570972|FG001|Overall Study|Physician Decision|1|||
160777581|NCT00420407|580570971|FG000|Overall Study|subject identified as detainee|1|||
160777582|NCT00420407|580570972|FG001|Overall Study|subject identified as detainee|0|||
160777583|NCT00420407|580570971|FG000|Overall Study|subject identified as Jehovah's witness|1|||
160777584|NCT00420407|580570972|FG001|Overall Study|subject identified as Jehovah's witness|0|||
160777585|NCT00420407|580570971|FG000|Overall Study|Withdrawal by Subject|0|||
160777586|NCT00420407|580570972|FG001|Overall Study|Withdrawal by Subject|2|||
160777587|NCT02397837|580570976|FG000|Overall Study|Withdrawal by Subject|6|||
160777588|NCT02397837|580570977|FG001|Overall Study|Withdrawal by Subject|5|||
160777589|NCT02397837|580570976|FG000|Overall Study|Physician Decision|1|||
160777590|NCT02397837|580570977|FG001|Overall Study|Physician Decision|1|||
160777591|NCT02506036|580570981|FG000|First Intervention (4-6 Weeks)|Death|1|||
160777592|NCT02506036|580570982|FG001|First Intervention (4-6 Weeks)|Death|0|||
160777593|NCT02506036|580570981|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
160777594|NCT02506036|580570982|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
160777595|NCT02506036|580570981|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
160777596|NCT02506036|580570982|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
160777597|NCT00898807|580570985|FG000|Overall Study|Withdrawal by Subject|5|||
160777598|NCT00898807|580570986|FG001|Overall Study|Withdrawal by Subject|3|||
160777599|NCT00898807|580570985|FG000|Overall Study|Family pressure to discontinue|2|||
160777600|NCT00898807|580570986|FG001|Overall Study|Family pressure to discontinue|2|||
160777601|NCT00898807|580570985|FG000|Overall Study|Lost to Follow-up|1|||
160777602|NCT00898807|580570986|FG001|Overall Study|Lost to Follow-up|3|||
160777603|NCT00898807|580570985|FG000|Overall Study|Death|0|||
160777604|NCT00898807|580570986|FG001|Overall Study|Death|1|||
160777605|NCT01482221|580570991|FG000|Overall Study|Lack of Efficacy|1|||
160777606|NCT01482221|580570992|FG001|Overall Study|Lack of Efficacy|0|||
160777607|NCT01482221|580570993|FG002|Overall Study|Lack of Efficacy|1|||
160777608|NCT01482221|580570991|FG000|Overall Study|Lost to Follow-up|3|||
160777609|NCT01482221|580570992|FG001|Overall Study|Lost to Follow-up|2|||
160777610|NCT01482221|580570993|FG002|Overall Study|Lost to Follow-up|1|||
160777611|NCT01482221|580570991|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
160777612|NCT01482221|580570992|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
160777613|NCT01482221|580570993|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
160777614|NCT01482221|580570991|FG000|Overall Study|Condition under Investigation Worsened|3|||
160777615|NCT01482221|580570992|FG001|Overall Study|Condition under Investigation Worsened|2|||
160777616|NCT01482221|580570993|FG002|Overall Study|Condition under Investigation Worsened|4|||
160777617|NCT01482221|580570991|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
160777618|NCT01482221|580570992|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
160777619|NCT01482221|580570993|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
160777620|NCT01482221|580570991|FG000|Overall Study|Adverse Event|1|||
160777621|NCT01482221|580570992|FG001|Overall Study|Adverse Event|7|||
160777622|NCT01482221|580570993|FG002|Overall Study|Adverse Event|3|||
160777623|NCT01482221|580570991|FG000|Overall Study|Withdrawal by Subject|10|||
160777624|NCT01482221|580570992|FG001|Overall Study|Withdrawal by Subject|7|||
160777625|NCT01482221|580570993|FG002|Overall Study|Withdrawal by Subject|12|||
160777626|NCT01482221|580570991|FG000|Overall Study|Incorrect randomization|0|||
160777627|NCT01482221|580570992|FG001|Overall Study|Incorrect randomization|1|||
160777628|NCT01482221|580570993|FG002|Overall Study|Incorrect randomization|0|||
160777629|NCT01482221|580570991|FG000|Overall Study|Physician Decision|0|||
160777630|NCT01482221|580570992|FG001|Overall Study|Physician Decision|1|||
160777631|NCT01482221|580570993|FG002|Overall Study|Physician Decision|0|||
160777632|NCT04602000|580570994|FG000|Overall Study|Withdrawal by Subject|3|||
160777633|NCT04602000|580570995|FG001|Overall Study|Withdrawal by Subject|6|||
160777634|NCT04602000|580570996|FG002|Overall Study|Withdrawal by Subject|3|||
161325954|NCT01808261|582579631|FG001|Overall Study|Adverse event, non-fatal|0|||
161325955|NCT01808261|582579630|FG000|Overall Study|Consent withdrawn by subject|6|||
161325956|NCT01808261|582579631|FG001|Overall Study|Consent withdrawn by subject|7|||
161325957|NCT01808261|582579630|FG000|Overall Study|Lost to Follow-up|3|||
161325958|NCT01808261|582579631|FG001|Overall Study|Lost to Follow-up|1|||
161325959|NCT02585713|582579634|FG000|Overall Study|Withdrew prior to treatment|2|||
161325960|NCT02585713|582579635|FG001|Overall Study|Withdrew prior to treatment|7|||
161325961|NCT02585713|582579634|FG000|Overall Study|Other|3|||
161325962|NCT02585713|582579635|FG001|Overall Study|Other|1|||
161325963|NCT04501952|582579640|FG000|Overall Study|Adverse Event|0|||
161325964|NCT04501952|582579641|FG001|Overall Study|Adverse Event|3|||
161325965|NCT04501952|582579640|FG000|Overall Study|Investigator's Discretion|0|||
160777635|NCT04602000|580570997|FG003|Overall Study|Withdrawal by Subject|27|||
160777636|NCT04602000|580570998|FG004|Overall Study|Withdrawal by Subject|39|||
160777637|NCT04602000|580570994|FG000|Overall Study|Physician Decision|1|||
160777638|NCT04602000|580570995|FG001|Overall Study|Physician Decision|0|||
160777639|NCT04602000|580570996|FG002|Overall Study|Physician Decision|0|||
160777640|NCT04602000|580570997|FG003|Overall Study|Physician Decision|2|||
160777641|NCT04602000|580570998|FG004|Overall Study|Physician Decision|2|||
160777642|NCT04602000|580570994|FG000|Overall Study|Death|0|||
160777643|NCT04602000|580570995|FG001|Overall Study|Death|1|||
160777644|NCT04602000|580570996|FG002|Overall Study|Death|0|||
160777645|NCT04602000|580570997|FG003|Overall Study|Death|1|||
160886903|NCT01163032|580980622|FG000|Open Label Extension Phase|Protocol Violation|0|||
160886904|NCT01163032|580980623|FG001|Open Label Extension Phase|Protocol Violation|0|||
160777646|NCT04602000|580570998|FG004|Overall Study|Death|2|||
160777647|NCT04602000|580570994|FG000|Overall Study|Lost to Follow-up|0|||
160777648|NCT04602000|580570995|FG001|Overall Study|Lost to Follow-up|0|||
161325966|NCT04501952|582579641|FG001|Overall Study|Investigator's Discretion|1|||
161325967|NCT04501952|582579640|FG000|Overall Study|Protocol Violation|1|||
160777649|NCT04602000|580570996|FG002|Overall Study|Lost to Follow-up|0|||
160777650|NCT04602000|580570997|FG003|Overall Study|Lost to Follow-up|3|||
160777651|NCT04602000|580570998|FG004|Overall Study|Lost to Follow-up|4|||
160777652|NCT04602000|580570994|FG000|Overall Study|Other|4|||
160777653|NCT04602000|580570995|FG001|Overall Study|Other|1|||
160777654|NCT04602000|580570996|FG002|Overall Study|Other|2|||
160777655|NCT04602000|580570997|FG003|Overall Study|Other|5|||
160777656|NCT04602000|580570998|FG004|Overall Study|Other|4|||
160777657|NCT04602000|580570994|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777658|NCT04602000|580570995|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777659|NCT04602000|580570996|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
160777660|NCT04602000|580570997|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777661|NCT04602000|580570998|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
160777662|NCT05607043|580570999|FG000|Overall Study|Lost to Follow-up|2|||
160777663|NCT05427916|580571006|FG000|Overall Study|Adverse Event|3|||
160777664|NCT05427916|580571007|FG001|Overall Study|Adverse Event|0|||
160777665|NCT05427916|580571006|FG000|Overall Study|Lack of Efficacy|6|||
160777666|NCT05427916|580571007|FG001|Overall Study|Lack of Efficacy|0|||
160777667|NCT05427916|580571006|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
160777668|NCT05427916|580571007|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
160777669|NCT00429299|580571010|FG000|Overall Study|Disease Progression|1|||
160777670|NCT00429299|580571011|FG001|Overall Study|Disease Progression|1|||
160777671|NCT00429299|580571012|FG002|Overall Study|Disease Progression|0|||
160777672|NCT00429299|580571010|FG000|Overall Study|Adverse Event|2|||
160777673|NCT00429299|580571011|FG001|Overall Study|Adverse Event|5|||
160777674|NCT00429299|580571012|FG002|Overall Study|Adverse Event|1|||
160777675|NCT00429299|580571010|FG000|Overall Study|Protocol Violation|1|||
160777676|NCT00429299|580571011|FG001|Overall Study|Protocol Violation|0|||
160777677|NCT00429299|580571012|FG002|Overall Study|Protocol Violation|0|||
160777678|NCT00429299|580571010|FG000|Overall Study|Withdrawal by Subject|0|||
160777679|NCT00429299|580571011|FG001|Overall Study|Withdrawal by Subject|1|||
160777680|NCT00429299|580571012|FG002|Overall Study|Withdrawal by Subject|3|||
160777681|NCT01257542|580571013|FG000|Overall Study|Protocol Violation|3|||
160777682|NCT01257542|580571014|FG001|Overall Study|Protocol Violation|5|||
160777683|NCT01257542|580571013|FG000|Overall Study|Withdrawal by Subject|0|||
160777684|NCT01257542|580571014|FG001|Overall Study|Withdrawal by Subject|2|||
160777685|NCT00081458|580571016|FG000|Overall Study|Adverse Event|1|||
160777686|NCT00081458|580571017|FG001|Overall Study|Adverse Event|5|||
160777687|NCT00081458|580571018|FG002|Overall Study|Adverse Event|2|||
160777688|NCT00081458|580571016|FG000|Overall Study|Withdrawal by Subject|0|||
160777689|NCT00081458|580571017|FG001|Overall Study|Withdrawal by Subject|3|||
160777690|NCT00081458|580571018|FG002|Overall Study|Withdrawal by Subject|1|||
160777691|NCT00081458|580571016|FG000|Overall Study|Randomized but not dosed|0|||
160777692|NCT00081458|580571017|FG001|Overall Study|Randomized but not dosed|0|||
160777693|NCT00081458|580571018|FG002|Overall Study|Randomized but not dosed|1|||
160777694|NCT03097315|580571021|FG000|Overall Study|Withdrawal by Subject|1|||
160777695|NCT00195429|580571022|FG000|Overall Study|Adverse Event|2|||
160777696|NCT00195429|580571023|FG001|Overall Study|Adverse Event|4|||
160777697|NCT00195429|580571022|FG000|Overall Study|Lack of Efficacy|2|||
160777698|NCT00195429|580571023|FG001|Overall Study|Lack of Efficacy|1|||
160777699|NCT00195429|580571022|FG000|Overall Study|Lost to Follow-up|1|||
160777700|NCT00195429|580571023|FG001|Overall Study|Lost to Follow-up|0|||
160777701|NCT02948400|580571028|FG000|Overall Study|Withdrawal by Subject|17|||
161229002|NCT00048568|582220321|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
161229003|NCT00048568|582220319|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
161229004|NCT00048568|582220320|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
161229005|NCT00048568|582220321|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
160777702|NCT02948400|580571029|FG001|Overall Study|Withdrawal by Subject|10|||
160777703|NCT02948400|580571028|FG000|Overall Study|failed to attend appointments|47|||
160777704|NCT02948400|580571029|FG001|Overall Study|failed to attend appointments|34|||
160777705|NCT02948400|580571028|FG000|Overall Study|COVID-related closure|6|||
160777706|NCT02948400|580571029|FG001|Overall Study|COVID-related closure|2|||
160777707|NCT02948400|580571028|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
160777708|NCT02948400|580571029|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
160777709|NCT02948400|580571028|FG000|Overall Study|motion sickness in virtual reality|2|||
160777710|NCT02948400|580571029|FG001|Overall Study|motion sickness in virtual reality|0|||
160777711|NCT05561140|580571030|FG000|Randomized Treatment Period|Adverse Event|1|||
160777712|NCT05561140|580571031|FG001|Randomized Treatment Period|Adverse Event|0|||
160886905|NCT01163032|580980624|FG002|Open Label Extension Phase|Protocol Violation|1|||
160777713|NCT05561140|580571030|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
160777714|NCT05561140|580571031|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
160777715|NCT05561140|580571030|FG000|Open Label Treatment Period|Adverse Event|6|||
160777716|NCT05561140|580571031|FG001|Open Label Treatment Period|Adverse Event|4|||
160777717|NCT05561140|580571030|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
160886906|NCT01163032|580980622|FG000|Open Label Extension Phase|Study Termination|0|||
160886907|NCT01163032|580980623|FG001|Open Label Extension Phase|Study Termination|0|||
160886908|NCT01163032|580980624|FG002|Open Label Extension Phase|Study Termination|7|||
160886909|NCT01163032|580980622|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
160886910|NCT01163032|580980623|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
160886911|NCT01163032|580980624|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
160886912|NCT02751931|580980626|FG000|Overall Study|Adverse Event|3|||
160886913|NCT02751931|580980627|FG001|Overall Study|Adverse Event|0|||
160886914|NCT02751931|580980626|FG000|Overall Study|Other: Miscelleneous|10|||
160886915|NCT02751931|580980627|FG001|Overall Study|Other: Miscelleneous|8|||
160886916|NCT03326206|580980633|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
160886917|NCT03326206|580980634|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
160886918|NCT03326206|580980633|FG000|Overall Study - 24 months|Death|8|||
160886919|NCT03326206|580980634|FG001|Overall Study - 24 months|Death|92|||
160886920|NCT03326206|580980633|FG000|Overall Study - 24 months|Observational data not available|43|||
160886921|NCT03326206|580980634|FG001|Overall Study - 24 months|Observational data not available|2879|||
160886922|NCT03326206|580980633|FG000|12 months|Unable to match cases with controls|17|||
160886923|NCT03326206|580980634|FG001|12 months|Unable to match cases with controls|22721|||
160886924|NCT03326206|580980633|FG000|12 months|Death|2|||
160886925|NCT03326206|580980634|FG001|12 months|Death|50|||
160886926|NCT03326206|580980633|FG000|12 months|Observational data not available|49|||
160886927|NCT03326206|580980634|FG001|12 months|Observational data not available|2921|||
160886928|NCT04090411|580980635|FG000|Induction Period|Adverse Event|3|||
160886929|NCT04090411|580980636|FG001|Induction Period|Adverse Event|1|||
160886930|NCT04090411|580980637|FG002|Induction Period|Adverse Event|1|||
160886931|NCT04090411|580980638|FG003|Induction Period|Adverse Event|1|||
160886932|NCT04090411|580980639|FG004|Induction Period|Adverse Event|0|||
160886933|NCT04090411|580980640|FG005|Induction Period|Adverse Event|0|||
160886934|NCT04090411|580980641|FG006|Induction Period|Adverse Event|0|||
160886935|NCT04090411|580980642|FG007|Induction Period|Adverse Event|0|||
160886936|NCT04090411|580980643|FG008|Induction Period|Adverse Event|0|||
160886937|NCT04090411|580980644|FG009|Induction Period|Adverse Event|0|||
160886938|NCT04090411|580980645|FG010|Induction Period|Adverse Event|0|||
160886939|NCT04090411|580980646|FG011|Induction Period|Adverse Event|0|||
160886940|NCT04090411|580980647|FG012|Induction Period|Adverse Event|0|||
160886941|NCT04090411|580980635|FG000|Induction Period|Lack of Efficacy|0|||
160886942|NCT04090411|580980636|FG001|Induction Period|Lack of Efficacy|0|||
160886943|NCT04090411|580980637|FG002|Induction Period|Lack of Efficacy|1|||
160886944|NCT04090411|580980638|FG003|Induction Period|Lack of Efficacy|1|||
160886945|NCT04090411|580980639|FG004|Induction Period|Lack of Efficacy|0|||
160886946|NCT04090411|580980640|FG005|Induction Period|Lack of Efficacy|0|||
160886947|NCT04090411|580980641|FG006|Induction Period|Lack of Efficacy|0|||
160886948|NCT04090411|580980642|FG007|Induction Period|Lack of Efficacy|0|||
160886949|NCT04090411|580980643|FG008|Induction Period|Lack of Efficacy|0|||
160886950|NCT04090411|580980644|FG009|Induction Period|Lack of Efficacy|0|||
160886951|NCT04090411|580980645|FG010|Induction Period|Lack of Efficacy|0|||
160886952|NCT04090411|580980646|FG011|Induction Period|Lack of Efficacy|0|||
160886953|NCT04090411|580980647|FG012|Induction Period|Lack of Efficacy|0|||
160886954|NCT04090411|580980635|FG000|Induction Period|Physician Decision|0|||
160886955|NCT04090411|580980636|FG001|Induction Period|Physician Decision|0|||
160886956|NCT04090411|580980637|FG002|Induction Period|Physician Decision|1|||
160886957|NCT04090411|580980638|FG003|Induction Period|Physician Decision|0|||
160886958|NCT04090411|580980639|FG004|Induction Period|Physician Decision|0|||
161122991|NCT01415752|581837437|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
161122992|NCT01415752|581837438|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
161122993|NCT01415752|581837439|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
161122994|NCT01415752|581837440|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
161122995|NCT01415752|581837437|FG000|Maintenance (Step 2)|Alternative therapy|0|||
161122996|NCT01415752|581837438|FG001|Maintenance (Step 2)|Alternative therapy|1|||
161122997|NCT01415752|581837439|FG002|Maintenance (Step 2)|Alternative therapy|0|||
161122998|NCT01415752|581837440|FG003|Maintenance (Step 2)|Alternative therapy|0|||
161122999|NCT01415752|581837437|FG000|Maintenance (Step 2)|Other reasons|3|||
161123000|NCT01415752|581837438|FG001|Maintenance (Step 2)|Other reasons|6|||
161123001|NCT01415752|581837439|FG002|Maintenance (Step 2)|Other reasons|4|||
161123002|NCT01415752|581837440|FG003|Maintenance (Step 2)|Other reasons|6|||
161123003|NCT01415752|581837437|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
161123004|NCT01415752|581837438|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
160886959|NCT04090411|580980640|FG005|Induction Period|Physician Decision|0|||
160886960|NCT04090411|580980641|FG006|Induction Period|Physician Decision|0|||
160886961|NCT04090411|580980642|FG007|Induction Period|Physician Decision|0|||
160886962|NCT04090411|580980643|FG008|Induction Period|Physician Decision|0|||
161123005|NCT01415752|581837439|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
161123006|NCT01415752|581837440|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
160886963|NCT04090411|580980644|FG009|Induction Period|Physician Decision|0|||
160886964|NCT04090411|580980645|FG010|Induction Period|Physician Decision|0|||
160777718|NCT05561140|580571031|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
160777719|NCT05561140|580571030|FG000|Open Label Treatment Period|Physician Decision|0|||
160777720|NCT05561140|580571031|FG001|Open Label Treatment Period|Physician Decision|1|||
160777721|NCT05561140|580571030|FG000|Open Label Treatment Period|Pregnancy|1|||
160777722|NCT05561140|580571031|FG001|Open Label Treatment Period|Pregnancy|0|||
160777723|NCT05561140|580571030|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
160777724|NCT05561140|580571031|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
160777725|NCT05561140|580571030|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
160777726|NCT05561140|580571031|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
160777727|NCT05561140|580571030|FG000|Open Label Treatment Period|Other|1|||
160777728|NCT05561140|580571031|FG001|Open Label Treatment Period|Other|0|||
160777729|NCT05774977|580571034|FG000|Overall Study|Withdrawal by Subject|2|||
160777730|NCT01132755|580571036|FG000|Overall Study|Procedure not done due to medical reason|23|||
160777731|NCT01132755|580571036|FG000|Overall Study|Protocol Violation|15|||
160777732|NCT01132755|580571036|FG000|Overall Study|Withdrawal by Subject|4|||
160777733|NCT02324153|580571039|FG000|Overall Study|Withdrawal by Subject|4|||
160777734|NCT02324153|580571040|FG001|Overall Study|Withdrawal by Subject|1|||
160777735|NCT02324153|580571039|FG000|Overall Study|Surgery postponed after randomization|3|||
160777736|NCT02324153|580571040|FG001|Overall Study|Surgery postponed after randomization|0|||
160777737|NCT02324153|580571039|FG000|Overall Study|Developed delirium preoperatively|1|||
160777738|NCT02324153|580571040|FG001|Overall Study|Developed delirium preoperatively|0|||
160777739|NCT04017962|580571041|FG000|Overall Study|Death|2|||
160777740|NCT04017962|580571042|FG001|Overall Study|Death|0|||
160777741|NCT04017962|580571041|FG000|Overall Study|Lost to Follow-up|2|||
160777742|NCT04017962|580571042|FG001|Overall Study|Lost to Follow-up|0|||
160777743|NCT04017962|580571041|FG000|Overall Study|Physician Decision|1|||
160777744|NCT04017962|580571042|FG001|Overall Study|Physician Decision|0|||
160777745|NCT04017962|580571041|FG000|Overall Study|Discontinued LTV|5|||
160777746|NCT04017962|580571042|FG001|Overall Study|Discontinued LTV|0|||
160777747|NCT00700635|580571043|FG000|Overall Study|Adverse Event|1|||
160777748|NCT00700635|580571044|FG001|Overall Study|Adverse Event|0|||
160777749|NCT00700635|580571045|FG002|Overall Study|Adverse Event|0|||
160777750|NCT00700635|580571043|FG000|Overall Study|Lost to Follow-up|1|||
160777751|NCT00700635|580571044|FG001|Overall Study|Lost to Follow-up|3|||
160777752|NCT00700635|580571045|FG002|Overall Study|Lost to Follow-up|0|||
160777753|NCT00700635|580571043|FG000|Overall Study|Protocol Violation|2|||
160777754|NCT00700635|580571044|FG001|Overall Study|Protocol Violation|2|||
160777755|NCT00700635|580571045|FG002|Overall Study|Protocol Violation|0|||
160777756|NCT00700635|580571043|FG000|Overall Study|Withdrawal by Subject|7|||
160777757|NCT00700635|580571044|FG001|Overall Study|Withdrawal by Subject|3|||
160777758|NCT00700635|580571045|FG002|Overall Study|Withdrawal by Subject|1|||
160777759|NCT05172570|580571046|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
160777760|NCT05172570|580571047|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
160777761|NCT05172570|580571048|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
160777762|NCT05172570|580571046|FG000|Overall Study|PI Decision due to equipment shortages|0|||
160777763|NCT05172570|580571047|FG001|Overall Study|PI Decision due to equipment shortages|0|||
160777764|NCT05172570|580571048|FG002|Overall Study|PI Decision due to equipment shortages|1|||
160777765|NCT00768053|580571049|FG000|Overall Study|Adverse Event|10|||
160777766|NCT00768053|580571049|FG000|Overall Study|Lost to Follow-up|1|||
160777767|NCT00632359|580571056|FG000|Overall Study|Withdrawal by Subject|2|||
160777768|NCT01127061|580571996|FG000|Overall Study|Lost to Follow-up|7|||
160777769|NCT01127061|580571997|FG001|Overall Study|Lost to Follow-up|10|||
160777770|NCT01127061|580571996|FG000|Overall Study|Physician Decision|3|||
160777771|NCT01127061|580571997|FG001|Overall Study|Physician Decision|3|||
160777772|NCT03921541|580572000|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
160777773|NCT03921541|580572001|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
160777774|NCT00182637|580572002|FG000|Overall Study|Adverse Event|2|||
160777775|NCT00182637|580572002|FG000|Overall Study|Disease Progression|1|||
160777776|NCT04941898|580572003|FG000|Overall Study|Protocol Violation|1|||
160777777|NCT03641924|580572004|FG000|Overall Study|Withdrawal by Subject|26|||
160777778|NCT03641924|580572004|FG000|Overall Study|Lost to Follow-up|16|||
160777779|NCT03641924|580572004|FG000|Overall Study|Protocol Violation|10|||
160777780|NCT02068794|580572005|FG000|Overall Study|Withdrawal by Subject|0|||
160777781|NCT02068794|580572006|FG001|Overall Study|Withdrawal by Subject|1|||
160777782|NCT02068794|580572007|FG002|Overall Study|Withdrawal by Subject|2|||
160777783|NCT02068794|580572005|FG000|Overall Study|Early Progression|1|||
161325968|NCT04501952|582579641|FG001|Overall Study|Protocol Violation|1|||
160777784|NCT02068794|580572006|FG001|Overall Study|Early Progression|0|||
160777785|NCT02068794|580572007|FG002|Overall Study|Early Progression|1|||
160777786|NCT02068794|580572005|FG000|Overall Study|Ineligible|0|||
160777787|NCT02068794|580572006|FG001|Overall Study|Ineligible|0|||
160777788|NCT02068794|580572007|FG002|Overall Study|Ineligible|1|||
160777789|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
160777790|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
160777791|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
160777792|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
160777793|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
160777794|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
160777795|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777796|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777797|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777798|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777799|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
160777800|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
160777801|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777802|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777803|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777804|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777805|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
160777806|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
160777807|NCT00541229|580572009|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
160777808|NCT00541229|580572010|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
160777809|NCT00541229|580572011|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
160777810|NCT00541229|580572012|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
160777811|NCT00541229|580572013|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
160777812|NCT00541229|580572014|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
160777813|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
160777814|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
160777815|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
160777816|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
160777817|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
160777818|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
160777819|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
160777820|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
160777821|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
160777822|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
160777823|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
160777824|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
160777825|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777826|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777827|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777828|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777829|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
160777830|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
160777831|NCT00541229|580572009|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
160777832|NCT00541229|580572010|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
160777833|NCT00541229|580572011|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
160777834|NCT00541229|580572012|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
160777835|NCT00541229|580572013|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
160777836|NCT00541229|580572014|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
160777837|NCT00541229|580572009|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
160777838|NCT00541229|580572010|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
160777839|NCT00541229|580572011|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
160777840|NCT00541229|580572012|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
160777841|NCT00541229|580572013|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
160777842|NCT00541229|580572014|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
160777843|NCT00541229|580572009|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
160777844|NCT00541229|580572010|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777845|NCT00541229|580572011|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777846|NCT00541229|580572012|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777847|NCT00541229|580572013|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
160777848|NCT00541229|580572014|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
160777849|NCT00541229|580572009|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
160777850|NCT00541229|580572010|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
160886965|NCT04090411|580980646|FG011|Induction Period|Physician Decision|0|||
160886966|NCT04090411|580980647|FG012|Induction Period|Physician Decision|0|||
160777851|NCT00541229|580572011|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777852|NCT00541229|580572012|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777853|NCT00541229|580572013|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777854|NCT00541229|580572014|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
160777855|NCT00541229|580572009|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160886967|NCT04090411|580980635|FG000|Induction Period|Protocol Violation|0|||
160886968|NCT04090411|580980636|FG001|Induction Period|Protocol Violation|0|||
160886969|NCT04090411|580980637|FG002|Induction Period|Protocol Violation|0|||
160777856|NCT00541229|580572010|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777857|NCT00541229|580572011|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777858|NCT00541229|580572012|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777859|NCT00541229|580572013|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
160777860|NCT00541229|580572014|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
160777861|NCT00541229|580572009|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
160777862|NCT00541229|580572010|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
160777863|NCT00541229|580572011|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
160777864|NCT00541229|580572012|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
160777865|NCT00541229|580572013|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
160777866|NCT00541229|580572014|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
160777867|NCT00541229|580572009|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
160777868|NCT00541229|580572010|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
160777869|NCT00541229|580572011|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
160777870|NCT00541229|580572012|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
160777871|NCT00541229|580572013|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
160777872|NCT00541229|580572014|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
160777873|NCT00541229|580572009|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777874|NCT00541229|580572010|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777875|NCT00541229|580572011|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777876|NCT00541229|580572012|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777877|NCT00541229|580572013|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
160777878|NCT00541229|580572014|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
160777879|NCT00541229|580572009|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777880|NCT00541229|580572010|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777881|NCT00541229|580572011|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
160777882|NCT00541229|580572012|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777883|NCT00541229|580572013|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777884|NCT00541229|580572014|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
160777885|NCT01500096|580572017|FG000|Overall Study|Lost to Follow-up|1|||
160777886|NCT01500096|580572018|FG001|Overall Study|Lost to Follow-up|0|||
160777887|NCT01500096|580572019|FG002|Overall Study|Lost to Follow-up|0|||
160777888|NCT01500096|580572020|FG003|Overall Study|Lost to Follow-up|2|||
160777889|NCT00263562|580572021|FG000|Overall Study|Protocol Violation|3|||
160777890|NCT00263562|580572022|FG001|Overall Study|Protocol Violation|0|||
160777891|NCT02143778|580572023|FG000|Overall Study|Withdrawal by Subject|2|||
160777892|NCT02143778|580572023|FG000|Overall Study|Device malfunction|1|||
160777893|NCT05630755|580572024|FG000|Overall Study|Lost to Follow-up|7|||
160777894|NCT05630755|580572025|FG001|Overall Study|Lost to Follow-up|0|||
160777895|NCT05630755|580572024|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
160777896|NCT05630755|580572025|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
160777897|NCT05630755|580572024|FG000|Overall Study|Withdrawal by Subject|9|||
160777898|NCT05630755|580572025|FG001|Overall Study|Withdrawal by Subject|3|||
160777899|NCT05630755|580572024|FG000|Overall Study|Participant moved away from trial site|0|||
160777900|NCT05630755|580572025|FG001|Overall Study|Participant moved away from trial site|1|||
160777901|NCT05630755|580572024|FG000|Overall Study|Status not Recorded|316|||
160777902|NCT05630755|580572025|FG001|Overall Study|Status not Recorded|161|||
160777903|NCT00367458|580572026|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
160777904|NCT00367458|580572027|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
160777905|NCT04790201|580572032|FG000|Overall Study|Lost to Follow-up|0|||
160777906|NCT04790201|580572033|FG001|Overall Study|Lost to Follow-up|0|||
160777907|NCT04790201|580572034|FG002|Overall Study|Lost to Follow-up|2|||
160777908|NCT04790201|580572032|FG000|Overall Study|Death|0|||
160777909|NCT04790201|580572033|FG001|Overall Study|Death|1|||
160777910|NCT04790201|580572034|FG002|Overall Study|Death|0|||
160777911|NCT04790201|580572032|FG000|Overall Study|Protocol Violation|1|||
160777912|NCT04790201|580572033|FG001|Overall Study|Protocol Violation|0|||
160777913|NCT04790201|580572034|FG002|Overall Study|Protocol Violation|1|||
160777914|NCT01334515|580572035|FG000|Overall Study|Adverse Event|1|||
160777915|NCT01334515|580572036|FG001|Overall Study|Adverse Event|6|||
160777916|NCT01334515|580572035|FG000|Overall Study|Death|1|||
161123007|NCT01415752|581837437|FG000|Maintenance (Step 2)|ineligible|1|||
161123008|NCT01415752|581837438|FG001|Maintenance (Step 2)|ineligible|1|||
161123009|NCT01415752|581837439|FG002|Maintenance (Step 2)|ineligible|1|||
161123010|NCT01415752|581837440|FG003|Maintenance (Step 2)|ineligible|0|||
161123011|NCT01415752|581837437|FG000|Maintenance (Step 2)|Missing|4|||
161123012|NCT01415752|581837438|FG001|Maintenance (Step 2)|Missing|1|||
161123013|NCT01415752|581837439|FG002|Maintenance (Step 2)|Missing|4|||
160777917|NCT01334515|580572036|FG001|Overall Study|Death|0|||
161123014|NCT01415752|581837440|FG003|Maintenance (Step 2)|Missing|3|||
161123015|NCT03083886|581837441|FG000|Overall Study|Withdrawal by Subject|51|||
161123016|NCT03083886|581837442|FG001|Overall Study|Withdrawal by Subject|73|||
160886970|NCT04090411|580980638|FG003|Induction Period|Protocol Violation|1|||
160886971|NCT04090411|580980639|FG004|Induction Period|Protocol Violation|0|||
160886972|NCT04090411|580980640|FG005|Induction Period|Protocol Violation|0|||
160886973|NCT04090411|580980641|FG006|Induction Period|Protocol Violation|0|||
161325969|NCT04501952|582579640|FG000|Overall Study|Withdrew Consent|5|||
161325970|NCT04501952|582579641|FG001|Overall Study|Withdrew Consent|4|||
161325971|NCT04501952|582579640|FG000|Overall Study|Lost to Follow-up|7|||
160777918|NCT01334515|580572035|FG000|Overall Study|Lack of Efficacy|8|||
160777919|NCT01334515|580572036|FG001|Overall Study|Lack of Efficacy|21|||
160777920|NCT01334515|580572035|FG000|Overall Study|Physician Decision|1|||
160777921|NCT01334515|580572036|FG001|Overall Study|Physician Decision|1|||
160777922|NCT01334515|580572035|FG000|Overall Study|Withdrawal by Subject|1|||
160777923|NCT01334515|580572036|FG001|Overall Study|Withdrawal by Subject|1|||
160777924|NCT03637374|580572037|FG000|Overall Study|Death|2|||
160777925|NCT03637374|580572038|FG001|Overall Study|Death|0|||
160777926|NCT02836769|580572042|FG000|Overall Study|Lost to Follow-up|10|||
160777927|NCT02836769|580572042|FG000|Overall Study|Medical withdrawal|2|||
160777928|NCT02836769|580572042|FG000|Overall Study|Withdrawal by Subject|3|||
160777929|NCT04339972|580572043|FG000|Overall Study|Scheduling Issues|3|||
160777930|NCT04339972|580572044|FG001|Overall Study|Scheduling Issues|3|||
160777931|NCT04339972|580572043|FG000|Overall Study|dropout|1|||
160777932|NCT04339972|580572044|FG001|Overall Study|dropout|1|||
160777933|NCT04339972|580572043|FG000|Overall Study|Technical issues|1|||
160777934|NCT04339972|580572044|FG001|Overall Study|Technical issues|0|||
160777935|NCT04339972|580572043|FG000|Overall Study|Claustraphobia|0|||
160777936|NCT04339972|580572044|FG001|Overall Study|Claustraphobia|1|||
160777937|NCT00776997|580572045|FG000|Overall Study|Adverse Event|2|||
160777938|NCT02403271|580572046|FG000|Period 1|Other varied reasons|1|||
160777939|NCT02403271|580572047|FG001|Period 1|Other varied reasons|0|||
160777940|NCT02403271|580572046|FG000|Period 2|Withdrawal by Subject|0|||
160777941|NCT02403271|580572047|FG001|Period 2|Withdrawal by Subject|14|||
160777942|NCT02403271|580572046|FG000|Period 2|Death|0|||
160777943|NCT02403271|580572047|FG001|Period 2|Death|84|||
160777944|NCT02403271|580572046|FG000|Period 2|Lost to Follow-up|0|||
160777945|NCT02403271|580572047|FG001|Period 2|Lost to Follow-up|2|||
160777946|NCT02403271|580572046|FG000|Period 2|Study Terminated by Sponsor|0|||
160777947|NCT02403271|580572047|FG001|Period 2|Study Terminated by Sponsor|14|||
160777948|NCT02403271|580572046|FG000|Period 2|Other varied reasons|0|||
160777949|NCT02403271|580572047|FG001|Period 2|Other varied reasons|10|||
160777950|NCT03925220|580572048|FG000|Overall Study|Withdrawal by Subject|4|||
160777951|NCT03925220|580572049|FG001|Overall Study|Withdrawal by Subject|4|||
160777952|NCT03925220|580572050|FG002|Overall Study|Withdrawal by Subject|4|||
160777953|NCT03925220|580572051|FG003|Overall Study|Withdrawal by Subject|4|||
160777954|NCT03925220|580572048|FG000|Overall Study|Lost to Follow-up|40|||
160777955|NCT03925220|580572049|FG001|Overall Study|Lost to Follow-up|46|||
160777956|NCT03925220|580572050|FG002|Overall Study|Lost to Follow-up|37|||
160777957|NCT03925220|580572051|FG003|Overall Study|Lost to Follow-up|38|||
160777958|NCT00374868|580572052|FG000|Overall Study|Adverse Event|12|||
160777959|NCT00374868|580572052|FG000|Overall Study|Progressive Disease|7|||
160777960|NCT00374868|580572052|FG000|Overall Study|Physician Decision|13|||
160777961|NCT00374868|580572052|FG000|Overall Study|Lost to Follow-up|1|||
160777962|NCT00374868|580572052|FG000|Overall Study|Death|2|||
160777963|NCT00374868|580572052|FG000|Overall Study|Other - Not Specified|1|||
160777964|NCT04470427|580572053|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
160777965|NCT04470427|580572054|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
160777966|NCT04470427|580572055|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
160777967|NCT04470427|580572056|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
160777968|NCT04470427|580572057|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
160777969|NCT04470427|580572058|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
160777970|NCT04470427|580572053|FG000|Part B :Open-label|Other than specified|0|||
160777971|NCT04470427|580572054|FG001|Part B :Open-label|Other than specified|0|||
160777972|NCT04470427|580572055|FG002|Part B :Open-label|Other than specified|788|||
160777973|NCT04470427|580572056|FG003|Part B :Open-label|Other than specified|0|||
160777974|NCT04470427|580572057|FG004|Part B :Open-label|Other than specified|523|||
160777975|NCT04470427|580572058|FG005|Part B :Open-label|Other than specified|0|||
160777976|NCT04470427|580572053|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
160777977|NCT04470427|580572054|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
160777978|NCT04470427|580572055|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
160777979|NCT04470427|580572056|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
160777980|NCT04470427|580572057|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
161325972|NCT04501952|582579641|FG001|Overall Study|Lost to Follow-up|2|||
160777981|NCT04470427|580572058|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
160777982|NCT04470427|580572053|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
160777983|NCT04470427|580572054|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
160777984|NCT04470427|580572055|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
160777985|NCT04470427|580572056|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
160777986|NCT04470427|580572057|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
160777987|NCT04470427|580572058|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
160777988|NCT03301714|580572059|FG000|Overall Study|Lost to Follow-up|10|||
160777989|NCT03301714|580572060|FG001|Overall Study|Lost to Follow-up|4|||
160777990|NCT03301714|580572061|FG002|Overall Study|Lost to Follow-up|4|||
160777991|NCT03301714|580572059|FG000|Overall Study|Did not receive allocated intervention|0|||
160777992|NCT03301714|580572060|FG001|Overall Study|Did not receive allocated intervention|2|||
160777993|NCT03301714|580572061|FG002|Overall Study|Did not receive allocated intervention|3|||
160777994|NCT03188185|580572062|FG000|Stage 1|Adverse Event|4|||
160777995|NCT03188185|580572063|FG001|Stage 1|Adverse Event|12|||
160777996|NCT03188185|580572064|FG002|Stage 1|Adverse Event|0|||
160777997|NCT03188185|580572065|FG003|Stage 1|Adverse Event|0|||
160777998|NCT03188185|580572062|FG000|Stage 1|Lack of Efficacy|0|||
160777999|NCT03188185|580572063|FG001|Stage 1|Lack of Efficacy|2|||
160778000|NCT03188185|580572064|FG002|Stage 1|Lack of Efficacy|0|||
160778001|NCT03188185|580572065|FG003|Stage 1|Lack of Efficacy|0|||
160778002|NCT03188185|580572062|FG000|Stage 1|Lost to Follow-up|6|||
160778003|NCT03188185|580572063|FG001|Stage 1|Lost to Follow-up|1|||
160778004|NCT03188185|580572064|FG002|Stage 1|Lost to Follow-up|0|||
160778005|NCT03188185|580572065|FG003|Stage 1|Lost to Follow-up|0|||
160778006|NCT03188185|580572062|FG000|Stage 1|Withdrawal by Subject|9|||
160778007|NCT03188185|580572063|FG001|Stage 1|Withdrawal by Subject|0|||
160778008|NCT03188185|580572064|FG002|Stage 1|Withdrawal by Subject|0|||
160778009|NCT03188185|580572065|FG003|Stage 1|Withdrawal by Subject|0|||
160778010|NCT03188185|580572062|FG000|Stage 1|Identified as a professional patient|0|||
160778011|NCT03188185|580572063|FG001|Stage 1|Identified as a professional patient|1|||
160778012|NCT03188185|580572064|FG002|Stage 1|Identified as a professional patient|0|||
160778013|NCT03188185|580572065|FG003|Stage 1|Identified as a professional patient|0|||
160778014|NCT03188185|580572062|FG000|Stage 2|Adverse Event|0|||
160778015|NCT03188185|580572063|FG001|Stage 2|Adverse Event|0|||
160778016|NCT03188185|580572064|FG002|Stage 2|Adverse Event|2|||
160778017|NCT03188185|580572065|FG003|Stage 2|Adverse Event|4|||
160778018|NCT03188185|580572062|FG000|Stage 2|Lack of Efficacy|0|||
160778019|NCT03188185|580572063|FG001|Stage 2|Lack of Efficacy|0|||
160778020|NCT03188185|580572064|FG002|Stage 2|Lack of Efficacy|3|||
160778021|NCT03188185|580572065|FG003|Stage 2|Lack of Efficacy|0|||
160778022|NCT03188185|580572062|FG000|Stage 2|Lost to Follow-up|0|||
160778023|NCT03188185|580572063|FG001|Stage 2|Lost to Follow-up|0|||
160778024|NCT03188185|580572064|FG002|Stage 2|Lost to Follow-up|1|||
160778025|NCT03188185|580572065|FG003|Stage 2|Lost to Follow-up|0|||
160778026|NCT03188185|580572062|FG000|Stage 2|Physician Decision|0|||
160778027|NCT03188185|580572063|FG001|Stage 2|Physician Decision|0|||
160778028|NCT03188185|580572064|FG002|Stage 2|Physician Decision|0|||
160778029|NCT03188185|580572065|FG003|Stage 2|Physician Decision|1|||
160778030|NCT03188185|580572062|FG000|Stage 2|Withdrawal by Subject|0|||
160778031|NCT03188185|580572063|FG001|Stage 2|Withdrawal by Subject|0|||
160778032|NCT03188185|580572064|FG002|Stage 2|Withdrawal by Subject|3|||
160778033|NCT03188185|580572065|FG003|Stage 2|Withdrawal by Subject|1|||
160778034|NCT02112552|580572068|FG000|Overall Study|Withdrawal by Subject|1|||
160778035|NCT02112552|580572068|FG000|Overall Study|Adverse Event|1|||
160778036|NCT03349515|580572072|FG000|Overall Study|Lack of Efficacy|2|||
160778037|NCT03349515|580572073|FG001|Overall Study|Lack of Efficacy|0|||
160778038|NCT03349515|580572072|FG000|Overall Study|Physician Decision|3|||
160778039|NCT03349515|580572073|FG001|Overall Study|Physician Decision|1|||
160778040|NCT01529268|580572078|FG000|Overall Study|Lost to Follow-up|9|||
160778041|NCT01529268|580572079|FG001|Overall Study|Lost to Follow-up|3|||
160778042|NCT01529268|580572078|FG000|Overall Study|Moved|3|||
160778043|NCT01529268|580572079|FG001|Overall Study|Moved|0|||
160778044|NCT00303953|580572080|FG000|Overall Study|Ineligible|1|||
161229006|NCT00048568|582220319|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
160778045|NCT00303953|580572080|FG000|Overall Study|Death|1|||
160778046|NCT00303953|580572080|FG000|Overall Study|Adverse Event|4|||
160778047|NCT00303953|580572080|FG000|Overall Study|Lack of Efficacy|12|||
160886974|NCT04090411|580980642|FG007|Induction Period|Protocol Violation|0|||
160778048|NCT00303953|580572080|FG000|Overall Study|Physician Decision|1|||
160778049|NCT02393755|580572081|FG000|Overall Study|Withdrawal by Subject|0|||
161229007|NCT00048568|582220320|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
160778050|NCT02393755|580572082|FG001|Overall Study|Withdrawal by Subject|3|||
160778051|NCT02393755|580572081|FG000|Overall Study|Adverse Event|0|||
160778052|NCT02393755|580572082|FG001|Overall Study|Adverse Event|2|||
161229008|NCT00048568|582220321|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
160778053|NCT02393755|580572081|FG000|Overall Study|Physician Decision|0|||
160778054|NCT02393755|580572082|FG001|Overall Study|Physician Decision|2|||
160778055|NCT01327703|580572083|FG000|Second Treatment Period|Adverse Event|1|||
160778056|NCT01327703|580572084|FG001|Second Treatment Period|Adverse Event|1|||
160778057|NCT01327703|580572083|FG000|Second Treatment Period|Protocol Violation|0|||
160778058|NCT01327703|580572084|FG001|Second Treatment Period|Protocol Violation|1|||
160778059|NCT05324371|580572085|FG000|Overall Study|Withdrawal by Subject|1|||
160778060|NCT05324371|580572085|FG000|Overall Study|Death|1|||
160778061|NCT00812097|580572086|FG000|Overall Study|Death|3|||
160778062|NCT00812097|580572087|FG001|Overall Study|Death|10|||
160778063|NCT00812097|580572088|FG002|Overall Study|Death|3|||
161325973|NCT04501952|582579640|FG000|Overall Study|Randomized and Never Treated|13|||
161325974|NCT04501952|582579641|FG001|Overall Study|Randomized and Never Treated|9|||
161325975|NCT02609984|582579643|FG000|Overall Study|Death|29|||
161325976|NCT02609984|582579644|FG001|Overall Study|Death|26|||
161325977|NCT02609984|582579643|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
161325978|NCT02609984|582579644|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
161325979|NCT02609984|582579643|FG000|Overall Study|Lost to Follow-up|1|||
161325980|NCT02609984|582579644|FG001|Overall Study|Lost to Follow-up|2|||
161325981|NCT02609984|582579643|FG000|Overall Study|Withdrawal by Subject|0|||
161325982|NCT02609984|582579644|FG001|Overall Study|Withdrawal by Subject|1|||
161325983|NCT02609984|582579643|FG000|Overall Study|Disease Progression|2|||
161325984|NCT02609984|582579644|FG001|Overall Study|Disease Progression|0|||
161325985|NCT02256839|582579646|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
161325986|NCT02256839|582579647|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
161325987|NCT01843803|582579648|FG000|Overall Study|not a Veteran, did not see provider|1|||
161325988|NCT01843803|582579649|FG001|Overall Study|not a Veteran, did not see provider|3|||
161325989|NCT00436826|582579655|FG000|Double Blind Period (DBP)|Adverse Event|2|||
161325990|NCT00436826|582579656|FG001|Double Blind Period (DBP)|Adverse Event|0|||
161325991|NCT00436826|582579657|FG002|Double Blind Period (DBP)|Adverse Event|0|||
161325992|NCT00436826|582579658|FG003|Double Blind Period (DBP)|Adverse Event|0|||
161325993|NCT00436826|582579659|FG004|Double Blind Period (DBP)|Adverse Event|0|||
161325994|NCT00436826|582579660|FG005|Double Blind Period (DBP)|Adverse Event|0|||
161325995|NCT00436826|582579655|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
161325996|NCT00436826|582579656|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
161325997|NCT00436826|582579657|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
161325998|NCT00436826|582579658|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
161325999|NCT00436826|582579659|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
161326000|NCT00436826|582579660|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
161326001|NCT00436826|582579655|FG000|Double Blind Period (DBP)|Other|10|||
161326002|NCT00436826|582579656|FG001|Double Blind Period (DBP)|Other|11|||
161326003|NCT00436826|582579657|FG002|Double Blind Period (DBP)|Other|0|||
161326004|NCT00436826|582579658|FG003|Double Blind Period (DBP)|Other|0|||
161326005|NCT00436826|582579659|FG004|Double Blind Period (DBP)|Other|0|||
161326006|NCT00436826|582579660|FG005|Double Blind Period (DBP)|Other|0|||
161326007|NCT00436826|582579655|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161326008|NCT00436826|582579656|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161326009|NCT00436826|582579657|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161326010|NCT00436826|582579658|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
161326011|NCT00436826|582579659|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
160778064|NCT00812097|580572089|FG003|Overall Study|Death|3|||
160778065|NCT00812097|580572086|FG000|Overall Study|Withdrawal by Subject|14|||
160778066|NCT00812097|580572087|FG001|Overall Study|Withdrawal by Subject|12|||
160778067|NCT00812097|580572088|FG002|Overall Study|Withdrawal by Subject|8|||
160778068|NCT00812097|580572089|FG003|Overall Study|Withdrawal by Subject|2|||
160778069|NCT00812097|580572086|FG000|Overall Study|Lost to Follow-up|90|||
160778070|NCT00812097|580572087|FG001|Overall Study|Lost to Follow-up|14|||
160778071|NCT00812097|580572088|FG002|Overall Study|Lost to Follow-up|17|||
160778072|NCT00812097|580572089|FG003|Overall Study|Lost to Follow-up|5|||
160778073|NCT00812097|580572086|FG000|Overall Study|Explantation of study device(s)|27|||
160778074|NCT00812097|580572087|FG001|Overall Study|Explantation of study device(s)|29|||
160778075|NCT00812097|580572088|FG002|Overall Study|Explantation of study device(s)|14|||
160778076|NCT00812097|580572089|FG003|Overall Study|Explantation of study device(s)|20|||
160778077|NCT00812097|580572086|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
160778078|NCT00812097|580572087|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
160778079|NCT00812097|580572088|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
160778080|NCT00812097|580572089|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
160778081|NCT04822194|580572090|FG000|Overall Study|Withdrawal by Subject|5|||
160778082|NCT04822194|580572091|FG001|Overall Study|Withdrawal by Subject|4|||
160778083|NCT04822194|580572090|FG000|Overall Study|Technical issues with MR scanner|1|||
160778084|NCT04822194|580572091|FG001|Overall Study|Technical issues with MR scanner|0|||
160778085|NCT04822194|580572090|FG000|Overall Study|Lost to Follow-up|5|||
160778086|NCT04822194|580572091|FG001|Overall Study|Lost to Follow-up|7|||
160778087|NCT04738487|580572092|FG000|Overall Study|Participant Ongoing in Study|298|||
160778088|NCT04738487|580572093|FG001|Overall Study|Participant Ongoing in Study|297|||
160778089|NCT04738487|580572092|FG000|Overall Study|Withdrawal by Subject|7|||
160778090|NCT04738487|580572093|FG001|Overall Study|Withdrawal by Subject|9|||
160778091|NCT04738487|580572092|FG000|Overall Study|Lost to Follow-up|2|||
160778092|NCT04738487|580572093|FG001|Overall Study|Lost to Follow-up|0|||
160778093|NCT04738487|580572092|FG000|Overall Study|Death|287|||
160778094|NCT04738487|580572093|FG001|Overall Study|Death|306|||
160778095|NCT04818112|580572094|FG000|Overall Study|Withdrawal by Subject|54|||
160778096|NCT04818112|580572095|FG001|Overall Study|Withdrawal by Subject|12|||
160778097|NCT04818112|580572094|FG000|Overall Study|Lost to Follow-up|38|||
161123017|NCT03083886|581837443|FG002|Overall Study|Withdrawal by Subject|104|||
161123018|NCT03083886|581837441|FG000|Overall Study|Missing Baseline data|43|||
161123019|NCT03083886|581837442|FG001|Overall Study|Missing Baseline data|42|||
161123020|NCT03083886|581837443|FG002|Overall Study|Missing Baseline data|31|||
161123021|NCT03083886|581837441|FG000|Overall Study|Investigator terminated|1|||
161123022|NCT03083886|581837442|FG001|Overall Study|Investigator terminated|6|||
161123023|NCT03083886|581837443|FG002|Overall Study|Investigator terminated|3|||
161123024|NCT03286842|581837444|FG000|Overall Study|Patients rolled over to another study|80|||
161123025|NCT01391507|581837445|FG000|Overall Study|Death|0|||
161123026|NCT01391507|581837446|FG001|Overall Study|Death|0|||
161123027|NCT01391507|581837447|FG002|Overall Study|Death|0|||
161123028|NCT01391507|581837448|FG003|Overall Study|Death|1|||
161123029|NCT01391507|581837445|FG000|Overall Study|Adverse Event|1|||
161123030|NCT01391507|581837446|FG001|Overall Study|Adverse Event|1|||
161123031|NCT01391507|581837447|FG002|Overall Study|Adverse Event|2|||
161123032|NCT01391507|581837448|FG003|Overall Study|Adverse Event|2|||
161123033|NCT01391507|581837445|FG000|Overall Study|Withdrawal by Subject|1|||
161123034|NCT01391507|581837446|FG001|Overall Study|Withdrawal by Subject|2|||
161123035|NCT01391507|581837447|FG002|Overall Study|Withdrawal by Subject|1|||
161123036|NCT01391507|581837448|FG003|Overall Study|Withdrawal by Subject|1|||
161123037|NCT01391507|581837445|FG000|Overall Study|Lack of Efficacy|0|||
161123038|NCT01391507|581837446|FG001|Overall Study|Lack of Efficacy|0|||
161123039|NCT01391507|581837447|FG002|Overall Study|Lack of Efficacy|0|||
161123040|NCT01391507|581837448|FG003|Overall Study|Lack of Efficacy|1|||
161123041|NCT01391507|581837445|FG000|Overall Study|Protocol Violation|2|||
161123042|NCT01391507|581837446|FG001|Overall Study|Protocol Violation|1|||
161123043|NCT01391507|581837447|FG002|Overall Study|Protocol Violation|1|||
161123044|NCT01391507|581837448|FG003|Overall Study|Protocol Violation|2|||
161123045|NCT01453855|581837449|FG000|Overall Study|Adverse Event|3|||
161123046|NCT01453855|581837450|FG001|Overall Study|Adverse Event|4|||
161123047|NCT01453855|581837449|FG000|Overall Study|Lost to Follow-up|2|||
161123048|NCT01453855|581837450|FG001|Overall Study|Lost to Follow-up|1|||
161123049|NCT01453855|581837449|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
161123050|NCT01453855|581837450|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
161229009|NCT00048568|582220319|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
161229010|NCT00048568|582220320|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
161229011|NCT00048568|582220321|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
161326012|NCT00436826|582579660|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
161326013|NCT00436826|582579655|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161326014|NCT00436826|582579656|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161326015|NCT00436826|582579657|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
161326016|NCT00436826|582579658|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
161326017|NCT00436826|582579659|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161326018|NCT00436826|582579660|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
161326019|NCT00436826|582579655|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161326020|NCT00436826|582579656|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161326021|NCT00436826|582579657|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161326022|NCT00436826|582579658|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
161326023|NCT00436826|582579659|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
161326024|NCT00436826|582579660|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
161123051|NCT01453855|581837449|FG000|Overall Study|Noncompliance|1|||
161123052|NCT01453855|581837450|FG001|Overall Study|Noncompliance|0|||
161229012|NCT00048568|582220319|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
161229013|NCT00048568|582220320|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
161229014|NCT00048568|582220321|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
161229015|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|Death|1|||
161229016|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|Death|1|||
161229017|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|Death|0|||
161229018|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
161229019|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
161229020|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
161229021|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
161229022|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
161229023|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
161229024|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
161123053|NCT01453855|581837449|FG000|Overall Study|Inadequate Control of IOP|1|||
161123054|NCT01453855|581837450|FG001|Overall Study|Inadequate Control of IOP|5|||
161123055|NCT01453855|581837449|FG000|Overall Study|Other|0|||
161123056|NCT01453855|581837450|FG001|Overall Study|Other|1|||
161123057|NCT01562548|581837455|FG000|Overall Study|Lost to Follow-up|0|||
161123058|NCT01562548|581837456|FG001|Overall Study|Lost to Follow-up|0|||
161123059|NCT01562548|581837457|FG002|Overall Study|Lost to Follow-up|1|||
160778098|NCT04818112|580572095|FG001|Overall Study|Lost to Follow-up|10|||
160778099|NCT00640289|580572096|FG000|Overall Study|Death|3|||
160778100|NCT00640289|580572096|FG000|Overall Study|Withdrawal by Subject|1|||
160778101|NCT00640289|580572096|FG000|Overall Study|Lost to Follow-up|1|||
160778102|NCT00640289|580572096|FG000|Overall Study|Data collected under different amendment|2|||
160778103|NCT00640289|580572096|FG000|Overall Study|Transferred to another center|1|||
160778104|NCT00640289|580572096|FG000|Overall Study|Missing status|5|||
160778105|NCT03550209|580572097|FG000|Overall Study|Lost to Follow-up|1|||
160778106|NCT03550209|580572098|FG001|Overall Study|Lost to Follow-up|0|||
160778107|NCT03550209|580572099|FG002|Overall Study|Lost to Follow-up|1|||
160778108|NCT03550209|580572100|FG003|Overall Study|Lost to Follow-up|0|||
160778109|NCT03550209|580572097|FG000|Overall Study|Withdrawal by Subject|0|||
160778110|NCT03550209|580572098|FG001|Overall Study|Withdrawal by Subject|3|||
160778111|NCT03550209|580572099|FG002|Overall Study|Withdrawal by Subject|1|||
160778112|NCT03550209|580572100|FG003|Overall Study|Withdrawal by Subject|2|||
160778113|NCT03550209|580572097|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
160778114|NCT03550209|580572098|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
160778115|NCT03550209|580572099|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
160778116|NCT03550209|580572100|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
160778117|NCT06170827|580572103|FG000|Overall Study|Withdrawal by Subject|1|||
160778118|NCT06170827|580572104|FG001|Overall Study|Withdrawal by Subject|1|||
160778119|NCT03599713|580572109|FG000|Overall Study|Death|38|||
160778120|NCT03599713|580572110|FG001|Overall Study|Death|3|||
160778121|NCT03599713|580572109|FG000|Overall Study|Withdrawal by Subject|17|||
160778122|NCT03599713|580572110|FG001|Overall Study|Withdrawal by Subject|0|||
160778123|NCT03599713|580572109|FG000|Overall Study|Lost to Follow-up|4|||
160778124|NCT03599713|580572110|FG001|Overall Study|Lost to Follow-up|0|||
160778125|NCT03599713|580572109|FG000|Overall Study|Discontinued Due to End of Study|42|||
160778126|NCT03599713|580572110|FG001|Overall Study|Discontinued Due to End of Study|3|||
160778127|NCT05578872|580572113|FG000|Overall Study|Withdrawal by Subject|2|||
160778128|NCT05578872|580572114|FG001|Overall Study|Withdrawal by Subject|1|||
160778129|NCT05578872|580572113|FG000|Overall Study|Adverse Event|1|||
160778130|NCT05578872|580572114|FG001|Overall Study|Adverse Event|1|||
161123060|NCT01562548|581837458|FG003|Overall Study|Lost to Follow-up|0|||
161123061|NCT01285908|581837459|FG000|Baseline Measurement|unable to insert catheter|1|||
161123062|NCT01285908|581837460|FG001|Baseline Measurement|unable to insert catheter|0|||
160778131|NCT05578872|580572113|FG000|Overall Study|Physician Decision|1|||
160778132|NCT05578872|580572114|FG001|Overall Study|Physician Decision|2|||
160778133|NCT05578872|580572113|FG000|Overall Study|Progressive disease|10|||
160778134|NCT05578872|580572114|FG001|Overall Study|Progressive disease|9|||
160778135|NCT05578872|580572113|FG000|Overall Study|Sponsor decision|0|||
160778136|NCT05578872|580572114|FG001|Overall Study|Sponsor decision|1|||
160778137|NCT05578872|580572113|FG000|Overall Study|Toxicity and Patient's decision|0|||
160778138|NCT05578872|580572114|FG001|Overall Study|Toxicity and Patient's decision|1|||
160778139|NCT05643794|580573399|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
160778140|NCT05643794|580573400|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
160778141|NCT05643794|580573401|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160778142|NCT05643794|580573399|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160778143|NCT05643794|580573400|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160778144|NCT05643794|580573401|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160778145|NCT05643794|580573399|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778146|NCT05643794|580573400|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
160778147|NCT05643794|580573401|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778148|NCT05643794|580573399|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160778149|NCT05643794|580573400|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160778150|NCT05643794|580573401|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160778151|NCT05643794|580573399|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
160778152|NCT05643794|580573400|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778153|NCT05643794|580573401|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
160778154|NCT05643794|580573399|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
160778155|NCT05643794|580573400|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
160778156|NCT05643794|580573401|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
160778157|NCT03439839|580573404|FG000|Overall Study|Death|3|||
160778158|NCT03439839|580573405|FG001|Overall Study|Death|0|||
160778159|NCT03720847|580573406|FG000|Washout|Physician Decision|1|||
160778160|NCT03720847|580573407|FG001|Washout|Physician Decision|2|||
160778161|NCT03033901|580573411|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
160778162|NCT03033901|580573411|FG000|Overall Study|Refused PSG|23|||
160778163|NCT03033901|580573411|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
160778164|NCT03033901|580573411|FG000|Overall Study|Missing Oximetry Data|3|||
160778165|NCT00924651|580573414|FG000|Overall Study|Chemo started too soon|2|||
160778166|NCT00924651|580573415|FG001|Overall Study|Chemo started too soon|3|||
160778167|NCT00924651|580573414|FG000|Overall Study|No Reason|3|||
160778168|NCT00924651|580573415|FG001|Overall Study|No Reason|7|||
160778169|NCT00924651|580573414|FG000|Overall Study|Overwhelmed|6|||
160778170|NCT00924651|580573415|FG001|Overall Study|Overwhelmed|6|||
160778171|NCT00924651|580573414|FG000|Overall Study|Noncompliant|1|||
160778172|NCT00924651|580573415|FG001|Overall Study|Noncompliant|4|||
160778173|NCT00924651|580573414|FG000|Overall Study|Medical|1|||
160778174|NCT00924651|580573415|FG001|Overall Study|Medical|3|||
160778175|NCT00924651|580573414|FG000|Overall Study|Changed Mind|10|||
160778176|NCT00924651|580573415|FG001|Overall Study|Changed Mind|1|||
160778177|NCT00924651|580573414|FG000|Overall Study|Incomplete Form|2|||
160778178|NCT00924651|580573415|FG001|Overall Study|Incomplete Form|1|||
160778179|NCT00723944|580573416|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
160778180|NCT00723944|580573417|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
160778181|NCT00723944|580573416|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
160778182|NCT00723944|580573417|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
160778183|NCT00723944|580573416|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
160778184|NCT00723944|580573417|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
160778185|NCT01847209|580573418|FG000|Overall Study|Withdrawal by Subject|1|||
160778186|NCT01847209|580573418|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
160778187|NCT00729586|580573419|FG000|Overall Study|Ineligible|0|||
160778188|NCT00729586|580573420|FG001|Overall Study|Ineligible|1|||
160778189|NCT00729586|580573419|FG000|Overall Study|never treated|1|||
160778190|NCT00729586|580573420|FG001|Overall Study|never treated|0|||
161229025|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
161229026|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
160778191|NCT02513199|580573423|FG000|Treatment|Death|1|||
160778192|NCT02513199|580573423|FG000|Treatment|Lost to Follow-up|1|||
160778193|NCT02513199|580573423|FG000|Follow-Up|Death|11|||
160778194|NCT00835978|580573424|FG000|Overall Study|Death|33|||
160778195|NCT00835978|580573425|FG001|Overall Study|Death|40|||
160778196|NCT00835978|580573426|FG002|Overall Study|Death|49|||
160778197|NCT00835978|580573427|FG003|Overall Study|Death|4|||
160778198|NCT00835978|580573424|FG000|Overall Study|Lost to Follow-up|3|||
160778199|NCT00835978|580573425|FG001|Overall Study|Lost to Follow-up|4|||
160778200|NCT00835978|580573426|FG002|Overall Study|Lost to Follow-up|2|||
160778201|NCT00835978|580573427|FG003|Overall Study|Lost to Follow-up|1|||
160778202|NCT00835978|580573424|FG000|Overall Study|Other|5|||
160778203|NCT00835978|580573425|FG001|Overall Study|Other|1|||
160778204|NCT00835978|580573426|FG002|Overall Study|Other|8|||
160778205|NCT00835978|580573427|FG003|Overall Study|Other|0|||
160778206|NCT00835978|580573424|FG000|Overall Study|Objective progression or relapse|2|||
160778207|NCT00835978|580573425|FG001|Overall Study|Objective progression or relapse|0|||
160778208|NCT00835978|580573426|FG002|Overall Study|Objective progression or relapse|1|||
160778209|NCT00835978|580573427|FG003|Overall Study|Objective progression or relapse|0|||
160778210|NCT00835978|580573424|FG000|Overall Study|Adverse Event|1|||
160778211|NCT00835978|580573425|FG001|Overall Study|Adverse Event|0|||
160778212|NCT00835978|580573426|FG002|Overall Study|Adverse Event|1|||
160778213|NCT00835978|580573427|FG003|Overall Study|Adverse Event|0|||
160778214|NCT00835978|580573424|FG000|Overall Study|Withdrawal by Subject|0|||
160778215|NCT00835978|580573425|FG001|Overall Study|Withdrawal by Subject|3|||
160778216|NCT00835978|580573426|FG002|Overall Study|Withdrawal by Subject|0|||
160778217|NCT00835978|580573427|FG003|Overall Study|Withdrawal by Subject|5|||
160778218|NCT00835978|580573424|FG000|Overall Study|Study terminated by sponsor|12|||
160778219|NCT00835978|580573425|FG001|Overall Study|Study terminated by sponsor|8|||
160778220|NCT00835978|580573426|FG002|Overall Study|Study terminated by sponsor|30|||
160778221|NCT00835978|580573427|FG003|Overall Study|Study terminated by sponsor|0|||
160778222|NCT03298061|580573431|FG000|Overall Study|Adverse Event|3|||
160778223|NCT03298061|580573431|FG000|Overall Study|Lack of Efficacy|6|||
160886975|NCT04090411|580980643|FG008|Induction Period|Protocol Violation|0|||
161229027|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
160778224|NCT03298061|580573431|FG000|Overall Study|Protocol Violation|1|||
160778225|NCT03298061|580573431|FG000|Overall Study|Physician Decision|7|||
160778226|NCT03298061|580573431|FG000|Overall Study|Withdrawal by Subject|10|||
161229028|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
161229029|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
161229030|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
160778227|NCT04307394|580573432|FG000|Overall Study|Lost to Follow-up|3|||
160778228|NCT04307394|580573432|FG000|Overall Study|Withdrawal by Subject|2|||
160778229|NCT01410604|580573433|FG000|Overall Study|Adverse Event|2|||
160778230|NCT01410604|580573434|FG001|Overall Study|Adverse Event|1|||
160778231|NCT01410604|580573433|FG000|Overall Study|Lost to Follow-up|1|||
160778232|NCT01410604|580573434|FG001|Overall Study|Lost to Follow-up|0|||
160778233|NCT01410604|580573433|FG000|Overall Study|Physician Decision|0|||
160778234|NCT01410604|580573434|FG001|Overall Study|Physician Decision|1|||
160778235|NCT00800540|580573439|FG000|Period One: 6 Weeks|Noncompliance|1|||
160778236|NCT00800540|580573440|FG001|Period One: 6 Weeks|Noncompliance|0|||
160778237|NCT00800540|580573439|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
160778238|NCT00800540|580573440|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
160778239|NCT00800540|580573439|FG000|Period 2: 6 Weeks|Adverse Event|0|||
160778240|NCT00800540|580573440|FG001|Period 2: 6 Weeks|Adverse Event|1|||
160778241|NCT04871113|580573441|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778242|NCT04871113|580573442|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778243|NCT04871113|580573443|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778244|NCT04871113|580573444|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778245|NCT04871113|580573445|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778246|NCT04871113|580573446|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
160778247|NCT04871113|580573447|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778248|NCT04871113|580573448|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778249|NCT04871113|580573449|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778250|NCT04871113|580573450|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
160778251|NCT04871113|580573441|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778252|NCT04871113|580573442|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778253|NCT04871113|580573443|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778254|NCT04871113|580573444|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778255|NCT04871113|580573445|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778256|NCT04871113|580573446|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778257|NCT04871113|580573447|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
160778258|NCT04871113|580573448|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
160778259|NCT04871113|580573449|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778260|NCT04871113|580573450|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
160778261|NCT01946802|580573455|FG000|Overall Study|Death|1|||
160778262|NCT01946802|580573455|FG000|Overall Study|Withdrawal by Subject|2|||
160778263|NCT01946802|580573455|FG000|Overall Study|Combined septic shock|1|||
160778264|NCT01946802|580573455|FG000|Overall Study|Protocol Violation|1|||
160778265|NCT00153920|580573456|FG000|Overall Study|Adverse Event|9|||
160778266|NCT00153920|580573456|FG000|Overall Study|Progressive Disease|9|||
160778267|NCT00153920|580573456|FG000|Overall Study|Physician Decision|3|||
160778268|NCT00153920|580573456|FG000|Overall Study|Lack of Response|3|||
160778269|NCT00153920|580573456|FG000|Overall Study|Death|2|||
160778270|NCT00153920|580573456|FG000|Overall Study|Withdrawal by Subject|1|||
160778271|NCT00153920|580573456|FG000|Overall Study|Non-Protocol Therapy|1|||
160778272|NCT00153920|580573456|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
160778273|NCT00153920|580573456|FG000|Overall Study|Progressive Disease before Trt|1|||
160778274|NCT00827242|580573458|FG000|Overall Study|Withdrawal by Subject|2|||
160778275|NCT00827242|580573459|FG001|Overall Study|Withdrawal by Subject|4|||
161123063|NCT01285908|581837461|FG002|Baseline Measurement|unable to insert catheter|0|||
161123064|NCT01285908|581837459|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
161123065|NCT01285908|581837460|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
161123066|NCT01285908|581837461|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
161123067|NCT01285908|581837459|FG000|Baseline Measurement|unable to tolerate procedure|1|||
161123068|NCT01285908|581837460|FG001|Baseline Measurement|unable to tolerate procedure|0|||
161123069|NCT01285908|581837461|FG002|Baseline Measurement|unable to tolerate procedure|0|||
161123070|NCT03655756|581837462|FG000|Overall Study|Death|1|||
161123071|NCT03237065|581837463|FG000|Overall Study|Adverse Event|0|||
161123072|NCT03237065|581837464|FG001|Overall Study|Adverse Event|2|||
161123073|NCT03237065|581837463|FG000|Overall Study|Protocol Violation|0|||
161123074|NCT03237065|581837464|FG001|Overall Study|Protocol Violation|1|||
161123075|NCT03237065|581837463|FG000|Overall Study|Withdrawal by Subject|3|||
161123076|NCT03237065|581837464|FG001|Overall Study|Withdrawal by Subject|0|||
161123077|NCT03237065|581837463|FG000|Overall Study|Lost to Follow-up|1|||
161123078|NCT03237065|581837464|FG001|Overall Study|Lost to Follow-up|0|||
161123079|NCT03237065|581837463|FG000|Overall Study|Unable to obtain venous access|0|||
161123080|NCT03237065|581837464|FG001|Overall Study|Unable to obtain venous access|1|||
161123081|NCT02475655|581837465|FG000|Overall Study|Lost to Follow-up|0|||
161123082|NCT02475655|581837466|FG001|Overall Study|Lost to Follow-up|1|||
161123083|NCT00257010|581837471|FG000|Overall Study|Lack of Efficacy|11|||
161123084|NCT00257010|581837471|FG000|Overall Study|Lost to Follow-up|53|||
161123085|NCT00257010|581837471|FG000|Overall Study|Withdrawal by Subject|34|||
161123086|NCT00257010|581837471|FG000|Overall Study|Adverse Event|10|||
161123087|NCT00257010|581837471|FG000|Overall Study|various|11|||
161123088|NCT00257010|581837471|FG000|Overall Study|no headache reported|9|||
161123089|NCT00662792|581837472|FG000|Period 1|Personal Reasons|0|||
161123090|NCT00662792|581837473|FG001|Period 1|Personal Reasons|0|||
161123091|NCT00662792|581837474|FG002|Period 1|Personal Reasons|1|||
161123092|NCT00662792|581837475|FG003|Period 1|Personal Reasons|0|||
161123093|NCT00662792|581837472|FG000|Period 1|Refused continuing medication|0|||
161123094|NCT00662792|581837473|FG001|Period 1|Refused continuing medication|1|||
161123095|NCT00662792|581837474|FG002|Period 1|Refused continuing medication|1|||
160778276|NCT00827242|580573458|FG000|Overall Study|Protocol Violation|1|||
160778277|NCT00827242|580573459|FG001|Overall Study|Protocol Violation|3|||
160778278|NCT00827242|580573458|FG000|Overall Study|Lost to Follow-up|0|||
160778279|NCT00827242|580573459|FG001|Overall Study|Lost to Follow-up|3|||
160778280|NCT00827242|580573458|FG000|Overall Study|Adverse Event Excluding Death|2|||
160778281|NCT00827242|580573459|FG001|Overall Study|Adverse Event Excluding Death|1|||
160778282|NCT00827242|580573458|FG000|Overall Study|Entry Criteria Not Met|4|||
160778283|NCT00827242|580573459|FG001|Overall Study|Entry Criteria Not Met|1|||
160778284|NCT00827242|580573458|FG000|Overall Study|Physician Decision|2|||
160778285|NCT00827242|580573459|FG001|Overall Study|Physician Decision|0|||
160778286|NCT00827242|580573458|FG000|Overall Study|Death|1|||
160778287|NCT00827242|580573459|FG001|Overall Study|Death|0|||
160778288|NCT00827242|580573458|FG000|Overall Study|Lack of Efficacy|1|||
160778289|NCT00827242|580573459|FG001|Overall Study|Lack of Efficacy|0|||
160778290|NCT05762679|580573460|FG000|Overall Study|Withdrawal by Subject|1|||
160778291|NCT05762679|580573460|FG000|Overall Study|No analyzable imaging data|1|||
160778292|NCT01479530|580573465|FG000|Overall Study|Adverse Event|5|||
160778293|NCT01479530|580573466|FG001|Overall Study|Adverse Event|6|||
160778294|NCT01479530|580573465|FG000|Overall Study|Lack of Efficacy|0|||
160778295|NCT01479530|580573466|FG001|Overall Study|Lack of Efficacy|1|||
160778296|NCT01479530|580573465|FG000|Overall Study|Protocol Violation|2|||
161229031|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
161229032|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
161229033|NCT00048568|582220319|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
161229034|NCT00048568|582220320|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
161229035|NCT00048568|582220321|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
161229036|NCT00048568|582220319|FG000|Open-Label Period|Death|0|||
161229037|NCT00048568|582220320|FG001|Open-Label Period|Death|0|||
161229038|NCT00048568|582220321|FG002|Open-Label Period|Death|13|||
161229039|NCT00048568|582220319|FG000|Open-Label Period|Adverse Event|0|||
161229040|NCT00048568|582220320|FG001|Open-Label Period|Adverse Event|0|||
161229041|NCT00048568|582220321|FG002|Open-Label Period|Adverse Event|49|||
161229042|NCT00048568|582220319|FG000|Open-Label Period|Lack of Efficacy|0|||
161229043|NCT00048568|582220320|FG001|Open-Label Period|Lack of Efficacy|0|||
161229044|NCT00048568|582220321|FG002|Open-Label Period|Lack of Efficacy|32|||
161229045|NCT00048568|582220319|FG000|Open-Label Period|Withdrawal by Subject|0|||
161229046|NCT00048568|582220320|FG001|Open-Label Period|Withdrawal by Subject|0|||
161229047|NCT00048568|582220321|FG002|Open-Label Period|Withdrawal by Subject|26|||
161229048|NCT00048568|582220319|FG000|Open-Label Period|Pregnancy|0|||
161229049|NCT00048568|582220320|FG001|Open-Label Period|Pregnancy|0|||
161229050|NCT00048568|582220321|FG002|Open-Label Period|Pregnancy|5|||
161229051|NCT00048568|582220319|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
161229052|NCT00048568|582220320|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
161229053|NCT00048568|582220321|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
161229054|NCT00048568|582220319|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
161229055|NCT00048568|582220320|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
161229056|NCT00048568|582220321|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
161229057|NCT00048568|582220319|FG000|Open-Label Period|Unknown Reasons|0|||
161229058|NCT00048568|582220320|FG001|Open-Label Period|Unknown Reasons|0|||
161229059|NCT00048568|582220321|FG002|Open-Label Period|Unknown Reasons|25|||
161229060|NCT00048568|582220319|FG000|Open-Label Period|Lost to Follow-up|0|||
161229061|NCT00048568|582220320|FG001|Open-Label Period|Lost to Follow-up|0|||
161229062|NCT00048568|582220321|FG002|Open-Label Period|Lost to Follow-up|7|||
161229063|NCT01717976|582220322|FG000|Overall Study|Protocol Violation|0|||
161229064|NCT01717976|582220323|FG001|Overall Study|Protocol Violation|1|||
161229065|NCT03831048|582220324|FG000|Overall Study|Protocol Violation|9|||
160778297|NCT01479530|580573466|FG001|Overall Study|Protocol Violation|3|||
160778298|NCT01479530|580573465|FG000|Overall Study|Withdrawal of Consent|3|||
160778299|NCT01479530|580573466|FG001|Overall Study|Withdrawal of Consent|2|||
160778300|NCT04795323|580573467|FG000|Overall Study|Did not interact with TARA|1|||
160778301|NCT04795323|580573468|FG001|Overall Study|Did not interact with TARA|0|||
160778302|NCT00933166|580573471|FG000|Overall Study|Lost to Follow-up|4|||
160778303|NCT00933166|580573471|FG000|Overall Study|Lack of Efficacy|9|||
160778304|NCT00933166|580573471|FG000|Overall Study|Unavailable|4|||
160778305|NCT00933166|580573471|FG000|Overall Study|Withdrawal by Subject|1|||
160778306|NCT01944774|580573472|FG000|Overall Study|Withdrawal by Subject|2|||
160778307|NCT01944774|580573473|FG001|Overall Study|Withdrawal by Subject|3|||
160778308|NCT01944774|580573474|FG002|Overall Study|Withdrawal by Subject|3|||
161229066|NCT03831048|582220325|FG001|Overall Study|Protocol Violation|3|||
161229067|NCT03831048|582220324|FG000|Overall Study|Death|4|||
161229068|NCT03831048|582220325|FG001|Overall Study|Death|9|||
160778309|NCT01944774|580573472|FG000|Overall Study|Adverse Event|3|||
160778310|NCT01944774|580573473|FG001|Overall Study|Adverse Event|2|||
160778311|NCT01944774|580573474|FG002|Overall Study|Adverse Event|3|||
160778312|NCT01944774|580573472|FG000|Overall Study|Lack of Efficacy|1|||
160778313|NCT01944774|580573473|FG001|Overall Study|Lack of Efficacy|2|||
160778314|NCT01944774|580573474|FG002|Overall Study|Lack of Efficacy|2|||
161229069|NCT03831048|582220324|FG000|Overall Study|Re-transplant|0|||
161229070|NCT03831048|582220325|FG001|Overall Study|Re-transplant|2|||
161229071|NCT03831048|582220324|FG000|Overall Study|Protocol violation and death|1|||
161229072|NCT03831048|582220325|FG001|Overall Study|Protocol violation and death|1|||
161229073|NCT01996033|582220327|FG000|Overall Study|Death|1|||
161229074|NCT01996033|582220327|FG000|Overall Study|Physician Decision|1|||
161229075|NCT01996033|582220327|FG000|Overall Study|Withdrawal by Subject|4|||
161229076|NCT01996033|582220327|FG000|Overall Study|Lost to Follow-up|3|||
161229077|NCT02731157|582220329|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
161229078|NCT02732210|582220330|FG000|Overall Study|Site Closed|0|||
161229079|NCT02732210|582220331|FG001|Overall Study|Site Closed|11|||
161229080|NCT02732210|582220330|FG000|Overall Study|Study Ended|13|||
161229081|NCT02732210|582220331|FG001|Overall Study|Study Ended|13|||
161229082|NCT02732210|582220330|FG000|Overall Study|Withdrawal by Subject|28|||
161229083|NCT02732210|582220331|FG001|Overall Study|Withdrawal by Subject|87|||
161229084|NCT02732210|582220330|FG000|Overall Study|Lost to Follow-up|5|||
161229085|NCT02732210|582220331|FG001|Overall Study|Lost to Follow-up|57|||
161229086|NCT02732210|582220330|FG000|Overall Study|Death|4|||
161229087|NCT02732210|582220331|FG001|Overall Study|Death|15|||
161229088|NCT02732210|582220330|FG000|Overall Study|Other|35|||
161229089|NCT02732210|582220331|FG001|Overall Study|Other|103|||
161229090|NCT02732210|582220330|FG000|Overall Study|Missing|0|||
161229091|NCT02732210|582220331|FG001|Overall Study|Missing|8|||
161229092|NCT01448057|582220333|FG000|Overall Study|Protocol Violation|3|||
161229093|NCT01448057|582220334|FG001|Overall Study|Protocol Violation|2|||
161229094|NCT01448057|582220333|FG000|Overall Study|Lost to Follow-up|3|||
161229095|NCT01448057|582220334|FG001|Overall Study|Lost to Follow-up|0|||
161229096|NCT01448057|582220333|FG000|Overall Study|Adverse Event|0|||
161229097|NCT01448057|582220334|FG001|Overall Study|Adverse Event|2|||
161229098|NCT01448057|582220333|FG000|Overall Study|Withdrawal by Subject|2|||
161229099|NCT01448057|582220334|FG001|Overall Study|Withdrawal by Subject|0|||
161229100|NCT03883906|582220335|FG000|Overall Study|Withdrawal by Subject|2|||
161229101|NCT03883906|582220335|FG000|Overall Study|Physician Decision|5|||
161229102|NCT03912337|582220340|FG000|Overall Study|Withdrawal of Consent From Study|1|||
161229103|NCT03912337|582220341|FG001|Overall Study|Withdrawal of Consent From Study|0|||
161229104|NCT03912337|582220340|FG000|Overall Study|Lost to Follow-up|1|||
161229105|NCT03912337|582220341|FG001|Overall Study|Lost to Follow-up|1|||
161229106|NCT03561883|582220342|FG000|Overall Study|Adverse Event|10|||
161229107|NCT03561883|582220343|FG001|Overall Study|Adverse Event|13|||
161229108|NCT03561883|582220342|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161229109|NCT03561883|582220343|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161229110|NCT03561883|582220342|FG000|Overall Study|Protocol Violation|2|||
161229111|NCT03561883|582220343|FG001|Overall Study|Protocol Violation|3|||
161229112|NCT03561883|582220342|FG000|Overall Study|Withdrawal by Subject|14|||
161229113|NCT03561883|582220343|FG001|Overall Study|Withdrawal by Subject|6|||
161229114|NCT03561883|582220342|FG000|Overall Study|Lost to Follow-up|2|||
161229115|NCT03561883|582220343|FG001|Overall Study|Lost to Follow-up|6|||
161229116|NCT03561883|582220342|FG000|Overall Study|Study Terminated by Sponsor|12|||
161229117|NCT03561883|582220343|FG001|Overall Study|Study Terminated by Sponsor|11|||
161229118|NCT03561883|582220342|FG000|Overall Study|Physician Decision|1|||
161229119|NCT03561883|582220343|FG001|Overall Study|Physician Decision|0|||
161229120|NCT03561883|582220342|FG000|Overall Study|Randomized by Mistake|1|||
161229121|NCT03561883|582220343|FG001|Overall Study|Randomized by Mistake|0|||
161229122|NCT03561883|582220342|FG000|Overall Study|Other, Not Specified|3|||
161229123|NCT03561883|582220343|FG001|Overall Study|Other, Not Specified|2|||
161229124|NCT03978624|582220344|FG000|Overall Study|Protocol Violation|1|||
161229125|NCT03978624|582220345|FG001|Overall Study|Protocol Violation|0|||
161229126|NCT00958243|582220350|FG000|Overall Study|Withdrawal by Subject|0|||
161229127|NCT00958243|582220351|FG001|Overall Study|Withdrawal by Subject|1|||
161229128|NCT00958243|582220352|FG002|Overall Study|Withdrawal by Subject|3|||
161229129|NCT00958243|582220353|FG003|Overall Study|Withdrawal by Subject|1|||
161229130|NCT00958243|582220354|FG004|Overall Study|Withdrawal by Subject|1|||
161229131|NCT00958243|582220355|FG005|Overall Study|Withdrawal by Subject|5|||
161229132|NCT00958243|582220350|FG000|Overall Study|Lost to Follow-up|2|||
161229133|NCT00958243|582220351|FG001|Overall Study|Lost to Follow-up|5|||
161229134|NCT00958243|582220352|FG002|Overall Study|Lost to Follow-up|11|||
161229135|NCT00958243|582220353|FG003|Overall Study|Lost to Follow-up|2|||
161229136|NCT00958243|582220354|FG004|Overall Study|Lost to Follow-up|8|||
161229137|NCT00958243|582220355|FG005|Overall Study|Lost to Follow-up|5|||
161229138|NCT04646109|582220356|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
161229139|NCT04646109|582220357|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
161229140|NCT06176768|582220358|FG000|Overall Study|Adverse Event|1|||
161229141|NCT06176768|582220359|FG001|Overall Study|Adverse Event|0|||
161229142|NCT06176768|582220358|FG000|Overall Study|Assigned treatment by mistake|1|||
161229143|NCT06176768|582220359|FG001|Overall Study|Assigned treatment by mistake|0|||
161229144|NCT06176768|582220358|FG000|Overall Study|Lost to Follow-up|0|||
161229145|NCT06176768|582220359|FG001|Overall Study|Lost to Follow-up|3|||
161229146|NCT06176768|582220358|FG000|Overall Study|Physician Decision|1|||
161229147|NCT06176768|582220359|FG001|Overall Study|Physician Decision|0|||
161229148|NCT06176768|582220358|FG000|Overall Study|Protocol deviation|3|||
161229149|NCT06176768|582220359|FG001|Overall Study|Protocol deviation|1|||
160778315|NCT01944774|580573472|FG000|Overall Study|Lost to Follow-up|0|||
160778316|NCT01944774|580573473|FG001|Overall Study|Lost to Follow-up|1|||
160778317|NCT01944774|580573474|FG002|Overall Study|Lost to Follow-up|0|||
160778318|NCT00774748|580573475|FG000|Overall Study|Lost to Follow-up|3|||
160778319|NCT02965456|580573476|FG000|Overall Study|Lost to Follow-up|40|||
160778320|NCT02965456|580573477|FG001|Overall Study|Lost to Follow-up|18|||
160778321|NCT02965456|580573476|FG000|Overall Study|Subject Request|22|||
160778322|NCT02965456|580573477|FG001|Overall Study|Subject Request|13|||
160778323|NCT02965456|580573476|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
160778324|NCT02965456|580573477|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
160778325|NCT02965456|580573476|FG000|Overall Study|Adverse Event|3|||
160778326|NCT02965456|580573477|FG001|Overall Study|Adverse Event|0|||
160778327|NCT02965456|580573476|FG000|Overall Study|Noncompliance with Study Drug|1|||
160778328|NCT02965456|580573477|FG001|Overall Study|Noncompliance with Study Drug|1|||
160778329|NCT02965456|580573476|FG000|Overall Study|Worsening Condition|0|||
160778330|NCT02965456|580573477|FG001|Overall Study|Worsening Condition|2|||
160778331|NCT02965456|580573476|FG000|Overall Study|Lack of Efficacy|1|||
160778332|NCT02965456|580573477|FG001|Overall Study|Lack of Efficacy|0|||
160778333|NCT02965456|580573476|FG000|Overall Study|Physician Decision|0|||
160778334|NCT02965456|580573477|FG001|Overall Study|Physician Decision|1|||
160778335|NCT02965456|580573476|FG000|Overall Study|Pregnancy|1|||
160778336|NCT02965456|580573477|FG001|Overall Study|Pregnancy|0|||
160778337|NCT02965456|580573476|FG000|Overall Study|Protocol Violation|0|||
160778338|NCT02965456|580573477|FG001|Overall Study|Protocol Violation|1|||
160778339|NCT02965456|580573476|FG000|Overall Study|Participant ran out of study drug|0|||
160778340|NCT02965456|580573477|FG001|Overall Study|Participant ran out of study drug|1|||
160778341|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
160778342|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
160778343|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
160778344|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Death|1|||
161229150|NCT06176768|582220358|FG000|Overall Study|Other|1|||
160778345|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Death|0|||
160778346|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Death|0|||
160778347|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
160886976|NCT04090411|580980644|FG009|Induction Period|Protocol Violation|0|||
160886977|NCT04090411|580980645|FG010|Induction Period|Protocol Violation|0|||
160886978|NCT04090411|580980646|FG011|Induction Period|Protocol Violation|0|||
160886979|NCT04090411|580980647|FG012|Induction Period|Protocol Violation|0|||
160886980|NCT04090411|580980635|FG000|Induction Period|Withdrawal by Subject|2|||
160886981|NCT04090411|580980636|FG001|Induction Period|Withdrawal by Subject|0|||
160886982|NCT04090411|580980637|FG002|Induction Period|Withdrawal by Subject|1|||
160886983|NCT04090411|580980638|FG003|Induction Period|Withdrawal by Subject|5|||
160886984|NCT04090411|580980639|FG004|Induction Period|Withdrawal by Subject|0|||
160886985|NCT04090411|580980640|FG005|Induction Period|Withdrawal by Subject|0|||
160886986|NCT04090411|580980641|FG006|Induction Period|Withdrawal by Subject|0|||
160886987|NCT04090411|580980642|FG007|Induction Period|Withdrawal by Subject|0|||
160886988|NCT04090411|580980643|FG008|Induction Period|Withdrawal by Subject|0|||
160886989|NCT04090411|580980644|FG009|Induction Period|Withdrawal by Subject|0|||
160886990|NCT04090411|580980645|FG010|Induction Period|Withdrawal by Subject|0|||
160886991|NCT04090411|580980646|FG011|Induction Period|Withdrawal by Subject|0|||
160886992|NCT04090411|580980647|FG012|Induction Period|Withdrawal by Subject|0|||
160886993|NCT04090411|580980635|FG000|Chronic Period|Adverse Event|0|||
160886994|NCT04090411|580980636|FG001|Chronic Period|Adverse Event|0|||
160886995|NCT04090411|580980637|FG002|Chronic Period|Adverse Event|0|||
160886996|NCT04090411|580980638|FG003|Chronic Period|Adverse Event|0|||
160886997|NCT04090411|580980639|FG004|Chronic Period|Adverse Event|0|||
160886998|NCT04090411|580980640|FG005|Chronic Period|Adverse Event|1|||
160886999|NCT04090411|580980641|FG006|Chronic Period|Adverse Event|0|||
161229151|NCT06176768|582220359|FG001|Overall Study|Other|0|||
161229152|NCT06176768|582220358|FG000|Overall Study|Withdrawal by Subject|6|||
160887000|NCT04090411|580980642|FG007|Chronic Period|Adverse Event|3|||
160887001|NCT04090411|580980643|FG008|Chronic Period|Adverse Event|0|||
160887002|NCT04090411|580980644|FG009|Chronic Period|Adverse Event|0|||
161229153|NCT06176768|582220359|FG001|Overall Study|Withdrawal by Subject|9|||
160778348|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
160778349|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
160778350|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
160778351|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
160778352|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
160778353|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
160778354|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
160887003|NCT04090411|580980645|FG010|Chronic Period|Adverse Event|5|||
160887004|NCT04090411|580980646|FG011|Chronic Period|Adverse Event|1|||
161229154|NCT02672553|582220364|FG000|Overall Study|Death|3|||
161229155|NCT02672553|582220365|FG001|Overall Study|Death|5|||
161326025|NCT03382418|582579663|FG000|Overall Study|Withdrawal by Subject|1|||
161326026|NCT03382418|582579664|FG001|Overall Study|Withdrawal by Subject|0|||
161326027|NCT03382418|582579665|FG002|Overall Study|Withdrawal by Subject|0|||
161326028|NCT03382418|582579663|FG000|Overall Study|Lost to Follow-up|2|||
161326029|NCT03382418|582579664|FG001|Overall Study|Lost to Follow-up|3|||
161326030|NCT03382418|582579665|FG002|Overall Study|Lost to Follow-up|0|||
161326031|NCT02716584|582579673|FG000|Overall Study|Lost to Follow-up|8|||
161326032|NCT02716584|582579674|FG001|Overall Study|Lost to Follow-up|5|||
161326033|NCT00420628|582579675|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
161326034|NCT00420628|582579676|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
161326035|NCT00420628|582579675|FG000|Overall Study|Lost to Follow-up|3|||
161326036|NCT00420628|582579676|FG001|Overall Study|Lost to Follow-up|2|||
161326037|NCT00420628|582579675|FG000|Overall Study|Adverse Event|1|||
161326038|NCT00420628|582579676|FG001|Overall Study|Adverse Event|0|||
161326039|NCT00282152|582579684|FG000|Overall Study|Withdrawal by Subject|1|||
161326040|NCT00282152|582579685|FG001|Overall Study|Withdrawal by Subject|0|||
161326041|NCT03301831|582579686|FG000|Overall Study|Lost to Follow-up|5|||
161326042|NCT03301831|582579687|FG001|Overall Study|Lost to Follow-up|3|||
161326043|NCT03301831|582579686|FG000|Overall Study|Protocol Violation|4|||
161326044|NCT03301831|582579687|FG001|Overall Study|Protocol Violation|0|||
161326045|NCT03301831|582579686|FG000|Overall Study|Withdrawal by Subject|11|||
161326046|NCT03301831|582579687|FG001|Overall Study|Withdrawal by Subject|0|||
161326047|NCT00585325|582579688|FG000|Overall Study|Withdrawal by Subject|1|||
161326048|NCT00585325|582579689|FG001|Overall Study|Withdrawal by Subject|1|||
161326049|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
161326050|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161326051|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161326052|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
161326053|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
161326054|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161326055|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161326056|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
161326057|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
161326058|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161326059|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161326060|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
161326061|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
161326062|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161326063|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161326064|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
161326065|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
161326066|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161326067|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161326068|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
161326069|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
161326070|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161326071|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161326072|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
161326073|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
161326074|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161326075|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161326076|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
161326077|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
161326078|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161326079|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161326080|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
161326081|NCT03538691|582579690|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
161326082|NCT03538691|582579691|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161326083|NCT03538691|582579692|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161326084|NCT03538691|582579693|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
161326085|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161326086|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
161326087|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161326088|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
161326089|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
160887005|NCT04090411|580980647|FG012|Chronic Period|Adverse Event|1|||
161326090|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
161326091|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161326092|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
161326093|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161326094|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
161326095|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161326096|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
161326097|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161326098|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
161326099|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161326100|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
161326101|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161326102|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
161326103|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161326104|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
161326105|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161326106|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
161326107|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161326108|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
161326109|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161326110|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
161326111|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161326112|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
161326113|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161326114|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
161326115|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161326116|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
161326117|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161326118|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
161326119|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161326120|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
161326121|NCT03538691|582579690|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161326122|NCT03538691|582579691|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
161326123|NCT03538691|582579692|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161326124|NCT03538691|582579693|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161326125|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
161326126|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
161326127|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
161326128|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
161326129|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
161326130|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
161326131|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
161326132|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
161326133|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
161326134|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
161326135|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
161326136|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
161326137|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
161326138|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
161326139|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
161326140|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
161326141|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
161326142|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
161326143|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
161326144|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
161326145|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161326146|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161326147|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
161326148|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
161326149|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
161326150|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
161326151|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
161229156|NCT02672553|582220364|FG000|Overall Study|Valve Explant|1|||
161229157|NCT02672553|582220365|FG001|Overall Study|Valve Explant|0|||
161229158|NCT02672553|582220364|FG000|Overall Study|Conversion to Commercial Valve|3|||
160778355|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
160778356|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
160778357|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
160778358|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
160778359|NCT05073315|580573478|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
160778360|NCT05073315|580573479|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
160778361|NCT05073315|580573480|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
160778362|NCT05073315|580573478|FG000|Period 2|Adverse Event|0|||
160778363|NCT05073315|580573479|FG001|Period 2|Adverse Event|3|||
160778364|NCT05073315|580573480|FG002|Period 2|Adverse Event|6|||
160778365|NCT05073315|580573478|FG000|Period 2|Lost to Follow-up|0|||
160778366|NCT05073315|580573479|FG001|Period 2|Lost to Follow-up|5|||
160778367|NCT05073315|580573480|FG002|Period 2|Lost to Follow-up|5|||
160778368|NCT05073315|580573478|FG000|Period 2|Withdrawal by Subject|0|||
160778369|NCT05073315|580573479|FG001|Period 2|Withdrawal by Subject|4|||
160778370|NCT05073315|580573480|FG002|Period 2|Withdrawal by Subject|9|||
160778371|NCT05073315|580573478|FG000|Period 2|Protocol Violation|0|||
160778372|NCT05073315|580573479|FG001|Period 2|Protocol Violation|0|||
160778373|NCT05073315|580573480|FG002|Period 2|Protocol Violation|1|||
160778374|NCT04465955|580573481|FG000|Overall Study|Withdrew consent|6|||
160778375|NCT04465955|580573482|FG001|Overall Study|Withdrew consent|10|||
160778376|NCT04465955|580573483|FG002|Overall Study|Withdrew consent|7|||
160778377|NCT04465955|580573481|FG000|Overall Study|Adverse Event|6|||
160778378|NCT04465955|580573482|FG001|Overall Study|Adverse Event|5|||
160778379|NCT04465955|580573483|FG002|Overall Study|Adverse Event|1|||
160778380|NCT04465955|580573481|FG000|Overall Study|Lost to Follow-up|2|||
160778381|NCT04465955|580573482|FG001|Overall Study|Lost to Follow-up|0|||
160778382|NCT04465955|580573483|FG002|Overall Study|Lost to Follow-up|3|||
160778383|NCT04465955|580573481|FG000|Overall Study|Other|1|||
160778384|NCT04465955|580573482|FG001|Overall Study|Other|1|||
160778385|NCT04465955|580573483|FG002|Overall Study|Other|3|||
160778386|NCT00021255|580573484|FG000|Overall Study|Death|1|||
160778387|NCT00021255|580573485|FG001|Overall Study|Death|0|||
160778388|NCT00021255|580573486|FG002|Overall Study|Death|2|||
160778389|NCT00021255|580573484|FG000|Overall Study|Breast cancer relapse|5|||
160778390|NCT00021255|580573485|FG001|Overall Study|Breast cancer relapse|18|||
160778391|NCT00021255|580573486|FG002|Overall Study|Breast cancer relapse|11|||
160778392|NCT00021255|580573484|FG000|Overall Study|Second primary malignancy|0|||
160778393|NCT00021255|580573485|FG001|Overall Study|Second primary malignancy|4|||
160778394|NCT00021255|580573486|FG002|Overall Study|Second primary malignancy|1|||
160778395|NCT00021255|580573484|FG000|Overall Study|Withdrawal by Subject|41|||
160778396|NCT00021255|580573485|FG001|Overall Study|Withdrawal by Subject|64|||
160778397|NCT00021255|580573486|FG002|Overall Study|Withdrawal by Subject|26|||
160778398|NCT00021255|580573484|FG000|Overall Study|Lost to Follow-up|0|||
160778399|NCT00021255|580573485|FG001|Overall Study|Lost to Follow-up|2|||
160778400|NCT00021255|580573486|FG002|Overall Study|Lost to Follow-up|3|||
160778401|NCT00021255|580573484|FG000|Overall Study|Cardiac toxicity|0|||
160778402|NCT00021255|580573485|FG001|Overall Study|Cardiac toxicity|61|||
160778403|NCT00021255|580573486|FG002|Overall Study|Cardiac toxicity|32|||
160778404|NCT00021255|580573484|FG000|Overall Study|Herceptin toxicity|0|||
160778405|NCT00021255|580573485|FG001|Overall Study|Herceptin toxicity|22|||
160778406|NCT00021255|580573486|FG002|Overall Study|Herceptin toxicity|6|||
160778407|NCT00021255|580573484|FG000|Overall Study|Adverse Event|46|||
160778408|NCT00021255|580573485|FG001|Overall Study|Adverse Event|30|||
160778409|NCT00021255|580573486|FG002|Overall Study|Adverse Event|18|||
160778410|NCT00021255|580573484|FG000|Overall Study|Protocol Violation|0|||
160778411|NCT00021255|580573485|FG001|Overall Study|Protocol Violation|2|||
160778412|NCT00021255|580573486|FG002|Overall Study|Protocol Violation|0|||
160778413|NCT00021255|580573484|FG000|Overall Study|Other than specified above|0|||
160778414|NCT00021255|580573485|FG001|Overall Study|Other than specified above|38|||
160778415|NCT00021255|580573486|FG002|Overall Study|Other than specified above|19|||
160887006|NCT04090411|580980635|FG000|Chronic Period|Lack of Efficacy|0|||
160887007|NCT04090411|580980636|FG001|Chronic Period|Lack of Efficacy|0|||
161229159|NCT02672553|582220365|FG001|Overall Study|Conversion to Commercial Valve|0|||
160778416|NCT00021255|580573484|FG000|Overall Study|Missing|0|||
160778417|NCT00021255|580573485|FG001|Overall Study|Missing|27|||
160778418|NCT00021255|580573486|FG002|Overall Study|Missing|13|||
160778419|NCT00021255|580573484|FG000|Overall Study|Randomized but not treated|28|||
160778420|NCT00021255|580573485|FG001|Overall Study|Randomized but not treated|2|||
160778421|NCT00021255|580573486|FG002|Overall Study|Randomized but not treated|18|||
160778422|NCT02232698|580573487|FG000|Overall Study|Pregnancy|1|||
160778423|NCT02232698|580573488|FG001|Overall Study|Pregnancy|1|||
160778424|NCT02232698|580573487|FG000|Overall Study|Met exclusion criteria|1|||
160778425|NCT02232698|580573488|FG001|Overall Study|Met exclusion criteria|1|||
161229160|NCT02672553|582220364|FG000|Overall Study|Withdrawal by Subject|3|||
161229161|NCT02672553|582220365|FG001|Overall Study|Withdrawal by Subject|3|||
160778426|NCT02232698|580573487|FG000|Overall Study|Had device-associated symptoms|7|||
160778427|NCT02232698|580573488|FG001|Overall Study|Had device-associated symptoms|0|||
160778428|NCT02232698|580573487|FG000|Overall Study|Non-compliance with study device|1|||
160778429|NCT02232698|580573488|FG001|Overall Study|Non-compliance with study device|4|||
160778430|NCT02232698|580573487|FG000|Overall Study|Allocated to control group|0|||
160778431|NCT02232698|580573488|FG001|Overall Study|Allocated to control group|3|||
160778432|NCT02232698|580573487|FG000|Overall Study|Withdrawal by Subject|0|||
160778433|NCT02232698|580573488|FG001|Overall Study|Withdrawal by Subject|11|||
160778434|NCT00927082|580573489|FG000|Overall Study|Lost to Follow-up|9|||
160778435|NCT00927082|580573490|FG001|Overall Study|Lost to Follow-up|8|||
160778436|NCT00927082|580573491|FG002|Overall Study|Lost to Follow-up|12|||
160778437|NCT00927082|580573492|FG003|Overall Study|Lost to Follow-up|16|||
160778438|NCT00927082|580573489|FG000|Overall Study|Withdrawal by Subject|3|||
160778439|NCT00927082|580573490|FG001|Overall Study|Withdrawal by Subject|2|||
160778440|NCT00927082|580573491|FG002|Overall Study|Withdrawal by Subject|7|||
160778441|NCT00927082|580573492|FG003|Overall Study|Withdrawal by Subject|2|||
160778442|NCT00927082|580573489|FG000|Overall Study|Death|0|||
160778443|NCT00927082|580573490|FG001|Overall Study|Death|0|||
160778444|NCT00927082|580573491|FG002|Overall Study|Death|1|||
160778445|NCT00927082|580573492|FG003|Overall Study|Death|0|||
160778446|NCT00927082|580573489|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
160778447|NCT00927082|580573490|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
160778448|NCT00927082|580573491|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
160778449|NCT00927082|580573492|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
160778450|NCT01786109|580573494|FG000|Overall Study|fail manometry barostat tube placement|1|||
160778451|NCT01786109|580573495|FG001|Overall Study|fail manometry barostat tube placement|0|||
160778452|NCT01786109|580573496|FG002|Overall Study|fail manometry barostat tube placement|0|||
160778453|NCT01786109|580573494|FG000|Overall Study|unrelated illness|0|||
160778454|NCT01786109|580573495|FG001|Overall Study|unrelated illness|0|||
160778455|NCT01786109|580573496|FG002|Overall Study|unrelated illness|1|||
160778456|NCT01786109|580573494|FG000|Overall Study|adverse effects colon preparation|0|||
160778457|NCT01786109|580573495|FG001|Overall Study|adverse effects colon preparation|0|||
160778458|NCT01786109|580573496|FG002|Overall Study|adverse effects colon preparation|1|||
160778459|NCT03369223|580573499|FG000|Overall Study|Lost to Follow-up|0|||
160778460|NCT03369223|580573500|FG001|Overall Study|Lost to Follow-up|0|||
160778461|NCT03369223|580573501|FG002|Overall Study|Lost to Follow-up|0|||
160778462|NCT03369223|580573502|FG003|Overall Study|Lost to Follow-up|0|||
160778463|NCT03369223|580573503|FG004|Overall Study|Lost to Follow-up|0|||
160778464|NCT03369223|580573504|FG005|Overall Study|Lost to Follow-up|0|||
160778465|NCT03369223|580573505|FG006|Overall Study|Lost to Follow-up|0|||
160778466|NCT03369223|580573506|FG007|Overall Study|Lost to Follow-up|0|||
160778467|NCT03369223|580573507|FG008|Overall Study|Lost to Follow-up|0|||
160778468|NCT03369223|580573508|FG009|Overall Study|Lost to Follow-up|0|||
160778469|NCT03369223|580573509|FG010|Overall Study|Lost to Follow-up|0|||
160778470|NCT03369223|580573510|FG011|Overall Study|Lost to Follow-up|0|||
160778471|NCT03369223|580573511|FG012|Overall Study|Lost to Follow-up|0|||
160778472|NCT03369223|580573512|FG013|Overall Study|Lost to Follow-up|0|||
160778473|NCT03369223|580573513|FG014|Overall Study|Lost to Follow-up|0|||
160887008|NCT04090411|580980637|FG002|Chronic Period|Lack of Efficacy|0|||
160887009|NCT04090411|580980638|FG003|Chronic Period|Lack of Efficacy|0|||
160887010|NCT04090411|580980639|FG004|Chronic Period|Lack of Efficacy|0|||
160887011|NCT04090411|580980640|FG005|Chronic Period|Lack of Efficacy|0|||
160778474|NCT03369223|580573514|FG015|Overall Study|Lost to Follow-up|0|||
160887012|NCT04090411|580980641|FG006|Chronic Period|Lack of Efficacy|1|||
160887013|NCT04090411|580980642|FG007|Chronic Period|Lack of Efficacy|4|||
160887014|NCT04090411|580980643|FG008|Chronic Period|Lack of Efficacy|2|||
160887015|NCT04090411|580980644|FG009|Chronic Period|Lack of Efficacy|2|||
160887016|NCT04090411|580980645|FG010|Chronic Period|Lack of Efficacy|2|||
160887017|NCT04090411|580980646|FG011|Chronic Period|Lack of Efficacy|1|||
160887018|NCT04090411|580980647|FG012|Chronic Period|Lack of Efficacy|2|||
160887019|NCT04090411|580980635|FG000|Chronic Period|Relocation|0|||
160778475|NCT03369223|580573515|FG016|Overall Study|Lost to Follow-up|0|||
160887020|NCT04090411|580980636|FG001|Chronic Period|Relocation|0|||
160778476|NCT03369223|580573516|FG017|Overall Study|Lost to Follow-up|0|||
160887021|NCT04090411|580980637|FG002|Chronic Period|Relocation|0|||
160887022|NCT04090411|580980638|FG003|Chronic Period|Relocation|0|||
160887023|NCT04090411|580980639|FG004|Chronic Period|Relocation|0|||
160887024|NCT04090411|580980640|FG005|Chronic Period|Relocation|0|||
161123096|NCT00662792|581837475|FG003|Period 1|Refused continuing medication|0|||
161123097|NCT00662792|581837472|FG000|Period 1|Lost to Follow-up|1|||
161123098|NCT00662792|581837473|FG001|Period 1|Lost to Follow-up|0|||
160778477|NCT03369223|580573517|FG018|Overall Study|Lost to Follow-up|2|||
160778478|NCT03369223|580573518|FG019|Overall Study|Lost to Follow-up|1|||
160778479|NCT03369223|580573499|FG000|Overall Study|Participant no longer meets study criteria|0|||
160887025|NCT04090411|580980641|FG006|Chronic Period|Relocation|0|||
160887026|NCT04090411|580980642|FG007|Chronic Period|Relocation|1|||
160887027|NCT04090411|580980643|FG008|Chronic Period|Relocation|0|||
160887028|NCT04090411|580980644|FG009|Chronic Period|Relocation|0|||
161123099|NCT00662792|581837474|FG002|Period 1|Lost to Follow-up|0|||
160887029|NCT04090411|580980645|FG010|Chronic Period|Relocation|0|||
160887030|NCT04090411|580980646|FG011|Chronic Period|Relocation|0|||
160887031|NCT04090411|580980647|FG012|Chronic Period|Relocation|0|||
160887032|NCT04090411|580980635|FG000|Chronic Period|Physician Decision|0|||
160887033|NCT04090411|580980636|FG001|Chronic Period|Physician Decision|0|||
160887034|NCT04090411|580980637|FG002|Chronic Period|Physician Decision|0|||
161229162|NCT02672553|582220364|FG000|Overall Study|Intraoperative screen failure|2|||
161229163|NCT02672553|582220365|FG001|Overall Study|Intraoperative screen failure|0|||
161229164|NCT01606306|582220366|FG000|Overall Study|Lack of Efficacy|2|||
161229165|NCT01606306|582220367|FG001|Overall Study|Lack of Efficacy|1|||
161229166|NCT01606306|582220368|FG002|Overall Study|Lack of Efficacy|4|||
161229167|NCT01606306|582220369|FG003|Overall Study|Lack of Efficacy|4|||
161229168|NCT01606306|582220370|FG004|Overall Study|Lack of Efficacy|1|||
161229169|NCT01606306|582220371|FG005|Overall Study|Lack of Efficacy|2|||
161229170|NCT01606306|582220366|FG000|Overall Study|Adverse Event|1|||
161229171|NCT01606306|582220367|FG001|Overall Study|Adverse Event|0|||
161229172|NCT01606306|582220368|FG002|Overall Study|Adverse Event|1|||
161229173|NCT01606306|582220369|FG003|Overall Study|Adverse Event|1|||
161229174|NCT01606306|582220370|FG004|Overall Study|Adverse Event|2|||
161229175|NCT01606306|582220371|FG005|Overall Study|Adverse Event|0|||
161229176|NCT01606306|582220366|FG000|Overall Study|Lost to Follow-up|7|||
161229177|NCT01606306|582220367|FG001|Overall Study|Lost to Follow-up|4|||
161229178|NCT01606306|582220368|FG002|Overall Study|Lost to Follow-up|5|||
161229179|NCT01606306|582220369|FG003|Overall Study|Lost to Follow-up|4|||
161229180|NCT01606306|582220370|FG004|Overall Study|Lost to Follow-up|3|||
161229181|NCT01606306|582220371|FG005|Overall Study|Lost to Follow-up|5|||
161229182|NCT01606306|582220366|FG000|Overall Study|Withdrawal by Subject|4|||
161326152|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
161326153|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161326154|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161326155|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
161326156|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
161326157|NCT03538691|582579690|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161326158|NCT03538691|582579691|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
161326159|NCT03538691|582579692|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
161326160|NCT03538691|582579693|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
161326161|NCT01124292|582579695|FG000|Overall Study|Lost to Follow-up|2|||
161326162|NCT01124292|582579696|FG001|Overall Study|Lost to Follow-up|4|||
161326163|NCT01124292|582579697|FG002|Overall Study|Lost to Follow-up|3|||
161326164|NCT01124292|582579695|FG000|Overall Study|Physician Decision|0|||
161326165|NCT01124292|582579696|FG001|Overall Study|Physician Decision|3|||
161326166|NCT01124292|582579697|FG002|Overall Study|Physician Decision|2|||
161326167|NCT01124292|582579695|FG000|Overall Study|Withdrawal by Subject|0|||
161326168|NCT01124292|582579696|FG001|Overall Study|Withdrawal by Subject|6|||
161326169|NCT01124292|582579697|FG002|Overall Study|Withdrawal by Subject|2|||
161326170|NCT01124292|582579695|FG000|Overall Study|medical issue unrelated to the study|0|||
161326171|NCT01124292|582579696|FG001|Overall Study|medical issue unrelated to the study|0|||
161326172|NCT01124292|582579697|FG002|Overall Study|medical issue unrelated to the study|2|||
161326173|NCT01124292|582579695|FG000|Overall Study|piercing track closed|0|||
161326174|NCT01124292|582579696|FG001|Overall Study|piercing track closed|2|||
161326175|NCT01124292|582579697|FG002|Overall Study|piercing track closed|1|||
161326176|NCT00481767|582579698|FG000|Overall Study|Withdrawal by Subject|16|||
161326177|NCT00481767|582579699|FG001|Overall Study|Withdrawal by Subject|11|||
161326178|NCT00481767|582579698|FG000|Overall Study|Lost to Follow-up|16|||
161326179|NCT00481767|582579699|FG001|Overall Study|Lost to Follow-up|10|||
161326180|NCT00636636|582579700|FG000|Overall Study|Other reason|4|||
161326181|NCT00636636|582579701|FG001|Overall Study|Other reason|6|||
161326182|NCT00636636|582579700|FG000|Overall Study|Adverse Event|19|||
161326183|NCT00636636|582579701|FG001|Overall Study|Adverse Event|8|||
161326184|NCT00636636|582579700|FG000|Overall Study|Lack of Efficacy|7|||
161326185|NCT00636636|582579701|FG001|Overall Study|Lack of Efficacy|12|||
161326186|NCT00636636|582579700|FG000|Overall Study|Protocol Violation|2|||
161326187|NCT00636636|582579701|FG001|Overall Study|Protocol Violation|2|||
161326188|NCT00636636|582579700|FG000|Overall Study|Lost to Follow-up|0|||
161326189|NCT00636636|582579701|FG001|Overall Study|Lost to Follow-up|1|||
161326190|NCT00636636|582579700|FG000|Overall Study|Death|0|||
161326191|NCT00636636|582579701|FG001|Overall Study|Death|1|||
161326192|NCT00636636|582579700|FG000|Overall Study|Withdrawal by Subject|4|||
161326193|NCT00636636|582579701|FG001|Overall Study|Withdrawal by Subject|9|||
160887035|NCT04090411|580980638|FG003|Chronic Period|Physician Decision|0|||
161229183|NCT01606306|582220367|FG001|Overall Study|Withdrawal by Subject|3|||
161229184|NCT01606306|582220368|FG002|Overall Study|Withdrawal by Subject|4|||
161229185|NCT01606306|582220369|FG003|Overall Study|Withdrawal by Subject|4|||
161229186|NCT01606306|582220370|FG004|Overall Study|Withdrawal by Subject|5|||
161229187|NCT01606306|582220371|FG005|Overall Study|Withdrawal by Subject|4|||
160778480|NCT03369223|580573500|FG001|Overall Study|Participant no longer meets study criteria|0|||
160778481|NCT03369223|580573501|FG002|Overall Study|Participant no longer meets study criteria|0|||
160778482|NCT03369223|580573502|FG003|Overall Study|Participant no longer meets study criteria|0|||
160778483|NCT03369223|580573503|FG004|Overall Study|Participant no longer meets study criteria|0|||
160778484|NCT03369223|580573504|FG005|Overall Study|Participant no longer meets study criteria|0|||
160778485|NCT03369223|580573505|FG006|Overall Study|Participant no longer meets study criteria|0|||
160778486|NCT03369223|580573506|FG007|Overall Study|Participant no longer meets study criteria|0|||
160778487|NCT03369223|580573507|FG008|Overall Study|Participant no longer meets study criteria|0|||
160778488|NCT03369223|580573508|FG009|Overall Study|Participant no longer meets study criteria|0|||
160778489|NCT03369223|580573509|FG010|Overall Study|Participant no longer meets study criteria|0|||
160778490|NCT03369223|580573510|FG011|Overall Study|Participant no longer meets study criteria|0|||
160778491|NCT03369223|580573511|FG012|Overall Study|Participant no longer meets study criteria|0|||
160778492|NCT03369223|580573512|FG013|Overall Study|Participant no longer meets study criteria|0|||
160778493|NCT03369223|580573513|FG014|Overall Study|Participant no longer meets study criteria|2|||
160778494|NCT03369223|580573514|FG015|Overall Study|Participant no longer meets study criteria|0|||
160778495|NCT03369223|580573515|FG016|Overall Study|Participant no longer meets study criteria|2|||
160778496|NCT03369223|580573516|FG017|Overall Study|Participant no longer meets study criteria|0|||
160778497|NCT03369223|580573517|FG018|Overall Study|Participant no longer meets study criteria|0|||
160778498|NCT03369223|580573518|FG019|Overall Study|Participant no longer meets study criteria|0|||
160778499|NCT03369223|580573499|FG000|Overall Study|Other reasons|0|||
160778500|NCT03369223|580573500|FG001|Overall Study|Other reasons|0|||
160778501|NCT03369223|580573501|FG002|Overall Study|Other reasons|0|||
160778502|NCT03369223|580573502|FG003|Overall Study|Other reasons|0|||
160778503|NCT03369223|580573503|FG004|Overall Study|Other reasons|0|||
160778504|NCT03369223|580573504|FG005|Overall Study|Other reasons|0|||
160778505|NCT03369223|580573505|FG006|Overall Study|Other reasons|0|||
160778506|NCT03369223|580573506|FG007|Overall Study|Other reasons|0|||
160778507|NCT03369223|580573507|FG008|Overall Study|Other reasons|0|||
160778508|NCT03369223|580573508|FG009|Overall Study|Other reasons|0|||
160778509|NCT03369223|580573509|FG010|Overall Study|Other reasons|0|||
160778510|NCT03369223|580573510|FG011|Overall Study|Other reasons|0|||
160778511|NCT03369223|580573511|FG012|Overall Study|Other reasons|0|||
160778512|NCT03369223|580573512|FG013|Overall Study|Other reasons|1|||
160778513|NCT03369223|580573513|FG014|Overall Study|Other reasons|2|||
160778514|NCT03369223|580573514|FG015|Overall Study|Other reasons|0|||
160778515|NCT03369223|580573515|FG016|Overall Study|Other reasons|1|||
160778516|NCT03369223|580573516|FG017|Overall Study|Other reasons|0|||
160778517|NCT03369223|580573517|FG018|Overall Study|Other reasons|0|||
160778518|NCT03369223|580573518|FG019|Overall Study|Other reasons|2|||
160778519|NCT03369223|580573499|FG000|Overall Study|Death|0|||
160778520|NCT03369223|580573500|FG001|Overall Study|Death|0|||
160778521|NCT03369223|580573501|FG002|Overall Study|Death|0|||
160778522|NCT03369223|580573502|FG003|Overall Study|Death|0|||
160778523|NCT03369223|580573503|FG004|Overall Study|Death|0|||
160778524|NCT03369223|580573504|FG005|Overall Study|Death|0|||
160778525|NCT03369223|580573505|FG006|Overall Study|Death|0|||
160778526|NCT03369223|580573506|FG007|Overall Study|Death|0|||
160778527|NCT03369223|580573507|FG008|Overall Study|Death|0|||
160778528|NCT03369223|580573508|FG009|Overall Study|Death|0|||
160778529|NCT03369223|580573509|FG010|Overall Study|Death|0|||
160778530|NCT03369223|580573510|FG011|Overall Study|Death|0|||
160778531|NCT03369223|580573511|FG012|Overall Study|Death|0|||
160778532|NCT03369223|580573512|FG013|Overall Study|Death|1|||
160778533|NCT03369223|580573513|FG014|Overall Study|Death|0|||
160887036|NCT04090411|580980639|FG004|Chronic Period|Physician Decision|1|||
160887037|NCT04090411|580980640|FG005|Chronic Period|Physician Decision|0|||
160887038|NCT04090411|580980641|FG006|Chronic Period|Physician Decision|0|||
160887039|NCT04090411|580980642|FG007|Chronic Period|Physician Decision|1|||
160887040|NCT04090411|580980643|FG008|Chronic Period|Physician Decision|0|||
160887041|NCT04090411|580980644|FG009|Chronic Period|Physician Decision|0|||
160887042|NCT04090411|580980645|FG010|Chronic Period|Physician Decision|0|||
160887043|NCT04090411|580980646|FG011|Chronic Period|Physician Decision|1|||
160887044|NCT04090411|580980647|FG012|Chronic Period|Physician Decision|1|||
160887045|NCT04090411|580980635|FG000|Chronic Period|Protocol Violation|0|||
160887046|NCT04090411|580980636|FG001|Chronic Period|Protocol Violation|0|||
161123100|NCT00662792|581837475|FG003|Period 1|Lost to Follow-up|0|||
160778534|NCT03369223|580573514|FG015|Overall Study|Death|0|||
160778535|NCT03369223|580573515|FG016|Overall Study|Death|0|||
160778536|NCT03369223|580573516|FG017|Overall Study|Death|0|||
161123101|NCT00662792|581837472|FG000|Period 1|Other adverse event (AE)|0|||
160778537|NCT03369223|580573517|FG018|Overall Study|Death|1|||
160778538|NCT03369223|580573518|FG019|Overall Study|Death|0|||
160778539|NCT03369223|580573499|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160778540|NCT03369223|580573500|FG001|Overall Study|Adverse event unrelated to study drug|0|||
160778541|NCT03369223|580573501|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160887047|NCT04090411|580980637|FG002|Chronic Period|Protocol Violation|0|||
160887048|NCT04090411|580980638|FG003|Chronic Period|Protocol Violation|0|||
161123102|NCT00662792|581837473|FG001|Period 1|Other adverse event (AE)|2|||
161123103|NCT00662792|581837474|FG002|Period 1|Other adverse event (AE)|0|||
161123104|NCT00662792|581837475|FG003|Period 1|Other adverse event (AE)|0|||
161123105|NCT00662792|581837472|FG000|Period 1|Worsening of disease under study (AE)|1|||
161123106|NCT00662792|581837473|FG001|Period 1|Worsening of disease under study (AE)|3|||
161123107|NCT00662792|581837474|FG002|Period 1|Worsening of disease under study (AE)|2|||
161123108|NCT00662792|581837475|FG003|Period 1|Worsening of disease under study (AE)|0|||
161123109|NCT00662792|581837472|FG000|Period 1|Not treated|0|||
161123110|NCT00662792|581837473|FG001|Period 1|Not treated|1|||
161326194|NCT00524173|582579702|FG000|Overall Study|Lost to Follow-up|0|||
161326195|NCT00524173|582579703|FG001|Overall Study|Lost to Follow-up|1|||
161326196|NCT00524173|582579702|FG000|Overall Study|Death|1|||
161326197|NCT00524173|582579703|FG001|Overall Study|Death|0|||
161326198|NCT00524173|582579702|FG000|Overall Study|Had not reached endpoint at study close|4|||
161326199|NCT00524173|582579703|FG001|Overall Study|Had not reached endpoint at study close|1|||
161326200|NCT03300180|582579704|FG000|Baseline|Withdrawal by Subject|4|||
161326201|NCT03300180|582579705|FG001|Baseline|Withdrawal by Subject|6|||
161326202|NCT03300180|582579706|FG002|Baseline|Withdrawal by Subject|4|||
161326203|NCT03300180|582579704|FG000|6 Month Outcome|Withdrawal by Subject|12|||
161326204|NCT03300180|582579705|FG001|6 Month Outcome|Withdrawal by Subject|12|||
161326205|NCT03300180|582579706|FG002|6 Month Outcome|Withdrawal by Subject|19|||
161326206|NCT03300180|582579704|FG000|6 Month Outcome|Death|2|||
161326207|NCT03300180|582579705|FG001|6 Month Outcome|Death|4|||
161326208|NCT03300180|582579706|FG002|6 Month Outcome|Death|3|||
161326209|NCT03300180|582579704|FG000|6 Month Outcome|Missed Assessment|43|||
161326210|NCT03300180|582579705|FG001|6 Month Outcome|Missed Assessment|52|||
161326211|NCT03300180|582579706|FG002|6 Month Outcome|Missed Assessment|46|||
161326212|NCT03300180|582579704|FG000|12 Month Outcome|Withdrawal by Subject|3|||
161326213|NCT03300180|582579705|FG001|12 Month Outcome|Withdrawal by Subject|6|||
161326214|NCT03300180|582579706|FG002|12 Month Outcome|Withdrawal by Subject|6|||
161326215|NCT03300180|582579704|FG000|12 Month Outcome|Death|9|||
161326216|NCT03300180|582579705|FG001|12 Month Outcome|Death|6|||
161326217|NCT03300180|582579706|FG002|12 Month Outcome|Death|6|||
161326218|NCT03300180|582579704|FG000|12 Month Outcome|Missed Assessment|62|||
161326219|NCT03300180|582579705|FG001|12 Month Outcome|Missed Assessment|59|||
161326220|NCT03300180|582579706|FG002|12 Month Outcome|Missed Assessment|58|||
161326221|NCT03300180|582579704|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
161326222|NCT03300180|582579705|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
161326223|NCT03300180|582579706|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
161326224|NCT03300180|582579704|FG000|18 Month Outcome Assessment|Death|8|||
161326225|NCT03300180|582579705|FG001|18 Month Outcome Assessment|Death|5|||
161326226|NCT03300180|582579706|FG002|18 Month Outcome Assessment|Death|5|||
161326227|NCT03300180|582579704|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
161326228|NCT03300180|582579705|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
161326229|NCT03300180|582579706|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
161326230|NCT03300180|582579704|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
161326231|NCT03300180|582579705|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
161326232|NCT03300180|582579706|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
161326233|NCT03300180|582579704|FG000|24 Month Outcome Assessment|Death|13|||
161326234|NCT03300180|582579705|FG001|24 Month Outcome Assessment|Death|13|||
161326235|NCT03300180|582579706|FG002|24 Month Outcome Assessment|Death|3|||
161326236|NCT03300180|582579704|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
161326237|NCT03300180|582579705|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
161326238|NCT03300180|582579706|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
161326239|NCT02557516|582579709|FG000|Overall Study|Adverse Event|1|||
161326240|NCT02557516|582579710|FG001|Overall Study|Adverse Event|0|||
161326241|NCT02557516|582579711|FG002|Overall Study|Adverse Event|2|||
161326242|NCT02557516|582579712|FG003|Overall Study|Adverse Event|1|||
161326243|NCT02557516|582579709|FG000|Overall Study|Disease progression|0|||
161326244|NCT02557516|582579710|FG001|Overall Study|Disease progression|2|||
161326245|NCT02557516|582579711|FG002|Overall Study|Disease progression|0|||
161123111|NCT00662792|581837474|FG002|Period 1|Not treated|0|||
161123112|NCT00662792|581837475|FG003|Period 1|Not treated|0|||
161123113|NCT00662792|581837472|FG000|Period 2|Worsening of disease under study|1|||
161123114|NCT00662792|581837473|FG001|Period 2|Worsening of disease under study|0|||
161326246|NCT02557516|582579712|FG003|Overall Study|Disease progression|0|||
161326247|NCT02557516|582579709|FG000|Overall Study|Physician Decision|0|||
161326248|NCT02557516|582579710|FG001|Overall Study|Physician Decision|2|||
161326249|NCT02557516|582579711|FG002|Overall Study|Physician Decision|0|||
161326250|NCT02557516|582579712|FG003|Overall Study|Physician Decision|0|||
161326251|NCT02557516|582579709|FG000|Overall Study|Sponsor decision|0|||
161326252|NCT02557516|582579710|FG001|Overall Study|Sponsor decision|1|||
161326253|NCT02557516|582579711|FG002|Overall Study|Sponsor decision|2|||
161326254|NCT02557516|582579712|FG003|Overall Study|Sponsor decision|8|||
161326255|NCT01972464|582579713|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
161326256|NCT01972464|582579714|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
161326257|NCT01972464|582579713|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
161326258|NCT01972464|582579714|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
160778542|NCT03369223|580573502|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160778543|NCT03369223|580573503|FG004|Overall Study|Adverse event unrelated to study drug|0|||
160778544|NCT03369223|580573504|FG005|Overall Study|Adverse event unrelated to study drug|0|||
160778545|NCT03369223|580573505|FG006|Overall Study|Adverse event unrelated to study drug|1|||
160778546|NCT03369223|580573506|FG007|Overall Study|Adverse event unrelated to study drug|0|||
160778547|NCT03369223|580573507|FG008|Overall Study|Adverse event unrelated to study drug|0|||
160778548|NCT03369223|580573508|FG009|Overall Study|Adverse event unrelated to study drug|1|||
160778549|NCT03369223|580573509|FG010|Overall Study|Adverse event unrelated to study drug|0|||
160778550|NCT03369223|580573510|FG011|Overall Study|Adverse event unrelated to study drug|0|||
160778551|NCT03369223|580573511|FG012|Overall Study|Adverse event unrelated to study drug|0|||
160778552|NCT03369223|580573512|FG013|Overall Study|Adverse event unrelated to study drug|4|||
160778553|NCT03369223|580573513|FG014|Overall Study|Adverse event unrelated to study drug|2|||
160778554|NCT03369223|580573514|FG015|Overall Study|Adverse event unrelated to study drug|0|||
160887049|NCT04090411|580980639|FG004|Chronic Period|Protocol Violation|0|||
161123115|NCT00662792|581837474|FG002|Period 2|Worsening of disease under study|0|||
161123116|NCT00662792|581837475|FG003|Period 2|Worsening of disease under study|3|||
161123117|NCT00662792|581837472|FG000|Period 3|Refused continuing medication|1|||
161123118|NCT00662792|581837473|FG001|Period 3|Refused continuing medication|0|||
161123119|NCT00662792|581837474|FG002|Period 3|Refused continuing medication|1|||
161123120|NCT00662792|581837475|FG003|Period 3|Refused continuing medication|0|||
161123121|NCT00662792|581837472|FG000|Period 3|Other adverse event (AE)|0|||
161123122|NCT00662792|581837473|FG001|Period 3|Other adverse event (AE)|0|||
161123123|NCT00662792|581837474|FG002|Period 3|Other adverse event (AE)|1|||
161123124|NCT00662792|581837475|FG003|Period 3|Other adverse event (AE)|1|||
161123125|NCT00662792|581837472|FG000|Period 4|Refused continuing medication|0|||
161123126|NCT00662792|581837473|FG001|Period 4|Refused continuing medication|1|||
161123127|NCT00662792|581837474|FG002|Period 4|Refused continuing medication|0|||
161123128|NCT00662792|581837475|FG003|Period 4|Refused continuing medication|0|||
161123129|NCT00662792|581837472|FG000|Period 4|Other adverse event (AE)|1|||
161123130|NCT00662792|581837473|FG001|Period 4|Other adverse event (AE)|0|||
161123131|NCT00662792|581837474|FG002|Period 4|Other adverse event (AE)|0|||
161123132|NCT00662792|581837475|FG003|Period 4|Other adverse event (AE)|0|||
161123133|NCT00662792|581837472|FG000|Period 4|Worsening of disease under study (AE)|0|||
161123134|NCT00662792|581837473|FG001|Period 4|Worsening of disease under study (AE)|0|||
161123135|NCT00662792|581837474|FG002|Period 4|Worsening of disease under study (AE)|0|||
161123136|NCT00662792|581837475|FG003|Period 4|Worsening of disease under study (AE)|1|||
161123137|NCT02347176|581837476|FG000|Overall Study|Lost to Follow-up|2|||
161123138|NCT02347176|581837477|FG001|Overall Study|Lost to Follow-up|3|||
161123139|NCT02347176|581837478|FG002|Overall Study|Lost to Follow-up|1|||
161123140|NCT02347176|581837479|FG003|Overall Study|Lost to Follow-up|1|||
161123141|NCT02347176|581837476|FG000|Overall Study|Withdrawal by Subject|9|||
161123142|NCT02347176|581837477|FG001|Overall Study|Withdrawal by Subject|5|||
161123143|NCT02347176|581837478|FG002|Overall Study|Withdrawal by Subject|5|||
161123144|NCT02347176|581837479|FG003|Overall Study|Withdrawal by Subject|3|||
161123145|NCT02347176|581837476|FG000|Overall Study|Other|1|||
161123146|NCT02347176|581837477|FG001|Overall Study|Other|2|||
161123147|NCT02347176|581837478|FG002|Overall Study|Other|2|||
161123148|NCT02347176|581837479|FG003|Overall Study|Other|0|||
161123149|NCT00699907|581837484|FG000|Overall Study|Withdrawal by Subject|2|||
161123150|NCT00699907|581837485|FG001|Overall Study|Withdrawal by Subject|1|||
161123151|NCT00699907|581837486|FG002|Overall Study|Withdrawal by Subject|0|||
161123152|NCT00699907|581837484|FG000|Overall Study|No usable sample|0|||
161123153|NCT00699907|581837485|FG001|Overall Study|No usable sample|9|||
161123154|NCT00699907|581837486|FG002|Overall Study|No usable sample|8|||
161123155|NCT02161211|581837487|FG000|Overall Study|Lost to Follow-up|21|||
161123156|NCT02161211|581837488|FG001|Overall Study|Lost to Follow-up|27|||
161123157|NCT02161211|581837489|FG002|Overall Study|Lost to Follow-up|21|||
161123158|NCT02161211|581837487|FG000|Overall Study|Dropped|12|||
160887050|NCT04090411|580980640|FG005|Chronic Period|Protocol Violation|0|||
160887051|NCT04090411|580980641|FG006|Chronic Period|Protocol Violation|0|||
161123159|NCT02161211|581837488|FG001|Overall Study|Dropped|5|||
161123160|NCT02161211|581837489|FG002|Overall Study|Dropped|9|||
161123161|NCT02462473|581837490|FG000|Overall Study|Death|1|||
161123162|NCT02462473|581837490|FG000|Overall Study|Other|3|||
161123163|NCT01536860|581837492|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
161123164|NCT01536860|581837493|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
161123165|NCT01536860|581837494|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
161123166|NCT01164722|581837495|FG000|Overall Study|Adverse Event|0|||
161123167|NCT01164722|581837496|FG001|Overall Study|Adverse Event|1|||
161123168|NCT01164722|581837495|FG000|Overall Study|Withdrawal by Subject|3|||
161123169|NCT01164722|581837496|FG001|Overall Study|Withdrawal by Subject|4|||
161123170|NCT01164722|581837495|FG000|Overall Study|Lost to Follow-up|3|||
161123171|NCT01164722|581837496|FG001|Overall Study|Lost to Follow-up|6|||
161123172|NCT01164722|581837495|FG000|Overall Study|met protocol criteria for non-treatment|11|||
161123173|NCT01164722|581837496|FG001|Overall Study|met protocol criteria for non-treatment|1|||
161123174|NCT01164722|581837495|FG000|Overall Study|enrolled on other study, concomitant med|1|||
160778555|NCT03369223|580573515|FG016|Overall Study|Adverse event unrelated to study drug|2|||
160778556|NCT03369223|580573516|FG017|Overall Study|Adverse event unrelated to study drug|1|||
160778557|NCT03369223|580573517|FG018|Overall Study|Adverse event unrelated to study drug|3|||
160778558|NCT03369223|580573518|FG019|Overall Study|Adverse event unrelated to study drug|2|||
160778559|NCT03369223|580573499|FG000|Overall Study|Disease progression|6|||
160778560|NCT03369223|580573500|FG001|Overall Study|Disease progression|8|||
160778561|NCT03369223|580573501|FG002|Overall Study|Disease progression|5|||
160778562|NCT03369223|580573502|FG003|Overall Study|Disease progression|1|||
160778563|NCT03369223|580573503|FG004|Overall Study|Disease progression|9|||
160778564|NCT03369223|580573504|FG005|Overall Study|Disease progression|9|||
160778565|NCT03369223|580573505|FG006|Overall Study|Disease progression|4|||
160778566|NCT03369223|580573506|FG007|Overall Study|Disease progression|6|||
160778567|NCT03369223|580573507|FG008|Overall Study|Disease progression|10|||
160778568|NCT03369223|580573508|FG009|Overall Study|Disease progression|7|||
160778569|NCT03369223|580573509|FG010|Overall Study|Disease progression|4|||
160778570|NCT03369223|580573510|FG011|Overall Study|Disease progression|1|||
160778571|NCT03369223|580573511|FG012|Overall Study|Disease progression|1|||
160778572|NCT03369223|580573512|FG013|Overall Study|Disease progression|25|||
160778573|NCT03369223|580573513|FG014|Overall Study|Disease progression|22|||
160778574|NCT03369223|580573514|FG015|Overall Study|Disease progression|2|||
160778575|NCT03369223|580573515|FG016|Overall Study|Disease progression|10|||
160778576|NCT03369223|580573516|FG017|Overall Study|Disease progression|1|||
160778577|NCT03369223|580573517|FG018|Overall Study|Disease progression|18|||
160778578|NCT03369223|580573518|FG019|Overall Study|Disease progression|28|||
160778579|NCT03369223|580573499|FG000|Overall Study|Study drug toxicity|0|||
160778580|NCT03369223|580573500|FG001|Overall Study|Study drug toxicity|1|||
160778581|NCT03369223|580573501|FG002|Overall Study|Study drug toxicity|4|||
160778582|NCT03369223|580573502|FG003|Overall Study|Study drug toxicity|0|||
160778583|NCT03369223|580573503|FG004|Overall Study|Study drug toxicity|1|||
160778584|NCT03369223|580573504|FG005|Overall Study|Study drug toxicity|2|||
160778585|NCT03369223|580573505|FG006|Overall Study|Study drug toxicity|4|||
160778586|NCT03369223|580573506|FG007|Overall Study|Study drug toxicity|2|||
160778587|NCT03369223|580573507|FG008|Overall Study|Study drug toxicity|2|||
160778588|NCT03369223|580573508|FG009|Overall Study|Study drug toxicity|0|||
160778589|NCT03369223|580573509|FG010|Overall Study|Study drug toxicity|6|||
160778590|NCT03369223|580573510|FG011|Overall Study|Study drug toxicity|1|||
160778591|NCT03369223|580573511|FG012|Overall Study|Study drug toxicity|2|||
160778592|NCT03369223|580573512|FG013|Overall Study|Study drug toxicity|19|||
160778593|NCT03369223|580573513|FG014|Overall Study|Study drug toxicity|19|||
160778594|NCT03369223|580573514|FG015|Overall Study|Study drug toxicity|0|||
160778595|NCT03369223|580573515|FG016|Overall Study|Study drug toxicity|18|||
160778596|NCT03369223|580573516|FG017|Overall Study|Study drug toxicity|3|||
160778597|NCT03369223|580573517|FG018|Overall Study|Study drug toxicity|11|||
160778598|NCT03369223|580573518|FG019|Overall Study|Study drug toxicity|7|||
160778599|NCT03369223|580573499|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160778600|NCT03369223|580573500|FG001|Overall Study|Participant request to discontinue study treatment|1|||
160778601|NCT03369223|580573501|FG002|Overall Study|Participant request to discontinue study treatment|0|||
160887052|NCT04090411|580980642|FG007|Chronic Period|Protocol Violation|0|||
160887053|NCT04090411|580980643|FG008|Chronic Period|Protocol Violation|0|||
160887054|NCT04090411|580980644|FG009|Chronic Period|Protocol Violation|0|||
160887055|NCT04090411|580980645|FG010|Chronic Period|Protocol Violation|0|||
160887056|NCT04090411|580980646|FG011|Chronic Period|Protocol Violation|0|||
160887057|NCT04090411|580980647|FG012|Chronic Period|Protocol Violation|1|||
160887058|NCT04090411|580980635|FG000|Chronic Period|Withdrawal by Subject|0|||
160887059|NCT04090411|580980636|FG001|Chronic Period|Withdrawal by Subject|0|||
160887060|NCT04090411|580980637|FG002|Chronic Period|Withdrawal by Subject|0|||
160887061|NCT04090411|580980638|FG003|Chronic Period|Withdrawal by Subject|0|||
160887062|NCT04090411|580980639|FG004|Chronic Period|Withdrawal by Subject|0|||
160887063|NCT04090411|580980640|FG005|Chronic Period|Withdrawal by Subject|1|||
160887064|NCT04090411|580980641|FG006|Chronic Period|Withdrawal by Subject|1|||
160887065|NCT04090411|580980642|FG007|Chronic Period|Withdrawal by Subject|3|||
160887066|NCT04090411|580980643|FG008|Chronic Period|Withdrawal by Subject|3|||
161123175|NCT01164722|581837496|FG001|Overall Study|enrolled on other study, concomitant med|3|||
160778602|NCT03369223|580573502|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160778603|NCT03369223|580573503|FG004|Overall Study|Participant request to discontinue study treatment|1|||
160778604|NCT03369223|580573504|FG005|Overall Study|Participant request to discontinue study treatment|1|||
160778605|NCT03369223|580573505|FG006|Overall Study|Participant request to discontinue study treatment|1|||
160778606|NCT03369223|580573506|FG007|Overall Study|Participant request to discontinue study treatment|0|||
160778607|NCT03369223|580573507|FG008|Overall Study|Participant request to discontinue study treatment|0|||
160778608|NCT03369223|580573508|FG009|Overall Study|Participant request to discontinue study treatment|0|||
160778609|NCT03369223|580573509|FG010|Overall Study|Participant request to discontinue study treatment|0|||
160887067|NCT04090411|580980644|FG009|Chronic Period|Withdrawal by Subject|3|||
160887068|NCT04090411|580980645|FG010|Chronic Period|Withdrawal by Subject|1|||
161229188|NCT01606306|582220366|FG000|Overall Study|Physician Decision|1|||
161229189|NCT01606306|582220367|FG001|Overall Study|Physician Decision|2|||
161229190|NCT01606306|582220368|FG002|Overall Study|Physician Decision|0|||
161229191|NCT01606306|582220369|FG003|Overall Study|Physician Decision|0|||
161229192|NCT01606306|582220370|FG004|Overall Study|Physician Decision|0|||
161229193|NCT01606306|582220371|FG005|Overall Study|Physician Decision|0|||
161229194|NCT00950872|582220372|FG000|Overall Study|Withdrawal by Subject|1|||
161229195|NCT00950872|582220372|FG000|Overall Study|Did not have surgery|2|||
161229196|NCT00970281|582220375|FG000|Overall Study|Lack of Efficacy|1|||
161229197|NCT00970281|582220376|FG001|Overall Study|Lack of Efficacy|14|||
161229198|NCT00970281|582220375|FG000|Overall Study|Withdrawal by Subject|0|||
161229199|NCT00970281|582220376|FG001|Overall Study|Withdrawal by Subject|1|||
161229200|NCT00970281|582220375|FG000|Overall Study|Physician Decision|1|||
161229201|NCT00970281|582220376|FG001|Overall Study|Physician Decision|1|||
161229202|NCT01759290|582220377|FG000|Overall Study|Subjects withdrawn consent|5|||
161229203|NCT01759290|582220377|FG000|Overall Study|Physician Decision|2|||
161229204|NCT01759290|582220377|FG000|Overall Study|Death|17|||
161229205|NCT01759290|582220377|FG000|Overall Study|Lost to Follow-up|53|||
161229206|NCT01759290|582220377|FG000|Overall Study|Unknown reason|4|||
161229207|NCT01766778|582220391|FG000|Overall Study|Adverse Event|4|||
161229208|NCT01766778|582220392|FG001|Overall Study|Adverse Event|4|||
161229209|NCT01766778|582220391|FG000|Overall Study|Withdrawal by Subject|1|||
161229210|NCT01766778|582220392|FG001|Overall Study|Withdrawal by Subject|0|||
161229211|NCT01054599|582220393|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
161229212|NCT01054599|582220394|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
161229213|NCT01054599|582220393|FG000|Overall Study|Protocol Violation|1|||
161229214|NCT01054599|582220394|FG001|Overall Study|Protocol Violation|0|||
161229215|NCT01054599|582220393|FG000|Overall Study|Spells/seizure-like episodes|1|||
161229216|NCT01054599|582220394|FG001|Overall Study|Spells/seizure-like episodes|1|||
161229217|NCT01054599|582220393|FG000|Overall Study|Timing/scheduling difficulties|1|||
160887069|NCT04090411|580980646|FG011|Chronic Period|Withdrawal by Subject|3|||
160887070|NCT04090411|580980647|FG012|Chronic Period|Withdrawal by Subject|0|||
161229218|NCT01054599|582220394|FG001|Overall Study|Timing/scheduling difficulties|1|||
161229219|NCT01054599|582220393|FG000|Overall Study|Visual impairment, WTAR <80|0|||
161229220|NCT01054599|582220394|FG001|Overall Study|Visual impairment, WTAR <80|1|||
161229221|NCT01054599|582220393|FG000|Overall Study|Lost to Follow-up|0|||
161229222|NCT01054599|582220394|FG001|Overall Study|Lost to Follow-up|2|||
161229223|NCT01054599|582220393|FG000|Overall Study|Adverse Event|0|||
161229224|NCT01054599|582220394|FG001|Overall Study|Adverse Event|1|||
161229225|NCT01054599|582220393|FG000|Overall Study|Withdrawal by Subject|0|||
161229226|NCT01054599|582220394|FG001|Overall Study|Withdrawal by Subject|1|||
161229227|NCT01104662|582220395|FG000|Overall Study|Adverse Event|2|||
161229228|NCT01104662|582220396|FG001|Overall Study|Adverse Event|2|||
161229229|NCT01104662|582220397|FG002|Overall Study|Adverse Event|0|||
161229230|NCT01104662|582220398|FG003|Overall Study|Adverse Event|1|||
161229231|NCT01104662|582220399|FG004|Overall Study|Adverse Event|1|||
161229232|NCT01104662|582220400|FG005|Overall Study|Adverse Event|1|||
161229233|NCT01104662|582220401|FG006|Overall Study|Adverse Event|0|||
161229234|NCT01104662|582220402|FG007|Overall Study|Adverse Event|0|||
161229235|NCT01104662|582220395|FG000|Overall Study|Clinical Failure|1|||
161229236|NCT01104662|582220396|FG001|Overall Study|Clinical Failure|0|||
161229237|NCT01104662|582220397|FG002|Overall Study|Clinical Failure|0|||
161229238|NCT01104662|582220398|FG003|Overall Study|Clinical Failure|0|||
161229239|NCT01104662|582220399|FG004|Overall Study|Clinical Failure|0|||
161229240|NCT01104662|582220400|FG005|Overall Study|Clinical Failure|1|||
161229241|NCT01104662|582220401|FG006|Overall Study|Clinical Failure|0|||
161229242|NCT01104662|582220402|FG007|Overall Study|Clinical Failure|0|||
161229243|NCT01104662|582220395|FG000|Overall Study|Participant left investigator's care|1|||
160887071|NCT01958827|580980655|FG000|Overall Study|Adverse Event|3|||
160887072|NCT01958827|580980655|FG000|Overall Study|Lack of Efficacy|6|||
160887073|NCT01958827|580980655|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
160887074|NCT04594369|580980659|FG000|Overall Study|Adverse Event|10|||
160887075|NCT04594369|580980660|FG001|Overall Study|Adverse Event|10|||
160887076|NCT04594369|580980661|FG002|Overall Study|Adverse Event|9|||
161229244|NCT01104662|582220396|FG001|Overall Study|Participant left investigator's care|1|||
161229245|NCT01104662|582220397|FG002|Overall Study|Participant left investigator's care|0|||
161229246|NCT01104662|582220398|FG003|Overall Study|Participant left investigator's care|0|||
161229247|NCT01104662|582220399|FG004|Overall Study|Participant left investigator's care|0|||
161229248|NCT01104662|582220400|FG005|Overall Study|Participant left investigator's care|0|||
161229249|NCT01104662|582220401|FG006|Overall Study|Participant left investigator's care|0|||
161229250|NCT01104662|582220402|FG007|Overall Study|Participant left investigator's care|0|||
161229251|NCT01104662|582220395|FG000|Overall Study|Reason not specified|3|||
161229252|NCT01104662|582220396|FG001|Overall Study|Reason not specified|3|||
160887077|NCT04594369|580980659|FG000|Overall Study|Death|2|||
160887078|NCT04594369|580980660|FG001|Overall Study|Death|4|||
160887079|NCT04594369|580980661|FG002|Overall Study|Death|8|||
160887080|NCT04594369|580980659|FG000|Overall Study|Lost to Follow-up|10|||
160887081|NCT04594369|580980660|FG001|Overall Study|Lost to Follow-up|2|||
161229253|NCT01104662|582220397|FG002|Overall Study|Reason not specified|0|||
161229254|NCT01104662|582220398|FG003|Overall Study|Reason not specified|0|||
160778610|NCT03369223|580573510|FG011|Overall Study|Participant request to discontinue study treatment|0|||
160778611|NCT03369223|580573511|FG012|Overall Study|Participant request to discontinue study treatment|0|||
160778612|NCT03369223|580573512|FG013|Overall Study|Participant request to discontinue study treatment|1|||
160778613|NCT03369223|580573513|FG014|Overall Study|Participant request to discontinue study treatment|1|||
160778614|NCT03369223|580573514|FG015|Overall Study|Participant request to discontinue study treatment|0|||
160778615|NCT03369223|580573515|FG016|Overall Study|Participant request to discontinue study treatment|0|||
160778616|NCT03369223|580573516|FG017|Overall Study|Participant request to discontinue study treatment|0|||
160778617|NCT03369223|580573517|FG018|Overall Study|Participant request to discontinue study treatment|1|||
160778618|NCT03369223|580573518|FG019|Overall Study|Participant request to discontinue study treatment|0|||
160778619|NCT03369223|580573499|FG000|Overall Study|Participant withdrew consent|0|||
160778620|NCT03369223|580573500|FG001|Overall Study|Participant withdrew consent|1|||
160778621|NCT03369223|580573501|FG002|Overall Study|Participant withdrew consent|1|||
160778622|NCT03369223|580573502|FG003|Overall Study|Participant withdrew consent|0|||
160778623|NCT03369223|580573503|FG004|Overall Study|Participant withdrew consent|0|||
160778624|NCT03369223|580573504|FG005|Overall Study|Participant withdrew consent|0|||
160778625|NCT03369223|580573505|FG006|Overall Study|Participant withdrew consent|1|||
160778626|NCT03369223|580573506|FG007|Overall Study|Participant withdrew consent|1|||
160778627|NCT03369223|580573507|FG008|Overall Study|Participant withdrew consent|1|||
160778628|NCT03369223|580573508|FG009|Overall Study|Participant withdrew consent|0|||
160778629|NCT03369223|580573509|FG010|Overall Study|Participant withdrew consent|0|||
160778630|NCT03369223|580573510|FG011|Overall Study|Participant withdrew consent|1|||
160778631|NCT03369223|580573511|FG012|Overall Study|Participant withdrew consent|0|||
160778632|NCT03369223|580573512|FG013|Overall Study|Participant withdrew consent|0|||
160778633|NCT03369223|580573513|FG014|Overall Study|Participant withdrew consent|3|||
160778634|NCT03369223|580573514|FG015|Overall Study|Participant withdrew consent|0|||
160778635|NCT03369223|580573515|FG016|Overall Study|Participant withdrew consent|1|||
160778636|NCT03369223|580573516|FG017|Overall Study|Participant withdrew consent|0|||
160778637|NCT03369223|580573517|FG018|Overall Study|Participant withdrew consent|4|||
160778638|NCT03369223|580573518|FG019|Overall Study|Participant withdrew consent|2|||
160778639|NCT03369223|580573499|FG000|Overall Study|Randomized but not treated|0|||
160778640|NCT03369223|580573500|FG001|Overall Study|Randomized but not treated|0|||
160778641|NCT03369223|580573501|FG002|Overall Study|Randomized but not treated|0|||
160778642|NCT03369223|580573502|FG003|Overall Study|Randomized but not treated|0|||
160778643|NCT03369223|580573503|FG004|Overall Study|Randomized but not treated|0|||
160778644|NCT03369223|580573504|FG005|Overall Study|Randomized but not treated|0|||
160778645|NCT03369223|580573505|FG006|Overall Study|Randomized but not treated|0|||
160778646|NCT03369223|580573506|FG007|Overall Study|Randomized but not treated|0|||
160778647|NCT03369223|580573507|FG008|Overall Study|Randomized but not treated|0|||
160778648|NCT03369223|580573508|FG009|Overall Study|Randomized but not treated|0|||
160778649|NCT03369223|580573509|FG010|Overall Study|Randomized but not treated|0|||
160778650|NCT03369223|580573510|FG011|Overall Study|Randomized but not treated|0|||
160778651|NCT03369223|580573511|FG012|Overall Study|Randomized but not treated|0|||
160778652|NCT03369223|580573512|FG013|Overall Study|Randomized but not treated|1|||
160778653|NCT03369223|580573513|FG014|Overall Study|Randomized but not treated|1|||
160778654|NCT03369223|580573514|FG015|Overall Study|Randomized but not treated|0|||
160778655|NCT03369223|580573515|FG016|Overall Study|Randomized but not treated|0|||
160778656|NCT03369223|580573516|FG017|Overall Study|Randomized but not treated|0|||
160778657|NCT03369223|580573517|FG018|Overall Study|Randomized but not treated|0|||
160778658|NCT03369223|580573518|FG019|Overall Study|Randomized but not treated|0|||
160861862|NCT02531802|580887858|FG013|Received Vaccination 2|Adverse Event|0|||
160861863|NCT02531802|580887859|FG014|Received Vaccination 2|Adverse Event|0|||
160861864|NCT02531802|580887860|FG015|Received Vaccination 2|Adverse Event|0|||
160861865|NCT02531802|580887861|FG016|Received Vaccination 2|Adverse Event|0|||
160861866|NCT02531802|580887862|FG017|Received Vaccination 2|Adverse Event|2|||
160861867|NCT02531802|580887863|FG018|Received Vaccination 2|Adverse Event|1|||
160861868|NCT02531802|580887864|FG019|Received Vaccination 2|Adverse Event|0|||
160861869|NCT02531802|580887865|FG020|Received Vaccination 2|Adverse Event|1|||
160861870|NCT02531802|580887845|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
160861871|NCT02531802|580887846|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
160861872|NCT02531802|580887847|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
160861873|NCT02531802|580887848|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
160861874|NCT02531802|580887849|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
160861875|NCT02531802|580887850|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
160861876|NCT02531802|580887851|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
160861877|NCT02531802|580887852|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
160861878|NCT02531802|580887853|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
160861879|NCT02531802|580887854|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
160861880|NCT02531802|580887855|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
160861881|NCT02531802|580887856|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
160861882|NCT02531802|580887857|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
160861883|NCT02531802|580887858|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
160778659|NCT04706403|580574922|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
160778660|NCT04706403|580574923|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
160778661|NCT04706403|580574924|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
160778662|NCT04706403|580574925|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
160778663|NCT04706403|580574926|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
160778664|NCT01653262|580574927|FG000|Overall Study|Lack of Efficacy|1|||
160778665|NCT01653262|580574927|FG000|Overall Study|SAE, non-fatal|1|||
160778666|NCT01653262|580574927|FG000|Overall Study|AE, non-serious non-fatal|1|||
160778667|NCT01112267|580574928|FG000|Overall Study|Adverse Event|24|||
160778668|NCT01112267|580574929|FG001|Overall Study|Adverse Event|6|||
160778669|NCT01112267|580574928|FG000|Overall Study|Withdrawal by Subject|3|||
160778670|NCT01112267|580574929|FG001|Overall Study|Withdrawal by Subject|5|||
160778671|NCT01112267|580574928|FG000|Overall Study|Protocol Violation|5|||
160778672|NCT01112267|580574929|FG001|Overall Study|Protocol Violation|3|||
160778673|NCT01112267|580574928|FG000|Overall Study|Participants not compliant|1|||
160778674|NCT01112267|580574929|FG001|Overall Study|Participants not compliant|2|||
160778675|NCT01112267|580574928|FG000|Overall Study|Participants not receive any study drug|1|||
160778676|NCT01112267|580574929|FG001|Overall Study|Participants not receive any study drug|2|||
160778677|NCT01373229|580574930|FG000|Overall Study|Death|3|||
160778678|NCT01373229|580574930|FG000|Overall Study|Physician Decision|3|||
160778679|NCT00587457|580574931|FG000|Overall Study|Adverse Event|1|||
160778680|NCT00587457|580574932|FG001|Overall Study|Adverse Event|2|||
160778681|NCT00587457|580574933|FG002|Overall Study|Adverse Event|1|||
160778682|NCT00587457|580574931|FG000|Overall Study|Disease progression|2|||
160778683|NCT00587457|580574932|FG001|Overall Study|Disease progression|0|||
160778684|NCT00587457|580574933|FG002|Overall Study|Disease progression|2|||
160778685|NCT00587457|580574931|FG000|Overall Study|Initiation of alternative therapy|0|||
160778686|NCT00587457|580574932|FG001|Overall Study|Initiation of alternative therapy|1|||
160778687|NCT00587457|580574933|FG002|Overall Study|Initiation of alternative therapy|0|||
160778688|NCT00587457|580574931|FG000|Overall Study|Undefined|0|||
160778689|NCT00587457|580574932|FG001|Overall Study|Undefined|0|||
160778690|NCT00587457|580574933|FG002|Overall Study|Undefined|1|||
160778691|NCT00587457|580574931|FG000|Overall Study|Development of neutralizing Abs|0|||
160778692|NCT00587457|580574932|FG001|Overall Study|Development of neutralizing Abs|0|||
160778693|NCT00587457|580574933|FG002|Overall Study|Development of neutralizing Abs|1|||
160778694|NCT04439175|580574934|FG000|Overall Study|Never started treatment|4|||
160778695|NCT04439175|580574934|FG000|Overall Study|Ineligible|5|||
160778696|NCT04439175|580574934|FG000|Overall Study|Adverse Event|6|||
160778697|NCT04439175|580574934|FG000|Overall Study|Death|4|||
160778698|NCT04439175|580574934|FG000|Overall Study|Disease progression|44|||
160778699|NCT04439175|580574934|FG000|Overall Study|Withdrawal by Subject|4|||
160778700|NCT04439175|580574934|FG000|Overall Study|Alternative Therapy|1|||
160778701|NCT04439175|580574934|FG000|Overall Study|Other|2|||
160778702|NCT05417113|580574937|FG000|Overall Study|Lost to Follow-up|2|||
160778703|NCT05417113|580574938|FG001|Overall Study|Lost to Follow-up|2|||
160778704|NCT01022580|580574939|FG000|Overall Study|Death|18|||
160778705|NCT01022580|580574940|FG001|Overall Study|Death|22|||
160778706|NCT01166945|580574944|FG000|Randomized|diagnosed with Group A strep|4|||
160778707|NCT01166945|580574945|FG001|Randomized|diagnosed with Group A strep|4|||
160778708|NCT01166945|580574944|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
160778709|NCT01166945|580574945|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
160778710|NCT01166945|580574944|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
160778711|NCT01166945|580574945|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
160778712|NCT01166945|580574944|FG000|Day 30|Lost to Follow-up|4|||
160778713|NCT01166945|580574945|FG001|Day 30|Lost to Follow-up|3|||
160778714|NCT01178411|580574948|FG000|Overall Study|Adverse Event|5|||
160778715|NCT01178411|580574948|FG000|Overall Study|Withdrawal by Subject|4|||
160778716|NCT01178411|580574948|FG000|Overall Study|Protocol Violation|1|||
160778717|NCT01178411|580574948|FG000|Overall Study|Progressive disease per RECIST|32|||
160778718|NCT01178411|580574948|FG000|Overall Study|Progressive disease per clinician|9|||
160778719|NCT01178411|580574948|FG000|Overall Study|Physician Decision|6|||
160778720|NCT01178411|580574948|FG000|Overall Study|Death|1|||
160778721|NCT01178411|580574948|FG000|Overall Study|No reason provided|1|||
160778722|NCT01178411|580574948|FG000|Overall Study|Drug manufacturing ended|1|||
160778723|NCT02453048|580574951|FG000|Overall Study|Only part of initial 6 mo. study|0|||
160778724|NCT02453048|580574952|FG001|Overall Study|Only part of initial 6 mo. study|0|||
160778725|NCT02453048|580574953|FG002|Overall Study|Only part of initial 6 mo. study|0|||
160778726|NCT02453048|580574954|FG003|Overall Study|Only part of initial 6 mo. study|0|||
160778727|NCT02453048|580574955|FG004|Overall Study|Only part of initial 6 mo. study|6|||
160778728|NCT02453048|580574951|FG000|Overall Study|Lost to Follow-up|0|||
160778729|NCT02453048|580574952|FG001|Overall Study|Lost to Follow-up|1|||
160778730|NCT02453048|580574953|FG002|Overall Study|Lost to Follow-up|2|||
160778731|NCT02453048|580574954|FG003|Overall Study|Lost to Follow-up|0|||
160778732|NCT02453048|580574955|FG004|Overall Study|Lost to Follow-up|0|||
160778733|NCT02383173|580574957|FG000|Overall Study|Palliative Care Team withdrew|0|||
160778734|NCT02383173|580574958|FG001|Overall Study|Palliative Care Team withdrew|2|||
160778735|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
160778736|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
160778737|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
160778738|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
160778739|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
160778740|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
160778741|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
160778742|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
160778743|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
160778744|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
160778745|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
160778746|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
160778747|NCT00447278|580574959|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
160778748|NCT00447278|580574960|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
160778749|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
160778750|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
160778751|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
160778752|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
160778753|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
160778754|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
160778755|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
160778756|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
160778757|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
160778758|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
160778759|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
160778760|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
160778761|NCT00447278|580574959|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
160778762|NCT00447278|580574960|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
160778763|NCT03677401|580574961|FG000|Overall Study|Adverse Event|4|||
160778764|NCT03677401|580574962|FG001|Overall Study|Adverse Event|14|||
160778765|NCT03677401|580574961|FG000|Overall Study|Lack of Efficacy|3|||
160778766|NCT03677401|580574962|FG001|Overall Study|Lack of Efficacy|1|||
160778767|NCT03677401|580574961|FG000|Overall Study|Withdrawal by Subject|2|||
160887082|NCT04594369|580980661|FG002|Overall Study|Lost to Follow-up|4|||
160887083|NCT04594369|580980659|FG000|Overall Study|Physician Decision|2|||
160887084|NCT04594369|580980660|FG001|Overall Study|Physician Decision|2|||
160887085|NCT04594369|580980661|FG002|Overall Study|Physician Decision|3|||
160887086|NCT04594369|580980659|FG000|Overall Study|Protocol deviation|1|||
160887087|NCT04594369|580980660|FG001|Overall Study|Protocol deviation|3|||
160887088|NCT04594369|580980661|FG002|Overall Study|Protocol deviation|2|||
160887089|NCT04594369|580980659|FG000|Overall Study|Withdrawal by Subject|40|||
160887090|NCT04594369|580980660|FG001|Overall Study|Withdrawal by Subject|32|||
160887091|NCT04594369|580980661|FG002|Overall Study|Withdrawal by Subject|37|||
160887092|NCT04594369|580980659|FG000|Overall Study|Reason not specified|60|||
160887093|NCT04594369|580980660|FG001|Overall Study|Reason not specified|56|||
160887094|NCT04594369|580980661|FG002|Overall Study|Reason not specified|43|||
160887095|NCT02477696|580980662|FG000|Overall Study|Death|89|||
160887096|NCT02477696|580980663|FG001|Overall Study|Death|106|||
160887097|NCT02477696|580980662|FG000|Overall Study|Lost to Follow-up|7|||
160887098|NCT02477696|580980663|FG001|Overall Study|Lost to Follow-up|5|||
160887099|NCT02477696|580980662|FG000|Overall Study|Withdrawal by Subject|37|||
160887100|NCT02477696|580980663|FG001|Overall Study|Withdrawal by Subject|34|||
160887101|NCT02477696|580980662|FG000|Overall Study|Physician Decision|7|||
161229255|NCT01104662|582220399|FG004|Overall Study|Reason not specified|0|||
161229256|NCT01104662|582220400|FG005|Overall Study|Reason not specified|1|||
160887102|NCT02477696|580980663|FG001|Overall Study|Physician Decision|9|||
161229257|NCT01104662|582220401|FG006|Overall Study|Reason not specified|0|||
160778768|NCT03677401|580574962|FG001|Overall Study|Withdrawal by Subject|2|||
160778769|NCT03677401|580574961|FG000|Overall Study|Sponsor decision|0|||
160778770|NCT03677401|580574962|FG001|Overall Study|Sponsor decision|1|||
160778771|NCT03677401|580574961|FG000|Overall Study|Reason Unspecified|1|||
160778772|NCT03677401|580574962|FG001|Overall Study|Reason Unspecified|0|||
160778773|NCT00726557|580574968|FG000|Overall Study|Screening failure|4|||
160778774|NCT00726557|580574968|FG000|Overall Study|No end of treatment documentation|37|||
160887103|NCT02477696|580980662|FG000|Overall Study|Study terminated by sponsor|103|||
160887104|NCT02477696|580980663|FG001|Overall Study|Study terminated by sponsor|99|||
161229258|NCT01104662|582220402|FG007|Overall Study|Reason not specified|0|||
160778775|NCT00726557|580574968|FG000|Overall Study|No follow-up documentation available|55|||
160778776|NCT00726557|580574968|FG000|Overall Study|Treatment less than 3 months|17|||
160887105|NCT02477696|580980662|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
160887106|NCT02477696|580980663|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
160778777|NCT00726557|580574968|FG000|Overall Study|Inclusion criteria not met|15|||
160778778|NCT01239745|580574969|FG000|Overall Study|Study terminated by sponsor|45|||
160778779|NCT01239745|580574969|FG000|Overall Study|Adverse Event|1|||
160778780|NCT06262607|580574972|FG000|Overall Study|Physician Decision|0|||
160778781|NCT06262607|580574973|FG001|Overall Study|Physician Decision|1|||
160778782|NCT06262607|580574972|FG000|Overall Study|Withdrawal by Subject|2|||
160778783|NCT06262607|580574973|FG001|Overall Study|Withdrawal by Subject|0|||
160778784|NCT05161936|580574974|FG000|Overall Study|Study terminated by Sponsor|1|||
160778785|NCT05161936|580574975|FG001|Overall Study|Study terminated by Sponsor|0|||
160778786|NCT05161936|580574976|FG002|Overall Study|Study terminated by Sponsor|0|||
160778787|NCT05161936|580574974|FG000|Overall Study|Withdrawal by Subject|0|||
160778788|NCT05161936|580574975|FG001|Overall Study|Withdrawal by Subject|0|||
160778789|NCT05161936|580574976|FG002|Overall Study|Withdrawal by Subject|1|||
160778790|NCT02541903|580574977|FG000|Overall Study|Death|1|||
160778791|NCT02969018|580574982|FG000|Overall Study|Adverse Event|2|||
160778792|NCT02969018|580574983|FG001|Overall Study|Adverse Event|4|||
160778793|NCT02969018|580574984|FG002|Overall Study|Adverse Event|1|||
160778794|NCT02969018|580574985|FG003|Overall Study|Adverse Event|2|||
160778795|NCT02969018|580574986|FG004|Overall Study|Adverse Event|0|||
160778796|NCT02969018|580574987|FG005|Overall Study|Adverse Event|1|||
160778797|NCT02969018|580574988|FG006|Overall Study|Adverse Event|2|||
160778798|NCT02969018|580574989|FG007|Overall Study|Adverse Event|0|||
160778799|NCT02969018|580574982|FG000|Overall Study|Lack of Efficacy|0|||
160778800|NCT02969018|580574983|FG001|Overall Study|Lack of Efficacy|1|||
160778801|NCT02969018|580574984|FG002|Overall Study|Lack of Efficacy|0|||
160778802|NCT02969018|580574985|FG003|Overall Study|Lack of Efficacy|0|||
160778803|NCT02969018|580574986|FG004|Overall Study|Lack of Efficacy|1|||
160778804|NCT02969018|580574987|FG005|Overall Study|Lack of Efficacy|1|||
160778805|NCT02969018|580574988|FG006|Overall Study|Lack of Efficacy|1|||
160778806|NCT02969018|580574989|FG007|Overall Study|Lack of Efficacy|1|||
160778807|NCT02969018|580574982|FG000|Overall Study|Lost to Follow-up|1|||
160778808|NCT02969018|580574983|FG001|Overall Study|Lost to Follow-up|2|||
160778809|NCT02969018|580574984|FG002|Overall Study|Lost to Follow-up|2|||
160778810|NCT02969018|580574985|FG003|Overall Study|Lost to Follow-up|0|||
160778811|NCT02969018|580574986|FG004|Overall Study|Lost to Follow-up|1|||
160778812|NCT02969018|580574987|FG005|Overall Study|Lost to Follow-up|1|||
160887107|NCT02477696|580980662|FG000|Overall Study|Missing/Unknown|2|||
160887108|NCT02477696|580980663|FG001|Overall Study|Missing/Unknown|0|||
160887109|NCT02003365|580981746|FG000|Overall Study|Lost to Follow-up|0|||
160887110|NCT02003365|580981747|FG001|Overall Study|Lost to Follow-up|0|||
160887111|NCT02003365|580981748|FG002|Overall Study|Lost to Follow-up|1|||
160887112|NCT02582255|580981753|FG000|Overall Study|Protocol Violation|0|||
160887113|NCT02582255|580981754|FG001|Overall Study|Protocol Violation|3|||
160887114|NCT01709578|580981755|FG000|Overall Study|Rescued and entered in long term safety|63|||
160887115|NCT01709578|580981756|FG001|Overall Study|Rescued and entered in long term safety|25|||
160887116|NCT01709578|580981757|FG002|Overall Study|Rescued and entered in long term safety|26|||
160887117|NCT01709578|580981755|FG000|Overall Study|Adverse Event|9|||
160887118|NCT01709578|580981756|FG001|Overall Study|Adverse Event|18|||
160887119|NCT01709578|580981757|FG002|Overall Study|Adverse Event|17|||
160887120|NCT01709578|580981755|FG000|Overall Study|Lack of Efficacy|5|||
160887121|NCT01709578|580981756|FG001|Overall Study|Lack of Efficacy|4|||
160887122|NCT01709578|580981757|FG002|Overall Study|Lack of Efficacy|2|||
160887123|NCT01709578|580981755|FG000|Overall Study|Poor compliance to protocol|1|||
160887124|NCT01709578|580981756|FG001|Overall Study|Poor compliance to protocol|2|||
160887125|NCT01709578|580981757|FG002|Overall Study|Poor compliance to protocol|1|||
160887126|NCT01709578|580981755|FG000|Overall Study|Other, not related to safety or efficacy|2|||
160887127|NCT01709578|580981756|FG001|Overall Study|Other, not related to safety or efficacy|7|||
160887128|NCT01709578|580981757|FG002|Overall Study|Other, not related to safety or efficacy|5|||
160887129|NCT04050371|580981758|FG000|Overall Study|Withdrawal by Subject|1|||
160887130|NCT04050371|580981759|FG001|Overall Study|Withdrawal by Subject|0|||
160778813|NCT02969018|580574988|FG006|Overall Study|Lost to Follow-up|0|||
160887131|NCT00597701|580981760|FG000|Overall Study|Withdrawal by Subject|5|||
160778814|NCT02969018|580574989|FG007|Overall Study|Lost to Follow-up|1|||
160778815|NCT02969018|580574982|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778816|NCT02969018|580574983|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778817|NCT02969018|580574984|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778818|NCT02969018|580574985|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778819|NCT02969018|580574986|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778820|NCT02969018|580574987|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778821|NCT02969018|580574988|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
160778822|NCT02969018|580574989|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160778823|NCT02969018|580574982|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160887132|NCT00597701|580981761|FG001|Overall Study|Withdrawal by Subject|5|||
160887133|NCT00597701|580981760|FG000|Overall Study|Death|0|||
160887134|NCT00597701|580981761|FG001|Overall Study|Death|1|||
160887135|NCT00597701|580981760|FG000|Overall Study|Physician Decision|2|||
160887136|NCT00597701|580981761|FG001|Overall Study|Physician Decision|0|||
161229259|NCT01104662|582220395|FG000|Overall Study|Randomized but not treated|3|||
161229260|NCT01104662|582220396|FG001|Overall Study|Randomized but not treated|4|||
161229261|NCT01104662|582220397|FG002|Overall Study|Randomized but not treated|1|||
161229262|NCT01104662|582220398|FG003|Overall Study|Randomized but not treated|0|||
161229263|NCT01104662|582220399|FG004|Overall Study|Randomized but not treated|0|||
161229264|NCT01104662|582220400|FG005|Overall Study|Randomized but not treated|1|||
161229265|NCT01104662|582220401|FG006|Overall Study|Randomized but not treated|0|||
161229266|NCT01104662|582220402|FG007|Overall Study|Randomized but not treated|0|||
161229267|NCT01478620|582220403|FG000|Overall Study|Lost to Follow-up|6|||
161229268|NCT02937701|582222394|FG000|Day 1 to Week 22|Adverse Event|11|||
161229269|NCT02937701|582222395|FG001|Day 1 to Week 22|Adverse Event|14|||
161229270|NCT02937701|582222396|FG002|Day 1 to Week 22|Adverse Event|0|||
161229271|NCT02937701|582222397|FG003|Day 1 to Week 22|Adverse Event|0|||
161229272|NCT02937701|582222398|FG004|Day 1 to Week 22|Adverse Event|0|||
161229273|NCT02937701|582222394|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
161229274|NCT02937701|582222395|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
160778824|NCT02969018|580574983|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160778825|NCT02969018|580574984|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160778826|NCT02969018|580574985|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160778827|NCT02969018|580574986|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160778828|NCT02969018|580574987|FG005|Overall Study|Non-Compliance With Study Drug|0|||
160778829|NCT02969018|580574988|FG006|Overall Study|Non-Compliance With Study Drug|0|||
160887137|NCT00597701|580981760|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
160887138|NCT00597701|580981761|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
160887139|NCT04617795|580981766|FG000|Main Study|Lost to Follow-up|1|||
160887140|NCT04617795|580981767|FG001|Main Study|Lost to Follow-up|0|||
160778830|NCT02969018|580574989|FG007|Overall Study|Non-Compliance With Study Drug|0|||
160778831|NCT02969018|580574982|FG000|Overall Study|Other|0|||
160778832|NCT02969018|580574983|FG001|Overall Study|Other|0|||
160778833|NCT02969018|580574984|FG002|Overall Study|Other|0|||
160778834|NCT02969018|580574985|FG003|Overall Study|Other|1|||
160778835|NCT02969018|580574986|FG004|Overall Study|Other|0|||
160778836|NCT02969018|580574987|FG005|Overall Study|Other|0|||
160778837|NCT02969018|580574988|FG006|Overall Study|Other|0|||
160778838|NCT02969018|580574989|FG007|Overall Study|Other|2|||
160778839|NCT02969018|580574982|FG000|Overall Study|Pregnancy|0|||
160778840|NCT02969018|580574983|FG001|Overall Study|Pregnancy|0|||
160778841|NCT02969018|580574984|FG002|Overall Study|Pregnancy|0|||
160778842|NCT02969018|580574985|FG003|Overall Study|Pregnancy|0|||
160778843|NCT02969018|580574986|FG004|Overall Study|Pregnancy|0|||
160778844|NCT02969018|580574987|FG005|Overall Study|Pregnancy|1|||
160778845|NCT02969018|580574988|FG006|Overall Study|Pregnancy|0|||
160778846|NCT02969018|580574989|FG007|Overall Study|Pregnancy|0|||
160778847|NCT02969018|580574982|FG000|Overall Study|Protocol Violation|0|||
160778848|NCT02969018|580574983|FG001|Overall Study|Protocol Violation|0|||
160778849|NCT02969018|580574984|FG002|Overall Study|Protocol Violation|1|||
160778850|NCT02969018|580574985|FG003|Overall Study|Protocol Violation|1|||
160778851|NCT02969018|580574986|FG004|Overall Study|Protocol Violation|0|||
160778852|NCT02969018|580574987|FG005|Overall Study|Protocol Violation|0|||
160778853|NCT02969018|580574988|FG006|Overall Study|Protocol Violation|0|||
160778854|NCT02969018|580574989|FG007|Overall Study|Protocol Violation|0|||
160778855|NCT02969018|580574982|FG000|Overall Study|Withdrawal by Subject|0|||
160778856|NCT02969018|580574983|FG001|Overall Study|Withdrawal by Subject|1|||
160778857|NCT02969018|580574984|FG002|Overall Study|Withdrawal by Subject|2|||
160778858|NCT02969018|580574985|FG003|Overall Study|Withdrawal by Subject|1|||
160778859|NCT02969018|580574986|FG004|Overall Study|Withdrawal by Subject|0|||
160778860|NCT02969018|580574987|FG005|Overall Study|Withdrawal by Subject|4|||
160778861|NCT02969018|580574988|FG006|Overall Study|Withdrawal by Subject|4|||
160778862|NCT02969018|580574989|FG007|Overall Study|Withdrawal by Subject|3|||
160778863|NCT00376506|580574997|FG000|Overall Study|Death|0|||
160778864|NCT00376506|580574998|FG001|Overall Study|Death|2|||
160887141|NCT00472459|580981768|FG000|Overall Study|Adverse Event|13|||
160887142|NCT00472459|580981769|FG001|Overall Study|Adverse Event|13|||
161229275|NCT02937701|582222396|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
160778865|NCT02503865|580574999|FG000|Overall Study|Moved out of area|1|||
161229276|NCT02937701|582222397|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
161229277|NCT02937701|582222398|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
160778866|NCT02503865|580575000|FG001|Overall Study|Moved out of area|8|||
160778867|NCT02503865|580575001|FG002|Overall Study|Moved out of area|0|||
160778868|NCT02503865|580574999|FG000|Overall Study|Refused treatment|4|||
160778869|NCT02503865|580575000|FG001|Overall Study|Refused treatment|39|||
160778870|NCT02503865|580575001|FG002|Overall Study|Refused treatment|2|||
160778871|NCT02513563|580575006|FG000|Overall Study|Death|4|||
160778872|NCT02513563|580575006|FG000|Overall Study|Withdrawal by Subject|4|||
160887143|NCT00472459|580981768|FG000|Overall Study|Withdrawal by Subject|5|||
161229278|NCT02937701|582222394|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
161229279|NCT02937701|582222395|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
161229280|NCT02937701|582222396|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
160778873|NCT02513563|580575006|FG000|Overall Study|Physician Decision|1|||
160778874|NCT00317369|580575007|FG000|Overall Study|Adverse Event|2|||
160778875|NCT00317369|580575008|FG001|Overall Study|Adverse Event|1|||
160778876|NCT00317369|580575009|FG002|Overall Study|Adverse Event|0|||
160778877|NCT00317369|580575007|FG000|Overall Study|Lack of Efficacy|0|||
160778878|NCT00317369|580575008|FG001|Overall Study|Lack of Efficacy|1|||
160778879|NCT00317369|580575009|FG002|Overall Study|Lack of Efficacy|1|||
160778880|NCT00317369|580575007|FG000|Overall Study|Withdrawal by Subject|0|||
160778881|NCT00317369|580575008|FG001|Overall Study|Withdrawal by Subject|0|||
160778882|NCT00317369|580575009|FG002|Overall Study|Withdrawal by Subject|1|||
160887144|NCT00472459|580981769|FG001|Overall Study|Withdrawal by Subject|5|||
161229281|NCT02937701|582222397|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161229282|NCT02937701|582222398|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
161229283|NCT02937701|582222394|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
161229284|NCT02937701|582222395|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
161229285|NCT02937701|582222396|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
161229286|NCT02937701|582222397|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
161229287|NCT02937701|582222398|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
161229288|NCT02937701|582222394|FG000|Day 1 to Week 22|Death|1|||
161229289|NCT02937701|582222395|FG001|Day 1 to Week 22|Death|1|||
160887145|NCT00472459|580981768|FG000|Overall Study|Protocol Violation|3|||
160887146|NCT00472459|580981769|FG001|Overall Study|Protocol Violation|3|||
160887147|NCT00472459|580981768|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
160887148|NCT00472459|580981769|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
160887149|NCT00472459|580981768|FG000|Overall Study|Lost to Follow-up|1|||
160887150|NCT00472459|580981769|FG001|Overall Study|Lost to Follow-up|1|||
160887151|NCT04850313|580981770|FG000|Overall Study|Withdrawal by Subject|0|||
160887152|NCT04850313|580981771|FG001|Overall Study|Withdrawal by Subject|1|||
160887153|NCT04393298|580981778|FG000|Overall Study|Adverse Event|0|||
160887154|NCT04393298|580981779|FG001|Overall Study|Adverse Event|0|||
160887155|NCT04393298|580981780|FG002|Overall Study|Adverse Event|0|||
160887156|NCT04393298|580981781|FG003|Overall Study|Adverse Event|0|||
160887157|NCT04393298|580981782|FG004|Overall Study|Adverse Event|1|||
160887158|NCT04393298|580981783|FG005|Overall Study|Adverse Event|0|||
160887159|NCT04393298|580981784|FG006|Overall Study|Adverse Event|0|||
160887160|NCT04393298|580981785|FG007|Overall Study|Adverse Event|0|||
160887161|NCT04393298|580981786|FG008|Overall Study|Adverse Event|2|||
160887162|NCT04393298|580981787|FG009|Overall Study|Adverse Event|0|||
160887163|NCT04393298|580981788|FG010|Overall Study|Adverse Event|0|||
160887164|NCT04393298|580981789|FG011|Overall Study|Adverse Event|0|||
160887165|NCT04393298|580981790|FG012|Overall Study|Adverse Event|1|||
160887166|NCT04393298|580981791|FG013|Overall Study|Adverse Event|1|||
160887167|NCT04393298|580981792|FG014|Overall Study|Adverse Event|0|||
160887168|NCT04393298|580981778|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887169|NCT04393298|580981779|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887170|NCT04393298|580981780|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
160887171|NCT04393298|580981781|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887172|NCT04393298|580981782|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887173|NCT04393298|580981783|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887174|NCT04393298|580981784|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
161229290|NCT02937701|582222396|FG002|Day 1 to Week 22|Death|0|||
161229291|NCT02937701|582222397|FG003|Day 1 to Week 22|Death|0|||
161229292|NCT02937701|582222398|FG004|Day 1 to Week 22|Death|0|||
161229293|NCT02937701|582222394|FG000|Day 1 to Week 22|Protocol Violation|1|||
161229294|NCT02937701|582222395|FG001|Day 1 to Week 22|Protocol Violation|1|||
160778883|NCT04069520|580575014|FG000|Overall Study|Lost to Follow-up|0|||
160778884|NCT04069520|580575015|FG001|Overall Study|Lost to Follow-up|2|||
160778885|NCT04069520|580575014|FG000|Overall Study|Withdrawal by Subject|0|||
160778886|NCT04069520|580575015|FG001|Overall Study|Withdrawal by Subject|1|||
160887175|NCT04393298|580981785|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887176|NCT04393298|580981786|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887177|NCT04393298|580981787|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887178|NCT04393298|580981788|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887179|NCT04393298|580981789|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887180|NCT04393298|580981790|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887181|NCT04393298|580981791|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
160887182|NCT04393298|580981792|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
160887183|NCT04393298|580981778|FG000|Overall Study|Lack of Efficacy|0|||
160887184|NCT04393298|580981779|FG001|Overall Study|Lack of Efficacy|0|||
160887185|NCT04393298|580981780|FG002|Overall Study|Lack of Efficacy|0|||
161229295|NCT02937701|582222396|FG002|Day 1 to Week 22|Protocol Violation|0|||
161229296|NCT02937701|582222397|FG003|Day 1 to Week 22|Protocol Violation|0|||
161229297|NCT02937701|582222398|FG004|Day 1 to Week 22|Protocol Violation|0|||
161229298|NCT02937701|582222394|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
160778887|NCT04069520|580575014|FG000|Overall Study|Prior Injury|1|||
160778888|NCT04069520|580575015|FG001|Overall Study|Prior Injury|0|||
160778889|NCT04069520|580575014|FG000|Overall Study|Orthodontia|1|||
160778890|NCT04069520|580575015|FG001|Overall Study|Orthodontia|0|||
160778891|NCT04069520|580575014|FG000|Overall Study|Cut from team|0|||
160778892|NCT04069520|580575015|FG001|Overall Study|Cut from team|2|||
160778893|NCT01068912|580575016|FG000|Overall Study|Adverse Event|2|||
160778894|NCT01068912|580575017|FG001|Overall Study|Adverse Event|3|||
160778895|NCT01068912|580575018|FG002|Overall Study|Adverse Event|2|||
160778896|NCT01068912|580575016|FG000|Overall Study|Withdrawal by Subject|5|||
160778897|NCT01068912|580575017|FG001|Overall Study|Withdrawal by Subject|6|||
160778898|NCT01068912|580575018|FG002|Overall Study|Withdrawal by Subject|6|||
160778899|NCT01068912|580575016|FG000|Overall Study|Lost to Follow-up|3|||
160778900|NCT01068912|580575017|FG001|Overall Study|Lost to Follow-up|7|||
160778901|NCT01068912|580575018|FG002|Overall Study|Lost to Follow-up|3|||
160778902|NCT01068912|580575016|FG000|Overall Study|Protocol Violation|0|||
160778903|NCT01068912|580575017|FG001|Overall Study|Protocol Violation|2|||
160778904|NCT01068912|580575018|FG002|Overall Study|Protocol Violation|0|||
160778905|NCT01068912|580575016|FG000|Overall Study|aggravation influenza|1|||
160778906|NCT01068912|580575017|FG001|Overall Study|aggravation influenza|1|||
160778907|NCT01068912|580575018|FG002|Overall Study|aggravation influenza|1|||
160778908|NCT01068912|580575016|FG000|Overall Study|other underlying illness|0|||
160778909|NCT01068912|580575017|FG001|Overall Study|other underlying illness|3|||
160778910|NCT01068912|580575018|FG002|Overall Study|other underlying illness|3|||
160778911|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
160778912|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
160778913|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
160778914|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
160778915|NCT00849472|580575019|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
160778916|NCT00849472|580575019|FG000|Weekly Paclitaxel|Disease Progression|1|||
160778917|NCT00849472|580575019|FG000|Weekly Paclitaxel|Adverse Event|11|||
160778918|NCT00849472|580575019|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
160778919|NCT00849472|580575019|FG000|Weekly Paclitaxel|Physician Decision|3|||
160778920|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
160778921|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
160778922|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
160778923|NCT00849472|580575019|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
160778924|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
160778925|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
160778926|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
160778927|NCT00849472|580575019|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
160778928|NCT00825175|580575020|FG000|Overall Study|Withdrawal by Subject|0|||
160778929|NCT00825175|580575021|FG001|Overall Study|Withdrawal by Subject|5|||
160778930|NCT03998462|580575025|FG000|Overall Study|Withdrawal by Subject|10|||
160778931|NCT03998462|580575026|FG001|Overall Study|Withdrawal by Subject|4|||
160778932|NCT03998462|580575025|FG000|Overall Study|Lost to Follow-up|1|||
160778933|NCT03998462|580575026|FG001|Overall Study|Lost to Follow-up|0|||
160778934|NCT03998462|580575025|FG000|Overall Study|Technical Difficulties|1|||
160778935|NCT03998462|580575026|FG001|Overall Study|Technical Difficulties|2|||
160778936|NCT05710224|580575027|FG000|Overall Study|Death|1|||
160778937|NCT05710224|580575028|FG001|Overall Study|Death|0|||
160778938|NCT05710224|580575027|FG000|Overall Study|Lost to Follow-up|16|||
160778939|NCT05710224|580575028|FG001|Overall Study|Lost to Follow-up|7|||
160778940|NCT05710224|580575027|FG000|Overall Study|Withdrawal by Subject|4|||
160778941|NCT05710224|580575028|FG001|Overall Study|Withdrawal by Subject|6|||
160778942|NCT05710224|580575027|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160778943|NCT05710224|580575028|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160778944|NCT05710224|580575027|FG000|Overall Study|Participants Left The City|0|||
160778945|NCT05710224|580575028|FG001|Overall Study|Participants Left The City|2|||
160778946|NCT05182125|580575029|FG000|Overall Study|Withdrawal by Subject|0|||
160778947|NCT05182125|580575030|FG001|Overall Study|Withdrawal by Subject|0|||
160778948|NCT05182125|580575031|FG002|Overall Study|Withdrawal by Subject|0|||
160778949|NCT05182125|580575032|FG003|Overall Study|Withdrawal by Subject|0|||
160778950|NCT05182125|580575033|FG004|Overall Study|Withdrawal by Subject|2|||
160887186|NCT04393298|580981781|FG003|Overall Study|Lack of Efficacy|0|||
160887187|NCT04393298|580981782|FG004|Overall Study|Lack of Efficacy|0|||
160778951|NCT05182125|580575034|FG005|Overall Study|Withdrawal by Subject|0|||
160778952|NCT05182125|580575029|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778953|NCT05182125|580575030|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778954|NCT05182125|580575031|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778955|NCT05182125|580575032|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
160778956|NCT05182125|580575033|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
160887188|NCT04393298|580981783|FG005|Overall Study|Lack of Efficacy|0|||
160887189|NCT04393298|580981784|FG006|Overall Study|Lack of Efficacy|0|||
160778957|NCT05182125|580575034|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
160778958|NCT05182125|580575029|FG000|Overall Study|Death|0|||
160778959|NCT05182125|580575030|FG001|Overall Study|Death|0|||
160778960|NCT05182125|580575031|FG002|Overall Study|Death|0|||
160778961|NCT05182125|580575032|FG003|Overall Study|Death|0|||
160778962|NCT05182125|580575033|FG004|Overall Study|Death|1|||
160778963|NCT05182125|580575034|FG005|Overall Study|Death|0|||
160778964|NCT04615507|580575035|FG000|Period 1|Covid-19 exposure|2|||
160778965|NCT04615507|580575036|FG001|Period 1|Covid-19 exposure|1|||
160778966|NCT04615507|580575035|FG000|Period 2|Covid-19 exposure|0|||
160778967|NCT04615507|580575036|FG001|Period 2|Covid-19 exposure|1|||
160778968|NCT04615507|580575035|FG000|Period 2|Protocol Violation|1|||
160778969|NCT04615507|580575036|FG001|Period 2|Protocol Violation|0|||
160778970|NCT04615507|580575035|FG000|Period 2|Withdrawal by Subject|1|||
160778971|NCT04615507|580575036|FG001|Period 2|Withdrawal by Subject|0|||
160778972|NCT04615507|580575035|FG000|Period 2|Adverse Event|0|||
160778973|NCT04615507|580575036|FG001|Period 2|Adverse Event|1|||
160778974|NCT04615507|580575035|FG000|Period 3|Covid-19 exposure|0|||
160778975|NCT04615507|580575036|FG001|Period 3|Covid-19 exposure|1|||
160778976|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
160778977|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
160778978|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160778979|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160778980|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
160778981|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
160778982|NCT02965833|580575037|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
160778983|NCT02965833|580575038|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
160778984|NCT02965833|580575037|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
160778985|NCT02965833|580575038|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
160778986|NCT03370302|580575040|FG000|Dose Escalation Phase|Other|0|||
160778987|NCT03370302|580575041|FG001|Dose Escalation Phase|Other|1|||
160778988|NCT03370302|580575042|FG002|Dose Escalation Phase|Other|1|||
160778989|NCT03370302|580575043|FG003|Dose Escalation Phase|Other|0|||
160778990|NCT03370302|580575044|FG004|Dose Escalation Phase|Other|0|||
161229299|NCT02937701|582222395|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
160778991|NCT03370302|580575045|FG005|Dose Escalation Phase|Other|0|||
160778992|NCT03370302|580575040|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160778993|NCT03370302|580575041|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
160778994|NCT03370302|580575042|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
160778995|NCT03370302|580575043|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160778996|NCT03370302|580575044|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
160778997|NCT03370302|580575045|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
160778998|NCT03370302|580575040|FG000|Dose Escalation Phase|Adverse Event|1|||
160778999|NCT03370302|580575041|FG001|Dose Escalation Phase|Adverse Event|0|||
160779000|NCT03370302|580575042|FG002|Dose Escalation Phase|Adverse Event|2|||
160779001|NCT03370302|580575043|FG003|Dose Escalation Phase|Adverse Event|0|||
160779002|NCT03370302|580575044|FG004|Dose Escalation Phase|Adverse Event|0|||
160779003|NCT03370302|580575045|FG005|Dose Escalation Phase|Adverse Event|0|||
160779004|NCT03370302|580575040|FG000|Dose Escalation Phase|Progressive Disease|2|||
160779005|NCT03370302|580575041|FG001|Dose Escalation Phase|Progressive Disease|4|||
160779006|NCT03370302|580575042|FG002|Dose Escalation Phase|Progressive Disease|2|||
160779007|NCT03370302|580575043|FG003|Dose Escalation Phase|Progressive Disease|0|||
160779008|NCT03370302|580575044|FG004|Dose Escalation Phase|Progressive Disease|3|||
160779009|NCT03370302|580575045|FG005|Dose Escalation Phase|Progressive Disease|1|||
160779010|NCT03370302|580575040|FG000|Dose Expansion Phase|Progressive Disease|0|||
160779011|NCT03370302|580575041|FG001|Dose Expansion Phase|Progressive Disease|0|||
160779012|NCT03370302|580575042|FG002|Dose Expansion Phase|Progressive Disease|0|||
160779013|NCT03370302|580575043|FG003|Dose Expansion Phase|Progressive Disease|6|||
160779014|NCT03370302|580575044|FG004|Dose Expansion Phase|Progressive Disease|0|||
160779015|NCT03370302|580575045|FG005|Dose Expansion Phase|Progressive Disease|0|||
160779016|NCT00118287|580575046|FG000|Overall Study|Intracranial haemorrhage|1|||
160779017|NCT00118287|580575046|FG000|Overall Study|Muscle pain|1|||
160779018|NCT03976375|580575047|FG000|Overall Study|Death|158|||
160779019|NCT03976375|580575048|FG001|Overall Study|Death|160|||
160779020|NCT03976375|580575049|FG002|Overall Study|Death|42|||
160779021|NCT03976375|580575047|FG000|Overall Study|Lost to Follow-up|2|||
160779022|NCT03976375|580575048|FG001|Overall Study|Lost to Follow-up|1|||
160779023|NCT03976375|580575049|FG002|Overall Study|Lost to Follow-up|1|||
160779024|NCT03976375|580575047|FG000|Overall Study|Withdrawal by Subject|5|||
160779025|NCT03976375|580575048|FG001|Overall Study|Withdrawal by Subject|9|||
160779026|NCT03976375|580575049|FG002|Overall Study|Withdrawal by Subject|4|||
160779027|NCT03976375|580575047|FG000|Overall Study|Sponsor decision|20|||
160779028|NCT03976375|580575048|FG001|Overall Study|Sponsor decision|19|||
160779029|NCT03976375|580575049|FG002|Overall Study|Sponsor decision|1|||
160779030|NCT03091439|580575050|FG000|Overall Study|Study Terminated by the Sponsor|1|||
160779031|NCT03091439|580575051|FG001|Overall Study|Study Terminated by the Sponsor|0|||
161229300|NCT02937701|582222396|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
160887190|NCT04393298|580981785|FG007|Overall Study|Lack of Efficacy|0|||
160887191|NCT04393298|580981786|FG008|Overall Study|Lack of Efficacy|0|||
160887192|NCT04393298|580981787|FG009|Overall Study|Lack of Efficacy|0|||
160887193|NCT04393298|580981788|FG010|Overall Study|Lack of Efficacy|0|||
160887194|NCT04393298|580981789|FG011|Overall Study|Lack of Efficacy|0|||
160887195|NCT04393298|580981790|FG012|Overall Study|Lack of Efficacy|0|||
160887196|NCT04393298|580981791|FG013|Overall Study|Lack of Efficacy|0|||
160887197|NCT04393298|580981792|FG014|Overall Study|Lack of Efficacy|1|||
160887198|NCT04393298|580981778|FG000|Overall Study|Progression|1|||
160887199|NCT04393298|580981779|FG001|Overall Study|Progression|0|||
160887200|NCT04393298|580981780|FG002|Overall Study|Progression|0|||
160887201|NCT04393298|580981781|FG003|Overall Study|Progression|0|||
160887202|NCT04393298|580981782|FG004|Overall Study|Progression|0|||
160887203|NCT04393298|580981783|FG005|Overall Study|Progression|0|||
160887204|NCT04393298|580981784|FG006|Overall Study|Progression|0|||
160887205|NCT04393298|580981785|FG007|Overall Study|Progression|0|||
160887206|NCT04393298|580981786|FG008|Overall Study|Progression|0|||
160887207|NCT04393298|580981787|FG009|Overall Study|Progression|0|||
160887208|NCT04393298|580981788|FG010|Overall Study|Progression|1|||
160887209|NCT04393298|580981789|FG011|Overall Study|Progression|1|||
160887210|NCT04393298|580981790|FG012|Overall Study|Progression|0|||
160887211|NCT04393298|580981791|FG013|Overall Study|Progression|0|||
160887212|NCT04393298|580981792|FG014|Overall Study|Progression|0|||
160887213|NCT04393298|580981778|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
160887214|NCT04393298|580981779|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887215|NCT04393298|580981780|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887216|NCT04393298|580981781|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887217|NCT04393298|580981782|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887218|NCT04393298|580981783|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887219|NCT04393298|580981784|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887220|NCT04393298|580981785|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887221|NCT04393298|580981786|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887222|NCT04393298|580981787|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887223|NCT04393298|580981788|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887224|NCT04393298|580981789|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887225|NCT04393298|580981790|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887226|NCT04393298|580981791|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887227|NCT04393298|580981792|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
160887228|NCT04393298|580981778|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887229|NCT04393298|580981779|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
160887230|NCT04393298|580981780|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887231|NCT04393298|580981781|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160779032|NCT03122106|580575052|FG000|Overall Study|Not enough tissue|1|||
160779033|NCT03122106|580575052|FG000|Overall Study|Disease progression during screening|2|||
160779034|NCT03122106|580575052|FG000|Overall Study|Poor RNA quality for vaccine|1|||
160779035|NCT02347787|580575053|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
160779036|NCT02347787|580575054|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
160779037|NCT02347787|580575053|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
160779038|NCT02347787|580575054|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
160779039|NCT02347787|580575053|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
160779040|NCT02347787|580575054|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
160779041|NCT02347787|580575053|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
160779042|NCT02347787|580575054|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
160779043|NCT00308685|580575056|FG000|Overall Study|Lost to Follow-up|1|||
160779044|NCT00308685|580575057|FG001|Overall Study|Lost to Follow-up|0|||
160779045|NCT00308685|580575056|FG000|Overall Study|Need to administer prohibited medication|1|||
160779046|NCT00308685|580575057|FG001|Overall Study|Need to administer prohibited medication|2|||
160779047|NCT00308685|580575056|FG000|Overall Study|Other than specified|1|||
160779048|NCT00308685|580575057|FG001|Overall Study|Other than specified|3|||
160887232|NCT04393298|580981782|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887233|NCT04393298|580981783|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887234|NCT04393298|580981784|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887235|NCT04393298|580981785|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887236|NCT04393298|580981786|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887237|NCT04393298|580981787|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887238|NCT04393298|580981788|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887239|NCT04393298|580981789|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887240|NCT04393298|580981790|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887241|NCT04393298|580981791|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887242|NCT04393298|580981792|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
160887243|NCT04393298|580981778|FG000|Overall Study|Clinical Progression|0|||
160887244|NCT04393298|580981779|FG001|Overall Study|Clinical Progression|2|||
160887245|NCT04393298|580981780|FG002|Overall Study|Clinical Progression|0|||
160779049|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
160887246|NCT04393298|580981781|FG003|Overall Study|Clinical Progression|0|||
160887247|NCT04393298|580981782|FG004|Overall Study|Clinical Progression|0|||
160887248|NCT04393298|580981783|FG005|Overall Study|Clinical Progression|0|||
160887249|NCT04393298|580981784|FG006|Overall Study|Clinical Progression|0|||
160887250|NCT04393298|580981785|FG007|Overall Study|Clinical Progression|0|||
160887251|NCT04393298|580981786|FG008|Overall Study|Clinical Progression|0|||
160887252|NCT04393298|580981787|FG009|Overall Study|Clinical Progression|0|||
160887253|NCT04393298|580981788|FG010|Overall Study|Clinical Progression|0|||
160887254|NCT04393298|580981789|FG011|Overall Study|Clinical Progression|0|||
160887255|NCT04393298|580981790|FG012|Overall Study|Clinical Progression|0|||
160887256|NCT04393298|580981791|FG013|Overall Study|Clinical Progression|0|||
160887257|NCT04393298|580981792|FG014|Overall Study|Clinical Progression|0|||
160887258|NCT04393298|580981778|FG000|Overall Study|Disease Progression|0|||
160887259|NCT04393298|580981779|FG001|Overall Study|Disease Progression|1|||
160779050|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779051|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779052|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
160779053|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779054|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779055|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779056|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
160779057|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779058|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779059|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
160779060|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
160779061|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779062|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779063|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779064|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
160779065|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779066|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779067|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
160779068|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779069|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779070|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779071|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779072|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
160779073|NCT02850406|580575061|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
160779074|NCT02850406|580575062|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
160779075|NCT02850406|580575063|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
160779076|NCT02850406|580575064|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
160779077|NCT02850406|580575065|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
160779078|NCT02850406|580575066|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
160779079|NCT02850406|580575067|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
160779080|NCT02850406|580575068|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
160779081|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779082|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779083|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779084|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779085|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
160779086|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
160779087|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779088|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
160779089|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779090|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779091|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779092|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779093|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
160779094|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
160779095|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779096|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779097|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779098|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779099|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779100|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779101|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
160779102|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779103|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779104|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
160779105|NCT02850406|580575061|FG000|Part C (Up to 52 Weeks)|Other|0|||
160779106|NCT02850406|580575062|FG001|Part C (Up to 52 Weeks)|Other|0|||
160779107|NCT02850406|580575063|FG002|Part C (Up to 52 Weeks)|Other|0|||
160887260|NCT04393298|580981780|FG002|Overall Study|Disease Progression|0|||
160779108|NCT02850406|580575064|FG003|Part C (Up to 52 Weeks)|Other|0|||
160779109|NCT02850406|580575065|FG004|Part C (Up to 52 Weeks)|Other|1|||
160779110|NCT02850406|580575066|FG005|Part C (Up to 52 Weeks)|Other|3|||
160779111|NCT02850406|580575067|FG006|Part C (Up to 52 Weeks)|Other|0|||
160779112|NCT02850406|580575068|FG007|Part C (Up to 52 Weeks)|Other|0|||
160779113|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779114|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779115|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779116|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779117|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779118|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779119|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
160779120|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
160779121|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779122|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779123|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779124|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779125|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779126|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779127|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
160779128|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
160779129|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779130|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779131|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779132|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779133|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779134|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
160779135|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
160779136|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
160779137|NCT02850406|580575061|FG000|Part D (Up to 52 Weeks)|Other|0|||
160779138|NCT02850406|580575062|FG001|Part D (Up to 52 Weeks)|Other|0|||
160779139|NCT02850406|580575063|FG002|Part D (Up to 52 Weeks)|Other|0|||
160779140|NCT02850406|580575064|FG003|Part D (Up to 52 Weeks)|Other|0|||
160779141|NCT02850406|580575065|FG004|Part D (Up to 52 Weeks)|Other|0|||
160779142|NCT02850406|580575066|FG005|Part D (Up to 52 Weeks)|Other|0|||
160779143|NCT02850406|580575067|FG006|Part D (Up to 52 Weeks)|Other|0|||
160779144|NCT02850406|580575068|FG007|Part D (Up to 52 Weeks)|Other|1|||
160779145|NCT04167670|580576589|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
160779146|NCT04167670|580576590|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
160779147|NCT04167670|580576591|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
160779148|NCT04167670|580576589|FG000|Overall Study|Significant protocol deviation|3|||
160779149|NCT04167670|580576590|FG001|Overall Study|Significant protocol deviation|1|||
160779150|NCT04167670|580576591|FG002|Overall Study|Significant protocol deviation|0|||
160779151|NCT04167670|580576589|FG000|Overall Study|Lost to Follow-up|0|||
160779152|NCT04167670|580576590|FG001|Overall Study|Lost to Follow-up|3|||
160779153|NCT04167670|580576591|FG002|Overall Study|Lost to Follow-up|3|||
160779154|NCT04167670|580576589|FG000|Overall Study|Voluntary Withdrawal|0|||
160779155|NCT04167670|580576590|FG001|Overall Study|Voluntary Withdrawal|1|||
160779156|NCT04167670|580576591|FG002|Overall Study|Voluntary Withdrawal|1|||
160779157|NCT04167670|580576589|FG000|Overall Study|Withdrawal of Consent|4|||
160779158|NCT04167670|580576590|FG001|Overall Study|Withdrawal of Consent|1|||
160779159|NCT04167670|580576591|FG002|Overall Study|Withdrawal of Consent|3|||
160779160|NCT04167670|580576589|FG000|Overall Study|Miscellaneous|7|||
160779161|NCT04167670|580576590|FG001|Overall Study|Miscellaneous|5|||
160779162|NCT04167670|580576591|FG002|Overall Study|Miscellaneous|3|||
160779163|NCT04827446|580576592|FG000|Overall Study|Lost to Follow-up|1|||
160779164|NCT04827446|580576593|FG001|Overall Study|Lost to Follow-up|1|||
160779165|NCT04827446|580576592|FG000|Overall Study|Death|2|||
160779166|NCT04827446|580576593|FG001|Overall Study|Death|0|||
160779167|NCT04827446|580576592|FG000|Overall Study|Withdrawal by Subject|2|||
160779168|NCT04827446|580576593|FG001|Overall Study|Withdrawal by Subject|2|||
160779169|NCT01363076|580576596|FG000|Overall Study|Withdrawal by Subject|0|||
160779170|NCT01363076|580576597|FG001|Overall Study|Withdrawal by Subject|1|||
160779171|NCT02642679|580576598|FG000|Overall Study|Withdrawal by Subject|1|||
160779172|NCT02642679|580576598|FG000|Overall Study|Physician Decision|1|||
160779173|NCT02642679|580576598|FG000|Overall Study|Physician Decision|1|||
160779174|NCT03735498|580576599|FG000|Overall Study|Withdrawal by Subject|3|||
160779175|NCT03735498|580576599|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
160779176|NCT02014103|580576601|FG000|Overall Study|Protocol Violation|7|||
160779177|NCT02014103|580576602|FG001|Overall Study|Protocol Violation|7|||
160779178|NCT02014103|580576601|FG000|Overall Study|Adverse Event|1|||
160779179|NCT02014103|580576602|FG001|Overall Study|Adverse Event|0|||
160779180|NCT02014103|580576601|FG000|Overall Study|Lost venous access|1|||
160779181|NCT02014103|580576602|FG001|Overall Study|Lost venous access|0|||
161123176|NCT03889639|581837498|FG000|Overall Study|Withdrawal by Subject|0|||
161123177|NCT03889639|581837499|FG001|Overall Study|Withdrawal by Subject|0|||
161123178|NCT03889639|581837500|FG002|Overall Study|Withdrawal by Subject|0|||
161123179|NCT03889639|581837501|FG003|Overall Study|Withdrawal by Subject|0|||
161123180|NCT03889639|581837502|FG004|Overall Study|Withdrawal by Subject|0|||
161123181|NCT03889639|581837503|FG005|Overall Study|Withdrawal by Subject|0|||
161123182|NCT03889639|581837504|FG006|Overall Study|Withdrawal by Subject|0|||
161123183|NCT03889639|581837505|FG007|Overall Study|Withdrawal by Subject|1|||
161123184|NCT01703858|581837506|FG000|Overall Study|Withdrawal by Subject|0|||
161123185|NCT01703858|581837507|FG001|Overall Study|Withdrawal by Subject|1|||
161123186|NCT01703858|581837508|FG002|Overall Study|Withdrawal by Subject|0|||
161123187|NCT02556255|581837509|FG000|Overall Study|Lost to Follow-up|4|||
161229301|NCT02937701|582222397|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
161229302|NCT02937701|582222398|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
161229303|NCT02937701|582222394|FG000|Day 1 to Week 22|Physician Decision|2|||
161229304|NCT02937701|582222395|FG001|Day 1 to Week 22|Physician Decision|0|||
161229305|NCT02937701|582222396|FG002|Day 1 to Week 22|Physician Decision|0|||
161229306|NCT02937701|582222397|FG003|Day 1 to Week 22|Physician Decision|0|||
161229307|NCT02937701|582222398|FG004|Day 1 to Week 22|Physician Decision|0|||
161229308|NCT02937701|582222394|FG000|Day 1 to Week 22|Other|1|||
161229309|NCT02937701|582222395|FG001|Day 1 to Week 22|Other|0|||
161229310|NCT02937701|582222396|FG002|Day 1 to Week 22|Other|0|||
161229311|NCT02937701|582222397|FG003|Day 1 to Week 22|Other|0|||
161229312|NCT02937701|582222398|FG004|Day 1 to Week 22|Other|0|||
161229313|NCT02937701|582222394|FG000|Week 22 to Week 50|Adverse Event|0|||
161229314|NCT02937701|582222395|FG001|Week 22 to Week 50|Adverse Event|0|||
161229315|NCT02937701|582222396|FG002|Week 22 to Week 50|Adverse Event|10|||
161229316|NCT02937701|582222397|FG003|Week 22 to Week 50|Adverse Event|3|||
161229317|NCT02937701|582222398|FG004|Week 22 to Week 50|Adverse Event|3|||
161229318|NCT02937701|582222394|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
161229319|NCT02937701|582222395|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
161229320|NCT02937701|582222396|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
161229321|NCT02937701|582222397|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
161229322|NCT02937701|582222398|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
161229323|NCT02937701|582222394|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
161229324|NCT02937701|582222395|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
161229325|NCT02937701|582222396|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
161229326|NCT02937701|582222397|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
161229327|NCT02937701|582222398|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
161229328|NCT02937701|582222394|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
161229329|NCT02937701|582222395|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
161229330|NCT02937701|582222396|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
161229331|NCT02937701|582222397|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
161229332|NCT02937701|582222398|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
161229333|NCT02937701|582222394|FG000|Week 22 to Week 50|Physician Decision|0|||
161229334|NCT02937701|582222395|FG001|Week 22 to Week 50|Physician Decision|0|||
161229335|NCT02937701|582222396|FG002|Week 22 to Week 50|Physician Decision|2|||
161229336|NCT02937701|582222397|FG003|Week 22 to Week 50|Physician Decision|0|||
161229337|NCT02937701|582222398|FG004|Week 22 to Week 50|Physician Decision|1|||
161229338|NCT02937701|582222394|FG000|Week 22 to Week 50|Other|0|||
161229339|NCT02937701|582222395|FG001|Week 22 to Week 50|Other|0|||
161229340|NCT02937701|582222396|FG002|Week 22 to Week 50|Other|0|||
161229341|NCT02937701|582222397|FG003|Week 22 to Week 50|Other|0|||
161229342|NCT02937701|582222398|FG004|Week 22 to Week 50|Other|1|||
161229343|NCT02289963|582222399|FG000|Overall Study|Adverse Event|1|||
161229344|NCT02289963|582222400|FG001|Overall Study|Adverse Event|2|||
161229345|NCT02289963|582222399|FG000|Overall Study|Poor compliance to protocol|1|||
161229346|NCT02289963|582222400|FG001|Overall Study|Poor compliance to protocol|0|||
161229347|NCT02289963|582222399|FG000|Overall Study|Withdrawal by Subject|1|||
161229348|NCT02289963|582222400|FG001|Overall Study|Withdrawal by Subject|0|||
161229349|NCT02289963|582222399|FG000|Overall Study|Last injection missed|2|||
161229350|NCT02289963|582222400|FG001|Overall Study|Last injection missed|2|||
161229351|NCT02289963|582222399|FG000|Overall Study|End treatment visit outside visit window|0|||
161229352|NCT02289963|582222400|FG001|Overall Study|End treatment visit outside visit window|4|||
161229353|NCT02289963|582222399|FG000|Overall Study|Other than specified above|0|||
161229354|NCT02289963|582222400|FG001|Overall Study|Other than specified above|2|||
161229355|NCT01507051|582222402|FG000|Overall Study|Withdrawal by Subject|1|||
160779182|NCT02014103|580576601|FG000|Overall Study|Withdrawal by Subject|0|||
160779183|NCT02014103|580576602|FG001|Overall Study|Withdrawal by Subject|2|||
161123188|NCT00993031|581837510|FG000|Overall Study|Death|0|||
161123189|NCT00993031|581837511|FG001|Overall Study|Death|1|||
161123190|NCT00993031|581837510|FG000|Overall Study|Physician Decision|0|||
161123191|NCT00993031|581837511|FG001|Overall Study|Physician Decision|2|||
161123192|NCT00993031|581837510|FG000|Overall Study|Withdrawal by Subject|3|||
161229356|NCT01507051|582222403|FG001|Overall Study|Withdrawal by Subject|3|||
161229357|NCT01507051|582222404|FG002|Overall Study|Withdrawal by Subject|1|||
161229358|NCT01507051|582222405|FG003|Overall Study|Withdrawal by Subject|6|||
160779184|NCT05638737|580576603|FG000|Overall Study|Withdrawal by Subject|4|||
160779185|NCT05638737|580576604|FG001|Overall Study|Withdrawal by Subject|7|||
160779186|NCT02927145|580576609|FG000|Initial Recruitment|Withdrawal by Subject|0|||
160779187|NCT02927145|580576610|FG001|Initial Recruitment|Withdrawal by Subject|1|||
160779188|NCT02927145|580576611|FG002|Initial Recruitment|Withdrawal by Subject|1|||
160779189|NCT02927145|580576612|FG003|Initial Recruitment|Withdrawal by Subject|4|||
160779190|NCT02927145|580576613|FG004|Initial Recruitment|Withdrawal by Subject|1|||
160779191|NCT02927145|580576614|FG005|Initial Recruitment|Withdrawal by Subject|1|||
160779192|NCT02927145|580576615|FG006|Initial Recruitment|Withdrawal by Subject|0|||
160779193|NCT02927145|580576616|FG007|Initial Recruitment|Withdrawal by Subject|0|||
160779194|NCT02927145|580576617|FG008|Initial Recruitment|Withdrawal by Subject|2|||
160779195|NCT02927145|580576609|FG000|Initial Recruitment|Adverse Event|0|||
160779196|NCT02927145|580576610|FG001|Initial Recruitment|Adverse Event|0|||
160779197|NCT02927145|580576611|FG002|Initial Recruitment|Adverse Event|0|||
160779198|NCT02927145|580576612|FG003|Initial Recruitment|Adverse Event|0|||
160779199|NCT02927145|580576613|FG004|Initial Recruitment|Adverse Event|2|||
160779200|NCT02927145|580576614|FG005|Initial Recruitment|Adverse Event|0|||
160779201|NCT02927145|580576615|FG006|Initial Recruitment|Adverse Event|0|||
160779202|NCT02927145|580576616|FG007|Initial Recruitment|Adverse Event|0|||
160779203|NCT02927145|580576617|FG008|Initial Recruitment|Adverse Event|0|||
160779204|NCT02927145|580576609|FG000|Invitation for Additional Challenge|Pregnancy|0|||
160779205|NCT02927145|580576610|FG001|Invitation for Additional Challenge|Pregnancy|0|||
160779206|NCT02927145|580576611|FG002|Invitation for Additional Challenge|Pregnancy|0|||
160779207|NCT02927145|580576612|FG003|Invitation for Additional Challenge|Pregnancy|0|||
160779208|NCT02927145|580576613|FG004|Invitation for Additional Challenge|Pregnancy|0|||
160779209|NCT02927145|580576614|FG005|Invitation for Additional Challenge|Pregnancy|0|||
160779210|NCT02927145|580576615|FG006|Invitation for Additional Challenge|Pregnancy|1|||
160779211|NCT02927145|580576616|FG007|Invitation for Additional Challenge|Pregnancy|0|||
160779212|NCT02927145|580576617|FG008|Invitation for Additional Challenge|Pregnancy|0|||
160779213|NCT01617967|580576621|FG000|Overall Study|Protocol Violation|0|||
160779214|NCT01617967|580576622|FG001|Overall Study|Protocol Violation|0|||
160779215|NCT01617967|580576623|FG002|Overall Study|Protocol Violation|0|||
160779216|NCT01617967|580576624|FG003|Overall Study|Protocol Violation|1|||
160779217|NCT01617967|580576625|FG004|Overall Study|Protocol Violation|0|||
160779218|NCT01617967|580576626|FG005|Overall Study|Protocol Violation|0|||
160779219|NCT01617967|580576621|FG000|Overall Study|Withdrawal by Subject|0|||
160779220|NCT01617967|580576622|FG001|Overall Study|Withdrawal by Subject|0|||
160779221|NCT01617967|580576623|FG002|Overall Study|Withdrawal by Subject|0|||
160779222|NCT01617967|580576624|FG003|Overall Study|Withdrawal by Subject|0|||
160779223|NCT01617967|580576625|FG004|Overall Study|Withdrawal by Subject|0|||
160779224|NCT01617967|580576626|FG005|Overall Study|Withdrawal by Subject|1|||
160779225|NCT01617967|580576621|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
160779226|NCT01617967|580576622|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
160779227|NCT01617967|580576623|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
160779228|NCT01617967|580576624|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
160779229|NCT01617967|580576625|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
160779230|NCT01617967|580576626|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
160779231|NCT00416949|580576627|FG000|Overall Study|Patients refused to participate|5|||
160779232|NCT01137812|580576630|FG000|Overall Study|Adverse Event|21|||
160779233|NCT01137812|580576631|FG001|Overall Study|Adverse Event|14|||
160779234|NCT01137812|580576630|FG000|Overall Study|Lost to Follow-up|6|||
160779235|NCT01137812|580576631|FG001|Overall Study|Lost to Follow-up|8|||
160779236|NCT01137812|580576630|FG000|Overall Study|Physician Decision|25|||
160779237|NCT01137812|580576631|FG001|Overall Study|Physician Decision|17|||
160779238|NCT01137812|580576630|FG000|Overall Study|Protocol Violation|5|||
160779239|NCT01137812|580576631|FG001|Overall Study|Protocol Violation|4|||
160779240|NCT01137812|580576630|FG000|Overall Study|Withdrawal by Subject|5|||
160779241|NCT01137812|580576631|FG001|Overall Study|Withdrawal by Subject|13|||
160779242|NCT01137812|580576630|FG000|Overall Study|Death|2|||
160779243|NCT01137812|580576631|FG001|Overall Study|Death|0|||
160779244|NCT01137812|580576630|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
160779245|NCT01137812|580576631|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
160779246|NCT01137812|580576630|FG000|Overall Study|Other|19|||
160779247|NCT01137812|580576631|FG001|Overall Study|Other|27|||
160779248|NCT00574951|580576634|FG000|Overall Study|Ineligible - improper prior treatment|1|||
161123193|NCT00993031|581837511|FG001|Overall Study|Withdrawal by Subject|3|||
160779249|NCT03142750|580576635|FG000|Overall Study|Lost to Follow-up|4|||
160779250|NCT03142750|580576636|FG001|Overall Study|Lost to Follow-up|1|||
160779251|NCT04925934|580576639|FG000|Overall Study|Adverse Event|1|||
161123194|NCT00993031|581837510|FG000|Overall Study|Lost to Follow-up|19|||
160779252|NCT04925934|580576640|FG001|Overall Study|Adverse Event|0|||
160779253|NCT04925934|580576641|FG002|Overall Study|Adverse Event|0|||
160779254|NCT04925934|580576639|FG000|Overall Study|Lost to Follow-up|2|||
160779255|NCT04925934|580576640|FG001|Overall Study|Lost to Follow-up|0|||
160779256|NCT04925934|580576641|FG002|Overall Study|Lost to Follow-up|1|||
160779257|NCT04925934|580576639|FG000|Overall Study|Death|0|||
160779258|NCT04925934|580576640|FG001|Overall Study|Death|1|||
160779259|NCT04925934|580576641|FG002|Overall Study|Death|0|||
160779260|NCT04925934|580576639|FG000|Overall Study|Withdrawal by Subject|8|||
160779261|NCT04925934|580576640|FG001|Overall Study|Withdrawal by Subject|5|||
160779262|NCT04925934|580576641|FG002|Overall Study|Withdrawal by Subject|9|||
160779263|NCT04925934|580576639|FG000|Overall Study|Other|2|||
160779264|NCT04925934|580576640|FG001|Overall Study|Other|2|||
160779265|NCT04925934|580576641|FG002|Overall Study|Other|2|||
160779266|NCT04925934|580576639|FG000|Overall Study|Eastern European Conflict|7|||
160779267|NCT04925934|580576640|FG001|Overall Study|Eastern European Conflict|3|||
160887261|NCT04393298|580981781|FG003|Overall Study|Disease Progression|0|||
160887262|NCT04393298|580981782|FG004|Overall Study|Disease Progression|0|||
160887263|NCT04393298|580981783|FG005|Overall Study|Disease Progression|3|||
160887264|NCT04393298|580981784|FG006|Overall Study|Disease Progression|2|||
160887265|NCT04393298|580981785|FG007|Overall Study|Disease Progression|1|||
160887266|NCT04393298|580981786|FG008|Overall Study|Disease Progression|2|||
160887267|NCT04393298|580981787|FG009|Overall Study|Disease Progression|1|||
160887268|NCT04393298|580981788|FG010|Overall Study|Disease Progression|0|||
160887269|NCT04393298|580981789|FG011|Overall Study|Disease Progression|3|||
160887270|NCT04393298|580981790|FG012|Overall Study|Disease Progression|0|||
160887271|NCT04393298|580981791|FG013|Overall Study|Disease Progression|0|||
160887272|NCT04393298|580981792|FG014|Overall Study|Disease Progression|1|||
160887273|NCT04393298|580981778|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887274|NCT04393298|580981779|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887275|NCT04393298|580981780|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
160887276|NCT04393298|580981781|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887277|NCT04393298|580981782|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887278|NCT04393298|580981783|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887279|NCT04393298|580981784|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887280|NCT04393298|580981785|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887281|NCT04393298|580981786|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887282|NCT04393298|580981787|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887283|NCT04393298|580981788|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887284|NCT04393298|580981789|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887285|NCT04393298|580981790|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887286|NCT04393298|580981791|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887287|NCT04393298|580981792|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
160887288|NCT04393298|580981778|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887289|NCT04393298|580981779|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887290|NCT04393298|580981780|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
160887291|NCT04393298|580981781|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887292|NCT04393298|580981782|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887293|NCT04393298|580981783|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887294|NCT04393298|580981784|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887295|NCT04393298|580981785|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887296|NCT04393298|580981786|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887297|NCT04393298|580981787|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887298|NCT04393298|580981788|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887299|NCT04393298|580981789|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887300|NCT04393298|580981790|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887301|NCT04393298|580981791|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887302|NCT04393298|580981792|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
160887303|NCT04393298|580981778|FG000|Overall Study|Progressive Disease (PD)|0|||
160887304|NCT04393298|580981779|FG001|Overall Study|Progressive Disease (PD)|0|||
160887305|NCT04393298|580981780|FG002|Overall Study|Progressive Disease (PD)|0|||
160887306|NCT04393298|580981781|FG003|Overall Study|Progressive Disease (PD)|3|||
161123195|NCT00993031|581837511|FG001|Overall Study|Lost to Follow-up|13|||
161123196|NCT03115151|581837512|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
161123197|NCT03115151|581837513|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
161123198|NCT03115151|581837512|FG000|Overall Study|Epidural catheter removal|1|||
161123199|NCT03115151|581837513|FG001|Overall Study|Epidural catheter removal|0|||
161123200|NCT03115151|581837512|FG000|Overall Study|Withdrawal by Subject|0|||
161123201|NCT03115151|581837513|FG001|Overall Study|Withdrawal by Subject|1|||
160779268|NCT04925934|580576641|FG002|Overall Study|Eastern European Conflict|2|||
160779269|NCT04425018|580576642|FG000|Overall Study|Withdrawal by Subject|1|||
160887307|NCT04393298|580981782|FG004|Overall Study|Progressive Disease (PD)|0|||
160887308|NCT04393298|580981783|FG005|Overall Study|Progressive Disease (PD)|0|||
160887309|NCT04393298|580981784|FG006|Overall Study|Progressive Disease (PD)|0|||
160887310|NCT04393298|580981785|FG007|Overall Study|Progressive Disease (PD)|0|||
160887311|NCT04393298|580981786|FG008|Overall Study|Progressive Disease (PD)|0|||
160887312|NCT04393298|580981787|FG009|Overall Study|Progressive Disease (PD)|0|||
160887313|NCT04393298|580981788|FG010|Overall Study|Progressive Disease (PD)|0|||
160887314|NCT04393298|580981789|FG011|Overall Study|Progressive Disease (PD)|0|||
160887315|NCT04393298|580981790|FG012|Overall Study|Progressive Disease (PD)|0|||
160887316|NCT04393298|580981791|FG013|Overall Study|Progressive Disease (PD)|0|||
160887317|NCT04393298|580981792|FG014|Overall Study|Progressive Disease (PD)|0|||
160887318|NCT04393298|580981778|FG000|Overall Study|Started a New Cancer Treatment|0|||
160887319|NCT04393298|580981779|FG001|Overall Study|Started a New Cancer Treatment|0|||
160887320|NCT04393298|580981780|FG002|Overall Study|Started a New Cancer Treatment|0|||
160887321|NCT04393298|580981781|FG003|Overall Study|Started a New Cancer Treatment|0|||
160887322|NCT04393298|580981782|FG004|Overall Study|Started a New Cancer Treatment|1|||
160887323|NCT04393298|580981783|FG005|Overall Study|Started a New Cancer Treatment|0|||
160887324|NCT04393298|580981784|FG006|Overall Study|Started a New Cancer Treatment|0|||
160887325|NCT04393298|580981785|FG007|Overall Study|Started a New Cancer Treatment|0|||
160887326|NCT04393298|580981786|FG008|Overall Study|Started a New Cancer Treatment|0|||
160887327|NCT04393298|580981787|FG009|Overall Study|Started a New Cancer Treatment|0|||
160887328|NCT04393298|580981788|FG010|Overall Study|Started a New Cancer Treatment|0|||
160887329|NCT04393298|580981789|FG011|Overall Study|Started a New Cancer Treatment|0|||
160887330|NCT04393298|580981790|FG012|Overall Study|Started a New Cancer Treatment|0|||
160887331|NCT04393298|580981791|FG013|Overall Study|Started a New Cancer Treatment|0|||
160887332|NCT04393298|580981792|FG014|Overall Study|Started a New Cancer Treatment|0|||
160887333|NCT04393298|580981778|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887334|NCT04393298|580981779|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887335|NCT04393298|580981780|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887336|NCT04393298|580981781|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887337|NCT04393298|580981782|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
160887338|NCT04393298|580981783|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887339|NCT04393298|580981784|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887340|NCT04393298|580981785|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887341|NCT04393298|580981786|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887342|NCT04393298|580981787|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887343|NCT04393298|580981788|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887344|NCT04393298|580981789|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887345|NCT04393298|580981790|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887346|NCT04393298|580981791|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887347|NCT04393298|580981792|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
160887348|NCT04393298|580981778|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887349|NCT04393298|580981779|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887350|NCT04393298|580981780|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887351|NCT04393298|580981781|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887352|NCT04393298|580981782|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887353|NCT04393298|580981783|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
160887354|NCT04393298|580981784|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887355|NCT04393298|580981785|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887356|NCT04393298|580981786|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887357|NCT04393298|580981787|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887358|NCT04393298|580981788|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887359|NCT04393298|580981789|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887360|NCT04393298|580981790|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887361|NCT04393298|580981791|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887362|NCT04393298|580981792|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
160887363|NCT04393298|580981778|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887364|NCT04393298|580981779|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887365|NCT04393298|580981780|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887366|NCT04393298|580981781|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887367|NCT04393298|580981782|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887368|NCT04393298|580981783|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
160887369|NCT04393298|580981784|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887370|NCT04393298|580981785|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887371|NCT04393298|580981786|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887372|NCT04393298|580981787|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887373|NCT04393298|580981788|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887374|NCT04393298|580981789|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887375|NCT04393298|580981790|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887376|NCT04393298|580981791|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
160887377|NCT04393298|580981792|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
160887378|NCT04393298|580981778|FG000|Overall Study|Death|0|||
160887379|NCT04393298|580981779|FG001|Overall Study|Death|0|||
161229359|NCT01507051|582222402|FG000|Overall Study|Physician Decision|0|||
160887380|NCT04393298|580981780|FG002|Overall Study|Death|0|||
160887381|NCT04393298|580981781|FG003|Overall Study|Death|0|||
160887382|NCT04393298|580981782|FG004|Overall Study|Death|0|||
161229360|NCT01507051|582222403|FG001|Overall Study|Physician Decision|0|||
161229361|NCT01507051|582222404|FG002|Overall Study|Physician Decision|0|||
161229362|NCT01507051|582222405|FG003|Overall Study|Physician Decision|1|||
161229363|NCT01507051|582222402|FG000|Overall Study|Adverse Event|1|||
161229364|NCT01507051|582222403|FG001|Overall Study|Adverse Event|0|||
161229365|NCT01507051|582222404|FG002|Overall Study|Adverse Event|0|||
160887383|NCT04393298|580981783|FG005|Overall Study|Death|1|||
160887384|NCT04393298|580981784|FG006|Overall Study|Death|1|||
160887385|NCT04393298|580981785|FG007|Overall Study|Death|0|||
160887386|NCT04393298|580981786|FG008|Overall Study|Death|1|||
160887387|NCT04393298|580981787|FG009|Overall Study|Death|1|||
160887388|NCT04393298|580981788|FG010|Overall Study|Death|0|||
160887389|NCT04393298|580981789|FG011|Overall Study|Death|1|||
160887390|NCT04393298|580981790|FG012|Overall Study|Death|1|||
160887391|NCT04393298|580981791|FG013|Overall Study|Death|0|||
160887392|NCT04393298|580981792|FG014|Overall Study|Death|1|||
160887393|NCT04393298|580981778|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887394|NCT04393298|580981779|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887395|NCT04393298|580981780|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887396|NCT04393298|580981781|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887397|NCT04393298|580981782|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887398|NCT04393298|580981783|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
160887399|NCT04393298|580981784|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887400|NCT04393298|580981785|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887401|NCT04393298|580981786|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887402|NCT04393298|580981787|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887403|NCT04393298|580981788|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887404|NCT04393298|580981789|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887405|NCT04393298|580981790|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887406|NCT04393298|580981791|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887407|NCT04393298|580981792|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
160887408|NCT04393298|580981778|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
160887409|NCT04393298|580981779|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
160887410|NCT04393298|580981780|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
160887411|NCT04393298|580981781|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
160887412|NCT04393298|580981782|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
160887413|NCT04393298|580981783|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
160887414|NCT04393298|580981784|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
160887415|NCT04393298|580981785|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
160887416|NCT04393298|580981786|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
160887417|NCT04393298|580981787|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
160887418|NCT04393298|580981788|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
160887419|NCT04393298|580981789|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
160887420|NCT04393298|580981790|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
160887421|NCT04393298|580981791|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
160887422|NCT04393298|580981792|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
160887423|NCT04393298|580981778|FG000|Overall Study|Patient Passed Away|0|||
160887424|NCT04393298|580981779|FG001|Overall Study|Patient Passed Away|0|||
160887425|NCT04393298|580981780|FG002|Overall Study|Patient Passed Away|0|||
160887426|NCT04393298|580981781|FG003|Overall Study|Patient Passed Away|0|||
160887427|NCT04393298|580981782|FG004|Overall Study|Patient Passed Away|0|||
160887428|NCT04393298|580981783|FG005|Overall Study|Patient Passed Away|0|||
160887429|NCT04393298|580981784|FG006|Overall Study|Patient Passed Away|0|||
160887430|NCT04393298|580981785|FG007|Overall Study|Patient Passed Away|1|||
160887431|NCT04393298|580981786|FG008|Overall Study|Patient Passed Away|0|||
160887432|NCT04393298|580981787|FG009|Overall Study|Patient Passed Away|0|||
160887433|NCT04393298|580981788|FG010|Overall Study|Patient Passed Away|0|||
160887434|NCT04393298|580981789|FG011|Overall Study|Patient Passed Away|0|||
160887435|NCT04393298|580981790|FG012|Overall Study|Patient Passed Away|0|||
160887436|NCT04393298|580981791|FG013|Overall Study|Patient Passed Away|0|||
160887437|NCT04393298|580981792|FG014|Overall Study|Patient Passed Away|0|||
160887438|NCT04393298|580981778|FG000|Overall Study|Patient Deceased|0|||
160887439|NCT04393298|580981779|FG001|Overall Study|Patient Deceased|0|||
160887440|NCT04393298|580981780|FG002|Overall Study|Patient Deceased|0|||
160887441|NCT04393298|580981781|FG003|Overall Study|Patient Deceased|0|||
160887442|NCT04393298|580981782|FG004|Overall Study|Patient Deceased|0|||
160887443|NCT04393298|580981783|FG005|Overall Study|Patient Deceased|0|||
161229366|NCT01507051|582222405|FG003|Overall Study|Adverse Event|0|||
161229367|NCT01941095|582222406|FG000|Overall Study|Insufficient therapeutic response|13|||
160887444|NCT04393298|580981784|FG006|Overall Study|Patient Deceased|0|||
160887445|NCT04393298|580981785|FG007|Overall Study|Patient Deceased|1|||
160887446|NCT04393298|580981786|FG008|Overall Study|Patient Deceased|0|||
160887447|NCT04393298|580981787|FG009|Overall Study|Patient Deceased|0|||
160887448|NCT04393298|580981788|FG010|Overall Study|Patient Deceased|0|||
160887449|NCT04393298|580981789|FG011|Overall Study|Patient Deceased|0|||
160887450|NCT04393298|580981790|FG012|Overall Study|Patient Deceased|0|||
160887451|NCT04393298|580981791|FG013|Overall Study|Patient Deceased|0|||
160887452|NCT04393298|580981792|FG014|Overall Study|Patient Deceased|0|||
160887453|NCT04393298|580981778|FG000|Overall Study|Patient Discharged to Hospice|0|||
160887454|NCT04393298|580981779|FG001|Overall Study|Patient Discharged to Hospice|0|||
160887455|NCT04393298|580981780|FG002|Overall Study|Patient Discharged to Hospice|0|||
160887456|NCT04393298|580981781|FG003|Overall Study|Patient Discharged to Hospice|0|||
160887457|NCT04393298|580981782|FG004|Overall Study|Patient Discharged to Hospice|0|||
160887458|NCT04393298|580981783|FG005|Overall Study|Patient Discharged to Hospice|0|||
160887459|NCT04393298|580981784|FG006|Overall Study|Patient Discharged to Hospice|0|||
160887460|NCT04393298|580981785|FG007|Overall Study|Patient Discharged to Hospice|0|||
160887461|NCT04393298|580981786|FG008|Overall Study|Patient Discharged to Hospice|1|||
160887462|NCT04393298|580981787|FG009|Overall Study|Patient Discharged to Hospice|0|||
160887463|NCT04393298|580981788|FG010|Overall Study|Patient Discharged to Hospice|0|||
160887464|NCT04393298|580981789|FG011|Overall Study|Patient Discharged to Hospice|0|||
160887465|NCT04393298|580981790|FG012|Overall Study|Patient Discharged to Hospice|0|||
160887466|NCT04393298|580981791|FG013|Overall Study|Patient Discharged to Hospice|0|||
160887467|NCT04393298|580981792|FG014|Overall Study|Patient Discharged to Hospice|0|||
160887468|NCT04393298|580981778|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887469|NCT04393298|580981779|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887470|NCT04393298|580981780|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887471|NCT04393298|580981781|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887472|NCT04393298|580981782|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887473|NCT04393298|580981783|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887474|NCT04393298|580981784|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887475|NCT04393298|580981785|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887476|NCT04393298|580981786|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887477|NCT04393298|580981787|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
160887478|NCT04393298|580981788|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887479|NCT04393298|580981789|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887480|NCT04393298|580981790|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887481|NCT04393298|580981791|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887482|NCT04393298|580981792|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
160887483|NCT04393298|580981778|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
160887484|NCT04393298|580981779|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
160887485|NCT04393298|580981780|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
160887486|NCT04393298|580981781|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
160887487|NCT04393298|580981782|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
160887488|NCT04393298|580981783|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
160887489|NCT04393298|580981784|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
160887490|NCT04393298|580981785|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
160887491|NCT04393298|580981786|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
160887492|NCT04393298|580981787|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
160887493|NCT04393298|580981788|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
160887494|NCT04393298|580981789|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
160887495|NCT04393298|580981790|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
160887496|NCT04393298|580981791|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
160887497|NCT04393298|580981792|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
160887498|NCT04950608|580981800|FG000|Overall Study|Withdrawal by Subject|2|||
160887499|NCT04950608|580981800|FG000|Overall Study|Physician Decision|3|||
160887500|NCT01282203|580981804|FG000|Overall Study|Adverse Event|1|||
160887501|NCT03977454|580981805|FG000|Overall Study|immediate postoperative revision|2|||
160887502|NCT03977454|580981806|FG001|Overall Study|immediate postoperative revision|2|||
160887503|NCT00768469|580981809|FG000|Overall Study|Adverse Event|0|||
160887504|NCT00768469|580981810|FG001|Overall Study|Adverse Event|2|||
160887505|NCT00768469|580981809|FG000|Overall Study|Disease Progression|3|||
160887506|NCT00768469|580981810|FG001|Overall Study|Disease Progression|4|||
160887507|NCT00768469|580981809|FG000|Overall Study|Withdrawal by Subject|0|||
160887508|NCT00768469|580981810|FG001|Overall Study|Withdrawal by Subject|1|||
160887509|NCT04193410|580981811|FG000|Overall Study|Lost to Follow-up|7|||
161123202|NCT03115151|581837512|FG000|Overall Study|Intervention not received according to the protocol.|1|||
160887510|NCT04193410|580981812|FG001|Overall Study|Lost to Follow-up|6|||
160887511|NCT01293799|580981816|FG000|Overall Study|Kidney transplantation|109|||
160887512|NCT01293799|580981817|FG001|Overall Study|Kidney transplantation|96|||
160779270|NCT04425018|580576643|FG001|Overall Study|Withdrawal by Subject|2|||
160779271|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
160779272|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
160779273|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
160779274|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
160779275|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
160779276|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
160779277|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
160779278|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
160779279|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
160779280|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
160779281|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
160779282|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
160779283|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
160779284|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
160779285|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
160779286|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
160779287|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
160779288|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
160779289|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
160779290|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
160779291|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
160779292|NCT02337946|580576644|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
160779293|NCT02337946|580576645|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
160779294|NCT02337946|580576646|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
160779295|NCT02337946|580576644|FG000|In-between Period|Without Informed Consent|1|||
160779296|NCT02337946|580576645|FG001|In-between Period|Without Informed Consent|0|||
160779297|NCT02337946|580576646|FG002|In-between Period|Without Informed Consent|0|||
160779298|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
160779299|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
160779300|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
160779301|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
160779302|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
160779303|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
160779304|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
160779305|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
160779306|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
160779307|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
160779308|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
160779309|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
160779310|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
160779311|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
160779312|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
160779313|NCT02337946|580576644|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
160779314|NCT02337946|580576645|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
160779315|NCT02337946|580576646|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
160779316|NCT01131585|580576648|FG000|Overall Study|Adverse Event|0|||
160779317|NCT01131585|580576649|FG001|Overall Study|Adverse Event|2|||
160779318|NCT01131585|580576648|FG000|Overall Study|Abnormal laboratory value|1|||
160779319|NCT01131585|580576649|FG001|Overall Study|Abnormal laboratory value|0|||
160779320|NCT01131585|580576648|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160779321|NCT01131585|580576649|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160779322|NCT01131585|580576648|FG000|Overall Study|Protocol Violation|2|||
160779323|NCT01131585|580576649|FG001|Overall Study|Protocol Violation|1|||
160779324|NCT01131585|580576648|FG000|Overall Study|Withdrawal by Subject|3|||
160779325|NCT01131585|580576649|FG001|Overall Study|Withdrawal by Subject|3|||
160779326|NCT01131585|580576648|FG000|Overall Study|Lost to Follow-up|0|||
160779327|NCT01131585|580576649|FG001|Overall Study|Lost to Follow-up|1|||
160779328|NCT01131585|580576648|FG000|Overall Study|Administrative problems|1|||
160779329|NCT01131585|580576649|FG001|Overall Study|Administrative problems|1|||
160779330|NCT01131585|580576648|FG000|Overall Study|Study termination|78|||
160779331|NCT01131585|580576649|FG001|Overall Study|Study termination|32|||
160779332|NCT02949934|580576652|FG000|Natural Drinking Period|Adverse Event|1|||
160779333|NCT02949934|580576653|FG001|Natural Drinking Period|Adverse Event|0|||
160779334|NCT02949934|580576654|FG002|Natural Drinking Period|Adverse Event|0|||
160779335|NCT02949934|580576655|FG003|Natural Drinking Period|Adverse Event|1|||
160779336|NCT02949934|580576656|FG004|Natural Drinking Period|Adverse Event|0|||
160779337|NCT02949934|580576657|FG005|Natural Drinking Period|Adverse Event|0|||
160779338|NCT02949934|580576652|FG000|Natural Drinking Period|Lost to Follow-up|0|||
160779339|NCT02949934|580576653|FG001|Natural Drinking Period|Lost to Follow-up|0|||
160887513|NCT01293799|580981816|FG000|Overall Study|Transfer to hemodialysis|70|||
160887514|NCT01293799|580981817|FG001|Overall Study|Transfer to hemodialysis|90|||
160887515|NCT01293799|580981816|FG000|Overall Study|Death|27|||
160887516|NCT01293799|580981817|FG001|Overall Study|Death|29|||
160887517|NCT01293799|580981816|FG000|Overall Study|Transfer to assisted PD|24|||
160887518|NCT01293799|580981817|FG001|Overall Study|Transfer to assisted PD|18|||
160887519|NCT01293799|580981816|FG000|Overall Study|Withdrawal by Subject|26|||
160887520|NCT01293799|580981817|FG001|Overall Study|Withdrawal by Subject|0|||
160887521|NCT01293799|580981816|FG000|Overall Study|Investigator decision|5|||
160887522|NCT01293799|580981817|FG001|Overall Study|Investigator decision|2|||
160887523|NCT01293799|580981816|FG000|Overall Study|Kidney function improved|6|||
160887524|NCT01293799|580981817|FG001|Overall Study|Kidney function improved|7|||
160887525|NCT01293799|580981816|FG000|Overall Study|Other causes|6|||
160887526|NCT01293799|580981817|FG001|Overall Study|Other causes|3|||
160887527|NCT04779216|580981820|FG000|Overall Study|Lost to Follow-up|1|||
160887528|NCT04779216|580981821|FG001|Overall Study|Lost to Follow-up|0|||
160887529|NCT04779216|580981820|FG000|Overall Study|Withdrawal by Subject|1|||
160887530|NCT04779216|580981821|FG001|Overall Study|Withdrawal by Subject|0|||
160887531|NCT02635646|580981822|FG000|Overall Study|Lost to Follow-up|24|||
160887532|NCT02635646|580981823|FG001|Overall Study|Lost to Follow-up|25|||
160887533|NCT02635646|580981822|FG000|Overall Study|Pregnancy|1|||
160887534|NCT02635646|580981823|FG001|Overall Study|Pregnancy|1|||
160887535|NCT00879879|580981824|FG000|Overall Study|Death|1|||
160887536|NCT00879879|580981824|FG000|Overall Study|Withdrawal by Subject|1|||
160887537|NCT00879879|580981824|FG000|Overall Study|Physician Decision|1|||
160887538|NCT00378079|580981828|FG000|Overall Study|Lost to Follow-up|6|||
160887539|NCT00378079|580981829|FG001|Overall Study|Lost to Follow-up|1|||
160887540|NCT00378079|580981830|FG002|Overall Study|Lost to Follow-up|0|||
160887541|NCT02274038|580981831|FG000|Overall Study|Death|1|||
160887542|NCT05458648|580981832|FG000|Overall Study|Physician Decision|1|||
160887543|NCT05458648|580981832|FG000|Overall Study|Patient presented in atrial flutter|1|||
160887544|NCT01163318|580981833|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
160887545|NCT01163318|580981833|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
160887546|NCT01163318|580981833|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
160887547|NCT01163318|580981833|FG000|Overall Study|Participants Without Case Report Form|7|||
160887548|NCT01163318|580981833|FG000|Overall Study|Multiple Reasons Per Participant|224|||
160887549|NCT03587727|580981837|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
160887550|NCT03587727|580981837|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
160887551|NCT05217927|580981838|FG000|DBT Phase|Adverse Event|7|||
160887552|NCT05217927|580981839|FG001|DBT Phase|Adverse Event|2|||
160887553|NCT05217927|580981840|FG002|DBT Phase|Adverse Event|5|||
160887554|NCT05217927|580981838|FG000|DBT Phase|Lack of Efficacy|1|||
160887555|NCT05217927|580981839|FG001|DBT Phase|Lack of Efficacy|0|||
160887556|NCT05217927|580981840|FG002|DBT Phase|Lack of Efficacy|0|||
160887557|NCT05217927|580981838|FG000|DBT Phase|Lost to Follow-up|0|||
160887558|NCT05217927|580981839|FG001|DBT Phase|Lost to Follow-up|2|||
160887559|NCT05217927|580981840|FG002|DBT Phase|Lost to Follow-up|0|||
160887560|NCT05217927|580981838|FG000|DBT Phase|Non-compliance|1|||
160887561|NCT05217927|580981839|FG001|DBT Phase|Non-compliance|0|||
160887562|NCT05217927|580981840|FG002|DBT Phase|Non-compliance|0|||
160887563|NCT05217927|580981838|FG000|DBT Phase|Pregnancy|0|||
160887564|NCT05217927|580981839|FG001|DBT Phase|Pregnancy|0|||
160887565|NCT05217927|580981840|FG002|DBT Phase|Pregnancy|1|||
160887566|NCT05217927|580981838|FG000|DBT Phase|Protocol Violation|0|||
161123203|NCT03115151|581837513|FG001|Overall Study|Intervention not received according to the protocol.|1|||
161123204|NCT03115151|581837512|FG000|Overall Study|Physician Decision|1|||
161123205|NCT03115151|581837513|FG001|Overall Study|Physician Decision|0|||
161123206|NCT03115151|581837512|FG000|Overall Study|Randomization not applied|1|||
161123207|NCT03115151|581837513|FG001|Overall Study|Randomization not applied|1|||
161123208|NCT01834729|581837518|FG000|Overall Study|Did not return bowel diaries|0|||
161123209|NCT01834729|581837519|FG001|Overall Study|Did not return bowel diaries|0|||
161123210|NCT01834729|581837520|FG002|Overall Study|Did not return bowel diaries|3|||
161123211|NCT01834729|581837521|FG003|Overall Study|Did not return bowel diaries|0|||
161123212|NCT01834729|581837518|FG000|Overall Study|Withdrawal by Subject|1|||
161123213|NCT01834729|581837519|FG001|Overall Study|Withdrawal by Subject|1|||
161123214|NCT01834729|581837520|FG002|Overall Study|Withdrawal by Subject|0|||
161123215|NCT01834729|581837521|FG003|Overall Study|Withdrawal by Subject|0|||
161123216|NCT01834729|581837518|FG000|Overall Study|Adverse Event|0|||
161123217|NCT01834729|581837519|FG001|Overall Study|Adverse Event|0|||
161229368|NCT01941095|582222406|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
161229369|NCT01941095|582222406|FG000|Overall Study|Adverse Event|11|||
161123218|NCT01834729|581837520|FG002|Overall Study|Adverse Event|0|||
161229370|NCT01941095|582222406|FG000|Overall Study|Physician Decision|3|||
160887567|NCT05217927|580981839|FG001|DBT Phase|Protocol Violation|2|||
160887568|NCT05217927|580981840|FG002|DBT Phase|Protocol Violation|1|||
160887569|NCT05217927|580981838|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
160887570|NCT05217927|580981839|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
160779340|NCT02949934|580576654|FG002|Natural Drinking Period|Lost to Follow-up|0|||
160779341|NCT02949934|580576655|FG003|Natural Drinking Period|Lost to Follow-up|0|||
160779342|NCT02949934|580576656|FG004|Natural Drinking Period|Lost to Follow-up|1|||
160779343|NCT02949934|580576657|FG005|Natural Drinking Period|Lost to Follow-up|0|||
160779344|NCT02949934|580576652|FG000|Neuroimaging|Protocol Violation|2|||
160779345|NCT02949934|580576653|FG001|Neuroimaging|Protocol Violation|0|||
160779346|NCT02949934|580576654|FG002|Neuroimaging|Protocol Violation|0|||
160779347|NCT02949934|580576655|FG003|Neuroimaging|Protocol Violation|0|||
160779348|NCT02949934|580576656|FG004|Neuroimaging|Protocol Violation|1|||
160779349|NCT02949934|580576657|FG005|Neuroimaging|Protocol Violation|0|||
160779350|NCT02949934|580576652|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
160779351|NCT02949934|580576653|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
160779352|NCT02949934|580576654|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
160779353|NCT02949934|580576655|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
160779354|NCT02949934|580576656|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
160779355|NCT02949934|580576657|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
160779356|NCT02949934|580576652|FG000|Neuroimaging|Not scanned|0|||
160779357|NCT02949934|580576653|FG001|Neuroimaging|Not scanned|0|||
160779358|NCT02949934|580576654|FG002|Neuroimaging|Not scanned|1|||
160779359|NCT02949934|580576655|FG003|Neuroimaging|Not scanned|0|||
160779360|NCT02949934|580576656|FG004|Neuroimaging|Not scanned|0|||
160779361|NCT02949934|580576657|FG005|Neuroimaging|Not scanned|2|||
160779362|NCT02949934|580576652|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
160779363|NCT02949934|580576653|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
160779364|NCT02949934|580576654|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
160779365|NCT02949934|580576655|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
160779366|NCT02949934|580576656|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
160779367|NCT02949934|580576657|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
160779368|NCT02949934|580576652|FG000|Bar Laboratory|Adverse Event|1|||
160779369|NCT02949934|580576653|FG001|Bar Laboratory|Adverse Event|0|||
160779370|NCT02949934|580576654|FG002|Bar Laboratory|Adverse Event|2|||
160779371|NCT02949934|580576655|FG003|Bar Laboratory|Adverse Event|0|||
160779372|NCT02949934|580576656|FG004|Bar Laboratory|Adverse Event|1|||
160779373|NCT02949934|580576657|FG005|Bar Laboratory|Adverse Event|0|||
160779374|NCT02949934|580576652|FG000|Bar Laboratory|Protocol Violation|0|||
160779375|NCT02949934|580576653|FG001|Bar Laboratory|Protocol Violation|0|||
160779376|NCT02949934|580576654|FG002|Bar Laboratory|Protocol Violation|0|||
160779377|NCT02949934|580576655|FG003|Bar Laboratory|Protocol Violation|1|||
160779378|NCT02949934|580576656|FG004|Bar Laboratory|Protocol Violation|0|||
160779379|NCT02949934|580576657|FG005|Bar Laboratory|Protocol Violation|0|||
160779380|NCT05128942|580576661|FG000|Overall Study|Withdrawal by Subject|1|||
160779381|NCT05128942|580576662|FG001|Overall Study|Withdrawal by Subject|0|||
160779382|NCT05128942|580576663|FG002|Overall Study|Withdrawal by Subject|1|||
160779383|NCT05128942|580576664|FG003|Overall Study|Withdrawal by Subject|0|||
160779384|NCT05128942|580576665|FG004|Overall Study|Withdrawal by Subject|0|||
160779385|NCT05128942|580576666|FG005|Overall Study|Withdrawal by Subject|0|||
160779386|NCT05128942|580576667|FG006|Overall Study|Withdrawal by Subject|0|||
160779387|NCT05128942|580576668|FG007|Overall Study|Withdrawal by Subject|0|||
160779388|NCT05128942|580576669|FG008|Overall Study|Withdrawal by Subject|0|||
160779389|NCT05128942|580576661|FG000|Overall Study|Other|2|||
160779390|NCT05128942|580576662|FG001|Overall Study|Other|0|||
160779391|NCT05128942|580576663|FG002|Overall Study|Other|2|||
160779392|NCT05128942|580576664|FG003|Overall Study|Other|0|||
160779393|NCT05128942|580576665|FG004|Overall Study|Other|0|||
160779394|NCT05128942|580576666|FG005|Overall Study|Other|0|||
160779395|NCT05128942|580576667|FG006|Overall Study|Other|0|||
160779396|NCT05128942|580576668|FG007|Overall Study|Other|0|||
160779397|NCT05128942|580576669|FG008|Overall Study|Other|0|||
160779398|NCT05128942|580576661|FG000|Overall Study|Termination by Sponsor|2|||
160779399|NCT05128942|580576662|FG001|Overall Study|Termination by Sponsor|6|||
160779400|NCT05128942|580576663|FG002|Overall Study|Termination by Sponsor|14|||
160779401|NCT05128942|580576664|FG003|Overall Study|Termination by Sponsor|2|||
160887571|NCT05217927|580981840|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
160887572|NCT05217927|580981838|FG000|DBT Phase|Withdrawal of consent|8|||
160887573|NCT05217927|580981839|FG001|DBT Phase|Withdrawal of consent|5|||
160887574|NCT05217927|580981840|FG002|DBT Phase|Withdrawal of consent|7|||
160887575|NCT05217927|580981838|FG000|DBT Phase|Other|7|||
160887576|NCT05217927|580981839|FG001|DBT Phase|Other|3|||
160779402|NCT05128942|580576665|FG004|Overall Study|Termination by Sponsor|4|||
160779403|NCT05128942|580576666|FG005|Overall Study|Termination by Sponsor|8|||
160779404|NCT05128942|580576667|FG006|Overall Study|Termination by Sponsor|11|||
160779405|NCT05128942|580576668|FG007|Overall Study|Termination by Sponsor|6|||
160779406|NCT05128942|580576669|FG008|Overall Study|Termination by Sponsor|0|||
160779407|NCT05128942|580576661|FG000|Overall Study|Adverse Event|0|||
160779408|NCT05128942|580576662|FG001|Overall Study|Adverse Event|0|||
160779409|NCT05128942|580576663|FG002|Overall Study|Adverse Event|0|||
160779410|NCT05128942|580576664|FG003|Overall Study|Adverse Event|0|||
160887577|NCT05217927|580981840|FG002|DBT Phase|Other|4|||
160887578|NCT05217927|580981838|FG000|DBT Phase|Randomized, not treated|2|||
160887579|NCT05217927|580981839|FG001|DBT Phase|Randomized, not treated|3|||
160887580|NCT05217927|580981840|FG002|DBT Phase|Randomized, not treated|2|||
160887581|NCT05217927|580981838|FG000|OLE Phase|Adverse Event|4|||
160887582|NCT05217927|580981839|FG001|OLE Phase|Adverse Event|1|||
160887583|NCT05217927|580981840|FG002|OLE Phase|Adverse Event|1|||
160887584|NCT05217927|580981838|FG000|OLE Phase|Extension phase eligibility failure|1|||
160887585|NCT05217927|580981839|FG001|OLE Phase|Extension phase eligibility failure|0|||
160887586|NCT05217927|580981840|FG002|OLE Phase|Extension phase eligibility failure|0|||
160887587|NCT05217927|580981838|FG000|OLE Phase|Lost to Follow-up|1|||
160887588|NCT05217927|580981839|FG001|OLE Phase|Lost to Follow-up|2|||
160887589|NCT05217927|580981840|FG002|OLE Phase|Lost to Follow-up|1|||
160887590|NCT05217927|580981838|FG000|OLE Phase|Non-compliance|0|||
160887591|NCT05217927|580981839|FG001|OLE Phase|Non-compliance|0|||
160887592|NCT05217927|580981840|FG002|OLE Phase|Non-compliance|1|||
160887593|NCT05217927|580981838|FG000|OLE Phase|Other|3|||
160887594|NCT05217927|580981839|FG001|OLE Phase|Other|5|||
160887595|NCT05217927|580981840|FG002|OLE Phase|Other|4|||
160887596|NCT05217927|580981838|FG000|OLE Phase|Withdrawal of consent|3|||
160887597|NCT05217927|580981839|FG001|OLE Phase|Withdrawal of consent|1|||
160887598|NCT05217927|580981840|FG002|OLE Phase|Withdrawal of consent|5|||
161123219|NCT01834729|581837521|FG003|Overall Study|Adverse Event|2|||
161123220|NCT01543087|581837522|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
161123221|NCT01543087|581837523|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
161123222|NCT01543087|581837524|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
161123223|NCT01543087|581837525|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
161123224|NCT01543087|581837526|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
161123225|NCT01543087|581837527|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
161123226|NCT01543087|581837522|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
161123227|NCT01543087|581837523|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161123228|NCT01543087|581837524|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
161123229|NCT01543087|581837525|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
161123230|NCT01543087|581837526|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161123231|NCT01543087|581837527|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
161123232|NCT01543087|581837522|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
161123233|NCT01543087|581837523|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
161123234|NCT01543087|581837524|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
161123235|NCT01543087|581837525|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
161123236|NCT01543087|581837526|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
161123237|NCT01543087|581837527|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
161123238|NCT01543087|581837522|FG000|Stage 1 (48 Months)|Other than specified|5|||
161123239|NCT01543087|581837523|FG001|Stage 1 (48 Months)|Other than specified|0|||
161123240|NCT01543087|581837524|FG002|Stage 1 (48 Months)|Other than specified|9|||
161123241|NCT01543087|581837525|FG003|Stage 1 (48 Months)|Other than specified|0|||
161123242|NCT01543087|581837526|FG004|Stage 1 (48 Months)|Other than specified|0|||
161123243|NCT01543087|581837527|FG005|Stage 1 (48 Months)|Other than specified|0|||
161123244|NCT01543087|581837522|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
161123245|NCT01543087|581837523|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
161123246|NCT01543087|581837524|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
161123247|NCT01543087|581837525|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
161123248|NCT01543087|581837526|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
161123249|NCT01543087|581837527|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
161123250|NCT01543087|581837522|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161123251|NCT01543087|581837523|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
161123252|NCT01543087|581837524|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161123253|NCT01543087|581837525|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161123254|NCT01543087|581837526|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
161123255|NCT01543087|581837527|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
161123256|NCT01543087|581837522|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
161123257|NCT01543087|581837523|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
161123258|NCT01543087|581837524|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
161123259|NCT01543087|581837525|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
161123260|NCT01543087|581837526|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
161123261|NCT01543087|581837527|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
160887599|NCT00076024|580982548|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
161123262|NCT03403192|581837528|FG000|Overall Study|Lost to Follow-up|1|||
161123263|NCT03403192|581837529|FG001|Overall Study|Lost to Follow-up|2|||
161123264|NCT03403192|581837530|FG002|Overall Study|Lost to Follow-up|0|||
161229371|NCT01941095|582222406|FG000|Overall Study|Withdrawal by Subject|17|||
161123265|NCT03403192|581837531|FG003|Overall Study|Lost to Follow-up|0|||
160887600|NCT00076024|580982549|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
160887601|NCT00076024|580982550|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
160887602|NCT00076024|580982551|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
160887603|NCT00076024|580982548|FG000|Phase 1, Lead-in|Adverse Event|1|||
160779411|NCT05128942|580576665|FG004|Overall Study|Adverse Event|0|||
160779412|NCT05128942|580576666|FG005|Overall Study|Adverse Event|0|||
160779413|NCT05128942|580576667|FG006|Overall Study|Adverse Event|1|||
160779414|NCT05128942|580576668|FG007|Overall Study|Adverse Event|1|||
160779415|NCT05128942|580576669|FG008|Overall Study|Adverse Event|0|||
160779416|NCT05128942|580576661|FG000|Overall Study|Lost to Follow-up|0|||
160779417|NCT05128942|580576662|FG001|Overall Study|Lost to Follow-up|0|||
160779418|NCT05128942|580576663|FG002|Overall Study|Lost to Follow-up|0|||
160779419|NCT05128942|580576664|FG003|Overall Study|Lost to Follow-up|0|||
160779420|NCT05128942|580576665|FG004|Overall Study|Lost to Follow-up|1|||
160779421|NCT05128942|580576666|FG005|Overall Study|Lost to Follow-up|0|||
160779422|NCT05128942|580576667|FG006|Overall Study|Lost to Follow-up|0|||
160779423|NCT05128942|580576668|FG007|Overall Study|Lost to Follow-up|0|||
160779424|NCT05128942|580576669|FG008|Overall Study|Lost to Follow-up|0|||
160779425|NCT03407482|580576670|FG000|Overall Study|Adverse Event|12|||
160779426|NCT03407482|580576670|FG000|Overall Study|Disease Relapse|1|||
160779427|NCT03407482|580576670|FG000|Overall Study|Lost to Follow-up|1|||
160779428|NCT03407482|580576670|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160779429|NCT03407482|580576670|FG000|Overall Study|Pregnancy|2|||
160779430|NCT03407482|580576670|FG000|Overall Study|Protocol Violation|1|||
160779431|NCT03407482|580576670|FG000|Overall Study|Study Terminated By Sponsor|106|||
160779432|NCT03407482|580576670|FG000|Overall Study|Withdrawal by Subject|6|||
160779433|NCT03407482|580576670|FG000|Overall Study|Data Entry Error|1|||
160779434|NCT05887401|580576674|FG000|Overall Study|Withdrawal by Subject|0|||
160779435|NCT05887401|580576675|FG001|Overall Study|Withdrawal by Subject|0|||
160779436|NCT05887401|580576676|FG002|Overall Study|Withdrawal by Subject|0|||
160779437|NCT05887401|580576677|FG003|Overall Study|Withdrawal by Subject|0|||
160779438|NCT05887401|580576678|FG004|Overall Study|Withdrawal by Subject|0|||
160779439|NCT05887401|580576679|FG005|Overall Study|Withdrawal by Subject|0|||
160779440|NCT05887401|580576680|FG006|Overall Study|Withdrawal by Subject|0|||
160779441|NCT05887401|580576681|FG007|Overall Study|Withdrawal by Subject|0|||
160779442|NCT05887401|580576682|FG008|Overall Study|Withdrawal by Subject|0|||
160779443|NCT05887401|580576683|FG009|Overall Study|Withdrawal by Subject|1|||
160779444|NCT05887401|580576684|FG010|Overall Study|Withdrawal by Subject|0|||
160779445|NCT05887401|580576685|FG011|Overall Study|Withdrawal by Subject|0|||
160779446|NCT05887401|580576686|FG012|Overall Study|Withdrawal by Subject|0|||
160779447|NCT05887401|580576687|FG013|Overall Study|Withdrawal by Subject|0|||
160779448|NCT05887401|580576688|FG014|Overall Study|Withdrawal by Subject|0|||
160779449|NCT05887401|580576689|FG015|Overall Study|Withdrawal by Subject|1|||
160779450|NCT05887401|580576674|FG000|Overall Study|Lost to Follow-up|0|||
160779451|NCT05887401|580576675|FG001|Overall Study|Lost to Follow-up|1|||
160779452|NCT05887401|580576676|FG002|Overall Study|Lost to Follow-up|1|||
160779453|NCT05887401|580576677|FG003|Overall Study|Lost to Follow-up|2|||
160779454|NCT05887401|580576678|FG004|Overall Study|Lost to Follow-up|0|||
160779455|NCT05887401|580576679|FG005|Overall Study|Lost to Follow-up|0|||
160779456|NCT05887401|580576680|FG006|Overall Study|Lost to Follow-up|0|||
160779457|NCT05887401|580576681|FG007|Overall Study|Lost to Follow-up|0|||
160779458|NCT05887401|580576682|FG008|Overall Study|Lost to Follow-up|1|||
160779459|NCT05887401|580576683|FG009|Overall Study|Lost to Follow-up|1|||
160779460|NCT05887401|580576684|FG010|Overall Study|Lost to Follow-up|2|||
160887604|NCT00076024|580982549|FG001|Phase 1, Lead-in|Adverse Event|0|||
160779461|NCT05887401|580576685|FG011|Overall Study|Lost to Follow-up|1|||
160779462|NCT05887401|580576686|FG012|Overall Study|Lost to Follow-up|0|||
160779463|NCT05887401|580576687|FG013|Overall Study|Lost to Follow-up|0|||
160779464|NCT05887401|580576688|FG014|Overall Study|Lost to Follow-up|0|||
160779465|NCT05887401|580576689|FG015|Overall Study|Lost to Follow-up|0|||
160779466|NCT05942040|580576690|FG000|Overall Study|No longer employed at study site.|0|||
160779467|NCT05942040|580576691|FG001|Overall Study|No longer employed at study site.|0|||
160779468|NCT05942040|580576692|FG002|Overall Study|No longer employed at study site.|3|||
160779469|NCT03442569|580576693|FG000|Overall Study|Subject was ineligible after enrollment|1|||
160779470|NCT06461455|580576694|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
160779471|NCT06461455|580576695|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
160779472|NCT06461455|580576694|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
160779473|NCT06461455|580576695|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
160779474|NCT06461455|580576694|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
160779475|NCT06461455|580576695|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
160779476|NCT06142383|580576696|FG000|Overall Study|Mis-randomized|0|||
160779477|NCT06142383|580576697|FG001|Overall Study|Mis-randomized|0|||
160887605|NCT00076024|580982550|FG002|Phase 1, Lead-in|Adverse Event|0|||
160779478|NCT06142383|580576698|FG002|Overall Study|Mis-randomized|1|||
160779479|NCT06142383|580576699|FG003|Overall Study|Mis-randomized|0|||
160779480|NCT06142383|580576700|FG004|Overall Study|Mis-randomized|0|||
160779481|NCT06142383|580576696|FG000|Overall Study|Adverse Event|0|||
160779482|NCT06142383|580576697|FG001|Overall Study|Adverse Event|1|||
160779483|NCT06142383|580576698|FG002|Overall Study|Adverse Event|1|||
160887606|NCT00076024|580982551|FG003|Phase 1, Lead-in|Adverse Event|0|||
160779484|NCT06142383|580576699|FG003|Overall Study|Adverse Event|0|||
160779485|NCT06142383|580576700|FG004|Overall Study|Adverse Event|0|||
160779486|NCT06142383|580576696|FG000|Overall Study|Death|0|||
160779487|NCT06142383|580576697|FG001|Overall Study|Death|1|||
160779488|NCT06142383|580576698|FG002|Overall Study|Death|3|||
160779489|NCT06142383|580576699|FG003|Overall Study|Death|0|||
160779490|NCT06142383|580576700|FG004|Overall Study|Death|1|||
160779491|NCT06142383|580576696|FG000|Overall Study|Study Terminated by Sponsor|20|||
160779492|NCT06142383|580576697|FG001|Overall Study|Study Terminated by Sponsor|17|||
160779493|NCT06142383|580576698|FG002|Overall Study|Study Terminated by Sponsor|33|||
160779494|NCT06142383|580576699|FG003|Overall Study|Study Terminated by Sponsor|0|||
160779495|NCT06142383|580576700|FG004|Overall Study|Study Terminated by Sponsor|21|||
160779496|NCT06142383|580576696|FG000|Overall Study|Subject Decision|0|||
160779497|NCT06142383|580576697|FG001|Overall Study|Subject Decision|1|||
160779498|NCT06142383|580576698|FG002|Overall Study|Subject Decision|2|||
160779499|NCT06142383|580576699|FG003|Overall Study|Subject Decision|0|||
160779500|NCT06142383|580576700|FG004|Overall Study|Subject Decision|0|||
160779501|NCT03010501|580576704|FG000|Study Week 1|Withdrawal by Subject|2|||
160779502|NCT03010501|580576705|FG001|Study Week 1|Withdrawal by Subject|1|||
160779503|NCT03010501|580576706|FG002|Study Week 1|Withdrawal by Subject|0|||
160779504|NCT03010501|580576707|FG003|Study Week 1|Withdrawal by Subject|2|||
160779505|NCT03010501|580576708|FG004|Study Week 1|Withdrawal by Subject|0|||
160779506|NCT03010501|580576709|FG005|Study Week 1|Withdrawal by Subject|0|||
160779507|NCT03010501|580576704|FG000|Study Week 3|Withdrawal by Subject|0|||
160779508|NCT03010501|580576705|FG001|Study Week 3|Withdrawal by Subject|0|||
160779509|NCT03010501|580576706|FG002|Study Week 3|Withdrawal by Subject|0|||
160779510|NCT03010501|580576707|FG003|Study Week 3|Withdrawal by Subject|1|||
160779511|NCT03010501|580576708|FG004|Study Week 3|Withdrawal by Subject|0|||
160779512|NCT03010501|580576709|FG005|Study Week 3|Withdrawal by Subject|0|||
160779513|NCT00544882|580576715|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
160779514|NCT00544882|580576716|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
160779515|NCT00544882|580576717|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
160779516|NCT00544882|580576715|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
160779517|NCT00544882|580576716|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
160779518|NCT00544882|580576717|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
160779519|NCT00544882|580576715|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
160779520|NCT00544882|580576716|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
160779521|NCT00544882|580576717|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
160779522|NCT00544882|580576715|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
160779523|NCT00544882|580576716|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
160779524|NCT00544882|580576717|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
160779525|NCT00544882|580576715|FG000|Cycle 3: Follow-up|Noncompliance|0|||
160779526|NCT00544882|580576716|FG001|Cycle 3: Follow-up|Noncompliance|1|||
160779527|NCT00544882|580576717|FG002|Cycle 3: Follow-up|Noncompliance|0|||
160779528|NCT00544882|580576715|FG000|Cycle 3: Follow-up|Pregnancy|0|||
160779529|NCT00544882|580576716|FG001|Cycle 3: Follow-up|Pregnancy|1|||
160779530|NCT00544882|580576717|FG002|Cycle 3: Follow-up|Pregnancy|0|||
160779531|NCT03770455|580576718|FG000|Overall Study|Screen failures|3|||
160779532|NCT01121575|580576719|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
160779533|NCT01121575|580576720|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
160779534|NCT01121575|580576721|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
160779535|NCT01121575|580576722|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
160887607|NCT00076024|580982548|FG000|Phase 1, Lead-in|Clinical progression|1|||
160887608|NCT00076024|580982549|FG001|Phase 1, Lead-in|Clinical progression|0|||
160887609|NCT00076024|580982550|FG002|Phase 1, Lead-in|Clinical progression|0|||
160887610|NCT00076024|580982551|FG003|Phase 1, Lead-in|Clinical progression|0|||
160887611|NCT00076024|580982548|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
160887612|NCT00076024|580982549|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
160887613|NCT00076024|580982550|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
160887614|NCT00076024|580982551|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
160887615|NCT00076024|580982548|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
160887616|NCT00076024|580982549|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
160887617|NCT00076024|580982550|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
160887618|NCT00076024|580982551|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
160887619|NCT00076024|580982548|FG000|Phase 2, Double-blind|Adverse Event|0|||
160887620|NCT00076024|580982549|FG001|Phase 2, Double-blind|Adverse Event|25|||
161229372|NCT01941095|582222406|FG000|Overall Study|Lost to Follow-up|10|||
160779536|NCT01121575|580576723|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
160887621|NCT00076024|580982550|FG002|Phase 2, Double-blind|Adverse Event|6|||
160779537|NCT01121575|580576724|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
160779538|NCT01121575|580576719|FG000|Overall Study|Unspecified Reasons|8|||
160887622|NCT00076024|580982551|FG003|Phase 2, Double-blind|Adverse Event|0|||
160887623|NCT00076024|580982548|FG000|Phase 2, Double-blind|Un-specified|0|||
160779539|NCT01121575|580576720|FG001|Overall Study|Unspecified Reasons|6|||
160779540|NCT01121575|580576721|FG002|Overall Study|Unspecified Reasons|7|||
160779541|NCT01121575|580576722|FG003|Overall Study|Unspecified Reasons|5|||
160887624|NCT00076024|580982549|FG001|Phase 2, Double-blind|Un-specified|14|||
160887625|NCT00076024|580982550|FG002|Phase 2, Double-blind|Un-specified|6|||
160887626|NCT00076024|580982551|FG003|Phase 2, Double-blind|Un-specified|0|||
160779542|NCT01121575|580576723|FG004|Overall Study|Unspecified Reasons|13|||
160779543|NCT01121575|580576724|FG005|Overall Study|Unspecified Reasons|10|||
160779544|NCT01121575|580576719|FG000|Overall Study|Death|6|||
160779545|NCT01121575|580576720|FG001|Overall Study|Death|0|||
160779546|NCT01121575|580576721|FG002|Overall Study|Death|0|||
160779547|NCT01121575|580576722|FG003|Overall Study|Death|1|||
160779548|NCT01121575|580576723|FG004|Overall Study|Death|7|||
160779549|NCT01121575|580576724|FG005|Overall Study|Death|1|||
160779550|NCT04937387|580576725|FG000|Overall Study|Adverse Event|1|||
160779551|NCT04937387|580576726|FG001|Overall Study|Adverse Event|0|||
160779552|NCT04937387|580576727|FG002|Overall Study|Adverse Event|2|||
160779553|NCT04937387|580576728|FG003|Overall Study|Adverse Event|0|||
160779554|NCT04937387|580576725|FG000|Overall Study|Lack of Efficacy|1|||
160779555|NCT04937387|580576726|FG001|Overall Study|Lack of Efficacy|0|||
160779556|NCT04937387|580576727|FG002|Overall Study|Lack of Efficacy|0|||
160779557|NCT04937387|580576728|FG003|Overall Study|Lack of Efficacy|1|||
160779558|NCT04937387|580576725|FG000|Overall Study|Withdrawal by Subject|1|||
160779559|NCT04937387|580576726|FG001|Overall Study|Withdrawal by Subject|0|||
160779560|NCT04937387|580576727|FG002|Overall Study|Withdrawal by Subject|1|||
160779561|NCT04937387|580576728|FG003|Overall Study|Withdrawal by Subject|1|||
160779562|NCT04937387|580576725|FG000|Overall Study|Randomized in error|0|||
160779563|NCT04937387|580576726|FG001|Overall Study|Randomized in error|0|||
160779564|NCT04937387|580576727|FG002|Overall Study|Randomized in error|0|||
160779565|NCT04937387|580576728|FG003|Overall Study|Randomized in error|1|||
160779566|NCT02583269|580576729|FG000|Overall Study|Patient hospitalized prior to start|1|||
160779567|NCT02583269|580576730|FG001|Overall Study|Patient hospitalized prior to start|0|||
160779568|NCT02583269|580576731|FG002|Overall Study|Patient hospitalized prior to start|0|||
160779569|NCT02583269|580576732|FG003|Overall Study|Patient hospitalized prior to start|0|||
160779570|NCT02583269|580576733|FG004|Overall Study|Patient hospitalized prior to start|0|||
160779571|NCT03244189|580576735|FG000|Overall Study|Death|0|||
160779572|NCT03244189|580576736|FG001|Overall Study|Death|2|||
160779573|NCT03244189|580576735|FG000|Overall Study|Lost to Follow-up|92|||
160779574|NCT03244189|580576736|FG001|Overall Study|Lost to Follow-up|107|||
160779575|NCT03244189|580576735|FG000|Overall Study|Physician Decision|4|||
160779576|NCT03244189|580576736|FG001|Overall Study|Physician Decision|2|||
160779577|NCT03244189|580576735|FG000|Overall Study|Pregnancy|7|||
160779578|NCT03244189|580576736|FG001|Overall Study|Pregnancy|5|||
160779579|NCT03244189|580576735|FG000|Overall Study|Protocol Violation|0|||
160779580|NCT03244189|580576736|FG001|Overall Study|Protocol Violation|2|||
160779581|NCT03244189|580576735|FG000|Overall Study|Withdrawal by Subject|45|||
160779582|NCT03244189|580576736|FG001|Overall Study|Withdrawal by Subject|23|||
160779583|NCT03244189|580576735|FG000|Overall Study|Technical Problems|2|||
160779584|NCT03244189|580576736|FG001|Overall Study|Technical Problems|0|||
160779585|NCT02369458|580576737|FG000|Overall Study|Determined to be not eligible|1|||
160887627|NCT00076024|580982548|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
160887628|NCT00076024|580982549|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
160887629|NCT00076024|580982550|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
160887630|NCT00076024|580982551|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
160779586|NCT02369458|580576738|FG001|Overall Study|Determined to be not eligible|0|||
160887631|NCT00076024|580982548|FG000|Phase 2, Open-label|Adverse Event|0|||
160887632|NCT00076024|580982549|FG001|Phase 2, Open-label|Adverse Event|0|||
160887633|NCT00076024|580982550|FG002|Phase 2, Open-label|Adverse Event|0|||
160887634|NCT00076024|580982551|FG003|Phase 2, Open-label|Adverse Event|2|||
160887635|NCT00076024|580982548|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
160887636|NCT00076024|580982549|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
160887637|NCT00076024|580982550|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
160887638|NCT00076024|580982551|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
160779587|NCT03853798|580576739|FG000|Overall Study|Death|0|||
160779588|NCT03853798|580576740|FG001|Overall Study|Death|0|||
160779589|NCT03853798|580576741|FG002|Overall Study|Death|0|||
160887639|NCT00076024|580982548|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
160887640|NCT00076024|580982549|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
160887641|NCT00076024|580982550|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
160887642|NCT00076024|580982551|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
160779590|NCT03853798|580576742|FG003|Overall Study|Death|0|||
160779591|NCT03853798|580576743|FG004|Overall Study|Death|0|||
160779592|NCT03853798|580576744|FG005|Overall Study|Death|1|||
160887643|NCT00076024|580982548|FG000|Phase 2, Open-label|Other|0|||
160887644|NCT00076024|580982549|FG001|Phase 2, Open-label|Other|0|||
161229373|NCT03527745|582222407|FG000|Overall Study|Lost to Follow-up|3|||
160779593|NCT03853798|580576745|FG006|Overall Study|Death|0|||
160779594|NCT03853798|580576746|FG007|Overall Study|Death|0|||
160779595|NCT03853798|580576747|FG008|Overall Study|Death|0|||
160779596|NCT03853798|580576739|FG000|Overall Study|Adverse Event|0|||
160779597|NCT03853798|580576740|FG001|Overall Study|Adverse Event|0|||
160779598|NCT03853798|580576741|FG002|Overall Study|Adverse Event|2|||
160779599|NCT03853798|580576742|FG003|Overall Study|Adverse Event|0|||
160779600|NCT03853798|580576743|FG004|Overall Study|Adverse Event|0|||
160779601|NCT03853798|580576744|FG005|Overall Study|Adverse Event|0|||
160779602|NCT03853798|580576745|FG006|Overall Study|Adverse Event|0|||
160779603|NCT03853798|580576746|FG007|Overall Study|Adverse Event|0|||
160779604|NCT03853798|580576747|FG008|Overall Study|Adverse Event|0|||
160779605|NCT03853798|580576739|FG000|Overall Study|Withdrawal by Subject|0|||
160779606|NCT03853798|580576740|FG001|Overall Study|Withdrawal by Subject|1|||
160779607|NCT03853798|580576741|FG002|Overall Study|Withdrawal by Subject|4|||
160779608|NCT03853798|580576742|FG003|Overall Study|Withdrawal by Subject|0|||
160779609|NCT03853798|580576743|FG004|Overall Study|Withdrawal by Subject|0|||
160779610|NCT03853798|580576744|FG005|Overall Study|Withdrawal by Subject|5|||
160779611|NCT03853798|580576745|FG006|Overall Study|Withdrawal by Subject|0|||
160779612|NCT03853798|580576746|FG007|Overall Study|Withdrawal by Subject|0|||
160779613|NCT03853798|580576747|FG008|Overall Study|Withdrawal by Subject|4|||
160779614|NCT03853798|580576739|FG000|Overall Study|Physician Decision|1|||
160779615|NCT03853798|580576740|FG001|Overall Study|Physician Decision|0|||
160779616|NCT03853798|580576741|FG002|Overall Study|Physician Decision|0|||
160779617|NCT03853798|580576742|FG003|Overall Study|Physician Decision|0|||
160779618|NCT03853798|580576743|FG004|Overall Study|Physician Decision|0|||
160779619|NCT03853798|580576744|FG005|Overall Study|Physician Decision|0|||
160779620|NCT03853798|580576745|FG006|Overall Study|Physician Decision|0|||
160779621|NCT03853798|580576746|FG007|Overall Study|Physician Decision|0|||
160779622|NCT03853798|580576747|FG008|Overall Study|Physician Decision|1|||
160779623|NCT03853798|580576739|FG000|Overall Study|Lack of Efficacy|0|||
160779624|NCT03853798|580576740|FG001|Overall Study|Lack of Efficacy|0|||
160779625|NCT03853798|580576741|FG002|Overall Study|Lack of Efficacy|2|||
160779626|NCT03853798|580576742|FG003|Overall Study|Lack of Efficacy|0|||
160779627|NCT03853798|580576743|FG004|Overall Study|Lack of Efficacy|0|||
160779628|NCT03853798|580576744|FG005|Overall Study|Lack of Efficacy|0|||
160779629|NCT03853798|580576745|FG006|Overall Study|Lack of Efficacy|0|||
160779630|NCT03853798|580576746|FG007|Overall Study|Lack of Efficacy|0|||
160779631|NCT03853798|580576747|FG008|Overall Study|Lack of Efficacy|1|||
160779632|NCT03853798|580576739|FG000|Overall Study|Approved Drug Available for Indication|0|||
160779633|NCT03853798|580576740|FG001|Overall Study|Approved Drug Available for Indication|0|||
160779634|NCT03853798|580576741|FG002|Overall Study|Approved Drug Available for Indication|1|||
160779635|NCT03853798|580576742|FG003|Overall Study|Approved Drug Available for Indication|0|||
160779636|NCT03853798|580576743|FG004|Overall Study|Approved Drug Available for Indication|0|||
160779637|NCT03853798|580576744|FG005|Overall Study|Approved Drug Available for Indication|1|||
160779638|NCT03853798|580576745|FG006|Overall Study|Approved Drug Available for Indication|0|||
160779639|NCT03853798|580576746|FG007|Overall Study|Approved Drug Available for Indication|0|||
160887645|NCT00076024|580982550|FG002|Phase 2, Open-label|Other|0|||
160887646|NCT00076024|580982551|FG003|Phase 2, Open-label|Other|2|||
160887647|NCT01362595|580982552|FG000|Overall Study|Screen failure|10|||
160887648|NCT01362595|580982552|FG000|Overall Study|Withdrawal by Subject|2|||
160887649|NCT00959374|580982553|FG000|Overall Study|Withdrawal by Subject|2|||
160887650|NCT00959374|580982553|FG000|Overall Study|Lost to Follow-up|14|||
160887651|NCT00959374|580982553|FG000|Overall Study|Death|1|||
160887652|NCT00959374|580982553|FG000|Overall Study|Protocol Violation|1|||
160887653|NCT00959374|580982553|FG000|Overall Study|Implant Removed/Not Replaced|4|||
160887654|NCT00959374|580982553|FG000|Overall Study|Physician Decision|1|||
160887655|NCT03350984|580982554|FG000|Overall Study|Death|1|||
160887656|NCT03350984|580982555|FG001|Overall Study|Death|0|||
160887657|NCT03350984|580982554|FG000|Overall Study|Lost to Follow-up|5|||
160887658|NCT03350984|580982555|FG001|Overall Study|Lost to Follow-up|6|||
160887659|NCT03350984|580982554|FG000|Overall Study|Protocol Violation|1|||
160887660|NCT03350984|580982555|FG001|Overall Study|Protocol Violation|2|||
160887661|NCT03350984|580982554|FG000|Overall Study|Physician Decision|1|||
160887662|NCT03350984|580982555|FG001|Overall Study|Physician Decision|0|||
160887663|NCT01741012|580982556|FG000|Overall Study|Lost to Follow-up|1|||
160887664|NCT01741012|580982556|FG000|Overall Study|Withdrawal by Subject|2|||
160887665|NCT00958789|580982557|FG000|Overall Study|Death|5|||
160887666|NCT00958789|580982557|FG000|Overall Study|Lost to Follow-up|14|||
160887667|NCT00958789|580982557|FG000|Overall Study|Withdrawal by Subject|17|||
160887668|NCT00958789|580982557|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
160887669|NCT00958789|580982557|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
160887670|NCT00958789|580982557|FG000|Overall Study|Subject terminated|2|||
160887671|NCT00958789|580982557|FG000|Overall Study|Revision|7|||
160887672|NCT04104438|580982560|FG000|Overall Study|Death|2|||
160779640|NCT03853798|580576747|FG008|Overall Study|Approved Drug Available for Indication|0|||
160779641|NCT03853798|580576739|FG000|Overall Study|Other un-specified|0|||
160779642|NCT03853798|580576740|FG001|Overall Study|Other un-specified|0|||
160887673|NCT04104438|580982561|FG001|Overall Study|Death|1|||
160887674|NCT04104438|580982562|FG002|Overall Study|Death|2|||
160779643|NCT03853798|580576741|FG002|Overall Study|Other un-specified|2|||
160779644|NCT03853798|580576742|FG003|Overall Study|Other un-specified|0|||
160779645|NCT03853798|580576743|FG004|Overall Study|Other un-specified|0|||
160779646|NCT03853798|580576744|FG005|Overall Study|Other un-specified|1|||
160887675|NCT04104438|580982560|FG000|Overall Study|Adverse Event|0|||
160887676|NCT04104438|580982561|FG001|Overall Study|Adverse Event|3|||
160887677|NCT04104438|580982562|FG002|Overall Study|Adverse Event|0|||
160887678|NCT04104438|580982560|FG000|Overall Study|Withdrawal by Subject|0|||
160779647|NCT03853798|580576745|FG006|Overall Study|Other un-specified|0|||
160779648|NCT03853798|580576746|FG007|Overall Study|Other un-specified|0|||
160779649|NCT03853798|580576747|FG008|Overall Study|Other un-specified|0|||
160779650|NCT02743494|580576748|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
160779651|NCT02743494|580576749|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
160779652|NCT02743494|580576748|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
160779653|NCT02743494|580576749|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
160779654|NCT02743494|580576748|FG000|Treatment Period|Disease recurrence|152|||
160779655|NCT02743494|580576749|FG001|Treatment Period|Disease recurrence|115|||
160779656|NCT02743494|580576748|FG000|Treatment Period|Study drug toxicity|56|||
160779657|NCT02743494|580576749|FG001|Treatment Period|Study drug toxicity|8|||
160779658|NCT02743494|580576748|FG000|Treatment Period|Death|1|||
160779659|NCT02743494|580576749|FG001|Treatment Period|Death|1|||
160779660|NCT02743494|580576748|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
160779661|NCT02743494|580576749|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
160779662|NCT02743494|580576748|FG000|Treatment Period|Participant request to discontinue treatment|31|||
160779663|NCT02743494|580576749|FG001|Treatment Period|Participant request to discontinue treatment|5|||
160779664|NCT02743494|580576748|FG000|Treatment Period|Participant withdrew consent|11|||
160779665|NCT02743494|580576749|FG001|Treatment Period|Participant withdrew consent|4|||
160779666|NCT02743494|580576748|FG000|Treatment Period|Lost to Follow-up|0|||
160779667|NCT02743494|580576749|FG001|Treatment Period|Lost to Follow-up|1|||
160779668|NCT02743494|580576748|FG000|Treatment Period|Poor/Non-compliance|2|||
160779669|NCT02743494|580576749|FG001|Treatment Period|Poor/Non-compliance|0|||
160779670|NCT02743494|580576748|FG000|Treatment Period|Other reasons|4|||
160779671|NCT02743494|580576749|FG001|Treatment Period|Other reasons|1|||
160779672|NCT02207608|580576750|FG000|Overall Study|Adverse Event|1|||
160779673|NCT02207608|580576751|FG001|Overall Study|Adverse Event|0|||
160779674|NCT05399485|580578536|FG000|DBT Phase|Other|6|||
160779675|NCT05399485|580578537|FG001|DBT Phase|Other|5|||
160779676|NCT05399485|580578536|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
160779677|NCT05399485|580578537|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
160779678|NCT05399485|580578536|FG000|DBT Phase|Withdrawal by Subject|3|||
160779679|NCT05399485|580578537|FG001|DBT Phase|Withdrawal by Subject|2|||
160779680|NCT05399485|580578536|FG000|DBT Phase|Protocol Violation|2|||
160779681|NCT05399485|580578537|FG001|DBT Phase|Protocol Violation|1|||
160779682|NCT05399485|580578536|FG000|DBT Phase|Physician Decision|0|||
160779683|NCT05399485|580578537|FG001|DBT Phase|Physician Decision|1|||
160779684|NCT05399485|580578536|FG000|DBT Phase|Adverse Event|2|||
160779685|NCT05399485|580578537|FG001|DBT Phase|Adverse Event|1|||
160779686|NCT05399485|580578536|FG000|OLE Phase|Protocol deviation|1|||
160779687|NCT05399485|580578537|FG001|OLE Phase|Protocol deviation|0|||
160779688|NCT05399485|580578536|FG000|OLE Phase|Other|5|||
160779689|NCT05399485|580578537|FG001|OLE Phase|Other|5|||
160779690|NCT05399485|580578536|FG000|OLE Phase|Withdrawal by Subject|12|||
160779691|NCT05399485|580578537|FG001|OLE Phase|Withdrawal by Subject|7|||
160779692|NCT05399485|580578536|FG000|OLE Phase|Pregnancy|0|||
160779693|NCT05399485|580578537|FG001|OLE Phase|Pregnancy|2|||
160887679|NCT04104438|580982561|FG001|Overall Study|Withdrawal by Subject|1|||
160887680|NCT04104438|580982562|FG002|Overall Study|Withdrawal by Subject|0|||
160887681|NCT04104438|580982560|FG000|Overall Study|Disenrolled due to noncompliance|0|||
160887682|NCT04104438|580982561|FG001|Overall Study|Disenrolled due to noncompliance|1|||
160887683|NCT04104438|580982562|FG002|Overall Study|Disenrolled due to noncompliance|0|||
161123266|NCT03403192|581837528|FG000|Overall Study|Unable to respond|0|||
161123267|NCT03403192|581837529|FG001|Overall Study|Unable to respond|1|||
161123268|NCT03403192|581837530|FG002|Overall Study|Unable to respond|0|||
161123269|NCT03403192|581837531|FG003|Overall Study|Unable to respond|0|||
161123270|NCT03403192|581837528|FG000|Overall Study|Incomplete|3|||
161123271|NCT03403192|581837529|FG001|Overall Study|Incomplete|1|||
161123272|NCT03403192|581837530|FG002|Overall Study|Incomplete|3|||
161123273|NCT03403192|581837531|FG003|Overall Study|Incomplete|6|||
161123274|NCT04673786|581837534|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
160887684|NCT04104438|580982560|FG000|Overall Study|stopped due to possible operation|0|||
161123275|NCT04673786|581837535|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
161123276|NCT04673786|581837536|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
160779694|NCT05399485|580578536|FG000|OLE Phase|Physician Decision|3|||
160779695|NCT05399485|580578537|FG001|OLE Phase|Physician Decision|0|||
160779696|NCT05399485|580578536|FG000|OLE Phase|Adverse Event|2|||
160779697|NCT05399485|580578537|FG001|OLE Phase|Adverse Event|2|||
160779698|NCT03554473|580578538|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
160779699|NCT03554473|580578539|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
160887685|NCT04104438|580982561|FG001|Overall Study|stopped due to possible operation|1|||
161123277|NCT04673786|581837534|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
161123278|NCT04673786|581837535|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
160779700|NCT03554473|580578540|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
160779701|NCT03554473|580578538|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
160779702|NCT03554473|580578539|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
160779703|NCT03554473|580578540|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
160779704|NCT03554473|580578538|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
160779705|NCT03554473|580578539|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
160779706|NCT03554473|580578540|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
160779707|NCT05206604|580578541|FG000|Overall Study|Non-compliance with study drug|0|||
160779708|NCT05206604|580578542|FG001|Overall Study|Non-compliance with study drug|0|||
160779709|NCT05206604|580578543|FG002|Overall Study|Non-compliance with study drug|0|||
160779710|NCT05206604|580578544|FG003|Overall Study|Non-compliance with study drug|0|||
160779711|NCT05206604|580578545|FG004|Overall Study|Non-compliance with study drug|0|||
160779712|NCT05206604|580578546|FG005|Overall Study|Non-compliance with study drug|1|||
160779713|NCT05206604|580578547|FG006|Overall Study|Non-compliance with study drug|0|||
160779714|NCT05206604|580578548|FG007|Overall Study|Non-compliance with study drug|0|||
160779715|NCT00160615|580578549|FG000|Overall Study|Adverse Event|5|||
160779716|NCT00160615|580578550|FG001|Overall Study|Adverse Event|12|||
160779717|NCT00160615|580578549|FG000|Overall Study|Withdrawal by Subject|0|||
160779718|NCT00160615|580578550|FG001|Overall Study|Withdrawal by Subject|2|||
160779719|NCT00160615|580578549|FG000|Overall Study|Lack of Efficacy|11|||
160779720|NCT00160615|580578550|FG001|Overall Study|Lack of Efficacy|23|||
160779721|NCT00160615|580578549|FG000|Overall Study|Patient decision|1|||
160779722|NCT00160615|580578550|FG001|Overall Study|Patient decision|2|||
160779723|NCT00160615|580578549|FG000|Overall Study|Investigator decision|1|||
160779724|NCT00160615|580578550|FG001|Overall Study|Investigator decision|1|||
160779725|NCT00160615|580578549|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
160779726|NCT00160615|580578550|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
160779727|NCT00160615|580578549|FG000|Overall Study|Switch to surgical treatment|0|||
160779728|NCT00160615|580578550|FG001|Overall Study|Switch to surgical treatment|2|||
160779729|NCT00160615|580578549|FG000|Overall Study|Non-compliance was suspected|0|||
160779730|NCT00160615|580578550|FG001|Overall Study|Non-compliance was suspected|1|||
160779731|NCT00160615|580578549|FG000|Overall Study|Poor compliance|0|||
160779732|NCT00160615|580578550|FG001|Overall Study|Poor compliance|1|||
160779733|NCT03971422|580578554|FG000|Overall Study|Lost to Follow-up|0|||
160779734|NCT03971422|580578555|FG001|Overall Study|Lost to Follow-up|1|||
160779735|NCT03971422|580578556|FG002|Overall Study|Lost to Follow-up|0|||
160779736|NCT03971422|580578554|FG000|Overall Study|Lack of Efficacy|5|||
160779737|NCT03971422|580578555|FG001|Overall Study|Lack of Efficacy|1|||
160779738|NCT03971422|580578556|FG002|Overall Study|Lack of Efficacy|1|||
160779739|NCT03971422|580578554|FG000|Overall Study|Adverse event, not fatal|2|||
160779740|NCT03971422|580578555|FG001|Overall Study|Adverse event, not fatal|2|||
160779741|NCT03971422|580578556|FG002|Overall Study|Adverse event, not fatal|5|||
160779742|NCT03971422|580578554|FG000|Overall Study|Worsening of MG Symptoms|1|||
160779743|NCT03971422|580578555|FG001|Overall Study|Worsening of MG Symptoms|4|||
160887686|NCT04104438|580982562|FG002|Overall Study|stopped due to possible operation|0|||
161123279|NCT04673786|581837536|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
161123280|NCT04673786|581837534|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
161123281|NCT04673786|581837535|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
161123282|NCT04673786|581837536|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
161123283|NCT04673786|581837534|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
161123284|NCT04673786|581837535|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
161123285|NCT04673786|581837536|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
161123286|NCT04673786|581837534|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
161123287|NCT04673786|581837535|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
161123288|NCT04673786|581837536|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
161123289|NCT04673786|581837534|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
161123290|NCT04673786|581837535|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
161123291|NCT04673786|581837536|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
161123292|NCT01325428|581837537|FG000|Part A|Progressive disease according to RECIST|9|||
161123293|NCT01325428|581837537|FG000|Part A|Clinical signs, symptoms of progression|2|||
161123294|NCT01325428|581837537|FG000|Part A|Other adverse event|1|||
161123295|NCT01325428|581837537|FG000|Part A|Refused continue taking trial medication|2|||
161123296|NCT01325428|581837537|FG000|Part A|Other reason not defined above|2|||
160779744|NCT03971422|580578556|FG002|Overall Study|Worsening of MG Symptoms|2|||
160779745|NCT03971422|580578554|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
160779746|NCT03971422|580578555|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
160779747|NCT03971422|580578556|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
160887687|NCT04104438|580982560|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
161123297|NCT01325428|581837537|FG000|Part B|Refused continue taking trial medication|2|||
161326259|NCT01972464|582579713|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
161326260|NCT01972464|582579714|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
161326261|NCT01972464|582579713|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
160779748|NCT03971422|580578554|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
161123298|NCT01325428|581837537|FG000|Part B|Other reason not defined above|1|||
161123299|NCT04849780|581837538|FG000|Period 1|Covid-19 Related|1|||
161123300|NCT04849780|581837539|FG001|Period 1|Covid-19 Related|0|||
161123301|NCT04849780|581837538|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
161123302|NCT04849780|581837539|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
161123303|NCT04849780|581837538|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
161123304|NCT04849780|581837539|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
161123305|NCT00725075|581837540|FG000|Overall Study|Use of Excluded Medication|0|||
161123306|NCT00725075|581837541|FG001|Overall Study|Use of Excluded Medication|1|||
161123307|NCT00725075|581837542|FG002|Overall Study|Use of Excluded Medication|0|||
161123308|NCT00725075|581837540|FG000|Overall Study|Protocol Violation|0|||
161123309|NCT00725075|581837541|FG001|Overall Study|Protocol Violation|0|||
161123310|NCT00725075|581837542|FG002|Overall Study|Protocol Violation|1|||
161123311|NCT00725075|581837540|FG000|Overall Study|Lost to Follow-up|1|||
161123312|NCT00725075|581837541|FG001|Overall Study|Lost to Follow-up|0|||
161123313|NCT00725075|581837542|FG002|Overall Study|Lost to Follow-up|0|||
161123314|NCT00725075|581837540|FG000|Overall Study|Withdrawal by Subject|4|||
161123315|NCT00725075|581837541|FG001|Overall Study|Withdrawal by Subject|5|||
161123316|NCT00725075|581837542|FG002|Overall Study|Withdrawal by Subject|4|||
161123317|NCT00725075|581837540|FG000|Overall Study|Adverse Event|2|||
161123318|NCT00725075|581837541|FG001|Overall Study|Adverse Event|1|||
161123319|NCT00725075|581837542|FG002|Overall Study|Adverse Event|1|||
161123320|NCT00725075|581837540|FG000|Overall Study|Worsening of Disease|2|||
161123321|NCT00725075|581837541|FG001|Overall Study|Worsening of Disease|1|||
161123322|NCT00725075|581837542|FG002|Overall Study|Worsening of Disease|2|||
161229374|NCT03527745|582222408|FG001|Overall Study|Lost to Follow-up|6|||
161229375|NCT03527745|582222409|FG002|Overall Study|Lost to Follow-up|7|||
161229376|NCT03527745|582222410|FG003|Overall Study|Lost to Follow-up|9|||
161229377|NCT03527745|582222411|FG004|Overall Study|Lost to Follow-up|0|||
161229378|NCT03527745|582222412|FG005|Overall Study|Lost to Follow-up|2|||
161229379|NCT03527745|582222413|FG006|Overall Study|Lost to Follow-up|3|||
161229380|NCT03527745|582222414|FG007|Overall Study|Lost to Follow-up|2|||
161229381|NCT03527745|582222415|FG008|Overall Study|Lost to Follow-up|3|||
161229382|NCT03527745|582222416|FG009|Overall Study|Lost to Follow-up|2|||
161229383|NCT03527745|582222417|FG010|Overall Study|Lost to Follow-up|1|||
161229384|NCT03527745|582222418|FG011|Overall Study|Lost to Follow-up|1|||
161229385|NCT03527745|582222419|FG012|Overall Study|Lost to Follow-up|0|||
161229386|NCT03527745|582222420|FG013|Overall Study|Lost to Follow-up|0|||
161229387|NCT03527745|582222421|FG014|Overall Study|Lost to Follow-up|0|||
161229388|NCT03527745|582222422|FG015|Overall Study|Lost to Follow-up|0|||
161229389|NCT03527745|582222423|FG016|Overall Study|Lost to Follow-up|1|||
161229390|NCT03527745|582222424|FG017|Overall Study|Lost to Follow-up|0|||
161229391|NCT03527745|582222425|FG018|Overall Study|Lost to Follow-up|0|||
161229392|NCT03527745|582222426|FG019|Overall Study|Lost to Follow-up|1|||
161229393|NCT03527745|582222427|FG020|Overall Study|Lost to Follow-up|1|||
161229394|NCT03527745|582222428|FG021|Overall Study|Lost to Follow-up|5|||
161229395|NCT03527745|582222429|FG022|Overall Study|Lost to Follow-up|6|||
161229396|NCT03527745|582222430|FG023|Overall Study|Lost to Follow-up|8|||
161229397|NCT03527745|582222431|FG024|Overall Study|Lost to Follow-up|1|||
161229398|NCT03527745|582222432|FG025|Overall Study|Lost to Follow-up|3|||
161229399|NCT01475838|582222436|FG000|Randomized Phase|Randomized but Not Treated|0|||
161229400|NCT01475838|582222437|FG001|Randomized Phase|Randomized but Not Treated|5|||
161229401|NCT01475838|582222436|FG000|Randomized Phase|Adverse Event|6|||
161229402|NCT01475838|582222437|FG001|Randomized Phase|Adverse Event|1|||
161229403|NCT01475838|582222436|FG000|Randomized Phase|Pregnancy|0|||
161229404|NCT01475838|582222437|FG001|Randomized Phase|Pregnancy|1|||
161229405|NCT01475838|582222436|FG000|Randomized Phase|Investigators Discretion|1|||
161229406|NCT01475838|582222437|FG001|Randomized Phase|Investigators Discretion|2|||
161229407|NCT01475838|582222436|FG000|Randomized Phase|Withdrew Consent|10|||
161229408|NCT01475838|582222437|FG001|Randomized Phase|Withdrew Consent|14|||
161229409|NCT01475838|582222436|FG000|Randomized Phase|Lost to Follow-up|3|||
161229410|NCT01475838|582222437|FG001|Randomized Phase|Lost to Follow-up|4|||
161229411|NCT01475838|582222436|FG000|Randomized Phase|Participant Noncompliance|1|||
161229412|NCT01475838|582222437|FG001|Randomized Phase|Participant Noncompliance|5|||
161229413|NCT01475838|582222436|FG000|Randomized Phase|Protocol Violation|9|||
161229414|NCT01475838|582222437|FG001|Randomized Phase|Protocol Violation|4|||
161229415|NCT01475838|582222436|FG000|Extension Phase|Participant Noncompliance|1|||
161229416|NCT01475838|582222437|FG001|Extension Phase|Participant Noncompliance|0|||
161229417|NCT00560235|582222443|FG000|Phase 1|Discontinued|8|||
161123323|NCT00725075|581837540|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
161123324|NCT00725075|581837541|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161229418|NCT00560235|582222444|FG001|Phase 1|Discontinued|0|||
161229419|NCT00560235|582222445|FG002|Phase 1|Discontinued|0|||
160779749|NCT03971422|580578555|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
160779750|NCT03971422|580578556|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
160779751|NCT03971422|580578554|FG000|Overall Study|Due to COVID-19 pandemic|0|||
160779752|NCT03971422|580578555|FG001|Overall Study|Due to COVID-19 pandemic|1|||
160779753|NCT03971422|580578556|FG002|Overall Study|Due to COVID-19 pandemic|1|||
160779754|NCT01658878|580578557|FG000|Treatment Period|Disease Progression|1|||
160779755|NCT01658878|580578558|FG001|Treatment Period|Disease Progression|3|||
160779756|NCT01658878|580578559|FG002|Treatment Period|Disease Progression|2|||
160779757|NCT01658878|580578560|FG003|Treatment Period|Disease Progression|1|||
160779758|NCT01658878|580578561|FG004|Treatment Period|Disease Progression|13|||
160779759|NCT01658878|580578562|FG005|Treatment Period|Disease Progression|3|||
160779760|NCT01658878|580578563|FG006|Treatment Period|Disease Progression|4|||
160779761|NCT01658878|580578564|FG007|Treatment Period|Disease Progression|3|||
160779762|NCT01658878|580578565|FG008|Treatment Period|Disease Progression|5|||
160779763|NCT01658878|580578566|FG009|Treatment Period|Disease Progression|3|||
160779764|NCT01658878|580578567|FG010|Treatment Period|Disease Progression|3|||
160779765|NCT01658878|580578568|FG011|Treatment Period|Disease Progression|4|||
160779766|NCT01658878|580578569|FG012|Treatment Period|Disease Progression|43|||
160779767|NCT01658878|580578570|FG013|Treatment Period|Disease Progression|48|||
160779768|NCT01658878|580578571|FG014|Treatment Period|Disease Progression|33|||
160779769|NCT01658878|580578572|FG015|Treatment Period|Disease Progression|46|||
160779770|NCT01658878|580578573|FG016|Treatment Period|Disease Progression|41|||
160779771|NCT01658878|580578574|FG017|Treatment Period|Disease Progression|42|||
160779772|NCT01658878|580578575|FG018|Treatment Period|Disease Progression|28|||
160779773|NCT01658878|580578576|FG019|Treatment Period|Disease Progression|37|||
160779774|NCT01658878|580578577|FG020|Treatment Period|Disease Progression|37|||
160779775|NCT01658878|580578578|FG021|Treatment Period|Disease Progression|39|||
160779776|NCT01658878|580578579|FG022|Treatment Period|Disease Progression|27|||
160779777|NCT01658878|580578580|FG023|Treatment Period|Disease Progression|19|||
160779778|NCT01658878|580578557|FG000|Treatment Period|Study Drug Toxicity|0|||
160779779|NCT01658878|580578558|FG001|Treatment Period|Study Drug Toxicity|0|||
160779780|NCT01658878|580578559|FG002|Treatment Period|Study Drug Toxicity|0|||
160779781|NCT01658878|580578560|FG003|Treatment Period|Study Drug Toxicity|1|||
160779782|NCT01658878|580578561|FG004|Treatment Period|Study Drug Toxicity|0|||
160779783|NCT01658878|580578562|FG005|Treatment Period|Study Drug Toxicity|0|||
160779784|NCT01658878|580578563|FG006|Treatment Period|Study Drug Toxicity|0|||
160779785|NCT01658878|580578564|FG007|Treatment Period|Study Drug Toxicity|0|||
160779786|NCT01658878|580578565|FG008|Treatment Period|Study Drug Toxicity|0|||
160779787|NCT01658878|580578566|FG009|Treatment Period|Study Drug Toxicity|0|||
160779788|NCT01658878|580578567|FG010|Treatment Period|Study Drug Toxicity|0|||
160779789|NCT01658878|580578568|FG011|Treatment Period|Study Drug Toxicity|0|||
160779790|NCT01658878|580578569|FG012|Treatment Period|Study Drug Toxicity|7|||
160779791|NCT01658878|580578570|FG013|Treatment Period|Study Drug Toxicity|1|||
160779792|NCT01658878|580578571|FG014|Treatment Period|Study Drug Toxicity|5|||
160779793|NCT01658878|580578572|FG015|Treatment Period|Study Drug Toxicity|0|||
160779794|NCT01658878|580578573|FG016|Treatment Period|Study Drug Toxicity|5|||
160779795|NCT01658878|580578574|FG017|Treatment Period|Study Drug Toxicity|10|||
160779796|NCT01658878|580578575|FG018|Treatment Period|Study Drug Toxicity|12|||
160779797|NCT01658878|580578576|FG019|Treatment Period|Study Drug Toxicity|4|||
160779798|NCT01658878|580578577|FG020|Treatment Period|Study Drug Toxicity|2|||
160779799|NCT01658878|580578578|FG021|Treatment Period|Study Drug Toxicity|3|||
160779800|NCT01658878|580578579|FG022|Treatment Period|Study Drug Toxicity|2|||
160779801|NCT01658878|580578580|FG023|Treatment Period|Study Drug Toxicity|6|||
160779802|NCT01658878|580578557|FG000|Treatment Period|Maximum Clinical Benefit|0|||
160779803|NCT01658878|580578558|FG001|Treatment Period|Maximum Clinical Benefit|0|||
160779804|NCT01658878|580578559|FG002|Treatment Period|Maximum Clinical Benefit|1|||
160779805|NCT01658878|580578560|FG003|Treatment Period|Maximum Clinical Benefit|0|||
160779806|NCT01658878|580578561|FG004|Treatment Period|Maximum Clinical Benefit|0|||
160779807|NCT01658878|580578562|FG005|Treatment Period|Maximum Clinical Benefit|0|||
161123325|NCT00725075|581837542|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
161123326|NCT00725075|581837540|FG000|Overall Study|Other|1|||
161123327|NCT00725075|581837541|FG001|Overall Study|Other|0|||
161123328|NCT00725075|581837542|FG002|Overall Study|Other|0|||
161123329|NCT01298492|581837543|FG000|Overall Study|Death|2|||
160779808|NCT01658878|580578563|FG006|Treatment Period|Maximum Clinical Benefit|0|||
160779809|NCT01658878|580578564|FG007|Treatment Period|Maximum Clinical Benefit|0|||
160779810|NCT01658878|580578565|FG008|Treatment Period|Maximum Clinical Benefit|0|||
160779811|NCT01658878|580578566|FG009|Treatment Period|Maximum Clinical Benefit|0|||
160779812|NCT01658878|580578567|FG010|Treatment Period|Maximum Clinical Benefit|0|||
160779813|NCT01658878|580578568|FG011|Treatment Period|Maximum Clinical Benefit|0|||
160779814|NCT01658878|580578569|FG012|Treatment Period|Maximum Clinical Benefit|0|||
160779815|NCT01658878|580578570|FG013|Treatment Period|Maximum Clinical Benefit|0|||
160779816|NCT01658878|580578571|FG014|Treatment Period|Maximum Clinical Benefit|0|||
160779817|NCT01658878|580578572|FG015|Treatment Period|Maximum Clinical Benefit|0|||
161123330|NCT01298492|581837543|FG000|Overall Study|Insufficient Clinical Response|22|||
161123331|NCT01298492|581837543|FG000|Overall Study|Lost to Follow-up|12|||
160779818|NCT01658878|580578573|FG016|Treatment Period|Maximum Clinical Benefit|0|||
160779819|NCT01658878|580578574|FG017|Treatment Period|Maximum Clinical Benefit|0|||
160779820|NCT01658878|580578575|FG018|Treatment Period|Maximum Clinical Benefit|1|||
160779821|NCT01658878|580578576|FG019|Treatment Period|Maximum Clinical Benefit|1|||
160779822|NCT01658878|580578577|FG020|Treatment Period|Maximum Clinical Benefit|0|||
160779823|NCT01658878|580578578|FG021|Treatment Period|Maximum Clinical Benefit|0|||
160779824|NCT01658878|580578579|FG022|Treatment Period|Maximum Clinical Benefit|0|||
160779825|NCT01658878|580578580|FG023|Treatment Period|Maximum Clinical Benefit|0|||
160779826|NCT01658878|580578557|FG000|Treatment Period|Other Reasons|0|||
160779827|NCT01658878|580578558|FG001|Treatment Period|Other Reasons|0|||
160779828|NCT01658878|580578559|FG002|Treatment Period|Other Reasons|0|||
160779829|NCT01658878|580578560|FG003|Treatment Period|Other Reasons|1|||
160779830|NCT01658878|580578561|FG004|Treatment Period|Other Reasons|0|||
160779831|NCT01658878|580578562|FG005|Treatment Period|Other Reasons|0|||
160779832|NCT01658878|580578563|FG006|Treatment Period|Other Reasons|0|||
160779833|NCT01658878|580578564|FG007|Treatment Period|Other Reasons|0|||
160779834|NCT01658878|580578565|FG008|Treatment Period|Other Reasons|0|||
160779835|NCT01658878|580578566|FG009|Treatment Period|Other Reasons|0|||
160779836|NCT01658878|580578567|FG010|Treatment Period|Other Reasons|0|||
160779837|NCT01658878|580578568|FG011|Treatment Period|Other Reasons|0|||
160779838|NCT01658878|580578569|FG012|Treatment Period|Other Reasons|2|||
160779839|NCT01658878|580578570|FG013|Treatment Period|Other Reasons|0|||
160779840|NCT01658878|580578571|FG014|Treatment Period|Other Reasons|0|||
160779841|NCT01658878|580578572|FG015|Treatment Period|Other Reasons|2|||
160779842|NCT01658878|580578573|FG016|Treatment Period|Other Reasons|1|||
160779843|NCT01658878|580578574|FG017|Treatment Period|Other Reasons|1|||
160779844|NCT01658878|580578575|FG018|Treatment Period|Other Reasons|3|||
160779845|NCT01658878|580578576|FG019|Treatment Period|Other Reasons|1|||
160779846|NCT01658878|580578577|FG020|Treatment Period|Other Reasons|4|||
160779847|NCT01658878|580578578|FG021|Treatment Period|Other Reasons|0|||
160779848|NCT01658878|580578579|FG022|Treatment Period|Other Reasons|0|||
160779849|NCT01658878|580578580|FG023|Treatment Period|Other Reasons|4|||
160779850|NCT01658878|580578557|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779851|NCT01658878|580578558|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779852|NCT01658878|580578559|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779853|NCT01658878|580578560|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779854|NCT01658878|580578561|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779855|NCT01658878|580578562|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779856|NCT01658878|580578563|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779857|NCT01658878|580578564|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779858|NCT01658878|580578565|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779859|NCT01658878|580578566|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779860|NCT01658878|580578567|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779861|NCT01658878|580578568|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779862|NCT01658878|580578569|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779863|NCT01658878|580578570|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779864|NCT01658878|580578571|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
160779865|NCT01658878|580578572|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779866|NCT01658878|580578573|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779867|NCT01658878|580578574|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
160779868|NCT01658878|580578575|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779869|NCT01658878|580578576|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779870|NCT01658878|580578577|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779871|NCT01658878|580578578|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779872|NCT01658878|580578579|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779873|NCT01658878|580578580|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
160779874|NCT01658878|580578557|FG000|Treatment Period|Poor/Non-compliance|0|||
160779875|NCT01658878|580578558|FG001|Treatment Period|Poor/Non-compliance|0|||
160779876|NCT01658878|580578559|FG002|Treatment Period|Poor/Non-compliance|0|||
160779877|NCT01658878|580578560|FG003|Treatment Period|Poor/Non-compliance|0|||
160779878|NCT01658878|580578561|FG004|Treatment Period|Poor/Non-compliance|0|||
160779879|NCT01658878|580578562|FG005|Treatment Period|Poor/Non-compliance|0|||
160779880|NCT01658878|580578563|FG006|Treatment Period|Poor/Non-compliance|0|||
160779881|NCT01658878|580578564|FG007|Treatment Period|Poor/Non-compliance|0|||
160779882|NCT01658878|580578565|FG008|Treatment Period|Poor/Non-compliance|0|||
160779883|NCT01658878|580578566|FG009|Treatment Period|Poor/Non-compliance|0|||
160779884|NCT01658878|580578567|FG010|Treatment Period|Poor/Non-compliance|0|||
160779885|NCT01658878|580578568|FG011|Treatment Period|Poor/Non-compliance|0|||
160779886|NCT01658878|580578569|FG012|Treatment Period|Poor/Non-compliance|0|||
160779887|NCT01658878|580578570|FG013|Treatment Period|Poor/Non-compliance|0|||
160779888|NCT01658878|580578571|FG014|Treatment Period|Poor/Non-compliance|0|||
160779889|NCT01658878|580578572|FG015|Treatment Period|Poor/Non-compliance|1|||
160779890|NCT01658878|580578573|FG016|Treatment Period|Poor/Non-compliance|0|||
160779891|NCT01658878|580578574|FG017|Treatment Period|Poor/Non-compliance|0|||
160779892|NCT01658878|580578575|FG018|Treatment Period|Poor/Non-compliance|0|||
160779893|NCT01658878|580578576|FG019|Treatment Period|Poor/Non-compliance|0|||
160779894|NCT01658878|580578577|FG020|Treatment Period|Poor/Non-compliance|0|||
160779895|NCT01658878|580578578|FG021|Treatment Period|Poor/Non-compliance|0|||
160779896|NCT01658878|580578579|FG022|Treatment Period|Poor/Non-compliance|0|||
160779897|NCT01658878|580578580|FG023|Treatment Period|Poor/Non-compliance|0|||
160779898|NCT01658878|580578557|FG000|Treatment Period|Participant Withdrew Consent|0|||
160779899|NCT01658878|580578558|FG001|Treatment Period|Participant Withdrew Consent|0|||
160779900|NCT01658878|580578559|FG002|Treatment Period|Participant Withdrew Consent|0|||
160779901|NCT01658878|580578560|FG003|Treatment Period|Participant Withdrew Consent|0|||
160779902|NCT01658878|580578561|FG004|Treatment Period|Participant Withdrew Consent|0|||
160779903|NCT01658878|580578562|FG005|Treatment Period|Participant Withdrew Consent|0|||
160779904|NCT01658878|580578563|FG006|Treatment Period|Participant Withdrew Consent|0|||
160779905|NCT01658878|580578564|FG007|Treatment Period|Participant Withdrew Consent|0|||
160779906|NCT01658878|580578565|FG008|Treatment Period|Participant Withdrew Consent|0|||
161123332|NCT01298492|581837543|FG000|Overall Study|Withdrawal by Subject|47|||
161123333|NCT01298492|581837543|FG000|Overall Study|Other (Unspecified)|7|||
161123334|NCT01298492|581837543|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
160779907|NCT01658878|580578566|FG009|Treatment Period|Participant Withdrew Consent|0|||
160779908|NCT01658878|580578567|FG010|Treatment Period|Participant Withdrew Consent|0|||
160779909|NCT01658878|580578568|FG011|Treatment Period|Participant Withdrew Consent|0|||
160779910|NCT01658878|580578569|FG012|Treatment Period|Participant Withdrew Consent|1|||
160779911|NCT01658878|580578570|FG013|Treatment Period|Participant Withdrew Consent|0|||
160779912|NCT01658878|580578571|FG014|Treatment Period|Participant Withdrew Consent|2|||
160779913|NCT01658878|580578572|FG015|Treatment Period|Participant Withdrew Consent|0|||
160779914|NCT01658878|580578573|FG016|Treatment Period|Participant Withdrew Consent|0|||
160779915|NCT01658878|580578574|FG017|Treatment Period|Participant Withdrew Consent|2|||
160779916|NCT01658878|580578575|FG018|Treatment Period|Participant Withdrew Consent|1|||
160779917|NCT01658878|580578576|FG019|Treatment Period|Participant Withdrew Consent|2|||
160779918|NCT01658878|580578577|FG020|Treatment Period|Participant Withdrew Consent|1|||
160779919|NCT01658878|580578578|FG021|Treatment Period|Participant Withdrew Consent|0|||
160779920|NCT01658878|580578579|FG022|Treatment Period|Participant Withdrew Consent|2|||
160779921|NCT01658878|580578580|FG023|Treatment Period|Participant Withdrew Consent|2|||
160779922|NCT01658878|580578557|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779923|NCT01658878|580578558|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779924|NCT01658878|580578559|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779925|NCT01658878|580578560|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779926|NCT01658878|580578561|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779927|NCT01658878|580578562|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779928|NCT01658878|580578563|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779929|NCT01658878|580578564|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779930|NCT01658878|580578565|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779931|NCT01658878|580578566|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779932|NCT01658878|580578567|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779933|NCT01658878|580578568|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779934|NCT01658878|580578569|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779935|NCT01658878|580578570|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
160779936|NCT01658878|580578571|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
160779937|NCT01658878|580578572|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779938|NCT01658878|580578573|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779939|NCT01658878|580578574|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779940|NCT01658878|580578575|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779941|NCT01658878|580578576|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779942|NCT01658878|580578577|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779943|NCT01658878|580578578|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
160779944|NCT01658878|580578579|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
160779945|NCT01658878|580578580|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
160779946|NCT01658878|580578557|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
160779947|NCT01658878|580578558|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
160779948|NCT01658878|580578559|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
160779949|NCT01658878|580578560|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
160779950|NCT01658878|580578561|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
161123335|NCT01298492|581837543|FG000|Overall Study|Protocol Violation|2|||
161123336|NCT01298492|581837543|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
161229420|NCT00560235|582222443|FG000|Phase 1B|Discontinued|0|||
161229421|NCT00560235|582222444|FG001|Phase 1B|Discontinued|19|||
161229422|NCT00560235|582222445|FG002|Phase 1B|Discontinued|0|||
161229423|NCT00560235|582222443|FG000|Phase 2|Discontinued|0|||
160779951|NCT01658878|580578562|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
160779952|NCT01658878|580578563|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
160779953|NCT01658878|580578564|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
160779954|NCT01658878|580578565|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
160779955|NCT01658878|580578566|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
160779956|NCT01658878|580578567|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
160779957|NCT01658878|580578568|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
160779958|NCT01658878|580578569|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
160779959|NCT01658878|580578570|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
160779960|NCT01658878|580578571|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
160779961|NCT01658878|580578572|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
160779962|NCT01658878|580578573|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
160779963|NCT01658878|580578574|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
160779964|NCT01658878|580578575|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
160779965|NCT01658878|580578576|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
160779966|NCT01658878|580578577|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
160779967|NCT01658878|580578578|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
160779968|NCT01658878|580578579|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
160779969|NCT01658878|580578580|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
160779970|NCT01658878|580578557|FG000|Treatment Period|Death|0|||
160779971|NCT01658878|580578558|FG001|Treatment Period|Death|0|||
160779972|NCT01658878|580578559|FG002|Treatment Period|Death|0|||
160779973|NCT01658878|580578560|FG003|Treatment Period|Death|0|||
160779974|NCT01658878|580578561|FG004|Treatment Period|Death|0|||
160779975|NCT01658878|580578562|FG005|Treatment Period|Death|0|||
160779976|NCT01658878|580578563|FG006|Treatment Period|Death|0|||
160779977|NCT01658878|580578564|FG007|Treatment Period|Death|0|||
160779978|NCT01658878|580578565|FG008|Treatment Period|Death|0|||
160779979|NCT01658878|580578566|FG009|Treatment Period|Death|0|||
160779980|NCT01658878|580578567|FG010|Treatment Period|Death|0|||
160779981|NCT01658878|580578568|FG011|Treatment Period|Death|0|||
160779982|NCT01658878|580578569|FG012|Treatment Period|Death|1|||
160779983|NCT01658878|580578570|FG013|Treatment Period|Death|0|||
160779984|NCT01658878|580578571|FG014|Treatment Period|Death|0|||
160779985|NCT01658878|580578572|FG015|Treatment Period|Death|0|||
160779986|NCT01658878|580578573|FG016|Treatment Period|Death|1|||
160779987|NCT01658878|580578574|FG017|Treatment Period|Death|1|||
160779988|NCT01658878|580578575|FG018|Treatment Period|Death|0|||
160779989|NCT01658878|580578576|FG019|Treatment Period|Death|0|||
160779990|NCT01658878|580578577|FG020|Treatment Period|Death|0|||
160779991|NCT01658878|580578578|FG021|Treatment Period|Death|2|||
160779992|NCT01658878|580578579|FG022|Treatment Period|Death|0|||
160779993|NCT01658878|580578580|FG023|Treatment Period|Death|0|||
160779994|NCT01658878|580578557|FG000|Treatment Period|Adverse Event|0|||
160779995|NCT01658878|580578558|FG001|Treatment Period|Adverse Event|0|||
160779996|NCT01658878|580578559|FG002|Treatment Period|Adverse Event|0|||
160779997|NCT01658878|580578560|FG003|Treatment Period|Adverse Event|0|||
160779998|NCT01658878|580578561|FG004|Treatment Period|Adverse Event|0|||
160779999|NCT01658878|580578562|FG005|Treatment Period|Adverse Event|0|||
160780000|NCT01658878|580578563|FG006|Treatment Period|Adverse Event|0|||
160780001|NCT01658878|580578564|FG007|Treatment Period|Adverse Event|0|||
160780002|NCT01658878|580578565|FG008|Treatment Period|Adverse Event|0|||
160780003|NCT01658878|580578566|FG009|Treatment Period|Adverse Event|0|||
160780004|NCT01658878|580578567|FG010|Treatment Period|Adverse Event|0|||
160780005|NCT01658878|580578568|FG011|Treatment Period|Adverse Event|0|||
160780006|NCT01658878|580578569|FG012|Treatment Period|Adverse Event|0|||
160780007|NCT01658878|580578570|FG013|Treatment Period|Adverse Event|0|||
160780008|NCT01658878|580578571|FG014|Treatment Period|Adverse Event|0|||
160780009|NCT01658878|580578572|FG015|Treatment Period|Adverse Event|0|||
160780010|NCT01658878|580578573|FG016|Treatment Period|Adverse Event|10|||
160780011|NCT01658878|580578574|FG017|Treatment Period|Adverse Event|3|||
160780012|NCT01658878|580578575|FG018|Treatment Period|Adverse Event|3|||
160780013|NCT01658878|580578576|FG019|Treatment Period|Adverse Event|2|||
160780014|NCT01658878|580578577|FG020|Treatment Period|Adverse Event|3|||
160780015|NCT01658878|580578578|FG021|Treatment Period|Adverse Event|3|||
160780016|NCT01658878|580578579|FG022|Treatment Period|Adverse Event|4|||
160780017|NCT01658878|580578580|FG023|Treatment Period|Adverse Event|3|||
160780018|NCT01658878|580578557|FG000|Treatment Period|Lost to Follow-up|0|||
160780019|NCT01658878|580578558|FG001|Treatment Period|Lost to Follow-up|0|||
160780020|NCT01658878|580578559|FG002|Treatment Period|Lost to Follow-up|0|||
160780021|NCT01658878|580578560|FG003|Treatment Period|Lost to Follow-up|0|||
160780022|NCT01658878|580578561|FG004|Treatment Period|Lost to Follow-up|0|||
160780023|NCT01658878|580578562|FG005|Treatment Period|Lost to Follow-up|0|||
160780024|NCT01658878|580578563|FG006|Treatment Period|Lost to Follow-up|0|||
160780025|NCT01658878|580578564|FG007|Treatment Period|Lost to Follow-up|0|||
160780026|NCT01658878|580578565|FG008|Treatment Period|Lost to Follow-up|0|||
160780027|NCT01658878|580578566|FG009|Treatment Period|Lost to Follow-up|0|||
160780028|NCT01658878|580578567|FG010|Treatment Period|Lost to Follow-up|0|||
160780029|NCT01658878|580578568|FG011|Treatment Period|Lost to Follow-up|0|||
160780030|NCT01658878|580578569|FG012|Treatment Period|Lost to Follow-up|0|||
160780031|NCT01658878|580578570|FG013|Treatment Period|Lost to Follow-up|0|||
160780032|NCT01658878|580578571|FG014|Treatment Period|Lost to Follow-up|0|||
160780033|NCT01658878|580578572|FG015|Treatment Period|Lost to Follow-up|0|||
160780034|NCT01658878|580578573|FG016|Treatment Period|Lost to Follow-up|1|||
160780035|NCT01658878|580578574|FG017|Treatment Period|Lost to Follow-up|0|||
160780036|NCT01658878|580578575|FG018|Treatment Period|Lost to Follow-up|1|||
160780037|NCT01658878|580578576|FG019|Treatment Period|Lost to Follow-up|1|||
160780038|NCT01658878|580578577|FG020|Treatment Period|Lost to Follow-up|0|||
160780039|NCT01658878|580578578|FG021|Treatment Period|Lost to Follow-up|0|||
160780040|NCT01658878|580578579|FG022|Treatment Period|Lost to Follow-up|1|||
160780041|NCT01658878|580578580|FG023|Treatment Period|Lost to Follow-up|0|||
160780042|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780043|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
160780044|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780045|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780046|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780047|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
160780048|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
160780049|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780050|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780051|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780052|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780053|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
160780054|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
160780055|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780056|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780057|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780058|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780059|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
160780060|NCT03928704|580578583|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
160780061|NCT03928704|580578584|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
160780062|NCT03928704|580578585|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780063|NCT03928704|580578586|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780064|NCT03928704|580578587|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780065|NCT03928704|580578588|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
160780066|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780067|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780068|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
160780069|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780070|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780071|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
160780072|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780073|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780074|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
160780075|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780076|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780077|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
160780078|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
160780079|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
160780080|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
160780081|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
160780082|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
160780083|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
160780084|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780085|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780086|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
160780087|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780088|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160780089|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
160887688|NCT04104438|580982561|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
160887689|NCT04104438|580982562|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
160780090|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780091|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780092|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780093|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780094|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
160780095|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
160780096|NCT03928704|580578583|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780097|NCT03928704|580578584|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780098|NCT03928704|580578585|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780099|NCT03928704|580578586|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780100|NCT03928704|580578587|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
160780101|NCT03928704|580578588|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
160780102|NCT01631188|580578589|FG000|Overall Study|Physician Decision|75|||
160780103|NCT04575324|580578593|FG000|Overall Study|Lost to Follow-up|29|||
160780104|NCT04575324|580578594|FG001|Overall Study|Lost to Follow-up|25|||
160780105|NCT04575324|580578593|FG000|Overall Study|Death|1|||
160780106|NCT04575324|580578594|FG001|Overall Study|Death|2|||
160780107|NCT04575324|580578593|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
160780108|NCT04575324|580578594|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
160780109|NCT01105130|580578595|FG000|Overall Study|Withdrawal by Subject|4|||
160780110|NCT01105130|580578596|FG001|Overall Study|Withdrawal by Subject|6|||
160780111|NCT01105130|580578597|FG002|Overall Study|Withdrawal by Subject|2|||
160780112|NCT01105130|580578595|FG000|Overall Study|Never Started|2|||
160780113|NCT01105130|580578596|FG001|Overall Study|Never Started|2|||
160780114|NCT01105130|580578597|FG002|Overall Study|Never Started|4|||
160780115|NCT01105130|580578595|FG000|Overall Study|Toxicity|1|||
160780116|NCT01105130|580578596|FG001|Overall Study|Toxicity|3|||
160780117|NCT01105130|580578597|FG002|Overall Study|Toxicity|2|||
160780118|NCT01105130|580578595|FG000|Overall Study|Multiple Reasons|3|||
160780119|NCT01105130|580578596|FG001|Overall Study|Multiple Reasons|0|||
160780120|NCT01105130|580578597|FG002|Overall Study|Multiple Reasons|2|||
160780121|NCT00530075|580578599|FG000|Overall Study|Adverse Event|1|||
160780122|NCT00530075|580578599|FG000|Overall Study|Death|1|||
160780123|NCT00530075|580578599|FG000|Overall Study|Lack of Efficacy|3|||
160780124|NCT00530075|580578599|FG000|Overall Study|Protocol Violation|1|||
160780125|NCT00530075|580578599|FG000|Overall Study|Withdrawal by Subject|1|||
160780126|NCT03520569|580578602|FG000|Overall Study|Withdrawal by Subject|1|||
160780127|NCT00784927|580578603|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
160780128|NCT00784927|580578603|FG000|Overall Study|Protocol Violation|1|||
160780129|NCT00784927|580578603|FG000|Overall Study|Ineligible|1|||
160780130|NCT01471574|580578604|FG000|Treatment Period|Lack of Efficacy|12|||
160780131|NCT01471574|580578605|FG001|Treatment Period|Lack of Efficacy|4|||
160780132|NCT01471574|580578606|FG002|Treatment Period|Lack of Efficacy|14|||
160780133|NCT01471574|580578607|FG003|Treatment Period|Lack of Efficacy|1|||
160780134|NCT01471574|580578604|FG000|Treatment Period|Adverse Event|7|||
160780135|NCT01471574|580578605|FG001|Treatment Period|Adverse Event|3|||
160780136|NCT01471574|580578606|FG002|Treatment Period|Adverse Event|6|||
160780137|NCT01471574|580578607|FG003|Treatment Period|Adverse Event|1|||
160780138|NCT01471574|580578604|FG000|Treatment Period|Withdrawal by Subject|5|||
160780139|NCT01471574|580578605|FG001|Treatment Period|Withdrawal by Subject|1|||
160780140|NCT01471574|580578606|FG002|Treatment Period|Withdrawal by Subject|1|||
160780141|NCT01471574|580578607|FG003|Treatment Period|Withdrawal by Subject|0|||
160780142|NCT01471574|580578604|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
160780143|NCT01471574|580578605|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
160780144|NCT01471574|580578606|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
160780145|NCT01471574|580578607|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
160780146|NCT01471574|580578604|FG000|Treatment Period|Lost to Follow-up|1|||
160780147|NCT01471574|580578605|FG001|Treatment Period|Lost to Follow-up|2|||
160780148|NCT01471574|580578606|FG002|Treatment Period|Lost to Follow-up|2|||
160780149|NCT01471574|580578607|FG003|Treatment Period|Lost to Follow-up|0|||
160780150|NCT01471574|580578604|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
160780151|NCT01471574|580578605|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
160780152|NCT01471574|580578606|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
160780153|NCT01471574|580578607|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
160780154|NCT01471574|580578604|FG000|Treatment Period|Other|1|||
160780155|NCT01471574|580578605|FG001|Treatment Period|Other|0|||
160780156|NCT01471574|580578606|FG002|Treatment Period|Other|0|||
160780157|NCT01471574|580578607|FG003|Treatment Period|Other|0|||
160780158|NCT01471574|580578604|FG000|Follow-up Period|Withdrawal by Subject|3|||
160780159|NCT01471574|580578605|FG001|Follow-up Period|Withdrawal by Subject|0|||
160780160|NCT01471574|580578606|FG002|Follow-up Period|Withdrawal by Subject|3|||
160780161|NCT01471574|580578607|FG003|Follow-up Period|Withdrawal by Subject|1|||
160780162|NCT01471574|580578604|FG000|Follow-up Period|Lost to Follow-up|4|||
160780163|NCT01471574|580578605|FG001|Follow-up Period|Lost to Follow-up|1|||
160780164|NCT01471574|580578606|FG002|Follow-up Period|Lost to Follow-up|3|||
160780165|NCT01471574|580578607|FG003|Follow-up Period|Lost to Follow-up|2|||
160780166|NCT01471574|580578604|FG000|Follow-up Period|Death|0|||
160780167|NCT01471574|580578605|FG001|Follow-up Period|Death|0|||
160780168|NCT01471574|580578606|FG002|Follow-up Period|Death|1|||
160780169|NCT01471574|580578607|FG003|Follow-up Period|Death|0|||
160780170|NCT01471574|580578604|FG000|Follow-up Period|Follow-up no longer required|0|||
160780171|NCT01471574|580578605|FG001|Follow-up Period|Follow-up no longer required|1|||
160780172|NCT01471574|580578606|FG002|Follow-up Period|Follow-up no longer required|0|||
160780173|NCT01471574|580578607|FG003|Follow-up Period|Follow-up no longer required|0|||
160780174|NCT01795937|580578608|FG000|Overall Study|Withdrawal by Subject|1|||
160780175|NCT01795937|580578609|FG001|Overall Study|Withdrawal by Subject|0|||
160780176|NCT01795937|580578610|FG002|Overall Study|Withdrawal by Subject|0|||
160780177|NCT01795937|580578608|FG000|Overall Study|Physician Decision|0|||
160780178|NCT01795937|580578609|FG001|Overall Study|Physician Decision|1|||
160780179|NCT01795937|580578610|FG002|Overall Study|Physician Decision|0|||
160780180|NCT03927157|580578611|FG000|Overall Study|Adverse Event|1|||
160780181|NCT03927157|580578612|FG001|Overall Study|Adverse Event|3|||
161123337|NCT01298492|581837543|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
161123338|NCT02340663|581837544|FG000|Overall Study|Lost to Follow-up|1|||
160780182|NCT03927157|580578611|FG000|Overall Study|Protocol Violation|1|||
160780183|NCT03927157|580578612|FG001|Overall Study|Protocol Violation|2|||
160780184|NCT03927157|580578611|FG000|Overall Study|Withdrawal by Subject|8|||
160780185|NCT03927157|580578612|FG001|Overall Study|Withdrawal by Subject|21|||
160780186|NCT03927157|580578611|FG000|Overall Study|Due to COVID-19 pandemic|5|||
160780187|NCT03927157|580578612|FG001|Overall Study|Due to COVID-19 pandemic|2|||
160780188|NCT03927157|580578611|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
160780189|NCT03927157|580578612|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
160780190|NCT03927157|580578611|FG000|Overall Study|Other than above|0|||
160780191|NCT03927157|580578612|FG001|Overall Study|Other than above|1|||
160780192|NCT02265744|580578615|FG000|Overall Study|Poor/Non-compliance|1|||
160780193|NCT02265744|580578616|FG001|Overall Study|Poor/Non-compliance|1|||
160780194|NCT02265744|580578617|FG002|Overall Study|Poor/Non-compliance|0|||
160780195|NCT02265744|580578618|FG003|Overall Study|Poor/Non-compliance|0|||
160780196|NCT02265744|580578619|FG004|Overall Study|Poor/Non-compliance|2|||
160780197|NCT02265744|580578615|FG000|Overall Study|Lost to Follow-up|0|||
160780198|NCT02265744|580578616|FG001|Overall Study|Lost to Follow-up|0|||
160780199|NCT02265744|580578617|FG002|Overall Study|Lost to Follow-up|0|||
160780200|NCT02265744|580578618|FG003|Overall Study|Lost to Follow-up|1|||
160780201|NCT02265744|580578619|FG004|Overall Study|Lost to Follow-up|0|||
160780202|NCT02265744|580578615|FG000|Overall Study|Death|0|||
160887690|NCT00930982|580982565|FG000|Overall Study|Adverse Event|19|||
160887691|NCT00930982|580982566|FG001|Overall Study|Adverse Event|23|||
160887692|NCT00930982|580982565|FG000|Overall Study|Protocol Violation|1|||
160887693|NCT00930982|580982566|FG001|Overall Study|Protocol Violation|5|||
160887694|NCT00930982|580982565|FG000|Overall Study|Withdrawal by Subject|1|||
160887695|NCT00930982|580982566|FG001|Overall Study|Withdrawal by Subject|1|||
160887696|NCT00518973|580982567|FG000|Overall Study|Withdrawal by Subject|3|||
160887697|NCT00518973|580982568|FG001|Overall Study|Withdrawal by Subject|2|||
160887698|NCT00582816|580982569|FG000|Overall Study|Engraftment Failure|3|||
160887699|NCT01923168|580982570|FG000|Overall Study|Protocol Violation|1|||
160887700|NCT01923168|580982571|FG001|Overall Study|Protocol Violation|1|||
160887701|NCT01923168|580982572|FG002|Overall Study|Protocol Violation|0|||
160887702|NCT01923168|580982570|FG000|Overall Study|Subject/guardian decision|14|||
160887703|NCT01923168|580982571|FG001|Overall Study|Subject/guardian decision|14|||
160887704|NCT01923168|580982572|FG002|Overall Study|Subject/guardian decision|4|||
160887705|NCT01923168|580982570|FG000|Overall Study|Adverse Event|12|||
160887706|NCT01923168|580982571|FG001|Overall Study|Adverse Event|12|||
161123339|NCT02340663|581837545|FG001|Overall Study|Lost to Follow-up|0|||
161123340|NCT02340663|581837544|FG000|Overall Study|Protocol Violation|1|||
161123341|NCT02340663|581837545|FG001|Overall Study|Protocol Violation|0|||
161123342|NCT02340663|581837544|FG000|Overall Study|Withdrawal by Subject|3|||
161123343|NCT02340663|581837545|FG001|Overall Study|Withdrawal by Subject|1|||
161326262|NCT01972464|582579714|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
161326263|NCT01919164|582581162|FG000|Overall Study|Adverse Event|6|||
160780203|NCT02265744|580578616|FG001|Overall Study|Death|0|||
160780204|NCT02265744|580578617|FG002|Overall Study|Death|0|||
160780205|NCT02265744|580578618|FG003|Overall Study|Death|2|||
160780206|NCT02265744|580578619|FG004|Overall Study|Death|0|||
160780207|NCT02265744|580578615|FG000|Overall Study|Withdrawal by Subject|2|||
160780208|NCT02265744|580578616|FG001|Overall Study|Withdrawal by Subject|0|||
160780209|NCT02265744|580578617|FG002|Overall Study|Withdrawal by Subject|0|||
160780210|NCT02265744|580578618|FG003|Overall Study|Withdrawal by Subject|2|||
160780211|NCT02265744|580578619|FG004|Overall Study|Withdrawal by Subject|0|||
160887707|NCT01923168|580982572|FG002|Overall Study|Adverse Event|0|||
160780212|NCT02265744|580578615|FG000|Overall Study|Participant request to discontinue|2|||
160780213|NCT02265744|580578616|FG001|Overall Study|Participant request to discontinue|2|||
160887708|NCT01923168|580982570|FG000|Overall Study|Physician Decision|6|||
160887709|NCT01923168|580982571|FG001|Overall Study|Physician Decision|9|||
160887710|NCT01923168|580982572|FG002|Overall Study|Physician Decision|5|||
160887711|NCT01923168|580982570|FG000|Overall Study|Progressive disease|4|||
160887712|NCT01923168|580982571|FG001|Overall Study|Progressive disease|3|||
160887713|NCT01923168|580982572|FG002|Overall Study|Progressive disease|7|||
160887714|NCT01923168|580982570|FG000|Overall Study|Death|0|||
160887715|NCT01923168|580982571|FG001|Overall Study|Death|0|||
160887716|NCT01923168|580982572|FG002|Overall Study|Death|1|||
160887717|NCT00476047|580982573|FG000|Overall Study|Lost to Follow-up|1|||
160887718|NCT02241889|580982580|FG000|Overall Study|device issues|0|||
160887719|NCT02241889|580982581|FG001|Overall Study|device issues|0|||
160887720|NCT02241889|580982582|FG002|Overall Study|device issues|1|||
160887721|NCT02241889|580982583|FG003|Overall Study|device issues|0|||
160887722|NCT02241889|580982584|FG004|Overall Study|device issues|0|||
160887723|NCT02241889|580982585|FG005|Overall Study|device issues|0|||
160887724|NCT02241889|580982580|FG000|Overall Study|Withdrawal by Subject|0|||
160887725|NCT02241889|580982581|FG001|Overall Study|Withdrawal by Subject|0|||
160887726|NCT02241889|580982582|FG002|Overall Study|Withdrawal by Subject|0|||
160887727|NCT02241889|580982583|FG003|Overall Study|Withdrawal by Subject|0|||
160887728|NCT02241889|580982584|FG004|Overall Study|Withdrawal by Subject|0|||
160780214|NCT02265744|580578617|FG002|Overall Study|Participant request to discontinue|2|||
160780215|NCT02265744|580578618|FG003|Overall Study|Participant request to discontinue|0|||
160780216|NCT02265744|580578619|FG004|Overall Study|Participant request to discontinue|0|||
160780217|NCT02265744|580578615|FG000|Overall Study|Adverse Event|8|||
160780218|NCT02265744|580578616|FG001|Overall Study|Adverse Event|4|||
160780219|NCT02265744|580578617|FG002|Overall Study|Adverse Event|9|||
160780220|NCT02265744|580578618|FG003|Overall Study|Adverse Event|8|||
160780221|NCT02265744|580578619|FG004|Overall Study|Adverse Event|2|||
160780222|NCT02265744|580578615|FG000|Overall Study|Lack of Efficacy|2|||
160887729|NCT02241889|580982585|FG005|Overall Study|Withdrawal by Subject|1|||
160887730|NCT00773838|580982586|FG000|Overall Study|Adverse Event|29|||
160887731|NCT00773838|580982586|FG000|Overall Study|Lost to Follow-up|1|||
160887732|NCT00773838|580982586|FG000|Overall Study|Physician Decision|8|||
160887733|NCT00773838|580982586|FG000|Overall Study|Progressive Disease|82|||
160887734|NCT00773838|580982586|FG000|Overall Study|Protocol Violation|2|||
160887735|NCT00773838|580982586|FG000|Overall Study|Withdrawal by Subject|21|||
160887736|NCT00459056|580982590|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
160887737|NCT00459056|580982591|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
160887738|NCT02522871|580982592|FG000|Overall Study|Protocol Violation|1|||
160887739|NCT02522871|580982593|FG001|Overall Study|Protocol Violation|4|||
160887740|NCT02522871|580982592|FG000|Overall Study|Treated without randomization|1|||
160887741|NCT02522871|580982593|FG001|Overall Study|Treated without randomization|0|||
160887742|NCT02522871|580982592|FG000|Overall Study|Death|9|||
160887743|NCT02522871|580982593|FG001|Overall Study|Death|9|||
160887744|NCT02522871|580982592|FG000|Overall Study|Died in operating room prior to transplant|0|||
160887745|NCT02522871|580982593|FG001|Overall Study|Died in operating room prior to transplant|1|||
160887746|NCT01658813|580982594|FG000|Overall Study|Disease progression|3|||
160887747|NCT02398227|580982595|FG000|Overall Study|Lost to Follow-up|21|||
160887748|NCT02398227|580982596|FG001|Overall Study|Lost to Follow-up|12|||
160887749|NCT02398227|580982595|FG000|Overall Study|Withdrawal by Subject|5|||
160887750|NCT02398227|580982596|FG001|Overall Study|Withdrawal by Subject|6|||
160887751|NCT02398227|580982595|FG000|Overall Study|Removed from treatment and dropped out|1|||
160887752|NCT02398227|580982596|FG001|Overall Study|Removed from treatment and dropped out|0|||
160887753|NCT01715129|580982597|FG000|Overall Study|Adverse Event, fatal|1|||
160887754|NCT01715129|580982597|FG000|Overall Study|Lack of Efficacy|3|||
160887755|NCT01715129|580982597|FG000|Overall Study|Protocol Violation|1|||
160887756|NCT01715129|580982597|FG000|Overall Study|Consent Withdrawn|2|||
160887757|NCT01715129|580982597|FG000|Overall Study|Lost to Follow-up|1|||
160887758|NCT01715129|580982597|FG000|Overall Study|Other|1|||
160887759|NCT02793622|580982598|FG000|Overall Study|Lost to Follow-up|31|||
160887760|NCT02793622|580982599|FG001|Overall Study|Lost to Follow-up|19|||
160887761|NCT02793622|580982598|FG000|Overall Study|Withdrawal by Subject|21|||
160887762|NCT02793622|580982599|FG001|Overall Study|Withdrawal by Subject|17|||
160887763|NCT02793622|580982598|FG000|Overall Study|Adverse Event|0|||
160887764|NCT02793622|580982599|FG001|Overall Study|Adverse Event|1|||
160887765|NCT02793622|580982598|FG000|Overall Study|Protocol Violation|1|||
160887766|NCT02793622|580982599|FG001|Overall Study|Protocol Violation|5|||
160887767|NCT01101191|580982600|FG000|Period 1|Withdrawal by Subject|1|||
160887768|NCT01101191|580982601|FG001|Period 1|Withdrawal by Subject|0|||
160887769|NCT01101191|580982600|FG000|Period 1|Adverse Event|1|||
160780223|NCT02265744|580578616|FG001|Overall Study|Lack of Efficacy|4|||
160780224|NCT02265744|580578617|FG002|Overall Study|Lack of Efficacy|3|||
160780225|NCT02265744|580578618|FG003|Overall Study|Lack of Efficacy|4|||
160887770|NCT01101191|580982601|FG001|Period 1|Adverse Event|2|||
160887771|NCT01146860|580982602|FG000|Overall Study|Withdrawal by Subject|0|||
160887772|NCT01146860|580982603|FG001|Overall Study|Withdrawal by Subject|1|||
160887773|NCT02674854|580982608|FG000|Overall Study|Adverse Event|17|||
160887774|NCT02674854|580982609|FG001|Overall Study|Adverse Event|15|||
160780226|NCT02265744|580578619|FG004|Overall Study|Lack of Efficacy|5|||
160780227|NCT02265744|580578615|FG000|Overall Study|Reason not provided by Investigator|1|||
160780228|NCT02265744|580578616|FG001|Overall Study|Reason not provided by Investigator|0|||
160780229|NCT02265744|580578617|FG002|Overall Study|Reason not provided by Investigator|0|||
160780230|NCT02265744|580578618|FG003|Overall Study|Reason not provided by Investigator|2|||
160780231|NCT02265744|580578619|FG004|Overall Study|Reason not provided by Investigator|0|||
160780232|NCT02265744|580578615|FG000|Overall Study|Administrative reason by sponsor|3|||
160780233|NCT02265744|580578616|FG001|Overall Study|Administrative reason by sponsor|2|||
160780234|NCT02265744|580578617|FG002|Overall Study|Administrative reason by sponsor|2|||
160887775|NCT02674854|580982610|FG002|Overall Study|Adverse Event|5|||
160887776|NCT02674854|580982608|FG000|Overall Study|Withdrawal by Subject|1|||
160887777|NCT02674854|580982609|FG001|Overall Study|Withdrawal by Subject|5|||
160887778|NCT02674854|580982610|FG002|Overall Study|Withdrawal by Subject|4|||
160887779|NCT02674854|580982608|FG000|Overall Study|No-compliant subject|1|||
160887780|NCT02674854|580982609|FG001|Overall Study|No-compliant subject|0|||
160887781|NCT02674854|580982610|FG002|Overall Study|No-compliant subject|1|||
160887782|NCT02674854|580982608|FG000|Overall Study|Lost to Follow-up|1|||
160887783|NCT02674854|580982609|FG001|Overall Study|Lost to Follow-up|0|||
160887784|NCT02674854|580982610|FG002|Overall Study|Lost to Follow-up|2|||
160887785|NCT02674854|580982608|FG000|Overall Study|Lack of Efficacy|0|||
160887786|NCT02674854|580982609|FG001|Overall Study|Lack of Efficacy|3|||
160887787|NCT02674854|580982610|FG002|Overall Study|Lack of Efficacy|0|||
160887788|NCT02674854|580982608|FG000|Overall Study|Disallowed Concurrent Medication|2|||
160887789|NCT02674854|580982609|FG001|Overall Study|Disallowed Concurrent Medication|2|||
160887790|NCT02674854|580982610|FG002|Overall Study|Disallowed Concurrent Medication|0|||
160887791|NCT02674854|580982608|FG000|Overall Study|Protocol Violation|1|||
160887792|NCT02674854|580982609|FG001|Overall Study|Protocol Violation|1|||
160887793|NCT02674854|580982610|FG002|Overall Study|Protocol Violation|2|||
160887794|NCT02674854|580982608|FG000|Overall Study|Death|0|||
160887795|NCT02674854|580982609|FG001|Overall Study|Death|1|||
160887796|NCT02674854|580982610|FG002|Overall Study|Death|0|||
160887797|NCT02674854|580982608|FG000|Overall Study|Subject missed V6.2|1|||
160887798|NCT02674854|580982609|FG001|Overall Study|Subject missed V6.2|0|||
160887799|NCT02674854|580982610|FG002|Overall Study|Subject missed V6.2|0|||
160887800|NCT03149848|580982611|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
160887801|NCT03149848|580982611|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
160887802|NCT04738318|580982613|FG000|Overall Study|Protocol Violation|1|||
160887803|NCT04738318|580982614|FG001|Overall Study|Protocol Violation|0|||
160887804|NCT00586664|580982619|FG000|Overall Study|Withdrawal by Subject|3|||
160887805|NCT00586664|580982620|FG001|Overall Study|Withdrawal by Subject|7|||
160887806|NCT00586664|580982621|FG002|Overall Study|Withdrawal by Subject|1|||
160887807|NCT00586664|580982619|FG000|Overall Study|Exclusion criteria met|2|||
160887808|NCT00586664|580982620|FG001|Overall Study|Exclusion criteria met|0|||
160887809|NCT00586664|580982621|FG002|Overall Study|Exclusion criteria met|0|||
160887810|NCT01602666|580982625|FG000|Induction Chemotherapy|Death|2|||
160887811|NCT01602666|580982626|FG001|Induction Chemotherapy|Death|1|||
160887812|NCT01602666|580982625|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
160887813|NCT01602666|580982626|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
160887814|NCT01602666|580982625|FG000|Induction Chemotherapy|Physician Decision|12|||
160887815|NCT01602666|580982626|FG001|Induction Chemotherapy|Physician Decision|5|||
160887816|NCT01602666|580982625|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
160887817|NCT01602666|580982626|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
160887818|NCT01602666|580982625|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
160887819|NCT01602666|580982626|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
160887820|NCT01602666|580982625|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
160887821|NCT01602666|580982626|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
160887822|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
160887823|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
160887824|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
160887825|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
160887826|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
160887827|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
160887828|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
160780235|NCT02265744|580578618|FG003|Overall Study|Administrative reason by sponsor|3|||
161123344|NCT02902120|581837546|FG000|Overall Study|Lack of Efficacy|1|||
160887829|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
160887830|NCT01602666|580982625|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
160887831|NCT01602666|580982626|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
160887832|NCT03610555|580982627|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
160887833|NCT03610555|580982628|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
160887834|NCT03610555|580982629|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
161123345|NCT03298022|581837548|FG000|Overall Study|Lack of Efficacy|4|||
160780236|NCT02265744|580578619|FG004|Overall Study|Administrative reason by sponsor|3|||
160780237|NCT02265744|580578615|FG000|Overall Study|Subject no longer meets study criteria|0|||
160780238|NCT02265744|580578616|FG001|Overall Study|Subject no longer meets study criteria|0|||
160780239|NCT02265744|580578617|FG002|Overall Study|Subject no longer meets study criteria|0|||
160780240|NCT02265744|580578618|FG003|Overall Study|Subject no longer meets study criteria|0|||
160887835|NCT03610555|580982630|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
160887836|NCT01155219|580984016|FG000|Overall Study|Adverse Event|3|||
160887837|NCT01155219|580984017|FG001|Overall Study|Adverse Event|1|||
160887838|NCT01155219|580984016|FG000|Overall Study|non-medical reason|1|||
160887839|NCT01155219|580984017|FG001|Overall Study|non-medical reason|2|||
160887840|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Adverse Event|2|||
160887841|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Adverse Event|0|||
160887842|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
160887843|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
160887844|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
160887845|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
160780241|NCT02265744|580578619|FG004|Overall Study|Subject no longer meets study criteria|1|||
160780242|NCT02265744|580578615|FG000|Overall Study|Pregnancy|1|||
160780243|NCT02265744|580578616|FG001|Overall Study|Pregnancy|2|||
160780244|NCT02265744|580578617|FG002|Overall Study|Pregnancy|1|||
160780245|NCT02265744|580578618|FG003|Overall Study|Pregnancy|1|||
160780246|NCT02265744|580578619|FG004|Overall Study|Pregnancy|0|||
160780247|NCT00923702|580578620|FG000|Overall Study|Ongoing enrollment|0|||
160780248|NCT00923702|580578621|FG001|Overall Study|Ongoing enrollment|0|||
160780249|NCT00923702|580578622|FG002|Overall Study|Ongoing enrollment|0|||
160780250|NCT00923702|580578623|FG003|Overall Study|Ongoing enrollment|0|||
160780251|NCT00923702|580578624|FG004|Overall Study|Ongoing enrollment|354|||
160780252|NCT05950906|580578628|FG000|Overall Study|Adverse Event|0|||
160780253|NCT05950906|580578629|FG001|Overall Study|Adverse Event|0|||
160780254|NCT05950906|580578630|FG002|Overall Study|Adverse Event|0|||
160780255|NCT05950906|580578631|FG003|Overall Study|Adverse Event|0|||
160780256|NCT05950906|580578632|FG004|Overall Study|Adverse Event|0|||
160780257|NCT05950906|580578633|FG005|Overall Study|Adverse Event|0|||
160780258|NCT05950906|580578634|FG006|Overall Study|Adverse Event|0|||
160780259|NCT05950906|580578635|FG007|Overall Study|Adverse Event|0|||
160780260|NCT05950906|580578636|FG008|Overall Study|Adverse Event|0|||
160780261|NCT05950906|580578637|FG009|Overall Study|Adverse Event|0|||
160780262|NCT05950906|580578638|FG010|Overall Study|Adverse Event|0|||
160780263|NCT05950906|580578639|FG011|Overall Study|Adverse Event|0|||
160780264|NCT05950906|580578640|FG012|Overall Study|Adverse Event|1|||
160780265|NCT05950906|580578641|FG013|Overall Study|Adverse Event|0|||
160780266|NCT05950906|580578628|FG000|Overall Study|Physician Decision|0|||
160780267|NCT05950906|580578629|FG001|Overall Study|Physician Decision|0|||
160780268|NCT05950906|580578630|FG002|Overall Study|Physician Decision|0|||
160780269|NCT05950906|580578631|FG003|Overall Study|Physician Decision|0|||
160780270|NCT05950906|580578632|FG004|Overall Study|Physician Decision|0|||
160780271|NCT05950906|580578633|FG005|Overall Study|Physician Decision|0|||
160780272|NCT05950906|580578634|FG006|Overall Study|Physician Decision|0|||
160780273|NCT05950906|580578635|FG007|Overall Study|Physician Decision|0|||
160780274|NCT05950906|580578636|FG008|Overall Study|Physician Decision|0|||
160780275|NCT05950906|580578637|FG009|Overall Study|Physician Decision|0|||
160780276|NCT05950906|580578638|FG010|Overall Study|Physician Decision|0|||
160780277|NCT05950906|580578639|FG011|Overall Study|Physician Decision|0|||
160780278|NCT05950906|580578640|FG012|Overall Study|Physician Decision|1|||
160780279|NCT05950906|580578641|FG013|Overall Study|Physician Decision|0|||
160780280|NCT02448043|580578642|FG000|Overall Study|Withdrawal by Subject|2|||
160780281|NCT02448043|580578643|FG001|Overall Study|Withdrawal by Subject|2|||
160780282|NCT02448043|580578642|FG000|Overall Study|Protocol Violation|1|||
160780283|NCT02448043|580578643|FG001|Overall Study|Protocol Violation|2|||
160780284|NCT00303628|580578644|FG000|Overall Study|Disease progression|0|||
160780285|NCT00303628|580578645|FG001|Overall Study|Disease progression|1|||
160780286|NCT00303628|580578644|FG000|Overall Study|Adverse Event|26|||
160780287|NCT00303628|580578645|FG001|Overall Study|Adverse Event|36|||
160780288|NCT00303628|580578644|FG000|Overall Study|Death|0|||
160780289|NCT00303628|580578645|FG001|Overall Study|Death|1|||
160780290|NCT00303628|580578644|FG000|Overall Study|Withdrawal by Subject|11|||
160780291|NCT00303628|580578645|FG001|Overall Study|Withdrawal by Subject|20|||
160780292|NCT00303628|580578644|FG000|Overall Study|Alternative therapy|2|||
160780293|NCT00303628|580578645|FG001|Overall Study|Alternative therapy|0|||
160780294|NCT00303628|580578644|FG000|Overall Study|Other complicating disease|0|||
160780295|NCT00303628|580578645|FG001|Overall Study|Other complicating disease|1|||
160780296|NCT00303628|580578644|FG000|Overall Study|Not start protocol therapy|3|||
160780297|NCT00303628|580578645|FG001|Overall Study|Not start protocol therapy|5|||
160780298|NCT00303628|580578644|FG000|Overall Study|Other|8|||
160780299|NCT00303628|580578645|FG001|Overall Study|Other|9|||
160780300|NCT03158688|580578646|FG000|Overall Study|Withdrawal by Subject|14|||
160780301|NCT03158688|580578647|FG001|Overall Study|Withdrawal by Subject|28|||
160780302|NCT03158688|580578646|FG000|Overall Study|Decision by sponsor|13|||
161229424|NCT00560235|582222444|FG001|Phase 2|Discontinued|0|||
161229425|NCT00560235|582222445|FG002|Phase 2|Discontinued|96|||
161229426|NCT00560235|582222443|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
161229427|NCT00560235|582222444|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
161229428|NCT00560235|582222445|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
161229429|NCT04015232|582222447|FG000|Overall Study|Withdrawal by Subject|7|||
161229430|NCT04015232|582222448|FG001|Overall Study|Withdrawal by Subject|4|||
161229431|NCT04015232|582222447|FG000|Overall Study|Protocol Violation|1|||
161229432|NCT04015232|582222448|FG001|Overall Study|Protocol Violation|0|||
161229433|NCT04015232|582222447|FG000|Overall Study|Medical Grounds|3|||
161229434|NCT04015232|582222448|FG001|Overall Study|Medical Grounds|3|||
161229435|NCT00365300|582222453|FG000|Open-label Phase|Adverse Event|4|||
161229436|NCT00365300|582222454|FG001|Open-label Phase|Adverse Event|0|||
161229437|NCT00365300|582222453|FG000|Open-label Phase|Failed to Return|1|||
161229438|NCT00365300|582222454|FG001|Open-label Phase|Failed to Return|0|||
161229439|NCT00365300|582222453|FG000|Open-label Phase|Physician Decision|1|||
161229440|NCT00365300|582222454|FG001|Open-label Phase|Physician Decision|0|||
161229441|NCT00365300|582222453|FG000|Open-label Phase|Noncompliance|9|||
161229442|NCT00365300|582222454|FG001|Open-label Phase|Noncompliance|0|||
161229443|NCT00365300|582222453|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
161229444|NCT00365300|582222454|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
161229445|NCT00365300|582222453|FG000|Open-label Phase|Protocol Violation|1|||
161229446|NCT00365300|582222454|FG001|Open-label Phase|Protocol Violation|0|||
161229447|NCT00365300|582222453|FG000|Open-label Phase|Lack of Efficacy|1|||
161229448|NCT00365300|582222454|FG001|Open-label Phase|Lack of Efficacy|0|||
161229449|NCT00365300|582222453|FG000|Open-label Phase|Patient skipped open label phase|1|||
161229450|NCT00365300|582222454|FG001|Open-label Phase|Patient skipped open label phase|0|||
161229451|NCT00365300|582222453|FG000|Double-blind Phase|Failed to return|1|||
161229452|NCT00365300|582222454|FG001|Double-blind Phase|Failed to return|0|||
161229453|NCT00365300|582222453|FG000|Double-blind Phase|Noncompliance|1|||
161229454|NCT00365300|582222454|FG001|Double-blind Phase|Noncompliance|1|||
161229455|NCT00365300|582222453|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161229456|NCT00365300|582222454|FG001|Double-blind Phase|Withdrawal by Subject|1|||
160887846|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
160887847|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160887848|NCT03052764|580984018|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
160887849|NCT03052764|580984019|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
160887850|NCT01314911|580984020|FG000|Overall Study|Lost to Follow-up|3|||
160887851|NCT01314911|580984021|FG001|Overall Study|Lost to Follow-up|2|||
160887852|NCT01314911|580984020|FG000|Overall Study|Withdrawal by Subject|1|||
160887853|NCT01314911|580984021|FG001|Overall Study|Withdrawal by Subject|3|||
160887854|NCT01314911|580984020|FG000|Overall Study|Received Non-randomized Study Drug|0|||
160887855|NCT01314911|580984021|FG001|Overall Study|Received Non-randomized Study Drug|1|||
160887856|NCT01314911|580984020|FG000|Overall Study|Never Started Treatment|1|||
160887857|NCT01314911|580984021|FG001|Overall Study|Never Started Treatment|0|||
160887858|NCT03150485|580984025|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160887859|NCT03150485|580984026|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160887860|NCT03150485|580984027|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
160887861|NCT03150485|580984028|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
160887862|NCT03150485|580984029|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
160887863|NCT03150485|580984030|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
160887864|NCT01394718|580984032|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
160887865|NCT01394718|580984033|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
160887866|NCT01695005|580984034|FG000|Overall Study|Lost to Follow-up|0|||
160887867|NCT01695005|580984035|FG001|Overall Study|Lost to Follow-up|1|||
161229457|NCT00365300|582222453|FG000|Double-blind Phase|Protocol Violation|3|||
161229458|NCT00365300|582222454|FG001|Double-blind Phase|Protocol Violation|1|||
161229459|NCT00365300|582222453|FG000|Double-blind Phase|Lack of Efficacy|6|||
161326264|NCT01919164|582581163|FG001|Overall Study|Adverse Event|4|||
160887868|NCT01695005|580984036|FG002|Overall Study|Lost to Follow-up|1|||
160887869|NCT01695005|580984037|FG003|Overall Study|Lost to Follow-up|0|||
160887870|NCT01695005|580984038|FG004|Overall Study|Lost to Follow-up|0|||
160887871|NCT01695005|580984039|FG005|Overall Study|Lost to Follow-up|1|||
160887872|NCT01695005|580984040|FG006|Overall Study|Lost to Follow-up|1|||
160887873|NCT01695005|580984041|FG007|Overall Study|Lost to Follow-up|1|||
160887874|NCT01695005|580984042|FG008|Overall Study|Lost to Follow-up|3|||
160887875|NCT01695005|580984043|FG009|Overall Study|Lost to Follow-up|3|||
161326265|NCT01919164|582581164|FG002|Overall Study|Adverse Event|9|||
160887876|NCT01695005|580984044|FG010|Overall Study|Lost to Follow-up|8|||
160887877|NCT01695005|580984045|FG011|Overall Study|Lost to Follow-up|5|||
161229460|NCT00365300|582222454|FG001|Double-blind Phase|Lack of Efficacy|6|||
161229461|NCT01991470|582222455|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
161229462|NCT01991470|582222455|FG000|Enlite 1 Period|Adverse Event|1|||
161229463|NCT01991470|582222455|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
161229464|NCT01991470|582222455|FG000|Enlite 3 Period|Lost to Follow-up|1|||
161326266|NCT01919164|582581165|FG003|Overall Study|Adverse Event|3|||
160887878|NCT01695005|580984046|FG012|Overall Study|Lost to Follow-up|2|||
160780303|NCT03158688|580578647|FG001|Overall Study|Decision by sponsor|37|||
160780304|NCT03158688|580578646|FG000|Overall Study|Lost to Follow-up|4|||
160780305|NCT03158688|580578647|FG001|Overall Study|Lost to Follow-up|3|||
160780306|NCT03158688|580578646|FG000|Overall Study|Death|74|||
160780307|NCT03158688|580578647|FG001|Overall Study|Death|142|||
160780308|NCT02942407|580578648|FG000|Overall Study|Lost to Follow-up|3|||
160780309|NCT02942407|580578649|FG001|Overall Study|Lost to Follow-up|2|||
160780310|NCT02942407|580578648|FG000|Overall Study|Withdrawal by Subject|7|||
160780311|NCT02942407|580578649|FG001|Overall Study|Withdrawal by Subject|9|||
160780312|NCT02942407|580578648|FG000|Overall Study|Death|16|||
160780313|NCT02942407|580578649|FG001|Overall Study|Death|13|||
160780314|NCT05937373|580578655|FG000|Overall Study|Out of Window|2|||
160780315|NCT05937373|580578656|FG001|Overall Study|Out of Window|0|||
160887879|NCT01695005|580984047|FG013|Overall Study|Lost to Follow-up|5|||
160887880|NCT01695005|580984048|FG014|Overall Study|Lost to Follow-up|0|||
160887881|NCT01695005|580984049|FG015|Overall Study|Lost to Follow-up|4|||
160887882|NCT01695005|580984050|FG016|Overall Study|Lost to Follow-up|0|||
160887883|NCT01695005|580984051|FG017|Overall Study|Lost to Follow-up|0|||
160887884|NCT01695005|580984052|FG018|Overall Study|Lost to Follow-up|0|||
160887885|NCT01695005|580984053|FG019|Overall Study|Lost to Follow-up|1|||
160887886|NCT01695005|580984054|FG020|Overall Study|Lost to Follow-up|1|||
160887887|NCT01695005|580984055|FG021|Overall Study|Lost to Follow-up|0|||
160887888|NCT01695005|580984056|FG022|Overall Study|Lost to Follow-up|2|||
160887889|NCT01695005|580984057|FG023|Overall Study|Lost to Follow-up|4|||
160887890|NCT01695005|580984058|FG024|Overall Study|Lost to Follow-up|2|||
160887891|NCT01695005|580984059|FG025|Overall Study|Lost to Follow-up|0|||
160887892|NCT01695005|580984060|FG026|Overall Study|Lost to Follow-up|0|||
160887893|NCT01695005|580984061|FG027|Overall Study|Lost to Follow-up|0|||
160887894|NCT01695005|580984062|FG028|Overall Study|Lost to Follow-up|1|||
160887895|NCT01695005|580984034|FG000|Overall Study|Withdrawal by Subject|0|||
160887896|NCT01695005|580984035|FG001|Overall Study|Withdrawal by Subject|0|||
160887897|NCT01695005|580984036|FG002|Overall Study|Withdrawal by Subject|0|||
160887898|NCT01695005|580984037|FG003|Overall Study|Withdrawal by Subject|2|||
160887899|NCT01695005|580984038|FG004|Overall Study|Withdrawal by Subject|0|||
160887900|NCT01695005|580984039|FG005|Overall Study|Withdrawal by Subject|1|||
160887901|NCT01695005|580984040|FG006|Overall Study|Withdrawal by Subject|0|||
160887902|NCT01695005|580984041|FG007|Overall Study|Withdrawal by Subject|1|||
160887903|NCT01695005|580984042|FG008|Overall Study|Withdrawal by Subject|0|||
160887904|NCT01695005|580984043|FG009|Overall Study|Withdrawal by Subject|1|||
160887905|NCT01695005|580984044|FG010|Overall Study|Withdrawal by Subject|2|||
160887906|NCT01695005|580984045|FG011|Overall Study|Withdrawal by Subject|1|||
160887907|NCT01695005|580984046|FG012|Overall Study|Withdrawal by Subject|1|||
160887908|NCT01695005|580984047|FG013|Overall Study|Withdrawal by Subject|0|||
160887909|NCT01695005|580984048|FG014|Overall Study|Withdrawal by Subject|0|||
160887910|NCT01695005|580984049|FG015|Overall Study|Withdrawal by Subject|0|||
160887911|NCT01695005|580984050|FG016|Overall Study|Withdrawal by Subject|0|||
160887912|NCT01695005|580984051|FG017|Overall Study|Withdrawal by Subject|0|||
160887913|NCT01695005|580984052|FG018|Overall Study|Withdrawal by Subject|2|||
160887914|NCT01695005|580984053|FG019|Overall Study|Withdrawal by Subject|0|||
160887915|NCT01695005|580984054|FG020|Overall Study|Withdrawal by Subject|1|||
160887916|NCT01695005|580984055|FG021|Overall Study|Withdrawal by Subject|0|||
160887917|NCT01695005|580984056|FG022|Overall Study|Withdrawal by Subject|0|||
160887918|NCT01695005|580984057|FG023|Overall Study|Withdrawal by Subject|0|||
160887919|NCT01695005|580984058|FG024|Overall Study|Withdrawal by Subject|1|||
160887920|NCT01695005|580984059|FG025|Overall Study|Withdrawal by Subject|0|||
160887921|NCT01695005|580984060|FG026|Overall Study|Withdrawal by Subject|0|||
160887922|NCT01695005|580984061|FG027|Overall Study|Withdrawal by Subject|1|||
160887923|NCT01695005|580984062|FG028|Overall Study|Withdrawal by Subject|0|||
160887924|NCT04478123|580984063|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
161123346|NCT03298022|581837548|FG000|Overall Study|Withdrawal by Subject|7|||
161123347|NCT03298022|581837548|FG000|Overall Study|Adverse Event|1|||
161123348|NCT03298022|581837548|FG000|Overall Study|disease relapse|1|||
160780316|NCT05937373|580578655|FG000|Overall Study|Device fell off prior to date of surgery|0|||
160887925|NCT04478123|580984063|FG000|Overall Study|NE|1|||
160887926|NCT02395016|580984064|FG000|Overall Study|Adverse Event|4|||
160887927|NCT02395016|580984065|FG001|Overall Study|Adverse Event|3|||
160887928|NCT02395016|580984064|FG000|Overall Study|Withdrawal by Subject|9|||
160887929|NCT02395016|580984065|FG001|Overall Study|Withdrawal by Subject|6|||
160887930|NCT02395016|580984064|FG000|Overall Study|Protocol Violation|2|||
160887931|NCT02395016|580984065|FG001|Overall Study|Protocol Violation|3|||
160887932|NCT01547780|580984066|FG000|Baseline PET Scan|Physician Decision|1|||
160887933|NCT01547780|580984067|FG001|Baseline PET Scan|Physician Decision|0|||
160887934|NCT01547780|580984068|FG002|Baseline PET Scan|Physician Decision|1|||
160887935|NCT01547780|580984069|FG003|Baseline PET Scan|Physician Decision|0|||
161123349|NCT03694925|581837549|FG000|Overall Study|Inadequate laboratory testing|0|||
161123350|NCT03694925|581837550|FG001|Overall Study|Inadequate laboratory testing|3|||
160780317|NCT05937373|580578656|FG001|Overall Study|Device fell off prior to date of surgery|2|||
161229465|NCT01991470|582222455|FG000|Enlite 3 Period|Physician Decision|2|||
161229466|NCT01991470|582222455|FG000|Enlite 3 Period|Physician Decision|8|||
161229467|NCT01991470|582222455|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
161229468|NCT02896361|582222456|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
161229469|NCT02896361|582222457|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
161229470|NCT02896361|582222458|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
161229471|NCT02896361|582222456|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
161229472|NCT02896361|582222457|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
161229473|NCT02896361|582222458|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
161229474|NCT02143102|582222463|FG000|Overall Study|Lost to Follow-up|11|||
161229475|NCT02143102|582222464|FG001|Overall Study|Lost to Follow-up|0|||
161229476|NCT03164772|582222467|FG000|Overall Study|Death|4|||
161229477|NCT03164772|582222468|FG001|Overall Study|Death|2|||
161229478|NCT03164772|582222467|FG000|Overall Study|Adverse Event|1|||
161229479|NCT03164772|582222468|FG001|Overall Study|Adverse Event|4|||
161229480|NCT03164772|582222467|FG000|Overall Study|Progressive Disease|11|||
161229481|NCT03164772|582222468|FG001|Overall Study|Progressive Disease|21|||
160780318|NCT03860584|580578664|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
160780319|NCT03860584|580578665|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
160780320|NCT03860584|580578664|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
160780321|NCT03860584|580578665|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
160780322|NCT03860584|580578664|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
160780323|NCT03860584|580578665|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
160780324|NCT03860584|580578664|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
160780325|NCT03860584|580578665|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
160780326|NCT05800145|580578666|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
160780327|NCT05800145|580578667|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780328|NCT05800145|580578668|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780329|NCT05800145|580578669|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
160780330|NCT05800145|580578670|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780331|NCT05800145|580578671|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160780332|NCT05800145|580578666|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
160780333|NCT05800145|580578667|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780334|NCT05800145|580578668|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780335|NCT05800145|580578669|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
160780336|NCT05800145|580578670|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780337|NCT05800145|580578671|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
160780338|NCT05800145|580578666|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
160780339|NCT05800145|580578667|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
160780340|NCT05800145|580578668|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
160780341|NCT05800145|580578669|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
160780342|NCT05800145|580578670|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
160780343|NCT05800145|580578671|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
160780344|NCT02582632|580579744|FG000|Overall Study|Other|1|||
160780345|NCT00327171|580579745|FG000|Overall Study|Did not receive study medication|3|||
160780346|NCT00327171|580579746|FG001|Overall Study|Did not receive study medication|0|||
160780347|NCT00327171|580579745|FG000|Overall Study|Adverse Event|23|||
160780348|NCT00327171|580579746|FG001|Overall Study|Adverse Event|23|||
160780349|NCT00327171|580579745|FG000|Overall Study|Disease progression/lack of efficacy|68|||
160780350|NCT00327171|580579746|FG001|Overall Study|Disease progression/lack of efficacy|69|||
160780351|NCT00327171|580579745|FG000|Overall Study|Investigator/participant request|1|||
160780352|NCT00327171|580579746|FG001|Overall Study|Investigator/participant request|8|||
160780353|NCT00327171|580579745|FG000|Overall Study|Clinical progression|12|||
160780354|NCT00327171|580579746|FG001|Overall Study|Clinical progression|8|||
160780355|NCT00327171|580579745|FG000|Overall Study|Undisclosed history of ischemia|0|||
160780356|NCT00327171|580579746|FG001|Overall Study|Undisclosed history of ischemia|1|||
160780357|NCT00327171|580579745|FG000|Overall Study|Other|1|||
160780358|NCT00327171|580579746|FG001|Overall Study|Other|0|||
160780359|NCT01363440|580579747|FG000|Overall Study|Adverse Event|5|||
160780360|NCT01363440|580579748|FG001|Overall Study|Adverse Event|4|||
160780361|NCT01363440|580579749|FG002|Overall Study|Adverse Event|4|||
160780362|NCT01363440|580579747|FG000|Overall Study|Death|3|||
160780363|NCT01363440|580579748|FG001|Overall Study|Death|7|||
160780364|NCT01363440|580579749|FG002|Overall Study|Death|5|||
160780365|NCT01363440|580579747|FG000|Overall Study|Withdrawal by Subject|9|||
160780366|NCT01363440|580579748|FG001|Overall Study|Withdrawal by Subject|11|||
160780367|NCT01363440|580579749|FG002|Overall Study|Withdrawal by Subject|11|||
160780368|NCT01363440|580579747|FG000|Overall Study|Lost to Follow-up|2|||
160780369|NCT01363440|580579748|FG001|Overall Study|Lost to Follow-up|4|||
160780370|NCT01363440|580579749|FG002|Overall Study|Lost to Follow-up|5|||
161229482|NCT03164772|582222467|FG000|Overall Study|Physician Decision|2|||
161229483|NCT03164772|582222468|FG001|Overall Study|Physician Decision|0|||
160780371|NCT01363440|580579747|FG000|Overall Study|Other|4|||
160780372|NCT01363440|580579748|FG001|Overall Study|Other|5|||
160887936|NCT01547780|580984066|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
160887937|NCT01547780|580984067|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
160887938|NCT01547780|580984068|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
160887939|NCT01547780|580984069|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
160887940|NCT00814879|580984071|FG000|By Week 24|Cancer Diagnosis|1|||
160887941|NCT00814879|580984072|FG001|By Week 24|Cancer Diagnosis|0|||
160887942|NCT00814879|580984071|FG000|By Week 24|Incarceration|0|||
160887943|NCT00814879|580984072|FG001|By Week 24|Incarceration|1|||
160887944|NCT00814879|580984071|FG000|By Week 48|Lost to Follow-up|2|||
160887945|NCT00814879|580984072|FG001|By Week 48|Lost to Follow-up|2|||
160887946|NCT00814879|580984071|FG000|By Week 48|Death|0|||
160887947|NCT00814879|580984072|FG001|By Week 48|Death|1|||
160887948|NCT00588952|580984073|FG000|Overall Study|Adverse Event|0|||
160887949|NCT00588952|580984074|FG001|Overall Study|Adverse Event|2|||
160887950|NCT00588952|580984073|FG000|Overall Study|Withdrawal by Subject|3|||
160887951|NCT00588952|580984074|FG001|Overall Study|Withdrawal by Subject|5|||
160887952|NCT01461057|580984075|FG000|Overall Study|Death|10|||
160887953|NCT01461057|580984076|FG001|Overall Study|Death|9|||
160887954|NCT01461057|580984075|FG000|Overall Study|Withdrawal by Subject|2|||
160887955|NCT01461057|580984076|FG001|Overall Study|Withdrawal by Subject|3|||
160887956|NCT01461057|580984075|FG000|Overall Study|Physician Decision|0|||
160887957|NCT01461057|580984076|FG001|Overall Study|Physician Decision|2|||
160887958|NCT01461057|580984075|FG000|Overall Study|Adverse Event|0|||
160887959|NCT01461057|580984076|FG001|Overall Study|Adverse Event|1|||
160887960|NCT01461057|580984075|FG000|Overall Study|Progression of Disease|1|||
160887961|NCT01461057|580984076|FG001|Overall Study|Progression of Disease|0|||
160780373|NCT01363440|580579749|FG002|Overall Study|Other|2|||
160780374|NCT01771913|580579750|FG000|Overall Study|Withdrawal by Subject|1|||
160780375|NCT01771913|580579751|FG001|Overall Study|Withdrawal by Subject|0|||
160780376|NCT00992836|580579752|FG000|Overall Study|Lost to Follow-up|1|||
160887962|NCT01461057|580984075|FG000|Overall Study|Study Terminated by Sponsor|2|||
160887963|NCT01461057|580984076|FG001|Overall Study|Study Terminated by Sponsor|0|||
160887964|NCT01288976|580984077|FG000|Overall Study|Withdrawal by Subject|58|||
160887965|NCT01288976|580984078|FG001|Overall Study|Withdrawal by Subject|12|||
160887966|NCT01288976|580984079|FG002|Overall Study|Withdrawal by Subject|9|||
160887967|NCT01288976|580984077|FG000|Overall Study|Death|98|||
160887968|NCT01288976|580984078|FG001|Overall Study|Death|6|||
160887969|NCT01288976|580984079|FG002|Overall Study|Death|4|||
160887970|NCT01288976|580984077|FG000|Overall Study|Data unavailable|22|||
160887971|NCT01288976|580984078|FG001|Overall Study|Data unavailable|9|||
160887972|NCT01288976|580984079|FG002|Overall Study|Data unavailable|7|||
160887973|NCT03560739|580984081|FG000|Overall Study|Adverse Event|0|||
160887974|NCT03560739|580984082|FG001|Overall Study|Adverse Event|1|||
160887975|NCT03560739|580984083|FG002|Overall Study|Adverse Event|0|||
160887976|NCT03560739|580984084|FG003|Overall Study|Adverse Event|0|||
160887977|NCT02448680|580984085|FG000|Overall Study|Physician Decision|1|||
160887978|NCT02448680|580984086|FG001|Overall Study|Physician Decision|1|||
160887979|NCT02448680|580984085|FG000|Overall Study|Withdrawal by Subject|0|||
160887980|NCT02448680|580984086|FG001|Overall Study|Withdrawal by Subject|2|||
160887981|NCT01739400|580984087|FG000|Overall Study|Physician Decision|3|||
160887982|NCT01739400|580984088|FG001|Overall Study|Physician Decision|0|||
161229484|NCT03164772|582222467|FG000|Overall Study|Withdrawal by Subject|0|||
161229485|NCT03164772|582222468|FG001|Overall Study|Withdrawal by Subject|4|||
161229486|NCT01029353|582222469|FG000|Overall Study|Lost to Follow-up|4|||
160780377|NCT00992836|580579752|FG000|Overall Study|Withdrawal by Subject|2|||
160780378|NCT00992836|580579752|FG000|Overall Study|Protocol Violation|2|||
160780379|NCT00266812|580579753|FG000|Overall Study|Disease Progression|9|||
160780380|NCT00266812|580579754|FG001|Overall Study|Disease Progression|3|||
160780381|NCT00266812|580579753|FG000|Overall Study|Death|5|||
160780382|NCT00266812|580579754|FG001|Overall Study|Death|4|||
160780383|NCT00266812|580579753|FG000|Overall Study|Adverse Event|3|||
160780384|NCT00266812|580579754|FG001|Overall Study|Adverse Event|1|||
160780385|NCT00266812|580579753|FG000|Overall Study|Protocol Violation|0|||
160780386|NCT00266812|580579754|FG001|Overall Study|Protocol Violation|1|||
160780387|NCT00266812|580579753|FG000|Overall Study|Withdrawal by Subject|0|||
160780388|NCT00266812|580579754|FG001|Overall Study|Withdrawal by Subject|2|||
160780389|NCT00266812|580579753|FG000|Overall Study|Discontinued before starting study drug|4|||
160780390|NCT00266812|580579754|FG001|Overall Study|Discontinued before starting study drug|0|||
160780391|NCT03695094|580579755|FG000|Overall Study|Adverse Event|1|||
160780392|NCT03695094|580579756|FG001|Overall Study|Adverse Event|1|||
160887983|NCT01739400|580984087|FG000|Overall Study|Lost to Follow-up|2|||
160887984|NCT01739400|580984088|FG001|Overall Study|Lost to Follow-up|0|||
160780393|NCT03695094|580579755|FG000|Overall Study|Withdrawal by Subject|1|||
160780394|NCT03695094|580579756|FG001|Overall Study|Withdrawal by Subject|0|||
160780395|NCT02323334|580579757|FG000|Period 3|Lost to Follow-up|0|||
160887985|NCT01739400|580984087|FG000|Overall Study|Death|5|||
160887986|NCT01739400|580984088|FG001|Overall Study|Death|2|||
160887987|NCT01739400|580984087|FG000|Overall Study|Withdrawal by Subject|7|||
160780396|NCT02323334|580579758|FG001|Period 3|Lost to Follow-up|0|||
160780397|NCT02323334|580579759|FG002|Period 3|Lost to Follow-up|1|||
160780398|NCT02323334|580579760|FG003|Period 3|Lost to Follow-up|0|||
160780399|NCT02323334|580579761|FG004|Period 3|Lost to Follow-up|0|||
160780400|NCT02323334|580579762|FG005|Period 3|Lost to Follow-up|0|||
160780401|NCT02323334|580579763|FG006|Period 3|Lost to Follow-up|0|||
160780402|NCT02323334|580579764|FG007|Period 3|Lost to Follow-up|0|||
160780403|NCT02323334|580579765|FG008|Period 3|Lost to Follow-up|0|||
160780404|NCT02323334|580579766|FG009|Period 3|Lost to Follow-up|0|||
160780405|NCT02323334|580579767|FG010|Period 3|Lost to Follow-up|0|||
160780406|NCT02323334|580579768|FG011|Period 3|Lost to Follow-up|0|||
160780407|NCT02323334|580579769|FG012|Period 3|Lost to Follow-up|0|||
160780408|NCT02323334|580579770|FG013|Period 3|Lost to Follow-up|0|||
160780409|NCT02323334|580579771|FG014|Period 3|Lost to Follow-up|0|||
160780410|NCT02323334|580579772|FG015|Period 3|Lost to Follow-up|0|||
160780411|NCT02323334|580579773|FG016|Period 3|Lost to Follow-up|0|||
160780412|NCT02323334|580579757|FG000|Period 3|Withdrawal by Subject|1|||
160780413|NCT02323334|580579758|FG001|Period 3|Withdrawal by Subject|0|||
160780414|NCT02323334|580579759|FG002|Period 3|Withdrawal by Subject|0|||
160780415|NCT02323334|580579760|FG003|Period 3|Withdrawal by Subject|0|||
160780416|NCT02323334|580579761|FG004|Period 3|Withdrawal by Subject|0|||
160780417|NCT02323334|580579762|FG005|Period 3|Withdrawal by Subject|0|||
160780418|NCT02323334|580579763|FG006|Period 3|Withdrawal by Subject|0|||
160780419|NCT02323334|580579764|FG007|Period 3|Withdrawal by Subject|0|||
160780420|NCT02323334|580579765|FG008|Period 3|Withdrawal by Subject|0|||
160780421|NCT02323334|580579766|FG009|Period 3|Withdrawal by Subject|0|||
160887988|NCT01739400|580984088|FG001|Overall Study|Withdrawal by Subject|7|||
160780422|NCT02323334|580579767|FG010|Period 3|Withdrawal by Subject|0|||
160887989|NCT01736657|580984089|FG000|Overall Study|insufficient vascular access|1|||
160887990|NCT00642473|580984098|FG000|Overall Study|Withdrawal by Subject|0|||
160887991|NCT00642473|580984099|FG001|Overall Study|Withdrawal by Subject|5|||
160887992|NCT00642473|580984098|FG000|Overall Study|Progression or death|2|||
160887993|NCT00642473|580984099|FG001|Overall Study|Progression or death|4|||
160887994|NCT00642473|580984098|FG000|Overall Study|Other|2|||
160887995|NCT00642473|580984099|FG001|Overall Study|Other|2|||
160887996|NCT04533880|580984100|FG000|Overall Study|Lost to Follow-up|0|||
160887997|NCT04533880|580984101|FG001|Overall Study|Lost to Follow-up|1|||
160887998|NCT04533880|580984102|FG002|Overall Study|Lost to Follow-up|1|||
160887999|NCT02284178|580984104|FG000|Overall Study|Met exclusion criteria|49|||
160888000|NCT02284178|580984105|FG001|Overall Study|Met exclusion criteria|54|||
160888001|NCT04123665|580984106|FG000|Overall Study|Withdrawal by Subject|7|||
160888002|NCT04123665|580984107|FG001|Overall Study|Withdrawal by Subject|0|||
160888003|NCT04123665|580984106|FG000|Overall Study|Lost to Follow-up|1|||
160888004|NCT04123665|580984107|FG001|Overall Study|Lost to Follow-up|0|||
160888005|NCT01711879|580984110|FG000|Overall Study|Death|1|||
160888006|NCT01711879|580984111|FG001|Overall Study|Death|0|||
160888007|NCT00478881|580984117|FG000|Overall Study|Adverse Event|31|||
160888008|NCT00478881|580984118|FG001|Overall Study|Adverse Event|12|||
160888009|NCT00478881|580984117|FG000|Overall Study|Lack of Efficacy|0|||
160888010|NCT00478881|580984118|FG001|Overall Study|Lack of Efficacy|3|||
160888011|NCT00478881|580984117|FG000|Overall Study|Lost to Follow-up|0|||
160888012|NCT00478881|580984118|FG001|Overall Study|Lost to Follow-up|1|||
160888013|NCT00478881|580984117|FG000|Overall Study|Protocol Violation|2|||
160888014|NCT00478881|580984118|FG001|Overall Study|Protocol Violation|2|||
160888015|NCT00478881|580984117|FG000|Overall Study|Withdrawal by Subject|6|||
160888016|NCT00478881|580984118|FG001|Overall Study|Withdrawal by Subject|2|||
160888017|NCT00478881|580984117|FG000|Overall Study|Non-Compliance with Study Medication|0|||
160888018|NCT00478881|580984118|FG001|Overall Study|Non-Compliance with Study Medication|2|||
160888019|NCT01466179|580984119|FG000|Overall Study|Ongoing in core study|2|||
160888020|NCT01466179|580984119|FG000|Overall Study|Physician Decision|46|||
160888021|NCT01466179|580984119|FG000|Overall Study|Progressive disease|43|||
161123351|NCT03694925|581837551|FG002|Overall Study|Inadequate laboratory testing|0|||
161123352|NCT01422239|581837552|FG000|Overall Study|Lost to Follow-up|4|||
161123353|NCT01422239|581837553|FG001|Overall Study|Lost to Follow-up|3|||
160780423|NCT02323334|580579768|FG011|Period 3|Withdrawal by Subject|0|||
160888022|NCT01466179|580984119|FG000|Overall Study|Adverse Event|32|||
160888023|NCT01466179|580984119|FG000|Overall Study|Disease relapse|23|||
160888024|NCT01466179|580984119|FG000|Overall Study|Lack of Efficacy|14|||
160888025|NCT01466179|580984119|FG000|Overall Study|Death|7|||
161123354|NCT03033875|581837554|FG000|Overall Study|Withdrawal by Subject|5|||
160780424|NCT02323334|580579769|FG012|Period 3|Withdrawal by Subject|0|||
161123355|NCT03033875|581837555|FG001|Overall Study|Withdrawal by Subject|9|||
160780425|NCT02323334|580579770|FG013|Period 3|Withdrawal by Subject|0|||
160780426|NCT02323334|580579771|FG014|Period 3|Withdrawal by Subject|0|||
160780427|NCT02323334|580579772|FG015|Period 3|Withdrawal by Subject|0|||
160780428|NCT02323334|580579773|FG016|Period 3|Withdrawal by Subject|0|||
160888026|NCT01466179|580984119|FG000|Overall Study|Withdrawal by Subject|7|||
160888027|NCT01466179|580984119|FG000|Overall Study|Protocol Violation|2|||
160888028|NCT01466179|580984119|FG000|Overall Study|Other|3|||
161123356|NCT03033875|581837556|FG002|Overall Study|Withdrawal by Subject|4|||
161229487|NCT01029353|582222470|FG001|Overall Study|Lost to Follow-up|5|||
161229488|NCT01029353|582222471|FG002|Overall Study|Lost to Follow-up|5|||
161229489|NCT01029353|582222472|FG003|Overall Study|Lost to Follow-up|4|||
161229490|NCT01029353|582222469|FG000|Overall Study|Consent Withdrawn|2|||
161229491|NCT01029353|582222470|FG001|Overall Study|Consent Withdrawn|0|||
160780429|NCT01177410|580579780|FG000|Overall Study|Adverse Event|0|||
160780430|NCT01177410|580579781|FG001|Overall Study|Adverse Event|2|||
160780431|NCT01177410|580579782|FG002|Overall Study|Adverse Event|2|||
160780432|NCT01177410|580579780|FG000|Overall Study|Withdrawal by Subject|1|||
160780433|NCT01177410|580579781|FG001|Overall Study|Withdrawal by Subject|4|||
160780434|NCT01177410|580579782|FG002|Overall Study|Withdrawal by Subject|3|||
160780435|NCT01177410|580579780|FG000|Overall Study|Lost to Follow-up|0|||
160780436|NCT01177410|580579781|FG001|Overall Study|Lost to Follow-up|1|||
160780437|NCT01177410|580579782|FG002|Overall Study|Lost to Follow-up|0|||
160780438|NCT00471354|580579783|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
160780439|NCT00471354|580579783|FG000|Overall Study|Adverse Event|13|||
160780440|NCT00471354|580579783|FG000|Overall Study|Protocol Violation|12|||
160780441|NCT00471354|580579783|FG000|Overall Study|Withdrawal by Subject|1|||
160780442|NCT00471354|580579783|FG000|Overall Study|Physician Decision|4|||
160780443|NCT00471354|580579783|FG000|Overall Study|Sponsor Decision|1|||
160780444|NCT00471354|580579783|FG000|Overall Study|Lost to Follow-up|3|||
160780445|NCT00471354|580579783|FG000|Overall Study|Lack of Efficacy|5|||
160780446|NCT00471354|580579783|FG000|Overall Study|Patient/Caregiver Decision|12|||
160780447|NCT05558410|580579785|FG000|Overall Study|Adverse Event|1|||
160780448|NCT05558410|580579786|FG001|Overall Study|Adverse Event|2|||
160780449|NCT05558410|580579787|FG002|Overall Study|Adverse Event|0|||
160780450|NCT05558410|580579785|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
160780451|NCT05558410|580579786|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
160780452|NCT05558410|580579787|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
160780453|NCT05558410|580579785|FG000|Overall Study|Lost to Follow-up|10|||
160780454|NCT05558410|580579786|FG001|Overall Study|Lost to Follow-up|17|||
160780455|NCT05558410|580579787|FG002|Overall Study|Lost to Follow-up|19|||
160780456|NCT05558410|580579785|FG000|Overall Study|Death|1|||
160780457|NCT05558410|580579786|FG001|Overall Study|Death|0|||
160780458|NCT05558410|580579787|FG002|Overall Study|Death|0|||
160780459|NCT05558410|580579785|FG000|Overall Study|Other non-compliance|0|||
160780460|NCT05558410|580579786|FG001|Overall Study|Other non-compliance|1|||
160780461|NCT05558410|580579787|FG002|Overall Study|Other non-compliance|2|||
160780462|NCT05558410|580579785|FG000|Overall Study|Sponsor Decision|1|||
160780463|NCT05558410|580579786|FG001|Overall Study|Sponsor Decision|0|||
160780464|NCT05558410|580579787|FG002|Overall Study|Sponsor Decision|0|||
160780465|NCT05558410|580579785|FG000|Overall Study|Other|1|||
160780466|NCT05558410|580579786|FG001|Overall Study|Other|0|||
160780467|NCT05558410|580579787|FG002|Overall Study|Other|1|||
160780468|NCT02691663|580579792|FG000|Overall Study|Screen failure after baseline|2|||
160780469|NCT02691663|580579793|FG001|Overall Study|Screen failure after baseline|2|||
160780470|NCT02691663|580579792|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
160780471|NCT02691663|580579793|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
160780472|NCT02691663|580579792|FG000|Overall Study|Withdrawn after Follow up 2|1|||
160780473|NCT02691663|580579793|FG001|Overall Study|Withdrawn after Follow up 2|1|||
160780474|NCT02691663|580579792|FG000|Overall Study|Lost to Follow-up|3|||
160780475|NCT02691663|580579793|FG001|Overall Study|Lost to Follow-up|2|||
160780476|NCT05887908|580579796|FG000|Overall Study|Adverse Event|6|||
160780477|NCT05887908|580579797|FG001|Overall Study|Adverse Event|1|||
160780478|NCT05887908|580579798|FG002|Overall Study|Adverse Event|1|||
160780479|NCT05887908|580579796|FG000|Overall Study|Physician Decision|4|||
160780480|NCT05887908|580579797|FG001|Overall Study|Physician Decision|1|||
160780481|NCT05887908|580579798|FG002|Overall Study|Physician Decision|0|||
160780482|NCT05887908|580579796|FG000|Overall Study|Withdrawal by Subject|3|||
160780483|NCT05887908|580579797|FG001|Overall Study|Withdrawal by Subject|2|||
160780484|NCT05887908|580579798|FG002|Overall Study|Withdrawal by Subject|3|||
160780485|NCT05887908|580579796|FG000|Overall Study|Ineligibility after the start of the study|4|||
160780486|NCT05887908|580579797|FG001|Overall Study|Ineligibility after the start of the study|1|||
160780487|NCT05887908|580579798|FG002|Overall Study|Ineligibility after the start of the study|0|||
160780488|NCT05887908|580579796|FG000|Overall Study|Subject non-compliance|4|||
160780489|NCT05887908|580579797|FG001|Overall Study|Subject non-compliance|0|||
160780490|NCT05887908|580579798|FG002|Overall Study|Subject non-compliance|4|||
161229492|NCT01029353|582222471|FG002|Overall Study|Consent Withdrawn|0|||
161229493|NCT01029353|582222472|FG003|Overall Study|Consent Withdrawn|0|||
160780491|NCT05887908|580579796|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
160780492|NCT05887908|580579797|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
160780493|NCT05887908|580579798|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
160780494|NCT05887908|580579796|FG000|Overall Study|Pregnancy|0|||
160780495|NCT05887908|580579797|FG001|Overall Study|Pregnancy|1|||
160780496|NCT05887908|580579798|FG002|Overall Study|Pregnancy|0|||
161229494|NCT01029353|582222469|FG000|Overall Study|Primary Outcome Indeterminate|1|||
161326267|NCT01919164|582581166|FG004|Overall Study|Adverse Event|2|||
160888029|NCT03707184|580984120|FG000|Overall Study|Withdrawal by Subject|2|||
160888030|NCT04704154|580984121|FG000|Overall Study|Adverse Event|3|||
160888031|NCT04704154|580984122|FG001|Overall Study|Adverse Event|2|||
160888032|NCT04704154|580984123|FG002|Overall Study|Adverse Event|4|||
160888033|NCT04704154|580984124|FG003|Overall Study|Adverse Event|2|||
160888034|NCT04704154|580984125|FG004|Overall Study|Adverse Event|3|||
160888035|NCT04704154|580984126|FG005|Overall Study|Adverse Event|0|||
160888036|NCT04704154|580984121|FG000|Overall Study|Death|3|||
160888037|NCT04704154|580984122|FG001|Overall Study|Death|0|||
160888038|NCT04704154|580984123|FG002|Overall Study|Death|0|||
160888039|NCT04704154|580984124|FG003|Overall Study|Death|0|||
160888040|NCT04704154|580984125|FG004|Overall Study|Death|3|||
160888041|NCT04704154|580984126|FG005|Overall Study|Death|0|||
160888042|NCT04704154|580984121|FG000|Overall Study|Physician Decision|1|||
160888043|NCT04704154|580984122|FG001|Overall Study|Physician Decision|0|||
160888044|NCT04704154|580984123|FG002|Overall Study|Physician Decision|1|||
160888045|NCT04704154|580984124|FG003|Overall Study|Physician Decision|0|||
160888046|NCT04704154|580984125|FG004|Overall Study|Physician Decision|2|||
160888047|NCT04704154|580984126|FG005|Overall Study|Physician Decision|0|||
160888048|NCT04704154|580984121|FG000|Overall Study|Participant Decision|1|||
160888049|NCT04704154|580984122|FG001|Overall Study|Participant Decision|1|||
160888050|NCT04704154|580984123|FG002|Overall Study|Participant Decision|0|||
160888051|NCT04704154|580984124|FG003|Overall Study|Participant Decision|0|||
160888052|NCT04704154|580984125|FG004|Overall Study|Participant Decision|0|||
160888053|NCT04704154|580984126|FG005|Overall Study|Participant Decision|0|||
160888054|NCT04704154|580984121|FG000|Overall Study|Progressive Disease|19|||
160888055|NCT04704154|580984122|FG001|Overall Study|Progressive Disease|17|||
160888056|NCT04704154|580984123|FG002|Overall Study|Progressive Disease|20|||
160888057|NCT04704154|580984124|FG003|Overall Study|Progressive Disease|18|||
160888058|NCT04704154|580984125|FG004|Overall Study|Progressive Disease|36|||
160888059|NCT04704154|580984126|FG005|Overall Study|Progressive Disease|30|||
160888060|NCT04704154|580984121|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
160888061|NCT04704154|580984122|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
160888062|NCT04704154|580984123|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
160888063|NCT04704154|580984124|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
160888064|NCT04704154|580984125|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
160888065|NCT04704154|580984126|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
160888066|NCT04704154|580984121|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
160888067|NCT04704154|580984122|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888068|NCT04704154|580984123|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
160888069|NCT04704154|580984124|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888070|NCT04704154|580984125|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888071|NCT04704154|580984126|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
160888072|NCT03220438|580984127|FG000|Overall Study|Lost to Follow-up|0|||
160888073|NCT03220438|580984128|FG001|Overall Study|Lost to Follow-up|0|||
160780497|NCT05887908|580579796|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
160780498|NCT05887908|580579797|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
160780499|NCT05887908|580579798|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
160780500|NCT05887908|580579796|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
160780501|NCT05887908|580579797|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
160780502|NCT05887908|580579798|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
160780503|NCT05887908|580579796|FG000|Overall Study|Other Reason|3|||
160888074|NCT03220438|580984129|FG002|Overall Study|Lost to Follow-up|1|||
160888075|NCT03220438|580984130|FG003|Overall Study|Lost to Follow-up|0|||
160888076|NCT04062123|580984131|FG000|Overall Study|Withdrawal by Subject|0|||
160888077|NCT04062123|580984132|FG001|Overall Study|Withdrawal by Subject|1|||
160780504|NCT05887908|580579797|FG001|Overall Study|Other Reason|3|||
160780505|NCT05887908|580579798|FG002|Overall Study|Other Reason|3|||
160780506|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
160780507|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
160780508|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
160888078|NCT04062123|580984133|FG002|Overall Study|Withdrawal by Subject|0|||
160888079|NCT04190680|580984134|FG000|Overall Study|Not meeting criteria for data analysis|1|||
160888080|NCT04190680|580984135|FG001|Overall Study|Not meeting criteria for data analysis|15|||
160888081|NCT04190680|580984134|FG000|Overall Study|Administrative error|0|||
160888082|NCT04190680|580984135|FG001|Overall Study|Administrative error|18|||
160888083|NCT01850602|580984136|FG000|Overall Study|Adverse Event|7|||
160888084|NCT01850602|580984137|FG001|Overall Study|Adverse Event|10|||
160888085|NCT01850602|580984136|FG000|Overall Study|Physician Decision|2|||
160888086|NCT01850602|580984137|FG001|Overall Study|Physician Decision|1|||
160780509|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
160780510|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
160780511|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
160780512|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
160780513|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
160780514|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
160780515|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
160780516|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
160780517|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
160780518|NCT03928743|580579802|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
160780519|NCT03928743|580579803|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
160780520|NCT03928743|580579804|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
160780521|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
160780522|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
160780523|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
160780524|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
160888087|NCT01850602|580984136|FG000|Overall Study|Withdrawal by Subject|2|||
160888088|NCT01850602|580984137|FG001|Overall Study|Withdrawal by Subject|4|||
160888089|NCT01850602|580984136|FG000|Overall Study|Decrease in serum calcium|2|||
160888090|NCT01850602|580984137|FG001|Overall Study|Decrease in serum calcium|3|||
160780525|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
160780526|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
160888091|NCT01850602|580984136|FG000|Overall Study|Increase in serum ferritin|1|||
160888092|NCT01850602|580984137|FG001|Overall Study|Increase in serum ferritin|0|||
160888093|NCT01001299|580984140|FG000|Overall Study|Insufficient Therapeutic Response|20|||
160888094|NCT01001299|580984140|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
160888095|NCT01001299|580984140|FG000|Overall Study|Death|1|||
160888096|NCT01001299|580984140|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
160888097|NCT01001299|580984140|FG000|Overall Study|Withdrew Consent|1|||
160888098|NCT01565499|580984141|FG000|Overall Study|Physician Decision|1|||
160888099|NCT01565499|580984141|FG000|Overall Study|Adverse Event|5|||
160888100|NCT01565499|580984141|FG000|Overall Study|Withdrawal by Subject|2|||
160888101|NCT01892722|580984142|FG000|Overall Study|Protocol deviation|0|||
160888102|NCT01892722|580984143|FG001|Overall Study|Protocol deviation|1|||
160888103|NCT01892722|580984142|FG000|Overall Study|Administrative problems|0|||
160888104|NCT01892722|580984143|FG001|Overall Study|Administrative problems|1|||
160888105|NCT01892722|580984142|FG000|Overall Study|Patient/guardian decision|0|||
160888106|NCT01892722|580984143|FG001|Overall Study|Patient/guardian decision|2|||
160888107|NCT01892722|580984142|FG000|Overall Study|Physician Decision|1|||
160888108|NCT01892722|580984143|FG001|Overall Study|Physician Decision|2|||
160888109|NCT01892722|580984142|FG000|Overall Study|Adverse Event|3|||
160888110|NCT01892722|580984143|FG001|Overall Study|Adverse Event|2|||
160888111|NCT01892722|580984142|FG000|Overall Study|Lack of Efficacy|0|||
160888112|NCT01892722|580984143|FG001|Overall Study|Lack of Efficacy|7|||
160888113|NCT01892722|580984142|FG000|Overall Study|Withdrawal by Subject|3|||
160888114|NCT01892722|580984143|FG001|Overall Study|Withdrawal by Subject|5|||
160888115|NCT02275910|580984144|FG000|Overall Study|Subject Choice|0|||
160888116|NCT02275910|580984145|FG001|Overall Study|Subject Choice|0|||
160888117|NCT02275910|580984146|FG002|Overall Study|Subject Choice|0|||
160888118|NCT02275910|580984147|FG003|Overall Study|Subject Choice|0|||
160888119|NCT02275910|580984148|FG004|Overall Study|Subject Choice|0|||
160888120|NCT02275910|580984149|FG005|Overall Study|Subject Choice|0|||
160888121|NCT02275910|580984150|FG006|Overall Study|Subject Choice|0|||
160888122|NCT02275910|580984151|FG007|Overall Study|Subject Choice|0|||
160888123|NCT02275910|580984152|FG008|Overall Study|Subject Choice|1|||
160888124|NCT02275910|580984153|FG009|Overall Study|Subject Choice|0|||
160888125|NCT02275910|580984154|FG010|Overall Study|Subject Choice|0|||
160888126|NCT02275910|580984155|FG011|Overall Study|Subject Choice|0|||
160888127|NCT02275910|580984144|FG000|Overall Study|Radiological Disease Progression|0|||
160888128|NCT02275910|580984145|FG001|Overall Study|Radiological Disease Progression|0|||
160888129|NCT02275910|580984146|FG002|Overall Study|Radiological Disease Progression|0|||
160888130|NCT02275910|580984147|FG003|Overall Study|Radiological Disease Progression|0|||
160888131|NCT02275910|580984148|FG004|Overall Study|Radiological Disease Progression|0|||
160888132|NCT02275910|580984149|FG005|Overall Study|Radiological Disease Progression|0|||
160888133|NCT02275910|580984150|FG006|Overall Study|Radiological Disease Progression|1|||
160888134|NCT02275910|580984151|FG007|Overall Study|Radiological Disease Progression|1|||
160888135|NCT02275910|580984152|FG008|Overall Study|Radiological Disease Progression|0|||
160888136|NCT02275910|580984153|FG009|Overall Study|Radiological Disease Progression|1|||
160888137|NCT02275910|580984154|FG010|Overall Study|Radiological Disease Progression|0|||
160888138|NCT02275910|580984155|FG011|Overall Study|Radiological Disease Progression|0|||
160888139|NCT00096954|580985448|FG000|Overall Study|Adverse Event|3|||
160888140|NCT00096954|580985449|FG001|Overall Study|Adverse Event|1|||
160888141|NCT00096954|580985448|FG000|Overall Study|Withdrawal by Subject|9|||
160888142|NCT00096954|580985449|FG001|Overall Study|Withdrawal by Subject|8|||
160888143|NCT00096954|580985448|FG000|Overall Study|Physician Decision|1|||
160888144|NCT00096954|580985449|FG001|Overall Study|Physician Decision|1|||
160888145|NCT00096954|580985448|FG000|Overall Study|Sponsors Decision|1|||
160888146|NCT00096954|580985449|FG001|Overall Study|Sponsors Decision|1|||
160888147|NCT00096954|580985448|FG000|Overall Study|Pregnancy|1|||
160888148|NCT00096954|580985449|FG001|Overall Study|Pregnancy|1|||
160888149|NCT00096954|580985448|FG000|Overall Study|Initiation of immunotherapy|1|||
160888150|NCT00096954|580985449|FG001|Overall Study|Initiation of immunotherapy|0|||
160888151|NCT00096954|580985448|FG000|Overall Study|Non-compliance|0|||
160888152|NCT00096954|580985449|FG001|Overall Study|Non-compliance|3|||
160888153|NCT00096954|580985448|FG000|Overall Study|Lost to Follow-up|8|||
160888154|NCT00096954|580985449|FG001|Overall Study|Lost to Follow-up|5|||
160888155|NCT03410823|580985450|FG000|Overall Study|Death|1|||
160888156|NCT03410823|580985450|FG000|Overall Study|Withdrawal by Subject|2|||
160888157|NCT03410823|580985450|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
160888158|NCT04626310|580985452|FG000|Overall Study|4-miss from treatment|6|||
160888159|NCT04626310|580985453|FG001|Overall Study|4-miss from treatment|5|||
160888160|NCT04626310|580985454|FG002|Overall Study|4-miss from treatment|5|||
160888161|NCT04626310|580985452|FG000|Overall Study|Withdrawal by Subject|1|||
160888162|NCT04626310|580985453|FG001|Overall Study|Withdrawal by Subject|0|||
160888163|NCT04626310|580985454|FG002|Overall Study|Withdrawal by Subject|3|||
160888164|NCT03780400|580985455|FG000|Overall Study|Lost to Follow-up|5|||
160888165|NCT03780400|580985455|FG000|Overall Study|Withdrawal by Subject|2|||
160888166|NCT00740051|580985456|FG000|Overall Study|Lack of Efficacy|2|||
160888167|NCT00740051|580985457|FG001|Overall Study|Lack of Efficacy|5|||
160888168|NCT00740051|580985456|FG000|Overall Study|Adverse Event|1|||
160888169|NCT00740051|580985457|FG001|Overall Study|Adverse Event|4|||
160888170|NCT00740051|580985456|FG000|Overall Study|Protocol Violation|2|||
160888171|NCT00740051|580985457|FG001|Overall Study|Protocol Violation|6|||
160888172|NCT00740051|580985456|FG000|Overall Study|Lost to Follow-up|3|||
160888173|NCT00740051|580985457|FG001|Overall Study|Lost to Follow-up|8|||
160888174|NCT00740051|580985456|FG000|Overall Study|Withdrawal by Subject|6|||
160888175|NCT00740051|580985457|FG001|Overall Study|Withdrawal by Subject|8|||
160888176|NCT00740051|580985456|FG000|Overall Study|Other reason (not specified)|4|||
160888177|NCT00740051|580985457|FG001|Overall Study|Other reason (not specified)|1|||
160888178|NCT02011893|580985458|FG000|Enrollment to Randomization|Adverse Event|2|||
160888179|NCT02011893|580985459|FG001|Enrollment to Randomization|Adverse Event|0|||
160888180|NCT02011893|580985460|FG002|Enrollment to Randomization|Adverse Event|0|||
160888181|NCT02011893|580985458|FG000|Enrollment to Randomization|Physician Decision|10|||
160888182|NCT02011893|580985459|FG001|Enrollment to Randomization|Physician Decision|0|||
160888183|NCT02011893|580985460|FG002|Enrollment to Randomization|Physician Decision|0|||
160888184|NCT02011893|580985458|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
160888185|NCT02011893|580985459|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
160888186|NCT02011893|580985460|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
160888187|NCT02011893|580985458|FG000|Enrollment to Randomization|Screening Failure|29|||
160888188|NCT02011893|580985459|FG001|Enrollment to Randomization|Screening Failure|0|||
160888189|NCT02011893|580985460|FG002|Enrollment to Randomization|Screening Failure|0|||
160888190|NCT02011893|580985458|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
160888191|NCT02011893|580985459|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
160888192|NCT02011893|580985460|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
160888193|NCT02011893|580985458|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
160888194|NCT02011893|580985459|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
160888195|NCT02011893|580985460|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
160888196|NCT02011893|580985458|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
160888197|NCT02011893|580985459|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
160888198|NCT02011893|580985460|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
160888199|NCT02011893|580985458|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
160888200|NCT02011893|580985459|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
160888201|NCT02011893|580985460|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
160888202|NCT02011893|580985458|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
160888203|NCT02011893|580985459|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
160888204|NCT02011893|580985460|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
160888205|NCT00991952|580985461|FG000|Overall Study|Adverse Event|0|||
160888206|NCT00991952|580985462|FG001|Overall Study|Adverse Event|1|||
161326268|NCT01919164|582581162|FG000|Overall Study|Lost to Follow-up|2|||
160888207|NCT03452527|580985463|FG000|Overall Study|Withdrawal by Subject|1|||
160888208|NCT03452527|580985464|FG001|Overall Study|Withdrawal by Subject|1|||
160888209|NCT03452527|580985463|FG000|Overall Study|Study Terminated|2|||
160888210|NCT03452527|580985464|FG001|Overall Study|Study Terminated|3|||
160888211|NCT03116347|580985468|FG000|Overall Study|Withdrawal by Subject|1|||
160888212|NCT03116347|580985469|FG001|Overall Study|Withdrawal by Subject|2|||
161326269|NCT01919164|582581163|FG001|Overall Study|Lost to Follow-up|2|||
161123357|NCT03033875|581837554|FG000|Overall Study|Other|14|||
161123358|NCT03033875|581837555|FG001|Overall Study|Other|15|||
161123359|NCT03033875|581837556|FG002|Overall Study|Other|8|||
161123360|NCT03595553|581837557|FG000|Overall Study|Withdrawal by Subject|20|||
161123361|NCT03595553|581837558|FG001|Overall Study|Withdrawal by Subject|8|||
161123362|NCT03595553|581837557|FG000|Overall Study|Physician Decision|3|||
161123363|NCT03595553|581837558|FG001|Overall Study|Physician Decision|2|||
161123364|NCT03595553|581837557|FG000|Overall Study|Adverse Event|2|||
161123365|NCT03595553|581837558|FG001|Overall Study|Adverse Event|5|||
161123366|NCT03595553|581837557|FG000|Overall Study|Death|24|||
161123367|NCT03595553|581837558|FG001|Overall Study|Death|22|||
161123368|NCT03595553|581837557|FG000|Overall Study|Lost to Follow-up|6|||
161123369|NCT03595553|581837558|FG001|Overall Study|Lost to Follow-up|7|||
161123370|NCT03595553|581837557|FG000|Overall Study|Other as indicated in CSR|3|||
161123371|NCT03595553|581837558|FG001|Overall Study|Other as indicated in CSR|3|||
161123372|NCT03595553|581837557|FG000|Overall Study|Sponsor Decision|0|||
161123373|NCT03595553|581837558|FG001|Overall Study|Sponsor Decision|1|||
161123374|NCT03467958|581837559|FG000|Overall Study|Adverse Event|20|||
160780527|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
160780528|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
160780529|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
160780530|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
160780531|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
160780532|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
160780533|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
160780534|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
160780535|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
160888213|NCT01255787|580985470|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
160888214|NCT01255787|580985471|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
160888215|NCT01255787|580985472|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
160888216|NCT01255787|580985473|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
160888217|NCT01255787|580985470|FG000|Overall Study|Major Protocol Deviation|1|||
160888218|NCT01255787|580985471|FG001|Overall Study|Major Protocol Deviation|1|||
160888219|NCT01255787|580985472|FG002|Overall Study|Major Protocol Deviation|0|||
160888220|NCT01255787|580985473|FG003|Overall Study|Major Protocol Deviation|4|||
160888221|NCT01255787|580985470|FG000|Overall Study|Lost to Follow-up|1|||
160888222|NCT01255787|580985471|FG001|Overall Study|Lost to Follow-up|2|||
160888223|NCT01255787|580985472|FG002|Overall Study|Lost to Follow-up|4|||
160888224|NCT01255787|580985473|FG003|Overall Study|Lost to Follow-up|2|||
160888225|NCT01255787|580985470|FG000|Overall Study|Withdrawal of Consent|3|||
160888226|NCT01255787|580985471|FG001|Overall Study|Withdrawal of Consent|9|||
160888227|NCT01255787|580985472|FG002|Overall Study|Withdrawal of Consent|3|||
160888228|NCT01255787|580985473|FG003|Overall Study|Withdrawal of Consent|4|||
160888229|NCT01255787|580985470|FG000|Overall Study|Pregnancy|0|||
160888230|NCT01255787|580985471|FG001|Overall Study|Pregnancy|0|||
160888231|NCT01255787|580985472|FG002|Overall Study|Pregnancy|0|||
160888232|NCT01255787|580985473|FG003|Overall Study|Pregnancy|1|||
160888233|NCT01255787|580985470|FG000|Overall Study|Lack of Efficacy|2|||
160888234|NCT01255787|580985471|FG001|Overall Study|Lack of Efficacy|2|||
160888235|NCT01255787|580985472|FG002|Overall Study|Lack of Efficacy|2|||
160888236|NCT01255787|580985473|FG003|Overall Study|Lack of Efficacy|2|||
160888237|NCT01255787|580985470|FG000|Overall Study|Noncompliance with Study Drug|3|||
160888238|NCT01255787|580985471|FG001|Overall Study|Noncompliance with Study Drug|1|||
160888239|NCT01255787|580985472|FG002|Overall Study|Noncompliance with Study Drug|0|||
160888240|NCT01255787|580985473|FG003|Overall Study|Noncompliance with Study Drug|0|||
160888241|NCT04966741|580985474|FG000|Overall Study|Lost to Follow-up|1|||
160888242|NCT04966741|580985475|FG001|Overall Study|Lost to Follow-up|0|||
160888243|NCT05101317|580985478|FG000|Week1-13|Adverse Event|0|||
160888244|NCT05101317|580985479|FG001|Week1-13|Adverse Event|1|||
160888245|NCT05101317|580985480|FG002|Week1-13|Adverse Event|0|||
160888246|NCT05101317|580985481|FG003|Week1-13|Adverse Event|0|||
160888247|NCT05101317|580985478|FG000|Week1-13|Withdrawal by Subject|0|||
160888248|NCT05101317|580985479|FG001|Week1-13|Withdrawal by Subject|2|||
160888249|NCT05101317|580985480|FG002|Week1-13|Withdrawal by Subject|0|||
160888250|NCT05101317|580985481|FG003|Week1-13|Withdrawal by Subject|0|||
160888251|NCT05101317|580985478|FG000|Week1-13|Early Withdrawl|0|||
161123375|NCT03467958|581837560|FG001|Overall Study|Adverse Event|32|||
160888252|NCT05101317|580985479|FG001|Week1-13|Early Withdrawl|0|||
160888253|NCT05101317|580985480|FG002|Week1-13|Early Withdrawl|0|||
160888254|NCT05101317|580985481|FG003|Week1-13|Early Withdrawl|1|||
160888255|NCT05101317|580985478|FG000|Week 13-25|Lost to Follow-up|0|||
160888256|NCT05101317|580985479|FG001|Week 13-25|Lost to Follow-up|0|||
160888257|NCT05101317|580985480|FG002|Week 13-25|Lost to Follow-up|1|||
161123376|NCT03467958|581837561|FG002|Overall Study|Adverse Event|5|||
160780536|NCT03928743|580579802|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
160888258|NCT05101317|580985481|FG003|Week 13-25|Lost to Follow-up|0|||
161123377|NCT03467958|581837562|FG003|Overall Study|Adverse Event|3|||
161123378|NCT03467958|581837563|FG004|Overall Study|Adverse Event|3|||
160888259|NCT05101317|580985478|FG000|Week 13-25|Withdrawal by Subject|1|||
160888260|NCT05101317|580985479|FG001|Week 13-25|Withdrawal by Subject|1|||
160888261|NCT05101317|580985480|FG002|Week 13-25|Withdrawal by Subject|0|||
160888262|NCT05101317|580985481|FG003|Week 13-25|Withdrawal by Subject|0|||
160888263|NCT05101317|580985478|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
160888264|NCT05101317|580985479|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
160888265|NCT05101317|580985480|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
160888266|NCT05101317|580985481|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
160888267|NCT05764265|580985482|FG000|Overall Study|Adverse Event|1|||
160888268|NCT05764265|580985483|FG001|Overall Study|Adverse Event|0|||
160888269|NCT05764265|580985482|FG000|Overall Study|Physician Decision|1|||
160888270|NCT05764265|580985483|FG001|Overall Study|Physician Decision|8|||
160888271|NCT05764265|580985482|FG000|Overall Study|Study Terminated By Sponsor|20|||
160888272|NCT05764265|580985483|FG001|Overall Study|Study Terminated By Sponsor|0|||
160888273|NCT05764265|580985482|FG000|Overall Study|Participant Decision|1|||
160888274|NCT05764265|580985483|FG001|Overall Study|Participant Decision|0|||
160888275|NCT00509262|580985484|FG000|Overall Study|Adverse Event|16|||
160888276|NCT00509262|580985485|FG001|Overall Study|Adverse Event|18|||
160888277|NCT00509262|580985484|FG000|Overall Study|Other|2|||
160888278|NCT00509262|580985485|FG001|Overall Study|Other|2|||
160888279|NCT00509262|580985484|FG000|Overall Study|Lack of Efficacy|1|||
160888280|NCT00509262|580985485|FG001|Overall Study|Lack of Efficacy|0|||
160888281|NCT00509262|580985484|FG000|Overall Study|Lost to Follow-up|1|||
160888282|NCT00509262|580985485|FG001|Overall Study|Lost to Follow-up|6|||
160888283|NCT00509262|580985484|FG000|Overall Study|Physician Decision|1|||
160888284|NCT00509262|580985485|FG001|Overall Study|Physician Decision|3|||
160888285|NCT00509262|580985484|FG000|Overall Study|Protocol Violation|2|||
160888286|NCT00509262|580985485|FG001|Overall Study|Protocol Violation|2|||
160888287|NCT00509262|580985484|FG000|Overall Study|Withdrawal by Subject|24|||
160888288|NCT00509262|580985485|FG001|Overall Study|Withdrawal by Subject|11|||
160888289|NCT00725842|580985486|FG000|Overall Study|Lost to Follow-up|19|||
160888290|NCT00725842|580985486|FG000|Overall Study|Death|1|||
160888291|NCT00725842|580985486|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
160888292|NCT00725842|580985486|FG000|Overall Study|Consent date prior to study start date|5|||
160888293|NCT00725842|580985486|FG000|Overall Study|Inclusion criterion not met|1|||
160888294|NCT00725842|580985486|FG000|Overall Study|No Visit 1 data|1|||
160888295|NCT01853618|580985487|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
160888296|NCT01853618|580985488|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888297|NCT01853618|580985489|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888298|NCT01853618|580985490|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888299|NCT01853618|580985491|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
160888300|NCT01853618|580985487|FG000|Overall Study|Progressive disease|1|||
160888301|NCT01853618|580985488|FG001|Overall Study|Progressive disease|1|||
160888302|NCT01853618|580985489|FG002|Overall Study|Progressive disease|1|||
160888303|NCT01853618|580985490|FG003|Overall Study|Progressive disease|1|||
160888304|NCT01853618|580985491|FG004|Overall Study|Progressive disease|2|||
160888305|NCT01853618|580985487|FG000|Overall Study|Physician Decision|0|||
161229495|NCT01029353|582222470|FG001|Overall Study|Primary Outcome Indeterminate|3|||
161229496|NCT01029353|582222471|FG002|Overall Study|Primary Outcome Indeterminate|2|||
161229497|NCT01029353|582222472|FG003|Overall Study|Primary Outcome Indeterminate|0|||
161229498|NCT04538170|582222475|FG000|Overall Study|Withdrawal by Subject|104|||
161229499|NCT04538170|582222476|FG001|Overall Study|Withdrawal by Subject|210|||
160888306|NCT01853618|580985488|FG001|Overall Study|Physician Decision|1|||
160888307|NCT01853618|580985489|FG002|Overall Study|Physician Decision|1|||
160888308|NCT01853618|580985490|FG003|Overall Study|Physician Decision|0|||
160888309|NCT01853618|580985491|FG004|Overall Study|Physician Decision|0|||
160888310|NCT01853618|580985487|FG000|Overall Study|Refused further treatment|0|||
160888311|NCT01853618|580985488|FG001|Overall Study|Refused further treatment|0|||
160888312|NCT01853618|580985489|FG002|Overall Study|Refused further treatment|0|||
160888313|NCT01853618|580985490|FG003|Overall Study|Refused further treatment|0|||
160888314|NCT01853618|580985491|FG004|Overall Study|Refused further treatment|1|||
160888315|NCT02009384|580985499|FG000|Overall Study|Death|2|||
160888316|NCT01092832|580985500|FG000|Overall Study|Other|1|||
160888317|NCT01092832|580985501|FG001|Overall Study|Other|0|||
160888318|NCT01075191|580985502|FG000|Overall Study|Death|1|||
160888319|NCT01075191|580985502|FG000|Overall Study|Intensification|3|||
160888320|NCT01075191|580985502|FG000|Overall Study|Co-morbidities|1|||
160888321|NCT01075191|580985502|FG000|Overall Study|Adverse Event|4|||
160888322|NCT01075191|580985502|FG000|Overall Study|Noncompliance|3|||
160888323|NCT01075191|580985502|FG000|Overall Study|Therapy Break|3|||
160888324|NCT01075191|580985502|FG000|Overall Study|Patient's Wish|2|||
160888325|NCT01075191|580985502|FG000|Overall Study|Unknown Reasons|1|||
160888326|NCT04777331|580985503|FG000|DBT Period|Death|2|||
161229500|NCT00324168|582222481|FG000|Overall Study|Lost to Follow-up|19|||
161229501|NCT00324168|582222482|FG001|Overall Study|Lost to Follow-up|18|||
160888327|NCT04777331|580985504|FG001|DBT Period|Death|1|||
160888328|NCT04777331|580985505|FG002|DBT Period|Death|0|||
161229502|NCT00324168|582222481|FG000|Overall Study|Death|3|||
161229503|NCT00324168|582222482|FG001|Overall Study|Death|3|||
161229504|NCT00324168|582222481|FG000|Overall Study|Patient did not visit in f/u window|6|||
161229505|NCT00324168|582222482|FG001|Overall Study|Patient did not visit in f/u window|9|||
161229506|NCT01203878|582222483|FG000|Overall Study|Withdrawal by Subject|0|||
161229507|NCT01203878|582222484|FG001|Overall Study|Withdrawal by Subject|0|||
161229508|NCT01203878|582222485|FG002|Overall Study|Withdrawal by Subject|1|||
161229509|NCT01203878|582222483|FG000|Overall Study|Adverse Event|0|||
160888329|NCT04777331|580985503|FG000|DBT Period|Reason not Specified|1|||
160888330|NCT04777331|580985504|FG001|DBT Period|Reason not Specified|1|||
160888331|NCT04777331|580985505|FG002|DBT Period|Reason not Specified|0|||
160888332|NCT04777331|580985503|FG000|DBT Period|Physician Decision|4|||
160888333|NCT04777331|580985504|FG001|DBT Period|Physician Decision|0|||
160888334|NCT04777331|580985505|FG002|DBT Period|Physician Decision|0|||
160888335|NCT04777331|580985503|FG000|DBT Period|Withdrawal by Subject|12|||
160888336|NCT04777331|580985504|FG001|DBT Period|Withdrawal by Subject|11|||
160888337|NCT04777331|580985505|FG002|DBT Period|Withdrawal by Subject|0|||
160888338|NCT04777331|580985503|FG000|DBT Period|Randomized but not Treated|1|||
160888339|NCT04777331|580985504|FG001|DBT Period|Randomized but not Treated|3|||
160888340|NCT04777331|580985505|FG002|DBT Period|Randomized but not Treated|0|||
160888341|NCT04777331|580985503|FG000|OLE Period|Ongoing in OLE|0|||
160888342|NCT04777331|580985504|FG001|OLE Period|Ongoing in OLE|0|||
160888343|NCT04777331|580985505|FG002|OLE Period|Ongoing in OLE|534|||
160888344|NCT01401959|580985506|FG000|Enrolled|Withdrawal by Subject|1|||
160888345|NCT01401959|580985507|FG001|Enrolled|Withdrawal by Subject|0|||
160888346|NCT01401959|580985508|FG002|Enrolled|Withdrawal by Subject|0|||
160888347|NCT01401959|580985506|FG000|Treated|Disease Progression|2|||
160888348|NCT01401959|580985507|FG001|Treated|Disease Progression|2|||
160888349|NCT01401959|580985508|FG002|Treated|Disease Progression|1|||
160888350|NCT01401959|580985506|FG000|Treated|Adverse Event|4|||
160888351|NCT01401959|580985507|FG001|Treated|Adverse Event|3|||
160888352|NCT01401959|580985508|FG002|Treated|Adverse Event|2|||
160888353|NCT01401959|580985506|FG000|Treated|Withdrawal by Subject|1|||
160888354|NCT01401959|580985507|FG001|Treated|Withdrawal by Subject|2|||
160888355|NCT01401959|580985508|FG002|Treated|Withdrawal by Subject|2|||
160888356|NCT01401959|580985506|FG000|Treated|Protocol Violation|0|||
160888357|NCT01401959|580985507|FG001|Treated|Protocol Violation|1|||
160888358|NCT01401959|580985508|FG002|Treated|Protocol Violation|0|||
160888359|NCT00400153|580985513|FG000|Overall Study|AE due to study disease worsening|14|||
160888360|NCT00400153|580985514|FG001|Overall Study|AE due to study disease worsening|19|||
160888361|NCT00400153|580985515|FG002|Overall Study|AE due to study disease worsening|20|||
160888362|NCT00400153|580985513|FG000|Overall Study|AE due to other disease worsening|2|||
160888363|NCT00400153|580985514|FG001|Overall Study|AE due to other disease worsening|1|||
160888364|NCT00400153|580985515|FG002|Overall Study|AE due to other disease worsening|0|||
160888365|NCT00400153|580985513|FG000|Overall Study|AE due to other condition|3|||
160888366|NCT00400153|580985514|FG001|Overall Study|AE due to other condition|14|||
160888367|NCT00400153|580985515|FG002|Overall Study|AE due to other condition|15|||
160888368|NCT00400153|580985513|FG000|Overall Study|Protocol Violation|7|||
160888369|NCT00400153|580985514|FG001|Overall Study|Protocol Violation|4|||
160888370|NCT00400153|580985515|FG002|Overall Study|Protocol Violation|9|||
160888371|NCT00400153|580985513|FG000|Overall Study|Lost to Follow-up|2|||
160888372|NCT00400153|580985514|FG001|Overall Study|Lost to Follow-up|1|||
160888373|NCT00400153|580985515|FG002|Overall Study|Lost to Follow-up|4|||
160888374|NCT00400153|580985513|FG000|Overall Study|Withdrawal by Subject|12|||
160888375|NCT00400153|580985514|FG001|Overall Study|Withdrawal by Subject|11|||
160888376|NCT00400153|580985515|FG002|Overall Study|Withdrawal by Subject|10|||
160888377|NCT00400153|580985513|FG000|Overall Study|Other reasons - not mentioned above|8|||
160888378|NCT00400153|580985514|FG001|Overall Study|Other reasons - not mentioned above|5|||
160888379|NCT00400153|580985515|FG002|Overall Study|Other reasons - not mentioned above|3|||
160888380|NCT01423604|580985517|FG000|Safety Run-In|Adverse Event|3|||
160888381|NCT01423604|580985518|FG001|Safety Run-In|Adverse Event|0|||
160888382|NCT01423604|580985517|FG000|Safety Run-In|Death|1|||
160888383|NCT01423604|580985518|FG001|Safety Run-In|Death|0|||
160888384|NCT01423604|580985517|FG000|Safety Run-In|Physician Decision|1|||
160888385|NCT01423604|580985518|FG001|Safety Run-In|Physician Decision|0|||
160888386|NCT01423604|580985517|FG000|Safety Run-In|Disease progression|3|||
160888387|NCT01423604|580985518|FG001|Safety Run-In|Disease progression|0|||
160888388|NCT01423604|580985517|FG000|Safety Run-In|Patient decision|1|||
160888389|NCT01423604|580985518|FG001|Safety Run-In|Patient decision|0|||
160888390|NCT01423604|580985517|FG000|Randomized|Adverse Event|4|||
160888391|NCT01423604|580985518|FG001|Randomized|Adverse Event|10|||
161326270|NCT01919164|582581164|FG002|Overall Study|Lost to Follow-up|2|||
161326271|NCT01919164|582581165|FG003|Overall Study|Lost to Follow-up|0|||
161229510|NCT01203878|582222484|FG001|Overall Study|Adverse Event|0|||
161229511|NCT01203878|582222485|FG002|Overall Study|Adverse Event|2|||
160888392|NCT01423604|580985517|FG000|Randomized|Death|1|||
160888393|NCT01423604|580985518|FG001|Randomized|Death|0|||
160888394|NCT01423604|580985517|FG000|Randomized|Physician Decision|16|||
160888395|NCT01423604|580985518|FG001|Randomized|Physician Decision|13|||
160888396|NCT01423604|580985517|FG000|Randomized|Other - unspecified|37|||
161229512|NCT00274937|582222486|FG000|Overall Study|Physician Decision|10|||
160780537|NCT03928743|580579803|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
160780538|NCT03928743|580579804|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
160780539|NCT06132386|580579814|FG000|Overall Study|ineligble laboratory|1|||
160780540|NCT06132386|580579815|FG001|Overall Study|ineligble laboratory|0|||
160780541|NCT06132386|580579816|FG002|Overall Study|ineligble laboratory|0|||
160780542|NCT06132386|580579817|FG003|Overall Study|ineligble laboratory|0|||
160780543|NCT06132386|580579818|FG004|Overall Study|ineligble laboratory|1|||
160780544|NCT06132386|580579819|FG005|Overall Study|ineligble laboratory|0|||
160780545|NCT06132386|580579814|FG000|Overall Study|ineligible vital signs|0|||
160780546|NCT06132386|580579815|FG001|Overall Study|ineligible vital signs|1|||
160780547|NCT06132386|580579816|FG002|Overall Study|ineligible vital signs|0|||
160780548|NCT06132386|580579817|FG003|Overall Study|ineligible vital signs|0|||
160780549|NCT06132386|580579818|FG004|Overall Study|ineligible vital signs|0|||
160780550|NCT06132386|580579819|FG005|Overall Study|ineligible vital signs|0|||
160780551|NCT02762604|580579820|FG000|Overall Study|Lost to Follow-up|2|||
160780552|NCT02762604|580579821|FG001|Overall Study|Lost to Follow-up|7|||
160780553|NCT02762604|580579820|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
160780554|NCT02762604|580579821|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
160780555|NCT04530526|580579824|FG000|Overall Study|Withdrawal by Subject|6|||
160780556|NCT05179603|580579825|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
160780557|NCT05179603|580579825|FG000|Overall Study|Withdrawal by Subject|1|||
160780558|NCT05179603|580579825|FG000|Overall Study|Progressive disease|4|||
160780559|NCT05179603|580579825|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
160888397|NCT01423604|580985518|FG001|Randomized|Other - unspecified|31|||
160888398|NCT01423604|580985517|FG000|Randomized|Patient decision|5|||
160888399|NCT01423604|580985518|FG001|Randomized|Patient decision|9|||
160888400|NCT02414139|580985521|FG000|Treatment Period|Adverse Event|11|||
160888401|NCT02414139|580985522|FG001|Treatment Period|Adverse Event|6|||
160888402|NCT02414139|580985523|FG002|Treatment Period|Adverse Event|8|||
160888403|NCT02414139|580985524|FG003|Treatment Period|Adverse Event|5|||
160888404|NCT02414139|580985525|FG004|Treatment Period|Adverse Event|14|||
160888405|NCT02414139|580985526|FG005|Treatment Period|Adverse Event|3|||
160888406|NCT02414139|580985527|FG006|Treatment Period|Adverse Event|6|||
160888407|NCT02414139|580985528|FG007|Treatment Period|Adverse Event|1|||
160888408|NCT02414139|580985529|FG008|Treatment Period|Adverse Event|6|||
160888409|NCT02414139|580985530|FG009|Treatment Period|Adverse Event|8|||
160888410|NCT02414139|580985521|FG000|Treatment Period|Death|0|||
160888411|NCT02414139|580985522|FG001|Treatment Period|Death|0|||
160888412|NCT02414139|580985523|FG002|Treatment Period|Death|1|||
160888413|NCT02414139|580985524|FG003|Treatment Period|Death|1|||
160888414|NCT02414139|580985525|FG004|Treatment Period|Death|0|||
160888415|NCT02414139|580985526|FG005|Treatment Period|Death|0|||
160888416|NCT02414139|580985527|FG006|Treatment Period|Death|0|||
160888417|NCT02414139|580985528|FG007|Treatment Period|Death|0|||
160888418|NCT02414139|580985529|FG008|Treatment Period|Death|0|||
160888419|NCT02414139|580985530|FG009|Treatment Period|Death|1|||
160888420|NCT02414139|580985521|FG000|Treatment Period|Physician Decision|5|||
160888421|NCT02414139|580985522|FG001|Treatment Period|Physician Decision|4|||
161326272|NCT01919164|582581166|FG004|Overall Study|Lost to Follow-up|4|||
161326273|NCT01919164|582581162|FG000|Overall Study|Death|1|||
161326274|NCT01919164|582581163|FG001|Overall Study|Death|0|||
161326275|NCT01919164|582581164|FG002|Overall Study|Death|0|||
161326276|NCT01919164|582581165|FG003|Overall Study|Death|0|||
161326277|NCT01919164|582581166|FG004|Overall Study|Death|0|||
161326278|NCT01919164|582581162|FG000|Overall Study|Protocol Violation|6|||
161326279|NCT01919164|582581163|FG001|Overall Study|Protocol Violation|0|||
161326280|NCT01919164|582581164|FG002|Overall Study|Protocol Violation|3|||
161326281|NCT01919164|582581165|FG003|Overall Study|Protocol Violation|2|||
161326282|NCT01919164|582581166|FG004|Overall Study|Protocol Violation|2|||
161326283|NCT01919164|582581162|FG000|Overall Study|Disease progression|2|||
161326284|NCT01919164|582581163|FG001|Overall Study|Disease progression|2|||
161326285|NCT01919164|582581164|FG002|Overall Study|Disease progression|1|||
161326286|NCT01919164|582581165|FG003|Overall Study|Disease progression|2|||
160780560|NCT06061952|580579827|FG000|Overall Study|Withdrawal by Subject|1|||
160780561|NCT06061952|580579828|FG001|Overall Study|Withdrawal by Subject|2|||
160780562|NCT06061952|580579827|FG000|Overall Study|Lost to Follow-up|2|||
160780563|NCT06061952|580579828|FG001|Overall Study|Lost to Follow-up|2|||
160780564|NCT01405911|580579829|FG000|Overall Study|Pre-treatment lab AE|0|||
160888422|NCT02414139|580985523|FG002|Treatment Period|Physician Decision|6|||
160888423|NCT02414139|580985524|FG003|Treatment Period|Physician Decision|1|||
160888424|NCT02414139|580985525|FG004|Treatment Period|Physician Decision|4|||
160888425|NCT02414139|580985526|FG005|Treatment Period|Physician Decision|0|||
160888426|NCT02414139|580985527|FG006|Treatment Period|Physician Decision|2|||
160888427|NCT02414139|580985528|FG007|Treatment Period|Physician Decision|0|||
160888428|NCT02414139|580985529|FG008|Treatment Period|Physician Decision|1|||
160888429|NCT02414139|580985530|FG009|Treatment Period|Physician Decision|4|||
160888430|NCT02414139|580985521|FG000|Treatment Period|Progressive disease|48|||
160888431|NCT02414139|580985522|FG001|Treatment Period|Progressive disease|31|||
160780565|NCT01405911|580579830|FG001|Overall Study|Pre-treatment lab AE|1|||
160780566|NCT01405911|580579831|FG002|Overall Study|Pre-treatment lab AE|0|||
160780567|NCT01405911|580579829|FG000|Overall Study|Lost to Follow-up|0|||
160780568|NCT01405911|580579830|FG001|Overall Study|Lost to Follow-up|1|||
160780569|NCT01405911|580579831|FG002|Overall Study|Lost to Follow-up|0|||
160780570|NCT01405911|580579829|FG000|Overall Study|Protocol Violation|1|||
160780571|NCT01405911|580579830|FG001|Overall Study|Protocol Violation|0|||
160780572|NCT01405911|580579831|FG002|Overall Study|Protocol Violation|0|||
160780573|NCT01405911|580579829|FG000|Overall Study|Withdrawal by Subject|3|||
160780574|NCT01405911|580579830|FG001|Overall Study|Withdrawal by Subject|1|||
160780575|NCT01405911|580579831|FG002|Overall Study|Withdrawal by Subject|1|||
160780576|NCT06375655|580579832|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
160780577|NCT06375655|580579833|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
160780578|NCT01685437|580579836|FG000|Overall Study|Withdrawal by Subject|22|||
160780579|NCT01685437|580579836|FG000|Overall Study|Lost to Follow-up|3|||
160780580|NCT01685437|580579836|FG000|Overall Study|Adverse Event|1|||
160780581|NCT01685437|580579836|FG000|Overall Study|Protocol Violation|4|||
160780582|NCT01685437|580579836|FG000|Overall Study|Unable to make visits due to work|1|||
160780583|NCT00134719|580580653|FG000|Primary Vaccination Phase|Adverse Event|4|||
160888432|NCT02414139|580985523|FG002|Treatment Period|Progressive disease|37|||
160888433|NCT02414139|580985524|FG003|Treatment Period|Progressive disease|21|||
160888434|NCT02414139|580985525|FG004|Treatment Period|Progressive disease|43|||
160888435|NCT02414139|580985526|FG005|Treatment Period|Progressive disease|12|||
160888436|NCT02414139|580985527|FG006|Treatment Period|Progressive disease|16|||
160888437|NCT02414139|580985528|FG007|Treatment Period|Progressive disease|2|||
160888438|NCT02414139|580985529|FG008|Treatment Period|Progressive disease|20|||
160888439|NCT02414139|580985530|FG009|Treatment Period|Progressive disease|14|||
160888440|NCT02414139|580985521|FG000|Treatment Period|Protocol deviation|0|||
160888441|NCT02414139|580985522|FG001|Treatment Period|Protocol deviation|0|||
160888442|NCT02414139|580985523|FG002|Treatment Period|Protocol deviation|1|||
160888443|NCT02414139|580985524|FG003|Treatment Period|Protocol deviation|0|||
160780584|NCT00134719|580580654|FG001|Primary Vaccination Phase|Adverse Event|0|||
160780585|NCT00134719|580580655|FG002|Primary Vaccination Phase|Adverse Event|0|||
160780586|NCT00134719|580580653|FG000|Primary Vaccination Phase|Protocol Violation|1|||
160780587|NCT00134719|580580654|FG001|Primary Vaccination Phase|Protocol Violation|0|||
160780588|NCT00134719|580580655|FG002|Primary Vaccination Phase|Protocol Violation|0|||
160780589|NCT00134719|580580653|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
160780590|NCT00134719|580580654|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
160780591|NCT00134719|580580655|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
160780592|NCT00134719|580580653|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
160888444|NCT02414139|580985525|FG004|Treatment Period|Protocol deviation|0|||
160888445|NCT02414139|580985526|FG005|Treatment Period|Protocol deviation|0|||
160888446|NCT02414139|580985527|FG006|Treatment Period|Protocol deviation|0|||
160888447|NCT02414139|580985528|FG007|Treatment Period|Protocol deviation|0|||
160888448|NCT02414139|580985529|FG008|Treatment Period|Protocol deviation|0|||
160888449|NCT02414139|580985530|FG009|Treatment Period|Protocol deviation|0|||
160888450|NCT02414139|580985521|FG000|Treatment Period|Subject/Guardian decision|5|||
160888451|NCT02414139|580985522|FG001|Treatment Period|Subject/Guardian decision|1|||
160888452|NCT02414139|580985523|FG002|Treatment Period|Subject/Guardian decision|1|||
160888453|NCT02414139|580985524|FG003|Treatment Period|Subject/Guardian decision|2|||
160888454|NCT02414139|580985525|FG004|Treatment Period|Subject/Guardian decision|5|||
160888455|NCT02414139|580985526|FG005|Treatment Period|Subject/Guardian decision|0|||
160888456|NCT02414139|580985527|FG006|Treatment Period|Subject/Guardian decision|2|||
160888457|NCT02414139|580985528|FG007|Treatment Period|Subject/Guardian decision|0|||
160888458|NCT02414139|580985529|FG008|Treatment Period|Subject/Guardian decision|1|||
160888459|NCT02414139|580985530|FG009|Treatment Period|Subject/Guardian decision|1|||
160888460|NCT02414139|580985521|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
161326287|NCT01919164|582581166|FG004|Overall Study|Disease progression|1|||
161326288|NCT01919164|582581162|FG000|Overall Study|Withdrew consent|13|||
160888461|NCT02414139|580985522|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888462|NCT02414139|580985523|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888463|NCT02414139|580985524|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888464|NCT02414139|580985525|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
161326289|NCT01919164|582581163|FG001|Overall Study|Withdrew consent|13|||
160780593|NCT00134719|580580654|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
160780594|NCT00134719|580580655|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
160888465|NCT02414139|580985526|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888466|NCT02414139|580985527|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
160780595|NCT00134719|580580653|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
160780596|NCT00134719|580580654|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
160780597|NCT00134719|580580655|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
160780598|NCT00134719|580580653|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
160888467|NCT02414139|580985528|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
160888468|NCT02414139|580985529|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
160888469|NCT02414139|580985530|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
160888470|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
160888471|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888472|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888473|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888474|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
160888475|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888476|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888477|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888478|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888479|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
160888480|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Death|0|||
160888481|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Death|1|||
160888482|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Death|0|||
160888483|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Death|0|||
161326290|NCT01919164|582581164|FG002|Overall Study|Withdrew consent|14|||
161326291|NCT01919164|582581165|FG003|Overall Study|Withdrew consent|14|||
161326292|NCT01919164|582581166|FG004|Overall Study|Withdrew consent|9|||
161326293|NCT01919164|582581162|FG000|Overall Study|Other Un-specified|13|||
161326294|NCT01919164|582581163|FG001|Overall Study|Other Un-specified|9|||
161326295|NCT01919164|582581164|FG002|Overall Study|Other Un-specified|8|||
161326296|NCT01919164|582581165|FG003|Overall Study|Other Un-specified|7|||
161326297|NCT01919164|582581166|FG004|Overall Study|Other Un-specified|15|||
161326298|NCT01409915|582581170|FG000|Overall Study|Adverse Event|0|||
161326299|NCT01409915|582581171|FG001|Overall Study|Adverse Event|2|||
161326300|NCT01409915|582581170|FG000|Overall Study|Withdrawal by Subject|0|||
161326301|NCT01409915|582581171|FG001|Overall Study|Withdrawal by Subject|1|||
161326302|NCT01409915|582581170|FG000|Overall Study|Protocol Violation|1|||
161326303|NCT01409915|582581171|FG001|Overall Study|Protocol Violation|0|||
161326304|NCT01845597|582581173|FG000|Overall Study|Death|8|||
161326305|NCT01845597|582581173|FG000|Overall Study|Lost to Follow-up|22|||
161326306|NCT01957579|582581180|FG000|Overall Study|Withdrawal of concent|0|||
161326307|NCT01957579|582581181|FG001|Overall Study|Withdrawal of concent|1|||
161326308|NCT01957579|582581182|FG002|Overall Study|Withdrawal of concent|0|||
161326309|NCT01957579|582581183|FG003|Overall Study|Withdrawal of concent|0|||
161326310|NCT01957579|582581180|FG000|Overall Study|Death|0|||
161326311|NCT01957579|582581181|FG001|Overall Study|Death|0|||
161326312|NCT01957579|582581182|FG002|Overall Study|Death|2|||
161326313|NCT01957579|582581183|FG003|Overall Study|Death|0|||
161326314|NCT02019550|582581184|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161326315|NCT02019550|582581185|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
161326316|NCT02750332|582581186|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161326317|NCT02750332|582581187|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161326318|NCT04194489|582581188|FG000|Overall Study|Withdrawal by Subject|5|||
161326319|NCT04194489|582581188|FG000|Overall Study|Lost to Follow-up|48|||
161326320|NCT02485483|582581189|FG000|Overall Study|Depression at baseline|15|||
161326321|NCT02485483|582581190|FG001|Overall Study|Depression at baseline|0|||
161326322|NCT02485483|582581189|FG000|Overall Study|Discontinued after baseline|39|||
161326323|NCT02485483|582581190|FG001|Overall Study|Discontinued after baseline|0|||
161326324|NCT00377637|582581191|FG000|Induction Phase|Adverse Event|12|||
161326325|NCT00377637|582581192|FG001|Induction Phase|Adverse Event|21|||
161326326|NCT00377637|582581193|FG002|Induction Phase|Adverse Event|0|||
161326327|NCT00377637|582581194|FG003|Induction Phase|Adverse Event|0|||
161326328|NCT00377637|582581191|FG000|Induction Phase|Deterioration/serum creatinine|2|||
161326329|NCT00377637|582581192|FG001|Induction Phase|Deterioration/serum creatinine|0|||
161326330|NCT00377637|582581193|FG002|Induction Phase|Deterioration/serum creatinine|0|||
161326331|NCT00377637|582581194|FG003|Induction Phase|Deterioration/serum creatinine|0|||
161326332|NCT00377637|582581191|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161326333|NCT00377637|582581192|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
161326334|NCT00377637|582581193|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
160888484|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Death|1|||
160888485|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Death|0|||
160888486|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Death|0|||
160888487|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Death|0|||
160888488|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Death|0|||
161326335|NCT00377637|582581194|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
161326336|NCT00377637|582581191|FG000|Induction Phase|Lost to Follow-up|2|||
161326337|NCT00377637|582581192|FG001|Induction Phase|Lost to Follow-up|1|||
161326338|NCT00377637|582581193|FG002|Induction Phase|Lost to Follow-up|0|||
161326339|NCT00377637|582581194|FG003|Induction Phase|Lost to Follow-up|0|||
161326340|NCT00377637|582581191|FG000|Induction Phase|Death|1|||
161326341|NCT00377637|582581192|FG001|Induction Phase|Death|3|||
161326342|NCT00377637|582581193|FG002|Induction Phase|Death|0|||
161326343|NCT00377637|582581194|FG003|Induction Phase|Death|0|||
160888489|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Death|1|||
160888490|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
160888491|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888492|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888493|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888494|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888495|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888496|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888497|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160780599|NCT00134719|580580654|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
160780600|NCT00134719|580580655|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
160780601|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780602|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
160780603|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
160780604|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780605|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780606|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780607|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
160780608|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
160780609|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780610|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
160780611|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780612|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780613|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780614|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
160780615|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780616|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780617|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
160780618|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780619|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780620|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780621|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
160780622|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
160780623|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780624|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780625|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780626|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780627|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780628|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
160780629|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780630|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780631|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
160780632|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780633|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780634|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780635|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
160780636|NCT01807520|580580656|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
160780637|NCT01807520|580580657|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780638|NCT01807520|580580658|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780639|NCT01807520|580580659|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780640|NCT01807520|580580660|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780641|NCT01807520|580580661|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780642|NCT01807520|580580662|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
160780643|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
160780644|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
161326344|NCT00377637|582581191|FG000|Induction Phase|Withdrawal by Subject|5|||
161326345|NCT00377637|582581192|FG001|Induction Phase|Withdrawal by Subject|6|||
161326346|NCT00377637|582581193|FG002|Induction Phase|Withdrawal by Subject|0|||
161326347|NCT00377637|582581194|FG003|Induction Phase|Withdrawal by Subject|0|||
161326348|NCT00377637|582581191|FG000|Induction Phase|Physician Decision|3|||
160888498|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160780645|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
160780646|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161326349|NCT00377637|582581192|FG001|Induction Phase|Physician Decision|1|||
160780647|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
160780648|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
161326350|NCT00377637|582581193|FG002|Induction Phase|Physician Decision|0|||
161326351|NCT00377637|582581194|FG003|Induction Phase|Physician Decision|0|||
160780649|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
160780650|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780651|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780652|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780653|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
160780654|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780655|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780656|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
160780657|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
160780658|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780659|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780660|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780661|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780662|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780663|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
160780664|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780665|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
160780666|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780667|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780668|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780669|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780670|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
160780671|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
160780672|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780673|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780674|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
160780675|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780676|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780677|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
160780678|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
160780679|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
160780680|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780681|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780682|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
160780683|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780684|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
160780685|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
160780686|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
160780687|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780688|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
160780689|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780690|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780691|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
160780692|NCT01807520|580580656|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
160780693|NCT01807520|580580657|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
160780694|NCT01807520|580580658|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
160780695|NCT01807520|580580659|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
160780696|NCT01807520|580580660|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
160780697|NCT01807520|580580661|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
160780698|NCT01807520|580580662|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
160780699|NCT01807520|580580656|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780700|NCT01807520|580580657|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780701|NCT01807520|580580658|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780702|NCT01807520|580580659|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780703|NCT01807520|580580660|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160780704|NCT01807520|580580661|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
160780705|NCT01807520|580580662|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
160888499|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
160888500|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
160888501|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161229513|NCT00274937|582222486|FG000|Overall Study|Withdrawal by Subject|6|||
160780706|NCT01807520|580580656|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780707|NCT01807520|580580657|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780708|NCT01807520|580580658|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
161229514|NCT00274937|582222486|FG000|Overall Study|Progressive Disease|4|||
161229515|NCT01682083|582222488|FG000|Overall Study|Lost to Follow-up|11|||
161229516|NCT01682083|582222489|FG001|Overall Study|Lost to Follow-up|18|||
160780709|NCT01807520|580580659|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780710|NCT01807520|580580660|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780711|NCT01807520|580580661|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
160780712|NCT01807520|580580662|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
160780713|NCT01807520|580580656|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780714|NCT01807520|580580657|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780715|NCT01807520|580580658|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780716|NCT01807520|580580659|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780717|NCT01807520|580580660|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
160780718|NCT01807520|580580661|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
160780719|NCT01807520|580580662|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
160780720|NCT03600350|580580665|FG000|Overall Study|Death|1|||
160780721|NCT03600350|580580665|FG000|Overall Study|On Follow Up|18|||
160780722|NCT02400736|580580668|FG000|Overall Study|Lost to Follow-up|6|||
160780723|NCT02400736|580580669|FG001|Overall Study|Lost to Follow-up|6|||
160780724|NCT02400736|580580668|FG000|Overall Study|Withdrawal by Subject|2|||
160780725|NCT02400736|580580669|FG001|Overall Study|Withdrawal by Subject|1|||
160780726|NCT02400736|580580668|FG000|Overall Study|Moved from the area|3|||
160780727|NCT02400736|580580669|FG001|Overall Study|Moved from the area|1|||
160780728|NCT01002105|580580670|FG000|Overall Study|Lost to Follow-up|10|||
160780729|NCT01002105|580580671|FG001|Overall Study|Lost to Follow-up|16|||
160780730|NCT01002105|580580670|FG000|Overall Study|non compliance|5|||
160780731|NCT01002105|580580671|FG001|Overall Study|non compliance|3|||
160780732|NCT01002105|580580670|FG000|Overall Study|condition worsened|4|||
160780733|NCT01002105|580580671|FG001|Overall Study|condition worsened|2|||
160780734|NCT00552058|580580672|FG000|Overall Study|Adverse Event|8|||
160780735|NCT00552058|580580673|FG001|Overall Study|Adverse Event|7|||
160780736|NCT00552058|580580672|FG000|Overall Study|Lack of Efficacy|1|||
160780737|NCT00552058|580580673|FG001|Overall Study|Lack of Efficacy|5|||
160780738|NCT00552058|580580672|FG000|Overall Study|Lost to Follow-up|1|||
160780739|NCT00552058|580580673|FG001|Overall Study|Lost to Follow-up|0|||
160780740|NCT00552058|580580672|FG000|Overall Study|Withdrawal by Subject|4|||
160780741|NCT00552058|580580673|FG001|Overall Study|Withdrawal by Subject|4|||
160780742|NCT00552058|580580672|FG000|Overall Study|Other: Protocol Violation|0|||
160780743|NCT00552058|580580673|FG001|Overall Study|Other: Protocol Violation|1|||
160780744|NCT00552058|580580672|FG000|Overall Study|Other: Non Compliance|1|||
160780745|NCT00552058|580580673|FG001|Overall Study|Other: Non Compliance|2|||
160780746|NCT00552058|580580672|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
160780747|NCT00552058|580580673|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
160780748|NCT00552058|580580672|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
160780749|NCT00552058|580580673|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
160780750|NCT00552058|580580672|FG000|Overall Study|Other: Positive Stool Result|0|||
160780751|NCT00552058|580580673|FG001|Overall Study|Other: Positive Stool Result|1|||
160780752|NCT00552058|580580672|FG000|Overall Study|Other: Randomized in error|0|||
160780753|NCT00552058|580580673|FG001|Overall Study|Other: Randomized in error|1|||
160780754|NCT00552058|580580672|FG000|Overall Study|Other: Sponsors Decision|0|||
160780755|NCT00552058|580580673|FG001|Overall Study|Other: Sponsors Decision|1|||
160780756|NCT00552058|580580672|FG000|Overall Study|Other: Early Roll Over|1|||
160780757|NCT00552058|580580673|FG001|Overall Study|Other: Early Roll Over|0|||
160780758|NCT04621760|580580674|FG000|Overall Study|Lost to Follow-up|2|||
160780759|NCT04621760|580580675|FG001|Overall Study|Lost to Follow-up|4|||
160780760|NCT04621760|580580674|FG000|Overall Study|Withdrawal by Subject|1|||
160780761|NCT04621760|580580675|FG001|Overall Study|Withdrawal by Subject|0|||
160780762|NCT02965716|580580676|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160780763|NCT02965716|580580677|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
160780764|NCT02965716|580580676|FG000|Overall Study|Progression/Relapse|8|||
160780765|NCT02965716|580580677|FG001|Overall Study|Progression/Relapse|16|||
160780766|NCT02965716|580580676|FG000|Overall Study|Death|1|||
160780767|NCT02965716|580580677|FG001|Overall Study|Death|0|||
160780768|NCT02965716|580580676|FG000|Overall Study|Not Protocol Specified|1|||
160780769|NCT02965716|580580677|FG001|Overall Study|Not Protocol Specified|3|||
160780770|NCT05141357|580580678|FG000|Overall Study|Adverse Event|3|||
160780771|NCT05141357|580580678|FG000|Overall Study|Lack of Efficacy|2|||
160780772|NCT01336972|580580679|FG000|Overall Study|Adverse Event|1|||
160780773|NCT01336972|580580680|FG001|Overall Study|Adverse Event|1|||
160780774|NCT01336972|580580681|FG002|Overall Study|Adverse Event|0|||
161229517|NCT01682083|582222488|FG000|Overall Study|Withdrawal by Subject|31|||
160780775|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
160780776|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
160780777|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
160780778|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
160780779|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
160780780|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
160780781|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
160780782|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
160780783|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
160780784|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
160780785|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
160780786|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
160780787|NCT03446573|580580686|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
160780788|NCT03446573|580580687|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
160780789|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
160780790|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
160780791|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
160780792|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
160780793|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
160780794|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
160780795|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
160780796|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
160780797|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
160780798|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
160780799|NCT03446573|580580686|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
160780800|NCT03446573|580580687|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
160780801|NCT02639559|580580688|FG000|Overall Study|Mobilization failure|0|||
160780802|NCT02639559|580580689|FG001|Overall Study|Mobilization failure|3|||
160780803|NCT02639559|580580688|FG000|Overall Study|Issues with vascular acess|1|||
160780804|NCT02639559|580580689|FG001|Overall Study|Issues with vascular acess|0|||
160780805|NCT04740567|580580690|FG000|Overall Study|Death|31|||
160780806|NCT04740567|580580691|FG001|Overall Study|Death|43|||
160780807|NCT04740567|580580690|FG000|Overall Study|Lost to Follow-up|2|||
160780808|NCT04740567|580580691|FG001|Overall Study|Lost to Follow-up|11|||
160780809|NCT04740567|580580690|FG000|Overall Study|Patient declined to participate|13|||
160780810|NCT04740567|580580691|FG001|Overall Study|Patient declined to participate|26|||
160780811|NCT04740567|580580690|FG000|Overall Study|Patient was physically incapable|1|||
160780812|NCT04740567|580580691|FG001|Overall Study|Patient was physically incapable|3|||
160780813|NCT04740567|580580690|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
160780814|NCT04740567|580580691|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
160780815|NCT04828486|580580692|FG000|Overall Study|Adverse Event|2|||
160780816|NCT04828486|580580692|FG000|Overall Study|Death|1|||
160780817|NCT04828486|580580692|FG000|Overall Study|Disease Progression|8|||
160780818|NCT04828486|580580692|FG000|Overall Study|Other Complicating Disease|1|||
160780819|NCT04828486|580580692|FG000|Overall Study|Withdrawal by Subject|1|||
160780820|NCT03325439|580580693|FG000|Overall Study|Ineligibility|3|||
160780821|NCT06204887|580580694|FG000|Overall Study|Lost to Follow-up|3|||
160780822|NCT06204887|580580695|FG001|Overall Study|Lost to Follow-up|4|||
160780823|NCT06204887|580580696|FG002|Overall Study|Lost to Follow-up|1|||
160780824|NCT06204887|580580697|FG003|Overall Study|Lost to Follow-up|6|||
160780825|NCT02315625|580580698|FG000|First Intervention|Disease Progression|1|||
160780826|NCT02315625|580580699|FG001|First Intervention|Disease Progression|0|||
160780827|NCT02315625|580580698|FG000|Second Intervention|Physician Decision|2|||
160780828|NCT02315625|580580699|FG001|Second Intervention|Physician Decision|1|||
160780829|NCT02315625|580580698|FG000|Second Intervention|Study closure|1|||
160780830|NCT02315625|580580699|FG001|Second Intervention|Study closure|0|||
160780831|NCT02315625|580580698|FG000|Second Intervention|Disease Progression|1|||
160780832|NCT02315625|580580699|FG001|Second Intervention|Disease Progression|0|||
160780833|NCT03833167|580580700|FG000|Overall Study|Withdrawal by Subject|4|||
160780834|NCT03833167|580580701|FG001|Overall Study|Withdrawal by Subject|6|||
160780835|NCT03833167|580580700|FG000|Overall Study|Ongoing|186|||
160780836|NCT03833167|580580701|FG001|Overall Study|Ongoing|194|||
160780837|NCT03833167|580580700|FG000|Overall Study|Lost to Follow-up|1|||
160780838|NCT03833167|580580701|FG001|Overall Study|Lost to Follow-up|1|||
160780839|NCT03833167|580580700|FG000|Overall Study|Physician Decision|0|||
160780840|NCT03833167|580580701|FG001|Overall Study|Physician Decision|2|||
160780841|NCT03833167|580580700|FG000|Overall Study|Death|34|||
160780842|NCT03833167|580580701|FG001|Overall Study|Death|22|||
160780843|NCT01039675|580580703|FG000|Overall Study|Adverse Event|0|||
160780844|NCT01039675|580580704|FG001|Overall Study|Adverse Event|2|||
160780845|NCT01039675|580580703|FG000|Overall Study|Lack of Efficacy|0|||
160780846|NCT01039675|580580704|FG001|Overall Study|Lack of Efficacy|2|||
160780847|NCT01039675|580580703|FG000|Overall Study|Withdrawal by Subject|0|||
160780848|NCT01039675|580580704|FG001|Overall Study|Withdrawal by Subject|1|||
160780849|NCT01039675|580580703|FG000|Overall Study|Lost to Follow-up|0|||
160780850|NCT01039675|580580704|FG001|Overall Study|Lost to Follow-up|1|||
160780851|NCT01039675|580580703|FG000|Overall Study|Physician Decision|0|||
160780852|NCT01039675|580580704|FG001|Overall Study|Physician Decision|1|||
160780853|NCT06991803|580580707|FG000|Overall Study|Lost to Follow-up|0|||
160780854|NCT06991803|580580708|FG001|Overall Study|Lost to Follow-up|4|||
160780855|NCT06991803|580580709|FG002|Overall Study|Lost to Follow-up|0|||
160780856|NCT06991803|580580710|FG003|Overall Study|Lost to Follow-up|3|||
160780857|NCT06991803|580580711|FG004|Overall Study|Lost to Follow-up|2|||
160780858|NCT06991803|580580712|FG005|Overall Study|Lost to Follow-up|5|||
160780859|NCT03514017|580580715|FG000|Overall Study|Death|1|||
160780860|NCT03514017|580580715|FG000|Overall Study|Adverse Event|1|||
160780861|NCT06394323|580580716|FG000|Overall Study|Death|0|||
160780862|NCT06394323|580580717|FG001|Overall Study|Death|1|||
160780863|NCT06394323|580580718|FG002|Overall Study|Death|0|||
160780864|NCT06394323|580580719|FG003|Overall Study|Death|0|||
160780865|NCT06394323|580580716|FG000|Overall Study|Physician Decision|0|||
160780866|NCT06394323|580580717|FG001|Overall Study|Physician Decision|2|||
160780867|NCT06394323|580580718|FG002|Overall Study|Physician Decision|0|||
160780868|NCT06394323|580580719|FG003|Overall Study|Physician Decision|0|||
160780869|NCT06394323|580580716|FG000|Overall Study|Withdrawal by Subject|4|||
160780870|NCT06394323|580580717|FG001|Overall Study|Withdrawal by Subject|4|||
160780871|NCT06394323|580580718|FG002|Overall Study|Withdrawal by Subject|0|||
160780872|NCT06394323|580580719|FG003|Overall Study|Withdrawal by Subject|0|||
160780873|NCT00567580|580581530|FG000|Overall Study|Protocol Violation|28|||
160780874|NCT00567580|580581531|FG001|Overall Study|Protocol Violation|24|||
160780875|NCT00567580|580581532|FG002|Overall Study|Protocol Violation|24|||
160780876|NCT05788328|580581535|FG000|Treatment Period 4 (5 Days)|Other|1|||
160780877|NCT05788328|580581535|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
160780878|NCT00422461|580581536|FG000|Overall Study|Adverse Event|1|||
160780879|NCT00422461|580581537|FG001|Overall Study|Adverse Event|2|||
160780880|NCT00422461|580581538|FG002|Overall Study|Adverse Event|1|||
160780881|NCT00422461|580581539|FG003|Overall Study|Adverse Event|1|||
160780882|NCT00422461|580581536|FG000|Overall Study|Other|0|||
160780883|NCT00422461|580581537|FG001|Overall Study|Other|0|||
160780884|NCT00422461|580581538|FG002|Overall Study|Other|0|||
160780885|NCT00422461|580581539|FG003|Overall Study|Other|2|||
160780886|NCT00422461|580581536|FG000|Overall Study|Participants no longer willing to participate in study|1|||
160780887|NCT00422461|580581537|FG001|Overall Study|Participants no longer willing to participate in study|0|||
160780888|NCT00422461|580581538|FG002|Overall Study|Participants no longer willing to participate in study|0|||
160780889|NCT00422461|580581539|FG003|Overall Study|Participants no longer willing to participate in study|0|||
160780890|NCT00422461|580581536|FG000|Overall Study|Randomized but not treated|1|||
160780891|NCT00422461|580581537|FG001|Overall Study|Randomized but not treated|1|||
160780892|NCT00422461|580581538|FG002|Overall Study|Randomized but not treated|0|||
160780893|NCT00422461|580581539|FG003|Overall Study|Randomized but not treated|0|||
160780894|NCT02181621|580581541|FG000|Overall Study|Adverse Event|1|||
160780895|NCT02181621|580581542|FG001|Overall Study|Adverse Event|0|||
160780896|NCT02181621|580581541|FG000|Overall Study|Previously Enrolled|0|||
160780897|NCT02181621|580581542|FG001|Overall Study|Previously Enrolled|1|||
160780898|NCT02181621|580581541|FG000|Overall Study|Enrollment Hold|1|||
160780899|NCT02181621|580581542|FG001|Overall Study|Enrollment Hold|1|||
160780900|NCT00145327|580581543|FG000|Overall Study|Withdrawal by Subject|77|||
161326352|NCT00377637|582581191|FG000|Induction Phase|Sponsor decision|1|||
161326353|NCT00377637|582581192|FG001|Induction Phase|Sponsor decision|2|||
161326354|NCT00377637|582581193|FG002|Induction Phase|Sponsor decision|0|||
161326355|NCT00377637|582581194|FG003|Induction Phase|Sponsor decision|0|||
160780901|NCT00145327|580581544|FG001|Overall Study|Withdrawal by Subject|72|||
160780902|NCT00145327|580581545|FG002|Overall Study|Withdrawal by Subject|164|||
160780903|NCT00145327|580581543|FG000|Overall Study|Death|26|||
160780904|NCT00145327|580581544|FG001|Overall Study|Death|18|||
160780905|NCT00145327|580581545|FG002|Overall Study|Death|30|||
160780906|NCT00145327|580581543|FG000|Overall Study|Adverse Event|14|||
161326356|NCT00377637|582581191|FG000|Induction Phase|Non-Compliance|1|||
161326357|NCT00377637|582581192|FG001|Induction Phase|Non-Compliance|0|||
161326358|NCT00377637|582581193|FG002|Induction Phase|Non-Compliance|0|||
161326359|NCT00377637|582581194|FG003|Induction Phase|Non-Compliance|0|||
161326360|NCT00377637|582581191|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
161326361|NCT00377637|582581192|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
161326362|NCT00377637|582581193|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
160780907|NCT00145327|580581544|FG001|Overall Study|Adverse Event|11|||
160780908|NCT00145327|580581545|FG002|Overall Study|Adverse Event|22|||
160780909|NCT00145327|580581543|FG000|Overall Study|Lost to Follow-up|9|||
160780910|NCT00145327|580581544|FG001|Overall Study|Lost to Follow-up|14|||
160780911|NCT00145327|580581545|FG002|Overall Study|Lost to Follow-up|14|||
160780912|NCT00145327|580581543|FG000|Overall Study|Administrative problems|12|||
160780913|NCT00145327|580581544|FG001|Overall Study|Administrative problems|9|||
160780914|NCT00145327|580581545|FG002|Overall Study|Administrative problems|13|||
160780915|NCT00145327|580581543|FG000|Overall Study|Protocol Violation|2|||
161326363|NCT00377637|582581194|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
160780916|NCT00145327|580581544|FG001|Overall Study|Protocol Violation|0|||
160780917|NCT00145327|580581545|FG002|Overall Study|Protocol Violation|2|||
160780918|NCT00145327|580581543|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160780919|NCT00145327|580581544|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161123379|NCT03467958|581837564|FG005|Overall Study|Adverse Event|3|||
160780920|NCT00145327|580581545|FG002|Overall Study|Abnormal laboratory value(s)|2|||
160780921|NCT00145327|580581543|FG000|Overall Study|Missing - not stated|1|||
160780922|NCT00145327|580581544|FG001|Overall Study|Missing - not stated|0|||
160888502|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
160888503|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160888504|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
160888505|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160888506|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160888507|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160888508|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160888509|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160888510|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
160888511|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
160888512|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
160888513|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
160888514|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
160888515|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
160888516|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
160888517|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
160888518|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160888519|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160888520|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888521|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
160888522|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888523|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888524|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888525|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888526|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888527|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888528|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
160888529|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
160888530|NCT02414139|580985521|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
160888531|NCT02414139|580985522|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160888532|NCT02414139|580985523|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
160888533|NCT02414139|580985524|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
160888534|NCT02414139|580985525|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
160888535|NCT02414139|580985526|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161123380|NCT03467958|581837565|FG006|Overall Study|Adverse Event|6|||
161123381|NCT03467958|581837566|FG007|Overall Study|Adverse Event|5|||
161123382|NCT03467958|581837567|FG008|Overall Study|Adverse Event|0|||
160780923|NCT00145327|580581545|FG002|Overall Study|Missing - not stated|1|||
160780924|NCT01028053|580581546|FG000|Overall Study|Screen Failure|113|||
160780925|NCT01028053|580581546|FG000|Overall Study|Patient Request|11|||
160780926|NCT01028053|580581546|FG000|Overall Study|Protocol Violation|1|||
160780927|NCT01028053|580581546|FG000|Overall Study|Physician Decision|2|||
160780928|NCT01028053|580581546|FG000|Overall Study|Technical Problem|1|||
160780929|NCT01028053|580581546|FG000|Overall Study|Terminated by Sponsor|1|||
160780930|NCT01028053|580581546|FG000|Overall Study|Various reasons|4|||
160780931|NCT00845182|580581547|FG000|Overall Study|Lost to Follow-up|3|||
160780932|NCT00845182|580581548|FG001|Overall Study|Lost to Follow-up|3|||
160780933|NCT00845182|580581549|FG002|Overall Study|Lost to Follow-up|4|||
160780934|NCT00845182|580581547|FG000|Overall Study|Adverse Event|0|||
160780935|NCT00845182|580581548|FG001|Overall Study|Adverse Event|1|||
160780936|NCT00845182|580581549|FG002|Overall Study|Adverse Event|1|||
160780937|NCT00845182|580581547|FG000|Overall Study|Physician Decision|0|||
160780938|NCT00845182|580581548|FG001|Overall Study|Physician Decision|0|||
161123383|NCT03467958|581837559|FG000|Overall Study|Lack of Efficacy|59|||
161123384|NCT03467958|581837560|FG001|Overall Study|Lack of Efficacy|120|||
161123385|NCT03467958|581837561|FG002|Overall Study|Lack of Efficacy|6|||
161123386|NCT03467958|581837562|FG003|Overall Study|Lack of Efficacy|9|||
161123387|NCT03467958|581837563|FG004|Overall Study|Lack of Efficacy|8|||
161123388|NCT03467958|581837564|FG005|Overall Study|Lack of Efficacy|9|||
161123389|NCT03467958|581837565|FG006|Overall Study|Lack of Efficacy|11|||
161123390|NCT03467958|581837566|FG007|Overall Study|Lack of Efficacy|9|||
161123391|NCT03467958|581837567|FG008|Overall Study|Lack of Efficacy|3|||
161123392|NCT03467958|581837559|FG000|Overall Study|Lost to Follow-up|1|||
161123393|NCT03467958|581837560|FG001|Overall Study|Lost to Follow-up|2|||
161123394|NCT03467958|581837561|FG002|Overall Study|Lost to Follow-up|1|||
161123395|NCT03467958|581837562|FG003|Overall Study|Lost to Follow-up|0|||
161123396|NCT03467958|581837563|FG004|Overall Study|Lost to Follow-up|4|||
161123397|NCT03467958|581837564|FG005|Overall Study|Lost to Follow-up|0|||
160888536|NCT02414139|580985527|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160888537|NCT02414139|580985528|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160888538|NCT02414139|580985529|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160888539|NCT02414139|580985530|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160888540|NCT01226121|580985531|FG000|Overall Study|Lost to Follow-up|2|||
160888541|NCT01226121|580985532|FG001|Overall Study|Lost to Follow-up|0|||
160888542|NCT01226121|580985533|FG002|Overall Study|Lost to Follow-up|1|||
160888543|NCT04473482|580985534|FG000|Overall Study|Death|0|||
160888544|NCT04473482|580985535|FG001|Overall Study|Death|3|||
160888545|NCT04473482|580985534|FG000|Overall Study|Lost to Follow-up|9|||
160888546|NCT04473482|580985535|FG001|Overall Study|Lost to Follow-up|7|||
160888547|NCT04473482|580985534|FG000|Overall Study|Withdrawal by Subject|2|||
160888548|NCT04473482|580985535|FG001|Overall Study|Withdrawal by Subject|1|||
160888549|NCT01585584|580985536|FG000|Overall Study|Lack of Efficacy|1|||
160888550|NCT01585584|580985536|FG000|Overall Study|Withdrawal by Subject|1|||
160888551|NCT01585584|580985536|FG000|Overall Study|Physician Decision|2|||
160888552|NCT06785857|580985552|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
160888553|NCT06785857|580985553|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
160888554|NCT05952401|580985561|FG000|Overall Study|Lost to Follow-up|4|||
160888555|NCT05952401|580985562|FG001|Overall Study|Lost to Follow-up|1|||
160888556|NCT04369053|580986524|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
160888557|NCT04369053|580986524|FG000|Overall Study|Withdrawal by Subject|773|||
160888558|NCT04369053|580986524|FG000|Overall Study|Lost to Follow-up|182|||
160888559|NCT04369053|580986524|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
160888560|NCT01483690|580986525|FG000|Overall Study|Adverse Event|1|||
160888561|NCT01483690|580986526|FG001|Overall Study|Adverse Event|2|||
160888562|NCT01483690|580986525|FG000|Overall Study|clinical deterioration|1|||
160888563|NCT01483690|580986526|FG001|Overall Study|clinical deterioration|0|||
160888564|NCT01483690|580986525|FG000|Overall Study|Physician Decision|0|||
160888565|NCT01483690|580986526|FG001|Overall Study|Physician Decision|2|||
160888566|NCT01483690|580986525|FG000|Overall Study|exclusionary procedure|0|||
160888567|NCT01483690|580986526|FG001|Overall Study|exclusionary procedure|1|||
160888568|NCT02239224|580986527|FG000|Overall Study|Administrative|0|||
160888569|NCT02239224|580986528|FG001|Overall Study|Administrative|0|||
160888570|NCT02239224|580986529|FG002|Overall Study|Administrative|3|||
160888571|NCT02239224|580986530|FG003|Overall Study|Administrative|1|||
160888572|NCT03183778|580986532|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
160888573|NCT03228420|580986540|FG000|Overall Study|Lost to Follow-up|5|||
160888574|NCT03228420|580986541|FG001|Overall Study|Lost to Follow-up|3|||
160888575|NCT03228420|580986540|FG000|Overall Study|Withdrawal by Subject|10|||
160888576|NCT03228420|580986541|FG001|Overall Study|Withdrawal by Subject|0|||
160888577|NCT03228420|580986540|FG000|Overall Study|Adverse Event|5|||
160888578|NCT03228420|580986541|FG001|Overall Study|Adverse Event|2|||
160888579|NCT01083173|580986542|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
160888580|NCT01083173|580986543|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
160888581|NCT01083173|580986542|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
160888582|NCT01083173|580986543|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
160888583|NCT01083173|580986542|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
160888584|NCT01083173|580986543|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
160888585|NCT01083173|580986542|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
160888586|NCT01083173|580986543|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
160888587|NCT01083173|580986542|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
160888588|NCT01083173|580986543|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
160888589|NCT01083173|580986542|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
160888590|NCT01083173|580986543|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
160888591|NCT01083173|580986542|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
160888592|NCT01083173|580986543|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
160888593|NCT01083173|580986542|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
160888594|NCT01083173|580986543|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
160888595|NCT01083173|580986542|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
160888596|NCT01083173|580986543|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
160888597|NCT01083173|580986542|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
160888598|NCT01083173|580986543|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
160888599|NCT01083173|580986542|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
160888600|NCT01083173|580986543|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
160888601|NCT03954041|580986544|FG000|Overall Study|Lost to Follow-up|3|||
160888602|NCT03954041|580986545|FG001|Overall Study|Lost to Follow-up|3|||
160888603|NCT03954041|580986546|FG002|Overall Study|Lost to Follow-up|6|||
160888604|NCT03954041|580986544|FG000|Overall Study|Death|4|||
160780939|NCT00845182|580581549|FG002|Overall Study|Physician Decision|1|||
160780940|NCT02441114|580581550|FG000|Washout2|Withdrawal by Subject|4|||
160780941|NCT00471107|580581553|FG000|Overall Study|Technical problems/data loss|3|||
160780942|NCT00471107|580581554|FG001|Overall Study|Technical problems/data loss|1|||
160780943|NCT00471107|580581555|FG002|Overall Study|Technical problems/data loss|3|||
160780944|NCT02063724|580581557|FG000|Overall Study|Disease progression|1|||
160780945|NCT00896233|580581558|FG000|Overall Study|Claustrophobia during MRI|1|||
160780946|NCT02697422|580581559|FG000|Overall Study|Declined exit survey|9|||
160780947|NCT02697422|580581560|FG001|Overall Study|Declined exit survey|2|||
160780948|NCT02697422|580581559|FG000|Overall Study|Lost to Follow-up|13|||
160780949|NCT02697422|580581560|FG001|Overall Study|Lost to Follow-up|8|||
160780950|NCT02697422|580581559|FG000|Overall Study|Death|2|||
160780951|NCT02697422|580581560|FG001|Overall Study|Death|1|||
160780952|NCT02697422|580581559|FG000|Overall Study|Withdrawal by Subject|0|||
160780953|NCT02697422|580581560|FG001|Overall Study|Withdrawal by Subject|1|||
160780954|NCT02697422|580581559|FG000|Overall Study|Physician Decision|1|||
160780955|NCT02697422|580581560|FG001|Overall Study|Physician Decision|1|||
160780956|NCT02697422|580581559|FG000|Overall Study|Exit survey data lost|1|||
160780957|NCT02697422|580581560|FG001|Overall Study|Exit survey data lost|0|||
160780958|NCT02068599|580581563|FG000|Overall Study|Adverse Event|4|||
160780959|NCT02068599|580581564|FG001|Overall Study|Adverse Event|1|||
160780960|NCT02068599|580581565|FG002|Overall Study|Adverse Event|1|||
160780961|NCT02068599|580581563|FG000|Overall Study|Withdrawal by Subject|2|||
160780962|NCT02068599|580581564|FG001|Overall Study|Withdrawal by Subject|7|||
160780963|NCT02068599|580581565|FG002|Overall Study|Withdrawal by Subject|5|||
160780964|NCT02068599|580581563|FG000|Overall Study|Protocol Violation|4|||
160780965|NCT02068599|580581564|FG001|Overall Study|Protocol Violation|2|||
160780966|NCT02068599|580581565|FG002|Overall Study|Protocol Violation|3|||
160780967|NCT02068599|580581563|FG000|Overall Study|Lost to Follow-up|1|||
160780968|NCT02068599|580581564|FG001|Overall Study|Lost to Follow-up|0|||
160780969|NCT02068599|580581565|FG002|Overall Study|Lost to Follow-up|0|||
160780970|NCT02068599|580581563|FG000|Overall Study|Lack of Efficacy|0|||
160780971|NCT02068599|580581564|FG001|Overall Study|Lack of Efficacy|0|||
160780972|NCT02068599|580581565|FG002|Overall Study|Lack of Efficacy|3|||
160780973|NCT02068599|580581563|FG000|Overall Study|Noncompliance|0|||
160780974|NCT02068599|580581564|FG001|Overall Study|Noncompliance|0|||
160780975|NCT02068599|580581565|FG002|Overall Study|Noncompliance|1|||
160780976|NCT01263028|580581566|FG000|Overall Study|Withdrawal by Subject|1|||
160780977|NCT01263028|580581566|FG000|Overall Study|Adverse Event|1|||
160780978|NCT01263028|580581566|FG000|Overall Study|Study terminated due to low enrollment.|4|||
160780979|NCT03019588|580581567|FG000|Overall Study|Death|44|||
160780980|NCT03019588|580581568|FG001|Overall Study|Death|46|||
160780981|NCT03019588|580581567|FG000|Overall Study|Study terminated by Sponsor|3|||
160780982|NCT03019588|580581568|FG001|Overall Study|Study terminated by Sponsor|1|||
160780983|NCT02227199|580581569|FG000|Overall Study|Physician Decision|0|||
160780984|NCT02227199|580581570|FG001|Overall Study|Physician Decision|0|||
160780985|NCT02227199|580581571|FG002|Overall Study|Physician Decision|1|||
160780986|NCT02227199|580581569|FG000|Overall Study|Adverse Event|0|||
160780987|NCT02227199|580581570|FG001|Overall Study|Adverse Event|0|||
160780988|NCT02227199|580581571|FG002|Overall Study|Adverse Event|3|||
160780989|NCT01428128|580581572|FG000|Overall Study|Withdrawal by Subject|4|||
161326364|NCT00377637|582581191|FG000|Maintenance Phase|Adverse Event|0|||
161326365|NCT00377637|582581192|FG001|Maintenance Phase|Adverse Event|0|||
161326366|NCT00377637|582581193|FG002|Maintenance Phase|Adverse Event|29|||
161326367|NCT00377637|582581194|FG003|Maintenance Phase|Adverse Event|43|||
161326368|NCT00377637|582581191|FG000|Maintenance Phase|Physician Decision|0|||
161326369|NCT00377637|582581192|FG001|Maintenance Phase|Physician Decision|0|||
161326370|NCT00377637|582581193|FG002|Maintenance Phase|Physician Decision|5|||
161326371|NCT00377637|582581194|FG003|Maintenance Phase|Physician Decision|4|||
161326372|NCT00377637|582581191|FG000|Maintenance Phase|Lost to Follow-up|0|||
160780990|NCT01428128|580581572|FG000|Overall Study|Screen failure by p53|10|||
160780991|NCT01428128|580581572|FG000|Overall Study|Received Neulasta in one cycle|2|||
160780992|NCT01428128|580581572|FG000|Overall Study|Adverse Event|1|||
160780993|NCT00250718|580581576|FG000|Overall Study|Death|1|||
161326373|NCT00377637|582581192|FG001|Maintenance Phase|Lost to Follow-up|0|||
161326374|NCT00377637|582581193|FG002|Maintenance Phase|Lost to Follow-up|3|||
160780994|NCT00250718|580581576|FG000|Overall Study|Adverse Event|1|||
160780995|NCT00250718|580581576|FG000|Overall Study|Withdrawal by Subject|1|||
160780996|NCT02939781|580581577|FG000|Overall Study|Protocol Violation|8|||
160780997|NCT02939781|580581577|FG000|Overall Study|Withdrawal by Subject|1|||
160780998|NCT03003962|580581580|FG000|Overall Study|Withdrawal by Subject|5|||
160780999|NCT03003962|580581581|FG001|Overall Study|Withdrawal by Subject|17|||
160781000|NCT03003962|580581580|FG000|Overall Study|Death|274|||
160781001|NCT03003962|580581581|FG001|Overall Study|Death|277|||
160781002|NCT03003962|580581580|FG000|Overall Study|Participants ongoing at DCO|55|||
160781003|NCT03003962|580581581|FG001|Overall Study|Participants ongoing at DCO|40|||
160781004|NCT06100250|580581582|FG000|Overall Study|Lost to Follow-up|5|||
160781005|NCT05259033|580581585|FG000|Overall Study|Withdrawal by Subject|10|||
161123398|NCT03467958|581837565|FG006|Overall Study|Lost to Follow-up|0|||
161123399|NCT03467958|581837566|FG007|Overall Study|Lost to Follow-up|0|||
161123400|NCT03467958|581837567|FG008|Overall Study|Lost to Follow-up|0|||
161123401|NCT03467958|581837559|FG000|Overall Study|Other reasons|8|||
161123402|NCT03467958|581837560|FG001|Overall Study|Other reasons|14|||
161123403|NCT03467958|581837561|FG002|Overall Study|Other reasons|2|||
161123404|NCT03467958|581837562|FG003|Overall Study|Other reasons|1|||
161123405|NCT03467958|581837563|FG004|Overall Study|Other reasons|4|||
161123406|NCT03467958|581837564|FG005|Overall Study|Other reasons|0|||
161123407|NCT03467958|581837565|FG006|Overall Study|Other reasons|1|||
161326375|NCT00377637|582581194|FG003|Maintenance Phase|Lost to Follow-up|1|||
161326376|NCT00377637|582581191|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161326377|NCT00377637|582581192|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161326378|NCT00377637|582581193|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161326379|NCT00377637|582581194|FG003|Maintenance Phase|Withdrawal by Subject|3|||
161326380|NCT00377637|582581191|FG000|Maintenance Phase|Sponsor decision|0|||
161326381|NCT00377637|582581192|FG001|Maintenance Phase|Sponsor decision|0|||
161326382|NCT00377637|582581193|FG002|Maintenance Phase|Sponsor decision|2|||
161326383|NCT00377637|582581194|FG003|Maintenance Phase|Sponsor decision|3|||
161326384|NCT00377637|582581191|FG000|Maintenance Phase|Non-compliance|0|||
161326385|NCT00377637|582581192|FG001|Maintenance Phase|Non-compliance|0|||
161326386|NCT00377637|582581193|FG002|Maintenance Phase|Non-compliance|1|||
161326387|NCT00377637|582581194|FG003|Maintenance Phase|Non-compliance|1|||
161326388|NCT00377637|582581191|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
161326389|NCT00377637|582581192|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
161326390|NCT00377637|582581193|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
161326391|NCT00377637|582581194|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
161326392|NCT00377637|582581191|FG000|Maintenance Phase|Death|0|||
161326393|NCT00377637|582581192|FG001|Maintenance Phase|Death|0|||
161326394|NCT00377637|582581193|FG002|Maintenance Phase|Death|0|||
161326395|NCT00377637|582581194|FG003|Maintenance Phase|Death|1|||
161326396|NCT02922153|582581195|FG000|Overall Study|Death|8|||
161326397|NCT02922153|582581196|FG001|Overall Study|Death|1|||
161326398|NCT02922153|582581195|FG000|Overall Study|Lost to Follow-up|1|||
161326399|NCT02922153|582581196|FG001|Overall Study|Lost to Follow-up|0|||
161326400|NCT02922153|582581195|FG000|Overall Study|Physician Decision|1|||
161326401|NCT02922153|582581196|FG001|Overall Study|Physician Decision|1|||
161326402|NCT03506438|582581197|FG000|Overall Study|Lost to Follow-up|8|||
161326403|NCT03506438|582581198|FG001|Overall Study|Lost to Follow-up|7|||
161326404|NCT03506438|582581199|FG002|Overall Study|Lost to Follow-up|8|||
161326405|NCT03506438|582581200|FG003|Overall Study|Lost to Follow-up|7|||
161326406|NCT03506438|582581201|FG004|Overall Study|Lost to Follow-up|0|||
161326407|NCT03506438|582581202|FG005|Overall Study|Lost to Follow-up|0|||
161326408|NCT01128296|582581203|FG000|Overall Study|Physician Decision|0|||
161326409|NCT01128296|582581204|FG001|Overall Study|Physician Decision|0|||
161326410|NCT01128296|582581205|FG002|Overall Study|Physician Decision|0|||
161326411|NCT01128296|582581206|FG003|Overall Study|Physician Decision|0|||
161326412|NCT01128296|582581207|FG004|Overall Study|Physician Decision|0|||
161326413|NCT01128296|582581208|FG005|Overall Study|Physician Decision|3|||
161326414|NCT01128296|582581203|FG000|Overall Study|Withdrawal by Subject|0|||
161326415|NCT01128296|582581204|FG001|Overall Study|Withdrawal by Subject|0|||
161326416|NCT01128296|582581205|FG002|Overall Study|Withdrawal by Subject|0|||
161326417|NCT01128296|582581206|FG003|Overall Study|Withdrawal by Subject|0|||
161326418|NCT01128296|582581207|FG004|Overall Study|Withdrawal by Subject|0|||
161326419|NCT01128296|582581208|FG005|Overall Study|Withdrawal by Subject|2|||
161326420|NCT04155463|582581209|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
161326421|NCT04155463|582581210|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
161326422|NCT00113295|582581211|FG000|Overall Study|Adverse Event|4|||
161326423|NCT00113295|582581212|FG001|Overall Study|Adverse Event|1|||
161326424|NCT00113295|582581211|FG000|Overall Study|Unrelated Medical Illness|1|||
161326425|NCT00113295|582581212|FG001|Overall Study|Unrelated Medical Illness|0|||
161326426|NCT01714544|582581213|FG000|Overall Study|Lost to Follow-up|1|||
161326427|NCT01714544|582581213|FG000|Overall Study|Physician Decision|1|||
161326428|NCT01714544|582581213|FG000|Overall Study|Withdrawal by Subject|1|||
161326429|NCT01053741|582581214|FG000|2nd Study Intervention|Physician Decision|0|||
161326430|NCT01053741|582581215|FG001|2nd Study Intervention|Physician Decision|1|||
161326431|NCT00666211|582581216|FG000|Overall Study|Withdrawal by Subject|10|||
161326432|NCT00666211|582581217|FG001|Overall Study|Withdrawal by Subject|13|||
161326433|NCT00666211|582581216|FG000|Overall Study|went off medication, no more pain|1|||
161123408|NCT03467958|581837566|FG007|Overall Study|Other reasons|0|||
161123409|NCT03467958|581837567|FG008|Overall Study|Other reasons|1|||
161123410|NCT03467958|581837559|FG000|Overall Study|Pregnancy|1|||
161326434|NCT00666211|582581217|FG001|Overall Study|went off medication, no more pain|0|||
161326435|NCT00666211|582581216|FG000|Overall Study|patient non-compliant|6|||
161326436|NCT00666211|582581217|FG001|Overall Study|patient non-compliant|6|||
161326437|NCT00666211|582581216|FG000|Overall Study|disease progression|1|||
161326438|NCT00666211|582581217|FG001|Overall Study|disease progression|8|||
161123411|NCT03467958|581837560|FG001|Overall Study|Pregnancy|0|||
160781006|NCT05259033|580581586|FG001|Overall Study|Withdrawal by Subject|5|||
160781007|NCT05259033|580581585|FG000|Overall Study|Lost to Follow-up|1|||
160781008|NCT05259033|580581586|FG001|Overall Study|Lost to Follow-up|0|||
160781009|NCT05259033|580581585|FG000|Overall Study|Death|2|||
160781010|NCT05259033|580581586|FG001|Overall Study|Death|0|||
160781011|NCT05537571|580581587|FG000|Overall Study|Withdrawal by Subject|1|||
160781012|NCT05537571|580581588|FG001|Overall Study|Withdrawal by Subject|1|||
160781013|NCT05537571|580581589|FG002|Overall Study|Withdrawal by Subject|0|||
160781014|NCT05537571|580581590|FG003|Overall Study|Withdrawal by Subject|0|||
160781015|NCT05537571|580581591|FG004|Overall Study|Withdrawal by Subject|0|||
160781016|NCT05537571|580581587|FG000|Overall Study|Adverse Event|2|||
160781017|NCT05537571|580581588|FG001|Overall Study|Adverse Event|0|||
160781018|NCT05537571|580581589|FG002|Overall Study|Adverse Event|0|||
160781019|NCT05537571|580581590|FG003|Overall Study|Adverse Event|0|||
160781020|NCT05537571|580581591|FG004|Overall Study|Adverse Event|0|||
160781021|NCT05537571|580581587|FG000|Overall Study|Hepatitis A screening result|2|||
160781022|NCT05537571|580581588|FG001|Overall Study|Hepatitis A screening result|0|||
160781023|NCT05537571|580581589|FG002|Overall Study|Hepatitis A screening result|0|||
160781024|NCT05537571|580581590|FG003|Overall Study|Hepatitis A screening result|0|||
160781025|NCT05537571|580581591|FG004|Overall Study|Hepatitis A screening result|0|||
160781026|NCT05537571|580581587|FG000|Overall Study|Lost to Follow-up|0|||
160781027|NCT05537571|580581588|FG001|Overall Study|Lost to Follow-up|0|||
160781028|NCT05537571|580581589|FG002|Overall Study|Lost to Follow-up|1|||
160781029|NCT05537571|580581590|FG003|Overall Study|Lost to Follow-up|0|||
160781030|NCT05537571|580581591|FG004|Overall Study|Lost to Follow-up|1|||
160781031|NCT04337021|580581592|FG000|Overall Study|Lost to Follow-up|54|||
160781032|NCT04337021|580581593|FG001|Overall Study|Lost to Follow-up|66|||
160781033|NCT00424008|580581594|FG000|Overall Study|Adverse Event|8|||
160781034|NCT00424008|580581595|FG001|Overall Study|Adverse Event|6|||
160781035|NCT00424008|580581594|FG000|Overall Study|Lack of Efficacy|40|||
160781036|NCT00424008|580581595|FG001|Overall Study|Lack of Efficacy|34|||
160781037|NCT00424008|580581594|FG000|Overall Study|Lost to Follow-up|1|||
160781038|NCT00424008|580581595|FG001|Overall Study|Lost to Follow-up|2|||
160781039|NCT00424008|580581594|FG000|Overall Study|Withdrawal by Subject|5|||
160781040|NCT00424008|580581595|FG001|Overall Study|Withdrawal by Subject|8|||
160781041|NCT00424008|580581594|FG000|Overall Study|Noncompliance with protocol|13|||
160781042|NCT00424008|580581595|FG001|Overall Study|Noncompliance with protocol|7|||
160781043|NCT00424008|580581594|FG000|Overall Study|Did not meet protocol eligibility|16|||
160781044|NCT00424008|580581595|FG001|Overall Study|Did not meet protocol eligibility|21|||
160781045|NCT00424008|580581594|FG000|Overall Study|Administrative|266|||
160781046|NCT00424008|580581595|FG001|Overall Study|Administrative|257|||
160781047|NCT02530242|580581599|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
160781048|NCT02530242|580581600|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
160781049|NCT00283959|580581601|FG000|Extension Period|Low Compliance|1|||
160781050|NCT02665455|580581604|FG000|Overall Study|Withdrawal by Subject|6|||
160781051|NCT02665455|580581604|FG000|Overall Study|Lost to Follow-up|1|||
160781052|NCT02665455|580581604|FG000|Overall Study|Adverse Event|1|||
160781053|NCT02665455|580581604|FG000|Overall Study|Protocol Violation|1|||
160781054|NCT05865886|580581605|FG000|Overall Study|Serious adverse event|0|||
160781055|NCT05865886|580581606|FG001|Overall Study|Serious adverse event|1|||
160781056|NCT01671059|580581607|FG000|Overall Study|Adverse Event|4|||
160781057|NCT01671059|580581607|FG000|Overall Study|Lack of Efficacy|1|||
160781058|NCT02564978|580581610|FG000|Overall Study|Adverse Event|8|||
160781059|NCT02564978|580581610|FG000|Overall Study|Death|1|||
160781060|NCT02564978|580581610|FG000|Overall Study|Lost to Follow-up|1|||
160781061|NCT02564978|580581610|FG000|Overall Study|Withdrawal by Subject|15|||
161326439|NCT00666211|582581216|FG000|Overall Study|Lost to Follow-up|2|||
161326440|NCT00666211|582581217|FG001|Overall Study|Lost to Follow-up|0|||
161326441|NCT00666211|582581216|FG000|Overall Study|toxicity|0|||
161326442|NCT00666211|582581217|FG001|Overall Study|toxicity|2|||
161326443|NCT00666211|582581216|FG000|Overall Study|hospital admission|0|||
160888605|NCT03954041|580986545|FG001|Overall Study|Death|0|||
161326444|NCT00666211|582581217|FG001|Overall Study|hospital admission|5|||
160888606|NCT03954041|580986546|FG002|Overall Study|Death|1|||
160781062|NCT02564978|580581610|FG000|Overall Study|Early Study Closure|2|||
160781063|NCT02564978|580581610|FG000|Overall Study|Other Reason|5|||
160888607|NCT03954041|580986544|FG000|Overall Study|Death by neurologic criteria|0|||
160781064|NCT03787212|580583055|FG000|Period 1|Study Termination|2|||
161326445|NCT00666211|582581216|FG000|Overall Study|Death|0|||
161326446|NCT00666211|582581217|FG001|Overall Study|Death|2|||
160781065|NCT03787212|580583056|FG001|Period 1|Study Termination|2|||
160781066|NCT04289298|580583057|FG000|Overall Study|Lost to Follow-up|5|||
160781067|NCT04289298|580583058|FG001|Overall Study|Lost to Follow-up|0|||
160888608|NCT03954041|580986545|FG001|Overall Study|Death by neurologic criteria|0|||
160781068|NCT04289298|580583057|FG000|Overall Study|Withdrawal by Subject|2|||
160781069|NCT04289298|580583058|FG001|Overall Study|Withdrawal by Subject|0|||
160781070|NCT00620035|580583059|FG000|Overall Study|Adverse Event|106|||
160781071|NCT00620035|580583059|FG000|Overall Study|Withdrawal of Informed Consent|1|||
160888609|NCT03954041|580986546|FG002|Overall Study|Death by neurologic criteria|1|||
160888610|NCT03954041|580986544|FG000|Overall Study|Reason not specified|7|||
160888611|NCT03954041|580986545|FG001|Overall Study|Reason not specified|4|||
160888612|NCT03954041|580986546|FG002|Overall Study|Reason not specified|2|||
160888613|NCT03954041|580986544|FG000|Overall Study|Withdrew prior to dosing|4|||
160888614|NCT03954041|580986545|FG001|Overall Study|Withdrew prior to dosing|2|||
160888615|NCT03954041|580986546|FG002|Overall Study|Withdrew prior to dosing|0|||
160888616|NCT04565236|580986549|FG000|Overall Study|Patient/Guardian Decision|0|||
160888617|NCT04565236|580986550|FG001|Overall Study|Patient/Guardian Decision|0|||
160888618|NCT04565236|580986551|FG002|Overall Study|Patient/Guardian Decision|1|||
160888619|NCT04565236|580986552|FG003|Overall Study|Patient/Guardian Decision|0|||
160888620|NCT01041495|580986553|FG000|Overall Study|Withdrawal by Subject|2|||
160888621|NCT01041495|580986554|FG001|Overall Study|Withdrawal by Subject|5|||
160888622|NCT01041495|580986553|FG000|Overall Study|Adverse Event|2|||
160888623|NCT01041495|580986554|FG001|Overall Study|Adverse Event|1|||
161326447|NCT00666211|582581216|FG000|Overall Study|off tx for other complicating disease|0|||
161326448|NCT00666211|582581217|FG001|Overall Study|off tx for other complicating disease|1|||
161326449|NCT00666211|582581216|FG000|Overall Study|Physician Decision|0|||
160888624|NCT01041495|580986553|FG000|Overall Study|Lost to Follow-up|0|||
160888625|NCT01041495|580986554|FG001|Overall Study|Lost to Follow-up|1|||
160888626|NCT00722371|580986555|FG000|Overall Study|Adverse Event|6|||
160888627|NCT00722371|580986556|FG001|Overall Study|Adverse Event|13|||
160888628|NCT00722371|580986557|FG002|Overall Study|Adverse Event|9|||
160888629|NCT00722371|580986558|FG003|Overall Study|Adverse Event|10|||
160888630|NCT00722371|580986559|FG004|Overall Study|Adverse Event|6|||
160888631|NCT00722371|580986560|FG005|Overall Study|Adverse Event|8|||
160888632|NCT00722371|580986561|FG006|Overall Study|Adverse Event|4|||
160888633|NCT00722371|580986555|FG000|Overall Study|Contraindication|0|||
160888634|NCT00722371|580986556|FG001|Overall Study|Contraindication|0|||
160888635|NCT00722371|580986557|FG002|Overall Study|Contraindication|1|||
160888636|NCT00722371|580986558|FG003|Overall Study|Contraindication|0|||
160888637|NCT00722371|580986559|FG004|Overall Study|Contraindication|0|||
160888638|NCT00722371|580986560|FG005|Overall Study|Contraindication|0|||
160888639|NCT00722371|580986561|FG006|Overall Study|Contraindication|0|||
160888640|NCT00722371|580986555|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
160888641|NCT00722371|580986556|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
160888642|NCT00722371|580986557|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
160888643|NCT00722371|580986558|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
160888644|NCT00722371|580986559|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
160888645|NCT00722371|580986560|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
160888646|NCT00722371|580986561|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
160888647|NCT00722371|580986555|FG000|Overall Study|Excluded medication|0|||
160888648|NCT00722371|580986556|FG001|Overall Study|Excluded medication|1|||
160888649|NCT00722371|580986557|FG002|Overall Study|Excluded medication|1|||
160888650|NCT00722371|580986558|FG003|Overall Study|Excluded medication|0|||
160888651|NCT00722371|580986559|FG004|Overall Study|Excluded medication|0|||
160888652|NCT00722371|580986560|FG005|Overall Study|Excluded medication|0|||
160888653|NCT00722371|580986561|FG006|Overall Study|Excluded medication|1|||
160888654|NCT00722371|580986555|FG000|Overall Study|Hyperglycemia|2|||
161326450|NCT00666211|582581217|FG001|Overall Study|Physician Decision|1|||
161326451|NCT00003537|582581228|FG000|Overall Study|Not evalauable|1|||
161326452|NCT01001520|582581229|FG000|Medication Period 1|Withdrawal by Subject|2|||
161326453|NCT01001520|582581230|FG001|Medication Period 1|Withdrawal by Subject|2|||
161326454|NCT01001520|582581229|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
161326455|NCT01001520|582581230|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
161326456|NCT01001520|582581229|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
161326457|NCT01001520|582581230|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
161326458|NCT01001520|582581229|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
161326459|NCT01001520|582581230|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
161326460|NCT01001520|582581229|FG000|Washout Period|Withdrawal by Subject|2|||
160888655|NCT00722371|580986556|FG001|Overall Study|Hyperglycemia|6|||
160888656|NCT00722371|580986557|FG002|Overall Study|Hyperglycemia|4|||
160888657|NCT00722371|580986558|FG003|Overall Study|Hyperglycemia|2|||
160888658|NCT00722371|580986559|FG004|Overall Study|Hyperglycemia|5|||
160888659|NCT00722371|580986560|FG005|Overall Study|Hyperglycemia|1|||
160888660|NCT00722371|580986561|FG006|Overall Study|Hyperglycemia|1|||
160888661|NCT00722371|580986555|FG000|Overall Study|Hypoglycemia|1|||
160888662|NCT00722371|580986556|FG001|Overall Study|Hypoglycemia|0|||
160888663|NCT00722371|580986557|FG002|Overall Study|Hypoglycemia|0|||
160888664|NCT00722371|580986558|FG003|Overall Study|Hypoglycemia|0|||
160888665|NCT00722371|580986559|FG004|Overall Study|Hypoglycemia|0|||
160888666|NCT00722371|580986560|FG005|Overall Study|Hypoglycemia|0|||
160888667|NCT00722371|580986561|FG006|Overall Study|Hypoglycemia|0|||
160888668|NCT00722371|580986555|FG000|Overall Study|Lack of Efficacy|4|||
160888669|NCT00722371|580986556|FG001|Overall Study|Lack of Efficacy|6|||
160888670|NCT00722371|580986557|FG002|Overall Study|Lack of Efficacy|6|||
160888671|NCT00722371|580986558|FG003|Overall Study|Lack of Efficacy|6|||
160888672|NCT00722371|580986559|FG004|Overall Study|Lack of Efficacy|2|||
160888673|NCT00722371|580986560|FG005|Overall Study|Lack of Efficacy|3|||
160888674|NCT00722371|580986561|FG006|Overall Study|Lack of Efficacy|0|||
160888675|NCT00722371|580986555|FG000|Overall Study|Lost to Follow-up|11|||
160888676|NCT00722371|580986556|FG001|Overall Study|Lost to Follow-up|14|||
160888677|NCT00722371|580986557|FG002|Overall Study|Lost to Follow-up|21|||
160888678|NCT00722371|580986558|FG003|Overall Study|Lost to Follow-up|13|||
160888679|NCT00722371|580986559|FG004|Overall Study|Lost to Follow-up|8|||
160888680|NCT00722371|580986560|FG005|Overall Study|Lost to Follow-up|16|||
160888681|NCT00722371|580986561|FG006|Overall Study|Lost to Follow-up|13|||
160888682|NCT00722371|580986555|FG000|Overall Study|Physician Decision|5|||
160888683|NCT00722371|580986556|FG001|Overall Study|Physician Decision|2|||
160888684|NCT00722371|580986557|FG002|Overall Study|Physician Decision|2|||
160888685|NCT00722371|580986558|FG003|Overall Study|Physician Decision|5|||
160888686|NCT00722371|580986559|FG004|Overall Study|Physician Decision|2|||
160888687|NCT00722371|580986560|FG005|Overall Study|Physician Decision|3|||
160888688|NCT00722371|580986561|FG006|Overall Study|Physician Decision|4|||
160888689|NCT00722371|580986555|FG000|Overall Study|Pregnancy|1|||
160888690|NCT00722371|580986556|FG001|Overall Study|Pregnancy|1|||
160888691|NCT00722371|580986557|FG002|Overall Study|Pregnancy|0|||
160888692|NCT00722371|580986558|FG003|Overall Study|Pregnancy|0|||
160888693|NCT00722371|580986559|FG004|Overall Study|Pregnancy|0|||
160888694|NCT00722371|580986560|FG005|Overall Study|Pregnancy|1|||
160888695|NCT00722371|580986561|FG006|Overall Study|Pregnancy|0|||
160888696|NCT00722371|580986555|FG000|Overall Study|Protocol Violation|6|||
160888697|NCT00722371|580986556|FG001|Overall Study|Protocol Violation|1|||
161229518|NCT01682083|582222489|FG001|Overall Study|Withdrawal by Subject|40|||
161229519|NCT01682083|582222488|FG000|Overall Study|Death|60|||
161229520|NCT01682083|582222489|FG001|Overall Study|Death|93|||
161229521|NCT01682083|582222488|FG000|Overall Study|Physician Decision|5|||
161229522|NCT01682083|582222489|FG001|Overall Study|Physician Decision|4|||
161229523|NCT02932878|582222492|FG000|Overall Study|Due to Lab Results|2|||
161229524|NCT02932878|582222493|FG001|Overall Study|Due to Lab Results|1|||
161229525|NCT01918397|582222495|FG000|Overall Study|Never started treatment|2|||
161229526|NCT01918397|582222496|FG001|Overall Study|Never started treatment|1|||
161229527|NCT01918397|582222497|FG002|Overall Study|Never started treatment|0|||
161229528|NCT01918397|582222498|FG003|Overall Study|Never started treatment|0|||
161229529|NCT01918397|582222495|FG000|Overall Study|Adverse Event|1|||
161229530|NCT01918397|582222496|FG001|Overall Study|Adverse Event|1|||
161229531|NCT01918397|582222497|FG002|Overall Study|Adverse Event|1|||
161229532|NCT01918397|582222498|FG003|Overall Study|Adverse Event|0|||
161229533|NCT01918397|582222495|FG000|Overall Study|Lack of compliance|2|||
161229534|NCT01918397|582222496|FG001|Overall Study|Lack of compliance|2|||
161229535|NCT01918397|582222497|FG002|Overall Study|Lack of compliance|3|||
161229536|NCT01918397|582222498|FG003|Overall Study|Lack of compliance|0|||
161229537|NCT01918397|582222495|FG000|Overall Study|Pregnancy|0|||
161229538|NCT01918397|582222496|FG001|Overall Study|Pregnancy|1|||
161326461|NCT01001520|582581230|FG001|Washout Period|Withdrawal by Subject|1|||
161326462|NCT01001520|582581229|FG000|Medication Period 2|Withdrawal by Subject|0|||
160888698|NCT00722371|580986557|FG002|Overall Study|Protocol Violation|0|||
160888699|NCT00722371|580986558|FG003|Overall Study|Protocol Violation|1|||
160888700|NCT00722371|580986559|FG004|Overall Study|Protocol Violation|4|||
160888701|NCT00722371|580986560|FG005|Overall Study|Protocol Violation|2|||
160888702|NCT00722371|580986561|FG006|Overall Study|Protocol Violation|1|||
160888703|NCT00722371|580986555|FG000|Overall Study|Withdrawal by Subject|18|||
160888704|NCT00722371|580986556|FG001|Overall Study|Withdrawal by Subject|27|||
160888705|NCT00722371|580986557|FG002|Overall Study|Withdrawal by Subject|19|||
160888706|NCT00722371|580986558|FG003|Overall Study|Withdrawal by Subject|23|||
160888707|NCT00722371|580986559|FG004|Overall Study|Withdrawal by Subject|19|||
160888708|NCT00722371|580986560|FG005|Overall Study|Withdrawal by Subject|18|||
160888709|NCT00722371|580986561|FG006|Overall Study|Withdrawal by Subject|26|||
160888710|NCT00718237|580986562|FG000|Overall Study|Adverse Event|1|||
160888711|NCT00718237|580986563|FG001|Overall Study|Adverse Event|3|||
160888712|NCT00718237|580986562|FG000|Overall Study|Lost to Follow-up|2|||
160888713|NCT00718237|580986563|FG001|Overall Study|Lost to Follow-up|2|||
160888714|NCT00718237|580986562|FG000|Overall Study|Physician Decision|1|||
161229539|NCT01918397|582222497|FG002|Overall Study|Pregnancy|0|||
161229540|NCT01918397|582222498|FG003|Overall Study|Pregnancy|0|||
161229541|NCT01918397|582222495|FG000|Overall Study|Rifampin susceptible|0|||
160888715|NCT00718237|580986563|FG001|Overall Study|Physician Decision|0|||
160888716|NCT00718237|580986562|FG000|Overall Study|Withdrawal by Subject|9|||
160888717|NCT00718237|580986563|FG001|Overall Study|Withdrawal by Subject|10|||
160888718|NCT01185834|580986564|FG000|Overall Study|Lost to Follow-up|2|||
160888719|NCT01185834|580986564|FG000|Overall Study|Discomfort|4|||
160888720|NCT01185834|580986564|FG000|Overall Study|Biomicroscopy|4|||
161229542|NCT01918397|582222496|FG001|Overall Study|Rifampin susceptible|0|||
161229543|NCT01918397|582222497|FG002|Overall Study|Rifampin susceptible|0|||
161229544|NCT01918397|582222498|FG003|Overall Study|Rifampin susceptible|2|||
161229545|NCT01918397|582222495|FG000|Overall Study|Treatment failure|0|||
161229546|NCT01918397|582222496|FG001|Overall Study|Treatment failure|0|||
161326463|NCT01001520|582581230|FG001|Medication Period 2|Withdrawal by Subject|3|||
161326464|NCT04668209|582581231|FG000|Overall Study|Withdrawal by Subject|2|||
161326465|NCT04668209|582581232|FG001|Overall Study|Withdrawal by Subject|2|||
161326466|NCT04668209|582581231|FG000|Overall Study|Lost to Follow-up|3|||
161326467|NCT04668209|582581232|FG001|Overall Study|Lost to Follow-up|4|||
161326468|NCT04668209|582581231|FG000|Overall Study|Subject Expired|2|||
161326469|NCT04668209|582581232|FG001|Overall Study|Subject Expired|0|||
161326470|NCT04668209|582581231|FG000|Overall Study|Withdrawn from study|0|||
161326471|NCT04668209|582581232|FG001|Overall Study|Withdrawn from study|1|||
161326472|NCT04668209|582581231|FG000|Overall Study|Adverse Event|0|||
161326473|NCT04668209|582581232|FG001|Overall Study|Adverse Event|1|||
161326474|NCT01004978|582581235|FG000|Overall Study|Disease progression|31|||
161326475|NCT01004978|582581236|FG001|Overall Study|Disease progression|48|||
161326476|NCT01004978|582581235|FG000|Overall Study|Adverse Event|42|||
160781072|NCT00620035|580583059|FG000|Overall Study|Other Reason|38|||
160781073|NCT01778985|580583060|FG000|Overall Study|Lost to Follow-up|1|||
160781074|NCT01778985|580583061|FG001|Overall Study|Lost to Follow-up|0|||
160781075|NCT01778985|580583060|FG000|Overall Study|Physician Decision|2|||
160781076|NCT01778985|580583061|FG001|Overall Study|Physician Decision|2|||
160781077|NCT01778985|580583060|FG000|Overall Study|Protocol Violation|4|||
160781078|NCT01778985|580583061|FG001|Overall Study|Protocol Violation|1|||
160781079|NCT00504231|580583062|FG000|Overall Study|Discrepant chart documentation re route|0|||
160781080|NCT00504231|580583063|FG001|Overall Study|Discrepant chart documentation re route|0|||
160781081|NCT00504231|580583064|FG002|Overall Study|Discrepant chart documentation re route|1|||
160781082|NCT00504231|580583065|FG003|Overall Study|Discrepant chart documentation re route|0|||
160781083|NCT02316613|580583068|FG000|Overall Study|Death|63|||
160781084|NCT02316613|580583068|FG000|Overall Study|Lost to Follow-up|9|||
160781085|NCT02316613|580583068|FG000|Overall Study|Lymphoma transformation|2|||
160781086|NCT02316613|580583068|FG000|Overall Study|Participant moved/changed medical team|11|||
160781087|NCT02316613|580583068|FG000|Overall Study|No data and duplicate cases|5|||
160781088|NCT02316613|580583068|FG000|Overall Study|Did not met selection criteria|14|||
160781089|NCT02082483|580583073|FG000|Overall Study|Lost to Follow-up|1|||
160781090|NCT02082483|580583074|FG001|Overall Study|Lost to Follow-up|1|||
160781091|NCT02082483|580583073|FG000|Overall Study|Withdrawal by Subject|2|||
160781092|NCT02082483|580583074|FG001|Overall Study|Withdrawal by Subject|1|||
160781093|NCT02082483|580583073|FG000|Overall Study|Physician Decision|1|||
160781094|NCT02082483|580583074|FG001|Overall Study|Physician Decision|1|||
160781095|NCT02082483|580583073|FG000|Overall Study|Death|2|||
160781096|NCT02082483|580583074|FG001|Overall Study|Death|3|||
160781097|NCT01875237|580583078|FG000|Overall Study|GVDH before DLI|1|||
160781098|NCT01875237|580583079|FG001|Overall Study|GVDH before DLI|0|||
160781099|NCT01875237|580583078|FG000|Overall Study|DLI cells could not be produced|1|||
160781100|NCT01875237|580583079|FG001|Overall Study|DLI cells could not be produced|0|||
160781101|NCT01028560|580583081|FG000|Overall Study|Lack of Efficacy|3|||
160781102|NCT01028560|580583082|FG001|Overall Study|Lack of Efficacy|6|||
160781103|NCT01028560|580583081|FG000|Overall Study|Withdrawal by Subject|7|||
160781104|NCT01028560|580583082|FG001|Overall Study|Withdrawal by Subject|12|||
160781105|NCT01960842|580583085|FG000|Overall Study|Adverse Event|1|||
160781106|NCT01960842|580583085|FG000|Overall Study|Withdrawal by Subject|2|||
160781107|NCT05278065|580583090|FG000|Overall Study|Withdrawal by Subject|1|||
160781108|NCT05278065|580583091|FG001|Overall Study|Withdrawal by Subject|0|||
160781109|NCT02029443|580583092|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
160781110|NCT02029443|580583093|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
160781111|NCT02029443|580583094|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
160781112|NCT02029443|580583095|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
160781113|NCT02029443|580583096|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
160781114|NCT02029443|580583092|FG000|Overall Study|Death|13|||
160781115|NCT02029443|580583093|FG001|Overall Study|Death|2|||
160781116|NCT02029443|580583094|FG002|Overall Study|Death|2|||
160781117|NCT02029443|580583095|FG003|Overall Study|Death|11|||
160781118|NCT02029443|580583096|FG004|Overall Study|Death|2|||
160781119|NCT02029443|580583092|FG000|Overall Study|Lost to Follow-up|1|||
160781120|NCT02029443|580583093|FG001|Overall Study|Lost to Follow-up|0|||
160781121|NCT02029443|580583094|FG002|Overall Study|Lost to Follow-up|1|||
160781122|NCT02029443|580583095|FG003|Overall Study|Lost to Follow-up|1|||
160781123|NCT02029443|580583096|FG004|Overall Study|Lost to Follow-up|0|||
160781124|NCT02029443|580583092|FG000|Overall Study|Started other anti-cancer therapy|17|||
160781125|NCT02029443|580583093|FG001|Overall Study|Started other anti-cancer therapy|4|||
160781126|NCT02029443|580583094|FG002|Overall Study|Started other anti-cancer therapy|7|||
160781127|NCT02029443|580583095|FG003|Overall Study|Started other anti-cancer therapy|9|||
160781128|NCT02029443|580583096|FG004|Overall Study|Started other anti-cancer therapy|3|||
160781129|NCT02029443|580583092|FG000|Overall Study|Withdrawal by Subject|3|||
160781130|NCT02029443|580583093|FG001|Overall Study|Withdrawal by Subject|1|||
160781131|NCT02029443|580583094|FG002|Overall Study|Withdrawal by Subject|1|||
160781132|NCT02029443|580583095|FG003|Overall Study|Withdrawal by Subject|1|||
160781133|NCT02029443|580583096|FG004|Overall Study|Withdrawal by Subject|0|||
161326477|NCT01004978|582581236|FG001|Overall Study|Adverse Event|22|||
160781134|NCT02029443|580583092|FG000|Overall Study|Other|6|||
160781135|NCT02029443|580583093|FG001|Overall Study|Other|6|||
160781136|NCT02029443|580583094|FG002|Overall Study|Other|4|||
160781137|NCT02029443|580583095|FG003|Overall Study|Other|2|||
161123412|NCT03467958|581837561|FG002|Overall Study|Pregnancy|0|||
161123413|NCT03467958|581837562|FG003|Overall Study|Pregnancy|0|||
161123414|NCT03467958|581837563|FG004|Overall Study|Pregnancy|0|||
161123415|NCT03467958|581837564|FG005|Overall Study|Pregnancy|1|||
161123416|NCT03467958|581837565|FG006|Overall Study|Pregnancy|0|||
161123417|NCT03467958|581837566|FG007|Overall Study|Pregnancy|0|||
161123418|NCT03467958|581837567|FG008|Overall Study|Pregnancy|0|||
161123419|NCT03467958|581837559|FG000|Overall Study|Study terminated by sponsor|65|||
161123420|NCT03467958|581837560|FG001|Overall Study|Study terminated by sponsor|117|||
161123421|NCT03467958|581837561|FG002|Overall Study|Study terminated by sponsor|45|||
161123422|NCT03467958|581837562|FG003|Overall Study|Study terminated by sponsor|64|||
161123423|NCT03467958|581837563|FG004|Overall Study|Study terminated by sponsor|66|||
161123424|NCT03467958|581837564|FG005|Overall Study|Study terminated by sponsor|17|||
161123425|NCT03467958|581837565|FG006|Overall Study|Study terminated by sponsor|11|||
161123426|NCT03467958|581837566|FG007|Overall Study|Study terminated by sponsor|5|||
161123427|NCT03467958|581837567|FG008|Overall Study|Study terminated by sponsor|5|||
161123428|NCT03467958|581837559|FG000|Overall Study|Withdrawal by Subject|25|||
161123429|NCT03467958|581837560|FG001|Overall Study|Withdrawal by Subject|44|||
161123430|NCT03467958|581837561|FG002|Overall Study|Withdrawal by Subject|7|||
161123431|NCT03467958|581837562|FG003|Overall Study|Withdrawal by Subject|8|||
161123432|NCT03467958|581837563|FG004|Overall Study|Withdrawal by Subject|6|||
161123433|NCT03467958|581837564|FG005|Overall Study|Withdrawal by Subject|8|||
161123434|NCT03467958|581837565|FG006|Overall Study|Withdrawal by Subject|4|||
161123435|NCT03467958|581837566|FG007|Overall Study|Withdrawal by Subject|1|||
161123436|NCT03467958|581837567|FG008|Overall Study|Withdrawal by Subject|4|||
161123437|NCT00730639|581837568|FG000|Overall Study|Adverse Event|3|||
161123438|NCT00730639|581837569|FG001|Overall Study|Adverse Event|0|||
161123439|NCT00730639|581837570|FG002|Overall Study|Adverse Event|9|||
161123440|NCT00730639|581837571|FG003|Overall Study|Adverse Event|8|||
161123441|NCT00730639|581837572|FG004|Overall Study|Adverse Event|23|||
161123442|NCT00730639|581837568|FG000|Overall Study|Complete Response|0|||
161123443|NCT00730639|581837569|FG001|Overall Study|Complete Response|0|||
161123444|NCT00730639|581837570|FG002|Overall Study|Complete Response|2|||
161123445|NCT00730639|581837571|FG003|Overall Study|Complete Response|2|||
161123446|NCT00730639|581837572|FG004|Overall Study|Complete Response|1|||
161123447|NCT00730639|581837568|FG000|Overall Study|Completed Maximum Cycles|0|||
161123448|NCT00730639|581837569|FG001|Overall Study|Completed Maximum Cycles|0|||
161123449|NCT00730639|581837570|FG002|Overall Study|Completed Maximum Cycles|11|||
161123450|NCT00730639|581837571|FG003|Overall Study|Completed Maximum Cycles|3|||
161123451|NCT00730639|581837572|FG004|Overall Study|Completed Maximum Cycles|6|||
161123452|NCT00730639|581837568|FG000|Overall Study|Death|0|||
161123453|NCT00730639|581837569|FG001|Overall Study|Death|0|||
161123454|NCT00730639|581837570|FG002|Overall Study|Death|0|||
161123455|NCT00730639|581837571|FG003|Overall Study|Death|0|||
161123456|NCT00730639|581837572|FG004|Overall Study|Death|2|||
161123457|NCT00730639|581837568|FG000|Overall Study|Disease Progression|12|||
161123458|NCT00730639|581837569|FG001|Overall Study|Disease Progression|13|||
161123459|NCT00730639|581837570|FG002|Overall Study|Disease Progression|48|||
161123460|NCT00730639|581837571|FG003|Overall Study|Disease Progression|32|||
161123461|NCT00730639|581837572|FG004|Overall Study|Disease Progression|88|||
161123462|NCT00730639|581837568|FG000|Overall Study|non-specified|0|||
161123463|NCT00730639|581837569|FG001|Overall Study|non-specified|0|||
161123464|NCT00730639|581837570|FG002|Overall Study|non-specified|4|||
161123465|NCT00730639|581837571|FG003|Overall Study|non-specified|2|||
161123466|NCT00730639|581837572|FG004|Overall Study|non-specified|3|||
161123467|NCT00730639|581837568|FG000|Overall Study|Protocol Violation|0|||
161123468|NCT00730639|581837569|FG001|Overall Study|Protocol Violation|0|||
161123469|NCT00730639|581837570|FG002|Overall Study|Protocol Violation|1|||
160781138|NCT02029443|580583096|FG004|Overall Study|Other|0|||
161123470|NCT00730639|581837571|FG003|Overall Study|Protocol Violation|0|||
161123471|NCT00730639|581837572|FG004|Overall Study|Protocol Violation|0|||
161123472|NCT00730639|581837568|FG000|Overall Study|Withdrawal by Subject|0|||
161123473|NCT00730639|581837569|FG001|Overall Study|Withdrawal by Subject|0|||
161123474|NCT00730639|581837570|FG002|Overall Study|Withdrawal by Subject|6|||
161123475|NCT00730639|581837571|FG003|Overall Study|Withdrawal by Subject|3|||
161123476|NCT00730639|581837572|FG004|Overall Study|Withdrawal by Subject|4|||
161123477|NCT00730639|581837568|FG000|Overall Study|Treatment on-going|2|||
160781139|NCT02070991|580583102|FG000|Overall Study|Death|2|||
160781140|NCT02070991|580583103|FG001|Overall Study|Death|0|||
160781141|NCT02070991|580583102|FG000|Overall Study|Withdrawal by Subject|1|||
161123478|NCT00730639|581837569|FG001|Overall Study|Treatment on-going|5|||
161123479|NCT00730639|581837570|FG002|Overall Study|Treatment on-going|5|||
161123480|NCT00730639|581837571|FG003|Overall Study|Treatment on-going|4|||
161123481|NCT00730639|581837572|FG004|Overall Study|Treatment on-going|4|||
161123482|NCT00516737|581837578|FG000|Overall Study|Lost to Follow-up|2|||
161123483|NCT00516737|581837579|FG001|Overall Study|Lost to Follow-up|0|||
161123484|NCT00516737|581837578|FG000|Overall Study|Physician Decision|0|||
161123485|NCT00516737|581837579|FG001|Overall Study|Physician Decision|1|||
161123486|NCT00516737|581837578|FG000|Overall Study|Withdrawal by Subject|0|||
161123487|NCT00516737|581837579|FG001|Overall Study|Withdrawal by Subject|1|||
161123488|NCT00516737|581837578|FG000|Overall Study|Lack of Qualifying Event|9|||
161123489|NCT00516737|581837579|FG001|Overall Study|Lack of Qualifying Event|6|||
161123490|NCT00848354|581837580|FG000|Phase 1|Adverse Event|5|||
161123491|NCT00848354|581837581|FG001|Phase 1|Adverse Event|4|||
161123492|NCT00848354|581837580|FG000|Phase 1|Discontinuation of study by sponsor|2|||
161123493|NCT00848354|581837581|FG001|Phase 1|Discontinuation of study by sponsor|1|||
161123494|NCT00848354|581837580|FG000|Phase 1|Failed to return|0|||
161123495|NCT00848354|581837581|FG001|Phase 1|Failed to return|1|||
161123496|NCT00848354|581837580|FG000|Phase 1|Lost to Follow-up|1|||
161123497|NCT00848354|581837581|FG001|Phase 1|Lost to Follow-up|1|||
161123498|NCT00848354|581837580|FG000|Phase 1|Unspecified Reason|1|||
161123499|NCT00848354|581837581|FG001|Phase 1|Unspecified Reason|1|||
161123500|NCT00848354|581837580|FG000|Phase 1|Protocol Violation|1|||
161123501|NCT00848354|581837581|FG001|Phase 1|Protocol Violation|1|||
161123502|NCT00848354|581837580|FG000|Phase 1|Withdrawal by Subject|2|||
161123503|NCT00848354|581837581|FG001|Phase 1|Withdrawal by Subject|4|||
161123504|NCT00848354|581837580|FG000|Phase 1|Lack of Efficacy|0|||
161123505|NCT00848354|581837581|FG001|Phase 1|Lack of Efficacy|1|||
161123506|NCT00848354|581837580|FG000|Phase 2 Year 1|Adverse Event|7|||
161123507|NCT00848354|581837581|FG001|Phase 2 Year 1|Adverse Event|2|||
161123508|NCT00848354|581837580|FG000|Phase 2 Year 1|Death|1|||
161123509|NCT00848354|581837581|FG001|Phase 2 Year 1|Death|0|||
161123510|NCT00848354|581837580|FG000|Phase 2 Year 1|Failed to Return|1|||
161123511|NCT00848354|581837581|FG001|Phase 2 Year 1|Failed to Return|1|||
161123512|NCT00848354|581837580|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
161123513|NCT00848354|581837581|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
161123514|NCT00848354|581837580|FG000|Phase 2 Year 1|Unspecified Reason|3|||
161123515|NCT00848354|581837581|FG001|Phase 2 Year 1|Unspecified Reason|0|||
161123516|NCT00848354|581837580|FG000|Phase 2 Year 1|Protocol Violation|4|||
161123517|NCT00848354|581837581|FG001|Phase 2 Year 1|Protocol Violation|1|||
161123518|NCT00848354|581837580|FG000|Phase 2 Year 1|Subject Request|1|||
161123519|NCT00848354|581837581|FG001|Phase 2 Year 1|Subject Request|2|||
161123520|NCT00848354|581837580|FG000|Phase 2 Year 2|Adverse Event|12|||
161123521|NCT00848354|581837581|FG001|Phase 2 Year 2|Adverse Event|2|||
161123522|NCT00848354|581837580|FG000|Phase 2 Year 2|Death|2|||
161123523|NCT00848354|581837581|FG001|Phase 2 Year 2|Death|0|||
161123524|NCT00848354|581837580|FG000|Phase 2 Year 2|Failed to return|3|||
161123525|NCT00848354|581837581|FG001|Phase 2 Year 2|Failed to return|0|||
161123526|NCT00848354|581837580|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
161123527|NCT00848354|581837581|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
161123528|NCT00848354|581837580|FG000|Phase 2 Year 2|Unspecified Reason|1|||
161123529|NCT00848354|581837581|FG001|Phase 2 Year 2|Unspecified Reason|0|||
161123530|NCT00848354|581837580|FG000|Phase 2 Year 2|Protocol Violation|1|||
161123531|NCT00848354|581837581|FG001|Phase 2 Year 2|Protocol Violation|1|||
161123532|NCT00848354|581837580|FG000|Phase 2 Year 2|Subject Request|1|||
161123533|NCT00848354|581837581|FG001|Phase 2 Year 2|Subject Request|1|||
161123534|NCT00848354|581837580|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
161123535|NCT00848354|581837581|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
161123536|NCT04484285|581839028|FG000|Overall Study|Unable to operate stimulator|3|||
161123537|NCT04484285|581839029|FG001|Overall Study|Unable to operate stimulator|0|||
161123538|NCT02527707|581839030|FG000|Overall Study|Adverse Event|1|||
161123539|NCT02527707|581839030|FG000|Overall Study|Adverse Event|1|||
161326478|NCT01004978|582581235|FG000|Overall Study|Death|3|||
161326479|NCT01004978|582581236|FG001|Overall Study|Death|2|||
160781142|NCT02070991|580583103|FG001|Overall Study|Withdrawal by Subject|0|||
160781143|NCT04999020|580583104|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
160781144|NCT04999020|580583105|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
160781145|NCT04999020|580583106|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
161123540|NCT04002310|581839031|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
161123541|NCT04002310|581839032|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
161123542|NCT04002310|581839033|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
161123543|NCT04002310|581839034|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
161123544|NCT04002310|581839035|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
161123545|NCT00352534|581839036|FG000|Initial Staging|Ineligible|8|||
161123546|NCT00352534|581839037|FG001|Initial Staging|Ineligible|9|||
161123547|NCT00352534|581839038|FG002|Initial Staging|Ineligible|0|||
161123548|NCT00352534|581839039|FG003|Initial Staging|Ineligible|0|||
161123549|NCT00352534|581839040|FG004|Initial Staging|Ineligible|0|||
161123550|NCT00352534|581839041|FG005|Initial Staging|Ineligible|0|||
161123551|NCT00352534|581839042|FG006|Initial Staging|Ineligible|0|||
161123552|NCT00352534|581839036|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
161123553|NCT00352534|581839037|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
161123554|NCT00352534|581839038|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
160781146|NCT04999020|580583107|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
160888721|NCT01185834|580986564|FG000|Overall Study|Time/Job Conflict|2|||
160888722|NCT01185834|580986564|FG000|Overall Study|Early exit - Site error|2|||
160888723|NCT01244490|580986565|FG000|Overall Study|Lack of Efficacy|14|||
160888724|NCT01244490|580986566|FG001|Overall Study|Lack of Efficacy|5|||
160888725|NCT01244490|580986567|FG002|Overall Study|Lack of Efficacy|5|||
160888726|NCT01244490|580986565|FG000|Overall Study|Withdrawal by Subject|4|||
160888727|NCT01244490|580986566|FG001|Overall Study|Withdrawal by Subject|4|||
160888728|NCT01244490|580986567|FG002|Overall Study|Withdrawal by Subject|9|||
160888729|NCT01244490|580986565|FG000|Overall Study|Adverse Event|1|||
160888730|NCT01244490|580986566|FG001|Overall Study|Adverse Event|9|||
160888731|NCT01244490|580986567|FG002|Overall Study|Adverse Event|5|||
160888732|NCT01244490|580986565|FG000|Overall Study|Lost to Follow-up|0|||
160888733|NCT01244490|580986566|FG001|Overall Study|Lost to Follow-up|6|||
160888734|NCT01244490|580986567|FG002|Overall Study|Lost to Follow-up|3|||
160888735|NCT01244490|580986565|FG000|Overall Study|Other|0|||
160888736|NCT01244490|580986566|FG001|Overall Study|Other|0|||
160888737|NCT01244490|580986567|FG002|Overall Study|Other|1|||
160888738|NCT02290431|580986570|FG000|Overall Study|Adverse Event|20|||
160888739|NCT02290431|580986570|FG000|Overall Study|Progressive disease|4|||
160888740|NCT02290431|580986570|FG000|Overall Study|Study terminated by Sponsor|1|||
160888741|NCT02290431|580986570|FG000|Overall Study|Physician Decision|2|||
160888742|NCT03324581|580986572|FG000|Overall Study|Adverse Event|18|||
160888743|NCT03324581|580986573|FG001|Overall Study|Adverse Event|11|||
160888744|NCT03324581|580986574|FG002|Overall Study|Adverse Event|7|||
160888745|NCT03324581|580986572|FG000|Overall Study|Lack of Efficacy|0|||
160888746|NCT03324581|580986573|FG001|Overall Study|Lack of Efficacy|1|||
160888747|NCT03324581|580986574|FG002|Overall Study|Lack of Efficacy|0|||
160888748|NCT03324581|580986572|FG000|Overall Study|Lost to Follow-up|5|||
160888749|NCT03324581|580986573|FG001|Overall Study|Lost to Follow-up|3|||
160888750|NCT03324581|580986574|FG002|Overall Study|Lost to Follow-up|6|||
160888751|NCT03324581|580986572|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
160888752|NCT03324581|580986573|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
160888753|NCT03324581|580986574|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
160888754|NCT03324581|580986572|FG000|Overall Study|Physician Decision|0|||
160888755|NCT03324581|580986573|FG001|Overall Study|Physician Decision|1|||
160888756|NCT03324581|580986574|FG002|Overall Study|Physician Decision|2|||
160888757|NCT03324581|580986572|FG000|Overall Study|Protocol Deviation|8|||
160888758|NCT03324581|580986573|FG001|Overall Study|Protocol Deviation|9|||
160888759|NCT03324581|580986574|FG002|Overall Study|Protocol Deviation|4|||
160888760|NCT03324581|580986572|FG000|Overall Study|Withdrawal by Subject|6|||
160888761|NCT03324581|580986573|FG001|Overall Study|Withdrawal by Subject|8|||
160888762|NCT03324581|580986574|FG002|Overall Study|Withdrawal by Subject|6|||
160888763|NCT03324581|580986572|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
160888764|NCT03324581|580986573|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
160888765|NCT03324581|580986574|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
160888766|NCT00321893|580986576|FG000|Overall Study|Non-Compliance/Refusal|16|||
160888767|NCT00321893|580986577|FG001|Overall Study|Non-Compliance/Refusal|10|||
160888768|NCT00321893|580986576|FG000|Overall Study|Lost to Follow-up|2|||
160888769|NCT00321893|580986577|FG001|Overall Study|Lost to Follow-up|1|||
160888770|NCT00321893|580986576|FG000|Overall Study|Adverse Event|6|||
160888771|NCT00321893|580986577|FG001|Overall Study|Adverse Event|3|||
160888772|NCT03523000|580986578|FG000|Overall Study|Withdrawal by Subject|3|||
160888773|NCT03523000|580986579|FG001|Overall Study|Withdrawal by Subject|0|||
160888774|NCT03523000|580986578|FG000|Overall Study|Unsuccessful trial|2|||
160888775|NCT03523000|580986579|FG001|Overall Study|Unsuccessful trial|0|||
160888776|NCT03993379|580986580|FG000|Overall Study|The study was terminated early due to business decision.|0|||
160888777|NCT03993379|580986581|FG001|Overall Study|The study was terminated early due to business decision.|2|||
161326480|NCT01004978|582581235|FG000|Overall Study|Withdrawal by Subject|16|||
161326481|NCT01004978|582581236|FG001|Overall Study|Withdrawal by Subject|16|||
161326482|NCT01004978|582581235|FG000|Overall Study|Alternative therapy|4|||
161326483|NCT01004978|582581236|FG001|Overall Study|Alternative therapy|8|||
161326484|NCT01004978|582581235|FG000|Overall Study|Physician Decision|6|||
161326485|NCT01004978|582581236|FG001|Overall Study|Physician Decision|3|||
161326486|NCT01004978|582581235|FG000|Overall Study|Other complicating disease|2|||
161326487|NCT01004978|582581236|FG001|Overall Study|Other complicating disease|2|||
161326488|NCT01004978|582581235|FG000|Overall Study|Protocol Violation|2|||
161326489|NCT01004978|582581236|FG001|Overall Study|Protocol Violation|3|||
161326490|NCT01004978|582581235|FG000|Overall Study|Non-compliance|3|||
160888778|NCT03993379|580986582|FG002|Overall Study|The study was terminated early due to business decision.|0|||
160888779|NCT03993379|580986583|FG003|Overall Study|The study was terminated early due to business decision.|0|||
160888780|NCT03993379|580986580|FG000|Overall Study|Withdrawal by Subject|0|||
160888781|NCT03993379|580986581|FG001|Overall Study|Withdrawal by Subject|1|||
160888782|NCT03993379|580986582|FG002|Overall Study|Withdrawal by Subject|0|||
160888783|NCT03993379|580986583|FG003|Overall Study|Withdrawal by Subject|0|||
161326491|NCT01004978|582581236|FG001|Overall Study|Non-compliance|2|||
161326492|NCT01004978|582581235|FG000|Overall Study|Ineligible|1|||
161123555|NCT00352534|581839039|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
161123556|NCT00352534|581839040|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
161123557|NCT00352534|581839041|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
161123558|NCT00352534|581839042|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
161123559|NCT00352534|581839036|FG000|Final Risk Group Assignment|Physician Decision|0|||
161123560|NCT00352534|581839037|FG001|Final Risk Group Assignment|Physician Decision|0|||
161123561|NCT00352534|581839038|FG002|Final Risk Group Assignment|Physician Decision|0|||
161123562|NCT00352534|581839039|FG003|Final Risk Group Assignment|Physician Decision|0|||
161123563|NCT00352534|581839040|FG004|Final Risk Group Assignment|Physician Decision|0|||
161123564|NCT00352534|581839041|FG005|Final Risk Group Assignment|Physician Decision|8|||
161123565|NCT00352534|581839042|FG006|Final Risk Group Assignment|Physician Decision|0|||
161123566|NCT00352534|581839036|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
161123567|NCT00352534|581839037|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
161123568|NCT00352534|581839038|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
161123569|NCT00352534|581839039|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
161123570|NCT00352534|581839040|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
160781147|NCT04999020|580583104|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
160781148|NCT04999020|580583105|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
160781149|NCT04999020|580583106|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
160781150|NCT04999020|580583107|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
160781151|NCT04999020|580583104|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
160781152|NCT04999020|580583105|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
160781153|NCT04999020|580583106|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
160781154|NCT04999020|580583107|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
160888784|NCT02380690|580986584|FG000|Overall Study|Lost to Follow-up|14|||
160888785|NCT02380690|580986585|FG001|Overall Study|Lost to Follow-up|4|||
160888786|NCT02380690|580986584|FG000|Overall Study|Withdrawal by Subject|20|||
160888787|NCT02380690|580986585|FG001|Overall Study|Withdrawal by Subject|8|||
160888788|NCT00266864|580986586|FG000|Overall Study|Lost to Follow-up|4|||
160888789|NCT00266864|580986587|FG001|Overall Study|Lost to Follow-up|1|||
160888790|NCT00266864|580986586|FG000|Overall Study|Withdrawal by Subject|1|||
160888791|NCT00266864|580986587|FG001|Overall Study|Withdrawal by Subject|1|||
160888792|NCT00727532|580986588|FG000|Overall Study|Adverse Event|1|||
160888793|NCT00727532|580986588|FG000|Overall Study|Withdrawal by Subject|1|||
160888794|NCT00829933|580986589|FG000|Overall Study|Adverse Event|2|||
160888795|NCT00829933|580986590|FG001|Overall Study|Adverse Event|3|||
160888796|NCT00829933|580986591|FG002|Overall Study|Adverse Event|2|||
160888797|NCT00829933|580986592|FG003|Overall Study|Adverse Event|1|||
160888798|NCT00829933|580986589|FG000|Overall Study|Death|0|||
160888799|NCT00829933|580986590|FG001|Overall Study|Death|0|||
160888800|NCT00829933|580986591|FG002|Overall Study|Death|1|||
160888801|NCT00829933|580986592|FG003|Overall Study|Death|1|||
160888802|NCT00829933|580986589|FG000|Overall Study|Lack of Efficacy|0|||
160888803|NCT00829933|580986590|FG001|Overall Study|Lack of Efficacy|1|||
160888804|NCT00829933|580986591|FG002|Overall Study|Lack of Efficacy|0|||
160888805|NCT00829933|580986592|FG003|Overall Study|Lack of Efficacy|0|||
160888806|NCT00829933|580986589|FG000|Overall Study|Physician Decision|5|||
160888807|NCT00829933|580986590|FG001|Overall Study|Physician Decision|7|||
160888808|NCT00829933|580986591|FG002|Overall Study|Physician Decision|8|||
160888809|NCT00829933|580986592|FG003|Overall Study|Physician Decision|1|||
160888810|NCT00829933|580986589|FG000|Overall Study|Pregnancy|0|||
161123571|NCT00352534|581839041|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
161123572|NCT00352534|581839042|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
160781155|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160781156|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160781157|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
160781158|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
160781159|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160781160|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
160781161|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
160781162|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
160781163|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
160781164|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
160781165|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
160781166|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
160781167|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160888811|NCT00829933|580986590|FG001|Overall Study|Pregnancy|0|||
160888812|NCT00829933|580986591|FG002|Overall Study|Pregnancy|0|||
160781168|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160888813|NCT00829933|580986592|FG003|Overall Study|Pregnancy|2|||
160888814|NCT00829933|580986589|FG000|Overall Study|Protocol Violation|2|||
160888815|NCT00829933|580986590|FG001|Overall Study|Protocol Violation|1|||
160888816|NCT00829933|580986591|FG002|Overall Study|Protocol Violation|0|||
161123573|NCT00352534|581839036|FG000|Final Risk Group Assignment|Ineligible|0|||
161123574|NCT00352534|581839037|FG001|Final Risk Group Assignment|Ineligible|0|||
161123575|NCT00352534|581839038|FG002|Final Risk Group Assignment|Ineligible|3|||
161123576|NCT00352534|581839039|FG003|Final Risk Group Assignment|Ineligible|1|||
161123577|NCT00352534|581839040|FG004|Final Risk Group Assignment|Ineligible|0|||
161123578|NCT00352534|581839041|FG005|Final Risk Group Assignment|Ineligible|13|||
161123579|NCT00352534|581839042|FG006|Final Risk Group Assignment|Ineligible|0|||
161123580|NCT00352534|581839036|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161123581|NCT00352534|581839037|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161123582|NCT00352534|581839038|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161123583|NCT00352534|581839039|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161123584|NCT00352534|581839040|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161123585|NCT00352534|581839041|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
161229547|NCT01918397|582222497|FG002|Overall Study|Treatment failure|0|||
160781169|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
160781170|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
160781171|NCT04999020|580583104|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
160781172|NCT04999020|580583105|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
160781173|NCT04999020|580583106|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
160781174|NCT04999020|580583107|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
160781175|NCT02609633|580583112|FG000|Overall Study|Consent Withdrawn|0|||
160781176|NCT02609633|580583113|FG001|Overall Study|Consent Withdrawn|1|||
160781177|NCT02609633|580583112|FG000|Overall Study|Protocol Deviation|1|||
160781178|NCT02609633|580583113|FG001|Overall Study|Protocol Deviation|0|||
160781179|NCT02609633|580583112|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
160781180|NCT02609633|580583113|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
160781181|NCT02609633|580583112|FG000|Overall Study|Reason not Specified|2|||
160781182|NCT02609633|580583113|FG001|Overall Study|Reason not Specified|1|||
160781183|NCT03123588|580583116|FG000|Overall Study|Study Terminated by Sponsor|2|||
160781184|NCT03123588|580583117|FG001|Overall Study|Study Terminated by Sponsor|5|||
160781185|NCT03123588|580583116|FG000|Overall Study|Withdrawal by Subject|1|||
160781186|NCT03123588|580583117|FG001|Overall Study|Withdrawal by Subject|0|||
160781187|NCT03123588|580583116|FG000|Overall Study|Adverse Event|1|||
160781188|NCT03123588|580583117|FG001|Overall Study|Adverse Event|0|||
160781189|NCT03123588|580583116|FG000|Overall Study|Physician Decision|2|||
160781190|NCT03123588|580583117|FG001|Overall Study|Physician Decision|1|||
160781191|NCT00866320|580583121|FG000|Overall Study|Withdrawal by Subject|4|||
160781192|NCT00866320|580583121|FG000|Overall Study|Death|2|||
160781193|NCT00366535|580583127|FG000|First Phase: 12 Weeks|Adverse Event|1|||
160781194|NCT00366535|580583128|FG001|First Phase: 12 Weeks|Adverse Event|3|||
160781195|NCT00366535|580583127|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
160781196|NCT00366535|580583128|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
160781197|NCT00366535|580583127|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
160781198|NCT00366535|580583128|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
160781199|NCT00366535|580583127|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
160781200|NCT00366535|580583128|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
160781201|NCT02958527|580583133|FG000|Overall Study|Not collected CRFs|12|||
160781202|NCT06042855|580583136|FG000|Overall Study|No Receipt of Study Drug|48|||
160781203|NCT06042855|580583137|FG001|Overall Study|No Receipt of Study Drug|57|||
160781204|NCT06042855|580583136|FG000|Overall Study|Administratively Withdrawn|59|||
160781205|NCT06042855|580583137|FG001|Overall Study|Administratively Withdrawn|59|||
160781206|NCT06038643|580583139|FG000|Overall Study|Withdrawal by Subject|9|||
160781207|NCT06038643|580583140|FG001|Overall Study|Withdrawal by Subject|4|||
160781208|NCT06038643|580583139|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
160781209|NCT06038643|580583140|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
160781210|NCT03573882|580583141|FG000|Overall Study|Study Terminated by Sponsor|22|||
160781211|NCT03573882|580583142|FG001|Overall Study|Study Terminated by Sponsor|17|||
160781212|NCT03573882|580583143|FG002|Overall Study|Study Terminated by Sponsor|18|||
160781213|NCT03573882|580583141|FG000|Overall Study|Withdrawal by Subject|6|||
160781214|NCT03573882|580583142|FG001|Overall Study|Withdrawal by Subject|11|||
160781215|NCT03573882|580583143|FG002|Overall Study|Withdrawal by Subject|7|||
160888817|NCT00829933|580986592|FG003|Overall Study|Protocol Violation|0|||
161123586|NCT00352534|581839042|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
161229548|NCT01918397|582222498|FG003|Overall Study|Treatment failure|1|||
161229549|NCT01918397|582222495|FG000|Overall Study|Withdrawal by Subject|3|||
160781216|NCT03573882|580583141|FG000|Overall Study|Adverse Event|7|||
160781217|NCT03573882|580583142|FG001|Overall Study|Adverse Event|5|||
160781218|NCT03573882|580583143|FG002|Overall Study|Adverse Event|6|||
160781219|NCT03573882|580583141|FG000|Overall Study|Lost to Follow-up|2|||
160781220|NCT03573882|580583142|FG001|Overall Study|Lost to Follow-up|5|||
160781221|NCT03573882|580583143|FG002|Overall Study|Lost to Follow-up|3|||
160781222|NCT03573882|580583141|FG000|Overall Study|Physician Decision|4|||
160781223|NCT03573882|580583142|FG001|Overall Study|Physician Decision|3|||
160781224|NCT03573882|580583143|FG002|Overall Study|Physician Decision|2|||
160781225|NCT03573882|580583141|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
160781226|NCT03573882|580583142|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
160781227|NCT03573882|580583143|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
160781228|NCT03573882|580583141|FG000|Overall Study|Pregnancy|1|||
160781229|NCT03573882|580583142|FG001|Overall Study|Pregnancy|2|||
160781230|NCT03573882|580583143|FG002|Overall Study|Pregnancy|0|||
160781231|NCT03573882|580583141|FG000|Overall Study|Other|4|||
161123587|NCT00352534|581839036|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161123588|NCT00352534|581839037|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161123589|NCT00352534|581839038|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161123590|NCT00352534|581839039|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161123591|NCT00352534|581839040|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161123592|NCT00352534|581839041|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
161123593|NCT00352534|581839042|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
161123594|NCT00352534|581839036|FG000|Final Risk Group Assignment|Death|0|||
161123595|NCT00352534|581839037|FG001|Final Risk Group Assignment|Death|0|||
161123596|NCT00352534|581839038|FG002|Final Risk Group Assignment|Death|0|||
161123597|NCT00352534|581839039|FG003|Final Risk Group Assignment|Death|0|||
161123598|NCT00352534|581839040|FG004|Final Risk Group Assignment|Death|0|||
161123599|NCT00352534|581839041|FG005|Final Risk Group Assignment|Death|2|||
161123600|NCT00352534|581839042|FG006|Final Risk Group Assignment|Death|0|||
161123601|NCT00544869|581839043|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
161123602|NCT00544869|581839044|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
161123603|NCT00544869|581839045|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
161123604|NCT00544869|581839043|FG000|Overall Study|Adverse Event|6|||
161123605|NCT00544869|581839044|FG001|Overall Study|Adverse Event|1|||
161123606|NCT00544869|581839045|FG002|Overall Study|Adverse Event|0|||
161123607|NCT00544869|581839043|FG000|Overall Study|Lack of Efficacy|1|||
161123608|NCT00544869|581839044|FG001|Overall Study|Lack of Efficacy|1|||
161123609|NCT00544869|581839045|FG002|Overall Study|Lack of Efficacy|0|||
161123610|NCT00544869|581839043|FG000|Overall Study|Physician Decision|2|||
161123611|NCT00544869|581839044|FG001|Overall Study|Physician Decision|0|||
161123612|NCT00544869|581839045|FG002|Overall Study|Physician Decision|0|||
161123613|NCT00619502|581839046|FG000|Overall Study|Lost to Follow-up|8|||
161123614|NCT00619502|581839047|FG001|Overall Study|Lost to Follow-up|10|||
161123615|NCT01354028|581839048|FG000|Overall Study|Physician Decision|0|||
161123616|NCT01354028|581839049|FG001|Overall Study|Physician Decision|2|||
161123617|NCT01354028|581839048|FG000|Overall Study|Discharged before study start|2|||
161123618|NCT01354028|581839049|FG001|Overall Study|Discharged before study start|2|||
161123619|NCT01354028|581839048|FG000|Overall Study|No quiet alert state|0|||
161123620|NCT01354028|581839049|FG001|Overall Study|No quiet alert state|1|||
161123621|NCT03968419|581839050|FG000|Treatment Period|Adverse Event|0|||
161123622|NCT03968419|581839051|FG001|Treatment Period|Adverse Event|0|||
161123623|NCT03968419|581839052|FG002|Treatment Period|Adverse Event|1|||
161123624|NCT03968419|581839050|FG000|Safety Follow-up Period|Death|3|||
161123625|NCT03968419|581839051|FG001|Safety Follow-up Period|Death|2|||
161123626|NCT03968419|581839052|FG002|Safety Follow-up Period|Death|1|||
161123627|NCT03968419|581839050|FG000|Safety Follow-up Period|Subject Decision|2|||
161123628|NCT03968419|581839051|FG001|Safety Follow-up Period|Subject Decision|1|||
161123629|NCT03968419|581839052|FG002|Safety Follow-up Period|Subject Decision|0|||
161123630|NCT00935883|581839055|FG000|Treatment Period|Physician Decision|1|||
161123631|NCT00935883|581839056|FG001|Treatment Period|Physician Decision|0|||
161123632|NCT00935883|581839055|FG000|Treatment Period|Withdrawal by Subject|0|||
161123633|NCT00935883|581839056|FG001|Treatment Period|Withdrawal by Subject|2|||
161123634|NCT01641939|581839057|FG000|Overall Study|Death|90|||
161123635|NCT01641939|581839058|FG001|Overall Study|Death|187|||
161123636|NCT01641939|581839059|FG002|Overall Study|Death|61|||
161123637|NCT01641939|581839057|FG000|Overall Study|Lost to Follow-up|3|||
161123638|NCT01641939|581839058|FG001|Overall Study|Lost to Follow-up|2|||
161123639|NCT01641939|581839059|FG002|Overall Study|Lost to Follow-up|1|||
161123640|NCT01641939|581839057|FG000|Overall Study|Withdrawal by Subject|14|||
161123641|NCT01641939|581839058|FG001|Overall Study|Withdrawal by Subject|11|||
161123642|NCT01641939|581839059|FG002|Overall Study|Withdrawal by Subject|5|||
160781232|NCT03573882|580583142|FG001|Overall Study|Other|2|||
161123643|NCT01641939|581839057|FG000|Overall Study|Study Terminated by Sponsor|10|||
161123644|NCT01641939|581839058|FG001|Overall Study|Study Terminated by Sponsor|28|||
161123645|NCT01641939|581839059|FG002|Overall Study|Study Terminated by Sponsor|3|||
161123646|NCT02894840|581839060|FG000|Overall Study|Lost to Follow-up|1|||
161123647|NCT02894840|581839061|FG001|Overall Study|Lost to Follow-up|0|||
161123648|NCT02894840|581839062|FG002|Overall Study|Lost to Follow-up|3|||
161123649|NCT02894840|581839063|FG003|Overall Study|Lost to Follow-up|0|||
161123650|NCT01072344|581839068|FG000|Overall Study|Relasped-reached end point|7|||
161123651|NCT01072344|581839069|FG001|Overall Study|Relasped-reached end point|12|||
161123652|NCT01072344|581839068|FG000|Overall Study|Protocol Violation|1|||
161123653|NCT01072344|581839069|FG001|Overall Study|Protocol Violation|2|||
160781233|NCT03573882|580583143|FG002|Overall Study|Other|2|||
160781234|NCT02691572|580583144|FG000|Overall Study|Withdrawal by Subject|1|||
161326493|NCT01004978|582581236|FG001|Overall Study|Ineligible|0|||
161326494|NCT01004978|582581235|FG000|Overall Study|Unblinded|0|||
161326495|NCT01004978|582581236|FG001|Overall Study|Unblinded|1|||
161326496|NCT01004978|582581235|FG000|Overall Study|Performance status worsening|0|||
161326497|NCT01004978|582581236|FG001|Overall Study|Performance status worsening|1|||
161326498|NCT01004978|582581235|FG000|Overall Study|Never started treatment|8|||
161326499|NCT01004978|582581236|FG001|Overall Study|Never started treatment|9|||
161326500|NCT00369915|582581237|FG000|Overall Study|expected side effects|2|||
161326501|NCT00369915|582581238|FG001|Overall Study|expected side effects|1|||
161326502|NCT00369915|582581237|FG000|Overall Study|Withdrawal by Subject|4|||
161326503|NCT00369915|582581238|FG001|Overall Study|Withdrawal by Subject|1|||
161326504|NCT00369915|582581237|FG000|Overall Study|W/drawl by investigators|0|||
161326505|NCT00369915|582581238|FG001|Overall Study|W/drawl by investigators|1|||
161326506|NCT01719380|582581241|FG000|Overall Study|Adverse Event|0|||
161326507|NCT01719380|582581242|FG001|Overall Study|Adverse Event|0|||
161326508|NCT01719380|582581243|FG002|Overall Study|Adverse Event|1|||
161326509|NCT01719380|582581244|FG003|Overall Study|Adverse Event|2|||
161326510|NCT01719380|582581245|FG004|Overall Study|Adverse Event|0|||
161326511|NCT01719380|582581246|FG005|Overall Study|Adverse Event|1|||
161326512|NCT01719380|582581247|FG006|Overall Study|Adverse Event|0|||
161326513|NCT01719380|582581248|FG007|Overall Study|Adverse Event|1|||
161326514|NCT01719380|582581249|FG008|Overall Study|Adverse Event|4|||
161326515|NCT01719380|582581250|FG009|Overall Study|Adverse Event|3|||
161326516|NCT01719380|582581241|FG000|Overall Study|Death|0|||
161326517|NCT01719380|582581242|FG001|Overall Study|Death|1|||
161326518|NCT01719380|582581243|FG002|Overall Study|Death|0|||
161326519|NCT01719380|582581244|FG003|Overall Study|Death|0|||
161326520|NCT01719380|582581245|FG004|Overall Study|Death|0|||
161326521|NCT01719380|582581246|FG005|Overall Study|Death|0|||
161326522|NCT01719380|582581247|FG006|Overall Study|Death|0|||
161326523|NCT01719380|582581248|FG007|Overall Study|Death|0|||
161326524|NCT01719380|582581249|FG008|Overall Study|Death|3|||
161123654|NCT01072344|581839068|FG000|Overall Study|Lost to Follow-up|3|||
161123655|NCT01072344|581839069|FG001|Overall Study|Lost to Follow-up|4|||
161123656|NCT00804687|581839070|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
161123657|NCT00804687|581839071|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
161123658|NCT00804687|581839072|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
161123659|NCT00804687|581839073|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
161123660|NCT00804687|581839074|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
160781235|NCT02691572|580583145|FG001|Overall Study|Withdrawal by Subject|0|||
160781236|NCT02691572|580583144|FG000|Overall Study|Protocol Violation|0|||
161123661|NCT00804687|581839075|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
161123662|NCT00804687|581839070|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
161123663|NCT00804687|581839071|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
161123664|NCT00804687|581839072|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
161123665|NCT00804687|581839073|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
161123666|NCT00804687|581839074|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
161326525|NCT01719380|582581250|FG009|Overall Study|Death|3|||
161326526|NCT01719380|582581241|FG000|Overall Study|Participant/Guardian Decision|0|||
161326527|NCT01719380|582581242|FG001|Overall Study|Participant/Guardian Decision|0|||
161326528|NCT01719380|582581243|FG002|Overall Study|Participant/Guardian Decision|1|||
161326529|NCT01719380|582581244|FG003|Overall Study|Participant/Guardian Decision|0|||
161326530|NCT01719380|582581245|FG004|Overall Study|Participant/Guardian Decision|0|||
161326531|NCT01719380|582581246|FG005|Overall Study|Participant/Guardian Decision|0|||
161326532|NCT01719380|582581247|FG006|Overall Study|Participant/Guardian Decision|0|||
160781237|NCT02691572|580583145|FG001|Overall Study|Protocol Violation|1|||
160781238|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
160781239|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
160781240|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Death|28|||
160781241|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Death|29|||
160781242|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
160781243|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
160781244|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Other|30|||
160781245|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Other|20|||
160781246|NCT00699751|580583146|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
161123667|NCT00804687|581839075|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
161123668|NCT00804687|581839070|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
161123669|NCT00804687|581839071|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
161123670|NCT00804687|581839072|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
161326533|NCT01719380|582581248|FG007|Overall Study|Participant/Guardian Decision|0|||
161326534|NCT01719380|582581249|FG008|Overall Study|Participant/Guardian Decision|2|||
161326535|NCT01719380|582581250|FG009|Overall Study|Participant/Guardian Decision|2|||
160781247|NCT00699751|580583147|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
160781248|NCT00699751|580583146|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
161326536|NCT01719380|582581241|FG000|Overall Study|Physician Decision|0|||
161123671|NCT00804687|581839073|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
161123672|NCT00804687|581839074|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
161123673|NCT00804687|581839075|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
161123674|NCT00804687|581839070|FG000|Period 5: Treatment Period|Positive drug test|1|||
161123675|NCT00804687|581839071|FG001|Period 5: Treatment Period|Positive drug test|0|||
161123676|NCT00804687|581839072|FG002|Period 5: Treatment Period|Positive drug test|0|||
161123677|NCT00804687|581839073|FG003|Period 5: Treatment Period|Positive drug test|0|||
161123678|NCT00804687|581839074|FG004|Period 5: Treatment Period|Positive drug test|0|||
161123679|NCT00804687|581839075|FG005|Period 5: Treatment Period|Positive drug test|0|||
161123680|NCT00716976|581839078|FG000|Overall Study|Adverse Event|2|||
161123681|NCT00716976|581839079|FG001|Overall Study|Adverse Event|0|||
161326537|NCT01719380|582581242|FG001|Overall Study|Physician Decision|0|||
161326538|NCT01719380|582581243|FG002|Overall Study|Physician Decision|2|||
161326539|NCT01719380|582581244|FG003|Overall Study|Physician Decision|0|||
161326540|NCT01719380|582581245|FG004|Overall Study|Physician Decision|0|||
161326541|NCT01719380|582581246|FG005|Overall Study|Physician Decision|0|||
161326542|NCT01719380|582581247|FG006|Overall Study|Physician Decision|0|||
161326543|NCT01719380|582581248|FG007|Overall Study|Physician Decision|0|||
161326544|NCT01719380|582581249|FG008|Overall Study|Physician Decision|1|||
160781249|NCT00699751|580583147|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
160781250|NCT00699751|580583146|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
160781251|NCT00699751|580583147|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
160781252|NCT00699751|580583146|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
160781253|NCT00699751|580583147|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
160781254|NCT01947933|580583148|FG000|Overall Study|Withdrawal by Subject|0|||
160781255|NCT01947933|580583149|FG001|Overall Study|Withdrawal by Subject|0|||
160781256|NCT01947933|580583150|FG002|Overall Study|Withdrawal by Subject|1|||
160781257|NCT01947933|580583151|FG003|Overall Study|Withdrawal by Subject|0|||
160781258|NCT01947933|580583152|FG004|Overall Study|Withdrawal by Subject|0|||
160781259|NCT01947933|580583153|FG005|Overall Study|Withdrawal by Subject|0|||
160781260|NCT01947933|580583154|FG006|Overall Study|Withdrawal by Subject|0|||
160781261|NCT01947933|580583155|FG007|Overall Study|Withdrawal by Subject|0|||
160781262|NCT01947933|580583156|FG008|Overall Study|Withdrawal by Subject|0|||
160781263|NCT01947933|580583148|FG000|Overall Study|Lost to Follow-up|0|||
160781264|NCT01947933|580583149|FG001|Overall Study|Lost to Follow-up|0|||
160781265|NCT01947933|580583150|FG002|Overall Study|Lost to Follow-up|0|||
160781266|NCT01947933|580583151|FG003|Overall Study|Lost to Follow-up|0|||
160781267|NCT01947933|580583152|FG004|Overall Study|Lost to Follow-up|0|||
160781268|NCT01947933|580583153|FG005|Overall Study|Lost to Follow-up|0|||
160781269|NCT01947933|580583154|FG006|Overall Study|Lost to Follow-up|0|||
160781270|NCT01947933|580583155|FG007|Overall Study|Lost to Follow-up|0|||
160781271|NCT01947933|580583156|FG008|Overall Study|Lost to Follow-up|1|||
160781272|NCT00294398|580583157|FG000|Overall Study|Lost to Follow-up|21|||
160781273|NCT00294398|580583158|FG001|Overall Study|Lost to Follow-up|26|||
160781274|NCT04439123|580583162|FG000|Overall Study|Adverse Event|11|||
160781275|NCT04439123|580583162|FG000|Overall Study|Death|1|||
160781276|NCT04439123|580583162|FG000|Overall Study|Disease progression|19|||
160781277|NCT04439123|580583162|FG000|Overall Study|Withdrawal by Subject|2|||
160781278|NCT04439123|580583162|FG000|Overall Study|Still on treatment|2|||
160781279|NCT02593864|580583164|FG000|Overall Study|Withdrawal by Subject|3|||
160781280|NCT02593864|580583164|FG000|Overall Study|Lost to Follow-up|3|||
160781281|NCT02114684|580583170|FG000|Overall Study|Death|6|||
160781282|NCT02114684|580583171|FG001|Overall Study|Death|4|||
160781283|NCT02114684|580583170|FG000|Overall Study|Lost to Follow-up|1|||
160781284|NCT02114684|580583171|FG001|Overall Study|Lost to Follow-up|2|||
160781285|NCT02114684|580583170|FG000|Overall Study|Withdrawal by Subject|1|||
160781286|NCT02114684|580583171|FG001|Overall Study|Withdrawal by Subject|2|||
160781287|NCT02114684|580583170|FG000|Overall Study|Relocation|3|||
160781288|NCT02114684|580583171|FG001|Overall Study|Relocation|1|||
160781289|NCT02114684|580583170|FG000|Overall Study|Rifampicin resistant on culture|0|||
160781290|NCT02114684|580583171|FG001|Overall Study|Rifampicin resistant on culture|1|||
160781291|NCT02114684|580583170|FG000|Overall Study|Patient Incarcerated|1|||
160781292|NCT02114684|580583171|FG001|Overall Study|Patient Incarcerated|0|||
160781293|NCT03345095|580583172|FG000|Overall Study|Lack of Efficacy|184|||
160781294|NCT03345095|580583173|FG001|Overall Study|Lack of Efficacy|156|||
160781295|NCT03345095|580583172|FG000|Overall Study|Adverse Event|36|||
160781296|NCT03345095|580583173|FG001|Overall Study|Adverse Event|118|||
160781297|NCT03345095|580583172|FG000|Overall Study|Withdrawal by Subject|22|||
160781298|NCT03345095|580583173|FG001|Overall Study|Withdrawal by Subject|59|||
160781299|NCT03345095|580583172|FG000|Overall Study|Physician Decision|3|||
160781300|NCT03345095|580583173|FG001|Overall Study|Physician Decision|18|||
160781301|NCT03345095|580583172|FG000|Overall Study|Death|2|||
160781302|NCT03345095|580583173|FG001|Overall Study|Death|4|||
160781303|NCT03345095|580583172|FG000|Overall Study|Other reasons|2|||
161326545|NCT01719380|582581250|FG009|Overall Study|Physician Decision|1|||
161326546|NCT01719380|582581241|FG000|Overall Study|Lack of Efficacy|2|||
161326547|NCT01719380|582581242|FG001|Overall Study|Lack of Efficacy|6|||
161123682|NCT00716976|581839078|FG000|Overall Study|Death|1|||
161123683|NCT00716976|581839079|FG001|Overall Study|Death|0|||
161123684|NCT00716976|581839078|FG000|Overall Study|Physician Decision|2|||
161123685|NCT00716976|581839079|FG001|Overall Study|Physician Decision|2|||
161123686|NCT00716976|581839078|FG000|Overall Study|Withdrawal by Subject|5|||
161123687|NCT00716976|581839079|FG001|Overall Study|Withdrawal by Subject|1|||
161123688|NCT00716976|581839078|FG000|Overall Study|Premature discontinuation cisplatin|5|||
161123689|NCT00716976|581839079|FG001|Overall Study|Premature discontinuation cisplatin|4|||
161326548|NCT01719380|582581243|FG002|Overall Study|Lack of Efficacy|5|||
161326549|NCT01719380|582581244|FG003|Overall Study|Lack of Efficacy|6|||
161326550|NCT01719380|582581245|FG004|Overall Study|Lack of Efficacy|3|||
161326551|NCT01719380|582581246|FG005|Overall Study|Lack of Efficacy|7|||
161326552|NCT01719380|582581247|FG006|Overall Study|Lack of Efficacy|10|||
161326553|NCT01719380|582581248|FG007|Overall Study|Lack of Efficacy|6|||
161326554|NCT01719380|582581249|FG008|Overall Study|Lack of Efficacy|39|||
161326555|NCT01719380|582581250|FG009|Overall Study|Lack of Efficacy|42|||
161326556|NCT01719380|582581241|FG000|Overall Study|Progressive Disease|0|||
161326557|NCT01719380|582581242|FG001|Overall Study|Progressive Disease|0|||
161326558|NCT01719380|582581243|FG002|Overall Study|Progressive Disease|0|||
161326559|NCT01719380|582581244|FG003|Overall Study|Progressive Disease|0|||
161326560|NCT01719380|582581245|FG004|Overall Study|Progressive Disease|0|||
161326561|NCT01719380|582581246|FG005|Overall Study|Progressive Disease|0|||
161326562|NCT01719380|582581247|FG006|Overall Study|Progressive Disease|0|||
161326563|NCT01719380|582581248|FG007|Overall Study|Progressive Disease|0|||
160781304|NCT03345095|580583173|FG001|Overall Study|Other reasons|11|||
160781305|NCT03345095|580583172|FG000|Overall Study|Protocol Violation|0|||
160781306|NCT03345095|580583173|FG001|Overall Study|Protocol Violation|1|||
160781307|NCT04971837|580584986|FG000|Overall Study|Long Term Illness|1|||
160781308|NCT04971837|580584986|FG000|Overall Study|BMI too low|9|||
161326564|NCT01719380|582581249|FG008|Overall Study|Progressive Disease|1|||
161326565|NCT01719380|582581250|FG009|Overall Study|Progressive Disease|0|||
161326566|NCT01096160|582581253|FG000|Overall Study|Adverse Event|0|||
161326567|NCT01096160|582581254|FG001|Overall Study|Adverse Event|0|||
161326568|NCT01096160|582581255|FG002|Overall Study|Adverse Event|1|||
161326569|NCT01096160|582581256|FG003|Overall Study|Adverse Event|0|||
161326570|NCT01096160|582581257|FG004|Overall Study|Adverse Event|0|||
161326571|NCT01096160|582581258|FG005|Overall Study|Adverse Event|0|||
161326572|NCT01096160|582581259|FG006|Overall Study|Adverse Event|0|||
161326573|NCT01096160|582581260|FG007|Overall Study|Adverse Event|0|||
161326574|NCT01096160|582581261|FG008|Overall Study|Adverse Event|0|||
160781309|NCT04971837|580584986|FG000|Overall Study|geographic location|1|||
160781310|NCT04971837|580584986|FG000|Overall Study|Discontinued scheduling conflict|1|||
160781311|NCT03166631|580584987|FG000|Overall Study|Progressive disease|2|||
160781312|NCT03166631|580584988|FG001|Overall Study|Progressive disease|1|||
160781313|NCT03166631|580584989|FG002|Overall Study|Progressive disease|3|||
160781314|NCT03166631|580584990|FG003|Overall Study|Progressive disease|4|||
160781315|NCT03166631|580584991|FG004|Overall Study|Progressive disease|2|||
160781316|NCT03166631|580584992|FG005|Overall Study|Progressive disease|2|||
160781317|NCT03166631|580584993|FG006|Overall Study|Progressive disease|5|||
160888818|NCT00829933|580986589|FG000|Overall Study|withdrew before treatment started|5|||
160888819|NCT00829933|580986590|FG001|Overall Study|withdrew before treatment started|1|||
160888820|NCT00829933|580986591|FG002|Overall Study|withdrew before treatment started|2|||
161123690|NCT00716976|581839078|FG000|Overall Study|Radiation during protocol|1|||
160781318|NCT03166631|580584994|FG007|Overall Study|Progressive disease|6|||
160781319|NCT03166631|580584995|FG008|Overall Study|Progressive disease|11|||
160781320|NCT03166631|580584996|FG009|Overall Study|Progressive disease|5|||
160781321|NCT03166631|580584997|FG010|Overall Study|Progressive disease|7|||
160781322|NCT03166631|580584987|FG000|Overall Study|Physician Decision|0|||
160781323|NCT03166631|580584988|FG001|Overall Study|Physician Decision|0|||
160781324|NCT03166631|580584989|FG002|Overall Study|Physician Decision|0|||
160781325|NCT03166631|580584990|FG003|Overall Study|Physician Decision|0|||
160781326|NCT03166631|580584991|FG004|Overall Study|Physician Decision|0|||
160781327|NCT03166631|580584992|FG005|Overall Study|Physician Decision|0|||
160781328|NCT03166631|580584993|FG006|Overall Study|Physician Decision|1|||
160781329|NCT03166631|580584994|FG007|Overall Study|Physician Decision|0|||
160781330|NCT03166631|580584995|FG008|Overall Study|Physician Decision|1|||
160781331|NCT03166631|580584996|FG009|Overall Study|Physician Decision|0|||
160781332|NCT03166631|580584997|FG010|Overall Study|Physician Decision|1|||
160781333|NCT03166631|580584987|FG000|Overall Study|Death|0|||
160781334|NCT03166631|580584988|FG001|Overall Study|Death|0|||
161123691|NCT00716976|581839079|FG001|Overall Study|Radiation during protocol|0|||
160781335|NCT03166631|580584989|FG002|Overall Study|Death|0|||
160781336|NCT03166631|580584990|FG003|Overall Study|Death|0|||
161123692|NCT00716976|581839078|FG000|Overall Study|Ineligibles|4|||
161326575|NCT01096160|582581262|FG009|Overall Study|Adverse Event|1|||
161326576|NCT01096160|582581253|FG000|Overall Study|Met stopping criteria per protocol|0|||
161326577|NCT01096160|582581254|FG001|Overall Study|Met stopping criteria per protocol|0|||
161326578|NCT01096160|582581255|FG002|Overall Study|Met stopping criteria per protocol|0|||
161326579|NCT01096160|582581256|FG003|Overall Study|Met stopping criteria per protocol|0|||
161326580|NCT01096160|582581257|FG004|Overall Study|Met stopping criteria per protocol|1|||
160888821|NCT00829933|580986592|FG003|Overall Study|withdrew before treatment started|9|||
160888822|NCT03687970|580986596|FG000|Overall Study|visit scheduling conflicts|2|||
160888823|NCT03687970|580986597|FG001|Overall Study|visit scheduling conflicts|0|||
160888824|NCT00686998|580986598|FG000|Overall Study|Adverse Event|3|||
160888825|NCT00686998|580986599|FG001|Overall Study|Adverse Event|2|||
160888826|NCT00686998|580986600|FG002|Overall Study|Adverse Event|1|||
160888827|NCT00686998|580986598|FG000|Overall Study|Withdrawal by Subject|2|||
160888828|NCT00686998|580986599|FG001|Overall Study|Withdrawal by Subject|1|||
160888829|NCT00686998|580986600|FG002|Overall Study|Withdrawal by Subject|2|||
160888830|NCT00686998|580986598|FG000|Overall Study|Lack of Efficacy|7|||
160888831|NCT00686998|580986599|FG001|Overall Study|Lack of Efficacy|5|||
160888832|NCT00686998|580986600|FG002|Overall Study|Lack of Efficacy|0|||
160888833|NCT00686998|580986598|FG000|Overall Study|Other|0|||
160888834|NCT00686998|580986599|FG001|Overall Study|Other|0|||
160888835|NCT00686998|580986600|FG002|Overall Study|Other|1|||
160888836|NCT00686998|580986598|FG000|Overall Study|Safety Reasons|1|||
160888837|NCT00686998|580986599|FG001|Overall Study|Safety Reasons|0|||
160888838|NCT00686998|580986600|FG002|Overall Study|Safety Reasons|0|||
160888839|NCT06374394|580986604|FG000|Overall Study|Adverse Event|0|||
160888840|NCT06374394|580986605|FG001|Overall Study|Adverse Event|2|||
160888841|NCT06374394|580986604|FG000|Overall Study|Lost to Follow-up|6|||
160888842|NCT06374394|580986605|FG001|Overall Study|Lost to Follow-up|9|||
160888843|NCT06374394|580986604|FG000|Overall Study|Withdrawal by Subject|1|||
160888844|NCT06374394|580986605|FG001|Overall Study|Withdrawal by Subject|7|||
160888845|NCT06374394|580986604|FG000|Overall Study|Other|1|||
160888846|NCT06374394|580986605|FG001|Overall Study|Other|0|||
160888847|NCT00356122|580986606|FG000|TREATMENT|Lack of Efficacy|26|||
160888848|NCT00356122|580986606|FG000|TREATMENT|Adverse Event|10|||
160888849|NCT00356122|580986606|FG000|TREATMENT|Subject's request|4|||
160888850|NCT00356122|580986606|FG000|TREATMENT|Other|4|||
160888851|NCT00356122|580986606|FG000|TREATMENT|Did not receive study medication|1|||
160888852|NCT00356122|580986606|FG000|FOLLOW-UP|Death|37|||
160888853|NCT00356122|580986606|FG000|FOLLOW-UP|Lost to Follow-up|2|||
160888854|NCT00356122|580986606|FG000|FOLLOW-UP|Other|2|||
160888855|NCT02483429|580986612|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
160888856|NCT02483429|580986613|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
160888857|NCT03576274|580986614|FG000|Overall Study|Lost to Follow-up|3|||
160888858|NCT03576274|580986615|FG001|Overall Study|Lost to Follow-up|2|||
160888859|NCT03576274|580986616|FG002|Overall Study|Lost to Follow-up|3|||
160888860|NCT03576274|580986617|FG003|Overall Study|Lost to Follow-up|1|||
160888861|NCT03576274|580986618|FG004|Overall Study|Lost to Follow-up|3|||
160888862|NCT03576274|580986614|FG000|Overall Study|Withdrawal by Subject|5|||
160888863|NCT03576274|580986615|FG001|Overall Study|Withdrawal by Subject|3|||
160888864|NCT03576274|580986616|FG002|Overall Study|Withdrawal by Subject|2|||
161229550|NCT01918397|582222496|FG001|Overall Study|Withdrawal by Subject|2|||
161229551|NCT01918397|582222497|FG002|Overall Study|Withdrawal by Subject|1|||
161229552|NCT01918397|582222498|FG003|Overall Study|Withdrawal by Subject|1|||
161229553|NCT01918397|582222495|FG000|Overall Study|XDR at baseline|0|||
161229554|NCT01918397|582222496|FG001|Overall Study|XDR at baseline|0|||
161229555|NCT01918397|582222497|FG002|Overall Study|XDR at baseline|1|||
161229556|NCT01918397|582222498|FG003|Overall Study|XDR at baseline|0|||
161229557|NCT01918397|582222495|FG000|Overall Study|Lost to Follow-up|2|||
161229558|NCT01918397|582222496|FG001|Overall Study|Lost to Follow-up|1|||
161229559|NCT01918397|582222497|FG002|Overall Study|Lost to Follow-up|1|||
161229560|NCT01918397|582222498|FG003|Overall Study|Lost to Follow-up|1|||
161229561|NCT01918397|582222495|FG000|Overall Study|Increased QTc|1|||
161229562|NCT01918397|582222496|FG001|Overall Study|Increased QTc|0|||
161229563|NCT01918397|582222497|FG002|Overall Study|Increased QTc|0|||
161229564|NCT01918397|582222498|FG003|Overall Study|Increased QTc|1|||
161229565|NCT01918397|582222495|FG000|Overall Study|Death|0|||
161229566|NCT01918397|582222496|FG001|Overall Study|Death|0|||
161229567|NCT01918397|582222497|FG002|Overall Study|Death|1|||
161229568|NCT01918397|582222498|FG003|Overall Study|Death|0|||
160888865|NCT03576274|580986617|FG003|Overall Study|Withdrawal by Subject|8|||
160888866|NCT03576274|580986618|FG004|Overall Study|Withdrawal by Subject|6|||
160888867|NCT00543855|580987772|FG000|Overall Study|Adverse Event|3|||
160888868|NCT00543855|580987773|FG001|Overall Study|Adverse Event|1|||
160888869|NCT00543855|580987774|FG002|Overall Study|Adverse Event|3|||
160888870|NCT00543855|580987775|FG003|Overall Study|Adverse Event|4|||
160888871|NCT00543855|580987772|FG000|Overall Study|Lost to Follow-up|0|||
160888872|NCT00543855|580987773|FG001|Overall Study|Lost to Follow-up|0|||
160888873|NCT00543855|580987774|FG002|Overall Study|Lost to Follow-up|1|||
160888874|NCT00543855|580987775|FG003|Overall Study|Lost to Follow-up|0|||
160888875|NCT00543855|580987772|FG000|Overall Study|Withdrawal by Subject|0|||
160888876|NCT00543855|580987773|FG001|Overall Study|Withdrawal by Subject|1|||
161229569|NCT01918397|582222495|FG000|Overall Study|Involved in another investigative trial|0|||
161229570|NCT01918397|582222496|FG001|Overall Study|Involved in another investigative trial|0|||
161229571|NCT01918397|582222497|FG002|Overall Study|Involved in another investigative trial|0|||
161229572|NCT01918397|582222498|FG003|Overall Study|Involved in another investigative trial|1|||
161123693|NCT00716976|581839079|FG001|Overall Study|Ineligibles|2|||
161326581|NCT01096160|582581258|FG005|Overall Study|Met stopping criteria per protocol|0|||
161123694|NCT00805740|581839081|FG000|Overall Study|Death|7|||
161123695|NCT00805740|581839082|FG001|Overall Study|Death|4|||
161123696|NCT00805740|581839081|FG000|Overall Study|Withdrawal by Subject|1|||
161123697|NCT00805740|581839082|FG001|Overall Study|Withdrawal by Subject|0|||
161123698|NCT00805740|581839081|FG000|Overall Study|Lost to Follow-up|1|||
161123699|NCT00805740|581839082|FG001|Overall Study|Lost to Follow-up|0|||
161123700|NCT00805740|581839081|FG000|Overall Study|Randomized, but not treated|2|||
161123701|NCT00805740|581839082|FG001|Overall Study|Randomized, but not treated|0|||
161123702|NCT05227690|581839088|FG000|Overall Study|Adverse Event|5|||
161123703|NCT05227690|581839089|FG001|Overall Study|Adverse Event|6|||
161123704|NCT05227690|581839090|FG002|Overall Study|Adverse Event|10|||
161123705|NCT05227690|581839088|FG000|Overall Study|Lack of Efficacy|2|||
161123706|NCT05227690|581839089|FG001|Overall Study|Lack of Efficacy|4|||
161123707|NCT05227690|581839090|FG002|Overall Study|Lack of Efficacy|1|||
161123708|NCT05227690|581839088|FG000|Overall Study|Physician Decision|6|||
161123709|NCT05227690|581839089|FG001|Overall Study|Physician Decision|0|||
161123710|NCT05227690|581839090|FG002|Overall Study|Physician Decision|4|||
161123711|NCT05227690|581839088|FG000|Overall Study|Withdrawal of consent|28|||
161123712|NCT05227690|581839089|FG001|Overall Study|Withdrawal of consent|27|||
161123713|NCT05227690|581839090|FG002|Overall Study|Withdrawal of consent|21|||
161123714|NCT05227690|581839088|FG000|Overall Study|Other, not specified|2|||
161123715|NCT05227690|581839089|FG001|Overall Study|Other, not specified|2|||
161123716|NCT05227690|581839090|FG002|Overall Study|Other, not specified|1|||
161123717|NCT00975156|581839091|FG000|Overall Study|Protocol Violation|0|||
161123718|NCT00975156|581839092|FG001|Overall Study|Protocol Violation|1|||
161123719|NCT05499559|581839093|FG000|Overall Study|Lost to Follow-up|467|||
161123720|NCT02971202|581839100|FG000|Overall Study|Pregnancy|1|||
161123721|NCT02971202|581839101|FG001|Overall Study|Pregnancy|0|||
161123722|NCT02971202|581839102|FG002|Overall Study|Pregnancy|0|||
161123723|NCT02971202|581839100|FG000|Overall Study|screen fail after consent|1|||
161123724|NCT02971202|581839101|FG001|Overall Study|screen fail after consent|0|||
161123725|NCT02971202|581839102|FG002|Overall Study|screen fail after consent|1|||
161123726|NCT04033367|581839103|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
161123727|NCT04033367|581839104|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
161123728|NCT04033367|581839103|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
161123729|NCT04033367|581839104|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
161123730|NCT04033367|581839103|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
161123731|NCT04033367|581839104|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
161123732|NCT04033367|581839103|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
161123733|NCT04033367|581839104|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
161123734|NCT02723201|581839105|FG000|Second Intervention Period|Protocol Violation|1|||
161123735|NCT02723201|581839106|FG001|Second Intervention Period|Protocol Violation|0|||
161123736|NCT02723201|581839107|FG002|Second Intervention Period|Protocol Violation|0|||
161123737|NCT02723201|581839105|FG000|Second Intervention Period|Adverse Event|1|||
161123738|NCT02723201|581839106|FG001|Second Intervention Period|Adverse Event|0|||
161123739|NCT02723201|581839107|FG002|Second Intervention Period|Adverse Event|0|||
161123740|NCT03472560|581839108|FG000|Overall Study|Subject transfer to continuation protocol|0|||
161123741|NCT03472560|581839109|FG001|Overall Study|Subject transfer to continuation protocol|1|||
161123742|NCT03472560|581839108|FG000|Overall Study|Withdrawal by Subject|4|||
161123743|NCT03472560|581839109|FG001|Overall Study|Withdrawal by Subject|0|||
161123744|NCT03472560|581839108|FG000|Overall Study|Progressive disease|24|||
161229573|NCT00849901|582222505|FG000|Acute Treatment Phase|Adverse Event|9|||
161229574|NCT00849901|582222506|FG001|Acute Treatment Phase|Adverse Event|1|||
161229575|NCT00849901|582222507|FG002|Acute Treatment Phase|Adverse Event|3|||
161229576|NCT00849901|582222505|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
161229577|NCT00849901|582222506|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
161229578|NCT00849901|582222507|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
161229579|NCT00849901|582222505|FG000|Acute Treatment Phase|Protocol Violation|0|||
161229580|NCT00849901|582222506|FG001|Acute Treatment Phase|Protocol Violation|2|||
161229581|NCT00849901|582222507|FG002|Acute Treatment Phase|Protocol Violation|1|||
161229582|NCT00849901|582222505|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
161229583|NCT00849901|582222506|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
161229584|NCT00849901|582222507|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
161229585|NCT00849901|582222505|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
161326582|NCT01096160|582581259|FG006|Overall Study|Met stopping criteria per protocol|2|||
160888877|NCT00543855|580987774|FG002|Overall Study|Withdrawal by Subject|2|||
161123745|NCT03472560|581839109|FG001|Overall Study|Progressive disease|8|||
161123746|NCT03472560|581839108|FG000|Overall Study|Physician Decision|1|||
161123747|NCT03472560|581839109|FG001|Overall Study|Physician Decision|0|||
161123748|NCT03472560|581839108|FG000|Overall Study|Death|7|||
161123749|NCT03472560|581839109|FG001|Overall Study|Death|4|||
161123750|NCT03472560|581839108|FG000|Overall Study|Adverse Event|5|||
161123751|NCT03472560|581839109|FG001|Overall Study|Adverse Event|3|||
161123752|NCT03472560|581839108|FG000|Overall Study|Global deterioration of health status|0|||
160888878|NCT00543855|580987775|FG003|Overall Study|Withdrawal by Subject|0|||
160888879|NCT00543855|580987772|FG000|Overall Study|Protocol Violation|1|||
160888880|NCT00543855|580987773|FG001|Overall Study|Protocol Violation|0|||
160888881|NCT00543855|580987774|FG002|Overall Study|Protocol Violation|0|||
160888882|NCT00543855|580987775|FG003|Overall Study|Protocol Violation|0|||
160888883|NCT04854642|580987776|FG000|Overall Study|Adverse Event|1|||
160888884|NCT04854642|580987777|FG001|Overall Study|Adverse Event|2|||
160888885|NCT04854642|580987776|FG000|Overall Study|Withdrawal by Subject|0|||
160888886|NCT04854642|580987777|FG001|Overall Study|Withdrawal by Subject|1|||
160888887|NCT00301821|580987782|FG000|Overall Study|Ineligible|25|||
160888888|NCT00301821|580987782|FG000|Overall Study|Cancel|1|||
160888889|NCT02294773|580987783|FG000|Overall Study|Withdrawal by Subject|0|||
160888890|NCT02294773|580987784|FG001|Overall Study|Withdrawal by Subject|2|||
160888891|NCT01865084|580987785|FG000|Double Blind Period (DB)|Adverse Event|2|||
160888892|NCT01865084|580987786|FG001|Double Blind Period (DB)|Adverse Event|2|||
160888893|NCT01865084|580987787|FG002|Double Blind Period (DB)|Adverse Event|1|||
160888894|NCT01865084|580987785|FG000|Double Blind Period (DB)|Protocol Violation|0|||
160888895|NCT01865084|580987786|FG001|Double Blind Period (DB)|Protocol Violation|0|||
160888896|NCT01865084|580987787|FG002|Double Blind Period (DB)|Protocol Violation|1|||
161326583|NCT01096160|582581260|FG007|Overall Study|Met stopping criteria per protocol|0|||
161326584|NCT01096160|582581261|FG008|Overall Study|Met stopping criteria per protocol|2|||
161326585|NCT01096160|582581262|FG009|Overall Study|Met stopping criteria per protocol|0|||
161326586|NCT02028507|582581263|FG000|Overall Study|Progressive Disease|122|||
161326587|NCT02028507|582581264|FG001|Overall Study|Progressive Disease|90|||
161326588|NCT02028507|582581265|FG002|Overall Study|Progressive Disease|102|||
161326589|NCT02028507|582581266|FG003|Overall Study|Progressive Disease|89|||
161326590|NCT02028507|582581263|FG000|Overall Study|Adverse Event|8|||
161326591|NCT02028507|582581264|FG001|Overall Study|Adverse Event|25|||
161326592|NCT02028507|582581265|FG002|Overall Study|Adverse Event|3|||
161326593|NCT02028507|582581266|FG003|Overall Study|Adverse Event|16|||
161326594|NCT02028507|582581263|FG000|Overall Study|Withdrawal by Subject|6|||
161326595|NCT02028507|582581264|FG001|Overall Study|Withdrawal by Subject|8|||
161326596|NCT02028507|582581265|FG002|Overall Study|Withdrawal by Subject|5|||
161326597|NCT02028507|582581266|FG003|Overall Study|Withdrawal by Subject|9|||
161326598|NCT02028507|582581263|FG000|Overall Study|Protocol Violation|2|||
161326599|NCT02028507|582581264|FG001|Overall Study|Protocol Violation|4|||
161326600|NCT02028507|582581265|FG002|Overall Study|Protocol Violation|1|||
161326601|NCT02028507|582581266|FG003|Overall Study|Protocol Violation|3|||
161326602|NCT02028507|582581263|FG000|Overall Study|Physician Decision|0|||
161326603|NCT02028507|582581264|FG001|Overall Study|Physician Decision|4|||
161326604|NCT02028507|582581265|FG002|Overall Study|Physician Decision|0|||
161326605|NCT02028507|582581266|FG003|Overall Study|Physician Decision|0|||
161326606|NCT02028507|582581263|FG000|Overall Study|Death|1|||
161326607|NCT02028507|582581264|FG001|Overall Study|Death|0|||
161326608|NCT02028507|582581265|FG002|Overall Study|Death|1|||
161326609|NCT02028507|582581266|FG003|Overall Study|Death|3|||
161326610|NCT02028507|582581263|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
161326611|NCT02028507|582581264|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
161326612|NCT02028507|582581265|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
161326613|NCT02028507|582581266|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
161326614|NCT02028507|582581263|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
161326615|NCT02028507|582581264|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
161326616|NCT02028507|582581265|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
161326617|NCT02028507|582581266|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
161326618|NCT02028507|582581263|FG000|Overall Study|Randomized But Not Treated|3|||
161326619|NCT02028507|582581264|FG001|Overall Study|Randomized But Not Treated|6|||
161326620|NCT02028507|582581265|FG002|Overall Study|Randomized But Not Treated|0|||
161326621|NCT02028507|582581266|FG003|Overall Study|Randomized But Not Treated|4|||
161326622|NCT02028507|582581263|FG000|Overall Study|Enzyme defect|0|||
161326623|NCT02028507|582581264|FG001|Overall Study|Enzyme defect|0|||
161326624|NCT02028507|582581265|FG002|Overall Study|Enzyme defect|0|||
161326625|NCT02028507|582581266|FG003|Overall Study|Enzyme defect|1|||
161326626|NCT02028507|582581263|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161326627|NCT02028507|582581264|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161326628|NCT02028507|582581265|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
161326629|NCT02028507|582581266|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
160888897|NCT01865084|580987785|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
160888898|NCT01865084|580987786|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
160888899|NCT01865084|580987787|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
160888900|NCT01865084|580987785|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
160888901|NCT01865084|580987786|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
160888902|NCT01865084|580987787|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
161326630|NCT02028507|582581263|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
161326631|NCT02028507|582581264|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
161123753|NCT03472560|581839109|FG001|Overall Study|Global deterioration of health status|4|||
161123754|NCT01946178|581839110|FG000|Overall Study|Pregnancy|1|||
161123755|NCT01946178|581839110|FG000|Overall Study|Lost to Follow-up|1|||
161123756|NCT02908880|581839112|FG000|Overall Study|Lost to Follow-up|4|||
161123757|NCT02908880|581839112|FG000|Overall Study|Explantation of the device|1|||
161123758|NCT02908880|581839112|FG000|Overall Study|Withdrawal by Subject|17|||
161123759|NCT02908880|581839112|FG000|Overall Study|Death|5|||
161123760|NCT03178487|581839120|FG000|Period 1|Adverse Event|1|||
161123761|NCT03178487|581839121|FG001|Period 1|Adverse Event|2|||
161123762|NCT03178487|581839120|FG000|Period 1|Withdrawal by Subject|2|||
161123763|NCT03178487|581839121|FG001|Period 1|Withdrawal by Subject|1|||
161123764|NCT03178487|581839120|FG000|Period 1|Lost to Follow-up|1|||
161123765|NCT03178487|581839121|FG001|Period 1|Lost to Follow-up|0|||
161123766|NCT03178487|581839120|FG000|Period 1|Other|0|||
161123767|NCT03178487|581839121|FG001|Period 1|Other|1|||
161123768|NCT03178487|581839120|FG000|Period 2|Adverse Event|4|||
161123769|NCT03178487|581839121|FG001|Period 2|Adverse Event|4|||
161123770|NCT03178487|581839120|FG000|Period 2|Withdrawal by Subject|6|||
161123771|NCT03178487|581839121|FG001|Period 2|Withdrawal by Subject|6|||
161123772|NCT03178487|581839120|FG000|Period 2|Lost to Follow-up|2|||
161123773|NCT03178487|581839121|FG001|Period 2|Lost to Follow-up|2|||
161123774|NCT03178487|581839120|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
161123775|NCT03178487|581839121|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
161123776|NCT03178487|581839120|FG000|Period 2|Other|8|||
161123777|NCT03178487|581839121|FG001|Period 2|Other|7|||
161123778|NCT02971670|581839122|FG000|Overall Study|Withdrawal by Subject|4|||
161123779|NCT02971670|581839123|FG001|Overall Study|Withdrawal by Subject|1|||
161123780|NCT02971670|581839124|FG002|Overall Study|Withdrawal by Subject|1|||
161123781|NCT02971670|581839125|FG003|Overall Study|Withdrawal by Subject|2|||
161123782|NCT01353703|581839126|FG000|Overall Study|Migrated/moved from study area|1|||
161123783|NCT01353703|581839127|FG001|Overall Study|Migrated/moved from study area|0|||
161123784|NCT02286947|581839134|FG000|Overall Study|Withdrawal by Subject|2|||
161123785|NCT01687712|581839135|FG000|Cycle 1|Not Biochemically Pregnant|386|||
161123786|NCT01687712|581839136|FG001|Cycle 1|Not Biochemically Pregnant|348|||
161123787|NCT01687712|581839135|FG000|Cycle 1|Early Pregnancy Loss|43|||
161123788|NCT01687712|581839136|FG001|Cycle 1|Early Pregnancy Loss|60|||
161123789|NCT01687712|581839135|FG000|Cycle 1|Ectopic Pregnancy|5|||
161123790|NCT01687712|581839136|FG001|Cycle 1|Ectopic Pregnancy|5|||
161123791|NCT01687712|581839135|FG000|Cycle 1|Heterotropic Pregnancy|1|||
161123792|NCT01687712|581839136|FG001|Cycle 1|Heterotropic Pregnancy|0|||
161123793|NCT01687712|581839135|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
161123794|NCT01687712|581839136|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
161123795|NCT01687712|581839135|FG000|Cycle 1|Abortion|3|||
161123796|NCT01687712|581839136|FG001|Cycle 1|Abortion|0|||
161123797|NCT01687712|581839135|FG000|Cycle 1|Intrauterine Fetal Death|0|||
161123798|NCT01687712|581839136|FG001|Cycle 1|Intrauterine Fetal Death|1|||
161123799|NCT01687712|581839135|FG000|Cycle 1|Lost to Follow-up|1|||
161123800|NCT01687712|581839136|FG001|Cycle 1|Lost to Follow-up|1|||
161123801|NCT01687712|581839135|FG000|Cycle 2|Not Biochemically Pregnant|74|||
161123802|NCT01687712|581839136|FG001|Cycle 2|Not Biochemically Pregnant|77|||
161123803|NCT01687712|581839135|FG000|Cycle 2|Early Pregnancy Loss|18|||
161123804|NCT01687712|581839136|FG001|Cycle 2|Early Pregnancy Loss|16|||
161123805|NCT01687712|581839135|FG000|Cycle 2|Ectopic Pregnancy|0|||
161123806|NCT01687712|581839136|FG001|Cycle 2|Ectopic Pregnancy|1|||
161123807|NCT01687712|581839135|FG000|Cycle 2|Still Birth|1|||
161123808|NCT01687712|581839136|FG001|Cycle 2|Still Birth|0|||
161123809|NCT01687712|581839135|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
161123810|NCT01687712|581839136|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
161123811|NCT01687712|581839135|FG000|Cycle 3|Not Biochemically Pregnant|21|||
160781337|NCT03166631|580584991|FG004|Overall Study|Death|1|||
161123812|NCT01687712|581839136|FG001|Cycle 3|Not Biochemically Pregnant|22|||
161123813|NCT01687712|581839135|FG000|Cycle 3|Early Pregnancy Loss|1|||
161123814|NCT01687712|581839136|FG001|Cycle 3|Early Pregnancy Loss|2|||
161123815|NCT01687712|581839135|FG000|Cycle 3|Ectopic Pregnancy|1|||
161123816|NCT01687712|581839136|FG001|Cycle 3|Ectopic Pregnancy|0|||
161123817|NCT01687712|581839135|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
161123818|NCT01687712|581839136|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
161123819|NCT00915343|581839137|FG000|Part B - Open Label Period|Treatment switch|0|||
161123820|NCT00915343|581839138|FG001|Part B - Open Label Period|Treatment switch|0|||
161123821|NCT00915343|581839139|FG002|Part B - Open Label Period|Treatment switch|1|||
161123822|NCT00915343|581839137|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
161123823|NCT00915343|581839138|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
161123824|NCT00915343|581839139|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
161123825|NCT00512798|581839140|FG000|Overall Study|Death|0|||
161123826|NCT00512798|581839141|FG001|Overall Study|Death|3|||
161123827|NCT00512798|581839140|FG000|Overall Study|Adverse Event|2|||
161123828|NCT00512798|581839141|FG001|Overall Study|Adverse Event|4|||
161123829|NCT00512798|581839140|FG000|Overall Study|Progression of disease|14|||
161123830|NCT00512798|581839141|FG001|Overall Study|Progression of disease|20|||
160888903|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
160888904|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
160888905|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
160888906|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
160888907|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
160888908|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
160888909|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
160888910|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
160888911|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
160888912|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
160888913|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
160888914|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
160888915|NCT01865084|580987785|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
160888916|NCT01865084|580987786|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
160888917|NCT01865084|580987787|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
160888918|NCT01994590|580987790|FG000|Overall Study|Adverse Event|1|||
160888919|NCT01994590|580987790|FG000|Overall Study|Trial Terminated|1|||
160888920|NCT00719264|580987792|FG000|Overall Study|Adverse Event|41|||
160888921|NCT00719264|580987793|FG001|Overall Study|Adverse Event|49|||
160888922|NCT00719264|580987792|FG000|Overall Study|Death|13|||
160888923|NCT00719264|580987793|FG001|Overall Study|Death|10|||
160888924|NCT00719264|580987792|FG000|Overall Study|Administrative Problems|6|||
160888925|NCT00719264|580987793|FG001|Overall Study|Administrative Problems|4|||
160888926|NCT00719264|580987792|FG000|Overall Study|Lost to Follow-up|1|||
160888927|NCT00719264|580987793|FG001|Overall Study|Lost to Follow-up|1|||
160888928|NCT00719264|580987792|FG000|Overall Study|Withdrawal by Subject|12|||
160888929|NCT00719264|580987793|FG001|Overall Study|Withdrawal by Subject|7|||
160888930|NCT00719264|580987792|FG000|Overall Study|Protocol Deviation|1|||
160888931|NCT00719264|580987793|FG001|Overall Study|Protocol Deviation|3|||
160888932|NCT00719264|580987792|FG000|Overall Study|New Cancer Therapy|4|||
160888933|NCT00719264|580987793|FG001|Overall Study|New Cancer Therapy|2|||
160888934|NCT00719264|580987792|FG000|Overall Study|Disease Progression|104|||
161326632|NCT02028507|582581265|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
161326633|NCT02028507|582581266|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
161326634|NCT01556932|582581267|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
161326635|NCT01556932|582581268|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
160888935|NCT00719264|580987793|FG001|Overall Study|Disease Progression|107|||
160888936|NCT01277042|580987794|FG000|Overall Study|Adverse Event|4|||
160888937|NCT01277042|580987795|FG001|Overall Study|Adverse Event|3|||
160888938|NCT01277042|580987794|FG000|Overall Study|Lost to Follow-up|2|||
160888939|NCT01277042|580987795|FG001|Overall Study|Lost to Follow-up|2|||
160888940|NCT01277042|580987794|FG000|Overall Study|Withdrawal by Subject|2|||
160888941|NCT01277042|580987795|FG001|Overall Study|Withdrawal by Subject|0|||
160888942|NCT03581786|580987800|FG000|Overall Study|Death|67|||
160888943|NCT03581786|580987801|FG001|Overall Study|Death|47|||
160888944|NCT03581786|580987800|FG000|Overall Study|Withdrawal by Subject|2|||
160888945|NCT03581786|580987801|FG001|Overall Study|Withdrawal by Subject|5|||
160888946|NCT03581786|580987800|FG000|Overall Study|Lost to Follow-up|7|||
160888947|NCT03581786|580987801|FG001|Overall Study|Lost to Follow-up|4|||
160888948|NCT03581786|580987800|FG000|Overall Study|reason other than specified above|0|||
160888949|NCT03581786|580987801|FG001|Overall Study|reason other than specified above|1|||
160888950|NCT02469038|580987804|FG000|Overall Study|Physician Decision|4|||
160888951|NCT02469038|580987805|FG001|Overall Study|Physician Decision|5|||
160888952|NCT03435640|580987806|FG000|Overall Study|Withdrawal by Subject|0|||
160888953|NCT03435640|580987807|FG001|Overall Study|Withdrawal by Subject|1|||
160888954|NCT03435640|580987808|FG002|Overall Study|Withdrawal by Subject|0|||
160888955|NCT03435640|580987809|FG003|Overall Study|Withdrawal by Subject|2|||
160888956|NCT03435640|580987810|FG004|Overall Study|Withdrawal by Subject|0|||
161123831|NCT00512798|581839140|FG000|Overall Study|Withdrawal by Subject|3|||
161123832|NCT00512798|581839141|FG001|Overall Study|Withdrawal by Subject|0|||
161123833|NCT02317562|581839142|FG000|Overall Study|Physician Decision|1|||
161123834|NCT02317562|581839142|FG000|Overall Study|early termination of the study|8|||
161123835|NCT02317562|581839142|FG000|Overall Study|Lack of Efficacy|4|||
161123836|NCT02317562|581839142|FG000|Overall Study|Withdrawal by Subject|1|||
161123837|NCT03551743|581839143|FG000|Overall Study|Adverse Event|1|||
161123838|NCT03551743|581839144|FG001|Overall Study|Adverse Event|0|||
161123839|NCT03551743|581839145|FG002|Overall Study|Adverse Event|0|||
161123840|NCT03551743|581839146|FG003|Overall Study|Adverse Event|0|||
161123841|NCT03551743|581839143|FG000|Overall Study|Withdrawal by Subject|1|||
161123842|NCT03551743|581839144|FG001|Overall Study|Withdrawal by Subject|0|||
161123843|NCT03551743|581839145|FG002|Overall Study|Withdrawal by Subject|0|||
161123844|NCT03551743|581839146|FG003|Overall Study|Withdrawal by Subject|0|||
161123845|NCT00911989|581839147|FG000|Overall Study|Adverse Event|1|||
161123846|NCT03434977|581839148|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
161326636|NCT02105285|582581269|FG000|Overall Study|Adverse Event|1|||
161326637|NCT02105285|582581270|FG001|Overall Study|Adverse Event|1|||
161326638|NCT02105285|582581271|FG002|Overall Study|Adverse Event|0|||
161326639|NCT02105285|582581269|FG000|Overall Study|Protocol Violation|0|||
161326640|NCT02105285|582581270|FG001|Overall Study|Protocol Violation|1|||
161326641|NCT02105285|582581271|FG002|Overall Study|Protocol Violation|0|||
161326642|NCT02105285|582581269|FG000|Overall Study|Withdrawal by Subject|1|||
161326643|NCT02105285|582581270|FG001|Overall Study|Withdrawal by Subject|0|||
161326644|NCT02105285|582581271|FG002|Overall Study|Withdrawal by Subject|0|||
161326645|NCT01421641|582581272|FG000|Overall Study|Protocol Violation|2|||
161326646|NCT01421641|582581273|FG001|Overall Study|Protocol Violation|2|||
161326647|NCT02420119|582581274|FG000|Overall Study|insufficient laboratory data|5|||
161326648|NCT01051817|582581275|FG000|Overall Study|Adverse Event|0|||
161326649|NCT01051817|582581276|FG001|Overall Study|Adverse Event|2|||
161326650|NCT01051817|582581275|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
161326651|NCT01051817|582581276|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
161326652|NCT01051817|582581275|FG000|Overall Study|Withdrawal by Subject|3|||
161326653|NCT01051817|582581276|FG001|Overall Study|Withdrawal by Subject|5|||
161326654|NCT01051817|582581275|FG000|Overall Study|Protocol Violation|0|||
161326655|NCT01051817|582581276|FG001|Overall Study|Protocol Violation|1|||
161326656|NCT02472886|582581277|FG000|Overall Study|Lack of Efficacy|0|||
161326657|NCT02472886|582581278|FG001|Overall Study|Lack of Efficacy|2|||
161326658|NCT02472886|582581279|FG002|Overall Study|Lack of Efficacy|1|||
161326659|NCT04346199|582581281|FG000|Overall Study|Death|8|||
161326660|NCT04346199|582581282|FG001|Overall Study|Death|9|||
161326661|NCT04346199|582581281|FG000|Overall Study|Lost to Follow-up|0|||
161326662|NCT04346199|582581282|FG001|Overall Study|Lost to Follow-up|1|||
161326663|NCT04346199|582581281|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
161326664|NCT04346199|582581282|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
161326665|NCT04346199|582581281|FG000|Overall Study|Withdrawal by Subject|5|||
161326666|NCT04346199|582581282|FG001|Overall Study|Withdrawal by Subject|1|||
161326667|NCT00627926|582581283|FG000|Overall Study|Adverse Event|26|||
161326668|NCT00627926|582581284|FG001|Overall Study|Adverse Event|37|||
161326669|NCT00627926|582581285|FG002|Overall Study|Adverse Event|36|||
161326670|NCT00627926|582581283|FG000|Overall Study|Death|1|||
161326671|NCT00627926|582581284|FG001|Overall Study|Death|0|||
161326672|NCT00627926|582581285|FG002|Overall Study|Death|0|||
161326673|NCT00627926|582581283|FG000|Overall Study|Lost to Follow-up|4|||
161326674|NCT00627926|582581284|FG001|Overall Study|Lost to Follow-up|3|||
161326675|NCT00627926|582581285|FG002|Overall Study|Lost to Follow-up|4|||
161326676|NCT00627926|582581283|FG000|Overall Study|Withdrawal by Subject|2|||
161326677|NCT00627926|582581284|FG001|Overall Study|Withdrawal by Subject|1|||
161326678|NCT00627926|582581285|FG002|Overall Study|Withdrawal by Subject|0|||
161326679|NCT00627926|582581283|FG000|Overall Study|Lack of Efficacy|118|||
161326680|NCT00627926|582581284|FG001|Overall Study|Lack of Efficacy|40|||
161326681|NCT00627926|582581285|FG002|Overall Study|Lack of Efficacy|38|||
161326682|NCT00627926|582581283|FG000|Overall Study|Noncompliance/unspecified|8|||
161326683|NCT00627926|582581284|FG001|Overall Study|Noncompliance/unspecified|23|||
161326684|NCT00627926|582581285|FG002|Overall Study|Noncompliance/unspecified|17|||
161326685|NCT03414229|582581286|FG000|Overall Study|Adverse Event|1|||
161123847|NCT03434977|581839149|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
161123848|NCT03064841|581839150|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
161123849|NCT03064841|581839150|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
161123850|NCT03064841|581839150|FG000|Overall Study|Screen failure|2|||
161123851|NCT01145066|581839151|FG000|Overall Study|To resume NSAIDs|2|||
161123852|NCT01145066|581839152|FG001|Overall Study|To resume NSAIDs|2|||
161123853|NCT01145066|581839153|FG002|Overall Study|To resume NSAIDs|1|||
161123854|NCT01145066|581839151|FG000|Overall Study|Non-related surgery|0|||
161123855|NCT01145066|581839152|FG001|Overall Study|Non-related surgery|0|||
161123856|NCT01145066|581839153|FG002|Overall Study|Non-related surgery|1|||
161123857|NCT01145066|581839151|FG000|Overall Study|Withdrawal by Subject|0|||
161123858|NCT01145066|581839152|FG001|Overall Study|Withdrawal by Subject|0|||
161326686|NCT03414229|582581287|FG001|Overall Study|Adverse Event|0|||
161326687|NCT03414229|582581288|FG002|Overall Study|Adverse Event|2|||
161326688|NCT03414229|582581289|FG003|Overall Study|Adverse Event|1|||
161326689|NCT03414229|582581286|FG000|Overall Study|Lack of Efficacy|7|||
161326690|NCT03414229|582581287|FG001|Overall Study|Lack of Efficacy|4|||
161326691|NCT03414229|582581288|FG002|Overall Study|Lack of Efficacy|1|||
160888957|NCT03435640|580987811|FG005|Overall Study|Withdrawal by Subject|0|||
161123859|NCT01145066|581839153|FG002|Overall Study|Withdrawal by Subject|2|||
161123860|NCT01145066|581839151|FG000|Overall Study|To start new med|1|||
161123861|NCT01145066|581839152|FG001|Overall Study|To start new med|0|||
161123862|NCT01145066|581839153|FG002|Overall Study|To start new med|0|||
161123863|NCT01145066|581839151|FG000|Overall Study|problems swallowing capsule|1|||
161123864|NCT01145066|581839152|FG001|Overall Study|problems swallowing capsule|0|||
161123865|NCT01145066|581839153|FG002|Overall Study|problems swallowing capsule|0|||
161123866|NCT01145066|581839151|FG000|Overall Study|Abdominal discomfort|0|||
161123867|NCT01145066|581839152|FG001|Overall Study|Abdominal discomfort|1|||
161326692|NCT03414229|582581289|FG003|Overall Study|Lack of Efficacy|9|||
161326693|NCT03414229|582581286|FG000|Overall Study|Change in therapy|1|||
161326694|NCT03414229|582581287|FG001|Overall Study|Change in therapy|0|||
161326695|NCT03414229|582581288|FG002|Overall Study|Change in therapy|0|||
161326696|NCT03414229|582581289|FG003|Overall Study|Change in therapy|0|||
161326697|NCT03414229|582581286|FG000|Overall Study|Pregnancy|0|||
161326698|NCT03414229|582581287|FG001|Overall Study|Pregnancy|0|||
161326699|NCT03414229|582581288|FG002|Overall Study|Pregnancy|1|||
161326700|NCT03414229|582581289|FG003|Overall Study|Pregnancy|0|||
161326701|NCT03414229|582581286|FG000|Overall Study|Withdrawal by Subject|0|||
161326702|NCT03414229|582581287|FG001|Overall Study|Withdrawal by Subject|1|||
161326703|NCT03414229|582581288|FG002|Overall Study|Withdrawal by Subject|1|||
161326704|NCT03414229|582581289|FG003|Overall Study|Withdrawal by Subject|0|||
161326705|NCT01118663|582581298|FG000|Overall Study|Adverse Event|2|||
161326706|NCT01118663|582581299|FG001|Overall Study|Adverse Event|1|||
161326707|NCT01118663|582581298|FG000|Overall Study|Withdrawal by Subject|0|||
161326708|NCT01118663|582581299|FG001|Overall Study|Withdrawal by Subject|1|||
161326709|NCT03046953|582581306|FG000|Overall Study|Relapse/progressive disease|21|||
161326710|NCT03046953|582581306|FG000|Overall Study|Death|2|||
161326711|NCT03046953|582581306|FG000|Overall Study|Withdrawal by Subject|3|||
161326712|NCT04039204|582581308|FG000|Overall Study|Withdrawal by Subject|0|||
161326713|NCT04039204|582581309|FG001|Overall Study|Withdrawal by Subject|2|||
161326714|NCT00396383|582581314|FG000|Overall Study|Death|2|||
161326715|NCT00396383|582581314|FG000|Overall Study|Lost to Follow-up|1|||
161326716|NCT02385110|582581317|FG000|Overall Study|Early Death|1|||
161326717|NCT02385110|582581318|FG001|Overall Study|Early Death|0|||
161326718|NCT00534638|582581319|FG000|Overall Study|Withdrawal by Subject|3|||
161326719|NCT00534638|582581320|FG001|Overall Study|Withdrawal by Subject|4|||
161326720|NCT00534638|582581319|FG000|Overall Study|Migrated/moved from study area|13|||
161326721|NCT00534638|582581320|FG001|Overall Study|Migrated/moved from study area|11|||
161326722|NCT00534638|582581319|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
161326723|NCT00534638|582581320|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
161326724|NCT00534638|582581319|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
161326725|NCT00534638|582581320|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
161326726|NCT00534638|582581319|FG000|Overall Study|Other|1685|||
161326727|NCT00534638|582581320|FG001|Overall Study|Other|902|||
161326728|NCT04980014|582583173|FG000|Overall Study|Participants who are Duplicated|1|||
161326729|NCT04980014|582583173|FG000|Overall Study|Follow-up Failure|13|||
161326730|NCT04980014|582583173|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
161326731|NCT04980014|582583173|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
161326732|NCT04980014|582583173|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
161326733|NCT00940888|582583174|FG000|Overall Study|Unsuccessful Implant|4|||
161326734|NCT00940888|582583174|FG000|Overall Study|Death|461|||
161326735|NCT00940888|582583174|FG000|Overall Study|Withdrawn - Non-Death|364|||
161326736|NCT00940888|582583174|FG000|Overall Study|Lost to Follow-up|6|||
161326737|NCT02250300|582583176|FG000|Expansion Phase|Death|6|||
161326738|NCT02250300|582583177|FG001|Expansion Phase|Death|7|||
161326739|NCT02250300|582583178|FG002|Expansion Phase|Death|0|||
161326740|NCT02250300|582583179|FG003|Expansion Phase|Death|0|||
161326741|NCT00715559|582583183|FG000|Overall Study|medication not tolerated - nausea|1|||
161326742|NCT00758498|582583184|FG000|Overall Study|Adverse Event|2|||
161326743|NCT00758498|582583185|FG001|Overall Study|Adverse Event|2|||
161326744|NCT00758498|582583186|FG002|Overall Study|Adverse Event|3|||
161326745|NCT00758498|582583184|FG000|Overall Study|Subject legally detained out of state|1|||
161326746|NCT00758498|582583185|FG001|Overall Study|Subject legally detained out of state|0|||
161326747|NCT00758498|582583186|FG002|Overall Study|Subject legally detained out of state|0|||
161326748|NCT00758498|582583184|FG000|Overall Study|Withdrawal by Subject|0|||
161326749|NCT00758498|582583185|FG001|Overall Study|Withdrawal by Subject|0|||
161326750|NCT00758498|582583186|FG002|Overall Study|Withdrawal by Subject|1|||
161326751|NCT00758498|582583184|FG000|Overall Study|Noncompliance to study procedures|0|||
161326752|NCT00758498|582583185|FG001|Overall Study|Noncompliance to study procedures|0|||
161326753|NCT00758498|582583186|FG002|Overall Study|Noncompliance to study procedures|1|||
161326754|NCT01516736|582583188|FG000|Overall Study|Withdrawal by Subject|10|||
161326755|NCT01516736|582583189|FG001|Overall Study|Withdrawal by Subject|4|||
161326756|NCT01516736|582583188|FG000|Overall Study|Adverse Event|4|||
161326757|NCT01516736|582583189|FG001|Overall Study|Adverse Event|5|||
161326758|NCT01516736|582583188|FG000|Overall Study|Death|3|||
161326759|NCT01516736|582583189|FG001|Overall Study|Death|1|||
161326760|NCT01516736|582583188|FG000|Overall Study|Physician Decision|2|||
161326761|NCT01516736|582583189|FG001|Overall Study|Physician Decision|1|||
161326762|NCT01516736|582583188|FG000|Overall Study|Lack of Efficacy|1|||
161326763|NCT01516736|582583189|FG001|Overall Study|Lack of Efficacy|0|||
161326764|NCT01516736|582583188|FG000|Overall Study|Protocol Violation|0|||
161326765|NCT01516736|582583189|FG001|Overall Study|Protocol Violation|1|||
161326766|NCT01516736|582583188|FG000|Overall Study|Other (not specified)|0|||
161326767|NCT01516736|582583189|FG001|Overall Study|Other (not specified)|1|||
161326768|NCT00524771|582583190|FG000|Overall Study|Protocol Violation|220|||
161123868|NCT01145066|581839153|FG002|Overall Study|Abdominal discomfort|0|||
161123869|NCT01145066|581839151|FG000|Overall Study|Low platelet count|0|||
161123870|NCT01145066|581839152|FG001|Overall Study|Low platelet count|1|||
161123871|NCT01145066|581839153|FG002|Overall Study|Low platelet count|0|||
161123872|NCT03920670|581839154|FG000|Overall Study|Protocol Violation|2|||
161123873|NCT03920670|581839155|FG001|Overall Study|Protocol Violation|2|||
161123874|NCT03920670|581839154|FG000|Overall Study|Adverse Event|1|||
161123875|NCT03920670|581839155|FG001|Overall Study|Adverse Event|0|||
161123876|NCT01250379|581839162|FG000|Overall Study|Death|141|||
161123877|NCT01250379|581839163|FG001|Overall Study|Death|148|||
161123878|NCT01250379|581839162|FG000|Overall Study|Withdrawal by Subject|32|||
161123879|NCT01250379|581839163|FG001|Overall Study|Withdrawal by Subject|20|||
161123880|NCT01250379|581839162|FG000|Overall Study|Physician Decision|11|||
161123881|NCT01250379|581839163|FG001|Overall Study|Physician Decision|3|||
161123882|NCT01250379|581839162|FG000|Overall Study|Protocol Violation|2|||
161123883|NCT01250379|581839163|FG001|Overall Study|Protocol Violation|8|||
161123884|NCT01250379|581839162|FG000|Overall Study|Lost to Follow-up|9|||
161123885|NCT01250379|581839163|FG001|Overall Study|Lost to Follow-up|6|||
161123886|NCT01250379|581839162|FG000|Overall Study|Adverse Event|5|||
161123887|NCT01250379|581839163|FG001|Overall Study|Adverse Event|4|||
161123888|NCT01250379|581839162|FG000|Overall Study|Other|0|||
161123889|NCT01250379|581839163|FG001|Overall Study|Other|4|||
161123890|NCT01250379|581839162|FG000|Overall Study|Participant noncompliance|2|||
161123891|NCT01250379|581839163|FG001|Overall Study|Participant noncompliance|0|||
161123892|NCT01984268|581839164|FG000|Overall Study|Study Terminated|15|||
161123893|NCT01314716|581839165|FG000|Double-Blind Phase|Randomized but not treated|1|||
161123894|NCT01314716|581839166|FG001|Double-Blind Phase|Randomized but not treated|1|||
161123895|NCT01314716|581839165|FG000|Double-Blind Phase|Adverse Event|10|||
161123896|NCT01314716|581839166|FG001|Double-Blind Phase|Adverse Event|4|||
161123897|NCT01314716|581839165|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
161123898|NCT01314716|581839166|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
161123899|NCT01314716|581839165|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161229586|NCT00849901|582222506|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
161229587|NCT00849901|582222507|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
161229588|NCT00849901|582222505|FG000|Acute Treatment Phase|Physician Decision|1|||
161229589|NCT00849901|582222506|FG001|Acute Treatment Phase|Physician Decision|1|||
161229590|NCT00849901|582222507|FG002|Acute Treatment Phase|Physician Decision|1|||
161229591|NCT00849901|582222505|FG000|Acute Treatment Phase|Sponsor Decision|1|||
161229592|NCT00849901|582222506|FG001|Acute Treatment Phase|Sponsor Decision|0|||
161229593|NCT00849901|582222507|FG002|Acute Treatment Phase|Sponsor Decision|0|||
161229594|NCT00849901|582222505|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
161229595|NCT00849901|582222506|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
161229596|NCT00849901|582222507|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
161229597|NCT00849901|582222505|FG000|Extension Phase|Adverse Event|2|||
161229598|NCT00849901|582222506|FG001|Extension Phase|Adverse Event|8|||
161229599|NCT00849901|582222507|FG002|Extension Phase|Adverse Event|4|||
161229600|NCT00849901|582222505|FG000|Extension Phase|Lost to Follow-up|3|||
161229601|NCT00849901|582222506|FG001|Extension Phase|Lost to Follow-up|0|||
161229602|NCT00849901|582222507|FG002|Extension Phase|Lost to Follow-up|1|||
161229603|NCT00849901|582222505|FG000|Extension Phase|Protocol Violation|2|||
161229604|NCT00849901|582222506|FG001|Extension Phase|Protocol Violation|2|||
161229605|NCT00849901|582222507|FG002|Extension Phase|Protocol Violation|4|||
161229606|NCT00849901|582222505|FG000|Extension Phase|Withdrawal by Subject|7|||
161229607|NCT00849901|582222506|FG001|Extension Phase|Withdrawal by Subject|6|||
161229608|NCT00849901|582222507|FG002|Extension Phase|Withdrawal by Subject|3|||
161229609|NCT00849901|582222505|FG000|Extension Phase|Parent or Caregiver Decision|10|||
161229610|NCT00849901|582222506|FG001|Extension Phase|Parent or Caregiver Decision|4|||
161229611|NCT00849901|582222507|FG002|Extension Phase|Parent or Caregiver Decision|4|||
161123900|NCT01314716|581839166|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161123901|NCT01314716|581839165|FG000|Double-Blind Phase|Sponsor request|1|||
161123902|NCT01314716|581839166|FG001|Double-Blind Phase|Sponsor request|2|||
161123903|NCT01314716|581839165|FG000|Double-Blind Phase|Physician Decision|0|||
161123904|NCT01314716|581839166|FG001|Double-Blind Phase|Physician Decision|1|||
161123905|NCT01314716|581839165|FG000|Open-Label Phase|Adverse Event|4|||
161123906|NCT01314716|581839166|FG001|Open-Label Phase|Adverse Event|6|||
161123907|NCT01314716|581839165|FG000|Open-Label Phase|Withdrawal by Subject|1|||
161123908|NCT01314716|581839166|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161123909|NCT01314716|581839165|FG000|Open-Label Phase|Physician Decision|5|||
161123910|NCT01314716|581839166|FG001|Open-Label Phase|Physician Decision|4|||
161123911|NCT01928381|581839170|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
161123912|NCT01928381|581839171|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161123913|NCT01928381|581839172|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161123914|NCT01928381|581839173|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161123915|NCT01928381|581839174|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161123916|NCT01928381|581839175|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161229612|NCT00849901|582222505|FG000|Extension Phase|Physician Decision|1|||
160888958|NCT03435640|580987812|FG006|Overall Study|Withdrawal by Subject|3|||
160888959|NCT03435640|580987813|FG007|Overall Study|Withdrawal by Subject|0|||
160888960|NCT03435640|580987814|FG008|Overall Study|Withdrawal by Subject|0|||
160888961|NCT03435640|580987815|FG009|Overall Study|Withdrawal by Subject|2|||
160888962|NCT03435640|580987816|FG010|Overall Study|Withdrawal by Subject|3|||
160888963|NCT03435640|580987806|FG000|Overall Study|Lost to Follow-up|0|||
160888964|NCT03435640|580987807|FG001|Overall Study|Lost to Follow-up|0|||
160888965|NCT03435640|580987808|FG002|Overall Study|Lost to Follow-up|1|||
160888966|NCT03435640|580987809|FG003|Overall Study|Lost to Follow-up|0|||
160888967|NCT03435640|580987810|FG004|Overall Study|Lost to Follow-up|0|||
160888968|NCT03435640|580987811|FG005|Overall Study|Lost to Follow-up|0|||
160888969|NCT03435640|580987812|FG006|Overall Study|Lost to Follow-up|0|||
160888970|NCT03435640|580987813|FG007|Overall Study|Lost to Follow-up|0|||
160888971|NCT03435640|580987814|FG008|Overall Study|Lost to Follow-up|0|||
160888972|NCT03435640|580987815|FG009|Overall Study|Lost to Follow-up|0|||
160888973|NCT03435640|580987816|FG010|Overall Study|Lost to Follow-up|0|||
160888974|NCT01347307|580987817|FG000|Overall Study|Death|0|||
160888975|NCT01347307|580987818|FG001|Overall Study|Death|4|||
160888976|NCT01347307|580987817|FG000|Overall Study|Physician Decision|0|||
160888977|NCT01347307|580987818|FG001|Overall Study|Physician Decision|1|||
160888978|NCT00740246|580987827|FG000|Overall Study|Received Blood Transfusion|0|||
160888979|NCT00740246|580987828|FG001|Overall Study|Received Blood Transfusion|1|||
160888980|NCT00740246|580987827|FG000|Overall Study|Adverse Event|1|||
160888981|NCT00740246|580987828|FG001|Overall Study|Adverse Event|2|||
160888982|NCT00740246|580987827|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
160888983|NCT00740246|580987828|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
160888984|NCT00740246|580987827|FG000|Overall Study|Lost to Follow-up|2|||
160888985|NCT00740246|580987828|FG001|Overall Study|Lost to Follow-up|2|||
160888986|NCT00740246|580987827|FG000|Overall Study|Withdrawal by Subject|4|||
160888987|NCT00740246|580987828|FG001|Overall Study|Withdrawal by Subject|3|||
160888988|NCT00740246|580987827|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
160888989|NCT00740246|580987828|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
160888990|NCT00740246|580987827|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
160888991|NCT00740246|580987828|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
160888992|NCT00740246|580987827|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
160888993|NCT00740246|580987828|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
160888994|NCT00740246|580987827|FG000|Overall Study|Unable To Comply With Study Visits|2|||
160888995|NCT00740246|580987828|FG001|Overall Study|Unable To Comply With Study Visits|0|||
160888996|NCT00740246|580987827|FG000|Overall Study|Unable to Access Vein|0|||
160888997|NCT00740246|580987828|FG001|Overall Study|Unable to Access Vein|2|||
160888998|NCT00740246|580987827|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
160888999|NCT00740246|580987828|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
160889000|NCT03584373|580987829|FG000|Overall Study|Lost to Follow-up|7|||
160889001|NCT03584373|580987830|FG001|Overall Study|Lost to Follow-up|8|||
160889002|NCT00662532|580987832|FG000|Overall Study|Adverse Event|0|||
160889003|NCT00662532|580987833|FG001|Overall Study|Adverse Event|1|||
160889004|NCT00662532|580987832|FG000|Overall Study|Lost to Follow-up|0|||
160889005|NCT00662532|580987833|FG001|Overall Study|Lost to Follow-up|1|||
160889006|NCT00366340|580987834|FG000|Infant Series|Protocol Violation|3|||
160889007|NCT00366340|580987835|FG001|Infant Series|Protocol Violation|4|||
160889008|NCT00366340|580987834|FG000|Infant Series|Withdrawal by Subject|3|||
160889009|NCT00366340|580987835|FG001|Infant Series|Withdrawal by Subject|3|||
160889010|NCT00366340|580987834|FG000|Infant Series|Adverse Event|0|||
160889011|NCT00366340|580987835|FG001|Infant Series|Adverse Event|2|||
160889012|NCT00366340|580987834|FG000|Infant Series|Lost to Follow-up|1|||
160889013|NCT00366340|580987835|FG001|Infant Series|Lost to Follow-up|1|||
160889014|NCT00366340|580987834|FG000|Infant Series|Failure to return|1|||
160889015|NCT00366340|580987835|FG001|Infant Series|Failure to return|0|||
160889016|NCT00366340|580987834|FG000|After the Infant Series|Parent/legal guardian request|1|||
160889017|NCT00366340|580987835|FG001|After the Infant Series|Parent/legal guardian request|1|||
160889018|NCT00366340|580987834|FG000|After the Infant Series|Failed to return|0|||
160889019|NCT00366340|580987835|FG001|After the Infant Series|Failed to return|1|||
160889020|NCT00366340|580987834|FG000|After the Infant Series|Protocol Violation|2|||
160889021|NCT00366340|580987835|FG001|After the Infant Series|Protocol Violation|2|||
160889022|NCT00366340|580987834|FG000|After the Infant Series|Adverse Event|0|||
160889023|NCT00366340|580987835|FG001|After the Infant Series|Adverse Event|1|||
160889024|NCT00366340|580987834|FG000|After the Infant Series|Lost to Follow-up|0|||
160889025|NCT00366340|580987835|FG001|After the Infant Series|Lost to Follow-up|1|||
160889026|NCT00366340|580987834|FG000|Toddler Dose|Failed to return|1|||
160889027|NCT00366340|580987835|FG001|Toddler Dose|Failed to return|0|||
160889028|NCT00366340|580987834|FG000|Toddler Dose|Parent/legal guardian request|0|||
160889029|NCT00366340|580987835|FG001|Toddler Dose|Parent/legal guardian request|1|||
160889030|NCT00367770|580987836|FG000|Overall Study|Adverse Event|1|||
160889031|NCT00367770|580987836|FG000|Overall Study|Withdrawal by Subject|1|||
160889032|NCT00442468|580987840|FG000|Overall Study|Adverse Event|4|||
160889033|NCT00442468|580987840|FG000|Overall Study|Withdrawal by Subject|91|||
160889034|NCT00442468|580987840|FG000|Overall Study|Did not complete all study procedures|88|||
160889035|NCT00589784|580987841|FG000|Overall Study|Withdrawal by Subject|0|||
160889036|NCT00589784|580987842|FG001|Overall Study|Withdrawal by Subject|6|||
160889037|NCT00589784|580987841|FG000|Overall Study|Patient inevaluable|1|||
160889038|NCT00589784|580987842|FG001|Overall Study|Patient inevaluable|0|||
160889039|NCT00589784|580987841|FG000|Overall Study|Adverse Event|0|||
160889040|NCT00589784|580987842|FG001|Overall Study|Adverse Event|4|||
160889041|NCT00287079|580987844|FG000|Overall Study|Qualifying relapse|12|||
160889042|NCT00287079|580987845|FG001|Overall Study|Qualifying relapse|1|||
160889043|NCT00287079|580987844|FG000|Overall Study|Non-qualifying relapse|1|||
160889044|NCT00287079|580987845|FG001|Overall Study|Non-qualifying relapse|0|||
160889045|NCT00287079|580987844|FG000|Overall Study|Adverse Event|5|||
160889046|NCT00287079|580987845|FG001|Overall Study|Adverse Event|0|||
160889047|NCT00287079|580987844|FG000|Overall Study|Protocol Violation|1|||
160889048|NCT00287079|580987845|FG001|Overall Study|Protocol Violation|0|||
160889049|NCT00287079|580987844|FG000|Overall Study|Other|3|||
160889050|NCT00287079|580987845|FG001|Overall Study|Other|0|||
160889051|NCT03282565|580987850|FG000|Overall Study|COVID-19 Research Shutdown|0|||
160889052|NCT03282565|580987851|FG001|Overall Study|COVID-19 Research Shutdown|2|||
160889053|NCT03282565|580987852|FG002|Overall Study|COVID-19 Research Shutdown|2|||
160889054|NCT00174291|580987858|FG000|Overall Study|Lost to Follow-up|1|||
160889055|NCT00174291|580987859|FG001|Overall Study|Lost to Follow-up|1|||
160889056|NCT00174291|580987858|FG000|Overall Study|Protocol Violation|0|||
160889057|NCT00174291|580987859|FG001|Overall Study|Protocol Violation|2|||
160889058|NCT00174291|580987858|FG000|Overall Study|Study terminated by sponsor|1|||
160889059|NCT00174291|580987859|FG001|Overall Study|Study terminated by sponsor|0|||
160889060|NCT00174291|580987858|FG000|Overall Study|Withdrawal by Subject|3|||
160889061|NCT00174291|580987859|FG001|Overall Study|Withdrawal by Subject|3|||
160889062|NCT03882008|580987860|FG000|Overall Study|Withdrawal by Subject|1|||
160889063|NCT03882008|580987860|FG000|Overall Study|Lost to Follow-up|1|||
160889064|NCT01582854|580987866|FG000|Overall Study|Death|8|||
160889065|NCT01582854|580987867|FG001|Overall Study|Death|5|||
160889066|NCT01582854|580987866|FG000|Overall Study|Adverse Event|2|||
160889067|NCT01582854|580987867|FG001|Overall Study|Adverse Event|3|||
160889068|NCT01582854|580987866|FG000|Overall Study|Withdrawal by Participant|8|||
160889069|NCT01582854|580987867|FG001|Overall Study|Withdrawal by Participant|11|||
160889070|NCT01582854|580987866|FG000|Overall Study|Lost to Follow-up|1|||
160889071|NCT01582854|580987867|FG001|Overall Study|Lost to Follow-up|2|||
160889072|NCT01582854|580987866|FG000|Overall Study|Physician Decision|0|||
160889073|NCT01582854|580987867|FG001|Overall Study|Physician Decision|1|||
160889074|NCT01582854|580987866|FG000|Overall Study|Recurrent Stroke|13|||
160889075|NCT01582854|580987867|FG001|Overall Study|Recurrent Stroke|8|||
160889076|NCT01582854|580987866|FG000|Overall Study|Disallowed Concomitant Medication|3|||
160889077|NCT01582854|580987867|FG001|Overall Study|Disallowed Concomitant Medication|2|||
160889078|NCT01582854|580987866|FG000|Overall Study|Carotid or Neurosurgery|0|||
160889079|NCT01582854|580987867|FG001|Overall Study|Carotid or Neurosurgery|1|||
160889080|NCT01582854|580987866|FG000|Overall Study|General Anaesthesia|0|||
160889081|NCT01582854|580987867|FG001|Overall Study|General Anaesthesia|1|||
160889082|NCT01582854|580987866|FG000|Overall Study|Other Miscellaneous Reason|1|||
160889083|NCT01582854|580987867|FG001|Overall Study|Other Miscellaneous Reason|0|||
160889084|NCT04068896|580987868|FG000|Overall Study|Adverse Event|2|||
160889085|NCT04068896|580987869|FG001|Overall Study|Adverse Event|0|||
160889086|NCT04068896|580987870|FG002|Overall Study|Adverse Event|1|||
160889087|NCT04068896|580987871|FG003|Overall Study|Adverse Event|0|||
160889088|NCT04068896|580987872|FG004|Overall Study|Adverse Event|0|||
160889089|NCT04068896|580987873|FG005|Overall Study|Adverse Event|0|||
160889090|NCT04068896|580987868|FG000|Overall Study|Death|3|||
160889091|NCT04068896|580987869|FG001|Overall Study|Death|1|||
160889092|NCT04068896|580987870|FG002|Overall Study|Death|3|||
160889093|NCT04068896|580987871|FG003|Overall Study|Death|19|||
160889094|NCT04068896|580987872|FG004|Overall Study|Death|17|||
160889095|NCT04068896|580987873|FG005|Overall Study|Death|0|||
160889096|NCT04068896|580987868|FG000|Overall Study|Physician Decision|0|||
160889097|NCT04068896|580987869|FG001|Overall Study|Physician Decision|0|||
160889098|NCT04068896|580987870|FG002|Overall Study|Physician Decision|0|||
160889099|NCT04068896|580987871|FG003|Overall Study|Physician Decision|1|||
160889100|NCT04068896|580987872|FG004|Overall Study|Physician Decision|0|||
160889101|NCT04068896|580987873|FG005|Overall Study|Physician Decision|0|||
160889102|NCT04068896|580987868|FG000|Overall Study|progressive disease|3|||
160889103|NCT04068896|580987869|FG001|Overall Study|progressive disease|5|||
160889104|NCT04068896|580987870|FG002|Overall Study|progressive disease|3|||
160889105|NCT04068896|580987871|FG003|Overall Study|progressive disease|2|||
160889106|NCT04068896|580987872|FG004|Overall Study|progressive disease|1|||
160889107|NCT04068896|580987873|FG005|Overall Study|progressive disease|2|||
160889108|NCT04068896|580987868|FG000|Overall Study|Study terminated by sponsor|0|||
160889109|NCT04068896|580987869|FG001|Overall Study|Study terminated by sponsor|0|||
160889110|NCT04068896|580987870|FG002|Overall Study|Study terminated by sponsor|1|||
160889111|NCT04068896|580987871|FG003|Overall Study|Study terminated by sponsor|2|||
160889112|NCT04068896|580987872|FG004|Overall Study|Study terminated by sponsor|1|||
160889113|NCT04068896|580987873|FG005|Overall Study|Study terminated by sponsor|4|||
160889114|NCT04068896|580987868|FG000|Overall Study|Protocol Violation|0|||
160889115|NCT04068896|580987869|FG001|Overall Study|Protocol Violation|0|||
160889116|NCT04068896|580987870|FG002|Overall Study|Protocol Violation|0|||
160889117|NCT04068896|580987871|FG003|Overall Study|Protocol Violation|1|||
160889118|NCT04068896|580987872|FG004|Overall Study|Protocol Violation|0|||
160889119|NCT04068896|580987873|FG005|Overall Study|Protocol Violation|0|||
160889120|NCT04068896|580987868|FG000|Overall Study|Withdrawal by Subject|0|||
160889121|NCT04068896|580987869|FG001|Overall Study|Withdrawal by Subject|3|||
160889122|NCT04068896|580987870|FG002|Overall Study|Withdrawal by Subject|0|||
160889123|NCT04068896|580987871|FG003|Overall Study|Withdrawal by Subject|2|||
160889124|NCT04068896|580987872|FG004|Overall Study|Withdrawal by Subject|1|||
160889125|NCT04068896|580987873|FG005|Overall Study|Withdrawal by Subject|0|||
160889126|NCT04068896|580987868|FG000|Overall Study|Symptomatic deterioration|2|||
160889127|NCT04068896|580987869|FG001|Overall Study|Symptomatic deterioration|0|||
160889128|NCT04068896|580987870|FG002|Overall Study|Symptomatic deterioration|0|||
160889129|NCT04068896|580987871|FG003|Overall Study|Symptomatic deterioration|0|||
161229613|NCT00849901|582222506|FG001|Extension Phase|Physician Decision|2|||
161229614|NCT00849901|582222507|FG002|Extension Phase|Physician Decision|0|||
161229615|NCT00849901|582222505|FG000|Extension Phase|Lack of Efficacy|2|||
161229616|NCT00849901|582222506|FG001|Extension Phase|Lack of Efficacy|4|||
161229617|NCT00849901|582222507|FG002|Extension Phase|Lack of Efficacy|1|||
161229618|NCT00262223|582222508|FG000|Treatment Phase|Withdrawal by Subject|3|||
160889130|NCT04068896|580987872|FG004|Overall Study|Symptomatic deterioration|0|||
160889131|NCT04068896|580987873|FG005|Overall Study|Symptomatic deterioration|0|||
160889132|NCT02953509|580987874|FG000|Overall Study|Death|1|||
160889133|NCT02953509|580987875|FG001|Overall Study|Death|3|||
160889134|NCT02953509|580987876|FG002|Overall Study|Death|3|||
160889135|NCT02953509|580987877|FG003|Overall Study|Death|4|||
160889136|NCT02953509|580987878|FG004|Overall Study|Death|12|||
160889137|NCT02953509|580987879|FG005|Overall Study|Death|3|||
160889138|NCT02953509|580987880|FG006|Overall Study|Death|25|||
160889139|NCT02953509|580987881|FG007|Overall Study|Death|10|||
160889140|NCT02953509|580987882|FG008|Overall Study|Death|21|||
160889141|NCT02953509|580987883|FG009|Overall Study|Death|20|||
160889142|NCT02953509|580987874|FG000|Overall Study|Reason Not Specified|0|||
160889143|NCT02953509|580987875|FG001|Overall Study|Reason Not Specified|2|||
160889144|NCT02953509|580987876|FG002|Overall Study|Reason Not Specified|8|||
160889145|NCT02953509|580987877|FG003|Overall Study|Reason Not Specified|2|||
160889146|NCT02953509|580987878|FG004|Overall Study|Reason Not Specified|11|||
160889147|NCT02953509|580987879|FG005|Overall Study|Reason Not Specified|4|||
160889148|NCT02953509|580987880|FG006|Overall Study|Reason Not Specified|12|||
160889149|NCT02953509|580987881|FG007|Overall Study|Reason Not Specified|2|||
160889150|NCT02953509|580987882|FG008|Overall Study|Reason Not Specified|7|||
160889151|NCT02953509|580987883|FG009|Overall Study|Reason Not Specified|2|||
161229619|NCT00262223|582222509|FG001|Treatment Phase|Withdrawal by Subject|6|||
161229620|NCT00262223|582222508|FG000|Treatment Phase|Adverse Event|1|||
161229621|NCT00262223|582222509|FG001|Treatment Phase|Adverse Event|2|||
161229622|NCT00262223|582222508|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
161229623|NCT00262223|582222509|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
160781338|NCT03166631|580584992|FG005|Overall Study|Death|0|||
160781339|NCT03166631|580584993|FG006|Overall Study|Death|1|||
160781340|NCT03166631|580584994|FG007|Overall Study|Death|0|||
160781341|NCT03166631|580584995|FG008|Overall Study|Death|0|||
160781342|NCT03166631|580584996|FG009|Overall Study|Death|0|||
160781343|NCT03166631|580584997|FG010|Overall Study|Death|0|||
160781344|NCT03166631|580584987|FG000|Overall Study|Adverse Event|1|||
160781345|NCT03166631|580584988|FG001|Overall Study|Adverse Event|0|||
160781346|NCT03166631|580584989|FG002|Overall Study|Adverse Event|0|||
160781347|NCT03166631|580584990|FG003|Overall Study|Adverse Event|0|||
160781348|NCT03166631|580584991|FG004|Overall Study|Adverse Event|0|||
160781349|NCT03166631|580584992|FG005|Overall Study|Adverse Event|1|||
160781350|NCT03166631|580584993|FG006|Overall Study|Adverse Event|1|||
160781351|NCT03166631|580584994|FG007|Overall Study|Adverse Event|0|||
160781352|NCT03166631|580584995|FG008|Overall Study|Adverse Event|1|||
160889152|NCT02953509|580987874|FG000|Overall Study|Consent Withdrawn|1|||
160889153|NCT02953509|580987875|FG001|Overall Study|Consent Withdrawn|1|||
160889154|NCT02953509|580987876|FG002|Overall Study|Consent Withdrawn|2|||
160889155|NCT02953509|580987877|FG003|Overall Study|Consent Withdrawn|1|||
160889156|NCT02953509|580987878|FG004|Overall Study|Consent Withdrawn|3|||
160889157|NCT02953509|580987879|FG005|Overall Study|Consent Withdrawn|0|||
161229624|NCT00262223|582222508|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
160889158|NCT02953509|580987880|FG006|Overall Study|Consent Withdrawn|4|||
160889159|NCT02953509|580987881|FG007|Overall Study|Consent Withdrawn|1|||
161229625|NCT00262223|582222509|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
160781353|NCT03166631|580584996|FG009|Overall Study|Adverse Event|2|||
160781354|NCT03166631|580584997|FG010|Overall Study|Adverse Event|1|||
160781355|NCT03166631|580584987|FG000|Overall Study|Withdrawal by Subject|0|||
160889160|NCT02953509|580987882|FG008|Overall Study|Consent Withdrawn|1|||
160889161|NCT02953509|580987883|FG009|Overall Study|Consent Withdrawn|4|||
160889162|NCT02953509|580987874|FG000|Overall Study|Lost to Follow-up|0|||
160889163|NCT02953509|580987875|FG001|Overall Study|Lost to Follow-up|0|||
160889164|NCT02953509|580987876|FG002|Overall Study|Lost to Follow-up|0|||
160889165|NCT02953509|580987877|FG003|Overall Study|Lost to Follow-up|0|||
161326769|NCT00524771|582583191|FG001|Overall Study|Protocol Violation|585|||
161326770|NCT02781818|582583192|FG000|Overall Study|Lost to Follow-up|4|||
161326771|NCT02781818|582583193|FG001|Overall Study|Lost to Follow-up|2|||
161326772|NCT02781818|582583194|FG002|Overall Study|Lost to Follow-up|1|||
161326773|NCT01877668|582583195|FG000|Overall Study|Death|0|||
161326774|NCT01877668|582583196|FG001|Overall Study|Death|0|||
160889166|NCT02953509|580987878|FG004|Overall Study|Lost to Follow-up|0|||
160889167|NCT02953509|580987879|FG005|Overall Study|Lost to Follow-up|0|||
160889168|NCT02953509|580987880|FG006|Overall Study|Lost to Follow-up|1|||
160889169|NCT02953509|580987881|FG007|Overall Study|Lost to Follow-up|1|||
160889170|NCT02953509|580987882|FG008|Overall Study|Lost to Follow-up|1|||
160889171|NCT02953509|580987883|FG009|Overall Study|Lost to Follow-up|1|||
160889172|NCT02953509|580987874|FG000|Overall Study|Study terminated by sponsor|1|||
160889173|NCT02953509|580987875|FG001|Overall Study|Study terminated by sponsor|0|||
160889174|NCT02953509|580987876|FG002|Overall Study|Study terminated by sponsor|0|||
160889175|NCT02953509|580987877|FG003|Overall Study|Study terminated by sponsor|0|||
160889176|NCT02953509|580987878|FG004|Overall Study|Study terminated by sponsor|0|||
160889177|NCT02953509|580987879|FG005|Overall Study|Study terminated by sponsor|0|||
160889178|NCT02953509|580987880|FG006|Overall Study|Study terminated by sponsor|1|||
160889179|NCT02953509|580987881|FG007|Overall Study|Study terminated by sponsor|0|||
160889180|NCT02953509|580987882|FG008|Overall Study|Study terminated by sponsor|1|||
160889181|NCT02953509|580987883|FG009|Overall Study|Study terminated by sponsor|1|||
160889182|NCT02325791|580987884|FG000|Overall Study|Adverse Event|0|||
160889183|NCT02325791|580987885|FG001|Overall Study|Adverse Event|1|||
160889184|NCT02325791|580987886|FG002|Overall Study|Adverse Event|1|||
160889185|NCT02325791|580987887|FG003|Overall Study|Adverse Event|0|||
160889186|NCT02325791|580987884|FG000|Overall Study|Death|0|||
161326775|NCT01877668|582583197|FG002|Overall Study|Death|0|||
161326776|NCT01877668|582583198|FG003|Overall Study|Death|1|||
161326777|NCT01877668|582583199|FG004|Overall Study|Death|0|||
161326778|NCT01877668|582583195|FG000|Overall Study|No longer met study criteria|1|||
161326779|NCT01877668|582583196|FG001|Overall Study|No longer met study criteria|0|||
161326780|NCT01877668|582583197|FG002|Overall Study|No longer met study criteria|1|||
161326781|NCT01877668|582583198|FG003|Overall Study|No longer met study criteria|0|||
161326782|NCT01877668|582583199|FG004|Overall Study|No longer met study criteria|0|||
161326783|NCT01877668|582583195|FG000|Overall Study|Insufficient clinical response|0|||
161326784|NCT01877668|582583196|FG001|Overall Study|Insufficient clinical response|1|||
161326785|NCT01877668|582583197|FG002|Overall Study|Insufficient clinical response|2|||
161326786|NCT01877668|582583198|FG003|Overall Study|Insufficient clinical response|2|||
161326787|NCT01877668|582583199|FG004|Overall Study|Insufficient clinical response|0|||
161326788|NCT01877668|582583195|FG000|Overall Study|Lost to Follow-up|0|||
161326789|NCT01877668|582583196|FG001|Overall Study|Lost to Follow-up|2|||
161326790|NCT01877668|582583197|FG002|Overall Study|Lost to Follow-up|1|||
161326791|NCT01877668|582583198|FG003|Overall Study|Lost to Follow-up|0|||
161326792|NCT01877668|582583199|FG004|Overall Study|Lost to Follow-up|0|||
161326793|NCT01877668|582583195|FG000|Overall Study|Withdrawal by Subject|2|||
161326794|NCT01877668|582583196|FG001|Overall Study|Withdrawal by Subject|0|||
161326795|NCT01877668|582583197|FG002|Overall Study|Withdrawal by Subject|3|||
160889187|NCT02325791|580987885|FG001|Overall Study|Death|3|||
160889188|NCT02325791|580987886|FG002|Overall Study|Death|0|||
161326796|NCT01877668|582583198|FG003|Overall Study|Withdrawal by Subject|2|||
161326797|NCT01877668|582583199|FG004|Overall Study|Withdrawal by Subject|2|||
161326798|NCT01877668|582583195|FG000|Overall Study|Other|1|||
161326799|NCT01877668|582583196|FG001|Overall Study|Other|1|||
161326800|NCT01877668|582583197|FG002|Overall Study|Other|1|||
161326801|NCT01877668|582583198|FG003|Overall Study|Other|1|||
160889189|NCT02325791|580987887|FG003|Overall Study|Death|1|||
160889190|NCT02325791|580987884|FG000|Overall Study|Lost to Follow-up|0|||
160889191|NCT02325791|580987885|FG001|Overall Study|Lost to Follow-up|15|||
160889192|NCT02325791|580987886|FG002|Overall Study|Lost to Follow-up|14|||
160889193|NCT02325791|580987887|FG003|Overall Study|Lost to Follow-up|9|||
161326802|NCT01877668|582583199|FG004|Overall Study|Other|3|||
160889194|NCT02325791|580987884|FG000|Overall Study|Physician Decision|0|||
160889195|NCT02325791|580987885|FG001|Overall Study|Physician Decision|1|||
160889196|NCT02325791|580987886|FG002|Overall Study|Physician Decision|1|||
160889197|NCT02325791|580987887|FG003|Overall Study|Physician Decision|0|||
160889198|NCT02325791|580987884|FG000|Overall Study|Protocol Violation|0|||
161326803|NCT01877668|582583195|FG000|Overall Study|Protocol Violation|1|||
161326804|NCT01877668|582583196|FG001|Overall Study|Protocol Violation|1|||
161326805|NCT01877668|582583197|FG002|Overall Study|Protocol Violation|0|||
161326806|NCT01877668|582583198|FG003|Overall Study|Protocol Violation|0|||
161326807|NCT01877668|582583199|FG004|Overall Study|Protocol Violation|3|||
161326808|NCT01877668|582583195|FG000|Overall Study|Adverse event related to study drug|2|||
160781356|NCT03166631|580584988|FG001|Overall Study|Withdrawal by Subject|0|||
160781357|NCT03166631|580584989|FG002|Overall Study|Withdrawal by Subject|0|||
160781358|NCT03166631|580584990|FG003|Overall Study|Withdrawal by Subject|0|||
160781359|NCT03166631|580584991|FG004|Overall Study|Withdrawal by Subject|0|||
160781360|NCT03166631|580584992|FG005|Overall Study|Withdrawal by Subject|0|||
160781361|NCT03166631|580584993|FG006|Overall Study|Withdrawal by Subject|0|||
160781362|NCT03166631|580584994|FG007|Overall Study|Withdrawal by Subject|0|||
160781363|NCT03166631|580584995|FG008|Overall Study|Withdrawal by Subject|1|||
160781364|NCT03166631|580584996|FG009|Overall Study|Withdrawal by Subject|1|||
160781365|NCT03166631|580584997|FG010|Overall Study|Withdrawal by Subject|0|||
160781366|NCT00456612|580585006|FG000|Overall Study|Withdrawal by Subject|3|||
160781367|NCT01108796|580585007|FG000|Overall Study|Adverse Event|0|||
160781368|NCT01108796|580585008|FG001|Overall Study|Adverse Event|1|||
161229626|NCT00262223|582222508|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
161229627|NCT00262223|582222509|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
161229628|NCT00437658|582222512|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
161229629|NCT00437658|582222513|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
161229630|NCT00437658|582222514|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
161229631|NCT00437658|582222512|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
161229632|NCT00437658|582222513|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
161229633|NCT00437658|582222514|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
161229634|NCT00437658|582222512|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
161229635|NCT00437658|582222513|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
161229636|NCT00437658|582222514|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
161229637|NCT00437658|582222512|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
161229638|NCT00437658|582222513|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
161229639|NCT00437658|582222514|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
161229640|NCT00437658|582222512|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
161229641|NCT00437658|582222513|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
161229642|NCT00437658|582222514|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
161229643|NCT00437658|582222512|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
161229644|NCT00437658|582222513|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
161229645|NCT00437658|582222514|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
161229646|NCT00437658|582222512|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
161229647|NCT00437658|582222513|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
161229648|NCT00437658|582222514|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
161229649|NCT00437658|582222512|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
161229650|NCT00437658|582222513|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
161229651|NCT00437658|582222514|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
161229652|NCT00437658|582222512|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
161229653|NCT00437658|582222513|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
161229654|NCT00437658|582222514|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
161229655|NCT00437658|582222512|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
161229656|NCT00437658|582222513|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
161229657|NCT00437658|582222514|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
161229658|NCT00437658|582222512|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
161229659|NCT00437658|582222513|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
161229660|NCT00437658|582222514|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
161229661|NCT00437658|582222512|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
161229662|NCT00437658|582222513|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
161229663|NCT00437658|582222514|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
161229664|NCT03952143|582222515|FG000|Lead-In Period|Adverse Event|2|||
161229665|NCT03952143|582222516|FG001|Lead-In Period|Adverse Event|0|||
161229666|NCT03952143|582222517|FG002|Lead-In Period|Adverse Event|0|||
161229667|NCT03952143|582222515|FG000|Lead-In Period|Lack of Efficacy|2|||
161229668|NCT03952143|582222516|FG001|Lead-In Period|Lack of Efficacy|0|||
161229669|NCT03952143|582222517|FG002|Lead-In Period|Lack of Efficacy|0|||
161229670|NCT03952143|582222515|FG000|Lead-In Period|Physician Decision|5|||
161229671|NCT03952143|582222516|FG001|Lead-In Period|Physician Decision|0|||
161229672|NCT03952143|582222517|FG002|Lead-In Period|Physician Decision|0|||
161229673|NCT03952143|582222515|FG000|Lead-In Period|Protocol Violation|5|||
161229674|NCT03952143|582222516|FG001|Lead-In Period|Protocol Violation|0|||
161229675|NCT03952143|582222517|FG002|Lead-In Period|Protocol Violation|0|||
161229676|NCT03952143|582222515|FG000|Lead-In Period|Withdrawal by Subject|19|||
161229677|NCT03952143|582222516|FG001|Lead-In Period|Withdrawal by Subject|0|||
161229678|NCT03952143|582222517|FG002|Lead-In Period|Withdrawal by Subject|0|||
161229679|NCT03952143|582222515|FG000|Treatment Period|Adverse Event|0|||
161229680|NCT03952143|582222516|FG001|Treatment Period|Adverse Event|0|||
161229681|NCT03952143|582222517|FG002|Treatment Period|Adverse Event|1|||
161229682|NCT03952143|582222515|FG000|Treatment Period|Lost to Follow-up|0|||
161229683|NCT03952143|582222516|FG001|Treatment Period|Lost to Follow-up|2|||
160781369|NCT01108796|580585007|FG000|Overall Study|Lost to Follow-up|7|||
160889199|NCT02325791|580987885|FG001|Overall Study|Protocol Violation|0|||
160889200|NCT02325791|580987886|FG002|Overall Study|Protocol Violation|1|||
160889201|NCT02325791|580987887|FG003|Overall Study|Protocol Violation|0|||
160889202|NCT02325791|580987884|FG000|Overall Study|Withdrawal by Subject|0|||
160889203|NCT02325791|580987885|FG001|Overall Study|Withdrawal by Subject|5|||
160889204|NCT02325791|580987886|FG002|Overall Study|Withdrawal by Subject|8|||
160889205|NCT02325791|580987887|FG003|Overall Study|Withdrawal by Subject|16|||
160889206|NCT02694718|580987889|FG000|Overall Study|Death|1|||
160889207|NCT02694718|580987889|FG000|Overall Study|Withdrawal by Subject|1|||
160889208|NCT00322153|580987891|FG000|Overall Study|Adverse Event|21|||
160889209|NCT00322153|580987892|FG001|Overall Study|Adverse Event|34|||
160889210|NCT00322153|580987891|FG000|Overall Study|Protocol Violation|6|||
160889211|NCT00322153|580987892|FG001|Overall Study|Protocol Violation|14|||
160889212|NCT00322153|580987891|FG000|Overall Study|Withdrawal by Subject|18|||
160889213|NCT00322153|580987892|FG001|Overall Study|Withdrawal by Subject|10|||
160889214|NCT00322153|580987891|FG000|Overall Study|Lack of Efficacy|8|||
160889215|NCT00322153|580987892|FG001|Overall Study|Lack of Efficacy|3|||
160889216|NCT00322153|580987891|FG000|Overall Study|Lost to Follow-up|5|||
160889217|NCT00322153|580987892|FG001|Overall Study|Lost to Follow-up|4|||
160889218|NCT00322153|580987891|FG000|Overall Study|Withdrawn for other reasons|5|||
160889219|NCT00322153|580987892|FG001|Overall Study|Withdrawn for other reasons|4|||
160889220|NCT03455764|580987894|FG000|Overall Study|Adverse Event|1|||
160889221|NCT03455764|580987895|FG001|Overall Study|Adverse Event|0|||
160889222|NCT03455764|580987896|FG002|Overall Study|Adverse Event|0|||
160889223|NCT03455764|580987897|FG003|Overall Study|Adverse Event|0|||
160889224|NCT03455764|580987898|FG004|Overall Study|Adverse Event|0|||
160889225|NCT03455764|580987894|FG000|Overall Study|Disease Progression|4|||
160889226|NCT03455764|580987895|FG001|Overall Study|Disease Progression|0|||
160889227|NCT03455764|580987896|FG002|Overall Study|Disease Progression|0|||
160889228|NCT03455764|580987897|FG003|Overall Study|Disease Progression|0|||
160889229|NCT03455764|580987898|FG004|Overall Study|Disease Progression|0|||
160889230|NCT03455764|580987894|FG000|Overall Study|On Treatment|1|||
160889231|NCT03455764|580987895|FG001|Overall Study|On Treatment|0|||
160889232|NCT03455764|580987896|FG002|Overall Study|On Treatment|0|||
160889233|NCT03455764|580987897|FG003|Overall Study|On Treatment|0|||
160889234|NCT03455764|580987898|FG004|Overall Study|On Treatment|0|||
160889235|NCT02361346|580987899|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889236|NCT02361346|580987900|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889237|NCT02361346|580987901|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889238|NCT02361346|580987902|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
160889239|NCT02361346|580987903|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889240|NCT02361346|580987904|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889241|NCT02361346|580987905|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889242|NCT02361346|580987906|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889243|NCT02361346|580987907|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
160889244|NCT02361346|580987899|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889245|NCT02361346|580987900|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889246|NCT02361346|580987901|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889247|NCT02361346|580987902|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889248|NCT02361346|580987903|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
160889249|NCT02361346|580987904|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889250|NCT02361346|580987905|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889251|NCT02361346|580987906|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889252|NCT02361346|580987907|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
160889253|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
160889254|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
160889255|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
160889256|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
160889257|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
161326809|NCT01877668|582583196|FG001|Overall Study|Adverse event related to study drug|2|||
161326810|NCT01877668|582583197|FG002|Overall Study|Adverse event related to study drug|2|||
161326811|NCT01877668|582583198|FG003|Overall Study|Adverse event related to study drug|2|||
161326812|NCT01877668|582583199|FG004|Overall Study|Adverse event related to study drug|1|||
161326813|NCT01877668|582583195|FG000|Overall Study|Adverse event unrelated to study drug|4|||
161326814|NCT01877668|582583196|FG001|Overall Study|Adverse event unrelated to study drug|1|||
161326815|NCT01877668|582583197|FG002|Overall Study|Adverse event unrelated to study drug|2|||
161326816|NCT01877668|582583198|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161326817|NCT01877668|582583199|FG004|Overall Study|Adverse event unrelated to study drug|1|||
160889258|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
160889259|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
160889260|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
160889261|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
160889262|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889263|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889264|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889265|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889266|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889267|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889268|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889269|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
160889270|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
160889271|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889272|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889273|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889274|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889275|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889276|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889277|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889278|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
160889279|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
160889280|NCT02361346|580987899|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889281|NCT02361346|580987900|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889282|NCT02361346|580987901|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889283|NCT02361346|580987902|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889284|NCT02361346|580987903|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889285|NCT02361346|580987904|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889286|NCT02361346|580987905|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889287|NCT02361346|580987906|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
160889288|NCT02361346|580987907|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
160889289|NCT01683019|580989484|FG000|Overall Study|Withdrawal by Subject|2|||
160889290|NCT01683019|580989485|FG001|Overall Study|Withdrawal by Subject|1|||
160889291|NCT01683019|580989486|FG002|Overall Study|Withdrawal by Subject|4|||
160889292|NCT03437512|580989487|FG000|Randomized|Withdrawal by Subject|0|||
160889293|NCT03437512|580989488|FG001|Randomized|Withdrawal by Subject|2|||
160889294|NCT03437512|580989487|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
160889295|NCT03437512|580989488|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
160889296|NCT03332771|580989489|FG000|Overall Study|Adverse Event|6|||
160889297|NCT03332771|580989490|FG001|Overall Study|Adverse Event|4|||
160889298|NCT03332771|580989491|FG002|Overall Study|Adverse Event|1|||
160889299|NCT03332771|580989492|FG003|Overall Study|Adverse Event|3|||
160889300|NCT03332771|580989489|FG000|Overall Study|Poor Compliance to Protocol|0|||
160889301|NCT03332771|580989490|FG001|Overall Study|Poor Compliance to Protocol|1|||
160889302|NCT03332771|580989491|FG002|Overall Study|Poor Compliance to Protocol|0|||
160889303|NCT03332771|580989492|FG003|Overall Study|Poor Compliance to Protocol|1|||
160889304|NCT03332771|580989489|FG000|Overall Study|Lost to Follow-up|2|||
160889305|NCT03332771|580989490|FG001|Overall Study|Lost to Follow-up|2|||
160889306|NCT03332771|580989491|FG002|Overall Study|Lost to Follow-up|1|||
160889307|NCT03332771|580989492|FG003|Overall Study|Lost to Follow-up|2|||
160889308|NCT03332771|580989489|FG000|Overall Study|At the Participant's own request|20|||
160889309|NCT03332771|580989490|FG001|Overall Study|At the Participant's own request|26|||
160889310|NCT03332771|580989491|FG002|Overall Study|At the Participant's own request|14|||
160889311|NCT03332771|580989492|FG003|Overall Study|At the Participant's own request|23|||
160889312|NCT03332771|580989489|FG000|Overall Study|Reason Not Specified|6|||
160889313|NCT03332771|580989490|FG001|Overall Study|Reason Not Specified|18|||
160889314|NCT03332771|580989491|FG002|Overall Study|Reason Not Specified|16|||
160889315|NCT03332771|580989492|FG003|Overall Study|Reason Not Specified|19|||
160889316|NCT03442764|580989493|FG000|Overall Study|Adverse Event|1|||
160889317|NCT03442764|580989494|FG001|Overall Study|Adverse Event|0|||
160889318|NCT03442764|580989495|FG002|Overall Study|Adverse Event|0|||
160889319|NCT01801072|580989496|FG000|Overall Study|Lost to Follow-up|17|||
160889320|NCT01801072|580989497|FG001|Overall Study|Lost to Follow-up|14|||
160889321|NCT01801072|580989496|FG000|Overall Study|Physician Decision|2|||
160889322|NCT01801072|580989497|FG001|Overall Study|Physician Decision|3|||
160889323|NCT01801072|580989496|FG000|Overall Study|Withdrawal by Subject|1|||
161326818|NCT02317991|582583200|FG000|Overall Study|Adverse Event|12|||
161326819|NCT02317991|582583200|FG000|Overall Study|Death|4|||
160889324|NCT01801072|580989497|FG001|Overall Study|Withdrawal by Subject|0|||
160889325|NCT01801072|580989496|FG000|Overall Study|Protocol Violation|2|||
160889326|NCT01801072|580989497|FG001|Overall Study|Protocol Violation|0|||
160889327|NCT01801072|580989496|FG000|Overall Study|Death|7|||
160889328|NCT01801072|580989497|FG001|Overall Study|Death|8|||
160889329|NCT03693170|580989498|FG000|Overall Study|Disease Progression|48|||
160889330|NCT03693170|580989498|FG000|Overall Study|Adverse Event|16|||
160889331|NCT03693170|580989498|FG000|Overall Study|Physician Decision|6|||
160889332|NCT03693170|580989498|FG000|Overall Study|Protocol Violation|2|||
160889333|NCT03693170|580989498|FG000|Overall Study|Death|1|||
160889334|NCT03693170|580989498|FG000|Overall Study|Non compliance with study drug|1|||
161123917|NCT01928381|581839176|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
161123918|NCT01928381|581839170|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
161123919|NCT01928381|581839171|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
161123920|NCT01928381|581839172|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
161123921|NCT01928381|581839173|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
161123922|NCT01928381|581839174|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
161123923|NCT01928381|581839175|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
161123924|NCT01928381|581839176|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
161123925|NCT01928381|581839170|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
161123926|NCT01928381|581839171|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
161123927|NCT01928381|581839172|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
161123928|NCT01928381|581839173|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
161123929|NCT01928381|581839174|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
161123930|NCT01928381|581839175|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
161123931|NCT01928381|581839176|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
161123932|NCT01928381|581839170|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
161123933|NCT01928381|581839171|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
161123934|NCT01928381|581839172|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
161123935|NCT01928381|581839173|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
161123936|NCT01928381|581839174|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
161123937|NCT01928381|581839175|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
161123938|NCT01928381|581839176|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
161123939|NCT01928381|581839170|FG000|Part 1 - Pain Training|Protocol Violation|1|||
161123940|NCT01928381|581839171|FG001|Part 1 - Pain Training|Protocol Violation|0|||
161123941|NCT01928381|581839172|FG002|Part 1 - Pain Training|Protocol Violation|0|||
161123942|NCT01928381|581839173|FG003|Part 1 - Pain Training|Protocol Violation|0|||
161123943|NCT01928381|581839174|FG004|Part 1 - Pain Training|Protocol Violation|0|||
161123944|NCT01928381|581839175|FG005|Part 1 - Pain Training|Protocol Violation|0|||
161123945|NCT01928381|581839176|FG006|Part 1 - Pain Training|Protocol Violation|0|||
161123946|NCT01928381|581839170|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
161123947|NCT01928381|581839171|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161123948|NCT01928381|581839172|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161123949|NCT01928381|581839173|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161123950|NCT01928381|581839174|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161123951|NCT01928381|581839175|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161123952|NCT01928381|581839176|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
161123953|NCT01928381|581839170|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
161123954|NCT01928381|581839171|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161123955|NCT01928381|581839172|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161229684|NCT03952143|582222517|FG002|Treatment Period|Lost to Follow-up|0|||
161229685|NCT03952143|582222515|FG000|Treatment Period|Physician Decision|0|||
161229686|NCT03952143|582222516|FG001|Treatment Period|Physician Decision|0|||
161229687|NCT03952143|582222517|FG002|Treatment Period|Physician Decision|2|||
161229688|NCT03952143|582222515|FG000|Treatment Period|Protocol Violation|0|||
161229689|NCT03952143|582222516|FG001|Treatment Period|Protocol Violation|0|||
161229690|NCT03952143|582222517|FG002|Treatment Period|Protocol Violation|1|||
161229691|NCT03952143|582222515|FG000|Treatment Period|Withdrawal by Subject|0|||
161229692|NCT03952143|582222516|FG001|Treatment Period|Withdrawal by Subject|5|||
161229693|NCT03952143|582222517|FG002|Treatment Period|Withdrawal by Subject|26|||
161229694|NCT03952143|582222515|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
161229695|NCT03952143|582222516|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
161229696|NCT03952143|582222517|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
161229697|NCT03952143|582222515|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
161229698|NCT03952143|582222516|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
161229699|NCT03952143|582222517|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
161229700|NCT02152566|582222518|FG000|Overall Study|Lost to Follow-up|1|||
161229701|NCT02152566|582222518|FG000|Overall Study|Withdrawal by Subject|2|||
161229702|NCT01866319|582222519|FG000|Overall Study|Adverse Event|12|||
161229703|NCT01866319|582222520|FG001|Overall Study|Adverse Event|5|||
161229704|NCT01866319|582222521|FG002|Overall Study|Adverse Event|9|||
161229705|NCT01866319|582222519|FG000|Overall Study|Clinical progression|3|||
161229706|NCT01866319|582222520|FG001|Overall Study|Clinical progression|2|||
161229707|NCT01866319|582222521|FG002|Overall Study|Clinical progression|2|||
161229708|NCT01866319|582222519|FG000|Overall Study|Death|153|||
161229709|NCT01866319|582222520|FG001|Overall Study|Death|154|||
161229710|NCT01866319|582222521|FG002|Overall Study|Death|147|||
161229711|NCT01866319|582222519|FG000|Overall Study|Lost to Follow-up|6|||
161229712|NCT01866319|582222520|FG001|Overall Study|Lost to Follow-up|3|||
161229713|NCT01866319|582222521|FG002|Overall Study|Lost to Follow-up|8|||
161229714|NCT01866319|582222519|FG000|Overall Study|Physician Decision|1|||
161229715|NCT01866319|582222520|FG001|Overall Study|Physician Decision|0|||
161229716|NCT01866319|582222521|FG002|Overall Study|Physician Decision|1|||
161229717|NCT01866319|582222519|FG000|Overall Study|Protocol Violation|0|||
160781370|NCT01108796|580585008|FG001|Overall Study|Lost to Follow-up|6|||
160781371|NCT01562444|580585024|FG000|Overall Study|Did not meet entry criteria|2|||
160889335|NCT03693170|580989498|FG000|Overall Study|Withdrawal by Subject|1|||
160889336|NCT04444895|580989499|FG000|Overall Study|Adverse Event|2|||
160889337|NCT04444895|580989499|FG000|Overall Study|Lost to Follow-up|2|||
160889338|NCT04444895|580989499|FG000|Overall Study|Withdrawal by Subject|5|||
160889339|NCT03034200|580989500|FG000|Overall Study|Disease progression|8|||
160889340|NCT03034200|580989501|FG001|Overall Study|Disease progression|10|||
160889341|NCT03034200|580989502|FG002|Overall Study|Disease progression|4|||
160889342|NCT03034200|580989500|FG000|Overall Study|Physician Decision|2|||
160889343|NCT03034200|580989501|FG001|Overall Study|Physician Decision|0|||
160889344|NCT03034200|580989502|FG002|Overall Study|Physician Decision|3|||
160889345|NCT03034200|580989500|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
160889346|NCT03034200|580989501|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
160889347|NCT03034200|580989502|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
161326820|NCT02317991|582583200|FG000|Overall Study|Withdrawal by Subject|8|||
161326821|NCT02317991|582583200|FG000|Overall Study|Progressive Disease|41|||
161326822|NCT01223404|582583201|FG000|First Intervention (1 Day)|Adverse Event|0|||
161326823|NCT01223404|582583202|FG001|First Intervention (1 Day)|Adverse Event|0|||
161326824|NCT01223404|582583203|FG002|First Intervention (1 Day)|Adverse Event|0|||
161326825|NCT01223404|582583204|FG003|First Intervention (1 Day)|Adverse Event|1|||
161326826|NCT01223404|582583205|FG004|First Intervention (1 Day)|Adverse Event|0|||
160781372|NCT01562444|580585025|FG001|Overall Study|Did not meet entry criteria|0|||
160781373|NCT01562444|580585026|FG002|Overall Study|Did not meet entry criteria|3|||
160781374|NCT01562444|580585024|FG000|Overall Study|Did not comply with blood draw schedule|1|||
160781375|NCT01562444|580585025|FG001|Overall Study|Did not comply with blood draw schedule|0|||
160781376|NCT01562444|580585026|FG002|Overall Study|Did not comply with blood draw schedule|1|||
160781377|NCT01562444|580585024|FG000|Overall Study|Unavailable serological results|0|||
160781378|NCT01562444|580585025|FG001|Overall Study|Unavailable serological results|2|||
160781379|NCT01562444|580585026|FG002|Overall Study|Unavailable serological results|2|||
160781380|NCT01562444|580585024|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
160781381|NCT01562444|580585025|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
160781382|NCT01562444|580585026|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
160781383|NCT01562444|580585024|FG000|Overall Study|Protocol forbidden medication|1|||
160781384|NCT01562444|580585025|FG001|Overall Study|Protocol forbidden medication|0|||
160781385|NCT01562444|580585026|FG002|Overall Study|Protocol forbidden medication|0|||
160781386|NCT00720083|580585029|FG000|Overall Study|Ineligible|1|||
160781387|NCT00720083|580585030|FG001|Overall Study|Ineligible|2|||
160781388|NCT00894647|580585031|FG000|Overall Study|Adverse Event|5|||
160781389|NCT00894647|580585032|FG001|Overall Study|Adverse Event|4|||
160781390|NCT00894647|580585031|FG000|Overall Study|Withdrawal by Subject|4|||
160781391|NCT00894647|580585032|FG001|Overall Study|Withdrawal by Subject|4|||
160781392|NCT00894647|580585031|FG000|Overall Study|Lost to Follow-up|0|||
160781393|NCT00894647|580585032|FG001|Overall Study|Lost to Follow-up|2|||
160781394|NCT00894647|580585031|FG000|Overall Study|Non-compliance with study procedures|0|||
160781395|NCT00894647|580585032|FG001|Overall Study|Non-compliance with study procedures|2|||
160781396|NCT00894647|580585031|FG000|Overall Study|Other, not due to AE|1|||
160781397|NCT00894647|580585032|FG001|Overall Study|Other, not due to AE|2|||
160781398|NCT01913470|580585039|FG000|Overall Study|Lost to Follow-up|0|||
160781399|NCT01913470|580585040|FG001|Overall Study|Lost to Follow-up|1|||
160781400|NCT01913470|580585039|FG000|Overall Study|Physician Decision|0|||
160781401|NCT01913470|580585040|FG001|Overall Study|Physician Decision|1|||
160781402|NCT01913470|580585039|FG000|Overall Study|Withdrawal by Subject|0|||
160781403|NCT01913470|580585040|FG001|Overall Study|Withdrawal by Subject|1|||
160781404|NCT00245570|580585041|FG000|Washout Between Periods III and IV|Adverse Event|0|||
160781405|NCT00245570|580585042|FG001|Washout Between Periods III and IV|Adverse Event|1|||
160781406|NCT00245570|580585043|FG002|Washout Between Periods III and IV|Adverse Event|0|||
160781407|NCT00245570|580585044|FG003|Washout Between Periods III and IV|Adverse Event|0|||
160781408|NCT00245570|580585045|FG004|Washout Between Periods III and IV|Adverse Event|0|||
160781409|NCT00245570|580585046|FG005|Washout Between Periods III and IV|Adverse Event|0|||
160781410|NCT01524705|580585047|FG000|Overall Study|Adverse Event|2|||
160781411|NCT01524705|580585048|FG001|Overall Study|Adverse Event|0|||
160781412|NCT01524705|580585047|FG000|Overall Study|Death|1|||
160781413|NCT01524705|580585048|FG001|Overall Study|Death|0|||
160781414|NCT01524705|580585047|FG000|Overall Study|Lost to Follow-up|0|||
160781415|NCT01524705|580585048|FG001|Overall Study|Lost to Follow-up|1|||
160889348|NCT03034200|580989500|FG000|Overall Study|Adjuvant Therapy|0|||
161326827|NCT01223404|582583206|FG005|First Intervention (1 Day)|Adverse Event|0|||
160781416|NCT01524705|580585047|FG000|Overall Study|Withdrawal by Subject|0|||
160781417|NCT01524705|580585048|FG001|Overall Study|Withdrawal by Subject|1|||
160781418|NCT01524705|580585047|FG000|Overall Study|Pancreatic Cancer|0|||
160781419|NCT01524705|580585048|FG001|Overall Study|Pancreatic Cancer|1|||
160781420|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
160781421|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
161326828|NCT01223404|582583201|FG000|Second Intervention (1 Day)|Adverse Event|1|||
161326829|NCT01223404|582583202|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161326830|NCT01223404|582583203|FG002|Second Intervention (1 Day)|Adverse Event|0|||
161326831|NCT01223404|582583204|FG003|Second Intervention (1 Day)|Adverse Event|0|||
161326832|NCT01223404|582583205|FG004|Second Intervention (1 Day)|Adverse Event|0|||
161326833|NCT01223404|582583206|FG005|Second Intervention (1 Day)|Adverse Event|0|||
161326834|NCT01223404|582583201|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161326835|NCT01223404|582583202|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161326836|NCT01223404|582583203|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161326837|NCT01223404|582583204|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
161326838|NCT01223404|582583205|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161326839|NCT01223404|582583206|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
161326840|NCT02492165|582583207|FG000|Overall Study|Withdrawal by Subject|0|||
161326841|NCT02492165|582583208|FG001|Overall Study|Withdrawal by Subject|1|||
161326842|NCT02492165|582583209|FG002|Overall Study|Withdrawal by Subject|0|||
161326843|NCT02492165|582583210|FG003|Overall Study|Withdrawal by Subject|0|||
161326844|NCT00707057|582583211|FG000|Overall Study|Withdrawal by Subject|8|||
161326845|NCT00707057|582583212|FG001|Overall Study|Withdrawal by Subject|3|||
161326846|NCT00707057|582583211|FG000|Overall Study|Dosed incorrectly|0|||
161326847|NCT00707057|582583212|FG001|Overall Study|Dosed incorrectly|1|||
161326848|NCT01697800|582583213|FG000|Overall Study|Death|0|||
161326849|NCT01697800|582583214|FG001|Overall Study|Death|1|||
161326850|NCT00954122|582583215|FG000|Overall Study|Withdrawal by Subject|5|||
161326851|NCT00954122|582583215|FG000|Overall Study|Adverse Event|1|||
161326852|NCT00954122|582583215|FG000|Overall Study|Safety Reason|1|||
161326853|NCT02806713|582583222|FG000|Overall Study|Urethral injury during procedure|1|||
161326854|NCT02806713|582583223|FG001|Overall Study|Urethral injury during procedure|0|||
161326855|NCT02806713|582583222|FG000|Overall Study|cancelled surgery|1|||
161326856|NCT02806713|582583223|FG001|Overall Study|cancelled surgery|2|||
161326857|NCT02999789|582583224|FG000|Overall Study|Withdrawal by Subject|0|||
161326858|NCT02999789|582583225|FG001|Overall Study|Withdrawal by Subject|1|||
161123956|NCT01928381|581839173|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161123957|NCT01928381|581839174|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161123958|NCT01928381|581839175|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161123959|NCT01928381|581839176|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
161123960|NCT01928381|581839170|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
161123961|NCT01928381|581839171|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161123962|NCT01928381|581839172|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161123963|NCT01928381|581839173|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161123964|NCT01928381|581839174|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161123965|NCT01928381|581839175|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161123966|NCT01928381|581839176|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
161123967|NCT01928381|581839170|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
161123968|NCT01928381|581839171|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161123969|NCT01928381|581839172|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161123970|NCT01928381|581839173|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161123971|NCT01928381|581839174|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161123972|NCT01928381|581839175|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161123973|NCT01928381|581839176|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
161123974|NCT01928381|581839170|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
161123975|NCT01928381|581839171|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
161123976|NCT01928381|581839172|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
161123977|NCT01928381|581839173|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
161123978|NCT01928381|581839174|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
161123979|NCT01928381|581839175|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
161123980|NCT01928381|581839176|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
161123981|NCT01928381|581839170|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161123982|NCT01928381|581839171|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161123983|NCT01928381|581839172|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
161123984|NCT01928381|581839173|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161123985|NCT01928381|581839174|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161123986|NCT01928381|581839175|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161123987|NCT01928381|581839176|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
161123988|NCT01928381|581839170|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
161123989|NCT01928381|581839171|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
161326859|NCT02999789|582583224|FG000|Overall Study|Became ineligible|1|||
161326860|NCT02999789|582583225|FG001|Overall Study|Became ineligible|2|||
161326861|NCT02824224|582583226|FG000|Overall Study|Discontinued, IUS expulsion|0|||
161326862|NCT02824224|582583227|FG001|Overall Study|Discontinued, IUS expulsion|1|||
161326863|NCT02824224|582583226|FG000|Overall Study|Did not show up for allocation visit|2|||
161326864|NCT02824224|582583227|FG001|Overall Study|Did not show up for allocation visit|0|||
161326865|NCT00368108|582583228|FG000|Overall Study|Adverse Event|38|||
161326866|NCT00368108|582583229|FG001|Overall Study|Adverse Event|26|||
161326867|NCT00368108|582583230|FG002|Overall Study|Adverse Event|44|||
161326868|NCT00368108|582583228|FG000|Overall Study|Abnormal Laboratory Value|0|||
161326869|NCT00368108|582583229|FG001|Overall Study|Abnormal Laboratory Value|0|||
161326870|NCT00368108|582583230|FG002|Overall Study|Abnormal Laboratory Value|3|||
161326871|NCT00368108|582583228|FG000|Overall Study|Protocol Violation|5|||
161326872|NCT00368108|582583229|FG001|Overall Study|Protocol Violation|9|||
161326873|NCT00368108|582583230|FG002|Overall Study|Protocol Violation|9|||
161326874|NCT00368108|582583228|FG000|Overall Study|Withdrawal by Subject|9|||
160781422|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
160781423|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
160781424|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
161123990|NCT01928381|581839172|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
161326875|NCT00368108|582583229|FG001|Overall Study|Withdrawal by Subject|3|||
161123991|NCT01928381|581839173|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
161123992|NCT01928381|581839174|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
161123993|NCT01928381|581839175|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
161123994|NCT01928381|581839176|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
161123995|NCT01928381|581839170|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
161123996|NCT01928381|581839171|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
161123997|NCT01928381|581839172|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
161123998|NCT01928381|581839173|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
161123999|NCT01928381|581839174|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
161124000|NCT01928381|581839175|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
161124001|NCT01928381|581839176|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
161124002|NCT01928381|581839170|FG000|Washout First Intervention|Protocol Violation|0|||
161124003|NCT01928381|581839171|FG001|Washout First Intervention|Protocol Violation|0|||
161124004|NCT01928381|581839172|FG002|Washout First Intervention|Protocol Violation|0|||
161124005|NCT01928381|581839173|FG003|Washout First Intervention|Protocol Violation|0|||
161124006|NCT01928381|581839174|FG004|Washout First Intervention|Protocol Violation|1|||
161124007|NCT01928381|581839175|FG005|Washout First Intervention|Protocol Violation|0|||
161124008|NCT01928381|581839176|FG006|Washout First Intervention|Protocol Violation|0|||
161124009|NCT01928381|581839170|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
161124010|NCT01928381|581839171|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
161124011|NCT01928381|581839172|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
161124012|NCT01928381|581839173|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
161124013|NCT01928381|581839174|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
161124014|NCT01928381|581839175|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
161124015|NCT01928381|581839176|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
161124016|NCT01928381|581839170|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
161124017|NCT01928381|581839171|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
161124018|NCT01928381|581839172|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
161124019|NCT01928381|581839173|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
161124020|NCT01928381|581839174|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
161124021|NCT01928381|581839175|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
161124022|NCT01928381|581839176|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
161124023|NCT02406781|581839180|FG000|Overall Study|Protocol Violation|2|||
161124024|NCT02406781|581839181|FG001|Overall Study|Protocol Violation|2|||
161124025|NCT02406781|581839182|FG002|Overall Study|Protocol Violation|2|||
161124026|NCT02406781|581839183|FG003|Overall Study|Protocol Violation|2|||
161124027|NCT02406781|581839184|FG004|Overall Study|Protocol Violation|1|||
161124028|NCT02406781|581839185|FG005|Overall Study|Protocol Violation|5|||
161124029|NCT02406781|581839186|FG006|Overall Study|Protocol Violation|3|||
161124030|NCT06272370|581841288|FG000|Overall Study|Lost to Follow-up|0|||
161124031|NCT06272370|581841289|FG001|Overall Study|Lost to Follow-up|3|||
161124032|NCT06272370|581841290|FG002|Overall Study|Lost to Follow-up|1|||
161124033|NCT06272370|581841291|FG003|Overall Study|Lost to Follow-up|1|||
161124034|NCT00930059|581841293|FG000|Overall Study|Death|1|||
161124035|NCT00930059|581841294|FG001|Overall Study|Death|0|||
161124036|NCT00930059|581841293|FG000|Overall Study|Did not meet entrance criteria|1|||
161124037|NCT00930059|581841294|FG001|Overall Study|Did not meet entrance criteria|1|||
161124038|NCT00930059|581841293|FG000|Overall Study|Withdrawal by Subject|3|||
161124039|NCT00930059|581841294|FG001|Overall Study|Withdrawal by Subject|4|||
161124040|NCT00930059|581841293|FG000|Overall Study|Other|1|||
161124041|NCT00930059|581841294|FG001|Overall Study|Other|0|||
161124042|NCT00930059|581841293|FG000|Overall Study|1 site terminated by sponsor|1|||
161326876|NCT00368108|582583230|FG002|Overall Study|Withdrawal by Subject|5|||
161326877|NCT00368108|582583228|FG000|Overall Study|Lack of Efficacy|7|||
161326878|NCT00368108|582583229|FG001|Overall Study|Lack of Efficacy|8|||
161326879|NCT00368108|582583230|FG002|Overall Study|Lack of Efficacy|5|||
160889349|NCT03034200|580989501|FG001|Overall Study|Adjuvant Therapy|0|||
160889350|NCT03034200|580989502|FG002|Overall Study|Adjuvant Therapy|1|||
160889351|NCT00510874|580989503|FG000|Overall Study|Withdrawal by Subject|1|||
160889352|NCT00510874|580989504|FG001|Overall Study|Withdrawal by Subject|1|||
160889353|NCT00510874|580989505|FG002|Overall Study|Withdrawal by Subject|0|||
160889354|NCT00510874|580989506|FG003|Overall Study|Withdrawal by Subject|0|||
160889355|NCT00510874|580989507|FG004|Overall Study|Withdrawal by Subject|3|||
160889356|NCT00510874|580989508|FG005|Overall Study|Withdrawal by Subject|0|||
160889357|NCT00510874|580989509|FG006|Overall Study|Withdrawal by Subject|0|||
160781425|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
160781426|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
160781427|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
160781428|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
160781429|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
160781430|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
160781431|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
160781432|NCT02573467|580585057|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
160889358|NCT00510874|580989503|FG000|Overall Study|Lost to Follow-up|2|||
160889359|NCT00510874|580989504|FG001|Overall Study|Lost to Follow-up|3|||
160889360|NCT00510874|580989505|FG002|Overall Study|Lost to Follow-up|1|||
160889361|NCT00510874|580989506|FG003|Overall Study|Lost to Follow-up|3|||
160889362|NCT00510874|580989507|FG004|Overall Study|Lost to Follow-up|4|||
160889363|NCT00510874|580989508|FG005|Overall Study|Lost to Follow-up|0|||
160889364|NCT00510874|580989509|FG006|Overall Study|Lost to Follow-up|1|||
160889365|NCT00636987|580989510|FG000|Overall Study|Death|44|||
160889366|NCT00636987|580989510|FG000|Overall Study|Explanted|13|||
160889367|NCT00636987|580989510|FG000|Overall Study|Lost to Follow-up|63|||
160889368|NCT00636987|580989510|FG000|Overall Study|5 year visit window not complete|69|||
160889369|NCT01251146|580989511|FG000|Overall Study|Lost to Follow-up|3|||
160889370|NCT01251146|580989512|FG001|Overall Study|Lost to Follow-up|10|||
160889371|NCT00053365|580989514|FG000|Overall Study|Incorrect cell type|1|||
160889372|NCT00053365|580989514|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
160889373|NCT00053365|580989514|FG000|Overall Study|Never treated|4|||
160889374|NCT00737464|580989523|FG000|Overall Study|Adverse Event|1|||
160889375|NCT00737464|580989523|FG000|Overall Study|Death|6|||
160889376|NCT00737464|580989523|FG000|Overall Study|Other - Failure to Return|1|||
160889377|NCT00737464|580989523|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
160889378|NCT00737464|580989523|FG000|Overall Study|Other reasons|4|||
160889379|NCT02423109|580989527|FG000|Lens 1|Adverse Event|1|||
160889380|NCT02423109|580989528|FG001|Lens 1|Adverse Event|0|||
160889381|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
160889382|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
160889383|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
160889384|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
160889385|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
160889386|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
160889387|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
160889388|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
160889389|NCT03347188|580989529|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
160889390|NCT03347188|580989530|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
160889391|NCT03347188|580989529|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
160889392|NCT03347188|580989530|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
160889393|NCT03347188|580989529|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
160889394|NCT03347188|580989530|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
160889395|NCT03347188|580989529|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
160889396|NCT03347188|580989530|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
160889397|NCT03868124|580989531|FG000|Overall Study|Withdrawal by Subject|4|||
161326880|NCT00368108|582583228|FG000|Overall Study|Physician Decision|2|||
161326881|NCT00368108|582583229|FG001|Overall Study|Physician Decision|0|||
161326882|NCT00368108|582583230|FG002|Overall Study|Physician Decision|1|||
160781433|NCT02573467|580585058|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
160781434|NCT02573467|580585059|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
160781435|NCT02573467|580585060|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
160889398|NCT03868124|580989532|FG001|Overall Study|Withdrawal by Subject|0|||
160889399|NCT03868124|580989533|FG002|Overall Study|Withdrawal by Subject|1|||
160889400|NCT03868124|580989531|FG000|Overall Study|Physician Decision|1|||
161326883|NCT00368108|582583228|FG000|Overall Study|Other|3|||
160889401|NCT03868124|580989532|FG001|Overall Study|Physician Decision|0|||
160889402|NCT03868124|580989533|FG002|Overall Study|Physician Decision|1|||
160889403|NCT03868124|580989531|FG000|Overall Study|Lost to Follow-up|1|||
160889404|NCT03868124|580989532|FG001|Overall Study|Lost to Follow-up|1|||
160889405|NCT03868124|580989533|FG002|Overall Study|Lost to Follow-up|2|||
161124043|NCT00930059|581841294|FG001|Overall Study|1 site terminated by sponsor|1|||
161326884|NCT00368108|582583229|FG001|Overall Study|Other|7|||
161326885|NCT00368108|582583230|FG002|Overall Study|Other|1|||
161326886|NCT02299388|582583235|FG000|Overall Study|Withdrawal by Subject|0|||
161326887|NCT02299388|582583236|FG001|Overall Study|Withdrawal by Subject|1|||
161326888|NCT01093586|582583241|FG000|Overall Study|Failed to engraft|3|||
161326889|NCT03442088|582583242|FG000|Overall Study|Adverse Event|1|||
161326890|NCT03442088|582583242|FG000|Overall Study|Lack of Efficacy|2|||
161326891|NCT03442088|582583242|FG000|Overall Study|Lost to Follow-up|2|||
161326892|NCT00357877|582583245|FG000|Overall Study|Death|2|||
161326893|NCT00357877|582583246|FG001|Overall Study|Death|1|||
161326894|NCT00357877|582583245|FG000|Overall Study|Lost to Follow-up|20|||
161326895|NCT00357877|582583246|FG001|Overall Study|Lost to Follow-up|23|||
161326896|NCT00357877|582583245|FG000|Overall Study|Withdrawal by Subject|3|||
161326897|NCT00357877|582583246|FG001|Overall Study|Withdrawal by Subject|3|||
161326898|NCT00357877|582583245|FG000|Overall Study|Administrative withdrawal|1|||
161326899|NCT00357877|582583246|FG001|Overall Study|Administrative withdrawal|1|||
161326900|NCT00357877|582583245|FG000|Overall Study|Other|0|||
161326901|NCT00357877|582583246|FG001|Overall Study|Other|2|||
161326902|NCT01051557|582583247|FG000|Overall Study|Physician Decision|1|||
161326903|NCT01051557|582583248|FG001|Overall Study|Physician Decision|0|||
161326904|NCT01051557|582583249|FG002|Overall Study|Physician Decision|0|||
161326905|NCT01051557|582583250|FG003|Overall Study|Physician Decision|0|||
161326906|NCT01051557|582583251|FG004|Overall Study|Physician Decision|0|||
161326907|NCT01051557|582583252|FG005|Overall Study|Physician Decision|0|||
161326908|NCT01051557|582583253|FG006|Overall Study|Physician Decision|0|||
161326909|NCT01051557|582583247|FG000|Overall Study|disease progression|3|||
161326910|NCT01051557|582583248|FG001|Overall Study|disease progression|3|||
161326911|NCT01051557|582583249|FG002|Overall Study|disease progression|5|||
161326912|NCT01051557|582583250|FG003|Overall Study|disease progression|2|||
161326913|NCT01051557|582583251|FG004|Overall Study|disease progression|4|||
161326914|NCT01051557|582583252|FG005|Overall Study|disease progression|3|||
161326915|NCT01051557|582583253|FG006|Overall Study|disease progression|1|||
161326916|NCT01051557|582583247|FG000|Overall Study|Withdrawal by Subject|0|||
161326917|NCT01051557|582583248|FG001|Overall Study|Withdrawal by Subject|0|||
161326918|NCT01051557|582583249|FG002|Overall Study|Withdrawal by Subject|1|||
161326919|NCT01051557|582583250|FG003|Overall Study|Withdrawal by Subject|0|||
161326920|NCT01051557|582583251|FG004|Overall Study|Withdrawal by Subject|2|||
161326921|NCT01051557|582583252|FG005|Overall Study|Withdrawal by Subject|0|||
161326922|NCT01051557|582583253|FG006|Overall Study|Withdrawal by Subject|1|||
161326923|NCT01051557|582583247|FG000|Overall Study|Adverse Event|0|||
161326924|NCT01051557|582583248|FG001|Overall Study|Adverse Event|0|||
161326925|NCT01051557|582583249|FG002|Overall Study|Adverse Event|0|||
161326926|NCT01051557|582583250|FG003|Overall Study|Adverse Event|1|||
161326927|NCT01051557|582583251|FG004|Overall Study|Adverse Event|1|||
161326928|NCT01051557|582583252|FG005|Overall Study|Adverse Event|3|||
161326929|NCT01051557|582583253|FG006|Overall Study|Adverse Event|4|||
161326930|NCT00613366|582583260|FG000|Overall Study|Withdrawal by Subject|3|||
161326931|NCT00613366|582583261|FG001|Overall Study|Withdrawal by Subject|2|||
161326932|NCT00268983|582583266|FG000|Overall Study|Death|3|||
161326933|NCT00268983|582583267|FG001|Overall Study|Death|0|||
161326934|NCT02532374|582583268|FG000|Overall Study|Withdrawal by Subject|1|||
161326935|NCT02532374|582583268|FG000|Overall Study|Physician Decision|1|||
161326936|NCT02762084|582583269|FG000|Overall Study|Withdrawal by Subject|1|||
161326937|NCT02762084|582583270|FG001|Overall Study|Withdrawal by Subject|0|||
161326938|NCT02762084|582583271|FG002|Overall Study|Withdrawal by Subject|0|||
161326939|NCT02762084|582583269|FG000|Overall Study|Adverse Event|0|||
161326940|NCT02762084|582583270|FG001|Overall Study|Adverse Event|0|||
161326941|NCT02762084|582583271|FG002|Overall Study|Adverse Event|1|||
161124044|NCT00930059|581841293|FG000|Overall Study|Adverse Event|1|||
161124045|NCT00930059|581841294|FG001|Overall Study|Adverse Event|6|||
161124046|NCT01299766|581841295|FG000|Overall Study|Death|5|||
161124047|NCT01299766|581841296|FG001|Overall Study|Death|4|||
161124048|NCT01299766|581841295|FG000|Overall Study|Withdrawal by Subject|29|||
161124049|NCT01299766|581841296|FG001|Overall Study|Withdrawal by Subject|19|||
161124050|NCT02090855|581841297|FG000|Overall Study|no evaluable Standard of Truth results|2|||
161124051|NCT05425563|581841307|FG000|Overall Study|Withdrawal by Subject|17|||
161124052|NCT01001702|581841308|FG000|Overall Study|Lost to Follow-up|7|||
161124053|NCT01001702|581841308|FG000|Overall Study|Adverse Event|7|||
161326942|NCT02659943|582583272|FG000|Overall Study|Switched to alternative treatment|1|||
161326943|NCT02659943|582583273|FG001|Overall Study|Switched to alternative treatment|1|||
161326944|NCT02659943|582583274|FG002|Overall Study|Switched to alternative treatment|0|||
161326945|NCT02659943|582583275|FG003|Overall Study|Switched to alternative treatment|2|||
161326946|NCT02659943|582583276|FG004|Overall Study|Switched to alternative treatment|1|||
161326947|NCT02659943|582583277|FG005|Overall Study|Switched to alternative treatment|0|||
161326948|NCT02659943|582583278|FG006|Overall Study|Switched to alternative treatment|1|||
161326949|NCT02659943|582583272|FG000|Overall Study|Disease progression on study|0|||
161124054|NCT01001702|581841308|FG000|Overall Study|Sponsor Discontinued Study|4|||
161124055|NCT01001702|581841308|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
161326950|NCT02659943|582583273|FG001|Overall Study|Disease progression on study|1|||
161326951|NCT02659943|582583274|FG002|Overall Study|Disease progression on study|1|||
161326952|NCT02659943|582583275|FG003|Overall Study|Disease progression on study|1|||
161326953|NCT02659943|582583276|FG004|Overall Study|Disease progression on study|1|||
161326954|NCT02659943|582583277|FG005|Overall Study|Disease progression on study|4|||
161326955|NCT02659943|582583278|FG006|Overall Study|Disease progression on study|0|||
161326956|NCT02659943|582583272|FG000|Overall Study|Patient's condition per principal investigator|0|||
161326957|NCT02659943|582583273|FG001|Overall Study|Patient's condition per principal investigator|0|||
161326958|NCT02659943|582583274|FG002|Overall Study|Patient's condition per principal investigator|0|||
161326959|NCT02659943|582583275|FG003|Overall Study|Patient's condition per principal investigator|0|||
161326960|NCT02659943|582583276|FG004|Overall Study|Patient's condition per principal investigator|0|||
161326961|NCT02659943|582583277|FG005|Overall Study|Patient's condition per principal investigator|1|||
161326962|NCT02659943|582583278|FG006|Overall Study|Patient's condition per principal investigator|0|||
161326963|NCT02659943|582583272|FG000|Overall Study|Ineligible|0|||
161326964|NCT02659943|582583273|FG001|Overall Study|Ineligible|0|||
161326965|NCT02659943|582583274|FG002|Overall Study|Ineligible|0|||
161326966|NCT02659943|582583275|FG003|Overall Study|Ineligible|0|||
161326967|NCT02659943|582583276|FG004|Overall Study|Ineligible|0|||
161326968|NCT02659943|582583277|FG005|Overall Study|Ineligible|0|||
161326969|NCT02659943|582583278|FG006|Overall Study|Ineligible|1|||
161326970|NCT02659943|582583272|FG000|Overall Study|No longer meets eligibility|0|||
161326971|NCT02659943|582583273|FG001|Overall Study|No longer meets eligibility|0|||
161326972|NCT02659943|582583274|FG002|Overall Study|No longer meets eligibility|0|||
161326973|NCT02659943|582583275|FG003|Overall Study|No longer meets eligibility|0|||
161326974|NCT02659943|582583276|FG004|Overall Study|No longer meets eligibility|0|||
161326975|NCT02659943|582583277|FG005|Overall Study|No longer meets eligibility|0|||
161326976|NCT02659943|582583278|FG006|Overall Study|No longer meets eligibility|1|||
160781436|NCT02573467|580585057|FG000|Post-treatment Follow up Epoch|Death|1|||
160781437|NCT02573467|580585058|FG001|Post-treatment Follow up Epoch|Death|1|||
160781438|NCT02573467|580585059|FG002|Post-treatment Follow up Epoch|Death|0|||
160781439|NCT02573467|580585060|FG003|Post-treatment Follow up Epoch|Death|1|||
160781440|NCT02573467|580585057|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
160781441|NCT02573467|580585058|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
160781442|NCT02573467|580585059|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
160781443|NCT02573467|580585060|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
160781444|NCT02573467|580585057|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
160781445|NCT02573467|580585058|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
160781446|NCT02573467|580585059|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
160781447|NCT02573467|580585060|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
160781448|NCT01829165|580585061|FG000|Overall Study|Did not complete intervention|2|||
160781449|NCT01829165|580585062|FG001|Overall Study|Did not complete intervention|0|||
160781450|NCT00103506|580585064|FG000|Overall Study|Study closed by sponsor|34|||
160781451|NCT00103506|580585065|FG001|Overall Study|Study closed by sponsor|37|||
160781452|NCT00103506|580585064|FG000|Overall Study|Death|257|||
160781453|NCT00103506|580585065|FG001|Overall Study|Death|253|||
160781454|NCT00103506|580585064|FG000|Overall Study|Lost to Follow-up|13|||
160781455|NCT00103506|580585065|FG001|Overall Study|Lost to Follow-up|13|||
160781456|NCT00103506|580585064|FG000|Overall Study|Withdrawal by Subject|18|||
160781457|NCT00103506|580585065|FG001|Overall Study|Withdrawal by Subject|21|||
160781458|NCT00710970|580585068|FG000|Overall Study|Never took drug|3|||
160781459|NCT02153827|580585069|FG000|Overall Study|Lost to Follow-up|3|||
160781460|NCT02153827|580585070|FG001|Overall Study|Lost to Follow-up|9|||
160781461|NCT01060111|580585071|FG000|Overall Study|Adverse Event|9|||
160781462|NCT01060111|580585072|FG001|Overall Study|Adverse Event|5|||
160781463|NCT01060111|580585073|FG002|Overall Study|Adverse Event|18|||
160781464|NCT01060111|580585071|FG000|Overall Study|Lack of Efficacy|2|||
160781465|NCT01060111|580585072|FG001|Overall Study|Lack of Efficacy|1|||
160781466|NCT01060111|580585073|FG002|Overall Study|Lack of Efficacy|0|||
160781467|NCT01060111|580585071|FG000|Overall Study|Inappropriate participant|5|||
160781468|NCT01060111|580585072|FG001|Overall Study|Inappropriate participant|4|||
160781469|NCT01060111|580585073|FG002|Overall Study|Inappropriate participant|5|||
160781470|NCT01060111|580585071|FG000|Overall Study|Participants' evasion for hospital visit|0|||
160781471|NCT01060111|580585072|FG001|Overall Study|Participants' evasion for hospital visit|3|||
160781472|NCT01060111|580585073|FG002|Overall Study|Participants' evasion for hospital visit|2|||
160781473|NCT01060111|580585071|FG000|Overall Study|Participants' non-cooperation|8|||
161326977|NCT02659943|582583272|FG000|Overall Study|No treatment, per protocol|0|||
161326978|NCT02659943|582583273|FG001|Overall Study|No treatment, per protocol|0|||
161326979|NCT02659943|582583274|FG002|Overall Study|No treatment, per protocol|0|||
161326980|NCT02659943|582583275|FG003|Overall Study|No treatment, per protocol|0|||
160781474|NCT01060111|580585072|FG001|Overall Study|Participants' non-cooperation|6|||
160781475|NCT01060111|580585073|FG002|Overall Study|Participants' non-cooperation|6|||
160781476|NCT01060111|580585071|FG000|Overall Study|Adverse event and insufficient effect|0|||
160781477|NCT01060111|580585072|FG001|Overall Study|Adverse event and insufficient effect|1|||
160781478|NCT01060111|580585073|FG002|Overall Study|Adverse event and insufficient effect|0|||
161326981|NCT02659943|582583276|FG004|Overall Study|No treatment, per protocol|0|||
161326982|NCT02659943|582583277|FG005|Overall Study|No treatment, per protocol|0|||
161326983|NCT02659943|582583278|FG006|Overall Study|No treatment, per protocol|3|||
161326984|NCT03478371|582583279|FG000|Overall Study|non-compliance|1|||
161326985|NCT03478371|582583279|FG000|Overall Study|Lost to Follow-up|4|||
161326986|NCT00627497|582583283|FG000|Overall Study|Lost to Follow-up|1|||
161326987|NCT00627497|582583284|FG001|Overall Study|Lost to Follow-up|1|||
161326988|NCT00627497|582583285|FG002|Overall Study|Lost to Follow-up|0|||
161326989|NCT00627497|582583286|FG003|Overall Study|Lost to Follow-up|0|||
161326990|NCT03361306|582583289|FG000|Overall Study|Death|6|||
161326991|NCT04767373|582583294|FG000|Overall Study|Death|6|||
161326992|NCT04767373|582583295|FG001|Overall Study|Death|3|||
161326993|NCT04767373|582583294|FG000|Overall Study|Lost to Follow-up|67|||
161326994|NCT04767373|582583295|FG001|Overall Study|Lost to Follow-up|35|||
161326995|NCT04767373|582583294|FG000|Overall Study|Physician Decision|15|||
161326996|NCT04767373|582583295|FG001|Overall Study|Physician Decision|4|||
161326997|NCT04767373|582583294|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161326998|NCT04767373|582583295|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161326999|NCT04767373|582583294|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
161327000|NCT04767373|582583295|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
161327001|NCT04767373|582583294|FG000|Overall Study|Other|1|||
161327002|NCT04767373|582583295|FG001|Overall Study|Other|2|||
161327003|NCT01502033|582583296|FG000|Overall Study|1 participant had scalp discomfort|1|||
161327004|NCT01502033|582583296|FG000|Overall Study|1 participant had worsening depression|1|||
161327005|NCT01502033|582583296|FG000|Overall Study|1 participant went back to school|1|||
161327006|NCT02983045|582583297|FG000|Overall Study|Withdrawal by Subject|0|||
161327007|NCT02983045|582583298|FG001|Overall Study|Withdrawal by Subject|1|||
161327008|NCT02983045|582583299|FG002|Overall Study|Withdrawal by Subject|0|||
161327009|NCT02983045|582583300|FG003|Overall Study|Withdrawal by Subject|5|||
161327010|NCT02983045|582583301|FG004|Overall Study|Withdrawal by Subject|0|||
160889406|NCT03868124|580989531|FG000|Overall Study|Death|1|||
160889407|NCT03868124|580989532|FG001|Overall Study|Death|1|||
160889408|NCT03868124|580989533|FG002|Overall Study|Death|2|||
160889409|NCT03868124|580989531|FG000|Overall Study|Adverse Event|0|||
160889410|NCT03868124|580989532|FG001|Overall Study|Adverse Event|0|||
160889411|NCT03868124|580989533|FG002|Overall Study|Adverse Event|3|||
160889412|NCT03868124|580989531|FG000|Overall Study|Explanted|2|||
160889413|NCT03868124|580989532|FG001|Overall Study|Explanted|1|||
160889414|NCT03868124|580989533|FG002|Overall Study|Explanted|0|||
160889415|NCT03868124|580989531|FG000|Overall Study|Ongoing in study|176|||
160889416|NCT03868124|580989532|FG001|Overall Study|Ongoing in study|180|||
160889417|NCT03868124|580989533|FG002|Overall Study|Ongoing in study|183|||
160889418|NCT04177355|580989534|FG000|Overall Study|Lost to Follow-up|0|||
160889419|NCT04177355|580989535|FG001|Overall Study|Lost to Follow-up|2|||
160889420|NCT04177355|580989536|FG002|Overall Study|Lost to Follow-up|0|||
160889421|NCT04177355|580989537|FG003|Overall Study|Lost to Follow-up|1|||
160889422|NCT04177355|580989538|FG004|Overall Study|Lost to Follow-up|2|||
160889423|NCT04177355|580989539|FG005|Overall Study|Lost to Follow-up|0|||
160889424|NCT04177355|580989540|FG006|Overall Study|Lost to Follow-up|1|||
160889425|NCT04177355|580989541|FG007|Overall Study|Lost to Follow-up|0|||
160889426|NCT04177355|580989542|FG008|Overall Study|Lost to Follow-up|0|||
160889427|NCT04177355|580989543|FG009|Overall Study|Lost to Follow-up|0|||
160889428|NCT04177355|580989544|FG010|Overall Study|Lost to Follow-up|0|||
160889429|NCT04177355|580989534|FG000|Overall Study|Withdrawal by Subject|0|||
160889430|NCT04177355|580989535|FG001|Overall Study|Withdrawal by Subject|0|||
160889431|NCT04177355|580989536|FG002|Overall Study|Withdrawal by Subject|0|||
160889432|NCT04177355|580989537|FG003|Overall Study|Withdrawal by Subject|1|||
160889433|NCT04177355|580989538|FG004|Overall Study|Withdrawal by Subject|1|||
160889434|NCT04177355|580989539|FG005|Overall Study|Withdrawal by Subject|0|||
160889435|NCT04177355|580989540|FG006|Overall Study|Withdrawal by Subject|0|||
160889436|NCT04177355|580989541|FG007|Overall Study|Withdrawal by Subject|0|||
160889437|NCT04177355|580989542|FG008|Overall Study|Withdrawal by Subject|1|||
160889438|NCT04177355|580989543|FG009|Overall Study|Withdrawal by Subject|0|||
160889439|NCT04177355|580989544|FG010|Overall Study|Withdrawal by Subject|0|||
160889440|NCT02742246|580989545|FG000|Overall Study|Never initiated treatment|5|||
160889441|NCT02742246|580989546|FG001|Overall Study|Never initiated treatment|3|||
160889442|NCT02742246|580989547|FG002|Overall Study|Never initiated treatment|1|||
161327011|NCT02983045|582583302|FG005|Overall Study|Withdrawal by Subject|72|||
160889443|NCT02742246|580989545|FG000|Overall Study|dropped out during treatment|7|||
160889444|NCT02742246|580989546|FG001|Overall Study|dropped out during treatment|13|||
160889445|NCT02742246|580989547|FG002|Overall Study|dropped out during treatment|10|||
160889446|NCT02742246|580989545|FG000|Overall Study|Death|1|||
160889447|NCT02742246|580989546|FG001|Overall Study|Death|0|||
160889448|NCT02742246|580989547|FG002|Overall Study|Death|0|||
161327012|NCT02983045|582583303|FG006|Overall Study|Withdrawal by Subject|0|||
161327013|NCT02983045|582583304|FG007|Overall Study|Withdrawal by Subject|0|||
161327014|NCT02983045|582583305|FG008|Overall Study|Withdrawal by Subject|0|||
161327015|NCT02983045|582583306|FG009|Overall Study|Withdrawal by Subject|2|||
160781479|NCT01060111|580585071|FG000|Overall Study|Participants' non-cooperation|1|||
160781480|NCT01060111|580585072|FG001|Overall Study|Participants' non-cooperation|0|||
160781481|NCT01060111|580585073|FG002|Overall Study|Participants' non-cooperation|0|||
160781482|NCT01060111|580585071|FG000|Overall Study|Other|2|||
160781483|NCT01060111|580585072|FG001|Overall Study|Other|3|||
160781484|NCT01060111|580585073|FG002|Overall Study|Other|4|||
160781485|NCT03954938|580585074|FG000|Overall Study|Withdrawal by Subject|2|||
160781486|NCT03954938|580585074|FG000|Overall Study|Adverse Event|1|||
160781487|NCT00625378|580585075|FG000|Overall Study|Adverse Event|22|||
160781488|NCT00625378|580585076|FG001|Overall Study|Adverse Event|0|||
160781489|NCT00625378|580585075|FG000|Overall Study|Withdrawal by Subject|16|||
160781490|NCT00625378|580585076|FG001|Overall Study|Withdrawal by Subject|0|||
160781491|NCT00625378|580585075|FG000|Overall Study|Death|38|||
160781492|NCT00625378|580585076|FG001|Overall Study|Death|0|||
160781493|NCT00625378|580585075|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
160781494|NCT00625378|580585076|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
160781495|NCT00625378|580585075|FG000|Overall Study|Lost to Follow-up|17|||
160781496|NCT00625378|580585076|FG001|Overall Study|Lost to Follow-up|0|||
160781497|NCT00625378|580585075|FG000|Overall Study|Non-compliant with study medication|3|||
160781498|NCT00625378|580585076|FG001|Overall Study|Non-compliant with study medication|0|||
160781499|NCT00625378|580585075|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
160781500|NCT00625378|580585076|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
160781501|NCT00625378|580585075|FG000|Overall Study|Medical decision|1|||
160781502|NCT00625378|580585076|FG001|Overall Study|Medical decision|0|||
160781503|NCT00625378|580585075|FG000|Overall Study|Multiple toxicities|1|||
160781504|NCT00625378|580585076|FG001|Overall Study|Multiple toxicities|0|||
160781505|NCT00625378|580585075|FG000|Overall Study|New cancer|1|||
160781506|NCT00625378|580585076|FG001|Overall Study|New cancer|0|||
160781507|NCT00625378|580585075|FG000|Overall Study|PTA program|2|||
160781508|NCT00625378|580585076|FG001|Overall Study|PTA program|0|||
160781509|NCT00625378|580585075|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
160781510|NCT00625378|580585076|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
160781511|NCT00625378|580585075|FG000|Overall Study|Sponsor decision|1|||
160781512|NCT00625378|580585076|FG001|Overall Study|Sponsor decision|0|||
160781513|NCT00625378|580585075|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
160781514|NCT00625378|580585076|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
160781515|NCT00625378|580585075|FG000|Overall Study|Switch to commercial drug|6|||
160781516|NCT00625378|580585076|FG001|Overall Study|Switch to commercial drug|1|||
160781517|NCT00625378|580585075|FG000|Overall Study|Missing|2|||
160781518|NCT00625378|580585076|FG001|Overall Study|Missing|0|||
160781519|NCT00625378|580585075|FG000|Overall Study|End of treatment not available|2|||
160781520|NCT00625378|580585076|FG001|Overall Study|End of treatment not available|0|||
160781521|NCT00625378|580585075|FG000|Overall Study|Never treated|2|||
160781522|NCT00625378|580585076|FG001|Overall Study|Never treated|0|||
160781523|NCT01371565|580585077|FG000|Overall Study|Withdrawal by Subject|1|||
160781524|NCT01371565|580585077|FG000|Overall Study|Death|1|||
160781525|NCT01371565|580585077|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
160781526|NCT00617903|580585078|FG000|Overall Study|Withdrawal by Subject|2|||
160781527|NCT00617903|580585079|FG001|Overall Study|Withdrawal by Subject|3|||
160781528|NCT00617903|580585078|FG000|Overall Study|Lost to Follow-up|1|||
160781529|NCT00617903|580585079|FG001|Overall Study|Lost to Follow-up|1|||
160781530|NCT00617903|580585078|FG000|Overall Study|Lack of Efficacy|0|||
160781531|NCT00617903|580585079|FG001|Overall Study|Lack of Efficacy|1|||
161124056|NCT01001702|581841308|FG000|Overall Study|Investigator withdrew Subject|10|||
161124057|NCT01001702|581841308|FG000|Overall Study|Withdrawal by Subject|19|||
161124058|NCT01001702|581841308|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
161124059|NCT00584233|581841311|FG000|Overall Study|Withdrawal by Subject|5|||
161124060|NCT00584233|581841311|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
161124061|NCT02494596|581841312|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161124062|NCT02494596|581841313|FG001|Overall Study|Insufficient Therapeutic Response|3|||
161124063|NCT02494596|581841314|FG002|Overall Study|Insufficient Therapeutic Response|1|||
161124064|NCT02494596|581841312|FG000|Overall Study|Adverse Event|0|||
161124065|NCT02494596|581841313|FG001|Overall Study|Adverse Event|1|||
161124066|NCT02494596|581841314|FG002|Overall Study|Adverse Event|0|||
161124067|NCT02494596|581841312|FG000|Overall Study|Refused Treatment|0|||
160781532|NCT00617903|580585078|FG000|Overall Study|Adverse Event|0|||
160781533|NCT00617903|580585079|FG001|Overall Study|Adverse Event|1|||
160781534|NCT00617903|580585078|FG000|Overall Study|noncompliance|0|||
160781535|NCT00617903|580585079|FG001|Overall Study|noncompliance|1|||
160781536|NCT04676646|580585080|FG000|Open-label Run-in Phase|Adverse Event|3|||
160781537|NCT04676646|580585081|FG001|Open-label Run-in Phase|Adverse Event|0|||
160781538|NCT04676646|580585082|FG002|Open-label Run-in Phase|Adverse Event|0|||
160781539|NCT04676646|580585080|FG000|Open-label Run-in Phase|Death|3|||
160781540|NCT04676646|580585081|FG001|Open-label Run-in Phase|Death|0|||
160781541|NCT04676646|580585082|FG002|Open-label Run-in Phase|Death|0|||
160781542|NCT04676646|580585080|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
161327016|NCT02983045|582583297|FG000|Overall Study|Lost to Follow-up|0|||
161327017|NCT02983045|582583298|FG001|Overall Study|Lost to Follow-up|0|||
161327018|NCT02983045|582583299|FG002|Overall Study|Lost to Follow-up|0|||
161327019|NCT02983045|582583300|FG003|Overall Study|Lost to Follow-up|0|||
161327020|NCT02983045|582583301|FG004|Overall Study|Lost to Follow-up|0|||
161327021|NCT02983045|582583302|FG005|Overall Study|Lost to Follow-up|10|||
161327022|NCT02983045|582583303|FG006|Overall Study|Lost to Follow-up|0|||
161327023|NCT02983045|582583304|FG007|Overall Study|Lost to Follow-up|0|||
161327024|NCT02983045|582583305|FG008|Overall Study|Lost to Follow-up|0|||
161327025|NCT02983045|582583306|FG009|Overall Study|Lost to Follow-up|0|||
161327026|NCT00991289|582583307|FG000|Overall Study|Adverse Event|1|||
161327027|NCT00991289|582583307|FG000|Overall Study|Physician Decision|2|||
161327028|NCT00991289|582583307|FG000|Overall Study|Withdrawal by Subject|3|||
161327029|NCT00991289|582583307|FG000|Overall Study|Lost to Follow-up|4|||
161327030|NCT00991289|582583307|FG000|Overall Study|Protocol Violation|2|||
160781543|NCT04676646|580585081|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
160781544|NCT04676646|580585082|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
160781545|NCT04676646|580585080|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
160781546|NCT04676646|580585081|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
160781547|NCT04676646|580585082|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
160781548|NCT04676646|580585080|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
160781549|NCT04676646|580585081|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
160781550|NCT04676646|580585082|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
160781551|NCT04676646|580585080|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
160781552|NCT04676646|580585081|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
160781553|NCT04676646|580585082|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
160781554|NCT04676646|580585080|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
160781555|NCT04676646|580585081|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
160781556|NCT04676646|580585082|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
160781557|NCT04676646|580585080|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
160781558|NCT04676646|580585081|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
160781559|NCT04676646|580585082|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
160781560|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
160781561|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
160781562|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
160781563|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Death|0|||
160781564|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Death|1|||
160781565|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Death|2|||
160781566|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
160781567|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
160781568|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
160781569|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
160781570|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
160781571|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
160781572|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
160781573|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
160781574|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
160781575|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
161124068|NCT02494596|581841313|FG001|Overall Study|Refused Treatment|1|||
161124069|NCT02494596|581841314|FG002|Overall Study|Refused Treatment|0|||
161124070|NCT02222714|581841315|FG000|Overall Study|Death|0|||
161124071|NCT02222714|581841316|FG001|Overall Study|Death|2|||
161124072|NCT02222714|581841317|FG002|Overall Study|Death|3|||
161124073|NCT02222714|581841318|FG003|Overall Study|Death|4|||
161124074|NCT02222714|581841319|FG004|Overall Study|Death|6|||
161124075|NCT02222714|581841315|FG000|Overall Study|Withdrawal by Subject|0|||
161124076|NCT02222714|581841316|FG001|Overall Study|Withdrawal by Subject|0|||
161124077|NCT02222714|581841317|FG002|Overall Study|Withdrawal by Subject|1|||
161124078|NCT02222714|581841318|FG003|Overall Study|Withdrawal by Subject|0|||
161124079|NCT02222714|581841319|FG004|Overall Study|Withdrawal by Subject|1|||
161124080|NCT00159432|581841320|FG000|Overall Study|Adverse Event|1|||
161124081|NCT00159432|581841320|FG000|Overall Study|Death|1|||
161124082|NCT00159432|581841320|FG000|Overall Study|Lack of Efficacy|8|||
161124083|NCT04537208|581841321|FG000|Overall Study|Adverse Event|0|||
161124084|NCT04537208|581841322|FG001|Overall Study|Adverse Event|0|||
161124085|NCT04537208|581841323|FG002|Overall Study|Adverse Event|0|||
161124086|NCT04537208|581841324|FG003|Overall Study|Adverse Event|0|||
161124087|NCT04537208|581841325|FG004|Overall Study|Adverse Event|0|||
161124088|NCT04537208|581841326|FG005|Overall Study|Adverse Event|0|||
161124089|NCT04537208|581841327|FG006|Overall Study|Adverse Event|0|||
161229718|NCT01866319|582222520|FG001|Overall Study|Protocol Violation|0|||
161229719|NCT01866319|582222521|FG002|Overall Study|Protocol Violation|1|||
161229720|NCT01866319|582222519|FG000|Overall Study|Withdrawal by Subject|32|||
161229721|NCT01866319|582222520|FG001|Overall Study|Withdrawal by Subject|14|||
161229722|NCT01866319|582222521|FG002|Overall Study|Withdrawal by Subject|12|||
161229723|NCT00496964|582222522|FG000|Overall Study|Withdrawal by Subject|0|||
161229724|NCT00496964|582222523|FG001|Overall Study|Withdrawal by Subject|1|||
161229725|NCT02942264|582222524|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161229726|NCT02942264|582222525|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
161229727|NCT02942264|582222526|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161229728|NCT02942264|582222527|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161229729|NCT02942264|582222528|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161327031|NCT04533438|582583326|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
161327032|NCT04533438|582583327|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
160781576|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
161124090|NCT04537208|581841328|FG007|Overall Study|Adverse Event|0|||
161124091|NCT04537208|581841329|FG008|Overall Study|Adverse Event|1|||
161124092|NCT04537208|581841330|FG009|Overall Study|Adverse Event|0|||
161124093|NCT04537208|581841331|FG010|Overall Study|Adverse Event|0|||
161124094|NCT04537208|581841321|FG000|Overall Study|Protocol deviation|0|||
161124095|NCT04537208|581841322|FG001|Overall Study|Protocol deviation|0|||
161124096|NCT04537208|581841323|FG002|Overall Study|Protocol deviation|2|||
161124097|NCT04537208|581841324|FG003|Overall Study|Protocol deviation|0|||
161124098|NCT04537208|581841325|FG004|Overall Study|Protocol deviation|0|||
161124099|NCT04537208|581841326|FG005|Overall Study|Protocol deviation|2|||
161124100|NCT04537208|581841327|FG006|Overall Study|Protocol deviation|4|||
161124101|NCT04537208|581841328|FG007|Overall Study|Protocol deviation|0|||
161124102|NCT04537208|581841329|FG008|Overall Study|Protocol deviation|1|||
161124103|NCT04537208|581841330|FG009|Overall Study|Protocol deviation|0|||
161124104|NCT04537208|581841331|FG010|Overall Study|Protocol deviation|2|||
161124105|NCT04537208|581841321|FG000|Overall Study|Withdrawal by Subject|4|||
161124106|NCT04537208|581841322|FG001|Overall Study|Withdrawal by Subject|2|||
161124107|NCT04537208|581841323|FG002|Overall Study|Withdrawal by Subject|1|||
161124108|NCT04537208|581841324|FG003|Overall Study|Withdrawal by Subject|3|||
161124109|NCT04537208|581841325|FG004|Overall Study|Withdrawal by Subject|5|||
161124110|NCT04537208|581841326|FG005|Overall Study|Withdrawal by Subject|1|||
161124111|NCT04537208|581841327|FG006|Overall Study|Withdrawal by Subject|6|||
161124112|NCT04537208|581841328|FG007|Overall Study|Withdrawal by Subject|1|||
161124113|NCT04537208|581841329|FG008|Overall Study|Withdrawal by Subject|7|||
161124114|NCT04537208|581841330|FG009|Overall Study|Withdrawal by Subject|2|||
161124115|NCT04537208|581841331|FG010|Overall Study|Withdrawal by Subject|4|||
161124116|NCT04537208|581841321|FG000|Overall Study|Lost to Follow-up|4|||
161124117|NCT04537208|581841322|FG001|Overall Study|Lost to Follow-up|1|||
161124118|NCT04537208|581841323|FG002|Overall Study|Lost to Follow-up|3|||
161124119|NCT04537208|581841324|FG003|Overall Study|Lost to Follow-up|4|||
161124120|NCT04537208|581841325|FG004|Overall Study|Lost to Follow-up|3|||
161124121|NCT04537208|581841326|FG005|Overall Study|Lost to Follow-up|2|||
161124122|NCT04537208|581841327|FG006|Overall Study|Lost to Follow-up|3|||
161124123|NCT04537208|581841328|FG007|Overall Study|Lost to Follow-up|2|||
161124124|NCT04537208|581841329|FG008|Overall Study|Lost to Follow-up|7|||
161124125|NCT04537208|581841330|FG009|Overall Study|Lost to Follow-up|2|||
161124126|NCT04537208|581841331|FG010|Overall Study|Lost to Follow-up|2|||
161124127|NCT01537211|581841336|FG000|Overall Study|Lost to Follow-up|0|||
161124128|NCT01537211|581841337|FG001|Overall Study|Lost to Follow-up|1|||
161124129|NCT00704964|581841338|FG000|Overall Study|Not completed on time|328|||
161124130|NCT02161562|581841339|FG000|Overall Study|Withdrawal by Subject|5|||
161124131|NCT02161562|581841340|FG001|Overall Study|Withdrawal by Subject|8|||
161124132|NCT02161562|581841339|FG000|Overall Study|Protocol Violation|9|||
161124133|NCT02161562|581841340|FG001|Overall Study|Protocol Violation|4|||
161124134|NCT02161562|581841339|FG000|Overall Study|Pregnancy|1|||
161124135|NCT02161562|581841340|FG001|Overall Study|Pregnancy|2|||
161124136|NCT02161562|581841339|FG000|Overall Study|Lost to Follow-up|3|||
161124137|NCT02161562|581841340|FG001|Overall Study|Lost to Follow-up|1|||
161124138|NCT02161562|581841339|FG000|Overall Study|Lack of Efficacy|4|||
161124139|NCT02161562|581841340|FG001|Overall Study|Lack of Efficacy|1|||
161124140|NCT02161562|581841339|FG000|Overall Study|Adverse Event|1|||
161124141|NCT02161562|581841340|FG001|Overall Study|Adverse Event|1|||
161124142|NCT02161562|581841339|FG000|Overall Study|Participant moved back to home country|1|||
161124143|NCT02161562|581841340|FG001|Overall Study|Participant moved back to home country|0|||
161124144|NCT02161562|581841339|FG000|Overall Study|Withdrew due to being out of the country|1|||
161124145|NCT02161562|581841340|FG001|Overall Study|Withdrew due to being out of the country|0|||
161124146|NCT02161562|581841339|FG000|Overall Study|Participant moved out of province|1|||
161124147|NCT02161562|581841340|FG001|Overall Study|Participant moved out of province|0|||
161124148|NCT02624492|581841344|FG000|Overall Study|Adverse Event|2|||
161124149|NCT02624492|581841345|FG001|Overall Study|Adverse Event|2|||
161229730|NCT02942264|582222529|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161229731|NCT02942264|582222530|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
161229732|NCT02942264|582222531|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161229733|NCT02942264|582222532|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
161229734|NCT02942264|582222524|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229735|NCT02942264|582222525|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229736|NCT02942264|582222526|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229737|NCT02942264|582222527|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229738|NCT02942264|582222528|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229739|NCT02942264|582222529|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229740|NCT02942264|582222530|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229741|NCT02942264|582222531|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
161229742|NCT02942264|582222532|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
161229743|NCT01328093|582222533|FG000|Double-Blind Phase|Adverse Event|78|||
161229744|NCT01328093|582222534|FG001|Double-Blind Phase|Adverse Event|15|||
161229745|NCT01328093|582222533|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
161229746|NCT01328093|582222534|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
161229747|NCT01328093|582222533|FG000|Double-Blind Phase|Lost to Follow-up|39|||
161229748|NCT01328093|582222534|FG001|Double-Blind Phase|Lost to Follow-up|14|||
161229749|NCT01328093|582222533|FG000|Double-Blind Phase|Protocol Violation|30|||
161229750|NCT01328093|582222534|FG001|Double-Blind Phase|Protocol Violation|10|||
161229751|NCT01328093|582222533|FG000|Double-Blind Phase|Lack of Efficacy|55|||
161229752|NCT01328093|582222534|FG001|Double-Blind Phase|Lack of Efficacy|13|||
161229753|NCT01328093|582222533|FG000|Double-Blind Phase|Sponsor Decision|17|||
161229754|NCT01328093|582222534|FG001|Double-Blind Phase|Sponsor Decision|3|||
161229755|NCT01328093|582222533|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
161229756|NCT01328093|582222534|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
161229757|NCT01328093|582222533|FG000|Double-Blind Phase|Scheduling conflict|8|||
161229758|NCT01328093|582222534|FG001|Double-Blind Phase|Scheduling conflict|3|||
161229759|NCT01328093|582222533|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
161229760|NCT01328093|582222534|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
161229761|NCT01328093|582222533|FG000|Double-Blind Phase|Death|1|||
161229762|NCT01328093|582222534|FG001|Double-Blind Phase|Death|0|||
161229763|NCT01328093|582222533|FG000|Open-Label Phase|Sponsor Decision|98|||
161229764|NCT01328093|582222534|FG001|Open-Label Phase|Sponsor Decision|34|||
161229765|NCT01328093|582222533|FG000|Open-Label Phase|Protocol Violation|8|||
161229766|NCT01328093|582222534|FG001|Open-Label Phase|Protocol Violation|3|||
161229767|NCT01328093|582222533|FG000|Open-Label Phase|Lost to Follow-up|10|||
161229768|NCT01328093|582222534|FG001|Open-Label Phase|Lost to Follow-up|1|||
161229769|NCT01328093|582222533|FG000|Open-Label Phase|Adverse Event|10|||
161229770|NCT01328093|582222534|FG001|Open-Label Phase|Adverse Event|4|||
161229771|NCT01328093|582222533|FG000|Open-Label Phase|Lack of Efficacy|5|||
161229772|NCT01328093|582222534|FG001|Open-Label Phase|Lack of Efficacy|6|||
161229773|NCT01328093|582222533|FG000|Open-Label Phase|Withdrawal by Subject|4|||
161229774|NCT01328093|582222534|FG001|Open-Label Phase|Withdrawal by Subject|1|||
161229775|NCT01328093|582222533|FG000|Open-Label Phase|Scheduling conflict|2|||
161229776|NCT01328093|582222534|FG001|Open-Label Phase|Scheduling conflict|1|||
161229777|NCT01328093|582222533|FG000|Open-Label Phase|Subject is moving or has moved|2|||
161229778|NCT01328093|582222534|FG001|Open-Label Phase|Subject is moving or has moved|0|||
161229779|NCT01328093|582222533|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
161229780|NCT01328093|582222534|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
161229781|NCT03980483|582222537|FG000|Overall Study|Adverse Event|13|||
161229782|NCT03980483|582222538|FG001|Overall Study|Adverse Event|29|||
161229783|NCT03980483|582222539|FG002|Overall Study|Adverse Event|11|||
161229784|NCT03980483|582222540|FG003|Overall Study|Adverse Event|2|||
161229785|NCT03980483|582222541|FG004|Overall Study|Adverse Event|2|||
161229786|NCT03980483|582222542|FG005|Overall Study|Adverse Event|2|||
161229787|NCT03980483|582222537|FG000|Overall Study|Lack of Efficacy|7|||
161229788|NCT03980483|582222538|FG001|Overall Study|Lack of Efficacy|6|||
161229789|NCT03980483|582222539|FG002|Overall Study|Lack of Efficacy|0|||
161229790|NCT03980483|582222540|FG003|Overall Study|Lack of Efficacy|3|||
161229791|NCT03980483|582222541|FG004|Overall Study|Lack of Efficacy|1|||
161229792|NCT03980483|582222542|FG005|Overall Study|Lack of Efficacy|1|||
161229793|NCT03980483|582222537|FG000|Overall Study|Lost to Follow-up|2|||
161229794|NCT03980483|582222538|FG001|Overall Study|Lost to Follow-up|4|||
161229795|NCT03980483|582222539|FG002|Overall Study|Lost to Follow-up|2|||
161229796|NCT03980483|582222540|FG003|Overall Study|Lost to Follow-up|1|||
161229797|NCT03980483|582222541|FG004|Overall Study|Lost to Follow-up|2|||
161229798|NCT03980483|582222542|FG005|Overall Study|Lost to Follow-up|0|||
161229799|NCT03980483|582222537|FG000|Overall Study|Protocol Violation|4|||
161229800|NCT03980483|582222538|FG001|Overall Study|Protocol Violation|2|||
161229801|NCT03980483|582222539|FG002|Overall Study|Protocol Violation|1|||
161229802|NCT03980483|582222540|FG003|Overall Study|Protocol Violation|1|||
161229803|NCT03980483|582222541|FG004|Overall Study|Protocol Violation|0|||
161229804|NCT03980483|582222542|FG005|Overall Study|Protocol Violation|0|||
161229805|NCT03980483|582222537|FG000|Overall Study|Physician Decision|14|||
161229806|NCT03980483|582222538|FG001|Overall Study|Physician Decision|10|||
161229807|NCT03980483|582222539|FG002|Overall Study|Physician Decision|7|||
161229808|NCT03980483|582222540|FG003|Overall Study|Physician Decision|4|||
161229809|NCT03980483|582222541|FG004|Overall Study|Physician Decision|4|||
161229810|NCT03980483|582222542|FG005|Overall Study|Physician Decision|2|||
161229811|NCT03980483|582222537|FG000|Overall Study|Withdrawal by Subject|38|||
161229812|NCT03980483|582222538|FG001|Overall Study|Withdrawal by Subject|21|||
161229813|NCT03980483|582222539|FG002|Overall Study|Withdrawal by Subject|15|||
161229814|NCT03980483|582222540|FG003|Overall Study|Withdrawal by Subject|5|||
161229815|NCT03980483|582222541|FG004|Overall Study|Withdrawal by Subject|3|||
161229816|NCT03980483|582222542|FG005|Overall Study|Withdrawal by Subject|4|||
161229817|NCT03980483|582222537|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
161229818|NCT03980483|582222538|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161229819|NCT03980483|582222539|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161229820|NCT03980483|582222540|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161229821|NCT03980483|582222541|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161229822|NCT03980483|582222542|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161229823|NCT03980483|582222537|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161229824|NCT03980483|582222538|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
161229825|NCT03980483|582222539|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161229826|NCT03980483|582222540|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161229827|NCT03980483|582222541|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161229828|NCT03980483|582222542|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
161229829|NCT03980483|582222537|FG000|Overall Study|Other|0|||
161229830|NCT03980483|582222538|FG001|Overall Study|Other|1|||
161229831|NCT03980483|582222539|FG002|Overall Study|Other|0|||
161229832|NCT03980483|582222540|FG003|Overall Study|Other|0|||
161229833|NCT03980483|582222541|FG004|Overall Study|Other|0|||
161229834|NCT03980483|582222542|FG005|Overall Study|Other|0|||
161229835|NCT01225146|582222543|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
161229836|NCT01225146|582222544|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
161229837|NCT00623779|582222545|FG000|Overall Study|Adverse Event|1|||
161229838|NCT00623779|582222546|FG001|Overall Study|Adverse Event|3|||
161229839|NCT00623779|582222547|FG002|Overall Study|Adverse Event|0|||
161229840|NCT00623779|582222545|FG000|Overall Study|Criteria from CSR|2|||
161229841|NCT00623779|582222546|FG001|Overall Study|Criteria from CSR|0|||
161229842|NCT00623779|582222547|FG002|Overall Study|Criteria from CSR|1|||
161229843|NCT03657160|582222548|FG000|Overall Study|Adverse Event|5|||
161229844|NCT03657160|582222549|FG001|Overall Study|Adverse Event|6|||
161229845|NCT03657160|582222548|FG000|Overall Study|Protocol Deviation|3|||
161229846|NCT03657160|582222549|FG001|Overall Study|Protocol Deviation|0|||
161229847|NCT03657160|582222548|FG000|Overall Study|Withdrawal by Subject|18|||
161229848|NCT03657160|582222549|FG001|Overall Study|Withdrawal by Subject|16|||
161229849|NCT03657160|582222548|FG000|Overall Study|Site Termination|1|||
161229850|NCT03657160|582222549|FG001|Overall Study|Site Termination|0|||
161229851|NCT03657160|582222548|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
161229852|NCT03657160|582222549|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
161229853|NCT03657160|582222548|FG000|Overall Study|Death|33|||
161229854|NCT03657160|582222549|FG001|Overall Study|Death|26|||
161229855|NCT03657160|582222548|FG000|Overall Study|Death (COVID-19-Related)|1|||
161229856|NCT03657160|582222549|FG001|Overall Study|Death (COVID-19-Related)|0|||
161229857|NCT03657160|582222548|FG000|Overall Study|Reason Not Specified|5|||
161229858|NCT03657160|582222549|FG001|Overall Study|Reason Not Specified|5|||
161229859|NCT03657160|582222548|FG000|Overall Study|Other (COVID-19-Related)|0|||
161229860|NCT03657160|582222549|FG001|Overall Study|Other (COVID-19-Related)|1|||
161229861|NCT00686959|582222552|FG000|Overall Study|Participants censored (no death events)|124|||
161229862|NCT00686959|582222553|FG001|Overall Study|Participants censored (no death events)|117|||
161229863|NCT02191891|582222555|FG000|Overall Study|Withdrawal by Subject|0|||
161229864|NCT02191891|582222556|FG001|Overall Study|Withdrawal by Subject|1|||
161229865|NCT02191891|582222557|FG002|Overall Study|Withdrawal by Subject|0|||
161229866|NCT02191891|582222558|FG003|Overall Study|Withdrawal by Subject|0|||
161327033|NCT05568797|582583328|FG000|Overall Study|Adverse Event|0|||
161327034|NCT05568797|582583329|FG001|Overall Study|Adverse Event|8|||
161229867|NCT02191891|582222559|FG004|Overall Study|Withdrawal by Subject|1|||
161229868|NCT02191891|582222555|FG000|Overall Study|Adverse Event|0|||
161327035|NCT05568797|582583328|FG000|Overall Study|Lost to Follow-up|2|||
161327036|NCT05568797|582583329|FG001|Overall Study|Lost to Follow-up|3|||
161327037|NCT05568797|582583328|FG000|Overall Study|Withdrawal by Subject|1|||
160861884|NCT02531802|580887859|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
161229869|NCT02191891|582222556|FG001|Overall Study|Adverse Event|1|||
161229870|NCT02191891|582222557|FG002|Overall Study|Adverse Event|0|||
161229871|NCT02191891|582222558|FG003|Overall Study|Adverse Event|0|||
161229872|NCT02191891|582222559|FG004|Overall Study|Adverse Event|2|||
161229873|NCT02191891|582222555|FG000|Overall Study|Disease Progression|4|||
161229874|NCT02191891|582222556|FG001|Overall Study|Disease Progression|10|||
161229875|NCT02191891|582222557|FG002|Overall Study|Disease Progression|4|||
161229876|NCT02191891|582222558|FG003|Overall Study|Disease Progression|2|||
161229877|NCT02191891|582222559|FG004|Overall Study|Disease Progression|7|||
161124150|NCT02624492|581841346|FG002|Overall Study|Adverse Event|2|||
161124151|NCT02624492|581841344|FG000|Overall Study|Progressive disease|0|||
161124152|NCT02624492|581841345|FG001|Overall Study|Progressive disease|2|||
161124153|NCT02624492|581841346|FG002|Overall Study|Progressive disease|3|||
161124154|NCT00197054|581841352|FG000|Overall Study|Withdrawal by Subject|9|||
161124155|NCT00197054|581841353|FG001|Overall Study|Withdrawal by Subject|3|||
161124156|NCT00197054|581841354|FG002|Overall Study|Withdrawal by Subject|3|||
161124157|NCT00197054|581841352|FG000|Overall Study|Moved from area|7|||
161124158|NCT00197054|581841353|FG001|Overall Study|Moved from area|14|||
161124159|NCT00197054|581841354|FG002|Overall Study|Moved from area|9|||
161229878|NCT01062256|582222562|FG000|Overall Study|Adverse Event|1|||
161229879|NCT01062256|582222563|FG001|Overall Study|Adverse Event|0|||
161229880|NCT01062256|582222564|FG002|Overall Study|Adverse Event|0|||
161229881|NCT01062256|582222562|FG000|Overall Study|Withdrawal by Subject|1|||
161229882|NCT01062256|582222563|FG001|Overall Study|Withdrawal by Subject|1|||
161229883|NCT01062256|582222564|FG002|Overall Study|Withdrawal by Subject|1|||
161229884|NCT01062256|582222562|FG000|Overall Study|Ineligible|1|||
161229885|NCT01062256|582222563|FG001|Overall Study|Ineligible|4|||
161229886|NCT01062256|582222564|FG002|Overall Study|Ineligible|3|||
161229887|NCT01062256|582222562|FG000|Overall Study|Administrative|0|||
161229888|NCT01062256|582222563|FG001|Overall Study|Administrative|2|||
161229889|NCT01062256|582222564|FG002|Overall Study|Administrative|0|||
161229890|NCT03099538|582222566|FG000|Overall Study|Lack of Efficacy|3|||
161229891|NCT02365207|582222578|FG000|Overall Study|Withdrawal by Subject|1|||
161229892|NCT02365207|582222578|FG000|Overall Study|Physician Decision|1|||
161229893|NCT01318499|582222579|FG000|Overall Study|Adverse Event|16|||
161229894|NCT01318499|582222580|FG001|Overall Study|Adverse Event|11|||
161229895|NCT01318499|582222581|FG002|Overall Study|Adverse Event|6|||
161229896|NCT01318499|582222579|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
161229897|NCT01318499|582222580|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
161229898|NCT01318499|582222581|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
161229899|NCT01318499|582222579|FG000|Overall Study|Noncompliance|2|||
161229900|NCT01318499|582222580|FG001|Overall Study|Noncompliance|3|||
161229901|NCT01318499|582222581|FG002|Overall Study|Noncompliance|0|||
161327038|NCT05568797|582583329|FG001|Overall Study|Withdrawal by Subject|10|||
161327039|NCT05568797|582583328|FG000|Overall Study|Other|2|||
161327040|NCT05568797|582583329|FG001|Overall Study|Other|2|||
161327041|NCT00099632|582583330|FG000|Overall Study|Lost to Follow-up|1|||
161327042|NCT00099632|582583331|FG001|Overall Study|Lost to Follow-up|0|||
161124160|NCT00197054|581841352|FG000|Overall Study|Lost to Follow-up|1|||
161124161|NCT00197054|581841353|FG001|Overall Study|Lost to Follow-up|4|||
161124162|NCT00197054|581841354|FG002|Overall Study|Lost to Follow-up|0|||
161124163|NCT01163786|581841355|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
161124164|NCT01163786|581841355|FG000|Treatment With Bortezomib|Adverse Event|2|||
161124165|NCT01163786|581841355|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
161124166|NCT02167945|581841360|FG000|Overall Study|Adverse Event|16|||
161124167|NCT02167945|581841360|FG000|Overall Study|Withdrew Consent|42|||
161124168|NCT02167945|581841360|FG000|Overall Study|Lost to Follow-up|122|||
161124169|NCT02167945|581841360|FG000|Overall Study|COVID-19 logistical restrictions|6|||
161124170|NCT02167945|581841360|FG000|Overall Study|Other, not specified|63|||
161124171|NCT00132730|581841361|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
161124172|NCT00132730|581841362|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
161124173|NCT00132730|581841363|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
161124174|NCT00132730|581841364|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
161124175|NCT00132730|581841365|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
161124176|NCT00132730|581841366|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
161124177|NCT00132730|581841361|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
161124178|NCT00132730|581841362|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
161124179|NCT00132730|581841363|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161124180|NCT00132730|581841364|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161124181|NCT00132730|581841365|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161124182|NCT00132730|581841366|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
161124183|NCT00132730|581841361|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
161124184|NCT00132730|581841362|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
161124185|NCT00132730|581841363|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
161124186|NCT00132730|581841364|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
161229902|NCT01318499|582222579|FG000|Overall Study|Treatment Failure|19|||
161229903|NCT01318499|582222580|FG001|Overall Study|Treatment Failure|19|||
161229904|NCT01318499|582222581|FG002|Overall Study|Treatment Failure|101|||
161229905|NCT01318499|582222579|FG000|Overall Study|Protocol Violation|2|||
161327043|NCT00099632|582583332|FG002|Overall Study|Lost to Follow-up|3|||
161229906|NCT01318499|582222580|FG001|Overall Study|Protocol Violation|4|||
161229907|NCT01318499|582222581|FG002|Overall Study|Protocol Violation|2|||
161229908|NCT01318499|582222579|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
161229909|NCT01318499|582222580|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
161229910|NCT01318499|582222581|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
161229911|NCT01318499|582222579|FG000|Overall Study|Other|7|||
161229912|NCT01318499|582222580|FG001|Overall Study|Other|10|||
161229913|NCT01318499|582222581|FG002|Overall Study|Other|22|||
161229914|NCT01395030|582222582|FG000|Overall Study|Did not complete FCH PET/CT|7|||
161229915|NCT02888171|582222586|FG000|Overall Study|Lost to Follow-up|2|||
161229916|NCT02888171|582222587|FG001|Overall Study|Lost to Follow-up|1|||
161229917|NCT02888171|582222586|FG000|Overall Study|Withdrawal by Subject|3|||
161229918|NCT02888171|582222587|FG001|Overall Study|Withdrawal by Subject|2|||
161229919|NCT02888171|582222586|FG000|Overall Study|Adverse Event|0|||
161229920|NCT02888171|582222587|FG001|Overall Study|Adverse Event|1|||
161229921|NCT02817841|582224026|FG000|Overall Study|Lost to Follow-up|287|||
161229922|NCT02817841|582224026|FG000|Overall Study|Withdrawal by Subject|183|||
161124187|NCT00132730|581841365|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
161124188|NCT00132730|581841366|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
161124189|NCT00132730|581841361|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161124190|NCT00132730|581841362|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161124191|NCT00132730|581841363|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
161124192|NCT00132730|581841364|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
161124193|NCT00132730|581841365|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161124194|NCT00132730|581841366|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
161124195|NCT00132730|581841361|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161124196|NCT00132730|581841362|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161124197|NCT00132730|581841363|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
161124198|NCT00132730|581841364|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
161124199|NCT00132730|581841365|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161124200|NCT00132730|581841366|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
161124201|NCT00132730|581841361|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161124202|NCT00132730|581841362|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161124203|NCT00132730|581841363|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161124204|NCT00132730|581841364|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
161124205|NCT00132730|581841365|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161124206|NCT00132730|581841366|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
161124207|NCT00132730|581841361|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161124208|NCT00132730|581841362|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161124209|NCT00132730|581841363|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
161124210|NCT00132730|581841364|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
161124211|NCT00132730|581841365|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161124212|NCT00132730|581841366|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
161124213|NCT00132730|581841361|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161124214|NCT00132730|581841362|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161124215|NCT00132730|581841363|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161124216|NCT00132730|581841364|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
161124217|NCT00132730|581841365|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
161124218|NCT00132730|581841366|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
161124219|NCT00132730|581841361|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161124220|NCT00132730|581841362|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161124221|NCT00132730|581841363|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161124222|NCT00132730|581841364|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161124223|NCT00132730|581841365|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
161124224|NCT00132730|581841366|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
161124225|NCT00132730|581841361|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161124226|NCT00132730|581841362|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161124227|NCT00132730|581841363|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161124228|NCT00132730|581841364|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161124229|NCT00132730|581841365|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
161124230|NCT00132730|581841366|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
161124231|NCT00132730|581841361|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161124232|NCT00132730|581841362|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161124233|NCT00132730|581841363|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161124234|NCT00132730|581841364|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161124235|NCT00132730|581841365|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
161229923|NCT02817841|582224026|FG000|Overall Study|Adverse event not related to bleeding|131|||
161229924|NCT02817841|582224026|FG000|Overall Study|Adverse event related to bleeding|51|||
161124236|NCT00132730|581841366|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
161124237|NCT00132730|581841361|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161124238|NCT00132730|581841362|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161124239|NCT00132730|581841363|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161124240|NCT00132730|581841364|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
161124241|NCT00132730|581841365|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
161124242|NCT00132730|581841366|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
161124243|NCT03021642|581841369|FG000|Washout Period (21 Days)|Adverse Event|1|||
161124244|NCT03021642|581841370|FG001|Washout Period (21 Days)|Adverse Event|1|||
161124245|NCT01192347|581841371|FG000|Overall Study|Death|3|||
161124246|NCT01192347|581841371|FG000|Overall Study|Lost to Follow-up|3|||
161124247|NCT01192347|581841371|FG000|Overall Study|Withdrawal by Subject|1|||
161124248|NCT01192347|581841371|FG000|Overall Study|Adverse Event|1|||
161124249|NCT01192347|581841371|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
161124250|NCT01192347|581841371|FG000|Overall Study|Patient seen in different hospital|1|||
161124251|NCT01192347|581841371|FG000|Overall Study|Patient not visiting hospital regularly|1|||
161124252|NCT01192347|581841371|FG000|Overall Study|Patient did not show up for visits|1|||
161124253|NCT02623335|581841372|FG000|Overall Study|Death|8|||
161124254|NCT02623335|581841373|FG001|Overall Study|Death|7|||
161124255|NCT02623335|581841372|FG000|Overall Study|Lost to Follow-up|15|||
161124256|NCT02623335|581841373|FG001|Overall Study|Lost to Follow-up|23|||
161124257|NCT02623335|581841372|FG000|Overall Study|Withdrawal by Subject|2|||
161124258|NCT02623335|581841373|FG001|Overall Study|Withdrawal by Subject|5|||
161124259|NCT02623335|581841372|FG000|Overall Study|Protocol Violation|2|||
161124260|NCT02623335|581841373|FG001|Overall Study|Protocol Violation|1|||
161124261|NCT00090545|581841374|FG000|Overall Study|Disease progression on study|21|||
161124262|NCT00090545|581841375|FG001|Overall Study|Disease progression on study|17|||
161124263|NCT00090545|581841374|FG000|Overall Study|Refused further treatment|1|||
161124264|NCT00090545|581841375|FG001|Overall Study|Refused further treatment|4|||
161124265|NCT00090545|581841374|FG000|Overall Study|Death|0|||
161124266|NCT00090545|581841375|FG001|Overall Study|Death|1|||
161124267|NCT00090545|581841374|FG000|Overall Study|Adverse Event|0|||
161124268|NCT00090545|581841375|FG001|Overall Study|Adverse Event|2|||
161124269|NCT02474082|581841376|FG000|Overall Study|Adverse Event|2|||
161124270|NCT02474082|581841377|FG001|Overall Study|Adverse Event|32|||
161124271|NCT02474082|581841376|FG000|Overall Study|Withdrawal of informed consent|1|||
161124272|NCT02474082|581841377|FG001|Overall Study|Withdrawal of informed consent|11|||
161124273|NCT02474082|581841376|FG000|Overall Study|Lost to Follow-up|2|||
161124274|NCT02474082|581841377|FG001|Overall Study|Lost to Follow-up|2|||
161124275|NCT02474082|581841376|FG000|Overall Study|Dose tapering not achieved|0|||
161124276|NCT02474082|581841377|FG001|Overall Study|Dose tapering not achieved|4|||
161124277|NCT02474082|581841376|FG000|Overall Study|Participant/guardian decision|1|||
161124278|NCT02474082|581841377|FG001|Overall Study|Participant/guardian decision|2|||
161124279|NCT02474082|581841376|FG000|Overall Study|Non-compliance with study treatment|0|||
161124280|NCT02474082|581841377|FG001|Overall Study|Non-compliance with study treatment|2|||
161124281|NCT02474082|581841376|FG000|Overall Study|Protocol deviation|0|||
161124282|NCT02474082|581841377|FG001|Overall Study|Protocol deviation|1|||
161124283|NCT04317274|581841380|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
161124284|NCT04317274|581841381|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
161124285|NCT04317274|581841382|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
161124286|NCT04317274|581841383|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
161124287|NCT00430508|581841384|FG000|Overall Study|Adverse Event|2|||
161124288|NCT00430508|581841385|FG001|Overall Study|Adverse Event|3|||
161124289|NCT00430508|581841386|FG002|Overall Study|Adverse Event|5|||
161124290|NCT00430508|581841387|FG003|Overall Study|Adverse Event|3|||
161124291|NCT00430508|581841384|FG000|Overall Study|Withdrawal by Subject|0|||
161124292|NCT00430508|581841385|FG001|Overall Study|Withdrawal by Subject|1|||
161124293|NCT00430508|581841386|FG002|Overall Study|Withdrawal by Subject|1|||
161124294|NCT00430508|581841387|FG003|Overall Study|Withdrawal by Subject|1|||
161124295|NCT00430508|581841384|FG000|Overall Study|responder at visit 4|0|||
161124296|NCT00430508|581841385|FG001|Overall Study|responder at visit 4|0|||
161229925|NCT02817841|582224026|FG000|Overall Study|Pregnancy|32|||
161229926|NCT02817841|582224026|FG000|Overall Study|Pregnancy wish|17|||
161229927|NCT02817841|582224026|FG000|Overall Study|Other reasons|53|||
161229928|NCT02817841|582224026|FG000|Overall Study|Protocol Violation|94|||
161229929|NCT04188106|582224027|FG000|Overall Study|Lost to Follow-up|5|||
161124297|NCT00430508|581841386|FG002|Overall Study|responder at visit 4|2|||
161124298|NCT00430508|581841387|FG003|Overall Study|responder at visit 4|0|||
161124299|NCT00430508|581841384|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
161124300|NCT00430508|581841385|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
161124301|NCT00430508|581841386|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
161124302|NCT00430508|581841387|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
161327044|NCT00099632|582583333|FG003|Overall Study|Lost to Follow-up|1|||
160781577|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
160781578|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
161124303|NCT00430508|581841384|FG000|Overall Study|Other|1|||
161124304|NCT00430508|581841385|FG001|Overall Study|Other|1|||
161124305|NCT00430508|581841386|FG002|Overall Study|Other|3|||
161124306|NCT00430508|581841387|FG003|Overall Study|Other|0|||
161124307|NCT00288080|581841394|FG000|Overall Study|Withdrawal by Subject|1|||
161124308|NCT00288080|581841395|FG001|Overall Study|Withdrawal by Subject|3|||
161124309|NCT00288080|581841394|FG000|Overall Study|Protocol Violation|25|||
161124310|NCT00288080|581841395|FG001|Overall Study|Protocol Violation|20|||
161124311|NCT00379795|581841396|FG000|Overall Study|Death|31|||
161124312|NCT00379795|581841397|FG001|Overall Study|Death|8|||
161124313|NCT00379795|581841398|FG002|Overall Study|Death|6|||
161124314|NCT00379795|581841399|FG003|Overall Study|Death|4|||
161124315|NCT00379795|581841400|FG004|Overall Study|Death|7|||
161124316|NCT00379795|581841396|FG000|Overall Study|Adverse Event|17|||
161124317|NCT00379795|581841397|FG001|Overall Study|Adverse Event|3|||
161124318|NCT00379795|581841398|FG002|Overall Study|Adverse Event|3|||
161124319|NCT00379795|581841399|FG003|Overall Study|Adverse Event|1|||
161124320|NCT00379795|581841400|FG004|Overall Study|Adverse Event|4|||
161124321|NCT00379795|581841396|FG000|Overall Study|Lost to Follow-up|8|||
161124322|NCT00379795|581841397|FG001|Overall Study|Lost to Follow-up|1|||
161124323|NCT00379795|581841398|FG002|Overall Study|Lost to Follow-up|2|||
161124324|NCT00379795|581841399|FG003|Overall Study|Lost to Follow-up|1|||
161124325|NCT00379795|581841400|FG004|Overall Study|Lost to Follow-up|4|||
161124326|NCT00379795|581841396|FG000|Overall Study|Physician Decision|25|||
161124327|NCT00379795|581841397|FG001|Overall Study|Physician Decision|0|||
161124328|NCT00379795|581841398|FG002|Overall Study|Physician Decision|2|||
161124329|NCT00379795|581841399|FG003|Overall Study|Physician Decision|2|||
161124330|NCT00379795|581841400|FG004|Overall Study|Physician Decision|2|||
161124331|NCT00379795|581841396|FG000|Overall Study|Withdrawal by Subject|94|||
161124332|NCT00379795|581841397|FG001|Overall Study|Withdrawal by Subject|11|||
161124333|NCT00379795|581841398|FG002|Overall Study|Withdrawal by Subject|19|||
161124334|NCT00379795|581841399|FG003|Overall Study|Withdrawal by Subject|7|||
161124335|NCT00379795|581841400|FG004|Overall Study|Withdrawal by Subject|14|||
161124336|NCT00379795|581841396|FG000|Overall Study|Subject non-compliance|7|||
161124337|NCT00379795|581841397|FG001|Overall Study|Subject non-compliance|2|||
161124338|NCT00379795|581841398|FG002|Overall Study|Subject non-compliance|0|||
161124339|NCT00379795|581841399|FG003|Overall Study|Subject non-compliance|0|||
161124340|NCT00379795|581841400|FG004|Overall Study|Subject non-compliance|1|||
161124341|NCT00379795|581841396|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
161124342|NCT00379795|581841397|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161124343|NCT00379795|581841398|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161124344|NCT00379795|581841399|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
161124345|NCT00379795|581841400|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
161124346|NCT00379795|581841396|FG000|Overall Study|Subjects condition mandated intervention|34|||
161124347|NCT00379795|581841397|FG001|Overall Study|Subjects condition mandated intervention|9|||
161124348|NCT00379795|581841398|FG002|Overall Study|Subjects condition mandated intervention|7|||
161124349|NCT00379795|581841399|FG003|Overall Study|Subjects condition mandated intervention|5|||
161124350|NCT00379795|581841400|FG004|Overall Study|Subjects condition mandated intervention|7|||
161124351|NCT00379795|581841396|FG000|Overall Study|Sponsor's decision|257|||
161124352|NCT00379795|581841397|FG001|Overall Study|Sponsor's decision|17|||
161124353|NCT00379795|581841398|FG002|Overall Study|Sponsor's decision|54|||
161124354|NCT00379795|581841399|FG003|Overall Study|Sponsor's decision|47|||
161124355|NCT00379795|581841400|FG004|Overall Study|Sponsor's decision|10|||
161124356|NCT00763321|581841401|FG000|Open-label Period|Adverse Event|24|||
161124357|NCT00763321|581841402|FG001|Open-label Period|Adverse Event|0|||
161124358|NCT00763321|581841403|FG002|Open-label Period|Adverse Event|0|||
161124359|NCT00763321|581841401|FG000|Open-label Period|Lost to Follow-up|14|||
161124360|NCT00763321|581841402|FG001|Open-label Period|Lost to Follow-up|0|||
161124361|NCT00763321|581841403|FG002|Open-label Period|Lost to Follow-up|0|||
161124362|NCT00763321|581841401|FG000|Open-label Period|Withdrawal by Subject|7|||
161124363|NCT00763321|581841402|FG001|Open-label Period|Withdrawal by Subject|0|||
161124364|NCT00763321|581841403|FG002|Open-label Period|Withdrawal by Subject|0|||
161124365|NCT00763321|581841401|FG000|Open-label Period|Subject noncompliant|7|||
161124366|NCT00763321|581841402|FG001|Open-label Period|Subject noncompliant|0|||
161124367|NCT00763321|581841403|FG002|Open-label Period|Subject noncompliant|0|||
161124368|NCT00763321|581841401|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
161124369|NCT00763321|581841402|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
161124370|NCT00763321|581841403|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
161124371|NCT00763321|581841401|FG000|Open-label Period|Lack of Efficacy|2|||
161124372|NCT00763321|581841402|FG001|Open-label Period|Lack of Efficacy|0|||
161327045|NCT00099632|582583334|FG004|Overall Study|Lost to Follow-up|1|||
161229930|NCT04188106|582224027|FG000|Overall Study|Non-Compliance|1|||
161229931|NCT00705536|582224028|FG000|Start Period 1|Withdrawal by Subject|0|||
161229932|NCT00705536|582224029|FG001|Start Period 1|Withdrawal by Subject|0|||
161229933|NCT00705536|582224030|FG002|Start Period 1|Withdrawal by Subject|0|||
161229934|NCT00705536|582224031|FG003|Start Period 1|Withdrawal by Subject|1|||
161229935|NCT04032977|582224032|FG000|Overall Study|Withdrawal by Subject|6|||
161229936|NCT04032977|582224033|FG001|Overall Study|Withdrawal by Subject|1|||
161229937|NCT04032977|582224032|FG000|Overall Study|Lost to Follow-up|2|||
161229938|NCT04032977|582224033|FG001|Overall Study|Lost to Follow-up|7|||
161229939|NCT04032977|582224032|FG000|Overall Study|Pregnancy|1|||
161327046|NCT00099632|582583335|FG005|Overall Study|Lost to Follow-up|0|||
161327047|NCT00099632|582583330|FG000|Overall Study|Withdrawal by Subject|0|||
160781579|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
160781580|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
161327048|NCT00099632|582583331|FG001|Overall Study|Withdrawal by Subject|1|||
161327049|NCT00099632|582583332|FG002|Overall Study|Withdrawal by Subject|0|||
161327050|NCT00099632|582583333|FG003|Overall Study|Withdrawal by Subject|0|||
161327051|NCT00099632|582583334|FG004|Overall Study|Withdrawal by Subject|0|||
161327052|NCT00099632|582583335|FG005|Overall Study|Withdrawal by Subject|1|||
161327053|NCT00099632|582583330|FG000|Overall Study|Protocol Violation|0|||
161327054|NCT00099632|582583331|FG001|Overall Study|Protocol Violation|0|||
161327055|NCT00099632|582583332|FG002|Overall Study|Protocol Violation|0|||
161327056|NCT00099632|582583333|FG003|Overall Study|Protocol Violation|0|||
161327057|NCT00099632|582583334|FG004|Overall Study|Protocol Violation|0|||
161327058|NCT00099632|582583335|FG005|Overall Study|Protocol Violation|1|||
161327059|NCT03131687|582583356|FG000|Overall Study|Adverse Event|0|||
161327060|NCT03131687|582583357|FG001|Overall Study|Adverse Event|1|||
161327061|NCT03131687|582583358|FG002|Overall Study|Adverse Event|0|||
161327062|NCT03131687|582583359|FG003|Overall Study|Adverse Event|1|||
161327063|NCT03131687|582583360|FG004|Overall Study|Adverse Event|2|||
161327064|NCT03131687|582583361|FG005|Overall Study|Adverse Event|2|||
161327065|NCT03131687|582583356|FG000|Overall Study|Death|1|||
161327066|NCT03131687|582583357|FG001|Overall Study|Death|0|||
161327067|NCT03131687|582583358|FG002|Overall Study|Death|0|||
161327068|NCT03131687|582583359|FG003|Overall Study|Death|0|||
161327069|NCT03131687|582583360|FG004|Overall Study|Death|0|||
161327070|NCT03131687|582583361|FG005|Overall Study|Death|0|||
161327071|NCT03131687|582583356|FG000|Overall Study|Withdrawal by Subject|3|||
161327072|NCT03131687|582583357|FG001|Overall Study|Withdrawal by Subject|3|||
161327073|NCT03131687|582583358|FG002|Overall Study|Withdrawal by Subject|3|||
161327074|NCT03131687|582583359|FG003|Overall Study|Withdrawal by Subject|1|||
161327075|NCT03131687|582583360|FG004|Overall Study|Withdrawal by Subject|2|||
161327076|NCT03131687|582583361|FG005|Overall Study|Withdrawal by Subject|1|||
161327077|NCT03131687|582583356|FG000|Overall Study|Lost to Follow-up|1|||
161327078|NCT03131687|582583357|FG001|Overall Study|Lost to Follow-up|4|||
161327079|NCT03131687|582583358|FG002|Overall Study|Lost to Follow-up|0|||
161327080|NCT03131687|582583359|FG003|Overall Study|Lost to Follow-up|1|||
161327081|NCT03131687|582583360|FG004|Overall Study|Lost to Follow-up|4|||
161327082|NCT03131687|582583361|FG005|Overall Study|Lost to Follow-up|2|||
161327083|NCT03131687|582583356|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
161327084|NCT03131687|582583357|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
161327085|NCT03131687|582583358|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
161327086|NCT03131687|582583359|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
161327087|NCT03131687|582583360|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
161327088|NCT03131687|582583361|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
161327089|NCT03131687|582583356|FG000|Overall Study|Principle Investigator Decision|0|||
161327090|NCT03131687|582583357|FG001|Overall Study|Principle Investigator Decision|1|||
161327091|NCT03131687|582583358|FG002|Overall Study|Principle Investigator Decision|0|||
161327092|NCT03131687|582583359|FG003|Overall Study|Principle Investigator Decision|0|||
161327093|NCT03131687|582583360|FG004|Overall Study|Principle Investigator Decision|0|||
161327094|NCT03131687|582583361|FG005|Overall Study|Principle Investigator Decision|0|||
161327095|NCT03131687|582583356|FG000|Overall Study|Inadvertent Enrollment|0|||
161327096|NCT03131687|582583357|FG001|Overall Study|Inadvertent Enrollment|0|||
161327097|NCT03131687|582583358|FG002|Overall Study|Inadvertent Enrollment|0|||
161327098|NCT03131687|582583359|FG003|Overall Study|Inadvertent Enrollment|1|||
161327099|NCT03131687|582583360|FG004|Overall Study|Inadvertent Enrollment|0|||
161327100|NCT03131687|582583361|FG005|Overall Study|Inadvertent Enrollment|0|||
161327101|NCT02797678|582583362|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
161327102|NCT02797678|582583363|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161327103|NCT02797678|582583364|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
161327104|NCT02797678|582583365|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
160861885|NCT02531802|580887860|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
161229940|NCT04032977|582224033|FG001|Overall Study|Pregnancy|0|||
161229941|NCT01101022|582224034|FG000|Overall Study|Adverse Event|6|||
161229942|NCT01101022|582224035|FG001|Overall Study|Adverse Event|2|||
161229943|NCT01101022|582224034|FG000|Overall Study|Protocol Violation|4|||
161229944|NCT01101022|582224035|FG001|Overall Study|Protocol Violation|3|||
161229945|NCT01101022|582224034|FG000|Overall Study|Withdrawal by Subject|3|||
161229946|NCT01101022|582224035|FG001|Overall Study|Withdrawal by Subject|8|||
161229947|NCT01101022|582224034|FG000|Overall Study|Lost to Follow-up|1|||
161229948|NCT01101022|582224035|FG001|Overall Study|Lost to Follow-up|4|||
161229949|NCT01101022|582224034|FG000|Overall Study|Lack of Efficacy|0|||
161229950|NCT01101022|582224035|FG001|Overall Study|Lack of Efficacy|7|||
161229951|NCT01101022|582224034|FG000|Overall Study|Sponsor decision|1|||
161229952|NCT01101022|582224035|FG001|Overall Study|Sponsor decision|1|||
161229953|NCT01101022|582224034|FG000|Overall Study|Non-compliance|1|||
161229954|NCT01101022|582224035|FG001|Overall Study|Non-compliance|0|||
161229955|NCT01101022|582224034|FG000|Overall Study|Work schedule|1|||
161229956|NCT01101022|582224035|FG001|Overall Study|Work schedule|1|||
160889449|NCT03489551|580989548|FG000|Overall Study|Withdrawal by Subject|2|||
160889450|NCT00054717|580989549|FG000|Overall Study|Randomized but not treated|2|||
160889451|NCT00054717|580989550|FG001|Overall Study|Randomized but not treated|8|||
160889452|NCT00054717|580989549|FG000|Overall Study|Adverse Event|70|||
160889453|NCT00054717|580989550|FG001|Overall Study|Adverse Event|22|||
160889454|NCT00054717|580989549|FG000|Overall Study|Protocol Violation|18|||
160889455|NCT00054717|580989550|FG001|Overall Study|Protocol Violation|19|||
160889456|NCT00054717|580989549|FG000|Overall Study|Lost to Follow-up|23|||
160889457|NCT00054717|580989550|FG001|Overall Study|Lost to Follow-up|13|||
160889458|NCT00054717|580989549|FG000|Overall Study|Withdrawal by Subject|32|||
161229957|NCT01101022|582224034|FG000|Overall Study|Vacation|0|||
161229958|NCT01101022|582224035|FG001|Overall Study|Vacation|1|||
161229959|NCT01519661|582224036|FG000|Overall Study|Protocol deviation|6|||
161229960|NCT01519661|582224036|FG000|Overall Study|Lost to Follow-up|3|||
161229961|NCT01519661|582224036|FG000|Overall Study|Withdrawal by Subject|17|||
161229962|NCT01519661|582224036|FG000|Overall Study|Lack of Efficacy|6|||
161229963|NCT01519661|582224036|FG000|Overall Study|Adverse Event|29|||
161229964|NCT03075761|582224037|FG000|Overall Study|Lost to Follow-up|1|||
161229965|NCT03075761|582224038|FG001|Overall Study|Lost to Follow-up|6|||
161229966|NCT01139047|582224039|FG000|Overall Study|Withdrawal by Subject|1|||
161229967|NCT00420303|582224044|FG000|Overall Study|Serious Adverse Event|1|||
161229968|NCT00420303|582224045|FG001|Overall Study|Serious Adverse Event|0|||
161229969|NCT00420303|582224044|FG000|Overall Study|Lack of Efficacy|0|||
161229970|NCT00420303|582224045|FG001|Overall Study|Lack of Efficacy|3|||
161229971|NCT00420303|582224044|FG000|Overall Study|Physician Decision|0|||
161229972|NCT00420303|582224045|FG001|Overall Study|Physician Decision|1|||
161229973|NCT05628675|582224046|FG000|Overall Study|Lost to Follow-up|2|||
161229974|NCT05628675|582224046|FG000|Overall Study|Withdrawal by Subject|1|||
161229975|NCT00633594|582224047|FG000|Overall Study|Adverse Event|0|||
161229976|NCT00633594|582224048|FG001|Overall Study|Adverse Event|4|||
161229977|NCT00633594|582224049|FG002|Overall Study|Adverse Event|7|||
161229978|NCT00633594|582224047|FG000|Overall Study|Death|0|||
161229979|NCT00633594|582224048|FG001|Overall Study|Death|1|||
161229980|NCT00633594|582224049|FG002|Overall Study|Death|2|||
161229981|NCT00633594|582224047|FG000|Overall Study|Disease Progression|0|||
161229982|NCT00633594|582224048|FG001|Overall Study|Disease Progression|0|||
161229983|NCT00633594|582224049|FG002|Overall Study|Disease Progression|1|||
161229984|NCT04455633|582224051|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
161229985|NCT04455633|582224052|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
161229986|NCT04455633|582224053|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
161327105|NCT02797678|582583362|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
161229987|NCT04455633|582224051|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
161229988|NCT04455633|582224052|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
161229989|NCT04455633|582224053|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
161229990|NCT04455633|582224051|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
161229991|NCT04455633|582224052|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
161229992|NCT04455633|582224053|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
161229993|NCT04455633|582224051|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
161229994|NCT04455633|582224052|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
161229995|NCT04455633|582224053|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
160889459|NCT00054717|580989550|FG001|Overall Study|Withdrawal by Subject|20|||
161229996|NCT01648166|582224054|FG000|Overall Study|inadequate toenail samples|53|||
161229997|NCT01648166|582224055|FG001|Overall Study|inadequate toenail samples|100|||
161229998|NCT00883090|582224056|FG000|Overall Study|Sponsor's decision|1|||
161229999|NCT00883090|582224056|FG000|Overall Study|Withdrawal by Subject|1|||
161230000|NCT01087970|582224059|FG000|Overall Study|Protocol Violation|2|||
160889460|NCT00054717|580989549|FG000|Overall Study|Other reason not defined above|117|||
161230001|NCT05150964|582224060|FG000|Overall Study|Lost to Follow-up|2|||
161230002|NCT01629381|582224065|FG000|Overall Study|Withdrawal by Subject|2|||
161230003|NCT01629381|582224066|FG001|Overall Study|Withdrawal by Subject|5|||
161124373|NCT00763321|581841403|FG002|Open-label Period|Lack of Efficacy|0|||
161124374|NCT00763321|581841401|FG000|Open-label Period|Other|4|||
161124375|NCT00763321|581841402|FG001|Open-label Period|Other|0|||
161124376|NCT00763321|581841403|FG002|Open-label Period|Other|0|||
161124377|NCT00763321|581841401|FG000|Double-blind Period|Lack of Efficacy|0|||
161124378|NCT00763321|581841402|FG001|Double-blind Period|Lack of Efficacy|9|||
161124379|NCT00763321|581841403|FG002|Double-blind Period|Lack of Efficacy|17|||
161124380|NCT00763321|581841401|FG000|Double-blind Period|Adverse Event|0|||
161124381|NCT00763321|581841402|FG001|Double-blind Period|Adverse Event|4|||
161124382|NCT00763321|581841403|FG002|Double-blind Period|Adverse Event|4|||
161124383|NCT00763321|581841401|FG000|Double-blind Period|Lost to Follow-up|0|||
161124384|NCT00763321|581841402|FG001|Double-blind Period|Lost to Follow-up|4|||
161124385|NCT00763321|581841403|FG002|Double-blind Period|Lost to Follow-up|2|||
161124386|NCT00763321|581841401|FG000|Double-blind Period|Withdrawal by Subject|0|||
161124387|NCT00763321|581841402|FG001|Double-blind Period|Withdrawal by Subject|2|||
161124388|NCT00763321|581841403|FG002|Double-blind Period|Withdrawal by Subject|3|||
161124389|NCT00763321|581841401|FG000|Double-blind Period|Other|0|||
161124390|NCT00763321|581841402|FG001|Double-blind Period|Other|2|||
161124391|NCT00763321|581841403|FG002|Double-blind Period|Other|3|||
161124392|NCT02793232|581841404|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124393|NCT02793232|581841405|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124394|NCT02793232|581841406|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124395|NCT02793232|581841407|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124396|NCT02793232|581841408|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
161124397|NCT02793232|581841409|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124398|NCT02793232|581841410|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
161124399|NCT02793232|581841411|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124400|NCT02793232|581841412|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
161124401|NCT02387580|581841415|FG000|Overall Study|Withdrawal by Subject|0|||
161124402|NCT02387580|581841416|FG001|Overall Study|Withdrawal by Subject|0|||
161124403|NCT02387580|581841417|FG002|Overall Study|Withdrawal by Subject|0|||
161124404|NCT02387580|581841418|FG003|Overall Study|Withdrawal by Subject|1|||
161124405|NCT02387580|581841419|FG004|Overall Study|Withdrawal by Subject|0|||
161124406|NCT02387580|581841420|FG005|Overall Study|Withdrawal by Subject|0|||
161124407|NCT00087646|581841421|FG000|Overall Study|Adverse Event|37|||
161124408|NCT00087646|581841422|FG001|Overall Study|Adverse Event|6|||
161124409|NCT00087646|581841423|FG002|Overall Study|Adverse Event|18|||
161124410|NCT00087646|581841424|FG003|Overall Study|Adverse Event|20|||
161124411|NCT00087646|581841421|FG000|Overall Study|Death|0|||
161124412|NCT00087646|581841422|FG001|Overall Study|Death|1|||
161124413|NCT00087646|581841423|FG002|Overall Study|Death|0|||
161124414|NCT00087646|581841424|FG003|Overall Study|Death|0|||
161124415|NCT00087646|581841421|FG000|Overall Study|Withdrawal by Subject|6|||
161124416|NCT00087646|581841422|FG001|Overall Study|Withdrawal by Subject|1|||
161124417|NCT00087646|581841423|FG002|Overall Study|Withdrawal by Subject|2|||
161124418|NCT00087646|581841424|FG003|Overall Study|Withdrawal by Subject|2|||
161124419|NCT00087646|581841421|FG000|Overall Study|Insufficient therapeutic response|64|||
161124420|NCT00087646|581841422|FG001|Overall Study|Insufficient therapeutic response|24|||
161124421|NCT00087646|581841423|FG002|Overall Study|Insufficient therapeutic response|38|||
161124422|NCT00087646|581841424|FG003|Overall Study|Insufficient therapeutic response|51|||
161124423|NCT00087646|581841421|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
161124424|NCT00087646|581841422|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
161124425|NCT00087646|581841423|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
161124426|NCT00087646|581841424|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
161124427|NCT00087646|581841421|FG000|Overall Study|Failure to Return|5|||
161124428|NCT00087646|581841422|FG001|Overall Study|Failure to Return|2|||
161124429|NCT00087646|581841423|FG002|Overall Study|Failure to Return|2|||
161124430|NCT00087646|581841424|FG003|Overall Study|Failure to Return|3|||
161124431|NCT00087646|581841421|FG000|Overall Study|Administrative/Other|6|||
161124432|NCT00087646|581841422|FG001|Overall Study|Administrative/Other|1|||
161124433|NCT00087646|581841423|FG002|Overall Study|Administrative/Other|1|||
161124434|NCT00087646|581841424|FG003|Overall Study|Administrative/Other|2|||
161124435|NCT00087646|581841421|FG000|Overall Study|Other Protocol Violation|3|||
161124436|NCT00087646|581841422|FG001|Overall Study|Other Protocol Violation|1|||
161124437|NCT00087646|581841423|FG002|Overall Study|Other Protocol Violation|0|||
161124438|NCT00087646|581841424|FG003|Overall Study|Other Protocol Violation|0|||
161124439|NCT00087646|581841421|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161124440|NCT00087646|581841422|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161124441|NCT00087646|581841423|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161124442|NCT00087646|581841424|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
161124443|NCT02301403|581841438|FG000|Overall Study|Withdrawal by Subject|28|||
161124444|NCT02301403|581841439|FG001|Overall Study|Withdrawal by Subject|41|||
161124445|NCT01060059|581841440|FG000|Overall Study|Adverse Event|1|||
161230004|NCT00906347|582224069|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
161124446|NCT01060059|581841441|FG001|Overall Study|Adverse Event|1|||
161230005|NCT00906347|582224070|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
161230006|NCT00906347|582224069|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
161230007|NCT00906347|582224070|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
161230008|NCT00906347|582224069|FG000|Received Study Drug|Refused study drug|1|||
161230009|NCT00906347|582224070|FG001|Received Study Drug|Refused study drug|0|||
161230010|NCT00906347|582224069|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
161230011|NCT00906347|582224070|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
161230012|NCT00680121|582224080|FG000|Overall Study|Lost to Follow-up|27|||
161230013|NCT00680121|582224081|FG001|Overall Study|Lost to Follow-up|23|||
161230014|NCT02849652|582224082|FG000|Overall Study|Lost to Follow-up|104|||
161230015|NCT02849652|582224083|FG001|Overall Study|Lost to Follow-up|35|||
161230016|NCT02849652|582224084|FG002|Overall Study|Lost to Follow-up|116|||
161230017|NCT02849652|582224085|FG003|Overall Study|Lost to Follow-up|22|||
161230018|NCT02849652|582224082|FG000|Overall Study|Withdrawal by Subject|10|||
161230019|NCT02849652|582224083|FG001|Overall Study|Withdrawal by Subject|2|||
161230020|NCT02849652|582224084|FG002|Overall Study|Withdrawal by Subject|8|||
161230021|NCT02849652|582224085|FG003|Overall Study|Withdrawal by Subject|4|||
161230022|NCT02545998|582224086|FG000|Overall Study|Lost to Follow-up|12|||
161230023|NCT02545998|582224087|FG001|Overall Study|Lost to Follow-up|3|||
161230024|NCT02545998|582224086|FG000|Overall Study|Withdrawal by Subject|3|||
161230025|NCT02545998|582224087|FG001|Overall Study|Withdrawal by Subject|2|||
161230026|NCT00472290|582224088|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
161230027|NCT00472290|582224088|FG000|Overall Study|Protocol Specified Criteria|7|||
161230028|NCT00472290|582224088|FG000|Overall Study|Administrative Decision|37|||
161230029|NCT00472290|582224088|FG000|Overall Study|Death|3|||
161230030|NCT00472290|582224088|FG000|Overall Study|Lost to Follow-up|1|||
161230031|NCT00472290|582224088|FG000|Overall Study|Lack of Efficacy|1|||
161230032|NCT00472290|582224088|FG000|Overall Study|Disease Progression|4|||
161230033|NCT00472290|582224088|FG000|Overall Study|Withdrawal by Subject|5|||
161230034|NCT00472290|582224088|FG000|Overall Study|Adverse Event|6|||
161230035|NCT00472290|582224088|FG000|Overall Study|Requirement for alternative therapy|7|||
161230036|NCT00777829|582224090|FG000|Overall Study|Withdrawal by Subject|0|||
161230037|NCT00777829|582224091|FG001|Overall Study|Withdrawal by Subject|2|||
161230038|NCT00745095|582224092|FG000|Overall Study|Declined to participate|1|||
161230039|NCT00745095|582224093|FG001|Overall Study|Declined to participate|0|||
161230040|NCT00745095|582224094|FG002|Overall Study|Declined to participate|0|||
161230041|NCT00745095|582224095|FG003|Overall Study|Declined to participate|0|||
161230042|NCT00745095|582224096|FG004|Overall Study|Declined to participate|92|||
161230043|NCT00745095|582224097|FG005|Overall Study|Declined to participate|95|||
161230044|NCT00745095|582224092|FG000|Overall Study|Ineligible due to GFR criteria|0|||
161230045|NCT00745095|582224093|FG001|Overall Study|Ineligible due to GFR criteria|2|||
161230046|NCT00745095|582224094|FG002|Overall Study|Ineligible due to GFR criteria|3|||
161230047|NCT00745095|582224095|FG003|Overall Study|Ineligible due to GFR criteria|3|||
161230048|NCT00745095|582224096|FG004|Overall Study|Ineligible due to GFR criteria|30|||
161230049|NCT00745095|582224097|FG005|Overall Study|Ineligible due to GFR criteria|28|||
161230050|NCT01226797|582224103|FG000|Overall Study|Adverse Event|1|||
161230051|NCT01226797|582224104|FG001|Overall Study|Adverse Event|0|||
161230052|NCT01226797|582224103|FG000|Overall Study|No longer willing to participate|1|||
161230053|NCT01226797|582224104|FG001|Overall Study|No longer willing to participate|0|||
161230054|NCT01226797|582224103|FG000|Overall Study|Protocol Violation|0|||
161230055|NCT01226797|582224104|FG001|Overall Study|Protocol Violation|1|||
161230056|NCT00577460|582224105|FG000|Overall Study|Adverse Event|11|||
161230057|NCT00577460|582224106|FG001|Overall Study|Adverse Event|7|||
161230058|NCT00577460|582224107|FG002|Overall Study|Adverse Event|14|||
161230059|NCT00577460|582224105|FG000|Overall Study|Protocol Violation|0|||
161230060|NCT00577460|582224106|FG001|Overall Study|Protocol Violation|1|||
161230061|NCT00577460|582224107|FG002|Overall Study|Protocol Violation|1|||
161230062|NCT00577460|582224105|FG000|Overall Study|Lost to Follow-up|0|||
161230063|NCT00577460|582224106|FG001|Overall Study|Lost to Follow-up|3|||
161230064|NCT00577460|582224107|FG002|Overall Study|Lost to Follow-up|4|||
161230065|NCT00577460|582224105|FG000|Overall Study|Withdrawal by Subject|5|||
161230066|NCT00577460|582224106|FG001|Overall Study|Withdrawal by Subject|5|||
161230067|NCT00577460|582224107|FG002|Overall Study|Withdrawal by Subject|6|||
161230068|NCT00577460|582224105|FG000|Overall Study|Other|0|||
161230069|NCT00577460|582224106|FG001|Overall Study|Other|3|||
161230070|NCT00577460|582224107|FG002|Overall Study|Other|2|||
161230071|NCT00162123|582224108|FG000|Overall Study|Disease progression|27|||
161230072|NCT00162123|582224109|FG001|Overall Study|Disease progression|19|||
161230073|NCT00162123|582224110|FG002|Overall Study|Disease progression|10|||
161230074|NCT00162123|582224111|FG003|Overall Study|Disease progression|4|||
161230075|NCT00162123|582224112|FG004|Overall Study|Disease progression|8|||
161230076|NCT00162123|582224113|FG005|Overall Study|Disease progression|3|||
161230077|NCT00162123|582224114|FG006|Overall Study|Disease progression|1|||
161230078|NCT00162123|582224115|FG007|Overall Study|Disease progression|0|||
161230079|NCT00162123|582224108|FG000|Overall Study|Study drug toxicity|6|||
161230080|NCT00162123|582224109|FG001|Overall Study|Study drug toxicity|1|||
161230081|NCT00162123|582224110|FG002|Overall Study|Study drug toxicity|5|||
161230082|NCT00162123|582224111|FG003|Overall Study|Study drug toxicity|0|||
161230083|NCT00162123|582224112|FG004|Overall Study|Study drug toxicity|4|||
161230084|NCT00162123|582224113|FG005|Overall Study|Study drug toxicity|1|||
161230085|NCT00162123|582224114|FG006|Overall Study|Study drug toxicity|1|||
161230086|NCT00162123|582224115|FG007|Overall Study|Study drug toxicity|0|||
161230087|NCT00162123|582224108|FG000|Overall Study|Death|3|||
161230088|NCT00162123|582224109|FG001|Overall Study|Death|3|||
161230089|NCT00162123|582224110|FG002|Overall Study|Death|1|||
161230090|NCT00162123|582224111|FG003|Overall Study|Death|1|||
161230091|NCT00162123|582224112|FG004|Overall Study|Death|1|||
161230092|NCT00162123|582224113|FG005|Overall Study|Death|1|||
161230093|NCT00162123|582224114|FG006|Overall Study|Death|0|||
161230094|NCT00162123|582224115|FG007|Overall Study|Death|0|||
160889461|NCT00054717|580989550|FG001|Overall Study|Other reason not defined above|217|||
160889462|NCT03139604|580989555|FG000|Overall Study|Other|7|||
160889463|NCT03139604|580989556|FG001|Overall Study|Other|3|||
160889464|NCT03139604|580989555|FG000|Overall Study|Withdrawal by Subject|16|||
160889465|NCT03139604|580989556|FG001|Overall Study|Withdrawal by Subject|17|||
160889466|NCT03139604|580989555|FG000|Overall Study|Physician Decision|1|||
160889467|NCT03139604|580989556|FG001|Overall Study|Physician Decision|2|||
160889468|NCT03139604|580989555|FG000|Overall Study|Lost to Follow-up|3|||
160889469|NCT03139604|580989556|FG001|Overall Study|Lost to Follow-up|1|||
160889470|NCT03139604|580989555|FG000|Overall Study|Death|65|||
160889471|NCT03139604|580989556|FG001|Overall Study|Death|67|||
160889472|NCT03139604|580989555|FG000|Overall Study|Study Terminated by Sponsor|122|||
160889473|NCT03139604|580989556|FG001|Overall Study|Study Terminated by Sponsor|127|||
160889474|NCT03139604|580989555|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
160889475|NCT03139604|580989556|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
160889476|NCT04148911|580989557|FG000|Overall Study|Death|104|||
160889477|NCT04148911|580989557|FG000|Overall Study|Lost to Follow-up|5|||
160889478|NCT04148911|580989557|FG000|Overall Study|Withdrawal by Subject|17|||
160889479|NCT04148911|580989557|FG000|Overall Study|Study Ended by Sponsor|56|||
160889480|NCT00470184|580989560|FG000|Overall Study|Not Treated(became ineligible)|4|||
161230095|NCT00162123|582224108|FG000|Overall Study|Withdrawal by Subject|2|||
161230096|NCT00162123|582224109|FG001|Overall Study|Withdrawal by Subject|0|||
161230097|NCT00162123|582224110|FG002|Overall Study|Withdrawal by Subject|2|||
161230098|NCT00162123|582224111|FG003|Overall Study|Withdrawal by Subject|1|||
161230099|NCT00162123|582224112|FG004|Overall Study|Withdrawal by Subject|1|||
161230100|NCT00162123|582224113|FG005|Overall Study|Withdrawal by Subject|2|||
161230101|NCT00162123|582224114|FG006|Overall Study|Withdrawal by Subject|1|||
161230102|NCT00162123|582224115|FG007|Overall Study|Withdrawal by Subject|0|||
161230103|NCT00162123|582224108|FG000|Overall Study|Deterioration without progression|2|||
161230104|NCT00162123|582224109|FG001|Overall Study|Deterioration without progression|2|||
161230105|NCT00162123|582224110|FG002|Overall Study|Deterioration without progression|3|||
161230106|NCT00162123|582224111|FG003|Overall Study|Deterioration without progression|0|||
161230107|NCT00162123|582224112|FG004|Overall Study|Deterioration without progression|1|||
161230108|NCT00162123|582224113|FG005|Overall Study|Deterioration without progression|0|||
161230109|NCT00162123|582224114|FG006|Overall Study|Deterioration without progression|0|||
161230110|NCT00162123|582224115|FG007|Overall Study|Deterioration without progression|0|||
161230111|NCT00162123|582224108|FG000|Overall Study|Adverse Event|1|||
161230112|NCT00162123|582224109|FG001|Overall Study|Adverse Event|2|||
161230113|NCT00162123|582224110|FG002|Overall Study|Adverse Event|0|||
161230114|NCT00162123|582224111|FG003|Overall Study|Adverse Event|2|||
161327106|NCT02797678|582583363|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
161327107|NCT02797678|582583364|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
161327108|NCT02797678|582583365|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
160889481|NCT00470184|580989560|FG000|Overall Study|Not treated (other)|1|||
160889482|NCT00470184|580989560|FG000|Overall Study|disease Progression|4|||
160889483|NCT00470184|580989560|FG000|Overall Study|Adverse Event|3|||
160889484|NCT00470184|580989560|FG000|Overall Study|Withdrawal by Subject|4|||
160889485|NCT00470184|580989560|FG000|Overall Study|other|5|||
160889486|NCT00470184|580989560|FG000|Overall Study|recurrence|1|||
160889487|NCT01606254|580989561|FG000|Overall Study|Withdrawal by Subject|1|||
160889488|NCT01606254|580989562|FG001|Overall Study|Withdrawal by Subject|3|||
160889489|NCT01606254|580989563|FG002|Overall Study|Withdrawal by Subject|0|||
160889490|NCT01606254|580989564|FG003|Overall Study|Withdrawal by Subject|2|||
160889491|NCT01606254|580989561|FG000|Overall Study|Adverse Event|1|||
161230115|NCT00162123|582224112|FG004|Overall Study|Adverse Event|1|||
161230116|NCT00162123|582224113|FG005|Overall Study|Adverse Event|0|||
161230117|NCT00162123|582224114|FG006|Overall Study|Adverse Event|0|||
161230118|NCT00162123|582224115|FG007|Overall Study|Adverse Event|0|||
161230119|NCT00162123|582224108|FG000|Overall Study|Not specified (before treatment)|2|||
161230120|NCT00162123|582224109|FG001|Overall Study|Not specified (before treatment)|0|||
161230121|NCT00162123|582224110|FG002|Overall Study|Not specified (before treatment)|0|||
160889492|NCT01606254|580989562|FG001|Overall Study|Adverse Event|1|||
160889493|NCT01606254|580989563|FG002|Overall Study|Adverse Event|0|||
160889494|NCT01606254|580989564|FG003|Overall Study|Adverse Event|1|||
160889495|NCT04543409|580989565|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160889496|NCT04543409|580989566|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
160889497|NCT04543409|580989565|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
160889498|NCT04543409|580989566|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
160889499|NCT04543409|580989565|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
160889500|NCT04543409|580989566|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
160889501|NCT04543409|580989565|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
160889502|NCT04543409|580989566|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
160889503|NCT04543409|580989565|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
160889504|NCT04543409|580989566|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
160889505|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
160889506|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
160889507|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
160889508|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
160889509|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
160889510|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
160889511|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
160889512|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
160889513|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
160889514|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
160889515|NCT04543409|580989565|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
160889516|NCT04543409|580989566|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
160889517|NCT02195011|580989569|FG000|Overall Study|Adverse Event|4|||
160889518|NCT02195011|580989570|FG001|Overall Study|Adverse Event|0|||
160889519|NCT02195011|580989569|FG000|Overall Study|Progressive Disease|18|||
160889520|NCT02195011|580989570|FG001|Overall Study|Progressive Disease|1|||
160889521|NCT02195011|580989569|FG000|Overall Study|Withdrawal by Subject|3|||
160889522|NCT02195011|580989570|FG001|Overall Study|Withdrawal by Subject|0|||
160889523|NCT00450112|580989571|FG000|Overall Study|Other Treatment Required|5|||
160889524|NCT00450112|580989572|FG001|Overall Study|Other Treatment Required|1|||
160889525|NCT00450112|580989571|FG000|Overall Study|Withdrawal by Subject|4|||
160889526|NCT00450112|580989572|FG001|Overall Study|Withdrawal by Subject|1|||
160889527|NCT00450112|580989571|FG000|Overall Study|Lost to Follow-up|2|||
160889528|NCT00450112|580989572|FG001|Overall Study|Lost to Follow-up|1|||
160889529|NCT00450112|580989571|FG000|Overall Study|Others|2|||
160889530|NCT00450112|580989572|FG001|Overall Study|Others|3|||
160889531|NCT03418571|580989573|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
160889532|NCT03418571|580989574|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
160889533|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
160889534|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
160889535|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
160889536|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
160889537|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
160889538|NCT00586326|580989575|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
160889539|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
160889540|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
160889541|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
160889542|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
160889543|NCT00586326|580989575|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
161124447|NCT01060059|581841440|FG000|Overall Study|Death|2|||
161124448|NCT01060059|581841441|FG001|Overall Study|Death|3|||
161124449|NCT01060059|581841440|FG000|Overall Study|Lost to Follow-up|18|||
161124450|NCT01060059|581841441|FG001|Overall Study|Lost to Follow-up|34|||
161124451|NCT01060059|581841440|FG000|Overall Study|entry criteria not met|4|||
161124452|NCT01060059|581841441|FG001|Overall Study|entry criteria not met|3|||
161124453|NCT01060059|581841440|FG000|Overall Study|Withdrawal by Subject|35|||
161124454|NCT01060059|581841441|FG001|Overall Study|Withdrawal by Subject|23|||
161124455|NCT01060059|581841440|FG000|Overall Study|lack of glycemic control|2|||
161124456|NCT01060059|581841441|FG001|Overall Study|lack of glycemic control|1|||
161124457|NCT01060059|581841440|FG000|Overall Study|lack of compliance|5|||
161124458|NCT01060059|581841441|FG001|Overall Study|lack of compliance|2|||
161124459|NCT02302963|581841444|FG000|Overall Study|Withdrawal by Subject|2|||
161124460|NCT02302963|581841445|FG001|Overall Study|Withdrawal by Subject|1|||
161124461|NCT02302963|581841444|FG000|Overall Study|Steroid injection|0|||
161124462|NCT02302963|581841445|FG001|Overall Study|Steroid injection|1|||
161124463|NCT02302963|581841444|FG000|Overall Study|Physician Decision|1|||
161124464|NCT02302963|581841445|FG001|Overall Study|Physician Decision|0|||
161124465|NCT01816243|581841446|FG000|Overall Study|Adverse Event|6|||
161124466|NCT01816243|581841446|FG000|Overall Study|Lost to Follow-up|1|||
161124467|NCT01816243|581841446|FG000|Overall Study|Lack of Efficacy|1|||
161230122|NCT00162123|582224111|FG003|Overall Study|Not specified (before treatment)|0|||
161230123|NCT00162123|582224112|FG004|Overall Study|Not specified (before treatment)|12|||
161230124|NCT00162123|582224113|FG005|Overall Study|Not specified (before treatment)|1|||
161230125|NCT00162123|582224114|FG006|Overall Study|Not specified (before treatment)|0|||
161230126|NCT00162123|582224115|FG007|Overall Study|Not specified (before treatment)|0|||
161230127|NCT00162123|582224108|FG000|Overall Study|Not specified (after start of treatment)|0|||
161230128|NCT00162123|582224109|FG001|Overall Study|Not specified (after start of treatment)|0|||
161230129|NCT00162123|582224110|FG002|Overall Study|Not specified (after start of treatment)|0|||
161230130|NCT00162123|582224111|FG003|Overall Study|Not specified (after start of treatment)|0|||
161230131|NCT00162123|582224112|FG004|Overall Study|Not specified (after start of treatment)|3|||
161230132|NCT00162123|582224113|FG005|Overall Study|Not specified (after start of treatment)|0|||
161230133|NCT00162123|582224114|FG006|Overall Study|Not specified (after start of treatment)|0|||
161230134|NCT00162123|582224115|FG007|Overall Study|Not specified (after start of treatment)|0|||
161230135|NCT00162123|582224108|FG000|Overall Study|Physician Decision|1|||
161230136|NCT00162123|582224109|FG001|Overall Study|Physician Decision|2|||
161230137|NCT00162123|582224110|FG002|Overall Study|Physician Decision|0|||
161230138|NCT00162123|582224111|FG003|Overall Study|Physician Decision|0|||
161230139|NCT00162123|582224112|FG004|Overall Study|Physician Decision|0|||
161230140|NCT00162123|582224113|FG005|Overall Study|Physician Decision|1|||
161230141|NCT00162123|582224114|FG006|Overall Study|Physician Decision|1|||
161230142|NCT00162123|582224115|FG007|Overall Study|Physician Decision|0|||
161230143|NCT00162123|582224108|FG000|Overall Study|Tumor assessment only (not treated)|0|||
161230144|NCT00162123|582224109|FG001|Overall Study|Tumor assessment only (not treated)|0|||
161230145|NCT00162123|582224110|FG002|Overall Study|Tumor assessment only (not treated)|0|||
161230146|NCT00162123|582224111|FG003|Overall Study|Tumor assessment only (not treated)|0|||
161230147|NCT00162123|582224112|FG004|Overall Study|Tumor assessment only (not treated)|0|||
161230148|NCT00162123|582224113|FG005|Overall Study|Tumor assessment only (not treated)|0|||
161230149|NCT00162123|582224114|FG006|Overall Study|Tumor assessment only (not treated)|0|||
161230150|NCT00162123|582224115|FG007|Overall Study|Tumor assessment only (not treated)|1|||
161230151|NCT00162123|582224108|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
161230152|NCT00162123|582224109|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
161230153|NCT00162123|582224110|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
161230154|NCT00162123|582224111|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
161230155|NCT00162123|582224112|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
161327109|NCT02797678|582583362|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161327110|NCT02797678|582583363|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161327111|NCT02797678|582583364|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
161327112|NCT02797678|582583365|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
161327113|NCT02401035|582583366|FG000|Overall Study|Withdrawal by Subject|1|||
161327114|NCT02401035|582583367|FG001|Overall Study|Withdrawal by Subject|0|||
161327115|NCT00869128|582583368|FG000|Overall Study|lack of Compliance|6|||
161327116|NCT00869128|582583369|FG001|Overall Study|lack of Compliance|6|||
161327117|NCT02137226|582583370|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
161327118|NCT02137226|582583371|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
161327119|NCT02137226|582583372|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
161327120|NCT02137226|582583373|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
161327121|NCT02137226|582583374|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
161327122|NCT02137226|582583370|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
161327123|NCT02137226|582583371|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
160781581|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
160781582|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
160781583|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
160781584|NCT04676646|580585080|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
160781585|NCT04676646|580585081|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
161230156|NCT00162123|582224113|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
161327124|NCT02137226|582583372|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161327125|NCT02137226|582583373|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161327126|NCT02137226|582583374|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
161327127|NCT02137226|582583370|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
161327128|NCT02137226|582583371|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
161327129|NCT02137226|582583372|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
161327130|NCT02137226|582583373|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
161327131|NCT02137226|582583374|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
161327132|NCT02137226|582583370|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
161327133|NCT02137226|582583371|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
161327134|NCT02137226|582583372|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161327135|NCT02137226|582583373|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161124468|NCT01816243|581841446|FG000|Overall Study|Not eligible for the study|1|||
161124469|NCT01816243|581841446|FG000|Overall Study|Amputation|3|||
161124470|NCT01920711|581841447|FG000|Overall Study|Death|347|||
161124471|NCT01920711|581841448|FG001|Overall Study|Death|356|||
161124472|NCT01920711|581841447|FG000|Overall Study|Lost to Follow-up|13|||
161124473|NCT01920711|581841448|FG001|Overall Study|Lost to Follow-up|14|||
161124474|NCT01920711|581841447|FG000|Overall Study|Withdrawal by Subject|4|||
161124475|NCT01920711|581841448|FG001|Overall Study|Withdrawal by Subject|3|||
161124476|NCT03891901|581841449|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
161124477|NCT03891901|581841450|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124478|NCT03891901|581841451|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124479|NCT03891901|581841452|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124480|NCT03891901|581841453|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124481|NCT03891901|581841454|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124482|NCT03891901|581841455|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124483|NCT03891901|581841456|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124484|NCT03891901|581841457|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
161124485|NCT03891901|581841449|FG000|Overall Study|Adverse Event|2|||
161124486|NCT03891901|581841450|FG001|Overall Study|Adverse Event|2|||
161124487|NCT03891901|581841451|FG002|Overall Study|Adverse Event|0|||
161124488|NCT03891901|581841452|FG003|Overall Study|Adverse Event|0|||
161124489|NCT03891901|581841453|FG004|Overall Study|Adverse Event|0|||
161124490|NCT03891901|581841454|FG005|Overall Study|Adverse Event|0|||
161124491|NCT03891901|581841455|FG006|Overall Study|Adverse Event|0|||
161124492|NCT03891901|581841456|FG007|Overall Study|Adverse Event|0|||
161124493|NCT03891901|581841457|FG008|Overall Study|Adverse Event|0|||
161124494|NCT03891901|581841449|FG000|Overall Study|Poor venous access|1|||
161124495|NCT03891901|581841450|FG001|Overall Study|Poor venous access|0|||
161124496|NCT03891901|581841451|FG002|Overall Study|Poor venous access|0|||
161124497|NCT03891901|581841452|FG003|Overall Study|Poor venous access|0|||
161124498|NCT03891901|581841453|FG004|Overall Study|Poor venous access|0|||
161124499|NCT03891901|581841454|FG005|Overall Study|Poor venous access|0|||
161124500|NCT03891901|581841455|FG006|Overall Study|Poor venous access|0|||
161124501|NCT03891901|581841456|FG007|Overall Study|Poor venous access|0|||
161124502|NCT03891901|581841457|FG008|Overall Study|Poor venous access|0|||
161124503|NCT03891901|581841449|FG000|Overall Study|Withdrawal by Subject|0|||
161124504|NCT03891901|581841450|FG001|Overall Study|Withdrawal by Subject|2|||
161124505|NCT03891901|581841451|FG002|Overall Study|Withdrawal by Subject|0|||
161124506|NCT03891901|581841452|FG003|Overall Study|Withdrawal by Subject|0|||
161124507|NCT03891901|581841453|FG004|Overall Study|Withdrawal by Subject|0|||
161124508|NCT03891901|581841454|FG005|Overall Study|Withdrawal by Subject|0|||
161124509|NCT03891901|581841455|FG006|Overall Study|Withdrawal by Subject|0|||
161124510|NCT03891901|581841456|FG007|Overall Study|Withdrawal by Subject|0|||
161124511|NCT03891901|581841457|FG008|Overall Study|Withdrawal by Subject|0|||
161124512|NCT00573794|581841458|FG000|Overall Study|Adverse Event|81|||
161124513|NCT00573794|581841458|FG000|Overall Study|Withdrew Consent|90|||
161124514|NCT00573794|581841458|FG000|Overall Study|Lost to Follow-up|13|||
161230157|NCT00162123|582224114|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
161230158|NCT00162123|582224115|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
161230159|NCT02016170|582224116|FG000|Overall Study|Adverse Event|1|||
161230160|NCT02016170|582224117|FG001|Overall Study|Adverse Event|1|||
161230161|NCT02016170|582224118|FG002|Overall Study|Adverse Event|0|||
161230162|NCT02016170|582224116|FG000|Overall Study|Protocol Violation|1|||
161230163|NCT02016170|582224117|FG001|Overall Study|Protocol Violation|0|||
161230164|NCT02016170|582224118|FG002|Overall Study|Protocol Violation|0|||
161230165|NCT05214560|582224123|FG000|Overall Study|Screening Failure|1|||
161230166|NCT05214560|582224123|FG000|Overall Study|Physician Decision|4|||
161230167|NCT05214560|582224123|FG000|Overall Study|Withdrawal by Subject|1|||
161230168|NCT05214560|582224123|FG000|Overall Study|Lost to Follow-up|2|||
161230169|NCT05214560|582224123|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
161230170|NCT05214560|582224123|FG000|Overall Study|Study physician not available for the anesthesia|3|||
161230171|NCT05214560|582224123|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
161230172|NCT05214560|582224123|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
161230173|NCT05214560|582224123|FG000|Overall Study|Surgery not performed|3|||
161230174|NCT00408902|582224127|FG000|Overall Study|Lack of Efficacy|7|||
161230175|NCT00408902|582224127|FG000|Overall Study|Adverse Event|3|||
161124515|NCT00573794|581841458|FG000|Overall Study|Protocol Violation|6|||
161124516|NCT00573794|581841458|FG000|Overall Study|Lack of Efficacy|94|||
161124517|NCT00573794|581841458|FG000|Overall Study|Other|46|||
161124518|NCT04202679|581841471|FG000|Overall Study|Adverse Event|2|||
161230176|NCT00878995|582224128|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
161230177|NCT00878995|582224129|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
161230178|NCT03629249|582224130|FG000|Overall Study|Study terminated by sponsor|197|||
161230179|NCT03629249|582224131|FG001|Overall Study|Study terminated by sponsor|197|||
161124519|NCT04202679|581841472|FG001|Overall Study|Adverse Event|0|||
160889544|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
160889545|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
160889546|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
160889547|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
160889548|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
160889549|NCT00586326|580989575|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
160889550|NCT01439347|580989576|FG000|Overall Study|Death|10|||
160889551|NCT01439347|580989577|FG001|Overall Study|Death|9|||
160889552|NCT01439347|580989576|FG000|Overall Study|Withdrawal by Subject|0|||
160889553|NCT01439347|580989577|FG001|Overall Study|Withdrawal by Subject|1|||
160889554|NCT01439347|580989576|FG000|Overall Study|Physician Decision|1|||
160889555|NCT01439347|580989577|FG001|Overall Study|Physician Decision|0|||
160889556|NCT01439347|580989576|FG000|Overall Study|Sponsor Terminated Study|2|||
160889557|NCT01439347|580989577|FG001|Overall Study|Sponsor Terminated Study|3|||
160889558|NCT03595774|580989578|FG000|Overall Study|Adverse Event|1|||
160889559|NCT03595774|580989579|FG001|Overall Study|Adverse Event|0|||
160889560|NCT03595774|580989580|FG002|Overall Study|Adverse Event|1|||
160889561|NCT03595774|580989581|FG003|Overall Study|Adverse Event|0|||
160889562|NCT03595774|580989578|FG000|Overall Study|screen failure|0|||
160889563|NCT03595774|580989579|FG001|Overall Study|screen failure|1|||
160889564|NCT03595774|580989580|FG002|Overall Study|screen failure|0|||
160889565|NCT03595774|580989581|FG003|Overall Study|screen failure|1|||
160889566|NCT03519386|580989586|FG000|Overall Study|Withdrawal by Subject|4|||
160889567|NCT03519386|580989587|FG001|Overall Study|Withdrawal by Subject|1|||
160889568|NCT03519386|580989588|FG002|Overall Study|Withdrawal by Subject|2|||
160889569|NCT03519386|580989586|FG000|Overall Study|Physician Decision|1|||
160889570|NCT03519386|580989587|FG001|Overall Study|Physician Decision|1|||
160889571|NCT03519386|580989588|FG002|Overall Study|Physician Decision|1|||
160889572|NCT03519386|580989586|FG000|Overall Study|Lost to Follow-up|0|||
160889573|NCT03519386|580989587|FG001|Overall Study|Lost to Follow-up|1|||
160889574|NCT03519386|580989588|FG002|Overall Study|Lost to Follow-up|1|||
160889575|NCT03519386|580989586|FG000|Overall Study|Death|1|||
160889576|NCT03519386|580989587|FG001|Overall Study|Death|0|||
160889577|NCT03519386|580989588|FG002|Overall Study|Death|4|||
160889578|NCT03519386|580989586|FG000|Overall Study|Adverse Event|2|||
160889579|NCT03519386|580989587|FG001|Overall Study|Adverse Event|1|||
160981510|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161230180|NCT03629249|582224132|FG002|Overall Study|Study terminated by sponsor|194|||
160781586|NCT04676646|580585082|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
160781587|NCT04270760|580585083|FG000|Overall Study|Withdrawal by Subject|0|||
160781588|NCT04270760|580585084|FG001|Overall Study|Withdrawal by Subject|1|||
160781589|NCT04270760|580585085|FG002|Overall Study|Withdrawal by Subject|3|||
160781590|NCT04270760|580585086|FG003|Overall Study|Withdrawal by Subject|0|||
160781591|NCT04270760|580585087|FG004|Overall Study|Withdrawal by Subject|0|||
160781592|NCT04270760|580585083|FG000|Overall Study|Lost to Follow-up|1|||
160781593|NCT04270760|580585084|FG001|Overall Study|Lost to Follow-up|2|||
160781594|NCT04270760|580585085|FG002|Overall Study|Lost to Follow-up|1|||
160781595|NCT04270760|580585086|FG003|Overall Study|Lost to Follow-up|0|||
160781596|NCT04270760|580585087|FG004|Overall Study|Lost to Follow-up|0|||
160781597|NCT04270760|580585083|FG000|Overall Study|Death|0|||
160781598|NCT04270760|580585084|FG001|Overall Study|Death|0|||
160781599|NCT04270760|580585085|FG002|Overall Study|Death|0|||
160781600|NCT04270760|580585086|FG003|Overall Study|Death|0|||
160781601|NCT04270760|580585087|FG004|Overall Study|Death|1|||
160781602|NCT03670628|580585088|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
160781603|NCT03670628|580585089|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
160781604|NCT03670628|580585088|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
160781605|NCT03670628|580585089|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
160781606|NCT00997126|580585091|FG000|Overall Study|Physician Decision|7|||
160781607|NCT00997126|580585092|FG001|Overall Study|Physician Decision|11|||
160781608|NCT01769443|580585093|FG000|Overall Study|Study closure|1|||
160781609|NCT01769443|580585094|FG001|Overall Study|Study closure|0|||
160781610|NCT00685698|580585095|FG000|Overall Study|Withdrawal by Subject|1|||
160781611|NCT00685698|580585095|FG000|Overall Study|Protocol Violation|6|||
160781612|NCT00685698|580585095|FG000|Overall Study|Adverse Event|3|||
160889580|NCT03519386|580989588|FG002|Overall Study|Adverse Event|2|||
160889581|NCT03519386|580989586|FG000|Overall Study|Explanted|2|||
160889582|NCT03519386|580989587|FG001|Overall Study|Explanted|1|||
160889583|NCT03519386|580989588|FG002|Overall Study|Explanted|0|||
160889584|NCT03519386|580989586|FG000|Overall Study|Ongoing in study|190|||
160889585|NCT03519386|580989587|FG001|Overall Study|Ongoing in study|192|||
160889586|NCT03519386|580989588|FG002|Overall Study|Ongoing in study|183|||
160889587|NCT03101267|580989589|FG000|Primary Study Period|Withdrawal by Subject|1|||
160781613|NCT00685698|580585095|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
160781614|NCT00685698|580585095|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
161327136|NCT02137226|582583374|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
161327137|NCT02137226|582583370|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
161327138|NCT02137226|582583371|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161327139|NCT02137226|582583372|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161327140|NCT02137226|582583373|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161327141|NCT02137226|582583374|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
161327142|NCT02137226|582583370|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
161327143|NCT02137226|582583371|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
161327144|NCT02137226|582583372|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
161327145|NCT02137226|582583373|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
161327146|NCT02137226|582583374|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
161327147|NCT02137226|582583370|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
161327148|NCT02137226|582583371|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
161327149|NCT02137226|582583372|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
161327150|NCT02137226|582583373|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
161327151|NCT02137226|582583374|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
161327152|NCT02137226|582583370|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
161327153|NCT02137226|582583371|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
161327154|NCT02137226|582583372|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
161327155|NCT02137226|582583373|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
161327156|NCT02137226|582583374|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
161327157|NCT02137226|582583370|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
161327158|NCT02137226|582583371|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
161327159|NCT02137226|582583372|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
161327160|NCT02137226|582583373|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
161327161|NCT02137226|582583374|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
161327162|NCT02137226|582583370|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161327163|NCT02137226|582583371|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161327164|NCT02137226|582583372|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
161327165|NCT02137226|582583373|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161327166|NCT02137226|582583374|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
161327167|NCT02137226|582583370|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161327168|NCT02137226|582583371|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161327169|NCT02137226|582583372|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
161327170|NCT02137226|582583373|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161327171|NCT02137226|582583374|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
161327172|NCT02137226|582583370|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
161327173|NCT02137226|582583371|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
161327174|NCT02137226|582583372|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
161327175|NCT02137226|582583373|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
161327176|NCT02137226|582583374|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
161327177|NCT00985686|582583376|FG000|Overall Study|Lost to Follow-up|1|||
161327178|NCT00985686|582583377|FG001|Overall Study|Lost to Follow-up|1|||
161327179|NCT00985686|582583378|FG002|Overall Study|Lost to Follow-up|0|||
161327180|NCT00985686|582583379|FG003|Overall Study|Lost to Follow-up|2|||
161327181|NCT03134911|582583380|FG000|Overall Study|Screen failure|31|||
161327182|NCT03134911|582583380|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
161327183|NCT03472521|582583383|FG000|Overall Study|Lost to Follow-up|3|||
161230181|NCT03629249|582224130|FG000|Overall Study|Protocol deviation|0|||
161230182|NCT03629249|582224131|FG001|Overall Study|Protocol deviation|2|||
160889588|NCT03101267|580989590|FG001|Primary Study Period|Withdrawal by Subject|2|||
160889589|NCT03101267|580989591|FG002|Primary Study Period|Withdrawal by Subject|3|||
160889590|NCT03101267|580989589|FG000|Primary Study Period|Miscellaneous|2|||
160889591|NCT03101267|580989590|FG001|Primary Study Period|Miscellaneous|0|||
160889592|NCT03101267|580989591|FG002|Primary Study Period|Miscellaneous|0|||
161230183|NCT03629249|582224132|FG002|Overall Study|Protocol deviation|5|||
161230184|NCT03629249|582224130|FG000|Overall Study|Subject decision|1|||
161230185|NCT03629249|582224131|FG001|Overall Study|Subject decision|1|||
161230186|NCT03629249|582224132|FG002|Overall Study|Subject decision|3|||
161230187|NCT03629249|582224130|FG000|Overall Study|Adverse Event|1|||
161230188|NCT03629249|582224131|FG001|Overall Study|Adverse Event|1|||
161230189|NCT03629249|582224132|FG002|Overall Study|Adverse Event|0|||
160889593|NCT00484185|580989594|FG000|Overall Study|Lost to Follow-up|44|||
161230190|NCT03629249|582224130|FG000|Overall Study|Death|1|||
160889594|NCT00484185|580989594|FG000|Overall Study|Other|20|||
161230191|NCT03629249|582224131|FG001|Overall Study|Death|0|||
161230192|NCT03629249|582224132|FG002|Overall Study|Death|0|||
161230193|NCT03629249|582224130|FG000|Overall Study|Physician Decision|1|||
160889595|NCT00484185|580989594|FG000|Overall Study|Randomized but not treated|5|||
160889596|NCT00484185|580989594|FG000|Overall Study|Death|2|||
161230194|NCT03629249|582224131|FG001|Overall Study|Physician Decision|0|||
161230195|NCT03629249|582224132|FG002|Overall Study|Physician Decision|0|||
161230196|NCT00352690|582224133|FG000|Overall Study|Determined to be ineligible|2|||
160781615|NCT00685698|580585095|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
160781616|NCT03412890|580585096|FG000|Overall Study|Adverse Event|5|||
160781617|NCT03412890|580585097|FG001|Overall Study|Adverse Event|5|||
160781618|NCT03412890|580585098|FG002|Overall Study|Adverse Event|9|||
160781619|NCT03412890|580585096|FG000|Overall Study|Protocol deviation|2|||
160781620|NCT03412890|580585097|FG001|Overall Study|Protocol deviation|1|||
160781621|NCT03412890|580585098|FG002|Overall Study|Protocol deviation|2|||
160781622|NCT03412890|580585096|FG000|Overall Study|Lost to Follow-up|7|||
160781623|NCT03412890|580585097|FG001|Overall Study|Lost to Follow-up|10|||
160781624|NCT03412890|580585098|FG002|Overall Study|Lost to Follow-up|10|||
160781625|NCT03412890|580585096|FG000|Overall Study|Withdrawal by Subject|9|||
160781626|NCT03412890|580585097|FG001|Overall Study|Withdrawal by Subject|12|||
160781627|NCT03412890|580585098|FG002|Overall Study|Withdrawal by Subject|11|||
160781628|NCT03412890|580585096|FG000|Overall Study|Lack of Efficacy|2|||
160781629|NCT03412890|580585097|FG001|Overall Study|Lack of Efficacy|7|||
160781630|NCT03412890|580585098|FG002|Overall Study|Lack of Efficacy|5|||
160781631|NCT03412890|580585096|FG000|Overall Study|Other|5|||
160781632|NCT03412890|580585097|FG001|Overall Study|Other|6|||
160781633|NCT03412890|580585098|FG002|Overall Study|Other|5|||
160781634|NCT03412890|580585096|FG000|Overall Study|Participants who did not receive any study drug|0|||
160781635|NCT03412890|580585097|FG001|Overall Study|Participants who did not receive any study drug|1|||
160781636|NCT03412890|580585098|FG002|Overall Study|Participants who did not receive any study drug|0|||
160781637|NCT02583477|580585099|FG000|Overall Study|Adverse Event|0|||
160781638|NCT02583477|580585100|FG001|Overall Study|Adverse Event|2|||
160781639|NCT02583477|580585099|FG000|Overall Study|Death|1|||
160781640|NCT02583477|580585100|FG001|Overall Study|Death|16|||
160781641|NCT02583477|580585099|FG000|Overall Study|Study terminated|2|||
160781642|NCT02583477|580585100|FG001|Overall Study|Study terminated|2|||
160781643|NCT05507450|580585101|FG000|Overall Study|Death|0|||
160781644|NCT05507450|580585102|FG001|Overall Study|Death|0|||
160781645|NCT05507450|580585103|FG002|Overall Study|Death|1|||
160781646|NCT05507450|580585104|FG003|Overall Study|Death|0|||
160781647|NCT05507450|580585101|FG000|Overall Study|Lost to Follow-up|22|||
160781648|NCT05507450|580585102|FG001|Overall Study|Lost to Follow-up|20|||
160781649|NCT05507450|580585103|FG002|Overall Study|Lost to Follow-up|20|||
160781650|NCT05507450|580585104|FG003|Overall Study|Lost to Follow-up|7|||
160781651|NCT05507450|580585101|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160781652|NCT05507450|580585102|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160781653|NCT05507450|580585103|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160781654|NCT05507450|580585104|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160781655|NCT05507450|580585101|FG000|Overall Study|Withdrawal by Subject|4|||
160781656|NCT05507450|580585102|FG001|Overall Study|Withdrawal by Subject|11|||
160781657|NCT05507450|580585103|FG002|Overall Study|Withdrawal by Subject|7|||
160781658|NCT05507450|580585104|FG003|Overall Study|Withdrawal by Subject|3|||
160781659|NCT05507450|580585101|FG000|Overall Study|Participant left the country|0|||
160781660|NCT05507450|580585102|FG001|Overall Study|Participant left the country|0|||
160781661|NCT05507450|580585103|FG002|Overall Study|Participant left the country|1|||
160781662|NCT05507450|580585104|FG003|Overall Study|Participant left the country|0|||
160781663|NCT05436288|580585105|FG000|Overall Study|Lost to Follow-up|1|||
160781664|NCT05436288|580585105|FG000|Overall Study|Adverse Event|1|||
160781665|NCT03767894|580585108|FG000|Overall Study|Withdrawal by Subject|1|||
160781666|NCT00387127|580585109|FG000|Overall Study|Lost to Follow-up|0|||
160781667|NCT00387127|580585110|FG001|Overall Study|Lost to Follow-up|4|||
160781668|NCT00387127|580585109|FG000|Overall Study|Death|16|||
160781669|NCT00387127|580585110|FG001|Overall Study|Death|16|||
160781670|NCT00387127|580585109|FG000|Overall Study|Physician Decision|0|||
160781671|NCT00387127|580585110|FG001|Overall Study|Physician Decision|1|||
160781672|NCT00387127|580585109|FG000|Overall Study|Withdrawal by Subject|3|||
160781673|NCT00387127|580585110|FG001|Overall Study|Withdrawal by Subject|2|||
160781674|NCT00387127|580585109|FG000|Overall Study|Required by Protocol Amendment #4|12|||
160781675|NCT00387127|580585110|FG001|Overall Study|Required by Protocol Amendment #4|10|||
160781676|NCT00387127|580585109|FG000|Overall Study|Serious Adverse Event|1|||
160781677|NCT00387127|580585110|FG001|Overall Study|Serious Adverse Event|1|||
160781678|NCT00387127|580585109|FG000|Overall Study|Sponsor Unblinded|1|||
160781679|NCT00387127|580585110|FG001|Overall Study|Sponsor Unblinded|0|||
160781680|NCT04149353|580585111|FG000|Overall Study|Study terminated|1|||
160781681|NCT01871727|580585112|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
160781682|NCT01871727|580585113|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
160781683|NCT01871727|580585114|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
160781684|NCT01871727|580585115|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
160781685|NCT01871727|580585116|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
161124520|NCT04202679|581841471|FG000|Overall Study|Poor compliance to protocol|1|||
161124521|NCT04202679|581841472|FG001|Overall Study|Poor compliance to protocol|0|||
160781686|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
160781687|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
160781688|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
161124522|NCT04202679|581841471|FG000|Overall Study|Withdrawal by Subject|23|||
161124523|NCT04202679|581841472|FG001|Overall Study|Withdrawal by Subject|6|||
160889597|NCT01222403|580989597|FG000|Overall Study|Inappropriate enrollment|0|||
160889598|NCT01222403|580989598|FG001|Overall Study|Inappropriate enrollment|2|||
160889599|NCT02068768|580989599|FG000|Overall Study|Lost to Follow-up|5|||
160889600|NCT02068768|580989599|FG000|Overall Study|Early Termination by Sponsor|2|||
160889601|NCT00555425|580989600|FG000|Overall Study|Missed Medication > 1 wk|34|||
160889602|NCT00555425|580989601|FG001|Overall Study|Missed Medication > 1 wk|15|||
160889603|NCT00555425|580989600|FG000|Overall Study|Missed 3 physician management visits|1|||
160889604|NCT00555425|580989601|FG001|Overall Study|Missed 3 physician management visits|0|||
160889605|NCT00555425|580989600|FG000|Overall Study|Met criteria for protective transfer|16|||
160889606|NCT00555425|580989601|FG001|Overall Study|Met criteria for protective transfer|3|||
160889607|NCT00555425|580989600|FG000|Overall Study|Became pregnant and transferred care|0|||
160889608|NCT00555425|580989601|FG001|Overall Study|Became pregnant and transferred care|1|||
160889609|NCT01262352|580989602|FG000|Period 1|Illness after randomization|1|||
160889610|NCT01262352|580989603|FG001|Period 1|Illness after randomization|0|||
160889611|NCT01262352|580989602|FG000|Washout|Adverse Event|1|||
160889612|NCT01262352|580989603|FG001|Washout|Adverse Event|1|||
160889613|NCT01262352|580989602|FG000|Washout|Extended Washout|0|||
160889614|NCT01262352|580989603|FG001|Washout|Extended Washout|1|||
160889615|NCT01298193|580989604|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
160889616|NCT01298193|580989604|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
160889617|NCT01298193|580989604|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
160889618|NCT01298193|580989604|FG000|Efficacy Phase (Second Cycle)|Death|1|||
160889619|NCT00913692|580989606|FG000|Screening (4 Months)|Physician Decision|3|||
160889620|NCT00913692|580989606|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
160889621|NCT00913692|580989606|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
160889622|NCT01975831|580989607|FG000|Overall Study|Adverse Event|1|||
160889623|NCT01975831|580989608|FG001|Overall Study|Adverse Event|2|||
160889624|NCT01975831|580989609|FG002|Overall Study|Adverse Event|2|||
160889625|NCT01975831|580989610|FG003|Overall Study|Adverse Event|0|||
160889626|NCT01975831|580989611|FG004|Overall Study|Adverse Event|1|||
160889627|NCT01975831|580989612|FG005|Overall Study|Adverse Event|1|||
160889628|NCT01975831|580989613|FG006|Overall Study|Adverse Event|3|||
160889629|NCT01975831|580989614|FG007|Overall Study|Adverse Event|4|||
160889630|NCT01975831|580989615|FG008|Overall Study|Adverse Event|1|||
160889631|NCT01975831|580989607|FG000|Overall Study|Death|1|||
161230197|NCT00352690|582224134|FG001|Overall Study|Determined to be ineligible|0|||
161230198|NCT03633721|582224137|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
161230199|NCT03633721|582224138|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
161230200|NCT03633721|582224139|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
161230201|NCT03633721|582224140|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
161230202|NCT01475474|582224144|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
161230203|NCT01475474|582224144|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
161230204|NCT02343120|582224145|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
161230205|NCT02343120|582224146|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
161230206|NCT02343120|582224147|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
161230207|NCT02343120|582224148|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
161230208|NCT02343120|582224149|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
161230209|NCT02343120|582224145|FG000|Part 1: Dose Escalation|Death|1|||
161230210|NCT02343120|582224146|FG001|Part 1: Dose Escalation|Death|2|||
161230211|NCT02343120|582224147|FG002|Part 1: Dose Escalation|Death|2|||
161230212|NCT02343120|582224148|FG003|Part 1: Dose Escalation|Death|2|||
161230213|NCT02343120|582224149|FG004|Part 1: Dose Escalation|Death|1|||
161230214|NCT02343120|582224145|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
161230215|NCT02343120|582224146|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161230216|NCT02343120|582224147|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161327184|NCT03472521|582583384|FG001|Overall Study|Lost to Follow-up|2|||
161124524|NCT05902364|581841473|FG000|Overall Study|Adverse Event|1|||
161124525|NCT05902364|581841474|FG001|Overall Study|Adverse Event|0|||
161124526|NCT02270242|581841475|FG000|Overall Study|Withdrawal by Subject|18|||
161124527|NCT02270242|581841476|FG001|Overall Study|Withdrawal by Subject|25|||
161124528|NCT02270242|581841475|FG000|Overall Study|Lost to Follow-up|41|||
161124529|NCT02270242|581841476|FG001|Overall Study|Lost to Follow-up|27|||
161124530|NCT02270242|581841475|FG000|Overall Study|Physician Decision|0|||
161124531|NCT02270242|581841476|FG001|Overall Study|Physician Decision|1|||
161230217|NCT02343120|582224148|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161230218|NCT02343120|582224149|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161230219|NCT02343120|582224145|FG000|Part 2: Expansion|Sponsor decision|0|||
161230220|NCT02343120|582224146|FG001|Part 2: Expansion|Sponsor decision|0|||
161230221|NCT02343120|582224147|FG002|Part 2: Expansion|Sponsor decision|0|||
161230222|NCT02343120|582224148|FG003|Part 2: Expansion|Sponsor decision|165|||
161124532|NCT03864653|581841477|FG000|Overall Study|Withdrawal by Subject|1|||
161124533|NCT00429585|581841478|FG000|Overall Study|Death|1|||
161230223|NCT02343120|582224149|FG004|Part 2: Expansion|Sponsor decision|67|||
160781689|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
160781690|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
160781691|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781692|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781693|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781694|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
160781695|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
160781696|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781697|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781698|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781699|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
160781700|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
160781701|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781702|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781703|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781704|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
160781705|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
160781706|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781707|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781708|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781709|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
160781710|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
160781711|NCT01871727|580585112|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781712|NCT01871727|580585113|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781713|NCT01871727|580585114|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781714|NCT01871727|580585115|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
160781715|NCT01871727|580585116|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
160781716|NCT00002874|580585119|FG000|Overall Study|Withdrawal by Subject|1|||
160781717|NCT00002874|580585120|FG001|Overall Study|Withdrawal by Subject|1|||
160781718|NCT00002874|580585119|FG000|Overall Study|Protocol Violation|44|||
160781719|NCT00002874|580585120|FG001|Overall Study|Protocol Violation|34|||
160781720|NCT01397747|580585137|FG000|Overall Study|Multitarget DNA test excluded|689|||
160781721|NCT01397747|580585137|FG000|Overall Study|Colonoscopy excluded|304|||
160781722|NCT01397747|580585137|FG000|Overall Study|FIT excluded|34|||
160781723|NCT03828383|580585140|FG000|Overall Study|Lost to Follow-up|3|||
160781724|NCT03828383|580585141|FG001|Overall Study|Lost to Follow-up|2|||
160781725|NCT03828383|580585140|FG000|Overall Study|Withdrawal by Subject|4|||
160781726|NCT03828383|580585141|FG001|Overall Study|Withdrawal by Subject|5|||
160781727|NCT00504309|580585143|FG000|Overall Study|Death|0|||
160781728|NCT00504309|580585144|FG001|Overall Study|Death|0|||
160889632|NCT01975831|580989608|FG001|Overall Study|Death|1|||
160889633|NCT01975831|580989609|FG002|Overall Study|Death|0|||
160889634|NCT01975831|580989610|FG003|Overall Study|Death|0|||
160889635|NCT01975831|580989611|FG004|Overall Study|Death|1|||
160889636|NCT01975831|580989612|FG005|Overall Study|Death|0|||
160889637|NCT01975831|580989613|FG006|Overall Study|Death|1|||
160889638|NCT01975831|580989614|FG007|Overall Study|Death|0|||
161124534|NCT00429585|581841479|FG001|Overall Study|Death|0|||
161124535|NCT00429585|581841478|FG000|Overall Study|Lost to Follow-up|27|||
161124536|NCT00429585|581841479|FG001|Overall Study|Lost to Follow-up|20|||
161124537|NCT00429585|581841478|FG000|Overall Study|Physician Decision|2|||
161124538|NCT00429585|581841479|FG001|Overall Study|Physician Decision|0|||
161124539|NCT01227902|581843721|FG000|Overall Study|Adverse Event|12|||
161124540|NCT01227902|581843722|FG001|Overall Study|Adverse Event|8|||
161124541|NCT01227902|581843723|FG002|Overall Study|Adverse Event|11|||
161124542|NCT01227902|581843724|FG003|Overall Study|Adverse Event|4|||
161124543|NCT01227902|581843721|FG000|Overall Study|Lack of Efficacy|1|||
161124544|NCT01227902|581843722|FG001|Overall Study|Lack of Efficacy|2|||
161124545|NCT01227902|581843723|FG002|Overall Study|Lack of Efficacy|2|||
161124546|NCT01227902|581843724|FG003|Overall Study|Lack of Efficacy|1|||
161124547|NCT01227902|581843721|FG000|Overall Study|Protocol Violation|1|||
161124548|NCT01227902|581843722|FG001|Overall Study|Protocol Violation|0|||
161124549|NCT01227902|581843723|FG002|Overall Study|Protocol Violation|0|||
161124550|NCT01227902|581843724|FG003|Overall Study|Protocol Violation|0|||
161124551|NCT01227902|581843721|FG000|Overall Study|Lost to Follow-up|0|||
161124552|NCT01227902|581843722|FG001|Overall Study|Lost to Follow-up|0|||
161124553|NCT01227902|581843723|FG002|Overall Study|Lost to Follow-up|1|||
161124554|NCT01227902|581843724|FG003|Overall Study|Lost to Follow-up|2|||
161124555|NCT01227902|581843721|FG000|Overall Study|Physician Decision|0|||
161124556|NCT01227902|581843722|FG001|Overall Study|Physician Decision|1|||
161124557|NCT01227902|581843723|FG002|Overall Study|Physician Decision|1|||
161124558|NCT01227902|581843724|FG003|Overall Study|Physician Decision|0|||
161124559|NCT01227902|581843721|FG000|Overall Study|Withdrawal by Subject|4|||
161124560|NCT01227902|581843722|FG001|Overall Study|Withdrawal by Subject|2|||
161124561|NCT01227902|581843723|FG002|Overall Study|Withdrawal by Subject|4|||
161327185|NCT03472521|582583383|FG000|Overall Study|Discontinued intervention|3|||
161327186|NCT03472521|582583384|FG001|Overall Study|Discontinued intervention|1|||
161327187|NCT01237327|582583385|FG000|Overall Study|Protocol Violation: Core Study|1|||
161327188|NCT01237327|582583386|FG001|Overall Study|Protocol Violation: Core Study|0|||
161327189|NCT01237327|582583385|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
161327190|NCT01237327|582583386|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
161327191|NCT01237327|582583385|FG000|Overall Study|Progression of Disease: Core Study|18|||
161327192|NCT01237327|582583386|FG001|Overall Study|Progression of Disease: Core Study|22|||
161327193|NCT01237327|582583385|FG000|Overall Study|Progression of Disease: Extension Study|15|||
161327194|NCT01237327|582583386|FG001|Overall Study|Progression of Disease: Extension Study|13|||
161327195|NCT01237327|582583385|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
161327196|NCT01237327|582583386|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
161327197|NCT01237327|582583385|FG000|Overall Study|Withdrawal by Subject|1|||
161327198|NCT01237327|582583386|FG001|Overall Study|Withdrawal by Subject|3|||
161327199|NCT01237327|582583385|FG000|Overall Study|Lost to Follow-up|3|||
161327200|NCT01237327|582583386|FG001|Overall Study|Lost to Follow-up|0|||
161327201|NCT02358031|582585312|FG000|Overall Study|Death|253|||
161327202|NCT02358031|582585313|FG001|Overall Study|Death|237|||
161327203|NCT02358031|582585314|FG002|Overall Study|Death|266|||
161327204|NCT02358031|582585312|FG000|Overall Study|Lost to Follow-up|1|||
161327205|NCT02358031|582585313|FG001|Overall Study|Lost to Follow-up|1|||
161327206|NCT02358031|582585314|FG002|Overall Study|Lost to Follow-up|0|||
161327207|NCT02358031|582585312|FG000|Overall Study|Withdrawal by Subject|19|||
161327208|NCT02358031|582585313|FG001|Overall Study|Withdrawal by Subject|14|||
161327209|NCT02358031|582585314|FG002|Overall Study|Withdrawal by Subject|18|||
161327210|NCT02358031|582585312|FG000|Overall Study|Sponsor Decision|26|||
161327211|NCT02358031|582585313|FG001|Overall Study|Sponsor Decision|28|||
161327212|NCT02358031|582585314|FG002|Overall Study|Sponsor Decision|16|||
161327213|NCT00823134|582585321|FG000|Overall Study|Invalid measurement|1|||
161327214|NCT01325350|582585328|FG000|Overall Study|Adverse Event|3|||
161327215|NCT01325350|582585329|FG001|Overall Study|Adverse Event|3|||
161327216|NCT01325350|582585330|FG002|Overall Study|Adverse Event|3|||
161327217|NCT01325350|582585331|FG003|Overall Study|Adverse Event|1|||
161327218|NCT01325350|582585332|FG004|Overall Study|Adverse Event|2|||
161327219|NCT01325350|582585328|FG000|Overall Study|Pregnancy|0|||
161327220|NCT01325350|582585329|FG001|Overall Study|Pregnancy|0|||
161327221|NCT01325350|582585330|FG002|Overall Study|Pregnancy|1|||
161327222|NCT01325350|582585331|FG003|Overall Study|Pregnancy|0|||
161327223|NCT01325350|582585332|FG004|Overall Study|Pregnancy|1|||
161327224|NCT01325350|582585328|FG000|Overall Study|Lost to Follow-up|1|||
161327225|NCT01325350|582585329|FG001|Overall Study|Lost to Follow-up|0|||
161327226|NCT01325350|582585330|FG002|Overall Study|Lost to Follow-up|5|||
161327227|NCT01325350|582585331|FG003|Overall Study|Lost to Follow-up|1|||
161327228|NCT01325350|582585332|FG004|Overall Study|Lost to Follow-up|5|||
161327229|NCT01325350|582585328|FG000|Overall Study|Personal Reasons|2|||
161327230|NCT01325350|582585329|FG001|Overall Study|Personal Reasons|1|||
161327231|NCT01325350|582585330|FG002|Overall Study|Personal Reasons|6|||
160889639|NCT01975831|580989615|FG008|Overall Study|Death|0|||
160889640|NCT01975831|580989607|FG000|Overall Study|Progressive Disease|1|||
160889641|NCT01975831|580989608|FG001|Overall Study|Progressive Disease|3|||
160889642|NCT01975831|580989609|FG002|Overall Study|Progressive Disease|2|||
160889643|NCT01975831|580989610|FG003|Overall Study|Progressive Disease|4|||
160889644|NCT01975831|580989611|FG004|Overall Study|Progressive Disease|13|||
160889645|NCT01975831|580989612|FG005|Overall Study|Progressive Disease|9|||
160889646|NCT01975831|580989613|FG006|Overall Study|Progressive Disease|10|||
160889647|NCT01975831|580989614|FG007|Overall Study|Progressive Disease|8|||
160889648|NCT01975831|580989615|FG008|Overall Study|Progressive Disease|10|||
160889649|NCT01975831|580989607|FG000|Overall Study|Withdrawal by Subject|0|||
160889650|NCT01975831|580989608|FG001|Overall Study|Withdrawal by Subject|3|||
160889651|NCT01975831|580989609|FG002|Overall Study|Withdrawal by Subject|0|||
160889652|NCT01975831|580989610|FG003|Overall Study|Withdrawal by Subject|0|||
160889653|NCT01975831|580989611|FG004|Overall Study|Withdrawal by Subject|3|||
160889654|NCT01975831|580989612|FG005|Overall Study|Withdrawal by Subject|1|||
160889655|NCT01975831|580989613|FG006|Overall Study|Withdrawal by Subject|1|||
160889656|NCT01975831|580989614|FG007|Overall Study|Withdrawal by Subject|0|||
160889657|NCT01975831|580989615|FG008|Overall Study|Withdrawal by Subject|0|||
160889658|NCT01975831|580989607|FG000|Overall Study|Physician Decision|0|||
160889659|NCT01975831|580989608|FG001|Overall Study|Physician Decision|0|||
160889660|NCT01975831|580989609|FG002|Overall Study|Physician Decision|0|||
160889661|NCT01975831|580989610|FG003|Overall Study|Physician Decision|0|||
160889662|NCT01975831|580989611|FG004|Overall Study|Physician Decision|0|||
160889663|NCT01975831|580989612|FG005|Overall Study|Physician Decision|1|||
160889664|NCT01975831|580989613|FG006|Overall Study|Physician Decision|0|||
160889665|NCT01975831|580989614|FG007|Overall Study|Physician Decision|1|||
161327232|NCT01325350|582585331|FG003|Overall Study|Personal Reasons|5|||
161327233|NCT01325350|582585332|FG004|Overall Study|Personal Reasons|3|||
161327234|NCT01325350|582585328|FG000|Overall Study|Protocol Violation|0|||
161327235|NCT01325350|582585329|FG001|Overall Study|Protocol Violation|0|||
161327236|NCT01325350|582585330|FG002|Overall Study|Protocol Violation|0|||
160781729|NCT00504309|580585145|FG002|Overall Study|Death|0|||
160781730|NCT00504309|580585146|FG003|Overall Study|Death|0|||
160781731|NCT00504309|580585147|FG004|Overall Study|Death|1|||
160781732|NCT00504309|580585148|FG005|Overall Study|Death|0|||
160781733|NCT00504309|580585143|FG000|Overall Study|Withdrawal by Subject|0|||
160781734|NCT00504309|580585144|FG001|Overall Study|Withdrawal by Subject|0|||
160781735|NCT00504309|580585145|FG002|Overall Study|Withdrawal by Subject|1|||
160781736|NCT00504309|580585146|FG003|Overall Study|Withdrawal by Subject|0|||
160781737|NCT00504309|580585147|FG004|Overall Study|Withdrawal by Subject|0|||
160781738|NCT00504309|580585148|FG005|Overall Study|Withdrawal by Subject|0|||
160781739|NCT03022630|580587145|FG000|Overall Study|Death|9|||
160781740|NCT03022630|580587146|FG001|Overall Study|Death|7|||
160781741|NCT03022630|580587145|FG000|Overall Study|Withdrawal by Subject|0|||
160781742|NCT03022630|580587146|FG001|Overall Study|Withdrawal by Subject|5|||
160781743|NCT00382070|580587147|FG000|Overall Study|No follow up data mapped to Other|17|||
160781744|NCT00382070|580587148|FG001|Overall Study|No follow up data mapped to Other|19|||
160781745|NCT00382070|580587147|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
160781746|NCT00382070|580587148|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
160781747|NCT00382070|580587147|FG000|Overall Study|No clinical assessment|9|||
160781748|NCT00382070|580587148|FG001|Overall Study|No clinical assessment|11|||
160781749|NCT01734928|580587149|FG000|Randomization|Physician Decision|0|||
160781750|NCT01734928|580587150|FG001|Randomization|Physician Decision|1|||
160781751|NCT01734928|580587149|FG000|Randomization|clinical progression|0|||
160781752|NCT01734928|580587150|FG001|Randomization|clinical progression|1|||
160781753|NCT01734928|580587149|FG000|Randomization|progressive disease|0|||
160781754|NCT01734928|580587150|FG001|Randomization|progressive disease|2|||
160781755|NCT01734928|580587149|FG000|Randomization|Withdrew informed consent|0|||
160781756|NCT01734928|580587150|FG001|Randomization|Withdrew informed consent|4|||
160781757|NCT01734928|580587149|FG000|Randomization|Death|1|||
160781758|NCT01734928|580587150|FG001|Randomization|Death|0|||
160781759|NCT01734928|580587149|FG000|Randomization|Randomization error|1|||
160781760|NCT01734928|580587150|FG001|Randomization|Randomization error|0|||
160781761|NCT01734928|580587149|FG000|Randomization|Lost to Follow-up|1|||
160781762|NCT01734928|580587150|FG001|Randomization|Lost to Follow-up|0|||
160781763|NCT01734928|580587149|FG000|Treatment Period|Lost to Follow-up|0|||
161327237|NCT01325350|582585331|FG003|Overall Study|Protocol Violation|1|||
161124562|NCT01227902|581843724|FG003|Overall Study|Withdrawal by Subject|3|||
161124563|NCT02363478|581843729|FG000|Overall Study|Lost to Follow-up|4|||
161124564|NCT02363478|581843729|FG000|Overall Study|Adverse Event|4|||
161124565|NCT01916980|581843733|FG000|Overall Study|Adverse Event|4|||
161327238|NCT01325350|582585332|FG004|Overall Study|Protocol Violation|0|||
161327239|NCT01325350|582585328|FG000|Overall Study|Withdrawal by Subject|0|||
161327240|NCT01325350|582585329|FG001|Overall Study|Withdrawal by Subject|0|||
161327241|NCT01325350|582585330|FG002|Overall Study|Withdrawal by Subject|1|||
161327242|NCT01325350|582585331|FG003|Overall Study|Withdrawal by Subject|1|||
161327243|NCT01325350|582585332|FG004|Overall Study|Withdrawal by Subject|0|||
161327244|NCT01325350|582585328|FG000|Overall Study|Did Not Receive Treatment|0|||
161327245|NCT01325350|582585329|FG001|Overall Study|Did Not Receive Treatment|1|||
161327246|NCT01325350|582585330|FG002|Overall Study|Did Not Receive Treatment|1|||
161327247|NCT01325350|582585331|FG003|Overall Study|Did Not Receive Treatment|0|||
161327248|NCT01325350|582585332|FG004|Overall Study|Did Not Receive Treatment|1|||
161327249|NCT00956839|582585333|FG000|Overall Study|Lost to Follow-up|3|||
161327250|NCT00956839|582585334|FG001|Overall Study|Lost to Follow-up|0|||
161327251|NCT00956839|582585335|FG002|Overall Study|Lost to Follow-up|3|||
161327252|NCT02692586|582585336|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
161327253|NCT02692586|582585336|FG000|Overall Study|Received adjunctive thrombolytics|2|||
161327254|NCT03316586|582585344|FG000|Overall Study|Adverse Event|2|||
160781764|NCT01734928|580587150|FG001|Treatment Period|Lost to Follow-up|2|||
160781765|NCT01734928|580587149|FG000|Treatment Period|Progressive Disease|167|||
161124566|NCT01916980|581843734|FG001|Overall Study|Adverse Event|2|||
161124567|NCT01916980|581843733|FG000|Overall Study|Lack of Efficacy|2|||
161124568|NCT01916980|581843734|FG001|Overall Study|Lack of Efficacy|2|||
161124569|NCT01916980|581843733|FG000|Overall Study|Withdrawal by Subject|1|||
161124570|NCT01916980|581843734|FG001|Overall Study|Withdrawal by Subject|0|||
161124571|NCT00546364|581843735|FG000|Overall Study|Disease progression|5|||
161124572|NCT00546364|581843736|FG001|Overall Study|Disease progression|11|||
161124573|NCT00546364|581843737|FG002|Overall Study|Disease progression|8|||
161124574|NCT00546364|581843735|FG000|Overall Study|Completed and off treatment|1|||
161124575|NCT00546364|581843736|FG001|Overall Study|Completed and off treatment|0|||
161327255|NCT03316586|582585344|FG000|Overall Study|Physician Decision|3|||
161327256|NCT03316586|582585344|FG000|Overall Study|Lack of Efficacy|10|||
161327257|NCT03316586|582585344|FG000|Overall Study|still on treatment|1|||
160781766|NCT01734928|580587150|FG001|Treatment Period|Progressive Disease|165|||
160781767|NCT01734928|580587149|FG000|Treatment Period|Adverse Event|39|||
160781768|NCT01734928|580587150|FG001|Treatment Period|Adverse Event|52|||
160781769|NCT01734928|580587149|FG000|Treatment Period|Withdrawal of Consent|25|||
160781770|NCT01734928|580587150|FG001|Treatment Period|Withdrawal of Consent|22|||
160781771|NCT01734928|580587149|FG000|Treatment Period|Death|20|||
160781772|NCT01734928|580587150|FG001|Treatment Period|Death|9|||
160781773|NCT01734928|580587149|FG000|Treatment Period|Other Reasons|27|||
160781774|NCT01734928|580587150|FG001|Treatment Period|Other Reasons|19|||
160781775|NCT01734928|580587149|FG000|Treatment Period|Pregnancy|0|||
160781776|NCT01734928|580587150|FG001|Treatment Period|Pregnancy|1|||
160781777|NCT01629563|580587151|FG000|Overall Study|Adverse Event|16|||
160781778|NCT01629563|580587152|FG001|Overall Study|Adverse Event|16|||
160781779|NCT01629563|580587151|FG000|Overall Study|Death|2|||
160781780|NCT01629563|580587152|FG001|Overall Study|Death|0|||
160781781|NCT01629563|580587151|FG000|Overall Study|Lack of Efficacy|2|||
160781782|NCT01629563|580587152|FG001|Overall Study|Lack of Efficacy|3|||
160781783|NCT01629563|580587151|FG000|Overall Study|Lost to Follow-up|1|||
160781784|NCT01629563|580587152|FG001|Overall Study|Lost to Follow-up|0|||
160781785|NCT01629563|580587151|FG000|Overall Study|Pregnancy|1|||
160781786|NCT01629563|580587152|FG001|Overall Study|Pregnancy|2|||
160781787|NCT01629563|580587151|FG000|Overall Study|Protocol Violation|0|||
160781788|NCT01629563|580587152|FG001|Overall Study|Protocol Violation|1|||
160781789|NCT01629563|580587151|FG000|Overall Study|Withdrawal by Subject|27|||
160781790|NCT01629563|580587152|FG001|Overall Study|Withdrawal by Subject|20|||
160781791|NCT01629563|580587151|FG000|Overall Study|surgery|0|||
160781792|NCT01629563|580587152|FG001|Overall Study|surgery|3|||
160781793|NCT01629563|580587151|FG000|Overall Study|Lack of return of menses|12|||
160781794|NCT01629563|580587152|FG001|Overall Study|Lack of return of menses|7|||
160781795|NCT01629563|580587151|FG000|Overall Study|Protocol Violation|0|||
160781796|NCT01629563|580587152|FG001|Overall Study|Protocol Violation|1|||
160781797|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
160781798|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Adverse Event|1|||
160781799|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
160781800|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Physician Decision|1|||
160781801|NCT00088881|580587154|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
160781802|NCT00088881|580587154|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
160781803|NCT00088881|580587154|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
160781804|NCT02370394|580587163|FG000|Overall Study|Lost to Follow-up|2|||
160781805|NCT02370394|580587164|FG001|Overall Study|Lost to Follow-up|1|||
160781806|NCT02370394|580587163|FG000|Overall Study|Withdrawal by Subject|0|||
160889666|NCT01975831|580989615|FG008|Overall Study|Physician Decision|0|||
160889667|NCT01975831|580989607|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
160889668|NCT01975831|580989608|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
160889669|NCT01975831|580989609|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
160889670|NCT01975831|580989610|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
160889671|NCT01975831|580989611|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
160889672|NCT01975831|580989612|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
160889673|NCT01975831|580989613|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
160889674|NCT01975831|580989614|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
160889675|NCT01975831|580989615|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
160889676|NCT01975831|580989607|FG000|Overall Study|Entered Hospice|0|||
160889677|NCT01975831|580989608|FG001|Overall Study|Entered Hospice|0|||
160889678|NCT01975831|580989609|FG002|Overall Study|Entered Hospice|0|||
160889679|NCT01975831|580989610|FG003|Overall Study|Entered Hospice|0|||
160889680|NCT01975831|580989611|FG004|Overall Study|Entered Hospice|0|||
160889681|NCT01975831|580989612|FG005|Overall Study|Entered Hospice|1|||
160889682|NCT01975831|580989613|FG006|Overall Study|Entered Hospice|0|||
160889683|NCT01975831|580989614|FG007|Overall Study|Entered Hospice|0|||
160889684|NCT01975831|580989615|FG008|Overall Study|Entered Hospice|0|||
160889685|NCT01975831|580989607|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889686|NCT01975831|580989608|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889687|NCT01975831|580989609|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889688|NCT01975831|580989610|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889689|NCT01975831|580989611|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
160781807|NCT02370394|580587164|FG001|Overall Study|Withdrawal by Subject|1|||
160781808|NCT03684057|580587165|FG000|Overall Study|Withdrawal by Subject|4|||
160781809|NCT03684057|580587166|FG001|Overall Study|Withdrawal by Subject|5|||
160889690|NCT01975831|580989612|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889691|NCT01975831|580989613|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
160781810|NCT02545127|580587167|FG000|Overall Study|Lost to Follow-up|1|||
160889692|NCT01975831|580989614|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
160889693|NCT01975831|580989615|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
160781811|NCT02545127|580587168|FG001|Overall Study|Lost to Follow-up|0|||
160781812|NCT03422718|580587169|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
160781813|NCT03422718|580587170|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
160781814|NCT03422718|580587171|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
160781815|NCT03422718|580587172|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
160781816|NCT03422718|580587173|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
160781817|NCT03422718|580587174|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
161230224|NCT02343120|582224145|FG000|Part 2: Expansion|Death|0|||
161230225|NCT02343120|582224146|FG001|Part 2: Expansion|Death|0|||
161230226|NCT02343120|582224147|FG002|Part 2: Expansion|Death|0|||
161230227|NCT02343120|582224148|FG003|Part 2: Expansion|Death|74|||
161230228|NCT02343120|582224149|FG004|Part 2: Expansion|Death|17|||
161230229|NCT02343120|582224145|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
161230230|NCT02343120|582224146|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
160781818|NCT03422718|580587175|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
160781819|NCT03422718|580587176|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
160781820|NCT03422718|580587169|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
160781821|NCT03422718|580587170|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
160781822|NCT03422718|580587171|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
160781823|NCT03422718|580587172|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
160781824|NCT03422718|580587173|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
160781825|NCT03422718|580587174|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
160781826|NCT03422718|580587175|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
160781827|NCT03422718|580587176|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
160781828|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
160781829|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
160781830|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
160781831|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
160781832|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
160781833|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
160781834|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
160781835|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
160781836|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781837|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
160781838|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781839|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781840|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
160781841|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
160781842|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781843|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
160781844|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
160781845|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
160781846|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
160781847|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
160781848|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
160781849|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
160781850|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
160781851|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
160781852|NCT03422718|580587169|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
160781853|NCT03422718|580587170|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
160781854|NCT03422718|580587171|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
160781855|NCT03422718|580587172|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
160781856|NCT03422718|580587173|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
160781857|NCT03422718|580587174|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
160781858|NCT03422718|580587175|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
160781859|NCT03422718|580587176|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
160781860|NCT03309605|580587177|FG000|Overall Study|Adverse Event|0|||
160781861|NCT03309605|580587178|FG001|Overall Study|Adverse Event|0|||
160781862|NCT03309605|580587179|FG002|Overall Study|Adverse Event|0|||
160781863|NCT03309605|580587180|FG003|Overall Study|Adverse Event|1|||
160781864|NCT03309605|580587181|FG004|Overall Study|Adverse Event|0|||
160781865|NCT03309605|580587182|FG005|Overall Study|Adverse Event|0|||
160781866|NCT03309605|580587183|FG006|Overall Study|Adverse Event|2|||
160781867|NCT03309605|580587184|FG007|Overall Study|Adverse Event|1|||
160781868|NCT03309605|580587177|FG000|Overall Study|Withdrawal by Subject|0|||
160781869|NCT03309605|580587178|FG001|Overall Study|Withdrawal by Subject|0|||
160781870|NCT03309605|580587179|FG002|Overall Study|Withdrawal by Subject|0|||
160781871|NCT03309605|580587180|FG003|Overall Study|Withdrawal by Subject|0|||
160781872|NCT03309605|580587181|FG004|Overall Study|Withdrawal by Subject|1|||
160781873|NCT03309605|580587182|FG005|Overall Study|Withdrawal by Subject|0|||
160781874|NCT03309605|580587183|FG006|Overall Study|Withdrawal by Subject|1|||
160889694|NCT02925793|580989616|FG000|Overall Study|Adverse Event|3|||
160781875|NCT03309605|580587184|FG007|Overall Study|Withdrawal by Subject|1|||
160781876|NCT01129284|580587185|FG000|Overall Study|Adverse Event|2|||
161230231|NCT02343120|582224147|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
161230232|NCT02343120|582224148|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
160781877|NCT01129284|580587186|FG001|Overall Study|Adverse Event|0|||
160781878|NCT01129284|580587187|FG002|Overall Study|Adverse Event|1|||
160781879|NCT03197935|580587190|FG000|Overall Study|Death due to any cause|26|||
160781880|NCT03197935|580587191|FG001|Overall Study|Death due to any cause|15|||
160781881|NCT03197935|580587190|FG000|Overall Study|Lost to Follow-up|3|||
160781882|NCT03197935|580587191|FG001|Overall Study|Lost to Follow-up|5|||
160781883|NCT03197935|580587190|FG000|Overall Study|Physician Decision|2|||
160781884|NCT03197935|580587191|FG001|Overall Study|Physician Decision|1|||
160781885|NCT03197935|580587190|FG000|Overall Study|Withdrawal by Subject|16|||
160781886|NCT03197935|580587191|FG001|Overall Study|Withdrawal by Subject|8|||
160781887|NCT00960856|580587192|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160781888|NCT00960856|580587193|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
160781889|NCT00960856|580587194|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
160781890|NCT00960856|580587195|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
160889695|NCT02925793|580989617|FG001|Overall Study|Adverse Event|3|||
160889696|NCT02925793|580989618|FG002|Overall Study|Adverse Event|6|||
160889697|NCT02925793|580989616|FG000|Overall Study|Withdrawal by Subject|16|||
160889698|NCT02925793|580989617|FG001|Overall Study|Withdrawal by Subject|15|||
160889699|NCT02925793|580989618|FG002|Overall Study|Withdrawal by Subject|13|||
160889700|NCT02925793|580989616|FG000|Overall Study|Investigator Discretion|0|||
160889701|NCT02925793|580989617|FG001|Overall Study|Investigator Discretion|1|||
160889702|NCT02925793|580989618|FG002|Overall Study|Investigator Discretion|1|||
160889703|NCT02925793|580989616|FG000|Overall Study|Lost to Follow-up|2|||
160889704|NCT02925793|580989617|FG001|Overall Study|Lost to Follow-up|3|||
160889705|NCT02925793|580989618|FG002|Overall Study|Lost to Follow-up|1|||
160889706|NCT02925793|580989616|FG000|Overall Study|Lack of Efficacy|2|||
160889707|NCT02925793|580989617|FG001|Overall Study|Lack of Efficacy|6|||
160889708|NCT02925793|580989618|FG002|Overall Study|Lack of Efficacy|4|||
160889709|NCT02925793|580989616|FG000|Overall Study|Other:|2|||
160889710|NCT02925793|580989617|FG001|Overall Study|Other:|1|||
160889711|NCT02925793|580989618|FG002|Overall Study|Other:|3|||
160889712|NCT03631355|580989621|FG000|Overall Study|Lost to Follow-up|1|||
160889713|NCT03631355|580989622|FG001|Overall Study|Lost to Follow-up|2|||
160889714|NCT00772070|580989628|FG000|Overall Study|Lost to Follow-up|0|||
160889715|NCT00772070|580989629|FG001|Overall Study|Lost to Follow-up|8|||
160889716|NCT00772070|580989628|FG000|Overall Study|Withdrawal by Subject|0|||
160889717|NCT00772070|580989629|FG001|Overall Study|Withdrawal by Subject|2|||
160889718|NCT00772070|580989628|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
160889719|NCT00772070|580989629|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
160889720|NCT01897714|580991496|FG000|Phase I (Dose Escalation)|Disease progression|3|||
160889721|NCT01897714|580991497|FG001|Phase I (Dose Escalation)|Disease progression|5|||
160889722|NCT01897714|580991498|FG002|Phase I (Dose Escalation)|Disease progression|1|||
160889723|NCT01897714|580991499|FG003|Phase I (Dose Escalation)|Disease progression|3|||
160889724|NCT01897714|580991500|FG004|Phase I (Dose Escalation)|Disease progression|0|||
160889725|NCT01897714|580991501|FG005|Phase I (Dose Escalation)|Disease progression|0|||
160889726|NCT01897714|580991496|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
160889727|NCT01897714|580991497|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
160889728|NCT01897714|580991498|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
160889729|NCT01897714|580991499|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
160889730|NCT01897714|580991500|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
160889731|NCT01897714|580991501|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
160889732|NCT01897714|580991496|FG000|Phase I (Dose Escalation)|Other|0|||
160889733|NCT01897714|580991497|FG001|Phase I (Dose Escalation)|Other|1|||
160889734|NCT01897714|580991498|FG002|Phase I (Dose Escalation)|Other|0|||
160889735|NCT01897714|580991499|FG003|Phase I (Dose Escalation)|Other|0|||
160889736|NCT01897714|580991500|FG004|Phase I (Dose Escalation)|Other|0|||
160889737|NCT01897714|580991501|FG005|Phase I (Dose Escalation)|Other|0|||
160889738|NCT01897714|580991496|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
160889739|NCT01897714|580991497|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
160889740|NCT01897714|580991498|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
160889741|NCT01897714|580991499|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
160889742|NCT01897714|580991500|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
160889743|NCT01897714|580991501|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
160781891|NCT00960856|580587192|FG000|Washout Period of 7 Days|Adverse Event|0|||
160781892|NCT00960856|580587193|FG001|Washout Period of 7 Days|Adverse Event|0|||
160889744|NCT01897714|580991496|FG000|Phase II (MTD)|Lost to Follow-up|0|||
160781893|NCT00960856|580587194|FG002|Washout Period of 7 Days|Adverse Event|1|||
160781894|NCT00960856|580587195|FG003|Washout Period of 7 Days|Adverse Event|0|||
160889745|NCT01897714|580991497|FG001|Phase II (MTD)|Lost to Follow-up|0|||
161230233|NCT02343120|582224149|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
160781895|NCT04027946|580587196|FG000|Overall Study|Screen failures|3|||
160889746|NCT01897714|580991498|FG002|Phase II (MTD)|Lost to Follow-up|0|||
160889747|NCT01897714|580991499|FG003|Phase II (MTD)|Lost to Follow-up|0|||
160889748|NCT01897714|580991500|FG004|Phase II (MTD)|Lost to Follow-up|1|||
160889749|NCT01897714|580991501|FG005|Phase II (MTD)|Lost to Follow-up|0|||
160889750|NCT01897714|580991496|FG000|Phase II (MTD)|Death|0|||
160889751|NCT01897714|580991497|FG001|Phase II (MTD)|Death|0|||
160781896|NCT00864513|580587197|FG000|Overall Study|Withdrawal by Subject|3|||
160781897|NCT00762788|580587198|FG000|Overall Study|Lost to Follow-up|26|||
160781898|NCT00762788|580587199|FG001|Overall Study|Lost to Follow-up|37|||
160781899|NCT00762788|580587200|FG002|Overall Study|Lost to Follow-up|21|||
160781900|NCT00762788|580587201|FG003|Overall Study|Lost to Follow-up|26|||
160781901|NCT00762788|580587202|FG004|Overall Study|Lost to Follow-up|13|||
160781902|NCT00762788|580587203|FG005|Overall Study|Lost to Follow-up|21|||
160781903|NCT05938010|580587204|FG000|Overall Study|Lost to Follow-up|2|||
160781904|NCT00985192|580587205|FG000|Overall Study|Withdrawal by Subject|1|||
160781905|NCT00985192|580587205|FG000|Overall Study|Disease Progression|1|||
160781906|NCT00985192|580587205|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
160781907|NCT01297244|580587208|FG000|Overall Study|Progressive disease|22|||
160781908|NCT01297244|580587209|FG001|Overall Study|Progressive disease|3|||
160781909|NCT01297244|580587208|FG000|Overall Study|Adverse Event|9|||
160781910|NCT01297244|580587209|FG001|Overall Study|Adverse Event|1|||
160781911|NCT01297244|580587208|FG000|Overall Study|Death|1|||
160781912|NCT01297244|580587209|FG001|Overall Study|Death|1|||
160781913|NCT01297244|580587208|FG000|Overall Study|Clinical progression|1|||
160781914|NCT01297244|580587209|FG001|Overall Study|Clinical progression|1|||
160781915|NCT01297244|580587208|FG000|Overall Study|Withdrawal by Subject|2|||
160781916|NCT01297244|580587209|FG001|Overall Study|Withdrawal by Subject|0|||
160781917|NCT02595749|580587210|FG000|Overall Study|Withdrawal by Subject|12|||
160781918|NCT02595749|580587211|FG001|Overall Study|Withdrawal by Subject|7|||
160781919|NCT01454063|580587212|FG000|Randomized|Adverse Event|1|||
160781920|NCT01454063|580587213|FG001|Randomized|Adverse Event|1|||
160781921|NCT01454063|580587212|FG000|Randomized|Protocol Violation|0|||
160781922|NCT01454063|580587213|FG001|Randomized|Protocol Violation|1|||
160781923|NCT00983957|580587219|FG000|Overall Study|Adverse Event|1|||
160781924|NCT00983957|580587219|FG000|Overall Study|Personal Reasons|1|||
160781925|NCT03055195|580587220|FG000|Overall Study|Lack of Efficacy|1|||
160781926|NCT03055195|580587221|FG001|Overall Study|Lack of Efficacy|0|||
160781927|NCT03055195|580587220|FG000|Overall Study|Withdrawal by Subject|6|||
160781928|NCT03055195|580587221|FG001|Overall Study|Withdrawal by Subject|7|||
160781929|NCT03055195|580587220|FG000|Overall Study|Study Terminated by Sponsor|2|||
160781930|NCT03055195|580587221|FG001|Overall Study|Study Terminated by Sponsor|6|||
160781931|NCT03055195|580587220|FG000|Overall Study|Protocol Violation|2|||
160781932|NCT03055195|580587221|FG001|Overall Study|Protocol Violation|1|||
160781933|NCT03055195|580587220|FG000|Overall Study|Physician Decision|1|||
161327258|NCT03316586|582585344|FG000|Overall Study|Patient needed radiation therapy|1|||
161327259|NCT03316586|582585344|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
161327260|NCT00994110|582585345|FG000|Overall Study|Withdrawal by Subject|9|||
161327261|NCT00994110|582585346|FG001|Overall Study|Withdrawal by Subject|9|||
161327262|NCT00994110|582585345|FG000|Overall Study|Not Treated|4|||
161327263|NCT00994110|582585346|FG001|Overall Study|Not Treated|8|||
161327264|NCT00994110|582585345|FG000|Overall Study|Adverse Event|1|||
161327265|NCT00994110|582585346|FG001|Overall Study|Adverse Event|0|||
161327266|NCT00994110|582585345|FG000|Overall Study|Patient not resected|41|||
161327267|NCT00994110|582585346|FG001|Overall Study|Patient not resected|52|||
161327268|NCT00994110|582585345|FG000|Overall Study|Pt not eligible|10|||
161327269|NCT00994110|582585346|FG001|Overall Study|Pt not eligible|5|||
161327270|NCT00619827|582585347|FG000|Overall Study|Adverse Event|1|||
161327271|NCT00619827|582585348|FG001|Overall Study|Adverse Event|2|||
161327272|NCT00619827|582585347|FG000|Overall Study|Withdrawal by Subject|2|||
161327273|NCT00619827|582585348|FG001|Overall Study|Withdrawal by Subject|2|||
161327274|NCT02163395|582585349|FG000|Overall Study|Withdrawal by Subject|1|||
161327275|NCT02163395|582585349|FG000|Overall Study|Lost to Follow-up|3|||
161327276|NCT02163395|582585349|FG000|Overall Study|Adverse Event|1|||
161327277|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
161327278|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161327279|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161327280|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161327281|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
161327282|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
161327283|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161327284|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161327285|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161327286|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
161327287|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
160781934|NCT03055195|580587221|FG001|Overall Study|Physician Decision|0|||
160781935|NCT00986232|580587222|FG000|Overall Study|Adverse Event|1|||
161327288|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161327289|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161327290|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
161327291|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
160781936|NCT00986232|580587223|FG001|Overall Study|Adverse Event|2|||
160781937|NCT00986232|580587224|FG002|Overall Study|Adverse Event|3|||
160781938|NCT00986232|580587225|FG003|Overall Study|Adverse Event|0|||
160781939|NCT00986232|580587222|FG000|Overall Study|Lost to Follow-up|19|||
160781940|NCT00986232|580587223|FG001|Overall Study|Lost to Follow-up|12|||
160781941|NCT00986232|580587224|FG002|Overall Study|Lost to Follow-up|12|||
160781942|NCT00986232|580587225|FG003|Overall Study|Lost to Follow-up|7|||
160781943|NCT00986232|580587222|FG000|Overall Study|Protocol Violation|2|||
160781944|NCT00986232|580587223|FG001|Overall Study|Protocol Violation|3|||
160781945|NCT00986232|580587224|FG002|Overall Study|Protocol Violation|0|||
160781946|NCT00986232|580587225|FG003|Overall Study|Protocol Violation|1|||
160781947|NCT00986232|580587222|FG000|Overall Study|Withdrawal by Subject|13|||
160781948|NCT00986232|580587223|FG001|Overall Study|Withdrawal by Subject|16|||
160781949|NCT00986232|580587224|FG002|Overall Study|Withdrawal by Subject|12|||
160781950|NCT00986232|580587225|FG003|Overall Study|Withdrawal by Subject|3|||
160781951|NCT00986232|580587222|FG000|Overall Study|Missed one or more bleeds|13|||
160781952|NCT00986232|580587223|FG001|Overall Study|Missed one or more bleeds|10|||
160781953|NCT00986232|580587224|FG002|Overall Study|Missed one or more bleeds|6|||
160781954|NCT00986232|580587225|FG003|Overall Study|Missed one or more bleeds|7|||
160781955|NCT00986232|580587222|FG000|Overall Study|Incomplete safety follow-up|3|||
160781956|NCT00986232|580587223|FG001|Overall Study|Incomplete safety follow-up|7|||
160781957|NCT00986232|580587224|FG002|Overall Study|Incomplete safety follow-up|2|||
160781958|NCT00986232|580587225|FG003|Overall Study|Incomplete safety follow-up|2|||
160781959|NCT02568423|580587228|FG000|Overall Study|Lost to Follow-up|0|||
160781960|NCT02568423|580587229|FG001|Overall Study|Lost to Follow-up|2|||
160781961|NCT02568423|580587230|FG002|Overall Study|Lost to Follow-up|0|||
160781962|NCT02568423|580587231|FG003|Overall Study|Lost to Follow-up|0|||
160781963|NCT02568423|580587232|FG004|Overall Study|Lost to Follow-up|0|||
160781964|NCT02568423|580587233|FG005|Overall Study|Lost to Follow-up|0|||
160781965|NCT02568423|580587234|FG006|Overall Study|Lost to Follow-up|0|||
160781966|NCT02568423|580587235|FG007|Overall Study|Lost to Follow-up|0|||
160781967|NCT02568423|580587228|FG000|Overall Study|Physician Decision|0|||
160781968|NCT02568423|580587229|FG001|Overall Study|Physician Decision|0|||
160781969|NCT02568423|580587230|FG002|Overall Study|Physician Decision|0|||
160889752|NCT01897714|580991498|FG002|Phase II (MTD)|Death|0|||
160889753|NCT01897714|580991499|FG003|Phase II (MTD)|Death|0|||
161124576|NCT00546364|581843737|FG002|Overall Study|Completed and off treatment|2|||
161124577|NCT00546364|581843735|FG000|Overall Study|Administrative reason by sponsor|1|||
161124578|NCT00546364|581843736|FG001|Overall Study|Administrative reason by sponsor|0|||
161124579|NCT00546364|581843737|FG002|Overall Study|Administrative reason by sponsor|0|||
161124580|NCT00546364|581843735|FG000|Overall Study|Poor compliance/noncompliance|0|||
161124581|NCT00546364|581843736|FG001|Overall Study|Poor compliance/noncompliance|0|||
161124582|NCT00546364|581843737|FG002|Overall Study|Poor compliance/noncompliance|1|||
161124583|NCT00546364|581843735|FG000|Overall Study|No longer meets study criteria|1|||
161124584|NCT00546364|581843736|FG001|Overall Study|No longer meets study criteria|1|||
161124585|NCT00546364|581843737|FG002|Overall Study|No longer meets study criteria|0|||
161124586|NCT00546364|581843735|FG000|Overall Study|Withdrawal by Subject|5|||
161124587|NCT00546364|581843736|FG001|Overall Study|Withdrawal by Subject|6|||
161124588|NCT00546364|581843737|FG002|Overall Study|Withdrawal by Subject|3|||
161124589|NCT00546364|581843735|FG000|Overall Study|Prior taxotere|1|||
161124590|NCT00546364|581843736|FG001|Overall Study|Prior taxotere|0|||
161124591|NCT00546364|581843737|FG002|Overall Study|Prior taxotere|0|||
161124592|NCT00546364|581843735|FG000|Overall Study|Mixed response|1|||
161124593|NCT00546364|581843736|FG001|Overall Study|Mixed response|0|||
161124594|NCT00546364|581843737|FG002|Overall Study|Mixed response|0|||
161124595|NCT00546364|581843735|FG000|Overall Study|Palliative treatment|1|||
161124596|NCT00546364|581843736|FG001|Overall Study|Palliative treatment|0|||
161124597|NCT00546364|581843737|FG002|Overall Study|Palliative treatment|1|||
161124598|NCT00546364|581843735|FG000|Overall Study|Target lesions resected|1|||
161124599|NCT00546364|581843736|FG001|Overall Study|Target lesions resected|0|||
161124600|NCT00546364|581843737|FG002|Overall Study|Target lesions resected|0|||
161124601|NCT00546364|581843735|FG000|Overall Study|Physician Decision|0|||
161124602|NCT00546364|581843736|FG001|Overall Study|Physician Decision|0|||
161124603|NCT00546364|581843737|FG002|Overall Study|Physician Decision|1|||
161124604|NCT00546364|581843735|FG000|Overall Study|Sponsor decision|0|||
161124605|NCT00546364|581843736|FG001|Overall Study|Sponsor decision|0|||
161124606|NCT00546364|581843737|FG002|Overall Study|Sponsor decision|1|||
161124607|NCT03064763|581843738|FG000|Overall Study|Lost to Follow-up|1|||
161124608|NCT03064763|581843738|FG000|Overall Study|Death|8|||
161124609|NCT02415712|581843739|FG000|Overall Study|Protocol Violation|16|||
160781970|NCT02568423|580587231|FG003|Overall Study|Physician Decision|0|||
160781971|NCT02568423|580587232|FG004|Overall Study|Physician Decision|0|||
160889754|NCT01897714|580991500|FG004|Phase II (MTD)|Death|25|||
161124610|NCT00343512|581843755|FG000|Overall Study|Withdrawal by Subject|2|||
161124611|NCT00323557|581843756|FG000|Overall Study|Physician Decision|1|||
161124612|NCT00323557|581843757|FG001|Overall Study|Physician Decision|0|||
161124613|NCT00684515|581843758|FG000|Overall Study|Adverse Event|3|||
160781972|NCT02568423|580587233|FG005|Overall Study|Physician Decision|1|||
161124614|NCT00684515|581843759|FG001|Overall Study|Adverse Event|3|||
160781973|NCT02568423|580587234|FG006|Overall Study|Physician Decision|0|||
160889755|NCT01897714|580991501|FG005|Phase II (MTD)|Death|10|||
160889756|NCT01897714|580991496|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
160889757|NCT01897714|580991497|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
160889758|NCT01897714|580991498|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
160889759|NCT01897714|580991499|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
160889760|NCT01897714|580991500|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
160889761|NCT01897714|580991501|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
160889762|NCT01897714|580991496|FG000|Phase II (MTD)|Other|0|||
160889763|NCT01897714|580991497|FG001|Phase II (MTD)|Other|0|||
160889764|NCT01897714|580991498|FG002|Phase II (MTD)|Other|0|||
160889765|NCT01897714|580991499|FG003|Phase II (MTD)|Other|0|||
160889766|NCT01897714|580991500|FG004|Phase II (MTD)|Other|3|||
160889767|NCT01897714|580991501|FG005|Phase II (MTD)|Other|0|||
160889768|NCT05828095|580991508|FG000|Overall Study|Lost to Follow-up|1|||
160889769|NCT05828095|580991509|FG001|Overall Study|Lost to Follow-up|0|||
160889770|NCT05828095|580991508|FG000|Overall Study|Reactogenicity symptom|0|||
160889771|NCT05828095|580991509|FG001|Overall Study|Reactogenicity symptom|1|||
160889772|NCT03206073|580991510|FG000|Overall Study|Participant Noncompliance|0|||
160889773|NCT03206073|580991511|FG001|Overall Study|Participant Noncompliance|1|||
160889774|NCT03206073|580991512|FG002|Overall Study|Participant Noncompliance|0|||
160889775|NCT03206073|580991513|FG003|Overall Study|Participant Noncompliance|0|||
160889776|NCT03206073|580991510|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
160889777|NCT03206073|580991511|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
160889778|NCT03206073|580991512|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
160889779|NCT03206073|580991513|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
160889780|NCT03206073|580991510|FG000|Overall Study|Death|0|||
161230234|NCT02343120|582224145|FG000|Part 2: Expansion|Lost to Follow-up|0|||
161230235|NCT02343120|582224146|FG001|Part 2: Expansion|Lost to Follow-up|0|||
161230236|NCT02343120|582224147|FG002|Part 2: Expansion|Lost to Follow-up|0|||
161230237|NCT02343120|582224148|FG003|Part 2: Expansion|Lost to Follow-up|5|||
161230238|NCT02343120|582224149|FG004|Part 2: Expansion|Lost to Follow-up|2|||
161230239|NCT02343120|582224145|FG000|Part 2: Expansion|Other|0|||
161230240|NCT02343120|582224146|FG001|Part 2: Expansion|Other|0|||
161230241|NCT02343120|582224147|FG002|Part 2: Expansion|Other|0|||
161230242|NCT02343120|582224148|FG003|Part 2: Expansion|Other|1|||
161230243|NCT02343120|582224149|FG004|Part 2: Expansion|Other|5|||
161230244|NCT02343120|582224145|FG000|Part 2: Expansion|Adverse Event|0|||
161230245|NCT02343120|582224146|FG001|Part 2: Expansion|Adverse Event|0|||
161230246|NCT02343120|582224147|FG002|Part 2: Expansion|Adverse Event|0|||
161230247|NCT02343120|582224148|FG003|Part 2: Expansion|Adverse Event|1|||
161230248|NCT02343120|582224149|FG004|Part 2: Expansion|Adverse Event|1|||
161230249|NCT02534493|582224155|FG000|Overall Study|Lost to Follow-up|1|||
161230250|NCT02534493|582224155|FG000|Overall Study|Withdrawal by Subject|1|||
161230251|NCT02514174|582224157|FG000|Overall Study|Patient refused to continue medication|1|||
161230252|NCT02514174|582224157|FG000|Overall Study|Adverse Event|2|||
161230253|NCT02514174|582224157|FG000|Overall Study|Study closed by sponsor|9|||
161230254|NCT02514174|582224157|FG000|Overall Study|Progressive disease|11|||
161230255|NCT02514174|582224157|FG000|Overall Study|Treatment change|1|||
161230256|NCT02514174|582224157|FG000|Overall Study|Treated off study with Afatinib.|1|||
161230257|NCT00591630|582224160|FG000|Overall Study|Death|0|||
161230258|NCT00591630|582224161|FG001|Overall Study|Death|0|||
161230259|NCT00591630|582224162|FG002|Overall Study|Death|1|||
161230260|NCT00591630|582224163|FG003|Overall Study|Death|0|||
161230261|NCT01691248|582224164|FG000|Overall Study|Protocol Violation|43|||
161230262|NCT01691248|582224165|FG001|Overall Study|Protocol Violation|27|||
161230263|NCT01691248|582224164|FG000|Overall Study|Adverse Event|24|||
161230264|NCT01691248|582224165|FG001|Overall Study|Adverse Event|22|||
161230265|NCT01691248|582224164|FG000|Overall Study|Withdrawal by Subject|20|||
161230266|NCT01691248|582224165|FG001|Overall Study|Withdrawal by Subject|18|||
161230267|NCT01691248|582224164|FG000|Overall Study|Confirmed CDAD|14|||
161230268|NCT01691248|582224165|FG001|Overall Study|Confirmed CDAD|31|||
161230269|NCT01691248|582224164|FG000|Overall Study|Lost to Follow-up|2|||
161230270|NCT01691248|582224165|FG001|Overall Study|Lost to Follow-up|5|||
161230271|NCT01691248|582224164|FG000|Overall Study|Reason not provided|4|||
161230272|NCT01691248|582224165|FG001|Overall Study|Reason not provided|4|||
161230273|NCT01691248|582224164|FG000|Overall Study|Not Treated|4|||
161230274|NCT01691248|582224165|FG001|Overall Study|Not Treated|7|||
161230275|NCT01432171|582224166|FG000|Overall Study|Death|1|||
161230276|NCT01432171|582224167|FG001|Overall Study|Death|2|||
161230277|NCT01432171|582224166|FG000|Overall Study|Lost to Follow-up|6|||
160781974|NCT02568423|580587235|FG007|Overall Study|Physician Decision|0|||
160781975|NCT03794544|580587237|FG000|Overall Study|Withdrawal by Subject|1|||
160781976|NCT03794544|580587238|FG001|Overall Study|Withdrawal by Subject|1|||
160781977|NCT03794544|580587239|FG002|Overall Study|Withdrawal by Subject|0|||
160781978|NCT03794544|580587240|FG003|Overall Study|Withdrawal by Subject|0|||
160781979|NCT03794544|580587237|FG000|Overall Study|Death|0|||
160781980|NCT03794544|580587238|FG001|Overall Study|Death|0|||
160781981|NCT03794544|580587239|FG002|Overall Study|Death|0|||
160781982|NCT03794544|580587240|FG003|Overall Study|Death|1|||
161327292|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
161327293|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161327294|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161327295|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161327296|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
161327297|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
161327298|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161327299|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161327300|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161327301|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
161327302|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
161327303|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161327304|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161327305|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161327306|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
161327307|NCT01111565|582585350|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
161327308|NCT01111565|582585351|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161327309|NCT01111565|582585352|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161327310|NCT01111565|582585353|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161327311|NCT01111565|582585354|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
161327312|NCT01111565|582585350|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161327313|NCT01111565|582585351|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161327314|NCT01111565|582585352|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161327315|NCT01111565|582585353|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161327316|NCT01111565|582585354|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161327317|NCT01111565|582585350|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161327318|NCT01111565|582585351|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161327319|NCT01111565|582585352|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
161327320|NCT01111565|582585353|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161327321|NCT01111565|582585354|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161327322|NCT01111565|582585350|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161327323|NCT01111565|582585351|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
161327324|NCT01111565|582585352|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161327325|NCT01111565|582585353|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
161327326|NCT01111565|582585354|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
161327327|NCT01111565|582585350|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161327328|NCT01111565|582585351|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161327329|NCT01111565|582585352|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161327330|NCT01111565|582585353|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
161327331|NCT01111565|582585354|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
161327332|NCT01111565|582585350|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161327333|NCT01111565|582585351|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161327334|NCT01111565|582585352|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161327335|NCT01111565|582585353|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
161327336|NCT01111565|582585354|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
161327337|NCT00943397|582585357|FG000|Overall Study|Adverse Event|0|||
160781983|NCT03794544|580587237|FG000|Overall Study|Lost to Follow-up|0|||
160781984|NCT03794544|580587238|FG001|Overall Study|Lost to Follow-up|1|||
160781985|NCT03794544|580587239|FG002|Overall Study|Lost to Follow-up|1|||
160781986|NCT03794544|580587240|FG003|Overall Study|Lost to Follow-up|0|||
160781987|NCT03794544|580587237|FG000|Overall Study|Other|0|||
160781988|NCT03794544|580587238|FG001|Overall Study|Other|1|||
160781989|NCT03794544|580587239|FG002|Overall Study|Other|0|||
160781990|NCT03794544|580587240|FG003|Overall Study|Other|0|||
160781991|NCT00421733|580587242|FG000|Overall Study|Adverse Event|4|||
160781992|NCT00421733|580587243|FG001|Overall Study|Adverse Event|9|||
160781993|NCT00421733|580587244|FG002|Overall Study|Adverse Event|2|||
160781994|NCT00421733|580587242|FG000|Overall Study|Lost to Follow-up|1|||
160781995|NCT00421733|580587243|FG001|Overall Study|Lost to Follow-up|2|||
160781996|NCT00421733|580587244|FG002|Overall Study|Lost to Follow-up|4|||
160781997|NCT00421733|580587242|FG000|Overall Study|Withdrawal by Subject|1|||
160781998|NCT00421733|580587243|FG001|Overall Study|Withdrawal by Subject|2|||
160781999|NCT00421733|580587244|FG002|Overall Study|Withdrawal by Subject|7|||
160782000|NCT00421733|580587242|FG000|Overall Study|Death|0|||
160782001|NCT00421733|580587243|FG001|Overall Study|Death|3|||
160782002|NCT00421733|580587244|FG002|Overall Study|Death|0|||
160782003|NCT00421733|580587242|FG000|Overall Study|Required dialysis|1|||
160782004|NCT00421733|580587243|FG001|Overall Study|Required dialysis|0|||
160782005|NCT00421733|580587244|FG002|Overall Study|Required dialysis|0|||
160782006|NCT00421733|580587242|FG000|Overall Study|Administrative|2|||
160782007|NCT00421733|580587243|FG001|Overall Study|Administrative|0|||
160782008|NCT00421733|580587244|FG002|Overall Study|Administrative|0|||
160782009|NCT00421733|580587242|FG000|Overall Study|Did not satisfy entry criteria|1|||
160782010|NCT00421733|580587243|FG001|Overall Study|Did not satisfy entry criteria|3|||
160782011|NCT00421733|580587244|FG002|Overall Study|Did not satisfy entry criteria|2|||
160782012|NCT00421733|580587242|FG000|Overall Study|Sponsor request|1|||
160782013|NCT00421733|580587243|FG001|Overall Study|Sponsor request|0|||
160782014|NCT00421733|580587244|FG002|Overall Study|Sponsor request|3|||
160782015|NCT00421733|580587242|FG000|Overall Study|Protocol deviation|4|||
160782016|NCT00421733|580587243|FG001|Overall Study|Protocol deviation|7|||
160782017|NCT00421733|580587244|FG002|Overall Study|Protocol deviation|2|||
160782018|NCT00790933|580587245|FG000|Overall Study|Adverse Event|94|||
160782019|NCT00790933|580587246|FG001|Overall Study|Adverse Event|119|||
160782020|NCT00790933|580587247|FG002|Overall Study|Adverse Event|65|||
160782021|NCT00790933|580587248|FG003|Overall Study|Adverse Event|5|||
160782022|NCT00790933|580587249|FG004|Overall Study|Adverse Event|69|||
160782023|NCT00790933|580587245|FG000|Overall Study|Protocol Violation(s)|8|||
160782024|NCT00790933|580587246|FG001|Overall Study|Protocol Violation(s)|18|||
160782025|NCT00790933|580587247|FG002|Overall Study|Protocol Violation(s)|7|||
160782026|NCT00790933|580587248|FG003|Overall Study|Protocol Violation(s)|0|||
161327338|NCT00943397|582585358|FG001|Overall Study|Adverse Event|6|||
161327339|NCT00943397|582585357|FG000|Overall Study|Lost to Follow-up|0|||
161327340|NCT00943397|582585358|FG001|Overall Study|Lost to Follow-up|4|||
161327341|NCT00943397|582585357|FG000|Overall Study|Protocol Violation|2|||
161327342|NCT00943397|582585358|FG001|Overall Study|Protocol Violation|5|||
161327343|NCT00943397|582585357|FG000|Overall Study|Withdrawal by Subject|1|||
161327344|NCT00943397|582585358|FG001|Overall Study|Withdrawal by Subject|1|||
161327345|NCT00943397|582585357|FG000|Overall Study|Site terminated and other|12|||
161327346|NCT00943397|582585358|FG001|Overall Study|Site terminated and other|56|||
161327347|NCT04878055|582585359|FG000|Overall Study|Patient transferred in another department|0|||
161327348|NCT04878055|582585360|FG001|Overall Study|Patient transferred in another department|2|||
161327349|NCT04878055|582585359|FG000|Overall Study|Physician Decision|1|||
161327350|NCT04878055|582585360|FG001|Overall Study|Physician Decision|1|||
161327351|NCT04878055|582585359|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
161327352|NCT04878055|582585360|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
161327353|NCT04878055|582585359|FG000|Overall Study|Adverse Event|12|||
161327354|NCT04878055|582585360|FG001|Overall Study|Adverse Event|7|||
161327355|NCT04878055|582585359|FG000|Overall Study|Other|5|||
161327356|NCT04878055|582585360|FG001|Overall Study|Other|0|||
161327357|NCT04878055|582585359|FG000|Overall Study|Withdrawal by Subject|7|||
161327358|NCT04878055|582585360|FG001|Overall Study|Withdrawal by Subject|3|||
161327359|NCT04878055|582585359|FG000|Overall Study|Lost to Follow-up|10|||
161124615|NCT00684515|581843760|FG002|Overall Study|Adverse Event|1|||
161124616|NCT00684515|581843758|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
161327360|NCT04878055|582585360|FG001|Overall Study|Lost to Follow-up|1|||
161327361|NCT01968811|582585361|FG000|Overall Study|Protocol Violation|4|||
161327362|NCT01968811|582585361|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
161327363|NCT01178125|582585362|FG000|Overall Study|Lost to Follow-up|397|||
161327364|NCT01178125|582585362|FG000|Overall Study|Adverse Event|244|||
161327365|NCT01178125|582585362|FG000|Overall Study|Withdrawal by Subject|209|||
161327366|NCT01178125|582585362|FG000|Overall Study|Noncompliance|184|||
161327367|NCT01178125|582585362|FG000|Overall Study|Pregnancy|55|||
161327368|NCT01178125|582585362|FG000|Overall Study|Other Reason|39|||
161327369|NCT01178125|582585362|FG000|Overall Study|Sponsor Decision|28|||
160782027|NCT00790933|580587249|FG004|Overall Study|Protocol Violation(s)|12|||
160782028|NCT00790933|580587245|FG000|Overall Study|Lack of Efficacy|192|||
160782029|NCT00790933|580587246|FG001|Overall Study|Lack of Efficacy|176|||
160782030|NCT00790933|580587247|FG002|Overall Study|Lack of Efficacy|130|||
161124617|NCT00684515|581843759|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
161124618|NCT00684515|581843760|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
161124619|NCT02450578|581843761|FG000|Overall Study|ECG abnormality so not treated|1|||
161124620|NCT02450578|581843762|FG001|Overall Study|ECG abnormality so not treated|0|||
161124621|NCT02450578|581843763|FG002|Overall Study|ECG abnormality so not treated|0|||
161124622|NCT02450578|581843764|FG003|Overall Study|ECG abnormality so not treated|0|||
161124623|NCT01699087|581843765|FG000|Overall Study|Lost to Follow-up|7|||
161124624|NCT01699087|581843765|FG000|Overall Study|Screen failure (prior to treatment)|15|||
161124625|NCT01699087|581843765|FG000|Overall Study|Unable to make future visits|2|||
160782031|NCT00790933|580587248|FG003|Overall Study|Lack of Efficacy|1|||
161327370|NCT01178125|582585362|FG000|Overall Study|Protocol Violation|17|||
161327371|NCT01178125|582585362|FG000|Overall Study|Investigator Decision|5|||
161327372|NCT00249873|582585366|FG000|Overall Study|Not treated|7|||
161327373|NCT00249873|582585367|FG001|Overall Study|Not treated|8|||
161327374|NCT00249873|582585366|FG000|Overall Study|Significant thrombocytopenia|9|||
161327375|NCT00249873|582585367|FG001|Overall Study|Significant thrombocytopenia|8|||
161327376|NCT00249873|582585366|FG000|Overall Study|Severe allergic reaction|8|||
161327377|NCT00249873|582585367|FG001|Overall Study|Severe allergic reaction|1|||
161230278|NCT01432171|582224167|FG001|Overall Study|Lost to Follow-up|5|||
161230279|NCT01432171|582224166|FG000|Overall Study|Withdrawal by Subject|3|||
161230280|NCT01432171|582224167|FG001|Overall Study|Withdrawal by Subject|1|||
161230281|NCT01432171|582224166|FG000|Overall Study|Noncompliance|2|||
161230282|NCT01432171|582224167|FG001|Overall Study|Noncompliance|3|||
161230283|NCT01432171|582224166|FG000|Overall Study|Insurance denial trial coverage|1|||
161230284|NCT01432171|582224167|FG001|Overall Study|Insurance denial trial coverage|0|||
161230285|NCT01432171|582224166|FG000|Overall Study|Patient moved to palliative care|1|||
161230286|NCT01432171|582224167|FG001|Overall Study|Patient moved to palliative care|0|||
161230287|NCT02863575|582224168|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
161230288|NCT02863575|582224169|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
161230289|NCT02863575|582224170|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
161230290|NCT02863575|582224168|FG000|Overall Study|Withdrawal by Subject|0|||
161230291|NCT02863575|582224169|FG001|Overall Study|Withdrawal by Subject|1|||
161230292|NCT02863575|582224170|FG002|Overall Study|Withdrawal by Subject|1|||
161230293|NCT02863575|582224168|FG000|Overall Study|Adverse Event|0|||
161230294|NCT02863575|582224169|FG001|Overall Study|Adverse Event|1|||
160782032|NCT00790933|580587249|FG004|Overall Study|Lack of Efficacy|121|||
160782033|NCT00790933|580587245|FG000|Overall Study|Study Terminated by Sponsor|0|||
160782034|NCT00790933|580587246|FG001|Overall Study|Study Terminated by Sponsor|0|||
160782035|NCT00790933|580587247|FG002|Overall Study|Study Terminated by Sponsor|1|||
160782036|NCT00790933|580587248|FG003|Overall Study|Study Terminated by Sponsor|0|||
160782037|NCT00790933|580587249|FG004|Overall Study|Study Terminated by Sponsor|0|||
160782038|NCT00790933|580587245|FG000|Overall Study|Withdrawal by Subject|123|||
160782039|NCT00790933|580587246|FG001|Overall Study|Withdrawal by Subject|120|||
160782040|NCT00790933|580587247|FG002|Overall Study|Withdrawal by Subject|52|||
160782041|NCT00790933|580587248|FG003|Overall Study|Withdrawal by Subject|6|||
160782042|NCT00790933|580587249|FG004|Overall Study|Withdrawal by Subject|50|||
160782043|NCT00790933|580587245|FG000|Overall Study|Lost to Follow-up|13|||
160782044|NCT00790933|580587246|FG001|Overall Study|Lost to Follow-up|31|||
160782045|NCT00790933|580587247|FG002|Overall Study|Lost to Follow-up|10|||
160782046|NCT00790933|580587248|FG003|Overall Study|Lost to Follow-up|1|||
160782047|NCT00790933|580587249|FG004|Overall Study|Lost to Follow-up|15|||
160782048|NCT00790933|580587245|FG000|Overall Study|Reason Not Specified|8|||
160782049|NCT00790933|580587246|FG001|Overall Study|Reason Not Specified|16|||
160782050|NCT00790933|580587247|FG002|Overall Study|Reason Not Specified|4|||
160782051|NCT00790933|580587248|FG003|Overall Study|Reason Not Specified|1|||
160782052|NCT00790933|580587249|FG004|Overall Study|Reason Not Specified|9|||
160782053|NCT00397930|580587252|FG000|Overall Study|Personal reasons|14|||
160782054|NCT00397930|580587253|FG001|Overall Study|Personal reasons|8|||
160782055|NCT00397930|580587252|FG000|Overall Study|Other medical|9|||
160782056|NCT00397930|580587253|FG001|Overall Study|Other medical|4|||
160782057|NCT00397930|580587252|FG000|Overall Study|Unknown reasons|9|||
160782058|NCT00397930|580587253|FG001|Overall Study|Unknown reasons|14|||
160782059|NCT00397930|580587252|FG000|Overall Study|Noncompliant|3|||
160782060|NCT00397930|580587253|FG001|Overall Study|Noncompliant|2|||
160782061|NCT00397930|580587252|FG000|Overall Study|Too time-consuming|2|||
160782062|NCT00397930|580587253|FG001|Overall Study|Too time-consuming|9|||
160782063|NCT00397930|580587252|FG000|Overall Study|Started own yoga program|1|||
160782064|NCT00397930|580587253|FG001|Overall Study|Started own yoga program|1|||
160782065|NCT00397930|580587252|FG000|Overall Study|Did not want to be in control group|0|||
160782066|NCT00397930|580587253|FG001|Overall Study|Did not want to be in control group|1|||
160782067|NCT00397930|580587252|FG000|Overall Study|Withdrawal by Subject|0|||
160782068|NCT00397930|580587253|FG001|Overall Study|Withdrawal by Subject|8|||
160782069|NCT00397930|580587252|FG000|Overall Study|Missing data|0|||
160782070|NCT00397930|580587253|FG001|Overall Study|Missing data|4|||
160782071|NCT01158404|580587254|FG000|Overall Study|Withdrawal by Subject|0|||
160782072|NCT01158404|580587255|FG001|Overall Study|Withdrawal by Subject|1|||
160782073|NCT01158404|580587256|FG002|Overall Study|Withdrawal by Subject|0|||
160782074|NCT01158404|580587257|FG003|Overall Study|Withdrawal by Subject|0|||
160782075|NCT01158404|580587258|FG004|Overall Study|Withdrawal by Subject|3|||
160782076|NCT01158404|580587259|FG005|Overall Study|Withdrawal by Subject|1|||
160782077|NCT01158404|580587260|FG006|Overall Study|Withdrawal by Subject|0|||
160782078|NCT01158404|580587261|FG007|Overall Study|Withdrawal by Subject|1|||
160782079|NCT01158404|580587254|FG000|Overall Study|Physician Decision|0|||
160782080|NCT01158404|580587255|FG001|Overall Study|Physician Decision|0|||
160782081|NCT01158404|580587256|FG002|Overall Study|Physician Decision|0|||
160782082|NCT01158404|580587257|FG003|Overall Study|Physician Decision|0|||
160782083|NCT01158404|580587258|FG004|Overall Study|Physician Decision|0|||
160782084|NCT01158404|580587259|FG005|Overall Study|Physician Decision|0|||
160782085|NCT01158404|580587260|FG006|Overall Study|Physician Decision|0|||
160782086|NCT01158404|580587261|FG007|Overall Study|Physician Decision|1|||
160782087|NCT01158404|580587254|FG000|Overall Study|Progressive Disease|0|||
160782088|NCT01158404|580587255|FG001|Overall Study|Progressive Disease|0|||
161230295|NCT02863575|582224170|FG002|Overall Study|Adverse Event|0|||
161230296|NCT01746017|582225718|FG000|Period 1|Withdrawal by Subject|0|||
161230297|NCT01746017|582225719|FG001|Period 1|Withdrawal by Subject|0|||
160782089|NCT01158404|580587256|FG002|Overall Study|Progressive Disease|0|||
160782090|NCT01158404|580587257|FG003|Overall Study|Progressive Disease|0|||
160782091|NCT01158404|580587258|FG004|Overall Study|Progressive Disease|0|||
160782092|NCT01158404|580587259|FG005|Overall Study|Progressive Disease|0|||
160782093|NCT01158404|580587260|FG006|Overall Study|Progressive Disease|1|||
160782094|NCT01158404|580587261|FG007|Overall Study|Progressive Disease|0|||
160782095|NCT02056288|580587262|FG000|In-Hospital Data|Surgery cancelled|1|||
160782096|NCT02056288|580587263|FG001|In-Hospital Data|Surgery cancelled|0|||
160782097|NCT02056288|580587262|FG000|In-Hospital Data|Protocol Violation|3|||
160782098|NCT02056288|580587263|FG001|In-Hospital Data|Protocol Violation|0|||
160782099|NCT02056288|580587262|FG000|In-Hospital Data|Physician Decision|1|||
160782100|NCT02056288|580587263|FG001|In-Hospital Data|Physician Decision|0|||
160782101|NCT02056288|580587262|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
160782102|NCT02056288|580587263|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
160782103|NCT02400580|580587266|FG000|Overall Study|Withdrawal by Subject|1|||
160782104|NCT02400580|580587267|FG001|Overall Study|Withdrawal by Subject|1|||
160782105|NCT02400580|580587266|FG000|Overall Study|Adverse Event|1|||
160782106|NCT02400580|580587267|FG001|Overall Study|Adverse Event|0|||
160782107|NCT00965094|580587268|FG000|Overall Study|Adverse Event|5|||
160782108|NCT00965094|580587269|FG001|Overall Study|Adverse Event|0|||
160782109|NCT00965094|580587268|FG000|Overall Study|Lost to Follow-up|0|||
160782110|NCT00965094|580587269|FG001|Overall Study|Lost to Follow-up|1|||
160782111|NCT01433978|580587270|FG000|Core Study|Adverse Event, Non-Fatal|0|||
160782112|NCT01433978|580587271|FG001|Core Study|Adverse Event, Non-Fatal|1|||
160782113|NCT01433978|580587272|FG002|Core Study|Adverse Event, Non-Fatal|0|||
160782114|NCT01433978|580587270|FG000|Core Study|Lack of Efficacy|5|||
160782115|NCT01433978|580587271|FG001|Core Study|Lack of Efficacy|1|||
160782116|NCT01433978|580587272|FG002|Core Study|Lack of Efficacy|0|||
160782117|NCT01433978|580587270|FG000|Core Study|Study Terminated by Sponsor|6|||
160782118|NCT01433978|580587271|FG001|Core Study|Study Terminated by Sponsor|9|||
160782119|NCT01433978|580587272|FG002|Core Study|Study Terminated by Sponsor|0|||
160782120|NCT01433978|580587270|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
160782121|NCT01433978|580587271|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
160782122|NCT01433978|580587272|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
160782123|NCT01433978|580587270|FG000|Extension Phase|Lack of Efficacy|0|||
160782124|NCT01433978|580587271|FG001|Extension Phase|Lack of Efficacy|0|||
160782125|NCT01433978|580587272|FG002|Extension Phase|Lack of Efficacy|1|||
160782126|NCT01433978|580587270|FG000|Extension Phase|Study Terminated by Sponsor|0|||
160782127|NCT01433978|580587271|FG001|Extension Phase|Study Terminated by Sponsor|0|||
160782128|NCT01433978|580587272|FG002|Extension Phase|Study Terminated by Sponsor|4|||
160782129|NCT01773889|580587273|FG000|Overall Study|lack of funding|2|||
160782130|NCT04233580|580587275|FG000|Overall Study|Adverse Event|3|||
160782131|NCT04233580|580587276|FG001|Overall Study|Adverse Event|3|||
160782132|NCT04233580|580587275|FG000|Overall Study|Withdrawal by Subject|2|||
160782133|NCT04233580|580587276|FG001|Overall Study|Withdrawal by Subject|1|||
160782134|NCT05156125|580587277|FG000|Overall Study|Lack of Efficacy|1|||
160782135|NCT05156125|580587278|FG001|Overall Study|Lack of Efficacy|1|||
160782136|NCT05156125|580587279|FG002|Overall Study|Lack of Efficacy|1|||
160782137|NCT05156125|580587277|FG000|Overall Study|Physician Decision|0|||
160782138|NCT05156125|580587278|FG001|Overall Study|Physician Decision|0|||
160782139|NCT05156125|580587279|FG002|Overall Study|Physician Decision|1|||
160782140|NCT05156125|580587277|FG000|Overall Study|Non-compliance|0|||
160782141|NCT05156125|580587278|FG001|Overall Study|Non-compliance|1|||
160782142|NCT05156125|580587279|FG002|Overall Study|Non-compliance|1|||
160782143|NCT05156125|580587277|FG000|Overall Study|Withdrawal by Subject|0|||
160782144|NCT05156125|580587278|FG001|Overall Study|Withdrawal by Subject|0|||
160782145|NCT05156125|580587279|FG002|Overall Study|Withdrawal by Subject|1|||
160782146|NCT05156125|580587277|FG000|Overall Study|Adverse Event|2|||
160782147|NCT05156125|580587278|FG001|Overall Study|Adverse Event|1|||
160782148|NCT05156125|580587279|FG002|Overall Study|Adverse Event|0|||
160782149|NCT03338023|580587282|FG000|Overall Study|Withdrawal by Subject|3|||
160782150|NCT03338023|580587283|FG001|Overall Study|Withdrawal by Subject|4|||
160782151|NCT03338023|580587282|FG000|Overall Study|Protocol Violation|3|||
161124626|NCT00094757|581843766|FG000|Overall Study|Adverse Event|11|||
160782152|NCT03338023|580587283|FG001|Overall Study|Protocol Violation|3|||
160782153|NCT03338023|580587282|FG000|Overall Study|Lost to Follow-up|2|||
160782154|NCT03338023|580587283|FG001|Overall Study|Lost to Follow-up|1|||
161124627|NCT00094757|581843767|FG001|Overall Study|Adverse Event|9|||
160782155|NCT03338023|580587282|FG000|Overall Study|Physician Decision|1|||
160782156|NCT03338023|580587283|FG001|Overall Study|Physician Decision|2|||
160782157|NCT00433290|580587284|FG000|Overall Study|Adverse Event|24|||
160782158|NCT00433290|580587285|FG001|Overall Study|Adverse Event|7|||
160782159|NCT00433290|580587284|FG000|Overall Study|Lack of Efficacy|1|||
160782160|NCT00433290|580587285|FG001|Overall Study|Lack of Efficacy|5|||
160782161|NCT00433290|580587284|FG000|Overall Study|Withdrawal by Subject|4|||
160782162|NCT00433290|580587285|FG001|Overall Study|Withdrawal by Subject|2|||
160782163|NCT00433290|580587284|FG000|Overall Study|Protocol Violation|3|||
160782164|NCT00433290|580587285|FG001|Overall Study|Protocol Violation|2|||
161327378|NCT00249873|582585366|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
161327379|NCT00249873|582585367|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
161124628|NCT00094757|581843768|FG002|Overall Study|Adverse Event|6|||
161124629|NCT00094757|581843766|FG000|Overall Study|Lack of Efficacy|11|||
161124630|NCT00094757|581843767|FG001|Overall Study|Lack of Efficacy|15|||
161124631|NCT00094757|581843768|FG002|Overall Study|Lack of Efficacy|8|||
161124632|NCT00094757|581843766|FG000|Overall Study|Lost to Follow-up|3|||
161124633|NCT00094757|581843767|FG001|Overall Study|Lost to Follow-up|5|||
161124634|NCT00094757|581843768|FG002|Overall Study|Lost to Follow-up|6|||
161124635|NCT00094757|581843766|FG000|Overall Study|Patient Moved|2|||
161124636|NCT00094757|581843767|FG001|Overall Study|Patient Moved|1|||
161124637|NCT00094757|581843768|FG002|Overall Study|Patient Moved|1|||
161124638|NCT00094757|581843766|FG000|Overall Study|Protocol Violation|8|||
161124639|NCT00094757|581843767|FG001|Overall Study|Protocol Violation|5|||
161124640|NCT00094757|581843768|FG002|Overall Study|Protocol Violation|3|||
161124641|NCT00094757|581843766|FG000|Overall Study|Withdrawal by Subject|14|||
161124642|NCT00094757|581843767|FG001|Overall Study|Withdrawal by Subject|21|||
161124643|NCT00094757|581843768|FG002|Overall Study|Withdrawal by Subject|5|||
161124644|NCT00094757|581843766|FG000|Overall Study|Other|3|||
161124645|NCT00094757|581843767|FG001|Overall Study|Other|3|||
161124646|NCT00094757|581843768|FG002|Overall Study|Other|1|||
161124647|NCT00094757|581843766|FG000|Overall Study|Protocol specified discontinuation|1|||
161124648|NCT00094757|581843767|FG001|Overall Study|Protocol specified discontinuation|3|||
161124649|NCT00094757|581843768|FG002|Overall Study|Protocol specified discontinuation|0|||
161124650|NCT01463098|581843773|FG000|Part A (11 Days)|Participant Choice|2|||
161124651|NCT01463098|581843774|FG001|Part A (11 Days)|Participant Choice|0|||
161124652|NCT01463098|581843775|FG002|Part A (11 Days)|Participant Choice|0|||
161124653|NCT01463098|581843776|FG003|Part A (11 Days)|Participant Choice|0|||
161124654|NCT01463098|581843777|FG004|Part A (11 Days)|Participant Choice|0|||
161124655|NCT01463098|581843778|FG005|Part A (11 Days)|Participant Choice|0|||
161124656|NCT01463098|581843779|FG006|Part A (11 Days)|Participant Choice|0|||
161124657|NCT01463098|581843780|FG007|Part A (11 Days)|Participant Choice|0|||
161124658|NCT01463098|581843781|FG008|Part A (11 Days)|Participant Choice|1|||
161124659|NCT01463098|581843782|FG009|Part A (11 Days)|Participant Choice|0|||
161124660|NCT01463098|581843783|FG010|Part A (11 Days)|Participant Choice|0|||
161124661|NCT01463098|581843784|FG011|Part A (11 Days)|Participant Choice|0|||
161124662|NCT01463098|581843785|FG012|Part A (11 Days)|Participant Choice|0|||
161124663|NCT01463098|581843786|FG013|Part A (11 Days)|Participant Choice|0|||
161124664|NCT01463098|581843773|FG000|Part A (11 Days)|Lost to Follow-up|0|||
161124665|NCT01463098|581843774|FG001|Part A (11 Days)|Lost to Follow-up|0|||
161124666|NCT01463098|581843775|FG002|Part A (11 Days)|Lost to Follow-up|0|||
161124667|NCT01463098|581843776|FG003|Part A (11 Days)|Lost to Follow-up|0|||
161124668|NCT01463098|581843777|FG004|Part A (11 Days)|Lost to Follow-up|1|||
161124669|NCT01463098|581843778|FG005|Part A (11 Days)|Lost to Follow-up|0|||
161124670|NCT01463098|581843779|FG006|Part A (11 Days)|Lost to Follow-up|0|||
161124671|NCT01463098|581843780|FG007|Part A (11 Days)|Lost to Follow-up|0|||
161124672|NCT01463098|581843781|FG008|Part A (11 Days)|Lost to Follow-up|0|||
161124673|NCT01463098|581843782|FG009|Part A (11 Days)|Lost to Follow-up|0|||
161124674|NCT01463098|581843783|FG010|Part A (11 Days)|Lost to Follow-up|0|||
161124675|NCT01463098|581843784|FG011|Part A (11 Days)|Lost to Follow-up|0|||
161124676|NCT01463098|581843785|FG012|Part A (11 Days)|Lost to Follow-up|0|||
161124677|NCT01463098|581843786|FG013|Part A (11 Days)|Lost to Follow-up|0|||
161124678|NCT01463098|581843773|FG000|Part B (11 Days)|Participant Choice|0|||
161124679|NCT01463098|581843774|FG001|Part B (11 Days)|Participant Choice|0|||
161124680|NCT01463098|581843775|FG002|Part B (11 Days)|Participant Choice|0|||
161124681|NCT01463098|581843776|FG003|Part B (11 Days)|Participant Choice|0|||
161124682|NCT01463098|581843777|FG004|Part B (11 Days)|Participant Choice|0|||
161124683|NCT01463098|581843778|FG005|Part B (11 Days)|Participant Choice|0|||
161124684|NCT01463098|581843779|FG006|Part B (11 Days)|Participant Choice|0|||
161124685|NCT01463098|581843780|FG007|Part B (11 Days)|Participant Choice|0|||
161124686|NCT01463098|581843781|FG008|Part B (11 Days)|Participant Choice|0|||
161124687|NCT01463098|581843782|FG009|Part B (11 Days)|Participant Choice|0|||
161124688|NCT01463098|581843783|FG010|Part B (11 Days)|Participant Choice|0|||
161124689|NCT01463098|581843784|FG011|Part B (11 Days)|Participant Choice|1|||
161124690|NCT01463098|581843785|FG012|Part B (11 Days)|Participant Choice|0|||
161124691|NCT01463098|581843786|FG013|Part B (11 Days)|Participant Choice|0|||
161124692|NCT00395967|581843787|FG000|Treatment Period|Failed Mobilization|1|||
161124693|NCT00395967|581843787|FG000|Follow-up Period|Death|1|||
161124694|NCT00395967|581843787|FG000|Follow-up Period|Lost to Follow-up|1|||
161327380|NCT00249873|582585366|FG000|Overall Study|Other Serious Adverse Event|86|||
161124695|NCT01262976|581843788|FG000|Up to Month 2|Serious Adverse Event|0|||
161124696|NCT01262976|581843789|FG001|Up to Month 2|Serious Adverse Event|0|||
161124697|NCT01262976|581843790|FG002|Up to Month 2|Serious Adverse Event|1|||
161124698|NCT01262976|581843791|FG003|Up to Month 2|Serious Adverse Event|0|||
161124699|NCT01262976|581843792|FG004|Up to Month 2|Serious Adverse Event|0|||
161124700|NCT01262976|581843793|FG005|Up to Month 2|Serious Adverse Event|0|||
160782165|NCT00433290|580587284|FG000|Overall Study|Physician Decision|2|||
160782166|NCT00433290|580587285|FG001|Overall Study|Physician Decision|0|||
160782167|NCT00433290|580587284|FG000|Overall Study|Entry Criteria Not Met|0|||
160782168|NCT00433290|580587285|FG001|Overall Study|Entry Criteria Not Met|1|||
160782169|NCT00433290|580587284|FG000|Overall Study|Lost to Follow-up|1|||
160782170|NCT00433290|580587285|FG001|Overall Study|Lost to Follow-up|0|||
160782171|NCT00086307|580587286|FG000|Overall Study|Lack of Efficacy|1|||
160782172|NCT00086307|580587287|FG001|Overall Study|Lack of Efficacy|1|||
160782173|NCT00086307|580587288|FG002|Overall Study|Lack of Efficacy|2|||
160782174|NCT00086307|580587286|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
160782175|NCT00086307|580587287|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
160782176|NCT00086307|580587288|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
160782177|NCT00086307|580587286|FG000|Overall Study|Nausea and headaches|0|||
160782178|NCT00086307|580587287|FG001|Overall Study|Nausea and headaches|0|||
160782179|NCT00086307|580587288|FG002|Overall Study|Nausea and headaches|1|||
160782180|NCT00086307|580587286|FG000|Overall Study|Constipation and sleepiness|0|||
160782181|NCT00086307|580587287|FG001|Overall Study|Constipation and sleepiness|0|||
160782182|NCT00086307|580587288|FG002|Overall Study|Constipation and sleepiness|1|||
160782183|NCT00086307|580587286|FG000|Overall Study|Suicidal ideation|0|||
160782184|NCT00086307|580587287|FG001|Overall Study|Suicidal ideation|0|||
160782185|NCT00086307|580587288|FG002|Overall Study|Suicidal ideation|1|||
160782186|NCT00086307|580587286|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
160782187|NCT00086307|580587287|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
160782188|NCT00086307|580587288|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
160782189|NCT00086307|580587286|FG000|Overall Study|Withdrawal by Subject|0|||
160782190|NCT00086307|580587287|FG001|Overall Study|Withdrawal by Subject|0|||
160782191|NCT00086307|580587288|FG002|Overall Study|Withdrawal by Subject|2|||
160782192|NCT03158311|580587291|FG000|Overall Study|Subject/Guardian Decision|10|||
160782193|NCT03158311|580587292|FG001|Overall Study|Subject/Guardian Decision|6|||
160782194|NCT03158311|580587293|FG002|Overall Study|Subject/Guardian Decision|11|||
160782195|NCT03158311|580587291|FG000|Overall Study|Adverse Event|5|||
160782196|NCT03158311|580587292|FG001|Overall Study|Adverse Event|3|||
160782197|NCT03158311|580587293|FG002|Overall Study|Adverse Event|3|||
160782198|NCT03158311|580587291|FG000|Overall Study|Techinical Problems|3|||
160782199|NCT03158311|580587292|FG001|Overall Study|Techinical Problems|1|||
160782200|NCT03158311|580587293|FG002|Overall Study|Techinical Problems|5|||
160782201|NCT03158311|580587291|FG000|Overall Study|Physician Decision|2|||
160782202|NCT03158311|580587292|FG001|Overall Study|Physician Decision|3|||
160782203|NCT03158311|580587293|FG002|Overall Study|Physician Decision|7|||
160782204|NCT03158311|580587291|FG000|Overall Study|Lost to Follow-up|1|||
160782205|NCT03158311|580587292|FG001|Overall Study|Lost to Follow-up|1|||
160782206|NCT03158311|580587293|FG002|Overall Study|Lost to Follow-up|1|||
160782207|NCT03158311|580587291|FG000|Overall Study|Sponsor decision|1|||
160782208|NCT03158311|580587292|FG001|Overall Study|Sponsor decision|0|||
160782209|NCT03158311|580587293|FG002|Overall Study|Sponsor decision|0|||
160782210|NCT03158311|580587291|FG000|Overall Study|Pregnancy|0|||
160782211|NCT03158311|580587292|FG001|Overall Study|Pregnancy|2|||
160782212|NCT03158311|580587293|FG002|Overall Study|Pregnancy|0|||
160782213|NCT03158311|580587291|FG000|Overall Study|Randomized in error|0|||
160782214|NCT03158311|580587292|FG001|Overall Study|Randomized in error|0|||
160782215|NCT03158311|580587293|FG002|Overall Study|Randomized in error|1|||
160889781|NCT03206073|580991511|FG001|Overall Study|Death|0|||
160889782|NCT03206073|580991512|FG002|Overall Study|Death|1|||
160889783|NCT03206073|580991513|FG003|Overall Study|Death|0|||
160889784|NCT03206073|580991510|FG000|Overall Study|Taken off active treatment|0|||
160889785|NCT03206073|580991511|FG001|Overall Study|Taken off active treatment|0|||
160889786|NCT03206073|580991512|FG002|Overall Study|Taken off active treatment|3|||
161230298|NCT01746017|582225720|FG002|Period 1|Withdrawal by Subject|0|||
161230299|NCT01746017|582225721|FG003|Period 1|Withdrawal by Subject|0|||
161230300|NCT01746017|582225722|FG004|Period 1|Withdrawal by Subject|0|||
160782216|NCT01018953|580587294|FG000|Overall Study|Adverse Event|2|||
160782217|NCT01018953|580587294|FG000|Overall Study|Withdrawal by Subject|1|||
160782218|NCT01018953|580587294|FG000|Overall Study|Study termination by sponsor|5|||
160782219|NCT00724503|580587295|FG000|Overall Study|Lost to Follow-up|4|||
160782220|NCT00724503|580587296|FG001|Overall Study|Lost to Follow-up|8|||
160782221|NCT00724503|580587295|FG000|Overall Study|Withdrawal by Subject|11|||
160782222|NCT00724503|580587296|FG001|Overall Study|Withdrawal by Subject|23|||
160782223|NCT00724503|580587295|FG000|Overall Study|Death|190|||
160782224|NCT00724503|580587296|FG001|Overall Study|Death|182|||
160782225|NCT00724503|580587295|FG000|Overall Study|Adverse Event|1|||
161230301|NCT01746017|582225723|FG005|Period 1|Withdrawal by Subject|0|||
160782226|NCT00724503|580587296|FG001|Overall Study|Adverse Event|0|||
160782227|NCT00724503|580587295|FG000|Overall Study|Not otherwise specified|4|||
160782228|NCT00724503|580587296|FG001|Overall Study|Not otherwise specified|7|||
160782229|NCT01186419|580587297|FG000|Overall Study|Withdrawal by Subject|5|||
160889787|NCT03206073|580991513|FG003|Overall Study|Taken off active treatment|0|||
160889788|NCT05523323|580991514|FG000|Overall Study|Death|26|||
160889789|NCT05523323|580991515|FG001|Overall Study|Death|21|||
160782230|NCT01186419|580587298|FG001|Overall Study|Withdrawal by Subject|3|||
160782231|NCT01186419|580587297|FG000|Overall Study|Adverse Event|1|||
160782232|NCT01186419|580587298|FG001|Overall Study|Adverse Event|2|||
160782233|NCT01186419|580587297|FG000|Overall Study|Physician Decision|0|||
160782234|NCT01186419|580587298|FG001|Overall Study|Physician Decision|3|||
160782235|NCT01186419|580587297|FG000|Overall Study|Other|1|||
160782236|NCT01186419|580587298|FG001|Overall Study|Other|1|||
160782237|NCT01560416|580587310|FG000|Randomized Phase|Crossover Participants|7|||
160782238|NCT01560416|580587311|FG001|Randomized Phase|Crossover Participants|0|||
160782239|NCT01033071|580587312|FG000|Overall Study|Adverse Event|28|||
160782240|NCT01033071|580587313|FG001|Overall Study|Adverse Event|51|||
160782241|NCT01033071|580587314|FG002|Overall Study|Adverse Event|26|||
160782242|NCT01033071|580587312|FG000|Overall Study|Protocol Violation|0|||
160782243|NCT01033071|580587313|FG001|Overall Study|Protocol Violation|2|||
160782244|NCT01033071|580587314|FG002|Overall Study|Protocol Violation|1|||
160782245|NCT01033071|580587312|FG000|Overall Study|Lost to Follow-up|4|||
160782246|NCT01033071|580587313|FG001|Overall Study|Lost to Follow-up|5|||
160782247|NCT01033071|580587314|FG002|Overall Study|Lost to Follow-up|5|||
160782248|NCT01033071|580587312|FG000|Overall Study|Withdrawal by Subject|17|||
160782249|NCT01033071|580587313|FG001|Overall Study|Withdrawal by Subject|14|||
160782250|NCT01033071|580587314|FG002|Overall Study|Withdrawal by Subject|11|||
160782251|NCT01033071|580587312|FG000|Overall Study|Lack of Efficacy|0|||
160782252|NCT01033071|580587313|FG001|Overall Study|Lack of Efficacy|1|||
160782253|NCT01033071|580587314|FG002|Overall Study|Lack of Efficacy|1|||
160782254|NCT01033071|580587312|FG000|Overall Study|Other|6|||
160889790|NCT05523323|580991514|FG000|Overall Study|Ongoing participants|35|||
160889791|NCT05523323|580991515|FG001|Overall Study|Ongoing participants|30|||
160889792|NCT02428608|580991520|FG000|Overall Study|Pregnancy|2|||
160889793|NCT02428608|580991520|FG000|Overall Study|Lost to Follow-up|37|||
160889794|NCT02428608|580991520|FG000|Overall Study|Withdrawal by Subject|2|||
160889795|NCT02428608|580991520|FG000|Overall Study|scheduling conflicts|15|||
160889796|NCT02428608|580991520|FG000|Overall Study|moved away|10|||
160889797|NCT02428608|580991520|FG000|Overall Study|Death|1|||
160889798|NCT02428608|580991520|FG000|Overall Study|various|16|||
160889799|NCT01117051|580991526|FG000|Overall Study|Withdrawal by Subject|5|||
160889800|NCT01117051|580991527|FG001|Overall Study|Withdrawal by Subject|3|||
160889801|NCT01117051|580991526|FG000|Overall Study|Adverse Event|4|||
160889802|NCT01117051|580991527|FG001|Overall Study|Adverse Event|3|||
160889803|NCT01117051|580991526|FG000|Overall Study|Lost to Follow-up|0|||
160889804|NCT01117051|580991527|FG001|Overall Study|Lost to Follow-up|1|||
160889805|NCT01117051|580991526|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
160889806|NCT01117051|580991527|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
160889807|NCT01117051|580991526|FG000|Overall Study|Sponsor's decision|3|||
160889808|NCT01117051|580991527|FG001|Overall Study|Sponsor's decision|1|||
160889809|NCT01117051|580991526|FG000|Overall Study|Surgical procedure|0|||
160889810|NCT01117051|580991527|FG001|Overall Study|Surgical procedure|1|||
160889811|NCT01117051|580991526|FG000|Overall Study|Randomized by mistake|0|||
160889812|NCT01117051|580991527|FG001|Overall Study|Randomized by mistake|1|||
160889813|NCT01117051|580991526|FG000|Overall Study|Convenience issue|1|||
160889814|NCT01117051|580991527|FG001|Overall Study|Convenience issue|0|||
160889815|NCT00206076|580991529|FG000|Overall Study|Physician Decision|2|||
160889816|NCT00206076|580991530|FG001|Overall Study|Physician Decision|0|||
160889817|NCT00206076|580991529|FG000|Overall Study|Withdrawal by Subject|1|||
160889818|NCT00206076|580991530|FG001|Overall Study|Withdrawal by Subject|1|||
160782255|NCT01033071|580587313|FG001|Overall Study|Other|4|||
160782256|NCT01033071|580587314|FG002|Overall Study|Other|3|||
160782257|NCT00884949|580588880|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
160889819|NCT00427960|580991531|FG000|Overall Study|Adverse Event|2|||
160889820|NCT00427960|580991532|FG001|Overall Study|Adverse Event|0|||
160889821|NCT00427960|580991531|FG000|Overall Study|Withdrawal by Subject|0|||
160889822|NCT00427960|580991532|FG001|Overall Study|Withdrawal by Subject|3|||
160889823|NCT00427960|580991531|FG000|Overall Study|Other|0|||
160782258|NCT00884949|580588880|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
160782259|NCT00758043|580588881|FG000|Overall Study|Adverse Event|1|||
160782260|NCT00758043|580588882|FG001|Overall Study|Adverse Event|20|||
160782261|NCT00758043|580588883|FG002|Overall Study|Adverse Event|12|||
160782262|NCT00758043|580588884|FG003|Overall Study|Adverse Event|62|||
160782263|NCT00758043|580588881|FG000|Overall Study|Lack of Efficacy|0|||
160782264|NCT00758043|580588882|FG001|Overall Study|Lack of Efficacy|6|||
160782265|NCT00758043|580588883|FG002|Overall Study|Lack of Efficacy|18|||
160782266|NCT00758043|580588884|FG003|Overall Study|Lack of Efficacy|12|||
160782267|NCT00758043|580588881|FG000|Overall Study|Refused Further Treatment|0|||
160889824|NCT00427960|580991532|FG001|Overall Study|Other|1|||
160889825|NCT01142128|580991533|FG000|Overall Study|Physician Decision|1|||
160889826|NCT01142128|580991533|FG000|Overall Study|Lost to Follow-up|1|||
160889827|NCT01142128|580991533|FG000|Overall Study|Withdrawal by Subject|2|||
160889828|NCT03355664|580991534|FG000|Overall Study|Adverse Event|1|||
160889829|NCT03355664|580991535|FG001|Overall Study|Adverse Event|2|||
160889830|NCT03355664|580991534|FG000|Overall Study|Lost to Follow-up|11|||
160889831|NCT03355664|580991535|FG001|Overall Study|Lost to Follow-up|7|||
160782268|NCT00758043|580588882|FG001|Overall Study|Refused Further Treatment|11|||
160782269|NCT00758043|580588883|FG002|Overall Study|Refused Further Treatment|5|||
160782270|NCT00758043|580588884|FG003|Overall Study|Refused Further Treatment|8|||
160782271|NCT00758043|580588881|FG000|Overall Study|Lost to Follow-up|0|||
160782272|NCT00758043|580588882|FG001|Overall Study|Lost to Follow-up|2|||
160782273|NCT00758043|580588883|FG002|Overall Study|Lost to Follow-up|2|||
160782274|NCT00758043|580588884|FG003|Overall Study|Lost to Follow-up|5|||
160782275|NCT00758043|580588881|FG000|Overall Study|Withdrawal by Subject|0|||
160782276|NCT00758043|580588882|FG001|Overall Study|Withdrawal by Subject|1|||
160782277|NCT00758043|580588883|FG002|Overall Study|Withdrawal by Subject|1|||
160782278|NCT00758043|580588884|FG003|Overall Study|Withdrawal by Subject|4|||
160782279|NCT00758043|580588881|FG000|Overall Study|Required Prohibited Medication|0|||
160782280|NCT00758043|580588882|FG001|Overall Study|Required Prohibited Medication|0|||
160889832|NCT03355664|580991534|FG000|Overall Study|Protocol Violation|1|||
160889833|NCT03355664|580991535|FG001|Overall Study|Protocol Violation|2|||
160889834|NCT03355664|580991534|FG000|Overall Study|Withdrawal by Subject|2|||
160889835|NCT03355664|580991535|FG001|Overall Study|Withdrawal by Subject|1|||
160889836|NCT00521001|580991538|FG000|Overall Study|Ineligible|1|||
160889837|NCT02821910|580991539|FG000|Overall Study|Withdrawal by Subject|0|||
160889838|NCT02821910|580991540|FG001|Overall Study|Withdrawal by Subject|0|||
160889839|NCT02821910|580991541|FG002|Overall Study|Withdrawal by Subject|1|||
160889840|NCT02821910|580991542|FG003|Overall Study|Withdrawal by Subject|0|||
160889841|NCT02821910|580991543|FG004|Overall Study|Withdrawal by Subject|0|||
160889842|NCT02821910|580991544|FG005|Overall Study|Withdrawal by Subject|1|||
160889843|NCT02821910|580991539|FG000|Overall Study|Other than specified|1|||
160889844|NCT02821910|580991540|FG001|Overall Study|Other than specified|0|||
160889845|NCT02821910|580991541|FG002|Overall Study|Other than specified|1|||
160889846|NCT02821910|580991542|FG003|Overall Study|Other than specified|0|||
160889847|NCT02821910|580991543|FG004|Overall Study|Other than specified|0|||
160889848|NCT02821910|580991544|FG005|Overall Study|Other than specified|0|||
160889849|NCT00900601|580991547|FG000|Overall Study|Physician Decision|1|||
160889850|NCT01082640|580991549|FG000|Overall Study|Adverse Event|9|||
160889851|NCT01082640|580991550|FG001|Overall Study|Adverse Event|5|||
160889852|NCT01082640|580991551|FG002|Overall Study|Adverse Event|3|||
160889853|NCT01082640|580991549|FG000|Overall Study|Withdrawal by Subject|3|||
160889854|NCT01082640|580991550|FG001|Overall Study|Withdrawal by Subject|3|||
160889855|NCT01082640|580991551|FG002|Overall Study|Withdrawal by Subject|2|||
160889856|NCT01082640|580991549|FG000|Overall Study|Major protocol deviation|3|||
160889857|NCT01082640|580991550|FG001|Overall Study|Major protocol deviation|3|||
160889858|NCT01082640|580991551|FG002|Overall Study|Major protocol deviation|0|||
160889859|NCT01082640|580991549|FG000|Overall Study|Lost to Follow-up|0|||
160889860|NCT01082640|580991550|FG001|Overall Study|Lost to Follow-up|3|||
160889861|NCT01082640|580991551|FG002|Overall Study|Lost to Follow-up|0|||
160889862|NCT01082640|580991549|FG000|Overall Study|Other|2|||
160889863|NCT01082640|580991550|FG001|Overall Study|Other|1|||
160889864|NCT01082640|580991551|FG002|Overall Study|Other|3|||
160889865|NCT03823378|580991556|FG000|Overall Study|Adverse Event|2|||
160889866|NCT03823378|580991557|FG001|Overall Study|Adverse Event|2|||
160889867|NCT03823378|580991558|FG002|Overall Study|Adverse Event|0|||
160889868|NCT03823378|580991559|FG003|Overall Study|Adverse Event|0|||
160889869|NCT03823378|580991560|FG004|Overall Study|Adverse Event|0|||
160889870|NCT03823378|580991561|FG005|Overall Study|Adverse Event|0|||
160889871|NCT03823378|580991556|FG000|Overall Study|Lost to Follow-up|0|||
160889872|NCT03823378|580991557|FG001|Overall Study|Lost to Follow-up|1|||
160889873|NCT03823378|580991558|FG002|Overall Study|Lost to Follow-up|0|||
160889874|NCT03823378|580991559|FG003|Overall Study|Lost to Follow-up|0|||
160889875|NCT03823378|580991560|FG004|Overall Study|Lost to Follow-up|1|||
160889876|NCT03823378|580991561|FG005|Overall Study|Lost to Follow-up|0|||
160889877|NCT03823378|580991556|FG000|Overall Study|Withdrawal by Subject|0|||
160889878|NCT03823378|580991557|FG001|Overall Study|Withdrawal by Subject|1|||
160889879|NCT03823378|580991558|FG002|Overall Study|Withdrawal by Subject|4|||
160889880|NCT03823378|580991559|FG003|Overall Study|Withdrawal by Subject|2|||
160889881|NCT03823378|580991560|FG004|Overall Study|Withdrawal by Subject|0|||
160782281|NCT00758043|580588883|FG002|Overall Study|Required Prohibited Medication|1|||
160782282|NCT00758043|580588884|FG003|Overall Study|Required Prohibited Medication|3|||
160889882|NCT03823378|580991561|FG005|Overall Study|Withdrawal by Subject|1|||
160889883|NCT03823378|580991556|FG000|Overall Study|Other, not specified|19|||
160889884|NCT03823378|580991557|FG001|Overall Study|Other, not specified|12|||
160889885|NCT03823378|580991558|FG002|Overall Study|Other, not specified|6|||
160889886|NCT03823378|580991559|FG003|Overall Study|Other, not specified|8|||
160889887|NCT03823378|580991560|FG004|Overall Study|Other, not specified|17|||
160889888|NCT03823378|580991561|FG005|Overall Study|Other, not specified|7|||
160889889|NCT01052844|580991564|FG000|Overall Study|Adverse Event|0|||
160889890|NCT01052844|580991565|FG001|Overall Study|Adverse Event|1|||
160889891|NCT01289782|580991566|FG000|Overall Study|Lost to Follow-up|14|||
160889892|NCT01289782|580991567|FG001|Overall Study|Lost to Follow-up|7|||
160889893|NCT01289782|580991566|FG000|Overall Study|Protocol Violation|1|||
160782283|NCT00758043|580588881|FG000|Overall Study|Non-Compliant With study Drug|0|||
160782284|NCT00758043|580588882|FG001|Overall Study|Non-Compliant With study Drug|0|||
160782285|NCT00758043|580588883|FG002|Overall Study|Non-Compliant With study Drug|0|||
160782286|NCT00758043|580588884|FG003|Overall Study|Non-Compliant With study Drug|1|||
160782287|NCT00758043|580588881|FG000|Overall Study|Other Reasons|0|||
160782288|NCT00758043|580588882|FG001|Overall Study|Other Reasons|1|||
160782289|NCT00758043|580588883|FG002|Overall Study|Other Reasons|0|||
160782290|NCT00758043|580588884|FG003|Overall Study|Other Reasons|5|||
160782291|NCT03315689|580588895|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
160782292|NCT03315689|580588896|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
160782293|NCT03315689|580588895|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
160782294|NCT03315689|580588896|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
160782295|NCT03315689|580588895|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
160782296|NCT03315689|580588896|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
160782297|NCT03073109|580588897|FG000|Overall Study|Adverse Event|0|||
160782298|NCT03073109|580588898|FG001|Overall Study|Adverse Event|1|||
160782299|NCT03073109|580588897|FG000|Overall Study|Other|2|||
160782300|NCT03073109|580588898|FG001|Overall Study|Other|0|||
160782301|NCT03073109|580588897|FG000|Overall Study|Lost to Follow-up|8|||
160782302|NCT03073109|580588898|FG001|Overall Study|Lost to Follow-up|1|||
160782303|NCT00669331|580588899|FG000|Randomisation to First Dose|Adverse Event|1|||
160782304|NCT00669331|580588900|FG001|Randomisation to First Dose|Adverse Event|0|||
160782305|NCT00669331|580588899|FG000|Randomisation to First Dose|Protocol Violation|1|||
160782306|NCT00669331|580588900|FG001|Randomisation to First Dose|Protocol Violation|0|||
160782307|NCT00669331|580588899|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
160782308|NCT00669331|580588900|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
160782309|NCT00669331|580588899|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
160782310|NCT00669331|580588900|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
160782311|NCT00669331|580588899|FG000|Randomisation to First Dose|Death|1|||
160782312|NCT00669331|580588900|FG001|Randomisation to First Dose|Death|0|||
160782313|NCT00669331|580588899|FG000|Randomisation to First Dose|Sponsor decision|0|||
160782314|NCT00669331|580588900|FG001|Randomisation to First Dose|Sponsor decision|1|||
160782315|NCT00669331|580588899|FG000|Randomisation to First Dose|Randomised in error|3|||
160782316|NCT00669331|580588900|FG001|Randomisation to First Dose|Randomised in error|10|||
160782317|NCT00669331|580588899|FG000|Blinded Treatment Period|Adverse Event|16|||
160782318|NCT00669331|580588900|FG001|Blinded Treatment Period|Adverse Event|10|||
160782319|NCT00669331|580588899|FG000|Blinded Treatment Period|Protocol Violation|1|||
160782320|NCT00669331|580588900|FG001|Blinded Treatment Period|Protocol Violation|1|||
160782321|NCT00669331|580588899|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
160782322|NCT00669331|580588900|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
160782323|NCT00669331|580588899|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
161327381|NCT00249873|582585367|FG001|Overall Study|Other Serious Adverse Event|97|||
161327382|NCT00249873|582585366|FG000|Overall Study|Qualifying condition not present|20|||
161327383|NCT00249873|582585367|FG001|Overall Study|Qualifying condition not present|23|||
161327384|NCT00249873|582585366|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
160889894|NCT01289782|580991567|FG001|Overall Study|Protocol Violation|1|||
160889895|NCT01289782|580991566|FG000|Overall Study|Withdrawal by Subject|8|||
160889896|NCT01289782|580991567|FG001|Overall Study|Withdrawal by Subject|2|||
160889897|NCT01289782|580991566|FG000|Overall Study|Sponsor's Decision|1|||
161327385|NCT00249873|582585367|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
160782324|NCT00669331|580588900|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
160782325|NCT00669331|580588899|FG000|Blinded Treatment Period|Death|0|||
160782326|NCT00669331|580588900|FG001|Blinded Treatment Period|Death|2|||
160889898|NCT01289782|580991567|FG001|Overall Study|Sponsor's Decision|0|||
160889899|NCT01289782|580991566|FG000|Overall Study|Reason not specified|1|||
161327386|NCT00249873|582585366|FG000|Overall Study|Withdrawal by Subject|504|||
161327387|NCT00249873|582585367|FG001|Overall Study|Withdrawal by Subject|466|||
161327388|NCT00249873|582585366|FG000|Overall Study|Lost to Follow-up|4|||
161327389|NCT00249873|582585367|FG001|Overall Study|Lost to Follow-up|7|||
161327390|NCT00249873|582585366|FG000|Overall Study|Minor bleeding|99|||
161327391|NCT00249873|582585367|FG001|Overall Study|Minor bleeding|37|||
161327392|NCT00249873|582585366|FG000|Overall Study|Non-compliance|41|||
161327393|NCT00249873|582585367|FG001|Overall Study|Non-compliance|46|||
160782327|NCT00669331|580588899|FG000|Blinded Treatment Period|Physician Decision|3|||
160782328|NCT00669331|580588900|FG001|Blinded Treatment Period|Physician Decision|3|||
160782329|NCT00669331|580588899|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
160782330|NCT00669331|580588900|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
160782331|NCT03387046|580588901|FG000|Overall Study|Adverse Event|1|||
160889900|NCT01289782|580991567|FG001|Overall Study|Reason not specified|2|||
160889901|NCT02093026|580991568|FG000|Overall Study|Adverse Event|26|||
160889902|NCT02093026|580991568|FG000|Overall Study|Death|10|||
161327394|NCT00249873|582585366|FG000|Overall Study|Other non serious Adverse Event|112|||
161327395|NCT00249873|582585367|FG001|Overall Study|Other non serious Adverse Event|108|||
161327396|NCT00249873|582585366|FG000|Overall Study|Other contraindicated medication|1|||
160981511|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981512|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
160981513|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
160981514|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981515|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981516|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981517|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
160981518|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
161124701|NCT01262976|581843788|FG000|Up to Month 2|Withdrawal by Subject|1|||
161124702|NCT01262976|581843789|FG001|Up to Month 2|Withdrawal by Subject|0|||
160981519|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161124703|NCT01262976|581843790|FG002|Up to Month 2|Withdrawal by Subject|0|||
161124704|NCT01262976|581843791|FG003|Up to Month 2|Withdrawal by Subject|0|||
161124705|NCT01262976|581843792|FG004|Up to Month 2|Withdrawal by Subject|0|||
161124706|NCT01262976|581843793|FG005|Up to Month 2|Withdrawal by Subject|0|||
161124707|NCT01262976|581843788|FG000|Up to Month 2|Migrated/moved from study area|0|||
161124708|NCT01262976|581843789|FG001|Up to Month 2|Migrated/moved from study area|1|||
161124709|NCT01262976|581843790|FG002|Up to Month 2|Migrated/moved from study area|0|||
161124710|NCT01262976|581843791|FG003|Up to Month 2|Migrated/moved from study area|0|||
161124711|NCT01262976|581843792|FG004|Up to Month 2|Migrated/moved from study area|1|||
161124712|NCT01262976|581843793|FG005|Up to Month 2|Migrated/moved from study area|1|||
161124713|NCT01262976|581843788|FG000|Up to Month 2|Lost to Follow-up|1|||
161124714|NCT01262976|581843789|FG001|Up to Month 2|Lost to Follow-up|0|||
161124715|NCT01262976|581843790|FG002|Up to Month 2|Lost to Follow-up|0|||
161124716|NCT01262976|581843791|FG003|Up to Month 2|Lost to Follow-up|1|||
161124717|NCT01262976|581843792|FG004|Up to Month 2|Lost to Follow-up|1|||
161124718|NCT01262976|581843793|FG005|Up to Month 2|Lost to Follow-up|1|||
161124719|NCT01262976|581843788|FG000|Up to Month 2|Other|1|||
161124720|NCT01262976|581843789|FG001|Up to Month 2|Other|0|||
161124721|NCT01262976|581843790|FG002|Up to Month 2|Other|0|||
161124722|NCT01262976|581843791|FG003|Up to Month 2|Other|1|||
161124723|NCT01262976|581843792|FG004|Up to Month 2|Other|0|||
161124724|NCT01262976|581843793|FG005|Up to Month 2|Other|2|||
161124725|NCT01262976|581843788|FG000|Up to Month 7|Serious Adverse Event|0|||
161124726|NCT01262976|581843789|FG001|Up to Month 7|Serious Adverse Event|0|||
161124727|NCT01262976|581843790|FG002|Up to Month 7|Serious Adverse Event|2|||
161124728|NCT01262976|581843791|FG003|Up to Month 7|Serious Adverse Event|0|||
161124729|NCT01262976|581843792|FG004|Up to Month 7|Serious Adverse Event|0|||
161124730|NCT01262976|581843793|FG005|Up to Month 7|Serious Adverse Event|0|||
161124731|NCT01262976|581843788|FG000|Up to Month 7|Withdrawal by Subject|1|||
161124732|NCT01262976|581843789|FG001|Up to Month 7|Withdrawal by Subject|0|||
161124733|NCT01262976|581843790|FG002|Up to Month 7|Withdrawal by Subject|0|||
161124734|NCT01262976|581843791|FG003|Up to Month 7|Withdrawal by Subject|0|||
161124735|NCT01262976|581843792|FG004|Up to Month 7|Withdrawal by Subject|0|||
161124736|NCT01262976|581843793|FG005|Up to Month 7|Withdrawal by Subject|0|||
161124737|NCT01262976|581843788|FG000|Up to Month 7|Migrated/moved from study area|0|||
161124738|NCT01262976|581843789|FG001|Up to Month 7|Migrated/moved from study area|0|||
161124739|NCT01262976|581843790|FG002|Up to Month 7|Migrated/moved from study area|1|||
161124740|NCT01262976|581843791|FG003|Up to Month 7|Migrated/moved from study area|3|||
161124741|NCT01262976|581843792|FG004|Up to Month 7|Migrated/moved from study area|1|||
161124742|NCT01262976|581843793|FG005|Up to Month 7|Migrated/moved from study area|1|||
161124743|NCT01262976|581843788|FG000|Up to Month 7|Lost to Follow-up|1|||
161124744|NCT01262976|581843789|FG001|Up to Month 7|Lost to Follow-up|0|||
161124745|NCT01262976|581843790|FG002|Up to Month 7|Lost to Follow-up|1|||
161124746|NCT01262976|581843791|FG003|Up to Month 7|Lost to Follow-up|3|||
161124747|NCT01262976|581843792|FG004|Up to Month 7|Lost to Follow-up|1|||
161124748|NCT01262976|581843793|FG005|Up to Month 7|Lost to Follow-up|3|||
161124749|NCT01262976|581843788|FG000|Up to Month 7|Other|3|||
161124750|NCT01262976|581843789|FG001|Up to Month 7|Other|0|||
161124751|NCT01262976|581843790|FG002|Up to Month 7|Other|2|||
161124752|NCT01262976|581843791|FG003|Up to Month 7|Other|0|||
161124753|NCT01262976|581843792|FG004|Up to Month 7|Other|0|||
161124754|NCT01262976|581843793|FG005|Up to Month 7|Other|0|||
161124755|NCT01262976|581843788|FG000|Up to Year 1|Serious Adverse Event|0|||
160981520|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
160981521|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
161124756|NCT01262976|581843789|FG001|Up to Year 1|Serious Adverse Event|0|||
161124757|NCT01262976|581843790|FG002|Up to Year 1|Serious Adverse Event|2|||
161124758|NCT01262976|581843791|FG003|Up to Year 1|Serious Adverse Event|0|||
161124759|NCT01262976|581843792|FG004|Up to Year 1|Serious Adverse Event|0|||
161124760|NCT01262976|581843793|FG005|Up to Year 1|Serious Adverse Event|0|||
161124761|NCT01262976|581843788|FG000|Up to Year 1|Withdrawal by Subject|1|||
161230302|NCT01746017|582225724|FG006|Period 1|Withdrawal by Subject|1|||
161230303|NCT01746017|582225725|FG007|Period 1|Withdrawal by Subject|0|||
161230304|NCT01746017|582225726|FG008|Period 1|Withdrawal by Subject|0|||
160782332|NCT03387046|580588902|FG001|Overall Study|Adverse Event|1|||
160782333|NCT00509600|580588903|FG000|Overall Study|Adverse Event|1|||
160782334|NCT01428713|580588906|FG000|Overall Study|Non-compliance|2|||
160782335|NCT01428713|580588907|FG001|Overall Study|Non-compliance|2|||
160782336|NCT01428713|580588906|FG000|Overall Study|Withdrawal by Subject|1|||
160782337|NCT01428713|580588907|FG001|Overall Study|Withdrawal by Subject|1|||
160782338|NCT01428713|580588906|FG000|Overall Study|Adverse Event|0|||
160782339|NCT01428713|580588907|FG001|Overall Study|Adverse Event|2|||
160782340|NCT00875667|580588910|FG000|Overall Study|Adverse Event|29|||
160782341|NCT00875667|580588911|FG001|Overall Study|Adverse Event|10|||
160782342|NCT00875667|580588910|FG000|Overall Study|Withdrawal by Subject|17|||
160782343|NCT00875667|580588911|FG001|Overall Study|Withdrawal by Subject|5|||
160782344|NCT00875667|580588910|FG000|Overall Study|Death|7|||
160782345|NCT00875667|580588911|FG001|Overall Study|Death|2|||
160782346|NCT00875667|580588910|FG000|Overall Study|Protocol Violation|2|||
160782347|NCT00875667|580588911|FG001|Overall Study|Protocol Violation|0|||
160782348|NCT00875667|580588910|FG000|Overall Study|Disease Progression|100|||
160782349|NCT00875667|580588911|FG001|Overall Study|Disease Progression|49|||
160782350|NCT00875667|580588910|FG000|Overall Study|Miscellaneous|12|||
160782351|NCT00875667|580588911|FG001|Overall Study|Miscellaneous|6|||
160782352|NCT00875667|580588910|FG000|Overall Study|Randomized but no Study Drug Given|3|||
160782353|NCT00875667|580588911|FG001|Overall Study|Randomized but no Study Drug Given|1|||
160782354|NCT00120250|580588912|FG000|Overall Study|Lost to Follow-up|1|||
160782355|NCT00120250|580588913|FG001|Overall Study|Lost to Follow-up|1|||
160782356|NCT00120250|580588912|FG000|Overall Study|Protocol Violation|0|||
160782357|NCT00120250|580588913|FG001|Overall Study|Protocol Violation|1|||
160782358|NCT01967277|580588914|FG000|Overall Study|Lost to Follow-up|1|||
160782359|NCT01967277|580588915|FG001|Overall Study|Lost to Follow-up|2|||
160782360|NCT01967277|580588914|FG000|Overall Study|Unrelated illness|0|||
160782361|NCT01967277|580588915|FG001|Overall Study|Unrelated illness|1|||
160782362|NCT00585585|580588918|FG000|Overall Study|Adverse Event|1|||
160782363|NCT02384460|580588931|FG000|Overall Study|Protocol Violation|0|||
160782364|NCT02384460|580588932|FG001|Overall Study|Protocol Violation|1|||
160782365|NCT02384460|580588931|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
160782366|NCT02384460|580588932|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
160782367|NCT02384460|580588931|FG000|Overall Study|Adverse Event|5|||
160782368|NCT02384460|580588932|FG001|Overall Study|Adverse Event|2|||
160782369|NCT02384460|580588931|FG000|Overall Study|Withdrawal by Subject|0|||
160782370|NCT02384460|580588932|FG001|Overall Study|Withdrawal by Subject|3|||
160782371|NCT02384460|580588931|FG000|Overall Study|Elective medical treatment|1|||
160782372|NCT02384460|580588932|FG001|Overall Study|Elective medical treatment|0|||
160782373|NCT02384460|580588931|FG000|Overall Study|Non-compliance|1|||
160782374|NCT02384460|580588932|FG001|Overall Study|Non-compliance|0|||
160782375|NCT02565186|580588937|FG000|Overall Study|Adverse Event|113|||
160782376|NCT02565186|580588938|FG001|Overall Study|Adverse Event|148|||
160782377|NCT02565186|580588937|FG000|Overall Study|Lost to Follow-up|102|||
160782378|NCT02565186|580588938|FG001|Overall Study|Lost to Follow-up|93|||
160782379|NCT02565186|580588937|FG000|Overall Study|Non-Compliance|57|||
160782380|NCT02565186|580588938|FG001|Overall Study|Non-Compliance|55|||
160782381|NCT02565186|580588937|FG000|Overall Study|Withdrawal by Subject|229|||
160782382|NCT02565186|580588938|FG001|Overall Study|Withdrawal by Subject|214|||
160782383|NCT02565186|580588937|FG000|Overall Study|Physician Decision|18|||
160782384|NCT02565186|580588938|FG001|Overall Study|Physician Decision|16|||
160782385|NCT02565186|580588937|FG000|Overall Study|Sponsor Request|5|||
160782386|NCT02565186|580588938|FG001|Overall Study|Sponsor Request|9|||
160782387|NCT02565186|580588937|FG000|Overall Study|Missing|1|||
160782388|NCT02565186|580588938|FG001|Overall Study|Missing|0|||
160782389|NCT02565186|580588937|FG000|Overall Study|Did Not Receive Study Drug|55|||
160782390|NCT02565186|580588938|FG001|Overall Study|Did Not Receive Study Drug|86|||
160782391|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
160782392|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
160782393|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
160782394|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
160782395|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
160782396|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
160782397|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
160782398|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
160889903|NCT02093026|580991568|FG000|Overall Study|Other|157|||
160889904|NCT01466595|580991581|FG000|Overall Study|Withdrawal by Subject|0|||
160889905|NCT01466595|580991582|FG001|Overall Study|Withdrawal by Subject|1|||
160889906|NCT00559754|580991585|FG000|Overall Study|Disease progression|1|||
160889907|NCT00559754|580991585|FG000|Overall Study|Adverse Event|5|||
160889908|NCT00559754|580991585|FG000|Overall Study|Protocol Violation|1|||
160889909|NCT00559754|580991585|FG000|Overall Study|Investigator criteria|2|||
160889910|NCT00559754|580991585|FG000|Overall Study|Withdrawal by Subject|2|||
160889911|NCT01264016|580991586|FG000|Overall Study|Withdrawal by Subject|1|||
160889912|NCT01264016|580991586|FG000|Overall Study|Felt faint at sight of blood|1|||
160889913|NCT01056380|580991587|FG000|Overall Study|Lost to Follow-up|2|||
160782399|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
160782400|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
160782401|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
160782402|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
160782403|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
160782404|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
160782405|NCT00976391|580588939|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
160782406|NCT00976391|580588940|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
160782407|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
160782408|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
160782409|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
160782410|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
160782411|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
160782412|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
160782413|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
160782414|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
160782415|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
160782416|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
160782417|NCT00976391|580588939|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
160782418|NCT00976391|580588940|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
160782419|NCT02217982|580588941|FG000|Overall Study|Trial discontinued|1|||
160782420|NCT02217982|580588942|FG001|Overall Study|Trial discontinued|0|||
160782421|NCT02217982|580588941|FG000|Overall Study|Adverse Event|0|||
160782422|NCT02217982|580588942|FG001|Overall Study|Adverse Event|1|||
160782423|NCT03791060|580588943|FG000|Overall Study|Withdrawal by Subject|1|||
160782424|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|No Data|249|||
160782425|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|No Data|66|||
160782426|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|No Data|2|||
160782427|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|Other|33|||
160782428|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|Other|20|||
160782429|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|Other|0|||
160782430|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
160782431|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
160782432|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
160782433|NCT01623752|580588944|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
160782434|NCT01623752|580588945|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
160782435|NCT01623752|580588946|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
160782436|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
160782437|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
160782438|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
160782439|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|Other|5|||
160782440|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|Other|1|||
160782441|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|Other|0|||
160782442|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|No Data|43|||
160782443|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|No Data|11|||
160782444|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|No Data|0|||
160782445|NCT01623752|580588944|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
160782446|NCT01623752|580588945|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
160782447|NCT01623752|580588946|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
160782448|NCT01814332|580588947|FG000|Overall Study|Adverse Event|8|||
160782449|NCT01814332|580588948|FG001|Overall Study|Adverse Event|3|||
160782450|NCT01814332|580588947|FG000|Overall Study|Withdrawal by Subject|3|||
160782451|NCT01814332|580588948|FG001|Overall Study|Withdrawal by Subject|8|||
160981522|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
160981523|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
160981524|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
160981525|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160981526|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
161124762|NCT01262976|581843789|FG001|Up to Year 1|Withdrawal by Subject|0|||
161124763|NCT01262976|581843790|FG002|Up to Year 1|Withdrawal by Subject|0|||
160782452|NCT01814332|580588947|FG000|Overall Study|Protocol Violation|0|||
160782453|NCT01814332|580588948|FG001|Overall Study|Protocol Violation|4|||
160782454|NCT01814332|580588947|FG000|Overall Study|Lost to Follow-up|5|||
160782455|NCT01814332|580588948|FG001|Overall Study|Lost to Follow-up|1|||
160782456|NCT01755637|580588950|FG000|Period 1|Adverse Event|0|||
160782457|NCT01755637|580588951|FG001|Period 1|Adverse Event|1|||
160782458|NCT04389671|580588952|FG000|Overall Study|Death|7|||
160782459|NCT02287025|580588953|FG000|Overall Study|Not treated|2|||
160782460|NCT02287025|580588954|FG001|Overall Study|Not treated|0|||
160782461|NCT02287025|580588953|FG000|Overall Study|Progression of disease|3|||
160782462|NCT02287025|580588954|FG001|Overall Study|Progression of disease|2|||
160782463|NCT02287025|580588953|FG000|Overall Study|Adverse Event|2|||
160981527|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160782464|NCT02287025|580588954|FG001|Overall Study|Adverse Event|4|||
160782465|NCT02287025|580588953|FG000|Overall Study|Withdrawal by Subject|2|||
160782466|NCT02287025|580588954|FG001|Overall Study|Withdrawal by Subject|2|||
160782467|NCT02287025|580588953|FG000|Overall Study|Screening failed|1|||
160782468|NCT02287025|580588954|FG001|Overall Study|Screening failed|1|||
160782469|NCT00899847|580588955|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
160782470|NCT05987540|580588956|FG000|Overall Study|Withdrawal by Subject|2|||
160782471|NCT05987540|580588956|FG000|Overall Study|Death|1|||
160782472|NCT05987540|580588956|FG000|Overall Study|Study Termination|1|||
160782473|NCT05987540|580588956|FG000|Overall Study|Adverse Event|2|||
160782474|NCT04996264|580588957|FG000|Overall Study|Lost to Follow-up|0|||
160782475|NCT04996264|580588958|FG001|Overall Study|Lost to Follow-up|1|||
160782476|NCT04996264|580588957|FG000|Overall Study|Withdrawal by Subject|4|||
160782477|NCT04996264|580588958|FG001|Overall Study|Withdrawal by Subject|3|||
160782478|NCT04996264|580588957|FG000|Overall Study|1 left AMA|0|||
160782479|NCT04996264|580588958|FG001|Overall Study|1 left AMA|1|||
160782480|NCT04996264|580588957|FG000|Overall Study|Subject changed hospitals|0|||
160782481|NCT04996264|580588958|FG001|Overall Study|Subject changed hospitals|1|||
160782482|NCT04996264|580588957|FG000|Overall Study|unable to complete due to work|0|||
160782483|NCT04996264|580588958|FG001|Overall Study|unable to complete due to work|1|||
160782484|NCT02030418|580588963|FG000|Overall Study|Death|78|||
160782485|NCT02030418|580588963|FG000|Overall Study|Missed 12-Month Visit|9|||
160782486|NCT02030418|580588963|FG000|Overall Study|Withdrawn|57|||
160782487|NCT01279200|580588970|FG000|Overall Study|Withdrawal by Subject|1|||
160782488|NCT01279200|580588971|FG001|Overall Study|Withdrawal by Subject|3|||
160782489|NCT01279200|580588970|FG000|Overall Study|Patient withdrawal due to high cost|0|||
160782490|NCT01279200|580588971|FG001|Overall Study|Patient withdrawal due to high cost|1|||
160782491|NCT01279200|580588970|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
160981528|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
160981529|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
160981530|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981531|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981532|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
160981533|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
160981534|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981535|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981536|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981537|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981538|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
160981539|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981540|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981541|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
160981542|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
160981543|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981544|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981545|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981546|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981547|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981548|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
160981549|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981550|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981551|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981552|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160782492|NCT01279200|580588971|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
160782493|NCT01279200|580588970|FG000|Overall Study|ultrasound screening failure|0|||
160981553|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
160981554|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981555|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981556|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
160981557|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161230305|NCT01746017|582225727|FG009|Period 1|Withdrawal by Subject|0|||
160782494|NCT01279200|580588971|FG001|Overall Study|ultrasound screening failure|1|||
160782495|NCT01279200|580588970|FG000|Overall Study|Lost to Follow-up|0|||
160782496|NCT01279200|580588971|FG001|Overall Study|Lost to Follow-up|1|||
160782497|NCT01279200|580588970|FG000|Overall Study|Adverse Event|1|||
160782498|NCT01279200|580588971|FG001|Overall Study|Adverse Event|0|||
160782499|NCT01399099|580588972|FG000|Overall Study|Lost to Follow-up|14|||
160782500|NCT01399099|580588972|FG000|Overall Study|Physician Decision|1|||
160782501|NCT01399099|580588972|FG000|Overall Study|Protocol Violation|1|||
160782502|NCT01399099|580588972|FG000|Overall Study|Skin Irritation|13|||
160782503|NCT01399099|580588972|FG000|Overall Study|Infection|1|||
160782504|NCT01399099|580588972|FG000|Overall Study|Miscellaneous|4|||
160782505|NCT01179516|580588973|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
160782506|NCT01179516|580588974|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
160782507|NCT01179516|580588975|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
160782508|NCT01179516|580588973|FG000|Overall Study|Lack of Efficacy|4|||
160782509|NCT01179516|580588974|FG001|Overall Study|Lack of Efficacy|2|||
160782510|NCT01179516|580588975|FG002|Overall Study|Lack of Efficacy|0|||
160782511|NCT01179516|580588973|FG000|Overall Study|Noncompliance with Study Drug|2|||
160782512|NCT01179516|580588974|FG001|Overall Study|Noncompliance with Study Drug|0|||
160782513|NCT01179516|580588975|FG002|Overall Study|Noncompliance with Study Drug|1|||
160782514|NCT01179516|580588973|FG000|Overall Study|Protocol Deviations|4|||
160782515|NCT01179516|580588974|FG001|Overall Study|Protocol Deviations|3|||
160782516|NCT01179516|580588975|FG002|Overall Study|Protocol Deviations|3|||
160782517|NCT01179516|580588973|FG000|Overall Study|Withdrawal of Consent|2|||
160782518|NCT01179516|580588974|FG001|Overall Study|Withdrawal of Consent|6|||
160782519|NCT01179516|580588975|FG002|Overall Study|Withdrawal of Consent|10|||
160782520|NCT01179516|580588973|FG000|Overall Study|Lost to Follow-up|7|||
160782521|NCT01179516|580588974|FG001|Overall Study|Lost to Follow-up|7|||
160782522|NCT01179516|580588975|FG002|Overall Study|Lost to Follow-up|3|||
160782523|NCT01179516|580588973|FG000|Overall Study|Other|2|||
160782524|NCT01179516|580588974|FG001|Overall Study|Other|0|||
160782525|NCT01179516|580588975|FG002|Overall Study|Other|2|||
160782526|NCT01668537|580588976|FG000|Overall Study|Request to Discontinue Prematurely|1|||
160782527|NCT01668537|580588977|FG001|Overall Study|Request to Discontinue Prematurely|1|||
160782528|NCT01668537|580588976|FG000|Overall Study|Subject unwilling/unable to comply|5|||
160782529|NCT01668537|580588977|FG001|Overall Study|Subject unwilling/unable to comply|0|||
160782530|NCT01668537|580588976|FG000|Overall Study|Reason Precludes Participation|1|||
160782531|NCT01668537|580588977|FG001|Overall Study|Reason Precludes Participation|0|||
160782532|NCT01668537|580588976|FG000|Overall Study|Lost to Follow-up|13|||
160782533|NCT01668537|580588977|FG001|Overall Study|Lost to Follow-up|6|||
160782534|NCT01668537|580588976|FG000|Overall Study|Other|2|||
160782535|NCT01668537|580588977|FG001|Overall Study|Other|3|||
160782536|NCT05064800|580588980|FG000|Period 3|Withdrawal by Subject|0|||
160782537|NCT05064800|580588981|FG001|Period 3|Withdrawal by Subject|0|||
160782538|NCT05064800|580588982|FG002|Period 3|Withdrawal by Subject|0|||
160782539|NCT05064800|580588983|FG003|Period 3|Withdrawal by Subject|0|||
160782540|NCT05064800|580588984|FG004|Period 3|Withdrawal by Subject|1|||
160782541|NCT05064800|580588985|FG005|Period 3|Withdrawal by Subject|0|||
160782542|NCT03983109|580588990|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
160782543|NCT03983109|580588991|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
160782544|NCT00887588|580588994|FG000|Core Period|Death|1|||
160782545|NCT00887588|580588995|FG001|Core Period|Death|1|||
160782546|NCT00887588|580588994|FG000|Core Period|Lost to Follow-up|3|||
160782547|NCT00887588|580588995|FG001|Core Period|Lost to Follow-up|1|||
160782548|NCT00887588|580588994|FG000|Core Period|Withdrawal by Subject|6|||
160782549|NCT00887588|580588995|FG001|Core Period|Withdrawal by Subject|8|||
160782550|NCT00887588|580588994|FG000|Core Period|Adverse Event|9|||
160782551|NCT00887588|580588995|FG001|Core Period|Adverse Event|11|||
160782552|NCT00887588|580588994|FG000|Extension Period|Adverse Event|4|||
160782553|NCT00887588|580588995|FG001|Extension Period|Adverse Event|4|||
160782554|NCT00887588|580588994|FG000|Extension Period|Death|0|||
160782555|NCT00887588|580588995|FG001|Extension Period|Death|1|||
160782556|NCT00887588|580588994|FG000|Extension Period|Protocol deviation|1|||
160782557|NCT00887588|580588995|FG001|Extension Period|Protocol deviation|0|||
160782558|NCT00887588|580588994|FG000|Extension Period|Lost to Follow-up|1|||
160782559|NCT00887588|580588995|FG001|Extension Period|Lost to Follow-up|0|||
160782560|NCT00567112|580588996|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
161327397|NCT00249873|582585367|FG001|Overall Study|Other contraindicated medication|0|||
161327398|NCT00249873|582585366|FG000|Overall Study|Patient not wish to continue after May08|3|||
161327399|NCT00249873|582585367|FG001|Overall Study|Patient not wish to continue after May08|4|||
161327400|NCT00249873|582585366|FG000|Overall Study|Physician withdrew consent|59|||
161327401|NCT00249873|582585367|FG001|Overall Study|Physician withdrew consent|60|||
161327402|NCT00249873|582585366|FG000|Overall Study|Open label clopidogrel required|31|||
161327403|NCT00249873|582585367|FG001|Overall Study|Open label clopidogrel required|42|||
161327404|NCT00249873|582585366|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
160782561|NCT00567112|580588997|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
160782562|NCT00567112|580588998|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
160782563|NCT00567112|580588996|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
160782564|NCT00567112|580588997|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
160782565|NCT00567112|580588998|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
160782566|NCT00567112|580588996|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
160782567|NCT00567112|580588997|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
160782568|NCT00567112|580588998|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
160782569|NCT03753542|580589002|FG000|Overall Study|Lost to Follow-up|9|||
160782570|NCT03753542|580589003|FG001|Overall Study|Lost to Follow-up|14|||
160782571|NCT01068249|580589009|FG000|Overall Study|Death|1|||
160782572|NCT01068249|580589009|FG000|Overall Study|Withdrawal by Subject|3|||
160782573|NCT04180696|580589010|FG000|Overall Study|Death|5|||
161327405|NCT00249873|582585367|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
161327406|NCT00249873|582585366|FG000|Overall Study|Oral anticoagulant required|159|||
161327407|NCT00249873|582585367|FG001|Overall Study|Oral anticoagulant required|157|||
161327408|NCT00249873|582585366|FG000|Overall Study|Study drug intolerance|5|||
161327409|NCT00249873|582585367|FG001|Overall Study|Study drug intolerance|0|||
161327410|NCT00249873|582585366|FG000|Overall Study|Surgery/ procedure|9|||
161327411|NCT00249873|582585367|FG001|Overall Study|Surgery/ procedure|9|||
160889914|NCT01056380|580991588|FG001|Overall Study|Lost to Follow-up|3|||
160889915|NCT01629706|580991589|FG000|Phase 1 PureVision|Screen Failure|4|||
160889916|NCT01629706|580991589|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
160889917|NCT01629706|580991589|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
160889918|NCT01629706|580991589|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
160889919|NCT01629706|580991589|FG000|Phase 2 Habitual|Screen Failure|6|||
160889920|NCT01629706|580991589|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
160889921|NCT01629706|580991589|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
160889922|NCT01629706|580991589|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
160889923|NCT01629706|580991589|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
160889924|NCT00048061|580991590|FG000|Overall Study|Adverse Event|41|||
160889925|NCT00048061|580991591|FG001|Overall Study|Adverse Event|32|||
160889926|NCT00048061|580991592|FG002|Overall Study|Adverse Event|44|||
160889927|NCT00048061|580991593|FG003|Overall Study|Adverse Event|37|||
160889928|NCT00048061|580991590|FG000|Overall Study|Lost to Follow-up|3|||
160889929|NCT00048061|580991591|FG001|Overall Study|Lost to Follow-up|2|||
160889930|NCT00048061|580991592|FG002|Overall Study|Lost to Follow-up|4|||
160889931|NCT00048061|580991593|FG003|Overall Study|Lost to Follow-up|5|||
160889932|NCT00048061|580991590|FG000|Overall Study|Withdrawal by Subject|20|||
160889933|NCT00048061|580991591|FG001|Overall Study|Withdrawal by Subject|29|||
160889934|NCT00048061|580991592|FG002|Overall Study|Withdrawal by Subject|29|||
160889935|NCT00048061|580991593|FG003|Overall Study|Withdrawal by Subject|32|||
160889936|NCT00048061|580991590|FG000|Overall Study|Did not follow-up|5|||
160889937|NCT00048061|580991591|FG001|Overall Study|Did not follow-up|5|||
160889938|NCT00048061|580991592|FG002|Overall Study|Did not follow-up|4|||
160889939|NCT00048061|580991593|FG003|Overall Study|Did not follow-up|5|||
160889940|NCT00048061|580991590|FG000|Overall Study|Early improvement|6|||
160889941|NCT00048061|580991591|FG001|Overall Study|Early improvement|5|||
160889942|NCT00048061|580991592|FG002|Overall Study|Early improvement|3|||
160889943|NCT00048061|580991593|FG003|Overall Study|Early improvement|0|||
160889944|NCT00393042|580991594|FG000|First Intervention|Withdrawal by Subject|1|||
160889945|NCT00393042|580991595|FG001|First Intervention|Withdrawal by Subject|2|||
160889946|NCT00393042|580991594|FG000|First Intervention|Lost to Follow-up|3|||
160889947|NCT00393042|580991595|FG001|First Intervention|Lost to Follow-up|3|||
160889948|NCT00393042|580991594|FG000|First Intervention|Protocol Violation|1|||
160889949|NCT00393042|580991595|FG001|First Intervention|Protocol Violation|0|||
160889950|NCT00393042|580991594|FG000|First Intervention|Adverse Event|0|||
160889951|NCT00393042|580991595|FG001|First Intervention|Adverse Event|1|||
160889952|NCT00393042|580991594|FG000|Second Intervetion|Adverse Event|0|||
160889953|NCT00393042|580991595|FG001|Second Intervetion|Adverse Event|3|||
160889954|NCT00393042|580991594|FG000|Second Intervetion|Withdrawal by Subject|0|||
160889955|NCT00393042|580991595|FG001|Second Intervetion|Withdrawal by Subject|2|||
160889956|NCT00393042|580991594|FG000|Second Intervetion|Lack of Efficacy|1|||
160889957|NCT00393042|580991595|FG001|Second Intervetion|Lack of Efficacy|0|||
160889958|NCT00393042|580991594|FG000|Second Intervetion|Lost to Follow-up|0|||
160889959|NCT00393042|580991595|FG001|Second Intervetion|Lost to Follow-up|2|||
160889960|NCT00393042|580991594|FG000|Second Intervetion|Protocol Violation|1|||
160889961|NCT00393042|580991595|FG001|Second Intervetion|Protocol Violation|1|||
160889962|NCT03475875|580991596|FG000|Period 1|Lost to Follow-up|1|||
160889963|NCT03475875|580991597|FG001|Period 1|Lost to Follow-up|0|||
160889964|NCT03475875|580991596|FG000|Period 1|Adverse Event|2|||
160889965|NCT03475875|580991597|FG001|Period 1|Adverse Event|1|||
160889966|NCT03475875|580991596|FG000|Period 2|Adverse Event|3|||
160889967|NCT03475875|580991597|FG001|Period 2|Adverse Event|0|||
160889968|NCT03475875|580991596|FG000|Period 2|Protocol Violation|0|||
160889969|NCT03475875|580991597|FG001|Period 2|Protocol Violation|1|||
160889970|NCT01642407|580991601|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
160889971|NCT01642407|580991601|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
160889972|NCT01642407|580991601|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
160889973|NCT02045303|580991602|FG000|Overall Study|Protocol Violation|2|||
160889974|NCT02045303|580991603|FG001|Overall Study|Protocol Violation|1|||
160889975|NCT02045303|580991604|FG002|Overall Study|Protocol Violation|0|||
160889976|NCT02045303|580991602|FG000|Overall Study|Withdrawal by Subject|0|||
160889977|NCT02045303|580991603|FG001|Overall Study|Withdrawal by Subject|2|||
160889978|NCT02045303|580991604|FG002|Overall Study|Withdrawal by Subject|0|||
160889979|NCT01856023|580991605|FG000|Overall Study|Death|1|||
160889980|NCT01856023|580991606|FG001|Overall Study|Death|2|||
160889981|NCT01856023|580991605|FG000|Overall Study|Adverse Event|2|||
160889982|NCT01856023|580991606|FG001|Overall Study|Adverse Event|1|||
160889983|NCT01856023|580991605|FG000|Overall Study|Lack of Efficacy|5|||
160782574|NCT04180696|580589011|FG001|Overall Study|Death|6|||
160782575|NCT04180696|580589010|FG000|Overall Study|Lost to Follow-up|1|||
160782576|NCT04180696|580589011|FG001|Overall Study|Lost to Follow-up|0|||
160782577|NCT04180696|580589010|FG000|Overall Study|Withdrawal by Subject|0|||
160782578|NCT04180696|580589011|FG001|Overall Study|Withdrawal by Subject|1|||
160782579|NCT01740427|580589012|FG000|Overall Study|Objective Progression or Relapse|286|||
160782580|NCT01740427|580589013|FG001|Overall Study|Objective Progression or Relapse|172|||
160782581|NCT01740427|580589012|FG000|Overall Study|Adverse Event|32|||
160782582|NCT01740427|580589013|FG001|Overall Study|Adverse Event|9|||
160782583|NCT01740427|580589012|FG000|Overall Study|Global Deterioration of Health Status|28|||
160782584|NCT01740427|580589013|FG001|Overall Study|Global Deterioration of Health Status|12|||
160782585|NCT01740427|580589012|FG000|Overall Study|Participant Refused Continued Treatment|27|||
160782586|NCT01740427|580589013|FG001|Overall Study|Participant Refused Continued Treatment|15|||
160782587|NCT01740427|580589012|FG000|Overall Study|Unspecified reasons|52|||
160782588|NCT01740427|580589013|FG001|Overall Study|Unspecified reasons|8|||
160782589|NCT01740427|580589012|FG000|Overall Study|Death|10|||
160782590|NCT01740427|580589013|FG001|Overall Study|Death|3|||
160782591|NCT01740427|580589012|FG000|Overall Study|Protocol Violation|5|||
160782592|NCT01740427|580589013|FG001|Overall Study|Protocol Violation|3|||
160782593|NCT01740427|580589012|FG000|Overall Study|Lost to Follow-up|3|||
160782594|NCT01740427|580589013|FG001|Overall Study|Lost to Follow-up|0|||
160782595|NCT01740427|580589012|FG000|Overall Study|Site Terminated by Sponsor|1|||
160782596|NCT01740427|580589013|FG001|Overall Study|Site Terminated by Sponsor|0|||
160782597|NCT04210375|580589015|FG000|Overall Study|Death|0|||
160782598|NCT04210375|580589016|FG001|Overall Study|Death|1|||
160782599|NCT04210375|580589017|FG002|Overall Study|Death|0|||
160782600|NCT04210375|580589018|FG003|Overall Study|Death|0|||
160782601|NCT05752487|580589021|FG000|Overall Study|Enrolled, not treated|9|||
160782602|NCT05752487|580589021|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
160782603|NCT05752487|580589021|FG000|Overall Study|Withdrawal by Subject|2|||
160782604|NCT04124965|580589023|FG000|Overall Study|Adverse event, non-fatal|3|||
160782605|NCT04124965|580589024|FG001|Overall Study|Adverse event, non-fatal|1|||
160782606|NCT04124965|580589023|FG000|Overall Study|Withdrawal by Subject|1|||
160782607|NCT04124965|580589024|FG001|Overall Study|Withdrawal by Subject|1|||
160782608|NCT04124965|580589023|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
160782609|NCT04124965|580589024|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
160782610|NCT04124965|580589023|FG000|Overall Study|Pregnancy|1|||
160782611|NCT04124965|580589024|FG001|Overall Study|Pregnancy|0|||
160782612|NCT04124965|580589023|FG000|Overall Study|Sponsor and participant decision|0|||
160782613|NCT04124965|580589024|FG001|Overall Study|Sponsor and participant decision|1|||
160782614|NCT04124965|580589023|FG000|Overall Study|Personal surgery|0|||
160782615|NCT04124965|580589024|FG001|Overall Study|Personal surgery|1|||
160782616|NCT04124965|580589023|FG000|Overall Study|Physician Decision|0|||
160782617|NCT04124965|580589024|FG001|Overall Study|Physician Decision|1|||
160782618|NCT02184156|580589025|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
160782619|NCT02184156|580589026|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
160782620|NCT02184156|580589025|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
160782621|NCT02184156|580589026|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
161124764|NCT01262976|581843791|FG003|Up to Year 1|Withdrawal by Subject|0|||
161124765|NCT01262976|581843792|FG004|Up to Year 1|Withdrawal by Subject|0|||
161124766|NCT01262976|581843793|FG005|Up to Year 1|Withdrawal by Subject|0|||
161124767|NCT01262976|581843788|FG000|Up to Year 1|Migrated/moved from study area|1|||
161124768|NCT01262976|581843789|FG001|Up to Year 1|Migrated/moved from study area|0|||
160782622|NCT01214720|580589028|FG000|Overall Study|Alive and still on treatment|34|||
160782623|NCT01214720|580589029|FG001|Overall Study|Alive and still on treatment|18|||
161124769|NCT01262976|581843790|FG002|Up to Year 1|Migrated/moved from study area|0|||
160782624|NCT01214720|580589028|FG000|Overall Study|Alive and in follow-up|45|||
160782625|NCT01214720|580589029|FG001|Overall Study|Alive and in follow-up|48|||
160782626|NCT01214720|580589028|FG000|Overall Study|Lost to Follow-up|6|||
160782627|NCT01214720|580589029|FG001|Overall Study|Lost to Follow-up|2|||
160782628|NCT01980888|580589030|FG000|Overall Study|Study Terminated by Sponsor|116|||
160782629|NCT01980888|580589031|FG001|Overall Study|Study Terminated by Sponsor|122|||
161230306|NCT01746017|582225728|FG010|Period 1|Withdrawal by Subject|0|||
161230307|NCT01746017|582225718|FG000|Period 3|Withdrawal by Subject|0|||
160782630|NCT01980888|580589030|FG000|Overall Study|Withdrew Consent|17|||
160782631|NCT01980888|580589031|FG001|Overall Study|Withdrew Consent|6|||
160782632|NCT01980888|580589030|FG000|Overall Study|Investigator's Discretion|8|||
160782633|NCT01980888|580589031|FG001|Overall Study|Investigator's Discretion|3|||
161230308|NCT01746017|582225719|FG001|Period 3|Withdrawal by Subject|0|||
161230309|NCT01746017|582225720|FG002|Period 3|Withdrawal by Subject|0|||
161230310|NCT01746017|582225721|FG003|Period 3|Withdrawal by Subject|0|||
161230311|NCT01746017|582225722|FG004|Period 3|Withdrawal by Subject|0|||
161230312|NCT01746017|582225723|FG005|Period 3|Withdrawal by Subject|1|||
161230313|NCT01746017|582225724|FG006|Period 3|Withdrawal by Subject|0|||
161230314|NCT01746017|582225725|FG007|Period 3|Withdrawal by Subject|0|||
161230315|NCT01746017|582225726|FG008|Period 3|Withdrawal by Subject|0|||
160782634|NCT01980888|580589030|FG000|Overall Study|Non-Compliance with Study Drug|3|||
160782635|NCT01980888|580589031|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160782636|NCT04625972|580589032|FG000|Overall Study|Death|3|||
160782637|NCT04625972|580589033|FG001|Overall Study|Death|2|||
160782638|NCT04625972|580589032|FG000|Overall Study|Lost to Follow-up|82|||
160782639|NCT04625972|580589033|FG001|Overall Study|Lost to Follow-up|38|||
160782640|NCT04625972|580589032|FG000|Overall Study|Physician Decision|2|||
160782641|NCT04625972|580589033|FG001|Overall Study|Physician Decision|0|||
160782642|NCT04625972|580589032|FG000|Overall Study|Protocol Violation|0|||
160782643|NCT04625972|580589033|FG001|Overall Study|Protocol Violation|1|||
160782644|NCT04625972|580589032|FG000|Overall Study|Withdrawal by Subject|37|||
160782645|NCT04625972|580589033|FG001|Overall Study|Withdrawal by Subject|24|||
160782646|NCT04625972|580589032|FG000|Overall Study|Not specified elsewhere|8|||
160782647|NCT04625972|580589033|FG001|Overall Study|Not specified elsewhere|6|||
160782648|NCT05591755|580589034|FG000|Overall Study|Screen Failure|1|||
160782649|NCT05591755|580589035|FG001|Overall Study|Screen Failure|0|||
160782650|NCT05591755|580589036|FG002|Overall Study|Screen Failure|0|||
160782651|NCT05591755|580589037|FG003|Overall Study|Screen Failure|0|||
160782652|NCT05591755|580589034|FG000|Overall Study|Protocol Violation|0|||
160782653|NCT05591755|580589035|FG001|Overall Study|Protocol Violation|0|||
160782654|NCT05591755|580589036|FG002|Overall Study|Protocol Violation|2|||
160782655|NCT05591755|580589037|FG003|Overall Study|Protocol Violation|0|||
160782656|NCT05591755|580589034|FG000|Overall Study|Withdrawal by Subject|0|||
160782657|NCT05591755|580589035|FG001|Overall Study|Withdrawal by Subject|1|||
160782658|NCT05591755|580589036|FG002|Overall Study|Withdrawal by Subject|0|||
160782659|NCT05591755|580589037|FG003|Overall Study|Withdrawal by Subject|0|||
160782660|NCT02502383|580590514|FG000|Overall Study|Lost to Follow-up|130|||
160782661|NCT02502383|580590515|FG001|Overall Study|Lost to Follow-up|131|||
160782662|NCT02502383|580590514|FG000|Overall Study|Withdrawal by Subject|31|||
160782663|NCT02502383|580590515|FG001|Overall Study|Withdrawal by Subject|24|||
160782664|NCT01964560|580590520|FG000|Overall Study|Adverse Event|23|||
160782665|NCT01964560|580590520|FG000|Overall Study|Lack of Efficacy|46|||
160782666|NCT01964560|580590520|FG000|Overall Study|Protocol deviation|2|||
160782667|NCT01964560|580590520|FG000|Overall Study|Lost to Follow-up|4|||
160782668|NCT01964560|580590520|FG000|Overall Study|Withdrawal by Subject|64|||
160782669|NCT01964560|580590520|FG000|Overall Study|Surgery-hemispherotomy|1|||
160782670|NCT01964560|580590520|FG000|Overall Study|Surgery|1|||
160782671|NCT01964560|580590520|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
160782672|NCT01964560|580590520|FG000|Overall Study|Patient and Investigator choice|1|||
160782673|NCT01964560|580590520|FG000|Overall Study|Patient was prescribed CBD|1|||
160782674|NCT01964560|580590520|FG000|Overall Study|Participant moved to another country|1|||
160782675|NCT02301429|580590526|FG000|Overall Study|not acceptable vascular anatomy|3|||
160782676|NCT01011283|580590527|FG000|Overall Study|Adverse Event|4|||
160782677|NCT01011283|580590528|FG001|Overall Study|Adverse Event|2|||
160782678|NCT01011283|580590527|FG000|Overall Study|Progressive Disease|0|||
160782679|NCT01011283|580590528|FG001|Overall Study|Progressive Disease|2|||
160782680|NCT01011283|580590527|FG000|Overall Study|Terminated by Sponsor|5|||
160782681|NCT01011283|580590528|FG001|Overall Study|Terminated by Sponsor|5|||
160782682|NCT01011283|580590527|FG000|Overall Study|Other|2|||
160782683|NCT01011283|580590528|FG001|Overall Study|Other|2|||
160782684|NCT01717859|580590529|FG000|Overall Study|Adverse Event|5|||
160782685|NCT01717859|580590529|FG000|Overall Study|Moved out of state|1|||
160782686|NCT01717859|580590529|FG000|Overall Study|Patient concerned about mental health|1|||
160782687|NCT01717859|580590529|FG000|Overall Study|Lost to Follow-up|1|||
160782688|NCT01717859|580590529|FG000|Overall Study|Withdrawal by Subject|2|||
160782689|NCT04053452|580590531|FG000|Overall Study|Withdrawal by Subject|1|||
160782690|NCT04053452|580590532|FG001|Overall Study|Withdrawal by Subject|0|||
160782691|NCT04053452|580590531|FG000|Overall Study|Time restraint due to inpatient needs|1|||
160782692|NCT04053452|580590532|FG001|Overall Study|Time restraint due to inpatient needs|2|||
160782693|NCT01421134|580590533|FG000|Overall Study|Adverse Event|3|||
160782694|NCT01421134|580590534|FG001|Overall Study|Adverse Event|5|||
160782695|NCT01421134|580590533|FG000|Overall Study|Lack of Efficacy|2|||
160782696|NCT01421134|580590534|FG001|Overall Study|Lack of Efficacy|4|||
160889984|NCT01856023|580991606|FG001|Overall Study|Lack of Efficacy|5|||
160782697|NCT01421134|580590533|FG000|Overall Study|Protocol Violation|0|||
160782698|NCT01421134|580590534|FG001|Overall Study|Protocol Violation|3|||
160782699|NCT01421134|580590533|FG000|Overall Study|Withdrawal by Subject|1|||
160782700|NCT01421134|580590534|FG001|Overall Study|Withdrawal by Subject|1|||
160782701|NCT01421134|580590533|FG000|Overall Study|Administrative|0|||
160782702|NCT01421134|580590534|FG001|Overall Study|Administrative|1|||
160782703|NCT01421134|580590533|FG000|Overall Study|Lost to Follow-up|1|||
160782704|NCT01421134|580590534|FG001|Overall Study|Lost to Follow-up|1|||
160782705|NCT02959892|580590535|FG000|Overall Study|PET tracer synthesis failure|1|||
160782706|NCT02959892|580590536|FG001|Overall Study|PET tracer synthesis failure|0|||
160782707|NCT02959892|580590535|FG000|Overall Study|Study termination|0|||
160782708|NCT02959892|580590536|FG001|Overall Study|Study termination|1|||
160889985|NCT01856023|580991605|FG000|Overall Study|non compliance, study closure|1|||
161230316|NCT01746017|582225727|FG009|Period 3|Withdrawal by Subject|0|||
160782709|NCT00122187|580590537|FG000|Overall Study|Withdrew because of resource limitations|2|||
160782710|NCT00122187|580590538|FG001|Overall Study|Withdrew because of resource limitations|2|||
160782711|NCT02061592|580590542|FG000|Period 1|Withdrawal by Subject|1|||
160782712|NCT02061592|580590543|FG001|Period 1|Withdrawal by Subject|0|||
160782713|NCT02061592|580590542|FG000|Period 1|Protocol Violation|1|||
160981558|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
161327412|NCT00249873|582585366|FG000|Overall Study|Event related to cardiac condition|12|||
161327413|NCT00249873|582585367|FG001|Overall Study|Event related to cardiac condition|21|||
161327414|NCT00249873|582585366|FG000|Overall Study|Thromboembolic/outcome event|82|||
161327415|NCT00249873|582585367|FG001|Overall Study|Thromboembolic/outcome event|122|||
161327416|NCT01348139|582585368|FG000|Period 1|Adverse Event|1|||
161327417|NCT01348139|582585369|FG001|Period 1|Adverse Event|0|||
161327418|NCT01348139|582585370|FG002|Period 1|Adverse Event|0|||
161327419|NCT01348139|582585371|FG003|Period 1|Adverse Event|0|||
161327420|NCT01348139|582585372|FG004|Period 1|Adverse Event|0|||
161327421|NCT01348139|582585373|FG005|Period 1|Adverse Event|0|||
161327422|NCT02254772|582585376|FG000|Overall Study|Ineligible|1|||
161327423|NCT02254772|582585376|FG000|Overall Study|Withdrawal by Subject|1|||
161327424|NCT03006562|582585377|FG000|Overall Study|Lost to Follow-up|0|||
161327425|NCT03006562|582585378|FG001|Overall Study|Lost to Follow-up|1|||
161327426|NCT02427841|582585387|FG000|Overall Study|Lack of Efficacy|5|||
161327427|NCT02427841|582585387|FG000|Overall Study|Physician Decision|2|||
161327428|NCT02427841|582585387|FG000|Overall Study|Withdrawal by Subject|1|||
161327429|NCT01765296|582585388|FG000|Overall Study|Protocol Violation|0|||
161327430|NCT01765296|582585389|FG001|Overall Study|Protocol Violation|5|||
161327431|NCT01765296|582585390|FG002|Overall Study|Protocol Violation|4|||
161327432|NCT01765296|582585388|FG000|Overall Study|Withdrawal by Subject|4|||
161327433|NCT01765296|582585389|FG001|Overall Study|Withdrawal by Subject|2|||
161327434|NCT01765296|582585390|FG002|Overall Study|Withdrawal by Subject|2|||
161327435|NCT01765296|582585388|FG000|Overall Study|Adverse Event|1|||
161327436|NCT01765296|582585389|FG001|Overall Study|Adverse Event|13|||
161327437|NCT01765296|582585390|FG002|Overall Study|Adverse Event|5|||
161327438|NCT01765296|582585388|FG000|Overall Study|Lack of Efficacy|0|||
161327439|NCT01765296|582585389|FG001|Overall Study|Lack of Efficacy|0|||
161327440|NCT01765296|582585390|FG002|Overall Study|Lack of Efficacy|2|||
161327441|NCT03257436|582585391|FG000|Overall Study|Withdrawal by Subject|76|||
161327442|NCT03257436|582585391|FG000|Overall Study|Death|19|||
161327443|NCT01619852|582585392|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
161327444|NCT01619852|582585393|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
161327445|NCT01619852|582585392|FG000|3 Month Follow up|Lost to Follow-up|31|||
161327446|NCT01619852|582585393|FG001|3 Month Follow up|Lost to Follow-up|34|||
161327447|NCT00970489|582585394|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
161327448|NCT00970489|582585395|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
161327449|NCT03489343|582585398|FG000|Overall Study|Documented progressive disease|1|||
161327450|NCT03489343|582585399|FG001|Overall Study|Documented progressive disease|0|||
161327451|NCT03489343|582585400|FG002|Overall Study|Documented progressive disease|3|||
161327452|NCT03489343|582585401|FG003|Overall Study|Documented progressive disease|1|||
161327453|NCT03489343|582585402|FG004|Overall Study|Documented progressive disease|3|||
161327454|NCT03489343|582585403|FG005|Overall Study|Documented progressive disease|5|||
161327455|NCT03489343|582585404|FG006|Overall Study|Documented progressive disease|4|||
161327456|NCT03489343|582585398|FG000|Overall Study|Adverse Event|0|||
161327457|NCT03489343|582585399|FG001|Overall Study|Adverse Event|1|||
161327458|NCT03489343|582585400|FG002|Overall Study|Adverse Event|0|||
160981559|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981560|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981561|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981562|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
160981563|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
160981564|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
160981565|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161327459|NCT03489343|582585401|FG003|Overall Study|Adverse Event|0|||
161327460|NCT03489343|582585402|FG004|Overall Study|Adverse Event|0|||
161327461|NCT03489343|582585403|FG005|Overall Study|Adverse Event|1|||
160981566|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
161327462|NCT03489343|582585404|FG006|Overall Study|Adverse Event|0|||
161327463|NCT03489343|582585398|FG000|Overall Study|Withdrawal by Subject|0|||
161327464|NCT03489343|582585399|FG001|Overall Study|Withdrawal by Subject|0|||
161327465|NCT03489343|582585400|FG002|Overall Study|Withdrawal by Subject|0|||
161327466|NCT03489343|582585401|FG003|Overall Study|Withdrawal by Subject|1|||
161327467|NCT03489343|582585402|FG004|Overall Study|Withdrawal by Subject|0|||
161327468|NCT03489343|582585403|FG005|Overall Study|Withdrawal by Subject|1|||
161327469|NCT03489343|582585404|FG006|Overall Study|Withdrawal by Subject|1|||
160782714|NCT02061592|580590543|FG001|Period 1|Protocol Violation|0|||
160782715|NCT02061592|580590542|FG000|Period 2|Lost to Follow-up|0|||
161327470|NCT03489343|582585398|FG000|Overall Study|Clinical progression|0|||
160782716|NCT02061592|580590543|FG001|Period 2|Lost to Follow-up|1|||
160782717|NCT04433975|580590544|FG000|1-month Follow Up|Withdrawal by Subject|1|||
160782718|NCT04433975|580590545|FG001|1-month Follow Up|Withdrawal by Subject|1|||
160782719|NCT04433975|580590544|FG000|1-month Follow Up|Lost to Follow-up|21|||
160782720|NCT04433975|580590545|FG001|1-month Follow Up|Lost to Follow-up|25|||
160782721|NCT04433975|580590544|FG000|3-month Follow Up|Lost to Follow-up|20|||
160782722|NCT04433975|580590545|FG001|3-month Follow Up|Lost to Follow-up|24|||
160782723|NCT04433975|580590544|FG000|3-month Follow Up|Death|1|||
160782724|NCT04433975|580590545|FG001|3-month Follow Up|Death|0|||
160782725|NCT04433975|580590544|FG000|3-month Follow Up|Withdrawal by Subject|2|||
160782726|NCT04433975|580590545|FG001|3-month Follow Up|Withdrawal by Subject|0|||
160782727|NCT04433975|580590544|FG000|6-month Follow Up|Lost to Follow-up|23|||
160782728|NCT04433975|580590545|FG001|6-month Follow Up|Lost to Follow-up|28|||
160782729|NCT04433975|580590544|FG000|6-month Follow Up|Withdrawal by Subject|1|||
160782730|NCT04433975|580590545|FG001|6-month Follow Up|Withdrawal by Subject|1|||
160782731|NCT04433975|580590544|FG000|9-month Follow Up|Lost to Follow-up|27|||
160782732|NCT04433975|580590545|FG001|9-month Follow Up|Lost to Follow-up|36|||
160782733|NCT04433975|580590544|FG000|9-month Follow Up|Death|0|||
160782734|NCT04433975|580590545|FG001|9-month Follow Up|Death|1|||
160782735|NCT04433975|580590544|FG000|12-month Follow Up|Lost to Follow-up|27|||
160782736|NCT04433975|580590545|FG001|12-month Follow Up|Lost to Follow-up|31|||
160782737|NCT04392635|580590546|FG000|Overall Study|Lost to Follow-up|0|||
160782738|NCT04392635|580590547|FG001|Overall Study|Lost to Follow-up|1|||
160782739|NCT00724893|580590552|FG000|Overall Study|Adverse Event|76|||
160782740|NCT00724893|580590553|FG001|Overall Study|Adverse Event|142|||
160782741|NCT00724893|580590552|FG000|Overall Study|Withdrawal by Subject|0|||
160782742|NCT00724893|580590553|FG001|Overall Study|Withdrawal by Subject|1|||
160782743|NCT00724893|580590552|FG000|Overall Study|Lack of virologic response|94|||
160782744|NCT00724893|580590553|FG001|Overall Study|Lack of virologic response|202|||
160782745|NCT00724893|580590552|FG000|Overall Study|Reason not specified|193|||
160782746|NCT00724893|580590553|FG001|Overall Study|Reason not specified|7|||
160782747|NCT00724893|580590552|FG000|Overall Study|Patient choice|0|||
160782748|NCT00724893|580590553|FG001|Overall Study|Patient choice|26|||
160782749|NCT00724893|580590552|FG000|Overall Study|Geographic reasons|0|||
160782750|NCT00724893|580590553|FG001|Overall Study|Geographic reasons|11|||
160782751|NCT00724893|580590552|FG000|Overall Study|Incarceration|0|||
160782752|NCT00724893|580590553|FG001|Overall Study|Incarceration|9|||
160782753|NCT00724893|580590552|FG000|Overall Study|Substance abuse|0|||
160782754|NCT00724893|580590553|FG001|Overall Study|Substance abuse|3|||
160782755|NCT00724893|580590552|FG000|Overall Study|Financial reasons|0|||
160782756|NCT00724893|580590553|FG001|Overall Study|Financial reasons|2|||
160782757|NCT00724893|580590552|FG000|Overall Study|Assigned shorter treatment|0|||
160782758|NCT00724893|580590553|FG001|Overall Study|Assigned shorter treatment|2|||
160782759|NCT00724893|580590552|FG000|Overall Study|Lost to Follow-up|0|||
160782760|NCT00724893|580590553|FG001|Overall Study|Lost to Follow-up|52|||
160782761|NCT00724893|580590552|FG000|Overall Study|Unknown, missing data|1|||
160782762|NCT00724893|580590553|FG001|Overall Study|Unknown, missing data|1|||
160782763|NCT01290731|580590554|FG000|Overall Study|Withdrawal by Subject|1|||
160782764|NCT02181738|580590560|FG000|Overall Study|Participant Withdrew Consent|2|||
160782765|NCT02181738|580590561|FG001|Overall Study|Participant Withdrew Consent|1|||
160981567|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981568|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
160981569|NCT02018861|581321704|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981570|NCT02018861|581321705|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160782766|NCT02181738|580590562|FG002|Overall Study|Participant Withdrew Consent|1|||
160782767|NCT02181738|580590563|FG003|Overall Study|Participant Withdrew Consent|1|||
160782768|NCT02181738|580590560|FG000|Overall Study|Lost to Follow-up|1|||
160782769|NCT02181738|580590561|FG001|Overall Study|Lost to Follow-up|2|||
160782770|NCT02181738|580590562|FG002|Overall Study|Lost to Follow-up|1|||
160782771|NCT02181738|580590563|FG003|Overall Study|Lost to Follow-up|1|||
160782772|NCT02181738|580590560|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
160782773|NCT02181738|580590561|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
160981571|NCT02018861|581321706|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981572|NCT02018861|581321707|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
161230317|NCT01746017|582225728|FG010|Period 3|Withdrawal by Subject|0|||
160782774|NCT02181738|580590562|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
160782775|NCT02181738|580590563|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
160782776|NCT02181738|580590560|FG000|Overall Study|Poor/Non-Compliance|1|||
160782777|NCT02181738|580590561|FG001|Overall Study|Poor/Non-Compliance|0|||
160782778|NCT02181738|580590562|FG002|Overall Study|Poor/Non-Compliance|2|||
160782779|NCT02181738|580590563|FG003|Overall Study|Poor/Non-Compliance|1|||
160782780|NCT02181738|580590560|FG000|Overall Study|Disease Progression|28|||
160782781|NCT02181738|580590561|FG001|Overall Study|Disease Progression|35|||
160782782|NCT02181738|580590562|FG002|Overall Study|Disease Progression|40|||
160782783|NCT02181738|580590563|FG003|Overall Study|Disease Progression|0|||
160782784|NCT02181738|580590560|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
160782785|NCT02181738|580590561|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
160782786|NCT02181738|580590562|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
160782787|NCT02181738|580590563|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
160782788|NCT02181738|580590560|FG000|Overall Study|Study Drug Toxicity|6|||
160782789|NCT02181738|580590561|FG001|Overall Study|Study Drug Toxicity|11|||
160981573|NCT02018861|581321708|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
160981574|NCT02018861|581321709|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981575|NCT02018861|581321710|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981576|NCT02018861|581321711|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981577|NCT02018861|581321712|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981578|NCT02018861|581321713|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
160981579|NCT02018861|581321704|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981580|NCT02018861|581321705|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981581|NCT02018861|581321706|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981582|NCT02018861|581321707|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981583|NCT02018861|581321708|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160782790|NCT02181738|580590562|FG002|Overall Study|Study Drug Toxicity|8|||
160782791|NCT02181738|580590563|FG003|Overall Study|Study Drug Toxicity|1|||
160782792|NCT02181738|580590560|FG000|Overall Study|Other Reasons|14|||
160782793|NCT02181738|580590561|FG001|Overall Study|Other Reasons|16|||
160782794|NCT02181738|580590562|FG002|Overall Study|Other Reasons|28|||
160782795|NCT02181738|580590563|FG003|Overall Study|Other Reasons|0|||
160782796|NCT02181738|580590560|FG000|Overall Study|Maximum Clinical Benefit|3|||
160782797|NCT02181738|580590561|FG001|Overall Study|Maximum Clinical Benefit|0|||
160782798|NCT02181738|580590562|FG002|Overall Study|Maximum Clinical Benefit|1|||
160782799|NCT02181738|580590563|FG003|Overall Study|Maximum Clinical Benefit|0|||
160782800|NCT02181738|580590560|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160782801|NCT02181738|580590561|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160782802|NCT02181738|580590562|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160782803|NCT02181738|580590563|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160782804|NCT01149538|580590566|FG000|Overall Study|Lost to Follow-up|0|||
160782805|NCT01149538|580590567|FG001|Overall Study|Lost to Follow-up|1|||
160782806|NCT01149538|580590566|FG000|Overall Study|Withdrawal by Subject|5|||
160782807|NCT01149538|580590567|FG001|Overall Study|Withdrawal by Subject|3|||
160782808|NCT00888849|580590568|FG000|Overall Study|Death|4|||
160782809|NCT00888849|580590569|FG001|Overall Study|Death|7|||
160782810|NCT00888849|580590568|FG000|Overall Study|Lost to Follow-up|1|||
160782811|NCT00888849|580590569|FG001|Overall Study|Lost to Follow-up|2|||
160782812|NCT00629239|580590570|FG000|Overall Study|Adverse Event|7|||
160782813|NCT00629239|580590571|FG001|Overall Study|Adverse Event|4|||
160782814|NCT00629239|580590570|FG000|Overall Study|Physician Decision|1|||
160782815|NCT00629239|580590571|FG001|Overall Study|Physician Decision|0|||
160782816|NCT01851369|580590574|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782817|NCT01851369|580590575|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782818|NCT01851369|580590576|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782819|NCT01851369|580590577|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782820|NCT01851369|580590578|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
161327471|NCT03489343|582585399|FG001|Overall Study|Clinical progression|0|||
161327472|NCT03489343|582585400|FG002|Overall Study|Clinical progression|0|||
161327473|NCT03489343|582585401|FG003|Overall Study|Clinical progression|1|||
161327474|NCT03489343|582585402|FG004|Overall Study|Clinical progression|0|||
160981584|NCT02018861|581321709|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981585|NCT02018861|581321710|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
160981586|NCT02018861|581321711|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
160782821|NCT01851369|580590579|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
160782822|NCT01851369|580590580|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782823|NCT01851369|580590581|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782824|NCT01851369|580590582|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782825|NCT01851369|580590583|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782826|NCT01851369|580590584|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782827|NCT01851369|580590585|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782828|NCT01851369|580590586|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
160782829|NCT00183391|580590587|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
161327475|NCT03489343|582585403|FG005|Overall Study|Clinical progression|0|||
160782830|NCT00183391|580590588|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
160782831|NCT00183391|580590587|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
160782832|NCT00183391|580590588|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
160782833|NCT02336503|580590589|FG000|Overall Study|Lost to Follow-up|0|||
160782834|NCT02336503|580590590|FG001|Overall Study|Lost to Follow-up|3|||
160782835|NCT02336503|580590591|FG002|Overall Study|Lost to Follow-up|0|||
160782836|NCT02336503|580590592|FG003|Overall Study|Lost to Follow-up|2|||
160782837|NCT02336503|580590589|FG000|Overall Study|Withdrawal by Subject|2|||
160782838|NCT02336503|580590590|FG001|Overall Study|Withdrawal by Subject|0|||
160782839|NCT02336503|580590591|FG002|Overall Study|Withdrawal by Subject|0|||
160782840|NCT02336503|580590592|FG003|Overall Study|Withdrawal by Subject|4|||
160782841|NCT02336503|580590589|FG000|Overall Study|Adverse Event|0|||
160782842|NCT02336503|580590590|FG001|Overall Study|Adverse Event|0|||
160782843|NCT02336503|580590591|FG002|Overall Study|Adverse Event|1|||
160782844|NCT02336503|580590592|FG003|Overall Study|Adverse Event|0|||
160782845|NCT00395512|580590593|FG000|Overall Study|Adverse Event|3|||
160782846|NCT00395512|580590594|FG001|Overall Study|Adverse Event|8|||
160782847|NCT00395512|580590595|FG002|Overall Study|Adverse Event|6|||
160782848|NCT00395512|580590596|FG003|Overall Study|Adverse Event|6|||
160782849|NCT00395512|580590593|FG000|Overall Study|Protocol Violation|2|||
160782850|NCT00395512|580590594|FG001|Overall Study|Protocol Violation|3|||
160782851|NCT00395512|580590595|FG002|Overall Study|Protocol Violation|6|||
160782852|NCT00395512|580590596|FG003|Overall Study|Protocol Violation|7|||
160782853|NCT00395512|580590593|FG000|Overall Study|Lost to Follow-up|2|||
160782854|NCT00395512|580590594|FG001|Overall Study|Lost to Follow-up|6|||
160782855|NCT00395512|580590595|FG002|Overall Study|Lost to Follow-up|5|||
160782856|NCT00395512|580590596|FG003|Overall Study|Lost to Follow-up|5|||
160782857|NCT00395512|580590593|FG000|Overall Study|Withdrawal by Subject|6|||
160782858|NCT00395512|580590594|FG001|Overall Study|Withdrawal by Subject|5|||
160782859|NCT00395512|580590595|FG002|Overall Study|Withdrawal by Subject|5|||
160782860|NCT00395512|580590596|FG003|Overall Study|Withdrawal by Subject|12|||
160782861|NCT00395512|580590593|FG000|Overall Study|Physician Decision|6|||
160782862|NCT00395512|580590594|FG001|Overall Study|Physician Decision|4|||
160782863|NCT00395512|580590595|FG002|Overall Study|Physician Decision|2|||
160782864|NCT00395512|580590596|FG003|Overall Study|Physician Decision|2|||
160782865|NCT00395512|580590593|FG000|Overall Study|Other|1|||
160782866|NCT00395512|580590594|FG001|Overall Study|Other|1|||
160782867|NCT00395512|580590595|FG002|Overall Study|Other|0|||
160782868|NCT00395512|580590596|FG003|Overall Study|Other|0|||
160782869|NCT00395512|580590593|FG000|Overall Study|Hyperglycemic Rescue|18|||
160782870|NCT00395512|580590594|FG001|Overall Study|Hyperglycemic Rescue|10|||
160782871|NCT00395512|580590595|FG002|Overall Study|Hyperglycemic Rescue|4|||
160782872|NCT00395512|580590596|FG003|Overall Study|Hyperglycemic Rescue|6|||
160782873|NCT04584554|580590597|FG000|Overall Study|Withdrawal by Subject|2|||
160782874|NCT04584554|580590598|FG001|Overall Study|Withdrawal by Subject|2|||
160782875|NCT01436500|580590603|FG000|Overall Study|Death|1|||
160782876|NCT01436500|580590604|FG001|Overall Study|Death|0|||
160782877|NCT01436500|580590605|FG002|Overall Study|Death|0|||
160782878|NCT01436500|580590606|FG003|Overall Study|Death|0|||
160782879|NCT01436500|580590607|FG004|Overall Study|Death|0|||
160782880|NCT01436500|580590603|FG000|Overall Study|Adverse Event|0|||
160782881|NCT01436500|580590604|FG001|Overall Study|Adverse Event|2|||
160782882|NCT01436500|580590605|FG002|Overall Study|Adverse Event|2|||
160782883|NCT01436500|580590606|FG003|Overall Study|Adverse Event|0|||
160782884|NCT01436500|580590607|FG004|Overall Study|Adverse Event|1|||
160782885|NCT01436500|580590603|FG000|Overall Study|Withdrawal by Subject|0|||
160782886|NCT01436500|580590604|FG001|Overall Study|Withdrawal by Subject|0|||
160782887|NCT01436500|580590605|FG002|Overall Study|Withdrawal by Subject|2|||
160782888|NCT01436500|580590606|FG003|Overall Study|Withdrawal by Subject|0|||
160782889|NCT01436500|580590607|FG004|Overall Study|Withdrawal by Subject|2|||
160782890|NCT01436500|580590603|FG000|Overall Study|Physician Decision|0|||
160782891|NCT01436500|580590604|FG001|Overall Study|Physician Decision|0|||
160782892|NCT01436500|580590605|FG002|Overall Study|Physician Decision|1|||
160889986|NCT01856023|580991606|FG001|Overall Study|non compliance, study closure|3|||
160889987|NCT01856023|580991605|FG000|Overall Study|Withdrawal by Subject|1|||
160889988|NCT01856023|580991606|FG001|Overall Study|Withdrawal by Subject|1|||
160889989|NCT00829283|580991607|FG000|Overall Study|Lost to Follow-up|7|||
160889990|NCT00829283|580991608|FG001|Overall Study|Lost to Follow-up|25|||
160889991|NCT00424255|580991609|FG000|Overall Study|Death|115|||
160889992|NCT00424255|580991610|FG001|Overall Study|Death|111|||
160889993|NCT00424255|580991609|FG000|Overall Study|Lost to Follow-up|26|||
160889994|NCT00424255|580991610|FG001|Overall Study|Lost to Follow-up|20|||
160889995|NCT00424255|580991609|FG000|Overall Study|Protocol Violation|0|||
160782893|NCT01436500|580590606|FG003|Overall Study|Physician Decision|0|||
160782894|NCT01436500|580590607|FG004|Overall Study|Physician Decision|0|||
160782895|NCT01436500|580590603|FG000|Overall Study|liver transplant|1|||
160782896|NCT01436500|580590604|FG001|Overall Study|liver transplant|0|||
160889996|NCT00424255|580991610|FG001|Overall Study|Protocol Violation|1|||
160782897|NCT01436500|580590605|FG002|Overall Study|liver transplant|0|||
160782898|NCT01436500|580590606|FG003|Overall Study|liver transplant|0|||
160782899|NCT01436500|580590607|FG004|Overall Study|liver transplant|0|||
160782900|NCT01436500|580590603|FG000|Overall Study|initiation of dialysis|0|||
160782901|NCT01436500|580590604|FG001|Overall Study|initiation of dialysis|0|||
160782902|NCT01436500|580590605|FG002|Overall Study|initiation of dialysis|0|||
160782903|NCT01436500|580590606|FG003|Overall Study|initiation of dialysis|0|||
160782904|NCT01436500|580590607|FG004|Overall Study|initiation of dialysis|1|||
160782905|NCT01436500|580590603|FG000|Overall Study|discontinued study drug|1|||
160782906|NCT01436500|580590604|FG001|Overall Study|discontinued study drug|0|||
160782907|NCT01436500|580590605|FG002|Overall Study|discontinued study drug|0|||
160782908|NCT01436500|580590606|FG003|Overall Study|discontinued study drug|0|||
160782909|NCT01436500|580590607|FG004|Overall Study|discontinued study drug|0|||
160782910|NCT01436500|580590603|FG000|Overall Study|Other|0|||
160782911|NCT01436500|580590604|FG001|Overall Study|Other|1|||
160782912|NCT01436500|580590605|FG002|Overall Study|Other|0|||
160782913|NCT01436500|580590606|FG003|Overall Study|Other|1|||
160782914|NCT01436500|580590607|FG004|Overall Study|Other|0|||
160782915|NCT02405962|580590610|FG000|Overall Study|Lost to Follow-up|1|||
160782916|NCT02405962|580590611|FG001|Overall Study|Lost to Follow-up|4|||
160782917|NCT02405962|580590610|FG000|Overall Study|A participant has moved to another place|0|||
160782918|NCT02405962|580590611|FG001|Overall Study|A participant has moved to another place|1|||
160782919|NCT00165698|580590612|FG000|Overall Study|Adverse Event|2|||
160782920|NCT00165698|580590613|FG001|Overall Study|Adverse Event|10|||
160782921|NCT00165698|580590612|FG000|Overall Study|Lost to Follow-up|2|||
160782922|NCT00165698|580590613|FG001|Overall Study|Lost to Follow-up|2|||
160782923|NCT00165698|580590612|FG000|Overall Study|Withdrawal by Subject|2|||
160782924|NCT00165698|580590613|FG001|Overall Study|Withdrawal by Subject|1|||
160782925|NCT00165698|580590612|FG000|Overall Study|Protocol Violation|1|||
160782926|NCT00165698|580590613|FG001|Overall Study|Protocol Violation|0|||
160782927|NCT00165698|580590612|FG000|Overall Study|Not Taken/Lost the medicine|1|||
160782928|NCT00165698|580590613|FG001|Overall Study|Not Taken/Lost the medicine|2|||
160782929|NCT01483651|580590614|FG000|Overall Study|Withdrawal by Subject|0|||
160782930|NCT01483651|580590615|FG001|Overall Study|Withdrawal by Subject|1|||
160782931|NCT01483651|580590616|FG002|Overall Study|Withdrawal by Subject|1|||
160782932|NCT01483651|580590617|FG003|Overall Study|Withdrawal by Subject|0|||
160782933|NCT01483651|580590618|FG004|Overall Study|Withdrawal by Subject|0|||
160782934|NCT01483651|580590619|FG005|Overall Study|Withdrawal by Subject|1|||
160782935|NCT02547935|580590626|FG000|Overall Study|Other|0|||
160782936|NCT02547935|580590627|FG001|Overall Study|Other|1|||
160782937|NCT02547935|580590628|FG002|Overall Study|Other|0|||
160782938|NCT02547935|580590626|FG000|Overall Study|Withdrawal by Subject|2|||
160782939|NCT02547935|580590627|FG001|Overall Study|Withdrawal by Subject|3|||
160782940|NCT02547935|580590628|FG002|Overall Study|Withdrawal by Subject|4|||
160782941|NCT02547935|580590626|FG000|Overall Study|Screen Failure|2|||
160782942|NCT02547935|580590627|FG001|Overall Study|Screen Failure|0|||
160782943|NCT02547935|580590628|FG002|Overall Study|Screen Failure|0|||
160782944|NCT02547935|580590626|FG000|Overall Study|Physician Decision|0|||
160782945|NCT02547935|580590627|FG001|Overall Study|Physician Decision|1|||
160782946|NCT02547935|580590628|FG002|Overall Study|Physician Decision|0|||
160782947|NCT02547935|580590626|FG000|Overall Study|Lost to Follow-up|0|||
160782948|NCT02547935|580590627|FG001|Overall Study|Lost to Follow-up|2|||
160782949|NCT02547935|580590628|FG002|Overall Study|Lost to Follow-up|1|||
160782950|NCT02547935|580590626|FG000|Overall Study|Death|1|||
160782951|NCT02547935|580590627|FG001|Overall Study|Death|1|||
160782952|NCT02547935|580590628|FG002|Overall Study|Death|0|||
160782953|NCT01184118|580590630|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
160782954|NCT01184118|580590630|FG000|Overall Study|No physiologic confirmation of asthma|8|||
160782955|NCT01184118|580590630|FG000|Overall Study|FEV1 <60% predicted|2|||
160782956|NCT01184118|580590630|FG000|Overall Study|Exclusionary medical condition|2|||
160782957|NCT01184118|580590630|FG000|Overall Study|Withdrawal by Subject|5|||
160782958|NCT01928771|580590633|FG000|Overall Study|Adverse Event|6|||
160782959|NCT01928771|580590634|FG001|Overall Study|Adverse Event|5|||
161327476|NCT03489343|582585404|FG006|Overall Study|Clinical progression|1|||
161327477|NCT00327717|582585405|FG000|Overall Study|Adverse Event|6|||
161327478|NCT00327717|582585406|FG001|Overall Study|Adverse Event|6|||
160782960|NCT01928771|580590635|FG002|Overall Study|Adverse Event|1|||
160782961|NCT01928771|580590633|FG000|Overall Study|Death|2|||
160782962|NCT01928771|580590634|FG001|Overall Study|Death|2|||
161327479|NCT00327717|582585405|FG000|Overall Study|Lack of Efficacy|0|||
160782963|NCT01928771|580590635|FG002|Overall Study|Death|2|||
160782964|NCT01928771|580590633|FG000|Overall Study|Lost to Follow-up|5|||
160782965|NCT01928771|580590634|FG001|Overall Study|Lost to Follow-up|6|||
160782966|NCT01928771|580590635|FG002|Overall Study|Lost to Follow-up|3|||
160782967|NCT01928771|580590633|FG000|Overall Study|Withdrawal by Subject|20|||
160782968|NCT01928771|580590634|FG001|Overall Study|Withdrawal by Subject|15|||
160782969|NCT01928771|580590635|FG002|Overall Study|Withdrawal by Subject|17|||
160782970|NCT01928771|580590633|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
160782971|NCT01928771|580590634|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161327480|NCT00327717|582585406|FG001|Overall Study|Lack of Efficacy|1|||
160782972|NCT01928771|580590635|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
160782973|NCT01928771|580590633|FG000|Overall Study|Other Reasons|9|||
160782974|NCT01928771|580590634|FG001|Overall Study|Other Reasons|9|||
160782975|NCT01928771|580590635|FG002|Overall Study|Other Reasons|14|||
160782976|NCT01928771|580590633|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
160782977|NCT01928771|580590634|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
160782978|NCT01928771|580590635|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
160782979|NCT01937117|580590636|FG000|Overall Study|Disease Progression|7|||
160782980|NCT01937117|580590636|FG000|Overall Study|Physician Decision|4|||
160782981|NCT01937117|580590636|FG000|Overall Study|Adverse Event|2|||
160782982|NCT01407367|580590641|FG000|Overall Study|Death|24|||
160782983|NCT01407367|580590642|FG001|Overall Study|Death|32|||
160782984|NCT01407367|580590641|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
160782985|NCT01407367|580590642|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
160782986|NCT01407367|580590641|FG000|Overall Study|Withdrawal by Subject|4|||
160782987|NCT01407367|580590642|FG001|Overall Study|Withdrawal by Subject|15|||
160782988|NCT01407367|580590641|FG000|Overall Study|Lost to Follow-up|0|||
160782989|NCT01407367|580590642|FG001|Overall Study|Lost to Follow-up|2|||
160782990|NCT01695772|580590644|FG000|Overall Study|Withdrawal by Subject|18|||
160782991|NCT01695772|580590644|FG000|Overall Study|Progressive Disease|8|||
160782992|NCT01695772|580590644|FG000|Overall Study|Investigator Decision|5|||
160782993|NCT01695772|580590644|FG000|Overall Study|Lost to Follow-up|4|||
160782994|NCT01695772|580590644|FG000|Overall Study|Protocol Violation|2|||
160782995|NCT01695772|580590644|FG000|Overall Study|Unspecified Reason|1|||
160782996|NCT00004859|580590647|FG000|Overall Study|Lack of Efficacy|43|||
160782997|NCT00004859|580590648|FG001|Overall Study|Lack of Efficacy|113|||
160782998|NCT00004859|580590647|FG000|Overall Study|Adverse Event|31|||
160782999|NCT00004859|580590648|FG001|Overall Study|Adverse Event|93|||
160783000|NCT00004859|580590647|FG000|Overall Study|Death|5|||
160783001|NCT00004859|580590648|FG001|Overall Study|Death|5|||
160783002|NCT00004859|580590647|FG000|Overall Study|Withdrawal by Subject|7|||
160783003|NCT00004859|580590648|FG001|Overall Study|Withdrawal by Subject|33|||
160783004|NCT00004859|580590647|FG000|Overall Study|Protocol Violation|2|||
160783005|NCT00004859|580590648|FG001|Overall Study|Protocol Violation|2|||
160783006|NCT00004859|580590647|FG000|Overall Study|other disease|0|||
160783007|NCT00004859|580590648|FG001|Overall Study|other disease|3|||
160783008|NCT00004859|580590647|FG000|Overall Study|error|3|||
160783009|NCT00004859|580590648|FG001|Overall Study|error|1|||
160783010|NCT00004859|580590647|FG000|Overall Study|missing data|14|||
160783011|NCT00004859|580590648|FG001|Overall Study|missing data|11|||
160783012|NCT00004859|580590647|FG000|Overall Study|Other|13|||
160783013|NCT00004859|580590648|FG001|Overall Study|Other|21|||
160783014|NCT04073407|580590649|FG000|Part 1|Withdrawal by Subject|1|||
160783015|NCT04073407|580590650|FG001|Part 1|Withdrawal by Subject|0|||
160783016|NCT04073407|580590649|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
160783017|NCT04073407|580590650|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
161124770|NCT01262976|581843791|FG003|Up to Year 1|Migrated/moved from study area|3|||
161124771|NCT01262976|581843792|FG004|Up to Year 1|Migrated/moved from study area|3|||
161124772|NCT01262976|581843793|FG005|Up to Year 1|Migrated/moved from study area|2|||
161124773|NCT01262976|581843788|FG000|Up to Year 1|Lost to Follow-up|4|||
161124774|NCT01262976|581843789|FG001|Up to Year 1|Lost to Follow-up|0|||
161124775|NCT01262976|581843790|FG002|Up to Year 1|Lost to Follow-up|0|||
161124776|NCT01262976|581843791|FG003|Up to Year 1|Lost to Follow-up|1|||
161124777|NCT01262976|581843792|FG004|Up to Year 1|Lost to Follow-up|6|||
161124778|NCT01262976|581843793|FG005|Up to Year 1|Lost to Follow-up|5|||
161124779|NCT01262976|581843788|FG000|Up to Year 1|Other|3|||
161124780|NCT01262976|581843789|FG001|Up to Year 1|Other|1|||
161124781|NCT01262976|581843790|FG002|Up to Year 1|Other|0|||
161124782|NCT01262976|581843791|FG003|Up to Year 1|Other|0|||
161124783|NCT01262976|581843792|FG004|Up to Year 1|Other|2|||
161124784|NCT01262976|581843793|FG005|Up to Year 1|Other|1|||
161124785|NCT01262976|581843788|FG000|Up to Year 1|Subjects with unknown completion status|0|||
161124786|NCT01262976|581843789|FG001|Up to Year 1|Subjects with unknown completion status|0|||
161124787|NCT01262976|581843790|FG002|Up to Year 1|Subjects with unknown completion status|1|||
160783018|NCT04073407|580590649|FG000|Part 2|Withdrawal by Subject|0|||
160783019|NCT04073407|580590650|FG001|Part 2|Withdrawal by Subject|1|||
160783020|NCT03882801|580592076|FG000|Period 1|Adverse Event|0|||
161124788|NCT01262976|581843791|FG003|Up to Year 1|Subjects with unknown completion status|0|||
160783021|NCT03882801|580592077|FG001|Period 1|Adverse Event|1|||
160783022|NCT03882801|580592076|FG000|Period 1|Non-compliance with study drug|1|||
160783023|NCT03882801|580592077|FG001|Period 1|Non-compliance with study drug|1|||
160783024|NCT03882801|580592076|FG000|Period 1|Never treated with study drug|1|||
160783025|NCT03882801|580592077|FG001|Period 1|Never treated with study drug|0|||
160783026|NCT03882801|580592076|FG000|Washout Period|Physician Decision|0|||
160783027|NCT03882801|580592077|FG001|Washout Period|Physician Decision|1|||
160783028|NCT03882801|580592076|FG000|Period 2|Non-compliance with study drug|0|||
160783029|NCT03882801|580592077|FG001|Period 2|Non-compliance with study drug|1|||
161124789|NCT01262976|581843792|FG004|Up to Year 1|Subjects with unknown completion status|0|||
161124790|NCT01262976|581843793|FG005|Up to Year 1|Subjects with unknown completion status|1|||
161124791|NCT01262976|581843788|FG000|Up to Year 2|Serious Adverse Event|0|||
161124792|NCT01262976|581843789|FG001|Up to Year 2|Serious Adverse Event|0|||
160783030|NCT01793129|580592078|FG000|Overall Study|Lost to Follow-up|3|||
160783031|NCT01793129|580592079|FG001|Overall Study|Lost to Follow-up|7|||
160783032|NCT01793129|580592078|FG000|Overall Study|Withdrawal by Subject|0|||
160783033|NCT01793129|580592079|FG001|Overall Study|Withdrawal by Subject|2|||
160783034|NCT01567085|580592082|FG000|Overall Study|Death|6|||
160783035|NCT01567085|580592082|FG000|Overall Study|Adverse Event|6|||
160783036|NCT01567085|580592082|FG000|Overall Study|Lost to Follow-up|3|||
160783037|NCT01567085|580592082|FG000|Overall Study|Graft loss|2|||
160783038|NCT01567085|580592082|FG000|Overall Study|Renal transplantectomy|1|||
160783039|NCT01567085|580592082|FG000|Overall Study|Returned to chronic dialysis|1|||
160783040|NCT01567085|580592082|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
160783041|NCT04193176|580592083|FG000|Overall Study|Withdrawal by Subject|6|||
160783042|NCT04193176|580592084|FG001|Overall Study|Withdrawal by Subject|10|||
160783043|NCT00944645|580592085|FG000|Period 2|Adverse Event|1|||
160783044|NCT00944645|580592086|FG001|Period 2|Adverse Event|0|||
160783045|NCT00944645|580592085|FG000|Period 2|Lost to Follow-up|0|||
160783046|NCT00944645|580592086|FG001|Period 2|Lost to Follow-up|3|||
160783047|NCT00944645|580592085|FG000|Period 2|Withdrawal by Subject|7|||
160783048|NCT00944645|580592086|FG001|Period 2|Withdrawal by Subject|6|||
160783049|NCT03537729|580592090|FG000|Overall Study|Death|2|||
160783050|NCT03537729|580592091|FG001|Overall Study|Death|2|||
160783051|NCT03537729|580592092|FG002|Overall Study|Death|7|||
160783052|NCT03537729|580592090|FG000|Overall Study|Withdrawal by Subject|3|||
160783053|NCT03537729|580592091|FG001|Overall Study|Withdrawal by Subject|3|||
160783054|NCT03537729|580592092|FG002|Overall Study|Withdrawal by Subject|0|||
161327481|NCT00327717|582585405|FG000|Overall Study|Withdrawal by Subject|3|||
161327482|NCT00327717|582585406|FG001|Overall Study|Withdrawal by Subject|7|||
161327483|NCT01630135|582585409|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
161327484|NCT01630135|582585410|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
161327485|NCT02658669|582585411|FG000|Overall Study|Lost to Follow-up|7|||
161327486|NCT02658669|582585412|FG001|Overall Study|Lost to Follow-up|5|||
161327487|NCT00838097|582585421|FG000|Overall Study|Ineligibility determined|6|||
161327488|NCT00838097|582585421|FG000|Overall Study|Adverse Event|2|||
161327489|NCT00838097|582585421|FG000|Overall Study|Withdrawal by Subject|3|||
161327490|NCT00838097|582585421|FG000|Overall Study|Requirement for alternative therapy|2|||
161327491|NCT00838097|582585421|FG000|Overall Study|Physician Decision|4|||
161327492|NCT00838097|582585421|FG000|Overall Study|Lost to Follow-up|11|||
161327493|NCT00838097|582585421|FG000|Overall Study|Death|6|||
160783055|NCT03537729|580592090|FG000|Overall Study|Subject Moved|8|||
161230318|NCT02424097|582225731|FG000|Overall Study|Lost to Follow-up|1|||
161230319|NCT02424097|582225732|FG001|Overall Study|Lost to Follow-up|2|||
161230320|NCT01675622|582225733|FG000|Overall Study|Withdrawal by Subject|2|||
161230321|NCT01675622|582225734|FG001|Overall Study|Withdrawal by Subject|2|||
161230322|NCT01675622|582225733|FG000|Overall Study|Adverse Event|12|||
161230323|NCT01675622|582225734|FG001|Overall Study|Adverse Event|10|||
161230324|NCT01675622|582225733|FG000|Overall Study|Protocol Violation|4|||
161230325|NCT01675622|582225734|FG001|Overall Study|Protocol Violation|1|||
161230326|NCT01675622|582225733|FG000|Overall Study|Lack of Efficacy|2|||
160783056|NCT03537729|580592091|FG001|Overall Study|Subject Moved|5|||
160783057|NCT03537729|580592092|FG002|Overall Study|Subject Moved|4|||
160783058|NCT03537729|580592090|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
160783059|NCT03537729|580592091|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
160783060|NCT03537729|580592092|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
160783061|NCT03537729|580592090|FG000|Overall Study|COVID-19 Site Restrictions|11|||
160783062|NCT03537729|580592091|FG001|Overall Study|COVID-19 Site Restrictions|15|||
160783063|NCT03537729|580592092|FG002|Overall Study|COVID-19 Site Restrictions|18|||
160783064|NCT03537729|580592090|FG000|Overall Study|Decline in Health|5|||
160783065|NCT03537729|580592091|FG001|Overall Study|Decline in Health|9|||
160783066|NCT03537729|580592092|FG002|Overall Study|Decline in Health|4|||
160783067|NCT03537729|580592090|FG000|Overall Study|Determined Ineligible|0|||
160783068|NCT03537729|580592091|FG001|Overall Study|Determined Ineligible|0|||
160783069|NCT03537729|580592092|FG002|Overall Study|Determined Ineligible|1|||
160783070|NCT01348698|580592098|FG000|Overall Study|Does not meet lesion size criteria|1|||
160783071|NCT01348698|580592098|FG000|Overall Study|Death|3|||
160783072|NCT01348698|580592098|FG000|Overall Study|PI decision to close study|68|||
160783073|NCT00504556|580592099|FG000|Overall Study|Adverse Event|11|||
160783074|NCT00504556|580592100|FG001|Overall Study|Adverse Event|11|||
160783075|NCT00504556|580592101|FG002|Overall Study|Adverse Event|14|||
161327494|NCT00838097|582585421|FG000|Overall Study|Protocol-specified criteria|142|||
161327495|NCT03311841|582585422|FG000|14-day Wash-out|Adverse Event|0|||
160783076|NCT00504556|580592102|FG003|Overall Study|Adverse Event|13|||
160783077|NCT00504556|580592103|FG004|Overall Study|Adverse Event|5|||
160783078|NCT00504556|580592099|FG000|Overall Study|Death|3|||
160783079|NCT00504556|580592100|FG001|Overall Study|Death|3|||
160783080|NCT00504556|580592101|FG002|Overall Study|Death|1|||
161230327|NCT01675622|582225734|FG001|Overall Study|Lack of Efficacy|4|||
161230328|NCT01675622|582225733|FG000|Overall Study|Lost to Follow-up|1|||
161327496|NCT03311841|582585423|FG001|14-day Wash-out|Adverse Event|1|||
160783081|NCT00504556|580592102|FG003|Overall Study|Death|0|||
160783082|NCT00504556|580592103|FG004|Overall Study|Death|2|||
160783083|NCT00504556|580592099|FG000|Overall Study|Protocol Violation|1|||
160783084|NCT00504556|580592100|FG001|Overall Study|Protocol Violation|3|||
160783085|NCT00504556|580592101|FG002|Overall Study|Protocol Violation|2|||
160783086|NCT00504556|580592102|FG003|Overall Study|Protocol Violation|1|||
160783087|NCT00504556|580592103|FG004|Overall Study|Protocol Violation|2|||
160783088|NCT00504556|580592099|FG000|Overall Study|Lost to Follow-up|0|||
160783089|NCT00504556|580592100|FG001|Overall Study|Lost to Follow-up|0|||
160783090|NCT00504556|580592101|FG002|Overall Study|Lost to Follow-up|1|||
160783091|NCT00504556|580592102|FG003|Overall Study|Lost to Follow-up|1|||
160783092|NCT00504556|580592103|FG004|Overall Study|Lost to Follow-up|1|||
160783093|NCT00504556|580592099|FG000|Overall Study|Withdrawal by Subject|16|||
160783094|NCT00504556|580592100|FG001|Overall Study|Withdrawal by Subject|16|||
160783095|NCT00504556|580592101|FG002|Overall Study|Withdrawal by Subject|7|||
160783096|NCT00504556|580592102|FG003|Overall Study|Withdrawal by Subject|8|||
160783097|NCT00504556|580592103|FG004|Overall Study|Withdrawal by Subject|12|||
160783098|NCT00504556|580592099|FG000|Overall Study|administrative reasons|0|||
160783099|NCT00504556|580592100|FG001|Overall Study|administrative reasons|2|||
160783100|NCT00504556|580592101|FG002|Overall Study|administrative reasons|2|||
160889997|NCT00424255|580991609|FG000|Overall Study|Withdrawal by Subject|34|||
160889998|NCT00424255|580991610|FG001|Overall Study|Withdrawal by Subject|38|||
160889999|NCT00424255|580991609|FG000|Overall Study|Physician Decision|3|||
160890000|NCT00424255|580991610|FG001|Overall Study|Physician Decision|7|||
160890001|NCT00424255|580991609|FG000|Overall Study|Cognitive Disturbance|1|||
160890002|NCT00424255|580991610|FG001|Overall Study|Cognitive Disturbance|0|||
160890003|NCT00424255|580991609|FG000|Overall Study|Non-compliance by Participants|1|||
160890004|NCT00424255|580991610|FG001|Overall Study|Non-compliance by Participants|0|||
160890005|NCT00424255|580991609|FG000|Overall Study|Fatigue|1|||
160890006|NCT00424255|580991610|FG001|Overall Study|Fatigue|0|||
160890007|NCT00424255|580991609|FG000|Overall Study|Disease Progression|0|||
160890008|NCT00424255|580991610|FG001|Overall Study|Disease Progression|2|||
160890009|NCT00424255|580991609|FG000|Overall Study|Sponsor Terminated Study|161|||
160890010|NCT00424255|580991610|FG001|Overall Study|Sponsor Terminated Study|167|||
160890011|NCT00256282|580991611|FG000|Overall Study|Disease progression, relapse during acti|12|||
160890012|NCT00256282|580991611|FG000|Overall Study|Adverse Event|3|||
160890013|NCT00256282|580991611|FG000|Overall Study|Physician Decision|1|||
160890014|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
160890015|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
160890016|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
160890017|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
160890018|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
160890019|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
160890020|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
160890021|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
160890022|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
160890023|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
160890024|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
160890025|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
160890026|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
160890027|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
160890028|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
160890029|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
160890030|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
160890031|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
160890032|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
160890033|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
160890034|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
160890035|NCT02431247|580991612|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
160890036|NCT02431247|580991613|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
160890037|NCT02431247|580991614|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
160890038|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
160890039|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
160890040|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
160890041|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
160890042|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
160783101|NCT00504556|580592102|FG003|Overall Study|administrative reasons|1|||
160783102|NCT00504556|580592103|FG004|Overall Study|administrative reasons|2|||
160783103|NCT00504556|580592099|FG000|Overall Study|did not meet entry criteria|2|||
160783104|NCT00504556|580592100|FG001|Overall Study|did not meet entry criteria|0|||
160783105|NCT00504556|580592101|FG002|Overall Study|did not meet entry criteria|1|||
160783106|NCT00504556|580592102|FG003|Overall Study|did not meet entry criteria|1|||
160981587|NCT02018861|581321712|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981588|NCT02018861|581321713|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
160981589|NCT02018861|581321704|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981590|NCT02018861|581321705|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981591|NCT02018861|581321706|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981592|NCT02018861|581321707|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981593|NCT02018861|581321708|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981594|NCT02018861|581321709|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981595|NCT02018861|581321710|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
160981596|NCT02018861|581321711|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
160981597|NCT02018861|581321712|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981598|NCT02018861|581321713|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
160981599|NCT02018861|581321704|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981600|NCT02018861|581321705|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981601|NCT02018861|581321706|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981602|NCT02018861|581321707|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981603|NCT02018861|581321708|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981604|NCT02018861|581321709|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981605|NCT02018861|581321710|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981606|NCT02018861|581321711|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981607|NCT02018861|581321712|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
160981608|NCT02018861|581321713|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
160981609|NCT02018861|581321704|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
161230329|NCT01675622|582225734|FG001|Overall Study|Lost to Follow-up|3|||
161230330|NCT01675622|582225733|FG000|Overall Study|Other|5|||
161230331|NCT01675622|582225734|FG001|Overall Study|Other|4|||
161230332|NCT00840632|582225737|FG000|First Intervention|Withdrawal by Subject|0|||
161230333|NCT00840632|582225738|FG001|First Intervention|Withdrawal by Subject|1|||
161230334|NCT00840632|582225737|FG000|Washout|Withdrawal by Subject|1|||
161230335|NCT00840632|582225738|FG001|Washout|Withdrawal by Subject|1|||
161230336|NCT05017480|582225739|FG000|Stage 1 Study|Withdrawal by Subject|8|||
160981610|NCT02018861|581321705|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981611|NCT02018861|581321706|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981612|NCT02018861|581321707|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981613|NCT02018861|581321708|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981614|NCT02018861|581321709|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981615|NCT02018861|581321710|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981616|NCT02018861|581321711|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981617|NCT02018861|581321712|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
160981618|NCT02018861|581321713|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
160981619|NCT02018861|581321704|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981620|NCT02018861|581321705|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981621|NCT02018861|581321706|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981622|NCT02018861|581321707|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981623|NCT02018861|581321708|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981624|NCT02018861|581321709|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981625|NCT02018861|581321710|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981626|NCT02018861|581321711|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981627|NCT02018861|581321712|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
160981628|NCT02018861|581321713|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
160981629|NCT00590980|581321721|FG000|Overall Study|Did not meet all inclusion criteria|10|||
160981630|NCT00504348|581321722|FG000|Overall Study|Adverse Event|3|||
160981631|NCT00504348|581321722|FG000|Overall Study|Lack of Efficacy|4|||
160981632|NCT00504348|581321722|FG000|Overall Study|Physician Decision|1|||
160981633|NCT00506285|581321725|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
160981634|NCT00506285|581321726|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
160981635|NCT00506285|581321725|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
160981636|NCT00506285|581321726|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
160981637|NCT00506285|581321725|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
160981638|NCT00506285|581321726|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
160981639|NCT00506285|581321725|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
160981640|NCT00506285|581321726|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
160981641|NCT00506285|581321725|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
160981642|NCT00506285|581321726|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
160981643|NCT00551213|581321729|FG000|Overall Study|Adverse Event|6|||
161230337|NCT05017480|582225740|FG001|Stage 1 Study|Withdrawal by Subject|6|||
161230338|NCT05017480|582225741|FG002|Stage 1 Study|Withdrawal by Subject|0|||
161230339|NCT05017480|582225742|FG003|Stage 1 Study|Withdrawal by Subject|0|||
161230340|NCT05017480|582225743|FG004|Stage 1 Study|Withdrawal by Subject|0|||
161124793|NCT01262976|581843790|FG002|Up to Year 2|Serious Adverse Event|2|||
161124794|NCT01262976|581843791|FG003|Up to Year 2|Serious Adverse Event|0|||
161124795|NCT01262976|581843792|FG004|Up to Year 2|Serious Adverse Event|0|||
161124796|NCT01262976|581843793|FG005|Up to Year 2|Serious Adverse Event|0|||
161124797|NCT01262976|581843788|FG000|Up to Year 2|Withdrawal by Subject|1|||
161124798|NCT01262976|581843789|FG001|Up to Year 2|Withdrawal by Subject|0|||
161124799|NCT01262976|581843790|FG002|Up to Year 2|Withdrawal by Subject|0|||
161124800|NCT01262976|581843791|FG003|Up to Year 2|Withdrawal by Subject|0|||
161124801|NCT01262976|581843792|FG004|Up to Year 2|Withdrawal by Subject|0|||
161124802|NCT01262976|581843793|FG005|Up to Year 2|Withdrawal by Subject|0|||
161124803|NCT01262976|581843788|FG000|Up to Year 2|Migrated/moved from study area|0|||
161124804|NCT01262976|581843789|FG001|Up to Year 2|Migrated/moved from study area|0|||
161124805|NCT01262976|581843790|FG002|Up to Year 2|Migrated/moved from study area|0|||
161124806|NCT01262976|581843791|FG003|Up to Year 2|Migrated/moved from study area|2|||
161124807|NCT01262976|581843792|FG004|Up to Year 2|Migrated/moved from study area|1|||
161124808|NCT01262976|581843793|FG005|Up to Year 2|Migrated/moved from study area|2|||
161124809|NCT01262976|581843788|FG000|Up to Year 2|Lost to Follow-up|1|||
161124810|NCT01262976|581843789|FG001|Up to Year 2|Lost to Follow-up|1|||
161124811|NCT01262976|581843790|FG002|Up to Year 2|Lost to Follow-up|2|||
161124812|NCT01262976|581843791|FG003|Up to Year 2|Lost to Follow-up|2|||
161124813|NCT01262976|581843792|FG004|Up to Year 2|Lost to Follow-up|3|||
161124814|NCT01262976|581843793|FG005|Up to Year 2|Lost to Follow-up|3|||
161124815|NCT01262976|581843788|FG000|Up to Year 2|Subjects with unknown completion status|0|||
161124816|NCT01262976|581843789|FG001|Up to Year 2|Subjects with unknown completion status|0|||
161124817|NCT01262976|581843790|FG002|Up to Year 2|Subjects with unknown completion status|1|||
161124818|NCT01262976|581843791|FG003|Up to Year 2|Subjects with unknown completion status|0|||
161124819|NCT01262976|581843792|FG004|Up to Year 2|Subjects with unknown completion status|0|||
161124820|NCT01262976|581843793|FG005|Up to Year 2|Subjects with unknown completion status|0|||
161124821|NCT01262976|581843788|FG000|Up to Year 2|Other|3|||
161124822|NCT01262976|581843789|FG001|Up to Year 2|Other|0|||
161124823|NCT01262976|581843790|FG002|Up to Year 2|Other|0|||
161124824|NCT01262976|581843791|FG003|Up to Year 2|Other|0|||
161124825|NCT01262976|581843792|FG004|Up to Year 2|Other|0|||
161124826|NCT01262976|581843793|FG005|Up to Year 2|Other|0|||
161124827|NCT01262976|581843788|FG000|Up to Year 3|Serious Adverse Event|0|||
161124828|NCT01262976|581843789|FG001|Up to Year 3|Serious Adverse Event|0|||
161124829|NCT01262976|581843790|FG002|Up to Year 3|Serious Adverse Event|2|||
161124830|NCT01262976|581843791|FG003|Up to Year 3|Serious Adverse Event|0|||
161124831|NCT01262976|581843792|FG004|Up to Year 3|Serious Adverse Event|0|||
161124832|NCT01262976|581843793|FG005|Up to Year 3|Serious Adverse Event|0|||
161124833|NCT01262976|581843788|FG000|Up to Year 3|Withdrawal by Subject|1|||
161124834|NCT01262976|581843789|FG001|Up to Year 3|Withdrawal by Subject|0|||
161124835|NCT01262976|581843790|FG002|Up to Year 3|Withdrawal by Subject|0|||
161124836|NCT01262976|581843791|FG003|Up to Year 3|Withdrawal by Subject|0|||
161124837|NCT01262976|581843792|FG004|Up to Year 3|Withdrawal by Subject|0|||
161124838|NCT01262976|581843793|FG005|Up to Year 3|Withdrawal by Subject|0|||
161124839|NCT01262976|581843788|FG000|Up to Year 3|Migrated/moved from study area|0|||
161124840|NCT01262976|581843789|FG001|Up to Year 3|Migrated/moved from study area|0|||
161124841|NCT01262976|581843790|FG002|Up to Year 3|Migrated/moved from study area|0|||
161124842|NCT01262976|581843791|FG003|Up to Year 3|Migrated/moved from study area|2|||
161124843|NCT01262976|581843792|FG004|Up to Year 3|Migrated/moved from study area|1|||
161124844|NCT01262976|581843793|FG005|Up to Year 3|Migrated/moved from study area|1|||
161124845|NCT01262976|581843788|FG000|Up to Year 3|Lost to Follow-up|2|||
161124846|NCT01262976|581843789|FG001|Up to Year 3|Lost to Follow-up|2|||
161124847|NCT01262976|581843790|FG002|Up to Year 3|Lost to Follow-up|4|||
161124848|NCT01262976|581843791|FG003|Up to Year 3|Lost to Follow-up|3|||
161124849|NCT01262976|581843792|FG004|Up to Year 3|Lost to Follow-up|1|||
161124850|NCT01262976|581843793|FG005|Up to Year 3|Lost to Follow-up|3|||
161124851|NCT01262976|581843788|FG000|Up to Year 3|Subjects with unknown completion status|0|||
161124852|NCT01262976|581843789|FG001|Up to Year 3|Subjects with unknown completion status|0|||
161124853|NCT01262976|581843790|FG002|Up to Year 3|Subjects with unknown completion status|1|||
161124854|NCT01262976|581843791|FG003|Up to Year 3|Subjects with unknown completion status|0|||
161124855|NCT01262976|581843792|FG004|Up to Year 3|Subjects with unknown completion status|0|||
161124856|NCT01262976|581843793|FG005|Up to Year 3|Subjects with unknown completion status|0|||
161124857|NCT01262976|581843788|FG000|Up to Year 3|Other|3|||
161124858|NCT01262976|581843789|FG001|Up to Year 3|Other|0|||
160981644|NCT00551213|581321730|FG001|Overall Study|Adverse Event|3|||
160981645|NCT00551213|581321729|FG000|Overall Study|Progressive Disease|41|||
161124859|NCT01262976|581843790|FG002|Up to Year 3|Other|0|||
161124860|NCT01262976|581843791|FG003|Up to Year 3|Other|0|||
161124861|NCT01262976|581843792|FG004|Up to Year 3|Other|0|||
161124862|NCT01262976|581843793|FG005|Up to Year 3|Other|0|||
161124863|NCT01528787|581843794|FG000|Overall Study|Withdrawal by Subject|0|||
161124864|NCT01528787|581843795|FG001|Overall Study|Withdrawal by Subject|0|||
161124865|NCT01528787|581843796|FG002|Overall Study|Withdrawal by Subject|0|||
160981646|NCT00551213|581321730|FG001|Overall Study|Progressive Disease|12|||
160981647|NCT00551213|581321729|FG000|Overall Study|Withdrawal by Subject|2|||
160981648|NCT00551213|581321730|FG001|Overall Study|Withdrawal by Subject|0|||
160981649|NCT00551213|581321729|FG000|Overall Study|Not Treated|1|||
160981650|NCT00551213|581321730|FG001|Overall Study|Not Treated|2|||
160981651|NCT01890967|581321731|FG000|Overall Study|Adverse Event|3|||
160981652|NCT01890967|581321732|FG001|Overall Study|Adverse Event|3|||
160981653|NCT01890967|581321733|FG002|Overall Study|Adverse Event|3|||
160981654|NCT01890967|581321734|FG003|Overall Study|Adverse Event|2|||
160981655|NCT01890967|581321735|FG004|Overall Study|Adverse Event|1|||
160981656|NCT01890967|581321736|FG005|Overall Study|Adverse Event|7|||
160981657|NCT01890967|581321731|FG000|Overall Study|Death|1|||
160981658|NCT01890967|581321732|FG001|Overall Study|Death|0|||
160981659|NCT01890967|581321733|FG002|Overall Study|Death|0|||
160981660|NCT01890967|581321734|FG003|Overall Study|Death|0|||
160981661|NCT01890967|581321735|FG004|Overall Study|Death|0|||
160981662|NCT01890967|581321736|FG005|Overall Study|Death|0|||
160981663|NCT01890967|581321731|FG000|Overall Study|Lost to Follow-up|1|||
160981664|NCT01890967|581321732|FG001|Overall Study|Lost to Follow-up|1|||
160783107|NCT00504556|580592103|FG004|Overall Study|did not meet entry criteria|0|||
160783108|NCT00504556|580592099|FG000|Overall Study|data monitor committee decision|0|||
160981665|NCT01890967|581321733|FG002|Overall Study|Lost to Follow-up|1|||
160981666|NCT01890967|581321734|FG003|Overall Study|Lost to Follow-up|1|||
160981667|NCT01890967|581321735|FG004|Overall Study|Lost to Follow-up|0|||
160981668|NCT01890967|581321736|FG005|Overall Study|Lost to Follow-up|1|||
160981669|NCT01890967|581321731|FG000|Overall Study|Protocol Violation|0|||
160981670|NCT01890967|581321732|FG001|Overall Study|Protocol Violation|3|||
161124866|NCT01528787|581843797|FG003|Overall Study|Withdrawal by Subject|1|||
161124867|NCT01528787|581843794|FG000|Overall Study|Family Emergency|0|||
161124868|NCT01528787|581843795|FG001|Overall Study|Family Emergency|0|||
161124869|NCT01528787|581843796|FG002|Overall Study|Family Emergency|1|||
160783109|NCT00504556|580592100|FG001|Overall Study|data monitor committee decision|0|||
160783110|NCT00504556|580592101|FG002|Overall Study|data monitor committee decision|0|||
160783111|NCT00504556|580592102|FG003|Overall Study|data monitor committee decision|100|||
160783112|NCT00504556|580592103|FG004|Overall Study|data monitor committee decision|0|||
160783113|NCT00504556|580592099|FG000|Overall Study|Other|2|||
160783114|NCT00504556|580592100|FG001|Overall Study|Other|2|||
160783115|NCT00504556|580592101|FG002|Overall Study|Other|2|||
160783116|NCT00504556|580592102|FG003|Overall Study|Other|3|||
160783117|NCT00504556|580592103|FG004|Overall Study|Other|0|||
160783118|NCT00504556|580592099|FG000|Overall Study|not in safety analysis set|0|||
160783119|NCT00504556|580592100|FG001|Overall Study|not in safety analysis set|1|||
160783120|NCT00504556|580592101|FG002|Overall Study|not in safety analysis set|1|||
160783121|NCT00504556|580592102|FG003|Overall Study|not in safety analysis set|0|||
160783122|NCT00504556|580592103|FG004|Overall Study|not in safety analysis set|1|||
160783123|NCT03558672|580592104|FG000|Overall Study|Study Early Termination|10|||
160783124|NCT03607695|580592105|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
160783125|NCT03607695|580592105|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
160783126|NCT01027416|580592106|FG000|Overall Study|Withdrawal by Subject|0|||
160783127|NCT01027416|580592107|FG001|Overall Study|Withdrawal by Subject|1|||
160783128|NCT01027416|580592106|FG000|Overall Study|Physician Decision|1|||
160783129|NCT01027416|580592107|FG001|Overall Study|Physician Decision|4|||
160783130|NCT01560988|580592129|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
160783131|NCT01560988|580592130|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
160783132|NCT01560988|580592129|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
160783133|NCT01560988|580592130|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
160783134|NCT01560988|580592129|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
160783135|NCT01560988|580592130|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
160783136|NCT01441414|580592133|FG000|Overall Study|Participant died|9|||
160783137|NCT01441414|580592133|FG000|Overall Study|Other reasons|3|||
160783138|NCT01441414|580592133|FG000|Overall Study|Study terminated by sponsor|2|||
160783139|NCT01441414|580592133|FG000|Overall Study|Subject refused further follow-up|1|||
160783140|NCT00605657|580592134|FG000|Overall Study|Adverse Event|1|||
160783141|NCT00605657|580592134|FG000|Overall Study|Protocol Violation|1|||
160783142|NCT04535362|580592138|FG000|Overall Study|Lost to Follow-up|3|||
161124870|NCT01528787|581843797|FG003|Overall Study|Family Emergency|0|||
161124871|NCT02568046|581843805|FG000|Overall Study|Adverse Event|0|||
161124872|NCT02568046|581843806|FG001|Overall Study|Adverse Event|1|||
161124873|NCT02568046|581843805|FG000|Overall Study|Death|2|||
161124874|NCT02568046|581843806|FG001|Overall Study|Death|0|||
161124875|NCT02568046|581843805|FG000|Overall Study|Progressive Disease|1|||
161124876|NCT02568046|581843806|FG001|Overall Study|Progressive Disease|0|||
160981671|NCT01890967|581321733|FG002|Overall Study|Protocol Violation|3|||
160981672|NCT01890967|581321734|FG003|Overall Study|Protocol Violation|2|||
160981673|NCT01890967|581321735|FG004|Overall Study|Protocol Violation|4|||
160981674|NCT01890967|581321736|FG005|Overall Study|Protocol Violation|1|||
160981675|NCT01890967|581321731|FG000|Overall Study|Sponsor Decision|2|||
160981676|NCT01890967|581321732|FG001|Overall Study|Sponsor Decision|0|||
160783143|NCT04535362|580592139|FG001|Overall Study|Lost to Follow-up|1|||
160783144|NCT02018887|580592147|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
160783145|NCT02018887|580592148|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783146|NCT02018887|580592149|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783147|NCT02018887|580592150|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783148|NCT02018887|580592151|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783149|NCT02018887|580592152|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783150|NCT02018887|580592153|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783151|NCT02018887|580592154|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783152|NCT02018887|580592155|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783153|NCT02018887|580592156|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783154|NCT02018887|580592157|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
160783155|NCT02018887|580592147|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783156|NCT02018887|580592148|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783157|NCT02018887|580592149|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783158|NCT02018887|580592150|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783159|NCT02018887|580592151|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
160783160|NCT02018887|580592152|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783161|NCT02018887|580592153|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
160783162|NCT02018887|580592154|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
160783163|NCT02018887|580592155|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783164|NCT02018887|580592156|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783165|NCT02018887|580592157|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
160783166|NCT02018887|580592147|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
160783167|NCT02018887|580592148|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
160783168|NCT02018887|580592149|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
160783169|NCT02018887|580592150|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
160783170|NCT02018887|580592151|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
160783171|NCT02018887|580592152|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
160783172|NCT02018887|580592153|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
160783173|NCT02018887|580592154|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
160783174|NCT02018887|580592155|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
160783175|NCT02018887|580592156|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
160783176|NCT02018887|580592157|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
160783177|NCT02018887|580592147|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
160783178|NCT02018887|580592148|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
160783179|NCT02018887|580592149|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
160783180|NCT02018887|580592150|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
160783181|NCT02018887|580592151|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
160783182|NCT02018887|580592152|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
160783183|NCT02018887|580592153|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
160783184|NCT02018887|580592154|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
160783185|NCT02018887|580592155|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
160783186|NCT02018887|580592156|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
160783187|NCT02018887|580592157|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
160783188|NCT01058005|580592158|FG000|Overall Study|Adverse Event|0|||
160783189|NCT01058005|580592159|FG001|Overall Study|Adverse Event|2|||
160783190|NCT01058005|580592160|FG002|Overall Study|Adverse Event|1|||
160783191|NCT01058005|580592158|FG000|Overall Study|Physician Decision|2|||
160783192|NCT01058005|580592159|FG001|Overall Study|Physician Decision|2|||
160783193|NCT01058005|580592160|FG002|Overall Study|Physician Decision|0|||
160783194|NCT01058005|580592158|FG000|Overall Study|Withdrawal by Subject|4|||
160783195|NCT01058005|580592159|FG001|Overall Study|Withdrawal by Subject|5|||
160783196|NCT01058005|580592160|FG002|Overall Study|Withdrawal by Subject|11|||
160783197|NCT01058005|580592158|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
160783198|NCT01058005|580592159|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
160783199|NCT01058005|580592160|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
160783200|NCT01058005|580592158|FG000|Overall Study|Reason Missing|5|||
160783201|NCT01058005|580592159|FG001|Overall Study|Reason Missing|3|||
160783202|NCT01058005|580592160|FG002|Overall Study|Reason Missing|1|||
160783203|NCT02460380|580592165|FG000|Overall Study|Withdrawal by Subject|10|||
160783204|NCT02460380|580592166|FG001|Overall Study|Withdrawal by Subject|5|||
161124877|NCT02568046|581843805|FG000|Overall Study|Withdrawal by Subject|2|||
160783205|NCT00052715|580592176|FG000|Overall Study|wrong histology|1|||
161124878|NCT02568046|581843806|FG001|Overall Study|Withdrawal by Subject|1|||
161124879|NCT02568046|581843805|FG000|Overall Study|Other Events|0|||
161124880|NCT02568046|581843806|FG001|Overall Study|Other Events|1|||
160783206|NCT01936974|580592177|FG000|Overall Study|Physician Decision|2|||
160783207|NCT01936974|580592178|FG001|Overall Study|Physician Decision|5|||
160783208|NCT00063999|580592179|FG000|Overall Study|Withdrawal by Subject|1|||
160783209|NCT00063999|580592180|FG001|Overall Study|Withdrawal by Subject|0|||
160783210|NCT00063999|580592179|FG000|Overall Study|Ineligible|44|||
160783211|NCT00063999|580592180|FG001|Overall Study|Ineligible|24|||
160783212|NCT02497755|580592185|FG000|Overall Study|Protocol Violation|1|||
160783213|NCT02497755|580592186|FG001|Overall Study|Protocol Violation|0|||
160783214|NCT04560309|580592197|FG000|Overall Study|Meet drop out criteria|1|||
160783215|NCT04560309|580592198|FG001|Overall Study|Meet drop out criteria|1|||
160783216|NCT01860404|580592199|FG000|Overall Study|Lost to Follow-up|3|||
160783217|NCT01860404|580592200|FG001|Overall Study|Lost to Follow-up|4|||
160783218|NCT01860404|580592201|FG002|Overall Study|Lost to Follow-up|1|||
160783219|NCT01860404|580592202|FG003|Overall Study|Lost to Follow-up|6|||
160783220|NCT01860404|580592203|FG004|Overall Study|Lost to Follow-up|4|||
160783221|NCT01860404|580592199|FG000|Overall Study|Withdrawal by Subject|0|||
160783222|NCT01860404|580592200|FG001|Overall Study|Withdrawal by Subject|0|||
160783223|NCT01860404|580592201|FG002|Overall Study|Withdrawal by Subject|4|||
160783224|NCT01860404|580592202|FG003|Overall Study|Withdrawal by Subject|0|||
160783225|NCT01860404|580592203|FG004|Overall Study|Withdrawal by Subject|0|||
160783226|NCT00356421|580592205|FG000|Overall Study|Lack of Efficacy|3|||
160783227|NCT00356421|580592206|FG001|Overall Study|Lack of Efficacy|0|||
160783228|NCT00356421|580592205|FG000|Overall Study|Withdrawal by Subject|9|||
160783229|NCT00356421|580592206|FG001|Overall Study|Withdrawal by Subject|2|||
160783230|NCT00356421|580592205|FG000|Overall Study|Related to study drug|15|||
160783231|NCT00356421|580592206|FG001|Overall Study|Related to study drug|12|||
160783232|NCT00356421|580592205|FG000|Overall Study|Not related to study drug|5|||
160783233|NCT00356421|580592206|FG001|Overall Study|Not related to study drug|3|||
160783234|NCT04689009|580592207|FG000|Overall Study|Adverse Event|1|||
160783235|NCT04689009|580592208|FG001|Overall Study|Adverse Event|0|||
160783236|NCT04689009|580592207|FG000|Overall Study|Lost to Follow-up|1|||
160783237|NCT04689009|580592208|FG001|Overall Study|Lost to Follow-up|2|||
160783238|NCT04689009|580592207|FG000|Overall Study|Withdrawal by Subject|4|||
160783239|NCT04689009|580592208|FG001|Overall Study|Withdrawal by Subject|3|||
160783240|NCT04689009|580592207|FG000|Overall Study|Protocol Violation|1|||
160783241|NCT04689009|580592208|FG001|Overall Study|Protocol Violation|0|||
160783242|NCT03462563|580592211|FG000|Overall Study|Death|1|||
160783243|NCT03462563|580592212|FG001|Overall Study|Death|1|||
160783244|NCT03462563|580592211|FG000|Overall Study|Termination of study|2|||
160783245|NCT03462563|580592212|FG001|Overall Study|Termination of study|1|||
160783246|NCT03462563|580592211|FG000|Overall Study|Adverse Event|1|||
160783247|NCT03462563|580592212|FG001|Overall Study|Adverse Event|3|||
160783248|NCT03462563|580592211|FG000|Overall Study|Unspecified reason|10|||
160783249|NCT03462563|580592212|FG001|Overall Study|Unspecified reason|12|||
160783250|NCT03462563|580592211|FG000|Overall Study|Physician Decision|1|||
160783251|NCT03462563|580592212|FG001|Overall Study|Physician Decision|0|||
160783252|NCT05089357|580592213|FG000|Overall Study|Withdrawal by Subject|23|||
160783253|NCT05089357|580592213|FG000|Overall Study|Lost to Follow-up|6|||
160783254|NCT05089357|580592213|FG000|Overall Study|Medical reason|1|||
160783255|NCT05089357|580592213|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
160783256|NCT05089357|580592213|FG000|Overall Study|Pregnancy|2|||
160783257|NCT02021318|580592214|FG000|Overall Study|Adverse Event|2|||
160783258|NCT02021318|580592215|FG001|Overall Study|Adverse Event|1|||
160783259|NCT02021318|580592214|FG000|Overall Study|Death|33|||
160783260|NCT02021318|580592215|FG001|Overall Study|Death|34|||
160783261|NCT02021318|580592214|FG000|Overall Study|Lost to Follow-up|3|||
160783262|NCT02021318|580592215|FG001|Overall Study|Lost to Follow-up|3|||
160783263|NCT02021318|580592214|FG000|Overall Study|Progressive Disease|0|||
160783264|NCT02021318|580592215|FG001|Overall Study|Progressive Disease|1|||
160783265|NCT02021318|580592214|FG000|Overall Study|Withdrawal by Subject|30|||
161124881|NCT02809833|581843807|FG000|Overall Study|Death|3|||
161124882|NCT02809833|581843807|FG000|Overall Study|Intolerance|54|||
161124883|NCT02809833|581843807|FG000|Overall Study|Lack of Efficacy|89|||
161124884|NCT02809833|581843807|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
161124885|NCT02809833|581843807|FG000|Overall Study|Noncompliance|1|||
161124886|NCT02809833|581843807|FG000|Overall Study|Withdrawal by Subject|34|||
161124887|NCT02809833|581843807|FG000|Overall Study|Lost to Follow-up|35|||
161124888|NCT02809833|581843807|FG000|Overall Study|Adverse Event (AE)|24|||
161124889|NCT02809833|581843807|FG000|Overall Study|Other|5|||
161230341|NCT05017480|582225739|FG000|Stage 1 Study|Adverse Event|1|||
161230342|NCT05017480|582225740|FG001|Stage 1 Study|Adverse Event|1|||
161230343|NCT05017480|582225741|FG002|Stage 1 Study|Adverse Event|0|||
161230344|NCT05017480|582225742|FG003|Stage 1 Study|Adverse Event|0|||
161230345|NCT05017480|582225743|FG004|Stage 1 Study|Adverse Event|0|||
161230346|NCT05017480|582225739|FG000|Stage 1 Study|Poor Compliance|1|||
161230347|NCT05017480|582225740|FG001|Stage 1 Study|Poor Compliance|1|||
161230348|NCT05017480|582225741|FG002|Stage 1 Study|Poor Compliance|0|||
160783266|NCT02021318|580592215|FG001|Overall Study|Withdrawal by Subject|18|||
160783267|NCT02021318|580592214|FG000|Overall Study|Physician Decision|3|||
160783268|NCT02021318|580592215|FG001|Overall Study|Physician Decision|3|||
160783269|NCT02021318|580592214|FG000|Overall Study|Miscellaneous|2|||
160783270|NCT02021318|580592215|FG001|Overall Study|Miscellaneous|3|||
160783271|NCT04796207|580592216|FG000|Overall Study|Lost to Follow-up|7|||
160783272|NCT04796207|580592217|FG001|Overall Study|Lost to Follow-up|2|||
161230349|NCT05017480|582225742|FG003|Stage 1 Study|Poor Compliance|0|||
160783273|NCT01860989|580592220|FG000|Overall Study|Unsatisfactory therapeutic|5|||
161124890|NCT02809833|581843807|FG000|Overall Study|Missing Information|52|||
161124891|NCT00408694|581843808|FG000|Overall Study|Ineligible|1|||
161124892|NCT00408694|581843808|FG000|Overall Study|No protocol treatment|1|||
161124893|NCT00523991|581843811|FG000|Overall Study|Adverse Event|6|||
161124894|NCT00523991|581843812|FG001|Overall Study|Adverse Event|5|||
161124895|NCT00523991|581843811|FG000|Overall Study|Protocol Violation|1|||
161124896|NCT00523991|581843812|FG001|Overall Study|Protocol Violation|4|||
161124897|NCT00523991|581843811|FG000|Overall Study|Lost to Follow-up|4|||
161124898|NCT00523991|581843812|FG001|Overall Study|Lost to Follow-up|1|||
161124899|NCT00523991|581843811|FG000|Overall Study|Withdrawal by Subject|7|||
161124900|NCT00523991|581843812|FG001|Overall Study|Withdrawal by Subject|17|||
161124901|NCT00523991|581843811|FG000|Overall Study|Other reason (not specified)|3|||
161124902|NCT00523991|581843812|FG001|Overall Study|Other reason (not specified)|0|||
161124903|NCT00193063|581843814|FG000|Overall Study|Lack of Efficacy|3|||
161124904|NCT00193063|581843814|FG000|Overall Study|Adverse Event|1|||
161124905|NCT00744874|581843816|FG000|Overall Study|Lost to Follow-up|1|||
161124906|NCT00744874|581843816|FG000|Overall Study|Withdrawal by Subject|1|||
161124907|NCT00744874|581843816|FG000|Overall Study|Study Device not available at procedure|1|||
161124908|NCT00744874|581843816|FG000|Overall Study|Unable to accomodate schedule|1|||
161124909|NCT01127165|581843819|FG000|Overall Study|Adverse Event|2|||
161124910|NCT01127165|581843820|FG001|Overall Study|Adverse Event|2|||
161124911|NCT01127165|581843819|FG000|Overall Study|Lack of Efficacy|10|||
161124912|NCT01127165|581843820|FG001|Overall Study|Lack of Efficacy|8|||
161124913|NCT01127165|581843819|FG000|Overall Study|Lost to Follow-up|3|||
161124914|NCT01127165|581843820|FG001|Overall Study|Lost to Follow-up|5|||
161124915|NCT01127165|581843819|FG000|Overall Study|Withdrawal by Subject|1|||
161124916|NCT01127165|581843820|FG001|Overall Study|Withdrawal by Subject|3|||
161124917|NCT01127165|581843819|FG000|Overall Study|Protocol Violation|0|||
161124918|NCT01127165|581843820|FG001|Overall Study|Protocol Violation|1|||
161124919|NCT03175549|581843821|FG000|Overall Study|Lost to Follow-up|2|||
161124920|NCT03175549|581843822|FG001|Overall Study|Lost to Follow-up|2|||
161124921|NCT03175549|581843821|FG000|Overall Study|Medication non-compliance|2|||
161124922|NCT03175549|581843822|FG001|Overall Study|Medication non-compliance|2|||
161124923|NCT02435849|581843823|FG000|Overall Study|Death|23|||
161124924|NCT02435849|581843824|FG001|Overall Study|Death|0|||
161124925|NCT02435849|581843823|FG000|Overall Study|Lack of Efficacy|10|||
161124926|NCT02435849|581843824|FG001|Overall Study|Lack of Efficacy|0|||
161124927|NCT02435849|581843823|FG000|Overall Study|New therapy for study indication|8|||
161124928|NCT02435849|581843824|FG001|Overall Study|New therapy for study indication|0|||
161124929|NCT02435849|581843823|FG000|Overall Study|Subject/guardian decision|5|||
161124930|NCT02435849|581843824|FG001|Overall Study|Subject/guardian decision|1|||
161124931|NCT02435849|581843823|FG000|Overall Study|Lost to Follow-up|1|||
161124932|NCT02435849|581843824|FG001|Overall Study|Lost to Follow-up|0|||
161124933|NCT02435849|581843823|FG000|Overall Study|Physician Decision|1|||
161124934|NCT02435849|581843824|FG001|Overall Study|Physician Decision|0|||
161124935|NCT02486757|581843825|FG000|Overall Study|Lost to Follow-up|1|||
161124936|NCT01064167|581843826|FG000|Overall Study|Protocol Violation|14|||
161124937|NCT01064167|581843827|FG001|Overall Study|Protocol Violation|15|||
161124938|NCT03984305|581843829|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
161124939|NCT03984305|581843830|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
161124940|NCT03984305|581843829|FG000|Overall Study|Withdrawal by Subject|3|||
161124941|NCT03984305|581843830|FG001|Overall Study|Withdrawal by Subject|3|||
161124942|NCT03984305|581843829|FG000|Overall Study|Lost to Follow-up|1|||
161124943|NCT03984305|581843830|FG001|Overall Study|Lost to Follow-up|0|||
161124944|NCT02883244|581843831|FG000|Overall Study|Lost to Follow-up|0|||
161124945|NCT02883244|581843832|FG001|Overall Study|Lost to Follow-up|1|||
161124946|NCT03979274|581843840|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161124947|NCT03979274|581843841|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161124948|NCT01614093|581843844|FG000|Overall Study|Withdrawal by Subject|1|||
161124949|NCT00603915|581843845|FG000|Overall Study|Physician Decision|1|||
161124950|NCT01724528|581843851|FG000|Overall Study|Death|3|||
161124951|NCT01724528|581843852|FG001|Overall Study|Death|0|||
161124952|NCT01724528|581843851|FG000|Overall Study|Withdrawal by Subject|0|||
161124953|NCT01724528|581843852|FG001|Overall Study|Withdrawal by Subject|2|||
161230350|NCT05017480|582225743|FG004|Stage 1 Study|Poor Compliance|0|||
161230351|NCT05017480|582225739|FG000|Stage 1 Study|Physician Decision|0|||
161124954|NCT01724528|581843851|FG000|Overall Study|Protocol Violation|0|||
161124955|NCT01724528|581843852|FG001|Overall Study|Protocol Violation|1|||
161124956|NCT01724528|581843851|FG000|Overall Study|Patient refused to attend last visit|1|||
161124957|NCT01724528|581843852|FG001|Overall Study|Patient refused to attend last visit|0|||
161124958|NCT02183519|581843856|FG000|Overall Study|computer error|3|||
161124959|NCT02183519|581843857|FG001|Overall Study|computer error|0|||
161124960|NCT02183519|581843856|FG000|Overall Study|Did not respond to cough inducter|0|||
161124961|NCT02183519|581843857|FG001|Overall Study|Did not respond to cough inducter|3|||
161124962|NCT05574062|581843860|FG000|Pre Run-In|Screening failure|3|||
161124963|NCT05574062|581843861|FG001|Pre Run-In|Screening failure|0|||
161124964|NCT05574062|581843862|FG002|Pre Run-In|Screening failure|0|||
161124965|NCT05574062|581843863|FG003|Pre Run-In|Screening failure|0|||
161124966|NCT05574062|581843864|FG004|Pre Run-In|Screening failure|0|||
160783274|NCT04739709|580592223|FG000|Overall Study|Physician Decision|1|||
160783275|NCT04739709|580592224|FG001|Overall Study|Physician Decision|0|||
160783276|NCT03003468|580592225|FG000|Overall Study|Withdrawal by Subject|0|||
160783277|NCT03003468|580592226|FG001|Overall Study|Withdrawal by Subject|0|||
160783278|NCT03003468|580592227|FG002|Overall Study|Withdrawal by Subject|1|||
160783279|NCT03003468|580592225|FG000|Overall Study|No measurable lesions|0|||
160783280|NCT03003468|580592226|FG001|Overall Study|No measurable lesions|0|||
160783281|NCT03003468|580592227|FG002|Overall Study|No measurable lesions|1|||
160783282|NCT00421993|580592230|FG000|Overall Study|Withdrawal by Subject|22|||
160783283|NCT00421993|580592231|FG001|Overall Study|Withdrawal by Subject|23|||
160783284|NCT00421993|580592232|FG002|Overall Study|Withdrawal by Subject|23|||
160783285|NCT00421993|580592233|FG003|Overall Study|Withdrawal by Subject|24|||
160783286|NCT00421993|580592230|FG000|Overall Study|Lost to Follow-up|18|||
160783287|NCT00421993|580592231|FG001|Overall Study|Lost to Follow-up|19|||
160783288|NCT00421993|580592232|FG002|Overall Study|Lost to Follow-up|22|||
160783289|NCT00421993|580592233|FG003|Overall Study|Lost to Follow-up|20|||
160783290|NCT00421993|580592230|FG000|Overall Study|Adverse Event|11|||
160783291|NCT00421993|580592231|FG001|Overall Study|Adverse Event|1|||
160783292|NCT00421993|580592232|FG002|Overall Study|Adverse Event|6|||
160783293|NCT00421993|580592233|FG003|Overall Study|Adverse Event|4|||
160783294|NCT00421993|580592230|FG000|Overall Study|Protocol Violation|2|||
160783295|NCT00421993|580592231|FG001|Overall Study|Protocol Violation|2|||
160783296|NCT00421993|580592232|FG002|Overall Study|Protocol Violation|0|||
160783297|NCT00421993|580592233|FG003|Overall Study|Protocol Violation|1|||
160783298|NCT00421993|580592230|FG000|Overall Study|Lack of Efficacy|0|||
160783299|NCT00421993|580592231|FG001|Overall Study|Lack of Efficacy|3|||
160783300|NCT00421993|580592232|FG002|Overall Study|Lack of Efficacy|0|||
160783301|NCT00421993|580592233|FG003|Overall Study|Lack of Efficacy|5|||
160783302|NCT00421993|580592230|FG000|Overall Study|Pregnancy|0|||
160783303|NCT00421993|580592231|FG001|Overall Study|Pregnancy|1|||
160783304|NCT00421993|580592232|FG002|Overall Study|Pregnancy|1|||
160783305|NCT00421993|580592233|FG003|Overall Study|Pregnancy|2|||
160783306|NCT00421993|580592230|FG000|Overall Study|Subject transportation issues|0|||
160783307|NCT00421993|580592231|FG001|Overall Study|Subject transportation issues|0|||
160783308|NCT00421993|580592232|FG002|Overall Study|Subject transportation issues|0|||
160783309|NCT00421993|580592233|FG003|Overall Study|Subject transportation issues|1|||
160783310|NCT01751685|580592235|FG000|6-mo Followup|Missed study visit|1|||
160783311|NCT01751685|580592236|FG001|6-mo Followup|Missed study visit|0|||
160783312|NCT01751685|580592235|FG000|6-mo Followup|Withdrawal by Subject|2|||
160783313|NCT01751685|580592236|FG001|6-mo Followup|Withdrawal by Subject|2|||
160783314|NCT01751685|580592235|FG000|6-mo Followup|Lost to Follow-up|0|||
160783315|NCT01751685|580592236|FG001|6-mo Followup|Lost to Follow-up|1|||
160783316|NCT01751685|580592235|FG000|12-mo Followup|Lost to Follow-up|5|||
160783317|NCT01751685|580592236|FG001|12-mo Followup|Lost to Follow-up|0|||
160783318|NCT03020888|580592241|FG000|Overall Study|Physician Decision|4|||
160783319|NCT03020888|580592241|FG000|Overall Study|Withdrawal by Subject|6|||
160783320|NCT03020888|580592241|FG000|Overall Study|Insurance coverage|2|||
160783321|NCT03020888|580592241|FG000|Overall Study|Lost to Follow-up|1|||
160783322|NCT00284934|580594196|FG000|Overall Study|Adverse Event|1|||
160783323|NCT00284934|580594197|FG001|Overall Study|Adverse Event|2|||
160783324|NCT00284934|580594196|FG000|Overall Study|Other reasons|3|||
160783325|NCT00284934|580594197|FG001|Overall Study|Other reasons|1|||
160783326|NCT00454142|580594198|FG000|Overall Study|Withdrawal by Subject|1|||
160783327|NCT01245751|580594199|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
160783328|NCT01245751|580594200|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
160783329|NCT01245751|580594201|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
160783330|NCT01245751|580594202|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
160783331|NCT01245751|580594199|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
161124967|NCT05574062|581843860|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
160783332|NCT01245751|580594200|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
160783333|NCT01245751|580594201|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
160783334|NCT01245751|580594202|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
160783335|NCT01245751|580594199|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
161124968|NCT05574062|581843861|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
160783336|NCT01245751|580594200|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
160783337|NCT01245751|580594201|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
160783338|NCT01245751|580594202|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
160783339|NCT01783015|580594205|FG000|Blinded Treatment|Adverse Event|0|||
161124969|NCT05574062|581843862|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
161124970|NCT05574062|581843863|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
161124971|NCT05574062|581843864|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
161124972|NCT05574062|581843860|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
161124973|NCT05574062|581843861|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
160783340|NCT01783015|580594206|FG001|Blinded Treatment|Adverse Event|1|||
160783341|NCT01783015|580594207|FG002|Blinded Treatment|Adverse Event|0|||
160783342|NCT01783015|580594205|FG000|Blinded Treatment|Protocol Violation|0|||
160783343|NCT01783015|580594206|FG001|Blinded Treatment|Protocol Violation|1|||
160783344|NCT01783015|580594207|FG002|Blinded Treatment|Protocol Violation|0|||
160783345|NCT01783015|580594205|FG000|Blinded Treatment|Withdrawal by Subject|0|||
160783346|NCT01783015|580594206|FG001|Blinded Treatment|Withdrawal by Subject|1|||
160783347|NCT01783015|580594207|FG002|Blinded Treatment|Withdrawal by Subject|0|||
160783348|NCT01783015|580594205|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
160783349|NCT01783015|580594206|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
160783350|NCT01783015|580594207|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
161327497|NCT03311841|582585424|FG002|14-day Wash-out|Adverse Event|0|||
161327498|NCT03311841|582585425|FG003|14-day Wash-out|Adverse Event|0|||
161327499|NCT03311841|582585426|FG004|14-day Wash-out|Adverse Event|0|||
161327500|NCT03311841|582585422|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
161327501|NCT03311841|582585423|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
161327502|NCT03311841|582585424|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
161327503|NCT03311841|582585425|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
161327504|NCT03311841|582585426|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
161327505|NCT00977613|582585429|FG000|Overall Study|Lost to Follow-up|16|||
161327506|NCT05464420|582585430|FG000|Overall Study|Death|0|||
161327507|NCT05464420|582585431|FG001|Overall Study|Death|0|||
161327508|NCT05464420|582585432|FG002|Overall Study|Death|0|||
161327509|NCT05464420|582585433|FG003|Overall Study|Death|1|||
161327510|NCT05464420|582585430|FG000|Overall Study|Lost to Follow-up|16|||
161327511|NCT05464420|582585431|FG001|Overall Study|Lost to Follow-up|11|||
161327512|NCT05464420|582585432|FG002|Overall Study|Lost to Follow-up|11|||
161327513|NCT05464420|582585433|FG003|Overall Study|Lost to Follow-up|11|||
161327514|NCT05464420|582585430|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
161327515|NCT05464420|582585431|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
161327516|NCT05464420|582585432|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
161327517|NCT05464420|582585433|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
161327518|NCT05464420|582585430|FG000|Overall Study|Withdrawal by Subject|4|||
161327519|NCT05464420|582585431|FG001|Overall Study|Withdrawal by Subject|8|||
161327520|NCT05464420|582585432|FG002|Overall Study|Withdrawal by Subject|3|||
161327521|NCT05464420|582585433|FG003|Overall Study|Withdrawal by Subject|1|||
161327522|NCT05464420|582585430|FG000|Overall Study|Protocol Violation|0|||
161327523|NCT05464420|582585431|FG001|Overall Study|Protocol Violation|0|||
161327524|NCT05464420|582585432|FG002|Overall Study|Protocol Violation|1|||
161327525|NCT05464420|582585433|FG003|Overall Study|Protocol Violation|1|||
161327526|NCT05464420|582585430|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
161327527|NCT05464420|582585431|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
161124974|NCT05574062|581843862|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
161124975|NCT05574062|581843863|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
161327528|NCT05464420|582585432|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
161327529|NCT05464420|582585433|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
161327530|NCT01383018|582585436|FG000|Overall Study|Adverse Event|14|||
161327531|NCT01383018|582585436|FG000|Overall Study|Death|10|||
161327532|NCT01383018|582585436|FG000|Overall Study|Lost to Follow-up|5|||
161327533|NCT01383018|582585436|FG000|Overall Study|Physician Decision|5|||
161327534|NCT01383018|582585436|FG000|Overall Study|Withdrawal by Subject|9|||
160783351|NCT01783015|580594205|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
160890043|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
161327535|NCT01383018|582585436|FG000|Overall Study|Subject not implanted|76|||
161327536|NCT01383018|582585436|FG000|Overall Study|Missed Visit|247|||
161327537|NCT01383018|582585436|FG000|Overall Study|Site closed early-not compliance related|7|||
161327538|NCT01383018|582585436|FG000|Overall Study|Patient moved away from site|1|||
161327539|NCT01383018|582585436|FG000|Overall Study|Subject Incarcerated|1|||
161327540|NCT01598610|582585439|FG000|Overall Study|Adverse Event|1|||
161327541|NCT02989402|582585447|FG000|Overall Study|Adverse event, or serious adverse event|4|||
161327542|NCT02989402|582585447|FG000|Overall Study|Death|2|||
161327543|NCT02989402|582585447|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
161327544|NCT02989402|582585447|FG000|Overall Study|Lost to Follow-up|8|||
161327545|NCT02989402|582585447|FG000|Overall Study|Patient no longer on monotherapy|1|||
161327546|NCT02989402|582585447|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
161327547|NCT02989402|582585447|FG000|Overall Study|Withdrawal by Subject|7|||
161327548|NCT02989402|582585447|FG000|Overall Study|Other|2|||
161327549|NCT03066830|582585448|FG000|Overall Study|At the Participant's own Request|16|||
161327550|NCT03066830|582585449|FG001|Overall Study|At the Participant's own Request|17|||
161327551|NCT03066830|582585448|FG000|Overall Study|Other|3|||
161327552|NCT03066830|582585449|FG001|Overall Study|Other|0|||
161327553|NCT03066830|582585448|FG000|Overall Study|Poor Compliance to Protocol|1|||
161327554|NCT03066830|582585449|FG001|Overall Study|Poor Compliance to Protocol|0|||
161327555|NCT03066830|582585448|FG000|Overall Study|Adverse Event|2|||
161327556|NCT03066830|582585449|FG001|Overall Study|Adverse Event|2|||
161327557|NCT03066830|582585448|FG000|Overall Study|Lost to Follow-up|11|||
161327558|NCT03066830|582585449|FG001|Overall Study|Lost to Follow-up|3|||
160783352|NCT01783015|580594206|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
160783353|NCT01783015|580594207|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
160783354|NCT02741193|580594208|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
160783355|NCT02741193|580594208|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
160783356|NCT00585169|580594209|FG000|Overall Study|Withdrawal by Subject|1|||
160783357|NCT02391584|580594213|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
160783358|NCT02391584|580594214|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
160783359|NCT02391584|580594213|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
160783360|NCT02391584|580594214|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
160783361|NCT02391584|580594213|FG000|3 Month|Lost to Follow-up|1|||
160783362|NCT02391584|580594214|FG001|3 Month|Lost to Follow-up|0|||
160783363|NCT02391584|580594213|FG000|6 Month|Withdrawal by Subject|1|||
160783364|NCT02391584|580594214|FG001|6 Month|Withdrawal by Subject|0|||
160783365|NCT02391584|580594213|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
160783366|NCT02391584|580594214|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
160783367|NCT01093885|580594215|FG000|Overall Study|Adverse Event|4|||
160783368|NCT01093885|580594215|FG000|Overall Study|Lost to Follow-up|1|||
160783369|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
160783370|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
160783371|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
160783372|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
160783373|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
160783374|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
160783375|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
160783376|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
160783377|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
160783378|NCT00292370|580594220|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
160783379|NCT00292370|580594221|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
160783380|NCT00292370|580594222|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
160783381|NCT00292370|580594220|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
160783382|NCT00292370|580594221|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
160783383|NCT00292370|580594222|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
160783384|NCT00292370|580594220|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
160783385|NCT00292370|580594221|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
160783386|NCT00292370|580594222|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
160783387|NCT01301001|580594223|FG000|First Intervention|Lost to Follow-up|4|||
160783388|NCT01301001|580594224|FG001|First Intervention|Lost to Follow-up|4|||
160783389|NCT01301001|580594223|FG000|First Intervention|Withdrawal by Subject|1|||
160783390|NCT01301001|580594224|FG001|First Intervention|Withdrawal by Subject|4|||
160783391|NCT01301001|580594223|FG000|First Intervention|Adverse Event|5|||
160783392|NCT01301001|580594224|FG001|First Intervention|Adverse Event|0|||
160783393|NCT01301001|580594223|FG000|First Intervention|Protocol Violation|0|||
160783394|NCT01301001|580594224|FG001|First Intervention|Protocol Violation|1|||
160783395|NCT01301001|580594223|FG000|Second Intervention|Adverse Event|2|||
160783396|NCT01301001|580594224|FG001|Second Intervention|Adverse Event|0|||
160783397|NCT01301001|580594223|FG000|Second Intervention|Withdrawal by Subject|2|||
160783398|NCT01301001|580594224|FG001|Second Intervention|Withdrawal by Subject|0|||
160783399|NCT00500110|580594227|FG000|Overall Study|Withdrawal by Subject|3|||
160783400|NCT02619812|580594232|FG000|Overall Study|Withdrawal by Subject|0|||
160783401|NCT02619812|580594233|FG001|Overall Study|Withdrawal by Subject|0|||
160783402|NCT02619812|580594234|FG002|Overall Study|Withdrawal by Subject|1|||
160783403|NCT02619812|580594235|FG003|Overall Study|Withdrawal by Subject|2|||
160783404|NCT04865978|580594236|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
160783405|NCT04865978|580594237|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
160783406|NCT05587998|580594238|FG000|Overall Study|Withdrawal by Subject|1|||
160783407|NCT05587998|580594239|FG001|Overall Study|Withdrawal by Subject|1|||
160783408|NCT05587998|580594238|FG000|Overall Study|Not treated|3|||
160783409|NCT05587998|580594239|FG001|Overall Study|Not treated|1|||
160783410|NCT05587998|580594238|FG000|Overall Study|Non-compliance with study procedures|0|||
160783411|NCT05587998|580594239|FG001|Overall Study|Non-compliance with study procedures|1|||
160783412|NCT04882215|580594240|FG000|Overall Study|Withdrawal by Subject|5|||
160783413|NCT04882215|580594241|FG001|Overall Study|Withdrawal by Subject|0|||
160783414|NCT04263532|580594242|FG000|Overall Study|Withdrawal by Subject|2|||
160783415|NCT04263532|580594243|FG001|Overall Study|Withdrawal by Subject|0|||
160783416|NCT06083493|580594244|FG000|Overall Study|Technical issues with the interventional device|2|||
160783417|NCT06083493|580594245|FG001|Overall Study|Technical issues with the interventional device|2|||
160783418|NCT06083493|580594244|FG000|Overall Study|Performed incorrect visual task|1|||
160783419|NCT06083493|580594245|FG001|Overall Study|Performed incorrect visual task|0|||
160783420|NCT06083493|580594244|FG000|Overall Study|Insufficient baseline performance|0|||
160783421|NCT06083493|580594245|FG001|Overall Study|Insufficient baseline performance|1|||
160981677|NCT01890967|581321733|FG002|Overall Study|Sponsor Decision|1|||
160783422|NCT04098302|580594248|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
160783423|NCT04098302|580594249|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
160783424|NCT04098302|580594250|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
160783425|NCT04098302|580594251|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
160783426|NCT04098302|580594248|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
160783427|NCT04098302|580594249|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
160783428|NCT04098302|580594250|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
160783429|NCT04098302|580594251|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
160783430|NCT04098302|580594248|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
160783431|NCT04098302|580594249|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
160783432|NCT04098302|580594250|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
160783433|NCT04098302|580594251|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
160783434|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
160783435|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
160783436|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
160783437|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
160783438|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
160783439|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
160783440|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
160783441|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
160783442|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
160783443|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
160783444|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
160783445|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
160783446|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
160783447|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
160783448|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
160783449|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
160783450|NCT04098302|580594248|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
160783451|NCT04098302|580594249|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
160783452|NCT04098302|580594250|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
160783453|NCT04098302|580594251|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
160783454|NCT05061706|580594252|FG000|Overall Study|Adverse Event|29|||
160783455|NCT05061706|580594253|FG001|Overall Study|Adverse Event|1|||
160783456|NCT05061706|580594252|FG000|Overall Study|Lack of Efficacy|0|||
160783457|NCT05061706|580594253|FG001|Overall Study|Lack of Efficacy|1|||
160783458|NCT05061706|580594252|FG000|Overall Study|Lost to Follow-up|2|||
160783459|NCT05061706|580594253|FG001|Overall Study|Lost to Follow-up|2|||
160783460|NCT05061706|580594252|FG000|Overall Study|Protocol Violation|3|||
160783461|NCT05061706|580594253|FG001|Overall Study|Protocol Violation|1|||
160783462|NCT05061706|580594252|FG000|Overall Study|Withdrawal by Subject|3|||
160783463|NCT05061706|580594253|FG001|Overall Study|Withdrawal by Subject|9|||
160783464|NCT00191152|580594254|FG000|Initial Treatment|Adverse Event|43|||
160783465|NCT00191152|580594255|FG001|Initial Treatment|Adverse Event|67|||
160783466|NCT00191152|580594254|FG000|Initial Treatment|Physician Decision|40|||
160783467|NCT00191152|580594255|FG001|Initial Treatment|Physician Decision|31|||
160783468|NCT00191152|580594254|FG000|Initial Treatment|Withdrawal by Subject|40|||
160783469|NCT00191152|580594255|FG001|Initial Treatment|Withdrawal by Subject|28|||
160981678|NCT01890967|581321734|FG003|Overall Study|Sponsor Decision|3|||
160981679|NCT01890967|581321735|FG004|Overall Study|Sponsor Decision|2|||
160981680|NCT01890967|581321736|FG005|Overall Study|Sponsor Decision|3|||
160981681|NCT01890967|581321731|FG000|Overall Study|Withdrawal by Subject|3|||
160981682|NCT01890967|581321732|FG001|Overall Study|Withdrawal by Subject|4|||
160981683|NCT01890967|581321733|FG002|Overall Study|Withdrawal by Subject|2|||
160981684|NCT01890967|581321734|FG003|Overall Study|Withdrawal by Subject|3|||
160981685|NCT01890967|581321735|FG004|Overall Study|Withdrawal by Subject|3|||
160981686|NCT01890967|581321736|FG005|Overall Study|Withdrawal by Subject|1|||
160981687|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
160981688|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
160981689|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
160981690|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
160981691|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
161230352|NCT05017480|582225740|FG001|Stage 1 Study|Physician Decision|1|||
160783470|NCT00191152|580594254|FG000|Initial Treatment|Lost to Follow-up|0|||
160783471|NCT00191152|580594255|FG001|Initial Treatment|Lost to Follow-up|6|||
160783472|NCT00191152|580594254|FG000|Initial Treatment|Other|18|||
160783473|NCT00191152|580594255|FG001|Initial Treatment|Other|21|||
160783474|NCT00191152|580594254|FG000|Crossover Treatment|Adverse Event|8|||
160783475|NCT00191152|580594255|FG001|Crossover Treatment|Adverse Event|8|||
160783476|NCT00191152|580594254|FG000|Crossover Treatment|Physician Decision|7|||
160783477|NCT00191152|580594255|FG001|Crossover Treatment|Physician Decision|7|||
160783478|NCT00191152|580594254|FG000|Crossover Treatment|Withdrawal by Subject|6|||
160783479|NCT00191152|580594255|FG001|Crossover Treatment|Withdrawal by Subject|9|||
160783480|NCT00191152|580594254|FG000|Crossover Treatment|Lost to Follow-up|2|||
160783481|NCT00191152|580594255|FG001|Crossover Treatment|Lost to Follow-up|1|||
160783482|NCT00191152|580594254|FG000|Crossover Treatment|Other|4|||
160783483|NCT00191152|580594255|FG001|Crossover Treatment|Other|3|||
160783484|NCT00114777|580594256|FG000|Randomization to Month 36|Death|10|||
160783485|NCT00114777|580594257|FG001|Randomization to Month 36|Death|4|||
160783486|NCT00114777|580594258|FG002|Randomization to Month 36|Death|3|||
160783487|NCT00114777|580594256|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
160783488|NCT00114777|580594257|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
160783489|NCT00114777|580594258|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
160783490|NCT00114777|580594256|FG000|Randomization to Month 36|Lack of Efficacy|19|||
160783491|NCT00114777|580594257|FG001|Randomization to Month 36|Lack of Efficacy|15|||
160783492|NCT00114777|580594258|FG002|Randomization to Month 36|Lack of Efficacy|17|||
160783493|NCT00114777|580594256|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
160783494|NCT00114777|580594257|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
160783495|NCT00114777|580594258|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
160783496|NCT00114777|580594256|FG000|Randomization to Month 36|Adverse Event|34|||
160783497|NCT00114777|580594257|FG001|Randomization to Month 36|Adverse Event|35|||
160783498|NCT00114777|580594258|FG002|Randomization to Month 36|Adverse Event|44|||
160783499|NCT00114777|580594256|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
160783500|NCT00114777|580594257|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
160783501|NCT00114777|580594258|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
160783502|NCT00114777|580594256|FG000|Randomization to Month 36|Other|9|||
160783503|NCT00114777|580594257|FG001|Randomization to Month 36|Other|3|||
160783504|NCT00114777|580594258|FG002|Randomization to Month 36|Other|12|||
160783505|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Death|8|||
160783506|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Death|13|||
160783507|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Death|7|||
160783508|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
160783509|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
160783510|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
160783511|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
161124976|NCT05574062|581843864|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
161124977|NCT05574062|581843860|FG000|Continuation Phase Period 1|Physician Decision|1|||
161124978|NCT05574062|581843861|FG001|Continuation Phase Period 1|Physician Decision|0|||
161124979|NCT05574062|581843862|FG002|Continuation Phase Period 1|Physician Decision|0|||
161124980|NCT05574062|581843863|FG003|Continuation Phase Period 1|Physician Decision|0|||
161124981|NCT05574062|581843864|FG004|Continuation Phase Period 1|Physician Decision|0|||
161124982|NCT05574062|581843860|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
161124983|NCT05574062|581843861|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
161124984|NCT05574062|581843862|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
161124985|NCT05574062|581843863|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
161124986|NCT05574062|581843864|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
161124987|NCT05574062|581843860|FG000|Continuation Phase Period 1|Adverse Event|1|||
161124988|NCT05574062|581843861|FG001|Continuation Phase Period 1|Adverse Event|0|||
161124989|NCT05574062|581843862|FG002|Continuation Phase Period 1|Adverse Event|0|||
161124990|NCT05574062|581843863|FG003|Continuation Phase Period 1|Adverse Event|0|||
161124991|NCT05574062|581843864|FG004|Continuation Phase Period 1|Adverse Event|0|||
161124992|NCT05574062|581843860|FG000|Continuation Phase Period 1|Death|1|||
161124993|NCT05574062|581843861|FG001|Continuation Phase Period 1|Death|0|||
161124994|NCT05574062|581843862|FG002|Continuation Phase Period 1|Death|0|||
161124995|NCT05574062|581843863|FG003|Continuation Phase Period 1|Death|0|||
161124996|NCT05574062|581843864|FG004|Continuation Phase Period 1|Death|0|||
161124997|NCT05574062|581843860|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
161124998|NCT05574062|581843861|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
161124999|NCT05574062|581843862|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
161125000|NCT05574062|581843863|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
161125001|NCT05574062|581843864|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
161125002|NCT04556617|581843867|FG000|Overall Study|progressive disease|0|||
161125003|NCT04556617|581843868|FG001|Overall Study|progressive disease|2|||
161125004|NCT04556617|581843869|FG002|Overall Study|progressive disease|2|||
161125005|NCT04556617|581843870|FG003|Overall Study|progressive disease|1|||
161125006|NCT04556617|581843871|FG004|Overall Study|progressive disease|1|||
161125007|NCT04556617|581843867|FG000|Overall Study|Physician Decision|0|||
161125008|NCT04556617|581843868|FG001|Overall Study|Physician Decision|0|||
161125009|NCT04556617|581843869|FG002|Overall Study|Physician Decision|2|||
160783512|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
160783513|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
160783514|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
160783515|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
161125010|NCT04556617|581843870|FG003|Overall Study|Physician Decision|0|||
161125011|NCT04556617|581843871|FG004|Overall Study|Physician Decision|0|||
160783516|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
160783517|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
160783518|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
160783519|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
160783520|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
160783521|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
160783522|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
160783523|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
160783524|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
160783525|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
160783526|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
160783527|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
160783528|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
160890044|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
160890045|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
160890046|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
160890047|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
160890048|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
160890049|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
160890050|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
160890051|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
160890052|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
160890053|NCT02431247|580991612|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
160890054|NCT02431247|580991613|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
160890055|NCT02431247|580991614|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
160890056|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
160890057|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
160890058|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Other|2|||
160890059|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Other|2|||
160890060|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Personal reasons|2|||
160890061|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Personal reasons|2|||
160890062|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
160890063|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
160890064|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
160890065|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
160890066|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
160890067|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
160890068|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
160890069|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
160890070|NCT00667446|580991615|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
160890071|NCT00667446|580991616|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
160890072|NCT00667446|580991615|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
160890073|NCT00667446|580991616|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
160890074|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
161125012|NCT04556617|581843867|FG000|Overall Study|Adverse Event|0|||
161125013|NCT04556617|581843868|FG001|Overall Study|Adverse Event|0|||
161125014|NCT04556617|581843869|FG002|Overall Study|Adverse Event|2|||
161125015|NCT04556617|581843870|FG003|Overall Study|Adverse Event|3|||
161125016|NCT04556617|581843871|FG004|Overall Study|Adverse Event|0|||
161125017|NCT04556617|581843867|FG000|Overall Study|Withdrawal by Subject|0|||
161125018|NCT04556617|581843868|FG001|Overall Study|Withdrawal by Subject|2|||
161125019|NCT04556617|581843869|FG002|Overall Study|Withdrawal by Subject|1|||
161125020|NCT04556617|581843870|FG003|Overall Study|Withdrawal by Subject|1|||
161125021|NCT04556617|581843871|FG004|Overall Study|Withdrawal by Subject|0|||
161125022|NCT04556617|581843867|FG000|Overall Study|PSA increase|0|||
161125023|NCT04556617|581843868|FG001|Overall Study|PSA increase|1|||
161125024|NCT04556617|581843869|FG002|Overall Study|PSA increase|0|||
161125025|NCT04556617|581843870|FG003|Overall Study|PSA increase|0|||
161125026|NCT04556617|581843871|FG004|Overall Study|PSA increase|0|||
161125027|NCT04556617|581843867|FG000|Overall Study|Sponsor study termination|1|||
161125028|NCT04556617|581843868|FG001|Overall Study|Sponsor study termination|0|||
161125029|NCT04556617|581843869|FG002|Overall Study|Sponsor study termination|0|||
161230353|NCT05017480|582225741|FG002|Stage 1 Study|Physician Decision|0|||
161230354|NCT05017480|582225742|FG003|Stage 1 Study|Physician Decision|0|||
160890075|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
161125030|NCT04556617|581843870|FG003|Overall Study|Sponsor study termination|0|||
161125031|NCT04556617|581843871|FG004|Overall Study|Sponsor study termination|0|||
161230355|NCT05017480|582225743|FG004|Stage 1 Study|Physician Decision|0|||
161125032|NCT04949841|581843872|FG000|Overall Study|Adverse Event|7|||
161125033|NCT04949841|581843872|FG000|Overall Study|Death|1|||
161125034|NCT04949841|581843872|FG000|Overall Study|Withdrawal by Subject|52|||
161125035|NCT04949841|581843872|FG000|Overall Study|Pregnancy|4|||
161125036|NCT04949841|581843872|FG000|Overall Study|Lost to Follow-up|9|||
161125037|NCT04949841|581843872|FG000|Overall Study|Lack of Efficacy|55|||
161125038|NCT04949841|581843872|FG000|Overall Study|Various reasons|9|||
161125039|NCT04820309|581843873|FG000|Overall Study|Adverse Event|96|||
161125040|NCT04820309|581843873|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
161125041|NCT04820309|581843873|FG000|Overall Study|Consent Withdrawn|93|||
161125042|NCT04820309|581843873|FG000|Overall Study|failure to adhere to protocol|32|||
161125043|NCT04820309|581843873|FG000|Overall Study|alcohol or drug use|6|||
161125044|NCT04820309|581843873|FG000|Overall Study|Lost to Follow-up|46|||
161125045|NCT04820309|581843873|FG000|Overall Study|Death|2|||
161125046|NCT04820309|581843873|FG000|Overall Study|Pregnancy|1|||
161125047|NCT04820309|581843873|FG000|Overall Study|Other reasons|12|||
161125048|NCT02531646|581843876|FG000|Overall Study|equip. image processing issue|5|||
161125049|NCT02531646|581843877|FG001|Overall Study|equip. image processing issue|1|||
161125050|NCT02531646|581843878|FG002|Overall Study|equip. image processing issue|0|||
161125051|NCT01582308|581843879|FG000|Period 1|Withdrawal by Subject|0|||
161125052|NCT01582308|581843880|FG001|Period 1|Withdrawal by Subject|0|||
161327559|NCT02039778|582585452|FG000|Overall Study|Death|2|||
161327560|NCT02039778|582585452|FG000|Overall Study|Withdrawal by Subject|1|||
161125053|NCT01582308|581843881|FG002|Period 1|Withdrawal by Subject|0|||
161125054|NCT01582308|581843882|FG003|Period 1|Withdrawal by Subject|0|||
161125055|NCT01582308|581843883|FG004|Period 1|Withdrawal by Subject|0|||
161125056|NCT01582308|581843884|FG005|Period 1|Withdrawal by Subject|0|||
161327561|NCT02039778|582585452|FG000|Overall Study|Never started the protocol treatment|1|||
161327562|NCT00656175|582585461|FG000|Overall Study|Adverse Event|1|||
161327563|NCT00656175|582585462|FG001|Overall Study|Adverse Event|0|||
161327564|NCT00656175|582585461|FG000|Overall Study|Transportation issues|0|||
161327565|NCT00656175|582585462|FG001|Overall Study|Transportation issues|1|||
161327566|NCT02149264|582585468|FG000|Overall Study|Withdrawal by Subject|9|||
161327567|NCT02149264|582585468|FG000|Overall Study|Adverse Event|7|||
161327568|NCT02149264|582585468|FG000|Overall Study|Physician Decision|3|||
161327569|NCT02149264|582585468|FG000|Overall Study|Protocol Violation|1|||
161327570|NCT02824627|582585472|FG000|Overall Study|Adverse Event|1|||
161327571|NCT02824627|582585473|FG001|Overall Study|Adverse Event|2|||
161327572|NCT02824627|582585472|FG000|Overall Study|Lost to Follow-up|2|||
161327573|NCT02824627|582585473|FG001|Overall Study|Lost to Follow-up|1|||
161327574|NCT00672633|582585474|FG000|Overall Study|Withdrawal by Subject|0|||
161327575|NCT00672633|582585475|FG001|Overall Study|Withdrawal by Subject|1|||
161327576|NCT01938846|582585476|FG000|Overall Study|Progressive disease|26|||
161327577|NCT01938846|582585477|FG001|Overall Study|Progressive disease|18|||
161327578|NCT01938846|582585478|FG002|Overall Study|Progressive disease|16|||
161327579|NCT01938846|582585476|FG000|Overall Study|Adverse Event|8|||
161327580|NCT01938846|582585477|FG001|Overall Study|Adverse Event|4|||
161327581|NCT01938846|582585478|FG002|Overall Study|Adverse Event|3|||
161327582|NCT01938846|582585476|FG000|Overall Study|Withdrawal by Subject|2|||
161327583|NCT01938846|582585477|FG001|Overall Study|Withdrawal by Subject|2|||
161327584|NCT01938846|582585478|FG002|Overall Study|Withdrawal by Subject|1|||
161327585|NCT01938846|582585476|FG000|Overall Study|Other than listed|5|||
161327586|NCT01938846|582585477|FG001|Overall Study|Other than listed|1|||
161327587|NCT01938846|582585478|FG002|Overall Study|Other than listed|4|||
161327588|NCT02499120|582585482|FG000|Overall Study|Death|52|||
161327589|NCT02499120|582585483|FG001|Overall Study|Death|43|||
161327590|NCT02499120|582585482|FG000|Overall Study|Lost to Follow-up|1|||
161327591|NCT02499120|582585483|FG001|Overall Study|Lost to Follow-up|2|||
161327592|NCT02499120|582585482|FG000|Overall Study|Participant refused further follow-up|1|||
161327593|NCT02499120|582585483|FG001|Overall Study|Participant refused further follow-up|0|||
161327594|NCT02499120|582585482|FG000|Overall Study|Withdrawal by Subject|2|||
161327595|NCT02499120|582585483|FG001|Overall Study|Withdrawal by Subject|5|||
161327596|NCT02499120|582585482|FG000|Overall Study|Other|9|||
161327597|NCT02499120|582585483|FG001|Overall Study|Other|10|||
161327598|NCT01868165|582585484|FG000|Overall Study|Withdrawal by Subject|36|||
161327599|NCT01868165|582585484|FG000|Overall Study|Physician Decision|2|||
161125057|NCT01582308|581843885|FG006|Period 1|Withdrawal by Subject|1|||
161327600|NCT01868165|582585484|FG000|Overall Study|Lost to Follow-up|3|||
161327601|NCT01868165|582585484|FG000|Overall Study|Death|4|||
161327602|NCT02282163|582585485|FG000|Overall Study|Protocol Violation|1|||
161327603|NCT01839916|582585486|FG000|Overall Study|Death|9|||
161327604|NCT01839916|582585486|FG000|Overall Study|Physician Decision|17|||
161327605|NCT01839916|582585486|FG000|Overall Study|Relapse|12|||
161327606|NCT01839916|582585486|FG000|Overall Study|GVHD|2|||
161327607|NCT01839916|582585486|FG000|Overall Study|Graft Failure|1|||
161327608|NCT01603407|582585487|FG000|Overall Study|Adverse Event|1|||
161125058|NCT01582308|581843886|FG007|Period 1|Withdrawal by Subject|0|||
161125059|NCT01582308|581843887|FG008|Period 1|Withdrawal by Subject|0|||
161125060|NCT01582308|581843888|FG009|Period 1|Withdrawal by Subject|0|||
161125061|NCT01582308|581843879|FG000|10-day Washout Following Period 1|Physician Decision|0|||
161327609|NCT01603407|582585488|FG001|Overall Study|Adverse Event|1|||
161327610|NCT01603407|582585489|FG002|Overall Study|Adverse Event|1|||
160783529|NCT00114777|580594256|FG000|Long-Term Extension to Month 84|Other|2|||
160783530|NCT00114777|580594257|FG001|Long-Term Extension to Month 84|Other|0|||
160783531|NCT00114777|580594258|FG002|Long-Term Extension to Month 84|Other|2|||
160783532|NCT01181128|580594262|FG000|Overall Study|Withdrawal by Subject|2|||
160783533|NCT01181128|580594263|FG001|Overall Study|Withdrawal by Subject|2|||
160783534|NCT01181128|580594264|FG002|Overall Study|Withdrawal by Subject|0|||
160783535|NCT01181128|580594262|FG000|Overall Study|Death|1|||
160783536|NCT01181128|580594263|FG001|Overall Study|Death|0|||
160783537|NCT01181128|580594264|FG002|Overall Study|Death|0|||
160783538|NCT01181128|580594262|FG000|Overall Study|Physician Decision|2|||
160783539|NCT01181128|580594263|FG001|Overall Study|Physician Decision|0|||
160783540|NCT01181128|580594264|FG002|Overall Study|Physician Decision|0|||
160783541|NCT01181128|580594262|FG000|Overall Study|Adverse Event|0|||
160783542|NCT01181128|580594263|FG001|Overall Study|Adverse Event|2|||
160783543|NCT01181128|580594264|FG002|Overall Study|Adverse Event|0|||
160783544|NCT01181128|580594262|FG000|Overall Study|Other|1|||
160783545|NCT01181128|580594263|FG001|Overall Study|Other|1|||
160783546|NCT01181128|580594264|FG002|Overall Study|Other|1|||
160783547|NCT04477486|580594267|FG000|Overall Study|Death|2|||
160783548|NCT04477486|580594267|FG000|Overall Study|Ongoing at Time of Analysis|11|||
160783549|NCT01543503|580594268|FG000|Overall Study|Lost to Follow-up|32|||
160783550|NCT01543503|580594269|FG001|Overall Study|Lost to Follow-up|36|||
160783551|NCT01543503|580594268|FG000|Overall Study|Adverse Event|9|||
160783552|NCT01543503|580594269|FG001|Overall Study|Adverse Event|13|||
160783553|NCT01543503|580594268|FG000|Overall Study|Lack of Efficacy|4|||
160783554|NCT01543503|580594269|FG001|Overall Study|Lack of Efficacy|16|||
160783555|NCT01543503|580594268|FG000|Overall Study|Participant withdrew informed consent|8|||
160783556|NCT01543503|580594269|FG001|Overall Study|Participant withdrew informed consent|10|||
160783557|NCT01543503|580594268|FG000|Overall Study|Change of jobs|0|||
160783558|NCT01543503|580594269|FG001|Overall Study|Change of jobs|1|||
160783559|NCT01543503|580594268|FG000|Overall Study|Intolerance to the biologic treatment|0|||
160783560|NCT01543503|580594269|FG001|Overall Study|Intolerance to the biologic treatment|1|||
160783561|NCT01543503|580594268|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
160783562|NCT01543503|580594269|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
160783563|NCT01543503|580594268|FG000|Overall Study|Participant did not complete last visit|0|||
160783564|NCT01543503|580594269|FG001|Overall Study|Participant did not complete last visit|2|||
160783565|NCT01543503|580594268|FG000|Overall Study|Refused to continue treatment|7|||
160783566|NCT01543503|580594269|FG001|Overall Study|Refused to continue treatment|0|||
160783567|NCT01543503|580594268|FG000|Overall Study|Incorrect medication received|1|||
160783568|NCT01543503|580594269|FG001|Overall Study|Incorrect medication received|0|||
160783569|NCT01543503|580594268|FG000|Overall Study|Participant moved to another city|2|||
160783570|NCT01543503|580594269|FG001|Overall Study|Participant moved to another city|0|||
160783571|NCT01543503|580594268|FG000|Overall Study|Participant will not return for visits|0|||
160783572|NCT01543503|580594269|FG001|Overall Study|Participant will not return for visits|2|||
160783573|NCT01543503|580594268|FG000|Overall Study|Participant transferred to another city|1|||
160783574|NCT01543503|580594269|FG001|Overall Study|Participant transferred to another city|0|||
160783575|NCT01543503|580594268|FG000|Overall Study|Participant moved to Scotland|1|||
160783576|NCT01543503|580594269|FG001|Overall Study|Participant moved to Scotland|0|||
160783577|NCT01543503|580594268|FG000|Overall Study|Participant decision to stop treatment|1|||
160783578|NCT01543503|580594269|FG001|Overall Study|Participant decision to stop treatment|0|||
160783579|NCT01543503|580594268|FG000|Overall Study|Investigator did not wish to participate|1|||
160783580|NCT01543503|580594269|FG001|Overall Study|Investigator did not wish to participate|1|||
160783581|NCT01543503|580594268|FG000|Overall Study|Participant recruited after closing date|0|||
160783582|NCT01543503|580594269|FG001|Overall Study|Participant recruited after closing date|1|||
160783583|NCT01543503|580594268|FG000|Overall Study|Site stopped participation|5|||
160783584|NCT01543503|580594269|FG001|Overall Study|Site stopped participation|1|||
160783585|NCT01543503|580594268|FG000|Overall Study|Participant did not attend a visit|1|||
160783586|NCT01543503|580594269|FG001|Overall Study|Participant did not attend a visit|0|||
160783587|NCT01543503|580594268|FG000|Overall Study|Moved to other rheumatologic site|0|||
161125062|NCT01582308|581843880|FG001|10-day Washout Following Period 1|Physician Decision|0|||
161125063|NCT01582308|581843881|FG002|10-day Washout Following Period 1|Physician Decision|0|||
161125064|NCT01582308|581843882|FG003|10-day Washout Following Period 1|Physician Decision|0|||
161125065|NCT01582308|581843883|FG004|10-day Washout Following Period 1|Physician Decision|1|||
161125066|NCT01582308|581843884|FG005|10-day Washout Following Period 1|Physician Decision|0|||
161125067|NCT01582308|581843885|FG006|10-day Washout Following Period 1|Physician Decision|0|||
161125068|NCT01582308|581843886|FG007|10-day Washout Following Period 1|Physician Decision|0|||
161230356|NCT05017480|582225739|FG000|Stage 2 Study|Withdrawal by Subject|0|||
160783588|NCT01543503|580594269|FG001|Overall Study|Moved to other rheumatologic site|1|||
160783589|NCT01543503|580594268|FG000|Overall Study|Participant consented to another study|0|||
160783590|NCT01543503|580594269|FG001|Overall Study|Participant consented to another study|2|||
160783591|NCT01543503|580594268|FG000|Overall Study|Participant went to United States|1|||
160783592|NCT01543503|580594269|FG001|Overall Study|Participant went to United States|0|||
160783593|NCT01543503|580594268|FG000|Overall Study|Screen failure|1|||
160783594|NCT01543503|580594269|FG001|Overall Study|Screen failure|0|||
160783595|NCT01986751|580594271|FG000|Overall Study|improperly consented|10|||
160783596|NCT01986751|580594272|FG001|Overall Study|improperly consented|2|||
160783597|NCT01774370|580594278|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
160783598|NCT01774370|580594278|FG000|Overall Study|Administered prior to the contract date|4|||
160783599|NCT01774370|580594278|FG000|Overall Study|Subjects of contraindications|34|||
160783600|NCT01774370|580594278|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
160783601|NCT01774370|580594278|FG000|Overall Study|Follow-up failure|34|||
160783602|NCT00514917|580594281|FG000|Overall Study|Death|4|||
160783603|NCT00514917|580594282|FG001|Overall Study|Death|10|||
160783604|NCT00514917|580594281|FG000|Overall Study|Protocol Violation|1|||
160783605|NCT00514917|580594282|FG001|Overall Study|Protocol Violation|0|||
160783606|NCT00514917|580594281|FG000|Overall Study|Lost to Follow-up|4|||
160783607|NCT00514917|580594282|FG001|Overall Study|Lost to Follow-up|3|||
160783608|NCT00514917|580594281|FG000|Overall Study|Withdrawal by Subject|18|||
160783609|NCT00514917|580594282|FG001|Overall Study|Withdrawal by Subject|16|||
160783610|NCT00514917|580594281|FG000|Overall Study|Discontinued due to study closure|88|||
160783611|NCT00514917|580594282|FG001|Overall Study|Discontinued due to study closure|81|||
160783612|NCT00514917|580594281|FG000|Overall Study|Undefined|11|||
160783613|NCT00514917|580594282|FG001|Overall Study|Undefined|5|||
160783614|NCT04243837|580594283|FG000|Overall Study|Adverse Event|2|||
160783615|NCT04243837|580594284|FG001|Overall Study|Adverse Event|1|||
160783616|NCT04243837|580594283|FG000|Overall Study|Withdrawal by Subject|4|||
160783617|NCT04243837|580594284|FG001|Overall Study|Withdrawal by Subject|2|||
160783618|NCT04243837|580594283|FG000|Overall Study|Covid-19 lock down|1|||
160783619|NCT04243837|580594284|FG001|Overall Study|Covid-19 lock down|0|||
160783620|NCT04243837|580594283|FG000|Overall Study|Study Terminated by Sponsor|11|||
160783621|NCT04243837|580594284|FG001|Overall Study|Study Terminated by Sponsor|12|||
160783622|NCT02280499|580594285|FG000|Overall Study|Death|14|||
160783623|NCT02280499|580594285|FG000|Overall Study|Lost to Follow-up|42|||
160783624|NCT02280499|580594285|FG000|Overall Study|Adverse Event|5|||
160783625|NCT05085405|580594293|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783626|NCT05085405|580594294|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783627|NCT05085405|580594295|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
160783628|NCT05085405|580594296|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
160783629|NCT05085405|580594297|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783630|NCT05085405|580594298|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
160783631|NCT05085405|580594293|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783632|NCT05085405|580594294|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783633|NCT05085405|580594295|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783634|NCT05085405|580594296|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
160783635|NCT05085405|580594297|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783636|NCT05085405|580594298|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
160783637|NCT02187055|580594299|FG000|Overall Study|Lack of Efficacy|10|||
160783638|NCT02187055|580594300|FG001|Overall Study|Lack of Efficacy|3|||
160783639|NCT02187055|580594301|FG002|Overall Study|Lack of Efficacy|7|||
160783640|NCT02187055|580594299|FG000|Overall Study|Lost to Follow-up|2|||
160783641|NCT02187055|580594300|FG001|Overall Study|Lost to Follow-up|7|||
160783642|NCT02187055|580594301|FG002|Overall Study|Lost to Follow-up|3|||
160783643|NCT02187055|580594299|FG000|Overall Study|No longer meets eligibility criteria|0|||
160783644|NCT02187055|580594300|FG001|Overall Study|No longer meets eligibility criteria|2|||
160783645|NCT02187055|580594301|FG002|Overall Study|No longer meets eligibility criteria|0|||
160783646|NCT02187055|580594299|FG000|Overall Study|No longer willing to participate|6|||
160783647|NCT02187055|580594300|FG001|Overall Study|No longer willing to participate|8|||
160783648|NCT02187055|580594301|FG002|Overall Study|No longer willing to participate|10|||
160783649|NCT02187055|580594299|FG000|Overall Study|Other|5|||
160783650|NCT02187055|580594300|FG001|Overall Study|Other|6|||
160783651|NCT02187055|580594301|FG002|Overall Study|Other|3|||
160783652|NCT02187055|580594299|FG000|Overall Study|Protocol Violation|9|||
160783653|NCT02187055|580594300|FG001|Overall Study|Protocol Violation|9|||
160783654|NCT02187055|580594301|FG002|Overall Study|Protocol Violation|4|||
160783655|NCT02187055|580594299|FG000|Overall Study|Pregnancy|3|||
160783656|NCT02187055|580594300|FG001|Overall Study|Pregnancy|1|||
161125069|NCT01582308|581843887|FG008|10-day Washout Following Period 1|Physician Decision|0|||
161327611|NCT01603407|582585487|FG000|Overall Study|Protocol Violation|2|||
160783657|NCT02187055|580594301|FG002|Overall Study|Pregnancy|0|||
160890076|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
160890077|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
160783658|NCT02187055|580594299|FG000|Overall Study|Withdrawal by Subject|11|||
160783659|NCT02187055|580594300|FG001|Overall Study|Withdrawal by Subject|11|||
160783660|NCT02187055|580594301|FG002|Overall Study|Withdrawal by Subject|11|||
160783661|NCT02187055|580594299|FG000|Overall Study|Adverse Event|21|||
161125070|NCT01582308|581843888|FG009|10-day Washout Following Period 1|Physician Decision|0|||
161125071|NCT01582308|581843879|FG000|Period 4|Physician Decision|1|||
161125072|NCT01582308|581843880|FG001|Period 4|Physician Decision|0|||
161125073|NCT01582308|581843881|FG002|Period 4|Physician Decision|0|||
161125074|NCT01582308|581843882|FG003|Period 4|Physician Decision|0|||
161125075|NCT01582308|581843883|FG004|Period 4|Physician Decision|0|||
161125076|NCT01582308|581843884|FG005|Period 4|Physician Decision|1|||
161125077|NCT01582308|581843885|FG006|Period 4|Physician Decision|0|||
161125078|NCT01582308|581843886|FG007|Period 4|Physician Decision|0|||
161125079|NCT01582308|581843887|FG008|Period 4|Physician Decision|0|||
161125080|NCT01582308|581843888|FG009|Period 4|Physician Decision|1|||
161125081|NCT00772668|581843891|FG000|Overall Study|Physician Decision|3|||
161125082|NCT01182428|581843892|FG000|Overall Study|Physician Decision|1|||
161125083|NCT01182428|581843893|FG001|Overall Study|Physician Decision|0|||
161125084|NCT01182428|581843892|FG000|Overall Study|Lost to Follow-up|9|||
161125085|NCT01182428|581843893|FG001|Overall Study|Lost to Follow-up|1|||
161125086|NCT01182428|581843892|FG000|Overall Study|Withdrawal by Subject|1|||
161125087|NCT01182428|581843893|FG001|Overall Study|Withdrawal by Subject|0|||
161125088|NCT03631706|581843895|FG000|Overall Study|Randomized, not treated|1|||
161125089|NCT03631706|581843896|FG001|Overall Study|Randomized, not treated|0|||
161125090|NCT00684957|581843899|FG000|Overall Study|Withdrawal by Subject|1|||
161125091|NCT00684957|581843900|FG001|Overall Study|Withdrawal by Subject|1|||
161125092|NCT00684957|581843899|FG000|Overall Study|Lost to Follow-up|1|||
161125093|NCT00684957|581843900|FG001|Overall Study|Lost to Follow-up|0|||
161125094|NCT04341948|581843901|FG000|Overall Study|Adverse Event|0|||
161125095|NCT04341948|581843902|FG001|Overall Study|Adverse Event|1|||
161125096|NCT04341948|581843901|FG000|Overall Study|Lost to Follow-up|6|||
161125097|NCT04341948|581843902|FG001|Overall Study|Lost to Follow-up|1|||
161125098|NCT04341948|581843901|FG000|Overall Study|Physician Decision|1|||
161125099|NCT04341948|581843902|FG001|Overall Study|Physician Decision|2|||
161125100|NCT04341948|581843901|FG000|Overall Study|Withdrawal by Participant|6|||
161125101|NCT04341948|581843902|FG001|Overall Study|Withdrawal by Participant|3|||
161125102|NCT04341948|581843901|FG000|Overall Study|Lack of compliance by Participant|1|||
161125103|NCT04341948|581843902|FG001|Overall Study|Lack of compliance by Participant|0|||
161125104|NCT03406897|581843903|FG000|Overall Study|Lost to Follow-up|1|||
161125105|NCT03406897|581843904|FG001|Overall Study|Lost to Follow-up|2|||
161125106|NCT03406897|581843903|FG000|Overall Study|Withdrawal by Subject|4|||
161125107|NCT03406897|581843904|FG001|Overall Study|Withdrawal by Subject|4|||
161125108|NCT03406897|581843903|FG000|Overall Study|Physician Decision|0|||
161125109|NCT03406897|581843904|FG001|Overall Study|Physician Decision|1|||
161125110|NCT02554929|581845326|FG000|Overall Study|Lost to Follow-up|4|||
161125111|NCT02554929|581845327|FG001|Overall Study|Lost to Follow-up|4|||
161125112|NCT02554929|581845326|FG000|Overall Study|Withdrawal by Subject|2|||
161125113|NCT02554929|581845327|FG001|Overall Study|Withdrawal by Subject|8|||
161125114|NCT00388947|581845329|FG000|Overall Study|Protocol Violation|47|||
161125115|NCT04187092|581845330|FG000|Overall Study|Lost to Follow-up|1|||
161125116|NCT04187092|581845331|FG001|Overall Study|Lost to Follow-up|1|||
161125117|NCT04187092|581845330|FG000|Overall Study|Withdrawal by Subject|1|||
161125118|NCT04187092|581845331|FG001|Overall Study|Withdrawal by Subject|1|||
161125119|NCT04187092|581845330|FG000|Overall Study|Adverse Event|0|||
161125120|NCT04187092|581845331|FG001|Overall Study|Adverse Event|1|||
161125121|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
161125122|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
161125123|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
161125124|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
161125125|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
161125126|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
161125127|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
161125128|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
161125129|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
161125130|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
161125131|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
161125132|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
161125133|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
161125134|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
161327612|NCT01603407|582585488|FG001|Overall Study|Protocol Violation|2|||
160890078|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
160890079|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
160890080|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
160890081|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
160890082|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
160890083|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
160890084|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
160890085|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
160890086|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
160783662|NCT02187055|580594300|FG001|Overall Study|Adverse Event|26|||
160783663|NCT02187055|580594301|FG002|Overall Study|Adverse Event|36|||
160783664|NCT02187055|580594299|FG000|Overall Study|Death|2|||
160783665|NCT02187055|580594300|FG001|Overall Study|Death|0|||
160783666|NCT02187055|580594301|FG002|Overall Study|Death|0|||
160783667|NCT00985790|580594304|FG000|Overall Study|Withdrawal by Subject|1|||
160783668|NCT00985790|580594305|FG001|Overall Study|Withdrawal by Subject|1|||
160783669|NCT00985790|580594304|FG000|Overall Study|Lost to Follow-up|6|||
160783670|NCT00985790|580594305|FG001|Overall Study|Lost to Follow-up|7|||
160783671|NCT01666314|580594306|FG000|Overall Study|Adverse Event|3|||
160783672|NCT01666314|580594307|FG001|Overall Study|Adverse Event|13|||
160783673|NCT01666314|580594308|FG002|Overall Study|Adverse Event|7|||
160783674|NCT01666314|580594309|FG003|Overall Study|Adverse Event|7|||
160783675|NCT01666314|580594306|FG000|Overall Study|Progressive Disease|11|||
160783676|NCT01666314|580594307|FG001|Overall Study|Progressive Disease|9|||
160783677|NCT01666314|580594308|FG002|Overall Study|Progressive Disease|19|||
160783678|NCT01666314|580594309|FG003|Overall Study|Progressive Disease|20|||
160783679|NCT01666314|580594306|FG000|Overall Study|Symptomatic Deterioration|1|||
160783680|NCT01666314|580594307|FG001|Overall Study|Symptomatic Deterioration|0|||
160783681|NCT01666314|580594308|FG002|Overall Study|Symptomatic Deterioration|2|||
160783682|NCT01666314|580594309|FG003|Overall Study|Symptomatic Deterioration|0|||
160783683|NCT01666314|580594306|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
160783684|NCT01666314|580594307|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
160783685|NCT01666314|580594308|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
160783686|NCT01666314|580594309|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
160783687|NCT01666314|580594306|FG000|Overall Study|Withdrawal by Subject|1|||
160783688|NCT01666314|580594307|FG001|Overall Study|Withdrawal by Subject|1|||
160783689|NCT01666314|580594308|FG002|Overall Study|Withdrawal by Subject|2|||
160783690|NCT01666314|580594309|FG003|Overall Study|Withdrawal by Subject|3|||
160783691|NCT01666314|580594306|FG000|Overall Study|Reason not Specified|10|||
160783692|NCT01666314|580594307|FG001|Overall Study|Reason not Specified|7|||
160783693|NCT01666314|580594308|FG002|Overall Study|Reason not Specified|5|||
160783694|NCT01666314|580594309|FG003|Overall Study|Reason not Specified|5|||
160783695|NCT00689052|580594311|FG000|Overall Study|Adverse Event|4|||
160783696|NCT00689052|580594312|FG001|Overall Study|Adverse Event|6|||
160783697|NCT00689052|580594311|FG000|Overall Study|Protocol Violation|1|||
160783698|NCT00689052|580594312|FG001|Overall Study|Protocol Violation|0|||
160783699|NCT00689052|580594311|FG000|Overall Study|Lost to Follow-up|2|||
160783700|NCT00689052|580594312|FG001|Overall Study|Lost to Follow-up|0|||
160783701|NCT00689052|580594311|FG000|Overall Study|Withdrawal by Subject|2|||
160783702|NCT00689052|580594312|FG001|Overall Study|Withdrawal by Subject|0|||
160783703|NCT00689052|580594311|FG000|Overall Study|Early termination of the trial|22|||
160783704|NCT00689052|580594312|FG001|Overall Study|Early termination of the trial|24|||
160783705|NCT01727154|580594316|FG000|Overall Study|Death|17|||
160783706|NCT01727154|580594316|FG000|Overall Study|Withdrawal by Subject|14|||
160783707|NCT01727154|580594316|FG000|Overall Study|Subject Withdrew Consent|18|||
160783708|NCT01727154|580594316|FG000|Overall Study|Study Terminated|6|||
160783709|NCT01727154|580594316|FG000|Overall Study|No Discontinuation Documentation|4|||
160783710|NCT00003474|580594317|FG000|Overall Study|Not Evaluable|14|||
160783711|NCT01198548|580594321|FG000|Overall Study|Disease Progression|9|||
160783712|NCT01198548|580594321|FG000|Overall Study|Administrative Decision|1|||
160783713|NCT02186171|580594323|FG000|Overall Study|Withdrawal by Subject|1|||
160783714|NCT02186171|580594324|FG001|Overall Study|Withdrawal by Subject|9|||
160783715|NCT02186171|580594323|FG000|Overall Study|Lost to Follow-up|2|||
160783716|NCT02186171|580594324|FG001|Overall Study|Lost to Follow-up|2|||
161327613|NCT01603407|582585489|FG002|Overall Study|Protocol Violation|0|||
161327614|NCT01603407|582585487|FG000|Overall Study|Withdrawal by Subject|8|||
161327615|NCT01603407|582585488|FG001|Overall Study|Withdrawal by Subject|5|||
161327616|NCT01603407|582585489|FG002|Overall Study|Withdrawal by Subject|7|||
161125135|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
161125136|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
161125137|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
161125138|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
161327617|NCT01603407|582585487|FG000|Overall Study|Lost to Follow-up|0|||
160783717|NCT02186171|580594323|FG000|Overall Study|Death|1|||
160783718|NCT02186171|580594324|FG001|Overall Study|Death|2|||
160783719|NCT02186171|580594323|FG000|Overall Study|Protocol-specified Criteria|0|||
160783720|NCT02186171|580594324|FG001|Overall Study|Protocol-specified Criteria|2|||
160783721|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
160783722|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
160783723|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
160783724|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Physician Decision|2|||
160783725|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Physician Decision|4|||
160783726|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Physician Decision|0|||
160783727|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
161327618|NCT01603407|582585488|FG001|Overall Study|Lost to Follow-up|3|||
161327619|NCT01603407|582585489|FG002|Overall Study|Lost to Follow-up|2|||
161327620|NCT04587336|582585492|FG000|Overall Study|Lost to Follow-up|1|||
161327621|NCT04587336|582585493|FG001|Overall Study|Lost to Follow-up|0|||
161327622|NCT03934216|582586999|FG000|Overall Study|Other Reasons|5|||
161327623|NCT03934216|582587000|FG001|Overall Study|Other Reasons|5|||
161327624|NCT03934216|582586999|FG000|Overall Study|Adverse Event|22|||
161327625|NCT03934216|582587000|FG001|Overall Study|Adverse Event|11|||
161327626|NCT03934216|582586999|FG000|Overall Study|Lack of Efficacy|8|||
161327627|NCT03934216|582587000|FG001|Overall Study|Lack of Efficacy|7|||
161327628|NCT03934216|582586999|FG000|Overall Study|Lost to Follow-up|2|||
161327629|NCT03934216|582587000|FG001|Overall Study|Lost to Follow-up|0|||
161327630|NCT03934216|582586999|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161327631|NCT03934216|582587000|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161327632|NCT03934216|582586999|FG000|Overall Study|Pregnancy|1|||
161327633|NCT03934216|582587000|FG001|Overall Study|Pregnancy|0|||
161327634|NCT03934216|582586999|FG000|Overall Study|Withdrawal by Subject|18|||
161327635|NCT03934216|582587000|FG001|Overall Study|Withdrawal by Subject|6|||
161327636|NCT03934216|582586999|FG000|Overall Study|Randomized but not treated|1|||
161327637|NCT03934216|582587000|FG001|Overall Study|Randomized but not treated|1|||
161327638|NCT01396083|582587001|FG000|Overall Study|Adverse Event|2|||
161327639|NCT01396083|582587002|FG001|Overall Study|Adverse Event|28|||
161327640|NCT01396083|582587001|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161327641|NCT01396083|582587002|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161327642|NCT01396083|582587001|FG000|Overall Study|Consent withdrawn|4|||
161327643|NCT01396083|582587002|FG001|Overall Study|Consent withdrawn|5|||
161327644|NCT01396083|582587001|FG000|Overall Study|Protocol deviation(s)|0|||
161327645|NCT01396083|582587002|FG001|Overall Study|Protocol deviation(s)|1|||
161327646|NCT01396083|582587001|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161327647|NCT01396083|582587002|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161327648|NCT01396083|582587001|FG000|Overall Study|Administrative problems|1|||
161327649|NCT01396083|582587002|FG001|Overall Study|Administrative problems|0|||
161327650|NCT01396083|582587001|FG000|Overall Study|Lost to Follow-up|1|||
161327651|NCT01396083|582587002|FG001|Overall Study|Lost to Follow-up|0|||
161327652|NCT01165307|582587003|FG000|Overall Study|Lost to Follow-up|11|||
161327653|NCT01165307|582587004|FG001|Overall Study|Lost to Follow-up|3|||
161327654|NCT01165307|582587003|FG000|Overall Study|Withdrawal by Subject|2|||
161327655|NCT01165307|582587004|FG001|Overall Study|Withdrawal by Subject|0|||
161327656|NCT01165307|582587003|FG000|Overall Study|Subject not available for contact|1|||
161327657|NCT01165307|582587004|FG001|Overall Study|Subject not available for contact|0|||
161327658|NCT03150082|582587005|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
161327659|NCT03150082|582587006|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
161327660|NCT01718483|582587007|FG000|Overall Study|Withdrawal by Subject|14|||
161327661|NCT01718483|582587008|FG001|Overall Study|Withdrawal by Subject|12|||
161327662|NCT01718483|582587007|FG000|Overall Study|Adverse Event|5|||
161327663|NCT01718483|582587008|FG001|Overall Study|Adverse Event|12|||
161327664|NCT01718483|582587007|FG000|Overall Study|Lost to Follow-up|8|||
161327665|NCT01718483|582587008|FG001|Overall Study|Lost to Follow-up|3|||
161327666|NCT01718483|582587007|FG000|Overall Study|Protocol Violation|4|||
161327667|NCT01718483|582587008|FG001|Overall Study|Protocol Violation|2|||
161327668|NCT01718483|582587007|FG000|Overall Study|Other|1|||
161327669|NCT01718483|582587008|FG001|Overall Study|Other|4|||
161327670|NCT01718483|582587007|FG000|Overall Study|Pregnancy|1|||
161327671|NCT01718483|582587008|FG001|Overall Study|Pregnancy|1|||
161327672|NCT01718483|582587007|FG000|Overall Study|Lack of Efficacy|1|||
161327673|NCT01718483|582587008|FG001|Overall Study|Lack of Efficacy|0|||
161327674|NCT04131712|582587009|FG000|Overall Study|COVID related|0|||
161327675|NCT04131712|582587010|FG001|Overall Study|COVID related|0|||
161327676|NCT04131712|582587011|FG002|Overall Study|COVID related|2|||
161327677|NCT04131712|582587012|FG003|Overall Study|COVID related|0|||
161327678|NCT04131712|582587009|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161327679|NCT04131712|582587010|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161327680|NCT04131712|582587011|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
161327681|NCT04131712|582587012|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
161327682|NCT03334188|582587013|FG000|Overall Study|Withdrawal by Subject|0|||
161327683|NCT03334188|582587014|FG001|Overall Study|Withdrawal by Subject|1|||
161327684|NCT03334188|582587013|FG000|Overall Study|Death|1|||
161327685|NCT03334188|582587014|FG001|Overall Study|Death|0|||
161327686|NCT03334188|582587013|FG000|Overall Study|Never had qualifying clinic visit|7|||
161327687|NCT03334188|582587014|FG001|Overall Study|Never had qualifying clinic visit|7|||
161327688|NCT00130689|582587018|FG000|Overall Study|Progressive Disease|29|||
161327689|NCT00130689|582587018|FG000|Overall Study|Death|1|||
161327690|NCT00130689|582587018|FG000|Overall Study|Clinical Deterioration|4|||
161327691|NCT00130689|582587018|FG000|Overall Study|Withdrawal by Subject|3|||
161327692|NCT00130689|582587018|FG000|Overall Study|Ineligible|6|||
161327693|NCT00766597|582587019|FG000|Overall Study|Unexpected closure of study|4|||
161327694|NCT00766597|582587019|FG000|Overall Study|Without CCR5-tropic virus|5|||
160783728|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
160783729|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
160783730|NCT01245062|580594325|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
160783731|NCT01245062|580594326|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
160783732|NCT01245062|580594327|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
160783733|NCT01245062|580594325|FG000|Cross-over Phase|Lost to Follow-up|0|||
160783734|NCT01245062|580594326|FG001|Cross-over Phase|Lost to Follow-up|0|||
160783735|NCT01245062|580594327|FG002|Cross-over Phase|Lost to Follow-up|1|||
160783736|NCT01245062|580594325|FG000|Cross-over Phase|Physician Decision|0|||
160783737|NCT01245062|580594326|FG001|Cross-over Phase|Physician Decision|0|||
160783738|NCT01245062|580594327|FG002|Cross-over Phase|Physician Decision|1|||
160783739|NCT01245062|580594325|FG000|Cross-over Phase|Withdrew Consent|0|||
160783740|NCT01245062|580594326|FG001|Cross-over Phase|Withdrew Consent|0|||
160783741|NCT01245062|580594327|FG002|Cross-over Phase|Withdrew Consent|4|||
160783742|NCT01245062|580594325|FG000|Cross-over Phase|Study closed/ terminated|0|||
160783743|NCT01245062|580594326|FG001|Cross-over Phase|Study closed/ terminated|0|||
160783744|NCT01245062|580594327|FG002|Cross-over Phase|Study closed/ terminated|11|||
160783745|NCT06025695|580594329|FG000|Overall Study|Adverse Event|5|||
160783746|NCT06025695|580594330|FG001|Overall Study|Adverse Event|6|||
160783747|NCT06025695|580594329|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
160783748|NCT06025695|580594330|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
160783749|NCT06025695|580594329|FG000|Overall Study|Other|23|||
160783750|NCT06025695|580594330|FG001|Overall Study|Other|19|||
160783751|NCT06025695|580594329|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
160783752|NCT06025695|580594330|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
160783753|NCT01452347|580594331|FG000|Overall Study|Adverse Event|2|||
160783754|NCT01452347|580594332|FG001|Overall Study|Adverse Event|1|||
160783755|NCT01452347|580594331|FG000|Overall Study|Non compliance protocol|2|||
160783756|NCT01452347|580594332|FG001|Overall Study|Non compliance protocol|0|||
160783757|NCT01452347|580594331|FG000|Overall Study|Lost to Follow-up|2|||
160783758|NCT01452347|580594332|FG001|Overall Study|Lost to Follow-up|0|||
160783759|NCT01452347|580594331|FG000|Overall Study|Withdrawal by Subject|3|||
160783760|NCT01452347|580594332|FG001|Overall Study|Withdrawal by Subject|3|||
160783761|NCT01452347|580594331|FG000|Overall Study|Not treated|6|||
160783762|NCT01452347|580594332|FG001|Overall Study|Not treated|3|||
160783763|NCT01452347|580594331|FG000|Overall Study|Other reason not defined above|2|||
160783764|NCT01452347|580594332|FG001|Overall Study|Other reason not defined above|0|||
160783765|NCT05762744|580594333|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
160783766|NCT05762744|580594334|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
160783767|NCT05762744|580594333|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
160783768|NCT05762744|580594334|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
160783769|NCT01030900|580594335|FG000|Overall Study|Not treated due to congestive heart failure|1|||
160783770|NCT01030900|580594335|FG000|Overall Study|Not treated due to rapid disease|1|||
160783771|NCT00441896|580594336|FG000|Overall Study|Withdrawal by Subject|0|||
160783772|NCT00441896|580594337|FG001|Overall Study|Withdrawal by Subject|0|||
160783773|NCT00441896|580594338|FG002|Overall Study|Withdrawal by Subject|0|||
160783774|NCT00441896|580594339|FG003|Overall Study|Withdrawal by Subject|1|||
161125139|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
161125140|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
161125141|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
161125142|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
161125143|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
161125144|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
161125145|NCT04660643|581845332|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
161125146|NCT04660643|581845333|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
161125147|NCT04660643|581845334|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
161125148|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
161125149|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
160783775|NCT00441896|580594340|FG004|Overall Study|Withdrawal by Subject|0|||
160783776|NCT00441896|580594341|FG005|Overall Study|Withdrawal by Subject|0|||
160783777|NCT00441896|580594342|FG006|Overall Study|Withdrawal by Subject|0|||
161125150|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
161125151|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
161125152|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
160783778|NCT00441896|580594343|FG007|Overall Study|Withdrawal by Subject|0|||
160783779|NCT00441896|580594344|FG008|Overall Study|Withdrawal by Subject|0|||
160783780|NCT00441896|580594345|FG009|Overall Study|Withdrawal by Subject|0|||
160783781|NCT00441896|580594336|FG000|Overall Study|Other|0|||
160783782|NCT00441896|580594337|FG001|Overall Study|Other|0|||
160783783|NCT00441896|580594338|FG002|Overall Study|Other|0|||
160783784|NCT00441896|580594339|FG003|Overall Study|Other|0|||
160783785|NCT00441896|580594340|FG004|Overall Study|Other|1|||
160783786|NCT00441896|580594341|FG005|Overall Study|Other|0|||
160783787|NCT00441896|580594342|FG006|Overall Study|Other|0|||
160783788|NCT00441896|580594343|FG007|Overall Study|Other|0|||
160783789|NCT00441896|580594344|FG008|Overall Study|Other|0|||
160783790|NCT00441896|580594345|FG009|Overall Study|Other|0|||
160783791|NCT01301092|580594346|FG000|Overall Study|Lost to Follow-up|0|||
160783792|NCT01301092|580594347|FG001|Overall Study|Lost to Follow-up|0|||
160783793|NCT01301092|580594348|FG002|Overall Study|Lost to Follow-up|1|||
160783794|NCT03334175|580594349|FG000|Overall Study|Lost to Follow-up|0|||
160783795|NCT03334175|580594350|FG001|Overall Study|Lost to Follow-up|1|||
160783796|NCT01350973|580594351|FG000|Overall Study|Adverse Event|4|||
160783797|NCT01350973|580594352|FG001|Overall Study|Adverse Event|7|||
160783798|NCT01350973|580594353|FG002|Overall Study|Adverse Event|7|||
160783799|NCT01350973|580594351|FG000|Overall Study|Voluntary Withdrawal|2|||
160783800|NCT01350973|580594352|FG001|Overall Study|Voluntary Withdrawal|1|||
160783801|NCT01350973|580594353|FG002|Overall Study|Voluntary Withdrawal|1|||
160783802|NCT02724644|580596249|FG000|Overall Study|Adverse Event|7|||
160783803|NCT02724644|580596250|FG001|Overall Study|Adverse Event|1|||
160783804|NCT02724644|580596249|FG000|Overall Study|Lost to Follow-up|6|||
160783805|NCT02724644|580596250|FG001|Overall Study|Lost to Follow-up|2|||
160783806|NCT02724644|580596249|FG000|Overall Study|Withdrawal by Subject|7|||
160783807|NCT02724644|580596250|FG001|Overall Study|Withdrawal by Subject|1|||
160783808|NCT02724644|580596249|FG000|Overall Study|Administrative|1|||
160783809|NCT02724644|580596250|FG001|Overall Study|Administrative|0|||
160783810|NCT01882829|580596251|FG000|Overall Study|Adverse Event|4|||
160783811|NCT01882829|580596251|FG000|Overall Study|Protocol Violation|1|||
160783812|NCT01882829|580596251|FG000|Overall Study|Withdrawal by Subject|1|||
160783813|NCT03312114|580596252|FG000|Overall Study|All the five enrolled dropped out of the|5|||
160783814|NCT00520572|580596256|FG000|Overall Study|Adverse Event|9|||
160783815|NCT00520572|580596257|FG001|Overall Study|Adverse Event|3|||
160783816|NCT00520572|580596258|FG002|Overall Study|Adverse Event|6|||
160783817|NCT00520572|580596259|FG003|Overall Study|Adverse Event|9|||
160783818|NCT00520572|580596260|FG004|Overall Study|Adverse Event|7|||
160783819|NCT00520572|580596261|FG005|Overall Study|Adverse Event|2|||
160783820|NCT00520572|580596256|FG000|Overall Study|Withdrawal by Subject|0|||
160783821|NCT00520572|580596257|FG001|Overall Study|Withdrawal by Subject|9|||
160783822|NCT00520572|580596258|FG002|Overall Study|Withdrawal by Subject|5|||
160783823|NCT00520572|580596259|FG003|Overall Study|Withdrawal by Subject|2|||
160783824|NCT00520572|580596260|FG004|Overall Study|Withdrawal by Subject|2|||
160783825|NCT00520572|580596261|FG005|Overall Study|Withdrawal by Subject|0|||
160783826|NCT00520572|580596256|FG000|Overall Study|Protocol Violation|0|||
160783827|NCT00520572|580596257|FG001|Overall Study|Protocol Violation|0|||
160783828|NCT00520572|580596258|FG002|Overall Study|Protocol Violation|1|||
160783829|NCT00520572|580596259|FG003|Overall Study|Protocol Violation|0|||
160783830|NCT00520572|580596260|FG004|Overall Study|Protocol Violation|0|||
160783831|NCT00520572|580596261|FG005|Overall Study|Protocol Violation|0|||
160783832|NCT00520572|580596256|FG000|Overall Study|Lack of Efficacy|1|||
160783833|NCT00520572|580596257|FG001|Overall Study|Lack of Efficacy|1|||
160783834|NCT00520572|580596258|FG002|Overall Study|Lack of Efficacy|1|||
160783835|NCT00520572|580596259|FG003|Overall Study|Lack of Efficacy|2|||
160783836|NCT00520572|580596260|FG004|Overall Study|Lack of Efficacy|1|||
160783837|NCT00520572|580596261|FG005|Overall Study|Lack of Efficacy|0|||
160783838|NCT00520572|580596256|FG000|Overall Study|Lost to Follow-up|0|||
160783839|NCT00520572|580596257|FG001|Overall Study|Lost to Follow-up|0|||
160783840|NCT00520572|580596258|FG002|Overall Study|Lost to Follow-up|0|||
160783841|NCT00520572|580596259|FG003|Overall Study|Lost to Follow-up|0|||
160783842|NCT00520572|580596260|FG004|Overall Study|Lost to Follow-up|1|||
160783843|NCT00520572|580596261|FG005|Overall Study|Lost to Follow-up|0|||
160783844|NCT00520572|580596256|FG000|Overall Study|Incorrect enrollment|1|||
161125153|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
161125154|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
161125155|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
161125156|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
161125157|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
161125158|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
160783845|NCT00520572|580596257|FG001|Overall Study|Incorrect enrollment|0|||
160783846|NCT00520572|580596258|FG002|Overall Study|Incorrect enrollment|1|||
160783847|NCT00520572|580596259|FG003|Overall Study|Incorrect enrollment|0|||
161125159|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
160783848|NCT00520572|580596260|FG004|Overall Study|Incorrect enrollment|1|||
160890087|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
160783849|NCT00520572|580596261|FG005|Overall Study|Incorrect enrollment|0|||
160783850|NCT00520572|580596256|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783851|NCT00520572|580596257|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
160783852|NCT00520572|580596258|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783853|NCT00520572|580596259|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783854|NCT00520572|580596260|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
161125160|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
161125161|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
161125162|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
161327695|NCT00048035|582587020|FG000|Core Period|Early Withdrawals|4|||
161327696|NCT00048035|582587021|FG001|Core Period|Early Withdrawals|2|||
161327697|NCT00048035|582587022|FG002|Core Period|Early Withdrawals|1|||
161327698|NCT00048035|582587023|FG003|Core Period|Early Withdrawals|1|||
161327699|NCT00048035|582587024|FG004|Core Period|Early Withdrawals|1|||
161327700|NCT00048035|582587025|FG005|Core Period|Early Withdrawals|1|||
161327701|NCT00048035|582587026|FG006|Core Period|Early Withdrawals|0|||
161327702|NCT00048035|582587027|FG007|Core Period|Early Withdrawals|0|||
161327703|NCT00048035|582587020|FG000|Extension Year 1|Early Withdrawals|0|||
161327704|NCT00048035|582587021|FG001|Extension Year 1|Early Withdrawals|0|||
161327705|NCT00048035|582587022|FG002|Extension Year 1|Early Withdrawals|0|||
161327706|NCT00048035|582587023|FG003|Extension Year 1|Early Withdrawals|0|||
161327707|NCT00048035|582587024|FG004|Extension Year 1|Early Withdrawals|0|||
161327708|NCT00048035|582587025|FG005|Extension Year 1|Early Withdrawals|0|||
161327709|NCT00048035|582587026|FG006|Extension Year 1|Early Withdrawals|11|||
161327710|NCT00048035|582587027|FG007|Extension Year 1|Early Withdrawals|11|||
161327711|NCT00048035|582587020|FG000|Extension Year 2|Early Withdrawals|0|||
161327712|NCT00048035|582587021|FG001|Extension Year 2|Early Withdrawals|0|||
161327713|NCT00048035|582587022|FG002|Extension Year 2|Early Withdrawals|0|||
161327714|NCT00048035|582587023|FG003|Extension Year 2|Early Withdrawals|0|||
161327715|NCT00048035|582587024|FG004|Extension Year 2|Early Withdrawals|0|||
161327716|NCT00048035|582587025|FG005|Extension Year 2|Early Withdrawals|0|||
161327717|NCT00048035|582587026|FG006|Extension Year 2|Early Withdrawals|3|||
161327718|NCT00048035|582587027|FG007|Extension Year 2|Early Withdrawals|3|||
161327719|NCT05137717|582587028|FG000|Overall Study|Death|2|||
161327720|NCT05137717|582587028|FG000|Overall Study|Withdrawal by Subject|6|||
161327721|NCT02619617|582587029|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
161327722|NCT02619617|582587030|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
161327723|NCT02619617|582587029|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
161327724|NCT02619617|582587030|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
161327725|NCT00509899|582587031|FG000|Overall Study|Progressive disease|1|||
161327726|NCT00509899|582587032|FG001|Overall Study|Progressive disease|3|||
161327727|NCT00509899|582587033|FG002|Overall Study|Progressive disease|5|||
161327728|NCT00509899|582587034|FG003|Overall Study|Progressive disease|1|||
161327729|NCT00509899|582587035|FG004|Overall Study|Progressive disease|0|||
161327730|NCT00509899|582587036|FG005|Overall Study|Progressive disease|1|||
161327731|NCT00509899|582587037|FG006|Overall Study|Progressive disease|0|||
161327732|NCT00509899|582587038|FG007|Overall Study|Progressive disease|0|||
161327733|NCT00509899|582587031|FG000|Overall Study|Unacceptable Toxicity|1|||
161327734|NCT00509899|582587032|FG001|Overall Study|Unacceptable Toxicity|0|||
161327735|NCT00509899|582587033|FG002|Overall Study|Unacceptable Toxicity|0|||
161327736|NCT00509899|582587034|FG003|Overall Study|Unacceptable Toxicity|2|||
161327737|NCT00509899|582587035|FG004|Overall Study|Unacceptable Toxicity|0|||
161327738|NCT00509899|582587036|FG005|Overall Study|Unacceptable Toxicity|0|||
161327739|NCT00509899|582587037|FG006|Overall Study|Unacceptable Toxicity|0|||
161327740|NCT00509899|582587038|FG007|Overall Study|Unacceptable Toxicity|0|||
161327741|NCT00509899|582587031|FG000|Overall Study|Withdrawal by Subject|6|||
161327742|NCT00509899|582587032|FG001|Overall Study|Withdrawal by Subject|2|||
161327743|NCT00509899|582587033|FG002|Overall Study|Withdrawal by Subject|3|||
161327744|NCT00509899|582587034|FG003|Overall Study|Withdrawal by Subject|0|||
161327745|NCT00509899|582587035|FG004|Overall Study|Withdrawal by Subject|3|||
161327746|NCT00509899|582587036|FG005|Overall Study|Withdrawal by Subject|2|||
161327747|NCT00509899|582587037|FG006|Overall Study|Withdrawal by Subject|0|||
161327748|NCT00509899|582587038|FG007|Overall Study|Withdrawal by Subject|0|||
161327749|NCT00509899|582587031|FG000|Overall Study|Physician Decision|4|||
161327750|NCT00509899|582587032|FG001|Overall Study|Physician Decision|2|||
161327751|NCT00509899|582587033|FG002|Overall Study|Physician Decision|7|||
161327752|NCT00509899|582587034|FG003|Overall Study|Physician Decision|0|||
161327753|NCT00509899|582587035|FG004|Overall Study|Physician Decision|1|||
161327754|NCT00509899|582587036|FG005|Overall Study|Physician Decision|4|||
161327755|NCT00509899|582587037|FG006|Overall Study|Physician Decision|0|||
161327756|NCT00509899|582587038|FG007|Overall Study|Physician Decision|0|||
161327757|NCT00509899|582587031|FG000|Overall Study|Intercurrent Illness|1|||
161327758|NCT00509899|582587032|FG001|Overall Study|Intercurrent Illness|0|||
161327759|NCT00509899|582587033|FG002|Overall Study|Intercurrent Illness|0|||
161327760|NCT00509899|582587034|FG003|Overall Study|Intercurrent Illness|1|||
161327761|NCT00509899|582587035|FG004|Overall Study|Intercurrent Illness|0|||
161327762|NCT00509899|582587036|FG005|Overall Study|Intercurrent Illness|1|||
161327763|NCT00509899|582587037|FG006|Overall Study|Intercurrent Illness|0|||
161327764|NCT00509899|582587038|FG007|Overall Study|Intercurrent Illness|0|||
161327765|NCT00509899|582587031|FG000|Overall Study|Death|2|||
161327766|NCT00509899|582587032|FG001|Overall Study|Death|2|||
161327767|NCT00509899|582587033|FG002|Overall Study|Death|3|||
161327768|NCT00509899|582587034|FG003|Overall Study|Death|0|||
160890088|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
160890089|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
160890090|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
160890091|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
160890092|NCT00591578|580991618|FG000|Double-Blind Treatment Phase|Other|4|||
160890093|NCT00591578|580991619|FG001|Double-Blind Treatment Phase|Other|9|||
160890094|NCT00591578|580991620|FG002|Double-Blind Treatment Phase|Other|4|||
160890095|NCT00591578|580991618|FG000|Open-Label Extension Phase|Adverse Event|3|||
160890096|NCT00591578|580991619|FG001|Open-Label Extension Phase|Adverse Event|5|||
160890097|NCT00591578|580991620|FG002|Open-Label Extension Phase|Adverse Event|0|||
160890098|NCT00591578|580991618|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
160890099|NCT00591578|580991619|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
160890100|NCT00591578|580991620|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160890101|NCT00591578|580991618|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
160890102|NCT00591578|580991619|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
160890103|NCT00591578|580991620|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
160890104|NCT00591578|580991618|FG000|Open-Label Extension Phase|Other|1|||
160981692|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
160981693|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
160981694|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
160981695|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
160981696|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
160981697|NCT01646320|581321737|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
160981698|NCT01646320|581321738|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
160981699|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
160981700|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
160981701|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
161327769|NCT00509899|582587035|FG004|Overall Study|Death|1|||
161327770|NCT00509899|582587036|FG005|Overall Study|Death|1|||
161327771|NCT00509899|582587037|FG006|Overall Study|Death|1|||
161327772|NCT00509899|582587038|FG007|Overall Study|Death|1|||
161327773|NCT00509899|582587031|FG000|Overall Study|Lack of Efficacy|1|||
161327774|NCT00509899|582587032|FG001|Overall Study|Lack of Efficacy|0|||
161327775|NCT00509899|582587033|FG002|Overall Study|Lack of Efficacy|2|||
161327776|NCT00509899|582587034|FG003|Overall Study|Lack of Efficacy|0|||
161327777|NCT00509899|582587035|FG004|Overall Study|Lack of Efficacy|0|||
161327778|NCT00509899|582587036|FG005|Overall Study|Lack of Efficacy|1|||
161327779|NCT00509899|582587037|FG006|Overall Study|Lack of Efficacy|0|||
161327780|NCT00509899|582587038|FG007|Overall Study|Lack of Efficacy|0|||
161327781|NCT01254656|582587039|FG000|Overall Study|Discontinued due to termination of study|40|||
161327782|NCT01254656|582587040|FG001|Overall Study|Discontinued due to termination of study|39|||
161327783|NCT01254656|582587041|FG002|Overall Study|Discontinued due to termination of study|13|||
161327784|NCT01254656|582587039|FG000|Overall Study|Lack of Efficacy|3|||
160890105|NCT00591578|580991619|FG001|Open-Label Extension Phase|Other|0|||
160890106|NCT00591578|580991620|FG002|Open-Label Extension Phase|Other|0|||
160890107|NCT02810340|580991621|FG000|Overall Study|Withdrawal by Subject|1|||
160890108|NCT02810340|580991622|FG001|Overall Study|Withdrawal by Subject|0|||
160890109|NCT02810340|580991623|FG002|Overall Study|Withdrawal by Subject|0|||
160890110|NCT02810340|580991621|FG000|Overall Study|Incarceration|0|||
160890111|NCT02810340|580991622|FG001|Overall Study|Incarceration|1|||
160890112|NCT02810340|580991623|FG002|Overall Study|Incarceration|0|||
160890113|NCT02810340|580991621|FG000|Overall Study|Lost to Follow-up|0|||
160890114|NCT02810340|580991622|FG001|Overall Study|Lost to Follow-up|0|||
160981702|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
160981703|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
160981704|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
160981705|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
160981706|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
160981707|NCT01646320|581321737|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
160981708|NCT01646320|581321738|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
160981709|NCT02892409|581321739|FG000|Overall Study|Adverse Event|1|||
160981710|NCT02892409|581321740|FG001|Overall Study|Adverse Event|0|||
160981711|NCT02892409|581321739|FG000|Overall Study|Withdrawal by Subject|2|||
160981712|NCT02892409|581321740|FG001|Overall Study|Withdrawal by Subject|1|||
160981713|NCT02406261|581321741|FG000|Period 1|Lost to Follow-up|2|||
160981714|NCT02406261|581321742|FG001|Period 1|Lost to Follow-up|0|||
160981715|NCT02406261|581321741|FG000|Period 1|Adverse Event|1|||
160981716|NCT02406261|581321742|FG001|Period 1|Adverse Event|0|||
160981717|NCT02406261|581321741|FG000|Period 2|Physician Decision|0|||
160981718|NCT02406261|581321742|FG001|Period 2|Physician Decision|1|||
160981719|NCT02406261|581321741|FG000|Period 2|Protocol Violation|0|||
161327785|NCT01254656|582587040|FG001|Overall Study|Lack of Efficacy|0|||
161327786|NCT01254656|582587041|FG002|Overall Study|Lack of Efficacy|0|||
160890115|NCT02810340|580991623|FG002|Overall Study|Lost to Follow-up|1|||
161327787|NCT01254656|582587039|FG000|Overall Study|Lost to Follow-up|1|||
161327788|NCT01254656|582587040|FG001|Overall Study|Lost to Follow-up|0|||
161327789|NCT01254656|582587041|FG002|Overall Study|Lost to Follow-up|2|||
161327790|NCT01254656|582587039|FG000|Overall Study|Withdrawal by Subject|2|||
160783855|NCT00520572|580596261|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
160783856|NCT00520572|580596256|FG000|Overall Study|Long break in taking Medication|0|||
160783857|NCT00520572|580596257|FG001|Overall Study|Long break in taking Medication|0|||
160783858|NCT00520572|580596258|FG002|Overall Study|Long break in taking Medication|0|||
160783859|NCT00520572|580596259|FG003|Overall Study|Long break in taking Medication|1|||
160783860|NCT00520572|580596260|FG004|Overall Study|Long break in taking Medication|0|||
160783861|NCT00520572|580596261|FG005|Overall Study|Long break in taking Medication|0|||
160783862|NCT00520572|580596256|FG000|Overall Study|Did not receive Treatment|1|||
160783863|NCT00520572|580596257|FG001|Overall Study|Did not receive Treatment|0|||
160783864|NCT00520572|580596258|FG002|Overall Study|Did not receive Treatment|1|||
160783865|NCT00520572|580596259|FG003|Overall Study|Did not receive Treatment|0|||
160783866|NCT00520572|580596260|FG004|Overall Study|Did not receive Treatment|0|||
160783867|NCT00520572|580596261|FG005|Overall Study|Did not receive Treatment|0|||
160783868|NCT03548415|580596264|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
160783869|NCT03548415|580596265|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
160783870|NCT03548415|580596266|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
160783871|NCT03548415|580596267|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
160783872|NCT03548415|580596268|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
160783873|NCT04605588|580596269|FG000|Overall Study|Withdrawal by Subject|1|||
160783874|NCT04605588|580596270|FG001|Overall Study|Withdrawal by Subject|0|||
160783875|NCT01230814|580596271|FG000|Overall Study|Lost to Follow-up|11|||
160783876|NCT01230814|580596272|FG001|Overall Study|Lost to Follow-up|3|||
160783877|NCT01230814|580596271|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
160783878|NCT01230814|580596272|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
160783879|NCT01803737|580596273|FG000|Overall Study|Lack of Time|1|||
160783880|NCT01803737|580596274|FG001|Overall Study|Lack of Time|0|||
160783881|NCT01803737|580596273|FG000|Overall Study|Medical Reason|0|||
160783882|NCT01803737|580596274|FG001|Overall Study|Medical Reason|1|||
160783883|NCT01803737|580596273|FG000|Overall Study|Lost to Follow-up|0|||
160783884|NCT01803737|580596274|FG001|Overall Study|Lost to Follow-up|2|||
160783885|NCT01386645|580596277|FG000|Overall Study|Physician Decision|0|||
160783886|NCT01386645|580596278|FG001|Overall Study|Physician Decision|0|||
160783887|NCT01386645|580596279|FG002|Overall Study|Physician Decision|1|||
160783888|NCT01386645|580596277|FG000|Overall Study|Withdrawal by Subject|0|||
160783889|NCT01386645|580596278|FG001|Overall Study|Withdrawal by Subject|1|||
160783890|NCT01386645|580596279|FG002|Overall Study|Withdrawal by Subject|1|||
160783891|NCT00676052|580596281|FG000|Overall Study|Adverse Event|0|||
160783892|NCT00676052|580596282|FG001|Overall Study|Adverse Event|1|||
160783893|NCT00676052|580596283|FG002|Overall Study|Adverse Event|1|||
160783894|NCT00676052|580596284|FG003|Overall Study|Adverse Event|2|||
160783895|NCT00676052|580596285|FG004|Overall Study|Adverse Event|2|||
160783896|NCT00676052|580596286|FG005|Overall Study|Adverse Event|2|||
160783897|NCT00676052|580596281|FG000|Overall Study|Lack of Efficacy|2|||
160783898|NCT00676052|580596282|FG001|Overall Study|Lack of Efficacy|2|||
160783899|NCT00676052|580596283|FG002|Overall Study|Lack of Efficacy|1|||
160783900|NCT00676052|580596284|FG003|Overall Study|Lack of Efficacy|1|||
160783901|NCT00676052|580596285|FG004|Overall Study|Lack of Efficacy|2|||
160783902|NCT00676052|580596286|FG005|Overall Study|Lack of Efficacy|1|||
160783903|NCT00676052|580596281|FG000|Overall Study|Protocol Violation|5|||
160783904|NCT00676052|580596282|FG001|Overall Study|Protocol Violation|3|||
160783905|NCT00676052|580596283|FG002|Overall Study|Protocol Violation|2|||
160783906|NCT00676052|580596284|FG003|Overall Study|Protocol Violation|2|||
160783907|NCT00676052|580596285|FG004|Overall Study|Protocol Violation|1|||
160783908|NCT00676052|580596286|FG005|Overall Study|Protocol Violation|2|||
160783909|NCT00676052|580596281|FG000|Overall Study|Lost to Follow-up|0|||
160783910|NCT00676052|580596282|FG001|Overall Study|Lost to Follow-up|0|||
160783911|NCT00676052|580596283|FG002|Overall Study|Lost to Follow-up|0|||
160783912|NCT00676052|580596284|FG003|Overall Study|Lost to Follow-up|0|||
160783913|NCT00676052|580596285|FG004|Overall Study|Lost to Follow-up|1|||
160783914|NCT00676052|580596286|FG005|Overall Study|Lost to Follow-up|0|||
160783915|NCT00676052|580596281|FG000|Overall Study|Physician Decision|1|||
160783916|NCT00676052|580596282|FG001|Overall Study|Physician Decision|1|||
161327791|NCT01254656|582587040|FG001|Overall Study|Withdrawal by Subject|2|||
161327792|NCT01254656|582587041|FG002|Overall Study|Withdrawal by Subject|1|||
161327793|NCT01254656|582587039|FG000|Overall Study|Pregnancy|0|||
160783917|NCT00676052|580596283|FG002|Overall Study|Physician Decision|1|||
160783918|NCT00676052|580596284|FG003|Overall Study|Physician Decision|0|||
160783919|NCT00676052|580596285|FG004|Overall Study|Physician Decision|0|||
160783920|NCT00676052|580596286|FG005|Overall Study|Physician Decision|1|||
160783921|NCT00676052|580596281|FG000|Overall Study|Withdrawal by Subject|1|||
160783922|NCT00676052|580596282|FG001|Overall Study|Withdrawal by Subject|0|||
160783923|NCT00676052|580596283|FG002|Overall Study|Withdrawal by Subject|1|||
160783924|NCT00676052|580596284|FG003|Overall Study|Withdrawal by Subject|0|||
160783925|NCT00676052|580596285|FG004|Overall Study|Withdrawal by Subject|0|||
160783926|NCT00676052|580596286|FG005|Overall Study|Withdrawal by Subject|0|||
160783927|NCT02930941|580596287|FG000|Overall Study|Lost to Follow-up|1|||
161125163|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
161125164|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
161125165|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
161125166|NCT04660643|581845332|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
161125167|NCT04660643|581845333|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
161125168|NCT04660643|581845334|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
161125169|NCT05162066|581845338|FG000|Overall Study|Adverse Event|1|||
161125170|NCT05162066|581845339|FG001|Overall Study|Adverse Event|0|||
161125171|NCT05162066|581845340|FG002|Overall Study|Adverse Event|0|||
161125172|NCT05162066|581845338|FG000|Overall Study|Perceived lack of efficacy|1|||
161125173|NCT05162066|581845339|FG001|Overall Study|Perceived lack of efficacy|0|||
161125174|NCT05162066|581845340|FG002|Overall Study|Perceived lack of efficacy|0|||
161125175|NCT01220414|581845341|FG000|Overall Study|Withdrawal by Subject|1|||
161125176|NCT01220414|581845342|FG001|Overall Study|Withdrawal by Subject|0|||
161125177|NCT01220414|581845343|FG002|Overall Study|Withdrawal by Subject|0|||
161125178|NCT01220414|581845344|FG003|Overall Study|Withdrawal by Subject|1|||
161125179|NCT00669617|581845347|FG000|Period 1|Withdrawal by Subject|0|||
161125180|NCT00669617|581845348|FG001|Period 1|Withdrawal by Subject|0|||
161125181|NCT00669617|581845349|FG002|Period 1|Withdrawal by Subject|1|||
161125182|NCT00669617|581845350|FG003|Period 1|Withdrawal by Subject|0|||
161125183|NCT00669617|581845351|FG004|Period 1|Withdrawal by Subject|0|||
161125184|NCT00669617|581845347|FG000|Period 1|Protocol Deviation|0|||
161125185|NCT00669617|581845348|FG001|Period 1|Protocol Deviation|0|||
161125186|NCT00669617|581845349|FG002|Period 1|Protocol Deviation|0|||
161125187|NCT00669617|581845350|FG003|Period 1|Protocol Deviation|0|||
161125188|NCT00669617|581845351|FG004|Period 1|Protocol Deviation|1|||
161125189|NCT00669617|581845347|FG000|Period 3|Lost to Follow-up|1|||
161125190|NCT00669617|581845348|FG001|Period 3|Lost to Follow-up|0|||
161125191|NCT00669617|581845349|FG002|Period 3|Lost to Follow-up|0|||
161125192|NCT00669617|581845350|FG003|Period 3|Lost to Follow-up|0|||
161125193|NCT00669617|581845351|FG004|Period 3|Lost to Follow-up|0|||
161125194|NCT00623831|581845352|FG000|Overall Study|Withdrawal by Subject|1|||
161125195|NCT00623831|581845353|FG001|Overall Study|Withdrawal by Subject|0|||
161125196|NCT00623831|581845352|FG000|Overall Study|Progressive Disease|0|||
161125197|NCT00623831|581845353|FG001|Overall Study|Progressive Disease|1|||
161125198|NCT01276821|581845354|FG000|Overall Study|Protocol Violation|0|||
161125199|NCT01276821|581845355|FG001|Overall Study|Protocol Violation|1|||
161125200|NCT01748071|581845356|FG000|Overall Study|Adverse Event|2|||
161125201|NCT01748071|581845357|FG001|Overall Study|Adverse Event|2|||
161125202|NCT01748071|581845358|FG002|Overall Study|Adverse Event|0|||
161125203|NCT03068325|581845359|FG000|Overall Study|Lost to Follow-up|5|||
161125204|NCT00066690|581845362|FG000|Overall Study|Adverse Event|145|||
161125205|NCT00066690|581845363|FG001|Overall Study|Adverse Event|58|||
161125206|NCT00066690|581845364|FG002|Overall Study|Adverse Event|126|||
161125207|NCT00066690|581845362|FG000|Overall Study|Death|3|||
161125208|NCT00066690|581845363|FG001|Overall Study|Death|0|||
161125209|NCT00066690|581845364|FG002|Overall Study|Death|2|||
161125210|NCT00066690|581845362|FG000|Overall Study|Lack of Efficacy|114|||
161125211|NCT00066690|581845363|FG001|Overall Study|Lack of Efficacy|110|||
161125212|NCT00066690|581845364|FG002|Overall Study|Lack of Efficacy|76|||
161125213|NCT00066690|581845362|FG000|Overall Study|Lost to Follow-up|40|||
161125214|NCT00066690|581845363|FG001|Overall Study|Lost to Follow-up|21|||
161125215|NCT00066690|581845364|FG002|Overall Study|Lost to Follow-up|29|||
161125216|NCT00066690|581845362|FG000|Overall Study|Withdrawal by Subject|50|||
161125217|NCT00066690|581845363|FG001|Overall Study|Withdrawal by Subject|55|||
161125218|NCT00066690|581845364|FG002|Overall Study|Withdrawal by Subject|49|||
161125219|NCT00066690|581845362|FG000|Overall Study|Treatment Ongoing|246|||
161125220|NCT00066690|581845363|FG001|Overall Study|Treatment Ongoing|278|||
161125221|NCT00066690|581845364|FG002|Overall Study|Treatment Ongoing|282|||
161125222|NCT00223496|581845365|FG000|Overall Study|screen failure|9|||
161125223|NCT00223496|581845365|FG000|Overall Study|Lost to Follow-up|4|||
161125224|NCT00223496|581845365|FG000|Overall Study|Lack of Efficacy|6|||
161125225|NCT00223496|581845365|FG000|Overall Study|Withdrawal by Subject|1|||
161125226|NCT00223496|581845365|FG000|Overall Study|Physician Decision|2|||
161125227|NCT02939131|581845368|FG000|Overall Study|Unable to get to clinic|6|||
161125228|NCT02939131|581845369|FG001|Overall Study|Unable to get to clinic|4|||
161125229|NCT02939131|581845368|FG000|Overall Study|Lost to Follow-up|2|||
161125230|NCT02939131|581845369|FG001|Overall Study|Lost to Follow-up|4|||
161125231|NCT02939131|581845368|FG000|Overall Study|severe debilitation|1|||
161125232|NCT02939131|581845369|FG001|Overall Study|severe debilitation|0|||
161125233|NCT02939131|581845368|FG000|Overall Study|Other|0|||
161125234|NCT02939131|581845369|FG001|Overall Study|Other|1|||
161125235|NCT02939131|581845368|FG000|Overall Study|not willing to adhere to protocol|2|||
160783928|NCT02930941|580596288|FG001|Overall Study|Lost to Follow-up|2|||
160981720|NCT02406261|581321742|FG001|Period 2|Protocol Violation|1|||
160981721|NCT02406261|581321741|FG000|Period 2|Withdrawal by Subject|0|||
160981722|NCT02406261|581321742|FG001|Period 2|Withdrawal by Subject|1|||
160981723|NCT01567163|581321746|FG000|Overall Study|Progressive Disease|2|||
160981724|NCT01567163|581321746|FG000|Overall Study|Lost to Follow-up|2|||
160981725|NCT01720797|581321747|FG000|Overall Study|Withdrawal by Subject|3|||
160981726|NCT01720797|581321748|FG001|Overall Study|Withdrawal by Subject|0|||
160981727|NCT00393094|581321751|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
160981728|NCT00393094|581321751|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
160981729|NCT01448044|581321752|FG000|Treatment Period|Adverse Event|4|||
160981730|NCT01448044|581321753|FG001|Treatment Period|Adverse Event|3|||
160981731|NCT01448044|581321752|FG000|Treatment Period|Lack of Efficacy|5|||
160981732|NCT01448044|581321753|FG001|Treatment Period|Lack of Efficacy|12|||
161327794|NCT01254656|582587040|FG001|Overall Study|Pregnancy|0|||
161327795|NCT01254656|582587041|FG002|Overall Study|Pregnancy|2|||
161327796|NCT01254656|582587039|FG000|Overall Study|Adverse Event|1|||
161327797|NCT01254656|582587040|FG001|Overall Study|Adverse Event|1|||
161327798|NCT01254656|582587041|FG002|Overall Study|Adverse Event|0|||
161327799|NCT01254656|582587039|FG000|Overall Study|Death|0|||
161327800|NCT01254656|582587040|FG001|Overall Study|Death|1|||
161327801|NCT01254656|582587041|FG002|Overall Study|Death|0|||
161327802|NCT02948829|582587044|FG000|Overall Study|Lost to Follow-up|2|||
161327803|NCT02948829|582587044|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
161327804|NCT02948829|582587044|FG000|Overall Study|Pregnancy|1|||
161327805|NCT02948829|582587044|FG000|Overall Study|Other: Reason not Specified|8|||
161327806|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327807|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
161327808|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161327809|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327810|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327811|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327812|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327813|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327814|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327815|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327816|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327817|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327818|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327819|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327820|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161327821|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161327822|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
161327823|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327824|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327825|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327826|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327827|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327828|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327829|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327830|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327831|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327832|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327833|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327834|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327835|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161327836|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
161327837|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
161327838|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161327839|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327840|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327841|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327842|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327843|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327844|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327845|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327846|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327847|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327848|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327849|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
160981733|NCT01448044|581321752|FG000|Treatment Period|Subject requested discontinue study drug|1|||
160783929|NCT00289978|580596289|FG000|Overall Study|Withdrawal by Subject|31|||
160783930|NCT00289978|580596290|FG001|Overall Study|Withdrawal by Subject|17|||
160783931|NCT00289978|580596291|FG002|Overall Study|Withdrawal by Subject|28|||
160783932|NCT00289978|580596289|FG000|Overall Study|Adverse Event|22|||
160783933|NCT00289978|580596290|FG001|Overall Study|Adverse Event|13|||
160783934|NCT00289978|580596291|FG002|Overall Study|Adverse Event|18|||
160783935|NCT00289978|580596289|FG000|Overall Study|Lack of Efficacy|13|||
160783936|NCT00289978|580596290|FG001|Overall Study|Lack of Efficacy|6|||
160783937|NCT00289978|580596291|FG002|Overall Study|Lack of Efficacy|25|||
160783938|NCT00289978|580596289|FG000|Overall Study|Abnormal laboratory value(s)|20|||
160783939|NCT00289978|580596290|FG001|Overall Study|Abnormal laboratory value(s)|9|||
160783940|NCT00289978|580596291|FG002|Overall Study|Abnormal laboratory value(s)|1|||
160783941|NCT00289978|580596289|FG000|Overall Study|Lost to Follow-up|3|||
160783942|NCT00289978|580596290|FG001|Overall Study|Lost to Follow-up|5|||
160783943|NCT00289978|580596291|FG002|Overall Study|Lost to Follow-up|7|||
160783944|NCT00289978|580596289|FG000|Overall Study|Protocol Violation|5|||
160783945|NCT00289978|580596290|FG001|Overall Study|Protocol Violation|5|||
160783946|NCT00289978|580596291|FG002|Overall Study|Protocol Violation|4|||
160783947|NCT00289978|580596289|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160783948|NCT00289978|580596290|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160783949|NCT00289978|580596291|FG002|Overall Study|Abnormal test procedure result(s)|1|||
160783950|NCT00289978|580596289|FG000|Overall Study|Death|1|||
160783951|NCT00289978|580596290|FG001|Overall Study|Death|0|||
160783952|NCT00289978|580596291|FG002|Overall Study|Death|2|||
160783953|NCT00903344|580596292|FG000|Overall Study|Pregnancy|2|||
160783954|NCT00903344|580596293|FG001|Overall Study|Pregnancy|3|||
160783955|NCT00903344|580596292|FG000|Overall Study|Lost to Follow-up|3|||
160783956|NCT00903344|580596293|FG001|Overall Study|Lost to Follow-up|0|||
160783957|NCT00527748|580596306|FG000|Overall Study|Other|3|||
160783958|NCT03055221|580596307|FG000|Overall Study|Adverse Event|2|||
160783959|NCT03055221|580596307|FG000|Overall Study|Withdrawal by Subject|4|||
160783960|NCT03055221|580596307|FG000|Overall Study|Death|6|||
160783961|NCT03055221|580596307|FG000|Overall Study|Physician Decision|1|||
160783962|NCT03055221|580596307|FG000|Overall Study|Study terminated by Sponsor|3|||
160783963|NCT03055221|580596307|FG000|Overall Study|Lost to Follow-up|4|||
160783964|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
160783965|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
160783966|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
160783967|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
160783968|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
160783969|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
160783970|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
160783971|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
160783972|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
160783973|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
160783974|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
160783975|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
160783976|NCT01243424|580596308|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
160783977|NCT01243424|580596309|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
160783978|NCT01243424|580596308|FG000|Discontinuation From Treatment|Not treated|5|||
160783979|NCT01243424|580596309|FG001|Discontinuation From Treatment|Not treated|4|||
160783980|NCT01243424|580596308|FG000|Discontinuation From Treatment|Adverse Event|457|||
160783981|NCT01243424|580596309|FG001|Discontinuation From Treatment|Adverse Event|523|||
160783982|NCT01243424|580596308|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
160783983|NCT01243424|580596309|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
160783984|NCT01243424|580596308|FG000|Discontinuation From Treatment|Protocol Violation|46|||
160783985|NCT01243424|580596309|FG001|Discontinuation From Treatment|Protocol Violation|47|||
161327850|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161327851|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327852|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160783986|NCT01243424|580596308|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
160783987|NCT01243424|580596309|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
161125236|NCT02939131|581845369|FG001|Overall Study|not willing to adhere to protocol|0|||
161125237|NCT03569202|581845373|FG000|Part 3|Physician Decision|1|||
161125238|NCT03569202|581845374|FG001|Part 3|Physician Decision|0|||
161125239|NCT03569202|581845373|FG000|Part 3|Other|1|||
161125240|NCT03569202|581845374|FG001|Part 3|Other|1|||
161125241|NCT00420511|581845375|FG000|Overall Study|Adverse Event|1|||
160783988|NCT01243424|580596308|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
160783989|NCT01243424|580596309|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
160783990|NCT01243424|580596308|FG000|Discontinuation From Treatment|Other than listed above|230|||
160783991|NCT01243424|580596309|FG001|Discontinuation From Treatment|Other than listed above|211|||
160783992|NCT04621786|580596312|FG000|Overall Study|Lost to Follow-up|9|||
160783993|NCT04621786|580596312|FG000|Overall Study|Protocol Violation|3|||
160783994|NCT00710554|580596313|FG000|Overall Study|Adverse Event|24|||
160783995|NCT00710554|580596314|FG001|Overall Study|Adverse Event|7|||
160783996|NCT00710554|580596313|FG000|Overall Study|Withdrawal by Subject|7|||
160783997|NCT00710554|580596314|FG001|Overall Study|Withdrawal by Subject|3|||
160783998|NCT00710554|580596313|FG000|Overall Study|Lost to Follow-up|7|||
160783999|NCT00710554|580596314|FG001|Overall Study|Lost to Follow-up|1|||
160784000|NCT00710554|580596313|FG000|Overall Study|Lack of Efficacy|11|||
160784001|NCT00710554|580596314|FG001|Overall Study|Lack of Efficacy|12|||
160784002|NCT00710554|580596313|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
160784003|NCT00710554|580596314|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
160784004|NCT01346709|580596315|FG000|Overall Study|Protocol Violation|35|||
160784005|NCT01346709|580596315|FG000|Overall Study|Lost to Follow-up|31|||
160784006|NCT01346709|580596315|FG000|Overall Study|Missing data in candidate risk factor|285|||
160784007|NCT01160744|580596319|FG000|Overall Study|Withdrawal by Subject|11|||
160784008|NCT01160744|580596320|FG001|Overall Study|Withdrawal by Subject|5|||
160784009|NCT01160744|580596321|FG002|Overall Study|Withdrawal by Subject|6|||
160784010|NCT01160744|580596322|FG003|Overall Study|Withdrawal by Subject|4|||
160784011|NCT01160744|580596319|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
160784012|NCT01160744|580596320|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
160784013|NCT01160744|580596321|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
160784014|NCT01160744|580596322|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
160981734|NCT01448044|581321753|FG001|Treatment Period|Subject requested discontinue study drug|0|||
160981735|NCT01448044|581321752|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
160981736|NCT01448044|581321753|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
160981737|NCT01448044|581321752|FG000|Treatment Period|Participant does not meet study criteria|1|||
160981738|NCT01448044|581321753|FG001|Treatment Period|Participant does not meet study criteria|0|||
160981739|NCT01448044|581321752|FG000|Treatment Period|Lost to Follow-up|2|||
160784015|NCT02365064|580596324|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
160784016|NCT02365064|580596325|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
160784017|NCT02365064|580596324|FG000|Overall Study|Withdrawal by Subject|6|||
160784018|NCT02365064|580596325|FG001|Overall Study|Withdrawal by Subject|9|||
160784019|NCT02365064|580596324|FG000|Overall Study|Treatment intolerance|2|||
160784020|NCT02365064|580596325|FG001|Overall Study|Treatment intolerance|4|||
160784021|NCT01502072|580596332|FG000|Overall Study|Withdrawal by Subject|1|||
160784022|NCT01502072|580596333|FG001|Overall Study|Withdrawal by Subject|0|||
160784023|NCT01502072|580596334|FG002|Overall Study|Withdrawal by Subject|0|||
160784024|NCT01502072|580596332|FG000|Overall Study|Death|0|||
160784025|NCT01502072|580596333|FG001|Overall Study|Death|1|||
160784026|NCT01502072|580596334|FG002|Overall Study|Death|0|||
160784027|NCT04821245|580596335|FG000|Overall Study|Withdrawal by Subject|3|||
160784028|NCT04821245|580596335|FG000|Overall Study|Physician Decision|1|||
160784029|NCT04821245|580596335|FG000|Overall Study|Protocol Violation|5|||
160784030|NCT02773537|580596343|FG000|Overall Study|Lost to Follow-up|0|||
160784031|NCT02773537|580596344|FG001|Overall Study|Lost to Follow-up|1|||
160784032|NCT02773537|580596345|FG002|Overall Study|Lost to Follow-up|4|||
160784033|NCT01840163|580596346|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
160784034|NCT01840163|580596347|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
160784035|NCT01840163|580596346|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
160784036|NCT01840163|580596347|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
160784037|NCT01840163|580596346|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
160784038|NCT01840163|580596347|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
160981740|NCT01448044|581321753|FG001|Treatment Period|Lost to Follow-up|1|||
160981741|NCT01448044|581321752|FG000|Treatment Period|Other reason|2|||
160981742|NCT01448044|581321753|FG001|Treatment Period|Other reason|0|||
160784039|NCT00662038|580596348|FG000|Overall Study|Reason not specified|3|||
160784040|NCT00662038|580596348|FG000|Overall Study|Withdrawn consent|22|||
160784041|NCT00662038|580596348|FG000|Overall Study|Withdrawal by Subject|83|||
160981743|NCT01448044|581321752|FG000|Follow Up Period|Withdrawal by Subject|1|||
160981744|NCT01448044|581321753|FG001|Follow Up Period|Withdrawal by Subject|1|||
161125242|NCT00420511|581845376|FG001|Overall Study|Adverse Event|1|||
161327853|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
161327854|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327855|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327856|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
160784042|NCT00662038|580596348|FG000|Overall Study|Sponsor decision|1|||
160784043|NCT00662038|580596348|FG000|Overall Study|Physician Decision|19|||
160784044|NCT00662038|580596348|FG000|Overall Study|Lung transplantation|44|||
160784045|NCT00662038|580596348|FG000|Overall Study|Lost to Follow-up|1|||
160784046|NCT00662038|580596348|FG000|Overall Study|Death|95|||
160981745|NCT01448044|581321752|FG000|Follow Up Period|Lost to Follow-up|6|||
160981746|NCT01448044|581321753|FG001|Follow Up Period|Lost to Follow-up|2|||
160981747|NCT01448044|581321752|FG000|Follow Up Period|Other|5|||
160981748|NCT01448044|581321753|FG001|Follow Up Period|Other|11|||
160981749|NCT02372058|581321756|FG000|Overall Study|Withdrawal by Subject|3|||
160981750|NCT00318149|581321757|FG000|Overall Study|Adverse Event|0|||
160981751|NCT00318149|581321758|FG001|Overall Study|Adverse Event|0|||
160981752|NCT00318149|581321759|FG002|Overall Study|Adverse Event|0|||
160981753|NCT00318149|581321760|FG003|Overall Study|Adverse Event|0|||
161230357|NCT05017480|582225740|FG001|Stage 2 Study|Withdrawal by Subject|0|||
161230358|NCT05017480|582225741|FG002|Stage 2 Study|Withdrawal by Subject|6|||
161230359|NCT05017480|582225742|FG003|Stage 2 Study|Withdrawal by Subject|9|||
161230360|NCT05017480|582225743|FG004|Stage 2 Study|Withdrawal by Subject|11|||
161230361|NCT05017480|582225739|FG000|Stage 2 Study|Lost to Follow-up|0|||
161230362|NCT05017480|582225740|FG001|Stage 2 Study|Lost to Follow-up|0|||
161230363|NCT05017480|582225741|FG002|Stage 2 Study|Lost to Follow-up|0|||
161230364|NCT05017480|582225742|FG003|Stage 2 Study|Lost to Follow-up|2|||
161230365|NCT05017480|582225743|FG004|Stage 2 Study|Lost to Follow-up|1|||
161230366|NCT05017480|582225739|FG000|Stage 2 Study|Adverse Event|0|||
161230367|NCT05017480|582225740|FG001|Stage 2 Study|Adverse Event|0|||
161230368|NCT05017480|582225741|FG002|Stage 2 Study|Adverse Event|0|||
161230369|NCT05017480|582225742|FG003|Stage 2 Study|Adverse Event|1|||
161230370|NCT05017480|582225743|FG004|Stage 2 Study|Adverse Event|0|||
161230371|NCT05017480|582225739|FG000|Stage 2 Study|COVID-19|0|||
161230372|NCT05017480|582225740|FG001|Stage 2 Study|COVID-19|0|||
161230373|NCT05017480|582225741|FG002|Stage 2 Study|COVID-19|0|||
161230374|NCT05017480|582225742|FG003|Stage 2 Study|COVID-19|1|||
161230375|NCT05017480|582225743|FG004|Stage 2 Study|COVID-19|0|||
161230376|NCT05017480|582225739|FG000|Stage 2 Study|Pregnancy|0|||
161230377|NCT05017480|582225740|FG001|Stage 2 Study|Pregnancy|0|||
161230378|NCT05017480|582225741|FG002|Stage 2 Study|Pregnancy|0|||
161230379|NCT05017480|582225742|FG003|Stage 2 Study|Pregnancy|0|||
161230380|NCT05017480|582225743|FG004|Stage 2 Study|Pregnancy|1|||
161230381|NCT02311361|582225744|FG000|Overall Study|Did not receive treatment|0|||
161230382|NCT02311361|582225745|FG001|Overall Study|Did not receive treatment|1|||
161230383|NCT02311361|582225746|FG002|Overall Study|Did not receive treatment|0|||
161230384|NCT02311361|582225747|FG003|Overall Study|Did not receive treatment|1|||
161230385|NCT02028715|582225754|FG000|Overall Study|Adverse Event|2|||
161230386|NCT02028715|582225755|FG001|Overall Study|Adverse Event|2|||
161230387|NCT02028715|582225754|FG000|Overall Study|Physician Decision|1|||
161230388|NCT02028715|582225755|FG001|Overall Study|Physician Decision|0|||
161230389|NCT02028715|582225754|FG000|Overall Study|Did not complete satisfaction surveys|2|||
161230390|NCT02028715|582225755|FG001|Overall Study|Did not complete satisfaction surveys|2|||
161230391|NCT01492361|582225756|FG000|Overall Study|Withdrawal by Subject|281|||
161230392|NCT01492361|582225757|FG001|Overall Study|Withdrawal by Subject|297|||
161230393|NCT01492361|582225756|FG000|Overall Study|Physician Decision|12|||
161230394|NCT01492361|582225757|FG001|Overall Study|Physician Decision|12|||
161230395|NCT01492361|582225756|FG000|Overall Study|Lost to Follow-up|6|||
161230396|NCT01492361|582225757|FG001|Overall Study|Lost to Follow-up|13|||
161230397|NCT01492361|582225756|FG000|Overall Study|Other than specified above|106|||
161230398|NCT01492361|582225757|FG001|Overall Study|Other than specified above|138|||
161230399|NCT01315249|582225763|FG000|Overall Study|Adverse Event|22|||
161230400|NCT01315249|582225764|FG001|Overall Study|Adverse Event|26|||
161230401|NCT01315249|582225763|FG000|Overall Study|Withdrawal by Subject|11|||
161230402|NCT01315249|582225764|FG001|Overall Study|Withdrawal by Subject|10|||
161230403|NCT01315249|582225763|FG000|Overall Study|Protocol Violation|8|||
161230404|NCT01315249|582225764|FG001|Overall Study|Protocol Violation|5|||
161230405|NCT01315249|582225763|FG000|Overall Study|Abnormal test results|1|||
161230406|NCT01315249|582225764|FG001|Overall Study|Abnormal test results|2|||
161230407|NCT01315249|582225763|FG000|Overall Study|Administrative problems|1|||
161230408|NCT01315249|582225764|FG001|Overall Study|Administrative problems|0|||
161230409|NCT01315249|582225763|FG000|Overall Study|inability to use device|1|||
161230410|NCT01315249|582225764|FG001|Overall Study|inability to use device|0|||
161230411|NCT01315249|582225763|FG000|Overall Study|Lack of Efficacy|0|||
161230412|NCT01315249|582225764|FG001|Overall Study|Lack of Efficacy|1|||
161230413|NCT01315249|582225763|FG000|Overall Study|Lost to Follow-up|0|||
161230414|NCT01315249|582225764|FG001|Overall Study|Lost to Follow-up|2|||
161230415|NCT01315249|582225763|FG000|Overall Study|Death|0|||
161230416|NCT01315249|582225764|FG001|Overall Study|Death|1|||
161230417|NCT03655106|582225765|FG000|Overall Study|Withdrawal by Subject|3|||
161230418|NCT03655106|582225766|FG001|Overall Study|Withdrawal by Subject|2|||
161230419|NCT03655106|582225765|FG000|Overall Study|Lost to Follow-up|2|||
161230420|NCT03655106|582225766|FG001|Overall Study|Lost to Follow-up|1|||
161230421|NCT03655106|582225765|FG000|Overall Study|Duplicate Enrollment|1|||
161230422|NCT03655106|582225766|FG001|Overall Study|Duplicate Enrollment|1|||
161230423|NCT03655106|582225765|FG000|Overall Study|Protocol Violation|3|||
161230424|NCT03655106|582225766|FG001|Overall Study|Protocol Violation|0|||
161230425|NCT03227445|582225767|FG000|Period 1 (28 Days)|Adverse Event|1|||
161230426|NCT03227445|582225768|FG001|Period 1 (28 Days)|Adverse Event|2|||
161230427|NCT03227445|582225769|FG002|Period 1 (28 Days)|Adverse Event|0|||
161230428|NCT03227445|582225770|FG003|Period 1 (28 Days)|Adverse Event|1|||
161125243|NCT00420511|581845375|FG000|Overall Study|Lost to Follow-up|1|||
161125244|NCT00420511|581845376|FG001|Overall Study|Lost to Follow-up|0|||
161125245|NCT04428411|581845379|FG000|Overall Study|Lost to Follow-up|114|||
161125246|NCT00634569|581845380|FG000|Overall Study|Withdrawal by Subject|0|||
161125247|NCT00634569|581845381|FG001|Overall Study|Withdrawal by Subject|4|||
161125248|NCT00634569|581845380|FG000|Overall Study|Physician Decision|0|||
161125249|NCT00634569|581845381|FG001|Overall Study|Physician Decision|1|||
161125250|NCT02918019|581845382|FG000|Overall Study|Death|0|||
161125251|NCT02918019|581845383|FG001|Overall Study|Death|0|||
161125252|NCT02918019|581845384|FG002|Overall Study|Death|1|||
161125253|NCT02918019|581845385|FG003|Overall Study|Death|0|||
161125254|NCT02918019|581845382|FG000|Overall Study|Lost to Follow-up|1|||
161125255|NCT02918019|581845383|FG001|Overall Study|Lost to Follow-up|1|||
161125256|NCT02918019|581845384|FG002|Overall Study|Lost to Follow-up|0|||
161125257|NCT02918019|581845385|FG003|Overall Study|Lost to Follow-up|1|||
161125258|NCT02918019|581845382|FG000|Overall Study|Principal investigator request|0|||
161125259|NCT02918019|581845383|FG001|Overall Study|Principal investigator request|0|||
161125260|NCT02918019|581845384|FG002|Overall Study|Principal investigator request|0|||
161125261|NCT02918019|581845385|FG003|Overall Study|Principal investigator request|1|||
161125262|NCT02918019|581845382|FG000|Overall Study|Physician Decision|1|||
161125263|NCT02918019|581845383|FG001|Overall Study|Physician Decision|3|||
161125264|NCT02918019|581845384|FG002|Overall Study|Physician Decision|2|||
161125265|NCT02918019|581845385|FG003|Overall Study|Physician Decision|0|||
161125266|NCT02918019|581845382|FG000|Overall Study|Protocol deviation|1|||
161125267|NCT02918019|581845383|FG001|Overall Study|Protocol deviation|1|||
161125268|NCT02918019|581845384|FG002|Overall Study|Protocol deviation|0|||
161125269|NCT02918019|581845385|FG003|Overall Study|Protocol deviation|2|||
161327857|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327858|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327859|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327860|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327861|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327862|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327863|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327864|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327865|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
161327866|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327867|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327868|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
161327869|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327870|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327871|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327872|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327873|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327874|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327875|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327876|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327877|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327878|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327879|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327880|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
161327881|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327882|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327883|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
161327884|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327885|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327886|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327887|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327888|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327889|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327890|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327891|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
160784047|NCT00662038|580596348|FG000|Overall Study|Adverse Event|358|||
160784048|NCT00662038|580596348|FG000|Overall Study|Continued treatment|5|||
160784049|NCT00397046|580596349|FG000|Overall Study|Disease Progression|3|||
161125270|NCT02918019|581845382|FG000|Overall Study|Withdrawal by Subject|3|||
161125271|NCT02918019|581845383|FG001|Overall Study|Withdrawal by Subject|4|||
161125272|NCT02918019|581845384|FG002|Overall Study|Withdrawal by Subject|6|||
160784050|NCT00397046|580596350|FG001|Overall Study|Disease Progression|3|||
160784051|NCT00397046|580596351|FG002|Overall Study|Disease Progression|10|||
160784052|NCT00397046|580596352|FG003|Overall Study|Disease Progression|5|||
160784053|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
160784054|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
160784055|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
160784056|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
160784057|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
160784058|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
160784059|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
160784060|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784061|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784062|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
160784063|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
160784064|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
160784065|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Other|6|||
160784066|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Other|3|||
160784067|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Other|0|||
160784068|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
160784069|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160784070|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
160784071|NCT03636269|580596354|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
160784072|NCT03636269|580596355|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
160784073|NCT03636269|580596356|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
160784074|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Adverse Event|0|||
160784075|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Adverse Event|0|||
160784076|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Adverse Event|21|||
160784077|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
160784078|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
160784079|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
160784080|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784081|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
160784082|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
160784083|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
160784084|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
160784085|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
160784086|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Administrative|0|||
160784087|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Administrative|0|||
160784088|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Administrative|36|||
160784089|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Other|0|||
160784090|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Other|0|||
160784091|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Other|9|||
160784092|NCT03636269|580596354|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
160784093|NCT03636269|580596355|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
160784094|NCT03636269|580596356|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
160784095|NCT01975285|580596374|FG000|Overall Study|Failed Block and follow up|2|||
160784096|NCT01975285|580596375|FG001|Overall Study|Failed Block and follow up|2|||
160784097|NCT02421510|580596376|FG000|Overall Study|Other|4|||
160784098|NCT02421510|580596377|FG001|Overall Study|Other|2|||
160784099|NCT02421510|580596378|FG002|Overall Study|Other|3|||
160784100|NCT02421510|580596376|FG000|Overall Study|Protocol Violation|1|||
160784101|NCT02421510|580596377|FG001|Overall Study|Protocol Violation|2|||
160784102|NCT02421510|580596378|FG002|Overall Study|Protocol Violation|0|||
160784103|NCT02421510|580596376|FG000|Overall Study|Death|1|||
160784104|NCT02421510|580596377|FG001|Overall Study|Death|0|||
160784105|NCT02421510|580596378|FG002|Overall Study|Death|0|||
160784106|NCT02421510|580596376|FG000|Overall Study|Noncompliance with study drug|1|||
160784107|NCT02421510|580596377|FG001|Overall Study|Noncompliance with study drug|0|||
160784108|NCT02421510|580596378|FG002|Overall Study|Noncompliance with study drug|0|||
160784109|NCT02421510|580596376|FG000|Overall Study|Physician Decision|1|||
160890116|NCT01307020|580991626|FG000|Overall Study|Lost to Follow-up|0|||
160890117|NCT01307020|580991627|FG001|Overall Study|Lost to Follow-up|0|||
160890118|NCT01307020|580991628|FG002|Overall Study|Lost to Follow-up|1|||
160890119|NCT01307020|580991629|FG003|Overall Study|Lost to Follow-up|1|||
160784110|NCT02421510|580596377|FG001|Overall Study|Physician Decision|1|||
160784111|NCT02421510|580596378|FG002|Overall Study|Physician Decision|3|||
160784112|NCT02421510|580596376|FG000|Overall Study|Adverse Event|9|||
160784113|NCT02421510|580596377|FG001|Overall Study|Adverse Event|10|||
160784114|NCT02421510|580596378|FG002|Overall Study|Adverse Event|18|||
160784115|NCT02421510|580596376|FG000|Overall Study|Pregnancy|1|||
160784116|NCT02421510|580596377|FG001|Overall Study|Pregnancy|1|||
160784117|NCT02421510|580596378|FG002|Overall Study|Pregnancy|0|||
160784118|NCT02421510|580596376|FG000|Overall Study|Withdrawal by Subject|14|||
160890120|NCT01307020|580991630|FG004|Overall Study|Lost to Follow-up|0|||
160784119|NCT02421510|580596377|FG001|Overall Study|Withdrawal by Subject|18|||
160784120|NCT02421510|580596378|FG002|Overall Study|Withdrawal by Subject|12|||
160784121|NCT02421510|580596376|FG000|Overall Study|Lost to Follow-up|1|||
160784122|NCT02421510|580596377|FG001|Overall Study|Lost to Follow-up|1|||
160784123|NCT02421510|580596378|FG002|Overall Study|Lost to Follow-up|0|||
160784124|NCT02852434|580596379|FG000|Overall Study|Withdrawal by Subject|0|||
160784125|NCT02852434|580596380|FG001|Overall Study|Withdrawal by Subject|1|||
160784126|NCT02852434|580596379|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
160784127|NCT02852434|580596380|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
160784128|NCT03774810|580596383|FG000|Phase 1|Lack of Efficacy|21|||
160784129|NCT03774810|580596384|FG001|Phase 1|Lack of Efficacy|0|||
160784130|NCT03774810|580596385|FG002|Phase 1|Lack of Efficacy|0|||
160784131|NCT03774810|580596386|FG003|Phase 1|Lack of Efficacy|0|||
160784132|NCT03774810|580596387|FG004|Phase 1|Lack of Efficacy|0|||
160784133|NCT03774810|580596383|FG000|Phase 1|Withdrawal by Subject|9|||
160784134|NCT03774810|580596384|FG001|Phase 1|Withdrawal by Subject|0|||
160784135|NCT03774810|580596385|FG002|Phase 1|Withdrawal by Subject|0|||
160784136|NCT03774810|580596386|FG003|Phase 1|Withdrawal by Subject|0|||
160784137|NCT03774810|580596387|FG004|Phase 1|Withdrawal by Subject|0|||
160784138|NCT03774810|580596383|FG000|Phase 1|Lost to Follow-up|2|||
160784139|NCT03774810|580596384|FG001|Phase 1|Lost to Follow-up|0|||
160784140|NCT03774810|580596385|FG002|Phase 1|Lost to Follow-up|0|||
160784141|NCT03774810|580596386|FG003|Phase 1|Lost to Follow-up|0|||
160784142|NCT03774810|580596387|FG004|Phase 1|Lost to Follow-up|0|||
160784143|NCT03774810|580596383|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
160784144|NCT03774810|580596384|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
160784145|NCT03774810|580596385|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
160784146|NCT03774810|580596386|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
160784147|NCT03774810|580596387|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
160784148|NCT03774810|580596383|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
160784149|NCT03774810|580596384|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
160784150|NCT03774810|580596385|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
160784151|NCT03774810|580596386|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
160784152|NCT03774810|580596387|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
160784153|NCT03774810|580596383|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784154|NCT03774810|580596384|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
160784155|NCT03774810|580596385|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784156|NCT03774810|580596386|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784157|NCT03774810|580596387|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
160784158|NCT03774810|580596383|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
160784159|NCT03774810|580596384|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
160784160|NCT03774810|580596385|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
160784161|NCT03774810|580596386|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
160784162|NCT03774810|580596387|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
160784163|NCT03774810|580596383|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
160784164|NCT03774810|580596384|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
160890121|NCT01307020|580991631|FG005|Overall Study|Lost to Follow-up|0|||
160890122|NCT01307020|580991632|FG006|Overall Study|Lost to Follow-up|1|||
160890123|NCT01307020|580991633|FG007|Overall Study|Lost to Follow-up|0|||
160890124|NCT01307020|580991634|FG008|Overall Study|Lost to Follow-up|0|||
160890125|NCT01307020|580991635|FG009|Overall Study|Lost to Follow-up|0|||
160890126|NCT01307020|580991626|FG000|Overall Study|Electronic data capture failure|0|||
160890127|NCT01307020|580991627|FG001|Overall Study|Electronic data capture failure|1|||
160890128|NCT01307020|580991628|FG002|Overall Study|Electronic data capture failure|0|||
160890129|NCT01307020|580991629|FG003|Overall Study|Electronic data capture failure|0|||
160890130|NCT01307020|580991630|FG004|Overall Study|Electronic data capture failure|0|||
160890131|NCT01307020|580991631|FG005|Overall Study|Electronic data capture failure|0|||
160890132|NCT01307020|580991632|FG006|Overall Study|Electronic data capture failure|0|||
160890133|NCT01307020|580991633|FG007|Overall Study|Electronic data capture failure|0|||
160890134|NCT01307020|580991634|FG008|Overall Study|Electronic data capture failure|0|||
160890135|NCT01307020|580991635|FG009|Overall Study|Electronic data capture failure|0|||
160890136|NCT00523367|580991636|FG000|Overall Study|19 screen failures|19|||
160890137|NCT00523367|580991636|FG000|Overall Study|4 Withdrawn by PI|4|||
160890138|NCT02793128|580991637|FG000|Overall Study|Death|4|||
160890139|NCT02793128|580991637|FG000|Overall Study|Withdrawal by Subject|2|||
160890140|NCT02793128|580991637|FG000|Overall Study|Physician Decision|1|||
160890141|NCT02793128|580991637|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
160890142|NCT02793128|580991637|FG000|Overall Study|Patient elected nephroureterectomy|1|||
160890143|NCT02125604|580991638|FG000|Overall Study|Other|4|||
160890144|NCT02125604|580991638|FG000|Overall Study|Investigator Decision|1|||
160890145|NCT02125604|580991638|FG000|Overall Study|Lost to Follow-up|2|||
160890146|NCT02125604|580991638|FG000|Overall Study|Consent Withdrawn|4|||
160890147|NCT02125604|580991638|FG000|Overall Study|Adverse Event|20|||
160890148|NCT04480424|580991639|FG000|Overall Study|Withdrawal by Subject|0|||
160890149|NCT04480424|580991640|FG001|Overall Study|Withdrawal by Subject|2|||
160784165|NCT03774810|580596385|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
160784166|NCT03774810|580596386|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
160784167|NCT03774810|580596387|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
160784168|NCT03774810|580596383|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
160784169|NCT03774810|580596384|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
160784170|NCT03774810|580596385|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
160784171|NCT03774810|580596386|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
160784172|NCT03774810|580596387|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
160784173|NCT00927186|580596390|FG000|12 Months Primary Study|Adverse Event|5|||
160784174|NCT00927186|580596391|FG001|12 Months Primary Study|Adverse Event|2|||
160784175|NCT00927186|580596390|FG000|12 Months Primary Study|Lost to Follow-up|1|||
160784176|NCT00927186|580596391|FG001|12 Months Primary Study|Lost to Follow-up|0|||
160784177|NCT00927186|580596390|FG000|12 Months Primary Study|Protocol Violation|0|||
160784178|NCT00927186|580596391|FG001|12 Months Primary Study|Protocol Violation|1|||
160784179|NCT00927186|580596390|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
160784180|NCT00927186|580596391|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
160784181|NCT01145222|580596392|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
160784182|NCT01145222|580596393|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
160784183|NCT01145222|580596394|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
160784184|NCT01145222|580596395|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
160784185|NCT01145222|580596392|FG000|Overall Study|Poor bowel preparation|0|||
160784186|NCT01145222|580596393|FG001|Overall Study|Poor bowel preparation|0|||
160784187|NCT01145222|580596394|FG002|Overall Study|Poor bowel preparation|0|||
160784188|NCT01145222|580596395|FG003|Overall Study|Poor bowel preparation|1|||
160784189|NCT00604383|580596396|FG000|Overall Study|Withdrawal by Subject|33|||
160784190|NCT00604383|580596397|FG001|Overall Study|Withdrawal by Subject|31|||
161125273|NCT02918019|581845385|FG003|Overall Study|Withdrawal by Subject|4|||
160784191|NCT00604383|580596396|FG000|Overall Study|Lost to Follow-up|24|||
161125274|NCT02918019|581845382|FG000|Overall Study|Adverse Event|0|||
161327892|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327893|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327894|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327895|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
161327896|NCT02326272|582587045|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327897|NCT02326272|582587046|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327898|NCT02326272|582587047|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
161327899|NCT02326272|582587048|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327900|NCT02326272|582587049|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327901|NCT02326272|582587050|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327902|NCT02326272|582587051|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327903|NCT02326272|582587052|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327904|NCT02326272|582587053|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327905|NCT02326272|582587054|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327906|NCT02326272|582587055|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327907|NCT02326272|582587056|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327908|NCT02326272|582587057|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327909|NCT02326272|582587058|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327910|NCT02326272|582587059|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
161327911|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327912|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327913|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327914|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327915|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161327916|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
161327917|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
161327918|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
161327919|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161327920|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327921|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327922|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327923|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327924|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161125275|NCT02918019|581845383|FG001|Overall Study|Adverse Event|1|||
161327925|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161327926|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327927|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327928|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327929|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327930|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327931|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
161327932|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161327933|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327934|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161327935|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
161327936|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327937|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327938|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327939|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327940|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
161327941|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327942|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161125276|NCT02918019|581845384|FG002|Overall Study|Adverse Event|0|||
161125277|NCT02918019|581845385|FG003|Overall Study|Adverse Event|1|||
161125278|NCT01212185|581845387|FG000|Overall Study|Protocol Violation|2|||
161125279|NCT01212185|581845388|FG001|Overall Study|Protocol Violation|1|||
161125280|NCT03370770|581845389|FG000|Overall Study|Patient was followed in another hospital center|1|||
161125281|NCT03370770|581845389|FG000|Overall Study|Progressive Disease|98|||
161125282|NCT03370770|581845389|FG000|Overall Study|Adverse Event|2|||
161125283|NCT03370770|581845389|FG000|Overall Study|Death|5|||
161327943|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327944|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327945|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327946|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161327947|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327948|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161327949|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327950|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327951|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327952|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327953|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327954|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327955|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161327956|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327957|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327958|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327959|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161327960|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327961|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
161327962|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161327963|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161327964|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327965|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161327966|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327967|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327968|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327969|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327970|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161327971|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327972|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327973|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327974|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327975|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327976|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327977|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327978|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
161327979|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327980|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
160784192|NCT00604383|580596397|FG001|Overall Study|Lost to Follow-up|19|||
160784193|NCT00604383|580596396|FG000|Overall Study|Death|14|||
160784194|NCT00604383|580596397|FG001|Overall Study|Death|22|||
160784195|NCT00604383|580596396|FG000|Overall Study|Adverse Event|16|||
160784196|NCT00604383|580596397|FG001|Overall Study|Adverse Event|9|||
160784197|NCT00604383|580596396|FG000|Overall Study|Physician Decision|0|||
160784198|NCT00604383|580596397|FG001|Overall Study|Physician Decision|3|||
160784199|NCT01698008|580596398|FG000|Overall Study|Withdrawal by Subject|1|||
160784200|NCT01698008|580596399|FG001|Overall Study|Withdrawal by Subject|2|||
160784201|NCT01429623|580596403|FG000|Overall Study|Death|1|||
160784202|NCT01429623|580596404|FG001|Overall Study|Death|0|||
160784203|NCT01429623|580596403|FG000|Overall Study|Adverse Event|7|||
160784204|NCT01429623|580596404|FG001|Overall Study|Adverse Event|14|||
160784205|NCT01429623|580596403|FG000|Overall Study|Withdrawal by Subject|19|||
160784206|NCT01429623|580596404|FG001|Overall Study|Withdrawal by Subject|13|||
160784207|NCT01429623|580596403|FG000|Overall Study|Physician Decision|2|||
160784208|NCT01429623|580596404|FG001|Overall Study|Physician Decision|3|||
160784209|NCT01429623|580596403|FG000|Overall Study|Protocol Violation|3|||
160784210|NCT01429623|580596404|FG001|Overall Study|Protocol Violation|2|||
160784211|NCT01429623|580596403|FG000|Overall Study|Assorted|1|||
160784212|NCT01429623|580596404|FG001|Overall Study|Assorted|2|||
160784213|NCT01429623|580596403|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
160784214|NCT01429623|580596404|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
160784215|NCT01429623|580596403|FG000|Overall Study|No post baseline data|4|||
160784216|NCT01429623|580596404|FG001|Overall Study|No post baseline data|4|||
160784217|NCT04985682|580596415|FG000|Overall Study|Withdrawal by Subject|1|||
160784218|NCT00621322|580596416|FG000|Overall Study|Lost to Follow-up|0|||
160784219|NCT00621322|580596417|FG001|Overall Study|Lost to Follow-up|0|||
160784220|NCT00621322|580596418|FG002|Overall Study|Lost to Follow-up|0|||
160784221|NCT00621322|580596419|FG003|Overall Study|Lost to Follow-up|0|||
160784222|NCT00621322|580596420|FG004|Overall Study|Lost to Follow-up|1|||
160784223|NCT00621322|580596421|FG005|Overall Study|Lost to Follow-up|0|||
160784224|NCT00621322|580596416|FG000|Overall Study|Physician Decision|0|||
160784225|NCT00621322|580596417|FG001|Overall Study|Physician Decision|0|||
160784226|NCT00621322|580596418|FG002|Overall Study|Physician Decision|1|||
160784227|NCT00621322|580596419|FG003|Overall Study|Physician Decision|1|||
160784228|NCT00621322|580596420|FG004|Overall Study|Physician Decision|0|||
160784229|NCT00621322|580596421|FG005|Overall Study|Physician Decision|0|||
160784230|NCT00621322|580596416|FG000|Overall Study|Withdrawal by Subject|0|||
160784231|NCT00621322|580596417|FG001|Overall Study|Withdrawal by Subject|0|||
160784232|NCT00621322|580596418|FG002|Overall Study|Withdrawal by Subject|0|||
160784233|NCT00621322|580596419|FG003|Overall Study|Withdrawal by Subject|1|||
160784234|NCT00621322|580596420|FG004|Overall Study|Withdrawal by Subject|0|||
160784235|NCT00621322|580596421|FG005|Overall Study|Withdrawal by Subject|2|||
160784236|NCT00621322|580596416|FG000|Overall Study|Migrated/moved from study area|1|||
160784237|NCT00621322|580596417|FG001|Overall Study|Migrated/moved from study area|0|||
160784238|NCT00621322|580596418|FG002|Overall Study|Migrated/moved from study area|1|||
160784239|NCT00621322|580596419|FG003|Overall Study|Migrated/moved from study area|1|||
160784240|NCT00621322|580596420|FG004|Overall Study|Migrated/moved from study area|0|||
160784241|NCT00621322|580596421|FG005|Overall Study|Migrated/moved from study area|2|||
160784242|NCT00756444|580596428|FG000|Overall Study|Adverse Event|1|||
160784243|NCT00756444|580596429|FG001|Overall Study|Adverse Event|1|||
160784244|NCT00756444|580596428|FG000|Overall Study|Withdrawal by Subject|6|||
160784245|NCT00756444|580596429|FG001|Overall Study|Withdrawal by Subject|8|||
160784246|NCT00756444|580596428|FG000|Overall Study|Lost to Follow-up|0|||
160784247|NCT00756444|580596429|FG001|Overall Study|Lost to Follow-up|1|||
160784248|NCT00756444|580596428|FG000|Overall Study|Death|5|||
160784249|NCT00756444|580596429|FG001|Overall Study|Death|4|||
160784250|NCT00756444|580596428|FG000|Overall Study|Disease Progression|2|||
160784251|NCT00756444|580596429|FG001|Overall Study|Disease Progression|7|||
160784252|NCT00756444|580596428|FG000|Overall Study|Ineligibility Determined|1|||
160784253|NCT00756444|580596429|FG001|Overall Study|Ineligibility Determined|0|||
160981754|NCT00318149|581321761|FG004|Overall Study|Adverse Event|0|||
160784254|NCT00601107|580596430|FG000|Overall Study|Adverse Event|0|||
160784255|NCT00601107|580596431|FG001|Overall Study|Adverse Event|1|||
160784256|NCT00601107|580596432|FG002|Overall Study|Adverse Event|3|||
160784257|NCT00601107|580596433|FG003|Overall Study|Adverse Event|0|||
160784258|NCT00601107|580596430|FG000|Overall Study|Withdrawal by Subject|5|||
160784259|NCT00601107|580596431|FG001|Overall Study|Withdrawal by Subject|4|||
160784260|NCT00601107|580596432|FG002|Overall Study|Withdrawal by Subject|7|||
160784261|NCT00601107|580596433|FG003|Overall Study|Withdrawal by Subject|4|||
160784262|NCT00601107|580596430|FG000|Overall Study|Lost to Follow-up|3|||
160784263|NCT00601107|580596431|FG001|Overall Study|Lost to Follow-up|3|||
160784264|NCT00601107|580596432|FG002|Overall Study|Lost to Follow-up|0|||
160784265|NCT00601107|580596433|FG003|Overall Study|Lost to Follow-up|3|||
160784266|NCT00601107|580596430|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
160784267|NCT00601107|580596431|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
160784268|NCT00601107|580596432|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
160784269|NCT00601107|580596433|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
160784270|NCT00601107|580596430|FG000|Overall Study|Worsening of Psoriasis|4|||
160784271|NCT00601107|580596431|FG001|Overall Study|Worsening of Psoriasis|1|||
160784272|NCT00601107|580596432|FG002|Overall Study|Worsening of Psoriasis|1|||
160784273|NCT00601107|580596433|FG003|Overall Study|Worsening of Psoriasis|4|||
160784274|NCT00601107|580596430|FG000|Overall Study|Undefined|1|||
160784275|NCT00601107|580596431|FG001|Overall Study|Undefined|0|||
160784276|NCT00601107|580596432|FG002|Overall Study|Undefined|1|||
160784277|NCT00601107|580596433|FG003|Overall Study|Undefined|0|||
160890150|NCT04480424|580991639|FG000|Overall Study|Lost to Follow-up|3|||
160890151|NCT04480424|580991640|FG001|Overall Study|Lost to Follow-up|3|||
160890152|NCT04480424|580991639|FG000|Overall Study|Death|14|||
160890153|NCT04480424|580991640|FG001|Overall Study|Death|16|||
160890154|NCT04480424|580991639|FG000|Overall Study|Reason not Specified|5|||
160890155|NCT04480424|580991640|FG001|Overall Study|Reason not Specified|5|||
160890156|NCT00721123|580992961|FG000|Overall Study|Adverse Event|96|||
160890157|NCT00721123|580992961|FG000|Overall Study|Death|10|||
160890158|NCT00721123|580992961|FG000|Overall Study|Insufficient Therapeutic Response|21|||
160890159|NCT00721123|580992961|FG000|Overall Study|Protocol Violation|1|||
160890160|NCT00721123|580992961|FG000|Overall Study|Refused Treatment|41|||
160890161|NCT00721123|580992961|FG000|Overall Study|Failure to Return|9|||
160890162|NCT00721123|580992961|FG000|Overall Study|Withdrawal by Subject|5|||
160890163|NCT05007717|580992962|FG000|Overall Study|Death|3|||
160890164|NCT05007717|580992963|FG001|Overall Study|Death|2|||
160890165|NCT00423670|580992967|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
160890166|NCT00423670|580992968|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890167|NCT00423670|580992969|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890168|NCT00423670|580992970|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890169|NCT00423670|580992971|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890170|NCT00423670|580992972|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890171|NCT00423670|580992973|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890172|NCT00423670|580992974|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
160890173|NCT00423670|580992967|FG000|Treatment Period|Adverse Event|8|||
160890174|NCT00423670|580992968|FG001|Treatment Period|Adverse Event|12|||
160890175|NCT00423670|580992969|FG002|Treatment Period|Adverse Event|15|||
160890176|NCT00423670|580992970|FG003|Treatment Period|Adverse Event|20|||
160890177|NCT00423670|580992971|FG004|Treatment Period|Adverse Event|9|||
160890178|NCT00423670|580992972|FG005|Treatment Period|Adverse Event|4|||
160890179|NCT00423670|580992973|FG006|Treatment Period|Adverse Event|7|||
160890180|NCT00423670|580992974|FG007|Treatment Period|Adverse Event|2|||
160784278|NCT03892915|580596434|FG000|Overall Study|Lost to Follow-up|6|||
160784279|NCT03892915|580596435|FG001|Overall Study|Lost to Follow-up|12|||
160784280|NCT03892915|580596434|FG000|Overall Study|Death|0|||
160784281|NCT03892915|580596435|FG001|Overall Study|Death|2|||
160784282|NCT03892915|580596434|FG000|Overall Study|Withdrawal by Subject|1|||
160784283|NCT03892915|580596435|FG001|Overall Study|Withdrawal by Subject|1|||
160784284|NCT03892915|580596434|FG000|Overall Study|unsuccessful delivery|13|||
160784285|NCT03892915|580596435|FG001|Overall Study|unsuccessful delivery|18|||
160784286|NCT04576949|580596441|FG000|Overall Study|Adverse Event|1|||
160784287|NCT04576949|580596442|FG001|Overall Study|Adverse Event|3|||
160784288|NCT04576949|580596443|FG002|Overall Study|Adverse Event|2|||
160784289|NCT04576949|580596441|FG000|Overall Study|Withdrawal by Subject|41|||
160890181|NCT00423670|580992967|FG000|Treatment Period|Protocol-defined clinical event|0|||
160890182|NCT00423670|580992968|FG001|Treatment Period|Protocol-defined clinical event|7|||
160890183|NCT00423670|580992969|FG002|Treatment Period|Protocol-defined clinical event|4|||
160890184|NCT00423670|580992970|FG003|Treatment Period|Protocol-defined clinical event|12|||
160890185|NCT00423670|580992971|FG004|Treatment Period|Protocol-defined clinical event|5|||
160890186|NCT00423670|580992972|FG005|Treatment Period|Protocol-defined clinical event|4|||
160890187|NCT00423670|580992973|FG006|Treatment Period|Protocol-defined clinical event|16|||
160890188|NCT00423670|580992974|FG007|Treatment Period|Protocol-defined clinical event|15|||
160890189|NCT00423670|580992967|FG000|Treatment Period|Lost to Follow-up|2|||
160890190|NCT00423670|580992968|FG001|Treatment Period|Lost to Follow-up|1|||
160890191|NCT00423670|580992969|FG002|Treatment Period|Lost to Follow-up|3|||
160890192|NCT00423670|580992970|FG003|Treatment Period|Lost to Follow-up|1|||
160890193|NCT00423670|580992971|FG004|Treatment Period|Lost to Follow-up|6|||
160890194|NCT00423670|580992972|FG005|Treatment Period|Lost to Follow-up|0|||
160890195|NCT00423670|580992973|FG006|Treatment Period|Lost to Follow-up|3|||
160890196|NCT00423670|580992974|FG007|Treatment Period|Lost to Follow-up|1|||
160890197|NCT00423670|580992967|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
160890198|NCT00423670|580992968|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
160784290|NCT04576949|580596442|FG001|Overall Study|Withdrawal by Subject|26|||
160784291|NCT04576949|580596443|FG002|Overall Study|Withdrawal by Subject|18|||
160890199|NCT00423670|580992969|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
160890200|NCT00423670|580992970|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
160890201|NCT00423670|580992971|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
160784292|NCT04576949|580596441|FG000|Overall Study|Physician Decision|3|||
160784293|NCT04576949|580596442|FG001|Overall Study|Physician Decision|0|||
160784294|NCT04576949|580596443|FG002|Overall Study|Physician Decision|0|||
160784295|NCT04576949|580596441|FG000|Overall Study|Death|0|||
160784296|NCT04576949|580596442|FG001|Overall Study|Death|1|||
160784297|NCT04576949|580596443|FG002|Overall Study|Death|0|||
160784298|NCT04576949|580596441|FG000|Overall Study|Lost to Follow-up|29|||
160784299|NCT04576949|580596442|FG001|Overall Study|Lost to Follow-up|37|||
160784300|NCT04576949|580596443|FG002|Overall Study|Lost to Follow-up|24|||
160784301|NCT04576949|580596441|FG000|Overall Study|Other, Not Specified|2|||
160784302|NCT04576949|580596442|FG001|Overall Study|Other, Not Specified|3|||
160784303|NCT04576949|580596443|FG002|Overall Study|Other, Not Specified|1|||
160784304|NCT04576949|580596441|FG000|Overall Study|Other|1|||
160784305|NCT04576949|580596442|FG001|Overall Study|Other|0|||
160784306|NCT04576949|580596443|FG002|Overall Study|Other|0|||
160784307|NCT01078545|580596444|FG000|Overall Study|Lost to Follow-up|13|||
160784308|NCT01078545|580596444|FG000|Overall Study|Physician Decision|6|||
160784309|NCT01078545|580596444|FG000|Overall Study|Withdrawal by Subject|3|||
160784310|NCT01078545|580596444|FG000|Overall Study|Death|3|||
160784311|NCT01078545|580596444|FG000|Overall Study|Participant moved to another physician|1|||
160784312|NCT03501277|580596451|FG000|Intervention Period 1 (4 Days)|Other|0|||
160784313|NCT03501277|580596452|FG001|Intervention Period 1 (4 Days)|Other|0|||
160784314|NCT03501277|580596453|FG002|Intervention Period 1 (4 Days)|Other|1|||
160784315|NCT03501277|580596454|FG003|Intervention Period 1 (4 Days)|Other|0|||
160784316|NCT03501277|580596451|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
160784317|NCT03501277|580596452|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
160784318|NCT03501277|580596453|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
160784319|NCT03501277|580596454|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
160784320|NCT03501277|580596451|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
160784321|NCT03501277|580596452|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
160784322|NCT03501277|580596453|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
160784323|NCT03501277|580596454|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
160784324|NCT03501277|580596451|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
160784325|NCT03501277|580596452|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
160784326|NCT03501277|580596453|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
160784327|NCT03501277|580596454|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
160784328|NCT01489358|580596455|FG000|Overall Study|Lost to Follow-up|0|||
160784329|NCT01489358|580596456|FG001|Overall Study|Lost to Follow-up|0|||
160784330|NCT01489358|580596457|FG002|Overall Study|Lost to Follow-up|2|||
160784331|NCT01873833|580596458|FG000|Overall Study|Withdrawal by Subject|1|||
160784332|NCT01968785|580596459|FG000|Overall Study|Withdrawal by Subject|1|||
160784333|NCT01968785|580596460|FG001|Overall Study|Withdrawal by Subject|0|||
160784334|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Adverse Event|14|||
160784335|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Adverse Event|27|||
160784336|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Adverse Event|60|||
160784337|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Adverse Event|0|||
160784338|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Adverse Event|0|||
160784339|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Pregnancy|0|||
160784340|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Pregnancy|7|||
160784341|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Pregnancy|9|||
160784342|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Pregnancy|0|||
160784343|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Pregnancy|0|||
160784344|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
160784345|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
160784346|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
160784347|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
160784348|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
160784349|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
160784350|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
160784351|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
160784352|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
160784353|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
161125284|NCT03433781|581845390|FG000|Overall Study|Progression of Disease|1|||
160890202|NCT00423670|580992972|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
161125285|NCT03433781|581845391|FG001|Overall Study|Progression of Disease|0|||
161125286|NCT03433781|581845392|FG002|Overall Study|Progression of Disease|0|||
160784354|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Death|1|||
160784355|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Death|2|||
160890203|NCT00423670|580992973|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
161125287|NCT03433781|581845390|FG000|Overall Study|Physician Decision|0|||
160784356|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Death|2|||
160784357|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Death|0|||
160784358|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Death|0|||
160784359|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
160784360|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
160784361|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
160784362|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
160784363|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
160784364|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
160784365|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
160784366|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
160784367|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
160784368|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
160784369|NCT00098293|580596461|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
160784370|NCT00098293|580596462|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784371|NCT00098293|580596463|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784372|NCT00098293|580596464|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784373|NCT00098293|580596465|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
160784374|NCT00098293|580596461|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784375|NCT00098293|580596462|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784376|NCT00098293|580596463|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
160784377|NCT00098293|580596464|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784378|NCT00098293|580596465|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
160784379|NCT00098293|580596461|FG000|Open-label (OL) Phase|Adverse Event|0|||
160784380|NCT00098293|580596462|FG001|Open-label (OL) Phase|Adverse Event|3|||
160784381|NCT00098293|580596463|FG002|Open-label (OL) Phase|Adverse Event|7|||
160784382|NCT00098293|580596464|FG003|Open-label (OL) Phase|Adverse Event|6|||
160784383|NCT00098293|580596465|FG004|Open-label (OL) Phase|Adverse Event|0|||
160784384|NCT00098293|580596461|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
160784385|NCT00098293|580596462|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
160784386|NCT00098293|580596463|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
160784387|NCT00098293|580596464|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
160981755|NCT00318149|581321762|FG005|Overall Study|Adverse Event|2|||
160981756|NCT03541642|581321763|FG000|Overall Study|Withdrawal by Subject|1|||
160784388|NCT00098293|580596465|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
160784389|NCT00098293|580596461|FG000|Open-label (OL) Phase|Pregnancy|0|||
160784390|NCT00098293|580596462|FG001|Open-label (OL) Phase|Pregnancy|1|||
160784391|NCT00098293|580596463|FG002|Open-label (OL) Phase|Pregnancy|0|||
160784392|NCT00098293|580596464|FG003|Open-label (OL) Phase|Pregnancy|3|||
160784393|NCT00098293|580596465|FG004|Open-label (OL) Phase|Pregnancy|0|||
160784394|NCT00098293|580596461|FG000|Open-label (OL) Phase|Protocol Violation|0|||
160784395|NCT00098293|580596462|FG001|Open-label (OL) Phase|Protocol Violation|6|||
160784396|NCT00098293|580596463|FG002|Open-label (OL) Phase|Protocol Violation|13|||
160784397|NCT00098293|580596464|FG003|Open-label (OL) Phase|Protocol Violation|16|||
160784398|NCT00098293|580596465|FG004|Open-label (OL) Phase|Protocol Violation|0|||
160784399|NCT00098293|580596461|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
160784400|NCT00098293|580596462|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
160784401|NCT00098293|580596463|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
160784402|NCT00098293|580596464|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
160784403|NCT00098293|580596465|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
160784404|NCT00098293|580596461|FG000|Open-label (OL) Phase|Death|0|||
160784405|NCT00098293|580596462|FG001|Open-label (OL) Phase|Death|2|||
160784406|NCT00098293|580596463|FG002|Open-label (OL) Phase|Death|3|||
160784407|NCT00098293|580596464|FG003|Open-label (OL) Phase|Death|0|||
160784408|NCT00098293|580596465|FG004|Open-label (OL) Phase|Death|0|||
160784409|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Death|0|||
160784410|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Death|0|||
160784411|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Death|0|||
160981757|NCT03541642|581321764|FG001|Overall Study|Withdrawal by Subject|2|||
160981758|NCT03541642|581321763|FG000|Overall Study|Lost to Follow-up|16|||
160981759|NCT03541642|581321764|FG001|Overall Study|Lost to Follow-up|12|||
160981760|NCT03541642|581321763|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
160981761|NCT03541642|581321764|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
160784412|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Death|0|||
160784413|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Death|1|||
160784414|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784415|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784416|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784417|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
160784418|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
160784419|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
161230429|NCT03227445|582225767|FG000|Period 1 (28 Days)|Protocol Violation|1|||
160784420|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160784421|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160981762|NCT03523871|581321765|FG000|Overall Study|Death|1|||
160784422|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
160784423|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
160784424|NCT00098293|580596461|FG000|Supplemental Phase (SP)|Other|0|||
161230430|NCT03227445|582225768|FG001|Period 1 (28 Days)|Protocol Violation|0|||
160784425|NCT00098293|580596462|FG001|Supplemental Phase (SP)|Other|0|||
160784426|NCT00098293|580596463|FG002|Supplemental Phase (SP)|Other|0|||
160784427|NCT00098293|580596464|FG003|Supplemental Phase (SP)|Other|0|||
160784428|NCT00098293|580596465|FG004|Supplemental Phase (SP)|Other|22|||
160784429|NCT01569763|580598206|FG000|Overall Study|Lack of Efficacy|2|||
160784430|NCT01569763|580598207|FG001|Overall Study|Lack of Efficacy|7|||
160784431|NCT01569763|580598206|FG000|Overall Study|Adverse Event|1|||
160784432|NCT01569763|580598207|FG001|Overall Study|Adverse Event|0|||
160784433|NCT01926509|580598208|FG000|Overall Study|vital sign met discontinuation criteria|1|||
160784434|NCT01926509|580598209|FG001|Overall Study|vital sign met discontinuation criteria|0|||
160784435|NCT01926509|580598210|FG002|Overall Study|vital sign met discontinuation criteria|0|||
160784436|NCT01926509|580598211|FG003|Overall Study|vital sign met discontinuation criteria|0|||
160784437|NCT02730169|580598212|FG000|Overall Study|Protocol Violation|1|||
160784438|NCT02730169|580598213|FG001|Overall Study|Protocol Violation|0|||
160784439|NCT02730169|580598214|FG002|Overall Study|Protocol Violation|0|||
160784440|NCT02730169|580598215|FG003|Overall Study|Protocol Violation|1|||
160784441|NCT02730169|580598212|FG000|Overall Study|Adverse Event|2|||
160784442|NCT02730169|580598213|FG001|Overall Study|Adverse Event|3|||
160784443|NCT02730169|580598214|FG002|Overall Study|Adverse Event|3|||
160784444|NCT02730169|580598215|FG003|Overall Study|Adverse Event|0|||
160784445|NCT02730169|580598212|FG000|Overall Study|Adverse Event of Special Interest|0|||
160784446|NCT02730169|580598213|FG001|Overall Study|Adverse Event of Special Interest|1|||
160784447|NCT02730169|580598214|FG002|Overall Study|Adverse Event of Special Interest|2|||
160784448|NCT02730169|580598215|FG003|Overall Study|Adverse Event of Special Interest|0|||
160784449|NCT02730169|580598212|FG000|Overall Study|Withdrawal by Subject|6|||
160784450|NCT02730169|580598213|FG001|Overall Study|Withdrawal by Subject|11|||
160784451|NCT02730169|580598214|FG002|Overall Study|Withdrawal by Subject|6|||
160784452|NCT02730169|580598215|FG003|Overall Study|Withdrawal by Subject|8|||
160784453|NCT02730169|580598212|FG000|Overall Study|Lost to Follow-up|5|||
160784454|NCT02730169|580598213|FG001|Overall Study|Lost to Follow-up|6|||
160784455|NCT02730169|580598214|FG002|Overall Study|Lost to Follow-up|5|||
160784456|NCT02730169|580598215|FG003|Overall Study|Lost to Follow-up|6|||
160784457|NCT02730169|580598212|FG000|Overall Study|Other|0|||
160784458|NCT02730169|580598213|FG001|Overall Study|Other|0|||
160784459|NCT02730169|580598214|FG002|Overall Study|Other|1|||
160784460|NCT02730169|580598215|FG003|Overall Study|Other|1|||
160784461|NCT03004183|580598216|FG000|Overall Study|Adverse Event|7|||
160784462|NCT03004183|580598216|FG000|Overall Study|Lost to Follow-up|1|||
160784463|NCT03004183|580598216|FG000|Overall Study|Physician Decision|40|||
160784464|NCT03004183|580598216|FG000|Overall Study|Withdrawal by Subject|1|||
160784465|NCT03004183|580598216|FG000|Overall Study|COVID-19|1|||
160784466|NCT02698787|580598220|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
160784467|NCT02698787|580598221|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
160784468|NCT02469961|580598229|FG000|Overall Study|Physician Decision|4|||
160784469|NCT02469961|580598230|FG001|Overall Study|Physician Decision|1|||
160784470|NCT01748552|580598237|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
160784471|NCT01748552|580598238|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
160784472|NCT01748552|580598239|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
160784473|NCT01748552|580598240|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
160784474|NCT01748552|580598241|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
160784475|NCT01748552|580598242|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
161125288|NCT03433781|581845391|FG001|Overall Study|Physician Decision|1|||
161125289|NCT03433781|581845392|FG002|Overall Study|Physician Decision|0|||
161125290|NCT02400255|581845393|FG000|Overall Study|Relapse|4|||
161125291|NCT02400255|581845394|FG001|Overall Study|Relapse|1|||
161125292|NCT02400255|581845395|FG002|Overall Study|Relapse|1|||
161125293|NCT02400255|581845396|FG003|Overall Study|Relapse|2|||
161125294|NCT02400255|581845393|FG000|Overall Study|Adverse Event|6|||
161125295|NCT02400255|581845394|FG001|Overall Study|Adverse Event|3|||
160784476|NCT01748552|580598243|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
160784477|NCT01748552|580598244|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
160784478|NCT01748552|580598245|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
160784479|NCT01748552|580598246|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
160784480|NCT01748552|580598247|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
160784481|NCT01748552|580598248|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
160784482|NCT01748552|580598237|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784483|NCT01748552|580598238|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
161125296|NCT02400255|581845395|FG002|Overall Study|Adverse Event|0|||
161125297|NCT02400255|581845396|FG003|Overall Study|Adverse Event|0|||
160784484|NCT01748552|580598239|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784485|NCT01748552|580598240|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784486|NCT01748552|580598241|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784487|NCT01748552|580598242|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784488|NCT01748552|580598243|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
161125298|NCT02400255|581845393|FG000|Overall Study|Physician Decision|6|||
161327981|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327982|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327983|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327984|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327985|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
161327986|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327987|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327988|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327989|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327990|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327991|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327992|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
161327993|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327994|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327995|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327996|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327997|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327998|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161327999|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161328000|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161328001|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328002|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328003|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328004|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328005|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328006|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328007|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328008|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328009|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
161328010|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328011|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328012|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328013|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328014|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328015|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
161328016|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328017|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328018|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328019|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328020|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328021|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
161328022|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
161328023|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
161328024|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
161328025|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328026|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328027|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328028|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328029|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328030|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
161328031|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328032|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328033|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328034|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328035|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328036|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
161328037|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328038|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328039|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328040|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328041|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328042|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
160784489|NCT01748552|580598244|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
160784490|NCT01748552|580598245|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
160784491|NCT01748552|580598246|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784492|NCT01748552|580598247|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784493|NCT01748552|580598248|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
160784494|NCT03994120|580598249|FG000|Overall Study|Lost to Follow-up|3|||
160784495|NCT03994120|580598250|FG001|Overall Study|Lost to Follow-up|1|||
160784496|NCT00981175|580598251|FG000|Primary Dose Vaccination|Adverse Event|1|||
160784497|NCT00981175|580598252|FG001|Primary Dose Vaccination|Adverse Event|0|||
160784498|NCT00981175|580598251|FG000|Primary Dose Vaccination|Protocol Violation|0|||
160784499|NCT00981175|580598252|FG001|Primary Dose Vaccination|Protocol Violation|1|||
160784500|NCT00981175|580598251|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
160784501|NCT00981175|580598252|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
160784502|NCT00981175|580598251|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
160784503|NCT00981175|580598252|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
160784504|NCT03156621|580598256|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
160784505|NCT03156621|580598257|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
160784506|NCT03156621|580598256|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160784507|NCT03156621|580598257|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
160784508|NCT03016403|580598260|FG000|Baseline|Death|5|||
160784509|NCT03016403|580598261|FG001|Baseline|Death|8|||
160784510|NCT03016403|580598262|FG002|Baseline|Death|1|||
160784511|NCT03016403|580598263|FG003|Baseline|Death|0|||
160784512|NCT03016403|580598260|FG000|Baseline|Withdrawal by Subject|2|||
160784513|NCT03016403|580598261|FG001|Baseline|Withdrawal by Subject|8|||
160784514|NCT03016403|580598262|FG002|Baseline|Withdrawal by Subject|4|||
160784515|NCT03016403|580598263|FG003|Baseline|Withdrawal by Subject|10|||
160784516|NCT03016403|580598260|FG000|Baseline|Lost to Follow-up|9|||
160784517|NCT03016403|580598261|FG001|Baseline|Lost to Follow-up|11|||
160784518|NCT03016403|580598262|FG002|Baseline|Lost to Follow-up|6|||
160784519|NCT03016403|580598263|FG003|Baseline|Lost to Follow-up|24|||
160784520|NCT03016403|580598260|FG000|6-week Follow-up|Death|1|||
160784521|NCT03016403|580598261|FG001|6-week Follow-up|Death|4|||
160784522|NCT03016403|580598262|FG002|6-week Follow-up|Death|0|||
160784523|NCT03016403|580598263|FG003|6-week Follow-up|Death|0|||
160784524|NCT03016403|580598260|FG000|6-week Follow-up|Lost to Follow-up|2|||
160784525|NCT03016403|580598261|FG001|6-week Follow-up|Lost to Follow-up|7|||
160784526|NCT03016403|580598262|FG002|6-week Follow-up|Lost to Follow-up|4|||
160784527|NCT03016403|580598263|FG003|6-week Follow-up|Lost to Follow-up|8|||
160784528|NCT03016403|580598260|FG000|6-week Follow-up|Withdrawal by Subject|0|||
160784529|NCT03016403|580598261|FG001|6-week Follow-up|Withdrawal by Subject|2|||
160784530|NCT03016403|580598262|FG002|6-week Follow-up|Withdrawal by Subject|0|||
160784531|NCT03016403|580598263|FG003|6-week Follow-up|Withdrawal by Subject|1|||
160784532|NCT03016403|580598260|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
160784533|NCT03016403|580598261|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
160784534|NCT03016403|580598262|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
160784535|NCT03016403|580598263|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
160784536|NCT03016403|580598260|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
160784537|NCT03016403|580598261|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
160784538|NCT03016403|580598262|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
160784539|NCT03016403|580598263|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
160784540|NCT03016403|580598260|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
160784541|NCT03016403|580598261|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
161328043|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328044|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161328045|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
161339975|NCT00042289|582633404|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160784542|NCT03016403|580598262|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
160784543|NCT03016403|580598263|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
160784544|NCT00799864|580598264|FG000|Overall Study|Participant reached a virologic endpoint|9|||
160784545|NCT00799864|580598265|FG001|Overall Study|Participant reached a virologic endpoint|2|||
160784546|NCT00799864|580598266|FG002|Overall Study|Participant reached a virologic endpoint|2|||
160784547|NCT00799864|580598267|FG003|Overall Study|Participant reached a virologic endpoint|0|||
160784548|NCT00799864|580598268|FG004|Overall Study|Participant reached a virologic endpoint|0|||
160784549|NCT00799864|580598264|FG000|Overall Study|Other|2|||
160784550|NCT00799864|580598265|FG001|Overall Study|Other|1|||
160784551|NCT00799864|580598266|FG002|Overall Study|Other|0|||
160784552|NCT00799864|580598267|FG003|Overall Study|Other|0|||
160784553|NCT00799864|580598268|FG004|Overall Study|Other|0|||
160784554|NCT00576407|580598269|FG000|Overall Study|Death|7|||
160784555|NCT00576407|580598269|FG000|Overall Study|Physician Decision|1|||
160784556|NCT00225758|580598270|FG000|Overall Study|Adverse Event|4|||
160784557|NCT04641975|580598271|FG000|Overall Study|Protocol Violation|1|||
160784558|NCT04641975|580598272|FG001|Overall Study|Protocol Violation|2|||
160981763|NCT01083160|581321766|FG000|Overall Study|Adverse Event|1|||
160981764|NCT01951092|581321767|FG000|Overall Study|Lost to Follow-up|10|||
160981765|NCT01951092|581321767|FG000|Overall Study|Incarceration|1|||
160784559|NCT04641975|580598273|FG002|Overall Study|Protocol Violation|0|||
160784560|NCT04641975|580598274|FG003|Overall Study|Protocol Violation|0|||
160784561|NCT04641975|580598271|FG000|Overall Study|Adverse Event|0|||
160981766|NCT01951092|581321767|FG000|Overall Study|Transfer of Care|1|||
160981767|NCT01712789|581321768|FG000|Overall Study|Lack of Efficacy|2|||
160981768|NCT01712789|581321768|FG000|Overall Study|Lost to Follow-up|1|||
160981769|NCT01712789|581321768|FG000|Overall Study|Progressive Disease|504|||
160981770|NCT01712789|581321768|FG000|Overall Study|Death|57|||
160981771|NCT01712789|581321768|FG000|Overall Study|Adverse Event|52|||
160981772|NCT01712789|581321768|FG000|Overall Study|Miscellaneous|31|||
160981773|NCT01712789|581321768|FG000|Overall Study|Withdrawal by Subject|21|||
160981774|NCT01712789|581321768|FG000|Overall Study|Transition to Commercial Treatment|8|||
160981775|NCT01712789|581321768|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
160981776|NCT00219141|581321769|FG000|Overall Study|Adverse Event|4|||
160981777|NCT00219141|581321770|FG001|Overall Study|Adverse Event|10|||
160981778|NCT00219141|581321771|FG002|Overall Study|Adverse Event|5|||
160981779|NCT00219141|581321769|FG000|Overall Study|Lack of Efficacy|3|||
160981780|NCT00219141|581321770|FG001|Overall Study|Lack of Efficacy|2|||
160981781|NCT00219141|581321771|FG002|Overall Study|Lack of Efficacy|0|||
160981782|NCT00219141|581321769|FG000|Overall Study|Administrative problems|0|||
160981783|NCT00219141|581321770|FG001|Overall Study|Administrative problems|1|||
160981784|NCT00219141|581321771|FG002|Overall Study|Administrative problems|0|||
160981785|NCT00219141|581321769|FG000|Overall Study|Lost to Follow-up|2|||
160981786|NCT00219141|581321770|FG001|Overall Study|Lost to Follow-up|4|||
160981787|NCT00219141|581321771|FG002|Overall Study|Lost to Follow-up|1|||
160981788|NCT00219141|581321769|FG000|Overall Study|Protocol Violation|3|||
160981789|NCT00219141|581321770|FG001|Overall Study|Protocol Violation|1|||
160981790|NCT00219141|581321771|FG002|Overall Study|Protocol Violation|1|||
160981791|NCT00219141|581321769|FG000|Overall Study|Withdrawal by Subject|1|||
160981792|NCT00219141|581321770|FG001|Overall Study|Withdrawal by Subject|3|||
160981793|NCT00219141|581321771|FG002|Overall Study|Withdrawal by Subject|5|||
160981794|NCT00219141|581321769|FG000|Overall Study|Condition no longer requires study drug|1|||
160981795|NCT00219141|581321770|FG001|Overall Study|Condition no longer requires study drug|0|||
160981796|NCT00219141|581321771|FG002|Overall Study|Condition no longer requires study drug|0|||
160981797|NCT01994720|581321772|FG000|Overall Study|Withdrawal by Subject|46|||
160981798|NCT01994720|581321773|FG001|Overall Study|Withdrawal by Subject|56|||
160981799|NCT01991197|581321774|FG000|Overall Study|Lost to Follow-up|1|||
160981800|NCT01991197|581321775|FG001|Overall Study|Lost to Follow-up|1|||
160981801|NCT01991197|581321774|FG000|Overall Study|Physician Decision|0|||
160981802|NCT01991197|581321775|FG001|Overall Study|Physician Decision|2|||
160981803|NCT01991197|581321774|FG000|Overall Study|Withdrawal by Subject|2|||
160981804|NCT01991197|581321775|FG001|Overall Study|Withdrawal by Subject|0|||
160981805|NCT01010217|581321777|FG000|Overall Study|Lost to Follow-up|4|||
160981806|NCT01010217|581321778|FG001|Overall Study|Lost to Follow-up|5|||
160981807|NCT01010217|581321779|FG002|Overall Study|Lost to Follow-up|1|||
160981808|NCT01010217|581321780|FG003|Overall Study|Lost to Follow-up|0|||
160981809|NCT01010217|581321781|FG004|Overall Study|Lost to Follow-up|0|||
160981810|NCT01010217|581321777|FG000|Overall Study|Withdrawal by Subject|1|||
160981811|NCT01010217|581321778|FG001|Overall Study|Withdrawal by Subject|0|||
160981812|NCT01010217|581321779|FG002|Overall Study|Withdrawal by Subject|0|||
160981813|NCT01010217|581321780|FG003|Overall Study|Withdrawal by Subject|0|||
160981814|NCT01010217|581321781|FG004|Overall Study|Withdrawal by Subject|0|||
160981815|NCT01010217|581321777|FG000|Overall Study|Physician Decision|0|||
160981816|NCT01010217|581321778|FG001|Overall Study|Physician Decision|0|||
160981817|NCT01010217|581321779|FG002|Overall Study|Physician Decision|0|||
160981818|NCT01010217|581321780|FG003|Overall Study|Physician Decision|6|||
160981819|NCT01010217|581321781|FG004|Overall Study|Physician Decision|3|||
160981820|NCT02061761|581321782|FG000|Overall Study|Disease progression|2|||
160981821|NCT02061761|581321783|FG001|Overall Study|Disease progression|8|||
160981822|NCT02061761|581321784|FG002|Overall Study|Disease progression|4|||
160981823|NCT02061761|581321785|FG003|Overall Study|Disease progression|5|||
160981824|NCT02061761|581321786|FG004|Overall Study|Disease progression|9|||
160981825|NCT02061761|581321787|FG005|Overall Study|Disease progression|3|||
160981826|NCT02061761|581321788|FG006|Overall Study|Disease progression|1|||
160981827|NCT02061761|581321789|FG007|Overall Study|Disease progression|2|||
160981828|NCT02061761|581321790|FG008|Overall Study|Disease progression|28|||
160981829|NCT02061761|581321782|FG000|Overall Study|Study Drug toxicity|0|||
160981830|NCT02061761|581321783|FG001|Overall Study|Study Drug toxicity|0|||
160981831|NCT02061761|581321784|FG002|Overall Study|Study Drug toxicity|0|||
160981832|NCT02061761|581321785|FG003|Overall Study|Study Drug toxicity|0|||
160981833|NCT02061761|581321786|FG004|Overall Study|Study Drug toxicity|0|||
160784562|NCT04641975|580598272|FG001|Overall Study|Adverse Event|0|||
160981834|NCT02061761|581321787|FG005|Overall Study|Study Drug toxicity|1|||
160981835|NCT02061761|581321788|FG006|Overall Study|Study Drug toxicity|0|||
160981836|NCT02061761|581321789|FG007|Overall Study|Study Drug toxicity|2|||
160784563|NCT04641975|580598273|FG002|Overall Study|Adverse Event|1|||
160784564|NCT04641975|580598274|FG003|Overall Study|Adverse Event|1|||
160784565|NCT04641975|580598271|FG000|Overall Study|Withdrawal by Subject|1|||
160784566|NCT04641975|580598272|FG001|Overall Study|Withdrawal by Subject|0|||
160784567|NCT04641975|580598273|FG002|Overall Study|Withdrawal by Subject|0|||
160784568|NCT04641975|580598274|FG003|Overall Study|Withdrawal by Subject|0|||
160784569|NCT01259024|580598275|FG000|Overall Study|Physician Decision|1|||
160784570|NCT01657500|580598276|FG000|Overall Study|set impropperly matched|3|||
160784571|NCT01657500|580598277|FG001|Overall Study|set impropperly matched|3|||
160784572|NCT01657500|580598276|FG000|Overall Study|Lost to Follow-up|2|||
160784573|NCT01657500|580598277|FG001|Overall Study|Lost to Follow-up|2|||
160784574|NCT03528577|580598280|FG000|Sequence 1|Failed Spirometry|1|||
160784575|NCT03528577|580598280|FG000|Sequence 1|Restricted medication|1|||
160784576|NCT03528577|580598280|FG000|Sequence 2|Adverse Event|1|||
160784577|NCT03528577|580598280|FG000|Sequence 2|Withdrawal by Subject|1|||
160784578|NCT03528577|580598280|FG000|Sequence 2|Failed Spirometry|1|||
160784579|NCT03528577|580598280|FG000|Sequence 3|Failed Spirometry|1|||
160784580|NCT03528577|580598280|FG000|Sequence 4|Failed Spirometry|2|||
160784581|NCT03528577|580598280|FG000|Sequence 4|Adverse Event|1|||
160784582|NCT03835117|580598281|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
160784583|NCT03835117|580598282|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
160784584|NCT03225989|580598286|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
160784585|NCT03225989|580598287|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
160784586|NCT03225989|580598288|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
160784587|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
160784588|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
160784589|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
160784590|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
160784591|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
160784592|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
160784593|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
160784594|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
160784595|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
160784596|NCT03225989|580598286|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
160784597|NCT03225989|580598287|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
160784598|NCT03225989|580598288|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
160784599|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
160784600|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
160784601|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
160784602|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
160784603|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
160784604|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
160784605|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
160981837|NCT02061761|581321790|FG008|Overall Study|Study Drug toxicity|6|||
160981838|NCT02061761|581321782|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
160981839|NCT02061761|581321783|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
160981840|NCT02061761|581321784|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
160981841|NCT02061761|581321785|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
160981842|NCT02061761|581321786|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
160981843|NCT02061761|581321787|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
160981844|NCT02061761|581321788|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
160981845|NCT02061761|581321789|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
160981846|NCT02061761|581321790|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
160981847|NCT02061761|581321782|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160981848|NCT02061761|581321783|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160981849|NCT02061761|581321784|FG002|Overall Study|Participant request to discontinue study treatment|2|||
160981850|NCT02061761|581321785|FG003|Overall Study|Participant request to discontinue study treatment|2|||
160981851|NCT02061761|581321786|FG004|Overall Study|Participant request to discontinue study treatment|0|||
160981852|NCT02061761|581321787|FG005|Overall Study|Participant request to discontinue study treatment|1|||
160981853|NCT02061761|581321788|FG006|Overall Study|Participant request to discontinue study treatment|0|||
160784606|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
160981854|NCT02061761|581321789|FG007|Overall Study|Participant request to discontinue study treatment|0|||
160981855|NCT02061761|581321790|FG008|Overall Study|Participant request to discontinue study treatment|2|||
160784607|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
160784608|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
160981856|NCT02061761|581321782|FG000|Overall Study|Withdrawal by Subject|0|||
160784609|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
160784610|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
160784611|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
161125299|NCT02400255|581845394|FG001|Overall Study|Physician Decision|0|||
161328046|NCT02326272|582587045|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328047|NCT02326272|582587046|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328048|NCT02326272|582587047|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328049|NCT02326272|582587048|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328050|NCT02326272|582587049|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328051|NCT02326272|582587050|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328052|NCT02326272|582587051|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
161328053|NCT02326272|582587052|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328054|NCT02326272|582587053|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328055|NCT02326272|582587054|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328056|NCT02326272|582587055|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328057|NCT02326272|582587056|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328058|NCT02326272|582587057|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328059|NCT02326272|582587058|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328060|NCT02326272|582587059|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
161328061|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
161328062|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
161328063|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
161328064|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
161328065|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
161328066|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
161328067|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
161328068|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
161328069|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
161328070|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
161328071|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
161328072|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
161328073|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
161328074|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
161328075|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
161328076|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328077|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328078|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328079|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328080|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328081|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328082|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328083|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328084|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328085|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328086|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
161328087|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
161328088|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161328089|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161328090|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
161328091|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328092|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328093|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328094|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328095|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161125300|NCT02400255|581845395|FG002|Overall Study|Physician Decision|0|||
161125301|NCT02400255|581845396|FG003|Overall Study|Physician Decision|0|||
161125302|NCT02400255|581845393|FG000|Overall Study|Loss of insurance|1|||
161125303|NCT02400255|581845394|FG001|Overall Study|Loss of insurance|0|||
161125304|NCT02400255|581845395|FG002|Overall Study|Loss of insurance|0|||
161125305|NCT02400255|581845396|FG003|Overall Study|Loss of insurance|0|||
161125306|NCT03261531|581845397|FG000|Overall Study|Withdrawal by Subject|4|||
161125307|NCT01017952|581845398|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
161125308|NCT01017952|581845399|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161328096|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328097|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328098|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328099|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161125309|NCT01017952|581845400|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161230431|NCT03227445|582225769|FG002|Period 1 (28 Days)|Protocol Violation|0|||
161230432|NCT03227445|582225770|FG003|Period 1 (28 Days)|Protocol Violation|0|||
161230433|NCT03227445|582225767|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
161230434|NCT03227445|582225768|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
161230435|NCT03227445|582225769|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
161230436|NCT03227445|582225770|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
161230437|NCT03227445|582225767|FG000|Period 2 (28 Days)|Adverse Event|1|||
161230438|NCT03227445|582225768|FG001|Period 2 (28 Days)|Adverse Event|0|||
161230439|NCT03227445|582225769|FG002|Period 2 (28 Days)|Adverse Event|2|||
161230440|NCT03227445|582225770|FG003|Period 2 (28 Days)|Adverse Event|1|||
161230441|NCT03227445|582225767|FG000|Period 2 (28 Days)|Protocol Violation|0|||
161230442|NCT03227445|582225768|FG001|Period 2 (28 Days)|Protocol Violation|0|||
161230443|NCT03227445|582225769|FG002|Period 2 (28 Days)|Protocol Violation|0|||
161230444|NCT03227445|582225770|FG003|Period 2 (28 Days)|Protocol Violation|1|||
161230445|NCT03227445|582225767|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
161230446|NCT03227445|582225768|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
161230447|NCT03227445|582225769|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
161230448|NCT03227445|582225770|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
161230449|NCT01287013|582225775|FG000|Overall Study|Non-evaluable|3|||
161230450|NCT01287013|582225776|FG001|Overall Study|Non-evaluable|5|||
161230451|NCT01287013|582225777|FG002|Overall Study|Non-evaluable|21|||
161230452|NCT00051025|582225778|FG000|Overall Study|Progressive Disease|1|||
161230453|NCT00051025|582225779|FG001|Overall Study|Progressive Disease|1|||
161230454|NCT00051025|582225778|FG000|Overall Study|Adverse Event|1|||
161230455|NCT00051025|582225779|FG001|Overall Study|Adverse Event|1|||
161230456|NCT00051025|582225778|FG000|Overall Study|Withdrawal by Subject|0|||
161230457|NCT00051025|582225779|FG001|Overall Study|Withdrawal by Subject|1|||
161230458|NCT00051025|582225778|FG000|Overall Study|Death|0|||
161230459|NCT00051025|582225779|FG001|Overall Study|Death|1|||
161230460|NCT01179048|582225780|FG000|Overall Study|Withdrawn - does not allow contact|4|||
161230461|NCT01179048|582225781|FG001|Overall Study|Withdrawn - does not allow contact|8|||
161230462|NCT01179048|582225780|FG000|Overall Study|Lost to Follow-up|8|||
161230463|NCT01179048|582225781|FG001|Overall Study|Lost to Follow-up|9|||
161230464|NCT01179048|582225780|FG000|Overall Study|Alive|127|||
161230465|NCT01179048|582225781|FG001|Overall Study|Alive|142|||
161230466|NCT01900730|582225782|FG000|Overall Study|Withdrawal by Subject|1|||
161230467|NCT01900730|582225783|FG001|Overall Study|Withdrawal by Subject|0|||
161230468|NCT01900730|582225782|FG000|Overall Study|Screen Failure|1|||
161230469|NCT01900730|582225783|FG001|Overall Study|Screen Failure|0|||
161230470|NCT02109042|582225784|FG000|Overall Study|Sponsor Decision|15|||
161230471|NCT03203447|582225785|FG000|Overall Study|Withdrawal by Subject|2|||
161230472|NCT03203447|582225786|FG001|Overall Study|Withdrawal by Subject|1|||
161230473|NCT03203447|582225785|FG000|Overall Study|Lost to Follow-up|1|||
161230474|NCT03203447|582225786|FG001|Overall Study|Lost to Follow-up|10|||
161230475|NCT03203447|582225785|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
161230476|NCT03203447|582225786|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
161230477|NCT02189941|582225791|FG000|Overall Study|Non-compliance|0|||
161230478|NCT02189941|582225792|FG001|Overall Study|Non-compliance|0|||
161230479|NCT02189941|582225793|FG002|Overall Study|Non-compliance|1|||
161230480|NCT00445003|582225794|FG000|Overall Study|Death|1|||
161230481|NCT00445003|582225795|FG001|Overall Study|Death|2|||
160890204|NCT00423670|580992974|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
161230482|NCT00445003|582225796|FG002|Overall Study|Death|1|||
161230483|NCT00445003|582225794|FG000|Overall Study|Missed Visit|3|||
161230484|NCT00445003|582225795|FG001|Overall Study|Missed Visit|5|||
161230485|NCT00445003|582225796|FG002|Overall Study|Missed Visit|1|||
161230486|NCT00445003|582225794|FG000|Overall Study|Dropped|1|||
161230487|NCT00445003|582225795|FG001|Overall Study|Dropped|3|||
161230488|NCT00445003|582225796|FG002|Overall Study|Dropped|2|||
161230489|NCT00528606|582225799|FG000|Overall Study|Withdrew consent|4|||
161230490|NCT00528606|582225800|FG001|Overall Study|Withdrew consent|3|||
161230491|NCT00528606|582225799|FG000|Overall Study|Lost to Follow-up|4|||
161230492|NCT00528606|582225800|FG001|Overall Study|Lost to Follow-up|1|||
161230493|NCT00528606|582225799|FG000|Overall Study|Adverse Event|3|||
161230494|NCT00528606|582225800|FG001|Overall Study|Adverse Event|0|||
161230495|NCT00528606|582225799|FG000|Overall Study|Other|2|||
161230496|NCT00528606|582225800|FG001|Overall Study|Other|0|||
161230497|NCT01471093|582225801|FG000|Overall Study|Adverse Event|1|||
161230498|NCT01471093|582225802|FG001|Overall Study|Adverse Event|0|||
160890205|NCT00423670|580992967|FG000|Treatment Period|Investigator decision|0|||
161230499|NCT01471093|582225803|FG002|Overall Study|Adverse Event|0|||
161230500|NCT01471093|582225804|FG003|Overall Study|Adverse Event|0|||
161230501|NCT02475954|582225805|FG000|Overall Study|Withdrawal by Subject|2|||
161230502|NCT02475954|582225806|FG001|Overall Study|Withdrawal by Subject|2|||
161230503|NCT02475954|582225805|FG000|Overall Study|Lost to Follow-up|11|||
161230504|NCT02475954|582225806|FG001|Overall Study|Lost to Follow-up|9|||
161230505|NCT02475954|582225805|FG000|Overall Study|Death|1|||
161230506|NCT02475954|582225806|FG001|Overall Study|Death|1|||
161230507|NCT00880568|582225808|FG000|Overall Study|Disease progression|3|||
160784612|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
160784613|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
160784614|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
160784615|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
160784616|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
160784617|NCT03225989|580598286|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
160784618|NCT03225989|580598287|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
160784619|NCT03225989|580598288|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
160784620|NCT03093870|580598292|FG000|Overall Study|Withdrawal by Subject|2|||
160784621|NCT03093870|580598293|FG001|Overall Study|Withdrawal by Subject|6|||
160784622|NCT03093870|580598294|FG002|Overall Study|Withdrawal by Subject|5|||
160784623|NCT03093870|580598292|FG000|Overall Study|Death|1|||
160784624|NCT03093870|580598293|FG001|Overall Study|Death|35|||
160784625|NCT03093870|580598294|FG002|Overall Study|Death|35|||
160784626|NCT03093870|580598292|FG000|Overall Study|Radiographic disease progression|10|||
160784627|NCT03093870|580598293|FG001|Overall Study|Radiographic disease progression|0|||
160784628|NCT03093870|580598294|FG002|Overall Study|Radiographic disease progression|0|||
160784629|NCT03093870|580598292|FG000|Overall Study|Clinical disease progression|1|||
160784630|NCT03093870|580598293|FG001|Overall Study|Clinical disease progression|0|||
160784631|NCT03093870|580598294|FG002|Overall Study|Clinical disease progression|0|||
160784632|NCT03093870|580598292|FG000|Overall Study|Physician Decision|2|||
160784633|NCT03093870|580598293|FG001|Overall Study|Physician Decision|0|||
160784634|NCT03093870|580598294|FG002|Overall Study|Physician Decision|0|||
160784635|NCT03093870|580598292|FG000|Overall Study|Adverse Event|7|||
160784636|NCT03093870|580598293|FG001|Overall Study|Adverse Event|0|||
160784637|NCT03093870|580598294|FG002|Overall Study|Adverse Event|0|||
161328100|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161230508|NCT00880568|582225809|FG001|Overall Study|Disease progression|3|||
161230509|NCT00880568|582225810|FG002|Overall Study|Disease progression|3|||
161230510|NCT00880568|582225811|FG003|Overall Study|Disease progression|1|||
161230511|NCT00880568|582225812|FG004|Overall Study|Disease progression|3|||
161230512|NCT00880568|582225813|FG005|Overall Study|Disease progression|3|||
161230513|NCT00880568|582225814|FG006|Overall Study|Disease progression|5|||
161230514|NCT00880568|582225815|FG007|Overall Study|Disease progression|0|||
161230515|NCT00880568|582225816|FG008|Overall Study|Disease progression|3|||
161230516|NCT00880568|582225808|FG000|Overall Study|Adverse Event|0|||
161230517|NCT00880568|582225809|FG001|Overall Study|Adverse Event|0|||
161230518|NCT00880568|582225810|FG002|Overall Study|Adverse Event|0|||
161230519|NCT00880568|582225811|FG003|Overall Study|Adverse Event|0|||
161230520|NCT00880568|582225812|FG004|Overall Study|Adverse Event|0|||
161230521|NCT00880568|582225813|FG005|Overall Study|Adverse Event|0|||
161230522|NCT00880568|582225814|FG006|Overall Study|Adverse Event|1|||
161230523|NCT00880568|582225815|FG007|Overall Study|Adverse Event|1|||
161230524|NCT00880568|582225816|FG008|Overall Study|Adverse Event|0|||
161230525|NCT00880568|582225808|FG000|Overall Study|Withdrawal by Subject|0|||
161230526|NCT00880568|582225809|FG001|Overall Study|Withdrawal by Subject|0|||
161230527|NCT00880568|582225810|FG002|Overall Study|Withdrawal by Subject|0|||
161230528|NCT00880568|582225811|FG003|Overall Study|Withdrawal by Subject|0|||
161230529|NCT00880568|582225812|FG004|Overall Study|Withdrawal by Subject|0|||
161230530|NCT00880568|582225813|FG005|Overall Study|Withdrawal by Subject|0|||
161328101|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161328102|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161328103|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161328104|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160784638|NCT03093870|580598292|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
160784639|NCT03093870|580598293|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
160784640|NCT03093870|580598294|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
161125310|NCT01017952|581845401|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161125311|NCT01017952|581845402|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161125312|NCT01017952|581845398|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
161125313|NCT01017952|581845399|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
161125314|NCT01017952|581845400|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
161125315|NCT01017952|581845401|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
161125316|NCT01017952|581845402|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
161125317|NCT01017952|581845398|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
161125318|NCT01017952|581845399|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161230531|NCT00880568|582225814|FG006|Overall Study|Withdrawal by Subject|0|||
161230532|NCT00880568|582225815|FG007|Overall Study|Withdrawal by Subject|1|||
161230533|NCT00880568|582225816|FG008|Overall Study|Withdrawal by Subject|0|||
161230534|NCT00620022|582225817|FG000|Treatment Period 1|Adverse Event|4|||
160784641|NCT03093870|580598292|FG000|Overall Study|Lost to Follow-up|0|||
160784642|NCT03093870|580598293|FG001|Overall Study|Lost to Follow-up|0|||
160890206|NCT00423670|580992968|FG001|Treatment Period|Investigator decision|0|||
161125319|NCT01017952|581845400|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161125320|NCT01017952|581845401|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161125321|NCT01017952|581845402|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
161125322|NCT01017952|581845398|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
161125323|NCT01017952|581845399|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161125324|NCT01017952|581845400|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161125325|NCT01017952|581845401|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161125326|NCT01017952|581845402|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161125327|NCT01017952|581845398|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
161125328|NCT01017952|581845399|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
161125329|NCT01017952|581845400|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
161125330|NCT01017952|581845401|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
161125331|NCT01017952|581845402|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
161125332|NCT01017952|581845398|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
161125333|NCT01017952|581845399|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161125334|NCT01017952|581845400|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161125335|NCT01017952|581845401|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161125336|NCT01017952|581845402|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161125337|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
161125338|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
161125339|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
161125340|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
161125341|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
161125342|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161125343|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
161125344|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
161125345|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
161125346|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
161125347|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161125348|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
161125349|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
161125350|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
161125351|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
161125352|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
161125353|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161125354|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
161125355|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
161125356|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161125357|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161125358|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
161125359|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161125360|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
161125361|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
161125362|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161125363|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161125364|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161125365|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161125366|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161125367|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161125368|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161125369|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
161125370|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161125371|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
161125372|NCT01017952|581845398|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
161125373|NCT01017952|581845399|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
161125374|NCT01017952|581845400|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
161125375|NCT01017952|581845401|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
161125376|NCT01017952|581845402|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
161125377|NCT00352105|581845404|FG000|Overall Study|Death|5|||
161125378|NCT00352105|581845404|FG000|Overall Study|Withdrawal by Subject|5|||
161125379|NCT00352105|581845404|FG000|Overall Study|Lack of Efficacy|9|||
161125380|NCT00352105|581845404|FG000|Overall Study|Adverse Event|19|||
161125381|NCT00352105|581845404|FG000|Overall Study|Protocol Violation|2|||
161125382|NCT02979431|581845407|FG000|Overall Study|Parent/guardian withdrew consent|2|||
161230535|NCT00620022|582225818|FG001|Treatment Period 1|Adverse Event|6|||
161230536|NCT00620022|582225817|FG000|Treatment Period 1|Subject withdrew consent|1|||
161230537|NCT00620022|582225818|FG001|Treatment Period 1|Subject withdrew consent|0|||
161230538|NCT00620022|582225817|FG000|Treatment Period 2|Adverse Event|2|||
161230539|NCT00620022|582225818|FG001|Treatment Period 2|Adverse Event|2|||
161230540|NCT00760266|582225820|FG000|Overall Study|Adverse Event|13|||
161230541|NCT00760266|582225821|FG001|Overall Study|Adverse Event|7|||
160784643|NCT03093870|580598294|FG002|Overall Study|Lost to Follow-up|1|||
160784644|NCT02829957|580598296|FG000|Overall Study|Lost to Follow-up|2|||
160784645|NCT02829957|580598297|FG001|Overall Study|Lost to Follow-up|1|||
160784646|NCT03511066|580598299|FG000|Overall Study|Withdrawal by Subject|1|||
160784647|NCT03511066|580598300|FG001|Overall Study|Withdrawal by Subject|2|||
160784648|NCT03511066|580598301|FG002|Overall Study|Withdrawal by Subject|3|||
160784649|NCT03511066|580598299|FG000|Overall Study|Lost to Follow-up|2|||
160784650|NCT03511066|580598300|FG001|Overall Study|Lost to Follow-up|3|||
160784651|NCT03511066|580598301|FG002|Overall Study|Lost to Follow-up|0|||
160784652|NCT04146909|580598302|FG000|Overall Study|Withdrawal by Subject|3|||
160784653|NCT04146909|580598302|FG000|Overall Study|Did not qualify after consented|1|||
160784654|NCT00345592|580598303|FG000|Overall Study|Death|14|||
160784655|NCT00345592|580598304|FG001|Overall Study|Death|16|||
160784656|NCT00345592|580598303|FG000|Overall Study|Withdrawal by Subject|11|||
160981857|NCT02061761|581321783|FG001|Overall Study|Withdrawal by Subject|0|||
160981858|NCT02061761|581321784|FG002|Overall Study|Withdrawal by Subject|0|||
161230542|NCT00760266|582225820|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161230543|NCT00760266|582225821|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161230544|NCT00760266|582225820|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161230545|NCT00760266|582225821|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161230546|NCT00760266|582225820|FG000|Overall Study|Lack of Efficacy|2|||
161230547|NCT00760266|582225821|FG001|Overall Study|Lack of Efficacy|2|||
161230548|NCT00760266|582225820|FG000|Overall Study|Protocol deviation|2|||
161230549|NCT00760266|582225821|FG001|Overall Study|Protocol deviation|4|||
161230550|NCT00760266|582225820|FG000|Overall Study|Patient withdrew consent|3|||
161230551|NCT00760266|582225821|FG001|Overall Study|Patient withdrew consent|3|||
161230552|NCT00760266|582225820|FG000|Overall Study|Lost to Follow-up|2|||
161230553|NCT00760266|582225821|FG001|Overall Study|Lost to Follow-up|1|||
161230554|NCT00760266|582225820|FG000|Overall Study|Administrative Problems|0|||
161230555|NCT00760266|582225821|FG001|Overall Study|Administrative Problems|1|||
161230556|NCT01239121|582225822|FG000|Overall Study|Withdrawal by Subject|2|||
161230557|NCT01239121|582225823|FG001|Overall Study|Withdrawal by Subject|4|||
161230558|NCT01239121|582225824|FG002|Overall Study|Withdrawal by Subject|0|||
161230559|NCT04006171|582225827|FG000|Overall Study|Withdrawal by Subject|8|||
161230560|NCT04006171|582225828|FG001|Overall Study|Withdrawal by Subject|7|||
161230561|NCT04006171|582225827|FG000|Overall Study|missing serum samples|2|||
161230562|NCT04006171|582225828|FG001|Overall Study|missing serum samples|2|||
161230563|NCT04006171|582225827|FG000|Overall Study|insufficient sample volume|2|||
161230564|NCT04006171|582225828|FG001|Overall Study|insufficient sample volume|3|||
161230565|NCT03049488|582225829|FG000|Overall Study|Lost to Follow-up|1|||
161230566|NCT03049488|582225830|FG001|Overall Study|Lost to Follow-up|1|||
161230567|NCT03049488|582225831|FG002|Overall Study|Lost to Follow-up|0|||
161230568|NCT03049488|582225832|FG003|Overall Study|Lost to Follow-up|0|||
161230569|NCT03049488|582225833|FG004|Overall Study|Lost to Follow-up|0|||
161230570|NCT03049488|582225834|FG005|Overall Study|Lost to Follow-up|0|||
161230571|NCT03049488|582225829|FG000|Overall Study|Moved from Area|1|||
161230572|NCT03049488|582225830|FG001|Overall Study|Moved from Area|0|||
161230573|NCT03049488|582225831|FG002|Overall Study|Moved from Area|0|||
161230574|NCT03049488|582225832|FG003|Overall Study|Moved from Area|1|||
161230575|NCT03049488|582225833|FG004|Overall Study|Moved from Area|1|||
161230576|NCT03049488|582225834|FG005|Overall Study|Moved from Area|0|||
161230577|NCT03049488|582225829|FG000|Overall Study|Physician Decision|0|||
161230578|NCT03049488|582225830|FG001|Overall Study|Physician Decision|1|||
161230579|NCT03049488|582225831|FG002|Overall Study|Physician Decision|0|||
161230580|NCT03049488|582225832|FG003|Overall Study|Physician Decision|0|||
161230581|NCT03049488|582225833|FG004|Overall Study|Physician Decision|0|||
161230582|NCT03049488|582225834|FG005|Overall Study|Physician Decision|0|||
161230583|NCT03049488|582225829|FG000|Overall Study|Withdrawal by Subject|0|||
161230584|NCT03049488|582225830|FG001|Overall Study|Withdrawal by Subject|0|||
161230585|NCT03049488|582225831|FG002|Overall Study|Withdrawal by Subject|0|||
161230586|NCT03049488|582225832|FG003|Overall Study|Withdrawal by Subject|1|||
161230587|NCT03049488|582225833|FG004|Overall Study|Withdrawal by Subject|1|||
161230588|NCT03049488|582225834|FG005|Overall Study|Withdrawal by Subject|0|||
161230589|NCT00440557|582225835|FG000|Overall Study|Withdrawal by Subject|10|||
161230590|NCT00440557|582225836|FG001|Overall Study|Withdrawal by Subject|5|||
161230591|NCT00440557|582225837|FG002|Overall Study|Withdrawal by Subject|11|||
161230592|NCT00440557|582225835|FG000|Overall Study|Lost to Follow-up|1|||
161230593|NCT00440557|582225836|FG001|Overall Study|Lost to Follow-up|2|||
161230594|NCT00440557|582225837|FG002|Overall Study|Lost to Follow-up|6|||
161230595|NCT00440557|582225835|FG000|Overall Study|Adverse Event|3|||
160784657|NCT00345592|580598304|FG001|Overall Study|Withdrawal by Subject|8|||
161230596|NCT00440557|582225836|FG001|Overall Study|Adverse Event|3|||
161230597|NCT00440557|582225837|FG002|Overall Study|Adverse Event|5|||
161230598|NCT00440557|582225835|FG000|Overall Study|Death|2|||
161230599|NCT00440557|582225836|FG001|Overall Study|Death|6|||
161230600|NCT00440557|582225837|FG002|Overall Study|Death|3|||
161230601|NCT00440557|582225835|FG000|Overall Study|Began Dialysis|4|||
161230602|NCT00440557|582225836|FG001|Overall Study|Began Dialysis|1|||
161230603|NCT00440557|582225837|FG002|Overall Study|Began Dialysis|4|||
161230604|NCT00440557|582225835|FG000|Overall Study|Principal Investigator decision|0|||
161230605|NCT00440557|582225836|FG001|Overall Study|Principal Investigator decision|3|||
161230606|NCT00440557|582225837|FG002|Overall Study|Principal Investigator decision|1|||
161230607|NCT00440557|582225835|FG000|Overall Study|Patient moved|1|||
161230608|NCT00440557|582225836|FG001|Overall Study|Patient moved|2|||
161230609|NCT00440557|582225837|FG002|Overall Study|Patient moved|1|||
161230610|NCT00440557|582225835|FG000|Overall Study|Principal Investigator's office closed|3|||
161230611|NCT00440557|582225836|FG001|Overall Study|Principal Investigator's office closed|6|||
161230612|NCT00440557|582225837|FG002|Overall Study|Principal Investigator's office closed|4|||
161230613|NCT00440557|582225835|FG000|Overall Study|Patient transferred to nursing home|0|||
161230614|NCT00440557|582225836|FG001|Overall Study|Patient transferred to nursing home|1|||
161230615|NCT00440557|582225837|FG002|Overall Study|Patient transferred to nursing home|0|||
161230616|NCT00440557|582225835|FG000|Overall Study|Patient had surgery|1|||
161230617|NCT00440557|582225836|FG001|Overall Study|Patient had surgery|0|||
161230618|NCT00440557|582225837|FG002|Overall Study|Patient had surgery|0|||
161230619|NCT01939197|582225838|FG000|Overall Study|Withdrawal by Subject|1|||
161230620|NCT01939197|582225839|FG001|Overall Study|Withdrawal by Subject|0|||
161328105|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161230621|NCT01939197|582225840|FG002|Overall Study|Withdrawal by Subject|0|||
161230622|NCT01939197|582225841|FG003|Overall Study|Withdrawal by Subject|0|||
161230623|NCT01939197|582225842|FG004|Overall Study|Withdrawal by Subject|1|||
161230624|NCT01939197|582225843|FG005|Overall Study|Withdrawal by Subject|0|||
161230625|NCT01939197|582225844|FG006|Overall Study|Withdrawal by Subject|0|||
161230626|NCT01939197|582225838|FG000|Overall Study|Lost to Follow-up|0|||
161230627|NCT01939197|582225839|FG001|Overall Study|Lost to Follow-up|1|||
161230628|NCT01939197|582225840|FG002|Overall Study|Lost to Follow-up|0|||
161230629|NCT01939197|582225841|FG003|Overall Study|Lost to Follow-up|1|||
161230630|NCT01939197|582225842|FG004|Overall Study|Lost to Follow-up|3|||
161328106|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328107|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328108|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161125383|NCT02979431|581845408|FG001|Overall Study|Parent/guardian withdrew consent|1|||
161125384|NCT02979431|581845409|FG002|Overall Study|Parent/guardian withdrew consent|1|||
161125385|NCT02979431|581845410|FG003|Overall Study|Parent/guardian withdrew consent|1|||
161125386|NCT02979431|581845407|FG000|Overall Study|Randomized but received no study drug|1|||
161125387|NCT02979431|581845408|FG001|Overall Study|Randomized but received no study drug|1|||
161125388|NCT02979431|581845409|FG002|Overall Study|Randomized but received no study drug|0|||
161125389|NCT02979431|581845410|FG003|Overall Study|Randomized but received no study drug|0|||
161125390|NCT02979431|581845407|FG000|Overall Study|Adverse Event|0|||
161125391|NCT02979431|581845408|FG001|Overall Study|Adverse Event|0|||
161125392|NCT02979431|581845409|FG002|Overall Study|Adverse Event|1|||
161125393|NCT02979431|581845410|FG003|Overall Study|Adverse Event|0|||
161125394|NCT02979431|581845407|FG000|Overall Study|Subject left country after Day14|1|||
161125395|NCT02979431|581845408|FG001|Overall Study|Subject left country after Day14|0|||
161125396|NCT02979431|581845409|FG002|Overall Study|Subject left country after Day14|0|||
161125397|NCT02979431|581845410|FG003|Overall Study|Subject left country after Day14|0|||
161125398|NCT01580397|581845411|FG000|Overall Study|Lack of Efficacy|14|||
161125399|NCT02435914|581845412|FG000|Overall Study|Ocular Adverse Event|1|||
161125400|NCT02435914|581845413|FG001|Overall Study|Ocular Adverse Event|0|||
161125401|NCT02435914|581845414|FG002|Overall Study|Ocular Adverse Event|0|||
161125402|NCT02435914|581845415|FG003|Overall Study|Ocular Adverse Event|0|||
161125403|NCT02435914|581845412|FG000|Overall Study|Withdrawal by Subject|0|||
161125404|NCT02435914|581845413|FG001|Overall Study|Withdrawal by Subject|1|||
161125405|NCT02435914|581845414|FG002|Overall Study|Withdrawal by Subject|0|||
161125406|NCT02435914|581845415|FG003|Overall Study|Withdrawal by Subject|0|||
161125407|NCT02435914|581845412|FG000|Overall Study|Other Miscellaneous Reason|0|||
161125408|NCT02435914|581845413|FG001|Overall Study|Other Miscellaneous Reason|0|||
161125409|NCT02435914|581845414|FG002|Overall Study|Other Miscellaneous Reason|1|||
161125410|NCT02435914|581845415|FG003|Overall Study|Other Miscellaneous Reason|0|||
161125411|NCT01727258|581845416|FG000|Overall Study|Adverse Event|0|||
161230631|NCT01939197|582225843|FG005|Overall Study|Lost to Follow-up|1|||
161230632|NCT01939197|582225844|FG006|Overall Study|Lost to Follow-up|2|||
161230633|NCT04977336|582225845|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
161125412|NCT01727258|581845417|FG001|Overall Study|Adverse Event|2|||
161125413|NCT01727258|581845418|FG002|Overall Study|Adverse Event|0|||
161125414|NCT01727258|581845416|FG000|Overall Study|Noncompliance with Study Drug|0|||
161230634|NCT04977336|582225846|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161230635|NCT04977336|582225847|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161230636|NCT04977336|582225848|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
161230637|NCT04977336|582225849|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161230638|NCT04977336|582225845|FG000|Overall Study|Lost to Follow-up|0|||
161230639|NCT04977336|582225846|FG001|Overall Study|Lost to Follow-up|0|||
161230640|NCT04977336|582225847|FG002|Overall Study|Lost to Follow-up|1|||
161230641|NCT04977336|582225848|FG003|Overall Study|Lost to Follow-up|0|||
161230642|NCT04977336|582225849|FG004|Overall Study|Lost to Follow-up|0|||
161230655|NCT02480764|582225855|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
161230656|NCT02480764|582225856|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161230657|NCT02480764|582225857|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
161230658|NCT02480764|582225855|FG000|Overall Study|Major Protocol Deviation|1|||
161328109|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161230659|NCT02480764|582225856|FG001|Overall Study|Major Protocol Deviation|4|||
161230660|NCT02480764|582225857|FG002|Overall Study|Major Protocol Deviation|3|||
161230661|NCT02480764|582225855|FG000|Overall Study|Lost to Follow-up|0|||
161230662|NCT02480764|582225856|FG001|Overall Study|Lost to Follow-up|1|||
161230663|NCT02480764|582225857|FG002|Overall Study|Lost to Follow-up|2|||
161230664|NCT02480764|582225855|FG000|Overall Study|Voluntary Withdrawal|6|||
161230665|NCT02480764|582225856|FG001|Overall Study|Voluntary Withdrawal|5|||
161230666|NCT02480764|582225857|FG002|Overall Study|Voluntary Withdrawal|10|||
161230667|NCT02480764|582225855|FG000|Overall Study|Lack of Efficacy|0|||
161230668|NCT02480764|582225856|FG001|Overall Study|Lack of Efficacy|3|||
161230669|NCT02480764|582225857|FG002|Overall Study|Lack of Efficacy|3|||
161230670|NCT02480764|582225855|FG000|Overall Study|Reason not Specified|0|||
161230671|NCT02480764|582225856|FG001|Overall Study|Reason not Specified|1|||
161230672|NCT02480764|582225857|FG002|Overall Study|Reason not Specified|0|||
161328110|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328111|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328112|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328113|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328114|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161230673|NCT01030965|582225860|FG000|Overall Study|Lack of Efficacy|3|||
161230674|NCT01030965|582225861|FG001|Overall Study|Lack of Efficacy|2|||
161230675|NCT01030965|582225862|FG002|Overall Study|Lack of Efficacy|0|||
161230676|NCT01030965|582225863|FG003|Overall Study|Lack of Efficacy|3|||
161230677|NCT01030965|582225860|FG000|Overall Study|Protocol Violation|1|||
161230678|NCT01030965|582225861|FG001|Overall Study|Protocol Violation|1|||
161230679|NCT01030965|582225862|FG002|Overall Study|Protocol Violation|1|||
161230680|NCT01030965|582225863|FG003|Overall Study|Protocol Violation|1|||
161230681|NCT01030965|582225860|FG000|Overall Study|Adverse Event|0|||
161230682|NCT01030965|582225861|FG001|Overall Study|Adverse Event|1|||
161230683|NCT01030965|582225862|FG002|Overall Study|Adverse Event|2|||
161230684|NCT01030965|582225863|FG003|Overall Study|Adverse Event|1|||
161230685|NCT01030965|582225860|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
161230686|NCT01030965|582225861|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
161230687|NCT01030965|582225862|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
161230688|NCT01030965|582225863|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
161230689|NCT01030965|582225860|FG000|Overall Study|Withdrawal by Subject|0|||
161328115|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328116|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
160784658|NCT04193527|580598309|FG000|Overall Study|Other|1|||
161230690|NCT01030965|582225861|FG001|Overall Study|Withdrawal by Subject|1|||
161230691|NCT01030965|582225862|FG002|Overall Study|Withdrawal by Subject|0|||
161230692|NCT01030965|582225863|FG003|Overall Study|Withdrawal by Subject|2|||
161230693|NCT02097290|582225864|FG000|Overall Study|Death|6|||
161230694|NCT02097290|582225864|FG000|Overall Study|Total Withdrawals|3|||
161230695|NCT02097290|582225864|FG000|Overall Study|Attempt|8|||
161230696|NCT03991494|582225865|FG000|Overall Study|Progressive Disease|4|||
161230697|NCT05277389|582225866|FG000|Overall Study|Lost to Follow-up|1|||
161230698|NCT05277389|582225867|FG001|Overall Study|Lost to Follow-up|4|||
161230699|NCT01411332|582225875|FG000|Enrollment|Protocol Violation|0|||
160784659|NCT04193527|580598310|FG001|Overall Study|Other|1|||
160784660|NCT04193527|580598311|FG002|Overall Study|Other|0|||
160784661|NCT03808909|580598312|FG000|Overall Study|Lost to Follow-up|3|||
160784662|NCT03808909|580598313|FG001|Overall Study|Lost to Follow-up|0|||
160784663|NCT00676689|580598316|FG000|Overall Study|Screen Failure|2|||
160784664|NCT00676689|580598316|FG000|Overall Study|Death|2|||
160784665|NCT00676689|580598316|FG000|Overall Study|Lost to Follow-up|4|||
160784666|NCT00676689|580598316|FG000|Overall Study|Physician Decision|1|||
160784667|NCT00676689|580598316|FG000|Overall Study|Withdrawal by Subject|3|||
160784668|NCT00676689|580598316|FG000|Overall Study|Continuing FU|49|||
160784669|NCT01827943|580598317|FG000|Overall Study|Protocol Violation|8|||
160784670|NCT01827943|580598317|FG000|Overall Study|Never treated because of an rapid progression|1|||
160784671|NCT00501085|580598318|FG000|Overall Study|Lost to Follow-up|195|||
160784672|NCT00501085|580598318|FG000|Overall Study|Withdrawal by Subject|34|||
160784673|NCT00501085|580598318|FG000|Overall Study|Subject Decision|1|||
160784674|NCT00501085|580598318|FG000|Overall Study|Revision Surgery|7|||
160784675|NCT00501085|580598318|FG000|Overall Study|Explantation Surgery|26|||
160784676|NCT00501085|580598318|FG000|Overall Study|Adverse Event|4|||
160784677|NCT00501085|580598318|FG000|Overall Study|Non-Compliance|24|||
160784678|NCT00501085|580598318|FG000|Overall Study|Study closed by sponsor|109|||
160784679|NCT00501085|580598318|FG000|Overall Study|Other loss to follow-up|32|||
160784680|NCT01487161|580598319|FG000|Overall Study|Adverse Event|1|||
160784681|NCT01487161|580598320|FG001|Overall Study|Adverse Event|0|||
160784682|NCT01487161|580598321|FG002|Overall Study|Adverse Event|0|||
160784683|NCT01487161|580598322|FG003|Overall Study|Adverse Event|0|||
160784684|NCT01487161|580598319|FG000|Overall Study|Withdrawal by Subject|1|||
160784685|NCT01487161|580598320|FG001|Overall Study|Withdrawal by Subject|1|||
160784686|NCT01487161|580598321|FG002|Overall Study|Withdrawal by Subject|1|||
160784687|NCT01487161|580598322|FG003|Overall Study|Withdrawal by Subject|2|||
160784688|NCT01487161|580598319|FG000|Overall Study|missing data|0|||
160784689|NCT01487161|580598320|FG001|Overall Study|missing data|1|||
160784690|NCT01487161|580598321|FG002|Overall Study|missing data|0|||
160784691|NCT01487161|580598322|FG003|Overall Study|missing data|0|||
160784692|NCT00663351|580598323|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
160784693|NCT00663351|580598324|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
160784694|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
160784695|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
160784696|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
160784697|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
160784698|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
160784699|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
160784700|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
160784701|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
160784702|NCT00663351|580598323|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
160784703|NCT00663351|580598324|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
160784704|NCT03113136|580598325|FG000|Overall Study|Lost to Follow-up|22|||
160784705|NCT03113136|580598326|FG001|Overall Study|Lost to Follow-up|47|||
160784706|NCT03113136|580598327|FG002|Overall Study|Lost to Follow-up|54|||
160784707|NCT03113136|580598325|FG000|Overall Study|Withdrawal by Subject|4|||
160784708|NCT03113136|580598326|FG001|Overall Study|Withdrawal by Subject|13|||
160784709|NCT03113136|580598327|FG002|Overall Study|Withdrawal by Subject|14|||
160784710|NCT03113136|580598325|FG000|Overall Study|Ineligible|0|||
160784711|NCT03113136|580598326|FG001|Overall Study|Ineligible|2|||
160784712|NCT03113136|580598327|FG002|Overall Study|Ineligible|1|||
160784713|NCT03113136|580598325|FG000|Overall Study|Study Team Decision|1|||
160784714|NCT03113136|580598326|FG001|Overall Study|Study Team Decision|4|||
160784715|NCT03113136|580598327|FG002|Overall Study|Study Team Decision|0|||
160784716|NCT00977561|580598329|FG000|Overall Study|Death|3|||
160784717|NCT00977561|580598330|FG001|Overall Study|Death|2|||
160784718|NCT00977561|580598329|FG000|Overall Study|Study terminated|0|||
160784719|NCT00977561|580598330|FG001|Overall Study|Study terminated|2|||
160784720|NCT00977561|580598329|FG000|Overall Study|Other|2|||
160784721|NCT00977561|580598330|FG001|Overall Study|Other|0|||
160784722|NCT03336866|580598331|FG000|Overall Study|Lost to Follow-up|2|||
160784723|NCT03336866|580598332|FG001|Overall Study|Lost to Follow-up|0|||
160784724|NCT03336866|580598333|FG002|Overall Study|Lost to Follow-up|3|||
160784725|NCT03336866|580598331|FG000|Overall Study|Withdrawal by Subject|1|||
160784726|NCT03336866|580598332|FG001|Overall Study|Withdrawal by Subject|1|||
160784727|NCT03336866|580598333|FG002|Overall Study|Withdrawal by Subject|0|||
161230700|NCT01411332|582225876|FG001|Enrollment|Protocol Violation|1|||
161230701|NCT01411332|582225875|FG000|Enrollment|Withdrawal by Subject|0|||
161230702|NCT01411332|582225876|FG001|Enrollment|Withdrawal by Subject|1|||
161230703|NCT01411332|582225875|FG000|Treatment|Lost to Follow-up|1|||
161230704|NCT01411332|582225876|FG001|Treatment|Lost to Follow-up|0|||
160784728|NCT03336866|580598331|FG000|Overall Study|Noncompliance with clinic house rules|0|||
160784729|NCT03336866|580598332|FG001|Overall Study|Noncompliance with clinic house rules|0|||
160784730|NCT03336866|580598333|FG002|Overall Study|Noncompliance with clinic house rules|1|||
160784731|NCT02218268|580598335|FG000|24 Hour Washout|Physician Decision|11|||
160784732|NCT02218268|580598336|FG001|24 Hour Washout|Physician Decision|9|||
160784733|NCT03651336|580598337|FG000|Overall Study|Withdrawal by Subject|4|||
160784734|NCT01341990|580598338|FG000|Overall Study|Adverse Event|0|||
160784735|NCT01341990|580598339|FG001|Overall Study|Adverse Event|1|||
160784736|NCT01341990|580598338|FG000|Overall Study|Torn Study Lens|1|||
160784737|NCT01341990|580598339|FG001|Overall Study|Torn Study Lens|0|||
160784738|NCT01341990|580598338|FG000|Overall Study|Withdrawal by Subject|2|||
160784739|NCT01341990|580598339|FG001|Overall Study|Withdrawal by Subject|0|||
160784740|NCT01125748|580598341|FG000|Overall Study|Adverse Event|0|||
160784741|NCT01125748|580598342|FG001|Overall Study|Adverse Event|2|||
160784742|NCT01125748|580598341|FG000|Overall Study|Lost to Follow-up|0|||
160784743|NCT01125748|580598342|FG001|Overall Study|Lost to Follow-up|1|||
160784744|NCT01125748|580598341|FG000|Overall Study|Physician Decision|8|||
160784745|NCT01125748|580598342|FG001|Overall Study|Physician Decision|7|||
160784746|NCT01125748|580598341|FG000|Overall Study|Patient Decision to Withdraw|2|||
160784747|NCT01125748|580598342|FG001|Overall Study|Patient Decision to Withdraw|4|||
160784748|NCT01028391|580598343|FG000|Overall Study|Adverse Event|4|||
160784749|NCT01028391|580598344|FG001|Overall Study|Adverse Event|0|||
160784750|NCT01028391|580598343|FG000|Overall Study|Lack of Efficacy|0|||
160784751|NCT01028391|580598344|FG001|Overall Study|Lack of Efficacy|2|||
160784752|NCT01028391|580598343|FG000|Overall Study|Lost to Follow-up|3|||
160784753|NCT01028391|580598344|FG001|Overall Study|Lost to Follow-up|4|||
160784754|NCT01028391|580598343|FG000|Overall Study|Physician Decision|0|||
160784755|NCT01028391|580598344|FG001|Overall Study|Physician Decision|1|||
160784756|NCT01028391|580598343|FG000|Overall Study|Withdrawal by Subject|6|||
160784757|NCT01028391|580598344|FG001|Overall Study|Withdrawal by Subject|3|||
160784758|NCT01028391|580598343|FG000|Overall Study|Needed excluded medication|1|||
160784759|NCT01028391|580598344|FG001|Overall Study|Needed excluded medication|1|||
160784760|NCT01107457|580598345|FG000|Part A|Adverse Event|1|||
160784761|NCT01107457|580598346|FG001|Part A|Adverse Event|2|||
160784762|NCT01107457|580598347|FG002|Part A|Adverse Event|1|||
160784763|NCT01107457|580598348|FG003|Part A|Adverse Event|0|||
160784764|NCT01107457|580598349|FG004|Part A|Adverse Event|0|||
160784765|NCT01107457|580598350|FG005|Part A|Adverse Event|0|||
160784766|NCT01107457|580598345|FG000|Part A|Withdrawal by Subject|3|||
160784767|NCT01107457|580598346|FG001|Part A|Withdrawal by Subject|3|||
160784768|NCT01107457|580598347|FG002|Part A|Withdrawal by Subject|0|||
160784769|NCT01107457|580598348|FG003|Part A|Withdrawal by Subject|3|||
160784770|NCT01107457|580598349|FG004|Part A|Withdrawal by Subject|1|||
160784771|NCT01107457|580598350|FG005|Part A|Withdrawal by Subject|0|||
160784772|NCT01107457|580598345|FG000|Part A|Lost to Follow-up|0|||
160784773|NCT01107457|580598346|FG001|Part A|Lost to Follow-up|1|||
160784774|NCT01107457|580598347|FG002|Part A|Lost to Follow-up|0|||
160784775|NCT01107457|580598348|FG003|Part A|Lost to Follow-up|0|||
160784776|NCT01107457|580598349|FG004|Part A|Lost to Follow-up|0|||
160784777|NCT01107457|580598350|FG005|Part A|Lost to Follow-up|0|||
160784778|NCT01107457|580598345|FG000|Part A|Lack of Efficacy|1|||
160784779|NCT01107457|580598346|FG001|Part A|Lack of Efficacy|0|||
160784780|NCT01107457|580598347|FG002|Part A|Lack of Efficacy|0|||
160784781|NCT01107457|580598348|FG003|Part A|Lack of Efficacy|0|||
160784782|NCT01107457|580598349|FG004|Part A|Lack of Efficacy|0|||
160784783|NCT01107457|580598350|FG005|Part A|Lack of Efficacy|0|||
160784784|NCT01107457|580598345|FG000|Part A|Protocol Violation|0|||
160784785|NCT01107457|580598346|FG001|Part A|Protocol Violation|1|||
160784786|NCT01107457|580598347|FG002|Part A|Protocol Violation|0|||
160784787|NCT01107457|580598348|FG003|Part A|Protocol Violation|0|||
160784788|NCT01107457|580598349|FG004|Part A|Protocol Violation|0|||
160784789|NCT01107457|580598350|FG005|Part A|Protocol Violation|0|||
160890207|NCT00423670|580992969|FG002|Treatment Period|Investigator decision|0|||
160890208|NCT00423670|580992970|FG003|Treatment Period|Investigator decision|0|||
161328117|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
161328118|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328119|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328120|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161328121|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328122|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160784790|NCT01107457|580598345|FG000|Part B and C|Adverse Event|0|||
160784791|NCT01107457|580598346|FG001|Part B and C|Adverse Event|0|||
160890209|NCT00423670|580992971|FG004|Treatment Period|Investigator decision|0|||
160784792|NCT01107457|580598347|FG002|Part B and C|Adverse Event|0|||
160784793|NCT01107457|580598348|FG003|Part B and C|Adverse Event|0|||
160784794|NCT01107457|580598349|FG004|Part B and C|Adverse Event|0|||
160784795|NCT01107457|580598350|FG005|Part B and C|Adverse Event|12|||
160784796|NCT01107457|580598345|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784797|NCT01107457|580598346|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784798|NCT01107457|580598347|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784799|NCT01107457|580598348|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784800|NCT01107457|580598349|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
160784801|NCT01107457|580598350|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
160784802|NCT01107457|580598345|FG000|Part B and C|Physician Decision|0|||
160784803|NCT01107457|580598346|FG001|Part B and C|Physician Decision|0|||
160784804|NCT01107457|580598347|FG002|Part B and C|Physician Decision|0|||
160784805|NCT01107457|580598348|FG003|Part B and C|Physician Decision|0|||
160784806|NCT01107457|580598349|FG004|Part B and C|Physician Decision|0|||
160784807|NCT01107457|580598350|FG005|Part B and C|Physician Decision|3|||
160784808|NCT01107457|580598345|FG000|Part B and C|Lack of Efficacy|0|||
160784809|NCT01107457|580598346|FG001|Part B and C|Lack of Efficacy|0|||
160784810|NCT01107457|580598347|FG002|Part B and C|Lack of Efficacy|0|||
160784811|NCT01107457|580598348|FG003|Part B and C|Lack of Efficacy|0|||
160784812|NCT01107457|580598349|FG004|Part B and C|Lack of Efficacy|0|||
160784813|NCT01107457|580598350|FG005|Part B and C|Lack of Efficacy|7|||
160784814|NCT01107457|580598345|FG000|Part B and C|Lost to Follow-up|0|||
160784815|NCT01107457|580598346|FG001|Part B and C|Lost to Follow-up|0|||
160784816|NCT01107457|580598347|FG002|Part B and C|Lost to Follow-up|0|||
160784817|NCT01107457|580598348|FG003|Part B and C|Lost to Follow-up|0|||
160784818|NCT01107457|580598349|FG004|Part B and C|Lost to Follow-up|0|||
160784819|NCT01107457|580598350|FG005|Part B and C|Lost to Follow-up|10|||
160784820|NCT01107457|580598345|FG000|Part B and C|Protocol Violation|0|||
160784821|NCT01107457|580598346|FG001|Part B and C|Protocol Violation|0|||
160784822|NCT01107457|580598347|FG002|Part B and C|Protocol Violation|0|||
160784823|NCT01107457|580598348|FG003|Part B and C|Protocol Violation|0|||
160784824|NCT01107457|580598349|FG004|Part B and C|Protocol Violation|0|||
160784825|NCT01107457|580598350|FG005|Part B and C|Protocol Violation|1|||
160784826|NCT01107457|580598345|FG000|Part B and C|Sponsor Decision|0|||
160784827|NCT01107457|580598346|FG001|Part B and C|Sponsor Decision|0|||
160784828|NCT01107457|580598347|FG002|Part B and C|Sponsor Decision|0|||
160784829|NCT01107457|580598348|FG003|Part B and C|Sponsor Decision|0|||
160784830|NCT01107457|580598349|FG004|Part B and C|Sponsor Decision|0|||
160784831|NCT01107457|580598350|FG005|Part B and C|Sponsor Decision|66|||
160784832|NCT01107457|580598345|FG000|Part B and C|Withdrawal by Subject|0|||
160784833|NCT01107457|580598346|FG001|Part B and C|Withdrawal by Subject|0|||
160784834|NCT01107457|580598347|FG002|Part B and C|Withdrawal by Subject|0|||
160784835|NCT01107457|580598348|FG003|Part B and C|Withdrawal by Subject|0|||
160784836|NCT01107457|580598349|FG004|Part B and C|Withdrawal by Subject|0|||
160784837|NCT01107457|580598350|FG005|Part B and C|Withdrawal by Subject|16|||
160784838|NCT01107457|580598345|FG000|Part B and C|Clinical Relapse|0|||
160784839|NCT01107457|580598346|FG001|Part B and C|Clinical Relapse|0|||
161328123|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328124|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328125|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328126|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328127|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328128|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328129|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328130|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160784840|NCT01107457|580598347|FG002|Part B and C|Clinical Relapse|0|||
161230705|NCT02170688|582225877|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
161230706|NCT02170688|582225878|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
161230707|NCT02170688|582225879|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
161230708|NCT02170688|582225880|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
161230709|NCT02170688|582225881|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
161230710|NCT02170688|582225877|FG000|Overall Study|Full dose not received|0|||
160784841|NCT01107457|580598348|FG003|Part B and C|Clinical Relapse|0|||
160784842|NCT01107457|580598349|FG004|Part B and C|Clinical Relapse|0|||
160784843|NCT01107457|580598350|FG005|Part B and C|Clinical Relapse|4|||
161230711|NCT02170688|582225878|FG001|Overall Study|Full dose not received|1|||
161328131|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
161230712|NCT02170688|582225879|FG002|Overall Study|Full dose not received|0|||
161230713|NCT02170688|582225880|FG003|Overall Study|Full dose not received|0|||
161230714|NCT02170688|582225881|FG004|Overall Study|Full dose not received|0|||
161328132|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161328133|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
161328134|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160784844|NCT00694161|580598351|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
160784845|NCT00694161|580598351|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
160784846|NCT00694161|580598351|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
160784847|NCT03601052|580598352|FG000|Overall Study|Lost to Follow-up|2|||
160784848|NCT01227395|580598353|FG000|Overall Study|Protocol Violation|0|||
160784849|NCT01227395|580598354|FG001|Overall Study|Protocol Violation|1|||
160784850|NCT00683384|580598355|FG000|Overall Study|Death|1|||
160784851|NCT00683384|580598355|FG000|Overall Study|Adverse Event|1|||
161230715|NCT02170688|582225877|FG000|Overall Study|Physician Decision|0|||
160784852|NCT02015104|580598358|FG000|Overall Study|Withdrew consent after first dose drug|1|||
160784853|NCT02015104|580598359|FG001|Overall Study|Withdrew consent after first dose drug|0|||
160784854|NCT02015104|580598358|FG000|Overall Study|Withdrew consent prior to treatment|0|||
160784855|NCT02015104|580598359|FG001|Overall Study|Withdrew consent prior to treatment|1|||
160784856|NCT03011372|580598360|FG000|Overall Study|Death|16|||
160784857|NCT03011372|580598360|FG000|Overall Study|Lost to Follow-up|2|||
160784858|NCT03011372|580598360|FG000|Overall Study|Sponsor Decision|17|||
160784859|NCT03011372|580598360|FG000|Overall Study|Withdrawal by Subject|7|||
160784860|NCT03011372|580598360|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
160784861|NCT03011372|580598360|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
160784862|NCT03011372|580598360|FG000|Overall Study|Sponsor's Decision|2|||
160784863|NCT03572218|580598361|FG000|Overall Study|Lost to Follow-up|3|||
160784864|NCT03572218|580598362|FG001|Overall Study|Lost to Follow-up|2|||
160784865|NCT03572218|580598361|FG000|Overall Study|No longer available for study visits|2|||
160784866|NCT03572218|580598362|FG001|Overall Study|No longer available for study visits|1|||
160784867|NCT03572218|580598361|FG000|Overall Study|No longer interested|1|||
160784868|NCT03572218|580598362|FG001|Overall Study|No longer interested|2|||
160784869|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
160784870|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
160784871|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
160784872|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
160784873|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
160784874|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
160784875|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
160784876|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
160784877|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
160784878|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
160784879|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
160784880|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
160784881|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
160784882|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
160784883|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
160784884|NCT03738215|580598363|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
160784885|NCT03738215|580598364|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
160784886|NCT03738215|580598365|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
160784887|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
160784888|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
160784889|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
160784890|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
160784891|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
160784892|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
160784893|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
160784894|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
160784895|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
160784896|NCT03738215|580598363|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
160784897|NCT03738215|580598364|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
160784898|NCT03738215|580598365|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
160784899|NCT00853047|580598366|FG000|Core Phase|Participant Request|0|||
160784900|NCT00853047|580598367|FG001|Core Phase|Participant Request|0|||
160784901|NCT00853047|580598368|FG002|Core Phase|Participant Request|0|||
160784902|NCT00853047|580598369|FG003|Core Phase|Participant Request|1|||
160784903|NCT00853047|580598370|FG004|Core Phase|Participant Request|0|||
160784904|NCT00853047|580598371|FG005|Core Phase|Participant Request|0|||
160784905|NCT00853047|580598366|FG000|Open-Label Extension Phase|Participant Request|0|||
160784906|NCT00853047|580598367|FG001|Open-Label Extension Phase|Participant Request|0|||
160784907|NCT00853047|580598368|FG002|Open-Label Extension Phase|Participant Request|0|||
161125415|NCT01727258|581845417|FG001|Overall Study|Noncompliance with Study Drug|0|||
161125416|NCT01727258|581845418|FG002|Overall Study|Noncompliance with Study Drug|1|||
161125417|NCT01727258|581845416|FG000|Overall Study|Withdrawal by Subject|1|||
161125418|NCT01727258|581845417|FG001|Overall Study|Withdrawal by Subject|1|||
161125419|NCT01727258|581845418|FG002|Overall Study|Withdrawal by Subject|0|||
161125420|NCT01727258|581845416|FG000|Overall Study|Lost to Follow-up|1|||
161125421|NCT01727258|581845417|FG001|Overall Study|Lost to Follow-up|0|||
161125422|NCT01727258|581845418|FG002|Overall Study|Lost to Follow-up|0|||
161125423|NCT01405053|581845421|FG000|Overall Study|Adverse Event|3|||
161125424|NCT01405053|581845422|FG001|Overall Study|Adverse Event|0|||
161125425|NCT01405053|581845421|FG000|Overall Study|Lost to Follow-up|0|||
161125426|NCT01405053|581845422|FG001|Overall Study|Lost to Follow-up|1|||
161125427|NCT01405053|581845421|FG000|Overall Study|Participant choice|2|||
161125428|NCT01405053|581845422|FG001|Overall Study|Participant choice|1|||
161125429|NCT01405053|581845421|FG000|Overall Study|Inadequate therapeutic effect|2|||
160784908|NCT00853047|580598369|FG003|Open-Label Extension Phase|Participant Request|0|||
160784909|NCT00853047|580598370|FG004|Open-Label Extension Phase|Participant Request|0|||
160784910|NCT00853047|580598371|FG005|Open-Label Extension Phase|Participant Request|7|||
160784911|NCT00853047|580598366|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160784912|NCT00853047|580598367|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160784913|NCT00853047|580598368|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160784914|NCT00853047|580598369|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
160784915|NCT00853047|580598370|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
160784916|NCT00853047|580598371|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
160784917|NCT00853047|580598366|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784918|NCT00853047|580598367|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784919|NCT00853047|580598368|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784920|NCT00853047|580598369|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784921|NCT00853047|580598370|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
160784922|NCT00853047|580598371|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
160784923|NCT00853047|580598366|FG000|Open-Label Extension Phase|Investigator Decision|0|||
160784924|NCT00853047|580598367|FG001|Open-Label Extension Phase|Investigator Decision|0|||
160784925|NCT00853047|580598368|FG002|Open-Label Extension Phase|Investigator Decision|0|||
160784926|NCT00853047|580598369|FG003|Open-Label Extension Phase|Investigator Decision|0|||
160784927|NCT00853047|580598370|FG004|Open-Label Extension Phase|Investigator Decision|0|||
160784928|NCT00853047|580598371|FG005|Open-Label Extension Phase|Investigator Decision|1|||
160784929|NCT00853047|580598366|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
160784930|NCT00853047|580598367|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
160784931|NCT00853047|580598368|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
160784932|NCT00853047|580598369|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
160784933|NCT00853047|580598370|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
160784934|NCT00853047|580598371|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
160784935|NCT02638493|580598372|FG000|Overall Study|Inability to provide semen samples|2|||
160784936|NCT02638493|580598373|FG001|Overall Study|Inability to provide semen samples|0|||
160784937|NCT02638493|580598374|FG002|Overall Study|Inability to provide semen samples|0|||
160784938|NCT00394472|580600919|FG000|Overall Study|Protocol Violation|1|||
160784939|NCT00394472|580600920|FG001|Overall Study|Protocol Violation|3|||
160784940|NCT00394472|580600919|FG000|Overall Study|incorrect enrolment|4|||
160784941|NCT00394472|580600920|FG001|Overall Study|incorrect enrolment|2|||
160784942|NCT00394472|580600919|FG000|Overall Study|Adverse Event|4|||
160784943|NCT00394472|580600920|FG001|Overall Study|Adverse Event|2|||
160784944|NCT00394472|580600919|FG000|Overall Study|Withdrawal by Subject|0|||
160784945|NCT00394472|580600920|FG001|Overall Study|Withdrawal by Subject|2|||
160784946|NCT00394472|580600919|FG000|Overall Study|Physician Decision|0|||
160784947|NCT00394472|580600920|FG001|Overall Study|Physician Decision|1|||
160784948|NCT00394472|580600919|FG000|Overall Study|Lost to Follow-up|0|||
160784949|NCT00394472|580600920|FG001|Overall Study|Lost to Follow-up|1|||
160784950|NCT03211858|580600921|FG000|Overall Study|Adverse Event|8|||
160784951|NCT03211858|580600922|FG001|Overall Study|Adverse Event|6|||
160784952|NCT03211858|580600921|FG000|Overall Study|Lack of Efficacy|0|||
160784953|NCT03211858|580600922|FG001|Overall Study|Lack of Efficacy|4|||
160784954|NCT03211858|580600921|FG000|Overall Study|Poor compliance to protocol|6|||
160784955|NCT03211858|580600922|FG001|Overall Study|Poor compliance to protocol|2|||
160784956|NCT03211858|580600921|FG000|Overall Study|Non-serious Hypoglycemia|1|||
160784957|NCT03211858|580600922|FG001|Overall Study|Non-serious Hypoglycemia|0|||
160784958|NCT03211858|580600921|FG000|Overall Study|Other than specified above|22|||
160784959|NCT03211858|580600922|FG001|Overall Study|Other than specified above|21|||
161328135|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
160784960|NCT01529112|580600925|FG000|Overall Study|Adverse Event|2|||
160784961|NCT01529112|580600926|FG001|Overall Study|Adverse Event|0|||
160784962|NCT01529112|580600925|FG000|Overall Study|Death|59|||
161125430|NCT01405053|581845422|FG001|Overall Study|Inadequate therapeutic effect|1|||
161125431|NCT01405053|581845421|FG000|Overall Study|Withdrawal by Subject|3|||
161125432|NCT01405053|581845422|FG001|Overall Study|Withdrawal by Subject|4|||
161125433|NCT01405053|581845421|FG000|Overall Study|Other|0|||
161125434|NCT01405053|581845422|FG001|Overall Study|Other|1|||
161125435|NCT00130286|581845423|FG000|Overall Study|Withdrawal by Subject|0|||
161125436|NCT00130286|581845424|FG001|Overall Study|Withdrawal by Subject|1|||
161125437|NCT00130286|581845425|FG002|Overall Study|Withdrawal by Subject|2|||
160784963|NCT01529112|580600926|FG001|Overall Study|Death|38|||
160784964|NCT01529112|580600925|FG000|Overall Study|Protocol Violation|1|||
160784965|NCT01529112|580600926|FG001|Overall Study|Protocol Violation|0|||
161125438|NCT00130286|581845426|FG003|Overall Study|Withdrawal by Subject|2|||
161125439|NCT00130286|581845423|FG000|Overall Study|Adverse Event|0|||
160784966|NCT01529112|580600925|FG000|Overall Study|Withdrawal by Subject|7|||
160784967|NCT01529112|580600926|FG001|Overall Study|Withdrawal by Subject|3|||
160784968|NCT00004228|580600927|FG000|Overall Study|Adverse Event|0|||
160784969|NCT00004228|580600928|FG001|Overall Study|Adverse Event|1|||
160784970|NCT00004228|580600929|FG002|Overall Study|Adverse Event|0|||
160784971|NCT00004228|580600930|FG003|Overall Study|Adverse Event|0|||
160784972|NCT00004228|580600931|FG004|Overall Study|Adverse Event|1|||
160784973|NCT00004228|580600932|FG005|Overall Study|Adverse Event|0|||
160784974|NCT00004228|580600933|FG006|Overall Study|Adverse Event|0|||
160784975|NCT00004228|580600927|FG000|Overall Study|Death|0|||
160784976|NCT00004228|580600928|FG001|Overall Study|Death|1|||
160784977|NCT00004228|580600929|FG002|Overall Study|Death|2|||
160784978|NCT00004228|580600930|FG003|Overall Study|Death|0|||
160784979|NCT00004228|580600931|FG004|Overall Study|Death|1|||
160784980|NCT00004228|580600932|FG005|Overall Study|Death|0|||
160784981|NCT00004228|580600933|FG006|Overall Study|Death|0|||
160784982|NCT00004228|580600927|FG000|Overall Study|Lack of Efficacy|1|||
160784983|NCT00004228|580600928|FG001|Overall Study|Lack of Efficacy|6|||
160784984|NCT00004228|580600929|FG002|Overall Study|Lack of Efficacy|5|||
160784985|NCT00004228|580600930|FG003|Overall Study|Lack of Efficacy|3|||
160784986|NCT00004228|580600931|FG004|Overall Study|Lack of Efficacy|9|||
160784987|NCT00004228|580600932|FG005|Overall Study|Lack of Efficacy|8|||
160784988|NCT00004228|580600933|FG006|Overall Study|Lack of Efficacy|4|||
160784989|NCT00004228|580600927|FG000|Overall Study|Lost to Follow-up|0|||
160784990|NCT00004228|580600928|FG001|Overall Study|Lost to Follow-up|0|||
160784991|NCT00004228|580600929|FG002|Overall Study|Lost to Follow-up|1|||
160784992|NCT00004228|580600930|FG003|Overall Study|Lost to Follow-up|0|||
160784993|NCT00004228|580600931|FG004|Overall Study|Lost to Follow-up|0|||
160784994|NCT00004228|580600932|FG005|Overall Study|Lost to Follow-up|0|||
160784995|NCT00004228|580600933|FG006|Overall Study|Lost to Follow-up|0|||
160784996|NCT00004228|580600927|FG000|Overall Study|Physician Decision|1|||
160784997|NCT00004228|580600928|FG001|Overall Study|Physician Decision|0|||
160784998|NCT00004228|580600929|FG002|Overall Study|Physician Decision|3|||
160784999|NCT00004228|580600930|FG003|Overall Study|Physician Decision|2|||
160785000|NCT00004228|580600931|FG004|Overall Study|Physician Decision|1|||
160785001|NCT00004228|580600932|FG005|Overall Study|Physician Decision|1|||
160785002|NCT00004228|580600933|FG006|Overall Study|Physician Decision|1|||
160785003|NCT00004228|580600927|FG000|Overall Study|Protocol Violation|0|||
160785004|NCT00004228|580600928|FG001|Overall Study|Protocol Violation|5|||
160785005|NCT00004228|580600929|FG002|Overall Study|Protocol Violation|2|||
160785006|NCT00004228|580600930|FG003|Overall Study|Protocol Violation|1|||
160785007|NCT00004228|580600931|FG004|Overall Study|Protocol Violation|1|||
160785008|NCT00004228|580600932|FG005|Overall Study|Protocol Violation|2|||
160785009|NCT00004228|580600933|FG006|Overall Study|Protocol Violation|0|||
160785010|NCT00004228|580600927|FG000|Overall Study|Withdrawal by Subject|3|||
160785011|NCT00004228|580600928|FG001|Overall Study|Withdrawal by Subject|0|||
160785012|NCT00004228|580600929|FG002|Overall Study|Withdrawal by Subject|1|||
160785013|NCT00004228|580600930|FG003|Overall Study|Withdrawal by Subject|0|||
160785014|NCT00004228|580600931|FG004|Overall Study|Withdrawal by Subject|2|||
160785015|NCT00004228|580600932|FG005|Overall Study|Withdrawal by Subject|1|||
160785016|NCT00004228|580600933|FG006|Overall Study|Withdrawal by Subject|2|||
160785017|NCT00004228|580600927|FG000|Overall Study|Other|0|||
160785018|NCT00004228|580600928|FG001|Overall Study|Other|0|||
160785019|NCT00004228|580600929|FG002|Overall Study|Other|1|||
160785020|NCT00004228|580600930|FG003|Overall Study|Other|0|||
160785021|NCT00004228|580600931|FG004|Overall Study|Other|0|||
160785022|NCT00004228|580600932|FG005|Overall Study|Other|0|||
160785023|NCT00004228|580600933|FG006|Overall Study|Other|0|||
160785024|NCT00004228|580600927|FG000|Overall Study|ineligible|4|||
160785025|NCT00004228|580600928|FG001|Overall Study|ineligible|2|||
160785026|NCT00004228|580600929|FG002|Overall Study|ineligible|4|||
160785027|NCT00004228|580600930|FG003|Overall Study|ineligible|1|||
160785028|NCT00004228|580600931|FG004|Overall Study|ineligible|1|||
160785029|NCT00004228|580600932|FG005|Overall Study|ineligible|2|||
160785030|NCT00004228|580600933|FG006|Overall Study|ineligible|5|||
160785031|NCT02168439|580600934|FG000|Overall Study|Protocol Violation|0|||
160785032|NCT02168439|580600935|FG001|Overall Study|Protocol Violation|2|||
160785033|NCT02004275|580600936|FG000|Phase 1|Ineligible|0|||
160785034|NCT02004275|580600937|FG001|Phase 1|Ineligible|0|||
160785035|NCT02004275|580600938|FG002|Phase 1|Ineligible|0|||
160785036|NCT02004275|580600939|FG003|Phase 1|Ineligible|1|||
160785037|NCT02004275|580600940|FG004|Phase 1|Ineligible|1|||
160785038|NCT02004275|580600941|FG005|Phase 1|Ineligible|0|||
160785039|NCT02004275|580600936|FG000|Phase 1|Protocol Violation|0|||
160785040|NCT02004275|580600937|FG001|Phase 1|Protocol Violation|0|||
160785041|NCT02004275|580600938|FG002|Phase 1|Protocol Violation|0|||
160785042|NCT02004275|580600939|FG003|Phase 1|Protocol Violation|1|||
160785043|NCT02004275|580600940|FG004|Phase 1|Protocol Violation|0|||
160785044|NCT02004275|580600941|FG005|Phase 1|Protocol Violation|5|||
160785045|NCT02004275|580600936|FG000|Phase 2 Part 1|Ineligible|6|||
160785046|NCT02004275|580600937|FG001|Phase 2 Part 1|Ineligible|9|||
160785047|NCT02004275|580600938|FG002|Phase 2 Part 1|Ineligible|0|||
160785048|NCT02004275|580600939|FG003|Phase 2 Part 1|Ineligible|0|||
160785049|NCT02004275|580600940|FG004|Phase 2 Part 1|Ineligible|0|||
160785050|NCT02004275|580600941|FG005|Phase 2 Part 1|Ineligible|0|||
160785051|NCT02004275|580600936|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
160785052|NCT02004275|580600937|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
160785053|NCT02004275|580600938|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
160785054|NCT02004275|580600939|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
161230716|NCT02170688|582225878|FG001|Overall Study|Physician Decision|0|||
161230717|NCT02170688|582225879|FG002|Overall Study|Physician Decision|1|||
161230718|NCT02170688|582225880|FG003|Overall Study|Physician Decision|0|||
161230719|NCT02170688|582225881|FG004|Overall Study|Physician Decision|0|||
161230720|NCT02079532|582225882|FG000|Overall Study|Adverse Event|7|||
161230721|NCT02079532|582225882|FG000|Overall Study|Additional or changed therapy|2|||
161230722|NCT02079532|582225882|FG000|Overall Study|Lack of Efficacy|9|||
161230723|NCT02079532|582225882|FG000|Overall Study|Protocol Violation|3|||
161230724|NCT02079532|582225882|FG000|Overall Study|Withdrawal by Subject|1|||
161230725|NCT02079532|582225882|FG000|Overall Study|Administrative problems|1|||
161230726|NCT02079532|582225882|FG000|Overall Study|Inclusion into ReFIRST|3|||
161230727|NCT02079532|582225882|FG000|Overall Study|Other|3|||
161230728|NCT01248247|582227249|FG000|Overall Study|Adverse Event|2|||
161328136|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161230729|NCT01248247|582227250|FG001|Overall Study|Adverse Event|4|||
161230730|NCT01248247|582227251|FG002|Overall Study|Adverse Event|4|||
161230731|NCT01248247|582227252|FG003|Overall Study|Adverse Event|2|||
161230732|NCT01248247|582227249|FG000|Overall Study|Death|0|||
161230733|NCT01248247|582227250|FG001|Overall Study|Death|1|||
161230734|NCT01248247|582227251|FG002|Overall Study|Death|4|||
161230735|NCT01248247|582227252|FG003|Overall Study|Death|7|||
161230736|NCT01248247|582227249|FG000|Overall Study|Lost to Follow-up|0|||
161230737|NCT01248247|582227250|FG001|Overall Study|Lost to Follow-up|1|||
161230738|NCT01248247|582227251|FG002|Overall Study|Lost to Follow-up|1|||
161230739|NCT01248247|582227252|FG003|Overall Study|Lost to Follow-up|0|||
161230740|NCT01248247|582227249|FG000|Overall Study|Alternative treatment|0|||
161230741|NCT01248247|582227250|FG001|Overall Study|Alternative treatment|1|||
161230742|NCT01248247|582227251|FG002|Overall Study|Alternative treatment|0|||
161230743|NCT01248247|582227252|FG003|Overall Study|Alternative treatment|0|||
161230744|NCT01248247|582227249|FG000|Overall Study|Other|2|||
161230745|NCT01248247|582227250|FG001|Overall Study|Other|8|||
161230746|NCT01248247|582227251|FG002|Overall Study|Other|8|||
161230747|NCT01248247|582227252|FG003|Overall Study|Other|5|||
161230748|NCT01248247|582227249|FG000|Overall Study|Progression|18|||
161230749|NCT01248247|582227250|FG001|Overall Study|Progression|27|||
161230750|NCT01248247|582227251|FG002|Overall Study|Progression|56|||
161230751|NCT01248247|582227252|FG003|Overall Study|Progression|44|||
161328137|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328138|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328139|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328140|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328141|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328142|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328143|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328144|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328145|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328146|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328147|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
161328148|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328149|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161328150|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
161328151|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328152|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328153|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161230752|NCT01248247|582227249|FG000|Overall Study|Refuse further treatment|0|||
161230753|NCT01248247|582227250|FG001|Overall Study|Refuse further treatment|0|||
161230754|NCT01248247|582227251|FG002|Overall Study|Refuse further treatment|1|||
161230755|NCT01248247|582227252|FG003|Overall Study|Refuse further treatment|2|||
161230756|NCT01248247|582227249|FG000|Overall Study|Complicating disease|0|||
161230757|NCT01248247|582227250|FG001|Overall Study|Complicating disease|0|||
161230758|NCT01248247|582227251|FG002|Overall Study|Complicating disease|1|||
161230759|NCT01248247|582227252|FG003|Overall Study|Complicating disease|1|||
161230760|NCT00549718|582227253|FG000|Overall Study|Insufficient clinical response|20|||
161230761|NCT00549718|582227254|FG001|Overall Study|Insufficient clinical response|7|||
161230762|NCT00549718|582227255|FG002|Overall Study|Insufficient clinical response|18|||
161230763|NCT00549718|582227256|FG003|Overall Study|Insufficient clinical response|32|||
161230764|NCT00549718|582227253|FG000|Overall Study|Adverse Event|6|||
161230765|NCT00549718|582227254|FG001|Overall Study|Adverse Event|8|||
161230766|NCT00549718|582227255|FG002|Overall Study|Adverse Event|7|||
161230767|NCT00549718|582227256|FG003|Overall Study|Adverse Event|3|||
161230768|NCT00549718|582227253|FG000|Overall Study|Lost to Follow-up|4|||
161230769|NCT00549718|582227254|FG001|Overall Study|Lost to Follow-up|2|||
161230770|NCT00549718|582227255|FG002|Overall Study|Lost to Follow-up|0|||
161230771|NCT00549718|582227256|FG003|Overall Study|Lost to Follow-up|6|||
160785055|NCT02004275|580600940|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
160785056|NCT02004275|580600941|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
160785057|NCT00493285|580600946|FG000|Overall Study|Lost to Follow-up|0|||
160785058|NCT00493285|580600947|FG001|Overall Study|Lost to Follow-up|0|||
160785059|NCT00493285|580600948|FG002|Overall Study|Lost to Follow-up|0|||
160785060|NCT00493285|580600949|FG003|Overall Study|Lost to Follow-up|0|||
160785061|NCT00493285|580600950|FG004|Overall Study|Lost to Follow-up|1|||
160785062|NCT00493285|580600951|FG005|Overall Study|Lost to Follow-up|0|||
160785063|NCT03021005|580600952|FG000|Overall Study|Lost to Follow-up|39|||
160785064|NCT03021005|580600953|FG001|Overall Study|Lost to Follow-up|26|||
160785065|NCT03188705|580600954|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
160785066|NCT03188705|580600954|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
160785067|NCT01174459|580600958|FG000|Overall Study|case report form (CRF) not collected|5|||
160785068|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
160785069|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
160785070|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
160785071|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
160785072|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
160785073|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
160785074|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
160785075|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
160785076|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
160785077|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
160785078|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
160785079|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
160785080|NCT00290758|580600959|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
160785081|NCT00290758|580600960|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
160785082|NCT00290758|580600959|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
161328154|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328155|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328156|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328157|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328158|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328159|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328160|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328161|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328162|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
161328163|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161328164|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161328165|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161328166|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328167|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328168|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328169|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328170|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328171|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328172|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328173|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161125440|NCT00130286|581845424|FG001|Overall Study|Adverse Event|0|||
161125441|NCT00130286|581845425|FG002|Overall Study|Adverse Event|2|||
161328174|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328175|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328176|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328177|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
161328178|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328179|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328180|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
161328181|NCT02326272|582587045|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328182|NCT02326272|582587046|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328183|NCT02326272|582587047|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160785083|NCT00290758|580600960|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
160785084|NCT00474968|580600962|FG000|Overall Study|Withdrawal by Subject|8|||
160785085|NCT00474968|580600963|FG001|Overall Study|Withdrawal by Subject|7|||
160785086|NCT00474968|580600962|FG000|Overall Study|Protocol Violation|9|||
160785087|NCT00474968|580600963|FG001|Overall Study|Protocol Violation|8|||
160785088|NCT00474968|580600962|FG000|Overall Study|Sample not collected|1|||
160785089|NCT00474968|580600963|FG001|Overall Study|Sample not collected|1|||
160785090|NCT01111292|580600964|FG000|Treatment|Physician Decision|1|||
160785091|NCT01111292|580600965|FG001|Treatment|Physician Decision|1|||
160785092|NCT00215553|580600966|FG000|Overall Study|Adverse Event|0|||
160785093|NCT00215553|580600967|FG001|Overall Study|Adverse Event|1|||
160785094|NCT00215553|580600968|FG002|Overall Study|Adverse Event|2|||
160785095|NCT00215553|580600969|FG003|Overall Study|Adverse Event|1|||
160785096|NCT00215553|580600970|FG004|Overall Study|Adverse Event|2|||
160785097|NCT00215553|580600971|FG005|Overall Study|Adverse Event|6|||
160785098|NCT00215553|580600972|FG006|Overall Study|Adverse Event|0|||
160785099|NCT04914000|580600973|FG000|Overall Study|Lost to Follow-up|8|||
160785100|NCT04914000|580600973|FG000|Overall Study|Withdrawal by Subject|1|||
160785101|NCT01658735|580600978|FG000|Overall Study|Lack of Efficacy|1|||
160785102|NCT01658735|580600979|FG001|Overall Study|Lack of Efficacy|0|||
160785103|NCT01658735|580600980|FG002|Overall Study|Lack of Efficacy|1|||
160785104|NCT01658735|580600978|FG000|Overall Study|Lost to Follow-up|1|||
160785105|NCT01658735|580600979|FG001|Overall Study|Lost to Follow-up|1|||
160785106|NCT01658735|580600980|FG002|Overall Study|Lost to Follow-up|0|||
160785107|NCT01658735|580600978|FG000|Overall Study|Protocol Violation|0|||
160785108|NCT01658735|580600979|FG001|Overall Study|Protocol Violation|1|||
160785109|NCT01658735|580600980|FG002|Overall Study|Protocol Violation|0|||
160785110|NCT01658735|580600978|FG000|Overall Study|Withdrawal by Subject|3|||
160785111|NCT01658735|580600979|FG001|Overall Study|Withdrawal by Subject|5|||
160785112|NCT01658735|580600980|FG002|Overall Study|Withdrawal by Subject|3|||
160785113|NCT02264821|580600981|FG000|Overall Study|Protocol Violation|1|||
160785114|NCT02264821|580600982|FG001|Overall Study|Protocol Violation|3|||
160785115|NCT02264821|580600983|FG002|Overall Study|Protocol Violation|6|||
160785116|NCT03142334|580600984|FG000|Overall Study|Death|18|||
160785117|NCT03142334|580600985|FG001|Overall Study|Death|33|||
160785118|NCT03142334|580600984|FG000|Overall Study|Withdrawal by Subject|15|||
160785119|NCT03142334|580600985|FG001|Overall Study|Withdrawal by Subject|11|||
160785120|NCT03142334|580600984|FG000|Overall Study|Ongoing on trial follow up|463|||
160785121|NCT03142334|580600985|FG001|Overall Study|Ongoing on trial follow up|454|||
160785122|NCT01217047|580600986|FG000|Overall Study|Lost to Follow-up|0|||
160785123|NCT01217047|580600987|FG001|Overall Study|Lost to Follow-up|1|||
160785124|NCT01217047|580600988|FG002|Overall Study|Lost to Follow-up|0|||
160785125|NCT01530997|580600989|FG000|Overall Study|Physician Decision|1|||
160785126|NCT01530997|580600989|FG000|Overall Study|Withdrawal by Subject|1|||
160785127|NCT02318277|580600990|FG000|Overall Study|Physician Decision|0|||
160785128|NCT02318277|580600991|FG001|Overall Study|Physician Decision|0|||
160785129|NCT02318277|580600992|FG002|Overall Study|Physician Decision|0|||
160785130|NCT02318277|580600993|FG003|Overall Study|Physician Decision|0|||
160785131|NCT02318277|580600994|FG004|Overall Study|Physician Decision|0|||
160785132|NCT02318277|580600995|FG005|Overall Study|Physician Decision|0|||
160785133|NCT02318277|580600996|FG006|Overall Study|Physician Decision|0|||
160785134|NCT02318277|580600997|FG007|Overall Study|Physician Decision|1|||
160785135|NCT02318277|580600990|FG000|Overall Study|Other|0|||
160785136|NCT02318277|580600991|FG001|Overall Study|Other|0|||
160785137|NCT02318277|580600992|FG002|Overall Study|Other|0|||
160785138|NCT02318277|580600993|FG003|Overall Study|Other|0|||
160785139|NCT02318277|580600994|FG004|Overall Study|Other|0|||
160785140|NCT02318277|580600995|FG005|Overall Study|Other|0|||
160785141|NCT02318277|580600996|FG006|Overall Study|Other|1|||
160785142|NCT02318277|580600997|FG007|Overall Study|Other|0|||
160785143|NCT02318277|580600990|FG000|Overall Study|Withdrawal by Subject|0|||
160785144|NCT02318277|580600991|FG001|Overall Study|Withdrawal by Subject|0|||
160785145|NCT02318277|580600992|FG002|Overall Study|Withdrawal by Subject|1|||
160785146|NCT02318277|580600993|FG003|Overall Study|Withdrawal by Subject|0|||
160785147|NCT02318277|580600994|FG004|Overall Study|Withdrawal by Subject|1|||
160785148|NCT02318277|580600995|FG005|Overall Study|Withdrawal by Subject|1|||
161125442|NCT00130286|581845426|FG003|Overall Study|Adverse Event|0|||
160785149|NCT02318277|580600996|FG006|Overall Study|Withdrawal by Subject|6|||
160785150|NCT02318277|580600997|FG007|Overall Study|Withdrawal by Subject|14|||
160785151|NCT02318277|580600990|FG000|Overall Study|Participant trial terminated by sponsor|0|||
160785152|NCT02318277|580600991|FG001|Overall Study|Participant trial terminated by sponsor|0|||
160785153|NCT02318277|580600992|FG002|Overall Study|Participant trial terminated by sponsor|1|||
160785154|NCT02318277|580600993|FG003|Overall Study|Participant trial terminated by sponsor|0|||
160785155|NCT02318277|580600994|FG004|Overall Study|Participant trial terminated by sponsor|1|||
160785156|NCT02318277|580600995|FG005|Overall Study|Participant trial terminated by sponsor|2|||
160785157|NCT02318277|580600996|FG006|Overall Study|Participant trial terminated by sponsor|5|||
160785158|NCT02318277|580600997|FG007|Overall Study|Participant trial terminated by sponsor|16|||
160785159|NCT02318277|580600990|FG000|Overall Study|Lost to Follow-up|1|||
160785160|NCT02318277|580600991|FG001|Overall Study|Lost to Follow-up|0|||
160785161|NCT02318277|580600992|FG002|Overall Study|Lost to Follow-up|1|||
161125443|NCT00130286|581845423|FG000|Overall Study|Missing lab specimens|0|||
160785162|NCT02318277|580600993|FG003|Overall Study|Lost to Follow-up|0|||
161125444|NCT00130286|581845424|FG001|Overall Study|Missing lab specimens|2|||
161125445|NCT00130286|581845425|FG002|Overall Study|Missing lab specimens|0|||
160785163|NCT02318277|580600994|FG004|Overall Study|Lost to Follow-up|0|||
160785164|NCT02318277|580600995|FG005|Overall Study|Lost to Follow-up|0|||
160785165|NCT02318277|580600996|FG006|Overall Study|Lost to Follow-up|3|||
160785166|NCT02318277|580600997|FG007|Overall Study|Lost to Follow-up|4|||
160785167|NCT02318277|580600990|FG000|Overall Study|Death|5|||
160785168|NCT02318277|580600991|FG001|Overall Study|Death|3|||
160785169|NCT02318277|580600992|FG002|Overall Study|Death|1|||
160785170|NCT02318277|580600993|FG003|Overall Study|Death|4|||
160785171|NCT02318277|580600994|FG004|Overall Study|Death|6|||
160785172|NCT02318277|580600995|FG005|Overall Study|Death|5|||
160785173|NCT02318277|580600996|FG006|Overall Study|Death|34|||
160785174|NCT02318277|580600997|FG007|Overall Study|Death|58|||
160785175|NCT02318277|580600990|FG000|Overall Study|Transitioned to Hospice|0|||
160785176|NCT02318277|580600991|FG001|Overall Study|Transitioned to Hospice|0|||
160785177|NCT02318277|580600992|FG002|Overall Study|Transitioned to Hospice|0|||
160785178|NCT02318277|580600993|FG003|Overall Study|Transitioned to Hospice|0|||
160785179|NCT02318277|580600994|FG004|Overall Study|Transitioned to Hospice|0|||
160785180|NCT02318277|580600995|FG005|Overall Study|Transitioned to Hospice|1|||
160785181|NCT02318277|580600996|FG006|Overall Study|Transitioned to Hospice|0|||
160785182|NCT02318277|580600997|FG007|Overall Study|Transitioned to Hospice|0|||
160785183|NCT02453191|580600998|FG000|Overall Study|Withdrawal by Subject|1|||
160785184|NCT03364686|580600999|FG000|Overall Study|Physician Decision|2|||
160785185|NCT01520714|580601000|FG000|Overall Study|Protocol Violation|0|||
160785186|NCT01520714|580601001|FG001|Overall Study|Protocol Violation|3|||
160785187|NCT01520714|580601000|FG000|Overall Study|Adverse Event|0|||
160785188|NCT01520714|580601001|FG001|Overall Study|Adverse Event|2|||
160785189|NCT01520714|580601000|FG000|Overall Study|Lack of Efficacy|0|||
160785190|NCT01520714|580601001|FG001|Overall Study|Lack of Efficacy|1|||
160785191|NCT01478087|580601005|FG000|Overall Study|due to sponsor closing study|1|||
160785192|NCT03566550|580601006|FG000|Overall Study|Withdrawal by Subject|0|||
160785193|NCT03566550|580601007|FG001|Overall Study|Withdrawal by Subject|1|||
160785194|NCT03518203|580601009|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
160785195|NCT03518203|580601009|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
160785196|NCT01084135|580601010|FG000|20 Week|Physician Decision|0|||
160785197|NCT01084135|580601011|FG001|20 Week|Physician Decision|1|||
160785198|NCT02366130|580601012|FG000|Overall Study|Withdrawal by Subject|3|||
161230772|NCT00549718|582227253|FG000|Overall Study|Withdrawal by Subject|9|||
161230773|NCT00549718|582227254|FG001|Overall Study|Withdrawal by Subject|18|||
161230774|NCT00549718|582227255|FG002|Overall Study|Withdrawal by Subject|12|||
161230775|NCT00549718|582227256|FG003|Overall Study|Withdrawal by Subject|13|||
161230776|NCT00549718|582227253|FG000|Overall Study|Administrative|2|||
161230777|NCT00549718|582227254|FG001|Overall Study|Administrative|2|||
161230778|NCT00549718|582227255|FG002|Overall Study|Administrative|2|||
161230779|NCT00549718|582227256|FG003|Overall Study|Administrative|1|||
161230780|NCT00397488|582227257|FG000|Overall Study|Withdrawal by Subject|3|||
161230781|NCT00397488|582227257|FG000|Overall Study|Adverse Event|3|||
161230782|NCT00397488|582227257|FG000|Overall Study|Death|1|||
161230783|NCT02880761|582227261|FG000|Overall Study|Death|6|||
161230784|NCT02880761|582227262|FG001|Overall Study|Death|8|||
161230785|NCT02880761|582227261|FG000|Overall Study|Withdrawal by Subject|3|||
161230786|NCT02880761|582227262|FG001|Overall Study|Withdrawal by Subject|6|||
161230787|NCT02880761|582227261|FG000|Overall Study|Protocol Violation|4|||
161230788|NCT02880761|582227262|FG001|Overall Study|Protocol Violation|3|||
161230789|NCT02880761|582227261|FG000|Overall Study|Lost to Follow-up|3|||
161230790|NCT02880761|582227262|FG001|Overall Study|Lost to Follow-up|4|||
161230791|NCT02943447|582227263|FG000|Blinded Study Phase|Withdrew Consent|1|||
161230792|NCT02943447|582227264|FG001|Blinded Study Phase|Withdrew Consent|2|||
161230793|NCT02943447|582227265|FG002|Blinded Study Phase|Withdrew Consent|1|||
161230794|NCT02943447|582227263|FG000|Blinded Study Phase|Adverse Event|3|||
161230795|NCT02943447|582227264|FG001|Blinded Study Phase|Adverse Event|0|||
161230796|NCT02943447|582227265|FG002|Blinded Study Phase|Adverse Event|0|||
161230797|NCT02943447|582227263|FG000|Blinded Study Phase|Investigator's discretion|1|||
161230798|NCT02943447|582227264|FG001|Blinded Study Phase|Investigator's discretion|0|||
160785199|NCT02366130|580601012|FG000|Overall Study|Ineligible|6|||
160785200|NCT01065766|580601013|FG000|Overall Study|Assessed before the contracted date|1|||
160785201|NCT01065766|580601013|FG000|Overall Study|Contraindication to administration|6|||
160785202|NCT01065766|580601013|FG000|Overall Study|Violated dosage/administration|25|||
160785203|NCT01608308|580601017|FG000|Overall Study|pretreatment medical and billing reasons|0|||
160785204|NCT01608308|580601018|FG001|Overall Study|pretreatment medical and billing reasons|2|||
161230799|NCT02943447|582227265|FG002|Blinded Study Phase|Investigator's discretion|0|||
161230800|NCT02943447|582227263|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
161230801|NCT02943447|582227264|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
161230802|NCT02943447|582227265|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
161230803|NCT02943447|582227263|FG000|Open-Label Extension Phase|Adverse Event|4|||
161230804|NCT02943447|582227264|FG001|Open-Label Extension Phase|Adverse Event|7|||
160785205|NCT02362412|580601023|FG000|Treatment Period III|Lost to Follow-up|0|||
161230805|NCT02943447|582227265|FG002|Open-Label Extension Phase|Adverse Event|3|||
161230806|NCT02943447|582227263|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
160785206|NCT02362412|580601024|FG001|Treatment Period III|Lost to Follow-up|1|||
160785207|NCT02675452|580601026|FG000|Overall Study|Sponsor decision|0|||
160785208|NCT02675452|580601027|FG001|Overall Study|Sponsor decision|0|||
160785209|NCT02675452|580601028|FG002|Overall Study|Sponsor decision|0|||
160785210|NCT02675452|580601029|FG003|Overall Study|Sponsor decision|0|||
160785211|NCT02675452|580601030|FG004|Overall Study|Sponsor decision|0|||
160785212|NCT02675452|580601031|FG005|Overall Study|Sponsor decision|0|||
160785213|NCT02675452|580601032|FG006|Overall Study|Sponsor decision|0|||
160785214|NCT02675452|580601033|FG007|Overall Study|Sponsor decision|0|||
160785215|NCT02675452|580601034|FG008|Overall Study|Sponsor decision|0|||
160785216|NCT02675452|580601035|FG009|Overall Study|Sponsor decision|1|||
160785217|NCT02675452|580601036|FG010|Overall Study|Sponsor decision|0|||
160785218|NCT02675452|580601037|FG011|Overall Study|Sponsor decision|0|||
160785219|NCT02675452|580601038|FG012|Overall Study|Sponsor decision|0|||
160785220|NCT02675452|580601039|FG013|Overall Study|Sponsor decision|2|||
160785221|NCT02675452|580601040|FG014|Overall Study|Sponsor decision|1|||
160785222|NCT02675452|580601041|FG015|Overall Study|Sponsor decision|0|||
160785223|NCT02675452|580601042|FG016|Overall Study|Sponsor decision|1|||
160785224|NCT02675452|580601043|FG017|Overall Study|Sponsor decision|0|||
160785225|NCT02675452|580601044|FG018|Overall Study|Sponsor decision|0|||
160785226|NCT02675452|580601045|FG019|Overall Study|Sponsor decision|0|||
160785227|NCT02675452|580601046|FG020|Overall Study|Sponsor decision|0|||
160785228|NCT02675452|580601047|FG021|Overall Study|Sponsor decision|0|||
160785229|NCT02675452|580601048|FG022|Overall Study|Sponsor decision|0|||
160785230|NCT02675452|580601049|FG023|Overall Study|Sponsor decision|0|||
160785231|NCT02675452|580601050|FG024|Overall Study|Sponsor decision|0|||
160785232|NCT02675452|580601051|FG025|Overall Study|Sponsor decision|0|||
160785233|NCT02675452|580601052|FG026|Overall Study|Sponsor decision|2|||
160785234|NCT02675452|580601053|FG027|Overall Study|Sponsor decision|0|||
160785235|NCT02675452|580601054|FG028|Overall Study|Sponsor decision|0|||
160785236|NCT02675452|580601026|FG000|Overall Study|Withdrawal by Subject|0|||
160785237|NCT02675452|580601027|FG001|Overall Study|Withdrawal by Subject|0|||
160785238|NCT02675452|580601028|FG002|Overall Study|Withdrawal by Subject|0|||
160785239|NCT02675452|580601029|FG003|Overall Study|Withdrawal by Subject|0|||
160785240|NCT02675452|580601030|FG004|Overall Study|Withdrawal by Subject|0|||
160785241|NCT02675452|580601031|FG005|Overall Study|Withdrawal by Subject|0|||
160785242|NCT02675452|580601032|FG006|Overall Study|Withdrawal by Subject|0|||
160785243|NCT02675452|580601033|FG007|Overall Study|Withdrawal by Subject|0|||
160785244|NCT02675452|580601034|FG008|Overall Study|Withdrawal by Subject|0|||
160785245|NCT02675452|580601035|FG009|Overall Study|Withdrawal by Subject|1|||
160785246|NCT02675452|580601036|FG010|Overall Study|Withdrawal by Subject|0|||
160785247|NCT02675452|580601037|FG011|Overall Study|Withdrawal by Subject|1|||
160785248|NCT02675452|580601038|FG012|Overall Study|Withdrawal by Subject|0|||
160785249|NCT02675452|580601039|FG013|Overall Study|Withdrawal by Subject|1|||
160785250|NCT02675452|580601040|FG014|Overall Study|Withdrawal by Subject|1|||
160785251|NCT02675452|580601041|FG015|Overall Study|Withdrawal by Subject|0|||
160785252|NCT02675452|580601042|FG016|Overall Study|Withdrawal by Subject|2|||
160785253|NCT02675452|580601043|FG017|Overall Study|Withdrawal by Subject|0|||
160785254|NCT02675452|580601044|FG018|Overall Study|Withdrawal by Subject|0|||
160785255|NCT02675452|580601045|FG019|Overall Study|Withdrawal by Subject|0|||
160785256|NCT02675452|580601046|FG020|Overall Study|Withdrawal by Subject|0|||
160785257|NCT02675452|580601047|FG021|Overall Study|Withdrawal by Subject|0|||
160785258|NCT02675452|580601048|FG022|Overall Study|Withdrawal by Subject|3|||
160785259|NCT02675452|580601049|FG023|Overall Study|Withdrawal by Subject|0|||
160785260|NCT02675452|580601050|FG024|Overall Study|Withdrawal by Subject|1|||
160785261|NCT02675452|580601051|FG025|Overall Study|Withdrawal by Subject|0|||
160785262|NCT02675452|580601052|FG026|Overall Study|Withdrawal by Subject|1|||
160785263|NCT02675452|580601053|FG027|Overall Study|Withdrawal by Subject|3|||
160785264|NCT02675452|580601054|FG028|Overall Study|Withdrawal by Subject|4|||
160785265|NCT02675452|580601026|FG000|Overall Study|Death|0|||
160785266|NCT02675452|580601027|FG001|Overall Study|Death|0|||
160785267|NCT02675452|580601028|FG002|Overall Study|Death|1|||
160890210|NCT00423670|580992972|FG005|Treatment Period|Investigator decision|0|||
160785268|NCT02675452|580601029|FG003|Overall Study|Death|0|||
160785269|NCT02675452|580601030|FG004|Overall Study|Death|0|||
160785270|NCT02675452|580601031|FG005|Overall Study|Death|1|||
160785271|NCT02675452|580601032|FG006|Overall Study|Death|0|||
160785272|NCT02675452|580601033|FG007|Overall Study|Death|0|||
161125446|NCT00130286|581845426|FG003|Overall Study|Missing lab specimens|0|||
161125447|NCT01818726|581845434|FG000|Overall Study|Administrative reasons|5|||
161125448|NCT01818726|581845435|FG001|Overall Study|Administrative reasons|1|||
161125449|NCT01818726|581845434|FG000|Overall Study|Withdrawal by Subject|0|||
161125450|NCT01818726|581845435|FG001|Overall Study|Withdrawal by Subject|1|||
161125451|NCT01818726|581845434|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
161125452|NCT01818726|581845435|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
161125453|NCT00357500|581845436|FG000|Overall Study|Adverse Event|3|||
161125454|NCT00357500|581845436|FG000|Overall Study|Withdrawal by Subject|5|||
161125455|NCT00357500|581845436|FG000|Overall Study|Progressive Disease|65|||
160785273|NCT02675452|580601034|FG008|Overall Study|Death|1|||
160785274|NCT02675452|580601035|FG009|Overall Study|Death|0|||
160785275|NCT02675452|580601036|FG010|Overall Study|Death|0|||
160785276|NCT02675452|580601037|FG011|Overall Study|Death|0|||
160785277|NCT02675452|580601038|FG012|Overall Study|Death|1|||
160785278|NCT02675452|580601039|FG013|Overall Study|Death|0|||
161125456|NCT00357500|581845436|FG000|Overall Study|Not Started Protocol Therapy|4|||
161125457|NCT00993928|581845437|FG000|Overall Study|Withdrawal by Subject|4|||
161125458|NCT00993928|581845438|FG001|Overall Study|Withdrawal by Subject|7|||
161125459|NCT00993928|581845437|FG000|Overall Study|ineligible|1|||
161125460|NCT00993928|581845438|FG001|Overall Study|ineligible|0|||
161125461|NCT02319044|581845440|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
161125462|NCT02319044|581845441|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
161125463|NCT02319044|581845442|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
161125464|NCT02319044|581845440|FG000|Overall Study|Withdrawal by Subject|3|||
161125465|NCT02319044|581845441|FG001|Overall Study|Withdrawal by Subject|3|||
161125466|NCT02319044|581845442|FG002|Overall Study|Withdrawal by Subject|6|||
161125467|NCT02319044|581845440|FG000|Overall Study|Condition under investigation worsened|100|||
161125468|NCT02319044|581845441|FG001|Overall Study|Condition under investigation worsened|50|||
161125469|NCT02319044|581845442|FG002|Overall Study|Condition under investigation worsened|46|||
161125470|NCT02319044|581845440|FG000|Overall Study|Adverse Event|17|||
161125471|NCT02319044|581845441|FG001|Overall Study|Adverse Event|2|||
161125472|NCT02319044|581845442|FG002|Overall Study|Adverse Event|8|||
161125473|NCT02319044|581845440|FG000|Overall Study|Study specific discontinuation criteria|2|||
161125474|NCT02319044|581845441|FG001|Overall Study|Study specific discontinuation criteria|2|||
161125475|NCT02319044|581845442|FG002|Overall Study|Study specific discontinuation criteria|1|||
161125476|NCT02319044|581845440|FG000|Overall Study|Not treated|0|||
161125477|NCT02319044|581845441|FG001|Overall Study|Not treated|2|||
161125478|NCT02319044|581845442|FG002|Overall Study|Not treated|2|||
161125479|NCT02154087|581845445|FG000|Overall Study|Study Termination|1|||
161125480|NCT03687502|581845446|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
161125481|NCT03687502|581845446|FG000|Overall Study|Lumason not available|1|||
161125482|NCT00486278|581845448|FG000|Overall Study|Adverse Event|5|||
161125483|NCT00486278|581845448|FG000|Overall Study|Withdrawal by Subject|2|||
161125484|NCT00486278|581845448|FG000|Overall Study|Physician Decision|2|||
161125485|NCT05702736|581845454|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
161125486|NCT05702736|581845455|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
161125487|NCT05702736|581845454|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
161125488|NCT05702736|581845455|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
161125489|NCT02482129|581845470|FG000|Overall Study|Adverse Event-prior to treatment|0|||
161125490|NCT02482129|581845471|FG001|Overall Study|Adverse Event-prior to treatment|1|||
161125491|NCT02482129|581845470|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
161125492|NCT02482129|581845471|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
161125493|NCT02482129|581845470|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
161125494|NCT02482129|581845471|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
161125495|NCT02482129|581845470|FG000|Overall Study|Criteria not met-prior to treatment|1|||
161125496|NCT02482129|581845471|FG001|Overall Study|Criteria not met-prior to treatment|0|||
161125497|NCT02482129|581845470|FG000|Overall Study|Adverse Event|1|||
161125498|NCT02482129|581845471|FG001|Overall Study|Adverse Event|0|||
161125499|NCT02482129|581845470|FG000|Overall Study|Withdrawal by Subject|2|||
161125500|NCT02482129|581845471|FG001|Overall Study|Withdrawal by Subject|0|||
161125501|NCT02482129|581845470|FG000|Overall Study|Criteria not met|1|||
161125502|NCT02482129|581845471|FG001|Overall Study|Criteria not met|0|||
161125503|NCT01031446|581845472|FG000|Overall Study|Disease Progression|38|||
161125504|NCT01031446|581845472|FG000|Overall Study|Adverse Event|9|||
161125505|NCT01031446|581845472|FG000|Overall Study|Physician Decision|4|||
161125506|NCT01031446|581845472|FG000|Overall Study|Withdrawal by Subject|3|||
161125507|NCT01031446|581845472|FG000|Overall Study|Still on treatment|1|||
161125508|NCT01877083|581845473|FG000|Treatment Phase|Disease Progression|10|||
161125509|NCT01877083|581845473|FG000|Treatment Phase|Clinical Progression|1|||
161125510|NCT01877083|581845473|FG000|Treatment Phase|Adverse Event|6|||
161125511|NCT01877083|581845473|FG000|Treatment Phase|Withdrawal by Subject|2|||
161125512|NCT01877083|581845473|FG000|Treatment Phase|Lost to Follow-up|1|||
161125513|NCT01877083|581845473|FG000|Extension Phase|Disease Progression|3|||
160785279|NCT02675452|580601040|FG014|Overall Study|Death|0|||
160981859|NCT02061761|581321785|FG003|Overall Study|Withdrawal by Subject|0|||
160981860|NCT02061761|581321786|FG004|Overall Study|Withdrawal by Subject|0|||
160981861|NCT02061761|581321787|FG005|Overall Study|Withdrawal by Subject|0|||
161125514|NCT01877083|581845473|FG000|Extension Phase|Adverse Event|2|||
161125515|NCT03344003|581845478|FG000|Overall Study|Switched to alternative treatment|1|||
161125516|NCT03344003|581845479|FG001|Overall Study|Switched to alternative treatment|0|||
161125517|NCT03344003|581845478|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
161125518|NCT03344003|581845479|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
160785280|NCT02675452|580601041|FG015|Overall Study|Death|2|||
161328184|NCT02326272|582587048|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328185|NCT02326272|582587049|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328186|NCT02326272|582587050|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328187|NCT02326272|582587051|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328188|NCT02326272|582587052|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328189|NCT02326272|582587053|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328190|NCT02326272|582587054|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328191|NCT02326272|582587055|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328192|NCT02326272|582587056|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161125519|NCT03786432|581846826|FG000|Overall Study|Screen Failure after consent|1|||
161125520|NCT03786432|581846826|FG000|Overall Study|Lost to Follow-up|4|||
161125521|NCT03786432|581846826|FG000|Overall Study|did not complete 12 month CT scan|1|||
161125522|NCT03988907|581846828|FG000|Overall Study|Unable to complete visit|0|||
161125523|NCT03988907|581846829|FG001|Overall Study|Unable to complete visit|1|||
161125524|NCT03523351|581846832|FG000|Overall Study|Death|13|||
161125525|NCT03523351|581846833|FG001|Overall Study|Death|11|||
161125526|NCT03523351|581846832|FG000|Overall Study|Lost to Follow-up|2|||
161125527|NCT03523351|581846833|FG001|Overall Study|Lost to Follow-up|3|||
161125528|NCT03523351|581846832|FG000|Overall Study|Withdrawal by Subject|4|||
161125529|NCT03523351|581846833|FG001|Overall Study|Withdrawal by Subject|0|||
161125530|NCT03523351|581846832|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
161125531|NCT03523351|581846833|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
161125532|NCT03609619|581846838|FG000|Overall Study|Adverse Event|1|||
161125533|NCT03609619|581846839|FG001|Overall Study|Adverse Event|0|||
161125534|NCT03609619|581846838|FG000|Overall Study|Lack of Efficacy|1|||
161125535|NCT03609619|581846839|FG001|Overall Study|Lack of Efficacy|2|||
161125536|NCT03609619|581846838|FG000|Overall Study|Protocol Violation|5|||
161125537|NCT03609619|581846839|FG001|Overall Study|Protocol Violation|0|||
161125538|NCT03609619|581846838|FG000|Overall Study|Withdrawal by Subject|2|||
161125539|NCT03609619|581846839|FG001|Overall Study|Withdrawal by Subject|3|||
161125540|NCT03609619|581846838|FG000|Overall Study|Lost to Follow-up|1|||
161125541|NCT03609619|581846839|FG001|Overall Study|Lost to Follow-up|1|||
161125542|NCT00568555|581846840|FG000|Overall Study|Withdrawal by Subject|1|||
161125543|NCT00568555|581846841|FG001|Overall Study|Withdrawal by Subject|1|||
161125544|NCT01231555|581846842|FG000|Overall Study|Study terminated|8|||
161125545|NCT01231555|581846843|FG001|Overall Study|Study terminated|5|||
161125546|NCT01231555|581846844|FG002|Overall Study|Study terminated|8|||
161125547|NCT01231555|581846842|FG000|Overall Study|Withdrawal by Subject|0|||
161125548|NCT01231555|581846843|FG001|Overall Study|Withdrawal by Subject|2|||
161125549|NCT01231555|581846844|FG002|Overall Study|Withdrawal by Subject|0|||
161125550|NCT00688909|581846845|FG000|Overall Study|Adverse Event|28|||
161125551|NCT00688909|581846845|FG000|Overall Study|Patient withdrew consent|2|||
161125552|NCT00688909|581846845|FG000|Overall Study|Administrative problems|1|||
161125553|NCT00688909|581846845|FG000|Overall Study|Protocol Violation|2|||
161125554|NCT00700180|581846851|FG000|Overall Study|Death|99|||
161125555|NCT00700180|581846852|FG001|Overall Study|Death|114|||
161125556|NCT00700180|581846851|FG000|Overall Study|Alive on treatment|5|||
161125557|NCT00700180|581846852|FG001|Overall Study|Alive on treatment|3|||
161125558|NCT00700180|581846851|FG000|Overall Study|Alive in follow-up|46|||
161125559|NCT00700180|581846852|FG001|Overall Study|Alive in follow-up|27|||
161125560|NCT00700180|581846851|FG000|Overall Study|Lost to Follow-up|4|||
161125561|NCT00700180|581846852|FG001|Overall Study|Lost to Follow-up|5|||
161125562|NCT03588741|581846853|FG000|Overall Study|Withdrawal by Subject|1|||
161125563|NCT01445535|581846854|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161125564|NCT01445535|581846855|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161125565|NCT01445535|581846856|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
161125566|NCT01445535|581846857|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
161125567|NCT01445535|581846854|FG000|Overall Study|Disease progression|1|||
161125568|NCT01445535|581846855|FG001|Overall Study|Disease progression|0|||
161125569|NCT01445535|581846856|FG002|Overall Study|Disease progression|1|||
161125570|NCT01445535|581846857|FG003|Overall Study|Disease progression|0|||
161125571|NCT01445535|581846854|FG000|Overall Study|PI discretion|0|||
161125572|NCT01445535|581846855|FG001|Overall Study|PI discretion|0|||
161125573|NCT01445535|581846856|FG002|Overall Study|PI discretion|0|||
161125574|NCT01445535|581846857|FG003|Overall Study|PI discretion|1|||
161125575|NCT01668654|581846862|FG000|Overall Study|Study Closed/Terminated|3|||
161125576|NCT01668654|581846862|FG000|Overall Study|Withdrawal by Subject|1|||
161125577|NCT00454779|581846863|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
161125578|NCT00454779|581846864|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
161125579|NCT00454779|581846863|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
161125580|NCT00454779|581846864|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
161125581|NCT00454779|581846863|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
161125582|NCT00454779|581846864|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
161125583|NCT00454779|581846863|FG000|First-line Treatment Phase|Protocol Violation|0|||
161125584|NCT00454779|581846864|FG001|First-line Treatment Phase|Protocol Violation|1|||
160785281|NCT02675452|580601042|FG016|Overall Study|Death|0|||
160785282|NCT02675452|580601043|FG017|Overall Study|Death|0|||
160785283|NCT02675452|580601044|FG018|Overall Study|Death|4|||
160785284|NCT02675452|580601045|FG019|Overall Study|Death|3|||
160785285|NCT02675452|580601046|FG020|Overall Study|Death|3|||
160785286|NCT02675452|580601047|FG021|Overall Study|Death|3|||
160785287|NCT02675452|580601048|FG022|Overall Study|Death|7|||
160785288|NCT02675452|580601049|FG023|Overall Study|Death|5|||
160785289|NCT02675452|580601050|FG024|Overall Study|Death|3|||
160785290|NCT02675452|580601051|FG025|Overall Study|Death|4|||
160785291|NCT02675452|580601052|FG026|Overall Study|Death|7|||
160785292|NCT02675452|580601053|FG027|Overall Study|Death|6|||
160785293|NCT02675452|580601054|FG028|Overall Study|Death|9|||
160785294|NCT02675452|580601026|FG000|Overall Study|Lost to Follow-up|0|||
160785295|NCT02675452|580601027|FG001|Overall Study|Lost to Follow-up|1|||
160785296|NCT02675452|580601028|FG002|Overall Study|Lost to Follow-up|0|||
160785297|NCT02675452|580601029|FG003|Overall Study|Lost to Follow-up|0|||
160785298|NCT02675452|580601030|FG004|Overall Study|Lost to Follow-up|0|||
161328193|NCT02326272|582587057|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
161328194|NCT02326272|582587058|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
160785299|NCT02675452|580601031|FG005|Overall Study|Lost to Follow-up|0|||
160785300|NCT02675452|580601032|FG006|Overall Study|Lost to Follow-up|0|||
160785301|NCT02675452|580601033|FG007|Overall Study|Lost to Follow-up|0|||
160785302|NCT02675452|580601034|FG008|Overall Study|Lost to Follow-up|0|||
160785303|NCT02675452|580601035|FG009|Overall Study|Lost to Follow-up|0|||
161125585|NCT00454779|581846863|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
161125586|NCT00454779|581846864|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
160785304|NCT02675452|580601036|FG010|Overall Study|Lost to Follow-up|0|||
160785305|NCT02675452|580601037|FG011|Overall Study|Lost to Follow-up|0|||
160785306|NCT02675452|580601038|FG012|Overall Study|Lost to Follow-up|1|||
160785307|NCT02675452|580601039|FG013|Overall Study|Lost to Follow-up|0|||
160785308|NCT02675452|580601040|FG014|Overall Study|Lost to Follow-up|0|||
160785309|NCT02675452|580601041|FG015|Overall Study|Lost to Follow-up|0|||
160785310|NCT02675452|580601042|FG016|Overall Study|Lost to Follow-up|0|||
160785311|NCT02675452|580601043|FG017|Overall Study|Lost to Follow-up|0|||
160785312|NCT02675452|580601044|FG018|Overall Study|Lost to Follow-up|0|||
160785313|NCT02675452|580601045|FG019|Overall Study|Lost to Follow-up|0|||
160785314|NCT02675452|580601046|FG020|Overall Study|Lost to Follow-up|0|||
160785315|NCT02675452|580601047|FG021|Overall Study|Lost to Follow-up|0|||
160785316|NCT02675452|580601048|FG022|Overall Study|Lost to Follow-up|0|||
160785317|NCT02675452|580601049|FG023|Overall Study|Lost to Follow-up|0|||
160785318|NCT02675452|580601050|FG024|Overall Study|Lost to Follow-up|0|||
160785319|NCT02675452|580601051|FG025|Overall Study|Lost to Follow-up|0|||
160785320|NCT02675452|580601052|FG026|Overall Study|Lost to Follow-up|1|||
160785321|NCT02675452|580601053|FG027|Overall Study|Lost to Follow-up|0|||
160785322|NCT02675452|580601054|FG028|Overall Study|Lost to Follow-up|0|||
160785323|NCT02675452|580601026|FG000|Overall Study|Other|0|||
160785324|NCT02675452|580601027|FG001|Overall Study|Other|0|||
160785325|NCT02675452|580601028|FG002|Overall Study|Other|0|||
160785326|NCT02675452|580601029|FG003|Overall Study|Other|0|||
160785327|NCT02675452|580601030|FG004|Overall Study|Other|0|||
160785328|NCT02675452|580601031|FG005|Overall Study|Other|0|||
160785329|NCT02675452|580601032|FG006|Overall Study|Other|0|||
160785330|NCT02675452|580601033|FG007|Overall Study|Other|0|||
160785331|NCT02675452|580601034|FG008|Overall Study|Other|0|||
160785332|NCT02675452|580601035|FG009|Overall Study|Other|0|||
160785333|NCT02675452|580601036|FG010|Overall Study|Other|0|||
160785334|NCT02675452|580601037|FG011|Overall Study|Other|0|||
161125587|NCT00454779|581846863|FG000|First-line Treatment Phase|Ongoing|1|||
161125588|NCT00454779|581846864|FG001|First-line Treatment Phase|Ongoing|0|||
161125589|NCT00454779|581846863|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
161125590|NCT00454779|581846864|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
161125591|NCT00454779|581846863|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
161125592|NCT00454779|581846864|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
160785335|NCT02675452|580601038|FG012|Overall Study|Other|0|||
160785336|NCT02675452|580601039|FG013|Overall Study|Other|0|||
160785337|NCT02675452|580601040|FG014|Overall Study|Other|0|||
160785338|NCT02675452|580601041|FG015|Overall Study|Other|0|||
160785339|NCT02675452|580601042|FG016|Overall Study|Other|0|||
160785340|NCT02675452|580601043|FG017|Overall Study|Other|0|||
160785341|NCT02675452|580601044|FG018|Overall Study|Other|0|||
160785342|NCT02675452|580601045|FG019|Overall Study|Other|0|||
160785343|NCT02675452|580601046|FG020|Overall Study|Other|0|||
160785344|NCT02675452|580601047|FG021|Overall Study|Other|0|||
160785345|NCT02675452|580601048|FG022|Overall Study|Other|0|||
160785346|NCT02675452|580601049|FG023|Overall Study|Other|0|||
160785347|NCT02675452|580601050|FG024|Overall Study|Other|0|||
160785348|NCT02675452|580601051|FG025|Overall Study|Other|0|||
160785349|NCT02675452|580601052|FG026|Overall Study|Other|1|||
160785350|NCT02675452|580601053|FG027|Overall Study|Other|0|||
160785351|NCT02675452|580601054|FG028|Overall Study|Other|0|||
160785352|NCT03467945|580601055|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161125593|NCT00454779|581846863|FG000|Second-line Treatment Phase|Ongoing|0|||
161125594|NCT00454779|581846864|FG001|Second-line Treatment Phase|Ongoing|1|||
161125595|NCT01337973|581846866|FG000|Overall Study|Lost to Follow-up|2|||
161125596|NCT01337973|581846867|FG001|Overall Study|Lost to Follow-up|4|||
161125597|NCT01337973|581846868|FG002|Overall Study|Lost to Follow-up|3|||
161125598|NCT01337973|581846866|FG000|Overall Study|Death|1|||
161125599|NCT01337973|581846867|FG001|Overall Study|Death|2|||
161125600|NCT01337973|581846868|FG002|Overall Study|Death|1|||
161125601|NCT01337973|581846866|FG000|Overall Study|Withdrawal by Subject|10|||
161125602|NCT01337973|581846867|FG001|Overall Study|Withdrawal by Subject|8|||
161125603|NCT01337973|581846868|FG002|Overall Study|Withdrawal by Subject|4|||
161125604|NCT01337973|581846866|FG000|Overall Study|missing data on primary outcome|3|||
161125605|NCT01337973|581846867|FG001|Overall Study|missing data on primary outcome|1|||
161125606|NCT01337973|581846868|FG002|Overall Study|missing data on primary outcome|3|||
161125607|NCT03634800|581846869|FG000|Overall Study|Adverse Event|1|||
161125608|NCT03634800|581846869|FG000|Overall Study|Disease Progression|4|||
161125609|NCT03634800|581846869|FG000|Overall Study|Withdrawal by Subject|1|||
161125610|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
161125611|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
161125612|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
161125613|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
161125614|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
161125615|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
161125616|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
161125617|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
161125618|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
161125619|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
161125620|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
161125621|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
161125622|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161125623|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161125624|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
161125625|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
161125626|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
161125627|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
161125628|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
161125629|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
161125630|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
161125631|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
161125632|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
161125633|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
161125634|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Death|2|||
161125635|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Death|1|||
161125636|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Death|2|||
161125637|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Graft loss|0|||
161125638|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Graft loss|2|||
161125639|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Graft loss|0|||
161125640|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
161125641|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
161125642|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
161125643|NCT01114529|581846870|FG000|Completed Study Medication at Month 24|Missing|2|||
161125644|NCT01114529|581846871|FG001|Completed Study Medication at Month 24|Missing|0|||
161125645|NCT01114529|581846872|FG002|Completed Study Medication at Month 24|Missing|0|||
161125646|NCT01114529|581846870|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
161125647|NCT01114529|581846871|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
161328195|NCT02326272|582587059|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
161328196|NCT01265394|582587078|FG000|Overall Study|Subjects withdrawn|37|||
161328197|NCT00928434|582587083|FG000|Overall Study|Adverse Event|14|||
161328198|NCT00928434|582587084|FG001|Overall Study|Adverse Event|5|||
161328199|NCT00928434|582587085|FG002|Overall Study|Adverse Event|18|||
161328200|NCT00928434|582587083|FG000|Overall Study|Protocol Violation|5|||
161328201|NCT00928434|582587084|FG001|Overall Study|Protocol Violation|0|||
161328202|NCT00928434|582587085|FG002|Overall Study|Protocol Violation|8|||
161328203|NCT00928434|582587083|FG000|Overall Study|Physician Decision|2|||
161328204|NCT00928434|582587084|FG001|Overall Study|Physician Decision|0|||
161328205|NCT00928434|582587085|FG002|Overall Study|Physician Decision|3|||
161328206|NCT00928434|582587083|FG000|Overall Study|Lost to Follow-up|1|||
161328207|NCT00928434|582587084|FG001|Overall Study|Lost to Follow-up|0|||
161328208|NCT00928434|582587085|FG002|Overall Study|Lost to Follow-up|3|||
161328209|NCT00928434|582587083|FG000|Overall Study|Withdrawal by Subject|5|||
160785353|NCT03467945|580601056|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160785354|NCT03467945|580601057|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160785355|NCT03467945|580601058|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160785356|NCT03467945|580601055|FG000|Treatment Period 3|Withdrawal by Subject|1|||
160785357|NCT03467945|580601056|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160785358|NCT03467945|580601057|FG002|Treatment Period 3|Withdrawal by Subject|2|||
160785359|NCT03467945|580601058|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160785360|NCT04595370|580601073|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
160785361|NCT04595370|580601074|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785362|NCT04595370|580601075|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785363|NCT04595370|580601076|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785364|NCT04595370|580601077|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785365|NCT04595370|580601078|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
160785366|NCT04595370|580601073|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785367|NCT04595370|580601074|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785368|NCT04595370|580601075|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
160785369|NCT04595370|580601076|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785370|NCT04595370|580601077|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785371|NCT04595370|580601078|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
160785372|NCT04595370|580601073|FG000|Overall Study|Adverse Event|0|||
160785373|NCT04595370|580601074|FG001|Overall Study|Adverse Event|4|||
160785374|NCT04595370|580601075|FG002|Overall Study|Adverse Event|3|||
160785375|NCT04595370|580601076|FG003|Overall Study|Adverse Event|1|||
160785376|NCT04595370|580601077|FG004|Overall Study|Adverse Event|1|||
160785377|NCT04595370|580601078|FG005|Overall Study|Adverse Event|1|||
160785378|NCT04595370|580601073|FG000|Overall Study|Withdrawal of Consent|1|||
160785379|NCT04595370|580601074|FG001|Overall Study|Withdrawal of Consent|1|||
160785380|NCT04595370|580601075|FG002|Overall Study|Withdrawal of Consent|1|||
160785381|NCT04595370|580601076|FG003|Overall Study|Withdrawal of Consent|0|||
160785382|NCT04595370|580601077|FG004|Overall Study|Withdrawal of Consent|0|||
160785383|NCT04595370|580601078|FG005|Overall Study|Withdrawal of Consent|0|||
160785384|NCT04595370|580601073|FG000|Overall Study|Death|0|||
160785385|NCT04595370|580601074|FG001|Overall Study|Death|1|||
160785386|NCT04595370|580601075|FG002|Overall Study|Death|0|||
160785387|NCT04595370|580601076|FG003|Overall Study|Death|0|||
160785388|NCT04595370|580601077|FG004|Overall Study|Death|1|||
160785389|NCT04595370|580601078|FG005|Overall Study|Death|0|||
160785390|NCT04595370|580601073|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785391|NCT04595370|580601074|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785392|NCT04595370|580601075|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160785393|NCT04595370|580601076|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785394|NCT04595370|580601077|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785395|NCT04595370|580601078|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160785396|NCT04595370|580601073|FG000|Overall Study|Withdrawal by Subject|0|||
160785397|NCT04595370|580601074|FG001|Overall Study|Withdrawal by Subject|0|||
160785398|NCT04595370|580601075|FG002|Overall Study|Withdrawal by Subject|1|||
161230807|NCT02943447|582227264|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
161230808|NCT02943447|582227265|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
161230809|NCT02943447|582227263|FG000|Open-Label Extension Phase|Withdrew consent|1|||
161230810|NCT02943447|582227264|FG001|Open-Label Extension Phase|Withdrew consent|1|||
161230811|NCT02943447|582227265|FG002|Open-Label Extension Phase|Withdrew consent|1|||
161230812|NCT02943447|582227263|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161230813|NCT02943447|582227264|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161230814|NCT02943447|582227265|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161230815|NCT02106156|582227266|FG000|Overall Study|Patient Died|19|||
161230816|NCT02106156|582227267|FG001|Overall Study|Patient Died|0|||
161230817|NCT02106156|582227268|FG002|Overall Study|Patient Died|0|||
161230818|NCT02106156|582227266|FG000|Overall Study|Lack of Tolerability|305|||
161230819|NCT02106156|582227267|FG001|Overall Study|Lack of Tolerability|3|||
161230820|NCT02106156|582227268|FG002|Overall Study|Lack of Tolerability|0|||
161230821|NCT02106156|582227266|FG000|Overall Study|Lack of Virological Response|1044|||
161230822|NCT02106156|582227267|FG001|Overall Study|Lack of Virological Response|8|||
161230823|NCT02106156|582227268|FG002|Overall Study|Lack of Virological Response|0|||
161230824|NCT02106156|582227266|FG000|Overall Study|Concomitant Disease|74|||
161230825|NCT02106156|582227267|FG001|Overall Study|Concomitant Disease|2|||
161230826|NCT02106156|582227268|FG002|Overall Study|Concomitant Disease|0|||
161230827|NCT02106156|582227266|FG000|Overall Study|Lack of Compliance|211|||
161230828|NCT02106156|582227267|FG001|Overall Study|Lack of Compliance|7|||
161230829|NCT02106156|582227268|FG002|Overall Study|Lack of Compliance|0|||
161230830|NCT02106156|582227266|FG000|Overall Study|Patients Request|307|||
161230831|NCT02106156|582227267|FG001|Overall Study|Patients Request|9|||
161230832|NCT02106156|582227268|FG002|Overall Study|Patients Request|0|||
160785399|NCT04595370|580601076|FG003|Overall Study|Withdrawal by Subject|0|||
160785400|NCT04595370|580601077|FG004|Overall Study|Withdrawal by Subject|2|||
160785401|NCT04595370|580601078|FG005|Overall Study|Withdrawal by Subject|0|||
160785402|NCT04595370|580601073|FG000|Overall Study|Lost to Follow-up|0|||
160785403|NCT04595370|580601074|FG001|Overall Study|Lost to Follow-up|0|||
160785404|NCT04595370|580601075|FG002|Overall Study|Lost to Follow-up|0|||
160785405|NCT04595370|580601076|FG003|Overall Study|Lost to Follow-up|0|||
160785406|NCT04595370|580601077|FG004|Overall Study|Lost to Follow-up|1|||
160785407|NCT04595370|580601078|FG005|Overall Study|Lost to Follow-up|0|||
160785408|NCT04595370|580601073|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
160785409|NCT04595370|580601074|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
160785410|NCT04595370|580601075|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
160785411|NCT04595370|580601076|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
160785412|NCT04595370|580601077|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
160785413|NCT04595370|580601078|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
160785414|NCT00541775|580601079|FG000|Overall Study|Adverse Event|3|||
160785415|NCT00541775|580601080|FG001|Overall Study|Adverse Event|2|||
160785416|NCT00541775|580601081|FG002|Overall Study|Adverse Event|1|||
160785417|NCT00541775|580601079|FG000|Overall Study|Lack of Efficacy|0|||
160785418|NCT00541775|580601080|FG001|Overall Study|Lack of Efficacy|0|||
160785419|NCT00541775|580601081|FG002|Overall Study|Lack of Efficacy|3|||
160785420|NCT00541775|580601079|FG000|Overall Study|Lost to Follow-up|0|||
160785421|NCT00541775|580601080|FG001|Overall Study|Lost to Follow-up|0|||
160785422|NCT00541775|580601081|FG002|Overall Study|Lost to Follow-up|2|||
160785423|NCT00541775|580601079|FG000|Overall Study|Protocol Violation|1|||
160785424|NCT00541775|580601080|FG001|Overall Study|Protocol Violation|0|||
160785425|NCT00541775|580601081|FG002|Overall Study|Protocol Violation|0|||
161328210|NCT00928434|582587084|FG001|Overall Study|Withdrawal by Subject|3|||
161328211|NCT00928434|582587085|FG002|Overall Study|Withdrawal by Subject|2|||
161328212|NCT00928434|582587083|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
161328213|NCT00928434|582587084|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
161328214|NCT00928434|582587085|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
161328215|NCT00928434|582587083|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
161328216|NCT00928434|582587084|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
161328217|NCT00928434|582587085|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
161328218|NCT00928434|582587083|FG000|Overall Study|Other (not meeting above criteria)|5|||
161328219|NCT00928434|582587084|FG001|Overall Study|Other (not meeting above criteria)|1|||
161328220|NCT00928434|582587085|FG002|Overall Study|Other (not meeting above criteria)|2|||
161328221|NCT00447772|582587086|FG000|Overall Study|Lack of Efficacy|3|||
161328222|NCT00447772|582587086|FG000|Overall Study|Insufficient compliance|6|||
161328223|NCT00447772|582587086|FG000|Overall Study|Discontinuation of drug therapy|1|||
161328224|NCT00447772|582587086|FG000|Overall Study|Lost to Follow-up|9|||
161328225|NCT00447772|582587086|FG000|Overall Study|Withdrawal by Subject|1|||
161328226|NCT00447772|582587086|FG000|Overall Study|Unable to attend all study visits|2|||
161328227|NCT00447772|582587086|FG000|Overall Study|Adverse Event|1|||
161328228|NCT00447772|582587086|FG000|Overall Study|Patient relocated|1|||
161328229|NCT00447772|582587086|FG000|Overall Study|Incomplete documentation at visit 1|1|||
161328230|NCT00447772|582587086|FG000|Overall Study|Chemotherapy for lung cancer|1|||
161328231|NCT00447772|582587086|FG000|Overall Study|Premature re-injection required|1|||
161328232|NCT00716456|582587087|FG000|Overall Study|Adverse Event|0|||
161328233|NCT00716456|582587088|FG001|Overall Study|Adverse Event|2|||
161328234|NCT00716456|582587089|FG002|Overall Study|Adverse Event|0|||
161328235|NCT05417412|582587091|FG000|Overall Study|Lost to Follow-up|2|||
161328236|NCT01576575|582587092|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
161328237|NCT01576575|582587092|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
161328238|NCT01576575|582587092|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
161328239|NCT01723072|582587097|FG000|Overall Study|Withdrawal by Subject|7|||
161328240|NCT01723072|582587098|FG001|Overall Study|Withdrawal by Subject|13|||
161328241|NCT01723072|582587097|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
161328242|NCT01723072|582587098|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
161328243|NCT01723072|582587097|FG000|Overall Study|Other|4|||
161328244|NCT01723072|582587098|FG001|Overall Study|Other|3|||
160785426|NCT00541775|580601079|FG000|Overall Study|Withdrawal by Subject and Other|5|||
160785427|NCT00541775|580601080|FG001|Overall Study|Withdrawal by Subject and Other|0|||
160785428|NCT00541775|580601081|FG002|Overall Study|Withdrawal by Subject and Other|2|||
160785429|NCT01945242|580601082|FG000|Overall Study|Physician Decision|3|||
160785430|NCT01945242|580601083|FG001|Overall Study|Physician Decision|3|||
160785431|NCT00032487|580601084|FG000|Overall Study|Withdrawal by Subject|67|||
160785432|NCT00032487|580601085|FG001|Overall Study|Withdrawal by Subject|43|||
160785433|NCT00032487|580601084|FG000|Overall Study|Adverse Event|3|||
161328245|NCT01841970|582587099|FG000|Overall Study|Withdrawal by Subject|1|||
161328246|NCT01841970|582587099|FG000|Overall Study|Physician Decision|2|||
161328247|NCT01841970|582587099|FG000|Overall Study|Lost to Follow-up|8|||
161328248|NCT01610037|582587106|FG000|All Patients|Adverse Event|27|||
160785434|NCT00032487|580601085|FG001|Overall Study|Adverse Event|7|||
160785435|NCT00032487|580601084|FG000|Overall Study|Lost to Follow-up|57|||
160785436|NCT00032487|580601085|FG001|Overall Study|Lost to Follow-up|58|||
160785437|NCT00032487|580601084|FG000|Overall Study|Had other reason|12|||
160785438|NCT00032487|580601085|FG001|Overall Study|Had other reason|12|||
160785439|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Death|0|||
160785440|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Death|2|||
160785441|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Death|2|||
160785442|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Death|0|||
160785443|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
160785444|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
160785445|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
160785446|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
160785447|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
160785448|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
160785449|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
160785450|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
160785451|NCT04913675|580601087|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
160785452|NCT04913675|580601088|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
160785453|NCT04913675|580601089|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
160785454|NCT04913675|580601090|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
160785455|NCT04913675|580601087|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
160785456|NCT04913675|580601088|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
160785457|NCT04913675|580601089|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
160785458|NCT04913675|580601090|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
161125648|NCT01114529|581846872|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
161125649|NCT01114529|581846870|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
161125650|NCT01114529|581846871|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
160785462|NCT01541254|580601094|FG000|Overall Study|Withdrawal by Subject|1|||
160785463|NCT01541254|580601094|FG000|Overall Study|excluded - metal allergy|1|||
160785464|NCT01541254|580601094|FG000|Overall Study|enrolled after study closed|1|||
160785465|NCT01541254|580601094|FG000|Overall Study|GI bleed prior to procedure|1|||
160785466|NCT01541254|580601094|FG000|Overall Study|stent not required|1|||
160785467|NCT01541254|580601094|FG000|Overall Study|alternate stent used|1|||
160785468|NCT05660538|580601095|FG000|Overall Study|Adverse Event|0|||
160785469|NCT05660538|580601096|FG001|Overall Study|Adverse Event|0|||
160785470|NCT05660538|580601097|FG002|Overall Study|Adverse Event|1|||
160785471|NCT05660538|580601098|FG003|Overall Study|Adverse Event|0|||
160785472|NCT05660538|580601095|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160785473|NCT05660538|580601096|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
160785474|NCT05660538|580601097|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
160785475|NCT05660538|580601098|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
160785476|NCT05660538|580601095|FG000|Overall Study|Lost to Follow-up|0|||
160785477|NCT05660538|580601096|FG001|Overall Study|Lost to Follow-up|0|||
160785478|NCT05660538|580601097|FG002|Overall Study|Lost to Follow-up|1|||
160785479|NCT05660538|580601098|FG003|Overall Study|Lost to Follow-up|1|||
160785480|NCT05660538|580601095|FG000|Overall Study|Death|0|||
161230833|NCT02106156|582227266|FG000|Overall Study|Lost to Follow-up|451|||
160785481|NCT05660538|580601096|FG001|Overall Study|Death|0|||
160785482|NCT05660538|580601097|FG002|Overall Study|Death|1|||
160785483|NCT05660538|580601098|FG003|Overall Study|Death|0|||
160785484|NCT05660538|580601095|FG000|Overall Study|Physician Decision|0|||
160785485|NCT05660538|580601096|FG001|Overall Study|Physician Decision|0|||
160785486|NCT05660538|580601097|FG002|Overall Study|Physician Decision|0|||
160785487|NCT05660538|580601098|FG003|Overall Study|Physician Decision|1|||
160785488|NCT05660538|580601095|FG000|Overall Study|Sponsor Decision|1|||
160785489|NCT05660538|580601096|FG001|Overall Study|Sponsor Decision|0|||
160785490|NCT05660538|580601097|FG002|Overall Study|Sponsor Decision|0|||
160785491|NCT05660538|580601098|FG003|Overall Study|Sponsor Decision|0|||
160785492|NCT05660538|580601095|FG000|Overall Study|Other|1|||
160785493|NCT05660538|580601096|FG001|Overall Study|Other|0|||
160785494|NCT05660538|580601097|FG002|Overall Study|Other|0|||
160785495|NCT05660538|580601098|FG003|Overall Study|Other|1|||
160785496|NCT05660538|580601095|FG000|Overall Study|Randomized but did not receive study drug|1|||
160785497|NCT05660538|580601096|FG001|Overall Study|Randomized but did not receive study drug|0|||
160785498|NCT05660538|580601097|FG002|Overall Study|Randomized but did not receive study drug|0|||
160785499|NCT05660538|580601098|FG003|Overall Study|Randomized but did not receive study drug|1|||
160785500|NCT05660538|580601095|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
160785501|NCT05660538|580601096|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
160785502|NCT05660538|580601097|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
160785503|NCT05660538|580601098|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
160785504|NCT04518410|580601099|FG000|Overall Study|Lost to Follow-up|1|||
160785505|NCT04518410|580601100|FG001|Overall Study|Lost to Follow-up|1|||
160785506|NCT04518410|580601101|FG002|Overall Study|Lost to Follow-up|8|||
160785507|NCT04518410|580601102|FG003|Overall Study|Lost to Follow-up|5|||
160785508|NCT04518410|580601103|FG004|Overall Study|Lost to Follow-up|92|||
160785509|NCT04518410|580601104|FG005|Overall Study|Lost to Follow-up|25|||
160785510|NCT04518410|580601105|FG006|Overall Study|Lost to Follow-up|25|||
160785511|NCT04518410|580601106|FG007|Overall Study|Lost to Follow-up|3|||
160785512|NCT04518410|580601107|FG008|Overall Study|Lost to Follow-up|2|||
160785513|NCT04518410|580601108|FG009|Overall Study|Lost to Follow-up|13|||
160785514|NCT04518410|580601109|FG010|Overall Study|Lost to Follow-up|9|||
160785515|NCT04518410|580601110|FG011|Overall Study|Lost to Follow-up|13|||
160785516|NCT04518410|580601111|FG012|Overall Study|Lost to Follow-up|9|||
160785517|NCT04518410|580601112|FG013|Overall Study|Lost to Follow-up|13|||
160785518|NCT04518410|580601113|FG014|Overall Study|Lost to Follow-up|8|||
160785519|NCT04518410|580601114|FG015|Overall Study|Lost to Follow-up|10|||
160785520|NCT04518410|580601115|FG016|Overall Study|Lost to Follow-up|6|||
160785521|NCT04518410|580601116|FG017|Overall Study|Lost to Follow-up|13|||
160785522|NCT04518410|580601117|FG018|Overall Study|Lost to Follow-up|21|||
160785523|NCT04518410|580601118|FG019|Overall Study|Lost to Follow-up|6|||
160785524|NCT04518410|580601119|FG020|Overall Study|Lost to Follow-up|7|||
160785525|NCT04518410|580601120|FG021|Overall Study|Lost to Follow-up|21|||
160785526|NCT04518410|580601121|FG022|Overall Study|Lost to Follow-up|1|||
160785527|NCT04518410|580601122|FG023|Overall Study|Lost to Follow-up|7|||
160785528|NCT04518410|580601123|FG024|Overall Study|Lost to Follow-up|6|||
160785529|NCT04518410|580601099|FG000|Overall Study|Withdrawal by Subject|1|||
160785530|NCT04518410|580601100|FG001|Overall Study|Withdrawal by Subject|2|||
160785531|NCT04518410|580601101|FG002|Overall Study|Withdrawal by Subject|2|||
160785532|NCT04518410|580601102|FG003|Overall Study|Withdrawal by Subject|3|||
160785533|NCT04518410|580601103|FG004|Overall Study|Withdrawal by Subject|20|||
160785534|NCT04518410|580601104|FG005|Overall Study|Withdrawal by Subject|20|||
160785535|NCT04518410|580601105|FG006|Overall Study|Withdrawal by Subject|25|||
160785536|NCT04518410|580601106|FG007|Overall Study|Withdrawal by Subject|6|||
160785537|NCT04518410|580601107|FG008|Overall Study|Withdrawal by Subject|1|||
160785538|NCT04518410|580601108|FG009|Overall Study|Withdrawal by Subject|12|||
160785539|NCT04518410|580601109|FG010|Overall Study|Withdrawal by Subject|5|||
160785540|NCT04518410|580601110|FG011|Overall Study|Withdrawal by Subject|7|||
160785541|NCT04518410|580601111|FG012|Overall Study|Withdrawal by Subject|2|||
160785542|NCT04518410|580601112|FG013|Overall Study|Withdrawal by Subject|13|||
160785543|NCT04518410|580601113|FG014|Overall Study|Withdrawal by Subject|4|||
160785544|NCT04518410|580601114|FG015|Overall Study|Withdrawal by Subject|9|||
160785545|NCT04518410|580601115|FG016|Overall Study|Withdrawal by Subject|0|||
160785546|NCT04518410|580601116|FG017|Overall Study|Withdrawal by Subject|15|||
160785547|NCT04518410|580601117|FG018|Overall Study|Withdrawal by Subject|12|||
160785548|NCT04518410|580601118|FG019|Overall Study|Withdrawal by Subject|9|||
160785549|NCT04518410|580601119|FG020|Overall Study|Withdrawal by Subject|14|||
160785550|NCT04518410|580601120|FG021|Overall Study|Withdrawal by Subject|3|||
160785551|NCT04518410|580601121|FG022|Overall Study|Withdrawal by Subject|2|||
160785552|NCT04518410|580601122|FG023|Overall Study|Withdrawal by Subject|9|||
160785553|NCT04518410|580601123|FG024|Overall Study|Withdrawal by Subject|8|||
160785554|NCT04518410|580601099|FG000|Overall Study|Other|1|||
160785555|NCT04518410|580601100|FG001|Overall Study|Other|0|||
160785556|NCT04518410|580601101|FG002|Overall Study|Other|0|||
160785557|NCT04518410|580601102|FG003|Overall Study|Other|1|||
160785558|NCT04518410|580601103|FG004|Overall Study|Other|6|||
160785559|NCT04518410|580601104|FG005|Overall Study|Other|6|||
160785560|NCT04518410|580601105|FG006|Overall Study|Other|5|||
160785561|NCT04518410|580601106|FG007|Overall Study|Other|2|||
160785562|NCT04518410|580601107|FG008|Overall Study|Other|0|||
160785563|NCT04518410|580601108|FG009|Overall Study|Other|1|||
160785564|NCT04518410|580601109|FG010|Overall Study|Other|0|||
160785565|NCT04518410|580601110|FG011|Overall Study|Other|2|||
160785566|NCT04518410|580601111|FG012|Overall Study|Other|0|||
160785567|NCT04518410|580601112|FG013|Overall Study|Other|0|||
160785568|NCT04518410|580601113|FG014|Overall Study|Other|0|||
160785569|NCT04518410|580601114|FG015|Overall Study|Other|3|||
160785570|NCT04518410|580601115|FG016|Overall Study|Other|1|||
160785571|NCT04518410|580601116|FG017|Overall Study|Other|1|||
160785572|NCT04518410|580601117|FG018|Overall Study|Other|1|||
160785573|NCT04518410|580601118|FG019|Overall Study|Other|0|||
160785574|NCT04518410|580601119|FG020|Overall Study|Other|1|||
160785575|NCT04518410|580601120|FG021|Overall Study|Other|0|||
160785576|NCT04518410|580601121|FG022|Overall Study|Other|1|||
160785577|NCT04518410|580601122|FG023|Overall Study|Other|2|||
160785578|NCT04518410|580601123|FG024|Overall Study|Other|2|||
160785579|NCT04518410|580601099|FG000|Overall Study|Protocol Violation|0|||
160785580|NCT04518410|580601100|FG001|Overall Study|Protocol Violation|0|||
160785581|NCT04518410|580601101|FG002|Overall Study|Protocol Violation|0|||
160785582|NCT04518410|580601102|FG003|Overall Study|Protocol Violation|2|||
160785583|NCT04518410|580601103|FG004|Overall Study|Protocol Violation|17|||
160785584|NCT04518410|580601104|FG005|Overall Study|Protocol Violation|1|||
160785585|NCT04518410|580601105|FG006|Overall Study|Protocol Violation|2|||
160785586|NCT04518410|580601106|FG007|Overall Study|Protocol Violation|1|||
160785587|NCT04518410|580601107|FG008|Overall Study|Protocol Violation|0|||
160785588|NCT04518410|580601108|FG009|Overall Study|Protocol Violation|0|||
160785589|NCT04518410|580601109|FG010|Overall Study|Protocol Violation|0|||
160785590|NCT04518410|580601110|FG011|Overall Study|Protocol Violation|0|||
160785591|NCT04518410|580601111|FG012|Overall Study|Protocol Violation|0|||
160785592|NCT04518410|580601112|FG013|Overall Study|Protocol Violation|0|||
160785593|NCT04518410|580601113|FG014|Overall Study|Protocol Violation|0|||
160785594|NCT04518410|580601114|FG015|Overall Study|Protocol Violation|0|||
160785595|NCT04518410|580601115|FG016|Overall Study|Protocol Violation|1|||
160785596|NCT04518410|580601116|FG017|Overall Study|Protocol Violation|1|||
160785597|NCT04518410|580601117|FG018|Overall Study|Protocol Violation|0|||
160785598|NCT04518410|580601118|FG019|Overall Study|Protocol Violation|0|||
160785599|NCT04518410|580601119|FG020|Overall Study|Protocol Violation|1|||
160785600|NCT04518410|580601120|FG021|Overall Study|Protocol Violation|2|||
160785601|NCT04518410|580601121|FG022|Overall Study|Protocol Violation|0|||
160785602|NCT04518410|580601122|FG023|Overall Study|Protocol Violation|3|||
160785603|NCT04518410|580601123|FG024|Overall Study|Protocol Violation|0|||
160785604|NCT04518410|580601099|FG000|Overall Study|Death|0|||
160785605|NCT04518410|580601100|FG001|Overall Study|Death|0|||
160785606|NCT04518410|580601101|FG002|Overall Study|Death|0|||
160785607|NCT04518410|580601102|FG003|Overall Study|Death|0|||
160785608|NCT04518410|580601103|FG004|Overall Study|Death|12|||
160785609|NCT04518410|580601104|FG005|Overall Study|Death|2|||
160785610|NCT04518410|580601105|FG006|Overall Study|Death|11|||
160785611|NCT04518410|580601106|FG007|Overall Study|Death|0|||
160785612|NCT04518410|580601107|FG008|Overall Study|Death|1|||
160785613|NCT04518410|580601108|FG009|Overall Study|Death|0|||
160785614|NCT04518410|580601109|FG010|Overall Study|Death|0|||
160785615|NCT04518410|580601110|FG011|Overall Study|Death|0|||
160785616|NCT04518410|580601111|FG012|Overall Study|Death|0|||
160785617|NCT04518410|580601112|FG013|Overall Study|Death|1|||
160785618|NCT04518410|580601113|FG014|Overall Study|Death|1|||
160785619|NCT04518410|580601114|FG015|Overall Study|Death|0|||
160785620|NCT04518410|580601115|FG016|Overall Study|Death|0|||
160785621|NCT04518410|580601116|FG017|Overall Study|Death|1|||
160785622|NCT04518410|580601117|FG018|Overall Study|Death|4|||
160785623|NCT04518410|580601118|FG019|Overall Study|Death|4|||
160785624|NCT04518410|580601119|FG020|Overall Study|Death|1|||
160785625|NCT04518410|580601120|FG021|Overall Study|Death|0|||
160785626|NCT04518410|580601121|FG022|Overall Study|Death|0|||
160785627|NCT04518410|580601122|FG023|Overall Study|Death|0|||
160785628|NCT04518410|580601123|FG024|Overall Study|Death|0|||
160785629|NCT04518410|580601099|FG000|Overall Study|Requirement to start alternative therapy|0|||
160785630|NCT04518410|580601100|FG001|Overall Study|Requirement to start alternative therapy|0|||
160785631|NCT04518410|580601101|FG002|Overall Study|Requirement to start alternative therapy|1|||
160785632|NCT04518410|580601102|FG003|Overall Study|Requirement to start alternative therapy|0|||
160785633|NCT04518410|580601103|FG004|Overall Study|Requirement to start alternative therapy|0|||
160785634|NCT04518410|580601104|FG005|Overall Study|Requirement to start alternative therapy|0|||
160785635|NCT04518410|580601105|FG006|Overall Study|Requirement to start alternative therapy|0|||
160785636|NCT04518410|580601106|FG007|Overall Study|Requirement to start alternative therapy|0|||
160785637|NCT04518410|580601107|FG008|Overall Study|Requirement to start alternative therapy|0|||
160785638|NCT04518410|580601108|FG009|Overall Study|Requirement to start alternative therapy|0|||
160785639|NCT04518410|580601109|FG010|Overall Study|Requirement to start alternative therapy|0|||
160785640|NCT04518410|580601110|FG011|Overall Study|Requirement to start alternative therapy|0|||
160785641|NCT04518410|580601111|FG012|Overall Study|Requirement to start alternative therapy|0|||
160785642|NCT04518410|580601112|FG013|Overall Study|Requirement to start alternative therapy|0|||
160785643|NCT04518410|580601113|FG014|Overall Study|Requirement to start alternative therapy|0|||
160785644|NCT04518410|580601114|FG015|Overall Study|Requirement to start alternative therapy|0|||
160785645|NCT04518410|580601115|FG016|Overall Study|Requirement to start alternative therapy|0|||
160785646|NCT04518410|580601116|FG017|Overall Study|Requirement to start alternative therapy|0|||
160785647|NCT04518410|580601117|FG018|Overall Study|Requirement to start alternative therapy|0|||
160785648|NCT04518410|580601118|FG019|Overall Study|Requirement to start alternative therapy|0|||
160785649|NCT04518410|580601119|FG020|Overall Study|Requirement to start alternative therapy|0|||
160785650|NCT04518410|580601120|FG021|Overall Study|Requirement to start alternative therapy|0|||
161230834|NCT02106156|582227267|FG001|Overall Study|Lost to Follow-up|8|||
161230835|NCT02106156|582227268|FG002|Overall Study|Lost to Follow-up|0|||
161230836|NCT02106156|582227266|FG000|Overall Study|Unplanned Event|82|||
161230837|NCT02106156|582227267|FG001|Overall Study|Unplanned Event|2|||
161230838|NCT02106156|582227268|FG002|Overall Study|Unplanned Event|0|||
161230839|NCT02106156|582227266|FG000|Overall Study|Change of Laboratory Parameter|10|||
161230840|NCT02106156|582227267|FG001|Overall Study|Change of Laboratory Parameter|0|||
161230841|NCT02106156|582227268|FG002|Overall Study|Change of Laboratory Parameter|0|||
161230842|NCT02106156|582227266|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
161230843|NCT02106156|582227267|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
161230844|NCT02106156|582227268|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
161230845|NCT02106156|582227266|FG000|Overall Study|Relocation/Change of Physician|40|||
160785651|NCT04518410|580601121|FG022|Overall Study|Requirement to start alternative therapy|0|||
160785652|NCT04518410|580601122|FG023|Overall Study|Requirement to start alternative therapy|0|||
160785653|NCT04518410|580601123|FG024|Overall Study|Requirement to start alternative therapy|0|||
160785654|NCT04518410|580601099|FG000|Overall Study|Randomized but not treated|0|||
160785655|NCT04518410|580601100|FG001|Overall Study|Randomized but not treated|0|||
160785656|NCT04518410|580601101|FG002|Overall Study|Randomized but not treated|0|||
160785657|NCT04518410|580601102|FG003|Overall Study|Randomized but not treated|2|||
160785658|NCT04518410|580601103|FG004|Overall Study|Randomized but not treated|6|||
160785659|NCT04518410|580601104|FG005|Overall Study|Randomized but not treated|4|||
160785660|NCT04518410|580601105|FG006|Overall Study|Randomized but not treated|3|||
160785661|NCT04518410|580601106|FG007|Overall Study|Randomized but not treated|3|||
160785662|NCT04518410|580601107|FG008|Overall Study|Randomized but not treated|0|||
160785663|NCT04518410|580601108|FG009|Overall Study|Randomized but not treated|4|||
160785664|NCT04518410|580601109|FG010|Overall Study|Randomized but not treated|0|||
160785665|NCT04518410|580601110|FG011|Overall Study|Randomized but not treated|0|||
160785666|NCT04518410|580601111|FG012|Overall Study|Randomized but not treated|1|||
160785667|NCT04518410|580601112|FG013|Overall Study|Randomized but not treated|3|||
160785668|NCT04518410|580601113|FG014|Overall Study|Randomized but not treated|3|||
160785669|NCT04518410|580601114|FG015|Overall Study|Randomized but not treated|3|||
160785670|NCT04518410|580601115|FG016|Overall Study|Randomized but not treated|4|||
160785671|NCT04518410|580601116|FG017|Overall Study|Randomized but not treated|5|||
160785672|NCT04518410|580601117|FG018|Overall Study|Randomized but not treated|4|||
160785673|NCT04518410|580601118|FG019|Overall Study|Randomized but not treated|0|||
160785674|NCT04518410|580601119|FG020|Overall Study|Randomized but not treated|0|||
160785675|NCT04518410|580601120|FG021|Overall Study|Randomized but not treated|5|||
160785676|NCT04518410|580601121|FG022|Overall Study|Randomized but not treated|0|||
160785677|NCT04518410|580601122|FG023|Overall Study|Randomized but not treated|3|||
160785678|NCT04518410|580601123|FG024|Overall Study|Randomized but not treated|1|||
160785679|NCT04518410|580601099|FG000|Overall Study|Screen Fail but Randomized|0|||
160785680|NCT04518410|580601100|FG001|Overall Study|Screen Fail but Randomized|0|||
160785681|NCT04518410|580601101|FG002|Overall Study|Screen Fail but Randomized|0|||
160785682|NCT04518410|580601102|FG003|Overall Study|Screen Fail but Randomized|0|||
160785683|NCT04518410|580601103|FG004|Overall Study|Screen Fail but Randomized|2|||
160785684|NCT04518410|580601104|FG005|Overall Study|Screen Fail but Randomized|0|||
160785685|NCT04518410|580601105|FG006|Overall Study|Screen Fail but Randomized|0|||
160785686|NCT04518410|580601106|FG007|Overall Study|Screen Fail but Randomized|0|||
160785687|NCT04518410|580601107|FG008|Overall Study|Screen Fail but Randomized|0|||
160785688|NCT04518410|580601108|FG009|Overall Study|Screen Fail but Randomized|0|||
160785689|NCT04518410|580601109|FG010|Overall Study|Screen Fail but Randomized|0|||
160785690|NCT04518410|580601110|FG011|Overall Study|Screen Fail but Randomized|0|||
160785691|NCT04518410|580601111|FG012|Overall Study|Screen Fail but Randomized|0|||
160785692|NCT04518410|580601112|FG013|Overall Study|Screen Fail but Randomized|0|||
160785693|NCT04518410|580601113|FG014|Overall Study|Screen Fail but Randomized|0|||
160785694|NCT04518410|580601114|FG015|Overall Study|Screen Fail but Randomized|0|||
160785695|NCT04518410|580601115|FG016|Overall Study|Screen Fail but Randomized|0|||
160785696|NCT04518410|580601116|FG017|Overall Study|Screen Fail but Randomized|0|||
160785697|NCT04518410|580601117|FG018|Overall Study|Screen Fail but Randomized|0|||
160785698|NCT04518410|580601118|FG019|Overall Study|Screen Fail but Randomized|0|||
160785699|NCT04518410|580601119|FG020|Overall Study|Screen Fail but Randomized|0|||
160785700|NCT04518410|580601120|FG021|Overall Study|Screen Fail but Randomized|0|||
160785701|NCT04518410|580601121|FG022|Overall Study|Screen Fail but Randomized|0|||
160785702|NCT04518410|580601122|FG023|Overall Study|Screen Fail but Randomized|0|||
160785703|NCT04518410|580601123|FG024|Overall Study|Screen Fail but Randomized|0|||
160785704|NCT04518410|580601099|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785705|NCT04518410|580601100|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785706|NCT04518410|580601101|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785707|NCT04518410|580601102|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785708|NCT04518410|580601103|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
160785709|NCT04518410|580601104|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
160785710|NCT04518410|580601105|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
160785711|NCT04518410|580601106|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160785712|NCT04518410|580601107|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
160785713|NCT04518410|580601108|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
160785714|NCT04518410|580601109|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160981862|NCT02061761|581321788|FG006|Overall Study|Withdrawal by Subject|0|||
160981863|NCT02061761|581321789|FG007|Overall Study|Withdrawal by Subject|0|||
160981864|NCT02061761|581321790|FG008|Overall Study|Withdrawal by Subject|2|||
160785715|NCT04518410|580601110|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785716|NCT04518410|580601111|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785717|NCT04518410|580601112|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160785718|NCT04518410|580601113|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
160785719|NCT04518410|580601114|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
160785720|NCT04518410|580601115|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
160785721|NCT04518410|580601116|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
160785722|NCT04518410|580601117|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
160785723|NCT04518410|580601118|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
160785724|NCT04518410|580601119|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
160785725|NCT04518410|580601120|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
160785726|NCT04518410|580601121|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
160785727|NCT04518410|580601122|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
160785728|NCT04518410|580601123|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
160785729|NCT04518410|580601099|FG000|Overall Study|Dual Enrolled Subject|0|||
160785730|NCT04518410|580601100|FG001|Overall Study|Dual Enrolled Subject|0|||
160785731|NCT04518410|580601101|FG002|Overall Study|Dual Enrolled Subject|0|||
160785732|NCT04518410|580601102|FG003|Overall Study|Dual Enrolled Subject|0|||
160785733|NCT04518410|580601103|FG004|Overall Study|Dual Enrolled Subject|0|||
160785734|NCT04518410|580601104|FG005|Overall Study|Dual Enrolled Subject|0|||
160785735|NCT04518410|580601105|FG006|Overall Study|Dual Enrolled Subject|0|||
160785736|NCT04518410|580601106|FG007|Overall Study|Dual Enrolled Subject|0|||
160785737|NCT04518410|580601107|FG008|Overall Study|Dual Enrolled Subject|0|||
160785738|NCT04518410|580601108|FG009|Overall Study|Dual Enrolled Subject|0|||
160785739|NCT04518410|580601109|FG010|Overall Study|Dual Enrolled Subject|0|||
160785740|NCT04518410|580601110|FG011|Overall Study|Dual Enrolled Subject|0|||
160785741|NCT04518410|580601111|FG012|Overall Study|Dual Enrolled Subject|0|||
160785742|NCT04518410|580601112|FG013|Overall Study|Dual Enrolled Subject|0|||
160785743|NCT04518410|580601113|FG014|Overall Study|Dual Enrolled Subject|0|||
160785744|NCT04518410|580601114|FG015|Overall Study|Dual Enrolled Subject|0|||
160785745|NCT04518410|580601115|FG016|Overall Study|Dual Enrolled Subject|0|||
160785746|NCT04518410|580601116|FG017|Overall Study|Dual Enrolled Subject|1|||
160785747|NCT04518410|580601117|FG018|Overall Study|Dual Enrolled Subject|0|||
160785748|NCT04518410|580601118|FG019|Overall Study|Dual Enrolled Subject|0|||
160785749|NCT04518410|580601119|FG020|Overall Study|Dual Enrolled Subject|0|||
160785750|NCT04518410|580601120|FG021|Overall Study|Dual Enrolled Subject|0|||
160785751|NCT04518410|580601121|FG022|Overall Study|Dual Enrolled Subject|0|||
160785752|NCT04518410|580601122|FG023|Overall Study|Dual Enrolled Subject|0|||
160785753|NCT04518410|580601123|FG024|Overall Study|Dual Enrolled Subject|0|||
160785754|NCT00837330|580601124|FG000|Overall Study|Lost to Follow-up|1|||
160785755|NCT00837330|580601125|FG001|Overall Study|Lost to Follow-up|3|||
160785756|NCT00694122|580601130|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
160785757|NCT00694122|580601131|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
160785758|NCT00694122|580601130|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
160785759|NCT00694122|580601131|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
160785760|NCT00694122|580601130|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
160785761|NCT00694122|580601131|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
160785762|NCT00105508|580601132|FG000|Overall Study|Prephase Dropout|1|||
160785763|NCT00105508|580601133|FG001|Overall Study|Prephase Dropout|0|||
160785764|NCT00105508|580601132|FG000|Overall Study|Adverse Event|16|||
160785765|NCT00105508|580601133|FG001|Overall Study|Adverse Event|19|||
160785766|NCT00105508|580601132|FG000|Overall Study|Insufficient Efficacy|1|||
160785767|NCT00105508|580601133|FG001|Overall Study|Insufficient Efficacy|0|||
160785768|NCT00105508|580601132|FG000|Overall Study|Withdrawal by Subject|10|||
160785769|NCT00105508|580601133|FG001|Overall Study|Withdrawal by Subject|6|||
160785770|NCT00105508|580601132|FG000|Overall Study|Lost to Follow-up|3|||
160785771|NCT00105508|580601133|FG001|Overall Study|Lost to Follow-up|0|||
160785772|NCT00105508|580601132|FG000|Overall Study|Protocol Violation|1|||
160785773|NCT00105508|580601133|FG001|Overall Study|Protocol Violation|2|||
160785774|NCT00105508|580601132|FG000|Overall Study|Other|8|||
160785775|NCT00105508|580601133|FG001|Overall Study|Other|9|||
160785776|NCT00120874|580601134|FG000|Overall Study|Death|0|||
160785777|NCT00120874|580601135|FG001|Overall Study|Death|1|||
160785778|NCT01108055|580601136|FG000|Overall Study|Ineligible|11|||
160785779|NCT01108055|580601136|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
160785780|NCT01348490|580601143|FG000|Overall Study|Death|1|||
160785781|NCT01348490|580601143|FG000|Overall Study|Adverse Event|3|||
160785782|NCT01348490|580601143|FG000|Overall Study|Consent withdrawn|7|||
160785783|NCT01348490|580601143|FG000|Overall Study|Disease progression|3|||
160785784|NCT01348490|580601143|FG000|Overall Study|Lost to Follow-up|1|||
160785785|NCT01348490|580601143|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
160785786|NCT01348490|580601143|FG000|Overall Study|Other Unspecified|8|||
160785787|NCT03632720|580601144|FG000|Overall Study|Adverse Event|2|||
160785788|NCT03632720|580601145|FG001|Overall Study|Adverse Event|0|||
160785789|NCT03632720|580601146|FG002|Overall Study|Adverse Event|0|||
160785790|NCT03632720|580601144|FG000|Overall Study|Lost to Follow-up|0|||
160785791|NCT03632720|580601145|FG001|Overall Study|Lost to Follow-up|1|||
160785792|NCT03632720|580601146|FG002|Overall Study|Lost to Follow-up|0|||
160785793|NCT03632720|580601144|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
160785794|NCT03632720|580601145|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
160785795|NCT03632720|580601146|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
160785796|NCT03632720|580601144|FG000|Overall Study|Screen failure|0|||
160785797|NCT03632720|580601145|FG001|Overall Study|Screen failure|1|||
160785798|NCT03632720|580601146|FG002|Overall Study|Screen failure|0|||
160785799|NCT01049828|580601147|FG000|Overall Study|Claustrophibia and Frustration|2|||
160785800|NCT00290238|580601148|FG000|Overall Study|Study terminated|27|||
160785801|NCT00290238|580601149|FG001|Overall Study|Study terminated|27|||
160785802|NCT00290238|580601148|FG000|Overall Study|Lost to Follow-up|0|||
160785803|NCT00290238|580601149|FG001|Overall Study|Lost to Follow-up|1|||
160785804|NCT00290238|580601148|FG000|Overall Study|Withdrawal by Subject|15|||
160785805|NCT00290238|580601149|FG001|Overall Study|Withdrawal by Subject|13|||
160785806|NCT03834883|580601150|FG000|Second Treatment|Withdrawal by Subject|1|||
160785807|NCT03834883|580601151|FG001|Second Treatment|Withdrawal by Subject|0|||
160785808|NCT03834883|580601152|FG002|Second Treatment|Withdrawal by Subject|0|||
160785809|NCT03834883|580601153|FG003|Second Treatment|Withdrawal by Subject|0|||
160785810|NCT03834883|580601150|FG000|Second Treatment|COVID-19 pandemic|1|||
160785811|NCT03834883|580601151|FG001|Second Treatment|COVID-19 pandemic|0|||
160785812|NCT03834883|580601152|FG002|Second Treatment|COVID-19 pandemic|1|||
160785813|NCT03834883|580601153|FG003|Second Treatment|COVID-19 pandemic|1|||
160785814|NCT01179399|580601154|FG000|Overall Study|Adverse Event|1|||
160785815|NCT01179399|580601154|FG000|Overall Study|Lack of Efficacy|30|||
160785816|NCT01179399|580601154|FG000|Overall Study|Withdrawal by Subject|1|||
160785817|NCT00090402|580602782|FG000|Overall Study|Death|1|||
160785818|NCT00090402|580602783|FG001|Overall Study|Death|1|||
160785819|NCT00090402|580602784|FG002|Overall Study|Death|0|||
160785820|NCT00090402|580602782|FG000|Overall Study|subject moved|0|||
160785821|NCT00090402|580602783|FG001|Overall Study|subject moved|1|||
160785822|NCT00090402|580602784|FG002|Overall Study|subject moved|0|||
160785823|NCT00090402|580602782|FG000|Overall Study|stopped taking study medication|1|||
160785824|NCT00090402|580602783|FG001|Overall Study|stopped taking study medication|0|||
160785825|NCT00090402|580602784|FG002|Overall Study|stopped taking study medication|1|||
160785826|NCT00862277|580602787|FG000|Overall Study|Protocol Violation|1|||
160785827|NCT00862277|580602788|FG001|Overall Study|Protocol Violation|2|||
160785828|NCT00862277|580602789|FG002|Overall Study|Protocol Violation|5|||
160785829|NCT02533674|580602790|FG000|Dose Level I|Progressive disease|1|||
160785830|NCT02533674|580602791|FG001|Dose Level I|Progressive disease|0|||
160785831|NCT02533674|580602792|FG002|Dose Level I|Progressive disease|0|||
160785832|NCT02533674|580602793|FG003|Dose Level I|Progressive disease|0|||
160785833|NCT02533674|580602794|FG004|Dose Level I|Progressive disease|0|||
160785834|NCT02533674|580602795|FG005|Dose Level I|Progressive disease|0|||
160785835|NCT02533674|580602796|FG006|Dose Level I|Progressive disease|0|||
160785836|NCT02533674|580602797|FG007|Dose Level I|Progressive disease|0|||
160785837|NCT02533674|580602790|FG000|Dose Level I|Withdrawal by Subject|1|||
161125651|NCT01114529|581846872|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
161125652|NCT01114529|581846870|FG000|Completed Study Phase at Month 24|Death|8|||
161125653|NCT01114529|581846871|FG001|Completed Study Phase at Month 24|Death|5|||
161125654|NCT01114529|581846872|FG002|Completed Study Phase at Month 24|Death|4|||
160785838|NCT02533674|580602791|FG001|Dose Level I|Withdrawal by Subject|0|||
160785839|NCT02533674|580602792|FG002|Dose Level I|Withdrawal by Subject|0|||
161125655|NCT01114529|581846870|FG000|Completed Study Phase at Month 24|Other|2|||
161125656|NCT01114529|581846871|FG001|Completed Study Phase at Month 24|Other|0|||
160785840|NCT02533674|580602793|FG003|Dose Level I|Withdrawal by Subject|0|||
161125657|NCT01114529|581846872|FG002|Completed Study Phase at Month 24|Other|0|||
161125658|NCT01114529|581846870|FG000|Completed Study Phase at Month 24|Missing|2|||
160785841|NCT02533674|580602794|FG004|Dose Level I|Withdrawal by Subject|0|||
160785842|NCT02533674|580602795|FG005|Dose Level I|Withdrawal by Subject|0|||
160785843|NCT02533674|580602796|FG006|Dose Level I|Withdrawal by Subject|0|||
160785844|NCT02533674|580602797|FG007|Dose Level I|Withdrawal by Subject|0|||
160785845|NCT02533674|580602790|FG000|Dose Level I|Physician Decision|1|||
160785846|NCT02533674|580602791|FG001|Dose Level I|Physician Decision|0|||
160785847|NCT02533674|580602792|FG002|Dose Level I|Physician Decision|0|||
160785848|NCT02533674|580602793|FG003|Dose Level I|Physician Decision|0|||
160785849|NCT02533674|580602794|FG004|Dose Level I|Physician Decision|0|||
160785850|NCT02533674|580602795|FG005|Dose Level I|Physician Decision|0|||
160785851|NCT02533674|580602796|FG006|Dose Level I|Physician Decision|0|||
160785852|NCT02533674|580602797|FG007|Dose Level I|Physician Decision|0|||
160785853|NCT02533674|580602790|FG000|Dose Level I|Death|1|||
160785854|NCT02533674|580602791|FG001|Dose Level I|Death|0|||
160785855|NCT02533674|580602792|FG002|Dose Level I|Death|0|||
160785856|NCT02533674|580602793|FG003|Dose Level I|Death|0|||
160785857|NCT02533674|580602794|FG004|Dose Level I|Death|0|||
160785858|NCT02533674|580602795|FG005|Dose Level I|Death|0|||
160785859|NCT02533674|580602796|FG006|Dose Level I|Death|0|||
160785860|NCT02533674|580602797|FG007|Dose Level I|Death|0|||
160785861|NCT02533674|580602790|FG000|Dose Level I|Never Treated|1|||
160785862|NCT02533674|580602791|FG001|Dose Level I|Never Treated|0|||
160785863|NCT02533674|580602792|FG002|Dose Level I|Never Treated|0|||
160785864|NCT02533674|580602793|FG003|Dose Level I|Never Treated|0|||
160785865|NCT02533674|580602794|FG004|Dose Level I|Never Treated|0|||
160785866|NCT02533674|580602795|FG005|Dose Level I|Never Treated|0|||
160785867|NCT02533674|580602796|FG006|Dose Level I|Never Treated|0|||
160785868|NCT02533674|580602797|FG007|Dose Level I|Never Treated|0|||
160785869|NCT02533674|580602790|FG000|Dose Level II|Progressive disease|0|||
160785870|NCT02533674|580602791|FG001|Dose Level II|Progressive disease|3|||
160785871|NCT02533674|580602792|FG002|Dose Level II|Progressive disease|0|||
160785872|NCT02533674|580602793|FG003|Dose Level II|Progressive disease|0|||
160785873|NCT02533674|580602794|FG004|Dose Level II|Progressive disease|0|||
160785874|NCT02533674|580602795|FG005|Dose Level II|Progressive disease|0|||
160785875|NCT02533674|580602796|FG006|Dose Level II|Progressive disease|0|||
160785876|NCT02533674|580602797|FG007|Dose Level II|Progressive disease|0|||
160785877|NCT02533674|580602790|FG000|Dose Level II|Withdrawal by Subject|0|||
160785878|NCT02533674|580602791|FG001|Dose Level II|Withdrawal by Subject|1|||
160785879|NCT02533674|580602792|FG002|Dose Level II|Withdrawal by Subject|0|||
160785880|NCT02533674|580602793|FG003|Dose Level II|Withdrawal by Subject|0|||
160785881|NCT02533674|580602794|FG004|Dose Level II|Withdrawal by Subject|0|||
160785882|NCT02533674|580602795|FG005|Dose Level II|Withdrawal by Subject|0|||
160785883|NCT02533674|580602796|FG006|Dose Level II|Withdrawal by Subject|0|||
160785884|NCT02533674|580602797|FG007|Dose Level II|Withdrawal by Subject|0|||
160785885|NCT02533674|580602790|FG000|Dose Level II|Treatment-related AE|0|||
160785886|NCT02533674|580602791|FG001|Dose Level II|Treatment-related AE|1|||
160785887|NCT02533674|580602792|FG002|Dose Level II|Treatment-related AE|0|||
160785888|NCT02533674|580602793|FG003|Dose Level II|Treatment-related AE|0|||
160785889|NCT02533674|580602794|FG004|Dose Level II|Treatment-related AE|0|||
160785890|NCT02533674|580602795|FG005|Dose Level II|Treatment-related AE|0|||
160785891|NCT02533674|580602796|FG006|Dose Level II|Treatment-related AE|0|||
160785892|NCT02533674|580602797|FG007|Dose Level II|Treatment-related AE|0|||
160785893|NCT02533674|580602790|FG000|Dose Level II|Physician Decision|0|||
160785894|NCT02533674|580602791|FG001|Dose Level II|Physician Decision|1|||
160785895|NCT02533674|580602792|FG002|Dose Level II|Physician Decision|0|||
160785896|NCT02533674|580602793|FG003|Dose Level II|Physician Decision|0|||
160785897|NCT02533674|580602794|FG004|Dose Level II|Physician Decision|0|||
160785898|NCT02533674|580602795|FG005|Dose Level II|Physician Decision|0|||
160785899|NCT02533674|580602796|FG006|Dose Level II|Physician Decision|0|||
160785900|NCT02533674|580602797|FG007|Dose Level II|Physician Decision|0|||
160785901|NCT02533674|580602790|FG000|Dose Level II|Non-treatment-related AE|0|||
160785902|NCT02533674|580602791|FG001|Dose Level II|Non-treatment-related AE|1|||
160785903|NCT02533674|580602792|FG002|Dose Level II|Non-treatment-related AE|0|||
160785904|NCT02533674|580602793|FG003|Dose Level II|Non-treatment-related AE|0|||
160785905|NCT02533674|580602794|FG004|Dose Level II|Non-treatment-related AE|0|||
160785906|NCT02533674|580602795|FG005|Dose Level II|Non-treatment-related AE|0|||
161328249|NCT01610037|582587107|FG001|All Patients|Adverse Event|22|||
161328250|NCT01610037|582587108|FG002|All Patients|Adverse Event|26|||
161328251|NCT01610037|582587106|FG000|All Patients|Withdrawal by Subject|12|||
161328252|NCT01610037|582587107|FG001|All Patients|Withdrawal by Subject|10|||
161328253|NCT01610037|582587108|FG002|All Patients|Withdrawal by Subject|20|||
161328254|NCT01610037|582587106|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
160785907|NCT02533674|580602796|FG006|Dose Level II|Non-treatment-related AE|0|||
160785908|NCT02533674|580602797|FG007|Dose Level II|Non-treatment-related AE|0|||
160785909|NCT02533674|580602790|FG000|Dose Level III|Progressive disease|0|||
160785910|NCT02533674|580602791|FG001|Dose Level III|Progressive disease|0|||
160785911|NCT02533674|580602792|FG002|Dose Level III|Progressive disease|2|||
160785912|NCT02533674|580602793|FG003|Dose Level III|Progressive disease|0|||
160785913|NCT02533674|580602794|FG004|Dose Level III|Progressive disease|0|||
160785914|NCT02533674|580602795|FG005|Dose Level III|Progressive disease|0|||
160785915|NCT02533674|580602796|FG006|Dose Level III|Progressive disease|0|||
160785916|NCT02533674|580602797|FG007|Dose Level III|Progressive disease|0|||
160785917|NCT02533674|580602790|FG000|Dose Level III|Withdrawal by Subject|0|||
160785918|NCT02533674|580602791|FG001|Dose Level III|Withdrawal by Subject|0|||
160785919|NCT02533674|580602792|FG002|Dose Level III|Withdrawal by Subject|1|||
160785920|NCT02533674|580602793|FG003|Dose Level III|Withdrawal by Subject|0|||
160785921|NCT02533674|580602794|FG004|Dose Level III|Withdrawal by Subject|0|||
160785922|NCT02533674|580602795|FG005|Dose Level III|Withdrawal by Subject|0|||
160785923|NCT02533674|580602796|FG006|Dose Level III|Withdrawal by Subject|0|||
160785924|NCT02533674|580602797|FG007|Dose Level III|Withdrawal by Subject|0|||
160785925|NCT02533674|580602790|FG000|Dose Level III|Treatment-related AE|0|||
160785926|NCT02533674|580602791|FG001|Dose Level III|Treatment-related AE|0|||
160785927|NCT02533674|580602792|FG002|Dose Level III|Treatment-related AE|1|||
160785928|NCT02533674|580602793|FG003|Dose Level III|Treatment-related AE|0|||
160785929|NCT02533674|580602794|FG004|Dose Level III|Treatment-related AE|0|||
160785930|NCT02533674|580602795|FG005|Dose Level III|Treatment-related AE|0|||
160785931|NCT02533674|580602796|FG006|Dose Level III|Treatment-related AE|0|||
160785932|NCT02533674|580602797|FG007|Dose Level III|Treatment-related AE|0|||
160785933|NCT02533674|580602790|FG000|Dose Level IV|Progressive disease|0|||
160785934|NCT02533674|580602791|FG001|Dose Level IV|Progressive disease|0|||
160785935|NCT02533674|580602792|FG002|Dose Level IV|Progressive disease|0|||
160785936|NCT02533674|580602793|FG003|Dose Level IV|Progressive disease|3|||
160785937|NCT02533674|580602794|FG004|Dose Level IV|Progressive disease|0|||
160785938|NCT02533674|580602795|FG005|Dose Level IV|Progressive disease|0|||
160785939|NCT02533674|580602796|FG006|Dose Level IV|Progressive disease|0|||
160785940|NCT02533674|580602797|FG007|Dose Level IV|Progressive disease|0|||
160785941|NCT02533674|580602790|FG000|Dose Level IV|Withdrawal by Subject|0|||
160785942|NCT02533674|580602791|FG001|Dose Level IV|Withdrawal by Subject|0|||
160785943|NCT02533674|580602792|FG002|Dose Level IV|Withdrawal by Subject|0|||
160785944|NCT02533674|580602793|FG003|Dose Level IV|Withdrawal by Subject|1|||
160785945|NCT02533674|580602794|FG004|Dose Level IV|Withdrawal by Subject|0|||
160785946|NCT02533674|580602795|FG005|Dose Level IV|Withdrawal by Subject|0|||
160785947|NCT02533674|580602796|FG006|Dose Level IV|Withdrawal by Subject|0|||
160785948|NCT02533674|580602797|FG007|Dose Level IV|Withdrawal by Subject|0|||
160785949|NCT02533674|580602790|FG000|Dose Level IV|Physician Decision|0|||
160785950|NCT02533674|580602791|FG001|Dose Level IV|Physician Decision|0|||
160785951|NCT02533674|580602792|FG002|Dose Level IV|Physician Decision|0|||
160785952|NCT02533674|580602793|FG003|Dose Level IV|Physician Decision|1|||
160785953|NCT02533674|580602794|FG004|Dose Level IV|Physician Decision|0|||
160785954|NCT02533674|580602795|FG005|Dose Level IV|Physician Decision|0|||
160785955|NCT02533674|580602796|FG006|Dose Level IV|Physician Decision|0|||
160785956|NCT02533674|580602797|FG007|Dose Level IV|Physician Decision|0|||
160785957|NCT02533674|580602790|FG000|Dose Level V|Progressive disease|0|||
160785958|NCT02533674|580602791|FG001|Dose Level V|Progressive disease|0|||
160785959|NCT02533674|580602792|FG002|Dose Level V|Progressive disease|0|||
160785960|NCT02533674|580602793|FG003|Dose Level V|Progressive disease|0|||
160785961|NCT02533674|580602794|FG004|Dose Level V|Progressive disease|3|||
160785962|NCT02533674|580602795|FG005|Dose Level V|Progressive disease|0|||
160785963|NCT02533674|580602796|FG006|Dose Level V|Progressive disease|0|||
160785964|NCT02533674|580602797|FG007|Dose Level V|Progressive disease|0|||
160785965|NCT02533674|580602790|FG000|Dose Level V|Withdrawal by Subject|0|||
160785966|NCT02533674|580602791|FG001|Dose Level V|Withdrawal by Subject|0|||
160785967|NCT02533674|580602792|FG002|Dose Level V|Withdrawal by Subject|0|||
160785968|NCT02533674|580602793|FG003|Dose Level V|Withdrawal by Subject|0|||
160785969|NCT02533674|580602794|FG004|Dose Level V|Withdrawal by Subject|1|||
160785970|NCT02533674|580602795|FG005|Dose Level V|Withdrawal by Subject|0|||
160785971|NCT02533674|580602796|FG006|Dose Level V|Withdrawal by Subject|0|||
160785972|NCT02533674|580602797|FG007|Dose Level V|Withdrawal by Subject|0|||
160785973|NCT02533674|580602790|FG000|Dose Level V|Physician Decision|0|||
160785974|NCT02533674|580602791|FG001|Dose Level V|Physician Decision|0|||
160785975|NCT02533674|580602792|FG002|Dose Level V|Physician Decision|0|||
160785976|NCT02533674|580602793|FG003|Dose Level V|Physician Decision|0|||
160785977|NCT02533674|580602794|FG004|Dose Level V|Physician Decision|1|||
160785978|NCT02533674|580602795|FG005|Dose Level V|Physician Decision|0|||
160785979|NCT02533674|580602796|FG006|Dose Level V|Physician Decision|0|||
160785980|NCT02533674|580602797|FG007|Dose Level V|Physician Decision|0|||
160785981|NCT02533674|580602790|FG000|Dose Level VI|Progressive disease|0|||
160785982|NCT02533674|580602791|FG001|Dose Level VI|Progressive disease|0|||
160785983|NCT02533674|580602792|FG002|Dose Level VI|Progressive disease|0|||
160785984|NCT02533674|580602793|FG003|Dose Level VI|Progressive disease|0|||
160785985|NCT02533674|580602794|FG004|Dose Level VI|Progressive disease|0|||
160785986|NCT02533674|580602795|FG005|Dose Level VI|Progressive disease|7|||
160981865|NCT02061761|581321782|FG000|Overall Study|Maximum clinical benefit|0|||
160785987|NCT02533674|580602796|FG006|Dose Level VI|Progressive disease|0|||
160785988|NCT02533674|580602797|FG007|Dose Level VI|Progressive disease|0|||
160785989|NCT02533674|580602790|FG000|Dose Level VI|Withdrawal by Subject|0|||
160785990|NCT02533674|580602791|FG001|Dose Level VI|Withdrawal by Subject|0|||
160785991|NCT02533674|580602792|FG002|Dose Level VI|Withdrawal by Subject|0|||
160785992|NCT02533674|580602793|FG003|Dose Level VI|Withdrawal by Subject|0|||
160785993|NCT02533674|580602794|FG004|Dose Level VI|Withdrawal by Subject|0|||
160785994|NCT02533674|580602795|FG005|Dose Level VI|Withdrawal by Subject|1|||
160785995|NCT02533674|580602796|FG006|Dose Level VI|Withdrawal by Subject|0|||
160785996|NCT02533674|580602797|FG007|Dose Level VI|Withdrawal by Subject|0|||
160785997|NCT02533674|580602790|FG000|Dose Level VI|Treatment-related AE|0|||
160785998|NCT02533674|580602791|FG001|Dose Level VI|Treatment-related AE|0|||
160785999|NCT02533674|580602792|FG002|Dose Level VI|Treatment-related AE|0|||
160786000|NCT02533674|580602793|FG003|Dose Level VI|Treatment-related AE|0|||
160786001|NCT02533674|580602794|FG004|Dose Level VI|Treatment-related AE|0|||
160786002|NCT02533674|580602795|FG005|Dose Level VI|Treatment-related AE|1|||
160786003|NCT02533674|580602796|FG006|Dose Level VI|Treatment-related AE|0|||
160786004|NCT02533674|580602797|FG007|Dose Level VI|Treatment-related AE|0|||
160786005|NCT02533674|580602790|FG000|Dose Level VII|Progressive disease|0|||
160786006|NCT02533674|580602791|FG001|Dose Level VII|Progressive disease|0|||
160786007|NCT02533674|580602792|FG002|Dose Level VII|Progressive disease|0|||
160786008|NCT02533674|580602793|FG003|Dose Level VII|Progressive disease|0|||
160786009|NCT02533674|580602794|FG004|Dose Level VII|Progressive disease|0|||
160786010|NCT02533674|580602795|FG005|Dose Level VII|Progressive disease|0|||
160786011|NCT02533674|580602796|FG006|Dose Level VII|Progressive disease|10|||
160786012|NCT02533674|580602797|FG007|Dose Level VII|Progressive disease|0|||
160786013|NCT02533674|580602790|FG000|Dose Level VII|Withdrawal by Subject|0|||
160786014|NCT02533674|580602791|FG001|Dose Level VII|Withdrawal by Subject|0|||
160786015|NCT02533674|580602792|FG002|Dose Level VII|Withdrawal by Subject|0|||
160786016|NCT02533674|580602793|FG003|Dose Level VII|Withdrawal by Subject|0|||
160786017|NCT02533674|580602794|FG004|Dose Level VII|Withdrawal by Subject|0|||
160786018|NCT02533674|580602795|FG005|Dose Level VII|Withdrawal by Subject|0|||
160786019|NCT02533674|580602796|FG006|Dose Level VII|Withdrawal by Subject|3|||
160786020|NCT02533674|580602797|FG007|Dose Level VII|Withdrawal by Subject|0|||
160786021|NCT02533674|580602790|FG000|Dose Level VII|Treatment-related AE|0|||
160786022|NCT02533674|580602791|FG001|Dose Level VII|Treatment-related AE|0|||
160786023|NCT02533674|580602792|FG002|Dose Level VII|Treatment-related AE|0|||
160786024|NCT02533674|580602793|FG003|Dose Level VII|Treatment-related AE|0|||
160786025|NCT02533674|580602794|FG004|Dose Level VII|Treatment-related AE|0|||
160786026|NCT02533674|580602795|FG005|Dose Level VII|Treatment-related AE|0|||
160786027|NCT02533674|580602796|FG006|Dose Level VII|Treatment-related AE|1|||
160786028|NCT02533674|580602797|FG007|Dose Level VII|Treatment-related AE|0|||
160786029|NCT02533674|580602790|FG000|Dose Level VII|Death|0|||
160786030|NCT02533674|580602791|FG001|Dose Level VII|Death|0|||
160786031|NCT02533674|580602792|FG002|Dose Level VII|Death|0|||
160786032|NCT02533674|580602793|FG003|Dose Level VII|Death|0|||
160786033|NCT02533674|580602794|FG004|Dose Level VII|Death|0|||
160786034|NCT02533674|580602795|FG005|Dose Level VII|Death|0|||
160786035|NCT02533674|580602796|FG006|Dose Level VII|Death|2|||
160786036|NCT02533674|580602797|FG007|Dose Level VII|Death|0|||
160786037|NCT02533674|580602790|FG000|Dose Level VIII|Progressive disease|0|||
160786038|NCT02533674|580602791|FG001|Dose Level VIII|Progressive disease|0|||
160786039|NCT02533674|580602792|FG002|Dose Level VIII|Progressive disease|0|||
160786040|NCT02533674|580602793|FG003|Dose Level VIII|Progressive disease|0|||
160786041|NCT02533674|580602794|FG004|Dose Level VIII|Progressive disease|0|||
160786042|NCT02533674|580602795|FG005|Dose Level VIII|Progressive disease|0|||
160786043|NCT02533674|580602796|FG006|Dose Level VIII|Progressive disease|0|||
160786044|NCT02533674|580602797|FG007|Dose Level VIII|Progressive disease|3|||
160786045|NCT02533674|580602790|FG000|Dose Level VIII|Withdrawal by Subject|0|||
160786046|NCT02533674|580602791|FG001|Dose Level VIII|Withdrawal by Subject|0|||
160786047|NCT02533674|580602792|FG002|Dose Level VIII|Withdrawal by Subject|0|||
160786048|NCT02533674|580602793|FG003|Dose Level VIII|Withdrawal by Subject|0|||
161328255|NCT01610037|582587107|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
161328256|NCT01610037|582587108|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
161328257|NCT01610037|582587106|FG000|All Patients|Death|4|||
161328258|NCT01610037|582587107|FG001|All Patients|Death|2|||
161328259|NCT01610037|582587108|FG002|All Patients|Death|1|||
161328260|NCT01610037|582587106|FG000|All Patients|Protocol deviation|4|||
161328261|NCT01610037|582587107|FG001|All Patients|Protocol deviation|3|||
161328262|NCT01610037|582587108|FG002|All Patients|Protocol deviation|3|||
161328263|NCT01610037|582587106|FG000|All Patients|Abnormal laboratory value|1|||
160786049|NCT02533674|580602794|FG004|Dose Level VIII|Withdrawal by Subject|0|||
160786050|NCT02533674|580602795|FG005|Dose Level VIII|Withdrawal by Subject|0|||
160786051|NCT02533674|580602796|FG006|Dose Level VIII|Withdrawal by Subject|0|||
160786052|NCT02533674|580602797|FG007|Dose Level VIII|Withdrawal by Subject|1|||
160786053|NCT02533674|580602790|FG000|Dose Level VIII|Treatment-related AE|0|||
160786054|NCT02533674|580602791|FG001|Dose Level VIII|Treatment-related AE|0|||
161328264|NCT01610037|582587107|FG001|All Patients|Abnormal laboratory value|1|||
161328265|NCT01610037|582587108|FG002|All Patients|Abnormal laboratory value|0|||
161328266|NCT01610037|582587106|FG000|All Patients|Administrative problems|1|||
161328267|NCT01610037|582587107|FG001|All Patients|Administrative problems|4|||
161328268|NCT01610037|582587108|FG002|All Patients|Administrative problems|4|||
160786055|NCT02533674|580602792|FG002|Dose Level VIII|Treatment-related AE|0|||
160786056|NCT02533674|580602793|FG003|Dose Level VIII|Treatment-related AE|0|||
160786057|NCT02533674|580602794|FG004|Dose Level VIII|Treatment-related AE|0|||
160786058|NCT02533674|580602795|FG005|Dose Level VIII|Treatment-related AE|0|||
160786059|NCT02533674|580602796|FG006|Dose Level VIII|Treatment-related AE|0|||
160786060|NCT02533674|580602797|FG007|Dose Level VIII|Treatment-related AE|1|||
160786061|NCT02533674|580602790|FG000|Dose Level VIII|Never treated|0|||
160786062|NCT02533674|580602791|FG001|Dose Level VIII|Never treated|0|||
160786063|NCT02533674|580602792|FG002|Dose Level VIII|Never treated|0|||
160786064|NCT02533674|580602793|FG003|Dose Level VIII|Never treated|0|||
160786065|NCT02533674|580602794|FG004|Dose Level VIII|Never treated|0|||
160786066|NCT02533674|580602795|FG005|Dose Level VIII|Never treated|0|||
160786067|NCT02533674|580602796|FG006|Dose Level VIII|Never treated|0|||
161125659|NCT01114529|581846871|FG001|Completed Study Phase at Month 24|Missing|0|||
161125660|NCT01114529|581846872|FG002|Completed Study Phase at Month 24|Missing|0|||
161125661|NCT03555266|581846873|FG000|Overall Study|Protocol Violation|6|||
161125662|NCT03555266|581846874|FG001|Overall Study|Protocol Violation|4|||
161125663|NCT00797823|581846875|FG000|First Period (Initial Randomization)|Physician Decision|1|||
161125664|NCT00797823|581846876|FG001|First Period (Initial Randomization)|Physician Decision|0|||
161125665|NCT00797823|581846877|FG002|First Period (Initial Randomization)|Physician Decision|0|||
161125666|NCT01700192|581846878|FG000|Overall Study|Adverse Event|73|||
161125667|NCT01700192|581846879|FG001|Overall Study|Adverse Event|18|||
161125668|NCT01700192|581846878|FG000|Overall Study|Lack of Efficacy|1|||
161125669|NCT01700192|581846879|FG001|Overall Study|Lack of Efficacy|0|||
161125670|NCT01700192|581846878|FG000|Overall Study|Lost to Follow-up|42|||
161125671|NCT01700192|581846879|FG001|Overall Study|Lost to Follow-up|29|||
161125672|NCT01700192|581846878|FG000|Overall Study|Noncompliance with study drug|0|||
161125673|NCT01700192|581846879|FG001|Overall Study|Noncompliance with study drug|5|||
161125674|NCT01700192|581846878|FG000|Overall Study|Physician Decision|2|||
160786068|NCT02533674|580602797|FG007|Dose Level VIII|Never treated|1|||
160786069|NCT01908699|580602801|FG000|Overall Study|Adverse Event|8|||
161125675|NCT01700192|581846879|FG001|Overall Study|Physician Decision|3|||
161125676|NCT01700192|581846878|FG000|Overall Study|Pregnancy|1|||
161125677|NCT01700192|581846879|FG001|Overall Study|Pregnancy|4|||
161230846|NCT02106156|582227267|FG001|Overall Study|Relocation/Change of Physician|1|||
161230847|NCT02106156|582227268|FG002|Overall Study|Relocation/Change of Physician|0|||
161230848|NCT01136382|582227271|FG000|Overall Study|Other|8|||
161230849|NCT01136382|582227272|FG001|Overall Study|Other|3|||
161230850|NCT01136382|582227271|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
161230851|NCT01136382|582227272|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
161230852|NCT01136382|582227271|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
160786070|NCT01908699|580602802|FG001|Overall Study|Adverse Event|12|||
160786071|NCT01908699|580602801|FG000|Overall Study|Lack of Efficacy|2|||
160786072|NCT01908699|580602802|FG001|Overall Study|Lack of Efficacy|2|||
160786073|NCT01908699|580602801|FG000|Overall Study|Lost to Follow-up|2|||
160786074|NCT01908699|580602802|FG001|Overall Study|Lost to Follow-up|4|||
160786075|NCT01908699|580602801|FG000|Overall Study|Physician Decision|8|||
161230853|NCT01136382|582227272|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161230854|NCT01136382|582227271|FG000|Overall Study|Withdrawal by Subject|4|||
160786076|NCT01908699|580602802|FG001|Overall Study|Physician Decision|8|||
160786077|NCT01908699|580602801|FG000|Overall Study|Withdrawal by Subject|15|||
160786078|NCT01908699|580602802|FG001|Overall Study|Withdrawal by Subject|10|||
160786079|NCT01908699|580602801|FG000|Overall Study|Pregnancy|0|||
160786080|NCT01908699|580602802|FG001|Overall Study|Pregnancy|1|||
160786081|NCT01908699|580602801|FG000|Overall Study|Randomized in Error|1|||
161230855|NCT01136382|582227272|FG001|Overall Study|Withdrawal by Subject|1|||
160786082|NCT01908699|580602802|FG001|Overall Study|Randomized in Error|0|||
160786083|NCT01908699|580602801|FG000|Overall Study|Death|9|||
161230856|NCT00358449|582227276|FG000|Overall Study|Adverse Event|1|||
161230857|NCT00358449|582227277|FG001|Overall Study|Adverse Event|0|||
161230858|NCT00358449|582227278|FG002|Overall Study|Adverse Event|1|||
160786084|NCT01908699|580602802|FG001|Overall Study|Death|12|||
160786085|NCT01908699|580602801|FG000|Overall Study|Progressive Disease|30|||
160786086|NCT01908699|580602802|FG001|Overall Study|Progressive Disease|29|||
160786087|NCT01697501|580602803|FG000|Overall Study|Protocol Violation|2|||
160786088|NCT02242903|580602804|FG000|Overall Study|Withdrawal by Subject|1|||
160786089|NCT02242903|580602805|FG001|Overall Study|Withdrawal by Subject|0|||
160786090|NCT02242903|580602806|FG002|Overall Study|Withdrawal by Subject|0|||
160786091|NCT02242903|580602807|FG003|Overall Study|Withdrawal by Subject|0|||
161230859|NCT00358449|582227276|FG000|Overall Study|Lost to Follow-up|1|||
160786092|NCT02242903|580602808|FG004|Overall Study|Withdrawal by Subject|0|||
160786093|NCT02242903|580602809|FG005|Overall Study|Withdrawal by Subject|0|||
160786094|NCT02242903|580602810|FG006|Overall Study|Withdrawal by Subject|0|||
161125678|NCT01700192|581846878|FG000|Overall Study|Progressive disease|1|||
161125679|NCT01700192|581846879|FG001|Overall Study|Progressive disease|0|||
161125680|NCT01700192|581846878|FG000|Overall Study|Protocol Violation|3|||
161125681|NCT01700192|581846879|FG001|Overall Study|Protocol Violation|4|||
161230860|NCT00358449|582227277|FG001|Overall Study|Lost to Follow-up|0|||
161230861|NCT00358449|582227278|FG002|Overall Study|Lost to Follow-up|0|||
161230862|NCT00358449|582227276|FG000|Overall Study|Withdrawal by Subject|2|||
160786095|NCT02105012|580602811|FG000|Overall Study|Withdrawal by Subject|11|||
160786096|NCT02105012|580602811|FG000|Overall Study|Protocol Specified Criteria|9|||
160786097|NCT02105012|580602811|FG000|Overall Study|Lost to Follow-up|4|||
160786098|NCT02105012|580602811|FG000|Overall Study|Protocol Violation|4|||
161125682|NCT01700192|581846878|FG000|Overall Study|Technical problems|0|||
161125683|NCT01700192|581846879|FG001|Overall Study|Technical problems|1|||
160786099|NCT02105012|580602811|FG000|Overall Study|Physician Decision|3|||
160786100|NCT02105012|580602811|FG000|Overall Study|Adverse Event|1|||
160786101|NCT02105012|580602811|FG000|Overall Study|Lack of Efficacy|1|||
160786102|NCT00779909|580602814|FG000|Overall Study|Lost to Follow-up|1|||
160786103|NCT00779909|580602815|FG001|Overall Study|Lost to Follow-up|0|||
160786104|NCT00779909|580602816|FG002|Overall Study|Lost to Follow-up|0|||
160786105|NCT00779909|580602817|FG003|Overall Study|Lost to Follow-up|1|||
160786106|NCT00779909|580602814|FG000|Overall Study|Withdrawal by Subject|0|||
160786107|NCT00779909|580602815|FG001|Overall Study|Withdrawal by Subject|1|||
160786108|NCT00779909|580602816|FG002|Overall Study|Withdrawal by Subject|0|||
160786109|NCT00779909|580602817|FG003|Overall Study|Withdrawal by Subject|0|||
160786110|NCT01096186|580602818|FG000|Overall Study|Adverse Event|16|||
160786111|NCT01096186|580602818|FG000|Overall Study|Death|4|||
160786112|NCT01096186|580602818|FG000|Overall Study|Lack of Efficacy|4|||
160786113|NCT01096186|580602818|FG000|Overall Study|Lost to Follow-up|2|||
160786114|NCT01096186|580602818|FG000|Overall Study|Withdrawal by Subject|22|||
160786115|NCT01096186|580602818|FG000|Overall Study|Physician Decision|1|||
160786116|NCT01096186|580602818|FG000|Overall Study|Noncompliance with study drug|1|||
160786117|NCT01750281|580602819|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
160786118|NCT01750281|580602820|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
160786119|NCT01750281|580602821|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
160786120|NCT01750281|580602819|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
160786121|NCT01750281|580602820|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
160786122|NCT01750281|580602821|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
160786123|NCT01750281|580602819|FG000|Overall Study|Did not receive treatment|0|||
160786124|NCT01750281|580602820|FG001|Overall Study|Did not receive treatment|1|||
160786125|NCT01750281|580602821|FG002|Overall Study|Did not receive treatment|0|||
160786126|NCT01896986|580602822|FG000|Overall Study|samples lost|14|||
160786127|NCT01896986|580602823|FG001|Overall Study|samples lost|23|||
160786128|NCT03302936|580602825|FG000|Overall Study|Protocol Violation|3|||
160786129|NCT03302936|580602826|FG001|Overall Study|Protocol Violation|4|||
160786130|NCT01379937|580602827|FG000|Overall Study|Protocol Violation|0|||
160786131|NCT01379937|580602828|FG001|Overall Study|Protocol Violation|0|||
160786132|NCT01379937|580602829|FG002|Overall Study|Protocol Violation|0|||
160786133|NCT01379937|580602830|FG003|Overall Study|Protocol Violation|1|||
160786134|NCT01379937|580602827|FG000|Overall Study|Consent withdrawal|0|||
160786135|NCT01379937|580602828|FG001|Overall Study|Consent withdrawal|1|||
160786136|NCT01379937|580602829|FG002|Overall Study|Consent withdrawal|0|||
160786137|NCT01379937|580602830|FG003|Overall Study|Consent withdrawal|0|||
160786138|NCT01379937|580602827|FG000|Overall Study|Lost to Follow-up|1|||
160786139|NCT01379937|580602828|FG001|Overall Study|Lost to Follow-up|2|||
160786140|NCT01379937|580602829|FG002|Overall Study|Lost to Follow-up|2|||
160786141|NCT01379937|580602830|FG003|Overall Study|Lost to Follow-up|0|||
160786142|NCT01122680|580602831|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
160786143|NCT01122680|580602832|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
160981866|NCT02061761|581321783|FG001|Overall Study|Maximum clinical benefit|0|||
161125684|NCT01700192|581846878|FG000|Overall Study|Withdrawal by Subject|56|||
161125685|NCT01700192|581846879|FG001|Overall Study|Withdrawal by Subject|64|||
161125686|NCT01700192|581846878|FG000|Overall Study|Never received study drug|1|||
161125687|NCT01700192|581846879|FG001|Overall Study|Never received study drug|0|||
161125688|NCT01656434|581846884|FG000|Overall Study|Adverse Event|199|||
161125689|NCT01656434|581846885|FG001|Overall Study|Adverse Event|63|||
161125690|NCT01656434|581846884|FG000|Overall Study|Enrollment terminated at trial site|2|||
161125691|NCT01656434|581846885|FG001|Overall Study|Enrollment terminated at trial site|0|||
161125692|NCT01656434|581846884|FG000|Overall Study|Lost to Follow-up|309|||
161125693|NCT01656434|581846885|FG001|Overall Study|Lost to Follow-up|76|||
161125694|NCT01656434|581846884|FG000|Overall Study|Site discontinued study participation|24|||
161125695|NCT01656434|581846885|FG001|Overall Study|Site discontinued study participation|9|||
161125696|NCT01656434|581846884|FG000|Overall Study|Screen failure|2|||
161125697|NCT01656434|581846885|FG001|Overall Study|Screen failure|0|||
161125698|NCT01656434|581846884|FG000|Overall Study|Protocol Violation|7|||
161125699|NCT01656434|581846885|FG001|Overall Study|Protocol Violation|0|||
161125700|NCT01656434|581846884|FG000|Overall Study|Pregnancy wish|18|||
161125701|NCT01656434|581846885|FG001|Overall Study|Pregnancy wish|6|||
161125702|NCT01656434|581846884|FG000|Overall Study|Pregnancy|45|||
160786144|NCT01122680|580602833|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
160786145|NCT01122680|580602834|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
160786146|NCT01122680|580602831|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
160786147|NCT01122680|580602832|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
160786148|NCT01122680|580602833|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
160786149|NCT01122680|580602834|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
160786150|NCT01122680|580602831|FG000|Period 1 (4 Weeks)|Other|1|||
160786151|NCT01122680|580602832|FG001|Period 1 (4 Weeks)|Other|1|||
160786152|NCT01122680|580602833|FG002|Period 1 (4 Weeks)|Other|0|||
160786153|NCT01122680|580602834|FG003|Period 1 (4 Weeks)|Other|0|||
160786154|NCT01122680|580602831|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
161125703|NCT01656434|581846885|FG001|Overall Study|Pregnancy|10|||
161125704|NCT01656434|581846884|FG000|Overall Study|Physician Decision|7|||
160786155|NCT01122680|580602832|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
160786156|NCT01122680|580602833|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
160786157|NCT01122680|580602834|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
160786158|NCT01122680|580602831|FG000|Period 2 (4 Weeks)|Other|1|||
160786159|NCT01122680|580602832|FG001|Period 2 (4 Weeks)|Other|0|||
160786160|NCT01122680|580602833|FG002|Period 2 (4 Weeks)|Other|0|||
160786161|NCT01122680|580602834|FG003|Period 2 (4 Weeks)|Other|0|||
160786162|NCT01122680|580602831|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
160786163|NCT01122680|580602832|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
160786164|NCT01122680|580602833|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
160786165|NCT01122680|580602834|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
160786166|NCT01122680|580602831|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160786167|NCT01122680|580602832|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
160786168|NCT01122680|580602833|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160786169|NCT01122680|580602834|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
160786170|NCT00079781|580602839|FG000|Pre-implant Period|Withdrawal by Subject|2|||
160786171|NCT00079781|580602840|FG001|Pre-implant Period|Withdrawal by Subject|0|||
160786172|NCT00079781|580602841|FG002|Pre-implant Period|Withdrawal by Subject|0|||
160786173|NCT00079781|580602839|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
160786174|NCT00079781|580602840|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
160786175|NCT00079781|580602841|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
160786176|NCT00079781|580602839|FG000|Follow-up Period|Withdrawal by Subject|3|||
160786177|NCT00079781|580602840|FG001|Follow-up Period|Withdrawal by Subject|0|||
160786178|NCT00079781|580602841|FG002|Follow-up Period|Withdrawal by Subject|1|||
160786179|NCT00079781|580602839|FG000|Follow-up Period|Lost to Follow-up|1|||
160786180|NCT00079781|580602840|FG001|Follow-up Period|Lost to Follow-up|0|||
160786181|NCT00079781|580602841|FG002|Follow-up Period|Lost to Follow-up|0|||
160786182|NCT00079781|580602839|FG000|Follow-up Period|Death|0|||
160786183|NCT00079781|580602840|FG001|Follow-up Period|Death|0|||
160786184|NCT00079781|580602841|FG002|Follow-up Period|Death|1|||
160786185|NCT00564070|580602842|FG000|Overall Study|Lost to Follow-up|9|||
160786186|NCT00564070|580602843|FG001|Overall Study|Lost to Follow-up|7|||
160786187|NCT00564070|580602842|FG000|Overall Study|Worsening depression, referred to care|3|||
160786188|NCT00564070|580602843|FG001|Overall Study|Worsening depression, referred to care|0|||
160786189|NCT00552279|580602844|FG000|Overall Study|Adverse Event|0|||
160786190|NCT00552279|580602845|FG001|Overall Study|Adverse Event|1|||
160786191|NCT00552279|580602844|FG000|Overall Study|Withdrawal by Subject|12|||
160786192|NCT00552279|580602845|FG001|Overall Study|Withdrawal by Subject|1|||
160786193|NCT00552279|580602844|FG000|Overall Study|Lost to Follow-up|1|||
160786194|NCT00552279|580602845|FG001|Overall Study|Lost to Follow-up|0|||
160786195|NCT00552279|580602844|FG000|Overall Study|Other|1|||
160786196|NCT00552279|580602845|FG001|Overall Study|Other|1|||
160786197|NCT01655069|580602847|FG000|Overall Study|Physician Decision|0|||
160786198|NCT01655069|580602848|FG001|Overall Study|Physician Decision|0|||
160786199|NCT01655069|580602849|FG002|Overall Study|Physician Decision|0|||
160786200|NCT01655069|580602850|FG003|Overall Study|Physician Decision|1|||
160786201|NCT01655069|580602847|FG000|Overall Study|Adverse Event|6|||
160786202|NCT01655069|580602848|FG001|Overall Study|Adverse Event|7|||
160786203|NCT01655069|580602849|FG002|Overall Study|Adverse Event|2|||
160786204|NCT01655069|580602850|FG003|Overall Study|Adverse Event|3|||
160786205|NCT01655069|580602847|FG000|Overall Study|Lack of Efficacy|0|||
160786206|NCT01655069|580602848|FG001|Overall Study|Lack of Efficacy|1|||
161125705|NCT01656434|581846885|FG001|Overall Study|Physician Decision|2|||
161125706|NCT01656434|581846884|FG000|Overall Study|Non-compliance with study drug|48|||
161125707|NCT01656434|581846885|FG001|Overall Study|Non-compliance with study drug|9|||
161125708|NCT01656434|581846884|FG000|Overall Study|Study terminated by sponsor|1501|||
161125709|NCT01656434|581846885|FG001|Overall Study|Study terminated by sponsor|348|||
161125710|NCT01656434|581846884|FG000|Overall Study|Participant discontinued; drug related|13|||
161125711|NCT01656434|581846885|FG001|Overall Study|Participant discontinued; drug related|4|||
161125712|NCT01656434|581846884|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
161125713|NCT01656434|581846885|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
161125714|NCT01656434|581846884|FG000|Overall Study|Non-compliance with protocol|39|||
161125715|NCT01656434|581846885|FG001|Overall Study|Non-compliance with protocol|15|||
161125716|NCT01656434|581846884|FG000|Overall Study|Participant moved|40|||
161125717|NCT01656434|581846885|FG001|Overall Study|Participant moved|12|||
160786207|NCT01655069|580602849|FG002|Overall Study|Lack of Efficacy|0|||
160786208|NCT01655069|580602850|FG003|Overall Study|Lack of Efficacy|0|||
160786209|NCT01655069|580602847|FG000|Overall Study|No Treatment Needed|0|||
160786210|NCT01655069|580602848|FG001|Overall Study|No Treatment Needed|1|||
160786211|NCT01655069|580602849|FG002|Overall Study|No Treatment Needed|0|||
160786212|NCT01655069|580602850|FG003|Overall Study|No Treatment Needed|0|||
160786213|NCT01655069|580602847|FG000|Overall Study|Withdrawal by Subject|2|||
160786214|NCT01655069|580602848|FG001|Overall Study|Withdrawal by Subject|3|||
160786215|NCT01655069|580602849|FG002|Overall Study|Withdrawal by Subject|0|||
160786216|NCT01655069|580602850|FG003|Overall Study|Withdrawal by Subject|0|||
160786217|NCT02346370|580602851|FG000|Overall Study|Not treated|1|||
160786218|NCT02346370|580602852|FG001|Overall Study|Not treated|0|||
160786219|NCT02346370|580602853|FG002|Overall Study|Not treated|0|||
160786220|NCT02346370|580602851|FG000|Overall Study|Withdrawal of consent|1|||
160786221|NCT02346370|580602852|FG001|Overall Study|Withdrawal of consent|0|||
160786222|NCT02346370|580602853|FG002|Overall Study|Withdrawal of consent|0|||
160786223|NCT02346370|580602851|FG000|Overall Study|Death|1|||
160786224|NCT02346370|580602852|FG001|Overall Study|Death|3|||
160786225|NCT02346370|580602853|FG002|Overall Study|Death|1|||
160786226|NCT02346370|580602851|FG000|Overall Study|Sponsor discontinued study|5|||
160786227|NCT02346370|580602852|FG001|Overall Study|Sponsor discontinued study|0|||
160786228|NCT02346370|580602853|FG002|Overall Study|Sponsor discontinued study|2|||
160786229|NCT02346370|580602851|FG000|Overall Study|Radiologic progression|0|||
160786230|NCT02346370|580602852|FG001|Overall Study|Radiologic progression|0|||
160786231|NCT02346370|580602853|FG002|Overall Study|Radiologic progression|1|||
160786232|NCT02346370|580602851|FG000|Overall Study|Physician Decision|0|||
160786233|NCT02346370|580602852|FG001|Overall Study|Physician Decision|1|||
160786234|NCT02346370|580602853|FG002|Overall Study|Physician Decision|0|||
160786235|NCT01210443|580602856|FG000|Overall Study|Study terminated by sponsor|2|||
160786236|NCT02807181|580602859|FG000|Overall Study|Death|28|||
160786237|NCT02807181|580602860|FG001|Overall Study|Death|24|||
160786238|NCT02807181|580602859|FG000|Overall Study|Withdrawal by Subject|1|||
160786239|NCT02807181|580602860|FG001|Overall Study|Withdrawal by Subject|1|||
160786240|NCT02807181|580602859|FG000|Overall Study|Lost to Follow-up|0|||
160786241|NCT02807181|580602860|FG001|Overall Study|Lost to Follow-up|2|||
160786242|NCT02807181|580602859|FG000|Overall Study|Subject decision|1|||
160786243|NCT02807181|580602860|FG001|Overall Study|Subject decision|0|||
160786244|NCT02807181|580602859|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
160786245|NCT02807181|580602860|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
160786246|NCT02807181|580602859|FG000|Overall Study|In Study|3|||
160786247|NCT02807181|580602860|FG001|Overall Study|In Study|3|||
160786248|NCT02807181|580602859|FG000|Overall Study|Post Progression|3|||
160786249|NCT02807181|580602860|FG001|Overall Study|Post Progression|2|||
160786250|NCT01309100|580602861|FG000|Overall Study|Protocol Violation|1|||
160786251|NCT01309100|580602861|FG000|Overall Study|Positive Slit lamp finding|1|||
160786252|NCT01452789|580602862|FG000|Overall Study|Withdrawal by Subject|3|||
160786253|NCT01452789|580602863|FG001|Overall Study|Withdrawal by Subject|2|||
160786254|NCT00066170|580602864|FG000|Overall Study|Adverse Event|2|||
160786255|NCT00066170|580602865|FG001|Overall Study|Adverse Event|4|||
160786256|NCT00066170|580602866|FG002|Overall Study|Adverse Event|1|||
160786257|NCT00066170|580602867|FG003|Overall Study|Adverse Event|7|||
160786258|NCT00066170|580602864|FG000|Overall Study|Serious Adverse Event|0|||
160890211|NCT00423670|580992973|FG006|Treatment Period|Investigator decision|0|||
161125718|NCT01656434|581846884|FG000|Overall Study|Participant withdrew consent|28|||
161125719|NCT01656434|581846885|FG001|Overall Study|Participant withdrew consent|9|||
161328269|NCT01610037|582587106|FG000|All Patients|Lost to Follow-up|1|||
161328270|NCT01610037|582587107|FG001|All Patients|Lost to Follow-up|0|||
161328271|NCT01610037|582587108|FG002|All Patients|Lost to Follow-up|0|||
161328272|NCT01610037|582587106|FG000|All Patients|Abnormal test procedure result(s)|0|||
161328273|NCT01610037|582587107|FG001|All Patients|Abnormal test procedure result(s)|1|||
161328274|NCT01610037|582587108|FG002|All Patients|Abnormal test procedure result(s)|3|||
161328275|NCT01610037|582587106|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
161328276|NCT01610037|582587107|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
161328277|NCT01610037|582587108|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
161328278|NCT01610037|582587106|FG000|Treatment and Follow up Period|Death|10|||
161328279|NCT01610037|582587107|FG001|Treatment and Follow up Period|Death|5|||
161328280|NCT01610037|582587108|FG002|Treatment and Follow up Period|Death|4|||
161328281|NCT01610037|582587106|FG000|Treatment and Follow up Period|Administrative problems|1|||
161328282|NCT01610037|582587107|FG001|Treatment and Follow up Period|Administrative problems|3|||
161328283|NCT01610037|582587108|FG002|Treatment and Follow up Period|Administrative problems|2|||
161328284|NCT01610037|582587106|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
161328285|NCT01610037|582587107|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
161328286|NCT01610037|582587108|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
161328287|NCT00274742|582587109|FG000|Overall Study|Adverse Event|0|||
160786259|NCT00066170|580602865|FG001|Overall Study|Serious Adverse Event|0|||
160786260|NCT00066170|580602866|FG002|Overall Study|Serious Adverse Event|1|||
160786261|NCT00066170|580602867|FG003|Overall Study|Serious Adverse Event|1|||
161328288|NCT00274742|582587110|FG001|Overall Study|Adverse Event|4|||
160786262|NCT00066170|580602864|FG000|Overall Study|Lost to Follow-up|0|||
160786263|NCT00066170|580602865|FG001|Overall Study|Lost to Follow-up|1|||
160786264|NCT00066170|580602866|FG002|Overall Study|Lost to Follow-up|0|||
160786265|NCT00066170|580602867|FG003|Overall Study|Lost to Follow-up|0|||
160786266|NCT00066170|580602864|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
160786267|NCT00066170|580602865|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
160786268|NCT00066170|580602866|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
160786269|NCT00066170|580602867|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
160786270|NCT00066170|580602864|FG000|Overall Study|Protocol Violation|3|||
160786271|NCT00066170|580602865|FG001|Overall Study|Protocol Violation|0|||
160786272|NCT00066170|580602866|FG002|Overall Study|Protocol Violation|0|||
160786273|NCT00066170|580602867|FG003|Overall Study|Protocol Violation|0|||
160786274|NCT00066170|580602864|FG000|Overall Study|Other|1|||
160786275|NCT00066170|580602865|FG001|Overall Study|Other|5|||
160786276|NCT00066170|580602866|FG002|Overall Study|Other|2|||
160786277|NCT00066170|580602867|FG003|Overall Study|Other|0|||
160786278|NCT03722030|580602868|FG000|Overall Study|Withdrawal by Subject|1|||
160786279|NCT03722030|580602869|FG001|Overall Study|Withdrawal by Subject|0|||
160786280|NCT01663987|580602871|FG000|Overall Study|Adverse Event|7|||
160786281|NCT01663987|580602872|FG001|Overall Study|Adverse Event|2|||
160786282|NCT01663987|580602871|FG000|Overall Study|Lost to Follow-up|1|||
160786283|NCT01663987|580602872|FG001|Overall Study|Lost to Follow-up|1|||
160786284|NCT01663987|580602871|FG000|Overall Study|Withdrawal by Subject|2|||
160786285|NCT01663987|580602872|FG001|Overall Study|Withdrawal by Subject|3|||
160786286|NCT01663987|580602871|FG000|Overall Study|Other reason not defined above|3|||
160786287|NCT01663987|580602872|FG001|Overall Study|Other reason not defined above|0|||
160786288|NCT02006654|580602876|FG000|Overall Study|Withdrawal before treatment|4|||
160786289|NCT02006654|580602877|FG001|Overall Study|Withdrawal before treatment|2|||
160786290|NCT02006654|580602876|FG000|Overall Study|Adverse Event|16|||
160786291|NCT02006654|580602877|FG001|Overall Study|Adverse Event|17|||
160786292|NCT02006654|580602876|FG000|Overall Study|Death|1|||
160786293|NCT02006654|580602877|FG001|Overall Study|Death|0|||
160786294|NCT02006654|580602876|FG000|Overall Study|Withdrawal by Subject|14|||
160786295|NCT02006654|580602877|FG001|Overall Study|Withdrawal by Subject|12|||
160786296|NCT02006654|580602876|FG000|Overall Study|Protocol Violation|5|||
160786297|NCT02006654|580602877|FG001|Overall Study|Protocol Violation|8|||
160786298|NCT02006654|580602876|FG000|Overall Study|Lost to Follow-up|1|||
160786299|NCT02006654|580602877|FG001|Overall Study|Lost to Follow-up|0|||
160786300|NCT02006654|580602876|FG000|Overall Study|patient's will|2|||
160786301|NCT02006654|580602877|FG001|Overall Study|patient's will|1|||
160786302|NCT02006654|580602876|FG000|Overall Study|insufficient compliance|1|||
160786303|NCT02006654|580602877|FG001|Overall Study|insufficient compliance|0|||
160786304|NCT02006654|580602876|FG000|Overall Study|worsening cognitive condition|0|||
160786305|NCT02006654|580602877|FG001|Overall Study|worsening cognitive condition|1|||
160786306|NCT02006654|580602876|FG000|Overall Study|faecal incontinence|0|||
160786307|NCT02006654|580602877|FG001|Overall Study|faecal incontinence|1|||
160786308|NCT02006654|580602876|FG000|Overall Study|mood disorder|0|||
160786309|NCT02006654|580602877|FG001|Overall Study|mood disorder|1|||
160786310|NCT02006654|580602876|FG000|Overall Study|disallowed medication|1|||
160786311|NCT02006654|580602877|FG001|Overall Study|disallowed medication|0|||
160786312|NCT02006654|580602876|FG000|Overall Study|moving out of state|0|||
160786313|NCT02006654|580602877|FG001|Overall Study|moving out of state|1|||
160786314|NCT03520387|580602878|FG000|Pre-Randomization|Withdrawal by Subject|1|||
160786315|NCT03520387|580602879|FG001|Pre-Randomization|Withdrawal by Subject|0|||
160786316|NCT03520387|580602880|FG002|Pre-Randomization|Withdrawal by Subject|0|||
160786317|NCT03520387|580602881|FG003|Pre-Randomization|Withdrawal by Subject|0|||
160786318|NCT03520387|580602882|FG004|Pre-Randomization|Withdrawal by Subject|0|||
160786319|NCT03520387|580602878|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
160786320|NCT03520387|580602879|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786321|NCT03520387|580602880|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786322|NCT03520387|580602881|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786323|NCT03520387|580602882|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
160786324|NCT05737745|580602883|FG000|Overall Study|Withdrawal by Subject|0|||
160786325|NCT05737745|580602884|FG001|Overall Study|Withdrawal by Subject|6|||
160786326|NCT05737745|580602885|FG002|Overall Study|Withdrawal by Subject|1|||
160786327|NCT04648241|580602886|FG000|Overall Study|Lost to Follow-up|1|||
160786328|NCT04648241|580602887|FG001|Overall Study|Lost to Follow-up|0|||
160786329|NCT02569242|580602888|FG000|Overall Study|Death|1|||
160786330|NCT02569242|580602889|FG001|Overall Study|Death|0|||
160786331|NCT02569242|580602888|FG000|Overall Study|Withdrawal by Subject|0|||
160786332|NCT02569242|580602889|FG001|Overall Study|Withdrawal by Subject|1|||
160786333|NCT02057666|580602890|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
160786334|NCT02057666|580602891|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
161125720|NCT01656434|581846884|FG000|Overall Study|Withdrawal by Subject|64|||
161125721|NCT01656434|581846885|FG001|Overall Study|Withdrawal by Subject|7|||
161125722|NCT01235962|581846886|FG000|Overall Study|Withdrawal by Subject|20|||
160786335|NCT02057666|580602890|FG000|Double Blind Treatment Period|Poor tolerability|7|||
160786336|NCT02057666|580602891|FG001|Double Blind Treatment Period|Poor tolerability|2|||
160786337|NCT02057666|580602890|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
160786338|NCT02057666|580602891|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
160786339|NCT02057666|580602890|FG000|Double Blind Treatment Period|Physician Decision|1|||
160786340|NCT02057666|580602891|FG001|Double Blind Treatment Period|Physician Decision|0|||
160786341|NCT02057666|580602890|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
160786342|NCT02057666|580602891|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
160786343|NCT02057666|580602890|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
160786344|NCT02057666|580602891|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
160786345|NCT02057666|580602890|FG000|Double Blind Treatment Period|Sponsor's request|70|||
160786346|NCT02057666|580602891|FG001|Double Blind Treatment Period|Sponsor's request|34|||
160786347|NCT02057666|580602890|FG000|Open-Label Treatment Period|Poor tolerability|0|||
160786348|NCT02057666|580602891|FG001|Open-Label Treatment Period|Poor tolerability|1|||
160786349|NCT02057666|580602890|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
160786350|NCT02057666|580602891|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
160786351|NCT02057666|580602890|FG000|Open-Label Treatment Period|Sponsor's request|0|||
160786352|NCT02057666|580602891|FG001|Open-Label Treatment Period|Sponsor's request|4|||
160786353|NCT05661734|580602892|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
160786354|NCT05661734|580602892|FG000|Overall Study|Lost to Follow-up|13|||
160786355|NCT05661734|580602892|FG000|Overall Study|Enrolled but not dosed|2|||
160786356|NCT02489045|580602893|FG000|Overall Study|unable to collect usable data|53|||
160786357|NCT02489045|580602893|FG000|Follow-up|Lost to Follow-up|10|||
160786358|NCT02774278|580602896|FG000|Overall Study|Lack of Efficacy|199|||
160786359|NCT02774278|580602896|FG000|Overall Study|Death|29|||
160786360|NCT02774278|580602896|FG000|Overall Study|Adverse event/intercurrent illness|16|||
160786361|NCT02774278|580602896|FG000|Overall Study|Refused treatment/did not cooperate|9|||
160786362|NCT02774278|580602896|FG000|Overall Study|Administrative reasons|6|||
160786363|NCT02774278|580602896|FG000|Overall Study|Withdrawal by Subject|3|||
160786364|NCT02774278|580602896|FG000|Overall Study|Protocol Violation|2|||
160786365|NCT03259308|580602899|FG000|Overall Study|Adverse Event|5|||
160786366|NCT03259308|580602900|FG001|Overall Study|Adverse Event|4|||
160786367|NCT03259308|580602901|FG002|Overall Study|Adverse Event|1|||
160786368|NCT03259308|580602899|FG000|Overall Study|Withdrawal by Subject|2|||
160786369|NCT03259308|580602900|FG001|Overall Study|Withdrawal by Subject|1|||
160786370|NCT03259308|580602901|FG002|Overall Study|Withdrawal by Subject|3|||
160786371|NCT03259308|580602899|FG000|Overall Study|Lost to Follow-up|0|||
160786372|NCT03259308|580602900|FG001|Overall Study|Lost to Follow-up|0|||
160786373|NCT03259308|580602901|FG002|Overall Study|Lost to Follow-up|1|||
160786374|NCT03259308|580602899|FG000|Overall Study|Pregnancy|0|||
160786375|NCT03259308|580602900|FG001|Overall Study|Pregnancy|0|||
160786376|NCT03259308|580602901|FG002|Overall Study|Pregnancy|1|||
160786377|NCT03259308|580602899|FG000|Overall Study|Protocol Deviation|0|||
160786378|NCT03259308|580602900|FG001|Overall Study|Protocol Deviation|3|||
160786379|NCT03259308|580602901|FG002|Overall Study|Protocol Deviation|0|||
160786380|NCT03259308|580602899|FG000|Overall Study|Lack of Efficacy|0|||
160786381|NCT03259308|580602900|FG001|Overall Study|Lack of Efficacy|0|||
160786382|NCT03259308|580602901|FG002|Overall Study|Lack of Efficacy|1|||
160786383|NCT03339453|580602907|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
160786384|NCT03339453|580602908|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
160786385|NCT00300495|580602912|FG000|Overall Study|Protocol Violation|4|||
160786386|NCT00300495|580602913|FG001|Overall Study|Protocol Violation|1|||
160786387|NCT01117350|580602925|FG000|Comparative Period|Not Treated|5|||
160786388|NCT01117350|580602926|FG001|Comparative Period|Not Treated|8|||
160786389|NCT01117350|580602925|FG000|Comparative Period|Adverse Event|6|||
160786390|NCT01117350|580602926|FG001|Comparative Period|Adverse Event|33|||
160786391|NCT01117350|580602925|FG000|Comparative Period|Lost to Follow-up|11|||
160786392|NCT01117350|580602926|FG001|Comparative Period|Lost to Follow-up|7|||
160786393|NCT01117350|580602925|FG000|Comparative Period|Withdrawal by Subject|9|||
160786394|NCT01117350|580602926|FG001|Comparative Period|Withdrawal by Subject|13|||
160786395|NCT01117350|580602925|FG000|Comparative Period|Protocol Violation|8|||
160786396|NCT01117350|580602926|FG001|Comparative Period|Protocol Violation|12|||
160786397|NCT01117350|580602925|FG000|Comparative Period|Lack of Efficacy|1|||
160786398|NCT01117350|580602926|FG001|Comparative Period|Lack of Efficacy|0|||
160786399|NCT01117350|580602925|FG000|Comparative Period|Physician Decision|0|||
160786400|NCT01117350|580602926|FG001|Comparative Period|Physician Decision|1|||
160786401|NCT01117350|580602925|FG000|Comparative Period|Move to another city/country|2|||
161125723|NCT01235962|581846887|FG001|Overall Study|Withdrawal by Subject|19|||
161125724|NCT01235962|581846888|FG002|Overall Study|Withdrawal by Subject|62|||
161125725|NCT01235962|581846889|FG003|Overall Study|Withdrawal by Subject|49|||
161125726|NCT01235962|581846886|FG000|Overall Study|Lost to Follow-up|21|||
161125727|NCT01235962|581846887|FG001|Overall Study|Lost to Follow-up|16|||
161125728|NCT01235962|581846888|FG002|Overall Study|Lost to Follow-up|47|||
161125729|NCT01235962|581846889|FG003|Overall Study|Lost to Follow-up|32|||
161125730|NCT01235962|581846886|FG000|Overall Study|Physician Decision|5|||
161125731|NCT01235962|581846887|FG001|Overall Study|Physician Decision|0|||
161125732|NCT01235962|581846888|FG002|Overall Study|Physician Decision|9|||
161125733|NCT01235962|581846889|FG003|Overall Study|Physician Decision|5|||
161125734|NCT02817087|581846893|FG000|Overall Study|Withdrawal by Subject|2|||
161125735|NCT02817087|581846894|FG001|Overall Study|Withdrawal by Subject|0|||
161125736|NCT06098729|581846897|FG000|Overall Study|Withdrawal by Subject|1|||
161125737|NCT01890421|581846898|FG000|Overall Study|Adverse Event|1|||
161125738|NCT01890421|581846898|FG000|Overall Study|Other reason|10|||
161125739|NCT04871711|581846899|FG000|Overall Study|Withdrawal by Subject|11|||
161125740|NCT04871711|581846900|FG001|Overall Study|Withdrawal by Subject|5|||
160786402|NCT01117350|580602926|FG001|Comparative Period|Move to another city/country|1|||
160786403|NCT01117350|580602925|FG000|Extension Period|Not included in extension, not treated|0|||
160786404|NCT01117350|580602926|FG001|Extension Period|Not included in extension, not treated|50|||
160786405|NCT01117350|580602925|FG000|Extension Period|Adverse Event|0|||
160786406|NCT01117350|580602926|FG001|Extension Period|Adverse Event|2|||
160786407|NCT01117350|580602925|FG000|Extension Period|Protocol Violation|0|||
160786408|NCT01117350|580602926|FG001|Extension Period|Protocol Violation|2|||
160786409|NCT01117350|580602925|FG000|Extension Period|Lost to Follow-up|0|||
160786410|NCT01117350|580602926|FG001|Extension Period|Lost to Follow-up|2|||
160786411|NCT01117350|580602925|FG000|Extension Period|Withdrawal by Subject|0|||
160786412|NCT01117350|580602926|FG001|Extension Period|Withdrawal by Subject|3|||
160786413|NCT01117350|580602925|FG000|Extension Period|Lack of Efficacy|0|||
160786414|NCT01117350|580602926|FG001|Extension Period|Lack of Efficacy|2|||
160786415|NCT01117350|580602925|FG000|Extension Period|Inclusion criteria not respected|0|||
160786416|NCT01117350|580602926|FG001|Extension Period|Inclusion criteria not respected|1|||
160786417|NCT01117350|580602925|FG000|Extension Period|Prohibited medication|0|||
160786418|NCT01117350|580602926|FG001|Extension Period|Prohibited medication|1|||
160786419|NCT06868667|580602931|FG000|Overall Study|Death|0|||
160786420|NCT06868667|580602932|FG001|Overall Study|Death|4|||
160786421|NCT06868667|580602931|FG000|Overall Study|Lost to Follow-up|0|||
160786422|NCT06868667|580602932|FG001|Overall Study|Lost to Follow-up|1|||
160786423|NCT06868667|580602931|FG000|Overall Study|Withdrawal by Subject|1|||
160786424|NCT06868667|580602932|FG001|Overall Study|Withdrawal by Subject|0|||
160786425|NCT06868667|580602931|FG000|Overall Study|Ongoing|9|||
160786426|NCT06868667|580602932|FG001|Overall Study|Ongoing|9|||
160786427|NCT02487199|580602934|FG000|Overall Study|Withdrew Consent|0|||
160786428|NCT02487199|580602935|FG001|Overall Study|Withdrew Consent|1|||
160786429|NCT00286455|580602936|FG000|Overall Study|Hyperglycemia rescue|19|||
160786430|NCT00286455|580602937|FG001|Overall Study|Hyperglycemia rescue|13|||
160786431|NCT00286455|580602938|FG002|Overall Study|Hyperglycemia rescue|10|||
160786432|NCT00286455|580602936|FG000|Overall Study|Adverse Event|1|||
160786433|NCT00286455|580602937|FG001|Overall Study|Adverse Event|3|||
160786434|NCT00286455|580602938|FG002|Overall Study|Adverse Event|2|||
160786435|NCT00286455|580602936|FG000|Overall Study|Lost to Follow-up|0|||
160786436|NCT00286455|580602937|FG001|Overall Study|Lost to Follow-up|3|||
160786437|NCT00286455|580602938|FG002|Overall Study|Lost to Follow-up|3|||
160786438|NCT00286455|580602936|FG000|Overall Study|Physician Decision|3|||
160786439|NCT00286455|580602937|FG001|Overall Study|Physician Decision|0|||
160786440|NCT00286455|580602938|FG002|Overall Study|Physician Decision|2|||
160786441|NCT00286455|580602936|FG000|Overall Study|Protocol Violation|1|||
160786442|NCT00286455|580602937|FG001|Overall Study|Protocol Violation|1|||
160786443|NCT00286455|580602938|FG002|Overall Study|Protocol Violation|0|||
160786444|NCT00286455|580602936|FG000|Overall Study|Participant Non-compliance|1|||
160786445|NCT00286455|580602937|FG001|Overall Study|Participant Non-compliance|0|||
160786446|NCT00286455|580602938|FG002|Overall Study|Participant Non-compliance|0|||
160786447|NCT00286455|580602936|FG000|Overall Study|Withdrawal by Subject|0|||
160786448|NCT00286455|580602937|FG001|Overall Study|Withdrawal by Subject|8|||
160786449|NCT00286455|580602938|FG002|Overall Study|Withdrawal by Subject|7|||
160786450|NCT03681093|580604599|FG000|Overall Study|Subject decision|0|||
160786451|NCT03681093|580604600|FG001|Overall Study|Subject decision|2|||
160786452|NCT03681093|580604601|FG002|Overall Study|Subject decision|1|||
160786453|NCT01213251|580604602|FG000|Overall Study|Death|2|||
160786454|NCT01213251|580604603|FG001|Overall Study|Death|1|||
160786455|NCT01213251|580604604|FG002|Overall Study|Death|2|||
160786456|NCT01213251|580604602|FG000|Overall Study|Exit|3|||
160786457|NCT01213251|580604603|FG001|Overall Study|Exit|2|||
160786458|NCT01213251|580604604|FG002|Overall Study|Exit|8|||
160786459|NCT01213251|580604602|FG000|Overall Study|Protocol Violation|1|||
160786460|NCT01213251|580604603|FG001|Overall Study|Protocol Violation|1|||
160786461|NCT01213251|580604604|FG002|Overall Study|Protocol Violation|0|||
160786462|NCT01213251|580604602|FG000|Overall Study|Missed 18-Month Follow-up|0|||
160786463|NCT01213251|580604603|FG001|Overall Study|Missed 18-Month Follow-up|0|||
160786464|NCT01213251|580604604|FG002|Overall Study|Missed 18-Month Follow-up|1|||
160786465|NCT00326495|580604608|FG000|Overall Study|Switched to alternative treatment|1|||
160786466|NCT00326495|580604608|FG000|Overall Study|Disease progression before treatment|1|||
160786467|NCT00326495|580604608|FG000|Overall Study|Refused further treatment|2|||
160786468|NCT00326495|580604608|FG000|Overall Study|Subject off study before assessment|1|||
160786469|NCT02933151|580604609|FG000|Overall Study|Lost to Follow-up|19|||
160786470|NCT02933151|580604610|FG001|Overall Study|Lost to Follow-up|18|||
160786471|NCT02933151|580604609|FG000|Overall Study|Death|1732|||
160786472|NCT02933151|580604610|FG001|Overall Study|Death|1827|||
160786473|NCT02933151|580604609|FG000|Overall Study|Transplant|210|||
160786474|NCT02933151|580604610|FG001|Overall Study|Transplant|278|||
160786475|NCT02933151|580604609|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
160786476|NCT02933151|580604610|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
160786477|NCT02933151|580604609|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
160786478|NCT02933151|580604610|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
160786479|NCT02933151|580604609|FG000|Overall Study|Recovered Kidney Function|47|||
160786480|NCT02933151|580604610|FG001|Overall Study|Recovered Kidney Function|29|||
160786481|NCT01654250|580604611|FG000|Overall Study|Lost to Follow-up|1|||
160786482|NCT01654250|580604612|FG001|Overall Study|Lost to Follow-up|0|||
160786483|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
160786484|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
160786485|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
160786486|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
160786487|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
160786488|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
160786489|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
160786490|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
160786491|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
160786492|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
160786493|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
160786494|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
160786495|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
160786496|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
160786497|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
160786498|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
160786499|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
160786500|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
160786501|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
160786502|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
160786503|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
160786504|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
160786505|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
160786506|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
160786507|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
160786508|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
160786509|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
160786510|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
160786511|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
160786512|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
160786513|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
160786514|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
160786515|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
160786516|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
160786517|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
160786518|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
160786519|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
160786520|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
160786521|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
160786522|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
160786523|NCT02596893|580604613|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
160786524|NCT02596893|580604614|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
160786525|NCT02596893|580604615|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
160786526|NCT02596893|580604616|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
160786527|NCT03280615|580604617|FG000|Overall Study|Lost to Follow-up|1|||
160786528|NCT03280615|580604618|FG001|Overall Study|Lost to Follow-up|2|||
160786529|NCT03280615|580604617|FG000|Overall Study|Adverse Event|1|||
160786530|NCT03280615|580604618|FG001|Overall Study|Adverse Event|1|||
160786531|NCT03280615|580604617|FG000|Overall Study|Withdrawal by Subject|2|||
160786532|NCT03280615|580604618|FG001|Overall Study|Withdrawal by Subject|2|||
160786533|NCT00107614|580604621|FG000|Overall Study|Physician Decision|10|||
160786534|NCT00107614|580604621|FG000|Overall Study|Death|2|||
160786535|NCT01013870|580604622|FG000|Overall Study|Lost to Follow-up|1|||
160786536|NCT01013870|580604623|FG001|Overall Study|Lost to Follow-up|3|||
160786537|NCT02457546|580604625|FG000|Overall Study|Other reasons|4|||
160786538|NCT02457546|580604626|FG001|Overall Study|Other reasons|1|||
160786539|NCT02457546|580604625|FG000|Overall Study|Refused to complete study/procedures|1|||
160786540|NCT02457546|580604626|FG001|Overall Study|Refused to complete study/procedures|1|||
160786541|NCT02457546|580604625|FG000|Overall Study|Lost to Follow-up|4|||
160786542|NCT02457546|580604626|FG001|Overall Study|Lost to Follow-up|1|||
160786543|NCT02457546|580604625|FG000|Overall Study|Adverse Event|0|||
160786544|NCT02457546|580604626|FG001|Overall Study|Adverse Event|1|||
160786545|NCT01530256|580604627|FG000|Overall Study|Death|2|||
160786546|NCT04432298|580604630|FG000|Overall Study|Other than specified|1|||
160786547|NCT04432298|580604631|FG001|Overall Study|Other than specified|0|||
160786548|NCT04432298|580604630|FG000|Overall Study|Lost to Follow-up|0|||
161230863|NCT00358449|582227277|FG001|Overall Study|Withdrawal by Subject|0|||
161230864|NCT00358449|582227278|FG002|Overall Study|Withdrawal by Subject|0|||
161230865|NCT00358449|582227276|FG000|Overall Study|Lack of Efficacy|0|||
161230866|NCT00358449|582227277|FG001|Overall Study|Lack of Efficacy|1|||
161230867|NCT00358449|582227278|FG002|Overall Study|Lack of Efficacy|0|||
161230868|NCT00358449|582227276|FG000|Overall Study|Steriod Inhaler was Increased|0|||
161230869|NCT00358449|582227277|FG001|Overall Study|Steriod Inhaler was Increased|0|||
161230870|NCT00358449|582227278|FG002|Overall Study|Steriod Inhaler was Increased|1|||
161230871|NCT01804270|582227279|FG000|Overall Study|Withdrawal by Subject|1|||
161230872|NCT01804270|582227280|FG001|Overall Study|Withdrawal by Subject|1|||
161230873|NCT02334722|582227282|FG000|Overall Study|Lost to Follow-up|4|||
161230874|NCT02334722|582227283|FG001|Overall Study|Lost to Follow-up|0|||
161230875|NCT02334722|582227282|FG000|Overall Study|6 week questionnaire not completed|2|||
161230876|NCT02334722|582227283|FG001|Overall Study|6 week questionnaire not completed|0|||
161230877|NCT02334722|582227282|FG000|Overall Study|Unable to obtain medication|1|||
161230878|NCT02334722|582227283|FG001|Overall Study|Unable to obtain medication|1|||
161230879|NCT02334722|582227282|FG000|Overall Study|Withdrawal by Subject|0|||
161230880|NCT02334722|582227283|FG001|Overall Study|Withdrawal by Subject|3|||
161230881|NCT02334722|582227282|FG000|Overall Study|Adverse Event|0|||
161230882|NCT02334722|582227283|FG001|Overall Study|Adverse Event|2|||
161230883|NCT02334722|582227282|FG000|Overall Study|Physician Decision|0|||
161230884|NCT02334722|582227283|FG001|Overall Study|Physician Decision|1|||
161230885|NCT03988803|582227284|FG000|Period 2|Prematurely discontinued from medication|2|||
161230886|NCT03988803|582227284|FG000|Period 2|Adverse Event|1|||
161230887|NCT01617668|582227285|FG000|Overall Study|Adverse Event|7|||
161230888|NCT01617668|582227286|FG001|Overall Study|Adverse Event|0|||
161230889|NCT01617668|582227287|FG002|Overall Study|Adverse Event|12|||
161230890|NCT01617668|582227288|FG003|Overall Study|Adverse Event|5|||
161230891|NCT01617668|582227285|FG000|Overall Study|Physician Decision|1|||
161230892|NCT01617668|582227286|FG001|Overall Study|Physician Decision|2|||
161230893|NCT01617668|582227287|FG002|Overall Study|Physician Decision|3|||
161230894|NCT01617668|582227288|FG003|Overall Study|Physician Decision|0|||
161230895|NCT01617668|582227285|FG000|Overall Study|Progressive Disease|4|||
161230896|NCT01617668|582227286|FG001|Overall Study|Progressive Disease|4|||
161230897|NCT01617668|582227287|FG002|Overall Study|Progressive Disease|6|||
161230898|NCT01617668|582227288|FG003|Overall Study|Progressive Disease|9|||
161230899|NCT01617668|582227285|FG000|Overall Study|Subject/guardian decision|1|||
161230900|NCT01617668|582227286|FG001|Overall Study|Subject/guardian decision|3|||
161230901|NCT01617668|582227287|FG002|Overall Study|Subject/guardian decision|2|||
161230902|NCT01617668|582227288|FG003|Overall Study|Subject/guardian decision|1|||
161230903|NCT00925769|582227289|FG000|Overall Study|Major toxicity|1|||
161230904|NCT00925769|582227290|FG001|Overall Study|Major toxicity|0|||
161230905|NCT00925769|582227291|FG002|Overall Study|Major toxicity|1|||
161230906|NCT00925769|582227292|FG003|Overall Study|Major toxicity|1|||
161230907|NCT00925769|582227293|FG004|Overall Study|Major toxicity|0|||
161230908|NCT00925769|582227294|FG005|Overall Study|Major toxicity|0|||
161230909|NCT00925769|582227289|FG000|Overall Study|Disease progression|4|||
161230910|NCT00925769|582227290|FG001|Overall Study|Disease progression|5|||
161230911|NCT00925769|582227291|FG002|Overall Study|Disease progression|3|||
161230912|NCT00925769|582227292|FG003|Overall Study|Disease progression|4|||
161230913|NCT00925769|582227293|FG004|Overall Study|Disease progression|2|||
161230914|NCT00925769|582227294|FG005|Overall Study|Disease progression|3|||
161230915|NCT00925769|582227289|FG000|Overall Study|Death|0|||
161230916|NCT00925769|582227290|FG001|Overall Study|Death|0|||
161230917|NCT00925769|582227291|FG002|Overall Study|Death|1|||
161230918|NCT00925769|582227292|FG003|Overall Study|Death|0|||
161230919|NCT00925769|582227293|FG004|Overall Study|Death|0|||
161230920|NCT00925769|582227294|FG005|Overall Study|Death|0|||
161230921|NCT00925769|582227289|FG000|Overall Study|Physician Decision|1|||
161230922|NCT00925769|582227290|FG001|Overall Study|Physician Decision|0|||
161230923|NCT00925769|582227291|FG002|Overall Study|Physician Decision|0|||
161230924|NCT00925769|582227292|FG003|Overall Study|Physician Decision|0|||
161230925|NCT00925769|582227293|FG004|Overall Study|Physician Decision|0|||
161230926|NCT00925769|582227294|FG005|Overall Study|Physician Decision|0|||
161230927|NCT00925769|582227289|FG000|Overall Study|Missing documentation|0|||
161230928|NCT00925769|582227290|FG001|Overall Study|Missing documentation|1|||
161230929|NCT00925769|582227291|FG002|Overall Study|Missing documentation|0|||
161230930|NCT00925769|582227292|FG003|Overall Study|Missing documentation|0|||
161230931|NCT00925769|582227293|FG004|Overall Study|Missing documentation|0|||
161230932|NCT00925769|582227294|FG005|Overall Study|Missing documentation|0|||
161230933|NCT00925769|582227289|FG000|Overall Study|End of study visit not done|0|||
161230934|NCT00925769|582227290|FG001|Overall Study|End of study visit not done|0|||
161230935|NCT00925769|582227291|FG002|Overall Study|End of study visit not done|1|||
160981867|NCT02061761|581321784|FG002|Overall Study|Maximum clinical benefit|0|||
161230936|NCT00925769|582227292|FG003|Overall Study|End of study visit not done|0|||
161230937|NCT00925769|582227293|FG004|Overall Study|End of study visit not done|0|||
161230938|NCT00925769|582227294|FG005|Overall Study|End of study visit not done|0|||
161230939|NCT00925769|582227289|FG000|Overall Study|Participant is unable to swallow drug|0|||
161328289|NCT00274742|582587111|FG002|Overall Study|Adverse Event|1|||
160786549|NCT04432298|580604631|FG001|Overall Study|Lost to Follow-up|1|||
160786550|NCT04432298|580604630|FG000|Overall Study|Death|3|||
160786551|NCT04432298|580604631|FG001|Overall Study|Death|2|||
160786552|NCT04432298|580604630|FG000|Overall Study|Withdrawal by Subject|2|||
160786553|NCT04432298|580604631|FG001|Overall Study|Withdrawal by Subject|0|||
160786554|NCT02451007|580604634|FG000|Overall Study|Withdrawal by Subject|4|||
160786555|NCT02451007|580604634|FG000|Overall Study|Adverse Event|1|||
160786556|NCT02451007|580604634|FG000|Overall Study|Disease Progression|2|||
160786557|NCT01716559|580604635|FG000|Overall Study|Adverse Event|11|||
160786558|NCT01716559|580604635|FG000|Overall Study|Death|21|||
160786559|NCT01716559|580604635|FG000|Overall Study|Withdrawal by Subject|4|||
160786560|NCT01716559|580604635|FG000|Overall Study|Other withdrawal reason|75|||
160786561|NCT00348374|580604636|FG000|Overall Study|Adverse Event|1|||
160786562|NCT00348374|580604637|FG001|Overall Study|Adverse Event|4|||
160786563|NCT00348374|580604636|FG000|Overall Study|Lost to Follow-up|1|||
160786564|NCT00348374|580604637|FG001|Overall Study|Lost to Follow-up|3|||
160786565|NCT00348374|580604636|FG000|Overall Study|Withdrawal by Subject|5|||
160786566|NCT00348374|580604637|FG001|Overall Study|Withdrawal by Subject|5|||
160786567|NCT00348374|580604636|FG000|Overall Study|Other|11|||
160786568|NCT00348374|580604637|FG001|Overall Study|Other|12|||
160786569|NCT00348374|580604636|FG000|Overall Study|ongoing at date of cutoff|1|||
160786570|NCT00348374|580604637|FG001|Overall Study|ongoing at date of cutoff|1|||
160786571|NCT00348374|580604636|FG000|Overall Study|randomized but did not receive treatment|0|||
160786572|NCT00348374|580604637|FG001|Overall Study|randomized but did not receive treatment|7|||
160786573|NCT02123511|580604646|FG000|Overall Study|Cancelled treatment|1|||
160786574|NCT02123511|580604647|FG001|Overall Study|Cancelled treatment|0|||
160786575|NCT02123511|580604646|FG000|Overall Study|Incomplete data|1|||
160786576|NCT02123511|580604647|FG001|Overall Study|Incomplete data|3|||
160786577|NCT02123511|580604646|FG000|Overall Study|Ineligible|0|||
160786578|NCT02123511|580604647|FG001|Overall Study|Ineligible|1|||
160786579|NCT01423084|580604648|FG000|Overall Study|Adverse Event|0|||
160786580|NCT01423084|580604649|FG001|Overall Study|Adverse Event|1|||
160786581|NCT01423084|580604648|FG000|Overall Study|Withdrawal by Subject|2|||
160786582|NCT01423084|580604649|FG001|Overall Study|Withdrawal by Subject|3|||
160786583|NCT01133977|580604653|FG000|Overall Study|Adverse Event|0|||
160786584|NCT01133977|580604654|FG001|Overall Study|Adverse Event|0|||
160786585|NCT01133977|580604655|FG002|Overall Study|Adverse Event|1|||
160786586|NCT01133977|580604656|FG003|Overall Study|Adverse Event|0|||
160786587|NCT01133977|580604657|FG004|Overall Study|Adverse Event|0|||
160786588|NCT01133977|580604653|FG000|Overall Study|Death|1|||
160786589|NCT01133977|580604654|FG001|Overall Study|Death|1|||
160786590|NCT01133977|580604655|FG002|Overall Study|Death|1|||
160786591|NCT01133977|580604656|FG003|Overall Study|Death|7|||
160786592|NCT01133977|580604657|FG004|Overall Study|Death|3|||
160786593|NCT01133977|580604653|FG000|Overall Study|Started a New Line of Therapy|2|||
160786594|NCT01133977|580604654|FG001|Overall Study|Started a New Line of Therapy|6|||
160786595|NCT01133977|580604655|FG002|Overall Study|Started a New Line of Therapy|4|||
160786596|NCT01133977|580604656|FG003|Overall Study|Started a New Line of Therapy|25|||
160786597|NCT01133977|580604657|FG004|Overall Study|Started a New Line of Therapy|33|||
160786598|NCT01133977|580604653|FG000|Overall Study|Lost to Follow-up|0|||
160786599|NCT01133977|580604654|FG001|Overall Study|Lost to Follow-up|0|||
160786600|NCT01133977|580604655|FG002|Overall Study|Lost to Follow-up|0|||
160786601|NCT01133977|580604656|FG003|Overall Study|Lost to Follow-up|2|||
160786602|NCT01133977|580604657|FG004|Overall Study|Lost to Follow-up|1|||
160786603|NCT01133977|580604653|FG000|Overall Study|Withdrawal by Subject|0|||
160786604|NCT01133977|580604654|FG001|Overall Study|Withdrawal by Subject|0|||
160786605|NCT01133977|580604655|FG002|Overall Study|Withdrawal by Subject|0|||
160786606|NCT01133977|580604656|FG003|Overall Study|Withdrawal by Subject|5|||
160786607|NCT01133977|580604657|FG004|Overall Study|Withdrawal by Subject|1|||
160786608|NCT02462057|580604658|FG000|Overall Study|Left Vitality|32|||
160786609|NCT02462057|580604659|FG001|Overall Study|Left Vitality|27|||
160786610|NCT02462057|580604660|FG002|Overall Study|Left Vitality|23|||
160786611|NCT02462057|580604661|FG003|Overall Study|Left Vitality|35|||
161125741|NCT04871711|581846899|FG000|Overall Study|Lack of Efficacy|5|||
161125742|NCT04871711|581846900|FG001|Overall Study|Lack of Efficacy|7|||
161125743|NCT04871711|581846899|FG000|Overall Study|Adverse Event|2|||
161125744|NCT04871711|581846900|FG001|Overall Study|Adverse Event|6|||
161125745|NCT04871711|581846899|FG000|Overall Study|Various reasons|2|||
161125746|NCT04871711|581846900|FG001|Overall Study|Various reasons|1|||
161125747|NCT04871711|581846899|FG000|Overall Study|Lost to Follow-up|0|||
161125748|NCT04871711|581846900|FG001|Overall Study|Lost to Follow-up|2|||
161125749|NCT01665144|581846901|FG000|Core Part|Withdrawal by Subject|96|||
161125750|NCT01665144|581846902|FG001|Core Part|Withdrawal by Subject|77|||
161125751|NCT01665144|581846903|FG002|Core Part|Withdrawal by Subject|0|||
161125752|NCT01665144|581846901|FG000|Core Part|Adverse Event|45|||
161125753|NCT01665144|581846902|FG001|Core Part|Adverse Event|18|||
161125754|NCT01665144|581846903|FG002|Core Part|Adverse Event|0|||
161125755|NCT01665144|581846901|FG000|Core Part|Lack of Efficacy|16|||
161125756|NCT01665144|581846902|FG001|Core Part|Lack of Efficacy|11|||
161125757|NCT01665144|581846903|FG002|Core Part|Lack of Efficacy|0|||
160786612|NCT02462057|580604662|FG004|Overall Study|Left Vitality|33|||
160786613|NCT02462057|580604658|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
160786614|NCT02462057|580604659|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
160786615|NCT02462057|580604660|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
160786616|NCT02462057|580604661|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
160786617|NCT02462057|580604662|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
160786618|NCT00281580|580604665|FG000|Overall Study|Adverse Event|2|||
160786619|NCT00281580|580604666|FG001|Overall Study|Adverse Event|0|||
160786620|NCT00281580|580604667|FG002|Overall Study|Adverse Event|2|||
160786621|NCT00281580|580604668|FG003|Overall Study|Adverse Event|4|||
160786622|NCT00281580|580604669|FG004|Overall Study|Adverse Event|1|||
160786623|NCT00281580|580604670|FG005|Overall Study|Adverse Event|0|||
160786624|NCT00281580|580604671|FG006|Overall Study|Adverse Event|1|||
160786625|NCT00281580|580604672|FG007|Overall Study|Adverse Event|0|||
160786626|NCT00281580|580604673|FG008|Overall Study|Adverse Event|1|||
160786627|NCT00281580|580604674|FG009|Overall Study|Adverse Event|6|||
160786628|NCT00281580|580604675|FG010|Overall Study|Adverse Event|0|||
160786629|NCT00281580|580604676|FG011|Overall Study|Adverse Event|5|||
160786630|NCT00281580|580604677|FG012|Overall Study|Adverse Event|8|||
160786631|NCT00281580|580604678|FG013|Overall Study|Adverse Event|2|||
160786632|NCT00281580|580604679|FG014|Overall Study|Adverse Event|3|||
160786633|NCT00281580|580604680|FG015|Overall Study|Adverse Event|3|||
160786634|NCT00281580|580604665|FG000|Overall Study|Protocol Violation|0|||
160786635|NCT00281580|580604666|FG001|Overall Study|Protocol Violation|0|||
160786636|NCT00281580|580604667|FG002|Overall Study|Protocol Violation|1|||
160786637|NCT00281580|580604668|FG003|Overall Study|Protocol Violation|1|||
160786638|NCT00281580|580604669|FG004|Overall Study|Protocol Violation|0|||
160786639|NCT00281580|580604670|FG005|Overall Study|Protocol Violation|0|||
160786640|NCT00281580|580604671|FG006|Overall Study|Protocol Violation|1|||
160786641|NCT00281580|580604672|FG007|Overall Study|Protocol Violation|0|||
160786642|NCT00281580|580604673|FG008|Overall Study|Protocol Violation|2|||
160786643|NCT00281580|580604674|FG009|Overall Study|Protocol Violation|0|||
160786644|NCT00281580|580604675|FG010|Overall Study|Protocol Violation|1|||
160786645|NCT00281580|580604676|FG011|Overall Study|Protocol Violation|2|||
160786646|NCT00281580|580604677|FG012|Overall Study|Protocol Violation|0|||
160786647|NCT00281580|580604678|FG013|Overall Study|Protocol Violation|1|||
160786648|NCT00281580|580604679|FG014|Overall Study|Protocol Violation|1|||
160786649|NCT00281580|580604680|FG015|Overall Study|Protocol Violation|3|||
160786650|NCT00281580|580604665|FG000|Overall Study|Withdrawal by Subject|3|||
160786651|NCT00281580|580604666|FG001|Overall Study|Withdrawal by Subject|0|||
160786652|NCT00281580|580604667|FG002|Overall Study|Withdrawal by Subject|1|||
160786653|NCT00281580|580604668|FG003|Overall Study|Withdrawal by Subject|1|||
160786654|NCT00281580|580604669|FG004|Overall Study|Withdrawal by Subject|1|||
160786655|NCT00281580|580604670|FG005|Overall Study|Withdrawal by Subject|2|||
160786656|NCT00281580|580604671|FG006|Overall Study|Withdrawal by Subject|2|||
160786657|NCT00281580|580604672|FG007|Overall Study|Withdrawal by Subject|0|||
160786658|NCT00281580|580604673|FG008|Overall Study|Withdrawal by Subject|1|||
160786659|NCT00281580|580604674|FG009|Overall Study|Withdrawal by Subject|4|||
160786660|NCT00281580|580604675|FG010|Overall Study|Withdrawal by Subject|1|||
160786661|NCT00281580|580604676|FG011|Overall Study|Withdrawal by Subject|1|||
160786662|NCT00281580|580604677|FG012|Overall Study|Withdrawal by Subject|2|||
160786663|NCT00281580|580604678|FG013|Overall Study|Withdrawal by Subject|2|||
160786664|NCT00281580|580604679|FG014|Overall Study|Withdrawal by Subject|1|||
160786665|NCT00281580|580604680|FG015|Overall Study|Withdrawal by Subject|5|||
160786666|NCT00281580|580604665|FG000|Overall Study|Lack of Efficacy|2|||
160786667|NCT00281580|580604666|FG001|Overall Study|Lack of Efficacy|1|||
160786668|NCT00281580|580604667|FG002|Overall Study|Lack of Efficacy|1|||
160786669|NCT00281580|580604668|FG003|Overall Study|Lack of Efficacy|6|||
160786670|NCT00281580|580604669|FG004|Overall Study|Lack of Efficacy|2|||
160786671|NCT00281580|580604670|FG005|Overall Study|Lack of Efficacy|0|||
160786672|NCT00281580|580604671|FG006|Overall Study|Lack of Efficacy|0|||
161230940|NCT00925769|582227290|FG001|Overall Study|Participant is unable to swallow drug|0|||
161230941|NCT00925769|582227291|FG002|Overall Study|Participant is unable to swallow drug|0|||
161230942|NCT00925769|582227292|FG003|Overall Study|Participant is unable to swallow drug|1|||
161230943|NCT00925769|582227293|FG004|Overall Study|Participant is unable to swallow drug|0|||
161230944|NCT00925769|582227294|FG005|Overall Study|Participant is unable to swallow drug|0|||
161230945|NCT00925769|582227289|FG000|Overall Study|Adverse Event|0|||
161230946|NCT00925769|582227290|FG001|Overall Study|Adverse Event|0|||
161230947|NCT00925769|582227291|FG002|Overall Study|Adverse Event|0|||
161230948|NCT00925769|582227292|FG003|Overall Study|Adverse Event|0|||
161230949|NCT00925769|582227293|FG004|Overall Study|Adverse Event|1|||
161230950|NCT00925769|582227294|FG005|Overall Study|Adverse Event|0|||
160786673|NCT00281580|580604672|FG007|Overall Study|Lack of Efficacy|0|||
160786674|NCT00281580|580604673|FG008|Overall Study|Lack of Efficacy|0|||
160786675|NCT00281580|580604674|FG009|Overall Study|Lack of Efficacy|0|||
160786676|NCT00281580|580604675|FG010|Overall Study|Lack of Efficacy|0|||
160890212|NCT00423670|580992974|FG007|Treatment Period|Investigator decision|1|||
161328290|NCT00274742|582587112|FG003|Overall Study|Adverse Event|4|||
161328291|NCT00274742|582587113|FG004|Overall Study|Adverse Event|12|||
161328292|NCT00274742|582587114|FG005|Overall Study|Adverse Event|3|||
161328293|NCT00274742|582587109|FG000|Overall Study|Lost to Follow-up|0|||
161328294|NCT00274742|582587110|FG001|Overall Study|Lost to Follow-up|0|||
161328295|NCT00274742|582587111|FG002|Overall Study|Lost to Follow-up|0|||
161328296|NCT00274742|582587112|FG003|Overall Study|Lost to Follow-up|0|||
161328297|NCT00274742|582587113|FG004|Overall Study|Lost to Follow-up|1|||
161328298|NCT00274742|582587114|FG005|Overall Study|Lost to Follow-up|0|||
161328299|NCT00274742|582587109|FG000|Overall Study|End of Study|0|||
161328300|NCT00274742|582587110|FG001|Overall Study|End of Study|0|||
161328301|NCT00274742|582587111|FG002|Overall Study|End of Study|0|||
161125758|NCT01665144|581846901|FG000|Core Part|Lost to Follow-up|9|||
161125759|NCT01665144|581846902|FG001|Core Part|Lost to Follow-up|8|||
161328302|NCT00274742|582587112|FG003|Overall Study|End of Study|1|||
161328303|NCT00274742|582587113|FG004|Overall Study|End of Study|0|||
161125760|NCT01665144|581846903|FG002|Core Part|Lost to Follow-up|0|||
161125761|NCT01665144|581846901|FG000|Core Part|Physician Decision|13|||
161125762|NCT01665144|581846902|FG001|Core Part|Physician Decision|1|||
161125763|NCT01665144|581846903|FG002|Core Part|Physician Decision|0|||
161125764|NCT01665144|581846901|FG000|Core Part|Progressive disease|8|||
161125765|NCT01665144|581846902|FG001|Core Part|Progressive disease|4|||
161125766|NCT01665144|581846903|FG002|Core Part|Progressive disease|0|||
161125767|NCT01665144|581846901|FG000|Core Part|Non-compliance with study treatment|5|||
161125768|NCT01665144|581846902|FG001|Core Part|Non-compliance with study treatment|0|||
161125769|NCT01665144|581846903|FG002|Core Part|Non-compliance with study treatment|0|||
161125770|NCT01665144|581846901|FG000|Core Part|Death|3|||
161125771|NCT01665144|581846902|FG001|Core Part|Death|1|||
161125772|NCT01665144|581846903|FG002|Core Part|Death|0|||
161125773|NCT01665144|581846901|FG000|Core Part|Protocol deviation|3|||
161125774|NCT01665144|581846902|FG001|Core Part|Protocol deviation|1|||
161125775|NCT01665144|581846903|FG002|Core Part|Protocol deviation|0|||
161125776|NCT01665144|581846901|FG000|Core Part|New therapy for study indication|2|||
161125777|NCT01665144|581846902|FG001|Core Part|New therapy for study indication|1|||
161125778|NCT01665144|581846903|FG002|Core Part|New therapy for study indication|0|||
161125779|NCT01665144|581846901|FG000|Core Part|Technical problems|2|||
161125780|NCT01665144|581846902|FG001|Core Part|Technical problems|0|||
161125781|NCT01665144|581846903|FG002|Core Part|Technical problems|0|||
161125782|NCT01665144|581846901|FG000|Extension Part|Patient/guardian decision|180|||
161125783|NCT01665144|581846902|FG001|Extension Part|Patient/guardian decision|0|||
161125784|NCT01665144|581846903|FG002|Extension Part|Patient/guardian decision|98|||
161125785|NCT01665144|581846901|FG000|Extension Part|Adverse Event|104|||
161125786|NCT01665144|581846902|FG001|Extension Part|Adverse Event|0|||
161125787|NCT01665144|581846903|FG002|Extension Part|Adverse Event|59|||
161125788|NCT01665144|581846901|FG000|Extension Part|Study closed early|42|||
161125789|NCT01665144|581846902|FG001|Extension Part|Study closed early|0|||
161125790|NCT01665144|581846903|FG002|Extension Part|Study closed early|19|||
161125791|NCT01665144|581846901|FG000|Extension Part|Progressive disease|36|||
161125792|NCT01665144|581846902|FG001|Extension Part|Progressive disease|0|||
161125793|NCT01665144|581846903|FG002|Extension Part|Progressive disease|14|||
161125794|NCT01665144|581846901|FG000|Extension Part|Lack of Efficacy|37|||
161125795|NCT01665144|581846902|FG001|Extension Part|Lack of Efficacy|0|||
161125796|NCT01665144|581846903|FG002|Extension Part|Lack of Efficacy|12|||
161125797|NCT01665144|581846901|FG000|Extension Part|Physician Decision|29|||
161125798|NCT01665144|581846902|FG001|Extension Part|Physician Decision|0|||
161125799|NCT01665144|581846903|FG002|Extension Part|Physician Decision|13|||
161125800|NCT01665144|581846901|FG000|Extension Part|Technical problems|20|||
161125801|NCT01665144|581846902|FG001|Extension Part|Technical problems|0|||
161125802|NCT01665144|581846903|FG002|Extension Part|Technical problems|8|||
161125803|NCT01665144|581846901|FG000|Extension Part|Death|20|||
161125804|NCT01665144|581846902|FG001|Extension Part|Death|0|||
161125805|NCT01665144|581846903|FG002|Extension Part|Death|4|||
161125806|NCT01665144|581846901|FG000|Extension Part|Missing|12|||
161125807|NCT01665144|581846902|FG001|Extension Part|Missing|0|||
161125808|NCT01665144|581846903|FG002|Extension Part|Missing|6|||
161125809|NCT01665144|581846901|FG000|Extension Part|Lost to Follow-up|9|||
161328304|NCT00274742|582587114|FG005|Overall Study|End of Study|0|||
161328305|NCT00274742|582587109|FG000|Overall Study|Disease Progression|0|||
161328306|NCT00274742|582587110|FG001|Overall Study|Disease Progression|1|||
161328307|NCT00274742|582587111|FG002|Overall Study|Disease Progression|1|||
161125810|NCT01665144|581846902|FG001|Extension Part|Lost to Follow-up|0|||
161125811|NCT01665144|581846903|FG002|Extension Part|Lost to Follow-up|5|||
161125812|NCT01665144|581846901|FG000|Extension Part|New therapy for study indication|3|||
161125813|NCT01665144|581846902|FG001|Extension Part|New therapy for study indication|0|||
161125814|NCT01665144|581846903|FG002|Extension Part|New therapy for study indication|2|||
161125815|NCT01665144|581846901|FG000|Extension Part|Protocol deviation|3|||
161125816|NCT01665144|581846902|FG001|Extension Part|Protocol deviation|0|||
161125817|NCT01665144|581846903|FG002|Extension Part|Protocol deviation|0|||
161125818|NCT01972074|581846911|FG000|Overall Study|Adverse Event|4|||
161328308|NCT00274742|582587112|FG003|Overall Study|Disease Progression|0|||
160786677|NCT00281580|580604676|FG011|Overall Study|Lack of Efficacy|1|||
160786678|NCT00281580|580604677|FG012|Overall Study|Lack of Efficacy|0|||
160786679|NCT00281580|580604678|FG013|Overall Study|Lack of Efficacy|2|||
160786680|NCT00281580|580604679|FG014|Overall Study|Lack of Efficacy|1|||
160786681|NCT00281580|580604680|FG015|Overall Study|Lack of Efficacy|0|||
160786682|NCT00281580|580604665|FG000|Overall Study|Lost to Follow-up|0|||
160786683|NCT00281580|580604666|FG001|Overall Study|Lost to Follow-up|0|||
160786684|NCT00281580|580604667|FG002|Overall Study|Lost to Follow-up|0|||
160786685|NCT00281580|580604668|FG003|Overall Study|Lost to Follow-up|3|||
160786686|NCT00281580|580604669|FG004|Overall Study|Lost to Follow-up|0|||
160786687|NCT00281580|580604670|FG005|Overall Study|Lost to Follow-up|1|||
160786688|NCT00281580|580604671|FG006|Overall Study|Lost to Follow-up|0|||
160786689|NCT00281580|580604672|FG007|Overall Study|Lost to Follow-up|1|||
160786690|NCT00281580|580604673|FG008|Overall Study|Lost to Follow-up|2|||
160786691|NCT00281580|580604674|FG009|Overall Study|Lost to Follow-up|1|||
160786692|NCT00281580|580604675|FG010|Overall Study|Lost to Follow-up|1|||
160786693|NCT00281580|580604676|FG011|Overall Study|Lost to Follow-up|0|||
160786694|NCT00281580|580604677|FG012|Overall Study|Lost to Follow-up|1|||
160786695|NCT00281580|580604678|FG013|Overall Study|Lost to Follow-up|0|||
160786696|NCT00281580|580604679|FG014|Overall Study|Lost to Follow-up|0|||
160786697|NCT00281580|580604680|FG015|Overall Study|Lost to Follow-up|0|||
160786698|NCT00281580|580604665|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
160786699|NCT00281580|580604666|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
160786700|NCT00281580|580604667|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
160786701|NCT00281580|580604668|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
160786702|NCT00281580|580604669|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
160786703|NCT00281580|580604670|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
160786704|NCT00281580|580604671|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
160786705|NCT00281580|580604672|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
160786706|NCT00281580|580604673|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
160786707|NCT00281580|580604674|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
160786708|NCT00281580|580604675|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
160786709|NCT00281580|580604676|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
160786710|NCT00281580|580604677|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
160786711|NCT00281580|580604678|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
160786712|NCT00281580|580604679|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
160786713|NCT00281580|580604680|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
160786714|NCT02067156|580604685|FG000|Overall Study|Lost to Follow-up|4|||
160786715|NCT03596983|580604686|FG000|Overall Study|Withdrawal by Subject|3|||
160786716|NCT03071965|580604687|FG000|Overall Study|Adverse Event|0|||
160786717|NCT03071965|580604688|FG001|Overall Study|Adverse Event|0|||
160786718|NCT03071965|580604689|FG002|Overall Study|Adverse Event|1|||
161328309|NCT00274742|582587113|FG004|Overall Study|Disease Progression|1|||
161328310|NCT00274742|582587114|FG005|Overall Study|Disease Progression|0|||
161328311|NCT00274742|582587109|FG000|Overall Study|Other|0|||
161328312|NCT00274742|582587110|FG001|Overall Study|Other|3|||
161328313|NCT00274742|582587111|FG002|Overall Study|Other|0|||
161328314|NCT00274742|582587112|FG003|Overall Study|Other|0|||
161328315|NCT00274742|582587113|FG004|Overall Study|Other|2|||
161328316|NCT00274742|582587114|FG005|Overall Study|Other|0|||
161328317|NCT00069823|582587125|FG000|Overall Study|Did not have follow-up diary cards|6|||
161328318|NCT00069823|582587126|FG001|Overall Study|Did not have follow-up diary cards|3|||
161328319|NCT01801111|582587127|FG000|Overall Study|Adverse Event|12|||
161328320|NCT01801111|582587127|FG000|Overall Study|Death|8|||
161328321|NCT01801111|582587127|FG000|Overall Study|Physician Decision|5|||
161328322|NCT01801111|582587127|FG000|Overall Study|Other|1|||
161328323|NCT01801111|582587127|FG000|Overall Study|Withdrawal by Subject|4|||
161328324|NCT01801111|582587127|FG000|Overall Study|Study Terminated by Sponsor|27|||
161328325|NCT01801111|582587127|FG000|Overall Study|Progressive Disease|81|||
161328326|NCT01210482|582587128|FG000|Overall Study|Protocol Violation|1|||
161328327|NCT01210482|582587128|FG000|Overall Study|Case Report Forms were not collected|18|||
161328328|NCT01210482|582587128|FG000|Overall Study|Duplicated|2|||
160786719|NCT03071965|580604690|FG003|Overall Study|Adverse Event|0|||
161328329|NCT01210482|582587128|FG000|Overall Study|No Drug Administration|28|||
160786720|NCT03071965|580604687|FG000|Overall Study|Death|0|||
161328330|NCT01223937|582587129|FG000|Overall Study|Withdrawal by Subject|3|||
161328331|NCT01223937|582587130|FG001|Overall Study|Withdrawal by Subject|2|||
161328332|NCT01223937|582587129|FG000|Overall Study|Lost to Follow-up|1|||
161328333|NCT01223937|582587130|FG001|Overall Study|Lost to Follow-up|4|||
161328334|NCT01223937|582587129|FG000|Overall Study|Adverse Event|1|||
160786721|NCT03071965|580604688|FG001|Overall Study|Death|0|||
160786722|NCT03071965|580604689|FG002|Overall Study|Death|1|||
160786723|NCT03071965|580604690|FG003|Overall Study|Death|1|||
160786724|NCT03071965|580604687|FG000|Overall Study|COVID-19|0|||
161328335|NCT01223937|582587130|FG001|Overall Study|Adverse Event|4|||
161328336|NCT01223937|582587129|FG000|Overall Study|Protocol Violation|8|||
161328337|NCT01223937|582587130|FG001|Overall Study|Protocol Violation|7|||
161328338|NCT01223937|582587129|FG000|Overall Study|Other|4|||
160786725|NCT03071965|580604688|FG001|Overall Study|COVID-19|1|||
160786726|NCT03071965|580604689|FG002|Overall Study|COVID-19|0|||
160786727|NCT03071965|580604690|FG003|Overall Study|COVID-19|1|||
160786728|NCT03071965|580604687|FG000|Overall Study|Other Health Reason|0|||
160786729|NCT03071965|580604688|FG001|Overall Study|Other Health Reason|0|||
160786730|NCT03071965|580604689|FG002|Overall Study|Other Health Reason|0|||
160786731|NCT03071965|580604690|FG003|Overall Study|Other Health Reason|1|||
160786732|NCT01853280|580604691|FG000|Overall Study|Lack of Efficacy|2|||
160786733|NCT01853280|580604692|FG001|Overall Study|Lack of Efficacy|2|||
160786734|NCT01853280|580604691|FG000|Overall Study|Lost to Follow-up|0|||
160786735|NCT01853280|580604692|FG001|Overall Study|Lost to Follow-up|1|||
160786736|NCT01853280|580604691|FG000|Overall Study|Physician Decision|0|||
160786737|NCT01853280|580604692|FG001|Overall Study|Physician Decision|1|||
160786738|NCT01853280|580604691|FG000|Overall Study|Withdrawal by Subject|0|||
160786739|NCT01853280|580604692|FG001|Overall Study|Withdrawal by Subject|1|||
160786740|NCT01853280|580604691|FG000|Overall Study|Ineligible|0|||
160786741|NCT01853280|580604692|FG001|Overall Study|Ineligible|1|||
160786742|NCT00104884|580604693|FG000|Overall Study|Disease progression|4|||
160786743|NCT03654326|580604694|FG000|Overall Study|Withdrawal by Subject|5|||
160786744|NCT03654326|580604695|FG001|Overall Study|Withdrawal by Subject|3|||
160786745|NCT03654326|580604694|FG000|Overall Study|Physician Decision|0|||
160786746|NCT03654326|580604695|FG001|Overall Study|Physician Decision|1|||
160786747|NCT03654326|580604694|FG000|Overall Study|Unable to adhere to study schedule|0|||
160786748|NCT03654326|580604695|FG001|Overall Study|Unable to adhere to study schedule|1|||
160786749|NCT03654326|580604694|FG000|Overall Study|Lost to Follow-up|1|||
160786750|NCT03654326|580604695|FG001|Overall Study|Lost to Follow-up|1|||
160786751|NCT03473301|580604696|FG000|Overall Study|Protocol Violation|4|||
160786752|NCT03473301|580604697|FG001|Overall Study|Protocol Violation|0|||
160786753|NCT03473301|580604698|FG002|Overall Study|Protocol Violation|0|||
160786754|NCT03473301|580604696|FG000|Overall Study|Withdrawal by Subject|0|||
160786755|NCT03473301|580604697|FG001|Overall Study|Withdrawal by Subject|1|||
160786756|NCT03473301|580604698|FG002|Overall Study|Withdrawal by Subject|0|||
160786757|NCT03473301|580604696|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
160786758|NCT03473301|580604697|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
160786759|NCT03473301|580604698|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
160786760|NCT05287685|580604699|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
160786761|NCT05287685|580604700|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
160786762|NCT05287685|580604699|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
160786763|NCT05287685|580604700|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
160786764|NCT04829214|580604701|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
160786765|NCT04829214|580604702|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
160786766|NCT04829214|580604701|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
160786767|NCT04829214|580604702|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
160786768|NCT06399471|580604703|FG000|Overall Study|Withdrawal by Subject|1|||
160786769|NCT05529173|580604704|FG000|Overall Study|Physician Decision|3|||
160786770|NCT05529173|580604705|FG001|Overall Study|Physician Decision|6|||
160786771|NCT05529173|580604704|FG000|Overall Study|Sample shipment delay more than one day|4|||
160786772|NCT05529173|580604705|FG001|Overall Study|Sample shipment delay more than one day|0|||
160786773|NCT00835042|580604708|FG000|First Intervention|Withdrawal by Subject|3|||
160786774|NCT00835042|580604709|FG001|First Intervention|Withdrawal by Subject|0|||
160786775|NCT00835042|580604708|FG000|First Intervention|Adverse Event|1|||
160786776|NCT00835042|580604709|FG001|First Intervention|Adverse Event|2|||
160786777|NCT00835042|580604708|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
160786778|NCT00835042|580604709|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
160786779|NCT03760081|580604710|FG000|Overall Study|Miscellaneous|0|||
160786780|NCT03760081|580604711|FG001|Overall Study|Miscellaneous|1|||
160786781|NCT03760081|580604710|FG000|Overall Study|Progressive Disease|5|||
160786782|NCT03760081|580604711|FG001|Overall Study|Progressive Disease|10|||
161125819|NCT01972074|581846912|FG001|Overall Study|Adverse Event|1|||
161125820|NCT01972074|581846913|FG002|Overall Study|Adverse Event|0|||
161328339|NCT01223937|582587130|FG001|Overall Study|Other|1|||
161328340|NCT05176717|582587131|FG000|Overall Study|Sponsor Decision|1|||
161328341|NCT05176717|582587132|FG001|Overall Study|Sponsor Decision|2|||
160786783|NCT03760081|580604710|FG000|Overall Study|Death|1|||
161125821|NCT01972074|581846911|FG000|Overall Study|Lack of Efficacy|1|||
161125822|NCT01972074|581846912|FG001|Overall Study|Lack of Efficacy|1|||
160786784|NCT03760081|580604711|FG001|Overall Study|Death|1|||
160786785|NCT04034056|580604712|FG000|Overall Study|Withdrawal by Subject|2|||
160786786|NCT04034056|580604712|FG000|Overall Study|Reason Not Specified|13|||
160786787|NCT04034056|580604712|FG000|Overall Study|Adverse Event|56|||
160786788|NCT01362270|580604715|FG000|Overall Study|Withdrawal by Subject|1|||
160981868|NCT02061761|581321785|FG003|Overall Study|Maximum clinical benefit|1|||
160786789|NCT01362270|580604716|FG001|Overall Study|Withdrawal by Subject|0|||
160786790|NCT01362270|580604715|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
160786791|NCT01362270|580604716|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
160786792|NCT01362270|580604715|FG000|Overall Study|Met excl. criteria before 1st session|1|||
161125823|NCT01972074|581846913|FG002|Overall Study|Lack of Efficacy|0|||
161125824|NCT01972074|581846911|FG000|Overall Study|Lost to Follow-up|0|||
161125825|NCT01972074|581846912|FG001|Overall Study|Lost to Follow-up|1|||
160786793|NCT01362270|580604716|FG001|Overall Study|Met excl. criteria before 1st session|1|||
160786794|NCT02571244|580604719|FG000|Overall Study|Lost to Follow-up|0|||
160786795|NCT02571244|580604720|FG001|Overall Study|Lost to Follow-up|1|||
160786796|NCT02571244|580604719|FG000|Overall Study|Unable to reach out post discharge|3|||
160786797|NCT02571244|580604720|FG001|Overall Study|Unable to reach out post discharge|0|||
160786798|NCT01696214|580604721|FG000|Overall Study|Lost to Follow-up|1|||
160786799|NCT01696214|580604722|FG001|Overall Study|Lost to Follow-up|0|||
160786800|NCT01696214|580604723|FG002|Overall Study|Lost to Follow-up|0|||
160786801|NCT01696214|580604724|FG003|Overall Study|Lost to Follow-up|0|||
160786802|NCT02134028|580604725|FG000|Overall Study|Lack of Efficacy|1|||
160786803|NCT02134028|580604726|FG001|Overall Study|Lack of Efficacy|0|||
160786804|NCT02134028|580604727|FG002|Overall Study|Lack of Efficacy|3|||
160786805|NCT02134028|580604728|FG003|Overall Study|Lack of Efficacy|2|||
160786806|NCT02134028|580604729|FG004|Overall Study|Lack of Efficacy|1|||
160786807|NCT02134028|580604730|FG005|Overall Study|Lack of Efficacy|2|||
160786808|NCT02134028|580604731|FG006|Overall Study|Lack of Efficacy|1|||
160786809|NCT02134028|580604732|FG007|Overall Study|Lack of Efficacy|0|||
160786810|NCT02134028|580604725|FG000|Overall Study|Poor compliance to protocol|1|||
160786811|NCT02134028|580604726|FG001|Overall Study|Poor compliance to protocol|1|||
160786812|NCT02134028|580604727|FG002|Overall Study|Poor compliance to protocol|3|||
160786813|NCT02134028|580604728|FG003|Overall Study|Poor compliance to protocol|7|||
160786814|NCT02134028|580604729|FG004|Overall Study|Poor compliance to protocol|1|||
160786815|NCT02134028|580604730|FG005|Overall Study|Poor compliance to protocol|1|||
160786816|NCT02134028|580604731|FG006|Overall Study|Poor compliance to protocol|0|||
160786817|NCT02134028|580604732|FG007|Overall Study|Poor compliance to protocol|0|||
160786818|NCT02134028|580604725|FG000|Overall Study|Other unspecified|4|||
160786819|NCT02134028|580604726|FG001|Overall Study|Other unspecified|22|||
160786820|NCT02134028|580604727|FG002|Overall Study|Other unspecified|33|||
160786821|NCT02134028|580604728|FG003|Overall Study|Other unspecified|64|||
160786822|NCT02134028|580604729|FG004|Overall Study|Other unspecified|8|||
160786823|NCT02134028|580604730|FG005|Overall Study|Other unspecified|6|||
160786824|NCT02134028|580604731|FG006|Overall Study|Other unspecified|2|||
160786825|NCT02134028|580604732|FG007|Overall Study|Other unspecified|1|||
160786826|NCT02134028|580604725|FG000|Overall Study|Adverse Event|3|||
160786827|NCT02134028|580604726|FG001|Overall Study|Adverse Event|19|||
160786828|NCT02134028|580604727|FG002|Overall Study|Adverse Event|13|||
160786829|NCT02134028|580604728|FG003|Overall Study|Adverse Event|32|||
160786830|NCT02134028|580604729|FG004|Overall Study|Adverse Event|4|||
160786831|NCT02134028|580604730|FG005|Overall Study|Adverse Event|5|||
160786832|NCT02134028|580604731|FG006|Overall Study|Adverse Event|1|||
160786833|NCT02134028|580604732|FG007|Overall Study|Adverse Event|2|||
160786834|NCT01370538|580604739|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
160786835|NCT01370538|580604740|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
160786836|NCT01370538|580604739|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160786837|NCT01370538|580604740|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160786838|NCT01370538|580604739|FG000|Overall Study|Adverse Event|1|||
160786839|NCT01370538|580604740|FG001|Overall Study|Adverse Event|0|||
161125826|NCT01972074|581846913|FG002|Overall Study|Lost to Follow-up|1|||
161125827|NCT01972074|581846911|FG000|Overall Study|Withdrawal by Subject|1|||
161125828|NCT01972074|581846912|FG001|Overall Study|Withdrawal by Subject|1|||
161125829|NCT01972074|581846913|FG002|Overall Study|Withdrawal by Subject|1|||
161125830|NCT01972074|581846911|FG000|Overall Study|Scanner Unavailable|0|||
161125831|NCT01972074|581846912|FG001|Overall Study|Scanner Unavailable|0|||
161125832|NCT01972074|581846913|FG002|Overall Study|Scanner Unavailable|1|||
161125833|NCT02026063|581846920|FG000|Overall Study|Physician Decision|0|||
161125834|NCT02026063|581846921|FG001|Overall Study|Physician Decision|10|||
161125835|NCT02026063|581846920|FG000|Overall Study|Noncompliance with Study Drug|1|||
161125836|NCT02026063|581846921|FG001|Overall Study|Noncompliance with Study Drug|1|||
161125837|NCT02026063|581846920|FG000|Overall Study|Withdrawal of Consent|1|||
161125838|NCT02026063|581846921|FG001|Overall Study|Withdrawal of Consent|6|||
160786840|NCT01370538|580604739|FG000|Overall Study|Protocol Violation|8|||
160786841|NCT01370538|580604740|FG001|Overall Study|Protocol Violation|5|||
160786842|NCT01370538|580604739|FG000|Overall Study|Development of study specific withdrawal|1|||
160786843|NCT01370538|580604740|FG001|Overall Study|Development of study specific withdrawal|1|||
160786844|NCT01370538|580604739|FG000|Overall Study|Lost to follow up|6|||
160786845|NCT01370538|580604740|FG001|Overall Study|Lost to follow up|10|||
160786846|NCT00309244|580604741|FG000|Overall Study|Adverse Event|29|||
160786847|NCT00309244|580604742|FG001|Overall Study|Adverse Event|12|||
160786848|NCT00309244|580604741|FG000|Overall Study|Lost to Follow-up|6|||
160786849|NCT00309244|580604742|FG001|Overall Study|Lost to Follow-up|22|||
160786850|NCT00309244|580604741|FG000|Overall Study|Physician Decision|5|||
160786851|NCT00309244|580604742|FG001|Overall Study|Physician Decision|8|||
160786852|NCT00309244|580604741|FG000|Overall Study|Protocol Violation|6|||
160786853|NCT00309244|580604742|FG001|Overall Study|Protocol Violation|3|||
161125839|NCT02026063|581846920|FG000|Overall Study|Adverse Event|5|||
160786854|NCT00309244|580604741|FG000|Overall Study|Withdrawal by Subject|50|||
160786855|NCT00309244|580604742|FG001|Overall Study|Withdrawal by Subject|32|||
160786856|NCT00309244|580604741|FG000|Overall Study|Various|7|||
160786857|NCT00309244|580604742|FG001|Overall Study|Various|7|||
160786858|NCT00309244|580604741|FG000|Overall Study|Randomized but not dosed|11|||
160786859|NCT00309244|580604742|FG001|Overall Study|Randomized but not dosed|12|||
160786860|NCT00309244|580604741|FG000|Overall Study|Death|4|||
160786861|NCT00309244|580604742|FG001|Overall Study|Death|1|||
160786862|NCT03438656|580604743|FG000|Overall Study|Lost to Follow-up|2|||
160786863|NCT03335566|580604744|FG000|Overall Study|Adverse Event|0|||
160786864|NCT03335566|580604745|FG001|Overall Study|Adverse Event|1|||
160786865|NCT03335566|580604744|FG000|Overall Study|Lost to Follow-up|1|||
160786866|NCT03335566|580604745|FG001|Overall Study|Lost to Follow-up|0|||
160786867|NCT03335566|580604744|FG000|Overall Study|Technical Problems|1|||
160786868|NCT03335566|580604745|FG001|Overall Study|Technical Problems|0|||
160786869|NCT03335566|580604744|FG000|Overall Study|Protocol Violation|1|||
160786870|NCT03335566|580604745|FG001|Overall Study|Protocol Violation|0|||
160786871|NCT03335566|580604744|FG000|Overall Study|Other than specified above|1|||
160786872|NCT03335566|580604745|FG001|Overall Study|Other than specified above|2|||
160786873|NCT04223687|580604746|FG000|Overall Study|Missing primary outcome|1|||
160786874|NCT04223687|580604747|FG001|Overall Study|Missing primary outcome|0|||
160786875|NCT02945046|580604749|FG000|Overall Study|Adverse Event|1|||
160786876|NCT02945046|580604750|FG001|Overall Study|Adverse Event|0|||
160786877|NCT02945046|580604751|FG002|Overall Study|Adverse Event|2|||
160786878|NCT02945046|580604749|FG000|Overall Study|Withdrawal by Subject|3|||
160786879|NCT02945046|580604750|FG001|Overall Study|Withdrawal by Subject|3|||
160786880|NCT02945046|580604751|FG002|Overall Study|Withdrawal by Subject|3|||
160786881|NCT02945046|580604749|FG000|Overall Study|Protocol Violation|2|||
160786882|NCT02945046|580604750|FG001|Overall Study|Protocol Violation|3|||
160786883|NCT02945046|580604751|FG002|Overall Study|Protocol Violation|2|||
160786884|NCT02945046|580604749|FG000|Overall Study|Lost to Follow-up|1|||
160786885|NCT02945046|580604750|FG001|Overall Study|Lost to Follow-up|1|||
160786886|NCT02945046|580604751|FG002|Overall Study|Lost to Follow-up|0|||
160786887|NCT02945046|580604749|FG000|Overall Study|Lack of Efficacy|1|||
160786888|NCT02945046|580604750|FG001|Overall Study|Lack of Efficacy|2|||
160786889|NCT02945046|580604751|FG002|Overall Study|Lack of Efficacy|1|||
160786890|NCT02945046|580604749|FG000|Overall Study|Other than specified|5|||
160786891|NCT02945046|580604750|FG001|Overall Study|Other than specified|4|||
160786892|NCT02945046|580604751|FG002|Overall Study|Other than specified|7|||
160786893|NCT00545948|580604753|FG000|Overall Study|Not Treated|1|||
160786894|NCT00545948|580604754|FG001|Overall Study|Not Treated|1|||
160786895|NCT00545948|580604755|FG002|Overall Study|Not Treated|7|||
160786896|NCT01251965|580607168|FG000|Overall Study|Participant/physician decision|1|||
160786897|NCT01251965|580607169|FG001|Overall Study|Participant/physician decision|2|||
160786898|NCT01251965|580607170|FG002|Overall Study|Participant/physician decision|0|||
160786899|NCT01251965|580607168|FG000|Overall Study|Death|0|||
160786900|NCT01251965|580607169|FG001|Overall Study|Death|0|||
160786901|NCT01251965|580607170|FG002|Overall Study|Death|11|||
160786902|NCT01027754|580607171|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
160786903|NCT01027754|580607172|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
160786904|NCT01027754|580607171|FG000|Overall Study|Withdrawal by Subject|0|||
160786905|NCT01027754|580607172|FG001|Overall Study|Withdrawal by Subject|5|||
160786906|NCT02529488|580607173|FG000|Overall Study|Adverse Event|1|||
160786907|NCT02529488|580607173|FG000|Overall Study|Death|3|||
160786908|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
160786909|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160786910|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160786911|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161328342|NCT05176717|582587133|FG002|Overall Study|Sponsor Decision|2|||
161328343|NCT03284853|582587134|FG000|Overall Study|Adverse Event|40|||
161328344|NCT03284853|582587135|FG001|Overall Study|Adverse Event|4|||
161328345|NCT03284853|582587134|FG000|Overall Study|Withdrawal by Subject|5|||
161328346|NCT03284853|582587135|FG001|Overall Study|Withdrawal by Subject|1|||
161328347|NCT03284853|582587134|FG000|Overall Study|Lost to Follow-up|1|||
161328348|NCT03284853|582587135|FG001|Overall Study|Lost to Follow-up|0|||
161328349|NCT03284853|582587134|FG000|Overall Study|Lack of Efficacy|1|||
161328350|NCT03284853|582587135|FG001|Overall Study|Lack of Efficacy|0|||
160786912|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
160786913|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
160786914|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
161328351|NCT03284853|582587134|FG000|Overall Study|Disallowed Concurrent Medication|1|||
161328352|NCT03284853|582587135|FG001|Overall Study|Disallowed Concurrent Medication|1|||
161328353|NCT03284853|582587134|FG000|Overall Study|Protocol Violation|3|||
160786915|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
160786916|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786917|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
161125840|NCT02026063|581846921|FG001|Overall Study|Adverse Event|20|||
160786918|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786919|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786920|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786921|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
160786922|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
160786923|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786924|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786925|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786926|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786927|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786928|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
160786929|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
160786930|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786931|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786932|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786933|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786934|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
160786935|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
160786936|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786937|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
160786938|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786939|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786940|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786941|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786942|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
160786943|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786944|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786945|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786946|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786947|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
160786948|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
160786949|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
160786950|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786951|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
160786952|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
160786953|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786954|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786955|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
161125841|NCT02026063|581846920|FG000|Overall Study|Lack of Efficacy|0|||
161125842|NCT02026063|581846921|FG001|Overall Study|Lack of Efficacy|4|||
161125843|NCT02026063|581846920|FG000|Overall Study|Lost to Follow-up|0|||
161328354|NCT03284853|582587135|FG001|Overall Study|Protocol Violation|3|||
161328355|NCT03284853|582587134|FG000|Overall Study|Death|0|||
161125844|NCT02026063|581846921|FG001|Overall Study|Lost to Follow-up|1|||
161125845|NCT02026063|581846920|FG000|Overall Study|Reason not Specified|2|||
161125846|NCT02026063|581846921|FG001|Overall Study|Reason not Specified|7|||
161125847|NCT01777581|581846927|FG000|Overall Study|Lost to Follow-up|1|||
161125848|NCT01777581|581846928|FG001|Overall Study|Lost to Follow-up|1|||
161125849|NCT01777581|581846927|FG000|Overall Study|Adverse Event|2|||
161125850|NCT01777581|581846928|FG001|Overall Study|Adverse Event|0|||
161125851|NCT01777581|581846927|FG000|Overall Study|Lack of Efficacy|0|||
161125852|NCT01777581|581846928|FG001|Overall Study|Lack of Efficacy|1|||
161328356|NCT03284853|582587135|FG001|Overall Study|Death|1|||
161328357|NCT03284853|582587134|FG000|Overall Study|Other - Reason not reported in CSR|4|||
161328358|NCT03284853|582587135|FG001|Overall Study|Other - Reason not reported in CSR|3|||
161328359|NCT02058589|582587137|FG000|Overall Study|Serious Adverse Event|1|||
161125853|NCT02887521|581846931|FG000|Overall Study|Withdrawal by Subject|0|||
161125854|NCT02887521|581846932|FG001|Overall Study|Withdrawal by Subject|3|||
161125855|NCT02937350|581846933|FG000|Overall Study|Withdrawal by Subject|0|||
161125856|NCT02937350|581846934|FG001|Overall Study|Withdrawal by Subject|1|||
161125857|NCT02937350|581846935|FG002|Overall Study|Withdrawal by Subject|0|||
161125858|NCT00695565|581846936|FG000|Overall Study|Lost to Follow-up|4|||
161125859|NCT00695565|581846937|FG001|Overall Study|Lost to Follow-up|4|||
161125860|NCT00695565|581846936|FG000|Overall Study|Adverse Event|3|||
161328360|NCT02058589|582587138|FG001|Overall Study|Serious Adverse Event|1|||
161230951|NCT01666730|582227301|FG000|Overall Study|Adverse Event|16|||
161230952|NCT01666730|582227301|FG000|Overall Study|Death|2|||
161230953|NCT01666730|582227301|FG000|Overall Study|Physician Decision|5|||
161230954|NCT01666730|582227301|FG000|Overall Study|Withdrawal by Subject|9|||
161230955|NCT01666730|582227301|FG000|Overall Study|Disease progression/relapse|18|||
161230956|NCT01434693|582227302|FG000|Overall Study|Adverse Event|1|||
161230957|NCT01434693|582227303|FG001|Overall Study|Adverse Event|0|||
161230958|NCT01434693|582227304|FG002|Overall Study|Adverse Event|0|||
161230959|NCT01434693|582227305|FG003|Overall Study|Adverse Event|0|||
161230960|NCT01434693|582227302|FG000|Overall Study|Withdrawal by Subject|1|||
161230961|NCT01434693|582227303|FG001|Overall Study|Withdrawal by Subject|0|||
161230962|NCT01434693|582227304|FG002|Overall Study|Withdrawal by Subject|1|||
161230963|NCT01434693|582227305|FG003|Overall Study|Withdrawal by Subject|1|||
161230964|NCT01434693|582227302|FG000|Overall Study|Lost to Follow-up|1|||
161230965|NCT01434693|582227303|FG001|Overall Study|Lost to Follow-up|0|||
160786956|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
160786957|NCT01557244|580607177|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
160786958|NCT01557244|580607178|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160786959|NCT01557244|580607179|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
160786960|NCT01557244|580607180|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160786961|NCT01557244|580607181|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161230966|NCT01434693|582227304|FG002|Overall Study|Lost to Follow-up|0|||
161230967|NCT01434693|582227305|FG003|Overall Study|Lost to Follow-up|0|||
161230968|NCT00912288|582227306|FG000|Overall Study|Death|0|||
161230969|NCT00912288|582227307|FG001|Overall Study|Death|1|||
161230970|NCT00912288|582227306|FG000|Overall Study|Adverse Event|1|||
161230971|NCT00912288|582227307|FG001|Overall Study|Adverse Event|1|||
161230972|NCT00912288|582227306|FG000|Overall Study|Lost to Follow-up|1|||
161230973|NCT00912288|582227307|FG001|Overall Study|Lost to Follow-up|0|||
161230974|NCT00912288|582227306|FG000|Overall Study|Protocol Violation|1|||
160786962|NCT01557244|580607182|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
160786963|NCT01557244|580607183|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
161230975|NCT00912288|582227307|FG001|Overall Study|Protocol Violation|0|||
161230976|NCT00912288|582227306|FG000|Overall Study|Withdrawal by Subject|3|||
161230977|NCT00912288|582227307|FG001|Overall Study|Withdrawal by Subject|3|||
161230978|NCT00912288|582227306|FG000|Overall Study|Study terminated by sponsor|34|||
161230979|NCT00912288|582227307|FG001|Overall Study|Study terminated by sponsor|35|||
161230980|NCT00912288|582227306|FG000|Overall Study|Other|1|||
161230981|NCT00912288|582227307|FG001|Overall Study|Other|0|||
161230982|NCT01449630|582227308|FG000|Period 1|Physician Decision|1|||
161230983|NCT01449630|582227309|FG001|Period 1|Physician Decision|0|||
161230984|NCT01449630|582227310|FG002|Period 1|Physician Decision|0|||
161230985|NCT01449630|582227311|FG003|Period 1|Physician Decision|1|||
161230986|NCT01449630|582227312|FG004|Period 1|Physician Decision|0|||
161230987|NCT01449630|582227313|FG005|Period 1|Physician Decision|0|||
161230988|NCT01449630|582227314|FG006|Period 1|Physician Decision|0|||
161230989|NCT01449630|582227315|FG007|Period 1|Physician Decision|0|||
161230990|NCT01449630|582227316|FG008|Period 1|Physician Decision|0|||
161230991|NCT01449630|582227308|FG000|Period 1|Sponsor Decision|0|||
161230992|NCT01449630|582227309|FG001|Period 1|Sponsor Decision|0|||
161230993|NCT01449630|582227310|FG002|Period 1|Sponsor Decision|0|||
161230994|NCT01449630|582227311|FG003|Period 1|Sponsor Decision|0|||
161230995|NCT01449630|582227312|FG004|Period 1|Sponsor Decision|0|||
161230996|NCT01449630|582227313|FG005|Period 1|Sponsor Decision|1|||
161230997|NCT01449630|582227314|FG006|Period 1|Sponsor Decision|0|||
160786964|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
160786965|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
160786966|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786967|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786968|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786969|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
160786970|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
160786971|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
160786972|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
160786973|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160786974|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161230998|NCT01449630|582227315|FG007|Period 1|Sponsor Decision|0|||
161230999|NCT01449630|582227316|FG008|Period 1|Sponsor Decision|0|||
161231000|NCT01449630|582227308|FG000|Period 2|Sponsor Decision|0|||
161231001|NCT01449630|582227309|FG001|Period 2|Sponsor Decision|0|||
161231002|NCT01449630|582227310|FG002|Period 2|Sponsor Decision|0|||
161231003|NCT01449630|582227311|FG003|Period 2|Sponsor Decision|0|||
160786975|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
161231004|NCT01449630|582227312|FG004|Period 2|Sponsor Decision|0|||
161231005|NCT01449630|582227313|FG005|Period 2|Sponsor Decision|0|||
161231006|NCT01449630|582227314|FG006|Period 2|Sponsor Decision|1|||
161231007|NCT01449630|582227315|FG007|Period 2|Sponsor Decision|0|||
161231008|NCT01449630|582227316|FG008|Period 2|Sponsor Decision|0|||
160786976|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160786977|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
160786978|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786979|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786980|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786981|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
160786982|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
161125861|NCT00695565|581846937|FG001|Overall Study|Adverse Event|1|||
161125862|NCT00695565|581846936|FG000|Overall Study|Protocol Violation|3|||
161125863|NCT00695565|581846937|FG001|Overall Study|Protocol Violation|1|||
161125864|NCT00695565|581846936|FG000|Overall Study|Withdrawal by Subject|1|||
161125865|NCT00695565|581846937|FG001|Overall Study|Withdrawal by Subject|1|||
161125866|NCT00695565|581846936|FG000|Overall Study|Lack of Efficacy|1|||
161125867|NCT00695565|581846937|FG001|Overall Study|Lack of Efficacy|1|||
161125868|NCT00695565|581846936|FG000|Overall Study|Subject did not follow instructions|1|||
161125869|NCT00695565|581846937|FG001|Overall Study|Subject did not follow instructions|1|||
161125870|NCT01462266|581846938|FG000|Overall Study|Adverse Event|7|||
161125871|NCT01462266|581846939|FG001|Overall Study|Adverse Event|6|||
161125872|NCT01462266|581846938|FG000|Overall Study|Death|2|||
161125873|NCT01462266|581846939|FG001|Overall Study|Death|1|||
161125874|NCT01462266|581846938|FG000|Overall Study|Lack of Efficacy|0|||
161125875|NCT01462266|581846939|FG001|Overall Study|Lack of Efficacy|2|||
161125876|NCT01462266|581846938|FG000|Overall Study|Lost to Follow-up|4|||
161125877|NCT01462266|581846939|FG001|Overall Study|Lost to Follow-up|3|||
161125878|NCT01462266|581846938|FG000|Overall Study|Non-compliance with study drug|3|||
161125879|NCT01462266|581846939|FG001|Overall Study|Non-compliance with study drug|0|||
161125880|NCT01462266|581846938|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
161125881|NCT01462266|581846939|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
161125882|NCT01462266|581846938|FG000|Overall Study|Physician Decision|2|||
161125883|NCT01462266|581846939|FG001|Overall Study|Physician Decision|5|||
161125884|NCT01462266|581846938|FG000|Overall Study|Protocol Violation|1|||
161125885|NCT01462266|581846939|FG001|Overall Study|Protocol Violation|3|||
161125886|NCT01462266|581846938|FG000|Overall Study|Withdrawal by Subject|7|||
161125887|NCT01462266|581846939|FG001|Overall Study|Withdrawal by Subject|2|||
161125888|NCT01462266|581846938|FG000|Overall Study|Screen failure|1|||
161125889|NCT01462266|581846939|FG001|Overall Study|Screen failure|1|||
161125890|NCT01106846|581846940|FG000|Overall Study|Change in surgical procedure|0|||
161125891|NCT01106846|581846941|FG001|Overall Study|Change in surgical procedure|1|||
161125892|NCT04811716|581846943|FG000|Overall Study|Withdrawal by Subject|2|||
161125893|NCT04811716|581846944|FG001|Overall Study|Withdrawal by Subject|0|||
161125894|NCT03110900|581846945|FG000|Overall Study|Sponsor withdrew|1|||
161125895|NCT03110900|581846946|FG001|Overall Study|Sponsor withdrew|1|||
161125896|NCT02321436|581846947|FG000|Overall Study|Withdrawal by Subject|1|||
161125897|NCT02321436|581846948|FG001|Overall Study|Withdrawal by Subject|0|||
161125898|NCT02321436|581846947|FG000|Overall Study|Lost to Follow-up|0|||
161125899|NCT02321436|581846948|FG001|Overall Study|Lost to Follow-up|1|||
161125900|NCT00644787|581846949|FG000|Period 1: Titration Phase|Adverse Event|11|||
161125901|NCT00644787|581846950|FG001|Period 1: Titration Phase|Adverse Event|0|||
161125902|NCT00644787|581846951|FG002|Period 1: Titration Phase|Adverse Event|0|||
161125903|NCT00644787|581846949|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
161125904|NCT00644787|581846950|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
161125905|NCT00644787|581846951|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
161125906|NCT00644787|581846949|FG000|Period 1: Titration Phase|Physician Decision|1|||
161125907|NCT00644787|581846950|FG001|Period 1: Titration Phase|Physician Decision|0|||
161125908|NCT00644787|581846951|FG002|Period 1: Titration Phase|Physician Decision|0|||
161125909|NCT00644787|581846949|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
161125910|NCT00644787|581846950|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
161125911|NCT00644787|581846951|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
161125912|NCT00644787|581846949|FG000|Period 1: Titration Phase|Worsening of complications|1|||
161125913|NCT00644787|581846950|FG001|Period 1: Titration Phase|Worsening of complications|0|||
161125914|NCT00644787|581846951|FG002|Period 1: Titration Phase|Worsening of complications|0|||
161125915|NCT00644787|581846949|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
161125916|NCT00644787|581846950|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
161125917|NCT00644787|581846951|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
161125918|NCT00644787|581846949|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
161125919|NCT00644787|581846950|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
161125920|NCT00644787|581846951|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
161125921|NCT00644787|581846949|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
161125922|NCT00644787|581846950|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
160786983|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786984|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
160786985|NCT01557244|580607177|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
160786986|NCT01557244|580607178|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
160786987|NCT01557244|580607179|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786988|NCT01557244|580607180|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786989|NCT01557244|580607181|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786990|NCT01557244|580607182|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786991|NCT01557244|580607183|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
160786992|NCT01313676|580607184|FG000|Overall Study|Adverse Event|395|||
160786993|NCT01313676|580607185|FG001|Overall Study|Adverse Event|365|||
160786994|NCT01313676|580607186|FG002|Overall Study|Adverse Event|372|||
160786995|NCT01313676|580607187|FG003|Overall Study|Adverse Event|333|||
160786996|NCT01313676|580607184|FG000|Overall Study|Lack of Efficacy|98|||
160786997|NCT01313676|580607185|FG001|Overall Study|Lack of Efficacy|90|||
160786998|NCT01313676|580607186|FG002|Overall Study|Lack of Efficacy|65|||
160786999|NCT01313676|580607187|FG003|Overall Study|Lack of Efficacy|46|||
160787000|NCT01313676|580607184|FG000|Overall Study|Protocol Violation|37|||
160787001|NCT01313676|580607185|FG001|Overall Study|Protocol Violation|44|||
160787002|NCT01313676|580607186|FG002|Overall Study|Protocol Violation|46|||
160787003|NCT01313676|580607187|FG003|Overall Study|Protocol Violation|44|||
160787004|NCT01313676|580607184|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
160787005|NCT01313676|580607185|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
160787006|NCT01313676|580607186|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
160787007|NCT01313676|580607187|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
161328361|NCT02058589|582587137|FG000|Overall Study|Non-Serious Adverse Event|1|||
161328362|NCT02058589|582587138|FG001|Overall Study|Non-Serious Adverse Event|0|||
161328363|NCT02058589|582587137|FG000|Overall Study|Withdrawal by Subject|0|||
161328364|NCT02058589|582587138|FG001|Overall Study|Withdrawal by Subject|1|||
161328365|NCT00765817|582587139|FG000|Overall Study|Adverse Event|13|||
161328366|NCT00765817|582587140|FG001|Overall Study|Adverse Event|1|||
161328367|NCT00765817|582587139|FG000|Overall Study|Death|0|||
161328368|NCT00765817|582587140|FG001|Overall Study|Death|1|||
161328369|NCT00765817|582587139|FG000|Overall Study|Entry criteria not met|2|||
161328370|NCT00765817|582587140|FG001|Overall Study|Entry criteria not met|2|||
161328371|NCT00765817|582587139|FG000|Overall Study|Loss of glucose control|0|||
161328372|NCT00765817|582587140|FG001|Overall Study|Loss of glucose control|2|||
161328373|NCT00765817|582587139|FG000|Overall Study|Lost to Follow-up|1|||
161328374|NCT00765817|582587140|FG001|Overall Study|Lost to Follow-up|3|||
161328375|NCT00765817|582587139|FG000|Overall Study|Physician Decision|2|||
161328376|NCT00765817|582587140|FG001|Overall Study|Physician Decision|1|||
161328377|NCT00765817|582587139|FG000|Overall Study|Protocol Violation|1|||
161328378|NCT00765817|582587140|FG001|Overall Study|Protocol Violation|1|||
161328379|NCT00765817|582587139|FG000|Overall Study|Subject decision|7|||
161328380|NCT00765817|582587140|FG001|Overall Study|Subject decision|11|||
161328381|NCT02143024|582587141|FG000|Overall Study|Lost to Follow-up|1|||
161328382|NCT02143024|582587142|FG001|Overall Study|Lost to Follow-up|1|||
161328383|NCT02143024|582587141|FG000|Overall Study|Withdrawal by Subject|1|||
161328384|NCT02143024|582587142|FG001|Overall Study|Withdrawal by Subject|0|||
161328385|NCT02308228|582587143|FG000|Overall Study|Adverse Event|3|||
161328386|NCT02308228|582587144|FG001|Overall Study|Adverse Event|4|||
161328387|NCT02308228|582587143|FG000|Overall Study|Withdrawal by Subject|5|||
161328388|NCT02308228|582587144|FG001|Overall Study|Withdrawal by Subject|3|||
161328389|NCT06597084|582587145|FG000|Overall Study|Withdrawal by Subject|4|||
161328390|NCT06597084|582587146|FG001|Overall Study|Withdrawal by Subject|9|||
161328391|NCT06597084|582587145|FG000|Overall Study|Consent was not given by the patient until V2|0|||
161328392|NCT06597084|582587146|FG001|Overall Study|Consent was not given by the patient until V2|3|||
161328393|NCT06597084|582587145|FG000|Overall Study|Physician Decision|1|||
161328394|NCT06597084|582587146|FG001|Overall Study|Physician Decision|0|||
160787008|NCT01313676|580607184|FG000|Overall Study|Study Closed/terminated|7|||
160787009|NCT01313676|580607185|FG001|Overall Study|Study Closed/terminated|6|||
160787010|NCT01313676|580607186|FG002|Overall Study|Study Closed/terminated|9|||
160787011|NCT01313676|580607187|FG003|Overall Study|Study Closed/terminated|9|||
160787012|NCT01313676|580607184|FG000|Overall Study|Lost to Follow-up|0|||
160787013|NCT01313676|580607185|FG001|Overall Study|Lost to Follow-up|0|||
161328395|NCT06597084|582587145|FG000|Overall Study|Adverse Event|3|||
161328396|NCT06597084|582587146|FG001|Overall Study|Adverse Event|2|||
161328397|NCT06597084|582587145|FG000|Overall Study|Death|4|||
161328398|NCT06597084|582587146|FG001|Overall Study|Death|0|||
161328399|NCT06597084|582587145|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
161328400|NCT06597084|582587146|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
161328401|NCT06597084|582587145|FG000|Overall Study|Lost to Follow-up|4|||
161328402|NCT06597084|582587146|FG001|Overall Study|Lost to Follow-up|2|||
161328403|NCT06597084|582587145|FG000|Overall Study|Other. Not specified|1|||
161328404|NCT06597084|582587146|FG001|Overall Study|Other. Not specified|0|||
161231009|NCT02087904|582227318|FG000|Overall Study|Did Not Receive Study Drug|0|||
161231010|NCT02087904|582227319|FG001|Overall Study|Did Not Receive Study Drug|0|||
161231011|NCT02087904|582227320|FG002|Overall Study|Did Not Receive Study Drug|2|||
161231012|NCT02087904|582227321|FG003|Overall Study|Did Not Receive Study Drug|1|||
161231013|NCT02087904|582227318|FG000|Overall Study|Adverse Event|8|||
161231014|NCT02087904|582227319|FG001|Overall Study|Adverse Event|4|||
161231015|NCT02087904|582227320|FG002|Overall Study|Adverse Event|4|||
161231016|NCT02087904|582227321|FG003|Overall Study|Adverse Event|12|||
161231017|NCT02087904|582227318|FG000|Overall Study|Lack of Efficacy|3|||
161231018|NCT02087904|582227319|FG001|Overall Study|Lack of Efficacy|6|||
161231019|NCT02087904|582227320|FG002|Overall Study|Lack of Efficacy|3|||
161231020|NCT02087904|582227321|FG003|Overall Study|Lack of Efficacy|2|||
161231021|NCT02087904|582227318|FG000|Overall Study|Other|6|||
161231022|NCT02087904|582227319|FG001|Overall Study|Other|2|||
161231023|NCT02087904|582227320|FG002|Overall Study|Other|4|||
161231024|NCT02087904|582227321|FG003|Overall Study|Other|4|||
161231025|NCT02087904|582227318|FG000|Overall Study|Withdrawal by Subject|8|||
161231026|NCT02087904|582227319|FG001|Overall Study|Withdrawal by Subject|3|||
161231027|NCT02087904|582227320|FG002|Overall Study|Withdrawal by Subject|7|||
161231028|NCT02087904|582227321|FG003|Overall Study|Withdrawal by Subject|4|||
160787014|NCT01313676|580607186|FG002|Overall Study|Lost to Follow-up|1|||
160787015|NCT01313676|580607187|FG003|Overall Study|Lost to Follow-up|0|||
160787016|NCT01313676|580607184|FG000|Overall Study|Physician Decision|53|||
160787017|NCT01313676|580607185|FG001|Overall Study|Physician Decision|64|||
160787018|NCT01313676|580607186|FG002|Overall Study|Physician Decision|62|||
160787019|NCT01313676|580607187|FG003|Overall Study|Physician Decision|48|||
160787020|NCT01313676|580607184|FG000|Overall Study|Decision by Participant or Proxy|643|||
160787021|NCT01313676|580607185|FG001|Overall Study|Decision by Participant or Proxy|527|||
160787022|NCT01313676|580607186|FG002|Overall Study|Decision by Participant or Proxy|515|||
160787023|NCT01313676|580607187|FG003|Overall Study|Decision by Participant or Proxy|492|||
161231029|NCT02087904|582227318|FG000|Overall Study|Lost to Follow-up|0|||
161231030|NCT02087904|582227319|FG001|Overall Study|Lost to Follow-up|4|||
161231031|NCT02087904|582227320|FG002|Overall Study|Lost to Follow-up|2|||
161231032|NCT02087904|582227321|FG003|Overall Study|Lost to Follow-up|2|||
161231033|NCT01735630|582227322|FG000|Overall Study|Adverse Event|8|||
161231034|NCT01735630|582227323|FG001|Overall Study|Adverse Event|7|||
161231035|NCT01735630|582227322|FG000|Overall Study|Lost to Follow-up|1|||
161231036|NCT01735630|582227323|FG001|Overall Study|Lost to Follow-up|0|||
161231037|NCT01735630|582227322|FG000|Overall Study|Physician Decision|0|||
161231038|NCT01735630|582227323|FG001|Overall Study|Physician Decision|1|||
161231039|NCT01735630|582227322|FG000|Overall Study|Sponsor Decision|2|||
161231040|NCT01735630|582227323|FG001|Overall Study|Sponsor Decision|1|||
161231041|NCT01735630|582227322|FG000|Overall Study|Withdrawal by Subject|7|||
161231042|NCT01735630|582227323|FG001|Overall Study|Withdrawal by Subject|9|||
161231043|NCT00891293|582227325|FG000|Overall Study|Adverse Event|2|||
161231044|NCT00891293|582227325|FG000|Overall Study|Protocol Violation|2|||
161231045|NCT00891293|582227325|FG000|Overall Study|Laboratory abnormality|4|||
161231046|NCT00891293|582227325|FG000|Overall Study|Lost to Follow-up|7|||
161231047|NCT00891293|582227325|FG000|Overall Study|Subject withdrew consent|7|||
161231048|NCT00891293|582227325|FG000|Overall Study|Sponsor termination|62|||
161231049|NCT02178722|582227326|FG000|Overall Study|Withdrawal by Subject|0|||
161231050|NCT02178722|582227327|FG001|Overall Study|Withdrawal by Subject|0|||
161231051|NCT02178722|582227328|FG002|Overall Study|Withdrawal by Subject|0|||
161328405|NCT00490971|582587151|FG000|Acute/Continuation|Adverse Event|62|||
161231052|NCT02178722|582227329|FG003|Overall Study|Withdrawal by Subject|2|||
161231053|NCT02178722|582227330|FG004|Overall Study|Withdrawal by Subject|33|||
161231054|NCT02178722|582227326|FG000|Overall Study|Death|2|||
161231055|NCT02178722|582227327|FG001|Overall Study|Death|13|||
161231056|NCT02178722|582227328|FG002|Overall Study|Death|12|||
161231057|NCT02178722|582227329|FG003|Overall Study|Death|12|||
161231058|NCT02178722|582227330|FG004|Overall Study|Death|205|||
161231059|NCT02178722|582227326|FG000|Overall Study|Lost to Follow-up|0|||
161231060|NCT02178722|582227327|FG001|Overall Study|Lost to Follow-up|0|||
161231061|NCT02178722|582227328|FG002|Overall Study|Lost to Follow-up|0|||
161231062|NCT02178722|582227329|FG003|Overall Study|Lost to Follow-up|2|||
161231063|NCT02178722|582227330|FG004|Overall Study|Lost to Follow-up|11|||
161328406|NCT00490971|582587152|FG001|Acute/Continuation|Adverse Event|13|||
161231064|NCT02178722|582227326|FG000|Overall Study|Study terminated by Sponsor|2|||
161231065|NCT02178722|582227327|FG001|Overall Study|Study terminated by Sponsor|7|||
161231066|NCT02178722|582227328|FG002|Overall Study|Study terminated by Sponsor|6|||
161231067|NCT02178722|582227329|FG003|Overall Study|Study terminated by Sponsor|4|||
161231068|NCT02178722|582227330|FG004|Overall Study|Study terminated by Sponsor|128|||
161231069|NCT02178722|582227326|FG000|Overall Study|Physician Decision|0|||
160787024|NCT01313676|580607184|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
161231070|NCT02178722|582227327|FG001|Overall Study|Physician Decision|0|||
161231071|NCT02178722|582227328|FG002|Overall Study|Physician Decision|0|||
161231072|NCT02178722|582227329|FG003|Overall Study|Physician Decision|0|||
161231073|NCT02178722|582227330|FG004|Overall Study|Physician Decision|3|||
161231074|NCT02178722|582227326|FG000|Overall Study|Other|0|||
160787025|NCT01313676|580607185|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
160787026|NCT01313676|580607186|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
160787027|NCT01313676|580607187|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
160787028|NCT01313676|580607184|FG000|Overall Study|Investigator Site Closed|12|||
160787029|NCT01313676|580607185|FG001|Overall Study|Investigator Site Closed|11|||
160787030|NCT01313676|580607186|FG002|Overall Study|Investigator Site Closed|15|||
160787031|NCT01313676|580607187|FG003|Overall Study|Investigator Site Closed|10|||
160787032|NCT01313676|580607184|FG000|Overall Study|Missing|1|||
160787033|NCT01313676|580607185|FG001|Overall Study|Missing|1|||
160787034|NCT01313676|580607186|FG002|Overall Study|Missing|1|||
160787035|NCT01313676|580607187|FG003|Overall Study|Missing|0|||
160787036|NCT01902303|580607188|FG000|Overall Study|Adverse Event|0|||
160787037|NCT01902303|580607189|FG001|Overall Study|Adverse Event|1|||
160787038|NCT01902303|580607188|FG000|Overall Study|Lost to Follow-up|0|||
160787039|NCT01902303|580607189|FG001|Overall Study|Lost to Follow-up|1|||
160787040|NCT01902303|580607188|FG000|Overall Study|Protocol Violation|2|||
160787041|NCT01902303|580607189|FG001|Overall Study|Protocol Violation|2|||
160787042|NCT01902303|580607188|FG000|Overall Study|subject lost investigational product|0|||
160787043|NCT01902303|580607189|FG001|Overall Study|subject lost investigational product|1|||
160787044|NCT01902303|580607188|FG000|Overall Study|Did not develop a cold sore|21|||
160787045|NCT01902303|580607189|FG001|Overall Study|Did not develop a cold sore|19|||
160787046|NCT05058456|580607190|FG000|Overall Study|Death|1|||
160787047|NCT05058456|580607190|FG000|Overall Study|End of Study data not yet due for release|34|||
160787048|NCT02802865|580607191|FG000|Overall Study|Pregnancy|1|||
161125923|NCT00644787|581846951|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
161125924|NCT00644787|581846949|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
161125925|NCT00644787|581846950|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
161125926|NCT00644787|581846951|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
161125927|NCT00644787|581846949|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
161125928|NCT00644787|581846950|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
161125929|NCT00644787|581846951|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
161125930|NCT00644787|581846949|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
160787049|NCT02802865|580607192|FG001|Overall Study|Pregnancy|1|||
160787050|NCT02802865|580607191|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
160787051|NCT02802865|580607192|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
161231075|NCT02178722|582227327|FG001|Overall Study|Other|0|||
161231076|NCT02178722|582227328|FG002|Overall Study|Other|0|||
161231077|NCT02178722|582227329|FG003|Overall Study|Other|0|||
161231078|NCT02178722|582227330|FG004|Overall Study|Other|2|||
161231079|NCT01572948|582227331|FG000|Overall Study|Lost to Follow-up|1|||
161231080|NCT01572948|582227332|FG001|Overall Study|Lost to Follow-up|0|||
161231081|NCT01572948|582227331|FG000|Overall Study|unable to contact|0|||
161231082|NCT01572948|582227332|FG001|Overall Study|unable to contact|1|||
161231083|NCT02107092|582227339|FG000|Overall Study|Miscellaneous|3|||
161231084|NCT02107092|582227339|FG000|Overall Study|Subject compliance|3|||
161231085|NCT02107092|582227339|FG000|Overall Study|Hypo-or hyperkalemia|2|||
161231086|NCT02107092|582227339|FG000|Overall Study|Met ECG withdrawal criteria|3|||
161231087|NCT02107092|582227339|FG000|Overall Study|Physician Decision|3|||
161231088|NCT02107092|582227339|FG000|Overall Study|Lost to Follow-up|2|||
161231089|NCT02107092|582227339|FG000|Overall Study|Withdrawal by Subject|9|||
161231090|NCT02107092|582227339|FG000|Overall Study|Adverse Event|7|||
161231091|NCT02107092|582227339|FG000|Overall Study|Expected progression of CKD|12|||
161231092|NCT00537030|582227340|FG000|Overall Study|Physician Decision|2|||
161231093|NCT00537030|582227340|FG000|Overall Study|Withdrawal by Subject|2|||
161231094|NCT00537030|582227340|FG000|Overall Study|≥ Grade 2 allergy|7|||
161231095|NCT00537030|582227340|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
161231096|NCT00537030|582227340|FG000|Overall Study|Ineligible|2|||
161231097|NCT00537030|582227340|FG000|Overall Study|Inevaluable|2|||
161231098|NCT04213326|582227342|FG000|Overall Study|Consent withdrawn|51|||
161231099|NCT04213326|582227343|FG001|Overall Study|Consent withdrawn|241|||
161231100|NCT04213326|582227342|FG000|Overall Study|Lost to Follow-up|50|||
161231101|NCT04213326|582227343|FG001|Overall Study|Lost to Follow-up|902|||
161231102|NCT04213326|582227342|FG000|Overall Study|Protocol Violation|3|||
161231103|NCT04213326|582227343|FG001|Overall Study|Protocol Violation|25|||
161231104|NCT04213326|582227342|FG000|Overall Study|Participant eligibility changed|106|||
161231105|NCT04213326|582227343|FG001|Overall Study|Participant eligibility changed|19|||
161231106|NCT04213326|582227342|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
161231107|NCT04213326|582227343|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
161231108|NCT04213326|582227342|FG000|Overall Study|Incomplete study visit|0|||
161231109|NCT04213326|582227343|FG001|Overall Study|Incomplete study visit|367|||
161231110|NCT01496183|582227344|FG000|Overall Study|Physician Decision|3|||
161231111|NCT01496183|582227345|FG001|Overall Study|Physician Decision|1|||
161231112|NCT01496183|582227344|FG000|Overall Study|Withdrawal by Subject|0|||
161231113|NCT01496183|582227345|FG001|Overall Study|Withdrawal by Subject|1|||
161231114|NCT01173692|582227348|FG000|Overall Study|Adverse Event|1|||
160787052|NCT01862029|580607193|FG000|Overall Study|Physician Decision|1|||
160787053|NCT03931785|580607194|FG000|Overall Study|Lost to Follow-up|4|||
160787054|NCT03931785|580607195|FG001|Overall Study|Lost to Follow-up|1|||
160787055|NCT03931785|580607196|FG002|Overall Study|Lost to Follow-up|4|||
160787056|NCT03931785|580607197|FG003|Overall Study|Lost to Follow-up|3|||
160787057|NCT03931785|580607194|FG000|Overall Study|Adverse Event|1|||
160787058|NCT03931785|580607195|FG001|Overall Study|Adverse Event|0|||
160787059|NCT03931785|580607196|FG002|Overall Study|Adverse Event|3|||
160787060|NCT03931785|580607197|FG003|Overall Study|Adverse Event|4|||
161125931|NCT00644787|581846950|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
161125932|NCT00644787|581846951|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
161125933|NCT00644787|581846949|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
161125934|NCT00644787|581846950|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
161125935|NCT00644787|581846951|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
161125936|NCT03355300|581846952|FG000|Overall Study|Physician Decision|0|||
161125937|NCT03355300|581846953|FG001|Overall Study|Physician Decision|1|||
161125938|NCT03355300|581846952|FG000|Overall Study|Lack of Efficacy|2|||
161125939|NCT03355300|581846953|FG001|Overall Study|Lack of Efficacy|1|||
161125940|NCT03355300|581846952|FG000|Overall Study|Other reason|1|||
161125941|NCT03355300|581846953|FG001|Overall Study|Other reason|0|||
161125942|NCT00546052|581846956|FG000|Overall Study|Adverse Event|47|||
161125943|NCT00546052|581846956|FG000|Overall Study|Lost to Follow-up|144|||
161231115|NCT01173692|582227349|FG001|Overall Study|Adverse Event|2|||
161231116|NCT01173692|582227348|FG000|Overall Study|Withdrawal by Subject|1|||
161231117|NCT01173692|582227349|FG001|Overall Study|Withdrawal by Subject|3|||
161231118|NCT00669864|582227352|FG000|Overall Study|Lost to Follow-up|2|||
161231119|NCT00669864|582227352|FG000|Overall Study|Protocol Violation|2|||
161231120|NCT00669864|582227352|FG000|Overall Study|Withdrawal by Subject|3|||
161231121|NCT00669864|582227352|FG000|Overall Study|Other|2|||
161231122|NCT01941030|582227358|FG000|Overall Study|Death|3|||
161231123|NCT01941030|582227359|FG001|Overall Study|Death|2|||
161231124|NCT01941030|582227358|FG000|Overall Study|Lost to Follow-up|6|||
161231125|NCT01941030|582227359|FG001|Overall Study|Lost to Follow-up|5|||
161231126|NCT01941030|582227358|FG000|Overall Study|Withdrawal by Subject|4|||
161231127|NCT01941030|582227359|FG001|Overall Study|Withdrawal by Subject|6|||
161231128|NCT02457832|582227366|FG000|Training|Lost to Follow-up|10|||
161231129|NCT02457832|582227367|FG001|Training|Lost to Follow-up|6|||
161231130|NCT02457832|582227368|FG002|Training|Lost to Follow-up|3|||
161231131|NCT02457832|582227366|FG000|One Month Washout|Lost to Follow-up|0|||
161231132|NCT02457832|582227367|FG001|One Month Washout|Lost to Follow-up|1|||
161231133|NCT02457832|582227368|FG002|One Month Washout|Lost to Follow-up|1|||
161231134|NCT01044732|582227369|FG000|Overall Study|Lost to Follow-up|2|||
161231135|NCT01044732|582227370|FG001|Overall Study|Lost to Follow-up|1|||
161231136|NCT01044732|582227369|FG000|Overall Study|Physician Decision|5|||
161231137|NCT01044732|582227370|FG001|Overall Study|Physician Decision|3|||
161231138|NCT01044732|582227369|FG000|Overall Study|Protocol Violation|11|||
161231139|NCT01044732|582227370|FG001|Overall Study|Protocol Violation|12|||
161231140|NCT01044732|582227369|FG000|Overall Study|Withdrawal by Subject|0|||
161231141|NCT01044732|582227370|FG001|Overall Study|Withdrawal by Subject|1|||
161231142|NCT01044732|582227369|FG000|Overall Study|Inadequate bowel preparation|11|||
161231143|NCT01044732|582227370|FG001|Overall Study|Inadequate bowel preparation|17|||
161231144|NCT01044732|582227369|FG000|Overall Study|Inability to reach cecum|5|||
161231145|NCT01044732|582227370|FG001|Overall Study|Inability to reach cecum|2|||
161231146|NCT01044732|582227369|FG000|Overall Study|Technical error or malfunction|15|||
161231147|NCT01044732|582227370|FG001|Overall Study|Technical error or malfunction|14|||
161231148|NCT03069937|582227375|FG000|Overall Study|Second primary malignancy noted|1|||
161231149|NCT03144687|582227376|FG000|Overall Study|Death|0|||
161231150|NCT03144687|582227377|FG001|Overall Study|Death|2|||
161231151|NCT03144687|582227376|FG000|Overall Study|Lost to Follow-up|0|||
161231152|NCT03144687|582227377|FG001|Overall Study|Lost to Follow-up|1|||
161231153|NCT03144687|582227376|FG000|Overall Study|Physician Decision|0|||
161231154|NCT03144687|582227377|FG001|Overall Study|Physician Decision|1|||
161231155|NCT03144687|582227376|FG000|Overall Study|Withdrawal by Subject|1|||
161231156|NCT03144687|582227377|FG001|Overall Study|Withdrawal by Subject|3|||
161231157|NCT03144687|582227376|FG000|Overall Study|Not Reported|2|||
161231158|NCT03144687|582227377|FG001|Overall Study|Not Reported|0|||
161231159|NCT00824265|582227380|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
161231160|NCT00824265|582227381|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
161231161|NCT00824265|582227380|FG000|Treatment Phase|Protocol Violation|1|||
161231162|NCT00824265|582227381|FG001|Treatment Phase|Protocol Violation|0|||
160787061|NCT03931785|580607194|FG000|Overall Study|Protocol Violation|0|||
160787062|NCT03931785|580607195|FG001|Overall Study|Protocol Violation|1|||
161231163|NCT00824265|582227380|FG000|Treatment Phase|Lost to Follow-up|1|||
160787063|NCT03931785|580607196|FG002|Overall Study|Protocol Violation|0|||
161125944|NCT00546052|581846956|FG000|Overall Study|Protocol Violation|9|||
161125945|NCT00546052|581846956|FG000|Overall Study|Withdrawal by Subject|20|||
161231164|NCT00824265|582227381|FG001|Treatment Phase|Lost to Follow-up|1|||
161231165|NCT00824265|582227380|FG000|Treatment Phase|Physician Decision|6|||
161231166|NCT00824265|582227381|FG001|Treatment Phase|Physician Decision|12|||
161231167|NCT00824265|582227380|FG000|Treatment Phase|Withdrawal by Subject|6|||
161231168|NCT00824265|582227381|FG001|Treatment Phase|Withdrawal by Subject|15|||
161231169|NCT00824265|582227380|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
161231170|NCT00824265|582227381|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
161231171|NCT00824265|582227380|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
161231172|NCT00824265|582227381|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
161231173|NCT02920996|582227384|FG000|Overall Study|Adverse Event|8|||
161231174|NCT02920996|582227385|FG001|Overall Study|Adverse Event|0|||
161231175|NCT02920996|582227384|FG000|Overall Study|Physician Decision|1|||
161231176|NCT02920996|582227385|FG001|Overall Study|Physician Decision|0|||
161231177|NCT02920996|582227384|FG000|Overall Study|Death|1|||
161231178|NCT02920996|582227385|FG001|Overall Study|Death|0|||
161231179|NCT02920996|582227384|FG000|Overall Study|Missing|1|||
161231180|NCT02920996|582227385|FG001|Overall Study|Missing|0|||
161231181|NCT02920996|582227384|FG000|Overall Study|Subject Non-Compliance|1|||
161231182|NCT02920996|582227385|FG001|Overall Study|Subject Non-Compliance|0|||
161231183|NCT01402947|582227386|FG000|First Intervention|Adverse Event|0|||
161231184|NCT01402947|582227387|FG001|First Intervention|Adverse Event|1|||
161231185|NCT01471522|582227388|FG000|Overall Study|Withdrawal by Subject|28|||
161231186|NCT01471522|582227389|FG001|Overall Study|Withdrawal by Subject|22|||
161231187|NCT01471522|582227388|FG000|Overall Study|Lost to Follow-up|36|||
161231188|NCT01471522|582227389|FG001|Overall Study|Lost to Follow-up|26|||
161231189|NCT01706926|582227391|FG000|Overall Study|Lost to Follow-up|0|||
161231190|NCT01706926|582227392|FG001|Overall Study|Lost to Follow-up|0|||
161231191|NCT01706926|582227393|FG002|Overall Study|Lost to Follow-up|1|||
161231192|NCT01706926|582227394|FG003|Overall Study|Lost to Follow-up|0|||
161231193|NCT01706926|582227391|FG000|Overall Study|Withdrawal by Subject|2|||
161231194|NCT01706926|582227392|FG001|Overall Study|Withdrawal by Subject|0|||
161231195|NCT01706926|582227393|FG002|Overall Study|Withdrawal by Subject|1|||
161231196|NCT01706926|582227394|FG003|Overall Study|Withdrawal by Subject|2|||
161231197|NCT01706926|582227391|FG000|Overall Study|Other|4|||
161231198|NCT01706926|582227392|FG001|Overall Study|Other|4|||
161231199|NCT01706926|582227393|FG002|Overall Study|Other|4|||
161231200|NCT01706926|582227394|FG003|Overall Study|Other|3|||
161231201|NCT01215981|582228709|FG000|Overall Study|Physician Decision|0|||
161231202|NCT01215981|582228710|FG001|Overall Study|Physician Decision|1|||
161231203|NCT01215981|582228709|FG000|Overall Study|Protocol Violation|1|||
161231204|NCT01215981|582228710|FG001|Overall Study|Protocol Violation|0|||
161231205|NCT01215981|582228709|FG000|Overall Study|Withdrawal by Subject|1|||
161231206|NCT01215981|582228710|FG001|Overall Study|Withdrawal by Subject|0|||
161231207|NCT03597256|582228711|FG000|Overall Study|Lost to Follow-up|3|||
160787064|NCT03931785|580607197|FG003|Overall Study|Protocol Violation|0|||
160787065|NCT03931785|580607194|FG000|Overall Study|Noncompliance With Study drug|0|||
160787066|NCT03931785|580607195|FG001|Overall Study|Noncompliance With Study drug|1|||
160787067|NCT03931785|580607196|FG002|Overall Study|Noncompliance With Study drug|0|||
160787068|NCT03931785|580607197|FG003|Overall Study|Noncompliance With Study drug|0|||
160787069|NCT03931785|580607194|FG000|Overall Study|Other Not specified|0|||
160787070|NCT03931785|580607195|FG001|Overall Study|Other Not specified|2|||
160787071|NCT03931785|580607196|FG002|Overall Study|Other Not specified|2|||
160787072|NCT03931785|580607197|FG003|Overall Study|Other Not specified|2|||
160787073|NCT03931785|580607194|FG000|Overall Study|Withdrawal by Subject|0|||
160787074|NCT03931785|580607195|FG001|Overall Study|Withdrawal by Subject|2|||
160787075|NCT03931785|580607196|FG002|Overall Study|Withdrawal by Subject|4|||
160787076|NCT03931785|580607197|FG003|Overall Study|Withdrawal by Subject|1|||
160787077|NCT03931785|580607194|FG000|Overall Study|Pregnancy|0|||
160787078|NCT03931785|580607195|FG001|Overall Study|Pregnancy|0|||
160787079|NCT03931785|580607196|FG002|Overall Study|Pregnancy|0|||
160787080|NCT03931785|580607197|FG003|Overall Study|Pregnancy|1|||
160787081|NCT01832038|580607198|FG000|Overall Study|Death|5|||
160787082|NCT01832038|580607198|FG000|Overall Study|Adverse Event|50|||
160787083|NCT01832038|580607198|FG000|Overall Study|Lack of Efficacy|81|||
160787084|NCT01832038|580607198|FG000|Overall Study|Protocol Violation|7|||
160787085|NCT01832038|580607198|FG000|Overall Study|Lost to Follow-up|10|||
160787086|NCT01832038|580607198|FG000|Overall Study|Withdrawal by Subject|49|||
160787087|NCT01832038|580607198|FG000|Overall Study|Visit non-compliance|2|||
160787088|NCT01832038|580607198|FG000|Overall Study|Subject refused to return visit|2|||
161231208|NCT03597256|582228712|FG001|Overall Study|Lost to Follow-up|1|||
161231209|NCT03597256|582228711|FG000|Overall Study|Withdrawal by Subject|0|||
160787089|NCT01832038|580607198|FG000|Overall Study|Not convenient to come back to site|2|||
160787090|NCT01832038|580607198|FG000|Overall Study|Participant was asked to quit|5|||
160787091|NCT01832038|580607198|FG000|Overall Study|Back home|1|||
161231210|NCT03597256|582228712|FG001|Overall Study|Withdrawal by Subject|1|||
161231211|NCT03597256|582228711|FG000|Overall Study|Could not return for treatment|0|||
161231212|NCT03597256|582228712|FG001|Overall Study|Could not return for treatment|1|||
161231213|NCT03597256|582228711|FG000|Overall Study|Moved from location|0|||
161231214|NCT03597256|582228712|FG001|Overall Study|Moved from location|1|||
161231215|NCT03597256|582228711|FG000|Overall Study|Not accepted the treatment|0|||
161231216|NCT03597256|582228712|FG001|Overall Study|Not accepted the treatment|1|||
161231217|NCT01725529|582228725|FG000|Overall Study|Adverse Event|1|||
161231218|NCT01725529|582228726|FG001|Overall Study|Adverse Event|0|||
161231219|NCT01725529|582228727|FG002|Overall Study|Adverse Event|0|||
161231220|NCT01725529|582228725|FG000|Overall Study|Lost to Follow-up|2|||
161231221|NCT01725529|582228726|FG001|Overall Study|Lost to Follow-up|1|||
161231222|NCT01725529|582228727|FG002|Overall Study|Lost to Follow-up|1|||
161231223|NCT01725529|582228725|FG000|Overall Study|Protocol Violation|0|||
161231224|NCT01725529|582228726|FG001|Overall Study|Protocol Violation|1|||
161231225|NCT01725529|582228727|FG002|Overall Study|Protocol Violation|1|||
161231226|NCT01725529|582228725|FG000|Overall Study|Withdrawal by Subject|12|||
161231227|NCT01725529|582228726|FG001|Overall Study|Withdrawal by Subject|14|||
161231228|NCT01725529|582228727|FG002|Overall Study|Withdrawal by Subject|8|||
161231229|NCT02653664|582228729|FG000|Post-Treatment|Withdrawal by Subject|6|||
161231230|NCT02653664|582228730|FG001|Post-Treatment|Withdrawal by Subject|5|||
161231231|NCT02653664|582228731|FG002|Post-Treatment|Withdrawal by Subject|7|||
161231232|NCT02653664|582228729|FG000|Post-Treatment|Lost to Follow-up|8|||
161231233|NCT02653664|582228730|FG001|Post-Treatment|Lost to Follow-up|1|||
161231234|NCT02653664|582228731|FG002|Post-Treatment|Lost to Follow-up|7|||
161231235|NCT02653664|582228729|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
161231236|NCT02653664|582228730|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
161231237|NCT02653664|582228731|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
161231238|NCT02653664|582228729|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
161231239|NCT02653664|582228730|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
161231240|NCT02653664|582228731|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
161231241|NCT02653664|582228729|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161231242|NCT02653664|582228730|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
161231243|NCT02653664|582228731|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161231244|NCT02653664|582228729|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
161231245|NCT02653664|582228730|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
161231246|NCT02653664|582228731|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
161231247|NCT02653664|582228729|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
161231248|NCT02653664|582228730|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
161231249|NCT02653664|582228731|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
161231250|NCT02653664|582228729|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
161231251|NCT02653664|582228730|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
161231252|NCT02653664|582228731|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
161231253|NCT02653664|582228729|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161231254|NCT02653664|582228730|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
161231255|NCT02653664|582228731|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
161231256|NCT02653664|582228729|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
161231257|NCT02653664|582228730|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
161231258|NCT02653664|582228731|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
161328407|NCT00490971|582587153|FG002|Acute/Continuation|Adverse Event|0|||
161328408|NCT00490971|582587154|FG003|Acute/Continuation|Adverse Event|0|||
161328409|NCT00490971|582587155|FG004|Acute/Continuation|Adverse Event|0|||
161328410|NCT00490971|582587151|FG000|Acute/Continuation|Death|2|||
161328411|NCT00490971|582587152|FG001|Acute/Continuation|Death|0|||
161328412|NCT00490971|582587153|FG002|Acute/Continuation|Death|0|||
161328413|NCT00490971|582587154|FG003|Acute/Continuation|Death|0|||
161328414|NCT00490971|582587155|FG004|Acute/Continuation|Death|0|||
161328415|NCT00490971|582587151|FG000|Acute/Continuation|Lack of Efficacy|106|||
161328416|NCT00490971|582587152|FG001|Acute/Continuation|Lack of Efficacy|12|||
161328417|NCT00490971|582587153|FG002|Acute/Continuation|Lack of Efficacy|0|||
161328418|NCT00490971|582587154|FG003|Acute/Continuation|Lack of Efficacy|0|||
161328419|NCT00490971|582587155|FG004|Acute/Continuation|Lack of Efficacy|0|||
161328420|NCT00490971|582587151|FG000|Acute/Continuation|Lost to Follow-up|23|||
161328421|NCT00490971|582587152|FG001|Acute/Continuation|Lost to Follow-up|7|||
161328422|NCT00490971|582587153|FG002|Acute/Continuation|Lost to Follow-up|0|||
161328423|NCT00490971|582587154|FG003|Acute/Continuation|Lost to Follow-up|0|||
161328424|NCT00490971|582587155|FG004|Acute/Continuation|Lost to Follow-up|0|||
161328425|NCT00490971|582587151|FG000|Acute/Continuation|Protocol Violation|10|||
161328426|NCT00490971|582587152|FG001|Acute/Continuation|Protocol Violation|2|||
161328427|NCT00490971|582587153|FG002|Acute/Continuation|Protocol Violation|0|||
161328428|NCT00490971|582587154|FG003|Acute/Continuation|Protocol Violation|0|||
161328429|NCT00490971|582587155|FG004|Acute/Continuation|Protocol Violation|0|||
161328430|NCT00490971|582587151|FG000|Acute/Continuation|Withdrawal by Subject|92|||
161328431|NCT00490971|582587152|FG001|Acute/Continuation|Withdrawal by Subject|24|||
161328432|NCT00490971|582587153|FG002|Acute/Continuation|Withdrawal by Subject|0|||
161328433|NCT00490971|582587154|FG003|Acute/Continuation|Withdrawal by Subject|0|||
161328434|NCT00490971|582587155|FG004|Acute/Continuation|Withdrawal by Subject|0|||
161328435|NCT00490971|582587151|FG000|Acute/Continuation|Other|11|||
161328436|NCT00490971|582587152|FG001|Acute/Continuation|Other|4|||
161231259|NCT04657770|582228732|FG000|Overall Study|Withdrawal by Subject|3|||
161328437|NCT00490971|582587153|FG002|Acute/Continuation|Other|0|||
160787092|NCT01832038|580607198|FG000|Overall Study|Pregnancy|1|||
160787093|NCT01832038|580607198|FG000|Overall Study|Low compliance|3|||
161125946|NCT00546052|581846956|FG000|Overall Study|Non Compliance|7|||
161125947|NCT03048422|581846957|FG000|Overall Study|Death|1|||
161125948|NCT03048422|581846958|FG001|Overall Study|Death|0|||
161125949|NCT03048422|581846959|FG002|Overall Study|Death|0|||
161125950|NCT03048422|581846957|FG000|Overall Study|Lost to Follow-up|5|||
161125951|NCT03048422|581846958|FG001|Overall Study|Lost to Follow-up|0|||
161125952|NCT03048422|581846959|FG002|Overall Study|Lost to Follow-up|1|||
161125953|NCT03048422|581846957|FG000|Overall Study|Withdrawal by Subject|5|||
161125954|NCT03048422|581846958|FG001|Overall Study|Withdrawal by Subject|7|||
161125955|NCT03048422|581846959|FG002|Overall Study|Withdrawal by Subject|4|||
161125956|NCT03048422|581846957|FG000|Overall Study|Moved|3|||
161125957|NCT03048422|581846958|FG001|Overall Study|Moved|2|||
161125958|NCT03048422|581846959|FG002|Overall Study|Moved|2|||
161125959|NCT03048422|581846957|FG000|Overall Study|Noncompliant with Study Requirements|2|||
161125960|NCT03048422|581846958|FG001|Overall Study|Noncompliant with Study Requirements|1|||
161125961|NCT03048422|581846959|FG002|Overall Study|Noncompliant with Study Requirements|2|||
161125962|NCT03048422|581846957|FG000|Overall Study|Not Able to Get to Clinic|1|||
161125963|NCT03048422|581846958|FG001|Overall Study|Not Able to Get to Clinic|0|||
161125964|NCT03048422|581846959|FG002|Overall Study|Not Able to Get to Clinic|0|||
161125965|NCT05900115|581848266|FG000|Overall Study|Lost to Follow-up|129|||
161125966|NCT05900115|581848267|FG001|Overall Study|Lost to Follow-up|98|||
161125967|NCT01602341|581848268|FG000|Overall Study|Adverse Event|0|||
161125968|NCT01602341|581848269|FG001|Overall Study|Adverse Event|1|||
161125969|NCT02152345|581848270|FG000|Overall Study|Case Cancellations|2|||
161125970|NCT02152345|581848271|FG001|Overall Study|Case Cancellations|4|||
161125971|NCT02152345|581848270|FG000|Overall Study|Withdrawal by Subject|2|||
161125972|NCT02152345|581848271|FG001|Overall Study|Withdrawal by Subject|1|||
161125973|NCT02324270|581848273|FG000|Overall Study|Withdrawal by Subject|0|||
161125974|NCT02324270|581848274|FG001|Overall Study|Withdrawal by Subject|1|||
161125975|NCT02324270|581848275|FG002|Overall Study|Withdrawal by Subject|0|||
161125976|NCT02324270|581848273|FG000|Overall Study|Lost to Follow-up|4|||
161125977|NCT02324270|581848274|FG001|Overall Study|Lost to Follow-up|3|||
161125978|NCT02324270|581848275|FG002|Overall Study|Lost to Follow-up|4|||
161125979|NCT02324270|581848273|FG000|Overall Study|Protocol Violation|0|||
161125980|NCT02324270|581848274|FG001|Overall Study|Protocol Violation|1|||
161125981|NCT02324270|581848275|FG002|Overall Study|Protocol Violation|1|||
161125982|NCT02324270|581848273|FG000|Overall Study|Non Compliance with Study Drug|1|||
161125983|NCT02324270|581848274|FG001|Overall Study|Non Compliance with Study Drug|2|||
161125984|NCT02324270|581848275|FG002|Overall Study|Non Compliance with Study Drug|0|||
161125985|NCT03521791|581848276|FG000|Overall Study|Protocol Violation|7|||
161125986|NCT03521791|581848277|FG001|Overall Study|Protocol Violation|17|||
161125987|NCT00680836|581848278|FG000|Overall Study|Withdrawal by Subject|3|||
161125988|NCT00680836|581848279|FG001|Overall Study|Withdrawal by Subject|0|||
161125989|NCT00680836|581848278|FG000|Overall Study|Lost to Follow-up|3|||
161125990|NCT00680836|581848279|FG001|Overall Study|Lost to Follow-up|1|||
161125991|NCT00680836|581848278|FG000|Overall Study|Physician Decision|2|||
161125992|NCT00680836|581848279|FG001|Overall Study|Physician Decision|1|||
161125993|NCT03038308|581848280|FG000|Overall Study|Surgical resection|1|||
161125994|NCT03038308|581848280|FG000|Overall Study|Withdrawal by Subject|2|||
161125995|NCT03038308|581848280|FG000|Overall Study|Lost to Follow-up|1|||
161125996|NCT01475734|581848283|FG000|Overall Study|Withdrawal by Subject|1|||
161125997|NCT01475734|581848284|FG001|Overall Study|Withdrawal by Subject|0|||
161125998|NCT01475734|581848283|FG000|Overall Study|Protocol Violation|1|||
161125999|NCT01475734|581848284|FG001|Overall Study|Protocol Violation|0|||
161126000|NCT01475734|581848283|FG000|Overall Study|Physician Decision|0|||
161126001|NCT01475734|581848284|FG001|Overall Study|Physician Decision|1|||
161126002|NCT00771472|581848285|FG000|Overall Study|Physician Decision|2|||
161126003|NCT00771472|581848286|FG001|Overall Study|Physician Decision|3|||
161126004|NCT00771472|581848285|FG000|Overall Study|Progressive Disease|3|||
161126005|NCT00771472|581848286|FG001|Overall Study|Progressive Disease|1|||
161126006|NCT00771472|581848285|FG000|Overall Study|Protocol Violation|1|||
161126007|NCT00771472|581848286|FG001|Overall Study|Protocol Violation|0|||
161126008|NCT00880750|581848292|FG000|First Intervention|Adverse Event|1|||
161126009|NCT00880750|581848293|FG001|First Intervention|Adverse Event|0|||
161126010|NCT00880750|581848292|FG000|First Intervention|Unable to collect urine|4|||
161126011|NCT00880750|581848293|FG001|First Intervention|Unable to collect urine|0|||
161126012|NCT00880750|581848292|FG000|First Intervention|Non-compliance with meals|0|||
161126013|NCT00880750|581848293|FG001|First Intervention|Non-compliance with meals|1|||
161126014|NCT00880750|581848292|FG000|First Intervention|Withdrawal by Subject|2|||
161126015|NCT00880750|581848293|FG001|First Intervention|Withdrawal by Subject|0|||
161126016|NCT00880750|581848292|FG000|First Intervention|Lost to Follow-up|2|||
161126017|NCT00880750|581848293|FG001|First Intervention|Lost to Follow-up|0|||
161126018|NCT00880750|581848292|FG000|Second Intervention|Withdrawal by Subject|2|||
161126019|NCT00880750|581848293|FG001|Second Intervention|Withdrawal by Subject|2|||
161126020|NCT00880750|581848292|FG000|Second Intervention|Protocol Violation|1|||
161126021|NCT00880750|581848293|FG001|Second Intervention|Protocol Violation|0|||
160787094|NCT01832038|580607198|FG000|Overall Study|Prohibit procedure|2|||
161126022|NCT00880750|581848292|FG000|Second Intervention|Unable to collect urine|1|||
161126023|NCT00880750|581848293|FG001|Second Intervention|Unable to collect urine|0|||
161126024|NCT00667576|581848294|FG000|Overall Study|Withdrawal by Subject|1|||
161126025|NCT00667576|581848295|FG001|Overall Study|Withdrawal by Subject|0|||
161126026|NCT00667576|581848296|FG002|Overall Study|Withdrawal by Subject|1|||
161126027|NCT00667576|581848297|FG003|Overall Study|Withdrawal by Subject|1|||
161126028|NCT00667576|581848298|FG004|Overall Study|Withdrawal by Subject|1|||
161126029|NCT00667576|581848294|FG000|Overall Study|Adverse Event|1|||
161126030|NCT00667576|581848295|FG001|Overall Study|Adverse Event|1|||
161126031|NCT00667576|581848296|FG002|Overall Study|Adverse Event|0|||
161126032|NCT00667576|581848297|FG003|Overall Study|Adverse Event|0|||
161126033|NCT00667576|581848298|FG004|Overall Study|Adverse Event|0|||
161126034|NCT00667576|581848294|FG000|Overall Study|Lost to Follow-up|0|||
161126035|NCT00667576|581848295|FG001|Overall Study|Lost to Follow-up|0|||
161126036|NCT00667576|581848296|FG002|Overall Study|Lost to Follow-up|1|||
161126037|NCT00667576|581848297|FG003|Overall Study|Lost to Follow-up|0|||
161126038|NCT00667576|581848298|FG004|Overall Study|Lost to Follow-up|0|||
161126039|NCT00667576|581848294|FG000|Overall Study|Protocol Violation|0|||
161126040|NCT00667576|581848295|FG001|Overall Study|Protocol Violation|0|||
161126041|NCT00667576|581848296|FG002|Overall Study|Protocol Violation|0|||
161126042|NCT00667576|581848297|FG003|Overall Study|Protocol Violation|1|||
161126043|NCT00667576|581848298|FG004|Overall Study|Protocol Violation|0|||
161126044|NCT00667576|581848294|FG000|Overall Study|Physician Decision|0|||
161126045|NCT00667576|581848295|FG001|Overall Study|Physician Decision|0|||
161126046|NCT00667576|581848296|FG002|Overall Study|Physician Decision|0|||
161126047|NCT00667576|581848297|FG003|Overall Study|Physician Decision|1|||
161126048|NCT00667576|581848298|FG004|Overall Study|Physician Decision|0|||
161126049|NCT00667576|581848294|FG000|Overall Study|Missed Visit|0|||
161126050|NCT00667576|581848295|FG001|Overall Study|Missed Visit|0|||
161126051|NCT00667576|581848296|FG002|Overall Study|Missed Visit|0|||
161126052|NCT00667576|581848297|FG003|Overall Study|Missed Visit|1|||
161126053|NCT00667576|581848298|FG004|Overall Study|Missed Visit|0|||
161126054|NCT00483327|581848302|FG000|Overall Study|Adverse Event|1|||
161126055|NCT00483327|581848302|FG000|Overall Study|Withdrawal by Subject|3|||
161126056|NCT00483327|581848302|FG000|Overall Study|Lost to Follow-up|4|||
161126057|NCT00483327|581848302|FG000|Overall Study|Patient Non Compliance|2|||
161126058|NCT01390389|581848303|FG000|Overall Study|Withdrawal by Subject|2|||
161126059|NCT01390389|581848304|FG001|Overall Study|Withdrawal by Subject|0|||
161126060|NCT01390389|581848303|FG000|Overall Study|Screen Fail|2|||
161126061|NCT01390389|581848304|FG001|Overall Study|Screen Fail|1|||
161126062|NCT03593915|581848305|FG000|Overall Study|Adverse Event|0|||
161126063|NCT03593915|581848306|FG001|Overall Study|Adverse Event|0|||
161126064|NCT03593915|581848307|FG002|Overall Study|Adverse Event|0|||
161126065|NCT03593915|581848308|FG003|Overall Study|Adverse Event|1|||
161126066|NCT03593915|581848309|FG004|Overall Study|Adverse Event|0|||
161126067|NCT03593915|581848310|FG005|Overall Study|Adverse Event|0|||
161126068|NCT03593915|581848305|FG000|Overall Study|Physician Decision|0|||
161126069|NCT03593915|581848306|FG001|Overall Study|Physician Decision|0|||
161126070|NCT03593915|581848307|FG002|Overall Study|Physician Decision|0|||
161126071|NCT03593915|581848308|FG003|Overall Study|Physician Decision|0|||
161126072|NCT03593915|581848309|FG004|Overall Study|Physician Decision|0|||
161126073|NCT03593915|581848310|FG005|Overall Study|Physician Decision|1|||
161126074|NCT01583179|581848311|FG000|Overall Study|Screen failure|1|||
161126075|NCT01583179|581848312|FG001|Overall Study|Screen failure|2|||
161126076|NCT01246206|581848313|FG000|Overall Study|Patient did not receive study regiments.|1|||
161126077|NCT02002975|581848314|FG000|Overall Study|Case Report Forms Uncollected|135|||
161126078|NCT02002975|581848314|FG000|Overall Study|Protocol Deviation|437|||
161126079|NCT02810964|581848315|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
161126080|NCT02810964|581848316|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
161126081|NCT02810964|581848315|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
161126082|NCT02810964|581848316|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
161126083|NCT02810964|581848315|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
160787095|NCT01832038|580607198|FG000|Overall Study|Not possible to visit the hospital|1|||
160787096|NCT01832038|580607198|FG000|Overall Study|Changes of implementation system|3|||
160787097|NCT01832038|580607198|FG000|Overall Study|Plan to pregnancy|7|||
161126084|NCT02810964|581848316|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
161126085|NCT02810964|581848315|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
161126086|NCT02810964|581848316|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
161126087|NCT04652804|581848317|FG000|Overall Study|Ineligible post randomization|1|||
160787098|NCT01832038|580607198|FG000|Overall Study|Bad mood and has suicidal thought|1|||
161126088|NCT04652804|581848318|FG001|Overall Study|Ineligible post randomization|0|||
161126089|NCT04652804|581848319|FG002|Overall Study|Ineligible post randomization|1|||
161126090|NCT04652804|581848320|FG003|Overall Study|Ineligible post randomization|0|||
161126091|NCT04652804|581848321|FG004|Overall Study|Ineligible post randomization|1|||
161126092|NCT04652804|581848322|FG005|Overall Study|Ineligible post randomization|1|||
160787099|NCT01832038|580607198|FG000|Overall Study|Prohibited concomitant medication|1|||
161126093|NCT04652804|581848317|FG000|Overall Study|Missing SVR lab results|2|||
161126094|NCT04652804|581848318|FG001|Overall Study|Missing SVR lab results|0|||
161126095|NCT04652804|581848319|FG002|Overall Study|Missing SVR lab results|0|||
161126096|NCT04652804|581848320|FG003|Overall Study|Missing SVR lab results|0|||
161126097|NCT04652804|581848321|FG004|Overall Study|Missing SVR lab results|0|||
161126098|NCT04652804|581848322|FG005|Overall Study|Missing SVR lab results|0|||
161126099|NCT03543410|581848323|FG000|Overall Study|Adverse Event|10|||
161126100|NCT03543410|581848324|FG001|Overall Study|Adverse Event|8|||
161126101|NCT03543410|581848325|FG002|Overall Study|Adverse Event|2|||
161126102|NCT03543410|581848323|FG000|Overall Study|Lack of Efficacy|0|||
161126103|NCT03543410|581848324|FG001|Overall Study|Lack of Efficacy|1|||
161126104|NCT03543410|581848325|FG002|Overall Study|Lack of Efficacy|0|||
161126105|NCT03543410|581848323|FG000|Overall Study|Lost to Follow-up|0|||
161126106|NCT03543410|581848324|FG001|Overall Study|Lost to Follow-up|1|||
161126107|NCT03543410|581848325|FG002|Overall Study|Lost to Follow-up|0|||
161126108|NCT03543410|581848323|FG000|Overall Study|Withdrawal by Subject|5|||
161126109|NCT03543410|581848324|FG001|Overall Study|Withdrawal by Subject|2|||
161126110|NCT03543410|581848325|FG002|Overall Study|Withdrawal by Subject|8|||
161126111|NCT03543410|581848323|FG000|Overall Study|Protocol Violation|0|||
161126112|NCT03543410|581848324|FG001|Overall Study|Protocol Violation|1|||
161126113|NCT03543410|581848325|FG002|Overall Study|Protocol Violation|0|||
161126114|NCT03543410|581848323|FG000|Overall Study|Due to COVID-19|4|||
161126115|NCT03543410|581848324|FG001|Overall Study|Due to COVID-19|0|||
161126116|NCT03543410|581848325|FG002|Overall Study|Due to COVID-19|2|||
161126117|NCT03543410|581848323|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
161126118|NCT03543410|581848324|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
161126119|NCT03543410|581848325|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
161126120|NCT03543410|581848323|FG000|Overall Study|Not Due to COVID-19|2|||
161126121|NCT03543410|581848324|FG001|Overall Study|Not Due to COVID-19|0|||
161126122|NCT03543410|581848325|FG002|Overall Study|Not Due to COVID-19|1|||
161126123|NCT01318122|581848326|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161126124|NCT01318122|581848327|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161126125|NCT01318122|581848328|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
161126126|NCT01318122|581848329|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161126127|NCT01318122|581848326|FG000|Enrolled - Long-Term Extension Study|Other|1|||
161126128|NCT01318122|581848327|FG001|Enrolled - Long-Term Extension Study|Other|0|||
161126129|NCT01318122|581848328|FG002|Enrolled - Long-Term Extension Study|Other|0|||
161126130|NCT01318122|581848329|FG003|Enrolled - Long-Term Extension Study|Other|0|||
161126131|NCT01318122|581848326|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
161126132|NCT01318122|581848327|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
161126133|NCT01318122|581848328|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
161126134|NCT01318122|581848329|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
161126135|NCT01318122|581848326|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
161126136|NCT01318122|581848327|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161126137|NCT01318122|581848328|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161126138|NCT01318122|581848329|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161126139|NCT01318122|581848326|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161126140|NCT01318122|581848327|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
161126141|NCT01318122|581848328|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161126142|NCT01318122|581848329|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161126143|NCT01318122|581848326|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161126144|NCT01318122|581848327|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
161126145|NCT01318122|581848328|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
161126146|NCT01318122|581848329|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161126147|NCT01486199|581848330|FG000|Two Year Period Between Study Days|Physician Decision|1|||
161126148|NCT01486199|581848331|FG001|Two Year Period Between Study Days|Physician Decision|0|||
161126149|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
161126150|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
161126151|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
161126152|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Death|28|||
161126153|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Death|0|||
161126154|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Death|0|||
161126155|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
161126156|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
161126157|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
161126158|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
161126159|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
161126160|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
161126161|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
161126162|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
161328438|NCT00490971|582587154|FG003|Acute/Continuation|Other|0|||
161231260|NCT04657770|582228732|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
161231261|NCT00485472|582228733|FG000|Overall Study|Adverse Event|8|||
161231262|NCT00485472|582228734|FG001|Overall Study|Adverse Event|5|||
161231263|NCT00485472|582228733|FG000|Overall Study|Lack of Efficacy|5|||
161231264|NCT00485472|582228734|FG001|Overall Study|Lack of Efficacy|4|||
161231265|NCT00485472|582228733|FG000|Overall Study|Withdrawal by Subject|1|||
161231266|NCT00485472|582228734|FG001|Overall Study|Withdrawal by Subject|0|||
161231267|NCT00485472|582228733|FG000|Overall Study|Protocol Violation|0|||
161231268|NCT00485472|582228734|FG001|Overall Study|Protocol Violation|1|||
161231269|NCT00485472|582228733|FG000|Overall Study|Other|2|||
161231270|NCT00485472|582228734|FG001|Overall Study|Other|1|||
161231271|NCT00485472|582228733|FG000|Overall Study|Lost to Follow-up|0|||
161231272|NCT00485472|582228734|FG001|Overall Study|Lost to Follow-up|1|||
161231273|NCT00746798|582228735|FG000|Overall Study|Protocol Violation|0|||
161231274|NCT00746798|582228736|FG001|Overall Study|Protocol Violation|1|||
161231275|NCT00746798|582228737|FG002|Overall Study|Protocol Violation|0|||
161231276|NCT00746798|582228738|FG003|Overall Study|Protocol Violation|0|||
161231277|NCT00746798|582228735|FG000|Overall Study|Withdrawal by Subject|0|||
161231278|NCT00746798|582228736|FG001|Overall Study|Withdrawal by Subject|1|||
161231279|NCT00746798|582228737|FG002|Overall Study|Withdrawal by Subject|1|||
161231280|NCT00746798|582228738|FG003|Overall Study|Withdrawal by Subject|0|||
161231281|NCT00746798|582228735|FG000|Overall Study|Death|0|||
161231282|NCT00746798|582228736|FG001|Overall Study|Death|0|||
161231283|NCT00746798|582228737|FG002|Overall Study|Death|2|||
161231284|NCT00746798|582228738|FG003|Overall Study|Death|0|||
161231285|NCT00746798|582228735|FG000|Overall Study|Participant unable to return for visit|1|||
161231286|NCT00746798|582228736|FG001|Overall Study|Participant unable to return for visit|0|||
161231287|NCT00746798|582228737|FG002|Overall Study|Participant unable to return for visit|0|||
161231288|NCT00746798|582228738|FG003|Overall Study|Participant unable to return for visit|0|||
161231289|NCT04915755|582228741|FG000|Overall Study|Physician Decision|3|||
161231290|NCT04915755|582228742|FG001|Overall Study|Physician Decision|2|||
161231291|NCT04915755|582228741|FG000|Overall Study|Withdrawal by Subject|1|||
161231292|NCT04915755|582228742|FG001|Overall Study|Withdrawal by Subject|1|||
161231293|NCT04915755|582228741|FG000|Overall Study|Ongoing for PACT|3|||
161231294|NCT04915755|582228742|FG001|Overall Study|Ongoing for PACT|2|||
161231295|NCT04915755|582228741|FG000|Overall Study|Other|7|||
161231296|NCT04915755|582228742|FG001|Overall Study|Other|11|||
161231297|NCT03247556|582228744|FG000|Overall Study|Adverse Event|1|||
161231298|NCT03247556|582228745|FG001|Overall Study|Adverse Event|4|||
161231299|NCT03247556|582228746|FG002|Overall Study|Adverse Event|5|||
161231300|NCT03247556|582228744|FG000|Overall Study|Lost to Follow-up|5|||
161231301|NCT03247556|582228745|FG001|Overall Study|Lost to Follow-up|5|||
161231302|NCT03247556|582228746|FG002|Overall Study|Lost to Follow-up|4|||
161231303|NCT03247556|582228744|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
161231304|NCT03247556|582228745|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
161231305|NCT03247556|582228746|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
161231306|NCT03247556|582228744|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
161231307|NCT03247556|582228745|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
161231308|NCT03247556|582228746|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
161231309|NCT03247556|582228744|FG000|Overall Study|Protocol Violation|2|||
161231310|NCT03247556|582228745|FG001|Overall Study|Protocol Violation|0|||
161231311|NCT03247556|582228746|FG002|Overall Study|Protocol Violation|1|||
161231312|NCT03247556|582228744|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
161231313|NCT03247556|582228745|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
161231314|NCT03247556|582228746|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
161231315|NCT01710657|582228748|FG000|Overall Study|Lost to Follow-up|2|||
161231316|NCT01710657|582228749|FG001|Overall Study|Lost to Follow-up|0|||
161328439|NCT00490971|582587155|FG004|Acute/Continuation|Other|0|||
161231317|NCT01710657|582228750|FG002|Overall Study|Lost to Follow-up|1|||
161231318|NCT01710657|582228748|FG000|Overall Study|Protocol Violation|2|||
161231319|NCT01710657|582228749|FG001|Overall Study|Protocol Violation|2|||
161328440|NCT00490971|582587151|FG000|Maintenance|Adverse Event|0|||
161328441|NCT00490971|582587152|FG001|Maintenance|Adverse Event|0|||
161328442|NCT00490971|582587153|FG002|Maintenance|Adverse Event|4|||
161328443|NCT00490971|582587154|FG003|Maintenance|Adverse Event|5|||
161328444|NCT00490971|582587155|FG004|Maintenance|Adverse Event|7|||
161328445|NCT00490971|582587151|FG000|Maintenance|Death|0|||
161328446|NCT00490971|582587152|FG001|Maintenance|Death|0|||
161328447|NCT00490971|582587153|FG002|Maintenance|Death|0|||
161328448|NCT00490971|582587154|FG003|Maintenance|Death|2|||
161231320|NCT01710657|582228750|FG002|Overall Study|Protocol Violation|0|||
161231321|NCT01710657|582228748|FG000|Overall Study|Adverse Event|14|||
161328449|NCT00490971|582587155|FG004|Maintenance|Death|0|||
161328450|NCT00490971|582587151|FG000|Maintenance|Lost to Follow-up|0|||
161231322|NCT01710657|582228749|FG001|Overall Study|Adverse Event|8|||
161231323|NCT01710657|582228750|FG002|Overall Study|Adverse Event|28|||
161231324|NCT01710657|582228748|FG000|Overall Study|Withdrawal by Subject|0|||
161231325|NCT01710657|582228749|FG001|Overall Study|Withdrawal by Subject|1|||
161328451|NCT00490971|582587152|FG001|Maintenance|Lost to Follow-up|0|||
161328452|NCT00490971|582587153|FG002|Maintenance|Lost to Follow-up|5|||
161231326|NCT01710657|582228750|FG002|Overall Study|Withdrawal by Subject|2|||
161231327|NCT01710657|582228748|FG000|Overall Study|Lack of Efficacy|0|||
161231328|NCT01710657|582228749|FG001|Overall Study|Lack of Efficacy|1|||
161231329|NCT01710657|582228750|FG002|Overall Study|Lack of Efficacy|1|||
161231330|NCT01367457|582228760|FG000|Overall Study|Death|2|||
161231331|NCT01367457|582228761|FG001|Overall Study|Death|0|||
161231332|NCT01367457|582228762|FG002|Overall Study|Death|0|||
161231333|NCT01367457|582228760|FG000|Overall Study|Investigator's decision|2|||
161231334|NCT01367457|582228761|FG001|Overall Study|Investigator's decision|0|||
161231335|NCT01367457|582228762|FG002|Overall Study|Investigator's decision|0|||
161231336|NCT01367457|582228760|FG000|Overall Study|Clinical decline (CD)|2|||
161231337|NCT01367457|582228761|FG001|Overall Study|Clinical decline (CD)|0|||
161231338|NCT01367457|582228762|FG002|Overall Study|Clinical decline (CD)|0|||
161231339|NCT01367457|582228760|FG000|Overall Study|Progression and death|8|||
161231340|NCT01367457|582228761|FG001|Overall Study|Progression and death|0|||
161231341|NCT01367457|582228762|FG002|Overall Study|Progression and death|0|||
161231342|NCT01367457|582228760|FG000|Overall Study|Toxicity|16|||
161231343|NCT01367457|582228761|FG001|Overall Study|Toxicity|0|||
161231344|NCT01367457|582228762|FG002|Overall Study|Toxicity|0|||
161231345|NCT01367457|582228760|FG000|Overall Study|Progression|137|||
161231346|NCT01367457|582228761|FG001|Overall Study|Progression|0|||
161231347|NCT01367457|582228762|FG002|Overall Study|Progression|0|||
161231348|NCT01367457|582228760|FG000|Overall Study|Patient asks for rest + slow progression|1|||
161231349|NCT01367457|582228761|FG001|Overall Study|Patient asks for rest + slow progression|0|||
161231350|NCT01367457|582228762|FG002|Overall Study|Patient asks for rest + slow progression|0|||
161231351|NCT01367457|582228760|FG000|Overall Study|Investigator's opinion, stable disease|1|||
161231352|NCT01367457|582228761|FG001|Overall Study|Investigator's opinion, stable disease|0|||
161231353|NCT01367457|582228762|FG002|Overall Study|Investigator's opinion, stable disease|0|||
161231354|NCT01367457|582228760|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
161231355|NCT01367457|582228761|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
161231356|NCT01367457|582228762|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
161231357|NCT01367457|582228760|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
161231358|NCT01367457|582228761|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
161231359|NCT01367457|582228762|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
161231360|NCT01367457|582228760|FG000|Overall Study|low grade toxicities + stable disease|1|||
161231361|NCT01367457|582228761|FG001|Overall Study|low grade toxicities + stable disease|0|||
161231362|NCT01367457|582228762|FG002|Overall Study|low grade toxicities + stable disease|0|||
161231363|NCT01367457|582228760|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
161231364|NCT01367457|582228761|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
161231365|NCT01367457|582228762|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
161231366|NCT01367457|582228760|FG000|Overall Study|Withdrawal by Subject|1|||
161231367|NCT01367457|582228761|FG001|Overall Study|Withdrawal by Subject|0|||
161231368|NCT01367457|582228762|FG002|Overall Study|Withdrawal by Subject|0|||
161231369|NCT01367457|582228760|FG000|Overall Study|CD, associated leukaemia|1|||
161231370|NCT01367457|582228761|FG001|Overall Study|CD, associated leukaemia|0|||
161231371|NCT01367457|582228762|FG002|Overall Study|CD, associated leukaemia|0|||
161328453|NCT00490971|582587154|FG003|Maintenance|Lost to Follow-up|8|||
161328454|NCT00490971|582587155|FG004|Maintenance|Lost to Follow-up|10|||
161328455|NCT00490971|582587151|FG000|Maintenance|Pregnancy|0|||
161328456|NCT00490971|582587152|FG001|Maintenance|Pregnancy|0|||
161328457|NCT00490971|582587153|FG002|Maintenance|Pregnancy|1|||
161328458|NCT00490971|582587154|FG003|Maintenance|Pregnancy|0|||
161328459|NCT00490971|582587155|FG004|Maintenance|Pregnancy|0|||
161328460|NCT00490971|582587151|FG000|Maintenance|Protocol Violation|0|||
161328461|NCT00490971|582587152|FG001|Maintenance|Protocol Violation|0|||
161328462|NCT00490971|582587153|FG002|Maintenance|Protocol Violation|4|||
161328463|NCT00490971|582587154|FG003|Maintenance|Protocol Violation|1|||
161328464|NCT00490971|582587155|FG004|Maintenance|Protocol Violation|1|||
161328465|NCT00490971|582587151|FG000|Maintenance|Withdrawal by Subject|0|||
161328466|NCT00490971|582587152|FG001|Maintenance|Withdrawal by Subject|0|||
161328467|NCT00490971|582587153|FG002|Maintenance|Withdrawal by Subject|26|||
161328468|NCT00490971|582587154|FG003|Maintenance|Withdrawal by Subject|28|||
161328469|NCT00490971|582587155|FG004|Maintenance|Withdrawal by Subject|18|||
161231372|NCT01367457|582228760|FG000|Overall Study|Uncontrolled pain|1|||
161231373|NCT01367457|582228761|FG001|Overall Study|Uncontrolled pain|0|||
161231374|NCT01367457|582228762|FG002|Overall Study|Uncontrolled pain|0|||
161231375|NCT01367457|582228760|FG000|Overall Study|Overall status worsens to grade 4|1|||
161231376|NCT01367457|582228761|FG001|Overall Study|Overall status worsens to grade 4|0|||
161231377|NCT01367457|582228762|FG002|Overall Study|Overall status worsens to grade 4|0|||
161231378|NCT01367457|582228760|FG000|Overall Study|Stabilisation + frequent infections|1|||
161328470|NCT00490971|582587151|FG000|Maintenance|Other|0|||
161231379|NCT01367457|582228761|FG001|Overall Study|Stabilisation + frequent infections|0|||
161231380|NCT01367457|582228762|FG002|Overall Study|Stabilisation + frequent infections|0|||
161328471|NCT00490971|582587152|FG001|Maintenance|Other|0|||
161328472|NCT00490971|582587153|FG002|Maintenance|Other|11|||
161328473|NCT00490971|582587154|FG003|Maintenance|Other|9|||
161231381|NCT01367457|582228760|FG000|Overall Study|No clinical benefit|1|||
161231382|NCT01367457|582228761|FG001|Overall Study|No clinical benefit|0|||
161231383|NCT01367457|582228762|FG002|Overall Study|No clinical benefit|0|||
161231384|NCT01367457|582228760|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
161231385|NCT01367457|582228761|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
161231386|NCT01367457|582228762|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
161231387|NCT01367457|582228760|FG000|Overall Study|Overall decline|1|||
161231388|NCT01367457|582228761|FG001|Overall Study|Overall decline|0|||
161231389|NCT01367457|582228762|FG002|Overall Study|Overall decline|0|||
161231390|NCT01367457|582228760|FG000|Overall Study|Rejection of treatment|1|||
161231391|NCT01367457|582228761|FG001|Overall Study|Rejection of treatment|0|||
161231392|NCT01367457|582228762|FG002|Overall Study|Rejection of treatment|0|||
161231393|NCT01367457|582228760|FG000|Overall Study|Lost to Follow-up|1|||
161231394|NCT01367457|582228761|FG001|Overall Study|Lost to Follow-up|0|||
161231395|NCT01367457|582228762|FG002|Overall Study|Lost to Follow-up|0|||
161231396|NCT01367457|582228760|FG000|Overall Study|Death from septic shock|1|||
161231397|NCT01367457|582228761|FG001|Overall Study|Death from septic shock|0|||
161231398|NCT01367457|582228762|FG002|Overall Study|Death from septic shock|0|||
161231399|NCT01367457|582228760|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
161231400|NCT01367457|582228761|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
161231401|NCT01367457|582228762|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
161231402|NCT01367457|582228760|FG000|Overall Study|Patient's Wish|1|||
161231403|NCT01367457|582228761|FG001|Overall Study|Patient's Wish|0|||
161231404|NCT01367457|582228762|FG002|Overall Study|Patient's Wish|0|||
161231405|NCT01367457|582228760|FG000|Overall Study|Palliative. Overall decline|1|||
161231406|NCT01367457|582228761|FG001|Overall Study|Palliative. Overall decline|0|||
161231407|NCT01367457|582228762|FG002|Overall Study|Palliative. Overall decline|0|||
161231408|NCT01367457|582228760|FG000|Overall Study|Suspected DP/suspected active infection|1|||
161231409|NCT01367457|582228761|FG001|Overall Study|Suspected DP/suspected active infection|0|||
161231410|NCT01367457|582228762|FG002|Overall Study|Suspected DP/suspected active infection|0|||
161231411|NCT02495857|582228763|FG000|Overall Study|Adverse Event|5|||
161231412|NCT02495857|582228764|FG001|Overall Study|Adverse Event|0|||
161231413|NCT02495857|582228765|FG002|Overall Study|Adverse Event|1|||
161231414|NCT02495857|582228763|FG000|Overall Study|Withdrawal by Subject|9|||
161231415|NCT02495857|582228764|FG001|Overall Study|Withdrawal by Subject|6|||
161231416|NCT02495857|582228765|FG002|Overall Study|Withdrawal by Subject|10|||
161231417|NCT02495857|582228763|FG000|Overall Study|Physician Decision|0|||
161231418|NCT02495857|582228764|FG001|Overall Study|Physician Decision|1|||
161231419|NCT02495857|582228765|FG002|Overall Study|Physician Decision|0|||
161231420|NCT02495857|582228763|FG000|Overall Study|Protocol Violation|1|||
161231421|NCT02495857|582228764|FG001|Overall Study|Protocol Violation|1|||
161231422|NCT02495857|582228765|FG002|Overall Study|Protocol Violation|2|||
161231423|NCT02495857|582228763|FG000|Overall Study|Lost to Follow-up|4|||
161231424|NCT02495857|582228764|FG001|Overall Study|Lost to Follow-up|5|||
161231425|NCT02495857|582228765|FG002|Overall Study|Lost to Follow-up|3|||
161231426|NCT02495857|582228763|FG000|Overall Study|Other|3|||
161231427|NCT02495857|582228764|FG001|Overall Study|Other|3|||
161231428|NCT02495857|582228765|FG002|Overall Study|Other|2|||
161231429|NCT04407806|582228770|FG000|Overall Study|Withdrawal by Subject|1|||
161231430|NCT04407806|582228771|FG001|Overall Study|Withdrawal by Subject|2|||
161231431|NCT03447262|582228772|FG000|Overall Study|Adverse Event|7|||
161231432|NCT03447262|582228772|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
161231433|NCT03447262|582228772|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
161231434|NCT03447262|582228772|FG000|Overall Study|Death|2|||
161231435|NCT03447262|582228772|FG000|Overall Study|Study Termination by Sponsor|455|||
161231436|NCT03447262|582228772|FG000|Overall Study|Other|4|||
161231437|NCT02058498|582228778|FG000|Overall Study|Withdrawal by Subject|4|||
161231438|NCT03478397|582228779|FG000|Overall Study|Refused to participate|31|||
161231439|NCT03478397|582228780|FG001|Overall Study|Refused to participate|7|||
161231440|NCT04605094|582228781|FG000|Overall Study|Adverse Event|2|||
160787100|NCT01832038|580607198|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
160787101|NCT01832038|580607198|FG000|Overall Study|Subject considered the efficacy was poor|1|||
160787102|NCT01897896|580607201|FG000|Overall Study|Death|1|||
160787103|NCT01897896|580607202|FG001|Overall Study|Death|0|||
160787104|NCT01897896|580607201|FG000|Overall Study|Adverse Event|11|||
160787105|NCT01897896|580607202|FG001|Overall Study|Adverse Event|1|||
160787106|NCT01897896|580607201|FG000|Overall Study|Lost to Follow-up|1|||
160787107|NCT01897896|580607202|FG001|Overall Study|Lost to Follow-up|0|||
160787108|NCT01897896|580607201|FG000|Overall Study|Non-compliance with study drug dosing|1|||
160890213|NCT00423670|580992967|FG000|Treatment Period|Non-compliance with protocol|3|||
161231441|NCT04605094|582228782|FG001|Overall Study|Adverse Event|2|||
161231442|NCT04605094|582228781|FG000|Overall Study|Lost to Follow-up|1|||
161231443|NCT04605094|582228782|FG001|Overall Study|Lost to Follow-up|4|||
161231444|NCT04605094|582228781|FG000|Overall Study|Physician Decision|2|||
161231445|NCT04605094|582228782|FG001|Overall Study|Physician Decision|2|||
161231446|NCT04605094|582228781|FG000|Overall Study|Study terminated by Sponsor|31|||
161328474|NCT00490971|582587155|FG004|Maintenance|Other|3|||
160787109|NCT01897896|580607202|FG001|Overall Study|Non-compliance with study drug dosing|1|||
160787110|NCT01897896|580607201|FG000|Overall Study|Withdrawal by Subject|7|||
160787111|NCT01897896|580607202|FG001|Overall Study|Withdrawal by Subject|1|||
160787112|NCT01897896|580607201|FG000|Overall Study|Require drug that interfere with study|1|||
160787113|NCT01897896|580607202|FG001|Overall Study|Require drug that interfere with study|4|||
160787114|NCT01897896|580607201|FG000|Overall Study|Protocol Violation|1|||
160787115|NCT01897896|580607202|FG001|Overall Study|Protocol Violation|1|||
160787116|NCT01897896|580607201|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
160787117|NCT01897896|580607202|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
160787118|NCT01897896|580607201|FG000|Overall Study|Caregiver can no longer participate|0|||
160787119|NCT01897896|580607202|FG001|Overall Study|Caregiver can no longer participate|2|||
160787120|NCT01897896|580607201|FG000|Overall Study|Other than specified|2|||
160787121|NCT01897896|580607202|FG001|Overall Study|Other than specified|1|||
160787122|NCT01292473|580607212|FG000|Overall Study|Adverse Event|1|||
160787123|NCT01292473|580607213|FG001|Overall Study|Adverse Event|0|||
160787124|NCT01292473|580607214|FG002|Overall Study|Adverse Event|1|||
160787125|NCT01292473|580607215|FG003|Overall Study|Adverse Event|1|||
160787126|NCT01292473|580607212|FG000|Overall Study|Lost to Follow-up|1|||
160787127|NCT01292473|580607213|FG001|Overall Study|Lost to Follow-up|1|||
160787128|NCT01292473|580607214|FG002|Overall Study|Lost to Follow-up|2|||
160787129|NCT01292473|580607215|FG003|Overall Study|Lost to Follow-up|2|||
160787130|NCT01292473|580607212|FG000|Overall Study|Withdrawal by Subject|3|||
161126163|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
161126164|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
161126165|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
161126166|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
161126167|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
161126168|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
160787131|NCT01292473|580607213|FG001|Overall Study|Withdrawal by Subject|4|||
160787132|NCT01292473|580607214|FG002|Overall Study|Withdrawal by Subject|3|||
161126169|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
161126170|NCT00820755|581848332|FG000|Period 1: Combination Therapy Phase|Other|11|||
161126171|NCT00820755|581848333|FG001|Period 1: Combination Therapy Phase|Other|0|||
161126172|NCT00820755|581848334|FG002|Period 1: Combination Therapy Phase|Other|0|||
161126173|NCT00820755|581848332|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
161126174|NCT00820755|581848333|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
161126175|NCT00820755|581848334|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
161126176|NCT03604445|581848336|FG000|Overall Study|Death|0|||
161126177|NCT03604445|581848337|FG001|Overall Study|Death|0|||
161126178|NCT03604445|581848338|FG002|Overall Study|Death|0|||
161126179|NCT03604445|581848339|FG003|Overall Study|Death|0|||
161126180|NCT03604445|581848340|FG004|Overall Study|Death|0|||
161126181|NCT03604445|581848341|FG005|Overall Study|Death|0|||
161126182|NCT03604445|581848342|FG006|Overall Study|Death|0|||
161126183|NCT03604445|581848343|FG007|Overall Study|Death|0|||
161126184|NCT03604445|581848344|FG008|Overall Study|Death|1|||
161126185|NCT03604445|581848336|FG000|Overall Study|Withdrawal by Subject|0|||
161126186|NCT03604445|581848337|FG001|Overall Study|Withdrawal by Subject|0|||
161126187|NCT03604445|581848338|FG002|Overall Study|Withdrawal by Subject|0|||
161126188|NCT03604445|581848339|FG003|Overall Study|Withdrawal by Subject|0|||
161126189|NCT03604445|581848340|FG004|Overall Study|Withdrawal by Subject|0|||
161126190|NCT03604445|581848341|FG005|Overall Study|Withdrawal by Subject|0|||
161126191|NCT03604445|581848342|FG006|Overall Study|Withdrawal by Subject|1|||
161126192|NCT03604445|581848343|FG007|Overall Study|Withdrawal by Subject|0|||
161126193|NCT03604445|581848344|FG008|Overall Study|Withdrawal by Subject|0|||
160787133|NCT01292473|580607215|FG003|Overall Study|Withdrawal by Subject|3|||
160787134|NCT01292473|580607212|FG000|Overall Study|Physician Decision|0|||
160787135|NCT01292473|580607213|FG001|Overall Study|Physician Decision|1|||
160787136|NCT01292473|580607214|FG002|Overall Study|Physician Decision|0|||
160787137|NCT01292473|580607215|FG003|Overall Study|Physician Decision|0|||
160787138|NCT01292473|580607212|FG000|Overall Study|Disease Progression|0|||
160787139|NCT01292473|580607213|FG001|Overall Study|Disease Progression|1|||
160787140|NCT01292473|580607214|FG002|Overall Study|Disease Progression|3|||
160787141|NCT01292473|580607215|FG003|Overall Study|Disease Progression|6|||
160787142|NCT00458705|580607218|FG000|Overall Study|Adverse Event|4|||
160787143|NCT00458705|580607218|FG000|Overall Study|Not Treated|1|||
161126194|NCT03604445|581848336|FG000|Overall Study|Missing visit|0|||
161126195|NCT03604445|581848337|FG001|Overall Study|Missing visit|0|||
160787144|NCT02180672|580607219|FG000|Overall Study|Lost to Follow-up|5|||
160787145|NCT02180672|580607220|FG001|Overall Study|Lost to Follow-up|7|||
160787146|NCT00378560|580607224|FG000|Overall Study|Adverse Event|1|||
160787147|NCT00378560|580607225|FG001|Overall Study|Adverse Event|0|||
160787148|NCT00378560|580607224|FG000|Overall Study|Lost to Follow-up|24|||
160787149|NCT00378560|580607225|FG001|Overall Study|Lost to Follow-up|29|||
160787150|NCT00378560|580607224|FG000|Overall Study|Protocol Violation|2|||
160787151|NCT00378560|580607225|FG001|Overall Study|Protocol Violation|0|||
160787152|NCT00378560|580607224|FG000|Overall Study|Withdrawal by Subject|17|||
160787153|NCT00378560|580607225|FG001|Overall Study|Withdrawal by Subject|21|||
160787154|NCT00378560|580607224|FG000|Overall Study|Moved|4|||
160787155|NCT00378560|580607225|FG001|Overall Study|Moved|3|||
160787156|NCT00378560|580607224|FG000|Overall Study|Pregnancy|7|||
160787157|NCT00378560|580607225|FG001|Overall Study|Pregnancy|5|||
160787158|NCT00378560|580607224|FG000|Overall Study|Laboratory test values abnormal|1|||
160787159|NCT00378560|580607225|FG001|Overall Study|Laboratory test values abnormal|0|||
160787160|NCT02070380|580607226|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
160787161|NCT02070380|580607227|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
160787162|NCT02070380|580607228|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
160787163|NCT02070380|580607229|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
160787164|NCT02070380|580607226|FG000|Second Injection|Image sets missing or technically inadeq|0|||
160787165|NCT02070380|580607227|FG001|Second Injection|Image sets missing or technically inadeq|1|||
160787166|NCT02070380|580607228|FG002|Second Injection|Image sets missing or technically inadeq|0|||
161126196|NCT03604445|581848338|FG002|Overall Study|Missing visit|0|||
161126197|NCT03604445|581848339|FG003|Overall Study|Missing visit|0|||
161126198|NCT03604445|581848340|FG004|Overall Study|Missing visit|0|||
161126199|NCT03604445|581848341|FG005|Overall Study|Missing visit|1|||
161126200|NCT03604445|581848342|FG006|Overall Study|Missing visit|0|||
161126201|NCT03604445|581848343|FG007|Overall Study|Missing visit|1|||
161126202|NCT03604445|581848344|FG008|Overall Study|Missing visit|0|||
161126203|NCT03604445|581848336|FG000|Overall Study|Adverse Event|0|||
161126204|NCT03604445|581848337|FG001|Overall Study|Adverse Event|0|||
161126205|NCT03604445|581848338|FG002|Overall Study|Adverse Event|0|||
161126206|NCT03604445|581848339|FG003|Overall Study|Adverse Event|1|||
161126207|NCT03604445|581848340|FG004|Overall Study|Adverse Event|0|||
161126208|NCT03604445|581848341|FG005|Overall Study|Adverse Event|0|||
161126209|NCT03604445|581848342|FG006|Overall Study|Adverse Event|0|||
161126210|NCT03604445|581848343|FG007|Overall Study|Adverse Event|0|||
161126211|NCT03604445|581848344|FG008|Overall Study|Adverse Event|1|||
161126212|NCT00611247|581848347|FG000|Overall Study|Death|1|||
161126213|NCT00611247|581848348|FG001|Overall Study|Death|5|||
161126214|NCT00611247|581848347|FG000|Overall Study|Lack of Efficacy|1|||
161126215|NCT00611247|581848348|FG001|Overall Study|Lack of Efficacy|16|||
161126216|NCT02551159|581848349|FG000|Overall Study|Death|352|||
161126217|NCT02551159|581848350|FG001|Overall Study|Death|174|||
161126218|NCT02551159|581848351|FG002|Overall Study|Death|161|||
161126219|NCT02551159|581848349|FG000|Overall Study|Withdrawal by Subject|8|||
161126220|NCT02551159|581848350|FG001|Overall Study|Withdrawal by Subject|5|||
161126221|NCT02551159|581848351|FG002|Overall Study|Withdrawal by Subject|16|||
161126222|NCT02551159|581848349|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
161126223|NCT02551159|581848350|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
161126224|NCT02551159|581848351|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
161126225|NCT00243659|581848352|FG000|Overall Study|Withdrawal by Subject|1|||
161126226|NCT00243659|581848353|FG001|Overall Study|Withdrawal by Subject|1|||
161126227|NCT00243659|581848352|FG000|Overall Study|Protocol Violation|1|||
161126228|NCT00243659|581848353|FG001|Overall Study|Protocol Violation|2|||
161126229|NCT00268242|581848354|FG000|Overall Study|Death|1|||
161126230|NCT01913483|581848355|FG000|Overall Study|Withdrawal by Subject|1|||
161126231|NCT01913483|581848356|FG001|Overall Study|Withdrawal by Subject|2|||
161126232|NCT01913483|581848355|FG000|Overall Study|Lost to Follow-up|6|||
161126233|NCT01913483|581848356|FG001|Overall Study|Lost to Follow-up|3|||
161126234|NCT01913483|581848355|FG000|Overall Study|Death|14|||
161126235|NCT01913483|581848356|FG001|Overall Study|Death|17|||
161126236|NCT03969888|581848357|FG000|Overall Study|Never Received Study Drug|0|||
161126237|NCT03969888|581848358|FG001|Overall Study|Never Received Study Drug|0|||
161126238|NCT03969888|581848359|FG002|Overall Study|Never Received Study Drug|1|||
161126239|NCT03969888|581848360|FG003|Overall Study|Never Received Study Drug|0|||
161126240|NCT03969888|581848361|FG004|Overall Study|Never Received Study Drug|0|||
161126241|NCT03969888|581848362|FG005|Overall Study|Never Received Study Drug|0|||
161126242|NCT03969888|581848363|FG006|Overall Study|Never Received Study Drug|1|||
161126243|NCT03969888|581848364|FG007|Overall Study|Never Received Study Drug|0|||
161126244|NCT03969888|581848357|FG000|Overall Study|Reason Not Specified|0|||
161126245|NCT03969888|581848358|FG001|Overall Study|Reason Not Specified|0|||
161126246|NCT03969888|581848359|FG002|Overall Study|Reason Not Specified|0|||
161126247|NCT03969888|581848360|FG003|Overall Study|Reason Not Specified|0|||
161126248|NCT03969888|581848361|FG004|Overall Study|Reason Not Specified|0|||
161126249|NCT03969888|581848362|FG005|Overall Study|Reason Not Specified|0|||
161126250|NCT03969888|581848363|FG006|Overall Study|Reason Not Specified|0|||
160787167|NCT02070380|580607229|FG003|Second Injection|Image sets missing or technically inadeq|0|||
161126251|NCT03969888|581848364|FG007|Overall Study|Reason Not Specified|1|||
161126252|NCT00464178|581848367|FG000|Overall Study|Protocol Violation|1|||
161126253|NCT00464178|581848367|FG000|Overall Study|Withdrawal by Subject|1|||
161126254|NCT04506294|581848368|FG000|Overall Study|Lost to Follow-up|70|||
161126255|NCT04506294|581848369|FG001|Overall Study|Lost to Follow-up|20|||
161231447|NCT04605094|582228782|FG001|Overall Study|Study terminated by Sponsor|33|||
161231448|NCT04605094|582228781|FG000|Overall Study|Withdrawal by Subject|22|||
161231449|NCT04605094|582228782|FG001|Overall Study|Withdrawal by Subject|19|||
161231450|NCT04605094|582228781|FG000|Overall Study|Other|1|||
161231451|NCT04605094|582228782|FG001|Overall Study|Other|1|||
161231452|NCT04206332|582228785|FG000|Part A|Lost to Follow-up|0|||
161231453|NCT04206332|582228786|FG001|Part A|Lost to Follow-up|1|||
161231454|NCT04206332|582228787|FG002|Part A|Lost to Follow-up|0|||
161231455|NCT04206332|582228788|FG003|Part A|Lost to Follow-up|0|||
161231456|NCT04206332|582228789|FG004|Part A|Lost to Follow-up|0|||
161231457|NCT04206332|582228790|FG005|Part A|Lost to Follow-up|0|||
161231458|NCT04206332|582228791|FG006|Part A|Lost to Follow-up|0|||
161231459|NCT04206332|582228792|FG007|Part A|Lost to Follow-up|0|||
161231460|NCT04206332|582228793|FG008|Part A|Lost to Follow-up|0|||
161231461|NCT04206332|582228794|FG009|Part A|Lost to Follow-up|0|||
161231462|NCT04206332|582228795|FG010|Part A|Lost to Follow-up|0|||
161231463|NCT04206332|582228796|FG011|Part A|Lost to Follow-up|0|||
161231464|NCT04206332|582228797|FG012|Part A|Lost to Follow-up|0|||
161231465|NCT04206332|582228798|FG013|Part A|Lost to Follow-up|0|||
161231466|NCT04206332|582228799|FG014|Part A|Lost to Follow-up|0|||
161231467|NCT04206332|582228800|FG015|Part A|Lost to Follow-up|0|||
161231468|NCT04206332|582228801|FG016|Part A|Lost to Follow-up|0|||
161231469|NCT04206332|582228785|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231470|NCT04206332|582228786|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231471|NCT04206332|582228787|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231472|NCT04206332|582228788|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231473|NCT04206332|582228789|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231474|NCT04206332|582228790|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
161231475|NCT04206332|582228791|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231476|NCT04206332|582228792|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231477|NCT04206332|582228793|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231478|NCT04206332|582228794|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231479|NCT04206332|582228795|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231480|NCT04206332|582228796|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231481|NCT04206332|582228797|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231482|NCT04206332|582228798|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231483|NCT04206332|582228799|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231484|NCT04206332|582228800|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231485|NCT04206332|582228801|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
161231486|NCT04206332|582228785|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231487|NCT04206332|582228786|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231488|NCT04206332|582228787|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231489|NCT04206332|582228788|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231490|NCT04206332|582228789|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231491|NCT04206332|582228790|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231492|NCT04206332|582228791|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231493|NCT04206332|582228792|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
161231494|NCT04206332|582228793|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231495|NCT04206332|582228794|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231496|NCT04206332|582228795|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
161231497|NCT04206332|582228796|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231498|NCT04206332|582228797|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231499|NCT04206332|582228798|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231500|NCT04206332|582228799|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231501|NCT04206332|582228800|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231502|NCT04206332|582228801|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231503|NCT04206332|582228785|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231504|NCT04206332|582228786|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231505|NCT04206332|582228787|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231506|NCT04206332|582228788|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231507|NCT04206332|582228789|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231508|NCT04206332|582228790|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231509|NCT04206332|582228791|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161126256|NCT04506294|581848368|FG000|Overall Study|Withdrawal by Subject|16|||
161126257|NCT04506294|581848369|FG001|Overall Study|Withdrawal by Subject|2|||
161126258|NCT01469000|581848371|FG000|Overall Study|Withdrawal by Subject|16|||
161126259|NCT01469000|581848372|FG001|Overall Study|Withdrawal by Subject|3|||
161126260|NCT01469000|581848371|FG000|Overall Study|Sponsor Decision|4|||
161126261|NCT01469000|581848372|FG001|Overall Study|Sponsor Decision|1|||
161126262|NCT00769119|581848375|FG000|Overall Study|Voluntary discontinuation|0|||
161126263|NCT00769119|581848376|FG001|Overall Study|Voluntary discontinuation|2|||
161126264|NCT00769119|581848375|FG000|Overall Study|Adverse Event|1|||
161126265|NCT00769119|581848376|FG001|Overall Study|Adverse Event|1|||
161126266|NCT00769119|581848375|FG000|Overall Study|Disallowed medication|1|||
161126267|NCT00769119|581848376|FG001|Overall Study|Disallowed medication|0|||
161126268|NCT01116544|581848379|FG000|Overall Study|Protocol Violation|1|||
161126269|NCT01116544|581848380|FG001|Overall Study|Protocol Violation|0|||
161126270|NCT01116544|581848379|FG000|Overall Study|Withdrawal by Subject|1|||
161126271|NCT01116544|581848380|FG001|Overall Study|Withdrawal by Subject|1|||
161126272|NCT05168267|581848381|FG000|Overall Study|Withdrawal by Subject|2|||
161126273|NCT05168267|581848382|FG001|Overall Study|Withdrawal by Subject|1|||
161126274|NCT05168267|581848381|FG000|Overall Study|Withdrawn by Therapist|1|||
161126275|NCT05168267|581848382|FG001|Overall Study|Withdrawn by Therapist|1|||
161126276|NCT05168267|581848381|FG000|Overall Study|Left Facility|1|||
161126277|NCT05168267|581848382|FG001|Overall Study|Left Facility|0|||
161126278|NCT01738971|581848385|FG000|Overall Study|Lost to Follow-up|19|||
161126279|NCT01738971|581848386|FG001|Overall Study|Lost to Follow-up|30|||
161126280|NCT01738971|581848387|FG002|Overall Study|Lost to Follow-up|17|||
161126281|NCT04698629|581848399|FG000|Overall Study|Adverse Event|1|||
161126282|NCT02320487|581848404|FG000|Overall Study|Reason not Specified|1|||
161126283|NCT02320487|581848404|FG000|Overall Study|Physician Decision|5|||
161126284|NCT02320487|581848404|FG000|Overall Study|Withdrawal by Subject|1|||
161126285|NCT02320487|581848404|FG000|Overall Study|Death|3|||
161126286|NCT02320487|581848404|FG000|Overall Study|Adverse Event|11|||
161126287|NCT02949128|581850632|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
161126288|NCT02949128|581850632|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
161126289|NCT02949128|581850632|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
161126290|NCT02949128|581850632|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
161126291|NCT02949128|581850632|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
161126292|NCT02949128|581850632|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
161231510|NCT04206332|582228792|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231511|NCT04206332|582228793|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231512|NCT04206332|582228794|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231513|NCT04206332|582228795|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231514|NCT04206332|582228796|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231515|NCT04206332|582228797|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231516|NCT04206332|582228798|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231517|NCT04206332|582228799|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231518|NCT04206332|582228800|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
161231519|NCT04206332|582228801|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
161231520|NCT04206332|582228785|FG000|Part C|Withdrawal by Subject|0|||
161231521|NCT04206332|582228786|FG001|Part C|Withdrawal by Subject|0|||
161231522|NCT04206332|582228787|FG002|Part C|Withdrawal by Subject|0|||
161231523|NCT04206332|582228788|FG003|Part C|Withdrawal by Subject|0|||
161231524|NCT04206332|582228789|FG004|Part C|Withdrawal by Subject|0|||
161231525|NCT04206332|582228790|FG005|Part C|Withdrawal by Subject|0|||
161231526|NCT04206332|582228791|FG006|Part C|Withdrawal by Subject|0|||
161231527|NCT04206332|582228792|FG007|Part C|Withdrawal by Subject|0|||
161231528|NCT04206332|582228793|FG008|Part C|Withdrawal by Subject|0|||
161231529|NCT04206332|582228794|FG009|Part C|Withdrawal by Subject|0|||
161231530|NCT04206332|582228795|FG010|Part C|Withdrawal by Subject|0|||
161231531|NCT04206332|582228796|FG011|Part C|Withdrawal by Subject|0|||
161231532|NCT04206332|582228797|FG012|Part C|Withdrawal by Subject|0|||
161231533|NCT04206332|582228798|FG013|Part C|Withdrawal by Subject|0|||
161231534|NCT04206332|582228799|FG014|Part C|Withdrawal by Subject|2|||
161231535|NCT04206332|582228800|FG015|Part C|Withdrawal by Subject|0|||
161231536|NCT04206332|582228801|FG016|Part C|Withdrawal by Subject|0|||
161126293|NCT02949128|581850632|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
161231537|NCT01126736|582228802|FG000|Overall Study|Death|2|||
161231538|NCT01126736|582228803|FG001|Overall Study|Death|2|||
161231539|NCT01126736|582228804|FG002|Overall Study|Death|1|||
161231540|NCT01126736|582228805|FG003|Overall Study|Death|19|||
161231541|NCT01126736|582228806|FG004|Overall Study|Death|19|||
161231542|NCT01126736|582228802|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161231543|NCT01126736|582228803|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161231544|NCT01126736|582228804|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
161231545|NCT01126736|582228805|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
161231546|NCT01126736|582228806|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
161231547|NCT01126736|582228802|FG000|Overall Study|Lost to Follow-up|0|||
161231548|NCT01126736|582228803|FG001|Overall Study|Lost to Follow-up|0|||
161231549|NCT01126736|582228804|FG002|Overall Study|Lost to Follow-up|0|||
161231550|NCT01126736|582228805|FG003|Overall Study|Lost to Follow-up|1|||
161231551|NCT01126736|582228806|FG004|Overall Study|Lost to Follow-up|1|||
161231552|NCT01126736|582228802|FG000|Overall Study|Administrative reasons|0|||
161231553|NCT01126736|582228803|FG001|Overall Study|Administrative reasons|0|||
161231554|NCT01126736|582228804|FG002|Overall Study|Administrative reasons|0|||
161231555|NCT01126736|582228805|FG003|Overall Study|Administrative reasons|0|||
161231556|NCT01126736|582228806|FG004|Overall Study|Administrative reasons|1|||
161231557|NCT01126736|582228802|FG000|Overall Study|Progressive disease|0|||
161231558|NCT01126736|582228803|FG001|Overall Study|Progressive disease|0|||
161231559|NCT01126736|582228804|FG002|Overall Study|Progressive disease|0|||
161231560|NCT01126736|582228805|FG003|Overall Study|Progressive disease|2|||
161231561|NCT01126736|582228806|FG004|Overall Study|Progressive disease|1|||
161231562|NCT01126736|582228802|FG000|Overall Study|Withdrawal by Subject|0|||
161231563|NCT01126736|582228803|FG001|Overall Study|Withdrawal by Subject|0|||
161231564|NCT01126736|582228804|FG002|Overall Study|Withdrawal by Subject|0|||
161231565|NCT01126736|582228805|FG003|Overall Study|Withdrawal by Subject|1|||
161231566|NCT01126736|582228806|FG004|Overall Study|Withdrawal by Subject|1|||
161231567|NCT01126736|582228802|FG000|Overall Study|Other|2|||
161231568|NCT01126736|582228803|FG001|Overall Study|Other|4|||
161231569|NCT01126736|582228804|FG002|Overall Study|Other|4|||
161231570|NCT01126736|582228805|FG003|Overall Study|Other|16|||
161231571|NCT01126736|582228806|FG004|Overall Study|Other|15|||
161231572|NCT00874237|582228807|FG000|Overall Study|Physician Decision|0|||
161231573|NCT00874237|582228808|FG001|Overall Study|Physician Decision|1|||
161231574|NCT00874237|582228809|FG002|Overall Study|Physician Decision|0|||
161231575|NCT00874237|582228810|FG003|Overall Study|Physician Decision|0|||
161231576|NCT00874237|582228811|FG004|Overall Study|Physician Decision|0|||
161231577|NCT00874237|582228812|FG005|Overall Study|Physician Decision|0|||
161231578|NCT00874237|582228807|FG000|Overall Study|Withdrawal by Subject|0|||
161231579|NCT00874237|582228808|FG001|Overall Study|Withdrawal by Subject|0|||
161231580|NCT00874237|582228809|FG002|Overall Study|Withdrawal by Subject|1|||
161231581|NCT00874237|582228810|FG003|Overall Study|Withdrawal by Subject|0|||
161231582|NCT00874237|582228811|FG004|Overall Study|Withdrawal by Subject|0|||
161231583|NCT00874237|582228812|FG005|Overall Study|Withdrawal by Subject|0|||
161231584|NCT00877032|582228817|FG000|Overall Study|Did not meet entrance criteria|0|||
161231585|NCT00877032|582228818|FG001|Overall Study|Did not meet entrance criteria|0|||
161231586|NCT00877032|582228819|FG002|Overall Study|Did not meet entrance criteria|0|||
161231587|NCT00877032|582228820|FG003|Overall Study|Did not meet entrance criteria|1|||
161231588|NCT00877032|582228821|FG004|Overall Study|Did not meet entrance criteria|0|||
161231589|NCT00877032|582228822|FG005|Overall Study|Did not meet entrance criteria|0|||
161231590|NCT00877032|582228823|FG006|Overall Study|Did not meet entrance criteria|2|||
161231591|NCT00813293|582228824|FG000|Overall Study|Intercurrent illness|1|||
161231592|NCT00813293|582228825|FG001|Overall Study|Intercurrent illness|0|||
161231593|NCT00813293|582228824|FG000|Overall Study|Adverse Event|0|||
161231594|NCT00813293|582228825|FG001|Overall Study|Adverse Event|1|||
161328475|NCT01216332|582587162|FG000|Overall Study|Withdrawal by Subject|4|||
161328476|NCT01216332|582587163|FG001|Overall Study|Withdrawal by Subject|0|||
161231595|NCT02794974|582228826|FG000|Overall Study|Physician Decision|0|||
161231596|NCT02794974|582228827|FG001|Overall Study|Physician Decision|1|||
161231597|NCT02202850|582228828|FG000|Overall Study|Other|2|||
161231598|NCT02202850|582228829|FG001|Overall Study|Other|2|||
161231599|NCT02202850|582228828|FG000|Overall Study|Enbrel treatment discontinued|15|||
161231600|NCT02202850|582228829|FG001|Overall Study|Enbrel treatment discontinued|3|||
161231601|NCT02202850|582228828|FG000|Overall Study|Lost to Follow-up|7|||
161231602|NCT02202850|582228829|FG001|Overall Study|Lost to Follow-up|1|||
161231603|NCT00615069|582228830|FG000|Overall Study|Death|10|||
161231604|NCT00615069|582228830|FG000|Overall Study|Physician Decision|2|||
161231605|NCT00615069|582228830|FG000|Overall Study|Withdrawal by Subject|4|||
161231606|NCT01479439|582228832|FG000|Overall Study|Adverse Event|1|||
161231607|NCT01479439|582228833|FG001|Overall Study|Adverse Event|0|||
161231608|NCT01479439|582228834|FG002|Overall Study|Adverse Event|0|||
161231609|NCT01479439|582228832|FG000|Overall Study|Lost to Follow-up|0|||
161231610|NCT01479439|582228833|FG001|Overall Study|Lost to Follow-up|1|||
161328477|NCT03999749|582587164|FG000|Overall Study|Toxicity|16|||
161328478|NCT03999749|582587164|FG000|Overall Study|Withdrawal by Subject|3|||
160787168|NCT02070380|580607226|FG000|Second Injection|Protocol Violation|0|||
160787169|NCT02070380|580607227|FG001|Second Injection|Protocol Violation|1|||
161231611|NCT01479439|582228834|FG002|Overall Study|Lost to Follow-up|0|||
161231612|NCT01479439|582228832|FG000|Overall Study|Protocol Violation|0|||
160787170|NCT02070380|580607228|FG002|Second Injection|Protocol Violation|1|||
160787171|NCT02070380|580607229|FG003|Second Injection|Protocol Violation|5|||
160787172|NCT01682603|580607240|FG000|Overall Study|Lost to Follow-up|3|||
161231613|NCT01479439|582228833|FG001|Overall Study|Protocol Violation|0|||
161231614|NCT01479439|582228834|FG002|Overall Study|Protocol Violation|2|||
161231615|NCT05067647|582228837|FG000|Overall Study|Lost to Follow-up|1|||
161231616|NCT02781727|582228838|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
161231617|NCT02781727|582228839|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
161231618|NCT02781727|582228838|FG000|Treatment Period|Withdrawal by Subject|1|||
161231619|NCT02781727|582228839|FG001|Treatment Period|Withdrawal by Subject|0|||
161231620|NCT02781727|582228838|FG000|Treatment Period|Lost to Follow-up|0|||
161231621|NCT02781727|582228839|FG001|Treatment Period|Lost to Follow-up|1|||
161231622|NCT01569152|582228843|FG000|Phase IIa, Period 1|Early Escape|5|||
161231623|NCT01569152|582228844|FG001|Phase IIa, Period 1|Early Escape|22|||
161231624|NCT01569152|582228845|FG002|Phase IIa, Period 1|Early Escape|0|||
161231625|NCT01569152|582228843|FG000|Phase IIa, Period 1|Adverse Event|4|||
161231626|NCT01569152|582228844|FG001|Phase IIa, Period 1|Adverse Event|0|||
161231627|NCT01569152|582228845|FG002|Phase IIa, Period 1|Adverse Event|0|||
161231628|NCT01569152|582228843|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
161231629|NCT01569152|582228844|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
161231630|NCT01569152|582228845|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
161231631|NCT01569152|582228843|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
161231632|NCT01569152|582228844|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
161231633|NCT01569152|582228845|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
161231634|NCT01569152|582228843|FG000|Phase IIa, Period 1|Protocol Violation|0|||
161231635|NCT01569152|582228844|FG001|Phase IIa, Period 1|Protocol Violation|1|||
161231636|NCT01569152|582228845|FG002|Phase IIa, Period 1|Protocol Violation|0|||
161231637|NCT01569152|582228843|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
161231638|NCT01569152|582228844|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
161231639|NCT01569152|582228845|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
161231640|NCT01569152|582228843|FG000|Safety Extension, Period 3|Adverse Event|0|||
161231641|NCT01569152|582228844|FG001|Safety Extension, Period 3|Adverse Event|0|||
161231642|NCT01569152|582228845|FG002|Safety Extension, Period 3|Adverse Event|4|||
161231643|NCT01569152|582228843|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
161231644|NCT01569152|582228844|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
161231645|NCT01569152|582228845|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
161231646|NCT01569152|582228843|FG000|Safety Extension, Period 3|Physician Decision|0|||
161231647|NCT01569152|582228844|FG001|Safety Extension, Period 3|Physician Decision|0|||
161231648|NCT01569152|582228845|FG002|Safety Extension, Period 3|Physician Decision|2|||
161231649|NCT01569152|582228843|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
160787173|NCT01791205|580607241|FG000|Phase II|Lack of Efficacy|6|||
160787174|NCT01791205|580607242|FG001|Phase II|Lack of Efficacy|0|||
160787175|NCT01791205|580607241|FG000|Phase II|Adverse Event|2|||
160787176|NCT01791205|580607242|FG001|Phase II|Adverse Event|0|||
160787177|NCT01791205|580607241|FG000|Phase II|Safety|1|||
160787178|NCT01791205|580607242|FG001|Phase II|Safety|0|||
160787179|NCT01791205|580607241|FG000|Phase II|Lost to Follow-up|1|||
160787180|NCT01791205|580607242|FG001|Phase II|Lost to Follow-up|0|||
160787181|NCT01791205|580607241|FG000|Phase II|Remission of disease|1|||
160787182|NCT01791205|580607242|FG001|Phase II|Remission of disease|0|||
160787183|NCT01791205|580607241|FG000|Phase II|Physician's decision|1|||
160787184|NCT01791205|580607242|FG001|Phase II|Physician's decision|0|||
160787185|NCT05345405|580607255|FG000|Overall Study|Withdrawal by Subject|2|||
161231650|NCT01569152|582228844|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
161231651|NCT01569152|582228845|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
161231652|NCT00683293|582228850|FG000|Overall Study|Withdrawal by Subject|2|||
161231653|NCT00683293|582228851|FG001|Overall Study|Withdrawal by Subject|3|||
161328479|NCT03999749|582587164|FG000|Overall Study|Disease progression|26|||
161231654|NCT00743197|582228854|FG000|Overall Study|Study terminated due to departure of PI.|1|||
161328480|NCT03999749|582587164|FG000|Overall Study|Physician Decision|4|||
161328481|NCT03999749|582587164|FG000|Overall Study|Death|5|||
161328482|NCT03999749|582587164|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
160787186|NCT05345405|580607256|FG001|Overall Study|Withdrawal by Subject|0|||
160787187|NCT05345405|580607257|FG002|Overall Study|Withdrawal by Subject|0|||
160787188|NCT05345405|580607255|FG000|Overall Study|Did not meet eligibility criteria|0|||
160787189|NCT05345405|580607256|FG001|Overall Study|Did not meet eligibility criteria|2|||
161231655|NCT00743197|582228855|FG001|Overall Study|Study terminated due to departure of PI.|2|||
161231656|NCT02507375|582228856|FG000|Overall Study|Progressive Disease|4|||
160787190|NCT05345405|580607257|FG002|Overall Study|Did not meet eligibility criteria|0|||
161328483|NCT00255164|582587165|FG000|Overall Study|Adverse Event|10|||
160787191|NCT05345405|580607255|FG000|Overall Study|Lost to Follow-up|0|||
160787192|NCT05345405|580607256|FG001|Overall Study|Lost to Follow-up|0|||
160787193|NCT05345405|580607257|FG002|Overall Study|Lost to Follow-up|1|||
160787194|NCT04189588|580607258|FG000|Overall Study|Death|0|||
160787195|NCT04189588|580607259|FG001|Overall Study|Death|1|||
160787196|NCT04189588|580607258|FG000|Overall Study|Lost to Follow-up|0|||
160787197|NCT04189588|580607259|FG001|Overall Study|Lost to Follow-up|1|||
160787198|NCT03757715|580607262|FG000|Overall Study|Lost to Follow-up|4|||
160787199|NCT03757715|580607263|FG001|Overall Study|Lost to Follow-up|9|||
160787200|NCT03757715|580607262|FG000|Overall Study|Withdrawal by Subject|1|||
160787201|NCT03757715|580607263|FG001|Overall Study|Withdrawal by Subject|1|||
160787202|NCT05463705|580607264|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
160787203|NCT05463705|580607265|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
160787204|NCT05463705|580607266|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
160787205|NCT05463705|580607267|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
160787206|NCT05463705|580607268|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
160787207|NCT05463705|580607269|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
160787208|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
160787209|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
160787210|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
160787211|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
160787212|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
160787213|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
160787214|NCT02662582|580607274|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160787215|NCT02662582|580607275|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160787216|NCT04135352|580607276|FG000|Overall Study|Not treated-randomization error|0|||
160787217|NCT04135352|580607277|FG001|Overall Study|Not treated-randomization error|0|||
160787218|NCT04135352|580607278|FG002|Overall Study|Not treated-randomization error|1|||
161126294|NCT02949128|581850632|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
161126295|NCT02949128|581850632|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
161126296|NCT02949128|581850632|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
161126297|NCT00670007|581850639|FG000|Overall Study|Drug abuse|1|||
161126298|NCT00670007|581850639|FG000|Overall Study|Lung transplant|1|||
161126299|NCT00670007|581850639|FG000|Overall Study|Travel/Vacation|1|||
161126300|NCT00670007|581850639|FG000|Overall Study|Adverse event, serious fatal|1|||
161126301|NCT00670007|581850639|FG000|Overall Study|Adverse Event|1|||
161126302|NCT00670007|581850639|FG000|Overall Study|Withdrawal by Subject|4|||
161126303|NCT00618722|581850640|FG000|Overall Study|Refusal of Treatment|0|||
161126304|NCT00618722|581850641|FG001|Overall Study|Refusal of Treatment|0|||
161126305|NCT00618722|581850642|FG002|Overall Study|Refusal of Treatment|1|||
161126306|NCT00618722|581850643|FG003|Overall Study|Refusal of Treatment|0|||
161126307|NCT00618722|581850640|FG000|Overall Study|Patient Request|1|||
161126308|NCT00618722|581850641|FG001|Overall Study|Patient Request|1|||
161126309|NCT00618722|581850642|FG002|Overall Study|Patient Request|1|||
161126310|NCT00618722|581850643|FG003|Overall Study|Patient Request|1|||
161126311|NCT00618722|581850640|FG000|Overall Study|Inability to Complete Study Procedure|0|||
161126312|NCT00618722|581850641|FG001|Overall Study|Inability to Complete Study Procedure|1|||
161126313|NCT00618722|581850642|FG002|Overall Study|Inability to Complete Study Procedure|0|||
161126314|NCT00618722|581850643|FG003|Overall Study|Inability to Complete Study Procedure|0|||
161126315|NCT00618722|581850640|FG000|Overall Study|Lost to Follow-up|2|||
161126316|NCT00618722|581850641|FG001|Overall Study|Lost to Follow-up|0|||
161126317|NCT00618722|581850642|FG002|Overall Study|Lost to Follow-up|0|||
161126318|NCT00618722|581850643|FG003|Overall Study|Lost to Follow-up|2|||
161126319|NCT00618722|581850640|FG000|Overall Study|Miscellaneous Reasons|0|||
161126320|NCT00618722|581850641|FG001|Overall Study|Miscellaneous Reasons|0|||
161126321|NCT00618722|581850642|FG002|Overall Study|Miscellaneous Reasons|1|||
161126322|NCT00618722|581850643|FG003|Overall Study|Miscellaneous Reasons|1|||
161126323|NCT00925600|581850644|FG000|Overall Study|Withdrawal by Subject|16|||
161126324|NCT00925600|581850645|FG001|Overall Study|Withdrawal by Subject|14|||
161126325|NCT00925600|581850644|FG000|Overall Study|Death|4|||
161126326|NCT00925600|581850645|FG001|Overall Study|Death|3|||
161126327|NCT00925600|581850644|FG000|Overall Study|Lost to Follow-up|2|||
161126328|NCT00925600|581850645|FG001|Overall Study|Lost to Follow-up|2|||
161126329|NCT00925600|581850644|FG000|Overall Study|Disease Progression|1|||
161126330|NCT00925600|581850645|FG001|Overall Study|Disease Progression|3|||
161126331|NCT00925600|581850644|FG000|Overall Study|Administrative Decision|1|||
161126332|NCT00925600|581850645|FG001|Overall Study|Administrative Decision|1|||
161126333|NCT00925600|581850644|FG000|Overall Study|Noncompliance|2|||
161231657|NCT02507375|582228857|FG001|Overall Study|Progressive Disease|5|||
161231658|NCT02507375|582228856|FG000|Overall Study|Death|0|||
161231659|NCT02507375|582228857|FG001|Overall Study|Death|1|||
161231660|NCT02507375|582228856|FG000|Overall Study|Refused treatment|0|||
161126334|NCT00925600|581850645|FG001|Overall Study|Noncompliance|0|||
161126335|NCT00925600|581850644|FG000|Overall Study|Ineligibility Determined|2|||
161126336|NCT00925600|581850645|FG001|Overall Study|Ineligibility Determined|0|||
161126337|NCT00925600|581850644|FG000|Overall Study|Protocol Deviation|0|||
160787219|NCT04135352|580607279|FG003|Overall Study|Not treated-randomization error|0|||
160787220|NCT04135352|580607280|FG004|Overall Study|Not treated-randomization error|0|||
160787221|NCT04135352|580607281|FG005|Overall Study|Not treated-randomization error|0|||
160787222|NCT04135352|580607282|FG006|Overall Study|Not treated-randomization error|0|||
160787223|NCT04135352|580607283|FG007|Overall Study|Not treated-randomization error|0|||
160787224|NCT04135352|580607276|FG000|Overall Study|Withdrawal by Subject|0|||
160787225|NCT04135352|580607277|FG001|Overall Study|Withdrawal by Subject|0|||
160787226|NCT04135352|580607278|FG002|Overall Study|Withdrawal by Subject|2|||
161328484|NCT00255164|582587166|FG001|Overall Study|Adverse Event|6|||
161328485|NCT00255164|582587167|FG002|Overall Study|Adverse Event|9|||
161328486|NCT00255164|582587165|FG000|Overall Study|Lost to Follow-up|4|||
161328487|NCT00255164|582587166|FG001|Overall Study|Lost to Follow-up|3|||
161328488|NCT00255164|582587167|FG002|Overall Study|Lost to Follow-up|4|||
161328489|NCT00255164|582587165|FG000|Overall Study|Withdrawal by Subject|18|||
161328490|NCT00255164|582587166|FG001|Overall Study|Withdrawal by Subject|17|||
160787227|NCT04135352|580607279|FG003|Overall Study|Withdrawal by Subject|0|||
161328491|NCT00255164|582587167|FG002|Overall Study|Withdrawal by Subject|8|||
161328492|NCT00255164|582587165|FG000|Overall Study|Noncompliance|0|||
161328493|NCT00255164|582587166|FG001|Overall Study|Noncompliance|1|||
161328494|NCT00255164|582587167|FG002|Overall Study|Noncompliance|2|||
161328495|NCT00255164|582587165|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
161328496|NCT00255164|582587166|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
161328497|NCT00255164|582587167|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
161328498|NCT00255164|582587165|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
161328499|NCT00255164|582587166|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
161328500|NCT00255164|582587167|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
161328501|NCT00255164|582587165|FG000|Overall Study|Possible Barrett's Esophagus|1|||
161328502|NCT00255164|582587166|FG001|Overall Study|Possible Barrett's Esophagus|3|||
161328503|NCT00255164|582587167|FG002|Overall Study|Possible Barrett's Esophagus|8|||
161126338|NCT00925600|581850645|FG001|Overall Study|Protocol Deviation|1|||
161328504|NCT00255164|582587165|FG000|Overall Study|Esophageal Stricture|0|||
161328505|NCT00255164|582587166|FG001|Overall Study|Esophageal Stricture|0|||
161328506|NCT00255164|582587167|FG002|Overall Study|Esophageal Stricture|1|||
161328507|NCT00255164|582587165|FG000|Overall Study|Therapeutic Failure|11|||
160787228|NCT04135352|580607280|FG004|Overall Study|Withdrawal by Subject|0|||
160787229|NCT04135352|580607281|FG005|Overall Study|Withdrawal by Subject|0|||
161126339|NCT00925600|581850644|FG000|Overall Study|Requirement for Alternative Therapy|0|||
161126340|NCT00925600|581850645|FG001|Overall Study|Requirement for Alternative Therapy|1|||
161126341|NCT00925600|581850644|FG000|Overall Study|Other|3|||
161126342|NCT00925600|581850645|FG001|Overall Study|Other|1|||
161126343|NCT00925600|581850644|FG000|Overall Study|Adverse Event|1|||
161126344|NCT00925600|581850645|FG001|Overall Study|Adverse Event|2|||
161126345|NCT00127127|581850650|FG000|Overall Study|Adverse Event|0|||
161126346|NCT00127127|581850651|FG001|Overall Study|Adverse Event|2|||
161126347|NCT00127127|581850652|FG002|Overall Study|Adverse Event|0|||
161126348|NCT00127127|581850653|FG003|Overall Study|Adverse Event|1|||
161126349|NCT00127127|581850650|FG000|Overall Study|Lack of Efficacy|1|||
161126350|NCT00127127|581850651|FG001|Overall Study|Lack of Efficacy|3|||
161126351|NCT00127127|581850652|FG002|Overall Study|Lack of Efficacy|0|||
161126352|NCT00127127|581850653|FG003|Overall Study|Lack of Efficacy|2|||
161126353|NCT00200057|581850654|FG000|Overall Study|Lack of Efficacy|3|||
161126354|NCT00200057|581850654|FG000|Overall Study|Exited due to terminal illness of PI|2|||
161126355|NCT00200057|581850654|FG000|Overall Study|Withdrawal by Subject|1|||
161126356|NCT00200057|581850654|FG000|Overall Study|Change in medical condition|1|||
161126357|NCT00200057|581850654|FG000|Overall Study|Infection|1|||
161126358|NCT00200057|581850654|FG000|Overall Study|Death|1|||
161126359|NCT01059448|581850656|FG000|Overall Study|Adverse Event|1|||
161126360|NCT01059448|581850657|FG001|Overall Study|Adverse Event|3|||
161126361|NCT01059448|581850658|FG002|Overall Study|Adverse Event|0|||
161126362|NCT01059448|581850659|FG003|Overall Study|Adverse Event|1|||
161126363|NCT01059448|581850656|FG000|Overall Study|Withdrawal by Subject|2|||
161126364|NCT01059448|581850657|FG001|Overall Study|Withdrawal by Subject|0|||
161126365|NCT01059448|581850658|FG002|Overall Study|Withdrawal by Subject|2|||
161126366|NCT01059448|581850659|FG003|Overall Study|Withdrawal by Subject|4|||
161126367|NCT01059448|581850656|FG000|Overall Study|Disease Progression|2|||
161126368|NCT01059448|581850657|FG001|Overall Study|Disease Progression|1|||
161126369|NCT01059448|581850658|FG002|Overall Study|Disease Progression|4|||
161126370|NCT01059448|581850659|FG003|Overall Study|Disease Progression|2|||
161126371|NCT01059448|581850656|FG000|Overall Study|Administrative Decision|43|||
161126372|NCT01059448|581850657|FG001|Overall Study|Administrative Decision|49|||
161328508|NCT00255164|582587166|FG001|Overall Study|Therapeutic Failure|2|||
161328509|NCT00255164|582587167|FG002|Overall Study|Therapeutic Failure|3|||
161328510|NCT03677869|582587168|FG000|Overall Study|Withdrawal by Subject|1|||
161126373|NCT01059448|581850658|FG002|Overall Study|Administrative Decision|45|||
161126374|NCT01059448|581850659|FG003|Overall Study|Administrative Decision|46|||
161126375|NCT01059448|581850656|FG000|Overall Study|Lost to Follow-up|0|||
161231661|NCT02507375|582228857|FG001|Overall Study|Refused treatment|1|||
161231662|NCT02507375|582228856|FG000|Overall Study|Adverse Event|0|||
161231663|NCT02507375|582228857|FG001|Overall Study|Adverse Event|1|||
161231664|NCT02158936|582228858|FG000|Overall Study|Study closed/ terminated|57|||
161231665|NCT02158936|582228859|FG001|Overall Study|Study closed/ terminated|77|||
161231666|NCT02158936|582228858|FG000|Overall Study|Azacitidine tx discontinued|53|||
161231667|NCT02158936|582228859|FG001|Overall Study|Azacitidine tx discontinued|46|||
161231668|NCT02158936|582228858|FG000|Overall Study|Adverse Event|39|||
161231669|NCT02158936|582228859|FG001|Overall Study|Adverse Event|24|||
161231670|NCT02158936|582228858|FG000|Overall Study|Withdrawal by Subject|15|||
161231671|NCT02158936|582228859|FG001|Overall Study|Withdrawal by Subject|16|||
161231672|NCT02158936|582228858|FG000|Overall Study|Physician Decision|15|||
161231673|NCT02158936|582228859|FG001|Overall Study|Physician Decision|13|||
161231674|NCT02158936|582228858|FG000|Overall Study|Lost to Follow-up|0|||
161231675|NCT02158936|582228859|FG001|Overall Study|Lost to Follow-up|1|||
161231676|NCT00522457|582228860|FG000|Overall Study|Due to disease progression|16|||
161231677|NCT00522457|582228860|FG000|Overall Study|Adverse Event|2|||
161231678|NCT00727571|582230439|FG000|Overall Study|Ineligibility determined|1|||
161231679|NCT00727571|582230440|FG001|Overall Study|Ineligibility determined|1|||
161231680|NCT00727571|582230441|FG002|Overall Study|Ineligibility determined|1|||
161231681|NCT00727571|582230442|FG003|Overall Study|Ineligibility determined|0|||
161231682|NCT00727571|582230439|FG000|Overall Study|Death|0|||
161231683|NCT00727571|582230440|FG001|Overall Study|Death|19|||
161231684|NCT00727571|582230441|FG002|Overall Study|Death|5|||
161231685|NCT00727571|582230442|FG003|Overall Study|Death|1|||
161231686|NCT00727571|582230439|FG000|Overall Study|Physician Decision|0|||
161231687|NCT00727571|582230440|FG001|Overall Study|Physician Decision|5|||
161231688|NCT00727571|582230441|FG002|Overall Study|Physician Decision|0|||
161231689|NCT00727571|582230442|FG003|Overall Study|Physician Decision|0|||
161231690|NCT00727571|582230439|FG000|Overall Study|Withdrawal by Subject|0|||
161231691|NCT00727571|582230440|FG001|Overall Study|Withdrawal by Subject|10|||
161231692|NCT00727571|582230441|FG002|Overall Study|Withdrawal by Subject|11|||
161231693|NCT00727571|582230442|FG003|Overall Study|Withdrawal by Subject|0|||
161231694|NCT00727571|582230439|FG000|Overall Study|Subject Non Compliance|0|||
161231695|NCT00727571|582230440|FG001|Overall Study|Subject Non Compliance|6|||
161231696|NCT00727571|582230441|FG002|Overall Study|Subject Non Compliance|0|||
161231697|NCT00727571|582230442|FG003|Overall Study|Subject Non Compliance|4|||
161231698|NCT00727571|582230439|FG000|Overall Study|Dismissed from nursing home|0|||
161231699|NCT00727571|582230440|FG001|Overall Study|Dismissed from nursing home|9|||
161231700|NCT00727571|582230441|FG002|Overall Study|Dismissed from nursing home|5|||
161231701|NCT00727571|582230442|FG003|Overall Study|Dismissed from nursing home|0|||
161231702|NCT00727571|582230439|FG000|Overall Study|Hospitalization|0|||
161231703|NCT00727571|582230440|FG001|Overall Study|Hospitalization|1|||
161231704|NCT00727571|582230441|FG002|Overall Study|Hospitalization|0|||
161231705|NCT00727571|582230442|FG003|Overall Study|Hospitalization|1|||
161231706|NCT00727571|582230439|FG000|Overall Study|AE not leading to hospitalization|0|||
161231707|NCT00727571|582230440|FG001|Overall Study|AE not leading to hospitalization|0|||
161231708|NCT00727571|582230441|FG002|Overall Study|AE not leading to hospitalization|2|||
161231709|NCT00727571|582230442|FG003|Overall Study|AE not leading to hospitalization|0|||
161231710|NCT00727571|582230439|FG000|Overall Study|Other|0|||
161231711|NCT00727571|582230440|FG001|Overall Study|Other|4|||
161231712|NCT00727571|582230441|FG002|Overall Study|Other|6|||
161231713|NCT00727571|582230442|FG003|Overall Study|Other|0|||
161231714|NCT02724462|582230443|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
161231715|NCT02724462|582230444|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
161231716|NCT02724462|582230443|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161231717|NCT02724462|582230444|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161231718|NCT02724462|582230443|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
161231719|NCT02724462|582230444|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
161231720|NCT02724462|582230443|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161231721|NCT02724462|582230444|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161231722|NCT02724462|582230443|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
161231723|NCT02724462|582230444|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
161231724|NCT02724462|582230443|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
161231725|NCT02724462|582230444|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
161231726|NCT00469417|582230445|FG000|Overall Study|Treatment failure all lesions|18|||
161231727|NCT00469417|582230446|FG001|Overall Study|Treatment failure all lesions|11|||
161231728|NCT00469417|582230445|FG000|Overall Study|Consent withdrawn|1|||
161231729|NCT00469417|582230446|FG001|Overall Study|Consent withdrawn|1|||
161231730|NCT00469417|582230445|FG000|Overall Study|Adverse Event|8|||
161231731|NCT00469417|582230446|FG001|Overall Study|Adverse Event|2|||
161231732|NCT00469417|582230445|FG000|Overall Study|Lost to Follow-up|1|||
161231733|NCT00469417|582230446|FG001|Overall Study|Lost to Follow-up|2|||
161231734|NCT00469417|582230445|FG000|Overall Study|Intercurrent disease|0|||
161231735|NCT00469417|582230446|FG001|Overall Study|Intercurrent disease|1|||
161231736|NCT00469417|582230445|FG000|Overall Study|Randomized but not treated|2|||
161231737|NCT00469417|582230446|FG001|Overall Study|Randomized but not treated|0|||
161231738|NCT05327491|582230449|FG000|Periods 1 & 2|Miscellaneous|0|||
161231739|NCT05327491|582230450|FG001|Periods 1 & 2|Miscellaneous|1|||
161231740|NCT05327491|582230451|FG002|Periods 1 & 2|Miscellaneous|0|||
161231741|NCT05327491|582230452|FG003|Periods 1 & 2|Miscellaneous|0|||
161231742|NCT05327491|582230449|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
161231743|NCT05327491|582230450|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
161231744|NCT05327491|582230451|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
161231745|NCT05327491|582230452|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
161231746|NCT02188303|582230453|FG000|Overall Study|Adverse Event|0|||
161231747|NCT02188303|582230454|FG001|Overall Study|Adverse Event|0|||
161231748|NCT02188303|582230455|FG002|Overall Study|Adverse Event|0|||
161231749|NCT02188303|582230456|FG003|Overall Study|Adverse Event|0|||
161231750|NCT02188303|582230457|FG004|Overall Study|Adverse Event|0|||
161231751|NCT02188303|582230458|FG005|Overall Study|Adverse Event|2|||
161231752|NCT02188303|582230459|FG006|Overall Study|Adverse Event|0|||
161231753|NCT02188303|582230460|FG007|Overall Study|Adverse Event|2|||
161231754|NCT02188303|582230453|FG000|Overall Study|Dose Termination Criteria Met|0|||
161231755|NCT02188303|582230454|FG001|Overall Study|Dose Termination Criteria Met|0|||
161231756|NCT02188303|582230455|FG002|Overall Study|Dose Termination Criteria Met|0|||
161231757|NCT02188303|582230456|FG003|Overall Study|Dose Termination Criteria Met|0|||
161231758|NCT02188303|582230457|FG004|Overall Study|Dose Termination Criteria Met|0|||
161231759|NCT02188303|582230458|FG005|Overall Study|Dose Termination Criteria Met|0|||
161231760|NCT02188303|582230459|FG006|Overall Study|Dose Termination Criteria Met|2|||
161231761|NCT02188303|582230460|FG007|Overall Study|Dose Termination Criteria Met|4|||
161231762|NCT05612724|582230463|FG000|Overall Study|Lost to Follow-up|4|||
161231763|NCT04000815|582230470|FG000|Overall Study|Lost to Follow-up|9|||
161231764|NCT04000815|582230471|FG001|Overall Study|Lost to Follow-up|2|||
161231765|NCT04000815|582230472|FG002|Overall Study|Lost to Follow-up|3|||
161231766|NCT04000815|582230470|FG000|Overall Study|Withdrawal by Subject|4|||
161231767|NCT04000815|582230471|FG001|Overall Study|Withdrawal by Subject|3|||
161231768|NCT04000815|582230472|FG002|Overall Study|Withdrawal by Subject|2|||
161231769|NCT04000815|582230470|FG000|Overall Study|Right ovarian cyst occured|1|||
161231770|NCT04000815|582230471|FG001|Overall Study|Right ovarian cyst occured|0|||
161231771|NCT04000815|582230472|FG002|Overall Study|Right ovarian cyst occured|0|||
161231772|NCT04000815|582230470|FG000|Overall Study|Hypertension occured on follow up|0|||
161231773|NCT04000815|582230471|FG001|Overall Study|Hypertension occured on follow up|0|||
161231774|NCT04000815|582230472|FG002|Overall Study|Hypertension occured on follow up|2|||
161231775|NCT00239577|582230473|FG000|Primary Phase|Adverse Event|0|||
161231776|NCT00239577|582230474|FG001|Primary Phase|Adverse Event|0|||
161231777|NCT00239577|582230475|FG002|Primary Phase|Adverse Event|1|||
161231778|NCT00239577|582230476|FG003|Primary Phase|Adverse Event|0|||
161231779|NCT00239577|582230473|FG000|Primary Phase|Other|5|||
161231780|NCT00239577|582230474|FG001|Primary Phase|Other|3|||
161231781|NCT00239577|582230475|FG002|Primary Phase|Other|2|||
161231782|NCT00239577|582230476|FG003|Primary Phase|Other|0|||
161231783|NCT00096447|582230479|FG000|Overall Study|Never treated|1|||
161231784|NCT01034358|582230480|FG000|Overall Study|Withdrawal by Subject|1|||
161231785|NCT01034358|582230480|FG000|Overall Study|Protocol Violation|1|||
161231786|NCT01838941|582230481|FG000|Overall Study|Adverse Event|1|||
161231787|NCT01838941|582230481|FG000|Overall Study|Withdrawal by Subject|1|||
161231788|NCT00377260|582230489|FG000|Overall Study|Lost to Follow-up|0|||
161231789|NCT00377260|582230490|FG001|Overall Study|Lost to Follow-up|1|||
161231790|NCT00377260|582230489|FG000|Overall Study|Withdrawal by Subject|2|||
161231791|NCT00377260|582230490|FG001|Overall Study|Withdrawal by Subject|4|||
161231792|NCT00829530|582230491|FG000|First Intervention|Adverse Event|0|||
161231793|NCT00829530|582230492|FG001|First Intervention|Adverse Event|1|||
161231794|NCT00829530|582230491|FG000|First Intervention|Intolerance to Venopuncture|0|||
161231795|NCT00829530|582230492|FG001|First Intervention|Intolerance to Venopuncture|1|||
161231796|NCT00829530|582230491|FG000|Second Intervention|Intolerance to Venopuncture|1|||
161328511|NCT05219968|582587169|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
161231797|NCT00829530|582230492|FG001|Second Intervention|Intolerance to Venopuncture|0|||
161231798|NCT02017964|582230493|FG000|Overall Study|Patient deemed ineligible|1|||
161231799|NCT02300103|582230494|FG000|Overall Study|Lack of Efficacy|3|||
161328512|NCT05219968|582587170|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161231800|NCT02300103|582230494|FG000|Overall Study|Protocol Violation|1|||
161231801|NCT02300103|582230494|FG000|Overall Study|Withdrew Consent|2|||
161231802|NCT04091971|582230495|FG000|Overall Study|Withdrawal by Subject|1|||
161231803|NCT04091971|582230495|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
161231804|NCT04091971|582230495|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
161231805|NCT01391793|582230496|FG000|Overall Study|Ineligible|3|||
161231806|NCT01391793|582230497|FG001|Overall Study|Ineligible|0|||
161231807|NCT01391793|582230496|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
161231808|NCT01391793|582230497|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
161231809|NCT01391793|582230496|FG000|Overall Study|No DMSA|73|||
161231810|NCT01391793|582230497|FG001|Overall Study|No DMSA|57|||
161231811|NCT01015625|582230498|FG000|Overall Study|Lost to Follow-up|3|||
161231812|NCT01015625|582230499|FG001|Overall Study|Lost to Follow-up|1|||
161231813|NCT01015625|582230498|FG000|Overall Study|Withdrawal by Subject|2|||
161231814|NCT01015625|582230499|FG001|Overall Study|Withdrawal by Subject|3|||
161231815|NCT01015625|582230498|FG000|Overall Study|Physician Decision|2|||
161231816|NCT01015625|582230499|FG001|Overall Study|Physician Decision|0|||
161231817|NCT01015625|582230498|FG000|Overall Study|Death|30|||
161231818|NCT01015625|582230499|FG001|Overall Study|Death|22|||
161231819|NCT00150462|582230502|FG000|Overall Study|Disease Progression or Relapse|3|||
161231820|NCT00150462|582230503|FG001|Overall Study|Disease Progression or Relapse|1|||
161231821|NCT00150462|582230504|FG002|Overall Study|Disease Progression or Relapse|2|||
161231822|NCT00150462|582230505|FG003|Overall Study|Disease Progression or Relapse|1|||
161231823|NCT00150462|582230506|FG004|Overall Study|Disease Progression or Relapse|2|||
161231824|NCT00150462|582230507|FG005|Overall Study|Disease Progression or Relapse|2|||
161231825|NCT00150462|582230508|FG006|Overall Study|Disease Progression or Relapse|3|||
161231826|NCT00150462|582230509|FG007|Overall Study|Disease Progression or Relapse|5|||
161231827|NCT00150462|582230510|FG008|Overall Study|Disease Progression or Relapse|5|||
161231828|NCT00150462|582230511|FG009|Overall Study|Disease Progression or Relapse|3|||
161231829|NCT00150462|582230512|FG010|Overall Study|Disease Progression or Relapse|2|||
161231830|NCT00150462|582230502|FG000|Overall Study|Withdrawal by Subject|0|||
161231831|NCT00150462|582230503|FG001|Overall Study|Withdrawal by Subject|1|||
161231832|NCT00150462|582230504|FG002|Overall Study|Withdrawal by Subject|1|||
161231833|NCT00150462|582230505|FG003|Overall Study|Withdrawal by Subject|0|||
161231834|NCT00150462|582230506|FG004|Overall Study|Withdrawal by Subject|1|||
161231835|NCT00150462|582230507|FG005|Overall Study|Withdrawal by Subject|2|||
161231836|NCT00150462|582230508|FG006|Overall Study|Withdrawal by Subject|0|||
161231837|NCT00150462|582230509|FG007|Overall Study|Withdrawal by Subject|1|||
161231838|NCT00150462|582230510|FG008|Overall Study|Withdrawal by Subject|0|||
161231839|NCT00150462|582230511|FG009|Overall Study|Withdrawal by Subject|1|||
161231840|NCT00150462|582230512|FG010|Overall Study|Withdrawal by Subject|0|||
161231841|NCT00150462|582230502|FG000|Overall Study|Death|0|||
161231842|NCT00150462|582230503|FG001|Overall Study|Death|1|||
160787230|NCT04135352|580607282|FG006|Overall Study|Withdrawal by Subject|0|||
160787231|NCT04135352|580607283|FG007|Overall Study|Withdrawal by Subject|0|||
160787232|NCT04135352|580607276|FG000|Overall Study|Sponsor Decision|0|||
160787233|NCT04135352|580607277|FG001|Overall Study|Sponsor Decision|0|||
160787234|NCT04135352|580607278|FG002|Overall Study|Sponsor Decision|2|||
160787235|NCT04135352|580607279|FG003|Overall Study|Sponsor Decision|5|||
160787236|NCT04135352|580607280|FG004|Overall Study|Sponsor Decision|1|||
161126376|NCT01059448|581850657|FG001|Overall Study|Lost to Follow-up|0|||
161126377|NCT01059448|581850658|FG002|Overall Study|Lost to Follow-up|2|||
161126378|NCT01059448|581850659|FG003|Overall Study|Lost to Follow-up|0|||
161126379|NCT01059448|581850656|FG000|Overall Study|Death|0|||
161126380|NCT01059448|581850657|FG001|Overall Study|Death|1|||
161126381|NCT01059448|581850658|FG002|Overall Study|Death|0|||
161126382|NCT01059448|581850659|FG003|Overall Study|Death|0|||
161126383|NCT01059448|581850656|FG000|Overall Study|Other|1|||
161126384|NCT01059448|581850657|FG001|Overall Study|Other|1|||
161126385|NCT01059448|581850658|FG002|Overall Study|Other|0|||
161126386|NCT01059448|581850659|FG003|Overall Study|Other|1|||
161126387|NCT00778830|581850660|FG000|Overall Study|Ongoing at data cut-off|0|||
161126388|NCT00778830|581850661|FG001|Overall Study|Ongoing at data cut-off|1|||
161126389|NCT05512949|581850662|FG000|Overall Study|Lost to Follow-up|4|||
161126390|NCT05512949|581850663|FG001|Overall Study|Lost to Follow-up|6|||
161126391|NCT05512949|581850664|FG002|Overall Study|Lost to Follow-up|2|||
161126392|NCT05512949|581850662|FG000|Overall Study|Protocol Violation|0|||
161126393|NCT05512949|581850663|FG001|Overall Study|Protocol Violation|0|||
161126394|NCT05512949|581850664|FG002|Overall Study|Protocol Violation|1|||
161126395|NCT05512949|581850662|FG000|Overall Study|Withdrawal by Subject|1|||
161126396|NCT05512949|581850663|FG001|Overall Study|Withdrawal by Subject|1|||
161126397|NCT05512949|581850664|FG002|Overall Study|Withdrawal by Subject|2|||
161126398|NCT05512949|581850662|FG000|Overall Study|Completion status unknown|1|||
161126399|NCT05512949|581850663|FG001|Overall Study|Completion status unknown|3|||
161126400|NCT05512949|581850664|FG002|Overall Study|Completion status unknown|0|||
161126401|NCT01891643|581850665|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161126402|NCT01891643|581850666|FG001|Overall Study|Adverse event unrelated to study drug|5|||
161126403|NCT01891643|581850665|FG000|Overall Study|Disease Progression|4|||
161126404|NCT01891643|581850666|FG001|Overall Study|Disease Progression|3|||
161231843|NCT00150462|582230504|FG002|Overall Study|Death|0|||
161231844|NCT00150462|582230505|FG003|Overall Study|Death|0|||
161231845|NCT00150462|582230506|FG004|Overall Study|Death|0|||
161231846|NCT00150462|582230507|FG005|Overall Study|Death|0|||
161126405|NCT01891643|581850665|FG000|Overall Study|Study Drug Toxicity|3|||
161126406|NCT01891643|581850666|FG001|Overall Study|Study Drug Toxicity|0|||
160787237|NCT04135352|580607281|FG005|Overall Study|Sponsor Decision|4|||
161126407|NCT01891643|581850665|FG000|Overall Study|Maximum Clinical Benefit|0|||
161231847|NCT00150462|582230508|FG006|Overall Study|Death|0|||
161231848|NCT00150462|582230509|FG007|Overall Study|Death|0|||
161231849|NCT00150462|582230510|FG008|Overall Study|Death|1|||
161231850|NCT00150462|582230511|FG009|Overall Study|Death|0|||
161231851|NCT00150462|582230512|FG010|Overall Study|Death|0|||
161231852|NCT00150462|582230502|FG000|Overall Study|Adverse Event|0|||
161231853|NCT00150462|582230503|FG001|Overall Study|Adverse Event|0|||
161231854|NCT00150462|582230504|FG002|Overall Study|Adverse Event|0|||
161231855|NCT00150462|582230505|FG003|Overall Study|Adverse Event|1|||
161328513|NCT05219968|582587171|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161328514|NCT05219968|582587172|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161126408|NCT01891643|581850666|FG001|Overall Study|Maximum Clinical Benefit|1|||
161231856|NCT00150462|582230506|FG004|Overall Study|Adverse Event|0|||
161231857|NCT00150462|582230507|FG005|Overall Study|Adverse Event|0|||
161231858|NCT00150462|582230508|FG006|Overall Study|Adverse Event|0|||
161231859|NCT00150462|582230509|FG007|Overall Study|Adverse Event|2|||
161231860|NCT00150462|582230510|FG008|Overall Study|Adverse Event|0|||
161231861|NCT00150462|582230511|FG009|Overall Study|Adverse Event|1|||
161231862|NCT00150462|582230512|FG010|Overall Study|Adverse Event|0|||
161231863|NCT00150462|582230502|FG000|Overall Study|Physician Decision|0|||
161231864|NCT00150462|582230503|FG001|Overall Study|Physician Decision|0|||
161231865|NCT00150462|582230504|FG002|Overall Study|Physician Decision|1|||
161231866|NCT00150462|582230505|FG003|Overall Study|Physician Decision|1|||
161231867|NCT00150462|582230506|FG004|Overall Study|Physician Decision|0|||
161231868|NCT00150462|582230507|FG005|Overall Study|Physician Decision|0|||
161231869|NCT00150462|582230508|FG006|Overall Study|Physician Decision|0|||
161231870|NCT00150462|582230509|FG007|Overall Study|Physician Decision|0|||
161231871|NCT00150462|582230510|FG008|Overall Study|Physician Decision|0|||
161231872|NCT00150462|582230511|FG009|Overall Study|Physician Decision|0|||
161231873|NCT00150462|582230512|FG010|Overall Study|Physician Decision|0|||
161231874|NCT00150462|582230502|FG000|Overall Study|Other|0|||
161231875|NCT00150462|582230503|FG001|Overall Study|Other|0|||
161231876|NCT00150462|582230504|FG002|Overall Study|Other|0|||
161231877|NCT00150462|582230505|FG003|Overall Study|Other|0|||
161231878|NCT00150462|582230506|FG004|Overall Study|Other|0|||
161231879|NCT00150462|582230507|FG005|Overall Study|Other|0|||
161328515|NCT05219968|582587173|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
161328516|NCT05219968|582587169|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
161328517|NCT05219968|582587170|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
161328518|NCT05219968|582587171|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
161328519|NCT05219968|582587172|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
161328520|NCT05219968|582587173|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
161328521|NCT05219968|582587169|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
161328522|NCT05219968|582587170|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
161328523|NCT05219968|582587171|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
161328524|NCT05219968|582587172|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
161328525|NCT05219968|582587173|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
161328526|NCT05219968|582587169|FG000|Week 24 Treatment Period|Adverse Event|3|||
161328527|NCT05219968|582587170|FG001|Week 24 Treatment Period|Adverse Event|0|||
161126409|NCT01891643|581850665|FG000|Overall Study|Poor/Non-compliance|0|||
161126410|NCT01891643|581850666|FG001|Overall Study|Poor/Non-compliance|1|||
161126411|NCT01891643|581850665|FG000|Overall Study|Participant request to discontinue|1|||
161126412|NCT01891643|581850666|FG001|Overall Study|Participant request to discontinue|0|||
161126413|NCT04047797|581850669|FG000|Overall Study|Progressive Disease|1|||
161126414|NCT01430442|581850670|FG000|Overall Study|Subject Withdrew Consent|3|||
161126415|NCT01430442|581850671|FG001|Overall Study|Subject Withdrew Consent|0|||
161126416|NCT01430442|581850672|FG002|Overall Study|Subject Withdrew Consent|1|||
161126417|NCT01430442|581850673|FG003|Overall Study|Subject Withdrew Consent|0|||
161126418|NCT01430442|581850674|FG004|Overall Study|Subject Withdrew Consent|2|||
161126419|NCT01430442|581850675|FG005|Overall Study|Subject Withdrew Consent|1|||
161126420|NCT01430442|581850676|FG006|Overall Study|Subject Withdrew Consent|5|||
161126421|NCT01430442|581850677|FG007|Overall Study|Subject Withdrew Consent|2|||
161126422|NCT01430442|581850670|FG000|Overall Study|Lost to Follow-up|2|||
161126423|NCT01430442|581850671|FG001|Overall Study|Lost to Follow-up|0|||
161126424|NCT01430442|581850672|FG002|Overall Study|Lost to Follow-up|1|||
161231880|NCT00150462|582230508|FG006|Overall Study|Other|0|||
161231881|NCT00150462|582230509|FG007|Overall Study|Other|0|||
161126425|NCT01430442|581850673|FG003|Overall Study|Lost to Follow-up|2|||
161231882|NCT00150462|582230510|FG008|Overall Study|Other|0|||
161231883|NCT00150462|582230511|FG009|Overall Study|Other|1|||
161231884|NCT00150462|582230512|FG010|Overall Study|Other|1|||
161231885|NCT00569374|582230513|FG000|Overall Study|Withdrawal by Subject|4|||
161231886|NCT03107091|582230514|FG000|Overall Study|Physician Decision|1|||
161231887|NCT00105196|582230517|FG000|Overall Study|Lack of Efficacy|2|||
161231888|NCT00105196|582230518|FG001|Overall Study|Lack of Efficacy|3|||
161231889|NCT00105196|582230517|FG000|Overall Study|Adverse Event|11|||
161328528|NCT05219968|582587171|FG002|Week 24 Treatment Period|Adverse Event|0|||
161231890|NCT00105196|582230518|FG001|Overall Study|Adverse Event|3|||
161231891|NCT00105196|582230517|FG000|Overall Study|Withdrawal by Subject|6|||
161231892|NCT00105196|582230518|FG001|Overall Study|Withdrawal by Subject|6|||
161231893|NCT00105196|582230517|FG000|Overall Study|Lost to Follow-up|3|||
161231894|NCT00105196|582230518|FG001|Overall Study|Lost to Follow-up|2|||
161231895|NCT00105196|582230517|FG000|Overall Study|Poor/noncompliance|3|||
161231896|NCT00105196|582230518|FG001|Overall Study|Poor/noncompliance|4|||
161231897|NCT00105196|582230517|FG000|Overall Study|Protocol Violation|5|||
161231898|NCT00105196|582230518|FG001|Overall Study|Protocol Violation|2|||
161231899|NCT00105196|582230517|FG000|Overall Study|pending surgery|0|||
161231900|NCT00105196|582230518|FG001|Overall Study|pending surgery|1|||
161231901|NCT00105196|582230517|FG000|Overall Study|marijuana use|0|||
161231902|NCT00105196|582230518|FG001|Overall Study|marijuana use|1|||
161231903|NCT00105196|582230517|FG000|Overall Study|Subject became unblinded|0|||
161231904|NCT00105196|582230518|FG001|Overall Study|Subject became unblinded|1|||
161231905|NCT03340727|582230519|FG000|Overall Study|Death|1|||
161231906|NCT03340727|582230520|FG001|Overall Study|Death|0|||
161231907|NCT03340727|582230519|FG000|Overall Study|Lost to Follow-up|31|||
161231908|NCT03340727|582230520|FG001|Overall Study|Lost to Follow-up|35|||
161231909|NCT03340727|582230519|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
161231910|NCT03340727|582230520|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
161231911|NCT03340727|582230519|FG000|Overall Study|Transferred to another facility|10|||
161231912|NCT03340727|582230520|FG001|Overall Study|Transferred to another facility|7|||
161231913|NCT03340727|582230519|FG000|Overall Study|Withdrawal by Subject|28|||
161231914|NCT03340727|582230520|FG001|Overall Study|Withdrawal by Subject|17|||
161231915|NCT00533273|582230523|FG000|Double-blind|Withdrew consent|0|||
161231916|NCT00533273|582230524|FG001|Double-blind|Withdrew consent|2|||
161231917|NCT00533273|582230523|FG000|Open-label|Withdrawal by Subject|6|||
161231918|NCT00533273|582230524|FG001|Open-label|Withdrawal by Subject|0|||
161231919|NCT01873586|582230526|FG000|Overall Study|Lost to Follow-up|3|||
161231920|NCT00669942|582230527|FG000|Parts 2 and 3|Adverse Event|0|||
161231921|NCT00669942|582230528|FG001|Parts 2 and 3|Adverse Event|0|||
161231922|NCT00669942|582230529|FG002|Parts 2 and 3|Adverse Event|0|||
161231923|NCT00669942|582230530|FG003|Parts 2 and 3|Adverse Event|0|||
161231924|NCT00669942|582230531|FG004|Parts 2 and 3|Adverse Event|0|||
161231925|NCT00669942|582230532|FG005|Parts 2 and 3|Adverse Event|0|||
161231926|NCT00669942|582230533|FG006|Parts 2 and 3|Adverse Event|0|||
161231927|NCT00669942|582230534|FG007|Parts 2 and 3|Adverse Event|2|||
161231928|NCT00669942|582230535|FG008|Parts 2 and 3|Adverse Event|1|||
161231929|NCT00669942|582230536|FG009|Parts 2 and 3|Adverse Event|0|||
161231930|NCT00669942|582230537|FG010|Parts 2 and 3|Adverse Event|0|||
161231931|NCT00669942|582230538|FG011|Parts 2 and 3|Adverse Event|0|||
161231932|NCT00669942|582230527|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
161231933|NCT00669942|582230528|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
161231934|NCT00669942|582230529|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
161231935|NCT00669942|582230530|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
161231936|NCT00669942|582230531|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
161231937|NCT00669942|582230532|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
161231938|NCT00669942|582230533|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
161231939|NCT00669942|582230534|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
161231940|NCT00669942|582230535|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
161231941|NCT00669942|582230536|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
161231942|NCT00669942|582230537|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
161231943|NCT00669942|582230538|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
161231944|NCT00669942|582230527|FG000|Parts 2 and 3|Protocol Violation|0|||
161231945|NCT00669942|582230528|FG001|Parts 2 and 3|Protocol Violation|0|||
161231946|NCT00669942|582230529|FG002|Parts 2 and 3|Protocol Violation|0|||
161231947|NCT00669942|582230530|FG003|Parts 2 and 3|Protocol Violation|0|||
161231948|NCT00669942|582230531|FG004|Parts 2 and 3|Protocol Violation|0|||
161231949|NCT00669942|582230532|FG005|Parts 2 and 3|Protocol Violation|1|||
161231950|NCT00669942|582230533|FG006|Parts 2 and 3|Protocol Violation|0|||
161231951|NCT00669942|582230534|FG007|Parts 2 and 3|Protocol Violation|0|||
161231952|NCT00669942|582230535|FG008|Parts 2 and 3|Protocol Violation|0|||
161231953|NCT00669942|582230536|FG009|Parts 2 and 3|Protocol Violation|0|||
161231954|NCT00669942|582230537|FG010|Parts 2 and 3|Protocol Violation|0|||
161231955|NCT00669942|582230538|FG011|Parts 2 and 3|Protocol Violation|0|||
161231956|NCT03752528|582230539|FG000|Part A|Lost to Follow-up|1|||
161231957|NCT03752528|582230539|FG000|Part A|Protocol Violation|1|||
161231958|NCT03752528|582230539|FG000|Part B|Protocol Violation|1|||
161231959|NCT03752528|582230539|FG000|Part B|Study terminated by sponsor|3|||
161231960|NCT01981720|582230540|FG000|Overall Study|Adverse Event|1|||
161231961|NCT01981720|582230540|FG000|Overall Study|Withdrawal by Subject|3|||
161231962|NCT01981720|582230540|FG000|Overall Study|Pregnancy|1|||
161231963|NCT00282048|582230541|FG000|Overall Study|Lack of Efficacy|30|||
161231964|NCT00282048|582230541|FG000|Overall Study|Adverse Event|22|||
161231965|NCT00282048|582230541|FG000|Overall Study|Withdrawal by Subject|1|||
161231966|NCT00282048|582230541|FG000|Overall Study|Other|8|||
161231967|NCT00282048|582230541|FG000|Overall Study|Ongoing|1|||
161231968|NCT00259012|582230544|FG000|Overall Study|Adverse Event|0|||
161231969|NCT00259012|582230545|FG001|Overall Study|Adverse Event|1|||
161231970|NCT00259012|582230544|FG000|Overall Study|Withdrawal by Subject|1|||
161231971|NCT00259012|582230545|FG001|Overall Study|Withdrawal by Subject|0|||
161231972|NCT00259012|582230544|FG000|Overall Study|Physician Decision|0|||
161231973|NCT00259012|582230545|FG001|Overall Study|Physician Decision|1|||
161231974|NCT00259012|582230544|FG000|Overall Study|Lost to Follow-up|0|||
161231975|NCT00259012|582230545|FG001|Overall Study|Lost to Follow-up|1|||
161231976|NCT00259012|582230544|FG000|Overall Study|Protocol Violation|1|||
161231977|NCT00259012|582230545|FG001|Overall Study|Protocol Violation|1|||
161231978|NCT03522675|582230546|FG000|Overall Study|Screen fail|1|||
161231979|NCT03522675|582230546|FG000|Overall Study|Non-reactive to histamine|1|||
161231980|NCT00707161|582230547|FG000|Overall Study|Physician Decision|6|||
161231981|NCT02674477|582230548|FG000|Overall Study|Protocol Violation|8|||
161231982|NCT02674477|582230549|FG001|Overall Study|Protocol Violation|2|||
161231983|NCT02336165|582230554|FG000|Overall Study|Death|3|||
161231984|NCT02336165|582230555|FG001|Overall Study|Death|0|||
161231985|NCT02336165|582230556|FG002|Overall Study|Death|0|||
161231986|NCT02336165|582230557|FG003|Overall Study|Death|0|||
161231987|NCT02336165|582230558|FG004|Overall Study|Death|1|||
161231988|NCT02336165|582230554|FG000|Overall Study|Physician Decision|2|||
161231989|NCT02336165|582230555|FG001|Overall Study|Physician Decision|2|||
161231990|NCT02336165|582230556|FG002|Overall Study|Physician Decision|1|||
161231991|NCT02336165|582230557|FG003|Overall Study|Physician Decision|1|||
161231992|NCT02336165|582230558|FG004|Overall Study|Physician Decision|0|||
161231993|NCT02336165|582230554|FG000|Overall Study|Withdrawal by Subject|0|||
161231994|NCT02336165|582230555|FG001|Overall Study|Withdrawal by Subject|0|||
161231995|NCT02336165|582230556|FG002|Overall Study|Withdrawal by Subject|1|||
161231996|NCT02336165|582230557|FG003|Overall Study|Withdrawal by Subject|0|||
161231997|NCT02336165|582230558|FG004|Overall Study|Withdrawal by Subject|1|||
161231998|NCT02336165|582230554|FG000|Overall Study|Adverse Event|4|||
161231999|NCT02336165|582230555|FG001|Overall Study|Adverse Event|1|||
161232000|NCT02336165|582230556|FG002|Overall Study|Adverse Event|2|||
161232001|NCT02336165|582230557|FG003|Overall Study|Adverse Event|4|||
161232002|NCT02336165|582230558|FG004|Overall Study|Adverse Event|1|||
161232003|NCT02336165|582230554|FG000|Overall Study|Progressive disease|23|||
161232004|NCT02336165|582230555|FG001|Overall Study|Progressive disease|22|||
161232005|NCT02336165|582230556|FG002|Overall Study|Progressive disease|27|||
161232006|NCT02336165|582230557|FG003|Overall Study|Progressive disease|24|||
161232007|NCT02336165|582230558|FG004|Overall Study|Progressive disease|19|||
161232008|NCT02336165|582230554|FG000|Overall Study|Non-compliance|1|||
160787238|NCT04135352|580607282|FG006|Overall Study|Sponsor Decision|0|||
161232009|NCT02336165|582230555|FG001|Overall Study|Non-compliance|0|||
161232010|NCT02336165|582230556|FG002|Overall Study|Non-compliance|0|||
161232011|NCT02336165|582230557|FG003|Overall Study|Non-compliance|1|||
161232012|NCT02336165|582230558|FG004|Overall Study|Non-compliance|0|||
161232013|NCT02336165|582230554|FG000|Overall Study|Other|1|||
161232014|NCT02336165|582230555|FG001|Overall Study|Other|0|||
161232015|NCT02336165|582230556|FG002|Overall Study|Other|0|||
161232016|NCT02336165|582230557|FG003|Overall Study|Other|1|||
161232017|NCT02336165|582230558|FG004|Overall Study|Other|0|||
161232018|NCT00450190|582230559|FG000|Overall Study|Withdrawal by Subject|2|||
161232019|NCT03002077|582230562|FG000|Overall Study|Non-compliance with Study Drug|4|||
161232020|NCT03002077|582230562|FG000|Overall Study|Non-compliance w/Background ADT|1|||
161232021|NCT03002077|582230562|FG000|Overall Study|Study Terminated by Sponsor|257|||
160787239|NCT04135352|580607283|FG007|Overall Study|Sponsor Decision|0|||
160787240|NCT04135352|580607276|FG000|Overall Study|Physician Decision|0|||
160787241|NCT04135352|580607277|FG001|Overall Study|Physician Decision|0|||
160787242|NCT04135352|580607278|FG002|Overall Study|Physician Decision|1|||
160787243|NCT04135352|580607279|FG003|Overall Study|Physician Decision|0|||
161232022|NCT03002077|582230562|FG000|Overall Study|Site Terminated by Sponsor|5|||
161232023|NCT03002077|582230562|FG000|Overall Study|Miscellaneous Reasons|10|||
160787244|NCT04135352|580607280|FG004|Overall Study|Physician Decision|1|||
160787245|NCT04135352|580607281|FG005|Overall Study|Physician Decision|0|||
160787246|NCT04135352|580607282|FG006|Overall Study|Physician Decision|0|||
161232024|NCT03002077|582230562|FG000|Overall Study|Adverse Event|23|||
161232025|NCT03002077|582230562|FG000|Overall Study|Lack of Efficacy|20|||
161232026|NCT03002077|582230562|FG000|Overall Study|Withdrawal by Subject|72|||
161232027|NCT03002077|582230562|FG000|Overall Study|Lost to Follow-up|21|||
161232028|NCT03002077|582230562|FG000|Overall Study|Pregnancy|4|||
161232029|NCT03002077|582230562|FG000|Overall Study|Protocol Violation|21|||
161232030|NCT00834756|582230565|FG000|First Intervention|Adverse Event|1|||
161232031|NCT00834756|582230566|FG001|First Intervention|Adverse Event|0|||
161232032|NCT00834756|582230565|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161232033|NCT00834756|582230566|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
161232034|NCT04625114|582230578|FG000|Overall Study|Adverse Event|3|||
161232035|NCT04625114|582230579|FG001|Overall Study|Adverse Event|1|||
161232036|NCT04625114|582230578|FG000|Overall Study|Withdrawal by Subject|2|||
161232037|NCT04625114|582230579|FG001|Overall Study|Withdrawal by Subject|0|||
160787247|NCT04135352|580607283|FG007|Overall Study|Physician Decision|0|||
160787248|NCT04135352|580607276|FG000|Overall Study|Death|3|||
160787249|NCT04135352|580607277|FG001|Overall Study|Death|4|||
161232038|NCT00986245|582230580|FG000|First Intervention|Poor compliance|8|||
161232039|NCT00986245|582230581|FG001|First Intervention|Poor compliance|4|||
161232040|NCT00986245|582230580|FG000|First Intervention|Lack of Efficacy|1|||
161232041|NCT00986245|582230581|FG001|First Intervention|Lack of Efficacy|2|||
161232042|NCT00986245|582230580|FG000|First Intervention|Withdrawal by Subject|0|||
161232043|NCT00986245|582230581|FG001|First Intervention|Withdrawal by Subject|1|||
161232044|NCT00986245|582230580|FG000|First Intervention|Protocol Violation|0|||
161232045|NCT00986245|582230581|FG001|First Intervention|Protocol Violation|1|||
161232046|NCT00986245|582230580|FG000|First Intervention|Out of indication|1|||
161232047|NCT00986245|582230581|FG001|First Intervention|Out of indication|0|||
161232048|NCT00986245|582230580|FG000|Second Intervention|Poor compliance|1|||
161232049|NCT00986245|582230581|FG001|Second Intervention|Poor compliance|0|||
161232050|NCT00986245|582230580|FG000|Second Intervention|Lost to Follow-up|1|||
161232051|NCT00986245|582230581|FG001|Second Intervention|Lost to Follow-up|0|||
161232052|NCT00986245|582230580|FG000|Second Intervention|Protocol Violation|0|||
161232053|NCT00986245|582230581|FG001|Second Intervention|Protocol Violation|1|||
161232054|NCT00854308|582230585|FG000|Overall Study|Disease progression|42|||
161232055|NCT00854308|582230586|FG001|Overall Study|Disease progression|50|||
161232056|NCT00854308|582230585|FG000|Overall Study|Adverse Event|8|||
161232057|NCT00854308|582230586|FG001|Overall Study|Adverse Event|3|||
161232058|NCT00854308|582230585|FG000|Overall Study|Death|2|||
161232059|NCT00854308|582230586|FG001|Overall Study|Death|5|||
161232060|NCT00854308|582230585|FG000|Overall Study|Physician Decision|6|||
161232061|NCT00854308|582230586|FG001|Overall Study|Physician Decision|6|||
161232062|NCT00854308|582230585|FG000|Overall Study|Withdrawal by Subject|4|||
161232063|NCT00854308|582230586|FG001|Overall Study|Withdrawal by Subject|2|||
161232064|NCT00854308|582230585|FG000|Overall Study|Sponsor's decision to terminate study|0|||
161232065|NCT00854308|582230586|FG001|Overall Study|Sponsor's decision to terminate study|1|||
161232066|NCT01390844|582230587|FG000|Treatment Phase|Adverse Event|12|||
161232067|NCT01390844|582230588|FG001|Treatment Phase|Adverse Event|2|||
161232068|NCT01390844|582230589|FG002|Treatment Phase|Adverse Event|3|||
161232069|NCT01390844|582230590|FG003|Treatment Phase|Adverse Event|2|||
161232070|NCT01390844|582230587|FG000|Treatment Phase|Treatment Failure|23|||
161232071|NCT01390844|582230588|FG001|Treatment Phase|Treatment Failure|25|||
161232072|NCT01390844|582230589|FG002|Treatment Phase|Treatment Failure|10|||
161232073|NCT01390844|582230590|FG003|Treatment Phase|Treatment Failure|13|||
161232074|NCT01390844|582230587|FG000|Treatment Phase|Non-Medical Reasons|5|||
161232075|NCT01390844|582230588|FG001|Treatment Phase|Non-Medical Reasons|1|||
161232076|NCT01390844|582230589|FG002|Treatment Phase|Non-Medical Reasons|8|||
161232077|NCT01390844|582230590|FG003|Treatment Phase|Non-Medical Reasons|1|||
161232078|NCT01390844|582230587|FG000|Treatment Phase|Non-GCP Compliant|0|||
161232079|NCT01390844|582230588|FG001|Treatment Phase|Non-GCP Compliant|0|||
161232080|NCT01390844|582230589|FG002|Treatment Phase|Non-GCP Compliant|10|||
161232081|NCT01390844|582230590|FG003|Treatment Phase|Non-GCP Compliant|3|||
161232082|NCT01390844|582230587|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
161232083|NCT01390844|582230588|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
161232084|NCT01390844|582230589|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
161232085|NCT01390844|582230590|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
161232086|NCT03048500|582230593|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
161232087|NCT03048500|582230593|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
161232088|NCT03048500|582230593|FG000|Reached 1st Response/Continued Treatment|Death|1|||
161232089|NCT03048500|582230593|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
161232090|NCT03048500|582230593|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
161232091|NCT03048500|582230593|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
161232092|NCT03048500|582230593|FG000|Follow up for 3 Years|Death|12|||
161232093|NCT02079766|582230594|FG000|Overall Study|Physician Decision|1|||
161232094|NCT02079766|582230595|FG001|Overall Study|Physician Decision|0|||
161232095|NCT02079766|582230594|FG000|Overall Study|Withdrawal by Subject|1|||
161232096|NCT02079766|582230595|FG001|Overall Study|Withdrawal by Subject|0|||
161232097|NCT03018249|582230606|FG000|Overall Study|Withdrawal by Subject|2|||
161232098|NCT03018249|582230607|FG001|Overall Study|Withdrawal by Subject|2|||
161232099|NCT03544138|582230608|FG000|Overall Study|Lost to Follow-up|29|||
161232100|NCT04466111|582232451|FG000|Prior to Trial Phase|Physician Decision|1|||
161232101|NCT03553823|582232460|FG000|Overall Study|Physician Decision|0|||
161232102|NCT03553823|582232461|FG001|Overall Study|Physician Decision|1|||
161232103|NCT00893464|582232462|FG000|Overall Study|Did not complete therapy/experience PD|0|||
161232104|NCT00893464|582232463|FG001|Overall Study|Did not complete therapy/experience PD|0|||
161232105|NCT00893464|582232464|FG002|Overall Study|Did not complete therapy/experience PD|0|||
161232106|NCT00893464|582232465|FG003|Overall Study|Did not complete therapy/experience PD|0|||
161232107|NCT00893464|582232466|FG004|Overall Study|Did not complete therapy/experience PD|0|||
161232108|NCT00893464|582232467|FG005|Overall Study|Did not complete therapy/experience PD|0|||
161232109|NCT00893464|582232468|FG006|Overall Study|Did not complete therapy/experience PD|2|||
161232110|NCT00893464|582232469|FG007|Overall Study|Did not complete therapy/experience PD|2|||
161232111|NCT03450070|582232470|FG000|Overall Study|Withdrawal by Subject|8|||
161232112|NCT02910037|582232471|FG000|Overall Study|Withdrawal by Subject|4|||
161232113|NCT02910037|582232471|FG000|Overall Study|Lost to Follow-up|6|||
161232114|NCT01035060|582232474|FG000|Overall Study|Lost to Follow-up|0|||
161232115|NCT01035060|582232475|FG001|Overall Study|Lost to Follow-up|7|||
161232116|NCT01035060|582232474|FG000|Overall Study|Did not quality after 2nd screening|14|||
161232117|NCT01035060|582232475|FG001|Overall Study|Did not quality after 2nd screening|1|||
161232118|NCT01035060|582232474|FG000|Overall Study|Withdrawal by Subject|8|||
161232119|NCT01035060|582232475|FG001|Overall Study|Withdrawal by Subject|6|||
161232120|NCT01035060|582232474|FG000|Overall Study|Physician Decision|2|||
161232121|NCT01035060|582232475|FG001|Overall Study|Physician Decision|0|||
161232122|NCT01720264|582232481|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
161232123|NCT01720264|582232481|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
161232124|NCT01720264|582232481|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
160787250|NCT04135352|580607278|FG002|Overall Study|Death|7|||
160787251|NCT04135352|580607279|FG003|Overall Study|Death|0|||
160787252|NCT04135352|580607280|FG004|Overall Study|Death|3|||
160787253|NCT04135352|580607281|FG005|Overall Study|Death|1|||
160787254|NCT04135352|580607282|FG006|Overall Study|Death|0|||
160787255|NCT04135352|580607283|FG007|Overall Study|Death|0|||
160787256|NCT00609973|580607284|FG000|Overall Study|Adverse Event|2|||
160787257|NCT00609973|580607285|FG001|Overall Study|Adverse Event|1|||
160787258|NCT00609973|580607284|FG000|Overall Study|Protocol Violation|4|||
160787259|NCT00609973|580607285|FG001|Overall Study|Protocol Violation|3|||
160787260|NCT00609973|580607284|FG000|Overall Study|Lost to Follow-up|2|||
160787261|NCT00609973|580607285|FG001|Overall Study|Lost to Follow-up|1|||
160787262|NCT00609973|580607284|FG000|Overall Study|Withdrawal by Subject|0|||
160787263|NCT00609973|580607285|FG001|Overall Study|Withdrawal by Subject|1|||
160787264|NCT01691482|580607286|FG000|Treatment Period 2|Adverse Event|0|||
160787265|NCT01691482|580607287|FG001|Treatment Period 2|Adverse Event|1|||
160787266|NCT01691482|580607286|FG000|Treatment Period 2|Protocol Violation|1|||
160787267|NCT01691482|580607287|FG001|Treatment Period 2|Protocol Violation|1|||
160787268|NCT01392495|580607288|FG000|Overall Study|Death|3|||
160787269|NCT01392495|580607288|FG000|Overall Study|Administrative problems|8|||
160787270|NCT01392495|580607288|FG000|Overall Study|Withdrawal by Subject|2|||
160787271|NCT01392495|580607288|FG000|Overall Study|Adverse Event|3|||
160787272|NCT01570192|580607289|FG000|Overall Study|no qualifying organism|6|||
160787273|NCT01570192|580607290|FG001|Overall Study|no qualifying organism|12|||
161232125|NCT00454909|582232482|FG000|Overall Study|Withdrawal by Subject|1|||
161232126|NCT00454909|582232483|FG001|Overall Study|Withdrawal by Subject|0|||
161232127|NCT00454909|582232484|FG002|Overall Study|Withdrawal by Subject|0|||
161232128|NCT00454909|582232482|FG000|Overall Study|Migrated/moved from study area|0|||
161232129|NCT00454909|582232483|FG001|Overall Study|Migrated/moved from study area|0|||
161232130|NCT00454909|582232484|FG002|Overall Study|Migrated/moved from study area|1|||
161232131|NCT00454909|582232482|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
161232132|NCT00454909|582232483|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
161232133|NCT00454909|582232484|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
161232134|NCT00454909|582232482|FG000|Overall Study|Others|1|||
161232135|NCT00454909|582232483|FG001|Overall Study|Others|0|||
161232136|NCT00454909|582232484|FG002|Overall Study|Others|0|||
161232137|NCT02549092|582232485|FG000|Treatment Period|Adverse Event|2|||
161232138|NCT02549092|582232486|FG001|Treatment Period|Adverse Event|2|||
161232139|NCT02549092|582232485|FG000|Treatment Period|Withdrawal by Subject|1|||
161232140|NCT02549092|582232486|FG001|Treatment Period|Withdrawal by Subject|3|||
161232141|NCT02549092|582232485|FG000|Treatment Period|Lack of Efficacy|0|||
161232142|NCT02549092|582232486|FG001|Treatment Period|Lack of Efficacy|2|||
161232143|NCT02549092|582232485|FG000|Extension/Transition Period|Adverse Event|1|||
161232144|NCT02549092|582232486|FG001|Extension/Transition Period|Adverse Event|1|||
161232145|NCT02549092|582232485|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
161232146|NCT02549092|582232486|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
161232147|NCT02549092|582232485|FG000|Extension/Transition Period|Other, Not Specified|4|||
160787274|NCT01570192|580607289|FG000|Overall Study|changed to palliative care|1|||
160787275|NCT01570192|580607290|FG001|Overall Study|changed to palliative care|0|||
160787276|NCT01570192|580607289|FG000|Overall Study|Physician Decision|0|||
161232148|NCT02549092|582232486|FG001|Extension/Transition Period|Other, Not Specified|2|||
160787277|NCT01570192|580607290|FG001|Overall Study|Physician Decision|1|||
160787278|NCT02965976|580607291|FG000|Overall Study|Withdrawal by Subject|2|||
161232149|NCT00910663|582232489|FG000|Period 1|Withdrawal by Subject|0|||
161232150|NCT00910663|582232490|FG001|Period 1|Withdrawal by Subject|1|||
161232151|NCT01772537|582232491|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
161232152|NCT01772537|582232492|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
161232153|NCT01772537|582232493|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
161232154|NCT01536574|582232497|FG000|Overall Study|Adverse Event|4|||
161232155|NCT01536574|582232498|FG001|Overall Study|Adverse Event|5|||
160787279|NCT02965976|580607292|FG001|Overall Study|Withdrawal by Subject|0|||
160787280|NCT00806026|580607293|FG000|Overall Study|Death|0|||
160787281|NCT00806026|580607294|FG001|Overall Study|Death|0|||
160787282|NCT00806026|580607295|FG002|Overall Study|Death|0|||
160787283|NCT00806026|580607296|FG003|Overall Study|Death|1|||
160787284|NCT00806026|580607297|FG004|Overall Study|Death|0|||
160787285|NCT00806026|580607298|FG005|Overall Study|Death|0|||
160787286|NCT00806026|580607293|FG000|Overall Study|Did not meet entrance criteria|4|||
160787287|NCT00806026|580607294|FG001|Overall Study|Did not meet entrance criteria|1|||
160787288|NCT00806026|580607295|FG002|Overall Study|Did not meet entrance criteria|2|||
160787289|NCT00806026|580607296|FG003|Overall Study|Did not meet entrance criteria|1|||
160787290|NCT00806026|580607297|FG004|Overall Study|Did not meet entrance criteria|0|||
160787291|NCT00806026|580607298|FG005|Overall Study|Did not meet entrance criteria|0|||
160787292|NCT00806026|580607293|FG000|Overall Study|Lack of Efficacy|5|||
160787293|NCT00806026|580607294|FG001|Overall Study|Lack of Efficacy|18|||
160787294|NCT00806026|580607295|FG002|Overall Study|Lack of Efficacy|13|||
160787295|NCT00806026|580607296|FG003|Overall Study|Lack of Efficacy|4|||
160787296|NCT00806026|580607297|FG004|Overall Study|Lack of Efficacy|8|||
160787297|NCT00806026|580607298|FG005|Overall Study|Lack of Efficacy|7|||
160787298|NCT00806026|580607293|FG000|Overall Study|Lost to Follow-up|8|||
160787299|NCT00806026|580607294|FG001|Overall Study|Lost to Follow-up|15|||
160787300|NCT00806026|580607295|FG002|Overall Study|Lost to Follow-up|8|||
160787301|NCT00806026|580607296|FG003|Overall Study|Lost to Follow-up|2|||
160787302|NCT00806026|580607297|FG004|Overall Study|Lost to Follow-up|6|||
160787303|NCT00806026|580607298|FG005|Overall Study|Lost to Follow-up|6|||
160787304|NCT00806026|580607293|FG000|Overall Study|Withdrawal by Subject|14|||
160787305|NCT00806026|580607294|FG001|Overall Study|Withdrawal by Subject|17|||
160787306|NCT00806026|580607295|FG002|Overall Study|Withdrawal by Subject|9|||
160787307|NCT00806026|580607296|FG003|Overall Study|Withdrawal by Subject|2|||
160787308|NCT00806026|580607297|FG004|Overall Study|Withdrawal by Subject|5|||
160787309|NCT00806026|580607298|FG005|Overall Study|Withdrawal by Subject|3|||
160787310|NCT00806026|580607293|FG000|Overall Study|Other|3|||
160787311|NCT00806026|580607294|FG001|Overall Study|Other|6|||
160787312|NCT00806026|580607295|FG002|Overall Study|Other|8|||
160787313|NCT00806026|580607296|FG003|Overall Study|Other|2|||
160787314|NCT00806026|580607297|FG004|Overall Study|Other|0|||
160787315|NCT00806026|580607298|FG005|Overall Study|Other|4|||
160787316|NCT00806026|580607293|FG000|Overall Study|Protocol Violation|6|||
160787317|NCT00806026|580607294|FG001|Overall Study|Protocol Violation|9|||
160787318|NCT00806026|580607295|FG002|Overall Study|Protocol Violation|9|||
160787319|NCT00806026|580607296|FG003|Overall Study|Protocol Violation|0|||
160787320|NCT00806026|580607297|FG004|Overall Study|Protocol Violation|2|||
160787321|NCT00806026|580607298|FG005|Overall Study|Protocol Violation|3|||
160787322|NCT00806026|580607293|FG000|Overall Study|Adverse Event|52|||
160787323|NCT00806026|580607294|FG001|Overall Study|Adverse Event|35|||
160787324|NCT00806026|580607295|FG002|Overall Study|Adverse Event|44|||
160787325|NCT00806026|580607296|FG003|Overall Study|Adverse Event|17|||
160787326|NCT00806026|580607297|FG004|Overall Study|Adverse Event|9|||
161232156|NCT01536574|582232497|FG000|Overall Study|Withdrawal by Subject|1|||
161232157|NCT01536574|582232498|FG001|Overall Study|Withdrawal by Subject|2|||
161232158|NCT01536574|582232497|FG000|Overall Study|Lack of Efficacy|1|||
161232159|NCT01536574|582232498|FG001|Overall Study|Lack of Efficacy|0|||
161328529|NCT05219968|582587172|FG003|Week 24 Treatment Period|Adverse Event|0|||
161328530|NCT05219968|582587173|FG004|Week 24 Treatment Period|Adverse Event|0|||
161328531|NCT05219968|582587169|FG000|Week 24 Treatment Period|Physician Decision|0|||
161328532|NCT05219968|582587170|FG001|Week 24 Treatment Period|Physician Decision|1|||
161328533|NCT05219968|582587171|FG002|Week 24 Treatment Period|Physician Decision|0|||
161328534|NCT05219968|582587172|FG003|Week 24 Treatment Period|Physician Decision|0|||
161328535|NCT05219968|582587173|FG004|Week 24 Treatment Period|Physician Decision|0|||
161232160|NCT01376167|582232499|FG000|Overall Study|Lost to Follow-up|2|||
161232161|NCT01376167|582232500|FG001|Overall Study|Lost to Follow-up|4|||
161232162|NCT01376167|582232501|FG002|Overall Study|Lost to Follow-up|2|||
161232163|NCT01376167|582232499|FG000|Overall Study|Physician Decision|1|||
161232164|NCT01376167|582232500|FG001|Overall Study|Physician Decision|1|||
161232165|NCT01376167|582232501|FG002|Overall Study|Physician Decision|0|||
161232166|NCT01376167|582232499|FG000|Overall Study|Withdrawal by Subject|1|||
161232167|NCT01376167|582232500|FG001|Overall Study|Withdrawal by Subject|5|||
161232168|NCT01376167|582232501|FG002|Overall Study|Withdrawal by Subject|4|||
161232169|NCT02193165|582232504|FG000|4 Week Product Use|Lost to Follow-up|1|||
161232170|NCT02193165|582232505|FG001|4 Week Product Use|Lost to Follow-up|1|||
161232171|NCT02193165|582232506|FG002|4 Week Product Use|Lost to Follow-up|1|||
161232172|NCT02193165|582232504|FG000|6 Week Product Use|Lost to Follow-up|0|||
161328536|NCT05219968|582587169|FG000|Week 24 Treatment Period|Other, not specified|3|||
160787327|NCT00806026|580607298|FG005|Overall Study|Adverse Event|9|||
160787328|NCT00819832|580607299|FG000|Overall Study|Sponsor Termination of Study|3|||
160787329|NCT00819832|580607300|FG001|Overall Study|Sponsor Termination of Study|0|||
160787330|NCT00819832|580607301|FG002|Overall Study|Sponsor Termination of Study|0|||
160787331|NCT00819832|580607302|FG003|Overall Study|Sponsor Termination of Study|0|||
160787332|NCT00819832|580607303|FG004|Overall Study|Sponsor Termination of Study|0|||
160787333|NCT00819832|580607304|FG005|Overall Study|Sponsor Termination of Study|0|||
160787334|NCT01063881|580607307|FG000|Overall Study|Adverse Event|12|||
160787335|NCT01063881|580607308|FG001|Overall Study|Adverse Event|2|||
160787336|NCT01063881|580607309|FG002|Overall Study|Adverse Event|0|||
160787337|NCT01063881|580607307|FG000|Overall Study|Lost to Follow-up|13|||
160787338|NCT01063881|580607308|FG001|Overall Study|Lost to Follow-up|7|||
160787339|NCT01063881|580607309|FG002|Overall Study|Lost to Follow-up|1|||
160787340|NCT01063881|580607307|FG000|Overall Study|Withdrawal by Subject|25|||
160787341|NCT01063881|580607308|FG001|Overall Study|Withdrawal by Subject|1|||
160787342|NCT01063881|580607309|FG002|Overall Study|Withdrawal by Subject|0|||
160787343|NCT01063881|580607307|FG000|Overall Study|Reason for not completed not specified|5|||
160787344|NCT01063881|580607308|FG001|Overall Study|Reason for not completed not specified|1|||
160787345|NCT01063881|580607309|FG002|Overall Study|Reason for not completed not specified|0|||
160787346|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
160787347|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
160787348|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
160787349|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
160787350|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
160787351|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
160787352|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
160787353|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
160787354|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
160787355|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
160787356|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
160787357|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
160787358|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
160787359|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
160787360|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
160787361|NCT00407030|580607310|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
160787362|NCT00407030|580607311|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
160787363|NCT00407030|580607312|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
161126426|NCT01430442|581850674|FG004|Overall Study|Lost to Follow-up|2|||
161328537|NCT05219968|582587170|FG001|Week 24 Treatment Period|Other, not specified|0|||
161328538|NCT05219968|582587171|FG002|Week 24 Treatment Period|Other, not specified|0|||
161328539|NCT05219968|582587172|FG003|Week 24 Treatment Period|Other, not specified|0|||
161328540|NCT05219968|582587173|FG004|Week 24 Treatment Period|Other, not specified|0|||
161328541|NCT05219968|582587169|FG000|Safety Extension Period|Treatment administration failure|0|||
161328542|NCT05219968|582587170|FG001|Safety Extension Period|Treatment administration failure|0|||
161328543|NCT05219968|582587171|FG002|Safety Extension Period|Treatment administration failure|0|||
161328544|NCT05219968|582587172|FG003|Safety Extension Period|Treatment administration failure|1|||
161328545|NCT05219968|582587173|FG004|Safety Extension Period|Treatment administration failure|4|||
161328546|NCT05219968|582587169|FG000|Safety Extension Period|Bilateral dislodgement|0|||
161328547|NCT05219968|582587170|FG001|Safety Extension Period|Bilateral dislodgement|0|||
161328548|NCT05219968|582587171|FG002|Safety Extension Period|Bilateral dislodgement|4|||
161328549|NCT05219968|582587172|FG003|Safety Extension Period|Bilateral dislodgement|0|||
161328550|NCT05219968|582587173|FG004|Safety Extension Period|Bilateral dislodgement|1|||
161328551|NCT05219968|582587169|FG000|Safety Extension Period|Withdrawal by Subject|0|||
161328552|NCT05219968|582587170|FG001|Safety Extension Period|Withdrawal by Subject|0|||
161328553|NCT05219968|582587171|FG002|Safety Extension Period|Withdrawal by Subject|2|||
161126427|NCT01430442|581850675|FG005|Overall Study|Lost to Follow-up|1|||
161126428|NCT01430442|581850676|FG006|Overall Study|Lost to Follow-up|5|||
161126429|NCT01430442|581850677|FG007|Overall Study|Lost to Follow-up|1|||
161126430|NCT01430442|581850670|FG000|Overall Study|Pregnancy|1|||
161126431|NCT01430442|581850671|FG001|Overall Study|Pregnancy|0|||
161126432|NCT01430442|581850672|FG002|Overall Study|Pregnancy|0|||
161126433|NCT01430442|581850673|FG003|Overall Study|Pregnancy|0|||
161126434|NCT01430442|581850674|FG004|Overall Study|Pregnancy|0|||
161126435|NCT01430442|581850675|FG005|Overall Study|Pregnancy|1|||
161126436|NCT01430442|581850676|FG006|Overall Study|Pregnancy|0|||
161126437|NCT01430442|581850677|FG007|Overall Study|Pregnancy|0|||
161126438|NCT01430442|581850670|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
161126439|NCT01430442|581850671|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
161126440|NCT01430442|581850672|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
161126441|NCT01430442|581850673|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
161126442|NCT01430442|581850674|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
161126443|NCT01430442|581850675|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
161126444|NCT01430442|581850676|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
161126445|NCT01430442|581850677|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
161126446|NCT00772629|581850679|FG000|Overall Study|Subject was not vaccinated|1|||
161126447|NCT00772629|581850680|FG001|Overall Study|Subject was not vaccinated|0|||
161126448|NCT03502330|581850685|FG000|Overall Study|Adverse Event|2|||
161126449|NCT03502330|581850686|FG001|Overall Study|Adverse Event|1|||
161126450|NCT03502330|581850687|FG002|Overall Study|Adverse Event|0|||
161126451|NCT03502330|581850688|FG003|Overall Study|Adverse Event|0|||
161126452|NCT03502330|581850689|FG004|Overall Study|Adverse Event|1|||
161126453|NCT03502330|581850690|FG005|Overall Study|Adverse Event|0|||
161126454|NCT03502330|581850691|FG006|Overall Study|Adverse Event|1|||
161126455|NCT03502330|581850692|FG007|Overall Study|Adverse Event|1|||
160787364|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
160787365|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
160787366|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
160787367|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
160787368|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
160787369|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
160787370|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
160787371|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
160787372|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
160787373|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
160787374|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
160787375|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
160787376|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
160787377|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
160787378|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
160787379|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
160787380|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
160787381|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
160787382|NCT00407030|580607310|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
160787383|NCT00407030|580607311|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
160787384|NCT00407030|580607312|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
160787385|NCT01370642|580607314|FG000|Overall Study|Adverse Event|2|||
160787386|NCT01370642|580607315|FG001|Overall Study|Adverse Event|1|||
160787387|NCT01370642|580607316|FG002|Overall Study|Adverse Event|1|||
160787388|NCT01370642|580607314|FG000|Overall Study|Detectable HCV RNA|0|||
160787389|NCT01370642|580607315|FG001|Overall Study|Detectable HCV RNA|0|||
160787390|NCT01370642|580607316|FG002|Overall Study|Detectable HCV RNA|22|||
160787391|NCT01370642|580607314|FG000|Overall Study|Lost to Follow-up|0|||
160787392|NCT01370642|580607315|FG001|Overall Study|Lost to Follow-up|0|||
160787393|NCT01370642|580607316|FG002|Overall Study|Lost to Follow-up|1|||
160787394|NCT01370642|580607314|FG000|Overall Study|Physician Decision|4|||
160787395|NCT01370642|580607315|FG001|Overall Study|Physician Decision|1|||
160787396|NCT01370642|580607316|FG002|Overall Study|Physician Decision|2|||
160787397|NCT01370642|580607314|FG000|Overall Study|Withdrawal by Subject|2|||
160787398|NCT01370642|580607315|FG001|Overall Study|Withdrawal by Subject|4|||
160787399|NCT01370642|580607316|FG002|Overall Study|Withdrawal by Subject|3|||
160787400|NCT00147537|580607323|FG000|Phase 1b|Death|0|||
160787401|NCT00147537|580607324|FG001|Phase 1b|Death|1|||
160787402|NCT00147537|580607325|FG002|Phase 1b|Death|2|||
160787403|NCT00147537|580607326|FG003|Phase 1b|Death|1|||
160787404|NCT00147537|580607327|FG004|Phase 1b|Death|2|||
160787405|NCT00147537|580607328|FG005|Phase 1b|Death|2|||
160787406|NCT00147537|580607329|FG006|Phase 1b|Death|1|||
160787407|NCT00147537|580607330|FG007|Phase 1b|Death|3|||
160787408|NCT00147537|580607331|FG008|Phase 1b|Death|9|||
160787409|NCT00147537|580607332|FG009|Phase 1b|Death|0|||
160787410|NCT00147537|580607333|FG010|Phase 1b|Death|0|||
160787411|NCT00147537|580607323|FG000|Phase 1b|Lost to Follow-up|2|||
160787412|NCT00147537|580607324|FG001|Phase 1b|Lost to Follow-up|1|||
160787413|NCT00147537|580607325|FG002|Phase 1b|Lost to Follow-up|0|||
160787414|NCT00147537|580607326|FG003|Phase 1b|Lost to Follow-up|0|||
160787415|NCT00147537|580607327|FG004|Phase 1b|Lost to Follow-up|0|||
160787416|NCT00147537|580607328|FG005|Phase 1b|Lost to Follow-up|0|||
160787417|NCT00147537|580607329|FG006|Phase 1b|Lost to Follow-up|2|||
160787418|NCT00147537|580607330|FG007|Phase 1b|Lost to Follow-up|0|||
160787419|NCT00147537|580607331|FG008|Phase 1b|Lost to Follow-up|1|||
160787420|NCT00147537|580607332|FG009|Phase 1b|Lost to Follow-up|0|||
160787421|NCT00147537|580607333|FG010|Phase 1b|Lost to Follow-up|0|||
160787422|NCT00147537|580607323|FG000|Phase 1b|Other|0|||
160787423|NCT00147537|580607324|FG001|Phase 1b|Other|0|||
160787424|NCT00147537|580607325|FG002|Phase 1b|Other|2|||
160787425|NCT00147537|580607326|FG003|Phase 1b|Other|1|||
160787426|NCT00147537|580607327|FG004|Phase 1b|Other|1|||
160787427|NCT00147537|580607328|FG005|Phase 1b|Other|1|||
160787428|NCT00147537|580607329|FG006|Phase 1b|Other|14|||
160787429|NCT00147537|580607330|FG007|Phase 1b|Other|4|||
160787430|NCT00147537|580607331|FG008|Phase 1b|Other|4|||
160787431|NCT00147537|580607332|FG009|Phase 1b|Other|0|||
160787432|NCT00147537|580607333|FG010|Phase 1b|Other|0|||
160787433|NCT00147537|580607323|FG000|Phase 1b|Withdrawal by Subject|0|||
160787434|NCT00147537|580607324|FG001|Phase 1b|Withdrawal by Subject|0|||
160787435|NCT00147537|580607325|FG002|Phase 1b|Withdrawal by Subject|0|||
160787436|NCT00147537|580607326|FG003|Phase 1b|Withdrawal by Subject|0|||
160787437|NCT00147537|580607327|FG004|Phase 1b|Withdrawal by Subject|0|||
160787438|NCT00147537|580607328|FG005|Phase 1b|Withdrawal by Subject|0|||
160787439|NCT00147537|580607329|FG006|Phase 1b|Withdrawal by Subject|0|||
161126456|NCT03502330|581850693|FG008|Overall Study|Adverse Event|0|||
161126457|NCT03502330|581850685|FG000|Overall Study|Lack of Efficacy|1|||
161126458|NCT03502330|581850686|FG001|Overall Study|Lack of Efficacy|5|||
160787440|NCT00147537|580607330|FG007|Phase 1b|Withdrawal by Subject|0|||
160787441|NCT00147537|580607331|FG008|Phase 1b|Withdrawal by Subject|2|||
160787442|NCT00147537|580607332|FG009|Phase 1b|Withdrawal by Subject|0|||
160787443|NCT00147537|580607333|FG010|Phase 1b|Withdrawal by Subject|0|||
160787444|NCT00147537|580607323|FG000|Phase 1b|Randomized but not treated|0|||
160787445|NCT00147537|580607324|FG001|Phase 1b|Randomized but not treated|0|||
160787446|NCT00147537|580607325|FG002|Phase 1b|Randomized but not treated|0|||
160787447|NCT00147537|580607326|FG003|Phase 1b|Randomized but not treated|0|||
160787448|NCT00147537|580607327|FG004|Phase 1b|Randomized but not treated|0|||
160787449|NCT00147537|580607328|FG005|Phase 1b|Randomized but not treated|0|||
160787450|NCT00147537|580607329|FG006|Phase 1b|Randomized but not treated|1|||
160787451|NCT00147537|580607330|FG007|Phase 1b|Randomized but not treated|0|||
160787452|NCT00147537|580607331|FG008|Phase 1b|Randomized but not treated|1|||
160787453|NCT00147537|580607332|FG009|Phase 1b|Randomized but not treated|0|||
160787454|NCT00147537|580607333|FG010|Phase 1b|Randomized but not treated|0|||
160787455|NCT00147537|580607323|FG000|Phase 2|Death|0|||
160787456|NCT00147537|580607324|FG001|Phase 2|Death|0|||
160787457|NCT00147537|580607325|FG002|Phase 2|Death|0|||
160787458|NCT00147537|580607326|FG003|Phase 2|Death|0|||
160787459|NCT00147537|580607327|FG004|Phase 2|Death|0|||
160787460|NCT00147537|580607328|FG005|Phase 2|Death|0|||
160787461|NCT00147537|580607329|FG006|Phase 2|Death|0|||
160787462|NCT00147537|580607330|FG007|Phase 2|Death|0|||
160787463|NCT00147537|580607331|FG008|Phase 2|Death|0|||
160787464|NCT00147537|580607332|FG009|Phase 2|Death|85|||
160787465|NCT00147537|580607333|FG010|Phase 2|Death|31|||
160787466|NCT00147537|580607323|FG000|Phase 2|Lost to Follow-up|0|||
160787467|NCT00147537|580607324|FG001|Phase 2|Lost to Follow-up|0|||
160787468|NCT00147537|580607325|FG002|Phase 2|Lost to Follow-up|0|||
160787469|NCT00147537|580607326|FG003|Phase 2|Lost to Follow-up|0|||
160787470|NCT00147537|580607327|FG004|Phase 2|Lost to Follow-up|0|||
160787471|NCT00147537|580607328|FG005|Phase 2|Lost to Follow-up|0|||
160787472|NCT00147537|580607329|FG006|Phase 2|Lost to Follow-up|0|||
160787473|NCT00147537|580607330|FG007|Phase 2|Lost to Follow-up|0|||
160787474|NCT00147537|580607331|FG008|Phase 2|Lost to Follow-up|0|||
160787475|NCT00147537|580607332|FG009|Phase 2|Lost to Follow-up|12|||
160787476|NCT00147537|580607333|FG010|Phase 2|Lost to Follow-up|4|||
160787477|NCT00147537|580607323|FG000|Phase 2|Other|0|||
160787478|NCT00147537|580607324|FG001|Phase 2|Other|0|||
160787479|NCT00147537|580607325|FG002|Phase 2|Other|0|||
160787480|NCT00147537|580607326|FG003|Phase 2|Other|0|||
160787481|NCT00147537|580607327|FG004|Phase 2|Other|0|||
160787482|NCT00147537|580607328|FG005|Phase 2|Other|0|||
160787483|NCT00147537|580607329|FG006|Phase 2|Other|0|||
160787484|NCT00147537|580607330|FG007|Phase 2|Other|0|||
160787485|NCT00147537|580607331|FG008|Phase 2|Other|0|||
160787486|NCT00147537|580607332|FG009|Phase 2|Other|47|||
160787487|NCT00147537|580607333|FG010|Phase 2|Other|12|||
160787488|NCT00147537|580607323|FG000|Phase 2|Withdrawal by Subject|0|||
160787489|NCT00147537|580607324|FG001|Phase 2|Withdrawal by Subject|0|||
160787490|NCT00147537|580607325|FG002|Phase 2|Withdrawal by Subject|0|||
160787491|NCT00147537|580607326|FG003|Phase 2|Withdrawal by Subject|0|||
160787492|NCT00147537|580607327|FG004|Phase 2|Withdrawal by Subject|0|||
160787493|NCT00147537|580607328|FG005|Phase 2|Withdrawal by Subject|0|||
160787494|NCT00147537|580607329|FG006|Phase 2|Withdrawal by Subject|0|||
161232173|NCT02193165|582232505|FG001|6 Week Product Use|Lost to Follow-up|1|||
161232174|NCT02193165|582232506|FG002|6 Week Product Use|Lost to Follow-up|0|||
161232175|NCT01546545|582232508|FG000|Overall Study|Withdrawal by Subject|1|||
161232176|NCT01214850|582232509|FG000|Overall Study|Withdrawal by Subject|38|||
161232177|NCT01214850|582232510|FG001|Overall Study|Withdrawal by Subject|31|||
161232178|NCT01214850|582232511|FG002|Overall Study|Withdrawal by Subject|28|||
161232179|NCT01214850|582232509|FG000|Overall Study|Lost to Follow-up|124|||
161232180|NCT01214850|582232510|FG001|Overall Study|Lost to Follow-up|98|||
161232181|NCT01214850|582232511|FG002|Overall Study|Lost to Follow-up|123|||
161232182|NCT01214850|582232509|FG000|Overall Study|Protocol Violation|5|||
160787495|NCT00147537|580607330|FG007|Phase 2|Withdrawal by Subject|0|||
160787496|NCT00147537|580607331|FG008|Phase 2|Withdrawal by Subject|0|||
160787497|NCT00147537|580607332|FG009|Phase 2|Withdrawal by Subject|16|||
160787498|NCT00147537|580607333|FG010|Phase 2|Withdrawal by Subject|4|||
160787499|NCT00147537|580607323|FG000|Phase 2|Randomized but not treated|0|||
160787500|NCT00147537|580607324|FG001|Phase 2|Randomized but not treated|0|||
160787501|NCT00147537|580607325|FG002|Phase 2|Randomized but not treated|0|||
161232183|NCT01214850|582232510|FG001|Overall Study|Protocol Violation|5|||
161232184|NCT01214850|582232511|FG002|Overall Study|Protocol Violation|6|||
161232185|NCT01214850|582232509|FG000|Overall Study|Adverse event or death|11|||
160787502|NCT00147537|580607326|FG003|Phase 2|Randomized but not treated|0|||
160787503|NCT00147537|580607327|FG004|Phase 2|Randomized but not treated|0|||
161328554|NCT05219968|582587172|FG003|Safety Extension Period|Withdrawal by Subject|0|||
160787504|NCT00147537|580607328|FG005|Phase 2|Randomized but not treated|0|||
160787505|NCT00147537|580607329|FG006|Phase 2|Randomized but not treated|0|||
160787506|NCT00147537|580607330|FG007|Phase 2|Randomized but not treated|0|||
160787507|NCT00147537|580607331|FG008|Phase 2|Randomized but not treated|0|||
160787508|NCT00147537|580607332|FG009|Phase 2|Randomized but not treated|1|||
160787509|NCT00147537|580607333|FG010|Phase 2|Randomized but not treated|1|||
160787510|NCT00987935|580607334|FG000|Overall Study|Progressive disease|3|||
161232186|NCT01214850|582232510|FG001|Overall Study|Adverse event or death|8|||
161232187|NCT01214850|582232511|FG002|Overall Study|Adverse event or death|3|||
161232188|NCT01214850|582232509|FG000|Overall Study|Inappropriate enrollment|2|||
161232189|NCT01214850|582232510|FG001|Overall Study|Inappropriate enrollment|1|||
161232190|NCT01214850|582232511|FG002|Overall Study|Inappropriate enrollment|0|||
161232191|NCT01214850|582232509|FG000|Overall Study|Administrative reason|1|||
161232192|NCT01214850|582232510|FG001|Overall Study|Administrative reason|0|||
161232193|NCT01214850|582232511|FG002|Overall Study|Administrative reason|0|||
161328555|NCT05219968|582587173|FG004|Safety Extension Period|Withdrawal by Subject|4|||
161328556|NCT05219968|582587169|FG000|Safety Extension Period|Adverse Event|0|||
161328557|NCT05219968|582587170|FG001|Safety Extension Period|Adverse Event|0|||
161328558|NCT05219968|582587171|FG002|Safety Extension Period|Adverse Event|2|||
161328559|NCT05219968|582587172|FG003|Safety Extension Period|Adverse Event|1|||
161328560|NCT05219968|582587173|FG004|Safety Extension Period|Adverse Event|1|||
161328561|NCT05219968|582587169|FG000|Safety Extension Period|Lost to Follow-up|0|||
161328562|NCT05219968|582587170|FG001|Safety Extension Period|Lost to Follow-up|0|||
161328563|NCT05219968|582587171|FG002|Safety Extension Period|Lost to Follow-up|0|||
161328564|NCT05219968|582587172|FG003|Safety Extension Period|Lost to Follow-up|1|||
161328565|NCT05219968|582587173|FG004|Safety Extension Period|Lost to Follow-up|0|||
161328566|NCT03877224|582587174|FG000|Overall Study|Death|3|||
161328567|NCT03877224|582587175|FG001|Overall Study|Death|2|||
161328568|NCT03877224|582587174|FG000|Overall Study|Withdrawal by Subject|1|||
161328569|NCT03877224|582587175|FG001|Overall Study|Withdrawal by Subject|6|||
161126459|NCT03502330|581850687|FG002|Overall Study|Lack of Efficacy|3|||
161126460|NCT03502330|581850688|FG003|Overall Study|Lack of Efficacy|5|||
161126461|NCT03502330|581850689|FG004|Overall Study|Lack of Efficacy|1|||
161126462|NCT03502330|581850690|FG005|Overall Study|Lack of Efficacy|5|||
161126463|NCT03502330|581850691|FG006|Overall Study|Lack of Efficacy|5|||
161126464|NCT03502330|581850692|FG007|Overall Study|Lack of Efficacy|6|||
161126465|NCT03502330|581850693|FG008|Overall Study|Lack of Efficacy|0|||
161126466|NCT03502330|581850685|FG000|Overall Study|Physician Decision|0|||
161126467|NCT03502330|581850686|FG001|Overall Study|Physician Decision|0|||
161126468|NCT03502330|581850687|FG002|Overall Study|Physician Decision|0|||
161126469|NCT03502330|581850688|FG003|Overall Study|Physician Decision|0|||
161126470|NCT03502330|581850689|FG004|Overall Study|Physician Decision|1|||
161126471|NCT03502330|581850690|FG005|Overall Study|Physician Decision|0|||
161126472|NCT03502330|581850691|FG006|Overall Study|Physician Decision|0|||
161126473|NCT03502330|581850692|FG007|Overall Study|Physician Decision|0|||
161126474|NCT03502330|581850693|FG008|Overall Study|Physician Decision|0|||
161126475|NCT03502330|581850685|FG000|Overall Study|Withdrawal by Subject|0|||
161126476|NCT03502330|581850686|FG001|Overall Study|Withdrawal by Subject|0|||
161126477|NCT03502330|581850687|FG002|Overall Study|Withdrawal by Subject|0|||
161126478|NCT03502330|581850688|FG003|Overall Study|Withdrawal by Subject|0|||
161126479|NCT03502330|581850689|FG004|Overall Study|Withdrawal by Subject|0|||
161126480|NCT03502330|581850690|FG005|Overall Study|Withdrawal by Subject|1|||
161126481|NCT03502330|581850691|FG006|Overall Study|Withdrawal by Subject|0|||
161126482|NCT03502330|581850692|FG007|Overall Study|Withdrawal by Subject|1|||
161126483|NCT03502330|581850693|FG008|Overall Study|Withdrawal by Subject|0|||
161126484|NCT03502330|581850685|FG000|Overall Study|Death|0|||
161126485|NCT03502330|581850686|FG001|Overall Study|Death|0|||
161126486|NCT03502330|581850687|FG002|Overall Study|Death|0|||
161126487|NCT03502330|581850688|FG003|Overall Study|Death|0|||
161126488|NCT03502330|581850689|FG004|Overall Study|Death|0|||
161126489|NCT03502330|581850690|FG005|Overall Study|Death|0|||
161126490|NCT03502330|581850691|FG006|Overall Study|Death|2|||
161126491|NCT03502330|581850692|FG007|Overall Study|Death|0|||
161126492|NCT03502330|581850693|FG008|Overall Study|Death|0|||
161126493|NCT02804763|581850694|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
161126494|NCT02804763|581850695|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161126495|NCT02804763|581850696|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161126496|NCT02804763|581850697|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
161126497|NCT02804763|581850694|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
161126498|NCT02804763|581850695|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
161126499|NCT02804763|581850696|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
161126500|NCT02804763|581850697|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
161126501|NCT02804763|581850694|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161126502|NCT02804763|581850695|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
161126503|NCT02804763|581850696|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161126504|NCT02804763|581850697|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
161126505|NCT02804763|581850694|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
161126506|NCT02804763|581850695|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
161126507|NCT02804763|581850696|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
161328570|NCT03877224|582587174|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
161232194|NCT01214850|582232509|FG000|Overall Study|Unable to classify|2|||
161232195|NCT01214850|582232510|FG001|Overall Study|Unable to classify|1|||
161232196|NCT01214850|582232511|FG002|Overall Study|Unable to classify|1|||
161232197|NCT00610363|582232516|FG000|Overall Study|Non-compliance with protocol|0|||
161232198|NCT00610363|582232517|FG001|Overall Study|Non-compliance with protocol|1|||
161232199|NCT00610363|582232516|FG000|Overall Study|Adverse Event|3|||
161232200|NCT00610363|582232517|FG001|Overall Study|Adverse Event|1|||
161232201|NCT00610363|582232516|FG000|Overall Study|Lack of Efficacy|2|||
161232202|NCT00610363|582232517|FG001|Overall Study|Lack of Efficacy|0|||
161232203|NCT00610363|582232516|FG000|Overall Study|Lost to Follow-up|4|||
161232204|NCT00610363|582232517|FG001|Overall Study|Lost to Follow-up|0|||
161232205|NCT00610363|582232516|FG000|Overall Study|Withdrawal by Subject|1|||
161232206|NCT00610363|582232517|FG001|Overall Study|Withdrawal by Subject|0|||
161232207|NCT00610363|582232516|FG000|Overall Study|Other than specified above|1|||
161232208|NCT00610363|582232517|FG001|Overall Study|Other than specified above|1|||
161232209|NCT03361228|582232527|FG000|Overall Study|Other|1|||
161232210|NCT03361228|582232528|FG001|Overall Study|Other|1|||
161232211|NCT03361228|582232527|FG000|Overall Study|Death|3|||
161232212|NCT03361228|582232528|FG001|Overall Study|Death|0|||
161232213|NCT01722877|582232530|FG000|Overall Study|Death|1|||
161232214|NCT01722877|582232530|FG000|Overall Study|Lost to Follow-up|1|||
161232215|NCT03693430|582232531|FG000|Overall Study|Lost to Follow-up|3|||
161232216|NCT03693430|582232532|FG001|Overall Study|Lost to Follow-up|14|||
161232217|NCT03693430|582232531|FG000|Overall Study|Death|1|||
161232218|NCT03693430|582232532|FG001|Overall Study|Death|0|||
161232219|NCT03693430|582232531|FG000|Overall Study|Withdrawal by Subject|0|||
161232220|NCT03693430|582232532|FG001|Overall Study|Withdrawal by Subject|4|||
161232221|NCT02930005|582232534|FG000|Overall Study|Lost to Follow-up|1|||
161232222|NCT02930005|582232535|FG001|Overall Study|Lost to Follow-up|5|||
161232223|NCT00585689|582232536|FG000|Overall Study|Received different ABI-007 schedule|3|||
161232224|NCT00585689|582232536|FG000|Overall Study|Adverse Event|1|||
161232225|NCT00585689|582232536|FG000|Overall Study|Patient Declined Surgery|1|||
161232226|NCT00585689|582232536|FG000|Overall Study|Patient had unresectable disease|1|||
161232227|NCT00585689|582232536|FG000|Overall Study|Death|1|||
161232228|NCT02373098|582232537|FG000|Overall Study|Lost to Follow-up|1|||
161232229|NCT02373098|582232538|FG001|Overall Study|Lost to Follow-up|0|||
161232230|NCT02373098|582232537|FG000|Overall Study|Protocol Violation|3|||
161232231|NCT02373098|582232538|FG001|Overall Study|Protocol Violation|0|||
161232232|NCT02373098|582232537|FG000|Overall Study|Withdrawal by Subject|5|||
161232233|NCT02373098|582232538|FG001|Overall Study|Withdrawal by Subject|0|||
161232234|NCT02373098|582232537|FG000|Overall Study|Adverse Event|3|||
161232235|NCT02373098|582232538|FG001|Overall Study|Adverse Event|0|||
161232236|NCT00304083|582232542|FG000|Overall Study|Withdrawal by Subject|4|||
161232237|NCT00304083|582232543|FG001|Overall Study|Withdrawal by Subject|2|||
161232238|NCT00304083|582232542|FG000|Overall Study|Physician Decision|8|||
161232239|NCT00304083|582232543|FG001|Overall Study|Physician Decision|3|||
161232240|NCT00304083|582232542|FG000|Overall Study|Disease Progression|5|||
161232241|NCT00304083|582232543|FG001|Overall Study|Disease Progression|1|||
161232242|NCT00304083|582232542|FG000|Overall Study|Other|5|||
161232243|NCT00304083|582232543|FG001|Overall Study|Other|2|||
161232244|NCT03966365|582232544|FG000|Overall Study|Protocol Violation|1|||
161232245|NCT03966365|582232545|FG001|Overall Study|Protocol Violation|0|||
161232246|NCT01378975|582232546|FG000|Overall Study|Death|77|||
161232247|NCT01378975|582232547|FG001|Overall Study|Death|46|||
161232248|NCT01378975|582232546|FG000|Overall Study|Investigator Request|1|||
161232249|NCT01378975|582232547|FG001|Overall Study|Investigator Request|0|||
161232250|NCT01378975|582232546|FG000|Overall Study|Lost to Follow-up|4|||
161232251|NCT01378975|582232547|FG001|Overall Study|Lost to Follow-up|1|||
161126508|NCT02804763|581850697|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
161126509|NCT02804763|581850694|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
161126510|NCT02804763|581850695|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
161126511|NCT02804763|581850696|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
161126512|NCT02804763|581850697|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
161126513|NCT02804763|581850694|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161126514|NCT02804763|581850695|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
161126515|NCT02804763|581850696|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161126516|NCT02804763|581850697|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
161126517|NCT02472847|581850698|FG000|Overall Study|Withdrawal by Subject|1|||
161126518|NCT02472847|581850699|FG001|Overall Study|Withdrawal by Subject|5|||
161126519|NCT04656990|581850700|FG000|Baseline|pandemic|20|||
161126520|NCT04656990|581850701|FG001|Baseline|pandemic|24|||
161126521|NCT04656990|581850700|FG000|Follow Up Period|Lost to Follow-up|61|||
161126522|NCT04656990|581850701|FG001|Follow Up Period|Lost to Follow-up|73|||
161126523|NCT03244059|581850702|FG000|Specific Aim 1|Physician Decision|1|||
161126524|NCT03244059|581850703|FG001|Specific Aim 1|Physician Decision|0|||
161232252|NCT01378975|582232546|FG000|Overall Study|Withdrew Consent|4|||
161232253|NCT01378975|582232547|FG001|Overall Study|Withdrew Consent|3|||
161232254|NCT03929393|582232550|FG000|Overall Study|Death|1|||
161232255|NCT03929393|582232551|FG001|Overall Study|Death|0|||
161232256|NCT03929393|582232550|FG000|Overall Study|Time Commitment|2|||
161232257|NCT03929393|582232551|FG001|Overall Study|Time Commitment|5|||
161232258|NCT03929393|582232550|FG000|Overall Study|Motor Vehicle Accident|0|||
161232259|NCT03929393|582232551|FG001|Overall Study|Motor Vehicle Accident|1|||
161232260|NCT03929393|582232550|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
161232261|NCT03929393|582232551|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
161232262|NCT03929393|582232550|FG000|Overall Study|Other|1|||
161232263|NCT03929393|582232551|FG001|Overall Study|Other|3|||
161232264|NCT00694551|582232564|FG000|Overall Study|Disease Progression|1|||
161232265|NCT00694551|582232565|FG001|Overall Study|Disease Progression|0|||
161232266|NCT00694551|582232566|FG002|Overall Study|Disease Progression|1|||
161232267|NCT01937390|582232570|FG000|Overall Study|Death|2|||
161232268|NCT01937390|582232570|FG000|Overall Study|Lost to Follow-up|7|||
161232269|NCT01937390|582232570|FG000|Overall Study|Withdrawal by Subject|5|||
161232270|NCT01937390|582232570|FG000|Overall Study|Fail to return|21|||
161232271|NCT02216071|582232580|FG000|Overall Study|Withdrawal by Subject|7|||
161232272|NCT02216071|582232581|FG001|Overall Study|Withdrawal by Subject|2|||
161232273|NCT02216071|582232580|FG000|Overall Study|Lost to Follow-up|3|||
161232274|NCT02216071|582232581|FG001|Overall Study|Lost to Follow-up|3|||
161232275|NCT02216071|582232580|FG000|Overall Study|Protocol Violation|3|||
161232276|NCT02216071|582232581|FG001|Overall Study|Protocol Violation|5|||
161232277|NCT02216071|582232580|FG000|Overall Study|Other|2|||
161232278|NCT02216071|582232581|FG001|Overall Study|Other|2|||
161232279|NCT01706536|582232582|FG000|Overall Study|Withdrawal by Subject|1|||
161232280|NCT01706536|582232583|FG001|Overall Study|Withdrawal by Subject|0|||
161328571|NCT03877224|582587175|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
161232281|NCT01706536|582232584|FG002|Overall Study|Withdrawal by Subject|1|||
161232282|NCT01706536|582232585|FG003|Overall Study|Withdrawal by Subject|0|||
161232283|NCT01706536|582232586|FG004|Overall Study|Withdrawal by Subject|0|||
161232284|NCT01706536|582232582|FG000|Overall Study|Adverse Event|2|||
161232285|NCT01706536|582232583|FG001|Overall Study|Adverse Event|3|||
161232286|NCT01706536|582232584|FG002|Overall Study|Adverse Event|4|||
161232287|NCT01706536|582232585|FG003|Overall Study|Adverse Event|3|||
161232288|NCT01706536|582232586|FG004|Overall Study|Adverse Event|2|||
161232289|NCT01706536|582232582|FG000|Overall Study|Lack of Efficacy|1|||
161232290|NCT01706536|582232583|FG001|Overall Study|Lack of Efficacy|0|||
161232291|NCT01706536|582232584|FG002|Overall Study|Lack of Efficacy|0|||
161232292|NCT01706536|582232585|FG003|Overall Study|Lack of Efficacy|1|||
161232293|NCT01706536|582232586|FG004|Overall Study|Lack of Efficacy|0|||
161232294|NCT01706536|582232582|FG000|Overall Study|non compliance|0|||
161232295|NCT01706536|582232583|FG001|Overall Study|non compliance|1|||
161232296|NCT01706536|582232584|FG002|Overall Study|non compliance|0|||
161232297|NCT01706536|582232585|FG003|Overall Study|non compliance|0|||
161232298|NCT01706536|582232586|FG004|Overall Study|non compliance|0|||
161232299|NCT03262012|582232587|FG000|Overall Study|Withdrawal by Subject|15|||
161232300|NCT03262012|582232588|FG001|Overall Study|Withdrawal by Subject|13|||
161232301|NCT03262012|582232589|FG002|Overall Study|Withdrawal by Subject|8|||
161232302|NCT03262012|582232590|FG003|Overall Study|Withdrawal by Subject|7|||
161232303|NCT03262012|582232587|FG000|Overall Study|Adverse Event|10|||
161232304|NCT03262012|582232588|FG001|Overall Study|Adverse Event|12|||
161232305|NCT03262012|582232589|FG002|Overall Study|Adverse Event|4|||
161232306|NCT03262012|582232590|FG003|Overall Study|Adverse Event|6|||
161232307|NCT03262012|582232587|FG000|Overall Study|Physician Decision|2|||
161232308|NCT03262012|582232588|FG001|Overall Study|Physician Decision|5|||
161232309|NCT03262012|582232589|FG002|Overall Study|Physician Decision|1|||
161232310|NCT03262012|582232590|FG003|Overall Study|Physician Decision|0|||
161232311|NCT03262012|582232587|FG000|Overall Study|Lack of Efficacy|0|||
161232312|NCT03262012|582232588|FG001|Overall Study|Lack of Efficacy|5|||
161232313|NCT03262012|582232589|FG002|Overall Study|Lack of Efficacy|1|||
161232314|NCT03262012|582232590|FG003|Overall Study|Lack of Efficacy|2|||
161232315|NCT03262012|582232587|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
161232316|NCT03262012|582232588|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
161232317|NCT03262012|582232589|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
161232318|NCT03262012|582232590|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
161232319|NCT04753437|582232593|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161232320|NCT04753437|582232594|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161232321|NCT04753437|582232593|FG000|Overall Study|Liver Function Test Abnormalities|2|||
161232322|NCT04753437|582232594|FG001|Overall Study|Liver Function Test Abnormalities|4|||
161232323|NCT00385684|582232597|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
161232324|NCT00385684|582232598|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
161232325|NCT00385684|582232597|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
161232326|NCT00385684|582232598|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
161232327|NCT00385684|582232597|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
161232328|NCT00385684|582232598|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
161232329|NCT00154102|582232599|FG000|Overall Study|investigational study phase ongoing|7|||
161232330|NCT00154102|582232600|FG001|Overall Study|investigational study phase ongoing|2|||
161328572|NCT05664581|582589073|FG000|Overall Study|Withdrawal by Subject|2|||
161328573|NCT01317641|582589074|FG000|Overall Study|Not treated|0|||
161328574|NCT01317641|582589075|FG001|Overall Study|Not treated|0|||
161328575|NCT01317641|582589076|FG002|Overall Study|Not treated|0|||
161328576|NCT01317641|582589077|FG003|Overall Study|Not treated|0|||
161328577|NCT01317641|582589078|FG004|Overall Study|Not treated|0|||
161328578|NCT01317641|582589079|FG005|Overall Study|Not treated|0|||
161328579|NCT01317641|582589080|FG006|Overall Study|Not treated|0|||
161328580|NCT01317641|582589081|FG007|Overall Study|Not treated|1|||
161328581|NCT01317641|582589082|FG008|Overall Study|Not treated|1|||
161328582|NCT01317641|582589074|FG000|Overall Study|Adverse Event|0|||
161328583|NCT01317641|582589075|FG001|Overall Study|Adverse Event|1|||
161328584|NCT01317641|582589076|FG002|Overall Study|Adverse Event|0|||
161328585|NCT01317641|582589077|FG003|Overall Study|Adverse Event|1|||
161328586|NCT01317641|582589078|FG004|Overall Study|Adverse Event|0|||
161328587|NCT01317641|582589079|FG005|Overall Study|Adverse Event|0|||
161328588|NCT01317641|582589080|FG006|Overall Study|Adverse Event|2|||
161328589|NCT01317641|582589081|FG007|Overall Study|Adverse Event|1|||
161328590|NCT01317641|582589082|FG008|Overall Study|Adverse Event|0|||
161328591|NCT01317641|582589074|FG000|Overall Study|Protocol Violation|1|||
161328592|NCT01317641|582589075|FG001|Overall Study|Protocol Violation|0|||
161328593|NCT01317641|582589076|FG002|Overall Study|Protocol Violation|0|||
161328594|NCT01317641|582589077|FG003|Overall Study|Protocol Violation|0|||
161328595|NCT01317641|582589078|FG004|Overall Study|Protocol Violation|0|||
161328596|NCT01317641|582589079|FG005|Overall Study|Protocol Violation|0|||
161328597|NCT01317641|582589080|FG006|Overall Study|Protocol Violation|0|||
161126525|NCT03244059|581850702|FG000|Specific Aim 2|Physician Decision|1|||
161126526|NCT03244059|581850703|FG001|Specific Aim 2|Physician Decision|0|||
161126527|NCT05499520|581850704|FG000|Overall Study|Lost to Follow-up|0|||
161126528|NCT05499520|581850705|FG001|Overall Study|Lost to Follow-up|0|||
161126529|NCT05499520|581850706|FG002|Overall Study|Lost to Follow-up|38|||
161126530|NCT05499520|581850707|FG003|Overall Study|Lost to Follow-up|41|||
161126531|NCT05499520|581850708|FG004|Overall Study|Lost to Follow-up|46|||
161126532|NCT05499520|581850709|FG005|Overall Study|Lost to Follow-up|0|||
161126533|NCT05499520|581850710|FG006|Overall Study|Lost to Follow-up|31|||
161126534|NCT05499520|581850711|FG007|Overall Study|Lost to Follow-up|45|||
161126535|NCT05499520|581850712|FG008|Overall Study|Lost to Follow-up|42|||
161126536|NCT05499520|581850713|FG009|Overall Study|Lost to Follow-up|0|||
161126537|NCT05499520|581850714|FG010|Overall Study|Lost to Follow-up|0|||
161126538|NCT05499520|581850715|FG011|Overall Study|Lost to Follow-up|37|||
161126539|NCT05499520|581850716|FG012|Overall Study|Lost to Follow-up|53|||
161126540|NCT05499520|581850717|FG013|Overall Study|Lost to Follow-up|49|||
161126541|NCT05499520|581850718|FG014|Overall Study|Lost to Follow-up|0|||
161126542|NCT05499520|581850719|FG015|Overall Study|Lost to Follow-up|36|||
161126543|NCT05499520|581850720|FG016|Overall Study|Lost to Follow-up|58|||
161126544|NCT05499520|581850721|FG017|Overall Study|Lost to Follow-up|53|||
161126545|NCT01613326|581850722|FG000|Overall Study|Adverse Event|7|||
161126546|NCT01613326|581850723|FG001|Overall Study|Adverse Event|5|||
161126547|NCT01613326|581850722|FG000|Overall Study|Withdrawal by Subject|3|||
161126548|NCT01613326|581850723|FG001|Overall Study|Withdrawal by Subject|4|||
161126549|NCT01613326|581850722|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161126550|NCT01613326|581850723|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161126551|NCT01613326|581850722|FG000|Overall Study|inability to use device|1|||
161126552|NCT01613326|581850723|FG001|Overall Study|inability to use device|0|||
161126553|NCT01613326|581850722|FG000|Overall Study|Lack of Efficacy|0|||
161126554|NCT01613326|581850723|FG001|Overall Study|Lack of Efficacy|1|||
161126555|NCT01613326|581850722|FG000|Overall Study|Lost to Follow-up|0|||
161126556|NCT01613326|581850723|FG001|Overall Study|Lost to Follow-up|1|||
161126557|NCT01613326|581850722|FG000|Overall Study|Administrative|0|||
161126558|NCT01613326|581850723|FG001|Overall Study|Administrative|2|||
161126559|NCT01613326|581850722|FG000|Overall Study|Protocol Violation|0|||
161126560|NCT01613326|581850723|FG001|Overall Study|Protocol Violation|1|||
161126561|NCT00605267|581850724|FG000|Overall Study|Adverse Event|0|||
161126562|NCT00605267|581850725|FG001|Overall Study|Adverse Event|1|||
161126563|NCT00605267|581850724|FG000|Overall Study|Lack of Efficacy|1|||
161126564|NCT00605267|581850725|FG001|Overall Study|Lack of Efficacy|5|||
161126565|NCT00605267|581850724|FG000|Overall Study|Withdrawal by Subject|2|||
161126566|NCT00605267|581850725|FG001|Overall Study|Withdrawal by Subject|3|||
161126567|NCT00793793|581850726|FG000|Overall Study|Adverse Event|0|||
161126568|NCT00793793|581850727|FG001|Overall Study|Adverse Event|0|||
161126569|NCT00793793|581850728|FG002|Overall Study|Adverse Event|1|||
161126570|NCT00793793|581850729|FG003|Overall Study|Adverse Event|1|||
161126571|NCT00793793|581850730|FG004|Overall Study|Adverse Event|0|||
161126572|NCT00793793|581850731|FG005|Overall Study|Adverse Event|1|||
161126573|NCT00793793|581850732|FG006|Overall Study|Adverse Event|2|||
161126574|NCT00793793|581850733|FG007|Overall Study|Adverse Event|0|||
161328598|NCT01317641|582589081|FG007|Overall Study|Protocol Violation|0|||
161328599|NCT01317641|582589082|FG008|Overall Study|Protocol Violation|0|||
161328600|NCT01317641|582589074|FG000|Overall Study|Disease progression|0|||
161328601|NCT01317641|582589075|FG001|Overall Study|Disease progression|0|||
161328602|NCT01317641|582589076|FG002|Overall Study|Disease progression|0|||
161328603|NCT01317641|582589077|FG003|Overall Study|Disease progression|0|||
161328604|NCT01317641|582589078|FG004|Overall Study|Disease progression|0|||
161328605|NCT01317641|582589079|FG005|Overall Study|Disease progression|0|||
161232331|NCT00463606|582232601|FG000|Overall Study|Adverse Event|21|||
161232332|NCT00463606|582232602|FG001|Overall Study|Adverse Event|18|||
161232333|NCT00463606|582232603|FG002|Overall Study|Adverse Event|11|||
161232334|NCT00463606|582232601|FG000|Overall Study|Withdrawal by Subject|11|||
161328606|NCT01317641|582589080|FG006|Overall Study|Disease progression|0|||
161328607|NCT01317641|582589081|FG007|Overall Study|Disease progression|3|||
161232335|NCT00463606|582232602|FG001|Overall Study|Withdrawal by Subject|11|||
161232336|NCT00463606|582232603|FG002|Overall Study|Withdrawal by Subject|5|||
161232337|NCT00463606|582232601|FG000|Overall Study|Lost to Follow-up|2|||
161232338|NCT00463606|582232602|FG001|Overall Study|Lost to Follow-up|2|||
161328608|NCT01317641|582589082|FG008|Overall Study|Disease progression|4|||
161328609|NCT01317641|582589074|FG000|Overall Study|Withdrawal by Subject|0|||
161232339|NCT00463606|582232603|FG002|Overall Study|Lost to Follow-up|3|||
161232340|NCT00463606|582232601|FG000|Overall Study|Subject noncompliance|1|||
161232341|NCT00463606|582232602|FG001|Overall Study|Subject noncompliance|1|||
161232342|NCT00463606|582232603|FG002|Overall Study|Subject noncompliance|0|||
161232343|NCT00463606|582232601|FG000|Overall Study|Subject moved out of town|1|||
161232344|NCT00463606|582232602|FG001|Overall Study|Subject moved out of town|0|||
161328610|NCT01317641|582589075|FG001|Overall Study|Withdrawal by Subject|0|||
161328611|NCT01317641|582589076|FG002|Overall Study|Withdrawal by Subject|0|||
161328612|NCT01317641|582589077|FG003|Overall Study|Withdrawal by Subject|0|||
161328613|NCT01317641|582589078|FG004|Overall Study|Withdrawal by Subject|0|||
161328614|NCT01317641|582589079|FG005|Overall Study|Withdrawal by Subject|0|||
161328615|NCT01317641|582589080|FG006|Overall Study|Withdrawal by Subject|1|||
161328616|NCT01317641|582589081|FG007|Overall Study|Withdrawal by Subject|0|||
161328617|NCT01317641|582589082|FG008|Overall Study|Withdrawal by Subject|0|||
161328618|NCT01302418|582589083|FG000|Overall Study|Protocol Violation|9|||
161328619|NCT01302418|582589083|FG000|Overall Study|Non-evaluable|9|||
161328620|NCT02787304|582589088|FG000|Overall Study|Adverse Event|9|||
161328621|NCT02787304|582589089|FG001|Overall Study|Adverse Event|3|||
161328622|NCT02787304|582589090|FG002|Overall Study|Adverse Event|8|||
161328623|NCT02787304|582589091|FG003|Overall Study|Adverse Event|1|||
161328624|NCT02787304|582589088|FG000|Overall Study|Withdrawal by Subject|1|||
161328625|NCT02787304|582589089|FG001|Overall Study|Withdrawal by Subject|4|||
161328626|NCT02787304|582589090|FG002|Overall Study|Withdrawal by Subject|0|||
161328627|NCT02787304|582589091|FG003|Overall Study|Withdrawal by Subject|0|||
161328628|NCT02787304|582589088|FG000|Overall Study|Lost to Follow-up|1|||
161328629|NCT02787304|582589089|FG001|Overall Study|Lost to Follow-up|0|||
161328630|NCT02787304|582589090|FG002|Overall Study|Lost to Follow-up|0|||
161328631|NCT02787304|582589091|FG003|Overall Study|Lost to Follow-up|1|||
161328632|NCT02787304|582589088|FG000|Overall Study|Noncompliance with study drug|0|||
161328633|NCT02787304|582589089|FG001|Overall Study|Noncompliance with study drug|0|||
161328634|NCT02787304|582589090|FG002|Overall Study|Noncompliance with study drug|1|||
161328635|NCT02787304|582589091|FG003|Overall Study|Noncompliance with study drug|0|||
161328636|NCT02787304|582589088|FG000|Overall Study|Physician Decision|0|||
161328637|NCT02787304|582589089|FG001|Overall Study|Physician Decision|0|||
161328638|NCT02787304|582589090|FG002|Overall Study|Physician Decision|1|||
161328639|NCT02787304|582589091|FG003|Overall Study|Physician Decision|0|||
161328640|NCT02787304|582589088|FG000|Overall Study|Study terminated by sponsor|25|||
161328641|NCT02787304|582589089|FG001|Overall Study|Study terminated by sponsor|31|||
161328642|NCT02787304|582589090|FG002|Overall Study|Study terminated by sponsor|31|||
161328643|NCT02787304|582589091|FG003|Overall Study|Study terminated by sponsor|32|||
161328644|NCT04771013|582589096|FG000|Overall Study|Withdrawal by Subject|2|||
161328645|NCT04771013|582589097|FG001|Overall Study|Withdrawal by Subject|0|||
161232345|NCT00463606|582232603|FG002|Overall Study|Subject moved out of town|0|||
161232346|NCT00463606|582232601|FG000|Overall Study|Physician Decision|0|||
161232347|NCT00463606|582232602|FG001|Overall Study|Physician Decision|1|||
161232348|NCT00463606|582232603|FG002|Overall Study|Physician Decision|0|||
161232349|NCT00463606|582232601|FG000|Overall Study|Sponsor request|0|||
161232350|NCT00463606|582232602|FG001|Overall Study|Sponsor request|1|||
161232351|NCT00463606|582232603|FG002|Overall Study|Sponsor request|0|||
161232352|NCT00463606|582232601|FG000|Overall Study|Exclusion criteria violation|2|||
161232353|NCT00463606|582232602|FG001|Overall Study|Exclusion criteria violation|0|||
161232354|NCT00463606|582232603|FG002|Overall Study|Exclusion criteria violation|0|||
161232355|NCT00463606|582232601|FG000|Overall Study|Coordinator error|1|||
161232356|NCT00463606|582232602|FG001|Overall Study|Coordinator error|0|||
161328646|NCT04771013|582589096|FG000|Overall Study|Death|0|||
161328647|NCT04771013|582589097|FG001|Overall Study|Death|5|||
161328648|NCT04771013|582589096|FG000|Overall Study|Referred to another hospital before day 20|0|||
161328649|NCT04771013|582589097|FG001|Overall Study|Referred to another hospital before day 20|1|||
161328650|NCT00419757|582589098|FG000|Overall Study|Adverse Event|1|||
161328651|NCT00419757|582589099|FG001|Overall Study|Adverse Event|4|||
161328652|NCT00419757|582589098|FG000|Overall Study|Lost to Follow-up|1|||
161328653|NCT00419757|582589099|FG001|Overall Study|Lost to Follow-up|4|||
161232357|NCT00463606|582232603|FG002|Overall Study|Coordinator error|0|||
161232358|NCT00463606|582232601|FG000|Overall Study|Patient randomized in error|1|||
161232359|NCT00463606|582232602|FG001|Overall Study|Patient randomized in error|0|||
161232360|NCT00463606|582232603|FG002|Overall Study|Patient randomized in error|0|||
161232361|NCT00463606|582232601|FG000|Overall Study|Participation in another ABT-335 trial|1|||
161232362|NCT00463606|582232602|FG001|Overall Study|Participation in another ABT-335 trial|0|||
161232363|NCT00463606|582232603|FG002|Overall Study|Participation in another ABT-335 trial|0|||
161232364|NCT00463606|582232601|FG000|Overall Study|Protocol Violation|0|||
161232365|NCT00463606|582232602|FG001|Overall Study|Protocol Violation|0|||
161232366|NCT00463606|582232603|FG002|Overall Study|Protocol Violation|1|||
161232367|NCT02682602|582232605|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
161232368|NCT02682602|582232606|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
161232369|NCT02682602|582232605|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
161232370|NCT02682602|582232606|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
161232371|NCT03567174|582232607|FG000|Overall Study|Death|24|||
161232372|NCT03567174|582232608|FG001|Overall Study|Death|31|||
161232373|NCT03567174|582232607|FG000|Overall Study|Lost to Follow-up|165|||
161232374|NCT03567174|582232608|FG001|Overall Study|Lost to Follow-up|174|||
161232375|NCT02140060|582232609|FG000|Overall Study|Adverse Event|0|||
161232376|NCT02140060|582232610|FG001|Overall Study|Adverse Event|0|||
161232377|NCT02140060|582232611|FG002|Overall Study|Adverse Event|0|||
161232378|NCT02140060|582232612|FG003|Overall Study|Adverse Event|1|||
161232379|NCT02140060|582232613|FG004|Overall Study|Adverse Event|1|||
161232380|NCT02140060|582232614|FG005|Overall Study|Adverse Event|1|||
161232381|NCT02140060|582232609|FG000|Overall Study|Lack of Efficacy|0|||
161232382|NCT02140060|582232610|FG001|Overall Study|Lack of Efficacy|0|||
161232383|NCT02140060|582232611|FG002|Overall Study|Lack of Efficacy|0|||
161232384|NCT02140060|582232612|FG003|Overall Study|Lack of Efficacy|1|||
161232385|NCT02140060|582232613|FG004|Overall Study|Lack of Efficacy|0|||
161232386|NCT02140060|582232614|FG005|Overall Study|Lack of Efficacy|0|||
161232387|NCT01066143|582234525|FG000|Overall Study|ineligible for the study|8|||
161232388|NCT05376319|582234526|FG000|Overall Study|Funding termination|2|||
161232389|NCT05376319|582234527|FG001|Overall Study|Funding termination|4|||
161232390|NCT01340495|582234528|FG000|Overall Study|Withdrawal by Subject|1|||
161232391|NCT03497897|582234529|FG000|Overall Study|Adverse Event|1|||
161232392|NCT03497897|582234530|FG001|Overall Study|Adverse Event|1|||
161232393|NCT03497897|582234531|FG002|Overall Study|Adverse Event|1|||
161232394|NCT03497897|582234529|FG000|Overall Study|Lost to Follow-up|2|||
161232395|NCT03497897|582234530|FG001|Overall Study|Lost to Follow-up|0|||
161232396|NCT03497897|582234531|FG002|Overall Study|Lost to Follow-up|2|||
161232397|NCT03497897|582234529|FG000|Overall Study|Physician Decision|1|||
161232398|NCT03497897|582234530|FG001|Overall Study|Physician Decision|0|||
161232399|NCT03497897|582234531|FG002|Overall Study|Physician Decision|0|||
161232400|NCT03497897|582234529|FG000|Overall Study|Subject/Guardian Decision|2|||
161232401|NCT03497897|582234530|FG001|Overall Study|Subject/Guardian Decision|1|||
161232402|NCT03497897|582234531|FG002|Overall Study|Subject/Guardian Decision|3|||
161232403|NCT00723528|582234532|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
161232404|NCT00723528|582234533|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
161232405|NCT00723528|582234534|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
161232406|NCT00723528|582234535|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
161232407|NCT00723528|582234536|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
161232408|NCT00723528|582234537|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
161232409|NCT00723528|582234538|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
161232410|NCT00723528|582234532|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
161232411|NCT00723528|582234533|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161328654|NCT00419757|582589098|FG000|Overall Study|Withdrawal by Subject|7|||
161328655|NCT00419757|582589099|FG001|Overall Study|Withdrawal by Subject|1|||
161328656|NCT00419757|582589098|FG000|Overall Study|Protocol Violation|2|||
161328657|NCT00419757|582589099|FG001|Overall Study|Protocol Violation|3|||
161328658|NCT00419757|582589098|FG000|Overall Study|Study specific discontinuation criteria|4|||
161328659|NCT00419757|582589099|FG001|Overall Study|Study specific discontinuation criteria|8|||
160787511|NCT00987935|580607335|FG001|Overall Study|Progressive disease|2|||
161232412|NCT00723528|582234534|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161232413|NCT00723528|582234535|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161232414|NCT00723528|582234536|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161232415|NCT00723528|582234537|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161232416|NCT00723528|582234538|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
161232417|NCT00723528|582234532|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
161232418|NCT00723528|582234533|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
161232419|NCT00723528|582234534|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
161232420|NCT00723528|582234535|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
161232421|NCT00723528|582234536|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
161232422|NCT00723528|582234537|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
161328660|NCT00419757|582589098|FG000|Overall Study|Multiple reasons|3|||
161328661|NCT00419757|582589099|FG001|Overall Study|Multiple reasons|1|||
161328662|NCT01051921|582589100|FG000|Overall Study|Physician Decision|9|||
161328663|NCT01051921|582589100|FG000|Overall Study|Adverse Event|8|||
161328664|NCT01051921|582589100|FG000|Overall Study|Withdrawal by Subject|7|||
161328665|NCT01051921|582589100|FG000|Overall Study|Lost to Follow-up|4|||
161328666|NCT01051921|582589100|FG000|Overall Study|virological failure|1|||
161328667|NCT01051921|582589100|FG000|Overall Study|patient moved|1|||
161328668|NCT00379834|582589104|FG000|Overall Study|Time constraints|2|||
161328669|NCT01519817|582589105|FG000|Overall Study|Withdrawal by Subject|1|||
161328670|NCT01519817|582589106|FG001|Overall Study|Withdrawal by Subject|0|||
161328671|NCT01519817|582589107|FG002|Overall Study|Withdrawal by Subject|0|||
161328672|NCT01519817|582589108|FG003|Overall Study|Withdrawal by Subject|0|||
161328673|NCT01519817|582589105|FG000|Overall Study|Off study due to infection|0|||
161328674|NCT01519817|582589106|FG001|Overall Study|Off study due to infection|0|||
161328675|NCT01519817|582589107|FG002|Overall Study|Off study due to infection|0|||
161328676|NCT01519817|582589108|FG003|Overall Study|Off study due to infection|1|||
161328677|NCT01716806|582589113|FG000|Overall Study|Patient withdrawal of consent|4|||
161328678|NCT01716806|582589114|FG001|Overall Study|Patient withdrawal of consent|2|||
161328679|NCT01716806|582589115|FG002|Overall Study|Patient withdrawal of consent|4|||
161328680|NCT01716806|582589116|FG003|Overall Study|Patient withdrawal of consent|3|||
161328681|NCT01716806|582589117|FG004|Overall Study|Patient withdrawal of consent|2|||
161328682|NCT01716806|582589118|FG005|Overall Study|Patient withdrawal of consent|0|||
161328683|NCT01716806|582589113|FG000|Overall Study|Lost to Follow-up|3|||
161328684|NCT01716806|582589114|FG001|Overall Study|Lost to Follow-up|3|||
161328685|NCT01716806|582589115|FG002|Overall Study|Lost to Follow-up|0|||
161328686|NCT01716806|582589116|FG003|Overall Study|Lost to Follow-up|2|||
161328687|NCT01716806|582589117|FG004|Overall Study|Lost to Follow-up|1|||
161328688|NCT01716806|582589118|FG005|Overall Study|Lost to Follow-up|0|||
161328689|NCT01716806|582589113|FG000|Overall Study|Death|13|||
161328690|NCT01716806|582589114|FG001|Overall Study|Death|9|||
161328691|NCT01716806|582589115|FG002|Overall Study|Death|12|||
161328692|NCT01716806|582589116|FG003|Overall Study|Death|4|||
161328693|NCT01716806|582589117|FG004|Overall Study|Death|10|||
161328694|NCT01716806|582589118|FG005|Overall Study|Death|5|||
161328695|NCT01716806|582589113|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161328696|NCT01716806|582589114|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161328697|NCT01716806|582589115|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161328698|NCT01716806|582589116|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
161328699|NCT01716806|582589117|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
161328700|NCT01716806|582589118|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
161328701|NCT01716806|582589113|FG000|Overall Study|PI decision|0|||
161328702|NCT01716806|582589114|FG001|Overall Study|PI decision|0|||
161328703|NCT01716806|582589115|FG002|Overall Study|PI decision|0|||
161328704|NCT01716806|582589116|FG003|Overall Study|PI decision|0|||
161328705|NCT01716806|582589117|FG004|Overall Study|PI decision|1|||
161328706|NCT01716806|582589118|FG005|Overall Study|PI decision|0|||
161328707|NCT01716806|582589113|FG000|Overall Study|Change in performance status|1|||
161328708|NCT01716806|582589114|FG001|Overall Study|Change in performance status|0|||
161328709|NCT01716806|582589115|FG002|Overall Study|Change in performance status|0|||
161328710|NCT01716806|582589116|FG003|Overall Study|Change in performance status|0|||
161328711|NCT01716806|582589117|FG004|Overall Study|Change in performance status|0|||
161328712|NCT01716806|582589118|FG005|Overall Study|Change in performance status|0|||
161328713|NCT01716806|582589113|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
161328714|NCT01716806|582589114|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
161328715|NCT01716806|582589115|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
161328716|NCT01716806|582589116|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
161328717|NCT01716806|582589117|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
161328718|NCT01716806|582589118|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
161328719|NCT01716806|582589113|FG000|Overall Study|Sponsor direction|7|||
161328720|NCT01716806|582589114|FG001|Overall Study|Sponsor direction|8|||
161328721|NCT01716806|582589115|FG002|Overall Study|Sponsor direction|5|||
161328722|NCT01716806|582589116|FG003|Overall Study|Sponsor direction|12|||
161328723|NCT01716806|582589117|FG004|Overall Study|Sponsor direction|16|||
161328724|NCT01716806|582589118|FG005|Overall Study|Sponsor direction|1|||
161328725|NCT01063855|582589127|FG000|Overall Study|Adverse Event|4|||
161328726|NCT01063855|582589128|FG001|Overall Study|Adverse Event|4|||
161328727|NCT01063855|582589127|FG000|Overall Study|Death|0|||
161328728|NCT01063855|582589128|FG001|Overall Study|Death|1|||
161328729|NCT01063855|582589127|FG000|Overall Study|Lost to Follow-up|8|||
161328730|NCT01063855|582589128|FG001|Overall Study|Lost to Follow-up|4|||
161328731|NCT01063855|582589127|FG000|Overall Study|Pregnancy|1|||
161328732|NCT01063855|582589128|FG001|Overall Study|Pregnancy|0|||
161328733|NCT01063855|582589127|FG000|Overall Study|Lack of Efficacy|0|||
161328734|NCT01063855|582589128|FG001|Overall Study|Lack of Efficacy|1|||
161232423|NCT00723528|582234538|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
161232424|NCT00723528|582234532|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161232425|NCT00723528|582234533|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161232426|NCT00723528|582234534|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
161232427|NCT00723528|582234535|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161232428|NCT00723528|582234536|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161232429|NCT00723528|582234537|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161232430|NCT00723528|582234538|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
161232431|NCT00723528|582234532|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
161232432|NCT00723528|582234533|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161232433|NCT00723528|582234534|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
161232434|NCT00723528|582234535|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161232435|NCT00723528|582234536|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161232436|NCT00723528|582234537|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161232437|NCT00723528|582234538|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
161232438|NCT00723528|582234532|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161232439|NCT00723528|582234533|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161232440|NCT00723528|582234534|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161232441|NCT00723528|582234535|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161232442|NCT00723528|582234536|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
161232443|NCT00723528|582234537|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161232444|NCT00723528|582234538|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
161232445|NCT00723528|582234532|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161232446|NCT00723528|582234533|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161232447|NCT00723528|582234534|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161232448|NCT00723528|582234535|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161232449|NCT00723528|582234536|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161232450|NCT00723528|582234537|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
161232451|NCT00723528|582234538|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
161232452|NCT00723528|582234532|FG000|Period 2: After Controlled Period|Other|0|||
161232453|NCT00723528|582234533|FG001|Period 2: After Controlled Period|Other|0|||
161232454|NCT00723528|582234534|FG002|Period 2: After Controlled Period|Other|0|||
161232455|NCT00723528|582234535|FG003|Period 2: After Controlled Period|Other|0|||
161232456|NCT00723528|582234536|FG004|Period 2: After Controlled Period|Other|1|||
161232457|NCT00723528|582234537|FG005|Period 2: After Controlled Period|Other|4|||
161232458|NCT00723528|582234538|FG006|Period 2: After Controlled Period|Other|0|||
161232459|NCT00723528|582234532|FG000|Period 2: After Controlled Period|Adverse Event|0|||
161232460|NCT00723528|582234533|FG001|Period 2: After Controlled Period|Adverse Event|0|||
161232461|NCT00723528|582234534|FG002|Period 2: After Controlled Period|Adverse Event|0|||
161232462|NCT00723528|582234535|FG003|Period 2: After Controlled Period|Adverse Event|0|||
161232463|NCT00723528|582234536|FG004|Period 2: After Controlled Period|Adverse Event|1|||
161232464|NCT00723528|582234537|FG005|Period 2: After Controlled Period|Adverse Event|0|||
161232465|NCT00723528|582234538|FG006|Period 2: After Controlled Period|Adverse Event|1|||
161232466|NCT00723528|582234532|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161232467|NCT00723528|582234533|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161232468|NCT00723528|582234534|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161232469|NCT00723528|582234535|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161328735|NCT01063855|582589127|FG000|Overall Study|Withdrawal by Subject|11|||
161328736|NCT01063855|582589128|FG001|Overall Study|Withdrawal by Subject|8|||
161328737|NCT01063855|582589127|FG000|Overall Study|Reason not specified|13|||
161328738|NCT01063855|582589128|FG001|Overall Study|Reason not specified|11|||
161328739|NCT00735709|582589129|FG000|Overall Study|Adverse Event|2|||
161328740|NCT00735709|582589130|FG001|Overall Study|Adverse Event|3|||
161328741|NCT00735709|582589131|FG002|Overall Study|Adverse Event|1|||
161328742|NCT00735709|582589132|FG003|Overall Study|Adverse Event|5|||
161328743|NCT00735709|582589129|FG000|Overall Study|Lack of Efficacy|8|||
161328744|NCT00735709|582589130|FG001|Overall Study|Lack of Efficacy|4|||
161328745|NCT00735709|582589131|FG002|Overall Study|Lack of Efficacy|2|||
161328746|NCT00735709|582589132|FG003|Overall Study|Lack of Efficacy|3|||
161232470|NCT00723528|582234536|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161232471|NCT00723528|582234537|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
161232472|NCT00723528|582234538|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
161232473|NCT00723528|582234532|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161328747|NCT00735709|582589129|FG000|Overall Study|Noncompliance|0|||
161328748|NCT00735709|582589130|FG001|Overall Study|Noncompliance|0|||
161328749|NCT00735709|582589131|FG002|Overall Study|Noncompliance|1|||
161328750|NCT00735709|582589132|FG003|Overall Study|Noncompliance|0|||
161232474|NCT00723528|582234533|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161232475|NCT00723528|582234534|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161232476|NCT00723528|582234535|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161232477|NCT00723528|582234536|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161232478|NCT00723528|582234537|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
161232479|NCT00723528|582234538|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
161232480|NCT00667862|582234540|FG000|Overall Study|Adverse Event|9|||
161232481|NCT00667862|582234540|FG000|Overall Study|Death|1|||
161232482|NCT00667862|582234540|FG000|Overall Study|Disease Progression|22|||
161232483|NCT00667862|582234540|FG000|Overall Study|Withdrawal by Subject|3|||
161232484|NCT00667095|582234544|FG000|Overall Study|Withdrawal by Subject|0|||
161232485|NCT00667095|582234545|FG001|Overall Study|Withdrawal by Subject|1|||
161232486|NCT01520909|582234546|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
161232487|NCT01520909|582234547|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
161232488|NCT01520909|582234548|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
161232489|NCT01520909|582234546|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
161232490|NCT01520909|582234547|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
161232491|NCT01520909|582234548|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
161232492|NCT01520909|582234546|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
161232493|NCT01520909|582234547|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
161232494|NCT01520909|582234548|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
161232495|NCT01520909|582234546|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
161232496|NCT01520909|582234547|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
161232497|NCT01520909|582234548|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
161232498|NCT01435265|582234550|FG000|Overall Study|Lost to Follow-up|0|||
161232499|NCT01435265|582234551|FG001|Overall Study|Lost to Follow-up|1|||
161232500|NCT01149473|582234552|FG000|First Intervention|Adverse Event|1|||
161232501|NCT01149473|582234553|FG001|First Intervention|Adverse Event|1|||
161232502|NCT01149473|582234552|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161232503|NCT01149473|582234553|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161328751|NCT00735709|582589129|FG000|Overall Study|Protocol deviations|1|||
161328752|NCT00735709|582589130|FG001|Overall Study|Protocol deviations|2|||
161328753|NCT00735709|582589131|FG002|Overall Study|Protocol deviations|1|||
161328754|NCT00735709|582589132|FG003|Overall Study|Protocol deviations|1|||
161328755|NCT00735709|582589129|FG000|Overall Study|Voluntary Withdrawal|1|||
161328756|NCT00735709|582589130|FG001|Overall Study|Voluntary Withdrawal|3|||
161328757|NCT00735709|582589131|FG002|Overall Study|Voluntary Withdrawal|5|||
161328758|NCT00735709|582589132|FG003|Overall Study|Voluntary Withdrawal|7|||
161328759|NCT00735709|582589129|FG000|Overall Study|Lost to Follow-up|0|||
161328760|NCT00735709|582589130|FG001|Overall Study|Lost to Follow-up|1|||
161328761|NCT00735709|582589131|FG002|Overall Study|Lost to Follow-up|1|||
161328762|NCT00735709|582589132|FG003|Overall Study|Lost to Follow-up|1|||
161328763|NCT00735709|582589129|FG000|Overall Study|Excluded medication|1|||
161328764|NCT00735709|582589130|FG001|Overall Study|Excluded medication|0|||
161328765|NCT00735709|582589131|FG002|Overall Study|Excluded medication|0|||
161328766|NCT00735709|582589132|FG003|Overall Study|Excluded medication|1|||
161328767|NCT03234036|582589136|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
161328768|NCT03234036|582589137|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
161328769|NCT03234036|582589138|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
161328770|NCT03234036|582589139|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
161328771|NCT02683239|582589157|FG000|Overall Study|Protocol Violation|35|||
161328772|NCT02683239|582589158|FG001|Overall Study|Protocol Violation|23|||
161328773|NCT02683239|582589159|FG002|Overall Study|Protocol Violation|26|||
161328774|NCT02683239|582589160|FG003|Overall Study|Protocol Violation|4|||
161328775|NCT02683239|582589161|FG004|Overall Study|Protocol Violation|35|||
161328776|NCT02683239|582589162|FG005|Overall Study|Protocol Violation|4|||
161328777|NCT02683239|582589163|FG006|Overall Study|Protocol Violation|5|||
161232504|NCT02128997|582234554|FG000|Overall Study|Lost to Follow-up|6|||
161328778|NCT02683239|582589157|FG000|Overall Study|Adverse Event|64|||
161232505|NCT02128997|582234555|FG001|Overall Study|Lost to Follow-up|11|||
161232506|NCT02422264|582234556|FG000|Overall Study|Serious Adverse Event|1|||
161232507|NCT02422264|582234557|FG001|Overall Study|Serious Adverse Event|0|||
161232508|NCT02422264|582234556|FG000|Overall Study|Withdrawal by Subject|1|||
161232509|NCT02422264|582234557|FG001|Overall Study|Withdrawal by Subject|2|||
161232510|NCT02422264|582234556|FG000|Overall Study|Migrated/moved from study area|3|||
161328779|NCT02683239|582589158|FG001|Overall Study|Adverse Event|39|||
161328780|NCT02683239|582589159|FG002|Overall Study|Adverse Event|42|||
161328781|NCT02683239|582589160|FG003|Overall Study|Adverse Event|16|||
161328782|NCT02683239|582589161|FG004|Overall Study|Adverse Event|189|||
161328783|NCT02683239|582589162|FG005|Overall Study|Adverse Event|9|||
161328784|NCT02683239|582589163|FG006|Overall Study|Adverse Event|9|||
161328785|NCT02683239|582589157|FG000|Overall Study|Physician Decision|38|||
161328786|NCT02683239|582589158|FG001|Overall Study|Physician Decision|19|||
161232511|NCT02422264|582234557|FG001|Overall Study|Migrated/moved from study area|1|||
161232512|NCT02422264|582234556|FG000|Overall Study|Subject vaccinated outside of the study|0|||
161232513|NCT02422264|582234557|FG001|Overall Study|Subject vaccinated outside of the study|1|||
161232514|NCT03021018|582234561|FG000|Overall Study|Adverse Event|1|||
161232515|NCT03021018|582234562|FG001|Overall Study|Adverse Event|0|||
161232516|NCT03021018|582234563|FG002|Overall Study|Adverse Event|0|||
161232517|NCT03021018|582234561|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
161232518|NCT03021018|582234562|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
161232519|NCT03021018|582234563|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
161232520|NCT00856388|582234572|FG000|Overall Study|Other|1|||
161232521|NCT05038293|582234573|FG000|Overall Study|device was not operating properly for one subject.|1|||
161232522|NCT05038293|582234574|FG001|Overall Study|device was not operating properly for one subject.|0|||
161232523|NCT05038293|582234573|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
161232524|NCT05038293|582234574|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
161232525|NCT01171989|582234576|FG000|Overall Study|Lost to Follow-up|0|||
161232526|NCT01171989|582234577|FG001|Overall Study|Lost to Follow-up|0|||
161232527|NCT01171989|582234578|FG002|Overall Study|Lost to Follow-up|1|||
161232528|NCT00418184|582234579|FG000|Double-blind Phase|Withdrawal by Subject|22|||
161232529|NCT00418184|582234580|FG001|Double-blind Phase|Withdrawal by Subject|9|||
161232530|NCT00418184|582234579|FG000|Double-blind Phase|Adverse Event|2|||
161232531|NCT00418184|582234580|FG001|Double-blind Phase|Adverse Event|1|||
161232532|NCT00418184|582234579|FG000|Double-blind Phase|Poor compliance|3|||
161232533|NCT00418184|582234580|FG001|Double-blind Phase|Poor compliance|1|||
161232534|NCT00620074|582234582|FG000|Overall Study|Adverse Event|1|||
161232535|NCT01247701|582234584|FG000|Overall Study|Death|2|||
161232536|NCT01247701|582234584|FG000|Overall Study|Relapsed|8|||
161232537|NCT04166630|582234585|FG000|Overall Study|Withdrawal by Subject|0|||
161232538|NCT04166630|582234586|FG001|Overall Study|Withdrawal by Subject|1|||
161232539|NCT02822235|582234587|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
161232540|NCT02822235|582234588|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
161328787|NCT02683239|582589159|FG002|Overall Study|Physician Decision|14|||
161328788|NCT02683239|582589160|FG003|Overall Study|Physician Decision|73|||
161328789|NCT02683239|582589161|FG004|Overall Study|Physician Decision|143|||
161232541|NCT02822235|582234587|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
161328790|NCT02683239|582589162|FG005|Overall Study|Physician Decision|14|||
161328791|NCT02683239|582589163|FG006|Overall Study|Physician Decision|15|||
161328792|NCT02683239|582589157|FG000|Overall Study|Withdrawal by Subject|187|||
161328793|NCT02683239|582589158|FG001|Overall Study|Withdrawal by Subject|99|||
161328794|NCT02683239|582589159|FG002|Overall Study|Withdrawal by Subject|91|||
161328795|NCT02683239|582589160|FG003|Overall Study|Withdrawal by Subject|18|||
161328796|NCT02683239|582589161|FG004|Overall Study|Withdrawal by Subject|248|||
161232542|NCT02822235|582234588|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
161232543|NCT02822235|582234587|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
161232544|NCT02822235|582234588|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
161232545|NCT02822235|582234587|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
161232546|NCT02822235|582234588|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
161232547|NCT02822235|582234587|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
161232548|NCT02822235|582234588|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
161232549|NCT02822235|582234587|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
161232550|NCT02822235|582234588|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
161232551|NCT01038856|582234591|FG000|Overall Study|Adverse Event|2|||
161232552|NCT04638153|582234592|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161232553|NCT04638153|582234593|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161232554|NCT04638153|582234594|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161232555|NCT04638153|582234592|FG000|Overall Study|Study terminated by sponsor|4|||
161232556|NCT04638153|582234593|FG001|Overall Study|Study terminated by sponsor|2|||
161232557|NCT04638153|582234594|FG002|Overall Study|Study terminated by sponsor|14|||
161232558|NCT01440283|582234595|FG000|Overall Study|Death|3|||
161232559|NCT01440283|582234595|FG000|Overall Study|Withdrawal by Subject|4|||
161232560|NCT01440283|582234595|FG000|Overall Study|Physician Decision|3|||
161232561|NCT01196052|582234596|FG000|Overall Study|Adverse Event|9|||
161232562|NCT01196052|582234596|FG000|Overall Study|Lost to Follow-up|1|||
161232563|NCT01196052|582234596|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
161232564|NCT01196052|582234596|FG000|Overall Study|Reason not Specified|5|||
161232565|NCT01196052|582234596|FG000|Overall Study|Withdrawal by Subject|6|||
161232566|NCT03603314|582234597|FG000|Overall Study|Lost to Follow-up|0|||
161232567|NCT03603314|582234598|FG001|Overall Study|Lost to Follow-up|3|||
161232568|NCT03603314|582234599|FG002|Overall Study|Lost to Follow-up|0|||
161232569|NCT03603314|582234597|FG000|Overall Study|Protocol Violation|0|||
161232570|NCT03603314|582234598|FG001|Overall Study|Protocol Violation|1|||
161232571|NCT03603314|582234599|FG002|Overall Study|Protocol Violation|0|||
161328797|NCT02683239|582589162|FG005|Overall Study|Withdrawal by Subject|22|||
161328798|NCT02683239|582589163|FG006|Overall Study|Withdrawal by Subject|28|||
161232572|NCT03603314|582234597|FG000|Overall Study|Adverse Event|2|||
161232573|NCT03603314|582234598|FG001|Overall Study|Adverse Event|0|||
161232574|NCT03603314|582234599|FG002|Overall Study|Adverse Event|0|||
161232575|NCT03603314|582234597|FG000|Overall Study|Physician Decision|1|||
161232576|NCT03603314|582234598|FG001|Overall Study|Physician Decision|1|||
161232577|NCT03603314|582234599|FG002|Overall Study|Physician Decision|0|||
161232578|NCT03603314|582234597|FG000|Overall Study|Withdrawal by Subject|4|||
161232579|NCT03603314|582234598|FG001|Overall Study|Withdrawal by Subject|5|||
161232580|NCT03603314|582234599|FG002|Overall Study|Withdrawal by Subject|3|||
161232581|NCT03603314|582234597|FG000|Overall Study|Other|0|||
161232582|NCT03603314|582234598|FG001|Overall Study|Other|1|||
161232583|NCT03603314|582234599|FG002|Overall Study|Other|0|||
161232584|NCT01389102|582234600|FG000|Overall Study|Adverse Event|1|||
161232585|NCT01389102|582234601|FG001|Overall Study|Adverse Event|3|||
161232586|NCT01389102|582234602|FG002|Overall Study|Adverse Event|2|||
161232587|NCT01389102|582234603|FG003|Overall Study|Adverse Event|2|||
161232588|NCT01389102|582234604|FG004|Overall Study|Adverse Event|2|||
161232589|NCT01389102|582234605|FG005|Overall Study|Adverse Event|2|||
161232590|NCT01389102|582234600|FG000|Overall Study|Hurricane Katrina|4|||
161232591|NCT01389102|582234601|FG001|Overall Study|Hurricane Katrina|2|||
161232592|NCT01389102|582234602|FG002|Overall Study|Hurricane Katrina|3|||
161232593|NCT01389102|582234603|FG003|Overall Study|Hurricane Katrina|0|||
161232594|NCT01389102|582234604|FG004|Overall Study|Hurricane Katrina|3|||
161232595|NCT01389102|582234605|FG005|Overall Study|Hurricane Katrina|1|||
161232596|NCT01389102|582234600|FG000|Overall Study|Lost to Follow-up|4|||
161232597|NCT01389102|582234601|FG001|Overall Study|Lost to Follow-up|1|||
161232598|NCT01389102|582234602|FG002|Overall Study|Lost to Follow-up|1|||
161232599|NCT01389102|582234603|FG003|Overall Study|Lost to Follow-up|2|||
161232600|NCT01389102|582234604|FG004|Overall Study|Lost to Follow-up|4|||
161232601|NCT01389102|582234605|FG005|Overall Study|Lost to Follow-up|1|||
161232602|NCT01389102|582234600|FG000|Overall Study|Protocol Violation|0|||
161232603|NCT01389102|582234601|FG001|Overall Study|Protocol Violation|0|||
161232604|NCT01389102|582234602|FG002|Overall Study|Protocol Violation|3|||
161232605|NCT01389102|582234603|FG003|Overall Study|Protocol Violation|0|||
161232606|NCT01389102|582234604|FG004|Overall Study|Protocol Violation|1|||
161232607|NCT01389102|582234605|FG005|Overall Study|Protocol Violation|1|||
161232608|NCT01389102|582234600|FG000|Overall Study|Withdrawal by Subject|7|||
161232609|NCT01389102|582234601|FG001|Overall Study|Withdrawal by Subject|4|||
161232610|NCT01389102|582234602|FG002|Overall Study|Withdrawal by Subject|9|||
161232611|NCT01389102|582234603|FG003|Overall Study|Withdrawal by Subject|2|||
161232612|NCT01389102|582234604|FG004|Overall Study|Withdrawal by Subject|3|||
161232613|NCT01389102|582234605|FG005|Overall Study|Withdrawal by Subject|3|||
161232614|NCT01389102|582234600|FG000|Overall Study|Subject Traveling Out of Country|0|||
161232615|NCT01389102|582234601|FG001|Overall Study|Subject Traveling Out of Country|0|||
161232616|NCT01389102|582234602|FG002|Overall Study|Subject Traveling Out of Country|0|||
161232617|NCT01389102|582234603|FG003|Overall Study|Subject Traveling Out of Country|1|||
161232618|NCT01389102|582234604|FG004|Overall Study|Subject Traveling Out of Country|0|||
161232619|NCT01389102|582234605|FG005|Overall Study|Subject Traveling Out of Country|0|||
161232620|NCT01389102|582234600|FG000|Overall Study|Subject Moved|2|||
161232621|NCT01389102|582234601|FG001|Overall Study|Subject Moved|0|||
161232622|NCT01389102|582234602|FG002|Overall Study|Subject Moved|1|||
161232623|NCT01389102|582234603|FG003|Overall Study|Subject Moved|0|||
161232624|NCT01389102|582234604|FG004|Overall Study|Subject Moved|0|||
161232625|NCT01389102|582234605|FG005|Overall Study|Subject Moved|0|||
161232626|NCT01389102|582234600|FG000|Overall Study|Unavailable due to husband's illness|0|||
161232627|NCT01389102|582234601|FG001|Overall Study|Unavailable due to husband's illness|1|||
161232628|NCT01389102|582234602|FG002|Overall Study|Unavailable due to husband's illness|0|||
161232629|NCT01389102|582234603|FG003|Overall Study|Unavailable due to husband's illness|0|||
161232630|NCT01389102|582234604|FG004|Overall Study|Unavailable due to husband's illness|0|||
161232631|NCT01389102|582234605|FG005|Overall Study|Unavailable due to husband's illness|0|||
161232632|NCT01389102|582234600|FG000|Overall Study|Investigator Judgement|0|||
161232633|NCT01389102|582234601|FG001|Overall Study|Investigator Judgement|1|||
161232634|NCT01389102|582234602|FG002|Overall Study|Investigator Judgement|0|||
161232635|NCT01389102|582234603|FG003|Overall Study|Investigator Judgement|0|||
161232636|NCT01389102|582234604|FG004|Overall Study|Investigator Judgement|0|||
161232637|NCT01389102|582234605|FG005|Overall Study|Investigator Judgement|0|||
161232638|NCT00050778|582234606|FG000|Overall Study|Adverse Event|13|||
161232639|NCT00050778|582234607|FG001|Overall Study|Adverse Event|3|||
161232640|NCT00050778|582234608|FG002|Overall Study|Adverse Event|2|||
161232641|NCT00050778|582234606|FG000|Overall Study|Death|0|||
161232642|NCT00050778|582234607|FG001|Overall Study|Death|1|||
161232643|NCT00050778|582234608|FG002|Overall Study|Death|1|||
161232644|NCT00050778|582234606|FG000|Overall Study|Lack of Efficacy|16|||
161232645|NCT00050778|582234607|FG001|Overall Study|Lack of Efficacy|2|||
161232646|NCT00050778|582234608|FG002|Overall Study|Lack of Efficacy|2|||
161232647|NCT00050778|582234606|FG000|Overall Study|Lost to Follow-up|0|||
161232648|NCT00050778|582234607|FG001|Overall Study|Lost to Follow-up|2|||
161232649|NCT00050778|582234608|FG002|Overall Study|Lost to Follow-up|4|||
161232650|NCT00050778|582234606|FG000|Overall Study|Physician Decision|3|||
161232651|NCT00050778|582234607|FG001|Overall Study|Physician Decision|0|||
161232652|NCT00050778|582234608|FG002|Overall Study|Physician Decision|2|||
161232653|NCT00050778|582234606|FG000|Overall Study|Protocol Violation|2|||
161232654|NCT00050778|582234607|FG001|Overall Study|Protocol Violation|0|||
161232655|NCT00050778|582234608|FG002|Overall Study|Protocol Violation|1|||
161232656|NCT00050778|582234606|FG000|Overall Study|Withdrawal by Subject|6|||
161232657|NCT00050778|582234607|FG001|Overall Study|Withdrawal by Subject|8|||
161232658|NCT00050778|582234608|FG002|Overall Study|Withdrawal by Subject|4|||
161232659|NCT00050778|582234606|FG000|Overall Study|Randomized but not treated|4|||
161232660|NCT00050778|582234607|FG001|Overall Study|Randomized but not treated|5|||
161232661|NCT00050778|582234608|FG002|Overall Study|Randomized but not treated|2|||
161232662|NCT00050778|582234606|FG000|Overall Study|Familial and personal reasons|1|||
161232663|NCT00050778|582234607|FG001|Overall Study|Familial and personal reasons|0|||
161232664|NCT00050778|582234608|FG002|Overall Study|Familial and personal reasons|0|||
161232665|NCT00064753|582234609|FG000|Overall Study|Death|251|||
161232666|NCT00064753|582234610|FG001|Overall Study|Death|242|||
161232667|NCT00064753|582234609|FG000|Overall Study|Withdrawal by Subject|198|||
161232668|NCT00064753|582234610|FG001|Overall Study|Withdrawal by Subject|171|||
161232669|NCT00064753|582234609|FG000|Overall Study|Lost to Follow-up|225|||
161232670|NCT00064753|582234610|FG001|Overall Study|Lost to Follow-up|235|||
161232671|NCT02193880|582234613|FG000|Overall Study|patients did not collect enough HPC|3|||
161232672|NCT01661686|582234617|FG000|Overall Study|Lost to Follow-up|2|||
161232673|NCT01661686|582234618|FG001|Overall Study|Lost to Follow-up|1|||
161232674|NCT01661686|582234617|FG000|Overall Study|did not receive allocated intervention|0|||
161232675|NCT01661686|582234618|FG001|Overall Study|did not receive allocated intervention|1|||
161232676|NCT04869787|582234619|FG000|Screening|Physician Decision|1|||
161232677|NCT04869787|582234619|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
161232678|NCT02914600|582234620|FG000|Overall Study|Adverse Event|298|||
161232679|NCT02914600|582234621|FG001|Overall Study|Adverse Event|35|||
161232680|NCT02914600|582234622|FG002|Overall Study|Adverse Event|25|||
161232681|NCT02914600|582234620|FG000|Overall Study|Sponsors decision|287|||
161232682|NCT02914600|582234621|FG001|Overall Study|Sponsors decision|41|||
161232683|NCT02914600|582234622|FG002|Overall Study|Sponsors decision|12|||
161232684|NCT02914600|582234620|FG000|Overall Study|Withdrawal by Subject|158|||
161232685|NCT02914600|582234621|FG001|Overall Study|Withdrawal by Subject|20|||
161232686|NCT02914600|582234622|FG002|Overall Study|Withdrawal by Subject|18|||
161232687|NCT02914600|582234620|FG000|Overall Study|Investigators discretion|169|||
161232688|NCT02914600|582234621|FG001|Overall Study|Investigators discretion|14|||
161232689|NCT02914600|582234622|FG002|Overall Study|Investigators discretion|13|||
161232690|NCT02914600|582234620|FG000|Overall Study|Lost to Follow-up|10|||
161232691|NCT02914600|582234621|FG001|Overall Study|Lost to Follow-up|4|||
161232692|NCT02914600|582234622|FG002|Overall Study|Lost to Follow-up|0|||
161232693|NCT02914600|582234620|FG000|Overall Study|Pregnancy|8|||
161232694|NCT02914600|582234621|FG001|Overall Study|Pregnancy|0|||
161232695|NCT02914600|582234622|FG002|Overall Study|Pregnancy|0|||
161232696|NCT02914600|582234620|FG000|Overall Study|Protocol Violation|5|||
161232697|NCT02914600|582234621|FG001|Overall Study|Protocol Violation|3|||
161232698|NCT02914600|582234622|FG002|Overall Study|Protocol Violation|0|||
161232699|NCT02914600|582234620|FG000|Overall Study|Non-compliance with study drug|6|||
161232700|NCT02914600|582234621|FG001|Overall Study|Non-compliance with study drug|1|||
161232701|NCT02914600|582234622|FG002|Overall Study|Non-compliance with study drug|0|||
161232702|NCT02914600|582234620|FG000|Overall Study|Death|3|||
161232703|NCT02914600|582234621|FG001|Overall Study|Death|1|||
161232704|NCT02914600|582234622|FG002|Overall Study|Death|1|||
161232705|NCT02914600|582234620|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
161232706|NCT02914600|582234621|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
161232707|NCT02914600|582234622|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
161232708|NCT02914600|582234620|FG000|Overall Study|Enrolled but not treated|1|||
161232709|NCT02914600|582234621|FG001|Overall Study|Enrolled but not treated|0|||
161232710|NCT02914600|582234622|FG002|Overall Study|Enrolled but not treated|0|||
161232711|NCT02996682|582234623|FG000|Overall Study|Death|0|||
161232712|NCT02996682|582234624|FG001|Overall Study|Death|3|||
161232713|NCT02457520|582234625|FG000|Active Treatment Phase|Adverse Event|10|||
161232714|NCT02457520|582234625|FG000|Active Treatment Phase|Lost to Follow-up|8|||
161232715|NCT02457520|582234625|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
161232716|NCT02457520|582234625|FG000|Active Treatment Phase|other|4|||
161232717|NCT02457520|582234625|FG000|Active Treatment Phase|Physician Decision|1|||
161232718|NCT02457520|582234625|FG000|Active Treatment Phase|Protocol Violation|1|||
161232719|NCT02457520|582234625|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
161232720|NCT02457520|582234625|FG000|Post-treatment Period|Other: Retreatment Required|7|||
161232721|NCT02457520|582234625|FG000|Post-treatment Period|Lost to Follow-up|23|||
161232722|NCT02457520|582234625|FG000|Post-treatment Period|Other|3|||
161232723|NCT02457520|582234625|FG000|Post-treatment Period|Physician Decision|1|||
161232724|NCT02457520|582234625|FG000|Post-treatment Period|Withdrawal by Subject|14|||
161232725|NCT02511782|582234628|FG000|Overall Study|Withdrawal by Subject|1|||
161232726|NCT02511782|582234629|FG001|Overall Study|Withdrawal by Subject|0|||
161232727|NCT02511782|582234630|FG002|Overall Study|Withdrawal by Subject|0|||
161232728|NCT00579670|582234631|FG000|Overall Study|Death|1|||
161232729|NCT00579670|582234632|FG001|Overall Study|Death|0|||
161232730|NCT00579670|582234633|FG002|Overall Study|Death|0|||
161232731|NCT00579670|582234634|FG003|Overall Study|Death|0|||
161232732|NCT00579670|582234635|FG004|Overall Study|Death|0|||
161232733|NCT00579670|582234631|FG000|Overall Study|Adverse Event|1|||
161232734|NCT00579670|582234632|FG001|Overall Study|Adverse Event|0|||
161232735|NCT00579670|582234633|FG002|Overall Study|Adverse Event|1|||
161232736|NCT00579670|582234634|FG003|Overall Study|Adverse Event|2|||
161232737|NCT00579670|582234635|FG004|Overall Study|Adverse Event|0|||
161232738|NCT00579670|582234631|FG000|Overall Study|Lack of Efficacy|0|||
161232739|NCT00579670|582234632|FG001|Overall Study|Lack of Efficacy|0|||
161232740|NCT00579670|582234633|FG002|Overall Study|Lack of Efficacy|1|||
161232741|NCT00579670|582234634|FG003|Overall Study|Lack of Efficacy|14|||
161232742|NCT00579670|582234635|FG004|Overall Study|Lack of Efficacy|0|||
161232743|NCT00579670|582234631|FG000|Overall Study|Lost to Follow-up|0|||
161232744|NCT00579670|582234632|FG001|Overall Study|Lost to Follow-up|1|||
161232745|NCT00579670|582234633|FG002|Overall Study|Lost to Follow-up|0|||
161232746|NCT00579670|582234634|FG003|Overall Study|Lost to Follow-up|4|||
161232747|NCT00579670|582234635|FG004|Overall Study|Lost to Follow-up|0|||
161232748|NCT00579670|582234631|FG000|Overall Study|Other|0|||
161232749|NCT00579670|582234632|FG001|Overall Study|Other|0|||
161232750|NCT00579670|582234633|FG002|Overall Study|Other|1|||
161232751|NCT00579670|582234634|FG003|Overall Study|Other|2|||
161232752|NCT00579670|582234635|FG004|Overall Study|Other|0|||
161232753|NCT00579670|582234631|FG000|Overall Study|Withdrawal by Subject|0|||
161232754|NCT00579670|582234632|FG001|Overall Study|Withdrawal by Subject|0|||
161232755|NCT00579670|582234633|FG002|Overall Study|Withdrawal by Subject|1|||
161232756|NCT00579670|582234634|FG003|Overall Study|Withdrawal by Subject|0|||
161232757|NCT00579670|582234635|FG004|Overall Study|Withdrawal by Subject|0|||
161232758|NCT00112463|582234636|FG000|Overall Study|Physician Decision|1|||
161232759|NCT00112463|582234636|FG000|Overall Study|Progression|30|||
161232760|NCT00112463|582234636|FG000|Overall Study|Second Primary|1|||
161232761|NCT00112463|582234636|FG000|Overall Study|Toxicity|3|||
161232762|NCT00112463|582234636|FG000|Overall Study|Withdrawal by Subject|2|||
161232763|NCT00112463|582234636|FG000|Overall Study|Never started treatment|2|||
161232764|NCT00678639|582234637|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
161232765|NCT00678639|582234638|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
161232766|NCT00870870|582234643|FG000|Overall Study|Withdrawal by Subject|0|||
161232767|NCT00870870|582234644|FG001|Overall Study|Withdrawal by Subject|1|||
161232768|NCT00870870|582234645|FG002|Overall Study|Withdrawal by Subject|1|||
161232769|NCT00870870|582234646|FG003|Overall Study|Withdrawal by Subject|3|||
161232770|NCT00870870|582234643|FG000|Overall Study|Adverse Event|0|||
161232771|NCT00870870|582234644|FG001|Overall Study|Adverse Event|0|||
161232772|NCT00870870|582234645|FG002|Overall Study|Adverse Event|2|||
161232773|NCT00870870|582234646|FG003|Overall Study|Adverse Event|2|||
161232774|NCT03639311|582234650|FG000|Maintenance Phase|Lost to Follow-up|1|||
161232775|NCT03639311|582234651|FG001|Maintenance Phase|Lost to Follow-up|0|||
161126575|NCT00793793|581850734|FG008|Overall Study|Adverse Event|0|||
161126576|NCT00793793|581850735|FG009|Overall Study|Adverse Event|0|||
161126577|NCT00793793|581850736|FG010|Overall Study|Adverse Event|0|||
161126578|NCT00793793|581850737|FG011|Overall Study|Adverse Event|2|||
161126579|NCT00793793|581850726|FG000|Overall Study|Protocol Violation|0|||
161126580|NCT00793793|581850727|FG001|Overall Study|Protocol Violation|0|||
161126581|NCT00793793|581850728|FG002|Overall Study|Protocol Violation|0|||
161126582|NCT00793793|581850729|FG003|Overall Study|Protocol Violation|1|||
161126583|NCT00793793|581850730|FG004|Overall Study|Protocol Violation|0|||
161126584|NCT00793793|581850731|FG005|Overall Study|Protocol Violation|0|||
161126585|NCT00793793|581850732|FG006|Overall Study|Protocol Violation|0|||
161126586|NCT00793793|581850733|FG007|Overall Study|Protocol Violation|0|||
161126587|NCT00793793|581850734|FG008|Overall Study|Protocol Violation|0|||
161126588|NCT00793793|581850735|FG009|Overall Study|Protocol Violation|0|||
161126589|NCT00793793|581850736|FG010|Overall Study|Protocol Violation|0|||
161126590|NCT00793793|581850737|FG011|Overall Study|Protocol Violation|0|||
161126591|NCT00793793|581850726|FG000|Overall Study|Lost to Follow-up|0|||
161232776|NCT03639311|582234652|FG002|Maintenance Phase|Lost to Follow-up|0|||
161232777|NCT03639311|582234650|FG000|Maintenance Phase|Adverse Event|1|||
161232778|NCT03639311|582234651|FG001|Maintenance Phase|Adverse Event|0|||
161126592|NCT00793793|581850727|FG001|Overall Study|Lost to Follow-up|0|||
161126593|NCT00793793|581850728|FG002|Overall Study|Lost to Follow-up|1|||
161126594|NCT00793793|581850729|FG003|Overall Study|Lost to Follow-up|0|||
161232779|NCT03639311|582234652|FG002|Maintenance Phase|Adverse Event|0|||
161232780|NCT03639311|582234650|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
161232781|NCT03639311|582234651|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
161232782|NCT03639311|582234652|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
161232783|NCT03639311|582234650|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
161126595|NCT00793793|581850730|FG004|Overall Study|Lost to Follow-up|0|||
161232784|NCT03639311|582234651|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
161232785|NCT03639311|582234652|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
161328799|NCT02683239|582589157|FG000|Overall Study|Lost to Follow-up|77|||
161328800|NCT02683239|582589158|FG001|Overall Study|Lost to Follow-up|24|||
161328801|NCT02683239|582589159|FG002|Overall Study|Lost to Follow-up|25|||
161328802|NCT02683239|582589160|FG003|Overall Study|Lost to Follow-up|7|||
161328803|NCT02683239|582589161|FG004|Overall Study|Lost to Follow-up|88|||
161328804|NCT02683239|582589162|FG005|Overall Study|Lost to Follow-up|8|||
161328805|NCT02683239|582589163|FG006|Overall Study|Lost to Follow-up|11|||
161328806|NCT02683239|582589157|FG000|Overall Study|Death|9|||
161328807|NCT02683239|582589158|FG001|Overall Study|Death|5|||
161328808|NCT02683239|582589159|FG002|Overall Study|Death|8|||
161328809|NCT02683239|582589160|FG003|Overall Study|Death|0|||
161328810|NCT02683239|582589161|FG004|Overall Study|Death|12|||
161328811|NCT02683239|582589162|FG005|Overall Study|Death|1|||
161328812|NCT02683239|582589163|FG006|Overall Study|Death|0|||
161328813|NCT02683239|582589157|FG000|Overall Study|Lack of Efficacy|50|||
161328814|NCT02683239|582589158|FG001|Overall Study|Lack of Efficacy|23|||
161328815|NCT02683239|582589159|FG002|Overall Study|Lack of Efficacy|12|||
161328816|NCT02683239|582589160|FG003|Overall Study|Lack of Efficacy|2|||
161328817|NCT02683239|582589161|FG004|Overall Study|Lack of Efficacy|29|||
161328818|NCT02683239|582589162|FG005|Overall Study|Lack of Efficacy|2|||
161328819|NCT02683239|582589163|FG006|Overall Study|Lack of Efficacy|3|||
161328820|NCT02683239|582589157|FG000|Overall Study|Missing data|0|||
161328821|NCT02683239|582589158|FG001|Overall Study|Missing data|1|||
161328822|NCT02683239|582589159|FG002|Overall Study|Missing data|1|||
161328823|NCT02683239|582589160|FG003|Overall Study|Missing data|0|||
161328824|NCT02683239|582589161|FG004|Overall Study|Missing data|1|||
161232786|NCT03639311|582234650|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
161232787|NCT03639311|582234651|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161232788|NCT03639311|582234652|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
161232789|NCT03639311|582234650|FG000|Maintenance Phase|Lack of Efficacy|1|||
161232790|NCT03639311|582234651|FG001|Maintenance Phase|Lack of Efficacy|0|||
161232791|NCT03639311|582234652|FG002|Maintenance Phase|Lack of Efficacy|0|||
161232792|NCT00822926|582234653|FG000|Second Injection Visit|Lost to Follow-up|1|||
161232793|NCT00822926|582234654|FG001|Second Injection Visit|Lost to Follow-up|0|||
161328825|NCT02683239|582589162|FG005|Overall Study|Missing data|0|||
161328826|NCT02683239|582589163|FG006|Overall Study|Missing data|0|||
161328827|NCT00521365|582589166|FG000|Overall Study|Adverse Event|3|||
161328828|NCT00521365|582589166|FG000|Overall Study|Lost to Follow-up|6|||
161328829|NCT00521365|582589166|FG000|Overall Study|Protocol deviation|2|||
161328830|NCT00521365|582589166|FG000|Overall Study|Drug compliance|3|||
161328831|NCT00521365|582589166|FG000|Overall Study|Usage of not allowed drugs|6|||
161328832|NCT02119299|582589169|FG000|Overall Study|Withdrawal by Subject|7|||
161328833|NCT02119299|582589169|FG000|Overall Study|Lack of Efficacy|1|||
161328834|NCT02119299|582589169|FG000|Overall Study|Pregnancy|1|||
161328835|NCT04613739|582589170|FG000|Overall Study|Lost to Follow-up|6|||
161328836|NCT04613739|582589171|FG001|Overall Study|Lost to Follow-up|9|||
161328837|NCT04613739|582589170|FG000|Overall Study|potentially duplicative/fraudulent|1|||
161328838|NCT04613739|582589171|FG001|Overall Study|potentially duplicative/fraudulent|3|||
161328839|NCT00483652|582589172|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161328840|NCT00483652|582589173|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161328841|NCT00483652|582589172|FG000|Double-blind Treatment Period|Adverse Event|3|||
161328842|NCT00483652|582589173|FG001|Double-blind Treatment Period|Adverse Event|4|||
161328843|NCT00483652|582589172|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
161328844|NCT00483652|582589173|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
161328845|NCT00483652|582589172|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
161328846|NCT00483652|582589173|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
161328847|NCT02154139|582589174|FG000|Overall Study|Injection not administered|2|||
161328848|NCT02154139|582589174|FG000|Overall Study|Other|2|||
161328849|NCT02154139|582589174|FG000|Overall Study|Investigator transferred|3|||
161328850|NCT00891813|582589175|FG000|Overall Study|Adverse Event|3|||
161328851|NCT00891813|582589175|FG000|Overall Study|Withdrawal by Subject|1|||
161328852|NCT00891813|582589175|FG000|Overall Study|Patient Noncompliance|6|||
161328853|NCT00891813|582589175|FG000|Overall Study|Protocol Violation|2|||
160981869|NCT02061761|581321786|FG004|Overall Study|Maximum clinical benefit|0|||
161232794|NCT00822926|582234653|FG000|Second Injection Visit|Withdrawal by Subject|0|||
161232795|NCT00822926|582234654|FG001|Second Injection Visit|Withdrawal by Subject|1|||
161232796|NCT00855738|582234655|FG000|Overall Study|Lost to Follow-up|2|||
161328854|NCT03075267|582589184|FG000|Overall Study|Protocol Violation|1|||
161328855|NCT03075267|582589185|FG001|Overall Study|Protocol Violation|0|||
161328856|NCT03075267|582589186|FG002|Overall Study|Protocol Violation|0|||
161328857|NCT03874013|582589187|FG000|Overall Study|Adverse Event|0|||
161328858|NCT03874013|582589188|FG001|Overall Study|Adverse Event|1|||
161328859|NCT01443858|582589195|FG000|Overall Study|Withdrawal by Subject|9|||
161328860|NCT01443858|582589196|FG001|Overall Study|Withdrawal by Subject|8|||
161328861|NCT01443858|582589197|FG002|Overall Study|Withdrawal by Subject|5|||
161328862|NCT01443858|582589195|FG000|Overall Study|Lack of Efficacy|1|||
161232797|NCT00855738|582234655|FG000|Overall Study|Adverse Event|1|||
161232798|NCT00855738|582234655|FG000|Overall Study|Subject Defaulted|1|||
161232799|NCT00855738|582234655|FG000|Overall Study|Death|1|||
161232800|NCT03135834|582234658|FG000|Stage 1|Adverse Event|1|||
161232801|NCT03135834|582234659|FG001|Stage 1|Adverse Event|2|||
161232802|NCT03135834|582234660|FG002|Stage 1|Adverse Event|2|||
161232803|NCT03135834|582234661|FG003|Stage 1|Adverse Event|1|||
161232804|NCT03135834|582234658|FG000|Stage 1|Death|1|||
161232805|NCT03135834|582234659|FG001|Stage 1|Death|0|||
161232806|NCT03135834|582234660|FG002|Stage 1|Death|0|||
161232807|NCT03135834|582234661|FG003|Stage 1|Death|0|||
161232808|NCT03135834|582234658|FG000|Stage 1|Lost to Follow-up|17|||
161232809|NCT03135834|582234659|FG001|Stage 1|Lost to Follow-up|24|||
161232810|NCT03135834|582234660|FG002|Stage 1|Lost to Follow-up|21|||
161232811|NCT03135834|582234661|FG003|Stage 1|Lost to Follow-up|38|||
161232812|NCT03135834|582234658|FG000|Stage 1|No longer met eligibility criteria|1|||
161232813|NCT03135834|582234659|FG001|Stage 1|No longer met eligibility criteria|6|||
161232814|NCT03135834|582234660|FG002|Stage 1|No longer met eligibility criteria|2|||
161232815|NCT03135834|582234661|FG003|Stage 1|No longer met eligibility criteria|5|||
161232816|NCT03135834|582234658|FG000|Stage 1|Other|0|||
161232817|NCT03135834|582234659|FG001|Stage 1|Other|2|||
161232818|NCT03135834|582234660|FG002|Stage 1|Other|1|||
161232819|NCT03135834|582234661|FG003|Stage 1|Other|0|||
161232820|NCT03135834|582234658|FG000|Stage 1|Physician Decision|0|||
161232821|NCT03135834|582234659|FG001|Stage 1|Physician Decision|1|||
161232822|NCT03135834|582234660|FG002|Stage 1|Physician Decision|0|||
161232823|NCT03135834|582234661|FG003|Stage 1|Physician Decision|0|||
161232824|NCT03135834|582234658|FG000|Stage 1|Pregnancy|0|||
161232825|NCT03135834|582234659|FG001|Stage 1|Pregnancy|4|||
161232826|NCT03135834|582234660|FG002|Stage 1|Pregnancy|2|||
161232827|NCT03135834|582234661|FG003|Stage 1|Pregnancy|4|||
161232828|NCT03135834|582234658|FG000|Stage 1|Protocol Violation|1|||
161232829|NCT03135834|582234659|FG001|Stage 1|Protocol Violation|1|||
161232830|NCT03135834|582234660|FG002|Stage 1|Protocol Violation|2|||
161232831|NCT03135834|582234661|FG003|Stage 1|Protocol Violation|1|||
161232832|NCT03135834|582234658|FG000|Stage 1|Withdrawal by parent/guardian|2|||
161232833|NCT03135834|582234659|FG001|Stage 1|Withdrawal by parent/guardian|10|||
161232834|NCT03135834|582234660|FG002|Stage 1|Withdrawal by parent/guardian|2|||
161232835|NCT03135834|582234661|FG003|Stage 1|Withdrawal by parent/guardian|1|||
161232836|NCT03135834|582234658|FG000|Stage 1|Withdrawal by Subject|16|||
161232837|NCT03135834|582234659|FG001|Stage 1|Withdrawal by Subject|22|||
161232838|NCT03135834|582234660|FG002|Stage 1|Withdrawal by Subject|7|||
161232839|NCT03135834|582234661|FG003|Stage 1|Withdrawal by Subject|10|||
161232840|NCT03135834|582234658|FG000|Stage 1|Randomized but not Vaccinated|0|||
161232841|NCT03135834|582234659|FG001|Stage 1|Randomized but not Vaccinated|3|||
161232842|NCT03135834|582234660|FG002|Stage 1|Randomized but not Vaccinated|1|||
161232843|NCT03135834|582234661|FG003|Stage 1|Randomized but not Vaccinated|6|||
161232844|NCT03135834|582234658|FG000|Stage 2|Lost to Follow-up|0|||
161232845|NCT03135834|582234659|FG001|Stage 2|Lost to Follow-up|1|||
161232846|NCT03135834|582234660|FG002|Stage 2|Lost to Follow-up|0|||
161232847|NCT03135834|582234661|FG003|Stage 2|Lost to Follow-up|0|||
161232848|NCT03135834|582234658|FG000|Stage 2|Withdrawal by Subject|0|||
161232849|NCT03135834|582234659|FG001|Stage 2|Withdrawal by Subject|1|||
161232850|NCT03135834|582234660|FG002|Stage 2|Withdrawal by Subject|0|||
161232851|NCT03135834|582234661|FG003|Stage 2|Withdrawal by Subject|0|||
161232852|NCT03135834|582234658|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
161232853|NCT03135834|582234659|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
161232854|NCT03135834|582234660|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
161232855|NCT03135834|582234661|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
161232856|NCT03135834|582234658|FG000|Stage 2|Did not receive Booster Vaccination|1|||
161232857|NCT03135834|582234659|FG001|Stage 2|Did not receive Booster Vaccination|1|||
161232858|NCT03135834|582234660|FG002|Stage 2|Did not receive Booster Vaccination|0|||
161232859|NCT03135834|582234661|FG003|Stage 2|Did not receive Booster Vaccination|0|||
161232860|NCT00319735|582234662|FG000|Overall Study|Death|2|||
161232861|NCT00119379|582234665|FG000|Overall Study|Adverse Event|4|||
161232862|NCT00119379|582234666|FG001|Overall Study|Adverse Event|1|||
161232863|NCT02421952|582234673|FG000|Overall Study|Diary Not Returned|93|||
161232864|NCT02421952|582234673|FG000|Overall Study|Failed seriation task|13|||
161232865|NCT02421952|582234673|FG000|Overall Study|Subject uncooperative for baseline test|2|||
161232866|NCT02421952|582234673|FG000|Overall Study|Surgery cancelled|1|||
161232867|NCT02865122|582234675|FG000|Overall Study|Adverse Event|1|||
161232868|NCT02865122|582234676|FG001|Overall Study|Adverse Event|0|||
161232869|NCT02865122|582234677|FG002|Overall Study|Adverse Event|0|||
161232870|NCT04123548|582236623|FG000|Overall Study|Withdrawal by Subject|1|||
161232871|NCT04123548|582236623|FG000|Overall Study|Lost to Follow-up|8|||
161232872|NCT04123548|582236623|FG000|Overall Study|Death|4|||
161232873|NCT04123548|582236623|FG000|Overall Study|Reason Not Specified|1|||
161232874|NCT04112823|582236626|FG000|Overall Study|Lost to Follow-up|2|||
161232875|NCT04112823|582236627|FG001|Overall Study|Lost to Follow-up|3|||
161232876|NCT00436553|582236630|FG000|Overall Study|Adverse Event|4|||
161232877|NCT00436553|582236631|FG001|Overall Study|Adverse Event|3|||
161232878|NCT00436553|582236632|FG002|Overall Study|Adverse Event|4|||
161232879|NCT00436553|582236630|FG000|Overall Study|Death|3|||
161232880|NCT00436553|582236631|FG001|Overall Study|Death|1|||
161232881|NCT00436553|582236632|FG002|Overall Study|Death|3|||
161232882|NCT00436553|582236630|FG000|Overall Study|Lost to Follow-up|0|||
161232883|NCT00436553|582236631|FG001|Overall Study|Lost to Follow-up|2|||
161232884|NCT00436553|582236632|FG002|Overall Study|Lost to Follow-up|0|||
161232885|NCT00436553|582236630|FG000|Overall Study|Protocol Violation|1|||
161232886|NCT00436553|582236631|FG001|Overall Study|Protocol Violation|0|||
161232887|NCT00436553|582236632|FG002|Overall Study|Protocol Violation|0|||
161232888|NCT00436553|582236630|FG000|Overall Study|Withdrawal by Subject|5|||
161232889|NCT00436553|582236631|FG001|Overall Study|Withdrawal by Subject|6|||
161232890|NCT00436553|582236632|FG002|Overall Study|Withdrawal by Subject|3|||
161232891|NCT00625443|582236641|FG000|Overall Study|Adverse Event|1|||
161232892|NCT00625443|582236642|FG001|Overall Study|Adverse Event|4|||
161232893|NCT00625443|582236643|FG002|Overall Study|Adverse Event|0|||
161232894|NCT00625443|582236641|FG000|Overall Study|Non-compliance with protocol|0|||
161232895|NCT00625443|582236642|FG001|Overall Study|Non-compliance with protocol|1|||
161232896|NCT00625443|582236643|FG002|Overall Study|Non-compliance with protocol|0|||
161232897|NCT00625443|582236641|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
161232898|NCT00625443|582236642|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
161232899|NCT00625443|582236643|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
161232900|NCT00625443|582236641|FG000|Overall Study|Withdrawal by Subject|0|||
161232901|NCT00625443|582236642|FG001|Overall Study|Withdrawal by Subject|1|||
161232902|NCT00625443|582236643|FG002|Overall Study|Withdrawal by Subject|2|||
161232903|NCT00625443|582236641|FG000|Overall Study|Physician Decision|0|||
161232904|NCT00625443|582236642|FG001|Overall Study|Physician Decision|4|||
161232905|NCT00625443|582236643|FG002|Overall Study|Physician Decision|2|||
161232906|NCT00625443|582236641|FG000|Overall Study|Other|0|||
161232907|NCT00625443|582236642|FG001|Overall Study|Other|1|||
161232908|NCT00625443|582236643|FG002|Overall Study|Other|1|||
161232909|NCT02015390|582236644|FG000|Overall Study|Lost to Follow-up|1|||
161232910|NCT02015390|582236645|FG001|Overall Study|Lost to Follow-up|0|||
161232911|NCT02015390|582236644|FG000|Overall Study|Adverse Event|0|||
161232912|NCT02015390|582236645|FG001|Overall Study|Adverse Event|3|||
161232913|NCT02015390|582236644|FG000|Overall Study|Physician Decision|0|||
161232914|NCT02015390|582236645|FG001|Overall Study|Physician Decision|1|||
161232915|NCT03136380|582236646|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161232916|NCT03136380|582236647|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
161232917|NCT03136380|582236648|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161232918|NCT03136380|582236649|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161232919|NCT03136380|582236650|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161232920|NCT02728102|582236651|FG000|Overall Study|Death|3|||
161232921|NCT02728102|582236652|FG001|Overall Study|Death|0|||
161232922|NCT02728102|582236653|FG002|Overall Study|Death|1|||
161232923|NCT02728102|582236651|FG000|Overall Study|Withdrawal by Subject|0|||
161232924|NCT02728102|582236652|FG001|Overall Study|Withdrawal by Subject|2|||
161232925|NCT02728102|582236653|FG002|Overall Study|Withdrawal by Subject|3|||
161232926|NCT02728102|582236651|FG000|Overall Study|Physician Decision|1|||
161232927|NCT02728102|582236652|FG001|Overall Study|Physician Decision|1|||
161232928|NCT02728102|582236653|FG002|Overall Study|Physician Decision|0|||
161232929|NCT02728102|582236651|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
161232930|NCT02728102|582236652|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
161232931|NCT02728102|582236653|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
161232932|NCT02728102|582236651|FG000|Overall Study|Covid|0|||
161232933|NCT02728102|582236652|FG001|Overall Study|Covid|0|||
161232934|NCT02728102|582236653|FG002|Overall Study|Covid|1|||
161232935|NCT02419937|582236657|FG000|Overall Study|Lost to Follow-up|1|||
161232936|NCT02419937|582236658|FG001|Overall Study|Lost to Follow-up|0|||
161232937|NCT00553280|582236660|FG000|Overall Study|Adverse Event|19|||
161232938|NCT00553280|582236660|FG000|Overall Study|Lack of Efficacy|3|||
161232939|NCT00553280|582236660|FG000|Overall Study|Withdrawal by Subject|3|||
161232940|NCT00553280|582236660|FG000|Overall Study|Physician Decision|1|||
161328863|NCT01443858|582589196|FG001|Overall Study|Lack of Efficacy|0|||
161328864|NCT01443858|582589197|FG002|Overall Study|Lack of Efficacy|0|||
161328865|NCT01443858|582589195|FG000|Overall Study|Lost to Follow-up|5|||
161328866|NCT01443858|582589196|FG001|Overall Study|Lost to Follow-up|5|||
161232941|NCT01182415|582236661|FG000|Overall Study|Lost to Follow-up|1|||
161232942|NCT01544127|582236662|FG000|Overall Study|Lost to Follow-up|4|||
161232943|NCT01544127|582236663|FG001|Overall Study|Lost to Follow-up|2|||
161232944|NCT01544127|582236664|FG002|Overall Study|Lost to Follow-up|9|||
161232945|NCT01544127|582236662|FG000|Overall Study|Withdrawal by Subject|2|||
161232946|NCT01544127|582236663|FG001|Overall Study|Withdrawal by Subject|2|||
161328867|NCT01443858|582589197|FG002|Overall Study|Lost to Follow-up|2|||
161232947|NCT01544127|582236664|FG002|Overall Study|Withdrawal by Subject|1|||
161232948|NCT01544127|582236662|FG000|Overall Study|Discharged out of catchment area|1|||
161232949|NCT01544127|582236663|FG001|Overall Study|Discharged out of catchment area|1|||
161232950|NCT01544127|582236664|FG002|Overall Study|Discharged out of catchment area|1|||
161232951|NCT01544127|582236662|FG000|Overall Study|Death|1|||
161232952|NCT01544127|582236663|FG001|Overall Study|Death|0|||
161232953|NCT01544127|582236664|FG002|Overall Study|Death|0|||
161232954|NCT01544127|582236662|FG000|Overall Study|Jail or Prison|1|||
161232955|NCT01544127|582236663|FG001|Overall Study|Jail or Prison|1|||
161232956|NCT01544127|582236664|FG002|Overall Study|Jail or Prison|2|||
161232957|NCT01544127|582236662|FG000|Overall Study|Became Psychotic|1|||
161232958|NCT01544127|582236663|FG001|Overall Study|Became Psychotic|0|||
161232959|NCT01544127|582236664|FG002|Overall Study|Became Psychotic|0|||
161232960|NCT01544127|582236662|FG000|Overall Study|Researcher withdrew|1|||
161232961|NCT01544127|582236663|FG001|Overall Study|Researcher withdrew|0|||
161232962|NCT01544127|582236664|FG002|Overall Study|Researcher withdrew|0|||
161232963|NCT01544127|582236662|FG000|Overall Study|Went active duty|0|||
161232964|NCT01544127|582236663|FG001|Overall Study|Went active duty|0|||
161232965|NCT01544127|582236664|FG002|Overall Study|Went active duty|1|||
161232966|NCT01256684|582236667|FG000|Overall Study|Adverse Event|1|||
161232967|NCT01256684|582236668|FG001|Overall Study|Adverse Event|4|||
161232968|NCT01256684|582236669|FG002|Overall Study|Adverse Event|2|||
161232969|NCT01256684|582236667|FG000|Overall Study|Withdrawal by Subject|4|||
161232970|NCT01256684|582236668|FG001|Overall Study|Withdrawal by Subject|0|||
161232971|NCT01256684|582236669|FG002|Overall Study|Withdrawal by Subject|2|||
161232972|NCT01256684|582236667|FG000|Overall Study|Physician Decision|0|||
161232973|NCT01256684|582236668|FG001|Overall Study|Physician Decision|1|||
161232974|NCT01256684|582236669|FG002|Overall Study|Physician Decision|0|||
161232975|NCT01256684|582236667|FG000|Overall Study|Lack of Efficacy|0|||
161232976|NCT01256684|582236668|FG001|Overall Study|Lack of Efficacy|1|||
161232977|NCT01256684|582236669|FG002|Overall Study|Lack of Efficacy|1|||
161232978|NCT01256684|582236667|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
161232979|NCT01256684|582236668|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
161232980|NCT01256684|582236669|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
161232981|NCT02587962|582236673|FG000|Overall Study|Adverse Event|0|||
161232982|NCT02587962|582236674|FG001|Overall Study|Adverse Event|0|||
161232983|NCT02587962|582236675|FG002|Overall Study|Adverse Event|1|||
161232984|NCT02587962|582236676|FG003|Overall Study|Adverse Event|0|||
161232985|NCT02587962|582236677|FG004|Overall Study|Adverse Event|0|||
161232986|NCT02587962|582236673|FG000|Overall Study|Withdrawal by Subject|0|||
161232987|NCT02587962|582236674|FG001|Overall Study|Withdrawal by Subject|0|||
161232988|NCT02587962|582236675|FG002|Overall Study|Withdrawal by Subject|1|||
161232989|NCT02587962|582236676|FG003|Overall Study|Withdrawal by Subject|1|||
161232990|NCT02587962|582236677|FG004|Overall Study|Withdrawal by Subject|4|||
161232991|NCT02587962|582236673|FG000|Overall Study|Radiological progression|2|||
161232992|NCT02587962|582236674|FG001|Overall Study|Radiological progression|2|||
161232993|NCT02587962|582236675|FG002|Overall Study|Radiological progression|2|||
161232994|NCT02587962|582236676|FG003|Overall Study|Radiological progression|5|||
161328868|NCT06060496|582589198|FG000|Overall Study|Withdrawal by Subject|2|||
161328869|NCT06060496|582589198|FG000|Overall Study|Lost to Follow-up|2|||
161328870|NCT00149396|582589201|FG000|Overall Study|Death|15|||
161328871|NCT00149396|582589201|FG000|Overall Study|Withdrawal by Subject|1|||
161328872|NCT00149396|582589201|FG000|Overall Study|Subject noncompliance|2|||
161328873|NCT00149396|582589201|FG000|Overall Study|other treatment|5|||
161328874|NCT00807885|582589202|FG000|Overall Study|Lost to Follow-up|0|||
161328875|NCT00807885|582589203|FG001|Overall Study|Lost to Follow-up|0|||
161328876|NCT00807885|582589204|FG002|Overall Study|Lost to Follow-up|0|||
161328877|NCT00807885|582589205|FG003|Overall Study|Lost to Follow-up|0|||
161328878|NCT00807885|582589206|FG004|Overall Study|Lost to Follow-up|0|||
161328879|NCT00807885|582589207|FG005|Overall Study|Lost to Follow-up|1|||
161328880|NCT00807885|582589208|FG006|Overall Study|Lost to Follow-up|0|||
161328881|NCT00807885|582589209|FG007|Overall Study|Lost to Follow-up|0|||
161328882|NCT00807885|582589210|FG008|Overall Study|Lost to Follow-up|0|||
161328883|NCT01670045|582589214|FG000|Overall Study|Withdrawal by Subject|3|||
161328884|NCT01670045|582589214|FG000|Overall Study|Adverse Event|1|||
161328885|NCT01670045|582589214|FG000|Overall Study|Death|1|||
161328886|NCT01670045|582589214|FG000|Overall Study|Lost to Follow-up|11|||
161328887|NCT03360019|582589215|FG000|Overall Study|Withdrawal by Subject|2|||
161328888|NCT03360019|582589216|FG001|Overall Study|Withdrawal by Subject|0|||
161328889|NCT03360019|582589217|FG002|Overall Study|Withdrawal by Subject|0|||
161328890|NCT03360019|582589215|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
161328891|NCT03360019|582589216|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
161232995|NCT02587962|582236677|FG004|Overall Study|Radiological progression|10|||
161232996|NCT02587962|582236673|FG000|Overall Study|Clinical progression|0|||
161232997|NCT02587962|582236674|FG001|Overall Study|Clinical progression|1|||
161232998|NCT02587962|582236675|FG002|Overall Study|Clinical progression|2|||
161232999|NCT02587962|582236676|FG003|Overall Study|Clinical progression|0|||
161233000|NCT02587962|582236677|FG004|Overall Study|Clinical progression|1|||
161328892|NCT03360019|582589217|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
161328893|NCT01462110|582589220|FG000|Overall Study|Adverse Event|1|||
161328894|NCT01462110|582589221|FG001|Overall Study|Adverse Event|0|||
161328895|NCT00753675|582589222|FG000|Overall Study|other reason|11|||
161328896|NCT00753675|582589223|FG001|Overall Study|other reason|12|||
161328897|NCT00753675|582589224|FG002|Overall Study|other reason|13|||
161328898|NCT00753675|582589222|FG000|Overall Study|Death|1|||
161233001|NCT00184600|582236678|FG000|Overall Study|Adverse Event|9|||
161233002|NCT00184600|582236679|FG001|Overall Study|Adverse Event|0|||
161233003|NCT00184600|582236680|FG002|Overall Study|Adverse Event|5|||
161233004|NCT00184600|582236678|FG000|Overall Study|Death|3|||
161233005|NCT00184600|582236679|FG001|Overall Study|Death|9|||
161233006|NCT00184600|582236680|FG002|Overall Study|Death|7|||
161233007|NCT00184600|582236678|FG000|Overall Study|Lack of Efficacy|3|||
161233008|NCT00184600|582236679|FG001|Overall Study|Lack of Efficacy|1|||
161233009|NCT00184600|582236680|FG002|Overall Study|Lack of Efficacy|3|||
161233010|NCT00184600|582236678|FG000|Overall Study|Lost to Follow-up|4|||
161233011|NCT00184600|582236679|FG001|Overall Study|Lost to Follow-up|6|||
161233012|NCT00184600|582236680|FG002|Overall Study|Lost to Follow-up|1|||
161233013|NCT00184600|582236678|FG000|Overall Study|Protocol Violation|2|||
161233014|NCT00184600|582236679|FG001|Overall Study|Protocol Violation|2|||
161233015|NCT00184600|582236680|FG002|Overall Study|Protocol Violation|3|||
161233016|NCT00184600|582236678|FG000|Overall Study|Withdrawal by Subject|20|||
161233017|NCT00184600|582236679|FG001|Overall Study|Withdrawal by Subject|28|||
161233018|NCT00184600|582236680|FG002|Overall Study|Withdrawal by Subject|12|||
161233019|NCT00184600|582236678|FG000|Overall Study|Unclassified|4|||
161233020|NCT00184600|582236679|FG001|Overall Study|Unclassified|5|||
161233021|NCT00184600|582236680|FG002|Overall Study|Unclassified|3|||
161233022|NCT00624065|582236683|FG000|Overall Study|Adverse Event|5|||
161233023|NCT00624065|582236684|FG001|Overall Study|Adverse Event|6|||
161233024|NCT00624065|582236683|FG000|Overall Study|Lost to Follow-up|4|||
161233025|NCT00624065|582236684|FG001|Overall Study|Lost to Follow-up|1|||
161233026|NCT00624065|582236683|FG000|Overall Study|Consent withdrawn|6|||
161233027|NCT00624065|582236684|FG001|Overall Study|Consent withdrawn|5|||
161233028|NCT00624065|582236683|FG000|Overall Study|Lack of Efficacy|0|||
161233029|NCT00624065|582236684|FG001|Overall Study|Lack of Efficacy|3|||
161233030|NCT00624065|582236683|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
161233031|NCT00624065|582236684|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
161233032|NCT00696020|582236685|FG000|Overall Study|Adverse Event|3|||
161233033|NCT00696020|582236686|FG001|Overall Study|Adverse Event|1|||
161233034|NCT00696020|582236687|FG002|Overall Study|Adverse Event|2|||
161233035|NCT00696020|582236688|FG003|Overall Study|Adverse Event|1|||
161328899|NCT00753675|582589223|FG001|Overall Study|Death|2|||
161328900|NCT00753675|582589224|FG002|Overall Study|Death|4|||
161328901|NCT00753675|582589222|FG000|Overall Study|Adverse Event|11|||
161328902|NCT00753675|582589223|FG001|Overall Study|Adverse Event|9|||
161126596|NCT00793793|581850731|FG005|Overall Study|Lost to Follow-up|0|||
161126597|NCT00793793|581850732|FG006|Overall Study|Lost to Follow-up|0|||
161126598|NCT00793793|581850733|FG007|Overall Study|Lost to Follow-up|0|||
161126599|NCT00793793|581850734|FG008|Overall Study|Lost to Follow-up|1|||
161126600|NCT00793793|581850735|FG009|Overall Study|Lost to Follow-up|3|||
161126601|NCT00793793|581850736|FG010|Overall Study|Lost to Follow-up|1|||
161126602|NCT00793793|581850737|FG011|Overall Study|Lost to Follow-up|0|||
161126603|NCT00793793|581850726|FG000|Overall Study|Withdrawal by Subject|0|||
161126604|NCT00793793|581850727|FG001|Overall Study|Withdrawal by Subject|0|||
161126605|NCT00793793|581850728|FG002|Overall Study|Withdrawal by Subject|0|||
161126606|NCT00793793|581850729|FG003|Overall Study|Withdrawal by Subject|0|||
161126607|NCT00793793|581850730|FG004|Overall Study|Withdrawal by Subject|1|||
161126608|NCT00793793|581850731|FG005|Overall Study|Withdrawal by Subject|0|||
161126609|NCT00793793|581850732|FG006|Overall Study|Withdrawal by Subject|0|||
161126610|NCT00793793|581850733|FG007|Overall Study|Withdrawal by Subject|0|||
161126611|NCT00793793|581850734|FG008|Overall Study|Withdrawal by Subject|1|||
161126612|NCT00793793|581850735|FG009|Overall Study|Withdrawal by Subject|0|||
161126613|NCT00793793|581850736|FG010|Overall Study|Withdrawal by Subject|0|||
161126614|NCT00793793|581850737|FG011|Overall Study|Withdrawal by Subject|0|||
161126615|NCT00793793|581850726|FG000|Overall Study|reason not specified|0|||
161126616|NCT00793793|581850727|FG001|Overall Study|reason not specified|1|||
161126617|NCT00793793|581850728|FG002|Overall Study|reason not specified|0|||
161126618|NCT00793793|581850729|FG003|Overall Study|reason not specified|1|||
161126619|NCT00793793|581850730|FG004|Overall Study|reason not specified|1|||
161126620|NCT00793793|581850731|FG005|Overall Study|reason not specified|1|||
161126621|NCT00793793|581850732|FG006|Overall Study|reason not specified|2|||
161126622|NCT00793793|581850733|FG007|Overall Study|reason not specified|0|||
161126623|NCT00793793|581850734|FG008|Overall Study|reason not specified|7|||
161126624|NCT00793793|581850735|FG009|Overall Study|reason not specified|6|||
161126625|NCT00793793|581850736|FG010|Overall Study|reason not specified|2|||
161126626|NCT00793793|581850737|FG011|Overall Study|reason not specified|4|||
161233036|NCT00696020|582236685|FG000|Overall Study|Lack of Efficacy|1|||
161233037|NCT00696020|582236686|FG001|Overall Study|Lack of Efficacy|0|||
161233038|NCT00696020|582236687|FG002|Overall Study|Lack of Efficacy|0|||
161233039|NCT00696020|582236688|FG003|Overall Study|Lack of Efficacy|0|||
161328903|NCT00753675|582589224|FG002|Overall Study|Adverse Event|4|||
160890214|NCT00423670|580992968|FG001|Treatment Period|Non-compliance with protocol|1|||
160890215|NCT00423670|580992969|FG002|Treatment Period|Non-compliance with protocol|1|||
160890216|NCT00423670|580992970|FG003|Treatment Period|Non-compliance with protocol|3|||
161126627|NCT00840827|581850738|FG000|Overall Study|Adverse Event|1|||
161126628|NCT00840827|581850738|FG000|Overall Study|Lack of Efficacy|4|||
161126629|NCT00840827|581850738|FG000|Overall Study|Physician Decision|1|||
161126630|NCT01940484|581850740|FG000|Overall Study|Withdrawal by Subject|3|||
161126631|NCT01940484|581850740|FG000|Overall Study|Underwent transplantation|4|||
161126632|NCT01940484|581850740|FG000|Overall Study|Death|2|||
161126633|NCT01940484|581850740|FG000|Overall Study|Adverse Event|1|||
161126634|NCT01705691|581850743|FG000|Overall Study|Death|1|||
161126635|NCT01705691|581850744|FG001|Overall Study|Death|2|||
161126636|NCT01705691|581850743|FG000|Overall Study|Withdrawal by Subject|1|||
161126637|NCT01705691|581850744|FG001|Overall Study|Withdrawal by Subject|2|||
161126638|NCT01705691|581850743|FG000|Overall Study|Lost to Follow-up|1|||
161126639|NCT01705691|581850744|FG001|Overall Study|Lost to Follow-up|1|||
161126640|NCT01705691|581850743|FG000|Overall Study|Other|0|||
161126641|NCT01705691|581850744|FG001|Overall Study|Other|1|||
161126642|NCT02658448|581850745|FG000|Overall Study|Lost to Follow-up|1|||
161126643|NCT03106779|581850746|FG000|Overall Study|Lack of Efficacy|33|||
161126644|NCT03106779|581850747|FG001|Overall Study|Lack of Efficacy|24|||
161126645|NCT03106779|581850746|FG000|Overall Study|Adverse Event|8|||
161126646|NCT03106779|581850747|FG001|Overall Study|Adverse Event|16|||
161126647|NCT03106779|581850746|FG000|Overall Study|Physician Decision|10|||
161126648|NCT03106779|581850747|FG001|Overall Study|Physician Decision|6|||
161126649|NCT03106779|581850746|FG000|Overall Study|Patient/guardian decision|4|||
161126650|NCT03106779|581850747|FG001|Overall Study|Patient/guardian decision|3|||
161126651|NCT03106779|581850746|FG000|Overall Study|Progressive disease|1|||
161126652|NCT03106779|581850747|FG001|Overall Study|Progressive disease|3|||
161126653|NCT03106779|581850746|FG000|Overall Study|Lost to Follow-up|1|||
161126654|NCT03106779|581850747|FG001|Overall Study|Lost to Follow-up|2|||
161126655|NCT03106779|581850746|FG000|Overall Study|Death|1|||
161126656|NCT03106779|581850747|FG001|Overall Study|Death|0|||
161126657|NCT03106779|581850746|FG000|Overall Study|Protocol Violation|1|||
161126658|NCT03106779|581850747|FG001|Overall Study|Protocol Violation|0|||
161126659|NCT03106779|581850746|FG000|Overall Study|Not treated|1|||
161126660|NCT03106779|581850747|FG001|Overall Study|Not treated|0|||
161126661|NCT04233229|581850748|FG000|Overall Study|Withdrawal by Subject|0|||
161126662|NCT04233229|581850749|FG001|Overall Study|Withdrawal by Subject|1|||
161126663|NCT04233229|581850748|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
161126664|NCT04233229|581850749|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
161126665|NCT04233229|581850748|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
161126666|NCT04233229|581850749|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
161126667|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
161126668|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
161126669|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
161126670|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
161126671|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
161126672|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
161126673|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
161126674|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
161126675|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
161126676|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
161126677|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
161126678|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
161126679|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
161126680|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
161126681|NCT02288247|581850750|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
161126682|NCT02288247|581850751|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
161126683|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
161126684|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
161126685|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
161126686|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
161126687|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
161126688|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
161126689|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
161126690|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
161126691|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
161126692|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
161126693|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
161126694|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
161233040|NCT00696020|582236685|FG000|Overall Study|Protocol Violation|0|||
161233041|NCT00696020|582236686|FG001|Overall Study|Protocol Violation|0|||
161233042|NCT00696020|582236687|FG002|Overall Study|Protocol Violation|0|||
161233043|NCT00696020|582236688|FG003|Overall Study|Protocol Violation|1|||
161233044|NCT00696020|582236685|FG000|Overall Study|Withdrawal by Subject|0|||
161233045|NCT00696020|582236686|FG001|Overall Study|Withdrawal by Subject|1|||
161233046|NCT00696020|582236687|FG002|Overall Study|Withdrawal by Subject|0|||
161233047|NCT00696020|582236688|FG003|Overall Study|Withdrawal by Subject|1|||
161233048|NCT00696020|582236685|FG000|Overall Study|Other not stated above|0|||
161233049|NCT00696020|582236686|FG001|Overall Study|Other not stated above|0|||
161233050|NCT00696020|582236687|FG002|Overall Study|Other not stated above|1|||
161233051|NCT00696020|582236688|FG003|Overall Study|Other not stated above|1|||
161233052|NCT01387022|582236689|FG000|Overall Study|Death|1|||
161233053|NCT01387022|582236690|FG001|Overall Study|Death|1|||
161233054|NCT01387022|582236689|FG000|Overall Study|Lost to Follow-up|0|||
161233055|NCT01387022|582236690|FG001|Overall Study|Lost to Follow-up|3|||
161233056|NCT02076022|582236691|FG000|Overall Study|Withdrawal by Subject|2|||
161233057|NCT02076022|582236692|FG001|Overall Study|Withdrawal by Subject|0|||
161233058|NCT01536405|582236695|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
161233059|NCT01536405|582236696|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
161233060|NCT01536405|582236695|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
161233061|NCT01536405|582236696|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
161233062|NCT01536405|582236695|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
161233063|NCT01536405|582236696|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
161233064|NCT01536405|582236695|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
161233065|NCT01536405|582236696|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
161233066|NCT01536405|582236695|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
161233067|NCT01536405|582236696|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
161233068|NCT01536405|582236695|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
161233069|NCT01536405|582236696|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
161233070|NCT01536405|582236695|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
161233071|NCT01536405|582236696|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
161233072|NCT01536405|582236695|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
161233073|NCT01536405|582236696|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
161233074|NCT01536405|582236695|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
161233075|NCT01536405|582236696|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
161233076|NCT01536405|582236695|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
161233077|NCT01536405|582236696|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
161233078|NCT01536405|582236695|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
161233079|NCT01536405|582236696|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
161233080|NCT01536405|582236695|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
161233081|NCT01536405|582236696|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
161233082|NCT01536405|582236695|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
161233083|NCT01536405|582236696|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
160890217|NCT00423670|580992971|FG004|Treatment Period|Non-compliance with protocol|2|||
161233084|NCT02661295|582236697|FG000|Overall Study|Death|1|||
161233085|NCT02661295|582236697|FG000|Overall Study|Transferred Out|1|||
161233086|NCT02661295|582236697|FG000|Overall Study|Kidney Transplant|1|||
161233087|NCT02661295|582236697|FG000|Overall Study|Withdrawn due to side effects|8|||
161233088|NCT02661295|582236697|FG000|Overall Study|Withdrawn due to access type|1|||
161233089|NCT02661295|582236697|FG000|Overall Study|Withdrawn due to allergies|1|||
161233090|NCT02661295|582236697|FG000|Overall Study|Withdrawn due to non-compliance|1|||
161233091|NCT02661295|582236697|FG000|Overall Study|Withdrawal by Subject|3|||
161233092|NCT02661295|582236697|FG000|Overall Study|Failed screening|2|||
161233093|NCT03687736|582236701|FG000|Overall Study|Lost to Follow-up|7|||
161233094|NCT03687736|582236701|FG000|Overall Study|Withdrawal by Subject|3|||
161233095|NCT01844375|582236702|FG000|Overall Study|Protocol Violation|1|||
161233096|NCT01844375|582236703|FG001|Overall Study|Protocol Violation|1|||
161233097|NCT03627091|582236704|FG000|Overall Study|Adverse Event|0|||
161233098|NCT03627091|582236705|FG001|Overall Study|Adverse Event|0|||
161233099|NCT03627091|582236706|FG002|Overall Study|Adverse Event|2|||
161233100|NCT03627091|582236704|FG000|Overall Study|Withdrawal by Subject|2|||
161233101|NCT03627091|582236705|FG001|Overall Study|Withdrawal by Subject|0|||
161233102|NCT03627091|582236706|FG002|Overall Study|Withdrawal by Subject|2|||
161233103|NCT03627091|582236704|FG000|Overall Study|Physician Decision|2|||
161233104|NCT03627091|582236705|FG001|Overall Study|Physician Decision|0|||
161233105|NCT03627091|582236706|FG002|Overall Study|Physician Decision|0|||
161233106|NCT03627091|582236704|FG000|Overall Study|Site terminated by sponsor|0|||
161233107|NCT03627091|582236705|FG001|Overall Study|Site terminated by sponsor|1|||
161233108|NCT03627091|582236706|FG002|Overall Study|Site terminated by sponsor|0|||
161233109|NCT03627091|582236704|FG000|Overall Study|Disease relapse|7|||
161233110|NCT03627091|582236705|FG001|Overall Study|Disease relapse|5|||
161233111|NCT03627091|582236706|FG002|Overall Study|Disease relapse|1|||
161233112|NCT03627091|582236704|FG000|Overall Study|Other|1|||
161233113|NCT03627091|582236705|FG001|Overall Study|Other|0|||
161233114|NCT03627091|582236706|FG002|Overall Study|Other|0|||
161233115|NCT02514122|582236707|FG000|Overall Study|Withdrawal by Subject|2|||
161233116|NCT02514122|582236708|FG001|Overall Study|Withdrawal by Subject|0|||
161233117|NCT01472341|582236712|FG000|Overall Study|Started insulin therapy|55|||
161233118|NCT01472341|582236712|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
161233119|NCT01472341|582236712|FG000|Overall Study|Withdrawal by Subject|39|||
161233120|NCT01472341|582236712|FG000|Overall Study|Lost to Follow-up|52|||
161233121|NCT01472341|582236712|FG000|Overall Study|Laboratory parameters unavailable|25|||
161233122|NCT01472341|582236712|FG000|Overall Study|Death|9|||
161233123|NCT00296647|582236716|FG000|Overall Study|Death|4|||
161233124|NCT00296647|582236717|FG001|Overall Study|Death|1|||
161233125|NCT00296647|582236718|FG002|Overall Study|Death|2|||
161233126|NCT00296647|582236719|FG003|Overall Study|Death|1|||
161233127|NCT00296647|582236720|FG004|Overall Study|Death|1|||
161233128|NCT00296647|582236716|FG000|Overall Study|Withdrawal by Subject|28|||
161233129|NCT00296647|582236717|FG001|Overall Study|Withdrawal by Subject|27|||
161233130|NCT00296647|582236718|FG002|Overall Study|Withdrawal by Subject|32|||
161233131|NCT00296647|582236719|FG003|Overall Study|Withdrawal by Subject|16|||
161233132|NCT00296647|582236720|FG004|Overall Study|Withdrawal by Subject|19|||
161233133|NCT05615935|582236723|FG000|Overall Study|Lost to Follow-up|1|||
161233134|NCT05615935|582236724|FG001|Overall Study|Lost to Follow-up|1|||
161233135|NCT01863745|582236725|FG000|Overall Study|Disease Progression|9|||
161233136|NCT01863745|582236725|FG000|Overall Study|Adverse Event|2|||
161233137|NCT01863745|582236725|FG000|Overall Study|Death|1|||
161233138|NCT01863745|582236725|FG000|Overall Study|Withdrawal by Subject|1|||
161233139|NCT00735904|582236726|FG000|Overall Study|Adverse Event|3|||
161233140|NCT00735904|582236726|FG000|Overall Study|Death|20|||
161233141|NCT00735904|582236726|FG000|Overall Study|Protocol Violation|1|||
161233142|NCT00735904|582236726|FG000|Overall Study|Withdrawal by Subject|1|||
161233143|NCT00735904|582236726|FG000|Overall Study|Study Terminated by Sponsor|5|||
161233144|NCT00735904|582236726|FG000|Overall Study|Other|8|||
161233145|NCT01171963|582236728|FG000|Overall Study|Adverse Event|10|||
161233146|NCT01171963|582236729|FG001|Overall Study|Adverse Event|15|||
161233147|NCT01171963|582236728|FG000|Overall Study|Lost to Follow-up|23|||
161233148|NCT01171963|582236729|FG001|Overall Study|Lost to Follow-up|24|||
161233149|NCT01171963|582236728|FG000|Overall Study|Other - diarrhoea|1|||
161233150|NCT01171963|582236729|FG001|Overall Study|Other - diarrhoea|0|||
161233151|NCT01171963|582236728|FG000|Overall Study|Withdrawal by Subject|114|||
161233152|NCT01171963|582236729|FG001|Overall Study|Withdrawal by Subject|129|||
161233153|NCT05093205|582236730|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
161233154|NCT05093205|582236731|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
161233155|NCT05093205|582236732|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
161233156|NCT05093205|582236733|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
161233157|NCT05093205|582236734|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
161233158|NCT05093205|582236735|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
161233159|NCT05093205|582236736|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
161233160|NCT05093205|582236737|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
161233161|NCT05093205|582236738|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
161233162|NCT05093205|582236739|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
161126695|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
161126696|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
161126697|NCT02288247|581850750|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
161126698|NCT02288247|581850751|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
161126699|NCT00584194|581850752|FG000|Overall Study|Other|135|||
161126700|NCT04093531|581850753|FG000|Overall Study|failed screening|4|||
161126701|NCT00648167|581850754|FG000|Overall Study|Adverse Event|6|||
161126702|NCT00648167|581850754|FG000|Overall Study|unable to swallow tablets|1|||
161126703|NCT00927368|581850755|FG000|Overall Study|enrollment in another study|1|||
161126704|NCT00927368|581850756|FG001|Overall Study|enrollment in another study|1|||
161126705|NCT00927368|581850757|FG002|Overall Study|enrollment in another study|2|||
161126706|NCT00927368|581850755|FG000|Overall Study|Lost to Follow-up|4|||
161233163|NCT05093205|582236740|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
161233164|NCT05093205|582236741|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
161233165|NCT05093205|582236742|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
161233166|NCT05093205|582236730|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161126707|NCT00927368|581850756|FG001|Overall Study|Lost to Follow-up|0|||
161126708|NCT00927368|581850757|FG002|Overall Study|Lost to Follow-up|0|||
161233167|NCT05093205|582236731|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233168|NCT05093205|582236732|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
161233169|NCT05093205|582236733|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233170|NCT05093205|582236734|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233171|NCT05093205|582236735|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233172|NCT05093205|582236736|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233173|NCT05093205|582236737|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233174|NCT05093205|582236738|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233175|NCT05093205|582236739|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233176|NCT05093205|582236740|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233177|NCT05093205|582236741|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233178|NCT05093205|582236742|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
161233179|NCT05093205|582236730|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
161233180|NCT05093205|582236731|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
161233181|NCT05093205|582236732|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
161233182|NCT05093205|582236733|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
161233183|NCT05093205|582236734|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
161233184|NCT05093205|582236735|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
161233185|NCT05093205|582236736|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
161233186|NCT05093205|582236737|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
161233187|NCT05093205|582236738|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
161233188|NCT05093205|582236739|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
161233189|NCT05093205|582236740|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
161233190|NCT05093205|582236741|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
161233191|NCT05093205|582236742|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
161233192|NCT05093205|582236730|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
161233193|NCT05093205|582236731|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
161233194|NCT05093205|582236732|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
161233195|NCT05093205|582236733|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
161233196|NCT05093205|582236734|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
161233197|NCT05093205|582236735|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
161233198|NCT05093205|582236736|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
161233199|NCT05093205|582236737|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
161233200|NCT05093205|582236738|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
161233201|NCT05093205|582236739|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
161233202|NCT05093205|582236740|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
161233203|NCT05093205|582236741|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
161233204|NCT05093205|582236742|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
161233205|NCT05093205|582236730|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
161233206|NCT05093205|582236731|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
161233207|NCT05093205|582236732|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
161233208|NCT05093205|582236733|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
161233209|NCT05093205|582236734|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
161233210|NCT05093205|582236735|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
161233211|NCT05093205|582236736|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
161233212|NCT05093205|582236737|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
161233213|NCT05093205|582236738|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
161233214|NCT05093205|582236739|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
161233215|NCT05093205|582236740|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
161233216|NCT05093205|582236741|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
161233217|NCT05093205|582236742|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
161233218|NCT05093205|582236730|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
161233219|NCT05093205|582236731|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
161233220|NCT05093205|582236732|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
161233221|NCT05093205|582236733|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
161328904|NCT00753675|582589222|FG000|Overall Study|Objective progression of disease|35|||
161328905|NCT00753675|582589223|FG001|Overall Study|Objective progression of disease|35|||
161328906|NCT00753675|582589224|FG002|Overall Study|Objective progression of disease|35|||
161328907|NCT00753675|582589222|FG000|Overall Study|Withdrawal by Subject|0|||
161328908|NCT00753675|582589223|FG001|Overall Study|Withdrawal by Subject|1|||
161328909|NCT00753675|582589224|FG002|Overall Study|Withdrawal by Subject|0|||
161328910|NCT00753675|582589222|FG000|Overall Study|Lost to Follow-up|1|||
161328911|NCT00753675|582589223|FG001|Overall Study|Lost to Follow-up|0|||
161328912|NCT00753675|582589224|FG002|Overall Study|Lost to Follow-up|0|||
161328913|NCT05279131|582589225|FG000|Overall Study|Lost to Follow-up|1|||
161328914|NCT05279131|582589225|FG000|Overall Study|Death|1|||
161328915|NCT05279131|582589225|FG000|Overall Study|Physician Decision|1|||
161233222|NCT05093205|582236734|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
161328916|NCT04754542|582589233|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
161328917|NCT04754542|582589234|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
161328918|NCT01212094|582590604|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
161328919|NCT01212094|582590605|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
161328920|NCT01212094|582590606|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
161233223|NCT05093205|582236735|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
161233224|NCT05093205|582236736|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
161233225|NCT05093205|582236737|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
161233226|NCT05093205|582236738|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
161233227|NCT05093205|582236739|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
161233228|NCT05093205|582236740|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
161328921|NCT01212094|582590604|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
161328922|NCT01212094|582590605|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
161233229|NCT05093205|582236741|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
161233230|NCT05093205|582236742|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
161233231|NCT05093205|582236730|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
161233232|NCT05093205|582236731|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
161233233|NCT05093205|582236732|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
161233234|NCT05093205|582236733|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
161233235|NCT05093205|582236734|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
161233236|NCT05093205|582236735|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
161233237|NCT05093205|582236736|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
161233238|NCT05093205|582236737|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
161233239|NCT05093205|582236738|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
161233240|NCT05093205|582236739|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
161233241|NCT05093205|582236740|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
161233242|NCT05093205|582236741|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
161233243|NCT05093205|582236742|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
161233244|NCT05093205|582236730|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
161233245|NCT05093205|582236731|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
161233246|NCT05093205|582236732|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
161233247|NCT05093205|582236733|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
161233248|NCT05093205|582236734|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
161233249|NCT05093205|582236735|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
161233250|NCT05093205|582236736|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
161233251|NCT05093205|582236737|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
161233252|NCT05093205|582236738|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
161233253|NCT05093205|582236739|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
161233254|NCT05093205|582236740|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
161233255|NCT05093205|582236741|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
161233256|NCT05093205|582236742|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
161233257|NCT05093205|582236730|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233258|NCT05093205|582236731|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233259|NCT05093205|582236732|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233260|NCT05093205|582236733|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233261|NCT05093205|582236734|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233262|NCT05093205|582236735|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233263|NCT05093205|582236736|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233264|NCT05093205|582236737|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233265|NCT05093205|582236738|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233266|NCT05093205|582236739|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
161233267|NCT05093205|582236740|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233268|NCT05093205|582236741|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233269|NCT05093205|582236742|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
161233270|NCT05093205|582236730|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
161233271|NCT05093205|582236731|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
161233272|NCT05093205|582236732|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
161233273|NCT05093205|582236733|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
161233274|NCT05093205|582236734|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
161233275|NCT05093205|582236735|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
161233276|NCT05093205|582236736|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
161233277|NCT05093205|582236737|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
161233278|NCT05093205|582236738|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
161233279|NCT05093205|582236739|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
161233280|NCT05093205|582236740|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
161233281|NCT05093205|582236741|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
161233282|NCT05093205|582236742|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
161233283|NCT05093205|582236730|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233284|NCT05093205|582236731|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233285|NCT05093205|582236732|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233286|NCT05093205|582236733|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233287|NCT05093205|582236734|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233288|NCT05093205|582236735|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233289|NCT05093205|582236736|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233290|NCT05093205|582236737|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233291|NCT05093205|582236738|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233292|NCT05093205|582236739|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233293|NCT05093205|582236740|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
161233294|NCT05093205|582236741|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233295|NCT05093205|582236742|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
161233296|NCT05093205|582236730|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233297|NCT05093205|582236731|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233298|NCT05093205|582236732|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233299|NCT05093205|582236733|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233300|NCT05093205|582236734|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233301|NCT05093205|582236735|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233302|NCT05093205|582236736|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233303|NCT05093205|582236737|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233304|NCT05093205|582236738|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233305|NCT05093205|582236739|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233306|NCT05093205|582236740|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233307|NCT05093205|582236741|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
161233308|NCT05093205|582236742|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
161233309|NCT05093205|582236730|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
161233310|NCT05093205|582236731|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
161233311|NCT05093205|582236732|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
161233312|NCT05093205|582236733|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
161233313|NCT05093205|582236734|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
161233314|NCT05093205|582236735|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
161233315|NCT05093205|582236736|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
161233316|NCT05093205|582236737|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
161233317|NCT05093205|582236738|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
161233318|NCT05093205|582236739|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
161233319|NCT05093205|582236740|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
161233320|NCT05093205|582236741|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
161233321|NCT05093205|582236742|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
161233322|NCT05093205|582236730|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233323|NCT05093205|582236731|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233324|NCT05093205|582236732|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233325|NCT05093205|582236733|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233326|NCT05093205|582236734|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233327|NCT05093205|582236735|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233328|NCT05093205|582236736|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233329|NCT05093205|582236737|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233330|NCT05093205|582236738|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233331|NCT05093205|582236739|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233332|NCT05093205|582236740|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233333|NCT05093205|582236741|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
161233334|NCT05093205|582236742|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
161233335|NCT02979353|582236751|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
161233336|NCT02979353|582236752|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
161233337|NCT02979353|582236751|FG000|Overall Study|Withdrawal by Subject|16|||
161233338|NCT02979353|582236752|FG001|Overall Study|Withdrawal by Subject|12|||
161233339|NCT02979353|582236751|FG000|Overall Study|Death|10|||
161233340|NCT02979353|582236752|FG001|Overall Study|Death|11|||
161233341|NCT02979353|582236751|FG000|Overall Study|Transfer to Hospice Care|19|||
161233342|NCT02979353|582236752|FG001|Overall Study|Transfer to Hospice Care|14|||
161233343|NCT02979353|582236751|FG000|Overall Study|Lost to Follow-up|1|||
161233344|NCT02979353|582236752|FG001|Overall Study|Lost to Follow-up|5|||
161233345|NCT00268905|582236754|FG000|Overall Study|Adverse Event|3|||
161233346|NCT00268905|582236755|FG001|Overall Study|Adverse Event|0|||
161233347|NCT00268905|582236756|FG002|Overall Study|Adverse Event|4|||
161233348|NCT00268905|582236754|FG000|Overall Study|Lost to Follow-up|0|||
161233349|NCT00268905|582236755|FG001|Overall Study|Lost to Follow-up|1|||
161233350|NCT00268905|582236756|FG002|Overall Study|Lost to Follow-up|0|||
161233351|NCT00268905|582236754|FG000|Overall Study|Withdrawal by Subject|0|||
161328923|NCT01212094|582590606|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
161328924|NCT01212094|582590604|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
161328925|NCT01212094|582590605|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
161328926|NCT01212094|582590606|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
161328927|NCT01212094|582590604|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
161328928|NCT01212094|582590605|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
161328929|NCT01212094|582590606|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
161328930|NCT01212094|582590604|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
161328931|NCT01212094|582590605|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
161328932|NCT01212094|582590606|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
160890218|NCT00423670|580992972|FG005|Treatment Period|Non-compliance with protocol|0|||
160890219|NCT00423670|580992973|FG006|Treatment Period|Non-compliance with protocol|2|||
161126709|NCT00927368|581850755|FG000|Overall Study|equipment failure|1|||
161126710|NCT00927368|581850756|FG001|Overall Study|equipment failure|0|||
161126711|NCT00927368|581850757|FG002|Overall Study|equipment failure|0|||
161126712|NCT00927368|581850755|FG000|Overall Study|ineligible post randomization|0|||
161126713|NCT00927368|581850756|FG001|Overall Study|ineligible post randomization|3|||
161126714|NCT00927368|581850757|FG002|Overall Study|ineligible post randomization|1|||
161126715|NCT00927368|581850755|FG000|Overall Study|cancellation of surgery|0|||
161126716|NCT00927368|581850756|FG001|Overall Study|cancellation of surgery|1|||
161126717|NCT00927368|581850757|FG002|Overall Study|cancellation of surgery|2|||
161233352|NCT00268905|582236755|FG001|Overall Study|Withdrawal by Subject|0|||
161233353|NCT00268905|582236756|FG002|Overall Study|Withdrawal by Subject|3|||
161233354|NCT00268905|582236754|FG000|Overall Study|Progressive Disease|28|||
161233355|NCT00268905|582236755|FG001|Overall Study|Progressive Disease|4|||
161233356|NCT00268905|582236756|FG002|Overall Study|Progressive Disease|3|||
161233357|NCT00268905|582236754|FG000|Overall Study|Physician Decision|3|||
161233358|NCT00268905|582236755|FG001|Overall Study|Physician Decision|0|||
161233359|NCT00268905|582236756|FG002|Overall Study|Physician Decision|1|||
161233360|NCT00268905|582236754|FG000|Overall Study|Clinical Progression|9|||
161233361|NCT00268905|582236755|FG001|Overall Study|Clinical Progression|4|||
161233362|NCT00268905|582236756|FG002|Overall Study|Clinical Progression|1|||
161233363|NCT04510285|582236757|FG000|Overall Study|Death|1|||
161233364|NCT00048581|582236758|FG000|Double-Blind Period|Adverse Event|9|||
161233365|NCT00048581|582236759|FG001|Double-Blind Period|Adverse Event|5|||
161233366|NCT00048581|582236760|FG002|Double-Blind Period|Adverse Event|0|||
161233367|NCT00048581|582236758|FG000|Double-Blind Period|Lack of Efficacy|14|||
161233368|NCT00048581|582236759|FG001|Double-Blind Period|Lack of Efficacy|27|||
161233369|NCT00048581|582236760|FG002|Double-Blind Period|Lack of Efficacy|0|||
161233370|NCT00048581|582236758|FG000|Double-Blind Period|Lost to Follow-up|5|||
161233371|NCT00048581|582236759|FG001|Double-Blind Period|Lost to Follow-up|0|||
161233372|NCT00048581|582236760|FG002|Double-Blind Period|Lost to Follow-up|0|||
161233373|NCT00048581|582236758|FG000|Double-Blind Period|Withdrawal by Subject|5|||
161233374|NCT00048581|582236759|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161233375|NCT00048581|582236760|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161233376|NCT00048581|582236758|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
161233377|NCT00048581|582236759|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
161233378|NCT00048581|582236760|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
161233379|NCT00048581|582236758|FG000|Double-Blind Period|Investigator Decision|1|||
161233380|NCT00048581|582236759|FG001|Double-Blind Period|Investigator Decision|0|||
161233381|NCT00048581|582236760|FG002|Double-Blind Period|Investigator Decision|0|||
161233382|NCT00048581|582236758|FG000|Open-Label Period|Death|0|||
161233383|NCT00048581|582236759|FG001|Open-Label Period|Death|0|||
161233384|NCT00048581|582236760|FG002|Open-Label Period|Death|4|||
161233385|NCT00048581|582236758|FG000|Open-Label Period|Adverse Event|0|||
161233386|NCT00048581|582236759|FG001|Open-Label Period|Adverse Event|0|||
161233387|NCT00048581|582236760|FG002|Open-Label Period|Adverse Event|37|||
161233388|NCT00048581|582236758|FG000|Open-Label Period|Lack of Efficacy|0|||
161233389|NCT00048581|582236759|FG001|Open-Label Period|Lack of Efficacy|0|||
161233390|NCT00048581|582236760|FG002|Open-Label Period|Lack of Efficacy|69|||
161233391|NCT00048581|582236758|FG000|Open-Label Period|Lost to Follow-up|0|||
161233392|NCT00048581|582236759|FG001|Open-Label Period|Lost to Follow-up|0|||
161233393|NCT00048581|582236760|FG002|Open-Label Period|Lost to Follow-up|14|||
161233394|NCT00048581|582236758|FG000|Open-Label Period|Withdrawal by Subject|0|||
161233395|NCT00048581|582236759|FG001|Open-Label Period|Withdrawal by Subject|0|||
161233396|NCT00048581|582236760|FG002|Open-Label Period|Withdrawal by Subject|20|||
161233397|NCT00048581|582236758|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
161233398|NCT00048581|582236759|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
161233399|NCT00048581|582236760|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
161233400|NCT00048581|582236758|FG000|Open-Label Period|Poor/Non-compliance|0|||
161233401|NCT00048581|582236759|FG001|Open-Label Period|Poor/Non-compliance|0|||
161233402|NCT00048581|582236760|FG002|Open-Label Period|Poor/Non-compliance|5|||
161233403|NCT00048581|582236758|FG000|Open-Label Period|Pregnancy|0|||
161233404|NCT00048581|582236759|FG001|Open-Label Period|Pregnancy|0|||
161233405|NCT00048581|582236760|FG002|Open-Label Period|Pregnancy|7|||
161233406|NCT00048581|582236758|FG000|Open-Label Period|Study Site Closure|0|||
161233407|NCT00048581|582236759|FG001|Open-Label Period|Study Site Closure|0|||
161233408|NCT00048581|582236760|FG002|Open-Label Period|Study Site Closure|2|||
161233409|NCT00048581|582236758|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
161233410|NCT00048581|582236759|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
161233411|NCT00048581|582236760|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
161233412|NCT00048581|582236758|FG000|Open-Label Period|Problem With Transportation To Site|0|||
161233413|NCT00048581|582236759|FG001|Open-Label Period|Problem With Transportation To Site|0|||
161233414|NCT00048581|582236760|FG002|Open-Label Period|Problem With Transportation To Site|1|||
161233415|NCT00048581|582236758|FG000|Open-Label Period|Primary Investigator Retired|0|||
161233416|NCT00048581|582236759|FG001|Open-Label Period|Primary Investigator Retired|0|||
161233417|NCT00048581|582236760|FG002|Open-Label Period|Primary Investigator Retired|2|||
161233418|NCT00048581|582236758|FG000|Open-Label Period|Study Ended By Sponsor|0|||
161233419|NCT00048581|582236759|FG001|Open-Label Period|Study Ended By Sponsor|0|||
161233420|NCT00048581|582236760|FG002|Open-Label Period|Study Ended By Sponsor|1|||
161233421|NCT01406795|582236761|FG000|Overall Study|Withdrawal by Subject|1|||
161233422|NCT03897088|582236764|FG000|Overall Study|Withdrawal by Subject|12|||
161233423|NCT03897088|582236765|FG001|Overall Study|Withdrawal by Subject|12|||
161233424|NCT03897088|582236764|FG000|Overall Study|Lost to Follow-up|7|||
161233425|NCT03897088|582236765|FG001|Overall Study|Lost to Follow-up|15|||
161233426|NCT03897088|582236764|FG000|Overall Study|Sponsor Decision|1|||
161233427|NCT03897088|582236765|FG001|Overall Study|Sponsor Decision|2|||
161233428|NCT03897088|582236764|FG000|Overall Study|COVID-19|2|||
161233429|NCT03897088|582236765|FG001|Overall Study|COVID-19|0|||
161233430|NCT03897088|582236764|FG000|Overall Study|Other|3|||
161233431|NCT03897088|582236765|FG001|Overall Study|Other|0|||
161233432|NCT03897088|582236764|FG000|Overall Study|Non-compliance with Study Drug|1|||
161233433|NCT03897088|582236765|FG001|Overall Study|Non-compliance with Study Drug|1|||
161233434|NCT03897088|582236764|FG000|Overall Study|Pregnancy|0|||
161233435|NCT03897088|582236765|FG001|Overall Study|Pregnancy|1|||
161233436|NCT04320849|582236774|FG000|Overall Study|Withdrawal by Subject|4|||
161233437|NCT04320849|582236774|FG000|Overall Study|Imaging data unavailable|2|||
161233438|NCT04320849|582236774|FG000|Overall Study|Incomplete imaging|2|||
161233439|NCT03125200|582236777|FG000|Overall Study|Study Termination|0|||
161233440|NCT03125200|582236778|FG001|Overall Study|Study Termination|0|||
161233441|NCT03125200|582236779|FG002|Overall Study|Study Termination|0|||
161233442|NCT03125200|582236780|FG003|Overall Study|Study Termination|1|||
161233443|NCT03125200|582236781|FG004|Overall Study|Study Termination|1|||
161233444|NCT03125200|582236782|FG005|Overall Study|Study Termination|2|||
161233445|NCT03125200|582236783|FG006|Overall Study|Study Termination|1|||
161233446|NCT03125200|582236777|FG000|Overall Study|Clinical Progression|0|||
161233447|NCT03125200|582236778|FG001|Overall Study|Clinical Progression|0|||
161233448|NCT03125200|582236779|FG002|Overall Study|Clinical Progression|0|||
161233449|NCT03125200|582236780|FG003|Overall Study|Clinical Progression|1|||
161233450|NCT03125200|582236781|FG004|Overall Study|Clinical Progression|0|||
161233451|NCT03125200|582236782|FG005|Overall Study|Clinical Progression|1|||
161233452|NCT03125200|582236783|FG006|Overall Study|Clinical Progression|0|||
161233453|NCT03125200|582236777|FG000|Overall Study|Progressive Disease|2|||
161233454|NCT03125200|582236778|FG001|Overall Study|Progressive Disease|1|||
161233455|NCT03125200|582236779|FG002|Overall Study|Progressive Disease|2|||
161233456|NCT03125200|582236780|FG003|Overall Study|Progressive Disease|1|||
161233457|NCT03125200|582236781|FG004|Overall Study|Progressive Disease|2|||
161233458|NCT03125200|582236782|FG005|Overall Study|Progressive Disease|0|||
161233459|NCT03125200|582236783|FG006|Overall Study|Progressive Disease|1|||
161233460|NCT03125200|582236777|FG000|Overall Study|Lack of Efficacy|0|||
161233461|NCT03125200|582236778|FG001|Overall Study|Lack of Efficacy|0|||
161233462|NCT03125200|582236779|FG002|Overall Study|Lack of Efficacy|0|||
161233463|NCT03125200|582236780|FG003|Overall Study|Lack of Efficacy|1|||
161233464|NCT03125200|582236781|FG004|Overall Study|Lack of Efficacy|0|||
161233465|NCT03125200|582236782|FG005|Overall Study|Lack of Efficacy|0|||
161233466|NCT03125200|582236783|FG006|Overall Study|Lack of Efficacy|0|||
161233467|NCT03125200|582236777|FG000|Overall Study|Toxicity|0|||
161233468|NCT03125200|582236778|FG001|Overall Study|Toxicity|0|||
161233469|NCT03125200|582236779|FG002|Overall Study|Toxicity|0|||
161233470|NCT03125200|582236780|FG003|Overall Study|Toxicity|1|||
161233471|NCT03125200|582236781|FG004|Overall Study|Toxicity|0|||
161233472|NCT03125200|582236782|FG005|Overall Study|Toxicity|0|||
161233473|NCT03125200|582236783|FG006|Overall Study|Toxicity|0|||
161233474|NCT03125200|582236777|FG000|Overall Study|Consent Withdrawn by Subject|0|||
161233475|NCT03125200|582236778|FG001|Overall Study|Consent Withdrawn by Subject|1|||
161233476|NCT03125200|582236779|FG002|Overall Study|Consent Withdrawn by Subject|0|||
161233477|NCT03125200|582236780|FG003|Overall Study|Consent Withdrawn by Subject|0|||
161233478|NCT03125200|582236781|FG004|Overall Study|Consent Withdrawn by Subject|1|||
161233479|NCT03125200|582236782|FG005|Overall Study|Consent Withdrawn by Subject|0|||
161233480|NCT03125200|582236783|FG006|Overall Study|Consent Withdrawn by Subject|1|||
161233481|NCT01469546|582236784|FG000|Received 5 mg Dose|Adverse Event|13|||
161233482|NCT01469546|582236784|FG000|Received 5 mg Dose|Death|2|||
161233483|NCT01469546|582236784|FG000|Received 5 mg Dose|Protocol Violation|2|||
161126718|NCT00191451|581850758|FG000|Overall Study|Withdrawal by Subject|2|||
161126719|NCT00191451|581850759|FG001|Overall Study|Withdrawal by Subject|3|||
161126720|NCT00191451|581850760|FG002|Overall Study|Withdrawal by Subject|5|||
161126721|NCT00191451|581850758|FG000|Overall Study|Physician Decision|2|||
161126722|NCT00191451|581850759|FG001|Overall Study|Physician Decision|9|||
161126723|NCT00191451|581850760|FG002|Overall Study|Physician Decision|6|||
161126724|NCT00191451|581850758|FG000|Overall Study|Sponsor Decision|1|||
161126725|NCT00191451|581850759|FG001|Overall Study|Sponsor Decision|0|||
161233484|NCT01469546|582236784|FG000|Received 5 mg Dose|Progressive Disease|3|||
161126726|NCT00191451|581850760|FG002|Overall Study|Sponsor Decision|0|||
161126727|NCT00191451|581850758|FG000|Overall Study|Ineligible|0|||
161233485|NCT01469546|582236784|FG000|Received 5 mg Dose|Physician Decision|3|||
161233486|NCT02801877|582236787|FG000|Overall Study|Lost to Follow-up|1|||
161233487|NCT02801877|582236788|FG001|Overall Study|Lost to Follow-up|1|||
161233488|NCT02801877|582236789|FG002|Overall Study|Lost to Follow-up|2|||
161233489|NCT02801877|582236790|FG003|Overall Study|Lost to Follow-up|0|||
161233490|NCT02801877|582236787|FG000|Overall Study|Never Started Treatment|2|||
161233491|NCT02801877|582236788|FG001|Overall Study|Never Started Treatment|0|||
161233492|NCT02801877|582236789|FG002|Overall Study|Never Started Treatment|4|||
161233493|NCT02801877|582236790|FG003|Overall Study|Never Started Treatment|0|||
161233494|NCT05369208|582238328|FG000|Core Phase|Prohibited Medication Required|2|||
161233495|NCT05369208|582238328|FG000|Core Phase|Adverse Event|1|||
161126728|NCT00191451|581850759|FG001|Overall Study|Ineligible|1|||
161126729|NCT00191451|581850760|FG002|Overall Study|Ineligible|0|||
161126730|NCT00191451|581850758|FG000|Overall Study|Reason Not Specified|2|||
161126731|NCT00191451|581850759|FG001|Overall Study|Reason Not Specified|1|||
161126732|NCT00191451|581850760|FG002|Overall Study|Reason Not Specified|3|||
161126733|NCT03222349|581850761|FG000|Overall Study|Treatment B not done|5|||
161126734|NCT03222349|581850762|FG001|Overall Study|Treatment B not done|0|||
161126735|NCT03222349|581850761|FG000|Overall Study|Lost to Follow-up|1|||
161126736|NCT03222349|581850762|FG001|Overall Study|Lost to Follow-up|2|||
161126737|NCT03222349|581850761|FG000|Overall Study|Withdrawal by Subject|1|||
161126738|NCT03222349|581850762|FG001|Overall Study|Withdrawal by Subject|0|||
161126739|NCT03222349|581850761|FG000|Overall Study|Treatment A not done|0|||
161126740|NCT03222349|581850762|FG001|Overall Study|Treatment A not done|5|||
161126741|NCT03222349|581850761|FG000|Overall Study|Study terminated by sponsor|1|||
161126742|NCT03222349|581850762|FG001|Overall Study|Study terminated by sponsor|0|||
161126743|NCT00236080|581850763|FG000|Overall Study|Adverse Event|0|||
161126744|NCT00236080|581850764|FG001|Overall Study|Adverse Event|0|||
161126745|NCT00236080|581850765|FG002|Overall Study|Adverse Event|3|||
161126746|NCT00236080|581850766|FG003|Overall Study|Adverse Event|1|||
161126747|NCT00236080|581850767|FG004|Overall Study|Adverse Event|0|||
161126748|NCT00236080|581850763|FG000|Overall Study|Lost to Follow-up|0|||
161126749|NCT00236080|581850764|FG001|Overall Study|Lost to Follow-up|1|||
161126750|NCT00236080|581850765|FG002|Overall Study|Lost to Follow-up|0|||
161126751|NCT00236080|581850766|FG003|Overall Study|Lost to Follow-up|0|||
161126752|NCT00236080|581850767|FG004|Overall Study|Lost to Follow-up|0|||
161126753|NCT00236080|581850763|FG000|Overall Study|Physician Decision|1|||
161126754|NCT00236080|581850764|FG001|Overall Study|Physician Decision|0|||
161126755|NCT00236080|581850765|FG002|Overall Study|Physician Decision|1|||
161126756|NCT00236080|581850766|FG003|Overall Study|Physician Decision|1|||
161126757|NCT00236080|581850767|FG004|Overall Study|Physician Decision|1|||
161126758|NCT00236080|581850763|FG000|Overall Study|Withdrawal by Subject|1|||
161126759|NCT00236080|581850764|FG001|Overall Study|Withdrawal by Subject|0|||
161126760|NCT00236080|581850765|FG002|Overall Study|Withdrawal by Subject|0|||
161126761|NCT00236080|581850766|FG003|Overall Study|Withdrawal by Subject|0|||
161126762|NCT00236080|581850767|FG004|Overall Study|Withdrawal by Subject|0|||
161126763|NCT00236080|581850763|FG000|Overall Study|Miscellaneous|0|||
161126764|NCT00236080|581850764|FG001|Overall Study|Miscellaneous|0|||
161126765|NCT00236080|581850765|FG002|Overall Study|Miscellaneous|1|||
161126766|NCT00236080|581850766|FG003|Overall Study|Miscellaneous|0|||
161126767|NCT00236080|581850767|FG004|Overall Study|Miscellaneous|0|||
161126768|NCT01214044|581850768|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
161126769|NCT01214044|581850768|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
161126770|NCT01214044|581850768|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
161126771|NCT01214044|581850768|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
161126772|NCT01214044|581850768|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
161126773|NCT01214044|581850768|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
161126774|NCT03665285|581850769|FG000|Overall Study|Started New Anticancer Treatment|1|||
161126775|NCT03665285|581850770|FG001|Overall Study|Started New Anticancer Treatment|1|||
161126776|NCT03665285|581850771|FG002|Overall Study|Started New Anticancer Treatment|2|||
161126777|NCT03665285|581850772|FG003|Overall Study|Started New Anticancer Treatment|4|||
161126778|NCT03665285|581850773|FG004|Overall Study|Started New Anticancer Treatment|1|||
161126779|NCT03665285|581850774|FG005|Overall Study|Started New Anticancer Treatment|1|||
161126780|NCT03665285|581850775|FG006|Overall Study|Started New Anticancer Treatment|2|||
161126781|NCT03665285|581850776|FG007|Overall Study|Started New Anticancer Treatment|15|||
161126782|NCT03665285|581850777|FG008|Overall Study|Started New Anticancer Treatment|1|||
161126783|NCT03665285|581850769|FG000|Overall Study|Disease Progression|0|||
161126784|NCT03665285|581850770|FG001|Overall Study|Disease Progression|0|||
161126785|NCT03665285|581850771|FG002|Overall Study|Disease Progression|3|||
161126786|NCT03665285|581850772|FG003|Overall Study|Disease Progression|1|||
161126787|NCT03665285|581850773|FG004|Overall Study|Disease Progression|0|||
161126788|NCT03665285|581850774|FG005|Overall Study|Disease Progression|0|||
161126789|NCT03665285|581850775|FG006|Overall Study|Disease Progression|0|||
161126790|NCT03665285|581850776|FG007|Overall Study|Disease Progression|7|||
161126791|NCT03665285|581850777|FG008|Overall Study|Disease Progression|1|||
161126792|NCT03665285|581850769|FG000|Overall Study|Hospice|0|||
161126793|NCT03665285|581850770|FG001|Overall Study|Hospice|0|||
161126794|NCT03665285|581850771|FG002|Overall Study|Hospice|0|||
161126795|NCT03665285|581850772|FG003|Overall Study|Hospice|0|||
161126796|NCT03665285|581850773|FG004|Overall Study|Hospice|0|||
161126797|NCT03665285|581850774|FG005|Overall Study|Hospice|0|||
161126798|NCT03665285|581850775|FG006|Overall Study|Hospice|0|||
161126799|NCT03665285|581850776|FG007|Overall Study|Hospice|2|||
161126800|NCT03665285|581850777|FG008|Overall Study|Hospice|0|||
161126801|NCT03665285|581850769|FG000|Overall Study|Withdrawal by Subject|0|||
161126802|NCT03665285|581850770|FG001|Overall Study|Withdrawal by Subject|0|||
161126803|NCT03665285|581850771|FG002|Overall Study|Withdrawal by Subject|0|||
161126804|NCT03665285|581850772|FG003|Overall Study|Withdrawal by Subject|0|||
161233496|NCT05369208|582238328|FG000|Core Phase|Lack of Efficacy|1|||
161233497|NCT04934722|582238329|FG000|Overall Study|Death|4|||
161233498|NCT04934722|582238330|FG001|Overall Study|Death|3|||
161233499|NCT04934722|582238329|FG000|Overall Study|Participants Ongoing|88|||
161233500|NCT04934722|582238330|FG001|Overall Study|Participants Ongoing|91|||
161233501|NCT06358820|582238331|FG000|Overall Study|Adverse Event|11|||
161233502|NCT06358820|582238331|FG000|Overall Study|kidney transplantation|3|||
161233503|NCT06358820|582238331|FG000|Overall Study|patient voluntary withdrawal|6|||
161233504|NCT06358820|582238331|FG000|Overall Study|Physician Decision|1|||
161233505|NCT01294787|582238332|FG000|Period 1|Adverse Event|0|||
161233506|NCT01294787|582238333|FG001|Period 1|Adverse Event|0|||
161233507|NCT01294787|582238334|FG002|Period 1|Adverse Event|0|||
161233508|NCT01294787|582238335|FG003|Period 1|Adverse Event|0|||
161233509|NCT01294787|582238336|FG004|Period 1|Adverse Event|1|||
161233510|NCT01294787|582238337|FG005|Period 1|Adverse Event|0|||
161233511|NCT01294787|582238332|FG000|Period 1|Withdrawal by Subject|0|||
161233512|NCT01294787|582238333|FG001|Period 1|Withdrawal by Subject|0|||
161233513|NCT01294787|582238334|FG002|Period 1|Withdrawal by Subject|0|||
161233514|NCT01294787|582238335|FG003|Period 1|Withdrawal by Subject|1|||
161233515|NCT01294787|582238336|FG004|Period 1|Withdrawal by Subject|1|||
161233516|NCT01294787|582238337|FG005|Period 1|Withdrawal by Subject|1|||
161233517|NCT01294787|582238332|FG000|Period 1|Administrative problem|0|||
161233518|NCT01294787|582238333|FG001|Period 1|Administrative problem|0|||
161233519|NCT01294787|582238334|FG002|Period 1|Administrative problem|1|||
161233520|NCT01294787|582238335|FG003|Period 1|Administrative problem|0|||
161233521|NCT01294787|582238336|FG004|Period 1|Administrative problem|0|||
161233522|NCT01294787|582238337|FG005|Period 1|Administrative problem|1|||
161233523|NCT01294787|582238332|FG000|Period 2|Adverse Event|0|||
161233524|NCT01294787|582238333|FG001|Period 2|Adverse Event|3|||
161233525|NCT01294787|582238334|FG002|Period 2|Adverse Event|0|||
161233526|NCT01294787|582238335|FG003|Period 2|Adverse Event|1|||
161233527|NCT01294787|582238336|FG004|Period 2|Adverse Event|0|||
161233528|NCT01294787|582238337|FG005|Period 2|Adverse Event|0|||
161233529|NCT01294787|582238332|FG000|Period 2|No longer needs study drug|0|||
161233530|NCT01294787|582238333|FG001|Period 2|No longer needs study drug|0|||
161233531|NCT01294787|582238334|FG002|Period 2|No longer needs study drug|0|||
161233532|NCT01294787|582238335|FG003|Period 2|No longer needs study drug|1|||
161233533|NCT01294787|582238336|FG004|Period 2|No longer needs study drug|0|||
161233534|NCT01294787|582238337|FG005|Period 2|No longer needs study drug|0|||
161233535|NCT01294787|582238332|FG000|Period 3|Adverse Event|0|||
161233536|NCT01294787|582238333|FG001|Period 3|Adverse Event|0|||
161233537|NCT01294787|582238334|FG002|Period 3|Adverse Event|0|||
161233538|NCT01294787|582238335|FG003|Period 3|Adverse Event|0|||
161233539|NCT01294787|582238336|FG004|Period 3|Adverse Event|1|||
161233540|NCT01294787|582238337|FG005|Period 3|Adverse Event|0|||
161233541|NCT01124175|582238338|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161233542|NCT01124175|582238339|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
161233543|NCT00942968|582238340|FG000|Overall Study|Adverse Event|60|||
161233544|NCT00942968|582238340|FG000|Overall Study|Death|76|||
161233545|NCT00942968|582238340|FG000|Overall Study|Protocol Violation|9|||
161233546|NCT00942968|582238340|FG000|Overall Study|Lost to Follow-up|4|||
161233547|NCT00942968|582238340|FG000|Overall Study|Withdrawal by Subject|44|||
161233548|NCT00942968|582238340|FG000|Overall Study|Sponsor request|5|||
161233549|NCT00942968|582238340|FG000|Overall Study|Physician Decision|11|||
161233550|NCT00942968|582238340|FG000|Overall Study|Progression of disease|12|||
161233551|NCT00942968|582238340|FG000|Overall Study|Inferior vena cava filter placement|4|||
161233552|NCT00942968|582238340|FG000|Overall Study|Pulmonary embolism (PE)|1|||
161233553|NCT00942968|582238340|FG000|Overall Study|Participant required pancreatic biopsy|1|||
161233554|NCT00942968|582238340|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
161233555|NCT01948258|582238341|FG000|Overall Study|Pregnancy|41|||
161233556|NCT01948258|582238341|FG000|Overall Study|Did not complete by cut-off date|35|||
161233557|NCT01948258|582238341|FG000|Overall Study|Lost to Follow-up|27|||
161233558|NCT01948258|582238341|FG000|Overall Study|Withdrawal by SPD|8|||
161233559|NCT01948258|582238341|FG000|Overall Study|Withdrawal by Subject|6|||
161233560|NCT01948258|582238341|FG000|Overall Study|Health Care Professional|43|||
161233561|NCT01948258|582238341|FG000|Overall Study|Removed from statistical analysis|2|||
161233562|NCT01811953|582238348|FG000|Overall Study|Adverse Event|0|||
161233563|NCT01811953|582238349|FG001|Overall Study|Adverse Event|0|||
161233564|NCT01811953|582238350|FG002|Overall Study|Adverse Event|0|||
161233565|NCT01811953|582238351|FG003|Overall Study|Adverse Event|1|||
161233566|NCT01811953|582238352|FG004|Overall Study|Adverse Event|0|||
161233567|NCT01811953|582238353|FG005|Overall Study|Adverse Event|1|||
161233568|NCT01811953|582238348|FG000|Overall Study|Protocol Violation|0|||
161233569|NCT01811953|582238349|FG001|Overall Study|Protocol Violation|0|||
161233570|NCT01811953|582238350|FG002|Overall Study|Protocol Violation|0|||
161233571|NCT01811953|582238351|FG003|Overall Study|Protocol Violation|0|||
161233572|NCT01811953|582238352|FG004|Overall Study|Protocol Violation|1|||
161233573|NCT01811953|582238353|FG005|Overall Study|Protocol Violation|0|||
161233574|NCT00520130|582238356|FG000|Overall Study|Disease progression on study|4|||
161233575|NCT00520130|582238357|FG001|Overall Study|Disease progression on study|0|||
161233576|NCT00520130|582238356|FG000|Overall Study|Physician Decision|1|||
161233577|NCT00520130|582238357|FG001|Overall Study|Physician Decision|1|||
161233578|NCT01045096|582238358|FG000|Overall Study|Withdrawal by Subject|2|||
161233579|NCT01045096|582238359|FG001|Overall Study|Withdrawal by Subject|0|||
161233580|NCT01045096|582238360|FG002|Overall Study|Withdrawal by Subject|0|||
161233581|NCT01045096|582238358|FG000|Overall Study|Other|1|||
161233582|NCT01045096|582238359|FG001|Overall Study|Other|0|||
161233583|NCT01045096|582238360|FG002|Overall Study|Other|0|||
161233584|NCT01900691|582238361|FG000|Overall Study|Death|7|||
161233585|NCT01900691|582238361|FG000|Overall Study|Lost to Follow-up|4|||
161233586|NCT01900691|582238361|FG000|Overall Study|Study Device Not Placed|3|||
161233587|NCT01900691|582238361|FG000|Overall Study|Non study stent placed|2|||
161233588|NCT01900691|582238361|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
161233589|NCT01900691|582238361|FG000|Overall Study|Complete stent migration through digestive tract|1|||
161328933|NCT01212094|582590604|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
161328934|NCT01212094|582590605|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
161233590|NCT01954394|582238362|FG000|Overall Study|Enrolled but not treated|1|||
161233591|NCT01954394|582238363|FG001|Overall Study|Enrolled but not treated|0|||
161233592|NCT01954394|582238362|FG000|Overall Study|Adverse Event|10|||
161233593|NCT01954394|582238363|FG001|Overall Study|Adverse Event|23|||
161328935|NCT01212094|582590606|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
161328936|NCT03101150|582590610|FG000|Overall Study|Lost to Follow-up|2|||
161328937|NCT03101150|582590611|FG001|Overall Study|Lost to Follow-up|4|||
161328938|NCT03101150|582590610|FG000|Overall Study|Miscarriage|3|||
161328939|NCT03101150|582590611|FG001|Overall Study|Miscarriage|6|||
161328940|NCT00329108|582590613|FG000|Overall Study|Adverse Event|2|||
161328941|NCT00329108|582590614|FG001|Overall Study|Adverse Event|2|||
161328942|NCT00329108|582590613|FG000|Overall Study|Lack of Efficacy|3|||
161328943|NCT00329108|582590614|FG001|Overall Study|Lack of Efficacy|3|||
161328944|NCT00329108|582590613|FG000|Overall Study|Withdrawal by Subject|0|||
161328945|NCT00329108|582590614|FG001|Overall Study|Withdrawal by Subject|2|||
161328946|NCT00329108|582590613|FG000|Overall Study|symptomatic deterioration|1|||
161328947|NCT00329108|582590614|FG001|Overall Study|symptomatic deterioration|1|||
161328948|NCT00329108|582590613|FG000|Overall Study|Subject no longer willing to participate|2|||
161328949|NCT00329108|582590614|FG001|Overall Study|Subject no longer willing to participate|2|||
161328950|NCT00329108|582590613|FG000|Overall Study|study terminated by sponsor|1|||
161328951|NCT00329108|582590614|FG001|Overall Study|study terminated by sponsor|0|||
161328952|NCT00329108|582590613|FG000|Overall Study|withdrew patient after SAE resolved|1|||
161328953|NCT00329108|582590614|FG001|Overall Study|withdrew patient after SAE resolved|0|||
161328954|NCT00329108|582590613|FG000|Overall Study|Protocol Violation|0|||
161328955|NCT00329108|582590614|FG001|Overall Study|Protocol Violation|2|||
161328956|NCT02498678|582590617|FG000|Overall Study|interference from the surgical team|0|||
161328957|NCT02498678|582590618|FG001|Overall Study|interference from the surgical team|2|||
161328958|NCT03627832|582590620|FG000|Overall Study|Withdrawal by Subject|10|||
161328959|NCT03627832|582590621|FG001|Overall Study|Withdrawal by Subject|1|||
161328960|NCT01145482|582590625|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161328961|NCT01145482|582590626|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161328962|NCT04547140|582590627|FG000|Overall Study|Adverse Event|0|||
161328963|NCT04547140|582590628|FG001|Overall Study|Adverse Event|1|||
161328964|NCT04547140|582590627|FG000|Overall Study|Withdrawal by Subject|0|||
161328965|NCT04547140|582590628|FG001|Overall Study|Withdrawal by Subject|1|||
161328966|NCT04547140|582590627|FG000|Overall Study|Lost to Follow-up|3|||
161328967|NCT04547140|582590628|FG001|Overall Study|Lost to Follow-up|1|||
161328968|NCT04547140|582590627|FG000|Overall Study|Death|2|||
161328969|NCT04547140|582590628|FG001|Overall Study|Death|1|||
161328970|NCT04547140|582590627|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
161328971|NCT04547140|582590628|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
161328972|NCT04547140|582590627|FG000|Overall Study|Pregnancy|1|||
161328973|NCT04547140|582590628|FG001|Overall Study|Pregnancy|0|||
161328974|NCT04547140|582590627|FG000|Overall Study|Reason Not Specified|4|||
161328975|NCT04547140|582590628|FG001|Overall Study|Reason Not Specified|1|||
161328976|NCT00873730|582590629|FG000|Overall Study|Protocol Deviation|5|||
161328977|NCT00873730|582590630|FG001|Overall Study|Protocol Deviation|2|||
161328978|NCT00873730|582590629|FG000|Overall Study|Adverse Event|0|||
161328979|NCT00873730|582590630|FG001|Overall Study|Adverse Event|2|||
161328980|NCT00873730|582590629|FG000|Overall Study|Withdrawal by Subject|0|||
161233594|NCT01954394|582238362|FG000|Overall Study|Poor compliance to protocol|7|||
161233595|NCT01954394|582238363|FG001|Overall Study|Poor compliance to protocol|7|||
161233596|NCT01954394|582238362|FG000|Overall Study|Participant Moved|0|||
161328981|NCT00873730|582590630|FG001|Overall Study|Withdrawal by Subject|1|||
161328982|NCT00873730|582590629|FG000|Overall Study|Sponsor decision|1|||
161328983|NCT00873730|582590630|FG001|Overall Study|Sponsor decision|0|||
161328984|NCT04110314|582590633|FG000|Overall Study|Did not meet inclusion criteria|35255|||
161233597|NCT01954394|582238363|FG001|Overall Study|Participant Moved|4|||
161233598|NCT01954394|582238362|FG000|Overall Study|Related to Study Drug administration|2|||
161233599|NCT01954394|582238363|FG001|Overall Study|Related to Study Drug administration|2|||
161233600|NCT01954394|582238362|FG000|Overall Study|Other than specified above|10|||
161233601|NCT01954394|582238363|FG001|Overall Study|Other than specified above|21|||
161233602|NCT00909610|582238364|FG000|Period: First Intervention|Adverse Event|0|||
161233603|NCT00909610|582238365|FG001|Period: First Intervention|Adverse Event|1|||
161233604|NCT00909610|582238364|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
161233605|NCT00909610|582238365|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
161233606|NCT00909610|582238364|FG000|Period: Second Intervention|Adverse Event|1|||
161233607|NCT00909610|582238365|FG001|Period: Second Intervention|Adverse Event|0|||
161233608|NCT00328926|582238373|FG000|Overall Study|Pregnancy|2|||
161233609|NCT00328926|582238374|FG001|Overall Study|Pregnancy|1|||
161233610|NCT00328926|582238375|FG002|Overall Study|Pregnancy|0|||
161233611|NCT00328926|582238373|FG000|Overall Study|Lost to Follow-up|0|||
161328985|NCT04110314|582590634|FG001|Overall Study|Did not meet inclusion criteria|35104|||
161328986|NCT04110314|582590635|FG002|Overall Study|Did not meet inclusion criteria|35636|||
161233612|NCT00328926|582238374|FG001|Overall Study|Lost to Follow-up|1|||
161233613|NCT00328926|582238375|FG002|Overall Study|Lost to Follow-up|0|||
161233614|NCT00328926|582238373|FG000|Overall Study|Death|0|||
161233615|NCT00328926|582238374|FG001|Overall Study|Death|0|||
161233616|NCT00328926|582238375|FG002|Overall Study|Death|1|||
161233617|NCT00328926|582238373|FG000|Overall Study|In vitro fertilization treatment|0|||
161233618|NCT00328926|582238374|FG001|Overall Study|In vitro fertilization treatment|0|||
161233619|NCT00328926|582238375|FG002|Overall Study|In vitro fertilization treatment|1|||
161233620|NCT00328926|582238373|FG000|Overall Study|Lack of ovarian response|0|||
161233621|NCT00328926|582238374|FG001|Overall Study|Lack of ovarian response|1|||
161233622|NCT00328926|582238375|FG002|Overall Study|Lack of ovarian response|0|||
161233623|NCT02269657|582238380|FG000|Overall Study|Protocol Violation|3|||
161233624|NCT00834249|582238383|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161233625|NCT00834249|582238384|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161233626|NCT00834249|582238383|FG000|Second Intervention|Adverse Event|1|||
161233627|NCT00834249|582238384|FG001|Second Intervention|Adverse Event|0|||
161233628|NCT00851877|582238385|FG000|Phase I-1|Death|1|||
161233629|NCT00851877|582238386|FG001|Phase I-1|Death|0|||
161233630|NCT00851877|582238387|FG002|Phase I-1|Death|0|||
161233631|NCT00851877|582238385|FG000|Phase II|Withdrawal by Subject|0|||
161233632|NCT00851877|582238386|FG001|Phase II|Withdrawal by Subject|0|||
161233633|NCT00851877|582238387|FG002|Phase II|Withdrawal by Subject|3|||
161233634|NCT00834743|582238388|FG000|Second Intervention|Withdrawal by Subject|1|||
161233635|NCT00834743|582238389|FG001|Second Intervention|Withdrawal by Subject|0|||
161233636|NCT01534663|582238390|FG000|Overall Study|Lost to Follow-up|0|||
161233637|NCT01534663|582238391|FG001|Overall Study|Lost to Follow-up|2|||
161233638|NCT01534663|582238390|FG000|Overall Study|Adverse Event|2|||
161233639|NCT01534663|582238391|FG001|Overall Study|Adverse Event|1|||
161233640|NCT00627016|582238392|FG000|Overall Study|Adverse Event|1|||
161233641|NCT00627016|582238393|FG001|Overall Study|Adverse Event|1|||
161233642|NCT00627016|582238392|FG000|Overall Study|Protocol Violation|0|||
161233643|NCT00627016|582238393|FG001|Overall Study|Protocol Violation|2|||
161233644|NCT00627016|582238392|FG000|Overall Study|Lost to Follow-up|0|||
161233645|NCT00627016|582238393|FG001|Overall Study|Lost to Follow-up|1|||
161233646|NCT00627016|582238392|FG000|Overall Study|Withdrawal by Subject|2|||
161233647|NCT00627016|582238393|FG001|Overall Study|Withdrawal by Subject|1|||
161233648|NCT00627016|582238392|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
161233649|NCT00627016|582238393|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
161233650|NCT00627016|582238392|FG000|Overall Study|Lack of Efficacy|1|||
161233651|NCT00627016|582238393|FG001|Overall Study|Lack of Efficacy|0|||
161233652|NCT00627016|582238392|FG000|Overall Study|Placed on Excluded Drugs|1|||
161233653|NCT00627016|582238393|FG001|Overall Study|Placed on Excluded Drugs|0|||
161233654|NCT00627016|582238392|FG000|Overall Study|Pregnancy|1|||
161233655|NCT00627016|582238393|FG001|Overall Study|Pregnancy|0|||
161233656|NCT04088760|582238394|FG000|Overall Study|Physician Decision|1|||
161233657|NCT01693523|582238395|FG000|Overall Study|Adverse Event|2|||
161233658|NCT01693523|582238396|FG001|Overall Study|Adverse Event|1|||
161233659|NCT01693523|582238397|FG002|Overall Study|Adverse Event|0|||
161233660|NCT01693523|582238395|FG000|Overall Study|Death|0|||
161233661|NCT01693523|582238396|FG001|Overall Study|Death|1|||
161233662|NCT01693523|582238397|FG002|Overall Study|Death|1|||
161328987|NCT04110314|582590636|FG003|Overall Study|Did not meet inclusion criteria|35135|||
161328988|NCT04110314|582590637|FG004|Overall Study|Did not meet inclusion criteria|35247|||
161233663|NCT01693523|582238395|FG000|Overall Study|Lost to Follow-up|0|||
161233664|NCT01693523|582238396|FG001|Overall Study|Lost to Follow-up|0|||
161233665|NCT01693523|582238397|FG002|Overall Study|Lost to Follow-up|4|||
161233666|NCT01693523|582238395|FG000|Overall Study|Physician Decision|0|||
161233667|NCT01693523|582238396|FG001|Overall Study|Physician Decision|0|||
161233668|NCT01693523|582238397|FG002|Overall Study|Physician Decision|1|||
161233669|NCT01693523|582238395|FG000|Overall Study|Withdrawal by Subject|1|||
161233670|NCT01693523|582238396|FG001|Overall Study|Withdrawal by Subject|2|||
161233671|NCT01693523|582238397|FG002|Overall Study|Withdrawal by Subject|2|||
161233672|NCT01693523|582238395|FG000|Overall Study|Lack of compliance study medication|1|||
161233673|NCT01693523|582238396|FG001|Overall Study|Lack of compliance study medication|2|||
161233674|NCT01693523|582238397|FG002|Overall Study|Lack of compliance study medication|0|||
161328989|NCT04110314|582590638|FG005|Overall Study|Did not meet inclusion criteria|35727|||
161328990|NCT01711983|582590646|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
161328991|NCT01711983|582590646|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
161126805|NCT03665285|581850773|FG004|Overall Study|Withdrawal by Subject|1|||
161126806|NCT03665285|581850774|FG005|Overall Study|Withdrawal by Subject|0|||
161126807|NCT03665285|581850775|FG006|Overall Study|Withdrawal by Subject|0|||
161126808|NCT03665285|581850776|FG007|Overall Study|Withdrawal by Subject|2|||
161126809|NCT03665285|581850777|FG008|Overall Study|Withdrawal by Subject|0|||
161126810|NCT03665285|581850769|FG000|Overall Study|Physician Decision|0|||
161126811|NCT03665285|581850770|FG001|Overall Study|Physician Decision|0|||
161126812|NCT03665285|581850771|FG002|Overall Study|Physician Decision|0|||
161126813|NCT03665285|581850772|FG003|Overall Study|Physician Decision|0|||
161126814|NCT03665285|581850773|FG004|Overall Study|Physician Decision|0|||
161126815|NCT03665285|581850774|FG005|Overall Study|Physician Decision|0|||
161126816|NCT03665285|581850775|FG006|Overall Study|Physician Decision|0|||
161126817|NCT03665285|581850776|FG007|Overall Study|Physician Decision|2|||
161126818|NCT03665285|581850777|FG008|Overall Study|Physician Decision|0|||
161126819|NCT02154425|581850783|FG000|Screening Period|Adverse Event|1|||
161126820|NCT02211261|581850784|FG000|Overall Study|Withdrawal by Subject|0|||
161126821|NCT02211261|581850785|FG001|Overall Study|Withdrawal by Subject|0|||
161126822|NCT02211261|581850786|FG002|Overall Study|Withdrawal by Subject|1|||
161126823|NCT02211261|581850787|FG003|Overall Study|Withdrawal by Subject|0|||
161126824|NCT02211261|581850788|FG004|Overall Study|Withdrawal by Subject|2|||
161126825|NCT02211261|581850789|FG005|Overall Study|Withdrawal by Subject|0|||
161126826|NCT02211261|581850790|FG006|Overall Study|Withdrawal by Subject|0|||
161126827|NCT02211261|581850791|FG007|Overall Study|Withdrawal by Subject|0|||
161126828|NCT02211261|581850792|FG008|Overall Study|Withdrawal by Subject|0|||
161126829|NCT02211261|581850793|FG009|Overall Study|Withdrawal by Subject|0|||
161126830|NCT02211261|581850794|FG010|Overall Study|Withdrawal by Subject|0|||
161126831|NCT02211261|581850784|FG000|Overall Study|Other|0|||
161126832|NCT02211261|581850785|FG001|Overall Study|Other|0|||
161126833|NCT02211261|581850786|FG002|Overall Study|Other|0|||
161126834|NCT02211261|581850787|FG003|Overall Study|Other|0|||
161126835|NCT02211261|581850788|FG004|Overall Study|Other|0|||
161126836|NCT02211261|581850789|FG005|Overall Study|Other|1|||
161126837|NCT02211261|581850790|FG006|Overall Study|Other|0|||
161126838|NCT02211261|581850791|FG007|Overall Study|Other|0|||
161126839|NCT02211261|581850792|FG008|Overall Study|Other|0|||
161126840|NCT02211261|581850793|FG009|Overall Study|Other|2|||
161126841|NCT02211261|581850794|FG010|Overall Study|Other|0|||
161126842|NCT02211261|581850784|FG000|Overall Study|Lost to Follow-up|0|||
161126843|NCT02211261|581850785|FG001|Overall Study|Lost to Follow-up|0|||
161126844|NCT02211261|581850786|FG002|Overall Study|Lost to Follow-up|0|||
161126845|NCT02211261|581850787|FG003|Overall Study|Lost to Follow-up|0|||
161126846|NCT02211261|581850788|FG004|Overall Study|Lost to Follow-up|0|||
161126847|NCT02211261|581850789|FG005|Overall Study|Lost to Follow-up|0|||
161126848|NCT02211261|581850790|FG006|Overall Study|Lost to Follow-up|0|||
161126849|NCT02211261|581850791|FG007|Overall Study|Lost to Follow-up|1|||
161126850|NCT02211261|581850792|FG008|Overall Study|Lost to Follow-up|0|||
161126851|NCT02211261|581850793|FG009|Overall Study|Lost to Follow-up|0|||
161126852|NCT02211261|581850794|FG010|Overall Study|Lost to Follow-up|0|||
161126853|NCT00480857|581850795|FG000|Overall Study|Lack of Efficacy|2|||
161126854|NCT02175680|581850804|FG000|Overall Study|non-compliance|1|||
161126855|NCT02175680|581850804|FG000|Overall Study|other non-medical reason|1|||
161126856|NCT02419508|581850810|FG000|Overall Study|Adverse Event|9|||
161126857|NCT02419508|581850811|FG001|Overall Study|Adverse Event|3|||
161126858|NCT02419508|581850810|FG000|Overall Study|Withdrawal by Subject|1|||
161126859|NCT02419508|581850811|FG001|Overall Study|Withdrawal by Subject|0|||
161126860|NCT02419508|581850810|FG000|Overall Study|Other - Reason not specified|0|||
161126861|NCT02419508|581850811|FG001|Overall Study|Other - Reason not specified|1|||
161126862|NCT06228586|581850814|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
161126863|NCT06228586|581850815|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
161126864|NCT00865020|581850826|FG000|Overall Study|Withdrawal by Subject|22|||
161126865|NCT00865020|581850827|FG001|Overall Study|Withdrawal by Subject|16|||
161126866|NCT00865020|581850826|FG000|Overall Study|Adverse Event|9|||
161126867|NCT00865020|581850827|FG001|Overall Study|Adverse Event|14|||
161126868|NCT00865020|581850826|FG000|Overall Study|Abnormal test procedure result(s)|6|||
161126869|NCT00865020|581850827|FG001|Overall Study|Abnormal test procedure result(s)|8|||
161126870|NCT00865020|581850826|FG000|Overall Study|Lost to Follow-up|6|||
161126871|NCT00865020|581850827|FG001|Overall Study|Lost to Follow-up|4|||
161126872|NCT00865020|581850826|FG000|Overall Study|Protocol deviation|4|||
161126873|NCT00865020|581850827|FG001|Overall Study|Protocol deviation|1|||
161126874|NCT00865020|581850826|FG000|Overall Study|Administrative problems|0|||
161126875|NCT00865020|581850827|FG001|Overall Study|Administrative problems|2|||
161126876|NCT00865020|581850826|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161126877|NCT00865020|581850827|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161126878|NCT00865020|581850826|FG000|Overall Study|Death|0|||
161126879|NCT00865020|581850827|FG001|Overall Study|Death|1|||
161328992|NCT01711983|582590646|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
161328993|NCT01711983|582590646|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
161328994|NCT00737100|582590647|FG000|Overall Study|Adverse Event|6|||
161328995|NCT00737100|582590648|FG001|Overall Study|Adverse Event|5|||
161328996|NCT00737100|582590649|FG002|Overall Study|Adverse Event|3|||
161328997|NCT00737100|582590647|FG000|Overall Study|Lost to Follow-up|0|||
161328998|NCT00737100|582590648|FG001|Overall Study|Lost to Follow-up|1|||
161328999|NCT00737100|582590649|FG002|Overall Study|Lost to Follow-up|0|||
161329000|NCT00737100|582590647|FG000|Overall Study|Withdrawal by Subject|0|||
161329001|NCT00737100|582590648|FG001|Overall Study|Withdrawal by Subject|0|||
161329002|NCT00737100|582590649|FG002|Overall Study|Withdrawal by Subject|3|||
161329003|NCT00737100|582590647|FG000|Overall Study|Reason discontinued not explained above|1|||
161329004|NCT00737100|582590648|FG001|Overall Study|Reason discontinued not explained above|1|||
161329005|NCT00737100|582590649|FG002|Overall Study|Reason discontinued not explained above|1|||
161329006|NCT00735943|582590654|FG000|Overall Study|Lost to Follow-up|1|||
161329007|NCT00735943|582590654|FG000|Overall Study|Adverse Event|1|||
161329008|NCT01607593|582590655|FG000|Overall Study|Adverse Event|15|||
161329009|NCT01607593|582590655|FG000|Overall Study|Lack of Efficacy|16|||
161329010|NCT01607593|582590655|FG000|Overall Study|Lost to Follow-up|25|||
161329011|NCT01607593|582590655|FG000|Overall Study|Continuation|33|||
161329012|NCT01607593|582590655|FG000|Overall Study|Other|4|||
161329013|NCT00115778|582590656|FG000|Overall Study|Withdrawal by Subject|0|||
161329014|NCT00115778|582590657|FG001|Overall Study|Withdrawal by Subject|1|||
161329015|NCT03713684|582590662|FG000|Overall Study|Adverse Event|1|||
161329016|NCT03713684|582590663|FG001|Overall Study|Adverse Event|3|||
161329017|NCT03713684|582590664|FG002|Overall Study|Adverse Event|1|||
161233675|NCT01693523|582238395|FG000|Overall Study|Chemotherapy was held|1|||
161233676|NCT01693523|582238396|FG001|Overall Study|Chemotherapy was held|2|||
161233677|NCT01693523|582238397|FG002|Overall Study|Chemotherapy was held|0|||
161233678|NCT03025880|582238398|FG000|Overall Study|Adverse Event|1|||
161233679|NCT03025880|582238399|FG001|Overall Study|Adverse Event|0|||
161233680|NCT03025880|582238398|FG000|Overall Study|Death|1|||
161233681|NCT03025880|582238399|FG001|Overall Study|Death|1|||
161233682|NCT03025880|582238398|FG000|Overall Study|Withdrawal by Subject|0|||
161233683|NCT03025880|582238399|FG001|Overall Study|Withdrawal by Subject|1|||
161233684|NCT03025880|582238398|FG000|Overall Study|Physician Decision|0|||
161233685|NCT03025880|582238399|FG001|Overall Study|Physician Decision|1|||
161233686|NCT03025880|582238398|FG000|Overall Study|Progressive Disease|12|||
161233687|NCT03025880|582238399|FG001|Overall Study|Progressive Disease|19|||
161233688|NCT01185548|582238401|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
161233689|NCT00086996|582238402|FG000|Overall Study|Adverse Event|29|||
161233690|NCT00086996|582238402|FG000|Overall Study|Death|4|||
161233691|NCT00086996|582238402|FG000|Overall Study|progression/relapse|7|||
161233692|NCT00086996|582238402|FG000|Overall Study|Withdrawal by Subject|13|||
161233693|NCT00086996|582238402|FG000|Overall Study|Other|6|||
161233694|NCT00086996|582238402|FG000|Overall Study|not eligible|5|||
161233695|NCT01422538|582238404|FG000|Overall Study|Lost to Follow-up|0|||
161233696|NCT01422538|582238405|FG001|Overall Study|Lost to Follow-up|1|||
161233697|NCT01422538|582238406|FG002|Overall Study|Lost to Follow-up|1|||
161233698|NCT01422538|582238404|FG000|Overall Study|Missed visit|0|||
161233699|NCT01422538|582238405|FG001|Overall Study|Missed visit|1|||
161233700|NCT01422538|582238406|FG002|Overall Study|Missed visit|1|||
161233701|NCT00312663|582238407|FG000|Immunization Phase|Adverse Event|0|||
161233702|NCT00312663|582238408|FG001|Immunization Phase|Adverse Event|1|||
161233703|NCT00312663|582238409|FG002|Immunization Phase|Adverse Event|0|||
161233704|NCT00286754|582238410|FG000|Overall Study|Adverse Event|2|||
161233705|NCT00286754|582238411|FG001|Overall Study|Adverse Event|2|||
161233706|NCT00286754|582238412|FG002|Overall Study|Adverse Event|3|||
161233707|NCT00286754|582238410|FG000|Overall Study|Withdrawal by Subject|6|||
161329018|NCT03713684|582590665|FG003|Overall Study|Adverse Event|0|||
161233708|NCT00286754|582238411|FG001|Overall Study|Withdrawal by Subject|2|||
161233709|NCT00286754|582238412|FG002|Overall Study|Withdrawal by Subject|0|||
161233710|NCT00286754|582238410|FG000|Overall Study|Lost to Follow-up|12|||
161329019|NCT03713684|582590662|FG000|Overall Study|Poor compliance to protocol|2|||
161329020|NCT03713684|582590663|FG001|Overall Study|Poor compliance to protocol|1|||
161329021|NCT03713684|582590664|FG002|Overall Study|Poor compliance to protocol|0|||
161329022|NCT03713684|582590665|FG003|Overall Study|Poor compliance to protocol|1|||
160787512|NCT00987935|580607336|FG002|Overall Study|Progressive disease|3|||
161233711|NCT00286754|582238411|FG001|Overall Study|Lost to Follow-up|14|||
161233712|NCT00286754|582238412|FG002|Overall Study|Lost to Follow-up|6|||
161233713|NCT00286754|582238410|FG000|Overall Study|Moved out of state|0|||
161233714|NCT00286754|582238411|FG001|Overall Study|Moved out of state|0|||
161233715|NCT00286754|582238412|FG002|Overall Study|Moved out of state|1|||
161233716|NCT00301366|582238413|FG000|Overall Study|Adverse Event|1|||
161233717|NCT01313273|582238414|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
161233718|NCT01313273|582238415|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
161233719|NCT01313273|582238414|FG000|Overall Study|Withdrawal by Subject|1|||
161329023|NCT03713684|582590662|FG000|Overall Study|Withdrawal by Subject|14|||
160787513|NCT00987935|580607337|FG003|Overall Study|Progressive disease|2|||
160787514|NCT00987935|580607338|FG004|Overall Study|Progressive disease|5|||
160787515|NCT00987935|580607339|FG005|Overall Study|Progressive disease|3|||
160787516|NCT00987935|580607340|FG006|Overall Study|Progressive disease|9|||
160787517|NCT00987935|580607341|FG007|Overall Study|Progressive disease|48|||
160787518|NCT00987935|580607342|FG008|Overall Study|Progressive disease|23|||
160787519|NCT00987935|580607334|FG000|Overall Study|Adverse Event|0|||
160787520|NCT00987935|580607335|FG001|Overall Study|Adverse Event|1|||
160787521|NCT00987935|580607336|FG002|Overall Study|Adverse Event|0|||
160787522|NCT00987935|580607337|FG003|Overall Study|Adverse Event|1|||
160787523|NCT00987935|580607338|FG004|Overall Study|Adverse Event|1|||
160787524|NCT00987935|580607339|FG005|Overall Study|Adverse Event|0|||
161126880|NCT00865020|581850826|FG000|Overall Study|Randomized but discontinued|2|||
161126881|NCT00865020|581850827|FG001|Overall Study|Randomized but discontinued|4|||
161126882|NCT00132041|581852507|FG000|Baseline|Ineligible|6|||
161126883|NCT00132041|581852507|FG000|3 Months Post Ablation|Transplant|1|||
161126884|NCT00132041|581852507|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
161126885|NCT00132041|581852507|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
161126886|NCT00132041|581852507|FG000|6 Months Post Ablation|Death|2|||
161126887|NCT00132041|581852507|FG000|6 Months Post Ablation|Transplant|6|||
161126888|NCT00132041|581852507|FG000|9 Months Post Ablation|Death|1|||
161126889|NCT00132041|581852507|FG000|9 Months Post Ablation|Transplant|1|||
161126890|NCT00132041|581852507|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
161126891|NCT00132041|581852507|FG000|12 Months Post Ablation|Death|1|||
161126892|NCT00132041|581852507|FG000|12 Months Post Ablation|Transplant|1|||
161126893|NCT00132041|581852507|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
161126894|NCT00132041|581852507|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
161126895|NCT00132041|581852507|FG000|15 Months Post Ablation|Death|1|||
161126896|NCT00132041|581852507|FG000|15 Months Post Ablation|Transplant|5|||
161126897|NCT00132041|581852507|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
161126898|NCT00132041|581852507|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
161126899|NCT00132041|581852507|FG000|18 Months Post Ablation|Transplant|1|||
161126900|NCT00132041|581852507|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
161126901|NCT00132041|581852507|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
161126902|NCT01171820|581852509|FG000|Overall Study|Death|3|||
161126903|NCT01171820|581852510|FG001|Overall Study|Death|3|||
161126904|NCT01171820|581852509|FG000|Overall Study|Lost to Follow-up|0|||
161126905|NCT01171820|581852510|FG001|Overall Study|Lost to Follow-up|1|||
161126906|NCT01171820|581852509|FG000|Overall Study|Withdrawal by Subject|2|||
161126907|NCT01171820|581852510|FG001|Overall Study|Withdrawal by Subject|0|||
161126908|NCT01171820|581852509|FG000|Overall Study|Physician Decision|0|||
161126909|NCT01171820|581852510|FG001|Overall Study|Physician Decision|1|||
161126910|NCT01171820|581852509|FG000|Overall Study|1-Year Missed Visit|1|||
161126911|NCT01171820|581852510|FG001|Overall Study|1-Year Missed Visit|1|||
161126912|NCT00167245|581852511|FG000|Overall Study|Lost to Follow-up|20|||
161126913|NCT00167245|581852512|FG001|Overall Study|Lost to Follow-up|31|||
161126914|NCT00167245|581852511|FG000|Overall Study|Withdrawal by Subject|5|||
161126915|NCT00167245|581852512|FG001|Overall Study|Withdrawal by Subject|8|||
161126916|NCT00167245|581852511|FG000|Overall Study|Incarcerated|3|||
161126917|NCT00167245|581852512|FG001|Overall Study|Incarcerated|2|||
161126918|NCT00167245|581852511|FG000|Overall Study|Drowsy|1|||
161126919|NCT00167245|581852512|FG001|Overall Study|Drowsy|0|||
161126920|NCT03969875|581852513|FG000|Overall Study|did not receive allocated intervention|3|||
161126921|NCT03969875|581852514|FG001|Overall Study|did not receive allocated intervention|3|||
161126922|NCT03969875|581852515|FG002|Overall Study|did not receive allocated intervention|4|||
161126923|NCT03969875|581852513|FG000|Overall Study|Protocol Violation|4|||
161126924|NCT03969875|581852514|FG001|Overall Study|Protocol Violation|2|||
161126925|NCT03969875|581852515|FG002|Overall Study|Protocol Violation|2|||
161126926|NCT01871090|581852516|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
161126927|NCT01871090|581852517|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
161126928|NCT01871090|581852516|FG000|Overall Study|Interrogation not completed correctly|1|||
161126929|NCT01871090|581852517|FG001|Overall Study|Interrogation not completed correctly|0|||
161126930|NCT01871090|581852516|FG000|Overall Study|Subject Non-Compliance|0|||
161126931|NCT01871090|581852517|FG001|Overall Study|Subject Non-Compliance|1|||
161126932|NCT02911688|581852523|FG000|Washout|Lost to Follow-up|1|||
161126933|NCT02911688|581852524|FG001|Washout|Lost to Follow-up|1|||
161126934|NCT02911688|581852523|FG000|Washout|Withdrawal by Subject|0|||
161126935|NCT02911688|581852524|FG001|Washout|Withdrawal by Subject|1|||
161126936|NCT01307033|581852525|FG000|8-week Double-blind Period|Adverse Event|2|||
161126937|NCT01307033|581852526|FG001|8-week Double-blind Period|Adverse Event|0|||
161126938|NCT01307033|581852527|FG002|8-week Double-blind Period|Adverse Event|0|||
161126939|NCT01307033|581852528|FG003|8-week Double-blind Period|Adverse Event|0|||
160787525|NCT00987935|580607340|FG006|Overall Study|Adverse Event|2|||
161126940|NCT01307033|581852525|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
161126941|NCT01307033|581852526|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
161126942|NCT01307033|581852527|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
161126943|NCT01307033|581852528|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
161329024|NCT03713684|582590663|FG001|Overall Study|Withdrawal by Subject|6|||
161329025|NCT03713684|582590664|FG002|Overall Study|Withdrawal by Subject|14|||
161329026|NCT03713684|582590665|FG003|Overall Study|Withdrawal by Subject|16|||
161233720|NCT01313273|582238415|FG001|Overall Study|Withdrawal by Subject|0|||
161233721|NCT01313273|582238414|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
161233722|NCT01313273|582238415|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
161233723|NCT02726581|582238416|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161233724|NCT02726581|582238417|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
161233725|NCT02726581|582238418|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161233726|NCT02726581|582238416|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
161233727|NCT02726581|582238417|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
161233728|NCT02726581|582238418|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
161233729|NCT02726581|582238416|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161233730|NCT02726581|582238417|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161233731|NCT02726581|582238418|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161233732|NCT02726581|582238416|FG000|Treatment Period|Disease progression|47|||
160787526|NCT00987935|580607341|FG007|Overall Study|Adverse Event|10|||
160787527|NCT00987935|580607342|FG008|Overall Study|Adverse Event|6|||
160787528|NCT00987935|580607334|FG000|Overall Study|Refused to continue taking trial med.|1|||
160787529|NCT00987935|580607335|FG001|Overall Study|Refused to continue taking trial med.|0|||
161233733|NCT02726581|582238417|FG001|Treatment Period|Disease progression|50|||
161233734|NCT02726581|582238418|FG002|Treatment Period|Disease progression|16|||
161233735|NCT02726581|582238416|FG000|Treatment Period|Other reasons|9|||
161233736|NCT02726581|582238417|FG001|Treatment Period|Other reasons|8|||
161233737|NCT02726581|582238418|FG002|Treatment Period|Other reasons|2|||
161233738|NCT02726581|582238416|FG000|Treatment Period|Study drug toxicity|6|||
161233739|NCT02726581|582238417|FG001|Treatment Period|Study drug toxicity|3|||
161233740|NCT02726581|582238418|FG002|Treatment Period|Study drug toxicity|2|||
161233741|NCT02726581|582238416|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
161233742|NCT02726581|582238417|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
161233743|NCT02726581|582238418|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
161233744|NCT02726581|582238416|FG000|Treatment Period|Participant withdrew consent|3|||
160787530|NCT00987935|580607336|FG002|Overall Study|Refused to continue taking trial med.|0|||
160787531|NCT00987935|580607337|FG003|Overall Study|Refused to continue taking trial med.|0|||
160787532|NCT00987935|580607338|FG004|Overall Study|Refused to continue taking trial med.|1|||
160787533|NCT00987935|580607339|FG005|Overall Study|Refused to continue taking trial med.|0|||
160787534|NCT00987935|580607340|FG006|Overall Study|Refused to continue taking trial med.|4|||
160787535|NCT00987935|580607341|FG007|Overall Study|Refused to continue taking trial med.|4|||
160787536|NCT00987935|580607342|FG008|Overall Study|Refused to continue taking trial med.|2|||
160787537|NCT00987935|580607334|FG000|Overall Study|Reason other than those specified above|0|||
160787538|NCT00987935|580607335|FG001|Overall Study|Reason other than those specified above|0|||
160787539|NCT00987935|580607336|FG002|Overall Study|Reason other than those specified above|0|||
160787540|NCT00987935|580607337|FG003|Overall Study|Reason other than those specified above|0|||
160787541|NCT00987935|580607338|FG004|Overall Study|Reason other than those specified above|0|||
160787542|NCT00987935|580607339|FG005|Overall Study|Reason other than those specified above|0|||
160787543|NCT00987935|580607340|FG006|Overall Study|Reason other than those specified above|0|||
160787544|NCT00987935|580607341|FG007|Overall Study|Reason other than those specified above|0|||
160787545|NCT00987935|580607342|FG008|Overall Study|Reason other than those specified above|1|||
160787546|NCT01089543|580607343|FG000|Overall Study|Withdrawal by Subject|2|||
160787547|NCT01089543|580607344|FG001|Overall Study|Withdrawal by Subject|3|||
160787548|NCT01089543|580607345|FG002|Overall Study|Withdrawal by Subject|3|||
160787549|NCT01089543|580607346|FG003|Overall Study|Withdrawal by Subject|1|||
160787550|NCT01089543|580607343|FG000|Overall Study|Physician Decision|1|||
160787551|NCT01089543|580607344|FG001|Overall Study|Physician Decision|0|||
160787552|NCT01089543|580607345|FG002|Overall Study|Physician Decision|0|||
160787553|NCT01089543|580607346|FG003|Overall Study|Physician Decision|1|||
160787554|NCT01089543|580607343|FG000|Overall Study|Adverse Event|0|||
160787555|NCT01089543|580607344|FG001|Overall Study|Adverse Event|1|||
160787556|NCT01089543|580607345|FG002|Overall Study|Adverse Event|0|||
160787557|NCT01089543|580607346|FG003|Overall Study|Adverse Event|0|||
160787558|NCT00452530|580607347|FG000|Overall Study|Death|1|||
160787559|NCT00452530|580607348|FG001|Overall Study|Death|0|||
160787560|NCT00452530|580607347|FG000|Overall Study|Adverse Event|40|||
160787561|NCT00452530|580607348|FG001|Overall Study|Adverse Event|44|||
160787562|NCT00452530|580607347|FG000|Overall Study|Withdrawal by Subject|68|||
160787563|NCT00452530|580607348|FG001|Overall Study|Withdrawal by Subject|57|||
161329027|NCT03713684|582590662|FG000|Overall Study|Other than specified|69|||
160787564|NCT00452530|580607347|FG000|Overall Study|Lost to Follow-up|1|||
160787565|NCT00452530|580607348|FG001|Overall Study|Lost to Follow-up|0|||
160787566|NCT00452530|580607347|FG000|Overall Study|Poor compliance/noncompliance|1|||
160787567|NCT00452530|580607348|FG001|Overall Study|Poor compliance/noncompliance|2|||
160787568|NCT00452530|580607347|FG000|Overall Study|No longer met study criteria|18|||
160787569|NCT00452530|580607348|FG001|Overall Study|No longer met study criteria|22|||
160787570|NCT00452530|580607347|FG000|Overall Study|Other|7|||
160787571|NCT00452530|580607348|FG001|Overall Study|Other|11|||
160787572|NCT00754559|580607350|FG000|Overall Study|Adverse Event|15|||
160787573|NCT00754559|580607350|FG000|Overall Study|Protocol Violation|11|||
160787574|NCT00754559|580607350|FG000|Overall Study|Lack of Efficacy|10|||
160787575|NCT00754559|580607350|FG000|Overall Study|Lost to Follow-up|2|||
160787576|NCT00754559|580607350|FG000|Overall Study|Administrative reason|1|||
161126944|NCT01307033|581852525|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
161126945|NCT01307033|581852526|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
161126946|NCT01307033|581852527|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
161126947|NCT01307033|581852528|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
161126948|NCT01307033|581852525|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161126949|NCT01307033|581852526|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
161126950|NCT01307033|581852527|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161126951|NCT01307033|581852528|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
161126952|NCT01307033|581852525|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
161126953|NCT01307033|581852526|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
161126954|NCT01307033|581852527|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
161126955|NCT01307033|581852528|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
161126956|NCT01307033|581852525|FG000|44-week Open-label Extension|Adverse Event|0|||
161126957|NCT01307033|581852526|FG001|44-week Open-label Extension|Adverse Event|0|||
161126958|NCT01307033|581852527|FG002|44-week Open-label Extension|Adverse Event|2|||
161126959|NCT01307033|581852528|FG003|44-week Open-label Extension|Adverse Event|1|||
161126960|NCT01307033|581852525|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
161126961|NCT01307033|581852526|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
161126962|NCT01307033|581852527|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
161126963|NCT01307033|581852528|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
161126964|NCT01307033|581852525|FG000|44-week Open-label Extension|Physician Decision|0|||
161126965|NCT01307033|581852526|FG001|44-week Open-label Extension|Physician Decision|0|||
161126966|NCT01307033|581852527|FG002|44-week Open-label Extension|Physician Decision|1|||
161126967|NCT01307033|581852528|FG003|44-week Open-label Extension|Physician Decision|0|||
161126968|NCT01307033|581852525|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161126969|NCT01307033|581852526|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161126970|NCT01307033|581852527|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
161126971|NCT01307033|581852528|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
161126972|NCT01307033|581852525|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
161126973|NCT01307033|581852526|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
161126974|NCT01307033|581852527|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
161126975|NCT01307033|581852528|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
161126976|NCT01307033|581852525|FG000|44-week Open-label Extension|Death|0|||
161126977|NCT01307033|581852526|FG001|44-week Open-label Extension|Death|0|||
161233745|NCT02726581|582238417|FG001|Treatment Period|Participant withdrew consent|1|||
161233746|NCT02726581|582238418|FG002|Treatment Period|Participant withdrew consent|1|||
161233747|NCT02726581|582238416|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
161233748|NCT02726581|582238417|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
161233749|NCT02726581|582238418|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
161233750|NCT02726581|582238416|FG000|Treatment Period|Maximum clinical benefit|0|||
161233751|NCT02726581|582238417|FG001|Treatment Period|Maximum clinical benefit|2|||
161233752|NCT02726581|582238418|FG002|Treatment Period|Maximum clinical benefit|0|||
161233753|NCT02726581|582238416|FG000|Treatment Period|Death|1|||
161233754|NCT02726581|582238417|FG001|Treatment Period|Death|0|||
161233755|NCT02726581|582238418|FG002|Treatment Period|Death|0|||
161233756|NCT02726581|582238416|FG000|Treatment Period|Poor/non-compliance|1|||
161233757|NCT02726581|582238417|FG001|Treatment Period|Poor/non-compliance|0|||
161233758|NCT02726581|582238418|FG002|Treatment Period|Poor/non-compliance|0|||
161233759|NCT02726581|582238416|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161233760|NCT02726581|582238417|FG001|Treatment Period|Participant no longer meets study criteria|1|||
161233761|NCT02726581|582238418|FG002|Treatment Period|Participant no longer meets study criteria|0|||
161233762|NCT03496623|582238422|FG000|Run-In Period (2 Weeks)|Death|1|||
161233763|NCT03496623|582238423|FG001|Run-In Period (2 Weeks)|Death|0|||
161233764|NCT03496623|582238424|FG002|Run-In Period (2 Weeks)|Death|0|||
161233765|NCT03496623|582238425|FG003|Run-In Period (2 Weeks)|Death|0|||
161233766|NCT03496623|582238426|FG004|Run-In Period (2 Weeks)|Death|0|||
161233767|NCT03496623|582238422|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
161233768|NCT03496623|582238423|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161233769|NCT03496623|582238424|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161329028|NCT03713684|582590663|FG001|Overall Study|Other than specified|77|||
161329029|NCT03713684|582590664|FG002|Overall Study|Other than specified|73|||
161329030|NCT03713684|582590665|FG003|Overall Study|Other than specified|70|||
161329031|NCT02515630|582590666|FG000|Overall Study|Withdrawal by Subject|5|||
161329032|NCT02515630|582590666|FG000|Overall Study|Adverse Event|4|||
161329033|NCT02515630|582590666|FG000|Overall Study|Physician Decision|4|||
161329034|NCT02515630|582590666|FG000|Overall Study|Death|2|||
161329035|NCT02515630|582590666|FG000|Overall Study|Disease Progression|1|||
161329036|NCT01064414|582590669|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
161329037|NCT01064414|582590670|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
161329038|NCT01064414|582590671|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
161329039|NCT01064414|582590669|FG000|Core Period: Baseline to Week 26|Death|0|||
161329040|NCT01064414|582590670|FG001|Core Period: Baseline to Week 26|Death|1|||
161329041|NCT01064414|582590671|FG002|Core Period: Baseline to Week 26|Death|0|||
161329042|NCT01064414|582590669|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
161329043|NCT01064414|582590670|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
161329044|NCT01064414|582590671|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
161329045|NCT01064414|582590669|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
161329046|NCT01064414|582590670|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
161329047|NCT01064414|582590671|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
161329048|NCT01064414|582590669|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161329049|NCT01064414|582590670|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161329050|NCT01064414|582590671|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161329051|NCT01064414|582590669|FG000|Core Period: Baseline to Week 26|Other|4|||
161329052|NCT01064414|582590670|FG001|Core Period: Baseline to Week 26|Other|7|||
161329053|NCT01064414|582590671|FG002|Core Period: Baseline to Week 26|Other|2|||
161329054|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161329055|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161329056|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161329057|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Death|0|||
161329058|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Death|1|||
161329059|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161329060|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161329061|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161329062|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161329063|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161329064|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161329065|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161329066|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161329067|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161329068|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161329069|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
161329070|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161329071|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
161329072|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161329073|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161329074|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161329075|NCT01064414|582590669|FG000|Extension Period: Week 26 to Week 52|Other|5|||
161329076|NCT01064414|582590670|FG001|Extension Period: Week 26 to Week 52|Other|2|||
161329077|NCT01064414|582590671|FG002|Extension Period: Week 26 to Week 52|Other|1|||
161329078|NCT00974311|582590672|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
161329079|NCT00974311|582590673|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
161329080|NCT00974311|582590672|FG000|DB Phase (up to 24 Months)|Death|561|||
161329081|NCT00974311|582590673|FG001|DB Phase (up to 24 Months)|Death|298|||
161329082|NCT00974311|582590672|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
161329083|NCT00974311|582590673|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
161329084|NCT00974311|582590672|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
161329085|NCT00974311|582590673|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
161329086|NCT00974311|582590672|FG000|DB Phase (up to 24 Months)|Other|1|||
161329087|NCT00974311|582590673|FG001|DB Phase (up to 24 Months)|Other|0|||
161329088|NCT00974311|582590672|FG000|OLE Phase (up to 77 Months)|Death|14|||
161329089|NCT00974311|582590673|FG001|OLE Phase (up to 77 Months)|Death|21|||
161329090|NCT00974311|582590672|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
161329091|NCT00974311|582590673|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
161329092|NCT00974311|582590672|FG000|OLE Phase (up to 77 Months)|Other|15|||
161329093|NCT00974311|582590673|FG001|OLE Phase (up to 77 Months)|Other|2|||
161329094|NCT00974311|582590672|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
161329095|NCT00974311|582590673|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
161329096|NCT02595502|582590674|FG000|Period 1|Adverse Event|0|||
161329097|NCT02595502|582590675|FG001|Period 1|Adverse Event|1|||
160787577|NCT00754559|580607350|FG000|Overall Study|Other|5|||
160787578|NCT00754559|580607350|FG000|Overall Study|Withdrawal by Subject|3|||
160787579|NCT01248468|580607351|FG000|Overall Study|Administrative problem|1|||
160787580|NCT01248468|580607352|FG001|Overall Study|Administrative problem|0|||
161329098|NCT02595502|582590674|FG000|Period 1|Withdrawal by Subject|1|||
161329099|NCT02595502|582590675|FG001|Period 1|Withdrawal by Subject|0|||
161329100|NCT02595502|582590674|FG000|Period 1|Lost to Follow-up|0|||
161329101|NCT02595502|582590675|FG001|Period 1|Lost to Follow-up|1|||
161329102|NCT02595502|582590674|FG000|Period 2|Adverse Event|1|||
161329103|NCT02595502|582590675|FG001|Period 2|Adverse Event|1|||
161329104|NCT02595502|582590674|FG000|Period 2|Received incorrect lens at Period 1|0|||
161329105|NCT02595502|582590675|FG001|Period 2|Received incorrect lens at Period 1|1|||
161329106|NCT02595502|582590674|FG000|Period 3|Protocol Violation|0|||
161329107|NCT02595502|582590675|FG001|Period 3|Protocol Violation|1|||
161329108|NCT02595502|582590674|FG000|Period 3|Lost to Follow-up|1|||
161329109|NCT02595502|582590675|FG001|Period 3|Lost to Follow-up|0|||
160787581|NCT01248468|580607353|FG002|Overall Study|Administrative problem|0|||
160787582|NCT01248468|580607351|FG000|Overall Study|Lost to Follow-up|9|||
160787583|NCT01248468|580607352|FG001|Overall Study|Lost to Follow-up|12|||
160787584|NCT01248468|580607353|FG002|Overall Study|Lost to Follow-up|4|||
160787585|NCT01248468|580607351|FG000|Overall Study|Pregnancy|1|||
160787586|NCT01248468|580607352|FG001|Overall Study|Pregnancy|0|||
160787587|NCT01248468|580607353|FG002|Overall Study|Pregnancy|0|||
160787588|NCT01248468|580607351|FG000|Overall Study|Withdrawal by Subject|4|||
160787589|NCT01248468|580607352|FG001|Overall Study|Withdrawal by Subject|2|||
160787590|NCT01248468|580607353|FG002|Overall Study|Withdrawal by Subject|0|||
160787591|NCT02191397|580607354|FG000|Overall Study|Adverse Event|28|||
160787592|NCT02191397|580607355|FG001|Overall Study|Adverse Event|17|||
160787593|NCT02191397|580607354|FG000|Overall Study|Lack of Efficacy|10|||
160787594|NCT02191397|580607355|FG001|Overall Study|Lack of Efficacy|5|||
160787595|NCT02191397|580607354|FG000|Overall Study|Protocol Violation|0|||
160787596|NCT02191397|580607355|FG001|Overall Study|Protocol Violation|3|||
160787597|NCT02191397|580607354|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
160787598|NCT02191397|580607355|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
160787599|NCT02191397|580607354|FG000|Overall Study|Lost to Follow-up|10|||
160787600|NCT02191397|580607355|FG001|Overall Study|Lost to Follow-up|11|||
160787601|NCT02191397|580607354|FG000|Overall Study|Physician Decision|8|||
160787602|NCT02191397|580607355|FG001|Overall Study|Physician Decision|3|||
160787603|NCT02191397|580607354|FG000|Overall Study|Withdrawal by Subject|22|||
160787604|NCT02191397|580607355|FG001|Overall Study|Withdrawal by Subject|27|||
160787605|NCT00468546|580607357|FG000|Week 24 Analysis|Lack of Efficacy|83|||
160787606|NCT00468546|580607358|FG001|Week 24 Analysis|Lack of Efficacy|37|||
160787607|NCT00468546|580607357|FG000|Week 24 Analysis|Refused treatment|5|||
160787608|NCT00468546|580607358|FG001|Week 24 Analysis|Refused treatment|5|||
160787609|NCT00468546|580607357|FG000|Week 24 Analysis|Adverse Event|1|||
160787610|NCT00468546|580607358|FG001|Week 24 Analysis|Adverse Event|8|||
160787611|NCT00468546|580607357|FG000|Week 24 Analysis|Failure to return|3|||
160787612|NCT00468546|580607358|FG001|Week 24 Analysis|Failure to return|4|||
160787613|NCT00468546|580607357|FG000|Week 24 Analysis|Rescue therapy|2|||
160787614|NCT00468546|580607358|FG001|Week 24 Analysis|Rescue therapy|0|||
160787615|NCT00468546|580607357|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
160787616|NCT00468546|580607358|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
160787617|NCT00468546|580607357|FG000|Week 24 Analysis|Due to clinical hold|1|||
160787618|NCT00468546|580607358|FG001|Week 24 Analysis|Due to clinical hold|0|||
160787619|NCT00468546|580607357|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
160787620|NCT00468546|580607358|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
160787621|NCT00468546|580607357|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
160787622|NCT00468546|580607358|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
160787623|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
160787624|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
160787625|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Death|1|||
160787626|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Death|0|||
160787627|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
160787628|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
160787629|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
160787630|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
161329110|NCT02595502|582590674|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
161329111|NCT02595502|582590675|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
160787631|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
160787632|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
160787633|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
160787634|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
160787635|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
160787636|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
160787637|NCT00468546|580607357|FG000|Week 24 to Week 104 Analysis|Other|17|||
161329112|NCT00458003|582590676|FG000|Overall Study|Non protocol spinal anesthesia|1|||
160787638|NCT00468546|580607358|FG001|Week 24 to Week 104 Analysis|Other|14|||
160787639|NCT04000724|580607359|FG000|Overall Study|Withdrawal by Subject|5|||
160787640|NCT04000724|580607360|FG001|Overall Study|Withdrawal by Subject|3|||
160787641|NCT04000724|580607361|FG002|Overall Study|Withdrawal by Subject|4|||
160787642|NCT04000724|580607359|FG000|Overall Study|Lost to Follow-up|11|||
160787643|NCT04000724|580607360|FG001|Overall Study|Lost to Follow-up|7|||
160787644|NCT04000724|580607361|FG002|Overall Study|Lost to Follow-up|13|||
160787645|NCT00455455|580607362|FG000|Washout|Withdrawal by Subject|0|||
160787646|NCT00455455|580607363|FG001|Washout|Withdrawal by Subject|1|||
160787647|NCT00455455|580607362|FG000|Washout|Withdrawal by Subject|1|||
160787648|NCT00455455|580607363|FG001|Washout|Withdrawal by Subject|0|||
161126978|NCT01307033|581852527|FG002|44-week Open-label Extension|Death|0|||
161126979|NCT01307033|581852528|FG003|44-week Open-label Extension|Death|1|||
161126980|NCT00947531|581852533|FG000|Overall Study|Withdrawal by Subject|10|||
161126981|NCT00947531|581852534|FG001|Overall Study|Withdrawal by Subject|7|||
161126982|NCT00947531|581852533|FG000|Overall Study|Administrative Reason|0|||
161126983|NCT00947531|581852534|FG001|Overall Study|Administrative Reason|1|||
161126984|NCT00947531|581852533|FG000|Overall Study|Adverse Event|2|||
161126985|NCT00947531|581852534|FG001|Overall Study|Adverse Event|2|||
161126986|NCT00947531|581852533|FG000|Overall Study|Lack of Efficacy|1|||
161126987|NCT00947531|581852534|FG001|Overall Study|Lack of Efficacy|0|||
161126988|NCT00947531|581852533|FG000|Overall Study|Other|1|||
161126989|NCT00947531|581852534|FG001|Overall Study|Other|1|||
161126990|NCT01773421|581852536|FG000|Treatment Phase|Other|0|||
161126991|NCT01773421|581852537|FG001|Treatment Phase|Other|0|||
161126992|NCT01773421|581852538|FG002|Treatment Phase|Other|2|||
161126993|NCT01773421|581852539|FG003|Treatment Phase|Other|0|||
161126994|NCT01773421|581852540|FG004|Treatment Phase|Other|0|||
161126995|NCT01773421|581852541|FG005|Treatment Phase|Other|0|||
161126996|NCT01773421|581852542|FG006|Treatment Phase|Other|0|||
161126997|NCT01773421|581852536|FG000|Treatment Phase|Adverse Event|0|||
161126998|NCT01773421|581852537|FG001|Treatment Phase|Adverse Event|0|||
161126999|NCT01773421|581852538|FG002|Treatment Phase|Adverse Event|3|||
161127000|NCT01773421|581852539|FG003|Treatment Phase|Adverse Event|1|||
161127001|NCT01773421|581852540|FG004|Treatment Phase|Adverse Event|0|||
161127002|NCT01773421|581852541|FG005|Treatment Phase|Adverse Event|0|||
161127003|NCT01773421|581852542|FG006|Treatment Phase|Adverse Event|0|||
161127004|NCT01773421|581852536|FG000|Treatment Phase|Withdrawal by Subject|0|||
161127005|NCT01773421|581852537|FG001|Treatment Phase|Withdrawal by Subject|0|||
161127006|NCT01773421|581852538|FG002|Treatment Phase|Withdrawal by Subject|1|||
161127007|NCT01773421|581852539|FG003|Treatment Phase|Withdrawal by Subject|1|||
161127008|NCT01773421|581852540|FG004|Treatment Phase|Withdrawal by Subject|0|||
161127009|NCT01773421|581852541|FG005|Treatment Phase|Withdrawal by Subject|0|||
161127010|NCT01773421|581852542|FG006|Treatment Phase|Withdrawal by Subject|0|||
161127011|NCT01773421|581852536|FG000|Extension Phase|Other|0|||
161127012|NCT01773421|581852537|FG001|Extension Phase|Other|0|||
161127013|NCT01773421|581852538|FG002|Extension Phase|Other|0|||
161127014|NCT01773421|581852539|FG003|Extension Phase|Other|0|||
161127015|NCT01773421|581852540|FG004|Extension Phase|Other|1|||
161127016|NCT01773421|581852541|FG005|Extension Phase|Other|2|||
161127017|NCT01773421|581852542|FG006|Extension Phase|Other|0|||
161127018|NCT01773421|581852536|FG000|Extension Phase|Adverse Event|0|||
161127019|NCT01773421|581852537|FG001|Extension Phase|Adverse Event|0|||
161127020|NCT01773421|581852538|FG002|Extension Phase|Adverse Event|0|||
161127021|NCT01773421|581852539|FG003|Extension Phase|Adverse Event|0|||
161127022|NCT01773421|581852540|FG004|Extension Phase|Adverse Event|2|||
161127023|NCT01773421|581852541|FG005|Extension Phase|Adverse Event|0|||
161127024|NCT01773421|581852542|FG006|Extension Phase|Adverse Event|0|||
161127025|NCT02327260|581852543|FG000|Overall Study|Lost to Follow-up|2|||
161127026|NCT02327260|581852544|FG001|Overall Study|Lost to Follow-up|3|||
161127027|NCT02327260|581852545|FG002|Overall Study|Lost to Follow-up|2|||
161127028|NCT02327260|581852543|FG000|Overall Study|invalid phone number|1|||
161127029|NCT02327260|581852544|FG001|Overall Study|invalid phone number|1|||
160787649|NCT00472641|580607364|FG000|Overall Study|Lack of Efficacy|3|||
160787650|NCT00472641|580607364|FG000|Overall Study|Adverse Event|3|||
161127030|NCT02327260|581852545|FG002|Overall Study|invalid phone number|0|||
161127031|NCT02327260|581852543|FG000|Overall Study|non-adherence to protocol|2|||
161127032|NCT02327260|581852544|FG001|Overall Study|non-adherence to protocol|0|||
161127033|NCT02327260|581852545|FG002|Overall Study|non-adherence to protocol|0|||
161127034|NCT02327260|581852543|FG000|Overall Study|cognitive concerns|1|||
161127035|NCT02327260|581852544|FG001|Overall Study|cognitive concerns|0|||
161127036|NCT02327260|581852545|FG002|Overall Study|cognitive concerns|0|||
161127037|NCT01400932|581852553|FG000|Overall Study|Adverse Event|10|||
161127038|NCT01400932|581852554|FG001|Overall Study|Adverse Event|5|||
161127039|NCT01400932|581852553|FG000|Overall Study|Lack of Efficacy|0|||
161127040|NCT01400932|581852554|FG001|Overall Study|Lack of Efficacy|3|||
161127041|NCT01400932|581852553|FG000|Overall Study|Withdrawal by Subject|2|||
161127042|NCT01400932|581852554|FG001|Overall Study|Withdrawal by Subject|6|||
160787651|NCT00472641|580607364|FG000|Overall Study|Lost to Follow-up|1|||
161127043|NCT01400932|581852553|FG000|Overall Study|Lost to Follow-up|1|||
161329113|NCT00458003|582590677|FG001|Overall Study|Non protocol spinal anesthesia|1|||
161329114|NCT03131167|582590678|FG000|Overall Study|Other (Unspecified)|0|||
161329115|NCT03131167|582590679|FG001|Overall Study|Other (Unspecified)|0|||
161329116|NCT03131167|582590680|FG002|Overall Study|Other (Unspecified)|0|||
161233770|NCT03496623|582238425|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161233771|NCT03496623|582238426|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
161233772|NCT03496623|582238422|FG000|Period 1 (12 Weeks)|Death|0|||
161233773|NCT03496623|582238423|FG001|Period 1 (12 Weeks)|Death|3|||
161233774|NCT03496623|582238424|FG002|Period 1 (12 Weeks)|Death|0|||
161233775|NCT03496623|582238425|FG003|Period 1 (12 Weeks)|Death|0|||
160787652|NCT01905267|580607365|FG000|Overall Study|Physician Decision|2|||
160787653|NCT01905267|580607366|FG001|Overall Study|Physician Decision|2|||
160787654|NCT01064622|580607371|FG000|Randomized Phase II|Withdrawal by Subject|2|||
160787655|NCT01064622|580607372|FG001|Randomized Phase II|Withdrawal by Subject|2|||
160787656|NCT01064622|580607371|FG000|Randomized Phase II|Protocol Violation|0|||
160787657|NCT01064622|580607372|FG001|Randomized Phase II|Protocol Violation|1|||
160787658|NCT05330429|580607373|FG000|Overall Study|Study Terminated by Sponsor|4|||
161329117|NCT03131167|582590681|FG003|Overall Study|Other (Unspecified)|0|||
161329118|NCT03131167|582590682|FG004|Overall Study|Other (Unspecified)|0|||
161329119|NCT03131167|582590683|FG005|Overall Study|Other (Unspecified)|1|||
161329120|NCT03131167|582590684|FG006|Overall Study|Other (Unspecified)|0|||
161329121|NCT03131167|582590685|FG007|Overall Study|Other (Unspecified)|0|||
161329122|NCT03131167|582590686|FG008|Overall Study|Other (Unspecified)|0|||
161329123|NCT03131167|582590687|FG009|Overall Study|Other (Unspecified)|0|||
161329124|NCT03131167|582590688|FG010|Overall Study|Other (Unspecified)|0|||
161329125|NCT03131167|582590689|FG011|Overall Study|Other (Unspecified)|0|||
161329126|NCT03131167|582590690|FG012|Overall Study|Other (Unspecified)|0|||
160787659|NCT05330429|580607374|FG001|Overall Study|Study Terminated by Sponsor|33|||
160787660|NCT05330429|580607375|FG002|Overall Study|Study Terminated by Sponsor|12|||
160787661|NCT05330429|580607373|FG000|Overall Study|Death|5|||
160787662|NCT05330429|580607374|FG001|Overall Study|Death|2|||
160787663|NCT05330429|580607375|FG002|Overall Study|Death|4|||
161233776|NCT03496623|582238426|FG004|Period 1 (12 Weeks)|Death|0|||
161233777|NCT03496623|582238422|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
160787664|NCT05330429|580607373|FG000|Overall Study|Withdrew Consent|0|||
160787665|NCT05330429|580607374|FG001|Overall Study|Withdrew Consent|5|||
160787666|NCT05330429|580607375|FG002|Overall Study|Withdrew Consent|4|||
160787667|NCT05330429|580607373|FG000|Overall Study|Investigator's Discretion|0|||
160787668|NCT05330429|580607374|FG001|Overall Study|Investigator's Discretion|1|||
160787669|NCT05330429|580607375|FG002|Overall Study|Investigator's Discretion|3|||
160787670|NCT05330429|580607373|FG000|Overall Study|Subject Decision|1|||
160787671|NCT05330429|580607374|FG001|Overall Study|Subject Decision|2|||
160787672|NCT05330429|580607375|FG002|Overall Study|Subject Decision|0|||
160787673|NCT05330429|580607373|FG000|Overall Study|Lost to Follow-up|0|||
160787674|NCT05330429|580607374|FG001|Overall Study|Lost to Follow-up|1|||
160787675|NCT05330429|580607375|FG002|Overall Study|Lost to Follow-up|0|||
160787676|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
160787677|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
160787678|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
160787679|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Adverse Event|5|||
160787680|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Adverse Event|1|||
160787681|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Adverse Event|0|||
160787682|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
160787683|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
160787684|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
160787685|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Death|8|||
160787686|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Death|24|||
160787687|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Death|0|||
160787688|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
160787689|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
160787690|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
160787691|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
160787692|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
161329127|NCT03286218|582590693|FG000|Qualification Phase Period 1|Adverse Event|1|||
161329128|NCT03286218|582590694|FG001|Qualification Phase Period 1|Adverse Event|0|||
161329129|NCT03286218|582590695|FG002|Qualification Phase Period 1|Adverse Event|0|||
161329130|NCT03286218|582590696|FG003|Qualification Phase Period 1|Adverse Event|0|||
161329131|NCT03286218|582590697|FG004|Qualification Phase Period 1|Adverse Event|0|||
160787693|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
160787694|NCT02931539|580607379|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
160787695|NCT02931539|580607380|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
160787696|NCT02931539|580607381|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
160787697|NCT02931539|580607379|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
160787698|NCT02931539|580607380|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
161233778|NCT03496623|582238423|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
160787699|NCT02931539|580607381|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
160787700|NCT06097273|580607384|FG000|Overall Study|Death|2|||
160787701|NCT06097273|580607385|FG001|Overall Study|Death|1|||
160787702|NCT06097273|580607386|FG002|Overall Study|Death|2|||
160787703|NCT06097273|580607387|FG003|Overall Study|Death|2|||
160787704|NCT06097273|580607384|FG000|Overall Study|Lost to Follow-up|27|||
160787705|NCT06097273|580607385|FG001|Overall Study|Lost to Follow-up|18|||
160787706|NCT06097273|580607386|FG002|Overall Study|Lost to Follow-up|36|||
160787707|NCT06097273|580607387|FG003|Overall Study|Lost to Follow-up|31|||
160787708|NCT06097273|580607384|FG000|Overall Study|Physician Decision|0|||
160787709|NCT06097273|580607385|FG001|Overall Study|Physician Decision|1|||
160787710|NCT06097273|580607386|FG002|Overall Study|Physician Decision|0|||
160787711|NCT06097273|580607387|FG003|Overall Study|Physician Decision|3|||
160787712|NCT06097273|580607384|FG000|Overall Study|Protocol Violation|1|||
160787713|NCT06097273|580607385|FG001|Overall Study|Protocol Violation|1|||
160787714|NCT06097273|580607386|FG002|Overall Study|Protocol Violation|2|||
160787715|NCT06097273|580607387|FG003|Overall Study|Protocol Violation|1|||
160787716|NCT06097273|580607384|FG000|Overall Study|Withdrawal by Subject|14|||
160787717|NCT06097273|580607385|FG001|Overall Study|Withdrawal by Subject|11|||
160787718|NCT06097273|580607386|FG002|Overall Study|Withdrawal by Subject|14|||
160787719|NCT06097273|580607387|FG003|Overall Study|Withdrawal by Subject|15|||
160787720|NCT06097273|580607384|FG000|Overall Study|Other Than Specified|7|||
160787721|NCT06097273|580607385|FG001|Overall Study|Other Than Specified|3|||
160787722|NCT06097273|580607386|FG002|Overall Study|Other Than Specified|11|||
160787723|NCT06097273|580607387|FG003|Overall Study|Other Than Specified|6|||
160787724|NCT02562040|580608985|FG000|Overall Study|Lost to Follow-up|20|||
160787725|NCT02562040|580608986|FG001|Overall Study|Lost to Follow-up|28|||
160787726|NCT02562040|580608985|FG000|Overall Study|Withdrawal by Subject|8|||
160787727|NCT02562040|580608986|FG001|Overall Study|Withdrawal by Subject|7|||
160787728|NCT02562040|580608985|FG000|Overall Study|Adverse Event|1|||
160787729|NCT02562040|580608986|FG001|Overall Study|Adverse Event|0|||
160787730|NCT00368849|580608990|FG000|Overall Study|Withdrawal by Subject|0|||
161329132|NCT03286218|582590698|FG005|Qualification Phase Period 1|Adverse Event|0|||
161329133|NCT03286218|582590699|FG006|Qualification Phase Period 1|Adverse Event|0|||
161329134|NCT03286218|582590700|FG007|Qualification Phase Period 1|Adverse Event|0|||
161329135|NCT03286218|582590701|FG008|Qualification Phase Period 1|Adverse Event|0|||
161329136|NCT03286218|582590702|FG009|Qualification Phase Period 1|Adverse Event|0|||
161329137|NCT03286218|582590703|FG010|Qualification Phase Period 1|Adverse Event|0|||
161329138|NCT03286218|582590704|FG011|Qualification Phase Period 1|Adverse Event|0|||
161329139|NCT03286218|582590693|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329140|NCT03286218|582590694|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
161329141|NCT03286218|582590695|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329142|NCT03286218|582590696|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329143|NCT03286218|582590697|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329144|NCT03286218|582590698|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329145|NCT03286218|582590699|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329146|NCT03286218|582590700|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329147|NCT03286218|582590701|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329148|NCT03286218|582590702|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329149|NCT03286218|582590703|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329150|NCT03286218|582590704|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
161329151|NCT03286218|582590693|FG000|Qualification Phase Period 2|Adverse Event|0|||
161329152|NCT03286218|582590694|FG001|Qualification Phase Period 2|Adverse Event|1|||
161329153|NCT03286218|582590695|FG002|Qualification Phase Period 2|Adverse Event|0|||
161329154|NCT03286218|582590696|FG003|Qualification Phase Period 2|Adverse Event|0|||
161329155|NCT03286218|582590697|FG004|Qualification Phase Period 2|Adverse Event|0|||
161329156|NCT03286218|582590698|FG005|Qualification Phase Period 2|Adverse Event|0|||
161329157|NCT03286218|582590699|FG006|Qualification Phase Period 2|Adverse Event|0|||
161329158|NCT03286218|582590700|FG007|Qualification Phase Period 2|Adverse Event|0|||
161329159|NCT03286218|582590701|FG008|Qualification Phase Period 2|Adverse Event|0|||
161329160|NCT03286218|582590702|FG009|Qualification Phase Period 2|Adverse Event|0|||
161329161|NCT03286218|582590703|FG010|Qualification Phase Period 2|Adverse Event|0|||
160787731|NCT00368849|580608991|FG001|Overall Study|Withdrawal by Subject|1|||
161329162|NCT03286218|582590704|FG011|Qualification Phase Period 2|Adverse Event|0|||
160787732|NCT00368849|580608990|FG000|Overall Study|Physician Decision|0|||
160787733|NCT00368849|580608991|FG001|Overall Study|Physician Decision|1|||
160787734|NCT01699685|580608993|FG000|Period 1|Adverse Event|1|||
160787735|NCT01699685|580608994|FG001|Period 1|Adverse Event|1|||
160787736|NCT01699685|580608993|FG000|Period 1|Medical or ethical, noncompliance|2|||
160787737|NCT01699685|580608994|FG001|Period 1|Medical or ethical, noncompliance|0|||
160787738|NCT01699685|580608993|FG000|Period 1|Other|0|||
160787739|NCT01699685|580608994|FG001|Period 1|Other|1|||
160787740|NCT01699685|580608993|FG000|Period 1|Patient request|0|||
160787741|NCT01699685|580608994|FG001|Period 1|Patient request|1|||
160787742|NCT01699685|580608993|FG000|Period 2|Lost to Follow-up|1|||
160787743|NCT01699685|580608994|FG001|Period 2|Lost to Follow-up|0|||
160787744|NCT03635996|580608995|FG000|Overall Study|Study terminated by Sponsor|94|||
160787745|NCT03635996|580608995|FG000|Overall Study|Withdrawal by Subject|20|||
160787746|NCT03635996|580608995|FG000|Overall Study|Ablation|26|||
161329163|NCT03286218|582590693|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
161329164|NCT03286218|582590694|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
161329165|NCT03286218|582590695|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329166|NCT03286218|582590696|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161233779|NCT03496623|582238424|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
161233780|NCT03496623|582238425|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
161233781|NCT03496623|582238426|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
161233782|NCT03496623|582238422|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161233783|NCT03496623|582238423|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161233784|NCT03496623|582238424|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
161233785|NCT03496623|582238425|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161233786|NCT03496623|582238426|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161233787|NCT03496623|582238422|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161233788|NCT03496623|582238423|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
161233789|NCT03496623|582238424|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
161233790|NCT03496623|582238425|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161233791|NCT03496623|582238426|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
161233792|NCT03496623|582238422|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161233793|NCT03496623|582238423|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161233794|NCT03496623|582238424|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
161233795|NCT03496623|582238425|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161233796|NCT03496623|582238426|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
161233797|NCT03496623|582238422|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
160787747|NCT03635996|580608995|FG000|Overall Study|Adverse Event|7|||
160787748|NCT03635996|580608995|FG000|Overall Study|Physician Decision|3|||
161233798|NCT03496623|582238423|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161329167|NCT03286218|582590697|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329168|NCT03286218|582590698|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329169|NCT03286218|582590699|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329170|NCT03286218|582590700|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329171|NCT03286218|582590701|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329172|NCT03286218|582590702|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329173|NCT03286218|582590703|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329174|NCT03286218|582590704|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
161329175|NCT03286218|582590693|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
161329176|NCT03286218|582590694|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
161329177|NCT03286218|582590695|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
161329178|NCT03286218|582590696|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
161329179|NCT03286218|582590697|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
161329180|NCT03286218|582590698|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
161329181|NCT03286218|582590699|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
161329182|NCT03286218|582590700|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
161329183|NCT03286218|582590701|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
161329184|NCT03286218|582590702|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
161329185|NCT03286218|582590703|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
161329186|NCT03286218|582590704|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
161329187|NCT03286218|582590693|FG000|Qualification Phase Period 2|Protocol Violation|2|||
161329188|NCT03286218|582590694|FG001|Qualification Phase Period 2|Protocol Violation|0|||
161329189|NCT03286218|582590695|FG002|Qualification Phase Period 2|Protocol Violation|0|||
161329190|NCT03286218|582590696|FG003|Qualification Phase Period 2|Protocol Violation|0|||
161329191|NCT03286218|582590697|FG004|Qualification Phase Period 2|Protocol Violation|0|||
161329192|NCT03286218|582590698|FG005|Qualification Phase Period 2|Protocol Violation|0|||
161233799|NCT03496623|582238424|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
161233800|NCT03496623|582238425|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161233801|NCT03496623|582238426|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
161233802|NCT03496623|582238422|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161233803|NCT03496623|582238423|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
161233804|NCT03496623|582238424|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160787749|NCT03635996|580608995|FG000|Overall Study|Prohibited medication|5|||
160787750|NCT03635996|580608995|FG000|Overall Study|Did not meet eligibility criteria|5|||
160787751|NCT03635996|580608995|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
161233805|NCT03496623|582238425|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161233806|NCT03496623|582238426|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161233807|NCT01061866|582238427|FG000|Overall Study|Adverse Event|2|||
160787752|NCT03635996|580608995|FG000|Overall Study|Protocol Violation|1|||
160787753|NCT03635996|580608995|FG000|Overall Study|Lost to Follow-up|1|||
160787754|NCT02821000|580608996|FG000|Overall Study|Death|89|||
160787755|NCT02821000|580608996|FG000|Overall Study|Sponsor Decision|12|||
160787756|NCT02821000|580608996|FG000|Overall Study|Withdrawal by Subject|2|||
160787757|NCT04359680|580608997|FG000|Overall Study|Withdrawal by Subject|29|||
160787758|NCT04359680|580608998|FG001|Overall Study|Withdrawal by Subject|24|||
160787759|NCT04359680|580608997|FG000|Overall Study|Adverse Event|6|||
160787760|NCT04359680|580608998|FG001|Overall Study|Adverse Event|2|||
160787761|NCT04359680|580608997|FG000|Overall Study|Lost to Follow-up|56|||
160787762|NCT04359680|580608998|FG001|Overall Study|Lost to Follow-up|59|||
160787763|NCT04359680|580608997|FG000|Overall Study|Protocol Violation|3|||
160787764|NCT04359680|580608998|FG001|Overall Study|Protocol Violation|5|||
160787765|NCT04359680|580608997|FG000|Overall Study|Physician Decision|1|||
160787766|NCT04359680|580608998|FG001|Overall Study|Physician Decision|1|||
160787767|NCT04359680|580608997|FG000|Overall Study|Sponsor Decision|0|||
161329193|NCT03286218|582590699|FG006|Qualification Phase Period 2|Protocol Violation|0|||
161329194|NCT03286218|582590700|FG007|Qualification Phase Period 2|Protocol Violation|0|||
161329195|NCT03286218|582590701|FG008|Qualification Phase Period 2|Protocol Violation|0|||
160787768|NCT04359680|580608998|FG001|Overall Study|Sponsor Decision|1|||
160787769|NCT00449787|580609000|FG000|Overall Study|Lost to Follow-up|10|||
160787770|NCT00449787|580609001|FG001|Overall Study|Lost to Follow-up|8|||
160787771|NCT00449787|580609000|FG000|Overall Study|Did not require medication|95|||
160787772|NCT00449787|580609001|FG001|Overall Study|Did not require medication|92|||
161329196|NCT03286218|582590702|FG009|Qualification Phase Period 2|Protocol Violation|0|||
161329197|NCT03286218|582590703|FG010|Qualification Phase Period 2|Protocol Violation|0|||
161329198|NCT03286218|582590704|FG011|Qualification Phase Period 2|Protocol Violation|0|||
161329199|NCT03286218|582590693|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
161329200|NCT03286218|582590694|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
161329201|NCT03286218|582590695|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329202|NCT03286218|582590696|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
160787773|NCT03574389|580609006|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
160787774|NCT03574389|580609007|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
160787775|NCT03574389|580609008|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
160787776|NCT03574389|580609009|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
161329203|NCT03286218|582590697|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329204|NCT03286218|582590698|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329205|NCT03286218|582590699|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329206|NCT03286218|582590700|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329207|NCT03286218|582590701|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329208|NCT03286218|582590702|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329209|NCT03286218|582590703|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329210|NCT03286218|582590704|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
161329211|NCT03286218|582590693|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329212|NCT03286218|582590694|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329213|NCT03286218|582590695|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
161329214|NCT03286218|582590696|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
161329215|NCT03286218|582590697|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329216|NCT03286218|582590698|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
161329217|NCT03286218|582590699|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329218|NCT03286218|582590700|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329219|NCT03286218|582590701|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329220|NCT03286218|582590702|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329221|NCT03286218|582590703|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
161329222|NCT03286218|582590704|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
161329223|NCT03286218|582590693|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329224|NCT03286218|582590694|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329225|NCT03286218|582590695|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329226|NCT03286218|582590696|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329227|NCT03286218|582590697|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329228|NCT03286218|582590698|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329229|NCT03286218|582590699|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329230|NCT03286218|582590700|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329231|NCT03286218|582590701|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329232|NCT03286218|582590702|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
160787777|NCT03574389|580609010|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
160787778|NCT03574389|580609011|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
160787779|NCT03574389|580609012|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
160787780|NCT03574389|580609006|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
160787781|NCT03574389|580609007|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
161127044|NCT01400932|581852554|FG001|Overall Study|Lost to Follow-up|0|||
161329233|NCT03286218|582590703|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
161329234|NCT03286218|582590704|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
161329235|NCT00165503|582590707|FG000|Overall Study|Death|1|||
161329236|NCT00165503|582590707|FG000|Overall Study|Lost to Follow-up|12|||
161329237|NCT00165503|582590707|FG000|Overall Study|Unresectable|3|||
161329238|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Death|20|||
161329239|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Death|26|||
161329240|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
161329241|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
161329242|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
161329243|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
161329244|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
161329245|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
161329246|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
161329247|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
161329248|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
161329249|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
161329250|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
161329251|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
161329252|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
161329253|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
161329254|NCT00643201|582590708|FG000|Randomized, Completed 6 Months of Study|Other|107|||
160787782|NCT03574389|580609008|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
160787783|NCT03574389|580609009|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
161329255|NCT00643201|582590709|FG001|Randomized, Completed 6 Months of Study|Other|107|||
161329256|NCT00643201|582590708|FG000|Completed Study Follow Up|Death|28|||
161329257|NCT00643201|582590709|FG001|Completed Study Follow Up|Death|34|||
161329258|NCT00643201|582590708|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
161329259|NCT00643201|582590709|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
161329260|NCT00643201|582590708|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
161329261|NCT00643201|582590709|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
161329262|NCT00643201|582590708|FG000|Completed Study Follow Up|non-specified|1|||
161329263|NCT00643201|582590709|FG001|Completed Study Follow Up|non-specified|0|||
161329264|NCT02346708|582590710|FG000|Overall Study|Adverse Event|2|||
161329265|NCT02346708|582590711|FG001|Overall Study|Adverse Event|0|||
161329266|NCT02346708|582590710|FG000|Overall Study|Protocol Violation|0|||
161329267|NCT02346708|582590711|FG001|Overall Study|Protocol Violation|1|||
161329268|NCT01781962|582590714|FG000|Overall Study|Other Miscellaneous Reasons|5|||
161329269|NCT04556760|582590721|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160787784|NCT03574389|580609010|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
160787785|NCT03574389|580609011|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
160787786|NCT03574389|580609012|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
160787787|NCT03574389|580609006|FG000|Vaccination Period|Other|6|||
160787788|NCT03574389|580609007|FG001|Vaccination Period|Other|0|||
160787789|NCT03574389|580609008|FG002|Vaccination Period|Other|0|||
160787790|NCT03574389|580609009|FG003|Vaccination Period|Other|0|||
160787791|NCT03574389|580609010|FG004|Vaccination Period|Other|0|||
160787792|NCT03574389|580609011|FG005|Vaccination Period|Other|0|||
160787793|NCT03574389|580609012|FG006|Vaccination Period|Other|0|||
160787794|NCT03574389|580609006|FG000|Vaccination Period|Adverse Event|0|||
160787795|NCT03574389|580609007|FG001|Vaccination Period|Adverse Event|1|||
160787796|NCT03574389|580609008|FG002|Vaccination Period|Adverse Event|0|||
160787797|NCT03574389|580609009|FG003|Vaccination Period|Adverse Event|0|||
160787798|NCT03574389|580609010|FG004|Vaccination Period|Adverse Event|0|||
160787799|NCT03574389|580609011|FG005|Vaccination Period|Adverse Event|0|||
160787800|NCT03574389|580609012|FG006|Vaccination Period|Adverse Event|0|||
160787801|NCT03574389|580609006|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
160787802|NCT03574389|580609007|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
160787803|NCT03574389|580609008|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
160787804|NCT03574389|580609009|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
160787805|NCT03574389|580609010|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
160787806|NCT03574389|580609011|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
160787807|NCT03574389|580609012|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
161127045|NCT01400932|581852553|FG000|Overall Study|Protocol Deviation|0|||
161127046|NCT01400932|581852554|FG001|Overall Study|Protocol Deviation|1|||
161329270|NCT04556760|582590722|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
161329271|NCT04556760|582590723|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
160787808|NCT00337194|580609017|FG000|Overall Study|Adverse Event|5|||
160787809|NCT00337194|580609018|FG001|Overall Study|Adverse Event|1|||
160787810|NCT00337194|580609017|FG000|Overall Study|Death|2|||
160787811|NCT00337194|580609018|FG001|Overall Study|Death|0|||
160787812|NCT00337194|580609017|FG000|Overall Study|Withdrawal by Subject|1|||
160787813|NCT00337194|580609018|FG001|Overall Study|Withdrawal by Subject|0|||
161329272|NCT04556760|582590724|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161329273|NCT04556760|582590725|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161329274|NCT04556760|582590726|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
161329275|NCT04556760|582590721|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161329276|NCT04556760|582590722|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161329277|NCT04556760|582590723|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161329278|NCT04556760|582590724|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
161329279|NCT04556760|582590725|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161329280|NCT04556760|582590726|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
161329281|NCT02849743|582590727|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
161329282|NCT02849743|582590728|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
161329283|NCT02849743|582590727|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
161329284|NCT02849743|582590728|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
161329285|NCT02168491|582590731|FG000|Overall Study|Withdrawal by Subject|1|||
161329286|NCT00809445|582590732|FG000|1 Month Follow-up|Lost contact|1|||
161329287|NCT00809445|582590733|FG001|1 Month Follow-up|Lost contact|2|||
161329288|NCT00809445|582590734|FG002|1 Month Follow-up|Lost contact|1|||
161329289|NCT00809445|582590732|FG000|1 Month Follow-up|Withdrew consent|1|||
161329290|NCT00809445|582590733|FG001|1 Month Follow-up|Withdrew consent|1|||
161329291|NCT00809445|582590734|FG002|1 Month Follow-up|Withdrew consent|1|||
161329292|NCT00809445|582590732|FG000|1 Month Follow-up|Death|0|||
161329293|NCT00809445|582590733|FG001|1 Month Follow-up|Death|1|||
161329294|NCT00809445|582590734|FG002|1 Month Follow-up|Death|1|||
161329295|NCT00809445|582590732|FG000|1 Month Follow-up|Incarcerated|0|||
161329296|NCT00809445|582590733|FG001|1 Month Follow-up|Incarcerated|0|||
161329297|NCT00809445|582590734|FG002|1 Month Follow-up|Incarcerated|1|||
161329298|NCT00809445|582590732|FG000|6 Month Follow-up|Lost contact|16|||
161329299|NCT00809445|582590733|FG001|6 Month Follow-up|Lost contact|14|||
161329300|NCT00809445|582590734|FG002|6 Month Follow-up|Lost contact|14|||
161329301|NCT00809445|582590732|FG000|6 Month Follow-up|Death|2|||
161329302|NCT00809445|582590733|FG001|6 Month Follow-up|Death|1|||
161329303|NCT00809445|582590734|FG002|6 Month Follow-up|Death|1|||
161329304|NCT00809445|582590732|FG000|6 Month Follow-up|Incarcerated|6|||
161329305|NCT00809445|582590733|FG001|6 Month Follow-up|Incarcerated|8|||
161329306|NCT00809445|582590734|FG002|6 Month Follow-up|Incarcerated|8|||
161329307|NCT00809445|582590732|FG000|6 Month Follow-up|Withdrew consent|0|||
161329308|NCT00809445|582590733|FG001|6 Month Follow-up|Withdrew consent|0|||
161329309|NCT00809445|582590734|FG002|6 Month Follow-up|Withdrew consent|1|||
161329310|NCT04919317|582590735|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
161329311|NCT04919317|582590736|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
161329312|NCT04919317|582590735|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
161329313|NCT04919317|582590736|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
161329314|NCT01566604|582590737|FG000|Overall Study|Patient's inability to use the device|1|||
161329315|NCT01566604|582590738|FG001|Overall Study|Patient's inability to use the device|0|||
161329316|NCT01566604|582590737|FG000|Overall Study|Administrative problems|1|||
161329317|NCT01566604|582590738|FG001|Overall Study|Administrative problems|0|||
161329318|NCT01566604|582590737|FG000|Overall Study|Lack of Efficacy|1|||
161329319|NCT01566604|582590738|FG001|Overall Study|Lack of Efficacy|2|||
161329320|NCT01566604|582590737|FG000|Overall Study|Protocol deviation|2|||
161329321|NCT01566604|582590738|FG001|Overall Study|Protocol deviation|0|||
161329322|NCT01566604|582590737|FG000|Overall Study|Abnormal laboratory value|2|||
161329323|NCT01566604|582590738|FG001|Overall Study|Abnormal laboratory value|0|||
161329324|NCT01566604|582590737|FG000|Overall Study|Death|4|||
161329325|NCT01566604|582590738|FG001|Overall Study|Death|1|||
161329326|NCT01566604|582590737|FG000|Overall Study|Adverse Event|4|||
161329327|NCT01566604|582590738|FG001|Overall Study|Adverse Event|2|||
161329328|NCT01566604|582590737|FG000|Overall Study|Withdrawal by Subject|9|||
161329329|NCT01566604|582590738|FG001|Overall Study|Withdrawal by Subject|6|||
161329330|NCT00661089|582590743|FG000|Overall Study|1 subject withdrawal|0|||
161329331|NCT00661089|582590744|FG001|Overall Study|1 subject withdrawal|1|||
161329332|NCT00661089|582590743|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
161329333|NCT00661089|582590744|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
161329334|NCT00964028|582590750|FG000|Overall Study|Withdrawal by Subject|0|||
161329335|NCT00964028|582590751|FG001|Overall Study|Withdrawal by Subject|1|||
161329336|NCT02106351|582590752|FG000|Treatment Cycle 1|Adverse Event|2|||
161329337|NCT02106351|582590753|FG001|Treatment Cycle 1|Adverse Event|0|||
161329338|NCT02106351|582590754|FG002|Treatment Cycle 1|Adverse Event|0|||
161329339|NCT02106351|582590752|FG000|Treatment Cycle 1|Consent withdrawn|1|||
161329340|NCT02106351|582590753|FG001|Treatment Cycle 1|Consent withdrawn|0|||
160787814|NCT00337194|580609017|FG000|Overall Study|Disease progression|1|||
161329341|NCT02106351|582590754|FG002|Treatment Cycle 1|Consent withdrawn|2|||
161329342|NCT02106351|582590752|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
160787815|NCT00337194|580609018|FG001|Overall Study|Disease progression|2|||
161329343|NCT02106351|582590753|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
161329344|NCT02106351|582590754|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
161329345|NCT02106351|582590752|FG000|Treatment Cycle 1|Other|0|||
161329346|NCT02106351|582590753|FG001|Treatment Cycle 1|Other|3|||
161329347|NCT02106351|582590754|FG002|Treatment Cycle 1|Other|1|||
161329348|NCT02106351|582590752|FG000|Treatment Cycle 1|Randomised but not treated|1|||
161329349|NCT02106351|582590753|FG001|Treatment Cycle 1|Randomised but not treated|0|||
160787816|NCT00337194|580609017|FG000|Overall Study|Subsequent non-protocol therapy|3|||
160787817|NCT00337194|580609018|FG001|Overall Study|Subsequent non-protocol therapy|1|||
160787818|NCT01061710|580609019|FG000|Overall Study|Protocol Violation|14|||
160787819|NCT01903720|580609020|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
160787820|NCT01903720|580609020|FG000|Overall Study|Adverse Event|1|||
160787821|NCT01903720|580609020|FG000|Overall Study|Rescinding of informed consent|2|||
160787822|NCT01903720|580609020|FG000|Overall Study|Lost to Follow-up|2|||
160787823|NCT01903720|580609020|FG000|Overall Study|Treatment with alternative drug|1|||
160787824|NCT01104870|580609021|FG000|Overall Study|Adverse Event|1|||
160787825|NCT01104870|580609022|FG001|Overall Study|Adverse Event|1|||
160787826|NCT01104870|580609023|FG002|Overall Study|Adverse Event|0|||
160787827|NCT01104870|580609021|FG000|Overall Study|Death|0|||
160787828|NCT01104870|580609022|FG001|Overall Study|Death|0|||
160787829|NCT01104870|580609023|FG002|Overall Study|Death|1|||
160787830|NCT01104870|580609021|FG000|Overall Study|Withdrawal by Subject|0|||
160787831|NCT01104870|580609022|FG001|Overall Study|Withdrawal by Subject|0|||
161127047|NCT01400932|581852553|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161127048|NCT01400932|581852554|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161127049|NCT00860158|581852555|FG000|Overall Study|Study Terminated|1|||
161127050|NCT00282243|581852558|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
161329350|NCT02106351|582590754|FG002|Treatment Cycle 1|Randomised but not treated|1|||
161329351|NCT02106351|582590752|FG000|Treatment Cycle 2|Adverse Event|0|||
161329352|NCT02106351|582590753|FG001|Treatment Cycle 2|Adverse Event|2|||
161329353|NCT02106351|582590754|FG002|Treatment Cycle 2|Adverse Event|0|||
161329354|NCT02106351|582590752|FG000|Treatment Cycle 2|Consent withdrawn|0|||
161329355|NCT02106351|582590753|FG001|Treatment Cycle 2|Consent withdrawn|1|||
161329356|NCT02106351|582590754|FG002|Treatment Cycle 2|Consent withdrawn|1|||
161329357|NCT02106351|582590752|FG000|Treatment Cycle 2|Other|0|||
161329358|NCT02106351|582590753|FG001|Treatment Cycle 2|Other|2|||
161329359|NCT02106351|582590754|FG002|Treatment Cycle 2|Other|2|||
161329360|NCT02106351|582590752|FG000|Treatment Cycle 3|Adverse Event|0|||
161329361|NCT02106351|582590753|FG001|Treatment Cycle 3|Adverse Event|1|||
161329362|NCT02106351|582590754|FG002|Treatment Cycle 3|Adverse Event|0|||
161329363|NCT02106351|582590752|FG000|Treatment Cycle 3|Consent withdrawn|0|||
161329364|NCT02106351|582590753|FG001|Treatment Cycle 3|Consent withdrawn|0|||
161329365|NCT02106351|582590754|FG002|Treatment Cycle 3|Consent withdrawn|2|||
161329366|NCT02106351|582590752|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
161329367|NCT02106351|582590753|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
161329368|NCT02106351|582590754|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
161329369|NCT02106351|582590752|FG000|Treatment Cycle 3|Other|0|||
161329370|NCT02106351|582590753|FG001|Treatment Cycle 3|Other|2|||
161329371|NCT02106351|582590754|FG002|Treatment Cycle 3|Other|3|||
161329372|NCT02106351|582590752|FG000|Treatment Cycle 4|Consent withdrawn|0|||
161329373|NCT02106351|582590753|FG001|Treatment Cycle 4|Consent withdrawn|0|||
161329374|NCT02106351|582590754|FG002|Treatment Cycle 4|Consent withdrawn|2|||
161329375|NCT02106351|582590752|FG000|Treatment Cycle 4|Other|0|||
160787832|NCT01104870|580609023|FG002|Overall Study|Withdrawal by Subject|1|||
161127051|NCT00282243|581852558|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
161127052|NCT00282243|581852558|FG000|Extension Treatment Period|Adverse Event|15|||
161127053|NCT00282243|581852558|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
161127054|NCT00282243|581852558|FG000|Extension Treatment Period|Non-compliance|2|||
161127055|NCT00282243|581852558|FG000|Extension Treatment Period|Physician Decision|1|||
161127056|NCT00270894|581852559|FG000|Overall Study|Adverse Event|1|||
161127057|NCT00270894|581852559|FG000|Overall Study|Withdrawal by Subject|1|||
161127058|NCT01070329|581852560|FG000|Overall Study|Adverse Event|13|||
161127059|NCT01070329|581852561|FG001|Overall Study|Adverse Event|10|||
161127060|NCT01070329|581852560|FG000|Overall Study|Lost to Follow-up|22|||
161127061|NCT01070329|581852561|FG001|Overall Study|Lost to Follow-up|12|||
160787833|NCT02771145|580609027|FG000|Overall Study|Adverse Event|3|||
161127062|NCT01070329|581852560|FG000|Overall Study|Withdrawal by Subject|9|||
161127063|NCT01070329|581852561|FG001|Overall Study|Withdrawal by Subject|11|||
161127064|NCT01070329|581852560|FG000|Overall Study|Protocol Violation|3|||
161127065|NCT01070329|581852561|FG001|Overall Study|Protocol Violation|8|||
160787834|NCT02771145|580609027|FG000|Overall Study|Lost to Follow-up|1|||
161329376|NCT02106351|582590753|FG001|Treatment Cycle 4|Other|1|||
161329377|NCT02106351|582590754|FG002|Treatment Cycle 4|Other|0|||
161329378|NCT01386606|582592448|FG000|Overall Study|Adverse Event|0|||
161329379|NCT01386606|582592449|FG001|Overall Study|Adverse Event|1|||
161329380|NCT01386606|582592450|FG002|Overall Study|Adverse Event|0|||
161329381|NCT01386606|582592451|FG003|Overall Study|Adverse Event|0|||
161329382|NCT01386606|582592448|FG000|Overall Study|Withdrawal by Subject|0|||
161329383|NCT01386606|582592449|FG001|Overall Study|Withdrawal by Subject|1|||
161329384|NCT01386606|582592450|FG002|Overall Study|Withdrawal by Subject|1|||
161329385|NCT01386606|582592451|FG003|Overall Study|Withdrawal by Subject|0|||
161329386|NCT01386606|582592448|FG000|Overall Study|Protocol Violation|1|||
161329387|NCT01386606|582592449|FG001|Overall Study|Protocol Violation|0|||
161329388|NCT01386606|582592450|FG002|Overall Study|Protocol Violation|1|||
161127066|NCT01070329|581852560|FG000|Overall Study|Lack of Efficacy|2|||
161329389|NCT01386606|582592451|FG003|Overall Study|Protocol Violation|1|||
161329390|NCT01386606|582592448|FG000|Overall Study|Lost to Follow-up|2|||
161329391|NCT01386606|582592449|FG001|Overall Study|Lost to Follow-up|0|||
161329392|NCT01386606|582592450|FG002|Overall Study|Lost to Follow-up|0|||
161329393|NCT01386606|582592451|FG003|Overall Study|Lost to Follow-up|0|||
161329394|NCT01386606|582592448|FG000|Overall Study|Subject incarcerated|0|||
161329395|NCT01386606|582592449|FG001|Overall Study|Subject incarcerated|1|||
161329396|NCT01386606|582592450|FG002|Overall Study|Subject incarcerated|0|||
161329397|NCT01386606|582592451|FG003|Overall Study|Subject incarcerated|0|||
161329398|NCT01386606|582592448|FG000|Overall Study|Unable to draw PK|1|||
161329399|NCT01386606|582592449|FG001|Overall Study|Unable to draw PK|0|||
161329400|NCT01386606|582592450|FG002|Overall Study|Unable to draw PK|0|||
161329401|NCT01386606|582592451|FG003|Overall Study|Unable to draw PK|0|||
161329402|NCT01386606|582592448|FG000|Overall Study|T levels too high|0|||
161329403|NCT01386606|582592449|FG001|Overall Study|T levels too high|1|||
161329404|NCT01386606|582592450|FG002|Overall Study|T levels too high|1|||
161329405|NCT01386606|582592451|FG003|Overall Study|T levels too high|0|||
161329406|NCT00593814|582592453|FG000|Overall Study|Death|7|||
161329407|NCT00593814|582592454|FG001|Overall Study|Death|0|||
161329408|NCT00593814|582592453|FG000|Overall Study|Withdrawal by Subject|7|||
161329409|NCT00593814|582592454|FG001|Overall Study|Withdrawal by Subject|0|||
161329410|NCT00593814|582592453|FG000|Overall Study|Lost to Follow-up|7|||
161329411|NCT00593814|582592454|FG001|Overall Study|Lost to Follow-up|0|||
161329412|NCT00593814|582592453|FG000|Overall Study|Physician Decision|3|||
161329413|NCT00593814|582592454|FG001|Overall Study|Physician Decision|0|||
161329414|NCT03110354|582592455|FG000|Overall Study|Death|1|||
161329415|NCT03110354|582592456|FG001|Overall Study|Death|0|||
161329416|NCT03110354|582592457|FG002|Overall Study|Death|0|||
161329417|NCT03110354|582592458|FG003|Overall Study|Death|1|||
161329418|NCT03110354|582592459|FG004|Overall Study|Death|0|||
161329419|NCT03110354|582592455|FG000|Overall Study|Start of new therapy|0|||
161329420|NCT03110354|582592456|FG001|Overall Study|Start of new therapy|0|||
161329421|NCT03110354|582592457|FG002|Overall Study|Start of new therapy|0|||
161329422|NCT03110354|582592458|FG003|Overall Study|Start of new therapy|0|||
161329423|NCT03110354|582592459|FG004|Overall Study|Start of new therapy|1|||
161329424|NCT03110354|582592455|FG000|Overall Study|Failure to achieve response|2|||
161329425|NCT03110354|582592456|FG001|Overall Study|Failure to achieve response|3|||
161329426|NCT03110354|582592457|FG002|Overall Study|Failure to achieve response|0|||
161329427|NCT03110354|582592458|FG003|Overall Study|Failure to achieve response|2|||
161329428|NCT03110354|582592459|FG004|Overall Study|Failure to achieve response|1|||
161329429|NCT03110354|582592455|FG000|Overall Study|Progressive disease|1|||
161329430|NCT03110354|582592456|FG001|Overall Study|Progressive disease|1|||
161329431|NCT03110354|582592457|FG002|Overall Study|Progressive disease|3|||
161127067|NCT01070329|581852561|FG001|Overall Study|Lack of Efficacy|6|||
161127068|NCT01070329|581852560|FG000|Overall Study|Physician Decision|2|||
161127069|NCT01070329|581852561|FG001|Overall Study|Physician Decision|1|||
161127070|NCT01070329|581852560|FG000|Overall Study|Entry Criteria Not Met|1|||
161127071|NCT01070329|581852561|FG001|Overall Study|Entry Criteria Not Met|0|||
161127072|NCT01070329|581852560|FG000|Overall Study|Sponsor Decision|0|||
161127073|NCT01070329|581852561|FG001|Overall Study|Sponsor Decision|1|||
161127074|NCT02863848|581852562|FG000|Overall Study|Lost to Follow-up|1|||
161127075|NCT02863848|581852563|FG001|Overall Study|Lost to Follow-up|1|||
161127076|NCT02863848|581852562|FG000|Overall Study|Protocol Violation|1|||
161127077|NCT02863848|581852563|FG001|Overall Study|Protocol Violation|2|||
161127078|NCT03980938|581852567|FG000|Treatment Period 1|Study Terminated|1|||
161127079|NCT03980938|581852568|FG001|Treatment Period 1|Study Terminated|1|||
161329432|NCT03110354|582592458|FG003|Overall Study|Progressive disease|4|||
161329433|NCT03110354|582592459|FG004|Overall Study|Progressive disease|2|||
161127080|NCT03980938|581852567|FG000|Treatment Period 2|Study Terminated|2|||
161127081|NCT03980938|581852568|FG001|Treatment Period 2|Study Terminated|2|||
161127082|NCT03706365|581852570|FG000|Overall Study|Lost to Follow-up|7|||
161127083|NCT03706365|581852571|FG001|Overall Study|Lost to Follow-up|0|||
161329434|NCT03110354|582592455|FG000|Overall Study|Adverse Event|0|||
161329435|NCT03110354|582592456|FG001|Overall Study|Adverse Event|0|||
161329436|NCT03110354|582592457|FG002|Overall Study|Adverse Event|0|||
161329437|NCT03110354|582592458|FG003|Overall Study|Adverse Event|2|||
161329438|NCT03110354|582592459|FG004|Overall Study|Adverse Event|2|||
161329439|NCT03110354|582592455|FG000|Overall Study|Other|0|||
161329440|NCT03110354|582592456|FG001|Overall Study|Other|0|||
161329441|NCT03110354|582592457|FG002|Overall Study|Other|0|||
161329442|NCT03110354|582592458|FG003|Overall Study|Other|1|||
161329443|NCT03110354|582592459|FG004|Overall Study|Other|1|||
161329444|NCT01965327|582592462|FG000|Overall Study|Physician Decision|2|||
161329445|NCT00528424|582592463|FG000|Overall Study|Lost to Follow-up|13|||
161329446|NCT00528424|582592463|FG000|Overall Study|Withdrew consent|2|||
161329447|NCT00528424|582592463|FG000|Overall Study|Administrative reason|2|||
161329448|NCT00528424|582592463|FG000|Overall Study|Other|12|||
161329449|NCT02185417|582592464|FG000|Overall Study|Death|448|||
161329450|NCT02185417|582592465|FG001|Overall Study|Death|446|||
161329451|NCT02185417|582592466|FG002|Overall Study|Death|0|||
161329452|NCT02185417|582592464|FG000|Overall Study|Withdrawal by Subject|7|||
161329453|NCT02185417|582592465|FG001|Overall Study|Withdrawal by Subject|12|||
161329454|NCT02185417|582592466|FG002|Overall Study|Withdrawal by Subject|0|||
161329455|NCT02976519|582592469|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161329456|NCT02976519|582592470|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
161329457|NCT02976519|582592471|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161329458|NCT02976519|582592472|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161329459|NCT02976519|582592473|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161329460|NCT02976519|582592474|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161329461|NCT02976519|582592475|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
161329462|NCT02976519|582592469|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
160787835|NCT00276380|580609028|FG000|Overall Study|Adverse Event|5|||
161127084|NCT03706365|581852570|FG000|Overall Study|Withdrawal by Subject|17|||
161127085|NCT03706365|581852571|FG001|Overall Study|Withdrawal by Subject|15|||
161127086|NCT03706365|581852570|FG000|Overall Study|On Study Treatment|51|||
161127087|NCT03706365|581852571|FG001|Overall Study|On Study Treatment|51|||
161127088|NCT00168831|581852576|FG000|Overall Study|Adverse Event|36|||
161127089|NCT00168831|581852577|FG001|Overall Study|Adverse Event|47|||
161127090|NCT00168831|581852578|FG002|Overall Study|Adverse Event|74|||
161127091|NCT00168831|581852576|FG000|Overall Study|Lost to Follow-up|5|||
161127092|NCT00168831|581852577|FG001|Overall Study|Lost to Follow-up|6|||
161127093|NCT00168831|581852578|FG002|Overall Study|Lost to Follow-up|4|||
161127094|NCT00168831|581852576|FG000|Overall Study|Withdrawal by Subject|7|||
161127095|NCT00168831|581852577|FG001|Overall Study|Withdrawal by Subject|14|||
161127096|NCT00168831|581852578|FG002|Overall Study|Withdrawal by Subject|19|||
161127097|NCT00168831|581852576|FG000|Overall Study|Protocol Violation|6|||
161127098|NCT00168831|581852577|FG001|Overall Study|Protocol Violation|11|||
161127099|NCT00168831|581852578|FG002|Overall Study|Protocol Violation|11|||
161127100|NCT00168831|581852576|FG000|Overall Study|Other|6|||
161127101|NCT00168831|581852577|FG001|Overall Study|Other|3|||
161127102|NCT00168831|581852578|FG002|Overall Study|Other|6|||
161127103|NCT01622569|581852579|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
161127104|NCT01622569|581852580|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
161127105|NCT01622569|581852581|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
161127106|NCT01622569|581852582|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
161127107|NCT01622569|581852579|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161127108|NCT01622569|581852580|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161127109|NCT01622569|581852581|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
161127110|NCT01622569|581852582|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
161127111|NCT01622569|581852579|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
161127112|NCT01622569|581852580|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
161127113|NCT01622569|581852581|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
161127114|NCT01622569|581852582|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
161127115|NCT01622569|581852579|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161127116|NCT01622569|581852580|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
161127117|NCT01622569|581852581|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
161127118|NCT01622569|581852582|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
161127119|NCT01622569|581852579|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161127120|NCT01622569|581852580|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161127121|NCT01622569|581852581|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
161127122|NCT01622569|581852582|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
161127123|NCT01622569|581852579|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161127124|NCT01622569|581852580|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
161127125|NCT01622569|581852581|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
161127126|NCT01622569|581852582|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
161127127|NCT01622569|581852579|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161127128|NCT01622569|581852580|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
161127129|NCT01622569|581852581|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
161127130|NCT01622569|581852582|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
161127131|NCT01622569|581852579|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161127132|NCT01622569|581852580|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161127133|NCT01622569|581852581|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
161329463|NCT02976519|582592470|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161329464|NCT02976519|582592471|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161329465|NCT02976519|582592472|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
161329466|NCT02976519|582592473|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161329467|NCT02976519|582592474|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161329468|NCT02976519|582592475|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
161329469|NCT02976519|582592469|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161329470|NCT02976519|582592470|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161329471|NCT02976519|582592471|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161329472|NCT02976519|582592472|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161329473|NCT02976519|582592473|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161329474|NCT02976519|582592474|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
161329475|NCT02976519|582592475|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
161329476|NCT02976519|582592469|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161329477|NCT02976519|582592470|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161329478|NCT02976519|582592471|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161329479|NCT02976519|582592472|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161329480|NCT02976519|582592473|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161329481|NCT02976519|582592474|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
161329482|NCT02976519|582592475|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
161329483|NCT02976519|582592469|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161329484|NCT02976519|582592470|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161329485|NCT02976519|582592471|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161329486|NCT02976519|582592472|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161329487|NCT02976519|582592473|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161329488|NCT02976519|582592474|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
161329489|NCT02976519|582592475|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
161329490|NCT01278342|582592476|FG000|Overall Study|Physician Decision|0|||
161329491|NCT01278342|582592477|FG001|Overall Study|Physician Decision|1|||
161127134|NCT01622569|581852582|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
161127135|NCT01505894|581852583|FG000|Overall Study|Adverse Event|1|||
161127136|NCT01505894|581852584|FG001|Overall Study|Adverse Event|0|||
161127137|NCT01505894|581852585|FG002|Overall Study|Adverse Event|0|||
161127138|NCT01505894|581852586|FG003|Overall Study|Adverse Event|0|||
161127139|NCT01505894|581852587|FG004|Overall Study|Adverse Event|0|||
161127140|NCT01505894|581852588|FG005|Overall Study|Adverse Event|0|||
161127141|NCT01505894|581852589|FG006|Overall Study|Adverse Event|0|||
161127142|NCT01505894|581852590|FG007|Overall Study|Adverse Event|0|||
161127143|NCT01505894|581852591|FG008|Overall Study|Adverse Event|0|||
161127144|NCT01505894|581852583|FG000|Overall Study|Other than specified|0|||
161127145|NCT01505894|581852584|FG001|Overall Study|Other than specified|0|||
161127146|NCT01505894|581852585|FG002|Overall Study|Other than specified|0|||
161127147|NCT01505894|581852586|FG003|Overall Study|Other than specified|0|||
161127148|NCT01505894|581852587|FG004|Overall Study|Other than specified|1|||
161127149|NCT01505894|581852588|FG005|Overall Study|Other than specified|0|||
161127150|NCT01505894|581852589|FG006|Overall Study|Other than specified|0|||
161127151|NCT01505894|581852590|FG007|Overall Study|Other than specified|0|||
161329492|NCT01278342|582592478|FG002|Overall Study|Physician Decision|0|||
161329493|NCT01278342|582592476|FG000|Overall Study|Lost to Follow-up|1|||
161329494|NCT01278342|582592477|FG001|Overall Study|Lost to Follow-up|0|||
160787836|NCT00276380|580609029|FG001|Overall Study|Adverse Event|3|||
160787837|NCT00276380|580609028|FG000|Overall Study|Lost to Follow-up|1|||
160787838|NCT00276380|580609029|FG001|Overall Study|Lost to Follow-up|1|||
160787839|NCT00276380|580609028|FG000|Overall Study|Withdrawal by Subject|3|||
160787840|NCT00276380|580609029|FG001|Overall Study|Withdrawal by Subject|6|||
160787841|NCT00276380|580609028|FG000|Overall Study|Death|5|||
160787842|NCT00276380|580609029|FG001|Overall Study|Death|3|||
160787843|NCT00276380|580609028|FG000|Overall Study|Abnormal aPPT Levels|0|||
160787844|NCT00276380|580609029|FG001|Overall Study|Abnormal aPPT Levels|1|||
160787845|NCT02150863|580609030|FG000|Overall Study|Lost to Follow-up|0|||
160787846|NCT02150863|580609031|FG001|Overall Study|Lost to Follow-up|1|||
160787847|NCT02150863|580609032|FG002|Overall Study|Lost to Follow-up|0|||
160787848|NCT01651208|580609033|FG000|Overall Study|Lost to Follow-up|14|||
160787849|NCT01651208|580609034|FG001|Overall Study|Lost to Follow-up|16|||
160787850|NCT00835549|580609038|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
160787851|NCT00835549|580609039|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161127152|NCT01505894|581852591|FG008|Overall Study|Other than specified|0|||
161127153|NCT04173741|581852593|FG000|Overall Study|IVC measurement cannot be done|1|||
160787852|NCT00986102|580609053|FG000|Overall Study|Lost to Follow-up|0|||
160787853|NCT00986102|580609054|FG001|Overall Study|Lost to Follow-up|1|||
160787854|NCT00986102|580609055|FG002|Overall Study|Lost to Follow-up|0|||
160787855|NCT00986102|580609056|FG003|Overall Study|Lost to Follow-up|1|||
161127154|NCT04173741|581852594|FG001|Overall Study|IVC measurement cannot be done|1|||
160787856|NCT00986102|580609053|FG000|Overall Study|Withdrawal by Subject|1|||
161127155|NCT02522767|581852595|FG000|Double-blind|Withdrawal by Subject|8|||
161329495|NCT01278342|582592478|FG002|Overall Study|Lost to Follow-up|0|||
161329496|NCT01278342|582592476|FG000|Overall Study|Administrative problems|2|||
161329497|NCT01278342|582592477|FG001|Overall Study|Administrative problems|0|||
161329498|NCT01278342|582592478|FG002|Overall Study|Administrative problems|0|||
161329499|NCT01278342|582592476|FG000|Overall Study|Other|1|||
161329500|NCT01278342|582592477|FG001|Overall Study|Other|0|||
161329501|NCT01278342|582592478|FG002|Overall Study|Other|0|||
161329502|NCT00473655|582592486|FG000|Overall Study|Lost to Follow-up|9|||
161329503|NCT00473655|582592487|FG001|Overall Study|Lost to Follow-up|5|||
161329504|NCT00473655|582592488|FG002|Overall Study|Lost to Follow-up|8|||
161329505|NCT00243919|582592496|FG000|Overall Study|Death|3|||
161329506|NCT00243919|582592497|FG001|Overall Study|Death|4|||
161329507|NCT00243919|582592498|FG002|Overall Study|Death|6|||
161329508|NCT00243919|582592496|FG000|Overall Study|Withdrawal by Subject|6|||
161329509|NCT00243919|582592497|FG001|Overall Study|Withdrawal by Subject|6|||
161329510|NCT00243919|582592498|FG002|Overall Study|Withdrawal by Subject|2|||
161329511|NCT00243919|582592496|FG000|Overall Study|Lost to Follow-up|6|||
161329512|NCT00243919|582592497|FG001|Overall Study|Lost to Follow-up|7|||
161329513|NCT00243919|582592498|FG002|Overall Study|Lost to Follow-up|3|||
161329514|NCT00243919|582592496|FG000|Overall Study|Administrative Error|1|||
161329515|NCT00243919|582592497|FG001|Overall Study|Administrative Error|0|||
161329516|NCT00243919|582592498|FG002|Overall Study|Administrative Error|0|||
161329517|NCT00243919|582592496|FG000|Overall Study|Physician Decision|1|||
161329518|NCT00243919|582592497|FG001|Overall Study|Physician Decision|1|||
161329519|NCT00243919|582592498|FG002|Overall Study|Physician Decision|0|||
161329520|NCT02513550|582592499|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
161329521|NCT02513550|582592500|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
161329522|NCT02513550|582592501|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
161329523|NCT02513550|582592502|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
161329524|NCT02513550|582592503|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161329525|NCT02513550|582592504|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
161329526|NCT02513550|582592499|FG000|Double Blind Treatment Period|Adverse Event|5|||
161329527|NCT02513550|582592500|FG001|Double Blind Treatment Period|Adverse Event|13|||
161329528|NCT02513550|582592501|FG002|Double Blind Treatment Period|Adverse Event|17|||
161329529|NCT02513550|582592502|FG003|Double Blind Treatment Period|Adverse Event|0|||
161329530|NCT02513550|582592503|FG004|Double Blind Treatment Period|Adverse Event|1|||
161329531|NCT02513550|582592504|FG005|Double Blind Treatment Period|Adverse Event|0|||
161329532|NCT02513550|582592499|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
161329533|NCT02513550|582592500|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
161329534|NCT02513550|582592501|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
161329535|NCT02513550|582592502|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
161329536|NCT02513550|582592503|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
161329537|NCT02513550|582592504|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
161329538|NCT02513550|582592499|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
161329539|NCT02513550|582592500|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
161329540|NCT02513550|582592501|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
161329541|NCT02513550|582592502|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
161329542|NCT02513550|582592503|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161329543|NCT02513550|582592504|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
161329544|NCT02513550|582592499|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161329545|NCT02513550|582592500|FG001|Double Blind Treatment Period|Protocol Violation|1|||
161329546|NCT02513550|582592501|FG002|Double Blind Treatment Period|Protocol Violation|4|||
161329547|NCT02513550|582592502|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161329548|NCT02513550|582592503|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161329549|NCT02513550|582592504|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161329550|NCT02513550|582592499|FG000|Double Blind Treatment Period|Physician Decision|2|||
161329551|NCT02513550|582592500|FG001|Double Blind Treatment Period|Physician Decision|0|||
161329552|NCT02513550|582592501|FG002|Double Blind Treatment Period|Physician Decision|4|||
161329553|NCT02513550|582592502|FG003|Double Blind Treatment Period|Physician Decision|0|||
161329554|NCT02513550|582592503|FG004|Double Blind Treatment Period|Physician Decision|0|||
161329555|NCT02513550|582592504|FG005|Double Blind Treatment Period|Physician Decision|0|||
161329556|NCT02513550|582592499|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
161329557|NCT02513550|582592500|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
161329558|NCT02513550|582592501|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
161329559|NCT02513550|582592502|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
161329560|NCT02513550|582592503|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
161329561|NCT02513550|582592504|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
161329562|NCT02513550|582592499|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161329563|NCT02513550|582592500|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161329564|NCT02513550|582592501|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
161329565|NCT02513550|582592502|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161329566|NCT02513550|582592503|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161329567|NCT02513550|582592504|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
161329568|NCT02513550|582592499|FG000|Double Blind Treatment Period|Due to personal business|2|||
161329569|NCT02513550|582592500|FG001|Double Blind Treatment Period|Due to personal business|0|||
161329570|NCT02513550|582592501|FG002|Double Blind Treatment Period|Due to personal business|1|||
161329571|NCT02513550|582592502|FG003|Double Blind Treatment Period|Due to personal business|0|||
161329572|NCT02513550|582592503|FG004|Double Blind Treatment Period|Due to personal business|0|||
161329573|NCT02513550|582592504|FG005|Double Blind Treatment Period|Due to personal business|0|||
161329574|NCT02513550|582592499|FG000|Double Blind Treatment Period|Death|1|||
161329575|NCT02513550|582592500|FG001|Double Blind Treatment Period|Death|0|||
161329576|NCT02513550|582592501|FG002|Double Blind Treatment Period|Death|2|||
161329577|NCT02513550|582592502|FG003|Double Blind Treatment Period|Death|0|||
161329578|NCT02513550|582592503|FG004|Double Blind Treatment Period|Death|0|||
161329579|NCT02513550|582592504|FG005|Double Blind Treatment Period|Death|0|||
161329580|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
161329581|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
161329582|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
161329583|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161329584|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161329585|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
161329586|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
161329587|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
161329588|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
161329589|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161329590|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161329591|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
161329592|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
161329593|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
161329594|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
161329595|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161329596|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161329597|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
161329598|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
161329599|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
161329600|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
161329601|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
161329602|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
161329603|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
161329604|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
161329605|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
161329606|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
161329607|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
161329608|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
161329609|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
161329610|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Death|0|||
161329611|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Death|0|||
161329612|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Death|1|||
161329613|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Death|0|||
161329614|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Death|0|||
161329615|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Death|0|||
161329616|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
161329617|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
161329618|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
161329619|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
161329620|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
161329621|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
161329622|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161329623|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161329624|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
161329625|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161329626|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161329627|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
161329628|NCT02513550|582592499|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
161329629|NCT02513550|582592500|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
161329630|NCT02513550|582592501|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
161329631|NCT02513550|582592502|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
161329632|NCT02513550|582592503|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
161329633|NCT02513550|582592504|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
161329634|NCT00321906|582592505|FG000|Overall Study|Adverse Event|36|||
161329635|NCT00321906|582592506|FG001|Overall Study|Adverse Event|44|||
161329636|NCT00321906|582592505|FG000|Overall Study|Death|9|||
161329637|NCT00321906|582592506|FG001|Overall Study|Death|6|||
161329638|NCT00321906|582592505|FG000|Overall Study|Lost to Follow-up|1|||
161329639|NCT00321906|582592506|FG001|Overall Study|Lost to Follow-up|2|||
161329640|NCT00321906|582592505|FG000|Overall Study|Withdrawal by Subject|0|||
161329641|NCT00321906|582592506|FG001|Overall Study|Withdrawal by Subject|4|||
161329642|NCT02221648|582592509|FG000|Overall Study|Withdrawal by Subject|3|||
161329643|NCT02221648|582592510|FG001|Overall Study|Withdrawal by Subject|3|||
161329644|NCT00810069|582592512|FG000|Lead-in Period I|Adverse Event|43|||
161329645|NCT00810069|582592513|FG001|Lead-in Period I|Adverse Event|0|||
161329646|NCT00810069|582592514|FG002|Lead-in Period I|Adverse Event|0|||
161329647|NCT00810069|582592512|FG000|Lead-in Period I|Lack of Efficacy|1|||
161329648|NCT00810069|582592513|FG001|Lead-in Period I|Lack of Efficacy|0|||
161329649|NCT00810069|582592514|FG002|Lead-in Period I|Lack of Efficacy|0|||
161329650|NCT00810069|582592512|FG000|Lead-in Period I|Lost to Follow-up|19|||
161329651|NCT00810069|582592513|FG001|Lead-in Period I|Lost to Follow-up|0|||
161329652|NCT00810069|582592514|FG002|Lead-in Period I|Lost to Follow-up|0|||
161329653|NCT00810069|582592512|FG000|Lead-in Period I|Physician Decision|1|||
161329654|NCT00810069|582592513|FG001|Lead-in Period I|Physician Decision|0|||
161329655|NCT00810069|582592514|FG002|Lead-in Period I|Physician Decision|0|||
161329656|NCT00810069|582592512|FG000|Lead-in Period I|Protocol Violation|1|||
161329657|NCT00810069|582592513|FG001|Lead-in Period I|Protocol Violation|0|||
161329658|NCT00810069|582592514|FG002|Lead-in Period I|Protocol Violation|0|||
161329659|NCT00810069|582592512|FG000|Lead-in Period I|Withdrawal by Subject|46|||
161329660|NCT00810069|582592513|FG001|Lead-in Period I|Withdrawal by Subject|0|||
161329661|NCT00810069|582592514|FG002|Lead-in Period I|Withdrawal by Subject|0|||
161329662|NCT00810069|582592512|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
161329663|NCT00810069|582592513|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
161329664|NCT00810069|582592514|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
161329665|NCT00810069|582592512|FG000|Lead-in Period I|Randomization criteria not met|158|||
161329666|NCT00810069|582592513|FG001|Lead-in Period I|Randomization criteria not met|0|||
161329667|NCT00810069|582592514|FG002|Lead-in Period I|Randomization criteria not met|0|||
161329668|NCT00810069|582592512|FG000|Double-Blind Period II|Adverse Event|0|||
161329669|NCT00810069|582592513|FG001|Double-Blind Period II|Adverse Event|9|||
161329670|NCT00810069|582592514|FG002|Double-Blind Period II|Adverse Event|8|||
161329671|NCT00810069|582592512|FG000|Double-Blind Period II|Lack of Efficacy|0|||
161329672|NCT00810069|582592513|FG001|Double-Blind Period II|Lack of Efficacy|7|||
161329673|NCT00810069|582592514|FG002|Double-Blind Period II|Lack of Efficacy|12|||
161329674|NCT00810069|582592512|FG000|Double-Blind Period II|Lost to Follow-up|0|||
161329675|NCT00810069|582592513|FG001|Double-Blind Period II|Lost to Follow-up|9|||
161329676|NCT00810069|582592514|FG002|Double-Blind Period II|Lost to Follow-up|9|||
161329677|NCT00810069|582592512|FG000|Double-Blind Period II|Physician Decision|0|||
161329678|NCT00810069|582592513|FG001|Double-Blind Period II|Physician Decision|0|||
161329679|NCT00810069|582592514|FG002|Double-Blind Period II|Physician Decision|1|||
161329680|NCT00810069|582592512|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
161329681|NCT00810069|582592513|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
161329682|NCT00810069|582592514|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
161329683|NCT00810069|582592512|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
161329684|NCT00810069|582592513|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
161329685|NCT00810069|582592514|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
161329686|NCT00810069|582592512|FG000|Double-Blind Period II|Clinical relapse|0|||
161329687|NCT00810069|582592513|FG001|Double-Blind Period II|Clinical relapse|3|||
161329688|NCT00810069|582592514|FG002|Double-Blind Period II|Clinical relapse|0|||
161329689|NCT00810069|582592512|FG000|Double-Blind Period II|Protocol Violation|0|||
161329690|NCT00810069|582592513|FG001|Double-Blind Period II|Protocol Violation|7|||
161329691|NCT00810069|582592514|FG002|Double-Blind Period II|Protocol Violation|6|||
161329692|NCT02899065|582592517|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
161329693|NCT02899065|582592518|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
161329694|NCT02899065|582592517|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
161329695|NCT02899065|582592518|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
161329696|NCT02899065|582592517|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
161329697|NCT02899065|582592518|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
161329698|NCT00186485|582592520|FG000|Overall Study|Lost to Follow-up|3|||
161329699|NCT00905424|582592521|FG000|Overall Study|Lost to Follow-up|3|||
161329700|NCT00905424|582592522|FG001|Overall Study|Lost to Follow-up|3|||
161329701|NCT00905424|582592521|FG000|Overall Study|Withdrawal by Subject|1|||
161329702|NCT00905424|582592522|FG001|Overall Study|Withdrawal by Subject|2|||
161329703|NCT00905424|582592521|FG000|Overall Study|Adverse Event|4|||
161329704|NCT00905424|582592522|FG001|Overall Study|Adverse Event|2|||
161329705|NCT00905424|582592521|FG000|Overall Study|Non-compliance with study medication|2|||
161329706|NCT00905424|582592522|FG001|Overall Study|Non-compliance with study medication|0|||
161329707|NCT00905424|582592521|FG000|Overall Study|Sponsor decision|1|||
161329708|NCT00905424|582592522|FG001|Overall Study|Sponsor decision|0|||
161329709|NCT00905424|582592521|FG000|Overall Study|Positive urine drug screen|0|||
161329710|NCT00905424|582592522|FG001|Overall Study|Positive urine drug screen|1|||
161329711|NCT00905424|582592521|FG000|Overall Study|Non-adherence to visit schedule|0|||
161329712|NCT00905424|582592522|FG001|Overall Study|Non-adherence to visit schedule|1|||
161329713|NCT00426764|582592523|FG000|Overall Study|Protocol Violation|1|||
161329714|NCT00426764|582592523|FG000|Overall Study|Withdrawal by Subject|4|||
161329715|NCT00426764|582592523|FG000|Overall Study|Physician Decision|6|||
161329716|NCT00426764|582592523|FG000|Overall Study|Compassionate Use|1|||
161329717|NCT00426764|582592523|FG000|Overall Study|Progressive Disease|83|||
161329718|NCT00426764|582592523|FG000|Overall Study|Adverse Event|24|||
161329719|NCT00426764|582592523|FG000|Overall Study|Other|1|||
161329720|NCT00426764|582592523|FG000|Overall Study|Death|1|||
161329721|NCT00426764|582592523|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
161329722|NCT01922258|582592524|FG000|Overall Study|Lost to Follow-up|1|||
161329723|NCT01922258|582592525|FG001|Overall Study|Lost to Follow-up|1|||
161329724|NCT01922258|582592524|FG000|Overall Study|Adverse Event|9|||
161329725|NCT01922258|582592525|FG001|Overall Study|Adverse Event|2|||
161329726|NCT01922258|582592524|FG000|Overall Study|Met Withdrawal Criteria|0|||
161329727|NCT01922258|582592525|FG001|Overall Study|Met Withdrawal Criteria|4|||
161329728|NCT01922258|582592524|FG000|Overall Study|Withdrawn by the Investigator|1|||
161329729|NCT01922258|582592525|FG001|Overall Study|Withdrawn by the Investigator|4|||
161329730|NCT01922258|582592524|FG000|Overall Study|Withdrawal by participant|5|||
161329731|NCT01922258|582592525|FG001|Overall Study|Withdrawal by participant|5|||
161329732|NCT01166750|582592526|FG000|Overall Study|Lost to Follow-up|1|||
161329733|NCT01166750|582592527|FG001|Overall Study|Lost to Follow-up|0|||
161329734|NCT05225389|582592528|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
161329735|NCT02417753|582592529|FG000|Overall Study|Death|1|||
161329736|NCT03113968|582592530|FG000|Overall Study|Withdrawal by Subject|31|||
161329737|NCT03113968|582592531|FG001|Overall Study|Withdrawal by Subject|4|||
161329738|NCT04805671|582592532|FG000|Overall Study|Death|2|||
161329739|NCT04805671|582592533|FG001|Overall Study|Death|7|||
161329740|NCT04805671|582592532|FG000|Overall Study|Lost to Follow-up|1|||
161329741|NCT04805671|582592533|FG001|Overall Study|Lost to Follow-up|0|||
161329742|NCT04805671|582592532|FG000|Overall Study|Withdrawal by Subject|9|||
161329743|NCT04805671|582592533|FG001|Overall Study|Withdrawal by Subject|7|||
161329744|NCT04805671|582592532|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
161329745|NCT04805671|582592533|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
161329746|NCT00901342|582592534|FG000|Overall Study|Adverse Event|1|||
161329747|NCT00901342|582592534|FG000|Overall Study|Death|4|||
161329748|NCT00901342|582592534|FG000|Overall Study|Disease progression|1|||
161329749|NCT00901342|582592534|FG000|Overall Study|Withdrawal by Subject|9|||
161329750|NCT03804268|582592535|FG000|Overall Study|Adverse Event|2|||
161329751|NCT03804268|582592536|FG001|Overall Study|Adverse Event|2|||
161329752|NCT03804268|582592535|FG000|Overall Study|Withdrawal by Subject|2|||
161329753|NCT03804268|582592536|FG001|Overall Study|Withdrawal by Subject|0|||
161329754|NCT03804268|582592535|FG000|Overall Study|Lost to Follow-up|1|||
161329755|NCT03804268|582592536|FG001|Overall Study|Lost to Follow-up|0|||
161329756|NCT03804268|582592535|FG000|Overall Study|Physician Decision|2|||
161329757|NCT03804268|582592536|FG001|Overall Study|Physician Decision|0|||
161329758|NCT02849587|582592537|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
161329759|NCT02849587|582592538|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
161329760|NCT02849587|582592539|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
161329761|NCT02849587|582592537|FG000|Overall Study|Withdrawal by Subject|0|||
161329762|NCT02849587|582592538|FG001|Overall Study|Withdrawal by Subject|1|||
161329763|NCT02849587|582592539|FG002|Overall Study|Withdrawal by Subject|0|||
161329764|NCT03380377|582592540|FG000|Overall Study|Physician Decision|1|||
161329765|NCT03380377|582592540|FG000|Overall Study|Withdrawal by Subject|1|||
161329766|NCT00385918|582592541|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
161329767|NCT00385918|582592542|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
161329768|NCT00385918|582592543|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
161329769|NCT00385918|582592541|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
161329770|NCT00385918|582592542|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
161329771|NCT00385918|582592543|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
161329772|NCT00385918|582592541|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
161329773|NCT00385918|582592542|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
161329774|NCT00385918|582592543|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
161329775|NCT00385918|582592541|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
161329776|NCT00385918|582592542|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
161233808|NCT02543203|582238428|FG000|Overall Study|Unpalatable Fragrance|2|||
161233809|NCT02543203|582238429|FG001|Overall Study|Unpalatable Fragrance|2|||
161233810|NCT02543203|582238428|FG000|Overall Study|Lost to Follow-up|1|||
161233811|NCT02543203|582238429|FG001|Overall Study|Lost to Follow-up|0|||
161233812|NCT02543203|582238428|FG000|Overall Study|Increased Irritability|1|||
161233813|NCT02543203|582238429|FG001|Overall Study|Increased Irritability|0|||
161233814|NCT02543203|582238428|FG000|Overall Study|Family|1|||
161233815|NCT02543203|582238429|FG001|Overall Study|Family|2|||
161233816|NCT02543203|582238428|FG000|Overall Study|Negative Behavior|1|||
161233817|NCT02543203|582238429|FG001|Overall Study|Negative Behavior|0|||
161233818|NCT02543203|582238428|FG000|Overall Study|Withdrawal by Subject|0|||
161233819|NCT02543203|582238429|FG001|Overall Study|Withdrawal by Subject|1|||
161233820|NCT01270503|582238430|FG000|Overall Study|Lost to Follow-up|1|||
161233821|NCT04786184|582238431|FG000|Overall Study|Adverse Event|4|||
161233822|NCT04786184|582238432|FG001|Overall Study|Adverse Event|0|||
161233823|NCT04786184|582238431|FG000|Overall Study|Withdrawal by Subject|3|||
161233824|NCT04786184|582238432|FG001|Overall Study|Withdrawal by Subject|1|||
161233825|NCT04786184|582238431|FG000|Overall Study|Lost to Follow-up|4|||
161233826|NCT04786184|582238432|FG001|Overall Study|Lost to Follow-up|2|||
161233827|NCT00565448|582238433|FG000|Overall Study|Adverse Event|1|||
161233828|NCT00565448|582238434|FG001|Overall Study|Adverse Event|2|||
161233829|NCT00565448|582238433|FG000|Overall Study|Disease progression|1|||
161233830|NCT00565448|582238434|FG001|Overall Study|Disease progression|0|||
161233831|NCT00565448|582238433|FG000|Overall Study|Withdrawal by Subject|1|||
161233832|NCT00565448|582238434|FG001|Overall Study|Withdrawal by Subject|0|||
161233833|NCT00193609|582238435|FG000|Overall Study|Lack of Efficacy|2|||
161233834|NCT00193609|582238435|FG000|Overall Study|Adverse Event|2|||
161233835|NCT00302952|582238436|FG000|Overall Study|Physician Decision|1|||
161233836|NCT00302952|582238437|FG001|Overall Study|Physician Decision|1|||
161233837|NCT00302952|582238436|FG000|Overall Study|Withdrawal by Subject|2|||
161233838|NCT00302952|582238437|FG001|Overall Study|Withdrawal by Subject|3|||
161233839|NCT00302952|582238436|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
161233840|NCT00302952|582238437|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
161233841|NCT04185909|582238438|FG000|Overall Study|Lost to Follow-up|1|||
161233842|NCT00857623|582238439|FG000|Overall Study|Adverse Event|5|||
161233843|NCT00857623|582238440|FG001|Overall Study|Adverse Event|2|||
161233844|NCT00857623|582238439|FG000|Overall Study|Study-specific discontinuation criteria|5|||
161233845|NCT00857623|582238440|FG001|Overall Study|Study-specific discontinuation criteria|3|||
161233846|NCT00857623|582238439|FG000|Overall Study|Withdrawal by Subject|2|||
161233847|NCT00857623|582238440|FG001|Overall Study|Withdrawal by Subject|1|||
161233848|NCT00857623|582238439|FG000|Overall Study|Lack of Efficacy|1|||
161233849|NCT00857623|582238440|FG001|Overall Study|Lack of Efficacy|1|||
161233850|NCT00857623|582238439|FG000|Overall Study|Severe non-compliance to protocol|1|||
161233851|NCT00857623|582238440|FG001|Overall Study|Severe non-compliance to protocol|1|||
161233852|NCT00857623|582238439|FG000|Overall Study|Intake of prohibited medication|0|||
161233853|NCT00857623|582238440|FG001|Overall Study|Intake of prohibited medication|1|||
161233854|NCT00857623|582238439|FG000|Overall Study|Positive for HEP C|0|||
161233855|NCT00857623|582238440|FG001|Overall Study|Positive for HEP C|1|||
161233856|NCT02193178|582238441|FG000|Overall Study|Lost to Follow-up|1|||
161233857|NCT02193178|582238441|FG000|Overall Study|Dry eyes|1|||
161233858|NCT03435081|582238442|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
161233859|NCT03435081|582238443|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
161233860|NCT03435081|582238444|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
161233861|NCT03435081|582238442|FG000|Week 0 to Week 16|Adverse Event|2|||
161233862|NCT03435081|582238443|FG001|Week 0 to Week 16|Adverse Event|2|||
161233863|NCT03435081|582238444|FG002|Week 0 to Week 16|Adverse Event|2|||
161233864|NCT03435081|582238442|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
161233865|NCT03435081|582238443|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
161233866|NCT03435081|582238444|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
161233867|NCT03435081|582238442|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
161233868|NCT03435081|582238443|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
161233869|NCT03435081|582238444|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
161233870|NCT03435081|582238442|FG000|Week 0 to Week 16|Pregnancy|1|||
161233871|NCT03435081|582238443|FG001|Week 0 to Week 16|Pregnancy|0|||
161233872|NCT03435081|582238444|FG002|Week 0 to Week 16|Pregnancy|0|||
161233873|NCT03435081|582238442|FG000|Week 0 to Week 16|Non-compliance|1|||
161233874|NCT03435081|582238443|FG001|Week 0 to Week 16|Non-compliance|0|||
161233875|NCT03435081|582238444|FG002|Week 0 to Week 16|Non-compliance|2|||
161233876|NCT03435081|582238442|FG000|Week 0 to Week 16|Inadequate Response|0|||
161233877|NCT03435081|582238443|FG001|Week 0 to Week 16|Inadequate Response|1|||
161233878|NCT03435081|582238444|FG002|Week 0 to Week 16|Inadequate Response|0|||
161233879|NCT03435081|582238442|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
161233880|NCT03435081|582238443|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
161233881|NCT03435081|582238444|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
161233882|NCT03435081|582238442|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
161233883|NCT03435081|582238443|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
161329777|NCT00385918|582592543|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
161329778|NCT00385918|582592541|FG000|Intervention Phase After Randomization|Physician Decision|1|||
161329779|NCT00385918|582592542|FG001|Intervention Phase After Randomization|Physician Decision|0|||
161329780|NCT00385918|582592543|FG002|Intervention Phase After Randomization|Physician Decision|0|||
161329781|NCT00385918|582592541|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
161329782|NCT00385918|582592542|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
161329783|NCT00385918|582592543|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
161329784|NCT00128661|582592544|FG000|Overall Study|Adverse Event|14|||
161329785|NCT00128661|582592545|FG001|Overall Study|Adverse Event|11|||
161329786|NCT00128661|582592544|FG000|Overall Study|Lost to Follow-up|10|||
161329787|NCT00128661|582592545|FG001|Overall Study|Lost to Follow-up|7|||
161329788|NCT00128661|582592544|FG000|Overall Study|Withdrawal by Subject|243|||
161329789|NCT00128661|582592545|FG001|Overall Study|Withdrawal by Subject|232|||
161329790|NCT00128661|582592544|FG000|Overall Study|Other|7|||
161329791|NCT00128661|582592545|FG001|Overall Study|Other|8|||
161329792|NCT03421379|582592546|FG000|Period 1|Withdrawal by Subject|0|||
161329793|NCT03421379|582592547|FG001|Period 1|Withdrawal by Subject|1|||
161329794|NCT03421379|582592546|FG000|Period 1|Physician Decision|1|||
161329795|NCT03421379|582592547|FG001|Period 1|Physician Decision|1|||
161329796|NCT03421379|582592546|FG000|Period 1|Did not receive treatment|1|||
161329797|NCT03421379|582592547|FG001|Period 1|Did not receive treatment|2|||
161329798|NCT01951417|582592549|FG000|Overall Study|Withdrawal by Subject|1|||
161329799|NCT01951417|582592549|FG000|Overall Study|Protocol Violation|2|||
161329800|NCT01951417|582592549|FG000|Overall Study|Lost to Follow-up|6|||
161329801|NCT04010461|582592550|FG000|Overall Study|COVID based withdrawal|5|||
161329802|NCT04010461|582592550|FG000|Overall Study|Withdrawal by Subject|5|||
161329803|NCT04010461|582592550|FG000|Overall Study|Adverse Event|1|||
161329804|NCT04010461|582592550|FG000|Overall Study|No Motor Threshold obtainable|1|||
161329805|NCT04010461|582592550|FG000|Overall Study|Physician Decision|1|||
161329806|NCT03771963|582592551|FG000|Overall Study|Lost to Follow-up|22|||
161329807|NCT03771963|582592551|FG000|Overall Study|Withdrawal of Consent|10|||
161329808|NCT01026948|582592552|FG000|Overall Study|Physician Decision|8|||
161329809|NCT00102596|582592553|FG000|Part A|Screen failures|6|||
161329810|NCT00102596|582592554|FG001|Part A|Screen failures|0|||
161329811|NCT00102596|582592553|FG000|Part A|Adverse Event|1|||
161329812|NCT00102596|582592554|FG001|Part A|Adverse Event|0|||
161329813|NCT01275144|582592555|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
161329814|NCT01275144|582592556|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
161329815|NCT05116202|582592557|FG000|Overall Study|Study Terminated by Sponsor|21|||
161329816|NCT05116202|582592558|FG001|Overall Study|Study Terminated by Sponsor|38|||
161329817|NCT05116202|582592559|FG002|Overall Study|Study Terminated by Sponsor|17|||
161329818|NCT05116202|582592560|FG003|Overall Study|Study Terminated by Sponsor|18|||
161329819|NCT05116202|582592561|FG004|Overall Study|Study Terminated by Sponsor|0|||
161329820|NCT05116202|582592557|FG000|Overall Study|Withdrawal by Subject|0|||
161329821|NCT05116202|582592558|FG001|Overall Study|Withdrawal by Subject|1|||
161329822|NCT05116202|582592559|FG002|Overall Study|Withdrawal by Subject|1|||
161329823|NCT05116202|582592560|FG003|Overall Study|Withdrawal by Subject|1|||
161329824|NCT05116202|582592561|FG004|Overall Study|Withdrawal by Subject|1|||
161329825|NCT05116202|582592557|FG000|Overall Study|Lost to Follow-up|0|||
161329826|NCT05116202|582592558|FG001|Overall Study|Lost to Follow-up|0|||
161329827|NCT05116202|582592559|FG002|Overall Study|Lost to Follow-up|0|||
161329828|NCT05116202|582592560|FG003|Overall Study|Lost to Follow-up|0|||
161329829|NCT05116202|582592561|FG004|Overall Study|Lost to Follow-up|2|||
161329830|NCT05116202|582592557|FG000|Overall Study|Death|1|||
161329831|NCT05116202|582592558|FG001|Overall Study|Death|1|||
161329832|NCT05116202|582592559|FG002|Overall Study|Death|2|||
161329833|NCT05116202|582592560|FG003|Overall Study|Death|1|||
161329834|NCT05116202|582592561|FG004|Overall Study|Death|5|||
161329835|NCT02864407|582592568|FG000|Overall Study|Protocol Violation|3|||
161329836|NCT02864407|582592568|FG000|Overall Study|Lost to Follow-up|115|||
161329837|NCT02864407|582592568|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
161329838|NCT02864407|582592568|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
161329839|NCT02864407|582592568|FG000|Overall Study|Consent prior to the contract date|1|||
161329840|NCT00096538|582592576|FG000|Overall Study|Withdrawal by Subject|1|||
161329841|NCT02686164|582592580|FG000|Overall Study|Adverse Event|1|||
161329842|NCT02686164|582592580|FG000|Overall Study|Withdrawal of consent|1|||
161329843|NCT02686164|582592580|FG000|Overall Study|Clinical progression|1|||
161329844|NCT01827592|582592585|FG000|Overall Study|Adverse Event|11|||
161329845|NCT01827592|582592586|FG001|Overall Study|Adverse Event|9|||
161329846|NCT01827592|582592587|FG002|Overall Study|Adverse Event|2|||
161329847|NCT01827592|582592585|FG000|Overall Study|Physician Decision|0|||
161329848|NCT01827592|582592586|FG001|Overall Study|Physician Decision|2|||
161329849|NCT01827592|582592587|FG002|Overall Study|Physician Decision|1|||
161329850|NCT01827592|582592585|FG000|Overall Study|Protocol Violation|2|||
161329851|NCT01827592|582592586|FG001|Overall Study|Protocol Violation|1|||
161329852|NCT01827592|582592587|FG002|Overall Study|Protocol Violation|0|||
161329853|NCT01827592|582592585|FG000|Overall Study|Lost to Follow-up|1|||
161233884|NCT03435081|582238444|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
161233885|NCT03435081|582238442|FG000|Week 16 to Week 104|Adverse Event|1|||
161233886|NCT03435081|582238443|FG001|Week 16 to Week 104|Adverse Event|0|||
161233887|NCT03435081|582238444|FG002|Week 16 to Week 104|Adverse Event|2|||
161233888|NCT03435081|582238442|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
161233889|NCT03435081|582238443|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
161233890|NCT03435081|582238444|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
161233891|NCT03435081|582238442|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
161233892|NCT03435081|582238443|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
161233893|NCT03435081|582238444|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
161233894|NCT03435081|582238442|FG000|Week 16 to Week 104|Non--Compliance|0|||
161233895|NCT03435081|582238443|FG001|Week 16 to Week 104|Non--Compliance|0|||
161233896|NCT03435081|582238444|FG002|Week 16 to Week 104|Non--Compliance|1|||
161233897|NCT02601560|582238445|FG000|Overall Study|Other|0|||
161233898|NCT02601560|582238446|FG001|Overall Study|Other|0|||
161233899|NCT02601560|582238447|FG002|Overall Study|Other|0|||
161233900|NCT02601560|582238448|FG003|Overall Study|Other|0|||
161233901|NCT02601560|582238449|FG004|Overall Study|Other|0|||
161233902|NCT02601560|582238450|FG005|Overall Study|Other|0|||
161233903|NCT02601560|582238451|FG006|Overall Study|Other|1|||
161233904|NCT02601560|582238452|FG007|Overall Study|Other|0|||
161233905|NCT00420238|582238453|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
161233906|NCT00420238|582238454|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
161233907|NCT00420238|582238453|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
161233908|NCT00420238|582238454|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
161233909|NCT00420238|582238453|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
161233910|NCT00420238|582238454|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
161233911|NCT00420238|582238453|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
161233912|NCT00420238|582238454|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
161233913|NCT00420238|582238453|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
161233914|NCT00420238|582238454|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
161233915|NCT00420238|582238453|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
161233916|NCT00420238|582238454|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
161233917|NCT00626548|582238455|FG000|Overall Study|Adverse Event|164|||
161233918|NCT00626548|582238456|FG001|Overall Study|Adverse Event|44|||
161233919|NCT00626548|582238455|FG000|Overall Study|Withdrawal by Subject|42|||
161233920|NCT00626548|582238456|FG001|Overall Study|Withdrawal by Subject|46|||
161233921|NCT00626548|582238455|FG000|Overall Study|Protocol Violation|4|||
161233922|NCT00626548|582238456|FG001|Overall Study|Protocol Violation|11|||
161233923|NCT00626548|582238455|FG000|Overall Study|Lost to Follow-up|2|||
161233924|NCT00626548|582238456|FG001|Overall Study|Lost to Follow-up|2|||
161233925|NCT00626548|582238455|FG000|Overall Study|Other termination reason|493|||
161233926|NCT00626548|582238456|FG001|Overall Study|Other termination reason|613|||
161233927|NCT03555305|582238457|FG000|Period 1|Physician Decision|0|||
161233928|NCT03555305|582238458|FG001|Period 1|Physician Decision|1|||
161233929|NCT03555305|582238457|FG000|Period 1|Adverse Event|0|||
161233930|NCT03555305|582238458|FG001|Period 1|Adverse Event|1|||
161233931|NCT03785548|582240382|FG000|Overall Study|age > 80|1|||
161233932|NCT03785548|582240383|FG001|Overall Study|age > 80|0|||
161233933|NCT03785548|582240382|FG000|Overall Study|no Postop queries|1|||
161233934|NCT03785548|582240383|FG001|Overall Study|no Postop queries|0|||
161233935|NCT00396279|582240386|FG000|Overall Study|Ongoing in study|26|||
161233936|NCT00396279|582240386|FG000|Overall Study|Disease progression|2|||
161233937|NCT00396279|582240386|FG000|Overall Study|Withdrawal by Subject|1|||
161233938|NCT00396279|582240386|FG000|Overall Study|Physician Decision|1|||
161233939|NCT01882257|582240395|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
161233940|NCT01882257|582240396|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
161233941|NCT01882257|582240397|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
161233942|NCT01882257|582240395|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
161233943|NCT01882257|582240396|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
161233944|NCT01882257|582240397|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
161233945|NCT00830206|582240398|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
161233946|NCT00830206|582240399|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
161233947|NCT00905346|582240403|FG000|Period 1|Withdrawal by Subject|1|||
161233948|NCT00905346|582240404|FG001|Period 1|Withdrawal by Subject|0|||
161233949|NCT03351335|582240405|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
161233950|NCT03351335|582240406|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
161233951|NCT03351335|582240407|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
161233952|NCT04089735|582240408|FG000|Overall Study|Adverse Event|1|||
161233953|NCT04089735|582240409|FG001|Overall Study|Adverse Event|0|||
161233954|NCT04089735|582240410|FG002|Overall Study|Adverse Event|1|||
161233955|NCT04089735|582240411|FG003|Overall Study|Adverse Event|1|||
161233956|NCT04089735|582240412|FG004|Overall Study|Adverse Event|0|||
161233957|NCT04089735|582240413|FG005|Overall Study|Adverse Event|0|||
161233958|NCT04089735|582240408|FG000|Overall Study|Physician Decision|0|||
161329854|NCT01827592|582592586|FG001|Overall Study|Lost to Follow-up|2|||
161329855|NCT01827592|582592587|FG002|Overall Study|Lost to Follow-up|2|||
161329856|NCT01827592|582592585|FG000|Overall Study|Withdrawal by Subject|12|||
161329857|NCT01827592|582592586|FG001|Overall Study|Withdrawal by Subject|11|||
161329858|NCT01827592|582592587|FG002|Overall Study|Withdrawal by Subject|11|||
161329859|NCT01827592|582592585|FG000|Overall Study|Patient's substantial non-compliance|1|||
161329860|NCT01827592|582592586|FG001|Overall Study|Patient's substantial non-compliance|1|||
161329861|NCT01827592|582592587|FG002|Overall Study|Patient's substantial non-compliance|6|||
161329862|NCT01827592|582592585|FG000|Overall Study|Trial terminated by Sponsor|47|||
161329863|NCT01827592|582592586|FG001|Overall Study|Trial terminated by Sponsor|53|||
161329864|NCT01827592|582592587|FG002|Overall Study|Trial terminated by Sponsor|51|||
161329865|NCT01827592|582592585|FG000|Overall Study|Others|0|||
161329866|NCT01827592|582592586|FG001|Overall Study|Others|1|||
161329867|NCT01827592|582592587|FG002|Overall Study|Others|3|||
161329868|NCT02324361|582592588|FG000|Overall Study|Lost to Follow-up|5|||
161329869|NCT02324361|582592589|FG001|Overall Study|Lost to Follow-up|2|||
161329870|NCT00003471|582592600|FG000|Overall Study|Not evaluable|4|||
161329871|NCT00715403|582592605|FG000|Overall Study|Progressive disease|0|||
161329872|NCT00715403|582592606|FG001|Overall Study|Progressive disease|1|||
161329873|NCT00715403|582592607|FG002|Overall Study|Progressive disease|3|||
161329874|NCT00715403|582592608|FG003|Overall Study|Progressive disease|9|||
161329875|NCT00715403|582592609|FG004|Overall Study|Progressive disease|5|||
161329876|NCT00715403|582592610|FG005|Overall Study|Progressive disease|14|||
161329877|NCT00715403|582592611|FG006|Overall Study|Progressive disease|1|||
161329878|NCT00715403|582592605|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
161329879|NCT00715403|582592606|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
161329880|NCT00715403|582592607|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
161329881|NCT00715403|582592608|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
161329882|NCT00715403|582592609|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
161329883|NCT00715403|582592610|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
161329884|NCT00715403|582592611|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
161329885|NCT00715403|582592605|FG000|Overall Study|Other Adverse Event than DLT|1|||
161329886|NCT00715403|582592606|FG001|Overall Study|Other Adverse Event than DLT|0|||
161329887|NCT00715403|582592607|FG002|Overall Study|Other Adverse Event than DLT|0|||
161329888|NCT00715403|582592608|FG003|Overall Study|Other Adverse Event than DLT|0|||
161329889|NCT00715403|582592609|FG004|Overall Study|Other Adverse Event than DLT|0|||
161329890|NCT00715403|582592610|FG005|Overall Study|Other Adverse Event than DLT|2|||
161329891|NCT00715403|582592611|FG006|Overall Study|Other Adverse Event than DLT|0|||
161329892|NCT00715403|582592605|FG000|Overall Study|Protocol Violation|0|||
161329893|NCT00715403|582592606|FG001|Overall Study|Protocol Violation|0|||
161127156|NCT02522767|581852596|FG001|Double-blind|Withdrawal by Subject|11|||
161127157|NCT02522767|581852595|FG000|Double-blind|Lost to Follow-up|1|||
161127158|NCT02522767|581852596|FG001|Double-blind|Lost to Follow-up|0|||
161127159|NCT02522767|581852595|FG000|Double-blind|Adverse Event|1|||
161127160|NCT02522767|581852596|FG001|Double-blind|Adverse Event|10|||
161127161|NCT02522767|581852595|FG000|Double-blind|Protocol Violation|0|||
161127162|NCT02522767|581852596|FG001|Double-blind|Protocol Violation|1|||
161127163|NCT02522767|581852595|FG000|Double-blind|Lack of Efficacy|0|||
161127164|NCT02522767|581852596|FG001|Double-blind|Lack of Efficacy|2|||
161127165|NCT02522767|581852595|FG000|Double-blind|Protocol Deviation|1|||
161127166|NCT02522767|581852596|FG001|Double-blind|Protocol Deviation|0|||
161127167|NCT02522767|581852595|FG000|Open-label|Withdrawal by Subject|2|||
161127168|NCT02522767|581852596|FG001|Open-label|Withdrawal by Subject|3|||
161127169|NCT02522767|581852595|FG000|Open-label|Lost to Follow-up|0|||
161127170|NCT02522767|581852596|FG001|Open-label|Lost to Follow-up|1|||
161127171|NCT02522767|581852595|FG000|Open-label|Adverse Event|2|||
161127172|NCT02522767|581852596|FG001|Open-label|Adverse Event|1|||
161127173|NCT02522767|581852595|FG000|Open-label|Lack of Efficacy|1|||
161127174|NCT02522767|581852596|FG001|Open-label|Lack of Efficacy|1|||
161127175|NCT02522767|581852595|FG000|Open-label|Protocol Violation|0|||
161127176|NCT02522767|581852596|FG001|Open-label|Protocol Violation|1|||
161329894|NCT00715403|582592607|FG002|Overall Study|Protocol Violation|0|||
161329895|NCT00715403|582592608|FG003|Overall Study|Protocol Violation|0|||
161329896|NCT00715403|582592609|FG004|Overall Study|Protocol Violation|0|||
161329897|NCT00715403|582592610|FG005|Overall Study|Protocol Violation|1|||
161329898|NCT00715403|582592611|FG006|Overall Study|Protocol Violation|0|||
161329899|NCT00715403|582592605|FG000|Overall Study|Other reason not defined above|0|||
161329900|NCT00715403|582592606|FG001|Overall Study|Other reason not defined above|0|||
160890220|NCT00423670|580992974|FG007|Treatment Period|Non-compliance with protocol|2|||
161127177|NCT00254566|581852598|FG000|Overall Study|Death|1|||
161127178|NCT00254566|581852599|FG001|Overall Study|Death|0|||
161127179|NCT00254566|581852598|FG000|Overall Study|Adverse Event|5|||
161127180|NCT00254566|581852599|FG001|Overall Study|Adverse Event|4|||
161127181|NCT00254566|581852598|FG000|Overall Study|Lack of Efficacy|12|||
161329901|NCT00715403|582592607|FG002|Overall Study|Other reason not defined above|1|||
161329902|NCT00715403|582592608|FG003|Overall Study|Other reason not defined above|0|||
161127182|NCT00254566|581852599|FG001|Overall Study|Lack of Efficacy|9|||
161329903|NCT00715403|582592609|FG004|Overall Study|Other reason not defined above|1|||
161329904|NCT00715403|582592610|FG005|Overall Study|Other reason not defined above|1|||
161329905|NCT00715403|582592611|FG006|Overall Study|Other reason not defined above|0|||
161329906|NCT00520039|582592614|FG000|Overall Study|Exclusion criteria met at first visit|7|||
161329907|NCT00520039|582592615|FG001|Overall Study|Exclusion criteria met at first visit|5|||
161329908|NCT03560869|582592616|FG000|Overall Study|Withdrawal by Subject|3|||
161329909|NCT03560869|582592617|FG001|Overall Study|Withdrawal by Subject|4|||
161329910|NCT03560869|582592616|FG000|Overall Study|Screening failure|4|||
161329911|NCT03560869|582592617|FG001|Overall Study|Screening failure|4|||
161329912|NCT03560869|582592616|FG000|Overall Study|Withdrawal by PI|0|||
161329913|NCT03560869|582592617|FG001|Overall Study|Withdrawal by PI|1|||
161329914|NCT02481050|582594729|FG000|Overall Study|Adverse Event|1|||
161329915|NCT02481050|582594729|FG000|Overall Study|Disease Progression|47|||
161329916|NCT02481050|582594729|FG000|Overall Study|Withdrawal by Subject|7|||
161329917|NCT02481050|582594729|FG000|Overall Study|Other|3|||
161329918|NCT00611806|582594733|FG000|Overall Study|Withdrawal by Subject|8|||
161329919|NCT00611806|582594734|FG001|Overall Study|Withdrawal by Subject|2|||
161329920|NCT00611806|582594733|FG000|Overall Study|Adverse Event|2|||
161329921|NCT00611806|582594734|FG001|Overall Study|Adverse Event|1|||
161329922|NCT00611806|582594733|FG000|Overall Study|Lost to Follow-up|6|||
161329923|NCT00611806|582594734|FG001|Overall Study|Lost to Follow-up|0|||
161233959|NCT04089735|582240409|FG001|Overall Study|Physician Decision|3|||
161233960|NCT04089735|582240410|FG002|Overall Study|Physician Decision|0|||
161329924|NCT04152200|582594735|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
161329925|NCT04152200|582594736|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
161329926|NCT04969289|582594737|FG000|Overall Study|Lost to Follow-up|13|||
161329927|NCT04969289|582594738|FG001|Overall Study|Lost to Follow-up|9|||
161329928|NCT02699996|582594739|FG000|Overall Study|Withdrawal by Subject|5|||
161329929|NCT02699996|582594740|FG001|Overall Study|Withdrawal by Subject|2|||
161329930|NCT01921517|582594741|FG000|Overall Study|Lost to Follow-up|5|||
161329931|NCT01921517|582594742|FG001|Overall Study|Lost to Follow-up|0|||
161329932|NCT01921517|582594741|FG000|Overall Study|Newly diagnosed health concern|2|||
160890221|NCT00423670|580992967|FG000|Follow-up Period|Lost to Follow-up|0|||
160890222|NCT00423670|580992968|FG001|Follow-up Period|Lost to Follow-up|12|||
160890223|NCT00423670|580992969|FG002|Follow-up Period|Lost to Follow-up|8|||
160890224|NCT00423670|580992970|FG003|Follow-up Period|Lost to Follow-up|3|||
160890225|NCT00423670|580992971|FG004|Follow-up Period|Lost to Follow-up|1|||
160890226|NCT00423670|580992972|FG005|Follow-up Period|Lost to Follow-up|0|||
160890227|NCT00423670|580992973|FG006|Follow-up Period|Lost to Follow-up|5|||
160890228|NCT00423670|580992974|FG007|Follow-up Period|Lost to Follow-up|0|||
160890229|NCT00423670|580992967|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890230|NCT00423670|580992968|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
160890231|NCT00423670|580992969|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
160890232|NCT00423670|580992970|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
161233961|NCT04089735|582240411|FG003|Overall Study|Physician Decision|0|||
161233962|NCT04089735|582240412|FG004|Overall Study|Physician Decision|0|||
161233963|NCT04089735|582240413|FG005|Overall Study|Physician Decision|0|||
161233964|NCT04089735|582240408|FG000|Overall Study|Withdrawal by Subject|0|||
161233965|NCT04089735|582240409|FG001|Overall Study|Withdrawal by Subject|0|||
161233966|NCT04089735|582240410|FG002|Overall Study|Withdrawal by Subject|1|||
161233967|NCT04089735|582240411|FG003|Overall Study|Withdrawal by Subject|0|||
161233968|NCT04089735|582240412|FG004|Overall Study|Withdrawal by Subject|0|||
161233969|NCT04089735|582240413|FG005|Overall Study|Withdrawal by Subject|0|||
161233970|NCT04089735|582240408|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
161233971|NCT04089735|582240409|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
161233972|NCT04089735|582240410|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
161233973|NCT04089735|582240411|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
161233974|NCT04089735|582240412|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
161329933|NCT01921517|582594742|FG001|Overall Study|Newly diagnosed health concern|0|||
160890233|NCT00423670|580992971|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890234|NCT00423670|580992972|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
161329934|NCT01921517|582594741|FG000|Overall Study|Physician Decision|0|||
161329935|NCT01921517|582594742|FG001|Overall Study|Physician Decision|2|||
161329936|NCT01921517|582594741|FG000|Overall Study|Withdrawal by Subject|7|||
161329937|NCT01921517|582594742|FG001|Overall Study|Withdrawal by Subject|3|||
161329938|NCT01921517|582594741|FG000|Overall Study|Subject missed final imaging|1|||
161329939|NCT01921517|582594742|FG001|Overall Study|Subject missed final imaging|4|||
161329940|NCT02723188|582594745|FG000|Overall Study|Withdrawal by Subject|1|||
161329941|NCT02723188|582594746|FG001|Overall Study|Withdrawal by Subject|0|||
161329942|NCT02723188|582594747|FG002|Overall Study|Withdrawal by Subject|0|||
161233975|NCT04089735|582240413|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
161233976|NCT02736721|582240418|FG000|Overall Study|Adverse Event|8|||
161233977|NCT02736721|582240418|FG000|Overall Study|Lost to Follow-up|3|||
161233978|NCT02736721|582240418|FG000|Overall Study|Other|5|||
161233979|NCT02956460|582240419|FG000|Lens 1|Lost to Follow-up|1|||
161233980|NCT02956460|582240420|FG001|Lens 1|Lost to Follow-up|0|||
161233981|NCT00829673|582240421|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161233982|NCT00829673|582240422|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161233983|NCT00272779|582240423|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
161233984|NCT00272779|582240424|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
161233985|NCT00272779|582240423|FG000|Baseline Through Week 48|Death before Week 48|4|||
161233986|NCT00272779|582240424|FG001|Baseline Through Week 48|Death before Week 48|4|||
161233987|NCT00272779|582240423|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
161233988|NCT00272779|582240424|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
161233989|NCT00272779|582240423|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
161233990|NCT00272779|582240424|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
161233991|NCT00272779|582240423|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
161233992|NCT00272779|582240424|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
161233993|NCT00272779|582240423|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
161233994|NCT00272779|582240424|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
161233995|NCT00272779|582240423|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
161233996|NCT00272779|582240424|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
161233997|NCT00272779|582240423|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
161233998|NCT00272779|582240424|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
161233999|NCT00272779|582240423|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
161234000|NCT00272779|582240424|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
161234001|NCT00272779|582240423|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
161234002|NCT00272779|582240424|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
161234003|NCT00272779|582240423|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
161234004|NCT00272779|582240424|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
161234005|NCT00272779|582240423|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
161234006|NCT00272779|582240424|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
161234007|NCT00272779|582240423|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
161234008|NCT00272779|582240424|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
161234009|NCT00272779|582240423|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
161234010|NCT00272779|582240424|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
161234011|NCT00272779|582240423|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
161234012|NCT00272779|582240424|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
161234013|NCT00272779|582240423|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
161234014|NCT00272779|582240424|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
161234015|NCT00272779|582240423|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
161234016|NCT00272779|582240424|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
161234017|NCT00272779|582240423|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
161234018|NCT00272779|582240424|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
161234019|NCT00272779|582240423|FG000|Baseline Through Week 48|Continuing treatment|385|||
161234020|NCT00272779|582240424|FG001|Baseline Through Week 48|Continuing treatment|368|||
161234021|NCT00272779|582240423|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
161234022|NCT00272779|582240424|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
161234023|NCT00272779|582240423|FG000|Baseline Through Week 48|Never treated|2|||
161234024|NCT00272779|582240424|FG001|Baseline Through Week 48|Never treated|3|||
161234025|NCT00272779|582240423|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
161234026|NCT00272779|582240424|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
161234027|NCT00272779|582240423|FG000|Baseline Through Week 96|Death before Week 96|6|||
161234028|NCT00272779|582240424|FG001|Baseline Through Week 96|Death before Week 96|5|||
161234029|NCT00272779|582240423|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
161234030|NCT00272779|582240424|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
161234031|NCT00272779|582240423|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
160890235|NCT00423670|580992973|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890236|NCT00423670|580992974|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
160890237|NCT00423670|580992967|FG000|Follow-up Period|Non-compliance with protocol|2|||
160890238|NCT00423670|580992968|FG001|Follow-up Period|Non-compliance with protocol|0|||
160890239|NCT00423670|580992969|FG002|Follow-up Period|Non-compliance with protocol|1|||
160890240|NCT00423670|580992970|FG003|Follow-up Period|Non-compliance with protocol|1|||
161234032|NCT00272779|582240424|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
160890241|NCT00423670|580992971|FG004|Follow-up Period|Non-compliance with protocol|0|||
161234033|NCT00272779|582240423|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
161234034|NCT00272779|582240424|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
161234035|NCT00272779|582240423|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
161234036|NCT00272779|582240424|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
161234037|NCT00272779|582240423|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
161234038|NCT00272779|582240424|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
161234039|NCT00272779|582240423|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
161234040|NCT00272779|582240424|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
161234041|NCT00272779|582240423|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
161234042|NCT00272779|582240424|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
161234043|NCT00272779|582240423|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
161234044|NCT00272779|582240424|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
161234045|NCT00272779|582240423|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
161234046|NCT00272779|582240424|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
161234047|NCT00272779|582240423|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
161234048|NCT00272779|582240424|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
161234049|NCT00272779|582240423|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
161234050|NCT00272779|582240424|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
161234051|NCT00272779|582240423|FG000|Baseline Through Week 96|Never treated|2|||
161234052|NCT00272779|582240424|FG001|Baseline Through Week 96|Never treated|3|||
161234053|NCT00272779|582240423|FG000|Baseline Through Week 96|Continuing on treatment|61|||
161234054|NCT00272779|582240424|FG001|Baseline Through Week 96|Continuing on treatment|38|||
161234055|NCT02440711|582240425|FG000|Second Intervention|Lost to Follow-up|1|||
161234056|NCT02440711|582240426|FG001|Second Intervention|Lost to Follow-up|0|||
161234057|NCT04129346|582240427|FG000|Overall Study|Death|1|||
161234058|NCT04129346|582240428|FG001|Overall Study|Death|0|||
160787857|NCT00986102|580609054|FG001|Overall Study|Withdrawal by Subject|1|||
160787858|NCT00986102|580609055|FG002|Overall Study|Withdrawal by Subject|0|||
160787859|NCT00986102|580609056|FG003|Overall Study|Withdrawal by Subject|0|||
160787860|NCT04008069|580609057|FG000|Open-Label Period|Adverse Event|1|||
160787861|NCT04008069|580609058|FG001|Open-Label Period|Adverse Event|0|||
160787862|NCT04008069|580609059|FG002|Open-Label Period|Adverse Event|0|||
160787863|NCT04008069|580609057|FG000|Open-Label Period|Lack of Efficacy|4|||
160787864|NCT04008069|580609058|FG001|Open-Label Period|Lack of Efficacy|0|||
160787865|NCT04008069|580609059|FG002|Open-Label Period|Lack of Efficacy|0|||
160787866|NCT04008069|580609057|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
160787867|NCT04008069|580609058|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
160787868|NCT04008069|580609059|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
160787869|NCT04008069|580609057|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
160787870|NCT04008069|580609058|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
160787871|NCT04008069|580609059|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
160787872|NCT00511199|580609060|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
160787873|NCT00511199|580609061|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
160787874|NCT00511199|580609060|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
160787875|NCT00511199|580609061|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
160787876|NCT00511199|580609060|FG000|Overall Study|Withdrawal of Informed Consent|19|||
160787877|NCT00511199|580609061|FG001|Overall Study|Withdrawal of Informed Consent|4|||
160787878|NCT00511199|580609060|FG000|Overall Study|Pregnancy|6|||
160787879|NCT00511199|580609061|FG001|Overall Study|Pregnancy|3|||
160787880|NCT00511199|580609060|FG000|Overall Study|Pregnancy Wish|16|||
160787881|NCT00511199|580609061|FG001|Overall Study|Pregnancy Wish|8|||
160787882|NCT00511199|580609060|FG000|Overall Study|Lost to Follow-up|40|||
160787883|NCT00511199|580609061|FG001|Overall Study|Lost to Follow-up|17|||
160787884|NCT00511199|580609060|FG000|Overall Study|Other Reason|78|||
160787885|NCT00511199|580609061|FG001|Overall Study|Other Reason|37|||
160787886|NCT01953354|580609069|FG000|Overall Study|Withdrawal by Subject|0|||
160787887|NCT01953354|580609070|FG001|Overall Study|Withdrawal by Subject|1|||
160787888|NCT01953354|580609069|FG000|Overall Study|Decision of Sponsor|0|||
160787889|NCT01953354|580609070|FG001|Overall Study|Decision of Sponsor|1|||
160787890|NCT01953354|580609069|FG000|Overall Study|Disease Exacerbation|1|||
160787891|NCT01953354|580609070|FG001|Overall Study|Disease Exacerbation|0|||
160787892|NCT01927861|580609071|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
160787893|NCT01927861|580609072|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
160787894|NCT01927861|580609071|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
160787895|NCT01927861|580609072|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
160787896|NCT00728182|580609074|FG000|Overall Study|Adverse Event|1|||
160787897|NCT00728182|580609075|FG001|Overall Study|Adverse Event|0|||
160787898|NCT00728182|580609074|FG000|Overall Study|Lost to Follow-up|2|||
160787899|NCT00728182|580609075|FG001|Overall Study|Lost to Follow-up|0|||
160787900|NCT00728182|580609074|FG000|Overall Study|Death|0|||
160787901|NCT00728182|580609075|FG001|Overall Study|Death|2|||
160787902|NCT00728182|580609074|FG000|Overall Study|Protocol Noncompliance|0|||
160787903|NCT00728182|580609075|FG001|Overall Study|Protocol Noncompliance|1|||
160787904|NCT01898091|580609079|FG000|Overall Study|Lost to Follow-up|1|||
160890242|NCT00423670|580992972|FG005|Follow-up Period|Non-compliance with protocol|0|||
160890243|NCT00423670|580992973|FG006|Follow-up Period|Non-compliance with protocol|3|||
160890244|NCT00423670|580992974|FG007|Follow-up Period|Non-compliance with protocol|2|||
160890245|NCT03190369|580992975|FG000|Overall Study|Poor compliance to protocol|0|||
160890246|NCT03190369|580992976|FG001|Overall Study|Poor compliance to protocol|1|||
160890247|NCT03190369|580992975|FG000|Overall Study|Withdraw before treatment|1|||
160890248|NCT03190369|580992976|FG001|Overall Study|Withdraw before treatment|5|||
160890249|NCT03190369|580992975|FG000|Overall Study|Randomized but not treated|0|||
160890250|NCT03190369|580992976|FG001|Overall Study|Randomized but not treated|2|||
160890251|NCT02131532|580992977|FG000|Overall Study|Withdrawal by Subject|1|||
160890252|NCT02131532|580992977|FG000|Overall Study|Physician Decision|1|||
160890253|NCT02131532|580992977|FG000|Overall Study|Other health conditions|2|||
160890254|NCT01241240|580992978|FG000|Overall Study|Adverse Event|5|||
160890255|NCT01241240|580992979|FG001|Overall Study|Adverse Event|4|||
160890256|NCT01241240|580992978|FG000|Overall Study|Lost to Follow-up|2|||
160890257|NCT01241240|580992979|FG001|Overall Study|Lost to Follow-up|4|||
160890258|NCT01241240|580992978|FG000|Overall Study|Personal Reasons|1|||
160890259|NCT01241240|580992979|FG001|Overall Study|Personal Reasons|1|||
160890260|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
160890261|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
160890262|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
160890263|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
160890264|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
160890265|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
160890266|NCT01369485|580992980|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
160890267|NCT01369485|580992981|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
160890268|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
160890269|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
160890270|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
160890271|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
160890272|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
160890273|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
160890274|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
160890275|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
160890276|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
160890277|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
160890278|NCT01369485|580992980|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
160890279|NCT01369485|580992981|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
160890280|NCT02942576|580992982|FG000|Overall Study|Adverse Event|28|||
160890281|NCT02942576|580992983|FG001|Overall Study|Adverse Event|6|||
160890282|NCT02942576|580992982|FG000|Overall Study|Withdrawal by Subject|7|||
160890283|NCT02942576|580992983|FG001|Overall Study|Withdrawal by Subject|5|||
160890284|NCT02942576|580992982|FG000|Overall Study|Physician Decision|1|||
160890285|NCT02942576|580992983|FG001|Overall Study|Physician Decision|4|||
160890286|NCT02942576|580992982|FG000|Overall Study|Other|10|||
160890287|NCT02942576|580992983|FG001|Overall Study|Other|8|||
160890288|NCT00769483|580992984|FG000|Overall Study|Withdrawal by Subject|0|||
160890289|NCT00769483|580992985|FG001|Overall Study|Withdrawal by Subject|1|||
160890290|NCT00769483|580992986|FG002|Overall Study|Withdrawal by Subject|0|||
160890291|NCT00769483|580992987|FG003|Overall Study|Withdrawal by Subject|0|||
160890292|NCT00769483|580992988|FG004|Overall Study|Withdrawal by Subject|1|||
160890293|NCT00769483|580992989|FG005|Overall Study|Withdrawal by Subject|0|||
160890294|NCT01306877|580992990|FG000|Overall Study|Lost to Follow-up|3|||
160890295|NCT01306877|580992991|FG001|Overall Study|Lost to Follow-up|3|||
160890296|NCT01306877|580992990|FG000|Overall Study|Physician Decision|0|||
160890297|NCT01306877|580992991|FG001|Overall Study|Physician Decision|1|||
160890298|NCT00006389|580992992|FG000|Overall Study|Adverse Event|1|||
160890299|NCT01309308|580993000|FG000|Overall Study|Lost to Follow-up|6|||
160890300|NCT01309308|580993001|FG001|Overall Study|Lost to Follow-up|4|||
160890301|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Adverse Event|1|||
160890302|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Adverse Event|0|||
160890303|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Adverse Event|0|||
160890304|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Adverse Event|0|||
160890305|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Adverse Event|0|||
160890306|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890307|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
160890308|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890309|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890310|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
160890311|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
160890312|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
160890313|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
160890314|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
160890315|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
160890316|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890317|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
160890318|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890319|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890320|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
160890321|NCT00473746|580993002|FG000|Period 1 (Phase 1)|Reason not specified|0|||
160890322|NCT00473746|580993003|FG001|Period 1 (Phase 1)|Reason not specified|1|||
160890323|NCT00473746|580993004|FG002|Period 1 (Phase 1)|Reason not specified|0|||
160890324|NCT00473746|580993005|FG003|Period 1 (Phase 1)|Reason not specified|0|||
160890325|NCT00473746|580993006|FG004|Period 1 (Phase 1)|Reason not specified|0|||
160890326|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Adverse Event|0|||
160890327|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Adverse Event|0|||
160890328|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Adverse Event|0|||
160890329|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Adverse Event|0|||
160890330|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Adverse Event|3|||
160890331|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Death|0|||
160890332|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Death|0|||
160890333|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Death|0|||
160890334|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Death|0|||
160890335|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Death|1|||
160890336|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
160890337|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
160890338|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
160890339|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
160890340|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
160890341|NCT00473746|580993002|FG000|Period 2 (Phase 2)|Reason not specified|0|||
160890342|NCT00473746|580993003|FG001|Period 2 (Phase 2)|Reason not specified|0|||
160890343|NCT00473746|580993004|FG002|Period 2 (Phase 2)|Reason not specified|0|||
160890344|NCT00473746|580993005|FG003|Period 2 (Phase 2)|Reason not specified|0|||
160890345|NCT00473746|580993006|FG004|Period 2 (Phase 2)|Reason not specified|3|||
160890346|NCT01017575|580993009|FG000|Overall Study|Lack of Efficacy|0|||
160890347|NCT01017575|580993010|FG001|Overall Study|Lack of Efficacy|1|||
160890348|NCT01017575|580993011|FG002|Overall Study|Lack of Efficacy|0|||
160890349|NCT01017575|580993012|FG003|Overall Study|Lack of Efficacy|1|||
160890350|NCT01017575|580993013|FG004|Overall Study|Lack of Efficacy|1|||
160890351|NCT01017575|580993009|FG000|Overall Study|Adverse Event|0|||
160890352|NCT01017575|580993010|FG001|Overall Study|Adverse Event|1|||
160890353|NCT01017575|580993011|FG002|Overall Study|Adverse Event|0|||
160890354|NCT01017575|580993012|FG003|Overall Study|Adverse Event|0|||
160890355|NCT01017575|580993013|FG004|Overall Study|Adverse Event|2|||
160890356|NCT01017575|580993009|FG000|Overall Study|Withdrawal by Subject|1|||
160890357|NCT01017575|580993010|FG001|Overall Study|Withdrawal by Subject|0|||
160890358|NCT01017575|580993011|FG002|Overall Study|Withdrawal by Subject|0|||
160890359|NCT01017575|580993012|FG003|Overall Study|Withdrawal by Subject|0|||
160890360|NCT01017575|580993013|FG004|Overall Study|Withdrawal by Subject|0|||
160890361|NCT01962922|580993014|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
160890362|NCT01962922|580993015|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
160890363|NCT01962922|580993014|FG000|PK Portion Day 7|non-compliance|1|||
160890364|NCT01962922|580993015|FG001|PK Portion Day 7|non-compliance|0|||
160890365|NCT01962922|580993014|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
160890366|NCT01962922|580993015|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
160890367|NCT01962922|580993014|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
160890368|NCT01962922|580993015|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
160890369|NCT00976573|580993026|FG000|Overall Study|Ineligible|0|||
160890370|NCT00976573|580993027|FG001|Overall Study|Ineligible|1|||
160890371|NCT00976573|580993026|FG000|Overall Study|Cancel prior to receiving treatment|4|||
160890372|NCT00976573|580993027|FG001|Overall Study|Cancel prior to receiving treatment|2|||
160890373|NCT02730208|580993028|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160890374|NCT02730208|580993029|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
160890375|NCT00995865|580993034|FG000|Overall Study|Protocol Violation|2|||
160890376|NCT00995865|580993035|FG001|Overall Study|Protocol Violation|0|||
160890377|NCT00995865|580993036|FG002|Overall Study|Protocol Violation|0|||
160890378|NCT00995865|580993034|FG000|Overall Study|Lost to Follow-up|0|||
160890379|NCT00995865|580993035|FG001|Overall Study|Lost to Follow-up|0|||
161127183|NCT00254566|581852598|FG000|Overall Study|Other|1|||
161127184|NCT00254566|581852599|FG001|Overall Study|Other|5|||
161127185|NCT00254566|581852598|FG000|Overall Study|Withdrawal by Subject|5|||
161127186|NCT00254566|581852599|FG001|Overall Study|Withdrawal by Subject|6|||
160890380|NCT00995865|580993036|FG002|Overall Study|Lost to Follow-up|1|||
160890381|NCT02021656|580993042|FG000|Overall Study|Adverse Event|1|||
160890382|NCT02021656|580993042|FG000|Overall Study|Lack of Efficacy|2|||
161127187|NCT00254566|581852598|FG000|Overall Study|Lost to Follow-up|7|||
160890383|NCT02021656|580993042|FG000|Overall Study|Lost to Follow-up|1|||
160890384|NCT02021656|580993042|FG000|Overall Study|Withdrew Consent|2|||
160890385|NCT00510952|580993045|FG000|Overall Study|Adverse Event|1|||
160890386|NCT00510952|580993046|FG001|Overall Study|Adverse Event|0|||
160890387|NCT00510952|580993045|FG000|Overall Study|Entry Criteria Not Met|3|||
160890388|NCT00510952|580993046|FG001|Overall Study|Entry Criteria Not Met|1|||
161234059|NCT05755282|582240429|FG000|Overall Study|Protocol Violation|0|||
160787905|NCT01898091|580609080|FG001|Overall Study|Lost to Follow-up|1|||
160890389|NCT00510952|580993045|FG000|Overall Study|Lost to Follow-up|5|||
160890390|NCT00510952|580993046|FG001|Overall Study|Lost to Follow-up|3|||
160890391|NCT00510952|580993045|FG000|Overall Study|Physician Decision|1|||
160890392|NCT00510952|580993046|FG001|Overall Study|Physician Decision|1|||
160890393|NCT00510952|580993045|FG000|Overall Study|Protocol Violation|7|||
160890394|NCT00510952|580993046|FG001|Overall Study|Protocol Violation|4|||
160890395|NCT00510952|580993045|FG000|Overall Study|Sponsor Decision|1|||
160890396|NCT00510952|580993046|FG001|Overall Study|Sponsor Decision|0|||
160890397|NCT00510952|580993045|FG000|Overall Study|Withdrawal by Subject|6|||
160890398|NCT00510952|580993046|FG001|Overall Study|Withdrawal by Subject|7|||
160890399|NCT00510952|580993045|FG000|Overall Study|Did Not Receive Study Drug|2|||
160890400|NCT00510952|580993046|FG001|Overall Study|Did Not Receive Study Drug|0|||
160890401|NCT00817479|580993053|FG000|Overall Study|Physician Decision|1|||
160890402|NCT00817479|580993054|FG001|Overall Study|Physician Decision|1|||
160890403|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890404|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890405|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890406|NCT05985980|580993057|FG000|Overall Study|Withdrawal by Subject|1|||
160890407|NCT02359851|580993061|FG000|Overall Study|Death|1|||
160890408|NCT02359851|580993061|FG000|Overall Study|Disease progression|1|||
160890409|NCT00055471|580993062|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
160890410|NCT00055471|580993063|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
160890411|NCT00055471|580993064|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
160890412|NCT00055471|580993062|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
160890413|NCT00055471|580993063|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
160890414|NCT00055471|580993064|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
160890415|NCT00055471|580993062|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
160890416|NCT00055471|580993063|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
160890417|NCT00055471|580993064|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
160890418|NCT01854944|580993065|FG000|Overall Study|Withdrawal by Subject|0|||
160787906|NCT01898091|580609079|FG000|Overall Study|Withdrawal by Subject|1|||
160787907|NCT01898091|580609080|FG001|Overall Study|Withdrawal by Subject|5|||
160787908|NCT03888482|580609083|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
160787909|NCT03888482|580609084|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
160787910|NCT03888482|580609083|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
160787911|NCT03888482|580609084|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
160787912|NCT02294019|580609085|FG000|Overall Study|Adverse Event|2|||
160787913|NCT02294019|580609085|FG000|Overall Study|Protocol Violation|68|||
160787914|NCT02294019|580609085|FG000|Overall Study|Lost to Follow-up|31|||
160787915|NCT02294019|580609085|FG000|Overall Study|Other|1|||
160787916|NCT02294019|580609085|FG000|Overall Study|Withdrawal by Subject|1|||
160787917|NCT01189227|580609087|FG000|Overall Study|Study terminated due to low accrual|6|||
160787918|NCT01189227|580609088|FG001|Overall Study|Study terminated due to low accrual|3|||
160787919|NCT04818086|580609091|FG000|Overall Study|Physician Decision|1|||
160787920|NCT04818086|580609092|FG001|Overall Study|Physician Decision|0|||
160787921|NCT04818086|580609091|FG000|Overall Study|Withdrawal by Subject|0|||
160787922|NCT04818086|580609092|FG001|Overall Study|Withdrawal by Subject|1|||
160787923|NCT04128228|580609094|FG000|Overall Study|Withdrawal by Subject|3|||
160787924|NCT04128228|580609095|FG001|Overall Study|Withdrawal by Subject|3|||
160787925|NCT04128228|580609096|FG002|Overall Study|Withdrawal by Subject|0|||
160787926|NCT04128228|580609097|FG003|Overall Study|Withdrawal by Subject|0|||
160787927|NCT04128228|580609094|FG000|Overall Study|noncompliance|2|||
160787928|NCT04128228|580609095|FG001|Overall Study|noncompliance|2|||
160787929|NCT04128228|580609096|FG002|Overall Study|noncompliance|0|||
160787930|NCT04128228|580609097|FG003|Overall Study|noncompliance|0|||
160787931|NCT01016015|580609098|FG000|Overall Study|Not Treated|3|||
160787932|NCT01016015|580609098|FG000|Overall Study|Withdrawal by Subject|1|||
160787933|NCT01016015|580609098|FG000|Overall Study|Adverse Event|15|||
160787934|NCT03163264|580609099|FG000|Overall Study|Withdrawal by Subject|13|||
160787935|NCT03163264|580609100|FG001|Overall Study|Withdrawal by Subject|3|||
160787936|NCT03163264|580609101|FG002|Overall Study|Withdrawal by Subject|4|||
160787937|NCT03163264|580609102|FG003|Overall Study|Withdrawal by Subject|2|||
160787938|NCT03163264|580609099|FG000|Overall Study|Lost to Follow-up|17|||
160787939|NCT03163264|580609100|FG001|Overall Study|Lost to Follow-up|20|||
160787940|NCT03163264|580609101|FG002|Overall Study|Lost to Follow-up|0|||
160787941|NCT03163264|580609102|FG003|Overall Study|Lost to Follow-up|0|||
160787942|NCT03163264|580609099|FG000|Overall Study|Death|0|||
160787943|NCT03163264|580609100|FG001|Overall Study|Death|2|||
160787944|NCT03163264|580609101|FG002|Overall Study|Death|0|||
160787945|NCT03163264|580609102|FG003|Overall Study|Death|0|||
160787946|NCT00362609|580609108|FG000|Overall Study|Withdrawal by Subject|0|||
160787947|NCT00362609|580609109|FG001|Overall Study|Withdrawal by Subject|1|||
160787948|NCT00362609|580609108|FG000|Overall Study|Protocol Violation|0|||
160787949|NCT00362609|580609109|FG001|Overall Study|Protocol Violation|1|||
161234060|NCT05755282|582240430|FG001|Overall Study|Protocol Violation|1|||
161234061|NCT00573066|582240431|FG000|Overall Study|Exclusion criteria|18|||
161234062|NCT00573066|582240431|FG000|Overall Study|IV malfunction|1|||
161234063|NCT00573066|582240431|FG000|Overall Study|Postoperative bleeding|1|||
161234064|NCT02770820|582240433|FG000|Overall Study|Death|1|||
161234065|NCT02770820|582240433|FG000|Overall Study|Physician Decision|2|||
161234066|NCT00376623|582240435|FG000|Overall Study|Progressive disease|35|||
161234067|NCT00376623|582240436|FG001|Overall Study|Progressive disease|22|||
161234068|NCT00376623|582240437|FG002|Overall Study|Progressive disease|17|||
161234069|NCT00376623|582240435|FG000|Overall Study|Lost to Follow-up|0|||
161234070|NCT00376623|582240436|FG001|Overall Study|Lost to Follow-up|1|||
161234071|NCT00376623|582240437|FG002|Overall Study|Lost to Follow-up|0|||
161234072|NCT00376623|582240435|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
161234073|NCT00376623|582240436|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
161234074|NCT00376623|582240437|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
161234075|NCT00376623|582240435|FG000|Overall Study|Not treated with BI 2536|1|||
161234076|NCT00376623|582240436|FG001|Overall Study|Not treated with BI 2536|0|||
161234077|NCT00376623|582240437|FG002|Overall Study|Not treated with BI 2536|0|||
161234078|NCT00376623|582240435|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
161234079|NCT00376623|582240436|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161234080|NCT00376623|582240437|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161234081|NCT00376623|582240435|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
161234082|NCT00376623|582240436|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
161234083|NCT00376623|582240437|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
161234084|NCT00376623|582240435|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
160787950|NCT02205359|580609110|FG000|Overall Study|Death|293|||
160787951|NCT02205359|580609111|FG001|Overall Study|Death|327|||
160787952|NCT02205359|580609110|FG000|Overall Study|Lost to Follow-up|182|||
160787953|NCT02205359|580609111|FG001|Overall Study|Lost to Follow-up|162|||
160787954|NCT02205359|580609110|FG000|Overall Study|Physician Decision|51|||
160787955|NCT02205359|580609111|FG001|Overall Study|Physician Decision|53|||
160787956|NCT02205359|580609110|FG000|Overall Study|Withdrawal by Subject|167|||
160787957|NCT02205359|580609111|FG001|Overall Study|Withdrawal by Subject|169|||
160787958|NCT00236197|580609112|FG000|Overall Study|Withdrawal by Subject|3|||
160787959|NCT00236197|580609113|FG001|Overall Study|Withdrawal by Subject|2|||
160787960|NCT00236197|580609112|FG000|Overall Study|Lost to Follow-up|1|||
160787961|NCT00236197|580609113|FG001|Overall Study|Lost to Follow-up|5|||
160787962|NCT00236197|580609112|FG000|Overall Study|Protocol Violation|0|||
160787963|NCT00236197|580609113|FG001|Overall Study|Protocol Violation|3|||
160787964|NCT00236197|580609112|FG000|Overall Study|Medication non-compliance|1|||
160787965|NCT00236197|580609113|FG001|Overall Study|Medication non-compliance|2|||
160787966|NCT00236197|580609112|FG000|Overall Study|Other|0|||
160787967|NCT00236197|580609113|FG001|Overall Study|Other|2|||
160787968|NCT00480025|580609114|FG000|Overall Study|Protocol Violation|12|||
160787969|NCT00480025|580609115|FG001|Overall Study|Protocol Violation|7|||
160787970|NCT00480025|580609114|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
160787971|NCT00480025|580609115|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
160787972|NCT00480025|580609114|FG000|Overall Study|Disease Progression / Recurrence|449|||
160787973|NCT00480025|580609115|FG001|Overall Study|Disease Progression / Recurrence|224|||
160787974|NCT00480025|580609114|FG000|Overall Study|Adverse Event|44|||
160787975|NCT00480025|580609115|FG001|Overall Study|Adverse Event|12|||
160787976|NCT00480025|580609114|FG000|Overall Study|Other|70|||
160787977|NCT00480025|580609115|FG001|Overall Study|Other|29|||
160787978|NCT00480025|580609114|FG000|Overall Study|SAE including intercurrent illness|76|||
160787979|NCT00480025|580609115|FG001|Overall Study|SAE including intercurrent illness|42|||
160787980|NCT03760666|580609116|FG000|Overall Study|Adverse Event|2|||
160787981|NCT03760666|580609117|FG001|Overall Study|Adverse Event|4|||
160787982|NCT03760666|580609118|FG002|Overall Study|Adverse Event|1|||
160787983|NCT03760666|580609116|FG000|Overall Study|AML Disease Progression|3|||
160787984|NCT03760666|580609117|FG001|Overall Study|AML Disease Progression|3|||
160787985|NCT03760666|580609118|FG002|Overall Study|AML Disease Progression|0|||
160787986|NCT03760666|580609116|FG000|Overall Study|Physician Decision|0|||
160787987|NCT03760666|580609117|FG001|Overall Study|Physician Decision|3|||
160787988|NCT03760666|580609118|FG002|Overall Study|Physician Decision|0|||
160787989|NCT03760666|580609116|FG000|Overall Study|Withdrawal by Subject|0|||
160787990|NCT03760666|580609117|FG001|Overall Study|Withdrawal by Subject|1|||
160787991|NCT03760666|580609118|FG002|Overall Study|Withdrawal by Subject|0|||
160787992|NCT01800058|580609124|FG000|Overall Study|Lost to Follow-up|1|||
160787993|NCT03810365|580610773|FG000|Overall Study|Lost to Follow-up|2|||
160787994|NCT03810365|580610774|FG001|Overall Study|Lost to Follow-up|2|||
160787995|NCT03810365|580610773|FG000|Overall Study|Withdrawal by Subject|4|||
160787996|NCT03810365|580610774|FG001|Overall Study|Withdrawal by Subject|5|||
160890419|NCT01854944|580993066|FG001|Overall Study|Withdrawal by Subject|0|||
160890420|NCT01854944|580993067|FG002|Overall Study|Withdrawal by Subject|1|||
160890421|NCT00282347|580993070|FG000|Treatment Period|Death|2|||
160890422|NCT00282347|580993071|FG001|Treatment Period|Death|0|||
160890423|NCT00282347|580993070|FG000|Treatment Period|Lost to Follow-up|2|||
160890424|NCT00282347|580993071|FG001|Treatment Period|Lost to Follow-up|5|||
160890425|NCT00282347|580993070|FG000|Treatment Period|Withdrawal by Subject|1|||
160890426|NCT00282347|580993071|FG001|Treatment Period|Withdrawal by Subject|3|||
160890427|NCT00282347|580993070|FG000|Treatment Period|Physician Decision|0|||
160890428|NCT00282347|580993071|FG001|Treatment Period|Physician Decision|1|||
160890429|NCT00282347|580993070|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
160890430|NCT00282347|580993071|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
160890431|NCT00282347|580993070|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
160890432|NCT00282347|580993071|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
160890433|NCT00282347|580993070|FG000|Safety Follow-up Period|Physician Decision|1|||
160890434|NCT00282347|580993071|FG001|Safety Follow-up Period|Physician Decision|1|||
160890435|NCT00282347|580993070|FG000|Safety Follow-up Period|Protocol Deviation|0|||
160890436|NCT00282347|580993071|FG001|Safety Follow-up Period|Protocol Deviation|2|||
160890437|NCT00282347|580993070|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
160890438|NCT00282347|580993071|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
160890439|NCT00282347|580993070|FG000|B Cell Follow-up Period|Physician Decision|1|||
160890440|NCT00282347|580993071|FG001|B Cell Follow-up Period|Physician Decision|0|||
160890441|NCT00282347|580993070|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
160890442|NCT00282347|580993071|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
160890443|NCT02101112|580993072|FG000|Overall Study|Adverse Event|0|||
160890444|NCT02101112|580993073|FG001|Overall Study|Adverse Event|0|||
160890445|NCT02101112|580993074|FG002|Overall Study|Adverse Event|1|||
160890446|NCT02101112|580993075|FG003|Overall Study|Adverse Event|0|||
160890447|NCT02101112|580993076|FG004|Overall Study|Adverse Event|0|||
160890448|NCT02101112|580993077|FG005|Overall Study|Adverse Event|0|||
160890449|NCT02101112|580993072|FG000|Overall Study|Withdrawal by Subject|0|||
160890450|NCT02101112|580993073|FG001|Overall Study|Withdrawal by Subject|0|||
160890451|NCT02101112|580993074|FG002|Overall Study|Withdrawal by Subject|0|||
160890452|NCT02101112|580993075|FG003|Overall Study|Withdrawal by Subject|0|||
160890453|NCT02101112|580993076|FG004|Overall Study|Withdrawal by Subject|1|||
160890454|NCT02101112|580993077|FG005|Overall Study|Withdrawal by Subject|0|||
160890455|NCT04340063|580993078|FG000|Overall Study|Withdrawal by Subject|1|||
160890456|NCT04340063|580993079|FG001|Overall Study|Withdrawal by Subject|2|||
160890457|NCT04340063|580993078|FG000|Overall Study|Lost to Follow-up|3|||
160890458|NCT04340063|580993079|FG001|Overall Study|Lost to Follow-up|1|||
160890459|NCT04340063|580993078|FG000|Overall Study|Protocol Violation|0|||
160890460|NCT04340063|580993079|FG001|Overall Study|Protocol Violation|1|||
161127188|NCT00254566|581852599|FG001|Overall Study|Lost to Follow-up|2|||
161127189|NCT00059202|581852601|FG000|Overall Study|Withdrawal by Subject|5|||
161127190|NCT00059202|581852602|FG001|Overall Study|Withdrawal by Subject|9|||
161127191|NCT00059202|581852601|FG000|Overall Study|Protocol Violation|1|||
161127192|NCT00059202|581852602|FG001|Overall Study|Protocol Violation|3|||
161127193|NCT00059202|581852601|FG000|Overall Study|drug toxicity|0|||
161127194|NCT00059202|581852602|FG001|Overall Study|drug toxicity|3|||
161127195|NCT00548548|581852605|FG000|Overall Study|Death|345|||
161127196|NCT00548548|581852606|FG001|Overall Study|Death|348|||
161127197|NCT00548548|581852605|FG000|Overall Study|Lost to Follow-up|17|||
161127198|NCT00548548|581852606|FG001|Overall Study|Lost to Follow-up|18|||
161127199|NCT04088409|581852607|FG000|Part A|Withdrawal by Subject|2|||
161127200|NCT04088409|581852608|FG001|Part A|Withdrawal by Subject|1|||
161127201|NCT04088409|581852607|FG000|Part A|Did Not Meet Randomization Criteria|2|||
161127202|NCT04088409|581852608|FG001|Part A|Did Not Meet Randomization Criteria|0|||
161127203|NCT04088409|581852607|FG000|Part A|Lack of Efficacy|9|||
161127204|NCT04088409|581852608|FG001|Part A|Lack of Efficacy|0|||
161127205|NCT04088409|581852607|FG000|Part A|Lost to Follow-up|1|||
161127206|NCT04088409|581852608|FG001|Part A|Lost to Follow-up|0|||
161127207|NCT04088409|581852607|FG000|Part A|Adverse Event|1|||
160890461|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
160890462|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
160890463|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
160890464|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
160890465|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
160890466|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
160890467|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
160890468|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
161127208|NCT04088409|581852608|FG001|Part A|Adverse Event|0|||
161127209|NCT04088409|581852607|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
161127210|NCT04088409|581852608|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
161127211|NCT04088409|581852607|FG000|Part B|Ongoing Treatment|10|||
161127212|NCT04088409|581852608|FG001|Part B|Ongoing Treatment|0|||
160787997|NCT02255279|580610775|FG000|Overall Study|Lost to Follow-up|2|||
160787998|NCT02255279|580610776|FG001|Overall Study|Lost to Follow-up|2|||
160787999|NCT02255279|580610775|FG000|Overall Study|Protocol Violation|0|||
160788000|NCT02255279|580610776|FG001|Overall Study|Protocol Violation|1|||
160788001|NCT02255279|580610775|FG000|Overall Study|Withdrawal by Subject|3|||
160788002|NCT02255279|580610776|FG001|Overall Study|Withdrawal by Subject|6|||
160788003|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
160890469|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
160890470|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
160890471|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
160890472|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
160890473|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
160890474|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
160890475|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
160890476|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
160890477|NCT00491556|580993080|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
160890478|NCT00491556|580993081|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
160890479|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
160890480|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
160890481|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
160890482|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
160890483|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
160890484|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
160890485|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
160890486|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
160890487|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
160890488|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
160890489|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
160890490|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
160890491|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
160890492|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
160890493|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
160890494|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
160890495|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
160890496|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
160890497|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
160890498|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
160890499|NCT00491556|580993080|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
160890500|NCT00491556|580993081|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
160890501|NCT00782795|580993084|FG000|Overall Study|Withdrawal by Subject|1|||
160890502|NCT00782795|580993085|FG001|Overall Study|Withdrawal by Subject|2|||
160890503|NCT02782923|580993086|FG000|Overall Study|Lost to Follow-up|15|||
160890504|NCT00993044|580993087|FG000|Irinotecan 50 mg|Physician Decision|1|||
160890505|NCT00734747|580993089|FG000|SRS Procedure|No staples placed|3|||
160890506|NCT00734747|580993089|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
160890507|NCT05063318|580993095|FG000|Overall Study|Progressive disease|2|||
160890508|NCT05063318|580993096|FG001|Overall Study|Progressive disease|0|||
160890509|NCT05063318|580993097|FG002|Overall Study|Progressive disease|3|||
160890510|NCT05063318|580993095|FG000|Overall Study|Compassionate use|1|||
160890511|NCT05063318|580993096|FG001|Overall Study|Compassionate use|3|||
160890512|NCT05063318|580993097|FG002|Overall Study|Compassionate use|3|||
160890513|NCT05063318|580993095|FG000|Overall Study|Adverse Event|0|||
160890514|NCT05063318|580993096|FG001|Overall Study|Adverse Event|1|||
160890515|NCT05063318|580993097|FG002|Overall Study|Adverse Event|0|||
160890516|NCT05063318|580993095|FG000|Overall Study|Withdrawal by Subject|0|||
160890517|NCT05063318|580993096|FG001|Overall Study|Withdrawal by Subject|1|||
160890518|NCT05063318|580993097|FG002|Overall Study|Withdrawal by Subject|0|||
161127213|NCT00272987|581852618|FG000|Overall Study|Adverse Event|1|||
161127214|NCT00272987|581852619|FG001|Overall Study|Adverse Event|0|||
161127215|NCT00272987|581852620|FG002|Overall Study|Adverse Event|0|||
161127216|NCT00272987|581852618|FG000|Overall Study|Lost to Follow-up|3|||
161127217|NCT00272987|581852619|FG001|Overall Study|Lost to Follow-up|1|||
161127218|NCT00272987|581852620|FG002|Overall Study|Lost to Follow-up|1|||
161127219|NCT00272987|581852618|FG000|Overall Study|Withdrawal by Subject|1|||
161127220|NCT00272987|581852619|FG001|Overall Study|Withdrawal by Subject|0|||
161127221|NCT00272987|581852620|FG002|Overall Study|Withdrawal by Subject|3|||
161127222|NCT00272987|581852618|FG000|Overall Study|Sponsor Terminated study|0|||
160788004|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
160788005|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
160788006|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
161127223|NCT00272987|581852619|FG001|Overall Study|Sponsor Terminated study|1|||
161234085|NCT00376623|582240436|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
161234086|NCT00376623|582240437|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
161234087|NCT00376623|582240435|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
161234088|NCT00376623|582240436|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
161234089|NCT00376623|582240437|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
161234090|NCT00376623|582240435|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
160890519|NCT03287635|580993098|FG000|Overall Study|Lost to Follow-up|5|||
160890520|NCT03287635|580993098|FG000|Overall Study|Withdrawal by Subject|1|||
160890521|NCT03287635|580993098|FG000|Overall Study|Physician Decision|1|||
160890522|NCT00920829|580995081|FG000|Allocation|No post randomization data|3|||
160890523|NCT00920829|580995082|FG001|Allocation|No post randomization data|1|||
160890524|NCT00920829|580995083|FG002|Allocation|No post randomization data|0|||
160890525|NCT00920829|580995084|FG003|Allocation|No post randomization data|2|||
160890526|NCT00920829|580995081|FG000|Available for Analysis|Withdrawal by Subject|6|||
160890527|NCT00920829|580995082|FG001|Available for Analysis|Withdrawal by Subject|6|||
160890528|NCT00920829|580995083|FG002|Available for Analysis|Withdrawal by Subject|6|||
160890529|NCT00920829|580995084|FG003|Available for Analysis|Withdrawal by Subject|10|||
160890530|NCT00920829|580995081|FG000|Available for Analysis|Required Medical Treatment|0|||
160890531|NCT00920829|580995082|FG001|Available for Analysis|Required Medical Treatment|1|||
160890532|NCT00920829|580995083|FG002|Available for Analysis|Required Medical Treatment|2|||
160890533|NCT00920829|580995084|FG003|Available for Analysis|Required Medical Treatment|0|||
160890534|NCT00920829|580995081|FG000|Available for Analysis|Adverse Event|1|||
160890535|NCT00920829|580995082|FG001|Available for Analysis|Adverse Event|2|||
160890536|NCT00920829|580995083|FG002|Available for Analysis|Adverse Event|1|||
160890537|NCT00920829|580995084|FG003|Available for Analysis|Adverse Event|0|||
160890538|NCT00920829|580995081|FG000|Available for Analysis|Death|1|||
160890539|NCT00920829|580995082|FG001|Available for Analysis|Death|0|||
160890540|NCT00920829|580995083|FG002|Available for Analysis|Death|0|||
160890541|NCT00920829|580995084|FG003|Available for Analysis|Death|0|||
160890542|NCT00920829|580995081|FG000|Available for Analysis|Protocol Violation|0|||
160890543|NCT00920829|580995082|FG001|Available for Analysis|Protocol Violation|0|||
160890544|NCT00920829|580995083|FG002|Available for Analysis|Protocol Violation|1|||
160890545|NCT00920829|580995084|FG003|Available for Analysis|Protocol Violation|0|||
160890546|NCT00920829|580995081|FG000|Available for Analysis|Required more treatment|0|||
160890547|NCT00920829|580995082|FG001|Available for Analysis|Required more treatment|2|||
160890548|NCT00920829|580995083|FG002|Available for Analysis|Required more treatment|0|||
160890549|NCT00920829|580995084|FG003|Available for Analysis|Required more treatment|1|||
160890550|NCT03875118|580995085|FG000|Overall Study|Withdrawal by Subject|4|||
160890551|NCT03875118|580995086|FG001|Overall Study|Withdrawal by Subject|4|||
160890552|NCT02237911|580995087|FG000|Overall Study|Withdrawal by Subject|4|||
160890553|NCT02237911|580995088|FG001|Overall Study|Withdrawal by Subject|7|||
160890554|NCT02237911|580995089|FG002|Overall Study|Withdrawal by Subject|2|||
160890555|NCT02237911|580995087|FG000|Overall Study|Lost to Follow-up|3|||
160890556|NCT02237911|580995088|FG001|Overall Study|Lost to Follow-up|1|||
160890557|NCT02237911|580995089|FG002|Overall Study|Lost to Follow-up|1|||
160890558|NCT03468985|580995090|FG000|Overall Study|Adverse Event|0|||
160890559|NCT03468985|580995091|FG001|Overall Study|Adverse Event|2|||
160890560|NCT03468985|580995092|FG002|Overall Study|Adverse Event|0|||
160890561|NCT03468985|580995093|FG003|Overall Study|Adverse Event|0|||
160890562|NCT03468985|580995090|FG000|Overall Study|Withdrawal by Subject|0|||
160890563|NCT03468985|580995091|FG001|Overall Study|Withdrawal by Subject|0|||
160890564|NCT03468985|580995092|FG002|Overall Study|Withdrawal by Subject|0|||
160890565|NCT03468985|580995093|FG003|Overall Study|Withdrawal by Subject|1|||
160890566|NCT03981822|580995094|FG000|Overall Study|Lost to Follow-up|0|||
160890567|NCT03981822|580995095|FG001|Overall Study|Lost to Follow-up|1|||
160890568|NCT03981822|580995096|FG002|Overall Study|Lost to Follow-up|1|||
160890569|NCT03981822|580995097|FG003|Overall Study|Lost to Follow-up|0|||
160890570|NCT03981822|580995098|FG004|Overall Study|Lost to Follow-up|6|||
160890571|NCT03981822|580995099|FG005|Overall Study|Lost to Follow-up|4|||
160890572|NCT03981822|580995100|FG006|Overall Study|Lost to Follow-up|4|||
160890573|NCT03981822|580995101|FG007|Overall Study|Lost to Follow-up|2|||
160890574|NCT03981822|580995094|FG000|Overall Study|Withdrawal by Subject|0|||
160890575|NCT03981822|580995095|FG001|Overall Study|Withdrawal by Subject|1|||
160890576|NCT03981822|580995096|FG002|Overall Study|Withdrawal by Subject|0|||
160890577|NCT03981822|580995097|FG003|Overall Study|Withdrawal by Subject|0|||
160890578|NCT03981822|580995098|FG004|Overall Study|Withdrawal by Subject|0|||
160890579|NCT03981822|580995099|FG005|Overall Study|Withdrawal by Subject|1|||
160890580|NCT03981822|580995100|FG006|Overall Study|Withdrawal by Subject|0|||
160890581|NCT03981822|580995101|FG007|Overall Study|Withdrawal by Subject|2|||
160890582|NCT03981822|580995094|FG000|Overall Study|COVID-19 Related|0|||
160890583|NCT03981822|580995095|FG001|Overall Study|COVID-19 Related|0|||
160890584|NCT03981822|580995096|FG002|Overall Study|COVID-19 Related|0|||
160890585|NCT03981822|580995097|FG003|Overall Study|COVID-19 Related|0|||
160890586|NCT03981822|580995098|FG004|Overall Study|COVID-19 Related|2|||
160890587|NCT03981822|580995099|FG005|Overall Study|COVID-19 Related|1|||
160890588|NCT03981822|580995100|FG006|Overall Study|COVID-19 Related|2|||
160890589|NCT03981822|580995101|FG007|Overall Study|COVID-19 Related|1|||
160890590|NCT00397943|580995102|FG000|Overall Study|Unspecified reasons|12|||
160890591|NCT00397943|580995103|FG001|Overall Study|Unspecified reasons|9|||
160890592|NCT00397943|580995104|FG002|Overall Study|Unspecified reasons|0|||
160890593|NCT00397943|580995105|FG003|Overall Study|Unspecified reasons|0|||
160890594|NCT00397943|580995106|FG004|Overall Study|Unspecified reasons|0|||
160890595|NCT04521777|580995108|FG000|Overall Study|Death|2|||
160890596|NCT04521777|580995108|FG000|Overall Study|Withdrawal by Subject|2|||
160890597|NCT02376829|580995116|FG000|Overall Study|Withdrawal by Subject|27|||
160890598|NCT02376829|580995117|FG001|Overall Study|Withdrawal by Subject|44|||
160890599|NCT00057954|580995118|FG000|Overall Study|Death|1|||
160890600|NCT00057954|580995118|FG000|Overall Study|Disease progression|1|||
160890601|NCT01251744|580995119|FG000|Overall Study|Lost to Follow-up|1|||
160890602|NCT01251744|580995120|FG001|Overall Study|Lost to Follow-up|0|||
160890603|NCT03170232|580995121|FG000|Overall Study|Adverse Event|0|||
160890604|NCT03170232|580995122|FG001|Overall Study|Adverse Event|1|||
160890605|NCT03170232|580995121|FG000|Overall Study|Protocol Violation|0|||
160890606|NCT03170232|580995122|FG001|Overall Study|Protocol Violation|1|||
160890607|NCT03170232|580995121|FG000|Overall Study|Lack of Efficacy|0|||
160890608|NCT03170232|580995122|FG001|Overall Study|Lack of Efficacy|1|||
160890609|NCT03170232|580995121|FG000|Overall Study|Study closed/terminated|26|||
160890610|NCT03170232|580995122|FG001|Overall Study|Study closed/terminated|23|||
160890611|NCT03170232|580995121|FG000|Overall Study|Lost to Follow-up|1|||
160890612|NCT03170232|580995122|FG001|Overall Study|Lost to Follow-up|0|||
160890613|NCT03170232|580995121|FG000|Overall Study|Withdrawal by Subject|0|||
160890614|NCT03170232|580995122|FG001|Overall Study|Withdrawal by Subject|1|||
160890615|NCT02663687|580995123|FG000|Overall Study|Adverse Event|1|||
160890616|NCT02663687|580995124|FG001|Overall Study|Adverse Event|0|||
160890617|NCT02663687|580995125|FG002|Overall Study|Adverse Event|0|||
160890618|NCT02663687|580995126|FG003|Overall Study|Adverse Event|0|||
160890619|NCT02663687|580995127|FG004|Overall Study|Adverse Event|0|||
160890620|NCT02663687|580995123|FG000|Overall Study|Other|1|||
160890621|NCT02663687|580995124|FG001|Overall Study|Other|0|||
160890622|NCT02663687|580995125|FG002|Overall Study|Other|1|||
160890623|NCT02663687|580995126|FG003|Overall Study|Other|0|||
160890624|NCT02663687|580995127|FG004|Overall Study|Other|0|||
160890625|NCT01323946|580995128|FG000|Overall Study|Lost to Follow-up|0|||
160890626|NCT01323946|580995129|FG001|Overall Study|Lost to Follow-up|1|||
160890627|NCT01323946|580995130|FG002|Overall Study|Lost to Follow-up|0|||
160890628|NCT01323946|580995128|FG000|Overall Study|Parents refused the last blood draw|1|||
160890629|NCT01323946|580995129|FG001|Overall Study|Parents refused the last blood draw|0|||
160890630|NCT01323946|580995130|FG002|Overall Study|Parents refused the last blood draw|0|||
160890631|NCT01323946|580995128|FG000|Overall Study|Withdrawal by Subject|2|||
160890632|NCT01323946|580995129|FG001|Overall Study|Withdrawal by Subject|2|||
160890633|NCT01323946|580995130|FG002|Overall Study|Withdrawal by Subject|0|||
160890634|NCT03583073|580995131|FG000|Overall Study|Lost to Follow-up|8|||
160890635|NCT03583073|580995132|FG001|Overall Study|Lost to Follow-up|12|||
160890636|NCT03189381|580995136|FG000|Overall Study|Death|1|||
160890637|NCT03189381|580995137|FG001|Overall Study|Death|0|||
160890638|NCT00107952|580995138|FG000|Overall Study|Death|75|||
160890639|NCT00107952|580995139|FG001|Overall Study|Death|61|||
160890640|NCT00107952|580995138|FG000|Overall Study|Lost to Follow-up|0|||
160890641|NCT00107952|580995139|FG001|Overall Study|Lost to Follow-up|3|||
160890642|NCT00107952|580995138|FG000|Overall Study|Withdrawal by Subject|9|||
160890643|NCT00107952|580995139|FG001|Overall Study|Withdrawal by Subject|6|||
160890644|NCT00107952|580995138|FG000|Overall Study|Other|2|||
160890645|NCT00107952|580995139|FG001|Overall Study|Other|5|||
160890646|NCT00107952|580995138|FG000|Overall Study|Never received study treatment|9|||
160890647|NCT00107952|580995139|FG001|Overall Study|Never received study treatment|6|||
160890648|NCT00251004|580995140|FG000|Overall Study|Withdrawal by Subject|23|||
160890649|NCT00251004|580995141|FG001|Overall Study|Withdrawal by Subject|16|||
160890650|NCT00251004|580995142|FG002|Overall Study|Withdrawal by Subject|14|||
160890651|NCT00251004|580995140|FG000|Overall Study|Death|9|||
160890652|NCT00251004|580995141|FG001|Overall Study|Death|10|||
160890653|NCT00251004|580995142|FG002|Overall Study|Death|8|||
161127224|NCT00272987|581852620|FG002|Overall Study|Sponsor Terminated study|1|||
160890654|NCT00251004|580995140|FG000|Overall Study|Lost to Follow-up|1|||
160890655|NCT00251004|580995141|FG001|Overall Study|Lost to Follow-up|2|||
160890656|NCT00251004|580995142|FG002|Overall Study|Lost to Follow-up|1|||
160890657|NCT00251004|580995140|FG000|Overall Study|Graft Loss|12|||
160890658|NCT00251004|580995141|FG001|Overall Study|Graft Loss|13|||
160890659|NCT00251004|580995142|FG002|Overall Study|Graft Loss|8|||
160890660|NCT00887744|580995143|FG000|Overall Study|Adverse Event|3|||
160890661|NCT00887744|580995143|FG000|Overall Study|Death|1|||
160890662|NCT00887744|580995143|FG000|Overall Study|Lost to Follow-up|3|||
160890663|NCT00887744|580995143|FG000|Overall Study|Withdrawal by Subject|18|||
160890664|NCT00887744|580995143|FG000|Overall Study|Various reasons|9|||
160890665|NCT01569464|580995144|FG000|Overall Study|Adverse Event|4|||
161127225|NCT00272987|581852618|FG000|Overall Study|Disease progression|1|||
160890666|NCT01569464|580995145|FG001|Overall Study|Adverse Event|0|||
160890667|NCT01569464|580995144|FG000|Overall Study|Lack of Efficacy|1|||
160890668|NCT01569464|580995145|FG001|Overall Study|Lack of Efficacy|0|||
160890669|NCT01569464|580995144|FG000|Overall Study|Protocol Violation|1|||
160890670|NCT01569464|580995145|FG001|Overall Study|Protocol Violation|0|||
160890671|NCT01569464|580995144|FG000|Overall Study|Lost to Follow-up|2|||
160890672|NCT01569464|580995145|FG001|Overall Study|Lost to Follow-up|3|||
160890673|NCT01569464|580995144|FG000|Overall Study|Withdrawal by Subject|1|||
160890674|NCT01569464|580995145|FG001|Overall Study|Withdrawal by Subject|1|||
160890675|NCT01569464|580995144|FG000|Overall Study|Other|1|||
160890676|NCT01569464|580995145|FG001|Overall Study|Other|1|||
160890677|NCT04025710|580995151|FG000|Overall Study|Death|3|||
160890678|NCT04025710|580995151|FG000|Overall Study|Lost to Follow-up|5|||
160890679|NCT04025710|580995151|FG000|Overall Study|Withdrawal by Subject|1|||
160890680|NCT04025710|580995151|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
160890681|NCT04025710|580995151|FG000|Overall Study|Drop-out according to protocol|34|||
160890682|NCT03533686|580995154|FG000|Overall Study|Withdrawal by Subject|1|||
160890683|NCT03533686|580995155|FG001|Overall Study|Withdrawal by Subject|0|||
160890684|NCT03533686|580995156|FG002|Overall Study|Withdrawal by Subject|0|||
160890685|NCT03533686|580995157|FG003|Overall Study|Withdrawal by Subject|3|||
160890686|NCT03533686|580995158|FG004|Overall Study|Withdrawal by Subject|5|||
160890687|NCT03533686|580995159|FG005|Overall Study|Withdrawal by Subject|1|||
160890688|NCT03533686|580995154|FG000|Overall Study|Lost to Follow-up|0|||
160890689|NCT03533686|580995155|FG001|Overall Study|Lost to Follow-up|1|||
160890690|NCT03533686|580995156|FG002|Overall Study|Lost to Follow-up|0|||
160890691|NCT03533686|580995157|FG003|Overall Study|Lost to Follow-up|0|||
160890692|NCT03533686|580995158|FG004|Overall Study|Lost to Follow-up|2|||
160890693|NCT03533686|580995159|FG005|Overall Study|Lost to Follow-up|0|||
160890694|NCT03533686|580995154|FG000|Overall Study|Screen Failure|0|||
160890695|NCT03533686|580995155|FG001|Overall Study|Screen Failure|0|||
160890696|NCT03533686|580995156|FG002|Overall Study|Screen Failure|0|||
160890697|NCT03533686|580995157|FG003|Overall Study|Screen Failure|2|||
160890698|NCT03533686|580995158|FG004|Overall Study|Screen Failure|0|||
160890699|NCT03533686|580995159|FG005|Overall Study|Screen Failure|0|||
160890700|NCT02632838|580995160|FG000|Overall Study|Withdrawal by Subject|3|||
160890701|NCT02632838|580995161|FG001|Overall Study|Withdrawal by Subject|0|||
160890702|NCT02632838|580995160|FG000|Overall Study|Lost to Follow-up|0|||
160890703|NCT02632838|580995161|FG001|Overall Study|Lost to Follow-up|2|||
160890704|NCT01343901|580995162|FG000|Overall Study|Death|85|||
160890705|NCT01343901|580995162|FG000|Overall Study|Physician Decision|4|||
160890706|NCT01343901|580995162|FG000|Overall Study|Lost to Follow-up|12|||
160890707|NCT01343901|580995162|FG000|Overall Study|Management by another medical team|11|||
160890708|NCT01343901|580995162|FG000|Overall Study|Participant decision|1|||
160890709|NCT03945175|580995163|FG000|Overall Study|Did not meet inclusion criteria|31|||
160890710|NCT03945175|580995163|FG000|Overall Study|Withdrew consent|2|||
160890711|NCT03945175|580995163|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
160890712|NCT03945175|580995163|FG000|Overall Study|Early termination during Mydayis treatment|1|||
160890713|NCT00870233|580995167|FG000|Overall Study|Withdrawal by Subject|18|||
160890714|NCT00870233|580995167|FG000|Overall Study|Did not undergo laparotomy|3|||
160890715|NCT00870233|580995167|FG000|Overall Study|Incompatible internet browser|2|||
160890716|NCT00870233|580995167|FG000|Overall Study|Death|1|||
160890717|NCT03370289|580995172|FG000|Overall Study|Screen Failure|1|||
160890718|NCT03370289|580995172|FG000|Overall Study|Sample Size Sufficient|4|||
160890719|NCT05308290|580995189|FG000|Overall Study|Death|1|||
160890720|NCT05308290|580995190|FG001|Overall Study|Death|0|||
160890721|NCT05308290|580995189|FG000|Overall Study|Lost to Follow-up|2|||
160890722|NCT05308290|580995190|FG001|Overall Study|Lost to Follow-up|1|||
160890723|NCT05308290|580995189|FG000|Overall Study|still in study followup|0|||
160890724|NCT05308290|580995190|FG001|Overall Study|still in study followup|1|||
160890725|NCT01285960|580995191|FG000|Overall Study|Withdrawal by Subject|2|||
160890726|NCT01285960|580995191|FG000|Overall Study|Lost to Follow-up|2|||
160890727|NCT01285960|580995191|FG000|Overall Study|2 subjects received less 10 sonications|2|||
160890728|NCT03500679|580995192|FG000|Overall Study|Lost to Follow-up|6|||
160890729|NCT03500679|580995193|FG001|Overall Study|Lost to Follow-up|3|||
160890730|NCT03500679|580995192|FG000|Overall Study|Withdrawal by Subject|3|||
160890731|NCT03500679|580995193|FG001|Overall Study|Withdrawal by Subject|0|||
161127226|NCT00272987|581852619|FG001|Overall Study|Disease progression|1|||
161127227|NCT00272987|581852620|FG002|Overall Study|Disease progression|2|||
160890732|NCT04706416|580995194|FG000|Overall Study|Lost to Follow-up|2|||
160890733|NCT04706416|580995195|FG001|Overall Study|Lost to Follow-up|0|||
160890734|NCT01484054|580995196|FG000|Period 1|Withdrawal by Subject|0|||
160890735|NCT01484054|580995197|FG001|Period 1|Withdrawal by Subject|1|||
160890736|NCT02117427|580995200|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
160890737|NCT02117427|580995201|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
160890738|NCT02117427|580995202|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
160890739|NCT02117427|580995200|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
160890740|NCT02117427|580995201|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
160788007|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
160788008|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
160788009|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
160788010|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
160788011|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
160890741|NCT02117427|580995202|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
160890742|NCT02117427|580995200|FG000|Overall Study|Physician Decision|0|||
160890743|NCT02117427|580995201|FG001|Overall Study|Physician Decision|2|||
160890744|NCT02117427|580995202|FG002|Overall Study|Physician Decision|0|||
160890745|NCT02117427|580995200|FG000|Overall Study|No longer meets inclusion criteria|0|||
160890746|NCT02117427|580995201|FG001|Overall Study|No longer meets inclusion criteria|1|||
160890747|NCT02117427|580995202|FG002|Overall Study|No longer meets inclusion criteria|0|||
160890748|NCT02117427|580995200|FG000|Overall Study|Death|0|||
160890749|NCT02117427|580995201|FG001|Overall Study|Death|1|||
160890750|NCT02117427|580995202|FG002|Overall Study|Death|0|||
160890751|NCT05281601|580995203|FG000|Overall Study|Physician Decision|2|||
160890752|NCT05281601|580995204|FG001|Overall Study|Physician Decision|0|||
160890753|NCT05281601|580995203|FG000|Overall Study|Lost to Follow-up|2|||
160890754|NCT05281601|580995204|FG001|Overall Study|Lost to Follow-up|0|||
160890755|NCT05281601|580995203|FG000|Overall Study|Death|1|||
160890756|NCT05281601|580995204|FG001|Overall Study|Death|0|||
160890757|NCT05281601|580995203|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160890758|NCT05281601|580995204|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160890759|NCT00410202|580995208|FG000|On-Treatment|Continuing treatment|69|||
160890760|NCT00410202|580995209|FG001|On-Treatment|Continuing treatment|71|||
160890761|NCT00410202|580995210|FG002|On-Treatment|Continuing treatment|66|||
160890762|NCT00410202|580995208|FG000|On-Treatment|Adverse Event|1|||
160890763|NCT00410202|580995209|FG001|On-Treatment|Adverse Event|3|||
160890764|NCT00410202|580995210|FG002|On-Treatment|Adverse Event|2|||
160890765|NCT00410202|580995208|FG000|On-Treatment|Death|1|||
160890766|NCT00410202|580995209|FG001|On-Treatment|Death|0|||
160890767|NCT00410202|580995210|FG002|On-Treatment|Death|0|||
160890768|NCT00410202|580995208|FG000|On-Treatment|Lost to Follow-up|1|||
160890769|NCT00410202|580995209|FG001|On-Treatment|Lost to Follow-up|0|||
160890770|NCT00410202|580995210|FG002|On-Treatment|Lost to Follow-up|1|||
160890771|NCT00410202|580995208|FG000|On-Treatment|Lack of Efficacy|1|||
160890772|NCT00410202|580995209|FG001|On-Treatment|Lack of Efficacy|4|||
160890773|NCT00410202|580995210|FG002|On-Treatment|Lack of Efficacy|0|||
160890774|NCT00410202|580995208|FG000|On-Treatment|Withdrawal by Subject|2|||
160890775|NCT00410202|580995209|FG001|On-Treatment|Withdrawal by Subject|1|||
160890776|NCT00410202|580995210|FG002|On-Treatment|Withdrawal by Subject|1|||
160890777|NCT00410202|580995208|FG000|On-Treatment|Other Reason|0|||
160890778|NCT00410202|580995209|FG001|On-Treatment|Other Reason|0|||
160890779|NCT00410202|580995210|FG002|On-Treatment|Other Reason|1|||
160890780|NCT00410202|580995208|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
160788012|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
160788013|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
160788014|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
160788015|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
160788016|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
160788017|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
160788018|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
160788019|NCT01755156|580610778|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
160788020|NCT01755156|580610779|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
160788021|NCT01755156|580610778|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
160788022|NCT01755156|580610779|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
160788023|NCT01755156|580610778|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
160788024|NCT01755156|580610779|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
160788025|NCT01052428|580610782|FG000|Overall Study|Death|1|||
160788026|NCT01052428|580610783|FG001|Overall Study|Death|0|||
160788027|NCT01052428|580610782|FG000|Overall Study|Withdrawal by Subject|0|||
160788028|NCT01052428|580610783|FG001|Overall Study|Withdrawal by Subject|1|||
160788029|NCT00382863|580610784|FG000|Overall Study|Death|9|||
160788030|NCT00382863|580610785|FG001|Overall Study|Death|9|||
160890781|NCT00410202|580995209|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
160890782|NCT00410202|580995210|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
160890783|NCT00410202|580995208|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
160890784|NCT00410202|580995209|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
160890785|NCT00410202|580995210|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
160890786|NCT00410202|580995208|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
160890787|NCT00410202|580995209|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
160890788|NCT00410202|580995210|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
160890789|NCT01178073|580995211|FG000|Overall Study|Adverse Event|34|||
160788031|NCT00382863|580610784|FG000|Overall Study|Lost to Follow-up|1|||
160788032|NCT00382863|580610785|FG001|Overall Study|Lost to Follow-up|2|||
160788033|NCT00382863|580610784|FG000|Overall Study|Withdrawal by Subject|5|||
160890790|NCT01178073|580995212|FG001|Overall Study|Adverse Event|27|||
160890791|NCT01178073|580995213|FG002|Overall Study|Adverse Event|24|||
160890792|NCT01178073|580995211|FG000|Overall Study|Protocol Violation|1|||
160890793|NCT01178073|580995212|FG001|Overall Study|Protocol Violation|1|||
160890794|NCT01178073|580995213|FG002|Overall Study|Protocol Violation|1|||
160890795|NCT01178073|580995211|FG000|Overall Study|Lost to Follow-up|2|||
160890796|NCT01178073|580995212|FG001|Overall Study|Lost to Follow-up|0|||
160890797|NCT01178073|580995213|FG002|Overall Study|Lost to Follow-up|3|||
160890798|NCT01178073|580995211|FG000|Overall Study|Physician Decision|14|||
160890799|NCT01178073|580995212|FG001|Overall Study|Physician Decision|10|||
160890800|NCT01178073|580995213|FG002|Overall Study|Physician Decision|10|||
160890801|NCT01178073|580995211|FG000|Overall Study|Withdrawal by Subject|10|||
160890802|NCT01178073|580995212|FG001|Overall Study|Withdrawal by Subject|6|||
160890803|NCT01178073|580995213|FG002|Overall Study|Withdrawal by Subject|8|||
160890804|NCT01178073|580995211|FG000|Overall Study|Missing Completion Status|1|||
160890805|NCT01178073|580995212|FG001|Overall Study|Missing Completion Status|0|||
160890806|NCT01178073|580995213|FG002|Overall Study|Missing Completion Status|0|||
160890807|NCT01674634|580995216|FG000|Overall Study|Withdrawal by Subject|3|||
160890808|NCT01674634|580995216|FG000|Overall Study|Lost to Follow-up|3|||
160890809|NCT00937391|580995217|FG000|Stage 2|Withdrawal by Subject|1|||
160890810|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
160890811|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
160890812|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
160890813|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
160890814|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
160890815|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
160890816|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
160890817|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
160890818|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
160890819|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
160890820|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
160890821|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
160890822|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
160890823|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
160890824|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
160890825|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
160890826|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
160890827|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
160890828|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
160890829|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
160890830|NCT01226043|580995227|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
160890831|NCT01226043|580995228|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
160890832|NCT01226043|580995229|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
160890833|NCT01226043|580995230|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
160890834|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Adverse Event|0|||
160890835|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Adverse Event|0|||
160890836|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Adverse Event|1|||
160890837|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Adverse Event|1|||
160890838|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
160890839|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
160890840|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
160890841|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
160890842|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
160890843|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
160890844|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
160890845|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
160890846|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
160890847|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
160890848|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
160890849|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
160890850|NCT01226043|580995227|FG000|6-week Re-randomization Phase|Physician Decision|0|||
160890851|NCT01226043|580995228|FG001|6-week Re-randomization Phase|Physician Decision|0|||
161127228|NCT00272987|581852618|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
160890852|NCT01226043|580995229|FG002|6-week Re-randomization Phase|Physician Decision|3|||
160890853|NCT01226043|580995230|FG003|6-week Re-randomization Phase|Physician Decision|2|||
161127229|NCT00272987|581852619|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
160890854|NCT01226043|580995227|FG000|6-week Re-randomization Phase|completed in error|0|||
160890855|NCT01226043|580995228|FG001|6-week Re-randomization Phase|completed in error|0|||
160890856|NCT01226043|580995229|FG002|6-week Re-randomization Phase|completed in error|0|||
161127230|NCT00272987|581852620|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
160890857|NCT01226043|580995230|FG003|6-week Re-randomization Phase|completed in error|1|||
160890858|NCT01226043|580995227|FG000|30-week Observational Phase|Adverse Event|0|||
160890859|NCT01226043|580995228|FG001|30-week Observational Phase|Adverse Event|0|||
160890860|NCT01226043|580995229|FG002|30-week Observational Phase|Adverse Event|1|||
160890861|NCT01226043|580995230|FG003|30-week Observational Phase|Adverse Event|1|||
160890862|NCT01226043|580995227|FG000|30-week Observational Phase|Protocol Violation|0|||
160890863|NCT01226043|580995228|FG001|30-week Observational Phase|Protocol Violation|0|||
160890864|NCT01226043|580995229|FG002|30-week Observational Phase|Protocol Violation|0|||
160890865|NCT01226043|580995230|FG003|30-week Observational Phase|Protocol Violation|1|||
160890866|NCT01226043|580995227|FG000|30-week Observational Phase|Lost to Follow-up|0|||
160890867|NCT01226043|580995228|FG001|30-week Observational Phase|Lost to Follow-up|0|||
160890868|NCT01226043|580995229|FG002|30-week Observational Phase|Lost to Follow-up|2|||
160890869|NCT01226043|580995230|FG003|30-week Observational Phase|Lost to Follow-up|2|||
160890870|NCT01226043|580995227|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
160890871|NCT01226043|580995228|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
160890872|NCT01226043|580995229|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
160890873|NCT01226043|580995230|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
160890874|NCT01226043|580995227|FG000|30-week Observational Phase|Physician Decision|0|||
160890875|NCT01226043|580995228|FG001|30-week Observational Phase|Physician Decision|0|||
160890876|NCT01226043|580995229|FG002|30-week Observational Phase|Physician Decision|2|||
160890877|NCT01226043|580995230|FG003|30-week Observational Phase|Physician Decision|2|||
160890878|NCT00596362|580995241|FG000|Overall Study|Progressive Disease|1|||
160890879|NCT02418156|580995242|FG000|Overall Study|Lost to Follow-up|12|||
160890880|NCT02418156|580995242|FG000|Overall Study|Death|2|||
160890881|NCT02418156|580995242|FG000|Overall Study|Physician Decision|1|||
160890882|NCT02418156|580995242|FG000|Overall Study|Withdrawal by Subject|1|||
160890883|NCT02418156|580995242|FG000|Overall Study|Subject refused to return|1|||
160890884|NCT00323869|580995245|FG000|Overall Study|Death|1|||
160890885|NCT04090957|580995246|FG000|Overall Study|Lost to Follow-up|22|||
160890886|NCT04090957|580995247|FG001|Overall Study|Lost to Follow-up|25|||
160890887|NCT04090957|580995248|FG002|Overall Study|Lost to Follow-up|25|||
160890888|NCT04090957|580995249|FG003|Overall Study|Lost to Follow-up|36|||
160890889|NCT04090957|580995246|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
160890890|NCT04090957|580995247|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
160890891|NCT04090957|580995248|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
160890892|NCT04090957|580995249|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
160890893|NCT04090957|580995246|FG000|Overall Study|Adverse Event|19|||
160890894|NCT04090957|580995247|FG001|Overall Study|Adverse Event|25|||
160890895|NCT04090957|580995248|FG002|Overall Study|Adverse Event|8|||
160890896|NCT04090957|580995249|FG003|Overall Study|Adverse Event|104|||
160890897|NCT04090957|580995246|FG000|Overall Study|Other|10|||
160890898|NCT04090957|580995247|FG001|Overall Study|Other|6|||
160890899|NCT04090957|580995248|FG002|Overall Study|Other|5|||
160890900|NCT04090957|580995249|FG003|Overall Study|Other|12|||
160890901|NCT04090957|580995246|FG000|Overall Study|Serious Adverse Event|7|||
160890902|NCT04090957|580995247|FG001|Overall Study|Serious Adverse Event|11|||
160890903|NCT04090957|580995248|FG002|Overall Study|Serious Adverse Event|1|||
160890904|NCT04090957|580995249|FG003|Overall Study|Serious Adverse Event|32|||
160890905|NCT04090957|580995246|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
160890906|NCT04090957|580995247|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
160890907|NCT04090957|580995248|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
160890908|NCT04090957|580995249|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
160890909|NCT04090957|580995246|FG000|Overall Study|Lack of Efficacy|1|||
160890910|NCT04090957|580995247|FG001|Overall Study|Lack of Efficacy|1|||
160890911|NCT04090957|580995248|FG002|Overall Study|Lack of Efficacy|9|||
160890912|NCT04090957|580995249|FG003|Overall Study|Lack of Efficacy|0|||
160890913|NCT04090957|580995246|FG000|Overall Study|Protocol Violation|3|||
160890914|NCT04090957|580995247|FG001|Overall Study|Protocol Violation|5|||
160890915|NCT04090957|580995248|FG002|Overall Study|Protocol Violation|2|||
160890916|NCT04090957|580995249|FG003|Overall Study|Protocol Violation|1|||
160890917|NCT04090957|580995246|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
160890918|NCT04090957|580995247|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
160890919|NCT04090957|580995248|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
160890920|NCT04090957|580995249|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
160890921|NCT04090957|580995246|FG000|Overall Study|COVID-19|2|||
160890922|NCT04090957|580995247|FG001|Overall Study|COVID-19|2|||
160890923|NCT04090957|580995248|FG002|Overall Study|COVID-19|3|||
160890924|NCT04090957|580995249|FG003|Overall Study|COVID-19|7|||
160890925|NCT04090957|580995246|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
160890926|NCT04090957|580995247|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
160890927|NCT04090957|580995248|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
160890928|NCT04090957|580995249|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
160890929|NCT04090957|580995246|FG000|Overall Study|Physician Decision|2|||
160890930|NCT04090957|580995247|FG001|Overall Study|Physician Decision|1|||
160890931|NCT04090957|580995248|FG002|Overall Study|Physician Decision|1|||
160890932|NCT04090957|580995249|FG003|Overall Study|Physician Decision|5|||
160890933|NCT04090957|580995246|FG000|Overall Study|Sponsor Decision|1|||
160890934|NCT04090957|580995247|FG001|Overall Study|Sponsor Decision|1|||
160890935|NCT04090957|580995248|FG002|Overall Study|Sponsor Decision|1|||
160890936|NCT04090957|580995249|FG003|Overall Study|Sponsor Decision|3|||
160890937|NCT04090957|580995246|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
160890938|NCT04090957|580995247|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
160890939|NCT04090957|580995248|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
160890940|NCT04090957|580995249|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
160890941|NCT04090957|580995246|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
160890942|NCT04090957|580995247|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
160890943|NCT04090957|580995248|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
160890944|NCT04090957|580995249|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
160890945|NCT04090957|580995246|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
160890946|NCT04090957|580995247|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
160890947|NCT04090957|580995248|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
160890948|NCT04090957|580995249|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
160890949|NCT04090957|580995246|FG000|Overall Study|Death|1|||
160890950|NCT04090957|580995247|FG001|Overall Study|Death|0|||
160890951|NCT04090957|580995248|FG002|Overall Study|Death|0|||
160890952|NCT04090957|580995249|FG003|Overall Study|Death|0|||
160890953|NCT04090957|580995246|FG000|Overall Study|No Treatment Administered|2|||
160890954|NCT04090957|580995247|FG001|Overall Study|No Treatment Administered|1|||
160890955|NCT04090957|580995248|FG002|Overall Study|No Treatment Administered|2|||
160788034|NCT00382863|580610785|FG001|Overall Study|Withdrawal by Subject|25|||
160788035|NCT02094885|580610786|FG000|Overall Study|Death|1|||
160788036|NCT02094885|580610787|FG001|Overall Study|Death|5|||
160788037|NCT02094885|580610786|FG000|Overall Study|Withdrawn due to age|1|||
160788038|NCT02094885|580610787|FG001|Overall Study|Withdrawn due to age|0|||
160788039|NCT00159874|580610790|FG000|Overall Study|Adverse Event|2|||
160788040|NCT00159874|580610791|FG001|Overall Study|Adverse Event|2|||
160788041|NCT00159874|580610792|FG002|Overall Study|Adverse Event|5|||
160788042|NCT00159874|580610793|FG003|Overall Study|Adverse Event|1|||
160788043|NCT00159874|580610794|FG004|Overall Study|Adverse Event|1|||
160788044|NCT00159874|580610795|FG005|Overall Study|Adverse Event|2|||
160788045|NCT00159874|580610796|FG006|Overall Study|Adverse Event|0|||
160788046|NCT00159874|580610790|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
160788047|NCT00159874|580610791|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
160788048|NCT00159874|580610792|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
160788049|NCT00159874|580610793|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
160788050|NCT00159874|580610794|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
160788051|NCT00159874|580610795|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
160788052|NCT00159874|580610796|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
160788053|NCT00159874|580610790|FG000|Overall Study|Lack of Efficacy|2|||
160788054|NCT00159874|580610791|FG001|Overall Study|Lack of Efficacy|0|||
160788055|NCT00159874|580610792|FG002|Overall Study|Lack of Efficacy|1|||
160788056|NCT00159874|580610793|FG003|Overall Study|Lack of Efficacy|1|||
160788057|NCT00159874|580610794|FG004|Overall Study|Lack of Efficacy|0|||
160788058|NCT00159874|580610795|FG005|Overall Study|Lack of Efficacy|3|||
160788059|NCT00159874|580610796|FG006|Overall Study|Lack of Efficacy|0|||
160788060|NCT00159874|580610790|FG000|Overall Study|Lost to Follow-up|1|||
160788061|NCT00159874|580610791|FG001|Overall Study|Lost to Follow-up|0|||
160788062|NCT00159874|580610792|FG002|Overall Study|Lost to Follow-up|3|||
160788063|NCT00159874|580610793|FG003|Overall Study|Lost to Follow-up|0|||
160788064|NCT00159874|580610794|FG004|Overall Study|Lost to Follow-up|1|||
160788065|NCT00159874|580610795|FG005|Overall Study|Lost to Follow-up|2|||
160788066|NCT00159874|580610796|FG006|Overall Study|Lost to Follow-up|1|||
160788067|NCT00159874|580610790|FG000|Overall Study|Other|8|||
160788068|NCT00159874|580610791|FG001|Overall Study|Other|8|||
160788069|NCT00159874|580610792|FG002|Overall Study|Other|8|||
160788070|NCT00159874|580610793|FG003|Overall Study|Other|0|||
160788071|NCT00159874|580610794|FG004|Overall Study|Other|2|||
160788072|NCT00159874|580610795|FG005|Overall Study|Other|1|||
160788073|NCT00159874|580610796|FG006|Overall Study|Other|3|||
160788074|NCT00159874|580610790|FG000|Overall Study|Protocol Violation|0|||
160788075|NCT00159874|580610791|FG001|Overall Study|Protocol Violation|5|||
160788076|NCT00159874|580610792|FG002|Overall Study|Protocol Violation|2|||
160788077|NCT00159874|580610793|FG003|Overall Study|Protocol Violation|0|||
160788078|NCT00159874|580610794|FG004|Overall Study|Protocol Violation|0|||
160788079|NCT00159874|580610795|FG005|Overall Study|Protocol Violation|0|||
160788080|NCT00159874|580610796|FG006|Overall Study|Protocol Violation|0|||
160788081|NCT00159874|580610790|FG000|Overall Study|Death|3|||
160788082|NCT00159874|580610791|FG001|Overall Study|Death|8|||
160788083|NCT00159874|580610792|FG002|Overall Study|Death|15|||
160788084|NCT00159874|580610793|FG003|Overall Study|Death|0|||
160890956|NCT04090957|580995249|FG003|Overall Study|No Treatment Administered|1|||
160890957|NCT01909453|580995250|FG000|Overall Study|Ongoing|118|||
160890958|NCT01909453|580995251|FG001|Overall Study|Ongoing|103|||
160890959|NCT01909453|580995252|FG002|Overall Study|Ongoing|83|||
160890960|NCT01909453|580995253|FG003|Overall Study|Ongoing|164|||
160890961|NCT01909453|580995254|FG004|Overall Study|Ongoing|50|||
160890962|NCT01909453|580995250|FG000|Overall Study|Death|69|||
161127231|NCT00272987|581852618|FG000|Overall Study|Death|1|||
161127232|NCT00272987|581852619|FG001|Overall Study|Death|0|||
161127233|NCT00272987|581852620|FG002|Overall Study|Death|0|||
161127234|NCT00331409|581852621|FG000|Overall Study|Lack of Efficacy|4|||
161127235|NCT01482910|581852622|FG000|Overall Study|Adverse Event|6|||
161127236|NCT01482910|581852623|FG001|Overall Study|Adverse Event|5|||
161127237|NCT01482910|581852622|FG000|Overall Study|Lost to Follow-up|0|||
161127238|NCT01482910|581852623|FG001|Overall Study|Lost to Follow-up|1|||
160788085|NCT00159874|580610794|FG004|Overall Study|Death|1|||
160788086|NCT00159874|580610795|FG005|Overall Study|Death|2|||
160788087|NCT00159874|580610796|FG006|Overall Study|Death|0|||
160788088|NCT00159874|580610790|FG000|Overall Study|Withdrawal by Subject|2|||
160788089|NCT00159874|580610791|FG001|Overall Study|Withdrawal by Subject|6|||
160788090|NCT00159874|580610792|FG002|Overall Study|Withdrawal by Subject|8|||
160788091|NCT00159874|580610793|FG003|Overall Study|Withdrawal by Subject|4|||
160788092|NCT00159874|580610794|FG004|Overall Study|Withdrawal by Subject|3|||
160788093|NCT00159874|580610795|FG005|Overall Study|Withdrawal by Subject|2|||
160788094|NCT00159874|580610796|FG006|Overall Study|Withdrawal by Subject|1|||
160788095|NCT00159874|580610790|FG000|Overall Study|Pregnancy|1|||
160788096|NCT00159874|580610791|FG001|Overall Study|Pregnancy|1|||
160788097|NCT00159874|580610792|FG002|Overall Study|Pregnancy|0|||
160788098|NCT00159874|580610793|FG003|Overall Study|Pregnancy|0|||
160788099|NCT00159874|580610794|FG004|Overall Study|Pregnancy|0|||
160788100|NCT00159874|580610795|FG005|Overall Study|Pregnancy|0|||
160788101|NCT00159874|580610796|FG006|Overall Study|Pregnancy|0|||
160788102|NCT02314247|580610799|FG000|Overall Study|Adverse Event|2|||
160788103|NCT02314247|580610800|FG001|Overall Study|Adverse Event|1|||
160788104|NCT02314247|580610801|FG002|Overall Study|Adverse Event|0|||
160788105|NCT02314247|580610799|FG000|Overall Study|Withdrawal by Subject|1|||
160788106|NCT02314247|580610800|FG001|Overall Study|Withdrawal by Subject|3|||
160788107|NCT02314247|580610801|FG002|Overall Study|Withdrawal by Subject|1|||
160788108|NCT02314247|580610799|FG000|Overall Study|Progression of Disease|6|||
160788109|NCT02314247|580610800|FG001|Overall Study|Progression of Disease|2|||
160788110|NCT02314247|580610801|FG002|Overall Study|Progression of Disease|0|||
160788111|NCT00489359|580610809|FG000|Overall Study|Death|0|||
160788112|NCT00489359|580610810|FG001|Overall Study|Death|2|||
160788113|NCT00489359|580610809|FG000|Overall Study|Progressive Disease|5|||
160788114|NCT00489359|580610810|FG001|Overall Study|Progressive Disease|6|||
160788115|NCT00489359|580610809|FG000|Overall Study|Lost to Follow-up|1|||
160788116|NCT00489359|580610810|FG001|Overall Study|Lost to Follow-up|0|||
160788117|NCT00489359|580610809|FG000|Overall Study|Withdrawal by Subject|1|||
160788118|NCT00489359|580610810|FG001|Overall Study|Withdrawal by Subject|5|||
160890963|NCT01909453|580995251|FG001|Overall Study|Death|74|||
160890964|NCT01909453|580995252|FG002|Overall Study|Death|88|||
160890965|NCT01909453|580995253|FG003|Overall Study|Death|86|||
160890966|NCT01909453|580995254|FG004|Overall Study|Death|29|||
160890967|NCT01909453|580995250|FG000|Overall Study|Lost to Follow-up|3|||
160890968|NCT01909453|580995251|FG001|Overall Study|Lost to Follow-up|4|||
160890969|NCT01909453|580995252|FG002|Overall Study|Lost to Follow-up|4|||
160890970|NCT01909453|580995253|FG003|Overall Study|Lost to Follow-up|3|||
160890971|NCT01909453|580995254|FG004|Overall Study|Lost to Follow-up|3|||
160890972|NCT01909453|580995250|FG000|Overall Study|Withdrawal by Subject|2|||
160890973|NCT01909453|580995251|FG001|Overall Study|Withdrawal by Subject|13|||
160890974|NCT01909453|580995252|FG002|Overall Study|Withdrawal by Subject|16|||
160890975|NCT01909453|580995253|FG003|Overall Study|Withdrawal by Subject|5|||
160890976|NCT01909453|580995254|FG004|Overall Study|Withdrawal by Subject|4|||
160890977|NCT02247531|580996792|FG000|Overall Study|Adverse Event|3|||
160890978|NCT02247531|580996793|FG001|Overall Study|Adverse Event|4|||
160890979|NCT02247531|580996794|FG002|Overall Study|Adverse Event|9|||
160890980|NCT02247531|580996792|FG000|Overall Study|Death|8|||
161127239|NCT01482910|581852622|FG000|Overall Study|Protocol Violation|1|||
161127240|NCT01482910|581852623|FG001|Overall Study|Protocol Violation|1|||
161127241|NCT01482910|581852622|FG000|Overall Study|Withdrawal by Subject|7|||
160788119|NCT00489359|580610809|FG000|Overall Study|Adverse Event|0|||
160788120|NCT00489359|580610810|FG001|Overall Study|Adverse Event|16|||
160788121|NCT03180138|580610811|FG000|Overall Study|Mobile-phone could not be verified|2|||
160788122|NCT03180138|580610812|FG001|Overall Study|Mobile-phone could not be verified|13|||
160788123|NCT03180138|580610813|FG002|Overall Study|Mobile-phone could not be verified|15|||
160788124|NCT03180138|580610811|FG000|Overall Study|No prior immunization records|17|||
160890981|NCT02247531|580996793|FG001|Overall Study|Death|9|||
160890982|NCT02247531|580996794|FG002|Overall Study|Death|5|||
160890983|NCT02247531|580996792|FG000|Overall Study|Lost to Follow-up|1|||
160890984|NCT02247531|580996793|FG001|Overall Study|Lost to Follow-up|8|||
160890985|NCT02247531|580996794|FG002|Overall Study|Lost to Follow-up|3|||
160890986|NCT02247531|580996792|FG000|Overall Study|Non-compliance|2|||
160890987|NCT02247531|580996793|FG001|Overall Study|Non-compliance|2|||
160890988|NCT02247531|580996794|FG002|Overall Study|Non-compliance|0|||
160890989|NCT02247531|580996792|FG000|Overall Study|Withdrawal by Subject|26|||
161127242|NCT01482910|581852623|FG001|Overall Study|Withdrawal by Subject|2|||
161127243|NCT01482910|581852622|FG000|Overall Study|Death|1|||
161127244|NCT01482910|581852623|FG001|Overall Study|Death|0|||
161127245|NCT02614079|581852627|FG000|Overall Study|Withdrawal by Subject|1|||
161127246|NCT03739528|581852630|FG000|Overall Study|Not treated|8|||
161127247|NCT03739528|581852631|FG001|Overall Study|Not treated|12|||
161127248|NCT03739528|581852630|FG000|Overall Study|Treatment and study discontinued|6|||
161127249|NCT03739528|581852631|FG001|Overall Study|Treatment and study discontinued|2|||
161127250|NCT03739528|581852630|FG000|Overall Study|Treatment discontinued + study completed|1|||
161127251|NCT03739528|581852631|FG001|Overall Study|Treatment discontinued + study completed|3|||
161127252|NCT01058096|581852632|FG000|Double-blind Treatment Phase|Adverse Event|11|||
161127253|NCT01058096|581852633|FG001|Double-blind Treatment Phase|Adverse Event|15|||
161127254|NCT01058096|581852632|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
161127255|NCT01058096|581852633|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
161127256|NCT01058096|581852632|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
161127257|NCT01058096|581852633|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
161127258|NCT01058096|581852632|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
161127259|NCT01058096|581852633|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
161127260|NCT01058096|581852632|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161127261|NCT01058096|581852633|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161127262|NCT01058096|581852632|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
161127263|NCT01058096|581852633|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
161127264|NCT05655377|581852634|FG000|Overall Study|Withdrawal by Subject|2|||
161127265|NCT04451330|581852635|FG000|Overall Study|Adverse Event|1|||
161127266|NCT04451330|581852636|FG001|Overall Study|Adverse Event|2|||
161127267|NCT04451330|581852635|FG000|Overall Study|Lost to Follow-up|5|||
161127268|NCT04451330|581852636|FG001|Overall Study|Lost to Follow-up|0|||
161127269|NCT04451330|581852635|FG000|Overall Study|Withdrawal by Subject|3|||
161127270|NCT04451330|581852636|FG001|Overall Study|Withdrawal by Subject|1|||
161127271|NCT04451330|581852635|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161127272|NCT04451330|581852636|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161127273|NCT04451330|581852635|FG000|Overall Study|Other than specified|0|||
161127274|NCT04451330|581852636|FG001|Overall Study|Other than specified|1|||
161127275|NCT05099640|581852637|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
161127276|NCT05099640|581852638|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
161127277|NCT05099640|581852639|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
161127278|NCT05099640|581852637|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
161127279|NCT05099640|581852638|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
161127280|NCT05099640|581852639|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
161127281|NCT05099640|581852637|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
161127282|NCT05099640|581852638|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
161127283|NCT05099640|581852639|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
161127284|NCT05099640|581852637|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
161127285|NCT05099640|581852638|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
161127286|NCT05099640|581852639|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
161127287|NCT05099640|581852637|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
161127288|NCT05099640|581852638|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
161127289|NCT05099640|581852639|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
161127290|NCT05099640|581852637|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
161127291|NCT05099640|581852638|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
161127292|NCT05099640|581852639|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
161127293|NCT00179959|581852640|FG000|Overall Study|Lost to Follow-up|3|||
161127294|NCT00179959|581852641|FG001|Overall Study|Lost to Follow-up|1|||
161127295|NCT00179959|581852640|FG000|Overall Study|Withdrawal by Subject|3|||
161127296|NCT00179959|581852641|FG001|Overall Study|Withdrawal by Subject|2|||
161127297|NCT01552681|581852646|FG000|Overall Study|Withdrawal by Subject|4|||
161127298|NCT01552681|581852647|FG001|Overall Study|Withdrawal by Subject|0|||
161127299|NCT01552681|581852646|FG000|Overall Study|Physician Decision|1|||
161127300|NCT01552681|581852647|FG001|Overall Study|Physician Decision|0|||
161127301|NCT01552681|581852646|FG000|Overall Study|Subject moved away|0|||
161127302|NCT01552681|581852647|FG001|Overall Study|Subject moved away|1|||
161127303|NCT03075163|581852648|FG000|Overall Study|not eligible for treatment limb|138|||
161234091|NCT00376623|582240436|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
161257867|NCT01197417|582323505|FG001|Overall Study|Subject transferred to intensive care|1|||
160890990|NCT02247531|580996793|FG001|Overall Study|Withdrawal by Subject|31|||
161127304|NCT03075163|581852649|FG001|Overall Study|not eligible for treatment limb|138|||
161127305|NCT04698525|581852650|FG000|Overall Study|Lost to Follow-up|1|||
161127306|NCT04698525|581852651|FG001|Overall Study|Lost to Follow-up|2|||
160788125|NCT03180138|580610812|FG001|Overall Study|No prior immunization records|0|||
160788126|NCT03180138|580610813|FG002|Overall Study|No prior immunization records|6|||
160788127|NCT03180138|580610811|FG000|Overall Study|Found to be >24 mon after randomization|3|||
160788128|NCT03180138|580610812|FG001|Overall Study|Found to be >24 mon after randomization|0|||
160788129|NCT03180138|580610813|FG002|Overall Study|Found to be >24 mon after randomization|3|||
160788130|NCT01260311|580610816|FG000|Overall Study|Adverse Event|11|||
160788131|NCT01260311|580610816|FG000|Overall Study|Lack of Efficacy|4|||
160788132|NCT01260311|580610816|FG000|Overall Study|Lost to Follow-up|25|||
160788133|NCT01260311|580610816|FG000|Overall Study|Withdrawal by Subject|6|||
160788134|NCT01260311|580610816|FG000|Overall Study|Financial Constraints|77|||
160788135|NCT01260311|580610816|FG000|Overall Study|Gone to Province|2|||
161127307|NCT04698525|581852650|FG000|Overall Study|Three suffered of Covid-19|2|||
161127308|NCT04698525|581852651|FG001|Overall Study|Three suffered of Covid-19|1|||
161127309|NCT01961544|581852652|FG000|Overall Study|Protocol Violation|1|||
161127310|NCT01961544|581852652|FG000|Overall Study|Withdrawal by Subject|7|||
161127311|NCT01961544|581852652|FG000|Overall Study|Adverse Event|1|||
160788136|NCT01260311|580610816|FG000|Overall Study|Medication Stopped|1|||
160788137|NCT01260311|580610816|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
160788138|NCT01340170|580610817|FG000|Overall Study|Lost to Follow-up|2|||
161127312|NCT01961544|581852652|FG000|Overall Study|Physician Decision|2|||
161127313|NCT01961544|581852652|FG000|Overall Study|Poor Tolerance|1|||
161127314|NCT01961544|581852652|FG000|Overall Study|Aggravation of Steral Pain|1|||
161127315|NCT03157531|581852655|FG000|Overall Study|Death|2|||
160788139|NCT01340170|580610818|FG001|Overall Study|Lost to Follow-up|4|||
160788140|NCT01340170|580610819|FG002|Overall Study|Lost to Follow-up|0|||
160788141|NCT01340170|580610817|FG000|Overall Study|Implant failure|1|||
160788142|NCT01340170|580610818|FG001|Overall Study|Implant failure|3|||
160788143|NCT01340170|580610819|FG002|Overall Study|Implant failure|0|||
160788144|NCT03878602|580610820|FG000|Overall Study|cord blood donation|7|||
160788145|NCT03878602|580610821|FG001|Overall Study|cord blood donation|1|||
160788146|NCT03878602|580610820|FG000|Overall Study|incomplete data collection|2|||
160788147|NCT03878602|580610821|FG001|Overall Study|incomplete data collection|0|||
160788148|NCT00736476|580610822|FG000|Overall Study|Adverse Event|1|||
160788149|NCT00736476|580610823|FG001|Overall Study|Adverse Event|0|||
160788150|NCT01796470|580610824|FG000|Overall Study|Adverse Event|4|||
160788151|NCT01796470|580610825|FG001|Overall Study|Adverse Event|2|||
160788152|NCT01796470|580610826|FG002|Overall Study|Adverse Event|2|||
160788153|NCT01796470|580610827|FG003|Overall Study|Adverse Event|1|||
160788154|NCT01796470|580610828|FG004|Overall Study|Adverse Event|3|||
160788155|NCT01796470|580610824|FG000|Overall Study|Death|2|||
160788156|NCT01796470|580610825|FG001|Overall Study|Death|0|||
160788157|NCT01796470|580610826|FG002|Overall Study|Death|0|||
160788158|NCT01796470|580610827|FG003|Overall Study|Death|0|||
160788159|NCT01796470|580610828|FG004|Overall Study|Death|1|||
160788160|NCT01796470|580610824|FG000|Overall Study|Initiated New Therapy|9|||
160788161|NCT01796470|580610825|FG001|Overall Study|Initiated New Therapy|0|||
160788162|NCT01796470|580610826|FG002|Overall Study|Initiated New Therapy|0|||
160788163|NCT01796470|580610827|FG003|Overall Study|Initiated New Therapy|0|||
160788164|NCT01796470|580610828|FG004|Overall Study|Initiated New Therapy|2|||
160788165|NCT01796470|580610824|FG000|Overall Study|Lost to Follow-up|0|||
160788166|NCT01796470|580610825|FG001|Overall Study|Lost to Follow-up|1|||
160788167|NCT01796470|580610826|FG002|Overall Study|Lost to Follow-up|0|||
160788168|NCT01796470|580610827|FG003|Overall Study|Lost to Follow-up|0|||
160788169|NCT01796470|580610828|FG004|Overall Study|Lost to Follow-up|0|||
160788170|NCT01796470|580610824|FG000|Overall Study|Physician Decision|5|||
160788171|NCT01796470|580610825|FG001|Overall Study|Physician Decision|4|||
160788172|NCT01796470|580610826|FG002|Overall Study|Physician Decision|1|||
160788173|NCT01796470|580610827|FG003|Overall Study|Physician Decision|0|||
160788174|NCT01796470|580610828|FG004|Overall Study|Physician Decision|1|||
160788175|NCT01796470|580610824|FG000|Overall Study|Progressive Disease|7|||
160788176|NCT01796470|580610825|FG001|Overall Study|Progressive Disease|7|||
160788177|NCT01796470|580610826|FG002|Overall Study|Progressive Disease|3|||
161127316|NCT03157531|581852655|FG000|Overall Study|Lost to Follow-up|4|||
160788178|NCT01796470|580610827|FG003|Overall Study|Progressive Disease|2|||
160788179|NCT01796470|580610828|FG004|Overall Study|Progressive Disease|0|||
160788180|NCT01796470|580610824|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
160788181|NCT01796470|580610825|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
160788182|NCT01796470|580610826|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
160788183|NCT01796470|580610827|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
160788184|NCT01796470|580610828|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
160788185|NCT01796470|580610824|FG000|Overall Study|Withdrawal by Subject|7|||
161127317|NCT01573910|581852660|FG000|Overall Study|Adverse Event|4|||
161127318|NCT01573910|581852661|FG001|Overall Study|Adverse Event|4|||
160788186|NCT01796470|580610825|FG001|Overall Study|Withdrawal by Subject|0|||
160788187|NCT01796470|580610826|FG002|Overall Study|Withdrawal by Subject|0|||
160788188|NCT01796470|580610827|FG003|Overall Study|Withdrawal by Subject|0|||
160788189|NCT01796470|580610828|FG004|Overall Study|Withdrawal by Subject|1|||
160788190|NCT02633527|580610829|FG000|Overall Study|Failed to meet eligibility|0|||
161234092|NCT00376623|582240437|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
161234093|NCT00376623|582240435|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
161234094|NCT00376623|582240436|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
161234095|NCT00376623|582240437|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
161234096|NCT00376623|582240435|FG000|Overall Study|Increase of tumour markers|0|||
161234097|NCT00376623|582240436|FG001|Overall Study|Increase of tumour markers|1|||
161234098|NCT00376623|582240437|FG002|Overall Study|Increase of tumour markers|0|||
161234099|NCT00376623|582240435|FG000|Overall Study|Bone metastasis|1|||
161234100|NCT00376623|582240436|FG001|Overall Study|Bone metastasis|0|||
161234101|NCT00376623|582240437|FG002|Overall Study|Bone metastasis|0|||
161234102|NCT02331394|582240440|FG000|Overall Study|Disease progression|1|||
161234103|NCT02098876|582240448|FG000|Overall Study|Withdrawal by Subject|5|||
161234104|NCT02098876|582240449|FG001|Overall Study|Withdrawal by Subject|5|||
161234105|NCT03195491|582240450|FG000|Overall Study|Study drug toxicity|25|||
161234106|NCT03195491|582240451|FG001|Overall Study|Study drug toxicity|3|||
161234107|NCT03195491|582240450|FG000|Overall Study|Maximum clinical benefit|5|||
161234108|NCT03195491|582240451|FG001|Overall Study|Maximum clinical benefit|0|||
161234109|NCT03195491|582240450|FG000|Overall Study|Lost to Follow-up|1|||
161234110|NCT03195491|582240451|FG001|Overall Study|Lost to Follow-up|0|||
161234111|NCT03195491|582240450|FG000|Overall Study|Death|3|||
161234112|NCT03195491|582240451|FG001|Overall Study|Death|0|||
161234113|NCT03195491|582240450|FG000|Overall Study|Adverse event unrelated to study drug|19|||
161234114|NCT03195491|582240451|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161234115|NCT03195491|582240450|FG000|Overall Study|Disease progression|266|||
161234116|NCT03195491|582240451|FG001|Overall Study|Disease progression|8|||
161234117|NCT03195491|582240450|FG000|Overall Study|Other reasons|10|||
161234118|NCT03195491|582240451|FG001|Overall Study|Other reasons|0|||
161234119|NCT03195491|582240450|FG000|Overall Study|Participant withdrew consent|8|||
161234120|NCT03195491|582240451|FG001|Overall Study|Participant withdrew consent|1|||
161234121|NCT03195491|582240450|FG000|Overall Study|Participant no longer meets study criteria|0|||
161234122|NCT03195491|582240451|FG001|Overall Study|Participant no longer meets study criteria|1|||
161234123|NCT03195491|582240450|FG000|Overall Study|Participant request to discontinue study treatment|10|||
161234124|NCT03195491|582240451|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161234125|NCT01263704|582240452|FG000|Overall Study|Progressive disease|18|||
161234126|NCT01263704|582240452|FG000|Overall Study|Adverse Event|3|||
161234127|NCT01263704|582240452|FG000|Overall Study|Death|2|||
161234128|NCT01263704|582240452|FG000|Overall Study|Patient withdrew consent|2|||
161234129|NCT01263704|582240452|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161234130|NCT01263704|582240452|FG000|Overall Study|Lost to Follow-up|1|||
161234131|NCT01263704|582240452|FG000|Overall Study|Colon metastases|1|||
161234132|NCT01263704|582240452|FG000|Overall Study|Principal Investigator (PI) decision|1|||
161234133|NCT02459951|582240453|FG000|Overall Study|Unable to meet holding requirement|1|||
161234134|NCT00102440|582240454|FG000|Overall Study|Lost to Follow-up|25|||
161234135|NCT00102440|582240455|FG001|Overall Study|Lost to Follow-up|18|||
161234136|NCT00102440|582240456|FG002|Overall Study|Lost to Follow-up|21|||
161234137|NCT00102440|582240454|FG000|Overall Study|Adverse Event|16|||
161234138|NCT00102440|582240455|FG001|Overall Study|Adverse Event|23|||
161234139|NCT00102440|582240456|FG002|Overall Study|Adverse Event|8|||
161234140|NCT00102440|582240454|FG000|Overall Study|Gout Flare|10|||
161234141|NCT00102440|582240455|FG001|Overall Study|Gout Flare|28|||
161234142|NCT00102440|582240456|FG002|Overall Study|Gout Flare|9|||
161234143|NCT00102440|582240454|FG000|Overall Study|Personal Reason(s)|19|||
161234144|NCT00102440|582240455|FG001|Overall Study|Personal Reason(s)|13|||
161234145|NCT00102440|582240456|FG002|Overall Study|Personal Reason(s)|13|||
161234146|NCT00102440|582240454|FG000|Overall Study|Other|11|||
161234147|NCT00102440|582240455|FG001|Overall Study|Other|14|||
161234148|NCT00102440|582240456|FG002|Overall Study|Other|14|||
161234149|NCT00102440|582240454|FG000|Overall Study|Protocol Violation|7|||
161234150|NCT00102440|582240455|FG001|Overall Study|Protocol Violation|2|||
161234151|NCT00102440|582240456|FG002|Overall Study|Protocol Violation|1|||
161234152|NCT02255097|582240458|FG000|Overall Study|Death|151|||
161234153|NCT02255097|582240458|FG000|Overall Study|Lost to Follow-up|5|||
161234154|NCT02255097|582240458|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
161234155|NCT02255097|582240458|FG000|Overall Study|Withdrawal by Subject|7|||
161234156|NCT02255097|582240458|FG000|Overall Study|Allocated but not treated|1|||
160890991|NCT02247531|580996794|FG002|Overall Study|Withdrawal by Subject|25|||
161234157|NCT04239872|582240459|FG000|Overall Study|Lost to Follow-up|0|||
161234158|NCT04239872|582240460|FG001|Overall Study|Lost to Follow-up|1|||
161234159|NCT01792635|582240463|FG000|Part B|Adverse Event|0|||
161234160|NCT01792635|582240464|FG001|Part B|Adverse Event|0|||
161234161|NCT01792635|582240465|FG002|Part B|Adverse Event|1|||
161234162|NCT01792635|582240463|FG000|Part B|Study terminated|0|||
161234163|NCT01792635|582240464|FG001|Part B|Study terminated|4|||
161234164|NCT01792635|582240465|FG002|Part B|Study terminated|3|||
161234165|NCT01010542|582240466|FG000|Overall Study|Adverse Event|0|||
161234166|NCT01010542|582240467|FG001|Overall Study|Adverse Event|1|||
161234167|NCT01010542|582240468|FG002|Overall Study|Adverse Event|0|||
160788191|NCT02633527|580610830|FG001|Overall Study|Failed to meet eligibility|1|||
160788192|NCT02633527|580610831|FG002|Overall Study|Failed to meet eligibility|1|||
160788193|NCT02633527|580610832|FG003|Overall Study|Failed to meet eligibility|0|||
160788194|NCT02633527|580610833|FG004|Overall Study|Failed to meet eligibility|1|||
160788195|NCT02633527|580610829|FG000|Overall Study|Adverse Event|0|||
160788196|NCT02633527|580610830|FG001|Overall Study|Adverse Event|4|||
160788197|NCT02633527|580610831|FG002|Overall Study|Adverse Event|3|||
160788198|NCT02633527|580610832|FG003|Overall Study|Adverse Event|1|||
160788199|NCT02633527|580610833|FG004|Overall Study|Adverse Event|5|||
160788200|NCT02633527|580610829|FG000|Overall Study|Lost to Follow-up|1|||
160788201|NCT02633527|580610830|FG001|Overall Study|Lost to Follow-up|2|||
160788202|NCT02633527|580610831|FG002|Overall Study|Lost to Follow-up|5|||
160788203|NCT02633527|580610832|FG003|Overall Study|Lost to Follow-up|5|||
160788204|NCT02633527|580610833|FG004|Overall Study|Lost to Follow-up|4|||
160788205|NCT02633527|580610829|FG000|Overall Study|Withdrawal by Subject|0|||
160788206|NCT02633527|580610830|FG001|Overall Study|Withdrawal by Subject|3|||
160788207|NCT02633527|580610831|FG002|Overall Study|Withdrawal by Subject|5|||
161234168|NCT01010542|582240466|FG000|Overall Study|Lost to Follow-up|0|||
161234169|NCT01010542|582240467|FG001|Overall Study|Lost to Follow-up|1|||
161234170|NCT01010542|582240468|FG002|Overall Study|Lost to Follow-up|0|||
161234171|NCT01010542|582240466|FG000|Overall Study|Withdrawal by Subject|0|||
160788208|NCT02633527|580610832|FG003|Overall Study|Withdrawal by Subject|4|||
160788209|NCT02633527|580610833|FG004|Overall Study|Withdrawal by Subject|4|||
160788210|NCT02633527|580610829|FG000|Overall Study|Protocol Violation|0|||
160788211|NCT02633527|580610830|FG001|Overall Study|Protocol Violation|1|||
160788212|NCT02633527|580610831|FG002|Overall Study|Protocol Violation|1|||
160788213|NCT02633527|580610832|FG003|Overall Study|Protocol Violation|1|||
160788214|NCT02633527|580610833|FG004|Overall Study|Protocol Violation|1|||
160788215|NCT02633527|580610829|FG000|Overall Study|Physician Decision|0|||
160788216|NCT02633527|580610830|FG001|Overall Study|Physician Decision|0|||
160788217|NCT02633527|580610831|FG002|Overall Study|Physician Decision|0|||
160788218|NCT02633527|580610832|FG003|Overall Study|Physician Decision|0|||
160788219|NCT02633527|580610833|FG004|Overall Study|Physician Decision|1|||
160788220|NCT02633527|580610829|FG000|Overall Study|Administrative reason|1|||
160788221|NCT02633527|580610830|FG001|Overall Study|Administrative reason|0|||
160788222|NCT02633527|580610831|FG002|Overall Study|Administrative reason|0|||
160788223|NCT02633527|580610832|FG003|Overall Study|Administrative reason|1|||
160788224|NCT02633527|580610833|FG004|Overall Study|Administrative reason|0|||
160788225|NCT02633527|580610829|FG000|Overall Study|Multiple reasons|1|||
160788226|NCT02633527|580610830|FG001|Overall Study|Multiple reasons|0|||
160788227|NCT02633527|580610831|FG002|Overall Study|Multiple reasons|2|||
160788228|NCT02633527|580610832|FG003|Overall Study|Multiple reasons|2|||
160788229|NCT02633527|580610833|FG004|Overall Study|Multiple reasons|1|||
160788230|NCT06091956|580610834|FG000|Overall Study|Withdrawal by Subject|1|||
160788231|NCT06091956|580610834|FG000|Overall Study|Complicating Disease|1|||
160788232|NCT02176525|580610837|FG000|Overall Study|Adverse Event|0|||
160788233|NCT02176525|580610838|FG001|Overall Study|Adverse Event|0|||
160788234|NCT02176525|580610839|FG002|Overall Study|Adverse Event|0|||
160788235|NCT02176525|580610840|FG003|Overall Study|Adverse Event|1|||
160788236|NCT02176525|580610841|FG004|Overall Study|Adverse Event|1|||
160788237|NCT02176525|580610842|FG005|Overall Study|Adverse Event|0|||
160788238|NCT02176525|580610843|FG006|Overall Study|Adverse Event|1|||
160788239|NCT02176525|580610844|FG007|Overall Study|Adverse Event|0|||
160788240|NCT02176525|580610837|FG000|Overall Study|not treated|1|||
160788241|NCT02176525|580610838|FG001|Overall Study|not treated|0|||
160788242|NCT02176525|580610839|FG002|Overall Study|not treated|0|||
160788243|NCT02176525|580610840|FG003|Overall Study|not treated|0|||
160788244|NCT02176525|580610841|FG004|Overall Study|not treated|0|||
160788245|NCT02176525|580610842|FG005|Overall Study|not treated|1|||
160788246|NCT02176525|580610843|FG006|Overall Study|not treated|0|||
160788247|NCT02176525|580610844|FG007|Overall Study|not treated|0|||
160788248|NCT02100644|580610847|FG000|LTG Escalation Phase|Adverse Event|9|||
160788249|NCT02100644|580610848|FG001|LTG Escalation Phase|Adverse Event|0|||
160788250|NCT02100644|580610849|FG002|LTG Escalation Phase|Adverse Event|0|||
160788251|NCT02100644|580610847|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
160788252|NCT02100644|580610848|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
160788253|NCT02100644|580610849|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
160788254|NCT02100644|580610847|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
160788255|NCT02100644|580610848|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
160788256|NCT02100644|580610849|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
160788257|NCT00478140|580610850|FG000|Overall Study|Clinical Disease Progression|1|||
160788258|NCT05652140|580610855|FG000|Overall Study|Lost to Follow-up|7|||
160788259|NCT05652140|580610856|FG001|Overall Study|Lost to Follow-up|16|||
160788260|NCT05652140|580610857|FG002|Overall Study|Lost to Follow-up|22|||
160788261|NCT05652140|580610858|FG003|Overall Study|Lost to Follow-up|31|||
160788262|NCT06048705|580610863|FG000|Overall Study|Physician Decision|1|||
160788263|NCT06048705|580610864|FG001|Overall Study|Physician Decision|0|||
160788264|NCT06048705|580610865|FG002|Overall Study|Physician Decision|0|||
161234172|NCT01010542|582240467|FG001|Overall Study|Withdrawal by Subject|3|||
160788265|NCT06048705|580610863|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
160788266|NCT06048705|580610864|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
160788267|NCT06048705|580610865|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
160788268|NCT06048705|580610863|FG000|Overall Study|Death prior to lymphodepletion|0|||
160788269|NCT06048705|580610864|FG001|Overall Study|Death prior to lymphodepletion|0|||
161234173|NCT01010542|582240468|FG002|Overall Study|Withdrawal by Subject|2|||
161234174|NCT03956862|582240471|FG000|Overall Study|Lost to Follow-up|1|||
160788270|NCT06048705|580610865|FG002|Overall Study|Death prior to lymphodepletion|1|||
160788271|NCT02614066|580610866|FG000|Overall Study|Death|6|||
161234175|NCT03956862|582240472|FG001|Overall Study|Lost to Follow-up|1|||
161234176|NCT03956862|582240471|FG000|Overall Study|Withdrawal by Subject|1|||
161234177|NCT03956862|582240472|FG001|Overall Study|Withdrawal by Subject|1|||
161234178|NCT01498120|582240473|FG000|Overall Study|Lost to Follow-up|1|||
161234179|NCT01498120|582240473|FG000|Overall Study|Withdrawal by Subject|5|||
161234180|NCT01498120|582240473|FG000|Overall Study|AE, non-serious non-fatal|3|||
161234181|NCT01498120|582240473|FG000|Overall Study|Other|4|||
161234182|NCT02294604|582240474|FG000|Overall Study|Did not provide samples for culture|0|||
161234183|NCT02294604|582240475|FG001|Overall Study|Did not provide samples for culture|1|||
161234184|NCT02294604|582240476|FG002|Overall Study|Did not provide samples for culture|0|||
161234185|NCT02294604|582240474|FG000|Overall Study|Culture contamination|1|||
161234186|NCT02294604|582240475|FG001|Overall Study|Culture contamination|2|||
161234187|NCT02294604|582240476|FG002|Overall Study|Culture contamination|0|||
161234188|NCT01118312|582240479|FG000|Overall Study|Lost to Follow-up|33|||
161234189|NCT01118312|582240480|FG001|Overall Study|Lost to Follow-up|32|||
161234190|NCT01118312|582240479|FG000|Overall Study|Withdrawal by Subject|1|||
161234191|NCT01118312|582240480|FG001|Overall Study|Withdrawal by Subject|3|||
161234192|NCT03965091|582240481|FG000|Overall Study|Adverse Event|0|||
161234193|NCT03965091|582240482|FG001|Overall Study|Adverse Event|2|||
161234194|NCT03965091|582240483|FG002|Overall Study|Adverse Event|3|||
161234195|NCT03965091|582240481|FG000|Overall Study|Withdrawal by Subject|11|||
161234196|NCT03965091|582240482|FG001|Overall Study|Withdrawal by Subject|3|||
161234197|NCT03965091|582240483|FG002|Overall Study|Withdrawal by Subject|5|||
161234198|NCT03965091|582240481|FG000|Overall Study|Non-compliance with study drug|0|||
161234199|NCT03965091|582240482|FG001|Overall Study|Non-compliance with study drug|0|||
161234200|NCT03965091|582240483|FG002|Overall Study|Non-compliance with study drug|1|||
161234201|NCT03965091|582240481|FG000|Overall Study|Lost to Follow-up|1|||
161234202|NCT03965091|582240482|FG001|Overall Study|Lost to Follow-up|1|||
161234203|NCT03965091|582240483|FG002|Overall Study|Lost to Follow-up|1|||
161234204|NCT03965091|582240481|FG000|Overall Study|Lack of Efficacy|2|||
161234205|NCT03965091|582240482|FG001|Overall Study|Lack of Efficacy|0|||
161234206|NCT03965091|582240483|FG002|Overall Study|Lack of Efficacy|0|||
161234207|NCT03965091|582240481|FG000|Overall Study|Other than specified|9|||
161234208|NCT03965091|582240482|FG001|Overall Study|Other than specified|11|||
161234209|NCT03965091|582240483|FG002|Overall Study|Other than specified|8|||
161234210|NCT04060147|582240485|FG000|Overall Study|Withdrew consent|1|||
161234211|NCT01534520|582240486|FG000|Overall Study|Adverse Event|0|||
161234212|NCT01534520|582240487|FG001|Overall Study|Adverse Event|1|||
161234213|NCT03204539|582240490|FG000|Overall Study|Loss of funding|0|||
161234214|NCT03204539|582240491|FG001|Overall Study|Loss of funding|1|||
161234215|NCT00550537|582240494|FG000|Overall Study|Death|18|||
161234216|NCT00550537|582240494|FG000|Overall Study|Adverse Event|20|||
161234217|NCT00550537|582240494|FG000|Overall Study|Disease progression before|46|||
161234218|NCT00550537|582240494|FG000|Overall Study|Withdrawal by Subject|7|||
161234219|NCT00550537|582240494|FG000|Overall Study|Change in treatment plan|4|||
160788272|NCT02614066|580610867|FG001|Overall Study|Death|14|||
160788273|NCT02614066|580610868|FG002|Overall Study|Death|11|||
160788274|NCT02614066|580610869|FG003|Overall Study|Death|29|||
160788275|NCT02614066|580610866|FG000|Overall Study|Full consent withdrawn|0|||
160788276|NCT02614066|580610867|FG001|Overall Study|Full consent withdrawn|1|||
160788277|NCT02614066|580610868|FG002|Overall Study|Full consent withdrawn|0|||
161234220|NCT00550537|582240494|FG000|Overall Study|Other complicating ilness|3|||
161234221|NCT00550537|582240494|FG000|Overall Study|Declining performance status|2|||
161234222|NCT00550537|582240494|FG000|Overall Study|Treated closer to home|4|||
161234223|NCT02008565|582240495|FG000|Overall Study|Protocol Violation|1|||
161234224|NCT02008565|582240496|FG001|Overall Study|Protocol Violation|1|||
161234225|NCT02008565|582240497|FG002|Overall Study|Protocol Violation|2|||
160788278|NCT02614066|580610869|FG003|Overall Study|Full consent withdrawn|8|||
160788279|NCT02614066|580610866|FG000|Overall Study|Lost to Follow-up|0|||
160788280|NCT02614066|580610867|FG001|Overall Study|Lost to Follow-up|2|||
161234226|NCT02008565|582240498|FG003|Overall Study|Protocol Violation|0|||
161234227|NCT00617305|582240499|FG000|Overall Study|Adverse Event|4|||
161234228|NCT00617305|582240500|FG001|Overall Study|Adverse Event|0|||
161234229|NCT00617305|582240501|FG002|Overall Study|Adverse Event|0|||
161234230|NCT00617305|582240499|FG000|Overall Study|Death|1|||
161234231|NCT00617305|582240500|FG001|Overall Study|Death|0|||
161234232|NCT00617305|582240501|FG002|Overall Study|Death|0|||
161234233|NCT00617305|582240499|FG000|Overall Study|Physician Decision|1|||
161234234|NCT00617305|582240500|FG001|Overall Study|Physician Decision|0|||
160788281|NCT02614066|580610868|FG002|Overall Study|Lost to Follow-up|2|||
160788282|NCT02614066|580610869|FG003|Overall Study|Lost to Follow-up|2|||
160788283|NCT02614066|580610866|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
160788284|NCT02614066|580610867|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
160788285|NCT02614066|580610868|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
160788286|NCT02614066|580610869|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
160788287|NCT02614066|580610866|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
160788288|NCT02614066|580610867|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
160788289|NCT02614066|580610868|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
160788290|NCT02614066|580610869|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
160788291|NCT02614066|580610866|FG000|Overall Study|Reason not specified|0|||
160788292|NCT02614066|580610867|FG001|Overall Study|Reason not specified|2|||
160788293|NCT02614066|580610868|FG002|Overall Study|Reason not specified|1|||
161127319|NCT01573910|581852660|FG000|Overall Study|Lost to Follow-up|2|||
161127320|NCT01573910|581852661|FG001|Overall Study|Lost to Follow-up|1|||
161127321|NCT01573910|581852660|FG000|Overall Study|Withdrawal by Subject|0|||
161127322|NCT01573910|581852661|FG001|Overall Study|Withdrawal by Subject|1|||
161127323|NCT01573910|581852660|FG000|Overall Study|Protocol Violation|3|||
161127324|NCT01573910|581852661|FG001|Overall Study|Protocol Violation|0|||
161127325|NCT01573910|581852660|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
161127326|NCT01573910|581852661|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
161127327|NCT02251912|581852662|FG000|Overall Study|Withdrawal by Subject|2|||
161127328|NCT02251912|581852663|FG001|Overall Study|Withdrawal by Subject|3|||
161127329|NCT02251912|581852662|FG000|Overall Study|Adverse Event|0|||
161127330|NCT02251912|581852663|FG001|Overall Study|Adverse Event|2|||
161127331|NCT04062214|581852665|FG000|Week 12|Death|1|||
161127332|NCT04062214|581852666|FG001|Week 12|Death|1|||
161127333|NCT04062214|581852665|FG000|Week 12|Withdrawal by Subject|14|||
161127334|NCT04062214|581852666|FG001|Week 12|Withdrawal by Subject|13|||
161127335|NCT04062214|581852665|FG000|Week 12|Lost to Follow-up|55|||
161127336|NCT04062214|581852666|FG001|Week 12|Lost to Follow-up|68|||
161127337|NCT04062214|581852665|FG000|Week 12|Intermittent missing|31|||
161127338|NCT04062214|581852666|FG001|Week 12|Intermittent missing|29|||
161127339|NCT04062214|581852665|FG000|Week 36|Withdrawal by Subject|4|||
161127340|NCT04062214|581852666|FG001|Week 36|Withdrawal by Subject|5|||
161127341|NCT04062214|581852665|FG000|Week 36|Lost to Follow-up|50|||
161127342|NCT04062214|581852666|FG001|Week 36|Lost to Follow-up|46|||
161127343|NCT04062214|581852665|FG000|Week 36|Death|0|||
161127344|NCT04062214|581852666|FG001|Week 36|Death|1|||
161127345|NCT01793792|581855096|FG000|Overall Study|Death|5|||
161127346|NCT01793792|581855096|FG000|Overall Study|Lost to Follow-up|5|||
161127347|NCT01793792|581855096|FG000|Overall Study|Withdrawal by Subject|1|||
161127348|NCT01793792|581855096|FG000|Overall Study|Device Not Implanted|1|||
161127349|NCT00851903|581855097|FG000|Overall Study|Withdrawal by Subject|2|||
161127350|NCT00686127|581855098|FG000|Overall Study|Withdrawal by Subject|14|||
161127351|NCT00686127|581855099|FG001|Overall Study|Withdrawal by Subject|6|||
161127352|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
161127353|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
161127354|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
161127355|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
161127356|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
161127357|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
161127358|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
161127359|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
161127360|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161127361|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161127362|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161127363|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
161127364|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
161127365|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161127366|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161127367|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
161127368|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
161127369|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
161127370|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161127371|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161127372|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
161127373|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161127374|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161234235|NCT00617305|582240501|FG002|Overall Study|Physician Decision|0|||
161234236|NCT00617305|582240499|FG000|Overall Study|Protocol Violation|1|||
161234237|NCT00617305|582240500|FG001|Overall Study|Protocol Violation|0|||
161234238|NCT00617305|582240501|FG002|Overall Study|Protocol Violation|1|||
161234239|NCT00617305|582240499|FG000|Overall Study|Withdrawal by Subject|1|||
161234240|NCT00617305|582240500|FG001|Overall Study|Withdrawal by Subject|0|||
161234241|NCT00617305|582240501|FG002|Overall Study|Withdrawal by Subject|0|||
161234242|NCT00537979|582240503|FG000|Overall Study|Adverse Event|2|||
161234243|NCT00537979|582240504|FG001|Overall Study|Adverse Event|2|||
161234244|NCT00537979|582240503|FG000|Overall Study|Withdrawal by Subject|1|||
161234245|NCT00537979|582240504|FG001|Overall Study|Withdrawal by Subject|4|||
161234246|NCT00537979|582240503|FG000|Overall Study|Lost to Follow-up|1|||
161234247|NCT00537979|582240504|FG001|Overall Study|Lost to Follow-up|4|||
161234248|NCT00537979|582240503|FG000|Overall Study|Lack of Efficacy|0|||
161234249|NCT00537979|582240504|FG001|Overall Study|Lack of Efficacy|1|||
161234250|NCT00537979|582240503|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
161234251|NCT00537979|582240504|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
161234252|NCT00537979|582240503|FG000|Overall Study|Death|0|||
161234253|NCT00537979|582240504|FG001|Overall Study|Death|3|||
161234254|NCT00537979|582240503|FG000|Overall Study|Kidney transplant|0|||
161234255|NCT00537979|582240504|FG001|Overall Study|Kidney transplant|3|||
161234256|NCT00537979|582240503|FG000|Overall Study|Heart failure|0|||
161234257|NCT00537979|582240504|FG001|Overall Study|Heart failure|1|||
161234258|NCT04384978|582240508|FG000|Overall Study|Withdrawal by Subject|4|||
161234259|NCT04384978|582240509|FG001|Overall Study|Withdrawal by Subject|0|||
161234260|NCT00385593|582240510|FG000|Overall Study|Adverse Event|3|||
161234261|NCT00385593|582240511|FG001|Overall Study|Adverse Event|2|||
161234262|NCT00385593|582240510|FG000|Overall Study|Withdrawal by Subject|17|||
161234263|NCT00385593|582240511|FG001|Overall Study|Withdrawal by Subject|7|||
161234264|NCT00385593|582240510|FG000|Overall Study|Lost to Follow-up|12|||
161234265|NCT00385593|582240511|FG001|Overall Study|Lost to Follow-up|8|||
161234266|NCT00385593|582240510|FG000|Overall Study|Protocol Violation|7|||
161234267|NCT00385593|582240511|FG001|Overall Study|Protocol Violation|4|||
161234268|NCT00385593|582240510|FG000|Overall Study|Several reasons|17|||
161234269|NCT00385593|582240511|FG001|Overall Study|Several reasons|15|||
161234270|NCT00385593|582240510|FG000|Overall Study|Incorrect inclusion|2|||
161234271|NCT00385593|582240511|FG001|Overall Study|Incorrect inclusion|0|||
161234272|NCT00385593|582240510|FG000|Overall Study|Incorrect randomization|0|||
161234273|NCT00385593|582240511|FG001|Overall Study|Incorrect randomization|1|||
161234274|NCT01223365|582240532|FG000|Open-label Titration Period|Enrolled but not treated|1|||
161234275|NCT01223365|582240532|FG000|Open-label Titration Period|Adverse Event|23|||
161234276|NCT01223365|582240532|FG000|Open-label Titration Period|Lack of Efficacy|3|||
161234277|NCT01223365|582240532|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
161234278|NCT01223365|582240532|FG000|Open-label Titration Period|Protocol Violation|1|||
161234279|NCT01223365|582240532|FG000|Open-label Titration Period|Lost to Follow-up|2|||
161234280|NCT01223365|582240532|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
161234281|NCT01223365|582240532|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
161234282|NCT01223365|582240532|FG000|Open-label Titration Period|Starting physical therapy|1|||
161234283|NCT01223365|582240532|FG000|Open-label Treatment Period|Adverse Event|39|||
161234284|NCT01223365|582240532|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
161234285|NCT01223365|582240532|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
160788294|NCT02614066|580610869|FG003|Overall Study|Reason not specified|1|||
160788295|NCT04565756|580610870|FG000|Overall Study|Withdrawal by Subject|0|||
160788296|NCT04565756|580610871|FG001|Overall Study|Withdrawal by Subject|0|||
160788297|NCT04565756|580610872|FG002|Overall Study|Withdrawal by Subject|0|||
160788298|NCT04565756|580610873|FG003|Overall Study|Withdrawal by Subject|0|||
160788299|NCT04565756|580610874|FG004|Overall Study|Withdrawal by Subject|1|||
160788300|NCT04565756|580610875|FG005|Overall Study|Withdrawal by Subject|0|||
160788301|NCT04565756|580610870|FG000|Overall Study|Protocol Violation|0|||
160788302|NCT04565756|580610871|FG001|Overall Study|Protocol Violation|0|||
160788303|NCT04565756|580610872|FG002|Overall Study|Protocol Violation|0|||
160788304|NCT04565756|580610873|FG003|Overall Study|Protocol Violation|0|||
160788305|NCT04565756|580610874|FG004|Overall Study|Protocol Violation|0|||
161234286|NCT01223365|582240532|FG000|Open-label Treatment Period|Protocol Violation|15|||
160788306|NCT04565756|580610875|FG005|Overall Study|Protocol Violation|1|||
160788307|NCT00968968|580610880|FG000|Overall Study|Study closed/terminated|10|||
160788308|NCT00968968|580610881|FG001|Overall Study|Study closed/terminated|10|||
160788309|NCT00968968|580610880|FG000|Overall Study|Protocol defined stopping criteria|3|||
161234287|NCT01223365|582240532|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
161234288|NCT01223365|582240532|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
161234289|NCT01223365|582240532|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
161234290|NCT01223365|582240532|FG000|Open-label Treatment Period|Moved out of area|2|||
161234291|NCT01223365|582240532|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
161234292|NCT01223365|582240532|FG000|Open-label Treatment Period|"Out of window"|1|||
161234293|NCT01223365|582240532|FG000|Open-label Treatment Period|Starting physical therapy|1|||
161234294|NCT01223365|582240532|FG000|Open-label Treatment Period|Physician Decision|2|||
161234295|NCT03041025|582240533|FG000|Overall Study|Adverse Event|0|||
161234296|NCT03041025|582240534|FG001|Overall Study|Adverse Event|0|||
161234297|NCT03041025|582240535|FG002|Overall Study|Adverse Event|1|||
161234298|NCT03041025|582240533|FG000|Overall Study|Lost to Follow-up|1|||
161234299|NCT03041025|582240534|FG001|Overall Study|Lost to Follow-up|0|||
161234300|NCT03041025|582240535|FG002|Overall Study|Lost to Follow-up|0|||
161234301|NCT03041025|582240533|FG000|Overall Study|Withdrawal by Subject|0|||
161234302|NCT03041025|582240534|FG001|Overall Study|Withdrawal by Subject|0|||
161234303|NCT03041025|582240535|FG002|Overall Study|Withdrawal by Subject|1|||
161234304|NCT02963259|582240536|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
161234305|NCT02963259|582240536|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
161234306|NCT02963259|582240536|FG000|Overall Study|Death|1|||
161234307|NCT02963259|582240536|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
161234308|NCT02131129|582240537|FG000|Overall Study|Withdrawal by Subject|1|||
161234309|NCT02131129|582240538|FG001|Overall Study|Withdrawal by Subject|0|||
161234310|NCT03880266|582240539|FG000|Overall Study|Withdrawal by Subject|0|||
161234311|NCT03880266|582240540|FG001|Overall Study|Withdrawal by Subject|1|||
161234312|NCT03880266|582240541|FG002|Overall Study|Withdrawal by Subject|1|||
161234313|NCT03880266|582240542|FG003|Overall Study|Withdrawal by Subject|0|||
161234314|NCT03880266|582240543|FG004|Overall Study|Withdrawal by Subject|0|||
161234315|NCT03880266|582240544|FG005|Overall Study|Withdrawal by Subject|0|||
161234316|NCT03880266|582240545|FG006|Overall Study|Withdrawal by Subject|0|||
161234317|NCT03880266|582240546|FG007|Overall Study|Withdrawal by Subject|0|||
161234318|NCT03235739|582241816|FG000|Overall Study|Withdrawal by Subject|2|||
161234319|NCT03235739|582241817|FG001|Overall Study|Withdrawal by Subject|2|||
161234320|NCT03235739|582241816|FG000|Overall Study|Physician Decision|0|||
161234321|NCT03235739|582241817|FG001|Overall Study|Physician Decision|1|||
161234322|NCT01511939|582241822|FG000|Overall Study|Withdrawal by Subject|2|||
161234323|NCT01511939|582241823|FG001|Overall Study|Withdrawal by Subject|1|||
161234324|NCT01511939|582241824|FG002|Overall Study|Withdrawal by Subject|0|||
161234325|NCT01993030|582241830|FG000|Overall Study|Adverse Event|0|||
161234326|NCT01993030|582241831|FG001|Overall Study|Adverse Event|4|||
161234327|NCT02883452|582241832|FG000|Overall Study|Withdrawal by Subject|1|||
161234328|NCT02883452|582241833|FG001|Overall Study|Withdrawal by Subject|1|||
161234329|NCT02883452|582241834|FG002|Overall Study|Withdrawal by Subject|3|||
161234330|NCT02883452|582241835|FG003|Overall Study|Withdrawal by Subject|0|||
161234331|NCT02883452|582241836|FG004|Overall Study|Withdrawal by Subject|2|||
161234332|NCT02883452|582241837|FG005|Overall Study|Withdrawal by Subject|5|||
161234333|NCT02883452|582241832|FG000|Overall Study|Disease progression|1|||
161234334|NCT02883452|582241833|FG001|Overall Study|Disease progression|0|||
161234335|NCT02883452|582241834|FG002|Overall Study|Disease progression|0|||
161234336|NCT02883452|582241835|FG003|Overall Study|Disease progression|1|||
161234337|NCT02883452|582241836|FG004|Overall Study|Disease progression|4|||
161234338|NCT02883452|582241837|FG005|Overall Study|Disease progression|5|||
160788310|NCT00968968|580610881|FG001|Overall Study|Protocol defined stopping criteria|1|||
160788311|NCT00968968|580610880|FG000|Overall Study|Withdrawal by Subject|2|||
160788312|NCT00968968|580610881|FG001|Overall Study|Withdrawal by Subject|0|||
160788313|NCT00968968|580610880|FG000|Overall Study|Physician Decision|1|||
160788314|NCT00968968|580610881|FG001|Overall Study|Physician Decision|2|||
160788315|NCT00968968|580610880|FG000|Overall Study|Lost to Follow-up|0|||
161329943|NCT02486692|582594751|FG000|Overall Study|did not login for randomization|4|||
161329944|NCT02486692|582594752|FG001|Overall Study|did not login for randomization|7|||
160788316|NCT00968968|580610881|FG001|Overall Study|Lost to Follow-up|1|||
161234339|NCT02883452|582241832|FG000|Overall Study|Adverse Event|2|||
161234340|NCT02883452|582241833|FG001|Overall Study|Adverse Event|1|||
161234341|NCT02883452|582241834|FG002|Overall Study|Adverse Event|1|||
161234342|NCT02883452|582241835|FG003|Overall Study|Adverse Event|1|||
161234343|NCT02883452|582241836|FG004|Overall Study|Adverse Event|1|||
161234344|NCT02883452|582241837|FG005|Overall Study|Adverse Event|3|||
161234345|NCT02883452|582241832|FG000|Overall Study|Physician Decision|0|||
161234346|NCT02883452|582241833|FG001|Overall Study|Physician Decision|0|||
161234347|NCT02883452|582241834|FG002|Overall Study|Physician Decision|0|||
161234348|NCT02883452|582241835|FG003|Overall Study|Physician Decision|0|||
161234349|NCT02883452|582241836|FG004|Overall Study|Physician Decision|4|||
161234350|NCT02883452|582241837|FG005|Overall Study|Physician Decision|1|||
161329945|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
160788317|NCT04401293|580610882|FG000|Overall Study|Withdrawal by Subject|1|||
160788318|NCT04401293|580610883|FG001|Overall Study|Withdrawal by Subject|3|||
160788319|NCT01026038|580610884|FG000|Overall Study|Lost to Follow-up|1|||
161234351|NCT02883452|582241832|FG000|Overall Study|Death|1|||
161234352|NCT02883452|582241833|FG001|Overall Study|Death|0|||
161234353|NCT02883452|582241834|FG002|Overall Study|Death|1|||
161234354|NCT02883452|582241835|FG003|Overall Study|Death|0|||
161234355|NCT02883452|582241836|FG004|Overall Study|Death|0|||
161234356|NCT02883452|582241837|FG005|Overall Study|Death|0|||
161234357|NCT02883452|582241832|FG000|Overall Study|Other|0|||
161234358|NCT02883452|582241833|FG001|Overall Study|Other|0|||
161127375|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161127376|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
161127377|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
161127378|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
161127379|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
161127380|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
161127381|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
161127382|NCT05195528|581855105|FG000|Placebo-controlled Treatment Period|Other|0|||
161127383|NCT05195528|581855106|FG001|Placebo-controlled Treatment Period|Other|0|||
161127384|NCT05195528|581855107|FG002|Placebo-controlled Treatment Period|Other|1|||
161127385|NCT05195528|581855108|FG003|Placebo-controlled Treatment Period|Other|0|||
161127386|NCT05195528|581855109|FG004|Placebo-controlled Treatment Period|Other|0|||
161127387|NCT05195528|581855105|FG000|Extension Period|PTE or AE or SAE|0|||
161127388|NCT05195528|581855106|FG001|Extension Period|PTE or AE or SAE|4|||
161127389|NCT05195528|581855107|FG002|Extension Period|PTE or AE or SAE|5|||
161127390|NCT05195528|581855108|FG003|Extension Period|PTE or AE or SAE|4|||
161127391|NCT05195528|581855109|FG004|Extension Period|PTE or AE or SAE|4|||
161127392|NCT05195528|581855105|FG000|Extension Period|Protocol Violation|0|||
161127393|NCT05195528|581855106|FG001|Extension Period|Protocol Violation|2|||
161127394|NCT05195528|581855107|FG002|Extension Period|Protocol Violation|1|||
161127395|NCT05195528|581855108|FG003|Extension Period|Protocol Violation|0|||
161127396|NCT05195528|581855109|FG004|Extension Period|Protocol Violation|1|||
161127397|NCT05195528|581855105|FG000|Extension Period|Lost to Follow-up|0|||
161127398|NCT05195528|581855106|FG001|Extension Period|Lost to Follow-up|6|||
161127399|NCT05195528|581855107|FG002|Extension Period|Lost to Follow-up|13|||
161127400|NCT05195528|581855108|FG003|Extension Period|Lost to Follow-up|3|||
161127401|NCT05195528|581855109|FG004|Extension Period|Lost to Follow-up|7|||
161127402|NCT05195528|581855105|FG000|Extension Period|Withdrawal by Subject|0|||
161127403|NCT05195528|581855106|FG001|Extension Period|Withdrawal by Subject|12|||
161127404|NCT05195528|581855107|FG002|Extension Period|Withdrawal by Subject|9|||
161127405|NCT05195528|581855108|FG003|Extension Period|Withdrawal by Subject|6|||
161127406|NCT05195528|581855109|FG004|Extension Period|Withdrawal by Subject|5|||
161127407|NCT05195528|581855105|FG000|Extension Period|Lack of Efficacy|0|||
161127408|NCT05195528|581855106|FG001|Extension Period|Lack of Efficacy|3|||
161127409|NCT05195528|581855107|FG002|Extension Period|Lack of Efficacy|0|||
161127410|NCT05195528|581855108|FG003|Extension Period|Lack of Efficacy|0|||
161127411|NCT05195528|581855109|FG004|Extension Period|Lack of Efficacy|2|||
161127412|NCT05195528|581855105|FG000|Extension Period|Not Treated|0|||
161127413|NCT05195528|581855106|FG001|Extension Period|Not Treated|0|||
161127414|NCT05195528|581855107|FG002|Extension Period|Not Treated|2|||
161127415|NCT05195528|581855108|FG003|Extension Period|Not Treated|3|||
161127416|NCT05195528|581855109|FG004|Extension Period|Not Treated|0|||
161127417|NCT05195528|581855105|FG000|Extension Period|Other|0|||
161127418|NCT05195528|581855106|FG001|Extension Period|Other|1|||
161127419|NCT05195528|581855107|FG002|Extension Period|Other|1|||
161127420|NCT05195528|581855108|FG003|Extension Period|Other|0|||
161127421|NCT05195528|581855109|FG004|Extension Period|Other|0|||
161127422|NCT01552902|581855110|FG000|Overall Study|Adverse Event|1|||
161127423|NCT01552902|581855111|FG001|Overall Study|Adverse Event|15|||
161127424|NCT01552902|581855112|FG002|Overall Study|Adverse Event|14|||
161127425|NCT01552902|581855110|FG000|Overall Study|Protocol Violation|3|||
161127426|NCT01552902|581855111|FG001|Overall Study|Protocol Violation|3|||
161127427|NCT01552902|581855112|FG002|Overall Study|Protocol Violation|3|||
161127428|NCT01552902|581855110|FG000|Overall Study|Lack of Efficacy|4|||
161127429|NCT01552902|581855111|FG001|Overall Study|Lack of Efficacy|3|||
161127430|NCT01552902|581855112|FG002|Overall Study|Lack of Efficacy|1|||
161127431|NCT01552902|581855110|FG000|Overall Study|Withdrawal by Subject|1|||
161127432|NCT01552902|581855111|FG001|Overall Study|Withdrawal by Subject|9|||
161127433|NCT01552902|581855112|FG002|Overall Study|Withdrawal by Subject|6|||
160788320|NCT01026038|580610885|FG001|Overall Study|Lost to Follow-up|1|||
160788321|NCT01026038|580610886|FG002|Overall Study|Lost to Follow-up|0|||
160788322|NCT03679884|580610887|FG000|Overall Study|Other|12|||
160788323|NCT03679884|580610888|FG001|Overall Study|Other|12|||
160788324|NCT03679884|580610889|FG002|Overall Study|Other|12|||
160788325|NCT03679884|580610890|FG003|Overall Study|Other|7|||
160788326|NCT03679884|580610891|FG004|Overall Study|Other|8|||
160788327|NCT03679884|580610887|FG000|Overall Study|Lack of Efficacy|15|||
160788328|NCT03679884|580610888|FG001|Overall Study|Lack of Efficacy|29|||
160788329|NCT03679884|580610889|FG002|Overall Study|Lack of Efficacy|13|||
160788330|NCT03679884|580610890|FG003|Overall Study|Lack of Efficacy|29|||
160788331|NCT03679884|580610891|FG004|Overall Study|Lack of Efficacy|10|||
161127434|NCT01552902|581855110|FG000|Overall Study|Lost to Follow-up|1|||
161127435|NCT01552902|581855111|FG001|Overall Study|Lost to Follow-up|3|||
161127436|NCT01552902|581855112|FG002|Overall Study|Lost to Follow-up|6|||
161127437|NCT01552902|581855110|FG000|Overall Study|Other|3|||
161127438|NCT01552902|581855111|FG001|Overall Study|Other|4|||
161127439|NCT01552902|581855112|FG002|Overall Study|Other|3|||
161127440|NCT02487108|581855113|FG000|Overall Study|Adverse Event|1|||
161127441|NCT02487108|581855114|FG001|Overall Study|Adverse Event|6|||
161329946|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
161329947|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
161329948|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
161329949|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
161329950|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
161329951|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
161329952|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
161329953|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
161329954|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
161329955|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
161329956|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
161329957|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
161329958|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
160890992|NCT02247531|580996792|FG000|Overall Study|Study Terminated by Sponsor|64|||
161127442|NCT02487108|581855115|FG002|Overall Study|Adverse Event|12|||
161127443|NCT02487108|581855116|FG003|Overall Study|Adverse Event|6|||
161127444|NCT02487108|581855113|FG000|Overall Study|Withdrawal by Subject|8|||
161127445|NCT02487108|581855114|FG001|Overall Study|Withdrawal by Subject|5|||
161127446|NCT02487108|581855115|FG002|Overall Study|Withdrawal by Subject|5|||
161127447|NCT02487108|581855116|FG003|Overall Study|Withdrawal by Subject|0|||
161127448|NCT02487108|581855113|FG000|Overall Study|Non-compliance to study medication|3|||
161127449|NCT02487108|581855114|FG001|Overall Study|Non-compliance to study medication|2|||
161127450|NCT02487108|581855115|FG002|Overall Study|Non-compliance to study medication|5|||
161127451|NCT02487108|581855116|FG003|Overall Study|Non-compliance to study medication|4|||
161127452|NCT02487108|581855113|FG000|Overall Study|Protocol Violation|1|||
161127453|NCT02487108|581855114|FG001|Overall Study|Protocol Violation|1|||
161127454|NCT02487108|581855115|FG002|Overall Study|Protocol Violation|2|||
161127455|NCT02487108|581855116|FG003|Overall Study|Protocol Violation|0|||
161127456|NCT02487108|581855113|FG000|Overall Study|Non-compliance to study procedures|0|||
161127457|NCT02487108|581855114|FG001|Overall Study|Non-compliance to study procedures|0|||
161127458|NCT02487108|581855115|FG002|Overall Study|Non-compliance to study procedures|0|||
161127459|NCT02487108|581855116|FG003|Overall Study|Non-compliance to study procedures|1|||
161127460|NCT02487108|581855113|FG000|Overall Study|Other than specified|3|||
161127461|NCT02487108|581855114|FG001|Overall Study|Other than specified|2|||
161127462|NCT02487108|581855115|FG002|Overall Study|Other than specified|2|||
161127463|NCT02487108|581855116|FG003|Overall Study|Other than specified|0|||
161127464|NCT02720757|581855117|FG000|Overall Study|Other reason|5|||
161127465|NCT02720757|581855117|FG000|Overall Study|Loss of contact|4|||
161127466|NCT02720757|581855117|FG000|Overall Study|Informed consent withdrawal|1|||
161127467|NCT02720757|581855117|FG000|Overall Study|Patients wish to withdraw|2|||
161127468|NCT02720757|581855117|FG000|Overall Study|Missing|3|||
161127469|NCT02720757|581855117|FG000|Overall Study|General exclusion|3|||
161127470|NCT00883493|581855118|FG000|Overall Study|Adverse Event|11|||
161127471|NCT00883493|581855119|FG001|Overall Study|Adverse Event|12|||
161127472|NCT00883493|581855118|FG000|Overall Study|Lack of Efficacy|4|||
161127473|NCT00883493|581855119|FG001|Overall Study|Lack of Efficacy|3|||
161127474|NCT00883493|581855118|FG000|Overall Study|Lost to Follow-up|7|||
161127475|NCT00883493|581855119|FG001|Overall Study|Lost to Follow-up|6|||
161127476|NCT00883493|581855118|FG000|Overall Study|Withdrawal by Subject|11|||
161127477|NCT00883493|581855119|FG001|Overall Study|Withdrawal by Subject|20|||
161127478|NCT00883493|581855118|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
161127479|NCT00883493|581855119|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
161127480|NCT00883493|581855118|FG000|Overall Study|Study specific disc. criteria|2|||
161127481|NCT00883493|581855119|FG001|Overall Study|Study specific disc. criteria|0|||
161127482|NCT00883493|581855118|FG000|Overall Study|Other|5|||
161127483|NCT00883493|581855119|FG001|Overall Study|Other|3|||
161127484|NCT04557384|581855120|FG000|Overall Study|Study Terminated by Sponsor|1|||
161127485|NCT04557384|581855120|FG000|Overall Study|Death|1|||
161127486|NCT00841763|581855121|FG000|Overall Study|Withdrawal by Subject|60|||
161127487|NCT00841763|581855122|FG001|Overall Study|Withdrawal by Subject|17|||
161127488|NCT00841763|581855123|FG002|Overall Study|Withdrawal by Subject|4|||
161127489|NCT00841763|581855124|FG003|Overall Study|Withdrawal by Subject|1|||
161127490|NCT00841763|581855121|FG000|Overall Study|Adverse Event|9|||
161127491|NCT00841763|581855122|FG001|Overall Study|Adverse Event|10|||
161127492|NCT00841763|581855123|FG002|Overall Study|Adverse Event|3|||
161127493|NCT00841763|581855124|FG003|Overall Study|Adverse Event|2|||
161127494|NCT00841763|581855121|FG000|Overall Study|Lost to Follow-up|63|||
161127495|NCT00841763|581855122|FG001|Overall Study|Lost to Follow-up|25|||
161127496|NCT00841763|581855123|FG002|Overall Study|Lost to Follow-up|0|||
161127497|NCT00841763|581855124|FG003|Overall Study|Lost to Follow-up|0|||
161127498|NCT00841763|581855121|FG000|Overall Study|Protocol Violation|20|||
161127499|NCT00841763|581855122|FG001|Overall Study|Protocol Violation|3|||
161127500|NCT00841763|581855123|FG002|Overall Study|Protocol Violation|1|||
161234359|NCT02883452|582241834|FG002|Overall Study|Other|0|||
161234360|NCT02883452|582241835|FG003|Overall Study|Other|0|||
161234361|NCT02883452|582241836|FG004|Overall Study|Other|0|||
161234362|NCT02883452|582241837|FG005|Overall Study|Other|1|||
161234363|NCT00829790|582241841|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
161234364|NCT00829790|582241842|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
161234365|NCT04247282|582241845|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
161234366|NCT04247282|582241846|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
161234367|NCT04247282|582241847|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
161234368|NCT04247282|582241848|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
161234369|NCT04247282|582241845|FG000|Overall Study|Refused further treatment|0|||
161234370|NCT04247282|582241846|FG001|Overall Study|Refused further treatment|1|||
161234371|NCT04247282|582241847|FG002|Overall Study|Refused further treatment|0|||
161234372|NCT04247282|582241848|FG003|Overall Study|Refused further treatment|0|||
161234373|NCT01401647|582241858|FG000|Overall Study|Withdrawal by Subject|1|||
161234374|NCT01401647|582241859|FG001|Overall Study|Withdrawal by Subject|5|||
161234375|NCT01401647|582241860|FG002|Overall Study|Withdrawal by Subject|2|||
161234376|NCT01401647|582241858|FG000|Overall Study|Lost to Follow-up|3|||
161234377|NCT01401647|582241859|FG001|Overall Study|Lost to Follow-up|3|||
161234378|NCT01401647|582241860|FG002|Overall Study|Lost to Follow-up|1|||
161234379|NCT00473330|582241865|FG000|Core Study|Adverse Event|4|||
161234380|NCT00473330|582241866|FG001|Core Study|Adverse Event|4|||
161234381|NCT00473330|582241867|FG002|Core Study|Adverse Event|1|||
161234382|NCT00473330|582241865|FG000|Core Study|Death|6|||
161234383|NCT00473330|582241866|FG001|Core Study|Death|4|||
161234384|NCT00473330|582241867|FG002|Core Study|Death|4|||
161234385|NCT00473330|582241865|FG000|Core Study|Lost to Follow-up|5|||
161234386|NCT00473330|582241866|FG001|Core Study|Lost to Follow-up|5|||
161234387|NCT00473330|582241867|FG002|Core Study|Lost to Follow-up|10|||
161234388|NCT00473330|582241865|FG000|Core Study|Physician Decision|2|||
161234389|NCT00473330|582241866|FG001|Core Study|Physician Decision|1|||
161234390|NCT00473330|582241867|FG002|Core Study|Physician Decision|3|||
160890993|NCT02247531|580996793|FG001|Overall Study|Study Terminated by Sponsor|66|||
160890994|NCT02247531|580996794|FG002|Overall Study|Study Terminated by Sponsor|62|||
160890995|NCT02247531|580996792|FG000|Overall Study|Physician Decision|0|||
160890996|NCT02247531|580996793|FG001|Overall Study|Physician Decision|2|||
160890997|NCT02247531|580996794|FG002|Overall Study|Physician Decision|2|||
160890998|NCT02247531|580996792|FG000|Overall Study|Unspecified Reason|2|||
160890999|NCT02247531|580996793|FG001|Overall Study|Unspecified Reason|3|||
160891000|NCT02247531|580996794|FG002|Overall Study|Unspecified Reason|4|||
160891001|NCT01751802|580996806|FG000|Overall Study|Adverse Event|4|||
160891002|NCT01751802|580996807|FG001|Overall Study|Adverse Event|2|||
160891003|NCT01229397|580996808|FG000|Overall Study|Withdrawal by Subject|3|||
161234391|NCT00473330|582241865|FG000|Core Study|Subject Non-compliance|1|||
161234392|NCT00473330|582241866|FG001|Core Study|Subject Non-compliance|2|||
161234393|NCT00473330|582241867|FG002|Core Study|Subject Non-compliance|1|||
161234394|NCT00473330|582241865|FG000|Core Study|Subject Required Other Therapy|0|||
161234395|NCT00473330|582241866|FG001|Core Study|Subject Required Other Therapy|1|||
161234396|NCT00473330|582241867|FG002|Core Study|Subject Required Other Therapy|3|||
161234397|NCT00473330|582241865|FG000|Core Study|Subject's Decision|9|||
161234398|NCT00473330|582241866|FG001|Core Study|Subject's Decision|8|||
161234399|NCT00473330|582241867|FG002|Core Study|Subject's Decision|19|||
161234400|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
161234401|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
161234402|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
161234403|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Death|2|||
161234404|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Death|0|||
161329959|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
161329960|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
161329961|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
161329962|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
161329963|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
161329964|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
161329965|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
161329966|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
160891004|NCT01229397|580996809|FG001|Overall Study|Withdrawal by Subject|3|||
160891005|NCT01229397|580996808|FG000|Overall Study|Lost to Follow-up|7|||
160891006|NCT01229397|580996809|FG001|Overall Study|Lost to Follow-up|6|||
160891007|NCT01229397|580996808|FG000|Overall Study|Migrated/moved from study area|1|||
161234405|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Death|0|||
161234406|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
161234407|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
161234408|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
161234409|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
161329967|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
161329968|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
161329969|NCT01198002|582594757|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
160891008|NCT01229397|580996809|FG001|Overall Study|Migrated/moved from study area|0|||
161329970|NCT01198002|582594758|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
161329971|NCT01198002|582594759|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
161329972|NCT01198002|582594757|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
161329973|NCT01198002|582594758|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
161329974|NCT01198002|582594759|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
161329975|NCT01198002|582594757|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
161329976|NCT01198002|582594758|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
161329977|NCT01198002|582594759|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
161329978|NCT01198002|582594757|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
161329979|NCT01198002|582594758|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
161329980|NCT01198002|582594759|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
161329981|NCT01198002|582594757|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
161329982|NCT01198002|582594758|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
161329983|NCT01198002|582594759|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
161329984|NCT01198002|582594757|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
161329985|NCT01198002|582594758|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
161329986|NCT01198002|582594759|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
161329987|NCT01198002|582594757|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
161329988|NCT01198002|582594758|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
160891009|NCT00608543|580996810|FG000|Overall Study|Adverse Event|4|||
160891010|NCT01143207|580996812|FG000|Overall Study|Lost to Follow-up|2|||
161127501|NCT00841763|581855124|FG003|Overall Study|Protocol Violation|0|||
161127502|NCT00841763|581855121|FG000|Overall Study|Administrative Reasons|3|||
161127503|NCT00841763|581855122|FG001|Overall Study|Administrative Reasons|1|||
161127504|NCT00841763|581855123|FG002|Overall Study|Administrative Reasons|0|||
161127505|NCT00841763|581855124|FG003|Overall Study|Administrative Reasons|0|||
161127506|NCT00841763|581855121|FG000|Overall Study|Unable to Classify|7|||
161127507|NCT00841763|581855122|FG001|Overall Study|Unable to Classify|1|||
161127508|NCT00841763|581855123|FG002|Overall Study|Unable to Classify|0|||
161127509|NCT00841763|581855124|FG003|Overall Study|Unable to Classify|0|||
161127510|NCT00400400|581855125|FG000|Overall Study|Adverse Event|9|||
161127511|NCT00400400|581855126|FG001|Overall Study|Adverse Event|8|||
161127512|NCT00400400|581855125|FG000|Overall Study|Protocol Violation|2|||
161127513|NCT00400400|581855126|FG001|Overall Study|Protocol Violation|0|||
161127514|NCT00400400|581855125|FG000|Overall Study|Withdrawal by Subject|1|||
161127515|NCT00400400|581855126|FG001|Overall Study|Withdrawal by Subject|3|||
161127516|NCT00400400|581855125|FG000|Overall Study|Administrative Problem|1|||
161127517|NCT00400400|581855126|FG001|Overall Study|Administrative Problem|0|||
161127518|NCT00400400|581855125|FG000|Overall Study|Lost to Follow-up|0|||
161127519|NCT00400400|581855126|FG001|Overall Study|Lost to Follow-up|1|||
161127520|NCT00400400|581855125|FG000|Overall Study|Did not receive study drug|1|||
161127521|NCT00400400|581855126|FG001|Overall Study|Did not receive study drug|3|||
161127522|NCT01688050|581855127|FG000|Overall Study|Death|7|||
161127523|NCT01688050|581855127|FG000|Overall Study|Conversion to open repair|1|||
161127524|NCT01688050|581855127|FG000|Overall Study|Lost to Follow-up|13|||
161127525|NCT01688050|581855127|FG000|Overall Study|Withdrawal by Subject|10|||
161127526|NCT01848145|581855128|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
161127527|NCT01848145|581855128|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
161127528|NCT01848145|581855128|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
161127529|NCT01848145|581855128|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
161127530|NCT01848145|581855128|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
161127531|NCT01848145|581855128|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
161127532|NCT01848145|581855128|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
161127533|NCT04303000|581855135|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
161127534|NCT04303000|581855136|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
161127535|NCT04303000|581855137|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
161127536|NCT04426695|581855138|FG000|Overall Study|Death|2|||
161127537|NCT04426695|581855139|FG001|Overall Study|Death|0|||
161127538|NCT04426695|581855140|FG002|Overall Study|Death|1|||
161127539|NCT04426695|581855141|FG003|Overall Study|Death|27|||
161127540|NCT04426695|581855142|FG004|Overall Study|Death|25|||
161127541|NCT04426695|581855143|FG005|Overall Study|Death|21|||
161127542|NCT04426695|581855144|FG006|Overall Study|Death|42|||
160891011|NCT01869725|580996813|FG000|Overall Study|ineligible after registration|1|||
161127543|NCT04426695|581855145|FG007|Overall Study|Death|23|||
161127544|NCT04426695|581855146|FG008|Overall Study|Death|37|||
161127545|NCT04426695|581855147|FG009|Overall Study|Death|14|||
161127546|NCT04426695|581855148|FG010|Overall Study|Death|8|||
161127547|NCT04426695|581855149|FG011|Overall Study|Death|7|||
161127548|NCT04426695|581855150|FG012|Overall Study|Death|13|||
161234410|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
161234411|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
161234412|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
161234413|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
161234414|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
161234415|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
161234416|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
161234417|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
161234418|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
161234419|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
161234420|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
161234421|NCT00473330|582241865|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
161234422|NCT00473330|582241866|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
161234423|NCT00473330|582241867|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
161234424|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
161234425|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
161234426|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
161234427|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Death|2|||
161234428|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Death|2|||
161234429|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Death|1|||
161234430|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
161234431|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
161234432|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
161234433|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
161234434|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
161234435|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
161234436|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
161234437|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
161234438|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
161234439|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
161234440|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
161234441|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
161234442|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
161234443|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
161234444|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
161234445|NCT00473330|582241865|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
161234446|NCT00473330|582241866|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
161234447|NCT00473330|582241867|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
161234448|NCT01975948|582241868|FG000|Overall Study|Withdrawal by Subject|17|||
161234449|NCT01975948|582241869|FG001|Overall Study|Withdrawal by Subject|21|||
161234450|NCT01975948|582241870|FG002|Overall Study|Withdrawal by Subject|7|||
161234451|NCT01975948|582241871|FG003|Overall Study|Withdrawal by Subject|6|||
161234452|NCT01675765|582241872|FG000|Overall Study|Progressive disease|4|||
161234453|NCT01675765|582241873|FG001|Overall Study|Progressive disease|4|||
161234454|NCT01675765|582241872|FG000|Overall Study|Adverse Event|1|||
161234455|NCT01675765|582241873|FG001|Overall Study|Adverse Event|2|||
160891012|NCT01869725|580996813|FG000|Overall Study|Death|1|||
161234456|NCT01675765|582241872|FG000|Overall Study|Withdrawal by Subject|2|||
161234457|NCT01675765|582241873|FG001|Overall Study|Withdrawal by Subject|0|||
161234458|NCT01675765|582241872|FG000|Overall Study|Death|1|||
161234459|NCT01675765|582241873|FG001|Overall Study|Death|0|||
161234460|NCT01675765|582241872|FG000|Overall Study|Clinical progression|3|||
161234461|NCT01675765|582241873|FG001|Overall Study|Clinical progression|2|||
161234462|NCT00365846|582241875|FG000|Overall Study|Lost to Follow-up|1|||
161234463|NCT01185821|582241876|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161234464|NCT01185821|582241877|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161234465|NCT01185821|582241878|FG002|Overall Study|Abnormal laboratory value(s)|1|||
161234466|NCT01185821|582241879|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161234467|NCT01185821|582241880|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161234468|NCT01185821|582241876|FG000|Overall Study|Protocol Violation|0|||
161234469|NCT01185821|582241877|FG001|Overall Study|Protocol Violation|0|||
161234470|NCT01185821|582241878|FG002|Overall Study|Protocol Violation|0|||
161234471|NCT01185821|582241879|FG003|Overall Study|Protocol Violation|1|||
161234472|NCT01185821|582241880|FG004|Overall Study|Protocol Violation|1|||
161234473|NCT01185821|582241876|FG000|Overall Study|Abnormal test procedure result|0|||
161234474|NCT01185821|582241877|FG001|Overall Study|Abnormal test procedure result|0|||
160891013|NCT01869725|580996813|FG000|Overall Study|Lost to Follow-up|2|||
161234475|NCT01185821|582241878|FG002|Overall Study|Abnormal test procedure result|0|||
161234476|NCT01185821|582241879|FG003|Overall Study|Abnormal test procedure result|0|||
161234477|NCT01185821|582241880|FG004|Overall Study|Abnormal test procedure result|1|||
161234478|NCT01185821|582241876|FG000|Overall Study|Death|0|||
161234479|NCT01185821|582241877|FG001|Overall Study|Death|1|||
161234480|NCT01185821|582241878|FG002|Overall Study|Death|0|||
161234481|NCT01185821|582241879|FG003|Overall Study|Death|0|||
161234482|NCT01185821|582241880|FG004|Overall Study|Death|0|||
161234483|NCT01185821|582241876|FG000|Overall Study|Condition no longer required study drug|0|||
161234484|NCT01185821|582241877|FG001|Overall Study|Condition no longer required study drug|0|||
161234485|NCT01185821|582241878|FG002|Overall Study|Condition no longer required study drug|0|||
161234486|NCT01185821|582241879|FG003|Overall Study|Condition no longer required study drug|0|||
161234487|NCT01185821|582241880|FG004|Overall Study|Condition no longer required study drug|1|||
161234488|NCT01185821|582241876|FG000|Overall Study|Adverse Event|2|||
161234489|NCT01185821|582241877|FG001|Overall Study|Adverse Event|3|||
161234490|NCT01185821|582241878|FG002|Overall Study|Adverse Event|1|||
161234491|NCT01185821|582241879|FG003|Overall Study|Adverse Event|2|||
161234492|NCT01185821|582241880|FG004|Overall Study|Adverse Event|5|||
161234493|NCT01185821|582241876|FG000|Overall Study|Lack of Efficacy|0|||
161234494|NCT01185821|582241877|FG001|Overall Study|Lack of Efficacy|0|||
161234495|NCT01185821|582241878|FG002|Overall Study|Lack of Efficacy|3|||
161234496|NCT01185821|582241879|FG003|Overall Study|Lack of Efficacy|0|||
161234497|NCT01185821|582241880|FG004|Overall Study|Lack of Efficacy|9|||
160788332|NCT03679884|580610887|FG000|Overall Study|Death|1|||
160788333|NCT03679884|580610888|FG001|Overall Study|Death|0|||
160788334|NCT03679884|580610889|FG002|Overall Study|Death|0|||
160788335|NCT03679884|580610890|FG003|Overall Study|Death|0|||
160788336|NCT03679884|580610891|FG004|Overall Study|Death|0|||
160788337|NCT03679884|580610887|FG000|Overall Study|Adverse Event|2|||
160788338|NCT03679884|580610888|FG001|Overall Study|Adverse Event|10|||
160788339|NCT03679884|580610889|FG002|Overall Study|Adverse Event|9|||
160788340|NCT03679884|580610890|FG003|Overall Study|Adverse Event|6|||
160788341|NCT03679884|580610891|FG004|Overall Study|Adverse Event|6|||
160788342|NCT03679884|580610887|FG000|Overall Study|Withdrawal by Subject|12|||
160788343|NCT03679884|580610888|FG001|Overall Study|Withdrawal by Subject|23|||
160788344|NCT03679884|580610889|FG002|Overall Study|Withdrawal by Subject|8|||
160788345|NCT03679884|580610890|FG003|Overall Study|Withdrawal by Subject|8|||
161234498|NCT01185821|582241876|FG000|Overall Study|Withdrawal by Subject|3|||
161234499|NCT01185821|582241877|FG001|Overall Study|Withdrawal by Subject|2|||
161234500|NCT01185821|582241878|FG002|Overall Study|Withdrawal by Subject|2|||
161234501|NCT01185821|582241879|FG003|Overall Study|Withdrawal by Subject|1|||
161234502|NCT01185821|582241880|FG004|Overall Study|Withdrawal by Subject|3|||
161234503|NCT01185821|582241876|FG000|Overall Study|Lost to Follow-up|1|||
161234504|NCT01185821|582241877|FG001|Overall Study|Lost to Follow-up|1|||
160788346|NCT03679884|580610891|FG004|Overall Study|Withdrawal by Subject|9|||
160788347|NCT03679884|580610887|FG000|Overall Study|Lost to Follow-up|1|||
160788348|NCT03679884|580610888|FG001|Overall Study|Lost to Follow-up|4|||
160788349|NCT03679884|580610889|FG002|Overall Study|Lost to Follow-up|2|||
160788350|NCT03679884|580610890|FG003|Overall Study|Lost to Follow-up|0|||
160788351|NCT03679884|580610891|FG004|Overall Study|Lost to Follow-up|3|||
161234505|NCT01185821|582241878|FG002|Overall Study|Lost to Follow-up|2|||
161234506|NCT01185821|582241879|FG003|Overall Study|Lost to Follow-up|1|||
161234507|NCT01185821|582241880|FG004|Overall Study|Lost to Follow-up|2|||
161234508|NCT01185821|582241876|FG000|Overall Study|Administrative problems|0|||
161234509|NCT01185821|582241877|FG001|Overall Study|Administrative problems|0|||
161234510|NCT01185821|582241878|FG002|Overall Study|Administrative problems|1|||
160788352|NCT00930176|580610895|FG000|Overall Study|Death|1|||
160788353|NCT02792257|580610898|FG000|Overall Study|Lost to Follow-up|3|||
160788354|NCT02792257|580610899|FG001|Overall Study|Lost to Follow-up|4|||
161234511|NCT01185821|582241879|FG003|Overall Study|Administrative problems|1|||
161234512|NCT01185821|582241880|FG004|Overall Study|Administrative problems|2|||
161234513|NCT00336479|582241882|FG000|Overall Study|Adverse Event|8|||
161234514|NCT00336479|582241883|FG001|Overall Study|Adverse Event|11|||
161234515|NCT00336479|582241884|FG002|Overall Study|Adverse Event|18|||
161234516|NCT00336479|582241885|FG003|Overall Study|Adverse Event|4|||
160788355|NCT02792257|580610898|FG000|Overall Study|Allergy|0|||
161234517|NCT00336479|582241882|FG000|Overall Study|Noncompliant|1|||
161234518|NCT00336479|582241883|FG001|Overall Study|Noncompliant|7|||
161234519|NCT00336479|582241884|FG002|Overall Study|Noncompliant|3|||
161234520|NCT00336479|582241885|FG003|Overall Study|Noncompliant|0|||
160788356|NCT02792257|580610899|FG001|Overall Study|Allergy|1|||
160788357|NCT02792257|580610898|FG000|Overall Study|Protocol Violation|2|||
160788358|NCT02792257|580610899|FG001|Overall Study|Protocol Violation|0|||
160788359|NCT02792257|580610898|FG000|Overall Study|Excessive Agitation|0|||
160788360|NCT02792257|580610899|FG001|Overall Study|Excessive Agitation|1|||
160788361|NCT02792257|580610898|FG000|Overall Study|Not Feeling Well|0|||
160788362|NCT02792257|580610899|FG001|Overall Study|Not Feeling Well|1|||
160788363|NCT00992394|580610903|FG000|Overall Study|Lack of Efficacy|6|||
161234521|NCT00336479|582241882|FG000|Overall Study|Physician Decision|2|||
161234522|NCT00336479|582241883|FG001|Overall Study|Physician Decision|3|||
161234523|NCT00336479|582241884|FG002|Overall Study|Physician Decision|1|||
161234524|NCT00336479|582241885|FG003|Overall Study|Physician Decision|0|||
161234525|NCT00336479|582241882|FG000|Overall Study|Lost to Follow-up|3|||
161234526|NCT00336479|582241883|FG001|Overall Study|Lost to Follow-up|2|||
161234527|NCT00336479|582241884|FG002|Overall Study|Lost to Follow-up|0|||
161234528|NCT00336479|582241885|FG003|Overall Study|Lost to Follow-up|0|||
161234529|NCT00336479|582241882|FG000|Overall Study|Withdrawal by Subject|3|||
161234530|NCT00336479|582241883|FG001|Overall Study|Withdrawal by Subject|2|||
161234531|NCT00336479|582241884|FG002|Overall Study|Withdrawal by Subject|3|||
161234532|NCT00336479|582241885|FG003|Overall Study|Withdrawal by Subject|0|||
161234533|NCT00336479|582241882|FG000|Overall Study|Other|0|||
161234534|NCT00336479|582241883|FG001|Overall Study|Other|0|||
161234535|NCT00336479|582241884|FG002|Overall Study|Other|1|||
161234536|NCT00336479|582241885|FG003|Overall Study|Other|0|||
161234537|NCT00336479|582241882|FG000|Overall Study|Virologic Stopping Rule|20|||
161234538|NCT00336479|582241883|FG001|Overall Study|Virologic Stopping Rule|0|||
161234539|NCT00336479|582241884|FG002|Overall Study|Virologic Stopping Rule|0|||
161234540|NCT00336479|582241885|FG003|Overall Study|Virologic Stopping Rule|0|||
161234541|NCT00846495|582241886|FG000|Overall Study|Lost to Follow-up|1|||
161234542|NCT00846495|582241887|FG001|Overall Study|Lost to Follow-up|0|||
161234543|NCT00846495|582241886|FG000|Overall Study|Adverse Event|5|||
161234544|NCT00846495|582241887|FG001|Overall Study|Adverse Event|1|||
161234545|NCT00846495|582241886|FG000|Overall Study|Lack of Efficacy|1|||
161234546|NCT00846495|582241887|FG001|Overall Study|Lack of Efficacy|2|||
161234547|NCT00846495|582241886|FG000|Overall Study|Physician Decision|1|||
161234548|NCT00846495|582241887|FG001|Overall Study|Physician Decision|0|||
161234549|NCT01079988|582241888|FG000|Overall Study|Lost to Follow-up|0|||
161234550|NCT01079988|582241889|FG001|Overall Study|Lost to Follow-up|0|||
161234551|NCT01079988|582241890|FG002|Overall Study|Lost to Follow-up|0|||
161234552|NCT01079988|582241891|FG003|Overall Study|Lost to Follow-up|1|||
161234553|NCT01079988|582241892|FG004|Overall Study|Lost to Follow-up|0|||
161234554|NCT01079988|582241888|FG000|Overall Study|Lack of Efficacy|1|||
161234555|NCT01079988|582241889|FG001|Overall Study|Lack of Efficacy|0|||
161234556|NCT01079988|582241890|FG002|Overall Study|Lack of Efficacy|0|||
161234557|NCT01079988|582241891|FG003|Overall Study|Lack of Efficacy|0|||
161234558|NCT01079988|582241892|FG004|Overall Study|Lack of Efficacy|0|||
161234559|NCT01079988|582241888|FG000|Overall Study|Other|0|||
161234560|NCT01079988|582241889|FG001|Overall Study|Other|0|||
161234561|NCT01079988|582241890|FG002|Overall Study|Other|0|||
161234562|NCT01079988|582241891|FG003|Overall Study|Other|2|||
161234563|NCT01079988|582241892|FG004|Overall Study|Other|1|||
161234564|NCT01265056|582241893|FG000|Initial Study Period|Withdrawal by Subject|1|||
161234565|NCT01265056|582241894|FG001|Initial Study Period|Withdrawal by Subject|1|||
161234566|NCT01265056|582241893|FG000|Initial Study Period|Withdrawal by Subject|1|||
161234567|NCT01265056|582241894|FG001|Initial Study Period|Withdrawal by Subject|1|||
161329989|NCT01198002|582594759|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
161329990|NCT02063672|582594760|FG000|Overall Study|Ongoing Follow-up|27|||
161329991|NCT02063672|582594761|FG001|Overall Study|Ongoing Follow-up|14|||
161329992|NCT02063672|582594760|FG000|Overall Study|Death|5|||
161329993|NCT02063672|582594761|FG001|Overall Study|Death|3|||
161329994|NCT02063672|582594760|FG000|Overall Study|Lost to Follow-up|1|||
161329995|NCT02063672|582594761|FG001|Overall Study|Lost to Follow-up|3|||
161329996|NCT02063672|582594760|FG000|Overall Study|Withdrawal by Subject|2|||
161329997|NCT02063672|582594761|FG001|Overall Study|Withdrawal by Subject|2|||
161329998|NCT01307787|582594763|FG000|Overall Study|Withdrawal by Subject|2|||
161329999|NCT01307787|582594764|FG001|Overall Study|Withdrawal by Subject|0|||
161330000|NCT03353792|582594768|FG000|Overall Study|Lost to Follow-up|1|||
161330001|NCT03353792|582594769|FG001|Overall Study|Lost to Follow-up|0|||
161330002|NCT03353792|582594768|FG000|Overall Study|Participant Unable to Manage Device|1|||
161330003|NCT03353792|582594769|FG001|Overall Study|Participant Unable to Manage Device|0|||
161330004|NCT04176939|582594778|FG000|Overall Study|Withdrawal by Subject|5|||
161330005|NCT04176939|582594778|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
161330006|NCT04176939|582594778|FG000|Overall Study|Lost to Follow-up|2|||
161330007|NCT04176939|582594778|FG000|Overall Study|Unspecified reason|4|||
161330008|NCT04176939|582594778|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
161330009|NCT02157519|582594779|FG000|Overall Study|Death|3|||
161234568|NCT01265056|582241893|FG000|Follow up|Lost to Follow-up|7|||
161234569|NCT01265056|582241894|FG001|Follow up|Lost to Follow-up|3|||
161330010|NCT02157519|582594780|FG001|Overall Study|Death|1|||
161330011|NCT02157519|582594779|FG000|Overall Study|Withdrawal by Subject|7|||
161330012|NCT02157519|582594780|FG001|Overall Study|Withdrawal by Subject|0|||
161330013|NCT02157519|582594779|FG000|Overall Study|Lost to Follow-up|1|||
161234570|NCT02711852|582241899|FG000|Overall Study|Death|5|||
161234571|NCT02711852|582241899|FG000|Overall Study|Lost to Follow-up|1|||
161234572|NCT02711852|582241899|FG000|Overall Study|Completed follow-up|3|||
161234573|NCT02711852|582241899|FG000|Overall Study|Withdrawal by Subject|1|||
161234574|NCT01417078|582241903|FG000|Overall Study|Withdrawal by Subject|1|||
161234575|NCT01059903|582241904|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
161234576|NCT01059903|582241905|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
161234577|NCT00858845|582241906|FG000|Overall Study|Patient underwent heart transplant.|0|||
161234578|NCT00858845|582241907|FG001|Overall Study|Patient underwent heart transplant.|1|||
161234579|NCT03031847|582241908|FG000|Overall Study|Death|1|||
161234580|NCT03031847|582241909|FG001|Overall Study|Death|1|||
161234581|NCT03031847|582241910|FG002|Overall Study|Death|2|||
161234582|NCT03031847|582241911|FG003|Overall Study|Death|3|||
161234583|NCT03031847|582241908|FG000|Overall Study|Lost to Follow-up|1|||
161234584|NCT03031847|582241909|FG001|Overall Study|Lost to Follow-up|1|||
161234585|NCT03031847|582241910|FG002|Overall Study|Lost to Follow-up|2|||
161234586|NCT03031847|582241911|FG003|Overall Study|Lost to Follow-up|3|||
161234587|NCT02100228|582241914|FG000|Overall Study|Other|19|||
161234588|NCT02100228|582241915|FG001|Overall Study|Other|19|||
161234589|NCT02100228|582241914|FG000|Overall Study|Administrative reason|0|||
161234590|NCT02100228|582241915|FG001|Overall Study|Administrative reason|1|||
160788364|NCT00992394|580610904|FG001|Overall Study|Lack of Efficacy|3|||
160788365|NCT00992394|580610903|FG000|Overall Study|Adverse Event|4|||
160788366|NCT00992394|580610904|FG001|Overall Study|Adverse Event|5|||
161234591|NCT02100228|582241914|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
160788367|NCT00992394|580610903|FG000|Overall Study|Withdrawal by Subject|8|||
161234592|NCT02100228|582241915|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
161234593|NCT02100228|582241914|FG000|Overall Study|Non-compliance|0|||
161234594|NCT02100228|582241915|FG001|Overall Study|Non-compliance|3|||
161234595|NCT02100228|582241914|FG000|Overall Study|Lost to Follow-up|0|||
161234596|NCT02100228|582241915|FG001|Overall Study|Lost to Follow-up|1|||
161234597|NCT02100228|582241914|FG000|Overall Study|Withdrawal by Subject|27|||
161234598|NCT02100228|582241915|FG001|Overall Study|Withdrawal by Subject|37|||
161234599|NCT02100228|582241914|FG000|Overall Study|Adverse Event|16|||
161234600|NCT02100228|582241915|FG001|Overall Study|Adverse Event|12|||
161234601|NCT02100228|582241914|FG000|Overall Study|Death|1|||
161234602|NCT02100228|582241915|FG001|Overall Study|Death|1|||
161234603|NCT00214422|582241916|FG000|Overall Study|Physician Decision|2|||
161234604|NCT00214422|582241917|FG001|Overall Study|Physician Decision|0|||
161234605|NCT00214422|582241918|FG002|Overall Study|Physician Decision|0|||
161234606|NCT00214422|582241916|FG000|Overall Study|Developed esophageal ca|1|||
161234607|NCT00214422|582241917|FG001|Overall Study|Developed esophageal ca|0|||
161234608|NCT00214422|582241918|FG002|Overall Study|Developed esophageal ca|0|||
161234609|NCT00214422|582241916|FG000|Overall Study|Pt taken off study|1|||
161234610|NCT00214422|582241917|FG001|Overall Study|Pt taken off study|1|||
161234611|NCT00214422|582241918|FG002|Overall Study|Pt taken off study|0|||
161234612|NCT00214422|582241916|FG000|Overall Study|Disease progression on study|1|||
161234613|NCT00214422|582241917|FG001|Overall Study|Disease progression on study|0|||
161234614|NCT00214422|582241918|FG002|Overall Study|Disease progression on study|0|||
161234615|NCT00214422|582241916|FG000|Overall Study|Unable to make a radiation treatment|0|||
161234616|NCT00214422|582241917|FG001|Overall Study|Unable to make a radiation treatment|0|||
161234617|NCT00214422|582241918|FG002|Overall Study|Unable to make a radiation treatment|1|||
161234618|NCT02612337|582241919|FG000|Overall Study|Lack of Efficacy|1|||
161234619|NCT02612337|582241920|FG001|Overall Study|Lack of Efficacy|0|||
161234620|NCT02612337|582241919|FG000|Overall Study|Withdrawal by Subject|2|||
161234621|NCT02612337|582241920|FG001|Overall Study|Withdrawal by Subject|2|||
161234622|NCT02612337|582241919|FG000|Overall Study|Did not receive study drug|0|||
161234623|NCT02612337|582241920|FG001|Overall Study|Did not receive study drug|1|||
161234624|NCT00854100|582241929|FG000|Overall Study|Inability to complete the study visits|0|||
161234625|NCT00854100|582241930|FG001|Overall Study|Inability to complete the study visits|0|||
161234626|NCT00854100|582241931|FG002|Overall Study|Inability to complete the study visits|1|||
160788368|NCT00992394|580610904|FG001|Overall Study|Withdrawal by Subject|2|||
160788369|NCT00992394|580610903|FG000|Overall Study|Physician Decision|1|||
160788370|NCT00992394|580610904|FG001|Overall Study|Physician Decision|0|||
160788371|NCT00992394|580610903|FG000|Overall Study|Protocol Violation|2|||
160788372|NCT00992394|580610904|FG001|Overall Study|Protocol Violation|4|||
160788373|NCT00992394|580610903|FG000|Overall Study|Lost to Follow-up|2|||
160788374|NCT00992394|580610904|FG001|Overall Study|Lost to Follow-up|0|||
160788375|NCT00992394|580610903|FG000|Overall Study|Other event|1|||
160788376|NCT00992394|580610904|FG001|Overall Study|Other event|0|||
160788377|NCT01245049|580610905|FG000|Overall Study|Migrated/moved from study area|0|||
160788378|NCT01245049|580610906|FG001|Overall Study|Migrated/moved from study area|1|||
161234627|NCT00854100|582241929|FG000|Overall Study|Lost to Follow-up|2|||
161234628|NCT00854100|582241930|FG001|Overall Study|Lost to Follow-up|0|||
160788379|NCT01245049|580610905|FG000|Overall Study|Withdrawal by Subject|0|||
160788380|NCT01245049|580610906|FG001|Overall Study|Withdrawal by Subject|1|||
160788381|NCT01245049|580610905|FG000|Overall Study|Lost to Follow-up|1|||
161234629|NCT00854100|582241931|FG002|Overall Study|Lost to Follow-up|3|||
161234630|NCT00854100|582241929|FG000|Overall Study|Withdrawal by Subject|3|||
161234631|NCT00854100|582241930|FG001|Overall Study|Withdrawal by Subject|1|||
161234632|NCT00854100|582241931|FG002|Overall Study|Withdrawal by Subject|2|||
161234633|NCT00854100|582241929|FG000|Overall Study|Protocol Violation|2|||
161234634|NCT00854100|582241930|FG001|Overall Study|Protocol Violation|4|||
160788382|NCT01245049|580610906|FG001|Overall Study|Lost to Follow-up|2|||
160788383|NCT00450749|580610907|FG000|Overall Study|Withdrawal by Subject|0|||
160788384|NCT00450749|580610908|FG001|Overall Study|Withdrawal by Subject|0|||
160788385|NCT00450749|580610909|FG002|Overall Study|Withdrawal by Subject|2|||
160788386|NCT00450749|580610907|FG000|Overall Study|Noncompliant|0|||
160788387|NCT00450749|580610908|FG001|Overall Study|Noncompliant|1|||
160788388|NCT00450749|580610909|FG002|Overall Study|Noncompliant|0|||
160788389|NCT02151604|580610910|FG000|Overall Study|Lost to Follow-up|3|||
160788390|NCT02151604|580610910|FG000|Overall Study|Withdrawal by Subject|2|||
161234635|NCT00854100|582241931|FG002|Overall Study|Protocol Violation|3|||
161234636|NCT00854100|582241929|FG000|Overall Study|Adverse Event|2|||
161234637|NCT00854100|582241930|FG001|Overall Study|Adverse Event|1|||
161234638|NCT00854100|582241931|FG002|Overall Study|Adverse Event|2|||
161234639|NCT02242201|582241933|FG000|Overall Study|preoperative identified neuropathy|2|||
161234640|NCT02242201|582241934|FG001|Overall Study|preoperative identified neuropathy|0|||
161234641|NCT02242201|582241935|FG002|Overall Study|preoperative identified neuropathy|0|||
161234642|NCT02242201|582241933|FG000|Overall Study|planned post-op anticoagulation|1|||
161234643|NCT02242201|582241934|FG001|Overall Study|planned post-op anticoagulation|0|||
161234644|NCT02242201|582241935|FG002|Overall Study|planned post-op anticoagulation|0|||
161234645|NCT02242201|582241933|FG000|Overall Study|changed surgical procedure|1|||
161234646|NCT02242201|582241934|FG001|Overall Study|changed surgical procedure|0|||
161234647|NCT02242201|582241935|FG002|Overall Study|changed surgical procedure|0|||
161234648|NCT02242201|582241933|FG000|Overall Study|postponed surgery|0|||
161234649|NCT02242201|582241934|FG001|Overall Study|postponed surgery|0|||
161234650|NCT02242201|582241935|FG002|Overall Study|postponed surgery|1|||
161234651|NCT02242201|582241933|FG000|Overall Study|preoperative opioid consumption|0|||
161234652|NCT02242201|582241934|FG001|Overall Study|preoperative opioid consumption|1|||
161234653|NCT02242201|582241935|FG002|Overall Study|preoperative opioid consumption|0|||
161234654|NCT00389064|582241936|FG000|Overall Study|Adverse Event|11|||
161234655|NCT00389064|582241937|FG001|Overall Study|Adverse Event|3|||
161234656|NCT00389064|582241936|FG000|Overall Study|Lack of Efficacy|3|||
161234657|NCT00389064|582241937|FG001|Overall Study|Lack of Efficacy|14|||
161234658|NCT00389064|582241936|FG000|Overall Study|Withdrawal by Subject|17|||
161234659|NCT00389064|582241937|FG001|Overall Study|Withdrawal by Subject|27|||
161234660|NCT00389064|582241936|FG000|Overall Study|Physician Decision|2|||
161234661|NCT00389064|582241937|FG001|Overall Study|Physician Decision|2|||
161234662|NCT00389064|582241936|FG000|Overall Study|Lost to Follow-up|1|||
161234663|NCT00389064|582241937|FG001|Overall Study|Lost to Follow-up|2|||
161234664|NCT00389064|582241936|FG000|Overall Study|Protocol Violation|2|||
161234665|NCT00389064|582241937|FG001|Overall Study|Protocol Violation|0|||
161234666|NCT00389064|582241936|FG000|Overall Study|Multiple Reasons|9|||
161234667|NCT00389064|582241937|FG001|Overall Study|Multiple Reasons|11|||
161234668|NCT01697696|582241940|FG000|Overall Study|Study terminated by sponsor|0|||
161234669|NCT01697696|582241941|FG001|Overall Study|Study terminated by sponsor|3|||
161234670|NCT01697696|582241940|FG000|Overall Study|Protocol deviation|1|||
161234671|NCT01697696|582241941|FG001|Overall Study|Protocol deviation|0|||
161234672|NCT01697696|582241940|FG000|Overall Study|Physician Decision|1|||
161234673|NCT01697696|582241941|FG001|Overall Study|Physician Decision|0|||
161234674|NCT01697696|582241940|FG000|Overall Study|Death|4|||
161234675|NCT01697696|582241941|FG001|Overall Study|Death|2|||
161234676|NCT01697696|582241940|FG000|Overall Study|Lost to Follow-up|10|||
161234677|NCT01697696|582241941|FG001|Overall Study|Lost to Follow-up|7|||
161234678|NCT01697696|582241940|FG000|Overall Study|Subject/guardian decision|31|||
161234679|NCT01697696|582241941|FG001|Overall Study|Subject/guardian decision|35|||
161234680|NCT03616106|582241942|FG000|Overall Study|Removed by PI|6|||
161234681|NCT03616106|582241943|FG001|Overall Study|Removed by PI|0|||
161234682|NCT03616106|582241942|FG000|Overall Study|Withdrawal by Subject|1|||
161234683|NCT03616106|582241943|FG001|Overall Study|Withdrawal by Subject|1|||
161234684|NCT03616106|582241942|FG000|Overall Study|Lost to Follow-up|7|||
161234685|NCT03616106|582241943|FG001|Overall Study|Lost to Follow-up|0|||
161234686|NCT01880593|582241946|FG000|Overall Study|Adverse Event|1|||
161234687|NCT01880593|582241947|FG001|Overall Study|Adverse Event|0|||
161234688|NCT01880593|582241946|FG000|Overall Study|Lack of Efficacy|1|||
161234689|NCT01880593|582241947|FG001|Overall Study|Lack of Efficacy|5|||
161234690|NCT01880593|582241946|FG000|Overall Study|Withdrawal by Subject|6|||
161234691|NCT01880593|582241947|FG001|Overall Study|Withdrawal by Subject|1|||
161234692|NCT05275205|582241950|FG000|Overall Study|Adverse Event|1|||
161234693|NCT05275205|582241951|FG001|Overall Study|Adverse Event|2|||
161234694|NCT05275205|582241950|FG000|Overall Study|Physician Decision|1|||
161234695|NCT05275205|582241951|FG001|Overall Study|Physician Decision|1|||
161234696|NCT05275205|582241950|FG000|Overall Study|Withdrawal by Subject|2|||
161234697|NCT05275205|582241951|FG001|Overall Study|Withdrawal by Subject|3|||
161234698|NCT05275205|582241950|FG000|Overall Study|Death|1|||
161234699|NCT05275205|582241951|FG001|Overall Study|Death|0|||
161234700|NCT05275205|582241950|FG000|Overall Study|Patient unable to attend visits|1|||
161234701|NCT05275205|582241951|FG001|Overall Study|Patient unable to attend visits|0|||
161234702|NCT03243630|582241954|FG000|Overall Study|Protocol Violation|1|||
161234703|NCT03243630|582241954|FG000|Overall Study|Physician Decision|1|||
161234704|NCT00939003|582241955|FG000|Double-blind Treatment Period|Adverse Event|1|||
161234705|NCT00939003|582241956|FG001|Double-blind Treatment Period|Adverse Event|1|||
161234706|NCT00939003|582241955|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161234707|NCT00939003|582241956|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161234708|NCT00939003|582241955|FG000|Double-blind Treatment Period|Pregnancy|0|||
161234709|NCT00939003|582241956|FG001|Double-blind Treatment Period|Pregnancy|1|||
161234710|NCT00939003|582241955|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
161234711|NCT00939003|582241956|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
161234712|NCT00939003|582241955|FG000|Open-label Treatment Period|Adverse Event|4|||
161234713|NCT00939003|582241956|FG001|Open-label Treatment Period|Adverse Event|8|||
161234714|NCT00939003|582241955|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
161234715|NCT00939003|582241956|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
161234716|NCT00939003|582241955|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
161234717|NCT00939003|582241956|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
161234718|NCT00939003|582241955|FG000|Open-label Treatment Period|Pregnancy|1|||
161234719|NCT00939003|582241956|FG001|Open-label Treatment Period|Pregnancy|1|||
161234720|NCT00939003|582241955|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
161234721|NCT00939003|582241956|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
161234722|NCT00939003|582241955|FG000|Open-label Treatment Period|Site Closure|3|||
161234723|NCT00939003|582241956|FG001|Open-label Treatment Period|Site Closure|4|||
161234724|NCT03707912|582241957|FG000|Overall Study|Violation of inclusion criteria|1|||
161234725|NCT03707912|582241958|FG001|Overall Study|Violation of inclusion criteria|0|||
161234726|NCT02186821|582241960|FG000|Overall Study|Adverse Event|9|||
161234727|NCT02186821|582241960|FG000|Overall Study|Death|2|||
161234728|NCT02186821|582241960|FG000|Overall Study|Disease progression|32|||
161234729|NCT02186821|582241960|FG000|Overall Study|Protocol Violation|1|||
161234730|NCT02186821|582241960|FG000|Overall Study|Physician Decision|1|||
161234731|NCT02186821|582241960|FG000|Overall Study|Study terminated by sponsor|2|||
161234732|NCT05472038|582243382|FG000|Overall Study|Adverse Event|0|||
161234733|NCT05472038|582243383|FG001|Overall Study|Adverse Event|0|||
161234734|NCT05472038|582243384|FG002|Overall Study|Adverse Event|1|||
161234735|NCT05472038|582243385|FG003|Overall Study|Adverse Event|0|||
161234736|NCT05472038|582243386|FG004|Overall Study|Adverse Event|0|||
161234737|NCT05472038|582243387|FG005|Overall Study|Adverse Event|0|||
161234738|NCT05472038|582243388|FG006|Overall Study|Adverse Event|0|||
161234739|NCT05472038|582243389|FG007|Overall Study|Adverse Event|0|||
161234740|NCT05472038|582243390|FG008|Overall Study|Adverse Event|0|||
161234741|NCT05472038|582243391|FG009|Overall Study|Adverse Event|0|||
161234742|NCT05472038|582243392|FG010|Overall Study|Adverse Event|0|||
161234743|NCT05472038|582243393|FG011|Overall Study|Adverse Event|0|||
161234744|NCT05472038|582243382|FG000|Overall Study|Death|0|||
161234745|NCT05472038|582243383|FG001|Overall Study|Death|0|||
161234746|NCT05472038|582243384|FG002|Overall Study|Death|0|||
161234747|NCT05472038|582243385|FG003|Overall Study|Death|0|||
161234748|NCT05472038|582243386|FG004|Overall Study|Death|0|||
161234749|NCT05472038|582243387|FG005|Overall Study|Death|1|||
161234750|NCT05472038|582243388|FG006|Overall Study|Death|0|||
161234751|NCT05472038|582243389|FG007|Overall Study|Death|0|||
161234752|NCT05472038|582243390|FG008|Overall Study|Death|0|||
161234753|NCT05472038|582243391|FG009|Overall Study|Death|0|||
161234754|NCT05472038|582243392|FG010|Overall Study|Death|0|||
161234755|NCT05472038|582243393|FG011|Overall Study|Death|0|||
161234756|NCT05472038|582243382|FG000|Overall Study|Lost to Follow-up|1|||
161234757|NCT05472038|582243383|FG001|Overall Study|Lost to Follow-up|3|||
161234758|NCT05472038|582243384|FG002|Overall Study|Lost to Follow-up|3|||
161234759|NCT05472038|582243385|FG003|Overall Study|Lost to Follow-up|9|||
161234760|NCT05472038|582243386|FG004|Overall Study|Lost to Follow-up|2|||
161234761|NCT05472038|582243387|FG005|Overall Study|Lost to Follow-up|2|||
161234762|NCT05472038|582243388|FG006|Overall Study|Lost to Follow-up|1|||
161234763|NCT05472038|582243389|FG007|Overall Study|Lost to Follow-up|0|||
161234764|NCT05472038|582243390|FG008|Overall Study|Lost to Follow-up|1|||
161234765|NCT05472038|582243391|FG009|Overall Study|Lost to Follow-up|0|||
161234766|NCT05472038|582243392|FG010|Overall Study|Lost to Follow-up|2|||
161234767|NCT05472038|582243393|FG011|Overall Study|Lost to Follow-up|1|||
161234768|NCT05472038|582243382|FG000|Overall Study|Physician Decision|0|||
161234769|NCT05472038|582243383|FG001|Overall Study|Physician Decision|0|||
161234770|NCT05472038|582243384|FG002|Overall Study|Physician Decision|0|||
161234771|NCT05472038|582243385|FG003|Overall Study|Physician Decision|0|||
161234772|NCT05472038|582243386|FG004|Overall Study|Physician Decision|1|||
161234773|NCT05472038|582243387|FG005|Overall Study|Physician Decision|0|||
161234774|NCT05472038|582243388|FG006|Overall Study|Physician Decision|0|||
161234775|NCT05472038|582243389|FG007|Overall Study|Physician Decision|0|||
161234776|NCT05472038|582243390|FG008|Overall Study|Physician Decision|0|||
161234777|NCT05472038|582243391|FG009|Overall Study|Physician Decision|0|||
161234778|NCT05472038|582243392|FG010|Overall Study|Physician Decision|0|||
161234779|NCT05472038|582243393|FG011|Overall Study|Physician Decision|0|||
161234780|NCT05472038|582243382|FG000|Overall Study|Withdrawal by Subject|1|||
161234781|NCT05472038|582243383|FG001|Overall Study|Withdrawal by Subject|3|||
161234782|NCT05472038|582243384|FG002|Overall Study|Withdrawal by Subject|1|||
161234783|NCT05472038|582243385|FG003|Overall Study|Withdrawal by Subject|6|||
161234784|NCT05472038|582243386|FG004|Overall Study|Withdrawal by Subject|1|||
161234785|NCT05472038|582243387|FG005|Overall Study|Withdrawal by Subject|3|||
161234786|NCT05472038|582243388|FG006|Overall Study|Withdrawal by Subject|0|||
161234787|NCT05472038|582243389|FG007|Overall Study|Withdrawal by Subject|2|||
161234788|NCT05472038|582243390|FG008|Overall Study|Withdrawal by Subject|3|||
161234789|NCT05472038|582243391|FG009|Overall Study|Withdrawal by Subject|1|||
161234790|NCT05472038|582243392|FG010|Overall Study|Withdrawal by Subject|2|||
161234791|NCT05472038|582243393|FG011|Overall Study|Withdrawal by Subject|2|||
161234792|NCT05472038|582243382|FG000|Overall Study|Protocol Violation|0|||
161234793|NCT05472038|582243383|FG001|Overall Study|Protocol Violation|0|||
161234794|NCT05472038|582243384|FG002|Overall Study|Protocol Violation|0|||
161234795|NCT05472038|582243385|FG003|Overall Study|Protocol Violation|0|||
161234796|NCT05472038|582243386|FG004|Overall Study|Protocol Violation|0|||
161234797|NCT05472038|582243387|FG005|Overall Study|Protocol Violation|0|||
161234798|NCT05472038|582243388|FG006|Overall Study|Protocol Violation|0|||
161234799|NCT05472038|582243389|FG007|Overall Study|Protocol Violation|1|||
161234800|NCT05472038|582243390|FG008|Overall Study|Protocol Violation|1|||
160891014|NCT03416374|580996818|FG000|Between Treatment Period I and II|Other|0|||
160891015|NCT03416374|580996819|FG001|Between Treatment Period I and II|Other|9|||
160891016|NCT03416374|580996818|FG000|Treatment Period II|Lack of Efficacy|3|||
160891017|NCT03416374|580996819|FG001|Treatment Period II|Lack of Efficacy|11|||
160891018|NCT03416374|580996818|FG000|Treatment Period II|Adverse Event|1|||
160891019|NCT03416374|580996819|FG001|Treatment Period II|Adverse Event|4|||
160891020|NCT03416374|580996818|FG000|Treatment Period II|Death|0|||
160891021|NCT03416374|580996819|FG001|Treatment Period II|Death|1|||
160891022|NCT03416374|580996818|FG000|Treatment Period II|Other|0|||
160891023|NCT03416374|580996819|FG001|Treatment Period II|Other|2|||
160891024|NCT03463031|580996822|FG000|Overall Study|Withdrawal by Subject|4|||
160891025|NCT03463031|580996823|FG001|Overall Study|Withdrawal by Subject|2|||
160891026|NCT03463031|580996822|FG000|Overall Study|Investigator/Sponsor Decision|0|||
160891027|NCT03463031|580996823|FG001|Overall Study|Investigator/Sponsor Decision|1|||
160891028|NCT03463031|580996822|FG000|Overall Study|Lost to Follow-up|1|||
160891029|NCT03463031|580996823|FG001|Overall Study|Lost to Follow-up|1|||
160891030|NCT03463031|580996822|FG000|Overall Study|Adverse Event|4|||
160891031|NCT03463031|580996823|FG001|Overall Study|Adverse Event|1|||
160891032|NCT03463031|580996822|FG000|Overall Study|Use of prohibited medication by subject|1|||
160891033|NCT03463031|580996823|FG001|Overall Study|Use of prohibited medication by subject|0|||
160891034|NCT01025154|580996824|FG000|Overall Study|Lost to Follow-up|1|||
160891035|NCT01025154|580996824|FG000|Overall Study|Withdrawal by Subject|1|||
160891036|NCT01810432|580996825|FG000|Washout|Protocol Violation|0|||
160891037|NCT01810432|580996826|FG001|Washout|Protocol Violation|1|||
160891038|NCT01810432|580996825|FG000|Washout|Adverse Event|1|||
160891039|NCT01810432|580996826|FG001|Washout|Adverse Event|0|||
160891040|NCT01810432|580996825|FG000|Period 2|Withdrawal by Subject|2|||
160891041|NCT01810432|580996826|FG001|Period 2|Withdrawal by Subject|1|||
160891042|NCT01810432|580996825|FG000|Period 2|Physician Decision|1|||
160891043|NCT01810432|580996826|FG001|Period 2|Physician Decision|0|||
160891044|NCT01810432|580996825|FG000|Period 2|Lost to Follow-up|1|||
160891045|NCT01810432|580996826|FG001|Period 2|Lost to Follow-up|1|||
160891046|NCT02147184|580996827|FG000|Overall Study|Lost to Follow-up|28|||
160891047|NCT02147184|580996828|FG001|Overall Study|Lost to Follow-up|15|||
160891048|NCT02147184|580996827|FG000|Overall Study|Study Burden|11|||
160891049|NCT02147184|580996828|FG001|Overall Study|Study Burden|7|||
160891050|NCT02147184|580996827|FG000|Overall Study|Pregnancy|6|||
160891051|NCT02147184|580996828|FG001|Overall Study|Pregnancy|0|||
161234801|NCT05472038|582243391|FG009|Overall Study|Protocol Violation|1|||
161234802|NCT05472038|582243392|FG010|Overall Study|Protocol Violation|1|||
161234803|NCT05472038|582243393|FG011|Overall Study|Protocol Violation|1|||
161234804|NCT05472038|582243382|FG000|Overall Study|Not vaccinated|0|||
161234805|NCT05472038|582243383|FG001|Overall Study|Not vaccinated|0|||
161234806|NCT05472038|582243384|FG002|Overall Study|Not vaccinated|0|||
161234807|NCT05472038|582243385|FG003|Overall Study|Not vaccinated|1|||
161234808|NCT05472038|582243386|FG004|Overall Study|Not vaccinated|0|||
161234809|NCT05472038|582243387|FG005|Overall Study|Not vaccinated|0|||
161234810|NCT05472038|582243388|FG006|Overall Study|Not vaccinated|0|||
161234811|NCT05472038|582243389|FG007|Overall Study|Not vaccinated|0|||
161234812|NCT05472038|582243390|FG008|Overall Study|Not vaccinated|0|||
161234813|NCT05472038|582243391|FG009|Overall Study|Not vaccinated|0|||
161234814|NCT05472038|582243392|FG010|Overall Study|Not vaccinated|0|||
161234815|NCT05472038|582243393|FG011|Overall Study|Not vaccinated|0|||
160891052|NCT02147184|580996827|FG000|Overall Study|Moved out of state|3|||
160891053|NCT02147184|580996828|FG001|Overall Study|Moved out of state|3|||
160891054|NCT02147184|580996827|FG000|Overall Study|Physician Decision|0|||
160891055|NCT02147184|580996828|FG001|Overall Study|Physician Decision|2|||
161234816|NCT00467896|582243394|FG000|Overall Study|Consent Withdrawal|18|||
161234817|NCT00467896|582243394|FG000|Overall Study|Adverse Event|7|||
161234818|NCT00467896|582243394|FG000|Overall Study|Serious Adverse Event|13|||
161234819|NCT00467896|582243394|FG000|Overall Study|Non-compliance|3|||
161234820|NCT00467896|582243394|FG000|Overall Study|Changed therapy|2|||
161234821|NCT00467896|582243394|FG000|Overall Study|Patient received transplant|2|||
161234822|NCT00467896|582243394|FG000|Overall Study|Patient had atrial septostomy|1|||
161234823|NCT00467896|582243394|FG000|Overall Study|Patient weaned off iloprost|1|||
161234824|NCT00467896|582243394|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
161234825|NCT00467896|582243394|FG000|Overall Study|Started intravenous prostacyclin|1|||
161234826|NCT00467896|582243394|FG000|Overall Study|Started inhaled Remodulin|1|||
161234827|NCT00467896|582243394|FG000|Overall Study|Patient had no improvement|1|||
161234828|NCT02847650|582243395|FG000|Overall Study|Adverse Event|2|||
161234829|NCT02847650|582243396|FG001|Overall Study|Adverse Event|4|||
161234830|NCT02847650|582243395|FG000|Overall Study|Lost to Follow-up|1|||
161234831|NCT02847650|582243396|FG001|Overall Study|Lost to Follow-up|0|||
161234832|NCT02847650|582243395|FG000|Overall Study|Protocol Violation|0|||
161234833|NCT02847650|582243396|FG001|Overall Study|Protocol Violation|1|||
161234834|NCT02847650|582243395|FG000|Overall Study|Withdrawal by Subject|1|||
161234835|NCT02847650|582243396|FG001|Overall Study|Withdrawal by Subject|1|||
161234836|NCT03818581|582243399|FG000|Overall Study|Adverse Event|1|||
161234837|NCT03818581|582243400|FG001|Overall Study|Adverse Event|0|||
161234838|NCT03818581|582243401|FG002|Overall Study|Adverse Event|0|||
161234839|NCT03818581|582243402|FG003|Overall Study|Adverse Event|0|||
161234840|NCT03818581|582243403|FG004|Overall Study|Adverse Event|0|||
161234841|NCT03818581|582243399|FG000|Overall Study|Covid-19|2|||
161234842|NCT03818581|582243400|FG001|Overall Study|Covid-19|0|||
161234843|NCT03818581|582243401|FG002|Overall Study|Covid-19|0|||
161234844|NCT03818581|582243402|FG003|Overall Study|Covid-19|0|||
161234845|NCT03818581|582243403|FG004|Overall Study|Covid-19|1|||
161234846|NCT03818581|582243399|FG000|Overall Study|Withdrawal by Subject|0|||
161234847|NCT03818581|582243400|FG001|Overall Study|Withdrawal by Subject|0|||
161234848|NCT03818581|582243401|FG002|Overall Study|Withdrawal by Subject|0|||
161234849|NCT03818581|582243402|FG003|Overall Study|Withdrawal by Subject|0|||
161234850|NCT03818581|582243403|FG004|Overall Study|Withdrawal by Subject|1|||
161234851|NCT03818581|582243399|FG000|Overall Study|No longer met study criteria|0|||
161234852|NCT03818581|582243400|FG001|Overall Study|No longer met study criteria|0|||
161234853|NCT03818581|582243401|FG002|Overall Study|No longer met study criteria|0|||
161234854|NCT03818581|582243402|FG003|Overall Study|No longer met study criteria|0|||
161234855|NCT03818581|582243403|FG004|Overall Study|No longer met study criteria|1|||
161234856|NCT01466166|582243409|FG000|Overall Study|Death|1|||
161234857|NCT01466166|582243409|FG000|Overall Study|Lost to Follow-up|7|||
161234858|NCT01466166|582243409|FG000|Overall Study|Infusion Reaction (IR)|27|||
161234859|NCT01466166|582243409|FG000|Overall Study|Adverse Event (Other than IR)|11|||
161234860|NCT01466166|582243409|FG000|Overall Study|Elevated Serum Uric Acid|78|||
161234861|NCT01466166|582243409|FG000|Overall Study|Withdrawal by Subject|13|||
161234862|NCT01466166|582243409|FG000|Overall Study|Sponsor Decision|4|||
161234863|NCT01466166|582243409|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
161234864|NCT01466166|582243409|FG000|Overall Study|Other|20|||
161234865|NCT00070291|582243410|FG000|Step 1|Withdrawal by Subject|1|||
161234866|NCT00070291|582243410|FG000|Step 1|Adverse Event|1|||
161234867|NCT00070291|582243410|FG000|Step 2|Adverse Event|1|||
161234868|NCT02262377|582243411|FG000|Overall Study|Lost to Follow-up|5|||
161234869|NCT02262377|582243412|FG001|Overall Study|Lost to Follow-up|6|||
161234870|NCT02262377|582243411|FG000|Overall Study|Found ineligible after enrollment|3|||
161234871|NCT02262377|582243412|FG001|Overall Study|Found ineligible after enrollment|0|||
161234872|NCT02262377|582243411|FG000|Overall Study|Withdrawal by Subject|4|||
161234873|NCT02262377|582243412|FG001|Overall Study|Withdrawal by Subject|0|||
161234874|NCT00371839|582243413|FG000|Overall Study|Death|4|||
161234875|NCT00371839|582243414|FG001|Overall Study|Death|0|||
161234876|NCT00371839|582243415|FG002|Overall Study|Death|0|||
161234877|NCT00371839|582243413|FG000|Overall Study|Withdrawal by Subject|7|||
161234878|NCT00371839|582243414|FG001|Overall Study|Withdrawal by Subject|4|||
161234879|NCT00371839|582243415|FG002|Overall Study|Withdrawal by Subject|0|||
161234880|NCT00371839|582243413|FG000|Overall Study|Lost to Follow-up|6|||
161234881|NCT00371839|582243414|FG001|Overall Study|Lost to Follow-up|3|||
161234882|NCT00371839|582243415|FG002|Overall Study|Lost to Follow-up|2|||
161234883|NCT02533258|582243417|FG000|Overall Study|Adverse Event|1|||
161234884|NCT02533258|582243417|FG000|Overall Study|Death|2|||
161234885|NCT02533258|582243417|FG000|Overall Study|Other|1|||
161234886|NCT02533258|582243417|FG000|Overall Study|Economic factor|1|||
161234887|NCT02533258|582243417|FG000|Overall Study|Progression of pleural effusion|1|||
161234888|NCT02533258|582243417|FG000|Overall Study|Lack of Efficacy|2|||
161234889|NCT02096211|582243418|FG000|Overall Study|Death|2|||
161234890|NCT02096211|582243418|FG000|Overall Study|Withdrawal by Subject|8|||
161234891|NCT02096211|582243418|FG000|Overall Study|Revision of implant|7|||
161234892|NCT02096211|582243418|FG000|Overall Study|Lost to Follow-up|43|||
161234893|NCT01591785|582243419|FG000|Overall Study|worsening condition|1|||
161234894|NCT01591785|582243420|FG001|Overall Study|worsening condition|2|||
161234895|NCT01591785|582243419|FG000|Overall Study|Protocol Violation|2|||
161234896|NCT01591785|582243420|FG001|Overall Study|Protocol Violation|0|||
161234897|NCT01591785|582243419|FG000|Overall Study|Lost to Follow-up|1|||
161234898|NCT01591785|582243420|FG001|Overall Study|Lost to Follow-up|0|||
161234899|NCT01049334|582243421|FG000|Overall Study|Withdrawal by Subject|5|||
161330014|NCT02157519|582594780|FG001|Overall Study|Lost to Follow-up|0|||
161127549|NCT04426695|581855151|FG013|Overall Study|Death|25|||
161127550|NCT04426695|581855152|FG014|Overall Study|Death|19|||
161127551|NCT04426695|581855153|FG015|Overall Study|Death|7|||
161127552|NCT04426695|581855154|FG016|Overall Study|Death|8|||
161127553|NCT04426695|581855155|FG017|Overall Study|Death|4|||
161127554|NCT04426695|581855138|FG000|Overall Study|Lost to Follow-up|2|||
161127555|NCT04426695|581855139|FG001|Overall Study|Lost to Follow-up|4|||
161127556|NCT04426695|581855140|FG002|Overall Study|Lost to Follow-up|1|||
161127557|NCT04426695|581855141|FG003|Overall Study|Lost to Follow-up|19|||
161127558|NCT04426695|581855142|FG004|Overall Study|Lost to Follow-up|10|||
161127559|NCT04426695|581855143|FG005|Overall Study|Lost to Follow-up|14|||
161127560|NCT04426695|581855144|FG006|Overall Study|Lost to Follow-up|5|||
161127561|NCT04426695|581855145|FG007|Overall Study|Lost to Follow-up|14|||
161127562|NCT04426695|581855146|FG008|Overall Study|Lost to Follow-up|10|||
161127563|NCT04426695|581855147|FG009|Overall Study|Lost to Follow-up|11|||
161127564|NCT04426695|581855148|FG010|Overall Study|Lost to Follow-up|12|||
161127565|NCT04426695|581855149|FG011|Overall Study|Lost to Follow-up|6|||
161127566|NCT04426695|581855150|FG012|Overall Study|Lost to Follow-up|2|||
161127567|NCT04426695|581855151|FG013|Overall Study|Lost to Follow-up|2|||
161127568|NCT04426695|581855152|FG014|Overall Study|Lost to Follow-up|2|||
161127569|NCT04426695|581855153|FG015|Overall Study|Lost to Follow-up|0|||
161127570|NCT04426695|581855154|FG016|Overall Study|Lost to Follow-up|0|||
161127571|NCT04426695|581855155|FG017|Overall Study|Lost to Follow-up|0|||
161127572|NCT04426695|581855138|FG000|Overall Study|Participant Decision|1|||
161127573|NCT04426695|581855139|FG001|Overall Study|Participant Decision|2|||
161127574|NCT04426695|581855140|FG002|Overall Study|Participant Decision|2|||
161127575|NCT04426695|581855141|FG003|Overall Study|Participant Decision|12|||
161127576|NCT04426695|581855142|FG004|Overall Study|Participant Decision|18|||
161127577|NCT04426695|581855143|FG005|Overall Study|Participant Decision|22|||
161127578|NCT04426695|581855144|FG006|Overall Study|Participant Decision|13|||
161127579|NCT04426695|581855145|FG007|Overall Study|Participant Decision|13|||
161127580|NCT04426695|581855146|FG008|Overall Study|Participant Decision|10|||
161127581|NCT04426695|581855147|FG009|Overall Study|Participant Decision|15|||
161127582|NCT04426695|581855148|FG010|Overall Study|Participant Decision|16|||
161127583|NCT04426695|581855149|FG011|Overall Study|Participant Decision|17|||
161127584|NCT04426695|581855150|FG012|Overall Study|Participant Decision|2|||
161127585|NCT04426695|581855151|FG013|Overall Study|Participant Decision|1|||
161127586|NCT04426695|581855152|FG014|Overall Study|Participant Decision|2|||
161127587|NCT04426695|581855153|FG015|Overall Study|Participant Decision|0|||
161127588|NCT04426695|581855154|FG016|Overall Study|Participant Decision|0|||
161127589|NCT04426695|581855155|FG017|Overall Study|Participant Decision|0|||
161127590|NCT04426695|581855138|FG000|Overall Study|Adverse Event|0|||
161127591|NCT04426695|581855139|FG001|Overall Study|Adverse Event|0|||
161127592|NCT04426695|581855140|FG002|Overall Study|Adverse Event|0|||
161127593|NCT04426695|581855141|FG003|Overall Study|Adverse Event|0|||
161127594|NCT04426695|581855142|FG004|Overall Study|Adverse Event|0|||
161127595|NCT04426695|581855143|FG005|Overall Study|Adverse Event|0|||
161127596|NCT04426695|581855144|FG006|Overall Study|Adverse Event|0|||
161127597|NCT04426695|581855145|FG007|Overall Study|Adverse Event|1|||
161127598|NCT04426695|581855146|FG008|Overall Study|Adverse Event|0|||
161127599|NCT04426695|581855147|FG009|Overall Study|Adverse Event|0|||
161127600|NCT04426695|581855148|FG010|Overall Study|Adverse Event|1|||
161127601|NCT04426695|581855149|FG011|Overall Study|Adverse Event|1|||
161127602|NCT04426695|581855150|FG012|Overall Study|Adverse Event|0|||
161127603|NCT04426695|581855151|FG013|Overall Study|Adverse Event|0|||
161127604|NCT04426695|581855152|FG014|Overall Study|Adverse Event|0|||
161127605|NCT04426695|581855153|FG015|Overall Study|Adverse Event|0|||
161127606|NCT04426695|581855154|FG016|Overall Study|Adverse Event|0|||
161127607|NCT04426695|581855155|FG017|Overall Study|Adverse Event|0|||
161127608|NCT04426695|581855138|FG000|Overall Study|Sponsor Request|0|||
161127609|NCT04426695|581855139|FG001|Overall Study|Sponsor Request|0|||
161127610|NCT04426695|581855140|FG002|Overall Study|Sponsor Request|0|||
161127611|NCT04426695|581855141|FG003|Overall Study|Sponsor Request|0|||
161127612|NCT04426695|581855142|FG004|Overall Study|Sponsor Request|0|||
161127613|NCT04426695|581855143|FG005|Overall Study|Sponsor Request|0|||
161127614|NCT04426695|581855144|FG006|Overall Study|Sponsor Request|1|||
161127615|NCT04426695|581855145|FG007|Overall Study|Sponsor Request|0|||
161127616|NCT04426695|581855146|FG008|Overall Study|Sponsor Request|0|||
161127617|NCT04426695|581855147|FG009|Overall Study|Sponsor Request|0|||
161127618|NCT04426695|581855148|FG010|Overall Study|Sponsor Request|0|||
161127619|NCT04426695|581855149|FG011|Overall Study|Sponsor Request|0|||
161127620|NCT04426695|581855150|FG012|Overall Study|Sponsor Request|0|||
161127621|NCT04426695|581855151|FG013|Overall Study|Sponsor Request|0|||
161127622|NCT04426695|581855152|FG014|Overall Study|Sponsor Request|0|||
161127623|NCT04426695|581855153|FG015|Overall Study|Sponsor Request|0|||
161127624|NCT04426695|581855154|FG016|Overall Study|Sponsor Request|0|||
161127625|NCT04426695|581855155|FG017|Overall Study|Sponsor Request|0|||
161127626|NCT04426695|581855138|FG000|Overall Study|Physician Decision|0|||
161127627|NCT04426695|581855139|FG001|Overall Study|Physician Decision|0|||
161234900|NCT01049334|582243422|FG001|Overall Study|Withdrawal by Subject|3|||
161234901|NCT01049334|582243421|FG000|Overall Study|Adverse Event|2|||
161234902|NCT01049334|582243422|FG001|Overall Study|Adverse Event|3|||
161234903|NCT01049334|582243421|FG000|Overall Study|Physician Decision|2|||
161234904|NCT01049334|582243422|FG001|Overall Study|Physician Decision|0|||
161234905|NCT01049334|582243421|FG000|Overall Study|Protocol Violation|0|||
161234906|NCT01049334|582243422|FG001|Overall Study|Protocol Violation|1|||
161234907|NCT01439880|582243431|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
161234908|NCT01439880|582243432|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
161234909|NCT01439880|582243431|FG000|SOC-controlled Period (Year 1)|Death|2|||
161234910|NCT01439880|582243432|FG001|SOC-controlled Period (Year 1)|Death|1|||
161234911|NCT01439880|582243431|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
161234912|NCT01439880|582243432|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
161234913|NCT01439880|582243431|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
161234914|NCT01439880|582243432|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
161234915|NCT01439880|582243431|FG000|SOC-controlled Period (Year 1)|Other|8|||
161234916|NCT01439880|582243432|FG001|SOC-controlled Period (Year 1)|Other|13|||
161234917|NCT01439880|582243431|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
161234918|NCT01439880|582243432|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
161234919|NCT01439880|582243431|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
161234920|NCT01439880|582243432|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
161234921|NCT01439880|582243431|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
161234922|NCT01439880|582243432|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
161234923|NCT01439880|582243431|FG000|All-IP Period (Years 2 to 5)|Death|3|||
161234924|NCT01439880|582243432|FG001|All-IP Period (Years 2 to 5)|Death|13|||
161234925|NCT01439880|582243431|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
161234926|NCT01439880|582243432|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
161234927|NCT01439880|582243431|FG000|All-IP Period (Years 2 to 5)|Other|14|||
161234928|NCT01439880|582243432|FG001|All-IP Period (Years 2 to 5)|Other|31|||
161234929|NCT01439880|582243431|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
161234930|NCT01439880|582243432|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
161234931|NCT02378935|582243436|FG000|Overall Study|Lack of Efficacy|10|||
161234932|NCT02378935|582243437|FG001|Overall Study|Lack of Efficacy|0|||
161234933|NCT02378935|582243438|FG002|Overall Study|Lack of Efficacy|2|||
161234934|NCT02378935|582243439|FG003|Overall Study|Lack of Efficacy|6|||
161234935|NCT02378935|582243440|FG004|Overall Study|Lack of Efficacy|0|||
161234936|NCT02378935|582243441|FG005|Overall Study|Lack of Efficacy|0|||
161234937|NCT02378935|582243442|FG006|Overall Study|Lack of Efficacy|0|||
161234938|NCT02378935|582243436|FG000|Overall Study|Death|0|||
161234939|NCT02378935|582243437|FG001|Overall Study|Death|0|||
161234940|NCT02378935|582243438|FG002|Overall Study|Death|1|||
161234941|NCT02378935|582243439|FG003|Overall Study|Death|0|||
161234942|NCT02378935|582243440|FG004|Overall Study|Death|0|||
161234943|NCT02378935|582243441|FG005|Overall Study|Death|0|||
161234944|NCT02378935|582243442|FG006|Overall Study|Death|0|||
160788391|NCT02151604|580610910|FG000|Overall Study|Physician Decision|3|||
160788392|NCT02151604|580610910|FG000|Overall Study|Death|1|||
160788393|NCT00537082|580610912|FG000|Overall Study|Adverse Event|6|||
161234945|NCT03450057|582243447|FG000|Overall Study|Death|17|||
161234946|NCT03450057|582243447|FG000|Overall Study|ICF withdrawal|4|||
161234947|NCT03450057|582243447|FG000|Overall Study|Lost to Follow-up|2|||
161234948|NCT03214952|582243450|FG000|Overall Study|Protocol Deviation|45|||
161330015|NCT01656395|582594781|FG000|Overall Study|Adverse Event|1|||
161330016|NCT01656395|582594782|FG001|Overall Study|Adverse Event|14|||
161330017|NCT01656395|582594783|FG002|Overall Study|Adverse Event|5|||
161330018|NCT01656395|582594784|FG003|Overall Study|Adverse Event|4|||
161330019|NCT01656395|582594785|FG004|Overall Study|Adverse Event|5|||
161330020|NCT01656395|582594786|FG005|Overall Study|Adverse Event|7|||
161330021|NCT01656395|582594787|FG006|Overall Study|Adverse Event|0|||
161330022|NCT01656395|582594788|FG007|Overall Study|Adverse Event|0|||
161330023|NCT01656395|582594781|FG000|Overall Study|Lack of Efficacy|1|||
161330024|NCT01656395|582594782|FG001|Overall Study|Lack of Efficacy|8|||
161330025|NCT01656395|582594783|FG002|Overall Study|Lack of Efficacy|6|||
161330026|NCT01656395|582594784|FG003|Overall Study|Lack of Efficacy|1|||
161330027|NCT01656395|582594785|FG004|Overall Study|Lack of Efficacy|1|||
161330028|NCT01656395|582594786|FG005|Overall Study|Lack of Efficacy|6|||
161330029|NCT01656395|582594787|FG006|Overall Study|Lack of Efficacy|0|||
161330030|NCT01656395|582594788|FG007|Overall Study|Lack of Efficacy|0|||
161330031|NCT01656395|582594781|FG000|Overall Study|Lost to Follow-up|1|||
161330032|NCT01656395|582594782|FG001|Overall Study|Lost to Follow-up|0|||
161330033|NCT01656395|582594783|FG002|Overall Study|Lost to Follow-up|0|||
160788394|NCT00537082|580610913|FG001|Overall Study|Adverse Event|6|||
160788395|NCT00537082|580610914|FG002|Overall Study|Adverse Event|3|||
161234949|NCT03214952|582243450|FG000|Overall Study|Case Report Forms Uncollected|13|||
161234950|NCT03935880|582243451|FG000|Overall Study|Lost to Follow-up|0|||
161234951|NCT03935880|582243452|FG001|Overall Study|Lost to Follow-up|1|||
161234952|NCT02476994|582243453|FG000|Overall Study|Based on feedback from FDA|1|||
161330034|NCT01656395|582594784|FG003|Overall Study|Lost to Follow-up|0|||
161234953|NCT02476994|582243454|FG001|Overall Study|Based on feedback from FDA|0|||
161234954|NCT02246166|582243455|FG000|Overall Study|Protocol Violation|1|||
161234955|NCT02246166|582243456|FG001|Overall Study|Protocol Violation|0|||
161234956|NCT03769896|582243457|FG000|Open-label Phase|Lack of Efficacy|5|||
161234957|NCT03769896|582243458|FG001|Open-label Phase|Lack of Efficacy|0|||
161234958|NCT03769896|582243457|FG000|Open-label Phase|Adverse Event|3|||
161234959|NCT03769896|582243458|FG001|Open-label Phase|Adverse Event|0|||
161234960|NCT03769896|582243457|FG000|Open-label Phase|Withdrawal by Subject|1|||
161234961|NCT03769896|582243458|FG001|Open-label Phase|Withdrawal by Subject|0|||
161234962|NCT01015703|582243459|FG000|Overall Study|Withdrawal by Subject|0|||
161234963|NCT01015703|582243460|FG001|Overall Study|Withdrawal by Subject|1|||
161234964|NCT01015703|582243461|FG002|Overall Study|Withdrawal by Subject|0|||
161234965|NCT01015703|582243462|FG003|Overall Study|Withdrawal by Subject|0|||
161234966|NCT01015703|582243463|FG004|Overall Study|Withdrawal by Subject|0|||
160891056|NCT02147184|580996827|FG000|Overall Study|Other|1|||
160891057|NCT02147184|580996828|FG001|Overall Study|Other|0|||
160891058|NCT02117414|580996829|FG000|Overall Study|Death|5|||
160891059|NCT02117414|580996830|FG001|Overall Study|Death|2|||
160891060|NCT02117414|580996829|FG000|Overall Study|Withdrawal by Subject|10|||
160891061|NCT02117414|580996830|FG001|Overall Study|Withdrawal by Subject|4|||
160891062|NCT02537574|580996832|FG000|Overall Study|Adverse Event|1|||
160891063|NCT02537574|580996833|FG001|Overall Study|Adverse Event|3|||
160891064|NCT02537574|580996834|FG002|Overall Study|Adverse Event|2|||
160891065|NCT02537574|580996832|FG000|Overall Study|Lost to Follow-up|40|||
160891066|NCT02537574|580996833|FG001|Overall Study|Lost to Follow-up|51|||
160891067|NCT02537574|580996834|FG002|Overall Study|Lost to Follow-up|55|||
160891068|NCT02537574|580996832|FG000|Overall Study|Noncompliance with study drug|0|||
160891069|NCT02537574|580996833|FG001|Overall Study|Noncompliance with study drug|1|||
160891070|NCT02537574|580996834|FG002|Overall Study|Noncompliance with study drug|1|||
160891071|NCT02537574|580996832|FG000|Overall Study|Physician Decision|2|||
160891072|NCT02537574|580996833|FG001|Overall Study|Physician Decision|0|||
160891073|NCT02537574|580996834|FG002|Overall Study|Physician Decision|0|||
160891074|NCT02537574|580996832|FG000|Overall Study|Protocol Violation|4|||
160891075|NCT02537574|580996833|FG001|Overall Study|Protocol Violation|2|||
160891076|NCT02537574|580996834|FG002|Overall Study|Protocol Violation|3|||
160891077|NCT02537574|580996832|FG000|Overall Study|Withdrawal by Subject|37|||
160891078|NCT02537574|580996833|FG001|Overall Study|Withdrawal by Subject|27|||
160891079|NCT02537574|580996834|FG002|Overall Study|Withdrawal by Subject|29|||
160891080|NCT02537574|580996832|FG000|Overall Study|Lack of Efficacy|14|||
160891081|NCT02537574|580996833|FG001|Overall Study|Lack of Efficacy|16|||
160891082|NCT02537574|580996834|FG002|Overall Study|Lack of Efficacy|15|||
160891083|NCT02537574|580996832|FG000|Overall Study|Duplicate Patient|1|||
160891084|NCT02537574|580996833|FG001|Overall Study|Duplicate Patient|0|||
160891085|NCT02537574|580996834|FG002|Overall Study|Duplicate Patient|0|||
160891086|NCT02537574|580996832|FG000|Overall Study|Patient not Stable|0|||
160891087|NCT02537574|580996833|FG001|Overall Study|Patient not Stable|1|||
160891088|NCT02537574|580996834|FG002|Overall Study|Patient not Stable|0|||
161234967|NCT01015703|582243459|FG000|Overall Study|Adverse Event|1|||
161234968|NCT01015703|582243460|FG001|Overall Study|Adverse Event|0|||
161234969|NCT01015703|582243461|FG002|Overall Study|Adverse Event|0|||
161234970|NCT01015703|582243462|FG003|Overall Study|Adverse Event|0|||
161234971|NCT01015703|582243463|FG004|Overall Study|Adverse Event|0|||
161234972|NCT01015703|582243459|FG000|Overall Study|Protocol Violation|1|||
161234973|NCT01015703|582243460|FG001|Overall Study|Protocol Violation|0|||
161234974|NCT01015703|582243461|FG002|Overall Study|Protocol Violation|0|||
161234975|NCT01015703|582243462|FG003|Overall Study|Protocol Violation|0|||
161234976|NCT01015703|582243463|FG004|Overall Study|Protocol Violation|0|||
161234977|NCT03122535|582243464|FG000|Overall Study|Lost to Follow-up|68|||
161234978|NCT03122535|582243465|FG001|Overall Study|Lost to Follow-up|68|||
161234979|NCT03122535|582243464|FG000|Overall Study|Physician Decision|3|||
161234980|NCT03122535|582243465|FG001|Overall Study|Physician Decision|3|||
161234981|NCT03122535|582243464|FG000|Overall Study|Withdrawal by Subject|2|||
161234982|NCT03122535|582243465|FG001|Overall Study|Withdrawal by Subject|2|||
161234983|NCT00857454|582243468|FG000|Overall Study|Withdrawal by Subject|2|||
161234984|NCT00857454|582243468|FG000|Overall Study|Lost to Follow-up|1|||
161234985|NCT00857454|582243468|FG000|Overall Study|Adverse Event|2|||
161234986|NCT00857454|582243468|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
161234987|NCT00857454|582243468|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
161234988|NCT00857454|582243468|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
161234989|NCT00984022|582243469|FG000|Overall Study|Lost to Follow-up|10|||
161234990|NCT00984022|582243470|FG001|Overall Study|Lost to Follow-up|14|||
161234991|NCT00573443|582243471|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161234992|NCT00573443|582243472|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161234993|NCT00573443|582243473|FG002|Double-Blind Phase|Lost to Follow-up|2|||
160891089|NCT02537574|580996832|FG000|Overall Study|Incarceration|0|||
160891090|NCT02537574|580996833|FG001|Overall Study|Incarceration|1|||
160891091|NCT02537574|580996834|FG002|Overall Study|Incarceration|0|||
161234994|NCT00573443|582243471|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
161234995|NCT00573443|582243472|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
161234996|NCT00573443|582243473|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
161234997|NCT00573443|582243471|FG000|Double-Blind Phase|Adverse Event|1|||
161234998|NCT00573443|582243472|FG001|Double-Blind Phase|Adverse Event|5|||
161234999|NCT00573443|582243473|FG002|Double-Blind Phase|Adverse Event|0|||
161235000|NCT00573443|582243471|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
161235001|NCT00573443|582243472|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
161235002|NCT00573443|582243473|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
161235003|NCT00573443|582243471|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
161235004|NCT00573443|582243472|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
161235005|NCT00573443|582243473|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
161235006|NCT00573443|582243471|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161235007|NCT00573443|582243472|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161235008|NCT00573443|582243473|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
161235009|NCT00573443|582243471|FG000|Double-Blind Phase|Protocol Violation|0|||
161235010|NCT00573443|582243472|FG001|Double-Blind Phase|Protocol Violation|2|||
161235011|NCT00573443|582243473|FG002|Double-Blind Phase|Protocol Violation|1|||
161235012|NCT00573443|582243471|FG000|Double-Blind Phase|Other|0|||
161235013|NCT00573443|582243472|FG001|Double-Blind Phase|Other|2|||
161235014|NCT00573443|582243473|FG002|Double-Blind Phase|Other|3|||
161235015|NCT00573443|582243471|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
161235016|NCT00573443|582243472|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161235017|NCT00573443|582243473|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
161235018|NCT00573443|582243471|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
161235019|NCT00573443|582243472|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
161235020|NCT00573443|582243473|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
161235021|NCT00573443|582243471|FG000|Open-Label Extension Phase|Adverse Event|3|||
161235022|NCT00573443|582243472|FG001|Open-Label Extension Phase|Adverse Event|0|||
161235023|NCT00573443|582243473|FG002|Open-Label Extension Phase|Adverse Event|0|||
161235024|NCT00573443|582243471|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
161235025|NCT00573443|582243472|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
161235026|NCT00573443|582243473|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
161235027|NCT00573443|582243471|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
161235028|NCT00573443|582243472|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
161235029|NCT00573443|582243473|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
161235030|NCT00573443|582243471|FG000|Open-Label Extension Phase|Protocol Violation|2|||
161235031|NCT00573443|582243472|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161235032|NCT00573443|582243473|FG002|Open-Label Extension Phase|Protocol Violation|0|||
161235033|NCT00573443|582243471|FG000|Open-Label Extension Phase|Other|2|||
161235034|NCT00573443|582243472|FG001|Open-Label Extension Phase|Other|0|||
161235035|NCT00573443|582243473|FG002|Open-Label Extension Phase|Other|0|||
161235036|NCT04567186|582243477|FG000|Period 1|COVID-19 related|1|||
161235037|NCT04567186|582243478|FG001|Period 1|COVID-19 related|0|||
161235038|NCT04567186|582243477|FG000|Period 1|Protocol Violation|0|||
161235039|NCT04567186|582243478|FG001|Period 1|Protocol Violation|1|||
161235040|NCT04567186|582243477|FG000|Period 1|Adverse Event|0|||
161235041|NCT04567186|582243478|FG001|Period 1|Adverse Event|2|||
161235042|NCT04567186|582243477|FG000|Period 2|COVID-19 Related|0|||
161235043|NCT04567186|582243478|FG001|Period 2|COVID-19 Related|1|||
161235044|NCT04567186|582243477|FG000|Period 2|Protocol Violation|0|||
161235045|NCT04567186|582243478|FG001|Period 2|Protocol Violation|1|||
161235046|NCT04567186|582243477|FG000|Period 2|Lost to Follow-up|0|||
161235047|NCT04567186|582243478|FG001|Period 2|Lost to Follow-up|1|||
161235048|NCT04567186|582243477|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
161235049|NCT04567186|582243478|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
161235050|NCT02924883|582243479|FG000|Overall Study|Death|39|||
161235051|NCT02924883|582243480|FG001|Overall Study|Death|20|||
161235052|NCT02924883|582243479|FG000|Overall Study|Lost to Follow-up|1|||
161235053|NCT02924883|582243480|FG001|Overall Study|Lost to Follow-up|0|||
161235054|NCT02924883|582243479|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
161235055|NCT02924883|582243480|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
161235056|NCT02924883|582243479|FG000|Overall Study|Protocol Violation|1|||
161235057|NCT02924883|582243480|FG001|Overall Study|Protocol Violation|0|||
161235058|NCT02924883|582243479|FG000|Overall Study|Withdrawal by Subject|22|||
161235059|NCT02924883|582243480|FG001|Overall Study|Withdrawal by Subject|16|||
161235060|NCT02924883|582243479|FG000|Overall Study|Progressive Disease|1|||
161235061|NCT02924883|582243480|FG001|Overall Study|Progressive Disease|0|||
160788396|NCT00537082|580610912|FG000|Overall Study|Protocol Violation|0|||
160788397|NCT00537082|580610913|FG001|Overall Study|Protocol Violation|2|||
161235062|NCT02924883|582243479|FG000|Overall Study|Study Terminated by Sponsor|69|||
161235063|NCT02924883|582243480|FG001|Overall Study|Study Terminated by Sponsor|32|||
161235064|NCT00004562|582243481|FG000|Overall Study|Lost to Follow-up|102|||
161235065|NCT00004562|582243482|FG001|Overall Study|Lost to Follow-up|91|||
161235066|NCT02865850|582243483|FG000|Overall Study|Death|15|||
161235067|NCT02865850|582243484|FG001|Overall Study|Death|19|||
161235068|NCT02865850|582243483|FG000|Overall Study|Withdrawal by Subject|3|||
161235069|NCT02865850|582243484|FG001|Overall Study|Withdrawal by Subject|2|||
161235070|NCT02865850|582243483|FG000|Overall Study|Lost to Follow-up|3|||
161235071|NCT02865850|582243484|FG001|Overall Study|Lost to Follow-up|2|||
161235072|NCT00552669|582243485|FG000|Overall Study|Death|3|||
161235073|NCT00552669|582243486|FG001|Overall Study|Death|7|||
161235074|NCT00252720|582243490|FG000|Overall Study|Withdrawal by Subject|95|||
161235075|NCT00252720|582243491|FG001|Overall Study|Withdrawal by Subject|97|||
161235076|NCT00252720|582243490|FG000|Overall Study|Death|7|||
161235077|NCT00252720|582243491|FG001|Overall Study|Death|8|||
161235078|NCT00252720|582243490|FG000|Overall Study|Moving|23|||
161235079|NCT00252720|582243491|FG001|Overall Study|Moving|42|||
161235080|NCT00252720|582243490|FG000|Overall Study|Mainly patients lost to follow-up|7|||
161235081|NCT00252720|582243491|FG001|Overall Study|Mainly patients lost to follow-up|18|||
161235082|NCT02481830|582243494|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
161235083|NCT02481830|582243495|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
161235084|NCT02481830|582243494|FG000|Pre-treatment|Withdrawal by Subject|0|||
161235085|NCT02481830|582243495|FG001|Pre-treatment|Withdrawal by Subject|10|||
161235086|NCT02481830|582243494|FG000|Pre-treatment|Disease Progression|1|||
161235087|NCT02481830|582243495|FG001|Pre-treatment|Disease Progression|1|||
161235088|NCT02481830|582243494|FG000|Pre-treatment|Other reasons|0|||
161235089|NCT02481830|582243495|FG001|Pre-treatment|Other reasons|1|||
161235090|NCT02481830|582243494|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
161235091|NCT02481830|582243495|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
161235092|NCT02481830|582243494|FG000|Treatment|Disease Progression|233|||
161235093|NCT02481830|582243495|FG001|Treatment|Disease Progression|171|||
161235094|NCT02481830|582243494|FG000|Treatment|Study drug toxicity|18|||
161235095|NCT02481830|582243495|FG001|Treatment|Study drug toxicity|38|||
161235096|NCT02481830|582243494|FG000|Treatment|Death|1|||
161235097|NCT02481830|582243495|FG001|Treatment|Death|1|||
161235098|NCT02481830|582243494|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
161235099|NCT02481830|582243495|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
161235100|NCT02481830|582243494|FG000|Treatment|Participants request to discontinue Study treatment|6|||
161235101|NCT02481830|582243495|FG001|Treatment|Participants request to discontinue Study treatment|34|||
161235102|NCT02481830|582243494|FG000|Treatment|Withdrawal by Subject|2|||
161235103|NCT02481830|582243495|FG001|Treatment|Withdrawal by Subject|3|||
161235104|NCT02481830|582243494|FG000|Treatment|Lost to Follow-up|1|||
161330035|NCT01656395|582594785|FG004|Overall Study|Lost to Follow-up|0|||
161330036|NCT01656395|582594786|FG005|Overall Study|Lost to Follow-up|0|||
161330037|NCT01656395|582594787|FG006|Overall Study|Lost to Follow-up|0|||
161330038|NCT01656395|582594788|FG007|Overall Study|Lost to Follow-up|0|||
161330039|NCT01656395|582594781|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161330040|NCT01656395|582594782|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161330041|NCT01656395|582594783|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161330042|NCT01656395|582594784|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161330043|NCT01656395|582594785|FG004|Overall Study|Non-Compliance with Study Drug|1|||
161330044|NCT01656395|582594786|FG005|Overall Study|Non-Compliance with Study Drug|1|||
161330045|NCT01656395|582594787|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161330046|NCT01656395|582594788|FG007|Overall Study|Non-Compliance with Study Drug|0|||
161330047|NCT01656395|582594781|FG000|Overall Study|Other|0|||
160891092|NCT02537574|580996832|FG000|Overall Study|Failed Naloxone Challenge|0|||
160891093|NCT02537574|580996833|FG001|Overall Study|Failed Naloxone Challenge|1|||
160891094|NCT02537574|580996834|FG002|Overall Study|Failed Naloxone Challenge|0|||
161330048|NCT01656395|582594782|FG001|Overall Study|Other|0|||
161330049|NCT01656395|582594783|FG002|Overall Study|Other|1|||
161330050|NCT01656395|582594784|FG003|Overall Study|Other|0|||
161330051|NCT01656395|582594785|FG004|Overall Study|Other|0|||
161330052|NCT01656395|582594786|FG005|Overall Study|Other|1|||
161330053|NCT01656395|582594787|FG006|Overall Study|Other|0|||
160891095|NCT02537574|580996832|FG000|Overall Study|Transportation Issues|0|||
161235105|NCT02481830|582243495|FG001|Treatment|Lost to Follow-up|0|||
161235106|NCT02481830|582243494|FG000|Treatment|Maximum Clinical Benefit|0|||
161235107|NCT02481830|582243495|FG001|Treatment|Maximum Clinical Benefit|5|||
161235108|NCT02481830|582243494|FG000|Treatment|Administrative reason by sponsor|1|||
161235109|NCT02481830|582243495|FG001|Treatment|Administrative reason by sponsor|1|||
161235110|NCT02481830|582243494|FG000|Treatment|Other reasons|6|||
161235111|NCT02481830|582243495|FG001|Treatment|Other reasons|1|||
161330054|NCT01656395|582594788|FG007|Overall Study|Other|0|||
161330055|NCT01656395|582594781|FG000|Overall Study|Physician Decision|2|||
161330056|NCT01656395|582594782|FG001|Overall Study|Physician Decision|3|||
161235112|NCT00772941|582243496|FG000|Overall Study|CRFs not available|195|||
161235113|NCT00772941|582243496|FG000|Overall Study|Study not completed|16|||
161235114|NCT00772941|582243496|FG000|Overall Study|Missed Visits|374|||
161235115|NCT00772941|582243496|FG000|Overall Study|Poor Compliance|7|||
161235116|NCT00772941|582243496|FG000|Overall Study|GPSP Violation|90|||
161235117|NCT04627038|582243497|FG000|Overall Study|Adverse Event|36|||
161235118|NCT04627038|582243498|FG001|Overall Study|Adverse Event|8|||
161235119|NCT04627038|582243497|FG000|Overall Study|Lost to Follow-up|1|||
161330057|NCT01656395|582594783|FG002|Overall Study|Physician Decision|3|||
161330058|NCT01656395|582594784|FG003|Overall Study|Physician Decision|2|||
160891096|NCT02537574|580996833|FG001|Overall Study|Transportation Issues|0|||
160891097|NCT02537574|580996834|FG002|Overall Study|Transportation Issues|1|||
160891098|NCT02537574|580996832|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
160891099|NCT02537574|580996833|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
160891100|NCT02537574|580996834|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
160891101|NCT02537574|580996832|FG000|Overall Study|Noncompliance with Protocol|0|||
160891102|NCT02537574|580996833|FG001|Overall Study|Noncompliance with Protocol|0|||
160891103|NCT02537574|580996834|FG002|Overall Study|Noncompliance with Protocol|1|||
160891104|NCT01151098|580996835|FG000|Overall Study|Adverse Event|82|||
160891105|NCT01151098|580996835|FG000|Overall Study|Lost to Follow-up|6|||
160891106|NCT01151098|580996835|FG000|Overall Study|Lack of Efficacy|15|||
160891107|NCT01151098|580996835|FG000|Overall Study|Protocol Violation|1|||
160891108|NCT01151098|580996835|FG000|Overall Study|Miscellaneous|13|||
160891109|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
160891110|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
160891111|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
160891112|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
160891113|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
160891114|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
160891115|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
160891116|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
160891117|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
160891118|NCT00417482|580996836|FG000|Phase B 1st 16 Weeks|Death|1|||
160891119|NCT00417482|580996837|FG001|Phase B 1st 16 Weeks|Death|0|||
160891120|NCT00417482|580996838|FG002|Phase B 1st 16 Weeks|Death|0|||
160891121|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
160891122|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
160891123|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
160891124|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
160891125|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
160891126|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
160891127|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
160891128|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
160891129|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
160891130|NCT00417482|580996836|FG000|Phase B 2nd 16 Weeks|Death|1|||
160891131|NCT00417482|580996837|FG001|Phase B 2nd 16 Weeks|Death|1|||
160891132|NCT00417482|580996838|FG002|Phase B 2nd 16 Weeks|Death|0|||
160891133|NCT02140775|580996841|FG000|Overall Study|Withdrawal by Subject|30|||
160891134|NCT02140775|580996842|FG001|Overall Study|Withdrawal by Subject|7|||
160891135|NCT00938964|580996844|FG000|Overall Study|Death|3|||
160891136|NCT00938964|580996845|FG001|Overall Study|Death|3|||
160891137|NCT00938964|580996844|FG000|Overall Study|Lost to Follow-up|2|||
160891138|NCT00938964|580996845|FG001|Overall Study|Lost to Follow-up|3|||
160891139|NCT00938964|580996844|FG000|Overall Study|Withdrawal by Subject|22|||
160891140|NCT00938964|580996845|FG001|Overall Study|Withdrawal by Subject|18|||
160891141|NCT00938964|580996844|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
160891142|NCT00938964|580996845|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
160891143|NCT01858636|580996846|FG000|Overall Study|No Device Deployment Attempted|24|||
160891144|NCT01858636|580996846|FG000|Overall Study|Physician Decision|1|||
160891145|NCT01858636|580996846|FG000|Overall Study|Death|1|||
160891146|NCT01858636|580996846|FG000|Overall Study|Lost to Follow-up|1|||
160891147|NCT01858636|580996846|FG000|Overall Study|Withdrawal by Subject|1|||
160891148|NCT01227564|580996852|FG000|Overall Study|No Longer Willing to Participate|4|||
160891149|NCT01227564|580996853|FG001|Overall Study|No Longer Willing to Participate|2|||
160891150|NCT01227564|580996854|FG002|Overall Study|No Longer Willing to Participate|5|||
160891151|NCT01227564|580996852|FG000|Overall Study|Participant moved to another town|0|||
160891152|NCT01227564|580996853|FG001|Overall Study|Participant moved to another town|0|||
160891153|NCT01227564|580996854|FG002|Overall Study|Participant moved to another town|1|||
160891154|NCT00999921|580996869|FG000|Overall Study|Lost to Follow-up|10|||
160891155|NCT00999921|580996870|FG001|Overall Study|Lost to Follow-up|19|||
161127628|NCT04426695|581855140|FG002|Overall Study|Physician Decision|0|||
161127629|NCT04426695|581855141|FG003|Overall Study|Physician Decision|0|||
161127630|NCT04426695|581855142|FG004|Overall Study|Physician Decision|0|||
161127631|NCT04426695|581855143|FG005|Overall Study|Physician Decision|0|||
161127632|NCT04426695|581855144|FG006|Overall Study|Physician Decision|0|||
161127633|NCT04426695|581855145|FG007|Overall Study|Physician Decision|0|||
161127634|NCT04426695|581855146|FG008|Overall Study|Physician Decision|0|||
161127635|NCT04426695|581855147|FG009|Overall Study|Physician Decision|1|||
161127636|NCT04426695|581855148|FG010|Overall Study|Physician Decision|0|||
161127637|NCT04426695|581855149|FG011|Overall Study|Physician Decision|0|||
161127638|NCT04426695|581855150|FG012|Overall Study|Physician Decision|1|||
161127639|NCT04426695|581855151|FG013|Overall Study|Physician Decision|0|||
161127640|NCT04426695|581855152|FG014|Overall Study|Physician Decision|0|||
161127641|NCT04426695|581855153|FG015|Overall Study|Physician Decision|0|||
160891156|NCT04650854|580996871|FG000|Overall Study|Adverse Event|1|||
161127642|NCT04426695|581855154|FG016|Overall Study|Physician Decision|0|||
161127643|NCT04426695|581855155|FG017|Overall Study|Physician Decision|0|||
160891157|NCT04650854|580996872|FG001|Overall Study|Adverse Event|12|||
160891158|NCT04650854|580996873|FG002|Overall Study|Adverse Event|14|||
160891159|NCT04650854|580996871|FG000|Overall Study|Lack of Efficacy|1|||
160891160|NCT04650854|580996872|FG001|Overall Study|Lack of Efficacy|3|||
160891161|NCT04650854|580996873|FG002|Overall Study|Lack of Efficacy|6|||
160891162|NCT04650854|580996871|FG000|Overall Study|Lost to Follow-up|1|||
160891163|NCT04650854|580996872|FG001|Overall Study|Lost to Follow-up|1|||
160891164|NCT04650854|580996873|FG002|Overall Study|Lost to Follow-up|0|||
160788398|NCT00537082|580610914|FG002|Overall Study|Protocol Violation|1|||
160788399|NCT00537082|580610912|FG000|Overall Study|Lack of Efficacy|0|||
160788400|NCT00537082|580610913|FG001|Overall Study|Lack of Efficacy|0|||
160788401|NCT00537082|580610914|FG002|Overall Study|Lack of Efficacy|2|||
160788402|NCT00537082|580610912|FG000|Overall Study|Withdrawal by Subject|0|||
160788403|NCT00537082|580610913|FG001|Overall Study|Withdrawal by Subject|1|||
160891165|NCT04650854|580996871|FG000|Overall Study|Withdrawal by Subject|2|||
160891166|NCT04650854|580996872|FG001|Overall Study|Withdrawal by Subject|17|||
160891167|NCT04650854|580996873|FG002|Overall Study|Withdrawal by Subject|9|||
160891168|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
160891169|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
160891170|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
160891171|NCT04650854|580996871|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
160891172|NCT04650854|580996872|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
160891173|NCT04650854|580996873|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
160891174|NCT04650854|580996871|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
160891175|NCT04650854|580996872|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
160891176|NCT04650854|580996873|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
160891177|NCT04650854|580996871|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
160891178|NCT04650854|580996872|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
160891179|NCT04650854|580996873|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
160891180|NCT04650854|580996871|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
160891181|NCT04650854|580996872|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
160891182|NCT04650854|580996873|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
160891183|NCT04650854|580996871|FG000|Overall Study|Use of Rescue Medication|0|||
160891184|NCT04650854|580996872|FG001|Overall Study|Use of Rescue Medication|0|||
160891185|NCT04650854|580996873|FG002|Overall Study|Use of Rescue Medication|1|||
161235120|NCT04627038|582243498|FG001|Overall Study|Lost to Follow-up|0|||
160891186|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Sponsor|0|||
160891187|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Sponsor|0|||
160891188|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Sponsor|2|||
160891189|NCT04650854|580996871|FG000|Overall Study|Rescue Medication|0|||
160891190|NCT04650854|580996872|FG001|Overall Study|Rescue Medication|0|||
160891191|NCT04650854|580996873|FG002|Overall Study|Rescue Medication|1|||
160891192|NCT04650854|580996871|FG000|Overall Study|Participant Want to Start a Family|0|||
160891193|NCT04650854|580996872|FG001|Overall Study|Participant Want to Start a Family|0|||
160891194|NCT04650854|580996873|FG002|Overall Study|Participant Want to Start a Family|1|||
160891195|NCT04650854|580996871|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
160891196|NCT04650854|580996872|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
160891197|NCT04650854|580996873|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
160891198|NCT04650854|580996871|FG000|Overall Study|Participant Screened For MG0020|0|||
160891199|NCT04650854|580996872|FG001|Overall Study|Participant Screened For MG0020|2|||
161235121|NCT04627038|582243497|FG000|Overall Study|Physician Decision|0|||
161235122|NCT04627038|582243498|FG001|Overall Study|Physician Decision|1|||
161235123|NCT04627038|582243497|FG000|Overall Study|Protocol Violation|3|||
161235124|NCT04627038|582243498|FG001|Overall Study|Protocol Violation|1|||
161235125|NCT04627038|582243497|FG000|Overall Study|Withdrawal by Subject|13|||
160788404|NCT00537082|580610914|FG002|Overall Study|Withdrawal by Subject|0|||
160788405|NCT00537082|580610912|FG000|Overall Study|Discontinued before initiating treatment|3|||
160788406|NCT00537082|580610913|FG001|Overall Study|Discontinued before initiating treatment|0|||
160788407|NCT00537082|580610914|FG002|Overall Study|Discontinued before initiating treatment|0|||
160788408|NCT02568254|580610915|FG000|Period 2|Adverse Event|0|||
160788409|NCT02568254|580610916|FG001|Period 2|Adverse Event|0|||
160788410|NCT02568254|580610917|FG002|Period 2|Adverse Event|1|||
160788411|NCT02568254|580610918|FG003|Period 2|Adverse Event|0|||
160788412|NCT02568254|580610919|FG004|Period 2|Adverse Event|0|||
160788413|NCT02568254|580610920|FG005|Period 2|Adverse Event|0|||
160788414|NCT02568254|580610915|FG000|Period 3|Unstatisfactory Lens fitting|0|||
160788415|NCT02568254|580610916|FG001|Period 3|Unstatisfactory Lens fitting|0|||
161235126|NCT04627038|582243498|FG001|Overall Study|Withdrawal by Subject|3|||
161235127|NCT04627038|582243497|FG000|Overall Study|Non-compliance with study drug|0|||
160788416|NCT02568254|580610917|FG002|Period 3|Unstatisfactory Lens fitting|0|||
160788417|NCT02568254|580610918|FG003|Period 3|Unstatisfactory Lens fitting|0|||
160788418|NCT02568254|580610919|FG004|Period 3|Unstatisfactory Lens fitting|1|||
160891200|NCT04650854|580996873|FG002|Overall Study|Participant Screened For MG0020|3|||
161235128|NCT04627038|582243498|FG001|Overall Study|Non-compliance with study drug|1|||
160891201|NCT04650854|580996871|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
160891202|NCT04650854|580996872|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
160891203|NCT04650854|580996873|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
160891204|NCT04650854|580996871|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
160891205|NCT04650854|580996872|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
160891206|NCT04650854|580996873|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
160891207|NCT04650854|580996871|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
160891208|NCT04650854|580996872|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
160891209|NCT04650854|580996873|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
160891210|NCT04650854|580996871|FG000|Overall Study|End Of Study|0|||
160891211|NCT04650854|580996872|FG001|Overall Study|End Of Study|2|||
160891212|NCT04650854|580996873|FG002|Overall Study|End Of Study|1|||
160891213|NCT04650854|580996871|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
160891214|NCT04650854|580996872|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
160891215|NCT04650854|580996873|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
160891216|NCT04650854|580996871|FG000|Overall Study|Participant Received Rescue Medication|0|||
160891217|NCT04650854|580996872|FG001|Overall Study|Participant Received Rescue Medication|1|||
160891218|NCT04650854|580996873|FG002|Overall Study|Participant Received Rescue Medication|0|||
160891219|NCT04650854|580996871|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
160891220|NCT04650854|580996872|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
160891221|NCT04650854|580996873|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
160891222|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
160891223|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
160891224|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
160891225|NCT04650854|580996871|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
160891226|NCT04650854|580996872|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
160891227|NCT04650854|580996873|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
160891228|NCT04650854|580996871|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
160891229|NCT04650854|580996872|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
160891230|NCT04650854|580996873|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
160891231|NCT04650854|580996871|FG000|Overall Study|Enrollment Cup|0|||
160891232|NCT04650854|580996872|FG001|Overall Study|Enrollment Cup|0|||
160891233|NCT04650854|580996873|FG002|Overall Study|Enrollment Cup|1|||
160891234|NCT00704808|580996888|FG000|Overall Study|Discontinued prior to starting treatment|14|||
160891235|NCT00704808|580996888|FG000|Overall Study|Death|7|||
160891236|NCT00704808|580996888|FG000|Overall Study|Tumor progression|80|||
160891237|NCT00704808|580996888|FG000|Overall Study|Patient's decision|11|||
160891238|NCT00704808|580996888|FG000|Overall Study|Early therapy discontinuation|16|||
160891239|NCT00704808|580996888|FG000|Overall Study|Adverse Event|1|||
160891240|NCT00704808|580996888|FG000|Overall Study|Lost to Follow-up|1|||
160891241|NCT00704808|580996888|FG000|Overall Study|Treatment change|1|||
160891242|NCT00667420|580996893|FG000|Overall Study|Adverse Event|2|||
160891243|NCT00667420|580996893|FG000|Overall Study|Lack of Efficacy|5|||
160891244|NCT00667420|580996893|FG000|Overall Study|Physician Decision|1|||
160891245|NCT00667420|580996893|FG000|Overall Study|Withdrawal by Subject|2|||
160891246|NCT04437368|580996897|FG000|Overall Study|Death|3|||
160891247|NCT04437368|580996898|FG001|Overall Study|Death|0|||
160891248|NCT04437368|580996899|FG002|Overall Study|Death|2|||
160891249|NCT04437368|580996897|FG000|Overall Study|Study terminated by sponsor|16|||
160891250|NCT04437368|580996898|FG001|Overall Study|Study terminated by sponsor|1|||
160891251|NCT04437368|580996899|FG002|Overall Study|Study terminated by sponsor|25|||
160891252|NCT04437368|580996897|FG000|Overall Study|Withdrawal by Subject|4|||
160891253|NCT04437368|580996898|FG001|Overall Study|Withdrawal by Subject|0|||
160891254|NCT04437368|580996899|FG002|Overall Study|Withdrawal by Subject|3|||
160788419|NCT02568254|580610920|FG005|Period 3|Unstatisfactory Lens fitting|0|||
160788420|NCT04495478|580610921|FG000|Overall Study|Withdrawal by Subject|0|||
160788421|NCT04495478|580610922|FG001|Overall Study|Withdrawal by Subject|0|||
160788422|NCT04495478|580610923|FG002|Overall Study|Withdrawal by Subject|0|||
160788423|NCT04495478|580610924|FG003|Overall Study|Withdrawal by Subject|1|||
160788424|NCT04495478|580610925|FG004|Overall Study|Withdrawal by Subject|0|||
160788425|NCT04495478|580610926|FG005|Overall Study|Withdrawal by Subject|0|||
160788426|NCT04495478|580610927|FG006|Overall Study|Withdrawal by Subject|0|||
160788427|NCT04495478|580610921|FG000|Overall Study|Physician Decision|0|||
160788428|NCT04495478|580610922|FG001|Overall Study|Physician Decision|1|||
160788429|NCT04495478|580610923|FG002|Overall Study|Physician Decision|0|||
160788430|NCT04495478|580610924|FG003|Overall Study|Physician Decision|0|||
160891255|NCT04437368|580996897|FG000|Overall Study|Sponsor instructions|23|||
160891256|NCT04437368|580996898|FG001|Overall Study|Sponsor instructions|0|||
160891257|NCT04437368|580996899|FG002|Overall Study|Sponsor instructions|0|||
160891258|NCT01982331|580996900|FG000|Received Vaccination 2|Adverse Event|1|||
160891259|NCT01982331|580996901|FG001|Received Vaccination 2|Adverse Event|2|||
160788431|NCT04495478|580610925|FG004|Overall Study|Physician Decision|1|||
160891260|NCT01982331|580996900|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
160891261|NCT01982331|580996901|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
160891262|NCT01982331|580996900|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
160891263|NCT01982331|580996901|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
160891264|NCT00095628|580996903|FG000|Overall Study|Disease progression prior to treatment|1|||
160891265|NCT00744471|580996904|FG000|Overall Study|Randomized but not treated|1|||
160891266|NCT00744471|580996905|FG001|Overall Study|Randomized but not treated|1|||
160891267|NCT00744471|580996906|FG002|Overall Study|Randomized but not treated|4|||
160891268|NCT00744471|580996907|FG003|Overall Study|Randomized but not treated|0|||
160891269|NCT00744471|580996904|FG000|Overall Study|Death|0|||
160891270|NCT00744471|580996905|FG001|Overall Study|Death|0|||
160891271|NCT00744471|580996906|FG002|Overall Study|Death|0|||
160891272|NCT00744471|580996907|FG003|Overall Study|Death|1|||
160891273|NCT00744471|580996904|FG000|Overall Study|Adverse Event|6|||
160891274|NCT00744471|580996905|FG001|Overall Study|Adverse Event|7|||
160891275|NCT00744471|580996906|FG002|Overall Study|Adverse Event|5|||
160891276|NCT00744471|580996907|FG003|Overall Study|Adverse Event|9|||
160891277|NCT00744471|580996904|FG000|Overall Study|Withdrawal by Subject|9|||
160891278|NCT00744471|580996905|FG001|Overall Study|Withdrawal by Subject|9|||
160891279|NCT00744471|580996906|FG002|Overall Study|Withdrawal by Subject|15|||
160891280|NCT00744471|580996907|FG003|Overall Study|Withdrawal by Subject|12|||
160891281|NCT00744471|580996904|FG000|Overall Study|Protocol Violation|1|||
160891282|NCT00744471|580996905|FG001|Overall Study|Protocol Violation|4|||
160891283|NCT00744471|580996906|FG002|Overall Study|Protocol Violation|1|||
160891284|NCT00744471|580996907|FG003|Overall Study|Protocol Violation|2|||
160891285|NCT00744471|580996904|FG000|Overall Study|Entered extension study|41|||
160891286|NCT00744471|580996905|FG001|Overall Study|Entered extension study|84|||
160891287|NCT00744471|580996906|FG002|Overall Study|Entered extension study|100|||
160891288|NCT00744471|580996907|FG003|Overall Study|Entered extension study|91|||
160891289|NCT00744471|580996904|FG000|Overall Study|Other|2|||
160891290|NCT00744471|580996905|FG001|Overall Study|Other|3|||
160891291|NCT00744471|580996906|FG002|Overall Study|Other|6|||
160891292|NCT00744471|580996907|FG003|Overall Study|Other|2|||
160891293|NCT00744471|580996904|FG000|Overall Study|Lack of Efficacy|83|||
160891294|NCT00744471|580996905|FG001|Overall Study|Lack of Efficacy|37|||
160891295|NCT00744471|580996906|FG002|Overall Study|Lack of Efficacy|19|||
160891296|NCT00744471|580996907|FG003|Overall Study|Lack of Efficacy|31|||
160891297|NCT00744471|580996904|FG000|Overall Study|Lost to Follow-up|0|||
160891298|NCT00744471|580996905|FG001|Overall Study|Lost to Follow-up|0|||
160891299|NCT00744471|580996906|FG002|Overall Study|Lost to Follow-up|2|||
160891300|NCT00744471|580996907|FG003|Overall Study|Lost to Follow-up|0|||
160891301|NCT03224546|580996908|FG000|Overall Study|Lost to Follow-up|9|||
160891302|NCT03224546|580996909|FG001|Overall Study|Lost to Follow-up|8|||
160891303|NCT03224546|580996910|FG002|Overall Study|Lost to Follow-up|3|||
160891304|NCT03224546|580996908|FG000|Overall Study|Withdrawal by Subject|7|||
160891305|NCT03224546|580996909|FG001|Overall Study|Withdrawal by Subject|14|||
160891306|NCT03224546|580996910|FG002|Overall Study|Withdrawal by Subject|12|||
160891307|NCT01280955|580996913|FG000|Overall Study|Death|2|||
160891308|NCT01280955|580996913|FG000|Overall Study|Withdrawal by Subject|1|||
160891309|NCT04223232|580996914|FG000|Overall Study|Withdrawal by Subject|1|||
160891310|NCT00901927|580996917|FG000|Overall Study|Lack of Efficacy|1|||
160891311|NCT00901927|580996917|FG000|Overall Study|Protocol Violation|3|||
160891312|NCT00901927|580996917|FG000|Overall Study|Withdrawal by Subject|2|||
160891313|NCT03119701|580996927|FG000|6-day Dosing|Death|4|||
160891314|NCT03119701|580996928|FG001|6-day Dosing|Death|1|||
160891315|NCT03119701|580996927|FG000|6-day Dosing|Adverse Event|3|||
160891316|NCT03119701|580996928|FG001|6-day Dosing|Adverse Event|0|||
160891317|NCT03119701|580996927|FG000|6-day Dosing|Physician Decision|0|||
160891318|NCT03119701|580996928|FG001|6-day Dosing|Physician Decision|1|||
160891319|NCT03119701|580996927|FG000|6-day Dosing|Withdrawal by Subject|0|||
160891320|NCT03119701|580996928|FG001|6-day Dosing|Withdrawal by Subject|1|||
160891321|NCT03119701|580996927|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
160891322|NCT03119701|580996928|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
160891323|NCT03172910|580998741|FG000|Overall Study|Adverse Event|0|||
160891324|NCT03172910|580998742|FG001|Overall Study|Adverse Event|0|||
160891325|NCT03172910|580998743|FG002|Overall Study|Adverse Event|0|||
160891326|NCT03172910|580998744|FG003|Overall Study|Adverse Event|0|||
161330059|NCT01656395|582594785|FG004|Overall Study|Physician Decision|3|||
161330060|NCT01656395|582594786|FG005|Overall Study|Physician Decision|3|||
161330061|NCT01656395|582594787|FG006|Overall Study|Physician Decision|0|||
161330062|NCT01656395|582594788|FG007|Overall Study|Physician Decision|0|||
161330063|NCT01656395|582594781|FG000|Overall Study|Pregnancy|0|||
160891327|NCT03172910|580998745|FG004|Overall Study|Adverse Event|1|||
160891328|NCT01659658|580998746|FG000|Overall Study|Withdrawal by Patient|18|||
160891329|NCT01659658|580998747|FG001|Overall Study|Withdrawal by Patient|4|||
160891330|NCT01659658|580998748|FG002|Overall Study|Withdrawal by Patient|2|||
160891331|NCT01659658|580998749|FG003|Overall Study|Withdrawal by Patient|0|||
160891332|NCT01659658|580998750|FG004|Overall Study|Withdrawal by Patient|11|||
160891333|NCT01659658|580998746|FG000|Overall Study|Study Terminated by Sponsor|9|||
161235129|NCT04627038|582243497|FG000|Overall Study|Prohibited Concomitant Medication|1|||
161235130|NCT04627038|582243498|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161235131|NCT02714062|582243504|FG000|Overall Study|Adverse Event|0|||
161235132|NCT02714062|582243505|FG001|Overall Study|Adverse Event|0|||
161235133|NCT02714062|582243506|FG002|Overall Study|Adverse Event|2|||
161235134|NCT02714062|582243504|FG000|Overall Study|Withdrawal by Subject|1|||
161235135|NCT02714062|582243505|FG001|Overall Study|Withdrawal by Subject|0|||
161235136|NCT02714062|582243506|FG002|Overall Study|Withdrawal by Subject|1|||
161235137|NCT02714062|582243504|FG000|Overall Study|Protocol Violation|0|||
161235138|NCT02714062|582243505|FG001|Overall Study|Protocol Violation|1|||
161235139|NCT02714062|582243506|FG002|Overall Study|Protocol Violation|0|||
161235140|NCT02682784|582243507|FG000|Overall Study|Withdrawal by Subject|0|||
161235141|NCT02682784|582243508|FG001|Overall Study|Withdrawal by Subject|2|||
161235142|NCT02682784|582243509|FG002|Overall Study|Withdrawal by Subject|1|||
161235143|NCT02682784|582243510|FG003|Overall Study|Withdrawal by Subject|2|||
161235144|NCT02682784|582243507|FG000|Overall Study|Physician Decision|1|||
161235145|NCT02682784|582243508|FG001|Overall Study|Physician Decision|0|||
161235146|NCT02682784|582243509|FG002|Overall Study|Physician Decision|1|||
161235147|NCT02682784|582243510|FG003|Overall Study|Physician Decision|1|||
161235148|NCT01702987|582243511|FG000|Overall Study|Withdrawal by Subject|1|||
161235149|NCT01702987|582243512|FG001|Overall Study|Withdrawal by Subject|0|||
161235150|NCT00467363|582243513|FG000|Overall Study|Lost to Follow-up|80|||
161235151|NCT00467363|582243514|FG001|Overall Study|Lost to Follow-up|70|||
161235152|NCT03181594|582243515|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
161330064|NCT01656395|582594782|FG001|Overall Study|Pregnancy|0|||
161330065|NCT01656395|582594783|FG002|Overall Study|Pregnancy|1|||
161330066|NCT01656395|582594784|FG003|Overall Study|Pregnancy|0|||
161330067|NCT01656395|582594785|FG004|Overall Study|Pregnancy|0|||
161330068|NCT01656395|582594786|FG005|Overall Study|Pregnancy|0|||
161330069|NCT01656395|582594787|FG006|Overall Study|Pregnancy|0|||
161330070|NCT01656395|582594788|FG007|Overall Study|Pregnancy|0|||
161330071|NCT01656395|582594781|FG000|Overall Study|Progressive Disease|0|||
161330072|NCT01656395|582594782|FG001|Overall Study|Progressive Disease|0|||
161330073|NCT01656395|582594783|FG002|Overall Study|Progressive Disease|0|||
161330074|NCT01656395|582594784|FG003|Overall Study|Progressive Disease|0|||
161330075|NCT01656395|582594785|FG004|Overall Study|Progressive Disease|0|||
161330076|NCT01656395|582594786|FG005|Overall Study|Progressive Disease|1|||
161330077|NCT01656395|582594787|FG006|Overall Study|Progressive Disease|0|||
160788432|NCT04495478|580610926|FG005|Overall Study|Physician Decision|0|||
160788433|NCT04495478|580610927|FG006|Overall Study|Physician Decision|0|||
161235153|NCT03181594|582243515|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
161235154|NCT03181594|582243515|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
161235155|NCT03181594|582243515|FG000|Initial Study Protocol (12-month FU)|Death|1|||
161235156|NCT03181594|582243515|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
161235157|NCT03181594|582243515|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
161235158|NCT02017223|582243516|FG000|Overall Study|Algorithm problems|2|||
161330078|NCT01656395|582594788|FG007|Overall Study|Progressive Disease|0|||
161330079|NCT01656395|582594781|FG000|Overall Study|Protocol Violation|6|||
161330080|NCT01656395|582594782|FG001|Overall Study|Protocol Violation|6|||
160788434|NCT00655746|580610928|FG000|Overall Study|Withdrawal by Subject|1|||
160788435|NCT00561821|580610929|FG000|Overall Study|Not treated|0|||
160788436|NCT00561821|580610930|FG001|Overall Study|Not treated|0|||
160788437|NCT00561821|580610931|FG002|Overall Study|Not treated|1|||
160788438|NCT00561821|580610932|FG003|Overall Study|Not treated|0|||
160788439|NCT00561821|580610929|FG000|Overall Study|Withdrawal by Subject|0|||
160788440|NCT00561821|580610930|FG001|Overall Study|Withdrawal by Subject|1|||
160788441|NCT00561821|580610931|FG002|Overall Study|Withdrawal by Subject|0|||
160788442|NCT00561821|580610932|FG003|Overall Study|Withdrawal by Subject|2|||
160788443|NCT00561821|580610929|FG000|Overall Study|Reasons not related to trial|2|||
160788444|NCT00561821|580610930|FG001|Overall Study|Reasons not related to trial|1|||
160788445|NCT00561821|580610931|FG002|Overall Study|Reasons not related to trial|0|||
160788446|NCT00561821|580610932|FG003|Overall Study|Reasons not related to trial|0|||
160788447|NCT00561821|580610929|FG000|Overall Study|Other (reason not specified)|1|||
160788448|NCT00561821|580610930|FG001|Overall Study|Other (reason not specified)|1|||
160788449|NCT00561821|580610931|FG002|Overall Study|Other (reason not specified)|0|||
160788450|NCT00561821|580610932|FG003|Overall Study|Other (reason not specified)|0|||
160788451|NCT00561821|580610929|FG000|Overall Study|Adverse Event|2|||
160788452|NCT00561821|580610930|FG001|Overall Study|Adverse Event|3|||
160788453|NCT00561821|580610931|FG002|Overall Study|Adverse Event|1|||
160788454|NCT00561821|580610932|FG003|Overall Study|Adverse Event|1|||
160788455|NCT03178942|580610933|FG000|Overall Study|Withdrawal by Subject|2|||
160788456|NCT03178942|580610934|FG001|Overall Study|Withdrawal by Subject|0|||
160788457|NCT03178942|580610933|FG000|Overall Study|Lost to Follow-up|1|||
161235159|NCT00904215|582243517|FG000|Overall Study|Adverse Event|25|||
161235160|NCT00904215|582243517|FG000|Overall Study|Protocol Violation|10|||
161330081|NCT01656395|582594783|FG002|Overall Study|Protocol Violation|9|||
160788458|NCT03178942|580610934|FG001|Overall Study|Lost to Follow-up|2|||
161330082|NCT01656395|582594784|FG003|Overall Study|Protocol Violation|2|||
160891334|NCT01659658|580998747|FG001|Overall Study|Study Terminated by Sponsor|7|||
160891335|NCT01659658|580998748|FG002|Overall Study|Study Terminated by Sponsor|0|||
160891336|NCT01659658|580998749|FG003|Overall Study|Study Terminated by Sponsor|1|||
160891337|NCT01659658|580998750|FG004|Overall Study|Study Terminated by Sponsor|4|||
160891338|NCT01659658|580998746|FG000|Overall Study|Reason not Specified|61|||
160891339|NCT01659658|580998747|FG001|Overall Study|Reason not Specified|15|||
160891340|NCT01659658|580998748|FG002|Overall Study|Reason not Specified|8|||
160891341|NCT01659658|580998749|FG003|Overall Study|Reason not Specified|1|||
160891342|NCT01659658|580998750|FG004|Overall Study|Reason not Specified|34|||
160891343|NCT01659658|580998746|FG000|Overall Study|Lost to Follow-up|2|||
160891344|NCT01659658|580998747|FG001|Overall Study|Lost to Follow-up|0|||
160891345|NCT01659658|580998748|FG002|Overall Study|Lost to Follow-up|0|||
160891346|NCT01659658|580998749|FG003|Overall Study|Lost to Follow-up|0|||
160891347|NCT01659658|580998750|FG004|Overall Study|Lost to Follow-up|0|||
160891348|NCT00122278|580998753|FG000|Overall Study|Lost to Follow-up|2|||
160891349|NCT00122278|580998754|FG001|Overall Study|Lost to Follow-up|0|||
160891350|NCT01002482|580998755|FG000|Overall Study|Withdrawal by Subject|14|||
160891351|NCT01002482|580998756|FG001|Overall Study|Withdrawal by Subject|21|||
160891352|NCT01002482|580998755|FG000|Overall Study|Included twice|1|||
160891353|NCT01002482|580998756|FG001|Overall Study|Included twice|0|||
160891354|NCT04879225|580998757|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
160891355|NCT04879225|580998757|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
160891356|NCT00736957|580998760|FG000|Overall Study|Adverse Event|43|||
160891357|NCT00736957|580998760|FG000|Overall Study|Withdrawal by Subject|49|||
160891358|NCT00736957|580998760|FG000|Overall Study|violation of eligibility criteria|2|||
160891359|NCT00736957|580998760|FG000|Overall Study|did not attend hospital appointments|1|||
161235161|NCT00904215|582243517|FG000|Overall Study|Lost to Follow-up|63|||
161235162|NCT00904215|582243517|FG000|Overall Study|Withdrawal by Subject|9|||
161235163|NCT00904215|582243517|FG000|Overall Study|Other|28|||
161235164|NCT01313780|582243528|FG000|Overall Study|Lack of Efficacy|4|||
160891360|NCT00736957|580998760|FG000|Overall Study|not eligible for Treatment Period I|22|||
160891361|NCT00736957|580998760|FG000|Overall Study|Physician Decision|5|||
160891362|NCT03646643|580998761|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
160891363|NCT03646643|580998762|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
160891364|NCT03646643|580998761|FG000|Overall Study|Lost to Follow-up|0|||
160891365|NCT03646643|580998762|FG001|Overall Study|Lost to Follow-up|1|||
160891366|NCT02806973|580998763|FG000|Period 1|Withdrawal by Subject|0|||
160891367|NCT02806973|580998764|FG001|Period 1|Withdrawal by Subject|2|||
160891368|NCT02806973|580998765|FG002|Period 1|Withdrawal by Subject|1|||
160891369|NCT02806973|580998766|FG003|Period 1|Withdrawal by Subject|1|||
160891370|NCT02806973|580998763|FG000|Period 1|Adverse Event|0|||
160891371|NCT02806973|580998764|FG001|Period 1|Adverse Event|0|||
160891372|NCT02806973|580998765|FG002|Period 1|Adverse Event|0|||
160891373|NCT02806973|580998766|FG003|Period 1|Adverse Event|1|||
160891374|NCT02806973|580998763|FG000|Period 3|Withdrawal by Subject|0|||
160891375|NCT02806973|580998764|FG001|Period 3|Withdrawal by Subject|0|||
161235165|NCT01313780|582243529|FG001|Overall Study|Lack of Efficacy|2|||
161235166|NCT01313780|582243528|FG000|Overall Study|Adverse Event|6|||
161235167|NCT01313780|582243529|FG001|Overall Study|Adverse Event|11|||
161235168|NCT01313780|582243528|FG000|Overall Study|Withdrawal by Subject|2|||
161235169|NCT01313780|582243529|FG001|Overall Study|Withdrawal by Subject|8|||
161235170|NCT01313780|582243528|FG000|Overall Study|Protocol Violation|10|||
161235171|NCT01313780|582243529|FG001|Overall Study|Protocol Violation|4|||
161235172|NCT01313780|582243528|FG000|Overall Study|missing data|3|||
161235173|NCT01313780|582243529|FG001|Overall Study|missing data|3|||
161235174|NCT02563561|582244791|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
161235175|NCT02563561|582244792|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
161235176|NCT02563561|582244793|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
161235177|NCT02563561|582244791|FG000|Overall Study|Withdrew of Consent|1|||
161235178|NCT02563561|582244792|FG001|Overall Study|Withdrew of Consent|1|||
161235179|NCT02563561|582244793|FG002|Overall Study|Withdrew of Consent|2|||
161235180|NCT02563561|582244791|FG000|Overall Study|Lost to Follow-up|1|||
160891376|NCT02806973|580998765|FG002|Period 3|Withdrawal by Subject|0|||
160891377|NCT02806973|580998766|FG003|Period 3|Withdrawal by Subject|3|||
160891378|NCT02806973|580998763|FG000|Period 3|Adverse Event|0|||
160891379|NCT02806973|580998764|FG001|Period 3|Adverse Event|0|||
160891380|NCT02806973|580998765|FG002|Period 3|Adverse Event|1|||
161235181|NCT02563561|582244792|FG001|Overall Study|Lost to Follow-up|1|||
161235182|NCT02563561|582244793|FG002|Overall Study|Lost to Follow-up|0|||
160891381|NCT02806973|580998766|FG003|Period 3|Adverse Event|0|||
160891382|NCT04209426|580998769|FG000|Overall Study|Lost to Follow-up|3|||
160891383|NCT04209426|580998770|FG001|Overall Study|Lost to Follow-up|2|||
160891384|NCT04060862|580998771|FG000|Overall Study|Symptomatic Deterioration|1|||
160891385|NCT04060862|580998771|FG000|Overall Study|Un-specified|6|||
160891386|NCT04060862|580998771|FG000|Overall Study|Progressive disease|12|||
160891387|NCT04060862|580998771|FG000|Overall Study|Physician Decision|1|||
160891388|NCT00214500|580998774|FG000|Treatment Period|Adverse Event|1|||
160891389|NCT00214500|580998774|FG000|Extension Period|Withdrawal by Subject|2|||
160891390|NCT01068652|580998775|FG000|Overall Study|Adverse Event|4|||
160891391|NCT01068652|580998776|FG001|Overall Study|Adverse Event|0|||
160891392|NCT01068652|580998775|FG000|Overall Study|Lack of Efficacy|0|||
160891393|NCT01068652|580998776|FG001|Overall Study|Lack of Efficacy|2|||
160891394|NCT01068652|580998775|FG000|Overall Study|Lost to Follow-up|2|||
160891395|NCT01068652|580998776|FG001|Overall Study|Lost to Follow-up|1|||
160891396|NCT01068652|580998775|FG000|Overall Study|Protocol Violation|3|||
160891397|NCT01068652|580998776|FG001|Overall Study|Protocol Violation|6|||
160891398|NCT01068652|580998775|FG000|Overall Study|Withdrawal criteria|1|||
160891399|NCT01068652|580998776|FG001|Overall Study|Withdrawal criteria|2|||
160891400|NCT01068652|580998775|FG000|Overall Study|Patient was not eligible|1|||
160891401|NCT01068652|580998776|FG001|Overall Study|Patient was not eligible|0|||
160891402|NCT01068652|580998775|FG000|Overall Study|Unclassified|7|||
160891403|NCT01068652|580998776|FG001|Overall Study|Unclassified|4|||
160891404|NCT00147251|580998777|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
160891405|NCT00147251|580998778|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
160891406|NCT03343067|580998781|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
160891407|NCT03343067|580998782|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
160891408|NCT03343067|580998783|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
160891409|NCT00542451|580998784|FG000|Overall Study|Adverse Event|31|||
160891410|NCT00542451|580998784|FG000|Overall Study|Withdrawal by Subject|30|||
160891411|NCT00542451|580998784|FG000|Overall Study|Physician Decision|4|||
160891412|NCT00542451|580998784|FG000|Overall Study|Recurrent disease|1|||
160891413|NCT00542451|580998784|FG000|Overall Study|unknown reason|1|||
160891414|NCT00542451|580998784|FG000|Overall Study|Death|2|||
160891415|NCT00542451|580998784|FG000|Overall Study|Lost to Follow-up|10|||
160891416|NCT00116168|580998785|FG000|Overall Study|Lost to Follow-up|6|||
160891417|NCT00116168|580998786|FG001|Overall Study|Lost to Follow-up|5|||
160891418|NCT00116168|580998787|FG002|Overall Study|Lost to Follow-up|0|||
160891419|NCT00116168|580998788|FG003|Overall Study|Lost to Follow-up|0|||
160891420|NCT03555435|580998789|FG000|Overall Study|Lost to Follow-up|17|||
160891421|NCT03555435|580998790|FG001|Overall Study|Lost to Follow-up|19|||
160891422|NCT03555435|580998791|FG002|Overall Study|Lost to Follow-up|8|||
160891423|NCT02964507|580998796|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891424|NCT02964507|580998797|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
160891425|NCT02964507|580998798|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891426|NCT02964507|580998799|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891427|NCT02964507|580998800|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
160891428|NCT02964507|580998801|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891429|NCT02964507|580998802|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891430|NCT02964507|580998803|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
160891431|NCT02964507|580998796|FG000|Overall Study|Study terminated by Sponsor|9|||
160891432|NCT02964507|580998797|FG001|Overall Study|Study terminated by Sponsor|1|||
160891433|NCT02964507|580998798|FG002|Overall Study|Study terminated by Sponsor|9|||
160891434|NCT02964507|580998799|FG003|Overall Study|Study terminated by Sponsor|3|||
160891435|NCT02964507|580998800|FG004|Overall Study|Study terminated by Sponsor|3|||
160891436|NCT02964507|580998801|FG005|Overall Study|Study terminated by Sponsor|2|||
160891437|NCT02964507|580998802|FG006|Overall Study|Study terminated by Sponsor|0|||
160891438|NCT02964507|580998803|FG007|Overall Study|Study terminated by Sponsor|0|||
160891439|NCT02964507|580998796|FG000|Overall Study|Other|3|||
160891440|NCT02964507|580998797|FG001|Overall Study|Other|0|||
160891441|NCT02964507|580998798|FG002|Overall Study|Other|0|||
160891442|NCT02964507|580998799|FG003|Overall Study|Other|0|||
160891443|NCT02964507|580998800|FG004|Overall Study|Other|1|||
160891444|NCT02964507|580998801|FG005|Overall Study|Other|0|||
160891445|NCT02964507|580998802|FG006|Overall Study|Other|0|||
160891446|NCT02964507|580998803|FG007|Overall Study|Other|0|||
160891447|NCT02964507|580998796|FG000|Overall Study|Death|11|||
160891448|NCT02964507|580998797|FG001|Overall Study|Death|9|||
160891449|NCT02964507|580998798|FG002|Overall Study|Death|12|||
160891450|NCT02964507|580998799|FG003|Overall Study|Death|2|||
160891451|NCT02964507|580998800|FG004|Overall Study|Death|10|||
160891452|NCT02964507|580998801|FG005|Overall Study|Death|5|||
160891453|NCT02964507|580998802|FG006|Overall Study|Death|0|||
160891454|NCT02964507|580998803|FG007|Overall Study|Death|0|||
160891455|NCT02964507|580998796|FG000|Overall Study|Withdrawal by Subject|1|||
160891456|NCT02964507|580998797|FG001|Overall Study|Withdrawal by Subject|0|||
160891457|NCT02964507|580998798|FG002|Overall Study|Withdrawal by Subject|1|||
160891458|NCT02964507|580998799|FG003|Overall Study|Withdrawal by Subject|1|||
160891459|NCT02964507|580998800|FG004|Overall Study|Withdrawal by Subject|0|||
160891460|NCT02964507|580998801|FG005|Overall Study|Withdrawal by Subject|1|||
160891461|NCT02964507|580998802|FG006|Overall Study|Withdrawal by Subject|0|||
160891462|NCT02964507|580998803|FG007|Overall Study|Withdrawal by Subject|0|||
161330083|NCT01656395|582594785|FG004|Overall Study|Protocol Violation|4|||
160891463|NCT02964507|580998796|FG000|Overall Study|Physician Decision|2|||
160891464|NCT02964507|580998797|FG001|Overall Study|Physician Decision|0|||
160891465|NCT02964507|580998798|FG002|Overall Study|Physician Decision|3|||
161235183|NCT02563561|582244791|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
161235184|NCT02563561|582244792|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
161235185|NCT02563561|582244793|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
161235186|NCT02563561|582244791|FG000|Overall Study|Investigator Decision|3|||
161235187|NCT02563561|582244792|FG001|Overall Study|Investigator Decision|4|||
161235188|NCT02563561|582244793|FG002|Overall Study|Investigator Decision|2|||
161235189|NCT02563561|582244791|FG000|Overall Study|Sponsor Decision|5|||
161235190|NCT02563561|582244792|FG001|Overall Study|Sponsor Decision|2|||
161235191|NCT02563561|582244793|FG002|Overall Study|Sponsor Decision|4|||
161235192|NCT02563561|582244791|FG000|Overall Study|Other|1|||
161235193|NCT02563561|582244792|FG001|Overall Study|Other|5|||
161235194|NCT02563561|582244793|FG002|Overall Study|Other|2|||
161235195|NCT02646124|582244794|FG000|Overall Study|Lost to Follow-up|0|||
161235196|NCT02646124|582244795|FG001|Overall Study|Lost to Follow-up|2|||
161235197|NCT03154047|582244796|FG000|Overall Study|Death|1|||
161235198|NCT03154047|582244796|FG000|Overall Study|Study terminated by sponsor|76|||
161235199|NCT03154047|582244796|FG000|Overall Study|Withdrawal by Subject|3|||
160788459|NCT03142451|580612629|FG000|Overall Study|Adverse Event|5|||
160788460|NCT03142451|580612630|FG001|Overall Study|Adverse Event|2|||
160788461|NCT03142451|580612629|FG000|Overall Study|Lost to Follow-up|25|||
160788462|NCT03142451|580612630|FG001|Overall Study|Lost to Follow-up|8|||
160788463|NCT03142451|580612629|FG000|Overall Study|Participant request|24|||
160788464|NCT03142451|580612630|FG001|Overall Study|Participant request|12|||
160788465|NCT03142451|580612629|FG000|Overall Study|Protocol Violation|3|||
160788466|NCT03142451|580612630|FG001|Overall Study|Protocol Violation|1|||
160788467|NCT03142451|580612629|FG000|Overall Study|Other|1|||
160788468|NCT03142451|580612630|FG001|Overall Study|Other|1|||
160788469|NCT05333965|580612631|FG000|First Intervention|Adverse Event|0|||
160788470|NCT05333965|580612632|FG001|First Intervention|Adverse Event|1|||
160788471|NCT05333965|580612631|FG000|First Intervention|Withdrawal by Subject|0|||
160788472|NCT05333965|580612632|FG001|First Intervention|Withdrawal by Subject|1|||
160788473|NCT03048019|580612633|FG000|Overall Study|Adverse Event|1|||
160788474|NCT03048019|580612634|FG001|Overall Study|Adverse Event|0|||
160788475|NCT01730729|580612635|FG000|Overall Study|Adverse Event|1|||
160788476|NCT01730729|580612635|FG000|Overall Study|Death|1|||
160788477|NCT01730729|580612635|FG000|Overall Study|Progressive Disease|12|||
160788478|NCT00871000|580612636|FG000|Overall Study|Withdrawal by Subject|1|||
160788479|NCT00871000|580612637|FG001|Overall Study|Withdrawal by Subject|0|||
160788480|NCT03400787|580612638|FG000|Overall Study|Lost to Follow-up|1|||
160788481|NCT03400787|580612639|FG001|Overall Study|Lost to Follow-up|0|||
160788482|NCT03400787|580612638|FG000|Overall Study|Death|1|||
160788483|NCT03400787|580612639|FG001|Overall Study|Death|0|||
160788484|NCT03400787|580612638|FG000|Overall Study|Protocol Violation|0|||
160788485|NCT03400787|580612639|FG001|Overall Study|Protocol Violation|2|||
160788486|NCT03400787|580612638|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
160788487|NCT03400787|580612639|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
160788488|NCT00203242|580612644|FG000|Overall Study|Lost to Follow-up|1|||
160788489|NCT02595437|580612646|FG000|Triferic Via IV|Withdrawal by Subject|1|||
160788490|NCT02837952|580612648|FG000|Overall Study|Adverse Event|0|||
160788491|NCT02837952|580612649|FG001|Overall Study|Adverse Event|1|||
160788492|NCT02837952|580612648|FG000|Overall Study|Withdrawal by Subject|4|||
160788493|NCT02837952|580612649|FG001|Overall Study|Withdrawal by Subject|5|||
160788494|NCT02837952|580612648|FG000|Overall Study|Medication Error|1|||
160788495|NCT02837952|580612649|FG001|Overall Study|Medication Error|0|||
160788496|NCT01959919|580612650|FG000|Overall Study|Did not meet the eligibility criteria|2|||
160788497|NCT03439072|580612653|FG000|Overall Study|Withdrawal by Subject|2|||
160788498|NCT03439072|580612654|FG001|Overall Study|Withdrawal by Subject|3|||
160788499|NCT03439072|580612653|FG000|Overall Study|Physician Decision|0|||
160788500|NCT03439072|580612654|FG001|Overall Study|Physician Decision|1|||
160788501|NCT02003898|580612656|FG000|Overall Study|Death|3|||
160788502|NCT02003898|580612656|FG000|Overall Study|Lost to Follow-up|12|||
160788503|NCT02003898|580612656|FG000|Overall Study|Withdrawal by Subject|52|||
160788504|NCT01537432|580612657|FG000|Overall Study|Lost to Follow-up|3|||
160788505|NCT01537432|580612658|FG001|Overall Study|Lost to Follow-up|1|||
160788506|NCT01537432|580612657|FG000|Overall Study|Withdrawal by Subject|0|||
160788507|NCT01537432|580612658|FG001|Overall Study|Withdrawal by Subject|1|||
160788508|NCT01537432|580612657|FG000|Overall Study|Administrative problems|1|||
160788509|NCT01537432|580612658|FG001|Overall Study|Administrative problems|0|||
160788510|NCT01537432|580612657|FG000|Overall Study|Adverse Event|1|||
160788511|NCT01537432|580612658|FG001|Overall Study|Adverse Event|0|||
160788512|NCT01537432|580612657|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160788513|NCT01537432|580612658|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160788514|NCT03682367|580612661|FG000|Overall Study|Protocol Violation|2|||
160788515|NCT03682367|580612662|FG001|Overall Study|Protocol Violation|1|||
160788516|NCT03682367|580612661|FG000|Overall Study|Closed Study Early|0|||
160788517|NCT03682367|580612662|FG001|Overall Study|Closed Study Early|3|||
160788518|NCT00128492|580612663|FG000|Overall Study|AE unrelated to study|2|||
160788519|NCT00128492|580612664|FG001|Overall Study|AE unrelated to study|9|||
160788520|NCT00128492|580612663|FG000|Overall Study|Study drug intolerance (AE)|2|||
160788521|NCT00128492|580612664|FG001|Overall Study|Study drug intolerance (AE)|8|||
160788522|NCT00128492|580612663|FG000|Overall Study|AE related to study|1|||
160788523|NCT00128492|580612664|FG001|Overall Study|AE related to study|4|||
160788524|NCT00128492|580612663|FG000|Overall Study|Death|1|||
160788525|NCT00128492|580612664|FG001|Overall Study|Death|0|||
160788526|NCT00128492|580612663|FG000|Overall Study|Lost to Follow-up|1|||
161330084|NCT01656395|582594786|FG005|Overall Study|Protocol Violation|10|||
161330085|NCT01656395|582594787|FG006|Overall Study|Protocol Violation|0|||
161330086|NCT01656395|582594788|FG007|Overall Study|Protocol Violation|0|||
161330087|NCT01656395|582594781|FG000|Overall Study|Screen Failure|2|||
161235200|NCT00365365|582244797|FG000|Overall Study|Randomized but not treated|0|||
161235201|NCT00365365|582244798|FG001|Overall Study|Randomized but not treated|2|||
161235202|NCT00365365|582244799|FG002|Overall Study|Randomized but not treated|0|||
161235203|NCT00365365|582244797|FG000|Overall Study|Poor compliance to protocol|0|||
161235204|NCT00365365|582244798|FG001|Overall Study|Poor compliance to protocol|1|||
160891466|NCT02964507|580998799|FG003|Overall Study|Physician Decision|0|||
160891467|NCT02964507|580998800|FG004|Overall Study|Physician Decision|1|||
160891468|NCT02964507|580998801|FG005|Overall Study|Physician Decision|0|||
160891469|NCT02964507|580998802|FG006|Overall Study|Physician Decision|0|||
160891470|NCT02964507|580998803|FG007|Overall Study|Physician Decision|0|||
160891471|NCT04341662|580998805|FG000|Overall Study|Did not have source-verified blood loss data|423|||
160891472|NCT04341662|580998806|FG001|Overall Study|Did not have source-verified blood loss data|514|||
160891473|NCT00245583|580998807|FG000|Overall Study|Lost to Follow-up|1|||
160891474|NCT00245583|580998808|FG001|Overall Study|Lost to Follow-up|5|||
160891475|NCT00245583|580998807|FG000|Overall Study|Adverse Event|2|||
160891476|NCT00245583|580998808|FG001|Overall Study|Adverse Event|1|||
160891477|NCT00245583|580998807|FG000|Overall Study|Lack of Efficacy|1|||
160891478|NCT00245583|580998808|FG001|Overall Study|Lack of Efficacy|0|||
160891479|NCT00245583|580998807|FG000|Overall Study|Withdrawal by Subject|2|||
160891480|NCT00245583|580998808|FG001|Overall Study|Withdrawal by Subject|3|||
160891481|NCT04718103|580998809|FG000|Overall Study|Adverse Event|1|||
160891482|NCT04718103|580998810|FG001|Overall Study|Adverse Event|1|||
160891483|NCT04718103|580998809|FG000|Overall Study|Lack of Efficacy|4|||
160891484|NCT04718103|580998810|FG001|Overall Study|Lack of Efficacy|1|||
160891485|NCT04718103|580998809|FG000|Overall Study|Lost to Follow-up|2|||
160891486|NCT04718103|580998810|FG001|Overall Study|Lost to Follow-up|2|||
160891487|NCT04718103|580998809|FG000|Overall Study|Physician Decision|2|||
160891488|NCT04718103|580998810|FG001|Overall Study|Physician Decision|0|||
160891489|NCT04718103|580998809|FG000|Overall Study|Pregnancy|0|||
160891490|NCT04718103|580998810|FG001|Overall Study|Pregnancy|1|||
160891491|NCT04718103|580998809|FG000|Overall Study|Withdrawal by Subject|10|||
160891492|NCT04718103|580998810|FG001|Overall Study|Withdrawal by Subject|6|||
160891493|NCT04718103|580998809|FG000|Overall Study|Randomized, not treated|4|||
160891494|NCT04718103|580998810|FG001|Overall Study|Randomized, not treated|1|||
160891495|NCT04718103|580998809|FG000|Overall Study|GCP violations|7|||
160891496|NCT04718103|580998810|FG001|Overall Study|GCP violations|5|||
160891497|NCT01309893|580998811|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
160891498|NCT01309893|580998812|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
160891499|NCT01309893|580998811|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
160891500|NCT01309893|580998812|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
160891501|NCT02017171|580998813|FG000|Overall Study|Death|10|||
161330088|NCT01656395|582594782|FG001|Overall Study|Screen Failure|1|||
160891502|NCT02017171|580998814|FG001|Overall Study|Death|4|||
160891503|NCT02017171|580998813|FG000|Overall Study|Withdrawal by Subject|23|||
160891504|NCT02017171|580998814|FG001|Overall Study|Withdrawal by Subject|17|||
160891505|NCT02017171|580998813|FG000|Overall Study|Lost to Follow-up|21|||
160891506|NCT02017171|580998814|FG001|Overall Study|Lost to Follow-up|20|||
160891507|NCT02017171|580998813|FG000|Overall Study|ESKD|6|||
160891508|NCT02017171|580998814|FG001|Overall Study|ESKD|2|||
161235205|NCT00365365|582244799|FG002|Overall Study|Poor compliance to protocol|0|||
161235206|NCT00365365|582244797|FG000|Overall Study|Lost to Follow-up|3|||
161235207|NCT00365365|582244798|FG001|Overall Study|Lost to Follow-up|3|||
161330089|NCT01656395|582594783|FG002|Overall Study|Screen Failure|7|||
161330090|NCT01656395|582594784|FG003|Overall Study|Screen Failure|1|||
161330091|NCT01656395|582594785|FG004|Overall Study|Screen Failure|0|||
160788527|NCT00128492|580612664|FG001|Overall Study|Lost to Follow-up|5|||
160788528|NCT00128492|580612663|FG000|Overall Study|Noncompliance|0|||
160788529|NCT00128492|580612664|FG001|Overall Study|Noncompliance|5|||
160788530|NCT00128492|580612663|FG000|Overall Study|Personal or administrative|10|||
160788531|NCT00128492|580612664|FG001|Overall Study|Personal or administrative|22|||
160788532|NCT00128492|580612663|FG000|Overall Study|Withdrawal by Subject|3|||
160891509|NCT02017171|580998813|FG000|Overall Study|Miscellaneous|2|||
160891510|NCT02017171|580998814|FG001|Overall Study|Miscellaneous|3|||
160891511|NCT01562873|580998815|FG000|Overall Study|Disease Progression per RECIST|10|||
160891512|NCT01562873|580998816|FG001|Overall Study|Disease Progression per RECIST|0|||
160891513|NCT01562873|580998815|FG000|Overall Study|Adverse Event|1|||
160891514|NCT01562873|580998816|FG001|Overall Study|Adverse Event|0|||
161330092|NCT01656395|582594786|FG005|Overall Study|Screen Failure|8|||
161235208|NCT00365365|582244799|FG002|Overall Study|Lost to Follow-up|3|||
161235209|NCT00365365|582244797|FG000|Overall Study|Death|1|||
161235210|NCT00365365|582244798|FG001|Overall Study|Death|3|||
161235211|NCT00365365|582244799|FG002|Overall Study|Death|0|||
161235212|NCT00365365|582244797|FG000|Overall Study|Subject's request|11|||
161235213|NCT00365365|582244798|FG001|Overall Study|Subject's request|13|||
160891515|NCT01562873|580998815|FG000|Overall Study|Clinical Disease Progression|9|||
160891516|NCT01562873|580998816|FG001|Overall Study|Clinical Disease Progression|0|||
160891517|NCT01562873|580998815|FG000|Overall Study|Clinical PD and adverse event|1|||
160891518|NCT01562873|580998816|FG001|Overall Study|Clinical PD and adverse event|0|||
160891519|NCT02220998|580998817|FG000|Overall Study|Randomized but Never Treated|1|||
160891520|NCT02220998|580998818|FG001|Overall Study|Randomized but Never Treated|2|||
160891521|NCT02220998|580998817|FG000|Overall Study|Death|2|||
160891522|NCT02220998|580998818|FG001|Overall Study|Death|0|||
160891523|NCT02220998|580998817|FG000|Overall Study|Lack of Efficacy|0|||
160891524|NCT02220998|580998818|FG001|Overall Study|Lack of Efficacy|5|||
160891525|NCT02220998|580998817|FG000|Overall Study|Lost to Follow-up|4|||
160891526|NCT02220998|580998818|FG001|Overall Study|Lost to Follow-up|4|||
160891527|NCT03309046|580998819|FG000|Overall Study|Withdrawal by Subject|4|||
160891528|NCT03309046|580998820|FG001|Overall Study|Withdrawal by Subject|17|||
160891529|NCT00873860|580998821|FG000|Overall Study|Lost to Follow-up|1|||
160891530|NCT00873860|580998822|FG001|Overall Study|Lost to Follow-up|0|||
160891531|NCT00873860|580998823|FG002|Overall Study|Lost to Follow-up|0|||
160891532|NCT00873860|580998824|FG003|Overall Study|Lost to Follow-up|1|||
160891533|NCT00873860|580998821|FG000|Overall Study|Withdrawal by Subject|1|||
160891534|NCT00873860|580998822|FG001|Overall Study|Withdrawal by Subject|0|||
160891535|NCT00873860|580998823|FG002|Overall Study|Withdrawal by Subject|2|||
160891536|NCT00873860|580998824|FG003|Overall Study|Withdrawal by Subject|0|||
160891537|NCT00873860|580998821|FG000|Overall Study|Death|1|||
160891538|NCT00873860|580998822|FG001|Overall Study|Death|0|||
160891539|NCT00873860|580998823|FG002|Overall Study|Death|0|||
160891540|NCT00873860|580998824|FG003|Overall Study|Death|0|||
160891541|NCT00873860|580998821|FG000|Overall Study|Other|1|||
160891542|NCT00873860|580998822|FG001|Overall Study|Other|0|||
160891543|NCT00873860|580998823|FG002|Overall Study|Other|1|||
160891544|NCT00873860|580998824|FG003|Overall Study|Other|0|||
160891545|NCT02764190|580998825|FG000|Overall Study|Lost to Follow-up|17|||
160891546|NCT02764190|580998826|FG001|Overall Study|Lost to Follow-up|13|||
160891547|NCT01484938|580998827|FG000|Overall Study|Adverse Event|2|||
160891548|NCT01484938|580998827|FG000|Overall Study|Lost to Follow-up|1|||
160891549|NCT01484938|580998827|FG000|Overall Study|Noncompliance|1|||
160891550|NCT01172275|580998831|FG000|Overall Study|Lost to Follow-up|1|||
160891551|NCT01172275|580998832|FG001|Overall Study|Lost to Follow-up|0|||
160891552|NCT01172275|580998831|FG000|Overall Study|Protocol Violation|1|||
160891553|NCT01172275|580998832|FG001|Overall Study|Protocol Violation|0|||
160891554|NCT02862600|580998833|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
160891555|NCT02862600|580998833|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
160891556|NCT02862600|580998833|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
160891557|NCT02862600|580998833|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
160891558|NCT00194675|580998834|FG000|Overall Study|Lost to Follow-up|1|||
160891559|NCT00194675|580998835|FG001|Overall Study|Lost to Follow-up|1|||
160891560|NCT00194675|580998834|FG000|Overall Study|lack of interest|1|||
160891561|NCT00194675|580998835|FG001|Overall Study|lack of interest|1|||
160891562|NCT00194675|580998834|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
160891563|NCT00194675|580998835|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
160891564|NCT00194675|580998834|FG000|Overall Study|Protocol Violation|1|||
160891565|NCT00194675|580998835|FG001|Overall Study|Protocol Violation|0|||
160891566|NCT00194675|580998834|FG000|Overall Study|Death|1|||
160891567|NCT00194675|580998835|FG001|Overall Study|Death|0|||
160891568|NCT04271280|580998836|FG000|Overall Study|Lost to Follow-up|300|||
160891569|NCT04271280|580998836|FG000|Overall Study|Death|153|||
160891570|NCT04271280|580998836|FG000|Overall Study|Withdrawal of consent by patient|59|||
160891571|NCT04271280|580998836|FG000|Overall Study|Other|51|||
160891572|NCT04271280|580998836|FG000|Overall Study|No end of study information|42|||
160891573|NCT00495131|580998837|FG000|Overall Study|Adverse Event|6|||
160891574|NCT00495131|580998838|FG001|Overall Study|Adverse Event|2|||
160891575|NCT00495131|580998837|FG000|Overall Study|Lack of Efficacy|0|||
160891576|NCT00495131|580998838|FG001|Overall Study|Lack of Efficacy|2|||
160891577|NCT00495131|580998837|FG000|Overall Study|Lost to Follow-up|0|||
160981870|NCT02061761|581321787|FG005|Overall Study|Maximum clinical benefit|0|||
160981871|NCT02061761|581321788|FG006|Overall Study|Maximum clinical benefit|0|||
161235214|NCT00365365|582244799|FG002|Overall Study|Subject's request|1|||
161235215|NCT00365365|582244797|FG000|Overall Study|Disease progression/relapse|9|||
161235216|NCT00365365|582244798|FG001|Overall Study|Disease progression/relapse|6|||
161235217|NCT00365365|582244799|FG002|Overall Study|Disease progression/relapse|7|||
161235218|NCT00365365|582244797|FG000|Overall Study|Adverse Event|6|||
160891578|NCT00495131|580998838|FG001|Overall Study|Lost to Follow-up|2|||
160891579|NCT00495131|580998837|FG000|Overall Study|Withdrawal by Subject|1|||
160891580|NCT00495131|580998838|FG001|Overall Study|Withdrawal by Subject|0|||
160891581|NCT01539317|580998841|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
160891582|NCT01539317|580998842|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
161127644|NCT04426695|581855138|FG000|Overall Study|Randomized but Never Treated|3|||
161127645|NCT04426695|581855139|FG001|Overall Study|Randomized but Never Treated|1|||
161127646|NCT04426695|581855140|FG002|Overall Study|Randomized but Never Treated|0|||
161127647|NCT04426695|581855141|FG003|Overall Study|Randomized but Never Treated|4|||
161127648|NCT04426695|581855142|FG004|Overall Study|Randomized but Never Treated|5|||
161330093|NCT01656395|582594787|FG006|Overall Study|Screen Failure|0|||
160891589|NCT00364130|580998845|FG000|Intervention Period|Lost to Follow-up|4|||
160891590|NCT00364130|580998846|FG001|Intervention Period|Lost to Follow-up|3|||
160891591|NCT00364130|580998845|FG000|Intervention Period|Pregnancy|1|||
160891592|NCT00364130|580998846|FG001|Intervention Period|Pregnancy|0|||
160891593|NCT00364130|580998845|FG000|Intervention Period|Withdrawal by Subject|4|||
160891594|NCT00364130|580998846|FG001|Intervention Period|Withdrawal by Subject|5|||
160891595|NCT00364130|580998845|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
160891596|NCT00364130|580998846|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
160891597|NCT00586846|580998854|FG000|Overall Study|Physician Decision|1|||
160891598|NCT00586846|580998854|FG000|Overall Study|Death|1|||
160891599|NCT00586846|580998854|FG000|Overall Study|Evaluable for Toxicity Only|4|||
160891600|NCT01702571|580998861|FG000|Overall Study|Death|1067|||
160891601|NCT01702571|580998862|FG001|Overall Study|Death|76|||
160891602|NCT01702571|580998861|FG000|Overall Study|Lost to Follow-up|144|||
160891603|NCT01702571|580998862|FG001|Overall Study|Lost to Follow-up|10|||
160891604|NCT01702571|580998861|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
160891605|NCT01702571|580998862|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
160891606|NCT01702571|580998861|FG000|Overall Study|Investigator Decision|5|||
160891607|NCT01702571|580998862|FG001|Overall Study|Investigator Decision|0|||
161330094|NCT01656395|582594788|FG007|Overall Study|Screen Failure|0|||
161330095|NCT01656395|582594781|FG000|Overall Study|Withdrawal by Subject|3|||
161330096|NCT01656395|582594782|FG001|Overall Study|Withdrawal by Subject|1|||
161330097|NCT01656395|582594783|FG002|Overall Study|Withdrawal by Subject|4|||
161330098|NCT01656395|582594784|FG003|Overall Study|Withdrawal by Subject|2|||
161330099|NCT01656395|582594785|FG004|Overall Study|Withdrawal by Subject|0|||
161330100|NCT01656395|582594786|FG005|Overall Study|Withdrawal by Subject|3|||
161330101|NCT01656395|582594787|FG006|Overall Study|Withdrawal by Subject|0|||
161330102|NCT01656395|582594788|FG007|Overall Study|Withdrawal by Subject|0|||
161330103|NCT00230048|582594793|FG000|Overall Study|Lost to Follow-up|13|||
161330104|NCT00230048|582594794|FG001|Overall Study|Lost to Follow-up|18|||
161330105|NCT00676403|582594795|FG000|Overall Study|Adverse Event|1|||
161330106|NCT00676403|582594796|FG001|Overall Study|Adverse Event|2|||
161330107|NCT00676403|582594797|FG002|Overall Study|Adverse Event|0|||
161330108|NCT00676403|582594798|FG003|Overall Study|Adverse Event|5|||
161330109|NCT00676403|582594799|FG004|Overall Study|Adverse Event|1|||
161330110|NCT00676403|582594800|FG005|Overall Study|Adverse Event|2|||
161330111|NCT00676403|582594795|FG000|Overall Study|Lost to Follow-up|0|||
161330112|NCT00676403|582594796|FG001|Overall Study|Lost to Follow-up|0|||
161330113|NCT00676403|582594797|FG002|Overall Study|Lost to Follow-up|0|||
161330114|NCT00676403|582594798|FG003|Overall Study|Lost to Follow-up|0|||
161330115|NCT00676403|582594799|FG004|Overall Study|Lost to Follow-up|0|||
161330116|NCT00676403|582594800|FG005|Overall Study|Lost to Follow-up|1|||
161330117|NCT00676403|582594795|FG000|Overall Study|Reason Unspecified|1|||
161330118|NCT00676403|582594796|FG001|Overall Study|Reason Unspecified|0|||
161330119|NCT00676403|582594797|FG002|Overall Study|Reason Unspecified|1|||
161330120|NCT00676403|582594798|FG003|Overall Study|Reason Unspecified|0|||
161330121|NCT00676403|582594799|FG004|Overall Study|Reason Unspecified|0|||
161330122|NCT00676403|582594800|FG005|Overall Study|Reason Unspecified|1|||
161330123|NCT00676403|582594795|FG000|Overall Study|Withdrawal by Subject|0|||
161330124|NCT00676403|582594796|FG001|Overall Study|Withdrawal by Subject|0|||
161330125|NCT00676403|582594797|FG002|Overall Study|Withdrawal by Subject|0|||
161330126|NCT00676403|582594798|FG003|Overall Study|Withdrawal by Subject|0|||
161330127|NCT00676403|582594799|FG004|Overall Study|Withdrawal by Subject|0|||
160891608|NCT01702571|580998861|FG000|Overall Study|Not Classifiable|1|||
160891609|NCT01702571|580998862|FG001|Overall Study|Not Classifiable|0|||
160891610|NCT01702571|580998861|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
160891611|NCT01702571|580998862|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
160891612|NCT01702571|580998861|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
160891613|NCT01702571|580998862|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
160891614|NCT01702571|580998861|FG000|Overall Study|Progressive Disease|3|||
160891615|NCT01702571|580998862|FG001|Overall Study|Progressive Disease|0|||
161330128|NCT00676403|582594800|FG005|Overall Study|Withdrawal by Subject|1|||
161330129|NCT03225170|582594801|FG000|Overall Study|Lost to Follow-up|4|||
161330130|NCT03225170|582594802|FG001|Overall Study|Lost to Follow-up|4|||
161330131|NCT03225170|582594803|FG002|Overall Study|Lost to Follow-up|0|||
161330132|NCT03225170|582594801|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
160891616|NCT01702571|580998861|FG000|Overall Study|Protocol Violation|2|||
160891617|NCT01702571|580998862|FG001|Overall Study|Protocol Violation|0|||
161235219|NCT00365365|582244798|FG001|Overall Study|Adverse Event|6|||
161235220|NCT00365365|582244799|FG002|Overall Study|Adverse Event|3|||
161235221|NCT00365365|582244797|FG000|Overall Study|Moved|2|||
161235222|NCT00365365|582244798|FG001|Overall Study|Moved|0|||
161235223|NCT00365365|582244799|FG002|Overall Study|Moved|0|||
160891618|NCT01702571|580998861|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
160891619|NCT01702571|580998862|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
160891620|NCT01702571|580998861|FG000|Overall Study|Termination By Sponsor|4|||
160891621|NCT01702571|580998862|FG001|Overall Study|Termination By Sponsor|0|||
160891622|NCT01702571|580998861|FG000|Overall Study|Withdrawal by Subject|177|||
160891623|NCT01702571|580998862|FG001|Overall Study|Withdrawal by Subject|29|||
160891624|NCT03004443|580998863|FG000|Overall Study|Pregnancy|0|||
160891625|NCT03004443|580998864|FG001|Overall Study|Pregnancy|1|||
160891626|NCT00828854|580998865|FG000|Overall Study|Disease Progression|17|||
160891627|NCT00828854|580998865|FG000|Overall Study|Adverse Event|9|||
160891628|NCT00828854|580998865|FG000|Overall Study|Reason not Specified|1|||
160891629|NCT04221230|580998866|FG000|Overall Study|Lost to Follow-up|12|||
160891630|NCT04221230|580998867|FG001|Overall Study|Lost to Follow-up|12|||
160891631|NCT04221230|580998866|FG000|Overall Study|Protocol Violation|2|||
160891632|NCT04221230|580998867|FG001|Overall Study|Protocol Violation|2|||
160891633|NCT04221230|580998866|FG000|Overall Study|Adverse Event|0|||
160891634|NCT04221230|580998867|FG001|Overall Study|Adverse Event|8|||
160891635|NCT04221230|580998866|FG000|Overall Study|Physician Decision|1|||
160891636|NCT04221230|580998867|FG001|Overall Study|Physician Decision|0|||
160891637|NCT04221230|580998866|FG000|Overall Study|Withdrawal by Subject|13|||
160891638|NCT04221230|580998867|FG001|Overall Study|Withdrawal by Subject|11|||
160891639|NCT04221230|580998866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160891640|NCT04221230|580998867|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160891641|NCT04221230|580998866|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160891642|NCT04221230|580998867|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
160891643|NCT04221230|580998866|FG000|Overall Study|Pregnancy|0|||
160891644|NCT04221230|580998867|FG001|Overall Study|Pregnancy|1|||
160891645|NCT04221230|580998866|FG000|Overall Study|Other|1|||
160891646|NCT04221230|580998867|FG001|Overall Study|Other|2|||
160891647|NCT00915356|580998868|FG000|Overall Study|Withdrawal by Subject|1|||
160891648|NCT00915356|580998869|FG001|Overall Study|Withdrawal by Subject|0|||
160891649|NCT00915356|580998870|FG002|Overall Study|Withdrawal by Subject|0|||
160891650|NCT00915356|580998871|FG003|Overall Study|Withdrawal by Subject|0|||
160891651|NCT00915356|580998872|FG004|Overall Study|Withdrawal by Subject|0|||
160891652|NCT00191646|580998874|FG000|Overall Study|Toxicity|26|||
160891653|NCT00191646|580998875|FG001|Overall Study|Toxicity|37|||
160891654|NCT00191646|580998874|FG000|Overall Study|Disease Progression|5|||
160891655|NCT00191646|580998875|FG001|Overall Study|Disease Progression|6|||
160891656|NCT00191646|580998874|FG000|Overall Study|Physician Decision|20|||
160891657|NCT00191646|580998875|FG001|Overall Study|Physician Decision|11|||
160891658|NCT00191646|580998874|FG000|Overall Study|Withdrawal by Subject|58|||
160891659|NCT00191646|580998875|FG001|Overall Study|Withdrawal by Subject|39|||
160891660|NCT00191646|580998874|FG000|Overall Study|Protocol Violation|5|||
160891661|NCT00191646|580998875|FG001|Overall Study|Protocol Violation|7|||
160891662|NCT00191646|580998874|FG000|Overall Study|Death|6|||
160891663|NCT00191646|580998875|FG001|Overall Study|Death|8|||
160891664|NCT00191646|580998874|FG000|Overall Study|Other|33|||
160891665|NCT00191646|580998875|FG001|Overall Study|Other|34|||
160891666|NCT00191646|580998874|FG000|Overall Study|Missing Data|18|||
160891667|NCT00191646|580998875|FG001|Overall Study|Missing Data|11|||
160891668|NCT05211284|580998881|FG000|Overall Study|Study Terminated|3|||
160891669|NCT05211284|580998882|FG001|Overall Study|Study Terminated|1|||
160891670|NCT00406718|580998891|FG000|Overall Study|Withdrawal by Subject|2|||
160891671|NCT00406718|580998892|FG001|Overall Study|Withdrawal by Subject|9|||
160891672|NCT00406718|580998893|FG002|Overall Study|Withdrawal by Subject|4|||
160891673|NCT00406718|580998891|FG000|Overall Study|Lost to Follow-up|2|||
160891674|NCT00406718|580998892|FG001|Overall Study|Lost to Follow-up|5|||
160891675|NCT00406718|580998893|FG002|Overall Study|Lost to Follow-up|4|||
160891676|NCT01888003|580998896|FG000|Overall Study|Study Terminated|5|||
160891677|NCT01888003|580998897|FG001|Overall Study|Study Terminated|6|||
160891678|NCT01888003|580998898|FG002|Overall Study|Study Terminated|40|||
160891679|NCT03187756|580998899|FG000|Overall Study|Termination of study|4|||
160891680|NCT01397201|581000404|FG000|Overall Study|Not treated|0|||
160891681|NCT01397201|581000405|FG001|Overall Study|Not treated|0|||
160891682|NCT01397201|581000406|FG002|Overall Study|Not treated|1|||
160891683|NCT01397201|581000407|FG003|Overall Study|Not treated|0|||
160891684|NCT01397201|581000408|FG004|Overall Study|Not treated|0|||
160891685|NCT01397201|581000404|FG000|Overall Study|Not yet defined|3|||
160891686|NCT01397201|581000405|FG001|Overall Study|Not yet defined|6|||
160891687|NCT01397201|581000406|FG002|Overall Study|Not yet defined|5|||
161235224|NCT00365365|582244797|FG000|Overall Study|New cancer|1|||
160891688|NCT01397201|581000407|FG003|Overall Study|Not yet defined|5|||
160891689|NCT01397201|581000408|FG004|Overall Study|Not yet defined|4|||
160891690|NCT01397201|581000404|FG000|Overall Study|Adverse Event|2|||
160891691|NCT01397201|581000405|FG001|Overall Study|Adverse Event|0|||
160891692|NCT01397201|581000406|FG002|Overall Study|Adverse Event|0|||
161235225|NCT00365365|582244798|FG001|Overall Study|New cancer|0|||
161235226|NCT00365365|582244799|FG002|Overall Study|New cancer|0|||
161235227|NCT00365365|582244797|FG000|Overall Study|Withdrew consent|1|||
161235228|NCT00365365|582244798|FG001|Overall Study|Withdrew consent|1|||
161235229|NCT00365365|582244799|FG002|Overall Study|Withdrew consent|0|||
161235230|NCT00365365|582244797|FG000|Overall Study|Second malignancy|0|||
161235231|NCT00365365|582244798|FG001|Overall Study|Second malignancy|1|||
161235232|NCT00365365|582244799|FG002|Overall Study|Second malignancy|0|||
161235233|NCT00365365|582244797|FG000|Overall Study|Patient/physician decision|0|||
161235234|NCT00365365|582244798|FG001|Overall Study|Patient/physician decision|0|||
161235235|NCT00365365|582244799|FG002|Overall Study|Patient/physician decision|1|||
161235236|NCT00838630|582244800|FG000|First Intervention|Adverse Event|1|||
161235237|NCT00838630|582244801|FG001|First Intervention|Adverse Event|0|||
161235238|NCT00838630|582244800|FG000|Washout: 7 Days|Protocol Violation|1|||
161235239|NCT00838630|582244801|FG001|Washout: 7 Days|Protocol Violation|0|||
161235240|NCT02057458|582244808|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
161235241|NCT02057458|582244809|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
161235242|NCT02057458|582244810|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
161235243|NCT02057458|582244808|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
161235244|NCT02057458|582244809|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
161235245|NCT02057458|582244810|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
161235246|NCT02057458|582244808|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
161235247|NCT02057458|582244809|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
161235248|NCT02057458|582244810|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
161235249|NCT04263649|582244811|FG000|Overall Study|Adverse Event|53|||
161235250|NCT04263649|582244811|FG000|Overall Study|Lost to Follow-up|3|||
161235251|NCT04263649|582244811|FG000|Overall Study|Death|29|||
161235252|NCT04263649|582244811|FG000|Overall Study|Device deficiency|19|||
161235253|NCT04263649|582244811|FG000|Overall Study|other reasons|11|||
161235254|NCT05169710|582244812|FG000|Overall Study|Adverse Event|1|||
161235255|NCT05169710|582244813|FG001|Overall Study|Adverse Event|2|||
161235256|NCT05169710|582244814|FG002|Overall Study|Adverse Event|2|||
161235257|NCT05169710|582244812|FG000|Overall Study|Lost to Follow-up|0|||
161235258|NCT05169710|582244813|FG001|Overall Study|Lost to Follow-up|0|||
161235259|NCT05169710|582244814|FG002|Overall Study|Lost to Follow-up|1|||
161235260|NCT05169710|582244812|FG000|Overall Study|Withdrawal by Subject|2|||
161235261|NCT05169710|582244813|FG001|Overall Study|Withdrawal by Subject|1|||
161235262|NCT05169710|582244814|FG002|Overall Study|Withdrawal by Subject|0|||
161235263|NCT05169710|582244812|FG000|Overall Study|Other Study Discontinuation Reason|0|||
161235264|NCT05169710|582244813|FG001|Overall Study|Other Study Discontinuation Reason|2|||
161235265|NCT05169710|582244814|FG002|Overall Study|Other Study Discontinuation Reason|0|||
161235266|NCT00723710|582244826|FG000|Overall Study|Disease progression|48|||
161235267|NCT00723710|582244826|FG000|Overall Study|Adverse Event|88|||
161235268|NCT00723710|582244826|FG000|Overall Study|Withdrawal by Subject|36|||
161235269|NCT00723710|582244826|FG000|Overall Study|Physician Decision|2|||
161235270|NCT00468286|582244827|FG000|Overall Study|Adverse Event|1|||
161235271|NCT00468286|582244828|FG001|Overall Study|Adverse Event|6|||
161235272|NCT00468286|582244827|FG000|Overall Study|Protocol Violation|2|||
161235273|NCT00468286|582244828|FG001|Overall Study|Protocol Violation|2|||
161235274|NCT00468286|582244827|FG000|Overall Study|Withdrawal by Subject|4|||
161235275|NCT00468286|582244828|FG001|Overall Study|Withdrawal by Subject|3|||
161235276|NCT00468286|582244827|FG000|Overall Study|Physician Decision|0|||
161235277|NCT00468286|582244828|FG001|Overall Study|Physician Decision|1|||
161235278|NCT02196675|582244832|FG000|Overall Study|Withdrawal by Subject|1|||
161235279|NCT02196675|582244833|FG001|Overall Study|Withdrawal by Subject|0|||
161235280|NCT02196675|582244834|FG002|Overall Study|Withdrawal by Subject|0|||
161235281|NCT02196675|582244832|FG000|Overall Study|Intra-operative surgical exclusion|1|||
161235282|NCT02196675|582244833|FG001|Overall Study|Intra-operative surgical exclusion|1|||
161235283|NCT02196675|582244834|FG002|Overall Study|Intra-operative surgical exclusion|0|||
161235284|NCT02196675|582244832|FG000|Overall Study|Protocol Violation|0|||
161235285|NCT02196675|582244833|FG001|Overall Study|Protocol Violation|1|||
161235286|NCT02196675|582244834|FG002|Overall Study|Protocol Violation|0|||
161235287|NCT02196675|582244832|FG000|Overall Study|Death|0|||
161235288|NCT02196675|582244833|FG001|Overall Study|Death|0|||
161235289|NCT02196675|582244834|FG002|Overall Study|Death|1|||
161235290|NCT02158663|582244835|FG000|Overall Study|Withdrawal by Subject|5|||
161235291|NCT02158663|582244836|FG001|Overall Study|Withdrawal by Subject|4|||
161235292|NCT03459807|582244837|FG000|Overall Study|Withdrawal due to transplant|0|||
161235293|NCT03459807|582244838|FG001|Overall Study|Withdrawal due to transplant|1|||
161235294|NCT00833937|582244843|FG000|Washout|Withdrawal by Subject|1|||
161235295|NCT00833937|582244844|FG001|Washout|Withdrawal by Subject|0|||
161235296|NCT02392000|582244845|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
161235297|NCT02392000|582244845|FG000|Overall Study|Withdrawal by Subject|1|||
161235298|NCT02392000|582244845|FG000|Overall Study|Lost to Follow-up|8|||
161235299|NCT03197883|582244848|FG000|Overall Study|Adverse Event|1|||
161235300|NCT03197883|582244849|FG001|Overall Study|Adverse Event|1|||
161235301|NCT03197883|582244848|FG000|Overall Study|Lost to Follow-up|1|||
161235302|NCT03197883|582244849|FG001|Overall Study|Lost to Follow-up|0|||
161235303|NCT03197883|582244848|FG000|Overall Study|Protocol Violation|1|||
161235304|NCT03197883|582244849|FG001|Overall Study|Protocol Violation|0|||
161235305|NCT03197883|582244848|FG000|Overall Study|Other (Not Specified)|0|||
161235306|NCT03197883|582244849|FG001|Overall Study|Other (Not Specified)|5|||
161235307|NCT00576056|582244850|FG000|Overall Study|Adverse Event|1|||
161235308|NCT00576056|582244850|FG000|Overall Study|Death|1|||
161235309|NCT00576056|582244850|FG000|Overall Study|Lack of Efficacy|1|||
161235310|NCT00576056|582244850|FG000|Overall Study|Withdrawal by Subject|2|||
161235311|NCT00576056|582244850|FG000|Overall Study|did not meet eligibility criteria|8|||
161235312|NCT00576056|582244850|FG000|Overall Study|Physician Decision|1|||
161235313|NCT01353664|582244851|FG000|Overall Study|Other|3|||
161235314|NCT01353664|582244851|FG000|Overall Study|Disease Progression|16|||
161235315|NCT03273153|582244852|FG000|Overall Study|Adverse Event|1|||
161235316|NCT03273153|582244853|FG001|Overall Study|Adverse Event|2|||
161330133|NCT03225170|582594802|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
161330134|NCT03225170|582594803|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
161330135|NCT01272908|582594804|FG000|Initial Treatment Period|Adverse Event|1|||
161330136|NCT01272908|582594804|FG000|Initial Treatment Period|Lack of Efficacy|5|||
161330137|NCT01272908|582594804|FG000|Initial Treatment Period|Protocol Violation|1|||
161330138|NCT01272908|582594804|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161330139|NCT01272908|582594804|FG000|Re-Treatment Period|Adverse Event|2|||
161330140|NCT01272908|582594804|FG000|Re-Treatment Period|Lack of Efficacy|3|||
161330141|NCT01272908|582594804|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
161235317|NCT03273153|582244852|FG000|Overall Study|Missing|0|||
161235318|NCT03273153|582244853|FG001|Overall Study|Missing|2|||
161235319|NCT03273153|582244852|FG000|Overall Study|Other|3|||
161235320|NCT03273153|582244853|FG001|Overall Study|Other|2|||
161235321|NCT03273153|582244852|FG000|Overall Study|Symptomatic Deterioration|0|||
161235322|NCT03273153|582244853|FG001|Overall Study|Symptomatic Deterioration|1|||
161235323|NCT03273153|582244852|FG000|Overall Study|Progressive Disease|6|||
161235324|NCT03273153|582244853|FG001|Overall Study|Progressive Disease|5|||
161235325|NCT03273153|582244852|FG000|Overall Study|Physician Decision|1|||
161235326|NCT03273153|582244853|FG001|Overall Study|Physician Decision|3|||
161235327|NCT03273153|582244852|FG000|Overall Study|Study Terminated by Sponsor|112|||
161235328|NCT03273153|582244853|FG001|Overall Study|Study Terminated by Sponsor|102|||
161235329|NCT03273153|582244852|FG000|Overall Study|Withdrawal by Subject|26|||
161235330|NCT03273153|582244853|FG001|Overall Study|Withdrawal by Subject|25|||
161235331|NCT03273153|582244852|FG000|Overall Study|Protocol Deviation|3|||
161235332|NCT03273153|582244853|FG001|Overall Study|Protocol Deviation|0|||
161235333|NCT03273153|582244852|FG000|Overall Study|Lost to Follow-up|6|||
161235334|NCT03273153|582244853|FG001|Overall Study|Lost to Follow-up|11|||
161235335|NCT03273153|582244852|FG000|Overall Study|Death|66|||
161235336|NCT03273153|582244853|FG001|Overall Study|Death|69|||
161235337|NCT00838539|582244854|FG000|Overall Study|Disease Progression|2|||
161235338|NCT00838539|582244855|FG001|Overall Study|Disease Progression|4|||
161235339|NCT00838539|582244856|FG002|Overall Study|Disease Progression|3|||
161235340|NCT00838539|582244857|FG003|Overall Study|Disease Progression|2|||
161235341|NCT00838539|582244858|FG004|Overall Study|Disease Progression|4|||
161235342|NCT00838539|582244859|FG005|Overall Study|Disease Progression|2|||
161235343|NCT00838539|582244860|FG006|Overall Study|Disease Progression|3|||
161235344|NCT00838539|582244861|FG007|Overall Study|Disease Progression|4|||
161235345|NCT00838539|582244862|FG008|Overall Study|Disease Progression|4|||
161235346|NCT00838539|582244863|FG009|Overall Study|Disease Progression|5|||
161235347|NCT00838539|582244864|FG010|Overall Study|Disease Progression|1|||
161330142|NCT00971867|582594805|FG000|Overall Study|Adverse Event|4|||
161235348|NCT00838539|582244865|FG011|Overall Study|Disease Progression|4|||
161235349|NCT00838539|582244854|FG000|Overall Study|Adverse Event|1|||
161235350|NCT00838539|582244855|FG001|Overall Study|Adverse Event|1|||
161235351|NCT00838539|582244856|FG002|Overall Study|Adverse Event|1|||
161235352|NCT00838539|582244857|FG003|Overall Study|Adverse Event|1|||
161235353|NCT00838539|582244858|FG004|Overall Study|Adverse Event|2|||
161235354|NCT00838539|582244859|FG005|Overall Study|Adverse Event|1|||
161235355|NCT00838539|582244860|FG006|Overall Study|Adverse Event|0|||
161235356|NCT00838539|582244861|FG007|Overall Study|Adverse Event|2|||
161235357|NCT00838539|582244862|FG008|Overall Study|Adverse Event|0|||
161235358|NCT00838539|582244863|FG009|Overall Study|Adverse Event|1|||
161235359|NCT00838539|582244864|FG010|Overall Study|Adverse Event|2|||
161235360|NCT00838539|582244865|FG011|Overall Study|Adverse Event|0|||
161330143|NCT00971867|582594805|FG000|Overall Study|Participant Withdrew Consent|1|||
161330144|NCT00971867|582594805|FG000|Overall Study|Disease Progression|6|||
161235361|NCT00838539|582244854|FG000|Overall Study|Withdrawal by Subject|0|||
161235362|NCT00838539|582244855|FG001|Overall Study|Withdrawal by Subject|1|||
161235363|NCT00838539|582244856|FG002|Overall Study|Withdrawal by Subject|0|||
161235364|NCT00838539|582244857|FG003|Overall Study|Withdrawal by Subject|0|||
161235365|NCT00838539|582244858|FG004|Overall Study|Withdrawal by Subject|0|||
161235366|NCT00838539|582244859|FG005|Overall Study|Withdrawal by Subject|0|||
160891693|NCT01397201|581000407|FG003|Overall Study|Adverse Event|0|||
160891694|NCT01397201|581000408|FG004|Overall Study|Adverse Event|0|||
160891695|NCT00398411|581000412|FG000|Overall Study|Death|0|||
160891696|NCT00398411|581000413|FG001|Overall Study|Death|1|||
160891697|NCT00401531|581000414|FG000|Overall Study|Adverse Event|2|||
160891698|NCT00401531|581000415|FG001|Overall Study|Adverse Event|0|||
160891699|NCT00401531|581000414|FG000|Overall Study|Protocol Violation|3|||
160891700|NCT00401531|581000415|FG001|Overall Study|Protocol Violation|7|||
160891701|NCT00401531|581000414|FG000|Overall Study|Lost to Follow-up|1|||
160891702|NCT00401531|581000415|FG001|Overall Study|Lost to Follow-up|1|||
160891703|NCT00401531|581000414|FG000|Overall Study|Withdrawal by Subject|3|||
160891704|NCT00401531|581000415|FG001|Overall Study|Withdrawal by Subject|2|||
160891705|NCT03403374|581000418|FG000|Overall Study|Lost to Follow-up|1|||
160891706|NCT05314478|581000422|FG000|Overall Study|Physician Decision|1|||
160891707|NCT00145600|581000423|FG000|Overall Study|Death|1|||
160891708|NCT00145600|581000424|FG001|Overall Study|Death|2|||
160891709|NCT00145600|581000425|FG002|Overall Study|Death|2|||
160891710|NCT00145600|581000426|FG003|Overall Study|Death|6|||
160891711|NCT00145600|581000423|FG000|Overall Study|Ineligible|3|||
160891712|NCT00145600|581000424|FG001|Overall Study|Ineligible|0|||
160891713|NCT00145600|581000425|FG002|Overall Study|Ineligible|1|||
160891714|NCT00145600|581000426|FG003|Overall Study|Ineligible|5|||
160891715|NCT00145600|581000423|FG000|Overall Study|Lost to Follow-up|2|||
160891716|NCT00145600|581000424|FG001|Overall Study|Lost to Follow-up|6|||
160891717|NCT00145600|581000425|FG002|Overall Study|Lost to Follow-up|2|||
160891718|NCT00145600|581000426|FG003|Overall Study|Lost to Follow-up|4|||
160891719|NCT00145600|581000423|FG000|Overall Study|Noncompliance|1|||
160891720|NCT00145600|581000424|FG001|Overall Study|Noncompliance|0|||
160891721|NCT00145600|581000425|FG002|Overall Study|Noncompliance|0|||
160891722|NCT00145600|581000426|FG003|Overall Study|Noncompliance|0|||
160891723|NCT00145600|581000423|FG000|Overall Study|Withdrawal by Subject|1|||
160891724|NCT00145600|581000424|FG001|Overall Study|Withdrawal by Subject|2|||
160891725|NCT00145600|581000425|FG002|Overall Study|Withdrawal by Subject|0|||
160891726|NCT00145600|581000426|FG003|Overall Study|Withdrawal by Subject|1|||
160891727|NCT03583164|581000430|FG000|Overall Study|Death in Main Phase|35|||
160891728|NCT03583164|581000430|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
160891729|NCT03583164|581000430|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
160891730|NCT03583164|581000430|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
161127649|NCT04426695|581855143|FG005|Overall Study|Randomized but Never Treated|5|||
161127650|NCT04426695|581855144|FG006|Overall Study|Randomized but Never Treated|4|||
161127651|NCT04426695|581855145|FG007|Overall Study|Randomized but Never Treated|6|||
161127652|NCT04426695|581855146|FG008|Overall Study|Randomized but Never Treated|6|||
161127653|NCT04426695|581855147|FG009|Overall Study|Randomized but Never Treated|3|||
161127654|NCT04426695|581855148|FG010|Overall Study|Randomized but Never Treated|3|||
161127655|NCT04426695|581855149|FG011|Overall Study|Randomized but Never Treated|6|||
161127656|NCT04426695|581855150|FG012|Overall Study|Randomized but Never Treated|1|||
161127657|NCT04426695|581855151|FG013|Overall Study|Randomized but Never Treated|2|||
161127658|NCT04426695|581855152|FG014|Overall Study|Randomized but Never Treated|0|||
161127659|NCT04426695|581855153|FG015|Overall Study|Randomized but Never Treated|0|||
161127660|NCT04426695|581855154|FG016|Overall Study|Randomized but Never Treated|0|||
161127661|NCT04426695|581855155|FG017|Overall Study|Randomized but Never Treated|0|||
161127662|NCT03653390|581855158|FG000|Overall Study|Lost to Follow-up|12|||
161127663|NCT03653390|581855159|FG001|Overall Study|Lost to Follow-up|8|||
161127664|NCT03653390|581855160|FG002|Overall Study|Lost to Follow-up|7|||
161127665|NCT03653390|581855158|FG000|Overall Study|Withdrawal by Subject|6|||
161127666|NCT03653390|581855159|FG001|Overall Study|Withdrawal by Subject|1|||
161127667|NCT03653390|581855160|FG002|Overall Study|Withdrawal by Subject|1|||
161127668|NCT03653390|581855158|FG000|Overall Study|Death|1|||
161127669|NCT03653390|581855159|FG001|Overall Study|Death|0|||
161127670|NCT03653390|581855160|FG002|Overall Study|Death|0|||
161127671|NCT03653390|581855158|FG000|Overall Study|Paper Survey Lost|1|||
161127672|NCT03653390|581855159|FG001|Overall Study|Paper Survey Lost|0|||
161127673|NCT03653390|581855160|FG002|Overall Study|Paper Survey Lost|0|||
161127674|NCT03118947|581855161|FG000|Overall Study|Adverse Event|7|||
161127675|NCT03118947|581855161|FG000|Overall Study|Death|3|||
161127676|NCT03118947|581855161|FG000|Overall Study|Lack of Efficacy|4|||
161127677|NCT03118947|581855161|FG000|Overall Study|Non-compliance with study drug|1|||
161127678|NCT03118947|581855161|FG000|Overall Study|Protocol Violation|2|||
161127679|NCT03118947|581855161|FG000|Overall Study|Withdrawal by Subject|3|||
161127680|NCT03118947|581855161|FG000|Overall Study|Withdrawal by caregiver|3|||
161127681|NCT03118947|581855161|FG000|Overall Study|Change in patient's living situation|4|||
160891731|NCT03583164|581000430|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
160891732|NCT03583164|581000430|FG000|Overall Study|Physician decision in Main Phase|1|||
160891733|NCT03583164|581000430|FG000|Overall Study|Physician decision in Extended Phase|2|||
160891734|NCT03583164|581000430|FG000|Overall Study|Death in Extended Phase|13|||
160891735|NCT03583164|581000430|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
161127682|NCT03118947|581855161|FG000|Overall Study|Lost to Follow-up|2|||
160891736|NCT03583164|581000430|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
160891737|NCT03583164|581000430|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
160891738|NCT03583164|581000430|FG000|Overall Study|Treatment failure in Main Phase|2|||
160891739|NCT03583164|581000430|FG000|Overall Study|Treatment failure in Extended Phase|4|||
160891740|NCT03583164|581000430|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
160891741|NCT03583164|581000430|FG000|Overall Study|Other not specified reason in Main Phase|2|||
160891742|NCT01031381|581000431|FG000|Overall Study|Physician Decision|3|||
160891743|NCT01031381|581000431|FG000|Overall Study|Withdrawal by Subject|6|||
160891744|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
160891745|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
160891746|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
160891747|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
160891748|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160891749|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
160891750|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160891751|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
160891752|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
160891753|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
160891754|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
160891755|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
160891756|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
160891757|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
161235367|NCT00838539|582244860|FG006|Overall Study|Withdrawal by Subject|0|||
161235368|NCT00838539|582244861|FG007|Overall Study|Withdrawal by Subject|0|||
161235369|NCT00838539|582244862|FG008|Overall Study|Withdrawal by Subject|0|||
161235370|NCT00838539|582244863|FG009|Overall Study|Withdrawal by Subject|1|||
161235371|NCT00838539|582244864|FG010|Overall Study|Withdrawal by Subject|2|||
161235372|NCT00838539|582244865|FG011|Overall Study|Withdrawal by Subject|0|||
161235373|NCT00838539|582244854|FG000|Overall Study|Death|0|||
161235374|NCT00838539|582244855|FG001|Overall Study|Death|0|||
161235375|NCT00838539|582244856|FG002|Overall Study|Death|0|||
161235376|NCT00838539|582244857|FG003|Overall Study|Death|0|||
161235377|NCT00838539|582244858|FG004|Overall Study|Death|0|||
161235378|NCT00838539|582244859|FG005|Overall Study|Death|0|||
161235379|NCT00838539|582244860|FG006|Overall Study|Death|1|||
161235380|NCT00838539|582244861|FG007|Overall Study|Death|0|||
161235381|NCT00838539|582244862|FG008|Overall Study|Death|0|||
161235382|NCT00838539|582244863|FG009|Overall Study|Death|0|||
160891758|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
160891759|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
160891760|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Program Termination|3|||
160891761|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Program Termination|0|||
160891762|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Program Termination|1|||
160891763|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Program Termination|1|||
160891764|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
160891765|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
160891766|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
160891767|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
160891768|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
160891769|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
160891770|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
160891771|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
161330145|NCT00379899|582594815|FG000|Overall Study|Adverse Event|7|||
161330146|NCT00379899|582594816|FG001|Overall Study|Adverse Event|3|||
161330147|NCT00379899|582594815|FG000|Overall Study|Death|10|||
161330148|NCT00379899|582594816|FG001|Overall Study|Death|10|||
161330149|NCT00379899|582594815|FG000|Overall Study|Lost to Follow-up|2|||
161330150|NCT00379899|582594816|FG001|Overall Study|Lost to Follow-up|4|||
161330151|NCT00379899|582594815|FG000|Overall Study|Physician Decision|3|||
161330152|NCT00379899|582594816|FG001|Overall Study|Physician Decision|4|||
160891772|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
160891773|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
160891774|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
160891775|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
160891776|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
160891777|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
160891778|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
160891779|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
161235383|NCT00838539|582244864|FG010|Overall Study|Death|0|||
161235384|NCT00838539|582244865|FG011|Overall Study|Death|0|||
161235385|NCT00838539|582244854|FG000|Overall Study|Physician Decision|0|||
161235386|NCT00838539|582244855|FG001|Overall Study|Physician Decision|0|||
161330153|NCT00379899|582594815|FG000|Overall Study|Withdrawal by Subject|5|||
161330154|NCT00379899|582594816|FG001|Overall Study|Withdrawal by Subject|5|||
160891780|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
160891781|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
160891782|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
161127683|NCT01109940|581855162|FG000|Overall Study|Administrative problems|2|||
161127684|NCT01109940|581855163|FG001|Overall Study|Administrative problems|0|||
161127685|NCT01109940|581855164|FG002|Overall Study|Administrative problems|0|||
161127686|NCT01109940|581855165|FG003|Overall Study|Administrative problems|0|||
161127687|NCT01109940|581855162|FG000|Overall Study|Serious Adverse Event|2|||
161127688|NCT01109940|581855163|FG001|Overall Study|Serious Adverse Event|1|||
161127689|NCT01109940|581855164|FG002|Overall Study|Serious Adverse Event|0|||
161127690|NCT01109940|581855165|FG003|Overall Study|Serious Adverse Event|0|||
161127691|NCT01109940|581855162|FG000|Overall Study|Lost to Follow-up|1|||
161127692|NCT01109940|581855163|FG001|Overall Study|Lost to Follow-up|0|||
161127693|NCT01109940|581855164|FG002|Overall Study|Lost to Follow-up|0|||
161127694|NCT01109940|581855165|FG003|Overall Study|Lost to Follow-up|0|||
161127695|NCT01109940|581855162|FG000|Overall Study|Patient withdrew consent|1|||
161127696|NCT01109940|581855163|FG001|Overall Study|Patient withdrew consent|1|||
161127697|NCT01109940|581855164|FG002|Overall Study|Patient withdrew consent|0|||
161127698|NCT01109940|581855165|FG003|Overall Study|Patient withdrew consent|0|||
161127699|NCT01109940|581855162|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161127700|NCT01109940|581855163|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161127701|NCT01109940|581855164|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161127702|NCT01109940|581855165|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161127703|NCT02769624|581855166|FG000|Overall Study|Lost to Follow-up|0|||
161127704|NCT02769624|581855167|FG001|Overall Study|Lost to Follow-up|1|||
161127705|NCT01987908|581855176|FG000|Placebo Lead-in Period|Adverse Event|2|||
161127706|NCT01987908|581855177|FG001|Placebo Lead-in Period|Adverse Event|0|||
161127707|NCT01987908|581855178|FG002|Placebo Lead-in Period|Adverse Event|0|||
161127708|NCT01987908|581855176|FG000|Placebo Lead-in Period|Physician Decision|2|||
161127709|NCT01987908|581855177|FG001|Placebo Lead-in Period|Physician Decision|0|||
161127710|NCT01987908|581855178|FG002|Placebo Lead-in Period|Physician Decision|0|||
161127711|NCT01987908|581855176|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
161127712|NCT01987908|581855177|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
161127713|NCT01987908|581855178|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
161127714|NCT01987908|581855176|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
161127715|NCT01987908|581855177|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
161127716|NCT01987908|581855178|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
161127717|NCT01987908|581855176|FG000|Treatment Period|Adverse Event|0|||
161127718|NCT01987908|581855177|FG001|Treatment Period|Adverse Event|1|||
161127719|NCT01987908|581855178|FG002|Treatment Period|Adverse Event|1|||
161127720|NCT01987908|581855176|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
161127721|NCT01987908|581855177|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
161127722|NCT01987908|581855178|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
161127723|NCT01987908|581855176|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
161127724|NCT01987908|581855177|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
161127725|NCT01987908|581855178|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
161127726|NCT01869348|581855180|FG000|Overall Study|Withdrawal by Subject|1|||
161127727|NCT01869348|581855181|FG001|Overall Study|Withdrawal by Subject|1|||
161127728|NCT02789657|581855182|FG000|Overall Study|Withdrawal by Subject|2|||
161127729|NCT02789657|581855183|FG001|Overall Study|Withdrawal by Subject|0|||
161127730|NCT02789657|581855184|FG002|Overall Study|Withdrawal by Subject|0|||
161127731|NCT02789657|581855185|FG003|Overall Study|Withdrawal by Subject|0|||
161127732|NCT01728779|581855186|FG000|Overall Study|Withdrawal by Subject|1|||
161127733|NCT00448708|581855187|FG000|Overall Study|Death|21|||
161127734|NCT00448708|581855188|FG001|Overall Study|Death|17|||
161127735|NCT00448708|581855187|FG000|Overall Study|Withdrawal by Subject|8|||
161127736|NCT00448708|581855188|FG001|Overall Study|Withdrawal by Subject|4|||
161127737|NCT00448708|581855187|FG000|Overall Study|Lost to Follow-up|6|||
161127738|NCT00448708|581855188|FG001|Overall Study|Lost to Follow-up|8|||
161127739|NCT00448708|581855187|FG000|Overall Study|not listed|0|||
161127740|NCT00448708|581855188|FG001|Overall Study|not listed|2|||
161127741|NCT01925209|581855189|FG000|Treatment Epoch|Physician Decision|1|||
161127742|NCT01925209|581855190|FG001|Treatment Epoch|Physician Decision|0|||
161127743|NCT01925209|581855191|FG002|Treatment Epoch|Physician Decision|0|||
161127744|NCT01925209|581855192|FG003|Treatment Epoch|Physician Decision|0|||
161127745|NCT01925209|581855189|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
161127746|NCT01925209|581855190|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
161127747|NCT01925209|581855191|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
161127748|NCT01925209|581855192|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
161127749|NCT01925209|581855189|FG000|Treatment Epoch|Death|1|||
161127750|NCT01925209|581855190|FG001|Treatment Epoch|Death|0|||
161127751|NCT01925209|581855191|FG002|Treatment Epoch|Death|0|||
161127752|NCT01925209|581855192|FG003|Treatment Epoch|Death|0|||
161127753|NCT01925209|581855189|FG000|Treatment Epoch|Protocol deviation|0|||
161127754|NCT01925209|581855190|FG001|Treatment Epoch|Protocol deviation|0|||
160891783|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
160891784|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
160891785|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
160891786|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
160891787|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
160891788|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
160891789|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
160891790|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
160891791|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
160891792|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
160891793|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
160891794|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
160788533|NCT00128492|580612664|FG001|Overall Study|Withdrawal by Subject|5|||
160788534|NCT00128492|580612663|FG000|Overall Study|Pregnancy|0|||
160891795|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
160891796|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
160891797|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
160891798|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
160788535|NCT00128492|580612664|FG001|Overall Study|Pregnancy|1|||
160788536|NCT03436420|580612666|FG000|Overall Study|Lack of Efficacy|3|||
160788537|NCT00756314|580612667|FG000|Overall Study|Lost to Follow-up|2|||
160788538|NCT00756314|580612668|FG001|Overall Study|Lost to Follow-up|59|||
160891799|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
160891800|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
160788539|NCT02605967|580612669|FG000|Overall Study|subject / guardian decision|1|||
160788540|NCT02605967|580612670|FG001|Overall Study|subject / guardian decision|2|||
160788541|NCT02605967|580612669|FG000|Overall Study|Physician Decision|10|||
160788542|NCT02605967|580612670|FG001|Overall Study|Physician Decision|1|||
160788543|NCT02605967|580612669|FG000|Overall Study|Death|4|||
160788544|NCT02605967|580612670|FG001|Overall Study|Death|2|||
160788545|NCT02605967|580612669|FG000|Overall Study|Adverse Event|1|||
160788546|NCT02605967|580612670|FG001|Overall Study|Adverse Event|0|||
160788547|NCT02605967|580612669|FG000|Overall Study|progressive disease|66|||
160788548|NCT02605967|580612670|FG001|Overall Study|progressive disease|35|||
160788549|NCT03627468|580612671|FG000|Overall Study|Adverse Event|5|||
160788550|NCT03627468|580612672|FG001|Overall Study|Adverse Event|33|||
160788551|NCT03627468|580612671|FG000|Overall Study|Withdrawal by Subject|13|||
160788552|NCT03627468|580612672|FG001|Overall Study|Withdrawal by Subject|23|||
160788553|NCT03627468|580612671|FG000|Overall Study|Physician Decision|1|||
160788554|NCT03627468|580612672|FG001|Overall Study|Physician Decision|0|||
160788555|NCT03627468|580612671|FG000|Overall Study|Protocol Violation|0|||
160788556|NCT03627468|580612672|FG001|Overall Study|Protocol Violation|2|||
160788557|NCT03627468|580612671|FG000|Overall Study|Lost to Follow-up|10|||
160788558|NCT03627468|580612672|FG001|Overall Study|Lost to Follow-up|16|||
160788559|NCT03627468|580612671|FG000|Overall Study|Death|1|||
160788560|NCT03627468|580612672|FG001|Overall Study|Death|0|||
160788561|NCT03627468|580612671|FG000|Overall Study|Pregnancy|1|||
160788562|NCT03627468|580612672|FG001|Overall Study|Pregnancy|1|||
160788563|NCT03627468|580612671|FG000|Overall Study|Lack of Efficacy|0|||
160788564|NCT03627468|580612672|FG001|Overall Study|Lack of Efficacy|2|||
160788565|NCT03627468|580612671|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
160788566|NCT03627468|580612672|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
160788567|NCT01475825|580612676|FG000|Overall Study|Adverse Event|41|||
160788568|NCT01475825|580612677|FG001|Overall Study|Adverse Event|15|||
161127755|NCT01925209|581855191|FG002|Treatment Epoch|Protocol deviation|1|||
161127756|NCT01925209|581855192|FG003|Treatment Epoch|Protocol deviation|1|||
161127757|NCT01925209|581855189|FG000|Treatment Epoch|Withdrawal by Subject|4|||
161127758|NCT01925209|581855190|FG001|Treatment Epoch|Withdrawal by Subject|3|||
161127759|NCT01925209|581855191|FG002|Treatment Epoch|Withdrawal by Subject|3|||
161127760|NCT01925209|581855192|FG003|Treatment Epoch|Withdrawal by Subject|2|||
161127761|NCT01925209|581855189|FG000|Treatment Epoch|Adverse Event|3|||
161127762|NCT01925209|581855190|FG001|Treatment Epoch|Adverse Event|5|||
161127763|NCT01925209|581855191|FG002|Treatment Epoch|Adverse Event|3|||
161127764|NCT01925209|581855192|FG003|Treatment Epoch|Adverse Event|1|||
161235387|NCT00838539|582244856|FG002|Overall Study|Physician Decision|0|||
160788569|NCT01475825|580612678|FG002|Overall Study|Adverse Event|27|||
160788570|NCT01475825|580612679|FG003|Overall Study|Adverse Event|11|||
160788571|NCT01475825|580612676|FG000|Overall Study|Death|1|||
160788572|NCT01475825|580612677|FG001|Overall Study|Death|0|||
160788573|NCT01475825|580612678|FG002|Overall Study|Death|1|||
160788574|NCT01475825|580612679|FG003|Overall Study|Death|0|||
160788575|NCT01475825|580612676|FG000|Overall Study|Lack of Efficacy|0|||
160788576|NCT01475825|580612677|FG001|Overall Study|Lack of Efficacy|0|||
160788577|NCT01475825|580612678|FG002|Overall Study|Lack of Efficacy|1|||
160788578|NCT01475825|580612679|FG003|Overall Study|Lack of Efficacy|0|||
160788579|NCT01475825|580612676|FG000|Overall Study|Lost to Follow-up|0|||
160788580|NCT01475825|580612677|FG001|Overall Study|Lost to Follow-up|0|||
160788581|NCT01475825|580612678|FG002|Overall Study|Lost to Follow-up|3|||
160788582|NCT01475825|580612679|FG003|Overall Study|Lost to Follow-up|1|||
160788583|NCT01475825|580612676|FG000|Overall Study|Non-compliance with Study Drug|1|||
160788584|NCT01475825|580612677|FG001|Overall Study|Non-compliance with Study Drug|2|||
160788585|NCT01475825|580612678|FG002|Overall Study|Non-compliance with Study Drug|4|||
160788586|NCT01475825|580612679|FG003|Overall Study|Non-compliance with Study Drug|0|||
160788587|NCT01475825|580612676|FG000|Overall Study|Other: Not available|0|||
160788588|NCT01475825|580612677|FG001|Overall Study|Other: Not available|0|||
160788589|NCT01475825|580612678|FG002|Overall Study|Other: Not available|2|||
160788590|NCT01475825|580612679|FG003|Overall Study|Other: Not available|0|||
160891801|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
160891802|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
160891803|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
160891804|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
160891805|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
160891806|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
160891807|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
160891808|NCT03739840|581000434|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
160891809|NCT03739840|581000435|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
160891810|NCT03739840|581000436|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
160891811|NCT03739840|581000437|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
160891812|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
160891813|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
160891814|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
160891815|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
160891816|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
160891817|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
160891818|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
160891819|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
160891820|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
160891821|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
160891822|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
160891823|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
160891824|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
160891825|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
160891826|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
160891827|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
160891828|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
160891829|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
160891830|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
160891831|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
160891832|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
160981872|NCT02061761|581321789|FG007|Overall Study|Maximum clinical benefit|0|||
161235388|NCT00838539|582244857|FG003|Overall Study|Physician Decision|0|||
160788591|NCT01475825|580612676|FG000|Overall Study|Protocol Violation|1|||
160788592|NCT01475825|580612677|FG001|Overall Study|Protocol Violation|0|||
160788593|NCT01475825|580612678|FG002|Overall Study|Protocol Violation|0|||
161235389|NCT00838539|582244858|FG004|Overall Study|Physician Decision|0|||
161235390|NCT00838539|582244859|FG005|Overall Study|Physician Decision|0|||
160788594|NCT01475825|580612679|FG003|Overall Study|Protocol Violation|0|||
160788595|NCT01475825|580612676|FG000|Overall Study|Physician Decision|0|||
160788596|NCT01475825|580612677|FG001|Overall Study|Physician Decision|1|||
160788597|NCT01475825|580612678|FG002|Overall Study|Physician Decision|0|||
160788598|NCT01475825|580612679|FG003|Overall Study|Physician Decision|0|||
160788599|NCT01475825|580612676|FG000|Overall Study|Withdrawal by Subject|8|||
160788600|NCT01475825|580612677|FG001|Overall Study|Withdrawal by Subject|3|||
160788601|NCT01475825|580612678|FG002|Overall Study|Withdrawal by Subject|11|||
161235391|NCT00838539|582244860|FG006|Overall Study|Physician Decision|0|||
161235392|NCT00838539|582244861|FG007|Overall Study|Physician Decision|0|||
161235393|NCT00838539|582244862|FG008|Overall Study|Physician Decision|1|||
161235394|NCT00838539|582244863|FG009|Overall Study|Physician Decision|0|||
160788602|NCT01475825|580612679|FG003|Overall Study|Withdrawal by Subject|7|||
160788603|NCT01475825|580612676|FG000|Overall Study|Did not enter OLC|15|||
160788604|NCT01475825|580612677|FG001|Overall Study|Did not enter OLC|11|||
160788605|NCT01475825|580612678|FG002|Overall Study|Did not enter OLC|15|||
160788606|NCT01475825|580612679|FG003|Overall Study|Did not enter OLC|11|||
160788607|NCT01714063|580612682|FG000|Overall Study|Equipment malfunction|2|||
160788608|NCT03721107|580612683|FG000|Overall Study|Adverse Event|1|||
160788609|NCT03721107|580612684|FG001|Overall Study|Adverse Event|1|||
160788610|NCT03721107|580612685|FG002|Overall Study|Adverse Event|6|||
160788611|NCT03721107|580612686|FG003|Overall Study|Adverse Event|5|||
160788612|NCT03721107|580612683|FG000|Overall Study|Lost to Follow-up|2|||
160788613|NCT03721107|580612684|FG001|Overall Study|Lost to Follow-up|0|||
160788614|NCT03721107|580612685|FG002|Overall Study|Lost to Follow-up|3|||
160788615|NCT03721107|580612686|FG003|Overall Study|Lost to Follow-up|0|||
160788616|NCT03721107|580612683|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
160788617|NCT03721107|580612684|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
160788618|NCT03721107|580612685|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
160788619|NCT03721107|580612686|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
160788620|NCT03721107|580612683|FG000|Overall Study|Physician Decision|0|||
160788621|NCT03721107|580612684|FG001|Overall Study|Physician Decision|1|||
160788622|NCT03721107|580612685|FG002|Overall Study|Physician Decision|0|||
160788623|NCT03721107|580612686|FG003|Overall Study|Physician Decision|0|||
160788624|NCT03721107|580612683|FG000|Overall Study|Pregnancy|0|||
161330155|NCT00379899|582594815|FG000|Overall Study|Ineligibility determined|0|||
161330156|NCT00379899|582594816|FG001|Overall Study|Ineligibility determined|1|||
161330157|NCT00379899|582594815|FG000|Overall Study|Noncompliance|1|||
161330158|NCT00379899|582594816|FG001|Overall Study|Noncompliance|1|||
161330159|NCT00379899|582594815|FG000|Overall Study|Parathyroidectomy|0|||
161330160|NCT00379899|582594816|FG001|Overall Study|Parathyroidectomy|2|||
161330161|NCT00379899|582594815|FG000|Overall Study|Renal transplantation|5|||
161330162|NCT00379899|582594816|FG001|Overall Study|Renal transplantation|4|||
161330163|NCT00379899|582594815|FG000|Overall Study|Coronary artery bypass graft|1|||
161127765|NCT01925209|581855189|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
161127766|NCT01925209|581855190|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
161127767|NCT01925209|581855191|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
161127768|NCT01925209|581855192|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
161127769|NCT01925209|581855189|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
161127770|NCT01925209|581855190|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
161127771|NCT01925209|581855191|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
161127772|NCT01925209|581855192|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
161127773|NCT01925209|581855189|FG000|Follow-up|Adverse Event|1|||
161127774|NCT01925209|581855190|FG001|Follow-up|Adverse Event|4|||
161127775|NCT01925209|581855191|FG002|Follow-up|Adverse Event|0|||
161127776|NCT01925209|581855192|FG003|Follow-up|Adverse Event|1|||
161127777|NCT01925209|581855189|FG000|Follow-up|Physician Decision|0|||
161127778|NCT01925209|581855190|FG001|Follow-up|Physician Decision|0|||
161127779|NCT01925209|581855191|FG002|Follow-up|Physician Decision|1|||
161127780|NCT01925209|581855192|FG003|Follow-up|Physician Decision|0|||
161127781|NCT01925209|581855189|FG000|Follow-up|Non-compliance with study treatment|0|||
161127782|NCT01925209|581855190|FG001|Follow-up|Non-compliance with study treatment|0|||
161127783|NCT01925209|581855191|FG002|Follow-up|Non-compliance with study treatment|0|||
161127784|NCT01925209|581855192|FG003|Follow-up|Non-compliance with study treatment|1|||
161127785|NCT01925209|581855189|FG000|Follow-up|Withdrawal by Subject|0|||
161127786|NCT01925209|581855190|FG001|Follow-up|Withdrawal by Subject|2|||
161127787|NCT01925209|581855191|FG002|Follow-up|Withdrawal by Subject|0|||
161127788|NCT01925209|581855192|FG003|Follow-up|Withdrawal by Subject|2|||
161127789|NCT01299727|581855194|FG000|Overall Study|Withdrawal by Subject|1|||
161127790|NCT01299727|581855195|FG001|Overall Study|Withdrawal by Subject|0|||
161127791|NCT01299727|581855196|FG002|Overall Study|Withdrawal by Subject|0|||
161330164|NCT00379899|582594816|FG001|Overall Study|Coronary artery bypass graft|1|||
161330165|NCT00379899|582594815|FG000|Overall Study|Other protocol-specified criteria|3|||
161330166|NCT00379899|582594816|FG001|Overall Study|Other protocol-specified criteria|4|||
161330167|NCT00379899|582594815|FG000|Overall Study|Other|3|||
160788625|NCT03721107|580612684|FG001|Overall Study|Pregnancy|0|||
160788626|NCT03721107|580612685|FG002|Overall Study|Pregnancy|1|||
160891833|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
160891834|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
160891835|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
160891836|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
160891837|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
160891838|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
161127792|NCT01299727|581855194|FG000|Overall Study|Adverse Event|0|||
161127793|NCT01299727|581855195|FG001|Overall Study|Adverse Event|0|||
161127794|NCT01299727|581855196|FG002|Overall Study|Adverse Event|1|||
161127795|NCT01299727|581855194|FG000|Overall Study|Completed the Treatment Period|3|||
161330168|NCT00379899|582594816|FG001|Overall Study|Other|1|||
161330169|NCT02716779|582594819|FG000|Monotherapy|Adverse Event|0|||
160788627|NCT03721107|580612686|FG003|Overall Study|Pregnancy|0|||
160788628|NCT03721107|580612683|FG000|Overall Study|Withdrawal by Subject|1|||
160788629|NCT03721107|580612684|FG001|Overall Study|Withdrawal by Subject|1|||
160788630|NCT03721107|580612685|FG002|Overall Study|Withdrawal by Subject|5|||
160788631|NCT03721107|580612686|FG003|Overall Study|Withdrawal by Subject|5|||
161127796|NCT01299727|581855195|FG001|Overall Study|Completed the Treatment Period|4|||
161127797|NCT01299727|581855196|FG002|Overall Study|Completed the Treatment Period|3|||
161330170|NCT02716779|582594820|FG001|Monotherapy|Adverse Event|1|||
160788632|NCT03721107|580612683|FG000|Overall Study|Other|1|||
161127798|NCT03882424|581855197|FG000|Overall Study|Lost to Follow-up|3|||
161127799|NCT03882424|581855198|FG001|Overall Study|Lost to Follow-up|0|||
161127800|NCT03882424|581855199|FG002|Overall Study|Lost to Follow-up|0|||
161127801|NCT03882424|581855197|FG000|Overall Study|schedule conflict|1|||
161127802|NCT03882424|581855198|FG001|Overall Study|schedule conflict|0|||
161127803|NCT03882424|581855199|FG002|Overall Study|schedule conflict|0|||
161127804|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Adverse Event|21|||
161127805|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Adverse Event|6|||
161127806|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
161127807|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
161127808|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
161127809|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
161127810|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
161127811|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
161127812|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Physician Decision|0|||
161127813|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Physician Decision|3|||
161127814|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
161127815|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
161127816|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
161127817|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
161127818|NCT00510276|581855209|FG000|Acute Double-Blind Phase|Subject Decision|26|||
161127819|NCT00510276|581855210|FG001|Acute Double-Blind Phase|Subject Decision|28|||
161127820|NCT00510276|581855209|FG000|Extension Open-Label Phase|Adverse Event|9|||
161127821|NCT00510276|581855210|FG001|Extension Open-Label Phase|Adverse Event|18|||
161127822|NCT00510276|581855209|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
161127823|NCT00510276|581855210|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
161127824|NCT00510276|581855209|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
161127825|NCT00510276|581855210|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
161127826|NCT00510276|581855209|FG000|Extension Open-Label Phase|Physician Decision|2|||
161127827|NCT00510276|581855210|FG001|Extension Open-Label Phase|Physician Decision|3|||
161127828|NCT00510276|581855209|FG000|Extension Open-Label Phase|Protocol Violation|0|||
161127829|NCT00510276|581855210|FG001|Extension Open-Label Phase|Protocol Violation|1|||
161127830|NCT00510276|581855209|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
161127831|NCT00510276|581855210|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
161127832|NCT00510276|581855209|FG000|Extension Open-Label Phase|Subject Decision|7|||
161127833|NCT00510276|581855210|FG001|Extension Open-Label Phase|Subject Decision|9|||
161127834|NCT00441792|581855211|FG000|Overall Study|Lost to Follow-up|0|||
161127835|NCT00441792|581855212|FG001|Overall Study|Lost to Follow-up|2|||
161127836|NCT01731678|581855213|FG000|Overall Study|Withdrawal by Subject|3|||
161127837|NCT01731678|581855213|FG000|Overall Study|Did not meet inclusion criteria|1|||
161127838|NCT01731678|581855213|FG000|Overall Study|RMT too high, making TMS difficult|3|||
161127839|NCT00888355|581855216|FG000|Overall Study|Adverse Event|10|||
161127840|NCT00888355|581855217|FG001|Overall Study|Adverse Event|0|||
161127841|NCT00888355|581855218|FG002|Overall Study|Adverse Event|3|||
161127842|NCT00888355|581855219|FG003|Overall Study|Adverse Event|3|||
161127843|NCT00888355|581855216|FG000|Overall Study|Lack of Efficacy|9|||
161127844|NCT00888355|581855217|FG001|Overall Study|Lack of Efficacy|2|||
161127845|NCT00888355|581855218|FG002|Overall Study|Lack of Efficacy|5|||
161127846|NCT00888355|581855219|FG003|Overall Study|Lack of Efficacy|2|||
161127847|NCT00888355|581855216|FG000|Overall Study|Lost to Follow-up|0|||
161127848|NCT00888355|581855217|FG001|Overall Study|Lost to Follow-up|2|||
161127849|NCT00888355|581855218|FG002|Overall Study|Lost to Follow-up|2|||
161127850|NCT00888355|581855219|FG003|Overall Study|Lost to Follow-up|0|||
161127851|NCT00888355|581855216|FG000|Overall Study|Protocol Violation|3|||
161127852|NCT00888355|581855217|FG001|Overall Study|Protocol Violation|2|||
161127853|NCT00888355|581855218|FG002|Overall Study|Protocol Violation|1|||
161127854|NCT00888355|581855219|FG003|Overall Study|Protocol Violation|2|||
161127855|NCT00888355|581855216|FG000|Overall Study|Withdrawal by Subject|0|||
161127856|NCT00888355|581855217|FG001|Overall Study|Withdrawal by Subject|3|||
161127857|NCT00888355|581855218|FG002|Overall Study|Withdrawal by Subject|1|||
161127858|NCT00888355|581855219|FG003|Overall Study|Withdrawal by Subject|3|||
161127859|NCT00354601|581855222|FG000|Overall Study|Protocol Violation|1|||
161235395|NCT00838539|582244864|FG010|Overall Study|Physician Decision|0|||
160788633|NCT03721107|580612684|FG001|Overall Study|Other|0|||
161127860|NCT00354601|581855222|FG000|Overall Study|progression|1|||
161127861|NCT02532855|581855225|FG000|Overall Study|Lost to Follow-up|4|||
161127862|NCT02532855|581855226|FG001|Overall Study|Lost to Follow-up|3|||
161127863|NCT02532855|581855225|FG000|Overall Study|Withdrawal by Subject|4|||
160788634|NCT03721107|580612685|FG002|Overall Study|Other|0|||
160788635|NCT03721107|580612686|FG003|Overall Study|Other|1|||
161127864|NCT02532855|581855226|FG001|Overall Study|Withdrawal by Subject|8|||
161127865|NCT00666926|581855227|FG000|Overall Study|Adverse Event|0|||
161127866|NCT00666926|581855228|FG001|Overall Study|Adverse Event|0|||
161127867|NCT00666926|581855229|FG002|Overall Study|Adverse Event|0|||
161127868|NCT00666926|581855230|FG003|Overall Study|Adverse Event|0|||
161127869|NCT00666926|581855231|FG004|Overall Study|Adverse Event|0|||
161235396|NCT00838539|582244865|FG011|Overall Study|Physician Decision|0|||
161235397|NCT00838539|582244854|FG000|Overall Study|Clinical Progression|0|||
161235398|NCT00838539|582244855|FG001|Overall Study|Clinical Progression|0|||
161235399|NCT00838539|582244856|FG002|Overall Study|Clinical Progression|0|||
161235400|NCT00838539|582244857|FG003|Overall Study|Clinical Progression|0|||
161235401|NCT00838539|582244858|FG004|Overall Study|Clinical Progression|0|||
161235402|NCT00838539|582244859|FG005|Overall Study|Clinical Progression|0|||
161235403|NCT00838539|582244860|FG006|Overall Study|Clinical Progression|1|||
161235404|NCT00838539|582244861|FG007|Overall Study|Clinical Progression|0|||
161235405|NCT00838539|582244862|FG008|Overall Study|Clinical Progression|0|||
161235406|NCT00838539|582244863|FG009|Overall Study|Clinical Progression|0|||
161235407|NCT00838539|582244864|FG010|Overall Study|Clinical Progression|0|||
161235408|NCT00838539|582244865|FG011|Overall Study|Clinical Progression|0|||
161235409|NCT00838539|582244854|FG000|Overall Study|Symptomatic Deterioration|0|||
161235410|NCT00838539|582244855|FG001|Overall Study|Symptomatic Deterioration|0|||
161235411|NCT00838539|582244856|FG002|Overall Study|Symptomatic Deterioration|1|||
161235412|NCT00838539|582244857|FG003|Overall Study|Symptomatic Deterioration|1|||
160788636|NCT02369159|580612689|FG000|Overall Study|Adverse Event|0|||
160788637|NCT02369159|580612690|FG001|Overall Study|Adverse Event|1|||
160788638|NCT02369159|580612689|FG000|Overall Study|Lost to Follow-up|1|||
160788639|NCT02369159|580612690|FG001|Overall Study|Lost to Follow-up|1|||
160981873|NCT02061761|581321790|FG008|Overall Study|Maximum clinical benefit|6|||
160981874|NCT02061761|581321782|FG000|Overall Study|Participant no longer meets study criteria|0|||
160981875|NCT02061761|581321783|FG001|Overall Study|Participant no longer meets study criteria|0|||
160788640|NCT02369159|580612689|FG000|Overall Study|Withdrawal by Subject|7|||
160788641|NCT02369159|580612690|FG001|Overall Study|Withdrawal by Subject|0|||
160788642|NCT00563316|580612693|FG000|Overall Study|Adverse Event|2|||
160788643|NCT00563316|580612693|FG000|Overall Study|Physician Decision|1|||
160788644|NCT00563316|580612693|FG000|Overall Study|Lost to Follow-up|2|||
160788645|NCT00563316|580612693|FG000|Overall Study|Death|1|||
160788646|NCT00563316|580612693|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
160788647|NCT00563316|580612693|FG000|Overall Study|Other|1|||
160788648|NCT02991859|580612697|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788649|NCT02991859|580612698|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
160788650|NCT02991859|580612699|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788651|NCT02991859|580612700|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788652|NCT02991859|580612701|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
160788653|NCT02991859|580612702|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788654|NCT02991859|580612703|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788655|NCT02991859|580612704|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788656|NCT02991859|580612705|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788657|NCT02991859|580612706|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788658|NCT02991859|580612707|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788659|NCT02991859|580612708|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788660|NCT02991859|580612709|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788661|NCT02991859|580612710|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788662|NCT02991859|580612711|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788663|NCT02991859|580612712|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788664|NCT02991859|580612713|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
160788665|NCT02991859|580612697|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788666|NCT02991859|580612698|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788667|NCT02991859|580612699|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788668|NCT02991859|580612700|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788669|NCT02991859|580612701|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788670|NCT02991859|580612702|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788671|NCT02991859|580612703|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788672|NCT02991859|580612704|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788673|NCT02991859|580612705|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788674|NCT02991859|580612706|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788675|NCT02991859|580612707|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788676|NCT02991859|580612708|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788677|NCT02991859|580612709|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
160788678|NCT02991859|580612710|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
161235413|NCT00838539|582244858|FG004|Overall Study|Symptomatic Deterioration|0|||
161235414|NCT00838539|582244859|FG005|Overall Study|Symptomatic Deterioration|1|||
161235415|NCT00838539|582244860|FG006|Overall Study|Symptomatic Deterioration|0|||
161235416|NCT00838539|582244861|FG007|Overall Study|Symptomatic Deterioration|0|||
161235417|NCT00838539|582244862|FG008|Overall Study|Symptomatic Deterioration|0|||
161235418|NCT00838539|582244863|FG009|Overall Study|Symptomatic Deterioration|1|||
160891839|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
160891840|NCT03739840|581000434|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
160891841|NCT03739840|581000435|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
160788679|NCT02991859|580612711|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788680|NCT02991859|580612712|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788681|NCT02991859|580612713|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
160788682|NCT02991859|580612697|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788683|NCT02991859|580612698|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788684|NCT02991859|580612699|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788685|NCT02991859|580612700|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788686|NCT02991859|580612701|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788687|NCT02991859|580612702|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
160788688|NCT02991859|580612703|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788689|NCT02991859|580612704|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788690|NCT02991859|580612705|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788691|NCT02991859|580612706|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788692|NCT02991859|580612707|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788693|NCT02991859|580612708|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788694|NCT02991859|580612709|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788695|NCT02991859|580612710|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788696|NCT02991859|580612711|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788697|NCT02991859|580612712|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788698|NCT02991859|580612713|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
160788699|NCT02991859|580612697|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788700|NCT02991859|580612698|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788701|NCT02991859|580612699|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160891842|NCT03739840|581000436|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
160891843|NCT03739840|581000437|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
160891844|NCT05153473|581000438|FG000|Overall Study|Death|46|||
160891845|NCT05153473|581000438|FG000|Overall Study|Lost to Follow-up|3|||
160891846|NCT02788474|581000439|FG000|Double Blind Treatment Period|Not treated|1|||
160891847|NCT02788474|581000440|FG001|Double Blind Treatment Period|Not treated|0|||
160891848|NCT02788474|581000439|FG000|Double Blind Treatment Period|Patient's refusal|3|||
160891849|NCT02788474|581000440|FG001|Double Blind Treatment Period|Patient's refusal|0|||
160891850|NCT02788474|581000439|FG000|Double Blind Treatment Period|Adverse Event|6|||
160891851|NCT02788474|581000440|FG001|Double Blind Treatment Period|Adverse Event|4|||
160891852|NCT02788474|581000439|FG000|Open Label Treatment Period|Adverse Event|29|||
160891853|NCT02788474|581000440|FG001|Open Label Treatment Period|Adverse Event|9|||
160891854|NCT02788474|581000439|FG000|Open Label Treatment Period|Other than reason specified|1|||
160891855|NCT02788474|581000440|FG001|Open Label Treatment Period|Other than reason specified|0|||
160891856|NCT02788474|581000439|FG000|Open Label Treatment Period|Patient's refusal|1|||
160891857|NCT02788474|581000440|FG001|Open Label Treatment Period|Patient's refusal|3|||
160891858|NCT02788474|581000439|FG000|Open Label Treatment Period|Non-compliance|1|||
160891859|NCT02788474|581000440|FG001|Open Label Treatment Period|Non-compliance|0|||
160891860|NCT02694523|581000441|FG000|Part A|Adverse Event|7|||
160891861|NCT02694523|581000442|FG001|Part A|Adverse Event|3|||
160891862|NCT02694523|581000443|FG002|Part A|Adverse Event|0|||
160891863|NCT02694523|581000444|FG003|Part A|Adverse Event|0|||
160981876|NCT02061761|581321784|FG002|Overall Study|Participant no longer meets study criteria|0|||
160981877|NCT02061761|581321785|FG003|Overall Study|Participant no longer meets study criteria|0|||
160981878|NCT02061761|581321786|FG004|Overall Study|Participant no longer meets study criteria|0|||
160981879|NCT02061761|581321787|FG005|Overall Study|Participant no longer meets study criteria|0|||
160981880|NCT02061761|581321788|FG006|Overall Study|Participant no longer meets study criteria|0|||
160981881|NCT02061761|581321789|FG007|Overall Study|Participant no longer meets study criteria|0|||
160981882|NCT02061761|581321790|FG008|Overall Study|Participant no longer meets study criteria|1|||
160981883|NCT02061761|581321782|FG000|Overall Study|Other reasons|0|||
160981884|NCT02061761|581321783|FG001|Overall Study|Other reasons|0|||
160981885|NCT02061761|581321784|FG002|Overall Study|Other reasons|0|||
160981886|NCT02061761|581321785|FG003|Overall Study|Other reasons|0|||
160981887|NCT02061761|581321786|FG004|Overall Study|Other reasons|2|||
160981888|NCT02061761|581321787|FG005|Overall Study|Other reasons|0|||
160981889|NCT02061761|581321788|FG006|Overall Study|Other reasons|0|||
160981890|NCT02061761|581321789|FG007|Overall Study|Other reasons|0|||
161127870|NCT00666926|581855232|FG005|Overall Study|Adverse Event|0|||
161330171|NCT02716779|582594821|FG002|Monotherapy|Adverse Event|1|||
161330172|NCT02716779|582594819|FG000|Combination Therapy|Adverse Event|0|||
160788702|NCT02991859|580612700|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160891864|NCT02694523|581000445|FG004|Part A|Adverse Event|0|||
160891865|NCT02694523|581000446|FG005|Part A|Adverse Event|0|||
160788703|NCT02991859|580612701|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788704|NCT02991859|580612702|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160891866|NCT02694523|581000447|FG006|Part A|Adverse Event|0|||
160891867|NCT02694523|581000441|FG000|Part A|Protocol Violation|1|||
161127871|NCT00666926|581855233|FG006|Overall Study|Adverse Event|0|||
161127872|NCT00666926|581855234|FG007|Overall Study|Adverse Event|0|||
161127873|NCT00666926|581855235|FG008|Overall Study|Adverse Event|0|||
161127874|NCT00666926|581855236|FG009|Overall Study|Adverse Event|2|||
161127875|NCT00666926|581855237|FG010|Overall Study|Adverse Event|2|||
161127876|NCT00666926|581855238|FG011|Overall Study|Adverse Event|2|||
161127877|NCT00666926|581855239|FG012|Overall Study|Adverse Event|0|||
161127878|NCT00666926|581855240|FG013|Overall Study|Adverse Event|1|||
161127879|NCT00666926|581855241|FG014|Overall Study|Adverse Event|0|||
161127880|NCT00666926|581855242|FG015|Overall Study|Adverse Event|0|||
161127881|NCT00666926|581855227|FG000|Overall Study|Laboratory abnormality|0|||
161127882|NCT00666926|581855228|FG001|Overall Study|Laboratory abnormality|0|||
161127883|NCT00666926|581855229|FG002|Overall Study|Laboratory abnormality|0|||
161127884|NCT00666926|581855230|FG003|Overall Study|Laboratory abnormality|0|||
161127885|NCT00666926|581855231|FG004|Overall Study|Laboratory abnormality|0|||
161127886|NCT00666926|581855232|FG005|Overall Study|Laboratory abnormality|0|||
161127887|NCT00666926|581855233|FG006|Overall Study|Laboratory abnormality|0|||
161127888|NCT00666926|581855234|FG007|Overall Study|Laboratory abnormality|0|||
161127889|NCT00666926|581855235|FG008|Overall Study|Laboratory abnormality|0|||
161127890|NCT00666926|581855236|FG009|Overall Study|Laboratory abnormality|0|||
161127891|NCT00666926|581855237|FG010|Overall Study|Laboratory abnormality|1|||
161127892|NCT00666926|581855238|FG011|Overall Study|Laboratory abnormality|0|||
161127893|NCT00666926|581855239|FG012|Overall Study|Laboratory abnormality|0|||
160788705|NCT02991859|580612703|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788706|NCT02991859|580612704|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
161127894|NCT00666926|581855240|FG013|Overall Study|Laboratory abnormality|0|||
161127895|NCT00666926|581855241|FG014|Overall Study|Laboratory abnormality|0|||
161127896|NCT00666926|581855242|FG015|Overall Study|Laboratory abnormality|1|||
161127897|NCT00666926|581855227|FG000|Overall Study|Lack of Efficacy|0|||
161127898|NCT00666926|581855228|FG001|Overall Study|Lack of Efficacy|0|||
161127899|NCT00666926|581855229|FG002|Overall Study|Lack of Efficacy|0|||
161127900|NCT00666926|581855230|FG003|Overall Study|Lack of Efficacy|0|||
161127901|NCT00666926|581855231|FG004|Overall Study|Lack of Efficacy|0|||
161127902|NCT00666926|581855232|FG005|Overall Study|Lack of Efficacy|1|||
161127903|NCT00666926|581855233|FG006|Overall Study|Lack of Efficacy|0|||
161127904|NCT00666926|581855234|FG007|Overall Study|Lack of Efficacy|0|||
161127905|NCT00666926|581855235|FG008|Overall Study|Lack of Efficacy|0|||
161127906|NCT00666926|581855236|FG009|Overall Study|Lack of Efficacy|0|||
161127907|NCT00666926|581855237|FG010|Overall Study|Lack of Efficacy|0|||
161127908|NCT00666926|581855238|FG011|Overall Study|Lack of Efficacy|1|||
161127909|NCT00666926|581855239|FG012|Overall Study|Lack of Efficacy|0|||
161127910|NCT00666926|581855240|FG013|Overall Study|Lack of Efficacy|0|||
161127911|NCT00666926|581855241|FG014|Overall Study|Lack of Efficacy|0|||
161127912|NCT00666926|581855242|FG015|Overall Study|Lack of Efficacy|0|||
161127913|NCT00666926|581855227|FG000|Overall Study|Lost to Follow-up|0|||
161127914|NCT00666926|581855228|FG001|Overall Study|Lost to Follow-up|0|||
161127915|NCT00666926|581855229|FG002|Overall Study|Lost to Follow-up|0|||
161127916|NCT00666926|581855230|FG003|Overall Study|Lost to Follow-up|1|||
161127917|NCT00666926|581855231|FG004|Overall Study|Lost to Follow-up|0|||
161127918|NCT00666926|581855232|FG005|Overall Study|Lost to Follow-up|0|||
161127919|NCT00666926|581855233|FG006|Overall Study|Lost to Follow-up|0|||
161127920|NCT00666926|581855234|FG007|Overall Study|Lost to Follow-up|0|||
161127921|NCT00666926|581855235|FG008|Overall Study|Lost to Follow-up|0|||
161127922|NCT00666926|581855236|FG009|Overall Study|Lost to Follow-up|0|||
161127923|NCT00666926|581855237|FG010|Overall Study|Lost to Follow-up|0|||
161127924|NCT00666926|581855238|FG011|Overall Study|Lost to Follow-up|0|||
161127925|NCT00666926|581855239|FG012|Overall Study|Lost to Follow-up|0|||
161127926|NCT00666926|581855240|FG013|Overall Study|Lost to Follow-up|0|||
161127927|NCT00666926|581855241|FG014|Overall Study|Lost to Follow-up|0|||
161127928|NCT00666926|581855242|FG015|Overall Study|Lost to Follow-up|0|||
161127929|NCT00666926|581855227|FG000|Overall Study|Other|2|||
161127930|NCT00666926|581855228|FG001|Overall Study|Other|4|||
161127931|NCT00666926|581855229|FG002|Overall Study|Other|3|||
161127932|NCT00666926|581855230|FG003|Overall Study|Other|3|||
161127933|NCT00666926|581855231|FG004|Overall Study|Other|3|||
161127934|NCT00666926|581855232|FG005|Overall Study|Other|3|||
161127935|NCT00666926|581855233|FG006|Overall Study|Other|4|||
161127936|NCT00666926|581855234|FG007|Overall Study|Other|0|||
161127937|NCT00666926|581855235|FG008|Overall Study|Other|3|||
161127938|NCT00666926|581855236|FG009|Overall Study|Other|5|||
161127939|NCT00666926|581855237|FG010|Overall Study|Other|3|||
161127940|NCT00666926|581855238|FG011|Overall Study|Other|26|||
160788707|NCT02991859|580612705|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788708|NCT02991859|580612706|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
160788709|NCT02991859|580612707|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788710|NCT02991859|580612708|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788711|NCT02991859|580612709|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788712|NCT02991859|580612710|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788713|NCT02991859|580612711|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788714|NCT02991859|580612712|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788715|NCT02991859|580612713|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
160788716|NCT02991859|580612697|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788717|NCT02991859|580612698|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788718|NCT02991859|580612699|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788719|NCT02991859|580612700|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788720|NCT02991859|580612701|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788721|NCT02991859|580612702|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788722|NCT02991859|580612703|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161127941|NCT00666926|581855239|FG012|Overall Study|Other|3|||
161127942|NCT00666926|581855240|FG013|Overall Study|Other|2|||
161127943|NCT00666926|581855241|FG014|Overall Study|Other|4|||
161127944|NCT00666926|581855242|FG015|Overall Study|Other|4|||
161127945|NCT00666926|581855227|FG000|Overall Study|Withdrawal by Subject|0|||
161127946|NCT00666926|581855228|FG001|Overall Study|Withdrawal by Subject|0|||
161127947|NCT00666926|581855229|FG002|Overall Study|Withdrawal by Subject|0|||
161127948|NCT00666926|581855230|FG003|Overall Study|Withdrawal by Subject|0|||
161127949|NCT00666926|581855231|FG004|Overall Study|Withdrawal by Subject|0|||
161127950|NCT00666926|581855232|FG005|Overall Study|Withdrawal by Subject|0|||
161127951|NCT00666926|581855233|FG006|Overall Study|Withdrawal by Subject|0|||
161127952|NCT00666926|581855234|FG007|Overall Study|Withdrawal by Subject|1|||
161127953|NCT00666926|581855235|FG008|Overall Study|Withdrawal by Subject|0|||
161127954|NCT00666926|581855236|FG009|Overall Study|Withdrawal by Subject|3|||
161127955|NCT00666926|581855237|FG010|Overall Study|Withdrawal by Subject|0|||
161127956|NCT00666926|581855238|FG011|Overall Study|Withdrawal by Subject|3|||
161127957|NCT00666926|581855239|FG012|Overall Study|Withdrawal by Subject|0|||
161127958|NCT00666926|581855240|FG013|Overall Study|Withdrawal by Subject|1|||
161127959|NCT00666926|581855241|FG014|Overall Study|Withdrawal by Subject|3|||
161127960|NCT00666926|581855242|FG015|Overall Study|Withdrawal by Subject|3|||
161127961|NCT00666926|581855227|FG000|Overall Study|Death|0|||
161127962|NCT00666926|581855228|FG001|Overall Study|Death|0|||
161127963|NCT00666926|581855229|FG002|Overall Study|Death|0|||
161127964|NCT00666926|581855230|FG003|Overall Study|Death|0|||
161127965|NCT00666926|581855231|FG004|Overall Study|Death|0|||
161127966|NCT00666926|581855232|FG005|Overall Study|Death|0|||
161127967|NCT00666926|581855233|FG006|Overall Study|Death|0|||
161127968|NCT00666926|581855234|FG007|Overall Study|Death|0|||
161127969|NCT00666926|581855235|FG008|Overall Study|Death|0|||
161127970|NCT00666926|581855236|FG009|Overall Study|Death|0|||
161127971|NCT00666926|581855237|FG010|Overall Study|Death|0|||
161127972|NCT00666926|581855238|FG011|Overall Study|Death|1|||
161127973|NCT00666926|581855239|FG012|Overall Study|Death|0|||
161127974|NCT00666926|581855240|FG013|Overall Study|Death|0|||
161127975|NCT00666926|581855241|FG014|Overall Study|Death|0|||
161127976|NCT00666926|581855242|FG015|Overall Study|Death|0|||
161127977|NCT01960855|581855243|FG000|Overall Study|Subject noncompliant|1|||
161127978|NCT01960855|581855244|FG001|Overall Study|Subject noncompliant|0|||
161127979|NCT01960855|581855245|FG002|Overall Study|Subject noncompliant|0|||
161127980|NCT01960855|581855246|FG003|Overall Study|Subject noncompliant|0|||
161127981|NCT01960855|581855247|FG004|Overall Study|Subject noncompliant|0|||
161127982|NCT01960855|581855243|FG000|Overall Study|Adverse Event|2|||
161127983|NCT01960855|581855244|FG001|Overall Study|Adverse Event|0|||
161127984|NCT01960855|581855245|FG002|Overall Study|Adverse Event|6|||
161127985|NCT01960855|581855246|FG003|Overall Study|Adverse Event|2|||
161127986|NCT01960855|581855247|FG004|Overall Study|Adverse Event|2|||
161127987|NCT01960855|581855243|FG000|Overall Study|Lack of Efficacy|1|||
161127988|NCT01960855|581855244|FG001|Overall Study|Lack of Efficacy|1|||
161127989|NCT01960855|581855245|FG002|Overall Study|Lack of Efficacy|0|||
161127990|NCT01960855|581855246|FG003|Overall Study|Lack of Efficacy|0|||
161127991|NCT01960855|581855247|FG004|Overall Study|Lack of Efficacy|0|||
161127992|NCT01960855|581855243|FG000|Overall Study|Other|2|||
161127993|NCT01960855|581855244|FG001|Overall Study|Other|1|||
161127994|NCT01960855|581855245|FG002|Overall Study|Other|1|||
161127995|NCT01960855|581855246|FG003|Overall Study|Other|1|||
161127996|NCT01960855|581855247|FG004|Overall Study|Other|0|||
161235419|NCT00838539|582244864|FG010|Overall Study|Symptomatic Deterioration|0|||
161235420|NCT00838539|582244865|FG011|Overall Study|Symptomatic Deterioration|0|||
160788723|NCT02991859|580612704|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
161127997|NCT01960855|581855243|FG000|Overall Study|Consent withdrawn by subject|3|||
161127998|NCT01960855|581855244|FG001|Overall Study|Consent withdrawn by subject|1|||
161127999|NCT01960855|581855245|FG002|Overall Study|Consent withdrawn by subject|2|||
161128000|NCT01960855|581855246|FG003|Overall Study|Consent withdrawn by subject|1|||
161128001|NCT01960855|581855247|FG004|Overall Study|Consent withdrawn by subject|1|||
161128002|NCT01960855|581855243|FG000|Overall Study|Lost to Follow-up|2|||
161128003|NCT01960855|581855244|FG001|Overall Study|Lost to Follow-up|1|||
161128004|NCT01960855|581855245|FG002|Overall Study|Lost to Follow-up|0|||
161128005|NCT01960855|581855246|FG003|Overall Study|Lost to Follow-up|0|||
161128006|NCT01960855|581855247|FG004|Overall Study|Lost to Follow-up|2|||
161128007|NCT02471716|581855249|FG000|Overall Study|Withdrawal by Subject|0|||
160788724|NCT02991859|580612705|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
160788725|NCT02991859|580612706|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788726|NCT02991859|580612707|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788727|NCT02991859|580612708|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788728|NCT02991859|580612709|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788729|NCT02991859|580612710|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160891868|NCT02694523|581000442|FG001|Part A|Protocol Violation|0|||
160891869|NCT02694523|581000443|FG002|Part A|Protocol Violation|0|||
160891870|NCT02694523|581000444|FG003|Part A|Protocol Violation|0|||
160891871|NCT02694523|581000445|FG004|Part A|Protocol Violation|0|||
160891872|NCT02694523|581000446|FG005|Part A|Protocol Violation|0|||
160788730|NCT02991859|580612711|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160891873|NCT02694523|581000447|FG006|Part A|Protocol Violation|0|||
160891874|NCT02694523|581000441|FG000|Part A|Lost to Follow-up|1|||
160891875|NCT02694523|581000442|FG001|Part A|Lost to Follow-up|2|||
160891876|NCT02694523|581000443|FG002|Part A|Lost to Follow-up|0|||
160891877|NCT02694523|581000444|FG003|Part A|Lost to Follow-up|0|||
160891878|NCT02694523|581000445|FG004|Part A|Lost to Follow-up|0|||
160891879|NCT02694523|581000446|FG005|Part A|Lost to Follow-up|0|||
160891880|NCT02694523|581000447|FG006|Part A|Lost to Follow-up|0|||
160891881|NCT02694523|581000441|FG000|Part A|Withdrawal by Subject|3|||
160891882|NCT02694523|581000442|FG001|Part A|Withdrawal by Subject|1|||
160891883|NCT02694523|581000443|FG002|Part A|Withdrawal by Subject|0|||
160891884|NCT02694523|581000444|FG003|Part A|Withdrawal by Subject|0|||
160891885|NCT02694523|581000445|FG004|Part A|Withdrawal by Subject|0|||
160891886|NCT02694523|581000446|FG005|Part A|Withdrawal by Subject|0|||
160891887|NCT02694523|581000447|FG006|Part A|Withdrawal by Subject|0|||
160891888|NCT02694523|581000441|FG000|Part A|Other|1|||
160891889|NCT02694523|581000442|FG001|Part A|Other|1|||
160891890|NCT02694523|581000443|FG002|Part A|Other|0|||
160891891|NCT02694523|581000444|FG003|Part A|Other|0|||
160788731|NCT02991859|580612712|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788732|NCT02991859|580612713|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
160788733|NCT00425854|580612721|FG000|Overall Study|Progressive Disease|19|||
160788734|NCT00425854|580612722|FG001|Overall Study|Progressive Disease|12|||
160788735|NCT00425854|580612721|FG000|Overall Study|Dose reduction toxicity AE|8|||
160788736|NCT00425854|580612722|FG001|Overall Study|Dose reduction toxicity AE|7|||
160788737|NCT00425854|580612721|FG000|Overall Study|Other Adverse Event|2|||
160788738|NCT00425854|580612722|FG001|Overall Study|Other Adverse Event|2|||
160788739|NCT01630811|580612723|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
160788740|NCT01630811|580612724|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160788741|NCT01725308|580612727|FG000|Treatment Period I|Did Not Receive Drug|1|||
160788742|NCT01725308|580612728|FG001|Treatment Period I|Did Not Receive Drug|0|||
160788743|NCT01725308|580612729|FG002|Treatment Period I|Did Not Receive Drug|0|||
160788744|NCT01725308|580612727|FG000|Treatment Period I|Adverse Event|5|||
160788745|NCT01725308|580612728|FG001|Treatment Period I|Adverse Event|4|||
160788746|NCT01725308|580612729|FG002|Treatment Period I|Adverse Event|21|||
160788747|NCT01725308|580612727|FG000|Treatment Period I|Insufficient Response|7|||
160788748|NCT01725308|580612728|FG001|Treatment Period I|Insufficient Response|0|||
160891892|NCT02694523|581000445|FG004|Part A|Other|0|||
160891893|NCT02694523|581000446|FG005|Part A|Other|0|||
160891894|NCT02694523|581000447|FG006|Part A|Other|0|||
160891895|NCT02694523|581000441|FG000|Part B|Adverse Event|0|||
160891896|NCT02694523|581000442|FG001|Part B|Adverse Event|0|||
160891897|NCT02694523|581000443|FG002|Part B|Adverse Event|7|||
160891898|NCT02694523|581000444|FG003|Part B|Adverse Event|1|||
160891899|NCT02694523|581000445|FG004|Part B|Adverse Event|1|||
160891900|NCT02694523|581000446|FG005|Part B|Adverse Event|2|||
160788749|NCT01725308|580612729|FG002|Treatment Period I|Insufficient Response|5|||
160788750|NCT01725308|580612727|FG000|Treatment Period I|Worsening of the Target Disease|8|||
160788751|NCT01725308|580612728|FG001|Treatment Period I|Worsening of the Target Disease|0|||
160788752|NCT01725308|580612729|FG002|Treatment Period I|Worsening of the Target Disease|2|||
160788753|NCT01725308|580612727|FG000|Treatment Period I|Changes in the Episodes|3|||
160788754|NCT01725308|580612728|FG001|Treatment Period I|Changes in the Episodes|0|||
160788755|NCT01725308|580612729|FG002|Treatment Period I|Changes in the Episodes|2|||
160788756|NCT01725308|580612727|FG000|Treatment Period I|Withdrawal of Consent|12|||
160788757|NCT01725308|580612728|FG001|Treatment Period I|Withdrawal of Consent|7|||
160788758|NCT01725308|580612729|FG002|Treatment Period I|Withdrawal of Consent|5|||
160891901|NCT02694523|581000447|FG006|Part B|Adverse Event|0|||
160891902|NCT02694523|581000441|FG000|Part B|Protocol Violation|0|||
160891903|NCT02694523|581000442|FG001|Part B|Protocol Violation|0|||
160891904|NCT02694523|581000443|FG002|Part B|Protocol Violation|1|||
160891905|NCT02694523|581000444|FG003|Part B|Protocol Violation|0|||
160891906|NCT02694523|581000445|FG004|Part B|Protocol Violation|0|||
160891907|NCT02694523|581000446|FG005|Part B|Protocol Violation|0|||
160891908|NCT02694523|581000447|FG006|Part B|Protocol Violation|0|||
160891909|NCT02694523|581000441|FG000|Part B|Lost to Follow-up|0|||
160891910|NCT02694523|581000442|FG001|Part B|Lost to Follow-up|0|||
160891911|NCT02694523|581000443|FG002|Part B|Lost to Follow-up|2|||
160788759|NCT01725308|580612727|FG000|Treatment Period I|Lost to Follow-up|3|||
160788760|NCT01725308|580612728|FG001|Treatment Period I|Lost to Follow-up|2|||
160788761|NCT01725308|580612729|FG002|Treatment Period I|Lost to Follow-up|2|||
160788762|NCT01725308|580612727|FG000|Treatment Period I|Protocol Deviations|3|||
160788763|NCT01725308|580612728|FG001|Treatment Period I|Protocol Deviations|1|||
160788764|NCT01725308|580612729|FG002|Treatment Period I|Protocol Deviations|1|||
160788765|NCT01725308|580612727|FG000|Treatment Period I|Miscellaneous|2|||
160788766|NCT01725308|580612728|FG001|Treatment Period I|Miscellaneous|0|||
160788767|NCT01725308|580612729|FG002|Treatment Period I|Miscellaneous|3|||
160788768|NCT01725308|580612727|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
160788769|NCT01725308|580612728|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
160788770|NCT01725308|580612729|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
160788771|NCT01725308|580612727|FG000|Treatment Period II|Did Not Receive Drug|4|||
160788772|NCT01725308|580612728|FG001|Treatment Period II|Did Not Receive Drug|0|||
160788773|NCT01725308|580612729|FG002|Treatment Period II|Did Not Receive Drug|0|||
160788774|NCT01725308|580612727|FG000|Treatment Period II|Adverse Event|13|||
160788775|NCT01725308|580612728|FG001|Treatment Period II|Adverse Event|8|||
160788776|NCT01725308|580612729|FG002|Treatment Period II|Adverse Event|20|||
160788777|NCT01725308|580612727|FG000|Treatment Period II|Insufficient Response|2|||
160788778|NCT01725308|580612728|FG001|Treatment Period II|Insufficient Response|4|||
160788779|NCT01725308|580612729|FG002|Treatment Period II|Insufficient Response|6|||
160788780|NCT01725308|580612727|FG000|Treatment Period II|Worsening of the Target Disease|1|||
160788781|NCT01725308|580612728|FG001|Treatment Period II|Worsening of the Target Disease|4|||
160788782|NCT01725308|580612729|FG002|Treatment Period II|Worsening of the Target Disease|2|||
160788783|NCT01725308|580612727|FG000|Treatment Period II|Changes in the Episodes|1|||
160788784|NCT01725308|580612728|FG001|Treatment Period II|Changes in the Episodes|0|||
160788785|NCT01725308|580612729|FG002|Treatment Period II|Changes in the Episodes|5|||
160788786|NCT01725308|580612727|FG000|Treatment Period II|Withdrawal of Consent|28|||
160788787|NCT01725308|580612728|FG001|Treatment Period II|Withdrawal of Consent|2|||
160788788|NCT01725308|580612729|FG002|Treatment Period II|Withdrawal of Consent|16|||
160788789|NCT01725308|580612727|FG000|Treatment Period II|Lost to Follow-up|1|||
160788790|NCT01725308|580612728|FG001|Treatment Period II|Lost to Follow-up|5|||
160788791|NCT01725308|580612729|FG002|Treatment Period II|Lost to Follow-up|3|||
160788792|NCT01725308|580612727|FG000|Treatment Period II|Protocol Deviations|0|||
160788793|NCT01725308|580612728|FG001|Treatment Period II|Protocol Deviations|0|||
160788794|NCT01725308|580612729|FG002|Treatment Period II|Protocol Deviations|1|||
160788795|NCT01725308|580612727|FG000|Treatment Period II|Miscellaneous|5|||
160788796|NCT01725308|580612728|FG001|Treatment Period II|Miscellaneous|3|||
160788797|NCT01725308|580612729|FG002|Treatment Period II|Miscellaneous|7|||
160788798|NCT01783938|580612737|FG000|Overall Study|Disease Progression|18|||
160788799|NCT01783938|580612738|FG001|Overall Study|Disease Progression|41|||
160788800|NCT01783938|580612737|FG000|Overall Study|Study Drug Toxicity|27|||
160788801|NCT01783938|580612738|FG001|Overall Study|Study Drug Toxicity|14|||
160788802|NCT01783938|580612737|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
160788803|NCT01783938|580612738|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160788804|NCT01783938|580612737|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
160891912|NCT02694523|581000444|FG003|Part B|Lost to Follow-up|3|||
160891913|NCT02694523|581000445|FG004|Part B|Lost to Follow-up|2|||
160891914|NCT02694523|581000446|FG005|Part B|Lost to Follow-up|0|||
160891915|NCT02694523|581000447|FG006|Part B|Lost to Follow-up|1|||
160891916|NCT02694523|581000441|FG000|Part B|Withdrawal by Subject|0|||
160891917|NCT02694523|581000442|FG001|Part B|Withdrawal by Subject|0|||
160891918|NCT02694523|581000443|FG002|Part B|Withdrawal by Subject|9|||
160981891|NCT02061761|581321790|FG008|Overall Study|Other reasons|6|||
160788805|NCT01783938|580612738|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
160788806|NCT01783938|580612737|FG000|Overall Study|Participant Withdrew Consent|2|||
160788807|NCT01783938|580612738|FG001|Overall Study|Participant Withdrew Consent|0|||
160788808|NCT01783938|580612737|FG000|Overall Study|Maximum Clinical Benefit|1|||
160788809|NCT01783938|580612738|FG001|Overall Study|Maximum Clinical Benefit|0|||
160788810|NCT01783938|580612737|FG000|Overall Study|Other Reasons|3|||
160788811|NCT01783938|580612738|FG001|Overall Study|Other Reasons|1|||
160788812|NCT01712074|580612741|FG000|Placebo Run-in Period|Adverse Event|2|||
160788813|NCT01712074|580612742|FG001|Placebo Run-in Period|Adverse Event|0|||
160788814|NCT01712074|580612743|FG002|Placebo Run-in Period|Adverse Event|0|||
160788815|NCT01712074|580612741|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
160788816|NCT01712074|580612742|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
160788817|NCT01712074|580612743|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
160788818|NCT01712074|580612741|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
160788819|NCT01712074|580612742|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
160891919|NCT02694523|581000444|FG003|Part B|Withdrawal by Subject|0|||
160891920|NCT02694523|581000445|FG004|Part B|Withdrawal by Subject|1|||
160981892|NCT01024751|581321791|FG000|Enrolled Participants|Ineligible at baseline|3|||
160788820|NCT01712074|580612743|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
160891921|NCT02694523|581000446|FG005|Part B|Withdrawal by Subject|3|||
160891922|NCT02694523|581000447|FG006|Part B|Withdrawal by Subject|0|||
160788821|NCT01712074|580612741|FG000|Placebo Run-in Period|Other|1|||
160788822|NCT01712074|580612742|FG001|Placebo Run-in Period|Other|0|||
160788823|NCT01712074|580612743|FG002|Placebo Run-in Period|Other|0|||
160788824|NCT01712074|580612741|FG000|Placebo Run-in Period|No longer willing to participate|1|||
160788825|NCT01712074|580612742|FG001|Placebo Run-in Period|No longer willing to participate|0|||
160788826|NCT01712074|580612743|FG002|Placebo Run-in Period|No longer willing to participate|0|||
160788827|NCT01712074|580612741|FG000|Double Blind Period|Adverse Event|0|||
160788828|NCT01712074|580612742|FG001|Double Blind Period|Adverse Event|2|||
160788829|NCT01712074|580612743|FG002|Double Blind Period|Adverse Event|1|||
160788830|NCT01712074|580612741|FG000|Double Blind Period|No longer willing to participate|0|||
160788831|NCT01712074|580612742|FG001|Double Blind Period|No longer willing to participate|2|||
160788832|NCT01712074|580612743|FG002|Double Blind Period|No longer willing to participate|4|||
160788833|NCT01712074|580612741|FG000|Double Blind Period|Death|0|||
160788834|NCT01712074|580612742|FG001|Double Blind Period|Death|1|||
160788835|NCT01712074|580612743|FG002|Double Blind Period|Death|0|||
160788836|NCT01712074|580612741|FG000|Double Blind Period|Lost to Follow-up|0|||
160788837|NCT01712074|580612742|FG001|Double Blind Period|Lost to Follow-up|2|||
160788838|NCT01712074|580612743|FG002|Double Blind Period|Lost to Follow-up|1|||
160788839|NCT01712074|580612741|FG000|Double Blind Period|Other|0|||
160788840|NCT01712074|580612742|FG001|Double Blind Period|Other|4|||
160788841|NCT01712074|580612743|FG002|Double Blind Period|Other|1|||
160788842|NCT01712074|580612741|FG000|Double Blind Period|Protocol Violation|0|||
160788843|NCT01712074|580612742|FG001|Double Blind Period|Protocol Violation|0|||
160788844|NCT01712074|580612743|FG002|Double Blind Period|Protocol Violation|1|||
160788845|NCT01712074|580612741|FG000|Double Blind Period|No longer met eligibility criteria|0|||
160788846|NCT01712074|580612742|FG001|Double Blind Period|No longer met eligibility criteria|3|||
160788847|NCT01712074|580612743|FG002|Double Blind Period|No longer met eligibility criteria|0|||
160788848|NCT03478787|580612744|FG000|Overall Study|Adverse Event|5|||
160788849|NCT03478787|580612745|FG001|Overall Study|Adverse Event|1|||
160788850|NCT03478787|580612744|FG000|Overall Study|Protocol Violation|3|||
160788851|NCT03478787|580612745|FG001|Overall Study|Protocol Violation|0|||
160788852|NCT03478787|580612744|FG000|Overall Study|Lack of Efficacy|7|||
160788853|NCT03478787|580612745|FG001|Overall Study|Lack of Efficacy|1|||
160788854|NCT03478787|580612744|FG000|Overall Study|Lost to Follow-up|9|||
160788855|NCT03478787|580612745|FG001|Overall Study|Lost to Follow-up|5|||
160788856|NCT03478787|580612744|FG000|Overall Study|Withdrawal by Subject|2|||
160788857|NCT03478787|580612745|FG001|Overall Study|Withdrawal by Subject|6|||
160788858|NCT03478787|580612744|FG000|Overall Study|Other, Not Specified|3|||
160788859|NCT03478787|580612745|FG001|Overall Study|Other, Not Specified|0|||
160788860|NCT03378635|580612748|FG000|Overall Study|Adverse Event|1|||
160788861|NCT03378635|580612749|FG001|Overall Study|Adverse Event|0|||
160788862|NCT03378635|580612750|FG002|Overall Study|Adverse Event|0|||
160788863|NCT03378635|580612748|FG000|Overall Study|Withdrawal by Subject|1|||
160788864|NCT03378635|580612749|FG001|Overall Study|Withdrawal by Subject|0|||
160788865|NCT03378635|580612750|FG002|Overall Study|Withdrawal by Subject|0|||
160788866|NCT02413346|580612751|FG000|Overall Study|Adverse Event|6|||
160788867|NCT02413346|580612752|FG001|Overall Study|Adverse Event|6|||
160788868|NCT02413346|580612751|FG000|Overall Study|Withdrawal by Subject|30|||
160788869|NCT02413346|580612752|FG001|Overall Study|Withdrawal by Subject|40|||
160788870|NCT02413346|580612751|FG000|Overall Study|Lost to Follow-up|17|||
160788871|NCT02413346|580612752|FG001|Overall Study|Lost to Follow-up|21|||
160788872|NCT02413346|580612751|FG000|Overall Study|Protocol Violation|2|||
160788873|NCT02413346|580612752|FG001|Overall Study|Protocol Violation|0|||
160788874|NCT02413346|580612751|FG000|Overall Study|Other Miscellaneous Reasons|4|||
160788875|NCT02413346|580612752|FG001|Overall Study|Other Miscellaneous Reasons|3|||
160788876|NCT01835431|580612755|FG000|Overall Study|Adverse Event|1|||
160788877|NCT01835431|580612756|FG001|Overall Study|Adverse Event|0|||
160788878|NCT01835431|580612755|FG000|Overall Study|other|0|||
160788879|NCT01835431|580612756|FG001|Overall Study|other|2|||
160788880|NCT01835431|580612755|FG000|Overall Study|Withdrawal by Subject|6|||
160788881|NCT01835431|580612756|FG001|Overall Study|Withdrawal by Subject|10|||
160788882|NCT01835431|580612755|FG000|Overall Study|Protocol Violation|1|||
160788883|NCT01835431|580612756|FG001|Overall Study|Protocol Violation|0|||
160788884|NCT00562861|580612759|FG000|Overall Study|Adverse Event|1|||
160788885|NCT00562861|580612760|FG001|Overall Study|Adverse Event|1|||
160788886|NCT00562861|580612759|FG000|Overall Study|Lack of Efficacy|5|||
160788887|NCT00562861|580612760|FG001|Overall Study|Lack of Efficacy|5|||
161235421|NCT01908205|582244866|FG000|Overall Study|Lost to Follow-up|2|||
160788888|NCT00562861|580612759|FG000|Overall Study|noncompliance, moved|7|||
160788889|NCT00562861|580612760|FG001|Overall Study|noncompliance, moved|2|||
160891923|NCT02694523|581000441|FG000|Part B|Other|0|||
160891924|NCT02694523|581000442|FG001|Part B|Other|0|||
160788890|NCT00562861|580612759|FG000|Overall Study|Lost to Follow-up|7|||
160788891|NCT00562861|580612760|FG001|Overall Study|Lost to Follow-up|3|||
160788892|NCT00655356|580612761|FG000|Overall Study|Withdrawal by Subject|3|||
160788893|NCT00655356|580612762|FG001|Overall Study|Withdrawal by Subject|4|||
160788894|NCT00655356|580612761|FG000|Overall Study|Sponsor Request|10|||
160891925|NCT02694523|581000443|FG002|Part B|Other|1|||
160788895|NCT00655356|580612762|FG001|Overall Study|Sponsor Request|4|||
160788896|NCT00655356|580612761|FG000|Overall Study|Adverse Event|1|||
160788897|NCT00655356|580612762|FG001|Overall Study|Adverse Event|1|||
160788898|NCT00655356|580612761|FG000|Overall Study|Protocol Violation|2|||
160788899|NCT00655356|580612762|FG001|Overall Study|Protocol Violation|1|||
160788900|NCT00655356|580612761|FG000|Overall Study|Other Reason|1|||
160788901|NCT00655356|580612762|FG001|Overall Study|Other Reason|0|||
160788902|NCT02766478|580612772|FG000|Overall Study|Withdrawal by Subject|1|||
160788903|NCT02766478|580612773|FG001|Overall Study|Withdrawal by Subject|1|||
160788904|NCT05626686|580612774|FG000|Overall Study|Protocol Violation|3|||
160788905|NCT05626686|580612774|FG000|Overall Study|Withdrawal by Subject|3|||
160788906|NCT01093573|580612775|FG000|Overall Study|Physician Decision|0|||
160788907|NCT01093573|580612776|FG001|Overall Study|Physician Decision|0|||
160788908|NCT01093573|580612777|FG002|Overall Study|Physician Decision|1|||
160788909|NCT01093573|580612775|FG000|Overall Study|Insurance Denied|0|||
160788910|NCT01093573|580612776|FG001|Overall Study|Insurance Denied|0|||
160788911|NCT01093573|580612777|FG002|Overall Study|Insurance Denied|1|||
160788912|NCT00682435|580612778|FG000|Overall Study|Insufficient data|5|||
160788913|NCT00682435|580612778|FG000|Overall Study|Erroneously enrolled twice|2|||
160788914|NCT00089583|580612779|FG000|Overall Study|Adverse Event|0|||
160788915|NCT00089583|580612780|FG001|Overall Study|Adverse Event|3|||
160788916|NCT00089583|580612779|FG000|Overall Study|Insufficient Viral Load Response|5|||
160788917|NCT00089583|580612780|FG001|Overall Study|Insufficient Viral Load Response|5|||
160788918|NCT00089583|580612779|FG000|Overall Study|Withdrawal by Subject|0|||
160788919|NCT00089583|580612780|FG001|Overall Study|Withdrawal by Subject|4|||
160788920|NCT00089583|580612779|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
160788921|NCT00089583|580612780|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
160788922|NCT00089583|580612779|FG000|Overall Study|Participant Refused Study Medication|0|||
160788923|NCT00089583|580612780|FG001|Overall Study|Participant Refused Study Medication|2|||
160788924|NCT00089583|580612779|FG000|Overall Study|Non-Compliance|0|||
160788925|NCT00089583|580612780|FG001|Overall Study|Non-Compliance|4|||
160788926|NCT00089583|580612779|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
160788927|NCT00089583|580612780|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
160891926|NCT02694523|581000444|FG003|Part B|Other|0|||
160891927|NCT02694523|581000445|FG004|Part B|Other|0|||
160891928|NCT02694523|581000446|FG005|Part B|Other|0|||
160891929|NCT02694523|581000447|FG006|Part B|Other|1|||
160891930|NCT01058265|581000449|FG000|Overall Study|Lost to Follow-up|11|||
160788928|NCT00089583|580612779|FG000|Overall Study|Participant Management Criteria Met|0|||
160891931|NCT01058265|581000450|FG001|Overall Study|Lost to Follow-up|12|||
160891932|NCT01243671|581000451|FG000|Overall Study|Adverse Event|3|||
160891933|NCT01243671|581000451|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
160891934|NCT01243671|581000451|FG000|Overall Study|Other|1|||
160891935|NCT02869438|581000452|FG000|Overall Study|Lost to Follow-up|1|||
160891936|NCT02869438|581000453|FG001|Overall Study|Lost to Follow-up|0|||
160891937|NCT02869438|581000452|FG000|Overall Study|Adverse Event|1|||
160891938|NCT02869438|581000453|FG001|Overall Study|Adverse Event|0|||
160891939|NCT02869438|581000452|FG000|Overall Study|Withdrawal by Subject|1|||
160891940|NCT02869438|581000453|FG001|Overall Study|Withdrawal by Subject|2|||
160891941|NCT02962765|581000454|FG000|Overall Study|Protocol Violation|9|||
160891942|NCT02962765|581000454|FG000|Overall Study|Withdrawal by Subject|3|||
160891943|NCT02962765|581000454|FG000|Overall Study|Lost to Follow-up|1|||
160891944|NCT02962765|581000454|FG000|Overall Study|Death|1|||
161128008|NCT02471716|581855250|FG001|Overall Study|Withdrawal by Subject|1|||
160788929|NCT00089583|580612780|FG001|Overall Study|Participant Management Criteria Met|1|||
160788930|NCT00089583|580612779|FG000|Overall Study|Reason Not Provided|0|||
160788931|NCT00089583|580612780|FG001|Overall Study|Reason Not Provided|1|||
160788932|NCT00089583|580612779|FG000|Overall Study|Protocol Violation|0|||
160788933|NCT00089583|580612780|FG001|Overall Study|Protocol Violation|3|||
160788934|NCT00089583|580612779|FG000|Overall Study|Principal Investigator Decision|0|||
160788935|NCT00089583|580612780|FG001|Overall Study|Principal Investigator Decision|10|||
161128009|NCT02471716|581855251|FG002|Overall Study|Withdrawal by Subject|0|||
161128010|NCT02471716|581855252|FG003|Overall Study|Withdrawal by Subject|2|||
161128011|NCT02471716|581855253|FG004|Overall Study|Withdrawal by Subject|5|||
161128012|NCT02471716|581855249|FG000|Overall Study|Study Terminiated by sponsor|0|||
160891945|NCT02962765|581000454|FG000|Overall Study|Limited access to study medication|3|||
160891946|NCT02169284|581000457|FG000|Overall Study|Physician Decision|0|||
160788936|NCT00089583|580612779|FG000|Overall Study|Start of Disallowed Medication|0|||
160788937|NCT00089583|580612780|FG001|Overall Study|Start of Disallowed Medication|1|||
160891947|NCT02169284|581000458|FG001|Overall Study|Physician Decision|1|||
160891948|NCT01367119|581000459|FG000|Overall Study|Adverse Event|1|||
160891949|NCT01367119|581000460|FG001|Overall Study|Adverse Event|0|||
160891950|NCT01367119|581000459|FG000|Overall Study|Withdrawal by Subject|1|||
160891951|NCT01367119|581000460|FG001|Overall Study|Withdrawal by Subject|1|||
160788938|NCT00089583|580612779|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
160788939|NCT00089583|580612780|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
160891952|NCT02675231|581000461|FG000|Overall Study|Withdrawal by Subject|2|||
160788940|NCT00089583|580612779|FG000|Overall Study|Participant Incarcerated|0|||
160788941|NCT00089583|580612780|FG001|Overall Study|Participant Incarcerated|1|||
160788942|NCT01412983|580612781|FG000|1st Period|Ineligible|0|||
160788943|NCT01412983|580612782|FG001|1st Period|Ineligible|1|||
160788944|NCT01412983|580612781|FG000|1st Period|Positive slit lamp finding|0|||
160788945|NCT01412983|580612782|FG001|1st Period|Positive slit lamp finding|1|||
160788946|NCT01412983|580612781|FG000|1st Period|Unacceptable lens movement|0|||
160788947|NCT01412983|580612782|FG001|1st Period|Unacceptable lens movement|1|||
160788948|NCT01412983|580612781|FG000|1st Period|Inability to maintain wear|0|||
160788949|NCT01412983|580612782|FG001|1st Period|Inability to maintain wear|1|||
160788950|NCT01623154|580612783|FG000|Overall Study|Did not drink Pranactin Citric|4|||
160788951|NCT04349098|580612784|FG000|Overall Study|Death|16|||
160788952|NCT04349098|580612785|FG001|Overall Study|Death|8|||
160788953|NCT04349098|580612784|FG000|Overall Study|Lost to Follow-up|11|||
160788954|NCT04349098|580612785|FG001|Overall Study|Lost to Follow-up|8|||
160788955|NCT04349098|580612784|FG000|Overall Study|Withdrawal by Subject|8|||
160788956|NCT04349098|580612785|FG001|Overall Study|Withdrawal by Subject|5|||
160788957|NCT04349098|580612784|FG000|Overall Study|Other|3|||
160788958|NCT04349098|580612785|FG001|Overall Study|Other|5|||
160788959|NCT00800384|580612786|FG000|Overall Study|Withdrawal by Subject|24|||
160788960|NCT00800384|580612787|FG001|Overall Study|Withdrawal by Subject|17|||
160788961|NCT00800384|580612786|FG000|Overall Study|Lost to Follow-up|17|||
160788962|NCT00800384|580612787|FG001|Overall Study|Lost to Follow-up|26|||
160788963|NCT02946996|580612788|FG000|Overall Study|non-evaluable|3|||
160788964|NCT02946996|580612789|FG001|Overall Study|non-evaluable|6|||
160788965|NCT02946996|580612790|FG002|Overall Study|non-evaluable|5|||
160788966|NCT00176254|580612791|FG000|Overall Study|Lost to Follow-up|1|||
160788967|NCT03289741|580612792|FG000|Overall Study|Adverse Event|1|||
160788968|NCT03289741|580612793|FG001|Overall Study|Adverse Event|1|||
160788969|NCT03289741|580612792|FG000|Overall Study|Physician Decision|2|||
160788970|NCT03289741|580612793|FG001|Overall Study|Physician Decision|2|||
160788971|NCT03289741|580612792|FG000|Overall Study|Withdrawal by Subject|1|||
160788972|NCT03289741|580612793|FG001|Overall Study|Withdrawal by Subject|0|||
160788973|NCT01197300|580614672|FG000|Overall Study|Lost to Follow-up|0|||
160788974|NCT01197300|580614673|FG001|Overall Study|Lost to Follow-up|1|||
160788975|NCT01197300|580614672|FG000|Overall Study|Protocol Violation|0|||
160788976|NCT01197300|580614673|FG001|Overall Study|Protocol Violation|1|||
160788977|NCT02113878|580614676|FG000|Overall Study|Adverse Event|1|||
160788978|NCT02113878|580614677|FG001|Overall Study|Adverse Event|0|||
160788979|NCT02113878|580614676|FG000|Overall Study|Withdrawal by Subject|1|||
160788980|NCT02113878|580614677|FG001|Overall Study|Withdrawal by Subject|0|||
160788981|NCT02113878|580614676|FG000|Overall Study|patient non-compliance|1|||
160788982|NCT02113878|580614677|FG001|Overall Study|patient non-compliance|0|||
160891953|NCT02675231|581000462|FG001|Overall Study|Withdrawal by Subject|4|||
161128013|NCT02471716|581855250|FG001|Overall Study|Study Terminiated by sponsor|0|||
161128014|NCT02471716|581855251|FG002|Overall Study|Study Terminiated by sponsor|0|||
161128015|NCT02471716|581855252|FG003|Overall Study|Study Terminiated by sponsor|1|||
161128016|NCT02471716|581855253|FG004|Overall Study|Study Terminiated by sponsor|0|||
161128017|NCT02471716|581855249|FG000|Overall Study|Lost to Follow-up|0|||
161128018|NCT02471716|581855250|FG001|Overall Study|Lost to Follow-up|0|||
161128019|NCT02471716|581855251|FG002|Overall Study|Lost to Follow-up|0|||
161128020|NCT02471716|581855252|FG003|Overall Study|Lost to Follow-up|3|||
161128021|NCT02471716|581855253|FG004|Overall Study|Lost to Follow-up|2|||
161128022|NCT02471716|581855249|FG000|Overall Study|Death|0|||
161128023|NCT02471716|581855250|FG001|Overall Study|Death|0|||
161128024|NCT02471716|581855251|FG002|Overall Study|Death|0|||
161128025|NCT02471716|581855252|FG003|Overall Study|Death|1|||
161128026|NCT02471716|581855253|FG004|Overall Study|Death|0|||
161128027|NCT02471716|581855249|FG000|Overall Study|Other|0|||
161128028|NCT02471716|581855250|FG001|Overall Study|Other|0|||
161128029|NCT02471716|581855251|FG002|Overall Study|Other|0|||
161128030|NCT02471716|581855252|FG003|Overall Study|Other|8|||
161128031|NCT02471716|581855253|FG004|Overall Study|Other|9|||
161128032|NCT00330187|581855266|FG000|Overall Study|Lost to Follow-up|12|||
161128033|NCT00330187|581855267|FG001|Overall Study|Lost to Follow-up|13|||
161128034|NCT00330187|581855268|FG002|Overall Study|Lost to Follow-up|14|||
161128035|NCT00330187|581855269|FG003|Overall Study|Lost to Follow-up|10|||
161128036|NCT00330187|581855266|FG000|Overall Study|Withdrawal by Subject|8|||
161128037|NCT00330187|581855267|FG001|Overall Study|Withdrawal by Subject|5|||
161128038|NCT00330187|581855268|FG002|Overall Study|Withdrawal by Subject|4|||
161128039|NCT00330187|581855269|FG003|Overall Study|Withdrawal by Subject|4|||
161128040|NCT01162421|581855275|FG000|Overall Study|Did not receive study drug|2|||
161235422|NCT01908205|582244867|FG001|Overall Study|Lost to Follow-up|0|||
161235423|NCT01908205|582244866|FG000|Overall Study|Withdrawal by Subject|3|||
161235424|NCT01908205|582244867|FG001|Overall Study|Withdrawal by Subject|1|||
160788998|NCT04280783|580614685|FG000|Overall Study|Family issues unrelated to the study.|1|||
160788999|NCT04280783|580614686|FG001|Overall Study|Family issues unrelated to the study.|0|||
160789000|NCT04280783|580614685|FG000|Overall Study|Withdrawal by Subject|0|||
160789001|NCT04280783|580614686|FG001|Overall Study|Withdrawal by Subject|1|||
160789002|NCT03443401|580614693|FG000|Overall Study|Lost to Follow-up|13|||
160789003|NCT03443401|580614693|FG000|Overall Study|Influential outlier|1|||
160789004|NCT02363283|580614694|FG000|Overall Study|Withdrawal by Subject|1|||
160789005|NCT02363283|580614694|FG000|Overall Study|Not eligible due to transaminitis|1|||
160789006|NCT00530257|580614700|FG000|Overall Study|Lost to Follow-up|1|||
160789007|NCT01394185|580614704|FG000|Overall Study|Withdrawal by Subject|2|||
160789008|NCT01394185|580614705|FG001|Overall Study|Withdrawal by Subject|0|||
160789009|NCT01394185|580614706|FG002|Overall Study|Withdrawal by Subject|0|||
160789010|NCT01394185|580614707|FG003|Overall Study|Withdrawal by Subject|0|||
160789011|NCT01394185|580614708|FG004|Overall Study|Withdrawal by Subject|1|||
160789012|NCT01394185|580614709|FG005|Overall Study|Withdrawal by Subject|0|||
160789013|NCT01394185|580614704|FG000|Overall Study|Change in protocol|3|||
160789014|NCT01394185|580614705|FG001|Overall Study|Change in protocol|0|||
160789015|NCT01394185|580614706|FG002|Overall Study|Change in protocol|0|||
160789016|NCT01394185|580614707|FG003|Overall Study|Change in protocol|0|||
160789017|NCT01394185|580614708|FG004|Overall Study|Change in protocol|3|||
160789018|NCT01394185|580614709|FG005|Overall Study|Change in protocol|0|||
160789019|NCT01394185|580614704|FG000|Overall Study|Protocol Violation|1|||
160789020|NCT01394185|580614705|FG001|Overall Study|Protocol Violation|0|||
160789021|NCT01394185|580614706|FG002|Overall Study|Protocol Violation|0|||
160789022|NCT01394185|580614707|FG003|Overall Study|Protocol Violation|1|||
160789023|NCT01394185|580614708|FG004|Overall Study|Protocol Violation|0|||
160789024|NCT01394185|580614709|FG005|Overall Study|Protocol Violation|1|||
160789025|NCT04110145|580614710|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789026|NCT04110145|580614711|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789027|NCT04110145|580614712|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789028|NCT04110145|580614713|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
160789029|NCT04110145|580614714|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
160789030|NCT05401409|580614715|FG000|Overall Study|Lost to Follow-up|1|||
160789031|NCT05401409|580614716|FG001|Overall Study|Lost to Follow-up|0|||
160789032|NCT02371889|580614717|FG000|Overall Study|Adverse medication effect|11|||
160789033|NCT02371889|580614718|FG001|Overall Study|Adverse medication effect|2|||
160789034|NCT02371889|580614717|FG000|Overall Study|Lost to Follow-up|6|||
160789035|NCT02371889|580614718|FG001|Overall Study|Lost to Follow-up|5|||
160789036|NCT02371889|580614717|FG000|Overall Study|Personal time constraints|2|||
160789037|NCT02371889|580614718|FG001|Overall Study|Personal time constraints|4|||
160789038|NCT02371889|580614717|FG000|Overall Study|Lack of Efficacy|0|||
160789039|NCT02371889|580614718|FG001|Overall Study|Lack of Efficacy|2|||
160789040|NCT02371889|580614717|FG000|Overall Study|Relapse|0|||
160789041|NCT02371889|580614718|FG001|Overall Study|Relapse|1|||
160789042|NCT02410200|580614722|FG000|Overall Study|Adverse Event|2|||
160789043|NCT00432991|580614723|FG000|Overall Study|Protocol Violation|7|||
160789044|NCT00432991|580614724|FG001|Overall Study|Protocol Violation|12|||
160789045|NCT00363467|580614725|FG000|Overall Study|Physician Decision|1|||
160789046|NCT03160573|580614728|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
160789047|NCT03160573|580614729|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
160891954|NCT02675231|581000463|FG002|Overall Study|Withdrawal by Subject|2|||
160891955|NCT02675231|581000461|FG000|Overall Study|Lost to Follow-up|3|||
160891956|NCT02675231|581000462|FG001|Overall Study|Lost to Follow-up|4|||
160891957|NCT02675231|581000463|FG002|Overall Study|Lost to Follow-up|3|||
160891958|NCT05323656|581000464|FG000|Overall Study|Still On-Treatment|6|||
160891959|NCT05323656|581000465|FG001|Overall Study|Still On-Treatment|6|||
160789048|NCT03160573|580614730|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
160789049|NCT03160573|580614731|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
160891960|NCT05323656|581000464|FG000|Overall Study|Progressive Disease|15|||
160891961|NCT05323656|581000465|FG001|Overall Study|Progressive Disease|14|||
160789050|NCT00101400|580614732|FG000|Survival Follow-Up|Alive|7|||
160789051|NCT02144337|580614757|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
160789052|NCT02144337|580614758|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
160789053|NCT02144337|580614757|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
160789054|NCT02144337|580614758|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
160891962|NCT05323656|581000464|FG000|Overall Study|Adverse Event|2|||
160789055|NCT02144337|580614757|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
160789056|NCT02144337|580614758|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
160789057|NCT02144337|580614757|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
160789058|NCT02144337|580614758|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
160789059|NCT02144337|580614757|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
160789060|NCT02144337|580614758|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
160789061|NCT02402907|580614759|FG000|Overall Study|Delivered vaginally|9|||
160789062|NCT02402907|580614760|FG001|Overall Study|Delivered vaginally|3|||
160789063|NCT02402907|580614759|FG000|Overall Study|Delivered outside of Sinai|1|||
160789064|NCT02402907|580614760|FG001|Overall Study|Delivered outside of Sinai|1|||
160789065|NCT02402907|580614759|FG000|Overall Study|Lost to follow up after C-Section|10|||
160789066|NCT02402907|580614760|FG001|Overall Study|Lost to follow up after C-Section|23|||
160789067|NCT05166902|580614761|FG000|First Intervention|Lost to Follow-up|0|||
160789068|NCT05166902|580614762|FG001|First Intervention|Lost to Follow-up|1|||
160789069|NCT02244957|580614763|FG000|Overall Study|Lack of Efficacy|1|||
160789070|NCT02244957|580614764|FG001|Overall Study|Lack of Efficacy|0|||
160789071|NCT02624687|580614766|FG000|Overall Study|Withdrawal by Subject|1|||
160789072|NCT02624687|580614767|FG001|Overall Study|Withdrawal by Subject|1|||
160789073|NCT02624687|580614766|FG000|Overall Study|medical leave from work|0|||
160789074|NCT02624687|580614767|FG001|Overall Study|medical leave from work|1|||
160789075|NCT03111108|580614768|FG000|Overall Study|Death|0|||
160789076|NCT03111108|580614769|FG001|Overall Study|Death|1|||
160789077|NCT03111108|580614768|FG000|Overall Study|Withdrawal by Subject|1|||
160789078|NCT03111108|580614769|FG001|Overall Study|Withdrawal by Subject|0|||
160789079|NCT01514357|580614770|FG000|Overall Study|Screen failure|2|||
160789080|NCT01514357|580614771|FG001|Overall Study|Screen failure|0|||
160789081|NCT01514357|580614770|FG000|Overall Study|Withdrawal by Subject|2|||
160789082|NCT01514357|580614771|FG001|Overall Study|Withdrawal by Subject|0|||
160789083|NCT04691115|580614774|FG000|Overall Study|Withdrawal by Subject|0|||
160789084|NCT04691115|580614775|FG001|Overall Study|Withdrawal by Subject|0|||
160789085|NCT04691115|580614776|FG002|Overall Study|Withdrawal by Subject|0|||
160789086|NCT04691115|580614777|FG003|Overall Study|Withdrawal by Subject|0|||
160891963|NCT05323656|581000465|FG001|Overall Study|Adverse Event|3|||
160891964|NCT05323656|581000464|FG000|Overall Study|Death|1|||
161330173|NCT02716779|582594820|FG001|Combination Therapy|Adverse Event|2|||
161330174|NCT02716779|582594821|FG002|Combination Therapy|Adverse Event|1|||
160891965|NCT05323656|581000465|FG001|Overall Study|Death|2|||
161330175|NCT01261390|582594826|FG000|Overall Study|Significant Concurrent Illness|1|||
161330176|NCT01261390|582594827|FG001|Overall Study|Significant Concurrent Illness|0|||
161235425|NCT05323396|582244868|FG000|Overall Study|Lost to Follow-up|1|||
161235426|NCT05323396|582244869|FG001|Overall Study|Lost to Follow-up|35|||
161235427|NCT05323396|582244868|FG000|Overall Study|Pregnancy|1|||
161235428|NCT05323396|582244869|FG001|Overall Study|Pregnancy|0|||
161235429|NCT03420300|582244871|FG000|Overall Study|Death|2|||
161235430|NCT03681470|582244879|FG000|Overall Study|Lack of Efficacy|3|||
161235431|NCT03681470|582244879|FG000|Overall Study|Lost to Follow-up|1|||
161235432|NCT03681470|582244879|FG000|Overall Study|Protocol Violation|3|||
161235433|NCT03681470|582244879|FG000|Overall Study|Withdrawal by Subject|1|||
161235434|NCT03500692|582244884|FG000|Overall Study|Death|163|||
161235435|NCT03500692|582244884|FG000|Overall Study|Lost to Follow-up|75|||
161330177|NCT01261390|582594828|FG002|Overall Study|Significant Concurrent Illness|1|||
161330178|NCT01261390|582594829|FG003|Overall Study|Significant Concurrent Illness|0|||
160789087|NCT04691115|580614778|FG004|Overall Study|Withdrawal by Subject|0|||
160789088|NCT04691115|580614779|FG005|Overall Study|Withdrawal by Subject|1|||
160789089|NCT04691115|580614780|FG006|Overall Study|Withdrawal by Subject|0|||
160789090|NCT04691115|580614781|FG007|Overall Study|Withdrawal by Subject|0|||
160789091|NCT04691115|580614782|FG008|Overall Study|Withdrawal by Subject|0|||
160891966|NCT05323656|581000464|FG000|Overall Study|Withdrawal by Subject|1|||
161330179|NCT01261390|582594826|FG000|Overall Study|Dissatisfaction with Treatment|2|||
161330180|NCT01261390|582594827|FG001|Overall Study|Dissatisfaction with Treatment|1|||
161330181|NCT01261390|582594828|FG002|Overall Study|Dissatisfaction with Treatment|1|||
161330182|NCT01261390|582594829|FG003|Overall Study|Dissatisfaction with Treatment|2|||
160789092|NCT04691115|580614783|FG009|Overall Study|Withdrawal by Subject|0|||
161330183|NCT01261390|582594826|FG000|Overall Study|Relocation|0|||
160789093|NCT04691115|580614784|FG010|Overall Study|Withdrawal by Subject|0|||
160789094|NCT04691115|580614785|FG011|Overall Study|Withdrawal by Subject|0|||
160789095|NCT04691115|580614786|FG012|Overall Study|Withdrawal by Subject|0|||
160789096|NCT04691115|580614787|FG013|Overall Study|Withdrawal by Subject|0|||
160789097|NCT00830336|580614791|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
160789098|NCT00830336|580614792|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
160789099|NCT00867334|580614793|FG000|Overall Study|Withdrawal by Subject|0|||
160789100|NCT00867334|580614794|FG001|Overall Study|Withdrawal by Subject|1|||
160789101|NCT00867334|580614793|FG000|Overall Study|Withdrawal by Subject|1|||
160789102|NCT00867334|580614794|FG001|Overall Study|Withdrawal by Subject|0|||
161235436|NCT03500692|582244884|FG000|Overall Study|Termination Reasons|3|||
161235437|NCT02305758|582244885|FG000|Overall Study|Death|27|||
160789103|NCT00867334|580614793|FG000|Overall Study|Withdrawal by Subject|1|||
160789104|NCT00867334|580614794|FG001|Overall Study|Withdrawal by Subject|0|||
160789105|NCT00347269|580614799|FG000|Overall Study|Lost to Follow-up|74|||
160789106|NCT00347269|580614800|FG001|Overall Study|Lost to Follow-up|65|||
160789107|NCT00347269|580614799|FG000|Overall Study|Withdrawal by Subject|18|||
160789108|NCT00347269|580614800|FG001|Overall Study|Withdrawal by Subject|38|||
160789109|NCT00347269|580614799|FG000|Overall Study|Death|2|||
160789110|NCT00347269|580614800|FG001|Overall Study|Death|3|||
160789111|NCT04893811|580614801|FG000|Vaccination Phase|Death|1|||
160789112|NCT04893811|580614802|FG001|Vaccination Phase|Death|0|||
161128041|NCT01162421|581855276|FG001|Overall Study|Did not receive study drug|1|||
161128042|NCT01162421|581855275|FG000|Overall Study|Adverse Event|2|||
161330184|NCT01261390|582594827|FG001|Overall Study|Relocation|1|||
160789113|NCT04893811|580614801|FG000|Vaccination Phase|Lost to Follow-up|1|||
160789114|NCT04893811|580614802|FG001|Vaccination Phase|Lost to Follow-up|1|||
160789115|NCT04893811|580614801|FG000|Vaccination Phase|Protocol Violation|2|||
160789116|NCT04893811|580614802|FG001|Vaccination Phase|Protocol Violation|0|||
160789117|NCT04893811|580614801|FG000|Vaccination Phase|Withdrawal by Subject|2|||
160789118|NCT04893811|580614802|FG001|Vaccination Phase|Withdrawal by Subject|1|||
160789119|NCT04893811|580614801|FG000|Vaccination Phase|Other|0|||
160789120|NCT04893811|580614802|FG001|Vaccination Phase|Other|1|||
160789121|NCT04893811|580614801|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
160789122|NCT04893811|580614802|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
160789123|NCT04893811|580614801|FG000|Follow-up Phase|Lost to Follow-up|0|||
160789124|NCT04893811|580614802|FG001|Follow-up Phase|Lost to Follow-up|1|||
160789125|NCT03268499|580614803|FG000|Overall Study|Withdrawal by Subject|2|||
160789126|NCT03268499|580614804|FG001|Overall Study|Withdrawal by Subject|1|||
160789127|NCT05071027|580614805|FG000|Overall Study|Lost to Follow-up|1|||
160789128|NCT05071027|580614806|FG001|Overall Study|Lost to Follow-up|4|||
160789129|NCT02739828|580614807|FG000|Overall Study|Adverse Event|1|||
160789130|NCT02739828|580614807|FG000|Overall Study|Lost to Follow-up|4|||
160789131|NCT04191733|580614809|FG000|Overall Study|Withdrawn due to study closure|13|||
160789132|NCT04191733|580614810|FG001|Overall Study|Withdrawn due to study closure|14|||
160789133|NCT04191733|580614809|FG000|Overall Study|Withdrawal by Subject|2|||
160789134|NCT04191733|580614810|FG001|Overall Study|Withdrawal by Subject|4|||
160789135|NCT04191733|580614809|FG000|Overall Study|Physician Decision|1|||
160789136|NCT04191733|580614810|FG001|Overall Study|Physician Decision|1|||
160789137|NCT04191733|580614809|FG000|Overall Study|Lost to Follow-up|5|||
160789138|NCT04191733|580614810|FG001|Overall Study|Lost to Follow-up|6|||
160789139|NCT04191733|580614809|FG000|Overall Study|Death|0|||
160789140|NCT04191733|580614810|FG001|Overall Study|Death|1|||
160789141|NCT01903733|580614811|FG000|Overall Study|Death|23|||
160789142|NCT01903733|580614812|FG001|Overall Study|Death|54|||
161330185|NCT01261390|582594828|FG002|Overall Study|Relocation|0|||
161330186|NCT01261390|582594829|FG003|Overall Study|Relocation|0|||
161330187|NCT01261390|582594826|FG000|Overall Study|Loss of Interest in the Study|3|||
161330188|NCT01261390|582594827|FG001|Overall Study|Loss of Interest in the Study|1|||
161330189|NCT01261390|582594828|FG002|Overall Study|Loss of Interest in the Study|0|||
161330190|NCT01261390|582594829|FG003|Overall Study|Loss of Interest in the Study|0|||
161330191|NCT01261390|582594826|FG000|Overall Study|Lost to Follow-up|1|||
161330192|NCT01261390|582594827|FG001|Overall Study|Lost to Follow-up|6|||
161330193|NCT01261390|582594828|FG002|Overall Study|Lost to Follow-up|5|||
160789143|NCT01903733|580614813|FG002|Overall Study|Death|30|||
160789144|NCT01903733|580614814|FG003|Overall Study|Death|98|||
160789145|NCT01903733|580614811|FG000|Overall Study|Participant refused further follow-up|35|||
160789146|NCT01903733|580614812|FG001|Overall Study|Participant refused further follow-up|38|||
160789147|NCT01903733|580614813|FG002|Overall Study|Participant refused further follow-up|13|||
160789148|NCT01903733|580614814|FG003|Overall Study|Participant refused further follow-up|9|||
160789149|NCT01903733|580614811|FG000|Overall Study|Lost to Follow-up|18|||
160789150|NCT01903733|580614812|FG001|Overall Study|Lost to Follow-up|19|||
160789151|NCT01903733|580614813|FG002|Overall Study|Lost to Follow-up|6|||
160789152|NCT01903733|580614814|FG003|Overall Study|Lost to Follow-up|9|||
160789153|NCT01903733|580614811|FG000|Overall Study|Other|10|||
160789154|NCT01903733|580614812|FG001|Overall Study|Other|15|||
160789155|NCT01903733|580614813|FG002|Overall Study|Other|12|||
160789156|NCT01903733|580614814|FG003|Overall Study|Other|3|||
160789157|NCT01903733|580614811|FG000|Overall Study|Missing|2|||
160789158|NCT01903733|580614812|FG001|Overall Study|Missing|0|||
160789159|NCT01903733|580614813|FG002|Overall Study|Missing|0|||
160789160|NCT01903733|580614814|FG003|Overall Study|Missing|0|||
160789161|NCT01903733|580614811|FG000|Overall Study|Investigator request|18|||
160789162|NCT01903733|580614812|FG001|Overall Study|Investigator request|0|||
160789163|NCT01903733|580614813|FG002|Overall Study|Investigator request|0|||
160789164|NCT01903733|580614814|FG003|Overall Study|Investigator request|0|||
160789165|NCT02202577|580614815|FG000|Overall Study|Lost to Follow-up|6|||
161330194|NCT01261390|582594829|FG003|Overall Study|Lost to Follow-up|6|||
160789166|NCT02202577|580614816|FG001|Overall Study|Lost to Follow-up|16|||
160789167|NCT02202577|580614815|FG000|Overall Study|Protocol Violation|7|||
160789168|NCT02202577|580614816|FG001|Overall Study|Protocol Violation|3|||
160789169|NCT01514422|580614817|FG000|Overall Study|Lost to Follow-up|1|||
160789170|NCT03511209|580614818|FG000|Overall Study|Withdrawal by Subject|2|||
160789171|NCT03511209|580614819|FG001|Overall Study|Withdrawal by Subject|4|||
160789172|NCT03511209|580614818|FG000|Overall Study|Death|1|||
160789173|NCT03511209|580614819|FG001|Overall Study|Death|0|||
160789174|NCT03511209|580614818|FG000|Overall Study|Lost to Follow-up|0|||
160789175|NCT03511209|580614819|FG001|Overall Study|Lost to Follow-up|2|||
160789176|NCT02757963|580614823|FG000|Overall Study|Adverse Event|3|||
160789177|NCT02757963|580614823|FG000|Overall Study|Reached Stopping Criteria|1054|||
160789178|NCT02757963|580614823|FG000|Overall Study|Lost to Follow-up|5|||
160789179|NCT02757963|580614823|FG000|Overall Study|Physician Decision|1|||
160789180|NCT02757963|580614823|FG000|Overall Study|Withdrawal by Subject|34|||
160789181|NCT02971137|580614824|FG000|Overall Study|Lost to Follow-up|44|||
160789182|NCT02971137|580614825|FG001|Overall Study|Lost to Follow-up|56|||
160789183|NCT00215657|580614826|FG000|Overall Study|Adverse Event|5|||
160789184|NCT00215657|580614827|FG001|Overall Study|Adverse Event|1|||
160789185|NCT00215657|580614828|FG002|Overall Study|Adverse Event|3|||
160789186|NCT00215657|580614829|FG003|Overall Study|Adverse Event|0|||
160789187|NCT00215657|580614830|FG004|Overall Study|Adverse Event|3|||
160789188|NCT00215657|580614831|FG005|Overall Study|Adverse Event|1|||
160789189|NCT00215657|580614832|FG006|Overall Study|Adverse Event|0|||
160789190|NCT00215657|580614833|FG007|Overall Study|Adverse Event|3|||
160789191|NCT00215657|580614826|FG000|Overall Study|Withdrawal by Subject|6|||
160789192|NCT00215657|580614827|FG001|Overall Study|Withdrawal by Subject|3|||
160789193|NCT00215657|580614828|FG002|Overall Study|Withdrawal by Subject|3|||
160789194|NCT00215657|580614829|FG003|Overall Study|Withdrawal by Subject|1|||
160789195|NCT00215657|580614830|FG004|Overall Study|Withdrawal by Subject|6|||
160789196|NCT00215657|580614831|FG005|Overall Study|Withdrawal by Subject|1|||
160789197|NCT00215657|580614832|FG006|Overall Study|Withdrawal by Subject|10|||
160789198|NCT00215657|580614833|FG007|Overall Study|Withdrawal by Subject|3|||
160789199|NCT00215657|580614826|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
160789200|NCT00215657|580614827|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
160789201|NCT00215657|580614828|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
160789202|NCT00215657|580614829|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
160789203|NCT00215657|580614830|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
160789204|NCT00215657|580614831|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
160789205|NCT00215657|580614832|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
160789206|NCT00215657|580614833|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
160789207|NCT00215657|580614826|FG000|Overall Study|Insufficient testosterone response|5|||
160789208|NCT00215657|580614827|FG001|Overall Study|Insufficient testosterone response|4|||
160789209|NCT00215657|580614828|FG002|Overall Study|Insufficient testosterone response|1|||
160789210|NCT00215657|580614829|FG003|Overall Study|Insufficient testosterone response|12|||
160789211|NCT00215657|580614830|FG004|Overall Study|Insufficient testosterone response|8|||
160789212|NCT00215657|580614831|FG005|Overall Study|Insufficient testosterone response|12|||
160789213|NCT00215657|580614832|FG006|Overall Study|Insufficient testosterone response|4|||
160789214|NCT00215657|580614833|FG007|Overall Study|Insufficient testosterone response|7|||
160789215|NCT00215657|580614826|FG000|Overall Study|Other|3|||
160789216|NCT00215657|580614827|FG001|Overall Study|Other|1|||
160789217|NCT00215657|580614828|FG002|Overall Study|Other|2|||
160789218|NCT00215657|580614829|FG003|Overall Study|Other|3|||
160789219|NCT00215657|580614830|FG004|Overall Study|Other|5|||
160789220|NCT00215657|580614831|FG005|Overall Study|Other|4|||
160789221|NCT00215657|580614832|FG006|Overall Study|Other|6|||
160789222|NCT00215657|580614833|FG007|Overall Study|Other|1|||
160789223|NCT03769467|580614837|FG000|Overall Study|Adverse Event|1|||
160789224|NCT03769467|580614838|FG001|Overall Study|Adverse Event|1|||
160789225|NCT03769467|580614839|FG002|Overall Study|Adverse Event|0|||
160789226|NCT03769467|580614837|FG000|Overall Study|Death|3|||
160789227|NCT03769467|580614838|FG001|Overall Study|Death|3|||
160789228|NCT03769467|580614839|FG002|Overall Study|Death|0|||
160789229|NCT03769467|580614837|FG000|Overall Study|Study Terminated By Sponsor|2|||
160789230|NCT03769467|580614838|FG001|Overall Study|Study Terminated By Sponsor|1|||
160789231|NCT03769467|580614839|FG002|Overall Study|Study Terminated By Sponsor|0|||
160891967|NCT05323656|581000465|FG001|Overall Study|Withdrawal by Subject|0|||
160891968|NCT05323656|581000464|FG000|Overall Study|Clinical disease progression|0|||
160789232|NCT03769467|580614837|FG000|Overall Study|Withdrawal by Subject|0|||
160789233|NCT03769467|580614838|FG001|Overall Study|Withdrawal by Subject|1|||
160789234|NCT03769467|580614839|FG002|Overall Study|Withdrawal by Subject|0|||
160789235|NCT00289900|580614840|FG000|Overall Study|Adverse Event|28|||
160789236|NCT00289900|580614841|FG001|Overall Study|Adverse Event|40|||
160789237|NCT00289900|580614842|FG002|Overall Study|Adverse Event|13|||
160789238|NCT00289900|580614843|FG003|Overall Study|Adverse Event|19|||
160789239|NCT00289900|580614844|FG004|Overall Study|Adverse Event|20|||
160789240|NCT00289900|580614845|FG005|Overall Study|Adverse Event|33|||
160789241|NCT00289900|580614840|FG000|Overall Study|Lost to Follow-up|7|||
160789242|NCT00289900|580614841|FG001|Overall Study|Lost to Follow-up|7|||
160789243|NCT00289900|580614842|FG002|Overall Study|Lost to Follow-up|8|||
160789244|NCT00289900|580614843|FG003|Overall Study|Lost to Follow-up|8|||
160789245|NCT00289900|580614844|FG004|Overall Study|Lost to Follow-up|4|||
160789246|NCT00289900|580614845|FG005|Overall Study|Lost to Follow-up|8|||
160789247|NCT00289900|580614840|FG000|Overall Study|Participant had flushing|18|||
160789248|NCT00289900|580614841|FG001|Overall Study|Participant had flushing|42|||
160789249|NCT00289900|580614842|FG002|Overall Study|Participant had flushing|1|||
160789250|NCT00289900|580614843|FG003|Overall Study|Participant had flushing|2|||
160789251|NCT00289900|580614844|FG004|Overall Study|Participant had flushing|0|||
160789252|NCT00289900|580614845|FG005|Overall Study|Participant had flushing|4|||
160789253|NCT00289900|580614840|FG000|Overall Study|Other|0|||
160789254|NCT00289900|580614841|FG001|Overall Study|Other|0|||
160789255|NCT00289900|580614842|FG002|Overall Study|Other|0|||
160789256|NCT00289900|580614843|FG003|Overall Study|Other|5|||
160789257|NCT00289900|580614844|FG004|Overall Study|Other|1|||
160789258|NCT00289900|580614845|FG005|Overall Study|Other|0|||
160789259|NCT00289900|580614840|FG000|Overall Study|Participant moved|1|||
160789260|NCT00289900|580614841|FG001|Overall Study|Participant moved|0|||
160789261|NCT00289900|580614842|FG002|Overall Study|Participant moved|0|||
160789262|NCT00289900|580614843|FG003|Overall Study|Participant moved|1|||
160789263|NCT00289900|580614844|FG004|Overall Study|Participant moved|1|||
160789264|NCT00289900|580614845|FG005|Overall Study|Participant moved|1|||
160789265|NCT00289900|580614840|FG000|Overall Study|Withdrawal by Subject|10|||
160789266|NCT00289900|580614841|FG001|Overall Study|Withdrawal by Subject|21|||
160789267|NCT00289900|580614842|FG002|Overall Study|Withdrawal by Subject|8|||
160789268|NCT00289900|580614843|FG003|Overall Study|Withdrawal by Subject|18|||
160789269|NCT00289900|580614844|FG004|Overall Study|Withdrawal by Subject|12|||
160789270|NCT00289900|580614845|FG005|Overall Study|Withdrawal by Subject|11|||
160789271|NCT00289900|580614840|FG000|Overall Study|Protocol Violation|3|||
160789272|NCT00289900|580614841|FG001|Overall Study|Protocol Violation|9|||
160789273|NCT00289900|580614842|FG002|Overall Study|Protocol Violation|2|||
160789274|NCT00289900|580614843|FG003|Overall Study|Protocol Violation|6|||
160789275|NCT00289900|580614844|FG004|Overall Study|Protocol Violation|7|||
160789276|NCT00289900|580614845|FG005|Overall Study|Protocol Violation|4|||
160789277|NCT00289900|580614840|FG000|Overall Study|site terminated|1|||
160789278|NCT00289900|580614841|FG001|Overall Study|site terminated|0|||
160789279|NCT00289900|580614842|FG002|Overall Study|site terminated|1|||
160789280|NCT00289900|580614843|FG003|Overall Study|site terminated|0|||
160891969|NCT05323656|581000465|FG001|Overall Study|Clinical disease progression|1|||
160891970|NCT05323656|581000464|FG000|Overall Study|Patient and Investigator decision|1|||
160891971|NCT05323656|581000465|FG001|Overall Study|Patient and Investigator decision|0|||
160891972|NCT05323656|581000464|FG000|Overall Study|Physician Decision|0|||
160891973|NCT05323656|581000465|FG001|Overall Study|Physician Decision|1|||
160891974|NCT03953183|581000466|FG000|Overall Study|Physician Decision|0|||
160891975|NCT03953183|581000467|FG001|Overall Study|Physician Decision|1|||
160891976|NCT03953183|581000466|FG000|Overall Study|Withdrawal by Subject|0|||
160891977|NCT03953183|581000467|FG001|Overall Study|Withdrawal by Subject|1|||
160789281|NCT00289900|580614844|FG004|Overall Study|site terminated|0|||
160789282|NCT00289900|580614845|FG005|Overall Study|site terminated|0|||
160789283|NCT00289900|580614840|FG000|Overall Study|Not treated|0|||
160891978|NCT01115803|581000478|FG000|Overall Study|Withdrawal by Subject|0|||
160891979|NCT01115803|581000479|FG001|Overall Study|Withdrawal by Subject|0|||
160891980|NCT01115803|581000480|FG002|Overall Study|Withdrawal by Subject|0|||
160891981|NCT01115803|581000481|FG003|Overall Study|Withdrawal by Subject|0|||
160789284|NCT00289900|580614841|FG001|Overall Study|Not treated|1|||
160789285|NCT00289900|580614842|FG002|Overall Study|Not treated|0|||
160789286|NCT00289900|580614843|FG003|Overall Study|Not treated|0|||
160789287|NCT00289900|580614844|FG004|Overall Study|Not treated|0|||
160789288|NCT00289900|580614845|FG005|Overall Study|Not treated|0|||
160891982|NCT01115803|581000482|FG004|Overall Study|Withdrawal by Subject|0|||
160891983|NCT01115803|581000483|FG005|Overall Study|Withdrawal by Subject|0|||
160891984|NCT01115803|581000484|FG006|Overall Study|Withdrawal by Subject|1|||
160891985|NCT01115803|581000478|FG000|Overall Study|Lost to Follow-up|0|||
160891986|NCT01115803|581000479|FG001|Overall Study|Lost to Follow-up|0|||
160891987|NCT01115803|581000480|FG002|Overall Study|Lost to Follow-up|1|||
160789289|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
160891988|NCT01115803|581000481|FG003|Overall Study|Lost to Follow-up|0|||
161128043|NCT01162421|581855276|FG001|Overall Study|Adverse Event|5|||
160789290|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
160789291|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
160789292|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
160789293|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
160789294|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
160789295|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
160789296|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160891989|NCT01115803|581000482|FG004|Overall Study|Lost to Follow-up|0|||
160891990|NCT01115803|581000483|FG005|Overall Study|Lost to Follow-up|0|||
160891991|NCT01115803|581000484|FG006|Overall Study|Lost to Follow-up|0|||
160891992|NCT01115803|581000478|FG000|Overall Study|Progressive Disease during Cycle1|0|||
160789297|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
160789298|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
160789299|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
160789300|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
160789301|NCT01703221|580614846|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160789302|NCT01703221|580614847|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
160789303|NCT01703221|580614848|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
160789304|NCT01703221|580614846|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
160789305|NCT01703221|580614847|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
160789306|NCT01703221|580614848|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
160789307|NCT01703221|580614846|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
160789308|NCT01703221|580614847|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
160789309|NCT01703221|580614848|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
160789310|NCT01703221|580614846|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
160789311|NCT01703221|580614847|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
160789312|NCT01703221|580614848|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
160789313|NCT01152385|580614849|FG000|Overall Study|Withdrawal by Subject|3|||
160789314|NCT01152385|580614850|FG001|Overall Study|Withdrawal by Subject|1|||
160789315|NCT01152385|580614851|FG002|Overall Study|Withdrawal by Subject|1|||
160789316|NCT01152385|580614852|FG003|Overall Study|Withdrawal by Subject|1|||
160789317|NCT01152385|580614849|FG000|Overall Study|Protocol Violation|0|||
160789318|NCT01152385|580614850|FG001|Overall Study|Protocol Violation|0|||
160789319|NCT01152385|580614851|FG002|Overall Study|Protocol Violation|0|||
160789320|NCT01152385|580614852|FG003|Overall Study|Protocol Violation|1|||
160789321|NCT01152385|580614849|FG000|Overall Study|Adverse Event|1|||
160789322|NCT01152385|580614850|FG001|Overall Study|Adverse Event|1|||
160789323|NCT01152385|580614851|FG002|Overall Study|Adverse Event|0|||
160789324|NCT01152385|580614852|FG003|Overall Study|Adverse Event|0|||
160789325|NCT01152385|580614849|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160789326|NCT01152385|580614850|FG001|Overall Study|Study-specific withdrawal criteria|1|||
160789327|NCT01152385|580614851|FG002|Overall Study|Study-specific withdrawal criteria|2|||
160789328|NCT01152385|580614852|FG003|Overall Study|Study-specific withdrawal criteria|0|||
160789329|NCT01152385|580614849|FG000|Overall Study|Other|4|||
160789330|NCT01152385|580614850|FG001|Overall Study|Other|3|||
160789331|NCT01152385|580614851|FG002|Overall Study|Other|2|||
160789332|NCT01152385|580614852|FG003|Overall Study|Other|3|||
160789333|NCT02656173|580614853|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
160789334|NCT02656173|580614854|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
160789335|NCT02656173|580614853|FG000|Overall Study|Adverse Event|7|||
160789336|NCT02656173|580614854|FG001|Overall Study|Adverse Event|5|||
160789337|NCT02656173|580614853|FG000|Overall Study|Withdrawal by Subject|1|||
160789338|NCT02656173|580614854|FG001|Overall Study|Withdrawal by Subject|3|||
160789339|NCT02656173|580614853|FG000|Overall Study|Protocol Violation|0|||
160789340|NCT02656173|580614854|FG001|Overall Study|Protocol Violation|1|||
160789341|NCT02656173|580614853|FG000|Overall Study|Miscellaneous|2|||
160789342|NCT02656173|580614854|FG001|Overall Study|Miscellaneous|0|||
160789343|NCT03927846|580614858|FG000|Overall Study|Lost to Follow-up|10|||
160789344|NCT03927846|580614859|FG001|Overall Study|Lost to Follow-up|11|||
160789345|NCT03061214|580614862|FG000|Overall Study|Withdrawal by Subject|21|||
160789346|NCT03061214|580614863|FG001|Overall Study|Withdrawal by Subject|26|||
160789347|NCT03061214|580614864|FG002|Overall Study|Withdrawal by Subject|9|||
160789348|NCT03061214|580614862|FG000|Overall Study|Lost to Follow-up|3|||
160789349|NCT03061214|580614863|FG001|Overall Study|Lost to Follow-up|1|||
160789350|NCT03061214|580614864|FG002|Overall Study|Lost to Follow-up|1|||
160789351|NCT03061214|580614862|FG000|Overall Study|Death|1|||
160789352|NCT03061214|580614863|FG001|Overall Study|Death|1|||
160789353|NCT03061214|580614864|FG002|Overall Study|Death|0|||
160789354|NCT05130281|580616606|FG000|Overall Study|Withdrawal by Subject|0|||
160789355|NCT05130281|580616607|FG001|Overall Study|Withdrawal by Subject|0|||
160789356|NCT05130281|580616608|FG002|Overall Study|Withdrawal by Subject|1|||
160789357|NCT06844812|580616609|FG000|Overall Study|Lost to Follow-up|5|||
160789358|NCT06844812|580616609|FG000|Overall Study|stigmatization concerns|2|||
160789359|NCT06844812|580616609|FG000|Overall Study|medication refusal|2|||
160789360|NCT06844812|580616609|FG000|Overall Study|concerns about possible side effects|2|||
160789361|NCT06844812|580616609|FG000|Overall Study|wanting to seek another specialist opinion|2|||
161128044|NCT01162421|581855275|FG000|Overall Study|Lost to Follow-up|0|||
161128045|NCT01162421|581855276|FG001|Overall Study|Lost to Follow-up|2|||
160789362|NCT06844812|580616609|FG000|Overall Study|side effects (dizziness)|1|||
160789363|NCT05520333|580616613|FG000|Overall Study|Lost to Follow-up|3|||
160789364|NCT05520333|580616614|FG001|Overall Study|Lost to Follow-up|6|||
161128046|NCT01162421|581855275|FG000|Overall Study|Lack of Efficacy|2|||
160789365|NCT05069415|580616620|FG000|Overall Study|Withdrawal by Subject|2|||
160789366|NCT05069415|580616621|FG001|Overall Study|Withdrawal by Subject|0|||
160789367|NCT05069415|580616620|FG000|Overall Study|Adverse Event|2|||
160789368|NCT05069415|580616621|FG001|Overall Study|Adverse Event|0|||
160789369|NCT03701074|580616622|FG000|Overall Study|Physician Decision|1|||
160789370|NCT03701074|580616623|FG001|Overall Study|Physician Decision|0|||
161128047|NCT01162421|581855276|FG001|Overall Study|Lack of Efficacy|2|||
160789371|NCT01500135|580616624|FG000|Overall Study|Withdrawal of Consent|4|||
160789372|NCT01500135|580616625|FG001|Overall Study|Withdrawal of Consent|0|||
160789373|NCT01500135|580616624|FG000|Overall Study|Lost to Follow-up|6|||
160789374|NCT01500135|580616625|FG001|Overall Study|Lost to Follow-up|4|||
160789375|NCT01500135|580616624|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
160789376|NCT01500135|580616625|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
160789377|NCT01500135|580616624|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
160789378|NCT01500135|580616625|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
160789379|NCT01500135|580616624|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
160789380|NCT01500135|580616625|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
160789381|NCT01500135|580616624|FG000|Overall Study|Participant was a Safety Concern|1|||
160789382|NCT01500135|580616625|FG001|Overall Study|Participant was a Safety Concern|0|||
160789383|NCT01500135|580616624|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
160789384|NCT01500135|580616625|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
160789385|NCT01661595|580616626|FG000|Phase 1: Week 0-4|Adverse Event|1|||
160789386|NCT01661595|580616627|FG001|Phase 1: Week 0-4|Adverse Event|0|||
160789387|NCT01661595|580616628|FG002|Phase 1: Week 0-4|Adverse Event|0|||
160789388|NCT01661595|580616629|FG003|Phase 1: Week 0-4|Adverse Event|0|||
160789389|NCT01661595|580616626|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
160789390|NCT01661595|580616627|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
160789391|NCT01661595|580616628|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
160789392|NCT01661595|580616629|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
160789393|NCT00661687|580616630|FG000|Overall Study|Study related symptoms and complaints|5|||
160789394|NCT00661687|580616630|FG000|Overall Study|Positive slit lamp findings|4|||
160789395|NCT00661687|580616630|FG000|Overall Study|Inability to maintain wearing schedule|3|||
160789396|NCT00661687|580616630|FG000|Overall Study|Physician Decision|1|||
160789397|NCT00661687|580616630|FG000|Overall Study|Adverse Event|2|||
160789398|NCT00912509|580616631|FG000|Overall Study|Lost to Follow-up|1|||
160789399|NCT00912509|580616632|FG001|Overall Study|Lost to Follow-up|0|||
160789400|NCT00912509|580616631|FG000|Overall Study|Lack of Efficacy|4|||
160789401|NCT00912509|580616632|FG001|Overall Study|Lack of Efficacy|3|||
160789402|NCT05538728|580616633|FG000|Overall Study|Withdrawal by Subject|1|||
160789403|NCT05538728|580616634|FG001|Overall Study|Withdrawal by Subject|1|||
160789404|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Adverse Event|2|||
160789405|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Adverse Event|0|||
160891993|NCT01115803|581000479|FG001|Overall Study|Progressive Disease during Cycle1|0|||
160891994|NCT01115803|581000480|FG002|Overall Study|Progressive Disease during Cycle1|0|||
160891995|NCT01115803|581000481|FG003|Overall Study|Progressive Disease during Cycle1|0|||
160891996|NCT01115803|581000482|FG004|Overall Study|Progressive Disease during Cycle1|0|||
160891997|NCT01115803|581000483|FG005|Overall Study|Progressive Disease during Cycle1|0|||
160891998|NCT01115803|581000484|FG006|Overall Study|Progressive Disease during Cycle1|1|||
160891999|NCT00064298|581000485|FG000|Overall Study|Withdrawal by Subject|2|||
160892000|NCT00064298|581000486|FG001|Overall Study|Withdrawal by Subject|1|||
160892001|NCT00064298|581000485|FG000|Overall Study|Lost to Follow-up|2|||
160892002|NCT00064298|581000486|FG001|Overall Study|Lost to Follow-up|2|||
160892003|NCT00064298|581000485|FG000|Overall Study|Death|0|||
160892004|NCT00064298|581000486|FG001|Overall Study|Death|1|||
160892005|NCT00064298|581000485|FG000|Overall Study|Disease Progression|2|||
160892006|NCT00064298|581000486|FG001|Overall Study|Disease Progression|1|||
160892007|NCT03063203|581000487|FG000|Overall Study|Chose alternative therapy|3|||
160892008|NCT03063203|581000487|FG000|Overall Study|Death|2|||
161128048|NCT01162421|581855275|FG000|Overall Study|Other|2|||
161128049|NCT01162421|581855276|FG001|Overall Study|Other|3|||
161128050|NCT01133171|581855280|FG000|Overall Study|Withdrawal by Subject|1|||
161128051|NCT01133171|581855281|FG001|Overall Study|Withdrawal by Subject|2|||
161128052|NCT01133171|581855282|FG002|Overall Study|Withdrawal by Subject|0|||
161128053|NCT02526550|581855283|FG000|Overall Study|Lost to Follow-up|1|||
161128054|NCT03434379|581855287|FG000|Global Period|Lost to Follow-up|3|||
161128055|NCT03434379|581855288|FG001|Global Period|Lost to Follow-up|6|||
161128056|NCT03434379|581855289|FG002|Global Period|Lost to Follow-up|0|||
161128057|NCT03434379|581855290|FG003|Global Period|Lost to Follow-up|0|||
161128058|NCT03434379|581855287|FG000|Global Period|Death|115|||
160789406|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Physician Decision|0|||
160789407|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Physician Decision|1|||
160789408|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
160789409|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
160789410|NCT01362530|580616636|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
160789411|NCT01362530|580616637|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
160892009|NCT03063203|581000487|FG000|Overall Study|Disease progression|4|||
160892010|NCT03063203|581000487|FG000|Overall Study|Physician Decision|5|||
160892011|NCT00591266|581000488|FG000|Overall Study|Adverse Event|2|||
160892012|NCT00591266|581000489|FG001|Overall Study|Adverse Event|2|||
161128059|NCT03434379|581855288|FG001|Global Period|Death|228|||
161128060|NCT03434379|581855289|FG002|Global Period|Death|0|||
161128061|NCT03434379|581855290|FG003|Global Period|Death|0|||
161128062|NCT03434379|581855287|FG000|Global Period|Withdrawal by Subject|20|||
160789412|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
160789413|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
160789414|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
160789415|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
160789416|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
160789417|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
160789418|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
160789419|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
160789420|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
160789421|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
160789422|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
160789423|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
160789424|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
160789425|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
160789426|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
160789427|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
160789428|NCT01362530|580616636|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
160789429|NCT01362530|580616637|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
160789430|NCT02715856|580616638|FG000|Overall Study|Software Issues|12|||
160789431|NCT02715856|580616639|FG001|Overall Study|Software Issues|7|||
160789432|NCT02715856|580616638|FG000|Overall Study|Death|6|||
161128063|NCT03434379|581855288|FG001|Global Period|Withdrawal by Subject|21|||
161128064|NCT03434379|581855289|FG002|Global Period|Withdrawal by Subject|0|||
160789433|NCT02715856|580616639|FG001|Overall Study|Death|5|||
160789434|NCT02715856|580616638|FG000|Overall Study|Non- Compliant|0|||
160789435|NCT02715856|580616639|FG001|Overall Study|Non- Compliant|40|||
160789436|NCT01517178|580616640|FG000|Period 1|Adverse Event|1|||
160789437|NCT01517178|580616641|FG001|Period 1|Adverse Event|2|||
160789438|NCT01517178|580616640|FG000|Period 1|Lack of Efficacy|0|||
160789439|NCT01517178|580616641|FG001|Period 1|Lack of Efficacy|1|||
160789440|NCT01517178|580616640|FG000|Period 1|E.g. study termination|3|||
160789441|NCT01517178|580616641|FG001|Period 1|E.g. study termination|1|||
160789442|NCT01517178|580616640|FG000|Period 1|Withdrawal by Subject|0|||
160789443|NCT01517178|580616641|FG001|Period 1|Withdrawal by Subject|1|||
160789444|NCT01517178|580616640|FG000|Period 2|Adverse Event|1|||
160789445|NCT01517178|580616641|FG001|Period 2|Adverse Event|0|||
160789446|NCT01517178|580616640|FG000|Period 2|Withdrawal by Subject|3|||
160789447|NCT01517178|580616641|FG001|Period 2|Withdrawal by Subject|0|||
160789448|NCT01517178|580616640|FG000|Period 2|E.g. study termination|2|||
160789449|NCT01517178|580616641|FG001|Period 2|E.g. study termination|2|||
160789450|NCT01557569|580616642|FG000|Overall Study|Adverse Event|2|||
160789451|NCT01557569|580616643|FG001|Overall Study|Adverse Event|0|||
160789452|NCT01557569|580616642|FG000|Overall Study|high blood pressure|0|||
160789453|NCT01557569|580616643|FG001|Overall Study|high blood pressure|1|||
160789454|NCT01557569|580616642|FG000|Overall Study|Withdrawal by Subject|3|||
160789455|NCT01557569|580616643|FG001|Overall Study|Withdrawal by Subject|5|||
160789456|NCT01557569|580616642|FG000|Overall Study|noncompliance with rules of residential|0|||
160789457|NCT01557569|580616643|FG001|Overall Study|noncompliance with rules of residential|1|||
160789458|NCT02254460|580616644|FG000|Overall Study|Adverse Event|1|||
160789459|NCT02254460|580616645|FG001|Overall Study|Adverse Event|0|||
160789460|NCT01050218|580616646|FG000|Overall Study|Adverse Event|37|||
160789461|NCT01050218|580616646|FG000|Overall Study|Lack of Efficacy|8|||
160789462|NCT01050218|580616646|FG000|Overall Study|Protocol Violation|3|||
160789463|NCT01050218|580616646|FG000|Overall Study|Withdrawal by Subject|18|||
160892013|NCT00591266|581000490|FG002|Overall Study|Adverse Event|3|||
160892014|NCT00591266|581000488|FG000|Overall Study|Lost to Follow-up|0|||
160892015|NCT00591266|581000489|FG001|Overall Study|Lost to Follow-up|1|||
160892016|NCT00591266|581000490|FG002|Overall Study|Lost to Follow-up|0|||
160892017|NCT00591266|581000488|FG000|Overall Study|Protocol Violation|0|||
160892018|NCT00591266|581000489|FG001|Overall Study|Protocol Violation|0|||
160892019|NCT00591266|581000490|FG002|Overall Study|Protocol Violation|1|||
160892020|NCT00591266|581000488|FG000|Overall Study|Withdrawal by Subject|6|||
160892021|NCT00591266|581000489|FG001|Overall Study|Withdrawal by Subject|2|||
160789464|NCT01050218|580616646|FG000|Overall Study|Discontinued by sponsor|18|||
160789465|NCT01050218|580616646|FG000|Overall Study|Compliance|2|||
160789466|NCT01050218|580616646|FG000|Overall Study|Failed to return|7|||
160789467|NCT01050218|580616646|FG000|Overall Study|Serious Adverse Event|1|||
160789468|NCT01050218|580616646|FG000|Overall Study|Family emergency|1|||
160789469|NCT02336555|580616647|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
160789470|NCT02336555|580616648|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
160789471|NCT02336555|580616647|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
160789472|NCT02336555|580616648|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
160892022|NCT00591266|581000490|FG002|Overall Study|Withdrawal by Subject|5|||
160892023|NCT00591266|581000488|FG000|Overall Study|Lack of Efficacy|0|||
161128065|NCT03434379|581855290|FG003|Global Period|Withdrawal by Subject|0|||
160789473|NCT02336555|580616647|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
160789474|NCT02336555|580616648|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
160789475|NCT01772693|580616649|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
160789476|NCT01772693|580616650|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
160789477|NCT01772693|580616649|FG000|Overall Study|Withdrawal by Subject|2|||
160789478|NCT01772693|580616650|FG001|Overall Study|Withdrawal by Subject|0|||
160789479|NCT01772693|580616649|FG000|Overall Study|Alternative Treatment|2|||
160789480|NCT01772693|580616650|FG001|Overall Study|Alternative Treatment|0|||
160789481|NCT02872142|580616654|FG000|Overall Study|Adverse Event|2|||
160789482|NCT02872142|580616654|FG000|Overall Study|Death|1|||
160789483|NCT02872142|580616654|FG000|Overall Study|Participant Decision|3|||
160789484|NCT01550965|580616660|FG000|Overall Study|Adverse Event|26|||
160789485|NCT01550965|580616660|FG000|Overall Study|Withdrawal by Subject|10|||
160789486|NCT01550965|580616660|FG000|Overall Study|Lost to Follow-up|2|||
160789487|NCT01550965|580616660|FG000|Overall Study|Lack of Efficacy|59|||
160789488|NCT01550965|580616660|FG000|Overall Study|Other|13|||
160789489|NCT04157738|580616663|FG000|Overall Study|Moved out of state|0|||
160789490|NCT04157738|580616664|FG001|Overall Study|Moved out of state|2|||
160789491|NCT04157738|580616663|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
160789492|NCT04157738|580616664|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
160789493|NCT00309946|580616665|FG000|Overall Study|Withdrawal by Subject|1|||
160789494|NCT01347086|580616666|FG000|Overall Study|failed screening visit|0|||
160789495|NCT01347086|580616667|FG001|Overall Study|failed screening visit|0|||
160789496|NCT01347086|580616668|FG002|Overall Study|failed screening visit|1|||
160789497|NCT01347086|580616669|FG003|Overall Study|failed screening visit|0|||
160789498|NCT01347086|580616670|FG004|Overall Study|failed screening visit|0|||
160789499|NCT01347086|580616671|FG005|Overall Study|failed screening visit|0|||
160789500|NCT01347086|580616672|FG006|Overall Study|failed screening visit|1|||
160789501|NCT01347086|580616673|FG007|Overall Study|failed screening visit|1|||
160789502|NCT01347086|580616674|FG008|Overall Study|failed screening visit|0|||
160789503|NCT01347086|580616675|FG009|Overall Study|failed screening visit|1|||
160789504|NCT01689649|580616677|FG000|Overall Study|Lack of Efficacy|3|||
160789505|NCT01689649|580616677|FG000|Overall Study|Non-compliance|11|||
160789506|NCT01689649|580616677|FG000|Overall Study|Protocol Violation|3|||
160789507|NCT01689649|580616677|FG000|Overall Study|Lost to Follow-up|5|||
160789508|NCT01725282|580616682|FG000|Overall Study|Adverse Event|1|||
160789509|NCT01725282|580616683|FG001|Overall Study|Adverse Event|3|||
160789510|NCT01725282|580616684|FG002|Overall Study|Adverse Event|6|||
160789511|NCT01725282|580616685|FG003|Overall Study|Adverse Event|4|||
160789512|NCT01725282|580616682|FG000|Overall Study|Exacerbation of Target Disease|1|||
160789513|NCT01725282|580616683|FG001|Overall Study|Exacerbation of Target Disease|0|||
160789514|NCT01725282|580616684|FG002|Overall Study|Exacerbation of Target Disease|0|||
160789515|NCT01725282|580616685|FG003|Overall Study|Exacerbation of Target Disease|1|||
160789516|NCT01725282|580616682|FG000|Overall Study|Met Exclusion Criteria|0|||
160789517|NCT01725282|580616683|FG001|Overall Study|Met Exclusion Criteria|0|||
160789518|NCT01725282|580616684|FG002|Overall Study|Met Exclusion Criteria|1|||
160789519|NCT01725282|580616685|FG003|Overall Study|Met Exclusion Criteria|0|||
160789520|NCT01725282|580616682|FG000|Overall Study|Study Site Withdrawal|0|||
160789521|NCT01725282|580616683|FG001|Overall Study|Study Site Withdrawal|1|||
160789522|NCT01725282|580616684|FG002|Overall Study|Study Site Withdrawal|0|||
160789523|NCT01725282|580616685|FG003|Overall Study|Study Site Withdrawal|0|||
160789524|NCT01725282|580616682|FG000|Overall Study|Withdrawal by Subject|0|||
160789525|NCT01725282|580616683|FG001|Overall Study|Withdrawal by Subject|0|||
160789526|NCT01725282|580616684|FG002|Overall Study|Withdrawal by Subject|1|||
160789527|NCT01725282|580616685|FG003|Overall Study|Withdrawal by Subject|1|||
160789528|NCT01725282|580616682|FG000|Overall Study|Lack of Efficacy|0|||
160789529|NCT01725282|580616683|FG001|Overall Study|Lack of Efficacy|1|||
160789530|NCT01725282|580616684|FG002|Overall Study|Lack of Efficacy|0|||
160789531|NCT01725282|580616685|FG003|Overall Study|Lack of Efficacy|1|||
160789532|NCT04064567|580616686|FG000|Overall Study|Lost to Follow-up|23|||
160789533|NCT04064567|580616687|FG001|Overall Study|Lost to Follow-up|22|||
160789534|NCT04064567|580616686|FG000|Overall Study|Withdrawal by Subject|0|||
160789535|NCT04064567|580616687|FG001|Overall Study|Withdrawal by Subject|1|||
160789536|NCT04064567|580616686|FG000|Overall Study|Reincarcerated|7|||
160789537|NCT04064567|580616687|FG001|Overall Study|Reincarcerated|10|||
160789538|NCT04064567|580616686|FG000|Overall Study|Moved out of U.S.|0|||
160789539|NCT04064567|580616687|FG001|Overall Study|Moved out of U.S.|1|||
160789540|NCT04576481|580616688|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
160789541|NCT04576481|580616689|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
160789542|NCT04576481|580616690|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
160789543|NCT04576481|580616691|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
160789544|NCT03464461|580616697|FG000|Overall Study|exclusionary medication given ,|1|||
161128066|NCT03434379|581855287|FG000|Global Period|Reason Unspecified|0|||
160789545|NCT03464461|580616698|FG001|Overall Study|exclusionary medication given ,|2|||
160789546|NCT03464461|580616699|FG002|Overall Study|exclusionary medication given ,|0|||
160789547|NCT03464461|580616697|FG000|Overall Study|Physician Decision|0|||
160789548|NCT03464461|580616698|FG001|Overall Study|Physician Decision|1|||
160789549|NCT03464461|580616699|FG002|Overall Study|Physician Decision|0|||
160789550|NCT05524948|580616700|FG000|Overall Study|Withdrawal by Subject|1|||
160789551|NCT05524948|580616701|FG001|Overall Study|Withdrawal by Subject|0|||
160789552|NCT05524948|580616700|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
160789553|NCT05524948|580616701|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
160789554|NCT05463952|580616704|FG000|Treatment|Progressive disease|4|||
160789555|NCT05463952|580616704|FG000|Treatment|Ongoing|2|||
160789556|NCT01646216|580616708|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
160789557|NCT01646216|580616709|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
160789558|NCT01646216|580616708|FG000|Overall Study|Did not complete training|0|||
160789559|NCT01646216|580616709|FG001|Overall Study|Did not complete training|2|||
160789560|NCT01646216|580616708|FG000|Overall Study|Investigator decision|1|||
160789561|NCT01646216|580616709|FG001|Overall Study|Investigator decision|1|||
160789562|NCT05259722|580616714|FG000|Overall Study|Adverse Event|2|||
160789563|NCT05259722|580616715|FG001|Overall Study|Adverse Event|24|||
160789564|NCT05259722|580616714|FG000|Overall Study|Lost to Follow-up|5|||
160789565|NCT05259722|580616715|FG001|Overall Study|Lost to Follow-up|1|||
160789566|NCT05259722|580616714|FG000|Overall Study|Lack of Efficacy|8|||
160789567|NCT05259722|580616715|FG001|Overall Study|Lack of Efficacy|26|||
160789568|NCT05259722|580616714|FG000|Overall Study|Withdrawal by Subject|15|||
160789569|NCT05259722|580616715|FG001|Overall Study|Withdrawal by Subject|33|||
160789570|NCT05259722|580616714|FG000|Overall Study|Various reasons|3|||
160789571|NCT05259722|580616715|FG001|Overall Study|Various reasons|9|||
160789572|NCT05259722|580616714|FG000|Overall Study|Not exposed to IMP|1|||
160789573|NCT05259722|580616715|FG001|Overall Study|Not exposed to IMP|12|||
160789574|NCT05259722|580616714|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
160789575|NCT05259722|580616715|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
160789576|NCT01887600|580616716|FG000|Overall Study|Death|39|||
160789577|NCT01887600|580616717|FG001|Overall Study|Death|16|||
160789578|NCT01887600|580616716|FG000|Overall Study|Lack of Efficacy|3|||
160789579|NCT01887600|580616717|FG001|Overall Study|Lack of Efficacy|26|||
160789580|NCT01887600|580616716|FG000|Overall Study|Lost to Follow-up|5|||
160789581|NCT01887600|580616717|FG001|Overall Study|Lost to Follow-up|1|||
160789582|NCT01887600|580616716|FG000|Overall Study|Physician Decision|7|||
160789583|NCT01887600|580616717|FG001|Overall Study|Physician Decision|8|||
160789584|NCT01887600|580616716|FG000|Overall Study|Protocol Deviation|3|||
160789585|NCT01887600|580616717|FG001|Overall Study|Protocol Deviation|0|||
160789586|NCT01887600|580616716|FG000|Overall Study|Withdrawal by Subject|58|||
160789587|NCT01887600|580616717|FG001|Overall Study|Withdrawal by Subject|52|||
160789588|NCT01887600|580616716|FG000|Overall Study|Adverse Event|21|||
160789589|NCT01887600|580616717|FG001|Overall Study|Adverse Event|9|||
160789590|NCT01887600|580616716|FG000|Overall Study|Non-compliance with study drug|3|||
160789591|NCT01887600|580616717|FG001|Overall Study|Non-compliance with study drug|0|||
160789592|NCT01887600|580616716|FG000|Overall Study|Miscellaneous|6|||
160789593|NCT01887600|580616717|FG001|Overall Study|Miscellaneous|2|||
160789594|NCT01887600|580616716|FG000|Overall Study|Progressive Disease|1|||
160789595|NCT01887600|580616717|FG001|Overall Study|Progressive Disease|0|||
160789596|NCT03688139|580616718|FG000|Overall Study|Lost to Follow-up|2|||
160789597|NCT03688139|580616719|FG001|Overall Study|Lost to Follow-up|0|||
160892024|NCT00591266|581000489|FG001|Overall Study|Lack of Efficacy|2|||
160892025|NCT00591266|581000490|FG002|Overall Study|Lack of Efficacy|0|||
160892026|NCT00591266|581000488|FG000|Overall Study|Other|1|||
160892027|NCT00591266|581000489|FG001|Overall Study|Other|4|||
160789598|NCT03688139|580616718|FG000|Overall Study|Physician Decision|0|||
160892028|NCT00591266|581000490|FG002|Overall Study|Other|5|||
160892029|NCT03488927|581000491|FG000|Overall Study|Withdrawal by Subject|44|||
160789599|NCT03688139|580616719|FG001|Overall Study|Physician Decision|1|||
160789600|NCT03688139|580616718|FG000|Overall Study|Withdrawal by Subject|2|||
160789601|NCT03688139|580616719|FG001|Overall Study|Withdrawal by Subject|3|||
160892030|NCT03488927|581000492|FG001|Overall Study|Withdrawal by Subject|118|||
160892031|NCT03488927|581000493|FG002|Overall Study|Withdrawal by Subject|217|||
160789602|NCT01185366|580616725|FG000|First Line Therapy|Insurance Coverage Denied|1|||
160981893|NCT01024751|581321792|FG001|Enrolled Participants|Ineligible at baseline|4|||
160789603|NCT01185366|580616726|FG001|First Line Therapy|Insurance Coverage Denied|1|||
160789604|NCT01185366|580616725|FG000|First Line Therapy|Withdrawal by Subject|1|||
160789605|NCT01185366|580616726|FG001|First Line Therapy|Withdrawal by Subject|0|||
160789606|NCT01185366|580616725|FG000|First Line Therapy|Lack of Metastatic Site|1|||
160789607|NCT01185366|580616726|FG001|First Line Therapy|Lack of Metastatic Site|0|||
160789608|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
160789609|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
160789610|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
160892032|NCT05080660|581000494|FG000|Overall Study|Adverse Event|4|||
160892033|NCT05080660|581000495|FG001|Overall Study|Adverse Event|0|||
161128067|NCT03434379|581855288|FG001|Global Period|Reason Unspecified|1|||
161128068|NCT03434379|581855289|FG002|Global Period|Reason Unspecified|0|||
160789611|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
160789612|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
160789613|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
160789614|NCT01185366|580616725|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
160789615|NCT01185366|580616726|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
160789616|NCT00127933|580616727|FG000|Overall Study|Randomized but not dosed|1|||
160789617|NCT00127933|580616728|FG001|Overall Study|Randomized but not dosed|0|||
160789618|NCT00498485|580616729|FG000|Overall Study|Adverse Event|1|||
160789619|NCT00498485|580616730|FG001|Overall Study|Adverse Event|5|||
160789620|NCT03072875|580616731|FG000|Overall Study|Lost to Follow-up|1|||
160789621|NCT03111732|580616735|FG000|Overall Study|Enrolled in different study|1|||
160789622|NCT03111732|580616735|FG000|Overall Study|Progressive disease|3|||
160789623|NCT03111732|580616735|FG000|Overall Study|Withdrawal by Subject|1|||
160789624|NCT00452400|580616736|FG000|Overall Study|Adverse Event|1|||
160789625|NCT00452400|580616737|FG001|Overall Study|Adverse Event|1|||
160789626|NCT00452400|580616738|FG002|Overall Study|Adverse Event|5|||
160789627|NCT00452400|580616739|FG003|Overall Study|Adverse Event|0|||
160789628|NCT00452400|580616740|FG004|Overall Study|Adverse Event|2|||
160789629|NCT00452400|580616736|FG000|Overall Study|Protocol Violation|0|||
160789630|NCT00452400|580616737|FG001|Overall Study|Protocol Violation|0|||
160789631|NCT00452400|580616738|FG002|Overall Study|Protocol Violation|1|||
160789632|NCT00452400|580616739|FG003|Overall Study|Protocol Violation|0|||
160789633|NCT00452400|580616740|FG004|Overall Study|Protocol Violation|0|||
160789634|NCT00452400|580616736|FG000|Overall Study|Lost to Follow-up|1|||
160789635|NCT00452400|580616737|FG001|Overall Study|Lost to Follow-up|0|||
160789636|NCT00452400|580616738|FG002|Overall Study|Lost to Follow-up|0|||
160789637|NCT00452400|580616739|FG003|Overall Study|Lost to Follow-up|0|||
160789638|NCT00452400|580616740|FG004|Overall Study|Lost to Follow-up|0|||
160789639|NCT00452400|580616736|FG000|Overall Study|Withdrawal by Subject|1|||
160789640|NCT00452400|580616737|FG001|Overall Study|Withdrawal by Subject|0|||
160789641|NCT00452400|580616738|FG002|Overall Study|Withdrawal by Subject|1|||
160789642|NCT00452400|580616739|FG003|Overall Study|Withdrawal by Subject|0|||
160789643|NCT00452400|580616740|FG004|Overall Study|Withdrawal by Subject|0|||
160789644|NCT00452400|580616736|FG000|Overall Study|Lack of Efficacy|2|||
160789645|NCT00452400|580616737|FG001|Overall Study|Lack of Efficacy|0|||
160789646|NCT00452400|580616738|FG002|Overall Study|Lack of Efficacy|0|||
160789647|NCT00452400|580616739|FG003|Overall Study|Lack of Efficacy|0|||
160789648|NCT00452400|580616740|FG004|Overall Study|Lack of Efficacy|0|||
160789649|NCT00452400|580616736|FG000|Overall Study|Other reasons not listed above|0|||
160789650|NCT00452400|580616737|FG001|Overall Study|Other reasons not listed above|0|||
160789651|NCT00452400|580616738|FG002|Overall Study|Other reasons not listed above|0|||
160789652|NCT00452400|580616739|FG003|Overall Study|Other reasons not listed above|1|||
160789653|NCT00452400|580616740|FG004|Overall Study|Other reasons not listed above|1|||
160789654|NCT01943825|580616743|FG000|Overall Study|Lost to Follow-up|9|||
160789655|NCT01943825|580616744|FG001|Overall Study|Lost to Follow-up|3|||
160789656|NCT01943825|580616745|FG002|Overall Study|Lost to Follow-up|12|||
160789657|NCT01943825|580616746|FG003|Overall Study|Lost to Follow-up|8|||
160789658|NCT01943825|580616743|FG000|Overall Study|Withdrawal by Subject|1|||
160789659|NCT01943825|580616744|FG001|Overall Study|Withdrawal by Subject|0|||
160789660|NCT01943825|580616745|FG002|Overall Study|Withdrawal by Subject|3|||
160789661|NCT01943825|580616746|FG003|Overall Study|Withdrawal by Subject|2|||
160892034|NCT05080660|581000494|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
160892035|NCT05080660|581000495|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
160892036|NCT05080660|581000494|FG000|Overall Study|Physician Decision|1|||
160892037|NCT05080660|581000495|FG001|Overall Study|Physician Decision|0|||
160892038|NCT05080660|581000494|FG000|Overall Study|Protocol Deviation|2|||
160892039|NCT05080660|581000495|FG001|Overall Study|Protocol Deviation|0|||
160892040|NCT05080660|581000494|FG000|Overall Study|Withdrawal by Subject|5|||
160892041|NCT05080660|581000495|FG001|Overall Study|Withdrawal by Subject|2|||
160892042|NCT03497676|581000496|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
160892043|NCT03497676|581000497|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
160892044|NCT03497676|581000498|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
160892045|NCT03497676|581000499|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
160892046|NCT03497676|581000496|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
160981894|NCT01024751|581321791|FG000|Eligible Participants|Withdrawal by Subject|0|||
161128069|NCT03434379|581855290|FG003|Global Period|Reason Unspecified|0|||
160892047|NCT03497676|581000497|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
160981895|NCT01024751|581321792|FG001|Eligible Participants|Withdrawal by Subject|1|||
160789662|NCT01943825|580616743|FG000|Overall Study|Other than specified above|0|||
160789663|NCT01943825|580616744|FG001|Overall Study|Other than specified above|1|||
160789664|NCT01943825|580616745|FG002|Overall Study|Other than specified above|0|||
160789665|NCT01943825|580616746|FG003|Overall Study|Other than specified above|1|||
160789666|NCT01472835|580616749|FG000|Overall Study|Lost to Follow-up|2|||
160789667|NCT01472835|580616750|FG001|Overall Study|Lost to Follow-up|0|||
160789668|NCT02539394|580616751|FG000|Overall Study|Protocol Violation|1|||
160789669|NCT02539394|580616752|FG001|Overall Study|Protocol Violation|3|||
160789670|NCT02539394|580616751|FG000|Overall Study|Lost to Follow-up|1|||
160789671|NCT02539394|580616752|FG001|Overall Study|Lost to Follow-up|2|||
160789672|NCT02539394|580616751|FG000|Overall Study|Incomplete dataset|6|||
160789673|NCT02539394|580616752|FG001|Overall Study|Incomplete dataset|6|||
160789674|NCT01316900|580616771|FG000|Overall Study|Adverse Event|10|||
160789675|NCT01316900|580616772|FG001|Overall Study|Adverse Event|10|||
160789676|NCT01316900|580616773|FG002|Overall Study|Adverse Event|15|||
160789677|NCT01316900|580616774|FG003|Overall Study|Adverse Event|9|||
160789678|NCT01316900|580616771|FG000|Overall Study|Lack of Efficacy|17|||
160789679|NCT01316900|580616772|FG001|Overall Study|Lack of Efficacy|9|||
160789680|NCT01316900|580616773|FG002|Overall Study|Lack of Efficacy|5|||
160789681|NCT01316900|580616774|FG003|Overall Study|Lack of Efficacy|7|||
160789682|NCT01316900|580616771|FG000|Overall Study|Protocol Violation|7|||
160789683|NCT01316900|580616772|FG001|Overall Study|Protocol Violation|1|||
160789684|NCT01316900|580616773|FG002|Overall Study|Protocol Violation|4|||
160789685|NCT01316900|580616774|FG003|Overall Study|Protocol Violation|0|||
160789686|NCT01316900|580616771|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
160789687|NCT01316900|580616772|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
160789688|NCT01316900|580616773|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
160789689|NCT01316900|580616774|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
160789690|NCT01316900|580616771|FG000|Overall Study|Lost to Follow-up|1|||
160789691|NCT01316900|580616772|FG001|Overall Study|Lost to Follow-up|0|||
160789692|NCT01316900|580616773|FG002|Overall Study|Lost to Follow-up|1|||
160789693|NCT01316900|580616774|FG003|Overall Study|Lost to Follow-up|1|||
160789694|NCT01316900|580616771|FG000|Overall Study|Withdrawal by Subject|7|||
160789695|NCT01316900|580616772|FG001|Overall Study|Withdrawal by Subject|8|||
160789696|NCT01316900|580616773|FG002|Overall Study|Withdrawal by Subject|6|||
160789697|NCT01316900|580616774|FG003|Overall Study|Withdrawal by Subject|9|||
160789698|NCT01684033|580616775|FG000|Period 1, First 30 Days|Adverse Event|1|||
160789699|NCT01684033|580616776|FG001|Period 1, First 30 Days|Adverse Event|1|||
160789700|NCT01684033|580616775|FG000|Period 1, First 30 Days|Noncompliance|1|||
160789701|NCT01684033|580616776|FG001|Period 1, First 30 Days|Noncompliance|0|||
160789702|NCT01684033|580616775|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
160789703|NCT01684033|580616776|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
160789704|NCT01684033|580616775|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
160789705|NCT01684033|580616776|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
160789706|NCT01684033|580616775|FG000|Period 2, Second 30 Days|Adverse Event|1|||
160789707|NCT01684033|580616776|FG001|Period 2, Second 30 Days|Adverse Event|0|||
160789708|NCT05346640|580616777|FG000|Overall Study|Lack of Efficacy|2|||
160789709|NCT05346640|580616777|FG000|Overall Study|Lost to Follow-up|14|||
160789710|NCT05346640|580616777|FG000|Overall Study|Protocol Violation|4|||
160789711|NCT05346640|580616777|FG000|Overall Study|Withdrawal by Subject|2|||
160789712|NCT05346640|580616777|FG000|Overall Study|Physiological Complications|3|||
160789713|NCT05346640|580616777|FG000|Overall Study|Other Reason|3|||
160789714|NCT02496156|580616778|FG000|Overall Study|Lost to Follow-up|5|||
160789715|NCT02496156|580616779|FG001|Overall Study|Lost to Follow-up|0|||
160789716|NCT02496156|580616778|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
160789717|NCT02496156|580616779|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
160789718|NCT03449147|580616780|FG000|52-week Treatment Period|Death|0|||
160789719|NCT03449147|580616781|FG001|52-week Treatment Period|Death|1|||
160789720|NCT03449147|580616782|FG002|52-week Treatment Period|Death|0|||
160789721|NCT03449147|580616780|FG000|52-week Treatment Period|Lost to Follow-up|6|||
160789722|NCT03449147|580616781|FG001|52-week Treatment Period|Lost to Follow-up|2|||
160789723|NCT03449147|580616782|FG002|52-week Treatment Period|Lost to Follow-up|5|||
160789724|NCT03449147|580616780|FG000|52-week Treatment Period|Other|0|||
160789725|NCT03449147|580616781|FG001|52-week Treatment Period|Other|1|||
160789726|NCT03449147|580616782|FG002|52-week Treatment Period|Other|2|||
160789727|NCT03449147|580616780|FG000|52-week Treatment Period|Physician Decision|1|||
160789728|NCT03449147|580616781|FG001|52-week Treatment Period|Physician Decision|0|||
160789729|NCT03449147|580616782|FG002|52-week Treatment Period|Physician Decision|3|||
160789730|NCT03449147|580616780|FG000|52-week Treatment Period|Screen Failure|1|||
160789731|NCT03449147|580616781|FG001|52-week Treatment Period|Screen Failure|2|||
160789732|NCT03449147|580616782|FG002|52-week Treatment Period|Screen Failure|0|||
160789733|NCT03449147|580616780|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
160789734|NCT03449147|580616781|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
160789735|NCT03449147|580616782|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
160789736|NCT03449147|580616780|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
160789737|NCT03449147|580616781|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
160789738|NCT03449147|580616782|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
160789739|NCT03449147|580616780|FG000|12-Week Off-Treatment Durability Period|Other|0|||
160789740|NCT03449147|580616781|FG001|12-Week Off-Treatment Durability Period|Other|1|||
160789741|NCT03449147|580616782|FG002|12-Week Off-Treatment Durability Period|Other|0|||
160789742|NCT00954538|580616784|FG000|Part III|Withdrawal by Subject|0|||
160789743|NCT00954538|580616785|FG001|Part III|Withdrawal by Subject|0|||
160789744|NCT00954538|580616786|FG002|Part III|Withdrawal by Subject|0|||
160789745|NCT00954538|580616787|FG003|Part III|Withdrawal by Subject|0|||
160789746|NCT00954538|580616788|FG004|Part III|Withdrawal by Subject|1|||
160789747|NCT00954538|580616789|FG005|Part III|Withdrawal by Subject|0|||
160789748|NCT01905683|580616790|FG000|Overall Study|Protocol Violation|1|||
160789749|NCT01905683|580616790|FG000|Overall Study|Re-injection criteria not met; others|13|||
160789750|NCT01905683|580616790|FG000|Overall Study|Physician Decision|1|||
160789751|NCT01905683|580616790|FG000|Overall Study|Lack of Efficacy|8|||
160789752|NCT01905683|580616790|FG000|Overall Study|Withdrawal by Subject|20|||
160789753|NCT01905683|580616790|FG000|Overall Study|Adverse Event|4|||
160789754|NCT01905683|580616790|FG000|Overall Study|Lost to Follow-up|4|||
160789755|NCT02037984|580616793|FG000|Overall Study|Lack of Efficacy|0|||
160789756|NCT02037984|580616794|FG001|Overall Study|Lack of Efficacy|0|||
160789757|NCT02037984|580616795|FG002|Overall Study|Lack of Efficacy|3|||
160789758|NCT02037984|580616796|FG003|Overall Study|Lack of Efficacy|10|||
160789759|NCT02037984|580616797|FG004|Overall Study|Lack of Efficacy|2|||
160789760|NCT02037984|580616798|FG005|Overall Study|Lack of Efficacy|2|||
160789761|NCT02037984|580616799|FG006|Overall Study|Lack of Efficacy|4|||
160789762|NCT02037984|580616800|FG007|Overall Study|Lack of Efficacy|3|||
160789763|NCT02037984|580616793|FG000|Overall Study|Lost to Follow-up|1|||
160789764|NCT02037984|580616794|FG001|Overall Study|Lost to Follow-up|0|||
160789765|NCT02037984|580616795|FG002|Overall Study|Lost to Follow-up|3|||
160789766|NCT02037984|580616796|FG003|Overall Study|Lost to Follow-up|5|||
160789767|NCT02037984|580616797|FG004|Overall Study|Lost to Follow-up|2|||
160789768|NCT02037984|580616798|FG005|Overall Study|Lost to Follow-up|2|||
160789769|NCT02037984|580616799|FG006|Overall Study|Lost to Follow-up|2|||
160789770|NCT02037984|580616800|FG007|Overall Study|Lost to Follow-up|4|||
160789771|NCT02037984|580616793|FG000|Overall Study|Physician Decision|0|||
160789772|NCT02037984|580616794|FG001|Overall Study|Physician Decision|0|||
160789773|NCT02037984|580616795|FG002|Overall Study|Physician Decision|0|||
160789774|NCT02037984|580616796|FG003|Overall Study|Physician Decision|0|||
160789775|NCT02037984|580616797|FG004|Overall Study|Physician Decision|0|||
160789776|NCT02037984|580616798|FG005|Overall Study|Physician Decision|0|||
160789777|NCT02037984|580616799|FG006|Overall Study|Physician Decision|1|||
160789778|NCT02037984|580616800|FG007|Overall Study|Physician Decision|0|||
160789779|NCT02037984|580616793|FG000|Overall Study|Protocol Violation|0|||
160789780|NCT02037984|580616794|FG001|Overall Study|Protocol Violation|0|||
160789781|NCT02037984|580616795|FG002|Overall Study|Protocol Violation|0|||
160789782|NCT02037984|580616796|FG003|Overall Study|Protocol Violation|0|||
160789783|NCT02037984|580616797|FG004|Overall Study|Protocol Violation|0|||
160789784|NCT02037984|580616798|FG005|Overall Study|Protocol Violation|1|||
160789785|NCT02037984|580616799|FG006|Overall Study|Protocol Violation|2|||
160789786|NCT02037984|580616800|FG007|Overall Study|Protocol Violation|0|||
160789787|NCT02037984|580616793|FG000|Overall Study|Technical Problems|0|||
160789788|NCT02037984|580616794|FG001|Overall Study|Technical Problems|0|||
160789789|NCT02037984|580616795|FG002|Overall Study|Technical Problems|3|||
160789790|NCT02037984|580616796|FG003|Overall Study|Technical Problems|3|||
160789791|NCT02037984|580616797|FG004|Overall Study|Technical Problems|2|||
160789792|NCT02037984|580616798|FG005|Overall Study|Technical Problems|3|||
160789793|NCT02037984|580616799|FG006|Overall Study|Technical Problems|4|||
160789794|NCT02037984|580616800|FG007|Overall Study|Technical Problems|2|||
160789795|NCT02037984|580616793|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160789796|NCT02037984|580616794|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160789797|NCT02037984|580616795|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
160789798|NCT02037984|580616796|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
160789799|NCT02037984|580616797|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
160789800|NCT02037984|580616798|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
160789801|NCT02037984|580616799|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
160789802|NCT02037984|580616800|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
160789803|NCT02037984|580616793|FG000|Overall Study|Withdrawal by Subject|0|||
160789804|NCT02037984|580616794|FG001|Overall Study|Withdrawal by Subject|0|||
160789805|NCT02037984|580616795|FG002|Overall Study|Withdrawal by Subject|0|||
160789806|NCT02037984|580616796|FG003|Overall Study|Withdrawal by Subject|1|||
160789807|NCT02037984|580616797|FG004|Overall Study|Withdrawal by Subject|1|||
160789808|NCT02037984|580616798|FG005|Overall Study|Withdrawal by Subject|3|||
160789809|NCT02037984|580616799|FG006|Overall Study|Withdrawal by Subject|0|||
160789810|NCT02037984|580616800|FG007|Overall Study|Withdrawal by Subject|1|||
160789811|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Death|2|||
160789812|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
160789813|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
160789814|NCT00974233|580616804|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
160789815|NCT00974233|580616804|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
160789816|NCT00974233|580616804|FG000|Maintenance Lenalidomide|Adverse Event|8|||
160789817|NCT01691092|580616805|FG000|Overall Study|Lost to Follow-up|10|||
160789818|NCT01691092|580616805|FG000|Overall Study|Physician Decision|4|||
160789819|NCT01691092|580616805|FG000|Overall Study|Withdrawal by Subject|3|||
160789820|NCT01691092|580616805|FG000|Overall Study|non-compliance|3|||
160789821|NCT01691092|580616805|FG000|Overall Study|used for different study|2|||
160789822|NCT01691092|580616805|FG000|Overall Study|screen fail|19|||
160789823|NCT01657942|580616806|FG000|Overall Study|Alternative Treatment|7|||
160789824|NCT01657942|580616806|FG000|Overall Study|Lost to Follow-up|1|||
160789825|NCT01633112|580618429|FG000|Overall Study|Lack of Efficacy|1|||
160789826|NCT01633112|580618430|FG001|Overall Study|Lack of Efficacy|6|||
160789827|NCT01633112|580618431|FG002|Overall Study|Lack of Efficacy|13|||
160789828|NCT01633112|580618429|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160789829|NCT01633112|580618430|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160789830|NCT01633112|580618431|FG002|Overall Study|Abnormal laboratory value(s)|0|||
160789831|NCT01633112|580618429|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160789832|NCT01633112|580618430|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160789833|NCT01633112|580618431|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160789834|NCT01633112|580618429|FG000|Overall Study|Administrative problems|1|||
160789835|NCT01633112|580618430|FG001|Overall Study|Administrative problems|2|||
160789836|NCT01633112|580618431|FG002|Overall Study|Administrative problems|5|||
160789837|NCT01633112|580618429|FG000|Overall Study|Adverse Event|16|||
160789838|NCT01633112|580618430|FG001|Overall Study|Adverse Event|18|||
160789839|NCT01633112|580618431|FG002|Overall Study|Adverse Event|20|||
160789840|NCT01633112|580618429|FG000|Overall Study|Lost to Follow-up|7|||
160789841|NCT01633112|580618430|FG001|Overall Study|Lost to Follow-up|19|||
160789842|NCT01633112|580618431|FG002|Overall Study|Lost to Follow-up|6|||
160789843|NCT01633112|580618429|FG000|Overall Study|Protocol Violation|4|||
160789844|NCT01633112|580618430|FG001|Overall Study|Protocol Violation|0|||
160789845|NCT01633112|580618431|FG002|Overall Study|Protocol Violation|2|||
160789846|NCT01633112|580618429|FG000|Overall Study|Subject no longer requires study drug|0|||
160789847|NCT01633112|580618430|FG001|Overall Study|Subject no longer requires study drug|0|||
160789848|NCT01633112|580618431|FG002|Overall Study|Subject no longer requires study drug|1|||
160789849|NCT01633112|580618429|FG000|Overall Study|Withdrawal by Subject|20|||
160789850|NCT01633112|580618430|FG001|Overall Study|Withdrawal by Subject|12|||
160789851|NCT01633112|580618431|FG002|Overall Study|Withdrawal by Subject|41|||
160789852|NCT01633112|580618429|FG000|Overall Study|missing Study Completion CRF|1|||
160789853|NCT01633112|580618430|FG001|Overall Study|missing Study Completion CRF|1|||
160789854|NCT01633112|580618431|FG002|Overall Study|missing Study Completion CRF|4|||
160789855|NCT00889005|580618442|FG000|Overall Study|Lost to Follow-up|4|||
160789856|NCT00889005|580618443|FG001|Overall Study|Lost to Follow-up|2|||
160789857|NCT00889005|580618442|FG000|Overall Study|Withdrawal by Subject|4|||
160789858|NCT00889005|580618443|FG001|Overall Study|Withdrawal by Subject|0|||
160789859|NCT01998477|580618444|FG000|Overall Study|Lost to Follow-up|4|||
160789860|NCT01998477|580618445|FG001|Overall Study|Lost to Follow-up|5|||
160789861|NCT01998477|580618444|FG000|Overall Study|Withdrawal by Subject|6|||
160789862|NCT01998477|580618445|FG001|Overall Study|Withdrawal by Subject|0|||
160789863|NCT00129974|580618446|FG000|Overall Study|Other|1|||
160789864|NCT00160563|580618447|FG000|Overall Study|Adverse Event|1|||
160789865|NCT00160563|580618448|FG001|Overall Study|Adverse Event|1|||
160789866|NCT00160563|580618449|FG002|Overall Study|Adverse Event|1|||
160789867|NCT00160563|580618447|FG000|Overall Study|Lost to Follow-up|1|||
160789868|NCT00160563|580618448|FG001|Overall Study|Lost to Follow-up|1|||
160789869|NCT00160563|580618449|FG002|Overall Study|Lost to Follow-up|2|||
160789870|NCT00160563|580618447|FG000|Overall Study|Protocol Violation|0|||
160789871|NCT00160563|580618448|FG001|Overall Study|Protocol Violation|0|||
160789872|NCT00160563|580618449|FG002|Overall Study|Protocol Violation|3|||
160789873|NCT00160563|580618447|FG000|Overall Study|Withdrawal by Subject|1|||
160789874|NCT00160563|580618448|FG001|Overall Study|Withdrawal by Subject|2|||
160789875|NCT00160563|580618449|FG002|Overall Study|Withdrawal by Subject|3|||
160789876|NCT00160563|580618447|FG000|Overall Study|Other (listed in the study report)|48|||
160789877|NCT00160563|580618448|FG001|Overall Study|Other (listed in the study report)|40|||
160789878|NCT00160563|580618449|FG002|Overall Study|Other (listed in the study report)|81|||
160789879|NCT00160563|580618447|FG000|Overall Study|Missing reason|0|||
160789880|NCT00160563|580618448|FG001|Overall Study|Missing reason|1|||
160789881|NCT00160563|580618449|FG002|Overall Study|Missing reason|0|||
160789882|NCT00395447|580618455|FG000|Overall Study|Death|37|||
160789883|NCT00395447|580618456|FG001|Overall Study|Death|32|||
160789884|NCT00395447|580618455|FG000|Overall Study|Lost to Follow-up|52|||
160789885|NCT00395447|580618456|FG001|Overall Study|Lost to Follow-up|43|||
160892048|NCT03497676|581000498|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
160789886|NCT00395447|580618455|FG000|Overall Study|Withdrawal by Subject|24|||
160789887|NCT00395447|580618456|FG001|Overall Study|Withdrawal by Subject|19|||
161128070|NCT03434379|581855287|FG000|Global Period|Study Ended by Sponsor|26|||
160789888|NCT00395447|580618455|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
160789889|NCT00395447|580618456|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
160789890|NCT03766906|580618457|FG000|Overall Study|Withdrawal by Subject|6|||
160789891|NCT00836901|580618458|FG000|First Intervention|Withdrawal by Subject|1|||
161128071|NCT03434379|581855288|FG001|Global Period|Study Ended by Sponsor|80|||
160789892|NCT00836901|580618459|FG001|First Intervention|Withdrawal by Subject|0|||
160789893|NCT01148771|580618462|FG000|Washout Period|Withdrawal by Subject|0|||
160789894|NCT01148771|580618463|FG001|Washout Period|Withdrawal by Subject|1|||
160789895|NCT01437189|580618464|FG000|Overall Study|Adverse Event|3|||
160789896|NCT01437189|580618464|FG000|Overall Study|Lack of Efficacy|4|||
160789897|NCT01437189|580618464|FG000|Overall Study|Withdrawal by Subject|8|||
160789898|NCT00595075|580618467|FG000|Overall Study|Withdrawal by Subject|1|||
160789899|NCT00595075|580618468|FG001|Overall Study|Withdrawal by Subject|0|||
160789900|NCT05261490|580618470|FG000|Overall Study|Other|1|||
160789901|NCT05261490|580618471|FG001|Overall Study|Other|0|||
160789902|NCT05261490|580618472|FG002|Overall Study|Other|0|||
160789903|NCT05261490|580618470|FG000|Overall Study|Study Terminated by Sponsor|1|||
160789904|NCT05261490|580618471|FG001|Overall Study|Study Terminated by Sponsor|1|||
160789905|NCT05261490|580618472|FG002|Overall Study|Study Terminated by Sponsor|4|||
161128072|NCT03434379|581855289|FG002|Global Period|Study Ended by Sponsor|0|||
161128073|NCT03434379|581855290|FG003|Global Period|Study Ended by Sponsor|0|||
160789906|NCT05261490|580618470|FG000|Overall Study|Death|1|||
160789907|NCT05261490|580618471|FG001|Overall Study|Death|2|||
160789908|NCT05261490|580618472|FG002|Overall Study|Death|0|||
160789909|NCT00113373|580618474|FG000|Overall Study|Ineligible: wrong primary|1|||
160789910|NCT00113373|580618474|FG000|Overall Study|Ineligible: second primary|1|||
160789911|NCT00113373|580618474|FG000|Overall Study|Never Treated|1|||
160789912|NCT04629521|580618475|FG000|Overall Study|Death|1|||
160789913|NCT04629521|580618475|FG000|Overall Study|Lost to Follow-up|3|||
160789914|NCT04629521|580618475|FG000|Overall Study|Subject withdrew consent|3|||
160789915|NCT04629521|580618475|FG000|Overall Study|Enrolled in error|1|||
160789916|NCT03163667|580618476|FG000|Overall Study|Death|15|||
160789917|NCT03163667|580618477|FG001|Overall Study|Death|27|||
160789918|NCT03163667|580618476|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
160789919|NCT03163667|580618477|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
160789920|NCT01335685|580618480|FG000|Overall Study|Study Terminated by Sponsor|2|||
160789921|NCT01335685|580618481|FG001|Overall Study|Study Terminated by Sponsor|1|||
160789922|NCT01335685|580618482|FG002|Overall Study|Study Terminated by Sponsor|1|||
160789923|NCT01335685|580618483|FG003|Overall Study|Study Terminated by Sponsor|10|||
160789924|NCT01335685|580618484|FG004|Overall Study|Study Terminated by Sponsor|0|||
160789925|NCT01335685|580618485|FG005|Overall Study|Study Terminated by Sponsor|4|||
160789926|NCT01335685|580618486|FG006|Overall Study|Study Terminated by Sponsor|2|||
160789927|NCT01335685|580618487|FG007|Overall Study|Study Terminated by Sponsor|3|||
160789928|NCT01335685|580618480|FG000|Overall Study|Withdrawal by Subject|1|||
160789929|NCT01335685|580618481|FG001|Overall Study|Withdrawal by Subject|0|||
160789930|NCT01335685|580618482|FG002|Overall Study|Withdrawal by Subject|0|||
160789931|NCT01335685|580618483|FG003|Overall Study|Withdrawal by Subject|1|||
160789932|NCT01335685|580618484|FG004|Overall Study|Withdrawal by Subject|0|||
160789933|NCT01335685|580618485|FG005|Overall Study|Withdrawal by Subject|0|||
160789934|NCT01335685|580618486|FG006|Overall Study|Withdrawal by Subject|0|||
160789935|NCT01335685|580618487|FG007|Overall Study|Withdrawal by Subject|0|||
160789936|NCT01335685|580618480|FG000|Overall Study|Reason not Specified|0|||
160789937|NCT01335685|580618481|FG001|Overall Study|Reason not Specified|0|||
160789938|NCT01335685|580618482|FG002|Overall Study|Reason not Specified|1|||
160789939|NCT01335685|580618483|FG003|Overall Study|Reason not Specified|0|||
160789940|NCT01335685|580618484|FG004|Overall Study|Reason not Specified|0|||
160789941|NCT01335685|580618485|FG005|Overall Study|Reason not Specified|1|||
160789942|NCT01335685|580618486|FG006|Overall Study|Reason not Specified|0|||
160789943|NCT01335685|580618487|FG007|Overall Study|Reason not Specified|0|||
160789944|NCT02554474|580618490|FG000|Overall Study|Protocol Violation|1|||
160789945|NCT02554474|580618491|FG001|Overall Study|Protocol Violation|1|||
160789946|NCT02554474|580618490|FG000|Overall Study|Health issue not related to the study|1|||
160789947|NCT02554474|580618491|FG001|Overall Study|Health issue not related to the study|0|||
160789948|NCT02554474|580618490|FG000|Overall Study|Withdrawal by Subject|1|||
160789949|NCT02554474|580618491|FG001|Overall Study|Withdrawal by Subject|1|||
160789950|NCT03211832|580618492|FG000|Overall Study|No longer with agency|32|||
160789951|NCT03211832|580618493|FG001|Overall Study|No longer with agency|49|||
160789952|NCT03211832|580618494|FG002|Overall Study|No longer with agency|30|||
160789953|NCT03211832|580618492|FG000|Overall Study|Declined survey|3|||
160789954|NCT03211832|580618493|FG001|Overall Study|Declined survey|3|||
160789955|NCT03211832|580618494|FG002|Overall Study|Declined survey|2|||
160789956|NCT03211832|580618492|FG000|Overall Study|Not available during data collection|1|||
160789957|NCT03211832|580618493|FG001|Overall Study|Not available during data collection|0|||
160789958|NCT03211832|580618494|FG002|Overall Study|Not available during data collection|2|||
160789959|NCT00855166|580618495|FG000|Overall Study|Adverse Event|0|||
160789960|NCT00855166|580618496|FG001|Overall Study|Adverse Event|2|||
160789961|NCT00855166|580618495|FG000|Overall Study|Death|0|||
160789962|NCT00855166|580618496|FG001|Overall Study|Death|1|||
160789963|NCT00855166|580618495|FG000|Overall Study|Withdrawal by Subject|1|||
160789964|NCT00855166|580618496|FG001|Overall Study|Withdrawal by Subject|4|||
160892049|NCT03497676|581000499|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
161128074|NCT03434379|581855287|FG000|Global Period|Physician Decision|1|||
160789965|NCT00855166|580618495|FG000|Overall Study|Poor/non-compliance|2|||
160789966|NCT00855166|580618496|FG001|Overall Study|Poor/non-compliance|0|||
160789967|NCT00855166|580618495|FG000|Overall Study|Administrative reasons by sponsor|1|||
160789968|NCT00855166|580618496|FG001|Overall Study|Administrative reasons by sponsor|0|||
160789969|NCT00855166|580618495|FG000|Overall Study|Subject no longer meets study criteria|1|||
160789970|NCT00855166|580618496|FG001|Overall Study|Subject no longer meets study criteria|1|||
160789971|NCT03777020|580618500|FG000|Overall Study|Withdrawal by Subject|4|||
160789972|NCT03777020|580618501|FG001|Overall Study|Withdrawal by Subject|4|||
160789973|NCT03777020|580618500|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
160789974|NCT03777020|580618501|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
160789975|NCT00489476|580618502|FG000|Overall Study|Lost to Follow-up|0|||
160789976|NCT00489476|580618503|FG001|Overall Study|Lost to Follow-up|1|||
160789977|NCT00489476|580618504|FG002|Overall Study|Lost to Follow-up|0|||
160789978|NCT00489476|580618505|FG003|Overall Study|Lost to Follow-up|0|||
160789979|NCT03460704|580618506|FG000|Overall Study|Withdrawal by Subject|11|||
160789980|NCT03460704|580618507|FG001|Overall Study|Withdrawal by Subject|14|||
160789981|NCT03460704|580618506|FG000|Overall Study|Study terminated by the Sponsor|29|||
160789982|NCT03460704|580618507|FG001|Overall Study|Study terminated by the Sponsor|19|||
160789983|NCT03460704|580618506|FG000|Overall Study|Adverse Event|10|||
160789984|NCT03460704|580618507|FG001|Overall Study|Adverse Event|5|||
160789985|NCT03460704|580618506|FG000|Overall Study|Death|3|||
160789986|NCT03460704|580618507|FG001|Overall Study|Death|2|||
160789987|NCT03460704|580618506|FG000|Overall Study|Non-Compliance with Study Drug|3|||
160789988|NCT03460704|580618507|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160789989|NCT03460704|580618506|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160789990|NCT03460704|580618507|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
160789991|NCT03460704|580618506|FG000|Overall Study|Other|2|||
160789992|NCT03460704|580618507|FG001|Overall Study|Other|1|||
160789993|NCT02913326|580618508|FG000|Overall Study|Reason not listed|0|||
160789994|NCT02913326|580618509|FG001|Overall Study|Reason not listed|1|||
160789995|NCT02913326|580618508|FG000|Overall Study|Lost to Follow-up|0|||
160789996|NCT02913326|580618509|FG001|Overall Study|Lost to Follow-up|1|||
160789997|NCT02913326|580618508|FG000|Overall Study|Adverse Event|1|||
160789998|NCT02913326|580618509|FG001|Overall Study|Adverse Event|0|||
160789999|NCT01767857|580618510|FG000|Overall Study|Adverse Event|27|||
160790000|NCT01767857|580618511|FG001|Overall Study|Adverse Event|7|||
160790001|NCT01767857|580618510|FG000|Overall Study|Death|28|||
160790002|NCT01767857|580618511|FG001|Overall Study|Death|13|||
160790003|NCT01767857|580618510|FG000|Overall Study|Lack of Efficacy|299|||
160790004|NCT01767857|580618511|FG001|Overall Study|Lack of Efficacy|151|||
160790005|NCT01767857|580618510|FG000|Overall Study|Lost to Follow-up|1|||
160790006|NCT01767857|580618511|FG001|Overall Study|Lost to Follow-up|1|||
160790007|NCT01767857|580618510|FG000|Overall Study|Withdrawal by Subject|38|||
160790008|NCT01767857|580618511|FG001|Overall Study|Withdrawal by Subject|18|||
160790009|NCT01767857|580618510|FG000|Overall Study|Physician Decision|17|||
160790010|NCT01767857|580618511|FG001|Overall Study|Physician Decision|10|||
160790011|NCT01767857|580618510|FG000|Overall Study|Protocol Terminated|1|||
160790012|NCT01767857|580618511|FG001|Overall Study|Protocol Terminated|0|||
160790013|NCT01767857|580618510|FG000|Overall Study|Randomized But Never Treated|19|||
160790014|NCT01767857|580618511|FG001|Overall Study|Randomized But Never Treated|13|||
160790015|NCT01421459|580618512|FG000|Overall Study|Adverse Event|6|||
160790016|NCT01421459|580618513|FG001|Overall Study|Adverse Event|10|||
160790017|NCT01421459|580618512|FG000|Overall Study|Death|1|||
160790018|NCT01421459|580618513|FG001|Overall Study|Death|1|||
160790019|NCT01421459|580618512|FG000|Overall Study|Lack of Efficacy|1|||
160790020|NCT01421459|580618513|FG001|Overall Study|Lack of Efficacy|2|||
160790021|NCT01421459|580618512|FG000|Overall Study|Lost to Follow-up|8|||
160790022|NCT01421459|580618513|FG001|Overall Study|Lost to Follow-up|9|||
160790023|NCT01421459|580618512|FG000|Overall Study|Physician Decision|9|||
160790024|NCT01421459|580618513|FG001|Overall Study|Physician Decision|9|||
160790025|NCT01421459|580618512|FG000|Overall Study|Protocol Violation|8|||
160790026|NCT01421459|580618513|FG001|Overall Study|Protocol Violation|5|||
160790027|NCT01421459|580618512|FG000|Overall Study|Withdrawal by Subject|12|||
160790028|NCT01421459|580618513|FG001|Overall Study|Withdrawal by Subject|16|||
160790029|NCT01422382|580618514|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
160790030|NCT00967499|580618517|FG000|Overall Study|Adverse Event|0|||
160790031|NCT00967499|580618518|FG001|Overall Study|Adverse Event|1|||
160790032|NCT00967499|580618517|FG000|Overall Study|Protocol Violation|1|||
160790033|NCT00967499|580618518|FG001|Overall Study|Protocol Violation|0|||
160790034|NCT00967499|580618517|FG000|Overall Study|Sponsor Decision|1|||
160790035|NCT00967499|580618518|FG001|Overall Study|Sponsor Decision|0|||
160790036|NCT00967499|580618517|FG000|Overall Study|Randomized but not treated|63|||
160790037|NCT00967499|580618518|FG001|Overall Study|Randomized but not treated|59|||
160790038|NCT04003389|580618519|FG000|Overall Study|Adverse Event|27|||
160790039|NCT04003389|580618520|FG001|Overall Study|Adverse Event|34|||
160790040|NCT04003389|580618521|FG002|Overall Study|Adverse Event|28|||
160790041|NCT04003389|580618519|FG000|Overall Study|Lost to Follow-up|39|||
160790042|NCT04003389|580618520|FG001|Overall Study|Lost to Follow-up|30|||
160790043|NCT04003389|580618521|FG002|Overall Study|Lost to Follow-up|33|||
160790044|NCT04003389|580618519|FG000|Overall Study|Protocol Violation|1|||
160790045|NCT04003389|580618520|FG001|Overall Study|Protocol Violation|6|||
160790046|NCT04003389|580618521|FG002|Overall Study|Protocol Violation|5|||
160790047|NCT04003389|580618519|FG000|Overall Study|Withdrawal by Subject|119|||
160790048|NCT04003389|580618520|FG001|Overall Study|Withdrawal by Subject|79|||
160790049|NCT04003389|580618521|FG002|Overall Study|Withdrawal by Subject|85|||
160790050|NCT04003389|580618519|FG000|Overall Study|Miscellaneous|14|||
160790051|NCT04003389|580618520|FG001|Overall Study|Miscellaneous|11|||
160790052|NCT04003389|580618521|FG002|Overall Study|Miscellaneous|14|||
160790053|NCT04003389|580618519|FG000|Overall Study|Participant did not receive study drug|1|||
160790054|NCT04003389|580618520|FG001|Overall Study|Participant did not receive study drug|0|||
160790055|NCT04003389|580618521|FG002|Overall Study|Participant did not receive study drug|0|||
160790056|NCT02899754|580618522|FG000|Overall Study|Lost to Follow-up|7|||
160790057|NCT02899754|580618523|FG001|Overall Study|Lost to Follow-up|9|||
160790058|NCT04818229|580618524|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
160790059|NCT04818229|580618525|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
160790060|NCT04818229|580618526|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
160790061|NCT04818229|580618524|FG000|Overall Study|Adverse Event|3|||
160790062|NCT04818229|580618525|FG001|Overall Study|Adverse Event|1|||
160790063|NCT04818229|580618526|FG002|Overall Study|Adverse Event|1|||
160790064|NCT04818229|580618524|FG000|Overall Study|Withdrawal by Subject|0|||
160790065|NCT04818229|580618525|FG001|Overall Study|Withdrawal by Subject|0|||
160790066|NCT04818229|580618526|FG002|Overall Study|Withdrawal by Subject|2|||
160790067|NCT04818229|580618524|FG000|Overall Study|Lost to Follow-up|0|||
160790068|NCT04818229|580618525|FG001|Overall Study|Lost to Follow-up|0|||
160790069|NCT04818229|580618526|FG002|Overall Study|Lost to Follow-up|1|||
160790070|NCT04082364|580618527|FG000|Overall Study|Death|23|||
160790071|NCT04082364|580618528|FG001|Overall Study|Death|1|||
160790072|NCT04082364|580618529|FG002|Overall Study|Death|1|||
160790073|NCT04082364|580618530|FG003|Overall Study|Death|2|||
160790074|NCT04082364|580618531|FG004|Overall Study|Death|1|||
160790075|NCT04082364|580618527|FG000|Overall Study|Lost to Follow-up|1|||
160790076|NCT04082364|580618528|FG001|Overall Study|Lost to Follow-up|0|||
160790077|NCT04082364|580618529|FG002|Overall Study|Lost to Follow-up|0|||
160790078|NCT04082364|580618530|FG003|Overall Study|Lost to Follow-up|0|||
160790079|NCT04082364|580618531|FG004|Overall Study|Lost to Follow-up|1|||
160790080|NCT04082364|580618527|FG000|Overall Study|Physician Decision|1|||
160790081|NCT04082364|580618528|FG001|Overall Study|Physician Decision|1|||
160790082|NCT04082364|580618529|FG002|Overall Study|Physician Decision|0|||
160790083|NCT04082364|580618530|FG003|Overall Study|Physician Decision|2|||
160790084|NCT04082364|580618531|FG004|Overall Study|Physician Decision|1|||
160790085|NCT04082364|580618527|FG000|Overall Study|Withdrawal by Subject|1|||
160790086|NCT04082364|580618528|FG001|Overall Study|Withdrawal by Subject|1|||
160790087|NCT04082364|580618529|FG002|Overall Study|Withdrawal by Subject|0|||
160790088|NCT04082364|580618530|FG003|Overall Study|Withdrawal by Subject|0|||
160790089|NCT04082364|580618531|FG004|Overall Study|Withdrawal by Subject|1|||
160790090|NCT04082364|580618527|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
160790091|NCT04082364|580618528|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
160790092|NCT04082364|580618529|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
160790093|NCT04082364|580618530|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
160790094|NCT04082364|580618531|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
160790095|NCT04082364|580618527|FG000|Overall Study|Disease progression|0|||
160790096|NCT04082364|580618528|FG001|Overall Study|Disease progression|0|||
160790097|NCT04082364|580618529|FG002|Overall Study|Disease progression|0|||
160790098|NCT04082364|580618530|FG003|Overall Study|Disease progression|1|||
160790099|NCT04082364|580618531|FG004|Overall Study|Disease progression|0|||
160790100|NCT03186378|580618534|FG000|Overall Study|Lost to Follow-up|1|||
160790101|NCT03186378|580618535|FG001|Overall Study|Lost to Follow-up|0|||
160790102|NCT03769116|580618538|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
160790103|NCT03769116|580618539|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
160790104|NCT03769116|580618538|FG000|Part 3 - Open Label|Physician Decision|1|||
160790105|NCT03769116|580618539|FG001|Part 3 - Open Label|Physician Decision|0|||
160790106|NCT03769116|580618538|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
160790107|NCT03769116|580618539|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
160790108|NCT02514746|580618541|FG000|Overall Study|Chronically Ill|1|||
160790109|NCT02514746|580618542|FG001|Overall Study|Chronically Ill|2|||
160790110|NCT02514746|580618541|FG000|Overall Study|Physician Decision|4|||
160892050|NCT03497676|581000496|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
160790111|NCT02514746|580618542|FG001|Overall Study|Physician Decision|2|||
160790112|NCT02514746|580618541|FG000|Overall Study|Withdrawal by Subject|12|||
160790113|NCT02514746|580618542|FG001|Overall Study|Withdrawal by Subject|10|||
160790114|NCT02514746|580618541|FG000|Overall Study|Other|5|||
160790115|NCT02514746|580618542|FG001|Overall Study|Other|1|||
160790116|NCT03382873|580618547|FG000|Overall Study|Lost to Follow-up|9|||
160790117|NCT03382873|580618548|FG001|Overall Study|Lost to Follow-up|10|||
160790118|NCT03382873|580618547|FG000|Overall Study|Withdrawal by Subject|6|||
160892051|NCT03497676|581000497|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
161128075|NCT03434379|581855288|FG001|Global Period|Physician Decision|0|||
160790119|NCT03382873|580618548|FG001|Overall Study|Withdrawal by Subject|11|||
160790120|NCT03382873|580618547|FG000|Overall Study|Visit not completed due to pandemic|16|||
160790121|NCT03382873|580618548|FG001|Overall Study|Visit not completed due to pandemic|41|||
160790122|NCT03247673|580618549|FG000|Overall Study|Withdrawal by Subject|1|||
160790123|NCT03247673|580618550|FG001|Overall Study|Withdrawal by Subject|0|||
160790124|NCT03247673|580618551|FG002|Overall Study|Withdrawal by Subject|3|||
160790125|NCT03247673|580618549|FG000|Overall Study|Lost to Follow-up|0|||
160790126|NCT03247673|580618550|FG001|Overall Study|Lost to Follow-up|0|||
160790127|NCT03247673|580618551|FG002|Overall Study|Lost to Follow-up|1|||
160790128|NCT04755231|580618554|FG000|Overall Study|Lost to Follow-up|5|||
160790129|NCT04755231|580618554|FG000|Overall Study|Withdrawal by Subject|5|||
160790130|NCT04754399|580618555|FG000|Overall Study|Adverse Event|5|||
160790131|NCT04754399|580618555|FG000|Overall Study|Withdrawal by Subject|6|||
160790132|NCT00962650|580618556|FG000|Overall Study|Transgastric DP was not completed|2|||
160790133|NCT00231465|580618557|FG000|Overall Study|Completed only one cycle|1|||
160790134|NCT00231465|580618557|FG000|Overall Study|Did not have follow up CT scans|1|||
160790135|NCT00420056|580618558|FG000|Overall Study|Objective progression or relapse|17|||
160790136|NCT03624036|580618561|FG000|Overall Study|Death|2|||
160790137|NCT03624036|580618562|FG001|Overall Study|Death|3|||
160790138|NCT03624036|580618563|FG002|Overall Study|Death|0|||
160790139|NCT03624036|580618564|FG003|Overall Study|Death|1|||
160790140|NCT03624036|580618561|FG000|Overall Study|Withdrawal by Subject|1|||
160790141|NCT03624036|580618562|FG001|Overall Study|Withdrawal by Subject|0|||
160790142|NCT03624036|580618563|FG002|Overall Study|Withdrawal by Subject|1|||
160790143|NCT03624036|580618564|FG003|Overall Study|Withdrawal by Subject|0|||
160790144|NCT03624036|580618561|FG000|Overall Study|Enrolled but Never Treated|1|||
160790145|NCT03624036|580618562|FG001|Overall Study|Enrolled but Never Treated|0|||
160790146|NCT03624036|580618563|FG002|Overall Study|Enrolled but Never Treated|0|||
160790147|NCT03624036|580618564|FG003|Overall Study|Enrolled but Never Treated|0|||
160790148|NCT03624036|580618561|FG000|Overall Study|Reason not Specified|3|||
160790149|NCT03624036|580618562|FG001|Overall Study|Reason not Specified|0|||
160790150|NCT03624036|580618563|FG002|Overall Study|Reason not Specified|2|||
160790151|NCT03624036|580618564|FG003|Overall Study|Reason not Specified|2|||
160790152|NCT02268851|580618572|FG000|Overall Study|Death|0|||
160790153|NCT02268851|580618573|FG001|Overall Study|Death|0|||
160790154|NCT02268851|580618574|FG002|Overall Study|Death|0|||
160790155|NCT02268851|580618575|FG003|Overall Study|Death|1|||
160790156|NCT02268851|580618576|FG004|Overall Study|Death|2|||
160790157|NCT02268851|580618577|FG005|Overall Study|Death|1|||
160790158|NCT02268851|580618572|FG000|Overall Study|Adverse Event|0|||
160790159|NCT02268851|580618573|FG001|Overall Study|Adverse Event|0|||
160790160|NCT02268851|580618574|FG002|Overall Study|Adverse Event|0|||
160790161|NCT02268851|580618575|FG003|Overall Study|Adverse Event|0|||
160790162|NCT02268851|580618576|FG004|Overall Study|Adverse Event|2|||
160790163|NCT02268851|580618577|FG005|Overall Study|Adverse Event|2|||
160790164|NCT02268851|580618572|FG000|Overall Study|Withdrawal by Subject|0|||
160790165|NCT02268851|580618573|FG001|Overall Study|Withdrawal by Subject|0|||
160790166|NCT02268851|580618574|FG002|Overall Study|Withdrawal by Subject|0|||
160790167|NCT02268851|580618575|FG003|Overall Study|Withdrawal by Subject|2|||
160790168|NCT02268851|580618576|FG004|Overall Study|Withdrawal by Subject|0|||
160790169|NCT02268851|580618577|FG005|Overall Study|Withdrawal by Subject|1|||
160790170|NCT02268851|580618572|FG000|Overall Study|Progressive Disease|1|||
160790171|NCT02268851|580618573|FG001|Overall Study|Progressive Disease|3|||
160790172|NCT02268851|580618574|FG002|Overall Study|Progressive Disease|0|||
160790173|NCT02268851|580618575|FG003|Overall Study|Progressive Disease|0|||
160790174|NCT02268851|580618576|FG004|Overall Study|Progressive Disease|1|||
160790175|NCT02268851|580618577|FG005|Overall Study|Progressive Disease|4|||
160790176|NCT02268851|580618572|FG000|Overall Study|Physician Decision|0|||
160790177|NCT02268851|580618573|FG001|Overall Study|Physician Decision|0|||
160790178|NCT02268851|580618574|FG002|Overall Study|Physician Decision|1|||
160790179|NCT02268851|580618575|FG003|Overall Study|Physician Decision|0|||
160790180|NCT02268851|580618576|FG004|Overall Study|Physician Decision|0|||
160790181|NCT02268851|580618577|FG005|Overall Study|Physician Decision|1|||
160790182|NCT02268851|580618572|FG000|Overall Study|Patient Compliance|0|||
160790183|NCT02268851|580618573|FG001|Overall Study|Patient Compliance|0|||
160790184|NCT02268851|580618574|FG002|Overall Study|Patient Compliance|0|||
160790185|NCT02268851|580618575|FG003|Overall Study|Patient Compliance|0|||
160790186|NCT02268851|580618576|FG004|Overall Study|Patient Compliance|1|||
160790187|NCT02268851|580618577|FG005|Overall Study|Patient Compliance|1|||
160790188|NCT02268851|580618572|FG000|Overall Study|Co-Morbid Condition|0|||
160790189|NCT02268851|580618573|FG001|Overall Study|Co-Morbid Condition|0|||
160790190|NCT02268851|580618574|FG002|Overall Study|Co-Morbid Condition|0|||
160790191|NCT02268851|580618575|FG003|Overall Study|Co-Morbid Condition|0|||
160790192|NCT02268851|580618576|FG004|Overall Study|Co-Morbid Condition|1|||
160790193|NCT02268851|580618577|FG005|Overall Study|Co-Morbid Condition|1|||
160790194|NCT03425188|580618579|FG000|Overall Study|Withdrawal by Subject|1|||
160790195|NCT03726879|580618580|FG000|Overall Study|Death|11|||
160790196|NCT03726879|580618581|FG001|Overall Study|Death|13|||
160790197|NCT03726879|580618580|FG000|Overall Study|Physician Decision|0|||
160790198|NCT03726879|580618581|FG001|Overall Study|Physician Decision|2|||
160790199|NCT03726879|580618580|FG000|Overall Study|Protocol Violation|0|||
160790200|NCT03726879|580618581|FG001|Overall Study|Protocol Violation|1|||
160790201|NCT03726879|580618580|FG000|Overall Study|Withdrawal by Subject|5|||
160790202|NCT03726879|580618581|FG001|Overall Study|Withdrawal by Subject|6|||
160790203|NCT03726879|580618580|FG000|Overall Study|TSH result is unstable|0|||
160790204|NCT03726879|580618581|FG001|Overall Study|TSH result is unstable|1|||
160790205|NCT03726879|580618580|FG000|Overall Study|Disease relapse|1|||
160790206|NCT03726879|580618581|FG001|Overall Study|Disease relapse|0|||
160790207|NCT03726879|580618580|FG000|Overall Study|Lost to Follow-up|3|||
160790208|NCT03726879|580618581|FG001|Overall Study|Lost to Follow-up|0|||
161330195|NCT02782741|582594831|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
161330196|NCT02782741|582594832|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
161330197|NCT02782741|582594833|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
160790209|NCT00507507|580618583|FG000|Treatment Period|Lost to Follow-up|0|||
160790210|NCT00507507|580618584|FG001|Treatment Period|Lost to Follow-up|2|||
160790211|NCT00507507|580618583|FG000|Treatment Period|Physician Decision|4|||
160790212|NCT00507507|580618584|FG001|Treatment Period|Physician Decision|1|||
160790213|NCT00507507|580618583|FG000|Treatment Period|Protocol Violation|1|||
160790214|NCT00507507|580618584|FG001|Treatment Period|Protocol Violation|2|||
160790215|NCT00507507|580618583|FG000|Treatment Period|Adverse Event|1|||
160790216|NCT00507507|580618584|FG001|Treatment Period|Adverse Event|1|||
160790217|NCT00507507|580618583|FG000|Treatment Period|Withdrawal by Subject|46|||
160790218|NCT00507507|580618584|FG001|Treatment Period|Withdrawal by Subject|47|||
160790219|NCT00507507|580618583|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
160790220|NCT00507507|580618584|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
160790221|NCT00507507|580618583|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
160790222|NCT00507507|580618584|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
160790223|NCT00507507|580618583|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
160790224|NCT00507507|580618584|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
160790225|NCT03249558|580618587|FG000|Overall Study|Lost to Follow-up|2|||
160790226|NCT03249558|580618588|FG001|Overall Study|Lost to Follow-up|1|||
160790227|NCT03249558|580618589|FG002|Overall Study|Lost to Follow-up|4|||
160790228|NCT03249558|580618587|FG000|Overall Study|Physician Decision|1|||
160790229|NCT03249558|580618588|FG001|Overall Study|Physician Decision|0|||
160790230|NCT03249558|580618589|FG002|Overall Study|Physician Decision|0|||
160790231|NCT03249558|580618587|FG000|Overall Study|Withdrawal by Subject|6|||
160790232|NCT03249558|580618588|FG001|Overall Study|Withdrawal by Subject|5|||
160790233|NCT03249558|580618589|FG002|Overall Study|Withdrawal by Subject|7|||
160790234|NCT03249558|580618587|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
160790235|NCT03249558|580618588|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
160790236|NCT03249558|580618589|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
160790237|NCT03249558|580618587|FG000|Overall Study|Protocol Violation|1|||
160790238|NCT03249558|580618588|FG001|Overall Study|Protocol Violation|1|||
160790239|NCT03249558|580618589|FG002|Overall Study|Protocol Violation|2|||
160790240|NCT00834587|580618590|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160790241|NCT00834587|580618591|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160790242|NCT02536339|580618593|FG000|Overall Study|Death|20|||
160790243|NCT02536339|580618593|FG000|Overall Study|Withdrawal by Subject|3|||
160790244|NCT02536339|580618593|FG000|Overall Study|Lost to Follow-up|2|||
160790245|NCT02536339|580618593|FG000|Overall Study|Treatment discontinued|2|||
160892052|NCT03497676|581000498|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
160892053|NCT03497676|581000499|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
160892054|NCT03497676|581000496|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
160892055|NCT03497676|581000497|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
160892056|NCT03497676|581000498|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
160892057|NCT03497676|581000499|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
160892058|NCT03497676|581000496|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
160892059|NCT03497676|581000497|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
160892060|NCT03497676|581000498|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
160892061|NCT03497676|581000499|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
160892062|NCT03497676|581000496|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
160790246|NCT02536339|580618593|FG000|Overall Study|Physician Decision|1|||
160790247|NCT00581100|580620023|FG000|Overall Study|Death|1|||
160790248|NCT00581100|580620024|FG001|Overall Study|Death|0|||
160790249|NCT00581100|580620023|FG000|Overall Study|Adverse Event|2|||
160790250|NCT00581100|580620024|FG001|Overall Study|Adverse Event|1|||
160790251|NCT00581100|580620023|FG000|Overall Study|Withdrawal by Subject|1|||
160790252|NCT00581100|580620024|FG001|Overall Study|Withdrawal by Subject|4|||
160790253|NCT00581100|580620023|FG000|Overall Study|Other|3|||
160790254|NCT00581100|580620024|FG001|Overall Study|Other|0|||
160790255|NCT04129398|580620025|FG000|Overall Study|Physician Decision|2|||
160790256|NCT00590317|580620026|FG000|Overall Study|Lack of Efficacy|1|||
161330198|NCT02782741|582594831|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
160790257|NCT00590317|580620027|FG001|Overall Study|Lack of Efficacy|5|||
160892063|NCT03497676|581000497|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
160892064|NCT03497676|581000498|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
160892065|NCT03497676|581000499|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
160892066|NCT03497676|581000496|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
160892067|NCT03497676|581000497|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
160892068|NCT03497676|581000498|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
161330199|NCT02782741|582594832|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
161330200|NCT02782741|582594833|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
161330201|NCT02782741|582594831|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
161330202|NCT02782741|582594832|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
161330203|NCT02782741|582594833|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
161330204|NCT02782741|582594831|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
161330205|NCT02782741|582594832|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
161330206|NCT02782741|582594833|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
161330207|NCT02782741|582594831|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
161330208|NCT02782741|582594832|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
161330209|NCT02782741|582594833|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
161330210|NCT04157088|582594834|FG000|Overall Study|Study terminated by sponsor|23|||
161330211|NCT04157088|582594834|FG000|Overall Study|Withdrawal by Subject|4|||
161330212|NCT04157088|582594834|FG000|Overall Study|Lost to Follow-up|2|||
161330213|NCT04157088|582594834|FG000|Overall Study|Death|1|||
161330214|NCT02421419|582594835|FG000|Overall Study|Physician Decision|0|||
161330215|NCT02421419|582594836|FG001|Overall Study|Physician Decision|0|||
161330216|NCT02421419|582594837|FG002|Overall Study|Physician Decision|1|||
161330217|NCT01497067|582594839|FG000|Overall Study|Lost to Follow-up|56|||
161330218|NCT01497067|582594839|FG000|Overall Study|Adverse Event|3|||
161330219|NCT01497067|582594839|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
161330220|NCT01497067|582594839|FG000|Overall Study|Other|13|||
161330221|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
161330222|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
161330223|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Adverse Event|57|||
161330224|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Adverse Event|49|||
161330225|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
161330226|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
161330227|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Site closure|3|||
161330228|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Site closure|2|||
161330229|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
161330230|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
161330231|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Physician Decision|48|||
161330232|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Physician Decision|38|||
161330233|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
161330234|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
161330235|NCT01705977|582594840|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
161330236|NCT01705977|582594841|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
161330237|NCT01705977|582594840|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
161330238|NCT01705977|582594841|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
161330239|NCT01705977|582594840|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
161330240|NCT01705977|582594841|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
161330241|NCT01705977|582594840|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
161330242|NCT01705977|582594841|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
161330243|NCT01705977|582594840|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
161330244|NCT01705977|582594841|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
161330245|NCT05067972|582594842|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
161330246|NCT05067972|582594843|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
161330247|NCT05067972|582594844|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
161330248|NCT05067972|582594845|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
161330249|NCT05067972|582594846|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
161330250|NCT05067972|582594847|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
161330251|NCT05067972|582594848|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
161330252|NCT05067972|582594842|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
161330253|NCT05067972|582594843|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
161330254|NCT05067972|582594844|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
161330255|NCT05067972|582594845|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
161330256|NCT05067972|582594846|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
161330257|NCT05067972|582594847|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
161330258|NCT05067972|582594848|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
161330259|NCT05067972|582594842|FG000|Part 1: Treatment|Progressive Disease|3|||
161330260|NCT05067972|582594843|FG001|Part 1: Treatment|Progressive Disease|3|||
161330261|NCT05067972|582594844|FG002|Part 1: Treatment|Progressive Disease|4|||
161330262|NCT05067972|582594845|FG003|Part 1: Treatment|Progressive Disease|2|||
160892069|NCT03497676|581000499|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
160892070|NCT03497676|581000496|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
160892071|NCT03497676|581000497|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
160892072|NCT03497676|581000498|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
160892073|NCT03497676|581000499|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
160892074|NCT01977937|581000500|FG000|Overall Study|Withdrawal by Subject|2|||
160892075|NCT01977937|581000501|FG001|Overall Study|Withdrawal by Subject|1|||
160892076|NCT01977937|581000500|FG000|Overall Study|Adverse Event|1|||
160892077|NCT01977937|581000501|FG001|Overall Study|Adverse Event|0|||
160892078|NCT01977937|581000500|FG000|Overall Study|Physician Decision|0|||
160892079|NCT01977937|581000501|FG001|Overall Study|Physician Decision|1|||
161330263|NCT05067972|582594846|FG004|Part 1: Treatment|Progressive Disease|3|||
161330264|NCT05067972|582594847|FG005|Part 1: Treatment|Progressive Disease|0|||
161330265|NCT05067972|582594848|FG006|Part 1: Treatment|Progressive Disease|2|||
161330266|NCT05067972|582594842|FG000|Part 1: Treatment|Physician Decision|0|||
161330267|NCT05067972|582594843|FG001|Part 1: Treatment|Physician Decision|0|||
161330268|NCT05067972|582594844|FG002|Part 1: Treatment|Physician Decision|0|||
161330269|NCT05067972|582594845|FG003|Part 1: Treatment|Physician Decision|1|||
161330270|NCT05067972|582594846|FG004|Part 1: Treatment|Physician Decision|0|||
161330271|NCT05067972|582594847|FG005|Part 1: Treatment|Physician Decision|0|||
161330272|NCT05067972|582594848|FG006|Part 1: Treatment|Physician Decision|0|||
161330273|NCT05067972|582594842|FG000|Part 1: Treatment|Death|0|||
161330274|NCT05067972|582594843|FG001|Part 1: Treatment|Death|0|||
161330275|NCT05067972|582594844|FG002|Part 1: Treatment|Death|0|||
161330276|NCT05067972|582594845|FG003|Part 1: Treatment|Death|2|||
161330277|NCT05067972|582594846|FG004|Part 1: Treatment|Death|0|||
161330278|NCT05067972|582594847|FG005|Part 1: Treatment|Death|0|||
161330279|NCT05067972|582594848|FG006|Part 1: Treatment|Death|0|||
161330280|NCT05067972|582594842|FG000|Part 1: Treatment|Adverse Event|0|||
161330281|NCT05067972|582594843|FG001|Part 1: Treatment|Adverse Event|0|||
161330282|NCT05067972|582594844|FG002|Part 1: Treatment|Adverse Event|0|||
161330283|NCT05067972|582594845|FG003|Part 1: Treatment|Adverse Event|0|||
161330284|NCT05067972|582594846|FG004|Part 1: Treatment|Adverse Event|0|||
160892080|NCT03194490|581000508|FG000|Overall Study|Lost to Follow-up|1|||
160892081|NCT03194490|581000509|FG001|Overall Study|Lost to Follow-up|3|||
160892082|NCT03194490|581000508|FG000|Overall Study|participant developed specific neck pain|1|||
160892083|NCT03194490|581000509|FG001|Overall Study|participant developed specific neck pain|0|||
161330285|NCT05067972|582594847|FG005|Part 1: Treatment|Adverse Event|2|||
161330286|NCT05067972|582594848|FG006|Part 1: Treatment|Adverse Event|1|||
161330287|NCT05067972|582594842|FG000|Part 1: Follow-up|Adverse Event|0|||
161330288|NCT05067972|582594843|FG001|Part 1: Follow-up|Adverse Event|0|||
161330289|NCT05067972|582594844|FG002|Part 1: Follow-up|Adverse Event|0|||
161330290|NCT05067972|582594845|FG003|Part 1: Follow-up|Adverse Event|0|||
161330291|NCT05067972|582594846|FG004|Part 1: Follow-up|Adverse Event|0|||
161330292|NCT05067972|582594847|FG005|Part 1: Follow-up|Adverse Event|1|||
161330293|NCT05067972|582594848|FG006|Part 1: Follow-up|Adverse Event|0|||
161330294|NCT05067972|582594842|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
161330295|NCT05067972|582594843|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
161330296|NCT05067972|582594844|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
161330297|NCT05067972|582594845|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
161330298|NCT05067972|582594846|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
161330299|NCT05067972|582594847|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
161330300|NCT05067972|582594848|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
161330301|NCT05067972|582594842|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161330302|NCT05067972|582594843|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161330303|NCT05067972|582594844|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161330304|NCT05067972|582594845|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161330305|NCT05067972|582594846|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161330306|NCT05067972|582594847|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
161330307|NCT05067972|582594848|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
161330308|NCT05067972|582594842|FG000|Part 1: Follow-up|Physician Decision|0|||
161330309|NCT05067972|582594843|FG001|Part 1: Follow-up|Physician Decision|0|||
161330310|NCT05067972|582594844|FG002|Part 1: Follow-up|Physician Decision|0|||
161330311|NCT05067972|582594845|FG003|Part 1: Follow-up|Physician Decision|1|||
161330312|NCT05067972|582594846|FG004|Part 1: Follow-up|Physician Decision|0|||
161330313|NCT05067972|582594847|FG005|Part 1: Follow-up|Physician Decision|0|||
161330314|NCT05067972|582594848|FG006|Part 1: Follow-up|Physician Decision|0|||
161330315|NCT05067972|582594842|FG000|Part 1: Follow-up|Death|1|||
161330316|NCT05067972|582594843|FG001|Part 1: Follow-up|Death|2|||
161330317|NCT05067972|582594844|FG002|Part 1: Follow-up|Death|1|||
161330318|NCT05067972|582594845|FG003|Part 1: Follow-up|Death|0|||
161330319|NCT05067972|582594846|FG004|Part 1: Follow-up|Death|1|||
161330320|NCT05067972|582594847|FG005|Part 1: Follow-up|Death|0|||
161330321|NCT05067972|582594848|FG006|Part 1: Follow-up|Death|1|||
161330322|NCT00810199|582594856|FG000|Overall Study|Adverse Event|24|||
161330323|NCT00810199|582594857|FG001|Overall Study|Adverse Event|26|||
161330324|NCT00810199|582594856|FG000|Overall Study|Death|4|||
161330325|NCT00810199|582594857|FG001|Overall Study|Death|6|||
160790258|NCT02904265|580620029|FG000|Overall Study|Physician Decision|1|||
160790259|NCT02904265|580620030|FG001|Overall Study|Physician Decision|2|||
160790260|NCT00185614|580620033|FG000|Inter-treatment Period|Physician Decision|1|||
160790261|NCT00185614|580620033|FG000|Inter-treatment Period|Relapse|2|||
160790262|NCT00185614|580620033|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
160790263|NCT01034657|580620044|FG000|Core Phase|Withdrawal by Subject|1|||
161330326|NCT00810199|582594856|FG000|Overall Study|Withdrew consent|9|||
160790264|NCT01034657|580620045|FG001|Core Phase|Withdrawal by Subject|0|||
160790265|NCT01034657|580620046|FG002|Core Phase|Withdrawal by Subject|0|||
161330327|NCT00810199|582594857|FG001|Overall Study|Withdrew consent|12|||
161330328|NCT00810199|582594856|FG000|Overall Study|Insufficient therapeutic response|5|||
161330329|NCT00810199|582594857|FG001|Overall Study|Insufficient therapeutic response|14|||
161330330|NCT00810199|582594856|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
161330331|NCT00810199|582594857|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
161330332|NCT00810199|582594856|FG000|Overall Study|Administrative/Other|5|||
161330333|NCT00810199|582594857|FG001|Overall Study|Administrative/Other|6|||
161330334|NCT00810199|582594856|FG000|Overall Study|Protocol Violation|2|||
161330335|NCT00810199|582594857|FG001|Overall Study|Protocol Violation|6|||
161330336|NCT00810199|582594856|FG000|Overall Study|Failure to return|1|||
161330337|NCT00810199|582594857|FG001|Overall Study|Failure to return|4|||
161330338|NCT00810199|582594856|FG000|Overall Study|Did not receive study drug|2|||
160790266|NCT01034657|580620044|FG000|Core Phase|Lack of Efficacy|2|||
160790267|NCT01034657|580620045|FG001|Core Phase|Lack of Efficacy|0|||
160790268|NCT01034657|580620046|FG002|Core Phase|Lack of Efficacy|0|||
160892084|NCT03911843|581000510|FG000|Overall Study|Adverse Event|2|||
161330339|NCT00810199|582594857|FG001|Overall Study|Did not receive study drug|1|||
161330340|NCT00101868|582594865|FG000|Overall Study|Death|10|||
161330341|NCT00101868|582594866|FG001|Overall Study|Death|10|||
161330342|NCT00101868|582594865|FG000|Overall Study|Withdrawal by Subject|8|||
161330343|NCT00101868|582594866|FG001|Overall Study|Withdrawal by Subject|9|||
161330344|NCT00101868|582594865|FG000|Overall Study|Protocol Violation|3|||
161330345|NCT00101868|582594866|FG001|Overall Study|Protocol Violation|0|||
161330346|NCT00101868|582594865|FG000|Overall Study|Lost to Follow-up|8|||
161330347|NCT00101868|582594866|FG001|Overall Study|Lost to Follow-up|13|||
161330348|NCT04001803|582594868|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
161330349|NCT04001803|582594868|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
161330350|NCT04001803|582594868|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
161330351|NCT04001803|582594868|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
161330352|NCT04001803|582594868|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
161330353|NCT04001803|582594868|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
161330354|NCT04001803|582594868|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
161330355|NCT04001803|582594868|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
161330356|NCT04001803|582594868|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
160892085|NCT03911843|581000511|FG001|Overall Study|Adverse Event|0|||
160892086|NCT03911843|581000510|FG000|Overall Study|Protocol Violation|2|||
161330357|NCT04001803|582594868|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
161330358|NCT01931397|582594871|FG000|Overall Study|Physician Decision|2|||
161330359|NCT01931397|582594871|FG000|Overall Study|Withdrawal by Subject|8|||
160790269|NCT01034657|580620044|FG000|Core Phase|Abnormal laboratory value|1|||
160790270|NCT01034657|580620045|FG001|Core Phase|Abnormal laboratory value|0|||
160790271|NCT01034657|580620046|FG002|Core Phase|Abnormal laboratory value|0|||
160790272|NCT01034657|580620044|FG000|Core Phase|Adverse Event|8|||
160892087|NCT03911843|581000511|FG001|Overall Study|Protocol Violation|0|||
160892088|NCT03911843|581000510|FG000|Overall Study|Lost to Follow-up|0|||
160892089|NCT03911843|581000511|FG001|Overall Study|Lost to Follow-up|1|||
160892090|NCT02819518|581000512|FG000|Overall Study|Death|9|||
160892091|NCT02819518|581000513|FG001|Overall Study|Death|12|||
160892092|NCT02819518|581000514|FG002|Overall Study|Death|9|||
160892093|NCT02819518|581000515|FG003|Overall Study|Death|475|||
160892094|NCT02819518|581000516|FG004|Overall Study|Death|244|||
160892095|NCT02819518|581000512|FG000|Overall Study|Withdrawal by Subject|0|||
160892096|NCT02819518|581000513|FG001|Overall Study|Withdrawal by Subject|0|||
160892097|NCT02819518|581000514|FG002|Overall Study|Withdrawal by Subject|0|||
160892098|NCT02819518|581000515|FG003|Overall Study|Withdrawal by Subject|25|||
160892099|NCT02819518|581000516|FG004|Overall Study|Withdrawal by Subject|8|||
160892100|NCT02819518|581000512|FG000|Overall Study|Lost to Follow-up|0|||
160892101|NCT02819518|581000513|FG001|Overall Study|Lost to Follow-up|0|||
160892102|NCT02819518|581000514|FG002|Overall Study|Lost to Follow-up|0|||
160892103|NCT02819518|581000515|FG003|Overall Study|Lost to Follow-up|0|||
160892104|NCT02819518|581000516|FG004|Overall Study|Lost to Follow-up|1|||
161330360|NCT01931397|582594871|FG000|Overall Study|moved out of state|1|||
161330361|NCT02329327|582594875|FG000|Overall Study|Death|78|||
161330362|NCT02329327|582594876|FG001|Overall Study|Death|0|||
161330363|NCT02329327|582594875|FG000|Overall Study|Withdrawal by Subject|3|||
161330364|NCT02329327|582594876|FG001|Overall Study|Withdrawal by Subject|0|||
160790273|NCT01034657|580620045|FG001|Core Phase|Adverse Event|0|||
160892105|NCT02819518|581000512|FG000|Overall Study|Sponsor Decision|1|||
160790274|NCT01034657|580620046|FG002|Core Phase|Adverse Event|0|||
160790275|NCT01034657|580620044|FG000|Core Phase|Protocol Violation|2|||
160790276|NCT01034657|580620045|FG001|Core Phase|Protocol Violation|0|||
160790277|NCT01034657|580620046|FG002|Core Phase|Protocol Violation|0|||
160790278|NCT01034657|580620044|FG000|Randomized Phase|Withdrawal by Subject|0|||
160790279|NCT01034657|580620045|FG001|Randomized Phase|Withdrawal by Subject|2|||
160790280|NCT01034657|580620046|FG002|Randomized Phase|Withdrawal by Subject|0|||
160790281|NCT01034657|580620044|FG000|Randomized Phase|Lack of Efficacy|5|||
160790282|NCT01034657|580620045|FG001|Randomized Phase|Lack of Efficacy|1|||
160790283|NCT01034657|580620046|FG002|Randomized Phase|Lack of Efficacy|0|||
160790284|NCT01034657|580620044|FG000|Randomized Phase|Abnormal laboratory value|0|||
160790285|NCT01034657|580620045|FG001|Randomized Phase|Abnormal laboratory value|1|||
161330365|NCT02329327|582594875|FG000|Overall Study|Lost to Follow-up|4|||
161330366|NCT02329327|582594876|FG001|Overall Study|Lost to Follow-up|0|||
161330367|NCT02493517|582594877|FG000|Overall Study|Protocol Violation|1|||
161330368|NCT02493517|582594878|FG001|Overall Study|Protocol Violation|2|||
161330369|NCT02493517|582594877|FG000|Overall Study|Withdrawal by Subject|1|||
161330370|NCT02493517|582594878|FG001|Overall Study|Withdrawal by Subject|2|||
161330371|NCT02493517|582594877|FG000|Overall Study|Adverse Event|0|||
160790286|NCT01034657|580620046|FG002|Randomized Phase|Abnormal laboratory value|0|||
160790287|NCT01034657|580620044|FG000|Randomized Phase|Adverse Event|0|||
160790288|NCT01034657|580620045|FG001|Randomized Phase|Adverse Event|2|||
160790289|NCT01034657|580620046|FG002|Randomized Phase|Adverse Event|1|||
160790290|NCT01225952|580620048|FG000|Overall Study|Lost to Follow-up|1|||
161330372|NCT02493517|582594878|FG001|Overall Study|Adverse Event|2|||
161330373|NCT02493517|582594877|FG000|Overall Study|Missed study visit|0|||
161330374|NCT02493517|582594878|FG001|Overall Study|Missed study visit|1|||
161330375|NCT01367249|582594879|FG000|Overall Study|Withdrawal by Subject|6|||
161330376|NCT01367249|582594880|FG001|Overall Study|Withdrawal by Subject|6|||
161330377|NCT01367249|582594879|FG000|Overall Study|Other|3|||
161330378|NCT01367249|582594880|FG001|Overall Study|Other|10|||
161330379|NCT03718429|582594881|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
161330380|NCT03718429|582594882|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
161330381|NCT03718429|582594883|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
161330382|NCT03718429|582594884|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
161330383|NCT05404711|582594885|FG000|Completed Study Visit|Withdrawal by Subject|1|||
161330384|NCT05404711|582594885|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
161330385|NCT05404711|582594885|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
161330386|NCT05404711|582594885|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
161330387|NCT05404711|582594885|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
161330388|NCT05404711|582594885|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
161330389|NCT00325819|582594886|FG000|Overall Study|Study product lost in mail|2|||
161330390|NCT00325819|582594887|FG001|Overall Study|Study product lost in mail|1|||
161330391|NCT00325819|582594886|FG000|Overall Study|Did not take a dose of study product|4|||
161330392|NCT00325819|582594887|FG001|Overall Study|Did not take a dose of study product|9|||
161330393|NCT00325819|582594886|FG000|Overall Study|Lost to Follow-up|3|||
161330394|NCT00325819|582594887|FG001|Overall Study|Lost to Follow-up|3|||
161330395|NCT02346877|582594888|FG000|Overall Study|Adverse Event|1|||
161330396|NCT02346877|582594889|FG001|Overall Study|Adverse Event|0|||
161330397|NCT02346877|582594888|FG000|Overall Study|Administrative Decision|1|||
161330398|NCT02346877|582594889|FG001|Overall Study|Administrative Decision|0|||
161330399|NCT02346877|582594888|FG000|Overall Study|Sponsor Decision|12|||
161330400|NCT02346877|582594889|FG001|Overall Study|Sponsor Decision|0|||
161330401|NCT02346877|582594888|FG000|Overall Study|Missing|5|||
161330402|NCT02346877|582594889|FG001|Overall Study|Missing|0|||
161330403|NCT01683604|582594896|FG000|Overall Study|Adverse Event|2|||
161330404|NCT01683604|582594896|FG000|Overall Study|Lack of Efficacy|1|||
161330405|NCT01683604|582594896|FG000|Overall Study|Other|2|||
161330406|NCT03430856|582594897|FG000|Overall Study|Adverse Event|0|||
161330407|NCT03430856|582594898|FG001|Overall Study|Adverse Event|1|||
161330408|NCT03430856|582594899|FG002|Overall Study|Adverse Event|0|||
161330409|NCT03430856|582594897|FG000|Overall Study|Rescue criteria|1|||
161330410|NCT03430856|582594898|FG001|Overall Study|Rescue criteria|1|||
160790291|NCT01225952|580620049|FG001|Overall Study|Lost to Follow-up|0|||
160892106|NCT02819518|581000513|FG001|Overall Study|Sponsor Decision|1|||
161330411|NCT03430856|582594899|FG002|Overall Study|Rescue criteria|0|||
160790292|NCT01225952|580620050|FG002|Overall Study|Lost to Follow-up|0|||
160790293|NCT01225952|580620048|FG000|Overall Study|Study Eye Explanted|0|||
160790294|NCT01225952|580620049|FG001|Overall Study|Study Eye Explanted|0|||
160790295|NCT01225952|580620050|FG002|Overall Study|Study Eye Explanted|1|||
160790296|NCT01225952|580620048|FG000|Overall Study|Withdrawal by Subject|4|||
161330412|NCT03430856|582594897|FG000|Overall Study|Voluntary withdrawal of consent|1|||
161330413|NCT03430856|582594898|FG001|Overall Study|Voluntary withdrawal of consent|1|||
161330414|NCT03430856|582594899|FG002|Overall Study|Voluntary withdrawal of consent|1|||
161330415|NCT01548599|582597100|FG000|Overall Study|Lost to Follow-up|0|||
161330416|NCT01548599|582597101|FG001|Overall Study|Lost to Follow-up|1|||
160790297|NCT01225952|580620049|FG001|Overall Study|Withdrawal by Subject|4|||
160790298|NCT01225952|580620050|FG002|Overall Study|Withdrawal by Subject|5|||
160790299|NCT01225952|580620048|FG000|Overall Study|Surgical complications|1|||
160790300|NCT01225952|580620049|FG001|Overall Study|Surgical complications|0|||
160790301|NCT01225952|580620050|FG002|Overall Study|Surgical complications|0|||
160790302|NCT05122143|580620053|FG000|Overall Study|Adverse Event|1|||
160790303|NCT05122143|580620054|FG001|Overall Study|Adverse Event|0|||
160790304|NCT05122143|580620055|FG002|Overall Study|Adverse Event|0|||
160790305|NCT05122143|580620056|FG003|Overall Study|Adverse Event|0|||
160790306|NCT05122143|580620057|FG004|Overall Study|Adverse Event|1|||
160790307|NCT05122143|580620058|FG005|Overall Study|Adverse Event|0|||
160790308|NCT05122143|580620053|FG000|Overall Study|Protocol non-compliance|0|||
160790309|NCT05122143|580620054|FG001|Overall Study|Protocol non-compliance|0|||
160790310|NCT05122143|580620055|FG002|Overall Study|Protocol non-compliance|1|||
160790311|NCT05122143|580620056|FG003|Overall Study|Protocol non-compliance|0|||
160790312|NCT05122143|580620057|FG004|Overall Study|Protocol non-compliance|0|||
160790313|NCT05122143|580620058|FG005|Overall Study|Protocol non-compliance|0|||
160790314|NCT05122143|580620053|FG000|Overall Study|Covid contact|0|||
160790315|NCT05122143|580620054|FG001|Overall Study|Covid contact|0|||
160790316|NCT05122143|580620055|FG002|Overall Study|Covid contact|0|||
160790317|NCT05122143|580620056|FG003|Overall Study|Covid contact|0|||
160790318|NCT05122143|580620057|FG004|Overall Study|Covid contact|1|||
160790319|NCT05122143|580620058|FG005|Overall Study|Covid contact|0|||
160790320|NCT00692237|580620059|FG000|Overall Study|Withdrawal by Subject|1|||
160790321|NCT00692237|580620060|FG001|Overall Study|Withdrawal by Subject|3|||
160790322|NCT00692237|580620059|FG000|Overall Study|Adverse Event|0|||
160790323|NCT00692237|580620060|FG001|Overall Study|Adverse Event|1|||
160790324|NCT01047540|580620061|FG000|Overall Study|Protocol Violation|1|||
160790325|NCT01047540|580620062|FG001|Overall Study|Protocol Violation|0|||
160790326|NCT01047540|580620063|FG002|Overall Study|Protocol Violation|0|||
160790327|NCT01047540|580620064|FG003|Overall Study|Protocol Violation|0|||
160790328|NCT01047540|580620065|FG004|Overall Study|Protocol Violation|0|||
160790329|NCT01047540|580620061|FG000|Overall Study|Lost to Follow-up|1|||
160790330|NCT01047540|580620062|FG001|Overall Study|Lost to Follow-up|0|||
160790331|NCT01047540|580620063|FG002|Overall Study|Lost to Follow-up|0|||
160790332|NCT01047540|580620064|FG003|Overall Study|Lost to Follow-up|0|||
160790333|NCT01047540|580620065|FG004|Overall Study|Lost to Follow-up|0|||
160790334|NCT01047540|580620061|FG000|Overall Study|Withdrawal by Subject|1|||
160790335|NCT01047540|580620062|FG001|Overall Study|Withdrawal by Subject|0|||
160790336|NCT01047540|580620063|FG002|Overall Study|Withdrawal by Subject|3|||
160790337|NCT01047540|580620064|FG003|Overall Study|Withdrawal by Subject|0|||
160790338|NCT01047540|580620065|FG004|Overall Study|Withdrawal by Subject|1|||
160790339|NCT01047540|580620061|FG000|Overall Study|Pregnancy|1|||
160790340|NCT01047540|580620062|FG001|Overall Study|Pregnancy|0|||
160790341|NCT01047540|580620063|FG002|Overall Study|Pregnancy|0|||
160790342|NCT01047540|580620064|FG003|Overall Study|Pregnancy|0|||
160790343|NCT01047540|580620065|FG004|Overall Study|Pregnancy|0|||
160790344|NCT01047540|580620061|FG000|Overall Study|Adverse Event|1|||
160790345|NCT01047540|580620062|FG001|Overall Study|Adverse Event|0|||
161128076|NCT03434379|581855289|FG002|Global Period|Physician Decision|0|||
161128077|NCT03434379|581855290|FG003|Global Period|Physician Decision|0|||
161128078|NCT03434379|581855287|FG000|China Extension Period|Lost to Follow-up|0|||
161128079|NCT03434379|581855288|FG001|China Extension Period|Lost to Follow-up|0|||
161128080|NCT03434379|581855289|FG002|China Extension Period|Lost to Follow-up|2|||
161128081|NCT03434379|581855290|FG003|China Extension Period|Lost to Follow-up|3|||
161128082|NCT03434379|581855287|FG000|China Extension Period|Death|0|||
161330417|NCT01548599|582597100|FG000|Overall Study|Withdrawal by Subject|4|||
161330418|NCT01548599|582597101|FG001|Overall Study|Withdrawal by Subject|0|||
161330419|NCT01548599|582597100|FG000|Overall Study|Death|2|||
161330420|NCT01548599|582597101|FG001|Overall Study|Death|1|||
161128083|NCT03434379|581855288|FG001|China Extension Period|Death|0|||
161128084|NCT03434379|581855289|FG002|China Extension Period|Death|46|||
161330421|NCT02188160|582597102|FG000|Overall Study|Adverse Event|1|||
160790346|NCT01047540|580620063|FG002|Overall Study|Adverse Event|0|||
160790347|NCT01047540|580620064|FG003|Overall Study|Adverse Event|0|||
160790348|NCT01047540|580620065|FG004|Overall Study|Adverse Event|0|||
160790349|NCT03032484|580620071|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
160790350|NCT03032484|580620072|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
160790351|NCT03032484|580620071|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
160790352|NCT03032484|580620072|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
160790353|NCT05451329|580620082|FG000|Overall Study|Adverse Event|1|||
160790354|NCT05451329|580620083|FG001|Overall Study|Adverse Event|1|||
160790355|NCT05451329|580620084|FG002|Overall Study|Adverse Event|0|||
160790356|NCT05451329|580620082|FG000|Overall Study|Withdrawal by Subject|1|||
160790357|NCT05451329|580620083|FG001|Overall Study|Withdrawal by Subject|0|||
160790358|NCT05451329|580620084|FG002|Overall Study|Withdrawal by Subject|0|||
161128085|NCT03434379|581855290|FG003|China Extension Period|Death|88|||
160790359|NCT05451329|580620082|FG000|Overall Study|Investigational Product Lot exchange|1|||
160892107|NCT02819518|581000514|FG002|Overall Study|Sponsor Decision|0|||
160790360|NCT05451329|580620083|FG001|Overall Study|Investigational Product Lot exchange|1|||
160790361|NCT05451329|580620084|FG002|Overall Study|Investigational Product Lot exchange|0|||
160790362|NCT00069953|580620085|FG000|Overall Study|Protocol Violation|2|||
160790363|NCT02395627|580620088|FG000|Overall Study|Withdrawal by Subject|0|||
160790364|NCT02395627|580620089|FG001|Overall Study|Withdrawal by Subject|2|||
160790365|NCT02395627|580620090|FG002|Overall Study|Withdrawal by Subject|0|||
160790366|NCT02395627|580620088|FG000|Overall Study|Did not receive pembrolizumab|3|||
160790367|NCT02395627|580620089|FG001|Overall Study|Did not receive pembrolizumab|1|||
160790368|NCT02395627|580620090|FG002|Overall Study|Did not receive pembrolizumab|0|||
160790369|NCT03253627|580620091|FG000|Overall Study|Lost to Follow-up|1|||
160790370|NCT03253627|580620092|FG001|Overall Study|Lost to Follow-up|2|||
160790371|NCT03253627|580620091|FG000|Overall Study|Withdrawal by Subject|0|||
160790372|NCT03253627|580620092|FG001|Overall Study|Withdrawal by Subject|2|||
160790373|NCT03253627|580620091|FG000|Overall Study|Inability to complete MRI|1|||
160790374|NCT03253627|580620092|FG001|Overall Study|Inability to complete MRI|0|||
160790375|NCT03829683|580620093|FG000|Overall Study|Lost to Follow-up|1|||
160790376|NCT03829683|580620094|FG001|Overall Study|Lost to Follow-up|0|||
160790377|NCT03829683|580620093|FG000|Overall Study|Physician Decision|3|||
160790378|NCT03829683|580620094|FG001|Overall Study|Physician Decision|1|||
160790379|NCT03829683|580620093|FG000|Overall Study|Withdrawal by Subject|0|||
160790380|NCT03829683|580620094|FG001|Overall Study|Withdrawal by Subject|1|||
160790381|NCT03829683|580620093|FG000|Overall Study|Discharge from hospital|1|||
160790382|NCT03829683|580620094|FG001|Overall Study|Discharge from hospital|0|||
160790383|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
160790384|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
160790385|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
160790386|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
160790387|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
161330422|NCT02188160|582597103|FG001|Overall Study|Adverse Event|0|||
161330423|NCT02188160|582597102|FG000|Overall Study|Use of an excluded medication|0|||
161330424|NCT02188160|582597103|FG001|Overall Study|Use of an excluded medication|1|||
161330425|NCT01022203|582597108|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
161330426|NCT01022203|582597109|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
161330427|NCT01022203|582597108|FG000|Post Treatment Assessment|Physician Decision|2|||
161330428|NCT01022203|582597109|FG001|Post Treatment Assessment|Physician Decision|0|||
161330429|NCT01022203|582597108|FG000|Post Treatment Assessment|Adverse Event|0|||
161330430|NCT01022203|582597109|FG001|Post Treatment Assessment|Adverse Event|2|||
161330431|NCT01022203|582597108|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
161330432|NCT01022203|582597109|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
161330433|NCT03638128|582597110|FG000|Overall Study|Withdrawal by Subject|1|||
161128086|NCT03434379|581855287|FG000|China Extension Period|Withdrawal by Subject|0|||
160790388|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
160790389|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
160790390|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
160790391|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
160790392|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
160790393|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
160790394|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
160790395|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
160790396|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
160790397|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
160790398|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
160790399|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
160790400|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
160790401|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
160790402|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
160790403|NCT04003142|580620104|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
160790404|NCT04003142|580620105|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
160790405|NCT04003142|580620106|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
160790406|NCT04003142|580620107|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
160790407|NCT04003142|580620108|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
160790408|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
161330434|NCT03638128|582597111|FG001|Overall Study|Withdrawal by Subject|7|||
161330435|NCT03638128|582597112|FG002|Overall Study|Withdrawal by Subject|6|||
161330436|NCT03638128|582597110|FG000|Overall Study|Sponsor Decision|15|||
161330437|NCT03638128|582597111|FG001|Overall Study|Sponsor Decision|12|||
161330438|NCT03638128|582597112|FG002|Overall Study|Sponsor Decision|19|||
160790409|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
160790410|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
160790411|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
160790412|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
160790413|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Death|0|||
160790414|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Death|0|||
161330439|NCT03638128|582597110|FG000|Overall Study|Lost to Follow-up|0|||
161330440|NCT03638128|582597111|FG001|Overall Study|Lost to Follow-up|0|||
160892108|NCT02819518|581000515|FG003|Overall Study|Sponsor Decision|34|||
161128087|NCT03434379|581855288|FG001|China Extension Period|Withdrawal by Subject|0|||
161330441|NCT03638128|582597112|FG002|Overall Study|Lost to Follow-up|1|||
161330442|NCT03163446|582597113|FG000|Overall Study|Unable to return for Day 180 visit|2|||
161330443|NCT03163446|582597114|FG001|Overall Study|Unable to return for Day 180 visit|0|||
161330444|NCT03163446|582597113|FG000|Overall Study|Withdrawal by Subject|2|||
161330445|NCT03163446|582597114|FG001|Overall Study|Withdrawal by Subject|6|||
161330446|NCT03163446|582597113|FG000|Overall Study|Death|16|||
161128088|NCT03434379|581855289|FG002|China Extension Period|Withdrawal by Subject|8|||
161128089|NCT03434379|581855290|FG003|China Extension Period|Withdrawal by Subject|6|||
161128090|NCT03434379|581855287|FG000|China Extension Period|Study Ended by Sponsor|0|||
161128091|NCT03434379|581855288|FG001|China Extension Period|Study Ended by Sponsor|0|||
161128092|NCT03434379|581855289|FG002|China Extension Period|Study Ended by Sponsor|5|||
161128093|NCT03434379|581855290|FG003|China Extension Period|Study Ended by Sponsor|36|||
161128094|NCT00686647|581855294|FG000|Overall Study|Lost to Follow-up|1|||
161128095|NCT00686647|581855294|FG000|Overall Study|Death|1|||
161128096|NCT00578643|581855295|FG000|Overall Study|Death|1|||
161128097|NCT00578643|581855295|FG000|Overall Study|Lost to Follow-up|1|||
161128098|NCT01725750|581855296|FG000|Overall Study|Adverse Event|1|||
161128099|NCT01725750|581855297|FG001|Overall Study|Adverse Event|0|||
161128100|NCT01725750|581855296|FG000|Overall Study|Lost to Follow-up|1|||
161128101|NCT01725750|581855297|FG001|Overall Study|Lost to Follow-up|1|||
161128102|NCT01725750|581855296|FG000|Overall Study|Withdrawal by Subject|0|||
161128103|NCT01725750|581855297|FG001|Overall Study|Withdrawal by Subject|9|||
161128104|NCT03179436|581855300|FG000|Overall Study|Withdrawal by Subject|1|||
161128105|NCT03179436|581855301|FG001|Overall Study|Withdrawal by Subject|0|||
161128106|NCT03179436|581855302|FG002|Overall Study|Withdrawal by Subject|0|||
161128107|NCT03179436|581855303|FG003|Overall Study|Withdrawal by Subject|4|||
161128108|NCT03179436|581855304|FG004|Overall Study|Withdrawal by Subject|2|||
161128109|NCT03179436|581855305|FG005|Overall Study|Withdrawal by Subject|2|||
161128110|NCT03179436|581855306|FG006|Overall Study|Withdrawal by Subject|5|||
161128111|NCT03179436|581855307|FG007|Overall Study|Withdrawal by Subject|0|||
161128112|NCT03179436|581855308|FG008|Overall Study|Withdrawal by Subject|3|||
161128113|NCT03179436|581855309|FG009|Overall Study|Withdrawal by Subject|0|||
161128114|NCT03179436|581855310|FG010|Overall Study|Withdrawal by Subject|0|||
161128115|NCT03179436|581855311|FG011|Overall Study|Withdrawal by Subject|0|||
161128116|NCT03179436|581855300|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161128117|NCT03179436|581855301|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161128118|NCT03179436|581855302|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161128119|NCT03179436|581855303|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161128120|NCT03179436|581855304|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161128121|NCT03179436|581855305|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161128122|NCT03179436|581855306|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161128123|NCT03179436|581855307|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
161128124|NCT03179436|581855308|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
161128125|NCT03179436|581855309|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
161128126|NCT03179436|581855310|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
161128127|NCT03179436|581855311|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
161128128|NCT03179436|581855300|FG000|Overall Study|Sponsor Decision|0|||
161128129|NCT03179436|581855301|FG001|Overall Study|Sponsor Decision|0|||
161128130|NCT03179436|581855302|FG002|Overall Study|Sponsor Decision|1|||
161128131|NCT03179436|581855303|FG003|Overall Study|Sponsor Decision|3|||
161128132|NCT03179436|581855304|FG004|Overall Study|Sponsor Decision|9|||
161128133|NCT03179436|581855305|FG005|Overall Study|Sponsor Decision|7|||
161128134|NCT03179436|581855306|FG006|Overall Study|Sponsor Decision|2|||
161128135|NCT03179436|581855307|FG007|Overall Study|Sponsor Decision|4|||
161128136|NCT03179436|581855308|FG008|Overall Study|Sponsor Decision|23|||
161128137|NCT03179436|581855309|FG009|Overall Study|Sponsor Decision|6|||
161128138|NCT03179436|581855310|FG010|Overall Study|Sponsor Decision|7|||
161128139|NCT03179436|581855311|FG011|Overall Study|Sponsor Decision|5|||
161330447|NCT03163446|582597114|FG001|Overall Study|Death|5|||
161330448|NCT03163446|582597113|FG000|Overall Study|Lost to Follow-up|6|||
161128140|NCT03179436|581855300|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128141|NCT03179436|581855301|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
161128142|NCT03179436|581855302|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128143|NCT03179436|581855303|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128144|NCT03179436|581855304|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128145|NCT03179436|581855305|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
161128146|NCT03179436|581855306|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128147|NCT03179436|581855307|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128148|NCT03179436|581855308|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
161330449|NCT03163446|582597114|FG001|Overall Study|Lost to Follow-up|5|||
160790415|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Death|0|||
160790416|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Death|0|||
160790417|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Death|1|||
160790418|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
161128149|NCT03179436|581855309|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128150|NCT03179436|581855310|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128151|NCT03179436|581855311|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
161128152|NCT03179436|581855300|FG000|Overall Study|Lost to Follow-up|1|||
161128153|NCT03179436|581855301|FG001|Overall Study|Lost to Follow-up|0|||
161128154|NCT03179436|581855302|FG002|Overall Study|Lost to Follow-up|0|||
161128155|NCT03179436|581855303|FG003|Overall Study|Lost to Follow-up|1|||
161128156|NCT03179436|581855304|FG004|Overall Study|Lost to Follow-up|0|||
161128157|NCT03179436|581855305|FG005|Overall Study|Lost to Follow-up|1|||
161128158|NCT03179436|581855306|FG006|Overall Study|Lost to Follow-up|0|||
161128159|NCT03179436|581855307|FG007|Overall Study|Lost to Follow-up|0|||
161128160|NCT03179436|581855308|FG008|Overall Study|Lost to Follow-up|1|||
160790419|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
160790420|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
160790421|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
160790422|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
160790423|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790424|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790425|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
160790426|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790427|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
160790428|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
160790429|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
160790430|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
160790431|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
160790432|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
160790433|NCT04003142|580620104|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
160790434|NCT04003142|580620105|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
160790435|NCT04003142|580620106|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
160790436|NCT04003142|580620107|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
160790437|NCT04003142|580620108|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
160790438|NCT04806373|580620109|FG000|Overall Study|Withdrawal by Subject|1|||
160790439|NCT04806373|580620110|FG001|Overall Study|Withdrawal by Subject|1|||
160790440|NCT05810597|580620111|FG000|Period 1|Adverse Event|2|||
160790441|NCT05810597|580620112|FG001|Period 1|Adverse Event|0|||
160790442|NCT05810597|580620111|FG000|Period 1|Physician Decision|1|||
160790443|NCT05810597|580620112|FG001|Period 1|Physician Decision|0|||
160790444|NCT01450631|580620113|FG000|Overall Study|Lost to Follow-up|2|||
160790445|NCT01450631|580620114|FG001|Overall Study|Lost to Follow-up|4|||
160790446|NCT01450631|580620113|FG000|Overall Study|Withdrawal by Subject|1|||
160790447|NCT01450631|580620114|FG001|Overall Study|Withdrawal by Subject|0|||
160790448|NCT04903093|580620115|FG000|Overall Study|Withdrawal by Subject|0|||
160790449|NCT04903093|580620116|FG001|Overall Study|Withdrawal by Subject|0|||
160790450|NCT04903093|580620117|FG002|Overall Study|Withdrawal by Subject|0|||
160790451|NCT04903093|580620118|FG003|Overall Study|Withdrawal by Subject|1|||
160790452|NCT04903093|580620119|FG004|Overall Study|Withdrawal by Subject|0|||
160790453|NCT04903093|580620120|FG005|Overall Study|Withdrawal by Subject|0|||
160790454|NCT01390584|580620129|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
160790455|NCT01390584|580620130|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
160790456|NCT01390584|580620131|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
160790457|NCT00025233|580620132|FG000|Overall Study|Ineligible: wrong cell type|1|||
160790458|NCT00025233|580620132|FG000|Overall Study|Ineligible: wrong primary|1|||
160790459|NCT00025233|580620132|FG000|Overall Study|Ineligible: improper prior treatment|1|||
160790460|NCT00025233|580620132|FG000|Overall Study|Never treated|1|||
160790461|NCT00401830|580620133|FG000|Overall Study|Adverse Event|10|||
160790462|NCT00401830|580620134|FG001|Overall Study|Adverse Event|18|||
160790463|NCT00401830|580620133|FG000|Overall Study|Lack of Efficacy|11|||
160790464|NCT00401830|580620134|FG001|Overall Study|Lack of Efficacy|5|||
160790465|NCT00401830|580620133|FG000|Overall Study|Withdrawal by Subject|4|||
160790466|NCT00401830|580620134|FG001|Overall Study|Withdrawal by Subject|3|||
160790467|NCT00401830|580620133|FG000|Overall Study|Protocol Violation|3|||
161128161|NCT03179436|581855309|FG009|Overall Study|Lost to Follow-up|1|||
160790468|NCT00401830|580620134|FG001|Overall Study|Protocol Violation|3|||
160790469|NCT00401830|580620133|FG000|Overall Study|Non-compliance with drug study|1|||
160790470|NCT00401830|580620134|FG001|Overall Study|Non-compliance with drug study|0|||
160790471|NCT00401830|580620133|FG000|Overall Study|Lost to Follow-up|1|||
160790472|NCT00401830|580620134|FG001|Overall Study|Lost to Follow-up|3|||
160790473|NCT00401830|580620133|FG000|Overall Study|Other: Personal / Family problems|1|||
160790474|NCT00401830|580620134|FG001|Overall Study|Other: Personal / Family problems|0|||
160790475|NCT01720602|580620135|FG000|Overall Study|Adverse Event|3|||
160790476|NCT01720602|580620135|FG000|Overall Study|Progressive disease on therapy|2|||
160892109|NCT02819518|581000516|FG004|Overall Study|Sponsor Decision|17|||
160892110|NCT02819518|581000512|FG000|Overall Study|Transferred to extension study|1|||
160892111|NCT02819518|581000513|FG001|Overall Study|Transferred to extension study|1|||
160892112|NCT02819518|581000514|FG002|Overall Study|Transferred to extension study|1|||
160892113|NCT02819518|581000515|FG003|Overall Study|Transferred to extension study|32|||
160892114|NCT02819518|581000516|FG004|Overall Study|Transferred to extension study|11|||
160892115|NCT00880165|581000517|FG000|Overall Study|Withdrawal by Subject|27|||
160892116|NCT00880165|581000518|FG001|Overall Study|Withdrawal by Subject|23|||
160892117|NCT00880165|581000517|FG000|Overall Study|Not diagnosed with OSA|14|||
160892118|NCT00880165|581000518|FG001|Overall Study|Not diagnosed with OSA|8|||
160892119|NCT00880165|581000517|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
160892120|NCT00880165|581000518|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
160892121|NCT00880165|581000517|FG000|Overall Study|Lost to follow|9|||
160892122|NCT00880165|581000518|FG001|Overall Study|Lost to follow|15|||
160892123|NCT01505647|581000519|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
160892124|NCT01505647|581000520|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
160892125|NCT01505647|581000519|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
160892126|NCT01505647|581000520|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
160892127|NCT01505647|581000519|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
160892128|NCT01505647|581000520|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
161128162|NCT03179436|581855310|FG010|Overall Study|Lost to Follow-up|0|||
160892129|NCT01505647|581000519|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
160892130|NCT01505647|581000520|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
160892131|NCT01505647|581000519|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
160892132|NCT01505647|581000520|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
160892133|NCT00395538|581000522|FG000|Overall Study|Did not re-consent to revised protocol|1|||
160892134|NCT00395538|581000523|FG001|Overall Study|Did not re-consent to revised protocol|10|||
160892135|NCT00395538|581000524|FG002|Overall Study|Did not re-consent to revised protocol|0|||
160892136|NCT00395538|581000522|FG000|Overall Study|FDA partial hold on PTH|0|||
160892137|NCT00395538|581000523|FG001|Overall Study|FDA partial hold on PTH|0|||
160892138|NCT00395538|581000524|FG002|Overall Study|FDA partial hold on PTH|11|||
160892139|NCT00395538|581000522|FG000|Overall Study|Failed screening|0|||
160892140|NCT00395538|581000523|FG001|Overall Study|Failed screening|0|||
160892141|NCT00395538|581000524|FG002|Overall Study|Failed screening|4|||
161235438|NCT02305758|582244886|FG001|Overall Study|Death|27|||
161235439|NCT02305758|582244885|FG000|Overall Study|Withdrew consent|9|||
161235440|NCT02305758|582244886|FG001|Overall Study|Withdrew consent|2|||
161235441|NCT02305758|582244885|FG000|Overall Study|Lost to Follow-up|6|||
161330450|NCT03163446|582597113|FG000|Overall Study|Physician Decision|1|||
161330451|NCT03163446|582597114|FG001|Overall Study|Physician Decision|1|||
161128163|NCT03179436|581855311|FG011|Overall Study|Lost to Follow-up|0|||
161128164|NCT03179436|581855300|FG000|Overall Study|Death|12|||
161128165|NCT03179436|581855301|FG001|Overall Study|Death|17|||
161128166|NCT03179436|581855302|FG002|Overall Study|Death|7|||
161128167|NCT03179436|581855303|FG003|Overall Study|Death|32|||
161128168|NCT03179436|581855304|FG004|Overall Study|Death|29|||
161128169|NCT03179436|581855305|FG005|Overall Study|Death|30|||
161128170|NCT03179436|581855306|FG006|Overall Study|Death|33|||
161128171|NCT03179436|581855307|FG007|Overall Study|Death|9|||
161128172|NCT03179436|581855308|FG008|Overall Study|Death|84|||
161128173|NCT03179436|581855309|FG009|Overall Study|Death|33|||
161128174|NCT03179436|581855310|FG010|Overall Study|Death|22|||
161128175|NCT03179436|581855311|FG011|Overall Study|Death|15|||
161128176|NCT02474329|581855312|FG000|Overall Study|Withdraw or did not contribute data.|13|||
161128177|NCT01634555|581855313|FG000|Overall Study|Adverse Event|3|||
161128178|NCT01634555|581855313|FG000|Overall Study|Physician Decision|1|||
161128179|NCT01506882|581855314|FG000|Overall Study|Lack of Efficacy|4|||
161128180|NCT01506882|581855315|FG001|Overall Study|Lack of Efficacy|3|||
161128181|NCT01506882|581855314|FG000|Overall Study|Lost to Follow-up|1|||
161128182|NCT01506882|581855315|FG001|Overall Study|Lost to Follow-up|0|||
161235442|NCT02305758|582244886|FG001|Overall Study|Lost to Follow-up|1|||
161235443|NCT02305758|582244885|FG000|Overall Study|Study Terminated by Sponsor|21|||
161235444|NCT02305758|582244886|FG001|Overall Study|Study Terminated by Sponsor|34|||
161235445|NCT02305758|582244885|FG000|Overall Study|Other, not specified|2|||
161235446|NCT02305758|582244886|FG001|Overall Study|Other, not specified|1|||
161235447|NCT04149964|582244887|FG000|Overall Study|Lost to Follow-up|19|||
161235448|NCT04149964|582244888|FG001|Overall Study|Lost to Follow-up|18|||
161235449|NCT01424644|582244889|FG000|Overall Study|Adverse Event|2|||
161330452|NCT03163446|582597113|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
161330453|NCT03163446|582597114|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
160892142|NCT00395538|581000522|FG000|Overall Study|Switch to Natpara|0|||
161128183|NCT01506882|581855314|FG000|Overall Study|Withdrawal by Subject|9|||
161128184|NCT01506882|581855315|FG001|Overall Study|Withdrawal by Subject|3|||
161128185|NCT01506882|581855314|FG000|Overall Study|SAE, non-fatal|2|||
161235450|NCT01424644|582244890|FG001|Overall Study|Adverse Event|0|||
161235451|NCT01424644|582244889|FG000|Overall Study|Withdrawal by Subject|9|||
161235452|NCT01424644|582244890|FG001|Overall Study|Withdrawal by Subject|12|||
161235453|NCT01424644|582244889|FG000|Overall Study|Lost to Follow-up|16|||
161235454|NCT01424644|582244890|FG001|Overall Study|Lost to Follow-up|12|||
161235455|NCT01424644|582244889|FG000|Overall Study|Protocol Violation|4|||
161235456|NCT01424644|582244890|FG001|Overall Study|Protocol Violation|3|||
161235457|NCT01424644|582244889|FG000|Overall Study|Administrative Reason|1|||
161235458|NCT01424644|582244890|FG001|Overall Study|Administrative Reason|0|||
161235459|NCT01424644|582244889|FG000|Overall Study|Unable to Classify|1|||
161235460|NCT01424644|582244890|FG001|Overall Study|Unable to Classify|0|||
161235461|NCT05593965|582244891|FG000|1st Intervention (1 Day)|Technical error|1|||
161235462|NCT05593965|582244892|FG001|1st Intervention (1 Day)|Technical error|0|||
161235463|NCT02272777|582244893|FG000|Overall Study|Adverse Event|0|||
161235464|NCT02272777|582244894|FG001|Overall Study|Adverse Event|1|||
161235465|NCT02272777|582244893|FG000|Overall Study|Withdrawal by Subject|0|||
161235466|NCT02272777|582244894|FG001|Overall Study|Withdrawal by Subject|3|||
161235467|NCT02272777|582244893|FG000|Overall Study|Lost to Follow-up|2|||
161235468|NCT02272777|582244894|FG001|Overall Study|Lost to Follow-up|0|||
161235469|NCT02272777|582244893|FG000|Overall Study|Other|2|||
161235470|NCT02272777|582244894|FG001|Overall Study|Other|0|||
161235471|NCT02066922|582244897|FG000|Overall Study|Adverse Event|1|||
161235472|NCT00440297|582244898|FG000|Overall Study|Adverse Event|8|||
161235473|NCT00440297|582244899|FG001|Overall Study|Adverse Event|5|||
161235474|NCT00440297|582244898|FG000|Overall Study|Lost to Follow-up|1|||
161235475|NCT00440297|582244899|FG001|Overall Study|Lost to Follow-up|0|||
161235476|NCT00440297|582244898|FG000|Overall Study|Physician Decision|1|||
161235477|NCT00440297|582244899|FG001|Overall Study|Physician Decision|0|||
161235478|NCT00440297|582244898|FG000|Overall Study|Protocol Violation|11|||
161235479|NCT00440297|582244899|FG001|Overall Study|Protocol Violation|7|||
161235480|NCT00440297|582244898|FG000|Overall Study|Withdrawal by Subject|1|||
161235481|NCT00440297|582244899|FG001|Overall Study|Withdrawal by Subject|6|||
161235482|NCT00440297|582244898|FG000|Overall Study|Randomized by mistake|1|||
161235483|NCT00440297|582244899|FG001|Overall Study|Randomized by mistake|0|||
161235484|NCT02024932|582244900|FG000|Overall Study|Adverse Event|2|||
161235485|NCT02024932|582244901|FG001|Overall Study|Adverse Event|3|||
161235486|NCT02024932|582244902|FG002|Overall Study|Adverse Event|0|||
161235487|NCT02024932|582244903|FG003|Overall Study|Adverse Event|0|||
161235488|NCT02024932|582244904|FG004|Overall Study|Adverse Event|2|||
161235489|NCT02024932|582244905|FG005|Overall Study|Adverse Event|0|||
161235490|NCT02024932|582244900|FG000|Overall Study|Abnormal laboratory value|0|||
161235491|NCT02024932|582244901|FG001|Overall Study|Abnormal laboratory value|0|||
161235492|NCT02024932|582244902|FG002|Overall Study|Abnormal laboratory value|0|||
161235493|NCT02024932|582244903|FG003|Overall Study|Abnormal laboratory value|2|||
161235494|NCT02024932|582244904|FG004|Overall Study|Abnormal laboratory value|0|||
161235495|NCT02024932|582244905|FG005|Overall Study|Abnormal laboratory value|0|||
161235496|NCT03206177|582244906|FG000|Overall Study|Withdrawal by Subject|1|||
161235497|NCT02445339|582244907|FG000|Overall Study|Physician Decision|1|||
161235498|NCT02445339|582244908|FG001|Overall Study|Physician Decision|0|||
161235499|NCT02445339|582244907|FG000|Overall Study|Lost to Follow-up|11|||
161235500|NCT02445339|582244908|FG001|Overall Study|Lost to Follow-up|15|||
161235501|NCT03020641|582244909|FG000|Overall Study|Lost to Follow-up|0|||
161235502|NCT03020641|582244910|FG001|Overall Study|Lost to Follow-up|1|||
161235503|NCT03020641|582244909|FG000|Overall Study|Converted to open surgery|2|||
160790477|NCT01539525|580620136|FG000|Overall Study|Lost to Follow-up|19|||
160790478|NCT01539525|580620137|FG001|Overall Study|Lost to Follow-up|12|||
160790479|NCT01539525|580620138|FG002|Overall Study|Lost to Follow-up|11|||
160790480|NCT01539525|580620136|FG000|Overall Study|Withdrawal by Subject|0|||
160790481|NCT01539525|580620137|FG001|Overall Study|Withdrawal by Subject|3|||
160790482|NCT01539525|580620138|FG002|Overall Study|Withdrawal by Subject|2|||
160790483|NCT01539525|580620136|FG000|Overall Study|Protocol Violation|1|||
161235504|NCT03020641|582244910|FG001|Overall Study|Converted to open surgery|1|||
161235505|NCT03020641|582244909|FG000|Overall Study|for surgery not performed|0|||
161235506|NCT03020641|582244910|FG001|Overall Study|for surgery not performed|1|||
161235507|NCT00727961|582244911|FG000|Overall Study|Lost to Follow-up|1|||
161235508|NCT00727961|582244911|FG000|Overall Study|Adverse Event|4|||
161235509|NCT00727961|582244911|FG000|Overall Study|Patient's refusal|2|||
161235510|NCT00727961|582244911|FG000|Overall Study|Progression|30|||
161235511|NCT03238781|582244912|FG000|Overall Study|Adverse Event|1|||
161235512|NCT03238781|582244913|FG001|Overall Study|Adverse Event|1|||
160790484|NCT01539525|580620137|FG001|Overall Study|Protocol Violation|1|||
160790485|NCT01539525|580620138|FG002|Overall Study|Protocol Violation|4|||
160790486|NCT02184442|580620141|FG000|Overall Study|Death|61|||
161235513|NCT03238781|582244914|FG002|Overall Study|Adverse Event|2|||
161235514|NCT03238781|582244912|FG000|Overall Study|Lost to Follow-up|2|||
161235515|NCT03238781|582244913|FG001|Overall Study|Lost to Follow-up|1|||
161235516|NCT03238781|582244914|FG002|Overall Study|Lost to Follow-up|2|||
161235517|NCT03238781|582244912|FG000|Overall Study|Withdrawal by Subject|23|||
161235518|NCT03238781|582244913|FG001|Overall Study|Withdrawal by Subject|14|||
161235519|NCT03238781|582244914|FG002|Overall Study|Withdrawal by Subject|16|||
161235520|NCT03238781|582244912|FG000|Overall Study|Decision by sponsor|0|||
161128186|NCT01506882|581855315|FG001|Overall Study|SAE, non-fatal|0|||
161128187|NCT01506882|581855314|FG000|Overall Study|AE, non-serious non-fatal|3|||
161128188|NCT01506882|581855315|FG001|Overall Study|AE, non-serious non-fatal|1|||
161128189|NCT01506882|581855314|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
161128190|NCT01506882|581855315|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
161128191|NCT01506882|581855314|FG000|Overall Study|Other Reason|2|||
161128192|NCT01506882|581855315|FG001|Overall Study|Other Reason|0|||
161128193|NCT04025632|581856810|FG000|Overall Study|Adverse Event|1|||
160790487|NCT02184442|580620142|FG001|Overall Study|Death|65|||
160790488|NCT02184442|580620141|FG000|Overall Study|Withdrawal by Subject|3|||
160790489|NCT02184442|580620142|FG001|Overall Study|Withdrawal by Subject|11|||
160790490|NCT01044459|580620143|FG000|Overall Study|Withdrawal by Subject|21|||
160790491|NCT01044459|580620144|FG001|Overall Study|Withdrawal by Subject|28|||
160790492|NCT01044459|580620143|FG000|Overall Study|Terminated by Sponsor|22|||
160790493|NCT01044459|580620144|FG001|Overall Study|Terminated by Sponsor|21|||
160790494|NCT01044459|580620143|FG000|Overall Study|Adverse Event|22|||
160790495|NCT01044459|580620144|FG001|Overall Study|Adverse Event|20|||
160790496|NCT01044459|580620143|FG000|Overall Study|Lack of Efficacy|23|||
160790497|NCT01044459|580620144|FG001|Overall Study|Lack of Efficacy|12|||
160790498|NCT01044459|580620143|FG000|Overall Study|Protocol Violation|11|||
160790499|NCT01044459|580620144|FG001|Overall Study|Protocol Violation|16|||
160790500|NCT01044459|580620143|FG000|Overall Study|Other Reason|7|||
160790501|NCT01044459|580620144|FG001|Overall Study|Other Reason|14|||
160790502|NCT01044459|580620143|FG000|Overall Study|COPD exacerbation|9|||
160790503|NCT01044459|580620144|FG001|Overall Study|COPD exacerbation|8|||
160790504|NCT01044459|580620143|FG000|Overall Study|Lost to Follow-up|18|||
160790505|NCT01044459|580620144|FG001|Overall Study|Lost to Follow-up|12|||
160790506|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
160790507|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
160790508|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
160790509|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160790510|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160790511|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
160790512|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Other|2|||
160892143|NCT00395538|581000523|FG001|Overall Study|Switch to Natpara|0|||
160892144|NCT00395538|581000524|FG002|Overall Study|Switch to Natpara|3|||
160892145|NCT00395538|581000522|FG000|Overall Study|Adverse Event|1|||
160892146|NCT00395538|581000523|FG001|Overall Study|Adverse Event|0|||
160892147|NCT00395538|581000524|FG002|Overall Study|Adverse Event|2|||
160790513|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Other|1|||
160790514|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Other|1|||
160790515|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
160790516|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
160790517|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
160790518|NCT02691494|580620147|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160892148|NCT00395538|581000522|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
160892149|NCT00395538|581000523|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
160892150|NCT00395538|581000524|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
160892151|NCT00395538|581000522|FG000|Overall Study|Non-compliance with study protocol|0|||
160892152|NCT00395538|581000523|FG001|Overall Study|Non-compliance with study protocol|1|||
160892153|NCT00395538|581000524|FG002|Overall Study|Non-compliance with study protocol|0|||
160892154|NCT00395538|581000522|FG000|Overall Study|PTH resistance|0|||
160892155|NCT00395538|581000523|FG001|Overall Study|PTH resistance|0|||
160790519|NCT02691494|580620148|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
160892156|NCT00395538|581000524|FG002|Overall Study|PTH resistance|1|||
160892157|NCT00395538|581000522|FG000|Overall Study|Pregnancy|1|||
161128194|NCT04025632|581856811|FG001|Overall Study|Adverse Event|1|||
161128195|NCT04025632|581856810|FG000|Overall Study|Withdrawal by Subject|1|||
161128196|NCT04025632|581856811|FG001|Overall Study|Withdrawal by Subject|1|||
161128197|NCT04025632|581856810|FG000|Overall Study|Study Terminated by Sponsor|10|||
161128198|NCT04025632|581856811|FG001|Overall Study|Study Terminated by Sponsor|9|||
161128199|NCT04025632|581856810|FG000|Overall Study|Physician Decision|3|||
161128200|NCT04025632|581856811|FG001|Overall Study|Physician Decision|1|||
161128201|NCT00376961|581856812|FG000|Initial Registration|Adverse Event|1|||
161128202|NCT00376961|581856813|FG001|Initial Registration|Adverse Event|0|||
161128203|NCT00376961|581856812|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
161128204|NCT00376961|581856813|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161128205|NCT00376961|581856812|FG000|Initial Registration|Progression/relapse|1|||
161128206|NCT00376961|581856813|FG001|Initial Registration|Progression/relapse|0|||
161128207|NCT00376961|581856812|FG000|Initial Registration|Ineligible|3|||
161128208|NCT00376961|581856813|FG001|Initial Registration|Ineligible|0|||
161128209|NCT00376961|581856812|FG000|Maintenance|Adverse Event|0|||
161128210|NCT00376961|581856813|FG001|Maintenance|Adverse Event|1|||
161128211|NCT00376961|581856812|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
161128212|NCT00376961|581856813|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
161128213|NCT00376961|581856812|FG000|Maintenance|Progression/relapse|0|||
161128214|NCT00376961|581856813|FG001|Maintenance|Progression/relapse|18|||
161128215|NCT00376961|581856812|FG000|Maintenance|Ineligible|0|||
161128216|NCT00376961|581856813|FG001|Maintenance|Ineligible|3|||
161128217|NCT02591615|581856820|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161128218|NCT02591615|581856821|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161128219|NCT02591615|581856822|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
161128220|NCT02591615|581856823|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
161128221|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161128222|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
161128223|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161128224|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
161128225|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
161128226|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
161128227|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
161128228|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
161128229|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
161128230|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
161128231|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
160790520|NCT02691494|580620149|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
160790521|NCT04634331|580620150|FG000|Overall Study|Withdrawal by Subject|2|||
160790522|NCT04634331|580620151|FG001|Overall Study|Withdrawal by Subject|2|||
161128232|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
161330454|NCT00903201|582597115|FG000|Overall Study|Adverse Event|1|||
161330455|NCT00903201|582597116|FG001|Overall Study|Adverse Event|4|||
161330456|NCT00903201|582597117|FG002|Overall Study|Adverse Event|0|||
161330457|NCT00903201|582597115|FG000|Overall Study|Protocol Violation|2|||
161330458|NCT00903201|582597116|FG001|Overall Study|Protocol Violation|1|||
160790523|NCT00553475|580620152|FG000|Overall Study|Adverse Event|7|||
160790524|NCT00553475|580620153|FG001|Overall Study|Adverse Event|17|||
160790525|NCT00553475|580620154|FG002|Overall Study|Adverse Event|13|||
160790526|NCT00553475|580620152|FG000|Overall Study|Lack of Efficacy|7|||
160790527|NCT00553475|580620153|FG001|Overall Study|Lack of Efficacy|1|||
160790528|NCT00553475|580620154|FG002|Overall Study|Lack of Efficacy|0|||
160790529|NCT00553475|580620152|FG000|Overall Study|Withdrawal by Subject|1|||
160790530|NCT00553475|580620153|FG001|Overall Study|Withdrawal by Subject|1|||
160790531|NCT00553475|580620154|FG002|Overall Study|Withdrawal by Subject|0|||
160790532|NCT00553475|580620152|FG000|Overall Study|Physician Decision|1|||
160790533|NCT00553475|580620153|FG001|Overall Study|Physician Decision|0|||
160790534|NCT00553475|580620154|FG002|Overall Study|Physician Decision|0|||
160790535|NCT00553475|580620152|FG000|Overall Study|Due to moving|0|||
160892158|NCT00395538|581000523|FG001|Overall Study|Pregnancy|0|||
161330459|NCT00903201|582597117|FG002|Overall Study|Protocol Violation|0|||
161330460|NCT00903201|582597115|FG000|Overall Study|Lost to Follow-up|0|||
161330461|NCT00903201|582597116|FG001|Overall Study|Lost to Follow-up|1|||
161330462|NCT00903201|582597117|FG002|Overall Study|Lost to Follow-up|0|||
161330463|NCT00903201|582597115|FG000|Overall Study|Physician Decision|1|||
161330464|NCT00903201|582597116|FG001|Overall Study|Physician Decision|0|||
161330465|NCT00903201|582597117|FG002|Overall Study|Physician Decision|1|||
161330466|NCT00903201|582597115|FG000|Overall Study|Withdrawal by Subject|1|||
161330467|NCT00903201|582597116|FG001|Overall Study|Withdrawal by Subject|0|||
161330468|NCT00903201|582597117|FG002|Overall Study|Withdrawal by Subject|1|||
161330469|NCT01094288|582597120|FG000|Overall Study|Adverse Event|0|||
161330470|NCT01094288|582597121|FG001|Overall Study|Adverse Event|3|||
161330471|NCT01094288|582597122|FG002|Overall Study|Adverse Event|1|||
161330472|NCT01094288|582597123|FG003|Overall Study|Adverse Event|1|||
161330473|NCT01094288|582597124|FG004|Overall Study|Adverse Event|0|||
161330474|NCT01094288|582597125|FG005|Overall Study|Adverse Event|0|||
161330475|NCT01094288|582597126|FG006|Overall Study|Adverse Event|0|||
161330476|NCT01094288|582597127|FG007|Overall Study|Adverse Event|0|||
161330477|NCT01094288|582597120|FG000|Overall Study|Withdrawal by Subject|0|||
161330478|NCT01094288|582597121|FG001|Overall Study|Withdrawal by Subject|1|||
161330479|NCT01094288|582597122|FG002|Overall Study|Withdrawal by Subject|2|||
161330480|NCT01094288|582597123|FG003|Overall Study|Withdrawal by Subject|0|||
161330481|NCT01094288|582597124|FG004|Overall Study|Withdrawal by Subject|0|||
161330482|NCT01094288|582597125|FG005|Overall Study|Withdrawal by Subject|0|||
161330483|NCT01094288|582597126|FG006|Overall Study|Withdrawal by Subject|0|||
161330484|NCT01094288|582597127|FG007|Overall Study|Withdrawal by Subject|2|||
161330485|NCT01094288|582597120|FG000|Overall Study|Initiation of Alternative Therapy|0|||
161330486|NCT01094288|582597121|FG001|Overall Study|Initiation of Alternative Therapy|0|||
160790536|NCT00553475|580620153|FG001|Overall Study|Due to moving|1|||
160790537|NCT00553475|580620154|FG002|Overall Study|Due to moving|0|||
160790538|NCT02916433|580620155|FG000|Overall Study|Withdrawal by Subject|1|||
160790539|NCT02916433|580620156|FG001|Overall Study|Withdrawal by Subject|0|||
160892159|NCT00395538|581000524|FG002|Overall Study|Pregnancy|0|||
161235521|NCT03238781|582244913|FG001|Overall Study|Decision by sponsor|1|||
161235522|NCT03238781|582244914|FG002|Overall Study|Decision by sponsor|0|||
161235523|NCT03161405|582244915|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
161235524|NCT01577381|582244916|FG000|Overall Study|Discontinued|2|||
161235525|NCT01577381|582244917|FG001|Overall Study|Discontinued|1|||
161235526|NCT01577381|582244918|FG002|Overall Study|Discontinued|2|||
161235527|NCT01577381|582244919|FG003|Overall Study|Discontinued|2|||
161235528|NCT01577381|582244916|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
161235529|NCT01577381|582244917|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
161235530|NCT01577381|582244918|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
161235531|NCT01577381|582244919|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
161235532|NCT01421277|582244920|FG000|Overall Study|Lack of qualifying event|0|||
161235533|NCT01421277|582244921|FG001|Overall Study|Lack of qualifying event|61|||
161235534|NCT01421277|582244920|FG000|Overall Study|Incomplete baseline data|0|||
161235535|NCT01421277|582244921|FG001|Overall Study|Incomplete baseline data|31|||
161235536|NCT02039908|582244922|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
161235537|NCT02039908|582244923|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
161235538|NCT02039908|582244924|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
161235539|NCT02039908|582244925|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
160790540|NCT02916433|580620155|FG000|Overall Study|Physician Decision|1|||
160790541|NCT02916433|580620156|FG001|Overall Study|Physician Decision|0|||
160790542|NCT01694771|580620157|FG000|Overall Study|Adverse Event|18|||
160790543|NCT01694771|580620158|FG001|Overall Study|Adverse Event|16|||
160790544|NCT01694771|580620157|FG000|Overall Study|Lack of Efficacy|1|||
161235540|NCT02039908|582244922|FG000|Phase 1-Summer|Protocol Violation|6|||
161235541|NCT02039908|582244923|FG001|Phase 1-Summer|Protocol Violation|0|||
161235542|NCT02039908|582244924|FG002|Phase 1-Summer|Protocol Violation|0|||
161235543|NCT02039908|582244925|FG003|Phase 1-Summer|Protocol Violation|0|||
161235544|NCT02039908|582244922|FG000|Phase 2-School Year|Lost to Follow-up|0|||
161235545|NCT02039908|582244923|FG001|Phase 2-School Year|Lost to Follow-up|0|||
161235546|NCT02039908|582244924|FG002|Phase 2-School Year|Lost to Follow-up|1|||
161235547|NCT02039908|582244925|FG003|Phase 2-School Year|Lost to Follow-up|3|||
161235548|NCT02039908|582244922|FG000|Phase 2-School Year|Protocol Violation|0|||
161235549|NCT02039908|582244923|FG001|Phase 2-School Year|Protocol Violation|0|||
161235550|NCT02039908|582244924|FG002|Phase 2-School Year|Protocol Violation|3|||
161235551|NCT02039908|582244925|FG003|Phase 2-School Year|Protocol Violation|0|||
161235552|NCT02039908|582244922|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
161235553|NCT02039908|582244923|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
161235554|NCT02039908|582244924|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
161235555|NCT02039908|582244925|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
161235556|NCT01597245|582244926|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
161235557|NCT01597245|582244927|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
161235558|NCT01597245|582244928|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
161235559|NCT01597245|582244929|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
161235560|NCT01597245|582244930|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235561|NCT01597245|582244931|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235562|NCT01597245|582244932|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235563|NCT01597245|582244933|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235564|NCT01597245|582244934|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235565|NCT01597245|582244935|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235566|NCT01597245|582244936|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235567|NCT01597245|582244937|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235568|NCT01597245|582244938|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235569|NCT01597245|582244939|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235570|NCT01597245|582244940|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235571|NCT01597245|582244941|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235572|NCT01597245|582244942|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
160790545|NCT01694771|580620158|FG001|Overall Study|Lack of Efficacy|0|||
160790546|NCT01694771|580620157|FG000|Overall Study|Non compliance protocol|7|||
160790547|NCT01694771|580620158|FG001|Overall Study|Non compliance protocol|6|||
160790548|NCT01694771|580620157|FG000|Overall Study|Lost to Follow-up|2|||
161235573|NCT01597245|582244943|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235574|NCT01597245|582244944|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235575|NCT01597245|582244945|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235576|NCT01597245|582244946|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
161235577|NCT01597245|582244926|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
161235578|NCT01597245|582244927|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
160790549|NCT01694771|580620158|FG001|Overall Study|Lost to Follow-up|3|||
160790550|NCT01694771|580620157|FG000|Overall Study|Consent withdrawn|7|||
160790551|NCT01694771|580620158|FG001|Overall Study|Consent withdrawn|9|||
160790552|NCT01694771|580620157|FG000|Overall Study|Other reasons|5|||
160790553|NCT01694771|580620158|FG001|Overall Study|Other reasons|6|||
160790554|NCT00890097|580620159|FG000|Overall Study|Adverse Event|21|||
160790555|NCT00890097|580620160|FG001|Overall Study|Adverse Event|32|||
160790556|NCT00890097|580620161|FG002|Overall Study|Adverse Event|28|||
160790557|NCT00890097|580620159|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
160790558|NCT00890097|580620160|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
160790559|NCT00890097|580620161|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
160790560|NCT00890097|580620159|FG000|Overall Study|Withdrew Consent|9|||
161128233|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
161128234|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
161128235|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
161128236|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
161128237|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161128238|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
161128239|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161128240|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
161128241|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
161128242|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
161128243|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
161128244|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
161128245|NCT02591615|581856820|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
161128246|NCT02591615|581856821|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161128247|NCT02591615|581856822|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161128248|NCT02591615|581856823|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
161128249|NCT02591615|581856820|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
161128250|NCT02591615|581856821|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
161128251|NCT02591615|581856822|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
161128252|NCT02591615|581856823|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
160790561|NCT00890097|580620160|FG001|Overall Study|Withdrew Consent|6|||
160790562|NCT00890097|580620161|FG002|Overall Study|Withdrew Consent|9|||
160790563|NCT00890097|580620159|FG000|Overall Study|Lost to Follow-up|5|||
160790564|NCT00890097|580620160|FG001|Overall Study|Lost to Follow-up|5|||
160790565|NCT00890097|580620161|FG002|Overall Study|Lost to Follow-up|5|||
160790566|NCT00890097|580620159|FG000|Overall Study|Noncompliance|0|||
160790567|NCT00890097|580620160|FG001|Overall Study|Noncompliance|4|||
160790568|NCT00890097|580620161|FG002|Overall Study|Noncompliance|4|||
160790569|NCT00890097|580620159|FG000|Overall Study|Sponsor Decision|7|||
160790570|NCT00890097|580620160|FG001|Overall Study|Sponsor Decision|11|||
160790571|NCT00890097|580620161|FG002|Overall Study|Sponsor Decision|7|||
160790572|NCT00890097|580620159|FG000|Overall Study|Did not attend final visit|2|||
160790573|NCT00890097|580620160|FG001|Overall Study|Did not attend final visit|3|||
160790574|NCT00890097|580620161|FG002|Overall Study|Did not attend final visit|0|||
160790575|NCT00890097|580620159|FG000|Overall Study|Subject Decision|3|||
160790576|NCT00890097|580620160|FG001|Overall Study|Subject Decision|2|||
160790577|NCT00890097|580620161|FG002|Overall Study|Subject Decision|6|||
160790578|NCT00890097|580620159|FG000|Overall Study|Randomization Error|2|||
160790579|NCT00890097|580620160|FG001|Overall Study|Randomization Error|0|||
160790580|NCT00890097|580620161|FG002|Overall Study|Randomization Error|0|||
160790581|NCT00890097|580620159|FG000|Overall Study|Failed inclusion criteria|3|||
160790582|NCT00890097|580620160|FG001|Overall Study|Failed inclusion criteria|4|||
160790583|NCT00890097|580620161|FG002|Overall Study|Failed inclusion criteria|0|||
160790584|NCT00890097|580620159|FG000|Overall Study|Transportation|0|||
160790585|NCT00890097|580620160|FG001|Overall Study|Transportation|2|||
160790586|NCT00890097|580620161|FG002|Overall Study|Transportation|0|||
160790587|NCT00890097|580620159|FG000|Overall Study|Subject Moved|0|||
160790588|NCT00890097|580620160|FG001|Overall Study|Subject Moved|4|||
160790589|NCT00890097|580620161|FG002|Overall Study|Subject Moved|0|||
160790590|NCT00890097|580620159|FG000|Overall Study|Protocol Deviation|1|||
160790591|NCT00890097|580620160|FG001|Overall Study|Protocol Deviation|1|||
160790592|NCT00890097|580620161|FG002|Overall Study|Protocol Deviation|1|||
160790593|NCT03878069|580620162|FG000|Overall Study|Death|0|||
160790594|NCT03878069|580620163|FG001|Overall Study|Death|1|||
160790595|NCT03878069|580620164|FG002|Overall Study|Death|0|||
160790596|NCT03810495|580620165|FG000|Overall Study|Lost to Follow-up|2|||
160790597|NCT03810495|580620165|FG000|Overall Study|Withdrawal by Subject|1|||
160790598|NCT04101331|580621496|FG000|Overall Study|Adverse Event|9|||
160790599|NCT04101331|580621496|FG000|Overall Study|Disease progression|82|||
160790600|NCT04101331|580621496|FG000|Overall Study|Withdrawal by Subject|1|||
160790601|NCT04101331|580621496|FG000|Overall Study|Investigator decision|6|||
160790602|NCT04101331|580621496|FG000|Overall Study|Death|6|||
160790603|NCT04101331|580621496|FG000|Overall Study|Allogenic transplant|1|||
160790604|NCT00866775|580621500|FG000|Overall Study|Adverse Event|5|||
160790605|NCT00866775|580621501|FG001|Overall Study|Adverse Event|19|||
160790606|NCT00866775|580621500|FG000|Overall Study|Death|1|||
160790607|NCT00866775|580621501|FG001|Overall Study|Death|0|||
160790608|NCT00866775|580621500|FG000|Overall Study|Lost to Follow-up|0|||
160790609|NCT00866775|580621501|FG001|Overall Study|Lost to Follow-up|4|||
160790610|NCT00866775|580621500|FG000|Overall Study|Physician Decision|0|||
160790611|NCT00866775|580621501|FG001|Overall Study|Physician Decision|3|||
160790612|NCT00866775|580621500|FG000|Overall Study|Protocol Violation|3|||
160892160|NCT00395538|581000522|FG000|Overall Study|Partial recovery of parathyroid function|0|||
160892161|NCT00395538|581000523|FG001|Overall Study|Partial recovery of parathyroid function|0|||
160892162|NCT00395538|581000524|FG002|Overall Study|Partial recovery of parathyroid function|1|||
160892163|NCT00395538|581000522|FG000|Overall Study|Participant elected to discontinue|0|||
160892164|NCT00395538|581000523|FG001|Overall Study|Participant elected to discontinue|0|||
160892165|NCT00395538|581000524|FG002|Overall Study|Participant elected to discontinue|1|||
160892166|NCT01074047|581000531|FG000|Treatment Phase|Adverse Event|89|||
160892167|NCT01074047|581000532|FG001|Treatment Phase|Adverse Event|66|||
160892168|NCT01074047|581000531|FG000|Treatment Phase|Disease Progression|16|||
160892169|NCT01074047|581000532|FG001|Treatment Phase|Disease Progression|21|||
160892170|NCT01074047|581000531|FG000|Treatment Phase|Withdrawal by Subject|27|||
160892171|NCT01074047|581000532|FG001|Treatment Phase|Withdrawal by Subject|48|||
160892172|NCT01074047|581000531|FG000|Treatment Phase|Death|53|||
160892173|NCT01074047|581000532|FG001|Treatment Phase|Death|58|||
160892174|NCT01074047|581000531|FG000|Treatment Phase|Lost to Follow-up|0|||
160892175|NCT01074047|581000532|FG001|Treatment Phase|Lost to Follow-up|1|||
160892176|NCT01074047|581000531|FG000|Treatment Phase|Protocol Violation|0|||
160892177|NCT01074047|581000532|FG001|Treatment Phase|Protocol Violation|1|||
160892178|NCT01074047|581000531|FG000|Treatment Phase|Miscellaneous|32|||
160892179|NCT01074047|581000532|FG001|Treatment Phase|Miscellaneous|39|||
160892180|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
160892181|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
160892182|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
160892183|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
160892184|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Death|116|||
160892185|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Death|124|||
160892186|NCT01074047|581000531|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
160892187|NCT01074047|581000532|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
160892188|NCT01074047|581000531|FG000|Extension Phase|Physician Decision|1|||
160892189|NCT01074047|581000532|FG001|Extension Phase|Physician Decision|0|||
160892190|NCT01074047|581000531|FG000|Extension Phase|Adverse Event|5|||
160892191|NCT01074047|581000532|FG001|Extension Phase|Adverse Event|0|||
160892192|NCT01074047|581000531|FG000|Extension Phase|Disease Progression|9|||
160892193|NCT01074047|581000532|FG001|Extension Phase|Disease Progression|0|||
160892194|NCT01074047|581000531|FG000|Extension Phase|Withdrawal by Subject|2|||
160892195|NCT01074047|581000532|FG001|Extension Phase|Withdrawal by Subject|0|||
160892196|NCT01074047|581000531|FG000|Extension Phase|Death|5|||
160892197|NCT01074047|581000532|FG001|Extension Phase|Death|0|||
160892198|NCT02211638|581000533|FG000|Overall Study|Case Report Forms Uncollected|291|||
160892199|NCT02211638|581000533|FG000|Overall Study|Protocol Violation|692|||
160892200|NCT03120624|581000535|FG000|Overall Study|Withdrawal by Subject|0|||
160892201|NCT03120624|581000536|FG001|Overall Study|Withdrawal by Subject|1|||
160892202|NCT03120624|581000537|FG002|Overall Study|Withdrawal by Subject|0|||
160892203|NCT03120624|581000538|FG003|Overall Study|Withdrawal by Subject|0|||
160892204|NCT03120624|581000539|FG004|Overall Study|Withdrawal by Subject|0|||
160892205|NCT03120624|581000540|FG005|Overall Study|Withdrawal by Subject|0|||
160892206|NCT03120624|581000541|FG006|Overall Study|Withdrawal by Subject|0|||
160892207|NCT03120624|581000542|FG007|Overall Study|Withdrawal by Subject|0|||
160892208|NCT05140382|581000543|FG000|Overall Study|Death|3|||
161235579|NCT01597245|582244928|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
161235580|NCT01597245|582244929|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
160790613|NCT00866775|580621501|FG001|Overall Study|Protocol Violation|4|||
160790614|NCT00866775|580621500|FG000|Overall Study|Withdrawal by Subject|4|||
160790615|NCT00866775|580621501|FG001|Overall Study|Withdrawal by Subject|4|||
160790616|NCT00866775|580621500|FG000|Overall Study|met exit criteria|23|||
160790617|NCT00866775|580621501|FG001|Overall Study|met exit criteria|17|||
160790618|NCT00866775|580621500|FG000|Overall Study|discontinued due to communication error|0|||
160790619|NCT00866775|580621501|FG001|Overall Study|discontinued due to communication error|1|||
160790620|NCT00833703|580621502|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
160790621|NCT00833703|580621503|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
160790622|NCT00003907|580621504|FG000|Overall Study|Adverse Event|2|||
160790623|NCT00003907|580621505|FG001|Overall Study|Adverse Event|11|||
160790624|NCT00003907|580621504|FG000|Overall Study|Death|2|||
160790625|NCT00003907|580621505|FG001|Overall Study|Death|0|||
160790626|NCT00003907|580621504|FG000|Overall Study|Withdrawal by Subject|1|||
160790627|NCT00003907|580621505|FG001|Overall Study|Withdrawal by Subject|3|||
160790628|NCT00003907|580621504|FG000|Overall Study|Progressive disease|4|||
160790629|NCT00003907|580621505|FG001|Overall Study|Progressive disease|4|||
160790630|NCT00003907|580621504|FG000|Overall Study|Complicating disease|1|||
160790631|NCT00003907|580621505|FG001|Overall Study|Complicating disease|0|||
160790632|NCT00003907|580621504|FG000|Overall Study|Other|1|||
160790633|NCT00003907|580621505|FG001|Overall Study|Other|3|||
160790634|NCT00003907|580621504|FG000|Overall Study|ineligible or not treated|2|||
160790635|NCT00003907|580621505|FG001|Overall Study|ineligible or not treated|2|||
160790636|NCT00993473|580621508|FG000|Overall Study|Adverse Event|0|||
160790637|NCT00993473|580621509|FG001|Overall Study|Adverse Event|2|||
160790638|NCT00993473|580621508|FG000|Overall Study|Protocol Violation|1|||
160790639|NCT00993473|580621509|FG001|Overall Study|Protocol Violation|2|||
160790640|NCT00993473|580621508|FG000|Overall Study|Lost to Follow-up|1|||
160790641|NCT00993473|580621509|FG001|Overall Study|Lost to Follow-up|0|||
160790642|NCT00993473|580621508|FG000|Overall Study|Withdrawal by Subject|1|||
160790643|NCT00993473|580621509|FG001|Overall Study|Withdrawal by Subject|5|||
160790644|NCT00993473|580621508|FG000|Overall Study|Technical problem with CGM device|0|||
160790645|NCT00993473|580621509|FG001|Overall Study|Technical problem with CGM device|1|||
160790646|NCT00993473|580621508|FG000|Overall Study|Family event|1|||
160790647|NCT00993473|580621509|FG001|Overall Study|Family event|0|||
160790648|NCT02439957|580621520|FG000|Overall Study|Study Terminated|3|||
160790649|NCT02439957|580621521|FG001|Overall Study|Study Terminated|3|||
160790650|NCT00770679|580621522|FG000|Overall Study|Lost to Follow-up|3|||
160790651|NCT00770679|580621522|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
160790652|NCT00831389|580621523|FG000|Overall Study|Withdrawal by Subject|0|||
160790653|NCT00831389|580621524|FG001|Overall Study|Withdrawal by Subject|1|||
160790654|NCT00752219|580621526|FG000|Overall Study|Clinical failure|0|||
160790655|NCT00752219|580621527|FG001|Overall Study|Clinical failure|1|||
160790656|NCT00752219|580621526|FG000|Overall Study|Adverse Event|5|||
160790657|NCT00752219|580621527|FG001|Overall Study|Adverse Event|3|||
160790658|NCT00752219|580621526|FG000|Overall Study|Protocol deviation|1|||
160790659|NCT00752219|580621527|FG001|Overall Study|Protocol deviation|0|||
160790660|NCT00752219|580621526|FG000|Overall Study|Lost to Follow-up|1|||
160790661|NCT00752219|580621527|FG001|Overall Study|Lost to Follow-up|2|||
160790662|NCT00752219|580621526|FG000|Overall Study|Randomized but not treated|1|||
160790663|NCT00752219|580621527|FG001|Overall Study|Randomized but not treated|0|||
160790664|NCT00752219|580621526|FG000|Overall Study|Other|3|||
161128253|NCT02591615|581856820|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
161330487|NCT01094288|582597122|FG002|Overall Study|Initiation of Alternative Therapy|1|||
161330488|NCT01094288|582597123|FG003|Overall Study|Initiation of Alternative Therapy|0|||
160790665|NCT00752219|580621527|FG001|Overall Study|Other|0|||
161128254|NCT02591615|581856821|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
161128255|NCT02591615|581856822|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
161128256|NCT02591615|581856823|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
161128257|NCT02591615|581856820|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
161128258|NCT02591615|581856821|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
161128259|NCT02591615|581856822|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
161128260|NCT02591615|581856823|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
161128261|NCT02591615|581856820|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161128262|NCT02591615|581856821|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161128263|NCT02591615|581856822|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
161128264|NCT02591615|581856823|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
161128265|NCT02591615|581856820|FG000|Maintenance MK-3475|Adverse Event|0|||
161128266|NCT02591615|581856821|FG001|Maintenance MK-3475|Adverse Event|3|||
161128267|NCT02591615|581856822|FG002|Maintenance MK-3475|Adverse Event|1|||
161128268|NCT02591615|581856823|FG003|Maintenance MK-3475|Adverse Event|2|||
161128269|NCT02591615|581856820|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
161128270|NCT02591615|581856821|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
161128271|NCT02591615|581856822|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
161128272|NCT02591615|581856823|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
161128273|NCT02591615|581856820|FG000|Maintenance MK-3475|Death|0|||
161128274|NCT02591615|581856821|FG001|Maintenance MK-3475|Death|1|||
161128275|NCT02591615|581856822|FG002|Maintenance MK-3475|Death|1|||
161128276|NCT02591615|581856823|FG003|Maintenance MK-3475|Death|0|||
161128277|NCT02591615|581856820|FG000|Maintenance MK-3475|Physician discretion|0|||
161128278|NCT02591615|581856821|FG001|Maintenance MK-3475|Physician discretion|0|||
161128279|NCT02591615|581856822|FG002|Maintenance MK-3475|Physician discretion|1|||
161128280|NCT02591615|581856823|FG003|Maintenance MK-3475|Physician discretion|0|||
161128281|NCT02591615|581856820|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
161128282|NCT02591615|581856821|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
161128283|NCT02591615|581856822|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
161128284|NCT02591615|581856823|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
161128285|NCT02591615|581856820|FG000|Maintenance MK-3475|In active treatment|2|||
161128286|NCT02591615|581856821|FG001|Maintenance MK-3475|In active treatment|0|||
161128287|NCT02591615|581856822|FG002|Maintenance MK-3475|In active treatment|0|||
160790666|NCT01682720|580621538|FG000|Overall Study|Randomized but Not Treated|0|||
160790667|NCT01682720|580621539|FG001|Overall Study|Randomized but Not Treated|1|||
160790668|NCT01682720|580621540|FG002|Overall Study|Randomized but Not Treated|1|||
161128288|NCT02591615|581856823|FG003|Maintenance MK-3475|In active treatment|1|||
161128289|NCT00469612|581856828|FG000|Overall Study|Study terminated before data collected|2|||
161128290|NCT00469612|581856829|FG001|Overall Study|Study terminated before data collected|0|||
161128291|NCT02357420|581856830|FG000|Overall Study|Adverse Event|3|||
161128292|NCT02357420|581856831|FG001|Overall Study|Adverse Event|3|||
160790669|NCT01682720|580621541|FG003|Overall Study|Randomized but Not Treated|0|||
160790670|NCT01682720|580621538|FG000|Overall Study|Terminated by Sponsor|83|||
160790671|NCT01682720|580621539|FG001|Overall Study|Terminated by Sponsor|0|||
161128293|NCT02357420|581856832|FG002|Overall Study|Adverse Event|8|||
161128294|NCT02357420|581856833|FG003|Overall Study|Adverse Event|9|||
161128295|NCT02357420|581856830|FG000|Overall Study|Investigator Decision|1|||
161128296|NCT02357420|581856831|FG001|Overall Study|Investigator Decision|0|||
161128297|NCT02357420|581856832|FG002|Overall Study|Investigator Decision|0|||
161128298|NCT02357420|581856833|FG003|Overall Study|Investigator Decision|0|||
161128299|NCT02357420|581856830|FG000|Overall Study|Prohibited Medication|1|||
161128300|NCT02357420|581856831|FG001|Overall Study|Prohibited Medication|1|||
161128301|NCT02357420|581856832|FG002|Overall Study|Prohibited Medication|0|||
161128302|NCT02357420|581856833|FG003|Overall Study|Prohibited Medication|0|||
161128303|NCT02357420|581856830|FG000|Overall Study|Protocol Non-compliance|0|||
161128304|NCT02357420|581856831|FG001|Overall Study|Protocol Non-compliance|0|||
161128305|NCT02357420|581856832|FG002|Overall Study|Protocol Non-compliance|0|||
161128306|NCT02357420|581856833|FG003|Overall Study|Protocol Non-compliance|1|||
161128307|NCT02357420|581856830|FG000|Overall Study|Withdrawn Consent|4|||
161128308|NCT02357420|581856831|FG001|Overall Study|Withdrawn Consent|8|||
160790672|NCT01682720|580621540|FG002|Overall Study|Terminated by Sponsor|0|||
160790673|NCT01682720|580621541|FG003|Overall Study|Terminated by Sponsor|0|||
160790674|NCT01682720|580621538|FG000|Overall Study|Efficacy Failure|0|||
160790675|NCT01682720|580621539|FG001|Overall Study|Efficacy Failure|3|||
161128309|NCT02357420|581856832|FG002|Overall Study|Withdrawn Consent|6|||
161128310|NCT02357420|581856833|FG003|Overall Study|Withdrawn Consent|6|||
161128311|NCT02357420|581856830|FG000|Overall Study|Lost to Follow-up|3|||
161128312|NCT02357420|581856831|FG001|Overall Study|Lost to Follow-up|0|||
160790676|NCT01682720|580621540|FG002|Overall Study|Efficacy Failure|3|||
160790677|NCT01682720|580621541|FG003|Overall Study|Efficacy Failure|30|||
161128313|NCT02357420|581856832|FG002|Overall Study|Lost to Follow-up|2|||
161128314|NCT02357420|581856833|FG003|Overall Study|Lost to Follow-up|3|||
161128315|NCT00214461|581856834|FG000|Overall Study|Adverse Event|0|||
161128316|NCT00214461|581856835|FG001|Overall Study|Adverse Event|0|||
161128317|NCT00214461|581856836|FG002|Overall Study|Adverse Event|1|||
161128318|NCT00214461|581856837|FG003|Overall Study|Adverse Event|1|||
161128319|NCT00214461|581856834|FG000|Overall Study|Withdrawal by Subject|0|||
161128320|NCT00214461|581856835|FG001|Overall Study|Withdrawal by Subject|0|||
161128321|NCT00214461|581856836|FG002|Overall Study|Withdrawal by Subject|1|||
161128322|NCT00214461|581856837|FG003|Overall Study|Withdrawal by Subject|0|||
161128323|NCT00364689|581856838|FG000|Overall Study|Lost to Follow-up|1|||
161128324|NCT00234039|581856839|FG000|Overall Study|Adverse Event|2|||
161128325|NCT00234039|581856839|FG000|Overall Study|Progression/relapse|34|||
161128326|NCT00234039|581856839|FG000|Overall Study|Other - Not Protocol Specified|3|||
161128327|NCT00234039|581856839|FG000|Overall Study|Ineligible|9|||
161128328|NCT00234039|581856839|FG000|Overall Study|No Protocol Treatment Received|2|||
161235581|NCT01597245|582244930|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235582|NCT01597245|582244931|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235583|NCT01597245|582244932|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235584|NCT01597245|582244933|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235585|NCT01597245|582244934|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160790678|NCT01682720|580621538|FG000|Overall Study|Lost to Follow-up|1|||
160790679|NCT01682720|580621539|FG001|Overall Study|Lost to Follow-up|1|||
160790680|NCT01682720|580621540|FG002|Overall Study|Lost to Follow-up|0|||
160790681|NCT01682720|580621541|FG003|Overall Study|Lost to Follow-up|6|||
160790682|NCT01682720|580621538|FG000|Overall Study|Subject Withdrew Consent|0|||
160790683|NCT01682720|580621539|FG001|Overall Study|Subject Withdrew Consent|0|||
160790684|NCT01682720|580621540|FG002|Overall Study|Subject Withdrew Consent|2|||
160790685|NCT01682720|580621541|FG003|Overall Study|Subject Withdrew Consent|2|||
160790686|NCT01682720|580621538|FG000|Overall Study|Adverse Event|1|||
160790687|NCT01682720|580621539|FG001|Overall Study|Adverse Event|0|||
160790688|NCT01682720|580621540|FG002|Overall Study|Adverse Event|1|||
160790689|NCT01682720|580621541|FG003|Overall Study|Adverse Event|1|||
161235586|NCT01597245|582244935|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235587|NCT01597245|582244936|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235588|NCT01597245|582244937|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235589|NCT01597245|582244938|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235590|NCT01597245|582244939|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
160790690|NCT01687595|580621542|FG000|Overall Study|Withdrawal by Subject|8|||
160790691|NCT01687595|580621543|FG001|Overall Study|Withdrawal by Subject|0|||
160790692|NCT01687595|580621542|FG000|Overall Study|Lost to Follow-up|3|||
160790693|NCT01687595|580621543|FG001|Overall Study|Lost to Follow-up|1|||
161128329|NCT01808612|581856840|FG000|Treatment Period|Adverse Event|8|||
161128330|NCT01808612|581856841|FG001|Treatment Period|Adverse Event|4|||
161128331|NCT01808612|581856842|FG002|Treatment Period|Adverse Event|3|||
161128332|NCT01808612|581856840|FG000|Treatment Period|Lost to Follow-up|2|||
161128333|NCT01808612|581856841|FG001|Treatment Period|Lost to Follow-up|2|||
161128334|NCT01808612|581856842|FG002|Treatment Period|Lost to Follow-up|1|||
160790694|NCT01687595|580621542|FG000|Overall Study|Investigator's decision|1|||
160790695|NCT01687595|580621543|FG001|Overall Study|Investigator's decision|0|||
160790696|NCT01687595|580621542|FG000|Overall Study|Sponsor's decision|1|||
160790697|NCT01687595|580621543|FG001|Overall Study|Sponsor's decision|0|||
160790698|NCT01687595|580621542|FG000|Overall Study|Noncompliance|1|||
160790699|NCT01687595|580621543|FG001|Overall Study|Noncompliance|2|||
160790700|NCT01687595|580621542|FG000|Overall Study|Other than specified|56|||
160790701|NCT01687595|580621543|FG001|Overall Study|Other than specified|7|||
160790702|NCT04204902|580621544|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
160790703|NCT04204902|580621545|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
161128335|NCT01808612|581856840|FG000|Treatment Period|Protocol Violation|1|||
161128336|NCT01808612|581856841|FG001|Treatment Period|Protocol Violation|0|||
161128337|NCT01808612|581856842|FG002|Treatment Period|Protocol Violation|0|||
161128338|NCT01808612|581856840|FG000|Treatment Period|Withdrawal by Subject|1|||
161128339|NCT01808612|581856841|FG001|Treatment Period|Withdrawal by Subject|0|||
161128340|NCT01808612|581856842|FG002|Treatment Period|Withdrawal by Subject|4|||
161128341|NCT01808612|581856840|FG000|Treatment Period|Physician Decision|1|||
161128342|NCT01808612|581856841|FG001|Treatment Period|Physician Decision|0|||
161128343|NCT01808612|581856842|FG002|Treatment Period|Physician Decision|4|||
161128344|NCT01808612|581856840|FG000|Treatment Period|Sponsor Decision|1|||
161128345|NCT01808612|581856841|FG001|Treatment Period|Sponsor Decision|0|||
161128346|NCT01808612|581856842|FG002|Treatment Period|Sponsor Decision|0|||
161128347|NCT01808612|581856840|FG000|Treatment Period|Lack of Efficacy|1|||
161128348|NCT01808612|581856841|FG001|Treatment Period|Lack of Efficacy|1|||
161128349|NCT01808612|581856842|FG002|Treatment Period|Lack of Efficacy|2|||
161128350|NCT01808612|581856840|FG000|Discontinuation Period|Adverse Event|1|||
161128351|NCT01808612|581856841|FG001|Discontinuation Period|Adverse Event|0|||
161128352|NCT01808612|581856842|FG002|Discontinuation Period|Adverse Event|0|||
161128353|NCT01808612|581856840|FG000|Discontinuation Period|Physician Decision|1|||
161128354|NCT01808612|581856841|FG001|Discontinuation Period|Physician Decision|0|||
161128355|NCT01808612|581856842|FG002|Discontinuation Period|Physician Decision|0|||
161128356|NCT01808612|581856840|FG000|Discontinuation Period|Lost to Follow-up|0|||
161128357|NCT01808612|581856841|FG001|Discontinuation Period|Lost to Follow-up|1|||
161128358|NCT01808612|581856842|FG002|Discontinuation Period|Lost to Follow-up|0|||
161128359|NCT03683394|581856843|FG000|Overall Study|Withdrawal by Subject|4|||
161128360|NCT03683394|581856844|FG001|Overall Study|Withdrawal by Subject|8|||
161128361|NCT03683394|581856843|FG000|Overall Study|Lost to Follow-up|7|||
161128362|NCT03683394|581856844|FG001|Overall Study|Lost to Follow-up|0|||
161128363|NCT03683394|581856843|FG000|Overall Study|Death|3|||
161128364|NCT03683394|581856844|FG001|Overall Study|Death|1|||
161128365|NCT02239263|581856847|FG000|Overall Study|Protocol Violation|6|||
161128366|NCT00849667|581856854|FG000|Overall Study|Withdrawal by Subject|16|||
161128367|NCT00849667|581856855|FG001|Overall Study|Withdrawal by Subject|33|||
161128368|NCT00849667|581856856|FG002|Overall Study|Withdrawal by Subject|35|||
161128369|NCT00849667|581856854|FG000|Overall Study|Lost to Follow-up|8|||
161128370|NCT00849667|581856855|FG001|Overall Study|Lost to Follow-up|8|||
161128371|NCT00849667|581856856|FG002|Overall Study|Lost to Follow-up|8|||
161128372|NCT00849667|581856854|FG000|Overall Study|Adverse Event|1|||
161128373|NCT00849667|581856855|FG001|Overall Study|Adverse Event|2|||
161128374|NCT00849667|581856856|FG002|Overall Study|Adverse Event|0|||
161128375|NCT00849667|581856854|FG000|Overall Study|Other|18|||
161128376|NCT00849667|581856855|FG001|Overall Study|Other|19|||
161128377|NCT00849667|581856856|FG002|Overall Study|Other|18|||
161128378|NCT00849667|581856854|FG000|Overall Study|Progressive disease|119|||
161128379|NCT00849667|581856855|FG001|Overall Study|Progressive disease|100|||
161128380|NCT00849667|581856856|FG002|Overall Study|Progressive disease|112|||
161128381|NCT00849667|581856854|FG000|Overall Study|Sponsor decision|208|||
161128382|NCT00849667|581856855|FG001|Overall Study|Sponsor decision|204|||
161128383|NCT00849667|581856856|FG002|Overall Study|Sponsor decision|190|||
161128384|NCT00849667|581856854|FG000|Overall Study|Investigator discretion|0|||
161128385|NCT00849667|581856855|FG001|Overall Study|Investigator discretion|0|||
161128386|NCT00849667|581856856|FG002|Overall Study|Investigator discretion|1|||
161128387|NCT00189462|581856857|FG000|Overall Study|Lack of Efficacy|5|||
161128388|NCT00189462|581856858|FG001|Overall Study|Lack of Efficacy|1|||
161128389|NCT00189462|581856857|FG000|Overall Study|Lost to Follow-up|18|||
161128390|NCT00189462|581856858|FG001|Overall Study|Lost to Follow-up|20|||
161128391|NCT00553462|581856859|FG000|Overall Study|Adverse Event|4|||
161128392|NCT00553462|581856859|FG000|Overall Study|Progression|4|||
161128393|NCT00553462|581856859|FG000|Overall Study|Withdrawal by Subject|5|||
161128394|NCT00553462|581856859|FG000|Overall Study|Physician Decision|1|||
161128395|NCT01262625|581856862|FG000|Overall Study|Administrative Error|1|||
161128396|NCT01262625|581856863|FG001|Overall Study|Administrative Error|1|||
161128397|NCT01262625|581856862|FG000|Overall Study|Site Closed|1|||
161128398|NCT01262625|581856863|FG001|Overall Study|Site Closed|0|||
161128399|NCT00110994|581856864|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
161128400|NCT00110994|581856865|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
161128401|NCT00110994|581856864|FG000|Double-blind (DB) Treatment|Death|1|||
161128402|NCT00110994|581856865|FG001|Double-blind (DB) Treatment|Death|0|||
161128403|NCT00110994|581856864|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
160790704|NCT00979407|580621548|FG000|Overall Study|Withdrawal by Subject|3|||
160790705|NCT00979407|580621549|FG001|Overall Study|Withdrawal by Subject|4|||
160790706|NCT00979407|580621548|FG000|Overall Study|Lost to Follow-up|3|||
160790707|NCT00979407|580621549|FG001|Overall Study|Lost to Follow-up|3|||
160790708|NCT02940223|580621550|FG000|Overall Study|Failed Requirement|2|||
160790709|NCT02940223|580621551|FG001|Overall Study|Failed Requirement|0|||
160790710|NCT00803049|580621553|FG000|Overall Study|Adverse Event|21|||
160790711|NCT00803049|580621554|FG001|Overall Study|Adverse Event|33|||
160790712|NCT00803049|580621555|FG002|Overall Study|Adverse Event|13|||
160790713|NCT00803049|580621556|FG003|Overall Study|Adverse Event|27|||
160790714|NCT00803049|580621553|FG000|Overall Study|Lack of Efficacy|10|||
160790715|NCT00803049|580621554|FG001|Overall Study|Lack of Efficacy|19|||
160790716|NCT00803049|580621555|FG002|Overall Study|Lack of Efficacy|6|||
160790717|NCT00803049|580621556|FG003|Overall Study|Lack of Efficacy|13|||
160790718|NCT00803049|580621553|FG000|Overall Study|Lost to Follow-up|0|||
160790719|NCT00803049|580621554|FG001|Overall Study|Lost to Follow-up|2|||
160790720|NCT00803049|580621555|FG002|Overall Study|Lost to Follow-up|0|||
160790721|NCT00803049|580621556|FG003|Overall Study|Lost to Follow-up|3|||
160790722|NCT00803049|580621553|FG000|Overall Study|Death|2|||
160790723|NCT00803049|580621554|FG001|Overall Study|Death|1|||
160790724|NCT00803049|580621555|FG002|Overall Study|Death|0|||
160790725|NCT00803049|580621556|FG003|Overall Study|Death|2|||
160790726|NCT00803049|580621553|FG000|Overall Study|Progressive Disease|6|||
160790727|NCT00803049|580621554|FG001|Overall Study|Progressive Disease|10|||
160790728|NCT00803049|580621555|FG002|Overall Study|Progressive Disease|6|||
160790729|NCT00803049|580621556|FG003|Overall Study|Progressive Disease|6|||
160790730|NCT00803049|580621553|FG000|Overall Study|Withdrawal by Subject|19|||
160790731|NCT00803049|580621554|FG001|Overall Study|Withdrawal by Subject|43|||
160790732|NCT00803049|580621555|FG002|Overall Study|Withdrawal by Subject|16|||
160790733|NCT00803049|580621556|FG003|Overall Study|Withdrawal by Subject|44|||
160790734|NCT00803049|580621553|FG000|Overall Study|Protocol Violation|0|||
160790735|NCT00803049|580621554|FG001|Overall Study|Protocol Violation|1|||
160790736|NCT00803049|580621555|FG002|Overall Study|Protocol Violation|1|||
160790737|NCT00803049|580621556|FG003|Overall Study|Protocol Violation|0|||
160790738|NCT00803049|580621553|FG000|Overall Study|Randomized and Not Treated|0|||
160790739|NCT00803049|580621554|FG001|Overall Study|Randomized and Not Treated|0|||
160790740|NCT00803049|580621555|FG002|Overall Study|Randomized and Not Treated|0|||
160790741|NCT00803049|580621556|FG003|Overall Study|Randomized and Not Treated|2|||
160790742|NCT00803049|580621553|FG000|Overall Study|Other than Specified Above|3|||
160790743|NCT00803049|580621554|FG001|Overall Study|Other than Specified Above|9|||
160790744|NCT00803049|580621555|FG002|Overall Study|Other than Specified Above|2|||
160790745|NCT00803049|580621556|FG003|Overall Study|Other than Specified Above|5|||
160790746|NCT03773562|580621557|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
160790747|NCT03773562|580621557|FG000|Overall Study|Lost to Follow-up|10|||
160790748|NCT03773562|580621557|FG000|Overall Study|Withdrawal by Subject|1|||
160790749|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
160790750|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
160790751|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
160790752|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
160790753|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
160790754|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
160790755|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
161235591|NCT01597245|582244940|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235592|NCT01597245|582244941|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235593|NCT01597245|582244942|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235594|NCT01597245|582244943|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235595|NCT01597245|582244944|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235596|NCT01597245|582244945|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235597|NCT01597245|582244946|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
161235598|NCT01597245|582244926|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
161235599|NCT01597245|582244927|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
161235600|NCT01597245|582244928|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
160790756|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
160790757|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
160790758|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
160790759|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
160790760|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
160790761|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
160790762|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
160790763|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
160790764|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
160790765|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
160790766|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
160790767|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
160790768|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
160790769|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
160790770|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
160790771|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
160790772|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
160790773|NCT01272219|580621558|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
160790774|NCT01272219|580621559|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
160790775|NCT01272219|580621560|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
160790776|NCT01272219|580621561|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
160790777|NCT01272219|580621562|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
160790778|NCT01272219|580621563|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
160790779|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
160790780|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
160790781|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
160790782|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
160790783|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
160790784|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
160790785|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790786|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790787|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790788|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
160790789|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790790|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
160790791|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790792|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
160790793|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790794|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
160790795|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790796|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
160790797|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
160790798|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
160790799|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
160790800|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
160790801|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
160790802|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
160790803|NCT01272219|580621558|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
160790804|NCT01272219|580621559|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
160790805|NCT01272219|580621560|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
160790806|NCT01272219|580621561|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
160790807|NCT01272219|580621562|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
160790808|NCT01272219|580621563|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
160790809|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790810|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790811|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790812|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
160790813|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
160790814|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
160790815|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160790816|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160790817|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
161235601|NCT01597245|582244929|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
160790818|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
160790819|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
160790820|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
161235602|NCT01597245|582244930|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235603|NCT01597245|582244931|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235604|NCT01597245|582244932|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235605|NCT01597245|582244933|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235606|NCT01597245|582244934|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235607|NCT01597245|582244935|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235608|NCT01597245|582244936|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235609|NCT01597245|582244937|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235610|NCT01597245|582244938|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235611|NCT01597245|582244939|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235612|NCT01597245|582244940|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
160790821|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790822|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790823|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790824|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
160790825|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
160790826|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
160790827|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790828|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790829|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790830|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
160790831|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
160790832|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
160892209|NCT05140382|581000544|FG001|Overall Study|Death|0|||
160892210|NCT05140382|581000545|FG002|Overall Study|Death|0|||
160892211|NCT05140382|581000543|FG000|Overall Study|Investigator decision|1|||
160892212|NCT05140382|581000544|FG001|Overall Study|Investigator decision|0|||
160892213|NCT05140382|581000545|FG002|Overall Study|Investigator decision|0|||
160892214|NCT05140382|581000543|FG000|Overall Study|Other|4|||
160892215|NCT05140382|581000544|FG001|Overall Study|Other|0|||
160892216|NCT05140382|581000545|FG002|Overall Study|Other|1|||
160892217|NCT05140382|581000543|FG000|Overall Study|Progressive disease|20|||
160892218|NCT05140382|581000544|FG001|Overall Study|Progressive disease|1|||
160892219|NCT05140382|581000545|FG002|Overall Study|Progressive disease|12|||
161235613|NCT01597245|582244941|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235614|NCT01597245|582244942|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235615|NCT01597245|582244943|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235616|NCT01597245|582244944|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235617|NCT01597245|582244945|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235618|NCT01597245|582244946|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
161235619|NCT01597245|582244926|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
161235620|NCT01597245|582244927|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
161235621|NCT01597245|582244928|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
161235622|NCT01597245|582244929|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235623|NCT01597245|582244930|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235624|NCT01597245|582244931|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235625|NCT01597245|582244932|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235626|NCT01597245|582244933|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235627|NCT01597245|582244934|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235628|NCT01597245|582244935|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235629|NCT01597245|582244936|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235630|NCT01597245|582244937|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235631|NCT01597245|582244938|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235632|NCT01597245|582244939|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235633|NCT01597245|582244940|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235634|NCT01597245|582244941|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235635|NCT01597245|582244942|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235636|NCT01597245|582244943|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235637|NCT01597245|582244944|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235638|NCT01597245|582244945|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235639|NCT01597245|582244946|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
161235640|NCT01597245|582244926|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
161235641|NCT01597245|582244927|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235642|NCT01597245|582244928|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235643|NCT01597245|582244929|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
161235644|NCT01597245|582244930|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235645|NCT01597245|582244931|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235646|NCT01597245|582244932|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235647|NCT01597245|582244933|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235648|NCT01597245|582244934|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235649|NCT01597245|582244935|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235650|NCT01597245|582244936|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235651|NCT01597245|582244937|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235652|NCT01597245|582244938|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
160790833|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
160790834|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
160892220|NCT05140382|581000543|FG000|Overall Study|Subjective disease progression|2|||
160892221|NCT05140382|581000544|FG001|Overall Study|Subjective disease progression|1|||
160892222|NCT05140382|581000545|FG002|Overall Study|Subjective disease progression|0|||
160790835|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
160790836|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
160790837|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
160790838|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
160790839|NCT01272219|580621558|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
160790840|NCT01272219|580621559|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
160790841|NCT01272219|580621560|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
161128404|NCT00110994|581856865|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
161128405|NCT00110994|581856864|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
161128406|NCT00110994|581856865|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
161128407|NCT00110994|581856864|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
161128408|NCT00110994|581856865|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
161128409|NCT00110994|581856864|FG000|Double-blind (DB) Treatment|other reasons|2|||
161128410|NCT00110994|581856865|FG001|Double-blind (DB) Treatment|other reasons|3|||
161128411|NCT00110994|581856864|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
161128412|NCT00110994|581856865|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
161128413|NCT00110994|581856864|FG000|Active Follow-up|Other reasons|0|||
161128414|NCT00110994|581856865|FG001|Active Follow-up|Other reasons|2|||
161128415|NCT00110994|581856864|FG000|Long Term Follow-up|Death|19|||
161128416|NCT00110994|581856865|FG001|Long Term Follow-up|Death|17|||
161128417|NCT04398732|581856866|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
161128418|NCT02772757|581856869|FG000|Overall Study|Withdrawal by Subject|1|||
161128419|NCT02772757|581856870|FG001|Overall Study|Withdrawal by Subject|0|||
161128420|NCT02772757|581856871|FG002|Overall Study|Withdrawal by Subject|1|||
161128421|NCT02772757|581856869|FG000|Overall Study|Protocol Violation|0|||
161128422|NCT02772757|581856870|FG001|Overall Study|Protocol Violation|0|||
161128423|NCT02772757|581856871|FG002|Overall Study|Protocol Violation|1|||
161128424|NCT02772757|581856869|FG000|Overall Study|Physician Decision|0|||
161128425|NCT02772757|581856870|FG001|Overall Study|Physician Decision|3|||
161128426|NCT02772757|581856871|FG002|Overall Study|Physician Decision|3|||
161128427|NCT01500057|581856877|FG000|Overall Study|Lost to Follow-up|6|||
161128428|NCT01500057|581856878|FG001|Overall Study|Lost to Follow-up|4|||
161128429|NCT03213366|581856880|FG000|Overall Study|Lost to Follow-up|9|||
161128430|NCT03213366|581856881|FG001|Overall Study|Lost to Follow-up|4|||
161128431|NCT02058147|581856882|FG000|Overall Study|Randomized but not treated|0|||
161128432|NCT02058147|581856883|FG001|Overall Study|Randomized but not treated|0|||
161128433|NCT02058147|581856884|FG002|Overall Study|Randomized but not treated|1|||
161128434|NCT02058147|581856882|FG000|Overall Study|Adverse Event|12|||
161128435|NCT02058147|581856883|FG001|Overall Study|Adverse Event|9|||
161128436|NCT02058147|581856884|FG002|Overall Study|Adverse Event|21|||
161128437|NCT02058147|581856882|FG000|Overall Study|Lack of Efficacy|1|||
161128438|NCT02058147|581856883|FG001|Overall Study|Lack of Efficacy|0|||
161128439|NCT02058147|581856884|FG002|Overall Study|Lack of Efficacy|3|||
161128440|NCT02058147|581856882|FG000|Overall Study|Poor compliance to protocol|8|||
161128441|NCT02058147|581856883|FG001|Overall Study|Poor compliance to protocol|9|||
161128442|NCT02058147|581856884|FG002|Overall Study|Poor compliance to protocol|4|||
161128443|NCT02058147|581856882|FG000|Overall Study|Other than specified|8|||
161128444|NCT02058147|581856883|FG001|Overall Study|Other than specified|9|||
161128445|NCT02058147|581856884|FG002|Overall Study|Other than specified|0|||
161128446|NCT04178772|581856887|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
161128447|NCT04178772|581856887|FG000|Overall Study|study terminated early due to COVID-19|7|||
161128448|NCT00773279|581856888|FG000|Period 1|Adverse Event|2|||
161128449|NCT00773279|581856889|FG001|Period 1|Adverse Event|1|||
161128450|NCT00773279|581856888|FG000|Period 1|Lack of Efficacy|0|||
161128451|NCT00773279|581856889|FG001|Period 1|Lack of Efficacy|2|||
161128452|NCT00773279|581856888|FG000|Period 1|Unclassified|5|||
161128453|NCT00773279|581856889|FG001|Period 1|Unclassified|1|||
161128454|NCT00773279|581856888|FG000|Period 2|Adverse Event|0|||
161128455|NCT00773279|581856889|FG001|Period 2|Adverse Event|1|||
161128456|NCT00773279|581856888|FG000|Period 2|Lack of Efficacy|1|||
161128457|NCT00773279|581856889|FG001|Period 2|Lack of Efficacy|0|||
161128458|NCT00773279|581856888|FG000|Period 2|Protocol Violation|0|||
161128459|NCT00773279|581856889|FG001|Period 2|Protocol Violation|3|||
161128460|NCT00773279|581856888|FG000|Period 2|Unclassified|2|||
161128461|NCT00773279|581856889|FG001|Period 2|Unclassified|2|||
160790842|NCT01272219|580621561|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
161128462|NCT01481896|581856893|FG000|Overall Study|Lost to Follow-up|12|||
161128463|NCT00364182|581856896|FG000|First Intervention|Secondary prophylaxis|1|||
161128464|NCT00364182|581856897|FG001|First Intervention|Secondary prophylaxis|0|||
161128465|NCT00364182|581856898|FG002|First Intervention|Secondary prophylaxis|0|||
161128466|NCT00364182|581856896|FG000|First Intervention|Withdrawal by Subject|2|||
161128467|NCT00364182|581856897|FG001|First Intervention|Withdrawal by Subject|0|||
161128468|NCT00364182|581856898|FG002|First Intervention|Withdrawal by Subject|0|||
161128469|NCT00364182|581856896|FG000|Second Intervention|non-compliance|0|||
161128470|NCT00364182|581856897|FG001|Second Intervention|non-compliance|1|||
161128471|NCT00364182|581856898|FG002|Second Intervention|non-compliance|1|||
160790843|NCT01272219|580621562|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
160790844|NCT01272219|580621563|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
160790845|NCT05021224|580621574|FG000|Overall Study|Did not complete all survey items|4|||
160790846|NCT05021224|580621575|FG001|Overall Study|Did not complete all survey items|1|||
160790847|NCT05021224|580621576|FG002|Overall Study|Did not complete all survey items|0|||
160790848|NCT05021224|580621577|FG003|Overall Study|Did not complete all survey items|2|||
160790849|NCT03996395|580621578|FG000|Overall Study|Lost to Follow-up|4|||
160790850|NCT03996395|580621578|FG000|Overall Study|Withdrawal by Subject|1|||
160790851|NCT03996395|580621578|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
160790852|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
160790853|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790854|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790855|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790856|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
160790857|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790858|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790859|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
160790860|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790861|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790862|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790863|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
160790864|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
161128472|NCT00364182|581856896|FG000|Second Intervention|Protocol Violation|0|||
161128473|NCT00364182|581856897|FG001|Second Intervention|Protocol Violation|1|||
161128474|NCT00364182|581856898|FG002|Second Intervention|Protocol Violation|0|||
161128475|NCT00364182|581856896|FG000|Second Intervention|Adverse Event|0|||
161128476|NCT00364182|581856897|FG001|Second Intervention|Adverse Event|0|||
161128477|NCT00364182|581856898|FG002|Second Intervention|Adverse Event|1|||
161128478|NCT00364182|581856896|FG000|Third Intervention|non-compliance|0|||
161128479|NCT00364182|581856897|FG001|Third Intervention|non-compliance|1|||
161128480|NCT00364182|581856898|FG002|Third Intervention|non-compliance|0|||
161128481|NCT00364182|581856896|FG000|Third Intervention|Lost to Follow-up|0|||
161128482|NCT00364182|581856897|FG001|Third Intervention|Lost to Follow-up|0|||
161128483|NCT00364182|581856898|FG002|Third Intervention|Lost to Follow-up|1|||
161128484|NCT03336502|581856899|FG000|Overall Study|Physician Decision|0|||
161128485|NCT03336502|581856900|FG001|Overall Study|Physician Decision|1|||
161128486|NCT03336502|581856899|FG000|Overall Study|Prohibited Drugs|1|||
161128487|NCT03336502|581856900|FG001|Overall Study|Prohibited Drugs|1|||
161128488|NCT03336502|581856899|FG000|Overall Study|Death|1|||
161128489|NCT03336502|581856900|FG001|Overall Study|Death|2|||
161128490|NCT03336502|581856899|FG000|Overall Study|Adverse Event|2|||
161128491|NCT03336502|581856900|FG001|Overall Study|Adverse Event|5|||
161128492|NCT02601573|581856901|FG000|Overall Study|Lost to Follow-up|0|||
161235653|NCT01597245|582244939|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235654|NCT01597245|582244940|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235655|NCT01597245|582244941|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235656|NCT01597245|582244942|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235657|NCT01597245|582244943|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235658|NCT01597245|582244944|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235659|NCT01597245|582244945|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235660|NCT01597245|582244946|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
161235661|NCT01597245|582244926|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
161235662|NCT01597245|582244927|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
161235663|NCT01597245|582244928|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
161235664|NCT01597245|582244929|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235665|NCT01597245|582244930|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235666|NCT01597245|582244931|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235667|NCT01597245|582244932|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235668|NCT01597245|582244933|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235669|NCT01597245|582244934|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235670|NCT01597245|582244935|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235671|NCT01597245|582244936|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235672|NCT01597245|582244937|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235673|NCT01597245|582244938|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235674|NCT01597245|582244939|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160790865|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790866|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
161128493|NCT02601573|581856902|FG001|Overall Study|Lost to Follow-up|3|||
161128494|NCT02601573|581856903|FG002|Overall Study|Lost to Follow-up|1|||
161128495|NCT02601573|581856904|FG003|Overall Study|Lost to Follow-up|0|||
160892223|NCT05140382|581000543|FG000|Overall Study|Unknown at data cut-off|0|||
160892224|NCT05140382|581000544|FG001|Overall Study|Unknown at data cut-off|0|||
160892225|NCT05140382|581000545|FG002|Overall Study|Unknown at data cut-off|1|||
160892226|NCT05140382|581000543|FG000|Overall Study|Withdrawal by Subject|1|||
160892227|NCT05140382|581000544|FG001|Overall Study|Withdrawal by Subject|0|||
160892228|NCT05140382|581000545|FG002|Overall Study|Withdrawal by Subject|4|||
160892229|NCT05140382|581000543|FG000|Overall Study|Withdrawal of consent|0|||
160892230|NCT05140382|581000544|FG001|Overall Study|Withdrawal of consent|0|||
160892231|NCT05140382|581000545|FG002|Overall Study|Withdrawal of consent|1|||
160917926|NCT02673489|581094149|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
160917927|NCT02673489|581094148|FG000|Follow Up Period|Unable to return for follow-up|0|||
160917928|NCT02673489|581094149|FG001|Follow Up Period|Unable to return for follow-up|1|||
160917929|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
160917930|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
160917931|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
160917932|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
161128496|NCT02601573|581856905|FG004|Overall Study|Lost to Follow-up|2|||
161128497|NCT02601573|581856901|FG000|Overall Study|Withdrawal by Subject|0|||
161128498|NCT02601573|581856902|FG001|Overall Study|Withdrawal by Subject|1|||
161128499|NCT02601573|581856903|FG002|Overall Study|Withdrawal by Subject|0|||
161128500|NCT02601573|581856904|FG003|Overall Study|Withdrawal by Subject|1|||
161128501|NCT02601573|581856905|FG004|Overall Study|Withdrawal by Subject|0|||
161128502|NCT01850615|581856906|FG000|Overall Study|Protocol Violation|4|||
161128503|NCT01850615|581856907|FG001|Overall Study|Protocol Violation|1|||
161128504|NCT01850615|581856906|FG000|Overall Study|Adverse Event|2|||
161128505|NCT01850615|581856907|FG001|Overall Study|Adverse Event|1|||
161128506|NCT01850615|581856906|FG000|Overall Study|Withdrawal by Subject|3|||
161128507|NCT01850615|581856907|FG001|Overall Study|Withdrawal by Subject|1|||
161128508|NCT01850615|581856906|FG000|Overall Study|Lost to Follow-up|0|||
161128509|NCT01850615|581856907|FG001|Overall Study|Lost to Follow-up|1|||
161128510|NCT01850615|581856906|FG000|Overall Study|Unclassified|0|||
161128511|NCT01850615|581856907|FG001|Overall Study|Unclassified|1|||
161128512|NCT02921425|581856908|FG000|Overall Study|Protocol Violation|9|||
161128513|NCT01227967|581856909|FG000|Overall Study|Protocol Violation|3|||
161128514|NCT01227967|581856910|FG001|Overall Study|Protocol Violation|1|||
161128515|NCT01227967|581856909|FG000|Overall Study|Death|0|||
161128516|NCT01227967|581856910|FG001|Overall Study|Death|1|||
161128517|NCT01227967|581856909|FG000|Overall Study|Lost to Follow-up|8|||
161128518|NCT01227967|581856910|FG001|Overall Study|Lost to Follow-up|3|||
161128519|NCT01227967|581856909|FG000|Overall Study|Withdrawal by Subject|4|||
161128520|NCT01227967|581856910|FG001|Overall Study|Withdrawal by Subject|3|||
161128521|NCT01227967|581856909|FG000|Overall Study|Physician Decision|0|||
161128522|NCT01227967|581856910|FG001|Overall Study|Physician Decision|1|||
161128523|NCT01227967|581856909|FG000|Overall Study|Never Started Treatment|0|||
161128524|NCT01227967|581856910|FG001|Overall Study|Never Started Treatment|4|||
161128525|NCT01227967|581856909|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
161128526|NCT01227967|581856910|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
161128527|NCT03403400|581856911|FG000|Overall Study|Lost to Follow-up|1|||
161128528|NCT03403400|581856912|FG001|Overall Study|Lost to Follow-up|0|||
161128529|NCT03403400|581856913|FG002|Overall Study|Lost to Follow-up|1|||
161128530|NCT03403400|581856911|FG000|Overall Study|Hospitalization|1|||
161128531|NCT03403400|581856912|FG001|Overall Study|Hospitalization|0|||
161128532|NCT03403400|581856913|FG002|Overall Study|Hospitalization|0|||
161128533|NCT03403400|581856911|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
161128534|NCT03403400|581856912|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
161128535|NCT03403400|581856913|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
161128536|NCT01107444|581856917|FG000|Overall Study|Withdrawal by Subject|8|||
161128537|NCT01107444|581856918|FG001|Overall Study|Withdrawal by Subject|12|||
161128538|NCT01107444|581856917|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
161128539|NCT01107444|581856918|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
161128540|NCT03310970|581856919|FG000|Overall Study|Withdrawal by Subject|0|||
161128541|NCT03310970|581856920|FG001|Overall Study|Withdrawal by Subject|1|||
161128542|NCT00091832|581856923|FG000|Overall Study|Physician Decision|1|||
161128543|NCT00091832|581856924|FG001|Overall Study|Physician Decision|0|||
161128544|NCT00091832|581856925|FG002|Overall Study|Physician Decision|0|||
161128545|NCT00091832|581856926|FG003|Overall Study|Physician Decision|0|||
161128546|NCT00091832|581856927|FG004|Overall Study|Physician Decision|0|||
161128547|NCT00091832|581856928|FG005|Overall Study|Physician Decision|0|||
161128548|NCT00091832|581856923|FG000|Overall Study|Adverse Event|0|||
161128549|NCT00091832|581856924|FG001|Overall Study|Adverse Event|0|||
161128550|NCT00091832|581856925|FG002|Overall Study|Adverse Event|0|||
161128551|NCT00091832|581856926|FG003|Overall Study|Adverse Event|1|||
160917933|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
161128552|NCT00091832|581856927|FG004|Overall Study|Adverse Event|3|||
161128553|NCT00091832|581856928|FG005|Overall Study|Adverse Event|0|||
161128554|NCT00091832|581856923|FG000|Overall Study|Withdrawal by Subject|4|||
160892232|NCT01927341|581002126|FG000|Phase 1b|Lost to Follow-up|1|||
160892233|NCT01927341|581002127|FG001|Phase 1b|Lost to Follow-up|0|||
160790867|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
160790868|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790869|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790870|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790871|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790872|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
160790873|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790874|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
160790875|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
160790876|NCT03973489|580621590|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
160790877|NCT03973489|580621591|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790878|NCT03973489|580621592|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790879|NCT03973489|580621593|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
160790880|NCT03973489|580621594|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790881|NCT03973489|580621595|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790882|NCT03973489|580621596|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790883|NCT03973489|580621597|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
160790884|NCT03973489|580621590|FG000|Second Intervention (1 Day)|Adverse Event|0|||
160790885|NCT03973489|580621591|FG001|Second Intervention (1 Day)|Adverse Event|0|||
160790886|NCT03973489|580621592|FG002|Second Intervention (1 Day)|Adverse Event|0|||
160790887|NCT03973489|580621593|FG003|Second Intervention (1 Day)|Adverse Event|1|||
160790888|NCT03973489|580621594|FG004|Second Intervention (1 Day)|Adverse Event|0|||
160790889|NCT03973489|580621595|FG005|Second Intervention (1 Day)|Adverse Event|0|||
160790890|NCT03973489|580621596|FG006|Second Intervention (1 Day)|Adverse Event|0|||
160790891|NCT03973489|580621597|FG007|Second Intervention (1 Day)|Adverse Event|0|||
160790892|NCT03301415|580621598|FG000|Overall Study|Lost to Follow-up|2|||
160790893|NCT03301415|580621598|FG000|Overall Study|Unable to comply with visit schedule|2|||
160790894|NCT00392288|580621599|FG000|Overall Study|Adverse Event|17|||
160790895|NCT00392288|580621600|FG001|Overall Study|Adverse Event|7|||
160790896|NCT00392288|580621601|FG002|Overall Study|Adverse Event|8|||
160790897|NCT00392288|580621599|FG000|Overall Study|Lack of Efficacy|8|||
160790898|NCT00392288|580621600|FG001|Overall Study|Lack of Efficacy|5|||
160790899|NCT00392288|580621601|FG002|Overall Study|Lack of Efficacy|3|||
160790900|NCT00392288|580621599|FG000|Overall Study|Protocol Violation|1|||
160790901|NCT00392288|580621600|FG001|Overall Study|Protocol Violation|3|||
160790902|NCT00392288|580621601|FG002|Overall Study|Protocol Violation|1|||
160790903|NCT00392288|580621599|FG000|Overall Study|Lost to Follow-up|1|||
160790904|NCT00392288|580621600|FG001|Overall Study|Lost to Follow-up|1|||
160790905|NCT00392288|580621601|FG002|Overall Study|Lost to Follow-up|1|||
160790906|NCT00392288|580621599|FG000|Overall Study|Withdrawal by Subject|1|||
160790907|NCT00392288|580621600|FG001|Overall Study|Withdrawal by Subject|0|||
160790908|NCT00392288|580621601|FG002|Overall Study|Withdrawal by Subject|2|||
160790909|NCT00392288|580621599|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
160790910|NCT00392288|580621600|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
160790911|NCT00392288|580621601|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
160790912|NCT00392288|580621599|FG000|Overall Study|Other|3|||
160790913|NCT00392288|580621600|FG001|Overall Study|Other|4|||
160790914|NCT00392288|580621601|FG002|Overall Study|Other|1|||
160790915|NCT02544763|580621602|FG000|Overall Study|Adverse Event|8|||
160790916|NCT02544763|580621603|FG001|Overall Study|Adverse Event|8|||
160790917|NCT02544763|580621604|FG002|Overall Study|Adverse Event|0|||
160892234|NCT01927341|581002128|FG002|Phase 1b|Lost to Follow-up|0|||
160892235|NCT01927341|581002129|FG003|Phase 1b|Lost to Follow-up|0|||
160892236|NCT01927341|581002130|FG004|Phase 1b|Lost to Follow-up|0|||
160892237|NCT01927341|581002126|FG000|Phase 1b|Death|2|||
160892238|NCT01927341|581002127|FG001|Phase 1b|Death|0|||
160892239|NCT01927341|581002128|FG002|Phase 1b|Death|0|||
160790918|NCT02544763|580621602|FG000|Overall Study|Withdrawn by parent/guardian|1|||
160790919|NCT02544763|580621603|FG001|Overall Study|Withdrawn by parent/guardian|1|||
160892240|NCT01927341|581002129|FG003|Phase 1b|Death|0|||
160790920|NCT02544763|580621604|FG002|Overall Study|Withdrawn by parent/guardian|1|||
160790921|NCT02544763|580621602|FG000|Overall Study|Met withdrawal criteria|0|||
160790922|NCT02544763|580621603|FG001|Overall Study|Met withdrawal criteria|2|||
160790923|NCT02544763|580621604|FG002|Overall Study|Met withdrawal criteria|0|||
160892241|NCT01927341|581002130|FG004|Phase 1b|Death|0|||
161128555|NCT00091832|581856924|FG001|Overall Study|Withdrawal by Subject|5|||
160790924|NCT02544763|580621602|FG000|Overall Study|Physician Decision|0|||
160790925|NCT02544763|580621603|FG001|Overall Study|Physician Decision|1|||
160892242|NCT01927341|581002126|FG000|Phase 1b|Follow-up completed|7|||
160790926|NCT02544763|580621604|FG002|Overall Study|Physician Decision|0|||
160790927|NCT02544763|580621602|FG000|Overall Study|Difficulties taking IMP|1|||
160790928|NCT02544763|580621603|FG001|Overall Study|Difficulties taking IMP|0|||
160892243|NCT01927341|581002127|FG001|Phase 1b|Follow-up completed|0|||
160790929|NCT02544763|580621604|FG002|Overall Study|Difficulties taking IMP|0|||
160790930|NCT02097225|580621605|FG000|Dose Level 4|Adverse Event|0|||
160790931|NCT02097225|580621606|FG001|Dose Level 4|Adverse Event|0|||
160790932|NCT02097225|580621607|FG002|Dose Level 4|Adverse Event|0|||
160790933|NCT02097225|580621608|FG003|Dose Level 4|Adverse Event|0|||
160790934|NCT02097225|580621609|FG004|Dose Level 4|Adverse Event|1|||
160790935|NCT00911157|580621612|FG000|Overall Study|Adverse Event|4|||
160790936|NCT00911157|580621613|FG001|Overall Study|Adverse Event|1|||
160790937|NCT00911157|580621612|FG000|Overall Study|Withdrawal by Subject|1|||
160790938|NCT00911157|580621613|FG001|Overall Study|Withdrawal by Subject|1|||
160790939|NCT00911157|580621612|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
160790940|NCT00911157|580621613|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
160790941|NCT00911157|580621612|FG000|Overall Study|Need to treat for lung cancer|1|||
160790942|NCT00911157|580621613|FG001|Overall Study|Need to treat for lung cancer|0|||
160790943|NCT00787800|580621616|FG000|Overall Study|Withdrawal by Subject|3|||
160790944|NCT00787800|580621617|FG001|Overall Study|Withdrawal by Subject|5|||
160790945|NCT00787800|580621616|FG000|Overall Study|Death|0|||
160790946|NCT00787800|580621617|FG001|Overall Study|Death|2|||
160790947|NCT00461812|580621624|FG000|Overall Study|study terminated|10|||
160790948|NCT02579759|580623715|FG000|Overall Study|Protocol Violation|2|||
160790949|NCT02579759|580623716|FG001|Overall Study|Protocol Violation|0|||
160790950|NCT02579759|580623717|FG002|Overall Study|Protocol Violation|0|||
160790951|NCT02579759|580623715|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
160790952|NCT02579759|580623716|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
160790953|NCT02579759|580623717|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
160790954|NCT02579759|580623715|FG000|Overall Study|BfArM hold|13|||
160790955|NCT02579759|580623716|FG001|Overall Study|BfArM hold|12|||
160790956|NCT02579759|580623717|FG002|Overall Study|BfArM hold|12|||
160790957|NCT02579759|580623715|FG000|Overall Study|Sponsor stopped Dose 2|0|||
160790958|NCT02579759|580623716|FG001|Overall Study|Sponsor stopped Dose 2|41|||
160790959|NCT02579759|580623717|FG002|Overall Study|Sponsor stopped Dose 2|0|||
160790960|NCT02579759|580623715|FG000|Overall Study|Non compliance|0|||
160790961|NCT02579759|580623716|FG001|Overall Study|Non compliance|1|||
160790962|NCT02579759|580623717|FG002|Overall Study|Non compliance|0|||
160790963|NCT02579759|580623715|FG000|Overall Study|Pregnancy|0|||
160790964|NCT02579759|580623716|FG001|Overall Study|Pregnancy|1|||
160790965|NCT02579759|580623717|FG002|Overall Study|Pregnancy|0|||
160790966|NCT02579759|580623715|FG000|Overall Study|Inclusion/exclusion criteria|0|||
160790967|NCT02579759|580623716|FG001|Overall Study|Inclusion/exclusion criteria|0|||
160790968|NCT02579759|580623717|FG002|Overall Study|Inclusion/exclusion criteria|1|||
160790969|NCT02579759|580623715|FG000|Overall Study|Adverse Event|4|||
160790970|NCT02579759|580623716|FG001|Overall Study|Adverse Event|3|||
160790971|NCT02579759|580623717|FG002|Overall Study|Adverse Event|1|||
160790972|NCT02579759|580623715|FG000|Overall Study|Withdrawal by Subject|3|||
160790973|NCT02579759|580623716|FG001|Overall Study|Withdrawal by Subject|3|||
160790974|NCT02579759|580623717|FG002|Overall Study|Withdrawal by Subject|5|||
160790975|NCT02579759|580623715|FG000|Overall Study|Lost to Follow-up|2|||
160790976|NCT02579759|580623716|FG001|Overall Study|Lost to Follow-up|2|||
160790977|NCT02579759|580623717|FG002|Overall Study|Lost to Follow-up|2|||
160790978|NCT01904279|580623724|FG000|Overall Study|Lack of Efficacy|2|||
160790979|NCT01904279|580623725|FG001|Overall Study|Lack of Efficacy|3|||
160790980|NCT01904279|580623724|FG000|Overall Study|Withdrawal by Subject|1|||
160790981|NCT01904279|580623725|FG001|Overall Study|Withdrawal by Subject|0|||
160790982|NCT03283241|580623726|FG000|Overall Study|Adverse Event|4|||
160790983|NCT03283241|580623727|FG001|Overall Study|Adverse Event|1|||
160790984|NCT03283241|580623726|FG000|Overall Study|Withdrawal by Subject|0|||
160790985|NCT03283241|580623727|FG001|Overall Study|Withdrawal by Subject|1|||
160790986|NCT03283241|580623726|FG000|Overall Study|Subject relocated to Finland|0|||
160790987|NCT03283241|580623727|FG001|Overall Study|Subject relocated to Finland|1|||
160790988|NCT00666263|580623728|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
160790989|NCT00666263|580623729|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
160790990|NCT00666263|580623728|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
160790991|NCT00666263|580623729|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
160790992|NCT00666263|580623728|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
160790993|NCT00666263|580623729|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
160790994|NCT00586157|580623730|FG000|First Intervention|Worsening behavior|1|||
160790995|NCT00586157|580623731|FG001|First Intervention|Worsening behavior|0|||
160790996|NCT00586157|580623730|FG000|Second Intervention|Withdrawal by Subject|1|||
160790997|NCT00586157|580623731|FG001|Second Intervention|Withdrawal by Subject|0|||
160790998|NCT00586157|580623730|FG000|Second Intervention|Worsening behavior|1|||
160790999|NCT00586157|580623731|FG001|Second Intervention|Worsening behavior|0|||
160791000|NCT00586157|580623730|FG000|Second Intervention|Adverse Event|0|||
160791001|NCT00586157|580623731|FG001|Second Intervention|Adverse Event|1|||
160791002|NCT00278161|580623733|FG000|Overall Study|Death|11|||
160892244|NCT01927341|581002128|FG002|Phase 1b|Follow-up completed|0|||
160892245|NCT01927341|581002129|FG003|Phase 1b|Follow-up completed|0|||
160892246|NCT01927341|581002130|FG004|Phase 1b|Follow-up completed|0|||
160892247|NCT01927341|581002126|FG000|Phase 2|Lost to Follow-up|0|||
160892248|NCT01927341|581002127|FG001|Phase 2|Lost to Follow-up|1|||
160892249|NCT01927341|581002128|FG002|Phase 2|Lost to Follow-up|0|||
160892250|NCT01927341|581002129|FG003|Phase 2|Lost to Follow-up|0|||
160892251|NCT01927341|581002130|FG004|Phase 2|Lost to Follow-up|0|||
160892252|NCT01927341|581002126|FG000|Phase 2|Participant withdrew consent|0|||
160892253|NCT01927341|581002127|FG001|Phase 2|Participant withdrew consent|2|||
160892254|NCT01927341|581002128|FG002|Phase 2|Participant withdrew consent|1|||
160791003|NCT01817777|580623734|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
160791004|NCT01817777|580623735|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
160791005|NCT01817777|580623736|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
160791006|NCT01817777|580623734|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
160791007|NCT01817777|580623735|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
160791008|NCT01817777|580623736|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
160791009|NCT01817777|580623734|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
160892255|NCT01927341|581002129|FG003|Phase 2|Participant withdrew consent|2|||
160892256|NCT01927341|581002130|FG004|Phase 2|Participant withdrew consent|3|||
160892257|NCT01927341|581002126|FG000|Phase 2|Death|0|||
160892258|NCT01927341|581002127|FG001|Phase 2|Death|4|||
160892259|NCT01927341|581002128|FG002|Phase 2|Death|0|||
160892260|NCT01927341|581002129|FG003|Phase 2|Death|3|||
160892261|NCT01927341|581002130|FG004|Phase 2|Death|2|||
160892262|NCT01927341|581002126|FG000|Phase 2|New cancer therapy|0|||
160892263|NCT01927341|581002127|FG001|Phase 2|New cancer therapy|1|||
160892264|NCT01927341|581002128|FG002|Phase 2|New cancer therapy|0|||
160892265|NCT01927341|581002129|FG003|Phase 2|New cancer therapy|4|||
160892266|NCT01927341|581002130|FG004|Phase 2|New cancer therapy|1|||
160892267|NCT01927341|581002126|FG000|Phase 2|Disease progression|0|||
160981896|NCT01024751|581321791|FG000|Eligible Participants|Lost to Follow-up|0|||
160981897|NCT01024751|581321792|FG001|Eligible Participants|Lost to Follow-up|1|||
160981898|NCT01024751|581321791|FG000|Eligible Participants|Ineligible|0|||
160981899|NCT01024751|581321792|FG001|Eligible Participants|Ineligible|1|||
160981900|NCT00577720|581321797|FG000|Overall Study|Adverse Event|2|||
160981901|NCT00577720|581321798|FG001|Overall Study|Adverse Event|1|||
160981902|NCT00577720|581321799|FG002|Overall Study|Adverse Event|0|||
160981903|NCT00577720|581321800|FG003|Overall Study|Adverse Event|4|||
160981904|NCT00577720|581321797|FG000|Overall Study|Lost to Follow-up|0|||
160981905|NCT00577720|581321798|FG001|Overall Study|Lost to Follow-up|0|||
160981906|NCT00577720|581321799|FG002|Overall Study|Lost to Follow-up|1|||
160981907|NCT00577720|581321800|FG003|Overall Study|Lost to Follow-up|0|||
160981908|NCT00577720|581321797|FG000|Overall Study|Protocol Violation|0|||
160981909|NCT00577720|581321798|FG001|Overall Study|Protocol Violation|0|||
160981910|NCT00577720|581321799|FG002|Overall Study|Protocol Violation|0|||
160981911|NCT00577720|581321800|FG003|Overall Study|Protocol Violation|1|||
160981912|NCT00577720|581321797|FG000|Overall Study|Withdrawal by Subject|2|||
160981913|NCT00577720|581321798|FG001|Overall Study|Withdrawal by Subject|0|||
160981914|NCT00577720|581321799|FG002|Overall Study|Withdrawal by Subject|0|||
160981915|NCT00577720|581321800|FG003|Overall Study|Withdrawal by Subject|2|||
160981916|NCT03246672|581321801|FG000|Overall Study|Lost to Follow-up|2|||
160981917|NCT03260504|581321802|FG000|Overall Study|Adverse Event|0|||
160981918|NCT03260504|581321803|FG001|Overall Study|Adverse Event|1|||
160981919|NCT00967018|581321804|FG000|Overall Study|Adverse Event|2|||
160981920|NCT00967018|581321804|FG000|Overall Study|Physician Decision|7|||
160981921|NCT00967018|581321804|FG000|Overall Study|Lost to Follow-up|2|||
160981922|NCT00967018|581321804|FG000|Overall Study|Withdrawal by Subject|1|||
160981923|NCT00967018|581321804|FG000|Overall Study|Miscellaneous Reasons|9|||
160981924|NCT01932996|581321805|FG000|Overall Study|Protocol Violation|2|||
160981925|NCT01932996|581321806|FG001|Overall Study|Protocol Violation|0|||
160981926|NCT00846742|581321809|FG000|Overall Study|Withdrawal by Subject|1|||
160981927|NCT04170296|581321825|FG000|Overall Study|Adverse Event|1|||
160981928|NCT04170296|581321826|FG001|Overall Study|Adverse Event|0|||
160791010|NCT01817777|580623735|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
160892268|NCT01927341|581002127|FG001|Phase 2|Disease progression|1|||
160892269|NCT01927341|581002128|FG002|Phase 2|Disease progression|1|||
160892270|NCT01927341|581002129|FG003|Phase 2|Disease progression|1|||
160892271|NCT01927341|581002130|FG004|Phase 2|Disease progression|0|||
160892272|NCT01927341|581002126|FG000|Phase 2|Follow-up completed|0|||
160892273|NCT01927341|581002127|FG001|Phase 2|Follow-up completed|6|||
160981929|NCT04170296|581321825|FG000|Overall Study|Withdrawal by Subject|3|||
160981930|NCT04170296|581321826|FG001|Overall Study|Withdrawal by Subject|2|||
160981931|NCT04170296|581321825|FG000|Overall Study|Lost to Follow-up|4|||
160981932|NCT04170296|581321826|FG001|Overall Study|Lost to Follow-up|2|||
160981933|NCT03567993|581321827|FG000|Overall Study|Lost to Follow-up|4|||
160791011|NCT01817777|580623736|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
160892274|NCT01927341|581002128|FG002|Phase 2|Follow-up completed|3|||
160892275|NCT01927341|581002129|FG003|Phase 2|Follow-up completed|5|||
160791012|NCT01817777|580623734|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
160791013|NCT01817777|580623735|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
160791014|NCT01817777|580623736|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
160791015|NCT01817777|580623734|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
160791016|NCT01817777|580623735|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
160791017|NCT01817777|580623736|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
160791018|NCT00414609|580623737|FG000|Core Study|Adverse Event|9|||
160791019|NCT00414609|580623738|FG001|Core Study|Adverse Event|11|||
160791020|NCT00414609|580623739|FG002|Core Study|Adverse Event|0|||
160791021|NCT00414609|580623737|FG000|Core Study|Abnormal laboratory values|0|||
160791022|NCT00414609|580623738|FG001|Core Study|Abnormal laboratory values|1|||
160791023|NCT00414609|580623739|FG002|Core Study|Abnormal laboratory values|0|||
160791024|NCT00414609|580623737|FG000|Core Study|Abnormal test procedure results|1|||
160791025|NCT00414609|580623738|FG001|Core Study|Abnormal test procedure results|1|||
160892276|NCT01927341|581002130|FG004|Phase 2|Follow-up completed|2|||
160892277|NCT01104701|581002131|FG000|Overall Study|Withdrawal by Subject|0|||
160892278|NCT01104701|581002132|FG001|Overall Study|Withdrawal by Subject|1|||
160892279|NCT01104701|581002133|FG002|Overall Study|Withdrawal by Subject|2|||
160892280|NCT01104701|581002134|FG003|Overall Study|Withdrawal by Subject|1|||
160892281|NCT01104701|581002131|FG000|Overall Study|Adverse Event|0|||
160892282|NCT01104701|581002132|FG001|Overall Study|Adverse Event|0|||
160892283|NCT01104701|581002133|FG002|Overall Study|Adverse Event|0|||
160892284|NCT01104701|581002134|FG003|Overall Study|Adverse Event|1|||
160892285|NCT01104701|581002131|FG000|Overall Study|Physician Decision|0|||
160892286|NCT01104701|581002132|FG001|Overall Study|Physician Decision|2|||
160892287|NCT01104701|581002133|FG002|Overall Study|Physician Decision|0|||
160892288|NCT01104701|581002134|FG003|Overall Study|Physician Decision|0|||
160892289|NCT00423722|581002135|FG000|Overall Study|Death|4|||
160892290|NCT00423722|581002136|FG001|Overall Study|Death|4|||
160892291|NCT00423722|581002135|FG000|Overall Study|Declined to participate|2|||
160892292|NCT00423722|581002136|FG001|Overall Study|Declined to participate|3|||
160892293|NCT00423722|581002135|FG000|Overall Study|Unable to complete questionnaires|4|||
160892294|NCT00423722|581002136|FG001|Overall Study|Unable to complete questionnaires|4|||
160892295|NCT00423722|581002135|FG000|Overall Study|Withdrawal by Subject|4|||
160892296|NCT00423722|581002136|FG001|Overall Study|Withdrawal by Subject|2|||
160892297|NCT00674973|581002137|FG000|Overall Study|Insufficient Therapeutic Response|77|||
160892298|NCT00674973|581002138|FG001|Overall Study|Insufficient Therapeutic Response|72|||
160892299|NCT00674973|581002137|FG000|Overall Study|Refused Treatment|1|||
160892300|NCT00674973|581002138|FG001|Overall Study|Refused Treatment|5|||
160892301|NCT00674973|581002137|FG000|Overall Study|Failure to Return|1|||
160892302|NCT00674973|581002138|FG001|Overall Study|Failure to Return|0|||
160892303|NCT00674973|581002137|FG000|Overall Study|Adverse Event|2|||
160892304|NCT00674973|581002138|FG001|Overall Study|Adverse Event|9|||
160892305|NCT00674973|581002137|FG000|Overall Study|Death|19|||
160892306|NCT00674973|581002138|FG001|Overall Study|Death|15|||
160892307|NCT00674973|581002137|FG000|Overall Study|Protocol Violation|0|||
160892308|NCT00674973|581002138|FG001|Overall Study|Protocol Violation|1|||
160892309|NCT00451451|581002139|FG000|Overall Study|Adverse Event|11|||
160892310|NCT00451451|581002140|FG001|Overall Study|Adverse Event|21|||
160892311|NCT00451451|581002141|FG002|Overall Study|Adverse Event|26|||
160892312|NCT00451451|581002142|FG003|Overall Study|Adverse Event|10|||
160892313|NCT00451451|581002139|FG000|Overall Study|Lost to Follow-up|11|||
160892314|NCT00451451|581002140|FG001|Overall Study|Lost to Follow-up|9|||
160892315|NCT00451451|581002141|FG002|Overall Study|Lost to Follow-up|8|||
160892316|NCT00451451|581002142|FG003|Overall Study|Lost to Follow-up|11|||
160892317|NCT00451451|581002139|FG000|Overall Study|Consent Withdrawn|14|||
160892318|NCT00451451|581002140|FG001|Overall Study|Consent Withdrawn|9|||
160892319|NCT00451451|581002141|FG002|Overall Study|Consent Withdrawn|17|||
160892320|NCT00451451|581002142|FG003|Overall Study|Consent Withdrawn|17|||
160892321|NCT00451451|581002139|FG000|Overall Study|Investigator Decision|6|||
160892322|NCT00451451|581002140|FG001|Overall Study|Investigator Decision|2|||
160892323|NCT00451451|581002141|FG002|Overall Study|Investigator Decision|1|||
160892324|NCT00451451|581002142|FG003|Overall Study|Investigator Decision|2|||
160892325|NCT00451451|581002139|FG000|Overall Study|Subject Non-Compliance|8|||
160892326|NCT00451451|581002140|FG001|Overall Study|Subject Non-Compliance|4|||
160892327|NCT00451451|581002141|FG002|Overall Study|Subject Non-Compliance|3|||
161128556|NCT00091832|581856925|FG002|Overall Study|Withdrawal by Subject|0|||
160892328|NCT00451451|581002142|FG003|Overall Study|Subject Non-Compliance|3|||
160892329|NCT00451451|581002139|FG000|Overall Study|Death|1|||
160892330|NCT00451451|581002140|FG001|Overall Study|Death|0|||
160892331|NCT00451451|581002141|FG002|Overall Study|Death|0|||
160892332|NCT00451451|581002142|FG003|Overall Study|Death|1|||
160892333|NCT00451451|581002139|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
160892334|NCT00451451|581002140|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
160892335|NCT00451451|581002141|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
160892336|NCT00451451|581002142|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
161128557|NCT00091832|581856926|FG003|Overall Study|Withdrawal by Subject|1|||
160981934|NCT03567993|581321828|FG001|Overall Study|Lost to Follow-up|2|||
160981935|NCT03567993|581321827|FG000|Overall Study|Death|1|||
160981936|NCT03567993|581321828|FG001|Overall Study|Death|1|||
160981937|NCT03567993|581321827|FG000|Overall Study|Withdrawal by Subject|1|||
160981938|NCT03567993|581321828|FG001|Overall Study|Withdrawal by Subject|0|||
160981939|NCT02044458|581321833|FG000|Overall Study|Protocol Violation|3|||
160981940|NCT02044458|581321834|FG001|Overall Study|Protocol Violation|8|||
160981941|NCT02819479|581323356|FG000|Overall Study|Adverse Event|2|||
160981942|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
160981943|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
160981944|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
160981945|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
160981946|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
160981947|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
160981948|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
160981949|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
160981950|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
160981951|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
160981952|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
160981953|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
160981954|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
160981955|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
160981956|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
160981957|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
160981958|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
160981959|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
160981960|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
160981961|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
160981962|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
160981963|NCT02718417|581323357|FG000|Chemotherapy Phase (CP)|Other|2|||
160981964|NCT02718417|581323358|FG001|Chemotherapy Phase (CP)|Other|0|||
160981965|NCT02718417|581323359|FG002|Chemotherapy Phase (CP)|Other|1|||
160981966|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Adverse Event|21|||
160981967|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Adverse Event|26|||
160981968|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Adverse Event|0|||
160981969|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
160981970|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
160981971|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
160981972|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
160981973|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
160981974|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
160981975|NCT02718417|581323357|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
160981976|NCT02718417|581323358|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
160981977|NCT02718417|581323359|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
160981978|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Physician's decision|6|||
160981979|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Physician's decision|7|||
160981980|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Physician's decision|0|||
160981981|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Progressive disease|100|||
160981982|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Progressive disease|88|||
160981983|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Progressive disease|0|||
160981984|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Other|2|||
160981985|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Other|1|||
160981986|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Other|0|||
160981987|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
160981988|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
160981989|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
160981990|NCT02718417|581323357|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
160981991|NCT02718417|581323358|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
160981992|NCT02718417|581323359|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
160981993|NCT02718417|581323357|FG000|Observation Phase (OP)|Adverse Event|0|||
160981994|NCT02718417|581323358|FG001|Observation Phase (OP)|Adverse Event|0|||
160981995|NCT02718417|581323359|FG002|Observation Phase (OP)|Adverse Event|1|||
160981996|NCT02718417|581323357|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
160981997|NCT02718417|581323358|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
160981998|NCT02718417|581323359|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
160981999|NCT02718417|581323357|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
161330489|NCT01094288|582597124|FG004|Overall Study|Initiation of Alternative Therapy|0|||
160982000|NCT02718417|581323358|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
160982001|NCT02718417|581323359|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
160982002|NCT02718417|581323357|FG000|Observation Phase (OP)|Physician Decision|0|||
160791026|NCT00414609|580623739|FG002|Core Study|Abnormal test procedure results|0|||
160791027|NCT00414609|580623737|FG000|Core Study|Protocol deviation|0|||
160791028|NCT00414609|580623738|FG001|Core Study|Protocol deviation|1|||
160791029|NCT00414609|580623739|FG002|Core Study|Protocol deviation|0|||
160791030|NCT00414609|580623737|FG000|Core Study|Patient withdrew consent|10|||
160791031|NCT00414609|580623738|FG001|Core Study|Patient withdrew consent|11|||
160791032|NCT00414609|580623739|FG002|Core Study|Patient withdrew consent|0|||
160791033|NCT00414609|580623737|FG000|Core Study|Lost to Follow-up|7|||
160791034|NCT00414609|580623738|FG001|Core Study|Lost to Follow-up|4|||
160791035|NCT00414609|580623739|FG002|Core Study|Lost to Follow-up|0|||
160791036|NCT00414609|580623737|FG000|Core Study|Administrative problems|0|||
160791037|NCT00414609|580623738|FG001|Core Study|Administrative problems|2|||
160791038|NCT00414609|580623739|FG002|Core Study|Administrative problems|0|||
160791039|NCT00414609|580623737|FG000|Core Study|Death|7|||
160791040|NCT00414609|580623738|FG001|Core Study|Death|14|||
160791041|NCT00414609|580623739|FG002|Core Study|Death|0|||
160791042|NCT00414609|580623737|FG000|Extension Study|Adverse Event|0|||
160791043|NCT00414609|580623738|FG001|Extension Study|Adverse Event|0|||
160982003|NCT02718417|581323358|FG001|Observation Phase (OP)|Physician Decision|0|||
160982004|NCT02718417|581323359|FG002|Observation Phase (OP)|Physician Decision|9|||
160982005|NCT02718417|581323357|FG000|Observation Phase (OP)|Progressive disease|0|||
160982006|NCT02718417|581323358|FG001|Observation Phase (OP)|Progressive disease|0|||
160982007|NCT02718417|581323359|FG002|Observation Phase (OP)|Progressive disease|92|||
160791044|NCT00414609|580623739|FG002|Extension Study|Adverse Event|14|||
160791045|NCT00414609|580623737|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
160791046|NCT00414609|580623738|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
160791047|NCT00414609|580623739|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
160791048|NCT00414609|580623737|FG000|Extension Study|Withdrawal by Subject|0|||
160791049|NCT00414609|580623738|FG001|Extension Study|Withdrawal by Subject|0|||
160791050|NCT00414609|580623739|FG002|Extension Study|Withdrawal by Subject|13|||
160791051|NCT00414609|580623737|FG000|Extension Study|Lost to Follow-up|0|||
160791052|NCT00414609|580623738|FG001|Extension Study|Lost to Follow-up|0|||
160791053|NCT00414609|580623739|FG002|Extension Study|Lost to Follow-up|10|||
160791054|NCT00414609|580623737|FG000|Extension Study|Administrative problems|0|||
160791055|NCT00414609|580623738|FG001|Extension Study|Administrative problems|0|||
160791056|NCT00414609|580623739|FG002|Extension Study|Administrative problems|1|||
160791057|NCT00414609|580623737|FG000|Extension Study|Death|0|||
160791058|NCT00414609|580623738|FG001|Extension Study|Death|0|||
160791059|NCT00414609|580623739|FG002|Extension Study|Death|17|||
160791060|NCT01592747|580623745|FG000|Overall Study|Loss of Therapeutic Response|107|||
160791061|NCT01592747|580623746|FG001|Overall Study|Loss of Therapeutic Response|108|||
160791062|NCT01592747|580623747|FG002|Overall Study|Loss of Therapeutic Response|100|||
160791063|NCT01592747|580623745|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160791064|NCT01592747|580623746|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
160791065|NCT01592747|580623747|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
160791066|NCT01592747|580623745|FG000|Overall Study|Adverse Event|1|||
160791067|NCT01592747|580623746|FG001|Overall Study|Adverse Event|0|||
160791068|NCT01592747|580623747|FG002|Overall Study|Adverse Event|0|||
160791069|NCT01592747|580623745|FG000|Overall Study|Protocol Violation|4|||
160791070|NCT01592747|580623746|FG001|Overall Study|Protocol Violation|0|||
160791071|NCT01592747|580623747|FG002|Overall Study|Protocol Violation|4|||
160791072|NCT01592747|580623745|FG000|Overall Study|Lack of Efficacy|0|||
160791073|NCT01592747|580623746|FG001|Overall Study|Lack of Efficacy|1|||
160791074|NCT01592747|580623747|FG002|Overall Study|Lack of Efficacy|0|||
160791075|NCT01592747|580623745|FG000|Overall Study|Withdrawal by Subject|2|||
160791076|NCT01592747|580623746|FG001|Overall Study|Withdrawal by Subject|0|||
160791077|NCT01592747|580623747|FG002|Overall Study|Withdrawal by Subject|2|||
160791078|NCT01592747|580623745|FG000|Overall Study|Lost to Follow-up|1|||
160791079|NCT01592747|580623746|FG001|Overall Study|Lost to Follow-up|0|||
160791080|NCT01592747|580623747|FG002|Overall Study|Lost to Follow-up|1|||
160791081|NCT01592747|580623745|FG000|Overall Study|Other Reasons|1|||
160791082|NCT01592747|580623746|FG001|Overall Study|Other Reasons|1|||
160791083|NCT01592747|580623747|FG002|Overall Study|Other Reasons|0|||
160791084|NCT00266032|580623748|FG000|Treatment|Adverse Event|42|||
160791085|NCT00266032|580623749|FG001|Treatment|Adverse Event|26|||
160791086|NCT00266032|580623750|FG002|Treatment|Adverse Event|10|||
160791087|NCT00266032|580623748|FG000|Treatment|Lost to Follow-up|19|||
160791088|NCT00266032|580623749|FG001|Treatment|Lost to Follow-up|4|||
160791089|NCT00266032|580623750|FG002|Treatment|Lost to Follow-up|2|||
160791090|NCT00266032|580623748|FG000|Treatment|Pregnancy|3|||
160791091|NCT00266032|580623749|FG001|Treatment|Pregnancy|2|||
160791092|NCT00266032|580623750|FG002|Treatment|Pregnancy|2|||
160791093|NCT00266032|580623748|FG000|Treatment|Protocol Violation|6|||
160791094|NCT00266032|580623749|FG001|Treatment|Protocol Violation|14|||
160791095|NCT00266032|580623750|FG002|Treatment|Protocol Violation|13|||
160791096|NCT00266032|580623748|FG000|Treatment|Withdrawal by Subject|28|||
160791097|NCT00266032|580623749|FG001|Treatment|Withdrawal by Subject|13|||
160791098|NCT00266032|580623750|FG002|Treatment|Withdrawal by Subject|12|||
160791099|NCT00266032|580623748|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
160791100|NCT00266032|580623749|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
160791101|NCT00266032|580623750|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
160791102|NCT00266032|580623748|FG000|Open-label Safety Extension|Adverse Event|5|||
160791103|NCT00266032|580623749|FG001|Open-label Safety Extension|Adverse Event|0|||
160791104|NCT00266032|580623750|FG002|Open-label Safety Extension|Adverse Event|4|||
160791105|NCT00266032|580623748|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
160791106|NCT00266032|580623749|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
160791107|NCT00266032|580623750|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
160791108|NCT00266032|580623748|FG000|Open-label Safety Extension|Pregnancy|4|||
160791109|NCT00266032|580623749|FG001|Open-label Safety Extension|Pregnancy|1|||
160791110|NCT00266032|580623750|FG002|Open-label Safety Extension|Pregnancy|2|||
160892337|NCT02598960|581002148|FG000|Treatment Period|Disease Progression|4|||
160892338|NCT02598960|581002149|FG001|Treatment Period|Disease Progression|4|||
160892339|NCT02598960|581002150|FG002|Treatment Period|Disease Progression|4|||
160892340|NCT02598960|581002151|FG003|Treatment Period|Disease Progression|6|||
160892341|NCT02598960|581002152|FG004|Treatment Period|Disease Progression|8|||
160892342|NCT02598960|581002153|FG005|Treatment Period|Disease Progression|2|||
160892343|NCT02598960|581002154|FG006|Treatment Period|Disease Progression|2|||
160892344|NCT02598960|581002155|FG007|Treatment Period|Disease Progression|3|||
160892345|NCT02598960|581002156|FG008|Treatment Period|Disease Progression|7|||
160892346|NCT02598960|581002157|FG009|Treatment Period|Disease Progression|9|||
160892347|NCT02598960|581002158|FG010|Treatment Period|Disease Progression|7|||
161330490|NCT01094288|582597125|FG005|Overall Study|Initiation of Alternative Therapy|0|||
160892348|NCT02598960|581002159|FG011|Treatment Period|Disease Progression|143|||
160892349|NCT02598960|581002160|FG012|Treatment Period|Disease Progression|23|||
160892350|NCT02598960|581002148|FG000|Treatment Period|Study drug toxicity|0|||
160892351|NCT02598960|581002149|FG001|Treatment Period|Study drug toxicity|0|||
160892352|NCT02598960|581002150|FG002|Treatment Period|Study drug toxicity|0|||
161330491|NCT01094288|582597126|FG006|Overall Study|Initiation of Alternative Therapy|0|||
161330492|NCT01094288|582597127|FG007|Overall Study|Initiation of Alternative Therapy|0|||
161330493|NCT01094288|582597120|FG000|Overall Study|Reason not Specified|2|||
161330494|NCT01094288|582597121|FG001|Overall Study|Reason not Specified|3|||
161330495|NCT01094288|582597122|FG002|Overall Study|Reason not Specified|0|||
161330496|NCT01094288|582597123|FG003|Overall Study|Reason not Specified|1|||
161330497|NCT01094288|582597124|FG004|Overall Study|Reason not Specified|0|||
161330498|NCT01094288|582597125|FG005|Overall Study|Reason not Specified|0|||
161330499|NCT01094288|582597126|FG006|Overall Study|Reason not Specified|0|||
161330500|NCT01094288|582597127|FG007|Overall Study|Reason not Specified|0|||
161330501|NCT01094288|582597120|FG000|Overall Study|Ongoing Participants|0|||
161330502|NCT01094288|582597121|FG001|Overall Study|Ongoing Participants|3|||
161330503|NCT01094288|582597122|FG002|Overall Study|Ongoing Participants|0|||
161330504|NCT01094288|582597123|FG003|Overall Study|Ongoing Participants|0|||
161330505|NCT01094288|582597124|FG004|Overall Study|Ongoing Participants|0|||
161330506|NCT01094288|582597125|FG005|Overall Study|Ongoing Participants|0|||
161330507|NCT01094288|582597126|FG006|Overall Study|Ongoing Participants|0|||
161330508|NCT01094288|582597127|FG007|Overall Study|Ongoing Participants|0|||
161330509|NCT01228591|582597128|FG000|Baseline|Lack of Efficacy|1|||
161330510|NCT01228591|582597129|FG001|Baseline|Lack of Efficacy|2|||
161330511|NCT02611882|582597130|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
161330512|NCT02611882|582597131|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
161330513|NCT02611882|582597132|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
161330514|NCT01389232|582597133|FG000|Overall Study|Had scaffold removed|15|||
161330515|NCT01389232|582597133|FG000|Overall Study|Personal reasons|2|||
161330516|NCT01389232|582597133|FG000|Overall Study|Adverse Event|1|||
161330517|NCT01389232|582597133|FG000|Overall Study|Death|1|||
161330518|NCT01317940|582597134|FG000|Overall Study|Death|1|||
161330519|NCT01317940|582597135|FG001|Overall Study|Death|0|||
161330520|NCT01317940|582597136|FG002|Overall Study|Death|1|||
161330521|NCT01317940|582597137|FG003|Overall Study|Death|0|||
161330522|NCT01317940|582597138|FG004|Overall Study|Death|0|||
161330523|NCT01317940|582597139|FG005|Overall Study|Death|0|||
161330524|NCT01317940|582597134|FG000|Overall Study|Lost to Follow-up|0|||
161330525|NCT01317940|582597135|FG001|Overall Study|Lost to Follow-up|0|||
161330526|NCT01317940|582597136|FG002|Overall Study|Lost to Follow-up|1|||
161330527|NCT01317940|582597137|FG003|Overall Study|Lost to Follow-up|1|||
161330528|NCT01317940|582597138|FG004|Overall Study|Lost to Follow-up|1|||
160892353|NCT02598960|581002151|FG003|Treatment Period|Study drug toxicity|0|||
160892354|NCT02598960|581002152|FG004|Treatment Period|Study drug toxicity|0|||
160892355|NCT02598960|581002153|FG005|Treatment Period|Study drug toxicity|0|||
160892356|NCT02598960|581002154|FG006|Treatment Period|Study drug toxicity|0|||
161330529|NCT01317940|582597139|FG005|Overall Study|Lost to Follow-up|0|||
161330530|NCT01317940|582597134|FG000|Overall Study|Change in therapy plan|0|||
160791111|NCT00266032|580623748|FG000|Open-label Safety Extension|Protocol Violation|1|||
161330531|NCT01317940|582597135|FG001|Overall Study|Change in therapy plan|0|||
160791112|NCT00266032|580623749|FG001|Open-label Safety Extension|Protocol Violation|3|||
160791113|NCT00266032|580623750|FG002|Open-label Safety Extension|Protocol Violation|2|||
160791114|NCT00266032|580623748|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
160791115|NCT00266032|580623749|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
160791116|NCT00266032|580623750|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
160791117|NCT00266032|580623748|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
160791118|NCT00266032|580623749|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
160791119|NCT00266032|580623750|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
160791120|NCT00124657|580623751|FG000|Overall Study|Toxicity|0|||
160791121|NCT00124657|580623752|FG001|Overall Study|Toxicity|0|||
160791122|NCT00124657|580623753|FG002|Overall Study|Toxicity|1|||
160791123|NCT00124657|580623751|FG000|Overall Study|Non-compliance|1|||
160791124|NCT00124657|580623752|FG001|Overall Study|Non-compliance|0|||
160791125|NCT00124657|580623753|FG002|Overall Study|Non-compliance|4|||
160791126|NCT00124657|580623751|FG000|Overall Study|Progressive disease|14|||
160791127|NCT00124657|580623752|FG001|Overall Study|Progressive disease|5|||
160791128|NCT00124657|580623753|FG002|Overall Study|Progressive disease|27|||
160791129|NCT00124657|580623751|FG000|Overall Study|Intercurrent illness|1|||
160791130|NCT00124657|580623752|FG001|Overall Study|Intercurrent illness|0|||
160791131|NCT00124657|580623753|FG002|Overall Study|Intercurrent illness|0|||
160791132|NCT01935947|580623758|FG000|Overall Study|Adverse Event|0|||
160791133|NCT01935947|580623759|FG001|Overall Study|Adverse Event|2|||
160791134|NCT01935947|580623760|FG002|Overall Study|Adverse Event|0|||
160791135|NCT01935947|580623758|FG000|Overall Study|Diease Progression|2|||
160791136|NCT01935947|580623759|FG001|Overall Study|Diease Progression|2|||
160791137|NCT01935947|580623760|FG002|Overall Study|Diease Progression|2|||
160791138|NCT01935947|580623758|FG000|Overall Study|Death|1|||
160791139|NCT01935947|580623759|FG001|Overall Study|Death|0|||
160791140|NCT01935947|580623760|FG002|Overall Study|Death|0|||
160791141|NCT02367885|580623761|FG000|Overall Study|Lost to Follow-up|1|||
160791142|NCT02367885|580623762|FG001|Overall Study|Lost to Follow-up|0|||
160791143|NCT02367885|580623763|FG002|Overall Study|Lost to Follow-up|0|||
160791144|NCT02367885|580623761|FG000|Overall Study|Withdrawal by Subject|1|||
160791145|NCT02367885|580623762|FG001|Overall Study|Withdrawal by Subject|0|||
160791146|NCT02367885|580623763|FG002|Overall Study|Withdrawal by Subject|0|||
160791147|NCT01378195|580623764|FG000|Overall Study|Lost to Follow-up|29|||
160791148|NCT01378195|580623765|FG001|Overall Study|Lost to Follow-up|18|||
160791149|NCT03533491|580623768|FG000|Overall Study|Lost to Follow-up|2|||
160791150|NCT05418426|580623774|FG000|Overall Study|Adverse Event|0|||
160791151|NCT05418426|580623775|FG001|Overall Study|Adverse Event|1|||
160791152|NCT05418426|580623776|FG002|Overall Study|Adverse Event|0|||
160791153|NCT05418426|580623774|FG000|Overall Study|Withdrawal by Subject|0|||
160791154|NCT05418426|580623775|FG001|Overall Study|Withdrawal by Subject|1|||
160791155|NCT05418426|580623776|FG002|Overall Study|Withdrawal by Subject|0|||
160791156|NCT05418426|580623774|FG000|Overall Study|Protocol Violation|0|||
160791157|NCT05418426|580623775|FG001|Overall Study|Protocol Violation|0|||
160791158|NCT05418426|580623776|FG002|Overall Study|Protocol Violation|1|||
160791159|NCT02758626|580623779|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
160791160|NCT02758626|580623780|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
160791161|NCT02758626|580623779|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
160791162|NCT02758626|580623780|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
160791163|NCT02758626|580623779|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
160791164|NCT02758626|580623780|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
160791165|NCT02758626|580623779|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
160791166|NCT02758626|580623780|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
160791167|NCT00456365|580623783|FG000|Overall Study|Lost to Follow-up|1|||
160791168|NCT00456365|580623784|FG001|Overall Study|Lost to Follow-up|3|||
160791169|NCT00456365|580623783|FG000|Overall Study|Withdrawal by Subject|4|||
160982008|NCT02718417|581323357|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
160982009|NCT02718417|581323358|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
160982010|NCT02718417|581323359|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
160791170|NCT00456365|580623784|FG001|Overall Study|Withdrawal by Subject|7|||
160791171|NCT00456365|580623783|FG000|Overall Study|Pregnancy|1|||
160791172|NCT00456365|580623784|FG001|Overall Study|Pregnancy|1|||
160982011|NCT02718417|581323357|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
160791173|NCT00456365|580623783|FG000|Overall Study|oncologic diagnosis|1|||
160791174|NCT00456365|580623784|FG001|Overall Study|oncologic diagnosis|1|||
160791175|NCT02096354|580623788|FG000|Overall Study|Physician Decision|4|||
160791176|NCT02096354|580623789|FG001|Overall Study|Physician Decision|5|||
160791177|NCT02096354|580623790|FG002|Overall Study|Physician Decision|0|||
160791178|NCT02096354|580623788|FG000|Overall Study|Withdrawal by Subject|3|||
160791179|NCT02096354|580623789|FG001|Overall Study|Withdrawal by Subject|1|||
160791180|NCT02096354|580623790|FG002|Overall Study|Withdrawal by Subject|0|||
160791181|NCT02096354|580623788|FG000|Overall Study|Adverse Event|7|||
160791182|NCT02096354|580623789|FG001|Overall Study|Adverse Event|4|||
160791183|NCT02096354|580623790|FG002|Overall Study|Adverse Event|0|||
160791184|NCT02096354|580623788|FG000|Overall Study|Ineligible|0|||
160791185|NCT02096354|580623789|FG001|Overall Study|Ineligible|0|||
160791186|NCT02096354|580623790|FG002|Overall Study|Ineligible|11|||
160791187|NCT03715829|580623791|FG000|Dose Ranging Period|Adverse Event|2|||
160791188|NCT03715829|580623792|FG001|Dose Ranging Period|Adverse Event|4|||
160791189|NCT03715829|580623793|FG002|Dose Ranging Period|Adverse Event|5|||
160791190|NCT03715829|580623794|FG003|Dose Ranging Period|Adverse Event|2|||
160791191|NCT03715829|580623795|FG004|Dose Ranging Period|Adverse Event|3|||
160791192|NCT03715829|580623796|FG005|Dose Ranging Period|Adverse Event|3|||
160791193|NCT03715829|580623797|FG006|Dose Ranging Period|Adverse Event|0|||
160791194|NCT03715829|580623798|FG007|Dose Ranging Period|Adverse Event|0|||
160791195|NCT03715829|580623799|FG008|Dose Ranging Period|Adverse Event|0|||
160791196|NCT03715829|580623800|FG009|Dose Ranging Period|Adverse Event|0|||
160791197|NCT03715829|580623801|FG010|Dose Ranging Period|Adverse Event|0|||
160791198|NCT03715829|580623791|FG000|Dose Ranging Period|Lack of Efficacy|0|||
160791199|NCT03715829|580623792|FG001|Dose Ranging Period|Lack of Efficacy|1|||
160791200|NCT03715829|580623793|FG002|Dose Ranging Period|Lack of Efficacy|0|||
160791201|NCT03715829|580623794|FG003|Dose Ranging Period|Lack of Efficacy|1|||
160791202|NCT03715829|580623795|FG004|Dose Ranging Period|Lack of Efficacy|0|||
160791203|NCT03715829|580623796|FG005|Dose Ranging Period|Lack of Efficacy|0|||
160791204|NCT03715829|580623797|FG006|Dose Ranging Period|Lack of Efficacy|0|||
160791205|NCT03715829|580623798|FG007|Dose Ranging Period|Lack of Efficacy|0|||
160791206|NCT03715829|580623799|FG008|Dose Ranging Period|Lack of Efficacy|0|||
160791207|NCT03715829|580623800|FG009|Dose Ranging Period|Lack of Efficacy|0|||
160791208|NCT03715829|580623801|FG010|Dose Ranging Period|Lack of Efficacy|0|||
160791209|NCT03715829|580623791|FG000|Dose Ranging Period|Lost to Follow-up|2|||
160791210|NCT03715829|580623792|FG001|Dose Ranging Period|Lost to Follow-up|0|||
160791211|NCT03715829|580623793|FG002|Dose Ranging Period|Lost to Follow-up|1|||
160791212|NCT03715829|580623794|FG003|Dose Ranging Period|Lost to Follow-up|1|||
160791213|NCT03715829|580623795|FG004|Dose Ranging Period|Lost to Follow-up|1|||
160791214|NCT03715829|580623796|FG005|Dose Ranging Period|Lost to Follow-up|2|||
160791215|NCT03715829|580623797|FG006|Dose Ranging Period|Lost to Follow-up|0|||
160791216|NCT03715829|580623798|FG007|Dose Ranging Period|Lost to Follow-up|0|||
160791217|NCT03715829|580623799|FG008|Dose Ranging Period|Lost to Follow-up|0|||
160791218|NCT03715829|580623800|FG009|Dose Ranging Period|Lost to Follow-up|0|||
160791219|NCT03715829|580623801|FG010|Dose Ranging Period|Lost to Follow-up|0|||
160791220|NCT03715829|580623791|FG000|Dose Ranging Period|Protocol Violation|0|||
160791221|NCT03715829|580623792|FG001|Dose Ranging Period|Protocol Violation|0|||
160791222|NCT03715829|580623793|FG002|Dose Ranging Period|Protocol Violation|0|||
160791223|NCT03715829|580623794|FG003|Dose Ranging Period|Protocol Violation|1|||
160791224|NCT03715829|580623795|FG004|Dose Ranging Period|Protocol Violation|0|||
160791225|NCT03715829|580623796|FG005|Dose Ranging Period|Protocol Violation|0|||
160791226|NCT03715829|580623797|FG006|Dose Ranging Period|Protocol Violation|0|||
160791227|NCT03715829|580623798|FG007|Dose Ranging Period|Protocol Violation|0|||
160791228|NCT03715829|580623799|FG008|Dose Ranging Period|Protocol Violation|0|||
160791229|NCT03715829|580623800|FG009|Dose Ranging Period|Protocol Violation|0|||
160791230|NCT03715829|580623801|FG010|Dose Ranging Period|Protocol Violation|0|||
160791231|NCT03715829|580623791|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
160791232|NCT03715829|580623792|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
160791233|NCT03715829|580623793|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
160791234|NCT03715829|580623794|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
160791235|NCT03715829|580623795|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
160791236|NCT03715829|580623796|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
160791237|NCT03715829|580623797|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
160791238|NCT03715829|580623798|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
160791239|NCT03715829|580623799|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
160791240|NCT03715829|580623800|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
160791241|NCT03715829|580623801|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
160791242|NCT03715829|580623791|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791243|NCT03715829|580623792|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791244|NCT03715829|580623793|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
160791245|NCT03715829|580623794|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791246|NCT03715829|580623795|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791247|NCT03715829|580623796|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791248|NCT03715829|580623797|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791249|NCT03715829|580623798|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791250|NCT03715829|580623799|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791251|NCT03715829|580623800|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791252|NCT03715829|580623801|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
160791253|NCT03715829|580623791|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791254|NCT03715829|580623792|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791255|NCT03715829|580623793|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
160982012|NCT02718417|581323358|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
160982013|NCT02718417|581323359|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
160982014|NCT02718417|581323357|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
160982015|NCT02718417|581323358|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
160982016|NCT02718417|581323359|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
160982017|NCT02718417|581323357|FG000|Observation Phase (OP)|Other|0|||
160982018|NCT02718417|581323358|FG001|Observation Phase (OP)|Other|0|||
160982019|NCT02718417|581323359|FG002|Observation Phase (OP)|Other|7|||
160982020|NCT02718417|581323357|FG000|Follow-up Phase|Adverse Event|3|||
160982021|NCT02718417|581323358|FG001|Follow-up Phase|Adverse Event|1|||
160982022|NCT02718417|581323359|FG002|Follow-up Phase|Adverse Event|1|||
160982023|NCT02718417|581323357|FG000|Follow-up Phase|Other|4|||
160982024|NCT02718417|581323358|FG001|Follow-up Phase|Other|6|||
160982025|NCT02718417|581323359|FG002|Follow-up Phase|Other|4|||
161128558|NCT00091832|581856927|FG004|Overall Study|Withdrawal by Subject|3|||
161128559|NCT00091832|581856928|FG005|Overall Study|Withdrawal by Subject|1|||
160791256|NCT03715829|580623794|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791257|NCT03715829|580623795|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
160791258|NCT03715829|580623796|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791259|NCT03715829|580623797|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791260|NCT03715829|580623798|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791261|NCT03715829|580623799|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791262|NCT03715829|580623800|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791263|NCT03715829|580623801|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
160791264|NCT03715829|580623791|FG000|Dose Ranging Period|Other|0|||
160791265|NCT03715829|580623792|FG001|Dose Ranging Period|Other|0|||
160791266|NCT03715829|580623793|FG002|Dose Ranging Period|Other|2|||
160791267|NCT03715829|580623794|FG003|Dose Ranging Period|Other|0|||
160791268|NCT03715829|580623795|FG004|Dose Ranging Period|Other|0|||
160791269|NCT03715829|580623796|FG005|Dose Ranging Period|Other|3|||
160791270|NCT03715829|580623797|FG006|Dose Ranging Period|Other|0|||
160791271|NCT03715829|580623798|FG007|Dose Ranging Period|Other|0|||
160791272|NCT03715829|580623799|FG008|Dose Ranging Period|Other|0|||
160791273|NCT03715829|580623800|FG009|Dose Ranging Period|Other|0|||
160791274|NCT03715829|580623801|FG010|Dose Ranging Period|Other|0|||
160791275|NCT03715829|580623791|FG000|Extension Period|Adverse Event|0|||
160791276|NCT03715829|580623792|FG001|Extension Period|Adverse Event|0|||
160791277|NCT03715829|580623793|FG002|Extension Period|Adverse Event|0|||
160791278|NCT03715829|580623794|FG003|Extension Period|Adverse Event|0|||
160791279|NCT03715829|580623795|FG004|Extension Period|Adverse Event|0|||
160791280|NCT03715829|580623796|FG005|Extension Period|Adverse Event|0|||
160791281|NCT03715829|580623797|FG006|Extension Period|Adverse Event|3|||
160791282|NCT03715829|580623798|FG007|Extension Period|Adverse Event|1|||
160791283|NCT03715829|580623799|FG008|Extension Period|Adverse Event|6|||
160791284|NCT03715829|580623800|FG009|Extension Period|Adverse Event|0|||
160791285|NCT03715829|580623801|FG010|Extension Period|Adverse Event|0|||
160791286|NCT03715829|580623791|FG000|Extension Period|Lack of Efficacy|0|||
160791287|NCT03715829|580623792|FG001|Extension Period|Lack of Efficacy|0|||
160791288|NCT03715829|580623793|FG002|Extension Period|Lack of Efficacy|0|||
160791289|NCT03715829|580623794|FG003|Extension Period|Lack of Efficacy|0|||
160791290|NCT03715829|580623795|FG004|Extension Period|Lack of Efficacy|0|||
160791291|NCT03715829|580623796|FG005|Extension Period|Lack of Efficacy|0|||
160791292|NCT03715829|580623797|FG006|Extension Period|Lack of Efficacy|1|||
160791293|NCT03715829|580623798|FG007|Extension Period|Lack of Efficacy|9|||
160791294|NCT03715829|580623799|FG008|Extension Period|Lack of Efficacy|2|||
160791295|NCT03715829|580623800|FG009|Extension Period|Lack of Efficacy|0|||
160791296|NCT03715829|580623801|FG010|Extension Period|Lack of Efficacy|0|||
160791297|NCT03715829|580623791|FG000|Extension Period|Lost to Follow-up|0|||
160791298|NCT03715829|580623792|FG001|Extension Period|Lost to Follow-up|0|||
160791299|NCT03715829|580623793|FG002|Extension Period|Lost to Follow-up|0|||
160791300|NCT03715829|580623794|FG003|Extension Period|Lost to Follow-up|0|||
160791301|NCT03715829|580623795|FG004|Extension Period|Lost to Follow-up|0|||
160791302|NCT03715829|580623796|FG005|Extension Period|Lost to Follow-up|0|||
160791303|NCT03715829|580623797|FG006|Extension Period|Lost to Follow-up|0|||
160982026|NCT02718417|581323357|FG000|Follow-up Phase|Withdrawal by Subject|19|||
160982027|NCT02718417|581323358|FG001|Follow-up Phase|Withdrawal by Subject|17|||
160982028|NCT02718417|581323359|FG002|Follow-up Phase|Withdrawal by Subject|5|||
160982029|NCT02718417|581323357|FG000|Follow-up Phase|Study terminated by sponsor|100|||
161128560|NCT00091832|581856923|FG000|Overall Study|Death|6|||
160791304|NCT03715829|580623798|FG007|Extension Period|Lost to Follow-up|0|||
160791305|NCT03715829|580623799|FG008|Extension Period|Lost to Follow-up|2|||
160791306|NCT03715829|580623800|FG009|Extension Period|Lost to Follow-up|0|||
160791307|NCT03715829|580623801|FG010|Extension Period|Lost to Follow-up|0|||
160791308|NCT03715829|580623791|FG000|Extension Period|Protocol Violation|0|||
160791309|NCT03715829|580623792|FG001|Extension Period|Protocol Violation|0|||
160982030|NCT02718417|581323358|FG001|Follow-up Phase|Study terminated by sponsor|138|||
160791310|NCT03715829|580623793|FG002|Extension Period|Protocol Violation|0|||
160791311|NCT03715829|580623794|FG003|Extension Period|Protocol Violation|0|||
160791312|NCT03715829|580623795|FG004|Extension Period|Protocol Violation|0|||
160791313|NCT03715829|580623796|FG005|Extension Period|Protocol Violation|0|||
160791314|NCT03715829|580623797|FG006|Extension Period|Protocol Violation|0|||
160791315|NCT03715829|580623798|FG007|Extension Period|Protocol Violation|0|||
160791316|NCT03715829|580623799|FG008|Extension Period|Protocol Violation|1|||
160791317|NCT03715829|580623800|FG009|Extension Period|Protocol Violation|0|||
160791318|NCT03715829|580623801|FG010|Extension Period|Protocol Violation|0|||
160791319|NCT03715829|580623791|FG000|Extension Period|Withdrawal by Subject|0|||
160791320|NCT03715829|580623792|FG001|Extension Period|Withdrawal by Subject|0|||
160791321|NCT03715829|580623793|FG002|Extension Period|Withdrawal by Subject|0|||
160791322|NCT03715829|580623794|FG003|Extension Period|Withdrawal by Subject|0|||
160791323|NCT03715829|580623795|FG004|Extension Period|Withdrawal by Subject|0|||
160791324|NCT03715829|580623796|FG005|Extension Period|Withdrawal by Subject|0|||
160791325|NCT03715829|580623797|FG006|Extension Period|Withdrawal by Subject|3|||
160791326|NCT03715829|580623798|FG007|Extension Period|Withdrawal by Subject|3|||
160791327|NCT03715829|580623799|FG008|Extension Period|Withdrawal by Subject|12|||
160791328|NCT03715829|580623800|FG009|Extension Period|Withdrawal by Subject|3|||
160791329|NCT03715829|580623801|FG010|Extension Period|Withdrawal by Subject|0|||
160791330|NCT03715829|580623791|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791331|NCT03715829|580623792|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791332|NCT03715829|580623793|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791333|NCT03715829|580623794|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791334|NCT03715829|580623795|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791335|NCT03715829|580623796|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791336|NCT03715829|580623797|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791337|NCT03715829|580623798|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
160791338|NCT03715829|580623799|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
160791339|NCT03715829|580623800|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791340|NCT03715829|580623801|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
160791341|NCT03715829|580623791|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791342|NCT03715829|580623792|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791343|NCT03715829|580623793|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791344|NCT03715829|580623794|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791345|NCT03715829|580623795|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791346|NCT03715829|580623796|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
160982031|NCT02718417|581323359|FG002|Follow-up Phase|Study terminated by sponsor|6|||
160982032|NCT02718417|581323357|FG000|Follow-up Phase|Lost to Follow-up|2|||
161235675|NCT01597245|582244940|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235676|NCT01597245|582244941|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160791347|NCT03715829|580623797|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791348|NCT03715829|580623798|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791349|NCT03715829|580623799|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
160791350|NCT03715829|580623800|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791351|NCT03715829|580623801|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
160791352|NCT03715829|580623791|FG000|Extension Period|Other|0|||
160791353|NCT03715829|580623792|FG001|Extension Period|Other|0|||
160791354|NCT03715829|580623793|FG002|Extension Period|Other|0|||
160791355|NCT03715829|580623794|FG003|Extension Period|Other|0|||
160791356|NCT03715829|580623795|FG004|Extension Period|Other|0|||
160791357|NCT03715829|580623796|FG005|Extension Period|Other|0|||
160791358|NCT03715829|580623797|FG006|Extension Period|Other|1|||
160791359|NCT03715829|580623798|FG007|Extension Period|Other|2|||
160791360|NCT03715829|580623799|FG008|Extension Period|Other|4|||
160791361|NCT03715829|580623800|FG009|Extension Period|Other|0|||
160791362|NCT03715829|580623801|FG010|Extension Period|Other|0|||
160791363|NCT03647137|580623803|FG000|Overall Study|Scan Limitation|2|||
160791364|NCT03647137|580623804|FG001|Overall Study|Scan Limitation|1|||
160791365|NCT03647137|580623805|FG002|Overall Study|Scan Limitation|1|||
160791366|NCT03647137|580623806|FG003|Overall Study|Scan Limitation|2|||
160791367|NCT01554904|580623808|FG000|Overall Study|Withdrawal by Subject|3|||
160791368|NCT01554904|580623808|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
160791369|NCT01051661|580623811|FG000|Overall Study|Adverse Event|1|||
160791370|NCT01051661|580623812|FG001|Overall Study|Adverse Event|1|||
160791371|NCT01051661|580623813|FG002|Overall Study|Adverse Event|1|||
160791372|NCT01051661|580623814|FG003|Overall Study|Adverse Event|1|||
160791373|NCT01051661|580623815|FG004|Overall Study|Adverse Event|0|||
160791374|NCT01051661|580623816|FG005|Overall Study|Adverse Event|0|||
160791375|NCT01051661|580623811|FG000|Overall Study|Lost to Follow-up|13|||
160791376|NCT01051661|580623812|FG001|Overall Study|Lost to Follow-up|22|||
161235677|NCT01597245|582244942|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160982033|NCT02718417|581323358|FG001|Follow-up Phase|Lost to Follow-up|3|||
160982034|NCT02718417|581323359|FG002|Follow-up Phase|Lost to Follow-up|0|||
160982035|NCT02718417|581323357|FG000|Follow-up Phase|Death leading to discontinuation|7|||
161235678|NCT01597245|582244943|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235679|NCT01597245|582244944|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
161235680|NCT01597245|582244945|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160982036|NCT02718417|581323358|FG001|Follow-up Phase|Death leading to discontinuation|7|||
160982037|NCT02718417|581323359|FG002|Follow-up Phase|Death leading to discontinuation|3|||
160982038|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
160982039|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
160982040|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
160982041|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
160982042|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
161235681|NCT01597245|582244946|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
160982043|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
160982044|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
160982045|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
160982046|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
160982047|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
160982048|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
160982049|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
160982050|NCT02718417|581323357|FG000|Long-term Follow-up Phase|Other|0|||
160982051|NCT02718417|581323358|FG001|Long-term Follow-up Phase|Other|2|||
160982052|NCT02718417|581323359|FG002|Long-term Follow-up Phase|Other|0|||
160982053|NCT00724061|581323365|FG000|Dose Escalation Phase|Adverse Event|2|||
160982054|NCT00724061|581323365|FG000|Dose Escalation Phase|Disease Progression|3|||
160982055|NCT01536145|581323368|FG000|Overall Study|Progressive disease|3|||
160982056|NCT01536145|581323369|FG001|Overall Study|Progressive disease|4|||
160982057|NCT01536145|581323370|FG002|Overall Study|Progressive disease|1|||
160982058|NCT01536145|581323371|FG003|Overall Study|Progressive disease|2|||
160982059|NCT01536145|581323372|FG004|Overall Study|Progressive disease|1|||
160982060|NCT01536145|581323373|FG005|Overall Study|Progressive disease|2|||
160982061|NCT01536145|581323374|FG006|Overall Study|Progressive disease|1|||
160982062|NCT01536145|581323375|FG007|Overall Study|Progressive disease|2|||
160982063|NCT01536145|581323376|FG008|Overall Study|Progressive disease|1|||
160982064|NCT01536145|581323377|FG009|Overall Study|Progressive disease|3|||
160982065|NCT01536145|581323378|FG010|Overall Study|Progressive disease|3|||
160982066|NCT01536145|581323368|FG000|Overall Study|Withdrawal by Subject|0|||
160982067|NCT01536145|581323369|FG001|Overall Study|Withdrawal by Subject|0|||
160982068|NCT01536145|581323370|FG002|Overall Study|Withdrawal by Subject|1|||
161235682|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235683|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235684|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235685|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235686|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235687|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
160982069|NCT01536145|581323371|FG003|Overall Study|Withdrawal by Subject|0|||
160982070|NCT01536145|581323372|FG004|Overall Study|Withdrawal by Subject|0|||
160982071|NCT01536145|581323373|FG005|Overall Study|Withdrawal by Subject|1|||
160982072|NCT01536145|581323374|FG006|Overall Study|Withdrawal by Subject|0|||
160982073|NCT01536145|581323375|FG007|Overall Study|Withdrawal by Subject|0|||
160982074|NCT01536145|581323376|FG008|Overall Study|Withdrawal by Subject|2|||
160982075|NCT01536145|581323377|FG009|Overall Study|Withdrawal by Subject|0|||
160982076|NCT01536145|581323378|FG010|Overall Study|Withdrawal by Subject|2|||
161235688|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
161330532|NCT01317940|582597136|FG002|Overall Study|Change in therapy plan|3|||
161330533|NCT01317940|582597137|FG003|Overall Study|Change in therapy plan|0|||
161330534|NCT01317940|582597138|FG004|Overall Study|Change in therapy plan|0|||
161330535|NCT01317940|582597139|FG005|Overall Study|Change in therapy plan|0|||
161330536|NCT00945243|582597141|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
161330537|NCT02371616|582597142|FG000|Overall Study|Protocol Violation|2|||
161330538|NCT02371616|582597143|FG001|Overall Study|Protocol Violation|1|||
161330539|NCT02371616|582597142|FG000|Overall Study|Adverse Event|0|||
161330540|NCT02371616|582597143|FG001|Overall Study|Adverse Event|1|||
161330541|NCT02371616|582597142|FG000|Overall Study|Withdrawal of Consent|1|||
161330542|NCT02371616|582597143|FG001|Overall Study|Withdrawal of Consent|0|||
161330543|NCT02371616|582597142|FG000|Overall Study|Other (Not specified)|1|||
161330544|NCT02371616|582597143|FG001|Overall Study|Other (Not specified)|5|||
160791377|NCT01051661|580623813|FG002|Overall Study|Lost to Follow-up|15|||
160982077|NCT01536145|581323368|FG000|Overall Study|Other|0|||
160982078|NCT01536145|581323369|FG001|Overall Study|Other|0|||
160982079|NCT01536145|581323370|FG002|Overall Study|Other|0|||
160982080|NCT01536145|581323371|FG003|Overall Study|Other|0|||
160982081|NCT01536145|581323372|FG004|Overall Study|Other|1|||
160982082|NCT01536145|581323373|FG005|Overall Study|Other|0|||
160982083|NCT01536145|581323374|FG006|Overall Study|Other|0|||
160982084|NCT01536145|581323375|FG007|Overall Study|Other|0|||
160791378|NCT01051661|580623814|FG003|Overall Study|Lost to Follow-up|17|||
160791379|NCT01051661|580623815|FG004|Overall Study|Lost to Follow-up|10|||
160791380|NCT01051661|580623816|FG005|Overall Study|Lost to Follow-up|24|||
160791381|NCT01051661|580623811|FG000|Overall Study|Migrated/moved from study area|1|||
160791382|NCT01051661|580623812|FG001|Overall Study|Migrated/moved from study area|6|||
160791383|NCT01051661|580623813|FG002|Overall Study|Migrated/moved from study area|6|||
160791384|NCT01051661|580623814|FG003|Overall Study|Migrated/moved from study area|8|||
160791385|NCT01051661|580623815|FG004|Overall Study|Migrated/moved from study area|7|||
160791386|NCT01051661|580623816|FG005|Overall Study|Migrated/moved from study area|3|||
160791387|NCT01051661|580623811|FG000|Overall Study|Refused blood sampling|0|||
160791388|NCT01051661|580623812|FG001|Overall Study|Refused blood sampling|0|||
160791389|NCT01051661|580623813|FG002|Overall Study|Refused blood sampling|0|||
160791390|NCT01051661|580623814|FG003|Overall Study|Refused blood sampling|0|||
160791391|NCT01051661|580623815|FG004|Overall Study|Refused blood sampling|0|||
160791392|NCT01051661|580623816|FG005|Overall Study|Refused blood sampling|1|||
160791393|NCT01051661|580623811|FG000|Overall Study|Data not reliable|1|||
160791394|NCT01051661|580623812|FG001|Overall Study|Data not reliable|0|||
160791395|NCT01051661|580623813|FG002|Overall Study|Data not reliable|0|||
160791396|NCT01051661|580623814|FG003|Overall Study|Data not reliable|0|||
160791397|NCT01051661|580623815|FG004|Overall Study|Data not reliable|0|||
160791398|NCT01051661|580623816|FG005|Overall Study|Data not reliable|1|||
160791399|NCT01051661|580623811|FG000|Overall Study|Unable to attend visit(s)|2|||
160791400|NCT01051661|580623812|FG001|Overall Study|Unable to attend visit(s)|4|||
160791401|NCT01051661|580623813|FG002|Overall Study|Unable to attend visit(s)|2|||
160791402|NCT01051661|580623814|FG003|Overall Study|Unable to attend visit(s)|1|||
160892357|NCT02598960|581002155|FG007|Treatment Period|Study drug toxicity|0|||
160892358|NCT02598960|581002156|FG008|Treatment Period|Study drug toxicity|0|||
160892359|NCT02598960|581002157|FG009|Treatment Period|Study drug toxicity|1|||
160892360|NCT02598960|581002158|FG010|Treatment Period|Study drug toxicity|0|||
160892361|NCT02598960|581002159|FG011|Treatment Period|Study drug toxicity|3|||
160982085|NCT01536145|581323376|FG008|Overall Study|Other|0|||
160892362|NCT02598960|581002160|FG012|Treatment Period|Study drug toxicity|0|||
160892363|NCT02598960|581002148|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
160892364|NCT02598960|581002149|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
160892365|NCT02598960|581002150|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
160892366|NCT02598960|581002151|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
160892367|NCT02598960|581002152|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
160892368|NCT02598960|581002153|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
160892369|NCT02598960|581002154|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
160892370|NCT02598960|581002155|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
160892371|NCT02598960|581002156|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
160892372|NCT02598960|581002157|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
160892373|NCT02598960|581002158|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
160892374|NCT02598960|581002159|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
160892375|NCT02598960|581002160|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
160892376|NCT02598960|581002148|FG000|Treatment Period|participant request to discontinue|0|||
160892377|NCT02598960|581002149|FG001|Treatment Period|participant request to discontinue|1|||
160892378|NCT02598960|581002150|FG002|Treatment Period|participant request to discontinue|0|||
160892379|NCT02598960|581002151|FG003|Treatment Period|participant request to discontinue|0|||
160892380|NCT02598960|581002152|FG004|Treatment Period|participant request to discontinue|1|||
160892381|NCT02598960|581002153|FG005|Treatment Period|participant request to discontinue|0|||
160892382|NCT02598960|581002154|FG006|Treatment Period|participant request to discontinue|0|||
160892383|NCT02598960|581002155|FG007|Treatment Period|participant request to discontinue|0|||
160892384|NCT02598960|581002156|FG008|Treatment Period|participant request to discontinue|0|||
160892385|NCT02598960|581002157|FG009|Treatment Period|participant request to discontinue|0|||
160982086|NCT01536145|581323377|FG009|Overall Study|Other|3|||
160982087|NCT01536145|581323378|FG010|Overall Study|Other|2|||
160982088|NCT01536145|581323368|FG000|Overall Study|Death|0|||
160791403|NCT01051661|580623815|FG004|Overall Study|Unable to attend visit(s)|3|||
160791404|NCT01051661|580623816|FG005|Overall Study|Unable to attend visit(s)|2|||
160791405|NCT01051661|580623811|FG000|Overall Study|Consent not received from both parents|0|||
160791406|NCT01051661|580623812|FG001|Overall Study|Consent not received from both parents|0|||
160982089|NCT01536145|581323369|FG001|Overall Study|Death|0|||
160791407|NCT01051661|580623813|FG002|Overall Study|Consent not received from both parents|0|||
160791408|NCT01051661|580623814|FG003|Overall Study|Consent not received from both parents|0|||
160791409|NCT01051661|580623815|FG004|Overall Study|Consent not received from both parents|0|||
160791410|NCT01051661|580623816|FG005|Overall Study|Consent not received from both parents|1|||
160791411|NCT01051661|580623811|FG000|Overall Study|Failure to comply with protocol|0|||
160791412|NCT01051661|580623812|FG001|Overall Study|Failure to comply with protocol|0|||
160791413|NCT01051661|580623813|FG002|Overall Study|Failure to comply with protocol|2|||
160791414|NCT01051661|580623814|FG003|Overall Study|Failure to comply with protocol|0|||
160791415|NCT01051661|580623815|FG004|Overall Study|Failure to comply with protocol|0|||
160791416|NCT01051661|580623816|FG005|Overall Study|Failure to comply with protocol|0|||
160791417|NCT01051661|580623811|FG000|Overall Study|Subject lost legal representation|0|||
160791418|NCT01051661|580623812|FG001|Overall Study|Subject lost legal representation|0|||
160791419|NCT01051661|580623813|FG002|Overall Study|Subject lost legal representation|0|||
160791420|NCT01051661|580623814|FG003|Overall Study|Subject lost legal representation|0|||
160791421|NCT01051661|580623815|FG004|Overall Study|Subject lost legal representation|1|||
160791422|NCT01051661|580623816|FG005|Overall Study|Subject lost legal representation|0|||
160791423|NCT01051661|580623811|FG000|Overall Study|Protocol Violation|0|||
160791424|NCT01051661|580623812|FG001|Overall Study|Protocol Violation|0|||
160791425|NCT01051661|580623813|FG002|Overall Study|Protocol Violation|0|||
160791426|NCT01051661|580623814|FG003|Overall Study|Protocol Violation|1|||
160791427|NCT01051661|580623815|FG004|Overall Study|Protocol Violation|2|||
160791428|NCT01051661|580623816|FG005|Overall Study|Protocol Violation|1|||
160791429|NCT01051661|580623811|FG000|Overall Study|Withdrawal by Subject|16|||
160791430|NCT01051661|580623812|FG001|Overall Study|Withdrawal by Subject|30|||
160791431|NCT01051661|580623813|FG002|Overall Study|Withdrawal by Subject|13|||
160791432|NCT01051661|580623814|FG003|Overall Study|Withdrawal by Subject|28|||
160791433|NCT01051661|580623815|FG004|Overall Study|Withdrawal by Subject|12|||
160791434|NCT01051661|580623816|FG005|Overall Study|Withdrawal by Subject|34|||
160791435|NCT04525183|580623817|FG000|Overall Study|Withdrawal by Subject|0|||
160791436|NCT04525183|580623818|FG001|Overall Study|Withdrawal by Subject|0|||
160791437|NCT04525183|580623819|FG002|Overall Study|Withdrawal by Subject|3|||
160791438|NCT04525183|580623817|FG000|Overall Study|Study non-compliance|0|||
160791439|NCT04525183|580623818|FG001|Overall Study|Study non-compliance|0|||
160791440|NCT04525183|580623819|FG002|Overall Study|Study non-compliance|1|||
160791441|NCT04525183|580623817|FG000|Overall Study|Recurrent disease before starting on study|0|||
160791442|NCT04525183|580623818|FG001|Overall Study|Recurrent disease before starting on study|0|||
160791443|NCT04525183|580623819|FG002|Overall Study|Recurrent disease before starting on study|1|||
160791444|NCT01922895|580623820|FG000|Overall Study|Death|0|||
160791445|NCT01922895|580623821|FG001|Overall Study|Death|1|||
160791446|NCT01922895|580623820|FG000|Overall Study|Withdrawal by Subject|1|||
160791447|NCT01922895|580623821|FG001|Overall Study|Withdrawal by Subject|2|||
160791448|NCT01922895|580623820|FG000|Overall Study|Lost to Follow-up|5|||
160791449|NCT01922895|580623821|FG001|Overall Study|Lost to Follow-up|11|||
160791450|NCT05142306|580623822|FG000|Overall Study|Withdrawal by Subject|0|||
160791451|NCT05142306|580623823|FG001|Overall Study|Withdrawal by Subject|0|||
160791452|NCT05142306|580623824|FG002|Overall Study|Withdrawal by Subject|1|||
160791453|NCT04079920|580623825|FG000|Overall Study|Adverse event, not related to study drug|2|||
160791454|NCT04079920|580623825|FG000|Overall Study|Adverse event related to study drug|10|||
160791455|NCT04079920|580623825|FG000|Overall Study|Death|2|||
160791456|NCT04079920|580623825|FG000|Overall Study|Lost to Follow-up|22|||
160791457|NCT04079920|580623825|FG000|Overall Study|Physician Decision|1|||
160791458|NCT04079920|580623825|FG000|Overall Study|Withdrawal by Subject|11|||
160791459|NCT05430919|580623826|FG000|Overall Study|Protocol Violation|0|||
160791460|NCT05430919|580623827|FG001|Overall Study|Protocol Violation|0|||
160791461|NCT05430919|580623828|FG002|Overall Study|Protocol Violation|1|||
160791462|NCT05430919|580623829|FG003|Overall Study|Protocol Violation|0|||
160791463|NCT05430919|580623826|FG000|Overall Study|Lost to Follow-up|0|||
160791464|NCT05430919|580623827|FG001|Overall Study|Lost to Follow-up|1|||
160791465|NCT05430919|580623828|FG002|Overall Study|Lost to Follow-up|0|||
160791466|NCT05430919|580623829|FG003|Overall Study|Lost to Follow-up|0|||
160791467|NCT05430919|580623826|FG000|Overall Study|Withdrawal by Subject|3|||
160791468|NCT05430919|580623827|FG001|Overall Study|Withdrawal by Subject|0|||
160791469|NCT05430919|580623828|FG002|Overall Study|Withdrawal by Subject|0|||
160791470|NCT05430919|580623829|FG003|Overall Study|Withdrawal by Subject|1|||
160791471|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
160791472|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
160791473|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
160892386|NCT02598960|581002158|FG010|Treatment Period|participant request to discontinue|1|||
160892387|NCT02598960|581002159|FG011|Treatment Period|participant request to discontinue|4|||
160892388|NCT02598960|581002160|FG012|Treatment Period|participant request to discontinue|0|||
160892389|NCT02598960|581002148|FG000|Treatment Period|participant withdrew consent|0|||
160892390|NCT02598960|581002149|FG001|Treatment Period|participant withdrew consent|0|||
160892391|NCT02598960|581002150|FG002|Treatment Period|participant withdrew consent|0|||
160791474|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
160791475|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
160791476|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
160791477|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
160791478|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
160791479|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
160892392|NCT02598960|581002151|FG003|Treatment Period|participant withdrew consent|0|||
160982090|NCT01536145|581323370|FG002|Overall Study|Death|0|||
160982091|NCT01536145|581323371|FG003|Overall Study|Death|0|||
160982092|NCT01536145|581323372|FG004|Overall Study|Death|0|||
160982093|NCT01536145|581323373|FG005|Overall Study|Death|0|||
160982094|NCT01536145|581323374|FG006|Overall Study|Death|1|||
160982095|NCT01536145|581323375|FG007|Overall Study|Death|0|||
160982096|NCT01536145|581323376|FG008|Overall Study|Death|0|||
160982097|NCT01536145|581323377|FG009|Overall Study|Death|0|||
160982098|NCT01536145|581323378|FG010|Overall Study|Death|0|||
160982099|NCT01536145|581323368|FG000|Overall Study|Adverse Event|0|||
160982100|NCT01536145|581323369|FG001|Overall Study|Adverse Event|0|||
160982101|NCT01536145|581323370|FG002|Overall Study|Adverse Event|0|||
161235689|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235690|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235691|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235692|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235693|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235694|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235695|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235696|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235697|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235698|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235699|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235700|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235701|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235702|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
161235703|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161330545|NCT00754741|582597146|FG000|Overall Study|Died or disenrolled|57|||
160982102|NCT01536145|581323371|FG003|Overall Study|Adverse Event|0|||
160982103|NCT01536145|581323372|FG004|Overall Study|Adverse Event|0|||
160982104|NCT01536145|581323373|FG005|Overall Study|Adverse Event|0|||
160982105|NCT01536145|581323374|FG006|Overall Study|Adverse Event|0|||
160982106|NCT01536145|581323375|FG007|Overall Study|Adverse Event|2|||
160982107|NCT01536145|581323376|FG008|Overall Study|Adverse Event|0|||
161330546|NCT00754741|582597147|FG001|Overall Study|Died or disenrolled|69|||
161330547|NCT00754741|582597148|FG002|Overall Study|Died or disenrolled|54|||
160791480|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
160982108|NCT01536145|581323377|FG009|Overall Study|Adverse Event|0|||
161330548|NCT04069715|582597149|FG000|Overall Study|Lost to Follow-up|1|||
161330549|NCT04069715|582597150|FG001|Overall Study|Lost to Follow-up|1|||
161330550|NCT04069715|582597149|FG000|Overall Study|Physician Decision|1|||
161330551|NCT04069715|582597150|FG001|Overall Study|Physician Decision|1|||
161330552|NCT04069715|582597149|FG000|Overall Study|Withdrawal by Subject|3|||
161330553|NCT04069715|582597150|FG001|Overall Study|Withdrawal by Subject|3|||
161330554|NCT03205150|582597151|FG000|Overall Study|Protocol deviation|1|||
161330555|NCT03205150|582597152|FG001|Overall Study|Protocol deviation|3|||
161330556|NCT03205150|582597153|FG002|Overall Study|Protocol deviation|0|||
161330557|NCT03205150|582597151|FG000|Overall Study|Patient/guardian decision|0|||
161330558|NCT03205150|582597152|FG001|Overall Study|Patient/guardian decision|3|||
161330559|NCT03205150|582597153|FG002|Overall Study|Patient/guardian decision|0|||
161330560|NCT03205150|582597151|FG000|Overall Study|Adverse Event|1|||
161330561|NCT03205150|582597152|FG001|Overall Study|Adverse Event|1|||
161330562|NCT03205150|582597153|FG002|Overall Study|Adverse Event|1|||
161330563|NCT03205150|582597151|FG000|Overall Study|Lost to Follow-up|0|||
161330564|NCT03205150|582597152|FG001|Overall Study|Lost to Follow-up|0|||
161330565|NCT03205150|582597153|FG002|Overall Study|Lost to Follow-up|1|||
161330566|NCT01095835|582597154|FG000|Overall Study|Adverse Event|8|||
161330567|NCT01095835|582597155|FG001|Overall Study|Adverse Event|6|||
161330568|NCT01095835|582597156|FG002|Overall Study|Adverse Event|6|||
161330569|NCT01095835|582597154|FG000|Overall Study|Lack of Efficacy|0|||
161330570|NCT01095835|582597155|FG001|Overall Study|Lack of Efficacy|1|||
161330571|NCT01095835|582597156|FG002|Overall Study|Lack of Efficacy|0|||
161330572|NCT01095835|582597154|FG000|Overall Study|Physician Decision|0|||
161330573|NCT01095835|582597155|FG001|Overall Study|Physician Decision|0|||
161330574|NCT01095835|582597156|FG002|Overall Study|Physician Decision|1|||
161330575|NCT01095835|582597154|FG000|Overall Study|Withdrawal by Subject|1|||
161330576|NCT01095835|582597155|FG001|Overall Study|Withdrawal by Subject|3|||
161330577|NCT01095835|582597156|FG002|Overall Study|Withdrawal by Subject|0|||
161330578|NCT01095835|582597154|FG000|Overall Study|Non study compliance|0|||
161330579|NCT01095835|582597155|FG001|Overall Study|Non study compliance|0|||
161330580|NCT01095835|582597156|FG002|Overall Study|Non study compliance|1|||
161330581|NCT01095835|582597154|FG000|Overall Study|Protocol Violation|1|||
161330582|NCT01095835|582597155|FG001|Overall Study|Protocol Violation|2|||
161330583|NCT01095835|582597156|FG002|Overall Study|Protocol Violation|0|||
160982109|NCT01536145|581323378|FG010|Overall Study|Adverse Event|3|||
160982110|NCT00088205|581323381|FG000|Overall Study|Adverse Event|4|||
160982111|NCT00088205|581323381|FG000|Overall Study|Progressive Disease|51|||
161235704|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235705|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235706|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235707|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
161235708|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
161235709|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
161235710|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
161235711|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235712|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
161235713|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235714|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235715|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235716|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235717|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235718|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235719|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235720|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235721|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235722|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235723|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
161235724|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235725|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235726|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235727|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235728|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235729|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
161235730|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235731|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235732|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
161235733|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235734|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
161235735|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
161330584|NCT03028142|582597159|FG000|Overall Study|Adverse Event|1|||
161330585|NCT03028142|582597160|FG001|Overall Study|Adverse Event|1|||
161330586|NCT03028142|582597161|FG002|Overall Study|Adverse Event|0|||
161330587|NCT03028142|582597162|FG003|Overall Study|Adverse Event|0|||
161330588|NCT03028142|582597163|FG004|Overall Study|Adverse Event|0|||
161330589|NCT03028142|582597164|FG005|Overall Study|Adverse Event|1|||
161330590|NCT03028142|582597159|FG000|Overall Study|Withdrawal by Subject|0|||
161330591|NCT03028142|582597160|FG001|Overall Study|Withdrawal by Subject|0|||
161330592|NCT03028142|582597161|FG002|Overall Study|Withdrawal by Subject|0|||
161330593|NCT03028142|582597162|FG003|Overall Study|Withdrawal by Subject|0|||
161330594|NCT03028142|582597163|FG004|Overall Study|Withdrawal by Subject|1|||
161330595|NCT03028142|582597164|FG005|Overall Study|Withdrawal by Subject|0|||
161330596|NCT00116688|582597169|FG000|Overall Study|Protocol deviation|1|||
161330597|NCT00116688|582597170|FG001|Overall Study|Protocol deviation|0|||
160892393|NCT02598960|581002152|FG004|Treatment Period|participant withdrew consent|0|||
160892394|NCT02598960|581002153|FG005|Treatment Period|participant withdrew consent|0|||
160892395|NCT02598960|581002154|FG006|Treatment Period|participant withdrew consent|0|||
160892396|NCT02598960|581002155|FG007|Treatment Period|participant withdrew consent|0|||
160892397|NCT02598960|581002156|FG008|Treatment Period|participant withdrew consent|0|||
160892398|NCT02598960|581002157|FG009|Treatment Period|participant withdrew consent|0|||
161330598|NCT00116688|582597169|FG000|Overall Study|Noncompliance|3|||
161330599|NCT00116688|582597170|FG001|Overall Study|Noncompliance|1|||
161330600|NCT00116688|582597169|FG000|Overall Study|Adverse Event|11|||
160892399|NCT02598960|581002158|FG010|Treatment Period|participant withdrew consent|0|||
160892400|NCT02598960|581002159|FG011|Treatment Period|participant withdrew consent|3|||
160892401|NCT02598960|581002160|FG012|Treatment Period|participant withdrew consent|0|||
160892402|NCT02598960|581002148|FG000|Treatment Period|No longer meets study criteria|0|||
160892403|NCT02598960|581002149|FG001|Treatment Period|No longer meets study criteria|0|||
160892404|NCT02598960|581002150|FG002|Treatment Period|No longer meets study criteria|0|||
160892405|NCT02598960|581002151|FG003|Treatment Period|No longer meets study criteria|0|||
160892406|NCT02598960|581002152|FG004|Treatment Period|No longer meets study criteria|0|||
160892407|NCT02598960|581002153|FG005|Treatment Period|No longer meets study criteria|0|||
160892408|NCT02598960|581002154|FG006|Treatment Period|No longer meets study criteria|0|||
160892409|NCT02598960|581002155|FG007|Treatment Period|No longer meets study criteria|0|||
160892410|NCT02598960|581002156|FG008|Treatment Period|No longer meets study criteria|0|||
160892411|NCT02598960|581002157|FG009|Treatment Period|No longer meets study criteria|0|||
161330601|NCT00116688|582597170|FG001|Overall Study|Adverse Event|0|||
160892412|NCT02598960|581002158|FG010|Treatment Period|No longer meets study criteria|0|||
160892413|NCT02598960|581002159|FG011|Treatment Period|No longer meets study criteria|1|||
160791481|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
160791482|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
160791483|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
160791484|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
160791485|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
160791486|NCT05014919|580623830|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
160791487|NCT05014919|580623831|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
160791488|NCT05014919|580623832|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
160791489|NCT05014919|580623830|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
160791490|NCT05014919|580623831|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
160791491|NCT05014919|580623832|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
160791492|NCT05014919|580623830|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
160791493|NCT05014919|580623831|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
160791494|NCT05014919|580623832|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
161128561|NCT00091832|581856924|FG001|Overall Study|Death|4|||
161128562|NCT00091832|581856925|FG002|Overall Study|Death|5|||
161128563|NCT00091832|581856926|FG003|Overall Study|Death|8|||
161128564|NCT00091832|581856927|FG004|Overall Study|Death|5|||
161128565|NCT00091832|581856928|FG005|Overall Study|Death|6|||
161128566|NCT00091832|581856923|FG000|Overall Study|Disease Progression|2|||
161128567|NCT00091832|581856924|FG001|Overall Study|Disease Progression|0|||
161128568|NCT00091832|581856925|FG002|Overall Study|Disease Progression|0|||
161128569|NCT00091832|581856926|FG003|Overall Study|Disease Progression|1|||
161128570|NCT00091832|581856927|FG004|Overall Study|Disease Progression|1|||
161128571|NCT00091832|581856928|FG005|Overall Study|Disease Progression|2|||
161128572|NCT00091832|581856923|FG000|Overall Study|Ineligibility Determined|0|||
161128573|NCT00091832|581856924|FG001|Overall Study|Ineligibility Determined|0|||
161128574|NCT00091832|581856925|FG002|Overall Study|Ineligibility Determined|1|||
161128575|NCT00091832|581856926|FG003|Overall Study|Ineligibility Determined|0|||
161128576|NCT00091832|581856927|FG004|Overall Study|Ineligibility Determined|1|||
161128577|NCT00091832|581856928|FG005|Overall Study|Ineligibility Determined|0|||
161128578|NCT00091832|581856923|FG000|Overall Study|Lost to Follow-up|1|||
161128579|NCT00091832|581856924|FG001|Overall Study|Lost to Follow-up|0|||
161128580|NCT00091832|581856925|FG002|Overall Study|Lost to Follow-up|3|||
161128581|NCT00091832|581856926|FG003|Overall Study|Lost to Follow-up|3|||
161128582|NCT00091832|581856927|FG004|Overall Study|Lost to Follow-up|2|||
161128583|NCT00091832|581856928|FG005|Overall Study|Lost to Follow-up|1|||
161128584|NCT00091832|581856923|FG000|Overall Study|Noncompliance|0|||
161128585|NCT00091832|581856924|FG001|Overall Study|Noncompliance|1|||
160791495|NCT04126174|580623838|FG000|Overall Study|Lost to Follow-up|3|||
160791496|NCT04126174|580623839|FG001|Overall Study|Lost to Follow-up|3|||
160791497|NCT05305651|580623850|FG000|Overall Study|Death|1|||
160791498|NCT05305651|580623850|FG000|Overall Study|Withdrawal by Subject|4|||
160791499|NCT05305651|580623850|FG000|Overall Study|Lost to Follow-up|4|||
160791500|NCT01491919|580623853|FG000|Overall Study|Insufficient PK sampling|1|||
160791501|NCT01491919|580623854|FG001|Overall Study|Insufficient PK sampling|2|||
160791502|NCT01491919|580623855|FG002|Overall Study|Insufficient PK sampling|1|||
160791503|NCT04439903|580623856|FG000|Overall Study|Withdrawal by Subject|2|||
160791504|NCT04439903|580623856|FG000|Overall Study|Screen Failure|1|||
160791505|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
160791506|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
160791507|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
160791508|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
160791509|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160791510|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160791511|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160791512|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160791513|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
160791514|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
160791515|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
160791516|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
160791517|NCT05375929|580623859|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
160791518|NCT05375929|580623860|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
160982112|NCT00088205|581323381|FG000|Overall Study|Physician Decision|1|||
161128586|NCT00091832|581856925|FG002|Overall Study|Noncompliance|0|||
161128587|NCT00091832|581856926|FG003|Overall Study|Noncompliance|0|||
161128588|NCT00091832|581856927|FG004|Overall Study|Noncompliance|0|||
161128589|NCT00091832|581856928|FG005|Overall Study|Noncompliance|0|||
161128590|NCT00091832|581856923|FG000|Overall Study|Other|0|||
161128591|NCT00091832|581856924|FG001|Overall Study|Other|1|||
161128592|NCT00091832|581856925|FG002|Overall Study|Other|2|||
161128593|NCT00091832|581856926|FG003|Overall Study|Other|0|||
161128594|NCT00091832|581856927|FG004|Overall Study|Other|0|||
160791519|NCT05375929|580623861|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
160791520|NCT05375929|580623862|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
160791521|NCT05375929|580623859|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
160791522|NCT05375929|580623860|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
160791523|NCT05375929|580623861|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
160791524|NCT05375929|580623862|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
160791525|NCT05375929|580623859|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
160791526|NCT05375929|580623860|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
160791527|NCT05375929|580623861|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
160791528|NCT05375929|580623862|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
160791529|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
160791530|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
160791531|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
160791532|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
160791533|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
160791534|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
160791535|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
160791536|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
160791537|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
160791538|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
160791539|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
160791540|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
160791541|NCT05375929|580623859|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
160791542|NCT05375929|580623860|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
160791543|NCT05375929|580623861|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
160791544|NCT05375929|580623862|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
160791545|NCT02528305|580623863|FG000|Overall Study|Withdrawal by Subject|1|||
160791546|NCT02528305|580623863|FG000|Overall Study|Adverse Event|1|||
160791547|NCT02528305|580623863|FG000|Overall Study|Physician Decision|1|||
160791548|NCT01852214|580623864|FG000|Period 1|Adverse Event|1|||
160791549|NCT01852214|580623865|FG001|Period 1|Adverse Event|2|||
160791550|NCT01852214|580623864|FG000|Period 1|Withdrawal by Subject|0|||
160791551|NCT01852214|580623865|FG001|Period 1|Withdrawal by Subject|1|||
160791552|NCT01852214|580623864|FG000|Washout Period|Withdrawal by Subject|0|||
160791553|NCT01852214|580623865|FG001|Washout Period|Withdrawal by Subject|1|||
160791554|NCT04091438|580623866|FG000|Treatment Period 1 (1 Day)|Other|1|||
160791555|NCT04091438|580623867|FG001|Treatment Period 1 (1 Day)|Other|0|||
160791556|NCT04091438|580623866|FG000|Washout Period (1 Day)|Protocol deviation|0|||
160791557|NCT04091438|580623867|FG001|Washout Period (1 Day)|Protocol deviation|1|||
160791558|NCT04091438|580623866|FG000|Washout Period (1 Day)|Other|0|||
160791559|NCT04091438|580623867|FG001|Washout Period (1 Day)|Other|1|||
160791560|NCT00421408|580623868|FG000|Overall Study|Lost to Follow-up|30|||
160791561|NCT00421408|580623869|FG001|Overall Study|Lost to Follow-up|20|||
160791562|NCT00421408|580623868|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
160791563|NCT00421408|580623869|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
160791564|NCT04105725|580623870|FG000|Primary Intervention|Lost to Follow-up|0|||
160791565|NCT04105725|580623871|FG001|Primary Intervention|Lost to Follow-up|2|||
160791566|NCT04105725|580623870|FG000|Primary Intervention|Withdrawal by Subject|0|||
160791567|NCT04105725|580623871|FG001|Primary Intervention|Withdrawal by Subject|1|||
160791568|NCT00773461|580623874|FG000|Overall Study|Adverse Event|1|||
160791569|NCT00773461|580623875|FG001|Overall Study|Adverse Event|3|||
160791570|NCT00773461|580623874|FG000|Overall Study|Withdrawal by Subject|4|||
160791571|NCT00773461|580623875|FG001|Overall Study|Withdrawal by Subject|1|||
160791572|NCT01308788|580623876|FG000|2-year Treatment|medication change by treating physician|4|||
160791573|NCT01308788|580623877|FG001|2-year Treatment|medication change by treating physician|11|||
160791574|NCT00322218|580623878|FG000|Overall Study|Death|3|||
160791575|NCT00322218|580623879|FG001|Overall Study|Death|6|||
160791576|NCT03379870|580625312|FG000|Overall Study|Lost to Follow-up|1|||
160791577|NCT03379870|580625313|FG001|Overall Study|Lost to Follow-up|0|||
160791578|NCT03379870|580625312|FG000|Overall Study|Protocol Violation|1|||
160791579|NCT03379870|580625313|FG001|Overall Study|Protocol Violation|1|||
160791580|NCT00003645|580625314|FG000|Overall Study|Death|4|||
160791581|NCT00003645|580625315|FG001|Overall Study|Death|1|||
160791582|NCT00003645|580625314|FG000|Overall Study|Lost to Follow-up|7|||
160791583|NCT00003645|580625315|FG001|Overall Study|Lost to Follow-up|8|||
160791584|NCT00003645|580625314|FG000|Overall Study|Withdrawal by Subject|1|||
160791585|NCT00003645|580625315|FG001|Overall Study|Withdrawal by Subject|3|||
160791586|NCT04616196|580625316|FG000|Overall Study|Progressive Disease|3|||
160791587|NCT04616196|580625317|FG001|Overall Study|Progressive Disease|0|||
160791588|NCT04616196|580625318|FG002|Overall Study|Progressive Disease|4|||
160791589|NCT04616196|580625319|FG003|Overall Study|Progressive Disease|1|||
160791590|NCT04616196|580625316|FG000|Overall Study|Death|2|||
160791591|NCT04616196|580625317|FG001|Overall Study|Death|4|||
161235736|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
161235737|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235738|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235739|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235740|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235741|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235742|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160791592|NCT04616196|580625318|FG002|Overall Study|Death|1|||
160791593|NCT04616196|580625319|FG003|Overall Study|Death|0|||
160791594|NCT04616196|580625316|FG000|Overall Study|Withdrawal by Subject|0|||
160791595|NCT04616196|580625317|FG001|Overall Study|Withdrawal by Subject|2|||
160791596|NCT04616196|580625318|FG002|Overall Study|Withdrawal by Subject|0|||
160791597|NCT04616196|580625319|FG003|Overall Study|Withdrawal by Subject|0|||
160791598|NCT04616196|580625316|FG000|Overall Study|Lost to Follow-up|1|||
160791599|NCT04616196|580625317|FG001|Overall Study|Lost to Follow-up|0|||
160791600|NCT04616196|580625318|FG002|Overall Study|Lost to Follow-up|0|||
160791601|NCT04616196|580625319|FG003|Overall Study|Lost to Follow-up|0|||
160791602|NCT04616196|580625316|FG000|Overall Study|Sponsor request|2|||
160791603|NCT04616196|580625317|FG001|Overall Study|Sponsor request|1|||
160791604|NCT04616196|580625318|FG002|Overall Study|Sponsor request|1|||
160791605|NCT04616196|580625319|FG003|Overall Study|Sponsor request|2|||
160791606|NCT02254291|580625320|FG000|Overall Study|Withdrawal by Subject|0|||
160791607|NCT02254291|580625321|FG001|Overall Study|Withdrawal by Subject|3|||
160791608|NCT02254291|580625322|FG002|Overall Study|Withdrawal by Subject|1|||
160791609|NCT02254291|580625320|FG000|Overall Study|Missing follow-up information|0|||
160791610|NCT02254291|580625321|FG001|Overall Study|Missing follow-up information|0|||
160791611|NCT02254291|580625322|FG002|Overall Study|Missing follow-up information|1|||
160791612|NCT06790303|580625323|FG000|Overall Study|Study Terminated by sponsor|4|||
160791613|NCT06790303|580625323|FG000|Overall Study|Death|4|||
160791614|NCT03436732|580625326|FG000|Overall Study|Not treated-enrolled in different study|1|||
160791615|NCT03436732|580625327|FG001|Overall Study|Not treated-enrolled in different study|0|||
160791616|NCT03436732|580625326|FG000|Overall Study|Off study after cycle 1|1|||
160791617|NCT03436732|580625327|FG001|Overall Study|Off study after cycle 1|0|||
160791618|NCT03436732|580625326|FG000|Overall Study|Adverse Event|2|||
160791619|NCT03436732|580625327|FG001|Overall Study|Adverse Event|0|||
160791620|NCT03436732|580625326|FG000|Overall Study|Death|0|||
160791621|NCT03436732|580625327|FG001|Overall Study|Death|1|||
160791622|NCT00668642|580625337|FG000|First Off-cycle|Cancer progression|1|||
160791623|NCT00668642|580625338|FG001|First Off-cycle|Cancer progression|0|||
160791624|NCT00668642|580625337|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
160791625|NCT00668642|580625338|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
160791626|NCT00337168|580625343|FG000|Overall Study|Death|5|||
160791627|NCT00337168|580625343|FG000|Overall Study|Not protocol specified|2|||
160791628|NCT00337168|580625343|FG000|Overall Study|Did not start therapy|1|||
160791629|NCT01230060|580625346|FG000|Overall Study|Withdrawal by Subject|1|||
160791630|NCT00443456|580625347|FG000|Overall Study|Adverse Event|16|||
160791631|NCT00443456|580625347|FG000|Overall Study|Move|1|||
160791632|NCT00443456|580625347|FG000|Overall Study|Withdrawal by Subject|1|||
160791633|NCT03242434|580625348|FG000|Overall Study|Death|0|||
160791634|NCT03242434|580625349|FG001|Overall Study|Death|2|||
160791635|NCT02157610|580625350|FG000|Overall Study|Death|4|||
160791636|NCT02157610|580625351|FG001|Overall Study|Death|4|||
160791637|NCT00814983|580625352|FG000|Overall Study|Screen failure|1|||
160791638|NCT00814983|580625353|FG001|Overall Study|Screen failure|0|||
160791639|NCT00814983|580625352|FG000|Overall Study|Withdrawal by Subject|1|||
160791640|NCT00814983|580625353|FG001|Overall Study|Withdrawal by Subject|0|||
160791641|NCT00814983|580625352|FG000|Overall Study|Graft failure|1|||
160791642|NCT00814983|580625353|FG001|Overall Study|Graft failure|0|||
160791643|NCT02853136|580625354|FG000|Wash-out|Adverse Event|0|||
160791644|NCT02853136|580625355|FG001|Wash-out|Adverse Event|0|||
160791645|NCT02853136|580625356|FG002|Wash-out|Adverse Event|0|||
160791646|NCT02853136|580625357|FG003|Wash-out|Adverse Event|1|||
160791647|NCT00841815|580625358|FG000|Washout|Withdrawal by Subject|0|||
161235743|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
161235744|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
160791648|NCT00841815|580625359|FG001|Washout|Withdrawal by Subject|1|||
160791649|NCT02327169|580625360|FG000|Overall Study|Progressive Disease|1|||
161330602|NCT00116688|582597169|FG000|Overall Study|Withdrawal by Subject|26|||
160791650|NCT02327169|580625361|FG001|Overall Study|Progressive Disease|3|||
160791651|NCT02327169|580625362|FG002|Overall Study|Progressive Disease|4|||
160791652|NCT02327169|580625363|FG003|Overall Study|Progressive Disease|3|||
160791653|NCT02327169|580625364|FG004|Overall Study|Progressive Disease|4|||
160791654|NCT02327169|580625365|FG005|Overall Study|Progressive Disease|3|||
160791655|NCT02327169|580625366|FG006|Overall Study|Progressive Disease|3|||
160791656|NCT02327169|580625367|FG007|Overall Study|Progressive Disease|3|||
160791657|NCT02327169|580625368|FG008|Overall Study|Progressive Disease|4|||
160791658|NCT02327169|580625369|FG009|Overall Study|Progressive Disease|4|||
160791659|NCT02327169|580625370|FG010|Overall Study|Progressive Disease|4|||
160791660|NCT02327169|580625371|FG011|Overall Study|Progressive Disease|3|||
160791661|NCT02327169|580625372|FG012|Overall Study|Progressive Disease|1|||
160791662|NCT02327169|580625373|FG013|Overall Study|Progressive Disease|3|||
160791663|NCT02327169|580625374|FG014|Overall Study|Progressive Disease|3|||
160791664|NCT02327169|580625360|FG000|Overall Study|Adverse Event|2|||
160791665|NCT02327169|580625361|FG001|Overall Study|Adverse Event|0|||
160791666|NCT02327169|580625362|FG002|Overall Study|Adverse Event|1|||
160791667|NCT02327169|580625363|FG003|Overall Study|Adverse Event|0|||
160791668|NCT02327169|580625364|FG004|Overall Study|Adverse Event|1|||
160791669|NCT02327169|580625365|FG005|Overall Study|Adverse Event|0|||
160791670|NCT02327169|580625366|FG006|Overall Study|Adverse Event|0|||
160791671|NCT02327169|580625367|FG007|Overall Study|Adverse Event|0|||
160791672|NCT02327169|580625368|FG008|Overall Study|Adverse Event|0|||
160791673|NCT02327169|580625369|FG009|Overall Study|Adverse Event|2|||
160791674|NCT02327169|580625370|FG010|Overall Study|Adverse Event|0|||
160791675|NCT02327169|580625371|FG011|Overall Study|Adverse Event|3|||
160791676|NCT02327169|580625372|FG012|Overall Study|Adverse Event|0|||
160791677|NCT02327169|580625373|FG013|Overall Study|Adverse Event|2|||
160791678|NCT02327169|580625374|FG014|Overall Study|Adverse Event|1|||
160791679|NCT02327169|580625360|FG000|Overall Study|Symptomatic Deterioration|0|||
160791680|NCT02327169|580625361|FG001|Overall Study|Symptomatic Deterioration|0|||
160791681|NCT02327169|580625362|FG002|Overall Study|Symptomatic Deterioration|1|||
160791682|NCT02327169|580625363|FG003|Overall Study|Symptomatic Deterioration|0|||
160791683|NCT02327169|580625364|FG004|Overall Study|Symptomatic Deterioration|1|||
160791684|NCT02327169|580625365|FG005|Overall Study|Symptomatic Deterioration|1|||
160791685|NCT02327169|580625366|FG006|Overall Study|Symptomatic Deterioration|0|||
160791686|NCT02327169|580625367|FG007|Overall Study|Symptomatic Deterioration|0|||
160791687|NCT02327169|580625368|FG008|Overall Study|Symptomatic Deterioration|2|||
160791688|NCT02327169|580625369|FG009|Overall Study|Symptomatic Deterioration|1|||
160791689|NCT02327169|580625370|FG010|Overall Study|Symptomatic Deterioration|0|||
160791690|NCT02327169|580625371|FG011|Overall Study|Symptomatic Deterioration|0|||
160791691|NCT02327169|580625372|FG012|Overall Study|Symptomatic Deterioration|0|||
160791692|NCT02327169|580625373|FG013|Overall Study|Symptomatic Deterioration|2|||
160791693|NCT02327169|580625374|FG014|Overall Study|Symptomatic Deterioration|1|||
160791694|NCT02327169|580625360|FG000|Overall Study|Reason Not Specified|0|||
160791695|NCT02327169|580625361|FG001|Overall Study|Reason Not Specified|0|||
160791696|NCT02327169|580625362|FG002|Overall Study|Reason Not Specified|1|||
160791697|NCT02327169|580625363|FG003|Overall Study|Reason Not Specified|0|||
160791698|NCT02327169|580625364|FG004|Overall Study|Reason Not Specified|0|||
160791699|NCT02327169|580625365|FG005|Overall Study|Reason Not Specified|0|||
160791700|NCT02327169|580625366|FG006|Overall Study|Reason Not Specified|0|||
160791701|NCT02327169|580625367|FG007|Overall Study|Reason Not Specified|0|||
160791702|NCT02327169|580625368|FG008|Overall Study|Reason Not Specified|0|||
160791703|NCT02327169|580625369|FG009|Overall Study|Reason Not Specified|1|||
160791704|NCT02327169|580625370|FG010|Overall Study|Reason Not Specified|2|||
160791705|NCT02327169|580625371|FG011|Overall Study|Reason Not Specified|1|||
160791706|NCT02327169|580625372|FG012|Overall Study|Reason Not Specified|0|||
160791707|NCT02327169|580625373|FG013|Overall Study|Reason Not Specified|0|||
160791708|NCT02327169|580625374|FG014|Overall Study|Reason Not Specified|2|||
160791709|NCT02327169|580625360|FG000|Overall Study|Withdrawal by Subject|1|||
160791710|NCT02327169|580625361|FG001|Overall Study|Withdrawal by Subject|0|||
160791711|NCT02327169|580625362|FG002|Overall Study|Withdrawal by Subject|0|||
160791712|NCT02327169|580625363|FG003|Overall Study|Withdrawal by Subject|0|||
160892414|NCT02598960|581002160|FG012|Treatment Period|No longer meets study criteria|0|||
160892415|NCT02598960|581002148|FG000|Treatment Period|Other Reasons|0|||
160892416|NCT02598960|581002149|FG001|Treatment Period|Other Reasons|0|||
160892417|NCT02598960|581002150|FG002|Treatment Period|Other Reasons|0|||
160892418|NCT02598960|581002151|FG003|Treatment Period|Other Reasons|0|||
160892419|NCT02598960|581002152|FG004|Treatment Period|Other Reasons|0|||
160791713|NCT02327169|580625364|FG004|Overall Study|Withdrawal by Subject|1|||
160892420|NCT02598960|581002153|FG005|Treatment Period|Other Reasons|0|||
160892421|NCT02598960|581002154|FG006|Treatment Period|Other Reasons|0|||
160892422|NCT02598960|581002155|FG007|Treatment Period|Other Reasons|0|||
160791714|NCT02327169|580625365|FG005|Overall Study|Withdrawal by Subject|0|||
160892423|NCT02598960|581002156|FG008|Treatment Period|Other Reasons|0|||
160791715|NCT02327169|580625366|FG006|Overall Study|Withdrawal by Subject|0|||
160892424|NCT02598960|581002157|FG009|Treatment Period|Other Reasons|0|||
160892425|NCT02598960|581002158|FG010|Treatment Period|Other Reasons|0|||
160791716|NCT02327169|580625367|FG007|Overall Study|Withdrawal by Subject|1|||
160791717|NCT02327169|580625368|FG008|Overall Study|Withdrawal by Subject|0|||
160791718|NCT02327169|580625369|FG009|Overall Study|Withdrawal by Subject|0|||
160791719|NCT02327169|580625370|FG010|Overall Study|Withdrawal by Subject|0|||
160791720|NCT02327169|580625371|FG011|Overall Study|Withdrawal by Subject|0|||
160791721|NCT02327169|580625372|FG012|Overall Study|Withdrawal by Subject|0|||
160791722|NCT02327169|580625373|FG013|Overall Study|Withdrawal by Subject|0|||
160892426|NCT02598960|581002159|FG011|Treatment Period|Other Reasons|0|||
160791723|NCT02327169|580625374|FG014|Overall Study|Withdrawal by Subject|3|||
160791724|NCT02327169|580625360|FG000|Overall Study|Lost to Follow-up|0|||
160791725|NCT02327169|580625361|FG001|Overall Study|Lost to Follow-up|0|||
160791726|NCT02327169|580625362|FG002|Overall Study|Lost to Follow-up|0|||
160791727|NCT02327169|580625363|FG003|Overall Study|Lost to Follow-up|0|||
160791728|NCT02327169|580625364|FG004|Overall Study|Lost to Follow-up|1|||
160791729|NCT02327169|580625365|FG005|Overall Study|Lost to Follow-up|0|||
160791730|NCT02327169|580625366|FG006|Overall Study|Lost to Follow-up|0|||
160791731|NCT02327169|580625367|FG007|Overall Study|Lost to Follow-up|0|||
160791732|NCT02327169|580625368|FG008|Overall Study|Lost to Follow-up|0|||
160982113|NCT00088205|581323381|FG000|Overall Study|Death Due to Study Disease|4|||
160982114|NCT05199233|581323382|FG000|Overall Study|Lack of Efficacy|1|||
160982115|NCT00688259|581323383|FG000|Overall Study|Lost to Follow-up|2|||
160982116|NCT00688259|581323384|FG001|Overall Study|Lost to Follow-up|4|||
160982117|NCT00688259|581323383|FG000|Overall Study|Physician Decision|1|||
160982118|NCT00688259|581323384|FG001|Overall Study|Physician Decision|0|||
160982119|NCT00688259|581323383|FG000|Overall Study|Withdrawal by Subject|2|||
160982120|NCT00688259|581323384|FG001|Overall Study|Withdrawal by Subject|0|||
160982121|NCT00688259|581323383|FG000|Overall Study|Declined Interview|2|||
160982122|NCT00688259|581323384|FG001|Overall Study|Declined Interview|3|||
160982123|NCT00688259|581323383|FG000|Overall Study|Hospitalized at Follow-up|0|||
160982124|NCT00688259|581323384|FG001|Overall Study|Hospitalized at Follow-up|1|||
160982125|NCT02982720|581323387|FG000|Overall Study|Adverse Event|3|||
160982126|NCT02982720|581323387|FG000|Overall Study|Death|1|||
160982127|NCT01734850|581323392|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
160982128|NCT01734850|581323393|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
160982129|NCT01734850|581323394|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
160982130|NCT01734850|581323392|FG000|Overall Study|Not infused due to manufacturing failure|0|||
160982131|NCT01734850|581323393|FG001|Overall Study|Not infused due to manufacturing failure|0|||
160982132|NCT01734850|581323394|FG002|Overall Study|Not infused due to manufacturing failure|1|||
160982133|NCT03824938|581323395|FG000|Overall Study|Withdrawal by Subject|2|||
160791733|NCT02327169|580625369|FG009|Overall Study|Lost to Follow-up|0|||
160791734|NCT02327169|580625370|FG010|Overall Study|Lost to Follow-up|0|||
160791735|NCT02327169|580625371|FG011|Overall Study|Lost to Follow-up|0|||
160791736|NCT02327169|580625372|FG012|Overall Study|Lost to Follow-up|0|||
160791737|NCT02327169|580625373|FG013|Overall Study|Lost to Follow-up|0|||
160791738|NCT02327169|580625374|FG014|Overall Study|Lost to Follow-up|0|||
160791739|NCT03787615|580625375|FG000|Overall Study|Withdrawal by Subject|2|||
160791740|NCT03787615|580625375|FG000|Overall Study|Lost to Follow-up|2|||
160791741|NCT01229111|580625377|FG000|Overall Study|Death|1|||
160791742|NCT04102514|580625378|FG000|Overall Study|Death|3|||
160791743|NCT04102514|580625379|FG001|Overall Study|Death|0|||
160791744|NCT04102514|580625380|FG002|Overall Study|Death|0|||
160791745|NCT04102514|580625381|FG003|Overall Study|Death|0|||
160791746|NCT04102514|580625378|FG000|Overall Study|Lost to Follow-up|0|||
160791747|NCT04102514|580625379|FG001|Overall Study|Lost to Follow-up|0|||
160791748|NCT04102514|580625380|FG002|Overall Study|Lost to Follow-up|3|||
160791749|NCT04102514|580625381|FG003|Overall Study|Lost to Follow-up|0|||
160791750|NCT04102514|580625378|FG000|Overall Study|Physician Decision|0|||
160791751|NCT04102514|580625379|FG001|Overall Study|Physician Decision|0|||
160791752|NCT04102514|580625380|FG002|Overall Study|Physician Decision|1|||
160791753|NCT04102514|580625381|FG003|Overall Study|Physician Decision|0|||
160791754|NCT04102514|580625378|FG000|Overall Study|Withdrawal by Subject|7|||
160791755|NCT04102514|580625379|FG001|Overall Study|Withdrawal by Subject|13|||
160791756|NCT04102514|580625380|FG002|Overall Study|Withdrawal by Subject|7|||
160791757|NCT04102514|580625381|FG003|Overall Study|Withdrawal by Subject|14|||
160791758|NCT04102514|580625378|FG000|Overall Study|Moved to longterm care facility|6|||
160791759|NCT04102514|580625379|FG001|Overall Study|Moved to longterm care facility|0|||
160791760|NCT04102514|580625380|FG002|Overall Study|Moved to longterm care facility|4|||
160791761|NCT04102514|580625381|FG003|Overall Study|Moved to longterm care facility|0|||
160791762|NCT00619918|580625382|FG000|Overall Study|Withdrawal by Subject|4|||
160791763|NCT00619918|580625383|FG001|Overall Study|Withdrawal by Subject|3|||
160791764|NCT00619918|580625382|FG000|Overall Study|Physician Decision|2|||
160791765|NCT00619918|580625383|FG001|Overall Study|Physician Decision|4|||
160791766|NCT00619918|580625382|FG000|Overall Study|Transfer to outside facility|3|||
160791767|NCT00619918|580625383|FG001|Overall Study|Transfer to outside facility|3|||
160791768|NCT00619918|580625382|FG000|Overall Study|Left before receiving first dose|7|||
160791769|NCT00619918|580625383|FG001|Overall Study|Left before receiving first dose|6|||
160791770|NCT00619918|580625382|FG000|Overall Study|ICU admission|4|||
160791771|NCT00619918|580625383|FG001|Overall Study|ICU admission|6|||
160791772|NCT03579719|580625389|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
160791773|NCT01443026|580625390|FG000|Overall Study|Physician Decision|1|||
160791774|NCT01443026|580625391|FG001|Overall Study|Physician Decision|0|||
160791775|NCT01443026|580625390|FG000|Overall Study|Death|0|||
160791776|NCT01443026|580625391|FG001|Overall Study|Death|1|||
160791777|NCT01443026|580625390|FG000|Overall Study|Withdrawal by Subject|0|||
160791778|NCT01443026|580625391|FG001|Overall Study|Withdrawal by Subject|3|||
160791779|NCT01443026|580625390|FG000|Overall Study|Lost to Follow-up|2|||
160791780|NCT01443026|580625391|FG001|Overall Study|Lost to Follow-up|1|||
160791781|NCT03900650|580625392|FG000|Overall Study|Withdrawal by Subject|1|||
160791782|NCT03900650|580625393|FG001|Overall Study|Withdrawal by Subject|1|||
160791783|NCT03900650|580625394|FG002|Overall Study|Withdrawal by Subject|0|||
160791784|NCT03900650|580625395|FG003|Overall Study|Withdrawal by Subject|0|||
160791785|NCT03900650|580625392|FG000|Overall Study|Withdrawn by staff|1|||
160791786|NCT03900650|580625393|FG001|Overall Study|Withdrawn by staff|0|||
160791787|NCT03900650|580625394|FG002|Overall Study|Withdrawn by staff|0|||
160791788|NCT03900650|580625395|FG003|Overall Study|Withdrawn by staff|0|||
160791789|NCT00829868|580625400|FG000|Washout|Physician Decision|1|||
160791790|NCT00829868|580625401|FG001|Washout|Physician Decision|0|||
160791791|NCT01969409|580625402|FG000|Overall Study|Death|2|||
160791792|NCT01969409|580625403|FG001|Overall Study|Death|2|||
160791793|NCT01969409|580625402|FG000|Overall Study|Transplant|1|||
160791794|NCT01969409|580625403|FG001|Overall Study|Transplant|1|||
160791795|NCT01969409|580625402|FG000|Overall Study|Withdrawal by Subject|0|||
160791796|NCT01969409|580625403|FG001|Overall Study|Withdrawal by Subject|1|||
160791797|NCT00721110|580625404|FG000|Overall Study|Ultram use|1|||
160791798|NCT00721110|580625405|FG001|Overall Study|Ultram use|0|||
160791799|NCT00721110|580625406|FG002|Overall Study|Ultram use|0|||
160791800|NCT00721110|580625407|FG003|Overall Study|Ultram use|0|||
160791801|NCT00721110|580625404|FG000|Overall Study|vertical incision|0|||
160791802|NCT00721110|580625405|FG001|Overall Study|vertical incision|0|||
160791803|NCT00721110|580625406|FG002|Overall Study|vertical incision|1|||
160791804|NCT00721110|580625407|FG003|Overall Study|vertical incision|0|||
160791805|NCT02799043|580625410|FG000|Overall Study|Adverse Event|0|||
160791806|NCT02799043|580625411|FG001|Overall Study|Adverse Event|1|||
160791807|NCT02799043|580625410|FG000|Overall Study|Death|1|||
160791808|NCT02799043|580625411|FG001|Overall Study|Death|1|||
160791809|NCT02799043|580625410|FG000|Overall Study|Lost to Follow-up|3|||
160791810|NCT02799043|580625411|FG001|Overall Study|Lost to Follow-up|6|||
160791811|NCT02799043|580625410|FG000|Overall Study|Withdrawal by Subject|4|||
160791812|NCT02799043|580625411|FG001|Overall Study|Withdrawal by Subject|4|||
160791813|NCT02799043|580625410|FG000|Overall Study|Moved to different country|0|||
160791814|NCT02799043|580625411|FG001|Overall Study|Moved to different country|1|||
160791815|NCT02799043|580625410|FG000|Overall Study|Trial Screen Failure|1|||
160791816|NCT02799043|580625411|FG001|Overall Study|Trial Screen Failure|0|||
160791817|NCT02799043|580625410|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
160791818|NCT02799043|580625411|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
160791819|NCT01681849|580625414|FG000|Overall Study|Protocol Violation|2|||
160791820|NCT01681849|580625415|FG001|Overall Study|Protocol Violation|0|||
160791821|NCT01681849|580625416|FG002|Overall Study|Protocol Violation|0|||
160791822|NCT01681849|580625414|FG000|Overall Study|Withdrawal by Subject|3|||
160791823|NCT01681849|580625415|FG001|Overall Study|Withdrawal by Subject|5|||
160791824|NCT01681849|580625416|FG002|Overall Study|Withdrawal by Subject|33|||
160791825|NCT01681849|580625414|FG000|Overall Study|Lost to Follow-up|3|||
160791826|NCT01681849|580625415|FG001|Overall Study|Lost to Follow-up|2|||
160791827|NCT01681849|580625416|FG002|Overall Study|Lost to Follow-up|6|||
160791828|NCT02852005|580625420|FG000|Overall Study|Lost to Follow-up|0|||
160791829|NCT02852005|580625421|FG001|Overall Study|Lost to Follow-up|0|||
160791830|NCT02852005|580625422|FG002|Overall Study|Lost to Follow-up|0|||
160791831|NCT02852005|580625423|FG003|Overall Study|Lost to Follow-up|0|||
160791832|NCT02852005|580625424|FG004|Overall Study|Lost to Follow-up|1|||
160791833|NCT02852005|580625420|FG000|Overall Study|Withdrawal by Subject|1|||
160791834|NCT02852005|580625421|FG001|Overall Study|Withdrawal by Subject|0|||
160791835|NCT02852005|580625422|FG002|Overall Study|Withdrawal by Subject|0|||
160791836|NCT02852005|580625423|FG003|Overall Study|Withdrawal by Subject|0|||
160791837|NCT02852005|580625424|FG004|Overall Study|Withdrawal by Subject|0|||
160791838|NCT01916226|580625425|FG000|Overall Study|Adverse Event|1|||
160791839|NCT01916226|580625426|FG001|Overall Study|Adverse Event|0|||
160791840|NCT01916226|580625427|FG002|Overall Study|Adverse Event|1|||
160791841|NCT01916226|580625428|FG003|Overall Study|Adverse Event|1|||
160791842|NCT01916226|580625425|FG000|Overall Study|Lack of Efficacy|0|||
160791843|NCT01916226|580625426|FG001|Overall Study|Lack of Efficacy|0|||
160791844|NCT01916226|580625427|FG002|Overall Study|Lack of Efficacy|2|||
160791845|NCT01916226|580625428|FG003|Overall Study|Lack of Efficacy|1|||
160791846|NCT01916226|580625425|FG000|Overall Study|Protocol Violation|0|||
160791847|NCT01916226|580625426|FG001|Overall Study|Protocol Violation|1|||
160791848|NCT01916226|580625427|FG002|Overall Study|Protocol Violation|0|||
160791849|NCT01916226|580625428|FG003|Overall Study|Protocol Violation|1|||
160791850|NCT01916226|580625425|FG000|Overall Study|Physician Decision|0|||
160791851|NCT01916226|580625426|FG001|Overall Study|Physician Decision|0|||
160791852|NCT01916226|580625427|FG002|Overall Study|Physician Decision|0|||
160791853|NCT01916226|580625428|FG003|Overall Study|Physician Decision|1|||
160791854|NCT01166646|580625432|FG000|Overall Study|Protocol Violation|0|||
160791855|NCT01166646|580625433|FG001|Overall Study|Protocol Violation|1|||
160791856|NCT01166646|580625432|FG000|Overall Study|Adverse Event|1|||
160791857|NCT01166646|580625433|FG001|Overall Study|Adverse Event|0|||
160791858|NCT03760068|580625434|FG000|Overall Study|Withdrawal by Subject|7|||
160791859|NCT03760068|580625435|FG001|Overall Study|Withdrawal by Subject|8|||
160791860|NCT03760068|580625434|FG000|Overall Study|Adverse Event|1|||
160791861|NCT03760068|580625435|FG001|Overall Study|Adverse Event|2|||
160791862|NCT03760068|580625434|FG000|Overall Study|Administrative Decision by Sponsor|0|||
160791863|NCT03760068|580625435|FG001|Overall Study|Administrative Decision by Sponsor|2|||
160791864|NCT03760068|580625434|FG000|Overall Study|Physician Decision|1|||
160791865|NCT03760068|580625435|FG001|Overall Study|Physician Decision|2|||
160791866|NCT03760068|580625434|FG000|Overall Study|Lost to Follow-up|4|||
160791867|NCT03760068|580625435|FG001|Overall Study|Lost to Follow-up|9|||
160791868|NCT03760068|580625434|FG000|Overall Study|Subject Moved Out of State|1|||
160791869|NCT03760068|580625435|FG001|Overall Study|Subject Moved Out of State|0|||
160791870|NCT01618708|580625436|FG000|Overall Study|Adverse Event|10|||
160791871|NCT01618708|580625437|FG001|Overall Study|Adverse Event|10|||
160791872|NCT01618708|580625436|FG000|Overall Study|Lost to Follow-up|3|||
160791873|NCT01618708|580625437|FG001|Overall Study|Lost to Follow-up|3|||
160892427|NCT02598960|581002160|FG012|Treatment Period|Other Reasons|1|||
160892428|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|Death|1|||
160892429|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|Death|0|||
160982134|NCT03824938|581323396|FG001|Overall Study|Withdrawal by Subject|1|||
160982135|NCT03824938|581323397|FG002|Overall Study|Withdrawal by Subject|0|||
160982136|NCT03824938|581323398|FG003|Overall Study|Withdrawal by Subject|2|||
160982137|NCT03824938|581323399|FG004|Overall Study|Withdrawal by Subject|0|||
160892430|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|Death|0|||
160892431|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|Death|0|||
160892432|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|Death|0|||
160892433|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|Death|0|||
160892434|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|Death|0|||
160892435|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|Death|0|||
160892436|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|Death|0|||
160892437|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|Death|1|||
160892438|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|Death|0|||
160892439|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|Death|11|||
160892440|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|Death|2|||
160892441|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892442|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892443|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892444|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892445|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892446|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892447|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892448|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892449|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892450|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892451|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892452|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
160892453|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
160892454|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
160892455|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
160892456|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
160892457|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
160892458|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
160892459|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
160892460|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
160892461|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
160892462|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
160892463|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
160892464|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
160892465|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
160892466|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
160982138|NCT03824938|581323400|FG005|Overall Study|Withdrawal by Subject|1|||
160982139|NCT03824938|581323395|FG000|Overall Study|Lost to Follow-up|0|||
160982140|NCT03824938|581323396|FG001|Overall Study|Lost to Follow-up|1|||
160791874|NCT01618708|580625436|FG000|Overall Study|Withdrawal by Subject|17|||
160791875|NCT01618708|580625437|FG001|Overall Study|Withdrawal by Subject|22|||
160791876|NCT01618708|580625436|FG000|Overall Study|Lack of Efficacy|8|||
160791877|NCT01618708|580625437|FG001|Overall Study|Lack of Efficacy|8|||
160791878|NCT01618708|580625436|FG000|Overall Study|Technical problems|2|||
160791879|NCT01618708|580625437|FG001|Overall Study|Technical problems|0|||
160791880|NCT01618708|580625436|FG000|Overall Study|Other than specified above|1|||
160791881|NCT01618708|580625437|FG001|Overall Study|Other than specified above|1|||
160791882|NCT01618708|580625436|FG000|Overall Study|Randomized but not treated|3|||
160791883|NCT01618708|580625437|FG001|Overall Study|Randomized but not treated|2|||
160791884|NCT03131479|580625442|FG000|Overall Study|Adverse Event|0|||
160791885|NCT03131479|580625443|FG001|Overall Study|Adverse Event|0|||
160791886|NCT03131479|580625444|FG002|Overall Study|Adverse Event|1|||
160791887|NCT03131479|580625445|FG003|Overall Study|Adverse Event|1|||
160791888|NCT03131479|580625446|FG004|Overall Study|Adverse Event|0|||
160791889|NCT03131479|580625442|FG000|Overall Study|Subject/Guardian Decision|0|||
160791890|NCT03131479|580625443|FG001|Overall Study|Subject/Guardian Decision|0|||
160791891|NCT03131479|580625444|FG002|Overall Study|Subject/Guardian Decision|0|||
160791892|NCT03131479|580625445|FG003|Overall Study|Subject/Guardian Decision|1|||
160791893|NCT03131479|580625446|FG004|Overall Study|Subject/Guardian Decision|0|||
160791894|NCT04309500|580625458|FG000|Overall Study|Lost to Follow-up|1|||
160791895|NCT04309500|580625459|FG001|Overall Study|Lost to Follow-up|0|||
160791896|NCT04309500|580625460|FG002|Overall Study|Lost to Follow-up|0|||
160791897|NCT04309500|580625461|FG003|Overall Study|Lost to Follow-up|0|||
160791898|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
160791899|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
160982141|NCT03824938|581323397|FG002|Overall Study|Lost to Follow-up|0|||
160982142|NCT03824938|581323398|FG003|Overall Study|Lost to Follow-up|0|||
160982143|NCT03824938|581323399|FG004|Overall Study|Lost to Follow-up|1|||
160982144|NCT03824938|581323400|FG005|Overall Study|Lost to Follow-up|0|||
160982145|NCT00287469|581323401|FG000|Overall Study|serious adverse event|1|||
160982146|NCT00287469|581323402|FG001|Overall Study|serious adverse event|6|||
160982147|NCT00287469|581323401|FG000|Overall Study|Adverse Event|1|||
160982148|NCT00287469|581323402|FG001|Overall Study|Adverse Event|1|||
160982149|NCT00287469|581323401|FG000|Overall Study|moved from area|144|||
160982150|NCT00287469|581323402|FG001|Overall Study|moved from area|138|||
160982151|NCT00287469|581323401|FG000|Overall Study|Lost to Follow-up|74|||
160982152|NCT00287469|581323402|FG001|Overall Study|Lost to Follow-up|69|||
160982153|NCT02019602|581323406|FG000|Screening Period|Ineligibility|4|||
160982154|NCT02019602|581323407|FG001|Screening Period|Ineligibility|0|||
160982155|NCT02019602|581323406|FG000|Screening Period|Adverse Event|1|||
160982156|NCT02019602|581323407|FG001|Screening Period|Adverse Event|0|||
160982157|NCT01058863|581323410|FG000|Overall Study|Lost to Follow-up|1|||
160982158|NCT01058863|581323410|FG000|Overall Study|Withdrawal by Subject|1|||
160982159|NCT01058863|581323410|FG000|Overall Study|Sponsor requested withdrawal|1|||
160982160|NCT01058863|581323410|FG000|Overall Study|Randomized in error|1|||
160982161|NCT03653416|581323411|FG000|Overall Study|Protocol Violation|6|||
160982162|NCT03653416|581323412|FG001|Overall Study|Protocol Violation|1|||
160982163|NCT03207711|581323413|FG000|Overall Study|Withdrawal by Subject|1|||
160982164|NCT03207711|581323414|FG001|Overall Study|Withdrawal by Subject|2|||
160982165|NCT02788006|581323418|FG000|Overall Study|Patient not treated|1|||
160982166|NCT03050398|581323425|FG000|Overall Study|Study terminated by sponsor|8|||
160982167|NCT05108649|581323426|FG000|Overall Study|Lost to Follow-up|0|||
161128595|NCT00091832|581856928|FG005|Overall Study|Other|0|||
161330603|NCT00116688|582597170|FG001|Overall Study|Withdrawal by Subject|2|||
160791900|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
160791901|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
160791902|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
160791903|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
160791904|NCT00913835|580625462|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
160791905|NCT00913835|580625463|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
160791906|NCT00913835|580625462|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
160791907|NCT00913835|580625463|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
160791908|NCT02657356|580626767|FG000|Overall Study|Death|1|||
160791909|NCT02657356|580626768|FG001|Overall Study|Death|0|||
160791910|NCT02657356|580626767|FG000|Overall Study|Withdrawal by Subject|5|||
160791911|NCT02657356|580626768|FG001|Overall Study|Withdrawal by Subject|6|||
160791912|NCT02657356|580626767|FG000|Overall Study|Terminated by Sponsor|8|||
160791913|NCT02657356|580626768|FG001|Overall Study|Terminated by Sponsor|5|||
160791914|NCT02657356|580626767|FG000|Overall Study|Rolled over to EAP study|6|||
160791915|NCT02657356|580626768|FG001|Overall Study|Rolled over to EAP study|4|||
160791916|NCT03058952|580626771|FG000|Overall Study|Adverse Event|1|||
160791917|NCT03058952|580626772|FG001|Overall Study|Adverse Event|0|||
160791918|NCT03058952|580626771|FG000|Overall Study|Lost to Follow-up|15|||
160791919|NCT03058952|580626772|FG001|Overall Study|Lost to Follow-up|15|||
160791920|NCT03058952|580626771|FG000|Overall Study|Withdrawal by Subject|7|||
160791921|NCT03058952|580626772|FG001|Overall Study|Withdrawal by Subject|11|||
160791922|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
160791923|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
160791924|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
160791925|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
160791926|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
160791927|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
160791928|NCT01373281|580626775|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
160791929|NCT01373281|580626776|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
160791930|NCT01373281|580626775|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
160791931|NCT01373281|580626776|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
160791932|NCT01373281|580626775|FG000|Surveillance Expansion Period|Protocol Violation|9|||
160791933|NCT01373281|580626776|FG001|Surveillance Expansion Period|Protocol Violation|1|||
160791934|NCT01373281|580626775|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
160791935|NCT01373281|580626776|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
160791936|NCT01373281|580626775|FG000|Surveillance Expansion Period|Serious adverse event|3|||
160791937|NCT01373281|580626776|FG001|Surveillance Expansion Period|Serious adverse event|4|||
160791938|NCT01397253|580626777|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
160892467|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160982168|NCT05108649|581323427|FG001|Overall Study|Lost to Follow-up|4|||
160982169|NCT05108649|581323428|FG002|Overall Study|Lost to Follow-up|3|||
160982170|NCT05108649|581323429|FG003|Overall Study|Lost to Follow-up|6|||
160892468|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892469|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892470|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892471|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892472|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892473|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892474|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892475|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892476|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892477|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892478|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
160892479|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
160892480|NCT02598960|581002148|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
160892481|NCT02598960|581002149|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
160892482|NCT02598960|581002150|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
160892483|NCT02598960|581002151|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
160892484|NCT02598960|581002152|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
160892485|NCT02598960|581002153|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
160892486|NCT02598960|581002154|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
160892487|NCT02598960|581002155|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
160892488|NCT02598960|581002156|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
160892489|NCT02598960|581002157|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
160892490|NCT02598960|581002158|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
160892491|NCT02598960|581002159|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
160892492|NCT02598960|581002160|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
160892493|NCT01614600|581002164|FG000|Overall Study|Unacceptable fit|1|||
160892494|NCT01614600|581002164|FG000|Overall Study|Discomfort|1|||
160892495|NCT01614600|581002164|FG000|Overall Study|Unable to remove lens at the end of day|1|||
160892496|NCT01614600|581002164|FG000|Overall Study|Protocol deviation|1|||
160892497|NCT00137631|581002165|FG000|Overall Study|Lost to Follow-up|37|||
160892498|NCT00137631|581002166|FG001|Overall Study|Lost to Follow-up|41|||
160892499|NCT02395666|581002167|FG000|Overall Study|Physician Decision|3|||
160892500|NCT02395666|581002168|FG001|Overall Study|Physician Decision|0|||
160892501|NCT02395666|581002167|FG000|Overall Study|Lost to Follow-up|1|||
160892502|NCT02395666|581002168|FG001|Overall Study|Lost to Follow-up|0|||
160892503|NCT02395666|581002167|FG000|Overall Study|Withdrawal by Subject|2|||
160892504|NCT02395666|581002168|FG001|Overall Study|Withdrawal by Subject|1|||
160892505|NCT02611960|581002169|FG000|Overall Study|Adverse Event|7|||
160892506|NCT02611960|581002170|FG001|Overall Study|Adverse Event|8|||
160892507|NCT02611960|581002169|FG000|Overall Study|Death|98|||
160982171|NCT05108649|581323426|FG000|Overall Study|Not Interested|1|||
160791939|NCT01397253|580626778|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
160791940|NCT02296476|580626779|FG000|Overall Study|Disease Progression|6|||
160791941|NCT02296476|580626780|FG001|Overall Study|Disease Progression|4|||
160791942|NCT02296476|580626781|FG002|Overall Study|Disease Progression|2|||
160791943|NCT00980044|580626786|FG000|Overall Study|Withdrawal by Subject|5|||
160791944|NCT00980044|580626787|FG001|Overall Study|Withdrawal by Subject|7|||
160791945|NCT00980044|580626788|FG002|Overall Study|Withdrawal by Subject|3|||
160791946|NCT00980044|580626786|FG000|Overall Study|Protocol Violation|0|||
160892508|NCT02611960|581002170|FG001|Overall Study|Death|92|||
160982172|NCT05108649|581323427|FG001|Overall Study|Not Interested|1|||
160982173|NCT05108649|581323428|FG002|Overall Study|Not Interested|0|||
161128596|NCT00091832|581856923|FG000|Overall Study|Protocol Violation|0|||
161128597|NCT00091832|581856924|FG001|Overall Study|Protocol Violation|0|||
161128598|NCT00091832|581856925|FG002|Overall Study|Protocol Violation|1|||
161128599|NCT00091832|581856926|FG003|Overall Study|Protocol Violation|0|||
161128600|NCT00091832|581856927|FG004|Overall Study|Protocol Violation|0|||
161128601|NCT00091832|581856928|FG005|Overall Study|Protocol Violation|1|||
161128602|NCT01557166|581856931|FG000|Overall Study|Adverse Event|20|||
160791947|NCT00980044|580626787|FG001|Overall Study|Protocol Violation|0|||
160791948|NCT00980044|580626788|FG002|Overall Study|Protocol Violation|2|||
160791949|NCT03502681|580626789|FG000|Overall Study|Adverse Event|1|||
160791950|NCT03502681|580626790|FG001|Overall Study|Adverse Event|1|||
160791951|NCT03502681|580626789|FG000|Overall Study|Disease Progression|2|||
160791952|NCT03502681|580626790|FG001|Overall Study|Disease Progression|1|||
160791953|NCT00442702|580626791|FG000|Titration Period|Adverse Event|2|||
160791954|NCT00442702|580626792|FG001|Titration Period|Adverse Event|0|||
160791955|NCT00442702|580626791|FG000|Titration Period|Death|3|||
160791956|NCT00442702|580626792|FG001|Titration Period|Death|2|||
160791957|NCT00442702|580626791|FG000|Titration Period|Insufficient Therapeutic Response|1|||
160791958|NCT00442702|580626792|FG001|Titration Period|Insufficient Therapeutic Response|0|||
160791959|NCT00442702|580626791|FG000|Titration Period|Refused Treatment|4|||
160791960|NCT00442702|580626792|FG001|Titration Period|Refused Treatment|1|||
160791961|NCT00442702|580626791|FG000|Titration Period|Failure to return|1|||
160791962|NCT00442702|580626792|FG001|Titration Period|Failure to return|0|||
160791963|NCT00442702|580626791|FG000|Titration Period|Hospitalized in another hospital|1|||
160791964|NCT00442702|580626792|FG001|Titration Period|Hospitalized in another hospital|0|||
160791965|NCT00442702|580626791|FG000|Evaluation Period|Adverse Event|1|||
160791966|NCT00442702|580626792|FG001|Evaluation Period|Adverse Event|0|||
160791967|NCT00442702|580626791|FG000|Evaluation Period|Death|1|||
160791968|NCT00442702|580626792|FG001|Evaluation Period|Death|1|||
160791969|NCT00442702|580626791|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
160791970|NCT00442702|580626792|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
160791971|NCT00442702|580626791|FG000|Evaluation Period|Refused treatment|1|||
160791972|NCT00442702|580626792|FG001|Evaluation Period|Refused treatment|1|||
160791973|NCT00442702|580626791|FG000|Evaluation Period|Renal transplant|0|||
160791974|NCT00442702|580626792|FG001|Evaluation Period|Renal transplant|1|||
160791975|NCT00442702|580626791|FG000|Evaluation Period|Failure to return|1|||
160791976|NCT00442702|580626792|FG001|Evaluation Period|Failure to return|0|||
160791977|NCT00442702|580626791|FG000|Evaluation Period|Site closure|0|||
160791978|NCT00442702|580626792|FG001|Evaluation Period|Site closure|1|||
160791979|NCT01444781|580626793|FG000|Overall Study|Lost to Follow-up|0|||
160791980|NCT01444781|580626794|FG001|Overall Study|Lost to Follow-up|3|||
160791981|NCT01444781|580626795|FG002|Overall Study|Lost to Follow-up|1|||
160791982|NCT01444781|580626793|FG000|Overall Study|Withdrawal by Subject|3|||
160791983|NCT01444781|580626794|FG001|Overall Study|Withdrawal by Subject|1|||
160791984|NCT01444781|580626795|FG002|Overall Study|Withdrawal by Subject|2|||
160791985|NCT00321932|580626797|FG000|Overall Study|Death|3|||
160791986|NCT00321932|580626798|FG001|Overall Study|Death|6|||
160791987|NCT00321932|580626797|FG000|Overall Study|Withdrawal by Subject|3|||
160791988|NCT00321932|580626798|FG001|Overall Study|Withdrawal by Subject|6|||
160791989|NCT00321932|580626797|FG000|Overall Study|Early relapse|2|||
160791990|NCT00321932|580626798|FG001|Overall Study|Early relapse|8|||
161128603|NCT01557166|581856932|FG001|Overall Study|Adverse Event|6|||
161128604|NCT01557166|581856931|FG000|Overall Study|Lack of Efficacy|2|||
161128605|NCT01557166|581856932|FG001|Overall Study|Lack of Efficacy|1|||
160791991|NCT00321932|580626797|FG000|Overall Study|Missing data|2|||
160791992|NCT00321932|580626798|FG001|Overall Study|Missing data|1|||
160791993|NCT03257657|580626801|FG000|Overall Study|Lost to Follow-up|0|||
160791994|NCT03257657|580626802|FG001|Overall Study|Lost to Follow-up|3|||
160791995|NCT03257657|580626801|FG000|Overall Study|Withdrawn|0|||
160791996|NCT03257657|580626802|FG001|Overall Study|Withdrawn|1|||
160791997|NCT03257657|580626801|FG000|Overall Study|Noted not eligible right after enrolled|0|||
160791998|NCT03257657|580626802|FG001|Overall Study|Noted not eligible right after enrolled|1|||
160791999|NCT02801578|580626803|FG000|Overall Study|Adverse Event|2|||
160792000|NCT00137449|580626804|FG000|Overall Study|Disease Progression|8|||
161235745|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160792001|NCT00137449|580626805|FG001|Overall Study|Disease Progression|13|||
160792002|NCT00137449|580626804|FG000|Overall Study|Death|4|||
160792003|NCT00137449|580626805|FG001|Overall Study|Death|3|||
160792004|NCT00137449|580626804|FG000|Overall Study|Adverse Event|3|||
160792005|NCT00137449|580626805|FG001|Overall Study|Adverse Event|1|||
160792006|NCT00137449|580626804|FG000|Overall Study|Withdrawal by Subject|1|||
160792007|NCT00137449|580626805|FG001|Overall Study|Withdrawal by Subject|1|||
160792008|NCT01356940|580626806|FG000|First Intervention (28 Days)|Adverse Event|1|||
160792009|NCT01356940|580626807|FG001|First Intervention (28 Days)|Adverse Event|0|||
160792010|NCT01356940|580626806|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
160792011|NCT01356940|580626807|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
160792012|NCT03412591|580626808|FG000|Overall Study|Withdrawal by Subject|1|||
160792013|NCT03412591|580626809|FG001|Overall Study|Withdrawal by Subject|8|||
160792014|NCT03412591|580626808|FG000|Overall Study|Adverse Event|0|||
161128606|NCT01557166|581856931|FG000|Overall Study|Protocol Violation|8|||
160792015|NCT03412591|580626809|FG001|Overall Study|Adverse Event|1|||
160792016|NCT02272985|580626810|FG000|Overall Study|Withdrawal by Subject|1|||
160792017|NCT02272985|580626810|FG000|Overall Study|hip fracture|1|||
160792018|NCT02272985|580626810|FG000|Overall Study|kidney transplantation|1|||
160792019|NCT02263547|580626813|FG000|Overall Study|Adverse Event|1|||
160792020|NCT02263547|580626813|FG000|Overall Study|Lost to Follow-up|2|||
160792021|NCT00505687|580626816|FG000|Overall Study|Important protocol violation|2|||
160792022|NCT00505687|580626816|FG000|Overall Study|Lack of Efficacy|15|||
160792023|NCT00505687|580626816|FG000|Overall Study|Adverse Event|48|||
161128607|NCT01557166|581856932|FG001|Overall Study|Protocol Violation|5|||
161128608|NCT01557166|581856931|FG000|Overall Study|Withdrawn consent|12|||
161128609|NCT01557166|581856932|FG001|Overall Study|Withdrawn consent|20|||
161128610|NCT01557166|581856931|FG000|Overall Study|Target dose not tolerated|1|||
160792024|NCT00505687|580626816|FG000|Overall Study|Subject withdrew consent|15|||
161128611|NCT01557166|581856932|FG001|Overall Study|Target dose not tolerated|0|||
160792025|NCT00505687|580626816|FG000|Overall Study|Lost to Follow-up|1|||
160792026|NCT00505687|580626816|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
160792027|NCT00505687|580626816|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
160792028|NCT00505687|580626816|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
160792029|NCT00505687|580626816|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
160792030|NCT00505687|580626816|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
160792031|NCT00505687|580626816|FG000|Overall Study|Other: Disease Progression|1|||
161128612|NCT01557166|581856931|FG000|Overall Study|Psychiatric disorder|1|||
161128613|NCT01557166|581856932|FG001|Overall Study|Psychiatric disorder|0|||
160792032|NCT00505687|580626816|FG000|Overall Study|Other: As Per Sponsor|8|||
160792033|NCT03707821|580626817|FG000|Overall Study|Protocol Violation|0|||
160792034|NCT03707821|580626818|FG001|Overall Study|Protocol Violation|1|||
160792035|NCT03707821|580626817|FG000|Overall Study|Unsatisfactory Visual Response|1|||
160792036|NCT03707821|580626818|FG001|Overall Study|Unsatisfactory Visual Response|0|||
160792037|NCT03707821|580626817|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
160792038|NCT03707821|580626818|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
160792039|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
160792040|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
160792041|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
160792042|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
160792043|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
160792044|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
160792045|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
160792046|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
160792047|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
160792048|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
160792049|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
160792050|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
160792051|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
160792052|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
160792053|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
160792054|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
160792055|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
160792056|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
160792057|NCT01432444|580626819|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
160792058|NCT01432444|580626820|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
160792059|NCT01432444|580626821|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
160792060|NCT01432444|580626819|FG000|Treatment Phase|Lost to Follow-up|0|||
160792061|NCT01432444|580626820|FG001|Treatment Phase|Lost to Follow-up|33|||
160792062|NCT01432444|580626821|FG002|Treatment Phase|Lost to Follow-up|0|||
160792063|NCT01432444|580626819|FG000|Treatment Phase|Adverse Event|0|||
160792064|NCT01432444|580626820|FG001|Treatment Phase|Adverse Event|37|||
160792065|NCT01432444|580626821|FG002|Treatment Phase|Adverse Event|0|||
160792066|NCT01432444|580626819|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
160792067|NCT01432444|580626820|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
160792068|NCT01432444|580626821|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
160792069|NCT01432444|580626819|FG000|Treatment Phase|Physician Decision|0|||
160792070|NCT01432444|580626820|FG001|Treatment Phase|Physician Decision|5|||
160792071|NCT01432444|580626821|FG002|Treatment Phase|Physician Decision|0|||
160792072|NCT01432444|580626819|FG000|Treatment Phase|Withdrawal by Subject|0|||
160792073|NCT01432444|580626820|FG001|Treatment Phase|Withdrawal by Subject|41|||
160792074|NCT01432444|580626821|FG002|Treatment Phase|Withdrawal by Subject|0|||
161330604|NCT00116688|582597169|FG000|Overall Study|Requirement for alternative therapy|11|||
160792075|NCT01432444|580626819|FG000|Treatment Phase|Protocol Deviation|0|||
160792076|NCT01432444|580626820|FG001|Treatment Phase|Protocol Deviation|3|||
160792077|NCT01432444|580626821|FG002|Treatment Phase|Protocol Deviation|0|||
161128614|NCT01557166|581856931|FG000|Overall Study|Unclassified|2|||
161128615|NCT01557166|581856932|FG001|Overall Study|Unclassified|5|||
160792078|NCT01432444|580626819|FG000|Treatment Phase|Lack of Efficacy|0|||
160792079|NCT01432444|580626820|FG001|Treatment Phase|Lack of Efficacy|10|||
160792080|NCT01432444|580626821|FG002|Treatment Phase|Lack of Efficacy|0|||
160792081|NCT01432444|580626819|FG000|Extension Phase|Lost to Follow-up|0|||
160792082|NCT01432444|580626820|FG001|Extension Phase|Lost to Follow-up|0|||
160792083|NCT01432444|580626821|FG002|Extension Phase|Lost to Follow-up|17|||
160792084|NCT01432444|580626819|FG000|Extension Phase|Adverse Event|0|||
160792085|NCT01432444|580626820|FG001|Extension Phase|Adverse Event|0|||
160792086|NCT01432444|580626821|FG002|Extension Phase|Adverse Event|10|||
160792087|NCT01432444|580626819|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
160792088|NCT01432444|580626820|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
160792089|NCT01432444|580626821|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
160792090|NCT01432444|580626819|FG000|Extension Phase|Met Withdrawal Criteria|0|||
160792091|NCT01432444|580626820|FG001|Extension Phase|Met Withdrawal Criteria|0|||
160792092|NCT01432444|580626821|FG002|Extension Phase|Met Withdrawal Criteria|144|||
160792093|NCT01432444|580626819|FG000|Extension Phase|Physician Decision|0|||
160792094|NCT01432444|580626820|FG001|Extension Phase|Physician Decision|0|||
160792095|NCT01432444|580626821|FG002|Extension Phase|Physician Decision|1|||
160792096|NCT01432444|580626819|FG000|Extension Phase|Withdrawal by Subject|0|||
160792097|NCT01432444|580626820|FG001|Extension Phase|Withdrawal by Subject|0|||
160792098|NCT01432444|580626821|FG002|Extension Phase|Withdrawal by Subject|13|||
160792099|NCT02301897|580626822|FG000|Treatment Course 1|Non-Compliance|0|||
160792100|NCT02301897|580626823|FG001|Treatment Course 1|Non-Compliance|0|||
160792101|NCT02301897|580626824|FG002|Treatment Course 1|Non-Compliance|1|||
160792102|NCT02301897|580626822|FG000|Treatment Course 1|Adverse Event|1|||
160792103|NCT02301897|580626823|FG001|Treatment Course 1|Adverse Event|1|||
160792104|NCT02301897|580626824|FG002|Treatment Course 1|Adverse Event|0|||
160792105|NCT02301897|580626822|FG000|Treatment Course 1|Lost to Follow-up|1|||
160792106|NCT02301897|580626823|FG001|Treatment Course 1|Lost to Follow-up|2|||
160792107|NCT02301897|580626824|FG002|Treatment Course 1|Lost to Follow-up|1|||
160792108|NCT02301897|580626822|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
160792109|NCT02301897|580626823|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
160792110|NCT02301897|580626824|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
160792111|NCT02301897|580626822|FG000|Treatment Course 1|Withdrawal by Subject|0|||
160792112|NCT02301897|580626823|FG001|Treatment Course 1|Withdrawal by Subject|0|||
160792113|NCT02301897|580626824|FG002|Treatment Course 1|Withdrawal by Subject|2|||
160792114|NCT02301897|580626822|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
160792115|NCT02301897|580626823|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
160792116|NCT02301897|580626824|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
160792117|NCT02301897|580626822|FG000|Treatment Course 2|Lost to Follow-up|0|||
160792118|NCT02301897|580626823|FG001|Treatment Course 2|Lost to Follow-up|2|||
160792119|NCT02301897|580626824|FG002|Treatment Course 2|Lost to Follow-up|0|||
160792120|NCT02301897|580626822|FG000|Treatment Course 2|Pregnancy|0|||
160792121|NCT02301897|580626823|FG001|Treatment Course 2|Pregnancy|1|||
160892509|NCT02611960|581002169|FG000|Overall Study|Withdrawal by Subject|1|||
160892510|NCT02611960|581002170|FG001|Overall Study|Withdrawal by Subject|5|||
160892511|NCT02611960|581002169|FG000|Overall Study|Sponsor Decision|11|||
160892512|NCT02611960|581002170|FG001|Overall Study|Sponsor Decision|11|||
160892513|NCT01229371|581002182|FG000|Overall Study|Withdrawal by Subject|0|||
160892514|NCT01229371|581002183|FG001|Overall Study|Withdrawal by Subject|1|||
160892515|NCT01229371|581002184|FG002|Overall Study|Withdrawal by Subject|0|||
160892516|NCT01229371|581002185|FG003|Overall Study|Withdrawal by Subject|0|||
160892517|NCT00736879|581002190|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
160792122|NCT02301897|580626824|FG002|Treatment Course 2|Pregnancy|1|||
160792123|NCT02301897|580626822|FG000|Treatment Course 2|Withdrawal by Subject|0|||
160792124|NCT02301897|580626823|FG001|Treatment Course 2|Withdrawal by Subject|2|||
160792125|NCT02301897|580626824|FG002|Treatment Course 2|Withdrawal by Subject|0|||
160792126|NCT02301897|580626822|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
160792127|NCT02301897|580626823|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
160792128|NCT02301897|580626824|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
160792129|NCT03673176|580626825|FG000|Overall Study|Death prior to intervention|1|||
160792130|NCT03673176|580626825|FG000|Overall Study|Death following intervention|3|||
160792131|NCT03673176|580626825|FG000|Overall Study|Withdrawal by Subject|1|||
160792132|NCT02378480|580626826|FG000|Overall Study|Physician Decision|1|||
160792133|NCT02378480|580626827|FG001|Overall Study|Physician Decision|1|||
160792134|NCT02378480|580626826|FG000|Overall Study|Death|1|||
160792135|NCT02378480|580626827|FG001|Overall Study|Death|2|||
160792136|NCT02378480|580626826|FG000|Overall Study|Randomized, but Not Treated|6|||
160792137|NCT02378480|580626827|FG001|Overall Study|Randomized, but Not Treated|4|||
160792138|NCT02378480|580626826|FG000|Overall Study|Adverse Event|0|||
160792139|NCT02378480|580626827|FG001|Overall Study|Adverse Event|1|||
160892518|NCT00736879|581002191|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161128616|NCT00946309|581856933|FG000|Overall Study|Protocol Violation|1|||
160792140|NCT02378480|580626826|FG000|Overall Study|Missed EOT/PTE Visit|1|||
160792141|NCT02378480|580626827|FG001|Overall Study|Missed EOT/PTE Visit|2|||
160792142|NCT02378480|580626826|FG000|Overall Study|Withdrawal by Subject|9|||
160792143|NCT02378480|580626827|FG001|Overall Study|Withdrawal by Subject|4|||
160792144|NCT02378480|580626826|FG000|Overall Study|Lost to Follow-up|10|||
160792145|NCT02378480|580626827|FG001|Overall Study|Lost to Follow-up|18|||
160792146|NCT02014467|580626831|FG000|Overall Study|Adverse Event|4|||
160792147|NCT02014467|580626832|FG001|Overall Study|Adverse Event|0|||
160792148|NCT02014467|580626831|FG000|Overall Study|Protocol Violation|3|||
160792149|NCT02014467|580626832|FG001|Overall Study|Protocol Violation|0|||
160792150|NCT02014467|580626831|FG000|Overall Study|Physician Decision|2|||
160792151|NCT02014467|580626832|FG001|Overall Study|Physician Decision|3|||
160792152|NCT02014467|580626831|FG000|Overall Study|Withdrawal by Subject|16|||
160792153|NCT02014467|580626832|FG001|Overall Study|Withdrawal by Subject|4|||
160792154|NCT01217892|580626834|FG000|Overall Study|Adverse Event|1|||
160792155|NCT01217892|580626835|FG001|Overall Study|Adverse Event|1|||
160792156|NCT01217892|580626836|FG002|Overall Study|Adverse Event|1|||
160792157|NCT01217892|580626837|FG003|Overall Study|Adverse Event|0|||
160792158|NCT01217892|580626834|FG000|Overall Study|Withdrawal by Subject|0|||
160792159|NCT01217892|580626835|FG001|Overall Study|Withdrawal by Subject|2|||
160792160|NCT01217892|580626836|FG002|Overall Study|Withdrawal by Subject|1|||
160792161|NCT01217892|580626837|FG003|Overall Study|Withdrawal by Subject|0|||
160792162|NCT01217892|580626834|FG000|Overall Study|Lab value|1|||
160792163|NCT01217892|580626835|FG001|Overall Study|Lab value|0|||
160792164|NCT01217892|580626836|FG002|Overall Study|Lab value|1|||
160792165|NCT01217892|580626837|FG003|Overall Study|Lab value|0|||
160792166|NCT01217892|580626834|FG000|Overall Study|Subject no longer meets study criteria|5|||
160792167|NCT01217892|580626835|FG001|Overall Study|Subject no longer meets study criteria|2|||
160792168|NCT01217892|580626836|FG002|Overall Study|Subject no longer meets study criteria|4|||
160792169|NCT01217892|580626837|FG003|Overall Study|Subject no longer meets study criteria|8|||
160792170|NCT01217892|580626834|FG000|Overall Study|Incorrect enrollment|0|||
160792171|NCT01217892|580626835|FG001|Overall Study|Incorrect enrollment|1|||
160792172|NCT01217892|580626836|FG002|Overall Study|Incorrect enrollment|1|||
160792173|NCT01217892|580626837|FG003|Overall Study|Incorrect enrollment|0|||
160792174|NCT01217892|580626834|FG000|Overall Study|Poor/Non-Compliance|0|||
160792175|NCT01217892|580626835|FG001|Overall Study|Poor/Non-Compliance|0|||
160792176|NCT01217892|580626836|FG002|Overall Study|Poor/Non-Compliance|1|||
160792177|NCT01217892|580626837|FG003|Overall Study|Poor/Non-Compliance|0|||
160892519|NCT00736879|581002192|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
160892520|NCT00736879|581002193|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
160892521|NCT00736879|581002190|FG000|Double Blind Treatment Period|Adverse Event|0|||
160892522|NCT00736879|581002191|FG001|Double Blind Treatment Period|Adverse Event|1|||
160892523|NCT00736879|581002192|FG002|Double Blind Treatment Period|Adverse Event|1|||
160892524|NCT00736879|581002193|FG003|Double Blind Treatment Period|Adverse Event|0|||
160892525|NCT00736879|581002190|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
160892526|NCT00736879|581002191|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
160892527|NCT00736879|581002192|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
160892528|NCT00736879|581002193|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
160892529|NCT00736879|581002190|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
160892530|NCT00736879|581002191|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160892531|NCT00736879|581002192|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
160892532|NCT00736879|581002193|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
160892533|NCT00736879|581002190|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
160892534|NCT00736879|581002191|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
160892535|NCT00736879|581002192|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
160892536|NCT00736879|581002193|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
160892537|NCT00736879|581002190|FG000|Double Blind Treatment Period|No longer met criteria|0|||
160892538|NCT00736879|581002191|FG001|Double Blind Treatment Period|No longer met criteria|1|||
160892539|NCT00736879|581002192|FG002|Double Blind Treatment Period|No longer met criteria|0|||
160892540|NCT00736879|581002193|FG003|Double Blind Treatment Period|No longer met criteria|0|||
160892541|NCT00736879|581002190|FG000|Double Blind Treatment Period|non-specified|0|||
160892542|NCT00736879|581002191|FG001|Double Blind Treatment Period|non-specified|1|||
160892543|NCT00736879|581002192|FG002|Double Blind Treatment Period|non-specified|0|||
160892544|NCT00736879|581002193|FG003|Double Blind Treatment Period|non-specified|0|||
160892545|NCT00736879|581002190|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
160892546|NCT00736879|581002191|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
160892547|NCT00736879|581002192|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
160892548|NCT00736879|581002193|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
160892549|NCT00736879|581002190|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
160892550|NCT00736879|581002191|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
160892551|NCT00736879|581002192|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
160892552|NCT00736879|581002193|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
160892553|NCT00735254|581002196|FG000|Overall Study|Protocol Violation|1|||
160892554|NCT00735254|581002197|FG001|Overall Study|Protocol Violation|1|||
160792178|NCT03802916|580626839|FG000|Overall Study|Adverse Event|0|||
160982174|NCT05108649|581323429|FG003|Overall Study|Not Interested|1|||
160982175|NCT05108649|581323426|FG000|Overall Study|Out of area|0|||
160982176|NCT05108649|581323427|FG001|Overall Study|Out of area|0|||
160982177|NCT05108649|581323428|FG002|Overall Study|Out of area|0|||
160982178|NCT05108649|581323429|FG003|Overall Study|Out of area|1|||
160982179|NCT05108649|581323426|FG000|Overall Study|PI decision|1|||
160982180|NCT05108649|581323427|FG001|Overall Study|PI decision|0|||
160982181|NCT05108649|581323428|FG002|Overall Study|PI decision|0|||
160982182|NCT05108649|581323429|FG003|Overall Study|PI decision|0|||
160982183|NCT05108649|581323426|FG000|Overall Study|Significant Non-Compliance|0|||
160982184|NCT05108649|581323427|FG001|Overall Study|Significant Non-Compliance|1|||
160982185|NCT05108649|581323428|FG002|Overall Study|Significant Non-Compliance|0|||
160982186|NCT05108649|581323429|FG003|Overall Study|Significant Non-Compliance|0|||
160982187|NCT05108649|581323426|FG000|Overall Study|Unable to adhere to study protocol|0|||
160982188|NCT05108649|581323427|FG001|Overall Study|Unable to adhere to study protocol|2|||
160982189|NCT05108649|581323428|FG002|Overall Study|Unable to adhere to study protocol|0|||
160982190|NCT05108649|581323429|FG003|Overall Study|Unable to adhere to study protocol|0|||
160982191|NCT00918749|581323430|FG000|Overall Study|Adverse Event|1|||
160982192|NCT00918749|581323431|FG001|Overall Study|Adverse Event|0|||
160982193|NCT00918749|581323432|FG002|Overall Study|Adverse Event|1|||
160982194|NCT00918749|581323430|FG000|Overall Study|Lost to Follow-up|0|||
160982195|NCT00918749|581323431|FG001|Overall Study|Lost to Follow-up|0|||
160982196|NCT00918749|581323432|FG002|Overall Study|Lost to Follow-up|1|||
160982197|NCT00918749|581323430|FG000|Overall Study|Withdrawal by Subject|5|||
160982198|NCT00918749|581323431|FG001|Overall Study|Withdrawal by Subject|3|||
160982199|NCT00918749|581323432|FG002|Overall Study|Withdrawal by Subject|5|||
160982200|NCT00918749|581323430|FG000|Overall Study|No Study Medication Taken|1|||
160892555|NCT00735254|581002198|FG002|Overall Study|Protocol Violation|1|||
160892556|NCT00735254|581002199|FG003|Overall Study|Protocol Violation|0|||
160892557|NCT03880461|581002207|FG000|Overall Study|Determined ineligible after enrollment|45|||
160892558|NCT03880461|581002208|FG001|Overall Study|Determined ineligible after enrollment|44|||
160982201|NCT00918749|581323431|FG001|Overall Study|No Study Medication Taken|0|||
161128617|NCT00946309|581856934|FG001|Overall Study|Protocol Violation|0|||
161128618|NCT00946309|581856933|FG000|Overall Study|Lost to Follow-up|0|||
161128619|NCT00946309|581856934|FG001|Overall Study|Lost to Follow-up|1|||
160892559|NCT03880461|581002207|FG000|Overall Study|No weight measurement after enrollment|24|||
160892560|NCT03880461|581002208|FG001|Overall Study|No weight measurement after enrollment|17|||
160892561|NCT02652767|581002210|FG000|Overall Study|Death|2|||
160892562|NCT02652767|581002210|FG000|Overall Study|Lost to Follow-up|1|||
160892563|NCT02652767|581002210|FG000|Overall Study|Withdrawal by Subject|1|||
160892564|NCT02273739|581002214|FG000|Overall Study|Progression of Disease|3|||
160892565|NCT02273739|581002215|FG001|Overall Study|Progression of Disease|4|||
160892566|NCT02273739|581002216|FG002|Overall Study|Progression of Disease|5|||
160892567|NCT02273739|581002217|FG003|Overall Study|Progression of Disease|2|||
160892568|NCT02273739|581002214|FG000|Overall Study|Death|0|||
160892569|NCT02273739|581002215|FG001|Overall Study|Death|0|||
160892570|NCT02273739|581002216|FG002|Overall Study|Death|0|||
160982202|NCT00918749|581323432|FG002|Overall Study|No Study Medication Taken|0|||
160982203|NCT00972179|581323433|FG000|Overall Study|Noncompliance|1|||
160982204|NCT00972179|581323434|FG001|Overall Study|Noncompliance|0|||
160982205|NCT00972179|581323435|FG002|Overall Study|Noncompliance|0|||
160982206|NCT00972179|581323436|FG003|Overall Study|Noncompliance|0|||
160982207|NCT00972179|581323437|FG004|Overall Study|Noncompliance|1|||
160982208|NCT00972179|581323438|FG005|Overall Study|Noncompliance|0|||
160982209|NCT00972179|581323439|FG006|Overall Study|Noncompliance|1|||
161128620|NCT00946309|581856933|FG000|Overall Study|Procedure cancelled/discontinued|0|||
161128621|NCT00946309|581856934|FG001|Overall Study|Procedure cancelled/discontinued|3|||
160792179|NCT03802916|580626840|FG001|Overall Study|Adverse Event|1|||
160792180|NCT03802916|580626839|FG000|Overall Study|Withdrawal by Subject|0|||
160792181|NCT03802916|580626840|FG001|Overall Study|Withdrawal by Subject|1|||
160792182|NCT00480532|580626841|FG000|Overall Study|Withdrawal by Subject|2|||
160792183|NCT00480532|580626842|FG001|Overall Study|Withdrawal by Subject|4|||
160792184|NCT00480532|580626843|FG002|Overall Study|Withdrawal by Subject|3|||
160792185|NCT00480532|580626844|FG003|Overall Study|Withdrawal by Subject|1|||
160792186|NCT00480532|580626841|FG000|Overall Study|Protocol Violation|0|||
160792187|NCT00480532|580626842|FG001|Overall Study|Protocol Violation|0|||
160792188|NCT00480532|580626843|FG002|Overall Study|Protocol Violation|1|||
160792189|NCT00480532|580626844|FG003|Overall Study|Protocol Violation|0|||
160792190|NCT01285102|580626845|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
160792191|NCT00557440|580626846|FG000|Treatment Period 1|Adverse Event|0|||
160792192|NCT00557440|580626847|FG001|Treatment Period 1|Adverse Event|0|||
160792193|NCT00557440|580626848|FG002|Treatment Period 1|Adverse Event|1|||
160792194|NCT01946880|580626851|FG000|Overall Study|Lost to Follow-up|1|||
160792195|NCT01946880|580626852|FG001|Overall Study|Lost to Follow-up|0|||
160792196|NCT01946880|580626851|FG000|Overall Study|Physician Decision|1|||
160792197|NCT01946880|580626852|FG001|Overall Study|Physician Decision|1|||
160792198|NCT01946880|580626851|FG000|Overall Study|Withdrawal by Subject|3|||
160792199|NCT01946880|580626852|FG001|Overall Study|Withdrawal by Subject|2|||
160792200|NCT01946880|580626851|FG000|Overall Study|Met Primary Endpoint|1|||
160792201|NCT01946880|580626852|FG001|Overall Study|Met Primary Endpoint|0|||
160792202|NCT01946880|580626851|FG000|Overall Study|Personal and Family Issues|1|||
160792203|NCT01946880|580626852|FG001|Overall Study|Personal and Family Issues|0|||
160792204|NCT02951819|580626853|FG000|Overall Study|Death|9|||
160792205|NCT02951819|580626854|FG001|Overall Study|Death|7|||
160792206|NCT02951819|580626853|FG000|Overall Study|Withdrawal by Subject|3|||
160792207|NCT02951819|580626854|FG001|Overall Study|Withdrawal by Subject|0|||
160792208|NCT02951819|580626853|FG000|Overall Study|Adverse Event|1|||
160792209|NCT02951819|580626854|FG001|Overall Study|Adverse Event|0|||
160792210|NCT02951819|580626853|FG000|Overall Study|Lack of Efficacy|4|||
160792211|NCT02951819|580626854|FG001|Overall Study|Lack of Efficacy|0|||
160792212|NCT02951819|580626853|FG000|Overall Study|Lost to Follow-up|1|||
160792213|NCT02951819|580626854|FG001|Overall Study|Lost to Follow-up|0|||
160792214|NCT02951819|580626853|FG000|Overall Study|Progressive Disease|1|||
160792215|NCT02951819|580626854|FG001|Overall Study|Progressive Disease|0|||
160792216|NCT02951819|580626853|FG000|Overall Study|Other|9|||
160792217|NCT02951819|580626854|FG001|Overall Study|Other|0|||
160792218|NCT02420314|580626858|FG000|Overall Study|Withdrawal by Subject|1|||
160792219|NCT02420314|580626858|FG000|Overall Study|Protocol Violation|1|||
160792220|NCT00680914|580626859|FG000|Overall Study|Consent withdrawal|6|||
160792221|NCT00680914|580626860|FG001|Overall Study|Consent withdrawal|3|||
160792222|NCT00680914|580626859|FG000|Overall Study|Lost to Follow-up|4|||
160792223|NCT00680914|580626860|FG001|Overall Study|Lost to Follow-up|0|||
160792224|NCT00680914|580626859|FG000|Overall Study|serious adverse event (SAE)|0|||
160792225|NCT00680914|580626860|FG001|Overall Study|serious adverse event (SAE)|1|||
160792226|NCT03204812|580626861|FG000|Overall Study|Adverse Event|3|||
160792227|NCT02412436|580626862|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
160792228|NCT02412436|580626862|FG000|Overall Study|Lost to Follow-up|6|||
160792229|NCT02412436|580626862|FG000|Overall Study|Unable to get to clinic|3|||
160792230|NCT02412436|580626862|FG000|Overall Study|Death|1|||
160792231|NCT02412436|580626862|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
160792232|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
160792233|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792234|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792235|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792236|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
160792237|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
160792238|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792239|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792240|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792241|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
160792242|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
160792243|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792244|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792245|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792246|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
160792247|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
160792248|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792249|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792250|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792251|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
160792252|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
160792253|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160792254|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
161235746|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235747|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235748|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235749|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
161235750|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
161235751|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
161235752|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
161235753|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
161235754|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
161235755|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
161235756|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
161235757|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
161235758|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235759|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235760|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235761|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160982210|NCT00972179|581323433|FG000|Overall Study|Withdrawal by Subject|0|||
160982211|NCT00972179|581323434|FG001|Overall Study|Withdrawal by Subject|3|||
160982212|NCT00972179|581323435|FG002|Overall Study|Withdrawal by Subject|0|||
160982213|NCT00972179|581323436|FG003|Overall Study|Withdrawal by Subject|1|||
160982214|NCT00972179|581323437|FG004|Overall Study|Withdrawal by Subject|0|||
160982215|NCT00972179|581323438|FG005|Overall Study|Withdrawal by Subject|0|||
160982216|NCT00972179|581323439|FG006|Overall Study|Withdrawal by Subject|2|||
160982217|NCT00972179|581323433|FG000|Overall Study|Administrative Decision|0|||
160982218|NCT00972179|581323434|FG001|Overall Study|Administrative Decision|0|||
160982219|NCT00972179|581323435|FG002|Overall Study|Administrative Decision|0|||
160982220|NCT00972179|581323436|FG003|Overall Study|Administrative Decision|0|||
160982221|NCT00972179|581323437|FG004|Overall Study|Administrative Decision|1|||
160982222|NCT00972179|581323438|FG005|Overall Study|Administrative Decision|0|||
160982223|NCT00972179|581323439|FG006|Overall Study|Administrative Decision|0|||
160982224|NCT00972179|581323433|FG000|Overall Study|Lost to Follow-up|0|||
160982225|NCT00972179|581323434|FG001|Overall Study|Lost to Follow-up|0|||
160982226|NCT00972179|581323435|FG002|Overall Study|Lost to Follow-up|1|||
160982227|NCT00972179|581323436|FG003|Overall Study|Lost to Follow-up|0|||
160892571|NCT02273739|581002217|FG003|Overall Study|Death|2|||
160892572|NCT02273739|581002214|FG000|Overall Study|Adverse Event|0|||
160892573|NCT02273739|581002215|FG001|Overall Study|Adverse Event|0|||
160892574|NCT02273739|581002216|FG002|Overall Study|Adverse Event|0|||
160892575|NCT02273739|581002217|FG003|Overall Study|Adverse Event|1|||
160892576|NCT02273739|581002214|FG000|Overall Study|Withdrawal by Subject|0|||
160892577|NCT02273739|581002215|FG001|Overall Study|Withdrawal by Subject|0|||
160892578|NCT02273739|581002216|FG002|Overall Study|Withdrawal by Subject|2|||
160892579|NCT02273739|581002217|FG003|Overall Study|Withdrawal by Subject|1|||
160892580|NCT02273739|581002214|FG000|Overall Study|Physician Decision|0|||
160892581|NCT02273739|581002215|FG001|Overall Study|Physician Decision|0|||
160892582|NCT02273739|581002216|FG002|Overall Study|Physician Decision|0|||
160892583|NCT02273739|581002217|FG003|Overall Study|Physician Decision|1|||
160892584|NCT02280473|581002219|FG000|Overall Study|Adverse Event|1|||
160892585|NCT02280473|581002220|FG001|Overall Study|Adverse Event|1|||
160892586|NCT02280473|581002219|FG000|Overall Study|Lack of Efficacy|0|||
160892587|NCT02280473|581002220|FG001|Overall Study|Lack of Efficacy|1|||
160892588|NCT02280473|581002219|FG000|Overall Study|Lost to Follow-up|0|||
160892589|NCT02280473|581002220|FG001|Overall Study|Lost to Follow-up|1|||
160892590|NCT02393690|581002221|FG000|Overall Study|Ineligible|0|||
160892591|NCT02393690|581002222|FG001|Overall Study|Ineligible|1|||
160892592|NCT05298306|581002223|FG000|Overall Study|Physician Decision|0|||
160892593|NCT05298306|581002224|FG001|Overall Study|Physician Decision|0|||
160892594|NCT05298306|581002225|FG002|Overall Study|Physician Decision|0|||
160892595|NCT05298306|581002226|FG003|Overall Study|Physician Decision|1|||
160892596|NCT05298306|581002227|FG004|Overall Study|Physician Decision|0|||
160892597|NCT05298306|581002228|FG005|Overall Study|Physician Decision|0|||
160892598|NCT00144027|581002230|FG000|Overall Study|Lost to Follow-up|1|||
160892599|NCT00144027|581002231|FG001|Overall Study|Lost to Follow-up|3|||
160892600|NCT00144027|581002230|FG000|Overall Study|Withdrawal by Subject|2|||
160892601|NCT00144027|581002231|FG001|Overall Study|Withdrawal by Subject|2|||
160892602|NCT00144027|581002230|FG000|Overall Study|did not complete baseline assessment|0|||
160892603|NCT00144027|581002231|FG001|Overall Study|did not complete baseline assessment|6|||
160892604|NCT00237185|581002232|FG000|Core|Adverse Event|3|||
160892605|NCT00237185|581002233|FG001|Core|Adverse Event|4|||
160892606|NCT00237185|581002232|FG000|Core|Abnormal laboratory value|0|||
160892607|NCT00237185|581002233|FG001|Core|Abnormal laboratory value|4|||
160892608|NCT00237185|581002232|FG000|Core|Abnormal test procedure results|1|||
160892609|NCT00237185|581002233|FG001|Core|Abnormal test procedure results|0|||
160892610|NCT00237185|581002232|FG000|Core|Lack of Efficacy|30|||
160892611|NCT00237185|581002233|FG001|Core|Lack of Efficacy|23|||
160982228|NCT00972179|581323437|FG004|Overall Study|Lost to Follow-up|0|||
160892612|NCT00237185|581002232|FG000|Core|Protocol Violation|1|||
160892613|NCT00237185|581002233|FG001|Core|Protocol Violation|1|||
160892614|NCT00237185|581002232|FG000|Core|Withdrawal by Subject|4|||
160982229|NCT00972179|581323438|FG005|Overall Study|Lost to Follow-up|3|||
161330605|NCT00116688|582597170|FG001|Overall Study|Requirement for alternative therapy|1|||
160892615|NCT00237185|581002233|FG001|Core|Withdrawal by Subject|4|||
160892616|NCT00237185|581002232|FG000|Core|Administrative problems|0|||
160892617|NCT00237185|581002233|FG001|Core|Administrative problems|1|||
160982230|NCT00972179|581323439|FG006|Overall Study|Lost to Follow-up|1|||
161330606|NCT00116688|582597169|FG000|Overall Study|Physician Decision|7|||
160892618|NCT00237185|581002232|FG000|Core|Death|4|||
160892619|NCT00237185|581002233|FG001|Core|Death|0|||
160892620|NCT00237185|581002232|FG000|Core|Determined ineligible post randomization|1|||
160892621|NCT00237185|581002233|FG001|Core|Determined ineligible post randomization|0|||
160892622|NCT00237185|581002232|FG000|Extension|Adverse Event|1|||
160892623|NCT00237185|581002233|FG001|Extension|Adverse Event|0|||
160982231|NCT03018106|581323440|FG000|Overall Study|Lost to Follow-up|0|||
160982232|NCT03018106|581323441|FG001|Overall Study|Lost to Follow-up|1|||
160982233|NCT03055832|581323442|FG000|Week 2|Withdrawal by Subject|1|||
160982234|NCT03055832|581323443|FG001|Week 2|Withdrawal by Subject|0|||
160792255|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160792256|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
160792257|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
160792258|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792259|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792260|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792261|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
160792262|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
160792263|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792264|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792265|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792266|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
160792267|NCT01111552|580626863|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
160792268|NCT01111552|580626864|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160792269|NCT01111552|580626865|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160892624|NCT00237185|581002232|FG000|Extension|Abnormal laboratory value|0|||
160892625|NCT00237185|581002233|FG001|Extension|Abnormal laboratory value|1|||
160892626|NCT00237185|581002232|FG000|Extension|Lack of Efficacy|9|||
160892627|NCT00237185|581002233|FG001|Extension|Lack of Efficacy|14|||
160892628|NCT00237185|581002232|FG000|Extension|Condition no longer required study drug|0|||
160892629|NCT00237185|581002233|FG001|Extension|Condition no longer required study drug|1|||
160892630|NCT00237185|581002232|FG000|Extension|Withdrawal by Subject|3|||
160892631|NCT00237185|581002233|FG001|Extension|Withdrawal by Subject|2|||
160892632|NCT00237185|581002232|FG000|Extension|Lost to Follow-up|1|||
160892633|NCT00237185|581002233|FG001|Extension|Lost to Follow-up|0|||
160892634|NCT00237185|581002232|FG000|Extension|Administrative problems|1|||
160892635|NCT00237185|581002233|FG001|Extension|Administrative problems|0|||
160892636|NCT00237185|581002232|FG000|Extension|Death|1|||
160892637|NCT00237185|581002233|FG001|Extension|Death|1|||
160892638|NCT02204007|581002234|FG000|Overall Study|Surgery Canceled|1|||
160892639|NCT02204007|581002235|FG001|Overall Study|Surgery Canceled|1|||
160892640|NCT00910988|581002236|FG000|Overall Study|Lost to Follow-up|2|||
160892641|NCT00910988|581002237|FG001|Overall Study|Lost to Follow-up|4|||
160892642|NCT00910988|581002238|FG002|Overall Study|Lost to Follow-up|3|||
160892643|NCT00910988|581002239|FG003|Overall Study|Lost to Follow-up|0|||
160892644|NCT02766465|581002240|FG000|Overall Study|Withdrawal by Subject|0|||
160892645|NCT02766465|581002241|FG001|Overall Study|Withdrawal by Subject|10|||
160892646|NCT01907100|581002242|FG000|Overall Study|PD based on modified RECIST criteria|31|||
160892647|NCT01907100|581002243|FG001|Overall Study|PD based on modified RECIST criteria|32|||
160892648|NCT01907100|581002244|FG002|Overall Study|PD based on modified RECIST criteria|95|||
160892649|NCT01907100|581002245|FG003|Overall Study|PD based on modified RECIST criteria|92|||
160892650|NCT01907100|581002242|FG000|Overall Study|Withdrawal by Subject|2|||
160892651|NCT01907100|581002243|FG001|Overall Study|Withdrawal by Subject|5|||
160892652|NCT01907100|581002244|FG002|Overall Study|Withdrawal by Subject|10|||
160892653|NCT01907100|581002245|FG003|Overall Study|Withdrawal by Subject|13|||
160892654|NCT01907100|581002242|FG000|Overall Study|Protocol Violation|0|||
160892655|NCT01907100|581002243|FG001|Overall Study|Protocol Violation|0|||
160892656|NCT01907100|581002244|FG002|Overall Study|Protocol Violation|1|||
160892657|NCT01907100|581002245|FG003|Overall Study|Protocol Violation|1|||
160892658|NCT01907100|581002242|FG000|Overall Study|Lost to Follow-up|0|||
160892659|NCT01907100|581002243|FG001|Overall Study|Lost to Follow-up|0|||
160892660|NCT01907100|581002244|FG002|Overall Study|Lost to Follow-up|0|||
160892661|NCT01907100|581002245|FG003|Overall Study|Lost to Follow-up|1|||
160892662|NCT01907100|581002242|FG000|Overall Study|Not treated|2|||
160892663|NCT01907100|581002243|FG001|Overall Study|Not treated|0|||
160892664|NCT01907100|581002244|FG002|Overall Study|Not treated|1|||
160892665|NCT01907100|581002245|FG003|Overall Study|Not treated|2|||
160892666|NCT01907100|581002242|FG000|Overall Study|Other than reasons specified|1|||
160892667|NCT01907100|581002243|FG001|Overall Study|Other than reasons specified|0|||
160892668|NCT01907100|581002244|FG002|Overall Study|Other than reasons specified|10|||
160982235|NCT00136916|581323444|FG000|Overall Study|Never received study treatment|3|||
160982236|NCT00136916|581323445|FG001|Overall Study|Never received study treatment|5|||
160892669|NCT01907100|581002245|FG003|Overall Study|Other than reasons specified|6|||
160892670|NCT01907100|581002242|FG000|Overall Study|Adverse event (AE)|6|||
160892671|NCT01907100|581002243|FG001|Overall Study|Adverse event (AE)|3|||
160892672|NCT01907100|581002244|FG002|Overall Study|Adverse event (AE)|22|||
160892673|NCT01907100|581002245|FG003|Overall Study|Adverse event (AE)|23|||
160892674|NCT01907100|581002242|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
160892675|NCT01907100|581002243|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
160892676|NCT01907100|581002244|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
160892677|NCT01907100|581002245|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
160892678|NCT01758289|581002246|FG000|Overall Study|Premature Study Termination|44|||
160892679|NCT01758289|581002246|FG000|Overall Study|Adverse Event|9|||
160892680|NCT01574079|581002247|FG000|Overall Study|Physician Decision|0|||
160792270|NCT01111552|580626866|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160792271|NCT01111552|580626867|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
160792272|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792273|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792274|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792275|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
160792276|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
160792277|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
160792278|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
160792279|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
160792280|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
160792281|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
160792282|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792283|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
160792284|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792285|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792286|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
160792287|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792288|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
160792289|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792290|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792291|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
160792292|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792293|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
160792294|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792295|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792296|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
160792297|NCT01111552|580626863|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792298|NCT01111552|580626864|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792299|NCT01111552|580626865|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
160792300|NCT01111552|580626866|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792301|NCT01111552|580626867|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
160792302|NCT01027351|580626869|FG000|Overall Study|Withdrawal by Subject|1|||
160792303|NCT01027351|580626870|FG001|Overall Study|Withdrawal by Subject|0|||
160792304|NCT01027351|580626871|FG002|Overall Study|Withdrawal by Subject|1|||
160792305|NCT01027351|580626872|FG003|Overall Study|Withdrawal by Subject|0|||
160792306|NCT01027351|580626873|FG004|Overall Study|Withdrawal by Subject|3|||
160792307|NCT01027351|580626874|FG005|Overall Study|Withdrawal by Subject|5|||
160792308|NCT01027351|580626869|FG000|Overall Study|Lost to Follow-up|1|||
160792309|NCT01027351|580626870|FG001|Overall Study|Lost to Follow-up|1|||
160792310|NCT01027351|580626871|FG002|Overall Study|Lost to Follow-up|0|||
160792311|NCT01027351|580626872|FG003|Overall Study|Lost to Follow-up|1|||
160792312|NCT01027351|580626873|FG004|Overall Study|Lost to Follow-up|6|||
160792313|NCT01027351|580626874|FG005|Overall Study|Lost to Follow-up|0|||
160792314|NCT01027351|580626869|FG000|Overall Study|Inappropriate enrollment|0|||
160792315|NCT01027351|580626870|FG001|Overall Study|Inappropriate enrollment|0|||
160792316|NCT01027351|580626871|FG002|Overall Study|Inappropriate enrollment|0|||
160792317|NCT01027351|580626872|FG003|Overall Study|Inappropriate enrollment|0|||
160792318|NCT01027351|580626873|FG004|Overall Study|Inappropriate enrollment|1|||
160792319|NCT01027351|580626874|FG005|Overall Study|Inappropriate enrollment|0|||
160792320|NCT01027351|580626869|FG000|Overall Study|Protocol Violation|1|||
160792321|NCT01027351|580626870|FG001|Overall Study|Protocol Violation|0|||
160792322|NCT01027351|580626871|FG002|Overall Study|Protocol Violation|0|||
160792323|NCT01027351|580626872|FG003|Overall Study|Protocol Violation|1|||
160792324|NCT01027351|580626873|FG004|Overall Study|Protocol Violation|1|||
160792325|NCT01027351|580626874|FG005|Overall Study|Protocol Violation|0|||
160792326|NCT04650893|580626875|FG000|Overall Study|Lost to Follow-up|11|||
160792327|NCT04650893|580626876|FG001|Overall Study|Lost to Follow-up|10|||
160892681|NCT01574079|581002248|FG001|Overall Study|Physician Decision|2|||
160892682|NCT01574079|581002247|FG000|Overall Study|Lost to Follow-up|1|||
160892683|NCT01574079|581002248|FG001|Overall Study|Lost to Follow-up|0|||
160892684|NCT02059005|581002251|FG000|Overall Study|Death|1|||
160892685|NCT02059005|581002252|FG001|Overall Study|Death|3|||
160892686|NCT02059005|581002251|FG000|Overall Study|Lost to Follow-up|19|||
160892687|NCT02059005|581002252|FG001|Overall Study|Lost to Follow-up|19|||
160892688|NCT02059005|581002251|FG000|Overall Study|Incarceration|0|||
160892689|NCT02059005|581002252|FG001|Overall Study|Incarceration|1|||
160892690|NCT02059005|581002251|FG000|Overall Study|Inpatient|0|||
161128622|NCT01465659|581856935|FG000|Completed 1 Cycle of Treatment|Death|0|||
160892691|NCT02059005|581002252|FG001|Overall Study|Inpatient|1|||
160792328|NCT04650893|580626877|FG002|Overall Study|Lost to Follow-up|11|||
160792329|NCT00637156|580626878|FG000|Overall Study|Withdrawal by Subject|0|||
160792330|NCT00637156|580626879|FG001|Overall Study|Withdrawal by Subject|7|||
160982237|NCT00136916|581323444|FG000|Overall Study|Death|1|||
160792331|NCT00637156|580626878|FG000|Overall Study|Death|0|||
160792332|NCT00637156|580626879|FG001|Overall Study|Death|1|||
160792333|NCT00637156|580626878|FG000|Overall Study|Lost to Follow-up|10|||
160792334|NCT00637156|580626879|FG001|Overall Study|Lost to Follow-up|16|||
160792335|NCT02679274|580626880|FG000|Overall Study|Withdrawal by Subject|1|||
160792336|NCT02679274|580626881|FG001|Overall Study|Withdrawal by Subject|0|||
160792337|NCT03193437|580626888|FG000|Overall Study|Adverse Event|4|||
160792338|NCT03193437|580626888|FG000|Overall Study|Withdrawal by Subject|2|||
160792339|NCT03193437|580626888|FG000|Overall Study|Disease Progression|2|||
160792340|NCT04976855|580626889|FG000|Part I|Withdrawal by Subject|0|||
160792341|NCT04976855|580626890|FG001|Part I|Withdrawal by Subject|1|||
160792342|NCT04976855|580626891|FG002|Part I|Withdrawal by Subject|0|||
160792343|NCT04976855|580626892|FG003|Part I|Withdrawal by Subject|0|||
160792344|NCT04976855|580626893|FG004|Part I|Withdrawal by Subject|0|||
160792345|NCT04976855|580626894|FG005|Part I|Withdrawal by Subject|0|||
160792346|NCT04976855|580626895|FG006|Part I|Withdrawal by Subject|0|||
160792347|NCT04976855|580626889|FG000|Part II|Adverse Event|0|||
160792348|NCT04976855|580626890|FG001|Part II|Adverse Event|0|||
160792349|NCT04976855|580626891|FG002|Part II|Adverse Event|0|||
160792350|NCT04976855|580626892|FG003|Part II|Adverse Event|1|||
160792351|NCT04976855|580626893|FG004|Part II|Adverse Event|0|||
160792352|NCT04976855|580626894|FG005|Part II|Adverse Event|0|||
160792353|NCT04976855|580626895|FG006|Part II|Adverse Event|0|||
160792354|NCT04976855|580626889|FG000|Part II|Withdrawal by Subject|0|||
160792355|NCT04976855|580626890|FG001|Part II|Withdrawal by Subject|0|||
160792356|NCT04976855|580626891|FG002|Part II|Withdrawal by Subject|0|||
160792357|NCT04976855|580626892|FG003|Part II|Withdrawal by Subject|0|||
160792358|NCT04976855|580626893|FG004|Part II|Withdrawal by Subject|1|||
160792359|NCT04976855|580626894|FG005|Part II|Withdrawal by Subject|0|||
160792360|NCT04976855|580626895|FG006|Part II|Withdrawal by Subject|0|||
160792361|NCT04976855|580626889|FG000|Part II|Lost to Follow-up|0|||
160792362|NCT04976855|580626890|FG001|Part II|Lost to Follow-up|0|||
160792363|NCT04976855|580626891|FG002|Part II|Lost to Follow-up|0|||
160792364|NCT04976855|580626892|FG003|Part II|Lost to Follow-up|0|||
160792365|NCT04976855|580626893|FG004|Part II|Lost to Follow-up|0|||
160792366|NCT04976855|580626894|FG005|Part II|Lost to Follow-up|1|||
160792367|NCT04976855|580626895|FG006|Part II|Lost to Follow-up|0|||
160792368|NCT02038036|580626896|FG000|Core Study|Adverse Event|7|||
160792369|NCT02038036|580626897|FG001|Core Study|Adverse Event|7|||
160792370|NCT02038036|580626896|FG000|Core Study|Death|1|||
160792371|NCT02038036|580626897|FG001|Core Study|Death|1|||
160792372|NCT02038036|580626896|FG000|Core Study|Disease progression|2|||
160792373|NCT02038036|580626897|FG001|Core Study|Disease progression|2|||
160792374|NCT02038036|580626896|FG000|Core Study|Lost to Follow-up|0|||
160792375|NCT02038036|580626897|FG001|Core Study|Lost to Follow-up|1|||
160792376|NCT02038036|580626896|FG000|Core Study|Physician Decision|2|||
160792377|NCT02038036|580626897|FG001|Core Study|Physician Decision|1|||
160792378|NCT02038036|580626896|FG000|Core Study|Subject/guardian decision|0|||
160792379|NCT02038036|580626897|FG001|Core Study|Subject/guardian decision|1|||
160792380|NCT02038036|580626896|FG000|Core Study|Withdrawal by Subject|3|||
160792381|NCT02038036|580626897|FG001|Core Study|Withdrawal by Subject|1|||
160792382|NCT02038036|580626896|FG000|Crossover Period|Withdrawal by Subject|0|||
160792383|NCT02038036|580626897|FG001|Crossover Period|Withdrawal by Subject|3|||
160792384|NCT02038036|580626896|FG000|Crossover Period|Adverse Event|0|||
160792385|NCT02038036|580626897|FG001|Crossover Period|Adverse Event|9|||
160792386|NCT02038036|580626896|FG000|Crossover Period|Death|0|||
160982238|NCT00136916|581323445|FG001|Overall Study|Death|3|||
160982239|NCT00136916|581323444|FG000|Overall Study|Adverse Event|27|||
160982240|NCT00136916|581323445|FG001|Overall Study|Adverse Event|8|||
160792387|NCT02038036|580626897|FG001|Crossover Period|Death|2|||
160792388|NCT02038036|580626896|FG000|Crossover Period|Disease progression|0|||
160792389|NCT02038036|580626897|FG001|Crossover Period|Disease progression|3|||
160792390|NCT02038036|580626896|FG000|Crossover Period|Lost to Follow-up|0|||
160792391|NCT02038036|580626897|FG001|Crossover Period|Lost to Follow-up|1|||
160792392|NCT02038036|580626896|FG000|Crossover Period|Physician Decision|0|||
160792393|NCT02038036|580626897|FG001|Crossover Period|Physician Decision|2|||
160792394|NCT00908141|580626906|FG000|Overall Study|Withdrawal by Subject|0|||
160792395|NCT00908141|580626907|FG001|Overall Study|Withdrawal by Subject|1|||
160792396|NCT03514134|580628191|FG000|Overall Study|Lost to Follow-up|0|||
160792397|NCT03514134|580628192|FG001|Overall Study|Lost to Follow-up|1|||
160792398|NCT03768336|580628194|FG000|Overall Study|Lost to Follow-up|3|||
160792399|NCT03768336|580628195|FG001|Overall Study|Lost to Follow-up|2|||
160792400|NCT03768336|580628194|FG000|Overall Study|Became Ineligible|2|||
160792401|NCT03768336|580628195|FG001|Overall Study|Became Ineligible|0|||
160792402|NCT03768336|580628194|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
160792403|NCT03768336|580628195|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
160792404|NCT03768336|580628194|FG000|Overall Study|Missed final survey (post-treatment|0|||
160982241|NCT00136916|581323444|FG000|Overall Study|Laboratory abnormality|0|||
160792405|NCT03768336|580628195|FG001|Overall Study|Missed final survey (post-treatment|1|||
160792406|NCT05654181|580628196|FG000|Overall Study|Adverse Event|1|||
160792407|NCT05654181|580628197|FG001|Overall Study|Adverse Event|0|||
160792408|NCT05654181|580628198|FG002|Overall Study|Adverse Event|0|||
160792409|NCT05654181|580628199|FG003|Overall Study|Adverse Event|0|||
160792410|NCT05654181|580628200|FG004|Overall Study|Adverse Event|0|||
160792411|NCT05654181|580628201|FG005|Overall Study|Adverse Event|0|||
160792412|NCT05654181|580628202|FG006|Overall Study|Adverse Event|0|||
160792413|NCT05654181|580628203|FG007|Overall Study|Adverse Event|1|||
160792414|NCT05654181|580628204|FG008|Overall Study|Adverse Event|0|||
160792415|NCT05654181|580628205|FG009|Overall Study|Adverse Event|0|||
160792416|NCT05654181|580628196|FG000|Overall Study|Withdrawal by Subject|0|||
160792417|NCT05654181|580628197|FG001|Overall Study|Withdrawal by Subject|0|||
160792418|NCT05654181|580628198|FG002|Overall Study|Withdrawal by Subject|0|||
160792419|NCT05654181|580628199|FG003|Overall Study|Withdrawal by Subject|0|||
160792420|NCT05654181|580628200|FG004|Overall Study|Withdrawal by Subject|0|||
160792421|NCT05654181|580628201|FG005|Overall Study|Withdrawal by Subject|0|||
160792422|NCT05654181|580628202|FG006|Overall Study|Withdrawal by Subject|0|||
160792423|NCT05654181|580628203|FG007|Overall Study|Withdrawal by Subject|1|||
160792424|NCT05654181|580628204|FG008|Overall Study|Withdrawal by Subject|0|||
160792425|NCT05654181|580628205|FG009|Overall Study|Withdrawal by Subject|0|||
160792426|NCT05654181|580628196|FG000|Overall Study|Other|0|||
160792427|NCT05654181|580628197|FG001|Overall Study|Other|0|||
160792428|NCT05654181|580628198|FG002|Overall Study|Other|0|||
160792429|NCT05654181|580628199|FG003|Overall Study|Other|0|||
160792430|NCT05654181|580628200|FG004|Overall Study|Other|1|||
160792431|NCT05654181|580628201|FG005|Overall Study|Other|1|||
160792432|NCT05654181|580628202|FG006|Overall Study|Other|0|||
160792433|NCT05654181|580628203|FG007|Overall Study|Other|0|||
160792434|NCT05654181|580628204|FG008|Overall Study|Other|0|||
160792435|NCT05654181|580628205|FG009|Overall Study|Other|0|||
160792436|NCT02278003|580628207|FG000|Overall Study|Withdrawal by Subject|11|||
160792437|NCT02278003|580628208|FG001|Overall Study|Withdrawal by Subject|0|||
160792438|NCT02278003|580628207|FG000|Overall Study|Not Treated|1|||
160792439|NCT02278003|580628208|FG001|Overall Study|Not Treated|0|||
160792440|NCT02278003|580628207|FG000|Overall Study|Recognition task improperly completed|7|||
160792441|NCT02278003|580628208|FG001|Overall Study|Recognition task improperly completed|0|||
160792442|NCT00500331|580628212|FG000|Overall Study|Adverse Event|0|||
160792443|NCT00500331|580628213|FG001|Overall Study|Adverse Event|2|||
160792444|NCT00500331|580628214|FG002|Overall Study|Adverse Event|0|||
160792445|NCT00500331|580628215|FG003|Overall Study|Adverse Event|1|||
160792446|NCT00500331|580628216|FG004|Overall Study|Adverse Event|2|||
160792447|NCT00500331|580628217|FG005|Overall Study|Adverse Event|2|||
160792448|NCT00500331|580628218|FG006|Overall Study|Adverse Event|0|||
160792449|NCT00500331|580628212|FG000|Overall Study|Lost to Follow-up|1|||
160792450|NCT00500331|580628213|FG001|Overall Study|Lost to Follow-up|1|||
160792451|NCT00500331|580628214|FG002|Overall Study|Lost to Follow-up|1|||
160792452|NCT00500331|580628215|FG003|Overall Study|Lost to Follow-up|2|||
160792453|NCT00500331|580628216|FG004|Overall Study|Lost to Follow-up|1|||
160792454|NCT00500331|580628217|FG005|Overall Study|Lost to Follow-up|0|||
160792455|NCT00500331|580628218|FG006|Overall Study|Lost to Follow-up|0|||
160792456|NCT00500331|580628212|FG000|Overall Study|Protocol Violation|3|||
160792457|NCT00500331|580628213|FG001|Overall Study|Protocol Violation|1|||
160792458|NCT00500331|580628214|FG002|Overall Study|Protocol Violation|1|||
160792459|NCT00500331|580628215|FG003|Overall Study|Protocol Violation|0|||
160792460|NCT00500331|580628216|FG004|Overall Study|Protocol Violation|1|||
160792461|NCT00500331|580628217|FG005|Overall Study|Protocol Violation|1|||
160982242|NCT00136916|581323445|FG001|Overall Study|Laboratory abnormality|1|||
160982243|NCT00136916|581323444|FG000|Overall Study|Lack of Efficacy|13|||
160982244|NCT00136916|581323445|FG001|Overall Study|Lack of Efficacy|3|||
160982245|NCT00136916|581323444|FG000|Overall Study|Lost to Follow-up|12|||
161235762|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235763|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235764|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
160792462|NCT00500331|580628218|FG006|Overall Study|Protocol Violation|1|||
160792463|NCT00500331|580628212|FG000|Overall Study|Withdrawal by Subject|4|||
160792464|NCT00500331|580628213|FG001|Overall Study|Withdrawal by Subject|0|||
160792465|NCT00500331|580628214|FG002|Overall Study|Withdrawal by Subject|1|||
160792466|NCT00500331|580628215|FG003|Overall Study|Withdrawal by Subject|5|||
160792467|NCT00500331|580628216|FG004|Overall Study|Withdrawal by Subject|0|||
160792468|NCT00500331|580628217|FG005|Overall Study|Withdrawal by Subject|1|||
160792469|NCT00500331|580628218|FG006|Overall Study|Withdrawal by Subject|1|||
160792470|NCT00500331|580628212|FG000|Overall Study|Lack of Efficacy|3|||
160792471|NCT00500331|580628213|FG001|Overall Study|Lack of Efficacy|1|||
160792472|NCT00500331|580628214|FG002|Overall Study|Lack of Efficacy|0|||
160792473|NCT00500331|580628215|FG003|Overall Study|Lack of Efficacy|0|||
160792474|NCT00500331|580628216|FG004|Overall Study|Lack of Efficacy|0|||
160792475|NCT00500331|580628217|FG005|Overall Study|Lack of Efficacy|0|||
160982246|NCT00136916|581323445|FG001|Overall Study|Lost to Follow-up|14|||
160982247|NCT00136916|581323444|FG000|Overall Study|Withdrawal by Subject|44|||
160982248|NCT00136916|581323445|FG001|Overall Study|Withdrawal by Subject|46|||
160982249|NCT00136916|581323444|FG000|Overall Study|Other|22|||
160982250|NCT00136916|581323445|FG001|Overall Study|Other|24|||
160982251|NCT00136916|581323444|FG000|Overall Study|Discontinued in follow up period|3|||
160982252|NCT00136916|581323445|FG001|Overall Study|Discontinued in follow up period|0|||
160982253|NCT03619174|581323446|FG000|Overall Study|Lost to Follow-up|3|||
160982254|NCT03619174|581323447|FG001|Overall Study|Lost to Follow-up|0|||
160982255|NCT03619174|581323446|FG000|Overall Study|Withdrawal by Subject|4|||
160982256|NCT03619174|581323447|FG001|Overall Study|Withdrawal by Subject|3|||
160982257|NCT03619174|581323446|FG000|Overall Study|Pregnancy|1|||
160982258|NCT03619174|581323447|FG001|Overall Study|Pregnancy|1|||
160982259|NCT03619174|581323446|FG000|Overall Study|Discomfort during treatment|1|||
160792476|NCT00500331|580628218|FG006|Overall Study|Lack of Efficacy|0|||
160792477|NCT00500331|580628212|FG000|Overall Study|Liver function test abnormality|0|||
160792478|NCT00500331|580628213|FG001|Overall Study|Liver function test abnormality|0|||
160792479|NCT00500331|580628214|FG002|Overall Study|Liver function test abnormality|1|||
160792480|NCT00500331|580628215|FG003|Overall Study|Liver function test abnormality|0|||
160792481|NCT00500331|580628216|FG004|Overall Study|Liver function test abnormality|0|||
160792482|NCT00500331|580628217|FG005|Overall Study|Liver function test abnormality|0|||
160792483|NCT00500331|580628218|FG006|Overall Study|Liver function test abnormality|0|||
160792484|NCT00500331|580628212|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
160792485|NCT00500331|580628213|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
160792486|NCT00500331|580628214|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
160792487|NCT00500331|580628215|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
160792488|NCT00500331|580628216|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
160792489|NCT00500331|580628217|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
160792490|NCT00500331|580628218|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
160792491|NCT00500331|580628212|FG000|Overall Study|Didn't return for continuation of study|1|||
160792492|NCT00500331|580628213|FG001|Overall Study|Didn't return for continuation of study|0|||
160792493|NCT00500331|580628214|FG002|Overall Study|Didn't return for continuation of study|0|||
160792494|NCT00500331|580628215|FG003|Overall Study|Didn't return for continuation of study|0|||
160792495|NCT00500331|580628216|FG004|Overall Study|Didn't return for continuation of study|0|||
160792496|NCT00500331|580628217|FG005|Overall Study|Didn't return for continuation of study|0|||
160792497|NCT00500331|580628218|FG006|Overall Study|Didn't return for continuation of study|0|||
160792498|NCT00500331|580628212|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
160792499|NCT00500331|580628213|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792500|NCT00500331|580628214|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792501|NCT00500331|580628215|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792502|NCT00500331|580628216|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792503|NCT00500331|580628217|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792504|NCT00500331|580628218|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
160792505|NCT00500331|580628212|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
160792506|NCT00500331|580628213|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
160792507|NCT00500331|580628214|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
160792508|NCT00500331|580628215|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
160792509|NCT00500331|580628216|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
160792510|NCT00500331|580628217|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
160792511|NCT00500331|580628218|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
160792512|NCT00500331|580628212|FG000|Overall Study|Participant was randomized by mistake|1|||
160792513|NCT00500331|580628213|FG001|Overall Study|Participant was randomized by mistake|0|||
160982260|NCT03619174|581323447|FG001|Overall Study|Discomfort during treatment|0|||
160982261|NCT01012973|581323450|FG000|Overall Study|Adverse Event|5|||
161128623|NCT01465659|581856936|FG001|Completed 1 Cycle of Treatment|Death|1|||
161128624|NCT01465659|581856937|FG002|Completed 1 Cycle of Treatment|Death|0|||
161128625|NCT01465659|581856938|FG003|Completed 1 Cycle of Treatment|Death|0|||
161128626|NCT01465659|581856935|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
161128627|NCT01465659|581856936|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
161128628|NCT01465659|581856937|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
161128629|NCT01465659|581856938|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
161128630|NCT01465659|581856935|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
160792514|NCT00500331|580628214|FG002|Overall Study|Participant was randomized by mistake|0|||
160792515|NCT00500331|580628215|FG003|Overall Study|Participant was randomized by mistake|0|||
160792516|NCT00500331|580628216|FG004|Overall Study|Participant was randomized by mistake|0|||
160792517|NCT00500331|580628217|FG005|Overall Study|Participant was randomized by mistake|0|||
160792518|NCT00500331|580628218|FG006|Overall Study|Participant was randomized by mistake|0|||
160982262|NCT01012973|581323451|FG001|Overall Study|Adverse Event|5|||
160982263|NCT01012973|581323450|FG000|Overall Study|Lack of Efficacy|0|||
161128631|NCT01465659|581856936|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
160792519|NCT00500331|580628212|FG000|Overall Study|Diabetologist nurse in the study|0|||
160792520|NCT00500331|580628213|FG001|Overall Study|Diabetologist nurse in the study|0|||
160792521|NCT00500331|580628214|FG002|Overall Study|Diabetologist nurse in the study|1|||
160792522|NCT00500331|580628215|FG003|Overall Study|Diabetologist nurse in the study|0|||
160792523|NCT00500331|580628216|FG004|Overall Study|Diabetologist nurse in the study|0|||
160792524|NCT00500331|580628217|FG005|Overall Study|Diabetologist nurse in the study|0|||
160792525|NCT00500331|580628218|FG006|Overall Study|Diabetologist nurse in the study|0|||
160792526|NCT00500331|580628212|FG000|Overall Study|State ban of biological samples export|0|||
160792527|NCT00500331|580628213|FG001|Overall Study|State ban of biological samples export|0|||
160792528|NCT00500331|580628214|FG002|Overall Study|State ban of biological samples export|0|||
160792529|NCT00500331|580628215|FG003|Overall Study|State ban of biological samples export|1|||
160792530|NCT00500331|580628216|FG004|Overall Study|State ban of biological samples export|0|||
160792531|NCT00500331|580628217|FG005|Overall Study|State ban of biological samples export|0|||
160792532|NCT00500331|580628218|FG006|Overall Study|State ban of biological samples export|0|||
160792533|NCT00500331|580628212|FG000|Overall Study|Protocol violated|0|||
160792534|NCT00500331|580628213|FG001|Overall Study|Protocol violated|0|||
160792535|NCT00500331|580628214|FG002|Overall Study|Protocol violated|0|||
160792536|NCT00500331|580628215|FG003|Overall Study|Protocol violated|1|||
160792537|NCT00500331|580628216|FG004|Overall Study|Protocol violated|0|||
160792538|NCT00500331|580628217|FG005|Overall Study|Protocol violated|0|||
160792539|NCT00500331|580628218|FG006|Overall Study|Protocol violated|0|||
160792540|NCT03345550|580628219|FG000|Overall Study|Withdrawal by Subject|1|||
160792541|NCT03345550|580628220|FG001|Overall Study|Withdrawal by Subject|0|||
160792542|NCT03345550|580628219|FG000|Overall Study|Lost to Follow-up|4|||
160792543|NCT03345550|580628220|FG001|Overall Study|Lost to Follow-up|5|||
160792544|NCT03033784|580628223|FG000|Overall Study|Anxiety related to MRI scanner|0|||
160792545|NCT03033784|580628224|FG001|Overall Study|Anxiety related to MRI scanner|1|||
160792546|NCT03033784|580628225|FG002|Overall Study|Anxiety related to MRI scanner|0|||
160792547|NCT03033784|580628226|FG003|Overall Study|Anxiety related to MRI scanner|0|||
160792548|NCT03033784|580628227|FG004|Overall Study|Anxiety related to MRI scanner|0|||
160792549|NCT03033784|580628228|FG005|Overall Study|Anxiety related to MRI scanner|0|||
160792550|NCT03033784|580628229|FG006|Overall Study|Anxiety related to MRI scanner|0|||
160792551|NCT03033784|580628230|FG007|Overall Study|Anxiety related to MRI scanner|0|||
160792552|NCT03033784|580628231|FG008|Overall Study|Anxiety related to MRI scanner|0|||
160792553|NCT03033784|580628232|FG009|Overall Study|Anxiety related to MRI scanner|0|||
160792554|NCT03033784|580628233|FG010|Overall Study|Anxiety related to MRI scanner|0|||
160792555|NCT03033784|580628234|FG011|Overall Study|Anxiety related to MRI scanner|0|||
160792556|NCT03033784|580628235|FG012|Overall Study|Anxiety related to MRI scanner|0|||
160792557|NCT03033784|580628223|FG000|Overall Study|Withdrawal by Subject|0|||
160792558|NCT03033784|580628224|FG001|Overall Study|Withdrawal by Subject|0|||
160792559|NCT03033784|580628225|FG002|Overall Study|Withdrawal by Subject|0|||
160792560|NCT03033784|580628226|FG003|Overall Study|Withdrawal by Subject|0|||
160792561|NCT03033784|580628227|FG004|Overall Study|Withdrawal by Subject|0|||
160792562|NCT03033784|580628228|FG005|Overall Study|Withdrawal by Subject|0|||
161235765|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
161235766|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235767|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235768|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160792563|NCT03033784|580628229|FG006|Overall Study|Withdrawal by Subject|0|||
160982264|NCT01012973|581323451|FG001|Overall Study|Lack of Efficacy|5|||
160982265|NCT01012973|581323450|FG000|Overall Study|Lost to Follow-up|1|||
160982266|NCT01012973|581323451|FG001|Overall Study|Lost to Follow-up|0|||
160982267|NCT01012973|581323450|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
160982268|NCT01012973|581323451|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
161330607|NCT00116688|582597170|FG001|Overall Study|Physician Decision|0|||
160792564|NCT03033784|580628230|FG007|Overall Study|Withdrawal by Subject|0|||
160792565|NCT03033784|580628231|FG008|Overall Study|Withdrawal by Subject|0|||
160792566|NCT03033784|580628232|FG009|Overall Study|Withdrawal by Subject|0|||
160792567|NCT03033784|580628233|FG010|Overall Study|Withdrawal by Subject|0|||
160792568|NCT03033784|580628234|FG011|Overall Study|Withdrawal by Subject|0|||
160792569|NCT03033784|580628235|FG012|Overall Study|Withdrawal by Subject|2|||
160792570|NCT03014089|580628237|FG000|Overall Study|Withdrawal by Subject|0|||
160792571|NCT03014089|580628238|FG001|Overall Study|Withdrawal by Subject|1|||
160792572|NCT03014089|580628239|FG002|Overall Study|Withdrawal by Subject|1|||
160792573|NCT03014089|580628240|FG003|Overall Study|Withdrawal by Subject|1|||
160792574|NCT03014089|580628237|FG000|Overall Study|Lost to Follow-up|1|||
160792575|NCT03014089|580628238|FG001|Overall Study|Lost to Follow-up|0|||
160792576|NCT03014089|580628239|FG002|Overall Study|Lost to Follow-up|0|||
160792577|NCT03014089|580628240|FG003|Overall Study|Lost to Follow-up|0|||
160792578|NCT03014089|580628237|FG000|Overall Study|Adverse Event|1|||
160792579|NCT03014089|580628238|FG001|Overall Study|Adverse Event|0|||
160792580|NCT03014089|580628239|FG002|Overall Study|Adverse Event|1|||
160982269|NCT01012973|581323450|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
160792581|NCT03014089|580628240|FG003|Overall Study|Adverse Event|0|||
160792582|NCT01149460|580628241|FG000|Overall Study|Withdrawal by Subject|0|||
160792583|NCT01149460|580628242|FG001|Overall Study|Withdrawal by Subject|2|||
160792584|NCT00734032|580628243|FG000|Overall Study|Adverse Event|0|||
160792585|NCT00734032|580628244|FG001|Overall Study|Adverse Event|1|||
160792586|NCT00734032|580628245|FG002|Overall Study|Adverse Event|0|||
160792587|NCT00734032|580628246|FG003|Overall Study|Adverse Event|0|||
160792588|NCT03468998|580628247|FG000|Overall Study|Withdrawal by Subject|1|||
160792589|NCT03468998|580628248|FG001|Overall Study|Withdrawal by Subject|1|||
160792590|NCT03468998|580628249|FG002|Overall Study|Withdrawal by Subject|0|||
160792591|NCT03468998|580628250|FG003|Overall Study|Withdrawal by Subject|4|||
160792592|NCT03468998|580628251|FG004|Overall Study|Withdrawal by Subject|1|||
160792593|NCT03468998|580628252|FG005|Overall Study|Withdrawal by Subject|0|||
160792594|NCT01892189|580628253|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
160792595|NCT01892189|580628254|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
160792596|NCT01892189|580628255|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
160792597|NCT01892189|580628256|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
160792598|NCT01892189|580628257|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
160792599|NCT01892189|580628258|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
160792600|NCT01892189|580628259|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
160792601|NCT01892189|580628260|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
160792602|NCT01892189|580628261|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
160792603|NCT01892189|580628253|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792604|NCT01892189|580628254|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792605|NCT01892189|580628255|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
160792606|NCT01892189|580628256|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160792607|NCT01892189|580628257|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792608|NCT01892189|580628258|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792609|NCT01892189|580628259|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160792610|NCT01892189|580628260|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160792611|NCT01892189|580628261|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160792612|NCT01892189|580628253|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792613|NCT01892189|580628254|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792614|NCT01892189|580628255|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792615|NCT01892189|580628256|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792616|NCT01892189|580628257|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792617|NCT01892189|580628258|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
160792618|NCT01892189|580628259|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792619|NCT01892189|580628260|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792620|NCT01892189|580628261|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
160792621|NCT02489279|580628264|FG000|Overall Study|Lost to Follow-up|12|||
160792622|NCT02489279|580628265|FG001|Overall Study|Lost to Follow-up|10|||
160792623|NCT03440411|580628266|FG000|Overall Study|Adverse Event|0|||
160792624|NCT03440411|580628267|FG001|Overall Study|Adverse Event|0|||
160792625|NCT03440411|580628268|FG002|Overall Study|Adverse Event|1|||
160792626|NCT03440411|580628269|FG003|Overall Study|Adverse Event|0|||
160792627|NCT03440411|580628266|FG000|Overall Study|PD|2|||
160792628|NCT03440411|580628267|FG001|Overall Study|PD|1|||
160792629|NCT03440411|580628268|FG002|Overall Study|PD|1|||
160792630|NCT03440411|580628269|FG003|Overall Study|PD|1|||
160792631|NCT03440411|580628266|FG000|Overall Study|Withdrawal by Subject|1|||
160792632|NCT03440411|580628267|FG001|Overall Study|Withdrawal by Subject|0|||
160792633|NCT03440411|580628268|FG002|Overall Study|Withdrawal by Subject|0|||
160792634|NCT03440411|580628269|FG003|Overall Study|Withdrawal by Subject|0|||
160792635|NCT03440411|580628266|FG000|Overall Study|Closed study by sponsor|0|||
160792636|NCT03440411|580628267|FG001|Overall Study|Closed study by sponsor|0|||
160792637|NCT03440411|580628268|FG002|Overall Study|Closed study by sponsor|0|||
160792638|NCT03440411|580628269|FG003|Overall Study|Closed study by sponsor|1|||
160792639|NCT02332928|580628270|FG000|Overall Study|Withdrawal by Subject|0|||
160792640|NCT02332928|580628271|FG001|Overall Study|Withdrawal by Subject|2|||
160792641|NCT02332928|580628270|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
160792642|NCT02332928|580628271|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
160792643|NCT00565747|580628272|FG000|Overall Study|No embryo transfer|67|||
160792644|NCT00565747|580628273|FG001|Overall Study|No embryo transfer|73|||
160792645|NCT01052779|580628274|FG000|Overall Study|Adverse Event|1|||
160792646|NCT01052779|580628275|FG001|Overall Study|Adverse Event|4|||
160792647|NCT01052779|580628274|FG000|Overall Study|Withdrawal by Subject|1|||
160792648|NCT01052779|580628275|FG001|Overall Study|Withdrawal by Subject|2|||
160792649|NCT01052779|580628274|FG000|Overall Study|Other-Protocol Violation|1|||
160792650|NCT01052779|580628275|FG001|Overall Study|Other-Protocol Violation|1|||
160792651|NCT01052779|580628274|FG000|Overall Study|Other-Surgery|0|||
160792652|NCT01052779|580628275|FG001|Overall Study|Other-Surgery|2|||
160792653|NCT01052779|580628274|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
160792654|NCT01052779|580628275|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
160792655|NCT03663582|580628276|FG000|Overall Study|Physician Decision|1|||
160792656|NCT05763381|580628279|FG000|Overall Study|Lost to Follow-up|2|||
160792657|NCT05763381|580628280|FG001|Overall Study|Lost to Follow-up|3|||
160792658|NCT05763381|580628279|FG000|Overall Study|Withdrawal by Subject|1|||
160792659|NCT05763381|580628280|FG001|Overall Study|Withdrawal by Subject|2|||
160792660|NCT02697448|580628285|FG000|Overall Study|Protocol Violation|2|||
160792661|NCT02697448|580628286|FG001|Overall Study|Protocol Violation|4|||
160792662|NCT02697448|580628285|FG000|Overall Study|Clinical concerns during ablation|1|||
160792663|NCT02697448|580628286|FG001|Overall Study|Clinical concerns during ablation|1|||
160792664|NCT02697448|580628285|FG000|Overall Study|No data collected|2|||
160792665|NCT02697448|580628286|FG001|Overall Study|No data collected|0|||
160792666|NCT05473715|580628287|FG000|Overall Study|Trial terminate|2|||
160792667|NCT05473715|580628288|FG001|Overall Study|Trial terminate|1|||
160892692|NCT00908011|581002253|FG000|Overall Study|Withdrawal by Subject|2|||
160892693|NCT00908011|581002254|FG001|Overall Study|Withdrawal by Subject|2|||
160892694|NCT00843726|581002255|FG000|Overall Study|Death|1|||
160892695|NCT00843726|581002256|FG001|Overall Study|Death|0|||
160892696|NCT00843726|581002255|FG000|Overall Study|Withdrawal by Subject|0|||
160892697|NCT00843726|581002256|FG001|Overall Study|Withdrawal by Subject|1|||
160892698|NCT00667602|581002257|FG000|Overall Study|Withdrawal by Subject|4|||
160892699|NCT00667602|581002258|FG001|Overall Study|Withdrawal by Subject|9|||
160892700|NCT00667602|581002259|FG002|Overall Study|Withdrawal by Subject|10|||
160892701|NCT00667602|581002257|FG000|Overall Study|Lost to Follow-up|4|||
160892702|NCT00667602|581002258|FG001|Overall Study|Lost to Follow-up|5|||
160892703|NCT00667602|581002259|FG002|Overall Study|Lost to Follow-up|6|||
160892704|NCT00667602|581002257|FG000|Overall Study|Administrative reason|0|||
160892705|NCT00667602|581002258|FG001|Overall Study|Administrative reason|0|||
160892706|NCT00667602|581002259|FG002|Overall Study|Administrative reason|2|||
160892707|NCT00667602|581002257|FG000|Overall Study|Protocol Violation|0|||
160892708|NCT00667602|581002258|FG001|Overall Study|Protocol Violation|1|||
160892709|NCT00667602|581002259|FG002|Overall Study|Protocol Violation|0|||
160892710|NCT03640559|581002260|FG000|Overall Study|Physician Decision|1|||
160892711|NCT03640559|581002261|FG001|Overall Study|Physician Decision|1|||
160892712|NCT03640559|581002260|FG000|Overall Study|Withdrawal by Subject|1|||
160892713|NCT03640559|581002261|FG001|Overall Study|Withdrawal by Subject|0|||
160892714|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
160892715|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
160892716|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
160892717|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
160892718|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
160892719|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
160892720|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
160892721|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
160892722|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
160892723|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
160892724|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
160892725|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
160892726|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
160892727|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160892728|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
160892729|NCT01436162|581002262|FG000|Single-blind Lead-in Phase|Other|107|||
160892730|NCT01436162|581002263|FG001|Single-blind Lead-in Phase|Other|0|||
160892731|NCT01436162|581002264|FG002|Single-blind Lead-in Phase|Other|0|||
160892732|NCT01436162|581002262|FG000|Randomized Phase|Adverse Event|1|||
160892733|NCT01436162|581002263|FG001|Randomized Phase|Adverse Event|5|||
160892734|NCT01436162|581002264|FG002|Randomized Phase|Adverse Event|6|||
160892735|NCT01436162|581002262|FG000|Randomized Phase|Protocol Violation|4|||
160892736|NCT01436162|581002263|FG001|Randomized Phase|Protocol Violation|4|||
160892737|NCT01436162|581002264|FG002|Randomized Phase|Protocol Violation|2|||
160892738|NCT01436162|581002262|FG000|Randomized Phase|Withdrawal by Subject|16|||
160892739|NCT01436162|581002263|FG001|Randomized Phase|Withdrawal by Subject|9|||
160892740|NCT01436162|581002264|FG002|Randomized Phase|Withdrawal by Subject|8|||
160892741|NCT01436162|581002262|FG000|Randomized Phase|Lost to Follow-up|17|||
160892742|NCT01436162|581002263|FG001|Randomized Phase|Lost to Follow-up|5|||
160892743|NCT01436162|581002264|FG002|Randomized Phase|Lost to Follow-up|4|||
160892744|NCT01436162|581002262|FG000|Randomized Phase|Lack of Efficacy|0|||
160892745|NCT01436162|581002263|FG001|Randomized Phase|Lack of Efficacy|1|||
160892746|NCT01436162|581002264|FG002|Randomized Phase|Lack of Efficacy|1|||
160792668|NCT02592863|580628290|FG000|Overall Study|Withdrawal by Subject|2|||
160892747|NCT01436162|581002262|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
161330608|NCT00116688|582597169|FG000|Overall Study|Lost to Follow-up|3|||
160792669|NCT02592863|580628291|FG001|Overall Study|Withdrawal by Subject|2|||
160792670|NCT02592863|580628290|FG000|Overall Study|Lost to Follow-up|1|||
160792671|NCT02592863|580628291|FG001|Overall Study|Lost to Follow-up|1|||
160892748|NCT01436162|581002263|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
160892749|NCT01436162|581002264|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
160892750|NCT01436162|581002262|FG000|Randomized Phase|Other|2|||
160792672|NCT02743221|580628292|FG000|Overall Study|Progressive disease|29|||
160792673|NCT02743221|580628293|FG001|Overall Study|Progressive disease|38|||
160792674|NCT02743221|580628292|FG000|Overall Study|Adverse Event|17|||
160792675|NCT02743221|580628293|FG001|Overall Study|Adverse Event|14|||
160792676|NCT02743221|580628292|FG000|Overall Study|non medical reason|8|||
160792677|NCT02743221|580628293|FG001|Overall Study|non medical reason|2|||
161128632|NCT01465659|581856937|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161128633|NCT01465659|581856938|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
161128634|NCT01465659|581856935|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
161128635|NCT01465659|581856936|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
161128636|NCT01465659|581856937|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
161128637|NCT01465659|581856938|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
161128638|NCT01465659|581856935|FG000|Completed Follow for 1 Year|Death|6|||
161128639|NCT01465659|581856936|FG001|Completed Follow for 1 Year|Death|3|||
161128640|NCT01465659|581856937|FG002|Completed Follow for 1 Year|Death|2|||
161128641|NCT01465659|581856938|FG003|Completed Follow for 1 Year|Death|4|||
161128642|NCT02411747|581856941|FG000|Overall Study|Withdrawal by Subject|1|||
161128643|NCT02411747|581856942|FG001|Overall Study|Withdrawal by Subject|0|||
161128644|NCT02411747|581856941|FG000|Overall Study|Protocol Violation|2|||
161128645|NCT02411747|581856942|FG001|Overall Study|Protocol Violation|4|||
161128646|NCT02149810|581856943|FG000|Overall Study|Physician Decision|1|||
161128647|NCT02149810|581856944|FG001|Overall Study|Physician Decision|2|||
161128648|NCT02149810|581856943|FG000|Overall Study|Lost to Follow-up|2|||
161128649|NCT02149810|581856944|FG001|Overall Study|Lost to Follow-up|1|||
161128650|NCT02149810|581856943|FG000|Overall Study|Withdrawal by Subject|5|||
161128651|NCT02149810|581856944|FG001|Overall Study|Withdrawal by Subject|1|||
161128652|NCT00428597|581856945|FG000|Overall Study|Randomized but not treated|3|||
160792678|NCT02743221|580628292|FG000|Overall Study|Physician Decision|2|||
161128653|NCT00428597|581856946|FG001|Overall Study|Randomized but not treated|3|||
161128654|NCT00428597|581856945|FG000|Overall Study|Objective Progression or Relapse|19|||
161128655|NCT00428597|581856946|FG001|Overall Study|Objective Progression or Relapse|47|||
161128656|NCT00428597|581856945|FG000|Overall Study|Study Terminated by Sponsor|41|||
161128657|NCT00428597|581856946|FG001|Overall Study|Study Terminated by Sponsor|16|||
161128658|NCT00428597|581856945|FG000|Overall Study|Adverse Event|15|||
161128659|NCT00428597|581856946|FG001|Overall Study|Adverse Event|7|||
161128660|NCT00428597|581856945|FG000|Overall Study|Global Deterioration of Health Status|1|||
161128661|NCT00428597|581856946|FG001|Overall Study|Global Deterioration of Health Status|5|||
161128662|NCT00428597|581856945|FG000|Overall Study|Protocol Violation|2|||
161128663|NCT00428597|581856946|FG001|Overall Study|Protocol Violation|1|||
161128664|NCT00428597|581856945|FG000|Overall Study|Withdrawal by Subject|2|||
161128665|NCT00428597|581856946|FG001|Overall Study|Withdrawal by Subject|1|||
161128666|NCT00428597|581856945|FG000|Overall Study|Other|1|||
161128667|NCT00428597|581856946|FG001|Overall Study|Other|1|||
161128668|NCT00428597|581856945|FG000|Overall Study|Lost to Follow-up|0|||
161128669|NCT00428597|581856946|FG001|Overall Study|Lost to Follow-up|1|||
161128670|NCT00428597|581856945|FG000|Overall Study|Pregnancy|1|||
160792679|NCT02743221|580628293|FG001|Overall Study|Physician Decision|5|||
160792680|NCT02743221|580628292|FG000|Overall Study|Patient not eligible, not treated|0|||
160792681|NCT02743221|580628293|FG001|Overall Study|Patient not eligible, not treated|1|||
160792682|NCT02609503|580628296|FG000|Overall Study|Adverse Event|1|||
160792683|NCT02609503|580628296|FG000|Overall Study|Death|1|||
160792684|NCT02609503|580628296|FG000|Overall Study|Withdrawal by Subject|1|||
160792685|NCT02609503|580628296|FG000|Overall Study|Disease progression|1|||
160792686|NCT04642079|580628297|FG000|Overall Study|Lost to Follow-up|2|||
160792687|NCT04642079|580628298|FG001|Overall Study|Lost to Follow-up|5|||
160792688|NCT04642079|580628299|FG002|Overall Study|Lost to Follow-up|2|||
160792689|NCT04642079|580628300|FG003|Overall Study|Lost to Follow-up|0|||
160792690|NCT04642079|580628297|FG000|Overall Study|Withdrawal by Subject|0|||
160792691|NCT04642079|580628298|FG001|Overall Study|Withdrawal by Subject|4|||
160792692|NCT04642079|580628299|FG002|Overall Study|Withdrawal by Subject|1|||
160792693|NCT04642079|580628300|FG003|Overall Study|Withdrawal by Subject|2|||
160792694|NCT04642079|580628297|FG000|Overall Study|Other|0|||
160792695|NCT04642079|580628298|FG001|Overall Study|Other|0|||
160792696|NCT04642079|580628299|FG002|Overall Study|Other|0|||
160792697|NCT04642079|580628300|FG003|Overall Study|Other|1|||
160792698|NCT04642079|580628297|FG000|Overall Study|No longer met eligibility criteria|1|||
160792699|NCT04642079|580628298|FG001|Overall Study|No longer met eligibility criteria|0|||
160792700|NCT04642079|580628299|FG002|Overall Study|No longer met eligibility criteria|1|||
160792701|NCT04642079|580628300|FG003|Overall Study|No longer met eligibility criteria|1|||
160792702|NCT02226653|580628301|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
160892751|NCT01436162|581002263|FG001|Randomized Phase|Other|5|||
161128671|NCT00428597|581856946|FG001|Overall Study|Pregnancy|0|||
161128672|NCT00428597|581856945|FG000|Overall Study|Death|1|||
161128673|NCT00428597|581856946|FG001|Overall Study|Death|3|||
161128674|NCT00675597|581856947|FG000|Overall Study|Withdrawal by Subject|3|||
161128675|NCT03828487|581856953|FG000|Overall Study|Physician Decision|1|||
161128676|NCT01356589|581856956|FG000|Overall Study|Enrolled, but not treated|3|||
160982270|NCT01012973|581323451|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
160982271|NCT01012973|581323450|FG000|Overall Study|Protocol Violation|5|||
160982272|NCT01012973|581323451|FG001|Overall Study|Protocol Violation|2|||
160982273|NCT01012973|581323450|FG000|Overall Study|Withdrawal by Subject|4|||
160982274|NCT01012973|581323451|FG001|Overall Study|Withdrawal by Subject|6|||
160982275|NCT02213055|581323452|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
160982276|NCT02213055|581323453|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
160982277|NCT02213055|581323452|FG000|Overall Study|Protocol was not Followed during Study|1|||
160982278|NCT02213055|581323453|FG001|Overall Study|Protocol was not Followed during Study|0|||
160982279|NCT02213055|581323452|FG000|Overall Study|Documentation Issue at Enrollment|1|||
160982280|NCT02213055|581323453|FG001|Overall Study|Documentation Issue at Enrollment|0|||
160982281|NCT02213055|581323452|FG000|Overall Study|Documentation Issue during Study|10|||
160982282|NCT02213055|581323453|FG001|Overall Study|Documentation Issue during Study|0|||
160982283|NCT02213055|581323452|FG000|Overall Study|Did not have Live Lice|8|||
160982284|NCT02213055|581323453|FG001|Overall Study|Did not have Live Lice|0|||
160982285|NCT02213055|581323452|FG000|Overall Study|Had another Treatment during the Study|3|||
160982286|NCT02213055|581323453|FG001|Overall Study|Had another Treatment during the Study|0|||
160982287|NCT02213055|581323452|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
160982288|NCT02213055|581323453|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
160982289|NCT02213055|581323452|FG000|Overall Study|Did not Return to School|5|||
160982290|NCT02213055|581323453|FG001|Overall Study|Did not Return to School|0|||
160982291|NCT05868954|581323460|FG000|Overall Study|Lost to Follow-up|0|||
160982292|NCT05868954|581323461|FG001|Overall Study|Lost to Follow-up|1|||
160982293|NCT05868954|581323460|FG000|Overall Study|Withdrawal by Subject|2|||
160982294|NCT05868954|581323461|FG001|Overall Study|Withdrawal by Subject|2|||
160982295|NCT05868954|581323460|FG000|Overall Study|Participant delivered|1|||
160982296|NCT05868954|581323461|FG001|Overall Study|Participant delivered|1|||
160982297|NCT05868954|581323460|FG000|Overall Study|Miscarriage|0|||
160982298|NCT05868954|581323461|FG001|Overall Study|Miscarriage|1|||
160982299|NCT01435798|581323464|FG000|Overall Study|Withdrawal by Subject|1|||
160982300|NCT03257995|581323465|FG000|Overall Study|Adverse Event|0|||
160982301|NCT03257995|581323466|FG001|Overall Study|Adverse Event|1|||
160982302|NCT03257995|581323467|FG002|Overall Study|Adverse Event|0|||
160982303|NCT03257995|581323468|FG003|Overall Study|Adverse Event|0|||
160982304|NCT03257995|581323469|FG004|Overall Study|Adverse Event|0|||
160982305|NCT03257995|581323470|FG005|Overall Study|Adverse Event|0|||
160982306|NCT03257995|581323465|FG000|Overall Study|Protocol deviation|0|||
161128677|NCT01356589|581856956|FG000|Overall Study|Dose data not recorded|2|||
161128678|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
161128679|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
161128680|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
161128681|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161128682|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
160792703|NCT02226653|580628302|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
160792704|NCT02226653|580628301|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
160792705|NCT02226653|580628302|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
160792706|NCT00759395|580628304|FG000|Overall Study|Adverse Event|1|||
160792707|NCT00759395|580628305|FG001|Overall Study|Adverse Event|0|||
160792708|NCT00759395|580628304|FG000|Overall Study|Withdrawal by Subject|1|||
160792709|NCT00759395|580628305|FG001|Overall Study|Withdrawal by Subject|0|||
160792710|NCT00759395|580628304|FG000|Overall Study|Lack of Efficacy|0|||
160792711|NCT00759395|580628305|FG001|Overall Study|Lack of Efficacy|2|||
160792712|NCT01848457|580628306|FG000|Overall Study|Death|1|||
160792713|NCT01848457|580628307|FG001|Overall Study|Death|0|||
160792714|NCT01848457|580628308|FG002|Overall Study|Death|0|||
160792715|NCT01848457|580628309|FG003|Overall Study|Death|0|||
160792716|NCT02181413|580628310|FG000|Overall Study|Withdrawal by Subject|45|||
161128683|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161128684|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161128685|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161128686|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
161128687|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
161128688|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
161235769|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160792717|NCT02181413|580628311|FG001|Overall Study|Withdrawal by Subject|61|||
160792718|NCT02181413|580628310|FG000|Overall Study|Reason Not Specified|2|||
160792719|NCT02181413|580628311|FG001|Overall Study|Reason Not Specified|5|||
160792720|NCT02181413|580628310|FG000|Overall Study|Lost to Follow-up|8|||
160982307|NCT03257995|581323466|FG001|Overall Study|Protocol deviation|0|||
160982308|NCT03257995|581323467|FG002|Overall Study|Protocol deviation|0|||
160982309|NCT03257995|581323468|FG003|Overall Study|Protocol deviation|0|||
160982310|NCT03257995|581323469|FG004|Overall Study|Protocol deviation|0|||
160982311|NCT03257995|581323470|FG005|Overall Study|Protocol deviation|2|||
160982312|NCT00903786|581323471|FG000|Overall Study|Physician Decision|6|||
160982313|NCT00903786|581323471|FG000|Overall Study|Lack of Efficacy|5|||
160982314|NCT00903786|581323471|FG000|Overall Study|Reason other than lack of efficacy|4|||
160982315|NCT04759885|581323472|FG000|Overall Study|Other|1|||
160982316|NCT04759885|581323473|FG001|Overall Study|Other|0|||
160982317|NCT04759885|581323474|FG002|Overall Study|Other|2|||
160982318|NCT04759885|581323475|FG003|Overall Study|Other|0|||
160982319|NCT04759885|581323476|FG004|Overall Study|Other|0|||
160982320|NCT04759885|581323472|FG000|Overall Study|Withdrawal by Subject|0|||
160982321|NCT04759885|581323473|FG001|Overall Study|Withdrawal by Subject|0|||
160982322|NCT04759885|581323474|FG002|Overall Study|Withdrawal by Subject|1|||
160982323|NCT04759885|581323475|FG003|Overall Study|Withdrawal by Subject|9|||
160982324|NCT04759885|581323476|FG004|Overall Study|Withdrawal by Subject|6|||
160982325|NCT04759885|581323472|FG000|Overall Study|Adverse Event|0|||
160982326|NCT04759885|581323473|FG001|Overall Study|Adverse Event|0|||
160982327|NCT04759885|581323474|FG002|Overall Study|Adverse Event|0|||
160982328|NCT04759885|581323475|FG003|Overall Study|Adverse Event|3|||
160982329|NCT04759885|581323476|FG004|Overall Study|Adverse Event|0|||
160982330|NCT04759885|581323472|FG000|Overall Study|Physician Decision|0|||
160982331|NCT04759885|581323473|FG001|Overall Study|Physician Decision|0|||
160982332|NCT04759885|581323474|FG002|Overall Study|Physician Decision|0|||
160982333|NCT04759885|581323475|FG003|Overall Study|Physician Decision|2|||
160982334|NCT04759885|581323476|FG004|Overall Study|Physician Decision|0|||
160982335|NCT02285595|581323477|FG000|Overall Study|Lost to Follow-up|14|||
160982336|NCT02285595|581323477|FG000|Overall Study|Withdrawal by Subject|1|||
160982337|NCT01960790|581323478|FG000|Overall Study|Survey forms could not be recovered|3|||
160982338|NCT01960790|581323478|FG000|Overall Study|Treat with Humira outside survey period|3|||
160982339|NCT01960790|581323478|FG000|Overall Study|Transferred to another hospital|4|||
160982340|NCT01960790|581323478|FG000|Overall Study|Unevaluable for safety|1|||
160792721|NCT02181413|580628311|FG001|Overall Study|Lost to Follow-up|7|||
160792722|NCT02298946|580628313|FG000|Overall Study|Did not receive treatment|2|||
160792723|NCT02298946|580628314|FG001|Overall Study|Did not receive treatment|0|||
160792724|NCT02298946|580628313|FG000|Overall Study|Unevaluable|2|||
160982341|NCT01267253|581323481|FG000|Overall Study|Ineligible - required test not done|1|||
160982342|NCT01267253|581323481|FG000|Overall Study|Inevaluable-never received study treatme|2|||
160982343|NCT00996580|581323482|FG000|Overall Study|Adverse Event|466|||
160982344|NCT00996580|581323482|FG000|Overall Study|Lost to Follow-up|480|||
160982345|NCT00996580|581323482|FG000|Overall Study|Noncompliance with the protocol|137|||
161128689|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161128690|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161128691|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
160792725|NCT02298946|580628314|FG001|Overall Study|Unevaluable|1|||
160792726|NCT03034044|580628315|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
160792727|NCT04042311|580628319|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
160792728|NCT04042311|580628319|FG000|Overall Study|Unable to tolerate|4|||
160792729|NCT04042311|580628319|FG000|Overall Study|Concurrent illness|2|||
160792730|NCT04042311|580628319|FG000|Overall Study|Adverse Event|2|||
160792731|NCT04042311|580628319|FG000|Overall Study|No longer meeting inclusion criteria|2|||
160792732|NCT04042311|580628319|FG000|Overall Study|No reason given|1|||
160792733|NCT04042311|580628319|FG000|Overall Study|Withdrawal by Subject|4|||
160792734|NCT03518060|580628320|FG000|Overall Study|Death|1|||
160792735|NCT03518060|580628320|FG000|Overall Study|Poor adherence|1|||
160792736|NCT03518060|580628320|FG000|Overall Study|Withdrawal of informed consent|2|||
160792737|NCT03518060|580628320|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
161128692|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161128693|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161128694|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
161128695|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
161128696|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
161128697|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161128698|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160792738|NCT03518060|580628320|FG000|Overall Study|Physician Decision|7|||
160792739|NCT03518060|580628320|FG000|Overall Study|Adverse drug reactions|23|||
160792740|NCT03518060|580628320|FG000|Overall Study|Withdrawal by Subject|25|||
160792741|NCT03518060|580628320|FG000|Overall Study|Lost to Follow-up|13|||
160792742|NCT00323622|580628321|FG000|Overall Study|Other|30|||
160982346|NCT00996580|581323482|FG000|Overall Study|Physician Decision|5|||
160982347|NCT00996580|581323482|FG000|Overall Study|Pregnancy|68|||
160982348|NCT00996580|581323482|FG000|Overall Study|Protocol Violation|16|||
160982349|NCT00996580|581323482|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
160982350|NCT00996580|581323482|FG000|Overall Study|Withdrawal by Subject|217|||
160982351|NCT00996580|581323482|FG000|Overall Study|Other|29|||
160982352|NCT00064025|581323483|FG000|Overall Study|Ineligible|4|||
160982353|NCT00064025|581323483|FG000|Overall Study|Inevaluable|3|||
160982354|NCT02468934|581323484|FG000|Overall Study|Withdrawal by Subject|4|||
160982355|NCT02468934|581323484|FG000|Overall Study|Screen Failure|3|||
160792743|NCT00323622|580628322|FG001|Overall Study|Other|91|||
160792744|NCT00323622|580628323|FG002|Overall Study|Other|4|||
160792745|NCT00323622|580628324|FG003|Overall Study|Other|12|||
160792746|NCT00323622|580628325|FG004|Overall Study|Other|32|||
160792747|NCT00323622|580628326|FG005|Overall Study|Other|74|||
160792748|NCT00323622|580628327|FG006|Overall Study|Other|5|||
160792749|NCT00323622|580628328|FG007|Overall Study|Other|13|||
160792750|NCT00323622|580628321|FG000|Overall Study|Death|1|||
160792751|NCT00323622|580628322|FG001|Overall Study|Death|1|||
160792752|NCT00323622|580628323|FG002|Overall Study|Death|0|||
160792753|NCT00323622|580628324|FG003|Overall Study|Death|0|||
160792754|NCT00323622|580628325|FG004|Overall Study|Death|7|||
160792755|NCT00323622|580628326|FG005|Overall Study|Death|0|||
160792756|NCT00323622|580628327|FG006|Overall Study|Death|0|||
160792757|NCT00323622|580628328|FG007|Overall Study|Death|2|||
160792758|NCT03709472|580628329|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
160792759|NCT03709472|580628330|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
160792760|NCT03709472|580628329|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
160792761|NCT03709472|580628330|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
160792762|NCT01385995|580628338|FG000|Period 1, 2 Months|Physician Decision|1|||
160792763|NCT01385995|580628339|FG001|Period 1, 2 Months|Physician Decision|0|||
160792764|NCT04976777|580629845|FG000|Overall Study|COVID-19 Infection|1|||
160792765|NCT04976777|580629846|FG001|Overall Study|COVID-19 Infection|0|||
160792766|NCT00462826|580629847|FG000|Overall Study|Ineligible - second primary|1|||
160792767|NCT00462826|580629847|FG000|Overall Study|Ineligible - wrong cell type|1|||
160792768|NCT00462826|580629847|FG000|Overall Study|Ineligible - wrong primary|2|||
160792769|NCT00462826|580629847|FG000|Overall Study|Never treated|1|||
160792770|NCT00267488|580629848|FG000|Overall Study|Sponsor Terminated Study|9|||
160792771|NCT00267488|580629848|FG000|Overall Study|Protocol Violation|1|||
160792772|NCT00267488|580629848|FG000|Overall Study|Other (Disease Progression)|1|||
160792773|NCT02093520|580629849|FG000|Overall Study|Not treated|6|||
160792774|NCT02093520|580629850|FG001|Overall Study|Not treated|22|||
160792775|NCT00856557|580629851|FG000|Overall Study|No patients with contextual flags|12|||
160792776|NCT00856557|580629852|FG001|Overall Study|No patients with contextual flags|16|||
160792777|NCT02684461|580629853|FG000|Overall Study|Adverse Event|1|||
160792778|NCT02684461|580629854|FG001|Overall Study|Adverse Event|0|||
160792779|NCT02684461|580629855|FG002|Overall Study|Adverse Event|0|||
160792780|NCT02684461|580629853|FG000|Overall Study|Lack of Efficacy|1|||
160792781|NCT02684461|580629854|FG001|Overall Study|Lack of Efficacy|2|||
160792782|NCT02684461|580629855|FG002|Overall Study|Lack of Efficacy|0|||
160792783|NCT03524157|580629865|FG000|Overall Study|cytology not readable|0|||
160792784|NCT03524157|580629866|FG001|Overall Study|cytology not readable|0|||
160792785|NCT03524157|580629867|FG002|Overall Study|cytology not readable|1|||
160792786|NCT04507763|580629868|FG000|Overall Study|Participants did not meet entrance criteria|201|||
160792787|NCT03322566|580629869|FG000|Overall Study|Death|34|||
160792788|NCT03322566|580629870|FG001|Overall Study|Death|35|||
160792789|NCT03322566|580629871|FG002|Overall Study|Death|23|||
160792790|NCT03322566|580629869|FG000|Overall Study|Physician Decision|6|||
160792791|NCT03322566|580629870|FG001|Overall Study|Physician Decision|7|||
160792792|NCT03322566|580629871|FG002|Overall Study|Physician Decision|2|||
160792793|NCT03322566|580629869|FG000|Overall Study|Withdrawal by Subject|4|||
160792794|NCT03322566|580629870|FG001|Overall Study|Withdrawal by Subject|3|||
160792795|NCT03322566|580629871|FG002|Overall Study|Withdrawal by Subject|6|||
160792796|NCT03322566|580629869|FG000|Overall Study|Lost to Follow-up|0|||
160792797|NCT03322566|580629870|FG001|Overall Study|Lost to Follow-up|0|||
160792798|NCT03322566|580629871|FG002|Overall Study|Lost to Follow-up|1|||
160792799|NCT03322566|580629869|FG000|Overall Study|Study terminated by sponsor|1|||
160792800|NCT03322566|580629870|FG001|Overall Study|Study terminated by sponsor|0|||
160792801|NCT03322566|580629871|FG002|Overall Study|Study terminated by sponsor|1|||
160892752|NCT01436162|581002264|FG002|Randomized Phase|Other|4|||
160892753|NCT02750943|581002269|FG000|Overall Study|Lost to Follow-up|1|||
161128699|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161128700|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161128701|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
160792802|NCT01602484|580629872|FG000|Overall Study|Airway issues unrelated to study|0|||
161330609|NCT00116688|582597170|FG001|Overall Study|Lost to Follow-up|0|||
160792803|NCT01602484|580629873|FG001|Overall Study|Airway issues unrelated to study|1|||
160792804|NCT00425555|580629876|FG000|Overall Study|Withdrawal by Subject|11|||
160792805|NCT00425555|580629877|FG001|Overall Study|Withdrawal by Subject|8|||
160792806|NCT00425555|580629876|FG000|Overall Study|Lost to Follow-up|0|||
160792807|NCT00425555|580629877|FG001|Overall Study|Lost to Follow-up|1|||
160792808|NCT00425555|580629876|FG000|Overall Study|Administrative problems|3|||
160792809|NCT00425555|580629877|FG001|Overall Study|Administrative problems|0|||
160792810|NCT00425555|580629876|FG000|Overall Study|Death|1|||
160792811|NCT00425555|580629877|FG001|Overall Study|Death|2|||
160792812|NCT00425555|580629876|FG000|Overall Study|New cancer therapy|2|||
160792813|NCT00425555|580629877|FG001|Overall Study|New cancer therapy|1|||
160792814|NCT00425555|580629876|FG000|Overall Study|Disease progression|36|||
160892754|NCT02750943|581002270|FG001|Overall Study|Lost to Follow-up|2|||
160792815|NCT00425555|580629877|FG001|Overall Study|Disease progression|33|||
160792816|NCT00425555|580629876|FG000|Overall Study|Adverse Event|25|||
160792817|NCT00425555|580629877|FG001|Overall Study|Adverse Event|15|||
160792818|NCT00425555|580629876|FG000|Overall Study|Protocol Violation|1|||
160792819|NCT00425555|580629877|FG001|Overall Study|Protocol Violation|0|||
160792820|NCT06582732|580629879|FG000|Initial Study Period|Adverse Event|0|||
160792821|NCT06582732|580629880|FG001|Initial Study Period|Adverse Event|0|||
160792822|NCT06582732|580629881|FG002|Initial Study Period|Adverse Event|0|||
160792823|NCT06582732|580629882|FG003|Initial Study Period|Adverse Event|2|||
160792824|NCT06582732|580629883|FG004|Initial Study Period|Adverse Event|0|||
160792825|NCT06582732|580629884|FG005|Initial Study Period|Adverse Event|0|||
160792826|NCT06582732|580629885|FG006|Initial Study Period|Adverse Event|0|||
160792827|NCT06582732|580629879|FG000|Initial Study Period|Death|1|||
160792828|NCT06582732|580629880|FG001|Initial Study Period|Death|0|||
160792829|NCT06582732|580629881|FG002|Initial Study Period|Death|0|||
160792830|NCT06582732|580629882|FG003|Initial Study Period|Death|0|||
160792831|NCT06582732|580629883|FG004|Initial Study Period|Death|1|||
160792832|NCT06582732|580629884|FG005|Initial Study Period|Death|0|||
160792833|NCT06582732|580629885|FG006|Initial Study Period|Death|0|||
160792834|NCT06582732|580629879|FG000|Initial Study Period|Lost to Follow-up|0|||
160792835|NCT06582732|580629880|FG001|Initial Study Period|Lost to Follow-up|0|||
160792836|NCT06582732|580629881|FG002|Initial Study Period|Lost to Follow-up|2|||
160792837|NCT06582732|580629882|FG003|Initial Study Period|Lost to Follow-up|0|||
160792838|NCT06582732|580629883|FG004|Initial Study Period|Lost to Follow-up|0|||
160792839|NCT06582732|580629884|FG005|Initial Study Period|Lost to Follow-up|0|||
160792840|NCT06582732|580629885|FG006|Initial Study Period|Lost to Follow-up|0|||
160792841|NCT06582732|580629879|FG000|Initial Study Period|Withdrawal by Subject|0|||
160792842|NCT06582732|580629880|FG001|Initial Study Period|Withdrawal by Subject|1|||
160792843|NCT06582732|580629881|FG002|Initial Study Period|Withdrawal by Subject|0|||
160792844|NCT06582732|580629882|FG003|Initial Study Period|Withdrawal by Subject|1|||
160792845|NCT06582732|580629883|FG004|Initial Study Period|Withdrawal by Subject|3|||
160792846|NCT06582732|580629884|FG005|Initial Study Period|Withdrawal by Subject|1|||
160792847|NCT06582732|580629885|FG006|Initial Study Period|Withdrawal by Subject|2|||
160792848|NCT06582732|580629879|FG000|Initial Study Period|Moved Away|0|||
160792849|NCT06582732|580629880|FG001|Initial Study Period|Moved Away|0|||
160792850|NCT06582732|580629881|FG002|Initial Study Period|Moved Away|0|||
160792851|NCT06582732|580629882|FG003|Initial Study Period|Moved Away|0|||
160792852|NCT06582732|580629883|FG004|Initial Study Period|Moved Away|1|||
160792853|NCT06582732|580629884|FG005|Initial Study Period|Moved Away|0|||
160792854|NCT06582732|580629885|FG006|Initial Study Period|Moved Away|0|||
160792855|NCT03931330|580629886|FG000|Overall Study|Physician Decision|1|||
160792856|NCT03412929|580629887|FG000|Overall Study|Protocol Violation|3|||
160792857|NCT01381679|580629888|FG000|Overall Study|Adverse Event|3|||
160792858|NCT01381679|580629888|FG000|Overall Study|Lost to Follow-up|885|||
160792859|NCT02919618|580629892|FG000|Overall Study|Death|1|||
160792860|NCT03528902|580629893|FG000|Overall Study|Adverse Event|1|||
160792861|NCT03528902|580629894|FG001|Overall Study|Adverse Event|0|||
160792862|NCT03411044|580629895|FG000|Overall Study|Death|30|||
160792863|NCT03411044|580629895|FG000|Overall Study|Withdrawal by Subject|48|||
160792864|NCT03411044|580629895|FG000|Overall Study|Lost to Follow-up|78|||
160792865|NCT03411044|580629895|FG000|Overall Study|Adverse Event|30|||
160792866|NCT03411044|580629895|FG000|Overall Study|Missing status|4|||
160792867|NCT01674062|580629903|FG000|Overall Study|Insufficient Therapeutic Response|56|||
160792868|NCT01674062|580629904|FG001|Overall Study|Insufficient Therapeutic Response|26|||
160792869|NCT01674062|580629903|FG000|Overall Study|Other|8|||
160792870|NCT01674062|580629904|FG001|Overall Study|Other|1|||
160792871|NCT01674062|580629903|FG000|Overall Study|Adverse Event|1|||
160792872|NCT01674062|580629904|FG001|Overall Study|Adverse Event|1|||
160792873|NCT01674062|580629903|FG000|Overall Study|Death|0|||
160892755|NCT02750943|581002269|FG000|Overall Study|Withdrawal by Subject|5|||
160892756|NCT02750943|581002270|FG001|Overall Study|Withdrawal by Subject|7|||
160892757|NCT04597918|581002271|FG000|Overall Study|Withdrawal by Subject|6|||
160792874|NCT01674062|580629904|FG001|Overall Study|Death|1|||
160792875|NCT01674062|580629903|FG000|Overall Study|Programming Error|1|||
160792876|NCT01674062|580629904|FG001|Overall Study|Programming Error|0|||
160792877|NCT04661839|580629905|FG000|Overall Study|Not Treated|0|||
160792878|NCT04661839|580629906|FG001|Overall Study|Not Treated|0|||
160792879|NCT04661839|580629907|FG002|Overall Study|Not Treated|1|||
160792880|NCT04661839|580629908|FG003|Overall Study|Not Treated|0|||
160792881|NCT04661839|580629905|FG000|Overall Study|Lost to Follow-up|1|||
160792882|NCT04661839|580629906|FG001|Overall Study|Lost to Follow-up|0|||
160792883|NCT04661839|580629907|FG002|Overall Study|Lost to Follow-up|0|||
160792884|NCT04661839|580629908|FG003|Overall Study|Lost to Follow-up|1|||
160792885|NCT03895372|580629909|FG000|Investigational Treatment Period|Adverse Event|1|||
160892758|NCT04597918|581002271|FG000|Overall Study|Lost to Follow-up|3|||
160792886|NCT03895372|580629910|FG001|Investigational Treatment Period|Adverse Event|0|||
160792887|NCT03895372|580629911|FG002|Investigational Treatment Period|Adverse Event|0|||
160792888|NCT03895372|580629912|FG003|Investigational Treatment Period|Adverse Event|0|||
160892759|NCT04597918|581002271|FG000|Overall Study|Death|1|||
160982356|NCT02036515|581323489|FG000|Overall Study|Adverse Event|1|||
160982357|NCT02036515|581323490|FG001|Overall Study|Adverse Event|1|||
160982358|NCT02036515|581323491|FG002|Overall Study|Adverse Event|2|||
160982359|NCT02036515|581323489|FG000|Overall Study|Lost to Follow-up|0|||
160792889|NCT03895372|580629913|FG004|Investigational Treatment Period|Adverse Event|0|||
160792890|NCT03895372|580629914|FG005|Investigational Treatment Period|Adverse Event|0|||
160792891|NCT03895372|580629915|FG006|Investigational Treatment Period|Adverse Event|4|||
160792892|NCT03895372|580629916|FG007|Investigational Treatment Period|Adverse Event|3|||
160792893|NCT03895372|580629909|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
160792894|NCT03895372|580629910|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
160792895|NCT03895372|580629911|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
160792896|NCT03895372|580629912|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
160792897|NCT03895372|580629913|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
160792898|NCT03895372|580629914|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
160792899|NCT03895372|580629915|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
160792900|NCT03895372|580629916|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
160792901|NCT03895372|580629909|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
160982360|NCT02036515|581323490|FG001|Overall Study|Lost to Follow-up|2|||
160982361|NCT02036515|581323491|FG002|Overall Study|Lost to Follow-up|0|||
160982362|NCT02036515|581323489|FG000|Overall Study|Non-compliance with study drug|0|||
160982363|NCT02036515|581323490|FG001|Overall Study|Non-compliance with study drug|0|||
160982364|NCT02036515|581323491|FG002|Overall Study|Non-compliance with study drug|2|||
160982365|NCT02036515|581323489|FG000|Overall Study|Screen failure|0|||
160982366|NCT02036515|581323490|FG001|Overall Study|Screen failure|2|||
160982367|NCT02036515|581323491|FG002|Overall Study|Screen failure|0|||
160982368|NCT02036515|581323489|FG000|Overall Study|Withdrawal by Subject|4|||
160982369|NCT02036515|581323490|FG001|Overall Study|Withdrawal by Subject|7|||
160982370|NCT02036515|581323491|FG002|Overall Study|Withdrawal by Subject|9|||
160982371|NCT02036515|581323489|FG000|Overall Study|Hyperglycemia|0|||
160792902|NCT03895372|580629910|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
160792903|NCT03895372|580629911|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
160792904|NCT03895372|580629912|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
160792905|NCT03895372|580629913|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
160792906|NCT03895372|580629914|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
160792907|NCT03895372|580629915|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
160792908|NCT03895372|580629916|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
160792909|NCT03895372|580629909|FG000|Investigational Treatment Period|Other|0|||
160792910|NCT03895372|580629910|FG001|Investigational Treatment Period|Other|0|||
160982372|NCT02036515|581323490|FG001|Overall Study|Hyperglycemia|0|||
160982373|NCT02036515|581323491|FG002|Overall Study|Hyperglycemia|1|||
160982374|NCT00547911|581323492|FG000|Overall Study|Adverse Event|0|||
160982375|NCT00547911|581323493|FG001|Overall Study|Adverse Event|0|||
160982376|NCT00547911|581323494|FG002|Overall Study|Adverse Event|0|||
160982377|NCT00547911|581323495|FG003|Overall Study|Adverse Event|1|||
161128702|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
161128703|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
161128704|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161128705|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161128706|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161128707|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161128708|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161128709|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161128710|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
161128711|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
161128712|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
161128713|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161128714|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161128715|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161128716|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161128717|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161128718|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
161128719|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
161128720|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161128721|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160792911|NCT03895372|580629911|FG002|Investigational Treatment Period|Other|0|||
160982378|NCT00547911|581323496|FG004|Overall Study|Adverse Event|0|||
160982379|NCT00547911|581323497|FG005|Overall Study|Adverse Event|0|||
160982380|NCT02133924|581323498|FG000|Overall Study|Death|38|||
160982381|NCT02133924|581323498|FG000|Overall Study|Physician Decision|1|||
160982382|NCT02133924|581323498|FG000|Overall Study|Withdrawal by Subject|3|||
160982383|NCT01644474|581323500|FG000|Overall Study|Poor compliance to protocol|1|||
160792912|NCT03895372|580629912|FG003|Investigational Treatment Period|Other|0|||
160792913|NCT03895372|580629913|FG004|Investigational Treatment Period|Other|0|||
160792914|NCT03895372|580629914|FG005|Investigational Treatment Period|Other|1|||
160792915|NCT03895372|580629915|FG006|Investigational Treatment Period|Other|0|||
160792916|NCT03895372|580629916|FG007|Investigational Treatment Period|Other|2|||
160792917|NCT03895372|580629909|FG000|Investigational Treatment Period|Protocol Violation|0|||
160792918|NCT03895372|580629910|FG001|Investigational Treatment Period|Protocol Violation|0|||
160792919|NCT03895372|580629911|FG002|Investigational Treatment Period|Protocol Violation|0|||
160792920|NCT03895372|580629912|FG003|Investigational Treatment Period|Protocol Violation|1|||
160792921|NCT03895372|580629913|FG004|Investigational Treatment Period|Protocol Violation|0|||
160982384|NCT01644474|581323501|FG001|Overall Study|Poor compliance to protocol|0|||
160982385|NCT01644474|581323500|FG000|Overall Study|Consent withdrawn by participant|0|||
160792922|NCT03895372|580629914|FG005|Investigational Treatment Period|Protocol Violation|0|||
160792923|NCT03895372|580629915|FG006|Investigational Treatment Period|Protocol Violation|0|||
160792924|NCT03895372|580629916|FG007|Investigational Treatment Period|Protocol Violation|0|||
160792925|NCT03895372|580629909|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
160792926|NCT03895372|580629910|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
160982386|NCT01644474|581323501|FG001|Overall Study|Consent withdrawn by participant|1|||
160982387|NCT01644474|581323500|FG000|Overall Study|Participant moved|0|||
160982388|NCT01644474|581323501|FG001|Overall Study|Participant moved|1|||
160982389|NCT01644474|581323500|FG000|Overall Study|Adverse Event|4|||
160982390|NCT01644474|581323501|FG001|Overall Study|Adverse Event|5|||
160982391|NCT01644474|581323500|FG000|Overall Study|Site scheduling error|1|||
160982392|NCT01644474|581323501|FG001|Overall Study|Site scheduling error|1|||
160982393|NCT01644474|581323500|FG000|Overall Study|Protocol Violation|1|||
160982394|NCT01644474|581323501|FG001|Overall Study|Protocol Violation|0|||
160982395|NCT01163747|581323503|FG000|Overall Study|Adverse Event|0|||
160982396|NCT01163747|581323504|FG001|Overall Study|Adverse Event|5|||
160982397|NCT01163747|581323503|FG000|Overall Study|Insufficient Therapeutic Response|0|||
160982398|NCT01163747|581323504|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160982399|NCT01163747|581323503|FG000|Overall Study|Protocol Violation|0|||
160982400|NCT01163747|581323504|FG001|Overall Study|Protocol Violation|1|||
160982401|NCT01163747|581323503|FG000|Overall Study|Refused Treatment|6|||
160982402|NCT01163747|581323504|FG001|Overall Study|Refused Treatment|4|||
160982403|NCT02924389|581323506|FG000|Overall Study|Lost to Follow-up|1|||
160982404|NCT02924389|581323507|FG001|Overall Study|Lost to Follow-up|0|||
160982405|NCT02924389|581323506|FG000|Overall Study|Physician Decision|2|||
160982406|NCT02924389|581323507|FG001|Overall Study|Physician Decision|0|||
160982407|NCT02924389|581323506|FG000|Overall Study|Withdrawal by Subject|3|||
160982408|NCT02924389|581323507|FG001|Overall Study|Withdrawal by Subject|0|||
160982409|NCT02924389|581323506|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
160982410|NCT02924389|581323507|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
160982411|NCT01268059|581324941|FG000|Overall Study|Lost to Follow-up|0|||
160982412|NCT01268059|581324942|FG001|Overall Study|Lost to Follow-up|1|||
160982413|NCT01268059|581324943|FG002|Overall Study|Lost to Follow-up|0|||
160982414|NCT01268059|581324944|FG003|Overall Study|Lost to Follow-up|0|||
160982415|NCT01268059|581324941|FG000|Overall Study|Withdrawal by Subject|7|||
160982416|NCT01268059|581324942|FG001|Overall Study|Withdrawal by Subject|4|||
160982417|NCT01268059|581324943|FG002|Overall Study|Withdrawal by Subject|0|||
160982418|NCT01268059|581324944|FG003|Overall Study|Withdrawal by Subject|0|||
160982419|NCT01268059|581324941|FG000|Overall Study|Death|20|||
160982420|NCT01268059|581324942|FG001|Overall Study|Death|30|||
160982421|NCT01268059|581324943|FG002|Overall Study|Death|3|||
160982422|NCT01268059|581324944|FG003|Overall Study|Death|5|||
160982423|NCT01268059|581324941|FG000|Overall Study|Progression of disease|1|||
160982424|NCT01268059|581324942|FG001|Overall Study|Progression of disease|0|||
160982425|NCT01268059|581324943|FG002|Overall Study|Progression of disease|0|||
160982426|NCT01268059|581324944|FG003|Overall Study|Progression of disease|0|||
160792927|NCT03895372|580629911|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
160792928|NCT03895372|580629912|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
160982427|NCT03660943|581324945|FG000|Overall Study|Adverse Event|5|||
160792929|NCT03895372|580629913|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
160982428|NCT03660943|581324946|FG001|Overall Study|Adverse Event|3|||
160982429|NCT03660943|581324945|FG000|Overall Study|Death|0|||
160982430|NCT03660943|581324946|FG001|Overall Study|Death|2|||
160982431|NCT03660943|581324945|FG000|Overall Study|Lost to Follow-up|7|||
160982432|NCT03660943|581324946|FG001|Overall Study|Lost to Follow-up|3|||
160982433|NCT03660943|581324945|FG000|Overall Study|Protocol Violation|3|||
160982434|NCT03660943|581324946|FG001|Overall Study|Protocol Violation|5|||
160982435|NCT03660943|581324945|FG000|Overall Study|Withdrawal by Subject|8|||
160982436|NCT03660943|581324946|FG001|Overall Study|Withdrawal by Subject|15|||
160982437|NCT03660943|581324945|FG000|Overall Study|Lack of Efficacy|9|||
160982438|NCT03660943|581324946|FG001|Overall Study|Lack of Efficacy|12|||
160982439|NCT03660943|581324945|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
160982440|NCT03660943|581324946|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
160982441|NCT03699124|581324947|FG000|Overall Study|Adverse Event|6|||
160982442|NCT03699124|581324948|FG001|Overall Study|Adverse Event|5|||
160982443|NCT03699124|581324949|FG002|Overall Study|Adverse Event|2|||
160982444|NCT03699124|581324947|FG000|Overall Study|Death|0|||
160982445|NCT03699124|581324948|FG001|Overall Study|Death|2|||
160982446|NCT03699124|581324949|FG002|Overall Study|Death|0|||
160982447|NCT03699124|581324947|FG000|Overall Study|Lost to Follow-up|20|||
160982448|NCT03699124|581324948|FG001|Overall Study|Lost to Follow-up|16|||
160982449|NCT03699124|581324949|FG002|Overall Study|Lost to Follow-up|15|||
160982450|NCT03699124|581324947|FG000|Overall Study|Protocol Violation|1|||
160982451|NCT03699124|581324948|FG001|Overall Study|Protocol Violation|0|||
160982452|NCT03699124|581324949|FG002|Overall Study|Protocol Violation|0|||
161128722|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161128723|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161128724|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
160792930|NCT03895372|580629914|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
160792931|NCT03895372|580629915|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
160792932|NCT03895372|580629916|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
160792933|NCT03895372|580629909|FG000|Extension Treatment Period|Adverse Event|0|||
160792934|NCT03895372|580629910|FG001|Extension Treatment Period|Adverse Event|1|||
160792935|NCT03895372|580629911|FG002|Extension Treatment Period|Adverse Event|0|||
160792936|NCT03895372|580629912|FG003|Extension Treatment Period|Adverse Event|1|||
160792937|NCT03895372|580629913|FG004|Extension Treatment Period|Adverse Event|0|||
160792938|NCT03895372|580629914|FG005|Extension Treatment Period|Adverse Event|0|||
160792939|NCT03895372|580629915|FG006|Extension Treatment Period|Adverse Event|3|||
160792940|NCT03895372|580629916|FG007|Extension Treatment Period|Adverse Event|3|||
160792941|NCT03895372|580629909|FG000|Extension Treatment Period|Other|1|||
160792942|NCT03895372|580629910|FG001|Extension Treatment Period|Other|3|||
160792943|NCT03895372|580629911|FG002|Extension Treatment Period|Other|0|||
160792944|NCT03895372|580629912|FG003|Extension Treatment Period|Other|0|||
160792945|NCT03895372|580629913|FG004|Extension Treatment Period|Other|1|||
160792946|NCT03895372|580629914|FG005|Extension Treatment Period|Other|0|||
160792947|NCT03895372|580629915|FG006|Extension Treatment Period|Other|0|||
160792948|NCT03895372|580629916|FG007|Extension Treatment Period|Other|2|||
160792949|NCT03895372|580629909|FG000|Extension Treatment Period|Pregnancy|0|||
160792950|NCT03895372|580629910|FG001|Extension Treatment Period|Pregnancy|0|||
160792951|NCT03895372|580629911|FG002|Extension Treatment Period|Pregnancy|0|||
160792952|NCT03895372|580629912|FG003|Extension Treatment Period|Pregnancy|0|||
160792953|NCT03895372|580629913|FG004|Extension Treatment Period|Pregnancy|1|||
160792954|NCT03895372|580629914|FG005|Extension Treatment Period|Pregnancy|0|||
160792955|NCT03895372|580629915|FG006|Extension Treatment Period|Pregnancy|0|||
160792956|NCT03895372|580629916|FG007|Extension Treatment Period|Pregnancy|0|||
160792957|NCT03895372|580629909|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
160792958|NCT03895372|580629910|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
160792959|NCT03895372|580629911|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
160792960|NCT03895372|580629912|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
160792961|NCT03895372|580629913|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
160792962|NCT03895372|580629914|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
160792963|NCT03895372|580629915|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
160792964|NCT03895372|580629916|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
160792965|NCT03685149|580629917|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
160792966|NCT03685149|580629918|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
160792967|NCT03685149|580629917|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160792968|NCT03685149|580629918|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160792969|NCT03685149|580629917|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
160792970|NCT03685149|580629918|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
160792971|NCT02034565|580629925|FG000|Overall Study|Adverse Event|1|||
160792972|NCT02034565|580629926|FG001|Overall Study|Adverse Event|0|||
160792973|NCT00581919|580629927|FG000|Overall Study|Adverse Event|8|||
161128725|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161128726|NCT01097629|581858350|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
160792974|NCT00581919|580629927|FG000|Overall Study|Death|1|||
160792975|NCT00581919|580629927|FG000|Overall Study|Disease Progression|10|||
160792976|NCT00581919|580629927|FG000|Overall Study|Physician Decision|1|||
160792977|NCT00581919|580629927|FG000|Overall Study|Other Complicating Disease|1|||
160892760|NCT05169567|581002274|FG000|Overall Study|On study treatment|116|||
160892761|NCT05169567|581002275|FG001|Overall Study|On study treatment|128|||
160892762|NCT05169567|581002274|FG000|Overall Study|Lost to Follow-up|1|||
160892763|NCT05169567|581002275|FG001|Overall Study|Lost to Follow-up|0|||
160892764|NCT05169567|581002274|FG000|Overall Study|Withdrawal by Subject|25|||
160892765|NCT05169567|581002275|FG001|Overall Study|Withdrawal by Subject|21|||
160892766|NCT04382755|581002276|FG000|Overall Study|Withdrawal by Subject|1|||
160892767|NCT04382755|581002277|FG001|Overall Study|Withdrawal by Subject|0|||
160892768|NCT04382755|581002276|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
160792978|NCT00581919|580629927|FG000|Overall Study|Started Non-Protocol Therapy|2|||
160792979|NCT00581919|580629927|FG000|Overall Study|Withdrawal by Subject|1|||
160792980|NCT03232567|580629930|FG000|Overall Study|Withdrawal by Subject|0|||
160792981|NCT03232567|580629931|FG001|Overall Study|Withdrawal by Subject|1|||
160792982|NCT03232567|580629932|FG002|Overall Study|Withdrawal by Subject|0|||
160792983|NCT03232567|580629933|FG003|Overall Study|Withdrawal by Subject|0|||
160792984|NCT02655601|580629934|FG000|Overall Study|Adverse Event|0|||
160792985|NCT02655601|580629935|FG001|Overall Study|Adverse Event|0|||
160792986|NCT02655601|580629936|FG002|Overall Study|Adverse Event|0|||
160792987|NCT02655601|580629937|FG003|Overall Study|Adverse Event|1|||
160792988|NCT02655601|580629938|FG004|Overall Study|Adverse Event|1|||
160792989|NCT02655601|580629939|FG005|Overall Study|Adverse Event|0|||
160792990|NCT02655601|580629934|FG000|Overall Study|Physician Decision|0|||
160792991|NCT02655601|580629935|FG001|Overall Study|Physician Decision|0|||
160792992|NCT02655601|580629936|FG002|Overall Study|Physician Decision|0|||
160792993|NCT02655601|580629937|FG003|Overall Study|Physician Decision|0|||
160792994|NCT02655601|580629938|FG004|Overall Study|Physician Decision|1|||
160792995|NCT02655601|580629939|FG005|Overall Study|Physician Decision|1|||
160792996|NCT02655601|580629934|FG000|Overall Study|Withdrawal by Subject|0|||
160792997|NCT02655601|580629935|FG001|Overall Study|Withdrawal by Subject|0|||
160792998|NCT02655601|580629936|FG002|Overall Study|Withdrawal by Subject|0|||
160792999|NCT02655601|580629937|FG003|Overall Study|Withdrawal by Subject|0|||
160793000|NCT02655601|580629938|FG004|Overall Study|Withdrawal by Subject|4|||
160793001|NCT02655601|580629939|FG005|Overall Study|Withdrawal by Subject|8|||
160793002|NCT02655601|580629934|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
160793003|NCT02655601|580629935|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793004|NCT02655601|580629936|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793005|NCT02655601|580629937|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793006|NCT02655601|580629938|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793007|NCT02655601|580629939|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
160793008|NCT05837481|580629940|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
160793009|NCT05837481|580629941|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
161235770|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
161235771|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
161235772|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
161235773|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160793010|NCT00427700|580629942|FG000|Overall Study|Lost to Follow-up|2|||
160793011|NCT00427700|580629943|FG001|Overall Study|Lost to Follow-up|5|||
160793012|NCT00427700|580629942|FG000|Overall Study|no induction of menses|1|||
160793013|NCT00427700|580629943|FG001|Overall Study|no induction of menses|4|||
160793014|NCT00427700|580629942|FG000|Overall Study|Pregnancy|0|||
160793015|NCT00427700|580629943|FG001|Overall Study|Pregnancy|2|||
160793016|NCT02014376|580629944|FG000|Overall Study|Adverse Event|1|||
160793017|NCT02014376|580629945|FG001|Overall Study|Adverse Event|1|||
160793018|NCT02014376|580629946|FG002|Overall Study|Adverse Event|0|||
160793019|NCT02014376|580629944|FG000|Overall Study|Lost to Follow-up|2|||
160793020|NCT02014376|580629945|FG001|Overall Study|Lost to Follow-up|0|||
160793021|NCT02014376|580629946|FG002|Overall Study|Lost to Follow-up|0|||
160793022|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
160793023|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
160793024|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
160793025|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
160793026|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
160793027|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
160793028|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
160793029|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
160793030|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
160793031|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
160793032|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
160793033|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
160793034|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
160793035|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
160793036|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
160793037|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
160793038|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
160793039|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
160793040|NCT00086515|580629950|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
160793041|NCT00086515|580629951|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
160793042|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
160793043|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
160793044|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
160982453|NCT03699124|581324947|FG000|Overall Study|Withdrawal by Subject|13|||
160982454|NCT03699124|581324948|FG001|Overall Study|Withdrawal by Subject|14|||
160982455|NCT03699124|581324949|FG002|Overall Study|Withdrawal by Subject|13|||
160982456|NCT03699124|581324947|FG000|Overall Study|Other reasons|5|||
160982457|NCT03699124|581324948|FG001|Overall Study|Other reasons|3|||
160982458|NCT03699124|581324949|FG002|Overall Study|Other reasons|10|||
160982459|NCT03595683|581324950|FG000|Overall Study|Adverse Event|1|||
160982460|NCT03595683|581324951|FG001|Overall Study|Adverse Event|0|||
160982461|NCT03595683|581324950|FG000|Overall Study|Pursue alternative therapy|1|||
160982462|NCT03595683|581324951|FG001|Overall Study|Pursue alternative therapy|1|||
160982463|NCT03595683|581324950|FG000|Overall Study|Progressive disease|1|||
160982464|NCT03595683|581324951|FG001|Overall Study|Progressive disease|3|||
160982465|NCT01021878|581324952|FG000|Overall Study|Lost to Follow-up|4|||
160982466|NCT01021878|581324953|FG001|Overall Study|Lost to Follow-up|3|||
160982467|NCT01021878|581324952|FG000|Overall Study|Death|0|||
160982468|NCT01021878|581324953|FG001|Overall Study|Death|1|||
160982469|NCT01021878|581324952|FG000|Overall Study|Adverse Event|6|||
160982470|NCT01021878|581324953|FG001|Overall Study|Adverse Event|5|||
160982471|NCT01021878|581324952|FG000|Overall Study|Transplantation|6|||
160982472|NCT01021878|581324953|FG001|Overall Study|Transplantation|1|||
160982473|NCT03158948|581324955|FG000|Overall Study|Death|1|||
160982474|NCT03158948|581324956|FG001|Overall Study|Death|1|||
160982475|NCT03158948|581324957|FG002|Overall Study|Death|3|||
160982476|NCT03158948|581324958|FG003|Overall Study|Death|2|||
160982477|NCT03158948|581324955|FG000|Overall Study|Physician Decision|0|||
160982478|NCT03158948|581324956|FG001|Overall Study|Physician Decision|0|||
160982479|NCT03158948|581324957|FG002|Overall Study|Physician Decision|0|||
160982480|NCT03158948|581324958|FG003|Overall Study|Physician Decision|1|||
160982481|NCT03415022|581324961|FG000|Overall Study|Withdrawal by Subject|1|||
160982482|NCT03415022|581324962|FG001|Overall Study|Withdrawal by Subject|2|||
160982483|NCT03415022|581324961|FG000|Overall Study|COVID-19 Suspension|2|||
160982484|NCT03415022|581324962|FG001|Overall Study|COVID-19 Suspension|3|||
160982485|NCT03415022|581324961|FG000|Overall Study|Lost to Follow-up|2|||
160982486|NCT03415022|581324962|FG001|Overall Study|Lost to Follow-up|0|||
160982487|NCT02086552|581324965|FG000|Overall Study|Withdrawal by Subject|1|||
160982488|NCT02206152|581324966|FG000|Pre-Randomization|Withdrawal by Subject|2|||
160982489|NCT00478608|581324967|FG000|Overall Study|Adverse Event|1|||
160982490|NCT00478608|581324967|FG000|Overall Study|Serious Adverse Event|14|||
160982491|NCT00478608|581324967|FG000|Overall Study|Withdrawal by Subject|2|||
160982492|NCT00478608|581324967|FG000|Overall Study|Protocol Violation|3|||
160982493|NCT03583541|581324968|FG000|Overall Study|Lost to Follow-up|31|||
160982494|NCT03583541|581324969|FG001|Overall Study|Lost to Follow-up|65|||
160982495|NCT01094171|581324971|FG000|Overall Study|Lost to Follow-up|2|||
160982496|NCT01094171|581324971|FG000|Overall Study|Informed consent withdrawal|4|||
160982497|NCT01094171|581324971|FG000|Overall Study|Migration from the study area|3|||
160982498|NCT01094171|581324971|FG000|Overall Study|Other|1|||
160982499|NCT00594932|581324972|FG000|First 3 Months|Withdrawal by Subject|1|||
160982500|NCT00594932|581324973|FG001|First 3 Months|Withdrawal by Subject|3|||
160982501|NCT00594932|581324972|FG000|Final 3 Months|Withdrawal by Subject|4|||
160982502|NCT00594932|581324973|FG001|Final 3 Months|Withdrawal by Subject|3|||
160982503|NCT02491892|581324978|FG000|Overall Study|Adverse Event|1|||
160982504|NCT02491892|581324979|FG001|Overall Study|Adverse Event|1|||
161128727|NCT01097629|581858351|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
161330610|NCT00116688|582597169|FG000|Overall Study|Death|15|||
161330611|NCT00116688|582597170|FG001|Overall Study|Death|0|||
161330612|NCT00116688|582597169|FG000|Overall Study|Protocol-specified criteria|3|||
161330613|NCT00116688|582597170|FG001|Overall Study|Protocol-specified criteria|0|||
161330614|NCT00116688|582597169|FG000|Overall Study|Pregnancy|1|||
161330615|NCT00116688|582597170|FG001|Overall Study|Pregnancy|0|||
161330616|NCT00116688|582597169|FG000|Overall Study|Other|11|||
161330617|NCT00116688|582597170|FG001|Overall Study|Other|0|||
161330618|NCT01775670|582597174|FG000|Overall Study|Lost to Follow-up|1|||
161330619|NCT01775670|582597175|FG001|Overall Study|Lost to Follow-up|1|||
161330620|NCT01298700|582597177|FG000|Overall Study|Adverse Event|50|||
161330621|NCT01298700|582597178|FG001|Overall Study|Adverse Event|51|||
160982505|NCT02491892|581324978|FG000|Overall Study|Death|1|||
160982506|NCT02491892|581324979|FG001|Overall Study|Death|1|||
160982507|NCT02491892|581324978|FG000|Overall Study|Lack of Efficacy|37|||
160982508|NCT02491892|581324979|FG001|Overall Study|Lack of Efficacy|36|||
160982509|NCT02491892|581324978|FG000|Overall Study|Refused Treatment|1|||
160982510|NCT02491892|581324979|FG001|Overall Study|Refused Treatment|0|||
160982511|NCT02491892|581324978|FG000|Overall Study|Lost to Follow-up|1|||
160982512|NCT02491892|581324979|FG001|Overall Study|Lost to Follow-up|0|||
160982513|NCT00681187|581324983|FG000|Overall Study|Withdrawal by Subject|1|||
160982514|NCT00681187|581324984|FG001|Overall Study|Withdrawal by Subject|0|||
160982515|NCT00681187|581324983|FG000|Overall Study|Death|0|||
161330622|NCT01298700|582597177|FG000|Overall Study|Lack of Efficacy|9|||
160982516|NCT00681187|581324984|FG001|Overall Study|Death|1|||
160982517|NCT00681187|581324983|FG000|Overall Study|Adverse Event|0|||
160982518|NCT00681187|581324984|FG001|Overall Study|Adverse Event|1|||
161330623|NCT01298700|582597178|FG001|Overall Study|Lack of Efficacy|14|||
160982519|NCT02448719|581324989|FG000|Overall Study|Withdrawal by Subject|0|||
160982520|NCT02448719|581324990|FG001|Overall Study|Withdrawal by Subject|0|||
160982521|NCT02448719|581324991|FG002|Overall Study|Withdrawal by Subject|0|||
160982522|NCT02448719|581324992|FG003|Overall Study|Withdrawal by Subject|0|||
160982523|NCT02448719|581324993|FG004|Overall Study|Withdrawal by Subject|1|||
160982524|NCT02448719|581324994|FG005|Overall Study|Withdrawal by Subject|0|||
160982525|NCT02448719|581324995|FG006|Overall Study|Withdrawal by Subject|0|||
160982526|NCT02448719|581324996|FG007|Overall Study|Withdrawal by Subject|0|||
160982527|NCT02448719|581324997|FG008|Overall Study|Withdrawal by Subject|0|||
160982528|NCT02448719|581324998|FG009|Overall Study|Withdrawal by Subject|0|||
160982529|NCT02448719|581324999|FG010|Overall Study|Withdrawal by Subject|0|||
160982530|NCT01406717|581325003|FG000|Overall Study|Subject non-compliance|4|||
160982531|NCT01406717|581325004|FG001|Overall Study|Subject non-compliance|3|||
160982532|NCT01406717|581325003|FG000|Overall Study|Protocol Violation|5|||
160982533|NCT01406717|581325004|FG001|Overall Study|Protocol Violation|1|||
160982534|NCT01406717|581325003|FG000|Overall Study|Lost to Follow-up|14|||
160982535|NCT01406717|581325004|FG001|Overall Study|Lost to Follow-up|8|||
160982536|NCT01406717|581325003|FG000|Overall Study|Withdrawal by Subject|19|||
160982537|NCT01406717|581325004|FG001|Overall Study|Withdrawal by Subject|15|||
160982538|NCT01406717|581325003|FG000|Overall Study|Adverse Event|1|||
160982539|NCT01406717|581325004|FG001|Overall Study|Adverse Event|2|||
160982540|NCT01406717|581325003|FG000|Overall Study|Lack of Efficacy|0|||
160982541|NCT01406717|581325004|FG001|Overall Study|Lack of Efficacy|1|||
160982542|NCT01406717|581325003|FG000|Overall Study|Non-completion of visit activity|0|||
160982543|NCT01406717|581325004|FG001|Overall Study|Non-completion of visit activity|1|||
160982544|NCT02275533|581325005|FG000|Overall Study|Protocol Violation|2|||
160982545|NCT02275533|581325006|FG001|Overall Study|Protocol Violation|0|||
160793045|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
160793046|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
160793047|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
160793048|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
160793049|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
160793050|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
160982546|NCT02275533|581325005|FG000|Overall Study|Never received study treatment|1|||
160982547|NCT02275533|581325006|FG001|Overall Study|Never received study treatment|0|||
160982548|NCT01570868|581325007|FG000|Overall Study|Adverse Event|8|||
160861886|NCT02531802|580887861|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
160982549|NCT01570868|581325008|FG001|Overall Study|Adverse Event|1|||
160982550|NCT01570868|581325007|FG000|Overall Study|FDA Recommendation|23|||
160982551|NCT01570868|581325008|FG001|Overall Study|FDA Recommendation|3|||
160982552|NCT01570868|581325007|FG000|Overall Study|Physician Decision|10|||
160982553|NCT01570868|581325008|FG001|Overall Study|Physician Decision|4|||
160982554|NCT01570868|581325007|FG000|Overall Study|Lost to Follow-up|1|||
160982555|NCT01570868|581325008|FG001|Overall Study|Lost to Follow-up|0|||
160861887|NCT02531802|580887862|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
160861888|NCT02531802|580887863|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
160861889|NCT02531802|580887864|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
160861890|NCT02531802|580887865|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
160861891|NCT00482053|580887866|FG000|Inter-treatment Period|Disease progression|1|||
160861892|NCT04842747|580887870|FG000|Overall Study|Withdrawal by Subject|6|||
160861893|NCT04842747|580887871|FG001|Overall Study|Withdrawal by Subject|2|||
160861894|NCT04842747|580887870|FG000|Overall Study|Lost to Follow-up|1|||
160861895|NCT04842747|580887871|FG001|Overall Study|Lost to Follow-up|2|||
160861896|NCT04842747|580887870|FG000|Overall Study|Physician Decision|1|||
160861897|NCT04842747|580887871|FG001|Overall Study|Physician Decision|0|||
160861898|NCT04842747|580887870|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
160861899|NCT04842747|580887871|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
160861900|NCT02559622|580887873|FG000|Overall Study|Progressive disease|0|||
160861901|NCT02559622|580887874|FG001|Overall Study|Progressive disease|1|||
160861902|NCT02559622|580887875|FG002|Overall Study|Progressive disease|0|||
160861903|NCT02559622|580887876|FG003|Overall Study|Progressive disease|0|||
160861904|NCT02559622|580887873|FG000|Overall Study|Adverse Event|0|||
160861905|NCT02559622|580887874|FG001|Overall Study|Adverse Event|2|||
160861906|NCT02559622|580887875|FG002|Overall Study|Adverse Event|2|||
160861907|NCT02559622|580887876|FG003|Overall Study|Adverse Event|2|||
160861908|NCT02559622|580887873|FG000|Overall Study|Patient/guardian decision|1|||
160861909|NCT02559622|580887874|FG001|Overall Study|Patient/guardian decision|2|||
160861910|NCT02559622|580887875|FG002|Overall Study|Patient/guardian decision|0|||
160861911|NCT02559622|580887876|FG003|Overall Study|Patient/guardian decision|1|||
160861912|NCT04011540|580887877|FG000|Overall Study|Lost to Follow-up|9|||
160861913|NCT04011540|580887878|FG001|Overall Study|Lost to Follow-up|6|||
160861914|NCT00449696|580887879|FG000|Overall Study|Other Treatment Required|6|||
160861915|NCT00449696|580887880|FG001|Overall Study|Other Treatment Required|1|||
160793051|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
160793052|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
160793053|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
160793054|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
160793055|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
160793056|NCT00086515|580629950|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
160793057|NCT00086515|580629951|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
160793058|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
160793059|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
160793060|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
160793061|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
160793062|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
160793063|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
160793064|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
160793065|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
160793066|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
160793067|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
160793068|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
160793069|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
160793070|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
160793071|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
160793072|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
160793073|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
160793074|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
160793075|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
160793076|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
160793077|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
160793078|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
160793079|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
160793080|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
160793081|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
160793082|NCT00086515|580629950|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
160793083|NCT00086515|580629951|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
160793084|NCT02251041|580629952|FG000|Overall Study|Did not receive intervention|15|||
160793085|NCT02251041|580629953|FG001|Overall Study|Did not receive intervention|4|||
160793086|NCT00050011|580629957|FG000|Overall Study|Adverse Event|41|||
160793087|NCT00050011|580629958|FG001|Overall Study|Adverse Event|46|||
160793088|NCT00050011|580629957|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160793089|NCT00050011|580629958|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160793090|NCT00050011|580629957|FG000|Overall Study|Abnormal test procedure results|0|||
160892769|NCT04382755|581002277|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
160892770|NCT04382755|581002276|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
160892771|NCT04382755|581002277|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
160892772|NCT04041700|581002284|FG000|Overall Study|Pregnancy|1|||
160892773|NCT04041700|581002284|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
160892774|NCT00458536|581002288|FG000|Overall Study|Disease progression prior to treatment|7|||
160892775|NCT00458536|581002288|FG000|Overall Study|Unable to make vaccine|3|||
160892776|NCT00458536|581002288|FG000|Overall Study|No measurable disease after surgery|2|||
160892777|NCT00458536|581002288|FG000|Overall Study|Did not have renal cell carcinoma|2|||
160892778|NCT00458536|581002288|FG000|Overall Study|Patient did not have surgery|1|||
160892779|NCT00458536|581002288|FG000|Overall Study|Ineligible due to toxicity|1|||
160892780|NCT00458536|581002288|FG000|Overall Study|Withdrawal by Subject|1|||
160892781|NCT00458536|581002288|FG000|Overall Study|Progressive disease during treatment|2|||
160892782|NCT00285207|581002289|FG000|Overall Study|Lost to Follow-up|3|||
160892783|NCT00285207|581002290|FG001|Overall Study|Lost to Follow-up|2|||
160892784|NCT00285207|581002289|FG000|Overall Study|Withdrawal by Subject|5|||
160892785|NCT00285207|581002290|FG001|Overall Study|Withdrawal by Subject|2|||
160892786|NCT00285207|581002289|FG000|Overall Study|Pregnancy|1|||
160892787|NCT00285207|581002290|FG001|Overall Study|Pregnancy|1|||
160892788|NCT00285207|581002289|FG000|Overall Study|non-compliance|0|||
160892789|NCT00285207|581002290|FG001|Overall Study|non-compliance|1|||
160892790|NCT05419908|581002291|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
161128728|NCT01097629|581858352|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
160793091|NCT00050011|580629958|FG001|Overall Study|Abnormal test procedure results|1|||
160793092|NCT00050011|580629957|FG000|Overall Study|Lack of Efficacy|16|||
160793093|NCT00050011|580629958|FG001|Overall Study|Lack of Efficacy|21|||
160793094|NCT00050011|580629957|FG000|Overall Study|Participant condition no longer required|1|||
160793095|NCT00050011|580629958|FG001|Overall Study|Participant condition no longer required|0|||
160793096|NCT00050011|580629957|FG000|Overall Study|Protocol Violation|4|||
160892791|NCT05419908|581002292|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
160892792|NCT05419908|581002291|FG000|Overall Study|Serious Adverse Event|0|||
160892793|NCT05419908|581002292|FG001|Overall Study|Serious Adverse Event|2|||
160892794|NCT05419908|581002291|FG000|Overall Study|Withdrawal by Subject|2|||
160892795|NCT05419908|581002292|FG001|Overall Study|Withdrawal by Subject|0|||
160892796|NCT05419908|581002291|FG000|Overall Study|Miscellaneous|1|||
160892797|NCT05419908|581002292|FG001|Overall Study|Miscellaneous|1|||
160892798|NCT03670836|581002293|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
160892799|NCT03670836|581002294|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
160892800|NCT03670836|581002293|FG000|Per Protocol Population (PP)|Physician Decision|9|||
160892801|NCT03670836|581002294|FG001|Per Protocol Population (PP)|Physician Decision|10|||
160892802|NCT03670836|581002293|FG000|Per Protocol Population (PP)|Physician Decision|4|||
160892803|NCT03670836|581002294|FG001|Per Protocol Population (PP)|Physician Decision|6|||
160892804|NCT03670836|581002293|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
160892805|NCT03670836|581002294|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
160892806|NCT00215683|581003726|FG000|Overall Study|Adverse Event|15|||
160892807|NCT00215683|581003727|FG001|Overall Study|Adverse Event|16|||
160892808|NCT00215683|581003728|FG002|Overall Study|Adverse Event|15|||
160892809|NCT00215683|581003726|FG000|Overall Study|Lack of Efficacy|5|||
160892810|NCT00215683|581003727|FG001|Overall Study|Lack of Efficacy|1|||
160892811|NCT00215683|581003728|FG002|Overall Study|Lack of Efficacy|2|||
160892812|NCT00215683|581003726|FG000|Overall Study|Lost to Follow-up|0|||
160892813|NCT00215683|581003727|FG001|Overall Study|Lost to Follow-up|2|||
160892814|NCT00215683|581003728|FG002|Overall Study|Lost to Follow-up|1|||
160892815|NCT00215683|581003726|FG000|Overall Study|Withdrawal by Subject|9|||
160892816|NCT00215683|581003727|FG001|Overall Study|Withdrawal by Subject|4|||
160892817|NCT00215683|581003728|FG002|Overall Study|Withdrawal by Subject|13|||
160892818|NCT00215683|581003726|FG000|Overall Study|Physician Decision|0|||
160892819|NCT00215683|581003727|FG001|Overall Study|Physician Decision|0|||
160892820|NCT00215683|581003728|FG002|Overall Study|Physician Decision|1|||
160892821|NCT00215683|581003726|FG000|Overall Study|Difficult to attend visits|0|||
160892822|NCT00215683|581003727|FG001|Overall Study|Difficult to attend visits|1|||
160892823|NCT00215683|581003728|FG002|Overall Study|Difficult to attend visits|0|||
160892824|NCT00215683|581003726|FG000|Overall Study|No study drug available|0|||
160892825|NCT00215683|581003727|FG001|Overall Study|No study drug available|1|||
160892826|NCT00215683|581003728|FG002|Overall Study|No study drug available|0|||
160892827|NCT00215683|581003726|FG000|Overall Study|Intermittent therapy required|0|||
160892828|NCT00215683|581003727|FG001|Overall Study|Intermittent therapy required|1|||
160892829|NCT00215683|581003728|FG002|Overall Study|Intermittent therapy required|0|||
160892830|NCT02171065|581003729|FG000|Overall Study|Withdrawal by Subject|1|||
160892831|NCT02171065|581003730|FG001|Overall Study|Withdrawal by Subject|0|||
160892832|NCT02171065|581003731|FG002|Overall Study|Withdrawal by Subject|0|||
160892833|NCT02171065|581003729|FG000|Overall Study|Lost to Follow-up|0|||
160892834|NCT02171065|581003730|FG001|Overall Study|Lost to Follow-up|0|||
160892835|NCT02171065|581003731|FG002|Overall Study|Lost to Follow-up|1|||
160892836|NCT00084838|581003733|FG000|Overall Study|Death|1|||
160892837|NCT00084838|581003733|FG000|Overall Study|Adverse Event|2|||
160892838|NCT00084838|581003733|FG000|Overall Study|Withdrawal by Subject|1|||
160892839|NCT00084838|581003733|FG000|Overall Study|Progressive Disease|4|||
160892840|NCT00084838|581003733|FG000|Overall Study|Pt Non-Compliance|1|||
160892841|NCT00084838|581003733|FG000|Overall Study|Ineligible|4|||
160892842|NCT00518687|581003734|FG000|Overall Study|Adverse Event|201|||
160892843|NCT00518687|581003735|FG001|Overall Study|Adverse Event|177|||
160892844|NCT00518687|581003734|FG000|Overall Study|Lost to Follow-up|144|||
160892845|NCT00518687|581003735|FG001|Overall Study|Lost to Follow-up|155|||
160892846|NCT00518687|581003734|FG000|Overall Study|Physician Decision|42|||
160892847|NCT00518687|581003735|FG001|Overall Study|Physician Decision|48|||
160892848|NCT00518687|581003734|FG000|Overall Study|Progressive disease|2|||
160892849|NCT00518687|581003735|FG001|Overall Study|Progressive disease|2|||
160892850|NCT00518687|581003734|FG000|Overall Study|Protocol Violation|8|||
161128729|NCT01097629|581858353|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161128730|NCT01097629|581858354|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161128731|NCT01097629|581858355|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160892851|NCT00518687|581003735|FG001|Overall Study|Protocol Violation|10|||
160892852|NCT00518687|581003734|FG000|Overall Study|Study terminated by sponsor|930|||
160892853|NCT00518687|581003735|FG001|Overall Study|Study terminated by sponsor|918|||
160892854|NCT00518687|581003734|FG000|Overall Study|Withdrawal by Subject|110|||
160892855|NCT00518687|581003735|FG001|Overall Study|Withdrawal by Subject|110|||
161128732|NCT01097629|581858356|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
160892856|NCT00851630|581003736|FG000|Overall Study|Death|2|||
160892857|NCT00851630|581003737|FG001|Overall Study|Death|1|||
160892858|NCT00851630|581003736|FG000|Overall Study|Clinical failure|0|||
160892859|NCT00851630|581003737|FG001|Overall Study|Clinical failure|1|||
160892860|NCT01442038|581003740|FG000|Overall Study|Death|35|||
160892861|NCT01442038|581003741|FG001|Overall Study|Death|29|||
160892862|NCT01442038|581003740|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
161330624|NCT01298700|582597177|FG000|Overall Study|Lost to Follow-up|5|||
160892863|NCT01442038|581003741|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
160892864|NCT01442038|581003740|FG000|Overall Study|Participant Withdrew Consent|137|||
160892865|NCT01442038|581003741|FG001|Overall Study|Participant Withdrew Consent|102|||
160892866|NCT01442038|581003740|FG000|Overall Study|Lost to Follow-up|37|||
160892867|NCT01442038|581003741|FG001|Overall Study|Lost to Follow-up|51|||
160892868|NCT01442038|581003740|FG000|Overall Study|Adverse Event|26|||
160892869|NCT01442038|581003741|FG001|Overall Study|Adverse Event|15|||
160892870|NCT01442038|581003740|FG000|Overall Study|Protocol Deviation|9|||
160892871|NCT01442038|581003741|FG001|Overall Study|Protocol Deviation|20|||
160892872|NCT01442038|581003740|FG000|Overall Study|Investigator's Discretion|13|||
160892873|NCT01442038|581003741|FG001|Overall Study|Investigator's Discretion|16|||
160892874|NCT01442038|581003740|FG000|Overall Study|Study Terminated By Sponsor|2|||
160892875|NCT01442038|581003741|FG001|Overall Study|Study Terminated By Sponsor|3|||
160892876|NCT00089284|581003742|FG000|Overall Study|Adverse event before starting treatment|0|||
160892877|NCT00089284|581003743|FG001|Overall Study|Adverse event before starting treatment|0|||
160892878|NCT00089284|581003744|FG002|Overall Study|Adverse event before starting treatment|0|||
160892879|NCT00089284|581003745|FG003|Overall Study|Adverse event before starting treatment|0|||
160892880|NCT00089284|581003746|FG004|Overall Study|Adverse event before starting treatment|0|||
160892881|NCT00089284|581003747|FG005|Overall Study|Adverse event before starting treatment|0|||
160892882|NCT00089284|581003748|FG006|Overall Study|Adverse event before starting treatment|1|||
160892883|NCT03956056|581003749|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
160892884|NCT03956056|581003749|FG000|Overall Study|Lack of Efficacy|1|||
160892885|NCT00595465|581003750|FG000|Overall Study|Adverse Event|4|||
160892886|NCT00595465|581003751|FG001|Overall Study|Adverse Event|3|||
160892887|NCT00595465|581003752|FG002|Overall Study|Adverse Event|3|||
160892888|NCT00595465|581003750|FG000|Overall Study|Pregnancy|0|||
160892889|NCT00595465|581003751|FG001|Overall Study|Pregnancy|0|||
160892890|NCT00595465|581003752|FG002|Overall Study|Pregnancy|1|||
160892891|NCT00595465|581003750|FG000|Overall Study|Protocol Violation|2|||
160892892|NCT00595465|581003751|FG001|Overall Study|Protocol Violation|1|||
160892893|NCT00595465|581003752|FG002|Overall Study|Protocol Violation|0|||
160892894|NCT00595465|581003750|FG000|Overall Study|Lost to Follow-up|0|||
160892895|NCT00595465|581003751|FG001|Overall Study|Lost to Follow-up|0|||
160892896|NCT00595465|581003752|FG002|Overall Study|Lost to Follow-up|2|||
160892897|NCT00595465|581003750|FG000|Overall Study|administrative reason|0|||
160892898|NCT00595465|581003751|FG001|Overall Study|administrative reason|0|||
160892899|NCT00595465|581003752|FG002|Overall Study|administrative reason|1|||
160892900|NCT00107783|581003753|FG000|Overall Study|Adverse Event|0|||
160892901|NCT00107783|581003754|FG001|Overall Study|Adverse Event|2|||
160892902|NCT00107783|581003753|FG000|Overall Study|Death|0|||
160892903|NCT00107783|581003754|FG001|Overall Study|Death|1|||
160892904|NCT00107783|581003753|FG000|Overall Study|Withdrawal by Subject|2|||
160892905|NCT00107783|581003754|FG001|Overall Study|Withdrawal by Subject|0|||
160892906|NCT00107783|581003753|FG000|Overall Study|Second hip replacement|1|||
160892907|NCT00107783|581003754|FG001|Overall Study|Second hip replacement|1|||
160892908|NCT01298531|581003755|FG000|Overall Study|Lack of Efficacy|0|||
160892909|NCT01298531|581003756|FG001|Overall Study|Lack of Efficacy|1|||
161128733|NCT01097629|581858357|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161128734|NCT01097629|581858350|FG000|DB RO Phase|Withdrawal by Subject|0|||
161128735|NCT01097629|581858351|FG001|DB RO Phase|Withdrawal by Subject|0|||
161128736|NCT01097629|581858352|FG002|DB RO Phase|Withdrawal by Subject|0|||
161128737|NCT01097629|581858353|FG003|DB RO Phase|Withdrawal by Subject|0|||
161128738|NCT01097629|581858354|FG004|DB RO Phase|Withdrawal by Subject|0|||
161128739|NCT01097629|581858355|FG005|DB RO Phase|Withdrawal by Subject|0|||
161128740|NCT01097629|581858356|FG006|DB RO Phase|Withdrawal by Subject|0|||
161330625|NCT01298700|582597178|FG001|Overall Study|Lost to Follow-up|2|||
160892910|NCT01298531|581003755|FG000|Overall Study|Lost to Follow-up|2|||
160892911|NCT01298531|581003756|FG001|Overall Study|Lost to Follow-up|0|||
160892912|NCT01298531|581003755|FG000|Overall Study|Protocol Violation|1|||
160892913|NCT01298531|581003756|FG001|Overall Study|Protocol Violation|1|||
160892914|NCT01298531|581003755|FG000|Overall Study|Adverse Event|4|||
160892915|NCT01298531|581003756|FG001|Overall Study|Adverse Event|3|||
161128741|NCT01097629|581858357|FG007|DB RO Phase|Withdrawal by Subject|1|||
161128742|NCT01097629|581858350|FG000|DB RO Phase|Protocol Violation|0|||
161128743|NCT01097629|581858351|FG001|DB RO Phase|Protocol Violation|0|||
161330626|NCT01298700|582597177|FG000|Overall Study|Withdrawal by Subject|12|||
161330627|NCT01298700|582597178|FG001|Overall Study|Withdrawal by Subject|9|||
160892916|NCT01298531|581003755|FG000|Overall Study|Does not meet entrance criteria|0|||
160892917|NCT01298531|581003756|FG001|Overall Study|Does not meet entrance criteria|1|||
160892918|NCT01298531|581003755|FG000|Overall Study|Other|2|||
160892919|NCT01298531|581003756|FG001|Overall Study|Other|1|||
160892920|NCT00422097|581003757|FG000|Dose Level 2|Still on treatment|0|||
160892921|NCT00422097|581003758|FG001|Dose Level 2|Still on treatment|1|||
160892922|NCT00422097|581003759|FG002|Dose Level 2|Still on treatment|0|||
160892923|NCT00422097|581003760|FG003|Dose Level 2|Still on treatment|0|||
160892924|NCT00422097|581003761|FG004|Dose Level 2|Still on treatment|0|||
161128744|NCT01097629|581858352|FG002|DB RO Phase|Protocol Violation|0|||
160793097|NCT00050011|580629958|FG001|Overall Study|Protocol Violation|10|||
160793098|NCT00050011|580629957|FG000|Overall Study|Withdrawal by Subject|34|||
160793099|NCT00050011|580629958|FG001|Overall Study|Withdrawal by Subject|26|||
160793100|NCT00050011|580629957|FG000|Overall Study|Lost to Follow-up|7|||
160793101|NCT00050011|580629958|FG001|Overall Study|Lost to Follow-up|9|||
160793102|NCT00050011|580629957|FG000|Overall Study|Administrative problems|10|||
160793103|NCT00050011|580629958|FG001|Overall Study|Administrative problems|6|||
160793104|NCT00050011|580629957|FG000|Overall Study|Death|7|||
160793105|NCT00050011|580629958|FG001|Overall Study|Death|4|||
160793106|NCT00050011|580629957|FG000|Overall Study|Unknown - Reason is missing|0|||
160793107|NCT00050011|580629958|FG001|Overall Study|Unknown - Reason is missing|2|||
160793108|NCT03312543|580629959|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
160793109|NCT03312543|580629960|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
160793110|NCT03312543|580629959|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
160793111|NCT03312543|580629960|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
160793112|NCT03312543|580629959|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
160793113|NCT03312543|580629960|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
160982556|NCT01570868|581325007|FG000|Overall Study|Withdrawal by Subject|1|||
160982557|NCT01570868|581325008|FG001|Overall Study|Withdrawal by Subject|0|||
160982558|NCT01556763|581325012|FG000|Overall Study|Withdrawal by Subject|0|||
161128745|NCT01097629|581858353|FG003|DB RO Phase|Protocol Violation|1|||
161128746|NCT01097629|581858354|FG004|DB RO Phase|Protocol Violation|0|||
161128747|NCT01097629|581858355|FG005|DB RO Phase|Protocol Violation|1|||
161128748|NCT01097629|581858356|FG006|DB RO Phase|Protocol Violation|1|||
161128749|NCT01097629|581858357|FG007|DB RO Phase|Protocol Violation|0|||
161128750|NCT01097629|581858350|FG000|DB RO Phase|Lost to Follow-up|0|||
161128751|NCT01097629|581858351|FG001|DB RO Phase|Lost to Follow-up|0|||
161128752|NCT01097629|581858352|FG002|DB RO Phase|Lost to Follow-up|0|||
161128753|NCT01097629|581858353|FG003|DB RO Phase|Lost to Follow-up|0|||
161128754|NCT01097629|581858354|FG004|DB RO Phase|Lost to Follow-up|0|||
161128755|NCT01097629|581858355|FG005|DB RO Phase|Lost to Follow-up|0|||
161128756|NCT01097629|581858356|FG006|DB RO Phase|Lost to Follow-up|2|||
161128757|NCT01097629|581858357|FG007|DB RO Phase|Lost to Follow-up|0|||
161128758|NCT00956943|581858358|FG000|Overall Study|Lost to Follow-up|9|||
161128759|NCT00956943|581858359|FG001|Overall Study|Lost to Follow-up|10|||
161128760|NCT02613208|581858360|FG000|Overall Study|Withdrawal by Subject|1|||
161128761|NCT02613208|581858360|FG000|Overall Study|Change of address|2|||
161128762|NCT02613208|581858360|FG000|Overall Study|Physician Decision|2|||
161128763|NCT02613208|581858360|FG000|Overall Study|Lost to Follow-up|5|||
161128764|NCT02613208|581858360|FG000|Overall Study|Death|37|||
161128765|NCT02663895|581858361|FG000|Overall Study|Adverse Event|3|||
161128766|NCT02663895|581858361|FG000|Overall Study|Physician Decision|2|||
161128767|NCT02663895|581858361|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
161128768|NCT02663895|581858361|FG000|Overall Study|Withdrawal by Subject|1|||
161128769|NCT00809328|581858362|FG000|Overall Study|Lack of Efficacy|18|||
161128770|NCT00809328|581858362|FG000|Overall Study|Adverse Event|6|||
161128771|NCT00809328|581858362|FG000|Overall Study|Protocol Violation|3|||
161128772|NCT00809328|581858362|FG000|Overall Study|Withdrawal by Subject|2|||
161128773|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128774|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161128775|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128776|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128777|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128778|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
161128779|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161128780|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161128781|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
161128782|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
161128783|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161128784|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161128785|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161128786|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161128787|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161128788|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161128789|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161128790|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
161330628|NCT01298700|582597177|FG000|Overall Study|Protocol Violation|6|||
160793114|NCT03312543|580629959|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
160793115|NCT03312543|580629960|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
160793116|NCT03312543|580629959|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
160793117|NCT03312543|580629960|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
160793118|NCT03312543|580629959|FG000|Regression (Week 12 to Week 24)|Death|0|||
160793119|NCT03312543|580629960|FG001|Regression (Week 12 to Week 24)|Death|1|||
160793120|NCT04507269|580629961|FG000|Overall Study|Withdrawal by Subject|1|||
160793121|NCT04507269|580629962|FG001|Overall Study|Withdrawal by Subject|1|||
160793122|NCT04507269|580629963|FG002|Overall Study|Withdrawal by Subject|0|||
160793123|NCT04507269|580629964|FG003|Overall Study|Withdrawal by Subject|0|||
160793124|NCT04507269|580629965|FG004|Overall Study|Withdrawal by Subject|0|||
160793125|NCT04507269|580629966|FG005|Overall Study|Withdrawal by Subject|0|||
160793126|NCT04507269|580629961|FG000|Overall Study|Lost to Follow-up|0|||
160793127|NCT04507269|580629962|FG001|Overall Study|Lost to Follow-up|0|||
160793128|NCT04507269|580629963|FG002|Overall Study|Lost to Follow-up|0|||
160793129|NCT04507269|580629964|FG003|Overall Study|Lost to Follow-up|0|||
160793130|NCT04507269|580629965|FG004|Overall Study|Lost to Follow-up|1|||
160793131|NCT04507269|580629966|FG005|Overall Study|Lost to Follow-up|0|||
160793132|NCT04197583|580629967|FG000|Overall Study|Study Stent Replacement|34|||
160793133|NCT04197583|580629968|FG001|Overall Study|Study Stent Replacement|8|||
160793134|NCT04197583|580629967|FG000|Overall Study|Lost to Follow-up|14|||
160793135|NCT04197583|580629968|FG001|Overall Study|Lost to Follow-up|3|||
160793136|NCT04197583|580629967|FG000|Overall Study|Death|3|||
160793137|NCT04197583|580629968|FG001|Overall Study|Death|0|||
160793138|NCT04197583|580629967|FG000|Overall Study|Physician Decision|1|||
160793139|NCT04197583|580629968|FG001|Overall Study|Physician Decision|0|||
160793140|NCT04197583|580629967|FG000|Overall Study|Withdrawal by Subject|1|||
160793141|NCT04197583|580629968|FG001|Overall Study|Withdrawal by Subject|1|||
160793142|NCT04197583|580629967|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
160793143|NCT04197583|580629968|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
160793144|NCT04197583|580629967|FG000|Overall Study|Screen Failure|0|||
160793145|NCT04197583|580629968|FG001|Overall Study|Screen Failure|20|||
160793146|NCT04134936|580629969|FG000|Overall Study|Adverse Event|3|||
160793147|NCT04134936|580629970|FG001|Overall Study|Adverse Event|2|||
160793148|NCT04134936|580629969|FG000|Overall Study|Withdrawal by Subject|2|||
160793149|NCT04134936|580629970|FG001|Overall Study|Withdrawal by Subject|3|||
160793150|NCT04134936|580629969|FG000|Overall Study|Physician Decision|0|||
160793151|NCT04134936|580629970|FG001|Overall Study|Physician Decision|1|||
160793152|NCT04134936|580629969|FG000|Overall Study|Progressive disease, joined another trial|1|||
160793153|NCT04134936|580629970|FG001|Overall Study|Progressive disease, joined another trial|0|||
160793154|NCT04134936|580629969|FG000|Overall Study|Progressive disease|1|||
160793155|NCT04134936|580629970|FG001|Overall Study|Progressive disease|0|||
160793156|NCT04629196|580629971|FG000|Overall Study|Subject discontinued study drug|1|||
160793157|NCT04629196|580629972|FG001|Overall Study|Subject discontinued study drug|0|||
160793158|NCT04629196|580629971|FG000|Overall Study|Subject study drug dosing increased|1|||
160793159|NCT04629196|580629972|FG001|Overall Study|Subject study drug dosing increased|1|||
160793160|NCT04629196|580629971|FG000|Overall Study|Withdrawal by Subject|1|||
160793161|NCT04629196|580629972|FG001|Overall Study|Withdrawal by Subject|2|||
160793162|NCT02061085|580629978|FG000|Overall Study|Adverse Event|8|||
160793163|NCT05487378|580629985|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
160793164|NCT05487378|580629986|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
160793165|NCT05487378|580629985|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
160793166|NCT05487378|580629986|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
160793167|NCT02414841|580629988|FG000|Overall Study|Withdrawal by Subject|7|||
160793168|NCT02414841|580629989|FG001|Overall Study|Withdrawal by Subject|5|||
160793169|NCT02414841|580629988|FG000|Overall Study|Lost to Follow-up|13|||
160793170|NCT02414841|580629989|FG001|Overall Study|Lost to Follow-up|6|||
160793171|NCT02414841|580629988|FG000|Overall Study|Death|17|||
160793172|NCT02414841|580629989|FG001|Overall Study|Death|14|||
160793173|NCT02414841|580629988|FG000|Overall Study|Received a Kidney Transplant|13|||
160793174|NCT02414841|580629989|FG001|Overall Study|Received a Kidney Transplant|4|||
160793175|NCT02414841|580629988|FG000|Overall Study|Randomized But Not Treated|6|||
160793176|NCT02414841|580629989|FG001|Overall Study|Randomized But Not Treated|4|||
160793177|NCT00112385|580629990|FG000|Overall Study|Lost to Follow-up|1|||
160793178|NCT00112385|580629991|FG001|Overall Study|Lost to Follow-up|0|||
160892925|NCT00422097|581003762|FG005|Dose Level 2|Still on treatment|0|||
161128791|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
160793179|NCT00112385|580629990|FG000|Overall Study|Withdrawal by Subject|0|||
160793180|NCT00112385|580629991|FG001|Overall Study|Withdrawal by Subject|1|||
160793181|NCT02613507|580629997|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
160793182|NCT02613507|580629998|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
160793183|NCT02613507|580629997|FG000|Pre-Treamtent|Participant withdrew consent|0|||
160793184|NCT02613507|580629998|FG001|Pre-Treamtent|Participant withdrew consent|4|||
160793185|NCT02613507|580629997|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
160793186|NCT02613507|580629998|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
160793187|NCT02613507|580629997|FG000|Treatment|Not reported|3|||
160793188|NCT02613507|580629998|FG001|Treatment|Not reported|0|||
160793189|NCT02613507|580629997|FG000|Treatment|Other reasons|8|||
160793190|NCT02613507|580629998|FG001|Treatment|Other reasons|0|||
160793191|NCT02613507|580629997|FG000|Treatment|Participant no longer meets criteria|3|||
160793192|NCT02613507|580629998|FG001|Treatment|Participant no longer meets criteria|0|||
160793193|NCT02613507|580629997|FG000|Treatment|Maximum clinical benefit|5|||
160793194|NCT02613507|580629998|FG001|Treatment|Maximum clinical benefit|10|||
160793195|NCT02613507|580629997|FG000|Treatment|Lost to Follow-up|1|||
160793196|NCT02613507|580629998|FG001|Treatment|Lost to Follow-up|0|||
160793197|NCT02613507|580629997|FG000|Treatment|Participant withdrew consent|0|||
160793198|NCT02613507|580629998|FG001|Treatment|Participant withdrew consent|2|||
160793199|NCT02613507|580629997|FG000|Treatment|Participant request to discontinue study treatment|13|||
160793200|NCT02613507|580629998|FG001|Treatment|Participant request to discontinue study treatment|17|||
160793201|NCT02613507|580629997|FG000|Treatment|Adverse event unrelated to study drug|20|||
160793202|NCT02613507|580629998|FG001|Treatment|Adverse event unrelated to study drug|3|||
160793203|NCT02613507|580629997|FG000|Treatment|Death|2|||
160793204|NCT02613507|580629998|FG001|Treatment|Death|0|||
160793205|NCT02613507|580629997|FG000|Treatment|Study drug toxicity|19|||
160793206|NCT02613507|580629998|FG001|Treatment|Study drug toxicity|14|||
160793207|NCT02613507|580629997|FG000|Treatment|Disease progression|263|||
160793208|NCT02613507|580629998|FG001|Treatment|Disease progression|110|||
160793209|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
160793210|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
160793211|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
160793212|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
160793213|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
160793214|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
160793215|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
160793216|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
160793217|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
160793218|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
160793219|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
160793220|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793221|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793222|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793223|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
160793224|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793225|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793226|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793227|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793228|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793229|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793230|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
160793231|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160892926|NCT00422097|581003763|FG006|Dose Level 2|Still on treatment|0|||
160892927|NCT00422097|581003764|FG007|Dose Level 2|Still on treatment|0|||
160892928|NCT02360995|581003765|FG000|Overall Study|Lost to Follow-up|2|||
160892929|NCT02360995|581003766|FG001|Overall Study|Lost to Follow-up|0|||
160892930|NCT02360995|581003767|FG002|Overall Study|Lost to Follow-up|2|||
160892931|NCT02360995|581003765|FG000|Overall Study|Withdrawal by Subject|0|||
160892932|NCT02360995|581003766|FG001|Overall Study|Withdrawal by Subject|1|||
160892933|NCT02360995|581003767|FG002|Overall Study|Withdrawal by Subject|0|||
160892934|NCT02231918|581003768|FG000|Overall Study|Withdrawal by Subject|0|||
160892935|NCT02231918|581003769|FG001|Overall Study|Withdrawal by Subject|1|||
160892936|NCT02231918|581003770|FG002|Overall Study|Withdrawal by Subject|0|||
160892937|NCT02231918|581003768|FG000|Overall Study|Adverse Event|0|||
160892938|NCT02231918|581003769|FG001|Overall Study|Adverse Event|0|||
160892939|NCT02231918|581003770|FG002|Overall Study|Adverse Event|1|||
160892940|NCT01092507|581003771|FG000|Overall Study|Withdrawal by Subject|2|||
160892941|NCT01092507|581003772|FG001|Overall Study|Withdrawal by Subject|0|||
160892942|NCT00085709|581003773|FG000|Overall Study|Adverse Event|8|||
160892943|NCT00085709|581003774|FG001|Overall Study|Adverse Event|0|||
160892944|NCT00085709|581003773|FG000|Overall Study|Death|8|||
160892945|NCT00085709|581003774|FG001|Overall Study|Death|2|||
161235774|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
160793232|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793233|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
160793234|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160892946|NCT00085709|581003773|FG000|Overall Study|Refusal unrelated to adverse events|1|||
160892947|NCT00085709|581003774|FG001|Overall Study|Refusal unrelated to adverse events|2|||
160892948|NCT00085709|581003773|FG000|Overall Study|Progression|3|||
160892949|NCT00085709|581003774|FG001|Overall Study|Progression|4|||
161235775|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
161235776|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
161235777|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
160892950|NCT00085709|581003773|FG000|Overall Study|Not protocol specified|12|||
160892951|NCT00085709|581003774|FG001|Overall Study|Not protocol specified|22|||
160793235|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793236|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793237|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793238|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793239|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793240|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793241|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
160793242|NCT02471144|580631620|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
160793243|NCT02471144|580631621|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
160793244|NCT02471144|580631622|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793245|NCT02471144|580631623|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793246|NCT02471144|580631624|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793247|NCT02471144|580631625|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793248|NCT02471144|580631626|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160892952|NCT00085709|581003773|FG000|Overall Study|Not eligible|19|||
160892953|NCT00085709|581003774|FG001|Overall Study|Not eligible|19|||
160892954|NCT00085709|581003773|FG000|Overall Study|Withdrawal by Subject|2|||
160892955|NCT00085709|581003774|FG001|Overall Study|Withdrawal by Subject|1|||
160892956|NCT04131556|581003775|FG000|Overall Study|Adverse Event|1|||
160793249|NCT02471144|580631627|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160892957|NCT04131556|581003775|FG000|Overall Study|Withdrawal by Subject|1|||
160892958|NCT04622735|581003778|FG000|Overall Study|Lost to Follow-up|1|||
160892959|NCT04622735|581003779|FG001|Overall Study|Lost to Follow-up|2|||
160892960|NCT04622735|581003780|FG002|Overall Study|Lost to Follow-up|1|||
160892961|NCT04622735|581003778|FG000|Overall Study|Adverse Event|0|||
160892962|NCT04622735|581003779|FG001|Overall Study|Adverse Event|0|||
160892963|NCT04622735|581003780|FG002|Overall Study|Adverse Event|1|||
160892964|NCT04622735|581003778|FG000|Overall Study|Protocol Violation|1|||
160892965|NCT04622735|581003779|FG001|Overall Study|Protocol Violation|0|||
160892966|NCT04622735|581003780|FG002|Overall Study|Protocol Violation|0|||
160892967|NCT04629508|581003782|FG000|Overall Study|Adverse Event|1|||
160892968|NCT04629508|581003782|FG000|Overall Study|Death|2|||
160892969|NCT04629508|581003782|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
160892970|NCT04073368|581003787|FG000|Overall Study|Adverse Event|2|||
160892971|NCT04073368|581003788|FG001|Overall Study|Adverse Event|0|||
160892972|NCT04073368|581003789|FG002|Overall Study|Adverse Event|1|||
160892973|NCT04073368|581003790|FG003|Overall Study|Adverse Event|1|||
160892974|NCT04073368|581003787|FG000|Overall Study|Withdrawal by Subject|2|||
160892975|NCT04073368|581003788|FG001|Overall Study|Withdrawal by Subject|2|||
160892976|NCT04073368|581003789|FG002|Overall Study|Withdrawal by Subject|1|||
160892977|NCT04073368|581003790|FG003|Overall Study|Withdrawal by Subject|1|||
160892978|NCT04073368|581003787|FG000|Overall Study|Lost to Follow-up|1|||
160892979|NCT04073368|581003788|FG001|Overall Study|Lost to Follow-up|1|||
160892980|NCT04073368|581003789|FG002|Overall Study|Lost to Follow-up|1|||
160892981|NCT04073368|581003790|FG003|Overall Study|Lost to Follow-up|0|||
160892982|NCT04073368|581003787|FG000|Overall Study|Protocol Violation|0|||
160892983|NCT04073368|581003788|FG001|Overall Study|Protocol Violation|1|||
160892984|NCT04073368|581003789|FG002|Overall Study|Protocol Violation|0|||
160892985|NCT04073368|581003790|FG003|Overall Study|Protocol Violation|0|||
160892986|NCT04073368|581003787|FG000|Overall Study|Subject noncompliance|7|||
160892987|NCT04073368|581003788|FG001|Overall Study|Subject noncompliance|4|||
160892988|NCT04073368|581003789|FG002|Overall Study|Subject noncompliance|0|||
160892989|NCT04073368|581003790|FG003|Overall Study|Subject noncompliance|0|||
160892990|NCT03026088|581003791|FG000|Overall Study|Study termination|20|||
160892991|NCT06400979|581003798|FG000|Overall Study|Lost to Follow-up|29|||
160892992|NCT06400979|581003798|FG000|Overall Study|Withdrawal by Subject|1|||
160892993|NCT01028378|581003802|FG000|Overall Study|Lost to Follow-up|12|||
160892994|NCT01028378|581003802|FG000|Overall Study|Withdrawal by Subject|1|||
160892995|NCT01028378|581003802|FG000|Overall Study|Adminstrative Reasons|4|||
160892996|NCT00450385|581003803|FG000|Overall Study|Death|3|||
160892997|NCT00450385|581003803|FG000|Overall Study|Protocol Violation|1|||
160892998|NCT00450385|581003803|FG000|Overall Study|Withdrawal by Subject|2|||
160892999|NCT00450385|581003803|FG000|Overall Study|Lack of Efficacy|2|||
160893000|NCT00450385|581003803|FG000|Overall Study|Adverse Event|1|||
160893001|NCT00450385|581003803|FG000|Overall Study|Physician Decision|1|||
160893002|NCT00450385|581003803|FG000|Overall Study|Other|3|||
160893003|NCT03091777|581003806|FG000|Overall Study|Pregnancy|2|||
161330629|NCT01298700|582597178|FG001|Overall Study|Protocol Violation|4|||
160893004|NCT03091777|581003807|FG001|Overall Study|Pregnancy|1|||
160893005|NCT03091777|581003808|FG002|Overall Study|Pregnancy|0|||
160893006|NCT03091777|581003806|FG000|Overall Study|Adverse Event|2|||
160893007|NCT03091777|581003807|FG001|Overall Study|Adverse Event|1|||
160893008|NCT03091777|581003808|FG002|Overall Study|Adverse Event|4|||
160893009|NCT03091777|581003806|FG000|Overall Study|Withdrawal by Subject|4|||
160893010|NCT03091777|581003807|FG001|Overall Study|Withdrawal by Subject|2|||
160893011|NCT03091777|581003808|FG002|Overall Study|Withdrawal by Subject|6|||
160793250|NCT02471144|580631628|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793251|NCT02471144|580631629|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793252|NCT02471144|580631630|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
160793253|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793254|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793255|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793256|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
161128792|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
161128793|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128794|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128795|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128796|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
160793257|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
160793258|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793259|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
160793260|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793261|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
160793262|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793263|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
160793264|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793265|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793266|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793267|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793268|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793269|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
160793270|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793271|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793272|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
160793273|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793274|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
160793275|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793276|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161128797|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128798|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161128799|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
160793277|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
161128800|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161128801|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161128802|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161128803|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
161128804|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
161128805|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
161128806|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
161128807|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
161128808|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161128809|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
161128810|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
161128811|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
161128812|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161128813|NCT00289913|581858365|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
161128814|NCT00289913|581858366|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128815|NCT00289913|581858367|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
161128816|NCT00289913|581858368|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128817|NCT00289913|581858369|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128818|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128819|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128820|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161128821|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128822|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128823|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
161128824|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
161128825|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
161235778|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
160893012|NCT03091777|581003806|FG000|Overall Study|Protocol Violation|2|||
160893013|NCT03091777|581003807|FG001|Overall Study|Protocol Violation|1|||
160893014|NCT03091777|581003808|FG002|Overall Study|Protocol Violation|1|||
160893015|NCT03091777|581003806|FG000|Overall Study|Lost to Follow-up|12|||
160893016|NCT03091777|581003807|FG001|Overall Study|Lost to Follow-up|14|||
160893017|NCT03091777|581003808|FG002|Overall Study|Lost to Follow-up|7|||
160893018|NCT03091777|581003806|FG000|Overall Study|Lack of Efficacy|0|||
160893019|NCT03091777|581003807|FG001|Overall Study|Lack of Efficacy|0|||
160893020|NCT03091777|581003808|FG002|Overall Study|Lack of Efficacy|5|||
160893021|NCT03091777|581003806|FG000|Overall Study|Noncompliance with study drug|2|||
160893022|NCT03091777|581003807|FG001|Overall Study|Noncompliance with study drug|3|||
160893023|NCT03091777|581003808|FG002|Overall Study|Noncompliance with study drug|1|||
160893024|NCT03091777|581003806|FG000|Overall Study|Physician Decision|1|||
160893025|NCT03091777|581003807|FG001|Overall Study|Physician Decision|0|||
160893026|NCT03091777|581003808|FG002|Overall Study|Physician Decision|1|||
160893027|NCT03091777|581003806|FG000|Overall Study|Abnormal Laboratory Value|7|||
160893028|NCT03091777|581003807|FG001|Overall Study|Abnormal Laboratory Value|11|||
160893029|NCT03091777|581003808|FG002|Overall Study|Abnormal Laboratory Value|12|||
160893030|NCT02536833|581003809|FG000|Overall Study|Discontinued Before Treatment|0|||
160893031|NCT02536833|581003810|FG001|Overall Study|Discontinued Before Treatment|0|||
160893032|NCT02536833|581003811|FG002|Overall Study|Discontinued Before Treatment|1|||
160893033|NCT02536833|581003812|FG003|Overall Study|Discontinued Before Treatment|2|||
160893034|NCT02536833|581003809|FG000|Overall Study|Adverse Event|1|||
160893035|NCT02536833|581003810|FG001|Overall Study|Adverse Event|3|||
160893036|NCT02536833|581003811|FG002|Overall Study|Adverse Event|4|||
160893037|NCT02536833|581003812|FG003|Overall Study|Adverse Event|1|||
160893038|NCT02536833|581003809|FG000|Overall Study|Lost to Follow-up|2|||
160893039|NCT02536833|581003810|FG001|Overall Study|Lost to Follow-up|1|||
160893040|NCT02536833|581003811|FG002|Overall Study|Lost to Follow-up|2|||
160893041|NCT02536833|581003812|FG003|Overall Study|Lost to Follow-up|2|||
160893042|NCT02536833|581003809|FG000|Overall Study|Physician Decision|0|||
160893043|NCT02536833|581003810|FG001|Overall Study|Physician Decision|0|||
160893044|NCT02536833|581003811|FG002|Overall Study|Physician Decision|0|||
160893045|NCT02536833|581003812|FG003|Overall Study|Physician Decision|1|||
160893046|NCT02536833|581003809|FG000|Overall Study|Site Terminated by Sponsor|2|||
160893047|NCT02536833|581003810|FG001|Overall Study|Site Terminated by Sponsor|2|||
160893048|NCT02536833|581003811|FG002|Overall Study|Site Terminated by Sponsor|2|||
160893049|NCT02536833|581003812|FG003|Overall Study|Site Terminated by Sponsor|2|||
160893050|NCT02536833|581003809|FG000|Overall Study|Subject Non-Compliance|0|||
160893051|NCT02536833|581003810|FG001|Overall Study|Subject Non-Compliance|1|||
160893052|NCT02536833|581003811|FG002|Overall Study|Subject Non-Compliance|1|||
160893053|NCT02536833|581003812|FG003|Overall Study|Subject Non-Compliance|0|||
160893054|NCT02536833|581003809|FG000|Overall Study|Withdrawal by Subject|4|||
160893055|NCT02536833|581003810|FG001|Overall Study|Withdrawal by Subject|3|||
160893056|NCT02536833|581003811|FG002|Overall Study|Withdrawal by Subject|5|||
160893057|NCT02536833|581003812|FG003|Overall Study|Withdrawal by Subject|11|||
160893058|NCT00089674|581003813|FG000|Overall Study|Physician Decision|4|||
160893059|NCT00089674|581003814|FG001|Overall Study|Physician Decision|2|||
160893060|NCT00089674|581003813|FG000|Overall Study|Adverse Event|23|||
160893061|NCT00089674|581003814|FG001|Overall Study|Adverse Event|29|||
160893062|NCT00089674|581003813|FG000|Overall Study|Withdrawal by Subject|143|||
161128826|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
161128827|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
161128828|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161128829|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
161128830|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161128831|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161128832|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
161128833|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
161128834|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
161128835|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
161235779|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235780|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
160893063|NCT00089674|581003814|FG001|Overall Study|Withdrawal by Subject|127|||
160893064|NCT00089674|581003813|FG000|Overall Study|Death|43|||
160893065|NCT00089674|581003814|FG001|Overall Study|Death|43|||
160893066|NCT00089674|581003813|FG000|Overall Study|Disease progression|21|||
160893067|NCT00089674|581003814|FG001|Overall Study|Disease progression|23|||
160893068|NCT00089674|581003813|FG000|Overall Study|Ineligibility determined|8|||
160893069|NCT00089674|581003814|FG001|Overall Study|Ineligibility determined|10|||
160893070|NCT00089674|581003813|FG000|Overall Study|Lost to Follow-up|21|||
160893071|NCT00089674|581003814|FG001|Overall Study|Lost to Follow-up|17|||
160893072|NCT00089674|581003813|FG000|Overall Study|Noncompliance|7|||
160893073|NCT00089674|581003814|FG001|Overall Study|Noncompliance|3|||
160893074|NCT00089674|581003813|FG000|Overall Study|Other|5|||
160793278|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793279|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793280|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793281|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793282|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793283|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
160793284|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793285|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
160793286|NCT02471144|580631620|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793287|NCT02471144|580631621|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793288|NCT02471144|580631622|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793289|NCT02471144|580631623|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793290|NCT02471144|580631624|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793291|NCT02471144|580631625|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793292|NCT02471144|580631626|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793293|NCT02471144|580631627|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
160793294|NCT02471144|580631628|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
160793295|NCT02471144|580631629|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793296|NCT02471144|580631630|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
160793297|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793298|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793299|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793300|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793301|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793302|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793303|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793304|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793305|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
160793306|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
160793307|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
160793308|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793309|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793310|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793311|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793312|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793313|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793314|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793315|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793316|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793317|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
160793318|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
160793319|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793320|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793321|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793322|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793323|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793324|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793325|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793326|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793327|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793328|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
160793329|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
160793330|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793331|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793332|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793333|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793334|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793335|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793336|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793337|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793338|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
160793339|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
160793340|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
160793341|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793342|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793343|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160982559|NCT01556763|581325013|FG001|Overall Study|Withdrawal by Subject|1|||
160982560|NCT01556763|581325014|FG002|Overall Study|Withdrawal by Subject|0|||
160982561|NCT02258464|581325015|FG000|Overall Study|Progressive disease (PD)|9|||
160982562|NCT02258464|581325016|FG001|Overall Study|Progressive disease (PD)|17|||
160982563|NCT02258464|581325015|FG000|Overall Study|Study drug never administered|1|||
160982564|NCT02258464|581325016|FG001|Overall Study|Study drug never administered|1|||
160982565|NCT02258464|581325015|FG000|Overall Study|AE not related to clinical PD|1|||
160982566|NCT02258464|581325016|FG001|Overall Study|AE not related to clinical PD|3|||
160982567|NCT02258464|581325015|FG000|Overall Study|Withdrawal by Subject|5|||
160982568|NCT02258464|581325016|FG001|Overall Study|Withdrawal by Subject|4|||
160982569|NCT02258464|581325015|FG000|Overall Study|AE related to clinical PD|1|||
160982570|NCT02258464|581325016|FG001|Overall Study|AE related to clinical PD|0|||
160982571|NCT00932646|581325017|FG000|Overall Study|Adverse Event|2|||
160982572|NCT00932646|581325018|FG001|Overall Study|Adverse Event|1|||
160982573|NCT00932646|581325019|FG002|Overall Study|Adverse Event|1|||
160982574|NCT00932646|581325020|FG003|Overall Study|Adverse Event|1|||
160982575|NCT00932646|581325017|FG000|Overall Study|Lost to Follow-up|2|||
160982576|NCT00932646|581325018|FG001|Overall Study|Lost to Follow-up|1|||
160982577|NCT00932646|581325019|FG002|Overall Study|Lost to Follow-up|0|||
160982578|NCT00932646|581325020|FG003|Overall Study|Lost to Follow-up|0|||
160982579|NCT00932646|581325017|FG000|Overall Study|Withdrawal by Subject|1|||
160982580|NCT00932646|581325018|FG001|Overall Study|Withdrawal by Subject|1|||
160982581|NCT00932646|581325019|FG002|Overall Study|Withdrawal by Subject|3|||
160982582|NCT00932646|581325020|FG003|Overall Study|Withdrawal by Subject|0|||
160982583|NCT00653263|581325021|FG000|Overall Study|Withdrawal by Subject|1|||
160982584|NCT00653263|581325021|FG000|Overall Study|Physician Decision|1|||
160982585|NCT00776100|581325022|FG000|Overall Study|Disease Progression|1|||
160982586|NCT00776100|581325023|FG001|Overall Study|Disease Progression|0|||
160982631|NCT00195715|581325041|FG000|Overall Study|Adverse Event|122|||
160982632|NCT00195715|581325041|FG000|Overall Study|Withdrawal by Subject|58|||
160893075|NCT00089674|581003814|FG001|Overall Study|Other|9|||
160893076|NCT00089674|581003813|FG000|Overall Study|Requirement for alternative therapy|14|||
160893077|NCT00089674|581003814|FG001|Overall Study|Requirement for alternative therapy|4|||
160893078|NCT01462227|581003815|FG000|Second Assignment|Lost to Follow-up|1|||
160893079|NCT01462227|581003816|FG001|Second Assignment|Lost to Follow-up|0|||
160893080|NCT01462227|581003817|FG002|Second Assignment|Lost to Follow-up|0|||
160893081|NCT01462227|581003818|FG003|Second Assignment|Lost to Follow-up|0|||
160893082|NCT01462227|581003815|FG000|Second Assignment|Protocol Violation|0|||
160893083|NCT01462227|581003816|FG001|Second Assignment|Protocol Violation|1|||
160893084|NCT01462227|581003817|FG002|Second Assignment|Protocol Violation|1|||
160893085|NCT01462227|581003818|FG003|Second Assignment|Protocol Violation|0|||
160893086|NCT00586066|581003821|FG000|Overall Study|Lost to Follow-up|6|||
160893087|NCT00586066|581003822|FG001|Overall Study|Lost to Follow-up|3|||
160893088|NCT00586066|581003821|FG000|Overall Study|Lack of Efficacy|5|||
160893089|NCT00586066|581003822|FG001|Overall Study|Lack of Efficacy|3|||
160893090|NCT00586066|581003821|FG000|Overall Study|Adverse Event|2|||
160893091|NCT00586066|581003822|FG001|Overall Study|Adverse Event|2|||
160893092|NCT00586066|581003821|FG000|Overall Study|Physician Decision|1|||
160893093|NCT00586066|581003822|FG001|Overall Study|Physician Decision|0|||
160893094|NCT00586066|581003821|FG000|Overall Study|Withdrawal of consent|4|||
160893095|NCT00586066|581003822|FG001|Overall Study|Withdrawal of consent|2|||
160893096|NCT00760084|581003826|FG000|Overall Study|Physician Decision|5|||
160893097|NCT00760084|581003826|FG000|Overall Study|Withdrawal by Subject|2|||
160893098|NCT00760084|581003826|FG000|Overall Study|Progressive Disease|3|||
160893099|NCT02567552|581003827|FG000|Overall Study|Adverse Event|0|||
160893100|NCT02567552|581003828|FG001|Overall Study|Adverse Event|1|||
160893101|NCT02301988|581003829|FG000|Overall Study|Withdrawal by Subject|2|||
160893102|NCT02301988|581003830|FG001|Overall Study|Withdrawal by Subject|1|||
160893103|NCT02301988|581003829|FG000|Overall Study|Physician Decision|2|||
160893104|NCT02301988|581003830|FG001|Overall Study|Physician Decision|2|||
160893105|NCT02301988|581003829|FG000|Overall Study|Unknown Reason|1|||
160893106|NCT02301988|581003830|FG001|Overall Study|Unknown Reason|3|||
160893107|NCT02301988|581003829|FG000|Overall Study|Lack of Efficacy|3|||
160893108|NCT02301988|581003830|FG001|Overall Study|Lack of Efficacy|2|||
160893109|NCT02301988|581003829|FG000|Overall Study|Death|1|||
160893110|NCT02301988|581003830|FG001|Overall Study|Death|0|||
160893111|NCT02301988|581003829|FG000|Overall Study|Adverse Event|1|||
160893112|NCT02301988|581003830|FG001|Overall Study|Adverse Event|1|||
160893113|NCT02891161|581003833|FG000|Study Treatment|Disease Progression|2|||
160893114|NCT02891161|581003834|FG001|Study Treatment|Disease Progression|4|||
160893115|NCT02891161|581003833|FG000|Study Treatment|AE/Side Effects/Complications|1|||
160893116|NCT02891161|581003834|FG001|Study Treatment|AE/Side Effects/Complications|5|||
160893117|NCT02891161|581003833|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
160893118|NCT02891161|581003834|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
160893119|NCT02891161|581003833|FG000|Follow up|Death|4|||
160893120|NCT02891161|581003834|FG001|Follow up|Death|8|||
160893121|NCT02891161|581003833|FG000|Follow up|Refused to Follow up|0|||
160893122|NCT02891161|581003834|FG001|Follow up|Refused to Follow up|2|||
160893123|NCT02891161|581003833|FG000|Follow up|Symptomatic deterioration|0|||
160893124|NCT02891161|581003834|FG001|Follow up|Symptomatic deterioration|1|||
160893125|NCT02891161|581003833|FG000|Follow up|Study terminated|0|||
160893126|NCT02891161|581003834|FG001|Follow up|Study terminated|6|||
160893127|NCT01931202|581003836|FG000|Overall Study|Withdrawal by Subject|0|||
160893128|NCT01931202|581003837|FG001|Overall Study|Withdrawal by Subject|0|||
160893129|NCT01931202|581003838|FG002|Overall Study|Withdrawal by Subject|2|||
160893130|NCT01931202|581003836|FG000|Overall Study|Lost to Follow-up|0|||
160893131|NCT01931202|581003837|FG001|Overall Study|Lost to Follow-up|5|||
160893132|NCT01931202|581003838|FG002|Overall Study|Lost to Follow-up|2|||
160893133|NCT00171054|581003839|FG000|Overall Study|Protocol Violation|1|||
160893134|NCT00171054|581003840|FG001|Overall Study|Protocol Violation|2|||
160893135|NCT00171054|581003839|FG000|Overall Study|Patient withdrew consent|1|||
160893136|NCT00171054|581003840|FG001|Overall Study|Patient withdrew consent|0|||
160893137|NCT00171054|581003839|FG000|Overall Study|Lost to Follow-up|0|||
160893138|NCT00171054|581003840|FG001|Overall Study|Lost to Follow-up|1|||
160893139|NCT00171054|581003839|FG000|Overall Study|Adverse Event|8|||
160893140|NCT00171054|581003840|FG001|Overall Study|Adverse Event|8|||
160893141|NCT00171054|581003839|FG000|Overall Study|Condition no longer required study drug|0|||
160893142|NCT00171054|581003840|FG001|Overall Study|Condition no longer required study drug|1|||
160893143|NCT04669535|581003841|FG000|Overall Study|Death|1|||
160893144|NCT04669535|581003842|FG001|Overall Study|Death|1|||
160893145|NCT04669535|581003843|FG002|Overall Study|Death|0|||
160893146|NCT04669535|581003844|FG003|Overall Study|Death|0|||
160893147|NCT01876810|581003845|FG000|Overall Study|Physician Decision|0|||
160893148|NCT01876810|581003846|FG001|Overall Study|Physician Decision|1|||
160893149|NCT01857583|581003848|FG000|Overall Study|Adverse Event|0|||
160893150|NCT01857583|581003849|FG001|Overall Study|Adverse Event|0|||
160893151|NCT01857583|581003850|FG002|Overall Study|Adverse Event|1|||
160893152|NCT01857583|581003851|FG003|Overall Study|Adverse Event|1|||
160893153|NCT01857583|581003848|FG000|Overall Study|Death|0|||
160982633|NCT00195715|581325041|FG000|Overall Study|Lost to Follow-up|27|||
160982634|NCT00195715|581325041|FG000|Overall Study|Protocol Violation|13|||
160982635|NCT00195715|581325041|FG000|Overall Study|Lack of Efficacy|93|||
160982636|NCT00195715|581325041|FG000|Overall Study|Pregnancy|14|||
160982637|NCT00195715|581325041|FG000|Overall Study|Investigative site closure|8|||
160982638|NCT00195715|581325041|FG000|Overall Study|Subject moved/relocated|7|||
160982639|NCT00195715|581325041|FG000|Overall Study|Subject non-compliance|6|||
160982640|NCT00195715|581325041|FG000|Overall Study|Subject started commercial Humira|5|||
160982641|NCT00195715|581325041|FG000|Overall Study|Subject choice|3|||
160982642|NCT00195715|581325041|FG000|Overall Study|Loss of response/no improvement|3|||
160982643|NCT00195715|581325041|FG000|Overall Study|Sponsor stopped study|1|||
160982644|NCT00195715|581325041|FG000|Overall Study|Administrative reasons|2|||
160982645|NCT00195715|581325041|FG000|Overall Study|Investigator's decision|2|||
160982646|NCT00195715|581325041|FG000|Overall Study|Subject wants to get pregnant|4|||
160982647|NCT00195715|581325041|FG000|Overall Study|Use of prohibited medication|2|||
160982648|NCT00195715|581325041|FG000|Overall Study|Planned surgery|2|||
160982649|NCT00195715|581325041|FG000|Overall Study|Increased infection rate|1|||
160982650|NCT00195715|581325041|FG000|Overall Study|Ineligible|1|||
160982651|NCT00195715|581325041|FG000|Overall Study|Colonic stricture|1|||
160982652|NCT00195715|581325041|FG000|Overall Study|Sponsor discontinued trial|1|||
160982653|NCT00195715|581325041|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
160982654|NCT05822921|581325046|FG000|Overall Study|Lost to Follow-up|1|||
160982655|NCT05822921|581325047|FG001|Overall Study|Lost to Follow-up|1|||
160982656|NCT02218489|581325054|FG000|Overall Study|Withdrawal by Subject|4|||
160982657|NCT02218489|581325055|FG001|Overall Study|Withdrawal by Subject|3|||
160982658|NCT02218489|581325054|FG000|Overall Study|Lost to Follow-up|1|||
160982659|NCT02218489|581325055|FG001|Overall Study|Lost to Follow-up|0|||
160982660|NCT04039503|581325056|FG000|Overall Study|Adverse Event|3|||
160982661|NCT04039503|581325057|FG001|Overall Study|Adverse Event|0|||
160982662|NCT04039503|581325058|FG002|Overall Study|Adverse Event|2|||
160982663|NCT04039503|581325059|FG003|Overall Study|Adverse Event|0|||
160982664|NCT04039503|581325056|FG000|Overall Study|Lost to Follow-up|0|||
160982665|NCT04039503|581325057|FG001|Overall Study|Lost to Follow-up|0|||
160982666|NCT04039503|581325058|FG002|Overall Study|Lost to Follow-up|1|||
160982667|NCT04039503|581325059|FG003|Overall Study|Lost to Follow-up|0|||
160982668|NCT04039503|581325056|FG000|Overall Study|Protocol Violation|0|||
160982669|NCT04039503|581325057|FG001|Overall Study|Protocol Violation|1|||
160982670|NCT04039503|581325058|FG002|Overall Study|Protocol Violation|2|||
160982671|NCT04039503|581325059|FG003|Overall Study|Protocol Violation|1|||
160982672|NCT04039503|581325056|FG000|Overall Study|Withdrawal by Subject|4|||
160982673|NCT04039503|581325057|FG001|Overall Study|Withdrawal by Subject|3|||
160982674|NCT04039503|581325058|FG002|Overall Study|Withdrawal by Subject|5|||
160982675|NCT04039503|581325059|FG003|Overall Study|Withdrawal by Subject|2|||
160982676|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982677|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982678|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982679|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
161235781|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235782|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235783|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235784|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235785|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235786|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
161235787|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235788|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235789|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235790|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235791|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161235792|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235793|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160982680|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982681|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
160982682|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982683|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982684|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982685|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982686|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
160982687|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
160982688|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982689|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160996827|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
160793344|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793345|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793346|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793347|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793348|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793349|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793350|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
160793351|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
160793352|NCT02471144|580631620|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793353|NCT02471144|580631621|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793354|NCT02471144|580631622|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793355|NCT02471144|580631623|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793356|NCT02471144|580631624|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793357|NCT02471144|580631625|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793358|NCT02471144|580631626|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793359|NCT02471144|580631627|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793360|NCT02471144|580631628|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
160793361|NCT02471144|580631629|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
160793362|NCT02471144|580631630|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
160793363|NCT03977155|580631634|FG000|Overall Study|Adverse Event|3|||
160793364|NCT03977155|580631635|FG001|Overall Study|Adverse Event|0|||
160793365|NCT03977155|580631636|FG002|Overall Study|Adverse Event|0|||
160793366|NCT03977155|580631634|FG000|Overall Study|Lost to Follow-up|0|||
160793367|NCT03977155|580631635|FG001|Overall Study|Lost to Follow-up|1|||
160793368|NCT03977155|580631636|FG002|Overall Study|Lost to Follow-up|0|||
160793369|NCT03977155|580631634|FG000|Overall Study|Withdrawal by Subject|1|||
160793370|NCT03977155|580631635|FG001|Overall Study|Withdrawal by Subject|1|||
160793371|NCT03977155|580631636|FG002|Overall Study|Withdrawal by Subject|2|||
160793372|NCT03977155|580631634|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
160793373|NCT03977155|580631635|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
160793374|NCT03977155|580631636|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
160793375|NCT00936936|580631637|FG000|Overall Study|Adverse Event|7|||
160793376|NCT00936936|580631638|FG001|Overall Study|Adverse Event|1|||
160793377|NCT00936936|580631637|FG000|Overall Study|Disease Progression|2|||
160793378|NCT00936936|580631638|FG001|Overall Study|Disease Progression|2|||
160793379|NCT00936936|580631637|FG000|Overall Study|Unrelated|3|||
160793380|NCT00936936|580631638|FG001|Overall Study|Unrelated|1|||
160793381|NCT03440385|580631647|FG000|Overall Study|Other Reason|4|||
160793382|NCT03440385|580631648|FG001|Overall Study|Other Reason|1|||
160793383|NCT03440385|580631647|FG000|Overall Study|Site Closed|1|||
160793384|NCT03440385|580631648|FG001|Overall Study|Site Closed|0|||
160793385|NCT03440385|580631647|FG000|Overall Study|Lost to Follow-up|2|||
160793386|NCT03440385|580631648|FG001|Overall Study|Lost to Follow-up|0|||
160793387|NCT03440385|580631647|FG000|Overall Study|Withdrawal by Subject|12|||
160793388|NCT03440385|580631648|FG001|Overall Study|Withdrawal by Subject|6|||
160793389|NCT03440385|580631647|FG000|Overall Study|Lack of Efficacy|9|||
160793390|NCT03440385|580631648|FG001|Overall Study|Lack of Efficacy|2|||
160793391|NCT03440385|580631647|FG000|Overall Study|Adverse Event|15|||
160793392|NCT03440385|580631648|FG001|Overall Study|Adverse Event|11|||
160793393|NCT00488293|580631649|FG000|Overall Study|Lost to Follow-up|28|||
160793394|NCT00488293|580631650|FG001|Overall Study|Lost to Follow-up|25|||
160793395|NCT00488293|580631649|FG000|Overall Study|Withdrawal by Subject|5|||
160793396|NCT00488293|580631650|FG001|Overall Study|Withdrawal by Subject|3|||
160793397|NCT00488293|580631649|FG000|Overall Study|Death|2|||
160793398|NCT00488293|580631650|FG001|Overall Study|Death|1|||
160793399|NCT00488293|580631649|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
160793400|NCT00488293|580631650|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
160793401|NCT00939185|580631651|FG000|Overall Study|Adverse Event|3|||
160793402|NCT00939185|580631651|FG000|Overall Study|Lack of Efficacy|1|||
160793403|NCT00939185|580631651|FG000|Overall Study|Lost to Follow-up|6|||
160793404|NCT00939185|580631651|FG000|Overall Study|Other|3|||
160793405|NCT00939185|580631651|FG000|Overall Study|Withdrawal by Subject|2|||
160793406|NCT00939185|580631651|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
160793407|NCT00363298|580631652|FG000|First Study Week|Lack of Efficacy|6|||
160793408|NCT00363298|580631653|FG001|First Study Week|Lack of Efficacy|5|||
160793409|NCT00363298|580631652|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
160793410|NCT00363298|580631653|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
160793411|NCT02374255|580631655|FG000|Overall Study|Withdrawal by Subject|2|||
160793412|NCT02374255|580631656|FG001|Overall Study|Withdrawal by Subject|0|||
160793413|NCT02374255|580631657|FG002|Overall Study|Withdrawal by Subject|0|||
160793414|NCT02374255|580631658|FG003|Overall Study|Withdrawal by Subject|0|||
160793415|NCT00851084|580631659|FG000|Overall Study|Randomized but not treated|1|||
160793416|NCT00851084|580631660|FG001|Overall Study|Randomized but not treated|0|||
161330630|NCT01298700|582597177|FG000|Overall Study|Other Miscellaneous Reasons|16|||
160793417|NCT00851084|580631659|FG000|Overall Study|Adverse Event|26|||
160793418|NCT00851084|580631660|FG001|Overall Study|Adverse Event|36|||
160982690|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982691|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982692|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982693|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
160982694|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982695|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982696|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982697|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
160982698|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982699|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982700|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
160982701|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982702|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982703|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982704|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160793419|NCT00851084|580631659|FG000|Overall Study|Disease progression|52|||
160793420|NCT00851084|580631660|FG001|Overall Study|Disease progression|47|||
160793421|NCT00851084|580631659|FG000|Overall Study|Poor compliance to protocol|1|||
160793422|NCT00851084|580631660|FG001|Overall Study|Poor compliance to protocol|1|||
160793423|NCT00851084|580631659|FG000|Overall Study|Physician Decision|13|||
160793424|NCT00851084|580631660|FG001|Overall Study|Physician Decision|14|||
160793425|NCT00851084|580631659|FG000|Overall Study|Consent withdrawn|0|||
160793426|NCT00851084|580631660|FG001|Overall Study|Consent withdrawn|2|||
160793427|NCT00851084|580631659|FG000|Overall Study|Withdrawal by Subject|11|||
160793428|NCT00851084|580631660|FG001|Overall Study|Withdrawal by Subject|12|||
160793429|NCT00851084|580631659|FG000|Overall Study|Metastatic surgery|6|||
160793430|NCT00851084|580631660|FG001|Overall Study|Metastatic surgery|6|||
160793431|NCT00851084|580631659|FG000|Overall Study|Other|7|||
160793432|NCT00851084|580631660|FG001|Overall Study|Other|1|||
160793433|NCT00095576|580631663|FG000|Overall Study|Adverse Event|5|||
160793434|NCT00095576|580631664|FG001|Overall Study|Adverse Event|3|||
160793435|NCT00095576|580631663|FG000|Overall Study|Lost to Follow-up|233|||
160793436|NCT00095576|580631664|FG001|Overall Study|Lost to Follow-up|229|||
160793437|NCT00095576|580631663|FG000|Overall Study|Protocol Violation|1|||
160793438|NCT00095576|580631664|FG001|Overall Study|Protocol Violation|0|||
160793439|NCT00095576|580631663|FG000|Overall Study|Withdrawal by Subject|34|||
160793440|NCT00095576|580631664|FG001|Overall Study|Withdrawal by Subject|47|||
160793441|NCT00095576|580631663|FG000|Overall Study|Option to switch to a rollover study|1097|||
160793442|NCT00095576|580631664|FG001|Overall Study|Option to switch to a rollover study|1099|||
160793443|NCT00095576|580631663|FG000|Overall Study|Site terminated|75|||
160793444|NCT00095576|580631664|FG001|Overall Study|Site terminated|67|||
160893154|NCT01857583|581003849|FG001|Overall Study|Death|1|||
160893155|NCT01857583|581003850|FG002|Overall Study|Death|1|||
160893156|NCT01857583|581003851|FG003|Overall Study|Death|0|||
160893157|NCT01857583|581003848|FG000|Overall Study|Physician Decision|0|||
160893158|NCT01857583|581003849|FG001|Overall Study|Physician Decision|0|||
160893159|NCT01857583|581003850|FG002|Overall Study|Physician Decision|0|||
160893160|NCT01857583|581003851|FG003|Overall Study|Physician Decision|1|||
160893161|NCT01857583|581003848|FG000|Overall Study|Withdrawal by Subject|1|||
160893162|NCT01857583|581003849|FG001|Overall Study|Withdrawal by Subject|0|||
160893163|NCT01857583|581003850|FG002|Overall Study|Withdrawal by Subject|1|||
160982705|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
161128836|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161128837|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161128838|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161128839|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128840|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161128841|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128842|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
160793445|NCT00095576|580631663|FG000|Overall Study|Subject moved|30|||
160793446|NCT00095576|580631664|FG001|Overall Study|Subject moved|36|||
160793447|NCT01497197|580631667|FG000|Overall Study|Lost to Follow-up|1|||
160793448|NCT01497197|580631668|FG001|Overall Study|Lost to Follow-up|0|||
160893164|NCT01857583|581003851|FG003|Overall Study|Withdrawal by Subject|2|||
161128843|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161330631|NCT01298700|582597178|FG001|Overall Study|Other Miscellaneous Reasons|15|||
161330632|NCT01298700|582597177|FG000|Overall Study|Did not Receive Study Drug|3|||
160893165|NCT02775903|581003854|FG000|Overall Study|Death|7|||
160893166|NCT02775903|581003855|FG001|Overall Study|Death|11|||
160793449|NCT01497197|580631667|FG000|Overall Study|Protocol Violation|0|||
160793450|NCT01497197|580631668|FG001|Overall Study|Protocol Violation|2|||
160793451|NCT01497197|580631667|FG000|Overall Study|Withdrawal by Subject|2|||
160793452|NCT01497197|580631668|FG001|Overall Study|Withdrawal by Subject|1|||
160793453|NCT01497197|580631667|FG000|Overall Study|Excessive/lack of response to treatment|1|||
160793454|NCT01497197|580631668|FG001|Overall Study|Excessive/lack of response to treatment|0|||
160793455|NCT01497197|580631667|FG000|Overall Study|Risk of OHSS|1|||
160793456|NCT01497197|580631668|FG001|Overall Study|Risk of OHSS|0|||
160793457|NCT01497197|580631667|FG000|Overall Study|No oocytes retrieved|3|||
160793458|NCT01497197|580631668|FG001|Overall Study|No oocytes retrieved|2|||
160793459|NCT01497197|580631667|FG000|Overall Study|No fertilisation|6|||
160793460|NCT01497197|580631668|FG001|Overall Study|No fertilisation|5|||
160793461|NCT01497197|580631667|FG000|Overall Study|Intention to freeze all embryos|0|||
160793462|NCT01497197|580631668|FG001|Overall Study|Intention to freeze all embryos|1|||
160793463|NCT01497197|580631667|FG000|Overall Study|All embryos discarded|0|||
161330633|NCT01298700|582597178|FG001|Overall Study|Did not Receive Study Drug|5|||
161330634|NCT04006145|582597181|FG000|Overall Study|Lost to Follow-up|0|||
160793464|NCT01497197|580631668|FG001|Overall Study|All embryos discarded|3|||
160793465|NCT01497197|580631667|FG000|Overall Study|Other|3|||
160793466|NCT01497197|580631668|FG001|Overall Study|Other|1|||
160793467|NCT04484857|580631670|FG000|Overall Study|Adverse Event|2|||
160793468|NCT04484857|580631670|FG000|Overall Study|Death|10|||
160793469|NCT04484857|580631670|FG000|Overall Study|Withdrawal by Subject|3|||
160793470|NCT04484857|580631670|FG000|Overall Study|Transferred/Relocation|5|||
160793471|NCT04484857|580631670|FG000|Overall Study|Kidney Transplant|7|||
160793472|NCT04484857|580631670|FG000|Overall Study|Other than specified|4|||
160793473|NCT04484857|580631670|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
160793474|NCT01425814|580631671|FG000|Period 1|Stability criteria not fulfilled|0|||
160793475|NCT01425814|580631672|FG001|Period 1|Stability criteria not fulfilled|1|||
160793476|NCT01425814|580631673|FG002|Period 1|Stability criteria not fulfilled|0|||
160793477|NCT01425814|580631674|FG003|Period 1|Stability criteria not fulfilled|0|||
160793478|NCT01425814|580631675|FG004|Period 1|Stability criteria not fulfilled|0|||
160793479|NCT01425814|580631676|FG005|Period 1|Stability criteria not fulfilled|0|||
160793480|NCT01425814|580631671|FG000|Period 2|Stability criteria not fulfilled|0|||
160793481|NCT01425814|580631672|FG001|Period 2|Stability criteria not fulfilled|1|||
160793482|NCT01425814|580631673|FG002|Period 2|Stability criteria not fulfilled|0|||
160793483|NCT01425814|580631674|FG003|Period 2|Stability criteria not fulfilled|0|||
160793484|NCT01425814|580631675|FG004|Period 2|Stability criteria not fulfilled|0|||
160793485|NCT01425814|580631676|FG005|Period 2|Stability criteria not fulfilled|0|||
160793486|NCT01425814|580631671|FG000|Period 3|Adverse Event|0|||
160793487|NCT01425814|580631672|FG001|Period 3|Adverse Event|0|||
160793488|NCT01425814|580631673|FG002|Period 3|Adverse Event|0|||
160793489|NCT01425814|580631674|FG003|Period 3|Adverse Event|0|||
160793490|NCT01425814|580631675|FG004|Period 3|Adverse Event|0|||
160793491|NCT01425814|580631676|FG005|Period 3|Adverse Event|1|||
160793492|NCT01425814|580631671|FG000|Period 4|Adverse Event|1|||
160793493|NCT01425814|580631672|FG001|Period 4|Adverse Event|0|||
160793494|NCT01425814|580631673|FG002|Period 4|Adverse Event|1|||
160793495|NCT01425814|580631674|FG003|Period 4|Adverse Event|0|||
160893167|NCT02775903|581003856|FG002|Overall Study|Death|12|||
160893168|NCT02775903|581003857|FG003|Overall Study|Death|11|||
160893169|NCT02775903|581003854|FG000|Overall Study|Adverse Event|0|||
160893170|NCT02775903|581003855|FG001|Overall Study|Adverse Event|1|||
160893171|NCT02775903|581003856|FG002|Overall Study|Adverse Event|12|||
160893172|NCT02775903|581003857|FG003|Overall Study|Adverse Event|3|||
160893173|NCT02775903|581003854|FG000|Overall Study|Progressive disease|15|||
160893174|NCT02775903|581003855|FG001|Overall Study|Progressive disease|14|||
160893175|NCT02775903|581003856|FG002|Overall Study|Progressive disease|30|||
160893176|NCT02775903|581003857|FG003|Overall Study|Progressive disease|20|||
160893177|NCT02775903|581003854|FG000|Overall Study|Lack of Efficacy|2|||
160893178|NCT02775903|581003855|FG001|Overall Study|Lack of Efficacy|2|||
160893179|NCT02775903|581003856|FG002|Overall Study|Lack of Efficacy|2|||
160893180|NCT02775903|581003857|FG003|Overall Study|Lack of Efficacy|6|||
161330635|NCT04006145|582597182|FG001|Overall Study|Lost to Follow-up|1|||
160793496|NCT01425814|580631675|FG004|Period 4|Adverse Event|0|||
160793497|NCT01425814|580631676|FG005|Period 4|Adverse Event|0|||
160793498|NCT01425814|580631671|FG000|Period 5|Stability criteria not fulfilled|0|||
160793499|NCT01425814|580631672|FG001|Period 5|Stability criteria not fulfilled|0|||
160793500|NCT01425814|580631673|FG002|Period 5|Stability criteria not fulfilled|1|||
160793501|NCT01425814|580631674|FG003|Period 5|Stability criteria not fulfilled|0|||
160793502|NCT01425814|580631675|FG004|Period 5|Stability criteria not fulfilled|0|||
160793503|NCT01425814|580631676|FG005|Period 5|Stability criteria not fulfilled|1|||
160793504|NCT03580044|580631677|FG000|Overall Study|Death|2|||
160793505|NCT03580044|580631678|FG001|Overall Study|Death|1|||
160793506|NCT03580044|580631677|FG000|Overall Study|Withdrawal by Subject|1|||
160893181|NCT02775903|581003854|FG000|Overall Study|Withdrawal by Subject|7|||
160893182|NCT02775903|581003855|FG001|Overall Study|Withdrawal by Subject|5|||
160893183|NCT02775903|581003856|FG002|Overall Study|Withdrawal by Subject|5|||
160893184|NCT02775903|581003857|FG003|Overall Study|Withdrawal by Subject|8|||
160982706|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982707|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160793507|NCT03580044|580631678|FG001|Overall Study|Withdrawal by Subject|1|||
160793508|NCT03427619|580631679|FG000|Overall Study|Physician Decision|3|||
160793509|NCT03427619|580631679|FG000|Overall Study|Withdrawal by Subject|4|||
160793510|NCT03427619|580631679|FG000|Overall Study|Lost to Follow-up|5|||
160793511|NCT03427619|580631679|FG000|Overall Study|Administrative|4|||
160793512|NCT03427619|580631679|FG000|Overall Study|Other|2|||
160793513|NCT03427619|580631679|FG000|Overall Study|Unknown or Missing Completion Status|48|||
160793514|NCT02743962|580631684|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
160793515|NCT02743962|580631685|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
160793516|NCT03729609|580631686|FG000|Overall Study|Protocol Violation|1|||
160982708|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
160982709|NCT02601937|581325066|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
160982710|NCT02601937|581325067|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
160982711|NCT02601937|581325068|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
160982712|NCT02601937|581325069|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
160982713|NCT02601937|581325070|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
161235794|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160793517|NCT01055028|580631695|FG000|Screening|Screen Failure|1|||
160793518|NCT01055028|580631696|FG001|Screening|Screen Failure|1|||
160793519|NCT01055028|580631695|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
160793520|NCT01055028|580631696|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
160793521|NCT01055028|580631695|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
160793522|NCT01055028|580631696|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
160793523|NCT01055028|580631695|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
160793524|NCT01055028|580631696|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
160793525|NCT04770285|580631699|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
160793526|NCT04770285|580631700|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
160793527|NCT04770285|580631699|FG000|Overall Study|Lack of Efficacy|0|||
160793528|NCT04770285|580631700|FG001|Overall Study|Lack of Efficacy|1|||
160793529|NCT04770285|580631699|FG000|Overall Study|Lost to Follow-up|11|||
160793530|NCT04770285|580631700|FG001|Overall Study|Lost to Follow-up|8|||
160793531|NCT04770285|580631699|FG000|Overall Study|Protocol Deviation|6|||
160793532|NCT04770285|580631700|FG001|Overall Study|Protocol Deviation|6|||
160793533|NCT04770285|580631699|FG000|Overall Study|Technical Problem|0|||
160793534|NCT04770285|580631700|FG001|Overall Study|Technical Problem|1|||
160793535|NCT04770285|580631699|FG000|Overall Study|Withdrawal by Subject|9|||
160793536|NCT04770285|580631700|FG001|Overall Study|Withdrawal by Subject|8|||
160793537|NCT04770285|580631699|FG000|Overall Study|Reason Not Specified|0|||
160793538|NCT04770285|580631700|FG001|Overall Study|Reason Not Specified|1|||
160793539|NCT04620668|580631701|FG000|Overall Study|Withdrawal by Subject|2|||
160793540|NCT04620668|580631702|FG001|Overall Study|Withdrawal by Subject|0|||
160793541|NCT04620668|580631701|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
160793542|NCT04620668|580631702|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
160793543|NCT04620668|580631701|FG000|Overall Study|Removed before analysis: missing data|2|||
160793544|NCT04620668|580631702|FG001|Overall Study|Removed before analysis: missing data|0|||
160793545|NCT04620668|580631701|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
160793546|NCT04620668|580631702|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
160793547|NCT04620668|580631701|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
160793548|NCT04620668|580631702|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
160793549|NCT04581395|580631709|FG000|Overall Study|Protocol Violation|4|||
160793550|NCT04581395|580631710|FG001|Overall Study|Protocol Violation|3|||
160793551|NCT04581395|580631711|FG002|Overall Study|Protocol Violation|2|||
160793552|NCT04581395|580631709|FG000|Overall Study|Physician Decision|0|||
160793553|NCT04581395|580631710|FG001|Overall Study|Physician Decision|1|||
160793554|NCT04581395|580631711|FG002|Overall Study|Physician Decision|0|||
160793555|NCT00815633|580631716|FG000|Overall Study|study terminated|1|||
160793556|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
160793557|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793558|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793559|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793560|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793561|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793562|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
160793563|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
160793564|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
160793565|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
160793566|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
160793567|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
160793568|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
160793569|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
160793570|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
160793571|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
160793572|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
160793573|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
160793574|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
160793575|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
160793576|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
160793577|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
160793578|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
160793579|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
160793580|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
160793581|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
160793582|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
160793583|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
160793584|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
160793585|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
160793586|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
160893185|NCT02775903|581003854|FG000|Overall Study|Other reasons|7|||
160893186|NCT02775903|581003855|FG001|Overall Study|Other reasons|8|||
160893187|NCT02775903|581003856|FG002|Overall Study|Other reasons|2|||
160893188|NCT02775903|581003857|FG003|Overall Study|Other reasons|12|||
160893189|NCT03552965|581003861|FG000|Overall Study|Death|1|||
160893190|NCT03552965|581003862|FG001|Overall Study|Death|1|||
160893191|NCT03552965|581003861|FG000|Overall Study|Lost to Follow-up|1|||
160893192|NCT03552965|581003862|FG001|Overall Study|Lost to Follow-up|1|||
160893193|NCT03552965|581003861|FG000|Overall Study|Physician Decision|1|||
160893194|NCT03552965|581003862|FG001|Overall Study|Physician Decision|1|||
160893195|NCT03552965|581003861|FG000|Overall Study|Withdrawal by Subject|0|||
160893196|NCT03552965|581003862|FG001|Overall Study|Withdrawal by Subject|2|||
160893197|NCT03552965|581003861|FG000|Overall Study|Continuation not in patient best interest|1|||
160893198|NCT03552965|581003862|FG001|Overall Study|Continuation not in patient best interest|0|||
160893199|NCT03552965|581003861|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
160893200|NCT03552965|581003862|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
160893201|NCT02160782|581004909|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
160893202|NCT02160782|581004910|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
160893203|NCT02160782|581004911|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
160893204|NCT02160782|581004912|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
160893205|NCT02160782|581004913|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
160893206|NCT02160782|581004909|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893207|NCT02160782|581004910|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893208|NCT02160782|581004911|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893209|NCT02160782|581004912|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
160893210|NCT02160782|581004913|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
160893211|NCT02160782|581004909|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893212|NCT02160782|581004910|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893213|NCT02160782|581004911|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893214|NCT02160782|581004912|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
160893215|NCT02160782|581004913|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
160893216|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893217|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893218|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893219|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
160893220|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
160893221|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893222|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893223|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893224|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
160893225|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
160893226|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160893227|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160893228|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
161128844|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
161142630|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
161330636|NCT04006145|582597181|FG000|Overall Study|Other|1|||
160793587|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
160893229|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
160893230|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
160893231|NCT02160782|581004909|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893232|NCT02160782|581004910|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893233|NCT02160782|581004911|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893234|NCT02160782|581004912|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
160893235|NCT02160782|581004913|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
160893236|NCT03061097|581004923|FG000|Overall Study|Withdrawal by Subject|0|||
160893237|NCT03061097|581004924|FG001|Overall Study|Withdrawal by Subject|3|||
160893238|NCT02437513|581004925|FG000|Overall Study|Withdrawal by Subject|2|||
160893239|NCT00761579|581004931|FG000|Overall Study|Adverse Event|10|||
160893240|NCT00761579|581004931|FG000|Overall Study|Death|2|||
160893241|NCT00761579|581004931|FG000|Overall Study|Lack of Efficacy|21|||
160893242|NCT00761579|581004931|FG000|Overall Study|Lost to Follow-up|16|||
160893243|NCT00761579|581004931|FG000|Overall Study|Pregnancy|1|||
160893244|NCT00761579|581004931|FG000|Overall Study|Withdrawal by Subject|34|||
160893245|NCT00761579|581004931|FG000|Overall Study|Lack of compliance|2|||
160893246|NCT00761579|581004931|FG000|Overall Study|Protocol deviation|1|||
160893247|NCT00761579|581004931|FG000|Overall Study|Drug overdose|1|||
160893248|NCT00761579|581004931|FG000|Overall Study|Aggravation of depression|1|||
160893249|NCT00761579|581004931|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
160893250|NCT00761579|581004931|FG000|Overall Study|Lost survey form|1|||
160893251|NCT00761579|581004931|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
160893252|NCT00950911|581004932|FG000|Overall Study|Adverse Event|0|||
160893253|NCT00950911|581004933|FG001|Overall Study|Adverse Event|2|||
160893254|NCT00950911|581004932|FG000|Overall Study|Death|4|||
160893255|NCT00950911|581004933|FG001|Overall Study|Death|6|||
160893256|NCT00950911|581004932|FG000|Overall Study|Disease progression|2|||
160893257|NCT00950911|581004933|FG001|Overall Study|Disease progression|2|||
160893258|NCT00950911|581004932|FG000|Overall Study|Consent withdrawn|1|||
160893259|NCT00950911|581004933|FG001|Overall Study|Consent withdrawn|3|||
160893260|NCT00950911|581004932|FG000|Overall Study|Administrative decision|3|||
160893261|NCT00950911|581004933|FG001|Overall Study|Administrative decision|1|||
160893262|NCT00950911|581004932|FG000|Overall Study|Ineligibility determined|1|||
160893263|NCT00950911|581004933|FG001|Overall Study|Ineligibility determined|0|||
160893264|NCT00950911|581004932|FG000|Overall Study|Noncompliance|1|||
160893265|NCT00950911|581004933|FG001|Overall Study|Noncompliance|0|||
160893266|NCT00950911|581004932|FG000|Overall Study|Poor performance status|0|||
160893267|NCT00950911|581004933|FG001|Overall Study|Poor performance status|1|||
160893268|NCT02600351|581004934|FG000|Overall Study|Lack of Efficacy|3|||
160893269|NCT02600351|581004935|FG001|Overall Study|Lack of Efficacy|0|||
160893270|NCT02600351|581004936|FG002|Overall Study|Lack of Efficacy|5|||
160893271|NCT02600351|581004937|FG003|Overall Study|Lack of Efficacy|2|||
160893272|NCT02600351|581004934|FG000|Overall Study|Lost to Follow-up|1|||
160893273|NCT02600351|581004935|FG001|Overall Study|Lost to Follow-up|0|||
160893274|NCT02600351|581004936|FG002|Overall Study|Lost to Follow-up|0|||
160893275|NCT02600351|581004937|FG003|Overall Study|Lost to Follow-up|0|||
160893276|NCT02600351|581004934|FG000|Overall Study|Randomized but Not Treated|1|||
160893277|NCT02600351|581004935|FG001|Overall Study|Randomized but Not Treated|0|||
160893278|NCT02600351|581004936|FG002|Overall Study|Randomized but Not Treated|1|||
160893279|NCT02600351|581004937|FG003|Overall Study|Randomized but Not Treated|3|||
160893280|NCT02063880|581004938|FG000|Overall Study|Death|21|||
160893281|NCT02063880|581004939|FG001|Overall Study|Death|18|||
160893282|NCT02063880|581004938|FG000|Overall Study|Lost to Follow-up|7|||
160893283|NCT02063880|581004939|FG001|Overall Study|Lost to Follow-up|7|||
160893284|NCT02063880|581004938|FG000|Overall Study|Ineligible|0|||
160893285|NCT02063880|581004939|FG001|Overall Study|Ineligible|2|||
160893286|NCT00567593|581004940|FG000|Overall Study|Adverse Event|1|||
160893287|NCT00567593|581004940|FG000|Overall Study|Physician Decision|1|||
160893288|NCT02106910|581004943|FG000|Overall Study|Lost to Follow-up|1|||
160893289|NCT02106910|581004944|FG001|Overall Study|Lost to Follow-up|1|||
160893290|NCT04087213|581004945|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
160893291|NCT04087213|581004945|FG000|In-Facility Introduction|Adverse Event|1|||
160893292|NCT04087213|581004945|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
161128845|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
161128846|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
160893293|NCT04087213|581004945|FG000|Assisted Evaluable Period|Personal reasons|3|||
160893294|NCT04087213|581004945|FG000|Transition Period B|Renal Transplantation|1|||
160893295|NCT02476422|581004946|FG000|Overall Study|Subject/guardian decision|0|||
160893296|NCT02476422|581004947|FG001|Overall Study|Subject/guardian decision|1|||
160893297|NCT03960554|581004954|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
160893298|NCT03960554|581004955|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
160893299|NCT02545075|581004956|FG000|Randomization|Lost to Follow-up|0|||
160893300|NCT02545075|581004957|FG001|Randomization|Lost to Follow-up|1|||
160893301|NCT02545075|581004956|FG000|Randomization|Withdrawal by Subject|0|||
160893302|NCT02545075|581004957|FG001|Randomization|Withdrawal by Subject|6|||
160893303|NCT02545075|581004956|FG000|Treatment|Disease progression|71|||
160793588|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
160793589|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
160793590|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
160793591|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
160793592|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
161128847|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
161128848|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
161128849|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
161128850|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
161128851|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
161128852|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
161128853|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161128854|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
161128855|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
161128856|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161128857|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
161128858|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
161128859|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161128860|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161128861|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161128862|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
161128863|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161128864|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161330637|NCT04006145|582597182|FG001|Overall Study|Other|2|||
161330638|NCT01001429|582597183|FG000|Overall Study|surgery cancelled|0|||
160793593|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
160793594|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
160793595|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
160793596|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
160793597|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
160793598|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
160793599|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793600|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793601|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793602|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793603|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793604|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
160793605|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793606|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
160793607|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793608|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793609|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793610|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793611|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
160793612|NCT01362790|580631717|FG000|Pilot Phase & Phase 2|Death on study|0|||
160793613|NCT01362790|580631718|FG001|Pilot Phase & Phase 2|Death on study|0|||
160793614|NCT01362790|580631719|FG002|Pilot Phase & Phase 2|Death on study|0|||
160793615|NCT01362790|580631720|FG003|Pilot Phase & Phase 2|Death on study|1|||
160793616|NCT01362790|580631721|FG004|Pilot Phase & Phase 2|Death on study|0|||
160793617|NCT01362790|580631722|FG005|Pilot Phase & Phase 2|Death on study|0|||
160793618|NCT01362790|580631723|FG006|Pilot Phase & Phase 2|Death on study|0|||
160793619|NCT01362790|580631717|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
160793620|NCT01362790|580631718|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
160793621|NCT01362790|580631719|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
160793622|NCT01362790|580631720|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
160793623|NCT01362790|580631721|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
160793624|NCT01362790|580631722|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
160793625|NCT01362790|580631723|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
160793626|NCT01362790|580631717|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793627|NCT01362790|580631718|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793628|NCT01362790|580631719|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793629|NCT01362790|580631720|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793630|NCT01362790|580631721|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
160793631|NCT01362790|580631722|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793632|NCT01362790|580631723|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
160793633|NCT01362790|580631717|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
160793634|NCT01362790|580631718|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
161235795|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
161235796|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161235797|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
161235798|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235799|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
161235800|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235801|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235802|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160893304|NCT02545075|581004957|FG001|Treatment|Disease progression|32|||
160893305|NCT02545075|581004956|FG000|Treatment|Participant dicontinued study treatment|7|||
160893306|NCT02545075|581004957|FG001|Treatment|Participant dicontinued study treatment|9|||
160893307|NCT02545075|581004956|FG000|Treatment|Withdrawal by Subject|1|||
160893308|NCT02545075|581004957|FG001|Treatment|Withdrawal by Subject|0|||
160893309|NCT02545075|581004956|FG000|Treatment|Adverse event not related to study drug|1|||
160893310|NCT02545075|581004957|FG001|Treatment|Adverse event not related to study drug|0|||
160893311|NCT02545075|581004956|FG000|Treatment|Death|1|||
160893312|NCT02545075|581004957|FG001|Treatment|Death|0|||
160893313|NCT02545075|581004956|FG000|Treatment|Participant drug toxicity|1|||
160893314|NCT02545075|581004957|FG001|Treatment|Participant drug toxicity|0|||
160893315|NCT02545075|581004956|FG000|Treatment|Completed treatment|40|||
160893316|NCT02545075|581004957|FG001|Treatment|Completed treatment|12|||
160893317|NCT01272661|581004959|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
160893318|NCT01272661|581004960|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
160893319|NCT01272661|581004961|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
160893320|NCT01086423|581004962|FG000|Overall Study|Protocol Violation|0|||
160893321|NCT01086423|581004963|FG001|Overall Study|Protocol Violation|0|||
160893322|NCT01086423|581004964|FG002|Overall Study|Protocol Violation|1|||
160893323|NCT01086423|581004962|FG000|Overall Study|Migrated/moved from study area|2|||
160893324|NCT01086423|581004963|FG001|Overall Study|Migrated/moved from study area|0|||
160893325|NCT01086423|581004964|FG002|Overall Study|Migrated/moved from study area|4|||
160893326|NCT01086423|581004962|FG000|Overall Study|Adverse event, fatal|1|||
160893327|NCT01086423|581004963|FG001|Overall Study|Adverse event, fatal|1|||
160893328|NCT01086423|581004964|FG002|Overall Study|Adverse event, fatal|0|||
160893329|NCT01086423|581004962|FG000|Overall Study|Adverse event, non-fatal|2|||
160893330|NCT01086423|581004963|FG001|Overall Study|Adverse event, non-fatal|1|||
160893331|NCT01086423|581004964|FG002|Overall Study|Adverse event, non-fatal|0|||
160893332|NCT01086423|581004962|FG000|Overall Study|Withdrawal by Subject|5|||
160893333|NCT01086423|581004963|FG001|Overall Study|Withdrawal by Subject|1|||
160893334|NCT01086423|581004964|FG002|Overall Study|Withdrawal by Subject|3|||
160893335|NCT01086423|581004962|FG000|Overall Study|Lost to Follow-up|0|||
160893336|NCT01086423|581004963|FG001|Overall Study|Lost to Follow-up|0|||
160893337|NCT01086423|581004964|FG002|Overall Study|Lost to Follow-up|1|||
160893338|NCT00750880|581004968|FG000|Overall Study|Adverse Event|76|||
160893339|NCT00750880|581004968|FG000|Overall Study|Death|4|||
160893340|NCT00750880|581004968|FG000|Overall Study|Lack of Efficacy|46|||
160893341|NCT00750880|581004968|FG000|Overall Study|Lost to Follow-up|10|||
160893342|NCT00750880|581004968|FG000|Overall Study|Protocol Violation|15|||
160893343|NCT00750880|581004968|FG000|Overall Study|Withdrawal by Subject|33|||
160893344|NCT00750880|581004968|FG000|Overall Study|Physician Decision|20|||
160893345|NCT00750880|581004968|FG000|Overall Study|Administrative|11|||
160893346|NCT00925990|581004969|FG000|Overall Study|Adverse Event|1|||
160893347|NCT00925990|581004970|FG001|Overall Study|Adverse Event|3|||
160893348|NCT00925990|581004969|FG000|Overall Study|Withdrawal by Subject|2|||
160893349|NCT00925990|581004970|FG001|Overall Study|Withdrawal by Subject|2|||
160893350|NCT00925990|581004969|FG000|Overall Study|Lost to Follow-up|1|||
160893351|NCT00925990|581004970|FG001|Overall Study|Lost to Follow-up|3|||
160893352|NCT00925990|581004969|FG000|Overall Study|Physician Decision|1|||
160893353|NCT00925990|581004970|FG001|Overall Study|Physician Decision|1|||
160893354|NCT00925990|581004969|FG000|Overall Study|moved out of state, missed medication|0|||
160893355|NCT00925990|581004970|FG001|Overall Study|moved out of state, missed medication|2|||
160893356|NCT00573248|581004979|FG000|Overall Study|scheduling conflicts|15|||
160893357|NCT00573248|581004980|FG001|Overall Study|scheduling conflicts|11|||
160893358|NCT05342532|581004981|FG000|Overall Study|Adverse Event|5|||
160893359|NCT05342532|581004982|FG001|Overall Study|Adverse Event|20|||
160893360|NCT05342532|581004981|FG000|Overall Study|Lost to Follow-up|10|||
161330639|NCT01001429|582597184|FG001|Overall Study|surgery cancelled|1|||
160893361|NCT05342532|581004982|FG001|Overall Study|Lost to Follow-up|15|||
160893362|NCT02057393|581004983|FG000|Overall Study|Withdrawal by Subject|1|||
160893363|NCT02057393|581004983|FG000|Overall Study|Patient did not meet criteria|1|||
160893364|NCT01130103|581004990|FG000|Randomized Treatment|Adverse Event|1|||
160893365|NCT01130103|581004991|FG001|Randomized Treatment|Adverse Event|1|||
160893366|NCT01130103|581004990|FG000|Randomized Treatment|Lost to Follow-up|1|||
160893367|NCT01130103|581004991|FG001|Randomized Treatment|Lost to Follow-up|0|||
160893368|NCT01130103|581004990|FG000|Randomized Treatment|Protocol Violation|3|||
160893369|NCT01130103|581004991|FG001|Randomized Treatment|Protocol Violation|2|||
160893370|NCT01130103|581004990|FG000|Randomized Treatment|Withdrawal by Subject|1|||
160893371|NCT01130103|581004991|FG001|Randomized Treatment|Withdrawal by Subject|2|||
160893372|NCT01130103|581004990|FG000|Maintenance Treatment|Lack of Efficacy|0|||
160893373|NCT01130103|581004991|FG001|Maintenance Treatment|Lack of Efficacy|1|||
160893374|NCT01130103|581004990|FG000|Maintenance Treatment|Lost to Follow-up|1|||
160893375|NCT01130103|581004991|FG001|Maintenance Treatment|Lost to Follow-up|1|||
160893376|NCT01130103|581004990|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
160893377|NCT01130103|581004991|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
160893378|NCT00249288|581004992|FG000|Overall Study|Lost to Follow-up|3|||
160893379|NCT00249288|581004993|FG001|Overall Study|Lost to Follow-up|3|||
160893380|NCT00249288|581004992|FG000|Overall Study|Withdrawal by Subject|2|||
160982714|NCT02601937|581325071|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
160982715|NCT02601937|581325072|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
160982716|NCT02601937|581325073|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
160893381|NCT00249288|581004993|FG001|Overall Study|Withdrawal by Subject|2|||
160893382|NCT01437878|581004994|FG000|Overall Study|Withdrawal by Subject|1|||
160893383|NCT01437878|581004995|FG001|Overall Study|Withdrawal by Subject|0|||
160893384|NCT01476644|581005002|FG000|Overall Study|Death|5|||
160893385|NCT01476644|581005002|FG000|Overall Study|moved to another state|2|||
160893386|NCT01476644|581005002|FG000|Overall Study|Lost to Follow-up|19|||
160893387|NCT01476644|581005002|FG000|Overall Study|Withdrawal by Subject|13|||
160893388|NCT00471146|581005004|FG000|Overall Study|Adverse Event|32|||
160893389|NCT00471146|581005005|FG001|Overall Study|Adverse Event|33|||
160893390|NCT00471146|581005004|FG000|Overall Study|Withdrawal by Subject|14|||
160893391|NCT00471146|581005005|FG001|Overall Study|Withdrawal by Subject|11|||
160893392|NCT00471146|581005004|FG000|Overall Study|Death|11|||
160893393|NCT00471146|581005005|FG001|Overall Study|Death|12|||
160893394|NCT00471146|581005004|FG000|Overall Study|Lost to Follow-up|4|||
160893395|NCT00471146|581005005|FG001|Overall Study|Lost to Follow-up|2|||
160893396|NCT00471146|581005004|FG000|Overall Study|Protocol Violation|2|||
160893397|NCT00471146|581005005|FG001|Overall Study|Protocol Violation|2|||
160893398|NCT00471146|581005004|FG000|Overall Study|Objective progression or relapse|84|||
160893399|NCT00471146|581005005|FG001|Overall Study|Objective progression or relapse|87|||
160893400|NCT00471146|581005004|FG000|Overall Study|Global deterioration of health status|12|||
160893401|NCT00471146|581005005|FG001|Overall Study|Global deterioration of health status|14|||
160893402|NCT00471146|581005004|FG000|Overall Study|Randomized but not treated|9|||
160893403|NCT00471146|581005005|FG001|Overall Study|Randomized but not treated|8|||
160893404|NCT00471146|581005004|FG000|Overall Study|Other|4|||
160893405|NCT00471146|581005005|FG001|Overall Study|Other|5|||
160893406|NCT00467610|581005008|FG000|Overall Study|Withdrawal by Subject|1|||
160893407|NCT02676466|581005010|FG000|Overall Study|Death|0|||
160893408|NCT02676466|581005011|FG001|Overall Study|Death|2|||
160893409|NCT02676466|581005012|FG002|Overall Study|Death|1|||
160893410|NCT02676466|581005013|FG003|Overall Study|Death|0|||
160893411|NCT02676466|581005014|FG004|Overall Study|Death|0|||
160893412|NCT02676466|581005015|FG005|Overall Study|Death|0|||
160893413|NCT02676466|581005016|FG006|Overall Study|Death|0|||
160893414|NCT02676466|581005017|FG007|Overall Study|Death|0|||
160893415|NCT02676466|581005010|FG000|Overall Study|Withdrawal by Subject|4|||
160982717|NCT02601937|581325074|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
160982718|NCT02601937|581325075|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
160982719|NCT02601937|581325076|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
160982720|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982721|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982722|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982723|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982724|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982725|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982726|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982727|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982728|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160982729|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
160893416|NCT02676466|581005011|FG001|Overall Study|Withdrawal by Subject|3|||
160893417|NCT02676466|581005012|FG002|Overall Study|Withdrawal by Subject|1|||
160893418|NCT02676466|581005013|FG003|Overall Study|Withdrawal by Subject|0|||
160893419|NCT02676466|581005014|FG004|Overall Study|Withdrawal by Subject|3|||
160893420|NCT02676466|581005015|FG005|Overall Study|Withdrawal by Subject|1|||
160893421|NCT02676466|581005016|FG006|Overall Study|Withdrawal by Subject|1|||
160893422|NCT02676466|581005017|FG007|Overall Study|Withdrawal by Subject|1|||
160893423|NCT01460368|581005018|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893424|NCT01460368|581005019|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893425|NCT01460368|581005020|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160982730|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
160893426|NCT01460368|581005021|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893427|NCT01460368|581005022|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
160893428|NCT01460368|581005023|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893429|NCT01460368|581005024|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
160893430|NCT01460368|581005018|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893431|NCT01460368|581005019|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
160893432|NCT01460368|581005020|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893433|NCT01460368|581005021|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893434|NCT01460368|581005022|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893435|NCT01460368|581005023|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
160893436|NCT01460368|581005024|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
160893437|NCT01460368|581005018|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893438|NCT01460368|581005019|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
160893439|NCT01460368|581005020|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893440|NCT01460368|581005021|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893441|NCT01460368|581005022|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893442|NCT01460368|581005023|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893443|NCT01460368|581005024|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
160893444|NCT01460368|581005018|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893445|NCT01460368|581005019|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893446|NCT01460368|581005020|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
160893447|NCT01460368|581005021|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893448|NCT01460368|581005022|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893449|NCT01460368|581005023|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893450|NCT01460368|581005024|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
160893451|NCT01460368|581005018|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893452|NCT01460368|581005019|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893453|NCT01460368|581005020|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
160893454|NCT01460368|581005021|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
160893455|NCT01460368|581005022|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893456|NCT01460368|581005023|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
160893457|NCT01460368|581005024|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
160893458|NCT01090973|581005025|FG000|Overall Study|Disease progression|1|||
160893459|NCT00445978|581005026|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
160893460|NCT00445978|581005026|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
160893461|NCT00445978|581005026|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
160893462|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
160893463|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
160893464|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
160893465|NCT00445978|581005026|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
160893466|NCT00445978|581005026|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
160893467|NCT00445978|581005026|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
160893468|NCT00739596|581005027|FG000|Overall Study|Adverse Event|12|||
160893469|NCT00739596|581005028|FG001|Overall Study|Adverse Event|6|||
160893470|NCT00739596|581005027|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
160893471|NCT00739596|581005028|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160893472|NCT00739596|581005027|FG000|Overall Study|Patient Withdrew Consent|8|||
160893473|NCT00739596|581005028|FG001|Overall Study|Patient Withdrew Consent|8|||
160893474|NCT00739596|581005027|FG000|Overall Study|Lost to Follow-up|0|||
160893475|NCT00739596|581005028|FG001|Overall Study|Lost to Follow-up|2|||
160893476|NCT00739596|581005027|FG000|Overall Study|Protocol Deviation|1|||
160893477|NCT00739596|581005028|FG001|Overall Study|Protocol Deviation|1|||
160893478|NCT02520661|581005029|FG000|Overall Study|Lost to Follow-up|7|||
160893479|NCT02520661|581005030|FG001|Overall Study|Lost to Follow-up|3|||
160893480|NCT02520661|581005029|FG000|Overall Study|Admitted from ED|49|||
160893481|NCT02520661|581005030|FG001|Overall Study|Admitted from ED|48|||
160893482|NCT02520661|581005029|FG000|Overall Study|ED greater than 24 hours|29|||
160893483|NCT02520661|581005030|FG001|Overall Study|ED greater than 24 hours|38|||
160893484|NCT02520661|581005029|FG000|Overall Study|other ineligibility|14|||
160893485|NCT02520661|581005030|FG001|Overall Study|other ineligibility|22|||
160893486|NCT02520661|581005029|FG000|Overall Study|Withdrawal by Subject|7|||
160893487|NCT02520661|581005030|FG001|Overall Study|Withdrawal by Subject|16|||
160893488|NCT01414608|581005037|FG000|Overall Study|Ineligible|5|||
160893489|NCT01414608|581005038|FG001|Overall Study|Ineligible|2|||
161330640|NCT00010257|582597187|FG000|Overall Study|Withdrawal by Subject|1|||
160893490|NCT00891462|581006304|FG000|Overall Study|Withdrawal by Subject|9|||
160893491|NCT00891462|581006305|FG001|Overall Study|Withdrawal by Subject|6|||
160893492|NCT00891462|581006306|FG002|Overall Study|Withdrawal by Subject|7|||
160893493|NCT00891462|581006304|FG000|Overall Study|Adverse Event|7|||
160893494|NCT00891462|581006305|FG001|Overall Study|Adverse Event|8|||
160893495|NCT00891462|581006306|FG002|Overall Study|Adverse Event|7|||
160793635|NCT01362790|580631719|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
160793636|NCT01362790|580631720|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
160793637|NCT01362790|580631721|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
160793638|NCT01362790|580631722|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
160793639|NCT01362790|580631723|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
160793640|NCT03485157|580631724|FG000|Double Blind Phase|Lost to Follow-up|4|||
160793641|NCT03485157|580631725|FG001|Double Blind Phase|Lost to Follow-up|4|||
160793642|NCT03485157|580631724|FG000|Double Blind Phase|Adverse Event|2|||
160793643|NCT03485157|580631725|FG001|Double Blind Phase|Adverse Event|1|||
160793644|NCT03485157|580631724|FG000|Double Blind Phase|Withdrawal by Subject|6|||
160793645|NCT03485157|580631725|FG001|Double Blind Phase|Withdrawal by Subject|9|||
160793646|NCT03485157|580631724|FG000|Double Blind Phase|Removal by PI|3|||
160793647|NCT03485157|580631725|FG001|Double Blind Phase|Removal by PI|7|||
160793648|NCT03485157|580631724|FG000|Open Label Phase|Lost to Follow-up|1|||
160793649|NCT03485157|580631725|FG001|Open Label Phase|Lost to Follow-up|2|||
160793650|NCT03485157|580631724|FG000|Open Label Phase|Adverse Event|0|||
160793651|NCT03485157|580631725|FG001|Open Label Phase|Adverse Event|1|||
160793652|NCT03485157|580631724|FG000|Open Label Phase|Withdrawal by Subject|1|||
160793653|NCT03485157|580631725|FG001|Open Label Phase|Withdrawal by Subject|2|||
160793654|NCT03485157|580631724|FG000|Open Label Phase|Removal by PI|2|||
160793655|NCT03485157|580631725|FG001|Open Label Phase|Removal by PI|0|||
160793656|NCT04347538|580631731|FG000|Overall Study|Lost to Follow-up|4|||
160793657|NCT04347538|580631732|FG001|Overall Study|Lost to Follow-up|5|||
160793658|NCT04347538|580631733|FG002|Overall Study|Lost to Follow-up|7|||
160793659|NCT02135133|580631734|FG000|Overall Study|Adverse Event|10|||
160793660|NCT02135133|580631734|FG000|Overall Study|regulatory mandate|5|||
160793661|NCT02259231|580631735|FG000|Overall Study|Adverse Event|1|||
160793662|NCT02259231|580631736|FG001|Overall Study|Adverse Event|1|||
160793663|NCT02259231|580631737|FG002|Overall Study|Adverse Event|2|||
160793664|NCT02259231|580631738|FG003|Overall Study|Adverse Event|0|||
160793665|NCT02259231|580631739|FG004|Overall Study|Adverse Event|0|||
160793666|NCT02259231|580631740|FG005|Overall Study|Adverse Event|0|||
160793667|NCT02259231|580631741|FG006|Overall Study|Adverse Event|0|||
160793668|NCT02259231|580631735|FG000|Overall Study|Progressive Disease|4|||
160793669|NCT02259231|580631736|FG001|Overall Study|Progressive Disease|5|||
160793670|NCT02259231|580631737|FG002|Overall Study|Progressive Disease|4|||
160793671|NCT02259231|580631738|FG003|Overall Study|Progressive Disease|5|||
160793672|NCT02259231|580631739|FG004|Overall Study|Progressive Disease|4|||
160793673|NCT02259231|580631740|FG005|Overall Study|Progressive Disease|5|||
160793674|NCT02259231|580631741|FG006|Overall Study|Progressive Disease|4|||
160793675|NCT02259231|580631735|FG000|Overall Study|Sponsor termination of study|1|||
160793676|NCT02259231|580631736|FG001|Overall Study|Sponsor termination of study|0|||
160793677|NCT02259231|580631737|FG002|Overall Study|Sponsor termination of study|0|||
160793678|NCT02259231|580631738|FG003|Overall Study|Sponsor termination of study|1|||
160793679|NCT02259231|580631739|FG004|Overall Study|Sponsor termination of study|2|||
160793680|NCT02259231|580631740|FG005|Overall Study|Sponsor termination of study|1|||
160793681|NCT02259231|580631741|FG006|Overall Study|Sponsor termination of study|1|||
160793682|NCT05081843|580631742|FG000|Overall Study|Lost to Follow-up|135|||
160793683|NCT05081843|580631743|FG001|Overall Study|Lost to Follow-up|145|||
160793684|NCT05852340|580631754|FG000|Period 5|Not completing the meal|0|||
160793685|NCT05852340|580631755|FG001|Period 5|Not completing the meal|1|||
160793686|NCT05852340|580631756|FG002|Period 5|Not completing the meal|0|||
160793687|NCT05852340|580631757|FG003|Period 5|Not completing the meal|0|||
160793688|NCT05852340|580631754|FG000|Period 5|Adverse Event|0|||
160793689|NCT05852340|580631755|FG001|Period 5|Adverse Event|0|||
160793690|NCT05852340|580631756|FG002|Period 5|Adverse Event|0|||
160793691|NCT05852340|580631757|FG003|Period 5|Adverse Event|1|||
160793692|NCT00071032|580631760|FG000|Overall Study|Lost to Follow-up|1|||
160793693|NCT00071032|580631761|FG001|Overall Study|Lost to Follow-up|1|||
160793694|NCT00071032|580631760|FG000|Overall Study|Withdrawal by Subject|8|||
160793695|NCT00071032|580631761|FG001|Overall Study|Withdrawal by Subject|6|||
160793696|NCT00071032|580631760|FG000|Overall Study|Missing Primary Outcome|0|||
160793697|NCT00071032|580631761|FG001|Overall Study|Missing Primary Outcome|1|||
160793698|NCT03648372|580631771|FG000|Overall Study|Withdrawal by Subject|2|||
160793699|NCT03648372|580631772|FG001|Overall Study|Withdrawal by Subject|0|||
160793700|NCT03648372|580631773|FG002|Overall Study|Withdrawal by Subject|0|||
160793701|NCT03648372|580631774|FG003|Overall Study|Withdrawal by Subject|0|||
160793702|NCT03648372|580631775|FG004|Overall Study|Withdrawal by Subject|0|||
160793703|NCT03648372|580631776|FG005|Overall Study|Withdrawal by Subject|1|||
160793704|NCT03648372|580631777|FG006|Overall Study|Withdrawal by Subject|2|||
160793705|NCT03648372|580631778|FG007|Overall Study|Withdrawal by Subject|0|||
160793706|NCT03648372|580631779|FG008|Overall Study|Withdrawal by Subject|0|||
160793707|NCT03648372|580631780|FG009|Overall Study|Withdrawal by Subject|0|||
160793708|NCT03648372|580631781|FG010|Overall Study|Withdrawal by Subject|2|||
160793709|NCT03648372|580631782|FG011|Overall Study|Withdrawal by Subject|0|||
160793710|NCT03648372|580631783|FG012|Overall Study|Withdrawal by Subject|2|||
160793711|NCT03648372|580631784|FG013|Overall Study|Withdrawal by Subject|0|||
160793712|NCT03648372|580631785|FG014|Overall Study|Withdrawal by Subject|0|||
160793713|NCT03648372|580631786|FG015|Overall Study|Withdrawal by Subject|0|||
160793714|NCT03648372|580631787|FG016|Overall Study|Withdrawal by Subject|1|||
160793715|NCT03648372|580631788|FG017|Overall Study|Withdrawal by Subject|0|||
160793716|NCT03648372|580631789|FG018|Overall Study|Withdrawal by Subject|0|||
160793717|NCT03648372|580631790|FG019|Overall Study|Withdrawal by Subject|0|||
160793718|NCT03648372|580631791|FG020|Overall Study|Withdrawal by Subject|0|||
160793719|NCT03648372|580631771|FG000|Overall Study|Progressive Disease|2|||
160793720|NCT03648372|580631772|FG001|Overall Study|Progressive Disease|3|||
160793721|NCT03648372|580631773|FG002|Overall Study|Progressive Disease|4|||
160793722|NCT03648372|580631774|FG003|Overall Study|Progressive Disease|3|||
160793723|NCT03648372|580631775|FG004|Overall Study|Progressive Disease|2|||
160793724|NCT03648372|580631776|FG005|Overall Study|Progressive Disease|2|||
160793725|NCT03648372|580631777|FG006|Overall Study|Progressive Disease|3|||
160793726|NCT03648372|580631778|FG007|Overall Study|Progressive Disease|3|||
160793727|NCT03648372|580631779|FG008|Overall Study|Progressive Disease|5|||
160793728|NCT03648372|580631780|FG009|Overall Study|Progressive Disease|5|||
160793729|NCT03648372|580631781|FG010|Overall Study|Progressive Disease|2|||
160793730|NCT03648372|580631782|FG011|Overall Study|Progressive Disease|3|||
160793731|NCT03648372|580631783|FG012|Overall Study|Progressive Disease|3|||
160793732|NCT03648372|580631784|FG013|Overall Study|Progressive Disease|3|||
160793733|NCT03648372|580631785|FG014|Overall Study|Progressive Disease|6|||
160793734|NCT03648372|580631786|FG015|Overall Study|Progressive Disease|0|||
160793735|NCT03648372|580631787|FG016|Overall Study|Progressive Disease|0|||
160793736|NCT03648372|580631788|FG017|Overall Study|Progressive Disease|0|||
160793737|NCT03648372|580631789|FG018|Overall Study|Progressive Disease|0|||
160793738|NCT03648372|580631790|FG019|Overall Study|Progressive Disease|0|||
160793739|NCT03648372|580631791|FG020|Overall Study|Progressive Disease|0|||
160793740|NCT03648372|580631771|FG000|Overall Study|Other|0|||
160793741|NCT03648372|580631772|FG001|Overall Study|Other|0|||
160793742|NCT03648372|580631773|FG002|Overall Study|Other|0|||
160793743|NCT03648372|580631774|FG003|Overall Study|Other|0|||
160982731|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160793744|NCT03648372|580631775|FG004|Overall Study|Other|1|||
160793745|NCT03648372|580631776|FG005|Overall Study|Other|0|||
160793746|NCT03648372|580631777|FG006|Overall Study|Other|0|||
160793747|NCT03648372|580631778|FG007|Overall Study|Other|0|||
160793748|NCT03648372|580631779|FG008|Overall Study|Other|0|||
160793749|NCT03648372|580631780|FG009|Overall Study|Other|0|||
160793750|NCT03648372|580631781|FG010|Overall Study|Other|1|||
160793751|NCT03648372|580631782|FG011|Overall Study|Other|2|||
160982732|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982733|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982734|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982735|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982736|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982737|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982738|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
160793752|NCT03648372|580631783|FG012|Overall Study|Other|1|||
160793753|NCT03648372|580631784|FG013|Overall Study|Other|3|||
160793754|NCT03648372|580631785|FG014|Overall Study|Other|0|||
160793755|NCT03648372|580631786|FG015|Overall Study|Other|5|||
160793756|NCT03648372|580631787|FG016|Overall Study|Other|1|||
160793757|NCT03648372|580631788|FG017|Overall Study|Other|5|||
160793758|NCT03648372|580631789|FG018|Overall Study|Other|0|||
160793759|NCT03648372|580631790|FG019|Overall Study|Other|1|||
160793760|NCT03648372|580631791|FG020|Overall Study|Other|0|||
160793761|NCT03648372|580631771|FG000|Overall Study|Lost to Follow-up|0|||
160793762|NCT03648372|580631772|FG001|Overall Study|Lost to Follow-up|0|||
160793763|NCT03648372|580631773|FG002|Overall Study|Lost to Follow-up|0|||
160793764|NCT03648372|580631774|FG003|Overall Study|Lost to Follow-up|0|||
160793765|NCT03648372|580631775|FG004|Overall Study|Lost to Follow-up|0|||
160793766|NCT03648372|580631776|FG005|Overall Study|Lost to Follow-up|0|||
160793767|NCT03648372|580631777|FG006|Overall Study|Lost to Follow-up|0|||
160793768|NCT03648372|580631778|FG007|Overall Study|Lost to Follow-up|0|||
160793769|NCT03648372|580631779|FG008|Overall Study|Lost to Follow-up|0|||
160982739|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
161330641|NCT00010257|582597188|FG001|Overall Study|Withdrawal by Subject|0|||
160793770|NCT03648372|580631780|FG009|Overall Study|Lost to Follow-up|0|||
160793771|NCT03648372|580631781|FG010|Overall Study|Lost to Follow-up|0|||
160793772|NCT03648372|580631782|FG011|Overall Study|Lost to Follow-up|0|||
160793773|NCT03648372|580631783|FG012|Overall Study|Lost to Follow-up|0|||
160793774|NCT03648372|580631784|FG013|Overall Study|Lost to Follow-up|1|||
160793775|NCT03648372|580631785|FG014|Overall Study|Lost to Follow-up|0|||
160793776|NCT03648372|580631786|FG015|Overall Study|Lost to Follow-up|1|||
160793777|NCT03648372|580631787|FG016|Overall Study|Lost to Follow-up|0|||
160793778|NCT03648372|580631788|FG017|Overall Study|Lost to Follow-up|1|||
160793779|NCT03648372|580631789|FG018|Overall Study|Lost to Follow-up|0|||
160793780|NCT03648372|580631790|FG019|Overall Study|Lost to Follow-up|0|||
160793781|NCT03648372|580631791|FG020|Overall Study|Lost to Follow-up|0|||
160793782|NCT03648372|580631771|FG000|Overall Study|Start of a New Systemic Treatment|0|||
160793783|NCT03648372|580631772|FG001|Overall Study|Start of a New Systemic Treatment|0|||
160793784|NCT03648372|580631773|FG002|Overall Study|Start of a New Systemic Treatment|0|||
160793785|NCT03648372|580631774|FG003|Overall Study|Start of a New Systemic Treatment|0|||
160793786|NCT03648372|580631775|FG004|Overall Study|Start of a New Systemic Treatment|0|||
160793787|NCT03648372|580631776|FG005|Overall Study|Start of a New Systemic Treatment|0|||
160793788|NCT03648372|580631777|FG006|Overall Study|Start of a New Systemic Treatment|0|||
160793789|NCT03648372|580631778|FG007|Overall Study|Start of a New Systemic Treatment|2|||
160793790|NCT03648372|580631779|FG008|Overall Study|Start of a New Systemic Treatment|0|||
160793791|NCT03648372|580631780|FG009|Overall Study|Start of a New Systemic Treatment|0|||
160793792|NCT03648372|580631781|FG010|Overall Study|Start of a New Systemic Treatment|1|||
160793793|NCT03648372|580631782|FG011|Overall Study|Start of a New Systemic Treatment|0|||
160793794|NCT03648372|580631783|FG012|Overall Study|Start of a New Systemic Treatment|0|||
160793795|NCT03648372|580631784|FG013|Overall Study|Start of a New Systemic Treatment|0|||
160793796|NCT03648372|580631785|FG014|Overall Study|Start of a New Systemic Treatment|0|||
160793797|NCT03648372|580631786|FG015|Overall Study|Start of a New Systemic Treatment|0|||
160793798|NCT03648372|580631787|FG016|Overall Study|Start of a New Systemic Treatment|0|||
160793799|NCT03648372|580631788|FG017|Overall Study|Start of a New Systemic Treatment|0|||
160793800|NCT03648372|580631789|FG018|Overall Study|Start of a New Systemic Treatment|0|||
160793801|NCT03648372|580631790|FG019|Overall Study|Start of a New Systemic Treatment|0|||
160793802|NCT03648372|580631791|FG020|Overall Study|Start of a New Systemic Treatment|0|||
160793803|NCT00730327|580633215|FG000|Overall Study|Lost to Follow-up|14|||
160793804|NCT00730327|580633216|FG001|Overall Study|Lost to Follow-up|16|||
160793805|NCT00730327|580633215|FG000|Overall Study|Adverse Event|8|||
160793806|NCT00730327|580633216|FG001|Overall Study|Adverse Event|1|||
160793807|NCT00730327|580633215|FG000|Overall Study|Withdrawal by Subject|3|||
160793808|NCT00730327|580633216|FG001|Overall Study|Withdrawal by Subject|13|||
160793809|NCT00730327|580633215|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
160793810|NCT00730327|580633216|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
160793811|NCT04507204|580633217|FG000|Overall Study|Adverse Event|8|||
160793812|NCT04507204|580633218|FG001|Overall Study|Adverse Event|13|||
160793813|NCT04507204|580633217|FG000|Overall Study|Death|0|||
160793814|NCT04507204|580633218|FG001|Overall Study|Death|1|||
160793815|NCT04507204|580633217|FG000|Overall Study|Lost to Follow-up|15|||
160793816|NCT04507204|580633218|FG001|Overall Study|Lost to Follow-up|14|||
160793817|NCT04507204|580633217|FG000|Overall Study|Poor Compliance with Protocol|2|||
160793818|NCT04507204|580633218|FG001|Overall Study|Poor Compliance with Protocol|4|||
160793819|NCT04507204|580633217|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
160793820|NCT04507204|580633218|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
160793821|NCT04507204|580633217|FG000|Overall Study|Withdrawal of Patient Consent|21|||
160793822|NCT04507204|580633218|FG001|Overall Study|Withdrawal of Patient Consent|13|||
160793823|NCT01358734|580633221|FG000|Overall Study|Adverse Event|4|||
160793824|NCT01358734|580633222|FG001|Overall Study|Adverse Event|7|||
160793825|NCT01358734|580633223|FG002|Overall Study|Adverse Event|3|||
160793826|NCT01358734|580633221|FG000|Overall Study|Lack of Efficacy|0|||
160793827|NCT01358734|580633222|FG001|Overall Study|Lack of Efficacy|1|||
160793828|NCT01358734|580633223|FG002|Overall Study|Lack of Efficacy|3|||
160793829|NCT01358734|580633221|FG000|Overall Study|Withdrawal by Subject|1|||
160793830|NCT01358734|580633222|FG001|Overall Study|Withdrawal by Subject|6|||
160793831|NCT01358734|580633223|FG002|Overall Study|Withdrawal by Subject|3|||
161330642|NCT02812186|582597189|FG000|Period 1|Post randomization screen failure|5|||
160793832|NCT01358734|580633221|FG000|Overall Study|Death|3|||
160793833|NCT01358734|580633222|FG001|Overall Study|Death|7|||
160793834|NCT01358734|580633223|FG002|Overall Study|Death|2|||
160793835|NCT01358734|580633221|FG000|Overall Study|Progressive Disease|5|||
160793836|NCT01358734|580633222|FG001|Overall Study|Progressive Disease|13|||
160793837|NCT01358734|580633223|FG002|Overall Study|Progressive Disease|16|||
160793838|NCT01358734|580633221|FG000|Overall Study|Non-compliance with study drug|0|||
160793839|NCT01358734|580633222|FG001|Overall Study|Non-compliance with study drug|0|||
160793840|NCT01358734|580633223|FG002|Overall Study|Non-compliance with study drug|1|||
160793841|NCT01358734|580633221|FG000|Overall Study|Other|2|||
160793842|NCT01358734|580633222|FG001|Overall Study|Other|5|||
160793843|NCT01358734|580633223|FG002|Overall Study|Other|4|||
160793844|NCT01358734|580633221|FG000|Overall Study|Protocol Violation|0|||
160793845|NCT01358734|580633222|FG001|Overall Study|Protocol Violation|0|||
160793846|NCT01358734|580633223|FG002|Overall Study|Protocol Violation|2|||
160793847|NCT01905540|580633226|FG000|Period 3|Other|1|||
160793848|NCT01905540|580633227|FG001|Period 3|Other|0|||
160793849|NCT01905540|580633228|FG002|Period 3|Other|1|||
160793850|NCT01905540|580633229|FG003|Period 3|Other|1|||
160793851|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Adverse Event|20|||
160793852|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Adverse Event|10|||
160793853|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Adverse Event|5|||
160793854|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Adverse Event|0|||
160982740|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982741|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
160982742|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160793855|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Adverse Event|0|||
160793856|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Adverse Event|0|||
160793857|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Adverse Event|0|||
160793858|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Adverse Event|0|||
160793859|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Adverse Event|0|||
160793860|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Adverse Event|0|||
160793861|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Adverse Event|0|||
160793862|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Adverse Event|0|||
160793863|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793864|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793865|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
160793866|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793867|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793868|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793869|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793870|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793871|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793872|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793873|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793874|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
160793875|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
160793876|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
160793877|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
160793878|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
160793879|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
160793880|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
160793881|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
160793882|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
160793883|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
160793884|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
160793885|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
160793886|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
160793887|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
160793888|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
160793889|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
160793890|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
160793891|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
160793892|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
160793893|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
160793894|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
160793895|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
160793896|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
160793897|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
160793898|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
160793899|NCT00725985|580633232|FG000|ITP- Treatment Disposition|Other|50|||
160793900|NCT00725985|580633233|FG001|ITP- Treatment Disposition|Other|38|||
160793901|NCT00725985|580633234|FG002|ITP- Treatment Disposition|Other|24|||
160793902|NCT00725985|580633235|FG003|ITP- Treatment Disposition|Other|0|||
160793903|NCT00725985|580633236|FG004|ITP- Treatment Disposition|Other|0|||
160793904|NCT00725985|580633237|FG005|ITP- Treatment Disposition|Other|0|||
160793905|NCT00725985|580633238|FG006|ITP- Treatment Disposition|Other|0|||
160793906|NCT00725985|580633239|FG007|ITP- Treatment Disposition|Other|0|||
160793907|NCT00725985|580633240|FG008|ITP- Treatment Disposition|Other|0|||
160793908|NCT00725985|580633241|FG009|ITP- Treatment Disposition|Other|0|||
160793909|NCT00725985|580633242|FG010|ITP- Treatment Disposition|Other|0|||
160793910|NCT00725985|580633243|FG011|ITP- Treatment Disposition|Other|0|||
160793911|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793912|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793913|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793914|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
160793915|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
160793916|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
160793917|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793918|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793919|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793920|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793921|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793922|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
160793923|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Death|0|||
160793924|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Death|0|||
160793925|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Death|0|||
160793926|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Death|0|||
160793927|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Death|1|||
160793928|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Death|0|||
160793929|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Death|0|||
160793930|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Death|0|||
160793931|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Death|0|||
160793932|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Death|0|||
160793933|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Death|0|||
160793934|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Death|0|||
160793935|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793936|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793937|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793938|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
160793939|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793940|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793941|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793942|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793943|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793944|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793945|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793946|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
160793947|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793948|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793949|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793950|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793951|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793952|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
160793953|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793954|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793955|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793956|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793957|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793958|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
160793959|NCT00725985|580633232|FG000|OLMP (Up to 96 Weeks)|Other|0|||
161330643|NCT02812186|582597190|FG001|Period 1|Post randomization screen failure|9|||
160793960|NCT00725985|580633233|FG001|OLMP (Up to 96 Weeks)|Other|0|||
160793961|NCT00725985|580633234|FG002|OLMP (Up to 96 Weeks)|Other|0|||
160793962|NCT00725985|580633235|FG003|OLMP (Up to 96 Weeks)|Other|15|||
160793963|NCT00725985|580633236|FG004|OLMP (Up to 96 Weeks)|Other|20|||
160793964|NCT00725985|580633237|FG005|OLMP (Up to 96 Weeks)|Other|44|||
160793965|NCT00725985|580633238|FG006|OLMP (Up to 96 Weeks)|Other|0|||
160793966|NCT00725985|580633239|FG007|OLMP (Up to 96 Weeks)|Other|0|||
160793967|NCT00725985|580633240|FG008|OLMP (Up to 96 Weeks)|Other|0|||
160793968|NCT00725985|580633241|FG009|OLMP (Up to 96 Weeks)|Other|0|||
160793969|NCT00725985|580633242|FG010|OLMP (Up to 96 Weeks)|Other|0|||
160793970|NCT00725985|580633243|FG011|OLMP (Up to 96 Weeks)|Other|0|||
160793971|NCT00725985|580633232|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793972|NCT00725985|580633233|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793973|NCT00725985|580633234|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793974|NCT00725985|580633235|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793975|NCT00725985|580633236|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793976|NCT00725985|580633237|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793977|NCT00725985|580633238|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793978|NCT00725985|580633239|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
160793979|NCT00725985|580633240|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793980|NCT00725985|580633241|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793981|NCT00725985|580633242|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793982|NCT00725985|580633243|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
160793983|NCT00725985|580633232|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793984|NCT00725985|580633233|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793985|NCT00725985|580633234|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793986|NCT00725985|580633235|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793987|NCT00725985|580633236|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793988|NCT00725985|580633237|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793989|NCT00725985|580633238|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793990|NCT00725985|580633239|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793991|NCT00725985|580633240|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
160793992|NCT00725985|580633241|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793993|NCT00725985|580633242|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160793994|NCT00725985|580633243|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
160893496|NCT00891462|581006304|FG000|Overall Study|Lack of Efficacy|10|||
160793995|NCT00725985|580633232|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793996|NCT00725985|580633233|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793997|NCT00725985|580633234|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793998|NCT00725985|580633235|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160793999|NCT00725985|580633236|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794000|NCT00725985|580633237|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794001|NCT00725985|580633238|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
160794002|NCT00725985|580633239|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
160794003|NCT00725985|580633240|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
160794004|NCT00725985|580633241|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794005|NCT00725985|580633242|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794006|NCT00725985|580633243|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
160794007|NCT00725985|580633232|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794008|NCT00725985|580633233|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794009|NCT00725985|580633234|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794010|NCT00725985|580633235|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794011|NCT00725985|580633236|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794012|NCT00725985|580633237|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794013|NCT00725985|580633238|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794014|NCT00725985|580633239|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794015|NCT00725985|580633240|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
160794016|NCT00725985|580633241|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
160794017|NCT00725985|580633242|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
160794018|NCT00725985|580633243|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
160794019|NCT01182350|580633244|FG000|Overall Study|Adverse Event|5|||
160794020|NCT01182350|580633245|FG001|Overall Study|Adverse Event|0|||
160794021|NCT01182350|580633246|FG002|Overall Study|Adverse Event|0|||
160794022|NCT01182350|580633247|FG003|Overall Study|Adverse Event|0|||
160794023|NCT01182350|580633248|FG004|Overall Study|Adverse Event|0|||
160794024|NCT01182350|580633244|FG000|Overall Study|Disease Progression|15|||
160794025|NCT01182350|580633245|FG001|Overall Study|Disease Progression|12|||
160794026|NCT01182350|580633246|FG002|Overall Study|Disease Progression|0|||
160794027|NCT01182350|580633247|FG003|Overall Study|Disease Progression|1|||
160794028|NCT01182350|580633248|FG004|Overall Study|Disease Progression|0|||
160794029|NCT01182350|580633244|FG000|Overall Study|Death|0|||
160794030|NCT01182350|580633245|FG001|Overall Study|Death|1|||
160794031|NCT01182350|580633246|FG002|Overall Study|Death|1|||
160794032|NCT01182350|580633247|FG003|Overall Study|Death|0|||
160794033|NCT01182350|580633248|FG004|Overall Study|Death|0|||
160794034|NCT01182350|580633244|FG000|Overall Study|Withdrawal by Subject|3|||
160794035|NCT01182350|580633245|FG001|Overall Study|Withdrawal by Subject|1|||
160794036|NCT01182350|580633246|FG002|Overall Study|Withdrawal by Subject|0|||
160794037|NCT01182350|580633247|FG003|Overall Study|Withdrawal by Subject|1|||
160794038|NCT01182350|580633248|FG004|Overall Study|Withdrawal by Subject|0|||
160794039|NCT01182350|580633244|FG000|Overall Study|Alternative Therapy|2|||
160794040|NCT01182350|580633245|FG001|Overall Study|Alternative Therapy|0|||
160794041|NCT01182350|580633246|FG002|Overall Study|Alternative Therapy|1|||
160794042|NCT01182350|580633247|FG003|Overall Study|Alternative Therapy|0|||
160794043|NCT01182350|580633248|FG004|Overall Study|Alternative Therapy|0|||
160794044|NCT01182350|580633244|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
160794045|NCT01182350|580633245|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
160794046|NCT01182350|580633246|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
160794047|NCT01182350|580633247|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
160794048|NCT01182350|580633248|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
160794049|NCT01182350|580633244|FG000|Overall Study|Unevaluable for Biopsy|0|||
160794050|NCT01182350|580633245|FG001|Overall Study|Unevaluable for Biopsy|0|||
160794051|NCT01182350|580633246|FG002|Overall Study|Unevaluable for Biopsy|0|||
160794052|NCT01182350|580633247|FG003|Overall Study|Unevaluable for Biopsy|0|||
160794053|NCT01182350|580633248|FG004|Overall Study|Unevaluable for Biopsy|3|||
160794054|NCT00605189|580633249|FG000|Overall Study|Adverse Event|1|||
160794055|NCT00605189|580633250|FG001|Overall Study|Adverse Event|0|||
160794056|NCT00605189|580633251|FG002|Overall Study|Adverse Event|0|||
160794057|NCT00605189|580633249|FG000|Overall Study|Other|2|||
160794058|NCT00605189|580633250|FG001|Overall Study|Other|2|||
160794059|NCT00605189|580633251|FG002|Overall Study|Other|0|||
160794060|NCT05030766|580633252|FG000|Phase 1 Participants|Lost to Follow-up|12|||
160794061|NCT05030766|580633253|FG001|Phase 1 Participants|Lost to Follow-up|22|||
160794062|NCT05030766|580633254|FG002|Phase 1 Participants|Lost to Follow-up|0|||
160794063|NCT05030766|580633255|FG003|Phase 1 Participants|Lost to Follow-up|0|||
160893497|NCT00891462|581006305|FG001|Overall Study|Lack of Efficacy|5|||
160893498|NCT00891462|581006306|FG002|Overall Study|Lack of Efficacy|1|||
160794064|NCT05030766|580633252|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
160794065|NCT05030766|580633253|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
160794066|NCT05030766|580633254|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
160893499|NCT00891462|581006304|FG000|Overall Study|COPD exacerbation|7|||
160794067|NCT05030766|580633255|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
160794068|NCT05030766|580633252|FG000|Phase 2 Participants|Lost to Follow-up|0|||
160794069|NCT05030766|580633253|FG001|Phase 2 Participants|Lost to Follow-up|0|||
160794070|NCT05030766|580633254|FG002|Phase 2 Participants|Lost to Follow-up|6|||
160794071|NCT05030766|580633255|FG003|Phase 2 Participants|Lost to Follow-up|2|||
160794072|NCT00645658|580633256|FG000|Overall Study|Withdrawal by Subject|1|||
160794073|NCT00645658|580633257|FG001|Overall Study|Withdrawal by Subject|0|||
160794074|NCT00645658|580633256|FG000|Overall Study|Did not complete all assesments|0|||
160794075|NCT00645658|580633257|FG001|Overall Study|Did not complete all assesments|2|||
160794076|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
160794077|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
160794078|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
160794079|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
160794080|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
160794081|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
160794082|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
160794083|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
160794084|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
160794085|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
160794086|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
160794087|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
160794088|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
160794089|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
160794090|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
160794091|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
160794092|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
160794093|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
160794094|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
161235803|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160794095|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
160794096|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
160794097|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
160794098|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
160794099|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
160794100|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
160794101|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
160893500|NCT00891462|581006305|FG001|Overall Study|COPD exacerbation|4|||
160893501|NCT00891462|581006306|FG002|Overall Study|COPD exacerbation|1|||
160893502|NCT00891462|581006304|FG000|Overall Study|Other Reason|2|||
160893503|NCT00891462|581006305|FG001|Overall Study|Other Reason|5|||
160893504|NCT00891462|581006306|FG002|Overall Study|Other Reason|3|||
160893505|NCT00891462|581006304|FG000|Overall Study|Protocol Violation|2|||
160893506|NCT00891462|581006305|FG001|Overall Study|Protocol Violation|1|||
160893507|NCT00891462|581006306|FG002|Overall Study|Protocol Violation|3|||
161235804|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235805|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
160794102|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
160794103|NCT03093415|580633260|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
160794104|NCT03093415|580633261|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
161235806|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235807|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
161235808|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
160794105|NCT03093415|580633262|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
160794106|NCT03093415|580633260|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
160794107|NCT03093415|580633261|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
160893508|NCT00891462|581006304|FG000|Overall Study|Inclusion/exclusion criteria|0|||
160893509|NCT00891462|581006305|FG001|Overall Study|Inclusion/exclusion criteria|2|||
160893510|NCT00891462|581006306|FG002|Overall Study|Inclusion/exclusion criteria|2|||
161235809|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235810|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235811|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235812|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
161235813|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
161330644|NCT02812186|582597189|FG000|Period 1|nonevaluable data sets|6|||
161330645|NCT02812186|582597190|FG001|Period 1|nonevaluable data sets|6|||
161330646|NCT00643760|582597193|FG000|Overall Study|Adverse Event|11|||
160893511|NCT00891462|581006304|FG000|Overall Study|Lost to Follow-up|0|||
160893512|NCT00891462|581006305|FG001|Overall Study|Lost to Follow-up|2|||
160893513|NCT00891462|581006306|FG002|Overall Study|Lost to Follow-up|0|||
160893514|NCT01083485|581006307|FG000|Overall Study|Adverse Event|0|||
160893515|NCT01083485|581006308|FG001|Overall Study|Adverse Event|1|||
160893516|NCT01083485|581006307|FG000|Overall Study|Protocol Violation|1|||
160893517|NCT01083485|581006308|FG001|Overall Study|Protocol Violation|0|||
160893518|NCT01083485|581006307|FG000|Overall Study|Withdrawal by Subject|5|||
160893519|NCT01083485|581006308|FG001|Overall Study|Withdrawal by Subject|2|||
160893520|NCT01083485|581006307|FG000|Overall Study|Other|1|||
160893521|NCT01083485|581006308|FG001|Overall Study|Other|0|||
160893522|NCT05108922|581006309|FG000|Overall Study|Adverse Event|2|||
160893523|NCT05108922|581006310|FG001|Overall Study|Adverse Event|3|||
160893524|NCT05108922|581006309|FG000|Overall Study|Lost to Follow-up|2|||
160893525|NCT05108922|581006310|FG001|Overall Study|Lost to Follow-up|1|||
160893526|NCT05108922|581006309|FG000|Overall Study|Inadvertent enrollment|0|||
160893527|NCT05108922|581006310|FG001|Overall Study|Inadvertent enrollment|1|||
160893528|NCT05108922|581006309|FG000|Overall Study|Physician Decision|2|||
160893529|NCT05108922|581006310|FG001|Overall Study|Physician Decision|3|||
160893530|NCT05108922|581006309|FG000|Overall Study|Protocol deviation|1|||
160893531|NCT05108922|581006310|FG001|Overall Study|Protocol deviation|0|||
160893532|NCT05108922|581006309|FG000|Overall Study|Screen failure|1|||
160893533|NCT05108922|581006310|FG001|Overall Study|Screen failure|0|||
160893534|NCT05108922|581006309|FG000|Overall Study|Withdrawal by Subject|11|||
160893535|NCT05108922|581006310|FG001|Overall Study|Withdrawal by Subject|8|||
160893536|NCT05036369|581006311|FG000|Overall Study|Run In non compliance|1|||
160893537|NCT05036369|581006312|FG001|Overall Study|Run In non compliance|2|||
160893538|NCT05036369|581006311|FG000|Overall Study|Change in eligibility criteria|0|||
160893539|NCT05036369|581006312|FG001|Overall Study|Change in eligibility criteria|1|||
160893540|NCT01846104|581006313|FG000|Overall Study|Withdrawal by Subject|1|||
160893541|NCT01854658|581006318|FG000|Overall Study|Protocol Violation|6|||
160893542|NCT01854658|581006319|FG001|Overall Study|Protocol Violation|2|||
160893543|NCT01854658|581006320|FG002|Overall Study|Protocol Violation|2|||
160893544|NCT01854658|581006321|FG003|Overall Study|Protocol Violation|1|||
160893545|NCT01854658|581006318|FG000|Overall Study|Physician Decision|7|||
160893546|NCT01854658|581006319|FG001|Overall Study|Physician Decision|5|||
160893547|NCT01854658|581006320|FG002|Overall Study|Physician Decision|2|||
160893548|NCT01854658|581006321|FG003|Overall Study|Physician Decision|4|||
160893549|NCT01854658|581006318|FG000|Overall Study|Lost to Follow-up|8|||
160893550|NCT01854658|581006319|FG001|Overall Study|Lost to Follow-up|9|||
160893551|NCT01854658|581006320|FG002|Overall Study|Lost to Follow-up|8|||
160893552|NCT01854658|581006321|FG003|Overall Study|Lost to Follow-up|4|||
160893553|NCT01854658|581006318|FG000|Overall Study|Withdrawal by Subject|28|||
160893554|NCT01854658|581006319|FG001|Overall Study|Withdrawal by Subject|21|||
160893555|NCT01854658|581006320|FG002|Overall Study|Withdrawal by Subject|29|||
160893556|NCT01854658|581006321|FG003|Overall Study|Withdrawal by Subject|15|||
160893557|NCT01854658|581006318|FG000|Overall Study|Protocol-specified criteria|15|||
160893558|NCT01854658|581006319|FG001|Overall Study|Protocol-specified criteria|15|||
160893559|NCT01854658|581006320|FG002|Overall Study|Protocol-specified criteria|10|||
160893560|NCT01854658|581006321|FG003|Overall Study|Protocol-specified criteria|7|||
160893561|NCT01854658|581006318|FG000|Overall Study|Lack of Efficacy|3|||
160893562|NCT01854658|581006319|FG001|Overall Study|Lack of Efficacy|8|||
160893563|NCT01854658|581006320|FG002|Overall Study|Lack of Efficacy|4|||
160893564|NCT01854658|581006321|FG003|Overall Study|Lack of Efficacy|7|||
160893565|NCT01854658|581006318|FG000|Overall Study|Adverse Event|21|||
160893566|NCT01854658|581006319|FG001|Overall Study|Adverse Event|14|||
160893567|NCT01854658|581006320|FG002|Overall Study|Adverse Event|23|||
160893568|NCT01854658|581006321|FG003|Overall Study|Adverse Event|19|||
160893569|NCT01854658|581006318|FG000|Overall Study|Administrative reasons|5|||
161330647|NCT00643760|582597194|FG001|Overall Study|Adverse Event|5|||
160893570|NCT01854658|581006319|FG001|Overall Study|Administrative reasons|1|||
160893571|NCT01854658|581006320|FG002|Overall Study|Administrative reasons|2|||
160893572|NCT01854658|581006321|FG003|Overall Study|Administrative reasons|2|||
160893573|NCT03906461|581006322|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
160893574|NCT03906461|581006322|FG000|Completed 12-month Follow-up|Missed Visit|6|||
160893575|NCT01795638|581006325|FG000|Overall Study|Death|0|||
160893576|NCT01795638|581006326|FG001|Overall Study|Death|3|||
160893577|NCT01795638|581006325|FG000|Overall Study|transferred to quaternary hospital|2|||
160893578|NCT01795638|581006326|FG001|Overall Study|transferred to quaternary hospital|3|||
160893579|NCT01795638|581006325|FG000|Overall Study|Protocol Violation|3|||
160893580|NCT01795638|581006326|FG001|Overall Study|Protocol Violation|0|||
160893581|NCT01795638|581006325|FG000|Overall Study|discharged from hospital|7|||
160893582|NCT01795638|581006326|FG001|Overall Study|discharged from hospital|5|||
160893583|NCT01795638|581006325|FG000|Overall Study|Withdrawal by Subject|1|||
160893584|NCT01795638|581006326|FG001|Overall Study|Withdrawal by Subject|0|||
160893585|NCT00331864|581006335|FG000|Overall Study|Adverse Event|30|||
160893586|NCT00331864|581006336|FG001|Overall Study|Adverse Event|1|||
160794108|NCT03093415|580633262|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
161128865|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161128866|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
161128867|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
161128868|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
160794109|NCT03559530|580633263|FG000|Overall Study|non-location of medical records|44|||
160794110|NCT03559530|580633264|FG001|Overall Study|non-location of medical records|0|||
160794111|NCT03559530|580633263|FG000|Overall Study|culture results not considered for treat|29|||
160794112|NCT03559530|580633264|FG001|Overall Study|culture results not considered for treat|0|||
160794113|NCT03559530|580633263|FG000|Overall Study|duplicate cases|8|||
160794114|NCT03559530|580633264|FG001|Overall Study|duplicate cases|0|||
160794115|NCT03559530|580633263|FG000|Overall Study|other species of Acinetobacte|7|||
160794116|NCT03559530|580633264|FG001|Overall Study|other species of Acinetobacte|0|||
160794117|NCT03559530|580633263|FG000|Overall Study|contamination / colonization|3|||
160794118|NCT03559530|580633264|FG001|Overall Study|contamination / colonization|0|||
160794119|NCT02457065|580633265|FG000|Overall Study|Lost to Follow-up|9|||
160794120|NCT02457065|580633266|FG001|Overall Study|Lost to Follow-up|11|||
160794121|NCT03038087|580633267|FG000|Overall Study|lost data|1|||
160794122|NCT00654355|580633268|FG000|Overall Study|Lost to Follow-up|2|||
160794123|NCT00654355|580633269|FG001|Overall Study|Lost to Follow-up|2|||
160794124|NCT01435356|580633271|FG000|Overall Study|Adverse Event|2|||
160794125|NCT01435356|580633272|FG001|Overall Study|Adverse Event|0|||
160794126|NCT01435356|580633271|FG000|Overall Study|Disease progression/recurrence|17|||
160794127|NCT01435356|580633272|FG001|Overall Study|Disease progression/recurrence|10|||
160794128|NCT01435356|580633271|FG000|Overall Study|Protocol Violation|0|||
160794129|NCT01435356|580633272|FG001|Overall Study|Protocol Violation|1|||
160794130|NCT01435356|580633271|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
160794131|NCT01435356|580633272|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
160794132|NCT01435356|580633271|FG000|Overall Study|Withdrawal by Subject|1|||
160794133|NCT01435356|580633272|FG001|Overall Study|Withdrawal by Subject|1|||
160794134|NCT01435356|580633271|FG000|Overall Study|Facial palsy|1|||
160794135|NCT01435356|580633272|FG001|Overall Study|Facial palsy|0|||
160794136|NCT01435356|580633271|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
160794137|NCT01435356|580633272|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
160794138|NCT01435356|580633271|FG000|Overall Study|Physician Decision|1|||
160794139|NCT01435356|580633272|FG001|Overall Study|Physician Decision|0|||
160794140|NCT01435356|580633271|FG000|Overall Study|Patient decision|3|||
160794141|NCT01435356|580633272|FG001|Overall Study|Patient decision|0|||
160794142|NCT01435356|580633271|FG000|Overall Study|Patient moved to another city|1|||
160794143|NCT01435356|580633272|FG001|Overall Study|Patient moved to another city|1|||
160794144|NCT02796651|580633273|FG000|Overall Study|Adverse Event|6|||
160794145|NCT02796651|580633273|FG000|Overall Study|Lost to Follow-up|1|||
160794146|NCT02796651|580633273|FG000|Overall Study|Withdrawal by Subject|4|||
160794147|NCT02796651|580633273|FG000|Overall Study|Protocol Violation|4|||
160794148|NCT02796651|580633273|FG000|Overall Study|Lack of Efficacy|1|||
160794149|NCT02796651|580633273|FG000|Overall Study|Other|10|||
160794150|NCT04875533|580633274|FG000|Overall Study|Adverse Event|6|||
160794151|NCT04875533|580633275|FG001|Overall Study|Adverse Event|4|||
160794152|NCT04875533|580633274|FG000|Overall Study|Protocol Violation|4|||
160893587|NCT00331864|581006335|FG000|Overall Study|Lack of Efficacy|4|||
160893588|NCT00331864|581006336|FG001|Overall Study|Lack of Efficacy|0|||
160893589|NCT00331864|581006335|FG000|Overall Study|Protocol Violation|3|||
160893590|NCT00331864|581006336|FG001|Overall Study|Protocol Violation|0|||
160893591|NCT00331864|581006335|FG000|Overall Study|Withdrawal by Subject|10|||
160893592|NCT00331864|581006336|FG001|Overall Study|Withdrawal by Subject|0|||
160893593|NCT00331864|581006335|FG000|Overall Study|Lost to Follow-up|4|||
160893594|NCT00331864|581006336|FG001|Overall Study|Lost to Follow-up|3|||
160893595|NCT00331864|581006335|FG000|Overall Study|Administrative Problems|1|||
160893596|NCT00331864|581006336|FG001|Overall Study|Administrative Problems|0|||
160893597|NCT00331864|581006335|FG000|Overall Study|Death|6|||
160893598|NCT00331864|581006336|FG001|Overall Study|Death|0|||
160893599|NCT01409434|581006338|FG000|Overall Study|Protocol Violation|4|||
160893600|NCT00293215|581006339|FG000|Overall Study|Progressive disease|3|||
160893601|NCT00293215|581006340|FG001|Overall Study|Progressive disease|1|||
160893602|NCT00293215|581006339|FG000|Overall Study|Adverse Event|2|||
161128869|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161330648|NCT00643760|582597195|FG002|Overall Study|Adverse Event|12|||
160893603|NCT00293215|581006340|FG001|Overall Study|Adverse Event|2|||
160893604|NCT02213042|581006341|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
161330649|NCT00643760|582597196|FG003|Overall Study|Adverse Event|21|||
160794153|NCT04875533|580633275|FG001|Overall Study|Protocol Violation|0|||
160794154|NCT04875533|580633274|FG000|Overall Study|Withdrawal by Subject|8|||
160794155|NCT04875533|580633275|FG001|Overall Study|Withdrawal by Subject|5|||
160794156|NCT04875533|580633274|FG000|Overall Study|No longer meets eligibility criteria|1|||
160794157|NCT04875533|580633275|FG001|Overall Study|No longer meets eligibility criteria|0|||
160794158|NCT04875533|580633274|FG000|Overall Study|Other|0|||
160794159|NCT04875533|580633275|FG001|Overall Study|Other|2|||
160794160|NCT04918771|580633276|FG000|Overall Study|Withdrawal by Subject|4|||
160794161|NCT04918771|580633277|FG001|Overall Study|Withdrawal by Subject|5|||
160794162|NCT04918771|580633276|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
160794163|NCT04918771|580633277|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
160794164|NCT02971163|580633278|FG000|Overall Study|Lost to Follow-up|4|||
160794165|NCT02971163|580633279|FG001|Overall Study|Lost to Follow-up|2|||
160794166|NCT01849276|580633280|FG000|Followed for Survival for 5 Years|Death|1|||
160794167|NCT01849276|580633280|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
160794168|NCT00539500|580633281|FG000|Overall Study|Disease Progression|1|||
160794169|NCT00539500|580633281|FG000|Overall Study|Lost to Follow-up|2|||
160794170|NCT02657343|580633284|FG000|Overall Study|Death|0|||
160794171|NCT02657343|580633285|FG001|Overall Study|Death|2|||
160794172|NCT02657343|580633286|FG002|Overall Study|Death|0|||
160794173|NCT02657343|580633287|FG003|Overall Study|Death|0|||
160794174|NCT02657343|580633288|FG004|Overall Study|Death|0|||
160794175|NCT02657343|580633289|FG005|Overall Study|Death|0|||
160794176|NCT02657343|580633284|FG000|Overall Study|Patient went to hospice|1|||
160794177|NCT02657343|580633285|FG001|Overall Study|Patient went to hospice|0|||
160794178|NCT02657343|580633286|FG002|Overall Study|Patient went to hospice|0|||
160794179|NCT02657343|580633287|FG003|Overall Study|Patient went to hospice|0|||
160794180|NCT02657343|580633288|FG004|Overall Study|Patient went to hospice|0|||
160794181|NCT02657343|580633289|FG005|Overall Study|Patient went to hospice|0|||
160794182|NCT02657343|580633284|FG000|Overall Study|Withdrawal by Subject|0|||
160794183|NCT02657343|580633285|FG001|Overall Study|Withdrawal by Subject|0|||
160794184|NCT02657343|580633286|FG002|Overall Study|Withdrawal by Subject|0|||
160794185|NCT02657343|580633287|FG003|Overall Study|Withdrawal by Subject|0|||
160794186|NCT02657343|580633288|FG004|Overall Study|Withdrawal by Subject|1|||
160794187|NCT02657343|580633289|FG005|Overall Study|Withdrawal by Subject|0|||
160794188|NCT02011542|580633297|FG000|Overall Study|Physician Decision|1|||
160794189|NCT01813357|580633298|FG000|Overall Study|Lost to Follow-up|5|||
160794190|NCT01813357|580633299|FG001|Overall Study|Lost to Follow-up|6|||
160794191|NCT00526799|580633303|FG000|Overall Study|Withdrawal by Subject|1|||
161128870|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161128871|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
161128872|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
161128873|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161128874|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161128875|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161128876|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
161128877|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
161128878|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161128879|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161128880|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161128881|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
161128882|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
161128883|NCT00289913|581858365|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161128884|NCT00289913|581858366|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161128885|NCT00289913|581858367|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161128886|NCT00289913|581858368|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
161128887|NCT00289913|581858369|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
161128888|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128889|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
161128890|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128891|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128892|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
161128893|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
161128894|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
161128895|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
161128896|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
161128897|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
161128898|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161128899|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161128900|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
161128901|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
161128902|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
160794192|NCT00526799|580633304|FG001|Overall Study|Withdrawal by Subject|0|||
160794193|NCT00526799|580633303|FG000|Overall Study|Intercurrent Complicating Disease|0|||
160794194|NCT00526799|580633304|FG001|Overall Study|Intercurrent Complicating Disease|1|||
160794195|NCT02607722|580633311|FG000|Overall Study|No data reliability|1|||
160893605|NCT02213042|581006342|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
160893606|NCT02213042|581006343|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
160893607|NCT02213042|581006341|FG000|Overall Study|Adverse Event|2|||
160893608|NCT02213042|581006342|FG001|Overall Study|Adverse Event|1|||
160893609|NCT02213042|581006343|FG002|Overall Study|Adverse Event|0|||
160893610|NCT02213042|581006341|FG000|Overall Study|Withdrawal by Subject|0|||
160893611|NCT02213042|581006342|FG001|Overall Study|Withdrawal by Subject|1|||
161128903|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161330650|NCT00643760|582597197|FG004|Overall Study|Adverse Event|6|||
161330651|NCT00643760|582597193|FG000|Overall Study|Lack of Efficacy|3|||
161330652|NCT00643760|582597194|FG001|Overall Study|Lack of Efficacy|1|||
161330653|NCT00643760|582597195|FG002|Overall Study|Lack of Efficacy|0|||
161330654|NCT00643760|582597196|FG003|Overall Study|Lack of Efficacy|4|||
161330655|NCT00643760|582597197|FG004|Overall Study|Lack of Efficacy|3|||
161330656|NCT00643760|582597193|FG000|Overall Study|Protocol Violation|7|||
161330657|NCT00643760|582597194|FG001|Overall Study|Protocol Violation|6|||
161330658|NCT00643760|582597195|FG002|Overall Study|Protocol Violation|4|||
161330659|NCT00643760|582597196|FG003|Overall Study|Protocol Violation|4|||
161330660|NCT00643760|582597197|FG004|Overall Study|Protocol Violation|6|||
161330661|NCT00643760|582597193|FG000|Overall Study|Lost to Follow-up|6|||
161330662|NCT00643760|582597194|FG001|Overall Study|Lost to Follow-up|2|||
161330663|NCT00643760|582597195|FG002|Overall Study|Lost to Follow-up|1|||
161330664|NCT00643760|582597196|FG003|Overall Study|Lost to Follow-up|3|||
161330665|NCT00643760|582597197|FG004|Overall Study|Lost to Follow-up|3|||
161330666|NCT00643760|582597193|FG000|Overall Study|Investigator Discretion|0|||
161330667|NCT00643760|582597194|FG001|Overall Study|Investigator Discretion|0|||
161128904|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128905|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128906|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
161128907|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
161128908|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
161128909|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
161128910|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
161128911|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
161128912|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
161128913|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161128914|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
161128915|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
161128916|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161128917|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
161128918|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161128919|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161128920|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161128921|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
161128922|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
161128923|NCT00289913|581858365|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128924|NCT00289913|581858366|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
161128925|NCT00289913|581858367|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128926|NCT00289913|581858368|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128927|NCT00289913|581858369|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
161128928|NCT03822884|581858370|FG000|Overall Study|Withdrawal by Subject|0|||
161128929|NCT03822884|581858371|FG001|Overall Study|Withdrawal by Subject|0|||
161128930|NCT03822884|581858372|FG002|Overall Study|Withdrawal by Subject|0|||
161128931|NCT03822884|581858373|FG003|Overall Study|Withdrawal by Subject|0|||
161128932|NCT03822884|581858374|FG004|Overall Study|Withdrawal by Subject|1|||
161128933|NCT03822884|581858375|FG005|Overall Study|Withdrawal by Subject|0|||
161128934|NCT03617705|581858382|FG000|Overall Study|Withdrawal by Subject|2|||
161330668|NCT00643760|582597195|FG002|Overall Study|Investigator Discretion|0|||
161330669|NCT00643760|582597196|FG003|Overall Study|Investigator Discretion|2|||
161330670|NCT00643760|582597197|FG004|Overall Study|Investigator Discretion|0|||
161330671|NCT00643760|582597193|FG000|Overall Study|Withdrawal by Subject|3|||
161330672|NCT00643760|582597194|FG001|Overall Study|Withdrawal by Subject|1|||
161330673|NCT00643760|582597195|FG002|Overall Study|Withdrawal by Subject|2|||
160893612|NCT02213042|581006343|FG002|Overall Study|Withdrawal by Subject|1|||
160893613|NCT02213042|581006341|FG000|Overall Study|Protocol Violation|1|||
160893614|NCT02213042|581006342|FG001|Overall Study|Protocol Violation|0|||
160893615|NCT02213042|581006343|FG002|Overall Study|Protocol Violation|0|||
160893616|NCT02213042|581006341|FG000|Overall Study|Investigator discretion|0|||
161330674|NCT00643760|582597196|FG003|Overall Study|Withdrawal by Subject|4|||
161330675|NCT00643760|582597197|FG004|Overall Study|Withdrawal by Subject|1|||
160893617|NCT02213042|581006342|FG001|Overall Study|Investigator discretion|0|||
161235814|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161235815|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235816|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161235817|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161235818|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161235819|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
161235820|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
161235821|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235822|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235823|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235824|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235825|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235826|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235827|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235828|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
161235829|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235830|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235831|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235832|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235833|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235834|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161235835|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235836|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235837|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161235838|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161235839|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161235840|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
161235841|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235842|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235843|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235844|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235845|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235846|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235847|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235848|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235849|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
161235850|NCT01597245|582244926|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235851|NCT01597245|582244927|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235852|NCT01597245|582244928|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235853|NCT01597245|582244929|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235854|NCT01597245|582244930|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235855|NCT01597245|582244931|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235856|NCT01597245|582244932|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235857|NCT01597245|582244933|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235858|NCT01597245|582244934|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235859|NCT01597245|582244935|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235860|NCT01597245|582244936|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
161235861|NCT01597245|582244937|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235862|NCT01597245|582244938|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235863|NCT01597245|582244939|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235864|NCT01597245|582244940|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160893618|NCT02213042|581006343|FG002|Overall Study|Investigator discretion|1|||
160893619|NCT02007512|581006344|FG000|Double Blind Treatment Period|Adverse Event|4|||
160893620|NCT02007512|581006345|FG001|Double Blind Treatment Period|Adverse Event|6|||
160893621|NCT02007512|581006346|FG002|Double Blind Treatment Period|Adverse Event|2|||
160893622|NCT02007512|581006347|FG003|Double Blind Treatment Period|Adverse Event|2|||
160893623|NCT02007512|581006344|FG000|Double Blind Treatment Period|Death|1|||
160893624|NCT02007512|581006345|FG001|Double Blind Treatment Period|Death|0|||
160893625|NCT02007512|581006346|FG002|Double Blind Treatment Period|Death|0|||
160893626|NCT02007512|581006347|FG003|Double Blind Treatment Period|Death|0|||
160893627|NCT02007512|581006344|FG000|Double Blind Treatment Period|Disease progression|51|||
160893628|NCT02007512|581006345|FG001|Double Blind Treatment Period|Disease progression|50|||
160893629|NCT02007512|581006346|FG002|Double Blind Treatment Period|Disease progression|57|||
160893630|NCT02007512|581006347|FG003|Double Blind Treatment Period|Disease progression|52|||
160893631|NCT02007512|581006344|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
160982743|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982744|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982745|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982746|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161330676|NCT00789321|582597201|FG000|Overall Study|Adverse Event|0|||
161330677|NCT00789321|582597202|FG001|Overall Study|Adverse Event|1|||
161330678|NCT00104052|582597203|FG000|Overall Study|Adverse Event|1|||
161330679|NCT00104052|582597203|FG000|Overall Study|Lack of Efficacy|26|||
161330680|NCT00104052|582597203|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
161330681|NCT01162343|582597204|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
161330682|NCT01162343|582597204|FG000|Overall Study|Refused psychiatrist assessment|12|||
161330683|NCT01294423|582597209|FG000|Overall Study|Adverse Event|1|||
161330684|NCT01294423|582597210|FG001|Overall Study|Adverse Event|2|||
161330685|NCT01294423|582597211|FG002|Overall Study|Adverse Event|3|||
161330686|NCT01294423|582597209|FG000|Overall Study|Withdrawal by Subject|1|||
161330687|NCT01294423|582597210|FG001|Overall Study|Withdrawal by Subject|2|||
161330688|NCT01294423|582597211|FG002|Overall Study|Withdrawal by Subject|2|||
161330689|NCT01294423|582597209|FG000|Overall Study|subject no longer meets study criteria|2|||
161330690|NCT01294423|582597210|FG001|Overall Study|subject no longer meets study criteria|5|||
161330691|NCT01294423|582597211|FG002|Overall Study|subject no longer meets study criteria|2|||
161330692|NCT01294423|582597209|FG000|Overall Study|poor/non-compliance|1|||
161330693|NCT01294423|582597210|FG001|Overall Study|poor/non-compliance|0|||
161330694|NCT01294423|582597211|FG002|Overall Study|poor/non-compliance|1|||
161330695|NCT01241279|582597212|FG000|Overall Study|Lost to Follow-up|0|||
161330696|NCT01241279|582597213|FG001|Overall Study|Lost to Follow-up|1|||
161330697|NCT01484951|582597214|FG000|Overall Study|Adverse Event|3|||
161330698|NCT01484951|582597214|FG000|Overall Study|Personal Reasons|1|||
161330699|NCT01484951|582597214|FG000|Overall Study|Non-Compliance|1|||
161330700|NCT02452047|582597216|FG000|Overall Study|Adverse Event|0|||
161330701|NCT02452047|582597217|FG001|Overall Study|Adverse Event|1|||
161330702|NCT02452047|582597218|FG002|Overall Study|Adverse Event|1|||
161330703|NCT02452047|582597216|FG000|Overall Study|Death|1|||
161330704|NCT02452047|582597217|FG001|Overall Study|Death|3|||
161330705|NCT02452047|582597218|FG002|Overall Study|Death|1|||
161330706|NCT02452047|582597216|FG000|Overall Study|Physician Decision|1|||
161330707|NCT02452047|582597217|FG001|Overall Study|Physician Decision|0|||
161330708|NCT02452047|582597218|FG002|Overall Study|Physician Decision|0|||
161330709|NCT02452047|582597216|FG000|Overall Study|Lost to Follow-up|1|||
161330710|NCT02452047|582597217|FG001|Overall Study|Lost to Follow-up|1|||
161330711|NCT02452047|582597218|FG002|Overall Study|Lost to Follow-up|0|||
161330712|NCT02452047|582597216|FG000|Overall Study|Withdrawal by Subject|1|||
161330713|NCT02452047|582597217|FG001|Overall Study|Withdrawal by Subject|0|||
161330714|NCT02452047|582597218|FG002|Overall Study|Withdrawal by Subject|0|||
160893632|NCT02007512|581006345|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
160893633|NCT02007512|581006346|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
160893634|NCT02007512|581006347|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
160893635|NCT02007512|581006344|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160893636|NCT02007512|581006345|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160893637|NCT02007512|581006346|FG002|Double Blind Treatment Period|Protocol Violation|0|||
160893638|NCT02007512|581006347|FG003|Double Blind Treatment Period|Protocol Violation|1|||
160982747|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982748|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982749|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
160982750|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
161330715|NCT02026141|582597220|FG000|Overall Study|Protocol Violation|0|||
161330716|NCT02026141|582597221|FG001|Overall Study|Protocol Violation|1|||
161330717|NCT02169505|582597222|FG000|Overall Study|Withdrawal by Subject|1|||
161330718|NCT01248455|582597223|FG000|Overall Study|switched to alternate treatment|1|||
160893639|NCT02007512|581006344|FG000|Double Blind Treatment Period|Other|2|||
160893640|NCT02007512|581006345|FG001|Double Blind Treatment Period|Other|1|||
160893641|NCT02007512|581006346|FG002|Double Blind Treatment Period|Other|1|||
160893642|NCT02007512|581006347|FG003|Double Blind Treatment Period|Other|2|||
160893643|NCT02007512|581006344|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
160893644|NCT02007512|581006345|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
160893645|NCT02007512|581006346|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
160893646|NCT02007512|581006347|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
160893647|NCT02007512|581006344|FG000|Open Label Treatment Period|Adverse Event|1|||
160893648|NCT02007512|581006345|FG001|Open Label Treatment Period|Adverse Event|0|||
160893649|NCT02007512|581006346|FG002|Open Label Treatment Period|Adverse Event|0|||
160893650|NCT02007512|581006347|FG003|Open Label Treatment Period|Adverse Event|0|||
161330719|NCT02735980|582597224|FG000|Overall Study|Adverse Event|0|||
161330720|NCT02735980|582597225|FG001|Overall Study|Adverse Event|4|||
160893651|NCT02007512|581006344|FG000|Open Label Treatment Period|Other|1|||
160893652|NCT02007512|581006345|FG001|Open Label Treatment Period|Other|1|||
160794196|NCT02607722|580633311|FG000|Overall Study|no patient visit|18|||
160794197|NCT02607722|580633311|FG000|Overall Study|missing info in CRF|13|||
160794198|NCT02607722|580633311|FG000|Overall Study|Withdrawal by Subject|616|||
160794199|NCT02607722|580633311|FG000|Overall Study|Lost to Follow-up|312|||
160794200|NCT02607722|580633311|FG000|Overall Study|Improved|22|||
160893653|NCT02007512|581006346|FG002|Open Label Treatment Period|Other|0|||
160893654|NCT02007512|581006347|FG003|Open Label Treatment Period|Other|0|||
160893655|NCT02007512|581006344|FG000|Open Label Treatment Period|Disease progression|23|||
160893656|NCT02007512|581006345|FG001|Open Label Treatment Period|Disease progression|11|||
160893657|NCT02007512|581006346|FG002|Open Label Treatment Period|Disease progression|0|||
160893658|NCT02007512|581006347|FG003|Open Label Treatment Period|Disease progression|0|||
160893659|NCT01225887|581006350|FG000|Overall Study|Ineligible:required test not done|2|||
160893660|NCT01225887|581006350|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
160893661|NCT01225887|581006350|FG000|Overall Study|Ineligible:inadequate pathology|2|||
160893662|NCT04505540|581006353|FG000|Baseline|Protocol Violation|10|||
160893663|NCT04505540|581006353|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
160893664|NCT04505540|581006353|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
160893665|NCT04505540|581006353|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
160893666|NCT04505540|581006353|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
160893667|NCT04505540|581006353|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
160893668|NCT04505540|581006353|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
160893669|NCT04505540|581006353|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
160893670|NCT04505540|581006353|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
160893671|NCT04505540|581006353|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
160893672|NCT04505540|581006353|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
160893673|NCT04505540|581006353|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
160893674|NCT04505540|581006353|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
160893675|NCT01123850|581006360|FG000|Overall Study|Slow enrollment|45|||
160893676|NCT03180684|581006361|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
160893677|NCT03180684|581006362|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
160893678|NCT03180684|581006361|FG000|Overall Study|Physician Decision|1|||
160893679|NCT03180684|581006362|FG001|Overall Study|Physician Decision|0|||
160893680|NCT03180684|581006361|FG000|Overall Study|Lost to Follow-up|1|||
160893681|NCT03180684|581006362|FG001|Overall Study|Lost to Follow-up|0|||
160893682|NCT03180684|581006361|FG000|Overall Study|Progressive Disease|1|||
160893683|NCT03180684|581006362|FG001|Overall Study|Progressive Disease|0|||
160893684|NCT02495233|581006363|FG000|Overall Study|Miscellaneous|0|||
160893685|NCT02495233|581006364|FG001|Overall Study|Miscellaneous|1|||
160893686|NCT04508140|581006366|FG000|Overall Study|Adverse Event|2|||
160893687|NCT04508140|581006367|FG001|Overall Study|Adverse Event|2|||
160893688|NCT04508140|581006366|FG000|Overall Study|Withdrawal by Subject|0|||
160893689|NCT04508140|581006367|FG001|Overall Study|Withdrawal by Subject|2|||
160893690|NCT04508140|581006366|FG000|Overall Study|progressive disease|9|||
160893691|NCT04508140|581006367|FG001|Overall Study|progressive disease|3|||
160893692|NCT01822678|581006368|FG000|Overall Study|Withdrawal by Subject|5|||
160893693|NCT01822678|581006369|FG001|Overall Study|Withdrawal by Subject|4|||
160982751|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
160794201|NCT02607722|580633311|FG000|Overall Study|Lack of Efficacy|316|||
160794202|NCT02607722|580633311|FG000|Overall Study|Adverse Event|2553|||
160794203|NCT02607722|580633311|FG000|Overall Study|Not treated|1|||
160794204|NCT02607722|580633311|FG000|Overall Study|No CRF collected|138|||
160794205|NCT02607722|580633311|FG000|Overall Study|without CRF|4225|||
160794206|NCT02607722|580633311|FG000|Overall Study|Physician Decision|367|||
160794207|NCT02871219|580633312|FG000|Overall Study|Adverse Event|15|||
160794208|NCT02871219|580633312|FG000|Overall Study|Death|3|||
160794209|NCT02871219|580633312|FG000|Overall Study|Progression|3|||
160794210|NCT02871219|580633312|FG000|Overall Study|Infections|7|||
160794211|NCT02871219|580633312|FG000|Overall Study|Infusion Related|4|||
160794212|NCT03238196|580633313|FG000|Overall Study|Adverse Event|3|||
160893694|NCT01822678|581006370|FG002|Overall Study|Withdrawal by Subject|4|||
161128935|NCT03617705|581858382|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
161128936|NCT03617705|581858382|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
161128937|NCT03502187|581858383|FG000|Overall Study|Withdrawal by Subject|4|||
161128938|NCT03502187|581858384|FG001|Overall Study|Withdrawal by Subject|3|||
161128939|NCT03502187|581858385|FG002|Overall Study|Withdrawal by Subject|3|||
161128940|NCT03502187|581858383|FG000|Overall Study|Lost to Follow-up|5|||
160893695|NCT01822678|581006368|FG000|Overall Study|Adverse Event|4|||
160893696|NCT01822678|581006369|FG001|Overall Study|Adverse Event|3|||
160794213|NCT03238196|580633314|FG001|Overall Study|Adverse Event|0|||
160794214|NCT03238196|580633315|FG002|Overall Study|Adverse Event|2|||
160794215|NCT03238196|580633316|FG003|Overall Study|Adverse Event|2|||
160794216|NCT03238196|580633313|FG000|Overall Study|Withdrawal by Subject|4|||
160794217|NCT03238196|580633314|FG001|Overall Study|Withdrawal by Subject|1|||
160794218|NCT03238196|580633315|FG002|Overall Study|Withdrawal by Subject|1|||
160982752|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
160982753|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982754|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982755|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982756|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982757|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982758|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982759|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
160982760|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
160982761|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
160982762|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
160982763|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
160982764|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Other|0|||
160982765|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Other|0|||
160982766|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Other|0|||
160982767|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Other|0|||
160982768|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Other|0|||
160982769|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Other|0|||
160982770|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Other|0|||
160982771|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Other|0|||
160982772|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Other|2|||
160982773|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Other|2|||
160982774|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Other|0|||
160982775|NCT02601937|581325066|FG000|Period 2: Dose Expansion Cohort|Death|0|||
160982776|NCT02601937|581325067|FG001|Period 2: Dose Expansion Cohort|Death|0|||
160982777|NCT02601937|581325068|FG002|Period 2: Dose Expansion Cohort|Death|0|||
160982778|NCT02601937|581325069|FG003|Period 2: Dose Expansion Cohort|Death|0|||
160982779|NCT02601937|581325070|FG004|Period 2: Dose Expansion Cohort|Death|0|||
160982780|NCT02601937|581325071|FG005|Period 2: Dose Expansion Cohort|Death|0|||
160982781|NCT02601937|581325072|FG006|Period 2: Dose Expansion Cohort|Death|0|||
160982782|NCT02601937|581325073|FG007|Period 2: Dose Expansion Cohort|Death|0|||
160982783|NCT02601937|581325074|FG008|Period 2: Dose Expansion Cohort|Death|1|||
160982784|NCT02601937|581325075|FG009|Period 2: Dose Expansion Cohort|Death|0|||
160982785|NCT02601937|581325076|FG010|Period 2: Dose Expansion Cohort|Death|0|||
160982786|NCT05567952|581326861|FG000|Overall Study|Lost to Follow-up|3|||
160982787|NCT05567952|581326862|FG001|Overall Study|Lost to Follow-up|2|||
160982788|NCT05567952|581326861|FG000|Overall Study|Withdrawal by Subject|6|||
160982789|NCT05567952|581326862|FG001|Overall Study|Withdrawal by Subject|3|||
160982790|NCT05567952|581326861|FG000|Overall Study|Other|3|||
160982791|NCT05567952|581326862|FG001|Overall Study|Other|1|||
160982792|NCT03280563|581326864|FG000|Stage 1|Death|2|||
160982793|NCT03280563|581326865|FG001|Stage 1|Death|1|||
160982794|NCT03280563|581326866|FG002|Stage 1|Death|0|||
160982795|NCT03280563|581326867|FG003|Stage 1|Death|0|||
160982796|NCT03280563|581326868|FG004|Stage 1|Death|0|||
161128941|NCT03502187|581858384|FG001|Overall Study|Lost to Follow-up|4|||
161128942|NCT03502187|581858385|FG002|Overall Study|Lost to Follow-up|5|||
161128943|NCT06118385|581858387|FG000|Overall Study|Protocol Violation|0|||
161128944|NCT06118385|581858388|FG001|Overall Study|Protocol Violation|0|||
161128945|NCT06118385|581858389|FG002|Overall Study|Protocol Violation|0|||
161128946|NCT06118385|581858390|FG003|Overall Study|Protocol Violation|0|||
161128947|NCT06118385|581858391|FG004|Overall Study|Protocol Violation|0|||
161128948|NCT06118385|581858392|FG005|Overall Study|Protocol Violation|0|||
161128949|NCT06118385|581858393|FG006|Overall Study|Protocol Violation|0|||
161128950|NCT06118385|581858394|FG007|Overall Study|Protocol Violation|0|||
161128951|NCT06118385|581858395|FG008|Overall Study|Protocol Violation|1|||
161128952|NCT06118385|581858396|FG009|Overall Study|Protocol Violation|0|||
161128953|NCT06118385|581858397|FG010|Overall Study|Protocol Violation|0|||
161128954|NCT06118385|581858398|FG011|Overall Study|Protocol Violation|0|||
161128955|NCT06118385|581858387|FG000|Overall Study|Out-of-range blood tests|0|||
161128956|NCT06118385|581858388|FG001|Overall Study|Out-of-range blood tests|0|||
161128957|NCT06118385|581858389|FG002|Overall Study|Out-of-range blood tests|0|||
161128958|NCT06118385|581858390|FG003|Overall Study|Out-of-range blood tests|0|||
161128959|NCT06118385|581858391|FG004|Overall Study|Out-of-range blood tests|0|||
161128960|NCT06118385|581858392|FG005|Overall Study|Out-of-range blood tests|0|||
161128961|NCT06118385|581858393|FG006|Overall Study|Out-of-range blood tests|0|||
161128962|NCT06118385|581858394|FG007|Overall Study|Out-of-range blood tests|0|||
160982797|NCT03280563|581326869|FG005|Stage 1|Death|3|||
160982798|NCT03280563|581326870|FG006|Stage 1|Death|0|||
160982799|NCT03280563|581326871|FG007|Stage 1|Death|0|||
160982800|NCT03280563|581326872|FG008|Stage 1|Death|0|||
160982801|NCT03280563|581326864|FG000|Stage 1|Study Ended by Sponsor|0|||
160982802|NCT03280563|581326865|FG001|Stage 1|Study Ended by Sponsor|0|||
161128963|NCT06118385|581858395|FG008|Overall Study|Out-of-range blood tests|1|||
161128964|NCT06118385|581858396|FG009|Overall Study|Out-of-range blood tests|0|||
161128965|NCT06118385|581858397|FG010|Overall Study|Out-of-range blood tests|0|||
161128966|NCT06118385|581858398|FG011|Overall Study|Out-of-range blood tests|0|||
160982803|NCT03280563|581326866|FG002|Stage 1|Study Ended by Sponsor|1|||
160982804|NCT03280563|581326867|FG003|Stage 1|Study Ended by Sponsor|0|||
160982805|NCT03280563|581326868|FG004|Stage 1|Study Ended by Sponsor|0|||
160982806|NCT03280563|581326869|FG005|Stage 1|Study Ended by Sponsor|1|||
160982807|NCT03280563|581326870|FG006|Stage 1|Study Ended by Sponsor|0|||
160982808|NCT03280563|581326871|FG007|Stage 1|Study Ended by Sponsor|0|||
160982809|NCT03280563|581326872|FG008|Stage 1|Study Ended by Sponsor|0|||
160982810|NCT03280563|581326864|FG000|Stage 1|Withdrawal by Subject|5|||
160982811|NCT03280563|581326865|FG001|Stage 1|Withdrawal by Subject|1|||
160982812|NCT03280563|581326866|FG002|Stage 1|Withdrawal by Subject|2|||
160982813|NCT03280563|581326867|FG003|Stage 1|Withdrawal by Subject|0|||
160982814|NCT03280563|581326868|FG004|Stage 1|Withdrawal by Subject|0|||
160982815|NCT03280563|581326869|FG005|Stage 1|Withdrawal by Subject|2|||
160982816|NCT03280563|581326870|FG006|Stage 1|Withdrawal by Subject|0|||
160982817|NCT03280563|581326871|FG007|Stage 1|Withdrawal by Subject|0|||
160982818|NCT03280563|581326872|FG008|Stage 1|Withdrawal by Subject|0|||
160982819|NCT03280563|581326864|FG000|Stage 1|Reason Not Specified|0|||
160982820|NCT03280563|581326865|FG001|Stage 1|Reason Not Specified|0|||
160982821|NCT03280563|581326866|FG002|Stage 1|Reason Not Specified|0|||
160982822|NCT03280563|581326867|FG003|Stage 1|Reason Not Specified|0|||
160982823|NCT03280563|581326868|FG004|Stage 1|Reason Not Specified|0|||
160982824|NCT03280563|581326869|FG005|Stage 1|Reason Not Specified|1|||
160982825|NCT03280563|581326870|FG006|Stage 1|Reason Not Specified|0|||
160982826|NCT03280563|581326871|FG007|Stage 1|Reason Not Specified|0|||
160982827|NCT03280563|581326872|FG008|Stage 1|Reason Not Specified|0|||
160982828|NCT03280563|581326864|FG000|Stage 1|Physician Decision|0|||
160982829|NCT03280563|581326865|FG001|Stage 1|Physician Decision|1|||
160982830|NCT03280563|581326866|FG002|Stage 1|Physician Decision|0|||
160982831|NCT03280563|581326867|FG003|Stage 1|Physician Decision|0|||
160982832|NCT03280563|581326868|FG004|Stage 1|Physician Decision|0|||
160982833|NCT03280563|581326869|FG005|Stage 1|Physician Decision|0|||
160982834|NCT03280563|581326870|FG006|Stage 1|Physician Decision|0|||
160982835|NCT03280563|581326871|FG007|Stage 1|Physician Decision|0|||
160982836|NCT03280563|581326872|FG008|Stage 1|Physician Decision|0|||
160982837|NCT03280563|581326864|FG000|Stage 2|Death|0|||
160982838|NCT03280563|581326865|FG001|Stage 2|Death|0|||
160982839|NCT03280563|581326866|FG002|Stage 2|Death|0|||
160982840|NCT03280563|581326867|FG003|Stage 2|Death|0|||
160982841|NCT03280563|581326868|FG004|Stage 2|Death|0|||
160982842|NCT03280563|581326869|FG005|Stage 2|Death|0|||
160982843|NCT03280563|581326870|FG006|Stage 2|Death|0|||
160982844|NCT03280563|581326871|FG007|Stage 2|Death|1|||
160982845|NCT03280563|581326872|FG008|Stage 2|Death|0|||
160982846|NCT03280563|581326864|FG000|Stage 2|Progressive Disease|0|||
160982847|NCT03280563|581326865|FG001|Stage 2|Progressive Disease|0|||
160982848|NCT03280563|581326866|FG002|Stage 2|Progressive Disease|0|||
160982849|NCT03280563|581326867|FG003|Stage 2|Progressive Disease|0|||
160982850|NCT03280563|581326868|FG004|Stage 2|Progressive Disease|0|||
160982851|NCT03280563|581326869|FG005|Stage 2|Progressive Disease|0|||
160982852|NCT03280563|581326870|FG006|Stage 2|Progressive Disease|2|||
160982853|NCT03280563|581326871|FG007|Stage 2|Progressive Disease|0|||
160982854|NCT03280563|581326872|FG008|Stage 2|Progressive Disease|0|||
160982855|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Death|10|||
160982856|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Death|14|||
160982857|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Death|15|||
160982858|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Death|3|||
160982859|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Death|6|||
160982860|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Death|18|||
160982861|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Death|11|||
160982862|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Death|1|||
160982863|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Death|3|||
160982864|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
160982865|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
160982866|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
160982867|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982868|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982869|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
160982870|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982871|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
160982872|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
160982873|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982874|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982875|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982876|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982877|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
160982878|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982879|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982880|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982881|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
160982882|NCT03280563|581326864|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982883|NCT03280563|581326865|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
160982884|NCT03280563|581326866|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
160982885|NCT03280563|581326867|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982886|NCT03280563|581326868|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
160982887|NCT03280563|581326869|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
160982888|NCT03280563|581326870|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982889|NCT03280563|581326871|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982890|NCT03280563|581326872|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
160982891|NCT03038672|581326873|FG000|Initial Treatment|Unacceptable chemistry|0|||
160982892|NCT03038672|581326874|FG001|Initial Treatment|Unacceptable chemistry|1|||
160982893|NCT03038672|581326873|FG000|Initial Treatment|Progression prior to treatment|1|||
160982894|NCT03038672|581326874|FG001|Initial Treatment|Progression prior to treatment|0|||
160982895|NCT03038672|581326873|FG000|Initial Treatment|No treatment per protocol|1|||
160982896|NCT03038672|581326874|FG001|Initial Treatment|No treatment per protocol|0|||
160982897|NCT04423393|581326875|FG000|Overall Study|Withdrawal by Subject|0|||
160982898|NCT04423393|581326876|FG001|Overall Study|Withdrawal by Subject|0|||
160982899|NCT04423393|581326877|FG002|Overall Study|Withdrawal by Subject|0|||
160982900|NCT04423393|581326878|FG003|Overall Study|Withdrawal by Subject|0|||
160982901|NCT04423393|581326879|FG004|Overall Study|Withdrawal by Subject|0|||
160982902|NCT04423393|581326880|FG005|Overall Study|Withdrawal by Subject|1|||
160982903|NCT04423393|581326881|FG006|Overall Study|Withdrawal by Subject|0|||
160982904|NCT04423393|581326882|FG007|Overall Study|Withdrawal by Subject|0|||
160982905|NCT04423393|581326883|FG008|Overall Study|Withdrawal by Subject|0|||
160982906|NCT04423393|581326884|FG009|Overall Study|Withdrawal by Subject|0|||
160982907|NCT04423393|581326885|FG010|Overall Study|Withdrawal by Subject|0|||
160982908|NCT04423393|581326886|FG011|Overall Study|Withdrawal by Subject|0|||
160982909|NCT04423393|581326887|FG012|Overall Study|Withdrawal by Subject|0|||
160982910|NCT04423393|581326888|FG013|Overall Study|Withdrawal by Subject|1|||
160982911|NCT04423393|581326889|FG014|Overall Study|Withdrawal by Subject|0|||
160982912|NCT04423393|581326890|FG015|Overall Study|Withdrawal by Subject|0|||
160982913|NCT04423393|581326891|FG016|Overall Study|Withdrawal by Subject|0|||
160982914|NCT04423393|581326892|FG017|Overall Study|Withdrawal by Subject|0|||
160982915|NCT04423393|581326875|FG000|Overall Study|Sponsor Decision|0|||
160982916|NCT04423393|581326876|FG001|Overall Study|Sponsor Decision|0|||
160982917|NCT04423393|581326877|FG002|Overall Study|Sponsor Decision|0|||
160982918|NCT04423393|581326878|FG003|Overall Study|Sponsor Decision|0|||
160982919|NCT04423393|581326879|FG004|Overall Study|Sponsor Decision|0|||
160982920|NCT04423393|581326880|FG005|Overall Study|Sponsor Decision|0|||
160982921|NCT04423393|581326881|FG006|Overall Study|Sponsor Decision|0|||
160982922|NCT04423393|581326882|FG007|Overall Study|Sponsor Decision|0|||
160982923|NCT04423393|581326883|FG008|Overall Study|Sponsor Decision|0|||
160893697|NCT01822678|581006370|FG002|Overall Study|Adverse Event|1|||
160893698|NCT01822678|581006368|FG000|Overall Study|Lack of Efficacy|3|||
160893699|NCT01822678|581006369|FG001|Overall Study|Lack of Efficacy|6|||
160893700|NCT01822678|581006370|FG002|Overall Study|Lack of Efficacy|5|||
160893701|NCT01822678|581006368|FG000|Overall Study|Lost to Follow-up|0|||
160893702|NCT01822678|581006369|FG001|Overall Study|Lost to Follow-up|2|||
160893703|NCT01822678|581006370|FG002|Overall Study|Lost to Follow-up|1|||
160893704|NCT02456103|581006371|FG000|Overall Study|Study Closure|207|||
160893705|NCT02456103|581006371|FG000|Overall Study|Physician Decision|1|||
160893706|NCT02456103|581006371|FG000|Overall Study|Required prohibited medications|5|||
160893707|NCT02456103|581006371|FG000|Overall Study|Protocol Violation|1|||
160893708|NCT02456103|581006371|FG000|Overall Study|Adverse Event|5|||
160893709|NCT02456103|581006371|FG000|Overall Study|Abnormal Laboratory Value|2|||
160893710|NCT02456103|581006371|FG000|Overall Study|Lost to Follow-up|1|||
160893711|NCT02456103|581006371|FG000|Overall Study|Withdrawal by Subject|24|||
160893712|NCT03614975|581006372|FG000|Overall Study|Physician Decision|7|||
160893713|NCT03614975|581006373|FG001|Overall Study|Physician Decision|5|||
160893714|NCT03614975|581006372|FG000|Overall Study|Withdrawal by Subject|2|||
160893715|NCT03614975|581006373|FG001|Overall Study|Withdrawal by Subject|2|||
160893716|NCT03614975|581006372|FG000|Overall Study|Specimens not in lab batch shipment|1|||
160893717|NCT03614975|581006373|FG001|Overall Study|Specimens not in lab batch shipment|1|||
160893718|NCT01390220|581006374|FG000|Test Dose Phase|Adverse Event|17|||
160893719|NCT01390220|581006375|FG001|Test Dose Phase|Adverse Event|0|||
160893720|NCT01390220|581006376|FG002|Test Dose Phase|Adverse Event|0|||
160893721|NCT01390220|581006374|FG000|Test Dose Phase|Withdrawal by Subject|8|||
160893722|NCT01390220|581006375|FG001|Test Dose Phase|Withdrawal by Subject|0|||
160893723|NCT01390220|581006376|FG002|Test Dose Phase|Withdrawal by Subject|0|||
160893724|NCT01390220|581006374|FG000|Test Dose Phase|Lost to Follow-up|2|||
160982924|NCT04423393|581326884|FG009|Overall Study|Sponsor Decision|0|||
160982925|NCT04423393|581326885|FG010|Overall Study|Sponsor Decision|0|||
160982926|NCT04423393|581326886|FG011|Overall Study|Sponsor Decision|0|||
160893725|NCT01390220|581006375|FG001|Test Dose Phase|Lost to Follow-up|0|||
160893726|NCT01390220|581006376|FG002|Test Dose Phase|Lost to Follow-up|0|||
160982927|NCT04423393|581326887|FG012|Overall Study|Sponsor Decision|0|||
160982928|NCT04423393|581326888|FG013|Overall Study|Sponsor Decision|1|||
160982929|NCT04423393|581326889|FG014|Overall Study|Sponsor Decision|0|||
160982930|NCT04423393|581326890|FG015|Overall Study|Sponsor Decision|0|||
160982931|NCT04423393|581326891|FG016|Overall Study|Sponsor Decision|0|||
160982932|NCT04423393|581326892|FG017|Overall Study|Sponsor Decision|0|||
160982933|NCT05220501|581326893|FG000|Overall Study|Withdrawal by Subject|11|||
160982934|NCT05220501|581326894|FG001|Overall Study|Withdrawal by Subject|21|||
160982935|NCT05220501|581326895|FG002|Overall Study|Withdrawal by Subject|32|||
160982936|NCT05220501|581326893|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
160982937|NCT05220501|581326894|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
160982938|NCT05220501|581326895|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
160982939|NCT02692235|581326896|FG000|Overall Study|Withdrawal by Subject|2|||
160982940|NCT02692235|581326897|FG001|Overall Study|Withdrawal by Subject|1|||
160982941|NCT02692235|581326896|FG000|Overall Study|Adverse Event|1|||
160982942|NCT02692235|581326897|FG001|Overall Study|Adverse Event|2|||
160982943|NCT00802841|581326898|FG000|Overall Study|Administrative problems|1|||
160982944|NCT00802841|581326899|FG001|Overall Study|Administrative problems|0|||
160982945|NCT00802841|581326898|FG000|Overall Study|Lost to Follow-up|2|||
160982946|NCT00802841|581326899|FG001|Overall Study|Lost to Follow-up|1|||
160982947|NCT00802841|581326898|FG000|Overall Study|Death|1|||
160982948|NCT00802841|581326899|FG001|Overall Study|Death|2|||
160982949|NCT00802841|581326898|FG000|Overall Study|Adverse Event|8|||
160982950|NCT00802841|581326899|FG001|Overall Study|Adverse Event|2|||
160982951|NCT00802841|581326898|FG000|Overall Study|Disease progression|7|||
160982952|NCT00802841|581326899|FG001|Overall Study|Disease progression|3|||
160982953|NCT00802841|581326898|FG000|Overall Study|Withdrawal by Subject|9|||
160982954|NCT00802841|581326899|FG001|Overall Study|Withdrawal by Subject|5|||
160982955|NCT00802841|581326898|FG000|Overall Study|Protocol deviation|2|||
160982956|NCT00802841|581326899|FG001|Overall Study|Protocol deviation|6|||
160982957|NCT00802841|581326898|FG000|Overall Study|Treatment duration completed|66|||
160982958|NCT00802841|581326899|FG001|Overall Study|Treatment duration completed|76|||
160982959|NCT00432159|581326900|FG000|Overall Study|Death|0|||
160982960|NCT00432159|581326901|FG001|Overall Study|Death|1|||
160982961|NCT00432159|581326902|FG002|Overall Study|Death|0|||
160982962|NCT00432159|581326903|FG003|Overall Study|Death|0|||
160982963|NCT00432159|581326904|FG004|Overall Study|Death|0|||
160982964|NCT00432159|581326900|FG000|Overall Study|Failure|9|||
160982965|NCT00432159|581326901|FG001|Overall Study|Failure|5|||
160982966|NCT00432159|581326902|FG002|Overall Study|Failure|3|||
160982967|NCT00432159|581326903|FG003|Overall Study|Failure|2|||
160982968|NCT00432159|581326904|FG004|Overall Study|Failure|3|||
160982969|NCT00432159|581326900|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
161128967|NCT01554579|581858402|FG000|Overall Study|Adverse Event|6|||
161128968|NCT01554579|581858403|FG001|Overall Study|Adverse Event|25|||
161128969|NCT01554579|581858402|FG000|Overall Study|Lack of Efficacy|2|||
161128970|NCT01554579|581858403|FG001|Overall Study|Lack of Efficacy|1|||
161128971|NCT01554579|581858402|FG000|Overall Study|Withdrawal by Subject|2|||
161128972|NCT01554579|581858403|FG001|Overall Study|Withdrawal by Subject|1|||
161128973|NCT00110019|581858404|FG000|Overall Study|Lack of Efficacy|253|||
161128974|NCT00110019|581858405|FG001|Overall Study|Lack of Efficacy|285|||
161128975|NCT00110019|581858404|FG000|Overall Study|Adverse Event|61|||
161128976|NCT00110019|581858405|FG001|Overall Study|Adverse Event|40|||
161128977|NCT00110019|581858404|FG000|Overall Study|Death|13|||
161128978|NCT00110019|581858405|FG001|Overall Study|Death|15|||
161128979|NCT00110019|581858404|FG000|Overall Study|Withdrawal by Subject|21|||
161128980|NCT00110019|581858405|FG001|Overall Study|Withdrawal by Subject|9|||
161128981|NCT00110019|581858404|FG000|Overall Study|alternative therapy|5|||
161128982|NCT00110019|581858405|FG001|Overall Study|alternative therapy|1|||
161128983|NCT00110019|581858404|FG000|Overall Study|complicating disease|1|||
161235865|NCT01597245|582244941|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235866|NCT01597245|582244942|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160982970|NCT00432159|581326901|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
160982971|NCT00432159|581326902|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
160982972|NCT00432159|581326903|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
160982973|NCT00432159|581326904|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
160982974|NCT01929993|581326906|FG000|Overall Study|Protocol Violation|4|||
160982975|NCT01929993|581326907|FG001|Overall Study|Protocol Violation|6|||
160982976|NCT01929993|581326906|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
160982977|NCT01929993|581326907|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
160982978|NCT00107380|581326908|FG000|Overall Study|Adverse Event|7|||
160982979|NCT00107380|581326908|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
161128984|NCT00110019|581858405|FG001|Overall Study|complicating disease|1|||
161128985|NCT00110019|581858404|FG000|Overall Study|symptom deterioration|13|||
161128986|NCT00110019|581858405|FG001|Overall Study|symptom deterioration|16|||
161128987|NCT00110019|581858404|FG000|Overall Study|Not start protocol therapy|17|||
161128988|NCT00110019|581858405|FG001|Overall Study|Not start protocol therapy|16|||
160893727|NCT01390220|581006374|FG000|Test Dose Phase|Protocol Violation|8|||
160893728|NCT01390220|581006375|FG001|Test Dose Phase|Protocol Violation|0|||
160893729|NCT01390220|581006376|FG002|Test Dose Phase|Protocol Violation|0|||
160893730|NCT01390220|581006374|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
160893731|NCT01390220|581006375|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
160893732|NCT01390220|581006376|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
160893733|NCT01390220|581006374|FG000|Test Dose Phase|Study/Site closure|6|||
160893734|NCT01390220|581006375|FG001|Test Dose Phase|Study/Site closure|0|||
160893735|NCT01390220|581006376|FG002|Test Dose Phase|Study/Site closure|0|||
160893736|NCT01390220|581006374|FG000|Test Dose Phase|Caregiver no longer available|5|||
160893737|NCT01390220|581006375|FG001|Test Dose Phase|Caregiver no longer available|0|||
160893738|NCT01390220|581006376|FG002|Test Dose Phase|Caregiver no longer available|0|||
160893739|NCT01390220|581006374|FG000|Test Dose Phase|Noncompliance|2|||
160893740|NCT01390220|581006375|FG001|Test Dose Phase|Noncompliance|0|||
160893741|NCT01390220|581006376|FG002|Test Dose Phase|Noncompliance|0|||
160893742|NCT01390220|581006374|FG000|Test Dose Phase|Logistical|6|||
160893743|NCT01390220|581006375|FG001|Test Dose Phase|Logistical|0|||
160893744|NCT01390220|581006376|FG002|Test Dose Phase|Logistical|0|||
160893745|NCT01390220|581006374|FG000|Comparative Phase|Withdrawal by Subject|0|||
160893746|NCT01390220|581006375|FG001|Comparative Phase|Withdrawal by Subject|1|||
160893747|NCT01390220|581006376|FG002|Comparative Phase|Withdrawal by Subject|0|||
160893748|NCT03059446|581006377|FG000|Overall Study|Adverse Event|11|||
160893749|NCT03059446|581006377|FG000|Overall Study|Withdrawal of Consent|16|||
160893750|NCT03059446|581006377|FG000|Overall Study|Lost to Follow-up|3|||
160893751|NCT03059446|581006377|FG000|Overall Study|Protocol Violation|1|||
160893752|NCT03059446|581006377|FG000|Overall Study|Study Terminated by Sponsor|131|||
160893753|NCT03059446|581006377|FG000|Overall Study|Reason not Specified|5|||
160893754|NCT00136604|581006378|FG000|Overall Study|Lost to Follow-up|1|||
160893755|NCT00136604|581006379|FG001|Overall Study|Lost to Follow-up|0|||
160893756|NCT00136604|581006380|FG002|Overall Study|Lost to Follow-up|0|||
160893757|NCT00136604|581006381|FG003|Overall Study|Lost to Follow-up|0|||
160893758|NCT00136604|581006382|FG004|Overall Study|Lost to Follow-up|1|||
160893759|NCT00136604|581006378|FG000|Overall Study|Migrated/moved from study area|0|||
160893760|NCT00136604|581006379|FG001|Overall Study|Migrated/moved from study area|1|||
160893761|NCT00136604|581006380|FG002|Overall Study|Migrated/moved from study area|0|||
160893762|NCT00136604|581006381|FG003|Overall Study|Migrated/moved from study area|0|||
160893763|NCT00136604|581006382|FG004|Overall Study|Migrated/moved from study area|0|||
160893764|NCT00470847|581006383|FG000|Overall Study|Pt still receiving treatment|1|||
161128989|NCT00110019|581858404|FG000|Overall Study|other reasons|22|||
161128990|NCT00110019|581858405|FG001|Overall Study|other reasons|30|||
161128991|NCT01046695|581858406|FG000|Overall Study|Subject had a pacemaker|0|||
161128992|NCT01046695|581858407|FG001|Overall Study|Subject had a pacemaker|1|||
161128993|NCT01046695|581858406|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
161128994|NCT01046695|581858407|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
161128995|NCT03072160|581858408|FG000|Overall Study|Adverse Event|3|||
160794219|NCT03238196|580633316|FG003|Overall Study|Withdrawal by Subject|0|||
160794220|NCT03238196|580633313|FG000|Overall Study|Disease progression|14|||
160794221|NCT03238196|580633314|FG001|Overall Study|Disease progression|2|||
160794222|NCT03238196|580633315|FG002|Overall Study|Disease progression|3|||
160794223|NCT03238196|580633316|FG003|Overall Study|Disease progression|2|||
160794224|NCT03238196|580633313|FG000|Overall Study|Still on treatment|1|||
160794225|NCT03238196|580633314|FG001|Overall Study|Still on treatment|0|||
160794226|NCT03238196|580633315|FG002|Overall Study|Still on treatment|0|||
160794227|NCT03238196|580633316|FG003|Overall Study|Still on treatment|0|||
160794228|NCT00835354|580633317|FG000|First Intervention|Adverse Event|0|||
160794229|NCT00835354|580633318|FG001|First Intervention|Adverse Event|1|||
160794230|NCT03559556|580633324|FG000|Overall Study|Withdrawal by Subject|1|||
160794231|NCT02496000|580633325|FG000|Overall Study|Withdrawal by Subject|1|||
161128996|NCT03072160|581858409|FG001|Overall Study|Adverse Event|1|||
161128997|NCT03072160|581858408|FG000|Overall Study|Refused further treatment|6|||
161128998|NCT03072160|581858409|FG001|Overall Study|Refused further treatment|1|||
161128999|NCT03072160|581858408|FG000|Overall Study|Physician Decision|1|||
161129000|NCT03072160|581858409|FG001|Overall Study|Physician Decision|0|||
160794232|NCT02496000|580633326|FG001|Overall Study|Withdrawal by Subject|2|||
160794233|NCT02496000|580633327|FG002|Overall Study|Withdrawal by Subject|0|||
160794234|NCT02496000|580633325|FG000|Overall Study|Lost to Follow-up|1|||
160893765|NCT01369615|581006385|FG000|Overall Study|Withdrawal by Subject|0|||
160893766|NCT01369615|581006386|FG001|Overall Study|Withdrawal by Subject|1|||
160893767|NCT01369615|581006385|FG000|Overall Study|Lost to Follow-up|0|||
160893768|NCT01369615|581006386|FG001|Overall Study|Lost to Follow-up|1|||
160893769|NCT04263454|581006387|FG000|Overall Study|Adverse Event|0|||
160893770|NCT04263454|581006388|FG001|Overall Study|Adverse Event|2|||
160982980|NCT00107380|581326908|FG000|Overall Study|Progression/relapse|4|||
160982981|NCT00107380|581326908|FG000|Overall Study|Death|3|||
161129001|NCT03072160|581858408|FG000|Overall Study|Disease progression on study|1|||
161330721|NCT02735980|582597226|FG002|Overall Study|Adverse Event|1|||
160893771|NCT04263454|581006387|FG000|Overall Study|Physician Decision|3|||
160893772|NCT04263454|581006388|FG001|Overall Study|Physician Decision|5|||
160893773|NCT04263454|581006387|FG000|Overall Study|Poor Data Quality|0|||
160893774|NCT04263454|581006388|FG001|Overall Study|Poor Data Quality|1|||
160893775|NCT00986479|581006389|FG000|Period 1|Improved mood|1|||
160893776|NCT00986479|581006390|FG001|Period 1|Improved mood|0|||
160893777|NCT00986479|581006389|FG000|Period 1|Administrative reasons|1|||
160893778|NCT00986479|581006390|FG001|Period 1|Administrative reasons|0|||
160893779|NCT01721070|581006391|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
160893780|NCT02035475|581006392|FG000|Overall Study|Withdrawal by Subject|4|||
160893781|NCT02035475|581006392|FG000|Overall Study|Physician Decision|1|||
160893782|NCT02035475|581006392|FG000|Overall Study|Equipment Error|1|||
160893783|NCT01231347|581006393|FG000|Overall Study|Full Consent withdrawn|19|||
160893784|NCT01231347|581006394|FG001|Overall Study|Full Consent withdrawn|19|||
160893785|NCT01231347|581006395|FG002|Overall Study|Full Consent withdrawn|11|||
160893786|NCT01231347|581006393|FG000|Overall Study|Lost to Follow-up|4|||
160893787|NCT01231347|581006394|FG001|Overall Study|Lost to Follow-up|2|||
160893788|NCT01231347|581006395|FG002|Overall Study|Lost to Follow-up|2|||
160893789|NCT01231347|581006393|FG000|Overall Study|Death|202|||
160893790|NCT01231347|581006394|FG001|Overall Study|Death|210|||
160893791|NCT01231347|581006395|FG002|Overall Study|Death|101|||
160893792|NCT01231347|581006393|FG000|Overall Study|other event|7|||
160893793|NCT01231347|581006394|FG001|Overall Study|other event|9|||
160893794|NCT01231347|581006395|FG002|Overall Study|other event|3|||
160893795|NCT02047227|581006396|FG000|Overall Study|Adverse Event|2|||
160893796|NCT02047227|581006397|FG001|Overall Study|Adverse Event|4|||
160893797|NCT02047227|581006396|FG000|Overall Study|Lost to Follow-up|0|||
160893798|NCT02047227|581006397|FG001|Overall Study|Lost to Follow-up|3|||
160893799|NCT02047227|581006396|FG000|Overall Study|Protocol Violation|1|||
160893800|NCT02047227|581006397|FG001|Overall Study|Protocol Violation|0|||
160893801|NCT02047227|581006396|FG000|Overall Study|Spontaneous pregnancy|1|||
160893802|NCT02047227|581006397|FG001|Overall Study|Spontaneous pregnancy|0|||
160893803|NCT02047227|581006396|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
160893804|NCT02047227|581006397|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
160893805|NCT02047227|581006396|FG000|Overall Study|No oocytes retrieved|21|||
160893806|NCT02047227|581006397|FG001|Overall Study|No oocytes retrieved|20|||
160893807|NCT02047227|581006396|FG000|Overall Study|No fertilization|61|||
160893808|NCT02047227|581006397|FG001|Overall Study|No fertilization|51|||
160893809|NCT02047227|581006396|FG000|Overall Study|Intention to freeze all embryos|1|||
160893810|NCT02047227|581006397|FG001|Overall Study|Intention to freeze all embryos|0|||
160893811|NCT02047227|581006396|FG000|Overall Study|All embryos discarded|12|||
160893812|NCT02047227|581006397|FG001|Overall Study|All embryos discarded|11|||
160893813|NCT02047227|581006396|FG000|Overall Study|Other|10|||
160893814|NCT02047227|581006397|FG001|Overall Study|Other|9|||
160893815|NCT01385371|581006410|FG000|Overall Study|Adverse Event|54|||
160893816|NCT01385371|581006411|FG001|Overall Study|Adverse Event|19|||
160893817|NCT01385371|581006410|FG000|Overall Study|Lost to Follow-up|16|||
160893818|NCT01385371|581006411|FG001|Overall Study|Lost to Follow-up|16|||
160893819|NCT01385371|581006410|FG000|Overall Study|Withdrawal by Subject|52|||
160893820|NCT01385371|581006411|FG001|Overall Study|Withdrawal by Subject|39|||
160893821|NCT01385371|581006410|FG000|Overall Study|Protocol Violation|25|||
160893822|NCT01385371|581006411|FG001|Overall Study|Protocol Violation|21|||
160893823|NCT01385371|581006410|FG000|Overall Study|Administrative|2|||
160893824|NCT01385371|581006411|FG001|Overall Study|Administrative|2|||
160893825|NCT02001181|581006420|FG000|Overall Study|Adverse Event|0|||
160893826|NCT02001181|581006421|FG001|Overall Study|Adverse Event|2|||
160893827|NCT02001181|581006420|FG000|Overall Study|Lost to Follow-up|1|||
160893828|NCT02001181|581006421|FG001|Overall Study|Lost to Follow-up|0|||
160893829|NCT02001181|581006420|FG000|Overall Study|Withdrawal by Subject|0|||
160893830|NCT02001181|581006421|FG001|Overall Study|Withdrawal by Subject|1|||
160893831|NCT03635788|581006431|FG000|Step 1|Death|1|||
160893832|NCT03635788|581006432|FG001|Step 1|Death|0|||
160893833|NCT03635788|581006433|FG002|Step 1|Death|0|||
160893834|NCT03635788|581006431|FG000|Step 1|Lost to Follow-up|31|||
160982982|NCT00107380|581326908|FG000|Overall Study|Other - not protocol specified|7|||
160982983|NCT00107380|581326908|FG000|Overall Study|Ineligible|2|||
160893835|NCT03635788|581006432|FG001|Step 1|Lost to Follow-up|0|||
160893836|NCT03635788|581006433|FG002|Step 1|Lost to Follow-up|0|||
160893837|NCT03635788|581006431|FG000|Step 1|Pregnancy|1|||
160893838|NCT03635788|581006432|FG001|Step 1|Pregnancy|0|||
160893839|NCT03635788|581006433|FG002|Step 1|Pregnancy|0|||
160893840|NCT03635788|581006431|FG000|Step 1|Protocol Violation|8|||
160893841|NCT03635788|581006432|FG001|Step 1|Protocol Violation|0|||
160893842|NCT03635788|581006433|FG002|Step 1|Protocol Violation|0|||
160893843|NCT03635788|581006431|FG000|Step 1|Withdrawal by Subject|13|||
160893844|NCT03635788|581006432|FG001|Step 1|Withdrawal by Subject|0|||
160893845|NCT03635788|581006433|FG002|Step 1|Withdrawal by Subject|0|||
160893846|NCT03635788|581006431|FG000|Step 1|Other reasons|12|||
160893847|NCT03635788|581006432|FG001|Step 1|Other reasons|0|||
160893848|NCT03635788|581006433|FG002|Step 1|Other reasons|0|||
160893849|NCT03635788|581006431|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
161129002|NCT03072160|581858409|FG001|Overall Study|Disease progression on study|1|||
161129003|NCT03072160|581858408|FG000|Overall Study|No contact|0|||
161129004|NCT03072160|581858409|FG001|Overall Study|No contact|1|||
161129005|NCT00559273|581858410|FG000|Correction Period (20 Weeks)|Death|3|||
161129006|NCT00559273|581858411|FG001|Correction Period (20 Weeks)|Death|4|||
161129007|NCT00559273|581858410|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
161129008|NCT00559273|581858411|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
161129009|NCT00559273|581858410|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
161129010|NCT00559273|581858411|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
161129011|NCT00559273|581858410|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
161129012|NCT00559273|581858411|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
161129013|NCT00559273|581858410|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
161129014|NCT00559273|581858411|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
160794235|NCT02496000|580633326|FG001|Overall Study|Lost to Follow-up|0|||
160794236|NCT02496000|580633327|FG002|Overall Study|Lost to Follow-up|1|||
160794237|NCT02496000|580633325|FG000|Overall Study|Protocol Violation|0|||
160982984|NCT03673098|581326909|FG000|Overall Study|Lost to Follow-up|2|||
160982985|NCT03673098|581326910|FG001|Overall Study|Lost to Follow-up|3|||
160982986|NCT03673098|581326909|FG000|Overall Study|Withdrawal by Subject|6|||
160982987|NCT03673098|581326910|FG001|Overall Study|Withdrawal by Subject|1|||
160982988|NCT03673098|581326909|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
160982989|NCT03673098|581326910|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
160982990|NCT03850444|581326911|FG000|Overall Study|Adverse Event|16|||
160982991|NCT03850444|581326912|FG001|Overall Study|Adverse Event|10|||
160982992|NCT03850444|581326911|FG000|Overall Study|Death|87|||
160982993|NCT03850444|581326912|FG001|Overall Study|Death|107|||
160982994|NCT03850444|581326911|FG000|Overall Study|Lost to Follow-up|1|||
160982995|NCT03850444|581326912|FG001|Overall Study|Lost to Follow-up|1|||
160982996|NCT03850444|581326911|FG000|Overall Study|Withdrawal by Subject|1|||
160982997|NCT03850444|581326912|FG001|Overall Study|Withdrawal by Subject|5|||
160982998|NCT03850444|581326911|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
160982999|NCT03850444|581326912|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
160983000|NCT01155726|581326914|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
160983001|NCT01155726|581326915|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
160983002|NCT01155726|581326916|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
160983003|NCT01155726|581326917|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
160983004|NCT02561455|581326918|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
160983005|NCT02561455|581326919|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
160983006|NCT02561455|581326920|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
160983007|NCT02561455|581326921|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
160983008|NCT02561455|581326918|FG000|Overall Study|Withdrawal by Subject|1|||
160983009|NCT02561455|581326919|FG001|Overall Study|Withdrawal by Subject|0|||
160983010|NCT02561455|581326920|FG002|Overall Study|Withdrawal by Subject|1|||
160983011|NCT02561455|581326921|FG003|Overall Study|Withdrawal by Subject|0|||
160983012|NCT02561455|581326918|FG000|Overall Study|Disease Progression|0|||
160983013|NCT02561455|581326919|FG001|Overall Study|Disease Progression|1|||
160983014|NCT02561455|581326920|FG002|Overall Study|Disease Progression|0|||
160983015|NCT02561455|581326921|FG003|Overall Study|Disease Progression|0|||
160983016|NCT03639675|581326924|FG000|Overall Study|Withdrawal by Subject|1|||
160983017|NCT00472186|581326928|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
160983018|NCT00472186|581326929|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
160983019|NCT01254565|581326930|FG000|Overall Study|Non-compliance to Study Procedures|0|||
160983020|NCT01254565|581326931|FG001|Overall Study|Non-compliance to Study Procedures|0|||
160983021|NCT01254565|581326932|FG002|Overall Study|Non-compliance to Study Procedures|0|||
160983022|NCT01254565|581326933|FG003|Overall Study|Non-compliance to Study Procedures|0|||
160983023|NCT01254565|581326934|FG004|Overall Study|Non-compliance to Study Procedures|1|||
160983024|NCT01254565|581326935|FG005|Overall Study|Non-compliance to Study Procedures|0|||
160983025|NCT01254565|581326930|FG000|Overall Study|Did not Receive Treatment|1|||
160983026|NCT01254565|581326931|FG001|Overall Study|Did not Receive Treatment|1|||
160983027|NCT01254565|581326932|FG002|Overall Study|Did not Receive Treatment|0|||
160983028|NCT01254565|581326933|FG003|Overall Study|Did not Receive Treatment|0|||
160983029|NCT01254565|581326934|FG004|Overall Study|Did not Receive Treatment|3|||
160983030|NCT01254565|581326935|FG005|Overall Study|Did not Receive Treatment|4|||
160983031|NCT01254565|581326930|FG000|Overall Study|Other|0|||
160983032|NCT01254565|581326931|FG001|Overall Study|Other|0|||
160983033|NCT01254565|581326932|FG002|Overall Study|Other|0|||
160983034|NCT01254565|581326933|FG003|Overall Study|Other|1|||
160983035|NCT01254565|581326934|FG004|Overall Study|Other|0|||
161129015|NCT00559273|581858410|FG000|Evaluation Period (8 Weeks)|Death|1|||
161129016|NCT00559273|581858411|FG001|Evaluation Period (8 Weeks)|Death|3|||
161129017|NCT00559273|581858410|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
161235867|NCT01597245|582244943|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
160794238|NCT02496000|580633326|FG001|Overall Study|Protocol Violation|0|||
161235868|NCT01597245|582244944|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235869|NCT01597245|582244945|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235870|NCT01597245|582244946|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
161235871|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235872|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235873|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235874|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235875|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160794239|NCT02496000|580633327|FG002|Overall Study|Protocol Violation|1|||
160794240|NCT02496000|580633325|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
160794241|NCT02496000|580633326|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
160794242|NCT02496000|580633327|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
160794243|NCT02496000|580633325|FG000|Overall Study|undetermined|0|||
160794244|NCT02496000|580633326|FG001|Overall Study|undetermined|1|||
160794245|NCT02496000|580633327|FG002|Overall Study|undetermined|0|||
160794246|NCT01877278|580633328|FG000|Overall Study|Lost to Follow-up|3|||
160794247|NCT01877278|580633329|FG001|Overall Study|Lost to Follow-up|3|||
160794248|NCT01969058|580633330|FG000|Overall Study|Withdrawal by Subject|2|||
160794249|NCT01969058|580633331|FG001|Overall Study|Withdrawal by Subject|0|||
160794250|NCT01969058|580633330|FG000|Overall Study|Adverse Event|1|||
160794251|NCT01969058|580633331|FG001|Overall Study|Adverse Event|0|||
160794252|NCT04090749|580633332|FG000|Open Label Pilot|Lost to Follow-up|1|||
160794253|NCT04090749|580633333|FG001|Open Label Pilot|Lost to Follow-up|0|||
160794254|NCT04090749|580633334|FG002|Open Label Pilot|Lost to Follow-up|0|||
160794255|NCT04090749|580633332|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
160794256|NCT04090749|580633333|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
160794257|NCT04090749|580633334|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
160794258|NCT04090749|580633332|FG000|Pilot Trial|Lost to Follow-up|0|||
160794259|NCT04090749|580633333|FG001|Pilot Trial|Lost to Follow-up|1|||
160794260|NCT04090749|580633334|FG002|Pilot Trial|Lost to Follow-up|1|||
160794261|NCT03510715|580633335|FG000|Overall Study|Adverse Event|1|||
160794262|NCT03510715|580633336|FG001|Overall Study|Adverse Event|0|||
160794263|NCT01972659|580633338|FG000|Overall Study|Protocol Violation|2|||
160794264|NCT01972659|580633339|FG001|Overall Study|Protocol Violation|2|||
160794265|NCT01972659|580633338|FG000|Overall Study|problems realted to acceleromyograph|2|||
160794266|NCT01972659|580633339|FG001|Overall Study|problems realted to acceleromyograph|1|||
160794267|NCT02457793|580633341|FG000|Overall Study|Reason not specified|0|||
160794268|NCT02457793|580633342|FG001|Overall Study|Reason not specified|0|||
160893850|NCT03635788|581006432|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
160893851|NCT03635788|581006433|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
160893852|NCT03635788|581006431|FG000|Step 2|Lost to Follow-up|0|||
160893853|NCT03635788|581006432|FG001|Step 2|Lost to Follow-up|8|||
160893854|NCT03635788|581006433|FG002|Step 2|Lost to Follow-up|15|||
160893855|NCT03635788|581006431|FG000|Step 2|Withdrawal by Subject|0|||
160893856|NCT03635788|581006432|FG001|Step 2|Withdrawal by Subject|6|||
160893857|NCT03635788|581006433|FG002|Step 2|Withdrawal by Subject|6|||
160893858|NCT03635788|581006431|FG000|Step 2|Death|0|||
160893859|NCT03635788|581006432|FG001|Step 2|Death|2|||
160893860|NCT03635788|581006433|FG002|Step 2|Death|0|||
160893861|NCT03635788|581006431|FG000|Step 2|Incarceration|0|||
160893862|NCT03635788|581006432|FG001|Step 2|Incarceration|2|||
160893863|NCT03635788|581006433|FG002|Step 2|Incarceration|0|||
160893864|NCT03635788|581006431|FG000|Step 2|Non-Compliance With Study Requirements|0|||
160893865|NCT03635788|581006432|FG001|Step 2|Non-Compliance With Study Requirements|1|||
160893866|NCT03635788|581006433|FG002|Step 2|Non-Compliance With Study Requirements|1|||
160893867|NCT03635788|581006431|FG000|Step 2|Confounding Medical Condition|0|||
160893868|NCT03635788|581006432|FG001|Step 2|Confounding Medical Condition|0|||
160893869|NCT03635788|581006433|FG002|Step 2|Confounding Medical Condition|1|||
160893870|NCT03635788|581006431|FG000|Step 2|Out Of State With No Plan To Return|0|||
160893871|NCT03635788|581006432|FG001|Step 2|Out Of State With No Plan To Return|1|||
160893872|NCT03635788|581006433|FG002|Step 2|Out Of State With No Plan To Return|0|||
160893873|NCT03635788|581006431|FG000|Step 2|Switched To Injectables|0|||
160893874|NCT03635788|581006432|FG001|Step 2|Switched To Injectables|0|||
160893875|NCT03635788|581006433|FG002|Step 2|Switched To Injectables|1|||
160893876|NCT03635788|581006431|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
160893877|NCT03635788|581006432|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
160893878|NCT03635788|581006433|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
160893879|NCT04571515|581006435|FG000|Overall Study|Physician Decision|0|||
160893880|NCT04571515|581006436|FG001|Overall Study|Physician Decision|0|||
160893881|NCT04571515|581006437|FG002|Overall Study|Physician Decision|0|||
160893882|NCT04571515|581006438|FG003|Overall Study|Physician Decision|0|||
160893883|NCT04571515|581006439|FG004|Overall Study|Physician Decision|1|||
160893884|NCT04571515|581006435|FG000|Overall Study|Withdrawal by Subject|0|||
160893885|NCT04571515|581006436|FG001|Overall Study|Withdrawal by Subject|0|||
160893886|NCT04571515|581006437|FG002|Overall Study|Withdrawal by Subject|0|||
161235876|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160983036|NCT01254565|581326935|FG005|Overall Study|Other|0|||
160983037|NCT03354637|581326940|FG000|Double-blind Period|Protocol Violation|2|||
160983038|NCT03354637|581326941|FG001|Double-blind Period|Protocol Violation|0|||
160983039|NCT03354637|581326942|FG002|Double-blind Period|Protocol Violation|0|||
160983040|NCT03354637|581326940|FG000|Double-blind Period|Adverse Event|1|||
160983041|NCT03354637|581326941|FG001|Double-blind Period|Adverse Event|2|||
160983042|NCT03354637|581326942|FG002|Double-blind Period|Adverse Event|0|||
160983043|NCT03354637|581326940|FG000|Double-blind Period|Lost to Follow-up|3|||
160983044|NCT03354637|581326941|FG001|Double-blind Period|Lost to Follow-up|4|||
160983045|NCT03354637|581326942|FG002|Double-blind Period|Lost to Follow-up|3|||
160983046|NCT03354637|581326940|FG000|Double-blind Period|Withdrawal by Subject|10|||
160983047|NCT03354637|581326941|FG001|Double-blind Period|Withdrawal by Subject|6|||
161129018|NCT00559273|581858411|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
161129019|NCT00559273|581858410|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
161129020|NCT00559273|581858411|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
161129021|NCT00559273|581858410|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
161129022|NCT00559273|581858411|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
161129023|NCT04276207|581858412|FG000|Period 1|Withdrawal by Subject|0|||
161129024|NCT04276207|581858413|FG001|Period 1|Withdrawal by Subject|1|||
161129025|NCT01256177|581858414|FG000|Overall Study|Withdrawal by Subject|23|||
161129026|NCT01256177|581858415|FG001|Overall Study|Withdrawal by Subject|22|||
161129027|NCT01256177|581858414|FG000|Overall Study|Lost to Follow-up|2|||
161129028|NCT01256177|581858415|FG001|Overall Study|Lost to Follow-up|2|||
161129029|NCT01256177|581858414|FG000|Overall Study|Adverse Event|8|||
161129030|NCT01256177|581858415|FG001|Overall Study|Adverse Event|9|||
161129031|NCT01256177|581858414|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161129032|NCT01256177|581858415|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161129033|NCT01256177|581858414|FG000|Overall Study|Condition under Investigation Worsened|1|||
161129034|NCT01256177|581858415|FG001|Overall Study|Condition under Investigation Worsened|0|||
161129035|NCT01256177|581858414|FG000|Overall Study|Lack of Efficacy|11|||
161129036|NCT01256177|581858415|FG001|Overall Study|Lack of Efficacy|2|||
161129037|NCT01256177|581858414|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
161129038|NCT01256177|581858415|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
161129039|NCT01596257|581858417|FG000|Overall Study|Inadequate Collection|23|||
161129040|NCT01596257|581858418|FG001|Overall Study|Inadequate Collection|19|||
161129041|NCT00531960|581858419|FG000|Overall Study|Adverse Event|5|||
161129042|NCT00531960|581858420|FG001|Overall Study|Adverse Event|4|||
161129043|NCT00531960|581858419|FG000|Overall Study|Death|3|||
161129044|NCT00531960|581858420|FG001|Overall Study|Death|2|||
161129045|NCT00531960|581858419|FG000|Overall Study|Lack of Efficacy|42|||
161129046|NCT00531960|581858420|FG001|Overall Study|Lack of Efficacy|41|||
161129047|NCT00531960|581858419|FG000|Overall Study|Violation of Selection Criteria|2|||
161129048|NCT00531960|581858420|FG001|Overall Study|Violation of Selection Criteria|0|||
161129049|NCT00531960|581858419|FG000|Overall Study|Refused Treatment|5|||
161129050|NCT00531960|581858420|FG001|Overall Study|Refused Treatment|6|||
161129051|NCT00531960|581858419|FG000|Overall Study|Other|4|||
161129052|NCT00531960|581858420|FG001|Overall Study|Other|10|||
161129053|NCT02318784|581858423|FG000|Overall Study|Adverse Event|13|||
161129054|NCT02318784|581858423|FG000|Overall Study|Death|2|||
161129055|NCT02318784|581858423|FG000|Overall Study|Progressive Disease|37|||
161129056|NCT02318784|581858423|FG000|Overall Study|Withdrawal by Subject|10|||
161129057|NCT03603652|581858427|FG000|Overall Study|Death|2|||
161129058|NCT01879410|581858435|FG000|Overall Study|Adverse Event|9|||
161129059|NCT01879410|581858436|FG001|Overall Study|Adverse Event|14|||
161129060|NCT01879410|581858435|FG000|Overall Study|Lack of Efficacy|4|||
161129061|NCT01879410|581858436|FG001|Overall Study|Lack of Efficacy|6|||
161129062|NCT01879410|581858435|FG000|Overall Study|Protocol Violation|1|||
161129063|NCT01879410|581858436|FG001|Overall Study|Protocol Violation|7|||
161129064|NCT01879410|581858435|FG000|Overall Study|Lost to Follow-up|2|||
161129065|NCT01879410|581858436|FG001|Overall Study|Lost to Follow-up|1|||
161129066|NCT01879410|581858435|FG000|Overall Study|Withdrawal by Subject|7|||
161129067|NCT01879410|581858436|FG001|Overall Study|Withdrawal by Subject|8|||
161129068|NCT01879410|581858435|FG000|Overall Study|Randomised in Error|1|||
161129069|NCT01879410|581858436|FG001|Overall Study|Randomised in Error|2|||
161129070|NCT00238264|581858437|FG000|Overall Study|Death|7|||
161129071|NCT00238264|581858437|FG000|Overall Study|Lost to Follow-up|18|||
161129072|NCT00238264|581858437|FG000|Overall Study|Withdrawal by Subject|4|||
161129073|NCT00238264|581858437|FG000|Overall Study|Ineligible|7|||
161129074|NCT01014585|581858438|FG000|Overall Study|Adverse Event|0|||
161129075|NCT01014585|581858439|FG001|Overall Study|Adverse Event|2|||
161129076|NCT01014585|581858440|FG002|Overall Study|Adverse Event|0|||
160983048|NCT03354637|581326942|FG002|Double-blind Period|Withdrawal by Subject|4|||
160983049|NCT03354637|581326940|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
160983050|NCT03354637|581326941|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
161129077|NCT01014585|581858441|FG003|Overall Study|Adverse Event|3|||
161330722|NCT02735980|582597224|FG000|Overall Study|Death|5|||
161129078|NCT01014585|581858438|FG000|Overall Study|Withdrawal by Subject|2|||
161129079|NCT01014585|581858439|FG001|Overall Study|Withdrawal by Subject|0|||
161129080|NCT01014585|581858440|FG002|Overall Study|Withdrawal by Subject|1|||
161129081|NCT01014585|581858441|FG003|Overall Study|Withdrawal by Subject|3|||
161129082|NCT01014585|581858438|FG000|Overall Study|Lost to Follow-up|0|||
161129083|NCT01014585|581858439|FG001|Overall Study|Lost to Follow-up|0|||
161129084|NCT01014585|581858440|FG002|Overall Study|Lost to Follow-up|0|||
161129085|NCT01014585|581858441|FG003|Overall Study|Lost to Follow-up|2|||
161129086|NCT01014585|581858438|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
161129087|NCT01014585|581858439|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
161129088|NCT01014585|581858440|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
161129089|NCT01014585|581858441|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
161129090|NCT01737931|581858448|FG000|Overall Study|Withdrawal by Subject|0|||
161129091|NCT01737931|581858449|FG001|Overall Study|Withdrawal by Subject|1|||
161129092|NCT01737931|581858450|FG002|Overall Study|Withdrawal by Subject|1|||
161129093|NCT01737931|581858448|FG000|Overall Study|Physician Decision|0|||
161129094|NCT01737931|581858449|FG001|Overall Study|Physician Decision|1|||
161129095|NCT01737931|581858450|FG002|Overall Study|Physician Decision|0|||
161129096|NCT04897867|581858451|FG000|Overall Study|Withdrawal of Consent|1|||
161129097|NCT04897867|581858451|FG000|Overall Study|Pregnancy|1|||
161129098|NCT04897867|581858451|FG000|Overall Study|Lost to Follow-up|7|||
161129099|NCT04897867|581858451|FG000|Overall Study|Reason not Specified|2|||
161129100|NCT00508391|581858452|FG000|First Treatment|Withdrawal by Subject|6|||
161129101|NCT00508391|581858453|FG001|First Treatment|Withdrawal by Subject|3|||
161129102|NCT00508391|581858452|FG000|Second Treatment|Withdrawal by Subject|2|||
161129103|NCT00508391|581858453|FG001|Second Treatment|Withdrawal by Subject|0|||
161129104|NCT00880256|581858457|FG000|Overall Study|Lost to Follow-up|28|||
161129105|NCT02041962|581858458|FG000|Overall Study|Lost Aetna Coverage|43|||
161129106|NCT02041962|581858459|FG001|Overall Study|Lost Aetna Coverage|40|||
161129107|NCT02041962|581858458|FG000|Overall Study|Death|1|||
161129108|NCT02041962|581858459|FG001|Overall Study|Death|1|||
160893887|NCT04571515|581006438|FG003|Overall Study|Withdrawal by Subject|0|||
160893888|NCT04571515|581006439|FG004|Overall Study|Withdrawal by Subject|1|||
160893889|NCT04571515|581006435|FG000|Overall Study|insufficient pain|1|||
160893890|NCT04571515|581006436|FG001|Overall Study|insufficient pain|0|||
160893891|NCT04571515|581006437|FG002|Overall Study|insufficient pain|0|||
160893892|NCT04571515|581006438|FG003|Overall Study|insufficient pain|0|||
160893893|NCT04571515|581006439|FG004|Overall Study|insufficient pain|1|||
160893894|NCT02095223|581008225|FG000|Overall Study|Withdrawal by Subject|1|||
160893895|NCT02095223|581008226|FG001|Overall Study|Withdrawal by Subject|0|||
160893896|NCT01859143|581008228|FG000|Overall Study|Lost to Follow-up|2|||
160893897|NCT01859143|581008229|FG001|Overall Study|Lost to Follow-up|0|||
160893898|NCT00760214|581008230|FG000|Overall Study|Adverse Event|8|||
160893899|NCT00760214|581008231|FG001|Overall Study|Adverse Event|9|||
160983051|NCT03354637|581326942|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
160983052|NCT03354637|581326940|FG000|Open Label Extension|Adverse Event|0|||
160983053|NCT03354637|581326941|FG001|Open Label Extension|Adverse Event|0|||
160983054|NCT03354637|581326942|FG002|Open Label Extension|Adverse Event|1|||
160983055|NCT03354637|581326940|FG000|Open Label Extension|Lost to Follow-up|0|||
160983056|NCT03354637|581326941|FG001|Open Label Extension|Lost to Follow-up|0|||
160983057|NCT03354637|581326942|FG002|Open Label Extension|Lost to Follow-up|2|||
160983058|NCT03354637|581326940|FG000|Open Label Extension|Withdrawal by Subject|0|||
160983059|NCT03354637|581326941|FG001|Open Label Extension|Withdrawal by Subject|0|||
160983060|NCT03354637|581326942|FG002|Open Label Extension|Withdrawal by Subject|5|||
160983061|NCT03354637|581326940|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
160983062|NCT03354637|581326941|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
160983063|NCT03354637|581326942|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
160983064|NCT03354637|581326940|FG000|Open Label Extension|Subject Noncompliance|0|||
160983065|NCT03354637|581326941|FG001|Open Label Extension|Subject Noncompliance|0|||
160983066|NCT03354637|581326942|FG002|Open Label Extension|Subject Noncompliance|1|||
161129109|NCT02041962|581858458|FG000|Overall Study|Lost to Follow-up|37|||
161129110|NCT02041962|581858459|FG001|Overall Study|Lost to Follow-up|32|||
161129111|NCT02041962|581858458|FG000|Overall Study|Withdrawal by Subject|0|||
161129112|NCT02041962|581858459|FG001|Overall Study|Withdrawal by Subject|11|||
161129113|NCT01686568|581858460|FG000|Main Study|Withdrawal by Subject|1|||
161129114|NCT01686568|581858461|FG001|Main Study|Withdrawal by Subject|3|||
161129115|NCT01686568|581858460|FG000|Main Study|Noncompliance with protocol|0|||
161129116|NCT01686568|581858461|FG001|Main Study|Noncompliance with protocol|1|||
160893900|NCT00760214|581008232|FG002|Overall Study|Adverse Event|12|||
161129117|NCT01686568|581858460|FG000|Main Study|Liver enzymes above range of exclusion|1|||
161129118|NCT01686568|581858461|FG001|Main Study|Liver enzymes above range of exclusion|0|||
161129119|NCT01686568|581858460|FG000|Sub-Study|Not consented for sub-study|2|||
161330723|NCT02735980|582597225|FG001|Overall Study|Death|4|||
160893901|NCT00760214|581008230|FG000|Overall Study|Protocol Violation|3|||
160893902|NCT00760214|581008231|FG001|Overall Study|Protocol Violation|0|||
160893903|NCT00760214|581008232|FG002|Overall Study|Protocol Violation|3|||
160893904|NCT00760214|581008230|FG000|Overall Study|Lost to Follow-up|0|||
160983067|NCT03354637|581326940|FG000|Open Label Extension|Lack of Efficacy|0|||
161330724|NCT02735980|582597226|FG002|Overall Study|Death|0|||
160794269|NCT02457793|580633343|FG002|Overall Study|Reason not specified|0|||
160794270|NCT02457793|580633344|FG003|Overall Study|Reason not specified|1|||
160794271|NCT02457793|580633345|FG004|Overall Study|Reason not specified|1|||
160794272|NCT02457793|580633346|FG005|Overall Study|Reason not specified|1|||
160794273|NCT02457793|580633341|FG000|Overall Study|Withdrawal by Subject|0|||
160794274|NCT02457793|580633342|FG001|Overall Study|Withdrawal by Subject|4|||
160794275|NCT02457793|580633343|FG002|Overall Study|Withdrawal by Subject|2|||
160794276|NCT02457793|580633344|FG003|Overall Study|Withdrawal by Subject|2|||
160794277|NCT02457793|580633345|FG004|Overall Study|Withdrawal by Subject|2|||
160794278|NCT02457793|580633346|FG005|Overall Study|Withdrawal by Subject|2|||
160794279|NCT02457793|580633341|FG000|Overall Study|Adverse Event|0|||
160794280|NCT02457793|580633342|FG001|Overall Study|Adverse Event|0|||
160794281|NCT02457793|580633343|FG002|Overall Study|Adverse Event|0|||
160794282|NCT02457793|580633344|FG003|Overall Study|Adverse Event|1|||
160794283|NCT02457793|580633345|FG004|Overall Study|Adverse Event|0|||
160794284|NCT02457793|580633346|FG005|Overall Study|Adverse Event|0|||
160794285|NCT02457793|580633341|FG000|Overall Study|Physician Decision|1|||
160794286|NCT02457793|580633342|FG001|Overall Study|Physician Decision|0|||
160794287|NCT02457793|580633343|FG002|Overall Study|Physician Decision|1|||
160794288|NCT02457793|580633344|FG003|Overall Study|Physician Decision|1|||
160794289|NCT02457793|580633345|FG004|Overall Study|Physician Decision|1|||
160794290|NCT02457793|580633346|FG005|Overall Study|Physician Decision|3|||
160794291|NCT00835172|580633351|FG000|Washout|Protocol Violation|0|||
160794292|NCT00835172|580633352|FG001|Washout|Protocol Violation|1|||
160794293|NCT03164356|580633353|FG000|Overall Study|Lost to Follow-up|1|||
160794294|NCT03164356|580633354|FG001|Overall Study|Lost to Follow-up|1|||
161330725|NCT02735980|582597224|FG000|Overall Study|Physician Decision|3|||
161330726|NCT02735980|582597225|FG001|Overall Study|Physician Decision|1|||
161330727|NCT02735980|582597226|FG002|Overall Study|Physician Decision|0|||
161330728|NCT02735980|582597224|FG000|Overall Study|Screen failure|1|||
160794295|NCT03164356|580633355|FG002|Overall Study|Lost to Follow-up|2|||
160794296|NCT03164356|580633356|FG003|Overall Study|Lost to Follow-up|1|||
160794297|NCT03164356|580633353|FG000|Overall Study|Physician Decision|0|||
160794298|NCT03164356|580633354|FG001|Overall Study|Physician Decision|0|||
160794299|NCT03164356|580633355|FG002|Overall Study|Physician Decision|3|||
160794300|NCT03164356|580633356|FG003|Overall Study|Physician Decision|0|||
160794301|NCT03164356|580633353|FG000|Overall Study|Protocol Violation|2|||
160794302|NCT03164356|580633354|FG001|Overall Study|Protocol Violation|1|||
160794303|NCT03164356|580633355|FG002|Overall Study|Protocol Violation|0|||
160794304|NCT03164356|580633356|FG003|Overall Study|Protocol Violation|0|||
160794305|NCT03164356|580633353|FG000|Overall Study|Withdrawal by Subject|1|||
160794306|NCT03164356|580633354|FG001|Overall Study|Withdrawal by Subject|0|||
160794307|NCT03164356|580633355|FG002|Overall Study|Withdrawal by Subject|0|||
160794308|NCT03164356|580633356|FG003|Overall Study|Withdrawal by Subject|0|||
160794309|NCT03164356|580633353|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
160794310|NCT03164356|580633354|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
160794311|NCT03164356|580633355|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
160794312|NCT03164356|580633356|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
160794313|NCT03164356|580633353|FG000|Overall Study|Subject Incarcerated|0|||
160794314|NCT03164356|580633354|FG001|Overall Study|Subject Incarcerated|1|||
160794315|NCT03164356|580633355|FG002|Overall Study|Subject Incarcerated|0|||
160794316|NCT03164356|580633356|FG003|Overall Study|Subject Incarcerated|0|||
160794317|NCT03164356|580633353|FG000|Overall Study|Prosthetist unable to participate|0|||
160794318|NCT03164356|580633354|FG001|Overall Study|Prosthetist unable to participate|2|||
160794319|NCT03164356|580633355|FG002|Overall Study|Prosthetist unable to participate|1|||
160794320|NCT03164356|580633356|FG003|Overall Study|Prosthetist unable to participate|0|||
160794321|NCT00791648|580635239|FG000|Overall Study|Physician Decision|0|||
160794322|NCT00791648|580635240|FG001|Overall Study|Physician Decision|1|||
160794323|NCT00791648|580635239|FG000|Overall Study|Withdrawal by Subject|0|||
160794324|NCT00791648|580635240|FG001|Overall Study|Withdrawal by Subject|1|||
160794325|NCT04123704|580635251|FG000|Overall Study|Disease progression|2|||
160794326|NCT03332056|580635254|FG000|Overall Study|Incomplete questionnaires|8|||
160794327|NCT03332056|580635255|FG001|Overall Study|Incomplete questionnaires|9|||
160794328|NCT03332056|580635254|FG000|Overall Study|Passed stone prior to surgery date|1|||
160794329|NCT03332056|580635255|FG001|Overall Study|Passed stone prior to surgery date|0|||
160794330|NCT03332056|580635254|FG000|Overall Study|Did not require a ureteral stent|0|||
160794331|NCT03332056|580635255|FG001|Overall Study|Did not require a ureteral stent|1|||
160794332|NCT03360344|580635258|FG000|Overall Study|Withdrawal by Subject|0|||
160794333|NCT03360344|580635259|FG001|Overall Study|Withdrawal by Subject|1|||
160794334|NCT03360344|580635260|FG002|Overall Study|Withdrawal by Subject|1|||
161330729|NCT02735980|582597225|FG001|Overall Study|Screen failure|0|||
161330730|NCT02735980|582597226|FG002|Overall Study|Screen failure|0|||
161330731|NCT02735980|582597224|FG000|Overall Study|Withdrawal by Subject|1|||
160794335|NCT00133705|580635265|FG000|Overall Study|Withdrawal by Subject|2|||
160794336|NCT00133705|580635266|FG001|Overall Study|Withdrawal by Subject|3|||
160794337|NCT00959049|580635267|FG000|Overall Study|Adverse Event|1|||
160794338|NCT00959049|580635268|FG001|Overall Study|Adverse Event|0|||
160794339|NCT00959049|580635269|FG002|Overall Study|Adverse Event|0|||
160794340|NCT00959049|580635270|FG003|Overall Study|Adverse Event|0|||
160794341|NCT00959049|580635271|FG004|Overall Study|Adverse Event|0|||
160794342|NCT00959049|580635272|FG005|Overall Study|Adverse Event|0|||
160794343|NCT00959049|580635267|FG000|Overall Study|Lost to Follow-up|17|||
161235877|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
160794344|NCT00959049|580635268|FG001|Overall Study|Lost to Follow-up|5|||
160794345|NCT00959049|580635269|FG002|Overall Study|Lost to Follow-up|1|||
160794346|NCT00959049|580635270|FG003|Overall Study|Lost to Follow-up|10|||
160794347|NCT00959049|580635271|FG004|Overall Study|Lost to Follow-up|9|||
160794348|NCT00959049|580635272|FG005|Overall Study|Lost to Follow-up|1|||
160794349|NCT00959049|580635267|FG000|Overall Study|Contraindicated medication|0|||
160794350|NCT00959049|580635268|FG001|Overall Study|Contraindicated medication|0|||
160794351|NCT00959049|580635269|FG002|Overall Study|Contraindicated medication|0|||
160893905|NCT00760214|581008231|FG001|Overall Study|Lost to Follow-up|0|||
160893906|NCT00760214|581008232|FG002|Overall Study|Lost to Follow-up|1|||
160893907|NCT00760214|581008230|FG000|Overall Study|Withdrawal by Subject|12|||
160893908|NCT00760214|581008231|FG001|Overall Study|Withdrawal by Subject|14|||
160893909|NCT00760214|581008232|FG002|Overall Study|Withdrawal by Subject|13|||
160893910|NCT00760214|581008230|FG000|Overall Study|Lack of Efficacy|3|||
160893911|NCT00760214|581008231|FG001|Overall Study|Lack of Efficacy|2|||
160893912|NCT00760214|581008232|FG002|Overall Study|Lack of Efficacy|4|||
160893913|NCT00760214|581008230|FG000|Overall Study|Pregnancy|0|||
160893914|NCT00760214|581008231|FG001|Overall Study|Pregnancy|0|||
160893915|NCT00760214|581008232|FG002|Overall Study|Pregnancy|1|||
160893916|NCT00760214|581008230|FG000|Overall Study|Physician Decision|1|||
160893917|NCT00760214|581008231|FG001|Overall Study|Physician Decision|1|||
160893918|NCT00760214|581008232|FG002|Overall Study|Physician Decision|1|||
160893919|NCT00760214|581008230|FG000|Overall Study|Other|3|||
160893920|NCT00760214|581008231|FG001|Overall Study|Other|4|||
160893921|NCT00760214|581008232|FG002|Overall Study|Other|6|||
160893922|NCT00700570|581008233|FG000|Overall Study|Adverse Event|2|||
160893923|NCT00700570|581008234|FG001|Overall Study|Adverse Event|6|||
160893924|NCT00700570|581008233|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
160893925|NCT00700570|581008234|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
160893926|NCT00700570|581008233|FG000|Overall Study|Disease Progression|8|||
160893927|NCT00700570|581008234|FG001|Overall Study|Disease Progression|11|||
160893928|NCT00700570|581008233|FG000|Overall Study|Withdrawal by Subject|1|||
160893929|NCT00700570|581008234|FG001|Overall Study|Withdrawal by Subject|6|||
160893930|NCT01134315|581008235|FG000|Overall Study|Adverse Event|1|||
160893931|NCT01134315|581008236|FG001|Overall Study|Adverse Event|2|||
160893932|NCT01134315|581008235|FG000|Overall Study|Other Reason|8|||
160893933|NCT01134315|581008236|FG001|Overall Study|Other Reason|17|||
160893934|NCT04587271|581008239|FG000|Overall Study|Lost to Follow-up|2|||
160893935|NCT04587271|581008240|FG001|Overall Study|Lost to Follow-up|2|||
160893936|NCT04587271|581008241|FG002|Overall Study|Lost to Follow-up|0|||
160893937|NCT04587271|581008242|FG003|Overall Study|Lost to Follow-up|2|||
160893938|NCT04587271|581008243|FG004|Overall Study|Lost to Follow-up|2|||
160893939|NCT04587271|581008244|FG005|Overall Study|Lost to Follow-up|0|||
160794352|NCT00959049|580635270|FG003|Overall Study|Contraindicated medication|1|||
160893940|NCT04587271|581008239|FG000|Overall Study|Caregiver brought child to visits|0|||
160893941|NCT04587271|581008240|FG001|Overall Study|Caregiver brought child to visits|0|||
160893942|NCT04587271|581008241|FG002|Overall Study|Caregiver brought child to visits|0|||
160893943|NCT04587271|581008242|FG003|Overall Study|Caregiver brought child to visits|1|||
160893944|NCT04587271|581008243|FG004|Overall Study|Caregiver brought child to visits|0|||
160983068|NCT03354637|581326941|FG001|Open Label Extension|Lack of Efficacy|0|||
160983069|NCT03354637|581326942|FG002|Open Label Extension|Lack of Efficacy|1|||
160794353|NCT00959049|580635271|FG004|Overall Study|Contraindicated medication|0|||
160983070|NCT03354637|581326940|FG000|Open Label Extension|Physician Decision|0|||
160983071|NCT03354637|581326941|FG001|Open Label Extension|Physician Decision|0|||
160983072|NCT03354637|581326942|FG002|Open Label Extension|Physician Decision|1|||
160794354|NCT00959049|580635272|FG005|Overall Study|Contraindicated medication|0|||
160794355|NCT00959049|580635267|FG000|Overall Study|Withdrawal by Subject|0|||
160794356|NCT00959049|580635268|FG001|Overall Study|Withdrawal by Subject|2|||
160794357|NCT00959049|580635269|FG002|Overall Study|Withdrawal by Subject|0|||
160794358|NCT00959049|580635270|FG003|Overall Study|Withdrawal by Subject|0|||
160794359|NCT00959049|580635271|FG004|Overall Study|Withdrawal by Subject|0|||
160794360|NCT00959049|580635272|FG005|Overall Study|Withdrawal by Subject|0|||
160794361|NCT00836706|580635280|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
160893945|NCT04587271|581008244|FG005|Overall Study|Caregiver brought child to visits|0|||
160893946|NCT02360111|581008245|FG000|Overall Study|Death|2|||
160893947|NCT00611533|581008246|FG000|First Intervention (6 Weeks)|Never started study|0|||
160893948|NCT00611533|581008247|FG001|First Intervention (6 Weeks)|Never started study|1|||
160893949|NCT00611533|581008246|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
160893950|NCT00611533|581008247|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160794362|NCT00836706|580635281|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
160794363|NCT02989857|580635282|FG000|Randomization Phase|Not Treated|3|||
160794364|NCT02989857|580635283|FG001|Randomization Phase|Not Treated|2|||
160794365|NCT02989857|580635284|FG002|Randomization Phase|Not Treated|0|||
160794366|NCT01992757|580635285|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
160794367|NCT00688740|580635289|FG000|Overall Study|Adverse Event|45|||
160794368|NCT00688740|580635290|FG001|Overall Study|Adverse Event|8|||
160794369|NCT00688740|580635289|FG000|Overall Study|Death|2|||
160794370|NCT00688740|580635290|FG001|Overall Study|Death|2|||
160794371|NCT00688740|580635289|FG000|Overall Study|Lost to Follow-up|0|||
160794372|NCT00688740|580635290|FG001|Overall Study|Lost to Follow-up|1|||
160794373|NCT00688740|580635289|FG000|Overall Study|Consent Withdrawn|17|||
160794374|NCT00688740|580635290|FG001|Overall Study|Consent Withdrawn|17|||
160794375|NCT00688740|580635289|FG000|Overall Study|Breast Cancer Relapse|1|||
160794376|NCT00688740|580635290|FG001|Overall Study|Breast Cancer Relapse|4|||
160794377|NCT00688740|580635289|FG000|Overall Study|Violation of Inclusion Criteria|1|||
160794378|NCT00688740|580635290|FG001|Overall Study|Violation of Inclusion Criteria|3|||
160794379|NCT01344356|580635291|FG000|Overall Study|Physician Decision|0|||
160794380|NCT01344356|580635292|FG001|Overall Study|Physician Decision|3|||
160794381|NCT01344356|580635291|FG000|Overall Study|Lost to Follow-up|0|||
160794382|NCT01344356|580635292|FG001|Overall Study|Lost to Follow-up|6|||
160794383|NCT02390076|580635295|FG000|Overall Study|Lost to Follow-up|2|||
160794384|NCT02390076|580635296|FG001|Overall Study|Lost to Follow-up|1|||
160794385|NCT02390076|580635297|FG002|Overall Study|Lost to Follow-up|4|||
160794386|NCT01206517|580635298|FG000|Overall Study|Withdrawal by Subject|0|||
160794387|NCT01206517|580635299|FG001|Overall Study|Withdrawal by Subject|0|||
160794388|NCT01206517|580635300|FG002|Overall Study|Withdrawal by Subject|2|||
160794389|NCT01206517|580635301|FG003|Overall Study|Withdrawal by Subject|0|||
160794390|NCT01206517|580635302|FG004|Overall Study|Withdrawal by Subject|1|||
160794391|NCT01206517|580635303|FG005|Overall Study|Withdrawal by Subject|0|||
161129120|NCT01686568|581858461|FG001|Sub-Study|Not consented for sub-study|2|||
160794392|NCT04023487|580635304|FG000|Overall Study|Lost to Follow-up|5|||
160794393|NCT04023487|580635305|FG001|Overall Study|Lost to Follow-up|4|||
160794394|NCT04023487|580635304|FG000|Overall Study|Pregnancy|1|||
160794395|NCT04023487|580635305|FG001|Overall Study|Pregnancy|2|||
160794396|NCT04023487|580635304|FG000|Overall Study|Withdrawal by Subject|4|||
160794397|NCT04023487|580635305|FG001|Overall Study|Withdrawal by Subject|5|||
160794398|NCT04023487|580635304|FG000|Overall Study|Partially completed testing|8|||
160794399|NCT04023487|580635305|FG001|Overall Study|Partially completed testing|4|||
160794400|NCT03898180|580635306|FG000|Overall Study|Death|178|||
160794401|NCT03898180|580635307|FG001|Overall Study|Death|173|||
160794402|NCT03898180|580635306|FG000|Overall Study|Physician Decision|1|||
160794403|NCT03898180|580635307|FG001|Overall Study|Physician Decision|0|||
160794404|NCT03898180|580635306|FG000|Overall Study|Sponsor Decision|3|||
160794405|NCT03898180|580635307|FG001|Overall Study|Sponsor Decision|0|||
160794406|NCT03898180|580635306|FG000|Overall Study|Lost to Follow-up|1|||
160794407|NCT03898180|580635307|FG001|Overall Study|Lost to Follow-up|0|||
160794408|NCT03898180|580635306|FG000|Overall Study|Withdrawal by Subject|5|||
160794409|NCT03898180|580635307|FG001|Overall Study|Withdrawal by Subject|4|||
160794410|NCT01472185|580635308|FG000|Overall Study|Randomized but Not Treated|0|||
160794411|NCT01472185|580635309|FG001|Overall Study|Randomized but Not Treated|1|||
160794412|NCT01472185|580635308|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
160794413|NCT01472185|580635309|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
160794414|NCT01472185|580635308|FG000|Overall Study|Hyperglycemia|5|||
160794415|NCT01472185|580635309|FG001|Overall Study|Hyperglycemia|2|||
160794416|NCT01472185|580635308|FG000|Overall Study|Investigator's Discretion|3|||
160794417|NCT01472185|580635309|FG001|Overall Study|Investigator's Discretion|1|||
160794418|NCT01472185|580635308|FG000|Overall Study|Lost to Follow-up|4|||
160794419|NCT01472185|580635309|FG001|Overall Study|Lost to Follow-up|1|||
160794420|NCT01472185|580635308|FG000|Overall Study|Protocol Violation|5|||
160794421|NCT01472185|580635309|FG001|Overall Study|Protocol Violation|1|||
160794422|NCT01472185|580635308|FG000|Overall Study|Subject Noncompliance|8|||
160794423|NCT01472185|580635309|FG001|Overall Study|Subject Noncompliance|15|||
160893951|NCT00611533|581008246|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160893952|NCT00611533|581008247|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
161129121|NCT01838044|581858462|FG000|Overall Study|Adverse Event|4|||
160794424|NCT01472185|580635308|FG000|Overall Study|Subject Withdrew Consent|6|||
160893953|NCT02180165|581008248|FG000|Overall Study|Not Treated|0|||
161129122|NCT01838044|581858463|FG001|Overall Study|Adverse Event|6|||
161129123|NCT01838044|581858462|FG000|Overall Study|Protocol Violation|3|||
160794425|NCT01472185|580635309|FG001|Overall Study|Subject Withdrew Consent|3|||
160794426|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794427|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
160893954|NCT02180165|581008249|FG001|Overall Study|Not Treated|0|||
160794428|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794429|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
160893955|NCT02180165|581008250|FG002|Overall Study|Not Treated|1|||
161129124|NCT01838044|581858463|FG001|Overall Study|Protocol Violation|3|||
160983073|NCT02726399|581326945|FG000|Overall Study|Participant Non-Compliance|1|||
160983074|NCT02726399|581326945|FG000|Overall Study|Adverse Event|2|||
160983075|NCT02726399|581326945|FG000|Overall Study|Progression of disease|4|||
160983076|NCT04006366|581326948|FG000|Overall Study|Withdrawal by Subject|1|||
160983077|NCT03468426|581326949|FG000|Overall Study|Progressive disease|3|||
160983078|NCT03468426|581326950|FG001|Overall Study|Progressive disease|0|||
160983079|NCT03468426|581326951|FG002|Overall Study|Progressive disease|4|||
160983080|NCT03468426|581326952|FG003|Overall Study|Progressive disease|20|||
160983081|NCT03468426|581326953|FG004|Overall Study|Progressive disease|23|||
160983082|NCT03468426|581326954|FG005|Overall Study|Progressive disease|15|||
160983083|NCT03468426|581326955|FG006|Overall Study|Progressive disease|24|||
160983084|NCT03468426|581326956|FG007|Overall Study|Progressive disease|27|||
160983085|NCT03468426|581326957|FG008|Overall Study|Progressive disease|13|||
160893956|NCT02180165|581008251|FG003|Overall Study|Not Treated|0|||
160893957|NCT02180165|581008248|FG000|Overall Study|Adverse Event|7|||
160983086|NCT03468426|581326958|FG009|Overall Study|Progressive disease|13|||
160983087|NCT03468426|581326959|FG010|Overall Study|Progressive disease|0|||
160983088|NCT03468426|581326949|FG000|Overall Study|Other adverse event or clinical progression|0|||
160893958|NCT02180165|581008249|FG001|Overall Study|Adverse Event|0|||
160893959|NCT02180165|581008250|FG002|Overall Study|Adverse Event|18|||
160893960|NCT02180165|581008251|FG003|Overall Study|Adverse Event|3|||
160893961|NCT02180165|581008248|FG000|Overall Study|Lack of Efficacy|0|||
160983089|NCT03468426|581326950|FG001|Overall Study|Other adverse event or clinical progression|1|||
160983090|NCT03468426|581326951|FG002|Overall Study|Other adverse event or clinical progression|3|||
160983091|NCT03468426|581326952|FG003|Overall Study|Other adverse event or clinical progression|14|||
160983092|NCT03468426|581326953|FG004|Overall Study|Other adverse event or clinical progression|10|||
160983093|NCT03468426|581326954|FG005|Overall Study|Other adverse event or clinical progression|8|||
160983094|NCT03468426|581326955|FG006|Overall Study|Other adverse event or clinical progression|5|||
160983095|NCT03468426|581326956|FG007|Overall Study|Other adverse event or clinical progression|4|||
160983096|NCT03468426|581326957|FG008|Overall Study|Other adverse event or clinical progression|6|||
160893962|NCT02180165|581008249|FG001|Overall Study|Lack of Efficacy|1|||
160893963|NCT02180165|581008250|FG002|Overall Study|Lack of Efficacy|3|||
160893964|NCT02180165|581008251|FG003|Overall Study|Lack of Efficacy|2|||
160893965|NCT02180165|581008248|FG000|Overall Study|Physician Decision|1|||
160893966|NCT02180165|581008249|FG001|Overall Study|Physician Decision|0|||
160893967|NCT02180165|581008250|FG002|Overall Study|Physician Decision|5|||
160893968|NCT02180165|581008251|FG003|Overall Study|Physician Decision|0|||
160893969|NCT02180165|581008248|FG000|Overall Study|Withdrawal by Subject|3|||
160893970|NCT02180165|581008249|FG001|Overall Study|Withdrawal by Subject|0|||
160893971|NCT02180165|581008250|FG002|Overall Study|Withdrawal by Subject|2|||
160893972|NCT02180165|581008251|FG003|Overall Study|Withdrawal by Subject|1|||
160893973|NCT01933217|581008252|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
160893974|NCT01933217|581008253|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
160893975|NCT01933217|581008252|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
160893976|NCT01933217|581008253|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
160893977|NCT03923738|581008257|FG000|Period 1|Adverse Event|1|||
160893978|NCT03923738|581008257|FG000|Period 1|Withdrawal by Subject|1|||
160893979|NCT05246397|581008258|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
160893980|NCT03875768|581008260|FG000|Overall Study|Lost to Follow-up|16|||
160893981|NCT03875768|581008261|FG001|Overall Study|Lost to Follow-up|13|||
160893982|NCT03875768|581008260|FG000|Overall Study|Withdrawal by Subject|10|||
160893983|NCT03875768|581008261|FG001|Overall Study|Withdrawal by Subject|21|||
160893984|NCT03875768|581008260|FG000|Overall Study|Did not complete assessment|21|||
160893985|NCT03875768|581008261|FG001|Overall Study|Did not complete assessment|12|||
160893986|NCT03875768|581008260|FG000|Overall Study|Became ineligible|1|||
160893987|NCT03875768|581008261|FG001|Overall Study|Became ineligible|0|||
160983097|NCT03468426|581326958|FG009|Overall Study|Other adverse event or clinical progression|11|||
160983098|NCT03468426|581326959|FG010|Overall Study|Other adverse event or clinical progression|0|||
160983099|NCT03468426|581326949|FG000|Overall Study|Refused to continue taking trial medication|0|||
160983100|NCT03468426|581326950|FG001|Overall Study|Refused to continue taking trial medication|0|||
160983101|NCT03468426|581326951|FG002|Overall Study|Refused to continue taking trial medication|0|||
160983102|NCT03468426|581326952|FG003|Overall Study|Refused to continue taking trial medication|2|||
160983103|NCT03468426|581326953|FG004|Overall Study|Refused to continue taking trial medication|0|||
160983104|NCT03468426|581326954|FG005|Overall Study|Refused to continue taking trial medication|3|||
160983105|NCT03468426|581326955|FG006|Overall Study|Refused to continue taking trial medication|0|||
160983106|NCT03468426|581326956|FG007|Overall Study|Refused to continue taking trial medication|0|||
161129125|NCT01838044|581858462|FG000|Overall Study|Withdrawal by Subject|0|||
161129126|NCT01838044|581858463|FG001|Overall Study|Withdrawal by Subject|2|||
161129127|NCT01838044|581858462|FG000|Overall Study|Insufficient clinical response|1|||
161129128|NCT01838044|581858463|FG001|Overall Study|Insufficient clinical response|2|||
160893988|NCT01925274|581008262|FG000|Overall Study|Death|1|||
160893989|NCT01925274|581008263|FG001|Overall Study|Death|0|||
160893990|NCT01925274|581008264|FG002|Overall Study|Death|0|||
160893991|NCT01925274|581008262|FG000|Overall Study|Lost to Follow-up|0|||
160893992|NCT01925274|581008263|FG001|Overall Study|Lost to Follow-up|1|||
160794430|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
160794431|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
160794432|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
160794433|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794434|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794435|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794436|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794437|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794438|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794439|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794440|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794441|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
160794442|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
160794443|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
160794444|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
160794445|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
160794446|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
160794447|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
160794448|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
160794449|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
160794450|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
160794451|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
160794452|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
160794453|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
160794454|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
160794455|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
160794456|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
160794457|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
160794458|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
160794459|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
160794460|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794461|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794462|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794463|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794464|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794465|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794466|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794467|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794468|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794469|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794470|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794471|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794472|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794473|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
160794474|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
160794475|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794476|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
160794477|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794478|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794479|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794480|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
160794481|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794482|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794483|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794484|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794485|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794486|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794487|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794488|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794489|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160794490|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794491|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794492|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794493|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
160794494|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794495|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794496|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
160893993|NCT01925274|581008264|FG002|Overall Study|Lost to Follow-up|0|||
161129129|NCT01838044|581858462|FG000|Overall Study|Medication error without associated AE|0|||
161129130|NCT01838044|581858463|FG001|Overall Study|Medication error without associated AE|1|||
161129131|NCT01838044|581858462|FG000|Overall Study|Lost to Follow-up|0|||
161129132|NCT01838044|581858463|FG001|Overall Study|Lost to Follow-up|2|||
161129133|NCT00974220|581858465|FG000|Treatment Period 1|Adverse Event|2|||
161129134|NCT00974220|581858466|FG001|Treatment Period 1|Adverse Event|1|||
161129135|NCT00974220|581858465|FG000|Treatment Period 1|noncompliant subjects|0|||
161129136|NCT00974220|581858466|FG001|Treatment Period 1|noncompliant subjects|1|||
161129137|NCT00706628|581858467|FG000|Overall Study|Other Adverse Event|16|||
161129138|NCT00706628|581858468|FG001|Overall Study|Other Adverse Event|5|||
161129139|NCT00706628|581858469|FG002|Overall Study|Other Adverse Event|5|||
161129140|NCT00706628|581858470|FG003|Overall Study|Other Adverse Event|2|||
161129141|NCT00706628|581858467|FG000|Overall Study|Non compliant with protocol|0|||
161129142|NCT00706628|581858468|FG001|Overall Study|Non compliant with protocol|1|||
161129143|NCT00706628|581858469|FG002|Overall Study|Non compliant with protocol|0|||
161129144|NCT00706628|581858470|FG003|Overall Study|Non compliant with protocol|0|||
161129145|NCT00706628|581858467|FG000|Overall Study|Consent withdrawn|6|||
161129146|NCT00706628|581858468|FG001|Overall Study|Consent withdrawn|1|||
161129147|NCT00706628|581858469|FG002|Overall Study|Consent withdrawn|3|||
161129148|NCT00706628|581858470|FG003|Overall Study|Consent withdrawn|0|||
161129149|NCT00706628|581858467|FG000|Overall Study|Progressive disease|20|||
161129150|NCT00706628|581858468|FG001|Overall Study|Progressive disease|13|||
161129151|NCT00706628|581858469|FG002|Overall Study|Progressive disease|8|||
161129152|NCT00706628|581858470|FG003|Overall Study|Progressive disease|1|||
161129153|NCT00706628|581858467|FG000|Overall Study|Other than those stated above|4|||
161129154|NCT00706628|581858468|FG001|Overall Study|Other than those stated above|0|||
161129155|NCT00706628|581858469|FG002|Overall Study|Other than those stated above|0|||
161129156|NCT00706628|581858470|FG003|Overall Study|Other than those stated above|0|||
161129157|NCT00706628|581858467|FG000|Overall Study|Not treated|1|||
161129158|NCT00706628|581858468|FG001|Overall Study|Not treated|1|||
161129159|NCT00706628|581858469|FG002|Overall Study|Not treated|0|||
161129160|NCT00706628|581858470|FG003|Overall Study|Not treated|0|||
161129161|NCT00737529|581858477|FG000|Overall Study|Disease Progression|95|||
161129162|NCT00737529|581858477|FG000|Overall Study|Adverse Event|24|||
161129163|NCT00737529|581858477|FG000|Overall Study|Withdrawal by Subject|5|||
161129164|NCT00737529|581858477|FG000|Overall Study|Death|4|||
161129165|NCT00737529|581858477|FG000|Overall Study|Protocol Violation|1|||
161129166|NCT00737529|581858477|FG000|Overall Study|Other|4|||
161129167|NCT01948830|581858478|FG000|Overall Study|Physician Decision|1|||
161129168|NCT01948830|581858479|FG001|Overall Study|Physician Decision|3|||
161129169|NCT01948830|581858478|FG000|Overall Study|Protocol deviation|1|||
161129170|NCT01948830|581858479|FG001|Overall Study|Protocol deviation|2|||
161129171|NCT01948830|581858478|FG000|Overall Study|Lost to Follow-up|5|||
161129172|NCT01948830|581858479|FG001|Overall Study|Lost to Follow-up|4|||
161129173|NCT01948830|581858478|FG000|Overall Study|Withdrawal by Subject|14|||
161129174|NCT01948830|581858479|FG001|Overall Study|Withdrawal by Subject|17|||
161129175|NCT01948830|581858478|FG000|Overall Study|Adverse Event|9|||
161129176|NCT01948830|581858479|FG001|Overall Study|Adverse Event|2|||
161129177|NCT01948830|581858478|FG000|Overall Study|Death|3|||
161129178|NCT01948830|581858479|FG001|Overall Study|Death|4|||
161129179|NCT01145560|581858480|FG000|Overall Study|Withdrawal by Subject|2|||
161129180|NCT01145560|581858481|FG001|Overall Study|Withdrawal by Subject|1|||
161129181|NCT01145560|581858482|FG002|Overall Study|Withdrawal by Subject|0|||
161129182|NCT01145560|581858480|FG000|Overall Study|Lost to Follow-up|1|||
161129183|NCT01145560|581858481|FG001|Overall Study|Lost to Follow-up|1|||
161129184|NCT01145560|581858482|FG002|Overall Study|Lost to Follow-up|1|||
161129185|NCT01145560|581858480|FG000|Overall Study|No study drug by 24h after organ failure|1|||
161129186|NCT01145560|581858481|FG001|Overall Study|No study drug by 24h after organ failure|0|||
161129187|NCT01145560|581858482|FG002|Overall Study|No study drug by 24h after organ failure|0|||
161129188|NCT01145560|581858480|FG000|Overall Study|Accidental unblinding of study treatment|0|||
161129189|NCT01145560|581858481|FG001|Overall Study|Accidental unblinding of study treatment|1|||
161129190|NCT01145560|581858482|FG002|Overall Study|Accidental unblinding of study treatment|0|||
161129191|NCT01145560|581858480|FG000|Overall Study|False insurance information|0|||
161129192|NCT01145560|581858481|FG001|Overall Study|False insurance information|1|||
161129193|NCT01145560|581858482|FG002|Overall Study|False insurance information|0|||
161129194|NCT01145560|581858480|FG000|Overall Study|Withdrawal of therapy|0|||
161129195|NCT01145560|581858481|FG001|Overall Study|Withdrawal of therapy|0|||
161129196|NCT01145560|581858482|FG002|Overall Study|Withdrawal of therapy|1|||
160983107|NCT03468426|581326957|FG008|Overall Study|Refused to continue taking trial medication|1|||
161129197|NCT00712348|581858483|FG000|Overall Study|Withdrawal by Subject|1|||
161129198|NCT01446419|581858487|FG000|Overall Study|Death|1|||
161129199|NCT01446419|581858488|FG001|Overall Study|Death|0|||
161129200|NCT01446419|581858487|FG000|Overall Study|Withdrawal by Subject|1|||
161129201|NCT01446419|581858488|FG001|Overall Study|Withdrawal by Subject|1|||
161129202|NCT01446419|581858487|FG000|Overall Study|Terminated per protocol|3|||
161129203|NCT01446419|581858488|FG001|Overall Study|Terminated per protocol|0|||
161129204|NCT00560755|581858489|FG000|Overall Study|Protocol Violation|15|||
160983108|NCT03468426|581326958|FG009|Overall Study|Refused to continue taking trial medication|0|||
160983109|NCT03468426|581326959|FG010|Overall Study|Refused to continue taking trial medication|0|||
160983110|NCT03468426|581326949|FG000|Overall Study|Other than listed|0|||
160983111|NCT03468426|581326950|FG001|Overall Study|Other than listed|1|||
160983112|NCT03468426|581326951|FG002|Overall Study|Other than listed|0|||
160983113|NCT03468426|581326952|FG003|Overall Study|Other than listed|0|||
160983114|NCT03468426|581326953|FG004|Overall Study|Other than listed|2|||
160983115|NCT03468426|581326954|FG005|Overall Study|Other than listed|2|||
160983116|NCT03468426|581326955|FG006|Overall Study|Other than listed|0|||
160983117|NCT03468426|581326956|FG007|Overall Study|Other than listed|0|||
160983118|NCT03468426|581326957|FG008|Overall Study|Other than listed|4|||
160983119|NCT03468426|581326958|FG009|Overall Study|Other than listed|4|||
160983120|NCT03468426|581326959|FG010|Overall Study|Other than listed|1|||
160983121|NCT03468426|581326949|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983122|NCT03468426|581326950|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983123|NCT03468426|581326951|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160983124|NCT03468426|581326952|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983125|NCT03468426|581326953|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983126|NCT03468426|581326954|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983127|NCT03468426|581326955|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983128|NCT03468426|581326956|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983129|NCT03468426|581326957|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983130|NCT03468426|581326958|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983131|NCT03468426|581326959|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160983132|NCT03468426|581326949|FG000|Overall Study|missing reason|0|||
160983133|NCT03468426|581326950|FG001|Overall Study|missing reason|0|||
160983134|NCT03468426|581326951|FG002|Overall Study|missing reason|0|||
160983135|NCT03468426|581326952|FG003|Overall Study|missing reason|0|||
160983136|NCT03468426|581326953|FG004|Overall Study|missing reason|0|||
160983137|NCT03468426|581326954|FG005|Overall Study|missing reason|0|||
160983138|NCT03468426|581326955|FG006|Overall Study|missing reason|0|||
160983139|NCT03468426|581326956|FG007|Overall Study|missing reason|0|||
160983140|NCT03468426|581326957|FG008|Overall Study|missing reason|0|||
160983141|NCT03468426|581326958|FG009|Overall Study|missing reason|1|||
160983142|NCT03468426|581326959|FG010|Overall Study|missing reason|0|||
160983143|NCT05876351|581326961|FG000|Overall Study|Other than specified|2|||
160983144|NCT05876351|581326961|FG000|Overall Study|Study specific discontinuation criteria|1|||
160983145|NCT01440049|581326962|FG000|Overall Study|Adverse Event|5|||
160983146|NCT02268552|581326963|FG000|Part 1|Death|1|||
160983147|NCT02268552|581326964|FG001|Part 1|Death|1|||
160983148|NCT02268552|581326965|FG002|Part 1|Death|1|||
160983149|NCT02268552|581326966|FG003|Part 1|Death|2|||
160983150|NCT02268552|581326967|FG004|Part 1|Death|0|||
160983151|NCT02268552|581326968|FG005|Part 1|Death|0|||
160983152|NCT02268552|581326969|FG006|Part 1|Death|0|||
160983153|NCT02268552|581326963|FG000|Part 1|Subject/guardian decision|0|||
160983154|NCT02268552|581326964|FG001|Part 1|Subject/guardian decision|0|||
160983155|NCT02268552|581326965|FG002|Part 1|Subject/guardian decision|0|||
160983156|NCT02268552|581326966|FG003|Part 1|Subject/guardian decision|1|||
160983157|NCT02268552|581326967|FG004|Part 1|Subject/guardian decision|0|||
160983158|NCT02268552|581326968|FG005|Part 1|Subject/guardian decision|0|||
160983159|NCT02268552|581326969|FG006|Part 1|Subject/guardian decision|0|||
160983160|NCT02268552|581326963|FG000|Part 2|Death|0|||
160983161|NCT02268552|581326964|FG001|Part 2|Death|0|||
160983162|NCT02268552|581326965|FG002|Part 2|Death|0|||
160983163|NCT02268552|581326966|FG003|Part 2|Death|0|||
160983164|NCT02268552|581326967|FG004|Part 2|Death|0|||
160983165|NCT02268552|581326968|FG005|Part 2|Death|0|||
160983166|NCT02268552|581326969|FG006|Part 2|Death|2|||
160983167|NCT02268552|581326963|FG000|Part 2|Subject/guardian decision|0|||
161330732|NCT02735980|582597225|FG001|Overall Study|Withdrawal by Subject|2|||
161330733|NCT02735980|582597226|FG002|Overall Study|Withdrawal by Subject|0|||
160983168|NCT02268552|581326964|FG001|Part 2|Subject/guardian decision|0|||
160983169|NCT02268552|581326965|FG002|Part 2|Subject/guardian decision|0|||
160983170|NCT02268552|581326966|FG003|Part 2|Subject/guardian decision|0|||
160983171|NCT02268552|581326967|FG004|Part 2|Subject/guardian decision|0|||
160983172|NCT02268552|581326968|FG005|Part 2|Subject/guardian decision|0|||
160983173|NCT02268552|581326969|FG006|Part 2|Subject/guardian decision|1|||
160983174|NCT02268552|581326963|FG000|Part 3 Extension|Death|0|||
160983175|NCT02268552|581326964|FG001|Part 3 Extension|Death|1|||
160983176|NCT02268552|581326965|FG002|Part 3 Extension|Death|1|||
160983177|NCT02268552|581326966|FG003|Part 3 Extension|Death|1|||
160983178|NCT02268552|581326967|FG004|Part 3 Extension|Death|1|||
160983179|NCT02268552|581326968|FG005|Part 3 Extension|Death|1|||
160983180|NCT02268552|581326969|FG006|Part 3 Extension|Death|0|||
160983181|NCT02268552|581326963|FG000|Part 3 Extension|Early termination of trial|1|||
160983182|NCT02268552|581326964|FG001|Part 3 Extension|Early termination of trial|0|||
160983183|NCT02268552|581326965|FG002|Part 3 Extension|Early termination of trial|0|||
160983184|NCT02268552|581326966|FG003|Part 3 Extension|Early termination of trial|0|||
160983185|NCT02268552|581326967|FG004|Part 3 Extension|Early termination of trial|2|||
160794497|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794498|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794499|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794500|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794501|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794502|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794503|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794504|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794505|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
160794506|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794507|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794508|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
160794509|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794510|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794511|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794512|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794513|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794514|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794515|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794516|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794517|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794518|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794519|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794520|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794521|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
160794522|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160794523|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160794524|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160794525|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794526|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794527|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794528|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794529|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794530|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794531|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794532|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794533|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794534|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794535|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161129205|NCT00560755|581858489|FG000|Overall Study|Withdrawal by Subject|26|||
161129206|NCT00560755|581858489|FG000|Overall Study|Lost to Follow-up|9|||
161129207|NCT00560755|581858489|FG000|Overall Study|Adverse Event|8|||
161129208|NCT00560755|581858489|FG000|Overall Study|Physician Decision|2|||
161129209|NCT05032950|581858491|FG000|Overall Study|Adverse Event|0|||
161129210|NCT05032950|581858492|FG001|Overall Study|Adverse Event|0|||
161129211|NCT05032950|581858493|FG002|Overall Study|Adverse Event|1|||
161129212|NCT05032950|581858494|FG003|Overall Study|Adverse Event|1|||
161129213|NCT05032950|581858495|FG004|Overall Study|Adverse Event|0|||
161129214|NCT05032950|581858496|FG005|Overall Study|Adverse Event|0|||
161129215|NCT02447848|581858497|FG000|Overall Study|Patient discharged|3|||
161129216|NCT02447848|581858497|FG000|Overall Study|Lack of Efficacy|4|||
161129217|NCT02447848|581858497|FG000|Overall Study|Withdrawal by Subject|4|||
161129218|NCT02307370|581858498|FG000|Overall Study|Death|5|||
161129219|NCT02307370|581858498|FG000|Overall Study|Lost to Follow-up|1|||
161129220|NCT02307370|581858498|FG000|Overall Study|Withdrawal by Subject|1|||
161129221|NCT02307370|581858498|FG000|Overall Study|Declined Addendum ICF|6|||
160794536|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794537|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160794538|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
160893994|NCT01925274|581008262|FG000|Overall Study|Withdrawal by Subject|1|||
160893995|NCT01925274|581008263|FG001|Overall Study|Withdrawal by Subject|2|||
160893996|NCT01925274|581008264|FG002|Overall Study|Withdrawal by Subject|0|||
160893997|NCT01925274|581008262|FG000|Overall Study|Study terminated by sponsor|4|||
160893998|NCT01925274|581008263|FG001|Overall Study|Study terminated by sponsor|0|||
160893999|NCT01925274|581008264|FG002|Overall Study|Study terminated by sponsor|0|||
160894000|NCT01925274|581008262|FG000|Overall Study|Protocol amendment|1|||
160894001|NCT01925274|581008263|FG001|Overall Study|Protocol amendment|3|||
160983186|NCT02268552|581326968|FG005|Part 3 Extension|Early termination of trial|9|||
161129222|NCT02307370|581858498|FG000|Overall Study|No response during telephone contact|5|||
160794539|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
160794540|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
160794541|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
160794542|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
160794543|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
160794544|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
160794545|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
160794546|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
160794547|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
160794548|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
160794549|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
160794550|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
160794551|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
160794552|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
160794553|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
160794554|NCT02958865|580635310|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794555|NCT02958865|580635311|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794556|NCT02958865|580635312|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794557|NCT02958865|580635313|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794558|NCT02958865|580635314|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
160794559|NCT02958865|580635315|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794560|NCT02958865|580635316|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794561|NCT02958865|580635317|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894002|NCT01925274|581008264|FG002|Overall Study|Protocol amendment|6|||
160894003|NCT04327674|581008266|FG000|Overall Study|Protocol Violation|19|||
160794562|NCT02958865|580635318|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794563|NCT02958865|580635319|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794564|NCT02958865|580635320|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794565|NCT02958865|580635321|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794566|NCT02958865|580635322|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894004|NCT00723398|581008271|FG000|Overall Study|Withdrawal by Subject|2|||
160894005|NCT00723398|581008272|FG001|Overall Study|Withdrawal by Subject|6|||
160894006|NCT00723398|581008273|FG002|Overall Study|Withdrawal by Subject|4|||
160894007|NCT00723398|581008274|FG003|Overall Study|Withdrawal by Subject|4|||
160894008|NCT00723398|581008275|FG004|Overall Study|Withdrawal by Subject|4|||
160894009|NCT00723398|581008271|FG000|Overall Study|Protocol Violation|2|||
160894010|NCT00723398|581008272|FG001|Overall Study|Protocol Violation|1|||
160894011|NCT00723398|581008273|FG002|Overall Study|Protocol Violation|5|||
160894012|NCT00723398|581008274|FG003|Overall Study|Protocol Violation|0|||
160894013|NCT00723398|581008275|FG004|Overall Study|Protocol Violation|0|||
160894014|NCT00723398|581008271|FG000|Overall Study|Physician Decision|2|||
160894015|NCT00723398|581008272|FG001|Overall Study|Physician Decision|2|||
160894016|NCT00723398|581008273|FG002|Overall Study|Physician Decision|5|||
160894017|NCT00723398|581008274|FG003|Overall Study|Physician Decision|0|||
160894018|NCT00723398|581008275|FG004|Overall Study|Physician Decision|1|||
160894019|NCT00723398|581008271|FG000|Overall Study|Adverse Event|0|||
160894020|NCT00723398|581008272|FG001|Overall Study|Adverse Event|5|||
160894021|NCT00723398|581008273|FG002|Overall Study|Adverse Event|3|||
160894022|NCT00723398|581008274|FG003|Overall Study|Adverse Event|1|||
160894023|NCT00723398|581008275|FG004|Overall Study|Adverse Event|4|||
160894024|NCT00723398|581008271|FG000|Overall Study|Lost to Follow-up|0|||
160894025|NCT00723398|581008272|FG001|Overall Study|Lost to Follow-up|1|||
160894026|NCT00723398|581008273|FG002|Overall Study|Lost to Follow-up|0|||
160894027|NCT00723398|581008274|FG003|Overall Study|Lost to Follow-up|0|||
160894028|NCT00723398|581008275|FG004|Overall Study|Lost to Follow-up|0|||
160894029|NCT00267189|581008276|FG000|Overall Study|Patient withdrew consent|1|||
160894030|NCT00267189|581008277|FG001|Overall Study|Patient withdrew consent|1|||
160894031|NCT00267189|581008276|FG000|Overall Study|Death|1|||
160894032|NCT00267189|581008277|FG001|Overall Study|Death|0|||
160894033|NCT00267189|581008276|FG000|Overall Study|Missing|3|||
160983187|NCT02268552|581326969|FG006|Part 3 Extension|Early termination of trial|11|||
160794567|NCT02958865|580635323|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894034|NCT00267189|581008277|FG001|Overall Study|Missing|0|||
160794568|NCT02958865|580635324|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160894035|NCT00751621|581008278|FG000|Overall Study|Adverse Event|1|||
160894036|NCT00751621|581008278|FG000|Overall Study|Withdrawal by Subject|1|||
160894037|NCT00751621|581008278|FG000|Overall Study|Subject moved to another country|1|||
160894038|NCT00751621|581008278|FG000|Overall Study|Poor adherence to asthma treatment|1|||
160894039|NCT03719586|581008281|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
160894040|NCT03719586|581008282|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
160894041|NCT03719586|581008283|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
160894042|NCT03719586|581008284|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
160794569|NCT02958865|580635325|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160794570|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160894043|NCT02791594|581008285|FG000|Overall Study|Physician Decision|2|||
160894044|NCT01400815|581008286|FG000|Overall Study|Adverse Event|3|||
160894045|NCT01400815|581008287|FG001|Overall Study|Adverse Event|0|||
160894046|NCT01400815|581008286|FG000|Overall Study|Death|0|||
160894047|NCT01400815|581008287|FG001|Overall Study|Death|1|||
160894048|NCT01400815|581008286|FG000|Overall Study|Lost to Follow-up|18|||
160894049|NCT01400815|581008287|FG001|Overall Study|Lost to Follow-up|11|||
160894050|NCT01400815|581008286|FG000|Overall Study|Protocol Violation|0|||
160894051|NCT01400815|581008287|FG001|Overall Study|Protocol Violation|1|||
160894052|NCT01400815|581008286|FG000|Overall Study|Physician Decision|1|||
160894053|NCT01400815|581008287|FG001|Overall Study|Physician Decision|0|||
160894054|NCT01400815|581008286|FG000|Overall Study|Withdrawal by Subject|15|||
160894055|NCT01400815|581008287|FG001|Overall Study|Withdrawal by Subject|8|||
160894056|NCT01400815|581008286|FG000|Overall Study|Subject in jail|1|||
160894057|NCT01400815|581008287|FG001|Overall Study|Subject in jail|0|||
160894058|NCT02310321|581008289|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
160894059|NCT02310321|581008290|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160894060|NCT02310321|581008291|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160894061|NCT02310321|581008289|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
160894062|NCT02310321|581008290|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160894063|NCT02310321|581008291|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160794571|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794572|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794573|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794574|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794575|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794576|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794577|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794578|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794579|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
160794580|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
160794581|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794582|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
160794583|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794584|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
160794585|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
160794586|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794587|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794588|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794589|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794590|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794591|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794592|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794593|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794594|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
160794595|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
160794596|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794597|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
160794598|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794599|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
160794600|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
160794601|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
160794602|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794603|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794604|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794605|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794606|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794607|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794608|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794609|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160894064|NCT02310321|581008289|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
160794610|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160894065|NCT02310321|581008290|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160894066|NCT02310321|581008291|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
160894067|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
160894068|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
160894069|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
160894070|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160794611|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
160794612|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794613|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794614|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794615|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794616|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
160794617|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
160794618|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794619|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794620|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794621|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794622|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794623|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794624|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794625|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794626|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794627|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794628|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
160794629|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
160794630|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
160794631|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
160794632|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
160794633|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
160794634|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
160794635|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
160794636|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
160794637|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
160794638|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
160794639|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
160794640|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
160794641|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
160794642|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
160794643|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
160794644|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
160794645|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
160794646|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
160794647|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
160794648|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
160794649|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
160794650|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794651|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794652|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794653|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794654|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794655|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794656|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794657|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794658|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794659|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794660|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794661|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794662|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794663|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
160794664|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794665|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
160794666|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794667|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794668|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794669|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794670|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794671|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794672|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794673|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794674|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794675|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794676|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794677|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794678|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794679|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
160794680|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794681|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
160794682|NCT02958865|580635310|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794683|NCT02958865|580635311|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794684|NCT02958865|580635312|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794685|NCT02958865|580635313|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794686|NCT02958865|580635314|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794687|NCT02958865|580635315|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794688|NCT02958865|580635316|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794689|NCT02958865|580635317|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794690|NCT02958865|580635318|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794691|NCT02958865|580635319|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
160794692|NCT02958865|580635320|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794693|NCT02958865|580635321|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794694|NCT02958865|580635322|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794695|NCT02958865|580635323|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794696|NCT02958865|580635324|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794697|NCT02958865|580635325|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
160794698|NCT02661815|580635326|FG000|Overall Study|Withdrawal by Subject|1|||
160794699|NCT02661815|580635327|FG001|Overall Study|Withdrawal by Subject|0|||
160794700|NCT02661815|580635328|FG002|Overall Study|Withdrawal by Subject|0|||
160794701|NCT02661815|580635329|FG003|Overall Study|Withdrawal by Subject|0|||
160794702|NCT00635050|580635332|FG000|Overall Study|Withdrawal by Subject|1|||
160794703|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Adverse Event|3|||
160794704|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Adverse Event|0|||
160794705|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Adverse Event|0|||
160794706|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
160794707|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
160794708|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
160794709|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
160794710|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
160794711|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
160794712|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
160794713|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
160794714|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
160794715|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
160794716|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
160794717|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
160794718|NCT04380142|580635337|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
160794719|NCT04380142|580635338|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
160794720|NCT04380142|580635339|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
160794721|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160794722|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160794723|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Adverse Event|14|||
160794724|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
160794725|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
160794726|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
160794727|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160794728|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
160794729|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
160794730|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
160794731|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
160794732|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
160794733|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
160794734|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
160794735|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
160794736|NCT04380142|580635337|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
160794737|NCT04380142|580635338|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
160794738|NCT04380142|580635339|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
160794739|NCT00209131|580635340|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
160794740|NCT00209131|580635341|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
160794741|NCT05360784|580635342|FG000|Overall Study|Discontinued|25|||
160794742|NCT05360784|580635343|FG001|Overall Study|Discontinued|11|||
160794743|NCT00437073|580635344|FG000|Overall Study|Sponsor Terminated Study|1|||
160794744|NCT00437073|580635345|FG001|Overall Study|Sponsor Terminated Study|0|||
160794745|NCT00437073|580635344|FG000|Overall Study|Physician Decision|0|||
160794746|NCT00437073|580635345|FG001|Overall Study|Physician Decision|1|||
160794747|NCT01299961|580635346|FG000|Overall Study|Adverse Event|3|||
160794748|NCT01299961|580635346|FG000|Overall Study|Lack of Efficacy|2|||
160794749|NCT01299961|580635346|FG000|Overall Study|Lost to Follow-up|1|||
160794750|NCT02904096|580635347|FG000|Overall Study|Adverse Event|1|||
160794751|NCT02904096|580635348|FG001|Overall Study|Adverse Event|0|||
160794752|NCT02904096|580635347|FG000|Overall Study|Withdrawal by Subject|4|||
160794753|NCT02904096|580635348|FG001|Overall Study|Withdrawal by Subject|3|||
160794754|NCT02904096|580635347|FG000|Overall Study|Lost to Follow-up|10|||
160794755|NCT02904096|580635348|FG001|Overall Study|Lost to Follow-up|17|||
160794756|NCT02904096|580635347|FG000|Overall Study|Non-compliant|3|||
160794757|NCT02904096|580635348|FG001|Overall Study|Non-compliant|1|||
160794758|NCT02904096|580635347|FG000|Overall Study|Sponsor instructed|1|||
160794759|NCT02904096|580635348|FG001|Overall Study|Sponsor instructed|0|||
160794760|NCT00980798|580635349|FG000|Overall Study|Adverse Event|7|||
160794761|NCT00980798|580635350|FG001|Overall Study|Adverse Event|36|||
160794762|NCT00980798|580635349|FG000|Overall Study|Lack of Efficacy|16|||
160794763|NCT00980798|580635350|FG001|Overall Study|Lack of Efficacy|5|||
160794764|NCT00980798|580635349|FG000|Overall Study|Lost to Follow-up|0|||
160794765|NCT00980798|580635350|FG001|Overall Study|Lost to Follow-up|1|||
160894071|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
160894072|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
160894073|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
160894074|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
160894075|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
160894076|NCT02310321|581008289|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
160894077|NCT02310321|581008290|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
160894078|NCT02310321|581008291|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
160894079|NCT02310321|581008289|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
160894080|NCT02310321|581008290|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
160894081|NCT02310321|581008291|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
160894082|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
160894083|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
160894084|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
160894085|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
160894086|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
160894087|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
160894088|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
160894089|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
160894090|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
160894091|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
160894092|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
160894093|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
160894094|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
160894095|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
160894096|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
160894097|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
160983188|NCT02268552|581326963|FG000|Part 3 Extension|Subject/guardian decision|0|||
160983189|NCT02268552|581326964|FG001|Part 3 Extension|Subject/guardian decision|0|||
160983190|NCT02268552|581326965|FG002|Part 3 Extension|Subject/guardian decision|0|||
160983191|NCT02268552|581326966|FG003|Part 3 Extension|Subject/guardian decision|0|||
161129223|NCT02307370|581858498|FG000|Overall Study|Protocol Violation|1|||
161129224|NCT03219164|581860763|FG000|Overall Study|Study Terminated by Sponsor|16|||
160794766|NCT00980798|580635349|FG000|Overall Study|Physician Decision|2|||
160794767|NCT00980798|580635350|FG001|Overall Study|Physician Decision|1|||
160794768|NCT00980798|580635349|FG000|Overall Study|Withdrawal by Subject|8|||
160794769|NCT00980798|580635350|FG001|Overall Study|Withdrawal by Subject|11|||
160794770|NCT00980798|580635349|FG000|Overall Study|Other|0|||
160794771|NCT00980798|580635350|FG001|Overall Study|Other|1|||
160794772|NCT04938427|580635351|FG000|Overall Study|Adverse Event|5|||
160794773|NCT04938427|580635352|FG001|Overall Study|Adverse Event|19|||
160794774|NCT04938427|580635351|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160794775|NCT04938427|580635352|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160794776|NCT04938427|580635351|FG000|Overall Study|Withdrawal by Subject|1|||
160894098|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
160794777|NCT04938427|580635352|FG001|Overall Study|Withdrawal by Subject|0|||
160794778|NCT04938427|580635351|FG000|Overall Study|Reason Not Specified|2|||
160794779|NCT04938427|580635352|FG001|Overall Study|Reason Not Specified|1|||
160794780|NCT03633058|580635353|FG000|Overall Study|Adverse Event|0|||
160794781|NCT03633058|580635354|FG001|Overall Study|Adverse Event|0|||
160794782|NCT03633058|580635355|FG002|Overall Study|Adverse Event|1|||
160794783|NCT03633058|580635356|FG003|Overall Study|Adverse Event|0|||
160794784|NCT01107496|580635357|FG000|Overall Study|Adverse Event|1|||
160794785|NCT01107496|580635358|FG001|Overall Study|Adverse Event|0|||
160794786|NCT01107496|580635357|FG000|Overall Study|Lack of Efficacy|1|||
160794787|NCT01107496|580635358|FG001|Overall Study|Lack of Efficacy|0|||
160794788|NCT01107496|580635357|FG000|Overall Study|Protocol Violation|0|||
160794789|NCT01107496|580635358|FG001|Overall Study|Protocol Violation|1|||
160794790|NCT01107496|580635357|FG000|Overall Study|Lost to Follow-up|0|||
160794791|NCT01107496|580635358|FG001|Overall Study|Lost to Follow-up|1|||
160794792|NCT03909971|580635359|FG000|Overall Study|Participant transition to rollover study|26|||
160794793|NCT03909971|580635360|FG001|Overall Study|Participant transition to rollover study|9|||
160794794|NCT03909971|580635359|FG000|Overall Study|Global Deterioration of Health Status|2|||
160794795|NCT03909971|580635360|FG001|Overall Study|Global Deterioration of Health Status|2|||
160794796|NCT03909971|580635359|FG000|Overall Study|Progressive Disease|28|||
160794797|NCT03909971|580635360|FG001|Overall Study|Progressive Disease|21|||
160794798|NCT03909971|580635359|FG000|Overall Study|Death|6|||
160794799|NCT03909971|580635360|FG001|Overall Study|Death|6|||
160794800|NCT03909971|580635359|FG000|Overall Study|Adverse Event|1|||
160794801|NCT03909971|580635360|FG001|Overall Study|Adverse Event|2|||
160794802|NCT03909971|580635359|FG000|Overall Study|Withdrawal by Subject|2|||
160794803|NCT03909971|580635360|FG001|Overall Study|Withdrawal by Subject|1|||
160794804|NCT03909971|580635359|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
160794805|NCT03909971|580635360|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
160794806|NCT03909971|580635359|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
160794807|NCT03909971|580635360|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
160794808|NCT04727151|580635364|FG000|Overall Study|Death|0|||
160794809|NCT04727151|580635365|FG001|Overall Study|Death|0|||
160794810|NCT04727151|580635366|FG002|Overall Study|Death|0|||
160794811|NCT04727151|580635367|FG003|Overall Study|Death|0|||
160794812|NCT04727151|580635368|FG004|Overall Study|Death|3|||
160794813|NCT04727151|580635364|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794814|NCT04727151|580635365|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794815|NCT04727151|580635366|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794816|NCT04727151|580635367|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
160794817|NCT04727151|580635368|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
160794818|NCT01587196|580635369|FG000|Overall Study|Lost to Follow-up|50|||
160794819|NCT01587196|580635369|FG000|Overall Study|Withdrawal by Subject|4|||
160794820|NCT00642759|580635372|FG000|Overall Study|Protocol Violation|1|||
160794821|NCT03537508|580635377|FG000|Overall Study|Adverse Event|2|||
160794822|NCT03537508|580635378|FG001|Overall Study|Adverse Event|1|||
160794823|NCT03537508|580635377|FG000|Overall Study|Protocol Violation|65|||
160794824|NCT03537508|580635378|FG001|Overall Study|Protocol Violation|48|||
160794825|NCT03537508|580635377|FG000|Overall Study|Lost to Follow-up|86|||
160794826|NCT03537508|580635378|FG001|Overall Study|Lost to Follow-up|60|||
160794827|NCT03537508|580635377|FG000|Overall Study|Withdrawal by parent/guardian|263|||
160794828|NCT03537508|580635378|FG001|Overall Study|Withdrawal by parent/guardian|149|||
160794829|NCT03814044|580635382|FG000|Overall Study|Protocol deviation|1|||
160894099|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
160894100|NCT02310321|581008289|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
161129225|NCT03219164|581860764|FG001|Overall Study|Study Terminated by Sponsor|12|||
160794830|NCT02757768|580635383|FG000|Overall Study|Randomized Never Received Study Drug|3|||
160894101|NCT02310321|581008290|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
161129226|NCT03219164|581860763|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
161129227|NCT03219164|581860764|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
161129228|NCT03219164|581860763|FG000|Overall Study|Lost to Follow-up|1|||
161129229|NCT03219164|581860764|FG001|Overall Study|Lost to Follow-up|1|||
161129230|NCT03219164|581860763|FG000|Overall Study|Adverse Event|1|||
161129231|NCT03219164|581860764|FG001|Overall Study|Adverse Event|0|||
161330734|NCT00917124|582597230|FG000|Overall Study|Protocol Violation|4|||
160794831|NCT02757768|580635384|FG001|Overall Study|Randomized Never Received Study Drug|4|||
160794832|NCT02757768|580635383|FG000|Overall Study|Adverse Event|5|||
160794833|NCT02757768|580635384|FG001|Overall Study|Adverse Event|3|||
160794834|NCT02757768|580635383|FG000|Overall Study|Lack of Efficacy|2|||
160794835|NCT02757768|580635384|FG001|Overall Study|Lack of Efficacy|1|||
160794836|NCT02757768|580635383|FG000|Overall Study|Lost to Follow-up|1|||
160794837|NCT02757768|580635384|FG001|Overall Study|Lost to Follow-up|0|||
160894102|NCT02310321|581008291|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
161129232|NCT03219164|581860763|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160794838|NCT02757768|580635383|FG000|Overall Study|Protocol Deviation|2|||
160794839|NCT02757768|580635384|FG001|Overall Study|Protocol Deviation|9|||
160794840|NCT02757768|580635383|FG000|Overall Study|Withdrawal by Subject|16|||
160794841|NCT02757768|580635384|FG001|Overall Study|Withdrawal by Subject|9|||
160894103|NCT02310321|581008289|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
161129233|NCT03219164|581860764|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161129234|NCT03219164|581860763|FG000|Overall Study|Protocol Violation|0|||
161129235|NCT03219164|581860764|FG001|Overall Study|Protocol Violation|1|||
161129236|NCT03219164|581860763|FG000|Overall Study|Withdrew Assent|1|||
161129237|NCT03219164|581860764|FG001|Overall Study|Withdrew Assent|0|||
160794842|NCT02757768|580635383|FG000|Overall Study|Miscellaneous|4|||
160794843|NCT02757768|580635384|FG001|Overall Study|Miscellaneous|2|||
160794844|NCT00835367|580635396|FG000|Washout|Adverse Event|2|||
160794845|NCT00835367|580635397|FG001|Washout|Adverse Event|0|||
160794846|NCT00835367|580635396|FG000|Washout|Withdrawal by Subject|1|||
160794847|NCT00835367|580635397|FG001|Washout|Withdrawal by Subject|0|||
160794848|NCT00835367|580635396|FG000|Second Intervention|Adverse Event|1|||
160794849|NCT00835367|580635397|FG001|Second Intervention|Adverse Event|1|||
160794850|NCT05929326|580635398|FG000|Overall Study|unqualified sample|2|||
160794851|NCT05929326|580635399|FG001|Overall Study|unqualified sample|3|||
160794852|NCT05929326|580635400|FG002|Overall Study|unqualified sample|7|||
160794853|NCT03941093|580635411|FG000|Overall Study|Protocol Violation|0|||
160794854|NCT03941093|580635412|FG001|Overall Study|Protocol Violation|1|||
160794855|NCT03941093|580635411|FG000|Overall Study|Withdrawal by Subject|9|||
160794856|NCT03941093|580635412|FG001|Overall Study|Withdrawal by Subject|6|||
160794857|NCT02495883|580635415|FG000|Overall Study|Excessive head motion|1|||
160794858|NCT02495883|580635416|FG001|Overall Study|Excessive head motion|0|||
160794859|NCT00964678|580635420|FG000|Overall Study|Physician Decision|4|||
160794860|NCT03359395|580635421|FG000|First Intervention A / B|Withdrawal by Subject|1|||
160794861|NCT03359395|580635422|FG001|First Intervention A / B|Withdrawal by Subject|0|||
160794862|NCT03359395|580635421|FG000|First Intervention A / B|Lost to Follow-up|2|||
160794863|NCT03359395|580635422|FG001|First Intervention A / B|Lost to Follow-up|3|||
160794864|NCT03359395|580635421|FG000|Second Intervention B/A|Exclusion criteria|0|||
160794865|NCT03359395|580635422|FG001|Second Intervention B/A|Exclusion criteria|1|||
160794866|NCT03359395|580635421|FG000|Second Intervention B/A|Lost to Follow-up|3|||
160794867|NCT03359395|580635422|FG001|Second Intervention B/A|Lost to Follow-up|2|||
160794868|NCT03396445|580637851|FG000|Treatment Period|Death|2|||
161129238|NCT04188197|581860768|FG000|Overall Study|Lost to Follow-up|4|||
160794869|NCT03396445|580637852|FG001|Treatment Period|Death|2|||
160794870|NCT03396445|580637853|FG002|Treatment Period|Death|1|||
160794871|NCT03396445|580637854|FG003|Treatment Period|Death|1|||
160794872|NCT03396445|580637855|FG004|Treatment Period|Death|3|||
160794873|NCT03396445|580637856|FG005|Treatment Period|Death|2|||
160794874|NCT03396445|580637857|FG006|Treatment Period|Death|5|||
160794875|NCT03396445|580637858|FG007|Treatment Period|Death|3|||
160794876|NCT03396445|580637859|FG008|Treatment Period|Death|3|||
160794877|NCT03396445|580637860|FG009|Treatment Period|Death|3|||
160794878|NCT03396445|580637861|FG010|Treatment Period|Death|7|||
160794879|NCT03396445|580637862|FG011|Treatment Period|Death|12|||
160794880|NCT03396445|580637863|FG012|Treatment Period|Death|28|||
160794881|NCT03396445|580637864|FG013|Treatment Period|Death|14|||
160794882|NCT03396445|580637865|FG014|Treatment Period|Death|10|||
160794883|NCT03396445|580637866|FG015|Treatment Period|Death|8|||
160794884|NCT03396445|580637867|FG016|Treatment Period|Death|18|||
160794885|NCT03396445|580637868|FG017|Treatment Period|Death|0|||
160794886|NCT03396445|580637869|FG018|Treatment Period|Death|0|||
160794887|NCT03396445|580637870|FG019|Treatment Period|Death|0|||
160794888|NCT03396445|580637871|FG020|Treatment Period|Death|0|||
160794889|NCT03396445|580637872|FG021|Treatment Period|Death|0|||
160794890|NCT03396445|580637873|FG022|Treatment Period|Death|0|||
160794891|NCT03396445|580637874|FG023|Treatment Period|Death|0|||
160794892|NCT03396445|580637875|FG024|Treatment Period|Death|0|||
160794893|NCT03396445|580637876|FG025|Treatment Period|Death|0|||
160794894|NCT03396445|580637851|FG000|Treatment Period|Lost to Follow-up|0|||
160794895|NCT03396445|580637852|FG001|Treatment Period|Lost to Follow-up|0|||
160794896|NCT03396445|580637853|FG002|Treatment Period|Lost to Follow-up|0|||
161129239|NCT04188197|581860769|FG001|Overall Study|Lost to Follow-up|1|||
161129240|NCT04188197|581860768|FG000|Overall Study|Withdrawal by Subject|1|||
161129241|NCT04188197|581860769|FG001|Overall Study|Withdrawal by Subject|1|||
161129242|NCT04188197|581860768|FG000|Overall Study|Pregnancy|0|||
160794897|NCT03396445|580637854|FG003|Treatment Period|Lost to Follow-up|0|||
160794898|NCT03396445|580637855|FG004|Treatment Period|Lost to Follow-up|0|||
160794899|NCT03396445|580637856|FG005|Treatment Period|Lost to Follow-up|0|||
160794900|NCT03396445|580637857|FG006|Treatment Period|Lost to Follow-up|0|||
160794901|NCT03396445|580637858|FG007|Treatment Period|Lost to Follow-up|0|||
160794902|NCT03396445|580637859|FG008|Treatment Period|Lost to Follow-up|0|||
160794903|NCT03396445|580637860|FG009|Treatment Period|Lost to Follow-up|0|||
160794904|NCT03396445|580637861|FG010|Treatment Period|Lost to Follow-up|0|||
160794905|NCT03396445|580637862|FG011|Treatment Period|Lost to Follow-up|0|||
160794906|NCT03396445|580637863|FG012|Treatment Period|Lost to Follow-up|1|||
160794907|NCT03396445|580637864|FG013|Treatment Period|Lost to Follow-up|0|||
160794908|NCT03396445|580637865|FG014|Treatment Period|Lost to Follow-up|1|||
160794909|NCT03396445|580637866|FG015|Treatment Period|Lost to Follow-up|0|||
160794910|NCT03396445|580637867|FG016|Treatment Period|Lost to Follow-up|0|||
160794911|NCT03396445|580637868|FG017|Treatment Period|Lost to Follow-up|0|||
160894104|NCT02310321|581008290|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
160894105|NCT02310321|581008291|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
160894106|NCT02310321|581008289|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
160894107|NCT02310321|581008290|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
160894108|NCT02310321|581008291|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
160894109|NCT02310321|581008289|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
160894110|NCT02310321|581008290|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
160894111|NCT02310321|581008291|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
160983192|NCT02268552|581326967|FG004|Part 3 Extension|Subject/guardian decision|0|||
160983193|NCT02268552|581326968|FG005|Part 3 Extension|Subject/guardian decision|0|||
160983194|NCT02268552|581326969|FG006|Part 3 Extension|Subject/guardian decision|1|||
160983195|NCT04168385|581326971|FG000|Overall Study|Withdrawal by Subject|1|||
160983196|NCT04168385|581326972|FG001|Overall Study|Withdrawal by Subject|0|||
161330735|NCT00917124|582597231|FG001|Overall Study|Protocol Violation|6|||
161330736|NCT01783743|582597232|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
161330737|NCT01783743|582597233|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
161330738|NCT01783743|582597232|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
161330739|NCT01783743|582597233|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
161330740|NCT01783743|582597232|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
161330741|NCT01783743|582597233|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
161330742|NCT00126594|582597250|FG000|Overall Study|Ineligible|2|||
161330743|NCT00126594|582597251|FG001|Overall Study|Ineligible|0|||
161330744|NCT00126594|582597250|FG000|Overall Study|Withdrawal by Subject|0|||
161330745|NCT00126594|582597251|FG001|Overall Study|Withdrawal by Subject|4|||
161330746|NCT00126594|582597250|FG000|Overall Study|Physician Decision|1|||
161330747|NCT00126594|582597251|FG001|Overall Study|Physician Decision|3|||
161330748|NCT00126594|582597250|FG000|Overall Study|Adverse Event|7|||
161330749|NCT00126594|582597251|FG001|Overall Study|Adverse Event|5|||
161330750|NCT00126594|582597250|FG000|Overall Study|Non-compliance|0|||
161330751|NCT00126594|582597251|FG001|Overall Study|Non-compliance|1|||
161330752|NCT00126594|582597250|FG000|Overall Study|Disease Progression|29|||
161330753|NCT00126594|582597251|FG001|Overall Study|Disease Progression|24|||
161330754|NCT01747499|582597254|FG000|Overall Study|Steroid refractory aGvHD|1|||
161330755|NCT01747499|582597255|FG001|Overall Study|Steroid refractory aGvHD|0|||
161330756|NCT01747499|582597256|FG002|Overall Study|Steroid refractory aGvHD|0|||
161330757|NCT01747499|582597257|FG003|Overall Study|Steroid refractory aGvHD|1|||
161330758|NCT01747499|582597258|FG004|Overall Study|Steroid refractory aGvHD|4|||
161330759|NCT01747499|582597254|FG000|Overall Study|Physician Decision|0|||
161330760|NCT01747499|582597255|FG001|Overall Study|Physician Decision|1|||
160894112|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
160983197|NCT04168385|581326971|FG000|Overall Study|Adverse Event|2|||
160983198|NCT04168385|581326972|FG001|Overall Study|Adverse Event|1|||
160983199|NCT04168385|581326971|FG000|Overall Study|Liver transplant|3|||
160983200|NCT04168385|581326972|FG001|Overall Study|Liver transplant|1|||
160983201|NCT04168385|581326971|FG000|Overall Study|Listed for liver transplant|1|||
160983202|NCT04168385|581326972|FG001|Overall Study|Listed for liver transplant|0|||
160983203|NCT02139982|581326973|FG000|Overall Study|Lack of Efficacy|0|||
160983204|NCT02139982|581326974|FG001|Overall Study|Lack of Efficacy|1|||
160983205|NCT02139982|581326975|FG002|Overall Study|Lack of Efficacy|0|||
160983206|NCT02139982|581326976|FG003|Overall Study|Lack of Efficacy|1|||
160983207|NCT02139982|581326977|FG004|Overall Study|Lack of Efficacy|0|||
160983208|NCT02139982|581326978|FG005|Overall Study|Lack of Efficacy|0|||
160983209|NCT02139982|581326979|FG006|Overall Study|Lack of Efficacy|0|||
160983210|NCT02139982|581326980|FG007|Overall Study|Lack of Efficacy|0|||
160983211|NCT02139982|581326981|FG008|Overall Study|Lack of Efficacy|0|||
161235878|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235879|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235880|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235881|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235882|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235883|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235884|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
161330761|NCT01747499|582597256|FG002|Overall Study|Physician Decision|0|||
161330762|NCT01747499|582597257|FG003|Overall Study|Physician Decision|0|||
161330763|NCT01747499|582597258|FG004|Overall Study|Physician Decision|2|||
161330764|NCT01747499|582597254|FG000|Overall Study|Death|0|||
160894113|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
160983212|NCT02139982|581326982|FG009|Overall Study|Lack of Efficacy|0|||
160983213|NCT02748512|581326985|FG000|Overall Study|Lost to Follow-up|1|||
160983214|NCT02748512|581326986|FG001|Overall Study|Lost to Follow-up|1|||
160983215|NCT00997243|581326989|FG000|Overall Study|Early termination of study by sponsor|7|||
160983216|NCT01349907|581326998|FG000|Overall Study|Adverse Event|37|||
161235885|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
160794912|NCT03396445|580637869|FG018|Treatment Period|Lost to Follow-up|0|||
160794913|NCT03396445|580637870|FG019|Treatment Period|Lost to Follow-up|0|||
160794914|NCT03396445|580637871|FG020|Treatment Period|Lost to Follow-up|0|||
160794915|NCT03396445|580637872|FG021|Treatment Period|Lost to Follow-up|0|||
160983217|NCT01349907|581326999|FG001|Overall Study|Adverse Event|11|||
160983218|NCT01349907|581326998|FG000|Overall Study|Treatment failure|13|||
160983219|NCT01349907|581326999|FG001|Overall Study|Treatment failure|4|||
160983220|NCT01349907|581326998|FG000|Overall Study|Lost to Follow-up|25|||
160983221|NCT01349907|581326999|FG001|Overall Study|Lost to Follow-up|6|||
160983222|NCT01349907|581326998|FG000|Overall Study|Withdrawal by Subject|30|||
160983223|NCT01349907|581326999|FG001|Overall Study|Withdrawal by Subject|8|||
160983224|NCT01349907|581326998|FG000|Overall Study|Protocol Violation|33|||
160983225|NCT01349907|581326999|FG001|Overall Study|Protocol Violation|13|||
160983226|NCT01349907|581326998|FG000|Overall Study|Administrative|1|||
160983227|NCT01349907|581326999|FG001|Overall Study|Administrative|1|||
160983228|NCT00884286|581327009|FG000|Overall Study|Progressive disease|21|||
160983229|NCT00884286|581327010|FG001|Overall Study|Progressive disease|28|||
160983230|NCT00884286|581327009|FG000|Overall Study|Toxicity|4|||
160983231|NCT00884286|581327010|FG001|Overall Study|Toxicity|1|||
160983232|NCT00884286|581327009|FG000|Overall Study|Death|2|||
160983233|NCT00884286|581327010|FG001|Overall Study|Death|2|||
160983234|NCT00884286|581327009|FG000|Overall Study|Physician Decision|1|||
160983235|NCT00884286|581327010|FG001|Overall Study|Physician Decision|0|||
160983236|NCT00884286|581327009|FG000|Overall Study|Septic shock|1|||
160983237|NCT00884286|581327010|FG001|Overall Study|Septic shock|0|||
160983238|NCT00884286|581327009|FG000|Overall Study|Thrombus in right auricle|1|||
160983239|NCT00884286|581327010|FG001|Overall Study|Thrombus in right auricle|0|||
160983240|NCT00884286|581327009|FG000|Overall Study|Not treated|2|||
160983241|NCT00884286|581327010|FG001|Overall Study|Not treated|1|||
160794916|NCT03396445|580637873|FG022|Treatment Period|Lost to Follow-up|0|||
160794917|NCT03396445|580637874|FG023|Treatment Period|Lost to Follow-up|0|||
160794918|NCT03396445|580637875|FG024|Treatment Period|Lost to Follow-up|0|||
160794919|NCT03396445|580637876|FG025|Treatment Period|Lost to Follow-up|0|||
160794920|NCT03396445|580637851|FG000|Treatment Period|Physician Decision|0|||
160794921|NCT03396445|580637852|FG001|Treatment Period|Physician Decision|0|||
160794922|NCT03396445|580637853|FG002|Treatment Period|Physician Decision|0|||
160794923|NCT03396445|580637854|FG003|Treatment Period|Physician Decision|0|||
160794924|NCT03396445|580637855|FG004|Treatment Period|Physician Decision|1|||
160794925|NCT03396445|580637856|FG005|Treatment Period|Physician Decision|0|||
160983242|NCT00884286|581327009|FG000|Overall Study|Comprised lung carcinoma|0|||
160983243|NCT00884286|581327010|FG001|Overall Study|Comprised lung carcinoma|1|||
160983244|NCT01196104|581327011|FG000|Overall Study|Lost to Follow-up|1|||
160983245|NCT01196104|581327012|FG001|Overall Study|Lost to Follow-up|0|||
160983246|NCT01196104|581327011|FG000|Overall Study|Physician Decision|0|||
160983247|NCT01196104|581327012|FG001|Overall Study|Physician Decision|1|||
160983248|NCT01196104|581327011|FG000|Overall Study|Withdrawal by Subject|3|||
161129243|NCT04188197|581860769|FG001|Overall Study|Pregnancy|1|||
161129244|NCT04574999|581860770|FG000|Overall Study|Adverse Event|1|||
160794926|NCT03396445|580637857|FG006|Treatment Period|Physician Decision|0|||
160794927|NCT03396445|580637858|FG007|Treatment Period|Physician Decision|0|||
160794928|NCT03396445|580637859|FG008|Treatment Period|Physician Decision|0|||
160794929|NCT03396445|580637860|FG009|Treatment Period|Physician Decision|1|||
160794930|NCT03396445|580637861|FG010|Treatment Period|Physician Decision|0|||
160794931|NCT03396445|580637862|FG011|Treatment Period|Physician Decision|0|||
160794932|NCT03396445|580637863|FG012|Treatment Period|Physician Decision|0|||
160794933|NCT03396445|580637864|FG013|Treatment Period|Physician Decision|0|||
160794934|NCT03396445|580637865|FG014|Treatment Period|Physician Decision|0|||
160794935|NCT03396445|580637866|FG015|Treatment Period|Physician Decision|0|||
160794936|NCT03396445|580637867|FG016|Treatment Period|Physician Decision|0|||
160794937|NCT03396445|580637868|FG017|Treatment Period|Physician Decision|0|||
160794938|NCT03396445|580637869|FG018|Treatment Period|Physician Decision|0|||
160794939|NCT03396445|580637870|FG019|Treatment Period|Physician Decision|0|||
160794940|NCT03396445|580637871|FG020|Treatment Period|Physician Decision|0|||
161129245|NCT04574999|581860771|FG001|Overall Study|Adverse Event|0|||
160794941|NCT03396445|580637872|FG021|Treatment Period|Physician Decision|0|||
160794942|NCT03396445|580637873|FG022|Treatment Period|Physician Decision|0|||
160983249|NCT01196104|581327012|FG001|Overall Study|Withdrawal by Subject|3|||
160983250|NCT01196104|581327011|FG000|Overall Study|Various|0|||
160983251|NCT01196104|581327012|FG001|Overall Study|Various|1|||
160983252|NCT00065468|581327018|FG000|Overall Study|Death|172|||
160983253|NCT00065468|581327019|FG001|Overall Study|Death|169|||
160983254|NCT00065468|581327020|FG002|Overall Study|Death|171|||
160983255|NCT00065468|581327018|FG000|Overall Study|Withdrawal by Subject|3|||
160794943|NCT03396445|580637874|FG023|Treatment Period|Physician Decision|0|||
160794944|NCT03396445|580637875|FG024|Treatment Period|Physician Decision|0|||
160983256|NCT00065468|581327019|FG001|Overall Study|Withdrawal by Subject|4|||
160794945|NCT03396445|580637876|FG025|Treatment Period|Physician Decision|0|||
160983257|NCT00065468|581327020|FG002|Overall Study|Withdrawal by Subject|5|||
161129246|NCT04574999|581860770|FG000|Overall Study|Lack of Efficacy|2|||
160794946|NCT03396445|580637851|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794947|NCT03396445|580637852|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794948|NCT03396445|580637853|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794949|NCT03396445|580637854|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794950|NCT03396445|580637855|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794951|NCT03396445|580637856|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794952|NCT03396445|580637857|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794953|NCT03396445|580637858|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794954|NCT03396445|580637859|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794955|NCT03396445|580637860|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794956|NCT03396445|580637861|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794957|NCT03396445|580637862|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794958|NCT03396445|580637863|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
160794959|NCT03396445|580637864|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794960|NCT03396445|580637865|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
160794961|NCT03396445|580637866|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794962|NCT03396445|580637867|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794963|NCT03396445|580637868|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794964|NCT03396445|580637869|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794965|NCT03396445|580637870|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794966|NCT03396445|580637871|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794967|NCT03396445|580637872|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794968|NCT03396445|580637873|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794969|NCT03396445|580637874|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794970|NCT03396445|580637875|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794971|NCT03396445|580637876|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
160794972|NCT03396445|580637851|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
160794973|NCT03396445|580637852|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
160794974|NCT03396445|580637853|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
160794975|NCT03396445|580637854|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
160794976|NCT03396445|580637855|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
160794977|NCT03396445|580637856|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794978|NCT03396445|580637857|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
160794979|NCT03396445|580637858|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794980|NCT03396445|580637859|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794981|NCT03396445|580637860|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794982|NCT03396445|580637861|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794983|NCT03396445|580637862|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794984|NCT03396445|580637863|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794985|NCT03396445|580637864|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794986|NCT03396445|580637865|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160894114|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
160894115|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
160894116|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
160894117|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
160894118|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
160894119|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
160894120|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
160894121|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
160894122|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
160894123|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
160894124|NCT02310321|581008289|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
161129247|NCT04574999|581860771|FG001|Overall Study|Lack of Efficacy|3|||
161129248|NCT04574999|581860770|FG000|Overall Study|Protocol Violation|1|||
161129249|NCT04574999|581860771|FG001|Overall Study|Protocol Violation|0|||
161129250|NCT04574999|581860770|FG000|Overall Study|Withdrawal by Subject|2|||
161129251|NCT04574999|581860771|FG001|Overall Study|Withdrawal by Subject|2|||
161129252|NCT04574999|581860770|FG000|Overall Study|Lost to Follow-up|1|||
161129253|NCT04574999|581860771|FG001|Overall Study|Lost to Follow-up|0|||
161129254|NCT04574999|581860770|FG000|Overall Study|Personal problems|1|||
160794987|NCT03396445|580637866|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794988|NCT03396445|580637867|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794989|NCT03396445|580637868|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794990|NCT03396445|580637869|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794991|NCT03396445|580637870|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794992|NCT03396445|580637871|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794993|NCT03396445|580637872|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794994|NCT03396445|580637873|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794995|NCT03396445|580637874|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794996|NCT03396445|580637875|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794997|NCT03396445|580637876|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
160794998|NCT03396445|580637851|FG000|Treatment Period|Withdrawal by Subject|0|||
160794999|NCT03396445|580637852|FG001|Treatment Period|Withdrawal by Subject|0|||
160795000|NCT03396445|580637853|FG002|Treatment Period|Withdrawal by Subject|0|||
160795001|NCT03396445|580637854|FG003|Treatment Period|Withdrawal by Subject|0|||
160795002|NCT03396445|580637855|FG004|Treatment Period|Withdrawal by Subject|0|||
160795003|NCT03396445|580637856|FG005|Treatment Period|Withdrawal by Subject|0|||
160795004|NCT03396445|580637857|FG006|Treatment Period|Withdrawal by Subject|0|||
160795005|NCT03396445|580637858|FG007|Treatment Period|Withdrawal by Subject|0|||
160795006|NCT03396445|580637859|FG008|Treatment Period|Withdrawal by Subject|0|||
160795007|NCT03396445|580637860|FG009|Treatment Period|Withdrawal by Subject|0|||
160795008|NCT03396445|580637861|FG010|Treatment Period|Withdrawal by Subject|0|||
160795009|NCT03396445|580637862|FG011|Treatment Period|Withdrawal by Subject|0|||
160795010|NCT03396445|580637863|FG012|Treatment Period|Withdrawal by Subject|0|||
160795011|NCT03396445|580637864|FG013|Treatment Period|Withdrawal by Subject|0|||
160795012|NCT03396445|580637865|FG014|Treatment Period|Withdrawal by Subject|1|||
160795013|NCT03396445|580637866|FG015|Treatment Period|Withdrawal by Subject|0|||
160795014|NCT03396445|580637867|FG016|Treatment Period|Withdrawal by Subject|1|||
160795015|NCT03396445|580637868|FG017|Treatment Period|Withdrawal by Subject|0|||
160795016|NCT03396445|580637869|FG018|Treatment Period|Withdrawal by Subject|0|||
160795017|NCT03396445|580637870|FG019|Treatment Period|Withdrawal by Subject|0|||
160795018|NCT03396445|580637871|FG020|Treatment Period|Withdrawal by Subject|0|||
160795019|NCT03396445|580637872|FG021|Treatment Period|Withdrawal by Subject|0|||
160795020|NCT03396445|580637873|FG022|Treatment Period|Withdrawal by Subject|0|||
160795021|NCT03396445|580637874|FG023|Treatment Period|Withdrawal by Subject|0|||
160795022|NCT03396445|580637875|FG024|Treatment Period|Withdrawal by Subject|0|||
160795023|NCT03396445|580637876|FG025|Treatment Period|Withdrawal by Subject|0|||
160795024|NCT03396445|580637851|FG000|Switch-over Period|Death|0|||
160795025|NCT03396445|580637852|FG001|Switch-over Period|Death|0|||
160795026|NCT03396445|580637853|FG002|Switch-over Period|Death|0|||
160795027|NCT03396445|580637854|FG003|Switch-over Period|Death|0|||
160795028|NCT03396445|580637855|FG004|Switch-over Period|Death|0|||
160795029|NCT03396445|580637856|FG005|Switch-over Period|Death|0|||
160795030|NCT03396445|580637857|FG006|Switch-over Period|Death|0|||
160795031|NCT03396445|580637858|FG007|Switch-over Period|Death|0|||
160795032|NCT03396445|580637859|FG008|Switch-over Period|Death|0|||
160795033|NCT03396445|580637860|FG009|Switch-over Period|Death|0|||
160795034|NCT03396445|580637861|FG010|Switch-over Period|Death|0|||
160795035|NCT03396445|580637862|FG011|Switch-over Period|Death|0|||
160795036|NCT03396445|580637863|FG012|Switch-over Period|Death|0|||
160795037|NCT03396445|580637864|FG013|Switch-over Period|Death|0|||
160795038|NCT03396445|580637865|FG014|Switch-over Period|Death|0|||
160795039|NCT03396445|580637866|FG015|Switch-over Period|Death|0|||
160795040|NCT03396445|580637867|FG016|Switch-over Period|Death|0|||
160795041|NCT03396445|580637868|FG017|Switch-over Period|Death|0|||
160795042|NCT03396445|580637869|FG018|Switch-over Period|Death|1|||
160795043|NCT03396445|580637870|FG019|Switch-over Period|Death|2|||
160795044|NCT03396445|580637871|FG020|Switch-over Period|Death|2|||
160795045|NCT03396445|580637872|FG021|Switch-over Period|Death|1|||
160795046|NCT03396445|580637873|FG022|Switch-over Period|Death|2|||
160795047|NCT03396445|580637874|FG023|Switch-over Period|Death|0|||
160795048|NCT03396445|580637875|FG024|Switch-over Period|Death|1|||
160795049|NCT03396445|580637876|FG025|Switch-over Period|Death|6|||
160795050|NCT03396445|580637851|FG000|Switch-over Period|Lost to Follow-up|0|||
160795051|NCT03396445|580637852|FG001|Switch-over Period|Lost to Follow-up|0|||
160795052|NCT03396445|580637853|FG002|Switch-over Period|Lost to Follow-up|0|||
160795053|NCT03396445|580637854|FG003|Switch-over Period|Lost to Follow-up|0|||
160795054|NCT03396445|580637855|FG004|Switch-over Period|Lost to Follow-up|0|||
160795055|NCT03396445|580637856|FG005|Switch-over Period|Lost to Follow-up|0|||
160795056|NCT03396445|580637857|FG006|Switch-over Period|Lost to Follow-up|0|||
160795057|NCT03396445|580637858|FG007|Switch-over Period|Lost to Follow-up|0|||
160795058|NCT03396445|580637859|FG008|Switch-over Period|Lost to Follow-up|0|||
160983258|NCT00065468|581327018|FG000|Overall Study|Lost to Follow-up|5|||
161129255|NCT04574999|581860771|FG001|Overall Study|Personal problems|0|||
161129256|NCT04574999|581860770|FG000|Overall Study|Previous planned surgery|1|||
161235886|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
161235887|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235888|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235889|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235890|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235891|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
161235892|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235893|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235894|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235895|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161129257|NCT04574999|581860771|FG001|Overall Study|Previous planned surgery|0|||
161235896|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160894125|NCT02310321|581008290|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
160894126|NCT02310321|581008291|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
160894127|NCT04950166|581008292|FG000|Overall Study|Withdrawal by Subject|1|||
160894128|NCT01698905|581008293|FG000|Overall Study|Adverse Event|4|||
160894129|NCT01698905|581008293|FG000|Overall Study|Physician Decision|2|||
160894130|NCT01698905|581008293|FG000|Overall Study|Pregnancy|1|||
160894131|NCT01698905|581008293|FG000|Overall Study|Protocol Violation|1|||
160894132|NCT01698905|581008293|FG000|Overall Study|Subject/guardian decision|2|||
160894133|NCT01698905|581008293|FG000|Overall Study|Death|1|||
160894134|NCT05896748|581008294|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
160894135|NCT05896748|581008294|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
160894136|NCT05896748|581008294|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
161129258|NCT00206726|581860773|FG000|Overall Study|Delayed recovery of blood counts|1|||
161129259|NCT00206726|581860773|FG000|Overall Study|Progressive disease or relapsed disease|18|||
161129260|NCT00206726|581860773|FG000|Overall Study|Placed on new protocol|1|||
161129261|NCT00206726|581860773|FG000|Overall Study|Bone marrow transplant|1|||
161129262|NCT00206726|581860773|FG000|Overall Study|Adverse Event|17|||
161129263|NCT00206726|581860773|FG000|Overall Study|Death|4|||
161129264|NCT00206726|581860773|FG000|Overall Study|Protocol Violation|1|||
161129265|NCT00206726|581860773|FG000|Overall Study|Withdrawal by Subject|8|||
161129266|NCT00008385|581860774|FG000|Overall Study|Off treatment reasons not reported|79|||
161129267|NCT00008385|581860775|FG001|Overall Study|Off treatment reasons not reported|70|||
161129268|NCT00008385|581860774|FG000|Overall Study|Progressive disease|52|||
161129269|NCT00008385|581860775|FG001|Overall Study|Progressive disease|117|||
161129270|NCT00008385|581860774|FG000|Overall Study|Adverse Event|8|||
161129271|NCT00008385|581860775|FG001|Overall Study|Adverse Event|20|||
161129272|NCT00008385|581860774|FG000|Overall Study|Death|12|||
161129273|NCT00008385|581860775|FG001|Overall Study|Death|18|||
161129274|NCT00008385|581860774|FG000|Overall Study|Withdrawal by Subject|67|||
161129275|NCT00008385|581860775|FG001|Overall Study|Withdrawal by Subject|157|||
161129276|NCT00008385|581860774|FG000|Overall Study|Start non-protocol therapy|3|||
161129277|NCT00008385|581860775|FG001|Overall Study|Start non-protocol therapy|1|||
161129278|NCT00008385|581860774|FG000|Overall Study|Other complicating disease|17|||
161129279|NCT00008385|581860775|FG001|Overall Study|Other complicating disease|30|||
161129280|NCT00008385|581860774|FG000|Overall Study|Maximum dose reached|0|||
161129281|NCT00008385|581860775|FG001|Overall Study|Maximum dose reached|2|||
161129282|NCT00008385|581860774|FG000|Overall Study|Other|105|||
161129283|NCT00008385|581860775|FG001|Overall Study|Other|212|||
161129284|NCT00008385|581860774|FG000|Overall Study|Not start protocol therapy|44|||
161129285|NCT00008385|581860775|FG001|Overall Study|Not start protocol therapy|175|||
161129286|NCT05148884|581860776|FG000|Overall Study|Withdrawal by Subject|3|||
161129287|NCT05148884|581860777|FG001|Overall Study|Withdrawal by Subject|0|||
161129288|NCT05148884|581860776|FG000|Overall Study|Deep brain stimulation operation|0|||
161129289|NCT05148884|581860777|FG001|Overall Study|Deep brain stimulation operation|1|||
161129290|NCT01341457|581860780|FG000|Overall Study|Adverse Event|2|||
161129291|NCT01341457|581860781|FG001|Overall Study|Adverse Event|0|||
161129292|NCT00317044|581860782|FG000|Overall Study|Protocol Violation|28|||
161129293|NCT00317044|581860783|FG001|Overall Study|Protocol Violation|22|||
161129294|NCT00317044|581860784|FG002|Overall Study|Protocol Violation|20|||
161129295|NCT00317044|581860782|FG000|Overall Study|Adverse Event|4|||
160983259|NCT00065468|581327019|FG001|Overall Study|Lost to Follow-up|3|||
161129296|NCT00317044|581860783|FG001|Overall Study|Adverse Event|7|||
161129297|NCT00317044|581860784|FG002|Overall Study|Adverse Event|4|||
161129298|NCT00317044|581860782|FG000|Overall Study|Withdrawal by Subject|10|||
161129299|NCT00317044|581860783|FG001|Overall Study|Withdrawal by Subject|7|||
161129300|NCT00317044|581860784|FG002|Overall Study|Withdrawal by Subject|12|||
161129301|NCT00317044|581860782|FG000|Overall Study|Lost to Follow-up|0|||
161129302|NCT00317044|581860783|FG001|Overall Study|Lost to Follow-up|2|||
161129303|NCT00317044|581860784|FG002|Overall Study|Lost to Follow-up|3|||
161129304|NCT00317044|581860782|FG000|Overall Study|Multiple Reasons|6|||
160795059|NCT03396445|580637860|FG009|Switch-over Period|Lost to Follow-up|0|||
160795060|NCT03396445|580637861|FG010|Switch-over Period|Lost to Follow-up|0|||
160795061|NCT03396445|580637862|FG011|Switch-over Period|Lost to Follow-up|0|||
160795062|NCT03396445|580637863|FG012|Switch-over Period|Lost to Follow-up|0|||
160795063|NCT03396445|580637864|FG013|Switch-over Period|Lost to Follow-up|0|||
160795064|NCT03396445|580637865|FG014|Switch-over Period|Lost to Follow-up|0|||
160894137|NCT05896748|581008294|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
160894138|NCT05896748|581008294|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
160894139|NCT00857415|581008301|FG000|Overall Study|Image acquisition failure|2|||
160894140|NCT00857415|581008302|FG001|Overall Study|Image acquisition failure|0|||
160894141|NCT00857415|581008301|FG000|Overall Study|Invalid image or not imaged|3|||
160894142|NCT00857415|581008302|FG001|Overall Study|Invalid image or not imaged|0|||
160894143|NCT00857415|581008301|FG000|Overall Study|Subject still living at end of study|110|||
160894144|NCT00857415|581008302|FG001|Overall Study|Subject still living at end of study|0|||
160894145|NCT00857415|581008301|FG000|Overall Study|Deceased with no autopsy|2|||
160894146|NCT00857415|581008302|FG001|Overall Study|Deceased with no autopsy|0|||
160894147|NCT00764504|581008303|FG000|Overall Study|Death|12|||
160894148|NCT00764504|581008304|FG001|Overall Study|Death|6|||
160894149|NCT00764504|581008305|FG002|Overall Study|Death|13|||
160894150|NCT00764504|581008303|FG000|Overall Study|Revision of Device|12|||
160894151|NCT00764504|581008304|FG001|Overall Study|Revision of Device|23|||
160894152|NCT00764504|581008305|FG002|Overall Study|Revision of Device|14|||
160894153|NCT00764504|581008303|FG000|Overall Study|Physician Decision|1|||
160894154|NCT00764504|581008304|FG001|Overall Study|Physician Decision|0|||
160894155|NCT00764504|581008305|FG002|Overall Study|Physician Decision|0|||
160894156|NCT00764504|581008303|FG000|Overall Study|Withdrawal by Subject|1|||
160894157|NCT00764504|581008304|FG001|Overall Study|Withdrawal by Subject|7|||
160894158|NCT00764504|581008305|FG002|Overall Study|Withdrawal by Subject|4|||
160894159|NCT00764504|581008303|FG000|Overall Study|Lost to Follow-up|40|||
160894160|NCT00764504|581008304|FG001|Overall Study|Lost to Follow-up|34|||
160894161|NCT00764504|581008305|FG002|Overall Study|Lost to Follow-up|72|||
160894162|NCT01465191|581008309|FG000|Overall Study|Protocol Violation|6|||
160894163|NCT01465191|581008310|FG001|Overall Study|Protocol Violation|3|||
160894164|NCT01465191|581008311|FG002|Overall Study|Protocol Violation|3|||
160894165|NCT01465191|581008309|FG000|Overall Study|Lost to Follow-up|3|||
160894166|NCT01465191|581008310|FG001|Overall Study|Lost to Follow-up|6|||
160894167|NCT01465191|581008311|FG002|Overall Study|Lost to Follow-up|4|||
160894168|NCT00943124|581008312|FG000|Period 1|Withdrawal by Subject|1|||
160894169|NCT00943124|581008313|FG001|Period 1|Withdrawal by Subject|1|||
160894170|NCT00943124|581008312|FG000|Period 1|Did Not Follow Study Procedures|1|||
160894171|NCT00943124|581008313|FG001|Period 1|Did Not Follow Study Procedures|0|||
160894172|NCT00943124|581008312|FG000|Period 1|Personal Reasons|0|||
160894173|NCT00943124|581008313|FG001|Period 1|Personal Reasons|1|||
160894174|NCT02992132|581008314|FG000|Overall Study|Adverse Event|4|||
160894175|NCT02992132|581008315|FG001|Overall Study|Adverse Event|1|||
160894176|NCT02992132|581008316|FG002|Overall Study|Adverse Event|3|||
160894177|NCT02992132|581008314|FG000|Overall Study|Lack of Efficacy|2|||
160894178|NCT02992132|581008315|FG001|Overall Study|Lack of Efficacy|0|||
160894179|NCT02992132|581008316|FG002|Overall Study|Lack of Efficacy|0|||
160894180|NCT02992132|581008314|FG000|Overall Study|Non-compliance with study drug|2|||
160894181|NCT02992132|581008315|FG001|Overall Study|Non-compliance with study drug|0|||
160894182|NCT02992132|581008316|FG002|Overall Study|Non-compliance with study drug|0|||
160894183|NCT02992132|581008314|FG000|Overall Study|Progressive disease|1|||
160894184|NCT02992132|581008315|FG001|Overall Study|Progressive disease|0|||
160894185|NCT02992132|581008316|FG002|Overall Study|Progressive disease|0|||
160894186|NCT02992132|581008314|FG000|Overall Study|Protocol Violation|2|||
160894187|NCT02992132|581008315|FG001|Overall Study|Protocol Violation|2|||
160894188|NCT02992132|581008316|FG002|Overall Study|Protocol Violation|0|||
160894189|NCT02992132|581008314|FG000|Overall Study|Caregiver withdrew consent|2|||
161129305|NCT00317044|581860783|FG001|Overall Study|Multiple Reasons|2|||
161129306|NCT00317044|581860784|FG002|Overall Study|Multiple Reasons|6|||
160795065|NCT03396445|580637866|FG015|Switch-over Period|Lost to Follow-up|0|||
160795066|NCT03396445|580637867|FG016|Switch-over Period|Lost to Follow-up|0|||
160795067|NCT03396445|580637868|FG017|Switch-over Period|Lost to Follow-up|0|||
160795068|NCT03396445|580637869|FG018|Switch-over Period|Lost to Follow-up|0|||
160795069|NCT03396445|580637870|FG019|Switch-over Period|Lost to Follow-up|0|||
160795070|NCT03396445|580637871|FG020|Switch-over Period|Lost to Follow-up|0|||
160795071|NCT03396445|580637872|FG021|Switch-over Period|Lost to Follow-up|0|||
160894190|NCT02992132|581008315|FG001|Overall Study|Caregiver withdrew consent|3|||
160894191|NCT02992132|581008316|FG002|Overall Study|Caregiver withdrew consent|2|||
160894192|NCT02992132|581008314|FG000|Overall Study|Withdrawal by Subject|0|||
160894193|NCT02992132|581008315|FG001|Overall Study|Withdrawal by Subject|2|||
160894194|NCT02992132|581008316|FG002|Overall Study|Withdrawal by Subject|1|||
160894195|NCT02992132|581008314|FG000|Overall Study|Physician Decision|0|||
160894196|NCT02992132|581008315|FG001|Overall Study|Physician Decision|0|||
160894197|NCT02992132|581008316|FG002|Overall Study|Physician Decision|1|||
160894198|NCT02448810|581008317|FG000|Overall Study|Adverse Event|0|||
160894199|NCT02448810|581008318|FG001|Overall Study|Adverse Event|0|||
161330765|NCT01747499|582597255|FG001|Overall Study|Death|0|||
161330766|NCT01747499|582597256|FG002|Overall Study|Death|0|||
161330767|NCT01747499|582597257|FG003|Overall Study|Death|1|||
161330768|NCT01747499|582597258|FG004|Overall Study|Death|1|||
161330769|NCT01747499|582597254|FG000|Overall Study|Withdrawal by Subject|0|||
161330770|NCT01747499|582597255|FG001|Overall Study|Withdrawal by Subject|0|||
161330771|NCT01747499|582597256|FG002|Overall Study|Withdrawal by Subject|0|||
161330772|NCT01747499|582597257|FG003|Overall Study|Withdrawal by Subject|0|||
161330773|NCT01747499|582597258|FG004|Overall Study|Withdrawal by Subject|6|||
161330774|NCT01747499|582597254|FG000|Overall Study|Developed AML and death|0|||
161330775|NCT01747499|582597255|FG001|Overall Study|Developed AML and death|0|||
160795072|NCT03396445|580637873|FG022|Switch-over Period|Lost to Follow-up|0|||
160795073|NCT03396445|580637874|FG023|Switch-over Period|Lost to Follow-up|1|||
160795074|NCT03396445|580637875|FG024|Switch-over Period|Lost to Follow-up|0|||
160795075|NCT03396445|580637876|FG025|Switch-over Period|Lost to Follow-up|0|||
160795076|NCT00366457|580637890|FG000|Overall Study|never began study therapy|2|||
160795077|NCT02829996|580637891|FG000|Overall Study|Withdrawal by Subject|1|||
160795078|NCT02829996|580637892|FG001|Overall Study|Withdrawal by Subject|0|||
160795079|NCT02829996|580637893|FG002|Overall Study|Withdrawal by Subject|0|||
160795080|NCT02829996|580637894|FG003|Overall Study|Withdrawal by Subject|0|||
160795081|NCT02829996|580637895|FG004|Overall Study|Withdrawal by Subject|0|||
160795082|NCT00183248|580637909|FG000|Overall Study|Lost to Follow-up|0|||
160795083|NCT00183248|580637910|FG001|Overall Study|Lost to Follow-up|1|||
160795084|NCT00183248|580637909|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
160795085|NCT00183248|580637910|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
160795086|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
160795087|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
160795088|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
160795089|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
160795090|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
160795091|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
160795092|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
160795093|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
160795094|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
160795095|NCT04734210|580637911|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
160795096|NCT04734210|580637912|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
160795097|NCT04734210|580637913|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
160795098|NCT01822925|580637914|FG000|Overall Study|Adverse Event|1|||
160795099|NCT01822925|580637915|FG001|Overall Study|Adverse Event|1|||
160795100|NCT01822925|580637916|FG002|Overall Study|Adverse Event|1|||
160795101|NCT01822925|580637917|FG003|Overall Study|Adverse Event|1|||
160795102|NCT01822925|580637914|FG000|Overall Study|Lost to Follow-up|0|||
160795103|NCT01822925|580637915|FG001|Overall Study|Lost to Follow-up|1|||
160795104|NCT01822925|580637916|FG002|Overall Study|Lost to Follow-up|0|||
160795105|NCT01822925|580637917|FG003|Overall Study|Lost to Follow-up|0|||
160795106|NCT01822925|580637914|FG000|Overall Study|Protocol Violation|1|||
160795107|NCT01822925|580637915|FG001|Overall Study|Protocol Violation|0|||
160795108|NCT01822925|580637916|FG002|Overall Study|Protocol Violation|0|||
160795109|NCT01822925|580637917|FG003|Overall Study|Protocol Violation|1|||
160795110|NCT01822925|580637914|FG000|Overall Study|Withdrawal by Subject|2|||
160795111|NCT01822925|580637915|FG001|Overall Study|Withdrawal by Subject|0|||
160795112|NCT01822925|580637916|FG002|Overall Study|Withdrawal by Subject|2|||
160795113|NCT01822925|580637917|FG003|Overall Study|Withdrawal by Subject|2|||
160795114|NCT01822925|580637914|FG000|Overall Study|Taking prohibited medication|2|||
160795115|NCT01822925|580637915|FG001|Overall Study|Taking prohibited medication|0|||
160795116|NCT01822925|580637916|FG002|Overall Study|Taking prohibited medication|0|||
160795117|NCT01822925|580637917|FG003|Overall Study|Taking prohibited medication|1|||
160795118|NCT03243084|580637919|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
160795119|NCT03243084|580637920|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
160795120|NCT02095106|580637925|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160795121|NCT02095106|580637926|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160795122|NCT00553254|580637934|FG000|Overall Study|Death|3|||
160795123|NCT00553254|580637935|FG001|Overall Study|Death|6|||
160795124|NCT00553254|580637936|FG002|Overall Study|Death|25|||
160795125|NCT00553254|580637934|FG000|Overall Study|Lost to Follow-up|0|||
160795126|NCT00553254|580637935|FG001|Overall Study|Lost to Follow-up|0|||
160795127|NCT00553254|580637936|FG002|Overall Study|Lost to Follow-up|2|||
160795128|NCT00553254|580637934|FG000|Overall Study|Withdrawal by Subject|2|||
161330776|NCT01747499|582597256|FG002|Overall Study|Developed AML and death|0|||
161330777|NCT01747499|582597257|FG003|Overall Study|Developed AML and death|0|||
160795129|NCT00553254|580637935|FG001|Overall Study|Withdrawal by Subject|0|||
160795130|NCT00553254|580637936|FG002|Overall Study|Withdrawal by Subject|2|||
160795131|NCT00553254|580637934|FG000|Overall Study|Study terminated by Sponsor|0|||
160795132|NCT00553254|580637935|FG001|Overall Study|Study terminated by Sponsor|0|||
160795133|NCT00553254|580637936|FG002|Overall Study|Study terminated by Sponsor|1|||
160795134|NCT00553254|580637934|FG000|Overall Study|Other|1|||
160795135|NCT00553254|580637935|FG001|Overall Study|Other|0|||
160795136|NCT00553254|580637936|FG002|Overall Study|Other|13|||
160795137|NCT02314923|580637939|FG000|Overall Study|Death|0|||
160795138|NCT02314923|580637940|FG001|Overall Study|Death|0|||
160795139|NCT02314923|580637941|FG002|Overall Study|Death|0|||
160795140|NCT02314923|580637942|FG003|Overall Study|Death|1|||
160795141|NCT02314923|580637943|FG004|Overall Study|Death|0|||
160795142|NCT02314923|580637944|FG005|Overall Study|Death|0|||
160795143|NCT02314923|580637945|FG006|Overall Study|Death|0|||
160795144|NCT02314923|580637946|FG007|Overall Study|Death|0|||
160795145|NCT02314923|580637947|FG008|Overall Study|Death|0|||
160795146|NCT02314923|580637948|FG009|Overall Study|Death|0|||
160795147|NCT02314923|580637939|FG000|Overall Study|Lost to Follow-up|2|||
160795148|NCT02314923|580637940|FG001|Overall Study|Lost to Follow-up|3|||
160795149|NCT02314923|580637941|FG002|Overall Study|Lost to Follow-up|1|||
160795150|NCT02314923|580637942|FG003|Overall Study|Lost to Follow-up|0|||
160795151|NCT02314923|580637943|FG004|Overall Study|Lost to Follow-up|0|||
160795152|NCT02314923|580637944|FG005|Overall Study|Lost to Follow-up|0|||
160795153|NCT02314923|580637945|FG006|Overall Study|Lost to Follow-up|3|||
160795154|NCT02314923|580637946|FG007|Overall Study|Lost to Follow-up|4|||
160795155|NCT02314923|580637947|FG008|Overall Study|Lost to Follow-up|2|||
160795156|NCT02314923|580637948|FG009|Overall Study|Lost to Follow-up|0|||
160795157|NCT02314923|580637939|FG000|Overall Study|Withdrawal by Subject|0|||
160795158|NCT02314923|580637940|FG001|Overall Study|Withdrawal by Subject|0|||
160795159|NCT02314923|580637941|FG002|Overall Study|Withdrawal by Subject|1|||
160795160|NCT02314923|580637942|FG003|Overall Study|Withdrawal by Subject|0|||
160795161|NCT02314923|580637943|FG004|Overall Study|Withdrawal by Subject|1|||
160795162|NCT02314923|580637944|FG005|Overall Study|Withdrawal by Subject|0|||
160795163|NCT02314923|580637945|FG006|Overall Study|Withdrawal by Subject|1|||
160795164|NCT02314923|580637946|FG007|Overall Study|Withdrawal by Subject|0|||
160795165|NCT02314923|580637947|FG008|Overall Study|Withdrawal by Subject|0|||
160795166|NCT02314923|580637948|FG009|Overall Study|Withdrawal by Subject|0|||
160795167|NCT02314923|580637939|FG000|Overall Study|Physician Decision|0|||
160795168|NCT02314923|580637940|FG001|Overall Study|Physician Decision|1|||
160795169|NCT02314923|580637941|FG002|Overall Study|Physician Decision|0|||
160795170|NCT02314923|580637942|FG003|Overall Study|Physician Decision|0|||
160795171|NCT02314923|580637943|FG004|Overall Study|Physician Decision|0|||
160795172|NCT02314923|580637944|FG005|Overall Study|Physician Decision|0|||
160795173|NCT02314923|580637945|FG006|Overall Study|Physician Decision|0|||
160795174|NCT02314923|580637946|FG007|Overall Study|Physician Decision|0|||
160795175|NCT02314923|580637947|FG008|Overall Study|Physician Decision|0|||
160795176|NCT02314923|580637948|FG009|Overall Study|Physician Decision|0|||
160795177|NCT02314923|580637939|FG000|Overall Study|Participant unavailable|0|||
160795178|NCT02314923|580637940|FG001|Overall Study|Participant unavailable|0|||
160795179|NCT02314923|580637941|FG002|Overall Study|Participant unavailable|0|||
160795180|NCT02314923|580637942|FG003|Overall Study|Participant unavailable|0|||
160795181|NCT02314923|580637943|FG004|Overall Study|Participant unavailable|0|||
160795182|NCT02314923|580637944|FG005|Overall Study|Participant unavailable|1|||
160894200|NCT02448810|581008319|FG002|Overall Study|Adverse Event|1|||
160894201|NCT02448810|581008320|FG003|Overall Study|Adverse Event|0|||
161235897|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235898|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235899|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235900|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160894202|NCT02448810|581008321|FG004|Overall Study|Adverse Event|0|||
161235901|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235902|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160795183|NCT02314923|580637945|FG006|Overall Study|Participant unavailable|0|||
160795184|NCT02314923|580637946|FG007|Overall Study|Participant unavailable|0|||
160795185|NCT02314923|580637947|FG008|Overall Study|Participant unavailable|0|||
160795186|NCT02314923|580637948|FG009|Overall Study|Participant unavailable|0|||
160795187|NCT02314923|580637939|FG000|Overall Study|Screen failure|0|||
160795188|NCT02314923|580637940|FG001|Overall Study|Screen failure|0|||
160795189|NCT02314923|580637941|FG002|Overall Study|Screen failure|0|||
160795190|NCT02314923|580637942|FG003|Overall Study|Screen failure|0|||
160795191|NCT02314923|580637943|FG004|Overall Study|Screen failure|0|||
160795192|NCT02314923|580637944|FG005|Overall Study|Screen failure|0|||
160795193|NCT02314923|580637945|FG006|Overall Study|Screen failure|1|||
160795194|NCT02314923|580637946|FG007|Overall Study|Screen failure|0|||
160795195|NCT02314923|580637947|FG008|Overall Study|Screen failure|0|||
160795196|NCT02314923|580637948|FG009|Overall Study|Screen failure|0|||
160894203|NCT02448810|581008322|FG005|Overall Study|Adverse Event|0|||
160795197|NCT02314923|580637939|FG000|Overall Study|Participant relocation|1|||
160795198|NCT02314923|580637940|FG001|Overall Study|Participant relocation|0|||
160795199|NCT02314923|580637941|FG002|Overall Study|Participant relocation|0|||
160795200|NCT02314923|580637942|FG003|Overall Study|Participant relocation|0|||
160795201|NCT02314923|580637943|FG004|Overall Study|Participant relocation|0|||
160795202|NCT02314923|580637944|FG005|Overall Study|Participant relocation|0|||
160795203|NCT02314923|580637945|FG006|Overall Study|Participant relocation|0|||
160795204|NCT02314923|580637946|FG007|Overall Study|Participant relocation|1|||
160795205|NCT02314923|580637947|FG008|Overall Study|Participant relocation|0|||
160795206|NCT02314923|580637948|FG009|Overall Study|Participant relocation|0|||
160795207|NCT02546323|580637949|FG000|Overall Study|Withdrawal by Subject|36|||
160795208|NCT02546323|580637950|FG001|Overall Study|Withdrawal by Subject|33|||
160795209|NCT02546323|580637949|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
160795210|NCT02546323|580637950|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
160795211|NCT02546323|580637949|FG000|Overall Study|Adverse Event|17|||
160795212|NCT02546323|580637950|FG001|Overall Study|Adverse Event|11|||
160795213|NCT02546323|580637949|FG000|Overall Study|Patient Specific Reasons|1|||
160795214|NCT02546323|580637950|FG001|Overall Study|Patient Specific Reasons|2|||
160795215|NCT02546323|580637949|FG000|Overall Study|Lost to Follow-up|2|||
160795216|NCT02546323|580637950|FG001|Overall Study|Lost to Follow-up|3|||
160795217|NCT02546323|580637949|FG000|Overall Study|Non-compliance with Study Drug|2|||
160795218|NCT02546323|580637950|FG001|Overall Study|Non-compliance with Study Drug|2|||
160795219|NCT02546323|580637949|FG000|Overall Study|Met Withdrawal Criteria|2|||
160795220|NCT02546323|580637950|FG001|Overall Study|Met Withdrawal Criteria|14|||
160795221|NCT04476784|580637951|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
160795222|NCT04476784|580637952|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
160795223|NCT00863304|580637956|FG000|Overall Study|Adverse Event|10|||
160795224|NCT00863304|580637957|FG001|Overall Study|Adverse Event|4|||
160795225|NCT00863304|580637958|FG002|Overall Study|Adverse Event|14|||
160795226|NCT00863304|580637959|FG003|Overall Study|Adverse Event|16|||
160795227|NCT00863304|580637956|FG000|Overall Study|Lost to Follow-up|1|||
160795228|NCT00863304|580637957|FG001|Overall Study|Lost to Follow-up|5|||
160795229|NCT00863304|580637958|FG002|Overall Study|Lost to Follow-up|4|||
160795230|NCT00863304|580637959|FG003|Overall Study|Lost to Follow-up|2|||
160795231|NCT00863304|580637956|FG000|Overall Study|Lack of Efficacy|57|||
160795232|NCT00863304|580637957|FG001|Overall Study|Lack of Efficacy|26|||
160795233|NCT00863304|580637958|FG002|Overall Study|Lack of Efficacy|30|||
160795234|NCT00863304|580637959|FG003|Overall Study|Lack of Efficacy|28|||
160795235|NCT00863304|580637956|FG000|Overall Study|Withdrawal by Subject|19|||
160795236|NCT00863304|580637957|FG001|Overall Study|Withdrawal by Subject|14|||
160795237|NCT00863304|580637958|FG002|Overall Study|Withdrawal by Subject|20|||
160795238|NCT00863304|580637959|FG003|Overall Study|Withdrawal by Subject|18|||
160795239|NCT00863304|580637956|FG000|Overall Study|Other|1|||
160795240|NCT00863304|580637957|FG001|Overall Study|Other|0|||
160795241|NCT00863304|580637958|FG002|Overall Study|Other|0|||
160795242|NCT00863304|580637959|FG003|Overall Study|Other|1|||
160795243|NCT00863304|580637956|FG000|Overall Study|Protocol Violation|2|||
160795244|NCT00863304|580637957|FG001|Overall Study|Protocol Violation|6|||
160795245|NCT00863304|580637958|FG002|Overall Study|Protocol Violation|2|||
160795246|NCT00863304|580637959|FG003|Overall Study|Protocol Violation|0|||
160795247|NCT00863304|580637956|FG000|Overall Study|Randomized, but not Treated|3|||
160795248|NCT00863304|580637957|FG001|Overall Study|Randomized, but not Treated|1|||
160795249|NCT00863304|580637958|FG002|Overall Study|Randomized, but not Treated|4|||
160795250|NCT00863304|580637959|FG003|Overall Study|Randomized, but not Treated|1|||
160795251|NCT00863304|580637956|FG000|Overall Study|Entered extension study|101|||
160795252|NCT00863304|580637957|FG001|Overall Study|Entered extension study|129|||
160795253|NCT00863304|580637958|FG002|Overall Study|Entered extension study|113|||
160795254|NCT00863304|580637959|FG003|Overall Study|Entered extension study|125|||
160795255|NCT00478257|580637960|FG000|Overall Study|Withdrawal by Subject|8|||
160795256|NCT00478257|580637961|FG001|Overall Study|Withdrawal by Subject|3|||
160795257|NCT00806585|580637962|FG000|Overall Study|Study terminated by Sponsor|0|||
160795258|NCT00806585|580637963|FG001|Overall Study|Study terminated by Sponsor|0|||
160795259|NCT00806585|580637964|FG002|Overall Study|Study terminated by Sponsor|1|||
160795260|NCT00806585|580637965|FG003|Overall Study|Study terminated by Sponsor|2|||
160795261|NCT00806585|580637966|FG004|Overall Study|Study terminated by Sponsor|0|||
160795262|NCT00806585|580637962|FG000|Overall Study|Protocol Violation|3|||
160795263|NCT00806585|580637963|FG001|Overall Study|Protocol Violation|1|||
160795264|NCT00806585|580637964|FG002|Overall Study|Protocol Violation|2|||
160795265|NCT00806585|580637965|FG003|Overall Study|Protocol Violation|0|||
160795266|NCT00806585|580637966|FG004|Overall Study|Protocol Violation|0|||
160795267|NCT00806585|580637962|FG000|Overall Study|Physician Decision|0|||
160795268|NCT00806585|580637963|FG001|Overall Study|Physician Decision|2|||
160795269|NCT00806585|580637964|FG002|Overall Study|Physician Decision|3|||
160795270|NCT00806585|580637965|FG003|Overall Study|Physician Decision|0|||
160795271|NCT00806585|580637966|FG004|Overall Study|Physician Decision|1|||
160795272|NCT00806585|580637962|FG000|Overall Study|Lost to Follow-up|2|||
160795273|NCT00806585|580637963|FG001|Overall Study|Lost to Follow-up|1|||
160795274|NCT00806585|580637964|FG002|Overall Study|Lost to Follow-up|2|||
160795275|NCT00806585|580637965|FG003|Overall Study|Lost to Follow-up|2|||
160795276|NCT00806585|580637966|FG004|Overall Study|Lost to Follow-up|5|||
160795277|NCT00806585|580637962|FG000|Overall Study|Lack of Efficacy|1|||
160795278|NCT00806585|580637963|FG001|Overall Study|Lack of Efficacy|0|||
160795279|NCT00806585|580637964|FG002|Overall Study|Lack of Efficacy|0|||
160795280|NCT00806585|580637965|FG003|Overall Study|Lack of Efficacy|0|||
160795281|NCT00806585|580637966|FG004|Overall Study|Lack of Efficacy|0|||
160795282|NCT00806585|580637962|FG000|Overall Study|Adverse Event|1|||
160795283|NCT00806585|580637963|FG001|Overall Study|Adverse Event|5|||
160795284|NCT00806585|580637964|FG002|Overall Study|Adverse Event|3|||
160795285|NCT00806585|580637965|FG003|Overall Study|Adverse Event|4|||
160795286|NCT00806585|580637966|FG004|Overall Study|Adverse Event|2|||
160795287|NCT00806585|580637962|FG000|Overall Study|Withdrawal by Subject|10|||
160795288|NCT00806585|580637963|FG001|Overall Study|Withdrawal by Subject|8|||
160795289|NCT00806585|580637964|FG002|Overall Study|Withdrawal by Subject|9|||
160795290|NCT00806585|580637965|FG003|Overall Study|Withdrawal by Subject|3|||
160795291|NCT00806585|580637966|FG004|Overall Study|Withdrawal by Subject|11|||
160795292|NCT00806585|580637962|FG000|Overall Study|Completion status unknown|15|||
160795293|NCT00806585|580637963|FG001|Overall Study|Completion status unknown|14|||
160795294|NCT00806585|580637964|FG002|Overall Study|Completion status unknown|12|||
160795295|NCT00806585|580637965|FG003|Overall Study|Completion status unknown|4|||
160795296|NCT00806585|580637966|FG004|Overall Study|Completion status unknown|12|||
160795297|NCT02507934|580637968|FG000|Overall Study|Lost to Follow-up|2|||
160795298|NCT02507934|580637969|FG001|Overall Study|Lost to Follow-up|0|||
160795299|NCT02507934|580637968|FG000|Overall Study|Withdrawal by Subject|2|||
160795300|NCT02507934|580637969|FG001|Overall Study|Withdrawal by Subject|0|||
160795301|NCT03766399|580637971|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795302|NCT03766399|580637972|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795303|NCT03766399|580637973|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795304|NCT03766399|580637974|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795305|NCT03766399|580637975|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795306|NCT03766399|580637976|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795307|NCT03766399|580637977|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795308|NCT03766399|580637978|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795309|NCT03766399|580637979|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795310|NCT03766399|580637980|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795311|NCT03766399|580637981|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795312|NCT03766399|580637982|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795313|NCT03766399|580637983|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795314|NCT03766399|580637984|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
160795315|NCT03766399|580637985|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795316|NCT03766399|580637986|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795317|NCT03766399|580637987|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795318|NCT03766399|580637988|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
160795319|NCT01309230|580637989|FG000|Overall Study|Withdrawal by Subject|0|||
160795320|NCT01309230|580637990|FG001|Overall Study|Withdrawal by Subject|2|||
160795321|NCT01309230|580637989|FG000|Overall Study|Observation arm closed|0|||
160894204|NCT02448810|581008323|FG006|Overall Study|Adverse Event|0|||
160894205|NCT02448810|581008324|FG007|Overall Study|Adverse Event|0|||
160894206|NCT02448810|581008317|FG000|Overall Study|Withdrawal by Subject|0|||
160894207|NCT02448810|581008318|FG001|Overall Study|Withdrawal by Subject|0|||
160894208|NCT02448810|581008319|FG002|Overall Study|Withdrawal by Subject|1|||
160894209|NCT02448810|581008320|FG003|Overall Study|Withdrawal by Subject|0|||
161129307|NCT04317690|581860787|FG000|Overall Study|did not have complete information for primary outcome|0|||
161129308|NCT04317690|581860788|FG001|Overall Study|did not have complete information for primary outcome|4|||
161129309|NCT04317690|581860789|FG002|Overall Study|did not have complete information for primary outcome|0|||
161129310|NCT04317690|581860790|FG003|Overall Study|did not have complete information for primary outcome|2|||
161129311|NCT04317690|581860791|FG004|Overall Study|did not have complete information for primary outcome|0|||
161129312|NCT02318095|581860792|FG000|Overall Study|Adverse Event|1|||
161129313|NCT01717638|581860793|FG000|Overall Study|Lost to Follow-up|0|||
161129314|NCT01717638|581860794|FG001|Overall Study|Lost to Follow-up|0|||
161129315|NCT01717638|581860795|FG002|Overall Study|Lost to Follow-up|0|||
160795322|NCT01309230|580637990|FG001|Overall Study|Observation arm closed|2|||
160795323|NCT01767987|580637991|FG000|Overall Study|Physician Decision|4|||
160795324|NCT01767987|580637992|FG001|Overall Study|Physician Decision|1|||
160795325|NCT01153516|580637993|FG000|Overall Study|Both subjects refused surgery|2|||
160795326|NCT01153516|580637994|FG001|Overall Study|Both subjects refused surgery|0|||
160894210|NCT02448810|581008321|FG004|Overall Study|Withdrawal by Subject|3|||
160983260|NCT00065468|581327020|FG002|Overall Study|Lost to Follow-up|2|||
160795327|NCT01605097|580638002|FG000|Overall Study|Protocol Violation|1|||
160894211|NCT02448810|581008322|FG005|Overall Study|Withdrawal by Subject|5|||
160983261|NCT00065468|581327018|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
160795328|NCT03261505|580638018|FG000|Overall Study|Withdrawal by Subject|2|||
160795329|NCT03261505|580638019|FG001|Overall Study|Withdrawal by Subject|3|||
160795330|NCT03261505|580638020|FG002|Overall Study|Withdrawal by Subject|4|||
160795331|NCT03261505|580638021|FG003|Overall Study|Withdrawal by Subject|3|||
160795332|NCT03261505|580638018|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
160795333|NCT03261505|580638019|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
160795334|NCT03261505|580638020|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
160795335|NCT03261505|580638021|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
160795336|NCT03261505|580638018|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
160795337|NCT03261505|580638019|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
160795338|NCT03261505|580638020|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
160795339|NCT03261505|580638021|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
160795340|NCT03261505|580638018|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
160795341|NCT03261505|580638019|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
160795342|NCT03261505|580638020|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
160795343|NCT03261505|580638021|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
160795344|NCT00663260|580638022|FG000|Overall Study|Lack of Efficacy|2|||
160795345|NCT00663260|580638023|FG001|Overall Study|Lack of Efficacy|0|||
160795346|NCT00663260|580638024|FG002|Overall Study|Lack of Efficacy|0|||
160795347|NCT00663260|580638022|FG000|Overall Study|Adverse Event|12|||
160795348|NCT00663260|580638023|FG001|Overall Study|Adverse Event|7|||
160795349|NCT00663260|580638024|FG002|Overall Study|Adverse Event|6|||
160795350|NCT00663260|580638022|FG000|Overall Study|Withdrawal by Subject|3|||
160795351|NCT00663260|580638023|FG001|Overall Study|Withdrawal by Subject|1|||
160795352|NCT00663260|580638024|FG002|Overall Study|Withdrawal by Subject|6|||
160795353|NCT00663260|580638022|FG000|Overall Study|Death|1|||
160795354|NCT00663260|580638023|FG001|Overall Study|Death|0|||
160795355|NCT00663260|580638024|FG002|Overall Study|Death|1|||
160795356|NCT00663260|580638022|FG000|Overall Study|Lost to Follow-up|0|||
160795357|NCT00663260|580638023|FG001|Overall Study|Lost to Follow-up|1|||
160795358|NCT00663260|580638024|FG002|Overall Study|Lost to Follow-up|0|||
160795359|NCT00663260|580638022|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
160795360|NCT00663260|580638023|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
160795361|NCT00663260|580638024|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
160795362|NCT01506726|580638025|FG000|Overall Study|Adverse Event|1|||
160894212|NCT02448810|581008323|FG006|Overall Study|Withdrawal by Subject|0|||
160894213|NCT02448810|581008324|FG007|Overall Study|Withdrawal by Subject|2|||
160894214|NCT02448810|581008317|FG000|Overall Study|Other (study terminated by sponsor)|0|||
160894215|NCT02448810|581008318|FG001|Overall Study|Other (study terminated by sponsor)|0|||
160894216|NCT02448810|581008319|FG002|Overall Study|Other (study terminated by sponsor)|0|||
160894217|NCT02448810|581008320|FG003|Overall Study|Other (study terminated by sponsor)|0|||
160894218|NCT02448810|581008321|FG004|Overall Study|Other (study terminated by sponsor)|4|||
160894219|NCT02448810|581008322|FG005|Overall Study|Other (study terminated by sponsor)|2|||
160894220|NCT02448810|581008323|FG006|Overall Study|Other (study terminated by sponsor)|2|||
160894221|NCT02448810|581008324|FG007|Overall Study|Other (study terminated by sponsor)|1|||
160894222|NCT02448810|581008317|FG000|Overall Study|Death|1|||
160894223|NCT02448810|581008318|FG001|Overall Study|Death|0|||
160894224|NCT02448810|581008319|FG002|Overall Study|Death|1|||
160894225|NCT02448810|581008320|FG003|Overall Study|Death|0|||
160894226|NCT02448810|581008321|FG004|Overall Study|Death|1|||
160894227|NCT02448810|581008322|FG005|Overall Study|Death|0|||
160894228|NCT02448810|581008323|FG006|Overall Study|Death|0|||
160894229|NCT02448810|581008324|FG007|Overall Study|Death|0|||
160894230|NCT02448810|581008317|FG000|Overall Study|Other (Progressive disease)|2|||
160894231|NCT02448810|581008318|FG001|Overall Study|Other (Progressive disease)|2|||
160894232|NCT02448810|581008319|FG002|Overall Study|Other (Progressive disease)|0|||
160894233|NCT02448810|581008320|FG003|Overall Study|Other (Progressive disease)|3|||
161235903|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235904|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160894234|NCT02448810|581008321|FG004|Overall Study|Other (Progressive disease)|23|||
160894235|NCT02448810|581008322|FG005|Overall Study|Other (Progressive disease)|9|||
160795363|NCT01506726|580638026|FG001|Overall Study|Adverse Event|2|||
160894236|NCT02448810|581008323|FG006|Overall Study|Other (Progressive disease)|14|||
160894237|NCT02448810|581008324|FG007|Overall Study|Other (Progressive disease)|5|||
160894238|NCT02448810|581008317|FG000|Overall Study|Lost to Follow-up|0|||
160894239|NCT02448810|581008318|FG001|Overall Study|Lost to Follow-up|1|||
160894240|NCT02448810|581008319|FG002|Overall Study|Lost to Follow-up|0|||
160894241|NCT02448810|581008320|FG003|Overall Study|Lost to Follow-up|0|||
160894242|NCT02448810|581008321|FG004|Overall Study|Lost to Follow-up|0|||
160894243|NCT02448810|581008322|FG005|Overall Study|Lost to Follow-up|0|||
160894244|NCT02448810|581008323|FG006|Overall Study|Lost to Follow-up|0|||
160894245|NCT02448810|581008324|FG007|Overall Study|Lost to Follow-up|0|||
160983262|NCT00065468|581327019|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
160983263|NCT00065468|581327020|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
160983264|NCT00065468|581327018|FG000|Overall Study|Disease progression|0|||
160983265|NCT00065468|581327019|FG001|Overall Study|Disease progression|0|||
160983266|NCT00065468|581327020|FG002|Overall Study|Disease progression|1|||
160983267|NCT00065468|581327018|FG000|Overall Study|Other|14|||
160983268|NCT00065468|581327019|FG001|Overall Study|Other|24|||
160983269|NCT00065468|581327020|FG002|Overall Study|Other|18|||
160983270|NCT04496167|581327021|FG000|Overall Study|Adverse Event|6|||
160983271|NCT04496167|581327022|FG001|Overall Study|Adverse Event|2|||
160983272|NCT04496167|581327021|FG000|Overall Study|Withdrawal by Subject|7|||
160983273|NCT04496167|581327022|FG001|Overall Study|Withdrawal by Subject|6|||
160983274|NCT04496167|581327021|FG000|Overall Study|Lost to Follow-up|3|||
160983275|NCT04496167|581327022|FG001|Overall Study|Lost to Follow-up|5|||
160983276|NCT04496167|581327021|FG000|Overall Study|Not Treated|1|||
160983277|NCT04496167|581327022|FG001|Overall Study|Not Treated|2|||
160983278|NCT04496167|581327021|FG000|Overall Study|Other Than Specified|1|||
160983279|NCT04496167|581327022|FG001|Overall Study|Other Than Specified|1|||
160983280|NCT00598481|581327023|FG000|Treatment|Physician Decision|1|||
160983281|NCT02500316|581327024|FG000|Overall Study|Adverse Event|3|||
160983282|NCT02500316|581327024|FG000|Overall Study|Lost to Follow-up|2|||
160983283|NCT02500316|581327024|FG000|Overall Study|Protocol Violation|1|||
160983284|NCT02500316|581327024|FG000|Overall Study|Withdrawal by Subject|15|||
160983285|NCT02500316|581327024|FG000|Overall Study|Final height achieved|5|||
160983286|NCT02500316|581327024|FG000|Overall Study|Due to war activity|1|||
160983287|NCT02040090|581327025|FG000|Overall Study|Adverse Event|2|||
160983288|NCT02040090|581327026|FG001|Overall Study|Adverse Event|0|||
160983289|NCT02040090|581327025|FG000|Overall Study|Physician Decision|1|||
160983290|NCT02040090|581327026|FG001|Overall Study|Physician Decision|0|||
160983291|NCT02040090|581327025|FG000|Overall Study|Withdrawal by Subject|0|||
160983292|NCT02040090|581327026|FG001|Overall Study|Withdrawal by Subject|1|||
160983293|NCT02040090|581327025|FG000|Overall Study|Lost to Follow-up|0|||
160983294|NCT02040090|581327026|FG001|Overall Study|Lost to Follow-up|1|||
160983295|NCT03370276|581327027|FG000|Overall Study|Death|0|||
160983296|NCT03370276|581327028|FG001|Overall Study|Death|2|||
160983297|NCT03370276|581327029|FG002|Overall Study|Death|5|||
160983298|NCT00895843|581327033|FG000|Overall Study|Protocol Violation|12|||
160983299|NCT00895843|581327034|FG001|Overall Study|Protocol Violation|12|||
160983300|NCT04963062|581327035|FG000|Overall Study|withdrew by the study team|4|||
160983301|NCT04963062|581327036|FG001|Overall Study|withdrew by the study team|2|||
160983302|NCT00544544|581327037|FG000|Overall Study|Withdrawal by Subject|1|||
160983303|NCT00544544|581327037|FG000|Overall Study|Adverse Event|1|||
160983304|NCT00544544|581327037|FG000|Overall Study|Lost to Follow-up|1|||
160983305|NCT04145349|581328603|FG000|Overall Study|Withdrawal by Subject|3|||
160983306|NCT04145349|581328604|FG001|Overall Study|Withdrawal by Subject|0|||
160983307|NCT04145349|581328603|FG000|Overall Study|Lost to Follow-up|0|||
160983308|NCT04145349|581328604|FG001|Overall Study|Lost to Follow-up|1|||
160983309|NCT04145349|581328603|FG000|Overall Study|On study treatment (Ongoing)|0|||
160983310|NCT04145349|581328604|FG001|Overall Study|On study treatment (Ongoing)|1|||
160983311|NCT01518257|581328605|FG000|Overall Study|Lost to Follow-up|1|||
160983312|NCT01518257|581328606|FG001|Overall Study|Lost to Follow-up|0|||
160983313|NCT01518257|581328605|FG000|Overall Study|Other Miscellaneous Reason|1|||
160983314|NCT01518257|581328606|FG001|Overall Study|Other Miscellaneous Reason|0|||
160983315|NCT02424344|581328612|FG000|Overall Study|Lack of Efficacy|0|||
160983316|NCT02424344|581328613|FG001|Overall Study|Lack of Efficacy|1|||
160983317|NCT02424344|581328612|FG000|Overall Study|Withdrawal by Subject|2|||
160983318|NCT02424344|581328613|FG001|Overall Study|Withdrawal by Subject|1|||
160983319|NCT02424344|581328612|FG000|Overall Study|Lost to Follow-up|1|||
160983320|NCT02424344|581328613|FG001|Overall Study|Lost to Follow-up|0|||
160983321|NCT02424344|581328612|FG000|Overall Study|Adverse Event|4|||
160983322|NCT02424344|581328613|FG001|Overall Study|Adverse Event|8|||
160983323|NCT04730947|581328614|FG000|Overall Study|Withdrawal by Subject|0|||
160983324|NCT04730947|581328615|FG001|Overall Study|Withdrawal by Subject|1|||
160983325|NCT02123966|581328616|FG000|Overall Study|Intercurrent Illness|1|||
160983326|NCT05257837|581328617|FG000|Overall Study|Excluded (did not find the guns)|4|||
160983327|NCT05257837|581328618|FG001|Overall Study|Excluded (did not find the guns)|2|||
160983328|NCT05257837|581328619|FG002|Overall Study|Excluded (did not find the guns)|4|||
160983329|NCT05257837|581328620|FG003|Overall Study|Excluded (did not find the guns)|0|||
160983330|NCT05675709|581328621|FG000|Overall Study|incomplete outcome data|2|||
160983331|NCT05675709|581328622|FG001|Overall Study|incomplete outcome data|8|||
160983332|NCT05343455|581328623|FG000|Overall Study|Withdrawal by Subject|4|||
161129316|NCT01717638|581860796|FG003|Overall Study|Lost to Follow-up|0|||
160983333|NCT05343455|581328624|FG001|Overall Study|Withdrawal by Subject|9|||
160983334|NCT05343455|581328625|FG002|Overall Study|Withdrawal by Subject|7|||
160983335|NCT05343455|581328623|FG000|Overall Study|Adverse Event|2|||
160983336|NCT05343455|581328624|FG001|Overall Study|Adverse Event|1|||
160983337|NCT05343455|581328625|FG002|Overall Study|Adverse Event|2|||
160983338|NCT05343455|581328623|FG000|Overall Study|Lost to Follow-up|1|||
160983339|NCT05343455|581328624|FG001|Overall Study|Lost to Follow-up|1|||
160795364|NCT02303821|580638027|FG000|Overall Study|Withdrawal by Subject|0|||
160795365|NCT02303821|580638028|FG001|Overall Study|Withdrawal by Subject|0|||
160795366|NCT02303821|580638029|FG002|Overall Study|Withdrawal by Subject|0|||
160795367|NCT02303821|580638030|FG003|Overall Study|Withdrawal by Subject|0|||
160795368|NCT02303821|580638031|FG004|Overall Study|Withdrawal by Subject|0|||
160795369|NCT02303821|580638032|FG005|Overall Study|Withdrawal by Subject|0|||
160795370|NCT02303821|580638033|FG006|Overall Study|Withdrawal by Subject|0|||
160795371|NCT02303821|580638034|FG007|Overall Study|Withdrawal by Subject|2|||
160795372|NCT02303821|580638027|FG000|Overall Study|Death|0|||
160795373|NCT02303821|580638028|FG001|Overall Study|Death|2|||
160795374|NCT02303821|580638029|FG002|Overall Study|Death|0|||
160795375|NCT02303821|580638030|FG003|Overall Study|Death|0|||
160795376|NCT02303821|580638031|FG004|Overall Study|Death|0|||
161330778|NCT01747499|582597258|FG004|Overall Study|Developed AML and death|1|||
161330779|NCT01747499|582597254|FG000|Overall Study|Determined not to be eligible|0|||
161330780|NCT01747499|582597255|FG001|Overall Study|Determined not to be eligible|0|||
161330781|NCT01747499|582597256|FG002|Overall Study|Determined not to be eligible|0|||
161330782|NCT01747499|582597257|FG003|Overall Study|Determined not to be eligible|0|||
161330783|NCT01747499|582597258|FG004|Overall Study|Determined not to be eligible|1|||
161330784|NCT01676701|582597259|FG000|Overall Study|Protocol Violation|1|||
161330785|NCT01676701|582597260|FG001|Overall Study|Protocol Violation|0|||
161330786|NCT01676701|582597259|FG000|Overall Study|Sponsor Decision|3|||
161330787|NCT01676701|582597260|FG001|Overall Study|Sponsor Decision|4|||
161330788|NCT00196105|582597261|FG000|Overall Study|Lost to Follow-up|4|||
161330789|NCT00196105|582597262|FG001|Overall Study|Lost to Follow-up|5|||
161330790|NCT00196105|582597263|FG002|Overall Study|Lost to Follow-up|7|||
161330791|NCT02227784|582597267|FG000|Double-Blind Phase|Adverse Event|3|||
161330792|NCT02227784|582597268|FG001|Double-Blind Phase|Adverse Event|2|||
161330793|NCT02227784|582597269|FG002|Double-Blind Phase|Adverse Event|1|||
160894246|NCT02448810|581008317|FG000|Overall Study|Other (unspecified)|0|||
160894247|NCT02448810|581008318|FG001|Overall Study|Other (unspecified)|0|||
160894248|NCT02448810|581008319|FG002|Overall Study|Other (unspecified)|0|||
160894249|NCT02448810|581008320|FG003|Overall Study|Other (unspecified)|0|||
160894250|NCT02448810|581008321|FG004|Overall Study|Other (unspecified)|0|||
160894251|NCT02448810|581008322|FG005|Overall Study|Other (unspecified)|0|||
160894252|NCT02448810|581008323|FG006|Overall Study|Other (unspecified)|2|||
160894253|NCT02448810|581008324|FG007|Overall Study|Other (unspecified)|0|||
160894254|NCT04795622|581008327|FG000|Overall Study|Adverse Event|1|||
160894255|NCT04795622|581008328|FG001|Overall Study|Adverse Event|0|||
160894256|NCT04795622|581008327|FG000|Overall Study|Withdrawal by Subject|3|||
160894257|NCT04795622|581008328|FG001|Overall Study|Withdrawal by Subject|3|||
160894258|NCT04795622|581008327|FG000|Overall Study|Protocol Violation|0|||
160894259|NCT04795622|581008328|FG001|Overall Study|Protocol Violation|2|||
160894260|NCT04795622|581008327|FG000|Overall Study|Lost to Follow-up|2|||
160894261|NCT04795622|581008328|FG001|Overall Study|Lost to Follow-up|3|||
160894262|NCT04795622|581008327|FG000|Overall Study|Other|7|||
160894263|NCT04795622|581008328|FG001|Overall Study|Other|8|||
160894264|NCT02314143|581008329|FG000|Overall Study|Adverse Event|0|||
160894265|NCT02314143|581008330|FG001|Overall Study|Adverse Event|6|||
160894266|NCT02314143|581008331|FG002|Overall Study|Adverse Event|4|||
160894267|NCT02314143|581008329|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
160894268|NCT02314143|581008330|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
160894269|NCT02314143|581008331|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
160894270|NCT02314143|581008329|FG000|Overall Study|Physician Decision|2|||
160894271|NCT02314143|581008330|FG001|Overall Study|Physician Decision|1|||
160894272|NCT02314143|581008331|FG002|Overall Study|Physician Decision|0|||
160894273|NCT02314143|581008329|FG000|Overall Study|Withdrawal by Subject|1|||
160894274|NCT02314143|581008330|FG001|Overall Study|Withdrawal by Subject|0|||
160894275|NCT02314143|581008331|FG002|Overall Study|Withdrawal by Subject|1|||
160894276|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
160894277|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
160894278|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
160894279|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
160894280|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
160894281|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
161129317|NCT01717638|581860797|FG004|Overall Study|Lost to Follow-up|0|||
161129318|NCT01717638|581860798|FG005|Overall Study|Lost to Follow-up|1|||
161129319|NCT01717638|581860799|FG006|Overall Study|Lost to Follow-up|0|||
161330794|NCT02227784|582597270|FG003|Double-Blind Phase|Adverse Event|3|||
161129320|NCT01717638|581860800|FG007|Overall Study|Lost to Follow-up|0|||
161330795|NCT02227784|582597271|FG004|Double-Blind Phase|Adverse Event|0|||
160795377|NCT02303821|580638032|FG005|Overall Study|Death|3|||
160894282|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
161129321|NCT01717638|581860801|FG008|Overall Study|Lost to Follow-up|0|||
160894283|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894284|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
160894285|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
161330796|NCT02227784|582597267|FG000|Double-Blind Phase|Physician Decision|1|||
160795378|NCT02303821|580638033|FG006|Overall Study|Death|41|||
160795379|NCT02303821|580638034|FG007|Overall Study|Death|29|||
160795380|NCT02303821|580638027|FG000|Overall Study|Lost to Follow-up|0|||
160795381|NCT02303821|580638028|FG001|Overall Study|Lost to Follow-up|0|||
160795382|NCT02303821|580638029|FG002|Overall Study|Lost to Follow-up|0|||
160795383|NCT02303821|580638030|FG003|Overall Study|Lost to Follow-up|0|||
160795384|NCT02303821|580638031|FG004|Overall Study|Lost to Follow-up|0|||
160795385|NCT02303821|580638032|FG005|Overall Study|Lost to Follow-up|0|||
160795386|NCT02303821|580638033|FG006|Overall Study|Lost to Follow-up|1|||
160795387|NCT02303821|580638034|FG007|Overall Study|Lost to Follow-up|0|||
160795388|NCT02303821|580638027|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795389|NCT02303821|580638028|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795390|NCT02303821|580638029|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795391|NCT02303821|580638030|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795392|NCT02303821|580638031|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795393|NCT02303821|580638032|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795394|NCT02303821|580638033|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
160795395|NCT02303821|580638034|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
160795396|NCT02303821|580638027|FG000|Overall Study|Decision by sponsor|0|||
160795397|NCT02303821|580638028|FG001|Overall Study|Decision by sponsor|0|||
160795398|NCT02303821|580638029|FG002|Overall Study|Decision by sponsor|0|||
160795399|NCT02303821|580638030|FG003|Overall Study|Decision by sponsor|0|||
160795400|NCT02303821|580638031|FG004|Overall Study|Decision by sponsor|0|||
160795401|NCT02303821|580638032|FG005|Overall Study|Decision by sponsor|1|||
160795402|NCT02303821|580638033|FG006|Overall Study|Decision by sponsor|0|||
160795403|NCT02303821|580638034|FG007|Overall Study|Decision by sponsor|0|||
160795404|NCT02303821|580638027|FG000|Overall Study|Protocol-specified criteria|0|||
160795405|NCT02303821|580638028|FG001|Overall Study|Protocol-specified criteria|1|||
160795406|NCT02303821|580638029|FG002|Overall Study|Protocol-specified criteria|0|||
160795407|NCT02303821|580638030|FG003|Overall Study|Protocol-specified criteria|0|||
160795408|NCT02303821|580638031|FG004|Overall Study|Protocol-specified criteria|0|||
160795409|NCT02303821|580638032|FG005|Overall Study|Protocol-specified criteria|1|||
160795410|NCT02303821|580638033|FG006|Overall Study|Protocol-specified criteria|0|||
160795411|NCT02303821|580638034|FG007|Overall Study|Protocol-specified criteria|0|||
160795412|NCT04562090|580638035|FG000|Overall Study|Withdrawal by Subject|3|||
160795413|NCT04562090|580638036|FG001|Overall Study|Withdrawal by Subject|4|||
160795414|NCT04562090|580638035|FG000|Overall Study|Protocol Violation|2|||
160795415|NCT04562090|580638036|FG001|Overall Study|Protocol Violation|0|||
160795416|NCT04562090|580638035|FG000|Overall Study|Lack of Efficacy|0|||
160795417|NCT04562090|580638036|FG001|Overall Study|Lack of Efficacy|1|||
160795418|NCT04562090|580638035|FG000|Overall Study|Adverse Event|1|||
160795419|NCT04562090|580638036|FG001|Overall Study|Adverse Event|4|||
160795420|NCT04562090|580638035|FG000|Overall Study|Miscellaneous|0|||
160795421|NCT04562090|580638036|FG001|Overall Study|Miscellaneous|3|||
160795422|NCT00847730|580638037|FG000|Overall Study|Multiple interruptions in therapy|8|||
161235905|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
161235906|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
161235907|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
161235908|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235909|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235910|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235911|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
160795423|NCT00210132|580638038|FG000|Overall Study|Protocol Violation|1|||
160795424|NCT00210132|580638039|FG001|Overall Study|Protocol Violation|4|||
160795425|NCT02711202|580638042|FG000|Overall Study|Adverse Event|3|||
160795426|NCT02711202|580638043|FG001|Overall Study|Adverse Event|0|||
160795427|NCT02711202|580638042|FG000|Overall Study|graft loss|1|||
161235912|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
161235913|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235914|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235915|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235916|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235917|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235918|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235919|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235920|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235921|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235922|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
160795428|NCT02711202|580638043|FG001|Overall Study|graft loss|0|||
160795429|NCT00432965|580638044|FG000|Overall Study|Lost to Follow-up|22|||
160795430|NCT00432965|580638045|FG001|Overall Study|Lost to Follow-up|19|||
160795431|NCT00432965|580638044|FG000|Overall Study|Withdrawal by Subject|13|||
160795432|NCT00432965|580638045|FG001|Overall Study|Withdrawal by Subject|13|||
160795433|NCT00432965|580638044|FG000|Overall Study|Physician Decision|14|||
160795434|NCT00432965|580638045|FG001|Overall Study|Physician Decision|13|||
160795435|NCT00432965|580638044|FG000|Overall Study|Lack of Efficacy|8|||
160795436|NCT00432965|580638045|FG001|Overall Study|Lack of Efficacy|13|||
160795437|NCT00432965|580638044|FG000|Overall Study|Non-compliance|7|||
160795438|NCT00432965|580638045|FG001|Overall Study|Non-compliance|0|||
160795439|NCT00432965|580638044|FG000|Overall Study|Adverse Event|22|||
160795440|NCT00432965|580638045|FG001|Overall Study|Adverse Event|19|||
160795441|NCT00432965|580638044|FG000|Overall Study|Death|3|||
160795442|NCT00432965|580638045|FG001|Overall Study|Death|4|||
160795443|NCT00432965|580638044|FG000|Overall Study|Exclusionary Methods|1|||
160795444|NCT00432965|580638045|FG001|Overall Study|Exclusionary Methods|2|||
160795445|NCT00432965|580638044|FG000|Overall Study|Incomplete Data|4|||
160795446|NCT00432965|580638045|FG001|Overall Study|Incomplete Data|3|||
160795447|NCT02402647|580638046|FG000|Overall Study|Lost to Follow-up|13|||
160795448|NCT02402647|580638047|FG001|Overall Study|Lost to Follow-up|7|||
160795449|NCT02402647|580638046|FG000|Overall Study|Protocol Violation|1|||
160795450|NCT02402647|580638047|FG001|Overall Study|Protocol Violation|1|||
160795451|NCT02402647|580638046|FG000|Overall Study|scheduled and timed out|2|||
160795452|NCT02402647|580638047|FG001|Overall Study|scheduled and timed out|1|||
160795453|NCT02402647|580638046|FG000|Overall Study|medical illness|2|||
160795454|NCT02402647|580638047|FG001|Overall Study|medical illness|4|||
160795455|NCT02402647|580638046|FG000|Overall Study|Moved|2|||
160795456|NCT02402647|580638047|FG001|Overall Study|Moved|0|||
160795457|NCT02402647|580638046|FG000|Overall Study|loved one illness|1|||
160795458|NCT02402647|580638047|FG001|Overall Study|loved one illness|0|||
160795459|NCT02402647|580638046|FG000|Overall Study|deceased preexisting condition|2|||
160795460|NCT02402647|580638047|FG001|Overall Study|deceased preexisting condition|0|||
160795461|NCT02402647|580638046|FG000|Overall Study|Other|2|||
160795462|NCT02402647|580638047|FG001|Overall Study|Other|1|||
160795463|NCT01903863|580638048|FG000|Overall Study|Physician Decision|2|||
160795464|NCT01903863|580638049|FG001|Overall Study|Physician Decision|0|||
160795465|NCT01722669|580638056|FG000|Overall Study|Withdrawal by Subject|0|||
160795466|NCT01722669|580638057|FG001|Overall Study|Withdrawal by Subject|0|||
160795467|NCT01722669|580638058|FG002|Overall Study|Withdrawal by Subject|0|||
160795468|NCT01722669|580638059|FG003|Overall Study|Withdrawal by Subject|0|||
160795469|NCT01722669|580638060|FG004|Overall Study|Withdrawal by Subject|0|||
160795470|NCT01722669|580638061|FG005|Overall Study|Withdrawal by Subject|2|||
160795471|NCT01344226|580638062|FG000|Overall Study|Protocol Violation|2|||
160795472|NCT01344226|580638062|FG000|Overall Study|Withdrawal by Subject|3|||
160795473|NCT01344226|580638062|FG000|Overall Study|Lack of Efficacy|3|||
160795474|NCT02255656|580638069|FG000|Overall Study|Adverse Event|11|||
160795475|NCT02255656|580638069|FG000|Overall Study|Poor compliance to protocol|3|||
160795476|NCT02255656|580638069|FG000|Overall Study|Lost to Follow-up|30|||
160795477|NCT02255656|580638069|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
160795478|NCT02255656|580638069|FG000|Overall Study|Other|126|||
160795479|NCT03734536|580638070|FG000|Overall Study|Withdrew Consent|1|||
160795480|NCT03734536|580638071|FG001|Overall Study|Withdrew Consent|5|||
160795481|NCT03734536|580638070|FG000|Overall Study|Lost to Follow-up|10|||
160795482|NCT03734536|580638071|FG001|Overall Study|Lost to Follow-up|7|||
160795483|NCT03448393|580638072|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795484|NCT03448393|580638073|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795485|NCT03448393|580638074|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
160894286|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894287|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
160894288|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
160894289|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
160894290|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
160894291|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
160894292|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
160894293|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
160894294|NCT03963401|581008335|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894295|NCT03963401|581008336|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
160795486|NCT03448393|580638075|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795487|NCT03448393|580638076|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795488|NCT03448393|580638077|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795489|NCT03448393|580638078|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795490|NCT03448393|580638079|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
160795491|NCT03448393|580638080|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
160795492|NCT03448393|580638072|FG000|Dose Expansion|Not treated - screen failure|0|||
160795493|NCT03448393|580638073|FG001|Dose Expansion|Not treated - screen failure|0|||
160795494|NCT03448393|580638074|FG002|Dose Expansion|Not treated - screen failure|0|||
160983340|NCT05343455|581328625|FG002|Overall Study|Lost to Follow-up|3|||
161235923|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235924|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235925|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235926|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235927|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
161235928|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
161235929|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235930|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235931|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235932|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235933|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
161235934|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235935|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235936|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235937|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235938|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235939|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235940|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235941|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235942|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235943|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235944|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235945|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235946|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235947|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235948|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
161235949|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
161235950|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235951|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235952|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235953|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235954|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
161235955|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235956|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235957|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235958|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235959|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235960|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235961|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235962|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235963|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235964|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235965|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235966|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235967|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235968|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
161235969|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
160894296|NCT03963401|581008337|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894297|NCT03963401|581008338|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894298|NCT03963401|581008339|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894299|NCT03963401|581008340|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
160894300|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
161235970|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
161235971|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235972|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235973|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
161235974|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160894301|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
160894302|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
160894303|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
160894304|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
160894305|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
160894306|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
160894307|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894308|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
160894309|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894310|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894311|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
160894312|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894313|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894314|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
160894315|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894316|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894317|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
160894318|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
160894319|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894320|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894321|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894322|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894323|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
160894324|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
160894325|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
160894326|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
160894327|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
160894328|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
160894329|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
160894330|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
160894331|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161235975|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
160894332|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
161235976|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235977|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235978|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235979|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235980|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235981|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235982|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235983|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235984|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235985|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235986|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235987|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235988|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235989|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235990|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
161235991|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
161235992|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235993|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235994|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235995|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235996|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
161235997|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161235998|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161235999|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236000|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236001|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236002|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236003|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236004|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236005|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236006|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236007|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236008|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236009|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236010|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236011|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
161236012|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
160795495|NCT03448393|580638075|FG003|Dose Expansion|Not treated - screen failure|0|||
160795496|NCT03448393|580638076|FG004|Dose Expansion|Not treated - screen failure|0|||
160795497|NCT03448393|580638077|FG005|Dose Expansion|Not treated - screen failure|0|||
160795498|NCT03448393|580638078|FG006|Dose Expansion|Not treated - screen failure|0|||
160795499|NCT03448393|580638079|FG007|Dose Expansion|Not treated - screen failure|0|||
160795500|NCT03448393|580638080|FG008|Dose Expansion|Not treated - screen failure|7|||
160795501|NCT03612570|580638084|FG000|Overall Study|Lost to Follow-up|1|||
160795502|NCT05318287|580638089|FG000|Overall Study|Lost to Follow-up|8|||
160795503|NCT05185453|580638090|FG000|Overall Study|Lost to Follow-up|13|||
160795504|NCT05185453|580638091|FG001|Overall Study|Lost to Follow-up|3|||
160795505|NCT01323192|580639573|FG000|Overall Study|Adverse Event|6|||
160795506|NCT01323192|580639574|FG001|Overall Study|Adverse Event|1|||
160795507|NCT01323192|580639573|FG000|Overall Study|Withdrawal by Subject|3|||
160795508|NCT01323192|580639574|FG001|Overall Study|Withdrawal by Subject|1|||
160795509|NCT01323192|580639573|FG000|Overall Study|Noncompliance with study medication|0|||
160795510|NCT01323192|580639574|FG001|Overall Study|Noncompliance with study medication|3|||
160795511|NCT01323192|580639573|FG000|Overall Study|Nonmedical reasons|0|||
160795512|NCT01323192|580639574|FG001|Overall Study|Nonmedical reasons|1|||
160795513|NCT03122184|580639575|FG000|Overall Study|Lost to Follow-up|4|||
160795514|NCT03122184|580639576|FG001|Overall Study|Lost to Follow-up|6|||
160795515|NCT03122184|580639575|FG000|Overall Study|Withdrawal by Subject|3|||
160795516|NCT03122184|580639576|FG001|Overall Study|Withdrawal by Subject|0|||
160795517|NCT03122184|580639575|FG000|Overall Study|Terminated due to cognitive problem|1|||
160795518|NCT03122184|580639576|FG001|Overall Study|Terminated due to cognitive problem|0|||
160795519|NCT00633126|580639577|FG000|Overall Study|Did not receive full dose|1|||
160795520|NCT01276704|580639580|FG000|Overall Study|Lost to Follow-up|2|||
160795521|NCT01276704|580639581|FG001|Overall Study|Lost to Follow-up|3|||
160795522|NCT01276704|580639580|FG000|Overall Study|Non-compliant|2|||
160795523|NCT01276704|580639581|FG001|Overall Study|Non-compliant|2|||
160795524|NCT01276704|580639580|FG000|Overall Study|Withdrawal by Subject|7|||
160795525|NCT01276704|580639581|FG001|Overall Study|Withdrawal by Subject|1|||
160795526|NCT01276704|580639580|FG000|Overall Study|Physician Decision|3|||
160795527|NCT01276704|580639581|FG001|Overall Study|Physician Decision|5|||
160795528|NCT01168596|580639582|FG000|Overall Study|Withdrawal by Subject|3|||
160795529|NCT01168596|580639583|FG001|Overall Study|Withdrawal by Subject|1|||
160795530|NCT02297516|580639584|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
160795531|NCT02297516|580639585|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
160795532|NCT02297516|580639584|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
160795533|NCT02297516|580639585|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
160795534|NCT02297516|580639584|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
160795535|NCT02297516|580639585|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
160795536|NCT00710593|580639586|FG000|Overall Study|Incarceration|1|||
160795537|NCT00710593|580639587|FG001|Overall Study|Incarceration|0|||
160795538|NCT00710593|580639586|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
160795539|NCT00710593|580639587|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
160795540|NCT00710593|580639586|FG000|Overall Study|Lost to Follow-up|3|||
160795541|NCT00710593|580639587|FG001|Overall Study|Lost to Follow-up|1|||
160795542|NCT00710593|580639586|FG000|Overall Study|Moved out of area|1|||
161129322|NCT01717638|581860802|FG009|Overall Study|Lost to Follow-up|0|||
161129323|NCT01717638|581860803|FG010|Overall Study|Lost to Follow-up|0|||
161129324|NCT01717638|581860804|FG011|Overall Study|Lost to Follow-up|0|||
161129325|NCT01717638|581860805|FG012|Overall Study|Lost to Follow-up|0|||
161129326|NCT01717638|581860793|FG000|Overall Study|Father in hospital|0|||
161129327|NCT01717638|581860794|FG001|Overall Study|Father in hospital|0|||
161129328|NCT01717638|581860795|FG002|Overall Study|Father in hospital|0|||
161129329|NCT01717638|581860796|FG003|Overall Study|Father in hospital|0|||
161129330|NCT01717638|581860797|FG004|Overall Study|Father in hospital|0|||
161129331|NCT01717638|581860798|FG005|Overall Study|Father in hospital|0|||
161129332|NCT01717638|581860799|FG006|Overall Study|Father in hospital|0|||
161129333|NCT01717638|581860800|FG007|Overall Study|Father in hospital|0|||
161129334|NCT01717638|581860801|FG008|Overall Study|Father in hospital|0|||
161129335|NCT01717638|581860802|FG009|Overall Study|Father in hospital|0|||
161129336|NCT01717638|581860803|FG010|Overall Study|Father in hospital|0|||
161129337|NCT01717638|581860804|FG011|Overall Study|Father in hospital|0|||
161129338|NCT01717638|581860805|FG012|Overall Study|Father in hospital|1|||
161129339|NCT01717638|581860793|FG000|Overall Study|Withdrawal by Subject|0|||
161129340|NCT01717638|581860794|FG001|Overall Study|Withdrawal by Subject|1|||
161129341|NCT01717638|581860795|FG002|Overall Study|Withdrawal by Subject|1|||
161129342|NCT01717638|581860796|FG003|Overall Study|Withdrawal by Subject|0|||
161129343|NCT01717638|581860797|FG004|Overall Study|Withdrawal by Subject|1|||
161129344|NCT01717638|581860798|FG005|Overall Study|Withdrawal by Subject|0|||
161129345|NCT01717638|581860799|FG006|Overall Study|Withdrawal by Subject|2|||
161129346|NCT01717638|581860800|FG007|Overall Study|Withdrawal by Subject|1|||
161129347|NCT01717638|581860801|FG008|Overall Study|Withdrawal by Subject|2|||
161129348|NCT01717638|581860802|FG009|Overall Study|Withdrawal by Subject|1|||
161129349|NCT01717638|581860803|FG010|Overall Study|Withdrawal by Subject|0|||
161236013|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236014|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236015|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236016|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161236017|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
161330797|NCT02227784|582597268|FG001|Double-Blind Phase|Physician Decision|0|||
161330798|NCT02227784|582597269|FG002|Double-Blind Phase|Physician Decision|0|||
161330799|NCT02227784|582597270|FG003|Double-Blind Phase|Physician Decision|1|||
161330800|NCT02227784|582597271|FG004|Double-Blind Phase|Physician Decision|0|||
161330801|NCT02227784|582597267|FG000|Double-Blind Phase|Protocol Violation|0|||
161330802|NCT02227784|582597268|FG001|Double-Blind Phase|Protocol Violation|0|||
161330803|NCT02227784|582597269|FG002|Double-Blind Phase|Protocol Violation|1|||
161330804|NCT02227784|582597270|FG003|Double-Blind Phase|Protocol Violation|1|||
161330805|NCT02227784|582597271|FG004|Double-Blind Phase|Protocol Violation|0|||
161330806|NCT02227784|582597267|FG000|Double-Blind Phase|Sponsor Decision|34|||
161330807|NCT02227784|582597268|FG001|Double-Blind Phase|Sponsor Decision|15|||
161236018|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236019|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236020|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236021|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161330808|NCT02227784|582597269|FG002|Double-Blind Phase|Sponsor Decision|14|||
161236022|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161330809|NCT02227784|582597270|FG003|Double-Blind Phase|Sponsor Decision|32|||
161330810|NCT02227784|582597271|FG004|Double-Blind Phase|Sponsor Decision|0|||
161330811|NCT02227784|582597267|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
161330812|NCT02227784|582597268|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
161330813|NCT02227784|582597269|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
161330814|NCT02227784|582597270|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
161330815|NCT02227784|582597271|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161330816|NCT02227784|582597267|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161330817|NCT02227784|582597268|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161330818|NCT02227784|582597269|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161330819|NCT02227784|582597270|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
161330820|NCT02227784|582597271|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
161330821|NCT02227784|582597267|FG000|Open-Label Extension Phase (OLE)|Death|0|||
161330822|NCT02227784|582597268|FG001|Open-Label Extension Phase (OLE)|Death|0|||
161330823|NCT02227784|582597269|FG002|Open-Label Extension Phase (OLE)|Death|0|||
161330824|NCT02227784|582597270|FG003|Open-Label Extension Phase (OLE)|Death|0|||
161330825|NCT02227784|582597271|FG004|Open-Label Extension Phase (OLE)|Death|1|||
161330826|NCT02227784|582597267|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161330827|NCT02227784|582597268|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161330828|NCT02227784|582597269|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161330829|NCT02227784|582597270|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
161330830|NCT02227784|582597271|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
161330831|NCT02227784|582597267|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161330832|NCT02227784|582597268|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161330833|NCT02227784|582597269|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161330834|NCT02227784|582597270|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
161330835|NCT02227784|582597271|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
161330836|NCT04058028|582597272|FG000|Overall Study|Withdrawal of Consent from Study|12|||
161330837|NCT04058028|582597273|FG001|Overall Study|Withdrawal of Consent from Study|8|||
161330838|NCT04058028|582597274|FG002|Overall Study|Withdrawal of Consent from Study|6|||
161330839|NCT04058028|582597275|FG003|Overall Study|Withdrawal of Consent from Study|7|||
161330840|NCT04058028|582597272|FG000|Overall Study|Decision by Sponsor|13|||
161330841|NCT04058028|582597273|FG001|Overall Study|Decision by Sponsor|4|||
161330842|NCT04058028|582597274|FG002|Overall Study|Decision by Sponsor|1|||
161330843|NCT04058028|582597275|FG003|Overall Study|Decision by Sponsor|35|||
161330844|NCT04058028|582597272|FG000|Overall Study|Lost to Follow-up|1|||
161330845|NCT04058028|582597273|FG001|Overall Study|Lost to Follow-up|1|||
161330846|NCT04058028|582597274|FG002|Overall Study|Lost to Follow-up|1|||
161330847|NCT04058028|582597275|FG003|Overall Study|Lost to Follow-up|0|||
161330848|NCT04058028|582597272|FG000|Overall Study|Death|0|||
161330849|NCT04058028|582597273|FG001|Overall Study|Death|1|||
161330850|NCT04058028|582597274|FG002|Overall Study|Death|0|||
161330851|NCT04058028|582597275|FG003|Overall Study|Death|0|||
161330852|NCT00248651|582597276|FG000|Overall Study|Withdrawal by Subject|28|||
161330853|NCT00248651|582597277|FG001|Overall Study|Withdrawal by Subject|40|||
161330854|NCT00248651|582597278|FG002|Overall Study|Withdrawal by Subject|32|||
161330855|NCT00828113|582597281|FG000|Overall Study|Withdrawal by Subject|27|||
161330856|NCT00828113|582597282|FG001|Overall Study|Withdrawal by Subject|26|||
161330857|NCT00828113|582597281|FG000|Overall Study|Lost to Follow-up|3|||
161330858|NCT00828113|582597282|FG001|Overall Study|Lost to Follow-up|5|||
161330859|NCT01365130|582597283|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
161236023|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236024|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236025|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236026|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236027|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160983341|NCT05343455|581328623|FG000|Overall Study|Pregnancy|1|||
160983342|NCT05343455|581328624|FG001|Overall Study|Pregnancy|0|||
160983343|NCT05343455|581328625|FG002|Overall Study|Pregnancy|0|||
160983344|NCT05343455|581328623|FG000|Overall Study|Physician Decision|0|||
160983345|NCT05343455|581328624|FG001|Overall Study|Physician Decision|0|||
160983346|NCT05343455|581328625|FG002|Overall Study|Physician Decision|1|||
160983347|NCT05343455|581328623|FG000|Overall Study|Protocol Violation|0|||
160983348|NCT05343455|581328624|FG001|Overall Study|Protocol Violation|1|||
160983349|NCT05343455|581328625|FG002|Overall Study|Protocol Violation|1|||
160983350|NCT01310868|581328626|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
160983351|NCT01708187|581328629|FG000|Overall Study|Lost to Follow-up|0|||
160983352|NCT01708187|581328630|FG001|Overall Study|Lost to Follow-up|1|||
160983353|NCT02408549|581328632|FG000|Overall Study|Adverse Event|15|||
160983354|NCT02408549|581328632|FG000|Overall Study|Death|4|||
160983355|NCT02408549|581328632|FG000|Overall Study|Lack of Efficacy|17|||
160983356|NCT02408549|581328632|FG000|Overall Study|Protocol Violation|4|||
160983357|NCT02408549|581328632|FG000|Overall Study|Lost to Follow-up|6|||
160983358|NCT02408549|581328632|FG000|Overall Study|Consent withdrawn|30|||
160983359|NCT02408549|581328632|FG000|Overall Study|Neurology research program closing at site|1|||
160983360|NCT02408549|581328632|FG000|Overall Study|Site closure|1|||
161236028|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236029|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236030|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160983361|NCT02408549|581328632|FG000|Overall Study|Pregnancy|1|||
160983362|NCT02408549|581328632|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
160983363|NCT02408549|581328632|FG000|Overall Study|Subject moved to another place, far from site|1|||
160983364|NCT02408549|581328632|FG000|Overall Study|Study terminated at site|1|||
160983365|NCT00231894|581328633|FG000|Overall Study|Withdrawal by Subject|1|||
160983366|NCT00231894|581328634|FG001|Overall Study|Withdrawal by Subject|1|||
160983367|NCT02025205|581328635|FG000|Overall Study|Withdrawal by Subject|1|||
160983368|NCT02025205|581328636|FG001|Overall Study|Withdrawal by Subject|1|||
160983369|NCT02025205|581328635|FG000|Overall Study|Protocol Violation|2|||
160983370|NCT02025205|581328636|FG001|Overall Study|Protocol Violation|1|||
160983371|NCT02025205|581328635|FG000|Overall Study|Death|0|||
160983372|NCT02025205|581328636|FG001|Overall Study|Death|1|||
160983373|NCT01232556|581328639|FG000|Overall Study|Withdrawal by Subject|21|||
160983374|NCT01232556|581328640|FG001|Overall Study|Withdrawal by Subject|17|||
160983375|NCT01232556|581328639|FG000|Overall Study|Death|97|||
160983376|NCT01232556|581328640|FG001|Overall Study|Death|97|||
160983377|NCT01232556|581328639|FG000|Overall Study|Lost to Follow-up|0|||
160983378|NCT01232556|581328640|FG001|Overall Study|Lost to Follow-up|2|||
160983379|NCT01232556|581328639|FG000|Overall Study|Terminated by Sponsor|35|||
160983380|NCT01232556|581328640|FG001|Overall Study|Terminated by Sponsor|51|||
160983381|NCT01232556|581328639|FG000|Overall Study|Other|6|||
160983382|NCT01232556|581328640|FG001|Overall Study|Other|4|||
160983383|NCT04707391|581328641|FG000|Overall Study|Adverse Event|5|||
160983384|NCT04707391|581328642|FG001|Overall Study|Adverse Event|8|||
160983385|NCT04707391|581328641|FG000|Overall Study|Lost to Follow-up|44|||
160983386|NCT04707391|581328642|FG001|Overall Study|Lost to Follow-up|31|||
160983387|NCT04707391|581328641|FG000|Overall Study|Protocol Violation|1|||
160983388|NCT04707391|581328642|FG001|Overall Study|Protocol Violation|5|||
161236031|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236032|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
161236033|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
161236034|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236035|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
160795543|NCT00710593|580639587|FG001|Overall Study|Moved out of area|0|||
160983389|NCT04707391|581328641|FG000|Overall Study|Withdrawal by Subject|27|||
160795544|NCT00710593|580639586|FG000|Overall Study|Failure to adhere or complete study eval|1|||
160983390|NCT04707391|581328642|FG001|Overall Study|Withdrawal by Subject|25|||
160983391|NCT04707391|581328641|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
160983392|NCT04707391|581328642|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
160983393|NCT04707391|581328641|FG000|Overall Study|Other|0|||
160983394|NCT04707391|581328642|FG001|Overall Study|Other|2|||
160983395|NCT03785340|581328643|FG000|Overall Study|Lost to Follow-up|2|||
160983396|NCT03785340|581328644|FG001|Overall Study|Lost to Follow-up|0|||
160983397|NCT03785340|581328643|FG000|Overall Study|Adverse Event|1|||
160983398|NCT03785340|581328644|FG001|Overall Study|Adverse Event|0|||
160983399|NCT01848834|581328645|FG000|Overall Study|Adverse Event|3|||
160983400|NCT01848834|581328646|FG001|Overall Study|Adverse Event|11|||
160983401|NCT01848834|581328647|FG002|Overall Study|Adverse Event|3|||
160983402|NCT01848834|581328648|FG003|Overall Study|Adverse Event|5|||
160983403|NCT01848834|581328649|FG004|Overall Study|Adverse Event|9|||
160983404|NCT01848834|581328645|FG000|Overall Study|Death|2|||
160983405|NCT01848834|581328646|FG001|Overall Study|Death|11|||
160983406|NCT01848834|581328647|FG002|Overall Study|Death|1|||
160983407|NCT01848834|581328648|FG003|Overall Study|Death|8|||
160983408|NCT01848834|581328649|FG004|Overall Study|Death|27|||
160983409|NCT01848834|581328645|FG000|Overall Study|Excluded Medication|5|||
160983410|NCT01848834|581328646|FG001|Overall Study|Excluded Medication|4|||
160983411|NCT01848834|581328647|FG002|Overall Study|Excluded Medication|3|||
160983412|NCT01848834|581328648|FG003|Overall Study|Excluded Medication|6|||
160983413|NCT01848834|581328649|FG004|Overall Study|Excluded Medication|6|||
160983414|NCT01848834|581328645|FG000|Overall Study|Lost to Follow-up|5|||
160983415|NCT01848834|581328646|FG001|Overall Study|Lost to Follow-up|5|||
160983416|NCT01848834|581328647|FG002|Overall Study|Lost to Follow-up|3|||
160983417|NCT01848834|581328648|FG003|Overall Study|Lost to Follow-up|0|||
160983418|NCT01848834|581328649|FG004|Overall Study|Lost to Follow-up|3|||
160983419|NCT01848834|581328645|FG000|Overall Study|Physician Decision|1|||
160983420|NCT01848834|581328646|FG001|Overall Study|Physician Decision|3|||
160983421|NCT01848834|581328647|FG002|Overall Study|Physician Decision|4|||
160983422|NCT01848834|581328648|FG003|Overall Study|Physician Decision|0|||
160983423|NCT01848834|581328649|FG004|Overall Study|Physician Decision|11|||
160983424|NCT01848834|581328645|FG000|Overall Study|Protocol Violation|0|||
160983425|NCT01848834|581328646|FG001|Overall Study|Protocol Violation|0|||
160983426|NCT01848834|581328647|FG002|Overall Study|Protocol Violation|0|||
160983427|NCT01848834|581328648|FG003|Overall Study|Protocol Violation|0|||
160983428|NCT01848834|581328649|FG004|Overall Study|Protocol Violation|1|||
160983429|NCT01848834|581328645|FG000|Overall Study|Sponsor Decision|1|||
160983430|NCT01848834|581328646|FG001|Overall Study|Sponsor Decision|1|||
160983431|NCT01848834|581328647|FG002|Overall Study|Sponsor Decision|0|||
160983432|NCT01848834|581328648|FG003|Overall Study|Sponsor Decision|1|||
160983433|NCT01848834|581328649|FG004|Overall Study|Sponsor Decision|1|||
160983434|NCT01848834|581328645|FG000|Overall Study|Withdrawal by Subject|2|||
160983435|NCT01848834|581328646|FG001|Overall Study|Withdrawal by Subject|13|||
160983436|NCT01848834|581328647|FG002|Overall Study|Withdrawal by Subject|10|||
160983437|NCT01848834|581328648|FG003|Overall Study|Withdrawal by Subject|6|||
160983438|NCT01848834|581328649|FG004|Overall Study|Withdrawal by Subject|36|||
160983439|NCT02584855|581328654|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
160983440|NCT02584855|581328655|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
160983441|NCT02584855|581328656|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
160983442|NCT02584855|581328657|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
160983443|NCT02584855|581328658|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
160983444|NCT02584855|581328659|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
160983445|NCT02584855|581328654|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
160983446|NCT02584855|581328655|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983447|NCT02584855|581328656|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983448|NCT02584855|581328657|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983449|NCT02584855|581328658|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983450|NCT02584855|581328659|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
160983451|NCT02584855|581328654|FG000|Open-Label Treatment Period|Adverse Event|14|||
160983452|NCT02584855|581328655|FG001|Open-Label Treatment Period|Adverse Event|0|||
160983453|NCT02584855|581328656|FG002|Open-Label Treatment Period|Adverse Event|0|||
160983454|NCT02584855|581328657|FG003|Open-Label Treatment Period|Adverse Event|0|||
160983455|NCT02584855|581328658|FG004|Open-Label Treatment Period|Adverse Event|0|||
160983456|NCT02584855|581328659|FG005|Open-Label Treatment Period|Adverse Event|0|||
160983457|NCT02584855|581328654|FG000|Open-Label Treatment Period|Death|2|||
160983458|NCT02584855|581328655|FG001|Open-Label Treatment Period|Death|0|||
160983459|NCT02584855|581328656|FG002|Open-Label Treatment Period|Death|0|||
161236036|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236037|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236038|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
161236039|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236040|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236041|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160983460|NCT02584855|581328657|FG003|Open-Label Treatment Period|Death|0|||
160983461|NCT02584855|581328658|FG004|Open-Label Treatment Period|Death|0|||
160983462|NCT02584855|581328659|FG005|Open-Label Treatment Period|Death|0|||
160983463|NCT02584855|581328654|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
161236042|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236043|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160983464|NCT02584855|581328655|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
160983465|NCT02584855|581328656|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
160983466|NCT02584855|581328657|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
160983467|NCT02584855|581328658|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
160983468|NCT02584855|581328659|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
160983469|NCT02584855|581328654|FG000|Open-Label Treatment Period|Protocol Violation|1|||
160795545|NCT00710593|580639587|FG001|Overall Study|Failure to adhere or complete study eval|1|||
160795546|NCT00710593|580639586|FG000|Overall Study|Protocol Violation|1|||
160795547|NCT00710593|580639587|FG001|Overall Study|Protocol Violation|1|||
160795548|NCT00710593|580639586|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
160795549|NCT00710593|580639587|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
160795550|NCT04490278|580639588|FG000|Overall Study|Lost to Follow-up|6|||
160795551|NCT03801525|580639591|FG000|Overall Study|Adverse Event|17|||
160795552|NCT03801525|580639592|FG001|Overall Study|Adverse Event|1|||
160795553|NCT03801525|580639593|FG002|Overall Study|Adverse Event|0|||
160795554|NCT03801525|580639591|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
160795555|NCT03801525|580639592|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
160795556|NCT03801525|580639593|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
160795557|NCT03801525|580639591|FG000|Overall Study|Death|29|||
160795558|NCT03801525|580639592|FG001|Overall Study|Death|1|||
160795559|NCT03801525|580639593|FG002|Overall Study|Death|4|||
160795560|NCT03801525|580639591|FG000|Overall Study|Disease Progression|6|||
160795561|NCT03801525|580639592|FG001|Overall Study|Disease Progression|0|||
160795562|NCT03801525|580639593|FG002|Overall Study|Disease Progression|1|||
160795563|NCT03801525|580639591|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
160795564|NCT03801525|580639592|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
160795565|NCT03801525|580639593|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
160795566|NCT03801525|580639591|FG000|Overall Study|Investigator Decision|18|||
160795567|NCT03801525|580639592|FG001|Overall Study|Investigator Decision|1|||
160795568|NCT03801525|580639593|FG002|Overall Study|Investigator Decision|0|||
160795569|NCT03801525|580639591|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
160795570|NCT03801525|580639592|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
160795571|NCT03801525|580639593|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
160795572|NCT03801525|580639591|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
160795573|NCT03801525|580639592|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
160795574|NCT03801525|580639593|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
160795575|NCT03801525|580639591|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
160795576|NCT03801525|580639592|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
160795577|NCT03801525|580639593|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
160795578|NCT03801525|580639591|FG000|Overall Study|Withdrawal of Subject Consent|38|||
160795579|NCT03801525|580639592|FG001|Overall Study|Withdrawal of Subject Consent|2|||
160795580|NCT03801525|580639593|FG002|Overall Study|Withdrawal of Subject Consent|1|||
160795581|NCT03801525|580639591|FG000|Overall Study|Reason not Specified|4|||
160795582|NCT03801525|580639592|FG001|Overall Study|Reason not Specified|0|||
160795583|NCT03801525|580639593|FG002|Overall Study|Reason not Specified|4|||
160795584|NCT03309202|580639594|FG000|Overall Study|Lost to Follow-up|1|||
160795585|NCT03309202|580639595|FG001|Overall Study|Lost to Follow-up|0|||
160795586|NCT03309202|580639596|FG002|Overall Study|Lost to Follow-up|0|||
160795587|NCT03309202|580639597|FG003|Overall Study|Lost to Follow-up|0|||
160795588|NCT00573768|580639598|FG000|Overall Study|Adverse Event|1|||
160795589|NCT00573768|580639599|FG001|Overall Study|Adverse Event|1|||
160795590|NCT00573768|580639600|FG002|Overall Study|Adverse Event|2|||
160795591|NCT00573768|580639598|FG000|Overall Study|Protocol Violation|1|||
160795592|NCT00573768|580639599|FG001|Overall Study|Protocol Violation|0|||
160795593|NCT00573768|580639600|FG002|Overall Study|Protocol Violation|1|||
160795594|NCT00573768|580639598|FG000|Overall Study|Withdrawal by Subject|0|||
160795595|NCT00573768|580639599|FG001|Overall Study|Withdrawal by Subject|1|||
160795596|NCT00573768|580639600|FG002|Overall Study|Withdrawal by Subject|0|||
160795597|NCT00573768|580639598|FG000|Overall Study|Lost to Follow-up|0|||
160795598|NCT00573768|580639599|FG001|Overall Study|Lost to Follow-up|0|||
160795599|NCT00573768|580639600|FG002|Overall Study|Lost to Follow-up|1|||
160795600|NCT03847519|580639604|FG000|Overall Study|Death|5|||
160795601|NCT03847519|580639605|FG001|Overall Study|Death|8|||
160795602|NCT03847519|580639606|FG002|Overall Study|Death|1|||
160795603|NCT03847519|580639604|FG000|Overall Study|Lost to Follow-up|1|||
160795604|NCT03847519|580639605|FG001|Overall Study|Lost to Follow-up|2|||
160795605|NCT03847519|580639606|FG002|Overall Study|Lost to Follow-up|0|||
160894333|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160894334|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160894335|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
160894336|NCT03963401|581008335|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
160795606|NCT03847519|580639604|FG000|Overall Study|Study Terminated by Sponsor|0|||
160795607|NCT03847519|580639605|FG001|Overall Study|Study Terminated by Sponsor|3|||
160795608|NCT03847519|580639606|FG002|Overall Study|Study Terminated by Sponsor|2|||
160795609|NCT01500317|580639611|FG000|Overall Study|Withdrawal by Subject|3|||
160795610|NCT01500317|580639612|FG001|Overall Study|Withdrawal by Subject|2|||
160795611|NCT01500317|580639613|FG002|Overall Study|Withdrawal by Subject|0|||
160795612|NCT00976456|580639614|FG000|Overall Study|Adverse Event|17|||
160795613|NCT00976456|580639615|FG001|Overall Study|Adverse Event|22|||
160795614|NCT00976456|580639614|FG000|Overall Study|Death|7|||
160795615|NCT00976456|580639615|FG001|Overall Study|Death|9|||
160795616|NCT00976456|580639614|FG000|Overall Study|Lack of Efficacy|5|||
160894337|NCT03963401|581008336|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
160894338|NCT03963401|581008337|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
160894339|NCT03963401|581008338|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
160894340|NCT03963401|581008339|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
160894341|NCT03963401|581008340|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
160894342|NCT01070043|581008352|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
160894343|NCT01070043|581008353|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
160894344|NCT01070043|581008354|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
160894345|NCT01070043|581008352|FG000|Double-Blind Treatment|Adverse Event|0|||
160894346|NCT01070043|581008353|FG001|Double-Blind Treatment|Adverse Event|0|||
160894347|NCT01070043|581008354|FG002|Double-Blind Treatment|Adverse Event|2|||
160894348|NCT01528215|581008355|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
160894349|NCT01528215|581008356|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
160894350|NCT01528215|581008355|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
160894351|NCT01528215|581008356|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
160894352|NCT01528215|581008355|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
160894353|NCT01528215|581008356|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
160894354|NCT01528215|581008355|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
160894355|NCT01528215|581008356|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
160894356|NCT01610271|581008359|FG000|Overall Study|Surgery not complete|0|||
160983470|NCT02584855|581328655|FG001|Open-Label Treatment Period|Protocol Violation|0|||
160983471|NCT02584855|581328656|FG002|Open-Label Treatment Period|Protocol Violation|0|||
160983472|NCT02584855|581328657|FG003|Open-Label Treatment Period|Protocol Violation|0|||
160795617|NCT00976456|580639615|FG001|Overall Study|Lack of Efficacy|2|||
160795618|NCT00976456|580639614|FG000|Overall Study|Withdrawal by Subject|3|||
160795619|NCT00976456|580639615|FG001|Overall Study|Withdrawal by Subject|1|||
160795620|NCT00976456|580639614|FG000|Overall Study|screening failure, unknown|11|||
160795621|NCT00976456|580639615|FG001|Overall Study|screening failure, unknown|4|||
160795622|NCT00335829|580639616|FG000|Overall Study|Withdrawal by Subject|1|||
160795623|NCT00335829|580639616|FG000|Overall Study|Lost to Follow-up|1|||
160795624|NCT00335829|580639616|FG000|Overall Study|Adverse Event|1|||
160795625|NCT04562116|580639617|FG000|Overall Study|Lost to Follow-up|1|||
160795626|NCT04562116|580639617|FG000|Overall Study|Withdrawal by Subject|3|||
160795627|NCT03331354|580639618|FG000|Overall Study|Withdrawal by Subject|1|||
160795628|NCT03331354|580639619|FG001|Overall Study|Withdrawal by Subject|3|||
160795629|NCT03331354|580639618|FG000|Overall Study|Lost to Follow-up|3|||
160795630|NCT03331354|580639619|FG001|Overall Study|Lost to Follow-up|3|||
160795631|NCT03331354|580639618|FG000|Overall Study|Found employment before initiated active intervention|0|||
160795632|NCT03331354|580639619|FG001|Overall Study|Found employment before initiated active intervention|4|||
160795633|NCT01559935|580639622|FG000|Car Phase|Toxicity|4|||
160795634|NCT01559935|580639622|FG000|Car Phase|Death|1|||
160795635|NCT01559935|580639622|FG000|Car Phase|Lack of Efficacy|2|||
160795636|NCT01559935|580639622|FG000|Car Phase|Lost to Follow-up|1|||
160795637|NCT01559935|580639622|FG000|Car Phase|Physician Decision|1|||
160795638|NCT01559935|580639622|FG000|Car Phase|Withdrawal by Subject|2|||
160795639|NCT01559935|580639622|FG000|Car Phase|Per protocol|1|||
160795640|NCT01559935|580639622|FG000|Car Phase|Insurance|1|||
160795641|NCT01559935|580639622|FG000|Car Phase|non-compliance|1|||
160795642|NCT01559935|580639622|FG000|BiRD Phase|Toxicity|1|||
160795643|NCT01559935|580639622|FG000|BiRD Phase|Lack of Efficacy|1|||
160795644|NCT01559935|580639622|FG000|BiRD Phase|Withdrawal by Subject|2|||
160795645|NCT01559935|580639622|FG000|Maintenance Phase|Remains on study|28|||
160795646|NCT01559935|580639622|FG000|Maintenance Phase|Toxicity|1|||
160795647|NCT01559935|580639622|FG000|Maintenance Phase|Lack of Efficacy|18|||
160795648|NCT01559935|580639622|FG000|Maintenance Phase|Withdrawal by Subject|5|||
160795649|NCT01559935|580639622|FG000|Maintenance Phase|Non-compliance|2|||
160795650|NCT05889468|580639624|FG000|Overall Study|Lost to Follow-up|9|||
160795651|NCT05889468|580639625|FG001|Overall Study|Lost to Follow-up|2|||
160795652|NCT05889468|580639624|FG000|Overall Study|Withdrawal by Subject|2|||
160795653|NCT05889468|580639625|FG001|Overall Study|Withdrawal by Subject|2|||
160894357|NCT01610271|581008360|FG001|Overall Study|Surgery not complete|1|||
160983473|NCT02584855|581328658|FG004|Open-Label Treatment Period|Protocol Violation|0|||
160795654|NCT02284893|580639631|FG000|26 Week (Short Term)|Adverse Event|1|||
160795655|NCT02284893|580639632|FG001|26 Week (Short Term)|Adverse Event|9|||
160795656|NCT02284893|580639631|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
160795657|NCT02284893|580639632|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
160795658|NCT02284893|580639631|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
160795659|NCT02284893|580639632|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
160795660|NCT02284893|580639631|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
160795661|NCT02284893|580639632|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
160795662|NCT02284893|580639631|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
160795663|NCT02284893|580639632|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
161236044|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236045|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236046|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236047|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236048|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160795664|NCT02284893|580639631|FG000|26 Week (Short Term)|Other|1|||
160795665|NCT02284893|580639632|FG001|26 Week (Short Term)|Other|1|||
160795666|NCT02284893|580639631|FG000|52 Week (Long Term)|Adverse Event|3|||
160795667|NCT02284893|580639632|FG001|52 Week (Long Term)|Adverse Event|1|||
160795668|NCT02284893|580639631|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
160795669|NCT02284893|580639632|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
160795670|NCT02284893|580639631|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
160795671|NCT02284893|580639632|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
160795672|NCT02284893|580639631|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
160795673|NCT02284893|580639632|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
160795674|NCT02284893|580639631|FG000|52 Week (Long Term)|Non-Compliance|2|||
160795675|NCT02284893|580639632|FG001|52 Week (Long Term)|Non-Compliance|3|||
160795676|NCT03078868|580639635|FG000|Overall Study|Physician Decision|3|||
160795677|NCT03038620|580639636|FG000|Overall Study|Lost to Follow-up|18|||
160795678|NCT03038620|580639637|FG001|Overall Study|Lost to Follow-up|23|||
160795679|NCT03038620|580639636|FG000|Overall Study|Withdrawal by Subject|0|||
160795680|NCT03038620|580639637|FG001|Overall Study|Withdrawal by Subject|15|||
160795681|NCT03038620|580639636|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
160795682|NCT03038620|580639637|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
160795683|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
160795684|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
160795685|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
160795686|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
160795687|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
160795688|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
160795689|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
160795690|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
160795691|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
160795692|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
160795693|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795694|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795695|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795696|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795697|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795698|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795699|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795700|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
160795701|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795702|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
160795703|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795704|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795705|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795706|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795707|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795708|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
160795709|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795710|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795711|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795712|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
160795713|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795714|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795715|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795716|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795717|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
160795718|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
160795719|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
160795720|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
160795721|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
160795722|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
160795723|NCT02082977|580639638|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795724|NCT02082977|580639639|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795725|NCT02082977|580639640|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795726|NCT02082977|580639641|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
161236049|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
160983474|NCT02584855|581328659|FG005|Open-Label Treatment Period|Protocol Violation|0|||
160983475|NCT02584855|581328654|FG000|Open-Label Treatment Period|No PI Available|2|||
160983476|NCT02584855|581328655|FG001|Open-Label Treatment Period|No PI Available|0|||
160983477|NCT02584855|581328656|FG002|Open-Label Treatment Period|No PI Available|0|||
160983478|NCT02584855|581328657|FG003|Open-Label Treatment Period|No PI Available|0|||
160983479|NCT02584855|581328658|FG004|Open-Label Treatment Period|No PI Available|0|||
160983480|NCT02584855|581328659|FG005|Open-Label Treatment Period|No PI Available|0|||
160983481|NCT02584855|581328654|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
160983482|NCT02584855|581328655|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
160983483|NCT02584855|581328656|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
160983484|NCT02584855|581328657|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
160983485|NCT02584855|581328658|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
160983486|NCT02584855|581328659|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
160983487|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983488|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983489|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
160983490|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983491|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983492|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
160983493|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
160983494|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
160983495|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
160983496|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
160983497|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
160983498|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
160983499|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983500|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
160983501|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983502|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983503|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983504|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
160983505|NCT02584855|581328654|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983506|NCT02584855|581328655|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
160983507|NCT02584855|581328656|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983508|NCT02584855|581328657|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983509|NCT02584855|581328658|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983510|NCT02584855|581328659|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
160983511|NCT02584855|581328654|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983512|NCT02584855|581328655|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983513|NCT02584855|581328656|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983514|NCT02584855|581328657|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983515|NCT02584855|581328658|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
160983516|NCT02584855|581328659|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160983517|NCT02584855|581328654|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
160983518|NCT02584855|581328655|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
160983519|NCT02584855|581328656|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
160983520|NCT02584855|581328657|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
160983521|NCT02584855|581328658|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
160983522|NCT02584855|581328659|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
160983523|NCT02337478|581328660|FG000|Overall Study|Lack of Efficacy|5|||
160983524|NCT02611830|581328661|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
160983525|NCT02611830|581328662|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
160983526|NCT02611830|581328663|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
160983527|NCT02611830|581328664|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
160983528|NCT02611830|581328661|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
160983529|NCT02611830|581328662|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
160983530|NCT02611830|581328663|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
160983531|NCT02611830|581328664|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
160983532|NCT02611830|581328661|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
160983533|NCT02611830|581328662|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
160983534|NCT02611830|581328663|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
160983535|NCT02611830|581328664|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
160983536|NCT02611830|581328661|FG000|OL Induction Phase|Lack of Efficacy|9|||
160983537|NCT02611830|581328662|FG001|OL Induction Phase|Lack of Efficacy|0|||
160983538|NCT02611830|581328663|FG002|OL Induction Phase|Lack of Efficacy|0|||
160983539|NCT02611830|581328664|FG003|OL Induction Phase|Lack of Efficacy|0|||
161129350|NCT01717638|581860804|FG011|Overall Study|Withdrawal by Subject|0|||
161330860|NCT05607576|582597285|FG000|Overall Study|immediate sensor error|2|||
160795727|NCT02082977|580639642|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795728|NCT02082977|580639643|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795729|NCT02082977|580639644|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795730|NCT02082977|580639645|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
160795731|NCT02082977|580639646|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795732|NCT02082977|580639647|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
160795733|NCT00105066|580639648|FG000|Overall Study|Adverse Event|2|||
160795734|NCT00105066|580639649|FG001|Overall Study|Adverse Event|5|||
160795735|NCT01979185|580639661|FG000|Period 2|Other|0|||
160795736|NCT01979185|580639662|FG001|Period 2|Other|1|||
160795737|NCT00522379|580639663|FG000|Overall Study|Adverse Event|12|||
160795738|NCT00522379|580639664|FG001|Overall Study|Adverse Event|15|||
160795739|NCT00522379|580639665|FG002|Overall Study|Adverse Event|12|||
160795740|NCT00522379|580639666|FG003|Overall Study|Adverse Event|5|||
160795741|NCT00522379|580639667|FG004|Overall Study|Adverse Event|17|||
160795742|NCT00522379|580639663|FG000|Overall Study|Lack of Efficacy|3|||
160795743|NCT00522379|580639664|FG001|Overall Study|Lack of Efficacy|0|||
160795744|NCT00522379|580639665|FG002|Overall Study|Lack of Efficacy|2|||
160795745|NCT00522379|580639666|FG003|Overall Study|Lack of Efficacy|2|||
160795746|NCT00522379|580639667|FG004|Overall Study|Lack of Efficacy|7|||
160795747|NCT00522379|580639663|FG000|Overall Study|Withdrawal by Subject|2|||
160795748|NCT00522379|580639664|FG001|Overall Study|Withdrawal by Subject|3|||
160795749|NCT00522379|580639665|FG002|Overall Study|Withdrawal by Subject|1|||
160795750|NCT00522379|580639666|FG003|Overall Study|Withdrawal by Subject|2|||
160795751|NCT00522379|580639667|FG004|Overall Study|Withdrawal by Subject|0|||
160795752|NCT00522379|580639663|FG000|Overall Study|Protocol Violation|1|||
160795753|NCT00522379|580639664|FG001|Overall Study|Protocol Violation|1|||
160795754|NCT00522379|580639665|FG002|Overall Study|Protocol Violation|2|||
160795755|NCT00522379|580639666|FG003|Overall Study|Protocol Violation|0|||
160795756|NCT00522379|580639667|FG004|Overall Study|Protocol Violation|0|||
160795757|NCT00522379|580639663|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
160795758|NCT00522379|580639664|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
160795759|NCT00522379|580639665|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
160795760|NCT00522379|580639666|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
160795761|NCT00522379|580639667|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
160795762|NCT00522379|580639663|FG000|Overall Study|Lost to Follow-up|1|||
160795763|NCT00522379|580639664|FG001|Overall Study|Lost to Follow-up|0|||
160795764|NCT00522379|580639665|FG002|Overall Study|Lost to Follow-up|4|||
160795765|NCT00522379|580639666|FG003|Overall Study|Lost to Follow-up|2|||
160795766|NCT00522379|580639667|FG004|Overall Study|Lost to Follow-up|2|||
160795767|NCT00522379|580639663|FG000|Overall Study|Randomization error|0|||
160795768|NCT00522379|580639664|FG001|Overall Study|Randomization error|0|||
160795769|NCT00522379|580639665|FG002|Overall Study|Randomization error|0|||
160795770|NCT00522379|580639666|FG003|Overall Study|Randomization error|0|||
160795771|NCT00522379|580639667|FG004|Overall Study|Randomization error|1|||
160795772|NCT00522379|580639663|FG000|Overall Study|Dispensing error|1|||
160795773|NCT00522379|580639664|FG001|Overall Study|Dispensing error|0|||
160795774|NCT00522379|580639665|FG002|Overall Study|Dispensing error|0|||
160795775|NCT00522379|580639666|FG003|Overall Study|Dispensing error|1|||
160795776|NCT00522379|580639667|FG004|Overall Study|Dispensing error|0|||
160795777|NCT00522379|580639663|FG000|Overall Study|Subject Moved|1|||
160795778|NCT00522379|580639664|FG001|Overall Study|Subject Moved|1|||
160795779|NCT00522379|580639665|FG002|Overall Study|Subject Moved|0|||
160795780|NCT00522379|580639666|FG003|Overall Study|Subject Moved|0|||
160795781|NCT00522379|580639667|FG004|Overall Study|Subject Moved|0|||
160795782|NCT00522379|580639663|FG000|Overall Study|Sponsor Request|0|||
160795783|NCT00522379|580639664|FG001|Overall Study|Sponsor Request|1|||
160795784|NCT00522379|580639665|FG002|Overall Study|Sponsor Request|0|||
160795785|NCT00522379|580639666|FG003|Overall Study|Sponsor Request|0|||
160795786|NCT00522379|580639667|FG004|Overall Study|Sponsor Request|0|||
160795787|NCT00522379|580639663|FG000|Overall Study|Family Problem|0|||
160795788|NCT00522379|580639664|FG001|Overall Study|Family Problem|0|||
160795789|NCT00522379|580639665|FG002|Overall Study|Family Problem|1|||
160795790|NCT00522379|580639666|FG003|Overall Study|Family Problem|0|||
160795791|NCT00522379|580639667|FG004|Overall Study|Family Problem|0|||
160795792|NCT00522379|580639663|FG000|Overall Study|Site Closed|0|||
160795793|NCT00522379|580639664|FG001|Overall Study|Site Closed|0|||
160795794|NCT00522379|580639665|FG002|Overall Study|Site Closed|0|||
160795795|NCT00522379|580639666|FG003|Overall Study|Site Closed|1|||
160795796|NCT00522379|580639667|FG004|Overall Study|Site Closed|0|||
160795797|NCT00522379|580639663|FG000|Overall Study|Subject Withdrawal|0|||
160795798|NCT00522379|580639664|FG001|Overall Study|Subject Withdrawal|0|||
160795799|NCT00522379|580639665|FG002|Overall Study|Subject Withdrawal|0|||
160795800|NCT00522379|580639666|FG003|Overall Study|Subject Withdrawal|1|||
160795801|NCT00522379|580639667|FG004|Overall Study|Subject Withdrawal|0|||
160795802|NCT03213509|580639668|FG000|Overall Study|Did not consent for verbal autopsy|4|||
160795803|NCT03213509|580639669|FG001|Overall Study|Did not consent for verbal autopsy|5|||
160795804|NCT04079738|580639670|FG000|Study Treatment|Death|1|||
160795805|NCT04079738|580639671|FG001|Study Treatment|Death|0|||
160795806|NCT04079738|580639672|FG002|Study Treatment|Death|0|||
160795807|NCT04079738|580639673|FG003|Study Treatment|Death|0|||
160795808|NCT04079738|580639670|FG000|Study Treatment|Adverse Event|2|||
160795809|NCT04079738|580639671|FG001|Study Treatment|Adverse Event|0|||
160795810|NCT04079738|580639672|FG002|Study Treatment|Adverse Event|0|||
160795811|NCT04079738|580639673|FG003|Study Treatment|Adverse Event|0|||
160795812|NCT04079738|580639670|FG000|Study Treatment|withdrawal before treatment|1|||
160795813|NCT04079738|580639671|FG001|Study Treatment|withdrawal before treatment|0|||
160795814|NCT04079738|580639672|FG002|Study Treatment|withdrawal before treatment|0|||
160795815|NCT04079738|580639673|FG003|Study Treatment|withdrawal before treatment|0|||
160795816|NCT04079738|580639670|FG000|Study Treatment|symptomatic deterioration|2|||
160795817|NCT04079738|580639671|FG001|Study Treatment|symptomatic deterioration|0|||
160795818|NCT04079738|580639672|FG002|Study Treatment|symptomatic deterioration|0|||
160795819|NCT04079738|580639673|FG003|Study Treatment|symptomatic deterioration|0|||
160795820|NCT04079738|580639670|FG000|Study Treatment|Disease Progression|1|||
160795821|NCT04079738|580639671|FG001|Study Treatment|Disease Progression|0|||
160795822|NCT04079738|580639672|FG002|Study Treatment|Disease Progression|0|||
160795823|NCT04079738|580639673|FG003|Study Treatment|Disease Progression|0|||
160795824|NCT04079738|580639670|FG000|Study Treatment|withdrawal after treatment|1|||
160795825|NCT04079738|580639671|FG001|Study Treatment|withdrawal after treatment|0|||
160795826|NCT04079738|580639672|FG002|Study Treatment|withdrawal after treatment|0|||
160795827|NCT04079738|580639673|FG003|Study Treatment|withdrawal after treatment|0|||
160795828|NCT04079738|580639670|FG000|Follow up|Withdrawal by Subject|3|||
160795829|NCT04079738|580639671|FG001|Follow up|Withdrawal by Subject|0|||
160795830|NCT04079738|580639672|FG002|Follow up|Withdrawal by Subject|0|||
160795831|NCT04079738|580639673|FG003|Follow up|Withdrawal by Subject|0|||
160795832|NCT04079738|580639670|FG000|Follow up|Death|5|||
160795833|NCT04079738|580639671|FG001|Follow up|Death|0|||
160795834|NCT04079738|580639672|FG002|Follow up|Death|0|||
160795835|NCT04079738|580639673|FG003|Follow up|Death|0|||
160795836|NCT03620981|580639674|FG000|Overall Study|Adverse Event|14|||
160795837|NCT03620981|580639675|FG001|Overall Study|Adverse Event|38|||
160795838|NCT03620981|580639676|FG002|Overall Study|Adverse Event|25|||
160795839|NCT03620981|580639674|FG000|Overall Study|Lack of Efficacy|2|||
160795840|NCT03620981|580639675|FG001|Overall Study|Lack of Efficacy|1|||
160795841|NCT03620981|580639676|FG002|Overall Study|Lack of Efficacy|1|||
160795842|NCT03620981|580639674|FG000|Overall Study|Physician Decision|7|||
160795843|NCT03620981|580639675|FG001|Overall Study|Physician Decision|4|||
160795844|NCT03620981|580639676|FG002|Overall Study|Physician Decision|4|||
160795845|NCT03620981|580639674|FG000|Overall Study|Protocol Violation|1|||
160795846|NCT03620981|580639675|FG001|Overall Study|Protocol Violation|2|||
160795847|NCT03620981|580639676|FG002|Overall Study|Protocol Violation|1|||
160795848|NCT03620981|580639674|FG000|Overall Study|Withdrawal by Legal Representative|2|||
160795849|NCT03620981|580639675|FG001|Overall Study|Withdrawal by Legal Representative|1|||
160795850|NCT03620981|580639676|FG002|Overall Study|Withdrawal by Legal Representative|1|||
160795851|NCT03620981|580639674|FG000|Overall Study|Withdrawal by Care Giver|2|||
160795852|NCT03620981|580639675|FG001|Overall Study|Withdrawal by Care Giver|0|||
160795853|NCT03620981|580639676|FG002|Overall Study|Withdrawal by Care Giver|1|||
160795854|NCT03620981|580639674|FG000|Overall Study|Non-compliance with Study Drug|1|||
160795855|NCT03620981|580639675|FG001|Overall Study|Non-compliance with Study Drug|1|||
160795856|NCT03620981|580639676|FG002|Overall Study|Non-compliance with Study Drug|0|||
160795857|NCT05552859|580639679|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
160795858|NCT05552859|580639680|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
160795859|NCT01380080|580639681|FG000|Overall Study|Death|36|||
160795860|NCT01380080|580639682|FG001|Overall Study|Death|44|||
160795861|NCT01380080|580639681|FG000|Overall Study|Site is closing|28|||
160795862|NCT01380080|580639682|FG001|Overall Study|Site is closing|31|||
160795863|NCT01380080|580639681|FG000|Overall Study|Not able to get to clinic|7|||
160795864|NCT01380080|580639682|FG001|Overall Study|Not able to get to clinic|1|||
160795865|NCT01380080|580639681|FG000|Overall Study|Not willing to adhere to requirements|6|||
160795866|NCT01380080|580639682|FG001|Overall Study|Not willing to adhere to requirements|2|||
160795867|NCT01380080|580639681|FG000|Overall Study|Withdrawal by Subject|5|||
160795868|NCT01380080|580639682|FG001|Overall Study|Withdrawal by Subject|2|||
160795869|NCT01380080|580639681|FG000|Overall Study|Lost to Follow-up|3|||
160795870|NCT01380080|580639682|FG001|Overall Study|Lost to Follow-up|3|||
160795871|NCT01889251|580639686|FG000|Overall Study|Adverse Event|1|||
160795872|NCT01889251|580639687|FG001|Overall Study|Adverse Event|0|||
160795873|NCT05852470|580639688|FG000|Overall Study|Withdrawal by Subject|0|||
160795874|NCT05852470|580639689|FG001|Overall Study|Withdrawal by Subject|1|||
160795875|NCT05484895|580641124|FG000|Overall Study|Lost to Follow-up|63|||
160795876|NCT05484895|580641125|FG001|Overall Study|Lost to Follow-up|64|||
160795877|NCT04795531|580641126|FG000|Overall Study|Withdrawal by Subject|4|||
160795878|NCT04795531|580641127|FG001|Overall Study|Withdrawal by Subject|4|||
160795879|NCT04795531|580641126|FG000|Overall Study|Lost to Follow-up|0|||
160795880|NCT04795531|580641127|FG001|Overall Study|Lost to Follow-up|1|||
160795881|NCT04795531|580641126|FG000|Overall Study|Physician Decision|0|||
160795882|NCT04795531|580641127|FG001|Overall Study|Physician Decision|2|||
160795883|NCT04795531|580641126|FG000|Overall Study|Death|2|||
160795884|NCT04795531|580641127|FG001|Overall Study|Death|1|||
160795885|NCT03698279|580641128|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160795886|NCT03698279|580641129|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160795887|NCT03698279|580641130|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160795888|NCT03698279|580641131|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160795889|NCT03698279|580641132|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160795890|NCT03698279|580641133|FG005|Overall Study|Withdrawal by parent/guardian|0|||
160795891|NCT03698279|580641128|FG000|Overall Study|Protocol deviation|1|||
160795892|NCT03698279|580641129|FG001|Overall Study|Protocol deviation|0|||
160795893|NCT03698279|580641130|FG002|Overall Study|Protocol deviation|1|||
160795894|NCT03698279|580641131|FG003|Overall Study|Protocol deviation|0|||
160795895|NCT03698279|580641132|FG004|Overall Study|Protocol deviation|0|||
160795896|NCT03698279|580641133|FG005|Overall Study|Protocol deviation|0|||
160795897|NCT03698279|580641128|FG000|Overall Study|Withdrawal by Subject|0|||
160795898|NCT03698279|580641129|FG001|Overall Study|Withdrawal by Subject|0|||
160795899|NCT03698279|580641130|FG002|Overall Study|Withdrawal by Subject|1|||
160795900|NCT03698279|580641131|FG003|Overall Study|Withdrawal by Subject|0|||
160795901|NCT03698279|580641132|FG004|Overall Study|Withdrawal by Subject|0|||
160795902|NCT03698279|580641133|FG005|Overall Study|Withdrawal by Subject|0|||
160795903|NCT03698279|580641128|FG000|Overall Study|Lost to Follow-up|3|||
160795904|NCT03698279|580641129|FG001|Overall Study|Lost to Follow-up|1|||
161330861|NCT05607576|582597285|FG000|Overall Study|Physician Decision|2|||
160795905|NCT03698279|580641130|FG002|Overall Study|Lost to Follow-up|4|||
160795906|NCT03698279|580641131|FG003|Overall Study|Lost to Follow-up|5|||
160795907|NCT03698279|580641132|FG004|Overall Study|Lost to Follow-up|0|||
160795908|NCT03698279|580641133|FG005|Overall Study|Lost to Follow-up|0|||
160795909|NCT03552029|580641134|FG000|Overall Study|Death|3|||
160795910|NCT03552029|580641135|FG001|Overall Study|Death|0|||
160795911|NCT03552029|580641134|FG000|Overall Study|Adverse Event|1|||
160795912|NCT03552029|580641135|FG001|Overall Study|Adverse Event|0|||
160795913|NCT03552029|580641134|FG000|Overall Study|Lack of Efficacy|0|||
160795914|NCT03552029|580641135|FG001|Overall Study|Lack of Efficacy|2|||
160795915|NCT03552029|580641134|FG000|Overall Study|Physician Decision|0|||
160795916|NCT03552029|580641135|FG001|Overall Study|Physician Decision|1|||
160795917|NCT03552029|580641134|FG000|Overall Study|Study terminated by Sponsor|0|||
160795918|NCT03552029|580641135|FG001|Overall Study|Study terminated by Sponsor|1|||
160795919|NCT03552029|580641134|FG000|Overall Study|Other|0|||
160795920|NCT03552029|580641135|FG001|Overall Study|Other|2|||
160795921|NCT02552225|580641136|FG000|Overall Study|Withdrawal by Subject|1|||
160795922|NCT02552225|580641137|FG001|Overall Study|Withdrawal by Subject|0|||
160795923|NCT00876447|580641138|FG000|Overall Study|Other miscellaneous reasons|3|||
160795924|NCT00876447|580641139|FG001|Overall Study|Other miscellaneous reasons|8|||
160795925|NCT00876447|580641138|FG000|Overall Study|Site closure|19|||
160795926|NCT00876447|580641139|FG001|Overall Study|Site closure|14|||
160795927|NCT00876447|580641138|FG000|Overall Study|Protocol Violation|9|||
160795928|NCT00876447|580641139|FG001|Overall Study|Protocol Violation|3|||
160795929|NCT00876447|580641138|FG000|Overall Study|Personal reasons|30|||
160795930|NCT00876447|580641139|FG001|Overall Study|Personal reasons|28|||
160795931|NCT00876447|580641138|FG000|Overall Study|Lost to Follow-up|6|||
160795932|NCT00876447|580641139|FG001|Overall Study|Lost to Follow-up|15|||
161330862|NCT05616013|582597286|FG000|Overall Study|Adverse Event|6|||
160795933|NCT00876447|580641138|FG000|Overall Study|Pregnancy|4|||
160795934|NCT00876447|580641139|FG001|Overall Study|Pregnancy|2|||
160795935|NCT00876447|580641138|FG000|Overall Study|Lack of Efficacy|5|||
160795936|NCT00876447|580641139|FG001|Overall Study|Lack of Efficacy|3|||
160795937|NCT00876447|580641138|FG000|Overall Study|Adverse Event|4|||
160795938|NCT00876447|580641139|FG001|Overall Study|Adverse Event|8|||
160894358|NCT01610271|581008359|FG000|Overall Study|Prosthesis not implanted|2|||
160894359|NCT01610271|581008360|FG001|Overall Study|Prosthesis not implanted|3|||
160894360|NCT01638819|581008361|FG000|Overall Study|Lost to Follow-up|1|||
160894361|NCT01638819|581008362|FG001|Overall Study|Lost to Follow-up|0|||
160894362|NCT00923936|581008363|FG000|Overall Study|progressive disease on study|2|||
160795939|NCT00567502|580641140|FG000|Overall Study|Lost to Follow-up|91|||
160795940|NCT00567502|580641141|FG001|Overall Study|Lost to Follow-up|14|||
160795941|NCT00567502|580641142|FG002|Overall Study|Lost to Follow-up|351|||
161330863|NCT05616013|582597287|FG001|Overall Study|Adverse Event|12|||
160795942|NCT00567502|580641143|FG003|Overall Study|Lost to Follow-up|2|||
160795943|NCT00567502|580641140|FG000|Overall Study|Death|65|||
160795944|NCT00567502|580641141|FG001|Overall Study|Death|16|||
160795945|NCT00567502|580641142|FG002|Overall Study|Death|360|||
160894363|NCT00923936|581008364|FG001|Overall Study|progressive disease on study|1|||
160795946|NCT00567502|580641143|FG003|Overall Study|Death|5|||
160795947|NCT00567502|580641140|FG000|Overall Study|Other|64|||
160795948|NCT00567502|580641141|FG001|Overall Study|Other|2|||
160795949|NCT00567502|580641142|FG002|Overall Study|Other|134|||
160795950|NCT00567502|580641143|FG003|Overall Study|Other|6|||
160795951|NCT00567502|580641140|FG000|Overall Study|Participant request|12|||
160795952|NCT00567502|580641141|FG001|Overall Study|Participant request|1|||
160795953|NCT00567502|580641142|FG002|Overall Study|Participant request|33|||
160795954|NCT00567502|580641143|FG003|Overall Study|Participant request|1|||
160795955|NCT00567502|580641140|FG000|Overall Study|Sponsor request|9|||
160795956|NCT00567502|580641141|FG001|Overall Study|Sponsor request|0|||
160795957|NCT00567502|580641142|FG002|Overall Study|Sponsor request|30|||
160795958|NCT00567502|580641143|FG003|Overall Study|Sponsor request|1|||
160795959|NCT00567502|580641140|FG000|Overall Study|Never Initiated Treatment|0|||
160795960|NCT00567502|580641141|FG001|Overall Study|Never Initiated Treatment|0|||
160795961|NCT00567502|580641142|FG002|Overall Study|Never Initiated Treatment|0|||
160795962|NCT00567502|580641143|FG003|Overall Study|Never Initiated Treatment|72|||
160795963|NCT03728933|580641144|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160795964|NCT03728933|580641145|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160795965|NCT03728933|580641146|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160795966|NCT03728933|580641144|FG000|Overall Study|Withdrawal by Subject|0|||
160795967|NCT03728933|580641145|FG001|Overall Study|Withdrawal by Subject|0|||
161330864|NCT05616013|582597288|FG002|Overall Study|Adverse Event|8|||
160795968|NCT03728933|580641146|FG002|Overall Study|Withdrawal by Subject|1|||
160795969|NCT03728933|580641144|FG000|Overall Study|Lost to Follow-up|0|||
160894364|NCT00923936|581008363|FG000|Overall Study|Adverse Event|2|||
160894365|NCT00923936|581008364|FG001|Overall Study|Adverse Event|1|||
161129351|NCT01717638|581860805|FG012|Overall Study|Withdrawal by Subject|18|||
161129352|NCT01719757|581860806|FG000|Overall Study|Adverse Event|38|||
161129353|NCT01719757|581860806|FG000|Overall Study|Withdrawal by Subject|15|||
161129354|NCT01719757|581860806|FG000|Overall Study|Lost to Follow-up|20|||
161129355|NCT01719757|581860806|FG000|Overall Study|Protocol Violation|1|||
161129356|NCT01719757|581860806|FG000|Overall Study|well controlled pain|27|||
161129357|NCT02626338|581860807|FG000|Overall Study|Lack of Efficacy|3|||
161129358|NCT02626338|581860808|FG001|Overall Study|Lack of Efficacy|2|||
161129359|NCT02626338|581860809|FG002|Overall Study|Lack of Efficacy|0|||
161129360|NCT03312218|581860815|FG000|Overall Study|Never signed in to access the app|54|||
161129361|NCT03312218|581860816|FG001|Overall Study|Never signed in to access the app|58|||
161129362|NCT01901224|581860817|FG000|Overall Study|study was not funded and terminated|2|||
161129363|NCT06441877|581860818|FG000|Overall Study|Withdrawal by Subject|0|||
161129364|NCT06441877|581860819|FG001|Overall Study|Withdrawal by Subject|2|||
161129365|NCT06441877|581860820|FG002|Overall Study|Withdrawal by Subject|0|||
161129366|NCT06441877|581860821|FG003|Overall Study|Withdrawal by Subject|0|||
161129367|NCT05742984|581860822|FG000|Overall Study|Adverse Event|0|||
161129368|NCT05742984|581860823|FG001|Overall Study|Adverse Event|0|||
161129369|NCT05742984|581860824|FG002|Overall Study|Adverse Event|1|||
161129370|NCT05742984|581860825|FG003|Overall Study|Adverse Event|0|||
161129371|NCT05742984|581860826|FG004|Overall Study|Adverse Event|1|||
161129372|NCT05742984|581860827|FG005|Overall Study|Adverse Event|1|||
161129373|NCT05742984|581860822|FG000|Overall Study|Withdrawal by Subject|0|||
161129374|NCT05742984|581860823|FG001|Overall Study|Withdrawal by Subject|1|||
161129375|NCT05742984|581860824|FG002|Overall Study|Withdrawal by Subject|0|||
161129376|NCT05742984|581860825|FG003|Overall Study|Withdrawal by Subject|0|||
161129377|NCT05742984|581860826|FG004|Overall Study|Withdrawal by Subject|0|||
161129378|NCT05742984|581860827|FG005|Overall Study|Withdrawal by Subject|2|||
161129379|NCT02162862|581860828|FG000|Overall Study|Lost to Follow-up|0|||
161129380|NCT02162862|581860829|FG001|Overall Study|Lost to Follow-up|11|||
161129381|NCT02162862|581860830|FG002|Overall Study|Lost to Follow-up|0|||
161129382|NCT02162862|581860828|FG000|Overall Study|Subject did not feel the med was needed|0|||
161129383|NCT02162862|581860829|FG001|Overall Study|Subject did not feel the med was needed|0|||
161129384|NCT02162862|581860830|FG002|Overall Study|Subject did not feel the med was needed|4|||
161129385|NCT03116113|581860831|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129386|NCT03116113|581860832|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129387|NCT03116113|581860833|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129388|NCT03116113|581860834|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129389|NCT03116113|581860835|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129390|NCT03116113|581860836|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129391|NCT03116113|581860837|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
161129392|NCT03116113|581860838|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
161129393|NCT03116113|581860839|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
161129394|NCT02159807|581860840|FG000|Overall Study|Adverse Event|0|||
161129395|NCT02159807|581860841|FG001|Overall Study|Adverse Event|0|||
161129396|NCT02159807|581860842|FG002|Overall Study|Adverse Event|1|||
161129397|NCT02159807|581860840|FG000|Overall Study|No CSF|1|||
161129398|NCT02159807|581860841|FG001|Overall Study|No CSF|1|||
161129399|NCT02159807|581860842|FG002|Overall Study|No CSF|1|||
161129400|NCT02159807|581860840|FG000|Overall Study|elevated blood pressure|0|||
161129401|NCT02159807|581860841|FG001|Overall Study|elevated blood pressure|0|||
161129402|NCT02159807|581860842|FG002|Overall Study|elevated blood pressure|1|||
160795970|NCT03728933|580641145|FG001|Overall Study|Lost to Follow-up|1|||
160795971|NCT03728933|580641146|FG002|Overall Study|Lost to Follow-up|0|||
161129403|NCT00950170|581860843|FG000|Overall Study|Parent/Legal Guardian Request|1|||
160795972|NCT03728933|580641144|FG000|Overall Study|Adverse Event|1|||
160795973|NCT03728933|580641145|FG001|Overall Study|Adverse Event|0|||
160795974|NCT03728933|580641146|FG002|Overall Study|Adverse Event|0|||
160795975|NCT02835690|580641147|FG000|Overall Study|Death|12|||
160795976|NCT02835690|580641148|FG001|Overall Study|Death|11|||
160795977|NCT02835690|580641149|FG002|Overall Study|Death|13|||
160795978|NCT02835690|580641147|FG000|Overall Study|Transferred to Extension Study|2|||
160795979|NCT02835690|580641148|FG001|Overall Study|Transferred to Extension Study|2|||
160795980|NCT02835690|580641149|FG002|Overall Study|Transferred to Extension Study|1|||
160894366|NCT00923936|581008363|FG000|Overall Study|Lost to follow up|2|||
160894367|NCT00923936|581008364|FG001|Overall Study|Lost to follow up|0|||
160894368|NCT00923936|581008363|FG000|Overall Study|Continuing in follow up period|2|||
160894369|NCT00923936|581008364|FG001|Overall Study|Continuing in follow up period|1|||
160894370|NCT02038452|581008365|FG000|Overall Study|Withdrawal by Subject|7|||
160894371|NCT02038452|581008366|FG001|Overall Study|Withdrawal by Subject|9|||
160894372|NCT02038452|581008365|FG000|Overall Study|Lost to Follow-up|31|||
160894373|NCT02038452|581008366|FG001|Overall Study|Lost to Follow-up|28|||
160894374|NCT01626495|581008368|FG000|Overall Study|Adverse Event|3|||
161330865|NCT05616013|582597289|FG003|Overall Study|Adverse Event|4|||
161330866|NCT05616013|582597290|FG004|Overall Study|Adverse Event|6|||
161330867|NCT05616013|582597291|FG005|Overall Study|Adverse Event|8|||
161330868|NCT05616013|582597292|FG006|Overall Study|Adverse Event|3|||
161330869|NCT05616013|582597293|FG007|Overall Study|Adverse Event|6|||
161330870|NCT05616013|582597294|FG008|Overall Study|Adverse Event|1|||
161330871|NCT05616013|582597286|FG000|Overall Study|Lost to Follow-up|5|||
161330872|NCT05616013|582597287|FG001|Overall Study|Lost to Follow-up|4|||
161330873|NCT05616013|582597288|FG002|Overall Study|Lost to Follow-up|3|||
161330874|NCT05616013|582597289|FG003|Overall Study|Lost to Follow-up|2|||
161330875|NCT05616013|582597290|FG004|Overall Study|Lost to Follow-up|0|||
161330876|NCT05616013|582597291|FG005|Overall Study|Lost to Follow-up|5|||
161330877|NCT05616013|582597292|FG006|Overall Study|Lost to Follow-up|2|||
161330878|NCT05616013|582597293|FG007|Overall Study|Lost to Follow-up|1|||
161330879|NCT05616013|582597294|FG008|Overall Study|Lost to Follow-up|2|||
161330880|NCT05616013|582597286|FG000|Overall Study|Non-compliance with study requirements|2|||
161330881|NCT05616013|582597287|FG001|Overall Study|Non-compliance with study requirements|2|||
161330882|NCT05616013|582597288|FG002|Overall Study|Non-compliance with study requirements|2|||
161330883|NCT05616013|582597289|FG003|Overall Study|Non-compliance with study requirements|3|||
161330884|NCT05616013|582597290|FG004|Overall Study|Non-compliance with study requirements|0|||
161330885|NCT05616013|582597291|FG005|Overall Study|Non-compliance with study requirements|2|||
161330886|NCT05616013|582597292|FG006|Overall Study|Non-compliance with study requirements|1|||
161330887|NCT05616013|582597293|FG007|Overall Study|Non-compliance with study requirements|1|||
161330888|NCT05616013|582597294|FG008|Overall Study|Non-compliance with study requirements|4|||
161330889|NCT05616013|582597286|FG000|Overall Study|Withdrawal by Subject|11|||
161330890|NCT05616013|582597287|FG001|Overall Study|Withdrawal by Subject|9|||
161330891|NCT05616013|582597288|FG002|Overall Study|Withdrawal by Subject|8|||
161330892|NCT05616013|582597289|FG003|Overall Study|Withdrawal by Subject|6|||
161330893|NCT05616013|582597290|FG004|Overall Study|Withdrawal by Subject|3|||
161330894|NCT05616013|582597291|FG005|Overall Study|Withdrawal by Subject|4|||
161330895|NCT05616013|582597292|FG006|Overall Study|Withdrawal by Subject|6|||
161330896|NCT05616013|582597293|FG007|Overall Study|Withdrawal by Subject|5|||
161330897|NCT05616013|582597294|FG008|Overall Study|Withdrawal by Subject|4|||
161330898|NCT05616013|582597286|FG000|Overall Study|Physician Decision|0|||
161330899|NCT05616013|582597287|FG001|Overall Study|Physician Decision|0|||
161330900|NCT05616013|582597288|FG002|Overall Study|Physician Decision|1|||
161330901|NCT05616013|582597289|FG003|Overall Study|Physician Decision|0|||
161330902|NCT05616013|582597290|FG004|Overall Study|Physician Decision|0|||
161330903|NCT05616013|582597291|FG005|Overall Study|Physician Decision|1|||
161330904|NCT05616013|582597292|FG006|Overall Study|Physician Decision|3|||
161330905|NCT05616013|582597293|FG007|Overall Study|Physician Decision|0|||
161330906|NCT05616013|582597294|FG008|Overall Study|Physician Decision|0|||
161330907|NCT05616013|582597286|FG000|Overall Study|Protocol Violation|0|||
161330908|NCT05616013|582597287|FG001|Overall Study|Protocol Violation|0|||
161330909|NCT05616013|582597288|FG002|Overall Study|Protocol Violation|0|||
161330910|NCT05616013|582597289|FG003|Overall Study|Protocol Violation|0|||
161330911|NCT05616013|582597290|FG004|Overall Study|Protocol Violation|0|||
160795981|NCT02835690|580641147|FG000|Overall Study|Did Not Continue on Extension Study|0|||
161330912|NCT05616013|582597291|FG005|Overall Study|Protocol Violation|0|||
161330913|NCT05616013|582597292|FG006|Overall Study|Protocol Violation|1|||
160795982|NCT02835690|580641148|FG001|Overall Study|Did Not Continue on Extension Study|0|||
160795983|NCT02835690|580641149|FG002|Overall Study|Did Not Continue on Extension Study|1|||
160795984|NCT02835690|580641147|FG000|Overall Study|Not Treated|0|||
161330914|NCT05616013|582597293|FG007|Overall Study|Protocol Violation|0|||
161330915|NCT05616013|582597294|FG008|Overall Study|Protocol Violation|2|||
161330916|NCT05616013|582597286|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
160894375|NCT01626495|581008368|FG000|Overall Study|Disease progression|27|||
161330917|NCT05616013|582597287|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330918|NCT05616013|582597288|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
160894376|NCT01626495|581008368|FG000|Overall Study|Withdrawal by Subject|1|||
161330919|NCT05616013|582597289|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330920|NCT05616013|582597290|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330921|NCT05616013|582597291|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330922|NCT05616013|582597292|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330923|NCT05616013|582597293|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330924|NCT05616013|582597294|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
161330925|NCT05616013|582597286|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
161330926|NCT05616013|582597287|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330927|NCT05616013|582597288|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330928|NCT05616013|582597289|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330929|NCT05616013|582597290|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330930|NCT05616013|582597291|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330931|NCT05616013|582597292|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330932|NCT05616013|582597293|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330933|NCT05616013|582597294|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
161330934|NCT05616013|582597286|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
161330935|NCT05616013|582597287|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330936|NCT05616013|582597288|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330937|NCT05616013|582597289|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330938|NCT05616013|582597290|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330939|NCT05616013|582597291|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330940|NCT05616013|582597292|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330941|NCT05616013|582597293|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330942|NCT05616013|582597294|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
161330943|NCT05616013|582597286|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330944|NCT05616013|582597287|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
161330945|NCT05616013|582597288|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330946|NCT05616013|582597289|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330947|NCT05616013|582597290|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330948|NCT05616013|582597291|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330949|NCT05616013|582597292|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330950|NCT05616013|582597293|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330951|NCT05616013|582597294|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
161330952|NCT05616013|582597286|FG000|Overall Study|Participant Decision, Time Constraints|0|||
161330953|NCT05616013|582597287|FG001|Overall Study|Participant Decision, Time Constraints|1|||
161330954|NCT05616013|582597288|FG002|Overall Study|Participant Decision, Time Constraints|0|||
161330955|NCT05616013|582597289|FG003|Overall Study|Participant Decision, Time Constraints|0|||
161330956|NCT05616013|582597290|FG004|Overall Study|Participant Decision, Time Constraints|0|||
161330957|NCT05616013|582597291|FG005|Overall Study|Participant Decision, Time Constraints|0|||
161330958|NCT05616013|582597292|FG006|Overall Study|Participant Decision, Time Constraints|0|||
161330959|NCT05616013|582597293|FG007|Overall Study|Participant Decision, Time Constraints|0|||
161330960|NCT05616013|582597294|FG008|Overall Study|Participant Decision, Time Constraints|0|||
161330961|NCT05616013|582597286|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161330962|NCT05616013|582597287|FG001|Overall Study|Prohibited Concomitant Medication|0|||
161330963|NCT05616013|582597288|FG002|Overall Study|Prohibited Concomitant Medication|1|||
161330964|NCT05616013|582597289|FG003|Overall Study|Prohibited Concomitant Medication|0|||
161330965|NCT05616013|582597290|FG004|Overall Study|Prohibited Concomitant Medication|0|||
161330966|NCT05616013|582597291|FG005|Overall Study|Prohibited Concomitant Medication|0|||
161330967|NCT05616013|582597292|FG006|Overall Study|Prohibited Concomitant Medication|0|||
161330968|NCT05616013|582597293|FG007|Overall Study|Prohibited Concomitant Medication|0|||
161330969|NCT05616013|582597294|FG008|Overall Study|Prohibited Concomitant Medication|0|||
161330970|NCT05616013|582597286|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
161330971|NCT05616013|582597287|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
161330972|NCT05616013|582597288|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
161330973|NCT05616013|582597289|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
161330974|NCT05616013|582597290|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
161330975|NCT05616013|582597291|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
161330976|NCT05616013|582597292|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
161330977|NCT05616013|582597293|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
160894377|NCT01626495|581008368|FG000|Overall Study|Administrative problem|1|||
160795985|NCT02835690|580641148|FG001|Overall Study|Not Treated|2|||
160795986|NCT02835690|580641149|FG002|Overall Study|Not Treated|0|||
160795987|NCT02538614|580641152|FG000|Overall Study|Progressive Disease|2|||
160795988|NCT00582907|580641153|FG000|1st Course|Withdrawal by Subject|1|||
160795989|NCT00582907|580641154|FG001|1st Course|Withdrawal by Subject|0|||
160795990|NCT00582907|580641155|FG002|1st Course|Withdrawal by Subject|0|||
160795991|NCT00582907|580641156|FG003|1st Course|Withdrawal by Subject|0|||
160795992|NCT00582907|580641153|FG000|1st Course|Lost to Follow-up|0|||
160795993|NCT00582907|580641154|FG001|1st Course|Lost to Follow-up|0|||
160795994|NCT00582907|580641155|FG002|1st Course|Lost to Follow-up|0|||
160795995|NCT00582907|580641156|FG003|1st Course|Lost to Follow-up|1|||
160795996|NCT00582907|580641153|FG000|2nd Course|Lack of Efficacy|1|||
160795997|NCT00582907|580641154|FG001|2nd Course|Lack of Efficacy|0|||
160795998|NCT00582907|580641155|FG002|2nd Course|Lack of Efficacy|0|||
160795999|NCT00582907|580641156|FG003|2nd Course|Lack of Efficacy|0|||
160796000|NCT01441960|580641158|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
160796001|NCT01441960|580641159|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
160796002|NCT01441960|580641158|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
160796003|NCT01441960|580641159|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
160796004|NCT01441960|580641158|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
160796005|NCT01441960|580641159|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
160796006|NCT00189423|580641160|FG000|Overall Study|Death|746|||
160796007|NCT00189423|580641161|FG001|Overall Study|Death|747|||
160796008|NCT00189423|580641160|FG000|Overall Study|Withdrawal by Subject|9|||
160796009|NCT00189423|580641161|FG001|Overall Study|Withdrawal by Subject|9|||
160796010|NCT00189423|580641160|FG000|Overall Study|Lost to Follow-up|10|||
160796011|NCT00189423|580641161|FG001|Overall Study|Lost to Follow-up|10|||
160796012|NCT00415636|580641167|FG000|Overall Study|Symptomatic deterioration|1|||
160796013|NCT00415636|580641168|FG001|Overall Study|Symptomatic deterioration|0|||
160796014|NCT00415636|580641169|FG002|Overall Study|Symptomatic deterioration|1|||
160796015|NCT00415636|580641170|FG003|Overall Study|Symptomatic deterioration|2|||
160796016|NCT00415636|580641171|FG004|Overall Study|Symptomatic deterioration|0|||
160796017|NCT00415636|580641172|FG005|Overall Study|Symptomatic deterioration|1|||
160796018|NCT00415636|580641167|FG000|Overall Study|Adverse Event|0|||
160796019|NCT00415636|580641168|FG001|Overall Study|Adverse Event|0|||
160796020|NCT00415636|580641169|FG002|Overall Study|Adverse Event|0|||
160796021|NCT00415636|580641170|FG003|Overall Study|Adverse Event|1|||
160796022|NCT00415636|580641171|FG004|Overall Study|Adverse Event|1|||
160796023|NCT00415636|580641172|FG005|Overall Study|Adverse Event|0|||
160796024|NCT00415636|580641167|FG000|Overall Study|Withdrawal by Subject|0|||
160796025|NCT00415636|580641168|FG001|Overall Study|Withdrawal by Subject|0|||
160796026|NCT00415636|580641169|FG002|Overall Study|Withdrawal by Subject|0|||
160796027|NCT00415636|580641170|FG003|Overall Study|Withdrawal by Subject|0|||
160796028|NCT00415636|580641171|FG004|Overall Study|Withdrawal by Subject|1|||
160796029|NCT00415636|580641172|FG005|Overall Study|Withdrawal by Subject|0|||
160796030|NCT00415636|580641167|FG000|Overall Study|Disease progression|0|||
160796031|NCT00415636|580641168|FG001|Overall Study|Disease progression|0|||
160796032|NCT00415636|580641169|FG002|Overall Study|Disease progression|0|||
160796033|NCT00415636|580641170|FG003|Overall Study|Disease progression|3|||
160796034|NCT00415636|580641171|FG004|Overall Study|Disease progression|0|||
160796035|NCT00415636|580641172|FG005|Overall Study|Disease progression|1|||
160796036|NCT01263119|580641173|FG000|Period 1|Protocol Violation|2|||
160796037|NCT01263119|580641173|FG000|Period 2|Adverse Event|2|||
160796038|NCT02138825|580641174|FG000|Main Study Treatment|Adverse Event|11|||
160796039|NCT02138825|580641175|FG001|Main Study Treatment|Adverse Event|3|||
160796040|NCT02138825|580641174|FG000|Main Study Treatment|Death|1|||
160796041|NCT02138825|580641175|FG001|Main Study Treatment|Death|2|||
160796042|NCT02138825|580641174|FG000|Main Study Treatment|Protocol Violation|2|||
160796043|NCT02138825|580641175|FG001|Main Study Treatment|Protocol Violation|2|||
160796044|NCT02138825|580641174|FG000|Main Study Treatment|Sponsor decision|12|||
160796045|NCT02138825|580641175|FG001|Main Study Treatment|Sponsor decision|18|||
160796046|NCT02138825|580641174|FG000|Main Study Treatment|Study terminated by sponsor|10|||
160796047|NCT02138825|580641175|FG001|Main Study Treatment|Study terminated by sponsor|9|||
160796048|NCT02138825|580641174|FG000|Main Study Treatment|Withdrawal by Subject|3|||
160796049|NCT02138825|580641175|FG001|Main Study Treatment|Withdrawal by Subject|1|||
160796050|NCT02138825|580641174|FG000|Main Study Treatment|Medical decision|1|||
160796051|NCT02138825|580641175|FG001|Main Study Treatment|Medical decision|0|||
160796052|NCT02138825|580641174|FG000|Long-term Extension|Study termination by sponsor|32|||
160796053|NCT02138825|580641175|FG001|Long-term Extension|Study termination by sponsor|38|||
160796054|NCT02138825|580641174|FG000|Safety Follow-up|Adverse Event|4|||
160894378|NCT01626495|581008368|FG000|Overall Study|Death|2|||
160894379|NCT01626495|581008368|FG000|Overall Study|Physician Decision|1|||
160796055|NCT02138825|580641175|FG001|Safety Follow-up|Adverse Event|3|||
160796056|NCT02138825|580641174|FG000|Safety Follow-up|Death|11|||
160894380|NCT01626495|581008368|FG000|Overall Study|New cancer therapy|16|||
160796057|NCT02138825|580641175|FG001|Safety Follow-up|Death|5|||
160796058|NCT02138825|580641174|FG000|Safety Follow-up|Withdrawal by Subject|5|||
160796059|NCT02138825|580641175|FG001|Safety Follow-up|Withdrawal by Subject|3|||
160796060|NCT02138825|580641174|FG000|Safety Follow-up|clinic worsening|1|||
160796061|NCT02138825|580641175|FG001|Safety Follow-up|clinic worsening|0|||
160796062|NCT02138825|580641174|FG000|Safety Follow-up|withdrawal by PI|1|||
160796063|NCT02138825|580641175|FG001|Safety Follow-up|withdrawal by PI|0|||
160796064|NCT02138825|580641174|FG000|Safety Follow-up|logistical difficulties|0|||
160796065|NCT02138825|580641175|FG001|Safety Follow-up|logistical difficulties|1|||
160796066|NCT02138825|580641174|FG000|Safety Follow-up|progressive disease|0|||
160796067|NCT02138825|580641175|FG001|Safety Follow-up|progressive disease|2|||
160796068|NCT02138825|580641174|FG000|Safety Follow-up|too unwell to attend the visit|0|||
160796069|NCT02138825|580641175|FG001|Safety Follow-up|too unwell to attend the visit|1|||
160796070|NCT02138825|580641174|FG000|Safety Follow-up|treatment unblinded|0|||
160796071|NCT02138825|580641175|FG001|Safety Follow-up|treatment unblinded|1|||
160796072|NCT02138825|580641174|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
160796073|NCT02138825|580641175|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
160796074|NCT01702298|580641181|FG000|Overall Study|Withdrawal by Subject|1|||
160796075|NCT02090764|580641189|FG000|Overall Study|Adverse Event|1|||
160796076|NCT02090764|580641190|FG001|Overall Study|Adverse Event|3|||
160796077|NCT02090764|580641189|FG000|Overall Study|Lack of Efficacy|0|||
160796078|NCT02090764|580641190|FG001|Overall Study|Lack of Efficacy|13|||
160796079|NCT02090764|580641189|FG000|Overall Study|Withdrawal by Subject|2|||
160796080|NCT02090764|580641190|FG001|Overall Study|Withdrawal by Subject|1|||
160796081|NCT02090764|580641189|FG000|Overall Study|Intercurrent illness and other|1|||
160796082|NCT02090764|580641190|FG001|Overall Study|Intercurrent illness and other|1|||
160796083|NCT02090764|580641189|FG000|Overall Study|Lost to Follow-up|2|||
160796084|NCT02090764|580641190|FG001|Overall Study|Lost to Follow-up|2|||
160796085|NCT03605693|580641193|FG000|Overall Study|Lost to Follow-up|4|||
160796086|NCT03605693|580641194|FG001|Overall Study|Lost to Follow-up|0|||
160796087|NCT03605693|580641193|FG000|Overall Study|Physician Decision|1|||
160796088|NCT03605693|580641194|FG001|Overall Study|Physician Decision|0|||
160796089|NCT04752566|580641195|FG000|Overall Study|Protocol Violation|0|||
160796090|NCT04752566|580641196|FG001|Overall Study|Protocol Violation|1|||
160796091|NCT04752566|580641195|FG000|Overall Study|Death|1|||
160796092|NCT04752566|580641196|FG001|Overall Study|Death|0|||
160796093|NCT04752566|580641195|FG000|Overall Study|Adverse Event|1|||
160796094|NCT04752566|580641196|FG001|Overall Study|Adverse Event|0|||
160796095|NCT04752566|580641195|FG000|Overall Study|Withdrawal by Subject|2|||
160796096|NCT04752566|580641196|FG001|Overall Study|Withdrawal by Subject|0|||
160796097|NCT04752566|580641195|FG000|Overall Study|Physician Decision|1|||
160796098|NCT04752566|580641196|FG001|Overall Study|Physician Decision|1|||
160796099|NCT05134649|580641197|FG000|Overall Study|Lost to Follow-up|12|||
160796100|NCT05134649|580641197|FG000|Overall Study|Withdrawal by Subject|14|||
160796101|NCT05134649|580641197|FG000|Overall Study|Pregnancy|1|||
160796102|NCT05134649|580641197|FG000|Overall Study|Other, not specified|3|||
160796103|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
160796104|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
160796105|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
160796106|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
160796107|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
160796108|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
160796109|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
160796110|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
160796111|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
160796112|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
160796113|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
160796114|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
160796115|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
160796116|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
160796117|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
160796118|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
160796119|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
160796120|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
160796121|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
160894381|NCT01626495|581008368|FG000|Overall Study|Manufacturing failure|1|||
160894382|NCT01278160|581008369|FG000|Overall Study|Adverse Event|1|||
160894383|NCT01278160|581008370|FG001|Overall Study|Adverse Event|1|||
160894384|NCT01278160|581008369|FG000|Overall Study|Lost to Follow-up|0|||
160796122|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
160796123|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
160894385|NCT01278160|581008370|FG001|Overall Study|Lost to Follow-up|1|||
160894386|NCT01278160|581008369|FG000|Overall Study|Withdrawal by Subject|3|||
160894387|NCT01278160|581008370|FG001|Overall Study|Withdrawal by Subject|2|||
160796124|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
160796125|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
160796126|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
160796127|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
160796128|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
160796129|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
160796130|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
160796131|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
160796132|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
160796133|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
160796134|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
160796135|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
160796136|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
160796137|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
160796138|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
160796139|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
160796140|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
160796141|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
160796142|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
160796143|NCT04392154|580641200|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
160796144|NCT04392154|580641201|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
160796145|NCT04392154|580641202|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
160796146|NCT04392154|580641203|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
160796147|NCT04392154|580641200|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
160796148|NCT04392154|580641201|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
160796149|NCT04392154|580641202|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
160796150|NCT04392154|580641203|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
160796151|NCT04392154|580641200|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
160796152|NCT04392154|580641201|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
160796153|NCT04392154|580641202|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
160796154|NCT04392154|580641203|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
160796155|NCT04392154|580641200|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
160796156|NCT04392154|580641201|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
160796157|NCT04392154|580641202|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
160796158|NCT04392154|580641203|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
160796159|NCT00023595|580641206|FG000|5 Year Follow up|Lost to Follow-up|2|||
160796160|NCT00023595|580641207|FG001|5 Year Follow up|Lost to Follow-up|2|||
160796161|NCT00023595|580641208|FG002|5 Year Follow up|Lost to Follow-up|1|||
160796162|NCT00023595|580641209|FG003|5 Year Follow up|Lost to Follow-up|7|||
160796163|NCT00023595|580641210|FG004|5 Year Follow up|Lost to Follow-up|3|||
160796164|NCT00023595|580641206|FG000|10 Year Follow up|Lost to Follow-up|12|||
160796165|NCT00023595|580641207|FG001|10 Year Follow up|Lost to Follow-up|10|||
160796166|NCT00023595|580641208|FG002|10 Year Follow up|Lost to Follow-up|3|||
160796167|NCT00023595|580641209|FG003|10 Year Follow up|Lost to Follow-up|0|||
160796168|NCT00023595|580641210|FG004|10 Year Follow up|Lost to Follow-up|0|||
160796169|NCT02231580|580641220|FG000|Overall Study|Adverse Event|5|||
160796170|NCT02231580|580641221|FG001|Overall Study|Adverse Event|0|||
160796171|NCT04144517|580641227|FG000|Overall Study|Physician Decision|0|||
160796172|NCT04144517|580641228|FG001|Overall Study|Physician Decision|1|||
160796173|NCT04144517|580641227|FG000|Overall Study|Other|2|||
160796174|NCT04144517|580641228|FG001|Overall Study|Other|2|||
160796175|NCT04144517|580641227|FG000|Overall Study|Death|6|||
160796176|NCT04144517|580641228|FG001|Overall Study|Death|3|||
160796177|NCT05212168|580641231|FG000|Overall Study|Lost to Follow-up|0|||
160796178|NCT05212168|580641232|FG001|Overall Study|Lost to Follow-up|3|||
160796179|NCT05212168|580641231|FG000|Overall Study|Study terminated by sponsor|30|||
160796180|NCT05212168|580641232|FG001|Overall Study|Study terminated by sponsor|27|||
160796181|NCT05212168|580641231|FG000|Overall Study|Other|4|||
160796182|NCT05212168|580641232|FG001|Overall Study|Other|7|||
160796183|NCT03557502|580641235|FG000|Protocol 2|Withdrawal by Subject|1|||
160796184|NCT03557502|580641236|FG001|Protocol 2|Withdrawal by Subject|1|||
160796185|NCT03557502|580641235|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
160796186|NCT03557502|580641236|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
160796187|NCT00618787|580641244|FG000|Overall Study|Adverse Event|0|||
160796188|NCT00618787|580641245|FG001|Overall Study|Adverse Event|1|||
160894388|NCT01278160|581008369|FG000|Overall Study|Unclassified|1|||
161330978|NCT05616013|582597294|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
160796189|NCT00618787|580641244|FG000|Overall Study|Withdrawal by Subject|2|||
160796190|NCT00618787|580641245|FG001|Overall Study|Withdrawal by Subject|1|||
160796191|NCT00618787|580641244|FG000|Overall Study|Lost to Follow-up|1|||
160796192|NCT00618787|580641245|FG001|Overall Study|Lost to Follow-up|0|||
160894389|NCT01278160|581008370|FG001|Overall Study|Unclassified|2|||
161129404|NCT00950170|581860843|FG000|Overall Study|Adverse Event|2|||
161129405|NCT00950170|581860843|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161330979|NCT05616013|582597286|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330980|NCT05616013|582597287|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330981|NCT05616013|582597288|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330982|NCT05616013|582597289|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
161330983|NCT05616013|582597290|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330984|NCT05616013|582597291|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330985|NCT05616013|582597292|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330986|NCT05616013|582597293|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330987|NCT05616013|582597294|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
161330988|NCT05616013|582597286|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330989|NCT05616013|582597287|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330990|NCT05616013|582597288|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330991|NCT05616013|582597289|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330992|NCT05616013|582597290|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330993|NCT05616013|582597291|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330994|NCT05616013|582597292|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
161330995|NCT05616013|582597293|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330996|NCT05616013|582597294|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
161330997|NCT05616013|582597286|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161330998|NCT05616013|582597287|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161330999|NCT05616013|582597288|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161331000|NCT05616013|582597289|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161331001|NCT05616013|582597290|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161331002|NCT05616013|582597291|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161331003|NCT05616013|582597292|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161331004|NCT05616013|582597293|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
161331005|NCT05616013|582597294|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
161331006|NCT05616013|582597286|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331007|NCT05616013|582597287|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331008|NCT05616013|582597288|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331009|NCT05616013|582597289|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331010|NCT05616013|582597290|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331011|NCT05616013|582597291|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331012|NCT05616013|582597292|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331013|NCT05616013|582597293|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
161331014|NCT05616013|582597294|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
161331015|NCT02357459|582598760|FG000|Overall Study|Adverse Event|0|||
161331016|NCT02357459|582598761|FG001|Overall Study|Adverse Event|1|||
161331017|NCT02357459|582598762|FG002|Overall Study|Adverse Event|1|||
161331018|NCT02357459|582598760|FG000|Overall Study|Withdrawal by Subject|5|||
161331019|NCT02357459|582598761|FG001|Overall Study|Withdrawal by Subject|3|||
161331020|NCT02357459|582598762|FG002|Overall Study|Withdrawal by Subject|3|||
161331021|NCT02357459|582598760|FG000|Overall Study|Physician Decision|0|||
161331022|NCT02357459|582598761|FG001|Overall Study|Physician Decision|2|||
161331023|NCT02357459|582598762|FG002|Overall Study|Physician Decision|0|||
161331024|NCT02357459|582598760|FG000|Overall Study|Protocol Violation|1|||
161331025|NCT02357459|582598761|FG001|Overall Study|Protocol Violation|1|||
161331026|NCT02357459|582598762|FG002|Overall Study|Protocol Violation|0|||
161331027|NCT02357459|582598760|FG000|Overall Study|Lost to Follow-up|1|||
161331028|NCT02357459|582598761|FG001|Overall Study|Lost to Follow-up|3|||
161331029|NCT02357459|582598762|FG002|Overall Study|Lost to Follow-up|0|||
161331030|NCT02357459|582598760|FG000|Overall Study|Lack of Efficacy|7|||
161331031|NCT02357459|582598761|FG001|Overall Study|Lack of Efficacy|4|||
161331032|NCT02357459|582598762|FG002|Overall Study|Lack of Efficacy|4|||
160894390|NCT00304239|581008371|FG000|Overall Study|Protocol Deviations/Violations|15|||
160894391|NCT00304239|581008372|FG001|Overall Study|Protocol Deviations/Violations|0|||
160894392|NCT00304239|581008371|FG000|Overall Study|Adverse Event|2|||
160894393|NCT00304239|581008372|FG001|Overall Study|Adverse Event|0|||
160894394|NCT02979197|581008373|FG000|Overall Study|Adverse Event|4|||
160894395|NCT02979197|581008374|FG001|Overall Study|Adverse Event|2|||
160894396|NCT02979197|581008375|FG002|Overall Study|Adverse Event|0|||
161129406|NCT00600171|581860849|FG000|Overall Study|Adverse Event|0|||
161236050|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236051|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236052|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236053|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
160796193|NCT01107886|580641246|FG000|Overall Study|Lost to Follow-up|15|||
161236054|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
161236055|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236056|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236057|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236058|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236059|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
161236060|NCT01597245|582244926|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236061|NCT01597245|582244927|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236062|NCT01597245|582244928|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236063|NCT01597245|582244929|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236064|NCT01597245|582244930|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236065|NCT01597245|582244931|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236066|NCT01597245|582244932|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236067|NCT01597245|582244933|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236068|NCT01597245|582244934|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236069|NCT01597245|582244935|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236070|NCT01597245|582244936|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236071|NCT01597245|582244937|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236072|NCT01597245|582244938|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236073|NCT01597245|582244939|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
161236074|NCT01597245|582244940|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236075|NCT01597245|582244941|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236076|NCT01597245|582244942|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236077|NCT01597245|582244943|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236078|NCT01597245|582244944|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236079|NCT01597245|582244945|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236080|NCT01597245|582244946|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
161236081|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236082|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236083|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236084|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236085|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236086|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236087|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236088|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236089|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236090|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236091|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236092|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236093|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236094|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236095|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236096|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
161236097|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
161236098|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
161236099|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
161236100|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
161236101|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
161236102|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236103|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236104|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236105|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236106|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236107|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236108|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236109|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236110|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236111|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160796194|NCT01107886|580641247|FG001|Overall Study|Lost to Follow-up|13|||
160796195|NCT01107886|580641246|FG000|Overall Study|Withdrawal by Subject|180|||
160796196|NCT01107886|580641247|FG001|Overall Study|Withdrawal by Subject|196|||
160796197|NCT01107886|580641246|FG000|Overall Study|Administrative withdrawal of consent|7|||
160796198|NCT01107886|580641247|FG001|Overall Study|Administrative withdrawal of consent|5|||
160796199|NCT01346176|580641248|FG000|Recruited|Protocol Violation|1|||
160796200|NCT01346176|580641249|FG001|Recruited|Protocol Violation|0|||
160796201|NCT01346176|580641250|FG002|Recruited|Protocol Violation|0|||
160796202|NCT01346176|580641248|FG000|Completed Advance Directive|Death|3|||
160796203|NCT01346176|580641249|FG001|Completed Advance Directive|Death|2|||
160796204|NCT01346176|580641250|FG002|Completed Advance Directive|Death|2|||
160796205|NCT01346176|580641248|FG000|Completed Advance Directive|Became Ineligible|3|||
160796206|NCT01346176|580641249|FG001|Completed Advance Directive|Became Ineligible|0|||
160796207|NCT01346176|580641250|FG002|Completed Advance Directive|Became Ineligible|1|||
160796208|NCT01346176|580641248|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
160796209|NCT01346176|580641249|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
160796210|NCT01346176|580641250|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
160796211|NCT01346176|580641248|FG000|Completed Satisfaction Survey|Death|3|||
160796212|NCT01346176|580641249|FG001|Completed Satisfaction Survey|Death|0|||
160796213|NCT01346176|580641250|FG002|Completed Satisfaction Survey|Death|2|||
160796214|NCT01346176|580641248|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
160796215|NCT01346176|580641249|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
160796216|NCT01346176|580641250|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
160796217|NCT01994876|580641251|FG000|Test Period 1|Withdrawal by Subject|0|||
160796218|NCT01994876|580641252|FG001|Test Period 1|Withdrawal by Subject|1|||
160796219|NCT01994876|580641251|FG000|Test Period 1|Adverse Event|0|||
160796220|NCT01994876|580641252|FG001|Test Period 1|Adverse Event|1|||
160796221|NCT01994876|580641251|FG000|Test Period 2|Adverse Event|1|||
160796222|NCT01994876|580641252|FG001|Test Period 2|Adverse Event|0|||
160796223|NCT01994876|580641251|FG000|Test Period 2|Protocol Violation|0|||
160796224|NCT01994876|580641252|FG001|Test Period 2|Protocol Violation|1|||
160796225|NCT05819398|580641253|FG000|Overall Study|Withdrawal by Subject|11|||
160796226|NCT05819398|580641254|FG001|Overall Study|Withdrawal by Subject|7|||
160796227|NCT05819398|580641255|FG002|Overall Study|Withdrawal by Subject|6|||
160796228|NCT05819398|580641256|FG003|Overall Study|Withdrawal by Subject|6|||
160796229|NCT05819398|580641253|FG000|Overall Study|Lost to Follow-up|0|||
160796230|NCT05819398|580641254|FG001|Overall Study|Lost to Follow-up|2|||
160796231|NCT05819398|580641255|FG002|Overall Study|Lost to Follow-up|0|||
160796232|NCT05819398|580641256|FG003|Overall Study|Lost to Follow-up|1|||
160796233|NCT05819398|580641253|FG000|Overall Study|Adverse Event|1|||
160796234|NCT05819398|580641254|FG001|Overall Study|Adverse Event|3|||
160894397|NCT02979197|581008373|FG000|Overall Study|Protocol Violation|0|||
160894398|NCT02979197|581008374|FG001|Overall Study|Protocol Violation|1|||
160894399|NCT02979197|581008375|FG002|Overall Study|Protocol Violation|0|||
160894400|NCT02979197|581008373|FG000|Overall Study|Subject unable to commit to study dates|0|||
160894401|NCT02979197|581008374|FG001|Overall Study|Subject unable to commit to study dates|1|||
160894402|NCT02979197|581008375|FG002|Overall Study|Subject unable to commit to study dates|0|||
160894403|NCT02435069|581008376|FG000|Dose Response - First Intervention|Adverse Event|0|||
160894404|NCT02435069|581008377|FG001|Dose Response - First Intervention|Adverse Event|1|||
160894405|NCT02435069|581008378|FG002|Dose Response - First Intervention|Adverse Event|1|||
160894406|NCT02435069|581008379|FG003|Dose Response - First Intervention|Adverse Event|0|||
160894407|NCT02435069|581008380|FG004|Dose Response - First Intervention|Adverse Event|0|||
160894408|NCT02435069|581008376|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894409|NCT02435069|581008377|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894410|NCT02435069|581008378|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894411|NCT02435069|581008379|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
160894412|NCT02435069|581008380|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
160894413|NCT03112590|581008381|FG000|Overall Study|Adverse Event|0|||
160894414|NCT03112590|581008382|FG001|Overall Study|Adverse Event|1|||
160894415|NCT03112590|581008383|FG002|Overall Study|Adverse Event|0|||
160894416|NCT02436681|581008384|FG000|Overall Study|Lost to Follow-up|10|||
160894417|NCT02436681|581008384|FG000|Overall Study|Withdrawal by Subject|2|||
160894418|NCT02436681|581008384|FG000|Overall Study|Death|2|||
160894419|NCT03148275|581008391|FG000|Overall Study|Death|6|||
160983540|NCT02611830|581328661|FG000|OL Induction Phase|Reason not specified|3|||
160983541|NCT02611830|581328662|FG001|OL Induction Phase|Reason not specified|0|||
160983542|NCT02611830|581328663|FG002|OL Induction Phase|Reason not specified|0|||
161236112|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
160796235|NCT05819398|580641255|FG002|Overall Study|Adverse Event|4|||
160796236|NCT05819398|580641256|FG003|Overall Study|Adverse Event|5|||
160796237|NCT05819398|580641253|FG000|Overall Study|Other than listed|0|||
160796238|NCT05819398|580641254|FG001|Overall Study|Other than listed|2|||
160796239|NCT05819398|580641255|FG002|Overall Study|Other than listed|2|||
160894420|NCT03148275|581008391|FG000|Overall Study|Adverse Event|3|||
160894421|NCT03148275|581008391|FG000|Overall Study|Liver transplant|2|||
160894422|NCT03148275|581008391|FG000|Overall Study|Patient decision|5|||
160894423|NCT03148275|581008391|FG000|Overall Study|transition to commercial drug|1|||
160894424|NCT03148275|581008391|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
160894425|NCT05098938|581008392|FG000|Overall Study|Adverse Event|4|||
160894426|NCT05098938|581008393|FG001|Overall Study|Adverse Event|3|||
160894427|NCT05098938|581008392|FG000|Overall Study|inclusion/exclusion criteria change|11|||
160894428|NCT05098938|581008393|FG001|Overall Study|inclusion/exclusion criteria change|5|||
160894429|NCT05098938|581008392|FG000|Overall Study|lack of compliance|26|||
160894430|NCT05098938|581008393|FG001|Overall Study|lack of compliance|19|||
160894431|NCT05098938|581008392|FG000|Overall Study|Lost to Follow-up|37|||
160894432|NCT05098938|581008393|FG001|Overall Study|Lost to Follow-up|40|||
160894433|NCT05098938|581008392|FG000|Overall Study|Lost in treatment period|17|||
160894434|NCT05098938|581008393|FG001|Overall Study|Lost in treatment period|13|||
160894435|NCT05098938|581008392|FG000|Overall Study|Met an exclusion criterion|0|||
160894436|NCT05098938|581008393|FG001|Overall Study|Met an exclusion criterion|3|||
160894437|NCT05098938|581008392|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
160894438|NCT05098938|581008393|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
160894439|NCT05098938|581008392|FG000|Overall Study|Physician Decision|25|||
160894440|NCT05098938|581008393|FG001|Overall Study|Physician Decision|32|||
160894441|NCT05098938|581008392|FG000|Overall Study|Run in failure in treatment phase|1|||
160894442|NCT05098938|581008393|FG001|Overall Study|Run in failure in treatment phase|1|||
160894443|NCT05098938|581008392|FG000|Overall Study|Withdrawal by Subject|0|||
160894444|NCT05098938|581008393|FG001|Overall Study|Withdrawal by Subject|3|||
160894445|NCT05098938|581008392|FG000|Overall Study|Run-in Failure in early study|505|||
160894446|NCT05098938|581008393|FG001|Overall Study|Run-in Failure in early study|514|||
160894447|NCT05098938|581008392|FG000|Overall Study|IMP delivery missed|1|||
160894448|NCT05098938|581008393|FG001|Overall Study|IMP delivery missed|5|||
160894449|NCT05098938|581008392|FG000|Overall Study|6 months visit was missed|2|||
160894450|NCT05098938|581008393|FG001|Overall Study|6 months visit was missed|0|||
160894451|NCT05098938|581008392|FG000|Overall Study|fit for use was not completed within window|3|||
160894452|NCT05098938|581008393|FG001|Overall Study|fit for use was not completed within window|0|||
160894453|NCT05098938|581008392|FG000|Overall Study|V2 visit was not completed within window|0|||
160894454|NCT05098938|581008393|FG001|Overall Study|V2 visit was not completed within window|1|||
160894455|NCT05098938|581008392|FG000|Overall Study|exclusionary medication use|1|||
160894456|NCT05098938|581008393|FG001|Overall Study|exclusionary medication use|2|||
160894457|NCT05098938|581008392|FG000|Overall Study|change in medication|1|||
160894458|NCT05098938|581008393|FG001|Overall Study|change in medication|0|||
160894459|NCT05098938|581008392|FG000|Overall Study|treatment failure|2|||
160894460|NCT05098938|581008393|FG001|Overall Study|treatment failure|1|||
160894461|NCT01828320|581008394|FG000|Overall Study|Lost to Follow-up|1|||
161129407|NCT00600171|581860850|FG001|Overall Study|Adverse Event|1|||
161129408|NCT00600171|581860851|FG002|Overall Study|Adverse Event|0|||
161129409|NCT00600171|581860852|FG003|Overall Study|Adverse Event|0|||
161129410|NCT00600171|581860853|FG004|Overall Study|Adverse Event|1|||
161129411|NCT00600171|581860854|FG005|Overall Study|Adverse Event|0|||
161129412|NCT00600171|581860849|FG000|Overall Study|Lack of Efficacy|9|||
161129413|NCT00600171|581860850|FG001|Overall Study|Lack of Efficacy|12|||
161129414|NCT00600171|581860851|FG002|Overall Study|Lack of Efficacy|3|||
161129415|NCT00600171|581860852|FG003|Overall Study|Lack of Efficacy|5|||
161129416|NCT00600171|581860853|FG004|Overall Study|Lack of Efficacy|4|||
161129417|NCT00600171|581860854|FG005|Overall Study|Lack of Efficacy|0|||
161236113|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236114|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236115|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236116|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236117|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236118|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
161236119|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
161236120|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
161236121|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
161236122|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
161236123|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236124|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236125|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236126|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236127|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236128|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236129|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236130|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236131|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236132|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236133|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
160796240|NCT05819398|580641256|FG003|Overall Study|Other than listed|0|||
160796241|NCT05819398|580641253|FG000|Overall Study|Lack of Efficacy|0|||
160796242|NCT05819398|580641254|FG001|Overall Study|Lack of Efficacy|1|||
160796243|NCT05819398|580641255|FG002|Overall Study|Lack of Efficacy|0|||
160796244|NCT05819398|580641256|FG003|Overall Study|Lack of Efficacy|0|||
160796245|NCT05819398|580641253|FG000|Overall Study|Study terminated by sponsor|20|||
160796246|NCT05819398|580641254|FG001|Overall Study|Study terminated by sponsor|18|||
160796247|NCT05819398|580641255|FG002|Overall Study|Study terminated by sponsor|20|||
160796248|NCT05819398|580641256|FG003|Overall Study|Study terminated by sponsor|22|||
160894462|NCT01828320|581008395|FG001|Overall Study|Lost to Follow-up|3|||
160894463|NCT01828320|581008394|FG000|Overall Study|Withdrawal by Subject|7|||
160894464|NCT01828320|581008395|FG001|Overall Study|Withdrawal by Subject|2|||
160894465|NCT01397162|581010809|FG000|Overall Study|Adverse Event|4|||
160894466|NCT01397162|581010810|FG001|Overall Study|Adverse Event|0|||
160894467|NCT01397162|581010811|FG002|Overall Study|Adverse Event|0|||
160894468|NCT01397162|581010812|FG003|Overall Study|Adverse Event|0|||
160894469|NCT01397162|581010813|FG004|Overall Study|Adverse Event|0|||
161236134|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236135|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236136|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236137|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236138|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236139|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
161236140|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236141|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
161236142|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
161236143|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
161236144|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236145|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236146|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236147|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236148|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236149|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236150|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236151|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236152|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236153|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236154|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236155|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236156|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236157|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236158|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236159|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236160|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236161|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
161236162|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
161236163|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
161236164|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
161236165|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236166|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236167|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236168|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236169|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236170|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236171|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236172|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236173|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236174|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236175|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236176|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161331033|NCT02357459|582598760|FG000|Overall Study|Patient Relocated|2|||
160796249|NCT02520154|580641257|FG000|Overall Study|Death|1|||
160796250|NCT02520154|580641257|FG000|Overall Study|Withdrawal by Subject|2|||
160796251|NCT02520154|580641257|FG000|Overall Study|Physician Decision|2|||
160796252|NCT06022107|580641258|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
160796253|NCT06022107|580641258|FG000|Overall Study|Dropped out of study for higher level of care|1|||
160894470|NCT01397162|581010809|FG000|Overall Study|Not yet defined|3|||
160796254|NCT06022107|580641258|FG000|Overall Study|Lost to Follow-up|2|||
160796255|NCT05943990|580641259|FG000|Overall Study|Study Terminated by Sponsor|0|||
160796256|NCT05943990|580641260|FG001|Overall Study|Study Terminated by Sponsor|0|||
160796257|NCT05943990|580641261|FG002|Overall Study|Study Terminated by Sponsor|1|||
160796258|NCT02333799|580643563|FG000|Treatment Period|Withdrawal by Subject|1|||
160796259|NCT02333799|580643563|FG000|Treatment Period|Death|6|||
160796260|NCT02333799|580643563|FG000|6 Month Follow Up Period|Physician Decision|1|||
160796261|NCT02333799|580643563|FG000|6 Month Follow Up Period|Death|1|||
160796262|NCT02333799|580643563|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
160796263|NCT02333799|580643563|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
160796264|NCT05847686|580643564|FG000|Overall Study|Withdrawal by Subject|3|||
160796265|NCT03716830|580643565|FG000|Overall Study|Withdrawal by Subject|2|||
160796266|NCT03716830|580643566|FG001|Overall Study|Withdrawal by Subject|2|||
161236177|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160796267|NCT03716830|580643567|FG002|Overall Study|Withdrawal by Subject|6|||
160796268|NCT03716830|580643568|FG003|Overall Study|Withdrawal by Subject|5|||
160796269|NCT03716830|580643565|FG000|Overall Study|Adverse Event|1|||
160796270|NCT03716830|580643566|FG001|Overall Study|Adverse Event|2|||
160796271|NCT03716830|580643567|FG002|Overall Study|Adverse Event|0|||
160796272|NCT03716830|580643568|FG003|Overall Study|Adverse Event|1|||
160796273|NCT03716830|580643565|FG000|Overall Study|Lost to Follow-up|1|||
160796274|NCT03716830|580643566|FG001|Overall Study|Lost to Follow-up|1|||
160796275|NCT03716830|580643567|FG002|Overall Study|Lost to Follow-up|0|||
160796276|NCT03716830|580643568|FG003|Overall Study|Lost to Follow-up|0|||
160796277|NCT04887831|580643570|FG000|Overall Study|Death|26|||
160796278|NCT04887831|580643571|FG001|Overall Study|Death|26|||
160796279|NCT04887831|580643570|FG000|Overall Study|Lost to Follow-up|0|||
160796280|NCT04887831|580643571|FG001|Overall Study|Lost to Follow-up|1|||
160796281|NCT04887831|580643570|FG000|Overall Study|Withdrawal by Subject|2|||
160796282|NCT04887831|580643571|FG001|Overall Study|Withdrawal by Subject|1|||
160796283|NCT04887831|580643570|FG000|Overall Study|Study Terminated by Sponsor|18|||
160796284|NCT04887831|580643571|FG001|Overall Study|Study Terminated by Sponsor|17|||
160796285|NCT04887831|580643570|FG000|Overall Study|Other|1|||
160796286|NCT04887831|580643571|FG001|Overall Study|Other|0|||
160796287|NCT02276040|580643574|FG000|Overall Study|Physician Decision|15|||
160796288|NCT03674281|580643575|FG000|Overall Study|screen failure|2|||
160796289|NCT03674281|580643576|FG001|Overall Study|screen failure|0|||
160796290|NCT03674281|580643577|FG002|Overall Study|screen failure|0|||
160796291|NCT03674281|580643575|FG000|Overall Study|Withdrawal by Subject|1|||
160796292|NCT03674281|580643576|FG001|Overall Study|Withdrawal by Subject|3|||
160796293|NCT03674281|580643577|FG002|Overall Study|Withdrawal by Subject|3|||
160796294|NCT04622592|580643578|FG000|Overall Study|Death|0|||
160796295|NCT04622592|580643579|FG001|Overall Study|Death|0|||
160796296|NCT04622592|580643580|FG002|Overall Study|Death|1|||
160796297|NCT04622592|580643581|FG003|Overall Study|Death|0|||
160796298|NCT04622592|580643582|FG004|Overall Study|Death|0|||
160796299|NCT04622592|580643583|FG005|Overall Study|Death|0|||
160796300|NCT04622592|580643584|FG006|Overall Study|Death|0|||
160796301|NCT04622592|580643585|FG007|Overall Study|Death|1|||
160796302|NCT04622592|580643578|FG000|Overall Study|Lost to Follow-up|0|||
160796303|NCT04622592|580643579|FG001|Overall Study|Lost to Follow-up|0|||
160796304|NCT04622592|580643580|FG002|Overall Study|Lost to Follow-up|0|||
160796305|NCT04622592|580643581|FG003|Overall Study|Lost to Follow-up|3|||
160796306|NCT04622592|580643582|FG004|Overall Study|Lost to Follow-up|1|||
160796307|NCT04622592|580643583|FG005|Overall Study|Lost to Follow-up|0|||
161236178|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160796308|NCT04622592|580643584|FG006|Overall Study|Lost to Follow-up|2|||
160796309|NCT04622592|580643585|FG007|Overall Study|Lost to Follow-up|2|||
160796310|NCT04622592|580643578|FG000|Overall Study|Physician Decision|0|||
160796311|NCT04622592|580643579|FG001|Overall Study|Physician Decision|0|||
160796312|NCT04622592|580643580|FG002|Overall Study|Physician Decision|0|||
160796313|NCT04622592|580643581|FG003|Overall Study|Physician Decision|0|||
160796314|NCT04622592|580643582|FG004|Overall Study|Physician Decision|1|||
160796315|NCT04622592|580643583|FG005|Overall Study|Physician Decision|0|||
160796316|NCT04622592|580643584|FG006|Overall Study|Physician Decision|0|||
160796317|NCT04622592|580643585|FG007|Overall Study|Physician Decision|0|||
161236179|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160796318|NCT04622592|580643578|FG000|Overall Study|Withdrawal by Subject|1|||
160796319|NCT04622592|580643579|FG001|Overall Study|Withdrawal by Subject|0|||
160894471|NCT01397162|581010810|FG001|Overall Study|Not yet defined|4|||
160894472|NCT01397162|581010811|FG002|Overall Study|Not yet defined|3|||
160796320|NCT04622592|580643580|FG002|Overall Study|Withdrawal by Subject|2|||
160796321|NCT04622592|580643581|FG003|Overall Study|Withdrawal by Subject|0|||
160796322|NCT04622592|580643582|FG004|Overall Study|Withdrawal by Subject|0|||
160796323|NCT04622592|580643583|FG005|Overall Study|Withdrawal by Subject|0|||
160796324|NCT04622592|580643584|FG006|Overall Study|Withdrawal by Subject|1|||
160796325|NCT04622592|580643585|FG007|Overall Study|Withdrawal by Subject|4|||
160796326|NCT04622592|580643578|FG000|Overall Study|Other than specified above|0|||
160894473|NCT01397162|581010812|FG003|Overall Study|Not yet defined|5|||
160796327|NCT04622592|580643579|FG001|Overall Study|Other than specified above|0|||
160796328|NCT04622592|580643580|FG002|Overall Study|Other than specified above|1|||
160796329|NCT04622592|580643581|FG003|Overall Study|Other than specified above|0|||
160796330|NCT04622592|580643582|FG004|Overall Study|Other than specified above|0|||
160796331|NCT04622592|580643583|FG005|Overall Study|Other than specified above|0|||
160796332|NCT04622592|580643584|FG006|Overall Study|Other than specified above|0|||
160796333|NCT04622592|580643585|FG007|Overall Study|Other than specified above|0|||
160796334|NCT00276419|580643588|FG000|First Intervention|Adverse Event|1|||
160796335|NCT00276419|580643589|FG001|First Intervention|Adverse Event|0|||
160796336|NCT00276419|580643588|FG000|First Intervention|Withdrawal by Subject|0|||
160796337|NCT00276419|580643589|FG001|First Intervention|Withdrawal by Subject|2|||
160796338|NCT01645176|580643594|FG000|Overall Study|Lack of Efficacy|4|||
160796339|NCT01645176|580643594|FG000|Overall Study|did not complete final MRI|1|||
160796340|NCT02569853|580643595|FG000|Overall Study|Adverse Event|2|||
160796341|NCT02569853|580643596|FG001|Overall Study|Adverse Event|0|||
160796342|NCT02569853|580643595|FG000|Overall Study|Withdrawal by Subject|3|||
160796343|NCT02569853|580643596|FG001|Overall Study|Withdrawal by Subject|2|||
160796344|NCT02569853|580643595|FG000|Overall Study|Lost to Follow-up|3|||
160796345|NCT02569853|580643596|FG001|Overall Study|Lost to Follow-up|3|||
160796346|NCT02569853|580643595|FG000|Overall Study|Protocol Violation|1|||
160796347|NCT02569853|580643596|FG001|Overall Study|Protocol Violation|1|||
160796348|NCT02569853|580643595|FG000|Overall Study|Did not experience migraine attack|10|||
160796349|NCT02569853|580643596|FG001|Overall Study|Did not experience migraine attack|7|||
160796350|NCT02569853|580643595|FG000|Overall Study|Physician Decision|1|||
160796351|NCT02569853|580643596|FG001|Overall Study|Physician Decision|1|||
160796352|NCT00402987|580643597|FG000|Overall Study|Lack of Efficacy|0|||
160796353|NCT00402987|580643598|FG001|Overall Study|Lack of Efficacy|0|||
160796354|NCT00402987|580643599|FG002|Overall Study|Lack of Efficacy|1|||
160796355|NCT00402987|580643600|FG003|Overall Study|Lack of Efficacy|0|||
160796356|NCT01668004|580643601|FG000|Overall Study|Adverse Event|7|||
160796357|NCT01668004|580643601|FG000|Overall Study|Withdrawal by Subject|2|||
160796358|NCT01668004|580643601|FG000|Overall Study|Lost to Follow-up|5|||
160796359|NCT01668004|580643601|FG000|Overall Study|Lack of Efficacy|9|||
160796360|NCT01668004|580643601|FG000|Overall Study|Non-compliance with treatment|2|||
160796361|NCT02448381|580643603|FG000|Overall Study|Adverse Event|2|||
160796362|NCT02448381|580643604|FG001|Overall Study|Adverse Event|0|||
160796363|NCT02448381|580643603|FG000|Overall Study|Lost to Follow-up|16|||
160796364|NCT02448381|580643604|FG001|Overall Study|Lost to Follow-up|9|||
160796365|NCT02448381|580643603|FG000|Overall Study|Physician Decision|1|||
160796366|NCT02448381|580643604|FG001|Overall Study|Physician Decision|1|||
160796367|NCT02448381|580643603|FG000|Overall Study|Pregnancy|1|||
160796368|NCT02448381|580643604|FG001|Overall Study|Pregnancy|0|||
160796369|NCT02448381|580643603|FG000|Overall Study|Withdrawal by Subject|13|||
160796370|NCT02448381|580643604|FG001|Overall Study|Withdrawal by Subject|9|||
160796371|NCT02448381|580643603|FG000|Overall Study|Noncompliance with Study Procedures|2|||
160796372|NCT02448381|580643604|FG001|Overall Study|Noncompliance with Study Procedures|0|||
160796373|NCT02300233|580643610|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
160796374|NCT02300233|580643611|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
160796375|NCT02300233|580643612|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
160796376|NCT02300233|580643610|FG000|Overall Study|Withdrawal by Subject|1|||
160796377|NCT02300233|580643611|FG001|Overall Study|Withdrawal by Subject|0|||
160796378|NCT02300233|580643612|FG002|Overall Study|Withdrawal by Subject|3|||
160796379|NCT02300233|580643610|FG000|Overall Study|Investigator Judgement|0|||
160796380|NCT02300233|580643611|FG001|Overall Study|Investigator Judgement|0|||
160796381|NCT02300233|580643612|FG002|Overall Study|Investigator Judgement|1|||
160796382|NCT02300233|580643610|FG000|Overall Study|Reason Not Specified|0|||
161129418|NCT00600171|581860849|FG000|Overall Study|Protocol Violation|1|||
160796383|NCT02300233|580643611|FG001|Overall Study|Reason Not Specified|0|||
160796384|NCT02300233|580643612|FG002|Overall Study|Reason Not Specified|5|||
160796385|NCT00833690|580643613|FG000|Overall Study|Withdrawal by Subject|1|||
160796386|NCT00833690|580643614|FG001|Overall Study|Withdrawal by Subject|0|||
161129419|NCT00600171|581860850|FG001|Overall Study|Protocol Violation|2|||
161129420|NCT00600171|581860851|FG002|Overall Study|Protocol Violation|0|||
161129421|NCT00600171|581860852|FG003|Overall Study|Protocol Violation|1|||
161129422|NCT00600171|581860853|FG004|Overall Study|Protocol Violation|0|||
160796387|NCT00833690|580643615|FG002|Overall Study|Withdrawal by Subject|0|||
161129423|NCT00600171|581860854|FG005|Overall Study|Protocol Violation|0|||
161129424|NCT00600171|581860849|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
160796388|NCT00833690|580643613|FG000|Overall Study|Discontinued study drug|3|||
160796389|NCT00833690|580643614|FG001|Overall Study|Discontinued study drug|2|||
160796390|NCT00833690|580643615|FG002|Overall Study|Discontinued study drug|0|||
160796391|NCT00744861|580643616|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
160796392|NCT00744861|580643617|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
160796393|NCT00744861|580643618|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
160796394|NCT00744861|580643619|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
160796395|NCT00744861|580643616|FG000|Feasibility Stage 1|Pregnancy|0|||
160796396|NCT00744861|580643617|FG001|Feasibility Stage 1|Pregnancy|1|||
160796397|NCT00744861|580643618|FG002|Feasibility Stage 1|Pregnancy|0|||
160796398|NCT00744861|580643619|FG003|Feasibility Stage 1|Pregnancy|0|||
160796399|NCT00744861|580643616|FG000|Pivotal Stage 2|Adverse Event|0|||
160796400|NCT00744861|580643617|FG001|Pivotal Stage 2|Adverse Event|0|||
160796401|NCT00744861|580643618|FG002|Pivotal Stage 2|Adverse Event|6|||
160796402|NCT00744861|580643619|FG003|Pivotal Stage 2|Adverse Event|11|||
160796403|NCT00744861|580643616|FG000|Pivotal Stage 2|Death|0|||
160796404|NCT00744861|580643617|FG001|Pivotal Stage 2|Death|0|||
160796405|NCT00744861|580643618|FG002|Pivotal Stage 2|Death|0|||
160796406|NCT00744861|580643619|FG003|Pivotal Stage 2|Death|1|||
160796407|NCT00744861|580643616|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
160796408|NCT00744861|580643617|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
160796409|NCT00744861|580643618|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
160796410|NCT00744861|580643619|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
160796411|NCT00744861|580643616|FG000|Pivotal Stage 2|Physician Decision|0|||
160796412|NCT00744861|580643617|FG001|Pivotal Stage 2|Physician Decision|0|||
160796413|NCT00744861|580643618|FG002|Pivotal Stage 2|Physician Decision|3|||
160796414|NCT00744861|580643619|FG003|Pivotal Stage 2|Physician Decision|1|||
160796415|NCT00744861|580643616|FG000|Pivotal Stage 2|Protocol Violation|0|||
160796416|NCT00744861|580643617|FG001|Pivotal Stage 2|Protocol Violation|0|||
160796417|NCT00744861|580643618|FG002|Pivotal Stage 2|Protocol Violation|0|||
160796418|NCT00744861|580643619|FG003|Pivotal Stage 2|Protocol Violation|1|||
160796419|NCT00744861|580643616|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
160796420|NCT00744861|580643617|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
160796421|NCT00744861|580643618|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
160796422|NCT00744861|580643619|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
160796423|NCT00744861|580643616|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
160796424|NCT00744861|580643617|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
160796425|NCT00744861|580643618|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
160796426|NCT00744861|580643619|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
160796427|NCT04856527|580643620|FG000|Overall Study|Unable to complete experimental task|2|||
160796428|NCT04856527|580643621|FG001|Overall Study|Unable to complete experimental task|0|||
160796429|NCT02115321|580643622|FG000|Overall Study|Death|1|||
160796430|NCT02115321|580643623|FG001|Overall Study|Death|0|||
160796431|NCT04403919|580643628|FG000|Overall Study|Lost to Follow-up|0|||
160796432|NCT04403919|580643629|FG001|Overall Study|Lost to Follow-up|0|||
160796433|NCT04403919|580643630|FG002|Overall Study|Lost to Follow-up|0|||
160796434|NCT04403919|580643631|FG003|Overall Study|Lost to Follow-up|1|||
160796435|NCT02038647|580643633|FG000|Overall Study|Progressive Disease|50|||
160796436|NCT02038647|580643634|FG001|Overall Study|Progressive Disease|59|||
160796437|NCT02038647|580643633|FG000|Overall Study|Adverse Event|18|||
160796438|NCT02038647|580643634|FG001|Overall Study|Adverse Event|10|||
160796439|NCT02038647|580643633|FG000|Overall Study|Symptomatic Deterioration|7|||
160796440|NCT02038647|580643634|FG001|Overall Study|Symptomatic Deterioration|7|||
160796441|NCT02038647|580643633|FG000|Overall Study|Withdrawal by Subject|5|||
160796442|NCT02038647|580643634|FG001|Overall Study|Withdrawal by Subject|2|||
160796443|NCT02038647|580643633|FG000|Overall Study|Not Reported|0|||
160796444|NCT02038647|580643634|FG001|Overall Study|Not Reported|1|||
160796445|NCT02038647|580643633|FG000|Overall Study|Ongoing at Datacut|9|||
160796446|NCT02038647|580643634|FG001|Overall Study|Ongoing at Datacut|10|||
160796447|NCT02757430|580643635|FG000|Overall Study|Physician Decision|6|||
160796448|NCT02757430|580643635|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
160796449|NCT02757430|580643635|FG000|Overall Study|No informed consent|1|||
160796450|NCT02757430|580643635|FG000|Overall Study|No procedure performed|2|||
160796451|NCT01983111|580643636|FG000|Overall Study|Withdrawal by Subject|8|||
160796452|NCT01983111|580643637|FG001|Overall Study|Withdrawal by Subject|6|||
160796453|NCT01983111|580643636|FG000|Overall Study|Adverse Event|4|||
160983543|NCT02611830|581328664|FG003|OL Induction Phase|Reason not specified|0|||
160983544|NCT02611830|581328661|FG000|Maintenance Phase|Lack of Efficacy|0|||
160983545|NCT02611830|581328662|FG001|Maintenance Phase|Lack of Efficacy|29|||
160796454|NCT01983111|580643637|FG001|Overall Study|Adverse Event|0|||
160796455|NCT01983111|580643636|FG000|Overall Study|Protocol Violation|0|||
160796456|NCT01983111|580643637|FG001|Overall Study|Protocol Violation|1|||
160796457|NCT03502200|580643638|FG000|Overall Study|Adverse Event|1|||
160796458|NCT03502200|580643639|FG001|Overall Study|Adverse Event|0|||
160796459|NCT03502200|580643638|FG000|Overall Study|Lost to Follow-up|36|||
160796460|NCT03502200|580643639|FG001|Overall Study|Lost to Follow-up|38|||
160796461|NCT03502200|580643638|FG000|Overall Study|Study Team Decision|1|||
160796462|NCT03502200|580643639|FG001|Overall Study|Study Team Decision|1|||
160796463|NCT03502200|580643638|FG000|Overall Study|Withdrawal by Subject|5|||
160983546|NCT02611830|581328663|FG002|Maintenance Phase|Lack of Efficacy|18|||
160796464|NCT03502200|580643639|FG001|Overall Study|Withdrawal by Subject|7|||
160796465|NCT03502200|580643638|FG000|Overall Study|Death|0|||
160796466|NCT03502200|580643639|FG001|Overall Study|Death|2|||
160796467|NCT00855335|580643640|FG000|Overall Study|Lost to Follow-up|0|||
160796468|NCT00855335|580643641|FG001|Overall Study|Lost to Follow-up|0|||
160796469|NCT00855335|580643642|FG002|Overall Study|Lost to Follow-up|3|||
160796470|NCT00855335|580643643|FG003|Overall Study|Lost to Follow-up|1|||
160796471|NCT00855335|580643644|FG004|Overall Study|Lost to Follow-up|0|||
160796472|NCT00855335|580643640|FG000|Overall Study|Withdrawal by Subject|0|||
160796473|NCT00855335|580643641|FG001|Overall Study|Withdrawal by Subject|0|||
160796474|NCT00855335|580643642|FG002|Overall Study|Withdrawal by Subject|0|||
160796475|NCT00855335|580643643|FG003|Overall Study|Withdrawal by Subject|1|||
160796476|NCT00855335|580643644|FG004|Overall Study|Withdrawal by Subject|0|||
160796477|NCT00855335|580643640|FG000|Overall Study|Adverse Event|2|||
160796478|NCT00855335|580643641|FG001|Overall Study|Adverse Event|0|||
160796479|NCT00855335|580643642|FG002|Overall Study|Adverse Event|0|||
160796480|NCT00855335|580643643|FG003|Overall Study|Adverse Event|0|||
160796481|NCT00855335|580643644|FG004|Overall Study|Adverse Event|0|||
160796482|NCT00855335|580643640|FG000|Overall Study|Physician Decision|1|||
160796483|NCT00855335|580643641|FG001|Overall Study|Physician Decision|1|||
160796484|NCT00855335|580643642|FG002|Overall Study|Physician Decision|0|||
160796485|NCT00855335|580643643|FG003|Overall Study|Physician Decision|0|||
160796486|NCT00855335|580643644|FG004|Overall Study|Physician Decision|0|||
160796487|NCT00855335|580643640|FG000|Overall Study|Other|2|||
160894474|NCT01397162|581010813|FG004|Overall Study|Not yet defined|3|||
160894475|NCT01507298|581010814|FG000|Overall Study|Protocol Violation|0|||
160894476|NCT01507298|581010815|FG001|Overall Study|Protocol Violation|6|||
160894477|NCT01920555|581010816|FG000|Overall Study|Physician Decision|1|||
160894478|NCT01920555|581010817|FG001|Overall Study|Physician Decision|2|||
160894479|NCT01920555|581010818|FG002|Overall Study|Physician Decision|1|||
160894480|NCT01920555|581010819|FG003|Overall Study|Physician Decision|2|||
160894481|NCT01920555|581010820|FG004|Overall Study|Physician Decision|0|||
160894482|NCT01920555|581010816|FG000|Overall Study|Lack of Efficacy|2|||
160894483|NCT01920555|581010817|FG001|Overall Study|Lack of Efficacy|0|||
160894484|NCT01920555|581010818|FG002|Overall Study|Lack of Efficacy|0|||
160894485|NCT01920555|581010819|FG003|Overall Study|Lack of Efficacy|0|||
160894486|NCT01920555|581010820|FG004|Overall Study|Lack of Efficacy|0|||
160894487|NCT01920555|581010816|FG000|Overall Study|Travel Difficulties|1|||
160894488|NCT01920555|581010817|FG001|Overall Study|Travel Difficulties|1|||
160894489|NCT01920555|581010818|FG002|Overall Study|Travel Difficulties|0|||
160894490|NCT01920555|581010819|FG003|Overall Study|Travel Difficulties|0|||
160894491|NCT01920555|581010820|FG004|Overall Study|Travel Difficulties|1|||
160894492|NCT01920555|581010816|FG000|Overall Study|Lost to Follow-up|0|||
160894493|NCT01920555|581010817|FG001|Overall Study|Lost to Follow-up|1|||
160894494|NCT01920555|581010818|FG002|Overall Study|Lost to Follow-up|0|||
160894495|NCT01920555|581010819|FG003|Overall Study|Lost to Follow-up|1|||
160894496|NCT01920555|581010820|FG004|Overall Study|Lost to Follow-up|0|||
160894497|NCT00195273|581010821|FG000|Overall Study|Adverse Event|9|||
160894498|NCT00195273|581010822|FG001|Overall Study|Adverse Event|9|||
160894499|NCT00195273|581010821|FG000|Overall Study|Protocol deviation|0|||
160894500|NCT00195273|581010822|FG001|Overall Study|Protocol deviation|1|||
160894501|NCT00195273|581010821|FG000|Overall Study|Lack of Efficacy|3|||
160894502|NCT00195273|581010822|FG001|Overall Study|Lack of Efficacy|1|||
160894503|NCT00195273|581010821|FG000|Overall Study|Procedural complications|9|||
160894504|NCT00195273|581010822|FG001|Overall Study|Procedural complications|3|||
160894505|NCT02367131|581010823|FG000|Overall Study|Adverse Event|64|||
160894506|NCT02367131|581010823|FG000|Overall Study|No visit since the first visit|3|||
160894507|NCT02367131|581010823|FG000|Overall Study|Request by patient|53|||
160894508|NCT02367131|581010823|FG000|Overall Study|Improvement/remission|2|||
160894509|NCT02367131|581010823|FG000|Overall Study|No change/progressive disease|78|||
160894510|NCT02367131|581010823|FG000|Overall Study|Other than stated above|20|||
160894511|NCT02367131|581010823|FG000|Overall Study|Not treated|2|||
160894512|NCT00810108|581010829|FG000|Overall Study|Withdrawal by Subject|1|||
160894513|NCT00810108|581010830|FG001|Overall Study|Withdrawal by Subject|0|||
160894514|NCT01051466|581010831|FG000|Overall Study|Adverse Event|1|||
161129425|NCT00600171|581860850|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161129426|NCT00600171|581860851|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
160796488|NCT00855335|580643641|FG001|Overall Study|Other|1|||
160796489|NCT00855335|580643642|FG002|Overall Study|Other|2|||
160796490|NCT00855335|580643643|FG003|Overall Study|Other|5|||
160796491|NCT00855335|580643644|FG004|Overall Study|Other|1|||
160796492|NCT03097289|580643646|FG000|Overall Study|Adverse Event|1|||
160796493|NCT03097289|580643646|FG000|Overall Study|Equipment failure|2|||
160796494|NCT03097289|580643646|FG000|Overall Study|Collected platelet product unusable|3|||
160796495|NCT02526290|580643649|FG000|Overall Study|Adverse Event|3|||
160894515|NCT01051466|581010832|FG001|Overall Study|Adverse Event|0|||
160894516|NCT01051466|581010831|FG000|Overall Study|Lost to Follow-up|1|||
160894517|NCT01051466|581010832|FG001|Overall Study|Lost to Follow-up|1|||
160894518|NCT01051466|581010831|FG000|Overall Study|Withdrawal by Subject|5|||
160894519|NCT01051466|581010832|FG001|Overall Study|Withdrawal by Subject|1|||
160894520|NCT01051466|581010831|FG000|Overall Study|Entry Criteria Not Met|0|||
160894521|NCT01051466|581010832|FG001|Overall Study|Entry Criteria Not Met|3|||
160796496|NCT02526290|580643649|FG000|Overall Study|Withdrawal by Subject|4|||
160796497|NCT02526290|580643649|FG000|Overall Study|Physician Decision|1|||
160894522|NCT01051466|581010831|FG000|Overall Study|Physician Decision|1|||
160894523|NCT01051466|581010832|FG001|Overall Study|Physician Decision|0|||
160796498|NCT00049543|580643652|FG000|Overall Study|still on treatment|2|||
160796499|NCT00049543|580643653|FG001|Overall Study|still on treatment|9|||
160796500|NCT02106832|580643654|FG000|Overall Study|Adverse Event|1|||
160796501|NCT02106832|580643655|FG001|Overall Study|Adverse Event|2|||
160796502|NCT02106832|580643656|FG002|Overall Study|Adverse Event|3|||
160796503|NCT02106832|580643657|FG003|Overall Study|Adverse Event|0|||
160796504|NCT02106832|580643654|FG000|Overall Study|Death|4|||
160796505|NCT02106832|580643655|FG001|Overall Study|Death|4|||
160796506|NCT02106832|580643656|FG002|Overall Study|Death|1|||
160796507|NCT02106832|580643657|FG003|Overall Study|Death|4|||
160796508|NCT02106832|580643654|FG000|Overall Study|Deterioration of general conditions|0|||
160796509|NCT02106832|580643655|FG001|Overall Study|Deterioration of general conditions|0|||
160796510|NCT02106832|580643656|FG002|Overall Study|Deterioration of general conditions|1|||
160796511|NCT02106832|580643657|FG003|Overall Study|Deterioration of general conditions|0|||
160796512|NCT02106832|580643654|FG000|Overall Study|Lost to Follow-up|0|||
160796513|NCT02106832|580643655|FG001|Overall Study|Lost to Follow-up|1|||
160796514|NCT02106832|580643656|FG002|Overall Study|Lost to Follow-up|1|||
160796515|NCT02106832|580643657|FG003|Overall Study|Lost to Follow-up|3|||
160796516|NCT02106832|580643654|FG000|Overall Study|Physician Decision|1|||
160796517|NCT02106832|580643655|FG001|Overall Study|Physician Decision|0|||
160796518|NCT02106832|580643656|FG002|Overall Study|Physician Decision|0|||
160796519|NCT02106832|580643657|FG003|Overall Study|Physician Decision|0|||
160796520|NCT02106832|580643654|FG000|Overall Study|Protocol Violation|0|||
160796521|NCT02106832|580643655|FG001|Overall Study|Protocol Violation|0|||
160796522|NCT02106832|580643656|FG002|Overall Study|Protocol Violation|0|||
160796523|NCT02106832|580643657|FG003|Overall Study|Protocol Violation|1|||
160796524|NCT02106832|580643654|FG000|Overall Study|Withdrawal by Subject|17|||
160796525|NCT02106832|580643655|FG001|Overall Study|Withdrawal by Subject|17|||
160796526|NCT02106832|580643656|FG002|Overall Study|Withdrawal by Subject|10|||
160796527|NCT02106832|580643657|FG003|Overall Study|Withdrawal by Subject|7|||
160796528|NCT02106832|580643654|FG000|Overall Study|Technical problems|0|||
160796529|NCT02106832|580643655|FG001|Overall Study|Technical problems|1|||
160796530|NCT02106832|580643656|FG002|Overall Study|Technical problems|0|||
160796531|NCT02106832|580643657|FG003|Overall Study|Technical problems|0|||
160796532|NCT00619866|580643676|FG000|Weeks 1 - 12|Adverse Event|0|||
160796533|NCT00619866|580643677|FG001|Weeks 1 - 12|Adverse Event|1|||
160796534|NCT00619866|580643678|FG002|Weeks 1 - 12|Adverse Event|2|||
160796535|NCT00619866|580643679|FG003|Weeks 1 - 12|Adverse Event|0|||
160796536|NCT00619866|580643680|FG004|Weeks 1 - 12|Adverse Event|0|||
160796537|NCT00619866|580643676|FG000|Weeks 1 - 12|Non-compliance|0|||
160796538|NCT00619866|580643677|FG001|Weeks 1 - 12|Non-compliance|0|||
160796539|NCT00619866|580643678|FG002|Weeks 1 - 12|Non-compliance|1|||
160796540|NCT00619866|580643679|FG003|Weeks 1 - 12|Non-compliance|0|||
160796541|NCT00619866|580643680|FG004|Weeks 1 - 12|Non-compliance|0|||
160796542|NCT00619866|580643676|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
160983547|NCT02611830|581328664|FG003|Maintenance Phase|Lack of Efficacy|6|||
160983548|NCT02611830|581328661|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
160983549|NCT02611830|581328662|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
160983550|NCT02611830|581328663|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
160983551|NCT02611830|581328664|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
160983552|NCT02611830|581328661|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
160983553|NCT02611830|581328662|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
160983554|NCT02611830|581328663|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
160983555|NCT02611830|581328664|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
160983556|NCT02611830|581328661|FG000|Maintenance Phase|Lost to Follow-up|0|||
160983557|NCT02611830|581328662|FG001|Maintenance Phase|Lost to Follow-up|0|||
160983558|NCT02611830|581328663|FG002|Maintenance Phase|Lost to Follow-up|0|||
160983559|NCT02611830|581328664|FG003|Maintenance Phase|Lost to Follow-up|1|||
160983560|NCT02611830|581328661|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
160983561|NCT02611830|581328662|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
160983562|NCT02611830|581328663|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
161129427|NCT00600171|581860852|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
161331034|NCT02357459|582598761|FG001|Overall Study|Patient Relocated|0|||
160983563|NCT02611830|581328664|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
161129428|NCT00600171|581860853|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
161129429|NCT00600171|581860854|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160796543|NCT00619866|580643677|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
160796544|NCT00619866|580643678|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
160796545|NCT00619866|580643679|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
160796546|NCT00619866|580643680|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
160796547|NCT00619866|580643676|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
160796548|NCT00619866|580643677|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
160796549|NCT00619866|580643678|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
161129430|NCT00600171|581860849|FG000|Overall Study|Withdrawal by Subject|3|||
160796550|NCT00619866|580643679|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
160796551|NCT00619866|580643680|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
160796552|NCT00619866|580643676|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
160796553|NCT00619866|580643677|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
160796554|NCT00619866|580643678|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
160796555|NCT00619866|580643679|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
160796556|NCT00619866|580643680|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
160796557|NCT00619866|580643676|FG000|Weeks 1 - 12|Sponsor Decision|0|||
160796558|NCT00619866|580643677|FG001|Weeks 1 - 12|Sponsor Decision|1|||
160796559|NCT00619866|580643678|FG002|Weeks 1 - 12|Sponsor Decision|0|||
160796560|NCT00619866|580643679|FG003|Weeks 1 - 12|Sponsor Decision|0|||
160796561|NCT00619866|580643680|FG004|Weeks 1 - 12|Sponsor Decision|0|||
160796562|NCT00619866|580643676|FG000|Weeks 13 - 24|Adverse Event|0|||
160796563|NCT00619866|580643677|FG001|Weeks 13 - 24|Adverse Event|0|||
160796564|NCT00619866|580643678|FG002|Weeks 13 - 24|Adverse Event|2|||
160796565|NCT00619866|580643679|FG003|Weeks 13 - 24|Adverse Event|1|||
160796566|NCT00619866|580643680|FG004|Weeks 13 - 24|Adverse Event|0|||
160796567|NCT00619866|580643676|FG000|Weeks 13 - 24|Protocol Deviation|0|||
160796568|NCT00619866|580643677|FG001|Weeks 13 - 24|Protocol Deviation|0|||
160796569|NCT00619866|580643678|FG002|Weeks 13 - 24|Protocol Deviation|0|||
160796570|NCT00619866|580643679|FG003|Weeks 13 - 24|Protocol Deviation|1|||
160796571|NCT00619866|580643680|FG004|Weeks 13 - 24|Protocol Deviation|0|||
160796572|NCT00619866|580643676|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
160796573|NCT00619866|580643677|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
160796574|NCT00619866|580643678|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
160796575|NCT00619866|580643679|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
160796576|NCT00619866|580643680|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
160796577|NCT00619866|580643676|FG000|Weeks 13 - 24|Non-compliance|0|||
160796578|NCT00619866|580643677|FG001|Weeks 13 - 24|Non-compliance|1|||
160796579|NCT00619866|580643678|FG002|Weeks 13 - 24|Non-compliance|1|||
160796580|NCT00619866|580643679|FG003|Weeks 13 - 24|Non-compliance|0|||
160796581|NCT00619866|580643680|FG004|Weeks 13 - 24|Non-compliance|0|||
160796582|NCT00619866|580643676|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
160796583|NCT00619866|580643677|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
160796584|NCT00619866|580643678|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
160796585|NCT00619866|580643679|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
160796586|NCT00619866|580643680|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
160796587|NCT04716894|580643681|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
160796588|NCT04716894|580643681|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
160796589|NCT05205616|580643688|FG000|Overall Study|Lost to Follow-up|4|||
160796590|NCT05205616|580643689|FG001|Overall Study|Lost to Follow-up|4|||
160796591|NCT01467466|580643692|FG000|Overall Study|Withdrawal by Subject|15|||
160796592|NCT01467466|580643693|FG001|Overall Study|Withdrawal by Subject|18|||
160796593|NCT01467466|580643694|FG002|Overall Study|Withdrawal by Subject|13|||
160796594|NCT01467466|580643695|FG003|Overall Study|Withdrawal by Subject|11|||
160796595|NCT01467466|580643692|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
160796596|NCT01467466|580643693|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
160796597|NCT01467466|580643694|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
160796598|NCT01467466|580643695|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
160796599|NCT01467466|580643692|FG000|Overall Study|Procedure Cancelled|46|||
160796600|NCT01467466|580643693|FG001|Overall Study|Procedure Cancelled|45|||
160796601|NCT01467466|580643694|FG002|Overall Study|Procedure Cancelled|25|||
160796602|NCT01467466|580643695|FG003|Overall Study|Procedure Cancelled|29|||
160796603|NCT01467466|580643692|FG000|Overall Study|No Endpoint Blood Draw|38|||
160796604|NCT01467466|580643693|FG001|Overall Study|No Endpoint Blood Draw|32|||
160796605|NCT01467466|580643694|FG002|Overall Study|No Endpoint Blood Draw|51|||
160796606|NCT01467466|580643695|FG003|Overall Study|No Endpoint Blood Draw|43|||
160796607|NCT00787150|580643696|FG000|Overall Study|Adverse Event|4|||
160796608|NCT00787150|580643697|FG001|Overall Study|Adverse Event|4|||
160796609|NCT00787150|580643698|FG002|Overall Study|Adverse Event|4|||
160796610|NCT00787150|580643696|FG000|Overall Study|Physician Decision|1|||
160796611|NCT00787150|580643697|FG001|Overall Study|Physician Decision|2|||
160796612|NCT00787150|580643698|FG002|Overall Study|Physician Decision|1|||
160796613|NCT00787150|580643696|FG000|Overall Study|Withdrawal by Subject|2|||
160796614|NCT00787150|580643697|FG001|Overall Study|Withdrawal by Subject|1|||
160983564|NCT02611830|581328661|FG000|Maintenance Phase|Pregnancy|0|||
161331035|NCT02357459|582598762|FG002|Overall Study|Patient Relocated|0|||
160796615|NCT00787150|580643698|FG002|Overall Study|Withdrawal by Subject|0|||
160796616|NCT00787150|580643696|FG000|Overall Study|Dosing incorrect study durg|2|||
160796617|NCT00787150|580643697|FG001|Overall Study|Dosing incorrect study durg|0|||
160796618|NCT00787150|580643698|FG002|Overall Study|Dosing incorrect study durg|0|||
160796619|NCT00982280|580643705|FG000|Observation Period|Not eligible to be dosed|19|||
160796620|NCT00982280|580643705|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
160796621|NCT00982280|580643705|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
160796622|NCT00982280|580643705|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
160796623|NCT00982280|580643705|FG000|Maintenance Period|Adverse Event|1|||
160796624|NCT06028464|580643713|FG000|Washout|Positive drug test.|1|||
160796625|NCT03636022|580643714|FG000|Overall Study|Withdrawal by Subject|1|||
160796626|NCT03636022|580643715|FG001|Overall Study|Withdrawal by Subject|3|||
160796627|NCT03330847|580643716|FG000|Overall Study|Patients ongoing study|62|||
160796628|NCT03330847|580643717|FG001|Overall Study|Patients ongoing study|65|||
160796629|NCT03330847|580643718|FG002|Overall Study|Patients ongoing study|15|||
160796630|NCT03274466|580643721|FG000|Overall Study|Withdrawal by Subject|7|||
160796631|NCT03274466|580643722|FG001|Overall Study|Withdrawal by Subject|3|||
160796632|NCT03274466|580643721|FG000|Overall Study|Protocol Specified Withdrawal|5|||
160796633|NCT03274466|580643722|FG001|Overall Study|Protocol Specified Withdrawal|11|||
160796634|NCT03274466|580643721|FG000|Overall Study|Lost to Follow-up|5|||
160796635|NCT03274466|580643722|FG001|Overall Study|Lost to Follow-up|7|||
160796636|NCT03274466|580643721|FG000|Overall Study|Subject Non-compliance|0|||
160796637|NCT03274466|580643722|FG001|Overall Study|Subject Non-compliance|1|||
160796638|NCT03274466|580643721|FG000|Overall Study|Adverse Event|3|||
160796639|NCT03274466|580643722|FG001|Overall Study|Adverse Event|3|||
160796640|NCT03274466|580643721|FG000|Overall Study|Physician Decision|0|||
160796641|NCT03274466|580643722|FG001|Overall Study|Physician Decision|1|||
160796642|NCT03274466|580643721|FG000|Overall Study|Protocol Violation|3|||
160796643|NCT03274466|580643722|FG001|Overall Study|Protocol Violation|3|||
160796644|NCT02581930|580643730|FG000|Overall Study|Withdrawal by Subject|1|||
160796645|NCT02581930|580643730|FG000|Overall Study|patient declined further treatment|1|||
160796646|NCT02776735|580643731|FG000|Overall Study|Adverse Event|0|||
160796647|NCT02776735|580643732|FG001|Overall Study|Adverse Event|0|||
160796648|NCT02776735|580643733|FG002|Overall Study|Adverse Event|0|||
160796649|NCT02776735|580643734|FG003|Overall Study|Adverse Event|1|||
160796650|NCT02776735|580643735|FG004|Overall Study|Adverse Event|0|||
160796651|NCT02776735|580643736|FG005|Overall Study|Adverse Event|1|||
160796652|NCT02776735|580643731|FG000|Overall Study|Lost to Follow-up|0|||
160796653|NCT02776735|580643732|FG001|Overall Study|Lost to Follow-up|0|||
160796654|NCT02776735|580643733|FG002|Overall Study|Lost to Follow-up|0|||
160796655|NCT02776735|580643734|FG003|Overall Study|Lost to Follow-up|1|||
160796656|NCT02776735|580643735|FG004|Overall Study|Lost to Follow-up|0|||
160796657|NCT02776735|580643736|FG005|Overall Study|Lost to Follow-up|0|||
160796658|NCT02776735|580643731|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160796659|NCT02776735|580643732|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160796660|NCT02776735|580643733|FG002|Overall Study|Withdrawal by parent/guardian|2|||
160796661|NCT02776735|580643734|FG003|Overall Study|Withdrawal by parent/guardian|2|||
160796662|NCT02776735|580643735|FG004|Overall Study|Withdrawal by parent/guardian|0|||
160796663|NCT02776735|580643736|FG005|Overall Study|Withdrawal by parent/guardian|0|||
160796664|NCT02776735|580643731|FG000|Overall Study|Withdrawal by Subject|1|||
160796665|NCT02776735|580643732|FG001|Overall Study|Withdrawal by Subject|0|||
160796666|NCT02776735|580643733|FG002|Overall Study|Withdrawal by Subject|0|||
160796667|NCT02776735|580643734|FG003|Overall Study|Withdrawal by Subject|0|||
160796668|NCT02776735|580643735|FG004|Overall Study|Withdrawal by Subject|0|||
160796669|NCT02776735|580643736|FG005|Overall Study|Withdrawal by Subject|1|||
160796670|NCT02776735|580643731|FG000|Overall Study|Other|0|||
160796671|NCT02776735|580643732|FG001|Overall Study|Other|0|||
160796672|NCT02776735|580643733|FG002|Overall Study|Other|3|||
160796673|NCT02776735|580643734|FG003|Overall Study|Other|0|||
160796674|NCT02776735|580643735|FG004|Overall Study|Other|0|||
160796675|NCT02776735|580643736|FG005|Overall Study|Other|0|||
160796676|NCT00560508|580645271|FG000|12 Week Double-blind Period|Adverse Event|3|||
160796677|NCT00560508|580645272|FG001|12 Week Double-blind Period|Adverse Event|2|||
160796678|NCT00560508|580645271|FG000|12 Week Double-blind Period|Protocol Violation|1|||
161129431|NCT00600171|581860850|FG001|Overall Study|Withdrawal by Subject|0|||
160796679|NCT00560508|580645272|FG001|12 Week Double-blind Period|Protocol Violation|0|||
160796680|NCT00560508|580645271|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
160796681|NCT00560508|580645272|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
160796682|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
160796683|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
160796684|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
160796685|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
160796686|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
160796687|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
161129432|NCT00600171|581860851|FG002|Overall Study|Withdrawal by Subject|0|||
161129433|NCT00600171|581860852|FG003|Overall Study|Withdrawal by Subject|1|||
161129434|NCT00600171|581860853|FG004|Overall Study|Withdrawal by Subject|1|||
161129435|NCT00600171|581860854|FG005|Overall Study|Withdrawal by Subject|1|||
160796688|NCT00560508|580645271|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
160796689|NCT00560508|580645272|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
160796690|NCT03493958|580645273|FG000|Overall Study|Withdrawal by Subject|6|||
160796691|NCT03493958|580645273|FG000|Overall Study|Lost to Follow-up|7|||
160796692|NCT03493958|580645273|FG000|Overall Study|Did not complete all required study procedures|2|||
160796693|NCT02367456|580645274|FG000|Overall Study|Death|8|||
160796694|NCT02367456|580645275|FG001|Overall Study|Death|24|||
160796695|NCT02367456|580645276|FG002|Overall Study|Death|17|||
161129436|NCT00600171|581860849|FG000|Overall Study|Physician Decision|0|||
161129437|NCT00600171|581860850|FG001|Overall Study|Physician Decision|1|||
160796696|NCT02367456|580645274|FG000|Overall Study|Lost to Follow-up|1|||
160796697|NCT02367456|580645275|FG001|Overall Study|Lost to Follow-up|3|||
160796698|NCT02367456|580645276|FG002|Overall Study|Lost to Follow-up|1|||
160796699|NCT02367456|580645274|FG000|Overall Study|Other reason|3|||
160796700|NCT02367456|580645275|FG001|Overall Study|Other reason|3|||
160796701|NCT02367456|580645276|FG002|Overall Study|Other reason|9|||
160796702|NCT02367456|580645274|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
160796703|NCT02367456|580645275|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
160796704|NCT02367456|580645276|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
160796705|NCT04617860|580645278|FG000|Overall Study|Adverse Event|0|||
160796706|NCT04617860|580645279|FG001|Overall Study|Adverse Event|2|||
160796707|NCT04617860|580645280|FG002|Overall Study|Adverse Event|2|||
160796708|NCT04617860|580645278|FG000|Overall Study|Withdrawal by Subject|0|||
160796709|NCT04617860|580645279|FG001|Overall Study|Withdrawal by Subject|0|||
160796710|NCT04617860|580645280|FG002|Overall Study|Withdrawal by Subject|2|||
160796711|NCT04617860|580645278|FG000|Overall Study|Physician Decision|0|||
160796712|NCT04617860|580645279|FG001|Overall Study|Physician Decision|1|||
160796713|NCT04617860|580645280|FG002|Overall Study|Physician Decision|0|||
160796714|NCT04617860|580645278|FG000|Overall Study|Sponsor Decision|0|||
160796715|NCT04617860|580645279|FG001|Overall Study|Sponsor Decision|3|||
160796716|NCT04617860|580645280|FG002|Overall Study|Sponsor Decision|1|||
160796717|NCT04617860|580645278|FG000|Overall Study|Termination of Study by Sponsor|8|||
160796718|NCT04617860|580645279|FG001|Overall Study|Termination of Study by Sponsor|4|||
160796719|NCT04617860|580645280|FG002|Overall Study|Termination of Study by Sponsor|13|||
160796720|NCT02735200|580645285|FG000|Overall Study|Lost to Follow-up|0|||
160796721|NCT02735200|580645286|FG001|Overall Study|Lost to Follow-up|5|||
160796722|NCT02735200|580645285|FG000|Overall Study|Withdrawal by Subject|8|||
160796723|NCT02735200|580645286|FG001|Overall Study|Withdrawal by Subject|0|||
160796724|NCT01493414|580645287|FG000|Overall Study|Adverse Event|405|||
160796725|NCT01493414|580645287|FG000|Overall Study|Disease progression|204|||
160796726|NCT01493414|580645287|FG000|Overall Study|Death|101|||
160796727|NCT01493414|580645287|FG000|Overall Study|Physician Decision|93|||
160796728|NCT01493414|580645287|FG000|Overall Study|Withdrawal by Subject|79|||
160796729|NCT01493414|580645287|FG000|Overall Study|Protocol deviation|27|||
160796730|NCT01493414|580645287|FG000|Overall Study|Administrative problems|25|||
160796731|NCT01493414|580645287|FG000|Overall Study|Lost to Follow-up|16|||
160796732|NCT05448950|580645298|FG000|Overall Study|Death|2|||
160796733|NCT05448950|580645298|FG000|Overall Study|Withdrawal by Subject|1|||
160796734|NCT05448950|580645298|FG000|Overall Study|AVG abandoned|4|||
160796735|NCT02706392|580645314|FG000|Overall Study|Death|1|||
160796736|NCT02706392|580645315|FG001|Overall Study|Death|0|||
160796737|NCT02706392|580645316|FG002|Overall Study|Death|2|||
160796738|NCT02706392|580645317|FG003|Overall Study|Death|2|||
160796739|NCT02706392|580645318|FG004|Overall Study|Death|5|||
160796740|NCT02706392|580645319|FG005|Overall Study|Death|2|||
160796741|NCT01656161|580645322|FG000|Overall Study|Death|3|||
160796742|NCT01656161|580645322|FG000|Overall Study|Adverse Event|2|||
160796743|NCT01656161|580645322|FG000|Overall Study|Protocol Violation|1|||
160796744|NCT01656161|580645322|FG000|Overall Study|Withdrawal by Subject|1|||
160796745|NCT03510273|580645327|FG000|Overall Study|Withdrawal by Subject|2|||
161331036|NCT02357459|582598760|FG000|Overall Study|Instruction from PCP|1|||
161331037|NCT02357459|582598761|FG001|Overall Study|Instruction from PCP|0|||
161331038|NCT02357459|582598762|FG002|Overall Study|Instruction from PCP|0|||
161331039|NCT02357459|582598760|FG000|Overall Study|Incarceration|0|||
161331040|NCT02357459|582598761|FG001|Overall Study|Incarceration|0|||
161331041|NCT02357459|582598762|FG002|Overall Study|Incarceration|1|||
161331042|NCT02357459|582598760|FG000|Overall Study|Pre-planned Knee surgery|0|||
161331043|NCT02357459|582598761|FG001|Overall Study|Pre-planned Knee surgery|0|||
161331044|NCT02357459|582598762|FG002|Overall Study|Pre-planned Knee surgery|2|||
160796746|NCT03510273|580645327|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
160894524|NCT02570074|581010840|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
161129438|NCT00600171|581860851|FG002|Overall Study|Physician Decision|0|||
161129439|NCT00600171|581860852|FG003|Overall Study|Physician Decision|1|||
161331045|NCT02357459|582598760|FG000|Overall Study|Job Commitments|0|||
160796747|NCT03510273|580645327|FG000|Overall Study|Moved away from study area|4|||
160796748|NCT00265122|580645331|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
160796749|NCT00265122|580645332|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
160796750|NCT00265122|580645333|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
160796751|NCT00265122|580645334|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
160796752|NCT00265122|580645335|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
160796753|NCT00265122|580645336|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
160796754|NCT00265122|580645331|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
160796755|NCT00265122|580645332|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796756|NCT00265122|580645333|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796757|NCT00265122|580645334|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
161331046|NCT02357459|582598761|FG001|Overall Study|Job Commitments|0|||
160796758|NCT00265122|580645335|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796759|NCT00265122|580645336|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
160796760|NCT00265122|580645331|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
160796761|NCT00265122|580645332|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
160796762|NCT00265122|580645333|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
160796763|NCT00265122|580645334|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
160796764|NCT00265122|580645335|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
160796765|NCT00265122|580645336|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
160796766|NCT00265122|580645331|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
160796767|NCT00265122|580645332|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
160796768|NCT00265122|580645333|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
160796769|NCT00265122|580645334|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
160796770|NCT00265122|580645335|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
160796771|NCT00265122|580645336|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
160796772|NCT00265122|580645331|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
160796773|NCT00265122|580645332|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
160796774|NCT00265122|580645333|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
160796775|NCT00265122|580645334|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
160796776|NCT00265122|580645335|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
160796777|NCT00265122|580645336|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
160796778|NCT00265122|580645331|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
160796779|NCT00265122|580645332|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
160796780|NCT00265122|580645333|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
160796781|NCT00265122|580645334|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
160796782|NCT00265122|580645335|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
160796783|NCT00265122|580645336|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
160796784|NCT02589938|580645337|FG000|Overall Study|Withdrawal by Subject|11|||
160796785|NCT02589938|580645338|FG001|Overall Study|Withdrawal by Subject|5|||
160796786|NCT02589938|580645339|FG002|Overall Study|Withdrawal by Subject|6|||
160796787|NCT02589938|580645337|FG000|Overall Study|Lost to Follow-up|3|||
160796788|NCT02589938|580645338|FG001|Overall Study|Lost to Follow-up|3|||
160796789|NCT02589938|580645339|FG002|Overall Study|Lost to Follow-up|3|||
160796790|NCT02589938|580645337|FG000|Overall Study|Death|1|||
160796791|NCT02589938|580645338|FG001|Overall Study|Death|0|||
160796792|NCT02589938|580645339|FG002|Overall Study|Death|1|||
160796793|NCT02589938|580645337|FG000|Overall Study|Protocol Violation|6|||
160796794|NCT02589938|580645338|FG001|Overall Study|Protocol Violation|2|||
160796795|NCT02589938|580645339|FG002|Overall Study|Protocol Violation|3|||
160796796|NCT02589938|580645337|FG000|Overall Study|Physician Decision|1|||
160796797|NCT02589938|580645338|FG001|Overall Study|Physician Decision|0|||
160796798|NCT02589938|580645339|FG002|Overall Study|Physician Decision|0|||
160796799|NCT02589938|580645337|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
160796800|NCT02589938|580645338|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
160796801|NCT02589938|580645339|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
160796802|NCT01121757|580645350|FG000|First Drug|Death|1|||
160796803|NCT01121757|580645351|FG001|First Drug|Death|0|||
160796804|NCT01121757|580645350|FG000|First Drug|Disease Progression|0|||
160796805|NCT01121757|580645351|FG001|First Drug|Disease Progression|2|||
160796806|NCT01121757|580645350|FG000|Combination|Physician Decision|0|||
161129440|NCT00600171|581860853|FG004|Overall Study|Physician Decision|0|||
161129441|NCT00600171|581860854|FG005|Overall Study|Physician Decision|2|||
161129442|NCT00600171|581860849|FG000|Overall Study|Lost to Follow-up|0|||
161129443|NCT00600171|581860850|FG001|Overall Study|Lost to Follow-up|0|||
161129444|NCT00600171|581860851|FG002|Overall Study|Lost to Follow-up|0|||
161129445|NCT00600171|581860852|FG003|Overall Study|Lost to Follow-up|1|||
161129446|NCT00600171|581860853|FG004|Overall Study|Lost to Follow-up|0|||
161129447|NCT00600171|581860854|FG005|Overall Study|Lost to Follow-up|0|||
161129448|NCT02367521|581860855|FG000|Overall Study|severe headache after intervention|2|||
161129449|NCT02367521|581860856|FG001|Overall Study|severe headache after intervention|0|||
161129450|NCT02367521|581860855|FG000|Overall Study|unable to find transportation|2|||
161129451|NCT02367521|581860856|FG001|Overall Study|unable to find transportation|0|||
161129452|NCT00542191|581860860|FG000|Overall Study|Death|3|||
160796807|NCT01121757|580645351|FG001|Combination|Physician Decision|1|||
160796808|NCT01121757|580645350|FG000|Combination|Disease Progression|2|||
160796809|NCT01121757|580645351|FG001|Combination|Disease Progression|0|||
160796810|NCT03773484|580645352|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
160796811|NCT04724837|580645353|FG000|Overall Study|Other|4|||
160796812|NCT04724837|580645354|FG001|Overall Study|Other|16|||
160796813|NCT04724837|580645355|FG002|Overall Study|Other|0|||
160796814|NCT04724837|580645353|FG000|Overall Study|Withdrawal by Subject|2|||
160796815|NCT04724837|580645354|FG001|Overall Study|Withdrawal by Subject|9|||
160796816|NCT04724837|580645355|FG002|Overall Study|Withdrawal by Subject|9|||
160796817|NCT04724837|580645353|FG000|Overall Study|Adverse Event|2|||
160796818|NCT04724837|580645354|FG001|Overall Study|Adverse Event|7|||
160796819|NCT04724837|580645355|FG002|Overall Study|Adverse Event|4|||
160796820|NCT04724837|580645353|FG000|Overall Study|Lost to Follow-up|0|||
160796821|NCT04724837|580645354|FG001|Overall Study|Lost to Follow-up|1|||
160796822|NCT04724837|580645355|FG002|Overall Study|Lost to Follow-up|3|||
160796823|NCT04724837|580645353|FG000|Overall Study|Physician Decision|1|||
160796824|NCT04724837|580645354|FG001|Overall Study|Physician Decision|2|||
160796825|NCT04724837|580645355|FG002|Overall Study|Physician Decision|0|||
160796826|NCT04724837|580645353|FG000|Overall Study|Death|0|||
160796827|NCT04724837|580645354|FG001|Overall Study|Death|0|||
160796828|NCT04724837|580645355|FG002|Overall Study|Death|1|||
160796829|NCT04724837|580645353|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
160796830|NCT04724837|580645354|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
160796831|NCT04724837|580645355|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
160796832|NCT04724837|580645353|FG000|Overall Study|Study Terminated by Sponsor|0|||
160796833|NCT04724837|580645354|FG001|Overall Study|Study Terminated by Sponsor|1|||
160796834|NCT04724837|580645355|FG002|Overall Study|Study Terminated by Sponsor|0|||
160796835|NCT04222673|580645356|FG000|Overall Study|Lost to Follow-up|5|||
160796836|NCT04251533|580645373|FG000|Overall Study|Progressive disease|33|||
160796837|NCT04251533|580645374|FG001|Overall Study|Progressive disease|29|||
160796838|NCT04251533|580645375|FG002|Overall Study|Progressive disease|22|||
160796839|NCT04251533|580645373|FG000|Overall Study|Death|5|||
160796840|NCT04251533|580645374|FG001|Overall Study|Death|1|||
160796841|NCT04251533|580645375|FG002|Overall Study|Death|3|||
160796842|NCT04251533|580645373|FG000|Overall Study|Physician Decision|3|||
160796843|NCT04251533|580645374|FG001|Overall Study|Physician Decision|2|||
160796844|NCT04251533|580645375|FG002|Overall Study|Physician Decision|4|||
160796845|NCT04251533|580645373|FG000|Overall Study|Participant decision|1|||
160796846|NCT04251533|580645374|FG001|Overall Study|Participant decision|3|||
160796847|NCT04251533|580645375|FG002|Overall Study|Participant decision|1|||
160796848|NCT04251533|580645373|FG000|Overall Study|Adverse Event|2|||
160796849|NCT04251533|580645374|FG001|Overall Study|Adverse Event|1|||
160796850|NCT04251533|580645375|FG002|Overall Study|Adverse Event|1|||
160796851|NCT06071104|580645376|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
160796852|NCT02420717|580645379|FG000|Overall Study|Did not receive all study medication|2|||
160796853|NCT02420717|580645380|FG001|Overall Study|Did not receive all study medication|0|||
160796854|NCT02420717|580645381|FG002|Overall Study|Did not receive all study medication|0|||
160796855|NCT04116489|580645382|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
161129453|NCT00434967|581860861|FG000|Overall Study|Adverse Event|2|||
160796856|NCT04116489|580645382|FG000|Overall Study|Withdrawal by Subject|1|||
160796857|NCT03781570|580645383|FG000|Overall Study|Technical Issues (equipment failure)|31|||
160796858|NCT03781570|580645383|FG000|Overall Study|Withdrawal by Subject|7|||
160796859|NCT03781570|580645383|FG000|Overall Study|Physical Constraints|11|||
160796860|NCT03138564|580645384|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
160796861|NCT03138564|580645385|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
160796862|NCT03138564|580645384|FG000|Overall Study|Lost to Follow-up|16|||
160796863|NCT03138564|580645385|FG001|Overall Study|Lost to Follow-up|2|||
161129454|NCT00434967|581860862|FG001|Overall Study|Adverse Event|4|||
161129455|NCT00434967|581860863|FG002|Overall Study|Adverse Event|3|||
161129456|NCT00434967|581860864|FG003|Overall Study|Adverse Event|3|||
161129457|NCT00434967|581860861|FG000|Overall Study|Lost to Follow-up|0|||
161129458|NCT00434967|581860862|FG001|Overall Study|Lost to Follow-up|0|||
161129459|NCT00434967|581860863|FG002|Overall Study|Lost to Follow-up|1|||
161129460|NCT00434967|581860864|FG003|Overall Study|Lost to Follow-up|0|||
161129461|NCT00434967|581860861|FG000|Overall Study|Withdrawal by Subject|2|||
161129462|NCT00434967|581860862|FG001|Overall Study|Withdrawal by Subject|2|||
161129463|NCT00434967|581860863|FG002|Overall Study|Withdrawal by Subject|4|||
161129464|NCT00434967|581860864|FG003|Overall Study|Withdrawal by Subject|6|||
161129465|NCT00434967|581860861|FG000|Overall Study|Randomized in error|0|||
161129466|NCT00434967|581860862|FG001|Overall Study|Randomized in error|0|||
161129467|NCT00434967|581860863|FG002|Overall Study|Randomized in error|0|||
161129468|NCT00434967|581860864|FG003|Overall Study|Randomized in error|1|||
161129469|NCT00434967|581860861|FG000|Overall Study|Protocol Violation|0|||
160796864|NCT03138564|580645384|FG000|Overall Study|Withdrawal by Subject|48|||
160796865|NCT03138564|580645385|FG001|Overall Study|Withdrawal by Subject|4|||
160796866|NCT03138564|580645384|FG000|Overall Study|No longer met eligibility criteria|2|||
160796867|NCT03138564|580645385|FG001|Overall Study|No longer met eligibility criteria|0|||
160796868|NCT03138564|580645384|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
160796869|NCT03138564|580645385|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
160796870|NCT03138564|580645384|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
160796871|NCT03138564|580645385|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
160796872|NCT03138564|580645384|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
160983565|NCT02611830|581328662|FG001|Maintenance Phase|Pregnancy|0|||
160796873|NCT03138564|580645385|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
160796874|NCT03138564|580645384|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
160796875|NCT03138564|580645385|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
160796876|NCT05177354|580645387|FG000|Implant to 30-day Visit|Physician Decision|1|||
160796877|NCT05177354|580645387|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
160796878|NCT05177354|580645387|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
160796879|NCT05177354|580645387|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
160796880|NCT02769481|580645393|FG000|Overall Study|Protocol Violation|1|||
160796881|NCT02769481|580645394|FG001|Overall Study|Protocol Violation|0|||
160796882|NCT02769481|580645393|FG000|Overall Study|Adverse Event|3|||
160796883|NCT02769481|580645394|FG001|Overall Study|Adverse Event|6|||
160796884|NCT02769481|580645393|FG000|Overall Study|Entry Criteria Not Met|1|||
160796885|NCT02769481|580645394|FG001|Overall Study|Entry Criteria Not Met|2|||
160796886|NCT02769481|580645393|FG000|Overall Study|Withdrawal by Subject|14|||
160796887|NCT02769481|580645394|FG001|Overall Study|Withdrawal by Subject|16|||
160796888|NCT02769481|580645393|FG000|Overall Study|Lost to Follow-up|9|||
160796889|NCT02769481|580645394|FG001|Overall Study|Lost to Follow-up|9|||
160796890|NCT02769481|580645393|FG000|Overall Study|Physician Decision|0|||
160796891|NCT02769481|580645394|FG001|Overall Study|Physician Decision|1|||
160796892|NCT02769481|580645393|FG000|Overall Study|Terminated by Sponsor|1|||
160796893|NCT02769481|580645394|FG001|Overall Study|Terminated by Sponsor|0|||
160796894|NCT02769481|580645393|FG000|Overall Study|Death|0|||
160796895|NCT02769481|580645394|FG001|Overall Study|Death|1|||
160796896|NCT02769481|580645393|FG000|Overall Study|Undefined|4|||
160796897|NCT02769481|580645394|FG001|Overall Study|Undefined|1|||
160796898|NCT01346592|580645395|FG000|Overall Study|Lost to Follow-up|62|||
160796899|NCT01346592|580645396|FG001|Overall Study|Lost to Follow-up|29|||
160796900|NCT01346592|580645397|FG002|Overall Study|Lost to Follow-up|29|||
160796901|NCT01346592|580645395|FG000|Overall Study|Protocol Violation|2|||
160796902|NCT01346592|580645396|FG001|Overall Study|Protocol Violation|1|||
160796903|NCT01346592|580645397|FG002|Overall Study|Protocol Violation|0|||
160796904|NCT01346592|580645395|FG000|Overall Study|Death|1|||
160796905|NCT01346592|580645396|FG001|Overall Study|Death|3|||
160796906|NCT01346592|580645397|FG002|Overall Study|Death|4|||
160796907|NCT01346592|580645395|FG000|Overall Study|Adverse Event|0|||
160796908|NCT01346592|580645396|FG001|Overall Study|Adverse Event|1|||
160796909|NCT01346592|580645397|FG002|Overall Study|Adverse Event|0|||
160796910|NCT01346592|580645395|FG000|Overall Study|Withdrawal by Subject|77|||
160796911|NCT01346592|580645396|FG001|Overall Study|Withdrawal by Subject|51|||
160796912|NCT01346592|580645397|FG002|Overall Study|Withdrawal by Subject|38|||
160796913|NCT01346592|580645395|FG000|Overall Study|Inappropriate enrollment|3|||
161331047|NCT02357459|582598762|FG002|Overall Study|Job Commitments|1|||
161331048|NCT03246347|582598763|FG000|Overall Study|On Study|23|||
161331049|NCT00916578|582598764|FG000|Overall Study|Physician Decision|2|||
161331050|NCT00916578|582598764|FG000|Overall Study|Withdrawal by Subject|3|||
161331051|NCT00916578|582598764|FG000|Overall Study|Insurance Denial|2|||
161331052|NCT01239797|582598767|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
160796914|NCT01346592|580645396|FG001|Overall Study|Inappropriate enrollment|1|||
160796915|NCT01346592|580645397|FG002|Overall Study|Inappropriate enrollment|1|||
160796916|NCT01346592|580645395|FG000|Overall Study|Administrative reason|1|||
160796917|NCT01346592|580645396|FG001|Overall Study|Administrative reason|0|||
160796918|NCT01346592|580645397|FG002|Overall Study|Administrative reason|0|||
160796919|NCT01346592|580645395|FG000|Overall Study|Unable to Classify|7|||
160796920|NCT01346592|580645396|FG001|Overall Study|Unable to Classify|3|||
160796921|NCT01346592|580645397|FG002|Overall Study|Unable to Classify|6|||
160796922|NCT00643279|580645400|FG000|Overall Study|Death|13|||
160796923|NCT00643279|580645401|FG001|Overall Study|Death|11|||
160796924|NCT00643279|580645400|FG000|Overall Study|Withdrawal by Subject|3|||
161129470|NCT00434967|581860862|FG001|Overall Study|Protocol Violation|1|||
161129471|NCT00434967|581860863|FG002|Overall Study|Protocol Violation|0|||
161129472|NCT00434967|581860864|FG003|Overall Study|Protocol Violation|1|||
161129473|NCT00434967|581860861|FG000|Overall Study|Physician Decision|1|||
161129474|NCT00434967|581860862|FG001|Overall Study|Physician Decision|1|||
161129475|NCT00434967|581860863|FG002|Overall Study|Physician Decision|1|||
161129476|NCT00434967|581860864|FG003|Overall Study|Physician Decision|0|||
161331053|NCT01239797|582598768|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
161129477|NCT00434967|581860861|FG000|Overall Study|Patient Disposition Challenges|2|||
161129478|NCT00434967|581860862|FG001|Overall Study|Patient Disposition Challenges|0|||
161129479|NCT00434967|581860863|FG002|Overall Study|Patient Disposition Challenges|0|||
160796925|NCT00643279|580645401|FG001|Overall Study|Withdrawal by Subject|0|||
160796926|NCT00643279|580645400|FG000|Overall Study|Lost to Follow-up|0|||
160796927|NCT00643279|580645401|FG001|Overall Study|Lost to Follow-up|1|||
160796928|NCT00643279|580645400|FG000|Overall Study|Physician Decision|0|||
160796929|NCT00643279|580645401|FG001|Overall Study|Physician Decision|1|||
160796930|NCT06272383|580645402|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
161331054|NCT01239797|582598767|FG000|Randomized Participants|Participant withdrew consent|1|||
160796931|NCT06272383|580645403|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
160796932|NCT05715827|580645404|FG000|Overall Study|Physician Decision|0|||
160796933|NCT05715827|580645405|FG001|Overall Study|Physician Decision|1|||
160796934|NCT05715827|580645404|FG000|Overall Study|console communication error|0|||
160796935|NCT05715827|580645405|FG001|Overall Study|console communication error|1|||
160796936|NCT04846868|580645406|FG000|Overall Study|Adverse Event|12|||
160796937|NCT04846868|580645407|FG001|Overall Study|Adverse Event|11|||
160796938|NCT04846868|580645406|FG000|Overall Study|Protocol deviation|6|||
160796939|NCT04846868|580645407|FG001|Overall Study|Protocol deviation|2|||
160796940|NCT04846868|580645406|FG000|Overall Study|Perceived lack of efficacy|3|||
160796941|NCT04846868|580645407|FG001|Overall Study|Perceived lack of efficacy|2|||
160796942|NCT04846868|580645406|FG000|Overall Study|Change of residence|2|||
160796943|NCT04846868|580645407|FG001|Overall Study|Change of residence|3|||
160796944|NCT04846868|580645406|FG000|Overall Study|Burden of study procedures|1|||
160796945|NCT04846868|580645407|FG001|Overall Study|Burden of study procedures|1|||
160796946|NCT04846868|580645406|FG000|Overall Study|No reason available|2|||
160796947|NCT04846868|580645407|FG001|Overall Study|No reason available|5|||
160796948|NCT04846868|580645406|FG000|Overall Study|Other reason listed|20|||
160796949|NCT04846868|580645407|FG001|Overall Study|Other reason listed|10|||
160796950|NCT04846868|580645406|FG000|Overall Study|Not treated|0|||
160796951|NCT04846868|580645407|FG001|Overall Study|Not treated|1|||
160796952|NCT04398706|580645408|FG000|Overall Study|Adverse Event|0|||
160796953|NCT04398706|580645409|FG001|Overall Study|Adverse Event|0|||
160796954|NCT04398706|580645410|FG002|Overall Study|Adverse Event|0|||
160796955|NCT04398706|580645411|FG003|Overall Study|Adverse Event|0|||
160796956|NCT04398706|580645412|FG004|Overall Study|Adverse Event|0|||
160796957|NCT04398706|580645413|FG005|Overall Study|Adverse Event|1|||
160796958|NCT04398706|580645414|FG006|Overall Study|Adverse Event|1|||
160796959|NCT04398706|580645415|FG007|Overall Study|Adverse Event|0|||
160796960|NCT04398706|580645408|FG000|Overall Study|Lost to Follow-up|0|||
160796961|NCT04398706|580645409|FG001|Overall Study|Lost to Follow-up|1|||
160796962|NCT04398706|580645410|FG002|Overall Study|Lost to Follow-up|2|||
160796963|NCT04398706|580645411|FG003|Overall Study|Lost to Follow-up|1|||
160796964|NCT04398706|580645412|FG004|Overall Study|Lost to Follow-up|6|||
161236180|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160796965|NCT04398706|580645413|FG005|Overall Study|Lost to Follow-up|3|||
160796966|NCT04398706|580645414|FG006|Overall Study|Lost to Follow-up|8|||
161236181|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
161236182|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
160796967|NCT04398706|580645415|FG007|Overall Study|Lost to Follow-up|2|||
160796968|NCT04398706|580645408|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160796969|NCT04398706|580645409|FG001|Overall Study|Withdrawal by parent/guardian|2|||
160796970|NCT04398706|580645410|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160796971|NCT04398706|580645411|FG003|Overall Study|Withdrawal by parent/guardian|2|||
161236183|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
161236184|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
161236185|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
161236186|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236187|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160796972|NCT04398706|580645412|FG004|Overall Study|Withdrawal by parent/guardian|19|||
160796973|NCT04398706|580645413|FG005|Overall Study|Withdrawal by parent/guardian|23|||
160796974|NCT04398706|580645414|FG006|Overall Study|Withdrawal by parent/guardian|13|||
160796975|NCT04398706|580645415|FG007|Overall Study|Withdrawal by parent/guardian|11|||
160796976|NCT04398706|580645408|FG000|Overall Study|Protocol deviation|0|||
160796977|NCT04398706|580645409|FG001|Overall Study|Protocol deviation|1|||
160796978|NCT04398706|580645410|FG002|Overall Study|Protocol deviation|0|||
160796979|NCT04398706|580645411|FG003|Overall Study|Protocol deviation|0|||
161236188|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160796980|NCT04398706|580645412|FG004|Overall Study|Protocol deviation|6|||
160796981|NCT04398706|580645413|FG005|Overall Study|Protocol deviation|4|||
160796982|NCT04398706|580645414|FG006|Overall Study|Protocol deviation|6|||
160796983|NCT04398706|580645415|FG007|Overall Study|Protocol deviation|3|||
160796984|NCT04890509|580645416|FG000|Overall Study|Death|4|||
160796985|NCT04890509|580645417|FG001|Overall Study|Death|4|||
160796986|NCT04116853|580645418|FG000|Overall Study|Adverse Event|1|||
160796987|NCT04116853|580645419|FG001|Overall Study|Adverse Event|3|||
160796988|NCT04116853|580645418|FG000|Overall Study|Lost to Follow-up|2|||
160796989|NCT04116853|580645419|FG001|Overall Study|Lost to Follow-up|0|||
160796990|NCT04116853|580645418|FG000|Overall Study|Incarceration|0|||
160796991|NCT04116853|580645419|FG001|Overall Study|Incarceration|1|||
160796992|NCT04116853|580645418|FG000|Overall Study|Pregnancy|1|||
160796993|NCT04116853|580645419|FG001|Overall Study|Pregnancy|1|||
160796994|NCT04116853|580645418|FG000|Overall Study|Began Other Weight Loss program|4|||
160796995|NCT04116853|580645419|FG001|Overall Study|Began Other Weight Loss program|8|||
160796996|NCT04116853|580645418|FG000|Overall Study|Began Anti-Obesity Medication|3|||
160796997|NCT04116853|580645419|FG001|Overall Study|Began Anti-Obesity Medication|3|||
160796998|NCT04116853|580645418|FG000|Overall Study|Protocol Violation|0|||
160796999|NCT04116853|580645419|FG001|Overall Study|Protocol Violation|1|||
160797002|NCT04696146|580647203|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
160797003|NCT04696146|580647204|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
160797004|NCT04696146|580647203|FG000|Overall Study|Off hours issue with product|1|||
160797005|NCT04696146|580647204|FG001|Overall Study|Off hours issue with product|0|||
160797006|NCT01576783|580647210|FG000|Overall Study|Change in Medical Care|1|||
160797007|NCT01576783|580647211|FG001|Overall Study|Change in Medical Care|0|||
160797008|NCT01576783|580647210|FG000|Overall Study|Lost to Follow-up|14|||
160797009|NCT01576783|580647211|FG001|Overall Study|Lost to Follow-up|16|||
160797010|NCT01576783|580647210|FG000|Overall Study|Withdrawal by Subject|5|||
160797011|NCT01576783|580647211|FG001|Overall Study|Withdrawal by Subject|1|||
160797012|NCT05489328|580647213|FG000|Overall Study|Lost to Follow-up|0|||
160797013|NCT05489328|580647214|FG001|Overall Study|Lost to Follow-up|0|||
160797014|NCT05489328|580647215|FG002|Overall Study|Lost to Follow-up|1|||
160797015|NCT05489328|580647216|FG003|Overall Study|Lost to Follow-up|0|||
160983566|NCT02611830|581328663|FG002|Maintenance Phase|Pregnancy|1|||
160797016|NCT05489328|580647217|FG004|Overall Study|Lost to Follow-up|2|||
160797017|NCT05489328|580647218|FG005|Overall Study|Lost to Follow-up|0|||
160797018|NCT05489328|580647219|FG006|Overall Study|Lost to Follow-up|0|||
160797019|NCT05489328|580647220|FG007|Overall Study|Lost to Follow-up|1|||
160983567|NCT02611830|581328664|FG003|Maintenance Phase|Pregnancy|0|||
160983568|NCT02611830|581328661|FG000|Maintenance Phase|Reason not specified|0|||
160983569|NCT02611830|581328662|FG001|Maintenance Phase|Reason not specified|1|||
160983570|NCT02611830|581328663|FG002|Maintenance Phase|Reason not specified|4|||
160983571|NCT02611830|581328664|FG003|Maintenance Phase|Reason not specified|0|||
160983572|NCT01987830|581328675|FG000|Overall Study|Never received baseline scan|1|||
160983573|NCT05764239|581328678|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
160983574|NCT05764239|581328678|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
161236189|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160797020|NCT05489328|580647221|FG008|Overall Study|Lost to Follow-up|0|||
160797021|NCT05489328|580647213|FG000|Overall Study|Withdrawal by Subject|0|||
160797022|NCT05489328|580647214|FG001|Overall Study|Withdrawal by Subject|0|||
160797023|NCT05489328|580647215|FG002|Overall Study|Withdrawal by Subject|0|||
160797024|NCT05489328|580647216|FG003|Overall Study|Withdrawal by Subject|0|||
160797025|NCT05489328|580647217|FG004|Overall Study|Withdrawal by Subject|0|||
160797026|NCT05489328|580647218|FG005|Overall Study|Withdrawal by Subject|0|||
160797027|NCT05489328|580647219|FG006|Overall Study|Withdrawal by Subject|1|||
160797028|NCT05489328|580647220|FG007|Overall Study|Withdrawal by Subject|1|||
160797029|NCT05489328|580647221|FG008|Overall Study|Withdrawal by Subject|0|||
160797030|NCT05489328|580647213|FG000|Overall Study|Other|0|||
160797031|NCT05489328|580647214|FG001|Overall Study|Other|0|||
160797032|NCT05489328|580647215|FG002|Overall Study|Other|0|||
160797033|NCT05489328|580647216|FG003|Overall Study|Other|0|||
160797034|NCT05489328|580647217|FG004|Overall Study|Other|0|||
160797035|NCT05489328|580647218|FG005|Overall Study|Other|0|||
160797036|NCT05489328|580647219|FG006|Overall Study|Other|0|||
160797037|NCT05489328|580647220|FG007|Overall Study|Other|1|||
160797038|NCT05489328|580647221|FG008|Overall Study|Other|1|||
160797039|NCT01083602|580647222|FG000|Overall Study|Adverse Event|11|||
160797040|NCT01083602|580647222|FG000|Overall Study|New Cancer Therapy|2|||
160797041|NCT01083602|580647222|FG000|Overall Study|Death|1|||
160797042|NCT01083602|580647222|FG000|Overall Study|Withdrawal by Subject|5|||
160983575|NCT05764239|581328678|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
160983576|NCT05764239|581328678|FG000|DEP (Part 1)|Adverse Event|1|||
160983577|NCT05764239|581328678|FG000|DEP (Part 1)|Lost to Follow-up|1|||
161236190|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236191|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236192|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236193|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236194|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236195|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160797043|NCT01083602|580647222|FG000|Overall Study|Lack of Efficacy|36|||
160983578|NCT05764239|581328678|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
160983579|NCT05764239|581328678|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
160983580|NCT05764239|581328678|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
160797044|NCT01657370|580647224|FG000|Overall Study|Withdrawal by Subject|0|||
160797045|NCT01657370|580647225|FG001|Overall Study|Withdrawal by Subject|0|||
160797046|NCT01657370|580647226|FG002|Overall Study|Withdrawal by Subject|1|||
160797047|NCT01657370|580647227|FG003|Overall Study|Withdrawal by Subject|0|||
160797048|NCT01657370|580647228|FG004|Overall Study|Withdrawal by Subject|0|||
160797049|NCT01657370|580647229|FG005|Overall Study|Withdrawal by Subject|1|||
160797050|NCT01657370|580647224|FG000|Overall Study|Physician Decision|2|||
160797051|NCT01657370|580647225|FG001|Overall Study|Physician Decision|3|||
160797052|NCT01657370|580647226|FG002|Overall Study|Physician Decision|1|||
160797053|NCT01657370|580647227|FG003|Overall Study|Physician Decision|2|||
160797054|NCT01657370|580647228|FG004|Overall Study|Physician Decision|5|||
160797055|NCT01657370|580647229|FG005|Overall Study|Physician Decision|0|||
160797056|NCT01657370|580647224|FG000|Overall Study|Lack of Qualifying Event|1|||
160797057|NCT01657370|580647225|FG001|Overall Study|Lack of Qualifying Event|0|||
160797058|NCT01657370|580647226|FG002|Overall Study|Lack of Qualifying Event|3|||
160797059|NCT01657370|580647227|FG003|Overall Study|Lack of Qualifying Event|2|||
160797060|NCT01657370|580647228|FG004|Overall Study|Lack of Qualifying Event|1|||
160797061|NCT01657370|580647229|FG005|Overall Study|Lack of Qualifying Event|2|||
160797062|NCT01657370|580647224|FG000|Overall Study|Adverse Event|0|||
160797063|NCT01657370|580647225|FG001|Overall Study|Adverse Event|0|||
160797064|NCT01657370|580647226|FG002|Overall Study|Adverse Event|0|||
160797065|NCT01657370|580647227|FG003|Overall Study|Adverse Event|0|||
160797066|NCT01657370|580647228|FG004|Overall Study|Adverse Event|1|||
160797067|NCT01657370|580647229|FG005|Overall Study|Adverse Event|0|||
160797068|NCT01657370|580647224|FG000|Overall Study|Protocol Violation|1|||
160797069|NCT01657370|580647225|FG001|Overall Study|Protocol Violation|1|||
160797070|NCT01657370|580647226|FG002|Overall Study|Protocol Violation|1|||
160797071|NCT01657370|580647227|FG003|Overall Study|Protocol Violation|1|||
160797072|NCT01657370|580647228|FG004|Overall Study|Protocol Violation|0|||
160797073|NCT01657370|580647229|FG005|Overall Study|Protocol Violation|0|||
160797074|NCT01657370|580647224|FG000|Overall Study|Lost to Follow-up|2|||
160797075|NCT01657370|580647225|FG001|Overall Study|Lost to Follow-up|0|||
160797076|NCT01657370|580647226|FG002|Overall Study|Lost to Follow-up|1|||
160797077|NCT01657370|580647227|FG003|Overall Study|Lost to Follow-up|0|||
160797078|NCT01657370|580647228|FG004|Overall Study|Lost to Follow-up|0|||
160797079|NCT01657370|580647229|FG005|Overall Study|Lost to Follow-up|1|||
160797080|NCT02777086|580647230|FG000|Overall Study|Lost to Follow-up|96|||
160797081|NCT02777086|580647231|FG001|Overall Study|Lost to Follow-up|99|||
160797082|NCT01133665|580647232|FG000|Overall Study|Physician Decision|2|||
160797083|NCT01819272|580647233|FG000|Overall Study|Adverse Event|1|||
160797084|NCT01819272|580647234|FG001|Overall Study|Adverse Event|0|||
160797085|NCT01819272|580647235|FG002|Overall Study|Adverse Event|0|||
160797086|NCT01819272|580647236|FG003|Overall Study|Adverse Event|2|||
160797087|NCT01819272|580647237|FG004|Overall Study|Adverse Event|0|||
160797088|NCT01819272|580647238|FG005|Overall Study|Adverse Event|0|||
160797089|NCT01819272|580647233|FG000|Overall Study|Lost to Follow-up|3|||
160797090|NCT01819272|580647234|FG001|Overall Study|Lost to Follow-up|0|||
160797091|NCT01819272|580647235|FG002|Overall Study|Lost to Follow-up|1|||
160797092|NCT01819272|580647236|FG003|Overall Study|Lost to Follow-up|0|||
160797093|NCT01819272|580647237|FG004|Overall Study|Lost to Follow-up|0|||
160797094|NCT01819272|580647238|FG005|Overall Study|Lost to Follow-up|3|||
160797095|NCT01819272|580647233|FG000|Overall Study|Protocol Violation|0|||
160797096|NCT01819272|580647234|FG001|Overall Study|Protocol Violation|0|||
160797097|NCT01819272|580647235|FG002|Overall Study|Protocol Violation|0|||
160797098|NCT01819272|580647236|FG003|Overall Study|Protocol Violation|1|||
160797099|NCT01819272|580647237|FG004|Overall Study|Protocol Violation|2|||
160797100|NCT01819272|580647238|FG005|Overall Study|Protocol Violation|3|||
160797101|NCT01819272|580647233|FG000|Overall Study|Physician Decision|0|||
160797102|NCT01819272|580647234|FG001|Overall Study|Physician Decision|1|||
160797103|NCT01819272|580647235|FG002|Overall Study|Physician Decision|0|||
160797104|NCT01819272|580647236|FG003|Overall Study|Physician Decision|0|||
160797105|NCT01819272|580647237|FG004|Overall Study|Physician Decision|0|||
160797106|NCT01819272|580647238|FG005|Overall Study|Physician Decision|0|||
160797107|NCT01819272|580647233|FG000|Overall Study|Withdrawal of Consent|0|||
160797108|NCT01819272|580647234|FG001|Overall Study|Withdrawal of Consent|1|||
160797109|NCT01819272|580647235|FG002|Overall Study|Withdrawal of Consent|2|||
160797110|NCT01819272|580647236|FG003|Overall Study|Withdrawal of Consent|1|||
160797111|NCT01819272|580647237|FG004|Overall Study|Withdrawal of Consent|0|||
161129480|NCT00434967|581860864|FG003|Overall Study|Patient Disposition Challenges|3|||
161129481|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
161129482|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
160797112|NCT01819272|580647238|FG005|Overall Study|Withdrawal of Consent|1|||
160797113|NCT01819272|580647233|FG000|Overall Study|Loss of Glucose Control|2|||
160797114|NCT01819272|580647234|FG001|Overall Study|Loss of Glucose Control|1|||
160797115|NCT01819272|580647235|FG002|Overall Study|Loss of Glucose Control|0|||
160797116|NCT01819272|580647236|FG003|Overall Study|Loss of Glucose Control|1|||
160797117|NCT01819272|580647237|FG004|Overall Study|Loss of Glucose Control|2|||
161129483|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
160797118|NCT01819272|580647238|FG005|Overall Study|Loss of Glucose Control|0|||
160797119|NCT03021486|580647239|FG000|Overall Study|Withdrawal by Subject|1|||
160797120|NCT03021486|580647240|FG001|Overall Study|Withdrawal by Subject|1|||
160797121|NCT03021486|580647241|FG002|Overall Study|Withdrawal by Subject|3|||
160797122|NCT03021486|580647239|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
160797123|NCT03021486|580647240|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
160797124|NCT03021486|580647241|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
160797125|NCT04043286|580647242|FG000|Overall Study|Withdrawal by Subject|2|||
160797126|NCT04043286|580647243|FG001|Overall Study|Withdrawal by Subject|2|||
160797127|NCT03376516|580647244|FG000|Overall Study|Not treated|1|||
160797128|NCT03376516|580647244|FG000|Overall Study|Consent withdrawn|1|||
160797129|NCT01581684|580647245|FG000|Overall Study|Other reason not defined|0|||
160797130|NCT01581684|580647246|FG001|Overall Study|Other reason not defined|0|||
160797131|NCT01581684|580647247|FG002|Overall Study|Other reason not defined|0|||
160797132|NCT01581684|580647248|FG003|Overall Study|Other reason not defined|0|||
160797133|NCT01581684|580647249|FG004|Overall Study|Other reason not defined|0|||
160797134|NCT01581684|580647250|FG005|Overall Study|Other reason not defined|0|||
160797135|NCT01581684|580647251|FG006|Overall Study|Other reason not defined|0|||
160797136|NCT01581684|580647252|FG007|Overall Study|Other reason not defined|0|||
160797137|NCT01581684|580647253|FG008|Overall Study|Other reason not defined|1|||
160797138|NCT01581684|580647254|FG009|Overall Study|Other reason not defined|0|||
160797139|NCT03186638|580647255|FG000|Overall Study|Withdrawal by Subject|4|||
160797140|NCT03186638|580647256|FG001|Overall Study|Withdrawal by Subject|4|||
160797141|NCT03186638|580647255|FG000|Overall Study|Withdrawn due to medical problem|3|||
160797142|NCT03186638|580647256|FG001|Overall Study|Withdrawn due to medical problem|2|||
160797143|NCT03186638|580647255|FG000|Overall Study|Lost to Follow-up|1|||
160797144|NCT03186638|580647256|FG001|Overall Study|Lost to Follow-up|0|||
160797145|NCT01664624|580647259|FG000|Overall Study|Adverse Event|0|||
160797146|NCT01664624|580647260|FG001|Overall Study|Adverse Event|1|||
160797147|NCT01664624|580647261|FG002|Overall Study|Adverse Event|0|||
160797148|NCT01664624|580647262|FG003|Overall Study|Adverse Event|0|||
160797149|NCT01029535|580647263|FG000|Overall Study|Lost to Follow-up|24|||
160797150|NCT01029535|580647263|FG000|Overall Study|Protocol Violation|2|||
160797151|NCT01029535|580647263|FG000|Overall Study|Participant Withdrew Consent|2|||
160797152|NCT01029535|580647263|FG000|Overall Study|Adverse Event|1|||
160797153|NCT01029535|580647263|FG000|Overall Study|Use of Another Treatment|1|||
160797154|NCT01029535|580647263|FG000|Overall Study|Death|1|||
160797155|NCT02410772|580647269|FG000|Overall Study|Death|3|||
160797156|NCT02410772|580647270|FG001|Overall Study|Death|4|||
160797157|NCT02410772|580647271|FG002|Overall Study|Death|8|||
160797158|NCT02410772|580647269|FG000|Overall Study|Lost to Follow-up|31|||
160797159|NCT02410772|580647270|FG001|Overall Study|Lost to Follow-up|23|||
160797160|NCT02410772|580647271|FG002|Overall Study|Lost to Follow-up|22|||
160797161|NCT02410772|580647269|FG000|Overall Study|Pregnancy|8|||
160797162|NCT02410772|580647270|FG001|Overall Study|Pregnancy|4|||
160797163|NCT02410772|580647271|FG002|Overall Study|Pregnancy|5|||
160797164|NCT02410772|580647269|FG000|Overall Study|Protocol Violation|8|||
160797165|NCT02410772|580647270|FG001|Overall Study|Protocol Violation|8|||
160797166|NCT02410772|580647271|FG002|Overall Study|Protocol Violation|4|||
160797167|NCT02410772|580647269|FG000|Overall Study|Baseline Drug Resistance|49|||
160797168|NCT02410772|580647270|FG001|Overall Study|Baseline Drug Resistance|40|||
160797169|NCT02410772|580647271|FG002|Overall Study|Baseline Drug Resistance|51|||
160797170|NCT02410772|580647269|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
160797171|NCT02410772|580647270|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
160797172|NCT02410772|580647271|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
160797173|NCT02410772|580647269|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
160797174|NCT02410772|580647270|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
160797175|NCT02410772|580647271|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
160797176|NCT01870869|580647276|FG000|Overall Study|Implanted with nonstudy device|1|||
160797177|NCT01870869|580647277|FG001|Overall Study|Implanted with nonstudy device|3|||
160797178|NCT01870869|580647278|FG002|Overall Study|Implanted with nonstudy device|14|||
160797179|NCT01870869|580647279|FG003|Overall Study|Implanted with nonstudy device|4|||
161331055|NCT01239797|582598768|FG001|Randomized Participants|Participant withdrew consent|7|||
161331056|NCT01239797|582598767|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
161331057|NCT01239797|582598768|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
161331058|NCT01239797|582598767|FG000|Treated Participants|Disease progression|185|||
161331059|NCT01239797|582598768|FG001|Treated Participants|Disease progression|185|||
161331060|NCT01239797|582598767|FG000|Treated Participants|Study drug toxicity|39|||
160797180|NCT01870869|580647276|FG000|Overall Study|Death|0|||
160797181|NCT01870869|580647277|FG001|Overall Study|Death|0|||
160797182|NCT01870869|580647278|FG002|Overall Study|Death|7|||
160797183|NCT01870869|580647279|FG003|Overall Study|Death|1|||
160797184|NCT01870869|580647276|FG000|Overall Study|Subject choice|6|||
160797185|NCT01870869|580647277|FG001|Overall Study|Subject choice|2|||
160797186|NCT01870869|580647278|FG002|Overall Study|Subject choice|22|||
160797187|NCT01870869|580647279|FG003|Overall Study|Subject choice|8|||
160797188|NCT01870869|580647276|FG000|Overall Study|Lost to Follow-up|10|||
160797189|NCT01870869|580647277|FG001|Overall Study|Lost to Follow-up|2|||
160797190|NCT01870869|580647278|FG002|Overall Study|Lost to Follow-up|25|||
160797191|NCT01870869|580647279|FG003|Overall Study|Lost to Follow-up|3|||
160797192|NCT01870869|580647276|FG000|Overall Study|Reason not Specified|1|||
160797193|NCT01870869|580647277|FG001|Overall Study|Reason not Specified|2|||
160797194|NCT01870869|580647278|FG002|Overall Study|Reason not Specified|20|||
160797195|NCT01870869|580647279|FG003|Overall Study|Reason not Specified|4|||
160797196|NCT01870869|580647276|FG000|Overall Study|Not evaluable|10|||
160797197|NCT01870869|580647277|FG001|Overall Study|Not evaluable|5|||
160797198|NCT01870869|580647278|FG002|Overall Study|Not evaluable|42|||
160797199|NCT01870869|580647279|FG003|Overall Study|Not evaluable|10|||
160797200|NCT00904371|580647280|FG000|Overall Study|Adverse Event|2|||
160797201|NCT00904371|580647280|FG000|Overall Study|Lost to Follow-up|4|||
160797202|NCT00904371|580647280|FG000|Overall Study|Discontinued at target blood pressure|2|||
160797203|NCT00904371|580647280|FG000|Overall Study|Continued with Tritace|1|||
160797204|NCT00419744|580647283|FG000|Overall Study|Adverse Event|39|||
160797205|NCT00419744|580647284|FG001|Overall Study|Adverse Event|40|||
160797206|NCT00419744|580647285|FG002|Overall Study|Adverse Event|50|||
160797207|NCT00419744|580647283|FG000|Overall Study|Withdrawal by Subject|45|||
160797208|NCT00419744|580647284|FG001|Overall Study|Withdrawal by Subject|49|||
160797209|NCT00419744|580647285|FG002|Overall Study|Withdrawal by Subject|52|||
160797210|NCT00419744|580647283|FG000|Overall Study|Lost to Follow-up|8|||
160797211|NCT00419744|580647284|FG001|Overall Study|Lost to Follow-up|10|||
160797212|NCT00419744|580647285|FG002|Overall Study|Lost to Follow-up|6|||
160797213|NCT00419744|580647283|FG000|Overall Study|Protocol Violation|4|||
160797214|NCT00419744|580647284|FG001|Overall Study|Protocol Violation|7|||
160797215|NCT00419744|580647285|FG002|Overall Study|Protocol Violation|8|||
160797216|NCT00419744|580647283|FG000|Overall Study|Randomized in error|9|||
160797217|NCT00419744|580647284|FG001|Overall Study|Randomized in error|6|||
160797218|NCT00419744|580647285|FG002|Overall Study|Randomized in error|7|||
160797219|NCT00419744|580647283|FG000|Overall Study|Moving out of state|2|||
160797220|NCT00419744|580647284|FG001|Overall Study|Moving out of state|0|||
160797221|NCT00419744|580647285|FG002|Overall Study|Moving out of state|1|||
160797222|NCT00419744|580647283|FG000|Overall Study|Physician Decision|10|||
160797223|NCT00419744|580647284|FG001|Overall Study|Physician Decision|5|||
160797224|NCT00419744|580647285|FG002|Overall Study|Physician Decision|6|||
160797225|NCT00419744|580647283|FG000|Overall Study|Spirometry mouthpiece issues|0|||
160797226|NCT00419744|580647284|FG001|Overall Study|Spirometry mouthpiece issues|1|||
161236196|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236197|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236198|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236199|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236200|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236201|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236202|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
161236203|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
161236204|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
160797227|NCT00419744|580647285|FG002|Overall Study|Spirometry mouthpiece issues|2|||
160797228|NCT00419744|580647283|FG000|Overall Study|Incorrect medication kit dispensed|0|||
160797229|NCT00419744|580647284|FG001|Overall Study|Incorrect medication kit dispensed|0|||
160797230|NCT00419744|580647285|FG002|Overall Study|Incorrect medication kit dispensed|1|||
160797231|NCT00673920|580647287|FG000|Baseline up to Week 48|Withdrew consent|1|||
160797232|NCT00673920|580647288|FG001|Baseline up to Week 48|Withdrew consent|0|||
160797233|NCT00673920|580647289|FG002|Baseline up to Week 48|Withdrew consent|2|||
160797234|NCT00673920|580647290|FG003|Baseline up to Week 48|Withdrew consent|0|||
160797235|NCT00673920|580647291|FG004|Baseline up to Week 48|Withdrew consent|0|||
160797236|NCT00673920|580647292|FG005|Baseline up to Week 48|Withdrew consent|0|||
160797237|NCT00673920|580647293|FG006|Baseline up to Week 48|Withdrew consent|0|||
160797238|NCT00673920|580647294|FG007|Baseline up to Week 48|Withdrew consent|0|||
160797239|NCT00673920|580647287|FG000|Baseline up to Week 48|Refused treatment|1|||
160797240|NCT00673920|580647288|FG001|Baseline up to Week 48|Refused treatment|0|||
160797241|NCT00673920|580647289|FG002|Baseline up to Week 48|Refused treatment|0|||
160797242|NCT00673920|580647290|FG003|Baseline up to Week 48|Refused treatment|0|||
160797243|NCT00673920|580647291|FG004|Baseline up to Week 48|Refused treatment|0|||
160797244|NCT00673920|580647292|FG005|Baseline up to Week 48|Refused treatment|0|||
160797245|NCT00673920|580647293|FG006|Baseline up to Week 48|Refused treatment|0|||
160797246|NCT00673920|580647294|FG007|Baseline up to Week 48|Refused treatment|0|||
161331061|NCT01239797|582598768|FG001|Treated Participants|Study drug toxicity|45|||
161331062|NCT01239797|582598767|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
161331063|NCT01239797|582598768|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
160797247|NCT00673920|580647287|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
160797248|NCT00673920|580647288|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
160797249|NCT00673920|580647289|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797250|NCT00673920|580647290|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797251|NCT00673920|580647291|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797252|NCT00673920|580647292|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797253|NCT00673920|580647293|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797254|NCT00673920|580647294|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
160797255|NCT00673920|580647287|FG000|Baseline up to Week 48|Protocol Violation|0|||
160797256|NCT00673920|580647288|FG001|Baseline up to Week 48|Protocol Violation|0|||
160797257|NCT00673920|580647289|FG002|Baseline up to Week 48|Protocol Violation|1|||
160797258|NCT00673920|580647290|FG003|Baseline up to Week 48|Protocol Violation|0|||
160797259|NCT00673920|580647291|FG004|Baseline up to Week 48|Protocol Violation|0|||
160797260|NCT00673920|580647292|FG005|Baseline up to Week 48|Protocol Violation|0|||
160797261|NCT00673920|580647293|FG006|Baseline up to Week 48|Protocol Violation|0|||
160797262|NCT00673920|580647294|FG007|Baseline up to Week 48|Protocol Violation|0|||
160797263|NCT00673920|580647287|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797264|NCT00673920|580647288|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797265|NCT00673920|580647289|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
160797266|NCT00673920|580647290|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797267|NCT00673920|580647291|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797268|NCT00673920|580647292|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797269|NCT00673920|580647293|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797270|NCT00673920|580647294|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
160797271|NCT00673920|580647287|FG000|Baseline up to Week 48|Administrative/Other|0|||
160797272|NCT00673920|580647288|FG001|Baseline up to Week 48|Administrative/Other|1|||
160797273|NCT00673920|580647289|FG002|Baseline up to Week 48|Administrative/Other|2|||
160797274|NCT00673920|580647290|FG003|Baseline up to Week 48|Administrative/Other|0|||
160797275|NCT00673920|580647291|FG004|Baseline up to Week 48|Administrative/Other|0|||
160797276|NCT00673920|580647292|FG005|Baseline up to Week 48|Administrative/Other|0|||
160797277|NCT00673920|580647293|FG006|Baseline up to Week 48|Administrative/Other|0|||
160797278|NCT00673920|580647294|FG007|Baseline up to Week 48|Administrative/Other|0|||
160797279|NCT00673920|580647287|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797280|NCT00673920|580647288|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
160797281|NCT00673920|580647289|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
160797282|NCT00673920|580647290|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797283|NCT00673920|580647291|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797284|NCT00673920|580647292|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797285|NCT00673920|580647293|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797286|NCT00673920|580647294|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
160797287|NCT00673920|580647287|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797288|NCT00673920|580647288|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160894525|NCT02570074|581010841|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
160894526|NCT03793556|581010844|FG000|Overall Study|Withdrawal by Subject|12|||
161129484|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
161129485|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
161129486|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
161129487|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
161129488|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
161129489|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
161129490|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
161129491|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
161129492|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
161129493|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
161129494|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
161129495|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
161129496|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
161129497|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
161129498|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
161129499|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
161129500|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
161129501|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
161129502|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
161129503|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
161129504|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
161129505|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
161129506|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
161129507|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
161129508|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
161129509|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161129510|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
161129511|NCT00849017|581860867|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
161129512|NCT00849017|581860868|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
161129513|NCT00849017|581860869|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
161129514|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
161129515|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161129516|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
160797289|NCT00673920|580647289|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797290|NCT00673920|580647290|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797291|NCT00673920|580647291|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797292|NCT00673920|580647292|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797293|NCT00673920|580647293|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
160797294|NCT00673920|580647294|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
160797295|NCT00673920|580647287|FG000|Week 24 to Week 48|Failure to return|0|||
160797296|NCT00673920|580647288|FG001|Week 24 to Week 48|Failure to return|0|||
160797297|NCT00673920|580647289|FG002|Week 24 to Week 48|Failure to return|0|||
160797298|NCT00673920|580647290|FG003|Week 24 to Week 48|Failure to return|0|||
160797299|NCT00673920|580647291|FG004|Week 24 to Week 48|Failure to return|0|||
160797300|NCT00673920|580647292|FG005|Week 24 to Week 48|Failure to return|1|||
160797301|NCT00673920|580647293|FG006|Week 24 to Week 48|Failure to return|0|||
160797302|NCT00673920|580647294|FG007|Week 24 to Week 48|Failure to return|0|||
160797303|NCT00673920|580647287|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797304|NCT00673920|580647288|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797305|NCT00673920|580647289|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797306|NCT00673920|580647290|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797307|NCT00673920|580647291|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797308|NCT00673920|580647292|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
160797309|NCT00673920|580647293|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797310|NCT00673920|580647294|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
160797311|NCT00673920|580647287|FG000|Week 24 to Week 48|Death|0|||
160797312|NCT00673920|580647288|FG001|Week 24 to Week 48|Death|0|||
160797313|NCT00673920|580647289|FG002|Week 24 to Week 48|Death|0|||
160797314|NCT00673920|580647290|FG003|Week 24 to Week 48|Death|0|||
160797315|NCT00673920|580647291|FG004|Week 24 to Week 48|Death|0|||
160797316|NCT00673920|580647292|FG005|Week 24 to Week 48|Death|1|||
160797317|NCT00673920|580647293|FG006|Week 24 to Week 48|Death|0|||
160797318|NCT00673920|580647294|FG007|Week 24 to Week 48|Death|0|||
160797319|NCT00673920|580647287|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
160797320|NCT00673920|580647288|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
160797321|NCT00673920|580647289|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
160797322|NCT00673920|580647290|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
160797323|NCT00673920|580647291|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
160797324|NCT00673920|580647292|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
160797325|NCT00673920|580647293|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
160797326|NCT00673920|580647294|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
160797327|NCT02493764|580647295|FG000|Overall Study|Adverse Event|2|||
160797328|NCT02493764|580647296|FG001|Overall Study|Adverse Event|2|||
160797329|NCT02493764|580647295|FG000|Overall Study|Death|44|||
160797330|NCT02493764|580647296|FG001|Overall Study|Death|58|||
160797331|NCT02493764|580647295|FG000|Overall Study|Lost to Follow-up|2|||
160797332|NCT02493764|580647296|FG001|Overall Study|Lost to Follow-up|1|||
160797333|NCT02493764|580647295|FG000|Overall Study|Protocol Violation|6|||
160797334|NCT02493764|580647296|FG001|Overall Study|Protocol Violation|7|||
160894527|NCT03793556|581010845|FG001|Overall Study|Withdrawal by Subject|1|||
160894528|NCT03793556|581010844|FG000|Overall Study|Lost to Follow-up|1|||
160894529|NCT03793556|581010845|FG001|Overall Study|Lost to Follow-up|1|||
161129517|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161129518|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
161129519|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
161129520|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
161129521|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
161129522|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
161129523|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
161129524|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
161129525|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
161129526|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
161129527|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161129528|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161129529|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
161129530|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
161129531|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
161129532|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
161129533|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
161331064|NCT01239797|582598767|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
161129534|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
161129535|NCT00849017|581860867|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
161129536|NCT00849017|581860868|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
160797335|NCT02493764|580647295|FG000|Overall Study|Physician Decision|1|||
160797336|NCT02493764|580647296|FG001|Overall Study|Physician Decision|1|||
160797337|NCT02493764|580647295|FG000|Overall Study|Participant moved|17|||
161236205|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
161236206|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
160894530|NCT01325623|581010846|FG000|Overall Study|Withdrawal by Subject|3|||
160894531|NCT02556203|581010855|FG000|Overall Study|Withdrawal by Subject|21|||
160894532|NCT02556203|581010856|FG001|Overall Study|Withdrawal by Subject|21|||
160894533|NCT02556203|581010855|FG000|Overall Study|Lost to Follow-up|5|||
160894534|NCT02556203|581010856|FG001|Overall Study|Lost to Follow-up|5|||
160894535|NCT02556203|581010855|FG000|Overall Study|Adverse Event|1|||
160894536|NCT02556203|581010856|FG001|Overall Study|Adverse Event|0|||
160894537|NCT02943460|581010861|FG000|Blinded Study Phase|Adverse Event|3|||
160894538|NCT02943460|581010862|FG001|Blinded Study Phase|Adverse Event|0|||
160894539|NCT02943460|581010863|FG002|Blinded Study Phase|Adverse Event|0|||
160894540|NCT02943460|581010861|FG000|Blinded Study Phase|Withdrew Consent|0|||
160894541|NCT02943460|581010862|FG001|Blinded Study Phase|Withdrew Consent|1|||
160894542|NCT02943460|581010863|FG002|Blinded Study Phase|Withdrew Consent|0|||
160894543|NCT02943460|581010861|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
160894544|NCT02943460|581010862|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
160894545|NCT02943460|581010863|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
160894546|NCT02943460|581010861|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
160894547|NCT02943460|581010862|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
160894548|NCT02943460|581010863|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
160894549|NCT02943460|581010861|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
160894550|NCT02943460|581010862|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
160894551|NCT02943460|581010863|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
160894552|NCT04171765|581010864|FG000|Overall Study|Adverse Event|2|||
160894553|NCT04171765|581010865|FG001|Overall Study|Adverse Event|0|||
160894554|NCT04171765|581010866|FG002|Overall Study|Adverse Event|1|||
160894555|NCT04171765|581010867|FG003|Overall Study|Adverse Event|0|||
160894556|NCT04171765|581010864|FG000|Overall Study|Lost to Follow-up|0|||
160894557|NCT04171765|581010865|FG001|Overall Study|Lost to Follow-up|2|||
160894558|NCT04171765|581010866|FG002|Overall Study|Lost to Follow-up|2|||
160894559|NCT04171765|581010867|FG003|Overall Study|Lost to Follow-up|2|||
160894560|NCT04171765|581010864|FG000|Overall Study|Week 58 visit missed|0|||
160894561|NCT04171765|581010865|FG001|Overall Study|Week 58 visit missed|0|||
160894562|NCT04171765|581010866|FG002|Overall Study|Week 58 visit missed|1|||
160894563|NCT04171765|581010867|FG003|Overall Study|Week 58 visit missed|0|||
160894564|NCT04171765|581010864|FG000|Overall Study|Study terminated by sponsor|2|||
160894565|NCT04171765|581010865|FG001|Overall Study|Study terminated by sponsor|0|||
160894566|NCT04171765|581010866|FG002|Overall Study|Study terminated by sponsor|0|||
160894567|NCT04171765|581010867|FG003|Overall Study|Study terminated by sponsor|0|||
160894568|NCT04171765|581010864|FG000|Overall Study|Withdrawal by Subject|1|||
160894569|NCT04171765|581010865|FG001|Overall Study|Withdrawal by Subject|0|||
160894570|NCT04171765|581010866|FG002|Overall Study|Withdrawal by Subject|0|||
160894571|NCT04171765|581010867|FG003|Overall Study|Withdrawal by Subject|3|||
160894572|NCT00809354|581010868|FG000|Overall Study|Adverse Event|32|||
160894573|NCT00809354|581010869|FG001|Overall Study|Adverse Event|45|||
160894574|NCT00809354|581010870|FG002|Overall Study|Adverse Event|37|||
160894575|NCT00809354|581010871|FG003|Overall Study|Adverse Event|53|||
160894576|NCT00809354|581010872|FG004|Overall Study|Adverse Event|26|||
160894577|NCT00809354|581010873|FG005|Overall Study|Adverse Event|33|||
160894578|NCT00809354|581010874|FG006|Overall Study|Adverse Event|44|||
160894579|NCT00809354|581010875|FG007|Overall Study|Adverse Event|40|||
161236207|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236208|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236209|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236210|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236211|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236212|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236213|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236214|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236215|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236216|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236217|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236218|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236219|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236220|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161331065|NCT01239797|582598768|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
160894580|NCT00809354|581010876|FG008|Overall Study|Adverse Event|46|||
160894581|NCT00809354|581010877|FG009|Overall Study|Adverse Event|26|||
160894582|NCT00809354|581010868|FG000|Overall Study|Lack of Efficacy|23|||
160894583|NCT00809354|581010869|FG001|Overall Study|Lack of Efficacy|23|||
160894584|NCT00809354|581010870|FG002|Overall Study|Lack of Efficacy|22|||
160894585|NCT00809354|581010871|FG003|Overall Study|Lack of Efficacy|15|||
160894586|NCT00809354|581010872|FG004|Overall Study|Lack of Efficacy|40|||
160894587|NCT00809354|581010873|FG005|Overall Study|Lack of Efficacy|19|||
160894588|NCT00809354|581010874|FG006|Overall Study|Lack of Efficacy|21|||
160894589|NCT00809354|581010875|FG007|Overall Study|Lack of Efficacy|15|||
160894590|NCT00809354|581010876|FG008|Overall Study|Lack of Efficacy|18|||
160894591|NCT00809354|581010877|FG009|Overall Study|Lack of Efficacy|38|||
160894592|NCT00809354|581010868|FG000|Overall Study|Lost to Follow-up|10|||
160894593|NCT00809354|581010869|FG001|Overall Study|Lost to Follow-up|11|||
160894594|NCT00809354|581010870|FG002|Overall Study|Lost to Follow-up|8|||
160894595|NCT00809354|581010871|FG003|Overall Study|Lost to Follow-up|13|||
160894596|NCT00809354|581010872|FG004|Overall Study|Lost to Follow-up|6|||
160894597|NCT00809354|581010873|FG005|Overall Study|Lost to Follow-up|2|||
160894598|NCT00809354|581010874|FG006|Overall Study|Lost to Follow-up|0|||
160894599|NCT00809354|581010875|FG007|Overall Study|Lost to Follow-up|5|||
160894600|NCT00809354|581010876|FG008|Overall Study|Lost to Follow-up|4|||
160797338|NCT02493764|580647296|FG001|Overall Study|Participant moved|5|||
160797339|NCT02493764|580647295|FG000|Overall Study|Withdrawal parent/guardian|0|||
160797340|NCT02493764|580647296|FG001|Overall Study|Withdrawal parent/guardian|1|||
160797341|NCT02493764|580647295|FG000|Overall Study|Withdrawal by Subject|11|||
160797342|NCT02493764|580647296|FG001|Overall Study|Withdrawal by Subject|7|||
160797343|NCT01463527|580647298|FG000|Overall Study|Protocol Violation|1|||
160797344|NCT01463527|580647299|FG001|Overall Study|Protocol Violation|1|||
160797345|NCT01463527|580647298|FG000|Overall Study|Crying >20% of sedation|5|||
160797346|NCT01463527|580647299|FG001|Overall Study|Crying >20% of sedation|6|||
160797347|NCT01977222|580647302|FG000|Overall Study|Withdrawal by Subject|1|||
160797348|NCT04846231|580647303|FG000|Overall Study|Lost to Follow-up|1|||
160797349|NCT04846231|580647304|FG001|Overall Study|Lost to Follow-up|0|||
160797350|NCT04846231|580647305|FG002|Overall Study|Lost to Follow-up|0|||
160797351|NCT04846231|580647306|FG003|Overall Study|Lost to Follow-up|0|||
160797352|NCT04846231|580647307|FG004|Overall Study|Lost to Follow-up|0|||
160797353|NCT04846231|580647308|FG005|Overall Study|Lost to Follow-up|0|||
160797354|NCT04846231|580647309|FG006|Overall Study|Lost to Follow-up|0|||
160797355|NCT04846231|580647310|FG007|Overall Study|Lost to Follow-up|1|||
160797356|NCT04846231|580647303|FG000|Overall Study|Withdrawal by Subject|0|||
160797357|NCT04846231|580647304|FG001|Overall Study|Withdrawal by Subject|1|||
160797358|NCT04846231|580647305|FG002|Overall Study|Withdrawal by Subject|2|||
160797359|NCT04846231|580647306|FG003|Overall Study|Withdrawal by Subject|1|||
160797360|NCT04846231|580647307|FG004|Overall Study|Withdrawal by Subject|0|||
160797361|NCT04846231|580647308|FG005|Overall Study|Withdrawal by Subject|0|||
160797362|NCT04846231|580647309|FG006|Overall Study|Withdrawal by Subject|0|||
160797363|NCT04846231|580647310|FG007|Overall Study|Withdrawal by Subject|0|||
160797364|NCT04846231|580647303|FG000|Overall Study|Protocol Violation|0|||
160797365|NCT04846231|580647304|FG001|Overall Study|Protocol Violation|1|||
160797366|NCT04846231|580647305|FG002|Overall Study|Protocol Violation|0|||
160797367|NCT04846231|580647306|FG003|Overall Study|Protocol Violation|0|||
160797368|NCT04846231|580647307|FG004|Overall Study|Protocol Violation|0|||
160797369|NCT04846231|580647308|FG005|Overall Study|Protocol Violation|0|||
160797370|NCT04846231|580647309|FG006|Overall Study|Protocol Violation|0|||
160797371|NCT04846231|580647310|FG007|Overall Study|Protocol Violation|0|||
160797372|NCT04846231|580647303|FG000|Overall Study|Adverse Event|0|||
160797373|NCT04846231|580647304|FG001|Overall Study|Adverse Event|0|||
160797374|NCT04846231|580647305|FG002|Overall Study|Adverse Event|0|||
160797375|NCT04846231|580647306|FG003|Overall Study|Adverse Event|0|||
160797376|NCT04846231|580647307|FG004|Overall Study|Adverse Event|0|||
160797377|NCT04846231|580647308|FG005|Overall Study|Adverse Event|0|||
160797378|NCT04846231|580647309|FG006|Overall Study|Adverse Event|1|||
160797379|NCT04846231|580647310|FG007|Overall Study|Adverse Event|1|||
160797380|NCT02980107|580647311|FG000|Overall Study|Withdrawal by Subject|51|||
160797381|NCT02980107|580647312|FG001|Overall Study|Withdrawal by Subject|62|||
160797382|NCT03746015|580647313|FG000|Overall Study|Withdrawal of Consent|1|||
160797383|NCT03746015|580647314|FG001|Overall Study|Withdrawal of Consent|0|||
160797384|NCT03746015|580647315|FG002|Overall Study|Withdrawal of Consent|0|||
160797385|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160797386|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
160797387|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160894601|NCT00809354|581010877|FG009|Overall Study|Lost to Follow-up|0|||
161236221|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236222|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236223|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
161236224|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236225|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236226|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
160894602|NCT00809354|581010868|FG000|Overall Study|Protocol Violation|7|||
160894603|NCT00809354|581010869|FG001|Overall Study|Protocol Violation|14|||
160894604|NCT00809354|581010870|FG002|Overall Study|Protocol Violation|14|||
160894605|NCT00809354|581010871|FG003|Overall Study|Protocol Violation|12|||
161331066|NCT01239797|582598767|FG000|Treated Participants|Administrative reason by sponsor|13|||
161331067|NCT01239797|582598768|FG001|Treated Participants|Administrative reason by sponsor|4|||
161331068|NCT01239797|582598767|FG000|Treated Participants|Other reasons|14|||
160894606|NCT00809354|581010872|FG004|Overall Study|Protocol Violation|14|||
160894607|NCT00809354|581010873|FG005|Overall Study|Protocol Violation|6|||
160894608|NCT00809354|581010874|FG006|Overall Study|Protocol Violation|4|||
160894609|NCT00809354|581010875|FG007|Overall Study|Protocol Violation|6|||
160894610|NCT00809354|581010876|FG008|Overall Study|Protocol Violation|9|||
160894611|NCT00809354|581010877|FG009|Overall Study|Protocol Violation|3|||
160894612|NCT00809354|581010868|FG000|Overall Study|Withdrawal by Subject|32|||
160894613|NCT00809354|581010869|FG001|Overall Study|Withdrawal by Subject|27|||
160894614|NCT00809354|581010870|FG002|Overall Study|Withdrawal by Subject|31|||
160894615|NCT00809354|581010871|FG003|Overall Study|Withdrawal by Subject|33|||
160894616|NCT00809354|581010872|FG004|Overall Study|Withdrawal by Subject|34|||
160894617|NCT00809354|581010873|FG005|Overall Study|Withdrawal by Subject|29|||
160894618|NCT00809354|581010874|FG006|Overall Study|Withdrawal by Subject|27|||
160894619|NCT00809354|581010875|FG007|Overall Study|Withdrawal by Subject|19|||
160894620|NCT00809354|581010876|FG008|Overall Study|Withdrawal by Subject|18|||
160894621|NCT00809354|581010877|FG009|Overall Study|Withdrawal by Subject|20|||
160894622|NCT00809354|581010868|FG000|Overall Study|Other|10|||
160894623|NCT00809354|581010869|FG001|Overall Study|Other|2|||
160894624|NCT00809354|581010870|FG002|Overall Study|Other|7|||
160894625|NCT00809354|581010871|FG003|Overall Study|Other|10|||
160894626|NCT00809354|581010872|FG004|Overall Study|Other|5|||
160894627|NCT00809354|581010873|FG005|Overall Study|Other|3|||
160894628|NCT00809354|581010874|FG006|Overall Study|Other|2|||
160894629|NCT00809354|581010875|FG007|Overall Study|Other|3|||
161331069|NCT01239797|582598768|FG001|Treated Participants|Other reasons|14|||
160894630|NCT00809354|581010876|FG008|Overall Study|Other|4|||
160894631|NCT00809354|581010877|FG009|Overall Study|Other|3|||
161129537|NCT00849017|581860869|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
161331070|NCT01239797|582598767|FG000|Treated Participants|Participant withdrew consent|6|||
161331071|NCT01239797|582598768|FG001|Treated Participants|Participant withdrew consent|11|||
161331072|NCT01239797|582598767|FG000|Treated Participants|Death|1|||
161331073|NCT01239797|582598768|FG001|Treated Participants|Death|1|||
161331074|NCT01239797|582598767|FG000|Treated Participants|Participant no longer meets study criteria|1|||
161331075|NCT01239797|582598768|FG001|Treated Participants|Participant no longer meets study criteria|1|||
161331076|NCT01239797|582598767|FG000|Treated Participants|Poor/non-compliance|0|||
161331077|NCT01239797|582598768|FG001|Treated Participants|Poor/non-compliance|1|||
161331078|NCT00853762|582598771|FG000|Overall Study|Premature Termination|16|||
161331079|NCT00853762|582598772|FG001|Overall Study|Premature Termination|15|||
161331080|NCT00853762|582598773|FG002|Overall Study|Premature Termination|14|||
161331081|NCT00853762|582598774|FG003|Overall Study|Premature Termination|21|||
161331082|NCT00853762|582598771|FG000|Overall Study|Protocol Violation|0|||
161331083|NCT00853762|582598772|FG001|Overall Study|Protocol Violation|0|||
161331084|NCT00853762|582598773|FG002|Overall Study|Protocol Violation|0|||
161331085|NCT00853762|582598774|FG003|Overall Study|Protocol Violation|1|||
161331086|NCT00853762|582598771|FG000|Overall Study|Withdrawal by Subject|0|||
161331087|NCT00853762|582598772|FG001|Overall Study|Withdrawal by Subject|0|||
161331088|NCT00853762|582598773|FG002|Overall Study|Withdrawal by Subject|1|||
161331089|NCT00853762|582598774|FG003|Overall Study|Withdrawal by Subject|0|||
161331090|NCT00853762|582598771|FG000|Overall Study|Other|0|||
161331091|NCT00853762|582598772|FG001|Overall Study|Other|2|||
161331092|NCT00853762|582598773|FG002|Overall Study|Other|0|||
161331093|NCT00853762|582598774|FG003|Overall Study|Other|0|||
161331094|NCT00853762|582598771|FG000|Overall Study|Randomised but not Treated|0|||
161331095|NCT00853762|582598772|FG001|Overall Study|Randomised but not Treated|2|||
161331096|NCT00853762|582598773|FG002|Overall Study|Randomised but not Treated|2|||
161331097|NCT00853762|582598774|FG003|Overall Study|Randomised but not Treated|0|||
161331098|NCT02000921|582598775|FG000|Overall Study|Withdrawal by Subject|3|||
161331099|NCT02000921|582598776|FG001|Overall Study|Withdrawal by Subject|10|||
161331100|NCT02000921|582598777|FG002|Overall Study|Withdrawal by Subject|5|||
161331101|NCT02000921|582598775|FG000|Overall Study|Lost to Follow-up|2|||
161331102|NCT02000921|582598776|FG001|Overall Study|Lost to Follow-up|4|||
161331103|NCT02000921|582598777|FG002|Overall Study|Lost to Follow-up|5|||
161331104|NCT02000921|582598775|FG000|Overall Study|Physician Decision|0|||
161331105|NCT02000921|582598776|FG001|Overall Study|Physician Decision|2|||
161331106|NCT02000921|582598777|FG002|Overall Study|Physician Decision|0|||
161331107|NCT02631941|582598784|FG000|Overall Study|Physician Decision|0|||
161331108|NCT02631941|582598785|FG001|Overall Study|Physician Decision|1|||
161331109|NCT02631941|582598786|FG002|Overall Study|Physician Decision|0|||
161331110|NCT02631941|582598787|FG003|Overall Study|Physician Decision|0|||
160894632|NCT00809354|581010868|FG000|Overall Study|Study terminated by sponsor|138|||
160894633|NCT00809354|581010869|FG001|Overall Study|Study terminated by sponsor|134|||
160894634|NCT00809354|581010870|FG002|Overall Study|Study terminated by sponsor|129|||
160894635|NCT00809354|581010871|FG003|Overall Study|Study terminated by sponsor|120|||
160894636|NCT00809354|581010872|FG004|Overall Study|Study terminated by sponsor|126|||
160894637|NCT00809354|581010873|FG005|Overall Study|Study terminated by sponsor|133|||
161236227|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
161236228|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236229|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236230|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236231|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236232|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236233|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236234|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236235|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236236|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236237|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236238|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236239|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236240|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236241|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236242|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236243|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236244|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
161236245|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236246|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236247|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
161236248|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
161236249|NCT01597245|582244926|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236250|NCT01597245|582244927|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236251|NCT01597245|582244928|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236252|NCT01597245|582244929|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236253|NCT01597245|582244930|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236254|NCT01597245|582244931|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236255|NCT01597245|582244932|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236256|NCT01597245|582244933|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236257|NCT01597245|582244934|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236258|NCT01597245|582244935|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236259|NCT01597245|582244936|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236260|NCT01597245|582244937|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236261|NCT01597245|582244938|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236262|NCT01597245|582244939|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236263|NCT01597245|582244940|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236264|NCT01597245|582244941|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236265|NCT01597245|582244942|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236266|NCT01597245|582244943|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236267|NCT01597245|582244944|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236268|NCT01597245|582244945|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
161236269|NCT01597245|582244946|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
161236270|NCT00731783|582244947|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
161236271|NCT00731783|582244948|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
161236272|NCT00731783|582244947|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
161236273|NCT00731783|582244948|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
161236274|NCT00731783|582244947|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
161236275|NCT00731783|582244948|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
161236276|NCT00731783|582244947|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
161236277|NCT00731783|582244948|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
161257868|NCT01197417|582323504|FG000|Overall Study|Not consented in time to receive drug|0|||
161257869|NCT01197417|582323505|FG001|Overall Study|Not consented in time to receive drug|1|||
161257870|NCT01197417|582323504|FG000|Overall Study|Hypotension|1|||
161257871|NCT01197417|582323505|FG001|Overall Study|Hypotension|2|||
161257872|NCT01197417|582323504|FG000|Overall Study|Found to be ineligible|2|||
161257873|NCT01197417|582323505|FG001|Overall Study|Found to be ineligible|5|||
161257874|NCT01197417|582323504|FG000|Overall Study|No 25-hour magnesium level|0|||
161257875|NCT01197417|582323505|FG001|Overall Study|No 25-hour magnesium level|2|||
161257876|NCT02813421|582323506|FG000|Overall Study|Withdrawal by Subject|1|||
161257877|NCT02813421|582323507|FG001|Overall Study|Withdrawal by Subject|2|||
161257878|NCT02813421|582323506|FG000|Overall Study|Lost to Follow-up|1|||
161257879|NCT02813421|582323507|FG001|Overall Study|Lost to Follow-up|1|||
161257880|NCT02129647|582323516|FG000|Overall Study|Adverse Event|2|||
161257881|NCT02129647|582323516|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
161257882|NCT02772562|582323517|FG000|Overall Study|Withdrawal by Subject|1|||
161257883|NCT02772562|582323517|FG000|Overall Study|Protocol Violation|1|||
161257884|NCT03756883|582323518|FG000|Overall Study|Adverse Event|2|||
161236278|NCT04115293|582246285|FG000|Overall Study|Adverse Event|0|||
161236279|NCT04115293|582246286|FG001|Overall Study|Adverse Event|2|||
161236280|NCT04115293|582246285|FG000|Overall Study|Withdrawal by Subject|2|||
161236281|NCT04115293|582246286|FG001|Overall Study|Withdrawal by Subject|1|||
161236282|NCT04115293|582246285|FG000|Overall Study|Physician Decision|1|||
161236283|NCT04115293|582246286|FG001|Overall Study|Physician Decision|0|||
161236284|NCT04115293|582246285|FG000|Overall Study|Death|1|||
161236285|NCT04115293|582246286|FG001|Overall Study|Death|1|||
161236286|NCT02674152|582246287|FG000|Overall Study|Personal Reasons|1|||
161236287|NCT02674152|582246288|FG001|Overall Study|Personal Reasons|0|||
161236288|NCT02674152|582246289|FG002|Overall Study|Personal Reasons|0|||
161236289|NCT02674152|582246290|FG003|Overall Study|Personal Reasons|1|||
161236290|NCT02674152|582246291|FG004|Overall Study|Personal Reasons|1|||
161236291|NCT02674152|582246287|FG000|Overall Study|Other adverse event or clinical progression|0|||
161236292|NCT02674152|582246288|FG001|Overall Study|Other adverse event or clinical progression|1|||
160797388|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
160797389|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
160797390|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
160797391|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
160797392|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
160797393|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
160797394|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
160797395|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
160797396|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
160797397|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160797398|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160797399|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160797400|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160797401|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
160797402|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
160797403|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
160797404|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
160797405|NCT02836249|580647318|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
160797406|NCT02836249|580647319|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
160797407|NCT02836249|580647320|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
160797408|NCT02836249|580647321|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
161236293|NCT02674152|582246289|FG002|Overall Study|Other adverse event or clinical progression|0|||
161236294|NCT02674152|582246290|FG003|Overall Study|Other adverse event or clinical progression|3|||
161236295|NCT02674152|582246291|FG004|Overall Study|Other adverse event or clinical progression|0|||
161236296|NCT02674152|582246287|FG000|Overall Study|Dose-limiting toxicity|0|||
160797409|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
160797410|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
160797411|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
160797412|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
160797413|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
160797414|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
160797415|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
161236297|NCT02674152|582246288|FG001|Overall Study|Dose-limiting toxicity|0|||
160797416|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
160797417|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Death|0|||
160797418|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Death|0|||
160797419|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Death|1|||
160797420|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Death|0|||
160797421|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
160797422|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
160797423|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
160797424|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
160797425|NCT02836249|580647318|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
160797426|NCT02836249|580647319|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
161236298|NCT02674152|582246289|FG002|Overall Study|Dose-limiting toxicity|0|||
160797427|NCT02836249|580647320|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
160797428|NCT02836249|580647321|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
160797429|NCT01646827|580647322|FG000|Overall Study|Lost to Follow-up|0|||
161236299|NCT02674152|582246290|FG003|Overall Study|Dose-limiting toxicity|0|||
161236300|NCT02674152|582246291|FG004|Overall Study|Dose-limiting toxicity|1|||
161236301|NCT02674152|582246287|FG000|Overall Study|Progressive Disease|2|||
161236302|NCT02674152|582246288|FG001|Overall Study|Progressive Disease|1|||
161236303|NCT02674152|582246289|FG002|Overall Study|Progressive Disease|1|||
161236304|NCT02674152|582246290|FG003|Overall Study|Progressive Disease|13|||
161236305|NCT02674152|582246291|FG004|Overall Study|Progressive Disease|2|||
161236306|NCT02674152|582246287|FG000|Overall Study|Adverse Event|0|||
161331111|NCT02631941|582598788|FG004|Overall Study|Physician Decision|0|||
161236307|NCT02674152|582246288|FG001|Overall Study|Adverse Event|0|||
160797430|NCT01646827|580647323|FG001|Overall Study|Lost to Follow-up|3|||
160797431|NCT01646827|580647322|FG000|Overall Study|Physician Decision|1|||
160797432|NCT01646827|580647323|FG001|Overall Study|Physician Decision|2|||
160797433|NCT01646827|580647322|FG000|Overall Study|Withdrawal by Subject|1|||
160797434|NCT01646827|580647323|FG001|Overall Study|Withdrawal by Subject|0|||
160797435|NCT00928668|580647324|FG000|Overall Study|Adverse Event|1|||
160797436|NCT00928668|580647325|FG001|Overall Study|Adverse Event|0|||
160797437|NCT00928668|580647326|FG002|Overall Study|Adverse Event|0|||
160797438|NCT00928668|580647327|FG003|Overall Study|Adverse Event|0|||
160797439|NCT00928668|580647328|FG004|Overall Study|Adverse Event|0|||
160797440|NCT00928668|580647324|FG000|Overall Study|Protocol Violation|0|||
160797441|NCT00928668|580647325|FG001|Overall Study|Protocol Violation|0|||
160797442|NCT00928668|580647326|FG002|Overall Study|Protocol Violation|0|||
160797443|NCT00928668|580647327|FG003|Overall Study|Protocol Violation|0|||
160797444|NCT00928668|580647328|FG004|Overall Study|Protocol Violation|1|||
160797445|NCT00928668|580647324|FG000|Overall Study|Withdrawal by Subject|0|||
160797446|NCT00928668|580647325|FG001|Overall Study|Withdrawal by Subject|1|||
160797447|NCT00928668|580647326|FG002|Overall Study|Withdrawal by Subject|1|||
160797448|NCT00928668|580647327|FG003|Overall Study|Withdrawal by Subject|0|||
160797449|NCT00928668|580647328|FG004|Overall Study|Withdrawal by Subject|0|||
160894638|NCT00809354|581010874|FG006|Overall Study|Study terminated by sponsor|124|||
160894639|NCT00809354|581010875|FG007|Overall Study|Study terminated by sponsor|148|||
160797450|NCT00928668|580647324|FG000|Overall Study|Other reasons not listed above|0|||
160797451|NCT00928668|580647325|FG001|Overall Study|Other reasons not listed above|0|||
160894640|NCT00809354|581010876|FG008|Overall Study|Study terminated by sponsor|127|||
161236308|NCT02674152|582246289|FG002|Overall Study|Adverse Event|1|||
161236309|NCT02674152|582246290|FG003|Overall Study|Adverse Event|0|||
161236310|NCT02674152|582246291|FG004|Overall Study|Adverse Event|1|||
161236311|NCT02571907|582246292|FG000|Overall Study|Death|4|||
161236312|NCT02571907|582246292|FG000|Overall Study|Lost to Follow-up|3|||
161236313|NCT02571907|582246292|FG000|Overall Study|Withdrawal by Subject|3|||
161236314|NCT03772522|582246293|FG000|Pre-intervention|Withdrawal by Subject|3|||
161236315|NCT03772522|582246294|FG001|Pre-intervention|Withdrawal by Subject|4|||
161236316|NCT03772522|582246293|FG000|Intervention|Withdrawal by Subject|1|||
161236317|NCT03772522|582246294|FG001|Intervention|Withdrawal by Subject|0|||
161236318|NCT03772522|582246293|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
161236319|NCT03772522|582246294|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
161236320|NCT03071575|582246295|FG000|Overall Study|Death|0|||
161236321|NCT03071575|582246296|FG001|Overall Study|Death|1|||
161236322|NCT03071575|582246295|FG000|Overall Study|Lost to Follow-up|5|||
161236323|NCT03071575|582246296|FG001|Overall Study|Lost to Follow-up|11|||
161236324|NCT03071575|582246295|FG000|Overall Study|Withdrawal by Subject|4|||
161236325|NCT03071575|582246296|FG001|Overall Study|Withdrawal by Subject|2|||
161236326|NCT00218257|582246297|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
161236327|NCT00218257|582246298|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
161236328|NCT00579345|582246299|FG000|Overall Study|Withdrawal by Subject|2|||
161236329|NCT00579345|582246300|FG001|Overall Study|Withdrawal by Subject|0|||
161236330|NCT00579345|582246301|FG002|Overall Study|Withdrawal by Subject|0|||
161236331|NCT00579345|582246302|FG003|Overall Study|Withdrawal by Subject|0|||
161236332|NCT00579345|582246303|FG004|Overall Study|Withdrawal by Subject|0|||
161236333|NCT00579345|582246304|FG005|Overall Study|Withdrawal by Subject|0|||
161236334|NCT00579345|582246305|FG006|Overall Study|Withdrawal by Subject|0|||
161236335|NCT00579345|582246306|FG007|Overall Study|Withdrawal by Subject|1|||
161236336|NCT00579345|582246299|FG000|Overall Study|Lost to Follow-up|1|||
161236337|NCT00579345|582246300|FG001|Overall Study|Lost to Follow-up|0|||
161236338|NCT00579345|582246301|FG002|Overall Study|Lost to Follow-up|0|||
161236339|NCT00579345|582246302|FG003|Overall Study|Lost to Follow-up|0|||
161236340|NCT00579345|582246303|FG004|Overall Study|Lost to Follow-up|0|||
161236341|NCT00579345|582246304|FG005|Overall Study|Lost to Follow-up|0|||
161236342|NCT00579345|582246305|FG006|Overall Study|Lost to Follow-up|0|||
161236343|NCT00579345|582246306|FG007|Overall Study|Lost to Follow-up|0|||
161236344|NCT00579345|582246299|FG000|Overall Study|Adverse Event|0|||
161236345|NCT00579345|582246300|FG001|Overall Study|Adverse Event|0|||
161236346|NCT00579345|582246301|FG002|Overall Study|Adverse Event|1|||
161236347|NCT00579345|582246302|FG003|Overall Study|Adverse Event|0|||
160797452|NCT00928668|580647326|FG002|Overall Study|Other reasons not listed above|0|||
160894641|NCT00809354|581010877|FG009|Overall Study|Study terminated by sponsor|135|||
161236348|NCT00579345|582246303|FG004|Overall Study|Adverse Event|0|||
161236349|NCT00579345|582246304|FG005|Overall Study|Adverse Event|0|||
161236350|NCT00579345|582246305|FG006|Overall Study|Adverse Event|0|||
161236351|NCT00579345|582246306|FG007|Overall Study|Adverse Event|0|||
161236352|NCT00579345|582246299|FG000|Overall Study|Protocol Violation|1|||
161236353|NCT00579345|582246300|FG001|Overall Study|Protocol Violation|0|||
161236354|NCT00579345|582246301|FG002|Overall Study|Protocol Violation|0|||
160797453|NCT00928668|580647327|FG003|Overall Study|Other reasons not listed above|1|||
160894642|NCT00809354|581010868|FG000|Overall Study|Withdrawn due to pregnancy|0|||
160894643|NCT00809354|581010869|FG001|Overall Study|Withdrawn due to pregnancy|1|||
161236355|NCT00579345|582246302|FG003|Overall Study|Protocol Violation|0|||
160797454|NCT00928668|580647328|FG004|Overall Study|Other reasons not listed above|0|||
160797455|NCT01143402|580647331|FG000|Overall Study|Rapid clinical decline|1|||
160797456|NCT01143402|580647332|FG001|Overall Study|Rapid clinical decline|1|||
160797457|NCT01143402|580647333|FG002|Overall Study|Rapid clinical decline|0|||
160797458|NCT01143402|580647331|FG000|Overall Study|Not Treated|0|||
160797459|NCT01143402|580647332|FG001|Overall Study|Not Treated|0|||
160797460|NCT01143402|580647333|FG002|Overall Study|Not Treated|1|||
160797461|NCT04462471|580647334|FG000|Overall Study|Adverse Event|0|||
160983581|NCT05764239|581328678|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
160983582|NCT00057811|581328682|FG000|Overall Study|Lack of Efficacy|1|||
160983583|NCT00057811|581328683|FG001|Overall Study|Lack of Efficacy|4|||
160983584|NCT00057811|581328682|FG000|Overall Study|Physician Decision|1|||
160983585|NCT00057811|581328683|FG001|Overall Study|Physician Decision|0|||
160983586|NCT00057811|581328682|FG000|Overall Study|Withdrawal by Subject|3|||
160983587|NCT00057811|581328683|FG001|Overall Study|Withdrawal by Subject|4|||
160983588|NCT00057811|581328682|FG000|Overall Study|Ineligible|4|||
160983589|NCT00057811|581328683|FG001|Overall Study|Ineligible|2|||
160983590|NCT00057811|581328682|FG000|Overall Study|Inevaluable|1|||
160983591|NCT00057811|581328683|FG001|Overall Study|Inevaluable|2|||
160983592|NCT00556374|581328684|FG000|Overall Study|Withdrawal by Subject|235|||
160983593|NCT00556374|581328685|FG001|Overall Study|Withdrawal by Subject|205|||
160983594|NCT00556374|581328684|FG000|Overall Study|Death|158|||
160983595|NCT00556374|581328685|FG001|Overall Study|Death|127|||
160983596|NCT00556374|581328684|FG000|Overall Study|Lost to Follow-up|24|||
160983597|NCT00556374|581328685|FG001|Overall Study|Lost to Follow-up|17|||
160983598|NCT00556374|581328684|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
160983599|NCT00556374|581328685|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
160983600|NCT00442286|581328686|FG000|Overall Study|Death|2|||
160983601|NCT00442286|581328687|FG001|Overall Study|Death|2|||
160983602|NCT00442286|581328686|FG000|Overall Study|Lost to Follow-up|1|||
160983603|NCT00442286|581328687|FG001|Overall Study|Lost to Follow-up|0|||
160983604|NCT00442286|581328686|FG000|Overall Study|Withdrawal by Subject|2|||
160983605|NCT00442286|581328687|FG001|Overall Study|Withdrawal by Subject|0|||
160983606|NCT00442286|581328686|FG000|Overall Study|System explanted|1|||
160983607|NCT00442286|581328687|FG001|Overall Study|System explanted|0|||
160983608|NCT00442286|581328686|FG000|Overall Study|Patient Injury|1|||
161331112|NCT02631941|582598789|FG005|Overall Study|Physician Decision|0|||
161331113|NCT02631941|582598790|FG006|Overall Study|Physician Decision|0|||
161331114|NCT02631941|582598791|FG007|Overall Study|Physician Decision|0|||
161331115|NCT02631941|582598792|FG008|Overall Study|Physician Decision|0|||
161331116|NCT02631941|582598793|FG009|Overall Study|Physician Decision|0|||
161331117|NCT02631941|582598784|FG000|Overall Study|Adverse Event|0|||
161331118|NCT02631941|582598785|FG001|Overall Study|Adverse Event|1|||
160983609|NCT00442286|581328687|FG001|Overall Study|Patient Injury|0|||
160983610|NCT00641186|581328688|FG000|Overall Study|Adverse Event|3|||
160983611|NCT05221749|581328691|FG000|Overall Study|Lost to Follow-up|2|||
160983612|NCT05221749|581328692|FG001|Overall Study|Lost to Follow-up|3|||
160983613|NCT03428815|581328693|FG000|Overall Study|Lost to Follow-up|2|||
160983614|NCT03428815|581328694|FG001|Overall Study|Lost to Follow-up|2|||
160983615|NCT03428815|581328693|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
160983616|NCT03428815|581328694|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
160983617|NCT03428815|581328693|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
160983618|NCT03428815|581328694|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
160983619|NCT01700348|581328697|FG000|Overall Study|Withdrawal by Subject|22|||
160983620|NCT01700348|581328697|FG000|Overall Study|Lost to Follow-up|1|||
160983621|NCT02404493|581328698|FG000|Overall Study|Adverse Event|1|||
160983622|NCT02404493|581328699|FG001|Overall Study|Adverse Event|1|||
161331119|NCT02631941|582598786|FG002|Overall Study|Adverse Event|0|||
161331120|NCT02631941|582598787|FG003|Overall Study|Adverse Event|0|||
161331121|NCT02631941|582598788|FG004|Overall Study|Adverse Event|0|||
160797462|NCT04462471|580647335|FG001|Overall Study|Adverse Event|1|||
160797463|NCT04462471|580647336|FG002|Overall Study|Adverse Event|0|||
160797464|NCT04462471|580647337|FG003|Overall Study|Adverse Event|0|||
160797465|NCT04462471|580647334|FG000|Overall Study|Disease progression|1|||
160797466|NCT04462471|580647335|FG001|Overall Study|Disease progression|0|||
161331122|NCT02631941|582598789|FG005|Overall Study|Adverse Event|0|||
161331123|NCT02631941|582598790|FG006|Overall Study|Adverse Event|0|||
160797467|NCT04462471|580647336|FG002|Overall Study|Disease progression|0|||
160797468|NCT04462471|580647337|FG003|Overall Study|Disease progression|0|||
160797469|NCT01276106|580647340|FG000|Overall Study|Adverse Event|3|||
160983623|NCT02102464|581328700|FG000|Randomized Study|Withdrawal by Subject|0|||
160983624|NCT02102464|581328701|FG001|Randomized Study|Withdrawal by Subject|1|||
160983625|NCT02102464|581328702|FG002|Randomized Study|Withdrawal by Subject|0|||
160983626|NCT04140890|581328703|FG000|Overall Study|Withdrawal by Subject|0|||
160983627|NCT04140890|581328704|FG001|Overall Study|Withdrawal by Subject|1|||
161331124|NCT02631941|582598791|FG007|Overall Study|Adverse Event|0|||
160983628|NCT02388074|581328705|FG000|Overall Study|Lost in Transit|2|||
160983629|NCT02388074|581328705|FG000|Overall Study|Sample Not Returned|1|||
160894644|NCT00809354|581010870|FG002|Overall Study|Withdrawn due to pregnancy|0|||
160894645|NCT00809354|581010871|FG003|Overall Study|Withdrawn due to pregnancy|0|||
160894646|NCT00809354|581010872|FG004|Overall Study|Withdrawn due to pregnancy|0|||
160894647|NCT00809354|581010873|FG005|Overall Study|Withdrawn due to pregnancy|0|||
160894648|NCT00809354|581010874|FG006|Overall Study|Withdrawn due to pregnancy|0|||
160894649|NCT00809354|581010875|FG007|Overall Study|Withdrawn due to pregnancy|0|||
160894650|NCT00809354|581010876|FG008|Overall Study|Withdrawn due to pregnancy|0|||
160894651|NCT00809354|581010877|FG009|Overall Study|Withdrawn due to pregnancy|0|||
160894652|NCT00809354|581010868|FG000|Overall Study|Randomized but not Treated|3|||
160894653|NCT00809354|581010869|FG001|Overall Study|Randomized but not Treated|1|||
160894654|NCT00809354|581010870|FG002|Overall Study|Randomized but not Treated|6|||
160894655|NCT00809354|581010871|FG003|Overall Study|Randomized but not Treated|0|||
160894656|NCT00809354|581010872|FG004|Overall Study|Randomized but not Treated|5|||
160894657|NCT00809354|581010873|FG005|Overall Study|Randomized but not Treated|0|||
160894658|NCT00809354|581010874|FG006|Overall Study|Randomized but not Treated|1|||
160894659|NCT00809354|581010875|FG007|Overall Study|Randomized but not Treated|1|||
160894660|NCT00809354|581010876|FG008|Overall Study|Randomized but not Treated|2|||
160894661|NCT00809354|581010877|FG009|Overall Study|Randomized but not Treated|1|||
160894662|NCT00809354|581010868|FG000|Overall Study|Death|0|||
160894663|NCT00809354|581010869|FG001|Overall Study|Death|0|||
160894664|NCT00809354|581010870|FG002|Overall Study|Death|0|||
160894665|NCT00809354|581010871|FG003|Overall Study|Death|0|||
160894666|NCT00809354|581010872|FG004|Overall Study|Death|0|||
160894667|NCT00809354|581010873|FG005|Overall Study|Death|0|||
160894668|NCT00809354|581010874|FG006|Overall Study|Death|0|||
160894669|NCT00809354|581010875|FG007|Overall Study|Death|1|||
160894670|NCT00809354|581010876|FG008|Overall Study|Death|0|||
160894671|NCT00809354|581010877|FG009|Overall Study|Death|0|||
160894672|NCT04137224|581010880|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
160894673|NCT04137224|581010881|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
160894674|NCT04137224|581010880|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
161236356|NCT00579345|582246303|FG004|Overall Study|Protocol Violation|0|||
161236357|NCT00579345|582246304|FG005|Overall Study|Protocol Violation|0|||
161236358|NCT00579345|582246305|FG006|Overall Study|Protocol Violation|0|||
161236359|NCT00579345|582246306|FG007|Overall Study|Protocol Violation|1|||
161236360|NCT00579345|582246299|FG000|Overall Study|Death|1|||
161236361|NCT00579345|582246300|FG001|Overall Study|Death|1|||
161236362|NCT00579345|582246301|FG002|Overall Study|Death|1|||
161236363|NCT00579345|582246302|FG003|Overall Study|Death|1|||
161236364|NCT00579345|582246303|FG004|Overall Study|Death|0|||
161236365|NCT00579345|582246304|FG005|Overall Study|Death|0|||
161236366|NCT00579345|582246305|FG006|Overall Study|Death|0|||
161236367|NCT00579345|582246306|FG007|Overall Study|Death|0|||
161236368|NCT03255733|582246310|FG000|Overall Study|Lost to Follow-up|4|||
161236369|NCT02472366|582246314|FG000|Overall Study|Lost to Follow-up|1|||
161236370|NCT02472366|582246315|FG001|Overall Study|Lost to Follow-up|0|||
161236371|NCT03699020|582246318|FG000|Overall Study|Withdrawal by Subject|3|||
161236372|NCT03699020|582246319|FG001|Overall Study|Withdrawal by Subject|2|||
161236373|NCT04274686|582246323|FG000|Overall Study|Physician Decision|1|||
161236374|NCT04274686|582246324|FG001|Overall Study|Physician Decision|0|||
161236375|NCT00905840|582246325|FG000|Overall Study|Lost to Follow-up|11|||
161236376|NCT00905840|582246325|FG000|Overall Study|Death|3|||
161236377|NCT00905840|582246325|FG000|Overall Study|Withdrawal by Subject|1|||
161236378|NCT00905840|582246325|FG000|Overall Study|Adverse Event|1|||
161236379|NCT00448019|582246326|FG000|Overall Study|Withdrawal by Subject|3|||
161236380|NCT00448019|582246326|FG000|Overall Study|Disease progression|1|||
161236381|NCT00448019|582246326|FG000|Overall Study|Death|2|||
161236382|NCT00448019|582246326|FG000|Overall Study|Insurance Issues|1|||
161236383|NCT03020615|582246327|FG000|Overall Study|Physician Decision|3|||
161236384|NCT03020615|582246328|FG001|Overall Study|Physician Decision|1|||
161236385|NCT03020615|582246329|FG002|Overall Study|Physician Decision|2|||
161236386|NCT03020615|582246327|FG000|Overall Study|Parent/guardian/patient choice|3|||
161236387|NCT03020615|582246328|FG001|Overall Study|Parent/guardian/patient choice|0|||
161236388|NCT03020615|582246329|FG002|Overall Study|Parent/guardian/patient choice|4|||
161236389|NCT03020615|582246327|FG000|Overall Study|Screen failure|0|||
161236390|NCT03020615|582246328|FG001|Overall Study|Screen failure|0|||
161236391|NCT03020615|582246329|FG002|Overall Study|Screen failure|1|||
161236392|NCT03020615|582246327|FG000|Overall Study|Death|1|||
161236393|NCT03020615|582246328|FG001|Overall Study|Death|0|||
161236394|NCT03020615|582246329|FG002|Overall Study|Death|0|||
161236395|NCT03020615|582246327|FG000|Overall Study|Lost to Follow-up|0|||
161236396|NCT03020615|582246328|FG001|Overall Study|Lost to Follow-up|1|||
161236397|NCT03020615|582246329|FG002|Overall Study|Lost to Follow-up|0|||
161236398|NCT02760368|582246330|FG000|Overall Study|Withdrawal by Subject|8|||
161236399|NCT02760368|582246331|FG001|Overall Study|Withdrawal by Subject|12|||
161236400|NCT02760368|582246332|FG002|Overall Study|Withdrawal by Subject|9|||
161236401|NCT02760368|582246330|FG000|Overall Study|Screen Failure|0|||
161236402|NCT02760368|582246331|FG001|Overall Study|Screen Failure|0|||
161236403|NCT02760368|582246332|FG002|Overall Study|Screen Failure|1|||
161236404|NCT02760368|582246330|FG000|Overall Study|Death|0|||
160797470|NCT01276106|580647341|FG001|Overall Study|Adverse Event|3|||
160797471|NCT01276106|580647342|FG002|Overall Study|Adverse Event|11|||
160894675|NCT04137224|581010881|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
160894676|NCT04137224|581010880|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
160894677|NCT04137224|581010881|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
160894678|NCT01669928|581010882|FG000|First Intervention|Withdrawal by Subject|3|||
160894679|NCT01669928|581010883|FG001|First Intervention|Withdrawal by Subject|5|||
160894680|NCT05085730|581010889|FG000|Overall Study|Withdrawal by Subject|4|||
160894681|NCT05085730|581010889|FG000|Overall Study|Physician Decision|1|||
160894682|NCT01199731|581010890|FG000|Overall Study|Adverse Event|0|||
160894683|NCT01199731|581010891|FG001|Overall Study|Adverse Event|1|||
160894684|NCT01199731|581010892|FG002|Overall Study|Adverse Event|0|||
160894685|NCT01199731|581010890|FG000|Overall Study|Study closed/terminated|7|||
160797472|NCT01276106|580647343|FG003|Overall Study|Adverse Event|3|||
160797473|NCT01276106|580647340|FG000|Overall Study|Withdrawal by Subject|6|||
160797474|NCT01276106|580647341|FG001|Overall Study|Withdrawal by Subject|3|||
160797475|NCT01276106|580647342|FG002|Overall Study|Withdrawal by Subject|1|||
160797476|NCT01276106|580647343|FG003|Overall Study|Withdrawal by Subject|6|||
160797477|NCT01276106|580647340|FG000|Overall Study|Lack of Efficacy|0|||
160797478|NCT01276106|580647341|FG001|Overall Study|Lack of Efficacy|1|||
160797479|NCT01276106|580647342|FG002|Overall Study|Lack of Efficacy|0|||
160894686|NCT01199731|581010891|FG001|Overall Study|Study closed/terminated|9|||
160894687|NCT01199731|581010892|FG002|Overall Study|Study closed/terminated|7|||
160894688|NCT01199731|581010890|FG000|Overall Study|Lost to Follow-up|0|||
160894689|NCT01199731|581010891|FG001|Overall Study|Lost to Follow-up|0|||
160894690|NCT01199731|581010892|FG002|Overall Study|Lost to Follow-up|2|||
160894691|NCT01199731|581010890|FG000|Overall Study|Physician Decision|0|||
161236405|NCT02760368|582246331|FG001|Overall Study|Death|1|||
160797480|NCT01276106|580647343|FG003|Overall Study|Lack of Efficacy|1|||
160797481|NCT01276106|580647340|FG000|Overall Study|Lost to Follow-up|2|||
160797482|NCT01276106|580647341|FG001|Overall Study|Lost to Follow-up|1|||
160797483|NCT01276106|580647342|FG002|Overall Study|Lost to Follow-up|1|||
160797484|NCT01276106|580647343|FG003|Overall Study|Lost to Follow-up|0|||
160797485|NCT01276106|580647340|FG000|Overall Study|Physician Decision|0|||
160797486|NCT01276106|580647341|FG001|Overall Study|Physician Decision|0|||
160797487|NCT01276106|580647342|FG002|Overall Study|Physician Decision|1|||
160797488|NCT01276106|580647343|FG003|Overall Study|Physician Decision|1|||
160797489|NCT01276106|580647340|FG000|Overall Study|Protocol Violation|1|||
160797490|NCT01276106|580647341|FG001|Overall Study|Protocol Violation|1|||
160797491|NCT01276106|580647342|FG002|Overall Study|Protocol Violation|0|||
160797492|NCT01276106|580647343|FG003|Overall Study|Protocol Violation|2|||
160797493|NCT01276106|580647340|FG000|Overall Study|Insufficient therapeutic effects|0|||
160797494|NCT01276106|580647341|FG001|Overall Study|Insufficient therapeutic effects|0|||
160797495|NCT01276106|580647342|FG002|Overall Study|Insufficient therapeutic effects|2|||
160797496|NCT01276106|580647343|FG003|Overall Study|Insufficient therapeutic effects|0|||
160797497|NCT02936323|580647350|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797498|NCT02936323|580647351|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797499|NCT02936323|580647352|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797500|NCT02936323|580647353|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797501|NCT02936323|580647354|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797502|NCT02936323|580647355|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
160797503|NCT02936323|580647356|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797504|NCT02936323|580647357|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797505|NCT02936323|580647358|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797506|NCT02936323|580647359|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
160797507|NCT02936323|580647350|FG000|Phase 1 Dose Escalation|Death|2|||
160797508|NCT02936323|580647351|FG001|Phase 1 Dose Escalation|Death|1|||
160797509|NCT02936323|580647352|FG002|Phase 1 Dose Escalation|Death|3|||
160797510|NCT02936323|580647353|FG003|Phase 1 Dose Escalation|Death|1|||
160894692|NCT01199731|581010891|FG001|Overall Study|Physician Decision|1|||
160894693|NCT01199731|581010892|FG002|Overall Study|Physician Decision|1|||
161236406|NCT02760368|582246332|FG002|Overall Study|Death|0|||
161236407|NCT02760368|582246330|FG000|Overall Study|Withdrawal by Sponsor|0|||
161236408|NCT02760368|582246331|FG001|Overall Study|Withdrawal by Sponsor|0|||
161236409|NCT02760368|582246332|FG002|Overall Study|Withdrawal by Sponsor|1|||
161236410|NCT00794963|582246333|FG000|Overall Study|Withdrawal by Subject|1|||
161236411|NCT00794963|582246334|FG001|Overall Study|Withdrawal by Subject|4|||
161236412|NCT01037114|582246335|FG000|Year 20|Others|1|||
160894694|NCT01199731|581010890|FG000|Overall Study|Withdrawal by Subject|2|||
160894695|NCT01199731|581010891|FG001|Overall Study|Withdrawal by Subject|0|||
160983630|NCT01778062|581328708|FG000|Overall Study|Adverse Event|1|||
160797511|NCT02936323|580647354|FG004|Phase 1 Dose Escalation|Death|2|||
160797512|NCT02936323|580647355|FG005|Phase 1 Dose Escalation|Death|3|||
160797513|NCT02936323|580647356|FG006|Phase 1 Dose Escalation|Death|3|||
160797514|NCT02936323|580647357|FG007|Phase 1 Dose Escalation|Death|0|||
160797515|NCT02936323|580647358|FG008|Phase 1 Dose Escalation|Death|0|||
161331125|NCT02631941|582598792|FG008|Overall Study|Adverse Event|0|||
160894696|NCT01199731|581010892|FG002|Overall Study|Withdrawal by Subject|0|||
160894697|NCT01916967|581010895|FG000|Overall Study|Adverse Event|0|||
160894698|NCT01916967|581010896|FG001|Overall Study|Adverse Event|0|||
160894699|NCT01916967|581010897|FG002|Overall Study|Adverse Event|2|||
160894700|NCT01916967|581010895|FG000|Overall Study|Lack of Efficacy|0|||
161331126|NCT02631941|582598793|FG009|Overall Study|Adverse Event|0|||
161331127|NCT02631941|582598784|FG000|Overall Study|Withdrawal by Subject|0|||
161331128|NCT02631941|582598785|FG001|Overall Study|Withdrawal by Subject|0|||
161331129|NCT02631941|582598786|FG002|Overall Study|Withdrawal by Subject|0|||
161331130|NCT02631941|582598787|FG003|Overall Study|Withdrawal by Subject|0|||
161331131|NCT02631941|582598788|FG004|Overall Study|Withdrawal by Subject|1|||
161331132|NCT02631941|582598789|FG005|Overall Study|Withdrawal by Subject|0|||
161331133|NCT02631941|582598790|FG006|Overall Study|Withdrawal by Subject|0|||
161331134|NCT02631941|582598791|FG007|Overall Study|Withdrawal by Subject|1|||
161331135|NCT02631941|582598792|FG008|Overall Study|Withdrawal by Subject|0|||
161331136|NCT02631941|582598793|FG009|Overall Study|Withdrawal by Subject|0|||
161331137|NCT02631941|582598784|FG000|Overall Study|Lost to Follow-up|0|||
161331138|NCT02631941|582598785|FG001|Overall Study|Lost to Follow-up|0|||
161331139|NCT02631941|582598786|FG002|Overall Study|Lost to Follow-up|0|||
161331140|NCT02631941|582598787|FG003|Overall Study|Lost to Follow-up|0|||
161331141|NCT02631941|582598788|FG004|Overall Study|Lost to Follow-up|0|||
161331142|NCT02631941|582598789|FG005|Overall Study|Lost to Follow-up|0|||
161331143|NCT02631941|582598790|FG006|Overall Study|Lost to Follow-up|0|||
161331144|NCT02631941|582598791|FG007|Overall Study|Lost to Follow-up|0|||
161331145|NCT02631941|582598792|FG008|Overall Study|Lost to Follow-up|1|||
161331146|NCT02631941|582598793|FG009|Overall Study|Lost to Follow-up|0|||
161331147|NCT03933449|582598794|FG000|Overall Study|Adverse Event|6|||
161331148|NCT03933449|582598795|FG001|Overall Study|Adverse Event|4|||
161331149|NCT03933449|582598794|FG000|Overall Study|Death|55|||
161331150|NCT03933449|582598795|FG001|Overall Study|Death|57|||
161331151|NCT03933449|582598794|FG000|Overall Study|Sponsor Decision|1|||
161331152|NCT03933449|582598795|FG001|Overall Study|Sponsor Decision|0|||
161331153|NCT02087774|582598798|FG000|Overall Study|Were absent day of data collection|8|||
161331154|NCT02087774|582598799|FG001|Overall Study|Were absent day of data collection|20|||
161331155|NCT02204917|582598800|FG000|Overall Study|Protocol Violation|1|||
161331156|NCT02869789|582598801|FG000|Overall Study|Disease progression|184|||
161331157|NCT02869789|582598802|FG001|Overall Study|Disease progression|109|||
161331158|NCT02869789|582598803|FG002|Overall Study|Disease progression|260|||
161331159|NCT02869789|582598804|FG003|Overall Study|Disease progression|19|||
161331160|NCT02869789|582598801|FG000|Overall Study|Study drug toxicity|90|||
161331161|NCT02869789|582598802|FG001|Overall Study|Study drug toxicity|32|||
161331162|NCT02869789|582598803|FG002|Overall Study|Study drug toxicity|55|||
161331163|NCT02869789|582598804|FG003|Overall Study|Study drug toxicity|14|||
161331164|NCT02869789|582598801|FG000|Overall Study|Death|7|||
161331165|NCT02869789|582598802|FG001|Overall Study|Death|3|||
161331166|NCT02869789|582598803|FG002|Overall Study|Death|5|||
161331167|NCT02869789|582598804|FG003|Overall Study|Death|1|||
161331168|NCT02869789|582598801|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
161331169|NCT02869789|582598802|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
161331170|NCT02869789|582598803|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
161331171|NCT02869789|582598804|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
161331172|NCT02869789|582598801|FG000|Overall Study|Participant request to discontinue study treatment|10|||
161331173|NCT02869789|582598802|FG001|Overall Study|Participant request to discontinue study treatment|5|||
161331174|NCT02869789|582598803|FG002|Overall Study|Participant request to discontinue study treatment|5|||
161331175|NCT02869789|582598804|FG003|Overall Study|Participant request to discontinue study treatment|3|||
161331176|NCT02869789|582598801|FG000|Overall Study|Withdrawal by Subject|5|||
161331177|NCT02869789|582598802|FG001|Overall Study|Withdrawal by Subject|2|||
161331178|NCT02869789|582598803|FG002|Overall Study|Withdrawal by Subject|7|||
161331179|NCT02869789|582598804|FG003|Overall Study|Withdrawal by Subject|2|||
161331180|NCT02869789|582598801|FG000|Overall Study|Lost to Follow-up|0|||
161331181|NCT02869789|582598802|FG001|Overall Study|Lost to Follow-up|0|||
161331182|NCT02869789|582598803|FG002|Overall Study|Lost to Follow-up|2|||
161331183|NCT02869789|582598804|FG003|Overall Study|Lost to Follow-up|0|||
161331184|NCT02869789|582598801|FG000|Overall Study|Maximum clinical benefit|5|||
161331185|NCT02869789|582598802|FG001|Overall Study|Maximum clinical benefit|2|||
161331186|NCT02869789|582598803|FG002|Overall Study|Maximum clinical benefit|1|||
161331187|NCT02869789|582598804|FG003|Overall Study|Maximum clinical benefit|0|||
160894701|NCT01916967|581010896|FG001|Overall Study|Lack of Efficacy|0|||
161331188|NCT02869789|582598801|FG000|Overall Study|Poor/Non-compliance|0|||
161331189|NCT02869789|582598802|FG001|Overall Study|Poor/Non-compliance|2|||
161331190|NCT02869789|582598803|FG002|Overall Study|Poor/Non-compliance|1|||
161331191|NCT02869789|582598804|FG003|Overall Study|Poor/Non-compliance|0|||
161331192|NCT02869789|582598801|FG000|Overall Study|Participant no longer meets study criteria|0|||
161331193|NCT02869789|582598802|FG001|Overall Study|Participant no longer meets study criteria|1|||
161331194|NCT02869789|582598803|FG002|Overall Study|Participant no longer meets study criteria|1|||
160894702|NCT01916967|581010897|FG002|Overall Study|Lack of Efficacy|6|||
161331195|NCT02869789|582598804|FG003|Overall Study|Participant no longer meets study criteria|0|||
161331196|NCT02869789|582598801|FG000|Overall Study|Administrative reason by sponsor|0|||
161331197|NCT02869789|582598802|FG001|Overall Study|Administrative reason by sponsor|0|||
161331198|NCT02869789|582598803|FG002|Overall Study|Administrative reason by sponsor|1|||
161331199|NCT02869789|582598804|FG003|Overall Study|Administrative reason by sponsor|0|||
161331200|NCT02869789|582598801|FG000|Overall Study|Other reasons|4|||
161331201|NCT02869789|582598802|FG001|Overall Study|Other reasons|8|||
161331202|NCT02869789|582598803|FG002|Overall Study|Other reasons|6|||
161331203|NCT02869789|582598804|FG003|Overall Study|Other reasons|0|||
161331204|NCT00297648|582598806|FG000|Overall Study|Adverse Event|13|||
161331205|NCT00297648|582598806|FG000|Overall Study|Lack of Efficacy|18|||
161331206|NCT00297648|582598806|FG000|Overall Study|Lost to Follow-up|1|||
161331207|NCT00297648|582598806|FG000|Overall Study|Withdrawal by Subject|3|||
161331208|NCT00297648|582598806|FG000|Overall Study|Other: Incompliance|1|||
161331209|NCT01529606|582598810|FG000|Overall Study|Lost to Follow-up|21|||
161331210|NCT01529606|582598811|FG001|Overall Study|Lost to Follow-up|18|||
161331211|NCT01746862|582598812|FG000|Overall Study|Withdrawal by Subject|1|||
161331212|NCT01746862|582598813|FG001|Overall Study|Withdrawal by Subject|1|||
161331213|NCT01746862|582598812|FG000|Overall Study|Protocol Violation|1|||
161331214|NCT01746862|582598813|FG001|Overall Study|Protocol Violation|0|||
161331215|NCT01746862|582598812|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
161331216|NCT01746862|582598813|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
161331217|NCT01746862|582598812|FG000|Overall Study|Entered puberty during the study|1|||
161331218|NCT01746862|582598813|FG001|Overall Study|Entered puberty during the study|0|||
161331219|NCT04742673|582598814|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
161331220|NCT04742673|582598815|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
161331221|NCT00731822|582598822|FG000|Overall Study|Adverse Event|2|||
161331222|NCT00731822|582598823|FG001|Overall Study|Adverse Event|1|||
161331223|NCT00731822|582598822|FG000|Overall Study|Protocol Violation|1|||
161331224|NCT00731822|582598823|FG001|Overall Study|Protocol Violation|0|||
161331225|NCT00731822|582598822|FG000|Overall Study|Lost to Follow-up|1|||
161331226|NCT00731822|582598823|FG001|Overall Study|Lost to Follow-up|0|||
161331227|NCT05209880|582598825|FG000|1-Month Follow-up|Spoke with Doctor|5|||
161331228|NCT05209880|582598826|FG001|1-Month Follow-up|Spoke with Doctor|5|||
161331229|NCT05209880|582598825|FG000|1-Month Follow-up|Lost to Follow-up|7|||
161331230|NCT05209880|582598826|FG001|1-Month Follow-up|Lost to Follow-up|9|||
161331231|NCT05209880|582598825|FG000|1-Month Follow-up|Discontinued|0|||
161331232|NCT05209880|582598826|FG001|1-Month Follow-up|Discontinued|1|||
161331233|NCT05209880|582598825|FG000|3-Month Follow-up|Spoke with Doctor|17|||
161331234|NCT05209880|582598826|FG001|3-Month Follow-up|Spoke with Doctor|7|||
161331235|NCT05209880|582598825|FG000|3-Month Follow-up|Lost to Follow-up|8|||
161331236|NCT05209880|582598826|FG001|3-Month Follow-up|Lost to Follow-up|10|||
161331237|NCT05209880|582598825|FG000|3-Month Follow-up|Discontinued|1|||
161331238|NCT05209880|582598826|FG001|3-Month Follow-up|Discontinued|3|||
161331239|NCT05209880|582598825|FG000|6-Month Follow-up|Spoke with Doctor|25|||
160797516|NCT02936323|580647359|FG009|Phase 1 Dose Escalation|Death|0|||
160797517|NCT02936323|580647350|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797518|NCT02936323|580647351|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797519|NCT02936323|580647352|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797520|NCT02936323|580647353|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797521|NCT02936323|580647354|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797522|NCT02936323|580647355|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
160797523|NCT02936323|580647356|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797524|NCT02936323|580647357|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797525|NCT02936323|580647358|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797526|NCT02936323|580647359|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
160797527|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797528|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797529|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797530|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797531|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
160797532|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161331240|NCT05209880|582598826|FG001|6-Month Follow-up|Spoke with Doctor|14|||
161331241|NCT05209880|582598825|FG000|6-Month Follow-up|Lost to Follow-up|9|||
161331242|NCT05209880|582598826|FG001|6-Month Follow-up|Lost to Follow-up|14|||
161331243|NCT05209880|582598825|FG000|6-Month Follow-up|Discontinued|1|||
161331244|NCT05209880|582598826|FG001|6-Month Follow-up|Discontinued|3|||
161331245|NCT02127658|582598827|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
161331246|NCT02127658|582598828|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
161331247|NCT02127658|582598827|FG000|Overall Study|Withdrawal by Subject|0|||
161331248|NCT02127658|582598828|FG001|Overall Study|Withdrawal by Subject|2|||
160797533|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
161236413|NCT01602419|582246336|FG000|Overall Study|Not treated with Wilate|9|||
161236414|NCT01602419|582246336|FG000|Overall Study|Adverse Drug Reaction|4|||
161236415|NCT01602419|582246336|FG000|Overall Study|Insurance issues|3|||
161236416|NCT01602419|582246336|FG000|Overall Study|Changed treatment centre|1|||
161236417|NCT01602419|582246336|FG000|Overall Study|Treatment centre closed|1|||
161236418|NCT01602419|582246336|FG000|Overall Study|Withdrawal by Subject|5|||
161236419|NCT01602419|582246336|FG000|Overall Study|Lost to Follow-up|6|||
161236420|NCT03620747|582246343|FG000|Overall Study|Participant decision|7|||
161236421|NCT03620747|582246343|FG000|Overall Study|Adverse Event|6|||
161236422|NCT03620747|582246343|FG000|Overall Study|Lack of Efficacy|1|||
161236423|NCT03620747|582246343|FG000|Overall Study|Poor compliance to protocol|2|||
161236424|NCT03620747|582246343|FG000|Overall Study|Other-unspecified|3|||
161236425|NCT01745120|582246346|FG000|Overall Study|Investigator decision|1|||
161236426|NCT01745120|582246347|FG001|Overall Study|Investigator decision|0|||
161236427|NCT00850174|582246355|FG000|Washout: One Week|Withdrawal by Subject|0|||
161236428|NCT00850174|582246356|FG001|Washout: One Week|Withdrawal by Subject|2|||
161236429|NCT00850174|582246355|FG000|Second Intervention|Withdrawal by Subject|1|||
161236430|NCT00850174|582246356|FG001|Second Intervention|Withdrawal by Subject|0|||
161236431|NCT00635492|582246357|FG000|Overall Study|Death|12|||
161236432|NCT00635492|582246358|FG001|Overall Study|Death|40|||
161236433|NCT00635492|582246357|FG000|Overall Study|Lost to Follow-up|151|||
161236434|NCT00635492|582246358|FG001|Overall Study|Lost to Follow-up|172|||
161236435|NCT00635492|582246357|FG000|Overall Study|Physician Decision|32|||
161236436|NCT00635492|582246358|FG001|Overall Study|Physician Decision|22|||
161236437|NCT00635492|582246357|FG000|Overall Study|Sponsor decision|2|||
161236438|NCT00635492|582246358|FG001|Overall Study|Sponsor decision|3|||
161236439|NCT00635492|582246357|FG000|Overall Study|Withdrawal by Subject|82|||
161236440|NCT00635492|582246358|FG001|Overall Study|Withdrawal by Subject|45|||
161236441|NCT04533594|582246363|FG000|Overall Study|Death|26|||
161236442|NCT01200810|582246366|FG000|Overall Study|Physician Decision|1|||
161236443|NCT01200810|582246367|FG001|Overall Study|Physician Decision|0|||
161236444|NCT01200810|582246366|FG000|Overall Study|Withdrawal by Subject|1|||
161236445|NCT01200810|582246367|FG001|Overall Study|Withdrawal by Subject|2|||
161236446|NCT01200810|582246366|FG000|Overall Study|Sponsor stopped making study drug|3|||
161236447|NCT01200810|582246367|FG001|Overall Study|Sponsor stopped making study drug|3|||
161236448|NCT03500341|582246371|FG000|Overall Study|Withdrawn prior to Completion|2|||
161236449|NCT00640562|582246374|FG000|Overall Study|Adverse Event|8|||
161236450|NCT00640562|582246375|FG001|Overall Study|Adverse Event|5|||
161236451|NCT00640562|582246374|FG000|Overall Study|Lack of Efficacy|1|||
161236452|NCT00640562|582246375|FG001|Overall Study|Lack of Efficacy|4|||
161236453|NCT00640562|582246374|FG000|Overall Study|Protocol Violation|2|||
160894703|NCT01916967|581010895|FG000|Overall Study|Physician Decision|0|||
160894704|NCT01916967|581010896|FG001|Overall Study|Physician Decision|0|||
160894705|NCT01916967|581010897|FG002|Overall Study|Physician Decision|1|||
160894706|NCT01916967|581010895|FG000|Overall Study|Protocol Violation|0|||
160894707|NCT01916967|581010896|FG001|Overall Study|Protocol Violation|1|||
160894708|NCT01916967|581010897|FG002|Overall Study|Protocol Violation|0|||
160894709|NCT02337738|581010898|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
160894710|NCT02337738|581010899|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
161236454|NCT00640562|582246375|FG001|Overall Study|Protocol Violation|4|||
161236455|NCT00640562|582246374|FG000|Overall Study|Withdrawal by Subject|6|||
161236456|NCT00640562|582246375|FG001|Overall Study|Withdrawal by Subject|10|||
161236457|NCT00640562|582246374|FG000|Overall Study|Known risperidone intolerance|0|||
161236458|NCT00640562|582246375|FG001|Overall Study|Known risperidone intolerance|1|||
161236459|NCT00640562|582246374|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
161236460|NCT00640562|582246375|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
161236461|NCT00640562|582246374|FG000|Overall Study|Low study drug dose|0|||
161236462|NCT00640562|582246375|FG001|Overall Study|Low study drug dose|1|||
161236463|NCT00640562|582246374|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
161236464|NCT00640562|582246375|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
161236465|NCT02699866|582246376|FG000|Overall Study|Withdrawal by Subject|3|||
161236466|NCT02699866|582246376|FG000|Overall Study|Physician Decision|2|||
161236467|NCT02699866|582246376|FG000|Overall Study|Adverse Event|3|||
161236468|NCT02937870|582246377|FG000|Overall Study|Adverse Event|1|||
161236469|NCT02937870|582246377|FG000|Overall Study|Protocol Deviation|2|||
161236470|NCT00244764|582246378|FG000|Overall Study|Adverse Event|37|||
161236471|NCT00244764|582246378|FG000|Overall Study|Lost to Follow-up|23|||
161236472|NCT00244764|582246378|FG000|Overall Study|Withdrawal by Subject|12|||
161236473|NCT00244764|582246378|FG000|Overall Study|Disease Progression|13|||
161236474|NCT00244764|582246378|FG000|Overall Study|Protocol Violation|2|||
161236475|NCT00244764|582246378|FG000|Overall Study|Death|1|||
161236476|NCT00244764|582246378|FG000|Overall Study|Off Study Medication for >21 Days|1|||
161236477|NCT00244764|582246378|FG000|Overall Study|Declining Performance Status|1|||
161236478|NCT00244764|582246378|FG000|Overall Study|Participant was Hospitalized until Death|1|||
161236479|NCT00244764|582246378|FG000|Overall Study|Primary Investigator Discretion|2|||
161236480|NCT00244764|582246378|FG000|Overall Study|Sponsor Terminated Study|2|||
160894711|NCT02337738|581010900|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
161129538|NCT02411448|581860870|FG000|Overall Study|Withdrawal by Subject|1|||
160894712|NCT02337738|581010898|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160894713|NCT02337738|581010899|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
160894714|NCT02337738|581010900|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
160894715|NCT02337738|581010898|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
160894716|NCT02337738|581010899|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
160894717|NCT02337738|581010900|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
160894718|NCT02337738|581010898|FG000|Overall Study|Voluntary Withdrawal|10|||
160894719|NCT02337738|581010899|FG001|Overall Study|Voluntary Withdrawal|5|||
160894720|NCT02337738|581010900|FG002|Overall Study|Voluntary Withdrawal|2|||
160894721|NCT02337738|581010898|FG000|Overall Study|Lack of Efficacy|2|||
160894722|NCT02337738|581010899|FG001|Overall Study|Lack of Efficacy|4|||
160894723|NCT02337738|581010900|FG002|Overall Study|Lack of Efficacy|0|||
160894724|NCT02337738|581010898|FG000|Overall Study|Investigator's Judgment|1|||
160894725|NCT02337738|581010899|FG001|Overall Study|Investigator's Judgment|1|||
160894726|NCT02337738|581010900|FG002|Overall Study|Investigator's Judgment|3|||
160894727|NCT02322021|581010901|FG000|Core Phase|Adverse Event|1|||
160894728|NCT02322021|581010902|FG001|Core Phase|Adverse Event|3|||
160894729|NCT02322021|581010903|FG002|Core Phase|Adverse Event|4|||
160894730|NCT02322021|581010904|FG003|Core Phase|Adverse Event|2|||
160894731|NCT02322021|581010905|FG004|Core Phase|Adverse Event|0|||
160894732|NCT02322021|581010901|FG000|Core Phase|Participant Choice|4|||
160894733|NCT02322021|581010902|FG001|Core Phase|Participant Choice|5|||
160894734|NCT02322021|581010903|FG002|Core Phase|Participant Choice|4|||
160894735|NCT02322021|581010904|FG003|Core Phase|Participant Choice|2|||
160894736|NCT02322021|581010905|FG004|Core Phase|Participant Choice|0|||
160894737|NCT02322021|581010901|FG000|Core Phase|Lost to Follow-up|0|||
160894738|NCT02322021|581010902|FG001|Core Phase|Lost to Follow-up|0|||
160894739|NCT02322021|581010903|FG002|Core Phase|Lost to Follow-up|0|||
160894740|NCT02322021|581010904|FG003|Core Phase|Lost to Follow-up|1|||
160894741|NCT02322021|581010905|FG004|Core Phase|Lost to Follow-up|0|||
160894742|NCT02322021|581010901|FG000|Core Phase|Other|0|||
160894743|NCT02322021|581010902|FG001|Core Phase|Other|0|||
160894744|NCT02322021|581010903|FG002|Core Phase|Other|1|||
160894745|NCT02322021|581010904|FG003|Core Phase|Other|0|||
160894746|NCT02322021|581010905|FG004|Core Phase|Other|0|||
160894747|NCT02322021|581010901|FG000|Extension Phase|Adverse Event|0|||
160894748|NCT02322021|581010902|FG001|Extension Phase|Adverse Event|0|||
160894749|NCT02322021|581010903|FG002|Extension Phase|Adverse Event|0|||
160894750|NCT02322021|581010904|FG003|Extension Phase|Adverse Event|0|||
160894751|NCT02322021|581010905|FG004|Extension Phase|Adverse Event|3|||
160894752|NCT02322021|581010901|FG000|Extension Phase|Participant Choice|0|||
160894753|NCT02322021|581010902|FG001|Extension Phase|Participant Choice|0|||
160894754|NCT02322021|581010903|FG002|Extension Phase|Participant Choice|0|||
160894755|NCT02322021|581010904|FG003|Extension Phase|Participant Choice|0|||
160894756|NCT02322021|581010905|FG004|Extension Phase|Participant Choice|6|||
160894757|NCT02322021|581010901|FG000|Extension Phase|Other|0|||
160894758|NCT02322021|581010902|FG001|Extension Phase|Other|0|||
160894759|NCT02322021|581010903|FG002|Extension Phase|Other|0|||
160894760|NCT02322021|581010904|FG003|Extension Phase|Other|0|||
160894761|NCT02322021|581010905|FG004|Extension Phase|Other|3|||
160894762|NCT02322021|581010901|FG000|Extension Phase|Lost to Follow-up|0|||
160894763|NCT02322021|581010902|FG001|Extension Phase|Lost to Follow-up|0|||
160894764|NCT02322021|581010903|FG002|Extension Phase|Lost to Follow-up|0|||
160894765|NCT02322021|581010904|FG003|Extension Phase|Lost to Follow-up|0|||
160894766|NCT02322021|581010905|FG004|Extension Phase|Lost to Follow-up|1|||
160894767|NCT02322021|581010901|FG000|Extension Phase|Study terminated by sponsor|0|||
161129539|NCT02411448|581860871|FG001|Overall Study|Withdrawal by Subject|14|||
161129540|NCT02411448|581860872|FG002|Overall Study|Withdrawal by Subject|9|||
161129541|NCT02411448|581860870|FG000|Overall Study|Other|0|||
161129542|NCT02411448|581860871|FG001|Overall Study|Other|2|||
161129543|NCT02411448|581860872|FG002|Overall Study|Other|0|||
161129544|NCT02411448|581860870|FG000|Overall Study|Did not receive study treatment|0|||
161129545|NCT02411448|581860871|FG001|Overall Study|Did not receive study treatment|3|||
160894768|NCT02322021|581010902|FG001|Extension Phase|Study terminated by sponsor|0|||
160894769|NCT02322021|581010903|FG002|Extension Phase|Study terminated by sponsor|0|||
160894770|NCT02322021|581010904|FG003|Extension Phase|Study terminated by sponsor|0|||
160894771|NCT02322021|581010905|FG004|Extension Phase|Study terminated by sponsor|28|||
160894772|NCT01565642|581010912|FG000|Overall Study|Withdrawal by Subject|2|||
160894773|NCT01565642|581010913|FG001|Overall Study|Withdrawal by Subject|1|||
160894774|NCT01934972|581010914|FG000|Overall Study|Withdrawal by Subject|9|||
160983631|NCT01778062|581328709|FG001|Overall Study|Adverse Event|3|||
160894775|NCT01934972|581010915|FG001|Overall Study|Withdrawal by Subject|6|||
160894776|NCT03438383|581010921|FG000|Overall Study|Protocol Violation|9|||
160894777|NCT03438383|581010922|FG001|Overall Study|Protocol Violation|3|||
160894778|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
160983632|NCT01778062|581328708|FG000|Overall Study|Consent Withdrawal|1|||
161129546|NCT02411448|581860872|FG002|Overall Study|Did not receive study treatment|0|||
161129547|NCT02411448|581860870|FG000|Overall Study|Alive on study treatment|3|||
161129548|NCT02411448|581860871|FG001|Overall Study|Alive on study treatment|64|||
161129549|NCT02411448|581860872|FG002|Overall Study|Alive on study treatment|43|||
160797534|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
160797535|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
160797536|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
160797537|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
160797538|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
160797539|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
160797540|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
160797541|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
160797542|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
160797543|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
160797544|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
160797545|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
160797546|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
160797547|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797548|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797549|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797550|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797551|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797552|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797553|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797554|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
160797555|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
160797556|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
160797557|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797558|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797559|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797560|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797561|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797562|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797563|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797564|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797565|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
160797566|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
160797567|NCT02936323|580647350|FG000|Phase 2a Dose Expansion|Death|0|||
160797568|NCT02936323|580647351|FG001|Phase 2a Dose Expansion|Death|0|||
160797569|NCT02936323|580647352|FG002|Phase 2a Dose Expansion|Death|0|||
160797570|NCT02936323|580647353|FG003|Phase 2a Dose Expansion|Death|0|||
160797571|NCT02936323|580647354|FG004|Phase 2a Dose Expansion|Death|0|||
160797572|NCT02936323|580647355|FG005|Phase 2a Dose Expansion|Death|0|||
160797573|NCT02936323|580647356|FG006|Phase 2a Dose Expansion|Death|0|||
160797574|NCT02936323|580647357|FG007|Phase 2a Dose Expansion|Death|4|||
160797575|NCT02936323|580647358|FG008|Phase 2a Dose Expansion|Death|8|||
160797576|NCT02936323|580647359|FG009|Phase 2a Dose Expansion|Death|10|||
160797577|NCT02781558|580647360|FG000|Overall Study|Lost to Follow-up|2|||
160797578|NCT02781558|580647361|FG001|Overall Study|Lost to Follow-up|2|||
160797579|NCT02781558|580647360|FG000|Overall Study|Adverse Event|1|||
160797580|NCT02781558|580647361|FG001|Overall Study|Adverse Event|0|||
160797581|NCT01334918|580649227|FG000|Overall Study|Did not receive study drug|6|||
160797582|NCT01334918|580649228|FG001|Overall Study|Did not receive study drug|0|||
160797583|NCT01334918|580649227|FG000|Overall Study|Adverse Event|2|||
160797584|NCT01334918|580649228|FG001|Overall Study|Adverse Event|0|||
160797585|NCT01334918|580649227|FG000|Overall Study|Withdrawal by Subject|0|||
160797586|NCT01334918|580649228|FG001|Overall Study|Withdrawal by Subject|1|||
160797587|NCT01732536|580649229|FG000|Overall Study|Withdrawal by Subject|1|||
160797588|NCT01732536|580649230|FG001|Overall Study|Withdrawal by Subject|1|||
160797589|NCT00370292|580649233|FG000|Overall Study|Disease Progression|4|||
160797590|NCT00370292|580649233|FG000|Overall Study|Adverse Event|7|||
160797591|NCT00370292|580649233|FG000|Overall Study|Physician Decision|2|||
160797592|NCT02986074|580649234|FG000|First Trial Period|Adverse Event|1|||
160797593|NCT02986074|580649235|FG001|First Trial Period|Adverse Event|0|||
160797594|NCT02986074|580649236|FG002|First Trial Period|Adverse Event|0|||
160797595|NCT02986074|580649237|FG003|First Trial Period|Adverse Event|0|||
160797596|NCT02986074|580649234|FG000|Follow up Period|system explant|0|||
160797597|NCT02986074|580649235|FG001|Follow up Period|system explant|0|||
160797598|NCT02986074|580649236|FG002|Follow up Period|system explant|1|||
160797599|NCT02986074|580649237|FG003|Follow up Period|system explant|2|||
161257885|NCT03756883|582323519|FG001|Overall Study|Adverse Event|2|||
160797600|NCT02986074|580649234|FG000|Follow up Period|Physician Decision|0|||
160797601|NCT02986074|580649235|FG001|Follow up Period|Physician Decision|0|||
160797602|NCT02986074|580649236|FG002|Follow up Period|Physician Decision|0|||
160797603|NCT02986074|580649237|FG003|Follow up Period|Physician Decision|1|||
160797604|NCT04099277|580649240|FG000|Overall Study|Physician Decision|1|||
160797605|NCT04099277|580649240|FG000|Overall Study|Withdrawal by Subject|1|||
160894779|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
160894780|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
160894781|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
160894782|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|Death|2|||
160894783|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|Death|2|||
160894784|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
160894785|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
160894786|NCT01528033|581010923|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
160894787|NCT01528033|581010924|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
160894788|NCT01528033|581010923|FG000|Follow Up|No data available|46|||
160894789|NCT01528033|581010924|FG001|Follow Up|No data available|44|||
160894790|NCT02030938|581010927|FG000|Overall Study|Lost to Follow-up|4|||
160894791|NCT02030938|581010927|FG000|Overall Study|Withdrawal by Subject|1|||
160894792|NCT03954132|581010929|FG000|Overall Study|Adverse Event|2|||
160894793|NCT03954132|581010930|FG001|Overall Study|Adverse Event|0|||
160894794|NCT03954132|581010929|FG000|Overall Study|Patient's wish|5|||
160894795|NCT03954132|581010930|FG001|Overall Study|Patient's wish|0|||
160894796|NCT03954132|581010929|FG000|Overall Study|Lost to Follow-up|10|||
160894797|NCT03954132|581010930|FG001|Overall Study|Lost to Follow-up|0|||
160894798|NCT03954132|581010929|FG000|Overall Study|Screening failure|0|||
160894799|NCT03954132|581010930|FG001|Overall Study|Screening failure|1|||
160894800|NCT03954132|581010929|FG000|Overall Study|No registration after Visit 1|5|||
160894801|NCT03954132|581010930|FG001|Overall Study|No registration after Visit 1|2|||
160894802|NCT03954132|581010929|FG000|Overall Study|Other reason than listed|2|||
160894803|NCT03954132|581010930|FG001|Overall Study|Other reason than listed|2|||
160894804|NCT03954132|581010929|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
160894805|NCT03954132|581010930|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
160894806|NCT03954132|581010929|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
160894807|NCT03954132|581010930|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
160894808|NCT00932737|581010933|FG000|Overall Study|Not treated in second episode|1|||
160894809|NCT00932737|581010934|FG001|Overall Study|Not treated in second episode|0|||
160894810|NCT00932737|581010933|FG000|Overall Study|Adverse Event|0|||
160894811|NCT00932737|581010934|FG001|Overall Study|Adverse Event|1|||
160894812|NCT02949700|581010937|FG000|Phase I|Withdrawal by Subject|1|||
160894813|NCT02949700|581010938|FG001|Phase I|Withdrawal by Subject|1|||
160894814|NCT02949700|581010939|FG002|Phase I|Withdrawal by Subject|0|||
160894815|NCT02949700|581010940|FG003|Phase I|Withdrawal by Subject|0|||
160894816|NCT02949700|581010937|FG000|Phase I|Protocol Violation|1|||
160894817|NCT02949700|581010938|FG001|Phase I|Protocol Violation|0|||
160894818|NCT02949700|581010939|FG002|Phase I|Protocol Violation|0|||
160894819|NCT02949700|581010940|FG003|Phase I|Protocol Violation|0|||
160894820|NCT02949700|581010937|FG000|Phase II|Withdrawal by Subject|0|||
160894821|NCT02949700|581010938|FG001|Phase II|Withdrawal by Subject|0|||
160894822|NCT02949700|581010939|FG002|Phase II|Withdrawal by Subject|0|||
160894823|NCT02949700|581010940|FG003|Phase II|Withdrawal by Subject|2|||
160894824|NCT02949700|581010937|FG000|Phase II|Protocol Violation|0|||
160894825|NCT02949700|581010938|FG001|Phase II|Protocol Violation|0|||
160894826|NCT02949700|581010939|FG002|Phase II|Protocol Violation|1|||
160894827|NCT02949700|581010940|FG003|Phase II|Protocol Violation|3|||
160894828|NCT05156073|581010941|FG000|Overall Study|Patient canceled appointment with PCP|1|||
160894829|NCT00973349|581010942|FG000|Overall Study|Adverse Event|0|||
160894830|NCT00973349|581010943|FG001|Overall Study|Adverse Event|0|||
160894831|NCT00973349|581010944|FG002|Overall Study|Adverse Event|0|||
160894832|NCT00973349|581010945|FG003|Overall Study|Adverse Event|0|||
161236481|NCT00244764|582246378|FG000|Overall Study|Developed Secondary Malignancy|1|||
161236482|NCT01294917|582246379|FG000|Overall Study|Relocation|5|||
161236483|NCT01294917|582246379|FG000|Overall Study|Inconvenience|1|||
161236484|NCT03017885|582246380|FG000|Overall Study|Adverse Event|2|||
161236485|NCT03017885|582246381|FG001|Overall Study|Adverse Event|0|||
161236486|NCT03017885|582246382|FG002|Overall Study|Adverse Event|0|||
161236487|NCT03017885|582246383|FG003|Overall Study|Adverse Event|0|||
161236488|NCT03017885|582246384|FG004|Overall Study|Adverse Event|0|||
161236489|NCT03017885|582246385|FG005|Overall Study|Adverse Event|0|||
161236490|NCT03017885|582246380|FG000|Overall Study|Progression of disease|4|||
161236491|NCT03017885|582246381|FG001|Overall Study|Progression of disease|3|||
161236492|NCT03017885|582246382|FG002|Overall Study|Progression of disease|4|||
161236493|NCT03017885|582246383|FG003|Overall Study|Progression of disease|0|||
161236494|NCT03017885|582246384|FG004|Overall Study|Progression of disease|0|||
161236495|NCT03017885|582246385|FG005|Overall Study|Progression of disease|0|||
160894833|NCT00973349|581010946|FG004|Overall Study|Adverse Event|1|||
160894834|NCT00973349|581010947|FG005|Overall Study|Adverse Event|0|||
160894835|NCT00973349|581010948|FG006|Overall Study|Adverse Event|0|||
160894836|NCT00973349|581010949|FG007|Overall Study|Adverse Event|0|||
160894837|NCT00973349|581010950|FG008|Overall Study|Adverse Event|1|||
160894838|NCT00973349|581010951|FG009|Overall Study|Adverse Event|0|||
160894839|NCT00973349|581010952|FG010|Overall Study|Adverse Event|0|||
161236496|NCT03017885|582246380|FG000|Overall Study|Other than listed|1|||
161236497|NCT03017885|582246381|FG001|Overall Study|Other than listed|2|||
161236498|NCT03017885|582246382|FG002|Overall Study|Other than listed|1|||
161236499|NCT03017885|582246383|FG003|Overall Study|Other than listed|0|||
161236500|NCT03017885|582246384|FG004|Overall Study|Other than listed|0|||
161236501|NCT03017885|582246385|FG005|Overall Study|Other than listed|0|||
161236502|NCT03017885|582246380|FG000|Overall Study|Lost to Follow-up|2|||
161236503|NCT03017885|582246381|FG001|Overall Study|Lost to Follow-up|0|||
161236504|NCT03017885|582246382|FG002|Overall Study|Lost to Follow-up|3|||
161236505|NCT03017885|582246383|FG003|Overall Study|Lost to Follow-up|0|||
161236506|NCT03017885|582246384|FG004|Overall Study|Lost to Follow-up|0|||
161236507|NCT03017885|582246385|FG005|Overall Study|Lost to Follow-up|0|||
161236508|NCT03017885|582246380|FG000|Overall Study|Change to other anti-cancer therapy|0|||
161236509|NCT03017885|582246381|FG001|Overall Study|Change to other anti-cancer therapy|0|||
161236510|NCT03017885|582246382|FG002|Overall Study|Change to other anti-cancer therapy|1|||
161236511|NCT03017885|582246383|FG003|Overall Study|Change to other anti-cancer therapy|0|||
161236512|NCT03017885|582246384|FG004|Overall Study|Change to other anti-cancer therapy|0|||
161236513|NCT03017885|582246385|FG005|Overall Study|Change to other anti-cancer therapy|0|||
161236514|NCT01208337|582246389|FG000|Overall Study|Death|3|||
161236515|NCT00836056|582246395|FG000|First Intervention|Adverse Event|1|||
161236516|NCT00836056|582246396|FG001|First Intervention|Adverse Event|0|||
161236517|NCT01001208|582246400|FG000|Overall Study|Adverse Event|10|||
160797606|NCT00524121|580649247|FG000|Overall Study|Disease progression|6|||
160797607|NCT00524121|580649247|FG000|Overall Study|Adverse Event|4|||
160797608|NCT00524121|580649247|FG000|Overall Study|Patient refused|2|||
160797609|NCT00524121|580649247|FG000|Overall Study|Other|1|||
160797610|NCT00524121|580649247|FG000|Overall Study|Death|1|||
160797611|NCT00524121|580649247|FG000|Overall Study|Not treated (became ineligible)|4|||
160797612|NCT00524121|580649247|FG000|Overall Study|Not treated (changed mind)|1|||
160797613|NCT02862574|580649248|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160797614|NCT02862574|580649249|FG001|Double-Blind Treatment Period|Adverse Event|1|||
160797615|NCT02862574|580649250|FG002|Double-Blind Treatment Period|Adverse Event|0|||
160797616|NCT02862574|580649248|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
160797617|NCT02862574|580649249|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
160797618|NCT02862574|580649250|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
160797619|NCT02862574|580649248|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
160797620|NCT02862574|580649249|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
160797621|NCT02862574|580649250|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
160797622|NCT00583219|580649256|FG000|Phase 2|Withdrawal by Subject|1|||
160797623|NCT02037529|580649257|FG000|Overall Study|Withdrawal by Subject|1|||
160797624|NCT02037529|580649258|FG001|Overall Study|Withdrawal by Subject|3|||
160797625|NCT02037529|580649257|FG000|Overall Study|Adverse Event|0|||
160797626|NCT02037529|580649258|FG001|Overall Study|Adverse Event|1|||
160797627|NCT02131766|580649259|FG000|Overall Study|Withdrawal by Subject|4|||
160797628|NCT00754572|580649260|FG000|Overall Study|Adverse Event|19|||
160797629|NCT00754572|580649260|FG000|Overall Study|Other|39|||
160797630|NCT00754572|580649260|FG000|Overall Study|Protocol Violation|3|||
160797631|NCT00754572|580649260|FG000|Overall Study|Withdrawal by Subject|3|||
160797632|NCT00754572|580649260|FG000|Overall Study|Lack of Efficacy|2|||
160797633|NCT00754572|580649260|FG000|Overall Study|Death|1|||
160797634|NCT00754572|580649260|FG000|Overall Study|Administrative Reason|3|||
160797635|NCT00754572|580649260|FG000|Overall Study|Lost to Follow-up|1|||
160797636|NCT00718315|580649261|FG000|Overall Study|Adverse Event|1|||
160797637|NCT00718315|580649262|FG001|Overall Study|Adverse Event|2|||
160797638|NCT00718315|580649263|FG002|Overall Study|Adverse Event|3|||
160797639|NCT00718315|580649261|FG000|Overall Study|Death|6|||
160797640|NCT00718315|580649262|FG001|Overall Study|Death|6|||
160797641|NCT00718315|580649263|FG002|Overall Study|Death|5|||
160797642|NCT00718315|580649261|FG000|Overall Study|Lost to Follow-up|2|||
160797643|NCT00718315|580649262|FG001|Overall Study|Lost to Follow-up|3|||
160797644|NCT00718315|580649263|FG002|Overall Study|Lost to Follow-up|4|||
160797645|NCT00718315|580649261|FG000|Overall Study|Protocol Violation|5|||
160797646|NCT00718315|580649262|FG001|Overall Study|Protocol Violation|5|||
160797647|NCT00718315|580649263|FG002|Overall Study|Protocol Violation|3|||
160797648|NCT00718315|580649261|FG000|Overall Study|Erlotinib dose decreased|4|||
160797649|NCT00718315|580649262|FG001|Overall Study|Erlotinib dose decreased|3|||
160797650|NCT00718315|580649263|FG002|Overall Study|Erlotinib dose decreased|1|||
160797651|NCT00718315|580649261|FG000|Overall Study|Use of Minocyclin|1|||
160797652|NCT00718315|580649262|FG001|Overall Study|Use of Minocyclin|1|||
160797653|NCT00718315|580649263|FG002|Overall Study|Use of Minocyclin|1|||
160797654|NCT00718315|580649261|FG000|Overall Study|Disease progression|0|||
160797655|NCT00718315|580649262|FG001|Overall Study|Disease progression|1|||
160797656|NCT00718315|580649263|FG002|Overall Study|Disease progression|1|||
160797657|NCT00718315|580649261|FG000|Overall Study|Other|0|||
160797658|NCT00718315|580649262|FG001|Overall Study|Other|0|||
160797659|NCT00718315|580649263|FG002|Overall Study|Other|1|||
160894840|NCT00973349|581010953|FG011|Overall Study|Adverse Event|0|||
160894841|NCT00973349|581010954|FG012|Overall Study|Adverse Event|0|||
160983633|NCT01778062|581328709|FG001|Overall Study|Consent Withdrawal|5|||
160983634|NCT01778062|581328708|FG000|Overall Study|major protocol deviation|4|||
160983635|NCT01778062|581328709|FG001|Overall Study|major protocol deviation|3|||
160983636|NCT03958630|581328714|FG000|Overall Study|Withdrawal by Subject|0|||
160983637|NCT03958630|581328715|FG001|Overall Study|Withdrawal by Subject|0|||
160983638|NCT03958630|581328716|FG002|Overall Study|Withdrawal by Subject|1|||
160983639|NCT03958630|581328714|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
160983640|NCT03958630|581328715|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
160983641|NCT03958630|581328716|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
160983642|NCT01824472|581328719|FG000|Overall Study|Lost to Follow-up|0|||
160983643|NCT01824472|581328720|FG001|Overall Study|Lost to Follow-up|0|||
160983644|NCT01824472|581328721|FG002|Overall Study|Lost to Follow-up|1|||
160983645|NCT01824472|581328719|FG000|Overall Study|Withdrawal by Subject|1|||
160983646|NCT01824472|581328720|FG001|Overall Study|Withdrawal by Subject|5|||
160983647|NCT01824472|581328721|FG002|Overall Study|Withdrawal by Subject|3|||
160983648|NCT01824472|581328719|FG000|Overall Study|Ineligible post randomization&screening|0|||
160983649|NCT01824472|581328720|FG001|Overall Study|Ineligible post randomization&screening|2|||
160983650|NCT01824472|581328721|FG002|Overall Study|Ineligible post randomization&screening|0|||
160983651|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
160983652|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
160983653|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
160983654|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
160983655|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
160983656|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
160983657|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
160983658|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
160983659|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
160983660|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
160983661|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
160983662|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
160983663|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
160983664|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
160983665|NCT01815736|581328722|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
160983666|NCT01815736|581328723|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
160983667|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
160983668|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
160983669|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
160983670|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
160983671|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
160983672|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
160983673|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
160983674|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
160983675|NCT01815736|581328722|FG000|Extension Treatment Phase- After Week 96|Death|1|||
160983676|NCT01815736|581328723|FG001|Extension Treatment Phase- After Week 96|Death|0|||
160983677|NCT03387514|581328725|FG000|Overall Study|Withdrawal by Subject|2|||
160983678|NCT03387514|581328725|FG000|Overall Study|Physician Decision|1|||
160983679|NCT03387514|581328725|FG000|Overall Study|Lost to Follow-up|2|||
160983680|NCT03040687|581328732|FG000|Overall Study|Withdrawal by Subject|1|||
160983681|NCT03040687|581328733|FG001|Overall Study|Withdrawal by Subject|0|||
160983682|NCT03040687|581328734|FG002|Overall Study|Withdrawal by Subject|0|||
160983683|NCT04157686|581328735|FG000|Overall Study|Adverse Event|1|||
160983684|NCT04157686|581328736|FG001|Overall Study|Adverse Event|0|||
160983685|NCT04157686|581328737|FG002|Overall Study|Adverse Event|1|||
160983686|NCT04157686|581328738|FG003|Overall Study|Adverse Event|0|||
160983687|NCT04157686|581328739|FG004|Overall Study|Adverse Event|1|||
160983688|NCT04157686|581328740|FG005|Overall Study|Adverse Event|0|||
160983689|NCT04157686|581328741|FG006|Overall Study|Adverse Event|0|||
160983690|NCT04157686|581328742|FG007|Overall Study|Adverse Event|0|||
160983691|NCT04157686|581328735|FG000|Overall Study|Pregnancy|0|||
161236518|NCT01001208|582246401|FG001|Overall Study|Adverse Event|5|||
161236519|NCT01001208|582246400|FG000|Overall Study|Lost to Follow-up|5|||
161236520|NCT01001208|582246401|FG001|Overall Study|Lost to Follow-up|9|||
161236521|NCT01001208|582246400|FG000|Overall Study|Physician Decision|1|||
161236522|NCT01001208|582246401|FG001|Overall Study|Physician Decision|0|||
161236523|NCT01001208|582246400|FG000|Overall Study|Withdrawal by Subject|4|||
160983692|NCT04157686|581328736|FG001|Overall Study|Pregnancy|1|||
161236524|NCT01001208|582246401|FG001|Overall Study|Withdrawal by Subject|5|||
161236525|NCT01001208|582246400|FG000|Overall Study|Ineligibility Determined|4|||
160983693|NCT04157686|581328737|FG002|Overall Study|Pregnancy|3|||
161236526|NCT01001208|582246401|FG001|Overall Study|Ineligibility Determined|2|||
161236527|NCT01001208|582246400|FG000|Overall Study|Noncompliance|4|||
160797660|NCT00718315|580649261|FG000|Overall Study|Use of ATB and Corticoids|0|||
160797661|NCT00718315|580649262|FG001|Overall Study|Use of ATB and Corticoids|1|||
160797662|NCT00718315|580649263|FG002|Overall Study|Use of ATB and Corticoids|2|||
160797663|NCT02271880|580649266|FG000|Overall Study|Premature discontinuation of study|3|||
160797664|NCT02271880|580649267|FG001|Overall Study|Premature discontinuation of study|4|||
160797665|NCT00474903|580649269|FG000|Overall Study|Protocol Violation|1|||
160797666|NCT00474903|580649270|FG001|Overall Study|Protocol Violation|5|||
160797667|NCT00474903|580649271|FG002|Overall Study|Protocol Violation|2|||
160797668|NCT02519842|580649274|FG000|Base Study: Cycle 1|Screening Failure|1|||
160797669|NCT02519842|580649275|FG001|Base Study: Cycle 1|Screening Failure|1|||
160797670|NCT02519842|580649276|FG002|Base Study: Cycle 1|Screening Failure|0|||
160797671|NCT02519842|580649274|FG000|Base Study: Cycle 1|Adverse Event|1|||
160797672|NCT02519842|580649275|FG001|Base Study: Cycle 1|Adverse Event|0|||
160797673|NCT02519842|580649276|FG002|Base Study: Cycle 1|Adverse Event|0|||
160797674|NCT02519842|580649274|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
160797675|NCT02519842|580649275|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
160797676|NCT02519842|580649276|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
160797677|NCT02519842|580649274|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
160797678|NCT02519842|580649275|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
160797679|NCT02519842|580649276|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
160797680|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
160797681|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
160797682|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
160797683|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
160797684|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
160797685|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
160797686|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160797687|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
160797688|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
160797689|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
160797690|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
160797691|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
160797692|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Death|0|||
160797693|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Death|0|||
160797694|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Death|1|||
160797695|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
160797696|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
160797697|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
160797698|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
160797699|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
160797700|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
160797701|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
160797702|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
160797703|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
160797704|NCT02519842|580649274|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
160797705|NCT02519842|580649275|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
160797706|NCT02519842|580649276|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
160797707|NCT01561976|580649277|FG000|Period 1|Adverse Event|0|||
160797708|NCT01561976|580649278|FG001|Period 1|Adverse Event|0|||
160797709|NCT01561976|580649279|FG002|Period 1|Adverse Event|1|||
160797710|NCT01561976|580649280|FG003|Period 1|Adverse Event|0|||
160797711|NCT01561976|580649281|FG004|Period 1|Adverse Event|0|||
160797712|NCT01561976|580649282|FG005|Period 1|Adverse Event|0|||
160797713|NCT01561976|580649277|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
160797714|NCT01561976|580649278|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
160797715|NCT01561976|580649279|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
160797716|NCT01561976|580649280|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
160797717|NCT01561976|580649281|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
160797718|NCT01561976|580649282|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
160797719|NCT01561976|580649277|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797720|NCT01561976|580649278|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797721|NCT01561976|580649279|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797722|NCT01561976|580649280|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797723|NCT01561976|580649281|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
160797724|NCT01561976|580649282|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
160797725|NCT01561976|580649277|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
160797726|NCT01561976|580649278|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
160797727|NCT01561976|580649279|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
160797728|NCT01561976|580649280|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
160797729|NCT01561976|580649281|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
160797730|NCT01561976|580649282|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
161331249|NCT02127658|582598827|FG000|Overall Study|Physician Decision|0|||
161331250|NCT02127658|582598828|FG001|Overall Study|Physician Decision|1|||
161331251|NCT03834493|582598829|FG000|Overall Study|Participants Ongoing|311|||
161331252|NCT03834493|582598830|FG001|Overall Study|Participants Ongoing|324|||
161331253|NCT03834493|582598829|FG000|Overall Study|Withdrawal by Subject|20|||
161331254|NCT03834493|582598830|FG001|Overall Study|Withdrawal by Subject|17|||
161331255|NCT03834493|582598829|FG000|Overall Study|Physician Decision|1|||
160797731|NCT02303262|580649283|FG000|Overall Study|Withdrawal by Subject|2|||
160797732|NCT02943473|580649284|FG000|Overall Study|enrolled but not dosed|1|||
160797733|NCT02943473|580649284|FG000|Overall Study|screen failure|1|||
160797734|NCT02943473|580649284|FG000|Overall Study|Physician Decision|4|||
160797735|NCT01728246|580649285|FG000|Overall Study|Participant needed rescue medication|1|||
160797736|NCT01728246|580649286|FG001|Overall Study|Participant needed rescue medication|5|||
160797737|NCT01728246|580649285|FG000|Overall Study|Protocol Violation|1|||
160797738|NCT01728246|580649286|FG001|Overall Study|Protocol Violation|0|||
160797739|NCT01728246|580649285|FG000|Overall Study|Withdrawal by Subject|2|||
160797740|NCT01728246|580649286|FG001|Overall Study|Withdrawal by Subject|3|||
160797741|NCT01728246|580649285|FG000|Overall Study|Lost to Follow-up|23|||
160797742|NCT01728246|580649286|FG001|Overall Study|Lost to Follow-up|22|||
160797743|NCT01728246|580649285|FG000|Overall Study|Lack of Efficacy|1|||
160797744|NCT01728246|580649286|FG001|Overall Study|Lack of Efficacy|1|||
160797745|NCT01728246|580649285|FG000|Overall Study|Adverse Event|8|||
160797746|NCT01728246|580649286|FG001|Overall Study|Adverse Event|5|||
160797747|NCT05805150|580649287|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
160797748|NCT05805150|580649288|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
160797749|NCT04138056|580649291|FG000|Primary Study|Lost to Follow-up|3|||
160797750|NCT04138056|580649292|FG001|Primary Study|Lost to Follow-up|4|||
160797751|NCT04138056|580649293|FG002|Primary Study|Lost to Follow-up|1|||
160797752|NCT04138056|580649294|FG003|Primary Study|Lost to Follow-up|1|||
160797753|NCT04138056|580649295|FG004|Primary Study|Lost to Follow-up|4|||
160797754|NCT04138056|580649291|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
160797755|NCT04138056|580649292|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
160797756|NCT04138056|580649293|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
160797757|NCT04138056|580649294|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
160797758|NCT04138056|580649295|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
160797759|NCT04138056|580649291|FG000|Extension Study|Lost to Follow-up|1|||
160797760|NCT04138056|580649292|FG001|Extension Study|Lost to Follow-up|2|||
160797761|NCT04138056|580649293|FG002|Extension Study|Lost to Follow-up|1|||
160797762|NCT04138056|580649294|FG003|Extension Study|Lost to Follow-up|0|||
160797763|NCT04138056|580649295|FG004|Extension Study|Lost to Follow-up|1|||
160797764|NCT01968980|580649299|FG000|Overall Study|Death|0|||
160797765|NCT01968980|580649300|FG001|Overall Study|Death|1|||
160797766|NCT01968980|580649299|FG000|Overall Study|Adverse Event|1|||
160797767|NCT01968980|580649300|FG001|Overall Study|Adverse Event|3|||
160797768|NCT01968980|580649299|FG000|Overall Study|Does not meet entry criteria|1|||
160797769|NCT01968980|580649300|FG001|Overall Study|Does not meet entry criteria|3|||
160797770|NCT01968980|580649299|FG000|Overall Study|Withdrawal by Subject|13|||
160797771|NCT01968980|580649300|FG001|Overall Study|Withdrawal by Subject|5|||
160797772|NCT01968980|580649299|FG000|Overall Study|Other unspecified|1|||
160797773|NCT01968980|580649300|FG001|Overall Study|Other unspecified|2|||
160797774|NCT01242514|580649301|FG000|Overall Study|e.g., project closure|1042|||
160797775|NCT01242514|580649302|FG001|Overall Study|e.g., project closure|305|||
160797776|NCT01242514|580649303|FG002|Overall Study|e.g., project closure|171|||
160797777|NCT01242514|580649301|FG000|Overall Study|Subject decision|33|||
160797778|NCT01242514|580649302|FG001|Overall Study|Subject decision|8|||
160797779|NCT01242514|580649303|FG002|Overall Study|Subject decision|2|||
160797780|NCT01242514|580649301|FG000|Overall Study|Severe non-compliance to protocol|5|||
160797781|NCT01242514|580649302|FG001|Overall Study|Severe non-compliance to protocol|2|||
160797782|NCT01242514|580649303|FG002|Overall Study|Severe non-compliance to protocol|1|||
160797783|NCT01242514|580649301|FG000|Overall Study|Lack of therapeutic response|99|||
160797784|NCT01242514|580649302|FG001|Overall Study|Lack of therapeutic response|16|||
160797785|NCT01242514|580649303|FG002|Overall Study|Lack of therapeutic response|10|||
160797786|NCT01242514|580649301|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
161331256|NCT03834493|582598830|FG001|Overall Study|Physician Decision|0|||
160797787|NCT01242514|580649302|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
160797788|NCT01242514|580649303|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
160797789|NCT01242514|580649301|FG000|Overall Study|Lost to Follow-up|14|||
160797790|NCT01242514|580649302|FG001|Overall Study|Lost to Follow-up|5|||
160894842|NCT00973349|581010955|FG013|Overall Study|Adverse Event|0|||
161331257|NCT03834493|582598829|FG000|Overall Study|Death|289|||
160797791|NCT01242514|580649303|FG002|Overall Study|Lost to Follow-up|4|||
160797792|NCT01242514|580649301|FG000|Overall Study|Adverse Event|129|||
160797793|NCT01242514|580649302|FG001|Overall Study|Adverse Event|18|||
160797794|NCT01242514|580649303|FG002|Overall Study|Adverse Event|19|||
160894843|NCT00973349|581010956|FG014|Overall Study|Adverse Event|1|||
160894844|NCT00973349|581010957|FG015|Overall Study|Adverse Event|0|||
161331258|NCT03834493|582598830|FG001|Overall Study|Death|282|||
161331259|NCT04003103|582598831|FG000|Overall Study|Death|1|||
161331260|NCT04003103|582598832|FG001|Overall Study|Death|0|||
161331261|NCT04003103|582598833|FG002|Overall Study|Death|0|||
161331262|NCT04003103|582598831|FG000|Overall Study|Lost to Follow-up|4|||
161331263|NCT04003103|582598832|FG001|Overall Study|Lost to Follow-up|3|||
161331264|NCT04003103|582598833|FG002|Overall Study|Lost to Follow-up|2|||
161331265|NCT04003103|582598831|FG000|Overall Study|Withdrawal by Subject|10|||
161331266|NCT04003103|582598832|FG001|Overall Study|Withdrawal by Subject|1|||
161331267|NCT04003103|582598833|FG002|Overall Study|Withdrawal by Subject|1|||
161331268|NCT04003103|582598831|FG000|Overall Study|Status not recorded|0|||
161331269|NCT04003103|582598832|FG001|Overall Study|Status not recorded|2|||
161331270|NCT04003103|582598833|FG002|Overall Study|Status not recorded|0|||
161331271|NCT04073303|582598838|FG000|Overall Study|Adverse Event|0|||
161331272|NCT04073303|582598839|FG001|Overall Study|Adverse Event|2|||
161331273|NCT04073303|582598838|FG000|Overall Study|Withdrawal by Subject|16|||
161331274|NCT04073303|582598839|FG001|Overall Study|Withdrawal by Subject|36|||
161331275|NCT04073303|582598838|FG000|Overall Study|Lost to Follow-up|6|||
161331276|NCT04073303|582598839|FG001|Overall Study|Lost to Follow-up|1|||
161331277|NCT04073303|582598838|FG000|Overall Study|Protocol Deviation|0|||
161331278|NCT04073303|582598839|FG001|Overall Study|Protocol Deviation|4|||
161331279|NCT04073303|582598838|FG000|Overall Study|Other|1|||
161331280|NCT04073303|582598839|FG001|Overall Study|Other|1|||
161331281|NCT02277028|582598842|FG000|Overall Study|Lost to Follow-up|1|||
161331282|NCT02277028|582598843|FG001|Overall Study|Lost to Follow-up|0|||
161331283|NCT02277028|582598842|FG000|Overall Study|Withdrawal by Subject|0|||
161331284|NCT02277028|582598843|FG001|Overall Study|Withdrawal by Subject|1|||
161331285|NCT02718911|582598844|FG000|Overall Study|Adverse Event|0|||
161331286|NCT02718911|582598845|FG001|Overall Study|Adverse Event|0|||
161331287|NCT02718911|582598846|FG002|Overall Study|Adverse Event|0|||
161331288|NCT02718911|582598847|FG003|Overall Study|Adverse Event|0|||
161331289|NCT02718911|582598848|FG004|Overall Study|Adverse Event|0|||
161331290|NCT02718911|582598849|FG005|Overall Study|Adverse Event|0|||
161331291|NCT02718911|582598850|FG006|Overall Study|Adverse Event|0|||
161331292|NCT02718911|582598851|FG007|Overall Study|Adverse Event|0|||
161331293|NCT02718911|582598852|FG008|Overall Study|Adverse Event|0|||
161331294|NCT02718911|582598853|FG009|Overall Study|Adverse Event|2|||
161331295|NCT02718911|582598844|FG000|Overall Study|Death|2|||
161331296|NCT02718911|582598845|FG001|Overall Study|Death|3|||
161331297|NCT02718911|582598846|FG002|Overall Study|Death|1|||
161331298|NCT02718911|582598847|FG003|Overall Study|Death|0|||
161331299|NCT02718911|582598848|FG004|Overall Study|Death|1|||
161331300|NCT02718911|582598849|FG005|Overall Study|Death|3|||
161331301|NCT02718911|582598850|FG006|Overall Study|Death|1|||
161331302|NCT02718911|582598851|FG007|Overall Study|Death|1|||
161331303|NCT02718911|582598852|FG008|Overall Study|Death|4|||
161331304|NCT02718911|582598853|FG009|Overall Study|Death|3|||
161331305|NCT02718911|582598844|FG000|Overall Study|Lost to Follow-up|0|||
161331306|NCT02718911|582598845|FG001|Overall Study|Lost to Follow-up|0|||
160894845|NCT00973349|581010942|FG000|Overall Study|Withdrawal by Subject|1|||
160894846|NCT00973349|581010943|FG001|Overall Study|Withdrawal by Subject|2|||
160894847|NCT00973349|581010944|FG002|Overall Study|Withdrawal by Subject|2|||
160894848|NCT00973349|581010945|FG003|Overall Study|Withdrawal by Subject|3|||
161129550|NCT02631538|581860873|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
161129551|NCT02631538|581860874|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
161129552|NCT02631538|581860875|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
161129553|NCT02631538|581860876|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
161129554|NCT02631538|581860873|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
161331307|NCT02718911|582598846|FG002|Overall Study|Lost to Follow-up|0|||
161331308|NCT02718911|582598847|FG003|Overall Study|Lost to Follow-up|0|||
161331309|NCT02718911|582598848|FG004|Overall Study|Lost to Follow-up|0|||
161331310|NCT02718911|582598849|FG005|Overall Study|Lost to Follow-up|0|||
161331311|NCT02718911|582598850|FG006|Overall Study|Lost to Follow-up|0|||
161331312|NCT02718911|582598851|FG007|Overall Study|Lost to Follow-up|0|||
161331313|NCT02718911|582598852|FG008|Overall Study|Lost to Follow-up|1|||
161331314|NCT02718911|582598853|FG009|Overall Study|Lost to Follow-up|0|||
161331315|NCT02718911|582598844|FG000|Overall Study|Physician Decision|2|||
161331316|NCT02718911|582598845|FG001|Overall Study|Physician Decision|0|||
161331317|NCT02718911|582598846|FG002|Overall Study|Physician Decision|1|||
161331318|NCT02718911|582598847|FG003|Overall Study|Physician Decision|1|||
161331319|NCT02718911|582598848|FG004|Overall Study|Physician Decision|0|||
161331320|NCT02718911|582598849|FG005|Overall Study|Physician Decision|0|||
161331321|NCT02718911|582598850|FG006|Overall Study|Physician Decision|0|||
161331322|NCT02718911|582598851|FG007|Overall Study|Physician Decision|1|||
161331323|NCT02718911|582598852|FG008|Overall Study|Physician Decision|2|||
160894849|NCT00973349|581010946|FG004|Overall Study|Withdrawal by Subject|2|||
161331324|NCT02718911|582598853|FG009|Overall Study|Physician Decision|1|||
161331325|NCT02718911|582598844|FG000|Overall Study|Withdrawal by Subject|0|||
161331326|NCT02718911|582598845|FG001|Overall Study|Withdrawal by Subject|0|||
161331327|NCT02718911|582598846|FG002|Overall Study|Withdrawal by Subject|0|||
161331328|NCT02718911|582598847|FG003|Overall Study|Withdrawal by Subject|0|||
161331329|NCT02718911|582598848|FG004|Overall Study|Withdrawal by Subject|1|||
161331330|NCT02718911|582598849|FG005|Overall Study|Withdrawal by Subject|0|||
161331331|NCT02718911|582598850|FG006|Overall Study|Withdrawal by Subject|0|||
161331332|NCT02718911|582598851|FG007|Overall Study|Withdrawal by Subject|0|||
161331333|NCT02718911|582598852|FG008|Overall Study|Withdrawal by Subject|1|||
160894850|NCT00973349|581010947|FG005|Overall Study|Withdrawal by Subject|0|||
160894851|NCT00973349|581010948|FG006|Overall Study|Withdrawal by Subject|2|||
160894852|NCT00973349|581010949|FG007|Overall Study|Withdrawal by Subject|2|||
160894853|NCT00973349|581010950|FG008|Overall Study|Withdrawal by Subject|0|||
160894854|NCT00973349|581010951|FG009|Overall Study|Withdrawal by Subject|2|||
160894855|NCT00973349|581010952|FG010|Overall Study|Withdrawal by Subject|0|||
160894856|NCT00973349|581010953|FG011|Overall Study|Withdrawal by Subject|1|||
160894857|NCT00973349|581010954|FG012|Overall Study|Withdrawal by Subject|0|||
160894858|NCT00973349|581010955|FG013|Overall Study|Withdrawal by Subject|0|||
160894859|NCT00973349|581010956|FG014|Overall Study|Withdrawal by Subject|0|||
160894860|NCT00973349|581010957|FG015|Overall Study|Withdrawal by Subject|0|||
160894861|NCT00973349|581010942|FG000|Overall Study|Lost to Follow-up|3|||
160894862|NCT00973349|581010943|FG001|Overall Study|Lost to Follow-up|1|||
160894863|NCT00973349|581010944|FG002|Overall Study|Lost to Follow-up|2|||
160894864|NCT00973349|581010945|FG003|Overall Study|Lost to Follow-up|2|||
160894865|NCT00973349|581010946|FG004|Overall Study|Lost to Follow-up|1|||
160894866|NCT00973349|581010947|FG005|Overall Study|Lost to Follow-up|3|||
160894867|NCT00973349|581010948|FG006|Overall Study|Lost to Follow-up|0|||
160894868|NCT00973349|581010949|FG007|Overall Study|Lost to Follow-up|1|||
160894869|NCT00973349|581010950|FG008|Overall Study|Lost to Follow-up|2|||
160894870|NCT00973349|581010951|FG009|Overall Study|Lost to Follow-up|1|||
160894871|NCT00973349|581010952|FG010|Overall Study|Lost to Follow-up|0|||
160894872|NCT00973349|581010953|FG011|Overall Study|Lost to Follow-up|1|||
160894873|NCT00973349|581010954|FG012|Overall Study|Lost to Follow-up|0|||
161129555|NCT02631538|581860874|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
161129556|NCT02631538|581860875|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
161129557|NCT02631538|581860876|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
161129558|NCT02631538|581860873|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
161129559|NCT02631538|581860874|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
161129560|NCT02631538|581860875|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
161129561|NCT02631538|581860876|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
161129562|NCT02631538|581860873|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
161129563|NCT02631538|581860874|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
161129564|NCT02631538|581860875|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
161129565|NCT02631538|581860876|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
161236528|NCT01001208|582246401|FG001|Overall Study|Noncompliance|7|||
161236529|NCT01001208|582246400|FG000|Overall Study|Disease Progression|0|||
160894874|NCT00973349|581010955|FG013|Overall Study|Lost to Follow-up|0|||
160894875|NCT00973349|581010956|FG014|Overall Study|Lost to Follow-up|0|||
160894876|NCT00973349|581010957|FG015|Overall Study|Lost to Follow-up|1|||
160894877|NCT00973349|581010942|FG000|Overall Study|Inappropriate enrolment|0|||
161236530|NCT01001208|582246401|FG001|Overall Study|Disease Progression|3|||
161236531|NCT01001208|582246400|FG000|Overall Study|Other|0|||
161236532|NCT01001208|582246401|FG001|Overall Study|Other|2|||
161236533|NCT01864174|582246402|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
161236534|NCT01864174|582246403|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
161236535|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
161236536|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
161236537|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
161236538|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
161236539|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
161236540|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
161236541|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Death|1|||
161236542|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Death|0|||
161236543|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
161236544|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
161236545|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
161236546|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
161236547|NCT01864174|582246402|FG000|Double Blind - Compliant Randomized|Other|6|||
161236548|NCT01864174|582246403|FG001|Double Blind - Compliant Randomized|Other|10|||
161236549|NCT01864174|582246402|FG000|Off Treatment Follow-Up|Other|2|||
161236550|NCT01864174|582246403|FG001|Off Treatment Follow-Up|Other|0|||
161236551|NCT01864174|582246402|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
161236552|NCT01864174|582246403|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
161236553|NCT02648347|582246404|FG000|Overall Study|Death|174|||
161236554|NCT02648347|582246405|FG001|Overall Study|Death|167|||
161236555|NCT02648347|582246404|FG000|Overall Study|Withdrawal by Subject|16|||
161236556|NCT02648347|582246405|FG001|Overall Study|Withdrawal by Subject|9|||
161236557|NCT02648347|582246404|FG000|Overall Study|Lost to Follow-up|18|||
161236558|NCT02648347|582246405|FG001|Overall Study|Lost to Follow-up|21|||
161236559|NCT02648347|582246404|FG000|Overall Study|Missing|1|||
161236560|NCT02648347|582246405|FG001|Overall Study|Missing|0|||
160894878|NCT00973349|581010943|FG001|Overall Study|Inappropriate enrolment|0|||
160894879|NCT00973349|581010944|FG002|Overall Study|Inappropriate enrolment|1|||
160894880|NCT00973349|581010945|FG003|Overall Study|Inappropriate enrolment|0|||
160894881|NCT00973349|581010946|FG004|Overall Study|Inappropriate enrolment|0|||
160894882|NCT00973349|581010947|FG005|Overall Study|Inappropriate enrolment|0|||
160894883|NCT00973349|581010948|FG006|Overall Study|Inappropriate enrolment|0|||
160894884|NCT00973349|581010949|FG007|Overall Study|Inappropriate enrolment|0|||
160894885|NCT00973349|581010950|FG008|Overall Study|Inappropriate enrolment|0|||
160894886|NCT00973349|581010951|FG009|Overall Study|Inappropriate enrolment|2|||
160894887|NCT00973349|581010952|FG010|Overall Study|Inappropriate enrolment|0|||
160894888|NCT00973349|581010953|FG011|Overall Study|Inappropriate enrolment|0|||
160894889|NCT00973349|581010954|FG012|Overall Study|Inappropriate enrolment|1|||
160894890|NCT00973349|581010955|FG013|Overall Study|Inappropriate enrolment|0|||
160894891|NCT00973349|581010956|FG014|Overall Study|Inappropriate enrolment|1|||
160894892|NCT00973349|581010957|FG015|Overall Study|Inappropriate enrolment|1|||
160894893|NCT00973349|581010942|FG000|Overall Study|Protocol Violation|0|||
160894894|NCT00973349|581010943|FG001|Overall Study|Protocol Violation|0|||
160894895|NCT00973349|581010944|FG002|Overall Study|Protocol Violation|0|||
160894896|NCT00973349|581010945|FG003|Overall Study|Protocol Violation|0|||
160894897|NCT00973349|581010946|FG004|Overall Study|Protocol Violation|0|||
160894898|NCT00973349|581010947|FG005|Overall Study|Protocol Violation|0|||
160894899|NCT00973349|581010948|FG006|Overall Study|Protocol Violation|0|||
160894900|NCT00973349|581010949|FG007|Overall Study|Protocol Violation|0|||
160894901|NCT00973349|581010950|FG008|Overall Study|Protocol Violation|1|||
160894902|NCT00973349|581010951|FG009|Overall Study|Protocol Violation|0|||
160894903|NCT00973349|581010952|FG010|Overall Study|Protocol Violation|0|||
160894904|NCT00973349|581010953|FG011|Overall Study|Protocol Violation|0|||
160894905|NCT00973349|581010954|FG012|Overall Study|Protocol Violation|0|||
160894906|NCT00973349|581010955|FG013|Overall Study|Protocol Violation|0|||
160894907|NCT00973349|581010956|FG014|Overall Study|Protocol Violation|0|||
160894908|NCT00973349|581010957|FG015|Overall Study|Protocol Violation|0|||
160894909|NCT00973349|581010942|FG000|Overall Study|Unable to classify|0|||
160894910|NCT00973349|581010943|FG001|Overall Study|Unable to classify|0|||
160894911|NCT00973349|581010944|FG002|Overall Study|Unable to classify|0|||
161236561|NCT03546842|582246406|FG000|Overall Study|Protocol Violation|1|||
161236562|NCT03546842|582246406|FG000|Overall Study|Withdrawal by Subject|2|||
161236563|NCT02739997|582246410|FG000|Overall Study|Death|1|||
161236564|NCT02739997|582246410|FG000|Overall Study|Withdrawal by Subject|1|||
161236565|NCT01723397|582246411|FG000|Study Period 1|Protocol Violation|0|||
161236566|NCT01723397|582246412|FG001|Study Period 1|Protocol Violation|1|||
161236567|NCT01723397|582246411|FG000|Study Period 2|Protocol Violation|0|||
161236568|NCT01723397|582246412|FG001|Study Period 2|Protocol Violation|1|||
161236569|NCT01302548|582246413|FG000|Overall Study|Lost to Follow-up|2|||
161236570|NCT01302548|582246414|FG001|Overall Study|Lost to Follow-up|1|||
161236571|NCT02409355|582246415|FG000|Overall Study|Withdrawal by Subject|1|||
161236572|NCT02409355|582246416|FG001|Overall Study|Withdrawal by Subject|0|||
161236573|NCT02409355|582246415|FG000|Overall Study|Death|1|||
161236574|NCT02409355|582246416|FG001|Overall Study|Death|1|||
161236575|NCT02409355|582246415|FG000|Overall Study|Study terminated by Sponsor|2|||
161236576|NCT02409355|582246416|FG001|Overall Study|Study terminated by Sponsor|3|||
161236577|NCT01237054|582246417|FG000|Overall Study|imaging 10C0096|1|||
161236578|NCT02089997|582246431|FG000|Overall Study|Case report forms uncollected|99|||
161236579|NCT02089997|582246431|FG000|Overall Study|Protocol Violation|147|||
161236580|NCT00095212|582246432|FG000|Overall Study|Withdrawal by Subject|1|||
161236581|NCT00095212|582246433|FG001|Overall Study|Withdrawal by Subject|3|||
161236582|NCT02032888|582246435|FG000|Treatment Period|Poor compliance/noncompliance|1|||
161236583|NCT02032888|582246436|FG001|Treatment Period|Poor compliance/noncompliance|1|||
161236584|NCT02032888|582246437|FG002|Treatment Period|Poor compliance/noncompliance|0|||
161236585|NCT02032888|582246435|FG000|Treatment Period|Other|1|||
161236586|NCT02032888|582246436|FG001|Treatment Period|Other|1|||
161236587|NCT02032888|582246437|FG002|Treatment Period|Other|0|||
161236588|NCT02032888|582246435|FG000|Follow-up Period|Lost to Follow-up|1|||
161236589|NCT02032888|582246436|FG001|Follow-up Period|Lost to Follow-up|1|||
161236590|NCT02032888|582246437|FG002|Follow-up Period|Lost to Follow-up|0|||
161236591|NCT02032888|582246435|FG000|Follow-up Period|Death|1|||
161236592|NCT02032888|582246436|FG001|Follow-up Period|Death|1|||
160894912|NCT00973349|581010945|FG003|Overall Study|Unable to classify|0|||
160894913|NCT00973349|581010946|FG004|Overall Study|Unable to classify|1|||
160894914|NCT00973349|581010947|FG005|Overall Study|Unable to classify|1|||
161236593|NCT02032888|582246437|FG002|Follow-up Period|Death|0|||
161236594|NCT02032888|582246435|FG000|Follow-up Period|Other|1|||
161236595|NCT02032888|582246436|FG001|Follow-up Period|Other|0|||
160894915|NCT00973349|581010948|FG006|Overall Study|Unable to classify|0|||
160894916|NCT00973349|581010949|FG007|Overall Study|Unable to classify|0|||
160894917|NCT00973349|581010950|FG008|Overall Study|Unable to classify|0|||
160894918|NCT00973349|581010951|FG009|Overall Study|Unable to classify|1|||
160894919|NCT00973349|581010952|FG010|Overall Study|Unable to classify|0|||
160894920|NCT00973349|581010953|FG011|Overall Study|Unable to classify|0|||
160894921|NCT00973349|581010954|FG012|Overall Study|Unable to classify|0|||
160894922|NCT00973349|581010955|FG013|Overall Study|Unable to classify|0|||
160894923|NCT00973349|581010956|FG014|Overall Study|Unable to classify|0|||
160894924|NCT00973349|581010957|FG015|Overall Study|Unable to classify|0|||
160894925|NCT02898116|581010958|FG000|Overall Study|Adverse Event|1|||
160894926|NCT02898116|581010958|FG000|Overall Study|Progressive disease|1|||
160894927|NCT05430022|581010976|FG000|Overall Study|Withdrawal by Subject|4|||
160894928|NCT05430022|581010977|FG001|Overall Study|Withdrawal by Subject|4|||
160894929|NCT05521906|581010978|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
160894930|NCT05521906|581010979|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
160894931|NCT02452697|581010982|FG000|Overall Study|Physician Decision|4|||
160894932|NCT02452697|581010983|FG001|Overall Study|Physician Decision|4|||
160894933|NCT02452697|581010984|FG002|Overall Study|Physician Decision|3|||
160894934|NCT02452697|581010985|FG003|Overall Study|Physician Decision|2|||
160894935|NCT02452697|581010982|FG000|Overall Study|Withdrawal by Subject|1|||
160894936|NCT02452697|581010983|FG001|Overall Study|Withdrawal by Subject|0|||
160894937|NCT02452697|581010984|FG002|Overall Study|Withdrawal by Subject|0|||
160894938|NCT02452697|581010985|FG003|Overall Study|Withdrawal by Subject|0|||
160894939|NCT02452697|581010982|FG000|Overall Study|still in follow-up|2|||
160894940|NCT02452697|581010983|FG001|Overall Study|still in follow-up|2|||
160894941|NCT02452697|581010984|FG002|Overall Study|still in follow-up|1|||
160894942|NCT02452697|581010985|FG003|Overall Study|still in follow-up|3|||
160894943|NCT00560885|581010988|FG000|Overall Study|Death|7|||
160894944|NCT00560885|581010988|FG000|Overall Study|Withdrawal by Subject|1|||
160894945|NCT03803683|581010989|FG000|Overall Study|Lost to Follow-up|41|||
160894946|NCT03803683|581010990|FG001|Overall Study|Lost to Follow-up|18|||
160894947|NCT03803683|581010991|FG002|Overall Study|Lost to Follow-up|12|||
160894948|NCT03803683|581010989|FG000|Overall Study|Withdrawal by Subject|9|||
160894949|NCT03803683|581010990|FG001|Overall Study|Withdrawal by Subject|1|||
160894950|NCT03803683|581010991|FG002|Overall Study|Withdrawal by Subject|4|||
160894951|NCT00866788|581012784|FG000|Overall Study|Adverse Event|0|||
160894952|NCT00866788|581012785|FG001|Overall Study|Adverse Event|2|||
160894953|NCT00866788|581012786|FG002|Overall Study|Adverse Event|0|||
160894954|NCT00866788|581012787|FG003|Overall Study|Adverse Event|1|||
160894955|NCT00866788|581012784|FG000|Overall Study|Lost to Follow-up|1|||
160894956|NCT00866788|581012785|FG001|Overall Study|Lost to Follow-up|1|||
160983694|NCT04157686|581328738|FG003|Overall Study|Pregnancy|0|||
160983695|NCT04157686|581328739|FG004|Overall Study|Pregnancy|0|||
160983696|NCT04157686|581328740|FG005|Overall Study|Pregnancy|0|||
161129566|NCT02631538|581860873|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
160894957|NCT00866788|581012786|FG002|Overall Study|Lost to Follow-up|0|||
160894958|NCT00866788|581012787|FG003|Overall Study|Lost to Follow-up|2|||
160894959|NCT00866788|581012784|FG000|Overall Study|Withdrawal by Subject|2|||
160894960|NCT00866788|581012785|FG001|Overall Study|Withdrawal by Subject|1|||
160894961|NCT00866788|581012786|FG002|Overall Study|Withdrawal by Subject|0|||
160894962|NCT00866788|581012787|FG003|Overall Study|Withdrawal by Subject|1|||
160894963|NCT00866788|581012784|FG000|Overall Study|Pregnancy|0|||
160894964|NCT00866788|581012785|FG001|Overall Study|Pregnancy|1|||
160894965|NCT00866788|581012786|FG002|Overall Study|Pregnancy|0|||
160894966|NCT00866788|581012787|FG003|Overall Study|Pregnancy|0|||
160894967|NCT00866788|581012784|FG000|Overall Study|Disease progression|3|||
160894968|NCT00866788|581012785|FG001|Overall Study|Disease progression|1|||
160894969|NCT00866788|581012786|FG002|Overall Study|Disease progression|1|||
160894970|NCT00866788|581012787|FG003|Overall Study|Disease progression|0|||
160894971|NCT00866788|581012784|FG000|Overall Study|Physician Decision|0|||
160894972|NCT00866788|581012785|FG001|Overall Study|Physician Decision|0|||
160894973|NCT00866788|581012786|FG002|Overall Study|Physician Decision|1|||
160894974|NCT00866788|581012787|FG003|Overall Study|Physician Decision|1|||
160894975|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
160894976|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
160894977|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
160894978|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
160894979|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
160894980|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
160894981|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
160894982|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
160894983|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
160894984|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
160894985|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
161129567|NCT02631538|581860874|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
161129568|NCT02631538|581860875|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
161331334|NCT02718911|582598853|FG009|Overall Study|Withdrawal by Subject|4|||
161331335|NCT02718911|582598844|FG000|Overall Study|Reason Not Collected|0|||
161331336|NCT02718911|582598845|FG001|Overall Study|Reason Not Collected|0|||
160797795|NCT00862940|580649308|FG000|Overall Study|Adverse Event|15|||
160797796|NCT00862940|580649309|FG001|Overall Study|Adverse Event|12|||
160797797|NCT00862940|580649308|FG000|Overall Study|Lack of Efficacy|1|||
160797798|NCT00862940|580649309|FG001|Overall Study|Lack of Efficacy|3|||
160797799|NCT00862940|580649308|FG000|Overall Study|Protocol Violation|2|||
160797800|NCT00862940|580649309|FG001|Overall Study|Protocol Violation|5|||
160797801|NCT00862940|580649308|FG000|Overall Study|Withdrawal by Subject|4|||
160797802|NCT00862940|580649309|FG001|Overall Study|Withdrawal by Subject|6|||
160797803|NCT00862940|580649308|FG000|Overall Study|Non-compliance|4|||
160797804|NCT00862940|580649309|FG001|Overall Study|Non-compliance|0|||
160797805|NCT00862940|580649308|FG000|Overall Study|Lost to Follow-up|0|||
160797806|NCT00862940|580649309|FG001|Overall Study|Lost to Follow-up|1|||
160797807|NCT00862940|580649308|FG000|Overall Study|Administrative or other reason(s)|4|||
160797808|NCT00862940|580649309|FG001|Overall Study|Administrative or other reason(s)|3|||
160797809|NCT00485173|580649310|FG000|Overall Study|Death|4|||
160797810|NCT00485173|580649311|FG001|Overall Study|Death|3|||
160797811|NCT00485173|580649310|FG000|Overall Study|Lost to Follow-up|32|||
160797812|NCT00485173|580649311|FG001|Overall Study|Lost to Follow-up|61|||
160797813|NCT00879398|580649314|FG000|Overall Study|Visit Stop|399|||
160797814|NCT00879398|580649314|FG000|Overall Study|Lack of Efficacy|64|||
160797815|NCT00879398|580649314|FG000|Overall Study|Adverse Event|41|||
160797816|NCT00879398|580649314|FG000|Overall Study|Other Reasons|171|||
160797817|NCT00829244|580649315|FG000|Overall Study|Adverse Event|1|||
160797818|NCT00829244|580649316|FG001|Overall Study|Adverse Event|3|||
160797819|NCT00829244|580649315|FG000|Overall Study|Protocol Violation|1|||
160797820|NCT00829244|580649316|FG001|Overall Study|Protocol Violation|0|||
160797821|NCT00829244|580649315|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
160797822|NCT00829244|580649316|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
160797823|NCT00829244|580649315|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
160797824|NCT00829244|580649316|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
160797825|NCT00829244|580649315|FG000|Overall Study|No fertilization|2|||
160797826|NCT00829244|580649316|FG001|Overall Study|No fertilization|2|||
160797827|NCT00829244|580649315|FG000|Overall Study|All embryos discarded|0|||
160797828|NCT00829244|580649316|FG001|Overall Study|All embryos discarded|3|||
160797829|NCT00829244|580649315|FG000|Overall Study|No embryo cleavage|0|||
160797830|NCT00829244|580649316|FG001|Overall Study|No embryo cleavage|2|||
160797831|NCT05901636|580649323|FG000|Overall Study|Lost to Follow-up|0|||
160797832|NCT05901636|580649324|FG001|Overall Study|Lost to Follow-up|1|||
160797833|NCT05901636|580649325|FG002|Overall Study|Lost to Follow-up|0|||
160797834|NCT05901636|580649326|FG003|Overall Study|Lost to Follow-up|1|||
160797835|NCT05901636|580649327|FG004|Overall Study|Lost to Follow-up|1|||
160797836|NCT05901636|580649328|FG005|Overall Study|Lost to Follow-up|3|||
160894986|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
160894987|NCT02349061|581012788|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
160894988|NCT02349061|581012789|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
160894989|NCT02349061|581012790|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
160894990|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
160894991|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
160894992|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
160894993|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
160894994|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
160894995|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
160797837|NCT05901636|580649329|FG006|Overall Study|Lost to Follow-up|1|||
160797838|NCT05901636|580649323|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
160894996|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
160894997|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
160894998|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
160894999|NCT02349061|581012788|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
160895000|NCT02349061|581012789|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
160895001|NCT02349061|581012790|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
161331337|NCT02718911|582598846|FG002|Overall Study|Reason Not Collected|1|||
161331338|NCT02718911|582598847|FG003|Overall Study|Reason Not Collected|0|||
160797839|NCT05901636|580649324|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
160797840|NCT05901636|580649325|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
160797841|NCT05901636|580649326|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
160797842|NCT05901636|580649327|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
160797843|NCT05901636|580649328|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
160797844|NCT05901636|580649329|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
160797845|NCT05901636|580649323|FG000|Overall Study|Withdrawal by Subject|1|||
160797846|NCT05901636|580649324|FG001|Overall Study|Withdrawal by Subject|1|||
160797847|NCT05901636|580649325|FG002|Overall Study|Withdrawal by Subject|0|||
160797848|NCT05901636|580649326|FG003|Overall Study|Withdrawal by Subject|0|||
160797849|NCT05901636|580649327|FG004|Overall Study|Withdrawal by Subject|1|||
160797850|NCT05901636|580649328|FG005|Overall Study|Withdrawal by Subject|1|||
160797851|NCT05901636|580649329|FG006|Overall Study|Withdrawal by Subject|0|||
160797852|NCT05901636|580649323|FG000|Overall Study|Other|0|||
160797853|NCT05901636|580649324|FG001|Overall Study|Other|0|||
160797854|NCT05901636|580649325|FG002|Overall Study|Other|1|||
160797855|NCT05901636|580649326|FG003|Overall Study|Other|1|||
160797856|NCT05901636|580649327|FG004|Overall Study|Other|0|||
160797857|NCT05901636|580649328|FG005|Overall Study|Other|0|||
160797858|NCT05901636|580649329|FG006|Overall Study|Other|0|||
160797859|NCT04583618|580649337|FG000|Overall Study|Adverse Event|0|||
160797860|NCT04583618|580649338|FG001|Overall Study|Adverse Event|0|||
160797861|NCT04583618|580649339|FG002|Overall Study|Adverse Event|1|||
160797862|NCT04583618|580649340|FG003|Overall Study|Adverse Event|0|||
160797863|NCT04583618|580649341|FG004|Overall Study|Adverse Event|0|||
160797864|NCT04583618|580649337|FG000|Overall Study|Protocol deviation|1|||
160797865|NCT04583618|580649338|FG001|Overall Study|Protocol deviation|1|||
160797866|NCT04583618|580649339|FG002|Overall Study|Protocol deviation|1|||
160797867|NCT04583618|580649340|FG003|Overall Study|Protocol deviation|0|||
160797868|NCT04583618|580649341|FG004|Overall Study|Protocol deviation|0|||
160797869|NCT04583618|580649337|FG000|Overall Study|Withdrawal by Subject|2|||
160797870|NCT04583618|580649338|FG001|Overall Study|Withdrawal by Subject|1|||
160797871|NCT04583618|580649339|FG002|Overall Study|Withdrawal by Subject|3|||
160797872|NCT04583618|580649340|FG003|Overall Study|Withdrawal by Subject|1|||
160797873|NCT04583618|580649341|FG004|Overall Study|Withdrawal by Subject|1|||
160797874|NCT04583618|580649337|FG000|Overall Study|Lost to Follow-up|0|||
160797875|NCT04583618|580649338|FG001|Overall Study|Lost to Follow-up|1|||
160797876|NCT04583618|580649339|FG002|Overall Study|Lost to Follow-up|3|||
160797877|NCT04583618|580649340|FG003|Overall Study|Lost to Follow-up|1|||
160797878|NCT04583618|580649341|FG004|Overall Study|Lost to Follow-up|1|||
160797879|NCT02302222|580649342|FG000|Overall Study|Physician Decision|0|||
160797880|NCT02302222|580649343|FG001|Overall Study|Physician Decision|4|||
160797881|NCT02302222|580649342|FG000|Overall Study|Lost to Follow-up|1|||
160797882|NCT02302222|580649343|FG001|Overall Study|Lost to Follow-up|0|||
160797883|NCT02302222|580649342|FG000|Overall Study|Treatment discontinued before day 5|0|||
160797884|NCT02302222|580649343|FG001|Overall Study|Treatment discontinued before day 5|1|||
160797885|NCT02302222|580649342|FG000|Overall Study|Withdrawn prior to any treatment|0|||
160797886|NCT02302222|580649343|FG001|Overall Study|Withdrawn prior to any treatment|1|||
161236596|NCT02032888|582246437|FG002|Follow-up Period|Other|0|||
160797887|NCT00016354|580649344|FG000|Overall Study|Lack of Efficacy|0|||
160797888|NCT00016354|580649345|FG001|Overall Study|Lack of Efficacy|0|||
160797889|NCT00016354|580649346|FG002|Overall Study|Lack of Efficacy|0|||
160797890|NCT00016354|580649347|FG003|Overall Study|Lack of Efficacy|0|||
160797891|NCT00016354|580649348|FG004|Overall Study|Lack of Efficacy|0|||
160797892|NCT00016354|580649349|FG005|Overall Study|Lack of Efficacy|0|||
160797893|NCT00016354|580649350|FG006|Overall Study|Lack of Efficacy|0|||
160797894|NCT00016354|580649351|FG007|Overall Study|Lack of Efficacy|1|||
160797895|NCT03193801|580649352|FG000|Overall Study|Physician Decision|2|||
160797896|NCT03193801|580649352|FG000|Overall Study|Withdrawal by Subject|1|||
160797897|NCT03110562|580649353|FG000|Initial Treatment Period|Disease Progression|1|||
160797898|NCT03110562|580649354|FG001|Initial Treatment Period|Disease Progression|1|||
160797899|NCT03110562|580649355|FG002|Initial Treatment Period|Disease Progression|0|||
160797900|NCT03110562|580649356|FG003|Initial Treatment Period|Disease Progression|0|||
160797901|NCT03110562|580649353|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
160797902|NCT03110562|580649354|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
160797903|NCT03110562|580649355|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
160797904|NCT03110562|580649356|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
160797905|NCT03110562|580649353|FG000|Initial Treatment Period|Adverse Event|1|||
160797906|NCT03110562|580649354|FG001|Initial Treatment Period|Adverse Event|0|||
160797907|NCT03110562|580649355|FG002|Initial Treatment Period|Adverse Event|0|||
160895002|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
161236597|NCT00837486|582246438|FG000|Blinded-treatment Phase|Physician Decision|1|||
161236598|NCT00837486|582246439|FG001|Blinded-treatment Phase|Physician Decision|0|||
161236599|NCT00837486|582246438|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
160797908|NCT03110562|580649356|FG003|Initial Treatment Period|Adverse Event|0|||
160797909|NCT03110562|580649353|FG000|Initial Treatment Period|Death|74|||
160797910|NCT03110562|580649354|FG001|Initial Treatment Period|Death|82|||
160797911|NCT03110562|580649355|FG002|Initial Treatment Period|Death|0|||
160797912|NCT03110562|580649356|FG003|Initial Treatment Period|Death|0|||
160797913|NCT03110562|580649353|FG000|Initial Treatment Period|Lost to Follow-up|13|||
160797914|NCT03110562|580649354|FG001|Initial Treatment Period|Lost to Follow-up|8|||
160797915|NCT03110562|580649355|FG002|Initial Treatment Period|Lost to Follow-up|0|||
160797916|NCT03110562|580649356|FG003|Initial Treatment Period|Lost to Follow-up|0|||
160797917|NCT03110562|580649353|FG000|Initial Treatment Period|Protocol Deviation|1|||
160895003|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
160797918|NCT03110562|580649354|FG001|Initial Treatment Period|Protocol Deviation|0|||
160797919|NCT03110562|580649355|FG002|Initial Treatment Period|Protocol Deviation|0|||
160797920|NCT03110562|580649356|FG003|Initial Treatment Period|Protocol Deviation|0|||
160797921|NCT03110562|580649353|FG000|Initial Treatment Period|Physician Decision|2|||
160797922|NCT03110562|580649354|FG001|Initial Treatment Period|Physician Decision|1|||
160797923|NCT03110562|580649355|FG002|Initial Treatment Period|Physician Decision|0|||
160797924|NCT03110562|580649356|FG003|Initial Treatment Period|Physician Decision|0|||
160797925|NCT03110562|580649353|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
160797926|NCT03110562|580649354|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
160797927|NCT03110562|580649355|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
160797928|NCT03110562|580649356|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
160797929|NCT03110562|580649353|FG000|Initial Treatment Period|Other|5|||
160797930|NCT03110562|580649354|FG001|Initial Treatment Period|Other|4|||
160797931|NCT03110562|580649355|FG002|Initial Treatment Period|Other|0|||
160797932|NCT03110562|580649356|FG003|Initial Treatment Period|Other|0|||
160797933|NCT03110562|580649353|FG000|Initial Treatment Period|Randomized but never treated|0|||
160797934|NCT03110562|580649354|FG001|Initial Treatment Period|Randomized but never treated|3|||
160797935|NCT03110562|580649355|FG002|Initial Treatment Period|Randomized but never treated|0|||
160797936|NCT03110562|580649356|FG003|Initial Treatment Period|Randomized but never treated|0|||
161236600|NCT00837486|582246439|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
160797937|NCT03110562|580649353|FG000|Crossover Period|Disease Progression|0|||
160797938|NCT03110562|580649354|FG001|Crossover Period|Disease Progression|0|||
160797939|NCT03110562|580649355|FG002|Crossover Period|Disease Progression|1|||
160797940|NCT03110562|580649356|FG003|Crossover Period|Disease Progression|0|||
160797941|NCT03110562|580649353|FG000|Crossover Period|Withdrawal by Subject|0|||
160797942|NCT03110562|580649354|FG001|Crossover Period|Withdrawal by Subject|0|||
160797943|NCT03110562|580649355|FG002|Crossover Period|Withdrawal by Subject|8|||
160797944|NCT03110562|580649356|FG003|Crossover Period|Withdrawal by Subject|6|||
160797945|NCT03110562|580649353|FG000|Crossover Period|Death|0|||
160797946|NCT03110562|580649354|FG001|Crossover Period|Death|0|||
160797947|NCT03110562|580649355|FG002|Crossover Period|Death|37|||
160797948|NCT03110562|580649356|FG003|Crossover Period|Death|3|||
160797949|NCT03110562|580649353|FG000|Crossover Period|Lost to Follow-up|0|||
160797950|NCT03110562|580649354|FG001|Crossover Period|Lost to Follow-up|0|||
160797951|NCT03110562|580649355|FG002|Crossover Period|Lost to Follow-up|0|||
160797952|NCT03110562|580649356|FG003|Crossover Period|Lost to Follow-up|1|||
160797953|NCT03110562|580649353|FG000|Crossover Period|Other|0|||
160797954|NCT03110562|580649354|FG001|Crossover Period|Other|0|||
160797955|NCT03110562|580649355|FG002|Crossover Period|Other|1|||
160797956|NCT03110562|580649356|FG003|Crossover Period|Other|1|||
160797957|NCT03110562|580649353|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
160797958|NCT03110562|580649354|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
160797959|NCT03110562|580649355|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
160797960|NCT03110562|580649356|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
160797961|NCT03189719|580649362|FG000|Overall Study|Death|325|||
160797962|NCT03189719|580649363|FG001|Overall Study|Death|361|||
160797963|NCT03189719|580649362|FG000|Overall Study|Physician Decision|1|||
160797964|NCT03189719|580649363|FG001|Overall Study|Physician Decision|0|||
160797965|NCT03189719|580649362|FG000|Overall Study|Sponsor Decision|40|||
160797966|NCT03189719|580649363|FG001|Overall Study|Sponsor Decision|12|||
160797967|NCT03189719|580649362|FG000|Overall Study|Withdrawal by Subject|7|||
160797968|NCT03189719|580649363|FG001|Overall Study|Withdrawal by Subject|3|||
160797969|NCT05211596|580649364|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
160797970|NCT05211596|580649364|FG000|Baseline to 6 Months|Death|1|||
160797971|NCT05211596|580649364|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
160797972|NCT05211596|580649364|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
160797973|NCT02293551|580649365|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
160797974|NCT02293551|580649366|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
160797975|NCT02293551|580649367|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
160797976|NCT02293551|580649368|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
160797977|NCT02293551|580649369|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
160797978|NCT02293551|580649370|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
160797979|NCT02293551|580649365|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
160797980|NCT02293551|580649366|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
160797981|NCT02293551|580649367|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
160797982|NCT02293551|580649368|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
160797983|NCT02293551|580649369|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
160797984|NCT02293551|580649370|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
160797985|NCT02293551|580649365|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
160797986|NCT02293551|580649366|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
161257886|NCT03756883|582323520|FG002|Overall Study|Adverse Event|2|||
160797987|NCT02293551|580649367|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
160797988|NCT02293551|580649368|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
160797989|NCT02293551|580649369|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
160797990|NCT02293551|580649370|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
160983697|NCT04157686|581328741|FG006|Overall Study|Pregnancy|3|||
160983698|NCT04157686|581328742|FG007|Overall Study|Pregnancy|0|||
160983699|NCT04157686|581328735|FG000|Overall Study|Lost to Follow-up|1|||
160983700|NCT04157686|581328736|FG001|Overall Study|Lost to Follow-up|2|||
160983701|NCT04157686|581328737|FG002|Overall Study|Lost to Follow-up|8|||
160983702|NCT04157686|581328738|FG003|Overall Study|Lost to Follow-up|6|||
160983703|NCT04157686|581328739|FG004|Overall Study|Lost to Follow-up|6|||
160983704|NCT04157686|581328740|FG005|Overall Study|Lost to Follow-up|3|||
160983705|NCT04157686|581328741|FG006|Overall Study|Lost to Follow-up|7|||
160983706|NCT04157686|581328742|FG007|Overall Study|Lost to Follow-up|9|||
160983707|NCT04157686|581328735|FG000|Overall Study|Lack of Efficacy|0|||
160983708|NCT04157686|581328736|FG001|Overall Study|Lack of Efficacy|0|||
160983709|NCT04157686|581328737|FG002|Overall Study|Lack of Efficacy|0|||
160983710|NCT04157686|581328738|FG003|Overall Study|Lack of Efficacy|0|||
160983711|NCT04157686|581328739|FG004|Overall Study|Lack of Efficacy|0|||
160983712|NCT04157686|581328740|FG005|Overall Study|Lack of Efficacy|2|||
160983713|NCT04157686|581328741|FG006|Overall Study|Lack of Efficacy|0|||
160983714|NCT04157686|581328742|FG007|Overall Study|Lack of Efficacy|1|||
160983715|NCT04157686|581328735|FG000|Overall Study|Withdrawal by Subject|10|||
160983716|NCT04157686|581328736|FG001|Overall Study|Withdrawal by Subject|10|||
160983717|NCT04157686|581328737|FG002|Overall Study|Withdrawal by Subject|12|||
160983718|NCT04157686|581328738|FG003|Overall Study|Withdrawal by Subject|20|||
160983719|NCT04157686|581328739|FG004|Overall Study|Withdrawal by Subject|12|||
160983720|NCT04157686|581328740|FG005|Overall Study|Withdrawal by Subject|11|||
160983721|NCT04157686|581328741|FG006|Overall Study|Withdrawal by Subject|18|||
160983722|NCT04157686|581328742|FG007|Overall Study|Withdrawal by Subject|24|||
160983723|NCT04157686|581328735|FG000|Overall Study|Physician Decision|0|||
160983724|NCT04157686|581328736|FG001|Overall Study|Physician Decision|0|||
160983725|NCT04157686|581328737|FG002|Overall Study|Physician Decision|1|||
160983726|NCT04157686|581328738|FG003|Overall Study|Physician Decision|0|||
160983727|NCT04157686|581328739|FG004|Overall Study|Physician Decision|1|||
160983728|NCT04157686|581328740|FG005|Overall Study|Physician Decision|0|||
160983729|NCT04157686|581328741|FG006|Overall Study|Physician Decision|3|||
160983730|NCT04157686|581328742|FG007|Overall Study|Physician Decision|0|||
160983731|NCT04157686|581328735|FG000|Overall Study|Death|0|||
160983732|NCT04157686|581328736|FG001|Overall Study|Death|0|||
160983733|NCT04157686|581328737|FG002|Overall Study|Death|0|||
160983734|NCT04157686|581328738|FG003|Overall Study|Death|2|||
160983735|NCT04157686|581328739|FG004|Overall Study|Death|0|||
160797991|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
160797992|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
160797993|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
160797994|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
160797995|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
160895004|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
160895005|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
160895006|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
160983736|NCT04157686|581328740|FG005|Overall Study|Death|0|||
160983737|NCT04157686|581328741|FG006|Overall Study|Death|0|||
160983738|NCT04157686|581328742|FG007|Overall Study|Death|0|||
160797996|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
160797997|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
160797998|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
160895007|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
160895008|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
160895009|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
160895010|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
160895011|NCT02349061|581012788|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
160983739|NCT04157686|581328735|FG000|Overall Study|Protocol Violation|0|||
160983740|NCT04157686|581328736|FG001|Overall Study|Protocol Violation|0|||
160797999|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
160983741|NCT04157686|581328737|FG002|Overall Study|Protocol Violation|0|||
160983742|NCT04157686|581328738|FG003|Overall Study|Protocol Violation|0|||
160983743|NCT04157686|581328739|FG004|Overall Study|Protocol Violation|1|||
160895012|NCT02349061|581012789|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
160895013|NCT02349061|581012790|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
160895014|NCT02339285|581012791|FG000|Overall Study|Withdrawal by Subject|0|||
160895015|NCT02339285|581012792|FG001|Overall Study|Withdrawal by Subject|1|||
160895016|NCT02339285|581012793|FG002|Overall Study|Withdrawal by Subject|1|||
160983744|NCT04157686|581328740|FG005|Overall Study|Protocol Violation|0|||
160983745|NCT04157686|581328741|FG006|Overall Study|Protocol Violation|0|||
160983746|NCT04157686|581328742|FG007|Overall Study|Protocol Violation|0|||
160983747|NCT04157686|581328735|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
160983748|NCT04157686|581328736|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
160983749|NCT04157686|581328737|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
160983750|NCT04157686|581328738|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
160798000|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
160798001|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
160798002|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
160798003|NCT04532749|580649371|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
160798004|NCT04532749|580649372|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
160798005|NCT04532749|580649371|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
160798006|NCT04532749|580649372|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
160798007|NCT04532749|580649371|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
160798008|NCT04532749|580649372|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
160798009|NCT04532749|580649371|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
160798010|NCT04532749|580649372|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
160798011|NCT05239221|580649373|FG000|Overall Study|Adverse Event|0|||
160798012|NCT05239221|580649374|FG001|Overall Study|Adverse Event|0|||
160798013|NCT05239221|580649375|FG002|Overall Study|Adverse Event|0|||
160798014|NCT05239221|580649376|FG003|Overall Study|Adverse Event|0|||
160798015|NCT05239221|580649377|FG004|Overall Study|Adverse Event|0|||
160798016|NCT05239221|580649378|FG005|Overall Study|Adverse Event|0|||
160798017|NCT05239221|580649379|FG006|Overall Study|Adverse Event|1|||
160798018|NCT05239221|580649380|FG007|Overall Study|Adverse Event|0|||
160798019|NCT05239221|580649381|FG008|Overall Study|Adverse Event|0|||
160798020|NCT05239221|580649382|FG009|Overall Study|Adverse Event|0|||
160798021|NCT05239221|580649383|FG010|Overall Study|Adverse Event|1|||
160798022|NCT05239221|580649384|FG011|Overall Study|Adverse Event|1|||
160798023|NCT05239221|580649385|FG012|Overall Study|Adverse Event|0|||
160798024|NCT05239221|580649386|FG013|Overall Study|Adverse Event|0|||
160798025|NCT05239221|580649387|FG014|Overall Study|Adverse Event|0|||
160798026|NCT05239221|580649388|FG015|Overall Study|Adverse Event|0|||
160798027|NCT05239221|580649373|FG000|Overall Study|Withdrawal by Subject|0|||
160798028|NCT05239221|580649374|FG001|Overall Study|Withdrawal by Subject|0|||
160798029|NCT05239221|580649375|FG002|Overall Study|Withdrawal by Subject|0|||
160798030|NCT05239221|580649376|FG003|Overall Study|Withdrawal by Subject|0|||
160798031|NCT05239221|580649377|FG004|Overall Study|Withdrawal by Subject|0|||
160798032|NCT05239221|580649378|FG005|Overall Study|Withdrawal by Subject|0|||
160798033|NCT05239221|580649379|FG006|Overall Study|Withdrawal by Subject|0|||
160798034|NCT05239221|580649380|FG007|Overall Study|Withdrawal by Subject|0|||
160798035|NCT05239221|580649381|FG008|Overall Study|Withdrawal by Subject|0|||
160798036|NCT05239221|580649382|FG009|Overall Study|Withdrawal by Subject|0|||
160798037|NCT05239221|580649383|FG010|Overall Study|Withdrawal by Subject|1|||
160798038|NCT05239221|580649384|FG011|Overall Study|Withdrawal by Subject|0|||
160798039|NCT05239221|580649385|FG012|Overall Study|Withdrawal by Subject|0|||
160798040|NCT05239221|580649386|FG013|Overall Study|Withdrawal by Subject|0|||
160798041|NCT05239221|580649387|FG014|Overall Study|Withdrawal by Subject|0|||
160798042|NCT05239221|580649388|FG015|Overall Study|Withdrawal by Subject|1|||
160798043|NCT01400412|580649389|FG000|Overall Study|Lost to Follow-up|4|||
160798044|NCT01400412|580649390|FG001|Overall Study|Lost to Follow-up|7|||
160798045|NCT01400412|580649389|FG000|Overall Study|Withdrawal by Subject|3|||
160798046|NCT01400412|580649390|FG001|Overall Study|Withdrawal by Subject|4|||
160798047|NCT01400412|580649389|FG000|Overall Study|Unable to complete|3|||
160798048|NCT01400412|580649390|FG001|Overall Study|Unable to complete|3|||
160798049|NCT01400412|580649389|FG000|Overall Study|Never started study treatment|0|||
161236601|NCT00837486|582246438|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
161257887|NCT03756883|582323518|FG000|Overall Study|Lack of Efficacy|0|||
160798050|NCT01400412|580649390|FG001|Overall Study|Never started study treatment|3|||
160798051|NCT01649869|580649391|FG000|Overall Study|Family member illness|1|||
160798052|NCT01649869|580649392|FG001|Overall Study|Family member illness|0|||
160798053|NCT01649869|580649391|FG000|Overall Study|Required treatment outside protocol|1|||
160798054|NCT01649869|580649392|FG001|Overall Study|Required treatment outside protocol|0|||
160798055|NCT01649869|580649391|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
160798056|NCT01649869|580649392|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
160798057|NCT02114177|580650979|FG000|Overall Study|Lost to Follow-up|1|||
160798058|NCT02114177|580650980|FG001|Overall Study|Lost to Follow-up|2|||
160798059|NCT02114177|580650979|FG000|Overall Study|Withdrawal by Subject|6|||
160798060|NCT02114177|580650980|FG001|Overall Study|Withdrawal by Subject|1|||
160798061|NCT02114177|580650979|FG000|Overall Study|Other|2|||
160798062|NCT02114177|580650980|FG001|Overall Study|Other|1|||
160798063|NCT01897493|580650981|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
160798064|NCT00805389|580650986|FG000|Overall Study|Adverse Event|0|||
160798065|NCT00805389|580650987|FG001|Overall Study|Adverse Event|0|||
160798066|NCT00805389|580650988|FG002|Overall Study|Adverse Event|1|||
160798067|NCT00805389|580650989|FG003|Overall Study|Adverse Event|2|||
160798068|NCT00805389|580650990|FG004|Overall Study|Adverse Event|0|||
160798069|NCT00805389|580650986|FG000|Overall Study|Lost to Follow-up|4|||
160798070|NCT00805389|580650987|FG001|Overall Study|Lost to Follow-up|3|||
160798071|NCT00805389|580650988|FG002|Overall Study|Lost to Follow-up|6|||
160798072|NCT00805389|580650989|FG003|Overall Study|Lost to Follow-up|10|||
160798073|NCT00805389|580650990|FG004|Overall Study|Lost to Follow-up|9|||
161236602|NCT00837486|582246439|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
161236603|NCT00837486|582246438|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
161236604|NCT00837486|582246439|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
161236605|NCT02267187|582248339|FG000|Overall Study|Physician Decision|2|||
161236606|NCT02267187|582248339|FG000|Overall Study|Screen fail|3|||
161236607|NCT00712959|582248344|FG000|Overall Study|Protocol Violation|3|||
161236608|NCT00712959|582248345|FG001|Overall Study|Protocol Violation|1|||
161236609|NCT00712959|582248344|FG000|Overall Study|Lost to Follow-up|13|||
161236610|NCT00712959|582248345|FG001|Overall Study|Lost to Follow-up|2|||
161236611|NCT00712959|582248344|FG000|Overall Study|Withdrawal by Subject|3|||
161236612|NCT00712959|582248345|FG001|Overall Study|Withdrawal by Subject|0|||
160798074|NCT00805389|580650986|FG000|Overall Study|Protocol Violation|0|||
160798075|NCT00805389|580650987|FG001|Overall Study|Protocol Violation|0|||
160798076|NCT00805389|580650988|FG002|Overall Study|Protocol Violation|1|||
160798077|NCT00805389|580650989|FG003|Overall Study|Protocol Violation|0|||
160798078|NCT00805389|580650990|FG004|Overall Study|Protocol Violation|0|||
160798079|NCT00805389|580650986|FG000|Overall Study|Withdrawal by Subject|3|||
160798080|NCT00805389|580650987|FG001|Overall Study|Withdrawal by Subject|2|||
160798081|NCT00805389|580650988|FG002|Overall Study|Withdrawal by Subject|4|||
160798082|NCT00805389|580650989|FG003|Overall Study|Withdrawal by Subject|5|||
160798083|NCT00805389|580650990|FG004|Overall Study|Withdrawal by Subject|4|||
160798084|NCT01246960|580650991|FG000|Overall Study|Lost to Follow-up|3|||
160798085|NCT01246960|580650992|FG001|Overall Study|Lost to Follow-up|1|||
160798086|NCT01246960|580650991|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
160798087|NCT01246960|580650992|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
160798088|NCT05111145|580650995|FG000|Overall Study|Commercial drug is available for participant|76|||
160798089|NCT05111145|580650995|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
160798090|NCT02336815|580650996|FG000|Overall Study|Disease Progression|45|||
160798091|NCT02336815|580650997|FG001|Overall Study|Disease Progression|70|||
160798092|NCT02336815|580650996|FG000|Overall Study|Adverse Event|18|||
160798093|NCT02336815|580650997|FG001|Overall Study|Adverse Event|39|||
160798094|NCT02336815|580650996|FG000|Overall Study|Physician Decision|11|||
160798095|NCT02336815|580650997|FG001|Overall Study|Physician Decision|4|||
160798096|NCT02336815|580650996|FG000|Overall Study|Withdrawal by Subject|3|||
160798097|NCT02336815|580650997|FG001|Overall Study|Withdrawal by Subject|2|||
160798098|NCT02336815|580650996|FG000|Overall Study|Lost to Follow-up|1|||
160798099|NCT02336815|580650997|FG001|Overall Study|Lost to Follow-up|3|||
160798100|NCT02336815|580650996|FG000|Overall Study|Other|1|||
160798101|NCT02336815|580650997|FG001|Overall Study|Other|5|||
160798102|NCT02239926|580650998|FG000|Overall Study|Withdrawal by Subject|0|||
160798103|NCT02239926|580650999|FG001|Overall Study|Withdrawal by Subject|1|||
160798104|NCT00598650|580651000|FG000|Overall Study|Withdrawal by Subject|3|||
160798105|NCT00598650|580651000|FG000|Overall Study|Adverse Event|18|||
160798106|NCT00598650|580651000|FG000|Overall Study|No treatment for 3 weeks|1|||
160798107|NCT00598650|580651000|FG000|Overall Study|Not eligible|1|||
160798108|NCT00598650|580651000|FG000|Overall Study|Prohibited Concomitant Medication|2|||
160798109|NCT00598650|580651000|FG000|Overall Study|Physician Decision|2|||
160798110|NCT01628913|580651001|FG000|Overall Study|Adverse Event|12|||
160798111|NCT01628913|580651002|FG001|Overall Study|Adverse Event|5|||
160798112|NCT01628913|580651001|FG000|Overall Study|Disease Progression|11|||
160798113|NCT01628913|580651002|FG001|Overall Study|Disease Progression|14|||
160798114|NCT01628913|580651001|FG000|Overall Study|Protocol Violation|1|||
160798115|NCT01628913|580651002|FG001|Overall Study|Protocol Violation|0|||
160798116|NCT01628913|580651001|FG000|Overall Study|Death|1|||
160798117|NCT01628913|580651002|FG001|Overall Study|Death|0|||
160798118|NCT01628913|580651001|FG000|Overall Study|study terminated by Sponsor|4|||
160798119|NCT01628913|580651002|FG001|Overall Study|study terminated by Sponsor|9|||
160798120|NCT01628913|580651001|FG000|Overall Study|Withdrawal by Subject|1|||
160798121|NCT01628913|580651002|FG001|Overall Study|Withdrawal by Subject|0|||
160798122|NCT01628913|580651001|FG000|Overall Study|Physician Decision|1|||
160798123|NCT01628913|580651002|FG001|Overall Study|Physician Decision|3|||
160798124|NCT05201807|580651006|FG000|Overall Study|Adverse Event|1|||
160798125|NCT05201807|580651006|FG000|Overall Study|COVID-19 Related|1|||
160798126|NCT00105534|580651007|FG000|Overall Study|Adverse Event|2|||
160798127|NCT00105534|580651008|FG001|Overall Study|Adverse Event|5|||
160798128|NCT00105534|580651007|FG000|Overall Study|Protocol Violation|1|||
160798129|NCT00105534|580651008|FG001|Overall Study|Protocol Violation|4|||
160798130|NCT00105534|580651007|FG000|Overall Study|Withdrawal by Subject|6|||
160798131|NCT00105534|580651008|FG001|Overall Study|Withdrawal by Subject|6|||
160798132|NCT00105534|580651007|FG000|Overall Study|Lost to Follow-up|5|||
160798133|NCT00105534|580651008|FG001|Overall Study|Lost to Follow-up|1|||
160798134|NCT00105534|580651007|FG000|Overall Study|Lack of Efficacy|7|||
160798135|NCT00105534|580651008|FG001|Overall Study|Lack of Efficacy|15|||
160798136|NCT00105534|580651007|FG000|Overall Study|Treatment unmasked|1|||
160798137|NCT00105534|580651008|FG001|Overall Study|Treatment unmasked|0|||
160798138|NCT00105534|580651007|FG000|Overall Study|Other Reason|0|||
161236613|NCT00934050|582248349|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
161236614|NCT00934050|582248350|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
160798139|NCT00105534|580651008|FG001|Overall Study|Other Reason|2|||
160798140|NCT02465931|580651009|FG000|Overall Study|Lost to Follow-up|9|||
160798141|NCT02465931|580651010|FG001|Overall Study|Lost to Follow-up|11|||
160798142|NCT02465931|580651009|FG000|Overall Study|Protocol Violation|1|||
160798143|NCT02465931|580651010|FG001|Overall Study|Protocol Violation|0|||
160798144|NCT02465931|580651009|FG000|Overall Study|Withdrawal by Subject|1|||
160798145|NCT02465931|580651010|FG001|Overall Study|Withdrawal by Subject|0|||
160798146|NCT03423121|580651012|FG000|Overall Study|Lost to Follow-up|2|||
160798147|NCT03423121|580651013|FG001|Overall Study|Lost to Follow-up|6|||
160798148|NCT03423121|580651012|FG000|Overall Study|Adverse Event|1|||
160798149|NCT03423121|580651013|FG001|Overall Study|Adverse Event|0|||
160798150|NCT03289143|580651018|FG000|Overall Study|Caregiver Unavailability|1|||
160798151|NCT03289143|580651019|FG001|Overall Study|Caregiver Unavailability|1|||
160798152|NCT03289143|580651020|FG002|Overall Study|Caregiver Unavailability|0|||
160798153|NCT03289143|580651021|FG003|Overall Study|Caregiver Unavailability|0|||
160798154|NCT03289143|580651018|FG000|Overall Study|Research Department Closure|0|||
160798155|NCT03289143|580651019|FG001|Overall Study|Research Department Closure|0|||
160798156|NCT03289143|580651020|FG002|Overall Study|Research Department Closure|1|||
160798157|NCT03289143|580651021|FG003|Overall Study|Research Department Closure|0|||
160798158|NCT03289143|580651018|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
160798159|NCT03289143|580651019|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
160798160|NCT03289143|580651020|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
160798161|NCT03289143|580651021|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
160798162|NCT03289143|580651018|FG000|Overall Study|Medical Monitor Decision|1|||
160798163|NCT03289143|580651019|FG001|Overall Study|Medical Monitor Decision|0|||
160798164|NCT03289143|580651020|FG002|Overall Study|Medical Monitor Decision|0|||
160895017|NCT02339285|581012791|FG000|Overall Study|Lost to Follow-up|1|||
160895018|NCT02339285|581012792|FG001|Overall Study|Lost to Follow-up|1|||
160895019|NCT02339285|581012793|FG002|Overall Study|Lost to Follow-up|1|||
160895020|NCT02339285|581012791|FG000|Overall Study|Protocol Deviation|0|||
160895021|NCT02339285|581012792|FG001|Overall Study|Protocol Deviation|1|||
160798165|NCT03289143|580651021|FG003|Overall Study|Medical Monitor Decision|0|||
160798166|NCT03289143|580651018|FG000|Overall Study|Participant Non-Compliance|0|||
160798167|NCT03289143|580651019|FG001|Overall Study|Participant Non-Compliance|0|||
160798168|NCT03289143|580651020|FG002|Overall Study|Participant Non-Compliance|1|||
160798169|NCT03289143|580651021|FG003|Overall Study|Participant Non-Compliance|0|||
160798170|NCT03289143|580651018|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
160798171|NCT03289143|580651019|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
160798172|NCT03289143|580651020|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
160798173|NCT03289143|580651021|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
160798174|NCT03289143|580651018|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
160798175|NCT03289143|580651019|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
160798176|NCT03289143|580651020|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
160798177|NCT03289143|580651021|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
160798178|NCT03289143|580651018|FG000|Overall Study|Caregiver Passed Away|1|||
160798179|NCT03289143|580651019|FG001|Overall Study|Caregiver Passed Away|0|||
160798180|NCT03289143|580651020|FG002|Overall Study|Caregiver Passed Away|0|||
160798181|NCT03289143|580651021|FG003|Overall Study|Caregiver Passed Away|0|||
160798182|NCT03289143|580651018|FG000|Overall Study|Physician Decision|0|||
160798183|NCT03289143|580651019|FG001|Overall Study|Physician Decision|2|||
160798184|NCT03289143|580651020|FG002|Overall Study|Physician Decision|2|||
160798185|NCT03289143|580651021|FG003|Overall Study|Physician Decision|2|||
160798186|NCT03289143|580651018|FG000|Overall Study|Protocol Deviation|2|||
160798187|NCT03289143|580651019|FG001|Overall Study|Protocol Deviation|1|||
160798188|NCT03289143|580651020|FG002|Overall Study|Protocol Deviation|3|||
160798189|NCT03289143|580651021|FG003|Overall Study|Protocol Deviation|1|||
160798190|NCT03289143|580651018|FG000|Overall Study|Study Terminated By Sponsor|101|||
160798191|NCT03289143|580651019|FG001|Overall Study|Study Terminated By Sponsor|75|||
160798192|NCT03289143|580651020|FG002|Overall Study|Study Terminated By Sponsor|100|||
160798193|NCT03289143|580651021|FG003|Overall Study|Study Terminated By Sponsor|69|||
160798194|NCT03289143|580651018|FG000|Overall Study|Withdrawal by Subject|14|||
160798195|NCT03289143|580651019|FG001|Overall Study|Withdrawal by Subject|6|||
160798196|NCT03289143|580651020|FG002|Overall Study|Withdrawal by Subject|14|||
160798197|NCT03289143|580651021|FG003|Overall Study|Withdrawal by Subject|12|||
160895022|NCT02339285|581012793|FG002|Overall Study|Protocol Deviation|0|||
160895023|NCT00282412|581012796|FG000|Overall Study|Death|2|||
160895024|NCT01193660|581012797|FG000|Overall Study|Withdrawal by Subject|2|||
160895025|NCT01193660|581012798|FG001|Overall Study|Withdrawal by Subject|3|||
160983751|NCT04157686|581328739|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
160798198|NCT03289143|580651018|FG000|Overall Study|Adverse Event|10|||
160798199|NCT03289143|580651019|FG001|Overall Study|Adverse Event|7|||
160798200|NCT03289143|580651020|FG002|Overall Study|Adverse Event|6|||
160798201|NCT03289143|580651021|FG003|Overall Study|Adverse Event|5|||
160798202|NCT03289143|580651018|FG000|Overall Study|Death|2|||
160895026|NCT01193660|581012799|FG002|Overall Study|Withdrawal by Subject|1|||
160798203|NCT03289143|580651019|FG001|Overall Study|Death|0|||
160798204|NCT03289143|580651020|FG002|Overall Study|Death|2|||
160798205|NCT03289143|580651021|FG003|Overall Study|Death|1|||
160798206|NCT03289143|580651018|FG000|Overall Study|Lost to Follow-up|2|||
160798207|NCT03289143|580651019|FG001|Overall Study|Lost to Follow-up|1|||
160798208|NCT03289143|580651020|FG002|Overall Study|Lost to Follow-up|1|||
160798209|NCT03289143|580651021|FG003|Overall Study|Lost to Follow-up|0|||
160798210|NCT03289143|580651018|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
160798211|NCT03289143|580651019|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
160798212|NCT03289143|580651020|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
160798213|NCT03289143|580651021|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
160798214|NCT03289143|580651018|FG000|Overall Study|Withdrawal by Caregiver|0|||
160798215|NCT03289143|580651019|FG001|Overall Study|Withdrawal by Caregiver|1|||
160798216|NCT03289143|580651020|FG002|Overall Study|Withdrawal by Caregiver|0|||
160798217|NCT03289143|580651021|FG003|Overall Study|Withdrawal by Caregiver|0|||
160798218|NCT03289143|580651018|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
160798219|NCT03289143|580651019|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
160798220|NCT03289143|580651020|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
160798221|NCT03289143|580651021|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
160798222|NCT03289143|580651018|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
160798223|NCT03289143|580651019|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
160798224|NCT03289143|580651020|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
160798225|NCT03289143|580651021|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
160798226|NCT00730756|580651022|FG000|Overall Study|Adverse Event|2|||
160798227|NCT00730756|580651023|FG001|Overall Study|Adverse Event|0|||
160798228|NCT00730756|580651022|FG000|Overall Study|Lack of Efficacy|1|||
160798229|NCT00730756|580651023|FG001|Overall Study|Lack of Efficacy|1|||
160798230|NCT00730756|580651022|FG000|Overall Study|Protocol Deviation|1|||
160798231|NCT00730756|580651023|FG001|Overall Study|Protocol Deviation|2|||
160798232|NCT00730756|580651022|FG000|Overall Study|Lost to Follow-up|0|||
160798233|NCT00730756|580651023|FG001|Overall Study|Lost to Follow-up|1|||
160798234|NCT00730756|580651022|FG000|Overall Study|Withdrew Consent|0|||
160798235|NCT00730756|580651023|FG001|Overall Study|Withdrew Consent|1|||
160798236|NCT00948688|580651024|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
160798237|NCT00948688|580651025|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
160798238|NCT00948688|580651024|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
160798239|NCT00948688|580651025|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
160798240|NCT00948688|580651024|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
160798241|NCT00948688|580651025|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
160798242|NCT04388826|580651026|FG000|Overall Study|Lost to Follow-up|3|||
160798243|NCT04388826|580651027|FG001|Overall Study|Lost to Follow-up|2|||
160798244|NCT04388826|580651026|FG000|Overall Study|Adverse Event|1|||
160798245|NCT04388826|580651027|FG001|Overall Study|Adverse Event|0|||
160798246|NCT01840943|580651028|FG000|Overall Study|Withdrawal by Subject|5|||
160798247|NCT01840943|580651029|FG001|Overall Study|Withdrawal by Subject|6|||
160798248|NCT01840943|580651028|FG000|Overall Study|Physician Decision|4|||
160798249|NCT01840943|580651029|FG001|Overall Study|Physician Decision|2|||
160798250|NCT01840943|580651028|FG000|Overall Study|Lost to Follow-up|4|||
160798251|NCT01840943|580651029|FG001|Overall Study|Lost to Follow-up|4|||
160798252|NCT04573972|580651035|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
160798253|NCT04573972|580651036|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
160798254|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
160798255|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
160798256|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
160798257|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
160798258|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
160798259|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
160798260|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
161236615|NCT00934050|582248351|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161236616|NCT00934050|582248352|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
161236617|NCT00934050|582248353|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161236618|NCT00934050|582248354|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
161236619|NCT00934050|582248349|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
160798261|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
160798262|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
160798263|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
160798264|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
160798265|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
160798266|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
160798267|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
161236620|NCT00934050|582248350|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
160798268|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
160798269|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
160798270|NCT05067335|580651039|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
160798271|NCT05067335|580651040|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
160798272|NCT05067335|580651041|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
160798273|NCT05067335|580651042|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
160798274|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
160798275|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
160798276|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
160798277|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
160798278|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
160798279|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
160798280|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
160798281|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
160798282|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
160798283|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
160798284|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
160798285|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
160798286|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
160798287|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
160798288|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
160798289|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
160798290|NCT05067335|580651039|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
160798291|NCT05067335|580651040|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
160798292|NCT05067335|580651041|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
160798293|NCT05067335|580651042|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
160798294|NCT02724839|580651043|FG000|Overall Study|Withdrawal by Subject|1|||
160798295|NCT02724839|580651044|FG001|Overall Study|Withdrawal by Subject|1|||
160798296|NCT02724839|580651045|FG002|Overall Study|Withdrawal by Subject|0|||
160798297|NCT02724839|580651043|FG000|Overall Study|Lost to Follow-up|0|||
160798298|NCT02724839|580651044|FG001|Overall Study|Lost to Follow-up|3|||
160798299|NCT02724839|580651045|FG002|Overall Study|Lost to Follow-up|2|||
160798300|NCT02724839|580651043|FG000|Overall Study|Physician Decision|0|||
160798301|NCT02724839|580651044|FG001|Overall Study|Physician Decision|0|||
160798302|NCT02724839|580651045|FG002|Overall Study|Physician Decision|3|||
160798303|NCT03610048|580651046|FG000|Overall Study|Study terminated by sponsor|84|||
160798304|NCT03610048|580651046|FG000|Overall Study|Adverse Event|32|||
160798305|NCT03610048|580651046|FG000|Overall Study|Withdrawal by Subject|31|||
160798306|NCT03610048|580651046|FG000|Overall Study|Lost to Follow-up|8|||
160798307|NCT03610048|580651046|FG000|Overall Study|Other|4|||
160798308|NCT03610048|580651046|FG000|Overall Study|Physician Decision|1|||
160798309|NCT03610048|580651046|FG000|Overall Study|Pregnancy|1|||
160798310|NCT01155050|580651048|FG000|Overall Study|Lost to Follow-up|15|||
160798311|NCT01155050|580651049|FG001|Overall Study|Lost to Follow-up|20|||
160798312|NCT01155050|580651050|FG002|Overall Study|Lost to Follow-up|19|||
160798313|NCT01155050|580651051|FG003|Overall Study|Lost to Follow-up|22|||
160798314|NCT01146613|580651052|FG000|Overall Study|Lost to Follow-up|3|||
160798315|NCT01146613|580651053|FG001|Overall Study|Lost to Follow-up|8|||
160798316|NCT01146613|580651052|FG000|Overall Study|Lack of Efficacy|0|||
160798317|NCT01146613|580651053|FG001|Overall Study|Lack of Efficacy|1|||
160798318|NCT01146613|580651052|FG000|Overall Study|Death|1|||
160798319|NCT01146613|580651053|FG001|Overall Study|Death|0|||
160798320|NCT01146613|580651052|FG000|Overall Study|Physician Decision|1|||
160798321|NCT01146613|580651053|FG001|Overall Study|Physician Decision|0|||
160798322|NCT01146613|580651052|FG000|Overall Study|Withdrawal by Subject|0|||
160798323|NCT01146613|580651053|FG001|Overall Study|Withdrawal by Subject|3|||
160798324|NCT01146613|580651052|FG000|Overall Study|schedule conflict|1|||
160798325|NCT01146613|580651053|FG001|Overall Study|schedule conflict|0|||
160798326|NCT01146613|580651052|FG000|Overall Study|Outpatient detox|1|||
160798327|NCT01146613|580651053|FG001|Overall Study|Outpatient detox|0|||
161236621|NCT00934050|582248351|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
160798328|NCT02136914|580651054|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
160798329|NCT02136914|580651055|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
160798330|NCT02136914|580651054|FG000|Overall Study|Withdrawal by Subject|3|||
160798331|NCT02136914|580651055|FG001|Overall Study|Withdrawal by Subject|10|||
160798332|NCT02136914|580651054|FG000|Overall Study|Subject Unwilling to Proceed|7|||
160798333|NCT02136914|580651055|FG001|Overall Study|Subject Unwilling to Proceed|2|||
160798334|NCT02136914|580651054|FG000|Overall Study|Lost to Follow-up|1|||
160798335|NCT02136914|580651055|FG001|Overall Study|Lost to Follow-up|1|||
160798336|NCT02136914|580651054|FG000|Overall Study|Did Not Receive Study Drug|2|||
160798337|NCT02136914|580651055|FG001|Overall Study|Did Not Receive Study Drug|0|||
160798338|NCT02136914|580651054|FG000|Overall Study|Lack of Efficacy|1|||
160798339|NCT02136914|580651055|FG001|Overall Study|Lack of Efficacy|0|||
160798340|NCT02136914|580651054|FG000|Overall Study|Death|0|||
160798341|NCT02136914|580651055|FG001|Overall Study|Death|1|||
160798342|NCT05878067|580651058|FG000|Overall Study|Lost to Follow-up|2|||
160798343|NCT00949533|580651059|FG000|Overall Study|Lost to Follow-up|0|||
160798344|NCT00949533|580651060|FG001|Overall Study|Lost to Follow-up|1|||
160798345|NCT01493089|580651063|FG000|Overall Study|Protocol Violation|2|||
160798346|NCT01493089|580651064|FG001|Overall Study|Protocol Violation|2|||
160798347|NCT01493089|580651063|FG000|Overall Study|Withdrawal by Subject|1|||
160798348|NCT01493089|580651064|FG001|Overall Study|Withdrawal by Subject|0|||
160798349|NCT01493089|580651063|FG000|Overall Study|Physician Decision|0|||
160798350|NCT01493089|580651064|FG001|Overall Study|Physician Decision|1|||
160798351|NCT02234362|580651065|FG000|Overall Study|Not eligible after first screening visit|17|||
160798352|NCT02234362|580651065|FG000|Overall Study|Lost to Follow-up|6|||
160798353|NCT02234362|580651065|FG000|Overall Study|Withdrawal by Subject|3|||
160798354|NCT00329030|580651066|FG000|Overall Study|Withdrawal by Subject|1|||
161236622|NCT00934050|582248352|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
161236623|NCT00934050|582248353|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
161236624|NCT00934050|582248354|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
161236625|NCT00934050|582248349|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161236626|NCT00934050|582248350|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161236627|NCT00934050|582248351|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
161236628|NCT00934050|582248352|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161236629|NCT00934050|582248353|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161236630|NCT00934050|582248354|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
161236631|NCT00934050|582248349|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
161236632|NCT00934050|582248350|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
161236633|NCT00934050|582248351|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
161236634|NCT00934050|582248352|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
161236635|NCT00934050|582248353|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
161236636|NCT00934050|582248354|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
161236637|NCT00934050|582248349|FG000|Enrolled After 15 Dec 2009|Death|0|||
160798355|NCT00329030|580651067|FG001|Overall Study|Withdrawal by Subject|3|||
160798356|NCT00329030|580651066|FG000|Overall Study|Progressive Disease|6|||
160798357|NCT00329030|580651067|FG001|Overall Study|Progressive Disease|2|||
160798358|NCT00329030|580651066|FG000|Overall Study|Ineligible Pathology|1|||
160798359|NCT00329030|580651067|FG001|Overall Study|Ineligible Pathology|1|||
160798360|NCT00560417|580651075|FG000|Overall Study|Adverse Event|3|||
160798361|NCT00560417|580651076|FG001|Overall Study|Adverse Event|2|||
160798362|NCT00560417|580651075|FG000|Overall Study|Entry Criteria Not Met|1|||
160798363|NCT00560417|580651076|FG001|Overall Study|Entry Criteria Not Met|0|||
160798364|NCT00560417|580651075|FG000|Overall Study|Lost to Follow-up|0|||
160798365|NCT00560417|580651076|FG001|Overall Study|Lost to Follow-up|1|||
160798366|NCT00560417|580651075|FG000|Overall Study|Physician Decision|2|||
160798367|NCT00560417|580651076|FG001|Overall Study|Physician Decision|6|||
160798368|NCT00560417|580651075|FG000|Overall Study|Protocol Violation|6|||
160895027|NCT01193660|581012797|FG000|Overall Study|Death|1|||
160895028|NCT01193660|581012798|FG001|Overall Study|Death|0|||
160895029|NCT01193660|581012799|FG002|Overall Study|Death|0|||
160895030|NCT01193660|581012797|FG000|Overall Study|Physician Decision|1|||
160895031|NCT01193660|581012798|FG001|Overall Study|Physician Decision|0|||
160895032|NCT01193660|581012799|FG002|Overall Study|Physician Decision|1|||
160895033|NCT01886716|581012800|FG000|Week 1|Lost to Follow-up|0|||
160895034|NCT01886716|581012801|FG001|Week 1|Lost to Follow-up|0|||
160895035|NCT01886716|581012802|FG002|Week 1|Lost to Follow-up|2|||
160895036|NCT01886716|581012803|FG003|Week 1|Lost to Follow-up|2|||
160895037|NCT01886716|581012800|FG000|Week 2|Lost to Follow-up|3|||
160895038|NCT01886716|581012801|FG001|Week 2|Lost to Follow-up|2|||
160895039|NCT01886716|581012802|FG002|Week 2|Lost to Follow-up|1|||
160895040|NCT01886716|581012803|FG003|Week 2|Lost to Follow-up|3|||
160895041|NCT01886716|581012800|FG000|Week 3|Lost to Follow-up|1|||
160895042|NCT01886716|581012801|FG001|Week 3|Lost to Follow-up|1|||
160895043|NCT01886716|581012802|FG002|Week 3|Lost to Follow-up|0|||
160895044|NCT01886716|581012803|FG003|Week 3|Lost to Follow-up|1|||
160895045|NCT04806503|581012808|FG000|Overall Study|Lost to Follow-up|0|||
160895046|NCT04806503|581012809|FG001|Overall Study|Lost to Follow-up|0|||
160895047|NCT04806503|581012810|FG002|Overall Study|Lost to Follow-up|1|||
160895048|NCT04806503|581012811|FG003|Overall Study|Lost to Follow-up|0|||
160798369|NCT00560417|580651076|FG001|Overall Study|Protocol Violation|5|||
160798370|NCT00560417|580651075|FG000|Overall Study|Sponsor Decision|2|||
160895049|NCT04806503|581012812|FG004|Overall Study|Lost to Follow-up|0|||
160895050|NCT04806503|581012808|FG000|Overall Study|Withdrawal by Subject|1|||
161236638|NCT00934050|582248350|FG001|Enrolled After 15 Dec 2009|Death|0|||
161236639|NCT00934050|582248351|FG002|Enrolled After 15 Dec 2009|Death|0|||
161236640|NCT00934050|582248352|FG003|Enrolled After 15 Dec 2009|Death|0|||
161236641|NCT00934050|582248353|FG004|Enrolled After 15 Dec 2009|Death|0|||
161236642|NCT00934050|582248354|FG005|Enrolled After 15 Dec 2009|Death|1|||
161236643|NCT00934050|582248349|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161236644|NCT00934050|582248350|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161236645|NCT00934050|582248351|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161236646|NCT00934050|582248352|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161236647|NCT00934050|582248353|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
161236648|NCT00934050|582248354|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
161236649|NCT00934050|582248349|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161236650|NCT00934050|582248350|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161236651|NCT00934050|582248351|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161236652|NCT00934050|582248352|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
161236653|NCT00934050|582248353|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
161236654|NCT00934050|582248354|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
161236655|NCT00834067|582248357|FG000|Washout of 21 Days|Protocol Violation|0|||
161236656|NCT00834067|582248358|FG001|Washout of 21 Days|Protocol Violation|1|||
161236657|NCT00418561|582248359|FG000|Overall Study|Participant's (guardian's) decision|0|||
161236658|NCT00418561|582248360|FG001|Overall Study|Participant's (guardian's) decision|1|||
161236659|NCT00418561|582248361|FG002|Overall Study|Participant's (guardian's) decision|0|||
161236660|NCT01796171|582248362|FG000|Enrolled|Death|0|||
161236661|NCT01796171|582248363|FG001|Enrolled|Death|0|||
161236662|NCT01796171|582248364|FG002|Enrolled|Death|0|||
161236663|NCT01796171|582248365|FG003|Enrolled|Death|0|||
161236664|NCT01796171|582248366|FG004|Enrolled|Death|0|||
161236665|NCT01796171|582248367|FG005|Enrolled|Death|0|||
161236666|NCT01796171|582248368|FG006|Enrolled|Death|0|||
161236667|NCT01796171|582248369|FG007|Enrolled|Death|0|||
161236668|NCT01796171|582248370|FG008|Enrolled|Death|0|||
161236669|NCT01796171|582248371|FG009|Enrolled|Death|0|||
161331339|NCT02718911|582598848|FG004|Overall Study|Reason Not Collected|0|||
161331340|NCT02718911|582598849|FG005|Overall Study|Reason Not Collected|0|||
161331341|NCT02718911|582598850|FG006|Overall Study|Reason Not Collected|2|||
160895051|NCT04806503|581012809|FG001|Overall Study|Withdrawal by Subject|0|||
160895052|NCT04806503|581012810|FG002|Overall Study|Withdrawal by Subject|1|||
160895053|NCT04806503|581012811|FG003|Overall Study|Withdrawal by Subject|1|||
160895054|NCT04806503|581012812|FG004|Overall Study|Withdrawal by Subject|1|||
160895055|NCT04806503|581012808|FG000|Overall Study|Adverse Event|1|||
160895056|NCT04806503|581012809|FG001|Overall Study|Adverse Event|1|||
160895057|NCT04806503|581012810|FG002|Overall Study|Adverse Event|0|||
160895058|NCT04806503|581012811|FG003|Overall Study|Adverse Event|1|||
160895059|NCT04806503|581012812|FG004|Overall Study|Adverse Event|0|||
160895060|NCT03589469|581012813|FG000|Overall Study|Withdrawal by Subject|8|||
160895061|NCT03589469|581012813|FG000|Overall Study|Physician Decision|20|||
160895062|NCT03589469|581012813|FG000|Overall Study|Death|97|||
160895063|NCT03589469|581012813|FG000|Overall Study|Lost to Follow-up|8|||
160895064|NCT03589469|581012813|FG000|Overall Study|Miscellaneous|1|||
160895065|NCT00639678|581012818|FG000|Overall Study|Withdrawal by Subject|3|||
160895066|NCT00639678|581012819|FG001|Overall Study|Withdrawal by Subject|0|||
160895067|NCT00639678|581012820|FG002|Overall Study|Withdrawal by Subject|4|||
160895068|NCT00639678|581012821|FG003|Overall Study|Withdrawal by Subject|0|||
160895069|NCT00639678|581012818|FG000|Overall Study|Lost to Follow-up|1|||
160895070|NCT00639678|581012819|FG001|Overall Study|Lost to Follow-up|0|||
160895071|NCT00639678|581012820|FG002|Overall Study|Lost to Follow-up|6|||
160895072|NCT00639678|581012821|FG003|Overall Study|Lost to Follow-up|0|||
160895073|NCT00639678|581012818|FG000|Overall Study|Adverse Event|0|||
160895074|NCT00639678|581012819|FG001|Overall Study|Adverse Event|1|||
160895075|NCT00639678|581012820|FG002|Overall Study|Adverse Event|0|||
160895076|NCT00639678|581012821|FG003|Overall Study|Adverse Event|0|||
160895077|NCT00639678|581012818|FG000|Overall Study|Lack of Compliance|0|||
160895078|NCT00639678|581012819|FG001|Overall Study|Lack of Compliance|0|||
160895079|NCT00639678|581012820|FG002|Overall Study|Lack of Compliance|1|||
160895080|NCT00639678|581012821|FG003|Overall Study|Lack of Compliance|0|||
160895081|NCT01973569|581012822|FG000|Overall Study|Adverse Event|9|||
160895082|NCT01973569|581012823|FG001|Overall Study|Adverse Event|2|||
160895083|NCT01973569|581012824|FG002|Overall Study|Adverse Event|4|||
160895084|NCT01973569|581012822|FG000|Overall Study|Protocol Violation|2|||
160895085|NCT01973569|581012823|FG001|Overall Study|Protocol Violation|1|||
160895086|NCT01973569|581012824|FG002|Overall Study|Protocol Violation|3|||
160895087|NCT01973569|581012822|FG000|Overall Study|Withdrawal by Subject|7|||
160895088|NCT01973569|581012823|FG001|Overall Study|Withdrawal by Subject|5|||
160895089|NCT01973569|581012824|FG002|Overall Study|Withdrawal by Subject|2|||
160895090|NCT01973569|581012822|FG000|Overall Study|Invasive dental treatment|3|||
160895091|NCT01973569|581012823|FG001|Overall Study|Invasive dental treatment|5|||
161236670|NCT01796171|582248372|FG010|Enrolled|Death|0|||
161236671|NCT01796171|582248373|FG011|Enrolled|Death|0|||
161236672|NCT01796171|582248374|FG012|Enrolled|Death|0|||
161236673|NCT01796171|582248375|FG013|Enrolled|Death|0|||
161236674|NCT01796171|582248376|FG014|Enrolled|Death|1|||
161236675|NCT01796171|582248362|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
161236676|NCT01796171|582248363|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
161236677|NCT01796171|582248364|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
161236678|NCT01796171|582248365|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
161236679|NCT01796171|582248366|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
161236680|NCT01796171|582248367|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
161236681|NCT01796171|582248368|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
161236682|NCT01796171|582248369|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
161236683|NCT01796171|582248370|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
161236684|NCT01796171|582248371|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
161236685|NCT01796171|582248372|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
161236686|NCT01796171|582248373|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
161236687|NCT01796171|582248374|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
161236688|NCT01796171|582248375|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
161236689|NCT01796171|582248376|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
161236690|NCT01796171|582248362|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236691|NCT01796171|582248363|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236692|NCT01796171|582248364|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236693|NCT01796171|582248365|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236694|NCT01796171|582248366|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236695|NCT01796171|582248367|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236696|NCT01796171|582248368|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236697|NCT01796171|582248369|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236698|NCT01796171|582248370|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236699|NCT01796171|582248371|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236700|NCT01796171|582248372|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236701|NCT01796171|582248373|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236702|NCT01796171|582248374|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236703|NCT01796171|582248375|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
161236704|NCT01796171|582248376|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
161236705|NCT01796171|582248362|FG000|Treatment Period With Betalutin|Progressive disease|0|||
161236706|NCT01796171|582248363|FG001|Treatment Period With Betalutin|Progressive disease|1|||
160798371|NCT00560417|580651076|FG001|Overall Study|Sponsor Decision|0|||
160798372|NCT00560417|580651075|FG000|Overall Study|Withdrawal by Subject|3|||
160798373|NCT00560417|580651076|FG001|Overall Study|Withdrawal by Subject|3|||
160798374|NCT02164864|580651079|FG000|Overall Study|Trial disease worsening|7|||
160798375|NCT02164864|580651080|FG001|Overall Study|Trial disease worsening|5|||
160798376|NCT02164864|580651081|FG002|Overall Study|Trial disease worsening|1|||
160798377|NCT02164864|580651079|FG000|Overall Study|Other pre-existing disease worsening|6|||
160798378|NCT02164864|580651080|FG001|Overall Study|Other pre-existing disease worsening|4|||
160798379|NCT02164864|580651081|FG002|Overall Study|Other pre-existing disease worsening|9|||
160798380|NCT02164864|580651079|FG000|Overall Study|Other Adverse Event (AE)|52|||
160798381|NCT02164864|580651080|FG001|Overall Study|Other Adverse Event (AE)|32|||
160798382|NCT02164864|580651081|FG002|Overall Study|Other Adverse Event (AE)|49|||
161129569|NCT02631538|581860876|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
160798383|NCT02164864|580651079|FG000|Overall Study|Protocol Violation|2|||
160798384|NCT02164864|580651080|FG001|Overall Study|Protocol Violation|4|||
160798385|NCT02164864|580651081|FG002|Overall Study|Protocol Violation|1|||
160798386|NCT02164864|580651079|FG000|Overall Study|Lost to Follow-up|4|||
160798387|NCT02164864|580651080|FG001|Overall Study|Lost to Follow-up|3|||
161129570|NCT02631538|581860873|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
161129571|NCT02631538|581860874|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
161129572|NCT02631538|581860875|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
161129573|NCT02631538|581860876|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
161129574|NCT00440726|581860877|FG000|Phase 1|Dose-Limiting Toxicity|0|||
161129575|NCT00440726|581860878|FG001|Phase 1|Dose-Limiting Toxicity|1|||
161129576|NCT00440726|581860879|FG002|Phase 1|Dose-Limiting Toxicity|0|||
161129577|NCT00440726|581860877|FG000|Phase 1|Physician Decision|1|||
161129578|NCT00440726|581860878|FG001|Phase 1|Physician Decision|0|||
161129579|NCT00440726|581860879|FG002|Phase 1|Physician Decision|0|||
161129580|NCT00440726|581860877|FG000|Phase 2|Death|0|||
161129581|NCT00440726|581860878|FG001|Phase 2|Death|0|||
161129582|NCT00440726|581860879|FG002|Phase 2|Death|1|||
161236707|NCT01796171|582248364|FG002|Treatment Period With Betalutin|Progressive disease|0|||
161236708|NCT01796171|582248365|FG003|Treatment Period With Betalutin|Progressive disease|0|||
160895092|NCT01973569|581012824|FG002|Overall Study|Invasive dental treatment|6|||
160895093|NCT01973569|581012822|FG000|Overall Study|Prohibited concomitant d|1|||
160895094|NCT01973569|581012823|FG001|Overall Study|Prohibited concomitant d|5|||
160895095|NCT01973569|581012824|FG002|Overall Study|Prohibited concomitant d|0|||
160798388|NCT02164864|580651081|FG002|Overall Study|Lost to Follow-up|2|||
160798389|NCT02164864|580651079|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
160895096|NCT01973569|581012822|FG000|Overall Study|Disease progression|0|||
160798390|NCT02164864|580651080|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
161129583|NCT00440726|581860877|FG000|Phase 2|Adverse Event|0|||
161129584|NCT00440726|581860878|FG001|Phase 2|Adverse Event|0|||
161129585|NCT00440726|581860879|FG002|Phase 2|Adverse Event|1|||
161236709|NCT01796171|582248366|FG004|Treatment Period With Betalutin|Progressive disease|0|||
161236710|NCT01796171|582248367|FG005|Treatment Period With Betalutin|Progressive disease|0|||
161236711|NCT01796171|582248368|FG006|Treatment Period With Betalutin|Progressive disease|0|||
161236712|NCT01796171|582248369|FG007|Treatment Period With Betalutin|Progressive disease|0|||
161236713|NCT01796171|582248370|FG008|Treatment Period With Betalutin|Progressive disease|0|||
161236714|NCT01796171|582248371|FG009|Treatment Period With Betalutin|Progressive disease|0|||
161236715|NCT01796171|582248372|FG010|Treatment Period With Betalutin|Progressive disease|0|||
161236716|NCT01796171|582248373|FG011|Treatment Period With Betalutin|Progressive disease|0|||
161236717|NCT01796171|582248374|FG012|Treatment Period With Betalutin|Progressive disease|0|||
161236718|NCT01796171|582248375|FG013|Treatment Period With Betalutin|Progressive disease|0|||
161236719|NCT01796171|582248376|FG014|Treatment Period With Betalutin|Progressive disease|0|||
161236720|NCT01796171|582248362|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236721|NCT01796171|582248363|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236722|NCT01796171|582248364|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236723|NCT01796171|582248365|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236724|NCT01796171|582248366|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236725|NCT01796171|582248367|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236726|NCT01796171|582248368|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236727|NCT01796171|582248369|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236728|NCT01796171|582248370|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161331342|NCT02718911|582598851|FG007|Overall Study|Reason Not Collected|1|||
161331343|NCT02718911|582598852|FG008|Overall Study|Reason Not Collected|4|||
161331344|NCT02718911|582598853|FG009|Overall Study|Reason Not Collected|9|||
161331345|NCT04817332|582598854|FG000|Overall Study|Lost to Follow-up|3|||
161331346|NCT04817332|582598855|FG001|Overall Study|Lost to Follow-up|3|||
161331347|NCT04817332|582598854|FG000|Overall Study|Protocol Violation|2|||
161331348|NCT04817332|582598855|FG001|Overall Study|Protocol Violation|0|||
161331349|NCT01867008|582598858|FG000|Overall Study|Withdrawal by Subject|1|||
161331350|NCT00983372|582598859|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
161331351|NCT00983372|582598859|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
161331352|NCT00983372|582598859|FG000|Diltiazem ER Alone|Adverse Event|1|||
161331353|NCT05635045|582598860|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161331354|NCT05635045|582598861|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161331355|NCT05635045|582598862|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
161331356|NCT05635045|582598863|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
161331357|NCT01158261|582598872|FG000|Overall Study|Lost to Follow-up|9|||
161331358|NCT01158261|582598872|FG000|Overall Study|Death|7|||
161331359|NCT01158261|582598872|FG000|Overall Study|Withdrawal by Subject|1|||
161331360|NCT03143101|582598873|FG000|Overall Study|Withdrawal by Subject|0|||
161331361|NCT03143101|582598874|FG001|Overall Study|Withdrawal by Subject|1|||
161331362|NCT03143101|582598875|FG002|Overall Study|Withdrawal by Subject|0|||
161331363|NCT03143101|582598873|FG000|Overall Study|Lost to Follow-up|2|||
161331364|NCT03143101|582598874|FG001|Overall Study|Lost to Follow-up|2|||
161331365|NCT03143101|582598875|FG002|Overall Study|Lost to Follow-up|0|||
161331366|NCT03727841|582598878|FG000|Overall Study|Physician Decision|3|||
161331367|NCT03727841|582598879|FG001|Overall Study|Physician Decision|1|||
161331368|NCT01601496|582598880|FG000|Overall Study|Physician Decision|1|||
161331369|NCT01601496|582598880|FG000|Overall Study|Withdrawal by Subject|1|||
161331370|NCT01601496|582598880|FG000|Overall Study|Lost to Follow-up|6|||
161331371|NCT01601496|582598880|FG000|Overall Study|Death|4|||
161331372|NCT01601496|582598880|FG000|Overall Study|Other: patient refusal to continue|3|||
161331373|NCT03126786|582598881|FG000|Overall Study|Adverse Event|3|||
160895097|NCT01973569|581012823|FG001|Overall Study|Disease progression|3|||
161331374|NCT03126786|582598882|FG001|Overall Study|Adverse Event|0|||
161331375|NCT03126786|582598881|FG000|Overall Study|Lost to Follow-up|0|||
161331376|NCT03126786|582598882|FG001|Overall Study|Lost to Follow-up|1|||
161331377|NCT03126786|582598881|FG000|Overall Study|Withdrawal by Subject|3|||
160798391|NCT02164864|580651081|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
160798392|NCT02164864|580651079|FG000|Overall Study|Other than stated|3|||
160798393|NCT02164864|580651080|FG001|Overall Study|Other than stated|4|||
160798394|NCT02164864|580651081|FG002|Overall Study|Other than stated|14|||
160798395|NCT03036852|580651082|FG000|Overall Study|Death|2|||
160798396|NCT03036852|580651082|FG000|Overall Study|Lack of Efficacy|2|||
160798397|NCT03036852|580651082|FG000|Overall Study|Adverse Event|1|||
160798398|NCT03036852|580651082|FG000|Overall Study|Lost to Follow-up|1|||
160798399|NCT00652834|580651083|FG000|Overall Study|Withdrawal by Subject|3|||
160798400|NCT00652834|580651083|FG000|Overall Study|Lost to Follow-up|2|||
160798401|NCT00320606|580651084|FG000|Overall Study|Adverse Event|1|||
160798402|NCT00320606|580651084|FG000|Overall Study|Protocol Violation|1|||
160798403|NCT00320606|580651084|FG000|Overall Study|Withdrawal by Subject|1|||
160798404|NCT03984825|580651085|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
161129586|NCT00331006|581860886|FG000|Screening Phase|Withdrawal by Subject|1|||
160895098|NCT01973569|581012824|FG002|Overall Study|Disease progression|0|||
160895099|NCT01973569|581012822|FG000|Overall Study|Other|1|||
160895100|NCT01973569|581012823|FG001|Overall Study|Other|1|||
160895101|NCT01973569|581012824|FG002|Overall Study|Other|0|||
161129587|NCT00331006|581860886|FG000|Screening Phase|enrollment halted|1|||
160895102|NCT01973569|581012822|FG000|Overall Study|Did not receive study drug|6|||
160895103|NCT01973569|581012823|FG001|Overall Study|Did not receive study drug|3|||
160895104|NCT01973569|581012824|FG002|Overall Study|Did not receive study drug|3|||
160895105|NCT00371826|581012825|FG000|Core Phase (12 Months)|Adverse Event|15|||
160895106|NCT00371826|581012826|FG001|Core Phase (12 Months)|Adverse Event|4|||
160895107|NCT00371826|581012827|FG002|Core Phase (12 Months)|Adverse Event|9|||
160895108|NCT00371826|581012825|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
160895109|NCT00371826|581012826|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
161129588|NCT00331006|581860886|FG000|Screening Phase|Lost to Follow-up|1|||
161129589|NCT00331006|581860886|FG000|Screening Phase|Ineligible for treatment phase|4|||
161129590|NCT00331006|581860886|FG000|Treatment Phase|Withdrawal by Subject|1|||
161129591|NCT00331006|581860886|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
161129592|NCT00331006|581860886|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
161129593|NCT03183128|581860887|FG000|Overall Study|Adverse Event|1|||
161129594|NCT03183128|581860888|FG001|Overall Study|Adverse Event|2|||
161129595|NCT03183128|581860887|FG000|Overall Study|Withdrawal by Subject|1|||
161129596|NCT03183128|581860888|FG001|Overall Study|Withdrawal by Subject|8|||
161129597|NCT03183128|581860887|FG000|Overall Study|Protocol Violation|2|||
161129598|NCT03183128|581860888|FG001|Overall Study|Protocol Violation|0|||
161129599|NCT03183128|581860887|FG000|Overall Study|Lack of Efficacy|4|||
161129600|NCT03183128|581860888|FG001|Overall Study|Lack of Efficacy|27|||
161129601|NCT03183128|581860887|FG000|Overall Study|Lost to Follow-up|1|||
161129602|NCT03183128|581860888|FG001|Overall Study|Lost to Follow-up|0|||
161129603|NCT03183128|581860887|FG000|Overall Study|Death|2|||
161129604|NCT03183128|581860888|FG001|Overall Study|Death|0|||
161129605|NCT03183128|581860887|FG000|Overall Study|Physician Decision|1|||
161129606|NCT03183128|581860888|FG001|Overall Study|Physician Decision|0|||
161129607|NCT01413958|581860889|FG000|Overall Study|Lost to Follow-up|0|||
161129608|NCT01413958|581860890|FG001|Overall Study|Lost to Follow-up|1|||
161129609|NCT02908516|581860891|FG000|Overall Study|Study Terminated|3|||
161129610|NCT02908516|581860892|FG001|Overall Study|Study Terminated|3|||
161129611|NCT01225562|581860895|FG000|Overall Study|Withdrawal by Subject|52|||
161129612|NCT01225562|581860896|FG001|Overall Study|Withdrawal by Subject|50|||
161129613|NCT01225562|581860897|FG002|Overall Study|Withdrawal by Subject|52|||
161129614|NCT01225562|581860895|FG000|Overall Study|Lost to Follow-up|3|||
161129615|NCT01225562|581860896|FG001|Overall Study|Lost to Follow-up|6|||
161129616|NCT01225562|581860897|FG002|Overall Study|Lost to Follow-up|1|||
161129617|NCT02928952|581860898|FG000|Overall Study|Lost to Follow-up|5|||
161129618|NCT02928952|581860899|FG001|Overall Study|Lost to Follow-up|5|||
161129619|NCT02928952|581860898|FG000|Overall Study|Withdrawal by Subject|5|||
161129620|NCT02928952|581860899|FG001|Overall Study|Withdrawal by Subject|1|||
161129621|NCT02928952|581860898|FG000|Overall Study|Physician Decision|0|||
161129622|NCT02928952|581860899|FG001|Overall Study|Physician Decision|1|||
161129623|NCT02266433|581860900|FG000|Overall Study|Lost to Follow-up|54|||
161129624|NCT02266433|581860901|FG001|Overall Study|Lost to Follow-up|46|||
161129625|NCT02266433|581860900|FG000|Overall Study|Withdrawal by Subject|5|||
161129626|NCT02266433|581860901|FG001|Overall Study|Withdrawal by Subject|7|||
161129627|NCT01375764|581860903|FG000|Overall Study|Lost to Follow-up|0|||
161129628|NCT01375764|581860904|FG001|Overall Study|Lost to Follow-up|1|||
161129629|NCT01375764|581860905|FG002|Overall Study|Lost to Follow-up|0|||
161129630|NCT01375764|581860906|FG003|Overall Study|Lost to Follow-up|0|||
161129631|NCT01375764|581860907|FG004|Overall Study|Lost to Follow-up|0|||
161129632|NCT01375764|581860903|FG000|Overall Study|Withdrawal by Subject|2|||
161129633|NCT01375764|581860904|FG001|Overall Study|Withdrawal by Subject|0|||
161129634|NCT01375764|581860905|FG002|Overall Study|Withdrawal by Subject|0|||
161129635|NCT01375764|581860906|FG003|Overall Study|Withdrawal by Subject|0|||
161129636|NCT01375764|581860907|FG004|Overall Study|Withdrawal by Subject|1|||
161257888|NCT03756883|582323519|FG001|Overall Study|Lack of Efficacy|1|||
161129637|NCT01375764|581860903|FG000|Overall Study|Other|0|||
161129638|NCT01375764|581860904|FG001|Overall Study|Other|0|||
161129639|NCT01375764|581860905|FG002|Overall Study|Other|0|||
161129640|NCT01375764|581860906|FG003|Overall Study|Other|1|||
161129641|NCT01375764|581860907|FG004|Overall Study|Other|0|||
161129642|NCT02445586|581860910|FG000|Overall Study|Death|14|||
161129643|NCT02445586|581860910|FG000|Overall Study|Withdrawal by Subject|13|||
161129644|NCT02445586|581860910|FG000|Overall Study|Disease Progression|10|||
161129645|NCT02445586|581860910|FG000|Overall Study|Protocol Violation|1|||
161129646|NCT02445586|581860910|FG000|Overall Study|Medical Condition|1|||
161129647|NCT01194440|581860911|FG000|Baseline (First Dose)|Reason not specified|4|||
161129648|NCT01194440|581860911|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
160895110|NCT00371826|581012827|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
161129649|NCT01194440|581860911|FG000|Baseline (First Dose)|Change in therapy|1|||
161129650|NCT01194440|581860911|FG000|Baseline (First Dose)|Adverse Event|1|||
161236729|NCT01796171|582248371|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236730|NCT01796171|582248372|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161236731|NCT01796171|582248373|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
161236732|NCT01796171|582248374|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236733|NCT01796171|582248375|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236734|NCT01796171|582248376|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
161236735|NCT01796171|582248362|FG000|Treatment Period With Betalutin|Physician Decision|0|||
161236736|NCT01796171|582248363|FG001|Treatment Period With Betalutin|Physician Decision|0|||
161257889|NCT03756883|582323520|FG002|Overall Study|Lack of Efficacy|2|||
161257890|NCT03756883|582323518|FG000|Overall Study|Lost to Follow-up|3|||
160798405|NCT03984825|580651085|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
160798406|NCT03984825|580651085|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
160895111|NCT00371826|581012825|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
160895112|NCT00371826|581012826|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
160895113|NCT00371826|581012827|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
160895114|NCT00371826|581012825|FG000|Core Phase (12 Months)|Protocol Violation|1|||
160895115|NCT00371826|581012826|FG001|Core Phase (12 Months)|Protocol Violation|0|||
160895116|NCT00371826|581012827|FG002|Core Phase (12 Months)|Protocol Violation|1|||
160895117|NCT00371826|581012825|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
160895118|NCT00371826|581012826|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
160895119|NCT00371826|581012827|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
160895120|NCT00371826|581012825|FG000|Core Phase (12 Months)|Administrative problems|1|||
160895121|NCT00371826|581012826|FG001|Core Phase (12 Months)|Administrative problems|0|||
160895122|NCT00371826|581012827|FG002|Core Phase (12 Months)|Administrative problems|8|||
160895123|NCT00371826|581012825|FG000|Core Phase (12 Months)|Graft Loss|0|||
160895124|NCT00371826|581012826|FG001|Core Phase (12 Months)|Graft Loss|1|||
160895125|NCT00371826|581012827|FG002|Core Phase (12 Months)|Graft Loss|0|||
160895126|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Adverse Event|4|||
160895127|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Adverse Event|5|||
160895128|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Adverse Event|0|||
160895129|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
160895130|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
160895131|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
160895132|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
160895133|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
160895134|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
160895135|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
160895136|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
160895137|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
160895138|NCT00371826|581012825|FG000|Extension Phase (24 Months)|Administrative problems|0|||
160798407|NCT00261833|580651086|FG000|Overall Study|Death|1|||
160798408|NCT00261833|580651087|FG001|Overall Study|Death|3|||
160798409|NCT00261833|580651086|FG000|Overall Study|Adverse Event|1|||
160798410|NCT00261833|580651087|FG001|Overall Study|Adverse Event|4|||
160798411|NCT00261833|580651086|FG000|Overall Study|Withdrawal by Subject|5|||
160798412|NCT00261833|580651087|FG001|Overall Study|Withdrawal by Subject|7|||
160798413|NCT00261833|580651086|FG000|Overall Study|Protocol Violation|0|||
160798414|NCT00261833|580651087|FG001|Overall Study|Protocol Violation|1|||
160798415|NCT00261833|580651086|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
160798416|NCT00261833|580651087|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
160798417|NCT00261833|580651086|FG000|Overall Study|Lung transplantation|1|||
160798418|NCT00261833|580651087|FG001|Overall Study|Lung transplantation|1|||
160798419|NCT00261833|580651086|FG000|Overall Study|Missing reason|1|||
160798420|NCT00261833|580651087|FG001|Overall Study|Missing reason|0|||
160798421|NCT00261833|580651086|FG000|Overall Study|Not interested in being participant|0|||
160798422|NCT00261833|580651087|FG001|Overall Study|Not interested in being participant|1|||
160798423|NCT00622726|580651088|FG000|March, 2008 to August, 2010|Death|5|||
160798424|NCT00622726|580651089|FG001|March, 2008 to August, 2010|Death|2|||
160798425|NCT00622726|580651088|FG000|August, 2010 to April, 2013|Death|1|||
160798426|NCT00622726|580651089|FG001|August, 2010 to April, 2013|Death|5|||
160895139|NCT00371826|581012826|FG001|Extension Phase (24 Months)|Administrative problems|0|||
160798427|NCT01948427|580651092|FG000|Overall Study|Serious Adverse Event|3|||
160798428|NCT01948427|580651093|FG001|Overall Study|Serious Adverse Event|0|||
160798429|NCT01948427|580651094|FG002|Overall Study|Serious Adverse Event|0|||
160798430|NCT01948427|580651095|FG003|Overall Study|Serious Adverse Event|0|||
160895140|NCT00371826|581012827|FG002|Extension Phase (24 Months)|Administrative problems|2|||
160895141|NCT05061966|581012828|FG000|Overall Study|Lost to Follow-up|13|||
160895142|NCT05061966|581012829|FG001|Overall Study|Lost to Follow-up|13|||
160895143|NCT02923427|581012830|FG000|Overall Study|convert to laparatomy|2|||
160798431|NCT01948427|580651096|FG004|Overall Study|Serious Adverse Event|1|||
160798432|NCT01948427|580651092|FG000|Overall Study|Investigator Request|0|||
161236737|NCT01796171|582248364|FG002|Treatment Period With Betalutin|Physician Decision|0|||
161236738|NCT01796171|582248365|FG003|Treatment Period With Betalutin|Physician Decision|0|||
161236739|NCT01796171|582248366|FG004|Treatment Period With Betalutin|Physician Decision|0|||
161236740|NCT01796171|582248367|FG005|Treatment Period With Betalutin|Physician Decision|0|||
161236741|NCT01796171|582248368|FG006|Treatment Period With Betalutin|Physician Decision|0|||
161236742|NCT01796171|582248369|FG007|Treatment Period With Betalutin|Physician Decision|0|||
161236743|NCT01796171|582248370|FG008|Treatment Period With Betalutin|Physician Decision|0|||
161236744|NCT01796171|582248371|FG009|Treatment Period With Betalutin|Physician Decision|0|||
161236745|NCT01796171|582248372|FG010|Treatment Period With Betalutin|Physician Decision|5|||
161236746|NCT01796171|582248373|FG011|Treatment Period With Betalutin|Physician Decision|1|||
161236747|NCT01796171|582248374|FG012|Treatment Period With Betalutin|Physician Decision|1|||
161236748|NCT01796171|582248375|FG013|Treatment Period With Betalutin|Physician Decision|0|||
161236749|NCT01796171|582248376|FG014|Treatment Period With Betalutin|Physician Decision|0|||
161236750|NCT01796171|582248362|FG000|Treatment Period With Betalutin|Death|0|||
161236751|NCT01796171|582248363|FG001|Treatment Period With Betalutin|Death|0|||
161236752|NCT01796171|582248364|FG002|Treatment Period With Betalutin|Death|0|||
161236753|NCT01796171|582248365|FG003|Treatment Period With Betalutin|Death|0|||
161236754|NCT01796171|582248366|FG004|Treatment Period With Betalutin|Death|0|||
161236755|NCT01796171|582248367|FG005|Treatment Period With Betalutin|Death|0|||
161236756|NCT01796171|582248368|FG006|Treatment Period With Betalutin|Death|0|||
161236757|NCT01796171|582248369|FG007|Treatment Period With Betalutin|Death|0|||
161236758|NCT01796171|582248370|FG008|Treatment Period With Betalutin|Death|0|||
161236759|NCT01796171|582248371|FG009|Treatment Period With Betalutin|Death|0|||
161236760|NCT01796171|582248372|FG010|Treatment Period With Betalutin|Death|2|||
161236761|NCT01796171|582248373|FG011|Treatment Period With Betalutin|Death|0|||
161236762|NCT01796171|582248374|FG012|Treatment Period With Betalutin|Death|0|||
161236763|NCT01796171|582248375|FG013|Treatment Period With Betalutin|Death|0|||
161236764|NCT01796171|582248376|FG014|Treatment Period With Betalutin|Death|0|||
161236765|NCT01796171|582248362|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
161236766|NCT01796171|582248363|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
161236767|NCT01796171|582248364|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
161236768|NCT01796171|582248365|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
161236769|NCT01796171|582248366|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
161236770|NCT01796171|582248367|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
161236771|NCT01796171|582248368|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
161236772|NCT01796171|582248369|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
161236773|NCT01796171|582248370|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
161236774|NCT01796171|582248371|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
161236775|NCT01796171|582248372|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
161236776|NCT01796171|582248373|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
161236777|NCT01796171|582248374|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
161236778|NCT01796171|582248375|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
161236779|NCT01796171|582248376|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
161236780|NCT01796171|582248362|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236781|NCT01796171|582248363|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236782|NCT01796171|582248364|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161331378|NCT03126786|582598882|FG001|Overall Study|Withdrawal by Subject|1|||
160798433|NCT01948427|580651093|FG001|Overall Study|Investigator Request|8|||
160798434|NCT01948427|580651094|FG002|Overall Study|Investigator Request|0|||
160798435|NCT01948427|580651095|FG003|Overall Study|Investigator Request|0|||
160798436|NCT01948427|580651096|FG004|Overall Study|Investigator Request|6|||
160798437|NCT01948427|580651092|FG000|Overall Study|Lost to Follow-up|1|||
160798438|NCT01948427|580651093|FG001|Overall Study|Lost to Follow-up|0|||
160798439|NCT01948427|580651094|FG002|Overall Study|Lost to Follow-up|0|||
160798440|NCT01948427|580651095|FG003|Overall Study|Lost to Follow-up|0|||
160798441|NCT01948427|580651096|FG004|Overall Study|Lost to Follow-up|4|||
160798442|NCT01948427|580651092|FG000|Overall Study|Withdrawal by Subject|2|||
160798443|NCT01948427|580651093|FG001|Overall Study|Withdrawal by Subject|0|||
160798444|NCT01948427|580651094|FG002|Overall Study|Withdrawal by Subject|0|||
160798445|NCT01948427|580651095|FG003|Overall Study|Withdrawal by Subject|0|||
160798446|NCT01948427|580651096|FG004|Overall Study|Withdrawal by Subject|1|||
160798447|NCT01948427|580651092|FG000|Overall Study|Other, Not Specified|1|||
160798448|NCT01948427|580651093|FG001|Overall Study|Other, Not Specified|9|||
160798449|NCT01948427|580651094|FG002|Overall Study|Other, Not Specified|0|||
160798450|NCT01948427|580651095|FG003|Overall Study|Other, Not Specified|0|||
160798451|NCT01948427|580651096|FG004|Overall Study|Other, Not Specified|2|||
160798452|NCT00399529|580651097|FG000|Overall Study|Off Study Prior to Treatment|2|||
160798453|NCT02006927|580651098|FG000|Overall Study|Adverse Event|2|||
160798454|NCT02006927|580651098|FG000|Overall Study|Withdrawal by Subject|1|||
160798455|NCT01164007|580651099|FG000|Overall Study|Adverse Event|5|||
160798456|NCT01164007|580651099|FG000|Overall Study|Progression of Disease|30|||
160798457|NCT01164007|580651099|FG000|Overall Study|Protocol Violation|1|||
161236783|NCT01796171|582248365|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236784|NCT01796171|582248366|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236785|NCT01796171|582248367|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
160798458|NCT01164007|580651099|FG000|Overall Study|Withdrawal by Subject|1|||
160798459|NCT01164007|580651099|FG000|Overall Study|Medical Decision|3|||
160983752|NCT04157686|581328740|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
160983753|NCT04157686|581328741|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
160983754|NCT04157686|581328742|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
160983755|NCT04445155|581328743|FG000|Overall Study|Lost to Follow-up|11|||
160983756|NCT04445155|581328744|FG001|Overall Study|Lost to Follow-up|2|||
160983757|NCT04445155|581328745|FG002|Overall Study|Lost to Follow-up|3|||
160983758|NCT04445155|581328746|FG003|Overall Study|Lost to Follow-up|0|||
160983759|NCT04445155|581328743|FG000|Overall Study|Withdrawal by Subject|8|||
160983760|NCT04445155|581328744|FG001|Overall Study|Withdrawal by Subject|0|||
160983761|NCT04445155|581328745|FG002|Overall Study|Withdrawal by Subject|0|||
160983762|NCT04445155|581328746|FG003|Overall Study|Withdrawal by Subject|0|||
160798460|NCT03218917|580651100|FG000|Overall Study|Adverse Event|3|||
160798461|NCT03218917|580651101|FG001|Overall Study|Adverse Event|3|||
160798462|NCT03218917|580651102|FG002|Overall Study|Adverse Event|2|||
160983763|NCT04445155|581328743|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
160983764|NCT04445155|581328744|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
161236786|NCT01796171|582248368|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236787|NCT01796171|582248369|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236788|NCT01796171|582248370|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236789|NCT01796171|582248371|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236790|NCT01796171|582248372|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
161236791|NCT01796171|582248373|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
161236792|NCT01796171|582248374|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236793|NCT01796171|582248375|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236794|NCT01796171|582248376|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
161236795|NCT01796171|582248362|FG000|Follow-up Period|Start of further anticancer therapy|4|||
161236796|NCT01796171|582248363|FG001|Follow-up Period|Start of further anticancer therapy|25|||
161236797|NCT01796171|582248364|FG002|Follow-up Period|Start of further anticancer therapy|2|||
161236798|NCT01796171|582248365|FG003|Follow-up Period|Start of further anticancer therapy|1|||
161236799|NCT01796171|582248366|FG004|Follow-up Period|Start of further anticancer therapy|2|||
161236800|NCT01796171|582248367|FG005|Follow-up Period|Start of further anticancer therapy|2|||
161236801|NCT01796171|582248368|FG006|Follow-up Period|Start of further anticancer therapy|1|||
161236802|NCT01796171|582248369|FG007|Follow-up Period|Start of further anticancer therapy|15|||
161236803|NCT01796171|582248370|FG008|Follow-up Period|Start of further anticancer therapy|2|||
161236804|NCT01796171|582248371|FG009|Follow-up Period|Start of further anticancer therapy|0|||
161236805|NCT01796171|582248372|FG010|Follow-up Period|Start of further anticancer therapy|0|||
161236806|NCT01796171|582248373|FG011|Follow-up Period|Start of further anticancer therapy|0|||
161236807|NCT01796171|582248374|FG012|Follow-up Period|Start of further anticancer therapy|0|||
161236808|NCT01796171|582248375|FG013|Follow-up Period|Start of further anticancer therapy|0|||
161236809|NCT01796171|582248376|FG014|Follow-up Period|Start of further anticancer therapy|0|||
161236810|NCT01796171|582248362|FG000|Follow-up Period|Progressive disease|0|||
161236811|NCT01796171|582248363|FG001|Follow-up Period|Progressive disease|1|||
161236812|NCT01796171|582248364|FG002|Follow-up Period|Progressive disease|0|||
161236813|NCT01796171|582248365|FG003|Follow-up Period|Progressive disease|0|||
161236814|NCT01796171|582248366|FG004|Follow-up Period|Progressive disease|0|||
161236815|NCT01796171|582248367|FG005|Follow-up Period|Progressive disease|0|||
161236816|NCT01796171|582248368|FG006|Follow-up Period|Progressive disease|0|||
161236817|NCT01796171|582248369|FG007|Follow-up Period|Progressive disease|3|||
161236818|NCT01796171|582248370|FG008|Follow-up Period|Progressive disease|0|||
161236819|NCT01796171|582248371|FG009|Follow-up Period|Progressive disease|0|||
161236820|NCT01796171|582248372|FG010|Follow-up Period|Progressive disease|0|||
161236821|NCT01796171|582248373|FG011|Follow-up Period|Progressive disease|0|||
161236822|NCT01796171|582248374|FG012|Follow-up Period|Progressive disease|0|||
161236823|NCT01796171|582248375|FG013|Follow-up Period|Progressive disease|0|||
161236824|NCT01796171|582248376|FG014|Follow-up Period|Progressive disease|0|||
161236825|NCT01796171|582248362|FG000|Follow-up Period|Physician Decision|0|||
161236826|NCT01796171|582248363|FG001|Follow-up Period|Physician Decision|2|||
161236827|NCT01796171|582248364|FG002|Follow-up Period|Physician Decision|0|||
161236828|NCT01796171|582248365|FG003|Follow-up Period|Physician Decision|0|||
161236829|NCT01796171|582248366|FG004|Follow-up Period|Physician Decision|0|||
161236830|NCT01796171|582248367|FG005|Follow-up Period|Physician Decision|0|||
161236831|NCT01796171|582248368|FG006|Follow-up Period|Physician Decision|0|||
161236832|NCT01796171|582248369|FG007|Follow-up Period|Physician Decision|0|||
161236833|NCT01796171|582248370|FG008|Follow-up Period|Physician Decision|0|||
161236834|NCT01796171|582248371|FG009|Follow-up Period|Physician Decision|0|||
161236835|NCT01796171|582248372|FG010|Follow-up Period|Physician Decision|5|||
161236836|NCT01796171|582248373|FG011|Follow-up Period|Physician Decision|0|||
161236837|NCT01796171|582248374|FG012|Follow-up Period|Physician Decision|0|||
161236838|NCT01796171|582248375|FG013|Follow-up Period|Physician Decision|0|||
161236839|NCT01796171|582248376|FG014|Follow-up Period|Physician Decision|0|||
161236840|NCT01796171|582248362|FG000|Follow-up Period|Withdrawal by Subject|0|||
161236841|NCT01796171|582248363|FG001|Follow-up Period|Withdrawal by Subject|1|||
161236842|NCT01796171|582248364|FG002|Follow-up Period|Withdrawal by Subject|0|||
161236843|NCT01796171|582248365|FG003|Follow-up Period|Withdrawal by Subject|0|||
161236844|NCT01796171|582248366|FG004|Follow-up Period|Withdrawal by Subject|0|||
161236845|NCT01796171|582248367|FG005|Follow-up Period|Withdrawal by Subject|1|||
161236846|NCT01796171|582248368|FG006|Follow-up Period|Withdrawal by Subject|0|||
161236847|NCT01796171|582248369|FG007|Follow-up Period|Withdrawal by Subject|0|||
161236848|NCT01796171|582248370|FG008|Follow-up Period|Withdrawal by Subject|0|||
161236849|NCT01796171|582248371|FG009|Follow-up Period|Withdrawal by Subject|0|||
161236850|NCT01796171|582248372|FG010|Follow-up Period|Withdrawal by Subject|3|||
161236851|NCT01796171|582248373|FG011|Follow-up Period|Withdrawal by Subject|1|||
161236852|NCT01796171|582248374|FG012|Follow-up Period|Withdrawal by Subject|0|||
161236853|NCT01796171|582248375|FG013|Follow-up Period|Withdrawal by Subject|0|||
161236854|NCT01796171|582248376|FG014|Follow-up Period|Withdrawal by Subject|0|||
161236855|NCT01796171|582248362|FG000|Follow-up Period|Death|0|||
161236856|NCT01796171|582248363|FG001|Follow-up Period|Death|0|||
161236857|NCT01796171|582248364|FG002|Follow-up Period|Death|0|||
161236858|NCT01796171|582248365|FG003|Follow-up Period|Death|0|||
161236859|NCT01796171|582248366|FG004|Follow-up Period|Death|0|||
161236860|NCT01796171|582248367|FG005|Follow-up Period|Death|0|||
161236861|NCT01796171|582248368|FG006|Follow-up Period|Death|1|||
161331379|NCT03243305|582598883|FG000|Overall Study|Lost to Follow-up|250|||
161331380|NCT03243305|582598883|FG000|Overall Study|Withdrawal by Subject|170|||
161331381|NCT03243305|582598883|FG000|Overall Study|Pregnancy|104|||
161331382|NCT03243305|582598883|FG000|Overall Study|Non-Compliance with Study Drug|38|||
161331383|NCT03243305|582598883|FG000|Overall Study|Adverse Event|23|||
161331384|NCT03243305|582598883|FG000|Overall Study|No sexually active|26|||
161331385|NCT03243305|582598883|FG000|Overall Study|Physician Decision|22|||
161331386|NCT03243305|582598883|FG000|Overall Study|Protocol Violation|22|||
161331387|NCT03243305|582598883|FG000|Overall Study|Study method no longer primary method|12|||
161331388|NCT03243305|582598883|FG000|Overall Study|Study Terminated by Sponsor|1|||
161331389|NCT03243305|582598883|FG000|Overall Study|Early terminations|267|||
161331390|NCT00227539|582598884|FG000|Overall Study|Protocol Violation|1|||
161331391|NCT02689804|582598885|FG000|Overall Study|Withdrawal by Subject|2|||
161331392|NCT02689804|582598886|FG001|Overall Study|Withdrawal by Subject|0|||
161331393|NCT00673257|582598887|FG000|Overall Study|Withdrawal by Subject|4|||
161331394|NCT00673257|582598887|FG000|Overall Study|Unable to obtain specimen|1|||
161331395|NCT01585246|582598894|FG000|Overall Study|Lost to Follow-up|0|||
161331396|NCT01585246|582598895|FG001|Overall Study|Lost to Follow-up|0|||
161331397|NCT01585246|582598896|FG002|Overall Study|Lost to Follow-up|2|||
161331398|NCT01585246|582598897|FG003|Overall Study|Lost to Follow-up|1|||
161331399|NCT01585246|582598898|FG004|Overall Study|Lost to Follow-up|0|||
161331400|NCT01585246|582598894|FG000|Overall Study|Protocol Violation|0|||
161331401|NCT01585246|582598895|FG001|Overall Study|Protocol Violation|0|||
161331402|NCT01585246|582598896|FG002|Overall Study|Protocol Violation|0|||
161331403|NCT01585246|582598897|FG003|Overall Study|Protocol Violation|0|||
161331404|NCT01585246|582598898|FG004|Overall Study|Protocol Violation|1|||
161331405|NCT01585246|582598894|FG000|Overall Study|Withdrawal by Subject|0|||
161331406|NCT01585246|582598895|FG001|Overall Study|Withdrawal by Subject|0|||
161331407|NCT01585246|582598896|FG002|Overall Study|Withdrawal by Subject|1|||
161331408|NCT01585246|582598897|FG003|Overall Study|Withdrawal by Subject|2|||
161331409|NCT01585246|582598898|FG004|Overall Study|Withdrawal by Subject|1|||
161331410|NCT01585246|582598894|FG000|Overall Study|Other|0|||
161331411|NCT01585246|582598895|FG001|Overall Study|Other|1|||
161331412|NCT01585246|582598896|FG002|Overall Study|Other|1|||
161331413|NCT01585246|582598897|FG003|Overall Study|Other|1|||
161331414|NCT01585246|582598898|FG004|Overall Study|Other|0|||
161331415|NCT04396626|582598899|FG000|Overall Study|Premature termination of study|975|||
161331416|NCT02111174|582598902|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
161331417|NCT02111174|582598903|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
161331418|NCT02111174|582598902|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
161331419|NCT02111174|582598903|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
161331420|NCT02111174|582598902|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
161331421|NCT02111174|582598903|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
161331422|NCT02111174|582598902|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
161331423|NCT02111174|582598903|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
161331424|NCT04552132|582598904|FG000|Overall Study|Lost to Follow-up|4|||
161236862|NCT01796171|582248369|FG007|Follow-up Period|Death|0|||
161331425|NCT04552132|582598905|FG001|Overall Study|Lost to Follow-up|3|||
161331426|NCT04552132|582598904|FG000|Overall Study|Protocol Violation|1|||
161331427|NCT04552132|582598905|FG001|Overall Study|Protocol Violation|0|||
160798463|NCT03218917|580651100|FG000|Overall Study|Subject withdrew consent|2|||
160798464|NCT03218917|580651101|FG001|Overall Study|Subject withdrew consent|4|||
160798465|NCT03218917|580651102|FG002|Overall Study|Subject withdrew consent|10|||
160798466|NCT03218917|580651100|FG000|Overall Study|Physician Decision|0|||
160798467|NCT03218917|580651101|FG001|Overall Study|Physician Decision|1|||
161236863|NCT01796171|582248370|FG008|Follow-up Period|Death|0|||
161236864|NCT01796171|582248371|FG009|Follow-up Period|Death|0|||
161236865|NCT01796171|582248372|FG010|Follow-up Period|Death|17|||
161236866|NCT01796171|582248373|FG011|Follow-up Period|Death|9|||
161236867|NCT01796171|582248374|FG012|Follow-up Period|Death|1|||
161236868|NCT01796171|582248375|FG013|Follow-up Period|Death|0|||
161236869|NCT01796171|582248376|FG014|Follow-up Period|Death|0|||
161236870|NCT01796171|582248362|FG000|Follow-up Period|Patient transferred to other hospital|0|||
161236871|NCT01796171|582248363|FG001|Follow-up Period|Patient transferred to other hospital|1|||
161236872|NCT01796171|582248364|FG002|Follow-up Period|Patient transferred to other hospital|0|||
161236873|NCT01796171|582248365|FG003|Follow-up Period|Patient transferred to other hospital|0|||
161236874|NCT01796171|582248366|FG004|Follow-up Period|Patient transferred to other hospital|0|||
161236875|NCT01796171|582248367|FG005|Follow-up Period|Patient transferred to other hospital|0|||
161236876|NCT01796171|582248368|FG006|Follow-up Period|Patient transferred to other hospital|0|||
161236877|NCT01796171|582248369|FG007|Follow-up Period|Patient transferred to other hospital|0|||
161236878|NCT01796171|582248370|FG008|Follow-up Period|Patient transferred to other hospital|0|||
161236879|NCT01796171|582248371|FG009|Follow-up Period|Patient transferred to other hospital|0|||
161236880|NCT01796171|582248372|FG010|Follow-up Period|Patient transferred to other hospital|0|||
161236881|NCT01796171|582248373|FG011|Follow-up Period|Patient transferred to other hospital|0|||
161236882|NCT01796171|582248374|FG012|Follow-up Period|Patient transferred to other hospital|0|||
161236883|NCT01796171|582248375|FG013|Follow-up Period|Patient transferred to other hospital|0|||
161236884|NCT01796171|582248376|FG014|Follow-up Period|Patient transferred to other hospital|0|||
161236885|NCT01796171|582248362|FG000|Follow-up Period|Sponsor Decision|0|||
161236886|NCT01796171|582248363|FG001|Follow-up Period|Sponsor Decision|0|||
161236887|NCT01796171|582248364|FG002|Follow-up Period|Sponsor Decision|0|||
161236888|NCT01796171|582248365|FG003|Follow-up Period|Sponsor Decision|0|||
161236889|NCT01796171|582248366|FG004|Follow-up Period|Sponsor Decision|0|||
161236890|NCT01796171|582248367|FG005|Follow-up Period|Sponsor Decision|0|||
161236891|NCT01796171|582248368|FG006|Follow-up Period|Sponsor Decision|0|||
161236892|NCT01796171|582248369|FG007|Follow-up Period|Sponsor Decision|0|||
161236893|NCT01796171|582248370|FG008|Follow-up Period|Sponsor Decision|0|||
161236894|NCT01796171|582248371|FG009|Follow-up Period|Sponsor Decision|0|||
161236895|NCT01796171|582248372|FG010|Follow-up Period|Sponsor Decision|40|||
161236896|NCT01796171|582248373|FG011|Follow-up Period|Sponsor Decision|15|||
161236897|NCT01796171|582248374|FG012|Follow-up Period|Sponsor Decision|7|||
161236898|NCT01796171|582248375|FG013|Follow-up Period|Sponsor Decision|0|||
161236899|NCT01796171|582248376|FG014|Follow-up Period|Sponsor Decision|0|||
161236900|NCT00829309|582248377|FG000|Washout: 7 Days|Protocol Violation|1|||
161236901|NCT00829309|582248378|FG001|Washout: 7 Days|Protocol Violation|0|||
161236902|NCT01083693|582248379|FG000|Overall Study|Adverse Event|1|||
161236903|NCT01083693|582248380|FG001|Overall Study|Adverse Event|1|||
161236904|NCT01083693|582248381|FG002|Overall Study|Adverse Event|0|||
161236905|NCT01083693|582248379|FG000|Overall Study|Lost to Follow-up|2|||
161236906|NCT01083693|582248380|FG001|Overall Study|Lost to Follow-up|0|||
161236907|NCT01083693|582248381|FG002|Overall Study|Lost to Follow-up|2|||
161236908|NCT01083693|582248379|FG000|Overall Study|Lack of effectiveness|13|||
161236909|NCT01083693|582248380|FG001|Overall Study|Lack of effectiveness|2|||
161236910|NCT01083693|582248381|FG002|Overall Study|Lack of effectiveness|2|||
161236911|NCT01083693|582248379|FG000|Overall Study|Patient Moved|0|||
161236912|NCT01083693|582248380|FG001|Overall Study|Patient Moved|1|||
161236913|NCT01083693|582248381|FG002|Overall Study|Patient Moved|0|||
161236914|NCT01083693|582248379|FG000|Overall Study|Complete remission|0|||
161236915|NCT01083693|582248380|FG001|Overall Study|Complete remission|1|||
161236916|NCT01083693|582248381|FG002|Overall Study|Complete remission|0|||
161236917|NCT01083693|582248379|FG000|Overall Study|Other medical condition/surgery|1|||
161236918|NCT01083693|582248380|FG001|Overall Study|Other medical condition/surgery|1|||
161236919|NCT01083693|582248381|FG002|Overall Study|Other medical condition/surgery|0|||
161236920|NCT01083693|582248379|FG000|Overall Study|Withdrawal by Subject|3|||
161236921|NCT01083693|582248380|FG001|Overall Study|Withdrawal by Subject|0|||
161236922|NCT01083693|582248381|FG002|Overall Study|Withdrawal by Subject|2|||
161236923|NCT01083693|582248379|FG000|Overall Study|Reason unknown|0|||
161236924|NCT01083693|582248380|FG001|Overall Study|Reason unknown|0|||
161236925|NCT01083693|582248381|FG002|Overall Study|Reason unknown|1|||
161236926|NCT00455312|582248382|FG000|Overall Study|Death|0|||
161236927|NCT00455312|582248383|FG001|Overall Study|Death|1|||
160798468|NCT03218917|580651102|FG002|Overall Study|Physician Decision|1|||
161236928|NCT00777023|582248385|FG000|Overall Study|Adverse Event|15|||
160798469|NCT03218917|580651100|FG000|Overall Study|Lost to Follow-up|1|||
160798470|NCT03218917|580651101|FG001|Overall Study|Lost to Follow-up|0|||
161236929|NCT00777023|582248386|FG001|Overall Study|Adverse Event|21|||
161236930|NCT00777023|582248387|FG002|Overall Study|Adverse Event|8|||
161236931|NCT00777023|582248385|FG000|Overall Study|Lack of Efficacy|1|||
161236932|NCT00777023|582248386|FG001|Overall Study|Lack of Efficacy|0|||
161236933|NCT00777023|582248387|FG002|Overall Study|Lack of Efficacy|14|||
161236934|NCT00777023|582248385|FG000|Overall Study|Protocol Violation|2|||
161236935|NCT00777023|582248386|FG001|Overall Study|Protocol Violation|1|||
161236936|NCT00777023|582248387|FG002|Overall Study|Protocol Violation|1|||
161236937|NCT00777023|582248385|FG000|Overall Study|Lost to Follow-up|2|||
161236938|NCT00777023|582248386|FG001|Overall Study|Lost to Follow-up|3|||
160798471|NCT03218917|580651102|FG002|Overall Study|Lost to Follow-up|0|||
160798472|NCT03218917|580651100|FG000|Overall Study|Reason Missing|0|||
160798473|NCT03218917|580651101|FG001|Overall Study|Reason Missing|2|||
160798474|NCT03218917|580651102|FG002|Overall Study|Reason Missing|0|||
160798475|NCT03218917|580651100|FG000|Overall Study|Death|0|||
160798476|NCT03218917|580651101|FG001|Overall Study|Death|1|||
160798477|NCT03218917|580651102|FG002|Overall Study|Death|0|||
160798478|NCT03218917|580651100|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161236939|NCT00777023|582248387|FG002|Overall Study|Lost to Follow-up|3|||
161236940|NCT00777023|582248385|FG000|Overall Study|Death|0|||
161236941|NCT00777023|582248386|FG001|Overall Study|Death|1|||
161236942|NCT00777023|582248387|FG002|Overall Study|Death|0|||
161236943|NCT00777023|582248385|FG000|Overall Study|Withdrawal by Subject|7|||
161236944|NCT00777023|582248386|FG001|Overall Study|Withdrawal by Subject|7|||
161236945|NCT00777023|582248387|FG002|Overall Study|Withdrawal by Subject|8|||
161236946|NCT00777023|582248385|FG000|Overall Study|Missing data|1|||
161236947|NCT00777023|582248386|FG001|Overall Study|Missing data|1|||
161236948|NCT00777023|582248387|FG002|Overall Study|Missing data|0|||
161236949|NCT00777023|582248385|FG000|Overall Study|Reasons not specified|4|||
161236950|NCT00777023|582248386|FG001|Overall Study|Reasons not specified|4|||
161236951|NCT00777023|582248387|FG002|Overall Study|Reasons not specified|2|||
161236952|NCT00777023|582248385|FG000|Overall Study|Last dose date unknown|3|||
161236953|NCT00777023|582248386|FG001|Overall Study|Last dose date unknown|3|||
161236954|NCT00777023|582248387|FG002|Overall Study|Last dose date unknown|1|||
160798479|NCT03218917|580651101|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160798480|NCT03218917|580651102|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160798481|NCT01908140|580651103|FG000|Overall Study|Other or Progressive Disease|5|||
160798482|NCT01908140|580651104|FG001|Overall Study|Other or Progressive Disease|12|||
160798483|NCT01908140|580651103|FG000|Overall Study|Lack of Efficacy|7|||
160798484|NCT01908140|580651104|FG001|Overall Study|Lack of Efficacy|5|||
160798485|NCT01908140|580651103|FG000|Overall Study|Withdrawal by Subject|23|||
160798486|NCT01908140|580651104|FG001|Overall Study|Withdrawal by Subject|24|||
160798487|NCT01908140|580651103|FG000|Overall Study|Lost to Follow-up|1|||
160798488|NCT01908140|580651104|FG001|Overall Study|Lost to Follow-up|6|||
160798489|NCT01908140|580651103|FG000|Overall Study|Protocol Violation|8|||
160798490|NCT01908140|580651104|FG001|Overall Study|Protocol Violation|9|||
160798491|NCT01908140|580651103|FG000|Overall Study|Adverse Event|22|||
160798492|NCT01908140|580651104|FG001|Overall Study|Adverse Event|23|||
160798493|NCT02639390|580651105|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
160798494|NCT02639390|580651106|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
160798495|NCT02412670|580651107|FG000|Overall Study|Adverse Event|4|||
160798496|NCT02412670|580651108|FG001|Overall Study|Adverse Event|1|||
160798497|NCT02412670|580651107|FG000|Overall Study|Physician Decision|1|||
160798498|NCT02412670|580651108|FG001|Overall Study|Physician Decision|0|||
160895144|NCT02923427|581012831|FG001|Overall Study|convert to laparatomy|2|||
160895145|NCT02923427|581012830|FG000|Overall Study|destaturation|1|||
160895146|NCT02923427|581012831|FG001|Overall Study|destaturation|0|||
161236955|NCT00089661|582248392|FG000|Overall Study|Adverse Event|0|||
161236956|NCT00089661|582248393|FG001|Overall Study|Adverse Event|2|||
160895147|NCT02923427|581012830|FG000|Overall Study|can not replace LMA|1|||
160895148|NCT02923427|581012831|FG001|Overall Study|can not replace LMA|0|||
160895149|NCT01539642|581012836|FG000|Overall Study|Lack of Efficacy|20|||
160895150|NCT01539642|581012837|FG001|Overall Study|Lack of Efficacy|18|||
160895151|NCT01539642|581012836|FG000|Overall Study|Patient ready for early discharge|8|||
160798499|NCT02412670|580651107|FG000|Overall Study|Withdrawal by Subject|1|||
160895152|NCT01539642|581012837|FG001|Overall Study|Patient ready for early discharge|7|||
160895153|NCT01539642|581012836|FG000|Overall Study|Adverse Event|6|||
160895154|NCT01539642|581012837|FG001|Overall Study|Adverse Event|4|||
161236957|NCT00089661|582248392|FG000|Overall Study|Death|1|||
161236958|NCT00089661|582248393|FG001|Overall Study|Death|0|||
161236959|NCT00089661|582248392|FG000|Overall Study|Lost to Follow-up|0|||
161236960|NCT00089661|582248393|FG001|Overall Study|Lost to Follow-up|3|||
161236961|NCT00089661|582248392|FG000|Overall Study|Withdrawal by Subject|11|||
161236962|NCT00089661|582248393|FG001|Overall Study|Withdrawal by Subject|9|||
161236963|NCT00089661|582248392|FG000|Overall Study|Disease progression|1|||
160798500|NCT02412670|580651108|FG001|Overall Study|Withdrawal by Subject|0|||
160798501|NCT02412670|580651107|FG000|Overall Study|Ineligible|1|||
160798502|NCT02412670|580651108|FG001|Overall Study|Ineligible|0|||
160798503|NCT00431964|580651112|FG000|Overall Study|Adverse Event|1|||
160895155|NCT01539642|581012836|FG000|Overall Study|Withdrawal by Subject|2|||
161236964|NCT00089661|582248393|FG001|Overall Study|Disease progression|3|||
161236965|NCT00089661|582248392|FG000|Overall Study|Ineligibility determined|4|||
160798504|NCT00431964|580651113|FG001|Overall Study|Adverse Event|0|||
160798505|NCT00431964|580651112|FG000|Overall Study|Lost to Follow-up|1|||
160798506|NCT00431964|580651113|FG001|Overall Study|Lost to Follow-up|2|||
161236966|NCT00089661|582248393|FG001|Overall Study|Ineligibility determined|4|||
161236967|NCT00089661|582248392|FG000|Overall Study|Noncompliance|2|||
161236968|NCT00089661|582248393|FG001|Overall Study|Noncompliance|4|||
161236969|NCT00089661|582248392|FG000|Overall Study|Other|2|||
161236970|NCT00089661|582248393|FG001|Overall Study|Other|1|||
161236971|NCT01273805|582248394|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
161236972|NCT01273805|582248395|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
161236973|NCT02647944|582248396|FG000|Overall Study|Withdrawal by Subject|0|||
161236974|NCT02647944|582248397|FG001|Overall Study|Withdrawal by Subject|3|||
161236975|NCT02647944|582248396|FG000|Overall Study|Adverse Event|2|||
160798507|NCT00431964|580651112|FG000|Overall Study|Physician Decision|2|||
161236976|NCT02647944|582248397|FG001|Overall Study|Adverse Event|0|||
161236977|NCT02077465|582248398|FG000|Overall Study|Withdrew Consent|0|||
160798508|NCT00431964|580651113|FG001|Overall Study|Physician Decision|2|||
160798509|NCT00431964|580651112|FG000|Overall Study|Withdrawal by Subject|2|||
160798510|NCT00431964|580651113|FG001|Overall Study|Withdrawal by Subject|1|||
160798511|NCT00431964|580651112|FG000|Overall Study|Parental Consent Withdrawn|0|||
160798512|NCT00431964|580651113|FG001|Overall Study|Parental Consent Withdrawn|2|||
160798513|NCT00431964|580651112|FG000|Overall Study|Due to Unstable Health|0|||
160798514|NCT00431964|580651113|FG001|Overall Study|Due to Unstable Health|1|||
161236978|NCT02077465|582248399|FG001|Overall Study|Withdrew Consent|1|||
161236979|NCT02077465|582248398|FG000|Overall Study|Lost to Follow-up|1|||
161236980|NCT02077465|582248399|FG001|Overall Study|Lost to Follow-up|0|||
161236981|NCT03375463|582248402|FG000|Period 1|Lost to Follow-up|0|||
161236982|NCT03375463|582248403|FG001|Period 1|Lost to Follow-up|0|||
161236983|NCT03375463|582248404|FG002|Period 1|Lost to Follow-up|1|||
161331428|NCT01657162|582598906|FG000|Overall Study|Adverse Event|26|||
161331429|NCT01657162|582598907|FG001|Overall Study|Adverse Event|36|||
161331430|NCT01657162|582598906|FG000|Overall Study|Withdrawal by Subject|13|||
161331431|NCT01657162|582598907|FG001|Overall Study|Withdrawal by Subject|13|||
161331432|NCT01657162|582598906|FG000|Overall Study|Continuing Significant Deterioration|9|||
161331433|NCT01657162|582598907|FG001|Overall Study|Continuing Significant Deterioration|3|||
161331434|NCT01657162|582598906|FG000|Overall Study|Refusal of Treatment|4|||
161331435|NCT01657162|582598907|FG001|Overall Study|Refusal of Treatment|6|||
161331436|NCT01657162|582598906|FG000|Overall Study|Lost to Follow-up|3|||
161331437|NCT01657162|582598907|FG001|Overall Study|Lost to Follow-up|4|||
161331438|NCT01657162|582598906|FG000|Overall Study|Death|2|||
161331439|NCT01657162|582598907|FG001|Overall Study|Death|3|||
161331440|NCT01657162|582598906|FG000|Overall Study|Inability to Complete Study Procedures|1|||
161331441|NCT01657162|582598907|FG001|Overall Study|Inability to Complete Study Procedures|7|||
161331442|NCT01657162|582598906|FG000|Overall Study|Protocol Violation|1|||
160798515|NCT00397540|580651114|FG000|Overall Study|short follow-up duration < 12 months|1|||
160798516|NCT00397540|580651115|FG001|Overall Study|short follow-up duration < 12 months|0|||
160895156|NCT01539642|581012837|FG001|Overall Study|Withdrawal by Subject|2|||
160895157|NCT03611010|581012838|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
160895158|NCT03611010|581012839|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
160895159|NCT03611010|581012840|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
160895160|NCT03611010|581012841|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
160895161|NCT00598702|581012842|FG000|Overall Study|Other|0|||
160895162|NCT00598702|581012843|FG001|Overall Study|Other|2|||
160895163|NCT00598702|581012844|FG002|Overall Study|Other|0|||
160895164|NCT00598702|581012845|FG003|Overall Study|Other|0|||
160895165|NCT00598702|581012846|FG004|Overall Study|Other|0|||
160895166|NCT00598702|581012847|FG005|Overall Study|Other|1|||
161236984|NCT03375463|582248405|FG003|Period 1|Lost to Follow-up|0|||
161236985|NCT03375463|582248406|FG004|Period 1|Lost to Follow-up|0|||
161236986|NCT03375463|582248407|FG005|Period 1|Lost to Follow-up|0|||
161331443|NCT01657162|582598907|FG001|Overall Study|Protocol Violation|0|||
160798517|NCT00776230|580651119|FG000|Overall Study|Lost to Follow-up|2|||
160895167|NCT00598702|581012848|FG006|Overall Study|Other|0|||
161236987|NCT03375463|582248402|FG000|Period 1|Adverse Event|0|||
161236988|NCT03375463|582248403|FG001|Period 1|Adverse Event|0|||
161236989|NCT03375463|582248404|FG002|Period 1|Adverse Event|0|||
160895168|NCT00598702|581012849|FG007|Overall Study|Other|0|||
161236990|NCT03375463|582248405|FG003|Period 1|Adverse Event|0|||
161236991|NCT03375463|582248406|FG004|Period 1|Adverse Event|1|||
161331444|NCT01657162|582598906|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
161331445|NCT01657162|582598907|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
161331446|NCT01657162|582598906|FG000|Overall Study|Other than Specified|0|||
161331447|NCT01657162|582598907|FG001|Overall Study|Other than Specified|2|||
160798518|NCT00776230|580651120|FG001|Overall Study|Lost to Follow-up|1|||
160895169|NCT00598702|581012842|FG000|Overall Study|Early discharge from hospital|0|||
160895170|NCT00598702|581012843|FG001|Overall Study|Early discharge from hospital|0|||
160895171|NCT00598702|581012844|FG002|Overall Study|Early discharge from hospital|2|||
160895172|NCT00598702|581012845|FG003|Overall Study|Early discharge from hospital|5|||
160798519|NCT00776230|580651121|FG002|Overall Study|Lost to Follow-up|5|||
160798520|NCT00776230|580651119|FG000|Overall Study|Not vaccinated at Day 0|1|||
160798521|NCT00776230|580651120|FG001|Overall Study|Not vaccinated at Day 0|0|||
160798522|NCT00776230|580651121|FG002|Overall Study|Not vaccinated at Day 0|0|||
160798523|NCT00776230|580651119|FG000|Overall Study|Withdrawal by Subject|0|||
160798524|NCT00776230|580651120|FG001|Overall Study|Withdrawal by Subject|1|||
160798525|NCT00776230|580651121|FG002|Overall Study|Withdrawal by Subject|0|||
160798526|NCT00776230|580651119|FG000|Overall Study|Subject missed Visit 4|0|||
160798527|NCT00776230|580651120|FG001|Overall Study|Subject missed Visit 4|1|||
160798528|NCT00776230|580651121|FG002|Overall Study|Subject missed Visit 4|0|||
160798529|NCT01215851|580651122|FG000|Treatment Period|Adverse Event|1|||
160895173|NCT00598702|581012846|FG004|Overall Study|Early discharge from hospital|0|||
160895174|NCT00598702|581012847|FG005|Overall Study|Early discharge from hospital|10|||
160895175|NCT00598702|581012848|FG006|Overall Study|Early discharge from hospital|1|||
160895176|NCT00598702|581012849|FG007|Overall Study|Early discharge from hospital|0|||
160895177|NCT00598702|581012842|FG000|Overall Study|Adverse Event|0|||
160895178|NCT00598702|581012843|FG001|Overall Study|Adverse Event|0|||
160895179|NCT00598702|581012844|FG002|Overall Study|Adverse Event|0|||
160895180|NCT00598702|581012845|FG003|Overall Study|Adverse Event|1|||
160895181|NCT00598702|581012846|FG004|Overall Study|Adverse Event|0|||
160895182|NCT00598702|581012847|FG005|Overall Study|Adverse Event|0|||
161236992|NCT03375463|582248407|FG005|Period 1|Adverse Event|0|||
161236993|NCT03375463|582248402|FG000|Period 2|Lost to Follow-up|1|||
161236994|NCT03375463|582248403|FG001|Period 2|Lost to Follow-up|1|||
161236995|NCT03375463|582248404|FG002|Period 2|Lost to Follow-up|0|||
161236996|NCT03375463|582248405|FG003|Period 2|Lost to Follow-up|0|||
161236997|NCT03375463|582248406|FG004|Period 2|Lost to Follow-up|0|||
161236998|NCT03375463|582248407|FG005|Period 2|Lost to Follow-up|0|||
161236999|NCT01827163|582248408|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
161237000|NCT01827163|582248408|FG000|Overall Study|Adverse Event|9|||
161237001|NCT01513174|582248411|FG000|Overall Study|Inclusion Error|1|||
161237002|NCT01513174|582248412|FG001|Overall Study|Inclusion Error|7|||
161237003|NCT01513174|582248411|FG000|Overall Study|Not receive study treatment|3|||
161237004|NCT01513174|582248412|FG001|Overall Study|Not receive study treatment|1|||
160895183|NCT00598702|581012848|FG006|Overall Study|Adverse Event|0|||
160895184|NCT00598702|581012849|FG007|Overall Study|Adverse Event|0|||
160895185|NCT00598702|581012842|FG000|Overall Study|Withdrawal by Subject|0|||
160895186|NCT00598702|581012843|FG001|Overall Study|Withdrawal by Subject|0|||
160895187|NCT00598702|581012844|FG002|Overall Study|Withdrawal by Subject|0|||
160895188|NCT00598702|581012845|FG003|Overall Study|Withdrawal by Subject|1|||
160895189|NCT00598702|581012846|FG004|Overall Study|Withdrawal by Subject|1|||
160895190|NCT00598702|581012847|FG005|Overall Study|Withdrawal by Subject|0|||
160895191|NCT00598702|581012848|FG006|Overall Study|Withdrawal by Subject|0|||
160895192|NCT00598702|581012849|FG007|Overall Study|Withdrawal by Subject|0|||
160895193|NCT00598702|581012842|FG000|Overall Study|Physician Decision|0|||
160895194|NCT00598702|581012843|FG001|Overall Study|Physician Decision|0|||
160895195|NCT00598702|581012844|FG002|Overall Study|Physician Decision|0|||
160895196|NCT00598702|581012845|FG003|Overall Study|Physician Decision|0|||
160895197|NCT00598702|581012846|FG004|Overall Study|Physician Decision|1|||
161237005|NCT01900626|582248415|FG000|Overall Study|study was closed due to low enrollment|1|||
161237006|NCT01900626|582248416|FG001|Overall Study|study was closed due to low enrollment|1|||
161237007|NCT02576938|582248419|FG000|Overall Study|Adverse Event|5|||
161237008|NCT02576938|582248420|FG001|Overall Study|Adverse Event|3|||
161237009|NCT02576938|582248421|FG002|Overall Study|Adverse Event|6|||
161237010|NCT02576938|582248419|FG000|Overall Study|Protocol Violation|1|||
161237011|NCT02576938|582248420|FG001|Overall Study|Protocol Violation|1|||
161237012|NCT02576938|582248421|FG002|Overall Study|Protocol Violation|1|||
161237013|NCT02576938|582248419|FG000|Overall Study|Withdrawal by Subject|3|||
161331448|NCT02600923|582598910|FG000|Overall Study|Death|10|||
160895198|NCT00598702|581012847|FG005|Overall Study|Physician Decision|0|||
160895199|NCT00598702|581012848|FG006|Overall Study|Physician Decision|0|||
160895200|NCT00598702|581012849|FG007|Overall Study|Physician Decision|0|||
160895201|NCT00598702|581012842|FG000|Overall Study|Dose limiting toxicity|0|||
160895202|NCT00598702|581012843|FG001|Overall Study|Dose limiting toxicity|0|||
160895203|NCT00598702|581012844|FG002|Overall Study|Dose limiting toxicity|0|||
160895204|NCT00598702|581012845|FG003|Overall Study|Dose limiting toxicity|1|||
160895205|NCT00598702|581012846|FG004|Overall Study|Dose limiting toxicity|1|||
160895206|NCT00598702|581012847|FG005|Overall Study|Dose limiting toxicity|1|||
160895207|NCT00598702|581012848|FG006|Overall Study|Dose limiting toxicity|0|||
160895208|NCT00598702|581012849|FG007|Overall Study|Dose limiting toxicity|0|||
161237014|NCT02576938|582248420|FG001|Overall Study|Withdrawal by Subject|2|||
161237015|NCT02576938|582248421|FG002|Overall Study|Withdrawal by Subject|4|||
160798530|NCT01215851|580651123|FG001|Treatment Period|Adverse Event|1|||
160895209|NCT02413372|581012853|FG000|Treatment|Lost to Follow-up|0|||
161237016|NCT02576938|582248419|FG000|Overall Study|Lack of Efficacy|9|||
161331449|NCT02600923|582598910|FG000|Overall Study|Adverse Event|3|||
160798531|NCT01215851|580651124|FG002|Treatment Period|Adverse Event|1|||
160895210|NCT02413372|581012854|FG001|Treatment|Lost to Follow-up|2|||
161331450|NCT02600923|582598910|FG000|Overall Study|Global deterioration of health status|2|||
161331451|NCT02600923|582598910|FG000|Overall Study|Insufficient clinical response|6|||
161331452|NCT02600923|582598910|FG000|Overall Study|Lost to Follow-up|1|||
161331453|NCT02600923|582598910|FG000|Overall Study|Withdrawal by Subject|5|||
161331454|NCT02600923|582598910|FG000|Overall Study|Objective progression or relapse|50|||
161331455|NCT02600923|582598910|FG000|Overall Study|Study terminated by Sponsor|53|||
161331456|NCT02600923|582598910|FG000|Overall Study|Not treated|1|||
161331457|NCT00792909|582598911|FG000|Overall Study|Withdrawal by Subject|0|||
161331458|NCT00792909|582598912|FG001|Overall Study|Withdrawal by Subject|1|||
161331459|NCT00792909|582598913|FG002|Overall Study|Withdrawal by Subject|0|||
161331460|NCT04391842|582598919|FG000|Overall Study|Withdrawal by Subject|2|||
161331461|NCT00992017|582598920|FG000|Overall Study|Lost to Follow-up|2|||
161331462|NCT00992017|582598920|FG000|Overall Study|Withdrawal by Subject|2|||
161331463|NCT00992017|582598920|FG000|Overall Study|Unable to get to clinic|5|||
161331464|NCT00992017|582598920|FG000|Overall Study|Not adhere to study requirements|1|||
161331465|NCT01691378|582598921|FG000|Overall Study|Withdrawal by Subject|2|||
161331466|NCT01691378|582598922|FG001|Overall Study|Withdrawal by Subject|0|||
161331467|NCT01691378|582598921|FG000|Overall Study|Lost to Follow-up|5|||
161331468|NCT01691378|582598922|FG001|Overall Study|Lost to Follow-up|2|||
161331469|NCT04888494|582598923|FG000|Overall Study|Lost to Follow-up|2|||
161331470|NCT04888494|582598924|FG001|Overall Study|Lost to Follow-up|3|||
161331471|NCT04888494|582598923|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
161331472|NCT04888494|582598924|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
161331473|NCT03652818|582601376|FG000|Overall Study|Adverse Event|1|||
161331474|NCT03652818|582601377|FG001|Overall Study|Adverse Event|0|||
161331475|NCT03652818|582601378|FG002|Overall Study|Adverse Event|0|||
161331476|NCT03652818|582601379|FG003|Overall Study|Adverse Event|0|||
161331477|NCT03652818|582601380|FG004|Overall Study|Adverse Event|0|||
161331478|NCT03652818|582601376|FG000|Overall Study|Physician Decision|1|||
161331479|NCT03652818|582601377|FG001|Overall Study|Physician Decision|0|||
161331480|NCT03652818|582601378|FG002|Overall Study|Physician Decision|0|||
161331481|NCT03652818|582601379|FG003|Overall Study|Physician Decision|0|||
161331482|NCT03652818|582601380|FG004|Overall Study|Physician Decision|0|||
161331483|NCT03652818|582601376|FG000|Overall Study|Lost to Follow-up|0|||
161331484|NCT03652818|582601377|FG001|Overall Study|Lost to Follow-up|1|||
161331485|NCT03652818|582601378|FG002|Overall Study|Lost to Follow-up|2|||
161331486|NCT03652818|582601379|FG003|Overall Study|Lost to Follow-up|1|||
161331487|NCT03652818|582601380|FG004|Overall Study|Lost to Follow-up|1|||
160983765|NCT04445155|581328745|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
160983766|NCT04445155|581328746|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
161237017|NCT02576938|582248420|FG001|Overall Study|Lack of Efficacy|4|||
161237018|NCT02576938|582248421|FG002|Overall Study|Lack of Efficacy|0|||
161237019|NCT02576938|582248419|FG000|Overall Study|Lost to Follow-up|2|||
161237020|NCT02576938|582248420|FG001|Overall Study|Lost to Follow-up|0|||
161237021|NCT02576938|582248421|FG002|Overall Study|Lost to Follow-up|1|||
161237022|NCT02576938|582248419|FG000|Overall Study|Physician Decision|0|||
161237023|NCT02576938|582248420|FG001|Overall Study|Physician Decision|1|||
161237024|NCT02576938|582248421|FG002|Overall Study|Physician Decision|0|||
161237025|NCT02576938|582248419|FG000|Overall Study|Met Exclusion Criteria|0|||
161237026|NCT02576938|582248420|FG001|Overall Study|Met Exclusion Criteria|1|||
161237027|NCT02576938|582248421|FG002|Overall Study|Met Exclusion Criteria|0|||
161237028|NCT00448591|582248422|FG000|Overall Study|Withdrawal by Subject|178|||
161237029|NCT00448591|582248422|FG000|Overall Study|Progressive Disease|1382|||
161237030|NCT00448591|582248422|FG000|Overall Study|Adverse Event|382|||
161237031|NCT00448591|582248422|FG000|Overall Study|Protocol Violation|41|||
161237032|NCT00448591|582248422|FG000|Overall Study|Lost to Follow-up|19|||
161237033|NCT00448591|582248422|FG000|Overall Study|Treatment Regimen Completed|70|||
161237034|NCT00448591|582248422|FG000|Overall Study|Other|154|||
161237035|NCT00448591|582248422|FG000|Overall Study|Termination of Study|70|||
161237036|NCT00571064|582248426|FG000|Overall Study|Adverse Event|13|||
161331488|NCT01854697|582601381|FG000|Overall Study|Adverse Event|1|||
161331489|NCT01854697|582601382|FG001|Overall Study|Adverse Event|0|||
161331490|NCT01854697|582601383|FG002|Overall Study|Adverse Event|0|||
161331491|NCT01854697|582601384|FG003|Overall Study|Adverse Event|0|||
161331492|NCT01854697|582601385|FG004|Overall Study|Adverse Event|1|||
161331493|NCT01854697|582601381|FG000|Overall Study|Lost to Follow-up|4|||
161331494|NCT01854697|582601382|FG001|Overall Study|Lost to Follow-up|1|||
161331495|NCT01854697|582601383|FG002|Overall Study|Lost to Follow-up|1|||
161237037|NCT00571064|582248426|FG000|Overall Study|Protocol Violation|4|||
161237038|NCT00571064|582248426|FG000|Overall Study|Withdrawal by Subject|2|||
161237039|NCT00571064|582248426|FG000|Overall Study|Other|2|||
161237040|NCT01518972|582248429|FG000|Overall Study|Lost to Follow-up|2|||
161237041|NCT01518972|582248430|FG001|Overall Study|Lost to Follow-up|1|||
161331496|NCT01854697|582601384|FG003|Overall Study|Lost to Follow-up|2|||
161331497|NCT01854697|582601385|FG004|Overall Study|Lost to Follow-up|0|||
161331498|NCT01854697|582601381|FG000|Overall Study|To enter another AbbVie study|1|||
161331499|NCT01854697|582601382|FG001|Overall Study|To enter another AbbVie study|0|||
161237042|NCT01518972|582248429|FG000|Overall Study|Withdrawal by Subject|1|||
161237043|NCT01518972|582248430|FG001|Overall Study|Withdrawal by Subject|0|||
161237044|NCT01518972|582248429|FG000|Overall Study|Moved from area|1|||
161237045|NCT01518972|582248430|FG001|Overall Study|Moved from area|0|||
161237046|NCT01518972|582248429|FG000|Overall Study|Transportation problems|1|||
161237047|NCT01518972|582248430|FG001|Overall Study|Transportation problems|0|||
161237048|NCT01518972|582248429|FG000|Overall Study|Exclusionary medical condition|1|||
161237049|NCT01518972|582248430|FG001|Overall Study|Exclusionary medical condition|0|||
161331500|NCT01854697|582601383|FG002|Overall Study|To enter another AbbVie study|0|||
161331501|NCT01854697|582601384|FG003|Overall Study|To enter another AbbVie study|0|||
160798532|NCT01215851|580651125|FG003|Treatment Period|Adverse Event|3|||
160798533|NCT01215851|580651126|FG004|Treatment Period|Adverse Event|0|||
160798534|NCT01215851|580651127|FG005|Treatment Period|Adverse Event|1|||
160798535|NCT01215851|580651122|FG000|Follow up Period|Lost to Follow-up|0|||
160798536|NCT01215851|580651123|FG001|Follow up Period|Lost to Follow-up|0|||
160798537|NCT01215851|580651124|FG002|Follow up Period|Lost to Follow-up|0|||
160798538|NCT01215851|580651125|FG003|Follow up Period|Lost to Follow-up|0|||
160798539|NCT01215851|580651126|FG004|Follow up Period|Lost to Follow-up|0|||
160798540|NCT01215851|580651127|FG005|Follow up Period|Lost to Follow-up|1|||
160798541|NCT02297412|580651128|FG000|Overall Study|Canceled|1|||
160798542|NCT02297412|580651129|FG001|Overall Study|Canceled|1|||
160798543|NCT03012880|580651130|FG000|Overall Study|Withdrawal by Subject|1|||
160798544|NCT03012880|580651131|FG001|Overall Study|Withdrawal by Subject|0|||
160798545|NCT03012880|580651130|FG000|Overall Study|Ineligible|1|||
160798546|NCT03012880|580651131|FG001|Overall Study|Ineligible|0|||
160798547|NCT00529633|580653018|FG000|Overall Study|Withdrawal by Subject|1|||
160798548|NCT00529633|580653019|FG001|Overall Study|Withdrawal by Subject|1|||
160798549|NCT01359956|580653020|FG000|Overall Study|Death|58|||
160798550|NCT01359956|580653021|FG001|Overall Study|Death|60|||
160798551|NCT01359956|580653022|FG002|Overall Study|Death|66|||
160798552|NCT01359956|580653023|FG003|Overall Study|Death|57|||
160798553|NCT01359956|580653020|FG000|Overall Study|Lost to Follow-up|3|||
160798554|NCT01359956|580653021|FG001|Overall Study|Lost to Follow-up|4|||
160798555|NCT01359956|580653022|FG002|Overall Study|Lost to Follow-up|1|||
160798556|NCT01359956|580653023|FG003|Overall Study|Lost to Follow-up|1|||
160798557|NCT01784029|580653024|FG000|Overall Study|Lost to Follow-up|19|||
160798558|NCT01784029|580653025|FG001|Overall Study|Lost to Follow-up|20|||
160798559|NCT01784029|580653026|FG002|Overall Study|Lost to Follow-up|22|||
160798560|NCT03235050|580653029|FG000|Overall Study|Adverse Event|0|||
160798561|NCT03235050|580653030|FG001|Overall Study|Adverse Event|0|||
160798562|NCT03235050|580653031|FG002|Overall Study|Adverse Event|1|||
160798563|NCT03235050|580653032|FG003|Overall Study|Adverse Event|4|||
160798564|NCT03235050|580653033|FG004|Overall Study|Adverse Event|1|||
160798565|NCT03235050|580653029|FG000|Overall Study|Death|0|||
160798566|NCT03235050|580653030|FG001|Overall Study|Death|0|||
160798567|NCT03235050|580653031|FG002|Overall Study|Death|0|||
160798568|NCT03235050|580653032|FG003|Overall Study|Death|2|||
160798569|NCT03235050|580653033|FG004|Overall Study|Death|1|||
160798570|NCT03235050|580653029|FG000|Overall Study|Lost to Follow-up|1|||
160798571|NCT03235050|580653030|FG001|Overall Study|Lost to Follow-up|2|||
160798572|NCT03235050|580653031|FG002|Overall Study|Lost to Follow-up|1|||
160798573|NCT03235050|580653032|FG003|Overall Study|Lost to Follow-up|2|||
160798574|NCT03235050|580653033|FG004|Overall Study|Lost to Follow-up|0|||
160798575|NCT03235050|580653029|FG000|Overall Study|Withdrawal by Subject|3|||
160798576|NCT03235050|580653030|FG001|Overall Study|Withdrawal by Subject|2|||
160798577|NCT03235050|580653031|FG002|Overall Study|Withdrawal by Subject|2|||
160798578|NCT03235050|580653032|FG003|Overall Study|Withdrawal by Subject|5|||
160798579|NCT03235050|580653033|FG004|Overall Study|Withdrawal by Subject|7|||
160798580|NCT03235050|580653029|FG000|Overall Study|Other reasons|0|||
160798581|NCT03235050|580653030|FG001|Overall Study|Other reasons|1|||
160798582|NCT03235050|580653031|FG002|Overall Study|Other reasons|0|||
160798583|NCT03235050|580653032|FG003|Overall Study|Other reasons|1|||
160798584|NCT03235050|580653033|FG004|Overall Study|Other reasons|2|||
160798585|NCT00069641|580653034|FG000|Overall Study|Death|1|||
160798586|NCT00069641|580653035|FG001|Overall Study|Death|0|||
160798587|NCT00069641|580653036|FG002|Overall Study|Death|1|||
160798588|NCT02704208|580653037|FG000|Overall Study|Lost to Follow-up|42|||
161237050|NCT01518972|582248429|FG000|Overall Study|Missed safety visits|0|||
160798589|NCT02704208|580653038|FG001|Overall Study|Lost to Follow-up|37|||
160798590|NCT03545672|580653039|FG000|Overall Study|Uncertain diagnosis|2|||
160798591|NCT03545672|580653040|FG001|Overall Study|Uncertain diagnosis|1|||
160798592|NCT03545672|580653039|FG000|Overall Study|Protocol Violation|2|||
160798593|NCT03545672|580653040|FG001|Overall Study|Protocol Violation|2|||
160798594|NCT02415556|580653041|FG000|Overall Study|Adverse Event|3|||
161237051|NCT01518972|582248430|FG001|Overall Study|Missed safety visits|1|||
160798595|NCT02415556|580653042|FG001|Overall Study|Adverse Event|4|||
160798596|NCT02415556|580653043|FG002|Overall Study|Adverse Event|2|||
160798597|NCT02415556|580653044|FG003|Overall Study|Adverse Event|4|||
160798598|NCT02415556|580653041|FG000|Overall Study|Lost to Follow-up|4|||
160798599|NCT02415556|580653042|FG001|Overall Study|Lost to Follow-up|5|||
161331502|NCT01854697|582601385|FG004|Overall Study|To enter another AbbVie study|1|||
161331503|NCT01854697|582601381|FG000|Overall Study|Withdrew Consent|0|||
161331504|NCT01854697|582601382|FG001|Overall Study|Withdrew Consent|1|||
161331505|NCT01854697|582601383|FG002|Overall Study|Withdrew Consent|0|||
161331506|NCT01854697|582601384|FG003|Overall Study|Withdrew Consent|1|||
161331507|NCT01854697|582601385|FG004|Overall Study|Withdrew Consent|0|||
161331508|NCT01854697|582601381|FG000|Overall Study|Other|0|||
161331509|NCT01854697|582601382|FG001|Overall Study|Other|1|||
161331510|NCT01854697|582601383|FG002|Overall Study|Other|1|||
161331511|NCT01854697|582601384|FG003|Overall Study|Other|0|||
160798600|NCT02415556|580653043|FG002|Overall Study|Lost to Follow-up|4|||
161331512|NCT01854697|582601385|FG004|Overall Study|Other|0|||
160798601|NCT02415556|580653044|FG003|Overall Study|Lost to Follow-up|1|||
160798602|NCT02415556|580653041|FG000|Overall Study|Withdrawal by Subject|13|||
160798603|NCT02415556|580653042|FG001|Overall Study|Withdrawal by Subject|4|||
160798604|NCT02415556|580653043|FG002|Overall Study|Withdrawal by Subject|14|||
160798605|NCT02415556|580653044|FG003|Overall Study|Withdrawal by Subject|12|||
160798606|NCT02415556|580653041|FG000|Overall Study|Physician Decision|1|||
160798607|NCT02415556|580653042|FG001|Overall Study|Physician Decision|3|||
160798608|NCT02415556|580653043|FG002|Overall Study|Physician Decision|1|||
160798609|NCT02415556|580653044|FG003|Overall Study|Physician Decision|2|||
160798610|NCT02415556|580653041|FG000|Overall Study|Censored - study completion|4|||
160798611|NCT02415556|580653042|FG001|Overall Study|Censored - study completion|5|||
160798612|NCT02415556|580653043|FG002|Overall Study|Censored - study completion|1|||
160798613|NCT02415556|580653044|FG003|Overall Study|Censored - study completion|0|||
160798614|NCT02415556|580653041|FG000|Overall Study|Family-related issues|0|||
160798615|NCT02415556|580653042|FG001|Overall Study|Family-related issues|0|||
160798616|NCT02415556|580653043|FG002|Overall Study|Family-related issues|0|||
160798617|NCT02415556|580653044|FG003|Overall Study|Family-related issues|1|||
160798618|NCT01209767|580653045|FG000|Overall Study|Withdrawal by Subject|1|||
160798619|NCT01209767|580653045|FG000|Overall Study|Lost to Follow-up|3|||
160798620|NCT01621178|580653046|FG000|Overall Study|Adverse Event|5|||
160798621|NCT01621178|580653047|FG001|Overall Study|Adverse Event|2|||
160798622|NCT01621178|580653048|FG002|Overall Study|Adverse Event|8|||
160798623|NCT01621178|580653046|FG000|Overall Study|Death|6|||
160798624|NCT01621178|580653047|FG001|Overall Study|Death|7|||
160798625|NCT01621178|580653048|FG002|Overall Study|Death|2|||
160798626|NCT01621178|580653046|FG000|Overall Study|Lost to Follow-up|1|||
160798627|NCT01621178|580653047|FG001|Overall Study|Lost to Follow-up|2|||
160798628|NCT01621178|580653048|FG002|Overall Study|Lost to Follow-up|1|||
160798629|NCT01621178|580653046|FG000|Overall Study|Withdrawal by Subject|14|||
160798630|NCT01621178|580653047|FG001|Overall Study|Withdrawal by Subject|17|||
160798631|NCT01621178|580653048|FG002|Overall Study|Withdrawal by Subject|18|||
160798632|NCT01621178|580653046|FG000|Overall Study|Physician Decision|5|||
160798633|NCT01621178|580653047|FG001|Overall Study|Physician Decision|2|||
160798634|NCT01621178|580653048|FG002|Overall Study|Physician Decision|7|||
160798635|NCT02935192|580653049|FG000|Overall Study|Withdrawal by Subject|8|||
160798636|NCT02935192|580653050|FG001|Overall Study|Withdrawal by Subject|4|||
160798637|NCT00492557|580653052|FG000|Overall Study|Subject request|12|||
160798638|NCT00492557|580653053|FG001|Overall Study|Subject request|11|||
160798639|NCT00492557|580653052|FG000|Overall Study|Protocol Violation|7|||
160798640|NCT00492557|580653053|FG001|Overall Study|Protocol Violation|8|||
160798641|NCT00492557|580653052|FG000|Overall Study|Other|2|||
160798642|NCT00492557|580653053|FG001|Overall Study|Other|2|||
160798643|NCT00492557|580653052|FG000|Overall Study|Death|1|||
160798644|NCT00492557|580653053|FG001|Overall Study|Death|1|||
160798645|NCT00492557|580653052|FG000|Overall Study|Adverse Event|1|||
160798646|NCT00492557|580653053|FG001|Overall Study|Adverse Event|0|||
160798647|NCT00492557|580653052|FG000|Overall Study|Failed to return|1|||
160798648|NCT00492557|580653053|FG001|Overall Study|Failed to return|0|||
160798649|NCT00492557|580653052|FG000|Overall Study|Lost to Follow-up|0|||
160798650|NCT00492557|580653053|FG001|Overall Study|Lost to Follow-up|1|||
160798651|NCT04778592|580653057|FG000|Overall Study|Adverse Event|1|||
160798652|NCT04778592|580653058|FG001|Overall Study|Adverse Event|2|||
160798653|NCT04778592|580653057|FG000|Overall Study|Withdrawal by Subject|1|||
160798654|NCT04778592|580653058|FG001|Overall Study|Withdrawal by Subject|2|||
160798655|NCT01354223|580653060|FG000|Overall Study|Withdrawal by Subject|3|||
160798656|NCT01354223|580653061|FG001|Overall Study|Withdrawal by Subject|1|||
160798657|NCT04102007|580653065|FG000|Overall Study|Adverse Event|4|||
160798658|NCT04102007|580653065|FG000|Overall Study|Lost to Follow-up|3|||
160798659|NCT04102007|580653065|FG000|Overall Study|Withdrawal by Subject|12|||
160798660|NCT04102007|580653065|FG000|Overall Study|Eligibility Violation|5|||
160798661|NCT04102007|580653065|FG000|Overall Study|Lack of Efficacy|6|||
161331513|NCT02771275|582601390|FG000|Overall Study|Reoperation|3|||
161331514|NCT02771275|582601390|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
161331515|NCT05556148|582601391|FG000|Overall Study|Early Termination|29|||
160798662|NCT04102007|580653065|FG000|Overall Study|Protocol Deviation|5|||
160798663|NCT04102007|580653065|FG000|Overall Study|Protocol Compliance|1|||
160798664|NCT04102007|580653065|FG000|Overall Study|Withdrew Treatment|2|||
161331516|NCT05556148|582601391|FG000|Overall Study|Baseline Tasks Expired|4|||
161237052|NCT01518972|582248429|FG000|Overall Study|Exclusionary medication|0|||
161237053|NCT01518972|582248430|FG001|Overall Study|Exclusionary medication|1|||
161237054|NCT01518972|582248429|FG000|Overall Study|Declined medication starting on day 12|0|||
161237055|NCT01518972|582248430|FG001|Overall Study|Declined medication starting on day 12|1|||
161237056|NCT00003659|582248432|FG000|Overall Study|Withdrawal by Subject|3|||
161237057|NCT04022954|582248433|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
161237058|NCT04022954|582248433|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
161237059|NCT04022954|582248433|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
161237060|NCT03637764|582248434|FG000|Overall Study|Adverse Event|2|||
161237061|NCT03637764|582248435|FG001|Overall Study|Adverse Event|0|||
161237062|NCT03637764|582248436|FG002|Overall Study|Adverse Event|0|||
161237063|NCT03637764|582248437|FG003|Overall Study|Adverse Event|1|||
161237064|NCT03637764|582248434|FG000|Overall Study|Progressive Disease|23|||
161237065|NCT03637764|582248435|FG001|Overall Study|Progressive Disease|23|||
161237066|NCT03637764|582248436|FG002|Overall Study|Progressive Disease|18|||
161237067|NCT03637764|582248437|FG003|Overall Study|Progressive Disease|31|||
161237068|NCT03637764|582248434|FG000|Overall Study|Withdrawal by Subject|1|||
161237069|NCT03637764|582248435|FG001|Overall Study|Withdrawal by Subject|3|||
161237070|NCT03637764|582248436|FG002|Overall Study|Withdrawal by Subject|0|||
161237071|NCT03637764|582248437|FG003|Overall Study|Withdrawal by Subject|1|||
161237072|NCT02648438|582248438|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161237073|NCT02648438|582248439|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161237074|NCT02648438|582248440|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161237075|NCT02648438|582248438|FG000|Overall Study|Protocol Violation|2|||
161237076|NCT02648438|582248439|FG001|Overall Study|Protocol Violation|0|||
161237077|NCT02648438|582248440|FG002|Overall Study|Protocol Violation|0|||
161237078|NCT02648438|582248438|FG000|Overall Study|Withdrawal by Subject|1|||
161237079|NCT02648438|582248439|FG001|Overall Study|Withdrawal by Subject|1|||
161237080|NCT02648438|582248440|FG002|Overall Study|Withdrawal by Subject|0|||
161237081|NCT03138967|582248441|FG000|Overall Study|Death|0|||
161237082|NCT03138967|582248442|FG001|Overall Study|Death|1|||
161237083|NCT03138967|582248441|FG000|Overall Study|Physician Decision|1|||
161237084|NCT03138967|582248442|FG001|Overall Study|Physician Decision|3|||
161237085|NCT04604275|582248445|FG000|Washout-1 Week|Withdrawal by Subject|1|||
161237086|NCT04604275|582248446|FG001|Washout-1 Week|Withdrawal by Subject|0|||
161237087|NCT04405570|582248447|FG000|Overall Study|Adverse Event|0|||
161237088|NCT04405570|582248448|FG001|Overall Study|Adverse Event|1|||
161237089|NCT04405570|582248449|FG002|Overall Study|Adverse Event|1|||
161237090|NCT04405570|582248450|FG003|Overall Study|Adverse Event|1|||
161237091|NCT04405570|582248447|FG000|Overall Study|Lost to Follow-up|0|||
161237092|NCT04405570|582248448|FG001|Overall Study|Lost to Follow-up|1|||
161237093|NCT04405570|582248449|FG002|Overall Study|Lost to Follow-up|0|||
161237094|NCT04405570|582248450|FG003|Overall Study|Lost to Follow-up|0|||
161237095|NCT04405570|582248447|FG000|Overall Study|Physician Decision|0|||
161237096|NCT04405570|582248448|FG001|Overall Study|Physician Decision|0|||
161237097|NCT04405570|582248449|FG002|Overall Study|Physician Decision|1|||
161237098|NCT04405570|582248450|FG003|Overall Study|Physician Decision|0|||
160798665|NCT04102007|580653065|FG000|Overall Study|Pregnancy|1|||
161237099|NCT04405570|582248447|FG000|Overall Study|Withdrawal by Subject|0|||
161237100|NCT04405570|582248448|FG001|Overall Study|Withdrawal by Subject|1|||
161237101|NCT04405570|582248449|FG002|Overall Study|Withdrawal by Subject|1|||
161237102|NCT04405570|582248450|FG003|Overall Study|Withdrawal by Subject|0|||
161237103|NCT04405570|582248447|FG000|Overall Study|Randomized not dosed|0|||
161237104|NCT04405570|582248448|FG001|Overall Study|Randomized not dosed|2|||
161237105|NCT04405570|582248449|FG002|Overall Study|Randomized not dosed|0|||
161237106|NCT04405570|582248450|FG003|Overall Study|Randomized not dosed|0|||
161237107|NCT04499963|582248451|FG000|Overall Study|Adverse Event|3|||
161237108|NCT04499963|582248452|FG001|Overall Study|Adverse Event|0|||
161237109|NCT04499963|582248451|FG000|Overall Study|Death|3|||
161237110|NCT04499963|582248452|FG001|Overall Study|Death|0|||
161237111|NCT04499963|582248451|FG000|Overall Study|Lack of Efficacy|7|||
160798666|NCT05173974|580653066|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
160798667|NCT05173974|580653067|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
160798668|NCT05173974|580653068|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
161237112|NCT04499963|582248452|FG001|Overall Study|Lack of Efficacy|0|||
161237113|NCT04499963|582248451|FG000|Overall Study|Lost to Follow-up|2|||
161237114|NCT04499963|582248452|FG001|Overall Study|Lost to Follow-up|0|||
161237115|NCT02601625|582248456|FG000|Overall Study|Lost to Follow-up|0|||
161237116|NCT02601625|582248457|FG001|Overall Study|Lost to Follow-up|0|||
161237117|NCT02601625|582248458|FG002|Overall Study|Lost to Follow-up|1|||
161237118|NCT02601625|582248459|FG003|Overall Study|Lost to Follow-up|1|||
161237119|NCT00838279|582248460|FG000|Washout|Protocol Violation|1|||
161237120|NCT00838279|582248461|FG001|Washout|Protocol Violation|0|||
161237121|NCT00838279|582248460|FG000|Washout|Withdrawal by Subject|0|||
161237122|NCT00838279|582248461|FG001|Washout|Withdrawal by Subject|1|||
161237123|NCT04608188|582248462|FG000|Overall Study|Withdrawal by Subject|4|||
161237124|NCT04608188|582248463|FG001|Overall Study|Withdrawal by Subject|8|||
161237125|NCT04419311|582248465|FG000|Overall Study|Lost to Follow-up|1|||
160798669|NCT05173974|580653069|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
160798670|NCT05173974|580653066|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
160798671|NCT05173974|580653067|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
160798672|NCT05173974|580653068|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
160798673|NCT05173974|580653069|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
160798674|NCT04047446|580653070|FG000|Overall Study|Physician Decision|1|||
160798675|NCT04047446|580653071|FG001|Overall Study|Physician Decision|0|||
160798676|NCT00329420|580653072|FG000|Re-induction Phase|Lack of Efficacy|0|||
160798677|NCT00329420|580653073|FG001|Re-induction Phase|Lack of Efficacy|1|||
160798678|NCT00329420|580653074|FG002|Re-induction Phase|Lack of Efficacy|0|||
160798679|NCT00329420|580653072|FG000|Re-induction Phase|Withdrawal of Consent|0|||
160798680|NCT00329420|580653073|FG001|Re-induction Phase|Withdrawal of Consent|0|||
160798681|NCT00329420|580653074|FG002|Re-induction Phase|Withdrawal of Consent|1|||
160798682|NCT00329420|580653072|FG000|Re-induction Phase|Did not respond to re-induction|6|||
160798683|NCT00329420|580653073|FG001|Re-induction Phase|Did not respond to re-induction|5|||
160798684|NCT00329420|580653074|FG002|Re-induction Phase|Did not respond to re-induction|7|||
160798685|NCT00329420|580653072|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
160798686|NCT00329420|580653073|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
160798687|NCT00329420|580653074|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
160798688|NCT00329420|580653072|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
160798689|NCT00329420|580653073|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
160798690|NCT00329420|580653074|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
160798691|NCT00329420|580653072|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
160798692|NCT00329420|580653073|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
160798693|NCT00329420|580653074|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
160798694|NCT01446874|580653075|FG000|Overall Study|Not eligible|1|||
160798695|NCT01446874|580653076|FG001|Overall Study|Not eligible|0|||
160798696|NCT01446874|580653077|FG002|Overall Study|Not eligible|0|||
160798697|NCT01446874|580653075|FG000|Overall Study|No surgery/No qualifying surgery|1|||
160798698|NCT01446874|580653076|FG001|Overall Study|No surgery/No qualifying surgery|0|||
160798699|NCT01446874|580653077|FG002|Overall Study|No surgery/No qualifying surgery|12|||
160798700|NCT01446874|580653075|FG000|Overall Study|Non-compliance|0|||
160798701|NCT01446874|580653076|FG001|Overall Study|Non-compliance|4|||
160798702|NCT01446874|580653077|FG002|Overall Study|Non-compliance|0|||
160895211|NCT02413372|581012855|FG002|Treatment|Lost to Follow-up|1|||
160895212|NCT02413372|581012853|FG000|Treatment|Withdrawal by Subject|1|||
160895213|NCT02413372|581012854|FG001|Treatment|Withdrawal by Subject|0|||
160895214|NCT02413372|581012855|FG002|Treatment|Withdrawal by Subject|0|||
160895215|NCT02413372|581012853|FG000|Follow-up|Lost to Follow-up|1|||
160895216|NCT02413372|581012854|FG001|Follow-up|Lost to Follow-up|1|||
161129651|NCT01194440|581860911|FG000|6-months (2nd Dose)|Change in therapy|4|||
161129652|NCT02959814|581860924|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
161129653|NCT02959814|581860924|FG000|Overall Study|Excluded based on anatomical criteria|2|||
161129654|NCT02959814|581860924|FG000|Overall Study|Protocol Violation|7|||
161129655|NCT02959814|581860924|FG000|Overall Study|FFR not measured|2|||
161129656|NCT02959814|581860924|FG000|Overall Study|In-procedure QFR not computed|6|||
161129657|NCT02959814|581860924|FG000|Overall Study|Excluded by FFR core-lab|24|||
161129658|NCT04343651|581860928|FG000|Overall Study|Physician Decision|2|||
161129659|NCT04343651|581860929|FG001|Overall Study|Physician Decision|1|||
161129660|NCT04343651|581860928|FG000|Overall Study|Lost to Follow-up|2|||
161129661|NCT04343651|581860929|FG001|Overall Study|Lost to Follow-up|1|||
161129662|NCT04343651|581860928|FG000|Overall Study|Protocol Violation|4|||
161129663|NCT04343651|581860929|FG001|Overall Study|Protocol Violation|6|||
161129664|NCT04343651|581860928|FG000|Overall Study|Missing|3|||
161129665|NCT04343651|581860929|FG001|Overall Study|Missing|9|||
161129666|NCT04343651|581860928|FG000|Overall Study|Withdrawal by Subject|0|||
161129667|NCT04343651|581860929|FG001|Overall Study|Withdrawal by Subject|4|||
161129668|NCT04343651|581860928|FG000|Overall Study|Death|0|||
161129669|NCT04343651|581860929|FG001|Overall Study|Death|1|||
161129670|NCT04343651|581860928|FG000|Overall Study|Did not start treatment|1|||
161129671|NCT04343651|581860929|FG001|Overall Study|Did not start treatment|1|||
161129672|NCT04343651|581860928|FG000|Overall Study|Patient did not complete visits 3-6|0|||
161237126|NCT04419311|582248466|FG001|Overall Study|Lost to Follow-up|0|||
160798703|NCT01446874|580653075|FG000|Overall Study|Antibiotics for pre-op infection|0|||
160798704|NCT01446874|580653076|FG001|Overall Study|Antibiotics for pre-op infection|0|||
160798705|NCT01446874|580653077|FG002|Overall Study|Antibiotics for pre-op infection|2|||
160895217|NCT02413372|581012855|FG002|Follow-up|Lost to Follow-up|0|||
160895218|NCT02413372|581012853|FG000|Follow-up|Subject Withdrew Consent|1|||
160895219|NCT02413372|581012854|FG001|Follow-up|Subject Withdrew Consent|0|||
160895220|NCT02413372|581012855|FG002|Follow-up|Subject Withdrew Consent|1|||
161129673|NCT04343651|581860929|FG001|Overall Study|Patient did not complete visits 3-6|1|||
161129674|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
161129675|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
161237127|NCT03586726|582248469|FG000|Overall Study|Withdrawal by Subject|1|||
160798706|NCT01446874|580653075|FG000|Overall Study|Withdrawal by Subject|0|||
160798707|NCT01446874|580653076|FG001|Overall Study|Withdrawal by Subject|0|||
160798708|NCT01446874|580653077|FG002|Overall Study|Withdrawal by Subject|4|||
160798709|NCT01977898|580653078|FG000|Overall Study|Non functioning catheter|1|||
160798710|NCT01977898|580653079|FG001|Overall Study|Non functioning catheter|1|||
160798711|NCT03386773|580653080|FG000|Overall Study|Lost to Follow-up|24|||
160798712|NCT03386773|580653081|FG001|Overall Study|Lost to Follow-up|33|||
160798713|NCT03386773|580653080|FG000|Overall Study|Withdrawal by Subject|3|||
160798714|NCT03386773|580653081|FG001|Overall Study|Withdrawal by Subject|2|||
160798715|NCT03983421|580653082|FG000|Overall Study|Lost to Follow-up|1|||
160798716|NCT03639610|580653083|FG000|Overall Study|Adverse Event|7|||
160798717|NCT03639610|580653084|FG001|Overall Study|Adverse Event|1|||
160798718|NCT03639610|580653085|FG002|Overall Study|Adverse Event|0|||
160798719|NCT03639610|580653083|FG000|Overall Study|Physician Decision|3|||
160798720|NCT03639610|580653084|FG001|Overall Study|Physician Decision|1|||
160798721|NCT03639610|580653085|FG002|Overall Study|Physician Decision|0|||
160798722|NCT03639610|580653083|FG000|Overall Study|Disease progression|8|||
160798723|NCT03639610|580653084|FG001|Overall Study|Disease progression|5|||
160798724|NCT03639610|580653085|FG002|Overall Study|Disease progression|3|||
160798725|NCT03639610|580653083|FG000|Overall Study|Study terminated by sponsor|2|||
160798726|NCT03639610|580653084|FG001|Overall Study|Study terminated by sponsor|1|||
160798727|NCT03639610|580653085|FG002|Overall Study|Study terminated by sponsor|1|||
160798728|NCT03639610|580653083|FG000|Overall Study|Patient request to stop treatment|1|||
160798729|NCT03639610|580653084|FG001|Overall Study|Patient request to stop treatment|2|||
160798730|NCT03639610|580653085|FG002|Overall Study|Patient request to stop treatment|0|||
160798731|NCT02660229|580653086|FG000|Overall Study|Adverse Event|2|||
160798732|NCT02660229|580653087|FG001|Overall Study|Adverse Event|0|||
160798733|NCT02660229|580653086|FG000|Overall Study|Withdrawal by Subject|0|||
160798734|NCT02660229|580653087|FG001|Overall Study|Withdrawal by Subject|1|||
160798735|NCT02727322|580653091|FG000|Overall Study|Withdrawal by Subject|1|||
160798736|NCT02727322|580653092|FG001|Overall Study|Withdrawal by Subject|1|||
160798737|NCT02727322|580653091|FG000|Overall Study|Protocol Violation|1|||
160798738|NCT02727322|580653092|FG001|Overall Study|Protocol Violation|0|||
160798739|NCT01049373|580653093|FG000|Overall Study|Protocol Violation|9|||
160798740|NCT01049373|580653094|FG001|Overall Study|Protocol Violation|9|||
160798741|NCT01049373|580653093|FG000|Overall Study|Withdrawal by Subject|8|||
160798742|NCT01049373|580653094|FG001|Overall Study|Withdrawal by Subject|5|||
160798743|NCT01049373|580653093|FG000|Overall Study|Adverse Event|3|||
160798744|NCT01049373|580653094|FG001|Overall Study|Adverse Event|3|||
160798745|NCT01049373|580653093|FG000|Overall Study|Lost to Follow-up|9|||
160798746|NCT01049373|580653094|FG001|Overall Study|Lost to Follow-up|4|||
160798747|NCT01049373|580653093|FG000|Overall Study|no evaluable study values|9|||
160798748|NCT01049373|580653094|FG001|Overall Study|no evaluable study values|21|||
160798749|NCT01049373|580653093|FG000|Overall Study|Other|1|||
160798750|NCT01049373|580653094|FG001|Overall Study|Other|1|||
160798751|NCT01049373|580653093|FG000|Overall Study|Non-cooperation|0|||
160798752|NCT01049373|580653094|FG001|Overall Study|Non-cooperation|1|||
160798753|NCT01517984|580653095|FG000|Overall Study|Lost to Follow-up|0|||
160798754|NCT01517984|580653096|FG001|Overall Study|Lost to Follow-up|1|||
160798755|NCT01517984|580653097|FG002|Overall Study|Lost to Follow-up|0|||
160798756|NCT01517984|580653098|FG003|Overall Study|Lost to Follow-up|0|||
160798757|NCT01517984|580653095|FG000|Overall Study|Withdrawal by Subject|1|||
160798758|NCT01517984|580653096|FG001|Overall Study|Withdrawal by Subject|8|||
160798759|NCT01517984|580653097|FG002|Overall Study|Withdrawal by Subject|4|||
160798760|NCT01517984|580653098|FG003|Overall Study|Withdrawal by Subject|1|||
160798761|NCT01517984|580653095|FG000|Overall Study|Screen Failure|4|||
160798762|NCT01517984|580653096|FG001|Overall Study|Screen Failure|0|||
160798763|NCT01517984|580653097|FG002|Overall Study|Screen Failure|0|||
160798764|NCT01517984|580653098|FG003|Overall Study|Screen Failure|0|||
160798765|NCT01517984|580653095|FG000|Overall Study|Ineligible for randomization|0|||
160798766|NCT01517984|580653096|FG001|Overall Study|Ineligible for randomization|14|||
160798767|NCT01517984|580653097|FG002|Overall Study|Ineligible for randomization|0|||
160798768|NCT01517984|580653098|FG003|Overall Study|Ineligible for randomization|0|||
160798769|NCT01198587|580653101|FG000|Overall Study|Lost to Follow-up|8|||
160798770|NCT01198587|580653102|FG001|Overall Study|Lost to Follow-up|0|||
160798771|NCT01198587|580653103|FG002|Overall Study|Lost to Follow-up|9|||
160798772|NCT01198587|580653104|FG003|Overall Study|Lost to Follow-up|0|||
160798773|NCT01496287|580653105|FG000|Overall Study|Lost to Follow-up|1|||
160798774|NCT01496287|580653105|FG000|Overall Study|Incomplete anesthesia|5|||
160798775|NCT01959529|580653106|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
160798776|NCT01959529|580653107|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
160798777|NCT01959529|580653106|FG000|Overall Study|Lost to Follow-up|4|||
160798778|NCT01959529|580653107|FG001|Overall Study|Lost to Follow-up|1|||
160798779|NCT01959529|580653106|FG000|Overall Study|Other|70|||
161237128|NCT01921062|582248470|FG000|Overall Study|Withdrawal by Subject|0|||
160798780|NCT01959529|580653107|FG001|Overall Study|Other|68|||
160798781|NCT01959529|580653106|FG000|Overall Study|Hypoglycaemia|1|||
160798782|NCT01959529|580653107|FG001|Overall Study|Hypoglycaemia|1|||
160798783|NCT01959529|580653106|FG000|Overall Study|Lack of glycaemic control|1|||
160798784|NCT01959529|580653107|FG001|Overall Study|Lack of glycaemic control|1|||
160798785|NCT00557193|580653108|FG000|Induction|Adverse Event|2|||
160798786|NCT00557193|580653109|FG001|Induction|Adverse Event|0|||
160798787|NCT00557193|580653110|FG002|Induction|Adverse Event|0|||
160798788|NCT00557193|580653111|FG003|Induction|Adverse Event|0|||
160798789|NCT00557193|580653112|FG004|Induction|Adverse Event|0|||
160798790|NCT00557193|580653113|FG005|Induction|Adverse Event|0|||
160798791|NCT00557193|580653108|FG000|Induction|Death|6|||
160798792|NCT00557193|580653109|FG001|Induction|Death|0|||
160798793|NCT00557193|580653110|FG002|Induction|Death|0|||
160798794|NCT00557193|580653111|FG003|Induction|Death|0|||
160798795|NCT00557193|580653112|FG004|Induction|Death|0|||
160798796|NCT00557193|580653113|FG005|Induction|Death|0|||
160798797|NCT00557193|580653108|FG000|Induction|Physician Decision|3|||
160798798|NCT00557193|580653109|FG001|Induction|Physician Decision|0|||
160798799|NCT00557193|580653110|FG002|Induction|Physician Decision|0|||
160798800|NCT00557193|580653111|FG003|Induction|Physician Decision|0|||
160798801|NCT00557193|580653112|FG004|Induction|Physician Decision|0|||
160798802|NCT00557193|580653113|FG005|Induction|Physician Decision|0|||
160798803|NCT00557193|580653108|FG000|Induction|Withdrawal by Subject|1|||
160798804|NCT00557193|580653109|FG001|Induction|Withdrawal by Subject|0|||
160798805|NCT00557193|580653110|FG002|Induction|Withdrawal by Subject|0|||
160798806|NCT00557193|580653111|FG003|Induction|Withdrawal by Subject|0|||
160798807|NCT00557193|580653112|FG004|Induction|Withdrawal by Subject|0|||
160798808|NCT00557193|580653113|FG005|Induction|Withdrawal by Subject|0|||
160798809|NCT00557193|580653108|FG000|Induction|Refusal of Further Protocol Therapy|2|||
160798810|NCT00557193|580653109|FG001|Induction|Refusal of Further Protocol Therapy|0|||
160798811|NCT00557193|580653110|FG002|Induction|Refusal of Further Protocol Therapy|0|||
160798812|NCT00557193|580653111|FG003|Induction|Refusal of Further Protocol Therapy|0|||
160895221|NCT02413372|581012853|FG000|Follow-up|Subject unable to return for visit|0|||
160895222|NCT02413372|581012854|FG001|Follow-up|Subject unable to return for visit|0|||
160895223|NCT02413372|581012855|FG002|Follow-up|Subject unable to return for visit|1|||
160895224|NCT00369122|581012857|FG000|Overall Study|Ineligible|10|||
160895225|NCT00369122|581012857|FG000|Overall Study|No protocol treatment|1|||
160895226|NCT03633617|581012859|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
160895227|NCT03633617|581012860|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
160895228|NCT03633617|581012861|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895229|NCT03633617|581012862|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895230|NCT03633617|581012863|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895231|NCT03633617|581012864|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895232|NCT03633617|581012865|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895233|NCT03633617|581012866|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895234|NCT03633617|581012867|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895235|NCT03633617|581012868|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895236|NCT03633617|581012869|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
160895237|NCT03633617|581012859|FG000|Part A|Unconfirmed early termination visit|1|||
160895238|NCT03633617|581012860|FG001|Part A|Unconfirmed early termination visit|0|||
160895239|NCT03633617|581012861|FG002|Part A|Unconfirmed early termination visit|0|||
160895240|NCT03633617|581012862|FG003|Part A|Unconfirmed early termination visit|0|||
160895241|NCT03633617|581012863|FG004|Part A|Unconfirmed early termination visit|0|||
160895242|NCT03633617|581012864|FG005|Part A|Unconfirmed early termination visit|0|||
160895243|NCT03633617|581012865|FG006|Part A|Unconfirmed early termination visit|0|||
160895244|NCT03633617|581012866|FG007|Part A|Unconfirmed early termination visit|0|||
160895245|NCT03633617|581012867|FG008|Part A|Unconfirmed early termination visit|0|||
160895246|NCT03633617|581012868|FG009|Part A|Unconfirmed early termination visit|0|||
160895247|NCT03633617|581012869|FG010|Part A|Unconfirmed early termination visit|0|||
160895248|NCT03633617|581012859|FG000|Part A|Adverse Event|0|||
161237129|NCT01921062|582248471|FG001|Overall Study|Withdrawal by Subject|7|||
161237130|NCT01921062|582248470|FG000|Overall Study|Adverse Event|5|||
161237131|NCT01921062|582248471|FG001|Overall Study|Adverse Event|6|||
160798813|NCT00557193|580653112|FG004|Induction|Refusal of Further Protocol Therapy|0|||
160798814|NCT00557193|580653113|FG005|Induction|Refusal of Further Protocol Therapy|0|||
160798815|NCT00557193|580653108|FG000|Induction|Ineligible|8|||
160798816|NCT00557193|580653109|FG001|Induction|Ineligible|0|||
160798817|NCT00557193|580653110|FG002|Induction|Ineligible|0|||
160798818|NCT00557193|580653111|FG003|Induction|Ineligible|0|||
160798819|NCT00557193|580653112|FG004|Induction|Ineligible|0|||
160798820|NCT00557193|580653113|FG005|Induction|Ineligible|0|||
160798821|NCT00557193|580653108|FG000|Induction|Inevaluable for post Induction|2|||
161237132|NCT01921062|582248470|FG000|Overall Study|Protocol Violation|0|||
160798822|NCT00557193|580653109|FG001|Induction|Inevaluable for post Induction|0|||
160798823|NCT00557193|580653110|FG002|Induction|Inevaluable for post Induction|0|||
160798824|NCT00557193|580653111|FG003|Induction|Inevaluable for post Induction|0|||
160798825|NCT00557193|580653112|FG004|Induction|Inevaluable for post Induction|0|||
160798826|NCT00557193|580653113|FG005|Induction|Inevaluable for post Induction|0|||
160798827|NCT00557193|580653108|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
160798828|NCT00557193|580653109|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798829|NCT00557193|580653110|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798830|NCT00557193|580653111|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798831|NCT00557193|580653112|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798832|NCT00557193|580653113|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
160798833|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160798834|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
160798835|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
160798836|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
161237133|NCT01921062|582248471|FG001|Overall Study|Protocol Violation|1|||
161237134|NCT01921062|582248470|FG000|Overall Study|VMIQ score > 72|4|||
161237135|NCT01921062|582248471|FG001|Overall Study|VMIQ score > 72|1|||
161237136|NCT01921062|582248470|FG000|Overall Study|Logistic error|0|||
161237137|NCT01921062|582248471|FG001|Overall Study|Logistic error|1|||
161237138|NCT00965185|582248472|FG000|Overall Study|Lost to Follow-up|2|||
161237139|NCT00965185|582248473|FG001|Overall Study|Lost to Follow-up|0|||
161237140|NCT00965185|582248472|FG000|Overall Study|Withdrawal by Subject|0|||
161237141|NCT00965185|582248473|FG001|Overall Study|Withdrawal by Subject|1|||
161237142|NCT03686033|582248474|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
161237143|NCT03686033|582248475|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
161237144|NCT03686033|582248476|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
161237145|NCT03686033|582248477|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
161237146|NCT03686033|582248478|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
161237147|NCT03686033|582248479|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
161237148|NCT01854047|582248480|FG000|Overall Study|Lack of Efficacy|1|||
160798837|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
160798838|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
160798839|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
160798840|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
160798841|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
161237149|NCT01854047|582248481|FG001|Overall Study|Lack of Efficacy|0|||
161237150|NCT01854047|582248482|FG002|Overall Study|Lack of Efficacy|0|||
161237151|NCT01854047|582248483|FG003|Overall Study|Lack of Efficacy|0|||
161237152|NCT01854047|582248484|FG004|Overall Study|Lack of Efficacy|0|||
161237153|NCT01854047|582248480|FG000|Overall Study|Poor compliance to protocol|3|||
161237154|NCT01854047|582248481|FG001|Overall Study|Poor compliance to protocol|0|||
161237155|NCT01854047|582248482|FG002|Overall Study|Poor compliance to protocol|2|||
161237156|NCT01854047|582248483|FG003|Overall Study|Poor compliance to protocol|0|||
161237157|NCT01854047|582248484|FG004|Overall Study|Poor compliance to protocol|0|||
161237158|NCT01854047|582248480|FG000|Overall Study|Adverse Event|5|||
161237159|NCT01854047|582248481|FG001|Overall Study|Adverse Event|4|||
161237160|NCT01854047|582248482|FG002|Overall Study|Adverse Event|6|||
161237161|NCT01854047|582248483|FG003|Overall Study|Adverse Event|10|||
161237162|NCT01854047|582248484|FG004|Overall Study|Adverse Event|7|||
161237163|NCT01854047|582248480|FG000|Overall Study|Randomized but not treated|0|||
161237164|NCT01854047|582248481|FG001|Overall Study|Randomized but not treated|1|||
161237165|NCT01854047|582248482|FG002|Overall Study|Randomized but not treated|2|||
161237166|NCT01854047|582248483|FG003|Overall Study|Randomized but not treated|0|||
161237167|NCT01854047|582248484|FG004|Overall Study|Randomized but not treated|4|||
161237168|NCT01854047|582248480|FG000|Overall Study|Other than specified above|3|||
161237169|NCT01854047|582248481|FG001|Overall Study|Other than specified above|3|||
160798842|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
160798843|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
160895249|NCT03633617|581012860|FG001|Part A|Adverse Event|1|||
160895250|NCT03633617|581012861|FG002|Part A|Adverse Event|0|||
160895251|NCT03633617|581012862|FG003|Part A|Adverse Event|0|||
160895252|NCT03633617|581012863|FG004|Part A|Adverse Event|0|||
160895253|NCT03633617|581012864|FG005|Part A|Adverse Event|0|||
160895254|NCT03633617|581012865|FG006|Part A|Adverse Event|0|||
160895255|NCT03633617|581012866|FG007|Part A|Adverse Event|0|||
160895256|NCT03633617|581012867|FG008|Part A|Adverse Event|0|||
160895257|NCT03633617|581012868|FG009|Part A|Adverse Event|0|||
160895258|NCT03633617|581012869|FG010|Part A|Adverse Event|0|||
160895259|NCT03633617|581012859|FG000|Part A|Pregnancy|1|||
160895260|NCT03633617|581012860|FG001|Part A|Pregnancy|0|||
161237170|NCT01854047|582248482|FG002|Overall Study|Other than specified above|3|||
161237171|NCT01854047|582248483|FG003|Overall Study|Other than specified above|5|||
161237172|NCT01854047|582248484|FG004|Overall Study|Other than specified above|8|||
161237173|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
161237174|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
161237175|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
161237176|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
160895261|NCT03633617|581012861|FG002|Part A|Pregnancy|0|||
160798844|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
160798845|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
160798846|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
160798847|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
160798848|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
160798849|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
160798850|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
160798851|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
160798852|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
160798853|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
160798854|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
160798855|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
160798856|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
160798857|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
160798858|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
160798859|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
160798860|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
160798861|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
160798862|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
160798863|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798864|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160895262|NCT03633617|581012862|FG003|Part A|Pregnancy|0|||
160895263|NCT03633617|581012863|FG004|Part A|Pregnancy|0|||
160895264|NCT03633617|581012864|FG005|Part A|Pregnancy|0|||
160895265|NCT03633617|581012865|FG006|Part A|Pregnancy|0|||
160895266|NCT03633617|581012866|FG007|Part A|Pregnancy|0|||
160895267|NCT03633617|581012867|FG008|Part A|Pregnancy|0|||
160895268|NCT03633617|581012868|FG009|Part A|Pregnancy|0|||
161129676|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
161129677|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161129678|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161129679|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161129680|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161129681|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161129682|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
161129683|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
161129684|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
161129685|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
161129686|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161129687|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161129688|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161129689|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161129690|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161129691|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161129692|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161129693|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
161129694|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129695|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129696|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129697|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129698|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129699|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129700|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
161129701|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
161129702|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
161129703|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
161129704|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161129705|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161129706|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161129707|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161129708|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161129709|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161129710|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
161129711|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
161129712|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161237177|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
161237178|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
161237179|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
161237180|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
161237181|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
161237182|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
161237183|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
161237184|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
161237185|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161237186|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161237187|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
161237188|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
161237189|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
161237190|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
161237191|NCT01045161|582248485|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
161237192|NCT01045161|582248486|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
161237193|NCT01045161|582248487|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
161237194|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
161237195|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
161237196|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
161237197|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
161237198|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
161237199|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
161237200|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
161237201|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
161237202|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
161237203|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
161237204|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
161237205|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
161237206|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
161237207|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
161237208|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
161237209|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
161237210|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
161237211|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
161237212|NCT01045161|582248485|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
161237213|NCT01045161|582248486|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
161237214|NCT01045161|582248487|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
161237215|NCT02374853|582248496|FG000|Overall Study|Surgery Cancelled|5|||
161237216|NCT02374853|582248497|FG001|Overall Study|Surgery Cancelled|11|||
160798865|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
160798866|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798867|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798868|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
160798869|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798870|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798871|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
160798872|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798873|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798874|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
160798875|NCT00557193|580653108|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798876|NCT00557193|580653109|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798877|NCT00557193|580653110|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
160798878|NCT00557193|580653111|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798879|NCT00557193|580653112|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
160798880|NCT00557193|580653113|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
160798881|NCT02434081|580653116|FG000|Overall Study|Death (never started treatment)|2|||
160798882|NCT02434081|580653116|FG000|Overall Study|Death|2|||
160798883|NCT02434081|580653116|FG000|Overall Study|Progression|20|||
160895269|NCT03633617|581012869|FG010|Part A|Pregnancy|0|||
161237217|NCT02281084|582248499|FG000|Overall Study|Death|21|||
161237218|NCT02281084|582248500|FG001|Overall Study|Death|18|||
160895270|NCT03633617|581012859|FG000|Part A|Withdrawal by Subject|0|||
160798884|NCT02434081|580653116|FG000|Overall Study|Adverse Event|20|||
160895271|NCT03633617|581012860|FG001|Part A|Withdrawal by Subject|1|||
161331517|NCT05556148|582601391|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
161331518|NCT05556148|582601391|FG000|Overall Study|No Longer Wished to Participate|1|||
161331519|NCT05556148|582601391|FG000|Overall Study|Bacterial Conjunctivitis|1|||
161331520|NCT01171898|582601392|FG000|Overall Study|Death|0|||
161331521|NCT01171898|582601393|FG001|Overall Study|Death|0|||
161331522|NCT01171898|582601394|FG002|Overall Study|Death|2|||
161331523|NCT01171898|582601395|FG003|Overall Study|Death|0|||
161331524|NCT01171898|582601392|FG000|Overall Study|Lost to Follow-up|0|||
161331525|NCT01171898|582601393|FG001|Overall Study|Lost to Follow-up|1|||
161331526|NCT01171898|582601394|FG002|Overall Study|Lost to Follow-up|1|||
161331527|NCT01171898|582601395|FG003|Overall Study|Lost to Follow-up|1|||
161331528|NCT01171898|582601392|FG000|Overall Study|Withdrawal by Subject|1|||
161331529|NCT01171898|582601393|FG001|Overall Study|Withdrawal by Subject|4|||
161331530|NCT01171898|582601394|FG002|Overall Study|Withdrawal by Subject|6|||
160895272|NCT03633617|581012861|FG002|Part A|Withdrawal by Subject|0|||
160895273|NCT03633617|581012862|FG003|Part A|Withdrawal by Subject|0|||
160895274|NCT03633617|581012863|FG004|Part A|Withdrawal by Subject|0|||
160895275|NCT03633617|581012864|FG005|Part A|Withdrawal by Subject|0|||
160895276|NCT03633617|581012865|FG006|Part A|Withdrawal by Subject|0|||
160895277|NCT03633617|581012866|FG007|Part A|Withdrawal by Subject|0|||
160895278|NCT03633617|581012867|FG008|Part A|Withdrawal by Subject|0|||
160895279|NCT03633617|581012868|FG009|Part A|Withdrawal by Subject|0|||
160895280|NCT03633617|581012869|FG010|Part A|Withdrawal by Subject|0|||
160895281|NCT03633617|581012859|FG000|Part B|Adverse Event|0|||
160895282|NCT03633617|581012860|FG001|Part B|Adverse Event|0|||
160895283|NCT03633617|581012861|FG002|Part B|Adverse Event|2|||
160895284|NCT03633617|581012862|FG003|Part B|Adverse Event|2|||
160895285|NCT03633617|581012863|FG004|Part B|Adverse Event|1|||
161129713|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161129714|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161129715|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161129716|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161129717|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161129718|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
161129719|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129720|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129721|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
161129722|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129723|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129724|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129725|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129726|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129727|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
161129728|NCT01583374|581860933|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129729|NCT01583374|581860934|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
161129730|NCT01583374|581860935|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129731|NCT01583374|581860936|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129732|NCT01583374|581860937|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129733|NCT01583374|581860938|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129734|NCT01583374|581860939|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129735|NCT01583374|581860940|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129736|NCT01583374|581860941|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
161129737|NCT01583374|581860933|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129738|NCT01583374|581860934|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129739|NCT01583374|581860935|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129740|NCT01583374|581860936|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129741|NCT01583374|581860937|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129742|NCT01583374|581860938|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129743|NCT01583374|581860939|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129744|NCT01583374|581860940|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
161129745|NCT01583374|581860941|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
161129746|NCT01583374|581860933|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161129747|NCT01583374|581860934|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161129748|NCT01583374|581860935|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
161331531|NCT01171898|582601395|FG003|Overall Study|Withdrawal by Subject|3|||
161331532|NCT01171898|582601392|FG000|Overall Study|Terminated by Sponsor|1|||
161331533|NCT01171898|582601393|FG001|Overall Study|Terminated by Sponsor|0|||
160895286|NCT03633617|581012864|FG005|Part B|Adverse Event|0|||
160895287|NCT03633617|581012865|FG006|Part B|Adverse Event|0|||
160895288|NCT03633617|581012866|FG007|Part B|Adverse Event|0|||
160895289|NCT03633617|581012867|FG008|Part B|Adverse Event|0|||
160895290|NCT03633617|581012868|FG009|Part B|Adverse Event|0|||
160895291|NCT03633617|581012869|FG010|Part B|Adverse Event|0|||
160895292|NCT03633617|581012859|FG000|Part B|Withdrawal by Subject|0|||
161237219|NCT02281084|582248501|FG002|Overall Study|Death|3|||
161237220|NCT02281084|582248502|FG003|Overall Study|Death|5|||
161237221|NCT02281084|582248499|FG000|Overall Study|Adverse Event|1|||
161237222|NCT02281084|582248500|FG001|Overall Study|Adverse Event|0|||
160798885|NCT02434081|580653116|FG000|Overall Study|Physician Decision|2|||
160798886|NCT02434081|580653116|FG000|Overall Study|Withdrawal by Subject|1|||
160798887|NCT02434081|580653116|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
160798888|NCT00854360|580653125|FG000|Overall Study|Adverse Event|0|||
160798889|NCT00854360|580653126|FG001|Overall Study|Adverse Event|1|||
160798890|NCT00854360|580653127|FG002|Overall Study|Adverse Event|2|||
160798891|NCT00854360|580653128|FG003|Overall Study|Adverse Event|6|||
160983767|NCT04445155|581328743|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
160983768|NCT04445155|581328744|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
160983769|NCT04445155|581328745|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
160983770|NCT04445155|581328746|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
160983771|NCT01556243|581328751|FG000|Overall Study|Ineligible|34|||
160983772|NCT01556243|581328751|FG000|Overall Study|Converted to mastectomy|14|||
160983773|NCT01556243|581328751|FG000|Overall Study|Unable to achieve negative margins|2|||
160983774|NCT01556243|581328751|FG000|Overall Study|Withdrawal by Subject|16|||
160983775|NCT01671748|581328752|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
160983776|NCT01671748|581328753|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
160983777|NCT01671748|581328752|FG000|4 Week run-in Phase|Adverse Event|1|||
160983778|NCT01671748|581328753|FG001|4 Week run-in Phase|Adverse Event|0|||
160983779|NCT01671748|581328752|FG000|4 Week run-in Phase|Not eligible|9|||
160983780|NCT01671748|581328753|FG001|4 Week run-in Phase|Not eligible|0|||
161129749|NCT01583374|581860936|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161129750|NCT01583374|581860937|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161129751|NCT01583374|581860938|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161129752|NCT01583374|581860939|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
160798892|NCT00854360|580653125|FG000|Overall Study|Withdrawal by Subject|0|||
160798893|NCT00854360|580653126|FG001|Overall Study|Withdrawal by Subject|0|||
160895293|NCT03633617|581012860|FG001|Part B|Withdrawal by Subject|0|||
160895294|NCT03633617|581012861|FG002|Part B|Withdrawal by Subject|1|||
160895295|NCT03633617|581012862|FG003|Part B|Withdrawal by Subject|0|||
160895296|NCT03633617|581012863|FG004|Part B|Withdrawal by Subject|2|||
160895297|NCT03633617|581012864|FG005|Part B|Withdrawal by Subject|0|||
160895298|NCT03633617|581012865|FG006|Part B|Withdrawal by Subject|0|||
160895299|NCT03633617|581012866|FG007|Part B|Withdrawal by Subject|0|||
160895300|NCT03633617|581012867|FG008|Part B|Withdrawal by Subject|0|||
160895301|NCT03633617|581012868|FG009|Part B|Withdrawal by Subject|0|||
160895302|NCT03633617|581012869|FG010|Part B|Withdrawal by Subject|0|||
160895303|NCT03633617|581012859|FG000|Part B|Lost to Follow-up|0|||
160895304|NCT03633617|581012860|FG001|Part B|Lost to Follow-up|0|||
160895305|NCT03633617|581012861|FG002|Part B|Lost to Follow-up|0|||
160895306|NCT03633617|581012862|FG003|Part B|Lost to Follow-up|0|||
160895307|NCT03633617|581012863|FG004|Part B|Lost to Follow-up|1|||
160895308|NCT03633617|581012864|FG005|Part B|Lost to Follow-up|0|||
160895309|NCT03633617|581012865|FG006|Part B|Lost to Follow-up|0|||
160895310|NCT03633617|581012866|FG007|Part B|Lost to Follow-up|0|||
160895311|NCT03633617|581012867|FG008|Part B|Lost to Follow-up|0|||
160895312|NCT03633617|581012868|FG009|Part B|Lost to Follow-up|0|||
160798894|NCT00854360|580653127|FG002|Overall Study|Withdrawal by Subject|0|||
160798895|NCT00854360|580653128|FG003|Overall Study|Withdrawal by Subject|1|||
161129753|NCT01583374|581860940|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
161129754|NCT01583374|581860941|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
161129755|NCT01583374|581860933|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
160798896|NCT00854360|580653125|FG000|Overall Study|Pregnancy|0|||
160798897|NCT00854360|580653126|FG001|Overall Study|Pregnancy|1|||
160895313|NCT03633617|581012869|FG010|Part B|Lost to Follow-up|0|||
160895314|NCT03633617|581012859|FG000|Part B|Physician Decision|0|||
160895315|NCT03633617|581012860|FG001|Part B|Physician Decision|0|||
160895316|NCT03633617|581012861|FG002|Part B|Physician Decision|0|||
160895317|NCT03633617|581012862|FG003|Part B|Physician Decision|0|||
160895318|NCT03633617|581012863|FG004|Part B|Physician Decision|1|||
161129756|NCT01583374|581860934|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161129757|NCT01583374|581860935|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
161129758|NCT01583374|581860936|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
161129759|NCT01583374|581860937|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
161129760|NCT01583374|581860938|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161129761|NCT01583374|581860939|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
161129762|NCT01583374|581860940|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
161129763|NCT01583374|581860941|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
161129764|NCT01583374|581860933|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161129765|NCT01583374|581860934|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
161129766|NCT01583374|581860935|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
161129767|NCT01583374|581860936|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160798898|NCT00854360|580653127|FG002|Overall Study|Pregnancy|0|||
160798899|NCT00854360|580653128|FG003|Overall Study|Pregnancy|0|||
160798900|NCT00854360|580653125|FG000|Overall Study|Lack of Efficacy|2|||
160798901|NCT00854360|580653126|FG001|Overall Study|Lack of Efficacy|1|||
160798902|NCT00854360|580653127|FG002|Overall Study|Lack of Efficacy|0|||
160798903|NCT00854360|580653128|FG003|Overall Study|Lack of Efficacy|0|||
160798904|NCT00854360|580653125|FG000|Overall Study|Other|0|||
160798905|NCT00854360|580653126|FG001|Overall Study|Other|0|||
160798906|NCT00854360|580653127|FG002|Overall Study|Other|0|||
160798907|NCT00854360|580653128|FG003|Overall Study|Other|3|||
160798908|NCT01076010|580653135|FG000|Overall Study|Death|15|||
160895319|NCT03633617|581012864|FG005|Part B|Physician Decision|0|||
160895320|NCT03633617|581012865|FG006|Part B|Physician Decision|0|||
160895321|NCT03633617|581012866|FG007|Part B|Physician Decision|0|||
160895322|NCT03633617|581012867|FG008|Part B|Physician Decision|0|||
160895323|NCT03633617|581012868|FG009|Part B|Physician Decision|0|||
160895324|NCT03633617|581012869|FG010|Part B|Physician Decision|0|||
160895325|NCT03633617|581012859|FG000|Part B|COVID-19 Restrictions|0|||
160895326|NCT03633617|581012860|FG001|Part B|COVID-19 Restrictions|0|||
160895327|NCT03633617|581012861|FG002|Part B|COVID-19 Restrictions|1|||
160895328|NCT03633617|581012862|FG003|Part B|COVID-19 Restrictions|0|||
160895329|NCT03633617|581012863|FG004|Part B|COVID-19 Restrictions|0|||
160895330|NCT03633617|581012864|FG005|Part B|COVID-19 Restrictions|0|||
160895331|NCT03633617|581012865|FG006|Part B|COVID-19 Restrictions|0|||
160895332|NCT03633617|581012866|FG007|Part B|COVID-19 Restrictions|0|||
160895333|NCT03633617|581012867|FG008|Part B|COVID-19 Restrictions|0|||
160895334|NCT03633617|581012868|FG009|Part B|COVID-19 Restrictions|0|||
160895335|NCT03633617|581012869|FG010|Part B|COVID-19 Restrictions|0|||
160895336|NCT03633617|581012859|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895337|NCT03633617|581012860|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895338|NCT03633617|581012861|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
160895339|NCT03633617|581012862|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895340|NCT03633617|581012863|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895341|NCT03633617|581012864|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895342|NCT03633617|581012865|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895343|NCT03633617|581012866|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895344|NCT03633617|581012867|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895345|NCT03633617|581012868|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895346|NCT03633617|581012869|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
160895347|NCT03633617|581012859|FG000|Part C (& Follow-up)|Adverse Event|0|||
160895348|NCT03633617|581012860|FG001|Part C (& Follow-up)|Adverse Event|0|||
160895349|NCT03633617|581012861|FG002|Part C (& Follow-up)|Adverse Event|0|||
160895350|NCT03633617|581012862|FG003|Part C (& Follow-up)|Adverse Event|0|||
160895351|NCT03633617|581012863|FG004|Part C (& Follow-up)|Adverse Event|0|||
160895352|NCT03633617|581012864|FG005|Part C (& Follow-up)|Adverse Event|1|||
160895353|NCT03633617|581012865|FG006|Part C (& Follow-up)|Adverse Event|0|||
160895354|NCT03633617|581012866|FG007|Part C (& Follow-up)|Adverse Event|1|||
160895355|NCT03633617|581012867|FG008|Part C (& Follow-up)|Adverse Event|0|||
160895356|NCT03633617|581012868|FG009|Part C (& Follow-up)|Adverse Event|0|||
160895357|NCT03633617|581012869|FG010|Part C (& Follow-up)|Adverse Event|0|||
160895358|NCT03633617|581012859|FG000|Part C (& Follow-up)|Pregnancy|0|||
160895359|NCT03633617|581012860|FG001|Part C (& Follow-up)|Pregnancy|0|||
160895360|NCT03633617|581012861|FG002|Part C (& Follow-up)|Pregnancy|0|||
160895361|NCT03633617|581012862|FG003|Part C (& Follow-up)|Pregnancy|0|||
160895362|NCT03633617|581012863|FG004|Part C (& Follow-up)|Pregnancy|0|||
160895363|NCT03633617|581012864|FG005|Part C (& Follow-up)|Pregnancy|0|||
160895364|NCT03633617|581012865|FG006|Part C (& Follow-up)|Pregnancy|0|||
160895365|NCT03633617|581012866|FG007|Part C (& Follow-up)|Pregnancy|0|||
160895366|NCT03633617|581012867|FG008|Part C (& Follow-up)|Pregnancy|0|||
160895367|NCT03633617|581012868|FG009|Part C (& Follow-up)|Pregnancy|1|||
160895368|NCT03633617|581012869|FG010|Part C (& Follow-up)|Pregnancy|0|||
160895369|NCT03633617|581012859|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895370|NCT03633617|581012860|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895371|NCT03633617|581012861|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895372|NCT03633617|581012862|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895373|NCT03633617|581012863|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895374|NCT03633617|581012864|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
160895375|NCT03633617|581012865|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
160895376|NCT03633617|581012866|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
160895377|NCT03633617|581012867|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
160798909|NCT01076010|580653136|FG001|Overall Study|Death|1|||
160798910|NCT01076010|580653137|FG002|Overall Study|Death|0|||
160798911|NCT01076010|580653135|FG000|Overall Study|Adverse Event|7|||
160798912|NCT01076010|580653136|FG001|Overall Study|Adverse Event|2|||
161129768|NCT01583374|581860937|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
161129769|NCT01583374|581860938|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
161129770|NCT01583374|581860939|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160983789|NCT04191135|581328756|FG000|Induction Treatment|Not Treated|2|||
160983790|NCT04191135|581328757|FG001|Induction Treatment|Not Treated|0|||
160798913|NCT01076010|580653137|FG002|Overall Study|Adverse Event|0|||
160798914|NCT01076010|580653135|FG000|Overall Study|Progressive disease|90|||
160798915|NCT01076010|580653136|FG001|Overall Study|Progressive disease|30|||
160798916|NCT01076010|580653137|FG002|Overall Study|Progressive disease|1|||
160798917|NCT01076010|580653135|FG000|Overall Study|Lack of Efficacy|4|||
160798918|NCT01076010|580653136|FG001|Overall Study|Lack of Efficacy|0|||
160798919|NCT01076010|580653137|FG002|Overall Study|Lack of Efficacy|0|||
160798920|NCT01076010|580653135|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
160798921|NCT01076010|580653136|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
160798922|NCT01076010|580653137|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
160798923|NCT01076010|580653135|FG000|Overall Study|Significant Surgical Procedure|0|||
160798924|NCT01076010|580653136|FG001|Overall Study|Significant Surgical Procedure|1|||
160798925|NCT01076010|580653137|FG002|Overall Study|Significant Surgical Procedure|0|||
160798926|NCT01076010|580653135|FG000|Overall Study|Protocol Violation|0|||
160798927|NCT01076010|580653136|FG001|Overall Study|Protocol Violation|1|||
160798928|NCT01076010|580653137|FG002|Overall Study|Protocol Violation|0|||
160798929|NCT01076010|580653135|FG000|Overall Study|Noncompliance|1|||
160798930|NCT01076010|580653136|FG001|Overall Study|Noncompliance|1|||
160798931|NCT01076010|580653137|FG002|Overall Study|Noncompliance|0|||
160798932|NCT01076010|580653135|FG000|Overall Study|Withdrawal by Subject|3|||
160798933|NCT01076010|580653136|FG001|Overall Study|Withdrawal by Subject|0|||
160798934|NCT01076010|580653137|FG002|Overall Study|Withdrawal by Subject|1|||
160798935|NCT01076010|580653135|FG000|Overall Study|Other|5|||
160798936|NCT01076010|580653136|FG001|Overall Study|Other|2|||
160983791|NCT04191135|581328758|FG002|Induction Treatment|Not Treated|0|||
160983792|NCT04191135|581328756|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
160983793|NCT04191135|581328757|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
160983794|NCT04191135|581328758|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
160983795|NCT04191135|581328756|FG000|Induction Treatment|Adverse Event|25|||
160983796|NCT04191135|581328757|FG001|Induction Treatment|Adverse Event|0|||
160983797|NCT04191135|581328758|FG002|Induction Treatment|Adverse Event|0|||
160983798|NCT04191135|581328756|FG000|Induction Treatment|Clinical Progression|8|||
160983799|NCT04191135|581328757|FG001|Induction Treatment|Clinical Progression|0|||
160983800|NCT04191135|581328758|FG002|Induction Treatment|Clinical Progression|0|||
160983801|NCT04191135|581328756|FG000|Induction Treatment|Excluded Medication|1|||
160983802|NCT04191135|581328757|FG001|Induction Treatment|Excluded Medication|0|||
160983803|NCT04191135|581328758|FG002|Induction Treatment|Excluded Medication|0|||
160983804|NCT04191135|581328756|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
160983805|NCT04191135|581328757|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
160983806|NCT04191135|581328758|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
160983807|NCT04191135|581328756|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
160983808|NCT04191135|581328757|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
160798937|NCT01076010|580653137|FG002|Overall Study|Other|0|||
160798938|NCT05200845|580653140|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
160798939|NCT05200845|580653141|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
160798940|NCT05200845|580653142|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
160798941|NCT05200845|580653143|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
160798942|NCT05200845|580653140|FG000|Overall Study|Withdrawal by Subject|0|||
160798943|NCT05200845|580653141|FG001|Overall Study|Withdrawal by Subject|1|||
160798944|NCT05200845|580653142|FG002|Overall Study|Withdrawal by Subject|1|||
160798945|NCT05200845|580653143|FG003|Overall Study|Withdrawal by Subject|0|||
160798946|NCT01959932|580653150|FG000|Overall Study|Withdrawal by Subject|1|||
160983809|NCT04191135|581328758|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
160983810|NCT04191135|581328756|FG000|Induction Treatment|Physician Decision|2|||
160798947|NCT01959932|580653151|FG001|Overall Study|Withdrawal by Subject|0|||
160983811|NCT04191135|581328757|FG001|Induction Treatment|Physician Decision|0|||
160983812|NCT04191135|581328758|FG002|Induction Treatment|Physician Decision|0|||
160798948|NCT01959932|580653152|FG002|Overall Study|Withdrawal by Subject|0|||
160798949|NCT00060944|580653155|FG000|Overall Study|Adverse Event|12|||
160798950|NCT00060944|580653156|FG001|Overall Study|Adverse Event|10|||
160798951|NCT00060944|580653155|FG000|Overall Study|Death|2|||
160798952|NCT00060944|580653156|FG001|Overall Study|Death|3|||
160983813|NCT04191135|581328756|FG000|Induction Treatment|Progressive Disease|135|||
161129771|NCT01583374|581860940|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160798953|NCT00060944|580653155|FG000|Overall Study|Withdrawal by Subject|18|||
160798954|NCT00060944|580653156|FG001|Overall Study|Withdrawal by Subject|5|||
160798955|NCT00060944|580653155|FG000|Overall Study|Disease Progression|93|||
160798956|NCT00060944|580653156|FG001|Overall Study|Disease Progression|94|||
160798957|NCT00060944|580653155|FG000|Overall Study|Lost to Follow-up|1|||
160895378|NCT03633617|581012868|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
160895379|NCT03633617|581012869|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
160895380|NCT03633617|581012859|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
160895381|NCT03633617|581012860|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
160895382|NCT03633617|581012861|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
160895383|NCT03633617|581012862|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
160895384|NCT03633617|581012863|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
160895385|NCT03633617|581012864|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
160895386|NCT03633617|581012865|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
160895387|NCT03633617|581012866|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
160895388|NCT03633617|581012867|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
160895389|NCT03633617|581012868|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
160895390|NCT03633617|581012869|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
160895391|NCT03633617|581012859|FG000|Part C (& Follow-up)|Physician Decision|0|||
160895392|NCT03633617|581012860|FG001|Part C (& Follow-up)|Physician Decision|0|||
160895393|NCT03633617|581012861|FG002|Part C (& Follow-up)|Physician Decision|0|||
160895394|NCT03633617|581012862|FG003|Part C (& Follow-up)|Physician Decision|0|||
160895395|NCT03633617|581012863|FG004|Part C (& Follow-up)|Physician Decision|0|||
160895396|NCT03633617|581012864|FG005|Part C (& Follow-up)|Physician Decision|0|||
160895397|NCT03633617|581012865|FG006|Part C (& Follow-up)|Physician Decision|0|||
160895398|NCT03633617|581012866|FG007|Part C (& Follow-up)|Physician Decision|1|||
160895399|NCT03633617|581012867|FG008|Part C (& Follow-up)|Physician Decision|0|||
160895400|NCT03633617|581012868|FG009|Part C (& Follow-up)|Physician Decision|0|||
160895401|NCT03633617|581012869|FG010|Part C (& Follow-up)|Physician Decision|1|||
160895402|NCT03633617|581012859|FG000|Part C (& Follow-up)|COVID-19 related|0|||
160895403|NCT03633617|581012860|FG001|Part C (& Follow-up)|COVID-19 related|0|||
160895404|NCT03633617|581012861|FG002|Part C (& Follow-up)|COVID-19 related|0|||
160895405|NCT03633617|581012862|FG003|Part C (& Follow-up)|COVID-19 related|0|||
160895406|NCT03633617|581012863|FG004|Part C (& Follow-up)|COVID-19 related|0|||
160895407|NCT03633617|581012864|FG005|Part C (& Follow-up)|COVID-19 related|1|||
160895408|NCT03633617|581012865|FG006|Part C (& Follow-up)|COVID-19 related|0|||
160895409|NCT03633617|581012866|FG007|Part C (& Follow-up)|COVID-19 related|0|||
160895410|NCT03633617|581012867|FG008|Part C (& Follow-up)|COVID-19 related|0|||
160895411|NCT03633617|581012868|FG009|Part C (& Follow-up)|COVID-19 related|0|||
160895412|NCT03633617|581012869|FG010|Part C (& Follow-up)|COVID-19 related|0|||
160895413|NCT03633617|581012859|FG000|Part C (& Follow-up)|Protocol Violation|0|||
160895414|NCT03633617|581012860|FG001|Part C (& Follow-up)|Protocol Violation|0|||
160895415|NCT03633617|581012861|FG002|Part C (& Follow-up)|Protocol Violation|0|||
160895416|NCT03633617|581012862|FG003|Part C (& Follow-up)|Protocol Violation|0|||
160895417|NCT03633617|581012863|FG004|Part C (& Follow-up)|Protocol Violation|0|||
160895418|NCT03633617|581012864|FG005|Part C (& Follow-up)|Protocol Violation|0|||
160895419|NCT03633617|581012865|FG006|Part C (& Follow-up)|Protocol Violation|0|||
160895420|NCT03633617|581012866|FG007|Part C (& Follow-up)|Protocol Violation|0|||
160895421|NCT03633617|581012867|FG008|Part C (& Follow-up)|Protocol Violation|0|||
160895422|NCT03633617|581012868|FG009|Part C (& Follow-up)|Protocol Violation|3|||
160895423|NCT03633617|581012869|FG010|Part C (& Follow-up)|Protocol Violation|1|||
160895424|NCT03633617|581012859|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
160895425|NCT03633617|581012860|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
160895426|NCT03633617|581012861|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
160895427|NCT03633617|581012862|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
160895428|NCT03633617|581012863|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
160895429|NCT03633617|581012864|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
160895430|NCT03633617|581012865|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
160895431|NCT03633617|581012866|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
160895432|NCT03633617|581012867|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
160895433|NCT03633617|581012868|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
160895434|NCT03633617|581012869|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
160895435|NCT03161093|581012882|FG000|Overall Study|Protocol Violation|11|||
160895436|NCT03161093|581012883|FG001|Overall Study|Protocol Violation|14|||
160895437|NCT03161093|581012884|FG002|Overall Study|Protocol Violation|6|||
160895438|NCT03161093|581012885|FG003|Overall Study|Protocol Violation|13|||
160895439|NCT03161093|581012886|FG004|Overall Study|Protocol Violation|1|||
160895440|NCT03161093|581012887|FG005|Overall Study|Protocol Violation|0|||
160895441|NCT03161093|581012882|FG000|Overall Study|Adverse Event|5|||
160895442|NCT03161093|581012883|FG001|Overall Study|Adverse Event|21|||
160895443|NCT03161093|581012884|FG002|Overall Study|Adverse Event|16|||
160895444|NCT03161093|581012885|FG003|Overall Study|Adverse Event|35|||
160895445|NCT03161093|581012886|FG004|Overall Study|Adverse Event|2|||
160895446|NCT03161093|581012887|FG005|Overall Study|Adverse Event|1|||
160895447|NCT03161093|581012882|FG000|Overall Study|Lack of Efficacy|9|||
160895448|NCT03161093|581012883|FG001|Overall Study|Lack of Efficacy|13|||
160895449|NCT03161093|581012884|FG002|Overall Study|Lack of Efficacy|9|||
160895450|NCT03161093|581012885|FG003|Overall Study|Lack of Efficacy|24|||
160895451|NCT03161093|581012886|FG004|Overall Study|Lack of Efficacy|4|||
160895452|NCT03161093|581012887|FG005|Overall Study|Lack of Efficacy|1|||
160895453|NCT03161093|581012882|FG000|Overall Study|Physician Decision|0|||
160798958|NCT00060944|580653156|FG001|Overall Study|Lost to Follow-up|0|||
160798959|NCT00060944|580653155|FG000|Overall Study|Subject Ineligible To Continue|2|||
160798960|NCT00060944|580653156|FG001|Overall Study|Subject Ineligible To Continue|1|||
160798961|NCT00060944|580653155|FG000|Overall Study|Treatment Switch|0|||
160983814|NCT04191135|581328757|FG001|Induction Treatment|Progressive Disease|0|||
160983815|NCT04191135|581328758|FG002|Induction Treatment|Progressive Disease|0|||
160983816|NCT04191135|581328756|FG000|Induction Treatment|Protocol Violation|10|||
160983817|NCT04191135|581328757|FG001|Induction Treatment|Protocol Violation|0|||
160983818|NCT04191135|581328758|FG002|Induction Treatment|Protocol Violation|0|||
160983819|NCT04191135|581328756|FG000|Induction Treatment|Withdrawal by Subject|4|||
160983820|NCT04191135|581328757|FG001|Induction Treatment|Withdrawal by Subject|0|||
160983821|NCT04191135|581328758|FG002|Induction Treatment|Withdrawal by Subject|0|||
160983822|NCT04191135|581328756|FG000|Randomized Treatment|Death|0|||
160983823|NCT04191135|581328757|FG001|Randomized Treatment|Death|50|||
160983824|NCT04191135|581328758|FG002|Randomized Treatment|Death|54|||
160983825|NCT04191135|581328756|FG000|Randomized Treatment|Lost to Follow-up|0|||
160983826|NCT04191135|581328757|FG001|Randomized Treatment|Lost to Follow-up|0|||
160983827|NCT04191135|581328758|FG002|Randomized Treatment|Lost to Follow-up|1|||
160983828|NCT04191135|581328756|FG000|Randomized Treatment|Withdrawal by Subject|0|||
160983829|NCT04191135|581328757|FG001|Randomized Treatment|Withdrawal by Subject|2|||
160983830|NCT04191135|581328758|FG002|Randomized Treatment|Withdrawal by Subject|0|||
160983831|NCT04191135|581328756|FG000|Randomized Treatment|Ongoing in Trial|0|||
160983832|NCT04191135|581328757|FG001|Randomized Treatment|Ongoing in Trial|83|||
160983833|NCT04191135|581328758|FG002|Randomized Treatment|Ongoing in Trial|81|||
160983834|NCT02107274|581330110|FG000|Treatment vs. Placebo|Adverse Event|3|||
160983835|NCT02107274|581330111|FG001|Treatment vs. Placebo|Adverse Event|0|||
160983836|NCT02107274|581330110|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
160983837|NCT02107274|581330111|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
160983838|NCT02107274|581330110|FG000|Control Phase|Lost to Follow-up|1|||
160983839|NCT02107274|581330111|FG001|Control Phase|Lost to Follow-up|1|||
160983840|NCT02107274|581330110|FG000|Control Phase|Death|2|||
160983841|NCT02107274|581330111|FG001|Control Phase|Death|0|||
160983842|NCT02107274|581330110|FG000|Control Phase|Adverse Event|0|||
160983843|NCT02107274|581330111|FG001|Control Phase|Adverse Event|1|||
160983844|NCT05305040|581330114|FG000|Overall Study|Not Dosed|37|||
160983845|NCT05305040|581330115|FG001|Overall Study|Not Dosed|37|||
160983846|NCT05305040|581330114|FG000|Overall Study|Study Closure|34|||
160983847|NCT05305040|581330115|FG001|Overall Study|Study Closure|46|||
160983848|NCT05305040|581330114|FG000|Overall Study|Death|14|||
160983849|NCT05305040|581330115|FG001|Overall Study|Death|13|||
160983850|NCT05305040|581330114|FG000|Overall Study|Withdrawal by Subject|15|||
160983851|NCT05305040|581330115|FG001|Overall Study|Withdrawal by Subject|10|||
160983852|NCT05305040|581330114|FG000|Overall Study|Other|13|||
160983853|NCT05305040|581330115|FG001|Overall Study|Other|10|||
160983854|NCT05305040|581330114|FG000|Overall Study|Primary Malignancy Relapse|3|||
160983855|NCT05305040|581330115|FG001|Overall Study|Primary Malignancy Relapse|4|||
160983856|NCT05305040|581330114|FG000|Overall Study|Adverse Event|3|||
160983857|NCT05305040|581330115|FG001|Overall Study|Adverse Event|3|||
160983858|NCT05305040|581330114|FG000|Overall Study|Lost to Follow-up|2|||
160983859|NCT05305040|581330115|FG001|Overall Study|Lost to Follow-up|1|||
160983860|NCT05305040|581330114|FG000|Overall Study|Graft versus host disease|2|||
160983861|NCT05305040|581330115|FG001|Overall Study|Graft versus host disease|0|||
160983862|NCT05305040|581330114|FG000|Overall Study|Investigator's Decision|1|||
160983863|NCT05305040|581330115|FG001|Overall Study|Investigator's Decision|1|||
161129772|NCT01583374|581860941|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
160798962|NCT00060944|580653156|FG001|Overall Study|Treatment Switch|13|||
160798963|NCT00060944|580653155|FG000|Overall Study|Other|2|||
160798964|NCT00060944|580653156|FG001|Overall Study|Other|4|||
160798965|NCT00060944|580653155|FG000|Overall Study|randomized but not treated|6|||
160798966|NCT00060944|580653156|FG001|Overall Study|randomized but not treated|4|||
160798967|NCT04756531|580653160|FG000|Overall Study|Adverse Event|0|||
160798968|NCT04756531|580653161|FG001|Overall Study|Adverse Event|0|||
160798969|NCT04756531|580653162|FG002|Overall Study|Adverse Event|0|||
160798970|NCT04756531|580653163|FG003|Overall Study|Adverse Event|0|||
160798971|NCT04756531|580653164|FG004|Overall Study|Adverse Event|1|||
160798972|NCT04756531|580653165|FG005|Overall Study|Adverse Event|0|||
160983864|NCT05305040|581330114|FG000|Overall Study|COVID-19 Reasons|1|||
160983865|NCT05305040|581330115|FG001|Overall Study|COVID-19 Reasons|0|||
160983866|NCT02206685|581330116|FG000|Overall Study|Surgery cancelled/changed|2|||
160983867|NCT02206685|581330117|FG001|Overall Study|Surgery cancelled/changed|3|||
160983868|NCT02206685|581330116|FG000|Overall Study|Withdrawal by Subject|1|||
160983869|NCT02206685|581330117|FG001|Overall Study|Withdrawal by Subject|2|||
160983870|NCT02206685|581330116|FG000|Overall Study|Protocol Violation|2|||
160983871|NCT02206685|581330117|FG001|Overall Study|Protocol Violation|2|||
160983872|NCT01195675|581330118|FG000|Overall Study|Adverse Event|1|||
161129773|NCT01583374|581860933|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160798973|NCT04756531|580653166|FG006|Overall Study|Adverse Event|0|||
160798974|NCT04756531|580653167|FG007|Overall Study|Adverse Event|0|||
160895454|NCT03161093|581012883|FG001|Overall Study|Physician Decision|1|||
160895455|NCT03161093|581012884|FG002|Overall Study|Physician Decision|0|||
160895456|NCT03161093|581012885|FG003|Overall Study|Physician Decision|2|||
160895457|NCT03161093|581012886|FG004|Overall Study|Physician Decision|17|||
160895458|NCT03161093|581012887|FG005|Overall Study|Physician Decision|15|||
160895459|NCT03161093|581012882|FG000|Overall Study|Withdrawal by Subject|24|||
160895460|NCT03161093|581012883|FG001|Overall Study|Withdrawal by Subject|73|||
160895461|NCT03161093|581012884|FG002|Overall Study|Withdrawal by Subject|44|||
160895462|NCT03161093|581012885|FG003|Overall Study|Withdrawal by Subject|97|||
160895463|NCT03161093|581012886|FG004|Overall Study|Withdrawal by Subject|11|||
160895464|NCT03161093|581012887|FG005|Overall Study|Withdrawal by Subject|10|||
160895465|NCT03161093|581012882|FG000|Overall Study|Lost to Follow-up|3|||
160895466|NCT03161093|581012883|FG001|Overall Study|Lost to Follow-up|12|||
160895467|NCT03161093|581012884|FG002|Overall Study|Lost to Follow-up|4|||
160895468|NCT03161093|581012885|FG003|Overall Study|Lost to Follow-up|7|||
160895469|NCT03161093|581012886|FG004|Overall Study|Lost to Follow-up|8|||
160895470|NCT03161093|581012887|FG005|Overall Study|Lost to Follow-up|13|||
160895471|NCT03161093|581012882|FG000|Overall Study|Death|3|||
160895472|NCT03161093|581012883|FG001|Overall Study|Death|9|||
160895473|NCT03161093|581012884|FG002|Overall Study|Death|7|||
160895474|NCT03161093|581012885|FG003|Overall Study|Death|9|||
161237223|NCT02281084|582248501|FG002|Overall Study|Adverse Event|0|||
161331534|NCT01171898|582601394|FG002|Overall Study|Terminated by Sponsor|0|||
161331535|NCT01171898|582601395|FG003|Overall Study|Terminated by Sponsor|0|||
161331536|NCT01171898|582601392|FG000|Overall Study|Ongoing|1|||
161331537|NCT01171898|582601393|FG001|Overall Study|Ongoing|9|||
161331538|NCT01171898|582601394|FG002|Overall Study|Ongoing|3|||
161331539|NCT01171898|582601395|FG003|Overall Study|Ongoing|0|||
161331540|NCT01171898|582601392|FG000|Overall Study|Other|1|||
161331541|NCT01171898|582601393|FG001|Overall Study|Other|5|||
161331542|NCT01171898|582601394|FG002|Overall Study|Other|0|||
161331543|NCT01171898|582601395|FG003|Overall Study|Other|2|||
161331544|NCT03191799|582601396|FG000|Overall Study|Withdrawal by Subject|4|||
161331545|NCT03191799|582601396|FG000|Overall Study|Physician Decision|2|||
161331546|NCT03191799|582601396|FG000|Overall Study|Lost to Follow-up|1|||
161331547|NCT03191799|582601396|FG000|Overall Study|Death|2|||
161331548|NCT00902577|582601397|FG000|Overall Study|Withdrawal by Subject|6|||
161331549|NCT00902577|582601397|FG000|Overall Study|FMISO production failure|2|||
161331550|NCT01232790|582601398|FG000|Randomization|Withdrawal by Subject|2|||
161331551|NCT01232790|582601399|FG001|Randomization|Withdrawal by Subject|0|||
161331552|NCT01232790|582601398|FG000|Randomization|Protocol Violation|0|||
161331553|NCT01232790|582601399|FG001|Randomization|Protocol Violation|1|||
161331554|NCT01232790|582601398|FG000|Randomization|Physician Decision|0|||
161331555|NCT01232790|582601399|FG001|Randomization|Physician Decision|1|||
161331556|NCT01232790|582601398|FG000|Initial Assessment|Withdrawal by Subject|0|||
161331557|NCT01232790|582601399|FG001|Initial Assessment|Withdrawal by Subject|1|||
161331558|NCT01232790|582601398|FG000|First Crossover|Withdrawal by Subject|1|||
161331559|NCT01232790|582601399|FG001|First Crossover|Withdrawal by Subject|0|||
161331560|NCT01232790|582601398|FG000|Second Crossover|Withdrawal by Subject|1|||
161331561|NCT01232790|582601399|FG001|Second Crossover|Withdrawal by Subject|2|||
161331562|NCT03769649|582601400|FG000|Overall Study|Lost to Follow-up|4|||
161331563|NCT03322293|582601401|FG000|Overall Study|Lost to Follow-up|0|||
161331564|NCT03322293|582601402|FG001|Overall Study|Lost to Follow-up|0|||
161331565|NCT03322293|582601403|FG002|Overall Study|Lost to Follow-up|1|||
161331566|NCT00083915|582601406|FG000|Overall Study|Death|6|||
161331567|NCT00083915|582601407|FG001|Overall Study|Death|3|||
161331568|NCT00083915|582601406|FG000|Overall Study|Physician Decision|11|||
161331569|NCT00083915|582601407|FG001|Overall Study|Physician Decision|6|||
161331570|NCT00083915|582601406|FG000|Overall Study|Withdrawal by Subject|8|||
160895475|NCT03161093|581012886|FG004|Overall Study|Death|0|||
160895476|NCT03161093|581012887|FG005|Overall Study|Death|0|||
160895477|NCT03161093|581012882|FG000|Overall Study|Unknown - Not reported|0|||
160895478|NCT03161093|581012883|FG001|Overall Study|Unknown - Not reported|1|||
160895479|NCT03161093|581012884|FG002|Overall Study|Unknown - Not reported|0|||
161237224|NCT02281084|582248502|FG003|Overall Study|Adverse Event|0|||
161237225|NCT02281084|582248499|FG000|Overall Study|Withdrawal by Subject|2|||
161237226|NCT02281084|582248500|FG001|Overall Study|Withdrawal by Subject|2|||
161237227|NCT02281084|582248501|FG002|Overall Study|Withdrawal by Subject|0|||
161237228|NCT02281084|582248502|FG003|Overall Study|Withdrawal by Subject|0|||
161237229|NCT02281084|582248499|FG000|Overall Study|Site Closure by Sponsor|5|||
161237230|NCT02281084|582248500|FG001|Overall Study|Site Closure by Sponsor|1|||
161237231|NCT02281084|582248501|FG002|Overall Study|Site Closure by Sponsor|2|||
161237232|NCT02281084|582248502|FG003|Overall Study|Site Closure by Sponsor|0|||
161237233|NCT02335658|582248503|FG000|Overall Study|Adverse Event|18|||
161237234|NCT02335658|582248504|FG001|Overall Study|Adverse Event|12|||
161237235|NCT02335658|582248503|FG000|Overall Study|Lack of Efficacy|4|||
161237236|NCT02335658|582248504|FG001|Overall Study|Lack of Efficacy|5|||
161237237|NCT02335658|582248503|FG000|Overall Study|Pregnancy|1|||
161237238|NCT02335658|582248504|FG001|Overall Study|Pregnancy|0|||
161237239|NCT02335658|582248503|FG000|Overall Study|Withdrawal by Subject|13|||
161129774|NCT01583374|581860934|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160798975|NCT04756531|580653168|FG008|Overall Study|Adverse Event|0|||
160798976|NCT04756531|580653169|FG009|Overall Study|Adverse Event|0|||
160798977|NCT04756531|580653170|FG010|Overall Study|Adverse Event|0|||
160798978|NCT04756531|580653171|FG011|Overall Study|Adverse Event|0|||
160798979|NCT04756531|580653172|FG012|Overall Study|Adverse Event|0|||
160798980|NCT04756531|580653173|FG013|Overall Study|Adverse Event|0|||
160798981|NCT04756531|580653174|FG014|Overall Study|Adverse Event|0|||
160798982|NCT04756531|580653175|FG015|Overall Study|Adverse Event|0|||
160798983|NCT04756531|580653176|FG016|Overall Study|Adverse Event|0|||
160798984|NCT04756531|580653177|FG017|Overall Study|Adverse Event|0|||
161129775|NCT01583374|581860935|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
161129776|NCT01583374|581860936|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160798985|NCT04756531|580653160|FG000|Overall Study|Withdrawal by Subject|0|||
160798986|NCT04756531|580653161|FG001|Overall Study|Withdrawal by Subject|0|||
160798987|NCT04756531|580653162|FG002|Overall Study|Withdrawal by Subject|0|||
160798988|NCT04756531|580653163|FG003|Overall Study|Withdrawal by Subject|0|||
160798989|NCT04756531|580653164|FG004|Overall Study|Withdrawal by Subject|0|||
160798990|NCT04756531|580653165|FG005|Overall Study|Withdrawal by Subject|0|||
160798991|NCT04756531|580653166|FG006|Overall Study|Withdrawal by Subject|1|||
160798992|NCT04756531|580653167|FG007|Overall Study|Withdrawal by Subject|0|||
160798993|NCT04756531|580653168|FG008|Overall Study|Withdrawal by Subject|0|||
160798994|NCT04756531|580653169|FG009|Overall Study|Withdrawal by Subject|0|||
160798995|NCT04756531|580653170|FG010|Overall Study|Withdrawal by Subject|0|||
160798996|NCT04756531|580653171|FG011|Overall Study|Withdrawal by Subject|0|||
160798997|NCT04756531|580653172|FG012|Overall Study|Withdrawal by Subject|0|||
160798998|NCT04756531|580653173|FG013|Overall Study|Withdrawal by Subject|0|||
160798999|NCT04756531|580653174|FG014|Overall Study|Withdrawal by Subject|0|||
160799000|NCT04756531|580653175|FG015|Overall Study|Withdrawal by Subject|0|||
160799001|NCT04756531|580653176|FG016|Overall Study|Withdrawal by Subject|0|||
160799002|NCT04756531|580653177|FG017|Overall Study|Withdrawal by Subject|0|||
160799003|NCT01729039|580653180|FG000|Overall Study|disqualified|2|||
160799004|NCT01729039|580653181|FG001|Overall Study|disqualified|5|||
160799005|NCT01729039|580653180|FG000|Overall Study|Withdrawal by Subject|8|||
160799006|NCT01729039|580653181|FG001|Overall Study|Withdrawal by Subject|7|||
160799007|NCT04237584|580653182|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
160799008|NCT04237584|580653183|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
160799009|NCT04237584|580653184|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
160799010|NCT04237584|580653185|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
160799011|NCT04237584|580653182|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
160799012|NCT04237584|580653183|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
160799013|NCT04237584|580653184|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
160799014|NCT04237584|580653185|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
160799015|NCT04237584|580653182|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
160799016|NCT04237584|580653183|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
160799017|NCT04237584|580653184|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
160799018|NCT04237584|580653185|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
160799019|NCT04237584|580653182|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
160799020|NCT04237584|580653183|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
160799021|NCT04237584|580653184|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
160799022|NCT04237584|580653185|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
160799023|NCT04237584|580653182|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
160799024|NCT04237584|580653183|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
160799025|NCT04237584|580653184|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
160799026|NCT04237584|580653185|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
160799027|NCT01135992|580654508|FG000|Overall Study|Adverse Event|1|||
160799028|NCT01135992|580654508|FG000|Overall Study|Lack of Efficacy|1|||
160799029|NCT01135992|580654508|FG000|Overall Study|Protocol Violation|2|||
160799030|NCT01135992|580654508|FG000|Overall Study|Withdrawal criteria|10|||
160799031|NCT01135992|580654508|FG000|Overall Study|Unclassified|7|||
160799032|NCT00256126|580654509|FG000|Overall Study|Adverse Event|1|||
160799033|NCT00256126|580654510|FG001|Overall Study|Adverse Event|0|||
160799034|NCT00256126|580654509|FG000|Overall Study|Other|1|||
160799035|NCT00256126|580654510|FG001|Overall Study|Other|2|||
160799036|NCT03435380|580654511|FG000|Overall Study|Death|1|||
160799037|NCT03435380|580654512|FG001|Overall Study|Death|2|||
160799038|NCT03435380|580654513|FG002|Overall Study|Death|1|||
160799039|NCT03435380|580654511|FG000|Overall Study|Lost to Follow-up|12|||
160799040|NCT03435380|580654512|FG001|Overall Study|Lost to Follow-up|8|||
160799041|NCT03435380|580654513|FG002|Overall Study|Lost to Follow-up|6|||
160799042|NCT03435380|580654511|FG000|Overall Study|Physician Decision|1|||
160799043|NCT03435380|580654512|FG001|Overall Study|Physician Decision|0|||
160799044|NCT03435380|580654513|FG002|Overall Study|Physician Decision|0|||
160983873|NCT01195675|581330118|FG000|Overall Study|Withdrawal by Subject|2|||
160983874|NCT01174550|581330119|FG000|Overall Study|Death|75|||
160983875|NCT01174550|581330120|FG001|Overall Study|Death|74|||
160983876|NCT01174550|581330119|FG000|Overall Study|Lost to Follow-up|652|||
160983877|NCT01174550|581330120|FG001|Overall Study|Lost to Follow-up|510|||
160983878|NCT01174550|581330119|FG000|Overall Study|Withdrawal by Subject|543|||
160983879|NCT01174550|581330120|FG001|Overall Study|Withdrawal by Subject|289|||
160983880|NCT01536262|581330121|FG000|Overall Study|Adverse Event|6|||
160983881|NCT01536262|581330122|FG001|Overall Study|Adverse Event|1|||
160983882|NCT01536262|581330123|FG002|Overall Study|Adverse Event|2|||
160983883|NCT01536262|581330121|FG000|Overall Study|Withdrawal by Subject|1|||
160983884|NCT01536262|581330122|FG001|Overall Study|Withdrawal by Subject|1|||
160983885|NCT01536262|581330123|FG002|Overall Study|Withdrawal by Subject|0|||
160983886|NCT01536262|581330121|FG000|Overall Study|Other than stated above|1|||
160983887|NCT01536262|581330122|FG001|Overall Study|Other than stated above|0|||
160983888|NCT01536262|581330123|FG002|Overall Study|Other than stated above|0|||
160983889|NCT00839917|581330127|FG000|Overall Study|Lost to Follow-up|1|||
160799045|NCT03435380|580654511|FG000|Overall Study|Withdrawal by Subject|0|||
160983890|NCT00839917|581330128|FG001|Overall Study|Lost to Follow-up|0|||
160983891|NCT00839917|581330127|FG000|Overall Study|Did not receive vaccine|0|||
160983892|NCT00839917|581330128|FG001|Overall Study|Did not receive vaccine|1|||
160983893|NCT04466618|581330133|FG000|Overall Study|Withdrawal by Subject|0|||
160983894|NCT04466618|581330134|FG001|Overall Study|Withdrawal by Subject|1|||
160983895|NCT02800928|581330135|FG000|Overall Study|Withdrawal by Subject|1|||
160799046|NCT03435380|580654512|FG001|Overall Study|Withdrawal by Subject|1|||
160799047|NCT03435380|580654513|FG002|Overall Study|Withdrawal by Subject|1|||
160799048|NCT03435380|580654511|FG000|Overall Study|Ineligible|0|||
160799049|NCT03435380|580654512|FG001|Overall Study|Ineligible|1|||
160799050|NCT03435380|580654513|FG002|Overall Study|Ineligible|1|||
160799051|NCT01170663|580654514|FG000|Overall Study|Lost to Follow-up|3|||
160799052|NCT01170663|580654515|FG001|Overall Study|Lost to Follow-up|9|||
160799053|NCT01170663|580654514|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
160799054|NCT01170663|580654515|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
160799055|NCT02746809|580654516|FG000|Enrollment|Inclusion Exclusion not met|9|||
160799056|NCT02746809|580654516|FG000|Enrollment|Withdrawal by Subject|1|||
160799057|NCT02746809|580654516|FG000|Enrollment|Expected Enrollment Met|2|||
160799058|NCT02746809|580654516|FG000|Procedure|Death|1|||
160799059|NCT02746809|580654516|FG000|1-Month|Death|5|||
160799060|NCT02746809|580654516|FG000|6-Month|Death|2|||
160799061|NCT02746809|580654516|FG000|6-Month|Withdrawal by Subject|1|||
160799062|NCT02746809|580654516|FG000|12-Month|Death|3|||
160799063|NCT02746809|580654516|FG000|12-Month|Withdrawal by Subject|2|||
160799064|NCT02746809|580654516|FG000|24-Month|Death|1|||
160799065|NCT02746809|580654516|FG000|24-Month|Withdrawal by Subject|1|||
160799066|NCT02746809|580654516|FG000|36-Month|Death|8|||
160799067|NCT02746809|580654516|FG000|36-Month|Withdrawal by Subject|1|||
160799068|NCT02746809|580654516|FG000|48-Month|Death|7|||
160799069|NCT02746809|580654516|FG000|48-Month|Withdrawal by Subject|1|||
160799070|NCT02746809|580654516|FG000|60-Month|Death|1|||
160799071|NCT02746809|580654516|FG000|60-Month|Lost to Follow-up|2|||
160799072|NCT00742625|580654517|FG000|Remission Induction|Progression|6|||
160799073|NCT00742625|580654517|FG000|Remission Induction|Failed induction|8|||
160799074|NCT00742625|580654517|FG000|Remission Induction|Adverse Event|3|||
160799075|NCT00742625|580654517|FG000|Remission Induction|Death|10|||
160799076|NCT00742625|580654517|FG000|Remission Induction|Refusal|5|||
160799077|NCT00742625|580654517|FG000|Remission Induction|Non protocol treatment|17|||
160799078|NCT00742625|580654517|FG000|Remission Induction|Other, not specified|5|||
160799079|NCT00742625|580654517|FG000|Consolidation|Progression|5|||
160799080|NCT00742625|580654517|FG000|Consolidation|Adverse Event|1|||
160799081|NCT00742625|580654517|FG000|Consolidation|Death|1|||
160799082|NCT00742625|580654517|FG000|Consolidation|Refused|1|||
160799083|NCT00742625|580654517|FG000|Consolidation|Non protocol therapy|13|||
160799084|NCT00894387|580654521|FG000|Overall Study|Adverse Event|44|||
160799085|NCT00894387|580654522|FG001|Overall Study|Adverse Event|45|||
160799086|NCT00894387|580654521|FG000|Overall Study|Abnormal Laboratory values|2|||
160799087|NCT00894387|580654522|FG001|Overall Study|Abnormal Laboratory values|2|||
160799088|NCT00894387|580654521|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160799089|NCT00894387|580654522|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160799090|NCT00894387|580654521|FG000|Overall Study|Lost to Follow-up|3|||
160799091|NCT00894387|580654522|FG001|Overall Study|Lost to Follow-up|5|||
160799092|NCT00894387|580654521|FG000|Overall Study|Administrative problems|2|||
160799093|NCT00894387|580654522|FG001|Overall Study|Administrative problems|2|||
160799094|NCT00894387|580654521|FG000|Overall Study|Death|77|||
160799095|NCT00894387|580654522|FG001|Overall Study|Death|76|||
160799096|NCT00894387|580654521|FG000|Overall Study|Protocol Deviation|4|||
160799097|NCT00894387|580654522|FG001|Overall Study|Protocol Deviation|0|||
160799098|NCT00894387|580654521|FG000|Overall Study|Patient's request|25|||
160799099|NCT00894387|580654522|FG001|Overall Study|Patient's request|30|||
160799100|NCT00894387|580654521|FG000|Overall Study|Other (Missing)|5|||
160983896|NCT02800928|581330136|FG001|Overall Study|Withdrawal by Subject|1|||
160983897|NCT02800928|581330135|FG000|Overall Study|Protocol Violation|1|||
160983898|NCT02800928|581330136|FG001|Overall Study|Protocol Violation|1|||
160983899|NCT02886728|581330144|FG000|Overall Study|Withdrew Consent|31|||
160983900|NCT02886728|581330145|FG001|Overall Study|Withdrew Consent|13|||
160983901|NCT02886728|581330146|FG002|Overall Study|Withdrew Consent|11|||
160983902|NCT02886728|581330147|FG003|Overall Study|Withdrew Consent|47|||
160983903|NCT02886728|581330144|FG000|Overall Study|Lost to Follow-up|12|||
160983904|NCT02886728|581330145|FG001|Overall Study|Lost to Follow-up|6|||
160983905|NCT02886728|581330146|FG002|Overall Study|Lost to Follow-up|13|||
160983906|NCT02886728|581330147|FG003|Overall Study|Lost to Follow-up|12|||
160983907|NCT02886728|581330144|FG000|Overall Study|Adverse Event|13|||
160983908|NCT02886728|581330145|FG001|Overall Study|Adverse Event|5|||
160983909|NCT02886728|581330146|FG002|Overall Study|Adverse Event|5|||
160983910|NCT02886728|581330147|FG003|Overall Study|Adverse Event|11|||
160983911|NCT02886728|581330144|FG000|Overall Study|Investigator's Discretion|11|||
160983912|NCT02886728|581330145|FG001|Overall Study|Investigator's Discretion|7|||
160983913|NCT02886728|581330146|FG002|Overall Study|Investigator's Discretion|5|||
160983914|NCT02886728|581330147|FG003|Overall Study|Investigator's Discretion|11|||
160983915|NCT02886728|581330144|FG000|Overall Study|Death|3|||
160983916|NCT02886728|581330145|FG001|Overall Study|Death|1|||
160983917|NCT02886728|581330146|FG002|Overall Study|Death|0|||
160983918|NCT02886728|581330147|FG003|Overall Study|Death|0|||
160983919|NCT02886728|581330144|FG000|Overall Study|Protocol Violation|0|||
160983920|NCT02886728|581330145|FG001|Overall Study|Protocol Violation|0|||
160983921|NCT02886728|581330146|FG002|Overall Study|Protocol Violation|0|||
160983922|NCT02886728|581330147|FG003|Overall Study|Protocol Violation|4|||
160983923|NCT02886728|581330144|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160983924|NCT02886728|581330145|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160983925|NCT02886728|581330146|FG002|Overall Study|Non-Compliance with Study Drug|1|||
160983926|NCT02886728|581330147|FG003|Overall Study|Non-Compliance with Study Drug|0|||
160983927|NCT02886728|581330144|FG000|Overall Study|Pregnancy|0|||
160983928|NCT02886728|581330145|FG001|Overall Study|Pregnancy|0|||
160983929|NCT02886728|581330146|FG002|Overall Study|Pregnancy|1|||
160983930|NCT02886728|581330147|FG003|Overall Study|Pregnancy|0|||
160983931|NCT02886728|581330144|FG000|Overall Study|Randomized but Not Dosed|1|||
160983932|NCT02886728|581330145|FG001|Overall Study|Randomized but Not Dosed|0|||
160983933|NCT02886728|581330146|FG002|Overall Study|Randomized but Not Dosed|0|||
160983934|NCT02886728|581330147|FG003|Overall Study|Randomized but Not Dosed|2|||
160983935|NCT00109928|581330148|FG000|Overall Study|Adverse Event|2|||
160983936|NCT00109928|581330148|FG000|Overall Study|Progression|6|||
160983937|NCT00109928|581330148|FG000|Overall Study|Death|2|||
160983938|NCT00109928|581330148|FG000|Overall Study|not protocol specified|2|||
160983939|NCT00109928|581330148|FG000|Overall Study|not eligible|1|||
160983940|NCT01364727|581330151|FG000|Overall Study|Not Eligible|2|||
160983941|NCT01676220|581330152|FG000|Overall Study|Randomized But Not Treated|4|||
160983942|NCT01676220|581330153|FG001|Overall Study|Randomized But Not Treated|1|||
160983943|NCT01676220|581330152|FG000|Overall Study|Adverse Event|10|||
160983944|NCT01676220|581330153|FG001|Overall Study|Adverse Event|8|||
160983945|NCT01676220|581330152|FG000|Overall Study|Lack of Efficacy|2|||
160983946|NCT01676220|581330153|FG001|Overall Study|Lack of Efficacy|5|||
160983947|NCT01676220|581330152|FG000|Overall Study|Protocol Violation|11|||
160983948|NCT01676220|581330153|FG001|Overall Study|Protocol Violation|12|||
160983949|NCT01676220|581330152|FG000|Overall Study|Received Rescue Therapy|14|||
160983950|NCT01676220|581330153|FG001|Overall Study|Received Rescue Therapy|22|||
160983951|NCT01676220|581330152|FG000|Overall Study|Personal Reason|34|||
160983952|NCT01676220|581330153|FG001|Overall Study|Personal Reason|45|||
160983953|NCT01676220|581330152|FG000|Overall Study|Lost to Follow-up|11|||
160983954|NCT01676220|581330153|FG001|Overall Study|Lost to Follow-up|18|||
160983955|NCT01676220|581330152|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
160983956|NCT01676220|581330153|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
160983957|NCT01676220|581330152|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
161129777|NCT01583374|581860937|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
160983958|NCT01676220|581330153|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
160983959|NCT01676220|581330152|FG000|Overall Study|Perceived Lack of Efficacy|3|||
160983960|NCT01676220|581330153|FG001|Overall Study|Perceived Lack of Efficacy|1|||
160983961|NCT01676220|581330152|FG000|Overall Study|Non Serious Hypoglycemia|2|||
160983962|NCT01676220|581330153|FG001|Overall Study|Non Serious Hypoglycemia|0|||
160983963|NCT01676220|581330152|FG000|Overall Study|No More Need of Insulin|1|||
160983964|NCT01676220|581330153|FG001|Overall Study|No More Need of Insulin|0|||
160983965|NCT02411591|581330154|FG000|Overall Study|Adverse Event|0|||
160983966|NCT02411591|581330155|FG001|Overall Study|Adverse Event|4|||
160983967|NCT02411591|581330156|FG002|Overall Study|Adverse Event|2|||
160983968|NCT02411591|581330154|FG000|Overall Study|Withdrawal by Subject|0|||
160983969|NCT02411591|581330155|FG001|Overall Study|Withdrawal by Subject|3|||
160983970|NCT02411591|581330156|FG002|Overall Study|Withdrawal by Subject|0|||
161257891|NCT03756883|582323519|FG001|Overall Study|Lost to Follow-up|3|||
160983971|NCT02411591|581330154|FG000|Overall Study|Physician Decision|0|||
160983972|NCT02411591|581330155|FG001|Overall Study|Physician Decision|3|||
160983973|NCT02411591|581330156|FG002|Overall Study|Physician Decision|1|||
160983974|NCT00873093|581330158|FG000|Overall Study|Adverse Event|0|||
160983975|NCT00873093|581330159|FG001|Overall Study|Adverse Event|2|||
160983976|NCT00873093|581330160|FG002|Overall Study|Adverse Event|0|||
160983977|NCT00873093|581330161|FG003|Overall Study|Adverse Event|0|||
160983978|NCT00873093|581330162|FG004|Overall Study|Adverse Event|0|||
160983979|NCT00873093|581330158|FG000|Overall Study|Death|0|||
160983980|NCT00873093|581330159|FG001|Overall Study|Death|3|||
160983981|NCT00873093|581330160|FG002|Overall Study|Death|2|||
160983982|NCT00873093|581330161|FG003|Overall Study|Death|0|||
160983983|NCT00873093|581330162|FG004|Overall Study|Death|0|||
160983984|NCT00873093|581330158|FG000|Overall Study|Physician Decision|0|||
160983985|NCT00873093|581330159|FG001|Overall Study|Physician Decision|17|||
160983986|NCT00873093|581330160|FG002|Overall Study|Physician Decision|10|||
160983987|NCT00873093|581330161|FG003|Overall Study|Physician Decision|10|||
160983988|NCT00873093|581330162|FG004|Overall Study|Physician Decision|2|||
160983989|NCT00873093|581330158|FG000|Overall Study|Withdrawal by Subject|1|||
160983990|NCT00873093|581330159|FG001|Overall Study|Withdrawal by Subject|4|||
160983991|NCT00873093|581330160|FG002|Overall Study|Withdrawal by Subject|4|||
160983992|NCT00873093|581330161|FG003|Overall Study|Withdrawal by Subject|0|||
160983993|NCT00873093|581330162|FG004|Overall Study|Withdrawal by Subject|0|||
160983994|NCT00873093|581330158|FG000|Overall Study|Ineligible|0|||
160983995|NCT00873093|581330159|FG001|Overall Study|Ineligible|1|||
160983996|NCT00873093|581330160|FG002|Overall Study|Ineligible|0|||
160983997|NCT00873093|581330161|FG003|Overall Study|Ineligible|1|||
160983998|NCT00873093|581330162|FG004|Overall Study|Ineligible|0|||
160983999|NCT01152554|581330164|FG000|Overall Study|Withdrawal by Subject|73|||
160984000|NCT01152554|581330165|FG001|Overall Study|Withdrawal by Subject|28|||
160984001|NCT01152554|581330164|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
160984002|NCT01152554|581330165|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
160984003|NCT01152554|581330164|FG000|Overall Study|Adverse Event|67|||
160984004|NCT01152554|581330165|FG001|Overall Study|Adverse Event|14|||
160984005|NCT01152554|581330164|FG000|Overall Study|Severe non-compliance to protocol|36|||
160984006|NCT01152554|581330165|FG001|Overall Study|Severe non-compliance to protocol|14|||
160984007|NCT01152554|581330164|FG000|Overall Study|Condition under investigation worsened|5|||
160984008|NCT01152554|581330165|FG001|Overall Study|Condition under investigation worsened|2|||
160984009|NCT01152554|581330164|FG000|Overall Study|Lack of Efficacy|20|||
160984010|NCT01152554|581330165|FG001|Overall Study|Lack of Efficacy|3|||
160984011|NCT01152554|581330164|FG000|Overall Study|Study-specific withdrawal criteria|17|||
160984012|NCT01152554|581330165|FG001|Overall Study|Study-specific withdrawal criteria|8|||
160799101|NCT00894387|580654522|FG001|Overall Study|Other (Missing)|3|||
160799102|NCT00894387|580654521|FG000|Overall Study|Mis-randomized|13|||
160799103|NCT00894387|580654522|FG001|Overall Study|Mis-randomized|9|||
160799104|NCT00894387|580654521|FG000|Overall Study|GCP non-compliance|0|||
160799105|NCT00894387|580654522|FG001|Overall Study|GCP non-compliance|2|||
160799106|NCT01865487|580654523|FG000|Overall Study|Lost to Follow-up|0|||
160799107|NCT01865487|580654524|FG001|Overall Study|Lost to Follow-up|0|||
160799108|NCT01865487|580654525|FG002|Overall Study|Lost to Follow-up|0|||
160799109|NCT01865487|580654526|FG003|Overall Study|Lost to Follow-up|1|||
160799110|NCT01865487|580654527|FG004|Overall Study|Lost to Follow-up|0|||
160799111|NCT01865487|580654528|FG005|Overall Study|Lost to Follow-up|0|||
160799112|NCT01865487|580654529|FG006|Overall Study|Lost to Follow-up|1|||
160799113|NCT01865487|580654530|FG007|Overall Study|Lost to Follow-up|0|||
160799114|NCT01865487|580654531|FG008|Overall Study|Lost to Follow-up|0|||
160799115|NCT01865487|580654532|FG009|Overall Study|Lost to Follow-up|0|||
160799116|NCT01865487|580654523|FG000|Overall Study|Withdrawal by Subject|0|||
160895480|NCT03161093|581012885|FG003|Overall Study|Unknown - Not reported|0|||
160895481|NCT03161093|581012886|FG004|Overall Study|Unknown - Not reported|0|||
160895482|NCT03161093|581012887|FG005|Overall Study|Unknown - Not reported|1|||
160895483|NCT02124161|581012888|FG000|Overall Study|Other unspecified|0|||
160895484|NCT02124161|581012889|FG001|Overall Study|Other unspecified|1|||
160895485|NCT02124161|581012888|FG000|Overall Study|Death|1|||
160895486|NCT02124161|581012889|FG001|Overall Study|Death|0|||
160895487|NCT02124161|581012888|FG000|Overall Study|Protocol Violation|2|||
160895488|NCT02124161|581012889|FG001|Overall Study|Protocol Violation|1|||
160895489|NCT02124161|581012888|FG000|Overall Study|Withdrawal by Subject|1|||
160984013|NCT01152554|581330164|FG000|Overall Study|Lost to Follow-up|87|||
160984014|NCT01152554|581330165|FG001|Overall Study|Lost to Follow-up|32|||
160984015|NCT01152554|581330164|FG000|Overall Study|Other|28|||
160984016|NCT01152554|581330165|FG001|Overall Study|Other|8|||
160984017|NCT01152554|581330164|FG000|Overall Study|Death|1|||
160799117|NCT01865487|580654524|FG001|Overall Study|Withdrawal by Subject|0|||
160799118|NCT01865487|580654525|FG002|Overall Study|Withdrawal by Subject|0|||
160799119|NCT01865487|580654526|FG003|Overall Study|Withdrawal by Subject|0|||
160895490|NCT02124161|581012889|FG001|Overall Study|Withdrawal by Subject|2|||
160895491|NCT02124161|581012888|FG000|Overall Study|Adverse Event|2|||
160895492|NCT02124161|581012889|FG001|Overall Study|Adverse Event|0|||
160799120|NCT01865487|580654527|FG004|Overall Study|Withdrawal by Subject|1|||
160984018|NCT01152554|581330165|FG001|Overall Study|Death|1|||
160984019|NCT00146640|581330168|FG000|Overall Study|Adverse Event|12|||
160984020|NCT00146640|581330169|FG001|Overall Study|Adverse Event|10|||
160984021|NCT00146640|581330168|FG000|Overall Study|Medical Reasons|3|||
160984022|NCT00146640|581330169|FG001|Overall Study|Medical Reasons|0|||
160984023|NCT00146640|581330168|FG000|Overall Study|Non-Medical Reasons|8|||
160984024|NCT00146640|581330169|FG001|Overall Study|Non-Medical Reasons|4|||
160984025|NCT02117544|581330170|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
160984026|NCT02117544|581330171|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
160984027|NCT04172987|581330173|FG000|Lead In Period|Adverse Event|1|||
160984028|NCT04172987|581330173|FG000|Lead In Period|Protocol Violation|1|||
160984029|NCT04172987|581330173|FG000|Period 1|Physician Decision|1|||
160984030|NCT04172987|581330173|FG000|Period 2|Adverse Event|5|||
160984031|NCT04172987|581330173|FG000|Period 2|Dosing Termination by Sponsor|4|||
160984032|NCT01603121|581330174|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
160984033|NCT01603121|581330175|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
160984034|NCT00738530|581330176|FG000|Overall Study|Death|220|||
160984035|NCT00738530|581330177|FG001|Overall Study|Death|224|||
160984036|NCT00738530|581330176|FG000|Overall Study|Lost to Follow-up|8|||
160984037|NCT00738530|581330177|FG001|Overall Study|Lost to Follow-up|6|||
160984038|NCT00738530|581330176|FG000|Overall Study|Withdrawal by Subject|6|||
160984039|NCT00738530|581330177|FG001|Overall Study|Withdrawal by Subject|8|||
160984040|NCT01656759|581330178|FG000|Overall Study|Protocol Violation|2|||
160984041|NCT01656759|581330179|FG001|Overall Study|Protocol Violation|3|||
160984042|NCT01628510|581330180|FG000|Overall Study|Withdrawal by Subject|0|||
160984043|NCT01628510|581330181|FG001|Overall Study|Withdrawal by Subject|4|||
160984044|NCT01628510|581330180|FG000|Overall Study|Death|3|||
160984045|NCT01628510|581330181|FG001|Overall Study|Death|1|||
160984046|NCT04179461|581330182|FG000|Overall Study|Lost to Follow-up|4|||
160984047|NCT03160079|581330188|FG000|Overall Study|Adverse Event|2|||
160984048|NCT03160079|581330189|FG001|Overall Study|Adverse Event|0|||
160984049|NCT03160079|581330188|FG000|Overall Study|Disease Progression|1|||
160984050|NCT03160079|581330189|FG001|Overall Study|Disease Progression|0|||
160984051|NCT03160079|581330188|FG000|Overall Study|Physician Decision|1|||
160984052|NCT03160079|581330189|FG001|Overall Study|Physician Decision|0|||
160984053|NCT03259373|581330201|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
160984054|NCT03259373|581330202|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
160984055|NCT03259373|581330201|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
160984056|NCT03259373|581330202|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
160984057|NCT03259373|581330201|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
160984058|NCT03259373|581330202|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
160984059|NCT03259373|581330201|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
160984060|NCT03259373|581330202|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
160984061|NCT03259373|581330201|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
160984062|NCT03259373|581330202|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
160984063|NCT03259373|581330201|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
160984064|NCT03259373|581330202|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
160984065|NCT01513967|581330206|FG000|Overall Study|Pregnancy|0|||
160984066|NCT01513967|581330207|FG001|Overall Study|Pregnancy|0|||
160984067|NCT01513967|581330208|FG002|Overall Study|Pregnancy|0|||
160984068|NCT01513967|581330209|FG003|Overall Study|Pregnancy|0|||
160984069|NCT01513967|581330210|FG004|Overall Study|Pregnancy|0|||
160984070|NCT01513967|581330211|FG005|Overall Study|Pregnancy|0|||
160984071|NCT01513967|581330212|FG006|Overall Study|Pregnancy|1|||
160984072|NCT01513967|581330213|FG007|Overall Study|Pregnancy|0|||
160984073|NCT01513967|581330206|FG000|Overall Study|missed a study visit|0|||
160984074|NCT01513967|581330207|FG001|Overall Study|missed a study visit|0|||
160984075|NCT01513967|581330208|FG002|Overall Study|missed a study visit|0|||
160984076|NCT01513967|581330209|FG003|Overall Study|missed a study visit|0|||
160984077|NCT01513967|581330210|FG004|Overall Study|missed a study visit|0|||
160984078|NCT01513967|581330211|FG005|Overall Study|missed a study visit|0|||
160984079|NCT01513967|581330212|FG006|Overall Study|missed a study visit|1|||
160984080|NCT01513967|581330213|FG007|Overall Study|missed a study visit|0|||
160984081|NCT01513967|581330206|FG000|Overall Study|excluded due to positive drug screen|0|||
160984082|NCT01513967|581330207|FG001|Overall Study|excluded due to positive drug screen|0|||
160984083|NCT01513967|581330208|FG002|Overall Study|excluded due to positive drug screen|0|||
160984084|NCT01513967|581330209|FG003|Overall Study|excluded due to positive drug screen|0|||
161129778|NCT01583374|581860938|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
161129779|NCT01583374|581860939|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
161129780|NCT01583374|581860940|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160984085|NCT01513967|581330210|FG004|Overall Study|excluded due to positive drug screen|0|||
160984086|NCT01513967|581330211|FG005|Overall Study|excluded due to positive drug screen|0|||
160984087|NCT01513967|581330212|FG006|Overall Study|excluded due to positive drug screen|0|||
161129781|NCT01583374|581860941|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160799121|NCT01865487|580654528|FG005|Overall Study|Withdrawal by Subject|0|||
160799122|NCT01865487|580654529|FG006|Overall Study|Withdrawal by Subject|0|||
160799123|NCT01865487|580654530|FG007|Overall Study|Withdrawal by Subject|0|||
160799124|NCT01865487|580654531|FG008|Overall Study|Withdrawal by Subject|0|||
160799125|NCT01865487|580654532|FG009|Overall Study|Withdrawal by Subject|0|||
160799126|NCT01307449|580654533|FG000|Overall Study|Adverse Event|1|||
160799127|NCT01307449|580654534|FG001|Overall Study|Adverse Event|0|||
160799128|NCT01307449|580654535|FG002|Overall Study|Adverse Event|0|||
160799129|NCT01307449|580654536|FG003|Overall Study|Adverse Event|0|||
160799130|NCT01531998|580654539|FG000|Overall Study|Withdrawal by Subject|3|||
160799131|NCT02581891|580654540|FG000|Overall Study|Adverse Event|4|||
160799132|NCT02581891|580654541|FG001|Overall Study|Adverse Event|6|||
160799133|NCT02581891|580654540|FG000|Overall Study|Death|3|||
160799134|NCT02581891|580654541|FG001|Overall Study|Death|4|||
160799135|NCT02581891|580654540|FG000|Overall Study|Lost to Follow-up|1|||
160799136|NCT02581891|580654541|FG001|Overall Study|Lost to Follow-up|2|||
160799137|NCT02581891|580654540|FG000|Overall Study|Physician Decision|0|||
160799138|NCT02581891|580654541|FG001|Overall Study|Physician Decision|1|||
160984088|NCT01513967|581330213|FG007|Overall Study|excluded due to positive drug screen|2|||
160799139|NCT02581891|580654540|FG000|Overall Study|Withdrawal by Subject|4|||
160799140|NCT02581891|580654541|FG001|Overall Study|Withdrawal by Subject|5|||
160799141|NCT02581891|580654540|FG000|Overall Study|Other Reasons|3|||
160799142|NCT02581891|580654541|FG001|Overall Study|Other Reasons|1|||
160799143|NCT02581891|580654540|FG000|Overall Study|Discontinued during followup|1|||
160799144|NCT02581891|580654541|FG001|Overall Study|Discontinued during followup|0|||
160799145|NCT02927795|580654542|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
160799146|NCT02927795|580654542|FG000|Overall Study|Not Treated|4|||
160799147|NCT01612676|580654543|FG000|Overall Study|Adverse Event|2|||
160799148|NCT01612676|580654544|FG001|Overall Study|Adverse Event|3|||
160799149|NCT01612676|580654545|FG002|Overall Study|Adverse Event|1|||
160799150|NCT01612676|580654546|FG003|Overall Study|Adverse Event|3|||
160799151|NCT01612676|580654543|FG000|Overall Study|Protocol Violation|0|||
160799152|NCT01612676|580654544|FG001|Overall Study|Protocol Violation|1|||
160799153|NCT01612676|580654545|FG002|Overall Study|Protocol Violation|0|||
160799154|NCT01612676|580654546|FG003|Overall Study|Protocol Violation|0|||
160799155|NCT00181844|580654553|FG000|Signed Consent|Withdrawal by Subject|5|||
160799156|NCT00181844|580654553|FG000|Signed Consent|Did not meet entrance criteria|7|||
160799157|NCT00181844|580654553|FG000|Exposed to Study Medication|Adverse Event|10|||
160799158|NCT00181844|580654553|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
160799159|NCT00181844|580654553|FG000|Exposed to Study Medication|Non-compliance|2|||
160799160|NCT00181844|580654553|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
160799161|NCT00181844|580654553|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
160799162|NCT04661033|580654554|FG000|Overall Study|Adverse Event|0|||
160799163|NCT04661033|580654555|FG001|Overall Study|Adverse Event|0|||
160799164|NCT04661033|580654556|FG002|Overall Study|Adverse Event|1|||
160799165|NCT04661033|580654557|FG003|Overall Study|Adverse Event|0|||
160799166|NCT04661033|580654554|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
160799167|NCT04661033|580654555|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
160799168|NCT04661033|580654556|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
160799169|NCT04661033|580654557|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
160799170|NCT04661033|580654554|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
160799171|NCT04661033|580654555|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
160799172|NCT04661033|580654556|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
160799173|NCT04661033|580654557|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
160799174|NCT04661033|580654554|FG000|Overall Study|Early discontinuation as per PI|1|||
160799175|NCT04661033|580654555|FG001|Overall Study|Early discontinuation as per PI|0|||
160799176|NCT04661033|580654556|FG002|Overall Study|Early discontinuation as per PI|0|||
160799177|NCT04661033|580654557|FG003|Overall Study|Early discontinuation as per PI|0|||
160799178|NCT03440008|580654558|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
160799179|NCT03440008|580654559|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
160799180|NCT03440008|580654558|FG000|Overall Study|Withdrawal by Subject|1|||
160799181|NCT03440008|580654559|FG001|Overall Study|Withdrawal by Subject|0|||
160799182|NCT01734902|580654568|FG000|Overall Study|Other than listed|0|||
160799183|NCT01734902|580654569|FG001|Overall Study|Other than listed|2|||
160799184|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
160799185|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
160799186|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
160799187|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Death|0|||
160799188|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Death|0|||
160799189|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Death|1|||
160799190|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
160799191|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
160984089|NCT01513967|581330206|FG000|Overall Study|Physician Decision|0|||
160984090|NCT01513967|581330207|FG001|Overall Study|Physician Decision|0|||
160984091|NCT01513967|581330208|FG002|Overall Study|Physician Decision|0|||
160984092|NCT01513967|581330209|FG003|Overall Study|Physician Decision|0|||
160984093|NCT01513967|581330210|FG004|Overall Study|Physician Decision|0|||
160984094|NCT01513967|581330211|FG005|Overall Study|Physician Decision|1|||
160984095|NCT01513967|581330212|FG006|Overall Study|Physician Decision|0|||
160984096|NCT01513967|581330213|FG007|Overall Study|Physician Decision|0|||
160984097|NCT04131907|581330214|FG000|Overall Study|Adverse Event|2|||
160984098|NCT04131907|581330215|FG001|Overall Study|Adverse Event|0|||
160984099|NCT04131907|581330216|FG002|Overall Study|Adverse Event|0|||
160984100|NCT04131907|581330214|FG000|Overall Study|Physician Decision|4|||
160984101|NCT04131907|581330215|FG001|Overall Study|Physician Decision|22|||
160984102|NCT04131907|581330216|FG002|Overall Study|Physician Decision|0|||
160984103|NCT04131907|581330214|FG000|Overall Study|Withdrawal by Subject|2|||
160984104|NCT04131907|581330215|FG001|Overall Study|Withdrawal by Subject|0|||
160984105|NCT04131907|581330216|FG002|Overall Study|Withdrawal by Subject|1|||
160984106|NCT04131907|581330214|FG000|Overall Study|Treatment failure|2|||
160984107|NCT04131907|581330215|FG001|Overall Study|Treatment failure|0|||
160984108|NCT04131907|581330216|FG002|Overall Study|Treatment failure|1|||
160984109|NCT05294419|581330217|FG000|Overall Study|Protocol Violation|4|||
160984110|NCT05294419|581330218|FG001|Overall Study|Protocol Violation|0|||
160984111|NCT05294419|581330219|FG002|Overall Study|Protocol Violation|0|||
160984112|NCT05294419|581330217|FG000|Overall Study|Lost to Follow-up|6|||
160984113|NCT05294419|581330218|FG001|Overall Study|Lost to Follow-up|0|||
160984114|NCT05294419|581330219|FG002|Overall Study|Lost to Follow-up|0|||
160984115|NCT05294419|581330217|FG000|Overall Study|Results voided after publishing|2|||
160984116|NCT05294419|581330218|FG001|Overall Study|Results voided after publishing|0|||
160984117|NCT05294419|581330219|FG002|Overall Study|Results voided after publishing|0|||
160984118|NCT00847301|581330220|FG000|Overall Study|Adverse Event|35|||
160984119|NCT00847301|581330220|FG000|Overall Study|Switch to other anticoagulants|16|||
160984120|NCT00847301|581330220|FG000|Overall Study|Lost to Follow-up|1|||
160984121|NCT00847301|581330220|FG000|Overall Study|No prescription after hospital discharge|1|||
160984122|NCT00847301|581330220|FG000|Overall Study|Other reason not defined above|1|||
160984123|NCT03317379|581330221|FG000|Overall Study|Lost to Follow-up|0|||
160984124|NCT03317379|581330222|FG001|Overall Study|Lost to Follow-up|3|||
160984125|NCT03317379|581330223|FG002|Overall Study|Lost to Follow-up|2|||
160984126|NCT02846558|581330224|FG000|Overall Study|Adverse Event|1|||
160984127|NCT02846558|581330225|FG001|Overall Study|Adverse Event|0|||
160984128|NCT02846558|581330226|FG002|Overall Study|Adverse Event|0|||
161331571|NCT00083915|582601407|FG001|Overall Study|Withdrawal by Subject|3|||
161331572|NCT00083915|582601406|FG000|Overall Study|disease progression|18|||
161331573|NCT00083915|582601407|FG001|Overall Study|disease progression|23|||
161331574|NCT00083915|582601406|FG000|Overall Study|Failure to collect|3|||
161331575|NCT00083915|582601407|FG001|Overall Study|Failure to collect|0|||
161331576|NCT00083915|582601406|FG000|Overall Study|No response|3|||
161331577|NCT00083915|582601407|FG001|Overall Study|No response|1|||
161331578|NCT00083915|582601406|FG000|Overall Study|Insurance issues|1|||
161331579|NCT00083915|582601407|FG001|Overall Study|Insurance issues|1|||
161331580|NCT00719901|582601408|FG000|Overall Study|Adverse Event|5|||
161331581|NCT00719901|582601408|FG000|Overall Study|Withdrawal by Subject|1|||
161331582|NCT00719901|582601408|FG000|Overall Study|Alternate Treatment|1|||
161331583|NCT00719901|582601408|FG000|Overall Study|Disease Progression|3|||
161331584|NCT00719901|582601408|FG000|Overall Study|Availability of Study Drug|1|||
161331585|NCT04456686|582601411|FG000|Overall Study|Adverse Event|2|||
161331586|NCT04456686|582601412|FG001|Overall Study|Adverse Event|1|||
161331587|NCT04456686|582601411|FG000|Overall Study|Lack of Efficacy|3|||
161331588|NCT04456686|582601412|FG001|Overall Study|Lack of Efficacy|1|||
161331589|NCT04456686|582601411|FG000|Overall Study|Withdrew consent|3|||
160984129|NCT02846558|581330227|FG003|Overall Study|Adverse Event|0|||
160984130|NCT02846558|581330224|FG000|Overall Study|Withdrawal by Subject|5|||
160984131|NCT02846558|581330225|FG001|Overall Study|Withdrawal by Subject|4|||
160984132|NCT02846558|581330226|FG002|Overall Study|Withdrawal by Subject|2|||
161331590|NCT04456686|582601412|FG001|Overall Study|Withdrew consent|1|||
161331591|NCT04456686|582601411|FG000|Overall Study|Physician Decision|2|||
161331592|NCT04456686|582601412|FG001|Overall Study|Physician Decision|2|||
161331593|NCT04456686|582601411|FG000|Overall Study|Withdrawal by Subject|5|||
160984133|NCT02846558|581330227|FG003|Overall Study|Withdrawal by Subject|2|||
160984134|NCT02846558|581330224|FG000|Overall Study|Lost to Follow-up|2|||
160984135|NCT02846558|581330225|FG001|Overall Study|Lost to Follow-up|0|||
160984136|NCT02846558|581330226|FG002|Overall Study|Lost to Follow-up|0|||
160984137|NCT02846558|581330227|FG003|Overall Study|Lost to Follow-up|0|||
160984138|NCT01388543|581330228|FG000|Day 14|Adverse Event|1|||
161331594|NCT04456686|582601412|FG001|Overall Study|Withdrawal by Subject|1|||
161331595|NCT04456686|582601411|FG000|Overall Study|Protocol Violation|0|||
161331596|NCT04456686|582601412|FG001|Overall Study|Protocol Violation|1|||
161331597|NCT02858401|582601415|FG000|Overall Study|Withdrew Consent|0|||
161331598|NCT02858401|582601416|FG001|Overall Study|Withdrew Consent|0|||
160984139|NCT01388543|581330229|FG001|Day 14|Adverse Event|4|||
161331599|NCT02858401|582601417|FG002|Overall Study|Withdrew Consent|0|||
161331600|NCT02858401|582601418|FG003|Overall Study|Withdrew Consent|0|||
160895493|NCT02124161|581012888|FG000|Overall Study|Does not meet entrance criteria|2|||
160895494|NCT02124161|581012889|FG001|Overall Study|Does not meet entrance criteria|3|||
160895495|NCT02124161|581012888|FG000|Overall Study|No longer meets eligibility criteria|5|||
160895496|NCT02124161|581012889|FG001|Overall Study|No longer meets eligibility criteria|4|||
160895497|NCT02124161|581012888|FG000|Overall Study|Lost to Follow-up|3|||
160895498|NCT02124161|581012889|FG001|Overall Study|Lost to Follow-up|4|||
160895499|NCT01954342|581012895|FG000|Overall Study|Missing data from 13-16week study visit|0|||
160895500|NCT01954342|581012896|FG001|Overall Study|Missing data from 13-16week study visit|0|||
160895501|NCT01954342|581012897|FG002|Overall Study|Missing data from 13-16week study visit|0|||
160895502|NCT01954342|581012898|FG003|Overall Study|Missing data from 13-16week study visit|1|||
160895503|NCT01954342|581012895|FG000|Overall Study|Miscarriage|0|||
160895504|NCT01954342|581012896|FG001|Overall Study|Miscarriage|0|||
160895505|NCT01954342|581012897|FG002|Overall Study|Miscarriage|0|||
160895506|NCT01954342|581012898|FG003|Overall Study|Miscarriage|3|||
160895507|NCT01954342|581012895|FG000|Overall Study|Lost to Follow-up|0|||
160895508|NCT01954342|581012896|FG001|Overall Study|Lost to Follow-up|0|||
160895509|NCT01954342|581012897|FG002|Overall Study|Lost to Follow-up|0|||
160895510|NCT01954342|581012898|FG003|Overall Study|Lost to Follow-up|5|||
160895511|NCT01954342|581012895|FG000|Overall Study|Preterm delivery|0|||
160895512|NCT01954342|581012896|FG001|Overall Study|Preterm delivery|0|||
160895513|NCT01954342|581012897|FG002|Overall Study|Preterm delivery|0|||
160895514|NCT01954342|581012898|FG003|Overall Study|Preterm delivery|3|||
160895515|NCT01954342|581012895|FG000|Overall Study|Pre-eclampsia|0|||
160895516|NCT01954342|581012896|FG001|Overall Study|Pre-eclampsia|0|||
160895517|NCT01954342|581012897|FG002|Overall Study|Pre-eclampsia|0|||
160895518|NCT01954342|581012898|FG003|Overall Study|Pre-eclampsia|4|||
160895519|NCT01954342|581012895|FG000|Overall Study|Unreliable Data|0|||
160895520|NCT01954342|581012896|FG001|Overall Study|Unreliable Data|0|||
160895521|NCT01954342|581012897|FG002|Overall Study|Unreliable Data|0|||
160895522|NCT01954342|581012898|FG003|Overall Study|Unreliable Data|2|||
160895523|NCT00984568|581012900|FG000|Overall Study|Withdrawal by Subject|1|||
160895524|NCT00984568|581012901|FG001|Overall Study|Withdrawal by Subject|2|||
160895525|NCT00984568|581012900|FG000|Overall Study|Lack of Efficacy|2|||
160895526|NCT00984568|581012901|FG001|Overall Study|Lack of Efficacy|0|||
160895527|NCT00984568|581012900|FG000|Overall Study|Adverse Event|2|||
160895528|NCT00984568|581012901|FG001|Overall Study|Adverse Event|0|||
160895529|NCT00984568|581012900|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
160895530|NCT00984568|581012901|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
160895531|NCT00984568|581012900|FG000|Overall Study|Lost to Follow-up|0|||
160895532|NCT00984568|581012901|FG001|Overall Study|Lost to Follow-up|1|||
160895533|NCT00984568|581012900|FG000|Overall Study|Opportunistic Infection|1|||
160895534|NCT00984568|581012901|FG001|Overall Study|Opportunistic Infection|0|||
160895535|NCT00984568|581012900|FG000|Overall Study|Unknown Reason|1|||
160895536|NCT00984568|581012901|FG001|Overall Study|Unknown Reason|3|||
160895537|NCT01649804|581012908|FG000|Overall Study|Administrative/Other|8|||
160895538|NCT03845543|581012909|FG000|Overall Study|Death|25|||
160895539|NCT03845543|581012909|FG000|Overall Study|Withdrawal by Subject|2|||
160895540|NCT03845543|581012909|FG000|Overall Study|Lost to Follow-up|12|||
160895541|NCT03845543|581012909|FG000|Overall Study|Adverse Event|17|||
160895542|NCT04010539|581012914|FG000|Overall Study|Withdrawal by Subject|4|||
160895543|NCT04010539|581012915|FG001|Overall Study|Withdrawal by Subject|1|||
160895544|NCT04010539|581012914|FG000|Overall Study|Physician Decision|0|||
160895545|NCT04010539|581012915|FG001|Overall Study|Physician Decision|2|||
160895546|NCT04010539|581012914|FG000|Overall Study|Lost to Follow-up|10|||
160895547|NCT04010539|581012915|FG001|Overall Study|Lost to Follow-up|14|||
160895548|NCT04010539|581012914|FG000|Overall Study|Adverse Event|3|||
160895549|NCT04010539|581012915|FG001|Overall Study|Adverse Event|0|||
160895550|NCT04010539|581012914|FG000|Overall Study|Participant Did Not Receive IP|0|||
160895551|NCT04010539|581012915|FG001|Overall Study|Participant Did Not Receive IP|1|||
160895552|NCT04010539|581012914|FG000|Overall Study|Protocol Deviation|0|||
160895553|NCT04010539|581012915|FG001|Overall Study|Protocol Deviation|1|||
160895554|NCT04010539|581012914|FG000|Overall Study|Randomized in Error/ Mistake|2|||
160895555|NCT04010539|581012915|FG001|Overall Study|Randomized in Error/ Mistake|0|||
161129782|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
161257892|NCT03756883|582323520|FG002|Overall Study|Lost to Follow-up|0|||
160895556|NCT04010539|581012914|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
160895557|NCT04010539|581012915|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
160895558|NCT02028871|581012916|FG000|Overall Study|Positive urine drug screen|1|||
160895559|NCT02028871|581012917|FG001|Overall Study|Positive urine drug screen|1|||
160895560|NCT02028871|581012916|FG000|Overall Study|Withdrawal by Subject|1|||
160895561|NCT02028871|581012917|FG001|Overall Study|Withdrawal by Subject|2|||
160895562|NCT02028871|581012916|FG000|Overall Study|IV placement difficulty|1|||
160895563|NCT02028871|581012917|FG001|Overall Study|IV placement difficulty|0|||
160895564|NCT02028871|581012916|FG000|Overall Study|Current Illness|1|||
160895565|NCT02028871|581012917|FG001|Overall Study|Current Illness|0|||
160895566|NCT01912963|581012919|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
161257893|NCT03756883|582323518|FG000|Overall Study|Protocol Violation|2|||
160984140|NCT04684914|581330230|FG000|Overall Study|Withdrawal by Subject|1|||
160984141|NCT04684914|581330231|FG001|Overall Study|Withdrawal by Subject|0|||
160984142|NCT04684914|581330230|FG000|Overall Study|Discontinued before receiving study treatment|1|||
160984143|NCT04684914|581330231|FG001|Overall Study|Discontinued before receiving study treatment|2|||
160984144|NCT03363659|581330232|FG000|Overall Study|Adverse Event|1|||
160984145|NCT03363659|581330232|FG000|Overall Study|Screen fail|1|||
160984146|NCT03363659|581330232|FG000|Overall Study|Withdrawal by Subject|1|||
160984147|NCT02353832|581330233|FG000|Overall Study|Ineligible after enrollment|1|||
160984148|NCT02353832|581330233|FG000|Overall Study|Lost to Follow-up|1|||
160984149|NCT00904150|581330234|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
160984150|NCT00904150|581330235|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
160984151|NCT00904150|581330234|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
160984152|NCT00904150|581330235|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
160984153|NCT03872388|581330238|FG000|Overall Study|Disease Progression|0|||
160984154|NCT03872388|581330239|FG001|Overall Study|Disease Progression|0|||
160984155|NCT03872388|581330240|FG002|Overall Study|Disease Progression|0|||
160984156|NCT03872388|581330241|FG003|Overall Study|Disease Progression|0|||
160984157|NCT03872388|581330242|FG004|Overall Study|Disease Progression|0|||
160984158|NCT03872388|581330243|FG005|Overall Study|Disease Progression|0|||
160984159|NCT03872388|581330244|FG006|Overall Study|Disease Progression|1|||
160984160|NCT03872388|581330245|FG007|Overall Study|Disease Progression|1|||
160984161|NCT01460381|581332163|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
160984162|NCT01460381|581332164|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
160984163|NCT01097655|581332165|FG000|Overall Study|Withdrawal by Subject|1|||
160984164|NCT01097655|581332165|FG000|Overall Study|Subject Documented Twice|1|||
160984165|NCT01097655|581332165|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
160984166|NCT01033643|581332166|FG000|Overall Study|Withdrew Consent|0|||
160984167|NCT01033643|581332167|FG001|Overall Study|Withdrew Consent|3|||
160984168|NCT01033643|581332168|FG002|Overall Study|Withdrew Consent|0|||
160984169|NCT01033643|581332169|FG003|Overall Study|Withdrew Consent|0|||
160984170|NCT01033643|581332170|FG004|Overall Study|Withdrew Consent|0|||
160799192|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
160799193|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
160799194|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
160799195|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
160799196|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
160799197|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
160799198|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
160799199|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Graft loss|0|||
160799200|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Graft loss|0|||
160799201|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Graft loss|7|||
160799202|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
160799203|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
160799204|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
160799205|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
160799206|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
160799207|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
160799208|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
160799209|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
160799210|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
160799211|NCT00956293|580654573|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
160799212|NCT00956293|580654574|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
160799213|NCT00956293|580654575|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
160799214|NCT00956293|580654573|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
160799215|NCT00956293|580654574|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
160799216|NCT00956293|580654575|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
160799217|NCT00956293|580654573|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
160799218|NCT00956293|580654574|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
160799219|NCT00956293|580654575|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
160799220|NCT00956293|580654573|FG000|Main Period (Randomization)|Adverse Event|0|||
160799221|NCT00956293|580654574|FG001|Main Period (Randomization)|Adverse Event|15|||
160799222|NCT00956293|580654575|FG002|Main Period (Randomization)|Adverse Event|0|||
160799223|NCT00956293|580654573|FG000|Follow-up Period|Follow-up period was terminated.|20|||
160799224|NCT00956293|580654574|FG001|Follow-up Period|Follow-up period was terminated.|32|||
160984171|NCT01033643|581332171|FG005|Overall Study|Withdrew Consent|1|||
160984172|NCT03527277|581332172|FG000|Overall Study|Withdrawal by Subject|5|||
160984173|NCT03527277|581332173|FG001|Overall Study|Withdrawal by Subject|0|||
160984174|NCT03527277|581332172|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
160984175|NCT03527277|581332173|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
161257894|NCT03756883|582323519|FG001|Overall Study|Protocol Violation|0|||
161257895|NCT03756883|582323520|FG002|Overall Study|Protocol Violation|1|||
160799225|NCT00956293|580654575|FG002|Follow-up Period|Follow-up period was terminated.|0|||
160799226|NCT02359903|580654576|FG000|Overall Study|Adverse Event|0|||
160799227|NCT02359903|580654577|FG001|Overall Study|Adverse Event|2|||
160799228|NCT03383666|580654578|FG000|Overall Study|Withdrawal by Subject|2|||
160799229|NCT03383666|580654578|FG000|Overall Study|Lost to Follow-up|2|||
160799230|NCT02536664|580654579|FG000|Overall Study|Inadequate completion of documentation|2|||
160799231|NCT02536664|580654580|FG001|Overall Study|Inadequate completion of documentation|4|||
160799232|NCT02536664|580654579|FG000|Overall Study|Progression|13|||
160799233|NCT02536664|580654580|FG001|Overall Study|Progression|18|||
160799234|NCT02536664|580654579|FG000|Overall Study|Death due to lymphoma|2|||
160799235|NCT02536664|580654580|FG001|Overall Study|Death due to lymphoma|1|||
160799236|NCT02536664|580654579|FG000|Overall Study|Death due to other reason|3|||
160799237|NCT02536664|580654580|FG001|Overall Study|Death due to other reason|2|||
160799238|NCT02536664|580654579|FG000|Overall Study|Intolerability|8|||
160799239|NCT02536664|580654580|FG001|Overall Study|Intolerability|6|||
160799240|NCT02536664|580654579|FG000|Overall Study|Withdrawal by Subject|8|||
160799241|NCT02536664|580654580|FG001|Overall Study|Withdrawal by Subject|5|||
160799242|NCT02536664|580654579|FG000|Overall Study|Other|18|||
160799243|NCT02536664|580654580|FG001|Overall Study|Other|24|||
160799244|NCT02536664|580654579|FG000|Overall Study|Missing|53|||
160799245|NCT02536664|580654580|FG001|Overall Study|Missing|20|||
160799246|NCT03507127|580654584|FG000|Overall Study|Withdrawal by Subject|1|||
160799247|NCT03507127|580654585|FG001|Overall Study|Withdrawal by Subject|0|||
160799248|NCT03507127|580654584|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
160799249|NCT03507127|580654585|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
160799250|NCT01240863|580654586|FG000|Open-label Titration Period|Adverse Event|47|||
160799251|NCT01240863|580654587|FG001|Open-label Titration Period|Adverse Event|0|||
160799252|NCT01240863|580654588|FG002|Open-label Titration Period|Adverse Event|0|||
160799253|NCT01240863|580654586|FG000|Open-label Titration Period|Lack of Efficacy|19|||
160799254|NCT01240863|580654587|FG001|Open-label Titration Period|Lack of Efficacy|0|||
160799255|NCT01240863|580654588|FG002|Open-label Titration Period|Lack of Efficacy|0|||
160799256|NCT01240863|580654586|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
160799257|NCT01240863|580654587|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
160799258|NCT01240863|580654588|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
160799259|NCT01240863|580654586|FG000|Open-label Titration Period|Protocol Violation|7|||
160799260|NCT01240863|580654587|FG001|Open-label Titration Period|Protocol Violation|0|||
160799261|NCT01240863|580654588|FG002|Open-label Titration Period|Protocol Violation|0|||
160799262|NCT01240863|580654586|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
160799263|NCT01240863|580654587|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
160799264|NCT01240863|580654588|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
160799265|NCT01240863|580654586|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
160799266|NCT01240863|580654587|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
160799267|NCT01240863|580654588|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
160799268|NCT01240863|580654586|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
160799269|NCT01240863|580654587|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
160799270|NCT01240863|580654588|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
160799271|NCT01240863|580654586|FG000|Open-label Titration Period|Other|7|||
160799272|NCT01240863|580654587|FG001|Open-label Titration Period|Other|0|||
160799273|NCT01240863|580654588|FG002|Open-label Titration Period|Other|0|||
160799274|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
160799275|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
160799276|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
160799277|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160799278|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
160799279|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
160799280|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160799281|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
160799282|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
160799283|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160799284|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
160799285|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
160799286|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
160799287|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
160799288|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
160799289|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
160799290|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
160799291|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
160799292|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
160799293|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
160799294|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
160799295|NCT01240863|580654586|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
160799296|NCT01240863|580654587|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
160984176|NCT03527277|581332172|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
160984177|NCT03527277|581332173|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
160984178|NCT01781611|581332174|FG000|Overall Study|Adverse Event|4|||
160984179|NCT01781611|581332175|FG001|Overall Study|Adverse Event|0|||
160984180|NCT02652130|581332176|FG000|Overall Study|Death|1|||
160984181|NCT00354029|581332177|FG000|Overall Study|Protocol Violation|4|||
160984182|NCT00354029|581332178|FG001|Overall Study|Protocol Violation|2|||
160984183|NCT01021332|581332179|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
160984184|NCT01021332|581332179|FG000|Overall Study|Adverse Event|43|||
160984185|NCT01021332|581332179|FG000|Overall Study|Lack of Efficacy|19|||
160984186|NCT01021332|581332179|FG000|Overall Study|Withdrawal of Consent|23|||
160984187|NCT01021332|581332179|FG000|Overall Study|Lost to Follow-up|4|||
160984188|NCT01021332|581332179|FG000|Overall Study|Protocol Violation|9|||
160984189|NCT01021332|581332179|FG000|Overall Study|Miscellaneous|3|||
160984190|NCT00826280|581332180|FG000|Overall Study|Randomized but drug not received|1|||
160984191|NCT00826280|581332181|FG001|Overall Study|Randomized but drug not received|0|||
160984192|NCT00826280|581332182|FG002|Overall Study|Randomized but drug not received|1|||
160984193|NCT00826280|581332180|FG000|Overall Study|Adverse Event|1|||
160984194|NCT00826280|581332181|FG001|Overall Study|Adverse Event|3|||
160984195|NCT00826280|581332182|FG002|Overall Study|Adverse Event|0|||
160984196|NCT00826280|581332180|FG000|Overall Study|Lost to Follow-up|0|||
160984197|NCT00826280|581332181|FG001|Overall Study|Lost to Follow-up|1|||
160799297|NCT01240863|580654588|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
160799298|NCT03961308|580654590|FG000|Overall Study|Withdrawal by Subject|1|||
160799299|NCT03961308|580654591|FG001|Overall Study|Withdrawal by Subject|0|||
160799300|NCT03961308|580654590|FG000|Overall Study|Other|1|||
160799301|NCT03961308|580654591|FG001|Overall Study|Other|0|||
160799302|NCT03961308|580654590|FG000|Overall Study|Lost to Follow-up|0|||
160799303|NCT03961308|580654591|FG001|Overall Study|Lost to Follow-up|1|||
160799304|NCT03961308|580654590|FG000|Overall Study|Adverse Event|0|||
160799305|NCT03961308|580654591|FG001|Overall Study|Adverse Event|1|||
160799306|NCT02081586|580654597|FG000|Overall Study|Lost to Follow-up|0|||
160799307|NCT02081586|580654598|FG001|Overall Study|Lost to Follow-up|1|||
160799308|NCT02081586|580654599|FG002|Overall Study|Lost to Follow-up|0|||
160799309|NCT02081586|580654600|FG003|Overall Study|Lost to Follow-up|1|||
160799310|NCT02081586|580654597|FG000|Overall Study|Head injury not related to study|0|||
160799311|NCT02081586|580654598|FG001|Overall Study|Head injury not related to study|0|||
160799312|NCT02081586|580654599|FG002|Overall Study|Head injury not related to study|1|||
160799313|NCT02081586|580654600|FG003|Overall Study|Head injury not related to study|0|||
160799314|NCT04549454|580654602|FG000|T1 to T2|Lost to Follow-up|22|||
160799315|NCT04549454|580654603|FG001|T1 to T2|Lost to Follow-up|26|||
160799316|NCT04549454|580654602|FG000|T1 to T3|Lost to Follow-up|31|||
160799317|NCT04549454|580654603|FG001|T1 to T3|Lost to Follow-up|36|||
160799318|NCT01355627|580654614|FG000|Overall Study|Request By the Patient to Discontinue|5|||
160799319|NCT01355627|580654615|FG001|Overall Study|Request By the Patient to Discontinue|7|||
160799320|NCT01355627|580654614|FG000|Overall Study|Lost to Follow-up|8|||
160799321|NCT01355627|580654615|FG001|Overall Study|Lost to Follow-up|7|||
160799322|NCT01355627|580654614|FG000|Overall Study|Fatal Adverse Event|19|||
160799323|NCT01355627|580654615|FG001|Overall Study|Fatal Adverse Event|23|||
160799324|NCT01355627|580654614|FG000|Overall Study|Other|1|||
160799325|NCT01355627|580654615|FG001|Overall Study|Other|1|||
160799326|NCT00545779|580654620|FG000|Overall Study|Violation of selection criteria at entry|8|||
160799327|NCT00545779|580654620|FG000|Overall Study|Other protocol violation|1|||
160799328|NCT00545779|580654620|FG000|Overall Study|Did not cooperate|7|||
160799329|NCT00545779|580654620|FG000|Overall Study|Withdrawal by Subject|20|||
160799330|NCT00545779|580654620|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
160799331|NCT00545779|580654620|FG000|Overall Study|Failure to return|3|||
160799332|NCT01405196|580654621|FG000|Overall Study|Study Terminated by Sponsor|0|||
160799333|NCT01405196|580654622|FG001|Overall Study|Study Terminated by Sponsor|0|||
160799334|NCT01405196|580654623|FG002|Overall Study|Study Terminated by Sponsor|9|||
160799335|NCT01405196|580654624|FG003|Overall Study|Study Terminated by Sponsor|0|||
160799336|NCT01405196|580654621|FG000|Overall Study|Other|2|||
160799337|NCT01405196|580654622|FG001|Overall Study|Other|2|||
160984198|NCT00826280|581332182|FG002|Overall Study|Lost to Follow-up|0|||
160799338|NCT01405196|580654623|FG002|Overall Study|Other|5|||
160799339|NCT01405196|580654624|FG003|Overall Study|Other|0|||
160799340|NCT01405196|580654621|FG000|Overall Study|Withdrawal by Subject|4|||
160799341|NCT01405196|580654622|FG001|Overall Study|Withdrawal by Subject|6|||
160799342|NCT01405196|580654623|FG002|Overall Study|Withdrawal by Subject|3|||
160984199|NCT00826280|581332180|FG000|Overall Study|Sponsor discontinued subject or study|1|||
160984200|NCT00826280|581332181|FG001|Overall Study|Sponsor discontinued subject or study|0|||
160984201|NCT00826280|581332182|FG002|Overall Study|Sponsor discontinued subject or study|0|||
160984202|NCT00826280|581332180|FG000|Overall Study|Reversible ischemic defect not present|43|||
160984203|NCT00826280|581332181|FG001|Overall Study|Reversible ischemic defect not present|40|||
161331601|NCT02858401|582601419|FG004|Overall Study|Withdrew Consent|0|||
161331602|NCT02858401|582601420|FG005|Overall Study|Withdrew Consent|1|||
161331603|NCT02858401|582601421|FG006|Overall Study|Withdrew Consent|0|||
161331604|NCT02858401|582601415|FG000|Overall Study|Lost to Follow-up|0|||
161331605|NCT02858401|582601416|FG001|Overall Study|Lost to Follow-up|1|||
161331606|NCT02858401|582601417|FG002|Overall Study|Lost to Follow-up|0|||
161331607|NCT02858401|582601418|FG003|Overall Study|Lost to Follow-up|0|||
161331608|NCT02858401|582601419|FG004|Overall Study|Lost to Follow-up|0|||
161331609|NCT02858401|582601420|FG005|Overall Study|Lost to Follow-up|0|||
161331610|NCT02858401|582601421|FG006|Overall Study|Lost to Follow-up|0|||
161331611|NCT03722576|582601422|FG000|Overall Study|Withdrawal by Subject|3|||
161331612|NCT03722576|582601422|FG000|Overall Study|Adverse Event|2|||
161331613|NCT03722576|582601422|FG000|Overall Study|Physician Decision|1|||
161331614|NCT03722576|582601422|FG000|Overall Study|Lost to Follow-up|1|||
161331615|NCT02059239|582601426|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
161331616|NCT02059239|582601427|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
161331617|NCT02059239|582601426|FG000|Overall Study|Physician Decision|1|||
161331618|NCT02059239|582601427|FG001|Overall Study|Physician Decision|0|||
161331619|NCT01408706|582601429|FG000|Overall Study|Physician Decision|1|||
161331620|NCT01408706|582601430|FG001|Overall Study|Physician Decision|0|||
161331621|NCT01268267|582601431|FG000|Overall Study|Protocol Violation|1|||
161331622|NCT01222104|582601432|FG000|Overall Study|Lost to Follow-up|37|||
161331623|NCT01222104|582601432|FG000|Overall Study|Death|10|||
161331624|NCT00888654|582601434|FG000|Overall Study|Problems swallowing oral meds.|1|||
161331625|NCT00888654|582601434|FG000|Overall Study|Not enough oral meds before surgery|3|||
161331626|NCT00888654|582601434|FG000|Overall Study|Surgery aborted|2|||
161331627|NCT00888654|582601434|FG000|Overall Study|Withdrawal by Subject|1|||
161331628|NCT00888654|582601434|FG000|Overall Study|Inelig. due to contraindication of med|1|||
161331629|NCT00888654|582601434|FG000|Overall Study|Change in surg date|1|||
161331630|NCT00888654|582601434|FG000|Overall Study|Stopped meds due to headaches|1|||
161331631|NCT01418339|582601435|FG000|Overall Study|Adverse Event|5|||
161331632|NCT01418339|582601436|FG001|Overall Study|Adverse Event|2|||
161331633|NCT01418339|582601435|FG000|Overall Study|Subject Withdrew Consent|1|||
161331634|NCT01418339|582601436|FG001|Overall Study|Subject Withdrew Consent|2|||
161331635|NCT01418339|582601435|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
161331636|NCT01418339|582601436|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
161331637|NCT02219685|582601441|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
161331638|NCT02219685|582601442|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
161331639|NCT02219685|582601441|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
161331640|NCT02219685|582601442|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
161331641|NCT02048722|582601443|FG000|2 Cycles of Treatment|Adverse Event|2|||
161331642|NCT02048722|582601443|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
161331643|NCT02048722|582601443|FG000|2 Cycles of Treatment|Progressive Disease|2|||
161331644|NCT02048722|582601443|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
161331645|NCT02048722|582601443|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
161331646|NCT02048722|582601443|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
161331647|NCT00705757|582601444|FG000|Overall Study|Lack of Efficacy|5|||
161331648|NCT00705757|582601445|FG001|Overall Study|Lack of Efficacy|1|||
161331649|NCT00705757|582601446|FG002|Overall Study|Lack of Efficacy|3|||
161331650|NCT00705757|582601444|FG000|Overall Study|Lost to Follow-up|7|||
161331651|NCT00705757|582601445|FG001|Overall Study|Lost to Follow-up|6|||
161331652|NCT00705757|582601446|FG002|Overall Study|Lost to Follow-up|6|||
161331653|NCT00705757|582601444|FG000|Overall Study|Withdrawal by Subject|1|||
161331654|NCT00705757|582601445|FG001|Overall Study|Withdrawal by Subject|1|||
161331655|NCT00705757|582601446|FG002|Overall Study|Withdrawal by Subject|2|||
161331656|NCT04144322|582601455|FG000|Overall Study|Lack of Efficacy|2|||
161331657|NCT04144322|582601456|FG001|Overall Study|Lack of Efficacy|2|||
161331658|NCT05227118|582601460|FG000|Overall Study|Adverse Event|0|||
161331659|NCT05227118|582601461|FG001|Overall Study|Adverse Event|0|||
161331660|NCT05227118|582601462|FG002|Overall Study|Adverse Event|1|||
161331661|NCT05227118|582601463|FG003|Overall Study|Adverse Event|0|||
161331662|NCT05227118|582601460|FG000|Overall Study|Withdrawal by Subject|0|||
161331663|NCT05227118|582601461|FG001|Overall Study|Withdrawal by Subject|0|||
161331664|NCT05227118|582601462|FG002|Overall Study|Withdrawal by Subject|2|||
161331665|NCT05227118|582601463|FG003|Overall Study|Withdrawal by Subject|0|||
161331666|NCT01435759|582601464|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
161331667|NCT01435759|582601465|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
161331668|NCT01435759|582601466|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
161331669|NCT01435759|582601467|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
161331670|NCT01435759|582601468|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
161331671|NCT01435759|582601469|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
161331672|NCT01435759|582601464|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
161331673|NCT01435759|582601465|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
161331674|NCT01435759|582601466|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
160984204|NCT00826280|581332182|FG002|Overall Study|Reversible ischemic defect not present|44|||
160984205|NCT00826280|581332180|FG000|Overall Study|Interpretation Failure|1|||
160984206|NCT00826280|581332181|FG001|Overall Study|Interpretation Failure|0|||
160984207|NCT00826280|581332182|FG002|Overall Study|Interpretation Failure|0|||
160984208|NCT00826280|581332180|FG000|Overall Study|Machine Failure|1|||
160984209|NCT00826280|581332181|FG001|Overall Study|Machine Failure|1|||
160984210|NCT00826280|581332182|FG002|Overall Study|Machine Failure|0|||
160984211|NCT00826280|581332180|FG000|Overall Study|One or more non-interpretable scan|0|||
160984212|NCT00826280|581332181|FG001|Overall Study|One or more non-interpretable scan|1|||
160984213|NCT00826280|581332182|FG002|Overall Study|One or more non-interpretable scan|1|||
160984214|NCT00750893|581332196|FG000|Overall Study|Adverse Event|5|||
160984215|NCT00750893|581332196|FG000|Overall Study|Withdrawal by Subject|10|||
160984216|NCT00750893|581332196|FG000|Overall Study|Lost to Follow-up|510|||
160984217|NCT00750893|581332196|FG000|Overall Study|Other|17|||
160984218|NCT00661258|581332203|FG000|Overall Study|Death|1|||
160984219|NCT00661258|581332204|FG001|Overall Study|Death|0|||
160984220|NCT00661258|581332203|FG000|Overall Study|caught by police and in detox center|2|||
160984221|NCT00661258|581332204|FG001|Overall Study|caught by police and in detox center|1|||
160984222|NCT01628874|581332205|FG000|Overall Study|Physician Decision|1|||
160984223|NCT01628874|581332206|FG001|Overall Study|Physician Decision|1|||
160984224|NCT01628874|581332205|FG000|Overall Study|Age >4 months|4|||
160984225|NCT01628874|581332206|FG001|Overall Study|Age >4 months|2|||
160984226|NCT03486899|581332207|FG000|Overall Study|Lost to Follow-up|4|||
160984227|NCT03486899|581332208|FG001|Overall Study|Lost to Follow-up|1|||
160984228|NCT03486899|581332209|FG002|Overall Study|Lost to Follow-up|4|||
160984229|NCT03486899|581332210|FG003|Overall Study|Lost to Follow-up|3|||
160984230|NCT03486899|581332207|FG000|Overall Study|Death|1|||
160984231|NCT03486899|581332208|FG001|Overall Study|Death|0|||
160984232|NCT03486899|581332209|FG002|Overall Study|Death|0|||
160984233|NCT03486899|581332210|FG003|Overall Study|Death|1|||
160984234|NCT03486899|581332207|FG000|Overall Study|Adverse Event|0|||
160984235|NCT03486899|581332208|FG001|Overall Study|Adverse Event|2|||
160984236|NCT03486899|581332209|FG002|Overall Study|Adverse Event|0|||
160984237|NCT03486899|581332210|FG003|Overall Study|Adverse Event|2|||
160984238|NCT03486899|581332207|FG000|Overall Study|Withdrawal by Subject|3|||
160984239|NCT03486899|581332208|FG001|Overall Study|Withdrawal by Subject|7|||
160984240|NCT03486899|581332209|FG002|Overall Study|Withdrawal by Subject|4|||
160984241|NCT03486899|581332210|FG003|Overall Study|Withdrawal by Subject|3|||
160984242|NCT03486899|581332207|FG000|Overall Study|Other Reasons|0|||
160984243|NCT03486899|581332208|FG001|Overall Study|Other Reasons|1|||
160984244|NCT03486899|581332209|FG002|Overall Study|Other Reasons|0|||
160984245|NCT03486899|581332210|FG003|Overall Study|Other Reasons|1|||
160984246|NCT01439711|581332211|FG000|Overall Study|Ineligible|13|||
160984247|NCT01439711|581332211|FG000|Overall Study|Cancel|3|||
160984248|NCT01439711|581332211|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
160895567|NCT01912963|581012920|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
160895568|NCT01912963|581012921|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
160895569|NCT01912963|581012919|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
160895570|NCT01912963|581012920|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
160895571|NCT01912963|581012921|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
160895572|NCT01912963|581012919|FG000|Overall Study|Adverse Event|0|||
160895573|NCT01912963|581012920|FG001|Overall Study|Adverse Event|1|||
160895574|NCT01912963|581012921|FG002|Overall Study|Adverse Event|1|||
160895575|NCT01912963|581012919|FG000|Overall Study|Withdrawal by Subject|0|||
160895576|NCT01912963|581012920|FG001|Overall Study|Withdrawal by Subject|1|||
160895577|NCT01912963|581012921|FG002|Overall Study|Withdrawal by Subject|0|||
160895578|NCT01912963|581012919|FG000|Overall Study|Sought treatment locally|0|||
160895579|NCT01912963|581012920|FG001|Overall Study|Sought treatment locally|1|||
160895580|NCT01912963|581012921|FG002|Overall Study|Sought treatment locally|0|||
160895581|NCT01336569|581012925|FG000|Overall Study|Lost to Follow-up|4|||
160895582|NCT00406354|581012926|FG000|All Randomized Patients|Protocol Violation|0|||
160895583|NCT00406354|581012927|FG001|All Randomized Patients|Protocol Violation|0|||
160895584|NCT00406354|581012928|FG002|All Randomized Patients|Protocol Violation|1|||
160895585|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
160895586|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
160895587|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
160895588|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Adverse Event|6|||
160984249|NCT01439711|581332211|FG000|Overall Study|Adverse Event|5|||
160895589|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Adverse Event|2|||
160984250|NCT01439711|581332211|FG000|Overall Study|Withdrawal by Subject|3|||
160984251|NCT01439711|581332211|FG000|Overall Study|Progression During Active Tx|3|||
160984252|NCT01439711|581332211|FG000|Overall Study|Noncompliance|3|||
160984253|NCT01439711|581332211|FG000|Overall Study|No MRI|9|||
160984254|NCT04242875|581332212|FG000|Overall Study|Adverse Event|2|||
160984255|NCT02397460|581332213|FG000|Treatment Period 2|Adverse Event|0|||
160984256|NCT02397460|581332214|FG001|Treatment Period 2|Adverse Event|0|||
160984257|NCT02397460|581332215|FG002|Treatment Period 2|Adverse Event|0|||
160895590|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Adverse Event|1|||
160895591|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
160895592|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
160895593|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
160895594|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
160895595|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
160895596|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
160895597|NCT00406354|581012926|FG000|All Randomized and Treated Patients|Physician Decision|0|||
160895598|NCT00406354|581012927|FG001|All Randomized and Treated Patients|Physician Decision|0|||
160895599|NCT00406354|581012928|FG002|All Randomized and Treated Patients|Physician Decision|1|||
160895600|NCT02027376|581012937|FG000|Overall Study|Death|1|||
160895601|NCT02027376|581012938|FG001|Overall Study|Death|0|||
160895602|NCT02027376|581012939|FG002|Overall Study|Death|0|||
160895603|NCT02130024|581012940|FG000|Overall Study|Adverse Event|10|||
160895604|NCT02130024|581012941|FG001|Overall Study|Adverse Event|11|||
160895605|NCT02130024|581012940|FG000|Overall Study|Death|2|||
160895606|NCT02130024|581012941|FG001|Overall Study|Death|2|||
160895607|NCT02130024|581012940|FG000|Overall Study|Lost to Follow-up|1|||
160895608|NCT02130024|581012941|FG001|Overall Study|Lost to Follow-up|1|||
160895609|NCT02130024|581012940|FG000|Overall Study|Physician Decision|1|||
160895610|NCT02130024|581012941|FG001|Overall Study|Physician Decision|3|||
160895611|NCT02130024|581012940|FG000|Overall Study|Protocol Deviation|4|||
160895612|NCT02130024|581012941|FG001|Overall Study|Protocol Deviation|0|||
160895613|NCT02130024|581012940|FG000|Overall Study|Site Administration Problems|1|||
160895614|NCT02130024|581012941|FG001|Overall Study|Site Administration Problems|0|||
160895615|NCT02130024|581012940|FG000|Overall Study|Subject Withdrew Consent|6|||
160895616|NCT02130024|581012941|FG001|Overall Study|Subject Withdrew Consent|14|||
160895617|NCT05597020|581012942|FG000|Washout|Forbidden medication|2|||
160895618|NCT05597020|581012943|FG001|Washout|Forbidden medication|0|||
160895619|NCT05597020|581012942|FG000|Treatment Period II|Advice from primary care physician|1|||
160895620|NCT05597020|581012943|FG001|Treatment Period II|Advice from primary care physician|0|||
160895621|NCT05597020|581012942|FG000|Treatment Period II|Subject lost investigational product|1|||
160895622|NCT05597020|581012943|FG001|Treatment Period II|Subject lost investigational product|0|||
160895623|NCT05597020|581012942|FG000|Treatment Period II|Private reasons|0|||
160895624|NCT05597020|581012943|FG001|Treatment Period II|Private reasons|1|||
160895625|NCT05736224|581012944|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
160895626|NCT01015131|581012945|FG000|Overall Study|Physician Decision|1|||
160895627|NCT01015131|581012945|FG000|Overall Study|Protocol Violation|1|||
160895628|NCT01015131|581012945|FG000|Overall Study|Withdrawal by Subject|2|||
160895629|NCT01015131|581012945|FG000|Overall Study|Other Protocol Specified Criteria|4|||
160895630|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
160895631|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895632|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895633|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895634|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895635|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895636|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
160895637|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
160895638|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895639|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895640|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895641|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895642|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895643|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
160895644|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
160895645|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895646|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895647|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895648|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895649|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160984258|NCT02397460|581332216|FG003|Treatment Period 2|Adverse Event|0|||
160895650|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
160895651|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
160895652|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895653|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895654|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895655|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895656|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895657|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
160895658|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
160895659|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895660|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895661|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895662|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895663|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895664|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
160895665|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
160895666|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895667|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895668|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895669|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895670|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895671|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
160895672|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
160895673|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895674|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895675|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895676|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895677|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895678|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
160895679|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
160895680|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895681|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895682|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895683|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895684|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895685|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
160895686|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
160895687|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895688|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895689|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895690|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895691|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895692|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
160895693|NCT04526509|581012946|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
160895694|NCT04526509|581012947|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895695|NCT04526509|581012948|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160984259|NCT02397460|581332217|FG004|Treatment Period 2|Adverse Event|0|||
160984260|NCT02397460|581332218|FG005|Treatment Period 2|Adverse Event|0|||
160984261|NCT02397460|581332219|FG006|Treatment Period 2|Adverse Event|0|||
160984262|NCT02397460|581332220|FG007|Treatment Period 2|Adverse Event|1|||
160984263|NCT02397460|581332213|FG000|Treatment Period 4|Adverse Event|0|||
160984264|NCT02397460|581332214|FG001|Treatment Period 4|Adverse Event|1|||
160984265|NCT02397460|581332215|FG002|Treatment Period 4|Adverse Event|0|||
160984266|NCT02397460|581332216|FG003|Treatment Period 4|Adverse Event|0|||
160984267|NCT02397460|581332217|FG004|Treatment Period 4|Adverse Event|0|||
160984268|NCT02397460|581332218|FG005|Treatment Period 4|Adverse Event|0|||
160984269|NCT02397460|581332219|FG006|Treatment Period 4|Adverse Event|0|||
160984270|NCT02397460|581332220|FG007|Treatment Period 4|Adverse Event|0|||
160984271|NCT02397460|581332213|FG000|Treatment Period 4|Physician Decision|0|||
160984272|NCT02397460|581332214|FG001|Treatment Period 4|Physician Decision|0|||
160984273|NCT02397460|581332215|FG002|Treatment Period 4|Physician Decision|0|||
160984274|NCT02397460|581332216|FG003|Treatment Period 4|Physician Decision|0|||
160984275|NCT02397460|581332217|FG004|Treatment Period 4|Physician Decision|1|||
160984276|NCT02397460|581332218|FG005|Treatment Period 4|Physician Decision|0|||
160984277|NCT02397460|581332219|FG006|Treatment Period 4|Physician Decision|0|||
160984278|NCT02397460|581332220|FG007|Treatment Period 4|Physician Decision|0|||
160984279|NCT01723826|581332224|FG000|Overall Study|Adverse Event|4|||
160984280|NCT01723826|581332225|FG001|Overall Study|Adverse Event|1|||
160984281|NCT01723826|581332226|FG002|Overall Study|Adverse Event|4|||
160984282|NCT01723826|581332227|FG003|Overall Study|Adverse Event|5|||
160984283|NCT01723826|581332224|FG000|Overall Study|Death according to AE eCRF|2|||
160984284|NCT01723826|581332225|FG001|Overall Study|Death according to AE eCRF|3|||
160984285|NCT01723826|581332226|FG002|Overall Study|Death according to AE eCRF|3|||
160984286|NCT01723826|581332227|FG003|Overall Study|Death according to AE eCRF|7|||
160984287|NCT01723826|581332224|FG000|Overall Study|Lost to Follow-up|1|||
160984288|NCT01723826|581332225|FG001|Overall Study|Lost to Follow-up|3|||
160984289|NCT01723826|581332226|FG002|Overall Study|Lost to Follow-up|1|||
160984290|NCT01723826|581332227|FG003|Overall Study|Lost to Follow-up|1|||
160984291|NCT01723826|581332224|FG000|Overall Study|Non-compliance|0|||
160984292|NCT01723826|581332225|FG001|Overall Study|Non-compliance|1|||
160984293|NCT01723826|581332226|FG002|Overall Study|Non-compliance|3|||
160984294|NCT01723826|581332227|FG003|Overall Study|Non-compliance|3|||
160984295|NCT01723826|581332224|FG000|Overall Study|Non-compliance With Study Drug|0|||
160984296|NCT01723826|581332225|FG001|Overall Study|Non-compliance With Study Drug|1|||
160984297|NCT01723826|581332226|FG002|Overall Study|Non-compliance With Study Drug|0|||
160984298|NCT01723826|581332227|FG003|Overall Study|Non-compliance With Study Drug|0|||
160984299|NCT01723826|581332224|FG000|Overall Study|Other Reason|8|||
160984300|NCT01723826|581332225|FG001|Overall Study|Other Reason|6|||
160984301|NCT01723826|581332226|FG002|Overall Study|Other Reason|12|||
160984302|NCT01723826|581332227|FG003|Overall Study|Other Reason|14|||
160984303|NCT01723826|581332224|FG000|Overall Study|Physician Decision|1|||
160984304|NCT01723826|581332225|FG001|Overall Study|Physician Decision|3|||
160984305|NCT01723826|581332226|FG002|Overall Study|Physician Decision|4|||
160984306|NCT01723826|581332227|FG003|Overall Study|Physician Decision|11|||
160984307|NCT01723826|581332224|FG000|Overall Study|Protocol Violation|1|||
160984308|NCT01723826|581332225|FG001|Overall Study|Protocol Violation|1|||
160984309|NCT01723826|581332226|FG002|Overall Study|Protocol Violation|3|||
160984310|NCT01723826|581332227|FG003|Overall Study|Protocol Violation|1|||
160984311|NCT01723826|581332224|FG000|Overall Study|Withdrawal by Subject|10|||
160984312|NCT01723826|581332225|FG001|Overall Study|Withdrawal by Subject|17|||
160984313|NCT01723826|581332226|FG002|Overall Study|Withdrawal by Subject|27|||
160984314|NCT01723826|581332227|FG003|Overall Study|Withdrawal by Subject|48|||
160984315|NCT01767129|581332228|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
160984316|NCT01767129|581332229|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
160984317|NCT01473420|581332232|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
160984318|NCT01473420|581332233|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
160984319|NCT01473420|581332232|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
160984320|NCT01473420|581332233|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
160984321|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
160984322|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
160984323|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
160984324|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
160984325|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
160984326|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
160984327|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
160984328|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
160984329|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
160984330|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
160984331|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
160984332|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
160984333|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
160984334|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
160895696|NCT04526509|581012949|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895697|NCT04526509|581012950|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895698|NCT04526509|581012951|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895699|NCT04526509|581012952|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
160895700|NCT04526509|581012946|FG000|Enrolled|Study Terminated by Sponsor|0|||
160895701|NCT04526509|581012947|FG001|Enrolled|Study Terminated by Sponsor|0|||
160895702|NCT04526509|581012948|FG002|Enrolled|Study Terminated by Sponsor|0|||
160895703|NCT04526509|581012949|FG003|Enrolled|Study Terminated by Sponsor|0|||
160895704|NCT04526509|581012950|FG004|Enrolled|Study Terminated by Sponsor|0|||
160895705|NCT04526509|581012951|FG005|Enrolled|Study Terminated by Sponsor|0|||
160895706|NCT04526509|581012952|FG006|Enrolled|Study Terminated by Sponsor|1|||
160895707|NCT04526509|581012946|FG000|Enrolled|Death prior to lymphodepletion|0|||
160895708|NCT04526509|581012947|FG001|Enrolled|Death prior to lymphodepletion|0|||
160895709|NCT04526509|581012948|FG002|Enrolled|Death prior to lymphodepletion|0|||
160895710|NCT04526509|581012949|FG003|Enrolled|Death prior to lymphodepletion|1|||
160895711|NCT04526509|581012950|FG004|Enrolled|Death prior to lymphodepletion|0|||
160895712|NCT04526509|581012951|FG005|Enrolled|Death prior to lymphodepletion|0|||
160895713|NCT04526509|581012952|FG006|Enrolled|Death prior to lymphodepletion|0|||
160895714|NCT04526509|581012946|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895715|NCT04526509|581012947|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895716|NCT04526509|581012948|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895717|NCT04526509|581012949|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
160895718|NCT04526509|581012950|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895719|NCT04526509|581012951|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895720|NCT04526509|581012952|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
160895721|NCT04526509|581012946|FG000|Enrolled|Physician Decision|0|||
160895722|NCT04526509|581012947|FG001|Enrolled|Physician Decision|1|||
160895723|NCT04526509|581012948|FG002|Enrolled|Physician Decision|0|||
160895724|NCT04526509|581012949|FG003|Enrolled|Physician Decision|0|||
160895725|NCT04526509|581012950|FG004|Enrolled|Physician Decision|0|||
160895726|NCT04526509|581012951|FG005|Enrolled|Physician Decision|0|||
160895727|NCT04526509|581012952|FG006|Enrolled|Physician Decision|0|||
160895728|NCT02887859|581012953|FG000|Overall Study|Ongoing|6|||
160895729|NCT02887859|581012953|FG000|Overall Study|Adverse Event|7|||
160895730|NCT02887859|581012953|FG000|Overall Study|Death|1|||
160895731|NCT02887859|581012953|FG000|Overall Study|Physician Decision|1|||
160895732|NCT01554397|581012954|FG000|Overall Study|Withdrawal by Subject|1|||
160895733|NCT01554397|581012955|FG001|Overall Study|Withdrawal by Subject|0|||
160895734|NCT01554397|581012954|FG000|Overall Study|Ineligible|7|||
160895735|NCT01554397|581012955|FG001|Overall Study|Ineligible|0|||
160895736|NCT03817879|581014843|FG000|Overall Study|Drop out|5|||
160895737|NCT03817879|581014844|FG001|Overall Study|Drop out|12|||
160895738|NCT03817879|581014843|FG000|Overall Study|Withdrawal by Subject|0|||
160895739|NCT03817879|581014844|FG001|Overall Study|Withdrawal by Subject|1|||
160895740|NCT04493333|581014845|FG000|Overall Study|Withdrawal by Subject|1|||
160895741|NCT04493333|581014846|FG001|Overall Study|Withdrawal by Subject|1|||
160895742|NCT04493333|581014845|FG000|Overall Study|Ineligible|0|||
160895743|NCT04493333|581014846|FG001|Overall Study|Ineligible|1|||
160895744|NCT04493333|581014845|FG000|Overall Study|Noncompliance|2|||
160895745|NCT04493333|581014846|FG001|Overall Study|Noncompliance|1|||
160895746|NCT02206048|581014852|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
160895747|NCT02925923|581014853|FG000|Overall Study|blood samples hemolyzed|0|||
160895748|NCT02925923|581014854|FG001|Overall Study|blood samples hemolyzed|2|||
160895749|NCT00697073|581014855|FG000|Overall Study|Withdrawal by Subject|2|||
160895750|NCT00697073|581014855|FG000|Overall Study|Pregnancy|1|||
160895751|NCT00697073|581014855|FG000|Overall Study|non compliance and other|6|||
160895752|NCT00426231|581014856|FG000|Overall Study|Withdrawal by Subject|9|||
160895753|NCT00426231|581014857|FG001|Overall Study|Withdrawal by Subject|12|||
160895754|NCT03911713|581014858|FG000|Overall Study|Lost to Follow-up|0|||
160895755|NCT03911713|581014859|FG001|Overall Study|Lost to Follow-up|2|||
160895756|NCT03911713|581014860|FG002|Overall Study|Lost to Follow-up|0|||
160895757|NCT03911713|581014861|FG003|Overall Study|Lost to Follow-up|0|||
160895758|NCT03911713|581014862|FG004|Overall Study|Lost to Follow-up|0|||
160895759|NCT03911713|581014858|FG000|Overall Study|Other|0|||
160895760|NCT03911713|581014859|FG001|Overall Study|Other|0|||
160895761|NCT03911713|581014860|FG002|Overall Study|Other|0|||
160895762|NCT03911713|581014861|FG003|Overall Study|Other|1|||
160895763|NCT03911713|581014862|FG004|Overall Study|Other|0|||
160895764|NCT03911713|581014858|FG000|Overall Study|Randomized, Never Dosed|1|||
160895765|NCT03911713|581014859|FG001|Overall Study|Randomized, Never Dosed|0|||
160895766|NCT03911713|581014860|FG002|Overall Study|Randomized, Never Dosed|0|||
160895767|NCT03911713|581014861|FG003|Overall Study|Randomized, Never Dosed|1|||
160895768|NCT03911713|581014862|FG004|Overall Study|Randomized, Never Dosed|0|||
160895769|NCT00108433|581014865|FG000|Overall Study|Lack of Efficacy|1|||
160799343|NCT01405196|580654624|FG003|Overall Study|Withdrawal by Subject|6|||
160799344|NCT01405196|580654621|FG000|Overall Study|Adverse Event|2|||
160799345|NCT01405196|580654622|FG001|Overall Study|Adverse Event|2|||
160799346|NCT01405196|580654623|FG002|Overall Study|Adverse Event|0|||
160799347|NCT01405196|580654624|FG003|Overall Study|Adverse Event|2|||
160799348|NCT01405196|580654621|FG000|Overall Study|Death|1|||
160799349|NCT01405196|580654622|FG001|Overall Study|Death|0|||
160799350|NCT01405196|580654623|FG002|Overall Study|Death|3|||
160799351|NCT01405196|580654624|FG003|Overall Study|Death|0|||
160799352|NCT01405196|580654621|FG000|Overall Study|Lost to Follow-up|2|||
160799353|NCT01405196|580654622|FG001|Overall Study|Lost to Follow-up|2|||
160799354|NCT01405196|580654623|FG002|Overall Study|Lost to Follow-up|3|||
160799355|NCT01405196|580654624|FG003|Overall Study|Lost to Follow-up|1|||
160799356|NCT01542788|580654625|FG000|Overall Study|Randomized but Not Treated|2|||
160799357|NCT01542788|580654626|FG001|Overall Study|Randomized but Not Treated|0|||
160799358|NCT01542788|580654625|FG000|Overall Study|Lack of Efficacy|41|||
160799359|NCT01542788|580654626|FG001|Overall Study|Lack of Efficacy|71|||
160799360|NCT01542788|580654625|FG000|Overall Study|Lost to Follow-up|5|||
160799361|NCT01542788|580654626|FG001|Overall Study|Lost to Follow-up|0|||
160799362|NCT01542788|580654625|FG000|Overall Study|Death|3|||
160799363|NCT01542788|580654626|FG001|Overall Study|Death|0|||
160799364|NCT01542788|580654625|FG000|Overall Study|Protocol Violation|2|||
160799365|NCT01542788|580654626|FG001|Overall Study|Protocol Violation|0|||
160799366|NCT01542788|580654625|FG000|Overall Study|Physician Decision|1|||
160799367|NCT01542788|580654626|FG001|Overall Study|Physician Decision|0|||
160799368|NCT01542788|580654625|FG000|Overall Study|Withdrawal by Subject|1|||
160799369|NCT01542788|580654626|FG001|Overall Study|Withdrawal by Subject|0|||
160799370|NCT05643495|580654627|FG000|Overall Study|Adverse Event|0|||
160895770|NCT00108433|581014866|FG001|Overall Study|Lack of Efficacy|2|||
160895771|NCT00108433|581014865|FG000|Overall Study|Death|3|||
160895772|NCT00108433|581014866|FG001|Overall Study|Death|0|||
160895773|NCT00108433|581014865|FG000|Overall Study|Adverse Event|3|||
160895774|NCT00108433|581014866|FG001|Overall Study|Adverse Event|1|||
160895775|NCT00108433|581014865|FG000|Overall Study|Other|14|||
160895776|NCT00108433|581014866|FG001|Overall Study|Other|14|||
160895777|NCT02203071|581014867|FG000|Overall Study|Lost to Follow-up|3|||
160895778|NCT02203071|581014868|FG001|Overall Study|Lost to Follow-up|1|||
160895779|NCT01845818|581014869|FG000|Overall Study|Withdrawal by Subject|0|||
160895780|NCT01845818|581014870|FG001|Overall Study|Withdrawal by Subject|1|||
160895781|NCT01845818|581014869|FG000|Overall Study|Lost to Follow-up|7|||
160895782|NCT01845818|581014870|FG001|Overall Study|Lost to Follow-up|5|||
160895783|NCT01845818|581014869|FG000|Overall Study|Administrative Reasons|3|||
160895784|NCT01845818|581014870|FG001|Overall Study|Administrative Reasons|1|||
160895785|NCT01845818|581014869|FG000|Overall Study|Serious Adverse Event|1|||
160895786|NCT01845818|581014870|FG001|Overall Study|Serious Adverse Event|1|||
160895787|NCT01845818|581014869|FG000|Overall Study|Other|25|||
160895788|NCT01845818|581014870|FG001|Overall Study|Other|8|||
160895789|NCT01845818|581014869|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
160895790|NCT01845818|581014870|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
160895791|NCT01845818|581014869|FG000|Overall Study|No Follow-Up Data Available|4|||
160895792|NCT01845818|581014870|FG001|Overall Study|No Follow-Up Data Available|1|||
160895793|NCT02595970|581014871|FG000|Overall Study|Withdrawal by Subject|2|||
160895794|NCT02595970|581014871|FG000|Overall Study|Physician Decision|2|||
160895795|NCT02595970|581014871|FG000|Overall Study|Protocol Violation|4|||
160895796|NCT02595970|581014871|FG000|Overall Study|Adverse Event|5|||
160895797|NCT02595970|581014871|FG000|Overall Study|Lack of Efficacy|7|||
160895798|NCT02572388|581014872|FG000|Overall Study|Withdrawal by Subject|1|||
160895799|NCT02572388|581014873|FG001|Overall Study|Withdrawal by Subject|1|||
160895800|NCT02572388|581014874|FG002|Overall Study|Withdrawal by Subject|2|||
160895801|NCT02572388|581014875|FG003|Overall Study|Withdrawal by Subject|2|||
160895802|NCT02202837|581014877|FG000|Overall Study|Enbrel treatment discontinued|36|||
160895803|NCT02202837|581014878|FG001|Overall Study|Enbrel treatment discontinued|4|||
160895804|NCT02202837|581014877|FG000|Overall Study|Other|10|||
160895805|NCT02202837|581014878|FG001|Overall Study|Other|0|||
160895806|NCT02202837|581014877|FG000|Overall Study|Lost to Follow-up|7|||
160895807|NCT02202837|581014878|FG001|Overall Study|Lost to Follow-up|1|||
160799371|NCT05643495|580654628|FG001|Overall Study|Adverse Event|1|||
160799372|NCT05643495|580654627|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160799373|NCT05643495|580654628|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
160799374|NCT02257528|580654629|FG000|Overall Study|Never received study treatment|1|||
160799375|NCT00698841|580654630|FG000|Overall Study|Withdrawal by Subject|2|||
160895808|NCT00231842|581014884|FG000|Overall Study|Withdrawal by Subject|3|||
160895809|NCT00231842|581014884|FG000|Overall Study|Did not complete the last 3 cycle|8|||
160895810|NCT02422303|581014885|FG000|Overall Study|Lost to Follow-up|1|||
160895811|NCT02422303|581014886|FG001|Overall Study|Lost to Follow-up|1|||
160895812|NCT00850343|581014887|FG000|Overall Study|Withdrawal by Subject|11|||
160895813|NCT00850343|581014888|FG001|Overall Study|Withdrawal by Subject|0|||
160895814|NCT00850343|581014889|FG002|Overall Study|Withdrawal by Subject|3|||
160895815|NCT00850343|581014890|FG003|Overall Study|Withdrawal by Subject|2|||
160984335|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
160984336|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
160984337|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
160984338|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
160984339|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
160984340|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
160984341|NCT01473420|581332232|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
160984342|NCT01473420|581332233|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
160984343|NCT02906202|581332244|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
160984344|NCT03990363|581332246|FG000|Overall Study|Withdrawal by Subject|10|||
160984345|NCT03990363|581332247|FG001|Overall Study|Withdrawal by Subject|9|||
160984346|NCT03990363|581332248|FG002|Overall Study|Withdrawal by Subject|18|||
160984347|NCT03990363|581332249|FG003|Overall Study|Withdrawal by Subject|11|||
160984348|NCT03990363|581332250|FG004|Overall Study|Withdrawal by Subject|9|||
160984349|NCT03990363|581332246|FG000|Overall Study|Physician Decision|1|||
160984350|NCT03990363|581332247|FG001|Overall Study|Physician Decision|0|||
160984351|NCT03990363|581332248|FG002|Overall Study|Physician Decision|0|||
160984352|NCT03990363|581332249|FG003|Overall Study|Physician Decision|0|||
160984353|NCT03990363|581332250|FG004|Overall Study|Physician Decision|0|||
160984354|NCT03990363|581332246|FG000|Overall Study|Adverse Event|1|||
160984355|NCT03990363|581332247|FG001|Overall Study|Adverse Event|3|||
160984356|NCT03990363|581332248|FG002|Overall Study|Adverse Event|2|||
160984357|NCT03990363|581332249|FG003|Overall Study|Adverse Event|2|||
160984358|NCT03990363|581332250|FG004|Overall Study|Adverse Event|0|||
160984359|NCT03990363|581332246|FG000|Overall Study|Death|14|||
160984360|NCT03990363|581332247|FG001|Overall Study|Death|8|||
160984361|NCT03990363|581332248|FG002|Overall Study|Death|14|||
160984362|NCT03990363|581332249|FG003|Overall Study|Death|10|||
160984363|NCT03990363|581332250|FG004|Overall Study|Death|11|||
160984364|NCT03990363|581332246|FG000|Overall Study|Failure to meet randomization criteria|0|||
160984365|NCT03990363|581332247|FG001|Overall Study|Failure to meet randomization criteria|1|||
161129783|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
161129784|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161129785|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161331675|NCT01435759|582601467|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
161331676|NCT01435759|582601468|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
161331677|NCT01435759|582601469|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
161331678|NCT01435759|582601464|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
161331679|NCT01435759|582601465|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161331680|NCT01435759|582601466|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161331681|NCT01435759|582601467|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161331682|NCT01435759|582601468|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
161331683|NCT01435759|582601469|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160895816|NCT00850343|581014887|FG000|Overall Study|Adverse Event|15|||
160895817|NCT00850343|581014888|FG001|Overall Study|Adverse Event|2|||
160895818|NCT00850343|581014889|FG002|Overall Study|Adverse Event|6|||
160895819|NCT00850343|581014890|FG003|Overall Study|Adverse Event|6|||
160895820|NCT00850343|581014887|FG000|Overall Study|Pregnancy|0|||
160895821|NCT00850343|581014888|FG001|Overall Study|Pregnancy|0|||
160895822|NCT00850343|581014889|FG002|Overall Study|Pregnancy|0|||
160895823|NCT00850343|581014890|FG003|Overall Study|Pregnancy|1|||
160895824|NCT00850343|581014887|FG000|Overall Study|Lack of Efficacy|17|||
160895825|NCT00850343|581014888|FG001|Overall Study|Lack of Efficacy|0|||
160895826|NCT00850343|581014889|FG002|Overall Study|Lack of Efficacy|3|||
160895827|NCT00850343|581014890|FG003|Overall Study|Lack of Efficacy|2|||
160895828|NCT00850343|581014887|FG000|Overall Study|Non-compliance with Study Procedures|1|||
160895829|NCT00850343|581014888|FG001|Overall Study|Non-compliance with Study Procedures|0|||
160984366|NCT03990363|581332248|FG002|Overall Study|Failure to meet randomization criteria|1|||
161331684|NCT01435759|582601464|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
161331685|NCT01435759|582601465|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161331686|NCT01435759|582601466|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161331687|NCT01435759|582601467|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161331688|NCT01435759|582601468|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161331689|NCT01435759|582601469|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
161331690|NCT01435759|582601464|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
161331691|NCT01435759|582601465|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331692|NCT01435759|582601466|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331693|NCT01435759|582601467|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331694|NCT01435759|582601468|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331695|NCT01435759|582601469|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331696|NCT01435759|582601464|FG000|Antidepressant Lead-in Phase|Other|119|||
160895830|NCT00850343|581014889|FG002|Overall Study|Non-compliance with Study Procedures|1|||
160984367|NCT03990363|581332249|FG003|Overall Study|Failure to meet randomization criteria|0|||
160984368|NCT03990363|581332250|FG004|Overall Study|Failure to meet randomization criteria|0|||
160984369|NCT03990363|581332246|FG000|Overall Study|Lost to Follow-up|0|||
160984370|NCT03990363|581332247|FG001|Overall Study|Lost to Follow-up|0|||
160984371|NCT03990363|581332248|FG002|Overall Study|Lost to Follow-up|0|||
160984372|NCT03990363|581332249|FG003|Overall Study|Lost to Follow-up|1|||
160984373|NCT03990363|581332250|FG004|Overall Study|Lost to Follow-up|2|||
160984374|NCT03990363|581332246|FG000|Overall Study|Non-compliance with study drug|2|||
160984375|NCT03990363|581332247|FG001|Overall Study|Non-compliance with study drug|1|||
160984376|NCT03990363|581332248|FG002|Overall Study|Non-compliance with study drug|2|||
160984377|NCT03990363|581332249|FG003|Overall Study|Non-compliance with study drug|0|||
160984378|NCT03990363|581332250|FG004|Overall Study|Non-compliance with study drug|0|||
160984379|NCT03990363|581332246|FG000|Overall Study|Study terminated by sponsor|0|||
160984380|NCT03990363|581332247|FG001|Overall Study|Study terminated by sponsor|1|||
160984381|NCT03990363|581332248|FG002|Overall Study|Study terminated by sponsor|0|||
160984382|NCT03990363|581332249|FG003|Overall Study|Study terminated by sponsor|0|||
160984383|NCT03990363|581332250|FG004|Overall Study|Study terminated by sponsor|0|||
160984384|NCT03990363|581332246|FG000|Overall Study|Site terminated by sponsor|2|||
160984385|NCT03990363|581332247|FG001|Overall Study|Site terminated by sponsor|1|||
160984386|NCT03990363|581332248|FG002|Overall Study|Site terminated by sponsor|2|||
160984387|NCT03990363|581332249|FG003|Overall Study|Site terminated by sponsor|0|||
160984388|NCT03990363|581332250|FG004|Overall Study|Site terminated by sponsor|2|||
160984389|NCT03990363|581332246|FG000|Overall Study|Not categorized|5|||
160984390|NCT03990363|581332247|FG001|Overall Study|Not categorized|5|||
160984391|NCT03990363|581332248|FG002|Overall Study|Not categorized|3|||
160984392|NCT03990363|581332249|FG003|Overall Study|Not categorized|2|||
160984393|NCT03990363|581332250|FG004|Overall Study|Not categorized|2|||
160984394|NCT01349660|581332256|FG000|Overall Study|Still Receiving Study Treatment|0|||
160984395|NCT01349660|581332257|FG001|Overall Study|Still Receiving Study Treatment|0|||
160984396|NCT01349660|581332258|FG002|Overall Study|Still Receiving Study Treatment|1|||
160984397|NCT01349660|581332256|FG000|Overall Study|Disease Progression|2|||
160984398|NCT01349660|581332257|FG001|Overall Study|Disease Progression|4|||
160984399|NCT01349660|581332258|FG002|Overall Study|Disease Progression|50|||
160984400|NCT01349660|581332256|FG000|Overall Study|Adverse Event|1|||
160799376|NCT00698841|580654630|FG000|Overall Study|Adverse Event|3|||
160799377|NCT00698841|580654630|FG000|Overall Study|Disease progression|7|||
160799378|NCT00698841|580654630|FG000|Overall Study|Failure to meet eligibility criteria|2|||
160799379|NCT00698841|580654630|FG000|Overall Study|Study drug toxicity|2|||
160799380|NCT00698841|580654630|FG000|Overall Study|Other|2|||
160799381|NCT04646005|580654634|FG000|Overall Study|Adverse Event|1|||
160799382|NCT04646005|580654634|FG000|Overall Study|Progressive Disease|71|||
160799383|NCT04646005|580654634|FG000|Overall Study|Death|20|||
160799384|NCT04646005|580654634|FG000|Overall Study|Withdrawal by Subject|12|||
160799385|NCT04646005|580654634|FG000|Overall Study|Sponsor Request|9|||
160799386|NCT05788991|580654636|FG000|Overall Study|Not treated with study medication|1|||
160799387|NCT05788991|580654637|FG001|Overall Study|Not treated with study medication|3|||
160799388|NCT05788991|580654636|FG000|Overall Study|Withdrawal by Subject|1|||
160799389|NCT05788991|580654637|FG001|Overall Study|Withdrawal by Subject|0|||
160799390|NCT05788991|580654636|FG000|Overall Study|Lack of Efficacy|0|||
160799391|NCT05788991|580654637|FG001|Overall Study|Lack of Efficacy|1|||
160799392|NCT05788991|580654636|FG000|Overall Study|Protocol Violation|1|||
160799393|NCT05788991|580654637|FG001|Overall Study|Protocol Violation|2|||
160799394|NCT04712669|580654638|FG000|Double Blind Phase|Adverse Event|4|||
160799395|NCT04712669|580654639|FG001|Double Blind Phase|Adverse Event|4|||
160799396|NCT04712669|580654640|FG002|Double Blind Phase|Adverse Event|3|||
160799397|NCT04712669|580654641|FG003|Double Blind Phase|Adverse Event|0|||
160799398|NCT04712669|580654642|FG004|Double Blind Phase|Adverse Event|0|||
160799399|NCT04712669|580654643|FG005|Double Blind Phase|Adverse Event|0|||
160799400|NCT04712669|580654644|FG006|Double Blind Phase|Adverse Event|0|||
160984401|NCT01349660|581332257|FG001|Overall Study|Adverse Event|1|||
160984402|NCT01349660|581332258|FG002|Overall Study|Adverse Event|12|||
160984403|NCT01349660|581332256|FG000|Overall Study|Withdrawal by Subject|2|||
160984404|NCT01349660|581332257|FG001|Overall Study|Withdrawal by Subject|0|||
160984405|NCT01349660|581332258|FG002|Overall Study|Withdrawal by Subject|9|||
161237240|NCT02335658|582248504|FG001|Overall Study|Withdrawal by Subject|21|||
160799401|NCT04712669|580654645|FG007|Double Blind Phase|Adverse Event|0|||
160984406|NCT01349660|581332256|FG000|Overall Study|Death|1|||
160984407|NCT01349660|581332257|FG001|Overall Study|Death|1|||
160984408|NCT01349660|581332258|FG002|Overall Study|Death|0|||
160799402|NCT04712669|580654638|FG000|Double Blind Phase|Physician Decision|1|||
160799403|NCT04712669|580654639|FG001|Double Blind Phase|Physician Decision|0|||
160799404|NCT04712669|580654640|FG002|Double Blind Phase|Physician Decision|0|||
160799405|NCT04712669|580654641|FG003|Double Blind Phase|Physician Decision|0|||
160799406|NCT04712669|580654642|FG004|Double Blind Phase|Physician Decision|0|||
160984409|NCT01349660|581332256|FG000|Overall Study|Non-Permitted Interventions|0|||
160984410|NCT01349660|581332257|FG001|Overall Study|Non-Permitted Interventions|0|||
160984411|NCT01349660|581332258|FG002|Overall Study|Non-Permitted Interventions|2|||
160895831|NCT00850343|581014890|FG003|Overall Study|Non-compliance with Study Procedures|1|||
160895832|NCT00850343|581014887|FG000|Overall Study|Physician Decision|2|||
160895833|NCT00850343|581014888|FG001|Overall Study|Physician Decision|1|||
160895834|NCT00850343|581014889|FG002|Overall Study|Physician Decision|1|||
160895835|NCT00850343|581014890|FG003|Overall Study|Physician Decision|1|||
160895836|NCT02436304|581014891|FG000|Overall Study|Lost to Follow-up|0|||
160895837|NCT02436304|581014892|FG001|Overall Study|Lost to Follow-up|1|||
161129786|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
161129787|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
160895838|NCT02436304|581014893|FG002|Overall Study|Lost to Follow-up|0|||
160895839|NCT02436304|581014891|FG000|Overall Study|Withdrawal by Subject|0|||
160895840|NCT02436304|581014892|FG001|Overall Study|Withdrawal by Subject|1|||
160895841|NCT02436304|581014893|FG002|Overall Study|Withdrawal by Subject|0|||
160895842|NCT02436304|581014891|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
160895843|NCT02436304|581014892|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
160895844|NCT02436304|581014893|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
160895845|NCT05274815|581014899|FG000|Overall Study|Adverse Event|1|||
160895846|NCT05274815|581014899|FG000|Overall Study|Death|2|||
160895847|NCT05274815|581014899|FG000|Overall Study|Lost to Follow-up|4|||
160895848|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
160895849|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
160895850|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
160895851|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
160895852|NCT05274815|581014899|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
160895853|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
160895854|NCT05274815|581014899|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
160895855|NCT05274815|581014899|FG000|Overall Study|Withdrawal by Subject|11|||
160895856|NCT04416633|581014900|FG000|Overall Study|Death|1|||
160895857|NCT04416633|581014900|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
160895858|NCT04416633|581014900|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
160895859|NCT04416633|581014900|FG000|Overall Study|Adverse Event|6|||
160895860|NCT04416633|581014900|FG000|Overall Study|Withdrawal by Subject|6|||
160895861|NCT00785928|581014901|FG000|Treatment Phase|Adverse Event|1|||
160895862|NCT00785928|581014902|FG001|Treatment Phase|Adverse Event|1|||
160895863|NCT00785928|581014903|FG002|Treatment Phase|Adverse Event|2|||
160895864|NCT00785928|581014904|FG003|Treatment Phase|Adverse Event|0|||
160895865|NCT00785928|581014905|FG004|Treatment Phase|Adverse Event|0|||
160895866|NCT00785928|581014906|FG005|Treatment Phase|Adverse Event|0|||
160895867|NCT00785928|581014907|FG006|Treatment Phase|Adverse Event|2|||
160895868|NCT00785928|581014901|FG000|Treatment Phase|Inadequate Response|0|||
160895869|NCT00785928|581014902|FG001|Treatment Phase|Inadequate Response|1|||
160895870|NCT00785928|581014903|FG002|Treatment Phase|Inadequate Response|0|||
160895871|NCT00785928|581014904|FG003|Treatment Phase|Inadequate Response|0|||
160895872|NCT00785928|581014905|FG004|Treatment Phase|Inadequate Response|0|||
160895873|NCT00785928|581014906|FG005|Treatment Phase|Inadequate Response|0|||
160895874|NCT00785928|581014907|FG006|Treatment Phase|Inadequate Response|0|||
160895875|NCT00785928|581014901|FG000|Treatment Phase|Lack of Efficacy|0|||
160895876|NCT00785928|581014902|FG001|Treatment Phase|Lack of Efficacy|1|||
160895877|NCT00785928|581014903|FG002|Treatment Phase|Lack of Efficacy|1|||
160895878|NCT00785928|581014904|FG003|Treatment Phase|Lack of Efficacy|0|||
160895879|NCT00785928|581014905|FG004|Treatment Phase|Lack of Efficacy|0|||
160895880|NCT00785928|581014906|FG005|Treatment Phase|Lack of Efficacy|0|||
160895881|NCT00785928|581014907|FG006|Treatment Phase|Lack of Efficacy|0|||
160895882|NCT00785928|581014901|FG000|Treatment Phase|Physician Decision|0|||
160895883|NCT00785928|581014902|FG001|Treatment Phase|Physician Decision|0|||
160895884|NCT00785928|581014903|FG002|Treatment Phase|Physician Decision|0|||
160895885|NCT00785928|581014904|FG003|Treatment Phase|Physician Decision|0|||
160895886|NCT00785928|581014905|FG004|Treatment Phase|Physician Decision|1|||
160895887|NCT00785928|581014906|FG005|Treatment Phase|Physician Decision|0|||
160895888|NCT00785928|581014907|FG006|Treatment Phase|Physician Decision|0|||
160895889|NCT00785928|581014901|FG000|Treatment Phase|Sponsor Decision|1|||
160895890|NCT00785928|581014902|FG001|Treatment Phase|Sponsor Decision|0|||
160895891|NCT00785928|581014903|FG002|Treatment Phase|Sponsor Decision|0|||
160895892|NCT00785928|581014904|FG003|Treatment Phase|Sponsor Decision|0|||
160895893|NCT00785928|581014905|FG004|Treatment Phase|Sponsor Decision|0|||
160895894|NCT00785928|581014906|FG005|Treatment Phase|Sponsor Decision|0|||
160895895|NCT00785928|581014907|FG006|Treatment Phase|Sponsor Decision|1|||
160895896|NCT00785928|581014901|FG000|Treatment Phase|Withdrawal by Subject|1|||
160895897|NCT00785928|581014902|FG001|Treatment Phase|Withdrawal by Subject|2|||
160895898|NCT00785928|581014903|FG002|Treatment Phase|Withdrawal by Subject|0|||
160895899|NCT00785928|581014904|FG003|Treatment Phase|Withdrawal by Subject|0|||
160895900|NCT00785928|581014905|FG004|Treatment Phase|Withdrawal by Subject|1|||
160895901|NCT00785928|581014906|FG005|Treatment Phase|Withdrawal by Subject|0|||
161129788|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
161129789|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
161129790|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
160799407|NCT04712669|580654643|FG005|Double Blind Phase|Physician Decision|0|||
160799408|NCT04712669|580654644|FG006|Double Blind Phase|Physician Decision|0|||
160799409|NCT04712669|580654645|FG007|Double Blind Phase|Physician Decision|0|||
160799410|NCT04712669|580654638|FG000|Double Blind Phase|Withdrawal by Subject|3|||
160799411|NCT04712669|580654639|FG001|Double Blind Phase|Withdrawal by Subject|6|||
160799412|NCT04712669|580654640|FG002|Double Blind Phase|Withdrawal by Subject|0|||
160799413|NCT04712669|580654641|FG003|Double Blind Phase|Withdrawal by Subject|0|||
160799414|NCT04712669|580654642|FG004|Double Blind Phase|Withdrawal by Subject|0|||
160799415|NCT04712669|580654643|FG005|Double Blind Phase|Withdrawal by Subject|0|||
160799416|NCT04712669|580654644|FG006|Double Blind Phase|Withdrawal by Subject|0|||
160799417|NCT04712669|580654645|FG007|Double Blind Phase|Withdrawal by Subject|0|||
160799418|NCT04712669|580654638|FG000|Double Blind Phase|Termination by Sponsor|0|||
160799419|NCT04712669|580654639|FG001|Double Blind Phase|Termination by Sponsor|0|||
160799420|NCT04712669|580654640|FG002|Double Blind Phase|Termination by Sponsor|1|||
160799421|NCT04712669|580654641|FG003|Double Blind Phase|Termination by Sponsor|0|||
160799422|NCT04712669|580654642|FG004|Double Blind Phase|Termination by Sponsor|0|||
160799423|NCT04712669|580654643|FG005|Double Blind Phase|Termination by Sponsor|0|||
160799424|NCT04712669|580654644|FG006|Double Blind Phase|Termination by Sponsor|0|||
160799425|NCT04712669|580654645|FG007|Double Blind Phase|Termination by Sponsor|0|||
160799426|NCT04712669|580654638|FG000|Open Label Phase|Adverse Event|0|||
160799427|NCT04712669|580654639|FG001|Open Label Phase|Adverse Event|0|||
160799428|NCT04712669|580654640|FG002|Open Label Phase|Adverse Event|0|||
160799429|NCT04712669|580654641|FG003|Open Label Phase|Adverse Event|1|||
160799430|NCT04712669|580654642|FG004|Open Label Phase|Adverse Event|1|||
160799431|NCT04712669|580654643|FG005|Open Label Phase|Adverse Event|3|||
160799432|NCT04712669|580654644|FG006|Open Label Phase|Adverse Event|1|||
160799433|NCT04712669|580654645|FG007|Open Label Phase|Adverse Event|2|||
160799434|NCT04712669|580654638|FG000|Open Label Phase|Death|0|||
160799435|NCT04712669|580654639|FG001|Open Label Phase|Death|0|||
160799436|NCT04712669|580654640|FG002|Open Label Phase|Death|0|||
160895902|NCT00785928|581014907|FG006|Treatment Phase|Withdrawal by Subject|0|||
160895903|NCT01675427|581014914|FG000|Overall Study|Withdrawal by Subject|7|||
160895904|NCT01675427|581014914|FG000|Overall Study|Participant Refused Sample Collection|18|||
160895905|NCT01675427|581014914|FG000|Overall Study|Sample not Collected by Mistake|2|||
160895906|NCT01675427|581014914|FG000|Overall Study|Lost to Follow-up|5|||
160895907|NCT01675427|581014914|FG000|Overall Study|Other|2|||
160895908|NCT05021081|581014918|FG000|Phase 2|Subject enrolled in error|1|||
160895909|NCT05021081|581014919|FG001|Phase 2|Subject enrolled in error|1|||
160895910|NCT05021081|581014920|FG002|Phase 2|Subject enrolled in error|0|||
160895911|NCT01890746|581014925|FG000|Overall Study|Death|39|||
160895912|NCT01890746|581014926|FG001|Overall Study|Death|30|||
160895913|NCT01890746|581014925|FG000|Overall Study|Adverse Event|1|||
160895914|NCT01890746|581014926|FG001|Overall Study|Adverse Event|0|||
160895915|NCT01890746|581014925|FG000|Overall Study|Lost to Follow-up|4|||
160895916|NCT01890746|581014926|FG001|Overall Study|Lost to Follow-up|1|||
160895917|NCT01890746|581014925|FG000|Overall Study|Physician Decision|3|||
160895918|NCT01890746|581014926|FG001|Overall Study|Physician Decision|2|||
160895919|NCT01890746|581014925|FG000|Overall Study|Withdrawal by Subject|5|||
160895920|NCT01890746|581014926|FG001|Overall Study|Withdrawal by Subject|8|||
160895921|NCT03257371|581014931|FG000|Overall Study|Lost to Follow-up|1|||
160895922|NCT02477839|581014932|FG000|Overall Study|Adverse Event|0|||
160895923|NCT02477839|581014933|FG001|Overall Study|Adverse Event|1|||
160895924|NCT02477839|581014932|FG000|Overall Study|Protocol Violation|0|||
160895925|NCT02477839|581014933|FG001|Overall Study|Protocol Violation|2|||
160895926|NCT02477839|581014932|FG000|Overall Study|Withdrawal by Subject|3|||
160895927|NCT02477839|581014933|FG001|Overall Study|Withdrawal by Subject|3|||
160895928|NCT02477839|581014932|FG000|Overall Study|Participant had PGS during V6|0|||
160895929|NCT02477839|581014933|FG001|Overall Study|Participant had PGS during V6|1|||
160895930|NCT02477839|581014932|FG000|Overall Study|Parents decided to stop medication|0|||
160895931|NCT02477839|581014933|FG001|Overall Study|Parents decided to stop medication|1|||
160895932|NCT02477839|581014932|FG000|Overall Study|Lack of tolerability|0|||
160895933|NCT02477839|581014933|FG001|Overall Study|Lack of tolerability|1|||
160895934|NCT02477839|581014932|FG000|Overall Study|Exclusion criterion|0|||
160895935|NCT02477839|581014933|FG001|Overall Study|Exclusion criterion|1|||
160895936|NCT03053271|581014936|FG000|Overall Study|Did not meet randomization criteria|3|||
160895937|NCT03053271|581014936|FG000|Overall Study|Withdrawal by Subject|1|||
160895938|NCT00580970|581014937|FG000|Pre-treatment|Non-compliance|1|||
160895939|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Non-compliance|6|||
160895940|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
160799437|NCT04712669|580654641|FG003|Open Label Phase|Death|1|||
160895941|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Physician Decision|4|||
160895942|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
160895943|NCT00580970|581014937|FG000|Treatment (Lovastatin)|Death|1|||
160799438|NCT04712669|580654642|FG004|Open Label Phase|Death|0|||
160984412|NCT01349660|581332256|FG000|Overall Study|Study Compliance|0|||
160984413|NCT01349660|581332257|FG001|Overall Study|Study Compliance|0|||
160984414|NCT01349660|581332258|FG002|Overall Study|Study Compliance|1|||
160984415|NCT01349660|581332256|FG000|Overall Study|Declining Performance Status|0|||
160984416|NCT01349660|581332257|FG001|Overall Study|Declining Performance Status|0|||
160984417|NCT01349660|581332258|FG002|Overall Study|Declining Performance Status|1|||
160984418|NCT01563978|581332260|FG000|Overall Study|Physician Decision|1|||
160984419|NCT01563978|581332261|FG001|Overall Study|Physician Decision|0|||
160984420|NCT01563978|581332260|FG000|Overall Study|Lost to Follow-up|1|||
160984421|NCT01563978|581332261|FG001|Overall Study|Lost to Follow-up|0|||
160984422|NCT01563978|581332260|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
160984423|NCT01563978|581332261|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
160984424|NCT01563978|581332260|FG000|Overall Study|Adverse Event|1|||
160984425|NCT01563978|581332261|FG001|Overall Study|Adverse Event|2|||
160984426|NCT04630756|581332262|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
160984427|NCT04630756|581332263|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
160984428|NCT04630756|581332264|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
160984429|NCT05593211|581332266|FG000|Overall Study|Withdrawal by Subject|1|||
160984430|NCT03225846|581332267|FG000|Overall Study|Adverse Event|0|||
160984431|NCT03225846|581332268|FG001|Overall Study|Adverse Event|0|||
160984432|NCT03225846|581332269|FG002|Overall Study|Adverse Event|0|||
160984433|NCT03225846|581332270|FG003|Overall Study|Adverse Event|0|||
160984434|NCT03225846|581332271|FG004|Overall Study|Adverse Event|0|||
160984435|NCT03225846|581332272|FG005|Overall Study|Adverse Event|0|||
160984436|NCT03225846|581332273|FG006|Overall Study|Adverse Event|6|||
160984437|NCT03225846|581332267|FG000|Overall Study|Withdrawal by Subject|0|||
160984438|NCT03225846|581332268|FG001|Overall Study|Withdrawal by Subject|1|||
160984439|NCT03225846|581332269|FG002|Overall Study|Withdrawal by Subject|0|||
160984440|NCT03225846|581332270|FG003|Overall Study|Withdrawal by Subject|0|||
160984441|NCT03225846|581332271|FG004|Overall Study|Withdrawal by Subject|0|||
160984442|NCT03225846|581332272|FG005|Overall Study|Withdrawal by Subject|0|||
160984443|NCT03225846|581332273|FG006|Overall Study|Withdrawal by Subject|0|||
160984444|NCT03225846|581332267|FG000|Overall Study|Death|0|||
160984445|NCT03225846|581332268|FG001|Overall Study|Death|1|||
160984446|NCT03225846|581332269|FG002|Overall Study|Death|0|||
160984447|NCT03225846|581332270|FG003|Overall Study|Death|0|||
160984448|NCT03225846|581332271|FG004|Overall Study|Death|0|||
160984449|NCT03225846|581332272|FG005|Overall Study|Death|0|||
160984450|NCT03225846|581332273|FG006|Overall Study|Death|0|||
160984451|NCT03225846|581332267|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984452|NCT03225846|581332268|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984453|NCT03225846|581332269|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
160984454|NCT03225846|581332270|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984455|NCT03225846|581332271|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984456|NCT03225846|581332272|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984457|NCT03225846|581332273|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
160984458|NCT03225846|581332267|FG000|Overall Study|Patient decision|0|||
160984459|NCT03225846|581332268|FG001|Overall Study|Patient decision|0|||
160984460|NCT03225846|581332269|FG002|Overall Study|Patient decision|0|||
160984461|NCT03225846|581332270|FG003|Overall Study|Patient decision|0|||
160984462|NCT03225846|581332271|FG004|Overall Study|Patient decision|0|||
160984463|NCT03225846|581332272|FG005|Overall Study|Patient decision|0|||
160984464|NCT03225846|581332273|FG006|Overall Study|Patient decision|1|||
160984465|NCT04248465|581332274|FG000|Randomized-Controlled Period|Death|12|||
160984466|NCT04248465|581332275|FG001|Randomized-Controlled Period|Death|5|||
160984467|NCT04248465|581332274|FG000|Randomized-Controlled Period|Adverse Event|2|||
160984468|NCT04248465|581332275|FG001|Randomized-Controlled Period|Adverse Event|0|||
160984469|NCT04248465|581332274|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
160984470|NCT04248465|581332275|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
161129791|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
160984471|NCT04248465|581332274|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
160984472|NCT04248465|581332275|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
160984473|NCT04248465|581332274|FG000|Randomized-Controlled Period|Physician Decision|1|||
160984474|NCT04248465|581332275|FG001|Randomized-Controlled Period|Physician Decision|1|||
160984475|NCT04248465|581332274|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
160984476|NCT04248465|581332275|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
160984477|NCT04248465|581332274|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
160984478|NCT04248465|581332275|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
160984479|NCT04248465|581332274|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160984480|NCT04248465|581332275|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
160984481|NCT05708846|581332276|FG000|Overall Study|Death|5|||
160984482|NCT05708846|581332276|FG000|Overall Study|Withdrawal by Subject|20|||
160984483|NCT03621982|581332277|FG000|Overall Study|Withdrawal by Subject|1|||
161129792|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
160895944|NCT00570765|581014938|FG000|DB Phase|Withdrawal by Subject|1|||
160895945|NCT00570765|581014939|FG001|DB Phase|Withdrawal by Subject|0|||
160895946|NCT00570765|581014940|FG002|DB Phase|Withdrawal by Subject|0|||
160895947|NCT00570765|581014941|FG003|DB Phase|Withdrawal by Subject|0|||
160895948|NCT00570765|581014938|FG000|DB Phase|Protocol Violation|0|||
160895949|NCT00570765|581014939|FG001|DB Phase|Protocol Violation|1|||
160895950|NCT00570765|581014940|FG002|DB Phase|Protocol Violation|0|||
160895951|NCT00570765|581014941|FG003|DB Phase|Protocol Violation|0|||
160895952|NCT00570765|581014938|FG000|DB Phase|Adverse Event|3|||
160895953|NCT00570765|581014939|FG001|DB Phase|Adverse Event|6|||
160895954|NCT00570765|581014940|FG002|DB Phase|Adverse Event|0|||
160895955|NCT00570765|581014941|FG003|DB Phase|Adverse Event|0|||
160895956|NCT00570765|581014938|FG000|DB Phase|Did Not Receive Study Drug|0|||
160895957|NCT00570765|581014939|FG001|DB Phase|Did Not Receive Study Drug|0|||
160895958|NCT00570765|581014940|FG002|DB Phase|Did Not Receive Study Drug|1|||
160895959|NCT00570765|581014941|FG003|DB Phase|Did Not Receive Study Drug|0|||
160895960|NCT00570765|581014938|FG000|LTSE Phase|Withdrawal by Subject|0|||
160895961|NCT00570765|581014939|FG001|LTSE Phase|Withdrawal by Subject|0|||
160895962|NCT00570765|581014940|FG002|LTSE Phase|Withdrawal by Subject|0|||
160895963|NCT00570765|581014941|FG003|LTSE Phase|Withdrawal by Subject|1|||
160895964|NCT00570765|581014938|FG000|LTSE Phase|Adverse Event|0|||
160895965|NCT00570765|581014939|FG001|LTSE Phase|Adverse Event|0|||
160895966|NCT00570765|581014940|FG002|LTSE Phase|Adverse Event|0|||
160895967|NCT00570765|581014941|FG003|LTSE Phase|Adverse Event|7|||
160895968|NCT00570765|581014938|FG000|LTSE Phase|Physician Decision|0|||
160895969|NCT00570765|581014939|FG001|LTSE Phase|Physician Decision|0|||
160895970|NCT00570765|581014940|FG002|LTSE Phase|Physician Decision|0|||
160895971|NCT00570765|581014941|FG003|LTSE Phase|Physician Decision|4|||
160895972|NCT01031706|581014942|FG000|Overall Study|Adverse Event|1|||
160895973|NCT01031706|581014943|FG001|Overall Study|Adverse Event|0|||
160895974|NCT01031706|581014942|FG000|Overall Study|Withdrawal by Subject|1|||
160895975|NCT01031706|581014943|FG001|Overall Study|Withdrawal by Subject|1|||
160895976|NCT03114488|581014944|FG000|Time Period 2|Withdrawal by Subject|1|||
160895977|NCT03114488|581014945|FG001|Time Period 2|Withdrawal by Subject|3|||
160895978|NCT03711266|581014947|FG000|Overall Study|Lost to Follow-up|10|||
160895979|NCT03387683|581014948|FG000|Overall Study|In receipt of disallowed medication|1|||
160895980|NCT03387683|581014949|FG001|Overall Study|In receipt of disallowed medication|0|||
160895981|NCT03387683|581014948|FG000|Overall Study|Did not receive treatment|1|||
160895982|NCT03387683|581014949|FG001|Overall Study|Did not receive treatment|0|||
160895983|NCT00566501|581014952|FG000|Overall Study|Adverse Event|68|||
160895984|NCT00566501|581014953|FG001|Overall Study|Adverse Event|59|||
160895985|NCT00566501|581014952|FG000|Overall Study|Medication Non-compliance|5|||
160895986|NCT00566501|581014953|FG001|Overall Study|Medication Non-compliance|0|||
160895987|NCT00566501|581014952|FG000|Overall Study|Protocol Violation|2|||
160895988|NCT00566501|581014953|FG001|Overall Study|Protocol Violation|2|||
160895989|NCT00566501|581014952|FG000|Overall Study|Request of Investigator or Sponsor|6|||
160895990|NCT00566501|581014953|FG001|Overall Study|Request of Investigator or Sponsor|7|||
160895991|NCT00566501|581014952|FG000|Overall Study|Withdrawal by Subject|33|||
160895992|NCT00566501|581014953|FG001|Overall Study|Withdrawal by Subject|30|||
160895993|NCT00566501|581014952|FG000|Overall Study|Lack of Efficacy|8|||
160895994|NCT00566501|581014953|FG001|Overall Study|Lack of Efficacy|3|||
160895995|NCT00566501|581014952|FG000|Overall Study|Other|25|||
160895996|NCT00566501|581014953|FG001|Overall Study|Other|21|||
160895997|NCT05095454|581014956|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
160895998|NCT05095454|581014957|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
160895999|NCT00057876|581014958|FG000|Overall Study|Adverse Event|8|||
160896000|NCT00057876|581014959|FG001|Overall Study|Adverse Event|8|||
160896001|NCT00057876|581014958|FG000|Overall Study|Death|2|||
160896002|NCT00057876|581014959|FG001|Overall Study|Death|1|||
160896003|NCT00057876|581014958|FG000|Overall Study|Withdrawal by Subject|5|||
160896004|NCT00057876|581014959|FG001|Overall Study|Withdrawal by Subject|6|||
161129793|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
160896005|NCT00057876|581014958|FG000|Overall Study|Lack of Efficacy|10|||
160896006|NCT00057876|581014959|FG001|Overall Study|Lack of Efficacy|8|||
161129794|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
161129795|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
160896007|NCT00057876|581014958|FG000|Overall Study|Ineligible|1|||
160896008|NCT00057876|581014959|FG001|Overall Study|Ineligible|2|||
160896009|NCT00057876|581014958|FG000|Overall Study|other reason|2|||
160896010|NCT00057876|581014959|FG001|Overall Study|other reason|2|||
160896011|NCT00057876|581014958|FG000|Overall Study|other complicating disease|1|||
160896012|NCT00057876|581014959|FG001|Overall Study|other complicating disease|0|||
160896013|NCT01368432|581014960|FG000|Overall Study|Lost to Follow-up|0|||
160896014|NCT01368432|581014961|FG001|Overall Study|Lost to Follow-up|1|||
160896015|NCT02758171|581014962|FG000|Wash-out|Withdrawal by Subject|1|||
160896016|NCT02758171|581014963|FG001|Wash-out|Withdrawal by Subject|0|||
160896017|NCT02758171|581014962|FG000|Wash-out|Other reason|1|||
160896018|NCT02758171|581014963|FG001|Wash-out|Other reason|0|||
160896019|NCT00853073|581014964|FG000|Overall Study|Withdrawal by Subject|3|||
160896020|NCT00853073|581014965|FG001|Overall Study|Withdrawal by Subject|2|||
160896021|NCT01999114|581014966|FG000|Overall Study|Adverse Event|8|||
160896022|NCT01999114|581014967|FG001|Overall Study|Adverse Event|7|||
160896023|NCT01999114|581014968|FG002|Overall Study|Adverse Event|2|||
160896024|NCT01999114|581014969|FG003|Overall Study|Adverse Event|2|||
160896025|NCT01999114|581014970|FG004|Overall Study|Adverse Event|1|||
160896026|NCT01999114|581014966|FG000|Overall Study|Withdrawal by Subject|0|||
160896027|NCT01999114|581014967|FG001|Overall Study|Withdrawal by Subject|0|||
160896028|NCT01999114|581014968|FG002|Overall Study|Withdrawal by Subject|1|||
160896029|NCT01999114|581014969|FG003|Overall Study|Withdrawal by Subject|0|||
160896030|NCT01999114|581014970|FG004|Overall Study|Withdrawal by Subject|1|||
160896031|NCT01999114|581014966|FG000|Overall Study|Lost to Follow-up|0|||
160896032|NCT01999114|581014967|FG001|Overall Study|Lost to Follow-up|0|||
160896033|NCT01999114|581014968|FG002|Overall Study|Lost to Follow-up|1|||
160896034|NCT01999114|581014969|FG003|Overall Study|Lost to Follow-up|0|||
160896035|NCT01999114|581014970|FG004|Overall Study|Lost to Follow-up|0|||
160896036|NCT01999114|581014966|FG000|Overall Study|Administrative|0|||
160896037|NCT01999114|581014967|FG001|Overall Study|Administrative|0|||
160896038|NCT01999114|581014968|FG002|Overall Study|Administrative|1|||
160896039|NCT01999114|581014969|FG003|Overall Study|Administrative|1|||
160896040|NCT01999114|581014970|FG004|Overall Study|Administrative|2|||
160896041|NCT03840174|581014971|FG000|Overall Study|Withdrawal by Subject|1|||
160896042|NCT03840174|581014972|FG001|Overall Study|Withdrawal by Subject|0|||
160896043|NCT03840174|581014973|FG002|Overall Study|Withdrawal by Subject|0|||
160896044|NCT03840174|581014974|FG003|Overall Study|Withdrawal by Subject|0|||
160896045|NCT01008150|581014975|FG000|Overall Study|did not receive study drug|1|||
160896046|NCT01008150|581014976|FG001|Overall Study|did not receive study drug|1|||
160896047|NCT01008150|581014977|FG002|Overall Study|did not receive study drug|1|||
160896048|NCT01008150|581014978|FG003|Overall Study|did not receive study drug|0|||
160896049|NCT01497275|581014979|FG000|Overall Study|Death|1|||
160896050|NCT01497275|581014979|FG000|Overall Study|Adverse Event|1|||
160896051|NCT00381381|581014988|FG000|Overall Study|Adverse Event|3|||
160896052|NCT00381381|581014988|FG000|Overall Study|Lost to Follow-up|52|||
160896053|NCT00381381|581014988|FG000|Overall Study|Withdrawal by Subject|9|||
160896054|NCT00568685|581014989|FG000|Overall Study|Adverse Event|2|||
160896055|NCT00568685|581014990|FG001|Overall Study|Adverse Event|3|||
160896056|NCT00568685|581014991|FG002|Overall Study|Adverse Event|3|||
160896057|NCT00568685|581014989|FG000|Overall Study|Withdrawal by Subject|7|||
160896058|NCT00568685|581014990|FG001|Overall Study|Withdrawal by Subject|2|||
160896059|NCT00568685|581014991|FG002|Overall Study|Withdrawal by Subject|2|||
160896060|NCT00568685|581014989|FG000|Overall Study|Protocol Violation|1|||
160896061|NCT00568685|581014990|FG001|Overall Study|Protocol Violation|0|||
160896062|NCT00568685|581014991|FG002|Overall Study|Protocol Violation|0|||
160896063|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Adverse Event|10|||
160896064|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Adverse Event|0|||
160896065|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
160896066|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
160896067|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
160896068|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
160896069|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
160896070|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
160896071|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
160896072|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
160896073|NCT02787551|581014992|FG000|Core Period: 26 Weeks|Other than specified|3|||
160896074|NCT02787551|581014993|FG001|Core Period: 26 Weeks|Other than specified|1|||
160896075|NCT02787551|581014992|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
160896076|NCT02787551|581014993|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
160896077|NCT02787551|581014992|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
160896078|NCT02787551|581014993|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
160896079|NCT02787551|581014992|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
160896080|NCT02787551|581014993|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
160896081|NCT03799211|581014994|FG000|Overall Study|Lost to Follow-up|2|||
160896082|NCT03799211|581014995|FG001|Overall Study|Lost to Follow-up|13|||
160896083|NCT03799211|581014994|FG000|Overall Study|Withdrawal by Subject|2|||
160896084|NCT03799211|581014995|FG001|Overall Study|Withdrawal by Subject|0|||
161129796|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
160896085|NCT00764491|581014996|FG000|Overall Study|Lost to Follow-up|35|||
160896086|NCT00764491|581014997|FG001|Overall Study|Lost to Follow-up|17|||
160896087|NCT03538431|581015000|FG000|Overall Study|Physician Decision|0|||
160896088|NCT03538431|581015001|FG001|Overall Study|Physician Decision|1|||
160896089|NCT03538431|581015000|FG000|Overall Study|Withdrawal by Subject|1|||
160896090|NCT03538431|581015001|FG001|Overall Study|Withdrawal by Subject|0|||
160896091|NCT00620464|581015002|FG000|Overall Study|Adverse Event|15|||
160896092|NCT00620464|581015003|FG001|Overall Study|Adverse Event|17|||
160896093|NCT00620464|581015002|FG000|Overall Study|Lost to Follow-up|1|||
160799439|NCT04712669|580654643|FG005|Open Label Phase|Death|0|||
160799440|NCT04712669|580654644|FG006|Open Label Phase|Death|0|||
160799441|NCT04712669|580654645|FG007|Open Label Phase|Death|0|||
160799442|NCT04712669|580654638|FG000|Open Label Phase|Lack of Efficacy|0|||
160799443|NCT04712669|580654639|FG001|Open Label Phase|Lack of Efficacy|0|||
160799444|NCT04712669|580654640|FG002|Open Label Phase|Lack of Efficacy|0|||
160799445|NCT04712669|580654641|FG003|Open Label Phase|Lack of Efficacy|0|||
160799446|NCT04712669|580654642|FG004|Open Label Phase|Lack of Efficacy|1|||
160799447|NCT04712669|580654643|FG005|Open Label Phase|Lack of Efficacy|0|||
160799448|NCT04712669|580654644|FG006|Open Label Phase|Lack of Efficacy|0|||
160799449|NCT04712669|580654645|FG007|Open Label Phase|Lack of Efficacy|0|||
160799450|NCT04712669|580654638|FG000|Open Label Phase|Lost to Follow-up|0|||
160799451|NCT04712669|580654639|FG001|Open Label Phase|Lost to Follow-up|0|||
160799452|NCT04712669|580654640|FG002|Open Label Phase|Lost to Follow-up|0|||
160799453|NCT04712669|580654641|FG003|Open Label Phase|Lost to Follow-up|0|||
160799454|NCT04712669|580654642|FG004|Open Label Phase|Lost to Follow-up|0|||
160799455|NCT04712669|580654643|FG005|Open Label Phase|Lost to Follow-up|0|||
160799456|NCT04712669|580654644|FG006|Open Label Phase|Lost to Follow-up|1|||
160799457|NCT04712669|580654645|FG007|Open Label Phase|Lost to Follow-up|1|||
160799458|NCT04712669|580654638|FG000|Open Label Phase|Physician Decision|0|||
160799459|NCT04712669|580654639|FG001|Open Label Phase|Physician Decision|0|||
160799460|NCT04712669|580654640|FG002|Open Label Phase|Physician Decision|0|||
160799461|NCT04712669|580654641|FG003|Open Label Phase|Physician Decision|1|||
160799462|NCT04712669|580654642|FG004|Open Label Phase|Physician Decision|0|||
160799463|NCT04712669|580654643|FG005|Open Label Phase|Physician Decision|0|||
160799464|NCT04712669|580654644|FG006|Open Label Phase|Physician Decision|0|||
160799465|NCT04712669|580654645|FG007|Open Label Phase|Physician Decision|0|||
160799466|NCT04712669|580654638|FG000|Open Label Phase|Withdrawal by Subject|0|||
160799467|NCT04712669|580654639|FG001|Open Label Phase|Withdrawal by Subject|0|||
160799468|NCT04712669|580654640|FG002|Open Label Phase|Withdrawal by Subject|0|||
160799469|NCT04712669|580654641|FG003|Open Label Phase|Withdrawal by Subject|1|||
160799470|NCT04712669|580654642|FG004|Open Label Phase|Withdrawal by Subject|5|||
160799471|NCT04712669|580654643|FG005|Open Label Phase|Withdrawal by Subject|5|||
160799472|NCT04712669|580654644|FG006|Open Label Phase|Withdrawal by Subject|0|||
160799473|NCT04712669|580654645|FG007|Open Label Phase|Withdrawal by Subject|4|||
160799474|NCT04712669|580654638|FG000|Open Label Phase|Termination by Sponsor|0|||
160799475|NCT04712669|580654639|FG001|Open Label Phase|Termination by Sponsor|0|||
160799476|NCT04712669|580654640|FG002|Open Label Phase|Termination by Sponsor|0|||
160799477|NCT04712669|580654641|FG003|Open Label Phase|Termination by Sponsor|11|||
160799478|NCT04712669|580654642|FG004|Open Label Phase|Termination by Sponsor|9|||
160799479|NCT04712669|580654643|FG005|Open Label Phase|Termination by Sponsor|14|||
160799480|NCT04712669|580654644|FG006|Open Label Phase|Termination by Sponsor|0|||
160799481|NCT04712669|580654645|FG007|Open Label Phase|Termination by Sponsor|14|||
160799482|NCT03802396|580654646|FG000|Overall Study|Withdrawal by Subject|2|||
160799483|NCT03802396|580654647|FG001|Overall Study|Withdrawal by Subject|0|||
160799484|NCT03802396|580654646|FG000|Overall Study|Surgery Cancelled|1|||
160799485|NCT03802396|580654647|FG001|Overall Study|Surgery Cancelled|0|||
160799486|NCT03549338|580655904|FG000|Overall Study|Progressive Disease|1|||
160799487|NCT03549338|580655905|FG001|Overall Study|Progressive Disease|0|||
160799488|NCT03549338|580655906|FG002|Overall Study|Progressive Disease|0|||
160799489|NCT03549338|580655904|FG000|Overall Study|Clinical Progression|0|||
160799490|NCT03549338|580655905|FG001|Overall Study|Clinical Progression|1|||
160799491|NCT03549338|580655906|FG002|Overall Study|Clinical Progression|0|||
160799492|NCT01492426|580655907|FG000|Treatment|Death|0|||
160799493|NCT01492426|580655908|FG001|Treatment|Death|1|||
160799494|NCT01492426|580655907|FG000|Treatment|Other|1|||
160799495|NCT01492426|580655908|FG001|Treatment|Other|0|||
160799496|NCT01492426|580655907|FG000|Treatment|Adverse Event|25|||
160799497|NCT01492426|580655908|FG001|Treatment|Adverse Event|25|||
160799498|NCT01492426|580655907|FG000|Treatment|Lack of Efficacy|38|||
160799499|NCT01492426|580655908|FG001|Treatment|Lack of Efficacy|5|||
160799500|NCT01492426|580655907|FG000|Treatment|Participant withdrew consent|1|||
160799501|NCT01492426|580655908|FG001|Treatment|Participant withdrew consent|2|||
160799502|NCT01492426|580655907|FG000|Treatment|Poor compliance/noncompliance|1|||
160799503|NCT01492426|580655908|FG001|Treatment|Poor compliance/noncompliance|0|||
160799504|NCT01492426|580655907|FG000|Treatment|Subject requested discontinue study drug|7|||
160799505|NCT01492426|580655908|FG001|Treatment|Subject requested discontinue study drug|3|||
160799506|NCT01492426|580655907|FG000|Treatment|Lost to Follow-up|9|||
160799507|NCT01492426|580655908|FG001|Treatment|Lost to Follow-up|4|||
160799508|NCT01492426|580655907|FG000|Treatment|Participant does not meet study criteria|1|||
160896094|NCT00620464|581015003|FG001|Overall Study|Lost to Follow-up|1|||
160896095|NCT00620464|581015002|FG000|Overall Study|Planning Pregnancy|1|||
160799509|NCT01492426|580655908|FG001|Treatment|Participant does not meet study criteria|0|||
160799510|NCT01492426|580655907|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
160799511|NCT01492426|580655908|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
160799512|NCT01492426|580655907|FG000|Follow-Up|Death|1|||
160799513|NCT01492426|580655908|FG001|Follow-Up|Death|0|||
160799514|NCT01492426|580655907|FG000|Follow-Up|Other|4|||
161331697|NCT01435759|582601465|FG001|Antidepressant Lead-in Phase|Other|0|||
161331698|NCT01435759|582601466|FG002|Antidepressant Lead-in Phase|Other|0|||
160984484|NCT03621982|581332278|FG001|Overall Study|Withdrawal by Subject|0|||
161331699|NCT01435759|582601467|FG003|Antidepressant Lead-in Phase|Other|0|||
161331700|NCT01435759|582601468|FG004|Antidepressant Lead-in Phase|Other|0|||
161331701|NCT01435759|582601469|FG005|Antidepressant Lead-in Phase|Other|0|||
161331702|NCT01435759|582601464|FG000|Double-blind Phase|Adverse Event|7|||
161331703|NCT01435759|582601465|FG001|Double-blind Phase|Adverse Event|0|||
161331704|NCT01435759|582601466|FG002|Double-blind Phase|Adverse Event|1|||
161331705|NCT01435759|582601467|FG003|Double-blind Phase|Adverse Event|1|||
161331706|NCT01435759|582601468|FG004|Double-blind Phase|Adverse Event|1|||
161331707|NCT01435759|582601469|FG005|Double-blind Phase|Adverse Event|3|||
161331708|NCT01435759|582601464|FG000|Double-blind Phase|Protocol Violation|2|||
161331709|NCT01435759|582601465|FG001|Double-blind Phase|Protocol Violation|0|||
161331710|NCT01435759|582601466|FG002|Double-blind Phase|Protocol Violation|1|||
161331711|NCT01435759|582601467|FG003|Double-blind Phase|Protocol Violation|2|||
161331712|NCT01435759|582601468|FG004|Double-blind Phase|Protocol Violation|0|||
161331713|NCT01435759|582601469|FG005|Double-blind Phase|Protocol Violation|1|||
161331714|NCT01435759|582601464|FG000|Double-blind Phase|Withdrawal by Subject|17|||
161331715|NCT01435759|582601465|FG001|Double-blind Phase|Withdrawal by Subject|4|||
161331716|NCT01435759|582601466|FG002|Double-blind Phase|Withdrawal by Subject|3|||
161331717|NCT01435759|582601467|FG003|Double-blind Phase|Withdrawal by Subject|4|||
161331718|NCT01435759|582601468|FG004|Double-blind Phase|Withdrawal by Subject|2|||
161331719|NCT01435759|582601469|FG005|Double-blind Phase|Withdrawal by Subject|2|||
161331720|NCT01435759|582601464|FG000|Double-blind Phase|Lost to Follow-up|31|||
161331721|NCT01435759|582601465|FG001|Double-blind Phase|Lost to Follow-up|1|||
161331722|NCT01435759|582601466|FG002|Double-blind Phase|Lost to Follow-up|2|||
161331723|NCT01435759|582601467|FG003|Double-blind Phase|Lost to Follow-up|0|||
161331724|NCT01435759|582601468|FG004|Double-blind Phase|Lost to Follow-up|3|||
161331725|NCT01435759|582601469|FG005|Double-blind Phase|Lost to Follow-up|3|||
161331726|NCT01435759|582601464|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
161331727|NCT01435759|582601465|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331728|NCT01435759|582601466|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331729|NCT01435759|582601467|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331730|NCT01435759|582601468|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
161331731|NCT01435759|582601469|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
161331732|NCT01435759|582601464|FG000|Double-blind Phase|Other|8|||
161331733|NCT01435759|582601465|FG001|Double-blind Phase|Other|2|||
161331734|NCT01435759|582601466|FG002|Double-blind Phase|Other|0|||
161331735|NCT01435759|582601467|FG003|Double-blind Phase|Other|2|||
161331736|NCT01435759|582601468|FG004|Double-blind Phase|Other|0|||
161331737|NCT01435759|582601469|FG005|Double-blind Phase|Other|0|||
161331738|NCT00570401|582601470|FG000|Overall Study|Adverse Event|2|||
161331739|NCT00427908|582601471|FG000|Primary Phase|Lost to Follow-up|4|||
161331740|NCT00427908|582601472|FG001|Primary Phase|Lost to Follow-up|0|||
161331741|NCT00427908|582601473|FG002|Primary Phase|Lost to Follow-up|2|||
160984485|NCT03621982|581332279|FG002|Overall Study|Withdrawal by Subject|0|||
160984486|NCT03621982|581332280|FG003|Overall Study|Withdrawal by Subject|1|||
160984487|NCT03621982|581332281|FG004|Overall Study|Withdrawal by Subject|0|||
160984488|NCT03621982|581332282|FG005|Overall Study|Withdrawal by Subject|1|||
160984489|NCT03621982|581332283|FG006|Overall Study|Withdrawal by Subject|1|||
160984490|NCT03621982|581332284|FG007|Overall Study|Withdrawal by Subject|0|||
160984491|NCT03621982|581332285|FG008|Overall Study|Withdrawal by Subject|1|||
160984492|NCT03621982|581332286|FG009|Overall Study|Withdrawal by Subject|0|||
160984493|NCT03621982|581332287|FG010|Overall Study|Withdrawal by Subject|2|||
160984494|NCT03621982|581332288|FG011|Overall Study|Withdrawal by Subject|1|||
160984495|NCT03621982|581332289|FG012|Overall Study|Withdrawal by Subject|2|||
161331742|NCT00427908|582601474|FG003|Primary Phase|Lost to Follow-up|0|||
161331743|NCT00427908|582601471|FG000|Primary Phase|Withdrawal by Subject|1|||
161331744|NCT00427908|582601472|FG001|Primary Phase|Withdrawal by Subject|2|||
161331745|NCT00427908|582601473|FG002|Primary Phase|Withdrawal by Subject|1|||
161331746|NCT00427908|582601474|FG003|Primary Phase|Withdrawal by Subject|0|||
161331747|NCT00427908|582601471|FG000|Primary Phase|Adverse Event|0|||
161331748|NCT00427908|582601472|FG001|Primary Phase|Adverse Event|1|||
161331749|NCT00427908|582601473|FG002|Primary Phase|Adverse Event|0|||
161331750|NCT00427908|582601474|FG003|Primary Phase|Adverse Event|0|||
160984496|NCT03621982|581332290|FG013|Overall Study|Withdrawal by Subject|2|||
160984497|NCT03621982|581332277|FG000|Overall Study|Investigator/Sponsor decision|0|||
160984498|NCT03621982|581332278|FG001|Overall Study|Investigator/Sponsor decision|0|||
161331751|NCT01710020|582601475|FG000|Period 1|Protocol Violation|1|||
161331752|NCT01764841|582601476|FG000|Overall Study|Logistical Difficulties|0|||
161331753|NCT01764841|582601477|FG001|Overall Study|Logistical Difficulties|1|||
161331754|NCT01764841|582601478|FG002|Overall Study|Logistical Difficulties|0|||
161331755|NCT01764841|582601479|FG003|Overall Study|Logistical Difficulties|0|||
161331756|NCT01764841|582601476|FG000|Overall Study|Death|3|||
161331757|NCT01764841|582601477|FG001|Overall Study|Death|0|||
161331758|NCT01764841|582601478|FG002|Overall Study|Death|1|||
160799515|NCT01492426|580655908|FG001|Follow-Up|Other|2|||
160799516|NCT01492426|580655907|FG000|Follow-Up|Participant Withdrew Consent|6|||
160799517|NCT01492426|580655908|FG001|Follow-Up|Participant Withdrew Consent|1|||
160799518|NCT01492426|580655907|FG000|Follow-Up|Lost to Follow-up|12|||
160799519|NCT01492426|580655908|FG001|Follow-Up|Lost to Follow-up|6|||
160799520|NCT00269113|580655909|FG000|Overall Study|Adverse Event|14|||
160799521|NCT00269113|580655910|FG001|Overall Study|Adverse Event|7|||
160799522|NCT00269113|580655909|FG000|Overall Study|Lack of Efficacy|35|||
160799523|NCT00269113|580655910|FG001|Overall Study|Lack of Efficacy|18|||
160799524|NCT00269113|580655909|FG000|Overall Study|Early Improvement|2|||
160799525|NCT00269113|580655910|FG001|Overall Study|Early Improvement|0|||
160799526|NCT00269113|580655909|FG000|Overall Study|Withdrawal by Subject|0|||
160799527|NCT00269113|580655910|FG001|Overall Study|Withdrawal by Subject|2|||
160799528|NCT00269113|580655909|FG000|Overall Study|Death|6|||
160799529|NCT00269113|580655910|FG001|Overall Study|Death|2|||
160799530|NCT00269113|580655909|FG000|Overall Study|Lost to Follow-up|2|||
160799531|NCT00269113|580655910|FG001|Overall Study|Lost to Follow-up|1|||
160799532|NCT00269113|580655909|FG000|Overall Study|Protocol Violation|15|||
160799533|NCT00269113|580655910|FG001|Overall Study|Protocol Violation|5|||
160799534|NCT00269113|580655909|FG000|Overall Study|Other|0|||
160799535|NCT00269113|580655910|FG001|Overall Study|Other|2|||
160799536|NCT00140140|580655911|FG000|Overall Study|Unacceptable toxicity|1|||
160799537|NCT00140140|580655912|FG001|Overall Study|Unacceptable toxicity|1|||
160799538|NCT00140140|580655913|FG002|Overall Study|Unacceptable toxicity|2|||
160799539|NCT00140140|580655911|FG000|Overall Study|Physician Decision|1|||
160799540|NCT00140140|580655912|FG001|Overall Study|Physician Decision|1|||
160799541|NCT00140140|580655913|FG002|Overall Study|Physician Decision|0|||
160799542|NCT00639457|580655914|FG000|Overall Study|Withdrawal by Subject|2|||
160799543|NCT00639457|580655915|FG001|Overall Study|Withdrawal by Subject|3|||
160799544|NCT01126190|580655916|FG000|Double-Blind Phase|Death|0|||
160799545|NCT01126190|580655917|FG001|Double-Blind Phase|Death|1|||
160799546|NCT01126190|580655918|FG002|Double-Blind Phase|Death|0|||
160799547|NCT01126190|580655916|FG000|Double-Blind Phase|Adverse Event|1|||
160799548|NCT01126190|580655917|FG001|Double-Blind Phase|Adverse Event|2|||
160799549|NCT01126190|580655918|FG002|Double-Blind Phase|Adverse Event|0|||
160799550|NCT01126190|580655916|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
160799551|NCT01126190|580655917|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
160799552|NCT01126190|580655918|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160799553|NCT01126190|580655916|FG000|Double-Blind Phase|Request of Investigator|1|||
160799554|NCT01126190|580655917|FG001|Double-Blind Phase|Request of Investigator|0|||
160799555|NCT01126190|580655918|FG002|Double-Blind Phase|Request of Investigator|0|||
160799556|NCT01126190|580655916|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
160799557|NCT01126190|580655917|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
160799558|NCT01126190|580655918|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
160799559|NCT01126190|580655916|FG000|Double-Blind Phase|Non-compliance|1|||
160799560|NCT01126190|580655917|FG001|Double-Blind Phase|Non-compliance|0|||
160799561|NCT01126190|580655918|FG002|Double-Blind Phase|Non-compliance|0|||
160799562|NCT01126190|580655916|FG000|Double-Blind Phase|Lost to Follow-up|1|||
160799563|NCT01126190|580655917|FG001|Double-Blind Phase|Lost to Follow-up|3|||
160799564|NCT01126190|580655918|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160799565|NCT01126190|580655916|FG000|Open-Label Phase|Death|0|||
160799566|NCT01126190|580655917|FG001|Open-Label Phase|Death|0|||
160799567|NCT01126190|580655918|FG002|Open-Label Phase|Death|1|||
160799568|NCT01126190|580655916|FG000|Open-Label Phase|Adverse Event|0|||
160799569|NCT01126190|580655917|FG001|Open-Label Phase|Adverse Event|0|||
160799570|NCT01126190|580655918|FG002|Open-Label Phase|Adverse Event|4|||
160799571|NCT01126190|580655916|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160799572|NCT01126190|580655917|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160799573|NCT01126190|580655918|FG002|Open-Label Phase|Withdrawal by Subject|6|||
160799574|NCT01128569|580655919|FG000|Washout Period 1|Adverse Event|0|||
160799575|NCT01128569|580655920|FG001|Washout Period 1|Adverse Event|0|||
160799576|NCT01128569|580655921|FG002|Washout Period 1|Adverse Event|1|||
160799577|NCT01128569|580655922|FG003|Washout Period 1|Adverse Event|0|||
160799578|NCT01128569|580655923|FG004|Washout Period 1|Adverse Event|0|||
160896096|NCT00620464|581015003|FG001|Overall Study|Planning Pregnancy|4|||
160896097|NCT00620464|581015002|FG000|Overall Study|Personal|2|||
160799579|NCT01128569|580655924|FG005|Washout Period 1|Adverse Event|0|||
160896098|NCT00620464|581015003|FG001|Overall Study|Personal|2|||
160896099|NCT00620464|581015002|FG000|Overall Study|Used prohibited medication|1|||
160896100|NCT00620464|581015003|FG001|Overall Study|Used prohibited medication|0|||
160799580|NCT01128569|580655919|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160799581|NCT01128569|580655920|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160799582|NCT01128569|580655921|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160799583|NCT01128569|580655922|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160799584|NCT01128569|580655923|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160799585|NCT01128569|580655924|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160799586|NCT03338400|580655925|FG000|Overall Study|Lost to Follow-up|1|||
160896101|NCT03139279|581015004|FG000|Overall Study|Physician Decision|2|||
160896102|NCT03139279|581015005|FG001|Overall Study|Physician Decision|0|||
160799587|NCT03338400|580655926|FG001|Overall Study|Lost to Follow-up|2|||
160799588|NCT01627691|580655927|FG000|Overall Study|Death|11|||
160799589|NCT01627691|580655927|FG000|Overall Study|Lost to Follow-up|3|||
160799590|NCT01627691|580655927|FG000|Overall Study|Withdrawal by Subject|1|||
160799591|NCT01627691|580655927|FG000|Overall Study|Missed the visit|3|||
160799592|NCT01156844|580655934|FG000|Overall Study|Adverse Event|0|||
160799593|NCT01156844|580655935|FG001|Overall Study|Adverse Event|0|||
160799594|NCT01156844|580655936|FG002|Overall Study|Adverse Event|1|||
160799595|NCT01156844|580655937|FG003|Overall Study|Adverse Event|1|||
160799596|NCT01156844|580655934|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160799597|NCT01156844|580655935|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160799598|NCT01156844|580655936|FG002|Overall Study|Abnormal test procedure result(s)|2|||
160799599|NCT01156844|580655937|FG003|Overall Study|Abnormal test procedure result(s)|2|||
160799600|NCT01156844|580655934|FG000|Overall Study|Withdrawal by Subject|0|||
160799601|NCT01156844|580655935|FG001|Overall Study|Withdrawal by Subject|0|||
160799602|NCT01156844|580655936|FG002|Overall Study|Withdrawal by Subject|2|||
160799603|NCT01156844|580655937|FG003|Overall Study|Withdrawal by Subject|2|||
160799604|NCT01156844|580655934|FG000|Overall Study|Lost to Follow-up|0|||
160799605|NCT01156844|580655935|FG001|Overall Study|Lost to Follow-up|0|||
160799606|NCT01156844|580655936|FG002|Overall Study|Lost to Follow-up|1|||
160799607|NCT01156844|580655937|FG003|Overall Study|Lost to Follow-up|0|||
160799608|NCT01156844|580655934|FG000|Overall Study|Administrative problems|0|||
160799609|NCT01156844|580655935|FG001|Overall Study|Administrative problems|1|||
160799610|NCT01156844|580655936|FG002|Overall Study|Administrative problems|0|||
160799611|NCT01156844|580655937|FG003|Overall Study|Administrative problems|1|||
160799612|NCT01156844|580655934|FG000|Overall Study|Protocol deviation|2|||
160799613|NCT01156844|580655935|FG001|Overall Study|Protocol deviation|0|||
160799614|NCT01156844|580655936|FG002|Overall Study|Protocol deviation|0|||
160799615|NCT01156844|580655937|FG003|Overall Study|Protocol deviation|0|||
160799616|NCT01130337|580655942|FG000|Overall Study|Withdrawal by Subject|3|||
160799617|NCT01130337|580655942|FG000|Overall Study|Principal investigator decision|1|||
160799618|NCT01130337|580655942|FG000|Overall Study|Death|1|||
160799619|NCT01130337|580655942|FG000|Overall Study|Disease progression|1|||
160799620|NCT01130337|580655942|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
160799621|NCT01130337|580655942|FG000|Overall Study|Surgical resection (R2)|1|||
160799622|NCT05525910|580655943|FG000|Period 4|Per sponsor due to study timelines|0|||
160799623|NCT05525910|580655944|FG001|Period 4|Per sponsor due to study timelines|0|||
160799624|NCT05525910|580655945|FG002|Period 4|Per sponsor due to study timelines|1|||
160799625|NCT05525910|580655946|FG003|Period 4|Per sponsor due to study timelines|1|||
160896103|NCT03139279|581015004|FG000|Overall Study|Protocol Violation|5|||
160896104|NCT03139279|581015005|FG001|Overall Study|Protocol Violation|4|||
160896105|NCT03139279|581015004|FG000|Overall Study|Withdrawal by Subject|0|||
160896106|NCT03139279|581015005|FG001|Overall Study|Withdrawal by Subject|2|||
160896107|NCT05394350|581015006|FG000|Overall Study|Death|2|||
160896108|NCT05394350|581015007|FG001|Overall Study|Death|2|||
160896109|NCT05394350|581015008|FG002|Overall Study|Death|4|||
160896110|NCT05394350|581015009|FG003|Overall Study|Death|0|||
160896111|NCT05394350|581015010|FG004|Overall Study|Death|1|||
160896112|NCT05394350|581015011|FG005|Overall Study|Death|0|||
160896113|NCT05394350|581015006|FG000|Overall Study|Study terminated by sponsor|1|||
160896114|NCT05394350|581015007|FG001|Overall Study|Study terminated by sponsor|1|||
160896115|NCT05394350|581015008|FG002|Overall Study|Study terminated by sponsor|7|||
160896116|NCT05394350|581015009|FG003|Overall Study|Study terminated by sponsor|3|||
160896117|NCT05394350|581015010|FG004|Overall Study|Study terminated by sponsor|2|||
160896118|NCT05394350|581015011|FG005|Overall Study|Study terminated by sponsor|4|||
160896119|NCT02024555|581015016|FG000|Overall Study|Lost to Follow-up|1|||
160896120|NCT02024555|581015017|FG001|Overall Study|Lost to Follow-up|1|||
160896121|NCT02024555|581015016|FG000|Overall Study|Withdrawal by Subject|5|||
160896122|NCT02024555|581015017|FG001|Overall Study|Withdrawal by Subject|1|||
160896123|NCT00492050|581015018|FG000|Overall Study|Adverse Event|1|||
160896124|NCT00492050|581015018|FG000|Overall Study|Lack of Efficacy|1|||
160896125|NCT00492050|581015018|FG000|Overall Study|Withdrawal by Subject|3|||
160799626|NCT05525910|580655947|FG004|Period 4|Per sponsor due to study timelines|1|||
160799627|NCT03886493|580655948|FG000|Overall Study|Adverse Event|1|||
160799628|NCT04067011|580655950|FG000|Overall Study|Not Treated|8|||
160799629|NCT04067011|580655951|FG001|Overall Study|Not Treated|7|||
160799630|NCT04067011|580655952|FG002|Overall Study|Not Treated|5|||
160799631|NCT04067011|580655950|FG000|Overall Study|Adverse Event|2|||
160799632|NCT04067011|580655951|FG001|Overall Study|Adverse Event|1|||
160799633|NCT04067011|580655952|FG002|Overall Study|Adverse Event|0|||
160896126|NCT00492050|581015018|FG000|Overall Study|Unable to collect SCT|2|||
160896127|NCT00492050|581015018|FG000|Overall Study|Progressive Disease|2|||
160896128|NCT04246372|581016837|FG000|Overall Study|Adverse Event|1|||
160896129|NCT04246372|581016837|FG000|Overall Study|Withdrawal by Subject|1|||
160896130|NCT04246372|581016837|FG000|Overall Study|Protocol Violation|2|||
160896131|NCT04246372|581016837|FG000|Overall Study|Physician Decision|1|||
160896132|NCT00392015|581016839|FG000|Overall Study|Lost to Follow-up|2|||
160896133|NCT00392015|581016840|FG001|Overall Study|Lost to Follow-up|0|||
160984499|NCT03621982|581332279|FG002|Overall Study|Investigator/Sponsor decision|0|||
160984500|NCT03621982|581332280|FG003|Overall Study|Investigator/Sponsor decision|0|||
160984501|NCT03621982|581332281|FG004|Overall Study|Investigator/Sponsor decision|0|||
160984502|NCT03621982|581332282|FG005|Overall Study|Investigator/Sponsor decision|0|||
160984503|NCT03621982|581332283|FG006|Overall Study|Investigator/Sponsor decision|0|||
160984504|NCT03621982|581332284|FG007|Overall Study|Investigator/Sponsor decision|0|||
160984505|NCT03621982|581332285|FG008|Overall Study|Investigator/Sponsor decision|0|||
160984506|NCT03621982|581332286|FG009|Overall Study|Investigator/Sponsor decision|0|||
160984507|NCT03621982|581332287|FG010|Overall Study|Investigator/Sponsor decision|0|||
160984508|NCT03621982|581332288|FG011|Overall Study|Investigator/Sponsor decision|4|||
160984509|NCT03621982|581332289|FG012|Overall Study|Investigator/Sponsor decision|0|||
160984510|NCT03621982|581332290|FG013|Overall Study|Investigator/Sponsor decision|2|||
160984511|NCT03621982|581332277|FG000|Overall Study|Death|2|||
160984512|NCT03621982|581332278|FG001|Overall Study|Death|4|||
160984513|NCT03621982|581332279|FG002|Overall Study|Death|4|||
160984514|NCT03621982|581332280|FG003|Overall Study|Death|3|||
160984515|NCT03621982|581332281|FG004|Overall Study|Death|8|||
160984516|NCT03621982|581332282|FG005|Overall Study|Death|4|||
160984517|NCT03621982|581332283|FG006|Overall Study|Death|6|||
160984518|NCT03621982|581332284|FG007|Overall Study|Death|3|||
160984519|NCT03621982|581332285|FG008|Overall Study|Death|0|||
160984520|NCT03621982|581332286|FG009|Overall Study|Death|3|||
160984521|NCT03621982|581332287|FG010|Overall Study|Death|8|||
160984522|NCT03621982|581332288|FG011|Overall Study|Death|4|||
160984523|NCT03621982|581332289|FG012|Overall Study|Death|2|||
160984524|NCT03621982|581332290|FG013|Overall Study|Death|2|||
160984525|NCT03621982|581332277|FG000|Overall Study|Lost to Follow-up|0|||
160984526|NCT03621982|581332278|FG001|Overall Study|Lost to Follow-up|0|||
160984527|NCT03621982|581332279|FG002|Overall Study|Lost to Follow-up|1|||
160984528|NCT03621982|581332280|FG003|Overall Study|Lost to Follow-up|0|||
160984529|NCT03621982|581332281|FG004|Overall Study|Lost to Follow-up|0|||
160984530|NCT03621982|581332282|FG005|Overall Study|Lost to Follow-up|0|||
160984531|NCT03621982|581332283|FG006|Overall Study|Lost to Follow-up|1|||
160984532|NCT03621982|581332284|FG007|Overall Study|Lost to Follow-up|0|||
160984533|NCT03621982|581332285|FG008|Overall Study|Lost to Follow-up|0|||
160984534|NCT03621982|581332286|FG009|Overall Study|Lost to Follow-up|1|||
160984535|NCT03621982|581332287|FG010|Overall Study|Lost to Follow-up|0|||
160984536|NCT03621982|581332288|FG011|Overall Study|Lost to Follow-up|0|||
160984537|NCT03621982|581332289|FG012|Overall Study|Lost to Follow-up|0|||
160984538|NCT03621982|581332290|FG013|Overall Study|Lost to Follow-up|0|||
160984539|NCT00238420|581332291|FG000|Overall Study|Protocol Violation|1|||
160984540|NCT00238420|581332292|FG001|Overall Study|Protocol Violation|1|||
160984541|NCT01254890|581332295|FG000|Overall Study|Ineligible|0|||
160984542|NCT01254890|581332296|FG001|Overall Study|Ineligible|3|||
160984543|NCT01254890|581332295|FG000|Overall Study|Withdrawal by Subject|1|||
160984544|NCT01254890|581332296|FG001|Overall Study|Withdrawal by Subject|2|||
160984545|NCT01254890|581332295|FG000|Overall Study|Disease Progression|0|||
160984546|NCT01254890|581332296|FG001|Overall Study|Disease Progression|5|||
160984547|NCT02419755|581332307|FG000|Overall Study|Death|1|||
160984548|NCT02419755|581332308|FG001|Overall Study|Death|3|||
160984549|NCT02419755|581332307|FG000|Overall Study|Relapse|0|||
160984550|NCT02419755|581332308|FG001|Overall Study|Relapse|1|||
160984551|NCT02419755|581332307|FG000|Overall Study|Ineligible|1|||
160984552|NCT02419755|581332308|FG001|Overall Study|Ineligible|0|||
160984553|NCT02419755|581332307|FG000|Overall Study|Withdrawal by Subject|1|||
160984554|NCT02419755|581332308|FG001|Overall Study|Withdrawal by Subject|0|||
160984555|NCT00810641|581332311|FG000|Overall Study|Withdrawal by Subject|0|||
160984556|NCT00810641|581332312|FG001|Overall Study|Withdrawal by Subject|1|||
160984557|NCT00810641|581332313|FG002|Overall Study|Withdrawal by Subject|2|||
160984558|NCT02325713|581332316|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984559|NCT02325713|581332317|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984560|NCT02325713|581332318|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984561|NCT02325713|581332319|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984562|NCT02325713|581332320|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984563|NCT02325713|581332321|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984564|NCT02325713|581332322|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984565|NCT02325713|581332323|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984566|NCT02325713|581332324|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984567|NCT02325713|581332325|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984568|NCT02325713|581332326|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
160984569|NCT02325713|581332327|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984570|NCT02325713|581332328|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984571|NCT02325713|581332329|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984572|NCT02325713|581332330|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984573|NCT02325713|581332331|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
160984574|NCT02325713|581332316|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
160799634|NCT04067011|580655950|FG000|Overall Study|Withdrawal by Subject|6|||
160799635|NCT04067011|580655951|FG001|Overall Study|Withdrawal by Subject|2|||
160799636|NCT04067011|580655952|FG002|Overall Study|Withdrawal by Subject|1|||
160799637|NCT04067011|580655950|FG000|Overall Study|Lost to Follow-up|0|||
160799638|NCT04067011|580655951|FG001|Overall Study|Lost to Follow-up|0|||
160799639|NCT04067011|580655952|FG002|Overall Study|Lost to Follow-up|1|||
160799640|NCT04067011|580655950|FG000|Overall Study|Physician Decision|1|||
160799641|NCT04067011|580655951|FG001|Overall Study|Physician Decision|1|||
160799642|NCT04067011|580655952|FG002|Overall Study|Physician Decision|0|||
160799643|NCT04067011|580655950|FG000|Overall Study|Other Reasons|2|||
160799644|NCT04067011|580655951|FG001|Overall Study|Other Reasons|0|||
160799645|NCT04067011|580655952|FG002|Overall Study|Other Reasons|1|||
160799646|NCT04067011|580655950|FG000|Overall Study|Missing|0|||
160799647|NCT04067011|580655951|FG001|Overall Study|Missing|2|||
160799648|NCT04067011|580655952|FG002|Overall Study|Missing|0|||
160799649|NCT05209386|580655953|FG000|Overall Study|Withdrawal by Subject|8|||
160799650|NCT05209386|580655953|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
160799651|NCT03179761|580655954|FG000|Overall Study|Death|2|||
160799652|NCT03179761|580655955|FG001|Overall Study|Death|5|||
160799653|NCT03179761|580655954|FG000|Overall Study|Lost to Follow-up|2|||
160799654|NCT03179761|580655955|FG001|Overall Study|Lost to Follow-up|2|||
160799655|NCT03179761|580655954|FG000|Overall Study|Protocol Violation|1|||
160799656|NCT03179761|580655955|FG001|Overall Study|Protocol Violation|0|||
160799657|NCT03179761|580655954|FG000|Overall Study|Withdrawal by Subject|1|||
160799658|NCT03179761|580655955|FG001|Overall Study|Withdrawal by Subject|4|||
160799659|NCT03179761|580655954|FG000|Overall Study|Investigator Request|0|||
160799660|NCT03179761|580655955|FG001|Overall Study|Investigator Request|2|||
160799661|NCT00565409|580655956|FG000|Period 1 Open Label|Adverse Event|17|||
160799662|NCT00565409|580655957|FG001|Period 1 Open Label|Adverse Event|0|||
160799663|NCT00565409|580655958|FG002|Period 1 Open Label|Adverse Event|0|||
160799664|NCT00565409|580655959|FG003|Period 1 Open Label|Adverse Event|0|||
160799665|NCT00565409|580655956|FG000|Period 1 Open Label|Death|2|||
160799666|NCT00565409|580655957|FG001|Period 1 Open Label|Death|0|||
160799667|NCT00565409|580655958|FG002|Period 1 Open Label|Death|0|||
160799668|NCT00565409|580655959|FG003|Period 1 Open Label|Death|0|||
160799669|NCT00565409|580655956|FG000|Period 1 Open Label|Lost to Follow-up|1|||
160799670|NCT00565409|580655957|FG001|Period 1 Open Label|Lost to Follow-up|0|||
160799671|NCT00565409|580655958|FG002|Period 1 Open Label|Lost to Follow-up|0|||
160799672|NCT00565409|580655959|FG003|Period 1 Open Label|Lost to Follow-up|0|||
160799673|NCT00565409|580655956|FG000|Period 1 Open Label|Other|21|||
160799674|NCT00565409|580655957|FG001|Period 1 Open Label|Other|0|||
160799675|NCT00565409|580655958|FG002|Period 1 Open Label|Other|0|||
160799676|NCT00565409|580655959|FG003|Period 1 Open Label|Other|0|||
160799677|NCT00565409|580655956|FG000|Period 1 Open Label|Protocol Violation|14|||
160799678|NCT00565409|580655957|FG001|Period 1 Open Label|Protocol Violation|0|||
160799679|NCT00565409|580655958|FG002|Period 1 Open Label|Protocol Violation|0|||
160799680|NCT00565409|580655959|FG003|Period 1 Open Label|Protocol Violation|0|||
160799681|NCT00565409|580655956|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
160799682|NCT00565409|580655957|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
160799683|NCT00565409|580655958|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
160799684|NCT00565409|580655959|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
160799685|NCT00565409|580655956|FG000|Period 1 Open Label|no conclusion of participation record|1|||
160799686|NCT00565409|580655957|FG001|Period 1 Open Label|no conclusion of participation record|0|||
160799687|NCT00565409|580655958|FG002|Period 1 Open Label|no conclusion of participation record|0|||
160799688|NCT00565409|580655959|FG003|Period 1 Open Label|no conclusion of participation record|0|||
160799689|NCT00565409|580655956|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
160799690|NCT00565409|580655957|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
160799691|NCT00565409|580655958|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
160799692|NCT00565409|580655959|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
160799693|NCT00565409|580655956|FG000|Period 2 Double-Blind|Adverse Event|0|||
160799694|NCT00565409|580655957|FG001|Period 2 Double-Blind|Adverse Event|7|||
160799695|NCT00565409|580655958|FG002|Period 2 Double-Blind|Adverse Event|4|||
160799696|NCT00565409|580655959|FG003|Period 2 Double-Blind|Adverse Event|5|||
160799697|NCT00565409|580655956|FG000|Period 2 Double-Blind|Death|0|||
160799698|NCT00565409|580655957|FG001|Period 2 Double-Blind|Death|2|||
160799699|NCT00565409|580655958|FG002|Period 2 Double-Blind|Death|0|||
160896134|NCT00392015|581016841|FG002|Overall Study|Lost to Follow-up|2|||
161237241|NCT02335658|582248503|FG000|Overall Study|non-compliance|2|||
160799700|NCT00565409|580655959|FG003|Period 2 Double-Blind|Death|0|||
160799701|NCT00565409|580655956|FG000|Period 2 Double-Blind|Protocol Violation|0|||
160799702|NCT00565409|580655957|FG001|Period 2 Double-Blind|Protocol Violation|4|||
160799703|NCT00565409|580655958|FG002|Period 2 Double-Blind|Protocol Violation|6|||
160799704|NCT00565409|580655959|FG003|Period 2 Double-Blind|Protocol Violation|2|||
160799705|NCT00565409|580655956|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
160799706|NCT00565409|580655957|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
160896135|NCT00392015|581016842|FG003|Overall Study|Lost to Follow-up|1|||
161237242|NCT02335658|582248504|FG001|Overall Study|non-compliance|3|||
160799707|NCT00565409|580655958|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
160799708|NCT00565409|580655959|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
160799709|NCT00565409|580655956|FG000|Period 2 Double-Blind|Other|0|||
160799710|NCT00565409|580655957|FG001|Period 2 Double-Blind|Other|4|||
160799711|NCT00565409|580655958|FG002|Period 2 Double-Blind|Other|5|||
160799712|NCT00565409|580655959|FG003|Period 2 Double-Blind|Other|9|||
160799713|NCT00565409|580655956|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
160799714|NCT00565409|580655957|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
160799715|NCT00565409|580655958|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
160799716|NCT00565409|580655959|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
160799717|NCT03139448|580655965|FG000|Overall Study|Lack of Efficacy|6|||
160799718|NCT03139448|580655966|FG001|Overall Study|Lack of Efficacy|7|||
160799719|NCT03139448|580655965|FG000|Overall Study|Location of procedure changed|2|||
160799720|NCT03139448|580655966|FG001|Overall Study|Location of procedure changed|8|||
160799721|NCT03139448|580655965|FG000|Overall Study|Withdrawal by Subject|3|||
160799722|NCT03139448|580655966|FG001|Overall Study|Withdrawal by Subject|6|||
160799723|NCT03139448|580655965|FG000|Overall Study|Screen fail|1|||
160799724|NCT03139448|580655966|FG001|Overall Study|Screen fail|3|||
160799725|NCT03139448|580655965|FG000|Overall Study|Physician Decision|0|||
160799726|NCT03139448|580655966|FG001|Overall Study|Physician Decision|2|||
160799727|NCT01038323|580655967|FG000|Overall Study|Withdrawal by Subject|3|||
160799728|NCT01038323|580655968|FG001|Overall Study|Withdrawal by Subject|2|||
160799729|NCT01038323|580655969|FG002|Overall Study|Withdrawal by Subject|4|||
160799730|NCT04436744|580655972|FG000|Overall Study|Adverse Event|1|||
160799731|NCT04436744|580655973|FG001|Overall Study|Adverse Event|1|||
160799732|NCT04436744|580655972|FG000|Overall Study|Death|1|||
160799733|NCT04436744|580655973|FG001|Overall Study|Death|0|||
160799734|NCT04436744|580655972|FG000|Overall Study|Lost to Follow-up|0|||
160799735|NCT04436744|580655973|FG001|Overall Study|Lost to Follow-up|2|||
160799736|NCT04436744|580655972|FG000|Overall Study|Physician Decision|0|||
160799737|NCT04436744|580655973|FG001|Overall Study|Physician Decision|1|||
160799738|NCT04436744|580655972|FG000|Overall Study|Progressive Disease|0|||
160799739|NCT04436744|580655973|FG001|Overall Study|Progressive Disease|4|||
160799740|NCT04436744|580655972|FG000|Overall Study|Protocol Deviation|1|||
160799741|NCT04436744|580655973|FG001|Overall Study|Protocol Deviation|1|||
160799742|NCT04436744|580655972|FG000|Overall Study|Withdrawal by Subject|1|||
160799743|NCT04436744|580655973|FG001|Overall Study|Withdrawal by Subject|2|||
160799744|NCT01463033|580655974|FG000|Overall Study|Lost to Follow-up|4|||
160799745|NCT01463033|580655975|FG001|Overall Study|Lost to Follow-up|4|||
160799746|NCT01463033|580655974|FG000|Overall Study|Death|3|||
160799747|NCT01463033|580655975|FG001|Overall Study|Death|2|||
160799748|NCT00746811|580655976|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
160799749|NCT00746811|580655977|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
160799750|NCT01538199|580655978|FG000|Overall Study|Lost to Follow-up|1|||
160799751|NCT01538199|580655979|FG001|Overall Study|Lost to Follow-up|2|||
160799752|NCT01538199|580655980|FG002|Overall Study|Lost to Follow-up|1|||
160799753|NCT01538199|580655981|FG003|Overall Study|Lost to Follow-up|0|||
160799754|NCT01538199|580655978|FG000|Overall Study|participant did not have time|1|||
160799755|NCT01538199|580655979|FG001|Overall Study|participant did not have time|0|||
160799756|NCT01538199|580655980|FG002|Overall Study|participant did not have time|0|||
160799757|NCT01538199|580655981|FG003|Overall Study|participant did not have time|2|||
160799758|NCT01538199|580655978|FG000|Overall Study|Lack of Efficacy|0|||
160799759|NCT01538199|580655979|FG001|Overall Study|Lack of Efficacy|1|||
160799760|NCT01538199|580655980|FG002|Overall Study|Lack of Efficacy|0|||
160799761|NCT01538199|580655981|FG003|Overall Study|Lack of Efficacy|0|||
160799762|NCT03358030|580655982|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
160799763|NCT03358030|580655983|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
160799764|NCT03358030|580655984|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
160799765|NCT03358030|580655985|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
160799766|NCT03358030|580655982|FG000|Overall Study|Ineligibility|0|||
160799767|NCT03358030|580655983|FG001|Overall Study|Ineligibility|0|||
160799768|NCT03358030|580655984|FG002|Overall Study|Ineligibility|0|||
160799769|NCT03358030|580655985|FG003|Overall Study|Ineligibility|2|||
160799770|NCT03358030|580655982|FG000|Overall Study|Voluntary Withdrawal|1|||
160799771|NCT03358030|580655983|FG001|Overall Study|Voluntary Withdrawal|1|||
160799772|NCT03358030|580655984|FG002|Overall Study|Voluntary Withdrawal|3|||
160799773|NCT03358030|580655985|FG003|Overall Study|Voluntary Withdrawal|1|||
160799774|NCT03358030|580655982|FG000|Overall Study|Other|0|||
160799775|NCT03358030|580655983|FG001|Overall Study|Other|0|||
160799776|NCT03358030|580655984|FG002|Overall Study|Other|1|||
160799777|NCT03358030|580655985|FG003|Overall Study|Other|0|||
160799778|NCT03342560|580655986|FG000|Overall Study|Lost to Follow-up|2|||
160799779|NCT02604511|580655987|FG000|Overall Study|Adverse Event|3|||
160799780|NCT02604511|580655987|FG000|Overall Study|Disease Progression|4|||
160799781|NCT02604511|580655987|FG000|Overall Study|Withdrawal by Subject|3|||
160799782|NCT02604511|580655987|FG000|Overall Study|Participant ineligible|1|||
160799783|NCT02604511|580655987|FG000|Overall Study|Intercurrent illness|1|||
160896136|NCT00392015|581016843|FG004|Overall Study|Lost to Follow-up|1|||
160896137|NCT00392015|581016844|FG005|Overall Study|Lost to Follow-up|0|||
160896138|NCT00392015|581016839|FG000|Overall Study|Withdrawal by Subject|0|||
160896139|NCT00392015|581016840|FG001|Overall Study|Withdrawal by Subject|0|||
161331759|NCT01764841|582601479|FG003|Overall Study|Death|4|||
161331760|NCT01764841|582601476|FG000|Overall Study|No Follow Up|1|||
161331761|NCT01764841|582601477|FG001|Overall Study|No Follow Up|0|||
161331762|NCT01764841|582601478|FG002|Overall Study|No Follow Up|1|||
160896140|NCT00392015|581016841|FG002|Overall Study|Withdrawal by Subject|2|||
161237243|NCT02335658|582248503|FG000|Overall Study|other reason|2|||
161331763|NCT01764841|582601479|FG003|Overall Study|No Follow Up|0|||
161331764|NCT01764841|582601476|FG000|Overall Study|Protocol Violation|0|||
161331765|NCT01764841|582601477|FG001|Overall Study|Protocol Violation|1|||
161331766|NCT01764841|582601478|FG002|Overall Study|Protocol Violation|0|||
161331767|NCT01764841|582601479|FG003|Overall Study|Protocol Violation|0|||
161331768|NCT01764841|582601476|FG000|Overall Study|Withdrawal by Subject|16|||
161331769|NCT01764841|582601477|FG001|Overall Study|Withdrawal by Subject|24|||
161331770|NCT01764841|582601478|FG002|Overall Study|Withdrawal by Subject|11|||
161331771|NCT01764841|582601479|FG003|Overall Study|Withdrawal by Subject|15|||
161331772|NCT01764841|582601476|FG000|Overall Study|Lost to Follow-up|3|||
161331773|NCT01764841|582601477|FG001|Overall Study|Lost to Follow-up|0|||
161331774|NCT01764841|582601478|FG002|Overall Study|Lost to Follow-up|1|||
161331775|NCT01764841|582601479|FG003|Overall Study|Lost to Follow-up|0|||
161331776|NCT02115607|582601480|FG000|Overall Study|Withdrawal by Subject|1|||
161331777|NCT04863872|582601483|FG000|Overall Study|Withdrawal by Subject|4|||
161331778|NCT04863872|582601484|FG001|Overall Study|Withdrawal by Subject|15|||
161331779|NCT04863872|582601483|FG000|Overall Study|Death|5|||
161331780|NCT04863872|582601484|FG001|Overall Study|Death|2|||
161331781|NCT04863872|582601483|FG000|Overall Study|Lost to Follow-up|2|||
161331782|NCT04863872|582601484|FG001|Overall Study|Lost to Follow-up|1|||
161331783|NCT00549549|582601485|FG000|Overall Study|Adverse Event|5|||
161331784|NCT00549549|582601486|FG001|Overall Study|Adverse Event|3|||
161331785|NCT00549549|582601487|FG002|Overall Study|Adverse Event|1|||
161237244|NCT02335658|582248504|FG001|Overall Study|other reason|3|||
161237245|NCT02957942|582248509|FG000|Overall Study|Withdrawal by Subject|0|||
161237246|NCT02957942|582248510|FG001|Overall Study|Withdrawal by Subject|1|||
161237247|NCT02957942|582248509|FG000|Overall Study|Practicing experiment protocol|0|||
161237248|NCT02957942|582248510|FG001|Overall Study|Practicing experiment protocol|6|||
161237249|NCT02655679|582248526|FG000|Overall Study|Adverse Event|0|||
161237250|NCT02655679|582248527|FG001|Overall Study|Adverse Event|1|||
161237251|NCT02655679|582248528|FG002|Overall Study|Adverse Event|0|||
161237252|NCT02655679|582248529|FG003|Overall Study|Adverse Event|0|||
161237253|NCT02655679|582248530|FG004|Overall Study|Adverse Event|0|||
161237254|NCT02655679|582248526|FG000|Overall Study|Withdrawal by Subject|1|||
161237255|NCT02655679|582248527|FG001|Overall Study|Withdrawal by Subject|1|||
161237256|NCT02655679|582248528|FG002|Overall Study|Withdrawal by Subject|0|||
161237257|NCT02655679|582248529|FG003|Overall Study|Withdrawal by Subject|3|||
161237258|NCT02655679|582248530|FG004|Overall Study|Withdrawal by Subject|1|||
161237259|NCT02655679|582248526|FG000|Overall Study|Inability to Comply with the Protocol|1|||
161237260|NCT02655679|582248527|FG001|Overall Study|Inability to Comply with the Protocol|0|||
161237261|NCT02655679|582248528|FG002|Overall Study|Inability to Comply with the Protocol|0|||
161237262|NCT02655679|582248529|FG003|Overall Study|Inability to Comply with the Protocol|0|||
161237263|NCT02655679|582248530|FG004|Overall Study|Inability to Comply with the Protocol|0|||
161237264|NCT02655679|582248526|FG000|Overall Study|Lost to Follow-up|0|||
161237265|NCT02655679|582248527|FG001|Overall Study|Lost to Follow-up|1|||
161237266|NCT02655679|582248528|FG002|Overall Study|Lost to Follow-up|1|||
161237267|NCT02655679|582248529|FG003|Overall Study|Lost to Follow-up|1|||
161237268|NCT02655679|582248530|FG004|Overall Study|Lost to Follow-up|0|||
161237269|NCT02655679|582248526|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161237270|NCT02655679|582248527|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161237271|NCT02655679|582248528|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161237272|NCT02655679|582248529|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161237273|NCT02655679|582248530|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161237274|NCT03801707|582248531|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
161237275|NCT01754597|582248532|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
161237276|NCT01754597|582248533|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
161237277|NCT00819741|582248534|FG000|Overall Study|Adverse Event|5|||
161237278|NCT00819741|582248535|FG001|Overall Study|Adverse Event|2|||
161237279|NCT00819741|582248534|FG000|Overall Study|Lack of Efficacy|0|||
161331786|NCT00549549|582601488|FG003|Overall Study|Adverse Event|9|||
161331787|NCT00549549|582601485|FG000|Overall Study|Lack of Efficacy|9|||
160896141|NCT00392015|581016842|FG003|Overall Study|Withdrawal by Subject|0|||
161331788|NCT00549549|582601486|FG001|Overall Study|Lack of Efficacy|6|||
161331789|NCT00549549|582601487|FG002|Overall Study|Lack of Efficacy|4|||
161331790|NCT00549549|582601488|FG003|Overall Study|Lack of Efficacy|2|||
161331791|NCT00549549|582601485|FG000|Overall Study|Lost to Follow-up|1|||
161331792|NCT00549549|582601486|FG001|Overall Study|Lost to Follow-up|0|||
160799784|NCT03770286|580655988|FG000|Overall Study|Lost to Follow-up|6|||
160799785|NCT03770286|580655989|FG001|Overall Study|Lost to Follow-up|4|||
160799786|NCT03770286|580655990|FG002|Overall Study|Lost to Follow-up|3|||
160799787|NCT03770286|580655988|FG000|Overall Study|Protocol Violation|1|||
160799788|NCT03770286|580655989|FG001|Overall Study|Protocol Violation|0|||
160799789|NCT03770286|580655990|FG002|Overall Study|Protocol Violation|2|||
160799790|NCT02505425|580655991|FG000|Overall Study|Lost to Follow-up|41|||
160799791|NCT02505425|580655992|FG001|Overall Study|Lost to Follow-up|61|||
160799792|NCT02505425|580655993|FG002|Overall Study|Lost to Follow-up|31|||
160799793|NCT02505425|580655994|FG003|Overall Study|Lost to Follow-up|19|||
160799794|NCT02505425|580655991|FG000|Overall Study|Withdrawal by Subject|39|||
160799795|NCT02505425|580655992|FG001|Overall Study|Withdrawal by Subject|9|||
160896142|NCT00392015|581016843|FG004|Overall Study|Withdrawal by Subject|0|||
160896143|NCT00392015|581016844|FG005|Overall Study|Withdrawal by Subject|0|||
160896144|NCT00392015|581016839|FG000|Overall Study|Adverse Event|0|||
160896145|NCT00392015|581016840|FG001|Overall Study|Adverse Event|0|||
160896146|NCT00392015|581016841|FG002|Overall Study|Adverse Event|0|||
160896147|NCT00392015|581016842|FG003|Overall Study|Adverse Event|0|||
160896148|NCT00392015|581016843|FG004|Overall Study|Adverse Event|1|||
160896149|NCT00392015|581016844|FG005|Overall Study|Adverse Event|0|||
160799796|NCT02505425|580655993|FG002|Overall Study|Withdrawal by Subject|19|||
160799797|NCT02505425|580655994|FG003|Overall Study|Withdrawal by Subject|7|||
160799798|NCT02505425|580655991|FG000|Overall Study|Death|8|||
160799799|NCT02505425|580655992|FG001|Overall Study|Death|12|||
160799800|NCT02505425|580655993|FG002|Overall Study|Death|0|||
160799801|NCT02505425|580655994|FG003|Overall Study|Death|0|||
160799802|NCT00404248|580656003|FG000|Overall Study|pts declining status|0|||
160799803|NCT00404248|580656004|FG001|Overall Study|pts declining status|1|||
160799804|NCT00404248|580656005|FG002|Overall Study|pts declining status|0|||
160799805|NCT00404248|580656006|FG003|Overall Study|pts declining status|0|||
160799806|NCT00404248|580656007|FG004|Overall Study|pts declining status|0|||
160799807|NCT00404248|580656008|FG005|Overall Study|pts declining status|0|||
160799808|NCT00404248|580656009|FG006|Overall Study|pts declining status|0|||
160799809|NCT00404248|580656010|FG007|Overall Study|pts declining status|0|||
160799810|NCT00404248|580656011|FG008|Overall Study|pts declining status|0|||
160799811|NCT00789555|580656012|FG000|Overall Study|Protocol Amendment|78|||
160799812|NCT00789555|580656013|FG001|Overall Study|Protocol Amendment|76|||
160799813|NCT00789555|580656014|FG002|Overall Study|Protocol Amendment|80|||
160799814|NCT00789555|580656012|FG000|Overall Study|Adverse Event|17|||
160799815|NCT00789555|580656013|FG001|Overall Study|Adverse Event|7|||
160799816|NCT00789555|580656014|FG002|Overall Study|Adverse Event|10|||
160799817|NCT00789555|580656012|FG000|Overall Study|Lost to Follow-up|9|||
160799818|NCT00789555|580656013|FG001|Overall Study|Lost to Follow-up|10|||
160799819|NCT00789555|580656014|FG002|Overall Study|Lost to Follow-up|18|||
160799820|NCT00789555|580656012|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
160896150|NCT00392015|581016839|FG000|Overall Study|Previous trial recipient|0|||
160896151|NCT00392015|581016840|FG001|Overall Study|Previous trial recipient|0|||
160896152|NCT00392015|581016841|FG002|Overall Study|Previous trial recipient|0|||
160896153|NCT00392015|581016842|FG003|Overall Study|Previous trial recipient|0|||
160896154|NCT00392015|581016843|FG004|Overall Study|Previous trial recipient|1|||
160896155|NCT00392015|581016844|FG005|Overall Study|Previous trial recipient|0|||
160896156|NCT02742441|581016846|FG000|Overall Study|Lost to Follow-up|4|||
160896157|NCT02742441|581016847|FG001|Overall Study|Lost to Follow-up|4|||
160896158|NCT02742441|581016846|FG000|Overall Study|Withdrawal by Subject|2|||
160896159|NCT02742441|581016847|FG001|Overall Study|Withdrawal by Subject|2|||
160896160|NCT02742441|581016846|FG000|Overall Study|Adverse Event|0|||
160896161|NCT02742441|581016847|FG001|Overall Study|Adverse Event|2|||
160896162|NCT00537238|581016848|FG000|Overall Study|Death|1|||
160799821|NCT00789555|580656013|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
160799822|NCT00789555|580656014|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
160799823|NCT00789555|580656012|FG000|Overall Study|Treatment failure|11|||
160799824|NCT00789555|580656013|FG001|Overall Study|Treatment failure|8|||
160799825|NCT00789555|580656014|FG002|Overall Study|Treatment failure|12|||
160799826|NCT00789555|580656012|FG000|Overall Study|Protocol Violation|6|||
160896163|NCT00537238|581016849|FG001|Overall Study|Death|2|||
160896164|NCT00537238|581016848|FG000|Overall Study|Adverse Event|31|||
160896165|NCT00537238|581016849|FG001|Overall Study|Adverse Event|22|||
160896166|NCT00537238|581016848|FG000|Overall Study|Lack of Efficacy|20|||
160896167|NCT00537238|581016849|FG001|Overall Study|Lack of Efficacy|21|||
160799827|NCT00789555|580656013|FG001|Overall Study|Protocol Violation|9|||
160799828|NCT00789555|580656014|FG002|Overall Study|Protocol Violation|13|||
160896168|NCT00537238|581016848|FG000|Overall Study|Lost to Follow-up|12|||
160896169|NCT00537238|581016849|FG001|Overall Study|Lost to Follow-up|8|||
160896170|NCT00537238|581016848|FG000|Overall Study|Withdrawal by Subject|51|||
160896171|NCT00537238|581016849|FG001|Overall Study|Withdrawal by Subject|47|||
160896172|NCT00537238|581016848|FG000|Overall Study|Protocol Violation|15|||
160896173|NCT00537238|581016849|FG001|Overall Study|Protocol Violation|19|||
160896174|NCT00537238|581016848|FG000|Overall Study|Does not meet entrance criteria|0|||
160896175|NCT00537238|581016849|FG001|Overall Study|Does not meet entrance criteria|2|||
160896176|NCT00537238|581016848|FG000|Overall Study|Other|44|||
160896177|NCT00537238|581016849|FG001|Overall Study|Other|52|||
160896178|NCT03265665|581016850|FG000|24-week Data Collection|Withdrawal by Subject|2|||
160896179|NCT03265665|581016851|FG001|24-week Data Collection|Withdrawal by Subject|2|||
160896180|NCT03265665|581016850|FG000|24-week Data Collection|Lost to Follow-up|4|||
160896181|NCT03265665|581016851|FG001|24-week Data Collection|Lost to Follow-up|5|||
161331793|NCT00549549|582601487|FG002|Overall Study|Lost to Follow-up|1|||
161331794|NCT00549549|582601488|FG003|Overall Study|Lost to Follow-up|2|||
161331795|NCT00549549|582601485|FG000|Overall Study|Withdrawal by Subject|0|||
161331796|NCT00549549|582601486|FG001|Overall Study|Withdrawal by Subject|4|||
161331797|NCT00549549|582601487|FG002|Overall Study|Withdrawal by Subject|1|||
161331798|NCT00549549|582601488|FG003|Overall Study|Withdrawal by Subject|0|||
161331799|NCT00549549|582601485|FG000|Overall Study|Other|9|||
161331800|NCT00549549|582601486|FG001|Overall Study|Other|9|||
161331801|NCT00549549|582601487|FG002|Overall Study|Other|9|||
161331802|NCT00549549|582601488|FG003|Overall Study|Other|11|||
161331803|NCT00549549|582601485|FG000|Overall Study|Randomized but not treated|0|||
161331804|NCT00549549|582601486|FG001|Overall Study|Randomized but not treated|0|||
161331805|NCT00549549|582601487|FG002|Overall Study|Randomized but not treated|1|||
161331806|NCT00549549|582601488|FG003|Overall Study|Randomized but not treated|1|||
161331807|NCT02155699|582601489|FG000|Overall Study|Withdrawal by Subject|0|||
161331808|NCT02155699|582601490|FG001|Overall Study|Withdrawal by Subject|3|||
161331809|NCT02155699|582601491|FG002|Overall Study|Withdrawal by Subject|6|||
161331810|NCT02155699|582601492|FG003|Overall Study|Withdrawal by Subject|1|||
161331811|NCT02155699|582601489|FG000|Overall Study|Lost to Follow-up|0|||
161331812|NCT02155699|582601490|FG001|Overall Study|Lost to Follow-up|0|||
161331813|NCT02155699|582601491|FG002|Overall Study|Lost to Follow-up|0|||
161331814|NCT02155699|582601492|FG003|Overall Study|Lost to Follow-up|3|||
161331815|NCT02155699|582601489|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
161331816|NCT02155699|582601490|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
161331817|NCT02155699|582601491|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
161331818|NCT02155699|582601492|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
161331819|NCT05547386|582601493|FG000|Overall Study|Withdrawal by Subject|7|||
161331820|NCT02573259|582601502|FG000|Overall Study|Death|1|||
161331821|NCT02573259|582601503|FG001|Overall Study|Death|6|||
161331822|NCT02573259|582601504|FG002|Overall Study|Death|5|||
161331823|NCT02573259|582601505|FG003|Overall Study|Death|6|||
161331824|NCT02573259|582601506|FG004|Overall Study|Death|9|||
161331825|NCT02573259|582601507|FG005|Overall Study|Death|32|||
161331826|NCT02573259|582601508|FG006|Overall Study|Death|21|||
161331827|NCT02573259|582601502|FG000|Overall Study|Lost to Follow-up|0|||
161331828|NCT02573259|582601503|FG001|Overall Study|Lost to Follow-up|0|||
161331829|NCT02573259|582601504|FG002|Overall Study|Lost to Follow-up|0|||
161331830|NCT02573259|582601505|FG003|Overall Study|Lost to Follow-up|0|||
161331831|NCT02573259|582601506|FG004|Overall Study|Lost to Follow-up|0|||
161331832|NCT02573259|582601507|FG005|Overall Study|Lost to Follow-up|2|||
161331833|NCT02573259|582601508|FG006|Overall Study|Lost to Follow-up|1|||
161331834|NCT02573259|582601502|FG000|Overall Study|Participant refused further follow-up|0|||
161331835|NCT02573259|582601503|FG001|Overall Study|Participant refused further follow-up|2|||
161331836|NCT02573259|582601504|FG002|Overall Study|Participant refused further follow-up|1|||
161331837|NCT02573259|582601505|FG003|Overall Study|Participant refused further follow-up|0|||
161331838|NCT02573259|582601506|FG004|Overall Study|Participant refused further follow-up|3|||
161331839|NCT02573259|582601507|FG005|Overall Study|Participant refused further follow-up|20|||
161331840|NCT02573259|582601508|FG006|Overall Study|Participant refused further follow-up|7|||
161331841|NCT02573259|582601502|FG000|Overall Study|Other|0|||
161331842|NCT02573259|582601503|FG001|Overall Study|Other|0|||
161331843|NCT02573259|582601504|FG002|Overall Study|Other|0|||
161331844|NCT02573259|582601505|FG003|Overall Study|Other|0|||
161331845|NCT02573259|582601506|FG004|Overall Study|Other|1|||
161331846|NCT02573259|582601507|FG005|Overall Study|Other|4|||
161331847|NCT02573259|582601508|FG006|Overall Study|Other|5|||
161331848|NCT00751140|582601509|FG000|Overall Study|benign angioma excluded from analysis|1|||
161331849|NCT00808067|582601510|FG000|Overall Study|Major/minor bleed|30|||
161331850|NCT00808067|582601511|FG001|Overall Study|Major/minor bleed|44|||
161331851|NCT00808067|582601510|FG000|Overall Study|Outcome event - other|33|||
161331852|NCT00808067|582601511|FG001|Overall Study|Outcome event - other|25|||
161331853|NCT00808067|582601510|FG000|Overall Study|Adverse Event|111|||
160896182|NCT03265665|581016850|FG000|36-week Data Collection|Lost to Follow-up|6|||
160896183|NCT03265665|581016851|FG001|36-week Data Collection|Lost to Follow-up|8|||
160896184|NCT01858376|581016852|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
161331854|NCT00808067|582601511|FG001|Overall Study|Adverse Event|121|||
161331855|NCT00808067|582601510|FG000|Overall Study|Hospitalization (not including surgery)|18|||
161331856|NCT00808067|582601511|FG001|Overall Study|Hospitalization (not including surgery)|17|||
161331857|NCT00808067|582601510|FG000|Overall Study|Hospitalization due to surgery|37|||
161331858|NCT00808067|582601511|FG001|Overall Study|Hospitalization due to surgery|40|||
161331859|NCT00808067|582601510|FG000|Overall Study|Reduced creatinine clearance|53|||
160984575|NCT02325713|581332317|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984576|NCT02325713|581332318|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984577|NCT02325713|581332319|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984578|NCT02325713|581332320|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984579|NCT02325713|581332321|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984580|NCT02325713|581332322|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984581|NCT02325713|581332323|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984582|NCT02325713|581332324|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984583|NCT02325713|581332325|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984584|NCT02325713|581332326|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984585|NCT02325713|581332327|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160896185|NCT01680965|581016856|FG000|Overall Study|Death|0|||
160896186|NCT01680965|581016857|FG001|Overall Study|Death|0|||
160896187|NCT01680965|581016858|FG002|Overall Study|Death|0|||
160896188|NCT01680965|581016859|FG003|Overall Study|Death|6|||
160896189|NCT01871142|581016870|FG000|Overall Study|Adverse Event|1|||
160896190|NCT00734474|581016873|FG000|Overall Study|Entry Criteria Not Met|0|||
160896191|NCT00734474|581016874|FG001|Overall Study|Entry Criteria Not Met|0|||
160896192|NCT00734474|581016875|FG002|Overall Study|Entry Criteria Not Met|5|||
160896193|NCT00734474|581016876|FG003|Overall Study|Entry Criteria Not Met|0|||
160896194|NCT00734474|581016877|FG004|Overall Study|Entry Criteria Not Met|3|||
160896195|NCT00734474|581016878|FG005|Overall Study|Entry Criteria Not Met|1|||
160896196|NCT00734474|581016879|FG006|Overall Study|Entry Criteria Not Met|0|||
160896197|NCT00734474|581016880|FG007|Overall Study|Entry Criteria Not Met|1|||
160896198|NCT00734474|581016881|FG008|Overall Study|Entry Criteria Not Met|1|||
160896199|NCT00734474|581016873|FG000|Overall Study|Lost to Follow-up|1|||
160896200|NCT00734474|581016874|FG001|Overall Study|Lost to Follow-up|0|||
160896201|NCT00734474|581016875|FG002|Overall Study|Lost to Follow-up|13|||
160896202|NCT00734474|581016876|FG003|Overall Study|Lost to Follow-up|0|||
160896203|NCT00734474|581016877|FG004|Overall Study|Lost to Follow-up|11|||
160896204|NCT00734474|581016878|FG005|Overall Study|Lost to Follow-up|1|||
160896205|NCT00734474|581016879|FG006|Overall Study|Lost to Follow-up|0|||
160896206|NCT00734474|581016880|FG007|Overall Study|Lost to Follow-up|9|||
160896207|NCT00734474|581016881|FG008|Overall Study|Lost to Follow-up|4|||
160896208|NCT00734474|581016873|FG000|Overall Study|Withdrawal by Subject|2|||
160896209|NCT00734474|581016874|FG001|Overall Study|Withdrawal by Subject|1|||
160896210|NCT00734474|581016875|FG002|Overall Study|Withdrawal by Subject|18|||
160896211|NCT00734474|581016876|FG003|Overall Study|Withdrawal by Subject|0|||
160896212|NCT00734474|581016877|FG004|Overall Study|Withdrawal by Subject|24|||
160896213|NCT00734474|581016878|FG005|Overall Study|Withdrawal by Subject|2|||
160896214|NCT00734474|581016879|FG006|Overall Study|Withdrawal by Subject|0|||
160896215|NCT00734474|581016880|FG007|Overall Study|Withdrawal by Subject|36|||
160896216|NCT00734474|581016881|FG008|Overall Study|Withdrawal by Subject|21|||
160896217|NCT00734474|581016873|FG000|Overall Study|Physician Decision|0|||
160896218|NCT00734474|581016874|FG001|Overall Study|Physician Decision|0|||
160896219|NCT00734474|581016875|FG002|Overall Study|Physician Decision|4|||
160896220|NCT00734474|581016876|FG003|Overall Study|Physician Decision|1|||
160896221|NCT00734474|581016877|FG004|Overall Study|Physician Decision|11|||
160896222|NCT00734474|581016878|FG005|Overall Study|Physician Decision|0|||
160896223|NCT00734474|581016879|FG006|Overall Study|Physician Decision|0|||
160896224|NCT00734474|581016880|FG007|Overall Study|Physician Decision|9|||
160896225|NCT00734474|581016881|FG008|Overall Study|Physician Decision|9|||
160896226|NCT00734474|581016873|FG000|Overall Study|Adverse Event|4|||
160896227|NCT00734474|581016874|FG001|Overall Study|Adverse Event|4|||
160896228|NCT00734474|581016875|FG002|Overall Study|Adverse Event|63|||
160896229|NCT00734474|581016876|FG003|Overall Study|Adverse Event|1|||
160896230|NCT00734474|581016877|FG004|Overall Study|Adverse Event|64|||
160896231|NCT00734474|581016878|FG005|Overall Study|Adverse Event|0|||
160896232|NCT00734474|581016879|FG006|Overall Study|Adverse Event|1|||
160896233|NCT00734474|581016880|FG007|Overall Study|Adverse Event|65|||
160896234|NCT00734474|581016881|FG008|Overall Study|Adverse Event|39|||
160896235|NCT00734474|581016873|FG000|Overall Study|Protocol Violation|0|||
160896236|NCT00734474|581016874|FG001|Overall Study|Protocol Violation|0|||
160896237|NCT00734474|581016875|FG002|Overall Study|Protocol Violation|4|||
160896238|NCT00734474|581016876|FG003|Overall Study|Protocol Violation|0|||
160896239|NCT00734474|581016877|FG004|Overall Study|Protocol Violation|3|||
160896240|NCT00734474|581016878|FG005|Overall Study|Protocol Violation|0|||
160896241|NCT00734474|581016879|FG006|Overall Study|Protocol Violation|0|||
160896242|NCT00734474|581016880|FG007|Overall Study|Protocol Violation|3|||
160896243|NCT00734474|581016881|FG008|Overall Study|Protocol Violation|1|||
160896244|NCT00734474|581016873|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
161237280|NCT00819741|582248535|FG001|Overall Study|Lack of Efficacy|2|||
161237281|NCT00819741|582248534|FG000|Overall Study|Lost to Follow-up|3|||
161237282|NCT00819741|582248535|FG001|Overall Study|Lost to Follow-up|1|||
160896245|NCT00734474|581016874|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
160896246|NCT00734474|581016875|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896247|NCT00734474|581016876|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
160799829|NCT04464473|580656015|FG000|Overall Study|New piercing could not be removed for scanning|0|||
160799830|NCT04464473|580656016|FG001|Overall Study|New piercing could not be removed for scanning|0|||
160799831|NCT04464473|580656017|FG002|Overall Study|New piercing could not be removed for scanning|0|||
160799832|NCT04464473|580656018|FG003|Overall Study|New piercing could not be removed for scanning|1|||
160799833|NCT04464473|580656019|FG004|Overall Study|New piercing could not be removed for scanning|0|||
160799834|NCT04464473|580656020|FG005|Overall Study|New piercing could not be removed for scanning|0|||
160799835|NCT04464473|580656015|FG000|Overall Study|Adverse Event|0|||
160799836|NCT04464473|580656016|FG001|Overall Study|Adverse Event|0|||
160799837|NCT04464473|580656017|FG002|Overall Study|Adverse Event|0|||
160799838|NCT04464473|580656018|FG003|Overall Study|Adverse Event|1|||
160799839|NCT04464473|580656019|FG004|Overall Study|Adverse Event|0|||
160799840|NCT04464473|580656020|FG005|Overall Study|Adverse Event|0|||
160799841|NCT04464473|580656015|FG000|Overall Study|Lost to Follow-up|0|||
160799842|NCT04464473|580656016|FG001|Overall Study|Lost to Follow-up|0|||
160799843|NCT04464473|580656017|FG002|Overall Study|Lost to Follow-up|0|||
160799844|NCT04464473|580656018|FG003|Overall Study|Lost to Follow-up|1|||
160799845|NCT04464473|580656019|FG004|Overall Study|Lost to Follow-up|0|||
160799846|NCT04464473|580656020|FG005|Overall Study|Lost to Follow-up|0|||
160799847|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
160799848|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
160799849|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
160799850|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
160799851|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
160799852|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
160799853|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
160799854|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
160799855|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
160799856|NCT01150357|580656036|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
160799857|NCT01150357|580656037|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
160799858|NCT01150357|580656038|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
160799859|NCT01150357|580656036|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
160799860|NCT01150357|580656037|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
160799861|NCT01150357|580656038|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
160799862|NCT01150357|580656036|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
160799863|NCT01150357|580656037|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
160799864|NCT01150357|580656038|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
160799865|NCT01150357|580656036|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
160799866|NCT01150357|580656037|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
160896248|NCT00734474|581016877|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896249|NCT00734474|581016878|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
160896250|NCT00734474|581016879|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
160896251|NCT00734474|581016880|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896252|NCT00734474|581016881|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
160896253|NCT00734474|581016873|FG000|Overall Study|Sponsor Decision|0|||
160896254|NCT00734474|581016874|FG001|Overall Study|Sponsor Decision|0|||
160896255|NCT00734474|581016875|FG002|Overall Study|Sponsor Decision|0|||
160896256|NCT00734474|581016876|FG003|Overall Study|Sponsor Decision|0|||
160896257|NCT00734474|581016877|FG004|Overall Study|Sponsor Decision|2|||
160896258|NCT00734474|581016878|FG005|Overall Study|Sponsor Decision|0|||
160896259|NCT00734474|581016879|FG006|Overall Study|Sponsor Decision|0|||
160896260|NCT00734474|581016880|FG007|Overall Study|Sponsor Decision|0|||
160896261|NCT00734474|581016881|FG008|Overall Study|Sponsor Decision|0|||
160896262|NCT00734474|581016873|FG000|Overall Study|Death|0|||
160896263|NCT00734474|581016874|FG001|Overall Study|Death|0|||
160896264|NCT00734474|581016875|FG002|Overall Study|Death|1|||
160896265|NCT00734474|581016876|FG003|Overall Study|Death|0|||
160896266|NCT00734474|581016877|FG004|Overall Study|Death|0|||
160896267|NCT00734474|581016878|FG005|Overall Study|Death|0|||
160896268|NCT00734474|581016879|FG006|Overall Study|Death|0|||
160896269|NCT00734474|581016880|FG007|Overall Study|Death|2|||
160896270|NCT00734474|581016881|FG008|Overall Study|Death|1|||
160896271|NCT00734474|581016873|FG000|Overall Study|Lack of Efficacy|0|||
160896272|NCT00734474|581016874|FG001|Overall Study|Lack of Efficacy|0|||
160896273|NCT00734474|581016875|FG002|Overall Study|Lack of Efficacy|4|||
160896274|NCT00734474|581016876|FG003|Overall Study|Lack of Efficacy|0|||
160799867|NCT01150357|580656038|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
160896275|NCT00734474|581016877|FG004|Overall Study|Lack of Efficacy|0|||
160896276|NCT00734474|581016878|FG005|Overall Study|Lack of Efficacy|0|||
160896277|NCT00734474|581016879|FG006|Overall Study|Lack of Efficacy|0|||
160896278|NCT00734474|581016880|FG007|Overall Study|Lack of Efficacy|4|||
160896279|NCT00734474|581016881|FG008|Overall Study|Lack of Efficacy|6|||
160896280|NCT02104752|581016884|FG000|Overall Study|Withdrawal by Subject|1|||
160896281|NCT02104752|581016885|FG001|Overall Study|Withdrawal by Subject|0|||
160896282|NCT02104752|581016884|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
160799868|NCT02661672|580656039|FG000|Overall Study|Lost to Follow-up|1|||
160799869|NCT02661672|580656039|FG000|Overall Study|Death|4|||
160799870|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
160799871|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
160799872|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
160799873|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
160799874|NCT02735421|580658131|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
160799875|NCT02735421|580658131|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
160799876|NCT02735421|580658131|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
160799877|NCT01978145|580658133|FG000|Treatment Period 1|Adverse Event|1|||
160799878|NCT01978145|580658134|FG001|Treatment Period 1|Adverse Event|9|||
160799879|NCT01978145|580658133|FG000|Treatment Period 1|Physician Decision|1|||
160799880|NCT01978145|580658134|FG001|Treatment Period 1|Physician Decision|0|||
160799881|NCT01978145|580658133|FG000|Treatment Period 1|Withdrawal by Subject|5|||
160799882|NCT01978145|580658134|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160799883|NCT01978145|580658133|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
160799884|NCT01978145|580658134|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
160799885|NCT01978145|580658133|FG000|Washout Period 1|Adverse Event|0|||
160799886|NCT01978145|580658134|FG001|Washout Period 1|Adverse Event|1|||
160799887|NCT01978145|580658133|FG000|Washout Period 1|Withdrawal by Subject|1|||
160799888|NCT01978145|580658134|FG001|Washout Period 1|Withdrawal by Subject|1|||
160799889|NCT01978145|580658133|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
160799890|NCT01978145|580658134|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
160799891|NCT01978145|580658133|FG000|Treatment Period 2|Adverse Event|3|||
160799892|NCT01978145|580658134|FG001|Treatment Period 2|Adverse Event|3|||
160799893|NCT01978145|580658133|FG000|Treatment Period 2|Protocol Violation|0|||
160799894|NCT01978145|580658134|FG001|Treatment Period 2|Protocol Violation|1|||
160799895|NCT01978145|580658133|FG000|Treatment Period 2|Lost to Follow-up|1|||
160799896|NCT01978145|580658134|FG001|Treatment Period 2|Lost to Follow-up|1|||
160799897|NCT01978145|580658133|FG000|Treatment Period 2|Withdrawal by Subject|7|||
160799898|NCT01978145|580658134|FG001|Treatment Period 2|Withdrawal by Subject|4|||
160799899|NCT01978145|580658133|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
160799900|NCT01978145|580658134|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
160896283|NCT02104752|581016885|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
160896284|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
160896285|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
160896286|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
160896287|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
160896288|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
160896289|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
160984586|NCT02325713|581332328|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984587|NCT02325713|581332329|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984588|NCT02325713|581332330|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984589|NCT02325713|581332331|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
160984590|NCT02325713|581332316|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984591|NCT02325713|581332317|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984592|NCT02325713|581332318|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984593|NCT02325713|581332319|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984594|NCT02325713|581332320|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984595|NCT02325713|581332321|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984596|NCT02325713|581332322|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984597|NCT02325713|581332323|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984598|NCT02325713|581332324|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984599|NCT02325713|581332325|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
160984600|NCT02325713|581332326|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984601|NCT02325713|581332327|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984602|NCT02325713|581332328|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984603|NCT02325713|581332329|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
161129797|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161129798|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
160799901|NCT01250054|580658135|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
160799902|NCT01250054|580658136|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
160799903|NCT00652743|580658137|FG000|Months 12-18|Lost to Follow-up|1|||
160799904|NCT00652743|580658138|FG001|Months 12-18|Lost to Follow-up|2|||
160799905|NCT00652743|580658139|FG002|Months 12-18|Lost to Follow-up|7|||
160799906|NCT00652743|580658137|FG000|Months 24-30|Other|5|||
160799907|NCT00652743|580658138|FG001|Months 24-30|Other|1|||
160799908|NCT00652743|580658139|FG002|Months 24-30|Other|11|||
160799909|NCT00652743|580658137|FG000|Months 36-42|Serious Adverse Events|0|||
160799910|NCT00652743|580658138|FG001|Months 36-42|Serious Adverse Events|1|||
160984604|NCT02325713|581332330|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160799911|NCT00652743|580658139|FG002|Months 36-42|Serious Adverse Events|1|||
160799912|NCT00652743|580658137|FG000|Months 36-42|Withdrawal by Subject|1|||
160799913|NCT00652743|580658138|FG001|Months 36-42|Withdrawal by Subject|1|||
160799914|NCT00652743|580658139|FG002|Months 36-42|Withdrawal by Subject|0|||
160799915|NCT00652743|580658137|FG000|Months 36-42|Lost to Follow-up|0|||
160799916|NCT00652743|580658138|FG001|Months 36-42|Lost to Follow-up|1|||
160799917|NCT00652743|580658139|FG002|Months 36-42|Lost to Follow-up|0|||
160799918|NCT00652743|580658137|FG000|Months 36-42|Migrated/moved from study area|1|||
160799919|NCT00652743|580658138|FG001|Months 36-42|Migrated/moved from study area|0|||
160799920|NCT00652743|580658139|FG002|Months 36-42|Migrated/moved from study area|0|||
160896290|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
160896291|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
160896292|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
160896293|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
160896294|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
160896295|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
160896296|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
160896297|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
160896298|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
160896299|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
160896300|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
160896301|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
160896302|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
160896303|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
160896304|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
160896305|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
160896306|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
160896307|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
160896308|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
160896309|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
160896310|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
160896311|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
160896312|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
160896313|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
160896314|NCT00313300|581016887|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
160896315|NCT00313300|581016888|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896316|NCT00313300|581016889|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896317|NCT00313300|581016890|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896318|NCT00313300|581016891|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
160896319|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
160896320|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
160896321|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
160896322|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
160896323|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
160896324|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
160896325|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
160896326|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
160896327|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
160896328|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
160896329|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
160896330|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
160896331|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
160896332|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
160896333|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
160896334|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
160896335|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
160896336|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
160896337|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
160896338|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
160896339|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
160896340|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
160896341|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
160896342|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
160896343|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
160896344|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
160896345|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
160799921|NCT00652743|580658137|FG000|Months 36-42|Other|4|||
160799922|NCT00652743|580658138|FG001|Months 36-42|Other|2|||
160799923|NCT00652743|580658139|FG002|Months 36-42|Other|8|||
160799924|NCT01192126|580658141|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
160799925|NCT01192126|580658142|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
160799926|NCT01192126|580658141|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
160799927|NCT01192126|580658142|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
160799928|NCT01248793|580658143|FG000|Overall Study|Lost to Follow-up|0|||
160799929|NCT01248793|580658144|FG001|Overall Study|Lost to Follow-up|1|||
160799930|NCT01248793|580658143|FG000|Overall Study|Adverse Event|1|||
160799931|NCT01248793|580658144|FG001|Overall Study|Adverse Event|1|||
160799932|NCT01248793|580658143|FG000|Overall Study|Protocol Violation|0|||
160799933|NCT01248793|580658144|FG001|Overall Study|Protocol Violation|1|||
160799934|NCT01248793|580658143|FG000|Overall Study|Withdrawal by Subject|3|||
160799935|NCT01248793|580658144|FG001|Overall Study|Withdrawal by Subject|3|||
160799936|NCT00517699|580658145|FG000|Overall Study|Withdrawal by Subject|1|||
160799937|NCT00517699|580658145|FG000|Overall Study|Lack of Efficacy|1|||
160799938|NCT00517699|580658145|FG000|Overall Study|Administrative error|1|||
160799939|NCT00517699|580658145|FG000|Overall Study|Study terminated by Sponsor|2|||
160799940|NCT01114737|580658146|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
160799941|NCT01114737|580658147|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
160799942|NCT01114737|580658146|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
160799943|NCT01114737|580658147|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
160799944|NCT01114737|580658146|FG000|Randomized Treatment Period|Pregnancy|1|||
160799945|NCT01114737|580658147|FG001|Randomized Treatment Period|Pregnancy|0|||
160799946|NCT01114737|580658146|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
160799947|NCT01114737|580658147|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
160799948|NCT01114737|580658146|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
160799949|NCT01114737|580658147|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
160799950|NCT01114737|580658146|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
160799951|NCT01114737|580658147|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
160799952|NCT02580877|580658150|FG000|Overall Study|Withdrawal by Subject|1|||
160799953|NCT02580877|580658151|FG001|Overall Study|Withdrawal by Subject|3|||
160799954|NCT02580877|580658150|FG000|Overall Study|Adverse Event|0|||
160799955|NCT02580877|580658151|FG001|Overall Study|Adverse Event|1|||
160799956|NCT00892008|580658152|FG000|Overall Study|Death|5|||
160799957|NCT00892008|580658152|FG000|Overall Study|Lack of Efficacy|3|||
160984605|NCT02325713|581332331|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
160984606|NCT01213173|581332333|FG000|Overall Study|Protocol Violation|2|||
160984607|NCT01213173|581332334|FG001|Overall Study|Protocol Violation|0|||
160984608|NCT01213173|581332333|FG000|Overall Study|Adverse Event|4|||
160984609|NCT01213173|581332334|FG001|Overall Study|Adverse Event|8|||
160984610|NCT01213173|581332333|FG000|Overall Study|Withdrawal by Subject|5|||
160984611|NCT01213173|581332334|FG001|Overall Study|Withdrawal by Subject|5|||
160984612|NCT01213173|581332333|FG000|Overall Study|Incorrect Enrollment|1|||
160984613|NCT01213173|581332334|FG001|Overall Study|Incorrect Enrollment|3|||
160984614|NCT02253316|581332335|FG000|Consolidation|Progression|4|||
160984615|NCT02253316|581332336|FG001|Consolidation|Progression|0|||
160984616|NCT02253316|581332337|FG002|Consolidation|Progression|0|||
160984617|NCT02253316|581332335|FG000|Consolidation|Non-Compliance|1|||
160984618|NCT02253316|581332336|FG001|Consolidation|Non-Compliance|0|||
160984619|NCT02253316|581332337|FG002|Consolidation|Non-Compliance|0|||
160984620|NCT02253316|581332335|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
160984621|NCT02253316|581332336|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
160984622|NCT02253316|581332337|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
160984623|NCT02253316|581332335|FG000|Consolidation|Secondary Malignancy|2|||
160984624|NCT02253316|581332336|FG001|Consolidation|Secondary Malignancy|0|||
160984625|NCT02253316|581332337|FG002|Consolidation|Secondary Malignancy|0|||
160984626|NCT02253316|581332335|FG000|Consolidation|Adverse Event|7|||
160984627|NCT02253316|581332336|FG001|Consolidation|Adverse Event|0|||
160984628|NCT02253316|581332337|FG002|Consolidation|Adverse Event|0|||
160984629|NCT02253316|581332335|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
160984630|NCT02253316|581332336|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
160984631|NCT02253316|581332337|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
160984632|NCT02253316|581332335|FG000|Maintenance|Physician Decision|0|||
160984633|NCT02253316|581332336|FG001|Maintenance|Physician Decision|7|||
161129799|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
161129800|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160799958|NCT00892008|580658152|FG000|Overall Study|Lost to Follow-up|142|||
160799959|NCT00892008|580658152|FG000|Overall Study|Other|378|||
160799960|NCT00892008|580658152|FG000|Overall Study|Adverse Event|37|||
160799961|NCT01466491|580658153|FG000|Overall Study|Protocol Violation|0|||
160799962|NCT01466491|580658154|FG001|Overall Study|Protocol Violation|3|||
160984634|NCT02253316|581332337|FG002|Maintenance|Physician Decision|16|||
160984635|NCT02253316|581332335|FG000|Maintenance|Non-Compliance|0|||
160984636|NCT02253316|581332336|FG001|Maintenance|Non-Compliance|1|||
160799963|NCT01466491|580658155|FG002|Overall Study|Protocol Violation|2|||
160799964|NCT01466491|580658156|FG003|Overall Study|Protocol Violation|0|||
160799965|NCT01466491|580658153|FG000|Overall Study|Missing Data|0|||
160799966|NCT01466491|580658154|FG001|Overall Study|Missing Data|0|||
160799967|NCT01466491|580658155|FG002|Overall Study|Missing Data|1|||
160799968|NCT01466491|580658156|FG003|Overall Study|Missing Data|0|||
160799969|NCT00355030|580658157|FG000|Study Period 1 Treatment|Adverse Event|1|||
160799970|NCT00355030|580658158|FG001|Study Period 1 Treatment|Adverse Event|1|||
160799971|NCT00355030|580658157|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
160799972|NCT00355030|580658158|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
160799973|NCT00355030|580658157|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
160799974|NCT00355030|580658158|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
160799975|NCT00355030|580658157|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
160799976|NCT00355030|580658158|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
160799977|NCT00355030|580658157|FG000|Study Period 1 Treatment|Physician Decision|0|||
160799978|NCT00355030|580658158|FG001|Study Period 1 Treatment|Physician Decision|1|||
160799979|NCT00355030|580658157|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
160799980|NCT00355030|580658158|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
160799981|NCT00355030|580658157|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
160799982|NCT00355030|580658158|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
160799983|NCT00355030|580658157|FG000|Study Period 1 Treatment|Other|2|||
160799984|NCT00355030|580658158|FG001|Study Period 1 Treatment|Other|6|||
160799985|NCT00355030|580658157|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
160799986|NCT00355030|580658158|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
160799987|NCT00355030|580658157|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
160799988|NCT00355030|580658158|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
160799989|NCT01123148|580658159|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
160799990|NCT01123148|580658159|FG000|Overall Study|Didn't meet milestone criteria|1|||
160799991|NCT01693367|580658160|FG000|Overall Study|Withdrawal by Subject|1|||
160799992|NCT01693367|580658161|FG001|Overall Study|Withdrawal by Subject|1|||
160799993|NCT01693367|580658160|FG000|Overall Study|Physician Decision|0|||
160799994|NCT01693367|580658161|FG001|Overall Study|Physician Decision|1|||
160799995|NCT00690794|580658162|FG000|Overall Study|Adverse Event|12|||
160799996|NCT00690794|580658163|FG001|Overall Study|Adverse Event|10|||
160799997|NCT00690794|580658162|FG000|Overall Study|Lost to Follow-up|1|||
160799998|NCT00690794|580658163|FG001|Overall Study|Lost to Follow-up|4|||
160799999|NCT00690794|580658162|FG000|Overall Study|Withdrawal by Subject|0|||
160800000|NCT00690794|580658163|FG001|Overall Study|Withdrawal by Subject|9|||
160800001|NCT00690794|580658162|FG000|Overall Study|Protocol Violation|6|||
160800002|NCT00690794|580658163|FG001|Overall Study|Protocol Violation|7|||
160800003|NCT00690794|580658162|FG000|Overall Study|Noncompliance|1|||
160800004|NCT00690794|580658163|FG001|Overall Study|Noncompliance|2|||
160800005|NCT00690794|580658162|FG000|Overall Study|Other not specified|1|||
160800006|NCT00690794|580658163|FG001|Overall Study|Other not specified|3|||
160800007|NCT00325143|580658164|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
160800008|NCT00325143|580658164|FG000|Overall Study|Migrated/moved from study area|1|||
160800009|NCT00325143|580658164|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
160800010|NCT00325143|580658164|FG000|Overall Study|Withdrawal by Subject|8|||
160800011|NCT02286895|580658165|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
160800012|NCT02286895|580658166|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
160800013|NCT02286895|580658165|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
160800014|NCT02286895|580658166|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
160800015|NCT02286895|580658165|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
160800016|NCT02286895|580658166|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
160800017|NCT00399035|580658168|FG000|Overall Study|Death|289|||
160800018|NCT00399035|580658169|FG001|Overall Study|Death|141|||
160800019|NCT00399035|580658170|FG002|Overall Study|Death|234|||
160800020|NCT00399035|580658168|FG000|Overall Study|Lost to Follow-up|2|||
160800021|NCT00399035|580658169|FG001|Overall Study|Lost to Follow-up|1|||
160896346|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
160896347|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
160896348|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
160896349|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
160896350|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
160896351|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
160896352|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
160896353|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
160800022|NCT00399035|580658170|FG002|Overall Study|Lost to Follow-up|5|||
160800023|NCT00399035|580658168|FG000|Overall Study|Withdrawal by Subject|19|||
160800024|NCT00399035|580658169|FG001|Overall Study|Withdrawal by Subject|15|||
160800025|NCT00399035|580658170|FG002|Overall Study|Withdrawal by Subject|12|||
160800026|NCT00399035|580658168|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
160800027|NCT00399035|580658169|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
160800028|NCT00399035|580658170|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
160800029|NCT00399035|580658168|FG000|Overall Study|Severe non-compliance with protocol|2|||
160800030|NCT00399035|580658169|FG001|Overall Study|Severe non-compliance with protocol|1|||
160800031|NCT00399035|580658170|FG002|Overall Study|Severe non-compliance with protocol|0|||
160800032|NCT02949011|580658173|FG000|Overall Study|Adverse Event|6|||
160800033|NCT02949011|580658174|FG001|Overall Study|Adverse Event|7|||
160800034|NCT02949011|580658175|FG002|Overall Study|Adverse Event|3|||
160800035|NCT02949011|580658173|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160800036|NCT02949011|580658174|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160800037|NCT02949011|580658175|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
160800038|NCT02949011|580658173|FG000|Overall Study|Protocol Deviation|5|||
160800039|NCT02949011|580658174|FG001|Overall Study|Protocol Deviation|3|||
160800040|NCT02949011|580658175|FG002|Overall Study|Protocol Deviation|3|||
161237283|NCT00819741|582248534|FG000|Overall Study|Protocol Violation|3|||
160800041|NCT02949011|580658173|FG000|Overall Study|Lack of Efficacy|0|||
160800042|NCT02949011|580658174|FG001|Overall Study|Lack of Efficacy|2|||
160800043|NCT02949011|580658175|FG002|Overall Study|Lack of Efficacy|0|||
160896354|NCT00313300|581016887|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
160896355|NCT00313300|581016888|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896356|NCT00313300|581016889|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896357|NCT00313300|581016890|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896358|NCT00313300|581016891|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
160896359|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
160896360|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
160896361|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
160896362|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
160896363|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
160896364|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896365|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
160896366|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896367|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896368|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
160896369|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
160896370|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
160896371|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
160896372|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
160896373|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
160896374|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
160896375|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896376|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896377|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896378|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
160896379|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
160896380|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
160896381|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
160896382|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
160896383|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
160896384|NCT00313300|581016887|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
160896385|NCT00313300|581016888|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
160896386|NCT00313300|581016889|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
160896387|NCT00313300|581016890|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
160896388|NCT00313300|581016891|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
160896389|NCT00428792|581016892|FG000|Overall Study|Lack of Efficacy|1|||
160896390|NCT00428792|581016893|FG001|Overall Study|Lack of Efficacy|3|||
160896391|NCT00428792|581016892|FG000|Overall Study|Lost to Follow-up|0|||
160896392|NCT00428792|581016893|FG001|Overall Study|Lost to Follow-up|1|||
160896393|NCT02468232|581016896|FG000|Core Part of Study|Adverse Event|0|||
160896394|NCT02468232|581016897|FG001|Core Part of Study|Adverse Event|1|||
160896395|NCT02468232|581016898|FG002|Core Part of Study|Adverse Event|0|||
160896396|NCT02468232|581016899|FG003|Core Part of Study|Adverse Event|0|||
160896397|NCT02468232|581016896|FG000|Core Part of Study|Death|20|||
160896398|NCT02468232|581016897|FG001|Core Part of Study|Death|17|||
160896399|NCT02468232|581016898|FG002|Core Part of Study|Death|0|||
160896400|NCT02468232|581016899|FG003|Core Part of Study|Death|0|||
160896401|NCT02468232|581016896|FG000|Core Part of Study|Technical Problems|1|||
160896402|NCT02468232|581016897|FG001|Core Part of Study|Technical Problems|1|||
160896403|NCT02468232|581016898|FG002|Core Part of Study|Technical Problems|0|||
160800044|NCT02949011|580658173|FG000|Overall Study|Withdrawal by Subject|13|||
160800045|NCT02949011|580658174|FG001|Overall Study|Withdrawal by Subject|13|||
160800046|NCT02949011|580658175|FG002|Overall Study|Withdrawal by Subject|21|||
160800047|NCT02949011|580658173|FG000|Overall Study|Lost to Follow-up|7|||
160800048|NCT02949011|580658174|FG001|Overall Study|Lost to Follow-up|5|||
160984637|NCT02253316|581332337|FG002|Maintenance|Non-Compliance|1|||
160984638|NCT02253316|581332335|FG000|Maintenance|Secondary Malignancy|0|||
160984639|NCT02253316|581332336|FG001|Maintenance|Secondary Malignancy|2|||
160984640|NCT02253316|581332337|FG002|Maintenance|Secondary Malignancy|6|||
160984641|NCT02253316|581332335|FG000|Maintenance|Adverse Event|0|||
160984642|NCT02253316|581332336|FG001|Maintenance|Adverse Event|8|||
160984643|NCT02253316|581332337|FG002|Maintenance|Adverse Event|12|||
160984644|NCT02253316|581332335|FG000|Maintenance|Still receiving active treatment|0|||
160984645|NCT02253316|581332336|FG001|Maintenance|Still receiving active treatment|4|||
160984646|NCT02253316|581332337|FG002|Maintenance|Still receiving active treatment|0|||
160984647|NCT02684903|581332338|FG000|Overall Study|COVID-19 shutdown of lab|4|||
160984648|NCT02684903|581332339|FG001|Overall Study|COVID-19 shutdown of lab|6|||
160984649|NCT02684903|581332338|FG000|Overall Study|Lost to Follow-up|31|||
160984650|NCT02684903|581332339|FG001|Overall Study|Lost to Follow-up|41|||
160984651|NCT06403605|581332344|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
160984652|NCT06403605|581332345|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
160984653|NCT06403605|581332344|FG000|Follow-up|Adverse Event|4|||
160984654|NCT06403605|581332345|FG001|Follow-up|Adverse Event|2|||
160984655|NCT06403605|581332344|FG000|Follow-up|Withdrawal by Subject|2|||
160984656|NCT06403605|581332345|FG001|Follow-up|Withdrawal by Subject|3|||
160984657|NCT06403605|581332344|FG000|Follow-up|Lost to Follow-up|1|||
160984658|NCT06403605|581332345|FG001|Follow-up|Lost to Follow-up|0|||
160984659|NCT06403605|581332344|FG000|Follow-up|Death|1|||
160984660|NCT06403605|581332345|FG001|Follow-up|Death|0|||
160984661|NCT06403605|581332344|FG000|Follow-up|Other reasons|0|||
160984662|NCT06403605|581332345|FG001|Follow-up|Other reasons|4|||
160984663|NCT07083843|581332346|FG000|Intervention period.|Withdrawal by Subject|1|||
160984664|NCT07083843|581332347|FG001|Intervention period.|Withdrawal by Subject|0|||
160984665|NCT07083843|581332346|FG000|Intervention period.|Death|0|||
160984666|NCT07083843|581332347|FG001|Intervention period.|Death|1|||
160984667|NCT04213846|581333736|FG000|Overall Study|Withdrawal by Subject|7|||
160984668|NCT04213846|581333737|FG001|Overall Study|Withdrawal by Subject|6|||
160984669|NCT04213846|581333736|FG000|Overall Study|Lost to Follow-up|15|||
160984670|NCT04213846|581333737|FG001|Overall Study|Lost to Follow-up|21|||
160984671|NCT04096365|581333745|FG000|Overall Study|Adverse Event|1|||
160984672|NCT01939158|581333750|FG000|Overall Study|Adverse Event|1|||
160984673|NCT01939158|581333751|FG001|Overall Study|Adverse Event|0|||
160984674|NCT01939158|581333752|FG002|Overall Study|Adverse Event|0|||
160984675|NCT01939158|581333753|FG003|Overall Study|Adverse Event|0|||
160984676|NCT01939158|581333750|FG000|Overall Study|Withdrawal by Subject|22|||
160984677|NCT01939158|581333751|FG001|Overall Study|Withdrawal by Subject|25|||
160984678|NCT01939158|581333752|FG002|Overall Study|Withdrawal by Subject|15|||
160984679|NCT01939158|581333753|FG003|Overall Study|Withdrawal by Subject|17|||
160984680|NCT01939158|581333750|FG000|Overall Study|Migrated/moved from study area|5|||
160984681|NCT01939158|581333751|FG001|Overall Study|Migrated/moved from study area|7|||
160984682|NCT01939158|581333752|FG002|Overall Study|Migrated/moved from study area|3|||
160984683|NCT01939158|581333753|FG003|Overall Study|Migrated/moved from study area|6|||
160984684|NCT01939158|581333750|FG000|Overall Study|Lost to Follow-up|18|||
160984685|NCT01939158|581333751|FG001|Overall Study|Lost to Follow-up|17|||
160984686|NCT01939158|581333752|FG002|Overall Study|Lost to Follow-up|17|||
160984687|NCT01939158|581333753|FG003|Overall Study|Lost to Follow-up|17|||
160984688|NCT01939158|581333750|FG000|Overall Study|Death|0|||
160984689|NCT01939158|581333751|FG001|Overall Study|Death|0|||
160984690|NCT01939158|581333752|FG002|Overall Study|Death|1|||
160984691|NCT01939158|581333753|FG003|Overall Study|Death|1|||
160984692|NCT01939158|581333750|FG000|Overall Study|No longer meets eligibility criteria|0|||
160984693|NCT01939158|581333751|FG001|Overall Study|No longer meets eligibility criteria|0|||
160800049|NCT02949011|580658175|FG002|Overall Study|Lost to Follow-up|5|||
160800050|NCT02949011|580658173|FG000|Overall Study|Death|0|||
160800051|NCT02949011|580658174|FG001|Overall Study|Death|0|||
160800052|NCT02949011|580658175|FG002|Overall Study|Death|1|||
160800053|NCT02949011|580658173|FG000|Overall Study|Miscellaneous|2|||
160800054|NCT02949011|580658174|FG001|Overall Study|Miscellaneous|4|||
160800055|NCT02949011|580658175|FG002|Overall Study|Miscellaneous|6|||
160800056|NCT00163189|580658176|FG000|Overall Study|Other|6|||
160984694|NCT01939158|581333752|FG002|Overall Study|No longer meets eligibility criteria|1|||
161331860|NCT00808067|582601511|FG001|Overall Study|Reduced creatinine clearance|55|||
160800057|NCT00163189|580658176|FG000|Overall Study|Lost to Follow-up|1|||
160800058|NCT00163189|580658176|FG000|Overall Study|Protocol Violation|2|||
160984695|NCT01939158|581333753|FG003|Overall Study|No longer meets eligibility criteria|0|||
160984696|NCT01939158|581333750|FG000|Overall Study|Other|1|||
160984697|NCT01939158|581333751|FG001|Overall Study|Other|3|||
160984698|NCT01939158|581333752|FG002|Overall Study|Other|4|||
160984699|NCT01939158|581333753|FG003|Overall Study|Other|3|||
160984700|NCT05310084|581333754|FG000|Overall Study|Withdrawal by Subject|2|||
160984701|NCT05310084|581333755|FG001|Overall Study|Withdrawal by Subject|3|||
160984702|NCT05310084|581333754|FG000|Overall Study|Participant availability|0|||
160984703|NCT05310084|581333755|FG001|Overall Study|Participant availability|4|||
160984704|NCT05310084|581333754|FG000|Overall Study|Lost to Follow-up|1|||
160800059|NCT00163189|580658176|FG000|Overall Study|Death|3|||
160800060|NCT00163189|580658176|FG000|Overall Study|Adverse Event|6|||
160800061|NCT00163189|580658176|FG000|Overall Study|Lack of Efficacy|7|||
160800062|NCT00163189|580658176|FG000|Overall Study|Study terminated by sponsor|11|||
160800063|NCT00163189|580658176|FG000|Overall Study|Withdrawal by Subject|11|||
160800064|NCT00163189|580658176|FG000|Overall Study|Did not meet continuation criterion|16|||
160800065|NCT00454116|580658177|FG000|Overall Study|Adverse Event|5|||
160800066|NCT00454116|580658178|FG001|Overall Study|Adverse Event|11|||
160800067|NCT00454116|580658179|FG002|Overall Study|Adverse Event|9|||
160800068|NCT00454116|580658177|FG000|Overall Study|Condition under investigation worsened|17|||
160896404|NCT02468232|581016899|FG003|Core Part of Study|Technical Problems|0|||
160896405|NCT02468232|581016896|FG000|OLE Part of Study|Adverse Event|0|||
160896406|NCT02468232|581016897|FG001|OLE Part of Study|Adverse Event|0|||
160896407|NCT02468232|581016898|FG002|OLE Part of Study|Adverse Event|4|||
160896408|NCT02468232|581016899|FG003|OLE Part of Study|Adverse Event|5|||
160896409|NCT02468232|581016896|FG000|OLE Part of Study|Death|0|||
160896410|NCT02468232|581016897|FG001|OLE Part of Study|Death|0|||
160896411|NCT02468232|581016898|FG002|OLE Part of Study|Death|4|||
160896412|NCT02468232|581016899|FG003|OLE Part of Study|Death|2|||
160896413|NCT02468232|581016896|FG000|OLE Part of Study|Physician Decision|0|||
160896414|NCT02468232|581016897|FG001|OLE Part of Study|Physician Decision|0|||
160896415|NCT02468232|581016898|FG002|OLE Part of Study|Physician Decision|4|||
160896416|NCT02468232|581016899|FG003|OLE Part of Study|Physician Decision|0|||
160896417|NCT02468232|581016896|FG000|OLE Part of Study|Subject/Guardian decision|0|||
160896418|NCT02468232|581016897|FG001|OLE Part of Study|Subject/Guardian decision|0|||
160896419|NCT02468232|581016898|FG002|OLE Part of Study|Subject/Guardian decision|2|||
160896420|NCT02468232|581016899|FG003|OLE Part of Study|Subject/Guardian decision|5|||
160896421|NCT04540497|581016902|FG000|Overall Study|Adverse Event|0|||
160896422|NCT04540497|581016903|FG001|Overall Study|Adverse Event|2|||
160896423|NCT04540497|581016902|FG000|Overall Study|Lost to Follow-up|1|||
160896424|NCT04540497|581016903|FG001|Overall Study|Lost to Follow-up|0|||
160896425|NCT04540497|581016902|FG000|Overall Study|Withdrawal by Subject|1|||
160896426|NCT04540497|581016903|FG001|Overall Study|Withdrawal by Subject|1|||
160896427|NCT04540497|581016902|FG000|Overall Study|Miscellaneous|2|||
160896428|NCT04540497|581016903|FG001|Overall Study|Miscellaneous|1|||
160896429|NCT03914326|581016904|FG000|Overall Study|Withdrawal by Subject|27|||
160896430|NCT03914326|581016905|FG001|Overall Study|Withdrawal by Subject|34|||
160896431|NCT03914326|581016904|FG000|Overall Study|Lost to Follow-up|43|||
160896432|NCT03914326|581016905|FG001|Overall Study|Lost to Follow-up|51|||
160896433|NCT03914326|581016904|FG000|Overall Study|Randomised more than once|0|||
160896434|NCT03914326|581016905|FG001|Overall Study|Randomised more than once|1|||
160896435|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Death|1|||
160896436|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Death|1|||
160896437|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Death|0|||
160896438|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Death|0|||
160896439|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
160896440|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
160896441|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
160896442|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
160896443|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
160896444|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
160896445|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
160896446|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
160896447|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
160896448|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
160896449|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
160896450|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
160896451|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
160896452|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
160896453|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
160896454|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
160896455|NCT04612790|581016906|FG000|DB Period (Up to 36 Weeks)|Other|1|||
160896456|NCT04612790|581016907|FG001|DB Period (Up to 36 Weeks)|Other|0|||
160800069|NCT00454116|580658178|FG001|Overall Study|Condition under investigation worsened|13|||
160896457|NCT04612790|581016908|FG002|DB Period (Up to 36 Weeks)|Other|0|||
160896458|NCT04612790|581016909|FG003|DB Period (Up to 36 Weeks)|Other|0|||
160800070|NCT00454116|580658179|FG002|Overall Study|Condition under investigation worsened|18|||
160896459|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
160896460|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
160984705|NCT05310084|581333755|FG001|Overall Study|Lost to Follow-up|1|||
160800071|NCT00454116|580658177|FG000|Overall Study|Withdrawal by Subject|3|||
160896461|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
160896462|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
160896463|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
160984706|NCT05310084|581333754|FG000|Overall Study|Adverse Event|1|||
160984707|NCT05310084|581333755|FG001|Overall Study|Adverse Event|1|||
161129801|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
160800072|NCT00454116|580658178|FG001|Overall Study|Withdrawal by Subject|3|||
160800073|NCT00454116|580658179|FG002|Overall Study|Withdrawal by Subject|1|||
160800074|NCT00454116|580658177|FG000|Overall Study|Other|2|||
160800075|NCT00454116|580658178|FG001|Overall Study|Other|2|||
160800076|NCT00454116|580658179|FG002|Overall Study|Other|0|||
160800077|NCT03500211|580658182|FG000|Overall Study|Withdrawal by Subject|1|||
160800078|NCT03500211|580658183|FG001|Overall Study|Withdrawal by Subject|1|||
160800079|NCT02431325|580658184|FG000|Overall Study|Adverse Event|3|||
160800080|NCT02431325|580658185|FG001|Overall Study|Adverse Event|0|||
160800081|NCT02431325|580658184|FG000|Overall Study|Lost to Follow-up|0|||
160800082|NCT02431325|580658185|FG001|Overall Study|Lost to Follow-up|1|||
160800083|NCT02431325|580658184|FG000|Overall Study|Withdrawal by Subject|1|||
160800084|NCT02431325|580658185|FG001|Overall Study|Withdrawal by Subject|2|||
160800085|NCT02431325|580658184|FG000|Overall Study|Declined to take study medication|1|||
160800086|NCT02431325|580658185|FG001|Overall Study|Declined to take study medication|0|||
160800087|NCT02431325|580658184|FG000|Overall Study|Withdrew before starting study medication|1|||
160800088|NCT02431325|580658185|FG001|Overall Study|Withdrew before starting study medication|0|||
160800089|NCT02431325|580658184|FG000|Overall Study|Placebo shortage|2|||
160800090|NCT02431325|580658185|FG001|Overall Study|Placebo shortage|0|||
160800091|NCT01917318|580658186|FG000|First Treatment|Withdrawal by Subject|0|||
160800092|NCT01917318|580658187|FG001|First Treatment|Withdrawal by Subject|1|||
160800093|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Physician Decision|2|||
160800094|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Physician Decision|0|||
160800095|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Physician Decision|0|||
160800096|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Adverse Event|33|||
160800097|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Adverse Event|0|||
160800098|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Adverse Event|0|||
160800099|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
160800100|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
160896464|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
160896465|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
160896466|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
160896467|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
160896468|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
160896469|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
160896470|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
160896471|NCT04612790|581016906|FG000|OLE Period (Up to 1 Year)|Other|0|||
160896472|NCT04612790|581016907|FG001|OLE Period (Up to 1 Year)|Other|0|||
160896473|NCT04612790|581016908|FG002|OLE Period (Up to 1 Year)|Other|0|||
160896474|NCT04612790|581016909|FG003|OLE Period (Up to 1 Year)|Other|1|||
160896475|NCT03323502|581016913|FG000|Overall Study|Resident could not be linked to CMS data|594|||
160896476|NCT03323502|581016914|FG001|Overall Study|Resident could not be linked to CMS data|435|||
160896477|NCT03323502|581016913|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
160896478|NCT03323502|581016914|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
160896479|NCT03323502|581016913|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
160896480|NCT03323502|581016914|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
160896481|NCT03323502|581016913|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
160896482|NCT03323502|581016914|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
160896483|NCT03323502|581016913|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
160896484|NCT03323502|581016914|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
160896485|NCT00902668|581016922|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
160896486|NCT01914757|581016923|FG000|Overall Study|Severe non-compliance to protocol|3|||
160896487|NCT01914757|581016924|FG001|Overall Study|Severe non-compliance to protocol|1|||
160896488|NCT01914757|581016925|FG002|Overall Study|Severe non-compliance to protocol|2|||
160896489|NCT01914757|581016923|FG000|Overall Study|Lost to Follow-up|5|||
160896490|NCT01914757|581016924|FG001|Overall Study|Lost to Follow-up|8|||
160800101|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
160800102|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
160800103|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
160896491|NCT01914757|581016925|FG002|Overall Study|Lost to Follow-up|6|||
160896492|NCT01914757|581016923|FG000|Overall Study|Withdrawal by Subject|15|||
161129802|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161129803|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161237284|NCT00819741|582248535|FG001|Overall Study|Protocol Violation|4|||
160800104|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
160800105|NCT01008618|580658188|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
160800106|NCT01008618|580658189|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
160800107|NCT01008618|580658190|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
160800108|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
160800109|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
160800110|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
160800111|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
160800112|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
160800113|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
160800114|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
160800115|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
160800116|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
160800117|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
160800118|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
160800119|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
160800120|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
160800121|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
160800122|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
160800123|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
160800124|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
160800125|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
160800126|NCT01008618|580658188|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
160800127|NCT01008618|580658189|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
160800128|NCT01008618|580658190|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
160800129|NCT00487981|580658191|FG000|Overall Study|Hypothyroidism diagnosis|1|||
160800130|NCT01213082|580658197|FG000|Overall Study|Lost to Follow-up|6|||
160800131|NCT01213082|580658198|FG001|Overall Study|Lost to Follow-up|7|||
160800132|NCT01213082|580658199|FG002|Overall Study|Lost to Follow-up|4|||
160800133|NCT01213082|580658197|FG000|Overall Study|Physician Decision|0|||
160800134|NCT01213082|580658198|FG001|Overall Study|Physician Decision|0|||
160800135|NCT01213082|580658199|FG002|Overall Study|Physician Decision|1|||
160800136|NCT00698828|580658205|FG000|Overall Study|Adverse Event|3|||
160800137|NCT00698828|580658206|FG001|Overall Study|Adverse Event|4|||
160800138|NCT00698828|580658207|FG002|Overall Study|Adverse Event|4|||
160800139|NCT00698828|580658205|FG000|Overall Study|Death|0|||
160800140|NCT00698828|580658206|FG001|Overall Study|Death|0|||
160800141|NCT00698828|580658207|FG002|Overall Study|Death|1|||
160800142|NCT00698828|580658205|FG000|Overall Study|Exacerbation of COPD|1|||
160800143|NCT00698828|580658206|FG001|Overall Study|Exacerbation of COPD|3|||
160800144|NCT00698828|580658207|FG002|Overall Study|Exacerbation of COPD|0|||
160800145|NCT00698828|580658205|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
160800146|NCT00698828|580658206|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
160800147|NCT00698828|580658207|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
160800148|NCT00698828|580658205|FG000|Overall Study|Investigator/Sponsor decision|1|||
160800149|NCT00698828|580658206|FG001|Overall Study|Investigator/Sponsor decision|0|||
160800150|NCT00698828|580658207|FG002|Overall Study|Investigator/Sponsor decision|2|||
160800151|NCT00698828|580658205|FG000|Overall Study|Lost to Follow-up|1|||
160800152|NCT00698828|580658206|FG001|Overall Study|Lost to Follow-up|1|||
160800153|NCT00698828|580658207|FG002|Overall Study|Lost to Follow-up|0|||
160800154|NCT00698828|580658205|FG000|Overall Study|Withdrew consent|0|||
160800155|NCT00698828|580658206|FG001|Overall Study|Withdrew consent|7|||
160800156|NCT00698828|580658207|FG002|Overall Study|Withdrew consent|4|||
160800157|NCT00698828|580658205|FG000|Overall Study|Withdrew consent (not treated)|2|||
160800158|NCT00698828|580658206|FG001|Overall Study|Withdrew consent (not treated)|0|||
160800159|NCT00698828|580658207|FG002|Overall Study|Withdrew consent (not treated)|0|||
160800160|NCT02013609|580658210|FG000|Overall Study|Withdrawal by Subject|9|||
160800161|NCT02013609|580658210|FG000|Overall Study|Lost to Follow-up|3|||
160800162|NCT02013609|580658210|FG000|Overall Study|Adverse Event|3|||
160800163|NCT02013609|580658210|FG000|Overall Study|Met Withdrawal Criteria|3|||
160800164|NCT01816295|580658211|FG000|Double Blind Phase|Adverse Event|11|||
160800165|NCT01816295|580658212|FG001|Double Blind Phase|Adverse Event|8|||
160800166|NCT01816295|580658211|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
160800167|NCT01816295|580658212|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
160800168|NCT01816295|580658211|FG000|Double Blind Phase|Lost to Follow-up|3|||
160800169|NCT01816295|580658212|FG001|Double Blind Phase|Lost to Follow-up|5|||
160800170|NCT01816295|580658211|FG000|Double Blind Phase|Physician Decision|2|||
160800171|NCT01816295|580658212|FG001|Double Blind Phase|Physician Decision|2|||
160800172|NCT01816295|580658211|FG000|Double Blind Phase|Protocol Violation|17|||
160896493|NCT01914757|581016924|FG001|Overall Study|Withdrawal by Subject|27|||
160896494|NCT01914757|581016925|FG002|Overall Study|Withdrawal by Subject|19|||
160896495|NCT01914757|581016923|FG000|Overall Study|Death|2|||
160896496|NCT01914757|581016924|FG001|Overall Study|Death|2|||
160896497|NCT01914757|581016925|FG002|Overall Study|Death|1|||
160896498|NCT01914757|581016923|FG000|Overall Study|Adverse Event|4|||
160896499|NCT01914757|581016924|FG001|Overall Study|Adverse Event|3|||
160896500|NCT01914757|581016925|FG002|Overall Study|Adverse Event|4|||
160800173|NCT01816295|580658212|FG001|Double Blind Phase|Protocol Violation|11|||
160800174|NCT01816295|580658211|FG000|Double Blind Phase|Sponsor Decision|8|||
160800175|NCT01816295|580658212|FG001|Double Blind Phase|Sponsor Decision|8|||
160800176|NCT01816295|580658211|FG000|Double Blind Phase|Withdrawal by Subject|22|||
160800177|NCT01816295|580658212|FG001|Double Blind Phase|Withdrawal by Subject|20|||
160800178|NCT01816295|580658211|FG000|OLE Phase|Adverse Event|17|||
160984708|NCT05310084|581333754|FG000|Overall Study|Randomized but not vaccinated|4|||
160984709|NCT05310084|581333755|FG001|Overall Study|Randomized but not vaccinated|2|||
160984710|NCT02065245|581333757|FG000|Infusion 1|Lost to Follow-up|0|||
160984711|NCT02065245|581333758|FG001|Infusion 1|Lost to Follow-up|0|||
160984712|NCT02065245|581333759|FG002|Infusion 1|Lost to Follow-up|0|||
160984713|NCT02065245|581333760|FG003|Infusion 1|Lost to Follow-up|0|||
160800179|NCT01816295|580658212|FG001|OLE Phase|Adverse Event|15|||
160800180|NCT01816295|580658211|FG000|OLE Phase|Death|1|||
160800181|NCT01816295|580658212|FG001|OLE Phase|Death|0|||
160800182|NCT01816295|580658211|FG000|OLE Phase|Entry Criteria Not Met|3|||
160800183|NCT01816295|580658212|FG001|OLE Phase|Entry Criteria Not Met|5|||
160800184|NCT01816295|580658211|FG000|OLE Phase|Lost to Follow-up|5|||
160800185|NCT01816295|580658212|FG001|OLE Phase|Lost to Follow-up|5|||
160800186|NCT01816295|580658211|FG000|OLE Phase|Physician Decision|3|||
160800187|NCT01816295|580658212|FG001|OLE Phase|Physician Decision|1|||
160800188|NCT01816295|580658211|FG000|OLE Phase|Protocol Violation|4|||
160800189|NCT01816295|580658212|FG001|OLE Phase|Protocol Violation|4|||
160800190|NCT01816295|580658211|FG000|OLE Phase|Sponsor Decision|7|||
160800191|NCT01816295|580658212|FG001|OLE Phase|Sponsor Decision|9|||
160800192|NCT01816295|580658211|FG000|OLE Phase|Withdrawal by Subject|10|||
160896501|NCT01914757|581016923|FG000|Overall Study|Study specific withdrawal criteria|0|||
160896502|NCT01914757|581016924|FG001|Overall Study|Study specific withdrawal criteria|1|||
160896503|NCT01914757|581016925|FG002|Overall Study|Study specific withdrawal criteria|0|||
160896504|NCT01914757|581016923|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160896505|NCT01914757|581016924|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160896506|NCT01914757|581016925|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
160896507|NCT01914757|581016923|FG000|Overall Study|Other reasons|5|||
160896508|NCT01914757|581016924|FG001|Overall Study|Other reasons|9|||
160896509|NCT01914757|581016925|FG002|Overall Study|Other reasons|4|||
160896510|NCT00408629|581016928|FG000|Overall Study|Adverse Event|13|||
160896511|NCT00408629|581016929|FG001|Overall Study|Adverse Event|27|||
160896512|NCT00408629|581016928|FG000|Overall Study|Withdrawal by Subject|8|||
160896513|NCT00408629|581016929|FG001|Overall Study|Withdrawal by Subject|4|||
160896514|NCT00408629|581016928|FG000|Overall Study|Lost to Follow-up|1|||
160896515|NCT00408629|581016929|FG001|Overall Study|Lost to Follow-up|1|||
160896516|NCT00408629|581016928|FG000|Overall Study|Lack of Efficacy|63|||
160896517|NCT00408629|581016929|FG001|Overall Study|Lack of Efficacy|73|||
160896518|NCT00408629|581016928|FG000|Overall Study|Protocol Violation|1|||
160896519|NCT00408629|581016929|FG001|Overall Study|Protocol Violation|5|||
160896520|NCT00408629|581016928|FG000|Overall Study|Miscellaneous|11|||
160896521|NCT00408629|581016929|FG001|Overall Study|Miscellaneous|15|||
160896522|NCT01461980|581016930|FG000|Overall Study|Other|9|||
160896523|NCT01461980|581016931|FG001|Overall Study|Other|8|||
160896524|NCT01461980|581016932|FG002|Overall Study|Other|6|||
160896525|NCT01461980|581016930|FG000|Overall Study|Medication error|7|||
160896526|NCT01461980|581016931|FG001|Overall Study|Medication error|5|||
160896527|NCT01461980|581016932|FG002|Overall Study|Medication error|6|||
160896528|NCT01461980|581016930|FG000|Overall Study|Adverse Event|12|||
160896529|NCT01461980|581016931|FG001|Overall Study|Adverse Event|5|||
160896530|NCT01461980|581016932|FG002|Overall Study|Adverse Event|6|||
160896531|NCT01461980|581016930|FG000|Overall Study|Protocol Violation|12|||
160896532|NCT01461980|581016931|FG001|Overall Study|Protocol Violation|19|||
160896533|NCT01461980|581016932|FG002|Overall Study|Protocol Violation|16|||
160896534|NCT01461980|581016930|FG000|Overall Study|No longer meets eligibility criteria|18|||
160896535|NCT01461980|581016931|FG001|Overall Study|No longer meets eligibility criteria|9|||
160896536|NCT01461980|581016932|FG002|Overall Study|No longer meets eligibility criteria|19|||
160984714|NCT02065245|581333761|FG004|Infusion 1|Lost to Follow-up|0|||
160896537|NCT01461980|581016930|FG000|Overall Study|Lost to Follow-up|52|||
161331861|NCT00808067|582601510|FG000|Overall Study|Elevated LFT results|7|||
160896538|NCT01461980|581016931|FG001|Overall Study|Lost to Follow-up|53|||
160896539|NCT01461980|581016932|FG002|Overall Study|Lost to Follow-up|51|||
160896540|NCT01461980|581016930|FG000|Overall Study|No longer willing to participate|52|||
160896541|NCT01461980|581016931|FG001|Overall Study|No longer willing to participate|38|||
160984715|NCT02065245|581333762|FG005|Infusion 1|Lost to Follow-up|0|||
160800193|NCT01816295|580658212|FG001|OLE Phase|Withdrawal by Subject|10|||
160800194|NCT01816295|580658211|FG000|OLE Phase|Lack of Efficacy|3|||
160800195|NCT01816295|580658212|FG001|OLE Phase|Lack of Efficacy|7|||
160800196|NCT00783432|580658213|FG000|Overall Study|Adverse Event|22|||
160800197|NCT00783432|580658214|FG001|Overall Study|Adverse Event|17|||
160896542|NCT01461980|581016932|FG002|Overall Study|No longer willing to participate|54|||
160896543|NCT01461980|581016930|FG000|Overall Study|Randomized but not vaccinated|4|||
160896544|NCT01461980|581016931|FG001|Overall Study|Randomized but not vaccinated|8|||
160800198|NCT00783432|580658213|FG000|Overall Study|Lack of Efficacy|20|||
160896545|NCT01461980|581016932|FG002|Overall Study|Randomized but not vaccinated|7|||
160896546|NCT00122109|581016933|FG000|Overall Study|Did not meet criteria|6|||
160896547|NCT00122109|581016934|FG001|Overall Study|Did not meet criteria|7|||
160896548|NCT00100178|581016935|FG000|Overall Study|Lost to Follow-up|0|||
160896549|NCT00100178|581016936|FG001|Overall Study|Lost to Follow-up|6|||
160896550|NCT00100178|581016937|FG002|Overall Study|Lost to Follow-up|5|||
160896551|NCT00100178|581016935|FG000|Overall Study|Adverse Event|2|||
160896552|NCT00100178|581016936|FG001|Overall Study|Adverse Event|2|||
160896553|NCT00100178|581016937|FG002|Overall Study|Adverse Event|1|||
160896554|NCT00100178|581016935|FG000|Overall Study|Withdrawal by Subject|1|||
160896555|NCT00100178|581016936|FG001|Overall Study|Withdrawal by Subject|1|||
160896556|NCT00100178|581016937|FG002|Overall Study|Withdrawal by Subject|1|||
160896557|NCT00100178|581016935|FG000|Overall Study|Physician Decision|6|||
160896558|NCT00100178|581016936|FG001|Overall Study|Physician Decision|1|||
160896559|NCT00100178|581016937|FG002|Overall Study|Physician Decision|3|||
160896560|NCT00631696|581016938|FG000|Overall Study|Entered, not randomized to treatment|1|||
160896561|NCT00631696|581016939|FG001|Overall Study|Entered, not randomized to treatment|1|||
160896562|NCT00631696|581016938|FG000|Overall Study|Discontinued after database release date|1|||
160896563|NCT00631696|581016939|FG001|Overall Study|Discontinued after database release date|0|||
160896564|NCT00631696|581016938|FG000|Overall Study|Follow up after database release date|1|||
160896565|NCT00631696|581016939|FG001|Overall Study|Follow up after database release date|0|||
160896566|NCT00631696|581016938|FG000|Overall Study|Lost to Follow-up|7|||
160896567|NCT00631696|581016939|FG001|Overall Study|Lost to Follow-up|10|||
160896568|NCT00631696|581016938|FG000|Overall Study|Withdrawal by Subject|2|||
160800199|NCT00783432|580658214|FG001|Overall Study|Lack of Efficacy|21|||
160800200|NCT00783432|580658213|FG000|Overall Study|Lost to Follow-up|11|||
160800201|NCT00783432|580658214|FG001|Overall Study|Lost to Follow-up|6|||
160800202|NCT00783432|580658213|FG000|Overall Study|Withdrawal by Subject|23|||
160800203|NCT00783432|580658214|FG001|Overall Study|Withdrawal by Subject|20|||
160800204|NCT00783432|580658213|FG000|Overall Study|subject moved|3|||
160800205|NCT00783432|580658214|FG001|Overall Study|subject moved|5|||
160800206|NCT00783432|580658213|FG000|Overall Study|Protocol Violation|6|||
160800207|NCT00783432|580658214|FG001|Overall Study|Protocol Violation|9|||
160800208|NCT01119287|580658215|FG000|Overall Study|Patient Decision, not related to AE|0|||
160800209|NCT01119287|580658216|FG001|Overall Study|Patient Decision, not related to AE|0|||
160800210|NCT01119287|580658217|FG002|Overall Study|Patient Decision, not related to AE|2|||
160800211|NCT01119287|580658218|FG003|Overall Study|Patient Decision, not related to AE|2|||
160800212|NCT01119287|580658219|FG004|Overall Study|Patient Decision, not related to AE|1|||
160800213|NCT01119287|580658220|FG005|Overall Study|Patient Decision, not related to AE|0|||
160800214|NCT01331681|580658225|FG000|Overall Study|Adverse Event|10|||
160800215|NCT01331681|580658226|FG001|Overall Study|Adverse Event|13|||
160800216|NCT01331681|580658227|FG002|Overall Study|Adverse Event|10|||
160800217|NCT01331681|580658225|FG000|Overall Study|Death|6|||
160800218|NCT01331681|580658226|FG001|Overall Study|Death|6|||
160800219|NCT01331681|580658227|FG002|Overall Study|Death|2|||
160800220|NCT01331681|580658225|FG000|Overall Study|Lack of Efficacy|0|||
160800221|NCT01331681|580658226|FG001|Overall Study|Lack of Efficacy|1|||
160800222|NCT01331681|580658227|FG002|Overall Study|Lack of Efficacy|0|||
160800223|NCT01331681|580658225|FG000|Overall Study|Withdrawal by Subject|12|||
160800224|NCT01331681|580658226|FG001|Overall Study|Withdrawal by Subject|8|||
160800225|NCT01331681|580658227|FG002|Overall Study|Withdrawal by Subject|15|||
160800226|NCT01331681|580658225|FG000|Overall Study|Protocol Violation|1|||
160800227|NCT01331681|580658226|FG001|Overall Study|Protocol Violation|1|||
160800228|NCT01331681|580658227|FG002|Overall Study|Protocol Violation|0|||
160800229|NCT01331681|580658225|FG000|Overall Study|Lost to Follow-up|2|||
160800230|NCT01331681|580658226|FG001|Overall Study|Lost to Follow-up|4|||
160800231|NCT01331681|580658227|FG002|Overall Study|Lost to Follow-up|1|||
160800232|NCT01331681|580658225|FG000|Overall Study|Physician Decision|2|||
160800233|NCT01331681|580658226|FG001|Overall Study|Physician Decision|0|||
160800234|NCT01331681|580658227|FG002|Overall Study|Physician Decision|4|||
160896569|NCT00631696|581016939|FG001|Overall Study|Withdrawal by Subject|9|||
160800235|NCT01331681|580658225|FG000|Overall Study|Therapeutic procedure required|1|||
160800236|NCT01331681|580658226|FG001|Overall Study|Therapeutic procedure required|0|||
160800237|NCT01331681|580658227|FG002|Overall Study|Therapeutic procedure required|0|||
160800238|NCT01331681|580658225|FG000|Overall Study|Sponsor decision|1|||
160800239|NCT01331681|580658226|FG001|Overall Study|Sponsor decision|1|||
160896570|NCT00631696|581016938|FG000|Overall Study|Other|8|||
160896571|NCT00631696|581016939|FG001|Overall Study|Other|8|||
160896572|NCT00631696|581016938|FG000|Overall Study|Protocol Violation|9|||
160896573|NCT00631696|581016939|FG001|Overall Study|Protocol Violation|9|||
160800240|NCT01331681|580658227|FG002|Overall Study|Sponsor decision|0|||
160800241|NCT01331681|580658225|FG000|Overall Study|Switching to other therapy|0|||
160800242|NCT01331681|580658226|FG001|Overall Study|Switching to other therapy|0|||
160800243|NCT01331681|580658227|FG002|Overall Study|Switching to other therapy|1|||
160800244|NCT01331681|580658225|FG000|Overall Study|Not Received Study Treatment|0|||
160800245|NCT01331681|580658226|FG001|Overall Study|Not Received Study Treatment|0|||
160800246|NCT01331681|580658227|FG002|Overall Study|Not Received Study Treatment|2|||
160800247|NCT01534481|580658228|FG000|Overall Study|Lost to Follow-up|29|||
160800248|NCT01534481|580658229|FG001|Overall Study|Lost to Follow-up|24|||
160800249|NCT01534481|580658228|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
160800250|NCT01534481|580658229|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
160896574|NCT00631696|581016938|FG000|Overall Study|Study terminated by sponsor|3|||
160896575|NCT00631696|581016939|FG001|Overall Study|Study terminated by sponsor|3|||
160896576|NCT00631696|581016938|FG000|Overall Study|Adverse Event|5|||
160800251|NCT00107276|580658230|FG000|Overall Study|Progression|46|||
160800252|NCT00107276|580658230|FG000|Overall Study|Adverse Event|6|||
160800253|NCT00107276|580658230|FG000|Overall Study|M.D. decision|2|||
160800254|NCT00107276|580658230|FG000|Overall Study|Patient refusal|1|||
160800255|NCT00107276|580658230|FG000|Overall Study|Death|1|||
160800256|NCT00107276|580658230|FG000|Overall Study|Ineligible|16|||
160800257|NCT03498716|580658240|FG000|Overall Study|Withdrawal by Subject|88|||
160800258|NCT03498716|580658241|FG001|Overall Study|Withdrawal by Subject|73|||
160800259|NCT03498716|580658240|FG000|Overall Study|Study Terminated By Sponsor|933|||
160800260|NCT03498716|580658241|FG001|Overall Study|Study Terminated By Sponsor|927|||
160800261|NCT03498716|580658240|FG000|Overall Study|Lost to Follow-up|15|||
160800262|NCT03498716|580658241|FG001|Overall Study|Lost to Follow-up|26|||
160800263|NCT03498716|580658240|FG000|Overall Study|Disease Relapse|0|||
160800264|NCT03498716|580658241|FG001|Overall Study|Disease Relapse|1|||
160800265|NCT03498716|580658240|FG000|Overall Study|Death|58|||
160800266|NCT03498716|580658241|FG001|Overall Study|Death|72|||
160800267|NCT03498716|580658240|FG000|Overall Study|Physician Decision|4|||
160800268|NCT03498716|580658241|FG001|Overall Study|Physician Decision|2|||
160800269|NCT02284191|580658242|FG000|Overall Study|Withdrawal by Subject|1|||
160800270|NCT02284191|580658243|FG001|Overall Study|Withdrawal by Subject|3|||
160800271|NCT02284191|580658242|FG000|Overall Study|Lost to Follow-up|1|||
160800272|NCT02284191|580658243|FG001|Overall Study|Lost to Follow-up|0|||
160800273|NCT04064905|580658244|FG000|Overall Study|Lost to Follow-up|0|||
160800274|NCT04064905|580658245|FG001|Overall Study|Lost to Follow-up|3|||
160800275|NCT04064905|580658246|FG002|Overall Study|Lost to Follow-up|1|||
160800276|NCT04064905|580658247|FG003|Overall Study|Lost to Follow-up|4|||
160800277|NCT04064905|580658248|FG004|Overall Study|Lost to Follow-up|2|||
160800278|NCT02257684|580658251|FG000|Overall Study|Adverse Event|2|||
160800279|NCT02257684|580658251|FG000|Overall Study|Lack of Efficacy|1|||
160800280|NCT02257684|580658251|FG000|Overall Study|Sponsor's Decision|1|||
160800281|NCT01987557|580658252|FG000|Overall Study|Protocol Violation|1|||
160800282|NCT01987557|580658253|FG001|Overall Study|Protocol Violation|0|||
160800283|NCT01987557|580658254|FG002|Overall Study|Protocol Violation|1|||
160800284|NCT01987557|580658252|FG000|Overall Study|Withdrawal by Subject|2|||
160800285|NCT01987557|580658253|FG001|Overall Study|Withdrawal by Subject|1|||
160800286|NCT01987557|580658254|FG002|Overall Study|Withdrawal by Subject|2|||
160800287|NCT01987557|580658252|FG000|Overall Study|Adverse Event|0|||
160800288|NCT01987557|580658253|FG001|Overall Study|Adverse Event|2|||
160800289|NCT01987557|580658254|FG002|Overall Study|Adverse Event|0|||
160800290|NCT00760552|580658255|FG000|Overall Study|Death|2|||
160800291|NCT00760552|580658256|FG001|Overall Study|Death|0|||
160800292|NCT00760552|580658255|FG000|Overall Study|Lost to Follow-up|11|||
160800293|NCT00760552|580658256|FG001|Overall Study|Lost to Follow-up|10|||
160800294|NCT01832727|580658260|FG000|Overall Study|Adverse Event|4|||
160800295|NCT01832727|580658261|FG001|Overall Study|Adverse Event|6|||
160800296|NCT01832727|580658262|FG002|Overall Study|Adverse Event|1|||
160800297|NCT01832727|580658263|FG003|Overall Study|Adverse Event|0|||
160800298|NCT01832727|580658264|FG004|Overall Study|Adverse Event|1|||
160800299|NCT01832727|580658265|FG005|Overall Study|Adverse Event|1|||
160800300|NCT01832727|580658266|FG006|Overall Study|Adverse Event|2|||
160800301|NCT01832727|580658267|FG007|Overall Study|Adverse Event|1|||
160800302|NCT01832727|580658268|FG008|Overall Study|Adverse Event|9|||
160800303|NCT01832727|580658260|FG000|Overall Study|Disease progression|3|||
160800304|NCT01832727|580658261|FG001|Overall Study|Disease progression|0|||
160800305|NCT01832727|580658262|FG002|Overall Study|Disease progression|2|||
160800306|NCT01832727|580658263|FG003|Overall Study|Disease progression|1|||
160800307|NCT01832727|580658264|FG004|Overall Study|Disease progression|3|||
160800308|NCT01832727|580658265|FG005|Overall Study|Disease progression|3|||
160800309|NCT01832727|580658266|FG006|Overall Study|Disease progression|6|||
160800310|NCT01832727|580658267|FG007|Overall Study|Disease progression|2|||
160800311|NCT01832727|580658268|FG008|Overall Study|Disease progression|7|||
160800312|NCT01832727|580658260|FG000|Overall Study|Lost to Follow-up|0|||
160800313|NCT01832727|580658261|FG001|Overall Study|Lost to Follow-up|0|||
160800314|NCT01832727|580658262|FG002|Overall Study|Lost to Follow-up|0|||
160800315|NCT01832727|580658263|FG003|Overall Study|Lost to Follow-up|1|||
160800316|NCT01832727|580658264|FG004|Overall Study|Lost to Follow-up|0|||
160800317|NCT01832727|580658265|FG005|Overall Study|Lost to Follow-up|0|||
160800318|NCT01832727|580658266|FG006|Overall Study|Lost to Follow-up|0|||
160800319|NCT01832727|580658267|FG007|Overall Study|Lost to Follow-up|0|||
160800320|NCT01832727|580658268|FG008|Overall Study|Lost to Follow-up|0|||
160896577|NCT00631696|581016939|FG001|Overall Study|Adverse Event|0|||
160800321|NCT01832727|580658260|FG000|Overall Study|Physician Decision|1|||
160896578|NCT01439568|581016941|FG000|Overall Study|Lost to Follow-up|1|||
160896579|NCT01439568|581016942|FG001|Overall Study|Lost to Follow-up|0|||
160896580|NCT01439568|581016941|FG000|Overall Study|Withdrawal by Subject|2|||
160896581|NCT01439568|581016942|FG001|Overall Study|Withdrawal by Subject|2|||
160896582|NCT03198078|581016943|FG000|Overall Study|Adverse Event|0|||
160896583|NCT03198078|581016944|FG001|Overall Study|Adverse Event|1|||
160896584|NCT03198078|581016945|FG002|Overall Study|Adverse Event|2|||
160896585|NCT03198078|581016943|FG000|Overall Study|Lack of Efficacy|0|||
160896586|NCT03198078|581016944|FG001|Overall Study|Lack of Efficacy|0|||
160896587|NCT03198078|581016945|FG002|Overall Study|Lack of Efficacy|3|||
160896588|NCT03198078|581016943|FG000|Overall Study|Lost to Follow-up|1|||
160896589|NCT03198078|581016944|FG001|Overall Study|Lost to Follow-up|0|||
160896590|NCT03198078|581016945|FG002|Overall Study|Lost to Follow-up|0|||
160896591|NCT03198078|581016943|FG000|Overall Study|Pregnancy|0|||
160896592|NCT03198078|581016944|FG001|Overall Study|Pregnancy|1|||
160896593|NCT03198078|581016945|FG002|Overall Study|Pregnancy|0|||
160896594|NCT03198078|581016943|FG000|Overall Study|Withdrawal by Subject|1|||
160896595|NCT03198078|581016944|FG001|Overall Study|Withdrawal by Subject|0|||
160896596|NCT03198078|581016945|FG002|Overall Study|Withdrawal by Subject|2|||
160896597|NCT03198078|581016943|FG000|Overall Study|Withdrawal by Caregiver|1|||
160896598|NCT03198078|581016944|FG001|Overall Study|Withdrawal by Caregiver|3|||
160896599|NCT03198078|581016945|FG002|Overall Study|Withdrawal by Caregiver|5|||
160896600|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
160896601|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
160896602|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
160896603|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
160896604|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
160896605|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
160896606|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
160896607|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
160896608|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
160896609|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
160896610|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
160896611|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
160896612|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
160896613|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
160896614|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
160896615|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
160896616|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
160896617|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
160896618|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
160896619|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
160896620|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
160896621|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
160896622|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
160896623|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
160896624|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Death|2|||
160896625|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Death|1|||
160896626|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Death|0|||
160896627|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Death|0|||
160896628|NCT02607930|581016946|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
160896629|NCT02607930|581016947|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
160896630|NCT02607930|581016948|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
160896631|NCT02607930|581016949|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
160896632|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160896633|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160896634|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
160896635|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
160896636|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
160896637|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
160896638|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
160896639|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
160896640|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
160896641|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
160896642|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
160896643|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
160896644|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
160896645|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
160984716|NCT02065245|581333763|FG006|Infusion 1|Lost to Follow-up|1|||
160984717|NCT02065245|581333757|FG000|Infusion 1|Death|0|||
161331862|NCT00808067|582601511|FG001|Overall Study|Elevated LFT results|3|||
160984718|NCT02065245|581333758|FG001|Infusion 1|Death|0|||
160984719|NCT02065245|581333759|FG002|Infusion 1|Death|1|||
160984720|NCT02065245|581333760|FG003|Infusion 1|Death|0|||
160984721|NCT02065245|581333761|FG004|Infusion 1|Death|1|||
160984722|NCT02065245|581333762|FG005|Infusion 1|Death|0|||
160984723|NCT02065245|581333763|FG006|Infusion 1|Death|0|||
160984724|NCT02065245|581333757|FG000|Infusion 2|Death|0|||
160984725|NCT02065245|581333758|FG001|Infusion 2|Death|0|||
160984726|NCT02065245|581333759|FG002|Infusion 2|Death|0|||
160984727|NCT02065245|581333760|FG003|Infusion 2|Death|0|||
160984728|NCT02065245|581333761|FG004|Infusion 2|Death|0|||
160984729|NCT02065245|581333762|FG005|Infusion 2|Death|0|||
160984730|NCT02065245|581333763|FG006|Infusion 2|Death|1|||
160984731|NCT02065245|581333757|FG000|Infusion 3|Lost to Follow-up|1|||
160984732|NCT02065245|581333758|FG001|Infusion 3|Lost to Follow-up|1|||
160984733|NCT02065245|581333759|FG002|Infusion 3|Lost to Follow-up|0|||
160984734|NCT02065245|581333760|FG003|Infusion 3|Lost to Follow-up|0|||
160984735|NCT02065245|581333761|FG004|Infusion 3|Lost to Follow-up|0|||
160984736|NCT02065245|581333762|FG005|Infusion 3|Lost to Follow-up|0|||
160984737|NCT02065245|581333763|FG006|Infusion 3|Lost to Follow-up|0|||
160984738|NCT00924664|581333764|FG000|Overall Study|Adverse Event|23|||
160984739|NCT00924664|581333765|FG001|Overall Study|Adverse Event|39|||
160984740|NCT00924664|581333764|FG000|Overall Study|Lack of Efficacy|10|||
160984741|NCT00924664|581333765|FG001|Overall Study|Lack of Efficacy|15|||
160984742|NCT00924664|581333764|FG000|Overall Study|Lost to Follow-up|10|||
160984743|NCT00924664|581333765|FG001|Overall Study|Lost to Follow-up|12|||
160984744|NCT00924664|581333764|FG000|Overall Study|Withdrawal by Subject|47|||
160984745|NCT00924664|581333765|FG001|Overall Study|Withdrawal by Subject|71|||
160984746|NCT00924664|581333764|FG000|Overall Study|Protocol Violation|2|||
160984747|NCT00924664|581333765|FG001|Overall Study|Protocol Violation|5|||
160984748|NCT00924664|581333764|FG000|Overall Study|Pregnancy|1|||
160984749|NCT00924664|581333765|FG001|Overall Study|Pregnancy|1|||
160984750|NCT00924664|581333764|FG000|Overall Study|Death|0|||
160984751|NCT00924664|581333765|FG001|Overall Study|Death|2|||
160984752|NCT00924664|581333764|FG000|Overall Study|Study terminated by sponsor|199|||
160984753|NCT00924664|581333765|FG001|Overall Study|Study terminated by sponsor|330|||
160984754|NCT00924664|581333764|FG000|Overall Study|Other|29|||
160984755|NCT00924664|581333765|FG001|Overall Study|Other|52|||
160984756|NCT00924664|581333764|FG000|Overall Study|Randomized but not Treated|1|||
160984757|NCT00924664|581333765|FG001|Overall Study|Randomized but not Treated|0|||
160984758|NCT01598987|581333766|FG000|Baseline to Month 12|Administrative problems|2|||
160984759|NCT01598987|581333766|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
160984760|NCT01598987|581333766|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
160984761|NCT01598987|581333766|FG000|Baseline to 24 Month|Administrative problems|2|||
160984762|NCT01598987|581333766|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
160984763|NCT03531905|581333767|FG000|Overall Study|Withdrawal by Subject|3|||
160984764|NCT03531905|581333768|FG001|Overall Study|Withdrawal by Subject|3|||
160984765|NCT03531905|581333769|FG002|Overall Study|Withdrawal by Subject|2|||
160984766|NCT03531905|581333767|FG000|Overall Study|Lost to Follow-up|2|||
160984767|NCT03531905|581333768|FG001|Overall Study|Lost to Follow-up|2|||
160984768|NCT03531905|581333769|FG002|Overall Study|Lost to Follow-up|1|||
160984769|NCT03531905|581333767|FG000|Overall Study|Participant was out of town|1|||
160984770|NCT03531905|581333768|FG001|Overall Study|Participant was out of town|0|||
160984771|NCT03531905|581333769|FG002|Overall Study|Participant was out of town|0|||
160984772|NCT03531905|581333767|FG000|Overall Study|Could not speak with the participant|1|||
160984773|NCT03531905|581333768|FG001|Overall Study|Could not speak with the participant|0|||
160984774|NCT03531905|581333769|FG002|Overall Study|Could not speak with the participant|0|||
160984775|NCT01616563|581333770|FG000|Overall Study|Lost to Follow-up|40|||
160984776|NCT01333943|581333776|FG000|Overall Study|Known neuropathy|1|||
160984777|NCT01333943|581333777|FG001|Overall Study|Known neuropathy|0|||
160984778|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Death|0|||
160984779|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Death|2|||
160984780|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
160984781|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
160984782|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
161129804|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
161129805|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161331863|NCT00808067|582601510|FG000|Overall Study|Patient refused to take study medication|65|||
160984783|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
160984784|NCT02459587|581333784|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
160984785|NCT02459587|581333785|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
160984786|NCT02459587|581333784|FG000|6-month Follow-up Assessment|Death|2|||
160984787|NCT02459587|581333785|FG001|6-month Follow-up Assessment|Death|1|||
160984788|NCT02459587|581333784|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
160984789|NCT02459587|581333785|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
160984790|NCT02459587|581333784|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
160984791|NCT02459587|581333785|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
160984792|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Death|2|||
160896646|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
160896647|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
160896648|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
160896649|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
160896650|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
160896651|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
160896652|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
160896653|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
160896654|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
160896655|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
160896656|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
160896657|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
160896658|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
160896659|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
160896660|NCT02607930|581016946|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
160896661|NCT02607930|581016947|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
160896662|NCT02607930|581016948|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
160896663|NCT02607930|581016949|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
160896664|NCT01676727|581016952|FG000|Overall Study|Death|18|||
160896665|NCT01676727|581016952|FG000|Overall Study|Withdrawal by Subject|6|||
160896666|NCT01676727|581016952|FG000|Overall Study|Screening failure|5|||
160896667|NCT01676727|581016952|FG000|Overall Study|Not willing to attend 1-year visit|2|||
160896668|NCT01676727|581016952|FG000|Overall Study|Valve explanted|1|||
160896669|NCT01578330|581016953|FG000|Overall Study|Adverse Event|2|||
160896670|NCT01578330|581016953|FG000|Overall Study|Protocol Violation|5|||
160896671|NCT01134731|581016954|FG000|Overall Study|Adverse Event|3|||
160896672|NCT01134731|581016955|FG001|Overall Study|Adverse Event|2|||
160896673|NCT01134731|581016956|FG002|Overall Study|Adverse Event|1|||
160896674|NCT01134731|581016954|FG000|Overall Study|Physician Decision|2|||
160896675|NCT01134731|581016955|FG001|Overall Study|Physician Decision|2|||
160896676|NCT01134731|581016956|FG002|Overall Study|Physician Decision|2|||
160896677|NCT01134731|581016954|FG000|Overall Study|Lack of Efficacy|0|||
160896678|NCT01134731|581016955|FG001|Overall Study|Lack of Efficacy|0|||
160896679|NCT01134731|581016956|FG002|Overall Study|Lack of Efficacy|1|||
160896680|NCT01134731|581016954|FG000|Overall Study|Withdrawal by Subject|3|||
160896681|NCT01134731|581016955|FG001|Overall Study|Withdrawal by Subject|3|||
160896682|NCT01134731|581016956|FG002|Overall Study|Withdrawal by Subject|1|||
160896683|NCT01134731|581016954|FG000|Overall Study|Lost to Follow-up|5|||
160896684|NCT01134731|581016955|FG001|Overall Study|Lost to Follow-up|4|||
160896685|NCT01134731|581016956|FG002|Overall Study|Lost to Follow-up|3|||
160896686|NCT01050543|581016957|FG000|Overall Study|Withdrawal by Subject|0|||
160896687|NCT01050543|581016958|FG001|Overall Study|Withdrawal by Subject|2|||
160896688|NCT01050543|581016957|FG000|Overall Study|Protocol Violation|0|||
160896689|NCT01050543|581016958|FG001|Overall Study|Protocol Violation|1|||
160896690|NCT01050543|581016957|FG000|Overall Study|Administrative|4|||
160896691|NCT01050543|581016958|FG001|Overall Study|Administrative|1|||
160896692|NCT02517866|581016962|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160896693|NCT02517866|581016963|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160896694|NCT02517866|581016964|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160896695|NCT02517866|581016962|FG000|Overall Study|Significant Protocol Deviation|4|||
160896696|NCT02517866|581016963|FG001|Overall Study|Significant Protocol Deviation|1|||
160896697|NCT02517866|581016964|FG002|Overall Study|Significant Protocol Deviation|0|||
160896698|NCT02517866|581016962|FG000|Overall Study|Lost to Follow-up|1|||
160896699|NCT02517866|581016963|FG001|Overall Study|Lost to Follow-up|0|||
160896700|NCT02517866|581016964|FG002|Overall Study|Lost to Follow-up|0|||
160896701|NCT02517866|581016962|FG000|Overall Study|Voluntary Withdrawal|2|||
160896702|NCT02517866|581016963|FG001|Overall Study|Voluntary Withdrawal|2|||
160896703|NCT02517866|581016964|FG002|Overall Study|Voluntary Withdrawal|0|||
160896704|NCT02517866|581016962|FG000|Overall Study|Investigator Decision|2|||
160896705|NCT02517866|581016963|FG001|Overall Study|Investigator Decision|1|||
160896706|NCT02517866|581016964|FG002|Overall Study|Investigator Decision|0|||
160896707|NCT02517866|581016962|FG000|Overall Study|Reason not specified|2|||
160896708|NCT02517866|581016963|FG001|Overall Study|Reason not specified|0|||
160896709|NCT02517866|581016964|FG002|Overall Study|Reason not specified|0|||
160896710|NCT01646073|581016965|FG000|Period A (12 Weeks)|Adverse Event|0|||
160896711|NCT01646073|581016966|FG001|Period A (12 Weeks)|Adverse Event|2|||
160896712|NCT01646073|581016965|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
160896713|NCT01646073|581016966|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
160896714|NCT01646073|581016965|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
160896715|NCT01646073|581016966|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
160896716|NCT01646073|581016965|FG000|Period A (12 Weeks)|Protocol Violation|0|||
160896717|NCT01646073|581016966|FG001|Period A (12 Weeks)|Protocol Violation|1|||
160896718|NCT01646073|581016965|FG000|Period A (12 Weeks)|Other|0|||
160896719|NCT01646073|581016966|FG001|Period A (12 Weeks)|Other|1|||
160984793|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Death|0|||
160984794|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
160984795|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
160984796|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
160800322|NCT01832727|580658261|FG001|Overall Study|Physician Decision|0|||
160800323|NCT01832727|580658262|FG002|Overall Study|Physician Decision|0|||
160800324|NCT01832727|580658263|FG003|Overall Study|Physician Decision|1|||
160800325|NCT01832727|580658264|FG004|Overall Study|Physician Decision|0|||
160800326|NCT01832727|580658265|FG005|Overall Study|Physician Decision|1|||
160800327|NCT01832727|580658266|FG006|Overall Study|Physician Decision|0|||
160984797|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
160984798|NCT02459587|581333784|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
160800328|NCT01832727|580658267|FG007|Overall Study|Physician Decision|0|||
160800329|NCT01832727|580658268|FG008|Overall Study|Physician Decision|0|||
160800330|NCT01832727|580658260|FG000|Overall Study|Withdrawal by Subject|1|||
160800331|NCT01832727|580658261|FG001|Overall Study|Withdrawal by Subject|1|||
160800332|NCT01832727|580658262|FG002|Overall Study|Withdrawal by Subject|0|||
160800333|NCT01832727|580658263|FG003|Overall Study|Withdrawal by Subject|1|||
160800334|NCT01832727|580658264|FG004|Overall Study|Withdrawal by Subject|0|||
160984799|NCT02459587|581333785|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
160984800|NCT02028884|581333788|FG000|Double-blind Period|Adverse Event|5|||
160984801|NCT02028884|581333789|FG001|Double-blind Period|Adverse Event|3|||
160984802|NCT02028884|581333790|FG002|Double-blind Period|Adverse Event|0|||
160984803|NCT02028884|581333788|FG000|Double-blind Period|Eligibility Violation|1|||
160984804|NCT02028884|581333789|FG001|Double-blind Period|Eligibility Violation|0|||
160984805|NCT02028884|581333790|FG002|Double-blind Period|Eligibility Violation|0|||
160984806|NCT02028884|581333788|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
160984807|NCT02028884|581333789|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
160984808|NCT02028884|581333790|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
160984809|NCT02028884|581333788|FG000|Double-blind Period|Withdrawal by Subject|2|||
160984810|NCT02028884|581333789|FG001|Double-blind Period|Withdrawal by Subject|0|||
160984811|NCT02028884|581333790|FG002|Double-blind Period|Withdrawal by Subject|0|||
160984812|NCT02028884|581333788|FG000|Open-label Extension Period|Adverse Event|3|||
161129806|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
161129807|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
160800335|NCT01832727|580658265|FG005|Overall Study|Withdrawal by Subject|1|||
160800336|NCT01832727|580658266|FG006|Overall Study|Withdrawal by Subject|0|||
160800337|NCT01832727|580658267|FG007|Overall Study|Withdrawal by Subject|2|||
160800338|NCT01832727|580658268|FG008|Overall Study|Withdrawal by Subject|1|||
160800339|NCT01832727|580658260|FG000|Overall Study|Study terminated by sponsor|0|||
160800340|NCT01832727|580658261|FG001|Overall Study|Study terminated by sponsor|0|||
160800341|NCT01832727|580658262|FG002|Overall Study|Study terminated by sponsor|0|||
160800342|NCT01832727|580658263|FG003|Overall Study|Study terminated by sponsor|0|||
160896720|NCT01646073|581016965|FG000|Period B (12 Weeks)|Adverse Event|0|||
160896721|NCT01646073|581016966|FG001|Period B (12 Weeks)|Adverse Event|7|||
160896722|NCT01646073|581016965|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
160896723|NCT01646073|581016966|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
160896724|NCT01646073|581016965|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
160896725|NCT01646073|581016966|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
160896726|NCT00679055|581016967|FG000|Overall Study|Adverse Event|0|||
160896727|NCT00679055|581016968|FG001|Overall Study|Adverse Event|1|||
160896728|NCT00679055|581016967|FG000|Overall Study|Other|0|||
160896729|NCT00679055|581016968|FG001|Overall Study|Other|3|||
160896730|NCT00679055|581016967|FG000|Overall Study|Study Terminated|2|||
160896731|NCT00679055|581016968|FG001|Overall Study|Study Terminated|1|||
160896732|NCT00629772|581016969|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
160896733|NCT00629772|581016970|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
160896734|NCT00629772|581016969|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
160896735|NCT00629772|581016970|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
160896736|NCT01393301|581016973|FG000|Overall Study|Lost to Follow-up|5|||
160896737|NCT01393301|581016974|FG001|Overall Study|Lost to Follow-up|3|||
160896738|NCT01393301|581016973|FG000|Overall Study|Withdrawal by Subject|2|||
160896739|NCT01393301|581016974|FG001|Overall Study|Withdrawal by Subject|0|||
160896740|NCT01393301|581016973|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
160896741|NCT01393301|581016974|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
160896742|NCT03342963|581016977|FG000|Overall Study|Adverse Event|1|||
160896743|NCT03342963|581016978|FG001|Overall Study|Adverse Event|2|||
160896744|NCT03342963|581016979|FG002|Overall Study|Adverse Event|0|||
160896745|NCT03342963|581016980|FG003|Overall Study|Adverse Event|0|||
160896746|NCT03342963|581016977|FG000|Overall Study|Withdrawal by Subject|1|||
160896747|NCT03342963|581016978|FG001|Overall Study|Withdrawal by Subject|0|||
160896748|NCT03342963|581016979|FG002|Overall Study|Withdrawal by Subject|0|||
160896749|NCT03342963|581016980|FG003|Overall Study|Withdrawal by Subject|0|||
160896750|NCT01309165|581016981|FG000|Overall Study|Lost to Follow-up|4|||
160800343|NCT01832727|580658264|FG004|Overall Study|Study terminated by sponsor|0|||
160800344|NCT01832727|580658265|FG005|Overall Study|Study terminated by sponsor|0|||
160800345|NCT01832727|580658266|FG006|Overall Study|Study terminated by sponsor|0|||
160800346|NCT01832727|580658267|FG007|Overall Study|Study terminated by sponsor|1|||
160800347|NCT01832727|580658268|FG008|Overall Study|Study terminated by sponsor|1|||
160800348|NCT02170064|580658269|FG000|Overall Study|Withdrawal by Subject|5|||
160800349|NCT02170064|580658270|FG001|Overall Study|Withdrawal by Subject|1|||
160800350|NCT02170064|580658271|FG002|Overall Study|Withdrawal by Subject|1|||
160800351|NCT02170064|580658269|FG000|Overall Study|Physician Decision|1|||
160800352|NCT02170064|580658270|FG001|Overall Study|Physician Decision|1|||
160800353|NCT02170064|580658271|FG002|Overall Study|Physician Decision|0|||
160800354|NCT04211363|580658272|FG000|Overall Study|Adverse Event|5|||
160800355|NCT04211363|580658273|FG001|Overall Study|Adverse Event|2|||
160800356|NCT04211363|580658272|FG000|Overall Study|Physician Decision|0|||
160800357|NCT04211363|580658273|FG001|Overall Study|Physician Decision|1|||
160800358|NCT04211363|580658272|FG000|Overall Study|Protocol Violation|1|||
160800359|NCT04211363|580658273|FG001|Overall Study|Protocol Violation|0|||
160800360|NCT04211363|580658272|FG000|Overall Study|Pregnancy|1|||
160800361|NCT04211363|580658273|FG001|Overall Study|Pregnancy|0|||
160800362|NCT04211363|580658272|FG000|Overall Study|Lost to Follow-up|12|||
160800363|NCT04211363|580658273|FG001|Overall Study|Lost to Follow-up|4|||
160800364|NCT04211363|580658272|FG000|Overall Study|Withdrawal by Subject|11|||
160800365|NCT04211363|580658273|FG001|Overall Study|Withdrawal by Subject|11|||
160800366|NCT04211363|580658272|FG000|Overall Study|Other|1|||
160800367|NCT04211363|580658273|FG001|Overall Study|Other|2|||
160800368|NCT00461708|580658274|FG000|Overall Study|Adverse Event|17|||
160800369|NCT00461708|580658275|FG001|Overall Study|Adverse Event|7|||
160800370|NCT00461708|580658274|FG000|Overall Study|Lack of Efficacy|68|||
160800371|NCT00461708|580658275|FG001|Overall Study|Lack of Efficacy|20|||
160800372|NCT00461708|580658274|FG000|Overall Study|Physician Decision|10|||
160800373|NCT00461708|580658275|FG001|Overall Study|Physician Decision|4|||
160800374|NCT00461708|580658274|FG000|Overall Study|Withdrawal by Subject|8|||
160800375|NCT00461708|580658275|FG001|Overall Study|Withdrawal by Subject|2|||
160800376|NCT00461708|580658274|FG000|Overall Study|Other|4|||
160800377|NCT00461708|580658275|FG001|Overall Study|Other|4|||
160800378|NCT00461708|580658274|FG000|Overall Study|Death|8|||
160800379|NCT00461708|580658275|FG001|Overall Study|Death|1|||
160800380|NCT01812057|580658276|FG000|Overall Study|Protocol Violation|1|||
160800381|NCT01812057|580658277|FG001|Overall Study|Protocol Violation|0|||
160800382|NCT01812057|580658276|FG000|Overall Study|Physician Decision|1|||
160800383|NCT01812057|580658277|FG001|Overall Study|Physician Decision|0|||
160984813|NCT02028884|581333789|FG001|Open-label Extension Period|Adverse Event|1|||
160984814|NCT02028884|581333790|FG002|Open-label Extension Period|Adverse Event|0|||
160800384|NCT01736917|580658278|FG000|Overall Study|Adverse Event|1|||
160800385|NCT01736917|580658278|FG000|Overall Study|Protocol Violation|10|||
160800386|NCT02961244|580658281|FG000|Overall Study|Protocol Violation|0|||
160800387|NCT02961244|580658282|FG001|Overall Study|Protocol Violation|1|||
160800388|NCT02961244|580658281|FG000|Overall Study|Withdrawal by Subject|1|||
160800389|NCT02961244|580658282|FG001|Overall Study|Withdrawal by Subject|2|||
160800390|NCT02961244|580658281|FG000|Overall Study|Surgery plan change after study approval|0|||
160800391|NCT02961244|580658282|FG001|Overall Study|Surgery plan change after study approval|2|||
160800392|NCT02961244|580658281|FG000|Overall Study|Lost to Follow-up|0|||
160800393|NCT02961244|580658282|FG001|Overall Study|Lost to Follow-up|2|||
160800394|NCT02961244|580658281|FG000|Overall Study|İnadequate data|0|||
160800395|NCT02961244|580658282|FG001|Overall Study|İnadequate data|2|||
160800396|NCT01368614|580658283|FG000|Screening Period|Screen Failure|58|||
160800397|NCT01368614|580658284|FG001|Screening Period|Screen Failure|0|||
160800398|NCT01368614|580658285|FG002|Screening Period|Screen Failure|0|||
160800399|NCT01368614|580658286|FG003|Screening Period|Screen Failure|0|||
160800400|NCT01368614|580658283|FG000|Study Period|Withdrawal by Subject|0|||
160800401|NCT01368614|580658284|FG001|Study Period|Withdrawal by Subject|1|||
160800402|NCT01368614|580658285|FG002|Study Period|Withdrawal by Subject|1|||
160800403|NCT01368614|580658286|FG003|Study Period|Withdrawal by Subject|3|||
160800404|NCT01368614|580658283|FG000|Study Period|Lost to Follow-up|0|||
160800405|NCT01368614|580658284|FG001|Study Period|Lost to Follow-up|0|||
160800406|NCT01368614|580658285|FG002|Study Period|Lost to Follow-up|1|||
160800407|NCT01368614|580658286|FG003|Study Period|Lost to Follow-up|0|||
160800408|NCT00659425|580658295|FG000|Overall Study|Disease progression|1|||
160800409|NCT00659425|580658296|FG001|Overall Study|Disease progression|0|||
160800410|NCT00659425|580658297|FG002|Overall Study|Disease progression|0|||
160800411|NCT00659425|580658298|FG003|Overall Study|Disease progression|1|||
160800412|NCT00659425|580658299|FG004|Overall Study|Disease progression|0|||
161129808|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
160800413|NCT00659425|580658300|FG005|Overall Study|Disease progression|2|||
160800414|NCT00659425|580658301|FG006|Overall Study|Disease progression|4|||
160800415|NCT00659425|580658302|FG007|Overall Study|Disease progression|3|||
160800416|NCT00659425|580658303|FG008|Overall Study|Disease progression|5|||
160800417|NCT00659425|580658304|FG009|Overall Study|Disease progression|3|||
160800418|NCT00659425|580658295|FG000|Overall Study|Death|0|||
160984815|NCT02028884|581333788|FG000|Open-label Extension Period|Lack of Efficacy|3|||
160984816|NCT02028884|581333789|FG001|Open-label Extension Period|Lack of Efficacy|0|||
160984817|NCT02028884|581333790|FG002|Open-label Extension Period|Lack of Efficacy|0|||
160984818|NCT02028884|581333788|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
160984819|NCT02028884|581333789|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
160984820|NCT02028884|581333790|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
160984821|NCT02028884|581333788|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
160984822|NCT02028884|581333789|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
160984823|NCT02028884|581333790|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
160984824|NCT02028884|581333788|FG000|Open-label Extension Period|Switched to another treatment option|3|||
160984825|NCT02028884|581333789|FG001|Open-label Extension Period|Switched to another treatment option|0|||
160984826|NCT02028884|581333790|FG002|Open-label Extension Period|Switched to another treatment option|0|||
160984827|NCT02297503|581333793|FG000|Overall Study|Withdrawal by Subject|1|||
160984828|NCT02297503|581333794|FG001|Overall Study|Withdrawal by Subject|1|||
160984829|NCT02297503|581333793|FG000|Overall Study|Protocol Violation|1|||
160984830|NCT02297503|581333794|FG001|Overall Study|Protocol Violation|0|||
160800419|NCT00659425|580658296|FG001|Overall Study|Death|0|||
160800420|NCT00659425|580658297|FG002|Overall Study|Death|0|||
160800421|NCT00659425|580658298|FG003|Overall Study|Death|1|||
160800422|NCT00659425|580658299|FG004|Overall Study|Death|0|||
160800423|NCT00659425|580658300|FG005|Overall Study|Death|0|||
160800424|NCT00659425|580658301|FG006|Overall Study|Death|1|||
160800425|NCT00659425|580658302|FG007|Overall Study|Death|0|||
160800426|NCT00659425|580658303|FG008|Overall Study|Death|0|||
160800427|NCT00659425|580658304|FG009|Overall Study|Death|0|||
160800428|NCT00659425|580658295|FG000|Overall Study|Adverse Event|0|||
160800429|NCT00659425|580658296|FG001|Overall Study|Adverse Event|0|||
160800430|NCT00659425|580658297|FG002|Overall Study|Adverse Event|0|||
160800431|NCT00659425|580658298|FG003|Overall Study|Adverse Event|0|||
160800432|NCT00659425|580658299|FG004|Overall Study|Adverse Event|0|||
160800433|NCT00659425|580658300|FG005|Overall Study|Adverse Event|1|||
160800434|NCT00659425|580658301|FG006|Overall Study|Adverse Event|0|||
160800435|NCT00659425|580658302|FG007|Overall Study|Adverse Event|3|||
160800436|NCT00659425|580658303|FG008|Overall Study|Adverse Event|1|||
160800437|NCT00659425|580658304|FG009|Overall Study|Adverse Event|4|||
160800438|NCT00659425|580658295|FG000|Overall Study|Investigator Discretion|0|||
160800439|NCT00659425|580658296|FG001|Overall Study|Investigator Discretion|0|||
160800440|NCT00659425|580658297|FG002|Overall Study|Investigator Discretion|0|||
160800441|NCT00659425|580658298|FG003|Overall Study|Investigator Discretion|0|||
160800442|NCT00659425|580658299|FG004|Overall Study|Investigator Discretion|0|||
160800443|NCT00659425|580658300|FG005|Overall Study|Investigator Discretion|1|||
160800444|NCT00659425|580658301|FG006|Overall Study|Investigator Discretion|0|||
160800445|NCT00659425|580658302|FG007|Overall Study|Investigator Discretion|3|||
160800446|NCT00659425|580658303|FG008|Overall Study|Investigator Discretion|0|||
160800447|NCT00659425|580658304|FG009|Overall Study|Investigator Discretion|0|||
160800448|NCT00659425|580658295|FG000|Overall Study|Other|0|||
160800449|NCT00659425|580658296|FG001|Overall Study|Other|1|||
160800450|NCT00659425|580658297|FG002|Overall Study|Other|1|||
160984831|NCT02297503|581333793|FG000|Overall Study|Pregnancy|0|||
160984832|NCT02297503|581333794|FG001|Overall Study|Pregnancy|1|||
160984833|NCT02297503|581333793|FG000|Overall Study|Lost to Follow-up|0|||
160984834|NCT02297503|581333794|FG001|Overall Study|Lost to Follow-up|1|||
160800451|NCT00659425|580658298|FG003|Overall Study|Other|2|||
160800452|NCT00659425|580658299|FG004|Overall Study|Other|4|||
160800453|NCT00659425|580658300|FG005|Overall Study|Other|0|||
160800454|NCT00659425|580658301|FG006|Overall Study|Other|3|||
160800455|NCT00659425|580658302|FG007|Overall Study|Other|2|||
160800456|NCT00659425|580658303|FG008|Overall Study|Other|0|||
160800457|NCT00659425|580658304|FG009|Overall Study|Other|6|||
160800458|NCT00636181|580658308|FG000|Overall Study|Withdrawal by Subject|8|||
160800459|NCT00636181|580658309|FG001|Overall Study|Withdrawal by Subject|6|||
160800460|NCT00636181|580658310|FG002|Overall Study|Withdrawal by Subject|10|||
160984835|NCT02297503|581333793|FG000|Overall Study|Medical reason|0|||
160984836|NCT02297503|581333794|FG001|Overall Study|Medical reason|1|||
160984837|NCT00765362|581333795|FG000|Overall Study|Death|9|||
160800461|NCT02561962|580658312|FG000|Overall Study|Withdrawal by Subject|1|||
160800462|NCT02561962|580658313|FG001|Overall Study|Withdrawal by Subject|0|||
160800463|NCT02561962|580658314|FG002|Overall Study|Withdrawal by Subject|0|||
160800464|NCT02561962|580658315|FG003|Overall Study|Withdrawal by Subject|0|||
160984838|NCT00765362|581333795|FG000|Overall Study|Adverse Event|2|||
160800465|NCT02561962|580658316|FG004|Overall Study|Withdrawal by Subject|1|||
160800466|NCT02561962|580658317|FG005|Overall Study|Withdrawal by Subject|1|||
160800467|NCT02561962|580658318|FG006|Overall Study|Withdrawal by Subject|2|||
160800468|NCT02561962|580658319|FG007|Overall Study|Withdrawal by Subject|1|||
160800469|NCT02561962|580658320|FG008|Overall Study|Withdrawal by Subject|0|||
160984839|NCT00765362|581333795|FG000|Overall Study|Protocol Violation|18|||
160800470|NCT02561962|580658312|FG000|Overall Study|Decision by sponsor|0|||
160800471|NCT02561962|580658313|FG001|Overall Study|Decision by sponsor|0|||
160800472|NCT02561962|580658314|FG002|Overall Study|Decision by sponsor|0|||
160800473|NCT02561962|580658315|FG003|Overall Study|Decision by sponsor|0|||
160800474|NCT02561962|580658316|FG004|Overall Study|Decision by sponsor|1|||
160800475|NCT02561962|580658317|FG005|Overall Study|Decision by sponsor|1|||
160800476|NCT02561962|580658318|FG006|Overall Study|Decision by sponsor|0|||
160800477|NCT02561962|580658319|FG007|Overall Study|Decision by sponsor|3|||
160800478|NCT02561962|580658320|FG008|Overall Study|Decision by sponsor|0|||
160800479|NCT02561962|580658312|FG000|Overall Study|Lost to Follow-up|0|||
160800480|NCT02561962|580658313|FG001|Overall Study|Lost to Follow-up|0|||
160800481|NCT02561962|580658314|FG002|Overall Study|Lost to Follow-up|0|||
160800482|NCT02561962|580658315|FG003|Overall Study|Lost to Follow-up|0|||
160800483|NCT02561962|580658316|FG004|Overall Study|Lost to Follow-up|0|||
160800484|NCT02561962|580658317|FG005|Overall Study|Lost to Follow-up|1|||
160800485|NCT02561962|580658318|FG006|Overall Study|Lost to Follow-up|0|||
160800486|NCT02561962|580658319|FG007|Overall Study|Lost to Follow-up|0|||
160800487|NCT02561962|580658320|FG008|Overall Study|Lost to Follow-up|0|||
160800488|NCT03586973|580658321|FG000|Overall Study|Death|15|||
160800489|NCT03586973|580658322|FG001|Overall Study|Death|8|||
160800490|NCT03586973|580658321|FG000|Overall Study|Site Terminated by Sponsor|3|||
160800491|NCT03586973|580658322|FG001|Overall Study|Site Terminated by Sponsor|6|||
160800492|NCT03586973|580658321|FG000|Overall Study|Withdrawal by Subject|1|||
160800493|NCT03586973|580658322|FG001|Overall Study|Withdrawal by Subject|0|||
160800494|NCT03586973|580658321|FG000|Overall Study|Lost to Follow-up|1|||
160800495|NCT03586973|580658322|FG001|Overall Study|Lost to Follow-up|0|||
160800496|NCT00322049|580659911|FG000|Overall Study|Moved out of area|0|||
160800497|NCT00322049|580659912|FG001|Overall Study|Moved out of area|0|||
160800498|NCT00322049|580659913|FG002|Overall Study|Moved out of area|0|||
160800499|NCT00322049|580659914|FG003|Overall Study|Moved out of area|1|||
160800500|NCT00322049|580659911|FG000|Overall Study|Infected with Dengue during study|0|||
160800501|NCT00322049|580659912|FG001|Overall Study|Infected with Dengue during study|1|||
160800502|NCT00322049|580659913|FG002|Overall Study|Infected with Dengue during study|0|||
160800503|NCT00322049|580659914|FG003|Overall Study|Infected with Dengue during study|0|||
160800504|NCT01770743|580659915|FG000|Overall Study|Adverse Event|1|||
160800505|NCT01770743|580659916|FG001|Overall Study|Adverse Event|0|||
160800506|NCT01770743|580659917|FG002|Overall Study|Adverse Event|0|||
160800507|NCT01770743|580659918|FG003|Overall Study|Adverse Event|0|||
160800508|NCT01770743|580659919|FG004|Overall Study|Adverse Event|0|||
160800509|NCT01770743|580659915|FG000|Overall Study|Withdrawal by Subject|0|||
160800510|NCT01770743|580659916|FG001|Overall Study|Withdrawal by Subject|0|||
160800511|NCT01770743|580659917|FG002|Overall Study|Withdrawal by Subject|1|||
160800512|NCT01770743|580659918|FG003|Overall Study|Withdrawal by Subject|1|||
160800513|NCT01770743|580659919|FG004|Overall Study|Withdrawal by Subject|1|||
160800514|NCT01770743|580659915|FG000|Overall Study|Lost to Follow-up|0|||
160800515|NCT01770743|580659916|FG001|Overall Study|Lost to Follow-up|2|||
160800516|NCT01770743|580659917|FG002|Overall Study|Lost to Follow-up|0|||
160800517|NCT01770743|580659918|FG003|Overall Study|Lost to Follow-up|0|||
160800518|NCT01770743|580659919|FG004|Overall Study|Lost to Follow-up|1|||
160800519|NCT01770743|580659915|FG000|Overall Study|Sponsor Terminated Subject|1|||
160800520|NCT01770743|580659916|FG001|Overall Study|Sponsor Terminated Subject|0|||
160800521|NCT01770743|580659917|FG002|Overall Study|Sponsor Terminated Subject|0|||
160800522|NCT01770743|580659918|FG003|Overall Study|Sponsor Terminated Subject|1|||
160800523|NCT01770743|580659919|FG004|Overall Study|Sponsor Terminated Subject|0|||
160800524|NCT01770743|580659915|FG000|Overall Study|Moving Out of State|0|||
160800525|NCT01770743|580659916|FG001|Overall Study|Moving Out of State|1|||
160800526|NCT01770743|580659917|FG002|Overall Study|Moving Out of State|0|||
160800527|NCT01770743|580659918|FG003|Overall Study|Moving Out of State|0|||
160800528|NCT01770743|580659919|FG004|Overall Study|Moving Out of State|0|||
160800529|NCT00755807|580659922|FG000|Acute Phase|Adverse Event|16|||
160800530|NCT00755807|580659923|FG001|Acute Phase|Adverse Event|5|||
160800531|NCT00755807|580659922|FG000|Acute Phase|Protocol Violation|1|||
160800532|NCT00755807|580659923|FG001|Acute Phase|Protocol Violation|3|||
160800533|NCT00755807|580659922|FG000|Acute Phase|Withdrawal by Subject|1|||
160800534|NCT00755807|580659923|FG001|Acute Phase|Withdrawal by Subject|2|||
160800535|NCT00755807|580659922|FG000|Acute Phase|Lack of Efficacy|0|||
160800536|NCT00755807|580659923|FG001|Acute Phase|Lack of Efficacy|1|||
160800537|NCT00755807|580659922|FG000|Acute Phase|Physician Decision|0|||
160800538|NCT00755807|580659923|FG001|Acute Phase|Physician Decision|1|||
160800539|NCT00755807|580659922|FG000|Open-label Extension Phase|Adverse Event|7|||
160800540|NCT00755807|580659923|FG001|Open-label Extension Phase|Adverse Event|7|||
160800541|NCT00755807|580659922|FG000|Open-label Extension Phase|Protocol Violation|5|||
160800542|NCT00755807|580659923|FG001|Open-label Extension Phase|Protocol Violation|2|||
160800543|NCT00755807|580659922|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
160800544|NCT00755807|580659923|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
160896751|NCT01309165|581016982|FG001|Overall Study|Lost to Follow-up|3|||
160896752|NCT01309165|581016981|FG000|Overall Study|Return to work|1|||
160896753|NCT01309165|581016982|FG001|Overall Study|Return to work|2|||
160896754|NCT01309165|581016981|FG000|Overall Study|Left country|0|||
160896755|NCT01309165|581016982|FG001|Overall Study|Left country|1|||
160800545|NCT00755807|580659922|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
160800546|NCT00755807|580659923|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
160800547|NCT00755807|580659922|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
160800548|NCT00755807|580659923|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
160800549|NCT00755807|580659922|FG000|Open-label Extension Phase|Sponsor Decision|0|||
160800550|NCT00755807|580659923|FG001|Open-label Extension Phase|Sponsor Decision|1|||
160800551|NCT00939107|580659926|FG000|Overall Study|Lost to Follow-up|14|||
160800552|NCT00939107|580659927|FG001|Overall Study|Lost to Follow-up|12|||
160800553|NCT01585025|580659934|FG000|Overall Study|Withdrawal by Subject|0|||
160800554|NCT01585025|580659935|FG001|Overall Study|Withdrawal by Subject|3|||
160800555|NCT01585025|580659936|FG002|Overall Study|Withdrawal by Subject|4|||
160800556|NCT00503984|580659937|FG000|Overall Study|Protocol Violation|0|||
160800557|NCT00503984|580659938|FG001|Overall Study|Protocol Violation|1|||
160800558|NCT00503984|580659939|FG002|Overall Study|Protocol Violation|0|||
160800559|NCT00503984|580659940|FG003|Overall Study|Protocol Violation|0|||
160800560|NCT00503984|580659941|FG004|Overall Study|Protocol Violation|0|||
160800561|NCT00503984|580659942|FG005|Overall Study|Protocol Violation|0|||
160800562|NCT00503984|580659937|FG000|Overall Study|Adverse Event|0|||
160800563|NCT00503984|580659938|FG001|Overall Study|Adverse Event|1|||
160800564|NCT00503984|580659939|FG002|Overall Study|Adverse Event|0|||
160800565|NCT00503984|580659940|FG003|Overall Study|Adverse Event|0|||
160800566|NCT00503984|580659941|FG004|Overall Study|Adverse Event|0|||
160800567|NCT00503984|580659942|FG005|Overall Study|Adverse Event|0|||
160800568|NCT00503984|580659937|FG000|Overall Study|Death|0|||
160800569|NCT00503984|580659938|FG001|Overall Study|Death|0|||
160800570|NCT00503984|580659939|FG002|Overall Study|Death|0|||
160800571|NCT00503984|580659940|FG003|Overall Study|Death|0|||
160800572|NCT00503984|580659941|FG004|Overall Study|Death|1|||
160800573|NCT00503984|580659942|FG005|Overall Study|Death|0|||
160800574|NCT02122380|580659945|FG000|First Intervention (30 Days)|Adverse Event|1|||
160800575|NCT02122380|580659946|FG001|First Intervention (30 Days)|Adverse Event|0|||
160800576|NCT02122380|580659945|FG000|First Intervention (30 Days)|Physician Decision|0|||
160984840|NCT00765362|581333795|FG000|Overall Study|Withdrawal by Subject|13|||
160800577|NCT02122380|580659946|FG001|First Intervention (30 Days)|Physician Decision|1|||
160800578|NCT02122380|580659945|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
160800579|NCT02122380|580659946|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
160800580|NCT02122380|580659945|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
160800581|NCT02122380|580659946|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
160800582|NCT02122380|580659945|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
160800583|NCT02122380|580659946|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
160800584|NCT00427011|580659947|FG000|Overall Study|Adverse Event|10|||
160800585|NCT00427011|580659947|FG000|Overall Study|Withdrawal by Subject|1|||
160800586|NCT00427011|580659947|FG000|Overall Study|Lack of Efficacy|2|||
160800587|NCT00427011|580659947|FG000|Overall Study|Other|12|||
160800588|NCT00952705|580659948|FG000|Overall Study|Lost to Follow-up|24|||
160800589|NCT00952705|580659949|FG001|Overall Study|Lost to Follow-up|8|||
160800590|NCT00952705|580659950|FG002|Overall Study|Lost to Follow-up|9|||
160800591|NCT00952705|580659948|FG000|Overall Study|Withdrawal by Subject|2|||
160800592|NCT00952705|580659949|FG001|Overall Study|Withdrawal by Subject|1|||
160800593|NCT00952705|580659950|FG002|Overall Study|Withdrawal by Subject|1|||
160800594|NCT00952705|580659948|FG000|Overall Study|Death|2|||
160800595|NCT00952705|580659949|FG001|Overall Study|Death|0|||
160800596|NCT00952705|580659950|FG002|Overall Study|Death|0|||
160800597|NCT00952705|580659948|FG000|Overall Study|Incarcerated post dose|5|||
160800598|NCT00952705|580659949|FG001|Overall Study|Incarcerated post dose|0|||
160800599|NCT00952705|580659950|FG002|Overall Study|Incarcerated post dose|0|||
160800600|NCT00952705|580659948|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
160800601|NCT00952705|580659949|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
160800602|NCT00952705|580659950|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
160800603|NCT00387088|580659951|FG000|Overall Study|Adverse Event|143|||
160800604|NCT00387088|580659952|FG001|Overall Study|Adverse Event|156|||
160800605|NCT00387088|580659951|FG000|Overall Study|Protocol Violation|47|||
160800606|NCT00387088|580659952|FG001|Overall Study|Protocol Violation|35|||
160800607|NCT00387088|580659951|FG000|Overall Study|Withdrawal by Subject|20|||
160800608|NCT00387088|580659952|FG001|Overall Study|Withdrawal by Subject|35|||
160800609|NCT00387088|580659951|FG000|Overall Study|Lack of Efficacy|28|||
160800610|NCT00387088|580659952|FG001|Overall Study|Lack of Efficacy|67|||
160800611|NCT00387088|580659951|FG000|Overall Study|Lost to Follow-up|22|||
160800612|NCT00387088|580659952|FG001|Overall Study|Lost to Follow-up|28|||
160800613|NCT00387088|580659951|FG000|Overall Study|Other|58|||
160800614|NCT00387088|580659952|FG001|Overall Study|Other|52|||
160800615|NCT04108273|580659953|FG000|Overall Study|COVID Pandemic|1|||
160800616|NCT04108273|580659954|FG001|Overall Study|COVID Pandemic|0|||
160984841|NCT00765362|581333795|FG000|Overall Study|Lost to Follow-up|95|||
160800617|NCT01541371|580659955|FG000|Overall Study|Withdrawal by Subject|14|||
160800618|NCT01541371|580659955|FG000|Overall Study|Lost to Follow-up|21|||
160800619|NCT01541371|580659955|FG000|Overall Study|Adverse Event|15|||
160800620|NCT01541371|580659955|FG000|Overall Study|Lack of Efficacy|12|||
160800621|NCT01541371|580659955|FG000|Overall Study|Protocol Violation|6|||
160800622|NCT01541371|580659955|FG000|Overall Study|Study medication non-compliance|3|||
160800623|NCT01541371|580659955|FG000|Overall Study|Other|6|||
160800624|NCT02441218|580659956|FG000|Overall Study|Death|503|||
160800625|NCT02441218|580659957|FG001|Overall Study|Death|553|||
160800626|NCT02441218|580659956|FG000|Overall Study|Withdrawal by Subject|73|||
160800627|NCT02441218|580659957|FG001|Overall Study|Withdrawal by Subject|58|||
160800628|NCT02441218|580659956|FG000|Overall Study|Lost to Follow-up|2|||
160800629|NCT02441218|580659957|FG001|Overall Study|Lost to Follow-up|1|||
160800630|NCT04460183|580659961|FG000|Overall Study|Lost to Follow-up|3|||
160800631|NCT04460183|580659962|FG001|Overall Study|Lost to Follow-up|1|||
160800632|NCT04460183|580659961|FG000|Overall Study|Withdrawal by Subject|1|||
160800633|NCT04460183|580659962|FG001|Overall Study|Withdrawal by Subject|0|||
160800634|NCT00856609|580659965|FG000|Overall Study|Adverse Event|1|||
160800635|NCT00856609|580659966|FG001|Overall Study|Adverse Event|0|||
160800636|NCT01788943|580659967|FG000|Overall Study|Withdrawal by Subject|1|||
160800637|NCT01788943|580659968|FG001|Overall Study|Withdrawal by Subject|0|||
160800638|NCT00186628|580659969|FG000|Overall Study|Death|2|||
160800639|NCT00186628|580659969|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
160800640|NCT00945659|580659973|FG000|Overall Study|Lost to Follow-up|7|||
160800641|NCT00945659|580659974|FG001|Overall Study|Lost to Follow-up|20|||
160800642|NCT00945659|580659975|FG002|Overall Study|Lost to Follow-up|17|||
160800643|NCT00658541|580659976|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
160800644|NCT00658541|580659977|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160800645|NCT00658541|580659976|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
160800646|NCT00658541|580659977|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
160800647|NCT04828707|580659978|FG000|Overall Study|Lost to Follow-up|3|||
160800648|NCT04828707|580659979|FG001|Overall Study|Lost to Follow-up|2|||
160800649|NCT04828707|580659978|FG000|Overall Study|Withdrawal by Subject|2|||
160800650|NCT04828707|580659979|FG001|Overall Study|Withdrawal by Subject|1|||
160800651|NCT01570387|580659986|FG000|Overall Study|Adverse Event|1|||
160800652|NCT01570387|580659987|FG001|Overall Study|Adverse Event|0|||
160800653|NCT01570387|580659988|FG002|Overall Study|Adverse Event|0|||
160800654|NCT01570387|580659989|FG003|Overall Study|Adverse Event|0|||
160800655|NCT01570387|580659986|FG000|Overall Study|Death|0|||
160800656|NCT01570387|580659987|FG001|Overall Study|Death|0|||
160800657|NCT01570387|580659988|FG002|Overall Study|Death|0|||
160800658|NCT01570387|580659989|FG003|Overall Study|Death|1|||
160800659|NCT01570387|580659986|FG000|Overall Study|Withdrawal by Subject|0|||
160800660|NCT01570387|580659987|FG001|Overall Study|Withdrawal by Subject|0|||
160800661|NCT01570387|580659988|FG002|Overall Study|Withdrawal by Subject|0|||
160800662|NCT01570387|580659989|FG003|Overall Study|Withdrawal by Subject|1|||
160800663|NCT01876381|580659990|FG000|Overall Study|Lack of Efficacy|5|||
160800664|NCT01876381|580659990|FG000|Overall Study|Physician Decision|1|||
160800665|NCT01876381|580659990|FG000|Overall Study|Withdrawal by Subject|1|||
160800666|NCT03323164|580659998|FG000|Overall Study|Poor quality imaging/scans|2|||
160800667|NCT03323164|580659999|FG001|Overall Study|Poor quality imaging/scans|2|||
160800668|NCT02394561|580660002|FG000|CORE Phase|Adverse Event|7|||
160800669|NCT02394561|580660003|FG001|CORE Phase|Adverse Event|9|||
160800670|NCT02394561|580660002|FG000|CORE Phase|Death|0|||
160800671|NCT02394561|580660003|FG001|CORE Phase|Death|1|||
160800672|NCT02394561|580660002|FG000|CORE Phase|Pregnancy|1|||
160800673|NCT02394561|580660003|FG001|CORE Phase|Pregnancy|0|||
160800674|NCT02394561|580660002|FG000|CORE Phase|Lost to Follow-up|1|||
160800675|NCT02394561|580660003|FG001|CORE Phase|Lost to Follow-up|0|||
160800676|NCT02394561|580660002|FG000|CORE Phase|Physician Decision|1|||
160800677|NCT02394561|580660003|FG001|CORE Phase|Physician Decision|1|||
160800678|NCT02394561|580660002|FG000|CORE Phase|Withdrawal by Subject|2|||
160800679|NCT02394561|580660003|FG001|CORE Phase|Withdrawal by Subject|2|||
160800680|NCT02394561|580660002|FG000|CORE Phase|Lack of Efficacy|1|||
160800681|NCT02394561|580660003|FG001|CORE Phase|Lack of Efficacy|6|||
160800682|NCT02394561|580660002|FG000|Extension Phase|Adverse Event|6|||
160800683|NCT02394561|580660003|FG001|Extension Phase|Adverse Event|1|||
160800684|NCT02394561|580660002|FG000|Extension Phase|Death|0|||
160800685|NCT02394561|580660003|FG001|Extension Phase|Death|1|||
160800686|NCT02394561|580660002|FG000|Extension Phase|Protocol Violation|1|||
160800687|NCT02394561|580660003|FG001|Extension Phase|Protocol Violation|0|||
160800688|NCT02394561|580660002|FG000|Extension Phase|Lost to Follow-up|1|||
160800689|NCT02394561|580660003|FG001|Extension Phase|Lost to Follow-up|0|||
160800690|NCT02394561|580660002|FG000|Extension Phase|Physician Decision|0|||
160800691|NCT02394561|580660003|FG001|Extension Phase|Physician Decision|2|||
160800692|NCT02394561|580660002|FG000|Extension Phase|Withdrawal by Subject|0|||
160800693|NCT02394561|580660003|FG001|Extension Phase|Withdrawal by Subject|5|||
160800694|NCT02394561|580660002|FG000|Extension Phase|Lack of Efficacy|3|||
160800695|NCT02394561|580660003|FG001|Extension Phase|Lack of Efficacy|3|||
160800696|NCT00501644|580660004|FG000|Overall Study|Adverse Event|4|||
160800697|NCT00501644|580660004|FG000|Overall Study|Withdrawal by Subject|1|||
160800698|NCT02553629|580660005|FG000|Overall Study|Logistic reasons|3|||
160800699|NCT02553629|580660006|FG001|Overall Study|Logistic reasons|6|||
161331864|NCT00808067|582601511|FG001|Overall Study|Patient refused to take study medication|76|||
161331865|NCT00808067|582601510|FG000|Overall Study|Missing|1|||
161331866|NCT00808067|582601511|FG001|Overall Study|Missing|0|||
161331867|NCT00808067|582601510|FG000|Overall Study|Death|1|||
161331868|NCT00808067|582601511|FG001|Overall Study|Death|1|||
161331869|NCT00808067|582601510|FG000|Overall Study|Procedure|6|||
161331870|NCT00808067|582601511|FG001|Overall Study|Procedure|7|||
161331871|NCT00808067|582601510|FG000|Overall Study|Withdrawal by Subject|21|||
161331872|NCT00808067|582601511|FG001|Overall Study|Withdrawal by Subject|25|||
161331873|NCT00808067|582601510|FG000|Overall Study|Site closed|4|||
161331874|NCT00808067|582601511|FG001|Overall Study|Site closed|3|||
161331875|NCT00808067|582601510|FG000|Overall Study|Physician Decision|47|||
161331876|NCT00808067|582601511|FG001|Overall Study|Physician Decision|38|||
161331877|NCT00808067|582601510|FG000|Overall Study|Protocol Violation|3|||
161331878|NCT00808067|582601511|FG001|Overall Study|Protocol Violation|11|||
161331879|NCT00808067|582601510|FG000|Overall Study|Patient elected|7|||
161331880|NCT00808067|582601511|FG001|Overall Study|Patient elected|9|||
161331881|NCT00808067|582601510|FG000|Overall Study|Site closed for cause|19|||
161331882|NCT00808067|582601511|FG001|Overall Study|Site closed for cause|19|||
161331883|NCT00808067|582601510|FG000|Overall Study|Other reason not defined above|5|||
161331884|NCT00808067|582601511|FG001|Overall Study|Other reason not defined above|5|||
161331885|NCT00808067|582601510|FG000|Overall Study|Excluded from analysis|13|||
161331886|NCT00808067|582601511|FG001|Overall Study|Excluded from analysis|19|||
161331887|NCT01939314|582601512|FG000|Overall Study|Withdrawal by Subject|3|||
161331888|NCT01939314|582601513|FG001|Overall Study|Withdrawal by Subject|1|||
161331889|NCT01939314|582601512|FG000|Overall Study|Protocol Violation|1|||
161331890|NCT01939314|582601513|FG001|Overall Study|Protocol Violation|0|||
161331891|NCT01939314|582601512|FG000|Overall Study|Pregnancy|0|||
161331892|NCT01939314|582601513|FG001|Overall Study|Pregnancy|1|||
161331893|NCT01939314|582601512|FG000|Overall Study|Lost to Follow-up|5|||
161331894|NCT01939314|582601513|FG001|Overall Study|Lost to Follow-up|6|||
161331895|NCT00735007|582601514|FG000|Overall Study|Adverse Event|4|||
161331896|NCT00735007|582601514|FG000|Overall Study|Protocol Violation|1|||
161331897|NCT01107925|582601521|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
161331898|NCT01107925|582601522|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161331899|NCT01107925|582601523|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161331900|NCT01107925|582601524|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161331901|NCT01107925|582601525|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
161331902|NCT01107925|582601526|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
161331903|NCT01107925|582601521|FG000|Period 2|Withdrawal by Subject|0|||
161331904|NCT01107925|582601522|FG001|Period 2|Withdrawal by Subject|1|||
161331905|NCT01107925|582601523|FG002|Period 2|Withdrawal by Subject|0|||
161331906|NCT01107925|582601524|FG003|Period 2|Withdrawal by Subject|0|||
161331907|NCT01107925|582601525|FG004|Period 2|Withdrawal by Subject|0|||
161331908|NCT01107925|582601526|FG005|Period 2|Withdrawal by Subject|1|||
161331909|NCT03311945|582601527|FG000|Overall Study|Adverse Event|2|||
161331910|NCT03311945|582601527|FG000|Overall Study|Lack of Efficacy|1|||
161331911|NCT04877990|582601528|FG000|Treatment|Other reasons|3|||
161331912|NCT04877990|582601529|FG001|Treatment|Other reasons|1|||
161331913|NCT04877990|582601528|FG000|Treatment|Administrative reasons by sponsor|17|||
161331914|NCT04877990|582601529|FG001|Treatment|Administrative reasons by sponsor|33|||
161331915|NCT04877990|582601528|FG000|Treatment|Withdrawal by Subject|2|||
161331916|NCT04877990|582601529|FG001|Treatment|Withdrawal by Subject|6|||
161331917|NCT04877990|582601528|FG000|Treatment|Adverse Event|2|||
161331918|NCT04877990|582601529|FG001|Treatment|Adverse Event|1|||
161331919|NCT04235504|582601530|FG000|Study Phase|Withdrawal by Subject|5|||
161331920|NCT04235504|582601531|FG001|Study Phase|Withdrawal by Subject|2|||
161331921|NCT04235504|582601532|FG002|Study Phase|Withdrawal by Subject|0|||
161331922|NCT04235504|582601533|FG003|Study Phase|Withdrawal by Subject|0|||
161331923|NCT04235504|582601530|FG000|Continuation Phase|Withdrawal by Subject|0|||
161331924|NCT04235504|582601531|FG001|Continuation Phase|Withdrawal by Subject|4|||
161331925|NCT04235504|582601532|FG002|Continuation Phase|Withdrawal by Subject|0|||
161331926|NCT04235504|582601533|FG003|Continuation Phase|Withdrawal by Subject|0|||
160800700|NCT03434834|580660007|FG000|Overall Study|unable to swallow OCT probe|16|||
160800701|NCT01823289|580660008|FG000|Overall Study|Lost to Follow-up|5|||
160800702|NCT01823289|580660008|FG000|Overall Study|Adverse Event|5|||
161331927|NCT04235504|582601530|FG000|Continuation Phase|Adverse Event|0|||
161331928|NCT04235504|582601531|FG001|Continuation Phase|Adverse Event|1|||
161331929|NCT04235504|582601532|FG002|Continuation Phase|Adverse Event|0|||
161331930|NCT04235504|582601533|FG003|Continuation Phase|Adverse Event|0|||
161331931|NCT04235504|582601530|FG000|Continuation Phase|Physician Decision|1|||
161331932|NCT04235504|582601531|FG001|Continuation Phase|Physician Decision|2|||
161331933|NCT04235504|582601532|FG002|Continuation Phase|Physician Decision|1|||
161331934|NCT04235504|582601533|FG003|Continuation Phase|Physician Decision|0|||
161331935|NCT03839394|582601534|FG000|Overall Study|Lost to Follow-up|6|||
161331936|NCT03839394|582601535|FG001|Overall Study|Lost to Follow-up|8|||
161331937|NCT03839394|582601534|FG000|Overall Study|Withdrawal by Subject|0|||
161331938|NCT03839394|582601535|FG001|Overall Study|Withdrawal by Subject|2|||
161331939|NCT01817075|582601545|FG000|Overall Study|Adverse Event|7|||
161331940|NCT01817075|582601546|FG001|Overall Study|Adverse Event|5|||
160896756|NCT01309165|581016981|FG000|Overall Study|No transportation|0|||
160896757|NCT01309165|581016982|FG001|Overall Study|No transportation|1|||
160896758|NCT01309165|581016981|FG000|Overall Study|Admitted to hospital for second stroke|1|||
160896759|NCT01309165|581016982|FG001|Overall Study|Admitted to hospital for second stroke|0|||
160896760|NCT00437320|581016983|FG000|Overall Study|Participant request|2|||
160896761|NCT00437320|581016984|FG001|Overall Study|Participant request|1|||
160896762|NCT00437320|581016985|FG002|Overall Study|Participant request|4|||
160896763|NCT01950169|581016986|FG000|Overall Study|Withdrawal by Subject|2|||
160896764|NCT01950169|581016987|FG001|Overall Study|Withdrawal by Subject|8|||
160896765|NCT01950169|581016988|FG002|Overall Study|Withdrawal by Subject|1|||
160896766|NCT01950169|581016986|FG000|Overall Study|Death|1|||
160896767|NCT01950169|581016987|FG001|Overall Study|Death|0|||
160896768|NCT01950169|581016988|FG002|Overall Study|Death|0|||
160896769|NCT01938573|581016989|FG000|Overall Study|Lack of Efficacy|1|||
160896770|NCT01938573|581016990|FG001|Overall Study|Lack of Efficacy|0|||
160896771|NCT01938573|581016989|FG000|Overall Study|Operation at other hospital|1|||
160896772|NCT01938573|581016990|FG001|Overall Study|Operation at other hospital|0|||
160896773|NCT00737438|581016991|FG000|Overall Study|Withdrawal by Subject|2|||
160896774|NCT00737438|581016991|FG000|Overall Study|Patient ineligible|1|||
160896775|NCT02410551|581016992|FG000|Overall Study|Adverse Event|1|||
160896776|NCT02410551|581016992|FG000|Overall Study|Withdrawal by Subject|1|||
160896777|NCT02410551|581016992|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
160896778|NCT01739309|581016993|FG000|Overall Study|Adverse Event|1|||
160896779|NCT01739309|581016993|FG000|Overall Study|Withdrawal by Subject|1|||
160896780|NCT05447897|581016994|FG000|Overall Study|Did not participate in survey|2|||
160896781|NCT00178633|581016995|FG000|Overall Study|Lost to Follow-up|6|||
160896782|NCT04810481|581016997|FG000|Overall Study|Disqualified data sets|10|||
160896783|NCT04810481|581016998|FG001|Overall Study|Disqualified data sets|28|||
160896784|NCT01484132|581017004|FG000|Overall Study|Lost to Follow-up|8|||
160896785|NCT01484132|581017004|FG000|Overall Study|Difficulty with time commitment|2|||
160896786|NCT01484132|581017004|FG000|Overall Study|Ineligible|1|||
160896787|NCT01484132|581017004|FG000|Overall Study|No pre-treatment urine sample collected|1|||
160896788|NCT01484132|581017004|FG000|Overall Study|No post-treatment urine sample collected|10|||
160896789|NCT03643159|581017005|FG000|Overall Study|Adverse Event|1|||
160896790|NCT03643159|581017005|FG000|Overall Study|Withdrawal by Subject|1|||
160896791|NCT01631812|581017006|FG000|Overall Study|Adverse Event|25|||
160896792|NCT01631812|581017006|FG000|Overall Study|Lack of Efficacy|5|||
160896793|NCT01631812|581017006|FG000|Overall Study|Withdrawal by Subject|4|||
160896794|NCT01631812|581017006|FG000|Overall Study|Physician Decision|3|||
161331941|NCT01817075|582601545|FG000|Overall Study|Physician Decision|9|||
161331942|NCT01817075|582601546|FG001|Overall Study|Physician Decision|12|||
161331943|NCT01817075|582601545|FG000|Overall Study|Withdrawal by Subject|31|||
161331944|NCT01817075|582601546|FG001|Overall Study|Withdrawal by Subject|15|||
161331945|NCT01817075|582601545|FG000|Overall Study|Received Sorafenib after enrollment|0|||
161331946|NCT01817075|582601546|FG001|Overall Study|Received Sorafenib after enrollment|1|||
161331947|NCT01817075|582601545|FG000|Overall Study|Ineligible|0|||
161331948|NCT01817075|582601546|FG001|Overall Study|Ineligible|2|||
161331949|NCT04157517|582601549|FG000|Overall Study|Death|1|||
161331950|NCT04157517|582601550|FG001|Overall Study|Death|2|||
161331951|NCT04157517|582601551|FG002|Overall Study|Death|2|||
161331952|NCT04157517|582601552|FG003|Overall Study|Death|3|||
161331953|NCT04157517|582601553|FG004|Overall Study|Death|3|||
161331954|NCT04157517|582601554|FG005|Overall Study|Death|4|||
161331955|NCT04157517|582601555|FG006|Overall Study|Death|1|||
161331956|NCT04157517|582601556|FG007|Overall Study|Death|2|||
161331957|NCT04157517|582601557|FG008|Overall Study|Death|4|||
161331958|NCT04157517|582601558|FG009|Overall Study|Death|0|||
161331959|NCT04157517|582601549|FG000|Overall Study|Withdrawal by Subject|1|||
161331960|NCT04157517|582601550|FG001|Overall Study|Withdrawal by Subject|1|||
161331961|NCT04157517|582601551|FG002|Overall Study|Withdrawal by Subject|1|||
161331962|NCT04157517|582601552|FG003|Overall Study|Withdrawal by Subject|0|||
161331963|NCT04157517|582601553|FG004|Overall Study|Withdrawal by Subject|0|||
160896795|NCT02718300|581017007|FG000|Overall Study|Death|4|||
160896796|NCT02718300|581017008|FG001|Overall Study|Death|5|||
160896797|NCT02718300|581017009|FG002|Overall Study|Death|17|||
160896798|NCT02718300|581017007|FG000|Overall Study|Lost to Follow-up|1|||
160896799|NCT02718300|581017008|FG001|Overall Study|Lost to Follow-up|0|||
160896800|NCT02718300|581017009|FG002|Overall Study|Lost to Follow-up|2|||
160896801|NCT02718300|581017007|FG000|Overall Study|Physician Decision|1|||
160896802|NCT02718300|581017008|FG001|Overall Study|Physician Decision|0|||
160896803|NCT02718300|581017009|FG002|Overall Study|Physician Decision|2|||
161331964|NCT04157517|582601554|FG005|Overall Study|Withdrawal by Subject|1|||
161331965|NCT04157517|582601555|FG006|Overall Study|Withdrawal by Subject|0|||
161331966|NCT04157517|582601556|FG007|Overall Study|Withdrawal by Subject|0|||
161331967|NCT04157517|582601557|FG008|Overall Study|Withdrawal by Subject|1|||
161331968|NCT04157517|582601558|FG009|Overall Study|Withdrawal by Subject|0|||
161331969|NCT04157517|582601549|FG000|Overall Study|Other|1|||
160800703|NCT01823289|580660008|FG000|Overall Study|Lack of Efficacy|1|||
160800704|NCT01823289|580660008|FG000|Overall Study|Physician Decision|9|||
160800705|NCT01823289|580660008|FG000|Overall Study|Administered contraindicated medicine|1|||
160800706|NCT01823289|580660008|FG000|Overall Study|Transaminase increased more than 3 times|1|||
160800707|NCT01823289|580660008|FG000|Overall Study|Drug affected efficacy and safety|1|||
160800708|NCT01823289|580660008|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
160800709|NCT00654732|580660016|FG000|Overall Study|Adverse Event|4|||
160800710|NCT00654732|580660017|FG001|Overall Study|Adverse Event|6|||
160800711|NCT01133847|580660024|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
160800712|NCT01133847|580660025|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
160800713|NCT01133847|580660026|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
160800714|NCT01133847|580660024|FG000|Follow-Up Phase|Lost to Follow-up|1|||
160800715|NCT01133847|580660025|FG001|Follow-Up Phase|Lost to Follow-up|3|||
160800716|NCT01133847|580660026|FG002|Follow-Up Phase|Lost to Follow-up|7|||
160800717|NCT01880957|580660027|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
160800718|NCT01880957|580660028|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
160800719|NCT01880957|580660027|FG000|Overall Study|Lost to Follow-up|11|||
160800720|NCT01880957|580660028|FG001|Overall Study|Lost to Follow-up|0|||
160800721|NCT01880957|580660027|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
160800722|NCT01880957|580660028|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
160800723|NCT01378117|580660029|FG000|Overall Study|withdrawal|2|||
160800724|NCT01378117|580660030|FG001|Overall Study|withdrawal|1|||
160800725|NCT01378117|580660031|FG002|Overall Study|withdrawal|2|||
160800726|NCT01378117|580660029|FG000|Overall Study|discharged before med given|2|||
160800727|NCT01378117|580660030|FG001|Overall Study|discharged before med given|0|||
160800728|NCT01378117|580660031|FG002|Overall Study|discharged before med given|1|||
160800729|NCT01854528|580660032|FG000|Overall Study|Adverse Event|0|||
160800730|NCT01854528|580660033|FG001|Overall Study|Adverse Event|4|||
160800731|NCT01854528|580660032|FG000|Overall Study|Withdrawal by Subject|0|||
160800732|NCT01854528|580660033|FG001|Overall Study|Withdrawal by Subject|2|||
160800733|NCT01854528|580660032|FG000|Overall Study|Virologic Failure|0|||
160800734|NCT01854528|580660033|FG001|Overall Study|Virologic Failure|9|||
160800735|NCT01696643|580660034|FG000|Overall Study|Adverse Event|15|||
160800736|NCT01696643|580660035|FG001|Overall Study|Adverse Event|7|||
160800737|NCT01696643|580660034|FG000|Overall Study|Death|1|||
160800738|NCT01696643|580660035|FG001|Overall Study|Death|2|||
160800739|NCT01696643|580660034|FG000|Overall Study|Lack of Efficacy|3|||
160800740|NCT01696643|580660035|FG001|Overall Study|Lack of Efficacy|0|||
160800741|NCT01696643|580660034|FG000|Overall Study|Lost to Follow-up|67|||
160800742|NCT01696643|580660035|FG001|Overall Study|Lost to Follow-up|67|||
160800743|NCT01696643|580660034|FG000|Overall Study|Physician Decision|3|||
160896804|NCT02718300|581017007|FG000|Overall Study|Study Terminated by Sponsor|6|||
160896805|NCT02718300|581017008|FG001|Overall Study|Study Terminated by Sponsor|3|||
160896806|NCT02718300|581017009|FG002|Overall Study|Study Terminated by Sponsor|4|||
160896807|NCT02718300|581017007|FG000|Overall Study|Withdrawal by Subject|0|||
160896808|NCT02718300|581017008|FG001|Overall Study|Withdrawal by Subject|4|||
160896809|NCT02718300|581017009|FG002|Overall Study|Withdrawal by Subject|3|||
160896810|NCT02718300|581017007|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
160896811|NCT02718300|581017008|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
160896812|NCT02718300|581017009|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
160896813|NCT00257608|581018679|FG000|Chemotherapy Phase|Adverse Event|138|||
160896814|NCT00257608|581018680|FG001|Chemotherapy Phase|Adverse Event|0|||
160896815|NCT00257608|581018681|FG002|Chemotherapy Phase|Adverse Event|0|||
160896816|NCT00257608|581018679|FG000|Chemotherapy Phase|Disease progression|139|||
160896817|NCT00257608|581018680|FG001|Chemotherapy Phase|Disease progression|0|||
160896818|NCT00257608|581018681|FG002|Chemotherapy Phase|Disease progression|0|||
160896819|NCT00257608|581018679|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
160896820|NCT00257608|581018680|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
160896821|NCT00257608|581018681|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
160896822|NCT00257608|581018679|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
161237285|NCT00819741|582248534|FG000|Overall Study|Withdrawal by Subject|2|||
160800744|NCT01696643|580660035|FG001|Overall Study|Physician Decision|2|||
160800745|NCT01696643|580660034|FG000|Overall Study|Pregnancy|0|||
160800746|NCT01696643|580660035|FG001|Overall Study|Pregnancy|1|||
160800747|NCT01696643|580660034|FG000|Overall Study|Protocol Violation|7|||
160800748|NCT01696643|580660035|FG001|Overall Study|Protocol Violation|7|||
160800749|NCT01696643|580660034|FG000|Overall Study|Study Terminated by Sponsor|286|||
160896823|NCT00257608|581018680|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
160896824|NCT00257608|581018681|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
160896825|NCT00257608|581018679|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
161237286|NCT00819741|582248535|FG001|Overall Study|Withdrawal by Subject|2|||
160800750|NCT01696643|580660035|FG001|Overall Study|Study Terminated by Sponsor|294|||
160800751|NCT01696643|580660034|FG000|Overall Study|Withdrawal by Subject|142|||
160800752|NCT01696643|580660035|FG001|Overall Study|Withdrawal by Subject|149|||
160800753|NCT01696643|580660034|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
160800754|NCT01696643|580660035|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
160800755|NCT01696643|580660034|FG000|Overall Study|Site Error|2|||
160800756|NCT01696643|580660035|FG001|Overall Study|Site Error|1|||
160800757|NCT01696643|580660034|FG000|Overall Study|Participant Incarcerated|0|||
160800758|NCT01696643|580660035|FG001|Overall Study|Participant Incarcerated|1|||
160800759|NCT01696643|580660034|FG000|Overall Study|Medical Monitor Decision|0|||
160800760|NCT01696643|580660035|FG001|Overall Study|Medical Monitor Decision|2|||
160800761|NCT01696643|580660034|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
160800762|NCT01696643|580660035|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
160800763|NCT00518180|580660039|FG000|Overall Study|Withdrawal by Subject|29|||
160800764|NCT00518180|580660040|FG001|Overall Study|Withdrawal by Subject|30|||
160800765|NCT00518180|580660041|FG002|Overall Study|Withdrawal by Subject|42|||
160800766|NCT00518180|580660039|FG000|Overall Study|Lost to Follow-up|30|||
160800767|NCT00518180|580660040|FG001|Overall Study|Lost to Follow-up|28|||
160800768|NCT00518180|580660041|FG002|Overall Study|Lost to Follow-up|34|||
160800769|NCT00518180|580660039|FG000|Overall Study|Administrative reason|0|||
160800770|NCT00518180|580660040|FG001|Overall Study|Administrative reason|2|||
160800771|NCT00518180|580660041|FG002|Overall Study|Administrative reason|2|||
160800772|NCT00518180|580660039|FG000|Overall Study|Protocol Violation|5|||
160800773|NCT00518180|580660040|FG001|Overall Study|Protocol Violation|7|||
160800774|NCT00518180|580660041|FG002|Overall Study|Protocol Violation|4|||
160800775|NCT00518180|580660039|FG000|Overall Study|Unable to classify|0|||
160800776|NCT00518180|580660040|FG001|Overall Study|Unable to classify|2|||
160800777|NCT00518180|580660041|FG002|Overall Study|Unable to classify|0|||
160800778|NCT00518180|580660039|FG000|Overall Study|Adverse Event|1|||
160800779|NCT00518180|580660040|FG001|Overall Study|Adverse Event|0|||
160800780|NCT00518180|580660041|FG002|Overall Study|Adverse Event|0|||
160800781|NCT02951780|580660042|FG000|Period 1|Adverse Event|0|||
160800782|NCT02951780|580660043|FG001|Period 1|Adverse Event|0|||
160800783|NCT02951780|580660044|FG002|Period 1|Adverse Event|0|||
160800784|NCT02951780|580660045|FG003|Period 1|Adverse Event|1|||
160800785|NCT02951780|580660046|FG004|Period 1|Adverse Event|0|||
160800786|NCT02951780|580660047|FG005|Period 1|Adverse Event|0|||
160800787|NCT02951780|580660048|FG006|Period 1|Adverse Event|0|||
160800788|NCT02951780|580660049|FG007|Period 1|Adverse Event|0|||
160984842|NCT00519779|581333798|FG000|Overall Study|Withdrawal by Subject|0|||
160800789|NCT02951780|580660050|FG008|Period 1|Adverse Event|0|||
160800790|NCT02951780|580660042|FG000|Period 1|Scheduling Conflicts|0|||
160800791|NCT02951780|580660043|FG001|Period 1|Scheduling Conflicts|0|||
160800792|NCT02951780|580660044|FG002|Period 1|Scheduling Conflicts|0|||
160800793|NCT02951780|580660045|FG003|Period 1|Scheduling Conflicts|0|||
160800794|NCT02951780|580660046|FG004|Period 1|Scheduling Conflicts|0|||
160800795|NCT02951780|580660047|FG005|Period 1|Scheduling Conflicts|0|||
160800796|NCT02951780|580660048|FG006|Period 1|Scheduling Conflicts|0|||
160800797|NCT02951780|580660049|FG007|Period 1|Scheduling Conflicts|1|||
160800798|NCT02951780|580660050|FG008|Period 1|Scheduling Conflicts|0|||
160800799|NCT02951780|580660042|FG000|Period 2|Scheduling Conflicts|0|||
160800800|NCT02951780|580660043|FG001|Period 2|Scheduling Conflicts|0|||
160800801|NCT02951780|580660044|FG002|Period 2|Scheduling Conflicts|0|||
160800802|NCT02951780|580660045|FG003|Period 2|Scheduling Conflicts|0|||
160800803|NCT02951780|580660046|FG004|Period 2|Scheduling Conflicts|0|||
160800804|NCT02951780|580660047|FG005|Period 2|Scheduling Conflicts|0|||
160800805|NCT02951780|580660048|FG006|Period 2|Scheduling Conflicts|0|||
160800806|NCT02951780|580660049|FG007|Period 2|Scheduling Conflicts|1|||
160800807|NCT02951780|580660050|FG008|Period 2|Scheduling Conflicts|0|||
160800808|NCT00508482|580660051|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
160800809|NCT00508482|580660052|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
160800810|NCT00508482|580660053|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
160800811|NCT00508482|580660051|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
160800812|NCT00508482|580660052|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
160800813|NCT00508482|580660053|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
160800814|NCT00508482|580660051|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
160800815|NCT00508482|580660052|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
160800816|NCT00508482|580660053|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
160800817|NCT00244621|580660054|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
160800818|NCT00244621|580660055|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160800819|NCT00244621|580660056|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
160800820|NCT00244621|580660054|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
160800821|NCT00244621|580660055|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160800822|NCT00244621|580660056|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160800823|NCT00244621|580660054|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
160800824|NCT00244621|580660055|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
160800825|NCT00244621|580660056|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
160800826|NCT00244621|580660054|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
160800827|NCT00244621|580660055|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
160800828|NCT00244621|580660056|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
160800829|NCT00244621|580660054|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
160800830|NCT00244621|580660055|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
160800831|NCT00244621|580660056|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
160800832|NCT00244621|580660054|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
160800833|NCT00244621|580660055|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160800834|NCT00244621|580660056|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
160800835|NCT00244621|580660054|FG000|Open-label Treatment Period|Adverse Event|0|||
160800836|NCT00244621|580660055|FG001|Open-label Treatment Period|Adverse Event|0|||
160800837|NCT00244621|580660056|FG002|Open-label Treatment Period|Adverse Event|1|||
160800838|NCT00244621|580660054|FG000|Open-label Treatment Period|Moved abroad|0|||
160800839|NCT00244621|580660055|FG001|Open-label Treatment Period|Moved abroad|0|||
160800840|NCT00244621|580660056|FG002|Open-label Treatment Period|Moved abroad|1|||
160800841|NCT01193101|580660057|FG000|Overall Study|Adverse Event|0|||
160800842|NCT01193101|580660058|FG001|Overall Study|Adverse Event|1|||
160800843|NCT01193101|580660059|FG002|Overall Study|Adverse Event|1|||
160800844|NCT01193101|580660060|FG003|Overall Study|Adverse Event|3|||
160800845|NCT01193101|580660057|FG000|Overall Study|Lack of Efficacy|3|||
160800846|NCT01193101|580660058|FG001|Overall Study|Lack of Efficacy|1|||
160800847|NCT01193101|580660059|FG002|Overall Study|Lack of Efficacy|0|||
160800848|NCT01193101|580660060|FG003|Overall Study|Lack of Efficacy|8|||
160800849|NCT01193101|580660057|FG000|Overall Study|Withdrawal by Subject|2|||
160800850|NCT01193101|580660058|FG001|Overall Study|Withdrawal by Subject|4|||
160800851|NCT01193101|580660059|FG002|Overall Study|Withdrawal by Subject|1|||
160800852|NCT01193101|580660060|FG003|Overall Study|Withdrawal by Subject|1|||
160800853|NCT01193101|580660057|FG000|Overall Study|Administrative problems|0|||
160800854|NCT01193101|580660058|FG001|Overall Study|Administrative problems|0|||
160800855|NCT01193101|580660059|FG002|Overall Study|Administrative problems|1|||
160800856|NCT01193101|580660060|FG003|Overall Study|Administrative problems|0|||
160800857|NCT01193101|580660057|FG000|Overall Study|Abnormal test procedure results|0|||
160800858|NCT01193101|580660058|FG001|Overall Study|Abnormal test procedure results|1|||
160800859|NCT01193101|580660059|FG002|Overall Study|Abnormal test procedure results|0|||
160800860|NCT01193101|580660060|FG003|Overall Study|Abnormal test procedure results|0|||
160800861|NCT02347085|580660061|FG000|Overall Study|Adverse Event|2|||
160800862|NCT02347085|580660061|FG000|Overall Study|Lack of Efficacy|1|||
160800863|NCT02347085|580660061|FG000|Overall Study|Withdrawal by Subject|4|||
160800864|NCT02347085|580660061|FG000|Overall Study|Lost to Follow-up|1|||
160800865|NCT02347085|580660061|FG000|Overall Study|Protocol Criteria|2|||
160800866|NCT01957865|580660062|FG000|Overall Study|Found HIV negative|0|||
160800867|NCT01957865|580660063|FG001|Overall Study|Found HIV negative|0|||
160800868|NCT01957865|580660064|FG002|Overall Study|Found HIV negative|1|||
160800869|NCT01957865|580660062|FG000|Overall Study|Lost to Follow-up|0|||
160800870|NCT01957865|580660063|FG001|Overall Study|Lost to Follow-up|2|||
160800871|NCT01957865|580660064|FG002|Overall Study|Lost to Follow-up|2|||
160800872|NCT00867035|580660066|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
160800873|NCT00867035|580660067|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
160800874|NCT00867035|580660066|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
160800875|NCT00867035|580660067|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
160800876|NCT00542178|580660068|FG000|Overall Study|did not complete year 4 follow-up|75|||
160800877|NCT00542178|580660069|FG001|Overall Study|did not complete year 4 follow-up|80|||
160800878|NCT00542178|580660070|FG002|Overall Study|did not complete year 4 follow-up|74|||
160800879|NCT00542178|580660071|FG003|Overall Study|did not complete year 4 follow-up|62|||
160800880|NCT00542178|580660072|FG004|Overall Study|did not complete year 4 follow-up|64|||
160800881|NCT00542178|580660073|FG005|Overall Study|did not complete year 4 follow-up|89|||
160800882|NCT00542178|580660074|FG006|Overall Study|did not complete year 4 follow-up|87|||
160800883|NCT00542178|580660075|FG007|Overall Study|did not complete year 4 follow-up|85|||
160800884|NCT02026011|580661233|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
160800885|NCT02026011|580661234|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
160800886|NCT02026011|580661233|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
160800887|NCT02026011|580661234|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
160800888|NCT02026011|580661233|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
160800889|NCT02026011|580661234|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
160800890|NCT02026011|580661233|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
160800891|NCT02026011|580661234|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
160800892|NCT05010070|580661235|FG000|Overall Study|Lost to Follow-up|1|||
160800893|NCT05010070|580661235|FG000|Overall Study|Withdrawal by Subject|1|||
160800894|NCT01669902|580661236|FG000|Overall Study|Adverse Event|11|||
160800895|NCT01669902|580661236|FG000|Overall Study|Lack of Efficacy|10|||
160800896|NCT01669902|580661236|FG000|Overall Study|Other|8|||
160800897|NCT00688467|580661245|FG000|Treatment Period 1|Adverse Event|2|||
160800898|NCT00688467|580661246|FG001|Treatment Period 1|Adverse Event|1|||
160800899|NCT00688467|580661245|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
160800900|NCT00688467|580661246|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
160800901|NCT00688467|580661245|FG000|Treatment Period 2|Protocol Violation|0|||
160800902|NCT00688467|580661246|FG001|Treatment Period 2|Protocol Violation|1|||
160800903|NCT00688467|580661245|FG000|Treatment Period 2|Adverse Event|0|||
160800904|NCT00688467|580661246|FG001|Treatment Period 2|Adverse Event|1|||
160800905|NCT02808897|580661247|FG000|Overall Study|Lost to Follow-up|9|||
160800906|NCT02808897|580661248|FG001|Overall Study|Lost to Follow-up|11|||
160800907|NCT00002766|580661249|FG000|Overall Study|Withdrawal by Subject|0|||
160800908|NCT00002766|580661250|FG001|Overall Study|Withdrawal by Subject|1|||
160800909|NCT00002766|580661249|FG000|Overall Study|Patient Not Treated|1|||
160800910|NCT00002766|580661250|FG001|Overall Study|Patient Not Treated|2|||
160800911|NCT00002766|580661249|FG000|Overall Study|Adverse Event|1|||
160800912|NCT00002766|580661250|FG001|Overall Study|Adverse Event|1|||
160800913|NCT00002766|580661249|FG000|Overall Study|Protocol Violation|1|||
160800914|NCT00002766|580661250|FG001|Overall Study|Protocol Violation|0|||
160800915|NCT03848416|580661270|FG000|Overall Study|Withdrawal by Subject|1|||
160800916|NCT03848416|580661271|FG001|Overall Study|Withdrawal by Subject|0|||
160800917|NCT03848416|580661272|FG002|Overall Study|Withdrawal by Subject|0|||
160800918|NCT03848416|580661270|FG000|Overall Study|Death|0|||
160800919|NCT03848416|580661271|FG001|Overall Study|Death|0|||
160800920|NCT03848416|580661272|FG002|Overall Study|Death|1|||
160800921|NCT01847092|580661278|FG000|Overall Study|Adverse Event|12|||
160800922|NCT01847092|580661279|FG001|Overall Study|Adverse Event|3|||
160800923|NCT01847092|580661278|FG000|Overall Study|Withdrawal by Subject|5|||
160800924|NCT01847092|580661279|FG001|Overall Study|Withdrawal by Subject|5|||
160800925|NCT01847092|580661278|FG000|Overall Study|Protocol Specified|8|||
160800926|NCT01847092|580661279|FG001|Overall Study|Protocol Specified|0|||
160800927|NCT01847092|580661278|FG000|Overall Study|Physician Decision|1|||
160800928|NCT01847092|580661279|FG001|Overall Study|Physician Decision|1|||
160800929|NCT01847092|580661278|FG000|Overall Study|Protocol Violation|0|||
160800930|NCT01847092|580661279|FG001|Overall Study|Protocol Violation|2|||
160800931|NCT03604497|580661281|FG000|Overall Study|Protocol Violation|52|||
160800932|NCT00811954|580661282|FG000|Overall Study|Death|10|||
160800933|NCT00811954|580661283|FG001|Overall Study|Death|6|||
160800934|NCT00811954|580661284|FG002|Overall Study|Death|13|||
160800935|NCT00811954|580661282|FG000|Overall Study|Lost to Follow-up|29|||
160800936|NCT00811954|580661283|FG001|Overall Study|Lost to Follow-up|23|||
160800937|NCT00811954|580661284|FG002|Overall Study|Lost to Follow-up|34|||
160800938|NCT00811954|580661282|FG000|Overall Study|Not able to get to clinic|28|||
160800939|NCT00811954|580661283|FG001|Overall Study|Not able to get to clinic|35|||
160800940|NCT00811954|580661284|FG002|Overall Study|Not able to get to clinic|30|||
160800941|NCT00811954|580661282|FG000|Overall Study|Not willing to adhere to requirements|12|||
160800942|NCT00811954|580661283|FG001|Overall Study|Not willing to adhere to requirements|2|||
160800943|NCT00811954|580661284|FG002|Overall Study|Not willing to adhere to requirements|16|||
160800944|NCT00811954|580661282|FG000|Overall Study|Withdraw consent prior study completion|4|||
160800945|NCT00811954|580661283|FG001|Overall Study|Withdraw consent prior study completion|6|||
160800946|NCT00811954|580661284|FG002|Overall Study|Withdraw consent prior study completion|5|||
161331970|NCT04157517|582601550|FG001|Overall Study|Other|0|||
161331971|NCT04157517|582601551|FG002|Overall Study|Other|0|||
161331972|NCT04157517|582601552|FG003|Overall Study|Other|0|||
161331973|NCT04157517|582601553|FG004|Overall Study|Other|0|||
161331974|NCT04157517|582601554|FG005|Overall Study|Other|1|||
161331975|NCT04157517|582601555|FG006|Overall Study|Other|2|||
161331976|NCT04157517|582601556|FG007|Overall Study|Other|7|||
161331977|NCT04157517|582601557|FG008|Overall Study|Other|7|||
161331978|NCT04157517|582601558|FG009|Overall Study|Other|0|||
161331979|NCT00565604|582601565|FG000|Overall Study|Failure to treat|2|||
161331980|NCT00565604|582601565|FG000|Overall Study|Lost to Follow-up|2|||
161331981|NCT01395810|582601566|FG000|Overall Study|Adverse Event|0|||
161331982|NCT01395810|582601567|FG001|Overall Study|Adverse Event|1|||
161331983|NCT01395810|582601568|FG002|Overall Study|Adverse Event|0|||
161331984|NCT01395810|582601569|FG003|Overall Study|Adverse Event|0|||
161331985|NCT01395810|582601566|FG000|Overall Study|Lack of Efficacy|0|||
161331986|NCT01395810|582601567|FG001|Overall Study|Lack of Efficacy|1|||
161331987|NCT01395810|582601568|FG002|Overall Study|Lack of Efficacy|0|||
161331988|NCT01395810|582601569|FG003|Overall Study|Lack of Efficacy|0|||
160800947|NCT00811954|580661282|FG000|Overall Study|Site Closure|4|||
161331989|NCT01395810|582601566|FG000|Overall Study|Withdrawal criteria|0|||
161331990|NCT01395810|582601567|FG001|Overall Study|Withdrawal criteria|2|||
161331991|NCT01395810|582601568|FG002|Overall Study|Withdrawal criteria|0|||
160800948|NCT00811954|580661283|FG001|Overall Study|Site Closure|0|||
160800949|NCT00811954|580661284|FG002|Overall Study|Site Closure|1|||
160800950|NCT00811954|580661282|FG000|Overall Study|Severe Debilitation|2|||
160800951|NCT00811954|580661283|FG001|Overall Study|Severe Debilitation|0|||
160800952|NCT00811954|580661284|FG002|Overall Study|Severe Debilitation|1|||
160800953|NCT00811954|580661282|FG000|Overall Study|Complete Protocol: No follow-up|0|||
160800954|NCT00811954|580661283|FG001|Overall Study|Complete Protocol: No follow-up|0|||
160800955|NCT00811954|580661284|FG002|Overall Study|Complete Protocol: No follow-up|1|||
160800956|NCT01016067|580661285|FG000|Overall Study|Lost to Follow-up|1|||
160800957|NCT01016067|580661286|FG001|Overall Study|Lost to Follow-up|2|||
161331992|NCT01395810|582601569|FG003|Overall Study|Withdrawal criteria|0|||
160800958|NCT01016067|580661285|FG000|Overall Study|Physician Decision|1|||
160800959|NCT01016067|580661286|FG001|Overall Study|Physician Decision|1|||
160800960|NCT01016067|580661285|FG000|Overall Study|Withdrew due to Relocation|0|||
160800961|NCT01016067|580661286|FG001|Overall Study|Withdrew due to Relocation|1|||
160800962|NCT01664247|580661288|FG000|Overall Study|Adverse Event|5|||
160800963|NCT01664247|580661289|FG001|Overall Study|Adverse Event|3|||
160800964|NCT01664247|580661288|FG000|Overall Study|Protocol Violation|3|||
160800965|NCT01664247|580661289|FG001|Overall Study|Protocol Violation|5|||
160800966|NCT01664247|580661288|FG000|Overall Study|Withdrawal Criteria|1|||
160800967|NCT01664247|580661289|FG001|Overall Study|Withdrawal Criteria|4|||
160800968|NCT01664247|580661288|FG000|Overall Study|Unclassified|5|||
160800969|NCT01664247|580661289|FG001|Overall Study|Unclassified|29|||
160800970|NCT01000506|580661290|FG000|Overall Study|Adverse Event|6|||
160800971|NCT01000506|580661291|FG001|Overall Study|Adverse Event|5|||
160800972|NCT01000506|580661292|FG002|Overall Study|Adverse Event|8|||
160800973|NCT01000506|580661293|FG003|Overall Study|Adverse Event|9|||
160800974|NCT01000506|580661290|FG000|Overall Study|Lack of Efficacy|8|||
160800975|NCT01000506|580661291|FG001|Overall Study|Lack of Efficacy|6|||
160800976|NCT01000506|580661292|FG002|Overall Study|Lack of Efficacy|4|||
160800977|NCT01000506|580661293|FG003|Overall Study|Lack of Efficacy|4|||
160800978|NCT01000506|580661290|FG000|Overall Study|Protocol Violation|1|||
160800979|NCT01000506|580661291|FG001|Overall Study|Protocol Violation|1|||
160800980|NCT01000506|580661292|FG002|Overall Study|Protocol Violation|0|||
160800981|NCT01000506|580661293|FG003|Overall Study|Protocol Violation|0|||
160800982|NCT01000506|580661290|FG000|Overall Study|Lost to Follow-up|1|||
160800983|NCT01000506|580661291|FG001|Overall Study|Lost to Follow-up|1|||
160800984|NCT01000506|580661292|FG002|Overall Study|Lost to Follow-up|4|||
160800985|NCT01000506|580661293|FG003|Overall Study|Lost to Follow-up|0|||
160800986|NCT01000506|580661290|FG000|Overall Study|Physician Decision|1|||
160800987|NCT01000506|580661291|FG001|Overall Study|Physician Decision|3|||
160800988|NCT01000506|580661292|FG002|Overall Study|Physician Decision|3|||
160800989|NCT01000506|580661293|FG003|Overall Study|Physician Decision|3|||
160800990|NCT01000506|580661290|FG000|Overall Study|Withdrawal by Subject|11|||
160800991|NCT01000506|580661291|FG001|Overall Study|Withdrawal by Subject|8|||
160800992|NCT01000506|580661292|FG002|Overall Study|Withdrawal by Subject|2|||
160984843|NCT00519779|581333799|FG001|Overall Study|Withdrawal by Subject|1|||
160984844|NCT01123161|581333800|FG000|Overall Study|Lost to Follow-up|1|||
160984845|NCT01123161|581333801|FG001|Overall Study|Lost to Follow-up|0|||
160984846|NCT01123161|581333800|FG000|Overall Study|Withdrawal by Subject|1|||
160984847|NCT01123161|581333801|FG001|Overall Study|Withdrawal by Subject|0|||
160984848|NCT03566680|581333818|FG000|Overall Study|Pregnancy|1|||
160984849|NCT03566680|581333818|FG000|Overall Study|Lost to Follow-up|13|||
160984850|NCT03566680|581333818|FG000|Overall Study|Withdrawal by Subject|3|||
160984851|NCT02724020|581333820|FG000|Overall Study|Death|16|||
160984852|NCT02724020|581333821|FG001|Overall Study|Death|18|||
160800993|NCT01000506|580661293|FG003|Overall Study|Withdrawal by Subject|7|||
160800994|NCT03064074|580661294|FG000|Overall Study|Physician Decision|0|||
160984853|NCT02724020|581333822|FG002|Overall Study|Death|19|||
160984854|NCT02724020|581333820|FG000|Overall Study|Lost to Follow-up|0|||
160984855|NCT02724020|581333821|FG001|Overall Study|Lost to Follow-up|3|||
160984856|NCT02724020|581333822|FG002|Overall Study|Lost to Follow-up|0|||
160984857|NCT02724020|581333820|FG000|Overall Study|Site Terminated by Sponsor|15|||
160984858|NCT02724020|581333821|FG001|Overall Study|Site Terminated by Sponsor|8|||
160800995|NCT03064074|580661295|FG001|Overall Study|Physician Decision|0|||
160800996|NCT03064074|580661296|FG002|Overall Study|Physician Decision|0|||
160800997|NCT03064074|580661297|FG003|Overall Study|Physician Decision|1|||
160800998|NCT00269087|580661298|FG000|Overall Study|Adverse Event|20|||
160800999|NCT00269087|580661298|FG000|Overall Study|Withdrawal by Subject|1|||
160801000|NCT00269087|580661298|FG000|Overall Study|Exacerbation of COPD|13|||
160801001|NCT01188967|580661304|FG000|Overall Study|Withdrawal by Subject|1|||
160984859|NCT02724020|581333822|FG002|Overall Study|Site Terminated by Sponsor|8|||
160984860|NCT02724020|581333820|FG000|Overall Study|Withdrawal by Subject|1|||
161129809|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
161129810|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
161129811|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
160801002|NCT01188967|580661305|FG001|Overall Study|Withdrawal by Subject|1|||
160984861|NCT02724020|581333821|FG001|Overall Study|Withdrawal by Subject|3|||
160801003|NCT01188967|580661304|FG000|Overall Study|Physician Decision|1|||
160801004|NCT01188967|580661305|FG001|Overall Study|Physician Decision|1|||
160801005|NCT01188967|580661304|FG000|Overall Study|Lost to Follow-up|3|||
160801006|NCT01188967|580661305|FG001|Overall Study|Lost to Follow-up|2|||
160801007|NCT01448616|580661306|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
160801008|NCT01448616|580661307|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
160801009|NCT01448616|580661308|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
160801010|NCT01448616|580661309|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
160984862|NCT02724020|581333822|FG002|Overall Study|Withdrawal by Subject|5|||
160984863|NCT02179918|581333823|FG000|Overall Study|Death|0|||
160984864|NCT02179918|581333824|FG001|Overall Study|Death|0|||
160801011|NCT01448616|580661306|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
160801012|NCT01448616|580661307|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
160801013|NCT01448616|580661308|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
160801014|NCT01448616|580661309|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
160801015|NCT01448616|580661306|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
160801016|NCT01448616|580661307|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
160801017|NCT01448616|580661308|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
160801018|NCT01448616|580661309|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
160801019|NCT01448616|580661306|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
160801020|NCT01448616|580661307|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
160984865|NCT02179918|581333825|FG002|Overall Study|Death|0|||
160984866|NCT02179918|581333826|FG003|Overall Study|Death|1|||
160984867|NCT02179918|581333827|FG004|Overall Study|Death|0|||
160984868|NCT02179918|581333823|FG000|Overall Study|Lost to Follow-up|0|||
160984869|NCT02179918|581333824|FG001|Overall Study|Lost to Follow-up|0|||
160984870|NCT02179918|581333825|FG002|Overall Study|Lost to Follow-up|1|||
160984871|NCT02179918|581333826|FG003|Overall Study|Lost to Follow-up|0|||
160984872|NCT02179918|581333827|FG004|Overall Study|Lost to Follow-up|0|||
160984873|NCT02179918|581333823|FG000|Overall Study|Progressive Disease|4|||
160984874|NCT02179918|581333824|FG001|Overall Study|Progressive Disease|1|||
160984875|NCT02179918|581333825|FG002|Overall Study|Progressive Disease|1|||
160984876|NCT02179918|581333826|FG003|Overall Study|Progressive Disease|2|||
160984877|NCT02179918|581333827|FG004|Overall Study|Progressive Disease|6|||
160984878|NCT02179918|581333823|FG000|Overall Study|Other|0|||
160984879|NCT02179918|581333824|FG001|Overall Study|Other|1|||
160984880|NCT02179918|581333825|FG002|Overall Study|Other|0|||
160984881|NCT02179918|581333826|FG003|Overall Study|Other|0|||
160984882|NCT02179918|581333827|FG004|Overall Study|Other|1|||
160984883|NCT02179918|581333823|FG000|Overall Study|Subject refused further follow-up|0|||
160801021|NCT01448616|580661308|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
160801022|NCT01448616|580661309|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
160801023|NCT01448616|580661306|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
160801024|NCT01448616|580661307|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
160801025|NCT01448616|580661308|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
160801026|NCT01448616|580661309|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
160801027|NCT00523978|580661310|FG000|Overall Study|Withdrawal by Subject|3|||
160801028|NCT00523978|580661311|FG001|Overall Study|Withdrawal by Subject|7|||
160801029|NCT00523978|580661310|FG000|Overall Study|Screen Failures|5|||
160801030|NCT00523978|580661311|FG001|Overall Study|Screen Failures|1|||
160801031|NCT00523978|580661310|FG000|Overall Study|Death|1|||
160801032|NCT00523978|580661311|FG001|Overall Study|Death|0|||
160801033|NCT01911260|580661314|FG000|Supplementation Period|transference or evasion of school|7|||
160801034|NCT01911260|580661315|FG001|Supplementation Period|transference or evasion of school|9|||
160801035|NCT01911260|580661316|FG002|Supplementation Period|transference or evasion of school|7|||
160801036|NCT01911260|580661317|FG003|Supplementation Period|transference or evasion of school|6|||
160801037|NCT01911260|580661314|FG000|Supplementation Period|Adverse Event|2|||
160801038|NCT01911260|580661315|FG001|Supplementation Period|Adverse Event|0|||
160801039|NCT01911260|580661316|FG002|Supplementation Period|Adverse Event|1|||
160801040|NCT01911260|580661317|FG003|Supplementation Period|Adverse Event|0|||
160801041|NCT01911260|580661314|FG000|Supplementation Period|refused to receive supplement|1|||
160801042|NCT01911260|580661315|FG001|Supplementation Period|refused to receive supplement|0|||
160801043|NCT01911260|580661316|FG002|Supplementation Period|refused to receive supplement|1|||
160801044|NCT01911260|580661317|FG003|Supplementation Period|refused to receive supplement|0|||
160801045|NCT01911260|580661314|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
160801046|NCT01911260|580661315|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
160801047|NCT01911260|580661316|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
160801048|NCT01911260|580661317|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
160801049|NCT01911260|580661314|FG000|Follow-up Period|transference or evasion of school|13|||
160801050|NCT01911260|580661315|FG001|Follow-up Period|transference or evasion of school|20|||
160801051|NCT01911260|580661316|FG002|Follow-up Period|transference or evasion of school|15|||
160801052|NCT01911260|580661317|FG003|Follow-up Period|transference or evasion of school|12|||
160801053|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
160801054|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
160801055|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
160801056|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
160801057|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
160801058|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
160984884|NCT02179918|581333824|FG001|Overall Study|Subject refused further follow-up|1|||
160984885|NCT02179918|581333825|FG002|Overall Study|Subject refused further follow-up|0|||
160984886|NCT02179918|581333826|FG003|Overall Study|Subject refused further follow-up|0|||
160984887|NCT02179918|581333827|FG004|Overall Study|Subject refused further follow-up|1|||
160801059|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
160801060|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
160801061|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
160801062|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
160801063|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
160801064|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
160801065|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
160801066|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
160801067|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
160801068|NCT00546481|580661323|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
160801069|NCT00546481|580661324|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
160801070|NCT00546481|580661325|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
160801071|NCT00546481|580661323|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
160801072|NCT00546481|580661324|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
160801073|NCT00546481|580661325|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
160801074|NCT00546481|580661323|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
160801075|NCT00546481|580661324|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
160801076|NCT00546481|580661325|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
160801077|NCT00546481|580661323|FG000|Maintenance Phase (CERA)|Other Reason|0|||
160801078|NCT00546481|580661324|FG001|Maintenance Phase (CERA)|Other Reason|0|||
160801079|NCT00546481|580661325|FG002|Maintenance Phase (CERA)|Other Reason|1|||
160801080|NCT02271529|580661331|FG000|Overall Study|Withdrawal by Subject|1|||
160801081|NCT03508050|580661333|FG000|Overall Study|Pleural adhesions|1|||
160801082|NCT03508050|580661334|FG001|Overall Study|Pleural adhesions|0|||
160801083|NCT03508050|580661333|FG000|Overall Study|Mucus plug|1|||
160801084|NCT03508050|580661334|FG001|Overall Study|Mucus plug|0|||
160801085|NCT03508050|580661333|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
160801086|NCT03508050|580661334|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
160801087|NCT03508050|580661333|FG000|Overall Study|Sustained desaturation|0|||
160801088|NCT03508050|580661334|FG001|Overall Study|Sustained desaturation|1|||
160801089|NCT01082614|580661335|FG000|Overall Study|Adverse Event|1|||
160801090|NCT01082614|580661336|FG001|Overall Study|Adverse Event|4|||
160801091|NCT01082614|580661335|FG000|Overall Study|Equipment Malfunction|0|||
160801092|NCT01082614|580661336|FG001|Overall Study|Equipment Malfunction|1|||
160801093|NCT01082614|580661335|FG000|Overall Study|Physician Decision|2|||
160801094|NCT01082614|580661336|FG001|Overall Study|Physician Decision|0|||
160801095|NCT00811720|580661337|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
160801096|NCT00811720|580661338|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
160801097|NCT00811720|580661337|FG000|All Treated Patients|Adverse Event|20|||
160801098|NCT00811720|580661338|FG001|All Treated Patients|Adverse Event|62|||
160801099|NCT00811720|580661337|FG000|All Treated Patients|Lack of Efficacy|22|||
160801100|NCT00811720|580661338|FG001|All Treated Patients|Lack of Efficacy|18|||
160801101|NCT00811720|580661337|FG000|All Treated Patients|Non-compliance|0|||
160801102|NCT00811720|580661338|FG001|All Treated Patients|Non-compliance|14|||
160801103|NCT00811720|580661337|FG000|All Treated Patients|Protocol Violation|9|||
160801104|NCT00811720|580661338|FG001|All Treated Patients|Protocol Violation|16|||
160801105|NCT00811720|580661337|FG000|All Treated Patients|Withdrawal by Subject|28|||
160801106|NCT00811720|580661338|FG001|All Treated Patients|Withdrawal by Subject|34|||
160801107|NCT00811720|580661337|FG000|All Treated Patients|Lost to Follow-up|10|||
160801108|NCT00811720|580661338|FG001|All Treated Patients|Lost to Follow-up|16|||
160801109|NCT00811720|580661337|FG000|All Treated Patients|Other Reason|7|||
160801110|NCT00811720|580661338|FG001|All Treated Patients|Other Reason|4|||
160801111|NCT00950651|580661346|FG000|Overall Study|Adverse Event|17|||
160801112|NCT00950651|580661347|FG001|Overall Study|Adverse Event|20|||
160801113|NCT00950651|580661346|FG000|Overall Study|Death|1|||
160801114|NCT00950651|580661347|FG001|Overall Study|Death|0|||
160801115|NCT00950651|580661346|FG000|Overall Study|Lack of Efficacy|2|||
160801116|NCT00950651|580661347|FG001|Overall Study|Lack of Efficacy|2|||
160801117|NCT00950651|580661346|FG000|Overall Study|Protocol Violation|3|||
160896826|NCT00257608|581018680|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
160896827|NCT00257608|581018681|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
160896828|NCT00257608|581018679|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
160896829|NCT00257608|581018680|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
160801118|NCT00950651|580661347|FG001|Overall Study|Protocol Violation|4|||
160801119|NCT00950651|580661346|FG000|Overall Study|Withdrawal by Subject|8|||
160801120|NCT00950651|580661347|FG001|Overall Study|Withdrawal by Subject|9|||
160801121|NCT03783780|580661348|FG000|Overall Study|Withdrawn prior to completion|1|||
160801122|NCT03768427|580661349|FG000|Overall Study|Death|0|||
160801123|NCT03768427|580661350|FG001|Overall Study|Death|0|||
160801124|NCT03768427|580661351|FG002|Overall Study|Death|1|||
160801125|NCT03768427|580661352|FG003|Overall Study|Death|0|||
160801126|NCT03768427|580661349|FG000|Overall Study|Lost to Follow-up|2|||
160801127|NCT03768427|580661350|FG001|Overall Study|Lost to Follow-up|0|||
160801128|NCT03768427|580661351|FG002|Overall Study|Lost to Follow-up|0|||
160801129|NCT03768427|580661352|FG003|Overall Study|Lost to Follow-up|0|||
160801130|NCT03768427|580661349|FG000|Overall Study|Physician Decision|3|||
160801131|NCT03768427|580661350|FG001|Overall Study|Physician Decision|2|||
160801132|NCT03768427|580661351|FG002|Overall Study|Physician Decision|4|||
160801133|NCT03768427|580661352|FG003|Overall Study|Physician Decision|4|||
160801134|NCT03768427|580661349|FG000|Overall Study|Withdrawal by Subject|7|||
160801135|NCT03768427|580661350|FG001|Overall Study|Withdrawal by Subject|2|||
160801136|NCT03768427|580661351|FG002|Overall Study|Withdrawal by Subject|6|||
160801137|NCT03768427|580661352|FG003|Overall Study|Withdrawal by Subject|7|||
160801138|NCT03710889|580661355|FG000|Overall Study|Adverse Event|2|||
160801139|NCT03710889|580661355|FG000|Overall Study|Protocol Deviation|1|||
160801140|NCT02121509|580661360|FG000|Washout Period (35 Days)|Adverse Event|1|||
160801141|NCT02121509|580661361|FG001|Washout Period (35 Days)|Adverse Event|1|||
160801142|NCT02121509|580661362|FG002|Washout Period (35 Days)|Adverse Event|0|||
160801143|NCT02121509|580661363|FG003|Washout Period (35 Days)|Adverse Event|0|||
160801144|NCT02121509|580661360|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
160801145|NCT02121509|580661361|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
160801146|NCT02121509|580661362|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
160801147|NCT02121509|580661363|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
160801148|NCT02121509|580661360|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
160801149|NCT02121509|580661361|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
160801150|NCT02121509|580661362|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
160801151|NCT02121509|580661363|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
160801152|NCT05076045|580661366|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
160801153|NCT05076045|580661367|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
160801154|NCT02993263|580661369|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
160801155|NCT00829998|580661372|FG000|Washout|Adverse Event|0|||
160801156|NCT00829998|580661373|FG001|Washout|Adverse Event|1|||
160801157|NCT01173679|580663074|FG000|Overall Study|Death|1|||
160801158|NCT00441272|580663075|FG000|Overall Study|Study terminated prior to enrollment|25|||
160801159|NCT00441272|580663076|FG001|Overall Study|Study terminated prior to enrollment|25|||
160801160|NCT02921789|580663077|FG000|Overall Study|Adverse Event|0|||
160801161|NCT02921789|580663078|FG001|Overall Study|Adverse Event|1|||
160801162|NCT02921789|580663077|FG000|Overall Study|Lost to Follow-up|1|||
160896830|NCT00257608|581018681|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
160896831|NCT00257608|581018679|FG000|Chemotherapy Phase|Physician Decision|28|||
160896832|NCT00257608|581018680|FG001|Chemotherapy Phase|Physician Decision|0|||
160801163|NCT02921789|580663078|FG001|Overall Study|Lost to Follow-up|0|||
160801164|NCT02921789|580663077|FG000|Overall Study|Protocol Deviation|2|||
160801165|NCT02921789|580663078|FG001|Overall Study|Protocol Deviation|0|||
160801166|NCT02921789|580663077|FG000|Overall Study|Withdrawal by Subject|2|||
160801167|NCT02921789|580663078|FG001|Overall Study|Withdrawal by Subject|1|||
160801168|NCT02921789|580663077|FG000|Overall Study|Miscellaneous|3|||
160801169|NCT02921789|580663078|FG001|Overall Study|Miscellaneous|2|||
160896833|NCT00257608|581018681|FG002|Chemotherapy Phase|Physician Decision|0|||
160896834|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Adverse Event|0|||
160801170|NCT01944020|580663079|FG000|Overall Study|Withdrawal by Subject|5|||
160801171|NCT01944020|580663080|FG001|Overall Study|Withdrawal by Subject|0|||
160801172|NCT03423602|580663085|FG000|Overall Study|Death|1|||
160801173|NCT03423602|580663085|FG000|Overall Study|Lost to Follow-up|6|||
160801174|NCT03423602|580663085|FG000|Overall Study|Protocol Violation|1|||
160896835|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Adverse Event|34|||
160896836|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Adverse Event|38|||
160896837|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Disease progression|0|||
160896838|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Disease progression|204|||
160896839|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Disease progression|168|||
160896840|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
160896841|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
160896842|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
160896843|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
160896844|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
160896845|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
160896846|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
160801175|NCT03423602|580663085|FG000|Overall Study|Withdrawal by Subject|4|||
160801176|NCT02332187|580663086|FG000|Overall Study|Withdrawal by Subject|2|||
160896847|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
160896848|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
160801177|NCT02332187|580663087|FG001|Overall Study|Withdrawal by Subject|2|||
160801178|NCT02332187|580663086|FG000|Overall Study|Adverse Event|0|||
160801179|NCT02332187|580663087|FG001|Overall Study|Adverse Event|1|||
160801180|NCT02903823|580663088|FG000|Overall Study|Physician Decision|5|||
160801181|NCT02903823|580663088|FG000|Overall Study|Could not advance catheter|1|||
160801182|NCT02903823|580663088|FG000|Overall Study|Catheter dislodgement|1|||
160801183|NCT01462929|580663095|FG000|Overall Study|Adverse Event|3|||
160801184|NCT01462929|580663096|FG001|Overall Study|Adverse Event|3|||
160801185|NCT01462929|580663097|FG002|Overall Study|Adverse Event|4|||
160801186|NCT01462929|580663095|FG000|Overall Study|Withdrawal by Subject|2|||
160801187|NCT01462929|580663096|FG001|Overall Study|Withdrawal by Subject|1|||
160801188|NCT01462929|580663097|FG002|Overall Study|Withdrawal by Subject|0|||
160801189|NCT01462929|580663095|FG000|Overall Study|Lack of Efficacy|0|||
160801190|NCT01462929|580663096|FG001|Overall Study|Lack of Efficacy|0|||
160801191|NCT01462929|580663097|FG002|Overall Study|Lack of Efficacy|1|||
160801192|NCT00887159|580663098|FG000|Overall Study|Disease progression|6|||
160801193|NCT00887159|580663099|FG001|Overall Study|Disease progression|39|||
160801194|NCT00887159|580663100|FG002|Overall Study|Disease progression|33|||
160801195|NCT00887159|580663098|FG000|Overall Study|Adverse Event|3|||
160801196|NCT00887159|580663099|FG001|Overall Study|Adverse Event|4|||
160801197|NCT00887159|580663100|FG002|Overall Study|Adverse Event|17|||
160801198|NCT00887159|580663098|FG000|Overall Study|Death|2|||
160801199|NCT00887159|580663099|FG001|Overall Study|Death|2|||
160801200|NCT00887159|580663100|FG002|Overall Study|Death|0|||
160801201|NCT00887159|580663098|FG000|Overall Study|Withdrawal by Subject|4|||
160801202|NCT00887159|580663099|FG001|Overall Study|Withdrawal by Subject|4|||
160801203|NCT00887159|580663100|FG002|Overall Study|Withdrawal by Subject|2|||
160801204|NCT00887159|580663098|FG000|Overall Study|Alternative therapy|2|||
160801205|NCT00887159|580663099|FG001|Overall Study|Alternative therapy|0|||
160801206|NCT00887159|580663100|FG002|Overall Study|Alternative therapy|0|||
160801207|NCT00887159|580663098|FG000|Overall Study|Physician Decision|1|||
160801208|NCT00887159|580663099|FG001|Overall Study|Physician Decision|1|||
160896849|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
160896850|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
160896851|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
160896852|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
160896853|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
160896854|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
160896855|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Physician Decision|0|||
160896856|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Physician Decision|8|||
160896857|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Physician Decision|11|||
160896858|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
160896859|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
160896860|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
160896861|NCT00257608|581018679|FG000|Post Chemotherapy Phase|Not treated|0|||
160896862|NCT00257608|581018680|FG001|Post Chemotherapy Phase|Not treated|4|||
160896863|NCT00257608|581018681|FG002|Post Chemotherapy Phase|Not treated|7|||
160896864|NCT03673046|581018682|FG000|Overall Study|Adverse Event|1|||
160896865|NCT03673046|581018683|FG001|Overall Study|Adverse Event|1|||
160896866|NCT03673046|581018682|FG000|Overall Study|Withdrawal by Subject|8|||
160896867|NCT03673046|581018683|FG001|Overall Study|Withdrawal by Subject|2|||
160896868|NCT01896050|581018684|FG000|Overall Study|Adverse Event|37|||
160896869|NCT01896050|581018685|FG001|Overall Study|Adverse Event|2|||
160896870|NCT01896050|581018684|FG000|Overall Study|Death|1|||
160896871|NCT01896050|581018685|FG001|Overall Study|Death|0|||
160896872|NCT03693300|581018686|FG000|Overall Study|Withdrawal by Subject|6|||
160896873|NCT03693300|581018687|FG001|Overall Study|Withdrawal by Subject|0|||
160896874|NCT03693300|581018686|FG000|Overall Study|Death|50|||
160896875|NCT03693300|581018687|FG001|Overall Study|Death|2|||
160896876|NCT03693300|581018686|FG000|Overall Study|Lost to Follow-up|2|||
160896877|NCT03693300|581018687|FG001|Overall Study|Lost to Follow-up|0|||
160896878|NCT01824342|581018691|FG000|Overall Study|Withdrawal by Subject|0|||
160896879|NCT01824342|581018692|FG001|Overall Study|Withdrawal by Subject|3|||
160896880|NCT01824342|581018691|FG000|Overall Study|Adverse Event|1|||
160896881|NCT01824342|581018692|FG001|Overall Study|Adverse Event|1|||
160896882|NCT01824342|581018691|FG000|Overall Study|Disease Progression|1|||
160896883|NCT01824342|581018692|FG001|Overall Study|Disease Progression|1|||
160896884|NCT01824342|581018691|FG000|Overall Study|Physician Decision|5|||
160896885|NCT01824342|581018692|FG001|Overall Study|Physician Decision|0|||
160801209|NCT00887159|580663100|FG002|Overall Study|Physician Decision|0|||
160896886|NCT01824342|581018691|FG000|Overall Study|Death|2|||
160896887|NCT01824342|581018692|FG001|Overall Study|Death|0|||
160896888|NCT02486302|581018693|FG000|Overall Study|Discontinued prematurely|410|||
160896889|NCT02486302|581018693|FG000|Overall Study|Documentation not completed|255|||
160896890|NCT02486302|581018693|FG000|Overall Study|Excluded due to legal reasons|8|||
160896891|NCT02486302|581018693|FG000|Overall Study|Not treated|3|||
160984888|NCT04770220|581333830|FG000|Overall Study|Adverse Event|2|||
160984889|NCT04770220|581333831|FG001|Overall Study|Adverse Event|11|||
160984890|NCT04770220|581333830|FG000|Overall Study|Withdrawal by Subject|5|||
160801210|NCT00887159|580663098|FG000|Overall Study|Sympomatic deterioration|1|||
160801211|NCT00887159|580663099|FG001|Overall Study|Sympomatic deterioration|0|||
160801212|NCT00887159|580663100|FG002|Overall Study|Sympomatic deterioration|0|||
160801213|NCT00887159|580663098|FG000|Overall Study|Treatment delayed|1|||
160801214|NCT00887159|580663099|FG001|Overall Study|Treatment delayed|1|||
160801215|NCT00887159|580663100|FG002|Overall Study|Treatment delayed|0|||
160984891|NCT04770220|581333831|FG001|Overall Study|Withdrawal by Subject|11|||
160984892|NCT04770220|581333830|FG000|Overall Study|Lost to Follow-up|4|||
160984893|NCT04770220|581333831|FG001|Overall Study|Lost to Follow-up|3|||
160984894|NCT04770220|581333830|FG000|Overall Study|not otherwise specified|2|||
160984895|NCT04770220|581333831|FG001|Overall Study|not otherwise specified|3|||
160984896|NCT04770220|581333830|FG000|Overall Study|Physician Decision|1|||
160984897|NCT04770220|581333831|FG001|Overall Study|Physician Decision|3|||
160984898|NCT04894903|581333833|FG000|Overall Study|Death|1|||
160984899|NCT04894903|581333834|FG001|Overall Study|Death|0|||
160984900|NCT04894903|581333833|FG000|Overall Study|Pregnancy|1|||
160984901|NCT04894903|581333834|FG001|Overall Study|Pregnancy|0|||
160984902|NCT04894903|581333833|FG000|Overall Study|Withdrawal by Subject|1|||
160801216|NCT00887159|580663098|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
160801217|NCT00887159|580663099|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
160801218|NCT00887159|580663100|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
160801219|NCT00887159|580663098|FG000|Overall Study|Received more tx instead of observation|1|||
160801220|NCT00887159|580663099|FG001|Overall Study|Received more tx instead of observation|0|||
160801221|NCT00887159|580663100|FG002|Overall Study|Received more tx instead of observation|0|||
160801222|NCT00887159|580663098|FG000|Overall Study|Ineligible|5|||
160801223|NCT00887159|580663099|FG001|Overall Study|Ineligible|1|||
160801224|NCT00887159|580663100|FG002|Overall Study|Ineligible|0|||
160801225|NCT00887159|580663098|FG000|Overall Study|Never started assigned therapy|3|||
160801226|NCT00887159|580663099|FG001|Overall Study|Never started assigned therapy|3|||
160801227|NCT00887159|580663100|FG002|Overall Study|Never started assigned therapy|4|||
160801228|NCT06164691|580663102|FG000|Overall Study|Withdrawal by Subject|2|||
160801229|NCT06164691|580663103|FG001|Overall Study|Withdrawal by Subject|0|||
160801230|NCT06164691|580663104|FG002|Overall Study|Withdrawal by Subject|0|||
160801231|NCT02391311|580663105|FG000|Overall Study|Lost to Follow-up|2|||
160801232|NCT02391311|580663106|FG001|Overall Study|Lost to Follow-up|1|||
160801233|NCT02391311|580663105|FG000|Overall Study|deemed ineligible after baseline|1|||
160801234|NCT02391311|580663106|FG001|Overall Study|deemed ineligible after baseline|1|||
160801235|NCT00305448|580663107|FG000|Overall Study|Protocol Violation|0|||
160801236|NCT00305448|580663108|FG001|Overall Study|Protocol Violation|1|||
160801237|NCT00305448|580663109|FG002|Overall Study|Protocol Violation|0|||
160801238|NCT00305448|580663107|FG000|Overall Study|Withdrawal by Subject|2|||
160801239|NCT00305448|580663108|FG001|Overall Study|Withdrawal by Subject|0|||
160984903|NCT04894903|581333834|FG001|Overall Study|Withdrawal by Subject|1|||
160984904|NCT04894903|581333833|FG000|Overall Study|moved or exited health system|1|||
160984905|NCT04894903|581333834|FG001|Overall Study|moved or exited health system|3|||
160801240|NCT00305448|580663109|FG002|Overall Study|Withdrawal by Subject|1|||
160801241|NCT00305448|580663107|FG000|Overall Study|Adverse Event|1|||
160801242|NCT00305448|580663108|FG001|Overall Study|Adverse Event|0|||
160801243|NCT00305448|580663109|FG002|Overall Study|Adverse Event|1|||
160801244|NCT00305448|580663107|FG000|Overall Study|Disease Progression|27|||
160801245|NCT00305448|580663108|FG001|Overall Study|Disease Progression|31|||
160801246|NCT00305448|580663109|FG002|Overall Study|Disease Progression|28|||
160801247|NCT00305448|580663107|FG000|Overall Study|Subjective Disease Progression|1|||
160801248|NCT00305448|580663108|FG001|Overall Study|Subjective Disease Progression|2|||
160801249|NCT00305448|580663109|FG002|Overall Study|Subjective Disease Progression|2|||
160801250|NCT00305448|580663107|FG000|Overall Study|Tumor Marker Elevation|0|||
160801251|NCT00305448|580663108|FG001|Overall Study|Tumor Marker Elevation|0|||
160801252|NCT00305448|580663109|FG002|Overall Study|Tumor Marker Elevation|1|||
160801253|NCT01343888|580663110|FG000|Overall Study|Adverse Event|12|||
160801254|NCT01343888|580663111|FG001|Overall Study|Adverse Event|22|||
160801255|NCT01343888|580663112|FG002|Overall Study|Adverse Event|5|||
160801256|NCT01343888|580663110|FG000|Overall Study|Lack of Efficacy|9|||
160801257|NCT01343888|580663111|FG001|Overall Study|Lack of Efficacy|9|||
160801258|NCT01343888|580663112|FG002|Overall Study|Lack of Efficacy|13|||
160801259|NCT01343888|580663110|FG000|Overall Study|Lost to Follow-up|0|||
160801260|NCT01343888|580663111|FG001|Overall Study|Lost to Follow-up|2|||
160801261|NCT01343888|580663112|FG002|Overall Study|Lost to Follow-up|1|||
160801262|NCT01343888|580663110|FG000|Overall Study|Protocol Violation|0|||
160801263|NCT01343888|580663111|FG001|Overall Study|Protocol Violation|2|||
160801264|NCT01343888|580663112|FG002|Overall Study|Protocol Violation|0|||
160801265|NCT01343888|580663110|FG000|Overall Study|Withdrawal by Subject|4|||
160801266|NCT01343888|580663111|FG001|Overall Study|Withdrawal by Subject|4|||
160801267|NCT01343888|580663112|FG002|Overall Study|Withdrawal by Subject|2|||
160801268|NCT01343888|580663110|FG000|Overall Study|other than stated above|0|||
160984906|NCT01923428|581333836|FG000|Overall Study|Adverse Event|8|||
160801269|NCT01343888|580663111|FG001|Overall Study|other than stated above|0|||
160801270|NCT01343888|580663112|FG002|Overall Study|other than stated above|1|||
160801271|NCT00558636|580663114|FG000|Treatment|Adverse Event|9|||
160801272|NCT00558636|580663115|FG001|Treatment|Adverse Event|2|||
160801273|NCT00558636|580663114|FG000|Treatment|Withdrawal by Subject|2|||
160801274|NCT00558636|580663115|FG001|Treatment|Withdrawal by Subject|0|||
160801275|NCT00558636|580663114|FG000|Treatment|Premature termination of the study|35|||
160984907|NCT01923428|581333837|FG001|Overall Study|Adverse Event|6|||
160896892|NCT02899299|581018696|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
160896893|NCT02899299|581018697|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
160896894|NCT02899299|581018696|FG000|Pre-treatment|Participant withdrew consent|1|||
160896895|NCT02899299|581018697|FG001|Pre-treatment|Participant withdrew consent|11|||
160896896|NCT02899299|581018696|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
160896897|NCT02899299|581018697|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
160896898|NCT02899299|581018696|FG000|Pre-treatment|Not reported|0|||
160896899|NCT02899299|581018697|FG001|Pre-treatment|Not reported|1|||
160896900|NCT02899299|581018696|FG000|Treatment|Disease Progression|182|||
160896901|NCT02899299|581018697|FG001|Treatment|Disease Progression|43|||
160896902|NCT02899299|581018696|FG000|Treatment|Study Drug Toxicity|60|||
160896903|NCT02899299|581018697|FG001|Treatment|Study Drug Toxicity|24|||
160896904|NCT02899299|581018696|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
160896905|NCT02899299|581018697|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
160896906|NCT02899299|581018696|FG000|Treatment|Participant request to discontinue Study treatment|4|||
160896907|NCT02899299|581018697|FG001|Treatment|Participant request to discontinue Study treatment|10|||
160896908|NCT02899299|581018696|FG000|Treatment|Participant withdrew consent|6|||
160896909|NCT02899299|581018697|FG001|Treatment|Participant withdrew consent|3|||
160896910|NCT02899299|581018696|FG000|Treatment|Lost to Follow-up|0|||
160896911|NCT02899299|581018697|FG001|Treatment|Lost to Follow-up|2|||
160896912|NCT02899299|581018696|FG000|Treatment|Maximum Clinical Benefit|11|||
160896913|NCT02899299|581018697|FG001|Treatment|Maximum Clinical Benefit|2|||
160896914|NCT02899299|581018696|FG000|Treatment|Poor/Non-compliance|1|||
160896915|NCT02899299|581018697|FG001|Treatment|Poor/Non-compliance|0|||
160896916|NCT02899299|581018696|FG000|Treatment|Participant no longer meets Study criteria|4|||
160896917|NCT02899299|581018697|FG001|Treatment|Participant no longer meets Study criteria|0|||
160896918|NCT02899299|581018696|FG000|Treatment|Administrative reason by Sponsor|2|||
160896919|NCT02899299|581018697|FG001|Treatment|Administrative reason by Sponsor|0|||
160896920|NCT02899299|581018696|FG000|Treatment|Other reasons|12|||
160896921|NCT02899299|581018697|FG001|Treatment|Other reasons|2|||
160896922|NCT02899299|581018696|FG000|Treatment|Not reported|7|||
160896923|NCT02899299|581018697|FG001|Treatment|Not reported|0|||
160896924|NCT01926015|581018698|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160896925|NCT01926015|581018699|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160896926|NCT01926015|581018698|FG000|Overall Study|Randomized not treated|2|||
160896927|NCT01926015|581018699|FG001|Overall Study|Randomized not treated|0|||
160896928|NCT01364649|581018700|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
160896929|NCT01364649|581018701|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
160896930|NCT01364649|581018700|FG000|Overall Study|Lack of Efficacy|6|||
160896931|NCT01364649|581018701|FG001|Overall Study|Lack of Efficacy|0|||
160896932|NCT01364649|581018700|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
160896933|NCT01364649|581018701|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
160896934|NCT01364649|581018700|FG000|Overall Study|Protocol Deviations|4|||
160896935|NCT01364649|581018701|FG001|Overall Study|Protocol Deviations|8|||
160896936|NCT01364649|581018700|FG000|Overall Study|Withdrawal of Consent|9|||
160896937|NCT01364649|581018701|FG001|Overall Study|Withdrawal of Consent|7|||
160896938|NCT01364649|581018700|FG000|Overall Study|Lost to Follow-up|12|||
160896939|NCT01364649|581018701|FG001|Overall Study|Lost to Follow-up|13|||
160896940|NCT01364649|581018700|FG000|Overall Study|Other|4|||
160896941|NCT01364649|581018701|FG001|Overall Study|Other|1|||
160896942|NCT01826604|581018702|FG000|Overall Study|Lost to Follow-up|8|||
160896943|NCT01826604|581018703|FG001|Overall Study|Lost to Follow-up|9|||
160896944|NCT06132659|581018704|FG000|Overall Study|Lost to Follow-up|0|||
160896945|NCT06132659|581018705|FG001|Overall Study|Lost to Follow-up|1|||
160896946|NCT06132659|581018706|FG002|Overall Study|Lost to Follow-up|0|||
160896947|NCT03615326|581018707|FG000|Overall Study|Death|266|||
160896948|NCT03615326|581018708|FG001|Overall Study|Death|286|||
160896949|NCT03615326|581018709|FG002|Overall Study|Death|14|||
160984908|NCT01923428|581333838|FG002|Overall Study|Adverse Event|3|||
160984909|NCT01923428|581333839|FG003|Overall Study|Adverse Event|3|||
160984910|NCT01923428|581333836|FG000|Overall Study|Withdrawal by Subject|5|||
160896950|NCT03615326|581018710|FG003|Overall Study|Death|17|||
160896951|NCT03615326|581018707|FG000|Overall Study|Lost to Follow-up|0|||
160896952|NCT03615326|581018708|FG001|Overall Study|Lost to Follow-up|1|||
160896953|NCT03615326|581018709|FG002|Overall Study|Lost to Follow-up|0|||
160896954|NCT03615326|581018710|FG003|Overall Study|Lost to Follow-up|0|||
160896955|NCT03615326|581018707|FG000|Overall Study|Withdrawal by Subject|1|||
160896956|NCT03615326|581018708|FG001|Overall Study|Withdrawal by Subject|3|||
160896957|NCT03615326|581018709|FG002|Overall Study|Withdrawal by Subject|0|||
160984911|NCT01923428|581333837|FG001|Overall Study|Withdrawal by Subject|3|||
160896958|NCT03615326|581018710|FG003|Overall Study|Withdrawal by Subject|0|||
160896959|NCT03615326|581018707|FG000|Overall Study|Participants Ongoing|83|||
160896960|NCT03615326|581018708|FG001|Overall Study|Participants Ongoing|58|||
160896961|NCT03615326|581018709|FG002|Overall Study|Participants Ongoing|6|||
160896962|NCT03615326|581018710|FG003|Overall Study|Participants Ongoing|3|||
160896963|NCT03794583|581018711|FG000|Overall Study|Death|8|||
160801276|NCT00558636|580663115|FG001|Treatment|Premature termination of the study|37|||
160801277|NCT00558636|580663114|FG000|Treatment|Disease progression|1|||
160801278|NCT00558636|580663115|FG001|Treatment|Disease progression|5|||
160801279|NCT00558636|580663114|FG000|Follow-up|Premature termination of the study|12|||
160801280|NCT00558636|580663115|FG001|Follow-up|Premature termination of the study|7|||
160801281|NCT01990742|580663116|FG000|Overall Study|Withdrawal by facility|407|||
160801282|NCT01990742|580663117|FG001|Overall Study|Withdrawal by facility|1083|||
160801283|NCT01990742|580663116|FG000|Overall Study|Facility closed|0|||
160801284|NCT01990742|580663117|FG001|Overall Study|Facility closed|270|||
160801285|NCT03443687|580663118|FG000|Overall Study|Lost to Follow-up|3|||
160801286|NCT03443687|580663119|FG001|Overall Study|Lost to Follow-up|5|||
160801287|NCT03443687|580663118|FG000|Overall Study|Withdrawal by Subject|1|||
160801288|NCT03443687|580663119|FG001|Overall Study|Withdrawal by Subject|0|||
160801289|NCT03443687|580663118|FG000|Overall Study|Discontinued intervention|1|||
160801290|NCT03443687|580663119|FG001|Overall Study|Discontinued intervention|1|||
160801291|NCT00800735|580663120|FG000|Overall Study|Administrative/Other|2|||
160801292|NCT00800735|580663120|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160801293|NCT00800735|580663120|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
160801294|NCT00800735|580663120|FG000|Overall Study|Withdrew Consent|3|||
160801295|NCT02805790|580663121|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
160801296|NCT02805790|580663122|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
160801297|NCT00506142|580663123|FG000|Overall Study|Adverse Event|8|||
161129812|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
160801298|NCT00506142|580663124|FG001|Overall Study|Adverse Event|7|||
160801299|NCT00506142|580663123|FG000|Overall Study|Lack of Efficacy|21|||
160801300|NCT00506142|580663124|FG001|Overall Study|Lack of Efficacy|7|||
160801301|NCT00506142|580663123|FG000|Overall Study|Withdrawal by Subject|4|||
160801302|NCT00506142|580663124|FG001|Overall Study|Withdrawal by Subject|5|||
160801303|NCT00506142|580663123|FG000|Overall Study|Physician Decision|1|||
160801304|NCT00506142|580663124|FG001|Overall Study|Physician Decision|0|||
160801305|NCT00506142|580663123|FG000|Overall Study|New health condition|1|||
160801306|NCT00506142|580663124|FG001|Overall Study|New health condition|0|||
160801307|NCT02154061|580663125|FG000|Overall Study|Pregnancy|1|||
160801308|NCT02154061|580663126|FG001|Overall Study|Pregnancy|0|||
160801309|NCT02154061|580663125|FG000|Overall Study|enrolled but not vaccinated|1|||
160801310|NCT02154061|580663126|FG001|Overall Study|enrolled but not vaccinated|0|||
160801311|NCT01936831|580663127|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801312|NCT01936831|580663128|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801313|NCT01936831|580663129|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801314|NCT01936831|580663130|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801315|NCT01936831|580663131|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801316|NCT01936831|580663132|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
160801317|NCT01936831|580663133|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801318|NCT01936831|580663134|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801319|NCT01936831|580663135|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
160801320|NCT02133573|580663141|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
160801321|NCT02133573|580663142|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
160801322|NCT02133573|580663141|FG000|Overall Study|Child Deaths|3|||
160801323|NCT02133573|580663142|FG001|Overall Study|Child Deaths|5|||
160801324|NCT02133573|580663141|FG000|Overall Study|Child Declined Follow Ups|2|||
160896964|NCT03794583|581018711|FG000|Overall Study|Study Terminated by Sponsor|24|||
160896965|NCT03794583|581018711|FG000|Overall Study|Withdrawal by Subject|9|||
160896966|NCT02497612|581018712|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
160896967|NCT02497612|581018713|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
160896968|NCT02497612|581018714|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
160896969|NCT02497612|581018715|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
160896970|NCT02497612|581018712|FG000|Overall Study|Participant's request|2|||
160896971|NCT02497612|581018713|FG001|Overall Study|Participant's request|3|||
160896972|NCT02497612|581018714|FG002|Overall Study|Participant's request|4|||
160896973|NCT02497612|581018715|FG003|Overall Study|Participant's request|1|||
160896974|NCT02497612|581018712|FG000|Overall Study|Investigator's judgement|1|||
160896975|NCT02497612|581018713|FG001|Overall Study|Investigator's judgement|0|||
160896976|NCT02497612|581018714|FG002|Overall Study|Investigator's judgement|0|||
160896977|NCT02497612|581018715|FG003|Overall Study|Investigator's judgement|2|||
160896978|NCT02497612|581018712|FG000|Overall Study|Adverse Event|3|||
160896979|NCT02497612|581018713|FG001|Overall Study|Adverse Event|1|||
160896980|NCT02497612|581018714|FG002|Overall Study|Adverse Event|4|||
161129813|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
160801325|NCT02133573|580663142|FG001|Overall Study|Child Declined Follow Ups|1|||
160801326|NCT02133573|580663141|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
160801327|NCT02133573|580663142|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
160801328|NCT02808429|580663144|FG000|Overall Study|Lost to Follow-up|1|||
160801329|NCT02808429|580663145|FG001|Overall Study|Lost to Follow-up|0|||
160801330|NCT02808429|580663146|FG002|Overall Study|Lost to Follow-up|0|||
160801331|NCT02808429|580663144|FG000|Overall Study|Protocol Violation|0|||
160801332|NCT02808429|580663145|FG001|Overall Study|Protocol Violation|1|||
160801333|NCT02808429|580663146|FG002|Overall Study|Protocol Violation|0|||
160801334|NCT02808429|580663144|FG000|Overall Study|Premature study termination by sponsor|2|||
160801335|NCT02808429|580663145|FG001|Overall Study|Premature study termination by sponsor|0|||
160801336|NCT02808429|580663146|FG002|Overall Study|Premature study termination by sponsor|1|||
160801337|NCT02808429|580663144|FG000|Overall Study|Relocation|0|||
160801338|NCT02808429|580663145|FG001|Overall Study|Relocation|0|||
160801339|NCT02808429|580663146|FG002|Overall Study|Relocation|1|||
160801340|NCT01436110|580663147|FG000|Overall Study|Lack of Efficacy|23|||
160801341|NCT01436110|580663148|FG001|Overall Study|Lack of Efficacy|14|||
160801342|NCT01436110|580663149|FG002|Overall Study|Lack of Efficacy|9|||
160801343|NCT01436110|580663147|FG000|Overall Study|Withdrawal by Subject|6|||
160801344|NCT01436110|580663148|FG001|Overall Study|Withdrawal by Subject|8|||
160801345|NCT01436110|580663149|FG002|Overall Study|Withdrawal by Subject|4|||
160801346|NCT01436110|580663147|FG000|Overall Study|Adverse Event|2|||
160801347|NCT01436110|580663148|FG001|Overall Study|Adverse Event|1|||
160801348|NCT01436110|580663149|FG002|Overall Study|Adverse Event|2|||
160801349|NCT01436110|580663147|FG000|Overall Study|Physician Decision|3|||
160801350|NCT01436110|580663148|FG001|Overall Study|Physician Decision|1|||
160801351|NCT01436110|580663149|FG002|Overall Study|Physician Decision|1|||
160801352|NCT01436110|580663147|FG000|Overall Study|Lost to Follow-up|1|||
160801353|NCT01436110|580663148|FG001|Overall Study|Lost to Follow-up|1|||
160801354|NCT01436110|580663149|FG002|Overall Study|Lost to Follow-up|3|||
160801355|NCT01436110|580663147|FG000|Overall Study|Protocol Violation|3|||
160801356|NCT01436110|580663148|FG001|Overall Study|Protocol Violation|1|||
160801357|NCT01436110|580663149|FG002|Overall Study|Protocol Violation|1|||
160801358|NCT01436110|580663147|FG000|Overall Study|Did Not Receive Trial Medication|1|||
160801359|NCT01436110|580663148|FG001|Overall Study|Did Not Receive Trial Medication|0|||
160801360|NCT01436110|580663149|FG002|Overall Study|Did Not Receive Trial Medication|3|||
160801361|NCT03273907|580663150|FG000|Overall Study|Death|1|||
160801362|NCT03273907|580663150|FG000|Overall Study|Lost to Follow-up|4|||
160801363|NCT03273907|580663150|FG000|Overall Study|Withdrawal by Subject|2|||
160801364|NCT03273907|580663150|FG000|Overall Study|COVID 19|2|||
160801365|NCT01088503|580663151|FG000|Overall Study|Withdrawal by Subject|118|||
160801366|NCT01088503|580663152|FG001|Overall Study|Withdrawal by Subject|327|||
160801367|NCT01088503|580663153|FG002|Overall Study|Withdrawal by Subject|10|||
160801368|NCT01088503|580663151|FG000|Overall Study|Death|64|||
160801369|NCT01088503|580663152|FG001|Overall Study|Death|358|||
160801370|NCT01088503|580663153|FG002|Overall Study|Death|7|||
160801371|NCT00110214|580663154|FG000|Overall Study|Never started treatment|21|||
160801372|NCT00110214|580663155|FG001|Overall Study|Never started treatment|20|||
160801373|NCT00110214|580663154|FG000|Overall Study|Disease progression or death|260|||
160801374|NCT00110214|580663155|FG001|Overall Study|Disease progression or death|151|||
160801375|NCT00110214|580663154|FG000|Overall Study|Adverse Event|115|||
160801376|NCT00110214|580663155|FG001|Overall Study|Adverse Event|192|||
160801377|NCT00110214|580663154|FG000|Overall Study|Refused further treatment|52|||
160801378|NCT00110214|580663155|FG001|Overall Study|Refused further treatment|65|||
160801379|NCT00110214|580663154|FG000|Overall Study|Other (not specified)|61|||
160801380|NCT00110214|580663155|FG001|Overall Study|Other (not specified)|75|||
160801381|NCT01673646|580663158|FG000|Overall Study|Adverse Event|2|||
160801382|NCT01673646|580663159|FG001|Overall Study|Adverse Event|1|||
160801383|NCT01673646|580663160|FG002|Overall Study|Adverse Event|1|||
160801384|NCT01673646|580663158|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160801385|NCT01673646|580663159|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160801386|NCT01673646|580663160|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160801387|NCT01673646|580663158|FG000|Overall Study|Condition no longer requires study drug|0|||
160801388|NCT01673646|580663159|FG001|Overall Study|Condition no longer requires study drug|1|||
160801389|NCT01673646|580663160|FG002|Overall Study|Condition no longer requires study drug|0|||
160801390|NCT01673646|580663158|FG000|Overall Study|Withdrawal by Subject|0|||
160801391|NCT01673646|580663159|FG001|Overall Study|Withdrawal by Subject|2|||
160801392|NCT01673646|580663160|FG002|Overall Study|Withdrawal by Subject|2|||
160801393|NCT01673646|580663158|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
160801394|NCT01673646|580663159|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
160801395|NCT01673646|580663160|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
160801396|NCT04577781|580663164|FG000|Overall Study|Adverse Event|2|||
160801397|NCT04577781|580663165|FG001|Overall Study|Adverse Event|2|||
160984912|NCT01923428|581333838|FG002|Overall Study|Withdrawal by Subject|0|||
160801398|NCT04577781|580663164|FG000|Overall Study|Physician Decision|1|||
160801399|NCT04577781|580663165|FG001|Overall Study|Physician Decision|0|||
160801400|NCT03894891|580663166|FG000|Overall Study|Withdrawal by Subject|1|||
160801401|NCT03894891|580663166|FG000|Overall Study|Completed protocol treatment per protocol|5|||
160801402|NCT04389866|580663170|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
160801403|NCT04389866|580663171|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
160801404|NCT00776789|580663174|FG000|Overall Study|Consent refusal|2|||
160801405|NCT00776789|580663175|FG001|Overall Study|Consent refusal|2|||
160801406|NCT00776789|580663174|FG000|Overall Study|Poor quality video|1|||
160801407|NCT00776789|580663175|FG001|Overall Study|Poor quality video|1|||
160801408|NCT04940130|580663176|FG000|Overall Study|Travel|1|||
160801409|NCT04940130|580663177|FG001|Overall Study|Travel|0|||
160801410|NCT04940130|580663178|FG002|Overall Study|Travel|2|||
160801411|NCT04940130|580663176|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
160801412|NCT04940130|580663177|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
160801413|NCT04940130|580663178|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
160801414|NCT04940130|580663176|FG000|Overall Study|Adverse Event|0|||
160801415|NCT04940130|580663177|FG001|Overall Study|Adverse Event|0|||
160801416|NCT04940130|580663178|FG002|Overall Study|Adverse Event|2|||
160801417|NCT04940130|580663176|FG000|Overall Study|Disease progression/treatment failure|0|||
160801418|NCT04940130|580663177|FG001|Overall Study|Disease progression/treatment failure|0|||
160801419|NCT04940130|580663178|FG002|Overall Study|Disease progression/treatment failure|1|||
160801420|NCT04940130|580663176|FG000|Overall Study|Participant refusal|0|||
160801421|NCT04940130|580663177|FG001|Overall Study|Participant refusal|0|||
160801422|NCT04940130|580663178|FG002|Overall Study|Participant refusal|1|||
160801423|NCT02850978|580663181|FG000|Overall Study|Uncollectable CRF|27|||
160801424|NCT02850978|580663181|FG000|Overall Study|No visit since the first visit|35|||
160801425|NCT02850978|580663181|FG000|Overall Study|Adverse Event|81|||
160801426|NCT02850978|580663181|FG000|Overall Study|Lack of Efficacy|40|||
160801427|NCT02850978|580663181|FG000|Overall Study|Improvement in condition|34|||
160801428|NCT02850978|580663181|FG000|Overall Study|Lost to Follow-up|121|||
160801429|NCT02850978|580663181|FG000|Overall Study|Reason not listed|88|||
160801430|NCT00114127|580663182|FG000|Overall Study|Adverse Event|2|||
160801431|NCT00114127|580663183|FG001|Overall Study|Adverse Event|1|||
160801432|NCT00114127|580663182|FG000|Overall Study|Lost to Follow-up|1|||
160801433|NCT00114127|580663183|FG001|Overall Study|Lost to Follow-up|0|||
160801434|NCT00114127|580663182|FG000|Overall Study|Withdrawal by Subject|1|||
160801435|NCT00114127|580663183|FG001|Overall Study|Withdrawal by Subject|3|||
160801436|NCT00421148|580663184|FG000|Overall Study|Lost to Follow-up|0|||
160801437|NCT00421148|580663185|FG001|Overall Study|Lost to Follow-up|0|||
160801438|NCT00421148|580663186|FG002|Overall Study|Lost to Follow-up|0|||
160801439|NCT00421148|580663187|FG003|Overall Study|Lost to Follow-up|0|||
160801440|NCT00421148|580663188|FG004|Overall Study|Lost to Follow-up|0|||
160801441|NCT00421148|580663189|FG005|Overall Study|Lost to Follow-up|0|||
160801442|NCT00421148|580663190|FG006|Overall Study|Lost to Follow-up|0|||
160801443|NCT00421148|580663191|FG007|Overall Study|Lost to Follow-up|0|||
160801444|NCT00421148|580663192|FG008|Overall Study|Lost to Follow-up|0|||
160801445|NCT00421148|580663193|FG009|Overall Study|Lost to Follow-up|0|||
160801446|NCT00421148|580663194|FG010|Overall Study|Lost to Follow-up|0|||
160801447|NCT00421148|580663195|FG011|Overall Study|Lost to Follow-up|0|||
160801448|NCT00421148|580663196|FG012|Overall Study|Lost to Follow-up|0|||
160801449|NCT00421148|580663197|FG013|Overall Study|Lost to Follow-up|0|||
160801450|NCT00421148|580663198|FG014|Overall Study|Lost to Follow-up|0|||
160801451|NCT00421148|580663199|FG015|Overall Study|Lost to Follow-up|0|||
160801452|NCT00421148|580663200|FG016|Overall Study|Lost to Follow-up|0|||
160801453|NCT00421148|580663201|FG017|Overall Study|Lost to Follow-up|1|||
160801454|NCT00421148|580663202|FG018|Overall Study|Lost to Follow-up|0|||
160801455|NCT00421148|580663203|FG019|Overall Study|Lost to Follow-up|0|||
160801456|NCT00421148|580663184|FG000|Overall Study|Withdrawal by Subject|0|||
160801457|NCT00421148|580663185|FG001|Overall Study|Withdrawal by Subject|0|||
160801458|NCT00421148|580663186|FG002|Overall Study|Withdrawal by Subject|0|||
160801459|NCT00421148|580663187|FG003|Overall Study|Withdrawal by Subject|0|||
160801460|NCT00421148|580663188|FG004|Overall Study|Withdrawal by Subject|0|||
160801461|NCT00421148|580663189|FG005|Overall Study|Withdrawal by Subject|0|||
160801462|NCT00421148|580663190|FG006|Overall Study|Withdrawal by Subject|0|||
160801463|NCT00421148|580663191|FG007|Overall Study|Withdrawal by Subject|0|||
160801464|NCT00421148|580663192|FG008|Overall Study|Withdrawal by Subject|0|||
160801465|NCT00421148|580663193|FG009|Overall Study|Withdrawal by Subject|0|||
160801466|NCT00421148|580663194|FG010|Overall Study|Withdrawal by Subject|0|||
160801467|NCT00421148|580663195|FG011|Overall Study|Withdrawal by Subject|0|||
160801468|NCT00421148|580663196|FG012|Overall Study|Withdrawal by Subject|0|||
160801469|NCT00421148|580663197|FG013|Overall Study|Withdrawal by Subject|0|||
160801470|NCT00421148|580663198|FG014|Overall Study|Withdrawal by Subject|0|||
160801471|NCT00421148|580663199|FG015|Overall Study|Withdrawal by Subject|0|||
160801472|NCT00421148|580663200|FG016|Overall Study|Withdrawal by Subject|0|||
160801473|NCT00421148|580663201|FG017|Overall Study|Withdrawal by Subject|1|||
160801474|NCT00421148|580663202|FG018|Overall Study|Withdrawal by Subject|0|||
160801475|NCT00421148|580663203|FG019|Overall Study|Withdrawal by Subject|0|||
160801476|NCT00421148|580663184|FG000|Overall Study|Protocol Violation|0|||
160801477|NCT00421148|580663185|FG001|Overall Study|Protocol Violation|0|||
160801478|NCT00421148|580663186|FG002|Overall Study|Protocol Violation|0|||
160801479|NCT00421148|580663187|FG003|Overall Study|Protocol Violation|0|||
160801480|NCT00421148|580663188|FG004|Overall Study|Protocol Violation|0|||
160801481|NCT00421148|580663189|FG005|Overall Study|Protocol Violation|1|||
160801482|NCT00421148|580663190|FG006|Overall Study|Protocol Violation|0|||
160801483|NCT00421148|580663191|FG007|Overall Study|Protocol Violation|0|||
160801484|NCT00421148|580663192|FG008|Overall Study|Protocol Violation|0|||
160801485|NCT00421148|580663193|FG009|Overall Study|Protocol Violation|0|||
160801486|NCT00421148|580663194|FG010|Overall Study|Protocol Violation|0|||
160801487|NCT00421148|580663195|FG011|Overall Study|Protocol Violation|0|||
160801488|NCT00421148|580663196|FG012|Overall Study|Protocol Violation|0|||
160801489|NCT00421148|580663197|FG013|Overall Study|Protocol Violation|0|||
160801490|NCT00421148|580663198|FG014|Overall Study|Protocol Violation|0|||
160801491|NCT00421148|580663199|FG015|Overall Study|Protocol Violation|0|||
160801492|NCT00421148|580663200|FG016|Overall Study|Protocol Violation|0|||
160801493|NCT00421148|580663201|FG017|Overall Study|Protocol Violation|0|||
160801494|NCT00421148|580663202|FG018|Overall Study|Protocol Violation|1|||
160801495|NCT00421148|580663203|FG019|Overall Study|Protocol Violation|0|||
160801496|NCT00570713|580663204|FG000|Overall Study|Adverse Event|16|||
160801497|NCT00570713|580663205|FG001|Overall Study|Adverse Event|9|||
160801498|NCT00570713|580663204|FG000|Overall Study|Death|7|||
160801499|NCT00570713|580663205|FG001|Overall Study|Death|7|||
160801500|NCT00570713|580663204|FG000|Overall Study|Lack of Efficacy|40|||
160801501|NCT00570713|580663205|FG001|Overall Study|Lack of Efficacy|49|||
160801502|NCT00570713|580663204|FG000|Overall Study|Physician Decision|2|||
160801503|NCT00570713|580663205|FG001|Overall Study|Physician Decision|2|||
160801504|NCT00570713|580663204|FG000|Overall Study|Withdrawal by Subject|3|||
160801505|NCT00570713|580663205|FG001|Overall Study|Withdrawal by Subject|3|||
160801506|NCT00570713|580663204|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
160801507|NCT00570713|580663205|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
160801508|NCT00469833|580663206|FG000|Overall Study|No IV access|2|||
160801509|NCT03289533|580663207|FG000|Overall Study|Death|12|||
160801510|NCT03289533|580663207|FG000|Overall Study|Terminated from study by sponsor|10|||
160801511|NCT00539240|580663208|FG000|Overall Study|Withdrawal by Subject|0|||
160801512|NCT00539240|580663209|FG001|Overall Study|Withdrawal by Subject|2|||
160801513|NCT00539240|580663210|FG002|Overall Study|Withdrawal by Subject|0|||
160801514|NCT00539240|580663208|FG000|Overall Study|Protocol Violation|1|||
160801515|NCT00539240|580663209|FG001|Overall Study|Protocol Violation|1|||
160801516|NCT00539240|580663210|FG002|Overall Study|Protocol Violation|4|||
160801517|NCT00539240|580663208|FG000|Overall Study|Lost to Follow-up|2|||
160801518|NCT00539240|580663209|FG001|Overall Study|Lost to Follow-up|3|||
160801519|NCT00539240|580663210|FG002|Overall Study|Lost to Follow-up|1|||
160801520|NCT00539240|580663208|FG000|Overall Study|Adverse Event|3|||
160801521|NCT00539240|580663209|FG001|Overall Study|Adverse Event|1|||
160801522|NCT00539240|580663210|FG002|Overall Study|Adverse Event|10|||
160801523|NCT01284959|580663211|FG000|Overall Study|Withdrawal by Subject|1|||
160801524|NCT01284959|580663212|FG001|Overall Study|Withdrawal by Subject|0|||
160801525|NCT01284959|580663213|FG002|Overall Study|Withdrawal by Subject|0|||
160801526|NCT01284959|580663211|FG000|Overall Study|Adverse Event|0|||
160801527|NCT01284959|580663212|FG001|Overall Study|Adverse Event|0|||
160801528|NCT01284959|580663213|FG002|Overall Study|Adverse Event|1|||
160801529|NCT01055613|580663214|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
160801530|NCT01055613|580663215|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160801531|NCT01055613|580663214|FG000|Overall Study|Unacceptable lens fit|1|||
160801532|NCT01055613|580663215|FG001|Overall Study|Unacceptable lens fit|0|||
160801533|NCT01055613|580663214|FG000|Overall Study|Discomfort|2|||
160801534|NCT01055613|580663215|FG001|Overall Study|Discomfort|1|||
160801535|NCT01055613|580663214|FG000|Overall Study|Lost to Follow-up|1|||
160801536|NCT01055613|580663215|FG001|Overall Study|Lost to Follow-up|1|||
160801537|NCT01055613|580663214|FG000|Overall Study|Protocol Violation|1|||
160801538|NCT01055613|580663215|FG001|Overall Study|Protocol Violation|1|||
160801539|NCT01055613|580663214|FG000|Overall Study|Subject Disinterest|1|||
160801540|NCT01055613|580663215|FG001|Overall Study|Subject Disinterest|1|||
160801541|NCT00363311|580663216|FG000|Overall Study|Adverse Event|6|||
160801542|NCT00363311|580663217|FG001|Overall Study|Adverse Event|4|||
160801543|NCT00363311|580663216|FG000|Overall Study|Lost to Follow-up|3|||
160984913|NCT01923428|581333839|FG003|Overall Study|Withdrawal by Subject|4|||
160984914|NCT01923428|581333836|FG000|Overall Study|Lost to Follow-up|2|||
160801544|NCT00363311|580663217|FG001|Overall Study|Lost to Follow-up|0|||
160801545|NCT00363311|580663216|FG000|Overall Study|Protocol Violation|1|||
160801546|NCT00363311|580663217|FG001|Overall Study|Protocol Violation|2|||
160801547|NCT00363311|580663216|FG000|Overall Study|Withdrawal by Subject|12|||
160801548|NCT00363311|580663217|FG001|Overall Study|Withdrawal by Subject|6|||
160801549|NCT00363311|580663216|FG000|Overall Study|Physician Decision|1|||
160801550|NCT00363311|580663217|FG001|Overall Study|Physician Decision|1|||
160801551|NCT00363311|580663216|FG000|Overall Study|Sponsor Terminated Study|2|||
160801552|NCT00363311|580663217|FG001|Overall Study|Sponsor Terminated Study|2|||
160801553|NCT00363311|580663216|FG000|Overall Study|Disease Progression|46|||
160801554|NCT00363311|580663217|FG001|Overall Study|Disease Progression|26|||
160801555|NCT00363311|580663216|FG000|Overall Study|Non-Compliance|1|||
160801556|NCT00363311|580663217|FG001|Overall Study|Non-Compliance|1|||
160801557|NCT00363311|580663216|FG000|Overall Study|Participant Refused Biopsy|1|||
160801558|NCT00363311|580663217|FG001|Overall Study|Participant Refused Biopsy|0|||
160801559|NCT00363311|580663216|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
160801560|NCT00363311|580663217|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
160984915|NCT01923428|581333837|FG001|Overall Study|Lost to Follow-up|1|||
160984916|NCT01923428|581333838|FG002|Overall Study|Lost to Follow-up|5|||
160984917|NCT01923428|581333839|FG003|Overall Study|Lost to Follow-up|0|||
160984918|NCT01923428|581333836|FG000|Overall Study|Protocol Violation|3|||
160984919|NCT01923428|581333837|FG001|Overall Study|Protocol Violation|0|||
160984920|NCT01923428|581333838|FG002|Overall Study|Protocol Violation|2|||
160984921|NCT01923428|581333839|FG003|Overall Study|Protocol Violation|1|||
160984922|NCT01923428|581333836|FG000|Overall Study|Non Compliance to treatment|1|||
160984923|NCT01923428|581333837|FG001|Overall Study|Non Compliance to treatment|2|||
160984924|NCT01923428|581333838|FG002|Overall Study|Non Compliance to treatment|0|||
160984925|NCT01923428|581333839|FG003|Overall Study|Non Compliance to treatment|1|||
160984926|NCT01923428|581333836|FG000|Overall Study|Lack of Efficacy|0|||
160984927|NCT01923428|581333837|FG001|Overall Study|Lack of Efficacy|0|||
160984928|NCT01923428|581333838|FG002|Overall Study|Lack of Efficacy|1|||
160984929|NCT01923428|581333839|FG003|Overall Study|Lack of Efficacy|1|||
160984930|NCT04320615|581333840|FG000|Overall Study|Withdrawal by Subject|4|||
160984931|NCT04320615|581333841|FG001|Overall Study|Withdrawal by Subject|10|||
160984932|NCT04320615|581333840|FG000|Overall Study|Physician Decision|2|||
160984933|NCT04320615|581333841|FG001|Overall Study|Physician Decision|0|||
160984934|NCT04320615|581333840|FG000|Overall Study|Other|2|||
160984935|NCT04320615|581333841|FG001|Overall Study|Other|0|||
160984936|NCT04320615|581333840|FG000|Overall Study|Lost to Follow-up|5|||
161331993|NCT01395810|582601566|FG000|Overall Study|Unclassified|2|||
161331994|NCT01395810|582601567|FG001|Overall Study|Unclassified|0|||
161331995|NCT01395810|582601568|FG002|Overall Study|Unclassified|0|||
161331996|NCT01395810|582601569|FG003|Overall Study|Unclassified|0|||
161331997|NCT04579380|582603476|FG000|Overall Study|Death|9|||
161331998|NCT04579380|582603477|FG001|Overall Study|Death|22|||
161331999|NCT04579380|582603478|FG002|Overall Study|Death|22|||
161332000|NCT04579380|582603479|FG003|Overall Study|Death|17|||
161332001|NCT04579380|582603480|FG004|Overall Study|Death|6|||
161332002|NCT04579380|582603481|FG005|Overall Study|Death|21|||
161332003|NCT04579380|582603482|FG006|Overall Study|Death|10|||
161332004|NCT04579380|582603483|FG007|Overall Study|Death|11|||
161332005|NCT04579380|582603484|FG008|Overall Study|Death|25|||
161332006|NCT04579380|582603476|FG000|Overall Study|Withdrawal by Subject|0|||
161332007|NCT04579380|582603477|FG001|Overall Study|Withdrawal by Subject|3|||
161332008|NCT04579380|582603478|FG002|Overall Study|Withdrawal by Subject|4|||
161332009|NCT04579380|582603479|FG003|Overall Study|Withdrawal by Subject|0|||
161332010|NCT04579380|582603480|FG004|Overall Study|Withdrawal by Subject|1|||
161332011|NCT04579380|582603481|FG005|Overall Study|Withdrawal by Subject|2|||
161332012|NCT04579380|582603482|FG006|Overall Study|Withdrawal by Subject|0|||
161332013|NCT04579380|582603483|FG007|Overall Study|Withdrawal by Subject|1|||
161332014|NCT04579380|582603484|FG008|Overall Study|Withdrawal by Subject|2|||
161332015|NCT04579380|582603476|FG000|Overall Study|Ongoing|2|||
161332016|NCT04579380|582603477|FG001|Overall Study|Ongoing|6|||
161332017|NCT04579380|582603478|FG002|Overall Study|Ongoing|4|||
161332018|NCT04579380|582603479|FG003|Overall Study|Ongoing|8|||
161332019|NCT04579380|582603480|FG004|Overall Study|Ongoing|5|||
161332020|NCT04579380|582603481|FG005|Overall Study|Ongoing|8|||
161332021|NCT04579380|582603482|FG006|Overall Study|Ongoing|3|||
161332022|NCT04579380|582603483|FG007|Overall Study|Ongoing|19|||
161332023|NCT04579380|582603484|FG008|Overall Study|Ongoing|6|||
161332024|NCT04113694|582603486|FG000|Overall Study|Adverse Event|2|||
161332025|NCT04113694|582603486|FG000|Overall Study|Lost to Follow-up|2|||
161332026|NCT04113694|582603486|FG000|Overall Study|Withdrawal by Subject|6|||
161332027|NCT04113694|582603486|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
161332028|NCT05630196|582603489|FG000|Overall Study|Adverse Event|2|||
161332029|NCT05630196|582603490|FG001|Overall Study|Adverse Event|1|||
161332030|NCT05630196|582603489|FG000|Overall Study|Lost to Follow-up|1|||
161332031|NCT05630196|582603490|FG001|Overall Study|Lost to Follow-up|1|||
161332032|NCT05630196|582603489|FG000|Overall Study|Protocol Violation|2|||
161332033|NCT05630196|582603490|FG001|Overall Study|Protocol Violation|3|||
161332034|NCT05630196|582603489|FG000|Overall Study|Physician Decision|1|||
161332035|NCT05630196|582603490|FG001|Overall Study|Physician Decision|0|||
161332036|NCT05630196|582603489|FG000|Overall Study|Withdrawal by Subject|3|||
161332037|NCT05630196|582603490|FG001|Overall Study|Withdrawal by Subject|4|||
161332038|NCT03973996|582603492|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161332039|NCT03973996|582603493|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161332040|NCT03973996|582603494|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161332041|NCT03973996|582603495|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
161332042|NCT04070989|582603496|FG000|Overall Study|Death|1|||
161332043|NCT04070989|582603497|FG001|Overall Study|Death|0|||
160984937|NCT04320615|581333841|FG001|Overall Study|Lost to Follow-up|23|||
161332044|NCT04070989|582603498|FG002|Overall Study|Death|0|||
161332045|NCT04070989|582603496|FG000|Overall Study|Study Terminated by Sponsor|7|||
161332046|NCT04070989|582603497|FG001|Overall Study|Study Terminated by Sponsor|8|||
160984938|NCT04320615|581333840|FG000|Overall Study|Death|35|||
160984939|NCT04320615|581333841|FG001|Overall Study|Death|71|||
161332047|NCT04070989|582603498|FG002|Overall Study|Study Terminated by Sponsor|23|||
160801561|NCT00363311|580663216|FG000|Overall Study|Participant Opted for Treatment|1|||
160801562|NCT00363311|580663217|FG001|Overall Study|Participant Opted for Treatment|0|||
160801563|NCT00363311|580663216|FG000|Overall Study|Participant Moved to Another Country|1|||
160801564|NCT00363311|580663217|FG001|Overall Study|Participant Moved to Another Country|0|||
160801565|NCT00363311|580663216|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
160801566|NCT00363311|580663217|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
160801567|NCT00363311|580663216|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
160801568|NCT00363311|580663217|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
160801569|NCT00363311|580663216|FG000|Overall Study|Participant Moved to Louisiana|0|||
160801570|NCT00363311|580663217|FG001|Overall Study|Participant Moved to Louisiana|1|||
160801571|NCT00401843|580663218|FG000|Overall Study|Achieved Complete Response|1|||
160801572|NCT00401843|580663219|FG001|Overall Study|Achieved Complete Response|5|||
160801573|NCT00401843|580663220|FG002|Overall Study|Achieved Complete Response|11|||
160801574|NCT00401843|580663218|FG000|Overall Study|Adverse Event|7|||
160801575|NCT00401843|580663219|FG001|Overall Study|Adverse Event|26|||
160801576|NCT00401843|580663220|FG002|Overall Study|Adverse Event|27|||
160801577|NCT00401843|580663218|FG000|Overall Study|Death|0|||
160801578|NCT00401843|580663219|FG001|Overall Study|Death|8|||
160801579|NCT00401843|580663220|FG002|Overall Study|Death|10|||
160801580|NCT00401843|580663218|FG000|Overall Study|Disease progression|10|||
160801581|NCT00401843|580663219|FG001|Overall Study|Disease progression|60|||
160801582|NCT00401843|580663220|FG002|Overall Study|Disease progression|49|||
160801583|NCT00401843|580663218|FG000|Overall Study|End of Study|1|||
160801584|NCT00401843|580663219|FG001|Overall Study|End of Study|1|||
160801585|NCT00401843|580663220|FG002|Overall Study|End of Study|2|||
160801586|NCT00401843|580663218|FG000|Overall Study|Lost to Follow-up|0|||
160801587|NCT00401843|580663219|FG001|Overall Study|Lost to Follow-up|0|||
160801588|NCT00401843|580663220|FG002|Overall Study|Lost to Follow-up|2|||
160801589|NCT00401843|580663218|FG000|Overall Study|Other Unspecified|0|||
160801590|NCT00401843|580663219|FG001|Overall Study|Other Unspecified|3|||
160801591|NCT00401843|580663220|FG002|Overall Study|Other Unspecified|5|||
160801592|NCT00401843|580663218|FG000|Overall Study|Physician Decision|0|||
160801593|NCT00401843|580663219|FG001|Overall Study|Physician Decision|16|||
160801594|NCT00401843|580663220|FG002|Overall Study|Physician Decision|10|||
160801595|NCT00401843|580663218|FG000|Overall Study|Protocol Violation|0|||
160801596|NCT00401843|580663219|FG001|Overall Study|Protocol Violation|0|||
160801597|NCT00401843|580663220|FG002|Overall Study|Protocol Violation|1|||
160801598|NCT00401843|580663218|FG000|Overall Study|Withdrawal by Subject|1|||
160801599|NCT00401843|580663219|FG001|Overall Study|Withdrawal by Subject|5|||
160801600|NCT00401843|580663220|FG002|Overall Study|Withdrawal by Subject|5|||
160801601|NCT00401843|580663218|FG000|Overall Study|Withdrawal of consent to study agent|1|||
160801602|NCT00401843|580663219|FG001|Overall Study|Withdrawal of consent to study agent|15|||
160801603|NCT00401843|580663220|FG002|Overall Study|Withdrawal of consent to study agent|17|||
160801604|NCT00401843|580663218|FG000|Overall Study|Randomized but not Treated|0|||
160801605|NCT00401843|580663219|FG001|Overall Study|Randomized but not Treated|2|||
160801606|NCT00401843|580663220|FG002|Overall Study|Randomized but not Treated|3|||
160801607|NCT00401843|580663218|FG000|Overall Study|Received incorrect treatment|0|||
160801608|NCT00401843|580663219|FG001|Overall Study|Received incorrect treatment|3|||
160801609|NCT00401843|580663220|FG002|Overall Study|Received incorrect treatment|0|||
160801610|NCT04881760|580663223|FG000|Overall Study|Adverse Event|0|||
160896981|NCT02497612|581018715|FG003|Overall Study|Adverse Event|1|||
160896982|NCT02497612|581018712|FG000|Overall Study|Lost to Follow-up|1|||
160896983|NCT02497612|581018713|FG001|Overall Study|Lost to Follow-up|1|||
160896984|NCT02497612|581018714|FG002|Overall Study|Lost to Follow-up|0|||
160896985|NCT02497612|581018715|FG003|Overall Study|Lost to Follow-up|1|||
160801611|NCT04881760|580663224|FG001|Overall Study|Adverse Event|1|||
160801612|NCT04881760|580663225|FG002|Overall Study|Adverse Event|1|||
160801613|NCT04881760|580663226|FG003|Overall Study|Adverse Event|0|||
160801614|NCT04881760|580663227|FG004|Overall Study|Adverse Event|1|||
160896986|NCT02497612|581018712|FG000|Overall Study|Other unspecified|1|||
160896987|NCT02497612|581018713|FG001|Overall Study|Other unspecified|1|||
160896988|NCT02497612|581018714|FG002|Overall Study|Other unspecified|2|||
160984940|NCT03873246|581333843|FG000|Overall Study|Adverse Event|1|||
160801615|NCT04881760|580663228|FG005|Overall Study|Adverse Event|1|||
160801616|NCT04881760|580663229|FG006|Overall Study|Adverse Event|2|||
160801617|NCT04881760|580663223|FG000|Overall Study|Death|0|||
160801618|NCT04881760|580663224|FG001|Overall Study|Death|0|||
160801619|NCT04881760|580663225|FG002|Overall Study|Death|0|||
160801620|NCT04881760|580663226|FG003|Overall Study|Death|1|||
160801621|NCT04881760|580663227|FG004|Overall Study|Death|0|||
160801622|NCT04881760|580663228|FG005|Overall Study|Death|0|||
160801623|NCT04881760|580663229|FG006|Overall Study|Death|0|||
160801624|NCT04881760|580663223|FG000|Overall Study|Lost to Follow-up|5|||
160801625|NCT04881760|580663224|FG001|Overall Study|Lost to Follow-up|7|||
160801626|NCT04881760|580663225|FG002|Overall Study|Lost to Follow-up|5|||
160801627|NCT04881760|580663226|FG003|Overall Study|Lost to Follow-up|1|||
160896989|NCT02497612|581018715|FG003|Overall Study|Other unspecified|0|||
160896990|NCT02497612|581018712|FG000|Overall Study|Not eligible|1|||
160801628|NCT04881760|580663227|FG004|Overall Study|Lost to Follow-up|2|||
160801629|NCT04881760|580663228|FG005|Overall Study|Lost to Follow-up|4|||
160984941|NCT03873246|581333844|FG001|Overall Study|Adverse Event|3|||
160984942|NCT03873246|581333845|FG002|Overall Study|Adverse Event|3|||
160801630|NCT04881760|580663229|FG006|Overall Study|Lost to Follow-up|4|||
160801631|NCT04881760|580663223|FG000|Overall Study|Withdrawal by Subject|13|||
160801632|NCT04881760|580663224|FG001|Overall Study|Withdrawal by Subject|1|||
160984943|NCT03873246|581333843|FG000|Overall Study|Lost to Follow-up|4|||
160984944|NCT03873246|581333844|FG001|Overall Study|Lost to Follow-up|4|||
160984945|NCT03873246|581333845|FG002|Overall Study|Lost to Follow-up|5|||
160984946|NCT03873246|581333843|FG000|Overall Study|Protocol Violation|0|||
160984947|NCT03873246|581333844|FG001|Overall Study|Protocol Violation|1|||
160984948|NCT03873246|581333845|FG002|Overall Study|Protocol Violation|0|||
160984949|NCT03873246|581333843|FG000|Overall Study|Withdrawal by Subject|0|||
160984950|NCT03873246|581333844|FG001|Overall Study|Withdrawal by Subject|4|||
160984951|NCT03873246|581333845|FG002|Overall Study|Withdrawal by Subject|1|||
160984952|NCT00946647|581333846|FG000|Phase 1 Part|Adverse Event|2|||
160984953|NCT00946647|581333847|FG001|Phase 1 Part|Adverse Event|5|||
160984954|NCT00946647|581333848|FG002|Phase 1 Part|Adverse Event|3|||
160801633|NCT04881760|580663225|FG002|Overall Study|Withdrawal by Subject|1|||
160801634|NCT04881760|580663226|FG003|Overall Study|Withdrawal by Subject|4|||
160801635|NCT04881760|580663227|FG004|Overall Study|Withdrawal by Subject|2|||
160801636|NCT04881760|580663228|FG005|Overall Study|Withdrawal by Subject|1|||
160801637|NCT04881760|580663229|FG006|Overall Study|Withdrawal by Subject|2|||
160801638|NCT04881760|580663223|FG000|Overall Study|Randomized but Never Treated|0|||
160801639|NCT04881760|580663224|FG001|Overall Study|Randomized but Never Treated|0|||
160801640|NCT04881760|580663225|FG002|Overall Study|Randomized but Never Treated|0|||
160801641|NCT04881760|580663226|FG003|Overall Study|Randomized but Never Treated|1|||
160801642|NCT04881760|580663227|FG004|Overall Study|Randomized but Never Treated|0|||
160801643|NCT04881760|580663228|FG005|Overall Study|Randomized but Never Treated|0|||
160801644|NCT04881760|580663229|FG006|Overall Study|Randomized but Never Treated|0|||
160801645|NCT04881760|580663223|FG000|Overall Study|Inadvertent Enrollment|2|||
160801646|NCT04881760|580663224|FG001|Overall Study|Inadvertent Enrollment|0|||
160801647|NCT04881760|580663225|FG002|Overall Study|Inadvertent Enrollment|0|||
160984955|NCT00946647|581333849|FG003|Phase 1 Part|Adverse Event|0|||
160984956|NCT00946647|581333850|FG004|Phase 1 Part|Adverse Event|0|||
160984957|NCT00946647|581333846|FG000|Phase 1 Part|Disease progression|3|||
160984958|NCT00946647|581333847|FG001|Phase 1 Part|Disease progression|6|||
160984959|NCT00946647|581333848|FG002|Phase 1 Part|Disease progression|1|||
160984960|NCT00946647|581333849|FG003|Phase 1 Part|Disease progression|0|||
160984961|NCT00946647|581333850|FG004|Phase 1 Part|Disease progression|0|||
160984962|NCT00946647|581333846|FG000|Phase 1 Part|Withdrawal by Subject|1|||
160984963|NCT00946647|581333847|FG001|Phase 1 Part|Withdrawal by Subject|4|||
160984964|NCT00946647|581333848|FG002|Phase 1 Part|Withdrawal by Subject|3|||
160801648|NCT04881760|580663226|FG003|Overall Study|Inadvertent Enrollment|0|||
160801649|NCT04881760|580663227|FG004|Overall Study|Inadvertent Enrollment|0|||
160801650|NCT04881760|580663228|FG005|Overall Study|Inadvertent Enrollment|0|||
160801651|NCT04881760|580663229|FG006|Overall Study|Inadvertent Enrollment|0|||
160801652|NCT04881760|580663223|FG000|Overall Study|Site Closure|0|||
160801653|NCT04881760|580663224|FG001|Overall Study|Site Closure|0|||
160801654|NCT04881760|580663225|FG002|Overall Study|Site Closure|0|||
160801655|NCT04881760|580663226|FG003|Overall Study|Site Closure|1|||
160801656|NCT04881760|580663227|FG004|Overall Study|Site Closure|0|||
160801657|NCT04881760|580663228|FG005|Overall Study|Site Closure|0|||
160801658|NCT04881760|580663229|FG006|Overall Study|Site Closure|0|||
160801659|NCT01182298|580663230|FG000|Overall Study|Lack of Efficacy|4|||
160801660|NCT01182298|580663230|FG000|Overall Study|Withdrawal by Subject|2|||
160801661|NCT01508910|580663231|FG000|Treatment|Death|2|||
160801662|NCT01508910|580663232|FG001|Treatment|Death|3|||
160801663|NCT01508910|580663233|FG002|Treatment|Death|2|||
160801664|NCT01508910|580663234|FG003|Treatment|Death|0|||
160984965|NCT00946647|581333849|FG003|Phase 1 Part|Withdrawal by Subject|0|||
160984966|NCT00946647|581333850|FG004|Phase 1 Part|Withdrawal by Subject|0|||
160984967|NCT00946647|581333846|FG000|Phase 1 Part|Abnormal values|0|||
160984968|NCT00946647|581333847|FG001|Phase 1 Part|Abnormal values|2|||
160984969|NCT00946647|581333848|FG002|Phase 1 Part|Abnormal values|0|||
161129814|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
160801665|NCT01508910|580663231|FG000|Treatment|Lost to Follow-up|0|||
160801666|NCT01508910|580663232|FG001|Treatment|Lost to Follow-up|0|||
160801667|NCT01508910|580663233|FG002|Treatment|Lost to Follow-up|2|||
160984970|NCT00946647|581333849|FG003|Phase 1 Part|Abnormal values|0|||
160984971|NCT00946647|581333850|FG004|Phase 1 Part|Abnormal values|0|||
160984972|NCT00946647|581333846|FG000|Phase 1 Part|Reason missing|0|||
161237287|NCT00819741|582248534|FG000|Overall Study|Unclassified|6|||
160801668|NCT01508910|580663234|FG003|Treatment|Lost to Follow-up|1|||
160801669|NCT01508910|580663231|FG000|Treatment|Withdrawal by Subject|0|||
160801670|NCT01508910|580663232|FG001|Treatment|Withdrawal by Subject|1|||
160801671|NCT01508910|580663233|FG002|Treatment|Withdrawal by Subject|6|||
160984973|NCT00946647|581333847|FG001|Phase 1 Part|Reason missing|1|||
161332048|NCT04070989|582603496|FG000|Overall Study|Withdrawal by Subject|0|||
161332049|NCT04070989|582603497|FG001|Overall Study|Withdrawal by Subject|1|||
161332050|NCT04070989|582603498|FG002|Overall Study|Withdrawal by Subject|0|||
161332051|NCT04070989|582603496|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
161332052|NCT04070989|582603497|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
161332053|NCT04070989|582603498|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
161332054|NCT04070989|582603496|FG000|Overall Study|Other|1|||
161332055|NCT04070989|582603497|FG001|Overall Study|Other|1|||
161332056|NCT04070989|582603498|FG002|Overall Study|Other|0|||
161332057|NCT06088784|582603499|FG000|Overall Study|Adverse Event|0|||
161332058|NCT06088784|582603500|FG001|Overall Study|Adverse Event|0|||
161332059|NCT06088784|582603501|FG002|Overall Study|Adverse Event|0|||
161332060|NCT06088784|582603502|FG003|Overall Study|Adverse Event|0|||
161332061|NCT06088784|582603503|FG004|Overall Study|Adverse Event|0|||
161332062|NCT06088784|582603504|FG005|Overall Study|Adverse Event|0|||
161332063|NCT06088784|582603505|FG006|Overall Study|Adverse Event|3|||
161332064|NCT06088784|582603506|FG007|Overall Study|Adverse Event|0|||
161332065|NCT06088784|582603507|FG008|Overall Study|Adverse Event|0|||
161332066|NCT06088784|582603508|FG009|Overall Study|Adverse Event|0|||
161332067|NCT06088784|582603509|FG010|Overall Study|Adverse Event|0|||
161332068|NCT06088784|582603510|FG011|Overall Study|Adverse Event|0|||
161332069|NCT06088784|582603499|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332070|NCT06088784|582603500|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332071|NCT06088784|582603501|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332072|NCT06088784|582603502|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332073|NCT06088784|582603503|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332074|NCT06088784|582603504|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332075|NCT06088784|582603505|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
161332076|NCT06088784|582603506|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332077|NCT06088784|582603507|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332078|NCT06088784|582603508|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332079|NCT06088784|582603509|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332080|NCT06088784|582603510|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
161332081|NCT05556616|582603513|FG000|Overall Study|Withdrawal by Subject|1|||
161332082|NCT05556616|582603514|FG001|Overall Study|Withdrawal by Subject|0|||
161332083|NCT05556616|582603515|FG002|Overall Study|Withdrawal by Subject|0|||
161332084|NCT05556616|582603516|FG003|Overall Study|Withdrawal by Subject|0|||
161332085|NCT05556616|582603517|FG004|Overall Study|Withdrawal by Subject|0|||
161332086|NCT05556616|582603518|FG005|Overall Study|Withdrawal by Subject|0|||
161332087|NCT05556616|582603519|FG006|Overall Study|Withdrawal by Subject|0|||
161332088|NCT05556616|582603513|FG000|Overall Study|Death|0|||
161332089|NCT05556616|582603514|FG001|Overall Study|Death|0|||
161332090|NCT05556616|582603515|FG002|Overall Study|Death|2|||
161332091|NCT05556616|582603516|FG003|Overall Study|Death|1|||
161332092|NCT05556616|582603517|FG004|Overall Study|Death|0|||
161332093|NCT05556616|582603518|FG005|Overall Study|Death|0|||
161332094|NCT05556616|582603519|FG006|Overall Study|Death|0|||
161332095|NCT05556616|582603513|FG000|Overall Study|Study Terminated by Sponsor|0|||
161332096|NCT05556616|582603514|FG001|Overall Study|Study Terminated by Sponsor|3|||
161332097|NCT05556616|582603515|FG002|Overall Study|Study Terminated by Sponsor|0|||
161332098|NCT05556616|582603516|FG003|Overall Study|Study Terminated by Sponsor|0|||
161332099|NCT05556616|582603517|FG004|Overall Study|Study Terminated by Sponsor|0|||
161332100|NCT05556616|582603518|FG005|Overall Study|Study Terminated by Sponsor|0|||
161332101|NCT05556616|582603519|FG006|Overall Study|Study Terminated by Sponsor|0|||
161332102|NCT03256578|582603520|FG000|Overall Study|Excluded Post Randomization|66|||
161332103|NCT03256578|582603521|FG001|Overall Study|Excluded Post Randomization|56|||
161332104|NCT05428436|582603522|FG000|Period 1 - 2 washout|Adverse Event|1|||
161332105|NCT05428436|582603523|FG001|Period 1 - 2 washout|Adverse Event|0|||
161332106|NCT05428436|582603524|FG002|Period 1 - 2 washout|Adverse Event|0|||
161332107|NCT03964207|582603525|FG000|First Treatment|Withdrawal by Subject|1|||
161332108|NCT03964207|582603526|FG001|First Treatment|Withdrawal by Subject|2|||
161332109|NCT03964207|582603525|FG000|First Treatment|Protocol Violation|1|||
161332110|NCT03964207|582603526|FG001|First Treatment|Protocol Violation|0|||
161332111|NCT03964207|582603525|FG000|First Treatment|Lost to Follow-up|1|||
161332112|NCT03964207|582603526|FG001|First Treatment|Lost to Follow-up|0|||
161332113|NCT03964207|582603525|FG000|Second Treatment|Lost to Follow-up|0|||
161332114|NCT03964207|582603526|FG001|Second Treatment|Lost to Follow-up|1|||
161332115|NCT03964207|582603525|FG000|Second Treatment|Adverse Event|1|||
161332116|NCT03964207|582603526|FG001|Second Treatment|Adverse Event|2|||
161332117|NCT00830219|582603527|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161332118|NCT00830219|582603528|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161332119|NCT01130272|582603529|FG000|Overall Study|Adverse Event|2|||
161332120|NCT01130272|582603530|FG001|Overall Study|Adverse Event|5|||
161332121|NCT01130272|582603531|FG002|Overall Study|Adverse Event|6|||
161332122|NCT01130272|582603532|FG003|Overall Study|Adverse Event|22|||
161332123|NCT01130272|582603533|FG004|Overall Study|Adverse Event|7|||
161332124|NCT01130272|582603529|FG000|Overall Study|IVRS-confirmed constipation|0|||
160801672|NCT01508910|580663234|FG003|Treatment|Withdrawal by Subject|1|||
160801673|NCT01508910|580663231|FG000|Treatment|Sponsor Decision|0|||
160801674|NCT01508910|580663232|FG001|Treatment|Sponsor Decision|0|||
160801675|NCT01508910|580663233|FG002|Treatment|Sponsor Decision|0|||
160801676|NCT01508910|580663234|FG003|Treatment|Sponsor Decision|1|||
160801677|NCT01595529|580663235|FG000|Overall Study|Adverse Event|2|||
160801678|NCT01595529|580663236|FG001|Overall Study|Adverse Event|0|||
160801679|NCT01595529|580663235|FG000|Overall Study|Subject Non-Compliant|2|||
160801680|NCT01595529|580663236|FG001|Overall Study|Subject Non-Compliant|0|||
160801681|NCT01595529|580663235|FG000|Overall Study|Lost to Follow-up|8|||
160801682|NCT01595529|580663236|FG001|Overall Study|Lost to Follow-up|14|||
160801683|NCT01595529|580663235|FG000|Overall Study|Protocol Violation|1|||
160801684|NCT01595529|580663236|FG001|Overall Study|Protocol Violation|2|||
160801685|NCT01595529|580663235|FG000|Overall Study|Physician Decision|1|||
160801686|NCT01595529|580663236|FG001|Overall Study|Physician Decision|0|||
160801687|NCT01595529|580663235|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
160801688|NCT01595529|580663236|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
160801689|NCT01595529|580663235|FG000|Overall Study|Administrative Decision|1|||
160801690|NCT01595529|580663236|FG001|Overall Study|Administrative Decision|0|||
160801691|NCT01595529|580663235|FG000|Overall Study|Entry Failure/Screening Failure|6|||
160801692|NCT01595529|580663236|FG001|Overall Study|Entry Failure/Screening Failure|1|||
160801693|NCT04016714|580663237|FG000|Overall Study|Death|1|||
160896991|NCT02497612|581018713|FG001|Overall Study|Not eligible|0|||
160896992|NCT02497612|581018714|FG002|Overall Study|Not eligible|0|||
160896993|NCT02497612|581018715|FG003|Overall Study|Not eligible|1|||
160896994|NCT02651467|581018716|FG000|Overall Study|Withdrawal by Subject|0|||
160896995|NCT02651467|581018717|FG001|Overall Study|Withdrawal by Subject|0|||
160896996|NCT02651467|581018718|FG002|Overall Study|Withdrawal by Subject|2|||
160896997|NCT02651467|581018716|FG000|Overall Study|Other (Not specified)|1|||
160896998|NCT02651467|581018717|FG001|Overall Study|Other (Not specified)|0|||
160896999|NCT02651467|581018718|FG002|Overall Study|Other (Not specified)|2|||
160897000|NCT05469113|581018719|FG000|Period 2|Adverse Event|0|||
160801694|NCT04016714|580663238|FG001|Overall Study|Death|0|||
160801695|NCT04016714|580663237|FG000|Overall Study|Lost to Follow-up|3|||
160801696|NCT04016714|580663238|FG001|Overall Study|Lost to Follow-up|1|||
160801697|NCT04016714|580663237|FG000|Overall Study|Physician Decision|3|||
160801698|NCT04016714|580663238|FG001|Overall Study|Physician Decision|3|||
160801699|NCT04016714|580663237|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
160801700|NCT04016714|580663238|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
160801701|NCT01677988|580663244|FG000|Overall Study|Lack of Efficacy|2|||
160801702|NCT02629861|580663249|FG000|Overall Study|Adverse Event|7|||
160801703|NCT02629861|580663250|FG001|Overall Study|Adverse Event|5|||
160801704|NCT02629861|580663251|FG002|Overall Study|Adverse Event|4|||
160801705|NCT02629861|580663249|FG000|Overall Study|Withdrawal by Subject|5|||
160801706|NCT02629861|580663250|FG001|Overall Study|Withdrawal by Subject|8|||
160801707|NCT02629861|580663251|FG002|Overall Study|Withdrawal by Subject|13|||
160897001|NCT05469113|581018720|FG001|Period 2|Adverse Event|3|||
160897002|NCT04553679|581018721|FG000|Overall Study|Withdrawal by Subject|2|||
160897003|NCT04553679|581018722|FG001|Overall Study|Withdrawal by Subject|0|||
160897004|NCT04553679|581018721|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
160801708|NCT02629861|580663249|FG000|Overall Study|Protocol Violation|2|||
160801709|NCT02629861|580663250|FG001|Overall Study|Protocol Violation|3|||
160801710|NCT02629861|580663251|FG002|Overall Study|Protocol Violation|7|||
160801711|NCT02629861|580663249|FG000|Overall Study|Lost to Follow-up|12|||
160801712|NCT02629861|580663250|FG001|Overall Study|Lost to Follow-up|9|||
160897005|NCT04553679|581018722|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
160984974|NCT00946647|581333848|FG002|Phase 1 Part|Reason missing|0|||
160984975|NCT00946647|581333849|FG003|Phase 1 Part|Reason missing|0|||
160984976|NCT00946647|581333850|FG004|Phase 1 Part|Reason missing|0|||
160984977|NCT00946647|581333846|FG000|Phase ll Part|Untreated|0|||
160801713|NCT02629861|580663251|FG002|Overall Study|Lost to Follow-up|4|||
160801714|NCT02629861|580663249|FG000|Overall Study|Other|1|||
160801715|NCT02629861|580663250|FG001|Overall Study|Other|1|||
160897006|NCT01230710|581018724|FG000|Overall Study|Disease Progression|41|||
160897007|NCT01230710|581018724|FG000|Overall Study|Lost to Follow-up|3|||
160897008|NCT01230710|581018724|FG000|Overall Study|Death|4|||
160984978|NCT00946647|581333847|FG001|Phase ll Part|Untreated|0|||
160801716|NCT02629861|580663251|FG002|Overall Study|Other|0|||
160801717|NCT02629861|580663249|FG000|Overall Study|Pregnancy|2|||
160801718|NCT02629861|580663250|FG001|Overall Study|Pregnancy|1|||
160801719|NCT02629861|580663251|FG002|Overall Study|Pregnancy|0|||
160801720|NCT01822665|580663252|FG000|Overall Study|Adverse Event|3|||
160801721|NCT01822665|580663252|FG000|Overall Study|Other Reason|5|||
160801722|NCT00165789|580663259|FG000|Overall Study|Adverse Event|0|||
160801723|NCT00165789|580663260|FG001|Overall Study|Adverse Event|3|||
160801724|NCT00165789|580663261|FG002|Overall Study|Adverse Event|0|||
160801725|NCT00165789|580663262|FG003|Overall Study|Adverse Event|12|||
160897009|NCT01230710|581018724|FG000|Overall Study|Withdrawal of Consent|1|||
160984979|NCT00946647|581333848|FG002|Phase ll Part|Untreated|0|||
160801726|NCT00165789|580663259|FG000|Overall Study|Withdrawal by Subject|0|||
160801727|NCT00165789|580663260|FG001|Overall Study|Withdrawal by Subject|1|||
160801728|NCT00165789|580663261|FG002|Overall Study|Withdrawal by Subject|1|||
160801729|NCT00165789|580663262|FG003|Overall Study|Withdrawal by Subject|2|||
160801730|NCT02031302|580663263|FG000|Overall Study|Death|115|||
160801731|NCT02031302|580663264|FG001|Overall Study|Death|0|||
160801732|NCT02031302|580663263|FG000|Overall Study|Not treated with study valve system|18|||
160801733|NCT02031302|580663264|FG001|Overall Study|Not treated with study valve system|0|||
160801734|NCT02031302|580663263|FG000|Overall Study|Missed Follow Up|27|||
160801735|NCT02031302|580663264|FG001|Overall Study|Missed Follow Up|0|||
160801736|NCT02031302|580663263|FG000|Overall Study|Lost to Follow-up|4|||
160801737|NCT02031302|580663264|FG001|Overall Study|Lost to Follow-up|0|||
160801738|NCT01847443|580663265|FG000|Study Period 1|Withdrawal by Subject|0|||
160801739|NCT01847443|580663266|FG001|Study Period 1|Withdrawal by Subject|1|||
160801740|NCT01847443|580663267|FG002|Study Period 1|Withdrawal by Subject|0|||
160801741|NCT01847443|580663268|FG003|Study Period 1|Withdrawal by Subject|0|||
160801742|NCT01847443|580663265|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
160801743|NCT01847443|580663266|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
160801744|NCT01847443|580663267|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
160801745|NCT01847443|580663268|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
160801746|NCT01847443|580663265|FG000|Washout Period Before Study Period 2|Other reason|1|||
160801747|NCT01847443|580663266|FG001|Washout Period Before Study Period 2|Other reason|0|||
160801748|NCT01847443|580663267|FG002|Washout Period Before Study Period 2|Other reason|0|||
160801749|NCT01847443|580663268|FG003|Washout Period Before Study Period 2|Other reason|0|||
160801750|NCT01847443|580663265|FG000|Washout Period Before Study Period 3|Other reason|1|||
160801751|NCT01847443|580663266|FG001|Washout Period Before Study Period 3|Other reason|0|||
160801752|NCT01847443|580663267|FG002|Washout Period Before Study Period 3|Other reason|0|||
160801753|NCT01847443|580663268|FG003|Washout Period Before Study Period 3|Other reason|0|||
160801754|NCT01847443|580663265|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
160801755|NCT01847443|580663266|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
160801756|NCT01847443|580663267|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
160801757|NCT01847443|580663268|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
160801758|NCT01847443|580663265|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
160801759|NCT01847443|580663266|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
160801760|NCT01847443|580663267|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
160801761|NCT01847443|580663268|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
160801762|NCT04422431|580663269|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
160801763|NCT04422431|580663269|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
160801764|NCT04422431|580663269|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
160801765|NCT04422431|580663269|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
160801766|NCT04422431|580663269|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
160801767|NCT04422431|580663269|FG000|Extension Period (48 Weeks)|Other than specified|2|||
160801768|NCT01174563|580663274|FG000|Overall Study|Progressive Disease|45|||
160801769|NCT01174563|580663274|FG000|Overall Study|Death|5|||
160801770|NCT01174563|580663274|FG000|Overall Study|Investigator's Discretion|5|||
160801771|NCT01174563|580663274|FG000|Overall Study|Participant Withdrew Consent|3|||
160801772|NCT01174563|580663274|FG000|Overall Study|Rash Adverse Event|1|||
160801773|NCT01174563|580663274|FG000|Overall Study|Sponsor's decision|1|||
160801774|NCT03402841|580663275|FG000|Overall Study|Withdrawal by Subject|3|||
160801775|NCT03402841|580663275|FG000|Overall Study|Lost to Follow-up|2|||
160801776|NCT03402841|580663275|FG000|Overall Study|Death|146|||
160801777|NCT00444106|580663276|FG000|Overall Study|Lost to Follow-up|2|||
160801778|NCT00444106|580663277|FG001|Overall Study|Lost to Follow-up|1|||
160801779|NCT00444106|580663278|FG002|Overall Study|Lost to Follow-up|0|||
160801780|NCT00444106|580663276|FG000|Overall Study|Abnormal Test Procedure Results|0|||
160801781|NCT00444106|580663277|FG001|Overall Study|Abnormal Test Procedure Results|0|||
160801782|NCT00444106|580663278|FG002|Overall Study|Abnormal Test Procedure Results|1|||
160801783|NCT04704193|580663279|FG000|Overall Study|Withdrawal by Subject|1|||
160801784|NCT05270863|580663280|FG000|Visit 2 First Intervention|Randomization error|0|||
160897010|NCT02905149|581018725|FG000|Overall Study|Lost to Follow-up|2|||
160897011|NCT02905149|581018726|FG001|Overall Study|Lost to Follow-up|0|||
160897012|NCT00747812|581018727|FG000|Overall Study|Research Site Staff Relocation|5|||
160897013|NCT00747812|581018728|FG001|Overall Study|Research Site Staff Relocation|3|||
160897014|NCT01708161|581018729|FG000|Overall Study|Adverse Event|1|||
160801785|NCT05270863|580663281|FG001|Visit 2 First Intervention|Randomization error|0|||
160801786|NCT05270863|580663282|FG002|Visit 2 First Intervention|Randomization error|0|||
160897015|NCT01708161|581018730|FG001|Overall Study|Adverse Event|3|||
160897016|NCT01708161|581018731|FG002|Overall Study|Adverse Event|4|||
160897017|NCT01708161|581018732|FG003|Overall Study|Adverse Event|2|||
160801787|NCT05270863|580663283|FG003|Visit 2 First Intervention|Randomization error|1|||
160897018|NCT01708161|581018733|FG004|Overall Study|Adverse Event|3|||
161332125|NCT01130272|582603530|FG001|Overall Study|IVRS-confirmed constipation|1|||
160801788|NCT05270863|580663284|FG004|Visit 2 First Intervention|Randomization error|0|||
160801789|NCT05270863|580663285|FG005|Visit 2 First Intervention|Randomization error|0|||
160801790|NCT05270863|580663280|FG000|First Washout|Withdrawal by Subject|0|||
160801791|NCT05270863|580663281|FG001|First Washout|Withdrawal by Subject|0|||
160801792|NCT05270863|580663282|FG002|First Washout|Withdrawal by Subject|0|||
160801793|NCT05270863|580663283|FG003|First Washout|Withdrawal by Subject|0|||
160801794|NCT05270863|580663284|FG004|First Washout|Withdrawal by Subject|1|||
160801795|NCT05270863|580663285|FG005|First Washout|Withdrawal by Subject|1|||
160801796|NCT05270863|580663280|FG000|First Washout|Lost to Follow-up|0|||
160801797|NCT05270863|580663281|FG001|First Washout|Lost to Follow-up|0|||
160801798|NCT05270863|580663282|FG002|First Washout|Lost to Follow-up|0|||
160801799|NCT05270863|580663283|FG003|First Washout|Lost to Follow-up|0|||
160801800|NCT05270863|580663284|FG004|First Washout|Lost to Follow-up|0|||
160801801|NCT05270863|580663285|FG005|First Washout|Lost to Follow-up|1|||
160801802|NCT05270863|580663280|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
160801803|NCT05270863|580663281|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801804|NCT05270863|580663282|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
160801805|NCT05270863|580663283|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801806|NCT05270863|580663284|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801807|NCT05270863|580663285|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
160801808|NCT05270863|580663280|FG000|Second Washout|Withdrawal by Subject|1|||
160801809|NCT05270863|580663281|FG001|Second Washout|Withdrawal by Subject|1|||
160801810|NCT05270863|580663282|FG002|Second Washout|Withdrawal by Subject|0|||
160801811|NCT05270863|580663283|FG003|Second Washout|Withdrawal by Subject|0|||
160801812|NCT05270863|580663284|FG004|Second Washout|Withdrawal by Subject|0|||
160801813|NCT05270863|580663285|FG005|Second Washout|Withdrawal by Subject|0|||
160801814|NCT05270863|580663280|FG000|Second Washout|Lost to Follow-up|0|||
160801815|NCT05270863|580663281|FG001|Second Washout|Lost to Follow-up|0|||
160801816|NCT05270863|580663282|FG002|Second Washout|Lost to Follow-up|0|||
160801817|NCT05270863|580663283|FG003|Second Washout|Lost to Follow-up|1|||
160801818|NCT05270863|580663284|FG004|Second Washout|Lost to Follow-up|0|||
160801819|NCT05270863|580663285|FG005|Second Washout|Lost to Follow-up|0|||
160801820|NCT03984188|580663286|FG000|Overall Study|Death|2|||
160801821|NCT03984188|580663287|FG001|Overall Study|Death|4|||
160801822|NCT03984188|580663286|FG000|Overall Study|Physician Decision|0|||
160801823|NCT03984188|580663287|FG001|Overall Study|Physician Decision|2|||
160801824|NCT03984188|580663286|FG000|Overall Study|Lost to Follow-up|3|||
160801825|NCT03984188|580663287|FG001|Overall Study|Lost to Follow-up|2|||
160801826|NCT03984188|580663286|FG000|Overall Study|Withdrawal by Subject|6|||
160801827|NCT03984188|580663287|FG001|Overall Study|Withdrawal by Subject|0|||
160801828|NCT03384875|580663288|FG000|Overall Study|Death|1|||
160984980|NCT00946647|581333849|FG003|Phase ll Part|Untreated|0|||
160984981|NCT00946647|581333850|FG004|Phase ll Part|Untreated|2|||
160984982|NCT00946647|581333846|FG000|Phase ll Part|Adverse Event|0|||
160984983|NCT00946647|581333847|FG001|Phase ll Part|Adverse Event|0|||
160984984|NCT00946647|581333848|FG002|Phase ll Part|Adverse Event|0|||
160984985|NCT00946647|581333849|FG003|Phase ll Part|Adverse Event|10|||
160801829|NCT03384875|580663289|FG001|Overall Study|Death|1|||
160801830|NCT03384875|580663290|FG002|Overall Study|Death|0|||
160801831|NCT03384875|580663288|FG000|Overall Study|Reason not provided|1|||
160801832|NCT03384875|580663289|FG001|Overall Study|Reason not provided|0|||
160801833|NCT03384875|580663290|FG002|Overall Study|Reason not provided|0|||
160801834|NCT04592341|580665835|FG000|Overall Study|Physician Decision|5|||
160801835|NCT04592341|580665835|FG000|Overall Study|Study Terminated by Sponsor|5|||
160801836|NCT04592341|580665835|FG000|Overall Study|Withdrawal by Subject|53|||
160801837|NCT04592341|580665835|FG000|Overall Study|Lost to Follow-up|3|||
160801838|NCT04592341|580665835|FG000|Overall Study|Death|1|||
160801839|NCT04592341|580665835|FG000|Overall Study|Adverse Event|5|||
160801840|NCT04592341|580665835|FG000|Overall Study|other|4|||
160801841|NCT02896257|580665836|FG000|Providers|Without eligible patients|21|||
160801842|NCT02896257|580665837|FG001|Providers|Without eligible patients|28|||
160801843|NCT02896257|580665836|FG000|Patients|PFT entry criteria not met|43|||
160801844|NCT02896257|580665837|FG001|Patients|PFT entry criteria not met|50|||
160801845|NCT02896257|580665836|FG000|Patients|No capacity to review|8|||
160801846|NCT02896257|580665837|FG001|Patients|No capacity to review|11|||
160801847|NCT02896257|580665836|FG000|Patients|Appointment rescheduled/cancelled|5|||
160801848|NCT02896257|580665837|FG001|Patients|Appointment rescheduled/cancelled|7|||
160801849|NCT02896257|580665836|FG000|Patients|PCP not assigned a clinic|4|||
160801850|NCT02896257|580665837|FG001|Patients|PCP not assigned a clinic|0|||
160801851|NCT02896257|580665836|FG000|Patients|No history of COPD|0|||
160801852|NCT02896257|580665837|FG001|Patients|No history of COPD|1|||
160801853|NCT02896257|580665836|FG000|Patients|Deceased between review and index date|0|||
160801854|NCT02896257|580665837|FG001|Patients|Deceased between review and index date|1|||
160801855|NCT02896257|580665836|FG000|Patients|No ICS Rx upon review|1|||
160801856|NCT02896257|580665837|FG001|Patients|No ICS Rx upon review|1|||
160801857|NCT02896257|580665836|FG000|Patients|Protocol Violation|2|||
160801858|NCT02896257|580665837|FG001|Patients|Protocol Violation|1|||
160801859|NCT02896257|580665836|FG000|Patients|Hospice care|0|||
160801860|NCT02896257|580665837|FG001|Patients|Hospice care|1|||
160801861|NCT03759600|580665838|FG000|Overall Study|Adverse Event|2|||
160801862|NCT03759600|580665838|FG000|Overall Study|Progressive Disease|15|||
160801863|NCT03759600|580665838|FG000|Overall Study|Site Terminated by Sponsor|3|||
160801864|NCT00692003|580665840|FG000|Overall Study|Sponsor Decision|5|||
160801865|NCT00692003|580665841|FG001|Overall Study|Sponsor Decision|1|||
160801866|NCT03257358|580665842|FG000|Overall Study|Adverse Event|25|||
160801867|NCT03257358|580665843|FG001|Overall Study|Adverse Event|12|||
160801868|NCT03257358|580665842|FG000|Overall Study|Lack of Efficacy|1|||
160801869|NCT03257358|580665843|FG001|Overall Study|Lack of Efficacy|1|||
160801870|NCT03257358|580665842|FG000|Overall Study|Lost to Follow-up|12|||
160801871|NCT03257358|580665843|FG001|Overall Study|Lost to Follow-up|4|||
160801872|NCT03257358|580665842|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
160801873|NCT03257358|580665843|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
160801874|NCT03257358|580665842|FG000|Overall Study|Physician Decision|2|||
160801875|NCT03257358|580665843|FG001|Overall Study|Physician Decision|2|||
160801876|NCT03257358|580665842|FG000|Overall Study|Protocol Violation|5|||
160801877|NCT03257358|580665843|FG001|Overall Study|Protocol Violation|3|||
160801878|NCT03257358|580665842|FG000|Overall Study|Technical problems|4|||
160801879|NCT03257358|580665843|FG001|Overall Study|Technical problems|1|||
160801880|NCT03257358|580665842|FG000|Overall Study|Withdrawal by Subject|8|||
160801881|NCT03257358|580665843|FG001|Overall Study|Withdrawal by Subject|3|||
160801882|NCT03257358|580665842|FG000|Overall Study|Withdrawal of informed consent|9|||
160801883|NCT03257358|580665843|FG001|Overall Study|Withdrawal of informed consent|5|||
160801884|NCT03257358|580665842|FG000|Overall Study|New therapy for study indication|1|||
160801885|NCT03257358|580665843|FG001|Overall Study|New therapy for study indication|0|||
160801886|NCT03257358|580665842|FG000|Overall Study|No longer requires treatment|0|||
160801887|NCT03257358|580665843|FG001|Overall Study|No longer requires treatment|1|||
160801888|NCT02852967|580665844|FG000|Overall Study|Adverse Event|3|||
160801889|NCT02852967|580665845|FG001|Overall Study|Adverse Event|1|||
160801890|NCT02852967|580665846|FG002|Overall Study|Adverse Event|0|||
160801891|NCT02852967|580665847|FG003|Overall Study|Adverse Event|1|||
160801892|NCT02852967|580665848|FG004|Overall Study|Adverse Event|0|||
160801893|NCT02852967|580665844|FG000|Overall Study|Death|1|||
160801894|NCT02852967|580665845|FG001|Overall Study|Death|0|||
160801895|NCT02852967|580665846|FG002|Overall Study|Death|0|||
160801896|NCT02852967|580665847|FG003|Overall Study|Death|0|||
160801897|NCT02852967|580665848|FG004|Overall Study|Death|0|||
160801898|NCT02852967|580665844|FG000|Overall Study|Lost to Follow-up|1|||
160801899|NCT02852967|580665845|FG001|Overall Study|Lost to Follow-up|2|||
160801900|NCT02852967|580665846|FG002|Overall Study|Lost to Follow-up|3|||
160801901|NCT02852967|580665847|FG003|Overall Study|Lost to Follow-up|4|||
160801902|NCT02852967|580665848|FG004|Overall Study|Lost to Follow-up|4|||
160801903|NCT02852967|580665844|FG000|Overall Study|Withdrawal by Subject|6|||
160801904|NCT02852967|580665845|FG001|Overall Study|Withdrawal by Subject|12|||
160801905|NCT02852967|580665846|FG002|Overall Study|Withdrawal by Subject|7|||
160801906|NCT02852967|580665847|FG003|Overall Study|Withdrawal by Subject|10|||
160801907|NCT02852967|580665848|FG004|Overall Study|Withdrawal by Subject|10|||
160801908|NCT02852967|580665844|FG000|Overall Study|SAE|0|||
160801909|NCT02852967|580665845|FG001|Overall Study|SAE|0|||
160801910|NCT02852967|580665846|FG002|Overall Study|SAE|0|||
160801911|NCT02852967|580665847|FG003|Overall Study|SAE|3|||
160801912|NCT02852967|580665848|FG004|Overall Study|SAE|0|||
160801913|NCT02852967|580665844|FG000|Overall Study|Elevated Liver Enzymes|2|||
160801914|NCT02852967|580665845|FG001|Overall Study|Elevated Liver Enzymes|0|||
160801915|NCT02852967|580665846|FG002|Overall Study|Elevated Liver Enzymes|0|||
160801916|NCT02852967|580665847|FG003|Overall Study|Elevated Liver Enzymes|2|||
160801917|NCT02852967|580665848|FG004|Overall Study|Elevated Liver Enzymes|2|||
160801918|NCT02852967|580665844|FG000|Overall Study|Physician Decision|0|||
160897019|NCT01708161|581018734|FG005|Overall Study|Adverse Event|0|||
160897020|NCT01708161|581018729|FG000|Overall Study|Death|0|||
160897021|NCT01708161|581018730|FG001|Overall Study|Death|0|||
160897022|NCT01708161|581018731|FG002|Overall Study|Death|0|||
160897023|NCT01708161|581018732|FG003|Overall Study|Death|1|||
160897024|NCT01708161|581018733|FG004|Overall Study|Death|0|||
161237288|NCT00819741|582248535|FG001|Overall Study|Unclassified|0|||
160801919|NCT02852967|580665845|FG001|Overall Study|Physician Decision|0|||
160801920|NCT02852967|580665846|FG002|Overall Study|Physician Decision|0|||
160897025|NCT01708161|581018734|FG005|Overall Study|Death|1|||
160897026|NCT01708161|581018729|FG000|Overall Study|Withdrawal by Subject|0|||
160897027|NCT01708161|581018730|FG001|Overall Study|Withdrawal by Subject|1|||
160801921|NCT02852967|580665847|FG003|Overall Study|Physician Decision|1|||
160801922|NCT02852967|580665848|FG004|Overall Study|Physician Decision|0|||
160801923|NCT02852967|580665844|FG000|Overall Study|Lack of Efficacy|0|||
160801924|NCT02852967|580665845|FG001|Overall Study|Lack of Efficacy|1|||
160801925|NCT02852967|580665846|FG002|Overall Study|Lack of Efficacy|0|||
160801926|NCT02852967|580665847|FG003|Overall Study|Lack of Efficacy|0|||
160801927|NCT02852967|580665848|FG004|Overall Study|Lack of Efficacy|0|||
160801928|NCT02852967|580665844|FG000|Overall Study|Non-compliance|0|||
160801929|NCT02852967|580665845|FG001|Overall Study|Non-compliance|0|||
160801930|NCT02852967|580665846|FG002|Overall Study|Non-compliance|1|||
160801931|NCT02852967|580665847|FG003|Overall Study|Non-compliance|1|||
160801932|NCT02852967|580665848|FG004|Overall Study|Non-compliance|0|||
160801933|NCT02852967|580665844|FG000|Overall Study|Dispensing Drug Violation|0|||
160801934|NCT02852967|580665845|FG001|Overall Study|Dispensing Drug Violation|0|||
160801935|NCT02852967|580665846|FG002|Overall Study|Dispensing Drug Violation|1|||
160801936|NCT02852967|580665847|FG003|Overall Study|Dispensing Drug Violation|0|||
160801937|NCT02852967|580665848|FG004|Overall Study|Dispensing Drug Violation|0|||
160801938|NCT02852967|580665844|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
160801939|NCT02852967|580665845|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
160801940|NCT02852967|580665846|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
160801941|NCT02852967|580665847|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
160801942|NCT02852967|580665848|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
160801943|NCT00339040|580665855|FG000|Stage I|Not able to attend clinic|1|||
160801944|NCT00339040|580665856|FG001|Stage I|Not able to attend clinic|0|||
160801945|NCT00339040|580665855|FG000|Stage I|Protocol Violation|1|||
160801946|NCT00339040|580665856|FG001|Stage I|Protocol Violation|1|||
160801947|NCT00339040|580665855|FG000|Stage II|Lost to Follow-up|3|||
160801948|NCT00339040|580665856|FG001|Stage II|Lost to Follow-up|0|||
160801949|NCT00339040|580665855|FG000|Stage II|Withdrawal by Subject|1|||
160801950|NCT00339040|580665856|FG001|Stage II|Withdrawal by Subject|2|||
160801951|NCT00339040|580665855|FG000|Stage II|Protocol Violation|3|||
160801952|NCT00339040|580665856|FG001|Stage II|Protocol Violation|0|||
160801953|NCT00339040|580665855|FG000|Stage II|Not able to attend clinic|1|||
160801954|NCT00339040|580665856|FG001|Stage II|Not able to attend clinic|0|||
160801955|NCT00339040|580665855|FG000|Stage II|Site closing|2|||
160801956|NCT00339040|580665856|FG001|Stage II|Site closing|0|||
160801957|NCT01747915|580665857|FG000|Overall Study|Other|1|||
160801958|NCT01747915|580665858|FG001|Overall Study|Other|1|||
160801959|NCT01747915|580665859|FG002|Overall Study|Other|1|||
160801960|NCT01747915|580665857|FG000|Overall Study|Adverse Event|8|||
160801961|NCT01747915|580665858|FG001|Overall Study|Adverse Event|5|||
160801962|NCT01747915|580665859|FG002|Overall Study|Adverse Event|2|||
160801963|NCT01747915|580665857|FG000|Overall Study|Death|0|||
160801964|NCT01747915|580665858|FG001|Overall Study|Death|0|||
160801965|NCT01747915|580665859|FG002|Overall Study|Death|1|||
160801966|NCT01747915|580665857|FG000|Overall Study|Lack of Efficacy|0|||
160801967|NCT01747915|580665858|FG001|Overall Study|Lack of Efficacy|1|||
160801968|NCT01747915|580665859|FG002|Overall Study|Lack of Efficacy|0|||
160801969|NCT01747915|580665857|FG000|Overall Study|Lost to Follow-up|1|||
160801970|NCT01747915|580665858|FG001|Overall Study|Lost to Follow-up|0|||
160801971|NCT01747915|580665859|FG002|Overall Study|Lost to Follow-up|0|||
160801972|NCT01747915|580665857|FG000|Overall Study|Withdrawal by Subject|4|||
160801973|NCT01747915|580665858|FG001|Overall Study|Withdrawal by Subject|4|||
160801974|NCT01747915|580665859|FG002|Overall Study|Withdrawal by Subject|1|||
161129815|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
160801975|NCT01747915|580665857|FG000|Overall Study|Protocol Violation|1|||
160801976|NCT01747915|580665858|FG001|Overall Study|Protocol Violation|0|||
160801977|NCT01747915|580665859|FG002|Overall Study|Protocol Violation|0|||
160801978|NCT01747915|580665857|FG000|Overall Study|Pregnancy|0|||
160801979|NCT01747915|580665858|FG001|Overall Study|Pregnancy|0|||
160801980|NCT01747915|580665859|FG002|Overall Study|Pregnancy|1|||
160801981|NCT03341637|580665860|FG000|Overall Study|Lost to Follow-up|1|||
160801982|NCT03341637|580665861|FG001|Overall Study|Lost to Follow-up|0|||
160801983|NCT03341637|580665860|FG000|Overall Study|Withdrawal by Subject|3|||
160801984|NCT03341637|580665861|FG001|Overall Study|Withdrawal by Subject|3|||
160801985|NCT03341637|580665860|FG000|Overall Study|Reason not Specified|1|||
160801986|NCT03341637|580665861|FG001|Overall Study|Reason not Specified|1|||
160801987|NCT00812955|580665862|FG000|Overall Study|Adverse Event|7|||
160801988|NCT00812955|580665863|FG001|Overall Study|Adverse Event|6|||
160801989|NCT00812955|580665864|FG002|Overall Study|Adverse Event|3|||
160801990|NCT00812955|580665865|FG003|Overall Study|Adverse Event|4|||
160801991|NCT00812955|580665862|FG000|Overall Study|Lost to Follow-up|2|||
160801992|NCT00812955|580665863|FG001|Overall Study|Lost to Follow-up|1|||
160801993|NCT00812955|580665864|FG002|Overall Study|Lost to Follow-up|1|||
160801994|NCT00812955|580665865|FG003|Overall Study|Lost to Follow-up|2|||
160801995|NCT00812955|580665862|FG000|Overall Study|Withdrawal by Subject|1|||
160801996|NCT00812955|580665863|FG001|Overall Study|Withdrawal by Subject|0|||
160801997|NCT00812955|580665864|FG002|Overall Study|Withdrawal by Subject|1|||
160801998|NCT00812955|580665865|FG003|Overall Study|Withdrawal by Subject|2|||
160801999|NCT00812955|580665862|FG000|Overall Study|randomized in error|0|||
160802000|NCT00812955|580665863|FG001|Overall Study|randomized in error|0|||
160802001|NCT00812955|580665864|FG002|Overall Study|randomized in error|1|||
160802002|NCT00812955|580665865|FG003|Overall Study|randomized in error|0|||
160802003|NCT03046446|580665866|FG000|Overall Study|Lack of Efficacy|7|||
160802004|NCT03046446|580665866|FG000|Overall Study|Adverse Event|6|||
160802005|NCT03046446|580665866|FG000|Overall Study|Lost to Follow-up|3|||
160802006|NCT03046446|580665866|FG000|Overall Study|Withdrawal by Subject|14|||
160984986|NCT00946647|581333850|FG004|Phase ll Part|Adverse Event|6|||
160802007|NCT03046446|580665866|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
160802008|NCT03046446|580665866|FG000|Overall Study|Disease Progression (see caveats)|25|||
160802009|NCT03046446|580665866|FG000|Overall Study|Non OA related knee surgery|1|||
160802010|NCT03183063|580665867|FG000|Overall Study|Withdrawal by Subject|2|||
160802011|NCT03183063|580665868|FG001|Overall Study|Withdrawal by Subject|0|||
160802012|NCT03183063|580665869|FG002|Overall Study|Withdrawal by Subject|0|||
160802013|NCT03183063|580665867|FG000|Overall Study|Physician Decision|3|||
160802014|NCT03183063|580665868|FG001|Overall Study|Physician Decision|4|||
160802015|NCT03183063|580665869|FG002|Overall Study|Physician Decision|4|||
160802016|NCT00399568|580665870|FG000|Overall Study|Adverse Event|1|||
160802017|NCT00399568|580665871|FG001|Overall Study|Adverse Event|2|||
160802018|NCT00399568|580665870|FG000|Overall Study|Withdrawal by Subject|7|||
160802019|NCT00399568|580665871|FG001|Overall Study|Withdrawal by Subject|3|||
160802020|NCT00399568|580665870|FG000|Overall Study|Protocol non-compliance|2|||
160802021|NCT00399568|580665871|FG001|Overall Study|Protocol non-compliance|2|||
160802022|NCT00399568|580665870|FG000|Overall Study|Lost to Follow-up|2|||
160802023|NCT00399568|580665871|FG001|Overall Study|Lost to Follow-up|2|||
160802024|NCT00925002|580665874|FG000|Overall Study|Other|1|||
160802025|NCT00925002|580665875|FG001|Overall Study|Other|4|||
160802026|NCT00925002|580665876|FG002|Overall Study|Other|0|||
160802027|NCT00925002|580665874|FG000|Overall Study|Death|1|||
160802028|NCT00925002|580665875|FG001|Overall Study|Death|1|||
160802029|NCT00925002|580665876|FG002|Overall Study|Death|5|||
160802030|NCT00925002|580665874|FG000|Overall Study|Adverse Event|3|||
160802031|NCT00925002|580665875|FG001|Overall Study|Adverse Event|1|||
160802032|NCT00925002|580665876|FG002|Overall Study|Adverse Event|2|||
160802033|NCT00925002|580665874|FG000|Overall Study|Participant withdrew consent|1|||
160802034|NCT00925002|580665875|FG001|Overall Study|Participant withdrew consent|3|||
160802035|NCT00925002|580665876|FG002|Overall Study|Participant withdrew consent|3|||
160802036|NCT02071771|580665884|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
160802037|NCT02071771|580665885|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
160802038|NCT02071771|580665884|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
160802039|NCT02071771|580665885|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
160802040|NCT02078752|580665886|FG000|Overall Study|Death|0|||
160802041|NCT02078752|580665887|FG001|Overall Study|Death|3|||
160802042|NCT02078752|580665888|FG002|Overall Study|Death|0|||
160802043|NCT02078752|580665889|FG003|Overall Study|Death|0|||
160802044|NCT02078752|580665890|FG004|Overall Study|Death|0|||
160802045|NCT02078752|580665891|FG005|Overall Study|Death|1|||
160802046|NCT02078752|580665892|FG006|Overall Study|Death|0|||
160802047|NCT02078752|580665893|FG007|Overall Study|Death|1|||
160802048|NCT02078752|580665894|FG008|Overall Study|Death|0|||
160802049|NCT02078752|580665895|FG009|Overall Study|Death|4|||
160802050|NCT02078752|580665886|FG000|Overall Study|Lost to Follow-up|1|||
160802051|NCT02078752|580665887|FG001|Overall Study|Lost to Follow-up|0|||
160802052|NCT02078752|580665888|FG002|Overall Study|Lost to Follow-up|0|||
160802053|NCT02078752|580665889|FG003|Overall Study|Lost to Follow-up|1|||
160802054|NCT02078752|580665890|FG004|Overall Study|Lost to Follow-up|0|||
160802055|NCT02078752|580665891|FG005|Overall Study|Lost to Follow-up|0|||
160802056|NCT02078752|580665892|FG006|Overall Study|Lost to Follow-up|0|||
160802057|NCT02078752|580665893|FG007|Overall Study|Lost to Follow-up|0|||
160802058|NCT02078752|580665894|FG008|Overall Study|Lost to Follow-up|0|||
160802059|NCT02078752|580665895|FG009|Overall Study|Lost to Follow-up|0|||
160802060|NCT02078752|580665886|FG000|Overall Study|Withdrawal by Subject|1|||
160802061|NCT02078752|580665887|FG001|Overall Study|Withdrawal by Subject|1|||
160802062|NCT02078752|580665888|FG002|Overall Study|Withdrawal by Subject|1|||
160802063|NCT02078752|580665889|FG003|Overall Study|Withdrawal by Subject|1|||
160802064|NCT02078752|580665890|FG004|Overall Study|Withdrawal by Subject|0|||
160802065|NCT02078752|580665891|FG005|Overall Study|Withdrawal by Subject|3|||
160802066|NCT02078752|580665892|FG006|Overall Study|Withdrawal by Subject|2|||
160802067|NCT02078752|580665893|FG007|Overall Study|Withdrawal by Subject|1|||
160802068|NCT02078752|580665894|FG008|Overall Study|Withdrawal by Subject|0|||
160802069|NCT02078752|580665895|FG009|Overall Study|Withdrawal by Subject|1|||
160802070|NCT02078752|580665886|FG000|Overall Study|Other|0|||
160802071|NCT02078752|580665887|FG001|Overall Study|Other|3|||
161237289|NCT00819741|582248534|FG000|Overall Study|Reasons unknown|3|||
160802072|NCT02078752|580665888|FG002|Overall Study|Other|0|||
160802073|NCT02078752|580665889|FG003|Overall Study|Other|0|||
160802074|NCT02078752|580665890|FG004|Overall Study|Other|1|||
160802075|NCT02078752|580665891|FG005|Overall Study|Other|0|||
160802076|NCT02078752|580665892|FG006|Overall Study|Other|0|||
160802077|NCT02078752|580665893|FG007|Overall Study|Other|1|||
160802078|NCT02078752|580665894|FG008|Overall Study|Other|0|||
160802079|NCT02078752|580665895|FG009|Overall Study|Other|0|||
160802080|NCT02078752|580665886|FG000|Overall Study|Study terminated by sponsor|0|||
160802081|NCT02078752|580665887|FG001|Overall Study|Study terminated by sponsor|0|||
160802082|NCT02078752|580665888|FG002|Overall Study|Study terminated by sponsor|0|||
160802083|NCT02078752|580665889|FG003|Overall Study|Study terminated by sponsor|0|||
160802084|NCT02078752|580665890|FG004|Overall Study|Study terminated by sponsor|0|||
160802085|NCT02078752|580665891|FG005|Overall Study|Study terminated by sponsor|0|||
160984987|NCT00946647|581333846|FG000|Phase ll Part|Withdrawal by Subject|0|||
160984988|NCT00946647|581333847|FG001|Phase ll Part|Withdrawal by Subject|0|||
160984989|NCT00946647|581333848|FG002|Phase ll Part|Withdrawal by Subject|0|||
160984990|NCT00946647|581333849|FG003|Phase ll Part|Withdrawal by Subject|8|||
160984991|NCT00946647|581333850|FG004|Phase ll Part|Withdrawal by Subject|6|||
160984992|NCT00946647|581333846|FG000|Phase ll Part|Administrative problems|0|||
160984993|NCT00946647|581333847|FG001|Phase ll Part|Administrative problems|0|||
160984994|NCT00946647|581333848|FG002|Phase ll Part|Administrative problems|0|||
160984995|NCT00946647|581333849|FG003|Phase ll Part|Administrative problems|3|||
160984996|NCT00946647|581333850|FG004|Phase ll Part|Administrative problems|8|||
160984997|NCT00946647|581333846|FG000|Phase ll Part|Death|0|||
160984998|NCT00946647|581333847|FG001|Phase ll Part|Death|0|||
160984999|NCT00946647|581333848|FG002|Phase ll Part|Death|0|||
160985000|NCT00946647|581333849|FG003|Phase ll Part|Death|7|||
160985001|NCT00946647|581333850|FG004|Phase ll Part|Death|4|||
160985002|NCT00946647|581333846|FG000|Phase ll Part|Disease progression|0|||
160985003|NCT00946647|581333847|FG001|Phase ll Part|Disease progression|0|||
160985004|NCT00946647|581333848|FG002|Phase ll Part|Disease progression|0|||
160985005|NCT00946647|581333849|FG003|Phase ll Part|Disease progression|6|||
160985006|NCT00946647|581333850|FG004|Phase ll Part|Disease progression|14|||
160985007|NCT00946647|581333846|FG000|Phase ll Part|Protocol Violation|0|||
160985008|NCT00946647|581333847|FG001|Phase ll Part|Protocol Violation|0|||
160985009|NCT00946647|581333848|FG002|Phase ll Part|Protocol Violation|0|||
160985010|NCT00946647|581333849|FG003|Phase ll Part|Protocol Violation|4|||
160985011|NCT00946647|581333850|FG004|Phase ll Part|Protocol Violation|2|||
160985012|NCT00946647|581333846|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
160985013|NCT00946647|581333847|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
160985014|NCT00946647|581333848|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
160985015|NCT00946647|581333849|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
160985016|NCT00946647|581333850|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
160985017|NCT01368211|581333851|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
160985018|NCT01368211|581333852|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
160985019|NCT04988477|581333859|FG000|Overall Study|Death|1|||
160985020|NCT04988477|581333860|FG001|Overall Study|Death|0|||
160985021|NCT04988477|581333861|FG002|Overall Study|Death|0|||
160985022|NCT04988477|581333859|FG000|Overall Study|Lost to Follow-up|5|||
160985023|NCT04988477|581333860|FG001|Overall Study|Lost to Follow-up|2|||
160985024|NCT04988477|581333861|FG002|Overall Study|Lost to Follow-up|0|||
160985025|NCT04988477|581333859|FG000|Overall Study|Withdrawal by Subject|2|||
160985026|NCT04988477|581333860|FG001|Overall Study|Withdrawal by Subject|0|||
160985027|NCT04988477|581333861|FG002|Overall Study|Withdrawal by Subject|0|||
160985028|NCT00394095|581335302|FG000|Screening|Withdrawal by Subject|1|||
160985029|NCT00394095|581335303|FG001|Screening|Withdrawal by Subject|0|||
160985030|NCT00394095|581335302|FG000|Randomized|Withdrawal by Subject|5|||
160985031|NCT00394095|581335303|FG001|Randomized|Withdrawal by Subject|1|||
160985032|NCT00394095|581335302|FG000|Randomized|Adverse Event|1|||
160985033|NCT00394095|581335303|FG001|Randomized|Adverse Event|1|||
160985034|NCT00394095|581335302|FG000|Randomized|Overdose|1|||
160985035|NCT00394095|581335303|FG001|Randomized|Overdose|0|||
160985036|NCT00394095|581335302|FG000|Randomized|Lost to Follow-up|1|||
160985037|NCT00394095|581335303|FG001|Randomized|Lost to Follow-up|2|||
160985038|NCT02401529|581335315|FG000|Overall Study|Lost to Follow-up|2|||
160985039|NCT02401529|581335316|FG001|Overall Study|Lost to Follow-up|1|||
160985040|NCT02401529|581335315|FG000|Overall Study|Physician Decision|2|||
160985041|NCT02401529|581335316|FG001|Overall Study|Physician Decision|6|||
160985042|NCT02401529|581335315|FG000|Overall Study|Protocol Violation|5|||
160985043|NCT02401529|581335316|FG001|Overall Study|Protocol Violation|0|||
160985044|NCT01036087|581335317|FG000|Overall Study|Adverse Event|2|||
160985045|NCT01036087|581335317|FG000|Overall Study|Lack of Efficacy|1|||
160985046|NCT00072475|581335320|FG000|Overall Study|Adverse Event|44|||
160985047|NCT00072475|581335320|FG000|Overall Study|Death|3|||
160985048|NCT00072475|581335320|FG000|Overall Study|Withdrawal by Subject|46|||
160985049|NCT00072475|581335320|FG000|Overall Study|Patient/Investigator Decision|4|||
160985050|NCT03303105|581335321|FG000|Overall Study|Adverse Event|0|||
160985051|NCT03303105|581335322|FG001|Overall Study|Adverse Event|2|||
160985052|NCT03303105|581335321|FG000|Overall Study|Lack of Efficacy|1|||
160985053|NCT03303105|581335322|FG001|Overall Study|Lack of Efficacy|0|||
161332126|NCT01130272|582603531|FG002|Overall Study|IVRS-confirmed constipation|1|||
161332127|NCT01130272|582603532|FG003|Overall Study|IVRS-confirmed constipation|2|||
160985054|NCT03303105|581335321|FG000|Overall Study|Protocol Violation|1|||
160985055|NCT03303105|581335322|FG001|Overall Study|Protocol Violation|0|||
160985056|NCT03303105|581335321|FG000|Overall Study|Withdrawal by Subject|0|||
160985057|NCT03303105|581335322|FG001|Overall Study|Withdrawal by Subject|2|||
160985058|NCT02954575|581335328|FG000|Overall Study|Withdrawal by Subject|2|||
160985059|NCT02954575|581335328|FG000|Overall Study|Adverse Event|1|||
160985060|NCT04227340|581335329|FG000|Overall Study|Withdrawal by Subject|3|||
160985061|NCT00570661|581335332|FG000|Overall Study|Disease worsening|5|||
160985062|NCT00570661|581335332|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
160802086|NCT02078752|580665892|FG006|Overall Study|Study terminated by sponsor|0|||
160802087|NCT02078752|580665893|FG007|Overall Study|Study terminated by sponsor|0|||
160802088|NCT02078752|580665894|FG008|Overall Study|Study terminated by sponsor|0|||
160802089|NCT02078752|580665895|FG009|Overall Study|Study terminated by sponsor|5|||
160802090|NCT01567722|580665904|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
160802091|NCT01567722|580665905|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
160802092|NCT01567722|580665906|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
160802093|NCT01567722|580665904|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
160802094|NCT01567722|580665905|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
160802095|NCT01567722|580665906|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
160802096|NCT01567722|580665904|FG000|Overall Study|Protocol closure by the OCG|2|||
160802097|NCT01567722|580665905|FG001|Overall Study|Protocol closure by the OCG|0|||
160802098|NCT01567722|580665906|FG002|Overall Study|Protocol closure by the OCG|0|||
160802099|NCT01567722|580665904|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
160802100|NCT01567722|580665905|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
160802101|NCT01567722|580665906|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
160802102|NCT00382174|580665907|FG000|Overall Study|Lost to Follow-up|1|||
160802103|NCT00382174|580665908|FG001|Overall Study|Lost to Follow-up|4|||
160802104|NCT00382174|580665909|FG002|Overall Study|Lost to Follow-up|5|||
160802105|NCT00382174|580665907|FG000|Overall Study|Adverse Event|1|||
160802106|NCT00382174|580665908|FG001|Overall Study|Adverse Event|4|||
160802107|NCT00382174|580665909|FG002|Overall Study|Adverse Event|5|||
160802108|NCT00382174|580665907|FG000|Overall Study|Withdrawal by Subject|1|||
160802109|NCT00382174|580665908|FG001|Overall Study|Withdrawal by Subject|4|||
160802110|NCT00382174|580665909|FG002|Overall Study|Withdrawal by Subject|5|||
160802111|NCT00382174|580665907|FG000|Overall Study|Non compliance|1|||
160802112|NCT00382174|580665908|FG001|Overall Study|Non compliance|0|||
160802113|NCT00382174|580665909|FG002|Overall Study|Non compliance|1|||
160802114|NCT00382174|580665907|FG000|Overall Study|Physician Decision|0|||
160802115|NCT00382174|580665908|FG001|Overall Study|Physician Decision|2|||
160802116|NCT00382174|580665909|FG002|Overall Study|Physician Decision|2|||
160802117|NCT00382174|580665907|FG000|Overall Study|Failed to meet criteria|0|||
160802118|NCT00382174|580665908|FG001|Overall Study|Failed to meet criteria|1|||
160802119|NCT00382174|580665909|FG002|Overall Study|Failed to meet criteria|1|||
160802120|NCT00382174|580665907|FG000|Overall Study|Wounds merged|0|||
160802121|NCT00382174|580665908|FG001|Overall Study|Wounds merged|2|||
160802122|NCT00382174|580665909|FG002|Overall Study|Wounds merged|2|||
160802123|NCT01464879|580665910|FG000|Overall Study|Physician Decision|1|||
160802124|NCT01464879|580665910|FG000|Overall Study|Non-compliance|1|||
160802125|NCT01657305|580665911|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
160802126|NCT01657305|580665911|FG000|Overall Study|Withdrawal by Subject|4|||
160802127|NCT01657305|580665911|FG000|Overall Study|Adverse Event|1|||
160802128|NCT01657305|580665911|FG000|Overall Study|Lost to Follow-up|1|||
160802129|NCT01657305|580665911|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
160802130|NCT02259114|580665914|FG000|Overall Study|Progressive Disease|14|||
160802131|NCT02259114|580665915|FG001|Overall Study|Progressive Disease|2|||
160802132|NCT02259114|580665916|FG002|Overall Study|Progressive Disease|10|||
160802133|NCT02259114|580665917|FG003|Overall Study|Progressive Disease|2|||
160802134|NCT02259114|580665918|FG004|Overall Study|Progressive Disease|5|||
160802135|NCT02259114|580665914|FG000|Overall Study|Adverse Event|2|||
160802136|NCT02259114|580665915|FG001|Overall Study|Adverse Event|1|||
160802137|NCT02259114|580665916|FG002|Overall Study|Adverse Event|0|||
160897028|NCT01708161|581018731|FG002|Overall Study|Withdrawal by Subject|1|||
160897029|NCT01708161|581018732|FG003|Overall Study|Withdrawal by Subject|0|||
160897030|NCT01708161|581018733|FG004|Overall Study|Withdrawal by Subject|0|||
160897031|NCT01708161|581018734|FG005|Overall Study|Withdrawal by Subject|0|||
160897032|NCT01708161|581018729|FG000|Overall Study|Administrative problems|0|||
160897033|NCT01708161|581018730|FG001|Overall Study|Administrative problems|1|||
160897034|NCT01708161|581018731|FG002|Overall Study|Administrative problems|0|||
160802138|NCT02259114|580665917|FG003|Overall Study|Adverse Event|0|||
160897035|NCT01708161|581018732|FG003|Overall Study|Administrative problems|0|||
160897036|NCT01708161|581018733|FG004|Overall Study|Administrative problems|0|||
160897037|NCT01708161|581018734|FG005|Overall Study|Administrative problems|0|||
160897038|NCT01708161|581018729|FG000|Overall Study|Disease progression|3|||
160897039|NCT01708161|581018730|FG001|Overall Study|Disease progression|5|||
160897040|NCT01708161|581018731|FG002|Overall Study|Disease progression|5|||
160897041|NCT01708161|581018732|FG003|Overall Study|Disease progression|13|||
160897042|NCT01708161|581018733|FG004|Overall Study|Disease progression|3|||
160897043|NCT01708161|581018734|FG005|Overall Study|Disease progression|0|||
160802139|NCT02259114|580665918|FG004|Overall Study|Adverse Event|1|||
160802140|NCT02259114|580665914|FG000|Overall Study|Death|3|||
160802141|NCT02259114|580665915|FG001|Overall Study|Death|0|||
160802142|NCT02259114|580665916|FG002|Overall Study|Death|1|||
160897044|NCT02633501|581018736|FG000|Overall Study|Adverse Event|0|||
160802143|NCT02259114|580665917|FG003|Overall Study|Death|0|||
160802144|NCT02259114|580665918|FG004|Overall Study|Death|0|||
160802145|NCT02259114|580665914|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802146|NCT02259114|580665915|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802147|NCT02259114|580665916|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
160802148|NCT02259114|580665917|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802149|NCT02259114|580665918|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
160802150|NCT02259114|580665914|FG000|Overall Study|Withdrawal by Subject|0|||
160802151|NCT02259114|580665915|FG001|Overall Study|Withdrawal by Subject|0|||
160802152|NCT02259114|580665916|FG002|Overall Study|Withdrawal by Subject|1|||
160802153|NCT02259114|580665917|FG003|Overall Study|Withdrawal by Subject|1|||
160802154|NCT02259114|580665918|FG004|Overall Study|Withdrawal by Subject|0|||
160802155|NCT02259114|580665914|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
160802156|NCT02259114|580665915|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
160802157|NCT02259114|580665916|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
160802158|NCT02259114|580665917|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
160802159|NCT02259114|580665918|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
160802160|NCT02259114|580665914|FG000|Overall Study|Not Treated|1|||
160802161|NCT02259114|580665915|FG001|Overall Study|Not Treated|0|||
160802162|NCT02259114|580665916|FG002|Overall Study|Not Treated|0|||
160802163|NCT02259114|580665917|FG003|Overall Study|Not Treated|0|||
160802164|NCT02259114|580665918|FG004|Overall Study|Not Treated|0|||
160802165|NCT03937479|580665919|FG000|Overall Study|Adverse Event|2|||
160802166|NCT03937479|580665920|FG001|Overall Study|Adverse Event|3|||
160802167|NCT03937479|580665921|FG002|Overall Study|Adverse Event|0|||
160802168|NCT03937479|580665922|FG003|Overall Study|Adverse Event|0|||
160802169|NCT03937479|580665923|FG004|Overall Study|Adverse Event|1|||
160802170|NCT03937479|580665919|FG000|Overall Study|Withdrawal by Subject|3|||
160802171|NCT03937479|580665920|FG001|Overall Study|Withdrawal by Subject|5|||
160802172|NCT03937479|580665921|FG002|Overall Study|Withdrawal by Subject|2|||
160802173|NCT03937479|580665922|FG003|Overall Study|Withdrawal by Subject|2|||
160802174|NCT03937479|580665923|FG004|Overall Study|Withdrawal by Subject|1|||
160802175|NCT03937479|580665919|FG000|Overall Study|Protocol Violation|5|||
160802176|NCT03937479|580665920|FG001|Overall Study|Protocol Violation|6|||
160802177|NCT03937479|580665921|FG002|Overall Study|Protocol Violation|4|||
160802178|NCT03937479|580665922|FG003|Overall Study|Protocol Violation|3|||
160802179|NCT03937479|580665923|FG004|Overall Study|Protocol Violation|2|||
160802180|NCT03937479|580665919|FG000|Overall Study|Lost to Follow-up|0|||
160802181|NCT03937479|580665920|FG001|Overall Study|Lost to Follow-up|1|||
160802182|NCT03937479|580665921|FG002|Overall Study|Lost to Follow-up|0|||
160802183|NCT03937479|580665922|FG003|Overall Study|Lost to Follow-up|1|||
160802184|NCT03937479|580665923|FG004|Overall Study|Lost to Follow-up|0|||
160802185|NCT03937479|580665919|FG000|Overall Study|Physician Decision|0|||
160802186|NCT03937479|580665920|FG001|Overall Study|Physician Decision|0|||
160802187|NCT03937479|580665921|FG002|Overall Study|Physician Decision|1|||
160802188|NCT03937479|580665922|FG003|Overall Study|Physician Decision|0|||
160802189|NCT03937479|580665923|FG004|Overall Study|Physician Decision|1|||
160802190|NCT00940602|580665926|FG000|Overall Study|Administrative problems|1|||
160802191|NCT00940602|580665927|FG001|Overall Study|Administrative problems|1|||
160802192|NCT00940602|580665926|FG000|Overall Study|Patient/guardian decision|13|||
160802193|NCT00940602|580665927|FG001|Overall Study|Patient/guardian decision|28|||
160985063|NCT00570661|581335332|FG000|Overall Study|Adverse Event|1|||
160985064|NCT01066156|581335333|FG000|Overall Study|ineligible|2|||
160802194|NCT00940602|580665926|FG000|Overall Study|Physician Decision|8|||
160802195|NCT00940602|580665927|FG001|Overall Study|Physician Decision|5|||
160802196|NCT00940602|580665926|FG000|Overall Study|Pregnancy|1|||
160802197|NCT00940602|580665927|FG001|Overall Study|Pregnancy|0|||
160802198|NCT00940602|580665926|FG000|Overall Study|Protocol Deviation (untreated)|1|||
160802199|NCT00940602|580665927|FG001|Overall Study|Protocol Deviation (untreated)|0|||
160802200|NCT00940602|580665926|FG000|Overall Study|Disease progression|8|||
160802201|NCT00940602|580665927|FG001|Overall Study|Disease progression|2|||
160802202|NCT00940602|580665926|FG000|Overall Study|Death|38|||
160802203|NCT00940602|580665927|FG001|Overall Study|Death|19|||
160802204|NCT00940602|580665926|FG000|Overall Study|Lost to Follow-up|3|||
160802205|NCT00940602|580665927|FG001|Overall Study|Lost to Follow-up|1|||
160802206|NCT00940602|580665926|FG000|Overall Study|Patient withdrew consent|26|||
160802207|NCT00940602|580665927|FG001|Overall Study|Patient withdrew consent|13|||
160802208|NCT00940602|580665926|FG000|Overall Study|Adverse Event|7|||
160802209|NCT00940602|580665927|FG001|Overall Study|Adverse Event|2|||
160802210|NCT00940602|580665926|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
160802211|NCT00940602|580665927|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
160802212|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
160802213|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
160802214|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
160802215|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
160985065|NCT01066156|581335333|FG000|Overall Study|Lost to Follow-up|7|||
160802216|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
160802217|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
160802218|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
160802219|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
160802220|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
160802221|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
160802222|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
160802223|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
160802224|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
160802225|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
160802226|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
160802227|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
160802228|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
160802229|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
160802230|NCT03789292|580665928|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
160897045|NCT02633501|581018737|FG001|Overall Study|Adverse Event|0|||
160897046|NCT02633501|581018738|FG002|Overall Study|Adverse Event|1|||
160897047|NCT02633501|581018739|FG003|Overall Study|Adverse Event|0|||
160897048|NCT02633501|581018740|FG004|Overall Study|Adverse Event|1|||
160897049|NCT02633501|581018741|FG005|Overall Study|Adverse Event|1|||
160897050|NCT02633501|581018736|FG000|Overall Study|Withdrawal by Subject|2|||
160897051|NCT02633501|581018737|FG001|Overall Study|Withdrawal by Subject|1|||
160897052|NCT02633501|581018738|FG002|Overall Study|Withdrawal by Subject|2|||
160897053|NCT02633501|581018739|FG003|Overall Study|Withdrawal by Subject|2|||
160897054|NCT02633501|581018740|FG004|Overall Study|Withdrawal by Subject|1|||
160897055|NCT02633501|581018741|FG005|Overall Study|Withdrawal by Subject|3|||
160897056|NCT02633501|581018736|FG000|Overall Study|Various other reasons|0|||
160897057|NCT02633501|581018737|FG001|Overall Study|Various other reasons|2|||
160897058|NCT02633501|581018738|FG002|Overall Study|Various other reasons|4|||
160897059|NCT02633501|581018739|FG003|Overall Study|Various other reasons|1|||
160897060|NCT02633501|581018740|FG004|Overall Study|Various other reasons|7|||
160897061|NCT02633501|581018741|FG005|Overall Study|Various other reasons|11|||
160897062|NCT02633501|581018736|FG000|Overall Study|Lost to Follow-up|0|||
160897063|NCT02633501|581018737|FG001|Overall Study|Lost to Follow-up|0|||
160897064|NCT02633501|581018738|FG002|Overall Study|Lost to Follow-up|0|||
160897065|NCT02633501|581018739|FG003|Overall Study|Lost to Follow-up|1|||
160897066|NCT02633501|581018740|FG004|Overall Study|Lost to Follow-up|2|||
160897067|NCT02633501|581018741|FG005|Overall Study|Lost to Follow-up|0|||
160897068|NCT01986140|581018743|FG000|Overall Study|Withdrawal by Subject|31|||
160897069|NCT01986140|581018744|FG001|Overall Study|Withdrawal by Subject|25|||
160897070|NCT01986140|581018743|FG000|Overall Study|alternative treatment|1|||
160897071|NCT01986140|581018744|FG001|Overall Study|alternative treatment|1|||
160897072|NCT01986140|581018743|FG000|Overall Study|found not eligible|3|||
160897073|NCT01986140|581018744|FG001|Overall Study|found not eligible|0|||
160897074|NCT01986140|581018743|FG000|Overall Study|Adverse Event|0|||
160897075|NCT01986140|581018744|FG001|Overall Study|Adverse Event|1|||
160897076|NCT01986140|581018743|FG000|Overall Study|progression disease|0|||
160897077|NCT01986140|581018744|FG001|Overall Study|progression disease|1|||
160897078|NCT01104155|581018749|FG000|Overall Study|Adverse Event|15|||
160897079|NCT01104155|581018750|FG001|Overall Study|Adverse Event|8|||
160897080|NCT01104155|581018749|FG000|Overall Study|Participant choice|6|||
160897081|NCT01104155|581018750|FG001|Overall Study|Participant choice|5|||
160897082|NCT01104155|581018749|FG000|Overall Study|Withdrawal of consent|1|||
160897083|NCT01104155|581018750|FG001|Overall Study|Withdrawal of consent|1|||
160897084|NCT01104155|581018749|FG000|Overall Study|Other|3|||
160897085|NCT01104155|581018750|FG001|Overall Study|Other|4|||
160897086|NCT01069627|581018762|FG000|Overall Study|Disease progression|7|||
160897087|NCT01069627|581018762|FG000|Overall Study|Adverse Event|12|||
160897088|NCT01069627|581018762|FG000|Overall Study|Protocol Violation|1|||
160897089|NCT02963935|581018767|FG000|Overall Study|Adverse Event|12|||
160897090|NCT02963935|581018768|FG001|Overall Study|Adverse Event|6|||
160897091|NCT02963935|581018767|FG000|Overall Study|Protocol Violation|2|||
160897092|NCT02963935|581018768|FG001|Overall Study|Protocol Violation|1|||
160897093|NCT02963935|581018767|FG000|Overall Study|Lack of Efficacy|0|||
161129816|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
161129817|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
161129818|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
161129819|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
160897094|NCT02963935|581018768|FG001|Overall Study|Lack of Efficacy|2|||
160897095|NCT02963935|581018767|FG000|Overall Study|Lost to Follow-up|1|||
160897096|NCT02963935|581018768|FG001|Overall Study|Lost to Follow-up|6|||
160897097|NCT02963935|581018767|FG000|Overall Study|Unclassified|13|||
160897098|NCT02963935|581018768|FG001|Overall Study|Unclassified|22|||
160897099|NCT00464269|581018769|FG000|Overall Study|Lack of Efficacy|1|||
160897100|NCT00464269|581018770|FG001|Overall Study|Lack of Efficacy|0|||
160802231|NCT03789292|580665929|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
160802232|NCT03789292|580665930|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
160802233|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
160802234|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
160802235|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
160802236|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
161237290|NCT00819741|582248535|FG001|Overall Study|Reasons unknown|3|||
160802237|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
160802238|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
160802239|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
160802240|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
160802241|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
160802242|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
160802243|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
160802244|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
160802245|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
160802246|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
160802247|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
160802248|NCT03789292|580665928|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
160802249|NCT03789292|580665929|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
160802250|NCT03789292|580665930|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
160802251|NCT00575666|580665931|FG000|Overall Study|Withdrawal by Subject|3|||
160802252|NCT00575666|580665932|FG001|Overall Study|Withdrawal by Subject|2|||
160802253|NCT00575666|580665931|FG000|Overall Study|Physician Decision|1|||
160802254|NCT00575666|580665932|FG001|Overall Study|Physician Decision|1|||
160802255|NCT01374425|580665933|FG000|Overall Study|Radiographic Disease Progression|86|||
160802256|NCT01374425|580665934|FG001|Overall Study|Radiographic Disease Progression|81|||
160802257|NCT01374425|580665933|FG000|Overall Study|Clinical Disease Progression|9|||
160802258|NCT01374425|580665934|FG001|Overall Study|Clinical Disease Progression|6|||
160802259|NCT01374425|580665933|FG000|Overall Study|Adverse Event|29|||
160802260|NCT01374425|580665934|FG001|Overall Study|Adverse Event|18|||
160802261|NCT01374425|580665933|FG000|Overall Study|Death (Progression of Disease)|1|||
160802262|NCT01374425|580665934|FG001|Overall Study|Death (Progression of Disease)|0|||
160802263|NCT01374425|580665933|FG000|Overall Study|Death (Adverse Event)|2|||
160802264|NCT01374425|580665934|FG001|Overall Study|Death (Adverse Event)|4|||
160802265|NCT01374425|580665933|FG000|Overall Study|Withdrawal by Subject|6|||
160802266|NCT01374425|580665934|FG001|Overall Study|Withdrawal by Subject|7|||
160802267|NCT01374425|580665933|FG000|Overall Study|Refused Treatment|10|||
160802268|NCT01374425|580665934|FG001|Overall Study|Refused Treatment|24|||
160802269|NCT01374425|580665933|FG000|Overall Study|Protocol Violation|2|||
160802270|NCT01374425|580665934|FG001|Overall Study|Protocol Violation|3|||
160802271|NCT01374425|580665933|FG000|Overall Study|Sponsor Decision|0|||
160802272|NCT01374425|580665934|FG001|Overall Study|Sponsor Decision|1|||
160802273|NCT01374425|580665933|FG000|Overall Study|Lost to Follow-up|2|||
160802274|NCT01374425|580665934|FG001|Overall Study|Lost to Follow-up|1|||
160802275|NCT01374425|580665933|FG000|Overall Study|Other|41|||
160802276|NCT01374425|580665934|FG001|Overall Study|Other|43|||
160802277|NCT02289469|580665935|FG000|Overall Study|Unable to match a control|6|||
160802278|NCT02289469|580665936|FG001|Overall Study|Unable to match a control|0|||
160802279|NCT01904721|580665939|FG000|Overall Study|Other Reasons|0|||
160802280|NCT01904721|580665940|FG001|Overall Study|Other Reasons|0|||
160802281|NCT01904721|580665941|FG002|Overall Study|Other Reasons|1|||
160802282|NCT01904721|580665942|FG003|Overall Study|Other Reasons|1|||
160802283|NCT01904721|580665943|FG004|Overall Study|Other Reasons|2|||
160802284|NCT01904721|580665944|FG005|Overall Study|Other Reasons|2|||
160802285|NCT01904721|580665945|FG006|Overall Study|Other Reasons|2|||
160802286|NCT01904721|580665939|FG000|Overall Study|Personal Reasons|0|||
160897101|NCT00464269|581018771|FG002|Overall Study|Lack of Efficacy|0|||
160897102|NCT00464269|581018772|FG003|Overall Study|Lack of Efficacy|0|||
160897103|NCT00464269|581018769|FG000|Overall Study|Lost to Follow-up|0|||
160897104|NCT00464269|581018770|FG001|Overall Study|Lost to Follow-up|4|||
160897105|NCT00464269|581018771|FG002|Overall Study|Lost to Follow-up|0|||
160897106|NCT00464269|581018772|FG003|Overall Study|Lost to Follow-up|1|||
160897107|NCT00464269|581018769|FG000|Overall Study|Withdrawal by Subject|0|||
160897108|NCT00464269|581018770|FG001|Overall Study|Withdrawal by Subject|2|||
160897109|NCT00464269|581018771|FG002|Overall Study|Withdrawal by Subject|1|||
161237291|NCT03447353|582250111|FG000|Overall Study|Failure at Screening Visit|2|||
160802287|NCT01904721|580665940|FG001|Overall Study|Personal Reasons|0|||
160802288|NCT01904721|580665941|FG002|Overall Study|Personal Reasons|0|||
160802289|NCT01904721|580665942|FG003|Overall Study|Personal Reasons|0|||
160897110|NCT00464269|581018772|FG003|Overall Study|Withdrawal by Subject|1|||
161237292|NCT03447353|582250111|FG000|Overall Study|Lost to Follow-up|4|||
160802290|NCT01904721|580665943|FG004|Overall Study|Personal Reasons|2|||
160802291|NCT01904721|580665944|FG005|Overall Study|Personal Reasons|3|||
160802292|NCT01904721|580665945|FG006|Overall Study|Personal Reasons|3|||
160802293|NCT01904721|580665939|FG000|Overall Study|Lost to Follow-up|0|||
160802294|NCT01904721|580665940|FG001|Overall Study|Lost to Follow-up|0|||
160802295|NCT01904721|580665941|FG002|Overall Study|Lost to Follow-up|0|||
160802296|NCT01904721|580665942|FG003|Overall Study|Lost to Follow-up|0|||
160802297|NCT01904721|580665943|FG004|Overall Study|Lost to Follow-up|1|||
160802298|NCT01904721|580665944|FG005|Overall Study|Lost to Follow-up|3|||
160802299|NCT01904721|580665945|FG006|Overall Study|Lost to Follow-up|1|||
160802300|NCT01904721|580665939|FG000|Overall Study|Lack of Efficacy|0|||
160802301|NCT01904721|580665940|FG001|Overall Study|Lack of Efficacy|0|||
160802302|NCT01904721|580665941|FG002|Overall Study|Lack of Efficacy|0|||
160802303|NCT01904721|580665942|FG003|Overall Study|Lack of Efficacy|0|||
160802304|NCT01904721|580665943|FG004|Overall Study|Lack of Efficacy|0|||
160802305|NCT01904721|580665944|FG005|Overall Study|Lack of Efficacy|0|||
160802306|NCT01904721|580665945|FG006|Overall Study|Lack of Efficacy|1|||
160802307|NCT01904721|580665939|FG000|Overall Study|Adverse Event|0|||
160802308|NCT01904721|580665940|FG001|Overall Study|Adverse Event|0|||
160802309|NCT01904721|580665941|FG002|Overall Study|Adverse Event|0|||
160802310|NCT01904721|580665942|FG003|Overall Study|Adverse Event|0|||
160802311|NCT01904721|580665943|FG004|Overall Study|Adverse Event|3|||
160802312|NCT01904721|580665944|FG005|Overall Study|Adverse Event|1|||
160802313|NCT01904721|580665945|FG006|Overall Study|Adverse Event|0|||
160802314|NCT00532844|580665949|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
160802315|NCT00532844|580665950|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
160802316|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
160802317|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
160802318|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
160802319|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
160802320|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
160802321|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
160802322|NCT00532844|580665949|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
160802323|NCT00532844|580665950|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
160802324|NCT01077063|580665952|FG000|Overall Study|Adverse Event|3|||
160802325|NCT01077063|580665953|FG001|Overall Study|Adverse Event|0|||
160802326|NCT01077063|580665952|FG000|Overall Study|Death|1|||
160802327|NCT01077063|580665953|FG001|Overall Study|Death|1|||
160802328|NCT01077063|580665952|FG000|Overall Study|Withdrawal by Subject|0|||
160802329|NCT01077063|580665953|FG001|Overall Study|Withdrawal by Subject|2|||
160802330|NCT02750930|580665954|FG000|Overall Study|Study closed/terminated|8|||
160802331|NCT00553631|580665956|FG000|Overall Study|Withdrawal by Subject|0|||
160802332|NCT00553631|580665957|FG001|Overall Study|Withdrawal by Subject|1|||
160802333|NCT00553631|580665956|FG000|Overall Study|Lost to Follow-up|1|||
160802334|NCT00553631|580665957|FG001|Overall Study|Lost to Follow-up|0|||
160802335|NCT02761642|580665958|FG000|Overall Study|Did not Receive Study Treatment|3|||
160802336|NCT02761642|580665958|FG000|Overall Study|Adverse Event|13|||
160802337|NCT02761642|580665958|FG000|Overall Study|Withdrawal by Subject|2|||
160802338|NCT02761642|580665958|FG000|Overall Study|Non-compliant|7|||
160802339|NCT02761642|580665958|FG000|Overall Study|Death|3|||
160802340|NCT02761642|580665958|FG000|Overall Study|Lack of Efficacy|20|||
160802341|NCT02761642|580665958|FG000|Overall Study|Physician Decision|1|||
160802342|NCT02761642|580665958|FG000|Overall Study|Reason Unspecified|21|||
160802343|NCT01644643|580665961|FG000|Overall Study|Death|1|||
160802344|NCT01644643|580665962|FG001|Overall Study|Death|0|||
160802345|NCT01644643|580665963|FG002|Overall Study|Death|3|||
160802346|NCT01644643|580665964|FG003|Overall Study|Death|3|||
160802347|NCT01644643|580665961|FG000|Overall Study|Lost to Follow-up|0|||
160802348|NCT01644643|580665962|FG001|Overall Study|Lost to Follow-up|0|||
160802349|NCT01644643|580665963|FG002|Overall Study|Lost to Follow-up|0|||
160802350|NCT01644643|580665964|FG003|Overall Study|Lost to Follow-up|4|||
160802351|NCT01644643|580665961|FG000|Overall Study|Withdrawal by Subject|1|||
160802352|NCT01644643|580665962|FG001|Overall Study|Withdrawal by Subject|0|||
160802353|NCT01644643|580665963|FG002|Overall Study|Withdrawal by Subject|2|||
160802354|NCT01644643|580665964|FG003|Overall Study|Withdrawal by Subject|1|||
160802355|NCT01644643|580665961|FG000|Overall Study|Other Eligibility criteria|0|||
160802356|NCT01644643|580665962|FG001|Overall Study|Other Eligibility criteria|0|||
160802357|NCT01644643|580665963|FG002|Overall Study|Other Eligibility criteria|0|||
160802358|NCT01644643|580665964|FG003|Overall Study|Other Eligibility criteria|2|||
160802359|NCT00271544|580665981|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
160802360|NCT00271544|580665981|FG000|Overall Study|Model 4196 lead not attempted|9|||
160802361|NCT00271544|580665981|FG000|Overall Study|Implant not attempted|4|||
160802362|NCT04540367|580665982|FG000|Overall Study|Withdrawal by Subject|0|||
160802363|NCT04540367|580665983|FG001|Overall Study|Withdrawal by Subject|0|||
160802364|NCT04540367|580665984|FG002|Overall Study|Withdrawal by Subject|0|||
160802365|NCT04540367|580665985|FG003|Overall Study|Withdrawal by Subject|2|||
160802366|NCT04540367|580665982|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
160802367|NCT04540367|580665983|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
160802368|NCT04540367|580665984|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
160802369|NCT04540367|580665985|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
160802370|NCT04540367|580665982|FG000|Overall Study|Adverse Event|0|||
160802371|NCT04540367|580665983|FG001|Overall Study|Adverse Event|0|||
160802372|NCT04540367|580665984|FG002|Overall Study|Adverse Event|1|||
160802373|NCT04540367|580665985|FG003|Overall Study|Adverse Event|1|||
160802374|NCT00902330|580665987|FG000|Overall Study|Too overwhelmed by treatment|2|||
160802375|NCT00902330|580665988|FG001|Overall Study|Too overwhelmed by treatment|5|||
160802376|NCT00902330|580665987|FG000|Overall Study|Adverse Event|1|||
160802377|NCT00902330|580665988|FG001|Overall Study|Adverse Event|0|||
160802378|NCT00902330|580665987|FG000|Overall Study|No post baseline data|1|||
160802379|NCT00902330|580665988|FG001|Overall Study|No post baseline data|0|||
160802380|NCT00730886|580665989|FG000|Overall Study|Lost to Follow-up|1|||
160802381|NCT00730886|580665990|FG001|Overall Study|Lost to Follow-up|0|||
160802382|NCT00730886|580665989|FG000|Overall Study|Physician Decision|1|||
160802383|NCT00730886|580665990|FG001|Overall Study|Physician Decision|0|||
160802384|NCT01816048|580665991|FG000|Overall Study|Adverse Event|1|||
160802385|NCT01816048|580665991|FG000|Overall Study|Death|1|||
160802386|NCT01816048|580665991|FG000|Overall Study|Withdrawal by Subject|1|||
160802387|NCT01816048|580665991|FG000|Overall Study|Disease Progression|3|||
160802388|NCT03571971|580665992|FG000|Overall Study|Lost to Follow-up|2|||
160802389|NCT03571971|580665993|FG001|Overall Study|Lost to Follow-up|2|||
160802390|NCT03571971|580665992|FG000|Overall Study|Protocol Violation|2|||
160802391|NCT03571971|580665993|FG001|Overall Study|Protocol Violation|3|||
160802392|NCT03571971|580665992|FG000|Overall Study|Withdrawal by Subject|2|||
160802393|NCT03571971|580665993|FG001|Overall Study|Withdrawal by Subject|0|||
160802394|NCT03571971|580665992|FG000|Overall Study|Incomplete primary outcome data|2|||
160802395|NCT03571971|580665993|FG001|Overall Study|Incomplete primary outcome data|0|||
160802396|NCT04067492|580665994|FG000|Overall Study|Lost to Follow-up|0|||
160802397|NCT04067492|580665995|FG001|Overall Study|Lost to Follow-up|0|||
160802398|NCT04067492|580665996|FG002|Overall Study|Lost to Follow-up|0|||
160802399|NCT04067492|580665997|FG003|Overall Study|Lost to Follow-up|0|||
160802400|NCT04067492|580665998|FG004|Overall Study|Lost to Follow-up|0|||
160802401|NCT04067492|580665999|FG005|Overall Study|Lost to Follow-up|1|||
160802402|NCT04067492|580665994|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802403|NCT04067492|580665995|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
160802404|NCT04067492|580665996|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802405|NCT04067492|580665997|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802406|NCT04067492|580665998|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802407|NCT04067492|580665999|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
160802408|NCT04067492|580665994|FG000|Overall Study|COVID-19 epidemiological situation|0|||
160802409|NCT04067492|580665995|FG001|Overall Study|COVID-19 epidemiological situation|0|||
160802410|NCT04067492|580665996|FG002|Overall Study|COVID-19 epidemiological situation|0|||
160802411|NCT04067492|580665997|FG003|Overall Study|COVID-19 epidemiological situation|1|||
160802412|NCT04067492|580665998|FG004|Overall Study|COVID-19 epidemiological situation|0|||
160802413|NCT04067492|580665999|FG005|Overall Study|COVID-19 epidemiological situation|0|||
160802414|NCT03950856|580666007|FG000|Overall Study|Death|1|||
160802415|NCT03950856|580666008|FG001|Overall Study|Death|2|||
160802416|NCT03950856|580666009|FG002|Overall Study|Death|0|||
160802417|NCT03950856|580666010|FG003|Overall Study|Death|0|||
160802418|NCT03950856|580666007|FG000|Overall Study|Lost to Follow-up|5|||
160802419|NCT03950856|580666008|FG001|Overall Study|Lost to Follow-up|6|||
160802420|NCT03950856|580666009|FG002|Overall Study|Lost to Follow-up|8|||
160802421|NCT03950856|580666010|FG003|Overall Study|Lost to Follow-up|2|||
160802422|NCT03950856|580666007|FG000|Overall Study|Protocol Violation|2|||
160802423|NCT03950856|580666008|FG001|Overall Study|Protocol Violation|0|||
160802424|NCT03950856|580666009|FG002|Overall Study|Protocol Violation|0|||
160802425|NCT03950856|580666010|FG003|Overall Study|Protocol Violation|1|||
160802426|NCT03950856|580666007|FG000|Overall Study|Withdrawal by Subject|4|||
160802427|NCT03950856|580666008|FG001|Overall Study|Withdrawal by Subject|1|||
160802428|NCT03950856|580666009|FG002|Overall Study|Withdrawal by Subject|3|||
160802429|NCT03950856|580666010|FG003|Overall Study|Withdrawal by Subject|1|||
160802430|NCT03950856|580666007|FG000|Overall Study|Unable to phone|7|||
160802431|NCT03950856|580666008|FG001|Overall Study|Unable to phone|6|||
160802432|NCT03950856|580666009|FG002|Overall Study|Unable to phone|7|||
160802433|NCT03950856|580666010|FG003|Overall Study|Unable to phone|2|||
160802434|NCT01816984|580666011|FG000|Overall Study|declining health status|1|||
160802435|NCT05899829|580666014|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
160802436|NCT05899829|580666015|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
160802437|NCT05899829|580666014|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
160802438|NCT05899829|580666015|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
160802439|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
160897111|NCT00464269|581018769|FG000|Overall Study|Other reason|3|||
161237293|NCT03447353|582250111|FG000|Overall Study|Scheduling Conflicts|3|||
161237294|NCT03447353|582250111|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
161332128|NCT01130272|582603533|FG004|Overall Study|IVRS-confirmed constipation|0|||
161332129|NCT01130272|582603529|FG000|Overall Study|Rescue medications due to diarrhea|3|||
161237295|NCT02175095|582250112|FG000|Overall Study|Withdrawal by Subject|3|||
161237296|NCT02635750|582250113|FG000|Part 1, Period 2|Adverse Event|1|||
161237297|NCT02635750|582250114|FG001|Part 1, Period 2|Adverse Event|0|||
161237298|NCT02635750|582250115|FG002|Part 1, Period 2|Adverse Event|0|||
161237299|NCT00462345|582250118|FG000|Overall Study|Withdrawal by Subject|2|||
161237300|NCT00462345|582250118|FG000|Overall Study|Did not complete second course|1|||
161237301|NCT02642653|582250120|FG000|Overall Study|Adverse Event|2|||
161237302|NCT02642653|582250121|FG001|Overall Study|Adverse Event|0|||
161237303|NCT02875392|582250125|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
161237304|NCT02875392|582250126|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
161237305|NCT00508651|582250130|FG000|Overall Study|Lost to Follow-up|3|||
161237306|NCT00508651|582250131|FG001|Overall Study|Lost to Follow-up|1|||
161237307|NCT00508651|582250130|FG000|Overall Study|Withdrawal by Subject|1|||
161237308|NCT00508651|582250131|FG001|Overall Study|Withdrawal by Subject|1|||
161237309|NCT03874715|582250133|FG000|Overall Study|Adverse Event|2|||
161237310|NCT03874715|582250134|FG001|Overall Study|Adverse Event|0|||
161237311|NCT03874715|582250133|FG000|Overall Study|Poor compliance to protocol|5|||
161237312|NCT03874715|582250134|FG001|Overall Study|Poor compliance to protocol|1|||
161237313|NCT03874715|582250133|FG000|Overall Study|Withdrawal by Subject|1|||
161237314|NCT03874715|582250134|FG001|Overall Study|Withdrawal by Subject|0|||
161237315|NCT03874715|582250133|FG000|Overall Study|Other-unspecified|1|||
161237316|NCT03874715|582250134|FG001|Overall Study|Other-unspecified|0|||
161237317|NCT00461786|582250135|FG000|Overall Study|Entry Criteria Not Met|2|||
161237318|NCT00461786|582250135|FG000|Overall Study|Inevaluable (Never Treated)|1|||
161332130|NCT01130272|582603530|FG001|Overall Study|Rescue medications due to diarrhea|5|||
161332131|NCT01130272|582603531|FG002|Overall Study|Rescue medications due to diarrhea|8|||
161332132|NCT01130272|582603532|FG003|Overall Study|Rescue medications due to diarrhea|8|||
161332133|NCT01130272|582603533|FG004|Overall Study|Rescue medications due to diarrhea|6|||
161332134|NCT01130272|582603529|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
161332135|NCT01130272|582603530|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
161332136|NCT01130272|582603531|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
161332137|NCT01130272|582603532|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
161332138|NCT01130272|582603533|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
161332139|NCT01130272|582603529|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161332140|NCT01130272|582603530|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161332141|NCT01130272|582603531|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161332142|NCT01130272|582603532|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
161332143|NCT01130272|582603533|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
161332144|NCT01130272|582603529|FG000|Overall Study|Protocol Violation|0|||
161332145|NCT01130272|582603530|FG001|Overall Study|Protocol Violation|0|||
161332146|NCT01130272|582603531|FG002|Overall Study|Protocol Violation|3|||
161332147|NCT01130272|582603532|FG003|Overall Study|Protocol Violation|5|||
161332148|NCT01130272|582603533|FG004|Overall Study|Protocol Violation|5|||
161332149|NCT01130272|582603529|FG000|Overall Study|Lost to Follow-up|4|||
161332150|NCT01130272|582603530|FG001|Overall Study|Lost to Follow-up|3|||
161332151|NCT01130272|582603531|FG002|Overall Study|Lost to Follow-up|4|||
161332152|NCT01130272|582603532|FG003|Overall Study|Lost to Follow-up|7|||
161332153|NCT01130272|582603533|FG004|Overall Study|Lost to Follow-up|6|||
161332154|NCT01130272|582603529|FG000|Overall Study|Withdrawal by Subject|4|||
161332155|NCT01130272|582603530|FG001|Overall Study|Withdrawal by Subject|11|||
161332156|NCT01130272|582603531|FG002|Overall Study|Withdrawal by Subject|10|||
161332157|NCT01130272|582603532|FG003|Overall Study|Withdrawal by Subject|9|||
161332158|NCT01130272|582603533|FG004|Overall Study|Withdrawal by Subject|8|||
161332159|NCT01130272|582603529|FG000|Overall Study|Physician Decision|1|||
161332160|NCT01130272|582603530|FG001|Overall Study|Physician Decision|1|||
161332161|NCT01130272|582603531|FG002|Overall Study|Physician Decision|0|||
161332162|NCT01130272|582603532|FG003|Overall Study|Physician Decision|1|||
161332163|NCT01130272|582603533|FG004|Overall Study|Physician Decision|2|||
161332164|NCT01130272|582603529|FG000|Overall Study|Sponsor decision|6|||
161332165|NCT01130272|582603530|FG001|Overall Study|Sponsor decision|15|||
161332166|NCT01130272|582603531|FG002|Overall Study|Sponsor decision|16|||
161332167|NCT01130272|582603532|FG003|Overall Study|Sponsor decision|13|||
161332168|NCT01130272|582603533|FG004|Overall Study|Sponsor decision|16|||
161332169|NCT01130272|582603529|FG000|Overall Study|Study arm discontinued|38|||
161332170|NCT01130272|582603530|FG001|Overall Study|Study arm discontinued|0|||
161332171|NCT01130272|582603531|FG002|Overall Study|Study arm discontinued|0|||
161237319|NCT03570749|582250138|FG000|Overall Study|Ongoing|26|||
161237320|NCT03570749|582250139|FG001|Overall Study|Ongoing|25|||
161237321|NCT03570749|582250140|FG002|Overall Study|Ongoing|25|||
161237322|NCT03570749|582250141|FG003|Overall Study|Ongoing|26|||
160802440|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
160802441|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
160802442|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
160802443|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
160802444|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
160802445|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
160802446|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
160802447|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
160802448|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
160802449|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
160802450|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
160802451|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
160802452|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
160802453|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
160802454|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
160802455|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
160802456|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
160802457|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
160802458|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
160802459|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
160802460|NCT04021290|580666016|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
160802461|NCT04021290|580666017|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
160802462|NCT04021290|580666018|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
160802463|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
160802464|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
160802465|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
160802466|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
160802467|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
160802468|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
160802469|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
160802470|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
160802471|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
160802472|NCT04021290|580666016|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
160802473|NCT04021290|580666017|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
160802474|NCT04021290|580666018|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
160802475|NCT03391882|580666019|FG000|Study Overall|Adverse Event|3|||
160802476|NCT03391882|580666020|FG001|Study Overall|Adverse Event|6|||
160802477|NCT03391882|580666021|FG002|Study Overall|Adverse Event|1|||
160802478|NCT03391882|580666022|FG003|Study Overall|Adverse Event|1|||
160802479|NCT03391882|580666023|FG004|Study Overall|Adverse Event|3|||
160802480|NCT03391882|580666024|FG005|Study Overall|Adverse Event|1|||
160802481|NCT03391882|580666019|FG000|Study Overall|Lack of Efficacy|13|||
160802482|NCT03391882|580666020|FG001|Study Overall|Lack of Efficacy|9|||
160802483|NCT03391882|580666021|FG002|Study Overall|Lack of Efficacy|0|||
160802484|NCT03391882|580666022|FG003|Study Overall|Lack of Efficacy|0|||
160802485|NCT03391882|580666023|FG004|Study Overall|Lack of Efficacy|0|||
160802486|NCT03391882|580666024|FG005|Study Overall|Lack of Efficacy|0|||
160802487|NCT03391882|580666019|FG000|Study Overall|Withdrawal by Subject|3|||
160802488|NCT03391882|580666020|FG001|Study Overall|Withdrawal by Subject|3|||
160802489|NCT03391882|580666021|FG002|Study Overall|Withdrawal by Subject|2|||
160802490|NCT03391882|580666022|FG003|Study Overall|Withdrawal by Subject|2|||
160802491|NCT03391882|580666023|FG004|Study Overall|Withdrawal by Subject|1|||
160802492|NCT03391882|580666024|FG005|Study Overall|Withdrawal by Subject|3|||
160802493|NCT03391882|580666019|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802494|NCT03391882|580666020|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
160802495|NCT03391882|580666021|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802496|NCT03391882|580666022|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160897112|NCT00464269|581018770|FG001|Overall Study|Other reason|3|||
160897113|NCT00464269|581018771|FG002|Overall Study|Other reason|1|||
160897114|NCT00464269|581018772|FG003|Overall Study|Other reason|1|||
160897115|NCT00464269|581018769|FG000|Overall Study|AE, serious fatal|0|||
160897116|NCT00464269|581018770|FG001|Overall Study|AE, serious fatal|0|||
160897117|NCT00464269|581018771|FG002|Overall Study|AE, serious fatal|1|||
160897118|NCT00464269|581018772|FG003|Overall Study|AE, serious fatal|1|||
160897119|NCT00464269|581018769|FG000|Overall Study|SAE, non-fatal|0|||
160802497|NCT03391882|580666023|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802498|NCT03391882|580666024|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
160802499|NCT03391882|580666019|FG000|Study Overall|Protocol Violation|1|||
160802500|NCT03391882|580666020|FG001|Study Overall|Protocol Violation|0|||
160897120|NCT00464269|581018770|FG001|Overall Study|SAE, non-fatal|0|||
160897121|NCT00464269|581018771|FG002|Overall Study|SAE, non-fatal|0|||
160802501|NCT03391882|580666021|FG002|Study Overall|Protocol Violation|0|||
160802502|NCT03391882|580666022|FG003|Study Overall|Protocol Violation|0|||
160802503|NCT03391882|580666023|FG004|Study Overall|Protocol Violation|0|||
160802504|NCT03391882|580666024|FG005|Study Overall|Protocol Violation|0|||
160802505|NCT03391882|580666019|FG000|Part A - Titration Phase|Adverse Event|3|||
160802506|NCT03391882|580666020|FG001|Part A - Titration Phase|Adverse Event|6|||
160802507|NCT03391882|580666021|FG002|Part A - Titration Phase|Adverse Event|0|||
160802508|NCT03391882|580666022|FG003|Part A - Titration Phase|Adverse Event|0|||
160802509|NCT03391882|580666023|FG004|Part A - Titration Phase|Adverse Event|0|||
160802510|NCT03391882|580666024|FG005|Part A - Titration Phase|Adverse Event|0|||
160802511|NCT03391882|580666019|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
160802512|NCT03391882|580666020|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
160802513|NCT03391882|580666021|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
160802514|NCT03391882|580666022|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
160802515|NCT03391882|580666023|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
160802516|NCT03391882|580666024|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
160802517|NCT03391882|580666019|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
160802518|NCT03391882|580666020|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
160802519|NCT03391882|580666021|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
160802520|NCT03391882|580666022|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
160802521|NCT03391882|580666023|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
160802522|NCT03391882|580666024|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
160802523|NCT03391882|580666019|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802524|NCT03391882|580666020|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
160802525|NCT03391882|580666021|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802526|NCT03391882|580666022|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802527|NCT03391882|580666023|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802528|NCT03391882|580666024|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
160802529|NCT03391882|580666019|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
160802530|NCT03391882|580666020|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
160802531|NCT03391882|580666021|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802532|NCT03391882|580666022|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802533|NCT03391882|580666023|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802534|NCT03391882|580666024|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
160802535|NCT03391882|580666019|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
160802536|NCT03391882|580666020|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
160802537|NCT03391882|580666021|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
160802538|NCT03391882|580666022|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
160802539|NCT03391882|580666023|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
160802540|NCT03391882|580666024|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
160802541|NCT03391882|580666019|FG000|Part B - Treatment Phase|Adverse Event|0|||
160802542|NCT03391882|580666020|FG001|Part B - Treatment Phase|Adverse Event|0|||
160802543|NCT03391882|580666021|FG002|Part B - Treatment Phase|Adverse Event|1|||
160802544|NCT03391882|580666022|FG003|Part B - Treatment Phase|Adverse Event|1|||
160802545|NCT03391882|580666023|FG004|Part B - Treatment Phase|Adverse Event|3|||
160802546|NCT03391882|580666024|FG005|Part B - Treatment Phase|Adverse Event|1|||
160802547|NCT03391882|580666019|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
160802548|NCT03391882|580666020|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
160802549|NCT03391882|580666021|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
160802550|NCT03391882|580666022|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
160802551|NCT03391882|580666023|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
160802552|NCT03391882|580666024|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
160802553|NCT03092479|580666025|FG000|Overall Study|Lost to Follow-up|3|||
160802554|NCT03092479|580666026|FG001|Overall Study|Lost to Follow-up|2|||
160802555|NCT03092479|580666025|FG000|Overall Study|Withdrawal by Subject|4|||
160802556|NCT03092479|580666026|FG001|Overall Study|Withdrawal by Subject|0|||
160802557|NCT03913130|580666029|FG000|Overall Study|Sponsor Decision|1|||
160802558|NCT04046939|580666034|FG000|Primary Assessment Period|Adverse Event|1|||
160802559|NCT04046939|580666035|FG001|Primary Assessment Period|Adverse Event|0|||
160802560|NCT04046939|580666036|FG002|Primary Assessment Period|Adverse Event|0|||
160802561|NCT04046939|580666037|FG003|Primary Assessment Period|Adverse Event|0|||
160802562|NCT04046939|580666034|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
160802563|NCT04046939|580666035|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
160985066|NCT01066156|581335333|FG000|Overall Study|Withdrawal by Subject|1|||
160802564|NCT04046939|580666036|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
160802565|NCT04046939|580666037|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
160802566|NCT04046939|580666034|FG000|Primary Assessment Period|Physician Decision|0|||
160802567|NCT04046939|580666035|FG001|Primary Assessment Period|Physician Decision|0|||
160802568|NCT04046939|580666036|FG002|Primary Assessment Period|Physician Decision|1|||
160802569|NCT04046939|580666037|FG003|Primary Assessment Period|Physician Decision|0|||
160802570|NCT04046939|580666034|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
160802571|NCT04046939|580666035|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
160985067|NCT01734382|581335337|FG000|Part 1|Adverse Event|2|||
161237323|NCT03570749|582250142|FG004|Overall Study|Ongoing|140|||
161237324|NCT03570749|582250143|FG005|Overall Study|Ongoing|142|||
161237325|NCT03570749|582250144|FG006|Overall Study|Ongoing|220|||
161237326|NCT03570749|582250138|FG000|Overall Study|Adverse Event|0|||
161237327|NCT03570749|582250139|FG001|Overall Study|Adverse Event|0|||
161237328|NCT03570749|582250140|FG002|Overall Study|Adverse Event|0|||
161237329|NCT03570749|582250141|FG003|Overall Study|Adverse Event|0|||
161237330|NCT03570749|582250142|FG004|Overall Study|Adverse Event|2|||
161237331|NCT03570749|582250143|FG005|Overall Study|Adverse Event|3|||
161237332|NCT03570749|582250144|FG006|Overall Study|Adverse Event|6|||
161237333|NCT03570749|582250138|FG000|Overall Study|Lack of Efficacy|0|||
161237334|NCT03570749|582250139|FG001|Overall Study|Lack of Efficacy|0|||
161237335|NCT03570749|582250140|FG002|Overall Study|Lack of Efficacy|0|||
161237336|NCT03570749|582250141|FG003|Overall Study|Lack of Efficacy|0|||
161237337|NCT03570749|582250142|FG004|Overall Study|Lack of Efficacy|8|||
161237338|NCT03570749|582250143|FG005|Overall Study|Lack of Efficacy|2|||
161237339|NCT03570749|582250144|FG006|Overall Study|Lack of Efficacy|7|||
161237340|NCT03570749|582250138|FG000|Overall Study|Lost to Follow-up|0|||
161237341|NCT03570749|582250139|FG001|Overall Study|Lost to Follow-up|0|||
161237342|NCT03570749|582250140|FG002|Overall Study|Lost to Follow-up|0|||
161237343|NCT03570749|582250141|FG003|Overall Study|Lost to Follow-up|0|||
161237344|NCT03570749|582250142|FG004|Overall Study|Lost to Follow-up|5|||
161237345|NCT03570749|582250143|FG005|Overall Study|Lost to Follow-up|10|||
161332172|NCT01130272|582603532|FG003|Overall Study|Study arm discontinued|0|||
161332173|NCT01130272|582603533|FG004|Overall Study|Study arm discontinued|0|||
161332174|NCT00641056|582603534|FG000|Overall Study|Adverse Event|12|||
161332175|NCT00641056|582603535|FG001|Overall Study|Adverse Event|2|||
161332176|NCT00641056|582603534|FG000|Overall Study|Lost to Follow-up|2|||
161332177|NCT00641056|582603535|FG001|Overall Study|Lost to Follow-up|1|||
161332178|NCT00641056|582603534|FG000|Overall Study|Physician Decision|3|||
161332179|NCT00641056|582603535|FG001|Overall Study|Physician Decision|1|||
161332180|NCT00641056|582603534|FG000|Overall Study|Protocol Violation|2|||
161332181|NCT00641056|582603535|FG001|Overall Study|Protocol Violation|0|||
161332182|NCT00641056|582603534|FG000|Overall Study|Entry Criteria Not Met|3|||
161332183|NCT00641056|582603535|FG001|Overall Study|Entry Criteria Not Met|0|||
161332184|NCT00641056|582603534|FG000|Overall Study|Subject Decision|6|||
161332185|NCT00641056|582603535|FG001|Overall Study|Subject Decision|19|||
161332186|NCT00641056|582603534|FG000|Overall Study|Sponsor Decision|1|||
161332187|NCT00641056|582603535|FG001|Overall Study|Sponsor Decision|2|||
161332188|NCT00239720|582603537|FG000|Overall Study|Adverse Event|1|||
161332189|NCT00239720|582603538|FG001|Overall Study|Adverse Event|0|||
161332190|NCT00239720|582603537|FG000|Overall Study|Lost to Follow-up|0|||
161332191|NCT00239720|582603538|FG001|Overall Study|Lost to Follow-up|1|||
161332192|NCT01405560|582603539|FG000|Overall Study|Physician Decision|1|||
161332193|NCT01699750|582603544|FG000|Overall Study|Withdrew Consent|0|||
161332194|NCT01699750|582603545|FG001|Overall Study|Withdrew Consent|1|||
161332195|NCT01699750|582603544|FG000|Overall Study|Other|0|||
161332196|NCT01699750|582603545|FG001|Overall Study|Other|2|||
161332197|NCT01868646|582603547|FG000|Overall Study|Do not meet inclusion criteria|3|||
161332198|NCT01868646|582603548|FG001|Overall Study|Do not meet inclusion criteria|5|||
161332199|NCT01831427|582603549|FG000|Overall Study|Adverse Event|0|||
161332200|NCT01831427|582603550|FG001|Overall Study|Adverse Event|1|||
161332201|NCT01831427|582603551|FG002|Overall Study|Adverse Event|0|||
161332202|NCT01831427|582603552|FG003|Overall Study|Adverse Event|0|||
161332203|NCT01831427|582603553|FG004|Overall Study|Adverse Event|0|||
161332204|NCT01831427|582603554|FG005|Overall Study|Adverse Event|1|||
161332205|NCT01831427|582603555|FG006|Overall Study|Adverse Event|0|||
161332206|NCT01831427|582603556|FG007|Overall Study|Adverse Event|1|||
161332207|NCT01831427|582603557|FG008|Overall Study|Adverse Event|0|||
161332208|NCT01831427|582603558|FG009|Overall Study|Adverse Event|0|||
161332209|NCT01831427|582603559|FG010|Overall Study|Adverse Event|2|||
161332210|NCT01831427|582603549|FG000|Overall Study|Investigator's Discretion|0|||
161332211|NCT01831427|582603550|FG001|Overall Study|Investigator's Discretion|0|||
161332212|NCT01831427|582603551|FG002|Overall Study|Investigator's Discretion|0|||
161332213|NCT01831427|582603552|FG003|Overall Study|Investigator's Discretion|1|||
161332214|NCT01831427|582603553|FG004|Overall Study|Investigator's Discretion|0|||
161332215|NCT01831427|582603554|FG005|Overall Study|Investigator's Discretion|0|||
161332216|NCT01831427|582603555|FG006|Overall Study|Investigator's Discretion|0|||
161332217|NCT01831427|582603556|FG007|Overall Study|Investigator's Discretion|0|||
161332218|NCT01831427|582603557|FG008|Overall Study|Investigator's Discretion|0|||
161332219|NCT01831427|582603558|FG009|Overall Study|Investigator's Discretion|0|||
161332220|NCT01831427|582603559|FG010|Overall Study|Investigator's Discretion|0|||
161332221|NCT01831427|582603549|FG000|Overall Study|Withdrew Consent|0|||
161332222|NCT01831427|582603550|FG001|Overall Study|Withdrew Consent|0|||
161332223|NCT01831427|582603551|FG002|Overall Study|Withdrew Consent|0|||
161332224|NCT01831427|582603552|FG003|Overall Study|Withdrew Consent|0|||
161332225|NCT01831427|582603553|FG004|Overall Study|Withdrew Consent|0|||
160897122|NCT00464269|581018772|FG003|Overall Study|SAE, non-fatal|1|||
161237346|NCT03570749|582250144|FG006|Overall Study|Lost to Follow-up|10|||
161237347|NCT03570749|582250138|FG000|Overall Study|Pregnancy|0|||
160897123|NCT00464269|581018769|FG000|Overall Study|AE, non-serious non-fatal|2|||
160897124|NCT00464269|581018770|FG001|Overall Study|AE, non-serious non-fatal|8|||
160897125|NCT00464269|581018771|FG002|Overall Study|AE, non-serious non-fatal|3|||
160897126|NCT00464269|581018772|FG003|Overall Study|AE, non-serious non-fatal|4|||
160897127|NCT00464269|581018769|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160897128|NCT00464269|581018770|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160897129|NCT00464269|581018771|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
160897130|NCT00464269|581018772|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
160897131|NCT03911154|581018773|FG000|Overall Study|Withdrawal by Subject|1|||
160897132|NCT05055128|581018774|FG000|Overall Study|Adverse Event|0|||
160897133|NCT05055128|581018775|FG001|Overall Study|Adverse Event|0|||
160897134|NCT05055128|581018776|FG002|Overall Study|Adverse Event|0|||
160897135|NCT05055128|581018777|FG003|Overall Study|Adverse Event|1|||
160897136|NCT05055128|581018778|FG004|Overall Study|Adverse Event|1|||
160897137|NCT05055128|581018774|FG000|Overall Study|Protocol Violation|0|||
160897138|NCT05055128|581018775|FG001|Overall Study|Protocol Violation|0|||
160897139|NCT05055128|581018776|FG002|Overall Study|Protocol Violation|0|||
160897140|NCT05055128|581018777|FG003|Overall Study|Protocol Violation|1|||
160897141|NCT05055128|581018778|FG004|Overall Study|Protocol Violation|0|||
160897142|NCT05055128|581018774|FG000|Overall Study|Withdrawal by Subject|5|||
160897143|NCT05055128|581018775|FG001|Overall Study|Withdrawal by Subject|2|||
160897144|NCT05055128|581018776|FG002|Overall Study|Withdrawal by Subject|2|||
160897145|NCT05055128|581018777|FG003|Overall Study|Withdrawal by Subject|4|||
160897146|NCT05055128|581018778|FG004|Overall Study|Withdrawal by Subject|2|||
160802572|NCT04046939|580666036|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
160802573|NCT04046939|580666037|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
160802574|NCT00038948|580666038|FG000|Overall Study|Adverse Event|131|||
160802575|NCT00038948|580666039|FG001|Overall Study|Adverse Event|43|||
160802576|NCT00038948|580666038|FG000|Overall Study|Lost to Follow-up|4|||
160802577|NCT00038948|580666039|FG001|Overall Study|Lost to Follow-up|4|||
160802578|NCT00038948|580666038|FG000|Overall Study|Nonmedical event|5|||
160802579|NCT00038948|580666039|FG001|Overall Study|Nonmedical event|7|||
160802580|NCT00038948|580666038|FG000|Overall Study|Withdrawal by Subject|23|||
160802581|NCT00038948|580666039|FG001|Overall Study|Withdrawal by Subject|10|||
160802582|NCT00038948|580666038|FG000|Overall Study|Protocol Violation|3|||
160802583|NCT00038948|580666039|FG001|Overall Study|Protocol Violation|7|||
160802584|NCT00038948|580666038|FG000|Overall Study|Lack of Efficacy|3|||
160802585|NCT00038948|580666039|FG001|Overall Study|Lack of Efficacy|6|||
160802586|NCT00810277|580667560|FG000|Overall Study|Adverse Event|1|||
160802587|NCT00529243|580667564|FG000|Overall Study|Adverse Event|1|||
160802588|NCT00529243|580667564|FG000|Overall Study|Death|1|||
160802589|NCT00529243|580667564|FG000|Overall Study|Relocated|1|||
160802590|NCT00678288|580667571|FG000|Overall Study|Adverse Event|0|||
160802591|NCT00678288|580667572|FG001|Overall Study|Adverse Event|2|||
160802592|NCT00678288|580667571|FG000|Overall Study|Withdrawal by Subject|1|||
160802593|NCT00678288|580667572|FG001|Overall Study|Withdrawal by Subject|1|||
160802594|NCT00678288|580667571|FG000|Overall Study|Study terminated by the sponsor|2|||
160802595|NCT00678288|580667572|FG001|Overall Study|Study terminated by the sponsor|0|||
160802596|NCT00678288|580667571|FG000|Overall Study|Not compliant with study medication|0|||
160802597|NCT00678288|580667572|FG001|Overall Study|Not compliant with study medication|1|||
160802598|NCT00678288|580667571|FG000|Overall Study|Switch to commercial drug|0|||
160802599|NCT00678288|580667572|FG001|Overall Study|Switch to commercial drug|1|||
160802600|NCT00678288|580667571|FG000|Overall Study|Reason not reported|1|||
160802601|NCT00678288|580667572|FG001|Overall Study|Reason not reported|0|||
160897147|NCT05055128|581018774|FG000|Overall Study|Randomized By Mistake|0|||
160897148|NCT05055128|581018775|FG001|Overall Study|Randomized By Mistake|1|||
160897149|NCT05055128|581018776|FG002|Overall Study|Randomized By Mistake|0|||
160897150|NCT05055128|581018777|FG003|Overall Study|Randomized By Mistake|0|||
160897151|NCT05055128|581018778|FG004|Overall Study|Randomized By Mistake|0|||
160897152|NCT05055128|581018774|FG000|Overall Study|Other|1|||
160897153|NCT05055128|581018775|FG001|Overall Study|Other|0|||
161237348|NCT03570749|582250139|FG001|Overall Study|Pregnancy|0|||
160802602|NCT00678288|580667571|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
160802603|NCT00678288|580667572|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
160802604|NCT04472650|580667583|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
160802605|NCT04472650|580667584|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
160802606|NCT03247829|580667587|FG000|Overall Study|Death|3|||
160802607|NCT03247829|580667588|FG001|Overall Study|Death|4|||
160802608|NCT03247829|580667587|FG000|Overall Study|Enter Hospice Care|1|||
160802609|NCT03247829|580667588|FG001|Overall Study|Enter Hospice Care|0|||
160897154|NCT05055128|581018776|FG002|Overall Study|Other|0|||
160897155|NCT05055128|581018777|FG003|Overall Study|Other|0|||
160897156|NCT05055128|581018778|FG004|Overall Study|Other|0|||
160897157|NCT00292318|581018780|FG000|Overall Study|Study terminated by officials|2|||
160897158|NCT00292318|581018781|FG001|Overall Study|Study terminated by officials|1|||
160897159|NCT01822496|581018782|FG000|Overall Study|Protocol Violation|2|||
160897160|NCT01822496|581018783|FG001|Overall Study|Protocol Violation|2|||
160802610|NCT03247829|580667587|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
160802611|NCT03247829|580667588|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
160802612|NCT03247829|580667587|FG000|Overall Study|LVAD Explant|1|||
160802613|NCT03247829|580667588|FG001|Overall Study|LVAD Explant|1|||
160802614|NCT03247829|580667587|FG000|Overall Study|Transplant|1|||
160802615|NCT03247829|580667588|FG001|Overall Study|Transplant|1|||
160802616|NCT01783444|580667589|FG000|Treatment Phase|Adverse Event|9|||
160802617|NCT01783444|580667590|FG001|Treatment Phase|Adverse Event|20|||
160802618|NCT01783444|580667591|FG002|Treatment Phase|Adverse Event|19|||
160802619|NCT01783444|580667589|FG000|Treatment Phase|Disease Progression|76|||
160802620|NCT01783444|580667590|FG001|Treatment Phase|Disease Progression|66|||
160802621|NCT01783444|580667591|FG002|Treatment Phase|Disease Progression|64|||
160802622|NCT01783444|580667589|FG000|Treatment Phase|Death|2|||
160802623|NCT01783444|580667590|FG001|Treatment Phase|Death|2|||
160802624|NCT01783444|580667591|FG002|Treatment Phase|Death|2|||
160802625|NCT01783444|580667589|FG000|Treatment Phase|Protocol Violation|1|||
160802626|NCT01783444|580667590|FG001|Treatment Phase|Protocol Violation|1|||
160802627|NCT01783444|580667591|FG002|Treatment Phase|Protocol Violation|2|||
160802628|NCT01783444|580667589|FG000|Treatment Phase|Withdrawal by Subject|6|||
160802629|NCT01783444|580667590|FG001|Treatment Phase|Withdrawal by Subject|8|||
160802630|NCT01783444|580667591|FG002|Treatment Phase|Withdrawal by Subject|9|||
160802631|NCT01783444|580667589|FG000|Treatment Phase|Administrative problems|2|||
160802632|NCT01783444|580667590|FG001|Treatment Phase|Administrative problems|0|||
160802633|NCT01783444|580667591|FG002|Treatment Phase|Administrative problems|1|||
160802634|NCT01783444|580667589|FG000|Treatment Phase|Physician Decision|8|||
160802635|NCT01783444|580667590|FG001|Treatment Phase|Physician Decision|6|||
161332226|NCT01831427|582603554|FG005|Overall Study|Withdrew Consent|0|||
161332227|NCT01831427|582603555|FG006|Overall Study|Withdrew Consent|2|||
161332228|NCT01831427|582603556|FG007|Overall Study|Withdrew Consent|0|||
161332229|NCT01831427|582603557|FG008|Overall Study|Withdrew Consent|0|||
161332230|NCT01831427|582603558|FG009|Overall Study|Withdrew Consent|1|||
161332231|NCT01831427|582603559|FG010|Overall Study|Withdrew Consent|1|||
161332232|NCT00536510|582603562|FG000|Overall Study|Adverse Event|27|||
161332233|NCT00536510|582603563|FG001|Overall Study|Adverse Event|4|||
161332234|NCT00536510|582603562|FG000|Overall Study|Lost to Follow-up|11|||
161332235|NCT00536510|582603563|FG001|Overall Study|Lost to Follow-up|8|||
161332236|NCT00536510|582603562|FG000|Overall Study|Protocol Violation|4|||
161332237|NCT00536510|582603563|FG001|Overall Study|Protocol Violation|5|||
161332238|NCT00536510|582603562|FG000|Overall Study|Withdrawal by Subject|16|||
161332239|NCT00536510|582603563|FG001|Overall Study|Withdrawal by Subject|9|||
161332240|NCT00536510|582603562|FG000|Overall Study|Flushing with Product|20|||
161332241|NCT00536510|582603563|FG001|Overall Study|Flushing with Product|0|||
161332242|NCT00536510|582603562|FG000|Overall Study|Laboratory Adverse Event|2|||
161332243|NCT00536510|582603563|FG001|Overall Study|Laboratory Adverse Event|1|||
161332244|NCT00536510|582603562|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
160802636|NCT01783444|580667591|FG002|Treatment Phase|Physician Decision|5|||
160802637|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
160802638|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
160802639|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
160802640|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
160802641|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
160802642|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
160802643|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
160802644|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
160897161|NCT01822496|581018784|FG002|Overall Study|Protocol Violation|0|||
160897162|NCT01822496|581018785|FG003|Overall Study|Protocol Violation|1|||
160897163|NCT01822496|581018782|FG000|Overall Study|Withdrawal by Subject|0|||
160897164|NCT01822496|581018783|FG001|Overall Study|Withdrawal by Subject|0|||
160897165|NCT01822496|581018784|FG002|Overall Study|Withdrawal by Subject|0|||
160897166|NCT01822496|581018785|FG003|Overall Study|Withdrawal by Subject|3|||
160897167|NCT02906332|581018786|FG000|Overall Study|Withdrawal by Subject|1|||
160897168|NCT03945266|581018787|FG000|Overall Study|Withdrawal by Subject|1|||
160897169|NCT03945266|581018788|FG001|Overall Study|Withdrawal by Subject|0|||
161332245|NCT00536510|582603563|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
161332246|NCT01249417|582603564|FG000|Randomised Population|Study treatment not received|0|||
161332247|NCT01249417|582603565|FG001|Randomised Population|Study treatment not received|0|||
161332248|NCT01249417|582603566|FG002|Randomised Population|Study treatment not received|2|||
161332249|NCT01249417|582603564|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
160802645|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
160802646|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
160897170|NCT03945266|581018787|FG000|Overall Study|Miscarriage|0|||
160897171|NCT03945266|581018788|FG001|Overall Study|Miscarriage|2|||
161129820|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
160897172|NCT03945266|581018787|FG000|Overall Study|Lost to Follow-up|1|||
160802647|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
160802648|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
160802649|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
160802650|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
160802651|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
160802652|NCT01783444|580667589|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
160802653|NCT01783444|580667590|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
160802654|NCT01783444|580667591|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
160802655|NCT00552071|580667593|FG000|Overall Study|Adverse Event|1|||
160802656|NCT00552071|580667594|FG001|Overall Study|Adverse Event|0|||
160802657|NCT00552071|580667593|FG000|Overall Study|Lack of Efficacy|1|||
160802658|NCT00552071|580667594|FG001|Overall Study|Lack of Efficacy|0|||
160802659|NCT00552071|580667593|FG000|Overall Study|Physician Decision|1|||
160802660|NCT00552071|580667594|FG001|Overall Study|Physician Decision|0|||
160802661|NCT00552071|580667593|FG000|Overall Study|Pregnancy|1|||
160802662|NCT00552071|580667594|FG001|Overall Study|Pregnancy|0|||
160802663|NCT00552071|580667593|FG000|Overall Study|Death|0|||
160802664|NCT00552071|580667594|FG001|Overall Study|Death|1|||
160802665|NCT00552071|580667593|FG000|Overall Study|Withdrawal by Subject|0|||
160802666|NCT00552071|580667594|FG001|Overall Study|Withdrawal by Subject|1|||
160802667|NCT00272792|580667595|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
160802668|NCT00272792|580667596|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
160802669|NCT00272792|580667595|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
160802670|NCT00272792|580667596|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
160802671|NCT00272792|580667595|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
160802672|NCT00272792|580667596|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
160802673|NCT00272792|580667595|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
160802674|NCT00272792|580667596|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
160802675|NCT00937495|580667601|FG000|Overall Study|Protocol Violation|2|||
160802676|NCT01856322|580667602|FG000|Overall Study|off study due to lack of accrual|0|||
160802677|NCT01856322|580667603|FG001|Overall Study|off study due to lack of accrual|0|||
160802678|NCT01856322|580667604|FG002|Overall Study|off study due to lack of accrual|3|||
160802679|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
160802680|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802681|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802682|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802683|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802684|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802685|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802686|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802687|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
160802688|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802689|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
160802690|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
160802691|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802692|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802693|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802694|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802695|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802696|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
160802697|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
160802698|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
160802699|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
160802700|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802701|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802702|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802703|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802704|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802705|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802706|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
160861916|NCT00449696|580887879|FG000|Overall Study|Withdrawal by Subject|5|||
160861917|NCT00449696|580887880|FG001|Overall Study|Withdrawal by Subject|5|||
160861918|NCT00449696|580887879|FG000|Overall Study|Lost to Follow-up|2|||
160802707|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
160802708|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
160802709|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802710|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802711|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802712|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802713|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802714|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
160802715|NCT02628444|580667605|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
160802716|NCT02628444|580667606|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
160802717|NCT02628444|580667607|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
160802718|NCT02628444|580667608|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802719|NCT02628444|580667609|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802720|NCT02628444|580667610|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802721|NCT02628444|580667611|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802722|NCT02628444|580667612|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802723|NCT02628444|580667613|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
160802724|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802725|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802726|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802727|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
160802728|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802729|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802730|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802731|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802732|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
160802733|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
160802734|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
160802735|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
160802736|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
160802737|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
160802738|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
160802739|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
160802740|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
160802741|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
160802742|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802743|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802744|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
160802745|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
160802746|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
160802747|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
160802748|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
160802749|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
160802750|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
160802751|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802752|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160985068|NCT01734382|581335338|FG001|Part 1|Adverse Event|0|||
160985069|NCT01734382|581335339|FG002|Part 1|Adverse Event|0|||
160985070|NCT01734382|581335337|FG000|Part 2|Adverse Event|0|||
160985071|NCT01734382|581335338|FG001|Part 2|Adverse Event|0|||
160802753|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802754|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802755|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
160802756|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802757|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
160802758|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
160802759|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
160861919|NCT00449696|580887880|FG001|Overall Study|Lost to Follow-up|3|||
160985072|NCT01734382|581335339|FG002|Part 2|Adverse Event|1|||
160985073|NCT01734382|581335337|FG000|Part 2|Lack of Efficacy|0|||
160985074|NCT01734382|581335338|FG001|Part 2|Lack of Efficacy|1|||
160985075|NCT01734382|581335339|FG002|Part 2|Lack of Efficacy|1|||
160985076|NCT01734382|581335337|FG000|Part 2|Other|0|||
160985077|NCT01734382|581335338|FG001|Part 2|Other|0|||
160985078|NCT01734382|581335339|FG002|Part 2|Other|1|||
160985079|NCT01734382|581335337|FG000|Part 2|Physician Decision|0|||
160802760|NCT02628444|580667605|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
160802761|NCT02628444|580667606|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
160802762|NCT02628444|580667607|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
160802763|NCT02628444|580667608|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
160802764|NCT02628444|580667609|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
160802765|NCT02628444|580667610|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
160802766|NCT02628444|580667611|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
160802767|NCT02628444|580667612|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
160802768|NCT02628444|580667613|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
160802769|NCT00288015|580667614|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
160802770|NCT00288015|580667614|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
161129821|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
161129822|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
160802771|NCT00288015|580667614|FG000|First Response Assessment|Withdrawal by Subject|1|||
160802772|NCT00288015|580667614|FG000|First Response Assessment|Death|1|||
160802773|NCT00288015|580667614|FG000|First Response Assessment|Physician Decision|2|||
160802774|NCT00288015|580667614|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
160802775|NCT00288015|580667614|FG000|Follow up for Survival x 2 Years|Death|13|||
160802776|NCT00288015|580667614|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
160802777|NCT00288015|580667614|FG000|Follow up for Survival x 2 Years|Other|9|||
160802778|NCT00443703|580667617|FG000|Overall Study|Never Treated|3|||
160802779|NCT00443703|580667618|FG001|Overall Study|Never Treated|1|||
160802780|NCT00443703|580667617|FG000|Overall Study|Adverse Event|7|||
160802781|NCT00443703|580667618|FG001|Overall Study|Adverse Event|3|||
160802782|NCT00443703|580667617|FG000|Overall Study|Lack of Efficacy|3|||
160802783|NCT00443703|580667618|FG001|Overall Study|Lack of Efficacy|1|||
160802784|NCT00443703|580667617|FG000|Overall Study|Lost to Follow-up|0|||
160802785|NCT00443703|580667618|FG001|Overall Study|Lost to Follow-up|4|||
160802786|NCT00443703|580667617|FG000|Overall Study|Physician Decision|4|||
160802787|NCT00443703|580667618|FG001|Overall Study|Physician Decision|2|||
160802788|NCT00443703|580667617|FG000|Overall Study|Protocol Violation|1|||
160802789|NCT00443703|580667618|FG001|Overall Study|Protocol Violation|1|||
160802790|NCT00443703|580667617|FG000|Overall Study|Withdrawal by Subject|9|||
160802791|NCT00443703|580667618|FG001|Overall Study|Withdrawal by Subject|6|||
160802792|NCT00443703|580667617|FG000|Overall Study|Progressive Disease|1|||
160802793|NCT00443703|580667618|FG001|Overall Study|Progressive Disease|0|||
160802794|NCT01047007|580667619|FG000|Overall Study|Adverse Event|0|||
160802795|NCT01047007|580667620|FG001|Overall Study|Adverse Event|2|||
160802796|NCT01047007|580667621|FG002|Overall Study|Adverse Event|1|||
160802797|NCT01047007|580667622|FG003|Overall Study|Adverse Event|0|||
160802798|NCT01047007|580667619|FG000|Overall Study|Progressive Disease|2|||
160802799|NCT01047007|580667620|FG001|Overall Study|Progressive Disease|4|||
160802800|NCT01047007|580667621|FG002|Overall Study|Progressive Disease|1|||
160802801|NCT01047007|580667622|FG003|Overall Study|Progressive Disease|0|||
160802802|NCT00592631|580667626|FG000|Overall Study|Lost to Follow-up|0|||
160802803|NCT00592631|580667627|FG001|Overall Study|Lost to Follow-up|2|||
160802804|NCT03389308|580667629|FG000|Overall Study|Withdrawal by Subject|5|||
160802805|NCT03389308|580667629|FG000|Overall Study|Lost to Follow-up|3|||
160802806|NCT03389308|580667629|FG000|Overall Study|Adverse Event|2|||
160802807|NCT03389308|580667629|FG000|Overall Study|Sponsor Request|2|||
160802808|NCT00616642|580667631|FG000|Overall Study|Withdrawal by Subject|0|||
160802809|NCT00616642|580667632|FG001|Overall Study|Withdrawal by Subject|1|||
160802810|NCT00570323|580667633|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
160802811|NCT00570323|580667634|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
160802812|NCT00570323|580667633|FG000|Started Treatment After Randomization|Protocol Violation|1|||
160802813|NCT00570323|580667634|FG001|Started Treatment After Randomization|Protocol Violation|0|||
160802814|NCT00570323|580667633|FG000|Started Treatment After Randomization|Physician Decision|1|||
160802815|NCT00570323|580667634|FG001|Started Treatment After Randomization|Physician Decision|0|||
160802816|NCT00570323|580667633|FG000|Complete Study After Start|Lost to Follow-up|0|||
160802817|NCT00570323|580667634|FG001|Complete Study After Start|Lost to Follow-up|1|||
160802818|NCT00570323|580667633|FG000|Complete Study After Start|Withdrawal by Subject|2|||
160802819|NCT00570323|580667634|FG001|Complete Study After Start|Withdrawal by Subject|0|||
160802820|NCT00570323|580667633|FG000|Complete Study After Start|Physician Decision|1|||
160802821|NCT00570323|580667634|FG001|Complete Study After Start|Physician Decision|0|||
160802822|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Physician Decision|0|||
160802823|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Physician Decision|0|||
160802824|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Physician Decision|1|||
160802825|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Physician Decision|0|||
160802826|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
160802827|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
160802828|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
160802829|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
161129823|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
160802830|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
160802831|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
160802832|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
160802833|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
160802834|NCT02266147|580667637|FG000|PART 1: Dose Escalation|Other|1|||
160802835|NCT02266147|580667638|FG001|PART 1: Dose Escalation|Other|1|||
160802836|NCT02266147|580667639|FG002|PART 1: Dose Escalation|Other|0|||
160802837|NCT02266147|580667640|FG003|PART 1: Dose Escalation|Other|0|||
160802838|NCT02266147|580667637|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
160802839|NCT02266147|580667638|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
160802840|NCT02266147|580667639|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
160802841|NCT02266147|580667640|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
160802842|NCT02266147|580667637|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
160802843|NCT02266147|580667638|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
160802844|NCT02266147|580667639|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
160802845|NCT02266147|580667640|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
160802846|NCT01023217|580667641|FG000|Overall Study|Withdrawal by Subject|1|||
160802847|NCT01023217|580667642|FG001|Overall Study|Withdrawal by Subject|0|||
160802848|NCT00332696|580667643|FG000|Overall Study|Death|24|||
160802849|NCT00332696|580667644|FG001|Overall Study|Death|14|||
161332250|NCT01249417|582603565|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
161332251|NCT01249417|582603566|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
160802850|NCT00332696|580667643|FG000|Overall Study|Insufficient therapeutic effect|4|||
160802851|NCT00332696|580667644|FG001|Overall Study|Insufficient therapeutic effect|11|||
160802852|NCT00332696|580667643|FG000|Overall Study|Adverse Event|1|||
160802853|NCT00332696|580667644|FG001|Overall Study|Adverse Event|2|||
160802854|NCT00332696|580667643|FG000|Overall Study|Condition does not justify treatment|0|||
160802855|NCT00332696|580667644|FG001|Overall Study|Condition does not justify treatment|2|||
160802856|NCT00332696|580667643|FG000|Overall Study|Lost to Follow-up|0|||
160802857|NCT00332696|580667644|FG001|Overall Study|Lost to Follow-up|1|||
160802858|NCT00332696|580667643|FG000|Overall Study|Withdrawal by Subject|1|||
160802859|NCT00332696|580667644|FG001|Overall Study|Withdrawal by Subject|0|||
160802860|NCT02216526|580667645|FG000|Overall Study|Adverse Event|1|||
160802861|NCT02216526|580667646|FG001|Overall Study|Adverse Event|1|||
160802862|NCT02216526|580667647|FG002|Overall Study|Adverse Event|0|||
160802863|NCT02216526|580667645|FG000|Overall Study|Death|0|||
160802864|NCT02216526|580667646|FG001|Overall Study|Death|1|||
160802865|NCT02216526|580667647|FG002|Overall Study|Death|3|||
160802866|NCT02216526|580667645|FG000|Overall Study|Protocol Violation|2|||
160802867|NCT02216526|580667646|FG001|Overall Study|Protocol Violation|0|||
160802868|NCT02216526|580667647|FG002|Overall Study|Protocol Violation|2|||
160802869|NCT02216526|580667645|FG000|Overall Study|Hospitalization|2|||
160802870|NCT02216526|580667646|FG001|Overall Study|Hospitalization|1|||
160802871|NCT02216526|580667647|FG002|Overall Study|Hospitalization|3|||
160802872|NCT04103450|580667652|FG000|Overall Study|Adverse Event|4|||
160802873|NCT04103450|580667653|FG001|Overall Study|Adverse Event|2|||
161129824|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
160802874|NCT04103450|580667652|FG000|Overall Study|Lack of Efficacy|3|||
160802875|NCT04103450|580667653|FG001|Overall Study|Lack of Efficacy|0|||
160802876|NCT04103450|580667652|FG000|Overall Study|Withdrawal by Subject|5|||
160802877|NCT04103450|580667653|FG001|Overall Study|Withdrawal by Subject|3|||
160802878|NCT04103450|580667652|FG000|Overall Study|Lost to Follow-up|1|||
160802879|NCT04103450|580667653|FG001|Overall Study|Lost to Follow-up|2|||
160802880|NCT04103450|580667652|FG000|Overall Study|Physician Decision|1|||
160802881|NCT04103450|580667653|FG001|Overall Study|Physician Decision|2|||
160802882|NCT04103450|580667652|FG000|Overall Study|Protocol Violation|1|||
160802883|NCT04103450|580667653|FG001|Overall Study|Protocol Violation|0|||
160802884|NCT04103450|580667652|FG000|Overall Study|Other|1|||
160802885|NCT04103450|580667653|FG001|Overall Study|Other|1|||
160802886|NCT00696878|580667654|FG000|Overall Study|Adverse Event|8|||
160802887|NCT00696878|580667654|FG000|Overall Study|Withdrawal by Subject|87|||
160802888|NCT00696878|580667654|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
160802889|NCT00696878|580667654|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
160802890|NCT00696878|580667654|FG000|Overall Study|Trial stopped|32|||
160802891|NCT00696878|580667654|FG000|Overall Study|Other reason (not specified)|55|||
160802892|NCT02712788|580667655|FG000|Overall Study|Physician Decision|1|||
160802893|NCT02712788|580667656|FG001|Overall Study|Physician Decision|0|||
160802894|NCT02712788|580667655|FG000|Overall Study|Protocol Violation|1|||
161129825|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
160802895|NCT02712788|580667656|FG001|Overall Study|Protocol Violation|0|||
160802896|NCT00967616|580667663|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
160802897|NCT00967616|580667664|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
160802898|NCT00967616|580667663|FG000|Overall Study|Death|0|||
160802899|NCT00967616|580667664|FG001|Overall Study|Death|3|||
160802900|NCT00967616|580667663|FG000|Overall Study|Withdrawal by Subject|8|||
160985080|NCT01734382|581335338|FG001|Part 2|Physician Decision|0|||
160802901|NCT00967616|580667664|FG001|Overall Study|Withdrawal by Subject|4|||
160802902|NCT00967616|580667663|FG000|Overall Study|Progressive Disease|31|||
160802903|NCT00967616|580667664|FG001|Overall Study|Progressive Disease|18|||
160802904|NCT00967616|580667663|FG000|Overall Study|Other|8|||
160802905|NCT00967616|580667664|FG001|Overall Study|Other|8|||
160802906|NCT00967616|580667663|FG000|Overall Study|Protocol Violation|1|||
160802907|NCT00967616|580667664|FG001|Overall Study|Protocol Violation|0|||
160802908|NCT03188263|580667670|FG000|Overall Study|Withdrawal by Subject|3|||
160802909|NCT03188263|580667671|FG001|Overall Study|Withdrawal by Subject|0|||
160802910|NCT03188263|580667670|FG000|Overall Study|Physician Decision|1|||
160802911|NCT03188263|580667671|FG001|Overall Study|Physician Decision|0|||
160802912|NCT00699413|580667672|FG000|Overall Study|Withdrawal by Subject|0|||
160802913|NCT00699413|580667673|FG001|Overall Study|Withdrawal by Subject|2|||
160802914|NCT00699413|580667672|FG000|Overall Study|Study terminated by sponsor|4|||
160802915|NCT00699413|580667673|FG001|Overall Study|Study terminated by sponsor|2|||
160802916|NCT00251693|580667674|FG000|Overall Study|Adverse Event|17|||
160802917|NCT00251693|580667675|FG001|Overall Study|Adverse Event|9|||
160802918|NCT00251693|580667676|FG002|Overall Study|Adverse Event|9|||
160802919|NCT00251693|580667674|FG000|Overall Study|Protocol Violation|2|||
160802920|NCT00251693|580667675|FG001|Overall Study|Protocol Violation|0|||
160802921|NCT00251693|580667676|FG002|Overall Study|Protocol Violation|2|||
160802922|NCT00251693|580667674|FG000|Overall Study|Lost to Follow-up|12|||
160802923|NCT00251693|580667675|FG001|Overall Study|Lost to Follow-up|7|||
160802924|NCT00251693|580667676|FG002|Overall Study|Lost to Follow-up|8|||
160802925|NCT00251693|580667674|FG000|Overall Study|Withdrawal by Subject|11|||
160802926|NCT00251693|580667675|FG001|Overall Study|Withdrawal by Subject|17|||
160802927|NCT00251693|580667676|FG002|Overall Study|Withdrawal by Subject|14|||
160802928|NCT00251693|580667674|FG000|Overall Study|Lack of Efficacy|0|||
160802929|NCT00251693|580667675|FG001|Overall Study|Lack of Efficacy|1|||
160802930|NCT00251693|580667676|FG002|Overall Study|Lack of Efficacy|0|||
160802931|NCT00251693|580667674|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
160802932|NCT00251693|580667675|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
160802933|NCT00251693|580667676|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
160802934|NCT00251693|580667674|FG000|Overall Study|Noncompliant|0|||
160802935|NCT00251693|580667675|FG001|Overall Study|Noncompliant|0|||
160802936|NCT00251693|580667676|FG002|Overall Study|Noncompliant|2|||
160802937|NCT00251693|580667674|FG000|Overall Study|Possible Barrett's esophagus|3|||
160802938|NCT00251693|580667675|FG001|Overall Study|Possible Barrett's esophagus|5|||
160802939|NCT00251693|580667676|FG002|Overall Study|Possible Barrett's esophagus|2|||
160802940|NCT00251693|580667674|FG000|Overall Study|Subject request/subject unavailable|1|||
160802941|NCT00251693|580667675|FG001|Overall Study|Subject request/subject unavailable|2|||
160802942|NCT00251693|580667676|FG002|Overall Study|Subject request/subject unavailable|0|||
160802943|NCT00251693|580667674|FG000|Overall Study|Abnormal laboratory findings|0|||
160802944|NCT00251693|580667675|FG001|Overall Study|Abnormal laboratory findings|0|||
160802945|NCT00251693|580667676|FG002|Overall Study|Abnormal laboratory findings|1|||
160802946|NCT02779777|580667677|FG000|Overall Study|Disease Progression|1|||
160802947|NCT02779777|580667678|FG001|Overall Study|Disease Progression|0|||
160802948|NCT02779777|580667679|FG002|Overall Study|Disease Progression|0|||
160802949|NCT02779777|580667677|FG000|Overall Study|Adverse Event|3|||
160802950|NCT02779777|580667678|FG001|Overall Study|Adverse Event|1|||
160802951|NCT02779777|580667679|FG002|Overall Study|Adverse Event|0|||
160897173|NCT03945266|581018788|FG001|Overall Study|Lost to Follow-up|0|||
160897174|NCT03698331|581018794|FG000|Overall Study|Adverse Event|2|||
160897175|NCT03698331|581018795|FG001|Overall Study|Adverse Event|3|||
160897176|NCT03698331|581018794|FG000|Overall Study|Withdrawal by Subject|1|||
160897177|NCT03698331|581018795|FG001|Overall Study|Withdrawal by Subject|1|||
160897178|NCT03698331|581018794|FG000|Overall Study|Lost to Follow-up|0|||
160897179|NCT03698331|581018795|FG001|Overall Study|Lost to Follow-up|2|||
160985081|NCT01734382|581335339|FG002|Part 2|Physician Decision|3|||
160985082|NCT01734382|581335337|FG000|Part 2|Protocol Violation|0|||
160985083|NCT01734382|581335338|FG001|Part 2|Protocol Violation|1|||
161129826|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
160802952|NCT02779777|580667677|FG000|Overall Study|Physician Decision|9|||
160802953|NCT02779777|580667678|FG001|Overall Study|Physician Decision|0|||
160802954|NCT02779777|580667679|FG002|Overall Study|Physician Decision|1|||
160802955|NCT02779777|580667677|FG000|Overall Study|Withdrawal by Subject|1|||
160802956|NCT02779777|580667678|FG001|Overall Study|Withdrawal by Subject|0|||
160802957|NCT02779777|580667679|FG002|Overall Study|Withdrawal by Subject|0|||
160802958|NCT01030822|580667681|FG000|Overall Study|Moved/migrated from study area|6|||
160802959|NCT01030822|580667682|FG001|Overall Study|Moved/migrated from study area|7|||
160802960|NCT01030822|580667683|FG002|Overall Study|Moved/migrated from study area|3|||
160897180|NCT03698331|581018794|FG000|Overall Study|Non-compliance with study drug|1|||
160897181|NCT03698331|581018795|FG001|Overall Study|Non-compliance with study drug|0|||
160897182|NCT04916769|581018799|FG000|Period 1|Physician Decision|0|||
160897183|NCT04916769|581018800|FG001|Period 1|Physician Decision|0|||
161129827|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
160897184|NCT04916769|581018801|FG002|Period 1|Physician Decision|0|||
160985084|NCT01734382|581335339|FG002|Part 2|Protocol Violation|0|||
160985085|NCT01734382|581335337|FG000|Part 2|Withdrawal by Subject|0|||
160985086|NCT01734382|581335338|FG001|Part 2|Withdrawal by Subject|0|||
160985087|NCT01734382|581335339|FG002|Part 2|Withdrawal by Subject|1|||
160985088|NCT04537949|581335340|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
160985089|NCT04537949|581335341|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
160985090|NCT04537949|581335342|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
160985091|NCT04537949|581335343|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
160985092|NCT04537949|581335344|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
160985093|NCT04537949|581335345|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
160985094|NCT04537949|581335346|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
160985095|NCT04537949|581335347|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
160985096|NCT04537949|581335340|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
160985097|NCT04537949|581335341|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
160985098|NCT04537949|581335342|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
160985099|NCT04537949|581335343|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
160985100|NCT04537949|581335344|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
160985101|NCT04537949|581335345|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
160985102|NCT04537949|581335346|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
160985103|NCT04537949|581335347|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
160985104|NCT04537949|581335340|FG000|Follow-up Phase|Lost to Follow-up|0|||
160985105|NCT04537949|581335341|FG001|Follow-up Phase|Lost to Follow-up|3|||
160985106|NCT04537949|581335342|FG002|Follow-up Phase|Lost to Follow-up|0|||
160985107|NCT04537949|581335343|FG003|Follow-up Phase|Lost to Follow-up|0|||
160985108|NCT04537949|581335344|FG004|Follow-up Phase|Lost to Follow-up|0|||
160985109|NCT04537949|581335345|FG005|Follow-up Phase|Lost to Follow-up|0|||
160985110|NCT04537949|581335346|FG006|Follow-up Phase|Lost to Follow-up|0|||
160985111|NCT04537949|581335347|FG007|Follow-up Phase|Lost to Follow-up|0|||
160985112|NCT04537949|581335340|FG000|Follow-up Phase|personal reasons|0|||
160985113|NCT04537949|581335341|FG001|Follow-up Phase|personal reasons|0|||
160985114|NCT04537949|581335342|FG002|Follow-up Phase|personal reasons|0|||
160985115|NCT04537949|581335343|FG003|Follow-up Phase|personal reasons|1|||
160985116|NCT04537949|581335344|FG004|Follow-up Phase|personal reasons|1|||
160985117|NCT04537949|581335345|FG005|Follow-up Phase|personal reasons|0|||
160985118|NCT04537949|581335346|FG006|Follow-up Phase|personal reasons|0|||
160985119|NCT04537949|581335347|FG007|Follow-up Phase|personal reasons|0|||
160985120|NCT04537949|581335340|FG000|Follow-up Phase|Withdrawal by Subject|0|||
160985121|NCT04537949|581335341|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160985122|NCT04537949|581335342|FG002|Follow-up Phase|Withdrawal by Subject|0|||
160985123|NCT04537949|581335343|FG003|Follow-up Phase|Withdrawal by Subject|0|||
160985124|NCT04537949|581335344|FG004|Follow-up Phase|Withdrawal by Subject|1|||
160985125|NCT04537949|581335345|FG005|Follow-up Phase|Withdrawal by Subject|0|||
160985126|NCT04537949|581335346|FG006|Follow-up Phase|Withdrawal by Subject|0|||
160985127|NCT04537949|581335347|FG007|Follow-up Phase|Withdrawal by Subject|0|||
160985128|NCT04003974|581335348|FG000|Overall Study|Missing|1|||
160985129|NCT04003974|581335349|FG001|Overall Study|Missing|0|||
160985130|NCT04003974|581335348|FG000|Overall Study|Withdrawal by Subject|0|||
160985131|NCT04003974|581335349|FG001|Overall Study|Withdrawal by Subject|2|||
160985132|NCT02400307|581335350|FG000|Overall Study|Enrolled and Never Dosed|1|||
160985133|NCT02400307|581335351|FG001|Overall Study|Enrolled and Never Dosed|0|||
160985134|NCT02015663|581335355|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
160985135|NCT02015663|581335356|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
160985136|NCT02015663|581335355|FG000|Overall Study|Withdrawal by Subject|1|||
160985137|NCT02015663|581335356|FG001|Overall Study|Withdrawal by Subject|0|||
160985138|NCT02015663|581335355|FG000|Overall Study|Protocol Violation|0|||
160985139|NCT02015663|581335356|FG001|Overall Study|Protocol Violation|1|||
160985140|NCT02015663|581335355|FG000|Overall Study|Adverse Event|3|||
160985141|NCT02015663|581335356|FG001|Overall Study|Adverse Event|0|||
160985142|NCT02015663|581335355|FG000|Overall Study|Administrative problems|10|||
160985143|NCT02015663|581335356|FG001|Overall Study|Administrative problems|11|||
160985144|NCT02059161|581335358|FG000|Overall Study|Pregnancy|0|||
160985145|NCT02059161|581335359|FG001|Overall Study|Pregnancy|2|||
160985146|NCT02059161|581335358|FG000|Overall Study|Adverse Event|2|||
161129828|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
161129829|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161129830|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160985147|NCT02059161|581335359|FG001|Overall Study|Adverse Event|6|||
160985148|NCT02059161|581335358|FG000|Overall Study|Lost to Follow-up|20|||
160985149|NCT02059161|581335359|FG001|Overall Study|Lost to Follow-up|12|||
160985150|NCT02059161|581335358|FG000|Overall Study|Physician Decision|4|||
160985151|NCT02059161|581335359|FG001|Overall Study|Physician Decision|4|||
160985152|NCT02059161|581335358|FG000|Overall Study|Protocol Violation|1|||
161129831|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160985153|NCT02059161|581335359|FG001|Overall Study|Protocol Violation|1|||
160985154|NCT02059161|581335358|FG000|Overall Study|Withdrawal by Subject|16|||
160985155|NCT02059161|581335359|FG001|Overall Study|Withdrawal by Subject|13|||
160802961|NCT01030822|580667681|FG000|Overall Study|Withdrawal by Subject|16|||
160802962|NCT01030822|580667682|FG001|Overall Study|Withdrawal by Subject|13|||
160802963|NCT01030822|580667683|FG002|Overall Study|Withdrawal by Subject|16|||
160802964|NCT01030822|580667681|FG000|Overall Study|Lost to Follow-up|9|||
160802965|NCT01030822|580667682|FG001|Overall Study|Lost to Follow-up|4|||
160802966|NCT01030822|580667683|FG002|Overall Study|Lost to Follow-up|7|||
160897185|NCT04916769|581018802|FG003|Period 1|Physician Decision|0|||
160897186|NCT04916769|581018803|FG004|Period 1|Physician Decision|0|||
160897187|NCT04916769|581018804|FG005|Period 1|Physician Decision|1|||
160897188|NCT04916769|581018799|FG000|Period 2|Physician Decision|0|||
160897189|NCT04916769|581018800|FG001|Period 2|Physician Decision|1|||
160897190|NCT04916769|581018801|FG002|Period 2|Physician Decision|0|||
160897191|NCT04916769|581018802|FG003|Period 2|Physician Decision|0|||
160897192|NCT04916769|581018803|FG004|Period 2|Physician Decision|0|||
160897193|NCT04916769|581018804|FG005|Period 2|Physician Decision|0|||
160802967|NCT00120627|580667689|FG000|Overall Study|Withdrawal by Subject|5|||
160802968|NCT00120627|580667690|FG001|Overall Study|Withdrawal by Subject|5|||
160802969|NCT03386435|580667691|FG000|Overall Study|Protocol Violation|5|||
160802970|NCT03386435|580667692|FG001|Overall Study|Protocol Violation|7|||
160802971|NCT00907621|580667694|FG000|Overall Study|Lost to Follow-up|6|||
160802972|NCT00907621|580667695|FG001|Overall Study|Lost to Follow-up|3|||
160802973|NCT00907621|580667694|FG000|Overall Study|intercurrent febrile illness|1|||
160802974|NCT00907621|580667695|FG001|Overall Study|intercurrent febrile illness|1|||
160802975|NCT00959907|580667696|FG000|Overall Study|Protocol Violation|0|||
160802976|NCT00959907|580667697|FG001|Overall Study|Protocol Violation|1|||
160802977|NCT00959907|580667696|FG000|Overall Study|Adverse Event|1|||
160802978|NCT00959907|580667697|FG001|Overall Study|Adverse Event|0|||
160802979|NCT00959907|580667696|FG000|Overall Study|Withdrawal by Subject|2|||
160802980|NCT00959907|580667697|FG001|Overall Study|Withdrawal by Subject|0|||
160802981|NCT04290624|580667698|FG000|Overall Study|Adverse Event|1|||
160897194|NCT05628103|581018822|FG000|Overall Study|Adverse Event|7|||
160897195|NCT05628103|581018822|FG000|Overall Study|Withdrawal by Subject|3|||
160897196|NCT05628103|581018822|FG000|Overall Study|Lost to Follow-up|3|||
160897197|NCT05628103|581018822|FG000|Overall Study|Lack of Efficacy|1|||
160897198|NCT05628103|581018822|FG000|Overall Study|Non-Compliance With Study Drug|4|||
160897199|NCT04840888|581018823|FG000|Period 1|Withdrawal by Subject|0|||
160897200|NCT04840888|581018824|FG001|Period 1|Withdrawal by Subject|0|||
160897201|NCT04840888|581018825|FG002|Period 1|Withdrawal by Subject|0|||
160897202|NCT04840888|581018826|FG003|Period 1|Withdrawal by Subject|0|||
160897203|NCT04840888|581018827|FG004|Period 1|Withdrawal by Subject|1|||
160897204|NCT04840888|581018828|FG005|Period 1|Withdrawal by Subject|0|||
160897205|NCT04840888|581018823|FG000|Period 1|Adverse Event|0|||
160897206|NCT04840888|581018824|FG001|Period 1|Adverse Event|0|||
160897207|NCT04840888|581018825|FG002|Period 1|Adverse Event|1|||
160897208|NCT04840888|581018826|FG003|Period 1|Adverse Event|1|||
160897209|NCT04840888|581018827|FG004|Period 1|Adverse Event|10|||
160897210|NCT04840888|581018828|FG005|Period 1|Adverse Event|1|||
160897211|NCT02719327|581018831|FG000|Overall Study|Withdrawal by Subject|11|||
160897212|NCT02719327|581018832|FG001|Overall Study|Withdrawal by Subject|8|||
160897213|NCT04340193|581018833|FG000|Overall Study|Other reason|0|||
160897214|NCT04340193|581018834|FG001|Overall Study|Other reason|0|||
160897215|NCT04340193|581018835|FG002|Overall Study|Other reason|1|||
160897216|NCT04340193|581018833|FG000|Overall Study|Disease recurrence|0|||
160897217|NCT04340193|581018834|FG001|Overall Study|Disease recurrence|1|||
160897218|NCT04340193|581018835|FG002|Overall Study|Disease recurrence|0|||
160897219|NCT04340193|581018833|FG000|Overall Study|Study drug toxicity|1|||
160897220|NCT04340193|581018834|FG001|Overall Study|Study drug toxicity|0|||
160897221|NCT04340193|581018835|FG002|Overall Study|Study drug toxicity|0|||
160897222|NCT04340193|581018833|FG000|Overall Study|Disease progression|1|||
160897223|NCT04340193|581018834|FG001|Overall Study|Disease progression|2|||
160897224|NCT04340193|581018835|FG002|Overall Study|Disease progression|3|||
160897225|NCT04340193|581018833|FG000|Overall Study|Administrative reasons by sponsor|0|||
160802982|NCT04290624|580667699|FG001|Overall Study|Adverse Event|0|||
160802983|NCT00027560|580667704|FG000|Overall Study|Withdrawal by Subject|1|||
160802984|NCT03559270|580667708|FG000|Overall Study|Adverse Event|6|||
160802985|NCT03559270|580667709|FG001|Overall Study|Adverse Event|5|||
160802986|NCT03559270|580667710|FG002|Overall Study|Adverse Event|3|||
160802987|NCT03559270|580667711|FG003|Overall Study|Adverse Event|0|||
160897226|NCT04340193|581018834|FG001|Overall Study|Administrative reasons by sponsor|1|||
160897227|NCT04340193|581018835|FG002|Overall Study|Administrative reasons by sponsor|0|||
160897228|NCT04340193|581018833|FG000|Overall Study|Adverse Event|1|||
160897229|NCT04340193|581018834|FG001|Overall Study|Adverse Event|1|||
160897230|NCT04340193|581018835|FG002|Overall Study|Adverse Event|0|||
160897231|NCT05741528|581018839|FG000|Overall Study|Withdrawal by Subject|11|||
160897232|NCT05741528|581018839|FG000|Overall Study|Lost to Follow-up|3|||
160897233|NCT05741528|581018839|FG000|Overall Study|Adverse Event|2|||
160897234|NCT05741528|581018839|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160897235|NCT05741528|581018839|FG000|Overall Study|Reason Not Specified|1|||
160897236|NCT03894046|581020031|FG000|Overall Study|Protocol Violation|1|||
160802988|NCT03559270|580667708|FG000|Overall Study|Lack of Efficacy|34|||
160802989|NCT03559270|580667709|FG001|Overall Study|Lack of Efficacy|52|||
160802990|NCT03559270|580667710|FG002|Overall Study|Lack of Efficacy|37|||
160802991|NCT03559270|580667711|FG003|Overall Study|Lack of Efficacy|2|||
160802992|NCT03559270|580667708|FG000|Overall Study|Death|0|||
160802993|NCT03559270|580667709|FG001|Overall Study|Death|2|||
160802994|NCT03559270|580667710|FG002|Overall Study|Death|0|||
160802995|NCT03559270|580667711|FG003|Overall Study|Death|0|||
160802996|NCT03559270|580667708|FG000|Overall Study|Lost to Follow-up|16|||
160802997|NCT03559270|580667709|FG001|Overall Study|Lost to Follow-up|4|||
160802998|NCT03559270|580667710|FG002|Overall Study|Lost to Follow-up|12|||
160802999|NCT03559270|580667711|FG003|Overall Study|Lost to Follow-up|3|||
160803000|NCT03559270|580667708|FG000|Overall Study|Sponsor Decision|38|||
160803001|NCT03559270|580667709|FG001|Overall Study|Sponsor Decision|31|||
160803002|NCT03559270|580667710|FG002|Overall Study|Sponsor Decision|35|||
160803003|NCT03559270|580667711|FG003|Overall Study|Sponsor Decision|18|||
160803004|NCT03559270|580667708|FG000|Overall Study|Withdrawal by Subject|19|||
160803005|NCT03559270|580667709|FG001|Overall Study|Withdrawal by Subject|21|||
160803006|NCT03559270|580667710|FG002|Overall Study|Withdrawal by Subject|18|||
160803007|NCT03559270|580667711|FG003|Overall Study|Withdrawal by Subject|7|||
160803008|NCT03559270|580667708|FG000|Overall Study|Physician Decision|3|||
160803009|NCT03559270|580667709|FG001|Overall Study|Physician Decision|2|||
160803010|NCT03559270|580667710|FG002|Overall Study|Physician Decision|1|||
160803011|NCT03559270|580667711|FG003|Overall Study|Physician Decision|0|||
160803012|NCT03559270|580667708|FG000|Overall Study|Pregnancy|0|||
160803013|NCT03559270|580667709|FG001|Overall Study|Pregnancy|1|||
160803014|NCT03559270|580667710|FG002|Overall Study|Pregnancy|0|||
160803015|NCT03559270|580667711|FG003|Overall Study|Pregnancy|0|||
160803016|NCT03559270|580667708|FG000|Overall Study|Protocol Violation|1|||
160803017|NCT03559270|580667709|FG001|Overall Study|Protocol Violation|0|||
160803018|NCT03559270|580667710|FG002|Overall Study|Protocol Violation|2|||
160803019|NCT03559270|580667711|FG003|Overall Study|Protocol Violation|0|||
160803020|NCT02549989|580669514|FG000|Overall Study|Adverse Event|4|||
160803021|NCT02549989|580669514|FG000|Overall Study|Death|1|||
160803022|NCT02549989|580669514|FG000|Overall Study|Lack of Efficacy|19|||
160803023|NCT02549989|580669514|FG000|Overall Study|Withdrawal by Subject|3|||
160803024|NCT01333722|580669518|FG000|Overall Study|Lack of Efficacy|0|||
160803025|NCT01333722|580669519|FG001|Overall Study|Lack of Efficacy|2|||
160803026|NCT01333722|580669518|FG000|Overall Study|Withdrawal by Subject|0|||
160803027|NCT01333722|580669519|FG001|Overall Study|Withdrawal by Subject|1|||
160803028|NCT00784368|580669520|FG000|Overall Study|Physician Decision|0|||
160803029|NCT00784368|580669521|FG001|Overall Study|Physician Decision|0|||
160803030|NCT00784368|580669522|FG002|Overall Study|Physician Decision|6|||
160803031|NCT00784368|580669520|FG000|Overall Study|Lack of Efficacy|2|||
160803032|NCT00784368|580669521|FG001|Overall Study|Lack of Efficacy|0|||
160803033|NCT00784368|580669522|FG002|Overall Study|Lack of Efficacy|1|||
160803034|NCT00784368|580669520|FG000|Overall Study|Adverse Event|6|||
160803035|NCT00784368|580669521|FG001|Overall Study|Adverse Event|9|||
160803036|NCT00784368|580669522|FG002|Overall Study|Adverse Event|2|||
160803037|NCT00784368|580669520|FG000|Overall Study|Diagnosis of fever|0|||
160803038|NCT00784368|580669521|FG001|Overall Study|Diagnosis of fever|0|||
160803039|NCT00784368|580669522|FG002|Overall Study|Diagnosis of fever|1|||
160803040|NCT00784368|580669520|FG000|Overall Study|Worsening of complications|0|||
160803041|NCT00784368|580669521|FG001|Overall Study|Worsening of complications|0|||
160803042|NCT00784368|580669522|FG002|Overall Study|Worsening of complications|1|||
160803043|NCT00784368|580669520|FG000|Overall Study|Worsening of symptoms|0|||
160803044|NCT00784368|580669521|FG001|Overall Study|Worsening of symptoms|1|||
160803045|NCT00784368|580669522|FG002|Overall Study|Worsening of symptoms|0|||
160803046|NCT00784368|580669520|FG000|Overall Study|Withdrawal of informed consent|0|||
160803047|NCT00784368|580669521|FG001|Overall Study|Withdrawal of informed consent|1|||
160803048|NCT00784368|580669522|FG002|Overall Study|Withdrawal of informed consent|0|||
160803049|NCT02079909|580669523|FG000|Overall Study|Adverse Event|23|||
160803050|NCT02079909|580669524|FG001|Overall Study|Adverse Event|23|||
160897237|NCT03894046|581020032|FG001|Overall Study|Protocol Violation|0|||
160803051|NCT02079909|580669525|FG002|Overall Study|Adverse Event|7|||
160803052|NCT02079909|580669523|FG000|Overall Study|Withdrawal by Subject|9|||
160803053|NCT02079909|580669524|FG001|Overall Study|Withdrawal by Subject|17|||
160803054|NCT02079909|580669525|FG002|Overall Study|Withdrawal by Subject|4|||
160803055|NCT02079909|580669523|FG000|Overall Study|Lost to Follow-up|2|||
160803056|NCT02079909|580669524|FG001|Overall Study|Lost to Follow-up|3|||
160803057|NCT02079909|580669525|FG002|Overall Study|Lost to Follow-up|1|||
160803058|NCT02079909|580669523|FG000|Overall Study|Death|2|||
160803059|NCT02079909|580669524|FG001|Overall Study|Death|2|||
160803060|NCT02079909|580669525|FG002|Overall Study|Death|0|||
160803061|NCT02079909|580669523|FG000|Overall Study|Lack of Efficacy|0|||
160803062|NCT02079909|580669524|FG001|Overall Study|Lack of Efficacy|0|||
160803063|NCT02079909|580669525|FG002|Overall Study|Lack of Efficacy|1|||
160803064|NCT02079909|580669523|FG000|Overall Study|Protocol Violation|0|||
160803065|NCT02079909|580669524|FG001|Overall Study|Protocol Violation|1|||
160803066|NCT02079909|580669525|FG002|Overall Study|Protocol Violation|1|||
160803067|NCT02079909|580669523|FG000|Overall Study|Physician Decision|0|||
160803068|NCT02079909|580669524|FG001|Overall Study|Physician Decision|1|||
160803069|NCT02079909|580669525|FG002|Overall Study|Physician Decision|1|||
160803070|NCT02079909|580669523|FG000|Overall Study|Relocation etc.|2|||
160803071|NCT02079909|580669524|FG001|Overall Study|Relocation etc.|2|||
160803072|NCT02079909|580669525|FG002|Overall Study|Relocation etc.|3|||
160803073|NCT00720356|580669530|FG000|Registration to Study|Determined to have methylated MGMT|67|||
160803074|NCT00720356|580669530|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
160803075|NCT00720356|580669530|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
160803076|NCT00720356|580669530|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
160803077|NCT00720356|580669530|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
160803078|NCT00720356|580669530|FG000|Follow up Until Death|Withdrawal by Subject|1|||
160803079|NCT00720356|580669530|FG000|Follow up Until Death|Alive at last data collection|4|||
160803080|NCT02237001|580669533|FG000|Overall Study|Lost to Follow-up|2|||
160803081|NCT02237001|580669533|FG000|Overall Study|Withdrawal by Subject|1|||
160803082|NCT02237001|580669533|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
160803083|NCT02237001|580669533|FG000|Overall Study|Re-operation|4|||
160803084|NCT02237001|580669533|FG000|Overall Study|Incarceration|1|||
160803085|NCT01713582|580669534|FG000|Overall Study|Disease progression|3|||
160803086|NCT01713582|580669535|FG001|Overall Study|Disease progression|3|||
160803087|NCT01713582|580669536|FG002|Overall Study|Disease progression|3|||
160803088|NCT01713582|580669537|FG003|Overall Study|Disease progression|2|||
160803089|NCT01713582|580669538|FG004|Overall Study|Disease progression|3|||
160803090|NCT01713582|580669539|FG005|Overall Study|Disease progression|3|||
160803091|NCT01713582|580669540|FG006|Overall Study|Disease progression|3|||
160803092|NCT01713582|580669541|FG007|Overall Study|Disease progression|3|||
160803093|NCT01713582|580669542|FG008|Overall Study|Disease progression|3|||
160803094|NCT01713582|580669543|FG009|Overall Study|Disease progression|11|||
160803095|NCT01713582|580669544|FG010|Overall Study|Disease progression|10|||
160803096|NCT01713582|580669545|FG011|Overall Study|Disease progression|5|||
160803097|NCT01713582|580669546|FG012|Overall Study|Disease progression|3|||
160803098|NCT01713582|580669547|FG013|Overall Study|Disease progression|3|||
160803099|NCT01713582|580669548|FG014|Overall Study|Disease progression|6|||
160803100|NCT01713582|580669549|FG015|Overall Study|Disease progression|6|||
160803101|NCT01713582|580669550|FG016|Overall Study|Disease progression|5|||
160803102|NCT01713582|580669551|FG017|Overall Study|Disease progression|2|||
160803103|NCT01713582|580669552|FG018|Overall Study|Disease progression|3|||
160803104|NCT01713582|580669553|FG019|Overall Study|Disease progression|5|||
160803105|NCT01713582|580669554|FG020|Overall Study|Disease progression|15|||
160803106|NCT01713582|580669534|FG000|Overall Study|Death|0|||
160803107|NCT01713582|580669535|FG001|Overall Study|Death|0|||
160803108|NCT01713582|580669536|FG002|Overall Study|Death|0|||
160803109|NCT01713582|580669537|FG003|Overall Study|Death|1|||
160803110|NCT01713582|580669538|FG004|Overall Study|Death|1|||
160803111|NCT01713582|580669539|FG005|Overall Study|Death|3|||
160803112|NCT01713582|580669540|FG006|Overall Study|Death|3|||
160803113|NCT01713582|580669541|FG007|Overall Study|Death|2|||
160803114|NCT01713582|580669542|FG008|Overall Study|Death|3|||
160803115|NCT01713582|580669543|FG009|Overall Study|Death|4|||
160803116|NCT01713582|580669544|FG010|Overall Study|Death|3|||
160803117|NCT01713582|580669545|FG011|Overall Study|Death|0|||
160803118|NCT01713582|580669546|FG012|Overall Study|Death|0|||
160803119|NCT01713582|580669547|FG013|Overall Study|Death|0|||
160803120|NCT01713582|580669548|FG014|Overall Study|Death|0|||
160803121|NCT01713582|580669549|FG015|Overall Study|Death|0|||
160803122|NCT01713582|580669550|FG016|Overall Study|Death|0|||
160803123|NCT01713582|580669551|FG017|Overall Study|Death|0|||
160803124|NCT01713582|580669552|FG018|Overall Study|Death|0|||
160803125|NCT01713582|580669553|FG019|Overall Study|Death|0|||
160803126|NCT01713582|580669554|FG020|Overall Study|Death|0|||
160803127|NCT01713582|580669534|FG000|Overall Study|Adverse event-related|0|||
160803128|NCT01713582|580669535|FG001|Overall Study|Adverse event-related|0|||
160803129|NCT01713582|580669536|FG002|Overall Study|Adverse event-related|0|||
160803130|NCT01713582|580669537|FG003|Overall Study|Adverse event-related|0|||
160803131|NCT01713582|580669538|FG004|Overall Study|Adverse event-related|0|||
160803132|NCT01713582|580669539|FG005|Overall Study|Adverse event-related|0|||
160803133|NCT01713582|580669540|FG006|Overall Study|Adverse event-related|0|||
160803134|NCT01713582|580669541|FG007|Overall Study|Adverse event-related|0|||
160803135|NCT01713582|580669542|FG008|Overall Study|Adverse event-related|0|||
160803136|NCT01713582|580669543|FG009|Overall Study|Adverse event-related|1|||
160803137|NCT01713582|580669544|FG010|Overall Study|Adverse event-related|1|||
160803138|NCT01713582|580669545|FG011|Overall Study|Adverse event-related|0|||
160803139|NCT01713582|580669546|FG012|Overall Study|Adverse event-related|0|||
160803140|NCT01713582|580669547|FG013|Overall Study|Adverse event-related|0|||
160803141|NCT01713582|580669548|FG014|Overall Study|Adverse event-related|0|||
160803142|NCT01713582|580669549|FG015|Overall Study|Adverse event-related|0|||
160803143|NCT01713582|580669550|FG016|Overall Study|Adverse event-related|0|||
160803144|NCT01713582|580669551|FG017|Overall Study|Adverse event-related|0|||
160803145|NCT01713582|580669552|FG018|Overall Study|Adverse event-related|1|||
160803146|NCT01713582|580669553|FG019|Overall Study|Adverse event-related|0|||
160897238|NCT03894046|581020033|FG002|Overall Study|Protocol Violation|0|||
160897239|NCT03894046|581020031|FG000|Overall Study|Adverse Event|0|||
160897240|NCT03894046|581020032|FG001|Overall Study|Adverse Event|1|||
160897241|NCT03894046|581020033|FG002|Overall Study|Adverse Event|0|||
160897242|NCT03894046|581020031|FG000|Overall Study|Withdrawal by Subject|2|||
160897243|NCT03894046|581020032|FG001|Overall Study|Withdrawal by Subject|3|||
160897244|NCT03894046|581020033|FG002|Overall Study|Withdrawal by Subject|1|||
160897245|NCT03894046|581020031|FG000|Overall Study|Death|15|||
160897246|NCT03894046|581020032|FG001|Overall Study|Death|21|||
160897247|NCT03894046|581020033|FG002|Overall Study|Death|4|||
160897248|NCT03894046|581020031|FG000|Overall Study|No growth of ABC|2|||
160897249|NCT03894046|581020032|FG001|Overall Study|No growth of ABC|1|||
160897250|NCT03894046|581020033|FG002|Overall Study|No growth of ABC|0|||
160897251|NCT03894046|581020031|FG000|Overall Study|Physician Decision|1|||
160897252|NCT03894046|581020032|FG001|Overall Study|Physician Decision|1|||
160897253|NCT03894046|581020033|FG002|Overall Study|Physician Decision|1|||
160897254|NCT03894046|581020031|FG000|Overall Study|Prohibited concomitant medication|1|||
160897255|NCT03894046|581020032|FG001|Overall Study|Prohibited concomitant medication|0|||
160897256|NCT03894046|581020033|FG002|Overall Study|Prohibited concomitant medication|0|||
160897257|NCT03894046|581020031|FG000|Overall Study|Transferred to other arm/group|1|||
160897258|NCT03894046|581020032|FG001|Overall Study|Transferred to other arm/group|1|||
160897259|NCT03894046|581020033|FG002|Overall Study|Transferred to other arm/group|0|||
160897260|NCT03270644|581020036|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
160897261|NCT03270644|581020036|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
160897262|NCT00004635|581020037|FG000|Period One|refused|2|||
160897263|NCT00004635|581020038|FG001|Period One|refused|1|||
160897264|NCT00004635|581020037|FG000|Period One|Withdrawal by Subject|1|||
160897265|NCT00004635|581020038|FG001|Period One|Withdrawal by Subject|1|||
160897266|NCT00004635|581020037|FG000|Period One|Protocol Violation|1|||
160897267|NCT00004635|581020038|FG001|Period One|Protocol Violation|0|||
160897268|NCT00004635|581020037|FG000|Period One|PSA did not go <5 ng/mL|1|||
160897269|NCT00004635|581020038|FG001|Period One|PSA did not go <5 ng/mL|0|||
160897270|NCT00004635|581020037|FG000|Period One|second malignancy|1|||
160897271|NCT00004635|581020038|FG001|Period One|second malignancy|0|||
160897272|NCT00004635|581020037|FG000|Period One|progressed|0|||
160897273|NCT00004635|581020038|FG001|Period One|progressed|2|||
160897274|NCT00004635|581020037|FG000|Period One|health problem|0|||
160897275|NCT00004635|581020038|FG001|Period One|health problem|1|||
160897276|NCT00004635|581020037|FG000|Period One|discrepancy in data entry|0|||
160897277|NCT00004635|581020038|FG001|Period One|discrepancy in data entry|1|||
160897278|NCT00004635|581020037|FG000|Period Two|progression|2|||
160897279|NCT00004635|581020038|FG001|Period Two|progression|3|||
160897280|NCT00004635|581020037|FG000|Period Two|Adverse Event|1|||
160897281|NCT00004635|581020038|FG001|Period Two|Adverse Event|0|||
160897282|NCT00004635|581020037|FG000|Period Two|refused|0|||
160897283|NCT00004635|581020038|FG001|Period Two|refused|2|||
160897284|NCT00004635|581020037|FG000|Period Two|health problem|1|||
160897285|NCT00004635|581020038|FG001|Period Two|health problem|1|||
160897286|NCT00004635|581020037|FG000|Period Two|travel issues|0|||
160897287|NCT00004635|581020038|FG001|Period Two|travel issues|1|||
160897288|NCT00004635|581020037|FG000|Period Two|secondary malignancy|1|||
160897289|NCT00004635|581020038|FG001|Period Two|secondary malignancy|1|||
160897290|NCT00004635|581020037|FG000|Period Two|Lost to Follow-up|1|||
160897291|NCT00004635|581020038|FG001|Period Two|Lost to Follow-up|0|||
160897292|NCT00004635|581020037|FG000|Period Two|discrepancy in data entry|0|||
160897293|NCT00004635|581020038|FG001|Period Two|discrepancy in data entry|1|||
160897294|NCT00191906|581020039|FG000|Study Period II|Adverse Event|0|||
160897295|NCT00191906|581020040|FG001|Study Period II|Adverse Event|1|||
160897296|NCT00191906|581020041|FG002|Study Period II|Adverse Event|0|||
160897297|NCT00191906|581020042|FG003|Study Period II|Adverse Event|0|||
160897298|NCT00191906|581020039|FG000|Study Period II|Withdrawal by Subject|0|||
160897299|NCT00191906|581020040|FG001|Study Period II|Withdrawal by Subject|3|||
160897300|NCT00191906|581020041|FG002|Study Period II|Withdrawal by Subject|0|||
160897301|NCT00191906|581020042|FG003|Study Period II|Withdrawal by Subject|0|||
160985156|NCT02059161|581335358|FG000|Overall Study|Randomized in error, no study drug|0|||
160897302|NCT00191906|581020039|FG000|Study Period II|Parent/Caregiver Decision|0|||
160897303|NCT00191906|581020040|FG001|Study Period II|Parent/Caregiver Decision|1|||
160897304|NCT00191906|581020041|FG002|Study Period II|Parent/Caregiver Decision|0|||
160897305|NCT00191906|581020042|FG003|Study Period II|Parent/Caregiver Decision|0|||
160897306|NCT00191906|581020039|FG000|Study Period II|Entry Criteria Exclusion|0|||
160897307|NCT00191906|581020040|FG001|Study Period II|Entry Criteria Exclusion|0|||
160897308|NCT00191906|581020041|FG002|Study Period II|Entry Criteria Exclusion|1|||
160897309|NCT00191906|581020042|FG003|Study Period II|Entry Criteria Exclusion|0|||
160897310|NCT00191906|581020039|FG000|Study Period III|Adverse Event|1|||
160897311|NCT00191906|581020040|FG001|Study Period III|Adverse Event|0|||
160897312|NCT00191906|581020041|FG002|Study Period III|Adverse Event|0|||
160897313|NCT00191906|581020042|FG003|Study Period III|Adverse Event|0|||
160897314|NCT00191906|581020039|FG000|Study Period III|Lost to Follow-up|0|||
160897315|NCT00191906|581020040|FG001|Study Period III|Lost to Follow-up|1|||
160803147|NCT01713582|580669554|FG020|Overall Study|Adverse event-related|0|||
160803148|NCT01713582|580669534|FG000|Overall Study|Adverse event-unrelated|0|||
160803149|NCT01713582|580669535|FG001|Overall Study|Adverse event-unrelated|0|||
160985157|NCT02059161|581335359|FG001|Overall Study|Randomized in error, no study drug|1|||
160985158|NCT02059161|581335358|FG000|Overall Study|Non-compliance with study drug|6|||
160803150|NCT01713582|580669536|FG002|Overall Study|Adverse event-unrelated|0|||
160985159|NCT02059161|581335359|FG001|Overall Study|Non-compliance with study drug|2|||
160803151|NCT01713582|580669537|FG003|Overall Study|Adverse event-unrelated|0|||
160803152|NCT01713582|580669538|FG004|Overall Study|Adverse event-unrelated|0|||
160803153|NCT01713582|580669539|FG005|Overall Study|Adverse event-unrelated|1|||
160803154|NCT01713582|580669540|FG006|Overall Study|Adverse event-unrelated|1|||
160803155|NCT01713582|580669541|FG007|Overall Study|Adverse event-unrelated|1|||
160803156|NCT01713582|580669542|FG008|Overall Study|Adverse event-unrelated|0|||
160897316|NCT00191906|581020041|FG002|Study Period III|Lost to Follow-up|0|||
160897317|NCT00191906|581020042|FG003|Study Period III|Lost to Follow-up|0|||
160897318|NCT00191906|581020039|FG000|Study Period III|Parent/Caregiver Decision|1|||
160897319|NCT00191906|581020040|FG001|Study Period III|Parent/Caregiver Decision|0|||
160897320|NCT00191906|581020041|FG002|Study Period III|Parent/Caregiver Decision|0|||
160897321|NCT00191906|581020042|FG003|Study Period III|Parent/Caregiver Decision|0|||
160897322|NCT00191906|581020039|FG000|Study Period III|Lack of Efficacy|3|||
160897323|NCT00191906|581020040|FG001|Study Period III|Lack of Efficacy|3|||
160897324|NCT00191906|581020041|FG002|Study Period III|Lack of Efficacy|0|||
160897325|NCT00191906|581020042|FG003|Study Period III|Lack of Efficacy|0|||
160897326|NCT00573937|581020043|FG000|Overall Study|Study Terminated|0|||
160897327|NCT00573937|581020044|FG001|Overall Study|Study Terminated|1|||
160897328|NCT00333801|581020045|FG000|Overall Study|Moved to another state|5|||
160897329|NCT00333801|581020046|FG001|Overall Study|Moved to another state|3|||
160897330|NCT00333801|581020045|FG000|Overall Study|Lost to Follow-up|2|||
160897331|NCT00333801|581020046|FG001|Overall Study|Lost to Follow-up|0|||
160897332|NCT00333801|581020045|FG000|Overall Study|Incarcerated|1|||
160897333|NCT00333801|581020046|FG001|Overall Study|Incarcerated|2|||
160897334|NCT00333801|581020045|FG000|Overall Study|Withdrawal by Subject|0|||
160897335|NCT00333801|581020046|FG001|Overall Study|Withdrawal by Subject|1|||
160897336|NCT02476201|581020047|FG000|Overall Study|Unable to program MPP|9|||
160897337|NCT02476201|581020047|FG000|Overall Study|Study echo not performed|5|||
160897338|NCT02476201|581020047|FG000|Overall Study|Adverse Event|4|||
160897339|NCT02476201|581020047|FG000|Overall Study|Death|2|||
160897340|NCT02476201|581020047|FG000|Overall Study|Lost to Follow-up|2|||
160897341|NCT02476201|581020047|FG000|Overall Study|MPP programmed to OFF|2|||
160897342|NCT02476201|581020047|FG000|Overall Study|Withdrawal by Subject|1|||
160897343|NCT02476201|581020047|FG000|Overall Study|Unsuccessful implant|1|||
160897344|NCT00777205|581020048|FG000|Overall Study|Lost to Follow-up|25|||
160897345|NCT00777205|581020049|FG001|Overall Study|Lost to Follow-up|9|||
160897346|NCT00777205|581020048|FG000|Overall Study|Withdrawal by Subject|6|||
160897347|NCT00777205|581020049|FG001|Overall Study|Withdrawal by Subject|4|||
160897348|NCT00777205|581020048|FG000|Overall Study|Death|0|||
160897349|NCT00777205|581020049|FG001|Overall Study|Death|2|||
160897350|NCT00777205|581020048|FG000|Overall Study|Protocol Violation|0|||
160897351|NCT00777205|581020049|FG001|Overall Study|Protocol Violation|56|||
160897352|NCT00722423|581020053|FG000|Overall Study|Protocol Violation|0|||
160985160|NCT03389893|581335360|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
160985161|NCT03389893|581335361|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
160897353|NCT00722423|581020054|FG001|Overall Study|Protocol Violation|1|||
160897354|NCT00747461|581020055|FG000|Overall Study|study terminated by sponsor|5|||
160897355|NCT02149875|581020056|FG000|Overall Study|Lost to Follow-up|3|||
160897356|NCT02149875|581020057|FG001|Overall Study|Lost to Follow-up|4|||
160897357|NCT02149875|581020058|FG002|Overall Study|Lost to Follow-up|5|||
160897358|NCT02149875|581020056|FG000|Overall Study|Withdrawal by Subject|3|||
160897359|NCT02149875|581020057|FG001|Overall Study|Withdrawal by Subject|2|||
160897360|NCT02149875|581020058|FG002|Overall Study|Withdrawal by Subject|2|||
160897361|NCT02149875|581020056|FG000|Overall Study|Physician Decision|1|||
160985162|NCT03389893|581335362|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
160803157|NCT01713582|580669543|FG009|Overall Study|Adverse event-unrelated|0|||
160897362|NCT02149875|581020057|FG001|Overall Study|Physician Decision|2|||
160897363|NCT02149875|581020058|FG002|Overall Study|Physician Decision|2|||
160897364|NCT00299182|581020060|FG000|Overall Study|Withdrawal by Subject|0|||
160897365|NCT00299182|581020061|FG001|Overall Study|Withdrawal by Subject|0|||
160897366|NCT00299182|581020062|FG002|Overall Study|Withdrawal by Subject|1|||
160897367|NCT00299182|581020063|FG003|Overall Study|Withdrawal by Subject|0|||
160897368|NCT00299182|581020064|FG004|Overall Study|Withdrawal by Subject|1|||
160897369|NCT00299182|581020065|FG005|Overall Study|Withdrawal by Subject|2|||
160897370|NCT00299182|581020066|FG006|Overall Study|Withdrawal by Subject|0|||
160897371|NCT00299182|581020060|FG000|Overall Study|Chemotherapy Changed|0|||
160897372|NCT00299182|581020061|FG001|Overall Study|Chemotherapy Changed|0|||
160897373|NCT00299182|581020062|FG002|Overall Study|Chemotherapy Changed|1|||
160897374|NCT00299182|581020063|FG003|Overall Study|Chemotherapy Changed|0|||
160803158|NCT01713582|580669544|FG010|Overall Study|Adverse event-unrelated|0|||
160803159|NCT01713582|580669545|FG011|Overall Study|Adverse event-unrelated|0|||
160803160|NCT01713582|580669546|FG012|Overall Study|Adverse event-unrelated|0|||
160803161|NCT01713582|580669547|FG013|Overall Study|Adverse event-unrelated|1|||
160803162|NCT01713582|580669548|FG014|Overall Study|Adverse event-unrelated|1|||
160803163|NCT01713582|580669549|FG015|Overall Study|Adverse event-unrelated|0|||
160803164|NCT01713582|580669550|FG016|Overall Study|Adverse event-unrelated|0|||
160803165|NCT01713582|580669551|FG017|Overall Study|Adverse event-unrelated|0|||
160803166|NCT01713582|580669552|FG018|Overall Study|Adverse event-unrelated|0|||
160803167|NCT01713582|580669553|FG019|Overall Study|Adverse event-unrelated|0|||
160803168|NCT01713582|580669554|FG020|Overall Study|Adverse event-unrelated|0|||
160803169|NCT01713582|580669534|FG000|Overall Study|Withdrawal of consent|0|||
160803170|NCT01713582|580669535|FG001|Overall Study|Withdrawal of consent|0|||
160803171|NCT01713582|580669536|FG002|Overall Study|Withdrawal of consent|1|||
160803172|NCT01713582|580669537|FG003|Overall Study|Withdrawal of consent|0|||
160803173|NCT01713582|580669538|FG004|Overall Study|Withdrawal of consent|0|||
160803174|NCT01713582|580669539|FG005|Overall Study|Withdrawal of consent|1|||
160803175|NCT01713582|580669540|FG006|Overall Study|Withdrawal of consent|0|||
160803176|NCT01713582|580669541|FG007|Overall Study|Withdrawal of consent|0|||
160803177|NCT01713582|580669542|FG008|Overall Study|Withdrawal of consent|0|||
160803178|NCT01713582|580669543|FG009|Overall Study|Withdrawal of consent|1|||
160803179|NCT01713582|580669544|FG010|Overall Study|Withdrawal of consent|0|||
160803180|NCT01713582|580669545|FG011|Overall Study|Withdrawal of consent|0|||
160803181|NCT01713582|580669546|FG012|Overall Study|Withdrawal of consent|0|||
160803182|NCT01713582|580669547|FG013|Overall Study|Withdrawal of consent|0|||
160803183|NCT01713582|580669548|FG014|Overall Study|Withdrawal of consent|0|||
160803184|NCT01713582|580669549|FG015|Overall Study|Withdrawal of consent|0|||
160803185|NCT01713582|580669550|FG016|Overall Study|Withdrawal of consent|0|||
160803186|NCT01713582|580669551|FG017|Overall Study|Withdrawal of consent|0|||
160803187|NCT01713582|580669552|FG018|Overall Study|Withdrawal of consent|1|||
160803188|NCT01713582|580669553|FG019|Overall Study|Withdrawal of consent|0|||
160803189|NCT01713582|580669554|FG020|Overall Study|Withdrawal of consent|0|||
160803190|NCT01713582|580669534|FG000|Overall Study|Lack of Efficacy|0|||
160803191|NCT01713582|580669535|FG001|Overall Study|Lack of Efficacy|0|||
160803192|NCT01713582|580669536|FG002|Overall Study|Lack of Efficacy|0|||
160803193|NCT01713582|580669537|FG003|Overall Study|Lack of Efficacy|0|||
160803194|NCT01713582|580669538|FG004|Overall Study|Lack of Efficacy|0|||
160803195|NCT01713582|580669539|FG005|Overall Study|Lack of Efficacy|0|||
160803196|NCT01713582|580669540|FG006|Overall Study|Lack of Efficacy|0|||
160803197|NCT01713582|580669541|FG007|Overall Study|Lack of Efficacy|0|||
160803198|NCT01713582|580669542|FG008|Overall Study|Lack of Efficacy|0|||
160803199|NCT01713582|580669543|FG009|Overall Study|Lack of Efficacy|1|||
160803200|NCT01713582|580669544|FG010|Overall Study|Lack of Efficacy|2|||
160803201|NCT01713582|580669545|FG011|Overall Study|Lack of Efficacy|0|||
160803202|NCT01713582|580669546|FG012|Overall Study|Lack of Efficacy|0|||
160803203|NCT01713582|580669547|FG013|Overall Study|Lack of Efficacy|0|||
160803204|NCT01713582|580669548|FG014|Overall Study|Lack of Efficacy|0|||
160803205|NCT01713582|580669549|FG015|Overall Study|Lack of Efficacy|0|||
160803206|NCT01713582|580669550|FG016|Overall Study|Lack of Efficacy|0|||
160803207|NCT01713582|580669551|FG017|Overall Study|Lack of Efficacy|0|||
160803208|NCT01713582|580669552|FG018|Overall Study|Lack of Efficacy|0|||
160803209|NCT01713582|580669553|FG019|Overall Study|Lack of Efficacy|0|||
160803210|NCT01713582|580669554|FG020|Overall Study|Lack of Efficacy|0|||
160803211|NCT01713582|580669534|FG000|Overall Study|Withdrawal by Subject|0|||
160803212|NCT01713582|580669535|FG001|Overall Study|Withdrawal by Subject|0|||
160803213|NCT01713582|580669536|FG002|Overall Study|Withdrawal by Subject|0|||
160803214|NCT01713582|580669537|FG003|Overall Study|Withdrawal by Subject|0|||
160803215|NCT01713582|580669538|FG004|Overall Study|Withdrawal by Subject|0|||
160803216|NCT01713582|580669539|FG005|Overall Study|Withdrawal by Subject|0|||
160803217|NCT01713582|580669540|FG006|Overall Study|Withdrawal by Subject|0|||
160803218|NCT01713582|580669541|FG007|Overall Study|Withdrawal by Subject|0|||
160803219|NCT01713582|580669542|FG008|Overall Study|Withdrawal by Subject|0|||
160803220|NCT01713582|580669543|FG009|Overall Study|Withdrawal by Subject|0|||
160803221|NCT01713582|580669544|FG010|Overall Study|Withdrawal by Subject|0|||
160803222|NCT01713582|580669545|FG011|Overall Study|Withdrawal by Subject|0|||
160803223|NCT01713582|580669546|FG012|Overall Study|Withdrawal by Subject|0|||
160803224|NCT01713582|580669547|FG013|Overall Study|Withdrawal by Subject|0|||
160803225|NCT01713582|580669548|FG014|Overall Study|Withdrawal by Subject|0|||
160803226|NCT01713582|580669549|FG015|Overall Study|Withdrawal by Subject|0|||
160803227|NCT01713582|580669550|FG016|Overall Study|Withdrawal by Subject|0|||
160803228|NCT01713582|580669551|FG017|Overall Study|Withdrawal by Subject|1|||
160803229|NCT01713582|580669552|FG018|Overall Study|Withdrawal by Subject|0|||
160803230|NCT01713582|580669553|FG019|Overall Study|Withdrawal by Subject|0|||
160803231|NCT01713582|580669554|FG020|Overall Study|Withdrawal by Subject|0|||
160803232|NCT01713582|580669534|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
160861920|NCT00449696|580887879|FG000|Overall Study|Others|7|||
160861921|NCT00449696|580887880|FG001|Overall Study|Others|0|||
160985163|NCT03389893|581335363|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
160803233|NCT01713582|580669535|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
160803234|NCT01713582|580669536|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
160803235|NCT01713582|580669537|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
160803236|NCT01713582|580669538|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
160803237|NCT01713582|580669539|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
160803238|NCT01713582|580669540|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
160803239|NCT01713582|580669541|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
160803240|NCT01713582|580669542|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
160803241|NCT01713582|580669543|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
160985164|NCT03389893|581335360|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
160803242|NCT01713582|580669544|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
160803243|NCT01713582|580669545|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
160803244|NCT01713582|580669546|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
160803245|NCT01713582|580669547|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
160803246|NCT01713582|580669548|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
160803247|NCT01713582|580669549|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
160803248|NCT01713582|580669550|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
160803249|NCT01713582|580669551|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
160803250|NCT01713582|580669552|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
160803251|NCT01713582|580669553|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
160803252|NCT01713582|580669554|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
160803253|NCT01713582|580669534|FG000|Overall Study|Disease progression and adverse event|0|||
160803254|NCT01713582|580669535|FG001|Overall Study|Disease progression and adverse event|0|||
160803255|NCT01713582|580669536|FG002|Overall Study|Disease progression and adverse event|0|||
160803256|NCT01713582|580669537|FG003|Overall Study|Disease progression and adverse event|0|||
160803257|NCT01713582|580669538|FG004|Overall Study|Disease progression and adverse event|0|||
160803258|NCT01713582|580669539|FG005|Overall Study|Disease progression and adverse event|0|||
160803259|NCT01713582|580669540|FG006|Overall Study|Disease progression and adverse event|0|||
160803260|NCT01713582|580669541|FG007|Overall Study|Disease progression and adverse event|0|||
160803261|NCT01713582|580669542|FG008|Overall Study|Disease progression and adverse event|0|||
160803262|NCT01713582|580669543|FG009|Overall Study|Disease progression and adverse event|0|||
160803263|NCT01713582|580669544|FG010|Overall Study|Disease progression and adverse event|0|||
160803264|NCT01713582|580669545|FG011|Overall Study|Disease progression and adverse event|0|||
160803265|NCT01713582|580669546|FG012|Overall Study|Disease progression and adverse event|0|||
160803266|NCT01713582|580669547|FG013|Overall Study|Disease progression and adverse event|0|||
160803267|NCT01713582|580669548|FG014|Overall Study|Disease progression and adverse event|0|||
160803268|NCT01713582|580669549|FG015|Overall Study|Disease progression and adverse event|0|||
160803269|NCT01713582|580669550|FG016|Overall Study|Disease progression and adverse event|1|||
160803270|NCT01713582|580669551|FG017|Overall Study|Disease progression and adverse event|0|||
160803271|NCT01713582|580669552|FG018|Overall Study|Disease progression and adverse event|0|||
160803272|NCT01713582|580669553|FG019|Overall Study|Disease progression and adverse event|0|||
160803273|NCT01713582|580669554|FG020|Overall Study|Disease progression and adverse event|0|||
160803274|NCT03427814|580669555|FG000|Overall Study|Withdrawal by Subject|4|||
160803275|NCT03427814|580669556|FG001|Overall Study|Withdrawal by Subject|4|||
160803276|NCT03427814|580669555|FG000|Overall Study|Lost to Follow-up|0|||
160803277|NCT03427814|580669556|FG001|Overall Study|Lost to Follow-up|2|||
160803278|NCT03427814|580669555|FG000|Overall Study|Death|42|||
160803279|NCT03427814|580669556|FG001|Overall Study|Death|31|||
160803280|NCT03427814|580669555|FG000|Overall Study|Sponsor's Decision|1|||
160803281|NCT03427814|580669556|FG001|Overall Study|Sponsor's Decision|0|||
160803282|NCT03427814|580669555|FG000|Overall Study|Investigator's Decision|1|||
160803283|NCT03427814|580669556|FG001|Overall Study|Investigator's Decision|2|||
160897375|NCT00299182|581020064|FG004|Overall Study|Chemotherapy Changed|1|||
160897376|NCT00299182|581020065|FG005|Overall Study|Chemotherapy Changed|0|||
160897377|NCT00299182|581020066|FG006|Overall Study|Chemotherapy Changed|1|||
160897378|NCT00299182|581020060|FG000|Overall Study|Adverse Event|0|||
160897379|NCT00299182|581020061|FG001|Overall Study|Adverse Event|0|||
160897380|NCT00299182|581020062|FG002|Overall Study|Adverse Event|0|||
160897381|NCT00299182|581020063|FG003|Overall Study|Adverse Event|0|||
160897382|NCT00299182|581020064|FG004|Overall Study|Adverse Event|0|||
160897383|NCT00299182|581020065|FG005|Overall Study|Adverse Event|1|||
160897384|NCT00299182|581020066|FG006|Overall Study|Adverse Event|0|||
160897385|NCT00299182|581020060|FG000|Overall Study|Not Eligible|0|||
160897386|NCT00299182|581020061|FG001|Overall Study|Not Eligible|0|||
160897387|NCT00299182|581020062|FG002|Overall Study|Not Eligible|0|||
160897388|NCT00299182|581020063|FG003|Overall Study|Not Eligible|0|||
160803284|NCT03427814|580669555|FG000|Overall Study|Disease progression|1|||
160803285|NCT03427814|580669556|FG001|Overall Study|Disease progression|0|||
160803286|NCT03427814|580669555|FG000|Overall Study|Treatment Completed|0|||
160803287|NCT03427814|580669556|FG001|Overall Study|Treatment Completed|1|||
160803288|NCT03427814|580669555|FG000|Overall Study|Sponsor's Decision to End study|21|||
160803289|NCT03427814|580669556|FG001|Overall Study|Sponsor's Decision to End study|25|||
160803290|NCT03427814|580669555|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
160803291|NCT03427814|580669556|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
160803292|NCT03846427|580669557|FG000|Overall Study|Death|13|||
160803293|NCT03846427|580669557|FG000|Overall Study|Withdrawal by Subject|3|||
160803294|NCT03846427|580669557|FG000|Overall Study|Physician Decision|1|||
160803295|NCT01334554|580669558|FG000|Overall Study|Adverse Event|4|||
160803296|NCT01334554|580669559|FG001|Overall Study|Adverse Event|2|||
160803297|NCT02393859|580669561|FG000|Overall Study|Decision by Sponsor|2|||
160803298|NCT02393859|580669562|FG001|Overall Study|Decision by Sponsor|4|||
160803299|NCT02393859|580669561|FG000|Overall Study|Withdrawal by Subject|11|||
160803300|NCT02393859|580669562|FG001|Overall Study|Withdrawal by Subject|6|||
160803301|NCT02393859|580669561|FG000|Overall Study|Death|27|||
160803302|NCT02393859|580669562|FG001|Overall Study|Death|10|||
160803303|NCT02393859|580669561|FG000|Overall Study|Lost to Follow-up|1|||
160803304|NCT02393859|580669562|FG001|Overall Study|Lost to Follow-up|1|||
160803305|NCT00954447|580669563|FG000|Overall Study|Adverse Event|33|||
160803306|NCT00954447|580669564|FG001|Overall Study|Adverse Event|25|||
160803307|NCT00954447|580669563|FG000|Overall Study|Lack of Efficacy|17|||
160803308|NCT00954447|580669564|FG001|Overall Study|Lack of Efficacy|3|||
160803309|NCT00954447|580669563|FG000|Overall Study|Protocol Violation|5|||
160803310|NCT00954447|580669564|FG001|Overall Study|Protocol Violation|7|||
160803311|NCT00954447|580669563|FG000|Overall Study|Lost to Follow-up|8|||
160803312|NCT00954447|580669564|FG001|Overall Study|Lost to Follow-up|14|||
160803313|NCT00954447|580669563|FG000|Overall Study|Withdrawal by Subject|26|||
160803314|NCT00954447|580669564|FG001|Overall Study|Withdrawal by Subject|21|||
160803315|NCT00954447|580669563|FG000|Overall Study|Other|21|||
160803316|NCT00954447|580669564|FG001|Overall Study|Other|18|||
160803317|NCT00488514|580669565|FG000|Overall Study|Adverse Event|41|||
160803318|NCT00488514|580669565|FG000|Overall Study|Lost to Follow-up|44|||
160803319|NCT00488514|580669565|FG000|Overall Study|Protocol Violation|32|||
160803320|NCT00488514|580669565|FG000|Overall Study|Withdrawal by Subject|106|||
160803321|NCT00488514|580669565|FG000|Overall Study|Lack of Efficacy|28|||
160803322|NCT00488514|580669565|FG000|Overall Study|Did not meet criteria for treatment|30|||
160803323|NCT00488514|580669565|FG000|Overall Study|Postive drug screen|1|||
160803324|NCT00488514|580669565|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
160803325|NCT00488514|580669565|FG000|Overall Study|Investigator decision|1|||
160803326|NCT00488514|580669565|FG000|Overall Study|Participant had too few migraines|5|||
160803327|NCT00488514|580669565|FG000|Overall Study|Increase in number of migraines|2|||
160803328|NCT00488514|580669565|FG000|Overall Study|Increased use of concomitant medication|1|||
160803329|NCT00305877|580669566|FG000|Overall Study|Lack of Efficacy|6|||
160803330|NCT00305877|580669567|FG001|Overall Study|Lack of Efficacy|9|||
160803331|NCT00305877|580669566|FG000|Overall Study|Adverse Event|9|||
160803332|NCT00305877|580669567|FG001|Overall Study|Adverse Event|14|||
160803333|NCT00305877|580669566|FG000|Overall Study|Death|0|||
160803334|NCT00305877|580669567|FG001|Overall Study|Death|1|||
160803335|NCT00305877|580669566|FG000|Overall Study|Withdrawal by Subject|4|||
160803336|NCT00305877|580669567|FG001|Overall Study|Withdrawal by Subject|2|||
160803337|NCT00305877|580669566|FG000|Overall Study|Physician Decision|1|||
160803338|NCT00305877|580669567|FG001|Overall Study|Physician Decision|1|||
160803339|NCT00305877|580669566|FG000|Overall Study|Never start treatment|2|||
160803340|NCT00305877|580669567|FG001|Overall Study|Never start treatment|5|||
160803341|NCT00305877|580669566|FG000|Overall Study|Ineligible|2|||
160803342|NCT00305877|580669567|FG001|Overall Study|Ineligible|1|||
160803343|NCT00305877|580669566|FG000|Overall Study|Transportation issue with daily RT|0|||
160803344|NCT00305877|580669567|FG001|Overall Study|Transportation issue with daily RT|1|||
160803345|NCT00457392|580669568|FG000|Overall Study|Objective Progression or Relapse|229|||
160803346|NCT00457392|580669569|FG001|Overall Study|Objective Progression or Relapse|296|||
160803347|NCT00457392|580669568|FG000|Overall Study|Death|106|||
160803348|NCT00457392|580669569|FG001|Overall Study|Death|106|||
160803349|NCT00457392|580669568|FG000|Overall Study|Adverse Event|84|||
160803350|NCT00457392|580669569|FG001|Overall Study|Adverse Event|41|||
160803351|NCT00457392|580669568|FG000|Overall Study|Global Deterioration of Health Status|22|||
160803352|NCT00457392|580669569|FG001|Overall Study|Global Deterioration of Health Status|8|||
160803353|NCT00457392|580669568|FG000|Overall Study|Withdrawal by Subject|14|||
160803354|NCT00457392|580669569|FG001|Overall Study|Withdrawal by Subject|8|||
160803355|NCT00457392|580669568|FG000|Overall Study|Lost to Follow-up|6|||
160803356|NCT00457392|580669569|FG001|Overall Study|Lost to Follow-up|7|||
160803357|NCT00457392|580669568|FG000|Overall Study|Protocol Violation|4|||
160803358|NCT00457392|580669569|FG001|Overall Study|Protocol Violation|3|||
160803359|NCT00457392|580669568|FG000|Overall Study|Other|7|||
160803360|NCT00457392|580669569|FG001|Overall Study|Other|4|||
160803361|NCT00457392|580669568|FG000|Overall Study|Study Terminated by Sponsor|1|||
160803362|NCT00457392|580669569|FG001|Overall Study|Study Terminated by Sponsor|4|||
160803363|NCT00457392|580669568|FG000|Overall Study|Randomized, Not Treated|7|||
160803364|NCT00457392|580669569|FG001|Overall Study|Randomized, Not Treated|3|||
160803365|NCT00756275|580669570|FG000|Overall Study|Lost to Follow-up|25|||
160803366|NCT00756275|580669571|FG001|Overall Study|Lost to Follow-up|21|||
160803367|NCT00756275|580669570|FG000|Overall Study|Withdrawal by Subject|4|||
160803368|NCT00756275|580669571|FG001|Overall Study|Withdrawal by Subject|7|||
160803369|NCT00980148|580669572|FG000|Overall Study|Discharged from facility|89|||
160803370|NCT00980148|580669573|FG001|Overall Study|Discharged from facility|96|||
160803371|NCT00980148|580669572|FG000|Overall Study|Received other antichlamydia treatment|20|||
160803372|NCT00980148|580669573|FG001|Overall Study|Received other antichlamydia treatment|14|||
160803373|NCT00980148|580669572|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
160803374|NCT00980148|580669573|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
160803375|NCT00980148|580669572|FG000|Overall Study|Various other reasons|8|||
160897389|NCT00299182|581020064|FG004|Overall Study|Not Eligible|1|||
160985165|NCT03389893|581335361|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
160985166|NCT03389893|581335362|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
160897390|NCT00299182|581020065|FG005|Overall Study|Not Eligible|0|||
160897391|NCT00299182|581020066|FG006|Overall Study|Not Eligible|0|||
160897392|NCT00771316|581020076|FG000|Overall Study|Adverse Event|0|||
160897393|NCT00771316|581020077|FG001|Overall Study|Adverse Event|1|||
161237349|NCT03570749|582250140|FG002|Overall Study|Pregnancy|0|||
161237350|NCT03570749|582250141|FG003|Overall Study|Pregnancy|0|||
160897394|NCT00771316|581020076|FG000|Overall Study|Patient withdrew consent|1|||
160897395|NCT00771316|581020077|FG001|Overall Study|Patient withdrew consent|0|||
160897396|NCT00771316|581020076|FG000|Overall Study|Discontinued due to early termination|1|||
160897397|NCT00771316|581020077|FG001|Overall Study|Discontinued due to early termination|0|||
160897398|NCT04043728|581020081|FG000|Overall Study|Lost to Follow-up|1|||
160897399|NCT04043728|581020082|FG001|Overall Study|Lost to Follow-up|2|||
160897400|NCT04043728|581020083|FG002|Overall Study|Lost to Follow-up|0|||
160897401|NCT00543543|581020084|FG000|Base Study|Adverse Event|1|||
160897402|NCT00543543|581020085|FG001|Base Study|Adverse Event|11|||
160897403|NCT00543543|581020086|FG002|Base Study|Adverse Event|0|||
160897404|NCT00543543|581020087|FG003|Base Study|Adverse Event|5|||
160897405|NCT00543543|581020084|FG000|Base Study|Lost to Follow-up|12|||
160897406|NCT00543543|581020085|FG001|Base Study|Lost to Follow-up|749|||
160897407|NCT00543543|581020086|FG002|Base Study|Lost to Follow-up|9|||
160897408|NCT00543543|581020087|FG003|Base Study|Lost to Follow-up|701|||
160897409|NCT00543543|581020084|FG000|Base Study|Physician Decision|0|||
160897410|NCT00543543|581020085|FG001|Base Study|Physician Decision|4|||
160897411|NCT00543543|581020086|FG002|Base Study|Physician Decision|0|||
160897412|NCT00543543|581020087|FG003|Base Study|Physician Decision|7|||
160897413|NCT00543543|581020084|FG000|Base Study|Protocol Violation|0|||
160897414|NCT00543543|581020085|FG001|Base Study|Protocol Violation|6|||
160897415|NCT00543543|581020086|FG002|Base Study|Protocol Violation|0|||
160897416|NCT00543543|581020087|FG003|Base Study|Protocol Violation|6|||
160897417|NCT00543543|581020084|FG000|Base Study|Withdrawal by Subject|7|||
160897418|NCT00543543|581020085|FG001|Base Study|Withdrawal by Subject|482|||
160897419|NCT00543543|581020086|FG002|Base Study|Withdrawal by Subject|5|||
160897420|NCT00543543|581020087|FG003|Base Study|Withdrawal by Subject|503|||
160897421|NCT00543543|581020084|FG000|Extension Study|Adverse Event|0|||
160897422|NCT00543543|581020085|FG001|Extension Study|Adverse Event|0|||
160897423|NCT00543543|581020086|FG002|Extension Study|Adverse Event|0|||
160897424|NCT00543543|581020087|FG003|Extension Study|Adverse Event|5|||
160897425|NCT00543543|581020084|FG000|Extension Study|Lost to Follow-up|0|||
160897426|NCT00543543|581020085|FG001|Extension Study|Lost to Follow-up|0|||
160897427|NCT00543543|581020086|FG002|Extension Study|Lost to Follow-up|0|||
160897428|NCT00543543|581020087|FG003|Extension Study|Lost to Follow-up|77|||
160897429|NCT00543543|581020084|FG000|Extension Study|Physician Decision|0|||
160897430|NCT00543543|581020085|FG001|Extension Study|Physician Decision|0|||
160897431|NCT00543543|581020086|FG002|Extension Study|Physician Decision|0|||
160897432|NCT00543543|581020087|FG003|Extension Study|Physician Decision|7|||
160897433|NCT00543543|581020084|FG000|Extension Study|Pregnancy|0|||
160897434|NCT00543543|581020085|FG001|Extension Study|Pregnancy|0|||
160897435|NCT00543543|581020086|FG002|Extension Study|Pregnancy|0|||
160897436|NCT00543543|581020087|FG003|Extension Study|Pregnancy|6|||
160897437|NCT00543543|581020084|FG000|Extension Study|Protocol Violation|0|||
160897438|NCT00543543|581020085|FG001|Extension Study|Protocol Violation|0|||
160897439|NCT00543543|581020086|FG002|Extension Study|Protocol Violation|0|||
160897440|NCT00543543|581020087|FG003|Extension Study|Protocol Violation|11|||
160897441|NCT00543543|581020084|FG000|Extension Study|Withdrawal by Subject|0|||
160897442|NCT00543543|581020085|FG001|Extension Study|Withdrawal by Subject|0|||
161237351|NCT03570749|582250142|FG004|Overall Study|Pregnancy|0|||
160897443|NCT00543543|581020086|FG002|Extension Study|Withdrawal by Subject|0|||
160897444|NCT00543543|581020087|FG003|Extension Study|Withdrawal by Subject|120|||
161237352|NCT03570749|582250143|FG005|Overall Study|Pregnancy|1|||
161237353|NCT03570749|582250144|FG006|Overall Study|Pregnancy|1|||
160897445|NCT04308304|581020088|FG000|Overall Study|Withdrawal by Subject|4|||
160897446|NCT04308304|581020089|FG001|Overall Study|Withdrawal by Subject|0|||
161237354|NCT03570749|582250138|FG000|Overall Study|Screen Fail|0|||
160897447|NCT04308304|581020088|FG000|Overall Study|Protocol Violation|1|||
160897448|NCT04308304|581020089|FG001|Overall Study|Protocol Violation|0|||
160803376|NCT00980148|580669573|FG001|Overall Study|Various other reasons|9|||
160803377|NCT03012334|580669576|FG000|Period 1|Withdrawal by Subject|0|||
161237355|NCT03570749|582250139|FG001|Overall Study|Screen Fail|0|||
161237356|NCT03570749|582250140|FG002|Overall Study|Screen Fail|0|||
161237357|NCT03570749|582250141|FG003|Overall Study|Screen Fail|0|||
161237358|NCT03570749|582250142|FG004|Overall Study|Screen Fail|0|||
161237359|NCT03570749|582250143|FG005|Overall Study|Screen Fail|0|||
161237360|NCT03570749|582250144|FG006|Overall Study|Screen Fail|1|||
161237361|NCT03570749|582250138|FG000|Overall Study|Withdrawal by Subject|2|||
161237362|NCT03570749|582250139|FG001|Overall Study|Withdrawal by Subject|3|||
161237363|NCT03570749|582250140|FG002|Overall Study|Withdrawal by Subject|2|||
161237364|NCT03570749|582250141|FG003|Overall Study|Withdrawal by Subject|1|||
161237365|NCT03570749|582250142|FG004|Overall Study|Withdrawal by Subject|17|||
161237366|NCT03570749|582250143|FG005|Overall Study|Withdrawal by Subject|12|||
161237367|NCT03570749|582250144|FG006|Overall Study|Withdrawal by Subject|15|||
161237368|NCT03570749|582250138|FG000|Overall Study|Other|0|||
161237369|NCT03570749|582250139|FG001|Overall Study|Other|0|||
161237370|NCT03570749|582250140|FG002|Overall Study|Other|0|||
161237371|NCT03570749|582250141|FG003|Overall Study|Other|0|||
161237372|NCT03570749|582250142|FG004|Overall Study|Other|17|||
161237373|NCT03570749|582250143|FG005|Overall Study|Other|14|||
161237374|NCT03570749|582250144|FG006|Overall Study|Other|21|||
161237375|NCT00561015|582250145|FG000|Overall Study|Adverse Event|0|||
161237376|NCT00561015|582250146|FG001|Overall Study|Adverse Event|0|||
161237377|NCT00561015|582250147|FG002|Overall Study|Adverse Event|0|||
161237378|NCT00561015|582250148|FG003|Overall Study|Adverse Event|0|||
161237379|NCT00561015|582250149|FG004|Overall Study|Adverse Event|1|||
161237380|NCT00561015|582250150|FG005|Overall Study|Adverse Event|0|||
161237381|NCT00561015|582250145|FG000|Overall Study|Lost to Follow-up|2|||
161237382|NCT00561015|582250146|FG001|Overall Study|Lost to Follow-up|0|||
161237383|NCT00561015|582250147|FG002|Overall Study|Lost to Follow-up|0|||
161237384|NCT00561015|582250148|FG003|Overall Study|Lost to Follow-up|1|||
161237385|NCT00561015|582250149|FG004|Overall Study|Lost to Follow-up|0|||
161237386|NCT00561015|582250150|FG005|Overall Study|Lost to Follow-up|3|||
161237387|NCT00561015|582250145|FG000|Overall Study|Participant non-compliance|2|||
161237388|NCT00561015|582250146|FG001|Overall Study|Participant non-compliance|0|||
161237389|NCT00561015|582250147|FG002|Overall Study|Participant non-compliance|0|||
161237390|NCT00561015|582250148|FG003|Overall Study|Participant non-compliance|0|||
161237391|NCT00561015|582250149|FG004|Overall Study|Participant non-compliance|0|||
161237392|NCT00561015|582250150|FG005|Overall Study|Participant non-compliance|0|||
161237393|NCT03616535|582250151|FG000|Overall Study|Death|2|||
161237394|NCT03616535|582250152|FG001|Overall Study|Death|0|||
161237395|NCT03616535|582250153|FG002|Overall Study|Death|0|||
161237396|NCT03616535|582250154|FG003|Overall Study|Death|1|||
161237397|NCT03616535|582250151|FG000|Overall Study|Lost to Follow-up|2|||
161237398|NCT03616535|582250152|FG001|Overall Study|Lost to Follow-up|1|||
161237399|NCT03616535|582250153|FG002|Overall Study|Lost to Follow-up|0|||
161237400|NCT03616535|582250154|FG003|Overall Study|Lost to Follow-up|2|||
161237401|NCT03616535|582250151|FG000|Overall Study|Withdrawal by Subject|1|||
161237402|NCT03616535|582250152|FG001|Overall Study|Withdrawal by Subject|2|||
161237403|NCT03616535|582250153|FG002|Overall Study|Withdrawal by Subject|5|||
161237404|NCT03616535|582250154|FG003|Overall Study|Withdrawal by Subject|1|||
161237405|NCT03616535|582250151|FG000|Overall Study|Not specified or change in eligibility|2|||
161237406|NCT03616535|582250152|FG001|Overall Study|Not specified or change in eligibility|3|||
161237407|NCT03616535|582250153|FG002|Overall Study|Not specified or change in eligibility|3|||
161237408|NCT03616535|582250154|FG003|Overall Study|Not specified or change in eligibility|1|||
161237409|NCT00834418|582250157|FG000|Overall Study|Adverse Event|0|||
161237410|NCT00834418|582250158|FG001|Overall Study|Adverse Event|2|||
161237411|NCT01705574|582250159|FG000|Double-Blind Phase|Lost to Follow-up|12|||
161237412|NCT01705574|582250160|FG001|Double-Blind Phase|Lost to Follow-up|16|||
161237413|NCT01705574|582250161|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161237414|NCT01705574|582250162|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161237415|NCT01705574|582250159|FG000|Double-Blind Phase|Adverse Event|3|||
161237416|NCT01705574|582250160|FG001|Double-Blind Phase|Adverse Event|10|||
161237417|NCT01705574|582250161|FG002|Double-Blind Phase|Adverse Event|0|||
161237418|NCT01705574|582250162|FG003|Double-Blind Phase|Adverse Event|0|||
161237419|NCT01705574|582250159|FG000|Double-Blind Phase|Withdrew Consent|8|||
161237420|NCT01705574|582250160|FG001|Double-Blind Phase|Withdrew Consent|5|||
161237421|NCT01705574|582250161|FG002|Double-Blind Phase|Withdrew Consent|0|||
161237422|NCT01705574|582250162|FG003|Double-Blind Phase|Withdrew Consent|0|||
161237423|NCT01705574|582250159|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
161237424|NCT01705574|582250160|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
161237425|NCT01705574|582250161|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
161237426|NCT01705574|582250162|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
161237427|NCT01705574|582250159|FG000|Double-Blind Phase|Pregnancy|1|||
161237428|NCT01705574|582250160|FG001|Double-Blind Phase|Pregnancy|1|||
161237429|NCT01705574|582250161|FG002|Double-Blind Phase|Pregnancy|0|||
161237430|NCT01705574|582250162|FG003|Double-Blind Phase|Pregnancy|0|||
161237431|NCT01705574|582250159|FG000|Double-Blind Phase|Protocol Violation|1|||
160985167|NCT03389893|581335363|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
160985168|NCT03389893|581335360|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
160985169|NCT03389893|581335361|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
160803378|NCT03012334|580669577|FG001|Period 1|Withdrawal by Subject|0|||
160803379|NCT03012334|580669578|FG002|Period 1|Withdrawal by Subject|0|||
160803380|NCT03012334|580669579|FG003|Period 1|Withdrawal by Subject|0|||
160803381|NCT03012334|580669580|FG004|Period 1|Withdrawal by Subject|0|||
160803382|NCT03012334|580669581|FG005|Period 1|Withdrawal by Subject|0|||
160803383|NCT03012334|580669582|FG006|Period 1|Withdrawal by Subject|0|||
160803384|NCT03012334|580669583|FG007|Period 1|Withdrawal by Subject|0|||
160803385|NCT03012334|580669584|FG008|Period 1|Withdrawal by Subject|0|||
160803386|NCT03012334|580669585|FG009|Period 1|Withdrawal by Subject|1|||
160803387|NCT03012334|580669576|FG000|Period 2|Withdrawal by Subject|0|||
160803388|NCT03012334|580669577|FG001|Period 2|Withdrawal by Subject|1|||
160803389|NCT03012334|580669578|FG002|Period 2|Withdrawal by Subject|0|||
160803390|NCT03012334|580669579|FG003|Period 2|Withdrawal by Subject|0|||
160803391|NCT03012334|580669580|FG004|Period 2|Withdrawal by Subject|0|||
160803392|NCT03012334|580669581|FG005|Period 2|Withdrawal by Subject|0|||
160803393|NCT03012334|580669582|FG006|Period 2|Withdrawal by Subject|0|||
160803394|NCT03012334|580669583|FG007|Period 2|Withdrawal by Subject|0|||
160803395|NCT03012334|580669584|FG008|Period 2|Withdrawal by Subject|0|||
160803396|NCT03012334|580669585|FG009|Period 2|Withdrawal by Subject|0|||
160803397|NCT03012334|580669576|FG000|Period 2|Protocol Violation|0|||
160803398|NCT03012334|580669577|FG001|Period 2|Protocol Violation|0|||
160803399|NCT03012334|580669578|FG002|Period 2|Protocol Violation|1|||
160803400|NCT03012334|580669579|FG003|Period 2|Protocol Violation|0|||
160803401|NCT03012334|580669580|FG004|Period 2|Protocol Violation|0|||
160897449|NCT00945555|581020090|FG000|Overall Study|Referred to another hospital|5|||
160897450|NCT00945555|581020090|FG000|Overall Study|Worsening condition, intensive care unit|1|||
160897451|NCT00945555|581020090|FG000|Overall Study|Withdrawal by Subject|2|||
160897452|NCT00945555|581020090|FG000|Overall Study|Participant continued treatment at home|1|||
160897453|NCT00945555|581020090|FG000|Overall Study|Death|18|||
160985170|NCT03389893|581335362|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
160985171|NCT03389893|581335363|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
160985172|NCT03389893|581335360|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
160985173|NCT03389893|581335361|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
160985174|NCT03389893|581335362|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
160985175|NCT03389893|581335363|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
160985176|NCT01719861|581335367|FG000|Cycle 1|Death|4|||
160985177|NCT01719861|581335367|FG000|Cycle 2|Death|1|||
160985178|NCT00958009|581335368|FG000|Overall Study|Adverse Event|1|||
160985179|NCT00958009|581335368|FG000|Overall Study|Subject found device difficult to use|1|||
160985180|NCT00087490|581335381|FG000|Overall Study|Death|6|||
160985181|NCT00087490|581335382|FG001|Overall Study|Death|4|||
160985182|NCT00087490|581335381|FG000|Overall Study|Adverse Event|3|||
160985183|NCT00087490|581335382|FG001|Overall Study|Adverse Event|8|||
160985184|NCT00087490|581335381|FG000|Overall Study|Lack of Efficacy|0|||
160985185|NCT00087490|581335382|FG001|Overall Study|Lack of Efficacy|2|||
160985186|NCT00087490|581335381|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
160985187|NCT00087490|581335382|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
160985188|NCT00087490|581335381|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
160985189|NCT00087490|581335382|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
160985190|NCT00087490|581335381|FG000|Overall Study|Randomized but not treated|7|||
160803402|NCT03012334|580669581|FG005|Period 2|Protocol Violation|0|||
160803403|NCT03012334|580669582|FG006|Period 2|Protocol Violation|0|||
160803404|NCT03012334|580669583|FG007|Period 2|Protocol Violation|1|||
160803405|NCT03012334|580669584|FG008|Period 2|Protocol Violation|0|||
160897454|NCT00945555|581020090|FG000|Overall Study|Other|1|||
160897455|NCT04502979|581020091|FG000|Overall Study|Lost to Follow-up|1|||
160897456|NCT04502979|581020092|FG001|Overall Study|Lost to Follow-up|3|||
160897457|NCT04502979|581020091|FG000|Overall Study|Withdrawal by Subject|2|||
160803406|NCT03012334|580669585|FG009|Period 2|Protocol Violation|0|||
160803407|NCT03012334|580669576|FG000|Period 4|Non-Compliance|0|||
160897458|NCT04502979|581020092|FG001|Overall Study|Withdrawal by Subject|1|||
160897459|NCT00586625|581020099|FG000|Overall Study|Adverse Event|6|||
160897460|NCT00586625|581020100|FG001|Overall Study|Adverse Event|6|||
160897461|NCT00586625|581020099|FG000|Overall Study|Protocol Violation|3|||
160897462|NCT00586625|581020100|FG001|Overall Study|Protocol Violation|0|||
160897463|NCT00586625|581020099|FG000|Overall Study|Withdrawal by Subject|32|||
160985191|NCT00087490|581335382|FG001|Overall Study|Randomized but not treated|18|||
161237432|NCT01705574|582250160|FG001|Double-Blind Phase|Protocol Violation|0|||
160803408|NCT03012334|580669577|FG001|Period 4|Non-Compliance|0|||
160897464|NCT00586625|581020100|FG001|Overall Study|Withdrawal by Subject|10|||
160897465|NCT00586625|581020099|FG000|Overall Study|Subject non-compliance|0|||
160803409|NCT03012334|580669578|FG002|Period 4|Non-Compliance|0|||
160803410|NCT03012334|580669579|FG003|Period 4|Non-Compliance|0|||
160803411|NCT03012334|580669580|FG004|Period 4|Non-Compliance|0|||
160803412|NCT03012334|580669581|FG005|Period 4|Non-Compliance|0|||
160803413|NCT03012334|580669582|FG006|Period 4|Non-Compliance|1|||
160803414|NCT03012334|580669583|FG007|Period 4|Non-Compliance|0|||
160803415|NCT03012334|580669584|FG008|Period 4|Non-Compliance|0|||
160803416|NCT03012334|580669585|FG009|Period 4|Non-Compliance|0|||
160803417|NCT03012334|580669576|FG000|Period 4|Adverse Event|0|||
160803418|NCT03012334|580669577|FG001|Period 4|Adverse Event|0|||
160803419|NCT03012334|580669578|FG002|Period 4|Adverse Event|0|||
160803420|NCT03012334|580669579|FG003|Period 4|Adverse Event|0|||
160803421|NCT03012334|580669580|FG004|Period 4|Adverse Event|0|||
160803422|NCT03012334|580669581|FG005|Period 4|Adverse Event|0|||
160803423|NCT03012334|580669582|FG006|Period 4|Adverse Event|0|||
160803424|NCT03012334|580669583|FG007|Period 4|Adverse Event|0|||
160803425|NCT03012334|580669584|FG008|Period 4|Adverse Event|1|||
160803426|NCT03012334|580669585|FG009|Period 4|Adverse Event|0|||
160803427|NCT01823107|580669586|FG000|Overall Study|Withdrawal by Subject|1|||
160803428|NCT01073293|580669587|FG000|Overall Study|Lost to Follow-up|0|||
160803429|NCT01073293|580669588|FG001|Overall Study|Lost to Follow-up|1|||
160803430|NCT01073293|580669587|FG000|Overall Study|Withdrawal by Subject|5|||
160803431|NCT01073293|580669588|FG001|Overall Study|Withdrawal by Subject|10|||
160803432|NCT00328172|580669591|FG000|Overall Study|Adverse Event|3|||
160803433|NCT00328172|580669592|FG001|Overall Study|Adverse Event|2|||
160803434|NCT00328172|580669593|FG002|Overall Study|Adverse Event|1|||
160803435|NCT00328172|580669594|FG003|Overall Study|Adverse Event|2|||
160803436|NCT00328172|580669595|FG004|Overall Study|Adverse Event|1|||
160803437|NCT00328172|580669591|FG000|Overall Study|Protocol Violation|0|||
160803438|NCT00328172|580669592|FG001|Overall Study|Protocol Violation|1|||
160803439|NCT00328172|580669593|FG002|Overall Study|Protocol Violation|1|||
160803440|NCT00328172|580669594|FG003|Overall Study|Protocol Violation|0|||
160803441|NCT00328172|580669595|FG004|Overall Study|Protocol Violation|0|||
160803442|NCT00328172|580669591|FG000|Overall Study|Lost to Follow-up|1|||
160803443|NCT00328172|580669592|FG001|Overall Study|Lost to Follow-up|1|||
160803444|NCT00328172|580669593|FG002|Overall Study|Lost to Follow-up|2|||
160803445|NCT00328172|580669594|FG003|Overall Study|Lost to Follow-up|1|||
160803446|NCT00328172|580669595|FG004|Overall Study|Lost to Follow-up|1|||
160803447|NCT00328172|580669591|FG000|Overall Study|Withdrawal by Subject|1|||
160803448|NCT00328172|580669592|FG001|Overall Study|Withdrawal by Subject|1|||
160803449|NCT00328172|580669593|FG002|Overall Study|Withdrawal by Subject|1|||
160803450|NCT00328172|580669594|FG003|Overall Study|Withdrawal by Subject|6|||
160803451|NCT00328172|580669595|FG004|Overall Study|Withdrawal by Subject|0|||
160803452|NCT00328172|580669591|FG000|Overall Study|Lack of Efficacy|14|||
160803453|NCT00328172|580669592|FG001|Overall Study|Lack of Efficacy|9|||
160803454|NCT00328172|580669593|FG002|Overall Study|Lack of Efficacy|4|||
160803455|NCT00328172|580669594|FG003|Overall Study|Lack of Efficacy|4|||
160803456|NCT00328172|580669595|FG004|Overall Study|Lack of Efficacy|3|||
160803457|NCT00328172|580669591|FG000|Overall Study|Other reason (not specified)|3|||
160803458|NCT00328172|580669592|FG001|Overall Study|Other reason (not specified)|0|||
160803459|NCT00328172|580669593|FG002|Overall Study|Other reason (not specified)|1|||
160803460|NCT00328172|580669594|FG003|Overall Study|Other reason (not specified)|0|||
160803461|NCT00328172|580669595|FG004|Overall Study|Other reason (not specified)|0|||
160803462|NCT00077974|580669596|FG000|Overall Study|Adverse Event|22|||
160803463|NCT00077974|580669596|FG000|Overall Study|Protocol Violation|1|||
160803464|NCT00077974|580669596|FG000|Overall Study|Withdrawal by Subject|3|||
160803465|NCT00077974|580669596|FG000|Overall Study|Lack of Efficacy|76|||
160803466|NCT00077974|580669596|FG000|Overall Study|Decision of Sponsor|2|||
160803467|NCT02897115|580669599|FG000|Overall Study|Early termination of study by sponsor|11|||
160803468|NCT02897115|580669600|FG001|Overall Study|Early termination of study by sponsor|8|||
160803469|NCT00420381|580669601|FG000|Overall Study|Protocol Violation|1|||
160803470|NCT01244035|580669613|FG000|Part 1: Period 1|Adverse Event|0|||
160803471|NCT01244035|580669614|FG001|Part 1: Period 1|Adverse Event|0|||
160803472|NCT01244035|580669615|FG002|Part 1: Period 1|Adverse Event|0|||
160803473|NCT01244035|580669616|FG003|Part 1: Period 1|Adverse Event|0|||
160803474|NCT01244035|580669617|FG004|Part 1: Period 1|Adverse Event|0|||
160803475|NCT01244035|580669618|FG005|Part 1: Period 1|Adverse Event|1|||
160803476|NCT01244035|580669613|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
160803477|NCT01244035|580669614|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
160803478|NCT01244035|580669615|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
160803479|NCT01244035|580669616|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
160803480|NCT01244035|580669617|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
160803481|NCT01244035|580669618|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
160803482|NCT01244035|580669613|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
160803483|NCT01244035|580669614|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
160803484|NCT01244035|580669615|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
160803485|NCT01244035|580669616|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
160803486|NCT01244035|580669617|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
160803487|NCT01244035|580669618|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
160803488|NCT01244035|580669613|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803489|NCT01244035|580669614|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803490|NCT01244035|580669615|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
160803491|NCT01244035|580669616|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803492|NCT01244035|580669617|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803493|NCT01244035|580669618|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
160803494|NCT01244035|580669613|FG000|Part 1: Period 3|Adverse Event|0|||
160803495|NCT01244035|580669614|FG001|Part 1: Period 3|Adverse Event|0|||
160803496|NCT01244035|580669615|FG002|Part 1: Period 3|Adverse Event|0|||
160897466|NCT00586625|581020100|FG001|Overall Study|Subject non-compliance|1|||
160897467|NCT00586625|581020099|FG000|Overall Study|Subject unable to return for visit|2|||
160897468|NCT00586625|581020100|FG001|Overall Study|Subject unable to return for visit|0|||
160897469|NCT00165984|581020103|FG000|Overall Study|Death|15|||
160897470|NCT01686828|581020107|FG000|Overall Study|Physician Decision|1|||
160897471|NCT01686828|581020108|FG001|Overall Study|Physician Decision|0|||
160897472|NCT01686828|581020109|FG002|Overall Study|Physician Decision|0|||
160897473|NCT01686828|581020110|FG003|Overall Study|Physician Decision|0|||
160897474|NCT01686828|581020107|FG000|Overall Study|New Job|0|||
160897475|NCT01686828|581020108|FG001|Overall Study|New Job|1|||
160897476|NCT01686828|581020109|FG002|Overall Study|New Job|0|||
160897477|NCT01686828|581020110|FG003|Overall Study|New Job|0|||
160897478|NCT01686828|581020107|FG000|Overall Study|Weight Loss|0|||
160897479|NCT01686828|581020108|FG001|Overall Study|Weight Loss|0|||
160897480|NCT01686828|581020109|FG002|Overall Study|Weight Loss|1|||
160897481|NCT01686828|581020110|FG003|Overall Study|Weight Loss|0|||
160897482|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Death|1|||
160897483|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Death|4|||
160897484|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Death|4|||
160897485|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Death|1|||
160897486|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Death|6|||
160897487|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Death|0|||
160897488|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
160897489|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
160897490|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
160897491|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
160897492|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
160897493|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
160897494|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897495|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
160897496|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897497|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
160897498|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897499|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
160897500|NCT04430738|581020111|FG000|Phase 1: Dose Escalation|Other|1|||
160897501|NCT04430738|581020112|FG001|Phase 1: Dose Escalation|Other|0|||
161237433|NCT01705574|582250161|FG002|Double-Blind Phase|Protocol Violation|0|||
161237434|NCT01705574|582250162|FG003|Double-Blind Phase|Protocol Violation|0|||
161237435|NCT01705574|582250159|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
161237436|NCT01705574|582250160|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
161237437|NCT01705574|582250161|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
161237438|NCT01705574|582250162|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
160897502|NCT04430738|581020113|FG002|Phase 1: Dose Escalation|Other|0|||
161237439|NCT01705574|582250159|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
161237440|NCT01705574|582250160|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161237441|NCT01705574|582250161|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
160897503|NCT04430738|581020114|FG003|Phase 1: Dose Escalation|Other|0|||
160897504|NCT04430738|581020115|FG004|Phase 1: Dose Escalation|Other|0|||
161237442|NCT01705574|582250162|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
161237443|NCT01705574|582250159|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
160803497|NCT01244035|580669616|FG003|Part 1: Period 3|Adverse Event|0|||
160803498|NCT01244035|580669617|FG004|Part 1: Period 3|Adverse Event|0|||
160803499|NCT01244035|580669618|FG005|Part 1: Period 3|Adverse Event|1|||
160803500|NCT01244035|580669613|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
160803501|NCT01244035|580669614|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
160803502|NCT01244035|580669615|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
160803503|NCT01244035|580669616|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
160897505|NCT04430738|581020116|FG005|Phase 1: Dose Escalation|Other|0|||
160897506|NCT04430738|581020111|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897507|NCT04430738|581020112|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897508|NCT04430738|581020113|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897509|NCT04430738|581020114|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897510|NCT04430738|581020115|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
160897511|NCT04430738|581020116|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
160803504|NCT01244035|580669617|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
160803505|NCT01244035|580669618|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
160803506|NCT01244035|580669613|FG000|Part 1: Period 3|Protocol Deviation|0|||
160803507|NCT01244035|580669614|FG001|Part 1: Period 3|Protocol Deviation|1|||
160803508|NCT01244035|580669615|FG002|Part 1: Period 3|Protocol Deviation|0|||
160803509|NCT01244035|580669616|FG003|Part 1: Period 3|Protocol Deviation|0|||
160803510|NCT01244035|580669617|FG004|Part 1: Period 3|Protocol Deviation|0|||
160803511|NCT01244035|580669618|FG005|Part 1: Period 3|Protocol Deviation|0|||
160803512|NCT04512001|580669621|FG000|Week 0 to Week 24|Adverse Event|14|||
160803513|NCT04512001|580669622|FG001|Week 0 to Week 24|Adverse Event|10|||
160803514|NCT04512001|580669623|FG002|Week 0 to Week 24|Adverse Event|0|||
160803515|NCT04512001|580669624|FG003|Week 0 to Week 24|Adverse Event|0|||
160803516|NCT04512001|580669625|FG004|Week 0 to Week 24|Adverse Event|0|||
160803517|NCT04512001|580669621|FG000|Week 0 to Week 24|Death|0|||
160803518|NCT04512001|580669622|FG001|Week 0 to Week 24|Death|2|||
160803519|NCT04512001|580669623|FG002|Week 0 to Week 24|Death|0|||
160803520|NCT04512001|580669624|FG003|Week 0 to Week 24|Death|0|||
160803521|NCT04512001|580669625|FG004|Week 0 to Week 24|Death|0|||
160803522|NCT04512001|580669621|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
160803523|NCT04512001|580669622|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
160803524|NCT04512001|580669623|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
160803525|NCT04512001|580669624|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
160803526|NCT04512001|580669625|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
160803527|NCT04512001|580669621|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
160803528|NCT04512001|580669622|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
160803529|NCT04512001|580669623|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
160803530|NCT04512001|580669624|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
160803531|NCT04512001|580669625|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
160803532|NCT04512001|580669621|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
160803533|NCT04512001|580669622|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803534|NCT04512001|580669623|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803535|NCT04512001|580669624|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803536|NCT04512001|580669625|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
160803537|NCT04512001|580669621|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803538|NCT04512001|580669622|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
160803539|NCT04512001|580669623|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803540|NCT04512001|580669624|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803541|NCT04512001|580669625|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
160803542|NCT04512001|580669621|FG000|Week 24 to Week 63|Adverse Event|0|||
160803543|NCT04512001|580669622|FG001|Week 24 to Week 63|Adverse Event|0|||
160803544|NCT04512001|580669623|FG002|Week 24 to Week 63|Adverse Event|13|||
160803545|NCT04512001|580669624|FG003|Week 24 to Week 63|Adverse Event|8|||
160803546|NCT04512001|580669625|FG004|Week 24 to Week 63|Adverse Event|6|||
160803547|NCT04512001|580669621|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
160803548|NCT04512001|580669622|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
160803549|NCT04512001|580669623|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
160803550|NCT04512001|580669624|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
160803551|NCT04512001|580669625|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
160803552|NCT04512001|580669621|FG000|Week 24 to Week 63|Death|0|||
160803553|NCT04512001|580669622|FG001|Week 24 to Week 63|Death|0|||
160803554|NCT04512001|580669623|FG002|Week 24 to Week 63|Death|0|||
160803555|NCT04512001|580669624|FG003|Week 24 to Week 63|Death|1|||
160803556|NCT04512001|580669625|FG004|Week 24 to Week 63|Death|1|||
160803557|NCT04512001|580669621|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
160803558|NCT04512001|580669622|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
160803559|NCT04512001|580669623|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
160803560|NCT04512001|580669624|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
160803561|NCT04512001|580669625|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
160803562|NCT04512001|580669621|FG000|Week 24 to Week 63|Miscellaneous|0|||
160803563|NCT04512001|580669622|FG001|Week 24 to Week 63|Miscellaneous|0|||
160803564|NCT04512001|580669623|FG002|Week 24 to Week 63|Miscellaneous|3|||
160803565|NCT04512001|580669624|FG003|Week 24 to Week 63|Miscellaneous|2|||
160803566|NCT04512001|580669625|FG004|Week 24 to Week 63|Miscellaneous|1|||
160803567|NCT02776683|580669626|FG000|Pre-switch Period|Protocol Violation|1|||
160803568|NCT02776683|580669627|FG001|Pre-switch Period|Protocol Violation|0|||
160803569|NCT02776683|580669626|FG000|Pre-switch Period|Adverse Event|21|||
160803570|NCT02776683|580669627|FG001|Pre-switch Period|Adverse Event|0|||
160803571|NCT02776683|580669626|FG000|Pre-switch Period|Withdrawal by Subject|9|||
160985192|NCT01925170|581335383|FG000|Overall Study|Unverified cancer status|53|||
160985193|NCT01077024|581335386|FG000|Overall Study|Lost to Follow-up|20|||
160803572|NCT02776683|580669627|FG001|Pre-switch Period|Withdrawal by Subject|0|||
160803573|NCT02776683|580669626|FG000|Pre-switch Period|Physician Decision|7|||
160803574|NCT02776683|580669627|FG001|Pre-switch Period|Physician Decision|0|||
160803575|NCT02776683|580669626|FG000|Pre-switch Period|Progressive disease|39|||
160803576|NCT02776683|580669627|FG001|Pre-switch Period|Progressive disease|0|||
160803577|NCT02776683|580669626|FG000|Pre-switch Period|Other than listed|3|||
160803578|NCT02776683|580669627|FG001|Pre-switch Period|Other than listed|0|||
160803579|NCT02776683|580669626|FG000|Post-switch Period|Adverse Event|0|||
160803580|NCT02776683|580669627|FG001|Post-switch Period|Adverse Event|3|||
160803581|NCT02776683|580669626|FG000|Post-switch Period|Withdrawal by Subject|0|||
160803582|NCT02776683|580669627|FG001|Post-switch Period|Withdrawal by Subject|2|||
160803583|NCT02776683|580669626|FG000|Post-switch Period|Physician Decision|0|||
160803584|NCT02776683|580669627|FG001|Post-switch Period|Physician Decision|3|||
160803585|NCT02776683|580669626|FG000|Post-switch Period|Progressive disease|0|||
160803586|NCT02776683|580669627|FG001|Post-switch Period|Progressive disease|20|||
160803587|NCT02776683|580669626|FG000|Post-switch Period|Other than listed|0|||
160803588|NCT02776683|580669627|FG001|Post-switch Period|Other than listed|15|||
160803589|NCT02298868|580669637|FG000|Overall Study|Adverse Event|1|||
160803590|NCT02298868|580669637|FG000|Overall Study|Death|1|||
160803591|NCT02298868|580669637|FG000|Overall Study|Patient underwent transplant|1|||
160803592|NCT01063348|580669638|FG000|Overall Study|Lost to Follow-up|3|||
160803593|NCT01063348|580669639|FG001|Overall Study|Lost to Follow-up|10|||
160803594|NCT03824392|580669640|FG000|Overall Study|Adverse Event|1|||
160803595|NCT03824392|580669641|FG001|Overall Study|Adverse Event|0|||
160803596|NCT03824392|580669642|FG002|Overall Study|Adverse Event|0|||
160803597|NCT03824392|580669643|FG003|Overall Study|Adverse Event|0|||
160803598|NCT03824392|580669640|FG000|Overall Study|Investigator Decision|0|||
160803599|NCT03824392|580669641|FG001|Overall Study|Investigator Decision|1|||
160803600|NCT03824392|580669642|FG002|Overall Study|Investigator Decision|0|||
160803601|NCT03824392|580669643|FG003|Overall Study|Investigator Decision|0|||
160803602|NCT03824392|580669640|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
160803603|NCT03824392|580669641|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
160803604|NCT03824392|580669642|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
160803605|NCT03824392|580669643|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
160803606|NCT02230189|580669644|FG000|Overall Study|Withdrawal by Subject|3|||
160803607|NCT02230189|580669645|FG001|Overall Study|Withdrawal by Subject|0|||
160803608|NCT02230189|580669646|FG002|Overall Study|Withdrawal by Subject|1|||
160803609|NCT02230189|580669644|FG000|Overall Study|Lost to Follow-up|1|||
160803610|NCT02230189|580669645|FG001|Overall Study|Lost to Follow-up|0|||
160803611|NCT02230189|580669646|FG002|Overall Study|Lost to Follow-up|0|||
160803612|NCT02230189|580669644|FG000|Overall Study|Physician Decision|1|||
160803613|NCT02230189|580669645|FG001|Overall Study|Physician Decision|0|||
160803614|NCT02230189|580669646|FG002|Overall Study|Physician Decision|0|||
160803615|NCT01847755|580669647|FG000|Overall Study|Adverse Event|2|||
160803616|NCT01847755|580669647|FG000|Overall Study|Withdrawal by Subject|2|||
160803617|NCT01847755|580669647|FG000|Overall Study|Physician Decision|1|||
160803618|NCT01261975|580669655|FG000|Overall Study|Surgical complication|1|||
160803619|NCT01932788|580669656|FG000|Overall Study|Protocol Violation|18|||
160803620|NCT01932788|580669657|FG001|Overall Study|Protocol Violation|0|||
160803621|NCT01932788|580669656|FG000|Overall Study|Lost to Follow-up|18|||
160803622|NCT01932788|580669657|FG001|Overall Study|Lost to Follow-up|46|||
160803623|NCT01932788|580669656|FG000|Overall Study|Lack of Efficacy|2|||
160803624|NCT01932788|580669657|FG001|Overall Study|Lack of Efficacy|0|||
160803625|NCT01932788|580669656|FG000|Overall Study|Withdrawal by Subject|0|||
160803626|NCT01932788|580669657|FG001|Overall Study|Withdrawal by Subject|5|||
160803627|NCT01171677|580669658|FG000|Overall Study|Withdrawal by Subject|0|||
160803628|NCT01171677|580669659|FG001|Overall Study|Withdrawal by Subject|3|||
160803629|NCT01171677|580669658|FG000|Overall Study|Adverse Event|1|||
160803630|NCT01171677|580669659|FG001|Overall Study|Adverse Event|0|||
160803631|NCT01171677|580669658|FG000|Overall Study|completed <70% IntenSati classes|5|||
160803632|NCT01171677|580669659|FG001|Overall Study|completed <70% IntenSati classes|0|||
160985194|NCT01077024|581335387|FG001|Overall Study|Lost to Follow-up|14|||
160803633|NCT00656370|580669660|FG000|Overall Study|Screen Failures|7|||
160803634|NCT00656370|580669660|FG000|Overall Study|Alternates|3|||
160803635|NCT05653700|580669678|FG000|Overall Study|Non Responders|9|||
160803636|NCT05653700|580669679|FG001|Overall Study|Non Responders|0|||
160803637|NCT01900665|580669686|FG000|Placebo Controlled Period|Death|9|||
160803638|NCT01900665|580669687|FG001|Placebo Controlled Period|Death|16|||
160803639|NCT01900665|580669686|FG000|Placebo Controlled Period|Adverse Event|48|||
160803640|NCT01900665|580669687|FG001|Placebo Controlled Period|Adverse Event|39|||
160803641|NCT01900665|580669686|FG000|Placebo Controlled Period|Protocol Violation|1|||
160803642|NCT01900665|580669687|FG001|Placebo Controlled Period|Protocol Violation|7|||
160803643|NCT01900665|580669686|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
160803644|NCT01900665|580669687|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
160803645|NCT01900665|580669686|FG000|Placebo Controlled Period|Physician Decision|11|||
160803646|NCT01900665|580669687|FG001|Placebo Controlled Period|Physician Decision|7|||
160803647|NCT01900665|580669686|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
160803648|NCT01900665|580669687|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
160803649|NCT01900665|580669686|FG000|Placebo Controlled Period|Caregiver Decision|33|||
160803650|NCT01900665|580669687|FG001|Placebo Controlled Period|Caregiver Decision|41|||
160803651|NCT01900665|580669686|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
160803652|NCT01900665|580669687|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
160803653|NCT01900665|580669686|FG000|Open Label Period|Adverse Event|16|||
160803654|NCT01900665|580669687|FG001|Open Label Period|Adverse Event|20|||
160803655|NCT01900665|580669686|FG000|Open Label Period|Death|5|||
160803656|NCT01900665|580669687|FG001|Open Label Period|Death|6|||
160803657|NCT01900665|580669686|FG000|Open Label Period|Lost to Follow-up|1|||
160803658|NCT01900665|580669687|FG001|Open Label Period|Lost to Follow-up|1|||
160803659|NCT01900665|580669686|FG000|Open Label Period|Parent/Caregiver Decision|33|||
160803660|NCT01900665|580669687|FG001|Open Label Period|Parent/Caregiver Decision|34|||
160803661|NCT01900665|580669686|FG000|Open Label Period|Physician Decision|4|||
160803662|NCT01900665|580669687|FG001|Open Label Period|Physician Decision|4|||
160803663|NCT01900665|580669686|FG000|Open Label Period|Protocol Violation|0|||
160803664|NCT01900665|580669687|FG001|Open Label Period|Protocol Violation|1|||
160803665|NCT01900665|580669686|FG000|Open Label Period|Sponsor Decision|802|||
160803666|NCT01900665|580669687|FG001|Open Label Period|Sponsor Decision|765|||
160803667|NCT01900665|580669686|FG000|Open Label Period|Withdrawal by Subject|20|||
160803668|NCT01900665|580669687|FG001|Open Label Period|Withdrawal by Subject|28|||
160803669|NCT02317627|580669688|FG000|Overall Study|Withdrawal by Subject|0|||
160803670|NCT02317627|580669689|FG001|Overall Study|Withdrawal by Subject|1|||
160803671|NCT02317627|580669690|FG002|Overall Study|Withdrawal by Subject|1|||
160803672|NCT02317627|580669688|FG000|Overall Study|Lost to Follow-up|2|||
160803673|NCT02317627|580669689|FG001|Overall Study|Lost to Follow-up|0|||
160803674|NCT02317627|580669690|FG002|Overall Study|Lost to Follow-up|0|||
160803675|NCT02317627|580669688|FG000|Overall Study|Stopped by Investigator|0|||
160803676|NCT02317627|580669689|FG001|Overall Study|Stopped by Investigator|1|||
160803677|NCT02317627|580669690|FG002|Overall Study|Stopped by Investigator|0|||
160803678|NCT02317627|580669688|FG000|Overall Study|Adverse Event|0|||
160803679|NCT02317627|580669689|FG001|Overall Study|Adverse Event|2|||
160803680|NCT02317627|580669690|FG002|Overall Study|Adverse Event|3|||
160803681|NCT02317627|580669688|FG000|Overall Study|Non-compliance with study drug|0|||
160803682|NCT02317627|580669689|FG001|Overall Study|Non-compliance with study drug|1|||
160803683|NCT02317627|580669690|FG002|Overall Study|Non-compliance with study drug|0|||
160803684|NCT00279214|580669691|FG000|Overall Study|Physician Decision|3|||
160803685|NCT00279214|580669692|FG001|Overall Study|Physician Decision|2|||
160803686|NCT04749914|580669693|FG000|Period 1|Adverse Event|1|||
160803687|NCT04749914|580669694|FG001|Period 1|Adverse Event|0|||
160803688|NCT04749914|580669695|FG002|Period 1|Adverse Event|0|||
160803689|NCT04749914|580669696|FG003|Period 1|Adverse Event|0|||
160803690|NCT04749914|580669693|FG000|Period 1|Withdrawal by Subject|1|||
160803691|NCT04749914|580669694|FG001|Period 1|Withdrawal by Subject|0|||
160803692|NCT04749914|580669695|FG002|Period 1|Withdrawal by Subject|1|||
160803693|NCT04749914|580669696|FG003|Period 1|Withdrawal by Subject|0|||
160803694|NCT01280968|580669697|FG000|Overall Study|Lost to Follow-up|8|||
160803695|NCT01280968|580669698|FG001|Overall Study|Lost to Follow-up|2|||
160803696|NCT01280968|580669697|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
160803697|NCT01280968|580669698|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
160803698|NCT01280968|580669697|FG000|Overall Study|Commuting Problems|2|||
160803699|NCT01280968|580669698|FG001|Overall Study|Commuting Problems|0|||
160897512|NCT04430738|581020111|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160803700|NCT01280968|580669697|FG000|Overall Study|Anxiety|2|||
160803701|NCT01280968|580669698|FG001|Overall Study|Anxiety|0|||
160897513|NCT04430738|581020112|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897514|NCT04430738|581020113|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897515|NCT04430738|581020114|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897516|NCT04430738|581020115|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
160897517|NCT04430738|581020116|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
160897518|NCT02734433|581020117|FG000|Overall Study|Disease progression|1|||
160897519|NCT02734433|581020118|FG001|Overall Study|Disease progression|5|||
160897520|NCT02734433|581020117|FG000|Overall Study|Clinical progression|0|||
160897521|NCT02734433|581020118|FG001|Overall Study|Clinical progression|1|||
160897522|NCT02734433|581020117|FG000|Overall Study|Withdrawal by Subject|1|||
160897523|NCT02734433|581020118|FG001|Overall Study|Withdrawal by Subject|2|||
160897524|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
160897525|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
161237444|NCT01705574|582250160|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
161237445|NCT01705574|582250161|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
160803702|NCT01280968|580669697|FG000|Overall Study|Adverse Event|1|||
160803703|NCT01280968|580669698|FG001|Overall Study|Adverse Event|0|||
160803704|NCT01280968|580669697|FG000|Overall Study|Scheduling Conflicts|1|||
160803705|NCT01280968|580669698|FG001|Overall Study|Scheduling Conflicts|1|||
160803706|NCT01280968|580669697|FG000|Overall Study|Pre-existing Neurological Condition|1|||
160803707|NCT01280968|580669698|FG001|Overall Study|Pre-existing Neurological Condition|0|||
160803708|NCT01280968|580669697|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
160897526|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
160897527|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
160897528|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
160803709|NCT01280968|580669698|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
160803710|NCT01897532|580669700|FG000|Discontinuation From Treatment|Not Treated|7|||
160803711|NCT01897532|580669701|FG001|Discontinuation From Treatment|Not Treated|5|||
160803712|NCT01897532|580669700|FG000|Discontinuation From Treatment|Other reason than specified|196|||
160803713|NCT01897532|580669701|FG001|Discontinuation From Treatment|Other reason than specified|176|||
160803714|NCT01897532|580669700|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
160803715|NCT01897532|580669701|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
160803716|NCT01897532|580669700|FG000|Discontinuation From Treatment|Non compliance|24|||
160803717|NCT01897532|580669701|FG001|Discontinuation From Treatment|Non compliance|15|||
160803718|NCT01897532|580669700|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
160803719|NCT01897532|580669701|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
160803720|NCT01897532|580669700|FG000|Discontinuation From Trial|Not Treated|7|||
160803721|NCT01897532|580669701|FG001|Discontinuation From Trial|Not Treated|5|||
160803722|NCT01897532|580669700|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
160803723|NCT01897532|580669701|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
160803724|NCT01074931|580669706|FG000|Overall Study|Economic reasons|1|||
160803725|NCT01074931|580669706|FG000|Overall Study|Death|5|||
160803726|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
160803727|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
160803728|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
160803729|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
160803730|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
160803731|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
160803732|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
160803733|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
160803734|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
160803735|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
160803736|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
160803737|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
160803738|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
160803739|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
160803740|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
160803741|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
160803742|NCT00953706|580669709|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
160803743|NCT00953706|580669710|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
160803744|NCT00953706|580669711|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
160803745|NCT00953706|580669712|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
160803746|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
160803747|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
160803748|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
160803749|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
160803750|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
160803751|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
160803752|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
160803753|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
160803754|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
160803755|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
160803756|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
160803757|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
160803758|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
160803759|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
160803760|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
160897529|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
160897530|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
160897531|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
160897532|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
160897533|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
160897534|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
160897535|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
160897536|NCT03659916|581020119|FG000|Treatment Period (72 Weeks)|Other|1|||
160897537|NCT03659916|581020120|FG001|Treatment Period (72 Weeks)|Other|3|||
160897538|NCT03659916|581020121|FG002|Treatment Period (72 Weeks)|Other|9|||
160985195|NCT01077024|581335386|FG000|Overall Study|Withdrawal by Subject|0|||
160985196|NCT01077024|581335387|FG001|Overall Study|Withdrawal by Subject|2|||
160985197|NCT01077024|581335386|FG000|Overall Study|Incarcerated|7|||
160803761|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
160803762|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
160803763|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
160803764|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
160803765|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
160803766|NCT00953706|580669709|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
160803767|NCT00953706|580669710|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
160803768|NCT00953706|580669711|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
160803769|NCT00953706|580669712|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
160803770|NCT01404234|580669713|FG000|Overall Study|Withdrawal by Subject|2|||
160803771|NCT01214837|580669714|FG000|Overall Study|Death|0|||
160803772|NCT01214837|580669715|FG001|Overall Study|Death|0|||
160803773|NCT01214837|580669716|FG002|Overall Study|Death|1|||
160803774|NCT01214837|580669714|FG000|Overall Study|Adverse Event|1|||
160803775|NCT01214837|580669715|FG001|Overall Study|Adverse Event|2|||
160803776|NCT01214837|580669716|FG002|Overall Study|Adverse Event|1|||
160803777|NCT01214837|580669714|FG000|Overall Study|Withdrawal by Subject|27|||
160803778|NCT01214837|580669715|FG001|Overall Study|Withdrawal by Subject|36|||
160803779|NCT01214837|580669716|FG002|Overall Study|Withdrawal by Subject|28|||
160803780|NCT01214837|580669714|FG000|Overall Study|Lost to Follow-up|20|||
160803781|NCT01214837|580669715|FG001|Overall Study|Lost to Follow-up|15|||
160803782|NCT01214837|580669716|FG002|Overall Study|Lost to Follow-up|21|||
160803783|NCT01214837|580669714|FG000|Overall Study|Inappropriate Enrolment|0|||
160803784|NCT01214837|580669715|FG001|Overall Study|Inappropriate Enrolment|1|||
160803785|NCT01214837|580669716|FG002|Overall Study|Inappropriate Enrolment|2|||
160803786|NCT01214837|580669714|FG000|Overall Study|Administrative Reason|2|||
160803787|NCT01214837|580669715|FG001|Overall Study|Administrative Reason|6|||
160803788|NCT01214837|580669716|FG002|Overall Study|Administrative Reason|4|||
160803789|NCT01214837|580669714|FG000|Overall Study|Protocol Violation|3|||
160803790|NCT01214837|580669715|FG001|Overall Study|Protocol Violation|1|||
160803791|NCT01214837|580669716|FG002|Overall Study|Protocol Violation|5|||
160803792|NCT01214837|580669714|FG000|Overall Study|Unable to Classify|1|||
160803793|NCT01214837|580669715|FG001|Overall Study|Unable to Classify|3|||
160803794|NCT01214837|580669716|FG002|Overall Study|Unable to Classify|0|||
160803795|NCT04790279|580671761|FG000|Overall Study|Did not meet medication start criteria|27|||
160803796|NCT04790279|580671762|FG001|Overall Study|Did not meet medication start criteria|15|||
160803797|NCT04790279|580671761|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
160803798|NCT04790279|580671762|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
160803799|NCT04790279|580671761|FG000|Overall Study|Protocol Violation|8|||
160803800|NCT04790279|580671762|FG001|Overall Study|Protocol Violation|3|||
160803801|NCT04790279|580671761|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
160803802|NCT04790279|580671762|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
160803803|NCT04776161|580671768|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
160803804|NCT04776161|580671769|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
160803805|NCT04776161|580671770|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
160803806|NCT04776161|580671768|FG000|Overall Study|Withdrawal by Subject|1|||
160803807|NCT04776161|580671769|FG001|Overall Study|Withdrawal by Subject|0|||
160803808|NCT04776161|580671770|FG002|Overall Study|Withdrawal by Subject|1|||
160803809|NCT04776161|580671768|FG000|Overall Study|Adverse Event|0|||
160803810|NCT04776161|580671769|FG001|Overall Study|Adverse Event|1|||
160803811|NCT04776161|580671770|FG002|Overall Study|Adverse Event|1|||
160803812|NCT00342628|580671771|FG000|Overall Study|Withdrawal by Subject|19|||
160803813|NCT00342628|580671772|FG001|Overall Study|Withdrawal by Subject|19|||
160803814|NCT00342628|580671773|FG002|Overall Study|Withdrawal by Subject|18|||
160803815|NCT00342628|580671771|FG000|Overall Study|Death|1|||
161129832|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161129833|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
160803816|NCT00342628|580671772|FG001|Overall Study|Death|1|||
160803817|NCT00342628|580671773|FG002|Overall Study|Death|0|||
160803818|NCT00342628|580671771|FG000|Overall Study|moved residence|0|||
160803819|NCT00342628|580671772|FG001|Overall Study|moved residence|1|||
160803820|NCT00342628|580671773|FG002|Overall Study|moved residence|1|||
160803821|NCT04551898|580671774|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
160803822|NCT04551898|580671775|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
161129834|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161129835|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
161129836|NCT01583374|581860933|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161129837|NCT01583374|581860934|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
161129838|NCT01583374|581860935|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
160803823|NCT04551898|580671776|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
160803824|NCT04551898|580671777|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
160803825|NCT04551898|580671774|FG000|Overall Study|Withdrawal by Subject|5|||
160803826|NCT04551898|580671775|FG001|Overall Study|Withdrawal by Subject|1|||
160803827|NCT04551898|580671776|FG002|Overall Study|Withdrawal by Subject|2|||
160803828|NCT04551898|580671777|FG003|Overall Study|Withdrawal by Subject|2|||
160803829|NCT04551898|580671774|FG000|Overall Study|Lost to Follow-up|2|||
160803830|NCT04551898|580671775|FG001|Overall Study|Lost to Follow-up|1|||
160803831|NCT04551898|580671776|FG002|Overall Study|Lost to Follow-up|2|||
160803832|NCT04551898|580671777|FG003|Overall Study|Lost to Follow-up|2|||
160803833|NCT04551898|580671774|FG000|Overall Study|Death|1|||
160803834|NCT04551898|580671775|FG001|Overall Study|Death|0|||
160803835|NCT04551898|580671776|FG002|Overall Study|Death|0|||
160803836|NCT04551898|580671777|FG003|Overall Study|Death|0|||
160803837|NCT04551898|580671774|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
160803838|NCT04551898|580671775|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
160803839|NCT04551898|580671776|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
160803840|NCT04551898|580671777|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
160803841|NCT01979614|580671778|FG000|Overall Study|Adverse Event|1|||
160803842|NCT01979614|580671779|FG001|Overall Study|Adverse Event|1|||
160803843|NCT01535287|580671780|FG000|Overall Study|drug not prepared in time|5|||
160803844|NCT01535287|580671781|FG001|Overall Study|drug not prepared in time|6|||
160803845|NCT00628446|580671784|FG000|Overall Study|Lost to Follow-up|3|||
160803846|NCT00628446|580671784|FG000|Overall Study|Withdrawal by Subject|1|||
160803847|NCT00628446|580671784|FG000|Overall Study|Protocol Violation|3|||
160803848|NCT04971967|580671785|FG000|Overall Study|Lost to Follow-up|6|||
160803849|NCT04971967|580671786|FG001|Overall Study|Lost to Follow-up|7|||
160803850|NCT00682929|580671789|FG000|Overall Study|Adverse Event|4|||
160803851|NCT00682929|580671790|FG001|Overall Study|Adverse Event|1|||
160803852|NCT00682929|580671791|FG002|Overall Study|Adverse Event|1|||
160803853|NCT00682929|580671789|FG000|Overall Study|Withdrawal by Subject|1|||
160803854|NCT00682929|580671790|FG001|Overall Study|Withdrawal by Subject|2|||
160803855|NCT00682929|580671791|FG002|Overall Study|Withdrawal by Subject|1|||
160803856|NCT00682929|580671789|FG000|Overall Study|dosing compliance < 80%|0|||
160803857|NCT00682929|580671790|FG001|Overall Study|dosing compliance < 80%|2|||
160803858|NCT00682929|580671791|FG002|Overall Study|dosing compliance < 80%|0|||
160803859|NCT00682929|580671789|FG000|Overall Study|lag in DEA renewal|1|||
160803860|NCT00682929|580671790|FG001|Overall Study|lag in DEA renewal|0|||
160803861|NCT00682929|580671791|FG002|Overall Study|lag in DEA renewal|0|||
160803862|NCT00938912|580671792|FG000|Overall Study|Withdrawal by Subject|28|||
160803863|NCT00938912|580671792|FG000|Overall Study|Lost to Follow-up|4|||
160803864|NCT00938912|580671792|FG000|Overall Study|Lack of Efficacy|43|||
160803865|NCT00938912|580671792|FG000|Overall Study|Adverse event, non-fatal|24|||
160803866|NCT00938912|580671792|FG000|Overall Study|Adverse event, fatal|1|||
160803867|NCT00938912|580671792|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
160803868|NCT00938912|580671792|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
160803869|NCT00938912|580671792|FG000|Overall Study|Participant needed prohibit medication|1|||
160803870|NCT00938912|580671792|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
160803871|NCT00938912|580671792|FG000|Overall Study|Did not meet Eligibility criteria|1|||
160803872|NCT00938912|580671792|FG000|Overall Study|Participant relocated not related to AE|1|||
160803873|NCT00938912|580671792|FG000|Overall Study|Participant moved to another city|1|||
160803874|NCT00938912|580671792|FG000|Overall Study|Participant experienced break through seizures|1|||
160803875|NCT00938912|580671792|FG000|Overall Study|No longer wished to participate in the study|1|||
160803876|NCT00938912|580671792|FG000|Overall Study|Protocol Deviation|2|||
160803877|NCT00803738|580671798|FG000|Overall Study|Adverse Event|3|||
160803878|NCT00803738|580671799|FG001|Overall Study|Adverse Event|5|||
160803879|NCT00803738|580671798|FG000|Overall Study|Lost to Follow-up|4|||
160803880|NCT00803738|580671799|FG001|Overall Study|Lost to Follow-up|4|||
160803881|NCT00803738|580671798|FG000|Overall Study|Protocol Violation|18|||
160803882|NCT00803738|580671799|FG001|Overall Study|Protocol Violation|10|||
160803883|NCT00803738|580671798|FG000|Overall Study|Withdrawal by Subject|1|||
160803884|NCT00803738|580671799|FG001|Overall Study|Withdrawal by Subject|4|||
160803885|NCT00803738|580671798|FG000|Overall Study|Lack of Efficacy|10|||
160803886|NCT00803738|580671799|FG001|Overall Study|Lack of Efficacy|16|||
160803887|NCT00803738|580671798|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
160803888|NCT00803738|580671799|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
160803889|NCT00803738|580671798|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
160803890|NCT00803738|580671799|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
160803891|NCT01048242|580671800|FG000|Overall Study|See study flow chart|4|||
160803892|NCT01048242|580671801|FG001|Overall Study|See study flow chart|2|||
160803893|NCT02964273|580671802|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
160803894|NCT02964273|580671803|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
160803895|NCT02964273|580671804|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
160803896|NCT02964273|580671805|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
160803897|NCT02964273|580671802|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
160803898|NCT02964273|580671803|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
160803899|NCT02964273|580671804|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
160803900|NCT02964273|580671805|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
160803901|NCT02964273|580671802|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
160803902|NCT02964273|580671803|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
160803903|NCT02964273|580671804|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
160803904|NCT02964273|580671805|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
160803905|NCT02964273|580671802|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
160803906|NCT02964273|580671803|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
160803907|NCT02964273|580671804|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
160803908|NCT02964273|580671805|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
160803909|NCT02964273|580671802|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
160803910|NCT02964273|580671803|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
160803911|NCT02964273|580671804|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
160803912|NCT02964273|580671805|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
160803913|NCT02964273|580671802|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
160803914|NCT02964273|580671803|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
160803915|NCT02964273|580671804|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
160803916|NCT02964273|580671805|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
160803917|NCT01772550|580671806|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
160803918|NCT01772550|580671807|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
160803919|NCT01772550|580671808|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
160803920|NCT01772550|580671806|FG000|Overall Study|Adverse Event|0|||
160803921|NCT01772550|580671807|FG001|Overall Study|Adverse Event|0|||
160803922|NCT01772550|580671808|FG002|Overall Study|Adverse Event|1|||
160803923|NCT00559104|580671810|FG000|Overall Study|Lack of Efficacy|9|||
160803924|NCT00559104|580671811|FG001|Overall Study|Lack of Efficacy|0|||
160803925|NCT01815424|580671812|FG000|Week 0 to 16|Adverse Event|1|||
160803926|NCT01815424|580671813|FG001|Week 0 to 16|Adverse Event|3|||
160803927|NCT01815424|580671814|FG002|Week 0 to 16|Adverse Event|3|||
160803928|NCT01815424|580671815|FG003|Week 0 to 16|Adverse Event|0|||
160803929|NCT01815424|580671816|FG004|Week 0 to 16|Adverse Event|0|||
160803930|NCT01815424|580671812|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
160803931|NCT01815424|580671813|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803932|NCT01815424|580671814|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803933|NCT01815424|580671815|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803934|NCT01815424|580671816|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
160803935|NCT01815424|580671812|FG000|Week 0 to 16|Lost to Follow-up|0|||
160803936|NCT01815424|580671813|FG001|Week 0 to 16|Lost to Follow-up|1|||
160803937|NCT01815424|580671814|FG002|Week 0 to 16|Lost to Follow-up|0|||
160803938|NCT01815424|580671815|FG003|Week 0 to 16|Lost to Follow-up|0|||
160803939|NCT01815424|580671816|FG004|Week 0 to 16|Lost to Follow-up|0|||
160803940|NCT01815424|580671812|FG000|Week 0 to 16|Withdrawal by Subject|0|||
160803941|NCT01815424|580671813|FG001|Week 0 to 16|Withdrawal by Subject|0|||
160803942|NCT01815424|580671814|FG002|Week 0 to 16|Withdrawal by Subject|1|||
160803943|NCT01815424|580671815|FG003|Week 0 to 16|Withdrawal by Subject|0|||
160803944|NCT01815424|580671816|FG004|Week 0 to 16|Withdrawal by Subject|0|||
160803945|NCT01815424|580671812|FG000|Week 0 to 16|Other|1|||
160803946|NCT01815424|580671813|FG001|Week 0 to 16|Other|0|||
160803947|NCT01815424|580671814|FG002|Week 0 to 16|Other|3|||
160803948|NCT01815424|580671815|FG003|Week 0 to 16|Other|0|||
160803949|NCT01815424|580671816|FG004|Week 0 to 16|Other|0|||
160803950|NCT01815424|580671812|FG000|Week 0 to 16|Protocol Violation|1|||
160803951|NCT01815424|580671813|FG001|Week 0 to 16|Protocol Violation|0|||
160803952|NCT01815424|580671814|FG002|Week 0 to 16|Protocol Violation|0|||
160803953|NCT01815424|580671815|FG003|Week 0 to 16|Protocol Violation|0|||
160897539|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
160897540|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
160803954|NCT01815424|580671816|FG004|Week 0 to 16|Protocol Violation|0|||
160803955|NCT01815424|580671812|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
160803956|NCT01815424|580671813|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
160897541|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
160897542|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
160897543|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
160897544|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
160897545|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
160897546|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
160897547|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
160985198|NCT01077024|581335387|FG001|Overall Study|Incarcerated|8|||
160803957|NCT01815424|580671814|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
160803958|NCT01815424|580671815|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
160803959|NCT01815424|580671816|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
160985199|NCT01077024|581335386|FG000|Overall Study|Other|4|||
160985200|NCT01077024|581335387|FG001|Overall Study|Other|4|||
160985201|NCT02034435|581335388|FG000|Overall Study|Withdrawal by Subject|1|||
160985202|NCT02034435|581335389|FG001|Overall Study|Withdrawal by Subject|0|||
160985203|NCT02034435|581335390|FG002|Overall Study|Withdrawal by Subject|0|||
160985204|NCT02034435|581335391|FG003|Overall Study|Withdrawal by Subject|0|||
160985205|NCT02034435|581335388|FG000|Overall Study|Illness|0|||
160985206|NCT02034435|581335389|FG001|Overall Study|Illness|2|||
160985207|NCT02034435|581335390|FG002|Overall Study|Illness|0|||
160985208|NCT02034435|581335391|FG003|Overall Study|Illness|0|||
161237446|NCT01705574|582250162|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
161237447|NCT01705574|582250159|FG000|Open-Label Extension Phase|Adverse Event|3|||
161237448|NCT01705574|582250160|FG001|Open-Label Extension Phase|Adverse Event|0|||
160985209|NCT02034435|581335388|FG000|Overall Study|Inadequate IV access|1|||
161237449|NCT01705574|582250161|FG002|Open-Label Extension Phase|Adverse Event|0|||
161237450|NCT01705574|582250162|FG003|Open-Label Extension Phase|Adverse Event|1|||
161237451|NCT01705574|582250159|FG000|Open-Label Extension Phase|Death|2|||
161237452|NCT01705574|582250160|FG001|Open-Label Extension Phase|Death|0|||
161237453|NCT01705574|582250161|FG002|Open-Label Extension Phase|Death|1|||
161237454|NCT01705574|582250162|FG003|Open-Label Extension Phase|Death|0|||
161237455|NCT01705574|582250159|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161237456|NCT01705574|582250160|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161237457|NCT01705574|582250161|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
161237458|NCT01705574|582250162|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
161237459|NCT01705574|582250159|FG000|Open-Label Extension Phase|Physician Decision|0|||
161237460|NCT01705574|582250160|FG001|Open-Label Extension Phase|Physician Decision|0|||
161237461|NCT01705574|582250161|FG002|Open-Label Extension Phase|Physician Decision|2|||
161237462|NCT01705574|582250162|FG003|Open-Label Extension Phase|Physician Decision|0|||
161237463|NCT01705574|582250159|FG000|Open-Label Extension Phase|Pregnancy|0|||
161237464|NCT01705574|582250160|FG001|Open-Label Extension Phase|Pregnancy|0|||
161237465|NCT01705574|582250161|FG002|Open-Label Extension Phase|Pregnancy|1|||
161237466|NCT01705574|582250162|FG003|Open-Label Extension Phase|Pregnancy|1|||
161237467|NCT02659150|582250163|FG000|Subject Enrollment|Physician Decision|3|||
161237468|NCT02659150|582250163|FG000|Subject Enrollment|Withdrawal by Subject|2|||
161237469|NCT02659150|582250163|FG000|Baseline Imaging|Withdrawal by Subject|1|||
161237470|NCT02659150|582250163|FG000|Baseline Imaging|Physician Decision|1|||
161237471|NCT02659150|582250163|FG000|Study Drug Dosing|Adverse Event|1|||
161237472|NCT02678286|582250164|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
161237473|NCT02678286|582250165|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
161237474|NCT02678286|582250164|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
161237475|NCT02678286|582250165|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
161237476|NCT02678286|582250164|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
161237477|NCT02678286|582250165|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
161237478|NCT02678286|582250164|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
161237479|NCT02678286|582250165|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
161237480|NCT02678286|582250164|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
161237481|NCT02678286|582250165|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
161237482|NCT02909907|582250166|FG000|Overall Study|Withdrawal by Subject|0|||
161237483|NCT02909907|582250167|FG001|Overall Study|Withdrawal by Subject|1|||
161237484|NCT02902211|582250168|FG000|First Three Months|Withdrawal by Subject|7|||
161237485|NCT02902211|582250169|FG001|First Three Months|Withdrawal by Subject|3|||
161237486|NCT03098394|582250177|FG000|Overall Study|Pregnancy|0|||
161237487|NCT03098394|582250178|FG001|Overall Study|Pregnancy|1|||
161237488|NCT04408794|582250179|FG000|Overall Study|Adverse Event|43|||
161237489|NCT04408794|582250179|FG000|Overall Study|Infrequent study drug usage|43|||
161237490|NCT04408794|582250179|FG000|Overall Study|Lack of Efficacy|61|||
161237491|NCT04408794|582250179|FG000|Overall Study|Lost to Follow-up|33|||
161237492|NCT04408794|582250179|FG000|Overall Study|Non-compliance|6|||
161237493|NCT04408794|582250179|FG000|Overall Study|Physician Decision|1|||
161237494|NCT04408794|582250179|FG000|Overall Study|Pregnancy|6|||
161237495|NCT04408794|582250179|FG000|Overall Study|Protocol Deviation|9|||
161237496|NCT04408794|582250179|FG000|Overall Study|Sheehan-STS Result|1|||
161237497|NCT04408794|582250179|FG000|Overall Study|Withdrawal by Subject|57|||
161237498|NCT04408794|582250179|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
161237499|NCT04408794|582250179|FG000|Overall Study|Never Treated Migraine|5|||
161237500|NCT02159950|582250186|FG000|Overall Study|Adverse Event|0|||
161237501|NCT02159950|582250187|FG001|Overall Study|Adverse Event|1|||
161237502|NCT02159950|582250186|FG000|Overall Study|Progression|0|||
161237503|NCT02159950|582250187|FG001|Overall Study|Progression|1|||
161237504|NCT03872128|582250190|FG000|Overall Study|Dropped out before treatment|1|||
161237505|NCT03872128|582250191|FG001|Overall Study|Dropped out before treatment|0|||
160985210|NCT02034435|581335389|FG001|Overall Study|Inadequate IV access|0|||
161237506|NCT03872128|582250192|FG002|Overall Study|Dropped out before treatment|4|||
161237507|NCT03872128|582250190|FG000|Overall Study|Lost to Follow-up|2|||
161237508|NCT03872128|582250191|FG001|Overall Study|Lost to Follow-up|5|||
160803960|NCT01815424|580671812|FG000|Week 16 to 52|Other|0|||
160803961|NCT01815424|580671813|FG001|Week 16 to 52|Other|1|||
160803962|NCT01815424|580671814|FG002|Week 16 to 52|Other|0|||
160803963|NCT01815424|580671815|FG003|Week 16 to 52|Other|0|||
160803964|NCT01815424|580671816|FG004|Week 16 to 52|Other|0|||
160803965|NCT01815424|580671812|FG000|Week 16 to 52|Adverse Event|0|||
160803966|NCT01815424|580671813|FG001|Week 16 to 52|Adverse Event|0|||
160803967|NCT01815424|580671814|FG002|Week 16 to 52|Adverse Event|0|||
160803968|NCT01815424|580671815|FG003|Week 16 to 52|Adverse Event|0|||
160803969|NCT01815424|580671816|FG004|Week 16 to 52|Adverse Event|1|||
160803970|NCT01815424|580671812|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
160803971|NCT01815424|580671813|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
160803972|NCT01815424|580671814|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
160803973|NCT01815424|580671815|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
161237509|NCT03872128|582250192|FG002|Overall Study|Lost to Follow-up|8|||
161237510|NCT04400890|582250197|FG000|Overall Study|Withdrawal by Subject|3|||
161237511|NCT04400890|582250198|FG001|Overall Study|Withdrawal by Subject|2|||
161237512|NCT03925532|582250199|FG000|Overall Study|Lost to Follow-up|1|||
161237513|NCT02258074|582250200|FG000|Overall Study|Withdrawal by Subject|1|||
161237514|NCT02258074|582250201|FG001|Overall Study|Withdrawal by Subject|0|||
161237515|NCT02258074|582250202|FG002|Overall Study|Withdrawal by Subject|0|||
161237516|NCT02258074|582250203|FG003|Overall Study|Withdrawal by Subject|0|||
161237517|NCT05446870|582250204|FG000|Overall Study|Death|6|||
161237518|NCT05446870|582250205|FG001|Overall Study|Death|5|||
161237519|NCT05446870|582250204|FG000|Overall Study|Lost to Follow-up|0|||
160803974|NCT01815424|580671816|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
160803975|NCT01815424|580671812|FG000|Week 16 to 52|Lost to Follow-up|0|||
160803976|NCT01815424|580671813|FG001|Week 16 to 52|Lost to Follow-up|2|||
160897548|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
160897549|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
160897550|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
160897551|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
160897552|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
160897553|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
160897554|NCT03659916|581020119|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
160897555|NCT03659916|581020120|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
160897556|NCT03659916|581020121|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
160897557|NCT04941456|581020122|FG000|Overall Study|Withdrawal by Subject|1|||
160897558|NCT04941456|581020123|FG001|Overall Study|Withdrawal by Subject|0|||
160897559|NCT04941456|581020122|FG000|Overall Study|Protocol Violation|1|||
160897560|NCT04941456|581020123|FG001|Overall Study|Protocol Violation|0|||
160897561|NCT01555983|581020124|FG000|Overall Study|Withdrawal by Subject|1|||
160897562|NCT01555983|581020125|FG001|Overall Study|Withdrawal by Subject|0|||
160897563|NCT01555983|581020126|FG002|Overall Study|Withdrawal by Subject|0|||
160897564|NCT01555983|581020127|FG003|Overall Study|Withdrawal by Subject|0|||
160897565|NCT01555983|581020128|FG004|Overall Study|Withdrawal by Subject|1|||
160897566|NCT01555983|581020129|FG005|Overall Study|Withdrawal by Subject|1|||
160897567|NCT04026711|581020130|FG000|Overall Study|Withdrawal by Subject|1|||
160897568|NCT04026711|581020131|FG001|Overall Study|Withdrawal by Subject|0|||
160897569|NCT04026711|581020130|FG000|Overall Study|mental health crisis|1|||
160897570|NCT04026711|581020131|FG001|Overall Study|mental health crisis|0|||
160897571|NCT05985395|581020137|FG000|Overall Study|Physician Decision|2|||
160897572|NCT05985395|581020138|FG001|Overall Study|Physician Decision|1|||
160897573|NCT05985395|581020137|FG000|Overall Study|Withdrawal by Subject|1|||
160897574|NCT05985395|581020138|FG001|Overall Study|Withdrawal by Subject|0|||
160897575|NCT04823650|581020139|FG000|Overall Study|Withdrawal by Subject|0|||
160897576|NCT04823650|581020140|FG001|Overall Study|Withdrawal by Subject|0|||
160897577|NCT04823650|581020141|FG002|Overall Study|Withdrawal by Subject|0|||
160897578|NCT04823650|581020142|FG003|Overall Study|Withdrawal by Subject|0|||
160897579|NCT04823650|581020143|FG004|Overall Study|Withdrawal by Subject|1|||
160897580|NCT04823650|581020144|FG005|Overall Study|Withdrawal by Subject|0|||
160897581|NCT04063384|581021370|FG000|Overall Study|placebo manipulation issue|1|||
161237520|NCT05446870|582250205|FG001|Overall Study|Lost to Follow-up|1|||
161237521|NCT05446870|582250204|FG000|Overall Study|Physician Decision|52|||
160803977|NCT01815424|580671814|FG002|Week 16 to 52|Lost to Follow-up|0|||
160803978|NCT01815424|580671815|FG003|Week 16 to 52|Lost to Follow-up|2|||
160803979|NCT01815424|580671816|FG004|Week 16 to 52|Lost to Follow-up|1|||
160897582|NCT04063384|581021371|FG001|Overall Study|placebo manipulation issue|2|||
160897583|NCT04063384|581021372|FG002|Overall Study|placebo manipulation issue|1|||
160897584|NCT04063384|581021373|FG003|Overall Study|placebo manipulation issue|1|||
160897585|NCT01823146|581021380|FG000|Overall Study|Withdrawal by Subject|0|||
161237522|NCT05446870|582250205|FG001|Overall Study|Physician Decision|53|||
161237523|NCT05446870|582250204|FG000|Overall Study|Withdrawal by Subject|3|||
160803980|NCT01815424|580671812|FG000|Week 16 to 52|Withdrawal by Subject|1|||
160803981|NCT01815424|580671813|FG001|Week 16 to 52|Withdrawal by Subject|2|||
160803982|NCT01815424|580671814|FG002|Week 16 to 52|Withdrawal by Subject|0|||
160803983|NCT01815424|580671815|FG003|Week 16 to 52|Withdrawal by Subject|0|||
160803984|NCT01815424|580671816|FG004|Week 16 to 52|Withdrawal by Subject|0|||
160803985|NCT01309204|580671817|FG000|Overall Study|Adverse Event|48|||
160803986|NCT01309204|580671818|FG001|Overall Study|Adverse Event|58|||
160803987|NCT01309204|580671817|FG000|Overall Study|Lost to Follow-up|2|||
160803988|NCT01309204|580671818|FG001|Overall Study|Lost to Follow-up|2|||
160803989|NCT01309204|580671817|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
160803990|NCT01309204|580671818|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
160803991|NCT01309204|580671817|FG000|Overall Study|Inadequate control of IOP|4|||
160803992|NCT01309204|580671818|FG001|Overall Study|Inadequate control of IOP|4|||
160803993|NCT01309204|580671817|FG000|Overall Study|Other|4|||
160803994|NCT01309204|580671818|FG001|Overall Study|Other|1|||
160803995|NCT04723355|580671819|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
160803996|NCT04723355|580671819|FG000|Overall Study|Errors in the informed consent form|2|||
160803997|NCT03374358|580671821|FG000|Overall Study|Withdrawal by Subject|0|||
160803998|NCT03374358|580671822|FG001|Overall Study|Withdrawal by Subject|2|||
160803999|NCT01127633|580671823|FG000|Overall Study|Adverse Event|74|||
160804000|NCT01127633|580671824|FG001|Overall Study|Adverse Event|73|||
160804001|NCT01127633|580671823|FG000|Overall Study|Death|40|||
160804002|NCT01127633|580671824|FG001|Overall Study|Death|43|||
160804003|NCT01127633|580671823|FG000|Overall Study|Lost to Follow-up|4|||
160804004|NCT01127633|580671824|FG001|Overall Study|Lost to Follow-up|0|||
160804005|NCT01127633|580671823|FG000|Overall Study|Parent/Caregiver Decision|246|||
160804006|NCT01127633|580671824|FG001|Overall Study|Parent/Caregiver Decision|228|||
160804007|NCT01127633|580671823|FG000|Overall Study|Physician Decision|60|||
160804008|NCT01127633|580671824|FG001|Overall Study|Physician Decision|45|||
160804009|NCT01127633|580671823|FG000|Overall Study|Withdrawal by Subject|57|||
160804010|NCT01127633|580671824|FG001|Overall Study|Withdrawal by Subject|72|||
160804011|NCT01127633|580671823|FG000|Overall Study|Sponsor Decision|163|||
160804012|NCT01127633|580671824|FG001|Overall Study|Sponsor Decision|195|||
160804013|NCT01127633|580671823|FG000|Overall Study|Protocol Violation|8|||
160804014|NCT01127633|580671824|FG001|Overall Study|Protocol Violation|16|||
160804015|NCT01127633|580671823|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
160804016|NCT01127633|580671824|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
160804017|NCT01127633|580671823|FG000|Overall Study|Not treated|1|||
160804018|NCT01127633|580671824|FG001|Overall Study|Not treated|0|||
160804019|NCT03432494|580671826|FG000|Overall Study|Death|1|||
160804020|NCT03432494|580671826|FG000|Overall Study|Noncompliance|1|||
160804021|NCT00775268|580671827|FG000|Baseline|Drug not synthesize dose|1|||
160804022|NCT00775268|580671828|FG001|Baseline|Drug not synthesize dose|0|||
160804023|NCT00775268|580671827|FG000|Baseline|Not treated-ineligible per CT|0|||
160804024|NCT00775268|580671828|FG001|Baseline|Not treated-ineligible per CT|1|||
160804025|NCT00775268|580671827|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
160804026|NCT00775268|580671828|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
160804027|NCT00775268|580671827|FG000|After Completion|Participant missed scan appointment|1|||
160985211|NCT02034435|581335390|FG002|Overall Study|Inadequate IV access|0|||
160985212|NCT02034435|581335391|FG003|Overall Study|Inadequate IV access|1|||
160985213|NCT02839681|581335394|FG000|Overall Study|Death|2|||
160985214|NCT00848211|581335395|FG000|Overall Study|Protocol Violation|0|||
160985215|NCT00848211|581335396|FG001|Overall Study|Protocol Violation|1|||
160985216|NCT00848211|581335397|FG002|Overall Study|Protocol Violation|1|||
160985217|NCT00848211|581335398|FG003|Overall Study|Protocol Violation|0|||
160985218|NCT00848211|581335395|FG000|Overall Study|Adverse Event|0|||
160985219|NCT00848211|581335396|FG001|Overall Study|Adverse Event|0|||
160985220|NCT00848211|581335397|FG002|Overall Study|Adverse Event|0|||
160985221|NCT00848211|581335398|FG003|Overall Study|Adverse Event|0|||
160985222|NCT00772928|581335399|FG000|Overall Study|Lost to Follow-up|9|||
160985223|NCT00772928|581335400|FG001|Overall Study|Lost to Follow-up|6|||
160985224|NCT00772928|581335399|FG000|Overall Study|Protocol Violation|10|||
160804028|NCT00775268|580671828|FG001|After Completion|Participant missed scan appointment|0|||
160804029|NCT04263766|580671829|FG000|Overall Study|Withdrawal by Subject|6|||
160804030|NCT04263766|580671830|FG001|Overall Study|Withdrawal by Subject|4|||
160804031|NCT04263766|580671829|FG000|Overall Study|Lack of Efficacy|1|||
160804032|NCT04263766|580671830|FG001|Overall Study|Lack of Efficacy|3|||
160804033|NCT04232943|580671831|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
160804034|NCT04232943|580671832|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
160985225|NCT00772928|581335400|FG001|Overall Study|Protocol Violation|12|||
160985226|NCT00772928|581335399|FG000|Overall Study|Withdrawal by Subject|25|||
160804035|NCT04232943|580671833|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
160985227|NCT00772928|581335400|FG001|Overall Study|Withdrawal by Subject|22|||
160985228|NCT00772928|581335399|FG000|Overall Study|Did not receive vaccine|0|||
160804036|NCT04232943|580671831|FG000|Overall Study|Withdrawal by Subject|1|||
160804037|NCT04232943|580671832|FG001|Overall Study|Withdrawal by Subject|1|||
160804038|NCT04232943|580671833|FG002|Overall Study|Withdrawal by Subject|0|||
160804039|NCT00573391|580671839|FG000|Overall Study|study stopped|2|||
160985229|NCT00772928|581335400|FG001|Overall Study|Did not receive vaccine|1|||
160804040|NCT00573391|580671840|FG001|Overall Study|study stopped|2|||
160804041|NCT00573391|580671839|FG000|Overall Study|Death|1|||
160804042|NCT00573391|580671840|FG001|Overall Study|Death|0|||
160804043|NCT03896477|580671841|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
160804044|NCT03896477|580671842|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
160804045|NCT03896477|580671843|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
160804046|NCT03896477|580671841|FG000|Overall Study|Parent Requested Withdrawal|8|||
160804047|NCT03896477|580671842|FG001|Overall Study|Parent Requested Withdrawal|12|||
160804048|NCT03896477|580671843|FG002|Overall Study|Parent Requested Withdrawal|9|||
160804049|NCT03896477|580671841|FG000|Overall Study|Adverse Event|0|||
160804050|NCT03896477|580671842|FG001|Overall Study|Adverse Event|0|||
160804051|NCT03896477|580671843|FG002|Overall Study|Adverse Event|1|||
160804052|NCT03896477|580671841|FG000|Overall Study|Death|1|||
160804053|NCT03896477|580671842|FG001|Overall Study|Death|0|||
160804054|NCT03896477|580671843|FG002|Overall Study|Death|0|||
160804055|NCT03896477|580671841|FG000|Overall Study|Other|5|||
160804056|NCT03896477|580671842|FG001|Overall Study|Other|6|||
160804057|NCT03896477|580671843|FG002|Overall Study|Other|7|||
160804058|NCT03896477|580671841|FG000|Overall Study|Lost to Follow-up|2|||
160804059|NCT03896477|580671842|FG001|Overall Study|Lost to Follow-up|1|||
160804060|NCT03896477|580671843|FG002|Overall Study|Lost to Follow-up|1|||
160804061|NCT00400517|580671844|FG000|Overall Study|Withdrawal by Subject|1|||
160804062|NCT00400517|580671844|FG000|Overall Study|Physician Decision|1|||
160804063|NCT01106157|580671845|FG000|Overall Study|Withdrawal by Subject|1|||
160804064|NCT01106157|580671846|FG001|Overall Study|Withdrawal by Subject|0|||
160804065|NCT01118780|580671848|FG000|Overall Study|Adverse Event|15|||
160804066|NCT01118780|580671849|FG001|Overall Study|Adverse Event|15|||
160804067|NCT01118780|580671848|FG000|Overall Study|Death|1|||
160804068|NCT01118780|580671849|FG001|Overall Study|Death|0|||
160804069|NCT01118780|580671848|FG000|Overall Study|Lack of Efficacy|2|||
160804070|NCT01118780|580671849|FG001|Overall Study|Lack of Efficacy|6|||
160804071|NCT01118780|580671848|FG000|Overall Study|Physician Decision|2|||
160804072|NCT01118780|580671849|FG001|Overall Study|Physician Decision|0|||
160804073|NCT01118780|580671848|FG000|Overall Study|Protocol Violation|3|||
160804074|NCT01118780|580671849|FG001|Overall Study|Protocol Violation|6|||
160804075|NCT01118780|580671848|FG000|Overall Study|Withdrawal by Subject|13|||
160804076|NCT01118780|580671849|FG001|Overall Study|Withdrawal by Subject|8|||
160804077|NCT05518461|580671850|FG000|Overall Study|Lost to Follow-up|25|||
160804078|NCT03962855|580671851|FG000|Overall Study|Death|0|||
160804079|NCT03962855|580671852|FG001|Overall Study|Death|1|||
160804080|NCT03962855|580671851|FG000|Overall Study|Lost to Follow-up|0|||
160804081|NCT03962855|580671852|FG001|Overall Study|Lost to Follow-up|1|||
160804082|NCT03962855|580671851|FG000|Overall Study|Adverse Event|0|||
160804083|NCT03962855|580671852|FG001|Overall Study|Adverse Event|1|||
160804084|NCT03962855|580671851|FG000|Overall Study|Physician Decision|0|||
160804085|NCT03962855|580671852|FG001|Overall Study|Physician Decision|2|||
160804086|NCT02750514|580671854|FG000|Track 1|Disease progression|20|||
160804087|NCT02750514|580671855|FG001|Track 1|Disease progression|1|||
160804088|NCT02750514|580671856|FG002|Track 1|Disease progression|0|||
160804089|NCT02750514|580671857|FG003|Track 1|Disease progression|1|||
160804090|NCT02750514|580671858|FG004|Track 1|Disease progression|0|||
160804091|NCT02750514|580671854|FG000|Track 1|Adverse event unrelated to study drug|1|||
160804092|NCT02750514|580671855|FG001|Track 1|Adverse event unrelated to study drug|0|||
160804093|NCT02750514|580671856|FG002|Track 1|Adverse event unrelated to study drug|0|||
160804094|NCT02750514|580671857|FG003|Track 1|Adverse event unrelated to study drug|0|||
160804095|NCT02750514|580671858|FG004|Track 1|Adverse event unrelated to study drug|0|||
160804096|NCT02750514|580671854|FG000|Track 1|Study drug toxicity|4|||
160804097|NCT02750514|580671855|FG001|Track 1|Study drug toxicity|1|||
160804098|NCT02750514|580671856|FG002|Track 1|Study drug toxicity|0|||
160804099|NCT02750514|580671857|FG003|Track 1|Study drug toxicity|1|||
160897586|NCT01823146|581021381|FG001|Overall Study|Withdrawal by Subject|1|||
160897587|NCT01823146|581021380|FG000|Overall Study|Lost to Follow-up|2|||
160897588|NCT01823146|581021381|FG001|Overall Study|Lost to Follow-up|1|||
160897589|NCT01788046|581021382|FG000|Overall Study|Withdrawal by Subject|12|||
160897590|NCT01788046|581021383|FG001|Overall Study|Withdrawal by Subject|12|||
160897591|NCT01788046|581021382|FG000|Overall Study|Lost to Follow-up|12|||
160897592|NCT01788046|581021383|FG001|Overall Study|Lost to Follow-up|19|||
160985230|NCT03100838|581335401|FG000|Overall Study|Adverse Event|1|||
160804100|NCT02750514|580671858|FG004|Track 1|Study drug toxicity|0|||
160804101|NCT02750514|580671854|FG000|Track 1|Participant request to discontinue|1|||
160804102|NCT02750514|580671855|FG001|Track 1|Participant request to discontinue|0|||
160804103|NCT02750514|580671856|FG002|Track 1|Participant request to discontinue|0|||
160804104|NCT02750514|580671857|FG003|Track 1|Participant request to discontinue|0|||
160804105|NCT02750514|580671858|FG004|Track 1|Participant request to discontinue|0|||
160804106|NCT02750514|580671854|FG000|Track 1|Other reasons|1|||
160804107|NCT02750514|580671855|FG001|Track 1|Other reasons|0|||
160804108|NCT02750514|580671856|FG002|Track 1|Other reasons|0|||
160804109|NCT02750514|580671857|FG003|Track 1|Other reasons|0|||
160897593|NCT01788046|581021382|FG000|Overall Study|Death|7|||
160985231|NCT03100838|581335402|FG001|Overall Study|Adverse Event|0|||
160985232|NCT03100838|581335403|FG002|Overall Study|Adverse Event|0|||
160985233|NCT03100838|581335404|FG003|Overall Study|Adverse Event|0|||
160985234|NCT03100838|581335401|FG000|Overall Study|Physician Decision|1|||
160985235|NCT03100838|581335402|FG001|Overall Study|Physician Decision|1|||
160985236|NCT03100838|581335403|FG002|Overall Study|Physician Decision|1|||
160985237|NCT03100838|581335404|FG003|Overall Study|Physician Decision|1|||
160804110|NCT02750514|580671858|FG004|Track 1|Other reasons|0|||
160804111|NCT02750514|580671854|FG000|Track 2|Disease progression|4|||
160804112|NCT02750514|580671855|FG001|Track 2|Disease progression|5|||
160804113|NCT02750514|580671856|FG002|Track 2|Disease progression|2|||
160804114|NCT02750514|580671857|FG003|Track 2|Disease progression|5|||
160804115|NCT02750514|580671858|FG004|Track 2|Disease progression|0|||
160804116|NCT02750514|580671854|FG000|Track 2|Adverse event unrelated to study drug|1|||
160804117|NCT02750514|580671855|FG001|Track 2|Adverse event unrelated to study drug|0|||
160804118|NCT02750514|580671856|FG002|Track 2|Adverse event unrelated to study drug|0|||
160804119|NCT02750514|580671857|FG003|Track 2|Adverse event unrelated to study drug|0|||
160804120|NCT02750514|580671858|FG004|Track 2|Adverse event unrelated to study drug|0|||
160804121|NCT02750514|580671854|FG000|Track 2|Study drug toxicity|1|||
160804122|NCT02750514|580671855|FG001|Track 2|Study drug toxicity|2|||
160804123|NCT02750514|580671856|FG002|Track 2|Study drug toxicity|0|||
160804124|NCT02750514|580671857|FG003|Track 2|Study drug toxicity|2|||
160804125|NCT02750514|580671858|FG004|Track 2|Study drug toxicity|0|||
160804126|NCT02750514|580671854|FG000|Track 2|Participant withdrew consent|0|||
160804127|NCT02750514|580671855|FG001|Track 2|Participant withdrew consent|1|||
160804128|NCT02750514|580671856|FG002|Track 2|Participant withdrew consent|0|||
160804129|NCT02750514|580671857|FG003|Track 2|Participant withdrew consent|0|||
160804130|NCT02750514|580671858|FG004|Track 2|Participant withdrew consent|0|||
160804131|NCT02750514|580671854|FG000|Track 3|Disease progression|0|||
160804132|NCT02750514|580671855|FG001|Track 3|Disease progression|24|||
160804133|NCT02750514|580671856|FG002|Track 3|Disease progression|13|||
160804134|NCT02750514|580671857|FG003|Track 3|Disease progression|14|||
160804135|NCT02750514|580671858|FG004|Track 3|Disease progression|0|||
160804136|NCT02750514|580671854|FG000|Track 3|Adverse event unrelated to study drug|0|||
160804137|NCT02750514|580671855|FG001|Track 3|Adverse event unrelated to study drug|1|||
160804138|NCT02750514|580671856|FG002|Track 3|Adverse event unrelated to study drug|1|||
160804139|NCT02750514|580671857|FG003|Track 3|Adverse event unrelated to study drug|1|||
160804140|NCT02750514|580671858|FG004|Track 3|Adverse event unrelated to study drug|0|||
160985238|NCT03100838|581335401|FG000|Overall Study|Pregnancy|0|||
160985239|NCT03100838|581335402|FG001|Overall Study|Pregnancy|1|||
160985240|NCT03100838|581335403|FG002|Overall Study|Pregnancy|0|||
160985241|NCT03100838|581335404|FG003|Overall Study|Pregnancy|0|||
160985242|NCT03100838|581335401|FG000|Overall Study|Lost to Follow-up|0|||
160985243|NCT03100838|581335402|FG001|Overall Study|Lost to Follow-up|0|||
160985244|NCT03100838|581335403|FG002|Overall Study|Lost to Follow-up|1|||
160985245|NCT03100838|581335404|FG003|Overall Study|Lost to Follow-up|0|||
160985246|NCT00801242|581335408|FG000|Overall Study|Adverse Event|10|||
160985247|NCT00801242|581335408|FG000|Overall Study|Withdrawal by Subject|13|||
160985248|NCT00801242|581335408|FG000|Overall Study|Protocol Violation|5|||
160985249|NCT00801242|581335408|FG000|Overall Study|Physician Decision|3|||
160985250|NCT00801242|581335408|FG000|Overall Study|Lost to Follow-up|1|||
160985251|NCT00801242|581335408|FG000|Overall Study|Miscellaneous reasons|20|||
160985252|NCT01347645|581335409|FG000|Overall Study|Death|1|||
160985253|NCT01347645|581335410|FG001|Overall Study|Death|5|||
160985254|NCT01347645|581335411|FG002|Overall Study|Death|2|||
160985255|NCT01347645|581335412|FG003|Overall Study|Death|7|||
160985256|NCT01347645|581335413|FG004|Overall Study|Death|7|||
160985257|NCT01347645|581335409|FG000|Overall Study|Lost to Follow-up|1|||
160985258|NCT01347645|581335410|FG001|Overall Study|Lost to Follow-up|1|||
160985259|NCT01347645|581335411|FG002|Overall Study|Lost to Follow-up|0|||
160985260|NCT01347645|581335412|FG003|Overall Study|Lost to Follow-up|1|||
161129839|NCT01583374|581860936|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
160804141|NCT02750514|580671854|FG000|Track 3|Study drug toxicity|0|||
160804142|NCT02750514|580671855|FG001|Track 3|Study drug toxicity|3|||
160804143|NCT02750514|580671856|FG002|Track 3|Study drug toxicity|0|||
160985261|NCT01347645|581335413|FG004|Overall Study|Lost to Follow-up|1|||
160804144|NCT02750514|580671857|FG003|Track 3|Study drug toxicity|1|||
160804145|NCT02750514|580671858|FG004|Track 3|Study drug toxicity|0|||
160804146|NCT02750514|580671854|FG000|Track 3|Participant request to discontinue|0|||
160804147|NCT02750514|580671855|FG001|Track 3|Participant request to discontinue|2|||
160985262|NCT01347645|581335409|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
160985263|NCT01347645|581335410|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
160985264|NCT01347645|581335411|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
160804148|NCT02750514|580671856|FG002|Track 3|Participant request to discontinue|0|||
160985265|NCT01347645|581335412|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
160996828|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
161129840|NCT01583374|581860937|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
160804149|NCT02750514|580671857|FG003|Track 3|Participant request to discontinue|0|||
160804150|NCT02750514|580671858|FG004|Track 3|Participant request to discontinue|0|||
160804151|NCT02750514|580671854|FG000|Track 3|Participant withdrew consent|0|||
160804152|NCT02750514|580671855|FG001|Track 3|Participant withdrew consent|3|||
160804153|NCT02750514|580671856|FG002|Track 3|Participant withdrew consent|1|||
160804154|NCT02750514|580671857|FG003|Track 3|Participant withdrew consent|0|||
160804155|NCT02750514|580671858|FG004|Track 3|Participant withdrew consent|0|||
160804156|NCT02750514|580671854|FG000|Track 3|Other reasons|0|||
160804157|NCT02750514|580671855|FG001|Track 3|Other reasons|3|||
160804158|NCT02750514|580671856|FG002|Track 3|Other reasons|0|||
160804159|NCT02750514|580671857|FG003|Track 3|Other reasons|0|||
160804160|NCT02750514|580671858|FG004|Track 3|Other reasons|0|||
160804161|NCT02750514|580671854|FG000|Track 4|Study drug toxicity|0|||
160804162|NCT02750514|580671855|FG001|Track 4|Study drug toxicity|6|||
160804163|NCT02750514|580671856|FG002|Track 4|Study drug toxicity|0|||
160804164|NCT02750514|580671857|FG003|Track 4|Study drug toxicity|5|||
160804165|NCT02750514|580671858|FG004|Track 4|Study drug toxicity|0|||
160804166|NCT02750514|580671854|FG000|Track 4|Participant request to discontinue|0|||
160804167|NCT02750514|580671855|FG001|Track 4|Participant request to discontinue|1|||
160804168|NCT02750514|580671856|FG002|Track 4|Participant request to discontinue|0|||
161129841|NCT01583374|581860938|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161129842|NCT01583374|581860939|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
161129843|NCT01583374|581860940|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
161129844|NCT01583374|581860941|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
161129845|NCT01292057|581860942|FG000|Overall Study|Protocol Violation|1|||
161129846|NCT01292057|581860943|FG001|Overall Study|Protocol Violation|1|||
161129847|NCT01292057|581860942|FG000|Overall Study|Lost to Follow-up|1|||
161129848|NCT01292057|581860943|FG001|Overall Study|Lost to Follow-up|1|||
161129849|NCT02732951|581863280|FG000|Overall Study|Other than listed|1|||
161129850|NCT02732951|581863281|FG001|Overall Study|Other than listed|0|||
161129851|NCT02732951|581863280|FG000|Overall Study|Lost to Follow-up|0|||
161129852|NCT02732951|581863281|FG001|Overall Study|Lost to Follow-up|1|||
161129853|NCT02732951|581863280|FG000|Overall Study|Adverse Event|4|||
161129854|NCT02732951|581863281|FG001|Overall Study|Adverse Event|4|||
161129855|NCT02732951|581863280|FG000|Overall Study|Protocol Violation|0|||
161129856|NCT02732951|581863281|FG001|Overall Study|Protocol Violation|1|||
161237524|NCT05446870|582250205|FG001|Overall Study|Withdrawal by Subject|3|||
161237525|NCT04108858|582250209|FG000|Overall Study|Adverse Event|1|||
160804169|NCT02750514|580671857|FG003|Track 4|Participant request to discontinue|1|||
161237526|NCT03663179|582250212|FG000|Overall Study|Withdrawal by Subject|2|||
161237527|NCT03663179|582250213|FG001|Overall Study|Withdrawal by Subject|0|||
161237528|NCT03663179|582250212|FG000|Overall Study|Lost to Follow-up|1|||
161237529|NCT03663179|582250213|FG001|Overall Study|Lost to Follow-up|1|||
161237530|NCT03663179|582250212|FG000|Overall Study|Revealed exclusionary condition|1|||
161237531|NCT03663179|582250213|FG001|Overall Study|Revealed exclusionary condition|0|||
161237532|NCT01615198|582250214|FG000|Overall Study|Withdrawal by Subject|5|||
161237533|NCT01615198|582250215|FG001|Overall Study|Withdrawal by Subject|5|||
161237534|NCT01615198|582250214|FG000|Overall Study|Protocol deviation|1|||
161237535|NCT01615198|582250215|FG001|Overall Study|Protocol deviation|1|||
161237536|NCT01615198|582250214|FG000|Overall Study|Physician Decision|5|||
161237537|NCT01615198|582250215|FG001|Overall Study|Physician Decision|1|||
161237538|NCT01615198|582250214|FG000|Overall Study|Lost to Follow-up|1|||
161237539|NCT01615198|582250215|FG001|Overall Study|Lost to Follow-up|1|||
161237540|NCT01615198|582250214|FG000|Overall Study|Lack of Efficacy|1|||
161237541|NCT01615198|582250215|FG001|Overall Study|Lack of Efficacy|6|||
161237542|NCT01615198|582250214|FG000|Overall Study|Adverse Event|11|||
161237543|NCT01615198|582250215|FG001|Overall Study|Adverse Event|5|||
161237544|NCT01686438|582250216|FG000|Overall Study|Lost to Follow-up|8|||
160804170|NCT02750514|580671858|FG004|Track 4|Participant request to discontinue|0|||
160804171|NCT02750514|580671854|FG000|Track 4|Participant withdrew consent|0|||
161129857|NCT03658889|581863286|FG000|Overall Study|Protocol Violation|2|||
161129858|NCT03658889|581863287|FG001|Overall Study|Protocol Violation|0|||
161129859|NCT01524991|581863290|FG000|Overall Study|Adverse Event|12|||
161237545|NCT01686438|582250217|FG001|Overall Study|Lost to Follow-up|9|||
161237546|NCT01686438|582250218|FG002|Overall Study|Lost to Follow-up|10|||
161237547|NCT01686438|582250216|FG000|Overall Study|Adverse Event|0|||
160804172|NCT02750514|580671855|FG001|Track 4|Participant withdrew consent|1|||
160804173|NCT02750514|580671856|FG002|Track 4|Participant withdrew consent|0|||
161129860|NCT01524991|581863290|FG000|Overall Study|Death|1|||
161129861|NCT01524991|581863290|FG000|Overall Study|Disease ProgressionDu|17|||
160804174|NCT02750514|580671857|FG003|Track 4|Participant withdrew consent|0|||
160804175|NCT02750514|580671858|FG004|Track 4|Participant withdrew consent|0|||
161129862|NCT01524991|581863290|FG000|Overall Study|Other complicating disease|1|||
161129863|NCT01524991|581863290|FG000|Overall Study|Withdrawal by Subject|2|||
161237548|NCT01686438|582250217|FG001|Overall Study|Adverse Event|0|||
161237549|NCT01686438|582250218|FG002|Overall Study|Adverse Event|1|||
161237550|NCT01686438|582250216|FG000|Overall Study|Protocol Violation|0|||
160804176|NCT02750514|580671854|FG000|Track 4|Other reasons|0|||
160804177|NCT02750514|580671855|FG001|Track 4|Other reasons|5|||
160804178|NCT02750514|580671856|FG002|Track 4|Other reasons|0|||
160804179|NCT02750514|580671857|FG003|Track 4|Other reasons|3|||
160804180|NCT02750514|580671858|FG004|Track 4|Other reasons|0|||
160804181|NCT02750514|580671854|FG000|Track 4|Disease progression|0|||
160804182|NCT02750514|580671855|FG001|Track 4|Disease progression|33|||
160804183|NCT02750514|580671856|FG002|Track 4|Disease progression|0|||
160804184|NCT02750514|580671857|FG003|Track 4|Disease progression|32|||
160804185|NCT02750514|580671858|FG004|Track 4|Disease progression|0|||
160804186|NCT02750514|580671854|FG000|Track 4|Adverse event unrelated to study drug|0|||
160804187|NCT02750514|580671855|FG001|Track 4|Adverse event unrelated to study drug|5|||
160804188|NCT02750514|580671856|FG002|Track 4|Adverse event unrelated to study drug|0|||
160804189|NCT02750514|580671857|FG003|Track 4|Adverse event unrelated to study drug|0|||
160804190|NCT02750514|580671858|FG004|Track 4|Adverse event unrelated to study drug|0|||
160804191|NCT02750514|580671854|FG000|Track 4|Death|0|||
160804192|NCT02750514|580671855|FG001|Track 4|Death|0|||
160804193|NCT02750514|580671856|FG002|Track 4|Death|0|||
160804194|NCT02750514|580671857|FG003|Track 4|Death|1|||
160804195|NCT02750514|580671858|FG004|Track 4|Death|0|||
160804196|NCT02750514|580671854|FG000|Track 5|Disease progression|0|||
160804197|NCT02750514|580671855|FG001|Track 5|Disease progression|0|||
160804198|NCT02750514|580671856|FG002|Track 5|Disease progression|0|||
160804199|NCT02750514|580671857|FG003|Track 5|Disease progression|0|||
160804200|NCT02750514|580671858|FG004|Track 5|Disease progression|34|||
160804201|NCT02750514|580671854|FG000|Track 5|Adverse event unrelated to study drug|0|||
160804202|NCT02750514|580671855|FG001|Track 5|Adverse event unrelated to study drug|0|||
160804203|NCT02750514|580671856|FG002|Track 5|Adverse event unrelated to study drug|0|||
160804204|NCT02750514|580671857|FG003|Track 5|Adverse event unrelated to study drug|0|||
160804205|NCT02750514|580671858|FG004|Track 5|Adverse event unrelated to study drug|2|||
160804206|NCT02750514|580671854|FG000|Track 5|Study drug toxicity|0|||
160804207|NCT02750514|580671855|FG001|Track 5|Study drug toxicity|0|||
160804208|NCT02750514|580671856|FG002|Track 5|Study drug toxicity|0|||
160804209|NCT02750514|580671857|FG003|Track 5|Study drug toxicity|0|||
160804210|NCT02750514|580671858|FG004|Track 5|Study drug toxicity|2|||
160804211|NCT02750514|580671854|FG000|Track 5|Participant request to discontinue|0|||
160804212|NCT02750514|580671855|FG001|Track 5|Participant request to discontinue|0|||
160804213|NCT02750514|580671856|FG002|Track 5|Participant request to discontinue|0|||
160804214|NCT02750514|580671857|FG003|Track 5|Participant request to discontinue|0|||
160804215|NCT02750514|580671858|FG004|Track 5|Participant request to discontinue|3|||
160804216|NCT02750514|580671854|FG000|Track 5|Other reasons|0|||
160804217|NCT02750514|580671855|FG001|Track 5|Other reasons|0|||
160804218|NCT02750514|580671856|FG002|Track 5|Other reasons|0|||
160804219|NCT02750514|580671857|FG003|Track 5|Other reasons|0|||
160804220|NCT02750514|580671858|FG004|Track 5|Other reasons|2|||
160804221|NCT01882465|580671859|FG000|Period 1|Lens Discomfort|0|||
160804222|NCT01882465|580671860|FG001|Period 1|Lens Discomfort|0|||
160804223|NCT01882465|580671861|FG002|Period 1|Lens Discomfort|0|||
160804224|NCT01882465|580671862|FG003|Period 1|Lens Discomfort|1|||
160804225|NCT01882465|580671863|FG004|Period 1|Lens Discomfort|0|||
160804226|NCT01882465|580671864|FG005|Period 1|Lens Discomfort|0|||
160804227|NCT01882465|580671865|FG006|Period 1|Lens Discomfort|0|||
160804228|NCT01882465|580671859|FG000|Period 1|Withdrawal by Subject|0|||
160804229|NCT01882465|580671860|FG001|Period 1|Withdrawal by Subject|0|||
160804230|NCT01882465|580671861|FG002|Period 1|Withdrawal by Subject|0|||
160804231|NCT01882465|580671862|FG003|Period 1|Withdrawal by Subject|0|||
160804232|NCT01882465|580671863|FG004|Period 1|Withdrawal by Subject|0|||
160804233|NCT01882465|580671864|FG005|Period 1|Withdrawal by Subject|0|||
160804234|NCT01882465|580671865|FG006|Period 1|Withdrawal by Subject|1|||
160804235|NCT01882465|580671859|FG000|Period 2|Protocol Violation|0|||
160804236|NCT01882465|580671860|FG001|Period 2|Protocol Violation|0|||
160804237|NCT01882465|580671861|FG002|Period 2|Protocol Violation|0|||
160804238|NCT01882465|580671862|FG003|Period 2|Protocol Violation|0|||
160804239|NCT01882465|580671863|FG004|Period 2|Protocol Violation|1|||
160804240|NCT01882465|580671864|FG005|Period 2|Protocol Violation|0|||
160804241|NCT01882465|580671865|FG006|Period 2|Protocol Violation|0|||
160804242|NCT01824290|580671868|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
160804243|NCT01824290|580671869|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
160804244|NCT01824290|580671870|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
160804245|NCT01824290|580671871|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
160804246|NCT01824290|580671868|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
160804247|NCT01824290|580671869|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
160804248|NCT01824290|580671870|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
160804249|NCT01824290|580671871|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
160804250|NCT01824290|580671868|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
160804251|NCT01824290|580671869|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
160804252|NCT01824290|580671870|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
160804253|NCT01824290|580671871|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
161332252|NCT01249417|582603564|FG000|Treatment Phase - ITT Population|Other|0|||
161332253|NCT01249417|582603565|FG001|Treatment Phase - ITT Population|Other|0|||
161332254|NCT01249417|582603566|FG002|Treatment Phase - ITT Population|Other|1|||
161332255|NCT01249417|582603564|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
161332256|NCT01249417|582603565|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
160804254|NCT01824290|580671868|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
160804255|NCT01824290|580671869|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
160804256|NCT01824290|580671870|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
160804257|NCT01824290|580671871|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
160804258|NCT01824290|580671868|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
160804259|NCT01824290|580671869|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
160804260|NCT01824290|580671870|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
160804261|NCT01824290|580671871|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
160804262|NCT01824290|580671868|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
160804263|NCT01824290|580671869|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
160804264|NCT01824290|580671870|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
160804265|NCT01824290|580671871|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
160804266|NCT00800982|580671872|FG000|Overall Study|Lost to Follow-up|1|||
160804267|NCT00800982|580671873|FG001|Overall Study|Lost to Follow-up|2|||
160804268|NCT00800982|580671872|FG000|Overall Study|Withdrawal by Subject|0|||
160804269|NCT00800982|580671873|FG001|Overall Study|Withdrawal by Subject|1|||
160804270|NCT00800982|580671872|FG000|Overall Study|Patient moved out of state|1|||
160804271|NCT00800982|580671873|FG001|Overall Study|Patient moved out of state|0|||
160804272|NCT00527618|580671874|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
160804273|NCT00527618|580671875|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
160804274|NCT00527618|580671874|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
160804275|NCT00527618|580671875|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
160804276|NCT00527618|580671874|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
160804277|NCT00527618|580671875|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
160804278|NCT00527618|580671874|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
160804279|NCT00527618|580671875|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
160804280|NCT00527618|580671874|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
160804281|NCT00527618|580671875|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
160804282|NCT00527618|580671874|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
160804283|NCT00527618|580671875|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
160897594|NCT01788046|581021383|FG001|Overall Study|Death|5|||
160897595|NCT01788046|581021382|FG000|Overall Study|Protocol Specified Criteria|25|||
160897596|NCT01788046|581021383|FG001|Overall Study|Protocol Specified Criteria|1|||
160897597|NCT01797731|581021389|FG000|Overall Study|Didn't have proper radiographs required|3|||
160897598|NCT01797731|581021390|FG001|Overall Study|Didn't have proper radiographs required|3|||
160897599|NCT01604408|581021391|FG000|Treatment Period 1|Protocol Violation|0|||
160897600|NCT01604408|581021392|FG001|Treatment Period 1|Protocol Violation|1|||
160897601|NCT01604408|581021391|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160897602|NCT01604408|581021392|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160897603|NCT01604408|581021391|FG000|Treatment Period 2|Protocol Violation|1|||
160897604|NCT01604408|581021392|FG001|Treatment Period 2|Protocol Violation|0|||
160897605|NCT01604408|581021391|FG000|Treatment Period 2|Adverse Event|0|||
160897606|NCT01604408|581021392|FG001|Treatment Period 2|Adverse Event|1|||
160897607|NCT01604408|581021391|FG000|Treatment Period 3|Protocol Violation|1|||
160897608|NCT01604408|581021392|FG001|Treatment Period 3|Protocol Violation|1|||
160897609|NCT01604408|581021391|FG000|Treatment Period 3|Adverse Event|0|||
160897610|NCT01604408|581021392|FG001|Treatment Period 3|Adverse Event|3|||
160897611|NCT01604408|581021391|FG000|Treatment Period 3|Withdrawal by Subject|3|||
160897612|NCT01604408|581021392|FG001|Treatment Period 3|Withdrawal by Subject|1|||
160897613|NCT01604408|581021391|FG000|Treatment Period 3|Sponsor Decision|1|||
160897614|NCT01604408|581021392|FG001|Treatment Period 3|Sponsor Decision|0|||
160897615|NCT01604408|581021391|FG000|Treatment Period 4|Death|1|||
160897616|NCT01604408|581021392|FG001|Treatment Period 4|Death|0|||
160897617|NCT01604408|581021391|FG000|Treatment Period 4|Withdrawal by Subject|2|||
160897618|NCT01604408|581021392|FG001|Treatment Period 4|Withdrawal by Subject|1|||
160897619|NCT01604408|581021391|FG000|Treatment Period 4|Adverse Event|0|||
160897620|NCT01604408|581021392|FG001|Treatment Period 4|Adverse Event|1|||
160897621|NCT01604408|581021391|FG000|Treatment Period 5|Adverse Event|4|||
160897622|NCT01604408|581021392|FG001|Treatment Period 5|Adverse Event|0|||
160897623|NCT01604408|581021391|FG000|Treatment Period 6|Lost to Follow-up|0|||
160897624|NCT01604408|581021392|FG001|Treatment Period 6|Lost to Follow-up|1|||
160897625|NCT01604408|581021391|FG000|Treatment Period 6|Adverse Event|2|||
161332257|NCT01249417|582603566|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
160897626|NCT01604408|581021392|FG001|Treatment Period 6|Adverse Event|0|||
160897627|NCT01604408|581021391|FG000|Treatment Period 6|Sponsor decision|0|||
160897628|NCT01604408|581021392|FG001|Treatment Period 6|Sponsor decision|1|||
160897629|NCT01604408|581021391|FG000|Observation Period|Adverse Event|1|||
160897630|NCT01604408|581021392|FG001|Observation Period|Adverse Event|1|||
160804284|NCT01490918|580671876|FG000|Overall Study|Lost to Follow-up|2|||
160804285|NCT01490918|580671877|FG001|Overall Study|Lost to Follow-up|1|||
160804286|NCT01490918|580671878|FG002|Overall Study|Lost to Follow-up|0|||
160804287|NCT01490918|580671876|FG000|Overall Study|Withdrawal by Subject|7|||
160804288|NCT01490918|580671877|FG001|Overall Study|Withdrawal by Subject|8|||
160804289|NCT01490918|580671878|FG002|Overall Study|Withdrawal by Subject|3|||
160804290|NCT01490918|580671876|FG000|Overall Study|Adverse Event|0|||
160804291|NCT01490918|580671877|FG001|Overall Study|Adverse Event|0|||
160804292|NCT01490918|580671878|FG002|Overall Study|Adverse Event|1|||
160804293|NCT01490918|580671876|FG000|Overall Study|other cause|4|||
160804294|NCT01490918|580671877|FG001|Overall Study|other cause|5|||
160804295|NCT01490918|580671878|FG002|Overall Study|other cause|8|||
160804296|NCT02240121|580671883|FG000|Overall Study|Protocol Violation|1|||
160804297|NCT02240121|580671884|FG001|Overall Study|Protocol Violation|2|||
160804298|NCT02240121|580671883|FG000|Overall Study|Physician Decision|0|||
160804299|NCT02240121|580671884|FG001|Overall Study|Physician Decision|1|||
160804300|NCT02240121|580671883|FG000|Overall Study|Change in protocol interpretation|1|||
160804301|NCT02240121|580671884|FG001|Overall Study|Change in protocol interpretation|0|||
160897631|NCT01604408|581021391|FG000|Observation Period|Withdrawal by Subject|0|||
160897632|NCT01604408|581021392|FG001|Observation Period|Withdrawal by Subject|2|||
160897633|NCT01189604|581021396|FG000|Overall Study|Impossible to visit|0|||
160804302|NCT02240121|580671883|FG000|Overall Study|Lack of Efficacy|2|||
160804303|NCT02240121|580671884|FG001|Overall Study|Lack of Efficacy|3|||
160804304|NCT02240121|580671883|FG000|Overall Study|Site closed|1|||
160804305|NCT02240121|580671884|FG001|Overall Study|Site closed|1|||
160804306|NCT02240121|580671883|FG000|Overall Study|Pregnancy|1|||
160804307|NCT02240121|580671884|FG001|Overall Study|Pregnancy|0|||
160804308|NCT02240121|580671883|FG000|Overall Study|Adverse Event|2|||
160804309|NCT02240121|580671884|FG001|Overall Study|Adverse Event|4|||
160804310|NCT02240121|580671883|FG000|Overall Study|Withdrawal by Subject|6|||
160804311|NCT02240121|580671884|FG001|Overall Study|Withdrawal by Subject|2|||
160804312|NCT02240121|580671883|FG000|Overall Study|Lost to Follow-up|3|||
160804313|NCT02240121|580671884|FG001|Overall Study|Lost to Follow-up|4|||
160804314|NCT02240121|580671883|FG000|Overall Study|Other than specified|1|||
160804315|NCT02240121|580671884|FG001|Overall Study|Other than specified|3|||
160804316|NCT00648037|580671885|FG000|Overall Study|Not Treated|1|||
160804317|NCT00648037|580671885|FG000|Overall Study|Withdrawal by Subject|1|||
160804318|NCT00648037|580671885|FG000|Overall Study|Adverse Event|11|||
160804319|NCT00648037|580671885|FG000|Overall Study|Relapse|2|||
160804320|NCT00648037|580671885|FG000|Overall Study|Other|1|||
160804321|NCT02765399|580671896|FG000|Overall Study|Nausea|1|||
160804322|NCT02765399|580671897|FG001|Overall Study|Nausea|0|||
160804323|NCT04068922|580671898|FG000|Overall Study|Lost to Follow-up|5|||
160804324|NCT04068922|580671898|FG000|Overall Study|Withdrawal by Subject|7|||
160804325|NCT04068922|580671898|FG000|Overall Study|Adverse Event|1|||
160804326|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
160804327|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804328|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804329|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804330|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804331|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
160804332|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
160804333|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
160804334|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
160804335|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
160804336|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
160804337|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
160804338|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
160804339|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804340|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804341|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804342|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804343|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
160804344|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
160804345|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
160804346|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
160804347|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
160804348|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
160897634|NCT01189604|581021397|FG001|Overall Study|Impossible to visit|0|||
160897635|NCT01189604|581021398|FG002|Overall Study|Impossible to visit|0|||
161332258|NCT01249417|582603564|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
160804349|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
160804350|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
160804351|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
160804352|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804353|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804354|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804355|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
160804356|NCT00716274|580671904|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804357|NCT00716274|580671905|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
160804358|NCT00716274|580671906|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804359|NCT00716274|580671907|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804360|NCT00716274|580671908|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160897636|NCT01189604|581021399|FG003|Overall Study|Impossible to visit|0|||
160897637|NCT01189604|581021400|FG004|Overall Study|Impossible to visit|0|||
160897638|NCT01189604|581021401|FG005|Overall Study|Impossible to visit|1|||
160897639|NCT01189604|581021402|FG006|Overall Study|Impossible to visit|0|||
160897640|NCT01189604|581021396|FG000|Overall Study|Adverse Event|0|||
161237551|NCT01686438|582250217|FG001|Overall Study|Protocol Violation|0|||
161237552|NCT01686438|582250218|FG002|Overall Study|Protocol Violation|1|||
161237553|NCT01686438|582250216|FG000|Overall Study|Withdrawal by Subject|0|||
160897641|NCT01189604|581021397|FG001|Overall Study|Adverse Event|1|||
160897642|NCT01189604|581021398|FG002|Overall Study|Adverse Event|0|||
160897643|NCT01189604|581021399|FG003|Overall Study|Adverse Event|0|||
160897644|NCT01189604|581021400|FG004|Overall Study|Adverse Event|2|||
160897645|NCT01189604|581021401|FG005|Overall Study|Adverse Event|0|||
160897646|NCT01189604|581021402|FG006|Overall Study|Adverse Event|1|||
160897647|NCT01189604|581021396|FG000|Overall Study|Withdrawal by Subject|1|||
160897648|NCT01189604|581021397|FG001|Overall Study|Withdrawal by Subject|0|||
160897649|NCT01189604|581021398|FG002|Overall Study|Withdrawal by Subject|0|||
160897650|NCT01189604|581021399|FG003|Overall Study|Withdrawal by Subject|0|||
160897651|NCT01189604|581021400|FG004|Overall Study|Withdrawal by Subject|0|||
160897652|NCT01189604|581021401|FG005|Overall Study|Withdrawal by Subject|0|||
160897653|NCT01189604|581021402|FG006|Overall Study|Withdrawal by Subject|0|||
160897654|NCT03945214|581021403|FG000|Overall Study|Lost to Follow-up|3|||
160897655|NCT03945214|581021404|FG001|Overall Study|Lost to Follow-up|4|||
160897656|NCT03945214|581021405|FG002|Overall Study|Lost to Follow-up|7|||
160897657|NCT03945214|581021406|FG003|Overall Study|Lost to Follow-up|4|||
160897658|NCT04102098|581021421|FG000|Main Study Period|Ongoing in study|302|||
160897659|NCT04102098|581021422|FG001|Main Study Period|Ongoing in study|291|||
160897660|NCT04102098|581021421|FG000|Main Study Period|Death|20|||
160897661|NCT04102098|581021422|FG001|Main Study Period|Death|27|||
160897662|NCT04102098|581021421|FG000|Main Study Period|Lost to Follow-up|1|||
160897663|NCT04102098|581021422|FG001|Main Study Period|Lost to Follow-up|1|||
160897664|NCT04102098|581021421|FG000|Main Study Period|Physician Decision|0|||
160897665|NCT04102098|581021422|FG001|Main Study Period|Physician Decision|1|||
160897666|NCT04102098|581021421|FG000|Main Study Period|Withdrawal by Subject|11|||
160897667|NCT04102098|581021422|FG001|Main Study Period|Withdrawal by Subject|14|||
160897668|NCT04102098|581021421|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
160897669|NCT04102098|581021422|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
160897670|NCT04102098|581021421|FG000|Crossover: AS Who Crossed Over|Death|11|||
160897671|NCT04102098|581021422|FG001|Crossover: AS Who Crossed Over|Death|0|||
160897672|NCT04102098|581021421|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
160897673|NCT04102098|581021422|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
160897674|NCT03755791|581021425|FG000|Overall Study|Did not receive any study treatment|3|||
160897675|NCT03755791|581021426|FG001|Overall Study|Did not receive any study treatment|0|||
160897676|NCT03755791|581021427|FG002|Overall Study|Did not receive any study treatment|10|||
160897677|NCT03755791|581021425|FG000|Overall Study|Radiographic progression|204|||
160897678|NCT03755791|581021426|FG001|Overall Study|Radiographic progression|92|||
160897679|NCT03755791|581021427|FG002|Overall Study|Radiographic progression|115|||
160897680|NCT03755791|581021425|FG000|Overall Study|Adverse Event|140|||
160897681|NCT03755791|581021426|FG001|Overall Study|Adverse Event|60|||
160897682|NCT03755791|581021427|FG002|Overall Study|Adverse Event|51|||
160897683|NCT03755791|581021425|FG000|Overall Study|Lack of Efficacy|12|||
160897684|NCT03755791|581021426|FG001|Overall Study|Lack of Efficacy|6|||
160897685|NCT03755791|581021427|FG002|Overall Study|Lack of Efficacy|6|||
160897686|NCT03755791|581021425|FG000|Overall Study|Withdrawal by Subject|26|||
160897687|NCT03755791|581021426|FG001|Overall Study|Withdrawal by Subject|23|||
161237554|NCT01686438|582250217|FG001|Overall Study|Withdrawal by Subject|0|||
161237555|NCT01686438|582250218|FG002|Overall Study|Withdrawal by Subject|1|||
161237556|NCT00984126|582250219|FG000|Overall Study|Protocol Violation|0|||
160897688|NCT03755791|581021427|FG002|Overall Study|Withdrawal by Subject|24|||
160897689|NCT03755791|581021425|FG000|Overall Study|Sponsor decision,|41|||
160897690|NCT03755791|581021426|FG001|Overall Study|Sponsor decision,|5|||
160897691|NCT03755791|581021427|FG002|Overall Study|Sponsor decision,|7|||
160897692|NCT03755791|581021425|FG000|Overall Study|Lost to Follow-up|1|||
160897693|NCT03755791|581021426|FG001|Overall Study|Lost to Follow-up|0|||
160897694|NCT03755791|581021427|FG002|Overall Study|Lost to Follow-up|2|||
160897695|NCT03755791|581021425|FG000|Overall Study|Protocol Violation|0|||
160897696|NCT03755791|581021426|FG001|Overall Study|Protocol Violation|0|||
160897697|NCT03755791|581021427|FG002|Overall Study|Protocol Violation|2|||
160897698|NCT03755791|581021425|FG000|Overall Study|Other than specified|5|||
161237557|NCT00984126|582250220|FG001|Overall Study|Protocol Violation|0|||
160804361|NCT00716274|580671909|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
160804362|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804363|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804364|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
160804365|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804366|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804367|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
160804368|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
160804369|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
160804370|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
160804371|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
160804372|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
160804373|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
160804374|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804375|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804376|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804377|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
160804378|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
160804379|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
160804380|NCT00716274|580671904|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
160804381|NCT00716274|580671905|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
160804382|NCT00716274|580671906|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
160804383|NCT00716274|580671907|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
160804384|NCT00716274|580671908|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
160804385|NCT00716274|580671909|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
160804386|NCT01342094|580671910|FG000|Overall Study|Adverse Event|5|||
160804387|NCT01342094|580671911|FG001|Overall Study|Adverse Event|0|||
160804388|NCT01342094|580671910|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
160804389|NCT01342094|580671911|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
160804390|NCT01342094|580671910|FG000|Overall Study|Withdrawal by Subject|0|||
160804391|NCT01342094|580671911|FG001|Overall Study|Withdrawal by Subject|2|||
160804392|NCT02806414|580671914|FG000|Overall Study|Lost to Follow-up|2|||
160804393|NCT00543985|580671917|FG000|Overall Study|Withdrawal by Subject|4|||
160804394|NCT01634152|580671918|FG000|Overall Study|Adverse Event|2|||
160804395|NCT01634152|580671919|FG001|Overall Study|Adverse Event|0|||
160804396|NCT01634152|580671920|FG002|Overall Study|Adverse Event|2|||
160804397|NCT01634152|580671918|FG000|Overall Study|Consent withdrawn not due to AE|1|||
160804398|NCT01634152|580671919|FG001|Overall Study|Consent withdrawn not due to AE|0|||
160804399|NCT01634152|580671920|FG002|Overall Study|Consent withdrawn not due to AE|1|||
160804400|NCT01634152|580671918|FG000|Overall Study|Not treated|0|||
160804401|NCT01634152|580671919|FG001|Overall Study|Not treated|1|||
160804402|NCT01634152|580671920|FG002|Overall Study|Not treated|0|||
160804403|NCT01634152|580671918|FG000|Overall Study|Other reason not defined above|1|||
160804404|NCT01634152|580671919|FG001|Overall Study|Other reason not defined above|0|||
160804405|NCT01634152|580671920|FG002|Overall Study|Other reason not defined above|1|||
160804406|NCT00403130|580671924|FG000|2 Years From Start of Treatment|Not Eligible|3|||
160804407|NCT00403130|580671924|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
160804408|NCT00403130|580671924|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
160804409|NCT00403130|580671924|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
160804410|NCT00806260|580671925|FG000|Period 1 (1 Day)|Adverse Event|0|||
160804411|NCT00806260|580671926|FG001|Period 1 (1 Day)|Adverse Event|0|||
160804412|NCT00806260|580671927|FG002|Period 1 (1 Day)|Adverse Event|0|||
160804413|NCT00806260|580671928|FG003|Period 1 (1 Day)|Adverse Event|0|||
160804414|NCT00806260|580671929|FG004|Period 1 (1 Day)|Adverse Event|3|||
160804415|NCT00806260|580671930|FG005|Period 1 (1 Day)|Adverse Event|0|||
160804416|NCT00806260|580671925|FG000|Period 2|Adverse Event|0|||
160804417|NCT00806260|580671926|FG001|Period 2|Adverse Event|0|||
160804418|NCT00806260|580671927|FG002|Period 2|Adverse Event|0|||
160804419|NCT00806260|580671928|FG003|Period 2|Adverse Event|1|||
160804420|NCT00806260|580671929|FG004|Period 2|Adverse Event|0|||
160804421|NCT00806260|580671930|FG005|Period 2|Adverse Event|0|||
160804422|NCT00806260|580671925|FG000|Period 2|Protocol Violation|1|||
160804423|NCT00806260|580671926|FG001|Period 2|Protocol Violation|0|||
160804424|NCT00806260|580671927|FG002|Period 2|Protocol Violation|1|||
160804425|NCT00806260|580671928|FG003|Period 2|Protocol Violation|0|||
160804426|NCT00806260|580671929|FG004|Period 2|Protocol Violation|0|||
160804427|NCT00806260|580671930|FG005|Period 2|Protocol Violation|0|||
160804428|NCT00806260|580671925|FG000|Period 2|Need to take concomitant medication|1|||
160804429|NCT00806260|580671926|FG001|Period 2|Need to take concomitant medication|0|||
160804430|NCT00806260|580671927|FG002|Period 2|Need to take concomitant medication|0|||
160804431|NCT00806260|580671928|FG003|Period 2|Need to take concomitant medication|0|||
160804432|NCT00806260|580671929|FG004|Period 2|Need to take concomitant medication|0|||
160804433|NCT00806260|580671930|FG005|Period 2|Need to take concomitant medication|0|||
160804434|NCT00806260|580671925|FG000|Period 2|sponsor request|0|||
160804435|NCT00806260|580671926|FG001|Period 2|sponsor request|0|||
161129864|NCT01524991|581863290|FG000|Overall Study|Symptomatic Deterioration|1|||
161129865|NCT00365989|581863291|FG000|Overall Study|Withdrawal by Subject|1|||
161129866|NCT00365989|581863291|FG000|Overall Study|Non-compliance|1|||
161129867|NCT00832819|581863294|FG000|Overall Study|Adverse Event|0|||
161129868|NCT00832819|581863295|FG001|Overall Study|Adverse Event|1|||
161129869|NCT00832819|581863296|FG002|Overall Study|Adverse Event|0|||
161129870|NCT00832819|581863294|FG000|Overall Study|Protocol Violation|0|||
161129871|NCT00832819|581863295|FG001|Overall Study|Protocol Violation|0|||
161129872|NCT00832819|581863296|FG002|Overall Study|Protocol Violation|1|||
161129873|NCT01254669|581863297|FG000|Overall Study|Withdrawal by Subject|0|||
161129874|NCT01254669|581863298|FG001|Overall Study|Withdrawal by Subject|1|||
161129875|NCT01254669|581863297|FG000|Overall Study|time constraint|2|||
161129876|NCT01254669|581863298|FG001|Overall Study|time constraint|2|||
161129877|NCT01254669|581863297|FG000|Overall Study|called to clinic during intervention|1|||
161129878|NCT01254669|581863298|FG001|Overall Study|called to clinic during intervention|1|||
161129879|NCT00103012|581863299|FG000|Overall Study|Withdrawal by Subject|2|||
161129880|NCT00103012|581863300|FG001|Overall Study|Withdrawal by Subject|1|||
161129881|NCT00103012|581863301|FG002|Overall Study|Withdrawal by Subject|2|||
161129882|NCT00103012|581863299|FG000|Overall Study|Pregnancy|1|||
161129883|NCT00103012|581863300|FG001|Overall Study|Pregnancy|0|||
161129884|NCT00103012|581863301|FG002|Overall Study|Pregnancy|0|||
161129885|NCT00103012|581863299|FG000|Overall Study|Adverse Event|0|||
161129886|NCT00103012|581863300|FG001|Overall Study|Adverse Event|0|||
161129887|NCT00103012|581863301|FG002|Overall Study|Adverse Event|1|||
161129888|NCT00103012|581863299|FG000|Overall Study|Subject non-compliant with medications|0|||
161129889|NCT00103012|581863300|FG001|Overall Study|Subject non-compliant with medications|0|||
161129890|NCT00103012|581863301|FG002|Overall Study|Subject non-compliant with medications|1|||
161129891|NCT00393718|581863311|FG000|Overall Study|Adverse Event|20|||
161129892|NCT00393718|581863312|FG001|Overall Study|Adverse Event|8|||
161129893|NCT00393718|581863311|FG000|Overall Study|Protocol Violation|1|||
161129894|NCT00393718|581863312|FG001|Overall Study|Protocol Violation|2|||
161129895|NCT00393718|581863311|FG000|Overall Study|Lack of Efficacy|10|||
161129896|NCT00393718|581863312|FG001|Overall Study|Lack of Efficacy|9|||
161129897|NCT00393718|581863311|FG000|Overall Study|Hypoglycaemia|3|||
161129898|NCT00393718|581863312|FG001|Overall Study|Hypoglycaemia|2|||
161129899|NCT00393718|581863311|FG000|Overall Study|Subject decision|5|||
161129900|NCT00393718|581863312|FG001|Overall Study|Subject decision|0|||
161129901|NCT00393718|581863311|FG000|Overall Study|Withdrawal of consent|2|||
161129902|NCT00393718|581863312|FG001|Overall Study|Withdrawal of consent|1|||
161129903|NCT00393718|581863311|FG000|Overall Study|Missed measurement|1|||
161129904|NCT00393718|581863312|FG001|Overall Study|Missed measurement|0|||
161129905|NCT00393718|581863311|FG000|Overall Study|Move|1|||
161129906|NCT00393718|581863312|FG001|Overall Study|Move|0|||
161129907|NCT01084551|581863314|FG000|Overall Study|Adverse Event|2|||
161129908|NCT01084551|581863315|FG001|Overall Study|Adverse Event|9|||
161129909|NCT01084551|581863316|FG002|Overall Study|Adverse Event|4|||
161129910|NCT01084551|581863314|FG000|Overall Study|Lack of Efficacy|2|||
161129911|NCT01084551|581863315|FG001|Overall Study|Lack of Efficacy|0|||
161129912|NCT01084551|581863316|FG002|Overall Study|Lack of Efficacy|1|||
161129913|NCT01084551|581863314|FG000|Overall Study|Withdrawal by Subject|2|||
161129914|NCT01084551|581863315|FG001|Overall Study|Withdrawal by Subject|1|||
161129915|NCT01084551|581863316|FG002|Overall Study|Withdrawal by Subject|0|||
161129916|NCT01084551|581863314|FG000|Overall Study|Protocol Violation|2|||
161129917|NCT01084551|581863315|FG001|Overall Study|Protocol Violation|4|||
161129918|NCT01084551|581863316|FG002|Overall Study|Protocol Violation|0|||
161129919|NCT01084551|581863314|FG000|Overall Study|Lost to Follow-up|0|||
161129920|NCT01084551|581863315|FG001|Overall Study|Lost to Follow-up|0|||
161129921|NCT01084551|581863316|FG002|Overall Study|Lost to Follow-up|3|||
161129922|NCT01084551|581863314|FG000|Overall Study|Physician Decision|1|||
161332259|NCT01249417|582603565|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
160804436|NCT00806260|580671927|FG002|Period 2|sponsor request|1|||
161129923|NCT01084551|581863315|FG001|Overall Study|Physician Decision|0|||
161129924|NCT01084551|581863316|FG002|Overall Study|Physician Decision|0|||
161129925|NCT03902080|581863317|FG000|Overall Study|Adverse Event|17|||
161129926|NCT03902080|581863318|FG001|Overall Study|Adverse Event|15|||
161129927|NCT03902080|581863317|FG000|Overall Study|Withdrawal by Subject|28|||
161129928|NCT03902080|581863318|FG001|Overall Study|Withdrawal by Subject|35|||
161129929|NCT03902080|581863317|FG000|Overall Study|Lost to Follow-up|6|||
161332260|NCT01249417|582603566|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
160804437|NCT00806260|580671928|FG003|Period 2|sponsor request|1|||
161129930|NCT03902080|581863318|FG001|Overall Study|Lost to Follow-up|7|||
161129931|NCT03902080|581863317|FG000|Overall Study|Other|3|||
161129932|NCT03902080|581863318|FG001|Overall Study|Other|5|||
161129933|NCT03902080|581863317|FG000|Overall Study|Non compliance|4|||
161129934|NCT03902080|581863318|FG001|Overall Study|Non compliance|3|||
161129935|NCT03902080|581863317|FG000|Overall Study|Physician Decision|5|||
161129936|NCT03902080|581863318|FG001|Overall Study|Physician Decision|1|||
161129937|NCT03902080|581863317|FG000|Overall Study|Protocol Violation|3|||
161129938|NCT03902080|581863318|FG001|Overall Study|Protocol Violation|3|||
161129939|NCT03902080|581863317|FG000|Overall Study|Lack of Efficacy|1|||
161129940|NCT03902080|581863318|FG001|Overall Study|Lack of Efficacy|3|||
161129941|NCT03902080|581863317|FG000|Overall Study|Withdrawn prior to dosing|0|||
161129942|NCT03902080|581863318|FG001|Overall Study|Withdrawn prior to dosing|1|||
161129943|NCT01703000|581863319|FG000|Overall Study|Death|1|||
161129944|NCT01279057|581863320|FG000|Overall Study|Adverse Event|1|||
161129945|NCT01279057|581863321|FG001|Overall Study|Adverse Event|0|||
161129946|NCT01279057|581863322|FG002|Overall Study|Adverse Event|1|||
161129947|NCT01279057|581863320|FG000|Overall Study|Insufficient therapeutic response|0|||
161129948|NCT01279057|581863321|FG001|Overall Study|Insufficient therapeutic response|0|||
161129949|NCT01279057|581863322|FG002|Overall Study|Insufficient therapeutic response|1|||
161129950|NCT01279057|581863320|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161129951|NCT01279057|581863321|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
161129952|NCT01279057|581863322|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161129953|NCT01279057|581863320|FG000|Overall Study|Withdrew consent|2|||
161129954|NCT01279057|581863321|FG001|Overall Study|Withdrew consent|0|||
161129955|NCT01279057|581863322|FG002|Overall Study|Withdrew consent|1|||
161129956|NCT01279057|581863320|FG000|Overall Study|Pregnancy|0|||
161129957|NCT01279057|581863321|FG001|Overall Study|Pregnancy|1|||
161129958|NCT01279057|581863322|FG002|Overall Study|Pregnancy|0|||
161129959|NCT01279057|581863320|FG000|Overall Study|Other|3|||
161129960|NCT01279057|581863321|FG001|Overall Study|Other|3|||
161129961|NCT01279057|581863322|FG002|Overall Study|Other|0|||
161129962|NCT01427309|581863323|FG000|Overall Study|Lost to Follow-up|130|||
161129963|NCT01427309|581863324|FG001|Overall Study|Lost to Follow-up|145|||
161129964|NCT01427309|581863325|FG002|Overall Study|Lost to Follow-up|122|||
161129965|NCT01427309|581863326|FG003|Overall Study|Lost to Follow-up|135|||
160804438|NCT00806260|580671929|FG004|Period 2|sponsor request|0|||
160804439|NCT00806260|580671930|FG005|Period 2|sponsor request|0|||
160804440|NCT00806260|580671925|FG000|Period 3|Protocol Violation|0|||
160804441|NCT00806260|580671926|FG001|Period 3|Protocol Violation|1|||
160804442|NCT00806260|580671927|FG002|Period 3|Protocol Violation|1|||
160804443|NCT00806260|580671928|FG003|Period 3|Protocol Violation|0|||
160804444|NCT00806260|580671929|FG004|Period 3|Protocol Violation|0|||
160804445|NCT00806260|580671930|FG005|Period 3|Protocol Violation|0|||
160804446|NCT00806260|580671925|FG000|Period 3|Pregnancy|1|||
160804447|NCT00806260|580671926|FG001|Period 3|Pregnancy|0|||
160804448|NCT00806260|580671927|FG002|Period 3|Pregnancy|0|||
160985266|NCT01347645|581335413|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
160985267|NCT01347645|581335409|FG000|Overall Study|Other|1|||
160985268|NCT01347645|581335410|FG001|Overall Study|Other|0|||
160985269|NCT01347645|581335411|FG002|Overall Study|Other|0|||
160985270|NCT01347645|581335412|FG003|Overall Study|Other|0|||
160985271|NCT01347645|581335413|FG004|Overall Study|Other|1|||
160804449|NCT00806260|580671928|FG003|Period 3|Pregnancy|0|||
160804450|NCT00806260|580671929|FG004|Period 3|Pregnancy|0|||
160804451|NCT00806260|580671930|FG005|Period 3|Pregnancy|0|||
160804452|NCT02670473|580671931|FG000|Overall Study|Withdrawal by Subject|1|||
160804453|NCT05414175|580671932|FG000|Overall Study|Withdrawal by Subject|1|||
160804454|NCT05414175|580671932|FG000|Overall Study|Other Reasons|1|||
160804455|NCT00456755|580673284|FG000|Overall Study|Lost to Follow-up|2|||
160804456|NCT00456755|580673285|FG001|Overall Study|Lost to Follow-up|1|||
160804457|NCT01475721|580673288|FG000|Overall Study|Death|3|||
160804458|NCT01475721|580673289|FG001|Overall Study|Death|6|||
160804459|NCT01475721|580673288|FG000|Overall Study|Withdrawal by Subject|8|||
160804460|NCT01475721|580673289|FG001|Overall Study|Withdrawal by Subject|8|||
160804461|NCT02364037|580673291|FG000|Overall Study|Withdrawal by Subject|7|||
160804462|NCT02364037|580673292|FG001|Overall Study|Withdrawal by Subject|4|||
160804463|NCT02364037|580673291|FG000|Overall Study|Lost to Follow-up|37|||
160804464|NCT02364037|580673292|FG001|Overall Study|Lost to Follow-up|49|||
160804465|NCT01453036|580673293|FG000|Overall Study|Lost to Follow-up|26|||
160985272|NCT01347645|581335409|FG000|Overall Study|Withdrawal by Subject|0|||
160985273|NCT01347645|581335410|FG001|Overall Study|Withdrawal by Subject|0|||
160985274|NCT01347645|581335411|FG002|Overall Study|Withdrawal by Subject|0|||
160804466|NCT01453036|580673294|FG001|Overall Study|Lost to Follow-up|115|||
160804467|NCT01453036|580673295|FG002|Overall Study|Lost to Follow-up|31|||
160985275|NCT01347645|581335412|FG003|Overall Study|Withdrawal by Subject|3|||
160985276|NCT01347645|581335413|FG004|Overall Study|Withdrawal by Subject|3|||
161129966|NCT01427309|581863323|FG000|Overall Study|Protocol Violation|42|||
161129967|NCT01427309|581863324|FG001|Overall Study|Protocol Violation|69|||
161129968|NCT01427309|581863325|FG002|Overall Study|Protocol Violation|125|||
161129969|NCT01427309|581863326|FG003|Overall Study|Protocol Violation|124|||
161129970|NCT01427309|581863323|FG000|Overall Study|Adverse Event|0|||
161129971|NCT01427309|581863324|FG001|Overall Study|Adverse Event|0|||
161129972|NCT01427309|581863325|FG002|Overall Study|Adverse Event|3|||
161129973|NCT01427309|581863326|FG003|Overall Study|Adverse Event|1|||
161129974|NCT01427309|581863323|FG000|Overall Study|Serious adverse event|52|||
161129975|NCT01427309|581863324|FG001|Overall Study|Serious adverse event|45|||
161129976|NCT01427309|581863325|FG002|Overall Study|Serious adverse event|50|||
161129977|NCT01427309|581863326|FG003|Overall Study|Serious adverse event|61|||
161129978|NCT01427309|581863323|FG000|Overall Study|Withdrawal by Subject|148|||
160804468|NCT04567524|580673296|FG000|Overall Study|Adverse Event|1|||
160804469|NCT04567524|580673297|FG001|Overall Study|Adverse Event|1|||
160804470|NCT04567524|580673298|FG002|Overall Study|Adverse Event|0|||
160804471|NCT04567524|580673299|FG003|Overall Study|Adverse Event|0|||
160804472|NCT04567524|580673296|FG000|Overall Study|Withdrawal by Subject|2|||
160804473|NCT04567524|580673297|FG001|Overall Study|Withdrawal by Subject|0|||
160804474|NCT04567524|580673298|FG002|Overall Study|Withdrawal by Subject|0|||
160804475|NCT04567524|580673299|FG003|Overall Study|Withdrawal by Subject|1|||
160804476|NCT02848092|580673300|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
160804477|NCT02848092|580673301|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
160804478|NCT02848092|580673300|FG000|1-month Post-training Follow-up|Adverse Event|2|||
160804479|NCT02848092|580673301|FG001|1-month Post-training Follow-up|Adverse Event|1|||
160804480|NCT02848092|580673300|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
160804481|NCT02848092|580673301|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
160897699|NCT03755791|581021426|FG001|Overall Study|Other than specified|2|||
160897700|NCT03755791|581021427|FG002|Overall Study|Other than specified|0|||
160897701|NCT02083081|581021431|FG000|Overall Study|Lost to Follow-up|31|||
160897702|NCT02083081|581021432|FG001|Overall Study|Lost to Follow-up|9|||
160897703|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
160897704|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
160897705|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Physician Decision|1|||
160897706|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Physician Decision|0|||
160897707|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
160897708|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
160897709|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
160897710|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
160897711|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Adverse Event|15|||
160897712|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Adverse Event|0|||
160897713|NCT03277690|581021435|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
160897714|NCT03277690|581021436|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
160897715|NCT03277690|581021435|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
160897716|NCT03277690|581021436|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
160897717|NCT03109847|581021437|FG000|Overall Study|Withdrawal by Subject|1|||
160897718|NCT03109847|581021438|FG001|Overall Study|Withdrawal by Subject|0|||
160897719|NCT04209348|581021439|FG000|Overall Study|Lost to Follow-up|1|||
160897720|NCT04209348|581021440|FG001|Overall Study|Lost to Follow-up|0|||
160897721|NCT02853344|581021441|FG000|Overall Study|Lost to Follow-up|1|||
160897722|NCT02853344|581021442|FG001|Overall Study|Lost to Follow-up|1|||
160897723|NCT02853344|581021441|FG000|Overall Study|Withdrawal by Subject|2|||
160897724|NCT02853344|581021442|FG001|Overall Study|Withdrawal by Subject|4|||
160897725|NCT02853344|581021441|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
160897726|NCT02853344|581021442|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
160897727|NCT02853344|581021441|FG000|Overall Study|Death|70|||
160897728|NCT02853344|581021442|FG001|Overall Study|Death|112|||
160897729|NCT02955797|581021443|FG000|Overall Study|Protocol Violation|1|||
160897730|NCT02955797|581021444|FG001|Overall Study|Protocol Violation|0|||
160897731|NCT02955797|581021445|FG002|Overall Study|Protocol Violation|0|||
160897732|NCT02955797|581021446|FG003|Overall Study|Protocol Violation|1|||
160897733|NCT02955797|581021443|FG000|Overall Study|Withdrawal by Subject|2|||
160897734|NCT02955797|581021444|FG001|Overall Study|Withdrawal by Subject|2|||
160897735|NCT02955797|581021445|FG002|Overall Study|Withdrawal by Subject|0|||
160897736|NCT02955797|581021446|FG003|Overall Study|Withdrawal by Subject|1|||
160897737|NCT02955797|581021443|FG000|Overall Study|Lost to Follow-up|0|||
160897738|NCT02955797|581021444|FG001|Overall Study|Lost to Follow-up|1|||
160897739|NCT02955797|581021445|FG002|Overall Study|Lost to Follow-up|0|||
160897740|NCT02955797|581021446|FG003|Overall Study|Lost to Follow-up|0|||
160897741|NCT03131453|581021447|FG000|Overall Study|Study terminated by Sponsor|424|||
160897742|NCT03131453|581021448|FG001|Overall Study|Study terminated by Sponsor|222|||
160897743|NCT03131453|581021449|FG002|Overall Study|Study terminated by Sponsor|438|||
160897744|NCT03131453|581021447|FG000|Overall Study|Withdrawal by Subject|18|||
160897745|NCT03131453|581021448|FG001|Overall Study|Withdrawal by Subject|7|||
160897746|NCT03131453|581021449|FG002|Overall Study|Withdrawal by Subject|13|||
161129979|NCT01427309|581863324|FG001|Overall Study|Withdrawal by Subject|148|||
161129980|NCT01427309|581863325|FG002|Overall Study|Withdrawal by Subject|61|||
160804482|NCT02848092|580673300|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
160804483|NCT02848092|580673301|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
160897747|NCT03131453|581021447|FG000|Overall Study|Adverse Event|10|||
160897748|NCT03131453|581021448|FG001|Overall Study|Adverse Event|3|||
160897749|NCT03131453|581021449|FG002|Overall Study|Adverse Event|3|||
160897750|NCT03131453|581021447|FG000|Overall Study|Lost to Follow-up|1|||
160897751|NCT03131453|581021448|FG001|Overall Study|Lost to Follow-up|0|||
161129981|NCT01427309|581863326|FG003|Overall Study|Withdrawal by Subject|55|||
160804484|NCT02848092|580673300|FG000|1-month Post-training Follow-up|fatigue|0|||
160804485|NCT02848092|580673301|FG001|1-month Post-training Follow-up|fatigue|1|||
160804486|NCT02848092|580673300|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
160804487|NCT02848092|580673301|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
160804488|NCT02848092|580673300|FG000|6-month Post-training Follow-up|Adverse Event|1|||
160804489|NCT02848092|580673301|FG001|6-month Post-training Follow-up|Adverse Event|1|||
160804490|NCT02848092|580673300|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
160804491|NCT02848092|580673301|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
160804492|NCT02848092|580673300|FG000|6-month Post-training Follow-up|frustrated with task|1|||
160804493|NCT02848092|580673301|FG001|6-month Post-training Follow-up|frustrated with task|0|||
160804494|NCT02848092|580673300|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
160804495|NCT02848092|580673301|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
160804496|NCT02848092|580673300|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
160804497|NCT02848092|580673301|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
160804498|NCT01147393|580673306|FG000|Dose Level 1|Dose limiting Toxicity|2|||
160804499|NCT01147393|580673306|FG000|Dose Level -1|Dose Limited Toxicity|1|||
160804500|NCT01833494|580673324|FG000|Overall Study|Adverse Event|24|||
160804501|NCT01833494|580673324|FG000|Overall Study|Physician Decision|6|||
160804502|NCT01833494|580673324|FG000|Overall Study|Withdrawal by Subject|6|||
160804503|NCT01833494|580673324|FG000|Overall Study|Decrease in serum phosphorus|4|||
161332261|NCT01249417|582603564|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
160804504|NCT01833494|580673324|FG000|Overall Study|Decrease in serum calcium|4|||
160804505|NCT01833494|580673324|FG000|Overall Study|Increase in serum ferritin|1|||
160804506|NCT01694433|580673329|FG000|Overall Study|Adverse Event|7|||
160804507|NCT01694433|580673330|FG001|Overall Study|Adverse Event|0|||
160804508|NCT01694433|580673329|FG000|Overall Study|Physician Decision|1|||
160804509|NCT01694433|580673330|FG001|Overall Study|Physician Decision|0|||
160804510|NCT01694433|580673329|FG000|Overall Study|Withdrawal by Subject|3|||
160804511|NCT01694433|580673330|FG001|Overall Study|Withdrawal by Subject|4|||
160804512|NCT00374595|580673331|FG000|Overall Study|Death|23|||
160804513|NCT00374595|580673331|FG000|Overall Study|Withdrawal by Subject|39|||
160804514|NCT00374595|580673331|FG000|Overall Study|Lost to Follow-up|3|||
160804515|NCT00374595|580673331|FG000|Overall Study|too much time commitment|1|||
160804516|NCT00374595|580673331|FG000|Overall Study|transfer care to other clinical site|1|||
160804517|NCT00374595|580673331|FG000|Overall Study|relocation|3|||
160804518|NCT03745768|580673333|FG000|Overall Study|discontinued study|2|||
160804519|NCT03745768|580673334|FG001|Overall Study|discontinued study|0|||
160804520|NCT00443118|580673335|FG000|Overall Study|unknown primary outcome|3|||
160804521|NCT00443118|580673336|FG001|Overall Study|unknown primary outcome|1|||
160804522|NCT00443118|580673337|FG002|Overall Study|unknown primary outcome|0|||
160804523|NCT00443118|580673335|FG000|Overall Study|Withdrawal by Subject|1|||
160804524|NCT00443118|580673336|FG001|Overall Study|Withdrawal by Subject|0|||
160804525|NCT00443118|580673337|FG002|Overall Study|Withdrawal by Subject|0|||
160804526|NCT00506779|580673340|FG000|Overall Study|Withdrawal by Subject|1|||
160804527|NCT00506779|580673341|FG001|Overall Study|Withdrawal by Subject|0|||
160804528|NCT00506779|580673342|FG002|Overall Study|Withdrawal by Subject|1|||
160804529|NCT00506779|580673343|FG003|Overall Study|Withdrawal by Subject|0|||
160804530|NCT00506779|580673340|FG000|Overall Study|Adverse Event|0|||
160804531|NCT00506779|580673341|FG001|Overall Study|Adverse Event|1|||
160804532|NCT00506779|580673342|FG002|Overall Study|Adverse Event|1|||
160804533|NCT00506779|580673343|FG003|Overall Study|Adverse Event|1|||
160804534|NCT02639247|580673344|FG000|Overall Study|Lost to Follow-up|2|||
160804535|NCT02639247|580673345|FG001|Overall Study|Lost to Follow-up|1|||
160804536|NCT02639247|580673344|FG000|Overall Study|Death|2|||
160804537|NCT02639247|580673345|FG001|Overall Study|Death|0|||
160804538|NCT02639247|580673344|FG000|Overall Study|Withdrew Consent|0|||
160804539|NCT02639247|580673345|FG001|Overall Study|Withdrew Consent|1|||
160804540|NCT02639247|580673344|FG000|Overall Study|Protocol Violation|1|||
160804541|NCT02639247|580673345|FG001|Overall Study|Protocol Violation|0|||
160804542|NCT01891396|580673346|FG000|Overall Study|Withdrawal by Subject|4|||
160804543|NCT01891396|580673347|FG001|Overall Study|Withdrawal by Subject|4|||
160804544|NCT01891396|580673348|FG002|Overall Study|Withdrawal by Subject|3|||
160804545|NCT01891396|580673346|FG000|Overall Study|Lost to Follow-up|0|||
160897752|NCT03131453|581021449|FG002|Overall Study|Lost to Follow-up|1|||
160897753|NCT03131453|581021447|FG000|Overall Study|Physician Decision|1|||
160897754|NCT03131453|581021448|FG001|Overall Study|Physician Decision|0|||
160897755|NCT03131453|581021449|FG002|Overall Study|Physician Decision|1|||
160897756|NCT03131453|581021447|FG000|Overall Study|Non-compliance with study treatment|1|||
160897757|NCT03131453|581021448|FG001|Overall Study|Non-compliance with study treatment|0|||
160804546|NCT01891396|580673347|FG001|Overall Study|Lost to Follow-up|1|||
161332262|NCT01249417|582603565|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
160804547|NCT01891396|580673348|FG002|Overall Study|Lost to Follow-up|0|||
160804548|NCT02168101|580673351|FG000|Overall Study|Death|2|||
160804549|NCT02168101|580673352|FG001|Overall Study|Death|2|||
160804550|NCT02168101|580673353|FG002|Overall Study|Death|1|||
160897758|NCT03131453|581021449|FG002|Overall Study|Non-compliance with study treatment|0|||
160804551|NCT01881009|580673354|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
160804552|NCT01881009|580673355|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
160804553|NCT04011735|580673356|FG000|Overall Study|Withdrawal by Subject|1|||
160804554|NCT04011735|580673357|FG001|Overall Study|Withdrawal by Subject|0|||
160804555|NCT04011735|580673358|FG002|Overall Study|Withdrawal by Subject|1|||
160804556|NCT04011735|580673356|FG000|Overall Study|Met exclusion criteria after study entry|0|||
160804557|NCT04011735|580673357|FG001|Overall Study|Met exclusion criteria after study entry|1|||
160804558|NCT04011735|580673358|FG002|Overall Study|Met exclusion criteria after study entry|0|||
160804559|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
160804560|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
160804561|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
160804562|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
160804563|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
160804564|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
160804565|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
160804566|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
160804567|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
160804568|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
160804569|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
160804570|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
160804571|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
160804572|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
160804573|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
160804574|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
160804575|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
160804576|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
160804577|NCT02831855|580673360|FG000|Open Label Phase (24 Weeks)|Other|4|||
160804578|NCT02831855|580673361|FG001|Open Label Phase (24 Weeks)|Other|0|||
160804579|NCT02831855|580673362|FG002|Open Label Phase (24 Weeks)|Other|0|||
160804580|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
160804581|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
160804582|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
160804583|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Death|0|||
160804584|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Death|0|||
160804585|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Death|2|||
160804586|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
160804587|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
160804588|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
160804589|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
160804590|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
160804591|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
160804592|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
160804593|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
160804594|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
160804595|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Other|0|||
160804596|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Other|2|||
160897759|NCT03131453|581021447|FG000|Overall Study|Technical problems|1|||
160897760|NCT03131453|581021448|FG001|Overall Study|Technical problems|0|||
160897761|NCT03131453|581021449|FG002|Overall Study|Technical problems|0|||
160897762|NCT03131453|581021447|FG000|Overall Study|Protocol deviation|0|||
160897763|NCT03131453|581021448|FG001|Overall Study|Protocol deviation|1|||
160897764|NCT03131453|581021449|FG002|Overall Study|Protocol deviation|0|||
160897765|NCT02081183|581021451|FG000|Overall Study|Lost to Follow-up|0|||
160897766|NCT02081183|581021452|FG001|Overall Study|Lost to Follow-up|1|||
160897767|NCT02081183|581021451|FG000|Overall Study|Protocol Violation|1|||
160897768|NCT02081183|581021452|FG001|Overall Study|Protocol Violation|0|||
160897769|NCT02081183|581021451|FG000|Overall Study|Other|3|||
160897770|NCT02081183|581021452|FG001|Overall Study|Other|3|||
160897771|NCT02840721|581021453|FG000|Treatment Period|Adverse Event|1|||
160897772|NCT02840721|581021453|FG000|Follow-Up|Lack of Efficacy|1|||
160897773|NCT02840721|581021453|FG000|Follow-Up|Withdrawal by Subject|4|||
160897774|NCT02840721|581021453|FG000|Follow-Up|Withdrawal of Consent|2|||
160897775|NCT05535972|581021457|FG000|Overall Study|Withdrawal by Subject|31|||
160897776|NCT05535972|581021457|FG000|Overall Study|Lost to Follow-up|5|||
160897777|NCT05535972|581021457|FG000|Overall Study|Adverse Event|6|||
160897778|NCT05535972|581021457|FG000|Overall Study|Protocol Deviation|2|||
160897779|NCT02649894|581021458|FG000|Overall Study|Adverse Event|1|||
160897780|NCT02649894|581021459|FG001|Overall Study|Adverse Event|0|||
160897781|NCT02649894|581021458|FG000|Overall Study|Physician Decision|0|||
160804597|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Other|5|||
160804598|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
160804599|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
160897782|NCT02649894|581021459|FG001|Overall Study|Physician Decision|1|||
160804600|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
160804601|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
160804602|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
160804603|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
160804604|NCT02831855|580673360|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
160804605|NCT02831855|580673361|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
160804606|NCT02831855|580673362|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
160804607|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
160804608|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
161237558|NCT00984126|582250221|FG002|Overall Study|Protocol Violation|1|||
161237559|NCT00984126|582250222|FG003|Overall Study|Protocol Violation|2|||
161237560|NCT00984126|582250219|FG000|Overall Study|Adverse Event|0|||
160804609|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160804610|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160804611|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
160804612|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
160804613|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160804614|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160897783|NCT02649894|581021458|FG000|Overall Study|Withdrawal by Subject|5|||
160897784|NCT02649894|581021459|FG001|Overall Study|Withdrawal by Subject|2|||
160804615|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160897785|NCT02649894|581021458|FG000|Overall Study|Lost to Follow-up|2|||
160897786|NCT02649894|581021459|FG001|Overall Study|Lost to Follow-up|1|||
160897787|NCT02649894|581021458|FG000|Overall Study|Death|30|||
160897788|NCT02649894|581021459|FG001|Overall Study|Death|7|||
160897789|NCT02649894|581021458|FG000|Overall Study|Other, not specified|6|||
160897790|NCT02649894|581021459|FG001|Overall Study|Other, not specified|0|||
160897791|NCT04590963|581021460|FG000|Overall Study|Death|118|||
160897792|NCT04590963|581021461|FG001|Overall Study|Death|59|||
160897793|NCT04590963|581021460|FG000|Overall Study|Lost to Follow-up|1|||
160897794|NCT04590963|581021461|FG001|Overall Study|Lost to Follow-up|1|||
160897795|NCT04590963|581021460|FG000|Overall Study|Progressive disease|0|||
160897796|NCT04590963|581021461|FG001|Overall Study|Progressive disease|1|||
160897797|NCT04590963|581021460|FG000|Overall Study|Study terminated by sponsor|103|||
160897798|NCT04590963|581021461|FG001|Overall Study|Study terminated by sponsor|50|||
160897799|NCT04590963|581021460|FG000|Overall Study|Withdrawal by Subject|15|||
160897800|NCT04590963|581021461|FG001|Overall Study|Withdrawal by Subject|8|||
160897801|NCT04590963|581021460|FG000|Overall Study|Ongoing at data cut-off|9|||
160897802|NCT04590963|581021461|FG001|Overall Study|Ongoing at data cut-off|4|||
160897803|NCT04590963|581021460|FG000|Overall Study|Screen failure|1|||
160897804|NCT04590963|581021461|FG001|Overall Study|Screen failure|0|||
160897805|NCT01736124|581021462|FG000|Post-intervention Assessment|Death|2|||
160897806|NCT01736124|581021463|FG001|Post-intervention Assessment|Death|2|||
160897807|NCT01736124|581021462|FG000|Post-intervention Assessment|lost computer access|1|||
160897808|NCT01736124|581021463|FG001|Post-intervention Assessment|lost computer access|1|||
160897809|NCT01736124|581021462|FG000|Post-intervention Assessment|Moved away|3|||
160897810|NCT01736124|581021463|FG001|Post-intervention Assessment|Moved away|1|||
160897811|NCT01736124|581021462|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
160897812|NCT01736124|581021463|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
160897813|NCT01736124|581021462|FG000|Post-intervention Assessment|Illness|3|||
160897814|NCT01736124|581021463|FG001|Post-intervention Assessment|Illness|2|||
160897815|NCT01736124|581021462|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
160897816|NCT01736124|581021463|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
160897817|NCT01736124|581021462|FG000|Post-intervention Assessment|Temporarily away|3|||
160897818|NCT01736124|581021463|FG001|Post-intervention Assessment|Temporarily away|1|||
160897819|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
160897820|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
160897821|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
160897822|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
160804616|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
160804617|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
160897823|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
160897824|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
161237561|NCT00984126|582250220|FG001|Overall Study|Adverse Event|0|||
160897825|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
160897826|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
160897827|NCT01736124|581021462|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
160897828|NCT01736124|581021463|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
160897829|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
160897830|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
160897831|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
160897832|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
160804618|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804619|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804620|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804621|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
160804622|NCT01194245|580673364|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
160804623|NCT01194245|580673365|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804624|NCT01194245|580673366|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804625|NCT01194245|580673367|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804626|NCT01194245|580673368|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
160804627|NCT01194245|580673364|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804628|NCT01194245|580673365|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804629|NCT01194245|580673366|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804630|NCT01194245|580673367|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160804631|NCT01194245|580673368|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
160804632|NCT01194245|580673364|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160804633|NCT01194245|580673365|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160804634|NCT01194245|580673366|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
160804635|NCT01194245|580673367|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
160804636|NCT01194245|580673368|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
160804637|NCT02457247|580673369|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
160804638|NCT02457247|580673370|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
160804639|NCT02457247|580673371|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
160804640|NCT02457247|580673372|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
160804641|NCT02457247|580673369|FG000|Period 1|Significant Protocol Deviation|1|||
160804642|NCT02457247|580673370|FG001|Period 1|Significant Protocol Deviation|1|||
160804643|NCT02457247|580673371|FG002|Period 1|Significant Protocol Deviation|0|||
160804644|NCT02457247|580673372|FG003|Period 1|Significant Protocol Deviation|0|||
160804645|NCT02457247|580673369|FG000|Period 1|Voluntary Withdrawal|1|||
160804646|NCT02457247|580673370|FG001|Period 1|Voluntary Withdrawal|0|||
160804647|NCT02457247|580673371|FG002|Period 1|Voluntary Withdrawal|0|||
160804648|NCT02457247|580673372|FG003|Period 1|Voluntary Withdrawal|0|||
160804649|NCT02457247|580673369|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
160804650|NCT02457247|580673370|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
160804651|NCT02457247|580673371|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
160804652|NCT02457247|580673372|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
160804653|NCT02457247|580673369|FG000|Period 2|Significant Protocol Deviation|1|||
160804654|NCT02457247|580673370|FG001|Period 2|Significant Protocol Deviation|0|||
160804655|NCT02457247|580673371|FG002|Period 2|Significant Protocol Deviation|0|||
160804656|NCT02457247|580673372|FG003|Period 2|Significant Protocol Deviation|0|||
160804657|NCT02457247|580673369|FG000|Period 2|Lost to Follow-up|0|||
160804658|NCT02457247|580673370|FG001|Period 2|Lost to Follow-up|1|||
160804659|NCT02457247|580673371|FG002|Period 2|Lost to Follow-up|0|||
160804660|NCT02457247|580673372|FG003|Period 2|Lost to Follow-up|0|||
160804661|NCT02457247|580673369|FG000|Period 2|Voluntary Withdrawal|1|||
160804662|NCT02457247|580673370|FG001|Period 2|Voluntary Withdrawal|1|||
160804663|NCT02457247|580673371|FG002|Period 2|Voluntary Withdrawal|0|||
160804664|NCT02457247|580673372|FG003|Period 2|Voluntary Withdrawal|0|||
160804665|NCT03326063|580673373|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
160804666|NCT03326063|580673374|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
160804667|NCT00739310|580673375|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
160804668|NCT00739310|580673375|FG000|Overall Study|Withdrawal by Subject|1|||
160804669|NCT00739310|580673375|FG000|Overall Study|Lost to Follow-up|2|||
160804670|NCT02954887|580673376|FG000|Overall Study|Withdrawal by Subject|3|||
160804671|NCT02954887|580673376|FG000|Overall Study|Lack of Efficacy|3|||
160804672|NCT02954887|580673376|FG000|Overall Study|Other|1|||
160804673|NCT01492088|580673379|FG000|Overall Study|Withdrawal by Patient|0|||
160804674|NCT01492088|580673380|FG001|Overall Study|Withdrawal by Patient|2|||
160804675|NCT01492088|580673381|FG002|Overall Study|Withdrawal by Patient|0|||
160804676|NCT01492088|580673379|FG000|Overall Study|Death|1|||
160804677|NCT01492088|580673380|FG001|Overall Study|Death|6|||
160804678|NCT01492088|580673381|FG002|Overall Study|Death|2|||
160804679|NCT01492088|580673379|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
160804680|NCT01492088|580673380|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
160804681|NCT01492088|580673381|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
160804682|NCT01492088|580673379|FG000|Overall Study|Alive at Last Follow-up|0|||
160804683|NCT01492088|580673380|FG001|Overall Study|Alive at Last Follow-up|6|||
160804684|NCT01492088|580673381|FG002|Overall Study|Alive at Last Follow-up|11|||
160804685|NCT00889707|580673382|FG000|Overall Study|Adverse Event|1|||
160804686|NCT00889707|580673383|FG001|Overall Study|Adverse Event|0|||
160804687|NCT00889707|580673382|FG000|Overall Study|Withdrawal by Subject|4|||
160804688|NCT00889707|580673383|FG001|Overall Study|Withdrawal by Subject|3|||
160804689|NCT00889707|580673382|FG000|Overall Study|Lost to Follow-up|0|||
160804690|NCT00889707|580673383|FG001|Overall Study|Lost to Follow-up|2|||
160804691|NCT00889707|580673382|FG000|Overall Study|Lack of Efficacy|2|||
160804692|NCT00889707|580673383|FG001|Overall Study|Lack of Efficacy|5|||
160804693|NCT02756403|580673385|FG000|Overall Study|Unable to swallow medication|0|||
160804694|NCT02756403|580673386|FG001|Overall Study|Unable to swallow medication|1|||
160804695|NCT02756403|580673387|FG002|Overall Study|Unable to swallow medication|1|||
160804696|NCT02756403|580673388|FG003|Overall Study|Unable to swallow medication|1|||
160804697|NCT02756403|580673385|FG000|Overall Study|Did not complete Procedure|0|||
160804698|NCT02756403|580673386|FG001|Overall Study|Did not complete Procedure|1|||
160804699|NCT02756403|580673387|FG002|Overall Study|Did not complete Procedure|0|||
160804700|NCT02756403|580673388|FG003|Overall Study|Did not complete Procedure|0|||
160804701|NCT02756403|580673385|FG000|Overall Study|Changed Mind About Procedure|0|||
160804702|NCT02756403|580673386|FG001|Overall Study|Changed Mind About Procedure|0|||
160804703|NCT02756403|580673387|FG002|Overall Study|Changed Mind About Procedure|1|||
160804704|NCT02756403|580673388|FG003|Overall Study|Changed Mind About Procedure|0|||
160804705|NCT02756403|580673385|FG000|Overall Study|Protocol Violation|0|||
160804706|NCT02756403|580673386|FG001|Overall Study|Protocol Violation|1|||
160804707|NCT02756403|580673387|FG002|Overall Study|Protocol Violation|0|||
160804708|NCT02756403|580673388|FG003|Overall Study|Protocol Violation|1|||
160804709|NCT01151020|580673389|FG000|Overall Study|Death|25|||
160804710|NCT01151020|580673389|FG000|Overall Study|Conversion to open repair|1|||
160804711|NCT01151020|580673389|FG000|Overall Study|Lost to Follow-up|4|||
160804712|NCT01151020|580673389|FG000|Overall Study|Withdrawal by Subject|22|||
160804713|NCT01151020|580673389|FG000|Overall Study|Patients did not receive the device|2|||
160804714|NCT01635998|580673390|FG000|Overall Study|Death|1|||
160804715|NCT01635998|580673391|FG001|Overall Study|Death|1|||
160804716|NCT01635998|580673390|FG000|Overall Study|Lost to Follow-up|2|||
160804717|NCT01635998|580673391|FG001|Overall Study|Lost to Follow-up|1|||
160804718|NCT01635998|580673390|FG000|Overall Study|Withdrawal by Subject|1|||
160804719|NCT01635998|580673391|FG001|Overall Study|Withdrawal by Subject|5|||
160804720|NCT00846846|580673392|FG000|Overall Study|Death|56|||
160804721|NCT00846846|580673392|FG000|Overall Study|Withdrawal by Subject|19|||
160804722|NCT02967679|580673396|FG000|Overall Study|Adverse Event|1|||
160804723|NCT00600067|580673399|FG000|Overall Study|Adverse Event|0|||
160804724|NCT00600067|580673400|FG001|Overall Study|Adverse Event|1|||
160804725|NCT00600067|580673399|FG000|Overall Study|Lost to Follow-up|2|||
160804726|NCT00600067|580673400|FG001|Overall Study|Lost to Follow-up|3|||
160804727|NCT00600067|580673399|FG000|Overall Study|protocol non-compliance|0|||
160804728|NCT00600067|580673400|FG001|Overall Study|protocol non-compliance|3|||
160804729|NCT00600067|580673399|FG000|Overall Study|Lack of Efficacy|1|||
160804730|NCT00600067|580673400|FG001|Overall Study|Lack of Efficacy|0|||
160804731|NCT00003631|580673401|FG000|Overall Study|Patient not treated|1|||
160804732|NCT00003631|580673402|FG001|Overall Study|Patient not treated|0|||
160804733|NCT00003631|580673403|FG002|Overall Study|Patient not treated|1|||
160804734|NCT00003631|580673401|FG000|Overall Study|Protocol Violation|1|||
160804735|NCT00003631|580673402|FG001|Overall Study|Protocol Violation|0|||
160804736|NCT00003631|580673403|FG002|Overall Study|Protocol Violation|0|||
160804737|NCT00003631|580673401|FG000|Overall Study|Adverse Event|1|||
160804738|NCT00003631|580673402|FG001|Overall Study|Adverse Event|1|||
160804739|NCT00003631|580673403|FG002|Overall Study|Adverse Event|5|||
160804740|NCT00003631|580673401|FG000|Overall Study|Death|0|||
160804741|NCT00003631|580673402|FG001|Overall Study|Death|0|||
160804742|NCT00003631|580673403|FG002|Overall Study|Death|1|||
160804743|NCT00003631|580673401|FG000|Overall Study|Evaluable for toxicity only|0|||
161129982|NCT02913313|581863327|FG000|Overall Study|DISEASE PROGRESSION|1|||
160804744|NCT00003631|580673402|FG001|Overall Study|Evaluable for toxicity only|0|||
160804745|NCT00003631|580673403|FG002|Overall Study|Evaluable for toxicity only|2|||
160804746|NCT00881894|580673405|FG000|Overall Study|Consent withdrawn|0|||
160804747|NCT00881894|580673406|FG001|Overall Study|Consent withdrawn|1|||
160804748|NCT00881894|580673405|FG000|Overall Study|Other reasons for premature termination|1|||
160804749|NCT00881894|580673406|FG001|Overall Study|Other reasons for premature termination|2|||
160804750|NCT01220401|580673411|FG000|Overall Study|Withdrawal by Subject|2|||
160804751|NCT01220401|580673411|FG000|Overall Study|Protocol Violation|1|||
160804752|NCT01853462|580673412|FG000|Overall Study|Withdrawal by Subject|1|||
160804753|NCT01853462|580673413|FG001|Overall Study|Withdrawal by Subject|1|||
160804754|NCT02103062|580673414|FG000|Overall Study|Adverse Event|1|||
160804755|NCT02103062|580673415|FG001|Overall Study|Adverse Event|2|||
160804756|NCT02103062|580673414|FG000|Overall Study|Progressive Disease|17|||
160804757|NCT02103062|580673415|FG001|Overall Study|Progressive Disease|20|||
160804758|NCT02103062|580673414|FG000|Overall Study|Death|0|||
160804759|NCT02103062|580673415|FG001|Overall Study|Death|1|||
160804760|NCT03958331|580673416|FG000|Overall Study|Withdrawal by Subject|3|||
160804761|NCT03958331|580673417|FG001|Overall Study|Withdrawal by Subject|1|||
160804762|NCT03958331|580673418|FG002|Overall Study|Withdrawal by Subject|5|||
160804763|NCT03958331|580673416|FG000|Overall Study|Weaned from medicine|2|||
160804764|NCT03958331|580673417|FG001|Overall Study|Weaned from medicine|0|||
160804765|NCT03958331|580673418|FG002|Overall Study|Weaned from medicine|0|||
160804766|NCT03958331|580673416|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
160985277|NCT01347645|581335409|FG000|Overall Study|Physician Decision|0|||
160804767|NCT03958331|580673417|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
160804768|NCT03958331|580673418|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
160804769|NCT01991483|580673419|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
160804770|NCT01991483|580673420|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
160804771|NCT01991483|580673421|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
160804772|NCT01991483|580673422|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
160804773|NCT01991483|580673419|FG000|Dose Level 600 mg|Physician Decision|0|||
160804774|NCT01991483|580673420|FG001|Dose Level 600 mg|Physician Decision|0|||
160804775|NCT01991483|580673421|FG002|Dose Level 600 mg|Physician Decision|1|||
160804776|NCT01991483|580673422|FG003|Dose Level 600 mg|Physician Decision|0|||
160804777|NCT01991483|580673419|FG000|Dose Level 1000 mg|Protocol Violation|0|||
160804778|NCT01991483|580673420|FG001|Dose Level 1000 mg|Protocol Violation|0|||
160804779|NCT01991483|580673421|FG002|Dose Level 1000 mg|Protocol Violation|0|||
160804780|NCT01991483|580673422|FG003|Dose Level 1000 mg|Protocol Violation|1|||
160804781|NCT02030821|580673423|FG000|Overall Study|Physician Decision|2|||
160804782|NCT02030821|580673424|FG001|Overall Study|Physician Decision|2|||
160804783|NCT02030821|580673425|FG002|Overall Study|Physician Decision|5|||
160804784|NCT02030821|580673426|FG003|Overall Study|Physician Decision|2|||
160804785|NCT03192137|580673427|FG000|Overall Study|Adverse Event|10|||
160804786|NCT03192137|580673428|FG001|Overall Study|Adverse Event|11|||
160804787|NCT03192137|580673427|FG000|Overall Study|Physician Decision|1|||
160804788|NCT03192137|580673428|FG001|Overall Study|Physician Decision|0|||
160804789|NCT03192137|580673427|FG000|Overall Study|Lack of Efficacy|20|||
160804790|NCT03192137|580673428|FG001|Overall Study|Lack of Efficacy|37|||
160804791|NCT03192137|580673427|FG000|Overall Study|Withdrawal by Subject|3|||
160804792|NCT03192137|580673428|FG001|Overall Study|Withdrawal by Subject|3|||
160804793|NCT03192137|580673427|FG000|Overall Study|Protocol Violation|4|||
160804794|NCT03192137|580673428|FG001|Overall Study|Protocol Violation|3|||
160804795|NCT03192137|580673427|FG000|Overall Study|Surgery Cancelled|4|||
160804796|NCT03192137|580673428|FG001|Overall Study|Surgery Cancelled|1|||
160804797|NCT03192137|580673427|FG000|Overall Study|Other - Various Administrative Reasons|8|||
160804798|NCT03192137|580673428|FG001|Overall Study|Other - Various Administrative Reasons|3|||
160804799|NCT00972023|580674555|FG000|Overall Study|Withdrawal by Subject|1|||
160804800|NCT01428219|580674567|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
160804801|NCT00825994|580674568|FG000|Overall Study|Withdrawal by Subject|2|||
160804802|NCT00825994|580674568|FG000|Overall Study|Lost to Follow-up|1|||
160804803|NCT00825994|580674568|FG000|Overall Study|Protocol Violation|1|||
160804804|NCT00825994|580674568|FG000|Overall Study|Placebo Responder at V2|1|||
160804805|NCT01665911|580674573|FG000|Overall Study|Protocol Violation|4|||
160804806|NCT01665911|580674573|FG000|Overall Study|Withdrawal by Subject|1|||
160804807|NCT01665911|580674573|FG000|Overall Study|Adverse Event|1|||
160804808|NCT01484496|580674574|FG000|Period 1|Protocol Violation|3|||
160804809|NCT01484496|580674575|FG001|Period 1|Protocol Violation|4|||
160804810|NCT01484496|580674576|FG002|Period 1|Protocol Violation|0|||
160804811|NCT01484496|580674577|FG003|Period 1|Protocol Violation|0|||
160804812|NCT01484496|580674574|FG000|Period 1|Physician Decision|5|||
160804813|NCT01484496|580674575|FG001|Period 1|Physician Decision|1|||
160804814|NCT01484496|580674576|FG002|Period 1|Physician Decision|0|||
160804815|NCT01484496|580674577|FG003|Period 1|Physician Decision|0|||
160804816|NCT01484496|580674574|FG000|Period 1|Lack of Efficacy|10|||
160804817|NCT01484496|580674575|FG001|Period 1|Lack of Efficacy|15|||
160804818|NCT01484496|580674576|FG002|Period 1|Lack of Efficacy|0|||
160804819|NCT01484496|580674577|FG003|Period 1|Lack of Efficacy|0|||
160897833|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
160897834|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
160897835|NCT01736124|581021462|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
160897836|NCT01736124|581021463|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
160897837|NCT04176705|581021465|FG000|Overall Study|Withdrawal by Subject|4|||
160897838|NCT04176705|581021466|FG001|Overall Study|Withdrawal by Subject|4|||
160897839|NCT04176705|581021465|FG000|Overall Study|Death|1|||
160897840|NCT04176705|581021466|FG001|Overall Study|Death|1|||
160897841|NCT04176705|581021465|FG000|Overall Study|Lost to Follow-up|3|||
160804820|NCT01484496|580674574|FG000|Period 1|Adverse Event|25|||
160804821|NCT01484496|580674575|FG001|Period 1|Adverse Event|40|||
160804822|NCT01484496|580674576|FG002|Period 1|Adverse Event|0|||
160804823|NCT01484496|580674577|FG003|Period 1|Adverse Event|0|||
160804824|NCT01484496|580674574|FG000|Period 1|Withdrawal by Subject|15|||
160804825|NCT01484496|580674575|FG001|Period 1|Withdrawal by Subject|12|||
160804826|NCT01484496|580674576|FG002|Period 1|Withdrawal by Subject|0|||
160897842|NCT04176705|581021466|FG001|Overall Study|Lost to Follow-up|3|||
160897843|NCT02628769|581021467|FG000|First Intervention|Adverse Event|1|||
160897844|NCT02628769|581021468|FG001|First Intervention|Adverse Event|0|||
160804827|NCT01484496|580674577|FG003|Period 1|Withdrawal by Subject|0|||
160804828|NCT01484496|580674574|FG000|Period 1|Lost to Follow-up|2|||
160804829|NCT01484496|580674575|FG001|Period 1|Lost to Follow-up|6|||
160804830|NCT01484496|580674576|FG002|Period 1|Lost to Follow-up|0|||
160804831|NCT01484496|580674577|FG003|Period 1|Lost to Follow-up|0|||
160804832|NCT01484496|580674574|FG000|Period 1|Positive Pregnancy|1|||
160804833|NCT01484496|580674575|FG001|Period 1|Positive Pregnancy|6|||
160804834|NCT01484496|580674576|FG002|Period 1|Positive Pregnancy|0|||
160804835|NCT01484496|580674577|FG003|Period 1|Positive Pregnancy|0|||
160804836|NCT01484496|580674574|FG000|Period 1|Treatment Failure|3|||
160804837|NCT01484496|580674575|FG001|Period 1|Treatment Failure|6|||
160804838|NCT01484496|580674576|FG002|Period 1|Treatment Failure|0|||
160804839|NCT01484496|580674577|FG003|Period 1|Treatment Failure|0|||
160804840|NCT01484496|580674574|FG000|Period 1|Lack of Compliance|2|||
160804841|NCT01484496|580674575|FG001|Period 1|Lack of Compliance|1|||
160804842|NCT01484496|580674576|FG002|Period 1|Lack of Compliance|0|||
160804843|NCT01484496|580674577|FG003|Period 1|Lack of Compliance|0|||
160804844|NCT01484496|580674574|FG000|Period 1|Unable to Visit Site|0|||
160804845|NCT01484496|580674575|FG001|Period 1|Unable to Visit Site|2|||
160804846|NCT01484496|580674576|FG002|Period 1|Unable to Visit Site|0|||
160804847|NCT01484496|580674577|FG003|Period 1|Unable to Visit Site|0|||
160804848|NCT01484496|580674574|FG000|Period 2|Lack of Efficacy|0|||
160804849|NCT01484496|580674575|FG001|Period 2|Lack of Efficacy|0|||
160804850|NCT01484496|580674576|FG002|Period 2|Lack of Efficacy|1|||
160804851|NCT01484496|580674577|FG003|Period 2|Lack of Efficacy|3|||
160804852|NCT01484496|580674574|FG000|Period 2|Adverse Event|0|||
160804853|NCT01484496|580674575|FG001|Period 2|Adverse Event|0|||
160804854|NCT01484496|580674576|FG002|Period 2|Adverse Event|5|||
160804855|NCT01484496|580674577|FG003|Period 2|Adverse Event|13|||
160804856|NCT01484496|580674574|FG000|Period 2|Other|0|||
160804857|NCT01484496|580674575|FG001|Period 2|Other|0|||
160804858|NCT01484496|580674576|FG002|Period 2|Other|9|||
160804859|NCT01484496|580674577|FG003|Period 2|Other|6|||
160804860|NCT01645735|580674578|FG000|Overall Study|Physician Decision|2|||
161332263|NCT01249417|582603566|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
161332264|NCT02035553|582603567|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
161332265|NCT02035553|582603568|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
161332266|NCT02035553|582603567|FG000|Overall Study|Adverse Event|10|||
160804861|NCT01645735|580674579|FG001|Overall Study|Physician Decision|0|||
160804862|NCT01645735|580674578|FG000|Overall Study|Withdrawal by Subject|1|||
160804863|NCT01645735|580674579|FG001|Overall Study|Withdrawal by Subject|0|||
160804864|NCT01645735|580674578|FG000|Overall Study|Protocol Violation|1|||
160804865|NCT01645735|580674579|FG001|Overall Study|Protocol Violation|0|||
160804866|NCT01645735|580674578|FG000|Overall Study|Adverse Event|0|||
160804867|NCT01645735|580674579|FG001|Overall Study|Adverse Event|1|||
160804868|NCT02010593|580674580|FG000|Overall Study|Lost to Follow-up|1|||
160804869|NCT02010593|580674581|FG001|Overall Study|Lost to Follow-up|0|||
160804870|NCT02010593|580674580|FG000|Overall Study|Physician Decision|1|||
160804871|NCT02010593|580674581|FG001|Overall Study|Physician Decision|0|||
160804872|NCT02010593|580674580|FG000|Overall Study|Unable to adhere to visit schedule|0|||
160804873|NCT02010593|580674581|FG001|Overall Study|Unable to adhere to visit schedule|2|||
160804874|NCT01887717|580674582|FG000|Overall Study|Withdrawal by Subject|1|||
160804875|NCT01887717|580674583|FG001|Overall Study|Withdrawal by Subject|7|||
160804876|NCT01887717|580674582|FG000|Overall Study|Physician Decision|0|||
160804877|NCT01887717|580674583|FG001|Overall Study|Physician Decision|2|||
160804878|NCT01887717|580674582|FG000|Overall Study|Administrative reasons|5|||
160804879|NCT01887717|580674583|FG001|Overall Study|Administrative reasons|2|||
160804880|NCT01299389|580674584|FG000|Double-blind|Adverse Event|45|||
160804881|NCT01299389|580674585|FG001|Double-blind|Adverse Event|27|||
160897845|NCT02628769|581021467|FG000|First Intervention|Withdrawal by Subject|0|||
160897846|NCT02628769|581021468|FG001|First Intervention|Withdrawal by Subject|1|||
160897847|NCT02628769|581021467|FG000|Second Intervention|Adverse Event|2|||
160897848|NCT02628769|581021468|FG001|Second Intervention|Adverse Event|0|||
160897849|NCT02628769|581021467|FG000|Second Intervention|Physician Decision|0|||
160897850|NCT02628769|581021468|FG001|Second Intervention|Physician Decision|1|||
160897851|NCT01467583|581021469|FG000|Overall Study|Death|1|||
160897852|NCT01467583|581021470|FG001|Overall Study|Death|1|||
160897853|NCT01467583|581021471|FG002|Overall Study|Death|0|||
160897854|NCT01467583|581021469|FG000|Overall Study|Withdrawal by Subject|1|||
160897855|NCT01467583|581021470|FG001|Overall Study|Withdrawal by Subject|0|||
160897856|NCT01467583|581021471|FG002|Overall Study|Withdrawal by Subject|0|||
160897857|NCT01467583|581021469|FG000|Overall Study|Protocol Violation|0|||
160897858|NCT01467583|581021470|FG001|Overall Study|Protocol Violation|0|||
160897859|NCT01467583|581021471|FG002|Overall Study|Protocol Violation|2|||
160897860|NCT05274165|581021473|FG000|Overall Study|Withdrawal by Subject|3|||
160897861|NCT05274165|581021474|FG001|Overall Study|Withdrawal by Subject|3|||
160897862|NCT02296684|581021476|FG000|Overall Study|Withdrawal by Subject|0|||
160804882|NCT01299389|580674586|FG002|Double-blind|Adverse Event|0|||
160804883|NCT01299389|580674587|FG003|Double-blind|Adverse Event|0|||
160804884|NCT01299389|580674584|FG000|Double-blind|Lack of Efficacy|45|||
160804885|NCT01299389|580674585|FG001|Double-blind|Lack of Efficacy|21|||
160804886|NCT01299389|580674586|FG002|Double-blind|Lack of Efficacy|0|||
160804887|NCT01299389|580674587|FG003|Double-blind|Lack of Efficacy|0|||
160804888|NCT01299389|580674584|FG000|Double-blind|Lost to Follow-up|2|||
160804889|NCT01299389|580674585|FG001|Double-blind|Lost to Follow-up|1|||
160804890|NCT01299389|580674586|FG002|Double-blind|Lost to Follow-up|0|||
160985278|NCT01347645|581335410|FG001|Overall Study|Physician Decision|0|||
160985279|NCT01347645|581335411|FG002|Overall Study|Physician Decision|0|||
160985280|NCT01347645|581335412|FG003|Overall Study|Physician Decision|0|||
160985281|NCT01347645|581335413|FG004|Overall Study|Physician Decision|1|||
160985282|NCT01347645|581335409|FG000|Overall Study|Adverse Event|0|||
160985283|NCT01347645|581335410|FG001|Overall Study|Adverse Event|0|||
160985284|NCT01347645|581335411|FG002|Overall Study|Adverse Event|0|||
160985285|NCT01347645|581335412|FG003|Overall Study|Adverse Event|1|||
160985286|NCT01347645|581335413|FG004|Overall Study|Adverse Event|1|||
161129983|NCT02913313|581863328|FG001|Overall Study|DISEASE PROGRESSION|2|||
161129984|NCT02913313|581863329|FG002|Overall Study|DISEASE PROGRESSION|2|||
161129985|NCT02913313|581863330|FG003|Overall Study|DISEASE PROGRESSION|4|||
161129986|NCT02913313|581863331|FG004|Overall Study|DISEASE PROGRESSION|6|||
160804891|NCT01299389|580674587|FG003|Double-blind|Lost to Follow-up|0|||
160804892|NCT01299389|580674584|FG000|Double-blind|Withdrawal by Subject|16|||
160804893|NCT01299389|580674585|FG001|Double-blind|Withdrawal by Subject|13|||
160804894|NCT01299389|580674586|FG002|Double-blind|Withdrawal by Subject|0|||
160804895|NCT01299389|580674587|FG003|Double-blind|Withdrawal by Subject|0|||
160804896|NCT01299389|580674584|FG000|Double-blind|Other|1|||
160804897|NCT01299389|580674585|FG001|Double-blind|Other|1|||
160804898|NCT01299389|580674586|FG002|Double-blind|Other|0|||
160804899|NCT01299389|580674587|FG003|Double-blind|Other|0|||
160804900|NCT01299389|580674584|FG000|Double-blind|"fail to meet study population criteria"|0|||
160804901|NCT01299389|580674585|FG001|Double-blind|"fail to meet study population criteria"|1|||
160804902|NCT01299389|580674586|FG002|Double-blind|"fail to meet study population criteria"|0|||
160804903|NCT01299389|580674587|FG003|Double-blind|"fail to meet study population criteria"|0|||
160804904|NCT01299389|580674584|FG000|Post-observational|Other|0|||
160804905|NCT01299389|580674585|FG001|Post-observational|Other|0|||
160804906|NCT01299389|580674586|FG002|Post-observational|Other|12|||
160804907|NCT01299389|580674587|FG003|Post-observational|Other|6|||
160804908|NCT03637491|580674588|FG000|Overall Study|Death|9|||
160804909|NCT03637491|580674589|FG001|Overall Study|Death|9|||
160804910|NCT03637491|580674590|FG002|Overall Study|Death|5|||
160804911|NCT03637491|580674591|FG003|Overall Study|Death|3|||
160804912|NCT03637491|580674588|FG000|Overall Study|Lost to Follow-up|0|||
160804913|NCT03637491|580674589|FG001|Overall Study|Lost to Follow-up|1|||
160804914|NCT03637491|580674590|FG002|Overall Study|Lost to Follow-up|0|||
160804915|NCT03637491|580674591|FG003|Overall Study|Lost to Follow-up|1|||
160804916|NCT03637491|580674588|FG000|Overall Study|Study Terminated By Sponsor|0|||
160804917|NCT03637491|580674589|FG001|Overall Study|Study Terminated By Sponsor|2|||
160804918|NCT03637491|580674590|FG002|Overall Study|Study Terminated By Sponsor|1|||
160804919|NCT03637491|580674591|FG003|Overall Study|Study Terminated By Sponsor|0|||
160804920|NCT03637491|580674588|FG000|Overall Study|Withdrawal by Subject|1|||
160804921|NCT03637491|580674589|FG001|Overall Study|Withdrawal by Subject|0|||
160804922|NCT03637491|580674590|FG002|Overall Study|Withdrawal by Subject|1|||
160804923|NCT03637491|580674591|FG003|Overall Study|Withdrawal by Subject|2|||
160804924|NCT02185534|580674593|FG000|First Period|Withdrawal by Subject|0|||
160804925|NCT02185534|580674594|FG001|First Period|Withdrawal by Subject|0|||
160804926|NCT02185534|580674595|FG002|First Period|Withdrawal by Subject|0|||
160804927|NCT02185534|580674596|FG003|First Period|Withdrawal by Subject|1|||
160804928|NCT02185534|580674597|FG004|First Period|Withdrawal by Subject|0|||
160804929|NCT02185534|580674598|FG005|First Period|Withdrawal by Subject|0|||
160804930|NCT02185534|580674593|FG000|First Washout Period|Withdrawal by Subject|1|||
160804931|NCT02185534|580674594|FG001|First Washout Period|Withdrawal by Subject|0|||
160804932|NCT02185534|580674595|FG002|First Washout Period|Withdrawal by Subject|0|||
160804933|NCT02185534|580674596|FG003|First Washout Period|Withdrawal by Subject|0|||
160804934|NCT02185534|580674597|FG004|First Washout Period|Withdrawal by Subject|1|||
160804935|NCT02185534|580674598|FG005|First Washout Period|Withdrawal by Subject|0|||
160804936|NCT02185534|580674593|FG000|First Washout Period|Protocol Violation|0|||
160804937|NCT02185534|580674594|FG001|First Washout Period|Protocol Violation|0|||
160804938|NCT02185534|580674595|FG002|First Washout Period|Protocol Violation|0|||
160804939|NCT02185534|580674596|FG003|First Washout Period|Protocol Violation|0|||
160804940|NCT02185534|580674597|FG004|First Washout Period|Protocol Violation|0|||
160804941|NCT02185534|580674598|FG005|First Washout Period|Protocol Violation|1|||
160804942|NCT04419467|580674601|FG000|Overall Study|Not treated with IP|0|||
160804943|NCT04419467|580674602|FG001|Overall Study|Not treated with IP|0|||
160804944|NCT04419467|580674603|FG002|Overall Study|Not treated with IP|2|||
160804945|NCT04419467|580674601|FG000|Overall Study|Adverse Event|0|||
160804946|NCT04419467|580674602|FG001|Overall Study|Adverse Event|2|||
160804947|NCT04419467|580674603|FG002|Overall Study|Adverse Event|0|||
161129987|NCT02913313|581863332|FG005|Overall Study|DISEASE PROGRESSION|4|||
160804948|NCT04419467|580674601|FG000|Overall Study|Death|1|||
160985287|NCT00184028|581335414|FG000|Overall Study|Death|1|||
160985288|NCT00184028|581335414|FG000|Overall Study|Lack of Efficacy|4|||
160985289|NCT00184028|581335414|FG000|Overall Study|Adverse Event|2|||
161129988|NCT02913313|581863333|FG006|Overall Study|DISEASE PROGRESSION|19|||
161129989|NCT02913313|581863334|FG007|Overall Study|DISEASE PROGRESSION|3|||
161129990|NCT02913313|581863335|FG008|Overall Study|DISEASE PROGRESSION|4|||
161129991|NCT02913313|581863336|FG009|Overall Study|DISEASE PROGRESSION|4|||
161129992|NCT02913313|581863337|FG010|Overall Study|DISEASE PROGRESSION|11|||
161129993|NCT02913313|581863338|FG011|Overall Study|DISEASE PROGRESSION|5|||
161129994|NCT02913313|581863339|FG012|Overall Study|DISEASE PROGRESSION|14|||
161129995|NCT02913313|581863340|FG013|Overall Study|DISEASE PROGRESSION|3|||
161129996|NCT02913313|581863327|FG000|Overall Study|Not Reported|0|||
160804949|NCT04419467|580674602|FG001|Overall Study|Death|0|||
160804950|NCT04419467|580674603|FG002|Overall Study|Death|0|||
160804951|NCT04419467|580674601|FG000|Overall Study|Lost to Follow-up|0|||
160804952|NCT04419467|580674602|FG001|Overall Study|Lost to Follow-up|1|||
160804953|NCT04419467|580674603|FG002|Overall Study|Lost to Follow-up|2|||
160804954|NCT04419467|580674601|FG000|Overall Study|Withdrawal by Subject|0|||
160804955|NCT04419467|580674602|FG001|Overall Study|Withdrawal by Subject|0|||
160804956|NCT04419467|580674603|FG002|Overall Study|Withdrawal by Subject|4|||
160804957|NCT04419467|580674601|FG000|Overall Study|Pandemic related|0|||
160804958|NCT04419467|580674602|FG001|Overall Study|Pandemic related|0|||
160804959|NCT04419467|580674603|FG002|Overall Study|Pandemic related|1|||
160804960|NCT04419467|580674601|FG000|Overall Study|Reason not known|1|||
160804961|NCT04419467|580674602|FG001|Overall Study|Reason not known|0|||
160804962|NCT04419467|580674603|FG002|Overall Study|Reason not known|0|||
160804963|NCT04571060|580674609|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
160804964|NCT04571060|580674610|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
160804965|NCT04571060|580674609|FG000|Overall Study|Never treated migraine|47|||
160804966|NCT04571060|580674610|FG001|Overall Study|Never treated migraine|36|||
160804967|NCT04571060|580674609|FG000|Overall Study|Protocol Violation|4|||
160804968|NCT04571060|580674610|FG001|Overall Study|Protocol Violation|2|||
160804969|NCT04571060|580674609|FG000|Overall Study|Withdrawal by Subject|6|||
160804970|NCT04571060|580674610|FG001|Overall Study|Withdrawal by Subject|2|||
160804971|NCT04571060|580674609|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
160804972|NCT04571060|580674610|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
160804973|NCT01253369|580674611|FG000|Overall Study|Adverse Event|4|||
160804974|NCT01253369|580674611|FG000|Overall Study|Withdrawal by Subject|2|||
160804975|NCT01253369|580674611|FG000|Overall Study|Death|1|||
160804976|NCT01253369|580674611|FG000|Overall Study|Progressive disease|23|||
160804977|NCT01253369|580674611|FG000|Overall Study|Not Evaluable|3|||
160804978|NCT03943290|580674614|FG000|Overall Study|Sponsor Terminated Study|6|||
160804979|NCT03943290|580674615|FG001|Overall Study|Sponsor Terminated Study|1|||
160804980|NCT03943290|580674616|FG002|Overall Study|Sponsor Terminated Study|11|||
160804981|NCT03943290|580674617|FG003|Overall Study|Sponsor Terminated Study|6|||
160804982|NCT03943290|580674618|FG004|Overall Study|Sponsor Terminated Study|7|||
160804983|NCT03943290|580674619|FG005|Overall Study|Sponsor Terminated Study|6|||
160804984|NCT03943290|580674620|FG006|Overall Study|Sponsor Terminated Study|6|||
160804985|NCT03943290|580674621|FG007|Overall Study|Sponsor Terminated Study|7|||
160804986|NCT03943290|580674622|FG008|Overall Study|Sponsor Terminated Study|8|||
160804987|NCT03943290|580674614|FG000|Overall Study|Lost to Follow-up|1|||
160804988|NCT03943290|580674615|FG001|Overall Study|Lost to Follow-up|0|||
160804989|NCT03943290|580674616|FG002|Overall Study|Lost to Follow-up|1|||
160804990|NCT03943290|580674617|FG003|Overall Study|Lost to Follow-up|0|||
160804991|NCT03943290|580674618|FG004|Overall Study|Lost to Follow-up|0|||
160804992|NCT03943290|580674619|FG005|Overall Study|Lost to Follow-up|0|||
160804993|NCT03943290|580674620|FG006|Overall Study|Lost to Follow-up|0|||
160804994|NCT03943290|580674621|FG007|Overall Study|Lost to Follow-up|1|||
160804995|NCT03943290|580674622|FG008|Overall Study|Lost to Follow-up|0|||
160804996|NCT03943290|580674614|FG000|Overall Study|Withdrawal by Subject|0|||
160804997|NCT03943290|580674615|FG001|Overall Study|Withdrawal by Subject|0|||
161129997|NCT02913313|581863328|FG001|Overall Study|Not Reported|0|||
161129998|NCT02913313|581863329|FG002|Overall Study|Not Reported|0|||
161129999|NCT02913313|581863330|FG003|Overall Study|Not Reported|0|||
161130000|NCT02913313|581863331|FG004|Overall Study|Not Reported|1|||
161130001|NCT02913313|581863332|FG005|Overall Study|Not Reported|0|||
161332267|NCT02035553|582603568|FG001|Overall Study|Adverse Event|6|||
160804998|NCT03943290|580674616|FG002|Overall Study|Withdrawal by Subject|1|||
160804999|NCT03943290|580674617|FG003|Overall Study|Withdrawal by Subject|0|||
160985290|NCT00184028|581335414|FG000|Overall Study|Withdrawal by Subject|1|||
160985291|NCT00184028|581335414|FG000|Overall Study|Non-compliance|2|||
160805000|NCT03943290|580674618|FG004|Overall Study|Withdrawal by Subject|0|||
160805001|NCT03943290|580674619|FG005|Overall Study|Withdrawal by Subject|0|||
160805002|NCT03943290|580674620|FG006|Overall Study|Withdrawal by Subject|0|||
160805003|NCT03943290|580674621|FG007|Overall Study|Withdrawal by Subject|0|||
160805004|NCT03943290|580674622|FG008|Overall Study|Withdrawal by Subject|0|||
161130002|NCT02913313|581863333|FG006|Overall Study|Not Reported|0|||
161130003|NCT02913313|581863334|FG007|Overall Study|Not Reported|0|||
161130004|NCT02913313|581863335|FG008|Overall Study|Not Reported|0|||
161130005|NCT02913313|581863336|FG009|Overall Study|Not Reported|0|||
161130006|NCT02913313|581863337|FG010|Overall Study|Not Reported|4|||
161130007|NCT02913313|581863338|FG011|Overall Study|Not Reported|0|||
161130008|NCT02913313|581863339|FG012|Overall Study|Not Reported|0|||
161130009|NCT02913313|581863340|FG013|Overall Study|Not Reported|0|||
160805005|NCT04179305|580674623|FG000|Overall Study|Death|1|||
160805006|NCT04179305|580674624|FG001|Overall Study|Death|1|||
160805007|NCT04179305|580674625|FG002|Overall Study|Death|0|||
160805008|NCT04179305|580674626|FG003|Overall Study|Death|0|||
161237562|NCT00984126|582250221|FG002|Overall Study|Adverse Event|0|||
160805009|NCT04179305|580674623|FG000|Overall Study|Lost to Follow-up|1|||
160805010|NCT04179305|580674624|FG001|Overall Study|Lost to Follow-up|1|||
160805011|NCT04179305|580674625|FG002|Overall Study|Lost to Follow-up|0|||
160805012|NCT04179305|580674626|FG003|Overall Study|Lost to Follow-up|0|||
160805013|NCT04179305|580674623|FG000|Overall Study|Withdrawal by Subject|0|||
160805014|NCT04179305|580674624|FG001|Overall Study|Withdrawal by Subject|1|||
160805015|NCT04179305|580674625|FG002|Overall Study|Withdrawal by Subject|0|||
160805016|NCT04179305|580674626|FG003|Overall Study|Withdrawal by Subject|0|||
160805017|NCT04179305|580674623|FG000|Overall Study|Did not have scan|1|||
160805018|NCT04179305|580674624|FG001|Overall Study|Did not have scan|0|||
160805019|NCT04179305|580674625|FG002|Overall Study|Did not have scan|0|||
160805020|NCT04179305|580674626|FG003|Overall Study|Did not have scan|0|||
160805021|NCT04179305|580674623|FG000|Overall Study|In hospice care|3|||
160805022|NCT04179305|580674624|FG001|Overall Study|In hospice care|0|||
160805023|NCT04179305|580674625|FG002|Overall Study|In hospice care|0|||
160805024|NCT04179305|580674626|FG003|Overall Study|In hospice care|0|||
160805025|NCT01737762|580674629|FG000|Overall Study|Adverse Event|2|||
160805026|NCT01737762|580674630|FG001|Overall Study|Adverse Event|2|||
160805027|NCT01737762|580674629|FG000|Overall Study|Lost to Follow-up|1|||
160805028|NCT01737762|580674630|FG001|Overall Study|Lost to Follow-up|0|||
160805029|NCT01737762|580674629|FG000|Overall Study|Withdrawal by Subject|2|||
160805030|NCT01737762|580674630|FG001|Overall Study|Withdrawal by Subject|2|||
160805031|NCT01737762|580674629|FG000|Overall Study|Progressive disease|1|||
160805032|NCT01737762|580674630|FG001|Overall Study|Progressive disease|2|||
160805033|NCT01737762|580674629|FG000|Overall Study|Physician Decision|1|||
160805034|NCT01737762|580674630|FG001|Overall Study|Physician Decision|1|||
160805035|NCT01737762|580674629|FG000|Overall Study|Moved from area|2|||
160805036|NCT01737762|580674630|FG001|Overall Study|Moved from area|1|||
160805037|NCT01737762|580674629|FG000|Overall Study|Trial termination|11|||
160805038|NCT01737762|580674630|FG001|Overall Study|Trial termination|9|||
160805039|NCT00326599|580674631|FG000|Overall Study|Withdrawal by Subject|1|||
160805040|NCT00326599|580674632|FG001|Overall Study|Withdrawal by Subject|0|||
160805041|NCT00326599|580674633|FG002|Overall Study|Withdrawal by Subject|5|||
160805042|NCT00326599|580674634|FG003|Overall Study|Withdrawal by Subject|2|||
160805043|NCT00326599|580674631|FG000|Overall Study|Adverse Event|1|||
160805044|NCT00326599|580674632|FG001|Overall Study|Adverse Event|0|||
160805045|NCT00326599|580674633|FG002|Overall Study|Adverse Event|32|||
160805046|NCT00326599|580674634|FG003|Overall Study|Adverse Event|3|||
160805047|NCT00326599|580674631|FG000|Overall Study|Disease Progression|3|||
160805048|NCT00326599|580674632|FG001|Overall Study|Disease Progression|1|||
160805049|NCT00326599|580674633|FG002|Overall Study|Disease Progression|13|||
160805050|NCT00326599|580674634|FG003|Overall Study|Disease Progression|11|||
160805051|NCT00326599|580674631|FG000|Overall Study|Alternate Treatment|1|||
160805052|NCT00326599|580674632|FG001|Overall Study|Alternate Treatment|0|||
160805053|NCT00326599|580674633|FG002|Overall Study|Alternate Treatment|0|||
160805054|NCT00326599|580674634|FG003|Overall Study|Alternate Treatment|0|||
160805055|NCT00326599|580674631|FG000|Overall Study|Death|0|||
160805056|NCT00326599|580674632|FG001|Overall Study|Death|0|||
160805057|NCT00326599|580674633|FG002|Overall Study|Death|1|||
160805058|NCT00326599|580674634|FG003|Overall Study|Death|2|||
160805059|NCT00326599|580674631|FG000|Overall Study|Other Unspecified Reason|0|||
160805060|NCT00326599|580674632|FG001|Overall Study|Other Unspecified Reason|0|||
160805061|NCT00326599|580674633|FG002|Overall Study|Other Unspecified Reason|2|||
160805062|NCT00326599|580674634|FG003|Overall Study|Other Unspecified Reason|1|||
160805063|NCT00625586|580674635|FG000|Overall Study|Adverse Event|1|||
160805064|NCT00625586|580674635|FG000|Overall Study|Progressive disease|1|||
160805065|NCT00437268|580674639|FG000|Overall Study|Adverse Event|1|||
160805066|NCT00437268|580674640|FG001|Overall Study|Adverse Event|1|||
160805067|NCT00437268|580674639|FG000|Overall Study|Withdrawal by Subject|2|||
160805068|NCT00437268|580674640|FG001|Overall Study|Withdrawal by Subject|2|||
160805069|NCT00437268|580674639|FG000|Overall Study|Progressive disease|9|||
160805070|NCT00437268|580674640|FG001|Overall Study|Progressive disease|9|||
160805071|NCT00437268|580674639|FG000|Overall Study|Physician Decision|1|||
160805072|NCT00437268|580674640|FG001|Overall Study|Physician Decision|0|||
160805073|NCT00437268|580674639|FG000|Overall Study|Death|0|||
160805074|NCT00437268|580674640|FG001|Overall Study|Death|1|||
160805075|NCT01085214|580674643|FG000|Overall Study|Alternate treatment required|1|||
160805076|NCT01985022|580674658|FG000|Overall Study|Lost to Follow-up|0|||
160805077|NCT01985022|580674659|FG001|Overall Study|Lost to Follow-up|1|||
160805078|NCT01985022|580674658|FG000|Overall Study|Protocol Violation|0|||
160805079|NCT01985022|580674659|FG001|Overall Study|Protocol Violation|1|||
160805080|NCT01985022|580674658|FG000|Overall Study|Withdrawal by Subject|4|||
160805081|NCT01985022|580674659|FG001|Overall Study|Withdrawal by Subject|1|||
160805082|NCT01152437|580674660|FG000|Overall Study|Other Adverse Event|8|||
160805083|NCT01152437|580674661|FG001|Overall Study|Other Adverse Event|1|||
160805084|NCT01152437|580674662|FG002|Overall Study|Other Adverse Event|7|||
160805085|NCT01152437|580674660|FG000|Overall Study|Not treated|0|||
160805086|NCT01152437|580674661|FG001|Overall Study|Not treated|1|||
160805087|NCT01152437|580674662|FG002|Overall Study|Not treated|2|||
160805088|NCT01152437|580674660|FG000|Overall Study|Progressive disease|27|||
160805089|NCT01152437|580674661|FG001|Overall Study|Progressive disease|13|||
160805090|NCT01152437|580674662|FG002|Overall Study|Progressive disease|32|||
160805091|NCT01152437|580674660|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
160805092|NCT01152437|580674661|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
160805093|NCT01152437|580674662|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
160805094|NCT02015039|580674663|FG000|Overall Study|Not eligible|0|||
160805095|NCT02015039|580674664|FG001|Overall Study|Not eligible|1|||
160805096|NCT03132467|580674665|FG000|Overall Study|Adverse Event|2|||
160805097|NCT03132467|580674665|FG000|Overall Study|Withdrawal by Subject|2|||
160805098|NCT01088906|580674666|FG000|Overall Study|Inclusion error|1|||
160805099|NCT01088906|580674666|FG000|Overall Study|Did not receive study treatment|3|||
160805100|NCT01088906|580674666|FG000|Overall Study|Missing data|1|||
160805101|NCT00457626|580674669|FG000|Overall Study|Adverse Event|3|||
160805102|NCT00457626|580674669|FG000|Overall Study|Administrative Problems|2|||
160897863|NCT02296684|581021477|FG001|Overall Study|Withdrawal by Subject|1|||
160897864|NCT02296684|581021478|FG002|Overall Study|Withdrawal by Subject|1|||
160897865|NCT02296684|581021476|FG000|Overall Study|Death|2|||
160897866|NCT02296684|581021477|FG001|Overall Study|Death|0|||
160897867|NCT02296684|581021478|FG002|Overall Study|Death|0|||
160897868|NCT03805646|581021479|FG000|Overall Study|Death|40|||
160897869|NCT03805646|581021480|FG001|Overall Study|Death|49|||
160897870|NCT03805646|581021479|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
160897871|NCT03805646|581021480|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
160897872|NCT04452344|581021481|FG000|Overall Study|Withdrawal by Subject|3|||
160897873|NCT04452344|581021482|FG001|Overall Study|Withdrawal by Subject|6|||
160897874|NCT04452344|581021481|FG000|Overall Study|Adverse Event|1|||
160897875|NCT04452344|581021482|FG001|Overall Study|Adverse Event|2|||
160897876|NCT04452344|581021481|FG000|Overall Study|Lost to Follow-up|2|||
160897877|NCT04452344|581021482|FG001|Overall Study|Lost to Follow-up|2|||
160897878|NCT04452344|581021481|FG000|Overall Study|No Post-Op Visit|6|||
160897879|NCT04452344|581021482|FG001|Overall Study|No Post-Op Visit|7|||
160897880|NCT05171777|581021483|FG000|Treatment Crossover Period|Adverse Event|9|||
160897881|NCT05171777|581021484|FG001|Treatment Crossover Period|Adverse Event|6|||
160897882|NCT05171777|581021485|FG002|Treatment Crossover Period|Adverse Event|0|||
160897883|NCT05171777|581021486|FG003|Treatment Crossover Period|Adverse Event|0|||
160897884|NCT05171777|581021483|FG000|Treatment Crossover Period|Death|5|||
160897885|NCT05171777|581021484|FG001|Treatment Crossover Period|Death|5|||
160897886|NCT05171777|581021485|FG002|Treatment Crossover Period|Death|0|||
160897887|NCT05171777|581021486|FG003|Treatment Crossover Period|Death|0|||
160897888|NCT05171777|581021483|FG000|Treatment Crossover Period|Disease Relapse|1|||
160897889|NCT05171777|581021484|FG001|Treatment Crossover Period|Disease Relapse|0|||
160897890|NCT05171777|581021485|FG002|Treatment Crossover Period|Disease Relapse|0|||
160897891|NCT05171777|581021486|FG003|Treatment Crossover Period|Disease Relapse|0|||
160897892|NCT05171777|581021483|FG000|Treatment Crossover Period|Reason not Specified|1|||
160897893|NCT05171777|581021484|FG001|Treatment Crossover Period|Reason not Specified|1|||
160897894|NCT05171777|581021485|FG002|Treatment Crossover Period|Reason not Specified|0|||
160897895|NCT05171777|581021486|FG003|Treatment Crossover Period|Reason not Specified|0|||
160897896|NCT05171777|581021483|FG000|Treatment Crossover Period|Physician Decision|0|||
160897897|NCT05171777|581021484|FG001|Treatment Crossover Period|Physician Decision|1|||
160897898|NCT05171777|581021485|FG002|Treatment Crossover Period|Physician Decision|0|||
160897899|NCT05171777|581021486|FG003|Treatment Crossover Period|Physician Decision|0|||
160897900|NCT05171777|581021483|FG000|Treatment Crossover Period|Progressive Disease|14|||
160897901|NCT05171777|581021484|FG001|Treatment Crossover Period|Progressive Disease|10|||
160897902|NCT05171777|581021485|FG002|Treatment Crossover Period|Progressive Disease|0|||
160897903|NCT05171777|581021486|FG003|Treatment Crossover Period|Progressive Disease|0|||
160897904|NCT05171777|581021483|FG000|Treatment Crossover Period|Protocol Violation|0|||
160897905|NCT05171777|581021484|FG001|Treatment Crossover Period|Protocol Violation|2|||
160897906|NCT05171777|581021485|FG002|Treatment Crossover Period|Protocol Violation|0|||
160897907|NCT05171777|581021486|FG003|Treatment Crossover Period|Protocol Violation|0|||
160897908|NCT05171777|581021483|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
160897909|NCT05171777|581021484|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
160897910|NCT05171777|581021485|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
160805103|NCT00457626|580674669|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
160805104|NCT01365455|580674670|FG000|Induction Period|Adverse Event|5|||
160897911|NCT05171777|581021486|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
160897912|NCT05171777|581021483|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
160897913|NCT05171777|581021484|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
160897914|NCT05171777|581021485|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
160805105|NCT01365455|580674671|FG001|Induction Period|Adverse Event|3|||
160805106|NCT01365455|580674672|FG002|Induction Period|Adverse Event|4|||
160805107|NCT01365455|580674673|FG003|Induction Period|Adverse Event|0|||
160805108|NCT01365455|580674674|FG004|Induction Period|Adverse Event|0|||
160805109|NCT01365455|580674670|FG000|Induction Period|Lack of Efficacy|1|||
160805110|NCT01365455|580674671|FG001|Induction Period|Lack of Efficacy|1|||
160805111|NCT01365455|580674672|FG002|Induction Period|Lack of Efficacy|0|||
160805112|NCT01365455|580674673|FG003|Induction Period|Lack of Efficacy|0|||
160805113|NCT01365455|580674674|FG004|Induction Period|Lack of Efficacy|0|||
160805114|NCT01365455|580674670|FG000|Induction Period|Pregnancy|0|||
160805115|NCT01365455|580674671|FG001|Induction Period|Pregnancy|1|||
160805116|NCT01365455|580674672|FG002|Induction Period|Pregnancy|0|||
160805117|NCT01365455|580674673|FG003|Induction Period|Pregnancy|0|||
160805118|NCT01365455|580674674|FG004|Induction Period|Pregnancy|0|||
160805119|NCT01365455|580674670|FG000|Induction Period|Protocol deviation|0|||
160805120|NCT01365455|580674671|FG001|Induction Period|Protocol deviation|1|||
160805121|NCT01365455|580674672|FG002|Induction Period|Protocol deviation|1|||
160805122|NCT01365455|580674673|FG003|Induction Period|Protocol deviation|0|||
160805123|NCT01365455|580674674|FG004|Induction Period|Protocol deviation|0|||
160805124|NCT01365455|580674670|FG000|Induction Period|Subject/guardian decision|9|||
160805125|NCT01365455|580674671|FG001|Induction Period|Subject/guardian decision|1|||
160985292|NCT00388362|581335415|FG000|Enrolled|Ineligible|1|||
160985293|NCT00388362|581335415|FG000|Enrolled|Adverse Event|9|||
160985294|NCT00388362|581335415|FG000|Enrolled|Death|1|||
160805126|NCT01365455|580674672|FG002|Induction Period|Subject/guardian decision|8|||
160805127|NCT01365455|580674673|FG003|Induction Period|Subject/guardian decision|0|||
160897915|NCT05171777|581021486|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
160897916|NCT05171777|581021483|FG000|Treatment Continuation Period|Adverse Event|0|||
160897917|NCT05171777|581021484|FG001|Treatment Continuation Period|Adverse Event|0|||
160897918|NCT05171777|581021485|FG002|Treatment Continuation Period|Adverse Event|3|||
160897919|NCT05171777|581021486|FG003|Treatment Continuation Period|Adverse Event|6|||
160897920|NCT05171777|581021483|FG000|Treatment Continuation Period|Death|0|||
160897921|NCT05171777|581021484|FG001|Treatment Continuation Period|Death|0|||
160897922|NCT05171777|581021485|FG002|Treatment Continuation Period|Death|1|||
160897923|NCT05171777|581021486|FG003|Treatment Continuation Period|Death|3|||
160897924|NCT05171777|581021483|FG000|Treatment Continuation Period|Disease Relapse|0|||
160897925|NCT05171777|581021484|FG001|Treatment Continuation Period|Disease Relapse|0|||
160897926|NCT05171777|581021485|FG002|Treatment Continuation Period|Disease Relapse|1|||
160897927|NCT05171777|581021486|FG003|Treatment Continuation Period|Disease Relapse|0|||
160897928|NCT05171777|581021483|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
160897929|NCT05171777|581021484|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
160897930|NCT05171777|581021485|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
160897931|NCT05171777|581021486|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
160897932|NCT05171777|581021483|FG000|Treatment Continuation Period|Physician Decision|0|||
160897933|NCT05171777|581021484|FG001|Treatment Continuation Period|Physician Decision|0|||
160897934|NCT05171777|581021485|FG002|Treatment Continuation Period|Physician Decision|0|||
160897935|NCT05171777|581021486|FG003|Treatment Continuation Period|Physician Decision|4|||
160897936|NCT05171777|581021483|FG000|Treatment Continuation Period|Progressive Disease|0|||
160897937|NCT05171777|581021484|FG001|Treatment Continuation Period|Progressive Disease|0|||
160897938|NCT05171777|581021485|FG002|Treatment Continuation Period|Progressive Disease|6|||
160897939|NCT05171777|581021486|FG003|Treatment Continuation Period|Progressive Disease|20|||
160897940|NCT05171777|581021483|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
160897941|NCT05171777|581021484|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
160897942|NCT05171777|581021485|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
160897943|NCT05171777|581021486|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
160897944|NCT05171777|581021483|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
160897945|NCT05171777|581021484|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
160897946|NCT05171777|581021485|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
160897947|NCT05171777|581021486|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
160897948|NCT05171777|581021483|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
160897949|NCT05171777|581021484|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
160897950|NCT05171777|581021485|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
160897951|NCT05171777|581021486|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
160897952|NCT02364713|581021487|FG000|Overall Study|Ineligible|2|||
160805128|NCT01365455|580674674|FG004|Induction Period|Subject/guardian decision|0|||
160805129|NCT01365455|580674670|FG000|Induction Period|Lost to Follow-up|0|||
160805130|NCT01365455|580674671|FG001|Induction Period|Lost to Follow-up|0|||
160897953|NCT02364713|581021488|FG001|Overall Study|Ineligible|2|||
160897954|NCT04686786|581021489|FG000|Overall Study|Adverse Event|9|||
160897955|NCT04686786|581021489|FG000|Overall Study|Death|1|||
160897956|NCT04686786|581021489|FG000|Overall Study|Lack of Efficacy|25|||
160805131|NCT01365455|580674672|FG002|Induction Period|Lost to Follow-up|3|||
160985295|NCT00388362|581335415|FG000|Enrolled|Loss insurance|1|||
160985296|NCT00388362|581335415|FG000|Enrolled|Withdrawal by Subject|1|||
160805132|NCT01365455|580674673|FG003|Induction Period|Lost to Follow-up|0|||
160985297|NCT00388362|581335415|FG000|Remained on Study Median of 514 Days|Death|2|||
160805133|NCT01365455|580674674|FG004|Induction Period|Lost to Follow-up|0|||
160805134|NCT01365455|580674670|FG000|Maintenance Period|Adverse Event|12|||
160805135|NCT01365455|580674671|FG001|Maintenance Period|Adverse Event|5|||
160805136|NCT01365455|580674672|FG002|Maintenance Period|Adverse Event|1|||
160805137|NCT01365455|580674673|FG003|Maintenance Period|Adverse Event|2|||
160805138|NCT01365455|580674674|FG004|Maintenance Period|Adverse Event|4|||
160805139|NCT01365455|580674670|FG000|Maintenance Period|Lack of Efficacy|10|||
160805140|NCT01365455|580674671|FG001|Maintenance Period|Lack of Efficacy|2|||
160805141|NCT01365455|580674672|FG002|Maintenance Period|Lack of Efficacy|0|||
160805142|NCT01365455|580674673|FG003|Maintenance Period|Lack of Efficacy|2|||
160805143|NCT01365455|580674674|FG004|Maintenance Period|Lack of Efficacy|2|||
160805144|NCT01365455|580674670|FG000|Maintenance Period|Lost to Follow-up|2|||
160805145|NCT01365455|580674671|FG001|Maintenance Period|Lost to Follow-up|4|||
160805146|NCT01365455|580674672|FG002|Maintenance Period|Lost to Follow-up|0|||
160805147|NCT01365455|580674673|FG003|Maintenance Period|Lost to Follow-up|0|||
160805148|NCT01365455|580674674|FG004|Maintenance Period|Lost to Follow-up|3|||
160805149|NCT01365455|580674670|FG000|Maintenance Period|Non-compliance with study treatment|0|||
160805150|NCT01365455|580674671|FG001|Maintenance Period|Non-compliance with study treatment|0|||
160805151|NCT01365455|580674672|FG002|Maintenance Period|Non-compliance with study treatment|0|||
160805152|NCT01365455|580674673|FG003|Maintenance Period|Non-compliance with study treatment|1|||
160805153|NCT01365455|580674674|FG004|Maintenance Period|Non-compliance with study treatment|0|||
160897957|NCT04686786|581021489|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
160897958|NCT04686786|581021489|FG000|Overall Study|Study Terminated by Sponsor|14|||
160897959|NCT04686786|581021489|FG000|Overall Study|Withdrawal by Subject|15|||
160897960|NCT04686786|581021489|FG000|Overall Study|Other than specified|1|||
160897961|NCT03924869|581021490|FG000|Overall Study|Death|73|||
160897962|NCT03924869|581021491|FG001|Overall Study|Death|62|||
160897963|NCT03924869|581021490|FG000|Overall Study|Lost to Follow-up|3|||
160897964|NCT03924869|581021491|FG001|Overall Study|Lost to Follow-up|0|||
160897965|NCT03924869|581021490|FG000|Overall Study|Physician Decision|0|||
160897966|NCT03924869|581021491|FG001|Overall Study|Physician Decision|3|||
160897967|NCT03924869|581021490|FG000|Overall Study|Withdrawal by Subject|7|||
160897968|NCT03924869|581021491|FG001|Overall Study|Withdrawal by Subject|3|||
160897969|NCT03924869|581021490|FG000|Overall Study|Study Terminated By Sponsor|144|||
160897970|NCT03924869|581021491|FG001|Overall Study|Study Terminated By Sponsor|153|||
160897971|NCT03001882|581021494|FG000|Overall Study|Death|1|||
160897972|NCT03001882|581021495|FG001|Overall Study|Death|0|||
160897973|NCT03001882|581021496|FG002|Overall Study|Death|0|||
160897974|NCT03001882|581021497|FG003|Overall Study|Death|3|||
160897975|NCT03001882|581021494|FG000|Overall Study|Participant withdrew consent|0|||
160897976|NCT03001882|581021495|FG001|Overall Study|Participant withdrew consent|1|||
160897977|NCT03001882|581021496|FG002|Overall Study|Participant withdrew consent|0|||
160897978|NCT03001882|581021497|FG003|Overall Study|Participant withdrew consent|5|||
160897979|NCT03001882|581021494|FG000|Overall Study|Other reasons|1|||
160897980|NCT03001882|581021495|FG001|Overall Study|Other reasons|2|||
160897981|NCT03001882|581021496|FG002|Overall Study|Other reasons|0|||
160897982|NCT03001882|581021497|FG003|Overall Study|Other reasons|5|||
160897983|NCT03001882|581021494|FG000|Overall Study|Administrative reason by sponsor|0|||
160897984|NCT03001882|581021495|FG001|Overall Study|Administrative reason by sponsor|0|||
160897985|NCT03001882|581021496|FG002|Overall Study|Administrative reason by sponsor|0|||
160897986|NCT03001882|581021497|FG003|Overall Study|Administrative reason by sponsor|1|||
160897987|NCT03001882|581021494|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
160897988|NCT03001882|581021495|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
160805154|NCT01365455|580674670|FG000|Maintenance Period|Physician Decision|0|||
160805155|NCT01365455|580674671|FG001|Maintenance Period|Physician Decision|1|||
160805156|NCT01365455|580674672|FG002|Maintenance Period|Physician Decision|0|||
160805157|NCT01365455|580674673|FG003|Maintenance Period|Physician Decision|0|||
160805158|NCT01365455|580674674|FG004|Maintenance Period|Physician Decision|1|||
160897989|NCT03001882|581021496|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
160897990|NCT03001882|581021497|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
160897991|NCT03001882|581021494|FG000|Overall Study|Not reported|0|||
160897992|NCT03001882|581021495|FG001|Overall Study|Not reported|0|||
160897993|NCT03001882|581021496|FG002|Overall Study|Not reported|0|||
160897994|NCT03001882|581021497|FG003|Overall Study|Not reported|6|||
160805159|NCT01365455|580674670|FG000|Maintenance Period|Pregnancy|0|||
160805160|NCT01365455|580674671|FG001|Maintenance Period|Pregnancy|4|||
160805161|NCT01365455|580674672|FG002|Maintenance Period|Pregnancy|0|||
160805162|NCT01365455|580674673|FG003|Maintenance Period|Pregnancy|0|||
160805163|NCT01365455|580674674|FG004|Maintenance Period|Pregnancy|2|||
160805164|NCT01365455|580674670|FG000|Maintenance Period|Protocol deviation|1|||
160897995|NCT03001882|581021494|FG000|Overall Study|Maximum clinical benefit|2|||
160897996|NCT03001882|581021495|FG001|Overall Study|Maximum clinical benefit|3|||
160897997|NCT03001882|581021496|FG002|Overall Study|Maximum clinical benefit|0|||
160897998|NCT03001882|581021497|FG003|Overall Study|Maximum clinical benefit|10|||
160897999|NCT03001882|581021494|FG000|Overall Study|AE unrelated to study drug|3|||
161130010|NCT02913313|581863327|FG000|Overall Study|Other reasons|0|||
161130011|NCT02913313|581863328|FG001|Overall Study|Other reasons|0|||
161130012|NCT02913313|581863329|FG002|Overall Study|Other reasons|0|||
161130013|NCT02913313|581863330|FG003|Overall Study|Other reasons|0|||
160805165|NCT01365455|580674671|FG001|Maintenance Period|Protocol deviation|1|||
160805166|NCT01365455|580674672|FG002|Maintenance Period|Protocol deviation|0|||
160805167|NCT01365455|580674673|FG003|Maintenance Period|Protocol deviation|0|||
160805168|NCT01365455|580674674|FG004|Maintenance Period|Protocol deviation|0|||
160805169|NCT01365455|580674670|FG000|Maintenance Period|Subject/guardian decision|4|||
160805170|NCT01365455|580674671|FG001|Maintenance Period|Subject/guardian decision|6|||
161130014|NCT02913313|581863331|FG004|Overall Study|Other reasons|1|||
161130015|NCT02913313|581863332|FG005|Overall Study|Other reasons|0|||
161130016|NCT02913313|581863333|FG006|Overall Study|Other reasons|0|||
161130017|NCT02913313|581863334|FG007|Overall Study|Other reasons|0|||
161130018|NCT02913313|581863335|FG008|Overall Study|Other reasons|0|||
161130019|NCT02913313|581863336|FG009|Overall Study|Other reasons|0|||
161130020|NCT02913313|581863337|FG010|Overall Study|Other reasons|1|||
161130021|NCT02913313|581863338|FG011|Overall Study|Other reasons|0|||
161130022|NCT02913313|581863339|FG012|Overall Study|Other reasons|0|||
161130023|NCT02913313|581863340|FG013|Overall Study|Other reasons|0|||
161130024|NCT02913313|581863327|FG000|Overall Study|Withdrawal by Subject|0|||
161130025|NCT02913313|581863328|FG001|Overall Study|Withdrawal by Subject|0|||
161130026|NCT02913313|581863329|FG002|Overall Study|Withdrawal by Subject|1|||
161130027|NCT02913313|581863330|FG003|Overall Study|Withdrawal by Subject|0|||
161130028|NCT02913313|581863331|FG004|Overall Study|Withdrawal by Subject|0|||
161130029|NCT02913313|581863332|FG005|Overall Study|Withdrawal by Subject|0|||
161130030|NCT02913313|581863333|FG006|Overall Study|Withdrawal by Subject|1|||
161130031|NCT02913313|581863334|FG007|Overall Study|Withdrawal by Subject|1|||
160805171|NCT01365455|580674672|FG002|Maintenance Period|Subject/guardian decision|2|||
160805172|NCT01365455|580674673|FG003|Maintenance Period|Subject/guardian decision|4|||
160805173|NCT01365455|580674674|FG004|Maintenance Period|Subject/guardian decision|1|||
160805174|NCT03965403|580674675|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
160805175|NCT00532129|580676513|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
160805176|NCT00532129|580676513|FG000|Treatment Period|Physician Decision|15|||
160805177|NCT00532129|580676513|FG000|Treatment Period|Disease progression|3|||
160805178|NCT00532129|580676513|FG000|Treatment Period|Protocol Violation|1|||
160805179|NCT00532129|580676513|FG000|Treatment Period|Other|5|||
160805180|NCT00532129|580676513|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
160805181|NCT00532129|580676513|FG000|Follow-up Period|Disease progression|57|||
160805182|NCT00532129|580676513|FG000|Follow-up Period|Lost to Follow-up|1|||
160805183|NCT00532129|580676513|FG000|Follow-up Period|Other|6|||
160805184|NCT03052608|580676514|FG000|Treatment Phase|Adverse Event|10|||
160805185|NCT03052608|580676515|FG001|Treatment Phase|Adverse Event|12|||
160985298|NCT01141660|581335416|FG000|Overall Study|Physician Decision|0|||
161130032|NCT02913313|581863335|FG008|Overall Study|Withdrawal by Subject|0|||
161130033|NCT02913313|581863336|FG009|Overall Study|Withdrawal by Subject|0|||
161130034|NCT02913313|581863337|FG010|Overall Study|Withdrawal by Subject|1|||
161130035|NCT02913313|581863338|FG011|Overall Study|Withdrawal by Subject|0|||
161130036|NCT02913313|581863339|FG012|Overall Study|Withdrawal by Subject|0|||
161130037|NCT02913313|581863340|FG013|Overall Study|Withdrawal by Subject|0|||
161130038|NCT02913313|581863327|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130039|NCT02913313|581863328|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130040|NCT02913313|581863329|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130041|NCT02913313|581863330|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130042|NCT02913313|581863331|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130043|NCT02913313|581863332|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130044|NCT02913313|581863333|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130045|NCT02913313|581863334|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130046|NCT02913313|581863335|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
160805186|NCT03052608|580676514|FG000|Treatment Phase|Death|6|||
160805187|NCT03052608|580676515|FG001|Treatment Phase|Death|4|||
160805188|NCT03052608|580676514|FG000|Treatment Phase|Withdrawal by Subject|4|||
160805189|NCT03052608|580676515|FG001|Treatment Phase|Withdrawal by Subject|12|||
160805190|NCT03052608|580676514|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
160805191|NCT03052608|580676515|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
160805192|NCT03052608|580676514|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
160805193|NCT03052608|580676515|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
160805194|NCT03052608|580676514|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
160805195|NCT03052608|580676515|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
160805196|NCT03052608|580676514|FG000|Treatment Phase|Ongoing|103|||
160805197|NCT03052608|580676515|FG001|Treatment Phase|Ongoing|31|||
160805198|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Death|23|||
160805199|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Death|28|||
160805200|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
160805201|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
160805202|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
160805203|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
160805204|NCT03052608|580676514|FG000|Long-Term Follow-up Phase|Ongoing|122|||
160805205|NCT03052608|580676515|FG001|Long-Term Follow-up Phase|Ongoing|99|||
160805206|NCT00551031|580676516|FG000|Overall Study|Adverse Event|0|||
160805207|NCT00551031|580676517|FG001|Overall Study|Adverse Event|1|||
160805208|NCT00551031|580676518|FG002|Overall Study|Adverse Event|0|||
160805209|NCT00551031|580676519|FG003|Overall Study|Adverse Event|0|||
160805210|NCT00551031|580676520|FG004|Overall Study|Adverse Event|0|||
160805211|NCT00551031|580676516|FG000|Overall Study|Protocol Violation|1|||
160805212|NCT00551031|580676517|FG001|Overall Study|Protocol Violation|1|||
160805213|NCT00551031|580676518|FG002|Overall Study|Protocol Violation|0|||
160805214|NCT00551031|580676519|FG003|Overall Study|Protocol Violation|0|||
160805215|NCT00551031|580676520|FG004|Overall Study|Protocol Violation|0|||
160805216|NCT00551031|580676516|FG000|Overall Study|Lost to Follow-up|0|||
160805217|NCT00551031|580676517|FG001|Overall Study|Lost to Follow-up|1|||
160805218|NCT00551031|580676518|FG002|Overall Study|Lost to Follow-up|0|||
160805219|NCT00551031|580676519|FG003|Overall Study|Lost to Follow-up|1|||
160805220|NCT00551031|580676520|FG004|Overall Study|Lost to Follow-up|1|||
160805221|NCT00551031|580676516|FG000|Overall Study|Withdrawal by Subject|0|||
160805222|NCT00551031|580676517|FG001|Overall Study|Withdrawal by Subject|4|||
160805223|NCT00551031|580676518|FG002|Overall Study|Withdrawal by Subject|1|||
160805224|NCT00551031|580676519|FG003|Overall Study|Withdrawal by Subject|2|||
160805225|NCT00551031|580676520|FG004|Overall Study|Withdrawal by Subject|0|||
160805226|NCT00551031|580676516|FG000|Overall Study|Serious Adverse Event|0|||
160805227|NCT00551031|580676517|FG001|Overall Study|Serious Adverse Event|2|||
160805228|NCT00551031|580676518|FG002|Overall Study|Serious Adverse Event|1|||
160805229|NCT00551031|580676519|FG003|Overall Study|Serious Adverse Event|0|||
160805230|NCT00551031|580676520|FG004|Overall Study|Serious Adverse Event|0|||
160805231|NCT00551031|580676516|FG000|Overall Study|Did not receive vaccine|1|||
160805232|NCT00551031|580676517|FG001|Overall Study|Did not receive vaccine|2|||
160805233|NCT00551031|580676518|FG002|Overall Study|Did not receive vaccine|0|||
160805234|NCT00551031|580676519|FG003|Overall Study|Did not receive vaccine|0|||
160805235|NCT00551031|580676520|FG004|Overall Study|Did not receive vaccine|0|||
160805236|NCT04072835|580676522|FG000|Overall Study|Overall trial ended|603|||
160805237|NCT04072835|580676522|FG000|Overall Study|Ablation|97|||
160805238|NCT04072835|580676522|FG000|Overall Study|Withdrawal of consent|66|||
160805239|NCT04072835|580676522|FG000|Overall Study|Physician Decision|50|||
160805240|NCT04072835|580676522|FG000|Overall Study|Lost to Follow-up|39|||
160805241|NCT04072835|580676522|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
160805242|NCT04072835|580676522|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
160805243|NCT04072835|580676522|FG000|Overall Study|Adverse Event|25|||
160805244|NCT04072835|580676522|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
160805245|NCT04072835|580676522|FG000|Overall Study|Death|11|||
160805246|NCT04072835|580676522|FG000|Overall Study|Participant felt the drug did not work|8|||
160805247|NCT04072835|580676522|FG000|Overall Study|Participant tolerability|5|||
160805248|NCT04072835|580676522|FG000|Overall Study|Missing|5|||
160805249|NCT04072835|580676522|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
160805250|NCT04072835|580676522|FG000|Overall Study|Pregnancy|3|||
160805251|NCT01336712|580676523|FG000|Overall Study|Death|2|||
160805252|NCT01336712|580676523|FG000|Overall Study|Lack of Efficacy|1|||
160805253|NCT00841776|580676524|FG000|Overall Study|Lack of Efficacy|0|||
160805254|NCT00841776|580676525|FG001|Overall Study|Lack of Efficacy|1|||
160805255|NCT00841776|580676524|FG000|Overall Study|Lost to Follow-up|2|||
160805256|NCT00841776|580676525|FG001|Overall Study|Lost to Follow-up|1|||
160805257|NCT00841776|580676524|FG000|Overall Study|Withdrawal by Subject|0|||
160805258|NCT00841776|580676525|FG001|Overall Study|Withdrawal by Subject|1|||
160805259|NCT03073525|580676528|FG000|Overall Study|Withdrawal by Subject|0|||
160805260|NCT03073525|580676529|FG001|Overall Study|Withdrawal by Subject|0|||
160805261|NCT03073525|580676530|FG002|Overall Study|Withdrawal by Subject|3|||
160805262|NCT01976299|580676531|FG000|Overall Study|Withdrawal by Subject|3|||
160805263|NCT01976299|580676532|FG001|Overall Study|Withdrawal by Subject|1|||
160805264|NCT01976299|580676531|FG000|Overall Study|Death|4|||
160805265|NCT01976299|580676532|FG001|Overall Study|Death|2|||
160805266|NCT01976299|580676531|FG000|Overall Study|Lost to Follow-up|7|||
160805267|NCT01976299|580676532|FG001|Overall Study|Lost to Follow-up|1|||
160805268|NCT01976299|580676531|FG000|Overall Study|See clarification above in comments|9|||
160805269|NCT01976299|580676532|FG001|Overall Study|See clarification above in comments|2|||
160805270|NCT00856323|580676534|FG000|Overall Study|Withdrawal by Subject|2|||
160805271|NCT01639469|580676535|FG000|Overall Study|Death|4|||
160805272|NCT01639469|580676536|FG001|Overall Study|Death|2|||
160805273|NCT01639469|580676535|FG000|Overall Study|Lost to Follow-up|1|||
160805274|NCT01639469|580676536|FG001|Overall Study|Lost to Follow-up|1|||
160805275|NCT01119443|580676537|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
160805276|NCT01119443|580676538|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
160805277|NCT02329743|580676541|FG000|Overall Study|Adverse Event|1|||
160805278|NCT02329743|580676542|FG001|Overall Study|Adverse Event|1|||
160805279|NCT02329743|580676543|FG002|Overall Study|Adverse Event|3|||
160805280|NCT02329743|580676541|FG000|Overall Study|Lost to Follow-up|1|||
160805281|NCT02329743|580676542|FG001|Overall Study|Lost to Follow-up|0|||
160805282|NCT02329743|580676543|FG002|Overall Study|Lost to Follow-up|1|||
160805283|NCT02329743|580676541|FG000|Overall Study|Withdrawal by Subject|4|||
160805284|NCT02329743|580676542|FG001|Overall Study|Withdrawal by Subject|4|||
160805285|NCT02329743|580676543|FG002|Overall Study|Withdrawal by Subject|1|||
160805286|NCT02329743|580676541|FG000|Overall Study|Other|0|||
160805287|NCT02329743|580676542|FG001|Overall Study|Other|2|||
160805288|NCT02329743|580676543|FG002|Overall Study|Other|3|||
160805289|NCT00355368|580676544|FG000|Overall Study|Protocol Violation|8|||
160805290|NCT00355368|580676545|FG001|Overall Study|Protocol Violation|7|||
160805291|NCT00355368|580676544|FG000|Overall Study|cardiac arrest prior to intubation|2|||
160805292|NCT00355368|580676545|FG001|Overall Study|cardiac arrest prior to intubation|2|||
160805293|NCT00347932|580676548|FG000|Overall Study|Adverse Event|4|||
160805294|NCT00347932|580676549|FG001|Overall Study|Adverse Event|5|||
160805295|NCT00347932|580676548|FG000|Overall Study|Lack of Efficacy|3|||
160805296|NCT00347932|580676549|FG001|Overall Study|Lack of Efficacy|14|||
160805297|NCT00347932|580676548|FG000|Overall Study|Lost to Follow-up|10|||
160805298|NCT00347932|580676549|FG001|Overall Study|Lost to Follow-up|9|||
160805299|NCT00347932|580676548|FG000|Overall Study|Withdrawal by Subject|10|||
160805300|NCT00347932|580676549|FG001|Overall Study|Withdrawal by Subject|16|||
160805301|NCT00347932|580676548|FG000|Overall Study|Did not meet inclusion criteria|4|||
160805302|NCT00347932|580676549|FG001|Overall Study|Did not meet inclusion criteria|8|||
160805303|NCT03462758|580676552|FG000|Overall Study|Chose no or other method of contraception|20|||
160805304|NCT03462758|580676553|FG001|Overall Study|Chose no or other method of contraception|23|||
160805305|NCT03462758|580676552|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
160805306|NCT03462758|580676553|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
160805307|NCT03462758|580676552|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
160805308|NCT03462758|580676553|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
160805309|NCT03462758|580676552|FG000|Overall Study|Medical contraindication|2|||
160805310|NCT03462758|580676553|FG001|Overall Study|Medical contraindication|2|||
160805311|NCT03462758|580676552|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
160805312|NCT03462758|580676553|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
160805313|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
160805314|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
160805315|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805316|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805317|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805318|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
160805319|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
160805320|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
160805321|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805322|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805323|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
161130047|NCT02913313|581863336|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130048|NCT02913313|581863337|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
160805324|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
160805325|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805326|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
160805327|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805328|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805329|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805330|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
160805331|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
160805332|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
160805333|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805334|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805335|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805336|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
160805337|NCT02820844|580676554|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
160805338|NCT02820844|580676555|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805339|NCT02820844|580676556|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161130049|NCT02913313|581863338|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161130050|NCT02913313|581863339|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
160805340|NCT02820844|580676557|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
161130051|NCT02913313|581863340|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161130052|NCT02913313|581863327|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
161130053|NCT02913313|581863328|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
160805341|NCT02820844|580676558|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805342|NCT02820844|580676559|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
160805343|NCT02820844|580676554|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805344|NCT02820844|580676555|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805345|NCT02820844|580676556|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
160805346|NCT02820844|580676557|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
160805347|NCT02820844|580676558|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805348|NCT02820844|580676559|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
160805349|NCT02820844|580676554|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805350|NCT02820844|580676555|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805351|NCT02820844|580676556|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
160805352|NCT02820844|580676557|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805353|NCT02820844|580676558|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805354|NCT02820844|580676559|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
160805355|NCT02820844|580676554|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805356|NCT02820844|580676555|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805357|NCT02820844|580676556|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
160805358|NCT02820844|580676557|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
160805359|NCT02820844|580676558|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805360|NCT02820844|580676559|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805361|NCT02820844|580676554|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805362|NCT02820844|580676555|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805363|NCT02820844|580676556|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805364|NCT02820844|580676557|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805365|NCT02820844|580676558|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
160805366|NCT02820844|580676559|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
160805367|NCT02820844|580676554|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805368|NCT02820844|580676555|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805369|NCT02820844|580676556|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805370|NCT02820844|580676557|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805371|NCT02820844|580676558|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
160805372|NCT02820844|580676559|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
160805373|NCT00413660|580676561|FG000|Up To Week 12|Adverse Event|1|||
160805374|NCT00413660|580676562|FG001|Up To Week 12|Adverse Event|3|||
160805375|NCT00413660|580676563|FG002|Up To Week 12|Adverse Event|1|||
160805376|NCT00413660|580676564|FG003|Up To Week 12|Adverse Event|4|||
160805377|NCT00413660|580676565|FG004|Up To Week 12|Adverse Event|6|||
160805378|NCT00413660|580676566|FG005|Up To Week 12|Adverse Event|4|||
160805379|NCT00413660|580676567|FG006|Up To Week 12|Adverse Event|1|||
160805380|NCT00413660|580676568|FG007|Up To Week 12|Adverse Event|0|||
160805381|NCT00413660|580676569|FG008|Up To Week 12|Adverse Event|0|||
160805382|NCT00413660|580676570|FG009|Up To Week 12|Adverse Event|0|||
160805383|NCT00413660|580676571|FG010|Up To Week 12|Adverse Event|0|||
160805384|NCT00413660|580676561|FG000|Up To Week 12|Lack of Efficacy|2|||
160805385|NCT00413660|580676562|FG001|Up To Week 12|Lack of Efficacy|0|||
160898000|NCT03001882|581021495|FG001|Overall Study|AE unrelated to study drug|3|||
160898001|NCT03001882|581021496|FG002|Overall Study|AE unrelated to study drug|0|||
160898002|NCT03001882|581021497|FG003|Overall Study|AE unrelated to study drug|11|||
160898003|NCT03001882|581021494|FG000|Overall Study|Study Drug Toxicity|8|||
160898004|NCT03001882|581021495|FG001|Overall Study|Study Drug Toxicity|5|||
160898005|NCT03001882|581021496|FG002|Overall Study|Study Drug Toxicity|0|||
160898006|NCT03001882|581021497|FG003|Overall Study|Study Drug Toxicity|37|||
160898007|NCT03001882|581021494|FG000|Overall Study|Disease progression|16|||
160898008|NCT03001882|581021495|FG001|Overall Study|Disease progression|14|||
160898009|NCT03001882|581021496|FG002|Overall Study|Disease progression|1|||
160898010|NCT03001882|581021497|FG003|Overall Study|Disease progression|90|||
160898011|NCT05268055|581021499|FG000|Overall Study|Lost to Follow-up|68|||
160898012|NCT05268055|581021500|FG001|Overall Study|Lost to Follow-up|68|||
160898013|NCT05268055|581021499|FG000|Overall Study|Withdrawal by Subject|12|||
160898014|NCT05268055|581021500|FG001|Overall Study|Withdrawal by Subject|8|||
160898015|NCT03507400|581021501|FG000|Overall Study|discontinued|5|||
160898016|NCT03507400|581021502|FG001|Overall Study|discontinued|1|||
160898017|NCT03507400|581021501|FG000|Overall Study|Lost to Follow-up|8|||
160805386|NCT00413660|580676563|FG002|Up To Week 12|Lack of Efficacy|0|||
160805387|NCT00413660|580676564|FG003|Up To Week 12|Lack of Efficacy|0|||
160805388|NCT00413660|580676565|FG004|Up To Week 12|Lack of Efficacy|0|||
160805389|NCT00413660|580676566|FG005|Up To Week 12|Lack of Efficacy|0|||
160898018|NCT03507400|581021502|FG001|Overall Study|Lost to Follow-up|6|||
160898019|NCT03507400|581021501|FG000|Overall Study|Protocol Violation|0|||
160898020|NCT03507400|581021502|FG001|Overall Study|Protocol Violation|1|||
160898021|NCT00717093|581023368|FG000|Overall Study|Adverse Event|19|||
160805390|NCT00413660|580676567|FG006|Up To Week 12|Lack of Efficacy|5|||
160805391|NCT00413660|580676568|FG007|Up To Week 12|Lack of Efficacy|0|||
160805392|NCT00413660|580676569|FG008|Up To Week 12|Lack of Efficacy|0|||
160805393|NCT00413660|580676570|FG009|Up To Week 12|Lack of Efficacy|0|||
160805394|NCT00413660|580676571|FG010|Up To Week 12|Lack of Efficacy|0|||
160805395|NCT00413660|580676561|FG000|Up To Week 12|Lost to Follow-up|0|||
160805396|NCT00413660|580676562|FG001|Up To Week 12|Lost to Follow-up|1|||
160805397|NCT00413660|580676563|FG002|Up To Week 12|Lost to Follow-up|0|||
160805398|NCT00413660|580676564|FG003|Up To Week 12|Lost to Follow-up|0|||
160805399|NCT00413660|580676565|FG004|Up To Week 12|Lost to Follow-up|1|||
160805400|NCT00413660|580676566|FG005|Up To Week 12|Lost to Follow-up|0|||
160805401|NCT00413660|580676567|FG006|Up To Week 12|Lost to Follow-up|0|||
160805402|NCT00413660|580676568|FG007|Up To Week 12|Lost to Follow-up|0|||
160805403|NCT00413660|580676569|FG008|Up To Week 12|Lost to Follow-up|0|||
160805404|NCT00413660|580676570|FG009|Up To Week 12|Lost to Follow-up|0|||
160805405|NCT00413660|580676571|FG010|Up To Week 12|Lost to Follow-up|0|||
160805406|NCT00413660|580676561|FG000|Up To Week 12|Withdrawal by Subject|0|||
160805407|NCT00413660|580676562|FG001|Up To Week 12|Withdrawal by Subject|2|||
160805408|NCT00413660|580676563|FG002|Up To Week 12|Withdrawal by Subject|0|||
160805409|NCT00413660|580676564|FG003|Up To Week 12|Withdrawal by Subject|2|||
160805410|NCT00413660|580676565|FG004|Up To Week 12|Withdrawal by Subject|0|||
160805411|NCT00413660|580676566|FG005|Up To Week 12|Withdrawal by Subject|2|||
160805412|NCT00413660|580676567|FG006|Up To Week 12|Withdrawal by Subject|2|||
160805413|NCT00413660|580676568|FG007|Up To Week 12|Withdrawal by Subject|0|||
160805414|NCT00413660|580676569|FG008|Up To Week 12|Withdrawal by Subject|0|||
160805415|NCT00413660|580676570|FG009|Up To Week 12|Withdrawal by Subject|0|||
160805416|NCT00413660|580676571|FG010|Up To Week 12|Withdrawal by Subject|0|||
160805417|NCT00413660|580676561|FG000|Up To Week 12|Randomized, Not Treated|1|||
160805418|NCT00413660|580676562|FG001|Up To Week 12|Randomized, Not Treated|0|||
160805419|NCT00413660|580676563|FG002|Up To Week 12|Randomized, Not Treated|0|||
160805420|NCT00413660|580676564|FG003|Up To Week 12|Randomized, Not Treated|1|||
160805421|NCT00413660|580676565|FG004|Up To Week 12|Randomized, Not Treated|0|||
160805422|NCT00413660|580676566|FG005|Up To Week 12|Randomized, Not Treated|0|||
160805423|NCT00413660|580676567|FG006|Up To Week 12|Randomized, Not Treated|0|||
160805424|NCT00413660|580676568|FG007|Up To Week 12|Randomized, Not Treated|0|||
160805425|NCT00413660|580676569|FG008|Up To Week 12|Randomized, Not Treated|0|||
160805426|NCT00413660|580676570|FG009|Up To Week 12|Randomized, Not Treated|0|||
160805427|NCT00413660|580676571|FG010|Up To Week 12|Randomized, Not Treated|0|||
160805428|NCT00413660|580676561|FG000|Up To Week 12|Other|3|||
160805429|NCT00413660|580676562|FG001|Up To Week 12|Other|1|||
160805430|NCT00413660|580676563|FG002|Up To Week 12|Other|6|||
160805431|NCT00413660|580676564|FG003|Up To Week 12|Other|1|||
160805432|NCT00413660|580676565|FG004|Up To Week 12|Other|2|||
160805433|NCT00413660|580676566|FG005|Up To Week 12|Other|4|||
160805434|NCT00413660|580676567|FG006|Up To Week 12|Other|3|||
160805435|NCT00413660|580676568|FG007|Up To Week 12|Other|0|||
160805436|NCT00413660|580676569|FG008|Up To Week 12|Other|0|||
160805437|NCT00413660|580676570|FG009|Up To Week 12|Other|0|||
160805438|NCT00413660|580676571|FG010|Up To Week 12|Other|0|||
160805439|NCT00413660|580676561|FG000|Post Week 12|Adverse Event|2|||
160805440|NCT00413660|580676562|FG001|Post Week 12|Adverse Event|0|||
160805441|NCT00413660|580676563|FG002|Post Week 12|Adverse Event|2|||
160805442|NCT00413660|580676564|FG003|Post Week 12|Adverse Event|1|||
160805443|NCT00413660|580676565|FG004|Post Week 12|Adverse Event|4|||
160805444|NCT00413660|580676566|FG005|Post Week 12|Adverse Event|2|||
160805445|NCT00413660|580676567|FG006|Post Week 12|Adverse Event|2|||
160805446|NCT00413660|580676568|FG007|Post Week 12|Adverse Event|0|||
160805447|NCT00413660|580676569|FG008|Post Week 12|Adverse Event|0|||
160805448|NCT00413660|580676570|FG009|Post Week 12|Adverse Event|0|||
160805449|NCT00413660|580676571|FG010|Post Week 12|Adverse Event|0|||
160805450|NCT00413660|580676561|FG000|Post Week 12|Lack of Efficacy|0|||
160805451|NCT00413660|580676562|FG001|Post Week 12|Lack of Efficacy|0|||
160805452|NCT00413660|580676563|FG002|Post Week 12|Lack of Efficacy|1|||
160805453|NCT00413660|580676564|FG003|Post Week 12|Lack of Efficacy|0|||
160805454|NCT00413660|580676565|FG004|Post Week 12|Lack of Efficacy|0|||
160805455|NCT00413660|580676566|FG005|Post Week 12|Lack of Efficacy|0|||
160805456|NCT00413660|580676567|FG006|Post Week 12|Lack of Efficacy|0|||
160805457|NCT00413660|580676568|FG007|Post Week 12|Lack of Efficacy|0|||
160805458|NCT00413660|580676569|FG008|Post Week 12|Lack of Efficacy|0|||
160805459|NCT00413660|580676570|FG009|Post Week 12|Lack of Efficacy|1|||
160805460|NCT00413660|580676571|FG010|Post Week 12|Lack of Efficacy|0|||
160805461|NCT00413660|580676561|FG000|Post Week 12|Lost to Follow-up|0|||
160805462|NCT00413660|580676562|FG001|Post Week 12|Lost to Follow-up|1|||
160805463|NCT00413660|580676563|FG002|Post Week 12|Lost to Follow-up|1|||
160805464|NCT00413660|580676564|FG003|Post Week 12|Lost to Follow-up|0|||
160805465|NCT00413660|580676565|FG004|Post Week 12|Lost to Follow-up|0|||
160805466|NCT00413660|580676566|FG005|Post Week 12|Lost to Follow-up|0|||
160805467|NCT00413660|580676567|FG006|Post Week 12|Lost to Follow-up|0|||
160805468|NCT00413660|580676568|FG007|Post Week 12|Lost to Follow-up|0|||
160805469|NCT00413660|580676569|FG008|Post Week 12|Lost to Follow-up|0|||
160805470|NCT00413660|580676570|FG009|Post Week 12|Lost to Follow-up|0|||
160805471|NCT00413660|580676571|FG010|Post Week 12|Lost to Follow-up|0|||
160805472|NCT00413660|580676561|FG000|Post Week 12|Withdrawal by Subject|0|||
160805473|NCT00413660|580676562|FG001|Post Week 12|Withdrawal by Subject|1|||
160805474|NCT00413660|580676563|FG002|Post Week 12|Withdrawal by Subject|1|||
160805475|NCT00413660|580676564|FG003|Post Week 12|Withdrawal by Subject|0|||
160805476|NCT00413660|580676565|FG004|Post Week 12|Withdrawal by Subject|1|||
160805477|NCT00413660|580676566|FG005|Post Week 12|Withdrawal by Subject|0|||
160805478|NCT00413660|580676567|FG006|Post Week 12|Withdrawal by Subject|0|||
160805479|NCT00413660|580676568|FG007|Post Week 12|Withdrawal by Subject|0|||
160805480|NCT00413660|580676569|FG008|Post Week 12|Withdrawal by Subject|0|||
160805481|NCT00413660|580676570|FG009|Post Week 12|Withdrawal by Subject|0|||
160805482|NCT00413660|580676571|FG010|Post Week 12|Withdrawal by Subject|1|||
160805483|NCT00413660|580676561|FG000|Post Week 12|Other|1|||
160805484|NCT00413660|580676562|FG001|Post Week 12|Other|2|||
160805485|NCT00413660|580676563|FG002|Post Week 12|Other|3|||
160805486|NCT00413660|580676564|FG003|Post Week 12|Other|0|||
160805487|NCT00413660|580676565|FG004|Post Week 12|Other|1|||
160805488|NCT00413660|580676566|FG005|Post Week 12|Other|1|||
160805489|NCT00413660|580676567|FG006|Post Week 12|Other|1|||
160805490|NCT00413660|580676568|FG007|Post Week 12|Other|0|||
160805491|NCT00413660|580676569|FG008|Post Week 12|Other|0|||
160805492|NCT00413660|580676570|FG009|Post Week 12|Other|0|||
160805493|NCT00413660|580676571|FG010|Post Week 12|Other|0|||
160805494|NCT01791517|580676574|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
160805495|NCT01791517|580676575|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
160805496|NCT01791517|580676576|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
160805497|NCT01791517|580676577|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
160805498|NCT01791517|580676578|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
160805499|NCT01791517|580676579|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
160805500|NCT01791517|580676580|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
160805501|NCT01791517|580676581|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
160805502|NCT01791517|580676582|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
160805503|NCT01791517|580676583|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
160805504|NCT01791517|580676584|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
160805505|NCT01791517|580676585|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
160805506|NCT01791517|580676574|FG000|Phase I: Period 1|Adverse Event|0|||
160805507|NCT01791517|580676575|FG001|Phase I: Period 1|Adverse Event|0|||
160805508|NCT01791517|580676576|FG002|Phase I: Period 1|Adverse Event|1|||
160805509|NCT01791517|580676577|FG003|Phase I: Period 1|Adverse Event|1|||
160805510|NCT01791517|580676578|FG004|Phase I: Period 1|Adverse Event|0|||
160805511|NCT01791517|580676579|FG005|Phase I: Period 1|Adverse Event|0|||
160805512|NCT01791517|580676580|FG006|Phase I: Period 1|Adverse Event|0|||
160805513|NCT01791517|580676581|FG007|Phase I: Period 1|Adverse Event|0|||
160805514|NCT01791517|580676582|FG008|Phase I: Period 1|Adverse Event|0|||
160805515|NCT01791517|580676583|FG009|Phase I: Period 1|Adverse Event|0|||
160805516|NCT01791517|580676584|FG010|Phase I: Period 1|Adverse Event|0|||
160805517|NCT01791517|580676585|FG011|Phase I: Period 1|Adverse Event|0|||
160805518|NCT01791517|580676574|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
160805519|NCT01791517|580676575|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805520|NCT01791517|580676576|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805521|NCT01791517|580676577|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805522|NCT01791517|580676578|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805523|NCT01791517|580676579|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805524|NCT01791517|580676580|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160985299|NCT01141660|581335417|FG001|Overall Study|Physician Decision|12|||
160985300|NCT00209027|581335419|FG000|Overall Study|study terminated|10|||
160985301|NCT00209027|581335420|FG001|Overall Study|study terminated|0|||
160985302|NCT02335268|581335421|FG000|Overall Study|Physician Decision|5|||
161130054|NCT02913313|581863329|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
160805525|NCT01791517|580676581|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
161130055|NCT02913313|581863330|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
160805526|NCT01791517|580676582|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805527|NCT01791517|580676583|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805528|NCT01791517|580676584|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805529|NCT01791517|580676585|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
160805530|NCT01791517|580676574|FG000|Phase I: Period 1|Protocol Violation|0|||
160805531|NCT01791517|580676575|FG001|Phase I: Period 1|Protocol Violation|1|||
160805532|NCT01791517|580676576|FG002|Phase I: Period 1|Protocol Violation|0|||
160805533|NCT01791517|580676577|FG003|Phase I: Period 1|Protocol Violation|0|||
160805534|NCT01791517|580676578|FG004|Phase I: Period 1|Protocol Violation|0|||
160805535|NCT01791517|580676579|FG005|Phase I: Period 1|Protocol Violation|0|||
160985303|NCT02335268|581335422|FG001|Overall Study|Physician Decision|1|||
161130056|NCT02913313|581863331|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
160805536|NCT01791517|580676580|FG006|Phase I: Period 1|Protocol Violation|0|||
160805537|NCT01791517|580676581|FG007|Phase I: Period 1|Protocol Violation|0|||
160985304|NCT02335268|581335421|FG000|Overall Study|Lack of Efficacy|2|||
160985305|NCT02335268|581335422|FG001|Overall Study|Lack of Efficacy|1|||
161130057|NCT02913313|581863332|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
161130058|NCT02913313|581863333|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
161130059|NCT02913313|581863334|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
161130060|NCT02913313|581863335|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
161130061|NCT02913313|581863336|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
161130062|NCT02913313|581863337|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
161130063|NCT02913313|581863338|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
161130064|NCT02913313|581863339|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
161130065|NCT02913313|581863340|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
161130066|NCT01061008|581863341|FG000|Overall Study|Badiocephalic fistula failed|3|||
161130067|NCT01061008|581863342|FG001|Overall Study|Badiocephalic fistula failed|2|||
161130068|NCT01061008|581863341|FG000|Overall Study|Death|1|||
161130069|NCT01061008|581863342|FG001|Overall Study|Death|0|||
161130070|NCT01061008|581863341|FG000|Overall Study|Withdrawal by Subject|1|||
161130071|NCT01061008|581863342|FG001|Overall Study|Withdrawal by Subject|3|||
161130072|NCT01061008|581863341|FG000|Overall Study|Unable to exercise following surgery|1|||
161130073|NCT01061008|581863342|FG001|Overall Study|Unable to exercise following surgery|0|||
161130074|NCT01061008|581863341|FG000|Overall Study|Adverse Event|0|||
161130075|NCT01061008|581863342|FG001|Overall Study|Adverse Event|1|||
161130076|NCT02908100|581863345|FG000|Overall Study|Adverse Event|7|||
161130077|NCT02908100|581863346|FG001|Overall Study|Adverse Event|6|||
161130078|NCT02908100|581863347|FG002|Overall Study|Adverse Event|9|||
161130079|NCT02908100|581863345|FG000|Overall Study|Death|2|||
161130080|NCT02908100|581863346|FG001|Overall Study|Death|0|||
161130081|NCT02908100|581863347|FG002|Overall Study|Death|0|||
161130082|NCT02908100|581863345|FG000|Overall Study|Lack of Efficacy|2|||
161130083|NCT02908100|581863346|FG001|Overall Study|Lack of Efficacy|3|||
161130084|NCT02908100|581863347|FG002|Overall Study|Lack of Efficacy|3|||
161130085|NCT02908100|581863345|FG000|Overall Study|Lost to Follow-up|0|||
161130086|NCT02908100|581863346|FG001|Overall Study|Lost to Follow-up|1|||
161130087|NCT02908100|581863347|FG002|Overall Study|Lost to Follow-up|2|||
160805538|NCT01791517|580676582|FG008|Phase I: Period 1|Protocol Violation|0|||
160805539|NCT01791517|580676583|FG009|Phase I: Period 1|Protocol Violation|0|||
160805540|NCT01791517|580676584|FG010|Phase I: Period 1|Protocol Violation|0|||
160805541|NCT01791517|580676585|FG011|Phase I: Period 1|Protocol Violation|0|||
160805542|NCT01791517|580676574|FG000|Phase I: Period 1|Lost to Follow-up|0|||
160805543|NCT01791517|580676575|FG001|Phase I: Period 1|Lost to Follow-up|0|||
160805544|NCT01791517|580676576|FG002|Phase I: Period 1|Lost to Follow-up|0|||
160805545|NCT01791517|580676577|FG003|Phase I: Period 1|Lost to Follow-up|1|||
160805546|NCT01791517|580676578|FG004|Phase I: Period 1|Lost to Follow-up|0|||
160805547|NCT01791517|580676579|FG005|Phase I: Period 1|Lost to Follow-up|0|||
160805548|NCT01791517|580676580|FG006|Phase I: Period 1|Lost to Follow-up|1|||
160805549|NCT01791517|580676581|FG007|Phase I: Period 1|Lost to Follow-up|0|||
160805550|NCT01791517|580676582|FG008|Phase I: Period 1|Lost to Follow-up|1|||
160805551|NCT01791517|580676583|FG009|Phase I: Period 1|Lost to Follow-up|1|||
160805552|NCT01791517|580676584|FG010|Phase I: Period 1|Lost to Follow-up|0|||
160805553|NCT01791517|580676585|FG011|Phase I: Period 1|Lost to Follow-up|0|||
160805554|NCT01791517|580676574|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805555|NCT01791517|580676575|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805556|NCT01791517|580676576|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805557|NCT01791517|580676577|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805558|NCT01791517|580676578|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805559|NCT01791517|580676579|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805560|NCT01791517|580676580|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805561|NCT01791517|580676581|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805562|NCT01791517|580676582|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805563|NCT01791517|580676583|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805564|NCT01791517|580676584|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
160805565|NCT01791517|580676585|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
160805566|NCT01791517|580676574|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
160805567|NCT01791517|580676575|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805568|NCT01791517|580676576|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805569|NCT01791517|580676577|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805570|NCT01791517|580676578|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805571|NCT01791517|580676579|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805572|NCT01791517|580676580|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805573|NCT01791517|580676581|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805574|NCT01791517|580676582|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805575|NCT01791517|580676583|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805576|NCT01791517|580676584|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805577|NCT01791517|580676585|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
160805578|NCT01791517|580676574|FG000|Phase I: Period 2|Protocol Violation|0|||
160805579|NCT01791517|580676575|FG001|Phase I: Period 2|Protocol Violation|0|||
160805580|NCT01791517|580676576|FG002|Phase I: Period 2|Protocol Violation|0|||
161130088|NCT02908100|581863345|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161130089|NCT02908100|581863346|FG001|Overall Study|Non-Compliance With Study Drug|1|||
160898022|NCT00717093|581023369|FG001|Overall Study|Adverse Event|9|||
160898023|NCT00717093|581023368|FG000|Overall Study|Lack of Efficacy|3|||
160898024|NCT00717093|581023369|FG001|Overall Study|Lack of Efficacy|13|||
160898025|NCT00717093|581023368|FG000|Overall Study|Lost to Follow-up|9|||
160898026|NCT00717093|581023369|FG001|Overall Study|Lost to Follow-up|6|||
160898027|NCT00717093|581023368|FG000|Overall Study|Withdrawal by Subject|12|||
160898028|NCT00717093|581023369|FG001|Overall Study|Withdrawal by Subject|19|||
160898029|NCT00717093|581023368|FG000|Overall Study|Other|0|||
160898030|NCT00717093|581023369|FG001|Overall Study|Other|1|||
160898031|NCT00717093|581023368|FG000|Overall Study|Randomized but not treated|1|||
160898032|NCT00717093|581023369|FG001|Overall Study|Randomized but not treated|0|||
160898033|NCT01543698|581023374|FG000|Phase 1b|Disease progression|2|||
160898034|NCT01543698|581023375|FG001|Phase 1b|Disease progression|4|||
160898035|NCT01543698|581023376|FG002|Phase 1b|Disease progression|3|||
160898036|NCT01543698|581023377|FG003|Phase 1b|Disease progression|2|||
160898037|NCT01543698|581023378|FG004|Phase 1b|Disease progression|10|||
160898038|NCT01543698|581023379|FG005|Phase 1b|Disease progression|6|||
160898039|NCT01543698|581023380|FG006|Phase 1b|Disease progression|5|||
160898040|NCT01543698|581023381|FG007|Phase 1b|Disease progression|3|||
160898041|NCT01543698|581023382|FG008|Phase 1b|Disease progression|4|||
160898042|NCT01543698|581023383|FG009|Phase 1b|Disease progression|5|||
160898043|NCT01543698|581023384|FG010|Phase 1b|Disease progression|1|||
160898044|NCT01543698|581023385|FG011|Phase 1b|Disease progression|0|||
161237563|NCT00984126|582250222|FG003|Overall Study|Adverse Event|2|||
161237564|NCT00984126|582250219|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
160805581|NCT01791517|580676577|FG003|Phase I: Period 2|Protocol Violation|1|||
160805582|NCT01791517|580676578|FG004|Phase I: Period 2|Protocol Violation|0|||
160805583|NCT01791517|580676579|FG005|Phase I: Period 2|Protocol Violation|0|||
160805584|NCT01791517|580676580|FG006|Phase I: Period 2|Protocol Violation|0|||
160805585|NCT01791517|580676581|FG007|Phase I: Period 2|Protocol Violation|0|||
160805586|NCT01791517|580676582|FG008|Phase I: Period 2|Protocol Violation|0|||
160805587|NCT01791517|580676583|FG009|Phase I: Period 2|Protocol Violation|0|||
160805588|NCT01791517|580676584|FG010|Phase I: Period 2|Protocol Violation|0|||
160805589|NCT01791517|580676585|FG011|Phase I: Period 2|Protocol Violation|0|||
160805590|NCT01791517|580676574|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
160805591|NCT01791517|580676575|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
160805592|NCT01791517|580676576|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
160805593|NCT01791517|580676577|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
160805594|NCT01791517|580676578|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
160805595|NCT01791517|580676579|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
160805596|NCT01791517|580676580|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
160805597|NCT01791517|580676581|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
160805598|NCT01791517|580676582|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
160805599|NCT01791517|580676583|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
160805600|NCT01791517|580676584|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
160805601|NCT01791517|580676585|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
160805602|NCT01791517|580676574|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805603|NCT01791517|580676575|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805604|NCT01791517|580676576|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805605|NCT01791517|580676577|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805606|NCT01791517|580676578|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805607|NCT01791517|580676579|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805608|NCT01791517|580676580|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805609|NCT01791517|580676581|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805610|NCT01791517|580676582|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805611|NCT01791517|580676583|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805612|NCT01791517|580676584|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
160805613|NCT01791517|580676585|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
160805614|NCT01791517|580676574|FG000|Phase I: Period 2|Lens Discomfort|0|||
160805615|NCT01791517|580676575|FG001|Phase I: Period 2|Lens Discomfort|0|||
160805616|NCT01791517|580676576|FG002|Phase I: Period 2|Lens Discomfort|0|||
160805617|NCT01791517|580676577|FG003|Phase I: Period 2|Lens Discomfort|0|||
160805618|NCT01791517|580676578|FG004|Phase I: Period 2|Lens Discomfort|0|||
160805619|NCT01791517|580676579|FG005|Phase I: Period 2|Lens Discomfort|1|||
160898045|NCT01543698|581023386|FG012|Phase 1b|Disease progression|0|||
160898046|NCT01543698|581023387|FG013|Phase 1b|Disease progression|0|||
160898047|NCT01543698|581023388|FG014|Phase 1b|Disease progression|0|||
160898048|NCT01543698|581023374|FG000|Phase 1b|Death|0|||
160805620|NCT01791517|580676580|FG006|Phase I: Period 2|Lens Discomfort|0|||
160898049|NCT01543698|581023375|FG001|Phase 1b|Death|0|||
160898050|NCT01543698|581023376|FG002|Phase 1b|Death|1|||
160985306|NCT02335268|581335421|FG000|Overall Study|Adverse Event|5|||
160898051|NCT01543698|581023377|FG003|Phase 1b|Death|1|||
160898052|NCT01543698|581023378|FG004|Phase 1b|Death|0|||
160898053|NCT01543698|581023379|FG005|Phase 1b|Death|0|||
160898054|NCT01543698|581023380|FG006|Phase 1b|Death|0|||
160898055|NCT01543698|581023381|FG007|Phase 1b|Death|0|||
160898056|NCT01543698|581023382|FG008|Phase 1b|Death|0|||
160985307|NCT02335268|581335422|FG001|Overall Study|Adverse Event|2|||
160805621|NCT01791517|580676581|FG007|Phase I: Period 2|Lens Discomfort|0|||
160805622|NCT01791517|580676582|FG008|Phase I: Period 2|Lens Discomfort|0|||
160805623|NCT01791517|580676583|FG009|Phase I: Period 2|Lens Discomfort|0|||
160805624|NCT01791517|580676584|FG010|Phase I: Period 2|Lens Discomfort|0|||
160805625|NCT01791517|580676585|FG011|Phase I: Period 2|Lens Discomfort|0|||
160805626|NCT01791517|580676574|FG000|Phase I: Period 2|Lost to Follow-up|0|||
160805627|NCT01791517|580676575|FG001|Phase I: Period 2|Lost to Follow-up|3|||
160805628|NCT01791517|580676576|FG002|Phase I: Period 2|Lost to Follow-up|2|||
160805629|NCT01791517|580676577|FG003|Phase I: Period 2|Lost to Follow-up|0|||
160805630|NCT01791517|580676578|FG004|Phase I: Period 2|Lost to Follow-up|0|||
160805631|NCT01791517|580676579|FG005|Phase I: Period 2|Lost to Follow-up|0|||
160805632|NCT01791517|580676580|FG006|Phase I: Period 2|Lost to Follow-up|0|||
160805633|NCT01791517|580676581|FG007|Phase I: Period 2|Lost to Follow-up|0|||
160805634|NCT01791517|580676582|FG008|Phase I: Period 2|Lost to Follow-up|0|||
160805635|NCT01791517|580676583|FG009|Phase I: Period 2|Lost to Follow-up|0|||
160805636|NCT01791517|580676584|FG010|Phase I: Period 2|Lost to Follow-up|0|||
160805637|NCT01791517|580676585|FG011|Phase I: Period 2|Lost to Follow-up|0|||
160805638|NCT01791517|580676574|FG000|Phase I: Period 3|Lens Discomfort|0|||
160805639|NCT01791517|580676575|FG001|Phase I: Period 3|Lens Discomfort|0|||
160805640|NCT01791517|580676576|FG002|Phase I: Period 3|Lens Discomfort|0|||
160805641|NCT01791517|580676577|FG003|Phase I: Period 3|Lens Discomfort|0|||
160805642|NCT01791517|580676578|FG004|Phase I: Period 3|Lens Discomfort|0|||
160805643|NCT01791517|580676579|FG005|Phase I: Period 3|Lens Discomfort|0|||
160805644|NCT01791517|580676580|FG006|Phase I: Period 3|Lens Discomfort|0|||
160805645|NCT01791517|580676581|FG007|Phase I: Period 3|Lens Discomfort|0|||
160805646|NCT01791517|580676582|FG008|Phase I: Period 3|Lens Discomfort|0|||
160805647|NCT01791517|580676583|FG009|Phase I: Period 3|Lens Discomfort|0|||
160805648|NCT01791517|580676584|FG010|Phase I: Period 3|Lens Discomfort|0|||
160805649|NCT01791517|580676585|FG011|Phase I: Period 3|Lens Discomfort|1|||
160805650|NCT01791517|580676574|FG000|Phase I: Period 3|Lost to Follow-up|0|||
160805651|NCT01791517|580676575|FG001|Phase I: Period 3|Lost to Follow-up|1|||
160805652|NCT01791517|580676576|FG002|Phase I: Period 3|Lost to Follow-up|0|||
160805653|NCT01791517|580676577|FG003|Phase I: Period 3|Lost to Follow-up|0|||
160805654|NCT01791517|580676578|FG004|Phase I: Period 3|Lost to Follow-up|1|||
160805655|NCT01791517|580676579|FG005|Phase I: Period 3|Lost to Follow-up|0|||
160805656|NCT01791517|580676580|FG006|Phase I: Period 3|Lost to Follow-up|0|||
160805657|NCT01791517|580676581|FG007|Phase I: Period 3|Lost to Follow-up|0|||
160805658|NCT01791517|580676582|FG008|Phase I: Period 3|Lost to Follow-up|0|||
160805659|NCT01791517|580676583|FG009|Phase I: Period 3|Lost to Follow-up|0|||
160805660|NCT01791517|580676584|FG010|Phase I: Period 3|Lost to Follow-up|0|||
160805661|NCT01791517|580676585|FG011|Phase I: Period 3|Lost to Follow-up|0|||
160805662|NCT01791517|580676574|FG000|Phase I: Period 3|Adverse Event|0|||
160805663|NCT01791517|580676575|FG001|Phase I: Period 3|Adverse Event|0|||
160805664|NCT01791517|580676576|FG002|Phase I: Period 3|Adverse Event|0|||
160805665|NCT01791517|580676577|FG003|Phase I: Period 3|Adverse Event|1|||
160805666|NCT01791517|580676578|FG004|Phase I: Period 3|Adverse Event|0|||
160805667|NCT01791517|580676579|FG005|Phase I: Period 3|Adverse Event|0|||
160805668|NCT01791517|580676580|FG006|Phase I: Period 3|Adverse Event|0|||
160805669|NCT01791517|580676581|FG007|Phase I: Period 3|Adverse Event|0|||
160805670|NCT01791517|580676582|FG008|Phase I: Period 3|Adverse Event|0|||
160805671|NCT01791517|580676583|FG009|Phase I: Period 3|Adverse Event|0|||
160805672|NCT01791517|580676584|FG010|Phase I: Period 3|Adverse Event|0|||
160985308|NCT02335268|581335421|FG000|Overall Study|increase blasts|2|||
160985309|NCT02335268|581335422|FG001|Overall Study|increase blasts|0|||
160985310|NCT02335268|581335421|FG000|Overall Study|Withdrawal by Subject|3|||
160985311|NCT02335268|581335422|FG001|Overall Study|Withdrawal by Subject|2|||
160985312|NCT05893797|581335423|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
160985313|NCT05893797|581335423|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
160985314|NCT05893797|581335423|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
160985315|NCT05893797|581335423|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
160985316|NCT01822353|581335424|FG000|Overall Study|Adverse Event|1|||
160985317|NCT01822353|581335425|FG001|Overall Study|Adverse Event|3|||
160985318|NCT01822353|581335426|FG002|Overall Study|Adverse Event|1|||
161130090|NCT02908100|581863347|FG002|Overall Study|Non-Compliance With Study Drug|2|||
161130091|NCT02908100|581863345|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
160805673|NCT01791517|580676585|FG011|Phase I: Period 3|Adverse Event|0|||
160805674|NCT01791517|580676574|FG000|Phase II|Lost to Follow-up|1|||
160805675|NCT01791517|580676575|FG001|Phase II|Lost to Follow-up|0|||
160805676|NCT01791517|580676576|FG002|Phase II|Lost to Follow-up|1|||
160805677|NCT01791517|580676577|FG003|Phase II|Lost to Follow-up|0|||
160805678|NCT01791517|580676578|FG004|Phase II|Lost to Follow-up|1|||
160805679|NCT01791517|580676579|FG005|Phase II|Lost to Follow-up|2|||
160805680|NCT01791517|580676580|FG006|Phase II|Lost to Follow-up|0|||
160805681|NCT01791517|580676581|FG007|Phase II|Lost to Follow-up|1|||
160805682|NCT01791517|580676582|FG008|Phase II|Lost to Follow-up|1|||
160805683|NCT01791517|580676583|FG009|Phase II|Lost to Follow-up|1|||
160985319|NCT01822353|581335424|FG000|Overall Study|Pregnancy|0|||
160985320|NCT01822353|581335425|FG001|Overall Study|Pregnancy|1|||
160805684|NCT01791517|580676584|FG010|Phase II|Lost to Follow-up|0|||
160805685|NCT01791517|580676585|FG011|Phase II|Lost to Follow-up|0|||
160805686|NCT01791517|580676574|FG000|Phase II|Withdrawal by Subject|1|||
160805687|NCT01791517|580676575|FG001|Phase II|Withdrawal by Subject|0|||
160805688|NCT01791517|580676576|FG002|Phase II|Withdrawal by Subject|0|||
160805689|NCT01791517|580676577|FG003|Phase II|Withdrawal by Subject|0|||
160805690|NCT01791517|580676578|FG004|Phase II|Withdrawal by Subject|0|||
160805691|NCT01791517|580676579|FG005|Phase II|Withdrawal by Subject|2|||
160805692|NCT01791517|580676580|FG006|Phase II|Withdrawal by Subject|0|||
160805693|NCT01791517|580676581|FG007|Phase II|Withdrawal by Subject|1|||
160805694|NCT01791517|580676582|FG008|Phase II|Withdrawal by Subject|0|||
160805695|NCT01791517|580676583|FG009|Phase II|Withdrawal by Subject|0|||
160805696|NCT01791517|580676584|FG010|Phase II|Withdrawal by Subject|1|||
160805697|NCT01791517|580676585|FG011|Phase II|Withdrawal by Subject|0|||
160805698|NCT01791517|580676574|FG000|Phase II|Lack of Efficacy|0|||
160805699|NCT01791517|580676575|FG001|Phase II|Lack of Efficacy|0|||
160805700|NCT01791517|580676576|FG002|Phase II|Lack of Efficacy|0|||
160805701|NCT01791517|580676577|FG003|Phase II|Lack of Efficacy|0|||
160805702|NCT01791517|580676578|FG004|Phase II|Lack of Efficacy|1|||
160805703|NCT01791517|580676579|FG005|Phase II|Lack of Efficacy|0|||
160805704|NCT01791517|580676580|FG006|Phase II|Lack of Efficacy|0|||
160805705|NCT01791517|580676581|FG007|Phase II|Lack of Efficacy|0|||
160805706|NCT01791517|580676582|FG008|Phase II|Lack of Efficacy|0|||
160805707|NCT01791517|580676583|FG009|Phase II|Lack of Efficacy|0|||
160805708|NCT01791517|580676584|FG010|Phase II|Lack of Efficacy|0|||
160805709|NCT01791517|580676585|FG011|Phase II|Lack of Efficacy|0|||
160805710|NCT01791517|580676574|FG000|Phase II|Adverse Event|0|||
160805711|NCT01791517|580676575|FG001|Phase II|Adverse Event|0|||
160805712|NCT01791517|580676576|FG002|Phase II|Adverse Event|0|||
160805713|NCT01791517|580676577|FG003|Phase II|Adverse Event|0|||
160805714|NCT01791517|580676578|FG004|Phase II|Adverse Event|0|||
160805715|NCT01791517|580676579|FG005|Phase II|Adverse Event|0|||
160805716|NCT01791517|580676580|FG006|Phase II|Adverse Event|2|||
160805717|NCT01791517|580676581|FG007|Phase II|Adverse Event|1|||
160805718|NCT01791517|580676582|FG008|Phase II|Adverse Event|0|||
160805719|NCT01791517|580676583|FG009|Phase II|Adverse Event|1|||
160805720|NCT01791517|580676584|FG010|Phase II|Adverse Event|0|||
160898057|NCT01543698|581023383|FG009|Phase 1b|Death|0|||
160898058|NCT01543698|581023384|FG010|Phase 1b|Death|1|||
160898059|NCT01543698|581023385|FG011|Phase 1b|Death|0|||
160898060|NCT01543698|581023386|FG012|Phase 1b|Death|0|||
160898061|NCT01543698|581023387|FG013|Phase 1b|Death|0|||
160898062|NCT01543698|581023388|FG014|Phase 1b|Death|0|||
160898063|NCT01543698|581023374|FG000|Phase 1b|Withdrawal by Subject|0|||
160898064|NCT01543698|581023375|FG001|Phase 1b|Withdrawal by Subject|1|||
160898065|NCT01543698|581023376|FG002|Phase 1b|Withdrawal by Subject|0|||
160898066|NCT01543698|581023377|FG003|Phase 1b|Withdrawal by Subject|1|||
160898067|NCT01543698|581023378|FG004|Phase 1b|Withdrawal by Subject|0|||
160898068|NCT01543698|581023379|FG005|Phase 1b|Withdrawal by Subject|0|||
160898069|NCT01543698|581023380|FG006|Phase 1b|Withdrawal by Subject|1|||
160898070|NCT01543698|581023381|FG007|Phase 1b|Withdrawal by Subject|0|||
160898071|NCT01543698|581023382|FG008|Phase 1b|Withdrawal by Subject|0|||
160898072|NCT01543698|581023383|FG009|Phase 1b|Withdrawal by Subject|0|||
160898073|NCT01543698|581023384|FG010|Phase 1b|Withdrawal by Subject|0|||
160898074|NCT01543698|581023385|FG011|Phase 1b|Withdrawal by Subject|0|||
160898075|NCT01543698|581023386|FG012|Phase 1b|Withdrawal by Subject|0|||
160898076|NCT01543698|581023387|FG013|Phase 1b|Withdrawal by Subject|0|||
160985321|NCT01822353|581335426|FG002|Overall Study|Pregnancy|0|||
160985322|NCT01822353|581335424|FG000|Overall Study|Withdrawal by Subject|3|||
160985323|NCT01822353|581335425|FG001|Overall Study|Withdrawal by Subject|1|||
161237565|NCT00984126|582250220|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
161237566|NCT00984126|582250221|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
160805721|NCT01791517|580676585|FG011|Phase II|Adverse Event|0|||
160805722|NCT01791517|580676574|FG000|Phase II|Lens Handling Difficulties|0|||
160805723|NCT01791517|580676575|FG001|Phase II|Lens Handling Difficulties|0|||
160805724|NCT01791517|580676576|FG002|Phase II|Lens Handling Difficulties|0|||
160805725|NCT01791517|580676577|FG003|Phase II|Lens Handling Difficulties|0|||
160805726|NCT01791517|580676578|FG004|Phase II|Lens Handling Difficulties|0|||
160805727|NCT01791517|580676579|FG005|Phase II|Lens Handling Difficulties|0|||
161332268|NCT02035553|582603567|FG000|Overall Study|Physician Decision|3|||
160898077|NCT01543698|581023388|FG014|Phase 1b|Withdrawal by Subject|0|||
160898078|NCT01543698|581023374|FG000|Phase 1b|Adverse Event|1|||
160805728|NCT01791517|580676580|FG006|Phase II|Lens Handling Difficulties|0|||
160805729|NCT01791517|580676581|FG007|Phase II|Lens Handling Difficulties|0|||
160805730|NCT01791517|580676582|FG008|Phase II|Lens Handling Difficulties|1|||
160805731|NCT01791517|580676583|FG009|Phase II|Lens Handling Difficulties|0|||
160805732|NCT01791517|580676584|FG010|Phase II|Lens Handling Difficulties|0|||
160805733|NCT01791517|580676585|FG011|Phase II|Lens Handling Difficulties|0|||
160805734|NCT01791517|580676574|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
160898079|NCT01543698|581023375|FG001|Phase 1b|Adverse Event|0|||
160898080|NCT01543698|581023376|FG002|Phase 1b|Adverse Event|0|||
160898081|NCT01543698|581023377|FG003|Phase 1b|Adverse Event|1|||
160985324|NCT01822353|581335426|FG002|Overall Study|Withdrawal by Subject|0|||
161237567|NCT00984126|582250222|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
161237568|NCT00984126|582250219|FG000|Overall Study|Withdrawal criteria|0|||
161237569|NCT00984126|582250220|FG001|Overall Study|Withdrawal criteria|1|||
161237570|NCT00984126|582250221|FG002|Overall Study|Withdrawal criteria|3|||
161237571|NCT00984126|582250222|FG003|Overall Study|Withdrawal criteria|9|||
161237572|NCT01029340|582250225|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
161237573|NCT01029340|582250226|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
161237574|NCT01029340|582250227|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
161237575|NCT01029340|582250228|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
161237576|NCT01029340|582250229|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
161237577|NCT01029340|582250230|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
161237578|NCT01029340|582250225|FG000|Part B Treatment Period|Protocol Violation|0|||
161237579|NCT01029340|582250226|FG001|Part B Treatment Period|Protocol Violation|0|||
161237580|NCT01029340|582250227|FG002|Part B Treatment Period|Protocol Violation|1|||
161237581|NCT01029340|582250228|FG003|Part B Treatment Period|Protocol Violation|0|||
161237582|NCT01029340|582250229|FG004|Part B Treatment Period|Protocol Violation|0|||
161237583|NCT01029340|582250230|FG005|Part B Treatment Period|Protocol Violation|0|||
161237584|NCT01029340|582250225|FG000|Extension Period|Adverse Event|0|||
161237585|NCT01029340|582250226|FG001|Extension Period|Adverse Event|0|||
161237586|NCT01029340|582250227|FG002|Extension Period|Adverse Event|0|||
161237587|NCT01029340|582250228|FG003|Extension Period|Adverse Event|0|||
161237588|NCT01029340|582250229|FG004|Extension Period|Adverse Event|0|||
161237589|NCT01029340|582250230|FG005|Extension Period|Adverse Event|1|||
161237590|NCT01029340|582250225|FG000|Extension Period|starting another study|0|||
161237591|NCT01029340|582250226|FG001|Extension Period|starting another study|0|||
161237592|NCT01029340|582250227|FG002|Extension Period|starting another study|0|||
161237593|NCT01029340|582250228|FG003|Extension Period|starting another study|0|||
161237594|NCT01029340|582250229|FG004|Extension Period|starting another study|0|||
161237595|NCT01029340|582250230|FG005|Extension Period|starting another study|8|||
161237596|NCT01029340|582250225|FG000|Extension Period|non-compliance|0|||
161237597|NCT01029340|582250226|FG001|Extension Period|non-compliance|0|||
161237598|NCT01029340|582250227|FG002|Extension Period|non-compliance|0|||
161237599|NCT01029340|582250228|FG003|Extension Period|non-compliance|0|||
161237600|NCT01029340|582250229|FG004|Extension Period|non-compliance|0|||
161237601|NCT01029340|582250230|FG005|Extension Period|non-compliance|1|||
161237602|NCT01029340|582250225|FG000|Extension Period|Withdrawal by Subject|0|||
161237603|NCT01029340|582250226|FG001|Extension Period|Withdrawal by Subject|0|||
161237604|NCT01029340|582250227|FG002|Extension Period|Withdrawal by Subject|0|||
161237605|NCT01029340|582250228|FG003|Extension Period|Withdrawal by Subject|0|||
161237606|NCT01029340|582250229|FG004|Extension Period|Withdrawal by Subject|0|||
161237607|NCT01029340|582250230|FG005|Extension Period|Withdrawal by Subject|1|||
161237608|NCT01029340|582250225|FG000|Extension Period|Physician Decision|0|||
161237609|NCT01029340|582250226|FG001|Extension Period|Physician Decision|0|||
161237610|NCT01029340|582250227|FG002|Extension Period|Physician Decision|0|||
161237611|NCT01029340|582250228|FG003|Extension Period|Physician Decision|0|||
161237612|NCT01029340|582250229|FG004|Extension Period|Physician Decision|0|||
161237613|NCT01029340|582250230|FG005|Extension Period|Physician Decision|1|||
161237614|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
161237615|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
161237616|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
161237617|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
161237618|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
161237619|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
161332269|NCT02035553|582603568|FG001|Overall Study|Physician Decision|2|||
161332270|NCT02035553|582603567|FG000|Overall Study|Lack of Efficacy|1|||
161332271|NCT02035553|582603568|FG001|Overall Study|Lack of Efficacy|1|||
161332272|NCT02035553|582603567|FG000|Overall Study|Withdrawal by Subject|4|||
161332273|NCT02035553|582603568|FG001|Overall Study|Withdrawal by Subject|7|||
161332274|NCT02035553|582603567|FG000|Overall Study|Non-compliance with Study Drug|0|||
161237620|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
161237621|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
161237622|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
161237623|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
161237624|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
161237625|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
161237626|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
161237627|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
161237628|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
161237629|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
161237630|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
161237631|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
161237632|NCT02009163|582250235|FG000|Open-label Period (Non-randomized)|Other|13|||
161332275|NCT02035553|582603568|FG001|Overall Study|Non-compliance with Study Drug|1|||
161237633|NCT02009163|582250236|FG001|Open-label Period (Non-randomized)|Other|0|||
161237634|NCT02009163|582250237|FG002|Open-label Period (Non-randomized)|Other|0|||
161237635|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
161237636|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
161237637|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
161237638|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
161237639|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
161237640|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
161237641|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Adverse Event|0|||
161237642|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Adverse Event|0|||
161237643|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Adverse Event|6|||
161237644|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
161237645|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
161237646|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
161237647|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
160898082|NCT01543698|581023378|FG004|Phase 1b|Adverse Event|2|||
161130092|NCT02908100|581863346|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
161130093|NCT02908100|581863347|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
161130094|NCT02908100|581863345|FG000|Overall Study|Physician Decision|0|||
161130095|NCT02908100|581863346|FG001|Overall Study|Physician Decision|1|||
161130096|NCT02908100|581863347|FG002|Overall Study|Physician Decision|0|||
161130097|NCT02908100|581863345|FG000|Overall Study|Pregnancy|1|||
161130098|NCT02908100|581863346|FG001|Overall Study|Pregnancy|2|||
161130099|NCT02908100|581863347|FG002|Overall Study|Pregnancy|0|||
161130100|NCT02908100|581863345|FG000|Overall Study|Withdrawal by Subject|8|||
161130101|NCT02908100|581863346|FG001|Overall Study|Withdrawal by Subject|7|||
161130102|NCT02908100|581863347|FG002|Overall Study|Withdrawal by Subject|5|||
161130103|NCT02908100|581863345|FG000|Overall Study|Randomised in Error|1|||
161130104|NCT02908100|581863346|FG001|Overall Study|Randomised in Error|0|||
161130105|NCT02908100|581863347|FG002|Overall Study|Randomised in Error|0|||
161130106|NCT02024971|581863348|FG000|Overall Study|Data Not Available|30|||
161130107|NCT02024971|581863348|FG000|Overall Study|Lost to Follow-up|6|||
161130108|NCT05254418|581863350|FG000|Overall Study|Adverse Event|2|||
161130109|NCT04067518|581863352|FG000|Overall Study|Adverse Event|1|||
161130110|NCT04067518|581863353|FG001|Overall Study|Adverse Event|3|||
161130111|NCT04067518|581863352|FG000|Overall Study|Screen failures|0|||
161130112|NCT04067518|581863353|FG001|Overall Study|Screen failures|1|||
161130113|NCT04067518|581863352|FG000|Overall Study|Enrolled but not treated|0|||
161130114|NCT04067518|581863353|FG001|Overall Study|Enrolled but not treated|1|||
161130115|NCT02690194|581863354|FG000|Overall Study|Withdrawal by Subject|1|||
161130116|NCT02690194|581863355|FG001|Overall Study|Withdrawal by Subject|4|||
161130117|NCT02690194|581863356|FG002|Overall Study|Withdrawal by Subject|0|||
161130118|NCT03624946|581863357|FG000|Overall Study|Lost to Follow-up|0|||
161130119|NCT03624946|581863358|FG001|Overall Study|Lost to Follow-up|1|||
161130120|NCT00862251|581863359|FG000|Overall Study|Adverse Event|8|||
161130121|NCT00862251|581863360|FG001|Overall Study|Adverse Event|3|||
161130122|NCT00862251|581863361|FG002|Overall Study|Adverse Event|1|||
161130123|NCT00862251|581863359|FG000|Overall Study|Lost to Follow-up|0|||
161130124|NCT00862251|581863360|FG001|Overall Study|Lost to Follow-up|0|||
161130125|NCT00862251|581863361|FG002|Overall Study|Lost to Follow-up|1|||
161130126|NCT00862251|581863359|FG000|Overall Study|Protocol Violation|2|||
161130127|NCT00862251|581863360|FG001|Overall Study|Protocol Violation|0|||
161130128|NCT00862251|581863361|FG002|Overall Study|Protocol Violation|1|||
161130129|NCT00862251|581863359|FG000|Overall Study|Withdrawal by Subject|9|||
161130130|NCT00862251|581863360|FG001|Overall Study|Withdrawal by Subject|2|||
161130131|NCT00862251|581863361|FG002|Overall Study|Withdrawal by Subject|6|||
161130132|NCT00624520|581863362|FG000|Overall Study|Withdrawal by Subject|12|||
161130133|NCT00624520|581863363|FG001|Overall Study|Withdrawal by Subject|7|||
161130134|NCT00624520|581863362|FG000|Overall Study|Death|0|||
161130135|NCT00624520|581863363|FG001|Overall Study|Death|1|||
161130136|NCT02796755|581863364|FG000|Overall Study|Adverse Event|2|||
160898083|NCT01543698|581023379|FG005|Phase 1b|Adverse Event|2|||
160898084|NCT01543698|581023380|FG006|Phase 1b|Adverse Event|0|||
160898085|NCT01543698|581023381|FG007|Phase 1b|Adverse Event|0|||
161130137|NCT02796755|581863365|FG001|Overall Study|Adverse Event|0|||
161130138|NCT00675025|581863366|FG000|Overall Study|Study Terminated by Sponsor|38|||
161130139|NCT00675025|581863367|FG001|Overall Study|Study Terminated by Sponsor|42|||
161130140|NCT00675025|581863366|FG000|Overall Study|Adverse Event|6|||
161130141|NCT00675025|581863367|FG001|Overall Study|Adverse Event|11|||
161130142|NCT00675025|581863366|FG000|Overall Study|Lost to Follow-up|6|||
161130143|NCT00675025|581863367|FG001|Overall Study|Lost to Follow-up|4|||
161130144|NCT00675025|581863366|FG000|Overall Study|Withdrawal by Subject|4|||
161130145|NCT00675025|581863367|FG001|Overall Study|Withdrawal by Subject|6|||
161130146|NCT00944034|581863369|FG000|Overall Study|Inappropriate enrollment|0|||
160898086|NCT01543698|581023382|FG008|Phase 1b|Adverse Event|1|||
161130147|NCT00944034|581863370|FG001|Overall Study|Inappropriate enrollment|1|||
161130148|NCT00944034|581863371|FG002|Overall Study|Inappropriate enrollment|0|||
160898087|NCT01543698|581023383|FG009|Phase 1b|Adverse Event|1|||
160898088|NCT01543698|581023384|FG010|Phase 1b|Adverse Event|2|||
160898089|NCT01543698|581023385|FG011|Phase 1b|Adverse Event|0|||
160898090|NCT01543698|581023386|FG012|Phase 1b|Adverse Event|0|||
160898091|NCT01543698|581023387|FG013|Phase 1b|Adverse Event|0|||
160898092|NCT01543698|581023388|FG014|Phase 1b|Adverse Event|0|||
160898093|NCT01543698|581023374|FG000|Phase 1b|Administrative problems|1|||
160898094|NCT01543698|581023375|FG001|Phase 1b|Administrative problems|0|||
160898095|NCT01543698|581023376|FG002|Phase 1b|Administrative problems|0|||
161130149|NCT00944034|581863372|FG003|Overall Study|Inappropriate enrollment|1|||
160898096|NCT01543698|581023377|FG003|Phase 1b|Administrative problems|0|||
160898097|NCT01543698|581023378|FG004|Phase 1b|Administrative problems|1|||
160898098|NCT01543698|581023379|FG005|Phase 1b|Administrative problems|0|||
160898099|NCT01543698|581023380|FG006|Phase 1b|Administrative problems|0|||
160898100|NCT01543698|581023381|FG007|Phase 1b|Administrative problems|1|||
160898101|NCT01543698|581023382|FG008|Phase 1b|Administrative problems|0|||
160898102|NCT01543698|581023383|FG009|Phase 1b|Administrative problems|0|||
160898103|NCT01543698|581023384|FG010|Phase 1b|Administrative problems|2|||
160898104|NCT01543698|581023385|FG011|Phase 1b|Administrative problems|0|||
160898105|NCT01543698|581023386|FG012|Phase 1b|Administrative problems|0|||
160898106|NCT01543698|581023387|FG013|Phase 1b|Administrative problems|0|||
160898107|NCT01543698|581023388|FG014|Phase 1b|Administrative problems|0|||
161130150|NCT00944034|581863373|FG004|Overall Study|Inappropriate enrollment|2|||
161130151|NCT00944034|581863374|FG005|Overall Study|Inappropriate enrollment|1|||
161130152|NCT00944034|581863375|FG006|Overall Study|Inappropriate enrollment|0|||
161130153|NCT00944034|581863376|FG007|Overall Study|Inappropriate enrollment|0|||
161130154|NCT00944034|581863377|FG008|Overall Study|Inappropriate enrollment|1|||
161130155|NCT00944034|581863378|FG009|Overall Study|Inappropriate enrollment|1|||
161130156|NCT00944034|581863379|FG010|Overall Study|Inappropriate enrollment|0|||
161130157|NCT00944034|581863380|FG011|Overall Study|Inappropriate enrollment|0|||
161130158|NCT00944034|581863369|FG000|Overall Study|Withdrawal by Subject|3|||
161130159|NCT00944034|581863370|FG001|Overall Study|Withdrawal by Subject|2|||
161130160|NCT00944034|581863371|FG002|Overall Study|Withdrawal by Subject|6|||
161130161|NCT00944034|581863372|FG003|Overall Study|Withdrawal by Subject|2|||
161130162|NCT00944034|581863373|FG004|Overall Study|Withdrawal by Subject|5|||
161130163|NCT00944034|581863374|FG005|Overall Study|Withdrawal by Subject|8|||
161130164|NCT00944034|581863375|FG006|Overall Study|Withdrawal by Subject|2|||
161130165|NCT00944034|581863376|FG007|Overall Study|Withdrawal by Subject|2|||
161130166|NCT00944034|581863377|FG008|Overall Study|Withdrawal by Subject|3|||
161130167|NCT00944034|581863378|FG009|Overall Study|Withdrawal by Subject|4|||
161130168|NCT00944034|581863379|FG010|Overall Study|Withdrawal by Subject|0|||
161130169|NCT00944034|581863380|FG011|Overall Study|Withdrawal by Subject|4|||
161130170|NCT00944034|581863369|FG000|Overall Study|Lost to Follow-up|0|||
161130171|NCT00944034|581863370|FG001|Overall Study|Lost to Follow-up|4|||
161130172|NCT00944034|581863371|FG002|Overall Study|Lost to Follow-up|2|||
161130173|NCT00944034|581863372|FG003|Overall Study|Lost to Follow-up|0|||
161130174|NCT00944034|581863373|FG004|Overall Study|Lost to Follow-up|5|||
161130175|NCT00944034|581863374|FG005|Overall Study|Lost to Follow-up|7|||
161130176|NCT00944034|581863375|FG006|Overall Study|Lost to Follow-up|0|||
161130177|NCT00944034|581863376|FG007|Overall Study|Lost to Follow-up|1|||
161130178|NCT00944034|581863377|FG008|Overall Study|Lost to Follow-up|5|||
161130179|NCT00944034|581863378|FG009|Overall Study|Lost to Follow-up|1|||
161130180|NCT00944034|581863379|FG010|Overall Study|Lost to Follow-up|1|||
161130181|NCT00944034|581863380|FG011|Overall Study|Lost to Follow-up|0|||
161130182|NCT00944034|581863369|FG000|Overall Study|Death|0|||
161130183|NCT00944034|581863370|FG001|Overall Study|Death|0|||
161130184|NCT00944034|581863371|FG002|Overall Study|Death|1|||
161130185|NCT00944034|581863372|FG003|Overall Study|Death|0|||
161130186|NCT00944034|581863373|FG004|Overall Study|Death|0|||
161130187|NCT00944034|581863374|FG005|Overall Study|Death|0|||
161130188|NCT00944034|581863375|FG006|Overall Study|Death|0|||
160898108|NCT01543698|581023374|FG000|Phase 1b|Protocol Violation|2|||
160898109|NCT01543698|581023375|FG001|Phase 1b|Protocol Violation|0|||
160898110|NCT01543698|581023376|FG002|Phase 1b|Protocol Violation|0|||
161130189|NCT00944034|581863376|FG007|Overall Study|Death|0|||
161130190|NCT00944034|581863377|FG008|Overall Study|Death|0|||
161130191|NCT00944034|581863378|FG009|Overall Study|Death|0|||
161130192|NCT00944034|581863379|FG010|Overall Study|Death|0|||
161130193|NCT00944034|581863380|FG011|Overall Study|Death|0|||
161130194|NCT00944034|581863369|FG000|Overall Study|Protocol Violation|2|||
161130195|NCT00944034|581863370|FG001|Overall Study|Protocol Violation|0|||
160898111|NCT01543698|581023377|FG003|Phase 1b|Protocol Violation|0|||
160898112|NCT01543698|581023378|FG004|Phase 1b|Protocol Violation|0|||
160898113|NCT01543698|581023379|FG005|Phase 1b|Protocol Violation|0|||
160898114|NCT01543698|581023380|FG006|Phase 1b|Protocol Violation|0|||
160898115|NCT01543698|581023381|FG007|Phase 1b|Protocol Violation|0|||
160898116|NCT01543698|581023382|FG008|Phase 1b|Protocol Violation|0|||
160898117|NCT01543698|581023383|FG009|Phase 1b|Protocol Violation|0|||
160898118|NCT01543698|581023384|FG010|Phase 1b|Protocol Violation|0|||
161130196|NCT00944034|581863371|FG002|Overall Study|Protocol Violation|0|||
161130197|NCT00944034|581863372|FG003|Overall Study|Protocol Violation|1|||
161237648|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
161237649|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
161237650|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Pregnancy|0|||
161237651|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Pregnancy|0|||
161237652|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Pregnancy|2|||
161237653|NCT02009163|582250235|FG000|Randomized-withdrawal Period|Other|0|||
161237654|NCT02009163|582250236|FG001|Randomized-withdrawal Period|Other|9|||
161237655|NCT02009163|582250237|FG002|Randomized-withdrawal Period|Other|5|||
161237656|NCT02453386|582250238|FG000|Overall Study|Adverse Event|22|||
161237657|NCT02453386|582250239|FG001|Overall Study|Adverse Event|30|||
161237658|NCT02453386|582250240|FG002|Overall Study|Adverse Event|15|||
161237659|NCT02453386|582250238|FG000|Overall Study|Protocol Violation|1|||
161237660|NCT02453386|582250239|FG001|Overall Study|Protocol Violation|0|||
161237661|NCT02453386|582250240|FG002|Overall Study|Protocol Violation|1|||
161237662|NCT02453386|582250238|FG000|Overall Study|Withdrawal by Subject|10|||
161237663|NCT02453386|582250239|FG001|Overall Study|Withdrawal by Subject|9|||
161237664|NCT02453386|582250240|FG002|Overall Study|Withdrawal by Subject|9|||
160898119|NCT01543698|581023385|FG011|Phase 1b|Protocol Violation|0|||
160898120|NCT01543698|581023386|FG012|Phase 1b|Protocol Violation|0|||
160898121|NCT01543698|581023387|FG013|Phase 1b|Protocol Violation|0|||
160898122|NCT01543698|581023388|FG014|Phase 1b|Protocol Violation|0|||
160898123|NCT01543698|581023374|FG000|Phase 2|Protocol Violation|0|||
160898124|NCT01543698|581023375|FG001|Phase 2|Protocol Violation|0|||
160898125|NCT01543698|581023376|FG002|Phase 2|Protocol Violation|0|||
160898126|NCT01543698|581023377|FG003|Phase 2|Protocol Violation|0|||
161237665|NCT02453386|582250238|FG000|Overall Study|Sponsor Terminated Study|14|||
161237666|NCT02453386|582250239|FG001|Overall Study|Sponsor Terminated Study|8|||
161237667|NCT02453386|582250240|FG002|Overall Study|Sponsor Terminated Study|11|||
161237668|NCT02453386|582250238|FG000|Overall Study|Subject Terminated by Sponsor|1|||
161237669|NCT02453386|582250239|FG001|Overall Study|Subject Terminated by Sponsor|1|||
161237670|NCT02453386|582250240|FG002|Overall Study|Subject Terminated by Sponsor|1|||
161237671|NCT02453386|582250238|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
161237672|NCT02453386|582250239|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
161237673|NCT02453386|582250240|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
160805735|NCT01791517|580676575|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
160805736|NCT01791517|580676576|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
160805737|NCT01791517|580676577|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
160805738|NCT01791517|580676578|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
160805739|NCT01791517|580676579|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
160805740|NCT01791517|580676580|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
160805741|NCT01791517|580676581|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
160805742|NCT01791517|580676582|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
160805743|NCT01791517|580676583|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
160805744|NCT01791517|580676584|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
160805745|NCT01791517|580676585|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
160805746|NCT01791517|580676574|FG000|Phase II|Pre-Existing Ocular Issue|0|||
160805747|NCT01791517|580676575|FG001|Phase II|Pre-Existing Ocular Issue|0|||
160805748|NCT01791517|580676576|FG002|Phase II|Pre-Existing Ocular Issue|0|||
160805749|NCT01791517|580676577|FG003|Phase II|Pre-Existing Ocular Issue|0|||
160898127|NCT01543698|581023378|FG004|Phase 2|Protocol Violation|0|||
160898128|NCT01543698|581023379|FG005|Phase 2|Protocol Violation|0|||
160898129|NCT01543698|581023380|FG006|Phase 2|Protocol Violation|0|||
160898130|NCT01543698|581023381|FG007|Phase 2|Protocol Violation|0|||
160898131|NCT01543698|581023382|FG008|Phase 2|Protocol Violation|0|||
160898132|NCT01543698|581023383|FG009|Phase 2|Protocol Violation|0|||
160898133|NCT01543698|581023384|FG010|Phase 2|Protocol Violation|0|||
160898134|NCT01543698|581023385|FG011|Phase 2|Protocol Violation|0|||
160898135|NCT01543698|581023386|FG012|Phase 2|Protocol Violation|1|||
160898136|NCT01543698|581023387|FG013|Phase 2|Protocol Violation|0|||
160898137|NCT01543698|581023388|FG014|Phase 2|Protocol Violation|0|||
160898138|NCT01543698|581023374|FG000|Phase 2|Disease progression|0|||
160898139|NCT01543698|581023375|FG001|Phase 2|Disease progression|0|||
160898140|NCT01543698|581023376|FG002|Phase 2|Disease progression|0|||
160898141|NCT01543698|581023377|FG003|Phase 2|Disease progression|0|||
160898142|NCT01543698|581023378|FG004|Phase 2|Disease progression|0|||
160898143|NCT01543698|581023379|FG005|Phase 2|Disease progression|0|||
160898144|NCT01543698|581023380|FG006|Phase 2|Disease progression|0|||
160898145|NCT01543698|581023381|FG007|Phase 2|Disease progression|0|||
160898146|NCT01543698|581023382|FG008|Phase 2|Disease progression|0|||
160898147|NCT01543698|581023383|FG009|Phase 2|Disease progression|0|||
160898148|NCT01543698|581023384|FG010|Phase 2|Disease progression|0|||
160898149|NCT01543698|581023385|FG011|Phase 2|Disease progression|10|||
160898150|NCT01543698|581023386|FG012|Phase 2|Disease progression|21|||
160898151|NCT01543698|581023387|FG013|Phase 2|Disease progression|30|||
161237674|NCT02453386|582250238|FG000|Overall Study|Lost to Follow-up|0|||
160898152|NCT01543698|581023388|FG014|Phase 2|Disease progression|25|||
161237675|NCT02453386|582250239|FG001|Overall Study|Lost to Follow-up|0|||
161237676|NCT02453386|582250240|FG002|Overall Study|Lost to Follow-up|1|||
161237677|NCT02453386|582250238|FG000|Overall Study|Other|1|||
161237678|NCT02453386|582250239|FG001|Overall Study|Other|0|||
161237679|NCT02453386|582250240|FG002|Overall Study|Other|1|||
161237680|NCT00359281|582250241|FG000|Overall Study|Adverse Event|1|||
161237681|NCT00359281|582250242|FG001|Overall Study|Adverse Event|0|||
161237682|NCT00359281|582250243|FG002|Overall Study|Adverse Event|0|||
161237683|NCT00359281|582250244|FG003|Overall Study|Adverse Event|0|||
161237684|NCT00359281|582250245|FG004|Overall Study|Adverse Event|0|||
161237685|NCT00359281|582250246|FG005|Overall Study|Adverse Event|0|||
161237686|NCT00359281|582250247|FG006|Overall Study|Adverse Event|1|||
161237687|NCT00359281|582250248|FG007|Overall Study|Adverse Event|0|||
161237688|NCT00359281|582250249|FG008|Overall Study|Adverse Event|0|||
161237689|NCT00359281|582250241|FG000|Overall Study|Withdrawal by Subject|0|||
161237690|NCT00359281|582250242|FG001|Overall Study|Withdrawal by Subject|0|||
161237691|NCT00359281|582250243|FG002|Overall Study|Withdrawal by Subject|0|||
161237692|NCT00359281|582250244|FG003|Overall Study|Withdrawal by Subject|0|||
161237693|NCT00359281|582250245|FG004|Overall Study|Withdrawal by Subject|0|||
161237694|NCT00359281|582250246|FG005|Overall Study|Withdrawal by Subject|0|||
161237695|NCT00359281|582250247|FG006|Overall Study|Withdrawal by Subject|1|||
161237696|NCT00359281|582250248|FG007|Overall Study|Withdrawal by Subject|0|||
161237697|NCT00359281|582250249|FG008|Overall Study|Withdrawal by Subject|0|||
161237698|NCT01289262|582250252|FG000|Overall Study|Lost to Follow-up|29|||
161237699|NCT01289262|582250253|FG001|Overall Study|Lost to Follow-up|16|||
161237700|NCT01289262|582250252|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
161237701|NCT01289262|582250253|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
161237702|NCT01415986|582250256|FG000|Overall Study|Lost to Follow-up|1|||
161237703|NCT01474551|582250257|FG000|Overall Study|Death|1|||
161237704|NCT03122457|582250265|FG000|Overall Study|Withdrawal by Subject|6|||
161237705|NCT00446563|582250270|FG000|Overall Study|Adverse Event|4|||
161237706|NCT00446563|582250271|FG001|Overall Study|Adverse Event|3|||
161237707|NCT00446563|582250270|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161237708|NCT00446563|582250271|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161237709|NCT00446563|582250270|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161237710|NCT00446563|582250271|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161237711|NCT00446563|582250270|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161237712|NCT00446563|582250271|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161237713|NCT00446563|582250270|FG000|Overall Study|Withdrawal by Subject|2|||
161237714|NCT00446563|582250271|FG001|Overall Study|Withdrawal by Subject|1|||
161237715|NCT00446563|582250270|FG000|Overall Study|Administrative problems|0|||
161237716|NCT00446563|582250271|FG001|Overall Study|Administrative problems|1|||
161237717|NCT03769025|582250272|FG000|Overall Study|Withdrawal by Subject|1|||
161237718|NCT03769025|582250273|FG001|Overall Study|Withdrawal by Subject|1|||
161237719|NCT03769025|582250272|FG000|Overall Study|Lost to Follow-up|4|||
161237720|NCT03769025|582250273|FG001|Overall Study|Lost to Follow-up|3|||
161237721|NCT01169558|582250274|FG000|Overall Study|Disease progression|98|||
161237722|NCT01169558|582250274|FG000|Overall Study|Adverse Event|25|||
161237723|NCT01169558|582250274|FG000|Overall Study|Withdrawal of Consent|8|||
161237724|NCT01169558|582250274|FG000|Overall Study|Medical Decision|7|||
161237725|NCT01169558|582250274|FG000|Overall Study|Stable Disease|4|||
161237726|NCT01169558|582250274|FG000|Overall Study|Lost to Follow-up|4|||
161237727|NCT01169558|582250274|FG000|Overall Study|Need for Surgery|4|||
161237728|NCT01169558|582250274|FG000|Overall Study|Non-compliance|2|||
161237729|NCT01169558|582250274|FG000|Overall Study|Protocol Violation|2|||
161237730|NCT01169558|582250274|FG000|Overall Study|Partial response|2|||
161237731|NCT02911701|582250277|FG000|Overall Study|Withdrawal by Subject|2|||
161237732|NCT02911701|582250278|FG001|Overall Study|Withdrawal by Subject|4|||
161237733|NCT02911701|582250277|FG000|Overall Study|Adverse Event|1|||
161237734|NCT02911701|582250278|FG001|Overall Study|Adverse Event|0|||
161237735|NCT03134222|582250281|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
161237736|NCT03134222|582250282|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
160898153|NCT01543698|581023374|FG000|Phase 2|Death|0|||
160898154|NCT01543698|581023375|FG001|Phase 2|Death|0|||
160898155|NCT01543698|581023376|FG002|Phase 2|Death|0|||
160898156|NCT01543698|581023377|FG003|Phase 2|Death|0|||
160898157|NCT01543698|581023378|FG004|Phase 2|Death|0|||
160898158|NCT01543698|581023379|FG005|Phase 2|Death|0|||
160898159|NCT01543698|581023380|FG006|Phase 2|Death|0|||
160898160|NCT01543698|581023381|FG007|Phase 2|Death|0|||
160898161|NCT01543698|581023382|FG008|Phase 2|Death|0|||
160898162|NCT01543698|581023383|FG009|Phase 2|Death|0|||
160898163|NCT01543698|581023384|FG010|Phase 2|Death|0|||
160898164|NCT01543698|581023385|FG011|Phase 2|Death|0|||
160898165|NCT01543698|581023386|FG012|Phase 2|Death|1|||
160898166|NCT01543698|581023387|FG013|Phase 2|Death|1|||
160898167|NCT01543698|581023388|FG014|Phase 2|Death|1|||
160898168|NCT01543698|581023374|FG000|Phase 2|Administrative problems|0|||
160898169|NCT01543698|581023375|FG001|Phase 2|Administrative problems|0|||
161237737|NCT03134222|582250283|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
161237738|NCT03134222|582250284|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
161237739|NCT03134222|582250285|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
161237740|NCT03134222|582250281|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161237741|NCT03134222|582250282|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161237742|NCT03134222|582250283|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
161237743|NCT03134222|582250284|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
161237744|NCT03134222|582250285|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
161237745|NCT03134222|582250281|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161237746|NCT03134222|582250282|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
161237747|NCT03134222|582250283|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161237748|NCT03134222|582250284|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161237749|NCT03134222|582250285|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
161237750|NCT03134222|582250281|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161237751|NCT03134222|582250282|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
161237752|NCT03134222|582250283|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
161237753|NCT03134222|582250284|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161237754|NCT03134222|582250285|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
161237755|NCT03134222|582250281|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161237756|NCT03134222|582250282|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
161237757|NCT03134222|582250283|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161237758|NCT03134222|582250284|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
161237759|NCT03134222|582250285|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
161237760|NCT03134222|582250281|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
161237761|NCT03134222|582250282|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161237762|NCT03134222|582250283|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161237763|NCT03134222|582250284|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161237764|NCT03134222|582250285|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
161237765|NCT03134222|582250281|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161237766|NCT03134222|582250282|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161237767|NCT03134222|582250283|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161237768|NCT03134222|582250284|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
161237769|NCT03134222|582250285|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
161237770|NCT03134222|582250281|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161237771|NCT03134222|582250282|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
161237772|NCT03134222|582250283|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161237773|NCT03134222|582250284|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161237774|NCT03134222|582250285|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
161237775|NCT03482882|582250288|FG000|Overall Study|Adverse Event|3|||
161237776|NCT03482882|582250288|FG000|Overall Study|Lost to Follow-up|1|||
161237777|NCT03482882|582250288|FG000|Overall Study|Protocol Violation|2|||
161237778|NCT03482882|582250288|FG000|Overall Study|Not further specified|1|||
161237779|NCT04659603|582250291|FG000|Overall Study|Study terminated by sponsor|0|||
161237780|NCT04659603|582250292|FG001|Overall Study|Study terminated by sponsor|0|||
161237781|NCT04659603|582250293|FG002|Overall Study|Study terminated by sponsor|2|||
161237782|NCT04659603|582250291|FG000|Overall Study|Withdrawal by Subject|0|||
161237783|NCT04659603|582250292|FG001|Overall Study|Withdrawal by Subject|5|||
161237784|NCT04659603|582250293|FG002|Overall Study|Withdrawal by Subject|0|||
161237785|NCT04659603|582250291|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
161237786|NCT04659603|582250292|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
161237787|NCT04659603|582250293|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
161237788|NCT01110005|582250294|FG000|Overall Study|ineligible|1|||
161237789|NCT01110005|582250295|FG001|Overall Study|ineligible|2|||
161237790|NCT01110005|582250294|FG000|Overall Study|missing consent|3|||
161237791|NCT01110005|582250295|FG001|Overall Study|missing consent|2|||
161237792|NCT01110005|582250294|FG000|Overall Study|Withdrawal by Subject|0|||
161237793|NCT01110005|582250295|FG001|Overall Study|Withdrawal by Subject|1|||
161237794|NCT04646213|582250296|FG000|Overall Study|Physician Decision|3|||
161237795|NCT04646213|582250296|FG000|Overall Study|Withdrawal by Subject|2|||
161237796|NCT02441309|582250301|FG000|Overall Study|Disease progression|2|||
160898170|NCT01543698|581023376|FG002|Phase 2|Administrative problems|0|||
160898171|NCT01543698|581023377|FG003|Phase 2|Administrative problems|0|||
160898172|NCT01543698|581023378|FG004|Phase 2|Administrative problems|0|||
160898173|NCT01543698|581023379|FG005|Phase 2|Administrative problems|0|||
160898174|NCT01543698|581023380|FG006|Phase 2|Administrative problems|0|||
161237797|NCT02441309|582250302|FG001|Overall Study|Disease progression|1|||
161237798|NCT02441309|582250303|FG002|Overall Study|Disease progression|2|||
161237799|NCT02441309|582250301|FG000|Overall Study|Adverse Event|0|||
161237800|NCT02441309|582250302|FG001|Overall Study|Adverse Event|1|||
161237801|NCT02441309|582250303|FG002|Overall Study|Adverse Event|0|||
160898175|NCT01543698|581023381|FG007|Phase 2|Administrative problems|0|||
160898176|NCT01543698|581023382|FG008|Phase 2|Administrative problems|0|||
161237802|NCT02441309|582250301|FG000|Overall Study|Withdrawal by Subject|1|||
161237803|NCT02441309|582250302|FG001|Overall Study|Withdrawal by Subject|0|||
160898177|NCT01543698|581023383|FG009|Phase 2|Administrative problems|0|||
161237804|NCT02441309|582250303|FG002|Overall Study|Withdrawal by Subject|1|||
161237805|NCT02820350|582250309|FG000|Overall Study|Withdrawal by Subject|3|||
161237806|NCT02820350|582250309|FG000|Overall Study|Death|4|||
161237807|NCT02057835|582251989|FG000|Overall Study|Withdrawal by Subject|0|||
161237808|NCT02057835|582251990|FG001|Overall Study|Withdrawal by Subject|2|||
161237809|NCT02057835|582251991|FG002|Overall Study|Withdrawal by Subject|0|||
161237810|NCT02057835|582251992|FG003|Overall Study|Withdrawal by Subject|0|||
161237811|NCT02057835|582251993|FG004|Overall Study|Withdrawal by Subject|0|||
161237812|NCT02057835|582251994|FG005|Overall Study|Withdrawal by Subject|0|||
161237813|NCT02057835|582251995|FG006|Overall Study|Withdrawal by Subject|0|||
161237814|NCT02057835|582251996|FG007|Overall Study|Withdrawal by Subject|0|||
161237815|NCT02057835|582251997|FG008|Overall Study|Withdrawal by Subject|0|||
161237816|NCT02057835|582251998|FG009|Overall Study|Withdrawal by Subject|0|||
161237817|NCT00834717|582251999|FG000|First Intervention|Adverse Event|1|||
161237818|NCT00834717|582252000|FG001|First Intervention|Adverse Event|0|||
161237819|NCT00834717|582251999|FG000|First Intervention|Withdrawal by Subject|0|||
161237820|NCT00834717|582252000|FG001|First Intervention|Withdrawal by Subject|1|||
161237821|NCT02222818|582252001|FG000|Period 1|Eligibility criteria not met|0|||
161237822|NCT02222818|582252002|FG001|Period 1|Eligibility criteria not met|3|||
161237823|NCT01660243|582252003|FG000|Overall Study|Adverse Event|1|||
161237824|NCT01660243|582252004|FG001|Overall Study|Adverse Event|0|||
161237825|NCT01660243|582252005|FG002|Overall Study|Adverse Event|1|||
161237826|NCT01660243|582252006|FG003|Overall Study|Adverse Event|0|||
161237827|NCT01660243|582252003|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
161237828|NCT01660243|582252004|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161237829|NCT01660243|582252005|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161237830|NCT01660243|582252006|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
161237831|NCT01660243|582252003|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161237832|NCT01660243|582252004|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161237833|NCT01660243|582252005|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
161237834|NCT01660243|582252006|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
161237835|NCT01660243|582252003|FG000|Overall Study|Randomization error|0|||
161237836|NCT01660243|582252004|FG001|Overall Study|Randomization error|0|||
161237837|NCT01660243|582252005|FG002|Overall Study|Randomization error|0|||
161237838|NCT01660243|582252006|FG003|Overall Study|Randomization error|1|||
161237839|NCT03025087|582252007|FG000|Overall Study|Physician Decision|3|||
161237840|NCT03025087|582252008|FG001|Overall Study|Physician Decision|3|||
161237841|NCT03025087|582252009|FG002|Overall Study|Physician Decision|0|||
161237842|NCT03025087|582252010|FG003|Overall Study|Physician Decision|0|||
161237843|NCT03025087|582252011|FG004|Overall Study|Physician Decision|0|||
161237844|NCT03025087|582252007|FG000|Overall Study|Withdrawal by Subject|1|||
161237845|NCT03025087|582252008|FG001|Overall Study|Withdrawal by Subject|1|||
161237846|NCT03025087|582252009|FG002|Overall Study|Withdrawal by Subject|0|||
161237847|NCT03025087|582252010|FG003|Overall Study|Withdrawal by Subject|0|||
161237848|NCT03025087|582252011|FG004|Overall Study|Withdrawal by Subject|0|||
161237849|NCT03025087|582252007|FG000|Overall Study|Unable to complete MRI|2|||
161237850|NCT03025087|582252008|FG001|Overall Study|Unable to complete MRI|2|||
161237851|NCT03025087|582252009|FG002|Overall Study|Unable to complete MRI|0|||
161237852|NCT03025087|582252010|FG003|Overall Study|Unable to complete MRI|0|||
161237853|NCT03025087|582252011|FG004|Overall Study|Unable to complete MRI|0|||
161237854|NCT04299087|582252012|FG000|Overall Study|Lost to Follow-up|2|||
161237855|NCT04299087|582252013|FG001|Overall Study|Lost to Follow-up|1|||
161237856|NCT00594035|582252014|FG000|Overall Study|Lost to Follow-up|1|||
161237857|NCT00594035|582252015|FG001|Overall Study|Lost to Follow-up|1|||
161237858|NCT00594035|582252014|FG000|Overall Study|Withdrawal by Subject|1|||
161237859|NCT00594035|582252015|FG001|Overall Study|Withdrawal by Subject|0|||
161237860|NCT00594035|582252014|FG000|Overall Study|Subject transferred to nursing home|0|||
161237861|NCT00594035|582252015|FG001|Overall Study|Subject transferred to nursing home|1|||
161237862|NCT00594035|582252014|FG000|Overall Study|Subject couldn't return due to job|0|||
160898178|NCT01543698|581023384|FG010|Phase 2|Administrative problems|0|||
161237863|NCT00594035|582252015|FG001|Overall Study|Subject couldn't return due to job|1|||
161237864|NCT00795821|582252016|FG000|Acute Treatment Phase|Adverse Event|23|||
161237865|NCT00795821|582252017|FG001|Acute Treatment Phase|Adverse Event|4|||
161237866|NCT00795821|582252016|FG000|Acute Treatment Phase|Death|1|||
161237867|NCT00795821|582252017|FG001|Acute Treatment Phase|Death|0|||
161237868|NCT00795821|582252016|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
161237869|NCT00795821|582252017|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
161237870|NCT00795821|582252016|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
161237871|NCT00795821|582252017|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
160898179|NCT01543698|581023385|FG011|Phase 2|Administrative problems|0|||
160898180|NCT01543698|581023386|FG012|Phase 2|Administrative problems|0|||
160898181|NCT01543698|581023387|FG013|Phase 2|Administrative problems|3|||
161237872|NCT00795821|582252016|FG000|Acute Treatment Phase|Physician Decision|1|||
161332276|NCT02035553|582603567|FG000|Overall Study|Lost to Follow-up|0|||
161332277|NCT02035553|582603568|FG001|Overall Study|Lost to Follow-up|1|||
161332278|NCT02035553|582603567|FG000|Overall Study|Other Reason|0|||
161332279|NCT02035553|582603568|FG001|Overall Study|Other Reason|4|||
161332280|NCT04539964|582603569|FG000|Overall Study|device malfunction|1|||
161332281|NCT04539964|582603570|FG001|Overall Study|device malfunction|0|||
161332282|NCT04539964|582603569|FG000|Overall Study|Withdrawal by Subject|1|||
161332283|NCT04539964|582603570|FG001|Overall Study|Withdrawal by Subject|2|||
161237873|NCT00795821|582252017|FG001|Acute Treatment Phase|Physician Decision|1|||
161237874|NCT00795821|582252016|FG000|Acute Treatment Phase|Protocol Violation|1|||
161237875|NCT00795821|582252017|FG001|Acute Treatment Phase|Protocol Violation|2|||
161237876|NCT00795821|582252016|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
161237877|NCT00795821|582252017|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
161237878|NCT00795821|582252016|FG000|Long-term Extension Phase|Adverse Event|25|||
161237879|NCT00795821|582252017|FG001|Long-term Extension Phase|Adverse Event|32|||
161237880|NCT00795821|582252016|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
161237881|NCT00795821|582252017|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
161237882|NCT00795821|582252016|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
161237883|NCT00795821|582252017|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
161237884|NCT00795821|582252016|FG000|Long-term Extension Phase|Physician Decision|1|||
161237885|NCT00795821|582252017|FG001|Long-term Extension Phase|Physician Decision|2|||
161332284|NCT04539964|582603569|FG000|Overall Study|Adverse Event|0|||
161332285|NCT04539964|582603570|FG001|Overall Study|Adverse Event|2|||
161237886|NCT00795821|582252016|FG000|Long-term Extension Phase|Protocol Violation|3|||
161237887|NCT00795821|582252017|FG001|Long-term Extension Phase|Protocol Violation|5|||
161237888|NCT00795821|582252016|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
161237889|NCT00795821|582252017|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
161237890|NCT00795821|582252016|FG000|Taper Phase|Adverse Event|2|||
161237891|NCT00795821|582252017|FG001|Taper Phase|Adverse Event|0|||
161332286|NCT01674725|582603571|FG000|Overall Study|Adverse Event|1|||
161332287|NCT01674725|582603572|FG001|Overall Study|Adverse Event|0|||
161332288|NCT01674725|582603571|FG000|Overall Study|Did not receive study drug|1|||
161237892|NCT00795821|582252016|FG000|Taper Phase|Lost to Follow-up|1|||
161332289|NCT01674725|582603572|FG001|Overall Study|Did not receive study drug|0|||
161332290|NCT01674725|582603571|FG000|Overall Study|Withdrawal by Subject|1|||
161332291|NCT01674725|582603572|FG001|Overall Study|Withdrawal by Subject|0|||
161332292|NCT01674725|582603571|FG000|Overall Study|Lost to Follow-up|0|||
161237893|NCT00795821|582252017|FG001|Taper Phase|Lost to Follow-up|0|||
161237894|NCT00795821|582252016|FG000|Taper Phase|Physician Decision|2|||
161237895|NCT00795821|582252017|FG001|Taper Phase|Physician Decision|0|||
161237896|NCT00795821|582252016|FG000|Taper Phase|Withdrawal by Subject|4|||
161237897|NCT00795821|582252017|FG001|Taper Phase|Withdrawal by Subject|0|||
161237898|NCT01376037|582252022|FG000|Overall Study|Lost to Follow-up|0|||
161237899|NCT01376037|582252023|FG001|Overall Study|Lost to Follow-up|2|||
161237900|NCT02328040|582252024|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
161237901|NCT02328040|582252025|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
161332293|NCT01674725|582603572|FG001|Overall Study|Lost to Follow-up|1|||
161332294|NCT03074695|582603573|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
161332295|NCT03074695|582603574|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
161332296|NCT03074695|582603573|FG000|Overall Study|Research staff not available|1|||
161332297|NCT03074695|582603574|FG001|Overall Study|Research staff not available|2|||
161332298|NCT03074695|582603573|FG000|Overall Study|Did not receive neuraxial block|2|||
161332299|NCT03074695|582603574|FG001|Overall Study|Did not receive neuraxial block|2|||
161332300|NCT00468585|582603577|FG000|Overall Study|Patient not treated|1|||
161332301|NCT00468585|582603578|FG001|Overall Study|Patient not treated|0|||
161332302|NCT00468585|582603579|FG002|Overall Study|Patient not treated|1|||
161332303|NCT00468585|582603580|FG003|Overall Study|Patient not treated|0|||
161332304|NCT00468585|582603577|FG000|Overall Study|Patient found to be ineligible|0|||
161332305|NCT00468585|582603578|FG001|Overall Study|Patient found to be ineligible|0|||
161332306|NCT00468585|582603579|FG002|Overall Study|Patient found to be ineligible|1|||
161332307|NCT00468585|582603580|FG003|Overall Study|Patient found to be ineligible|0|||
161332308|NCT00468585|582603577|FG000|Overall Study|Adverse Event|0|||
161332309|NCT00468585|582603578|FG001|Overall Study|Adverse Event|0|||
160805750|NCT01791517|580676578|FG004|Phase II|Pre-Existing Ocular Issue|0|||
160805751|NCT01791517|580676579|FG005|Phase II|Pre-Existing Ocular Issue|0|||
160805752|NCT01791517|580676580|FG006|Phase II|Pre-Existing Ocular Issue|0|||
160805753|NCT01791517|580676581|FG007|Phase II|Pre-Existing Ocular Issue|0|||
160805754|NCT01791517|580676582|FG008|Phase II|Pre-Existing Ocular Issue|0|||
161237902|NCT00835991|582252028|FG000|First Intervention|Adverse Event|0|||
160805755|NCT01791517|580676583|FG009|Phase II|Pre-Existing Ocular Issue|0|||
161332310|NCT00468585|582603579|FG002|Overall Study|Adverse Event|1|||
161332311|NCT00468585|582603580|FG003|Overall Study|Adverse Event|0|||
161332312|NCT00468585|582603577|FG000|Overall Study|Withdrawal by Subject|0|||
161332313|NCT00468585|582603578|FG001|Overall Study|Withdrawal by Subject|0|||
160805756|NCT01791517|580676584|FG010|Phase II|Pre-Existing Ocular Issue|0|||
160805757|NCT01791517|580676585|FG011|Phase II|Pre-Existing Ocular Issue|1|||
160805758|NCT00589797|580676586|FG000|Overall Study|Death|1|||
160805759|NCT00589797|580676587|FG001|Overall Study|Death|0|||
160805760|NCT00589797|580676586|FG000|Overall Study|Lost to Follow-up|12|||
161237903|NCT00835991|582252029|FG001|First Intervention|Adverse Event|1|||
161237904|NCT00835991|582252028|FG000|Washout|Protocol Violation|0|||
161237905|NCT00835991|582252029|FG001|Washout|Protocol Violation|2|||
161237906|NCT00835991|582252028|FG000|Washout|Withdrawal by Subject|3|||
161237907|NCT00835991|582252029|FG001|Washout|Withdrawal by Subject|1|||
161237908|NCT02149420|582252030|FG000|Core Study|Administrative problems|0|||
161237909|NCT02149420|582252031|FG001|Core Study|Administrative problems|1|||
161237910|NCT02149420|582252032|FG002|Core Study|Administrative problems|2|||
161237911|NCT02149420|582252030|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
161237912|NCT02149420|582252031|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
161237913|NCT02149420|582252032|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
161237914|NCT04278560|582252033|FG000|Overall Study|Adverse Event|1|||
161237915|NCT04278560|582252034|FG001|Overall Study|Adverse Event|2|||
161237916|NCT04278560|582252033|FG000|Overall Study|Withdrawal by Subject|0|||
161237917|NCT04278560|582252034|FG001|Overall Study|Withdrawal by Subject|1|||
161237918|NCT00440518|582252035|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
161237919|NCT00440518|582252036|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
161237920|NCT00440518|582252037|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
161237921|NCT00440518|582252035|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
161237922|NCT00440518|582252036|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
161237923|NCT00440518|582252037|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
161237924|NCT00440518|582252035|FG000|Randomized /Titration Period|Protocol Deviation|1|||
161237925|NCT00440518|582252036|FG001|Randomized /Titration Period|Protocol Deviation|0|||
161237926|NCT00440518|582252037|FG002|Randomized /Titration Period|Protocol Deviation|0|||
161237927|NCT00440518|582252035|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
161237928|NCT00440518|582252036|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
161237929|NCT00440518|582252037|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
161332314|NCT00468585|582603579|FG002|Overall Study|Withdrawal by Subject|2|||
161332315|NCT00468585|582603580|FG003|Overall Study|Withdrawal by Subject|1|||
161332316|NCT01290718|582603582|FG000|Overall Study|Early termination of the study|4|||
160805761|NCT00589797|580676587|FG001|Overall Study|Lost to Follow-up|9|||
160805762|NCT00589797|580676586|FG000|Overall Study|Physician Decision|8|||
160805763|NCT00589797|580676587|FG001|Overall Study|Physician Decision|3|||
160805764|NCT00589797|580676586|FG000|Overall Study|Withdrawal by Subject|6|||
160805765|NCT00589797|580676587|FG001|Overall Study|Withdrawal by Subject|5|||
160805766|NCT00589797|580676586|FG000|Overall Study|Non-Randomized Training Subjects|46|||
160805767|NCT00589797|580676587|FG001|Overall Study|Non-Randomized Training Subjects|6|||
160805768|NCT02141672|580676589|FG000|Overall Study|Adverse Event|0|||
160805769|NCT02141672|580676590|FG001|Overall Study|Adverse Event|1|||
160805770|NCT02141672|580676591|FG002|Overall Study|Adverse Event|0|||
160805771|NCT02141672|580676589|FG000|Overall Study|Death|10|||
160805772|NCT02141672|580676590|FG001|Overall Study|Death|2|||
160805773|NCT02141672|580676591|FG002|Overall Study|Death|1|||
160805774|NCT02141672|580676589|FG000|Overall Study|Lack of Efficacy|0|||
160805775|NCT02141672|580676590|FG001|Overall Study|Lack of Efficacy|0|||
160805776|NCT02141672|580676591|FG002|Overall Study|Lack of Efficacy|2|||
160805777|NCT02141672|580676589|FG000|Overall Study|Lost to Follow-up|1|||
160805778|NCT02141672|580676590|FG001|Overall Study|Lost to Follow-up|1|||
160805779|NCT02141672|580676591|FG002|Overall Study|Lost to Follow-up|3|||
160805780|NCT02141672|580676589|FG000|Overall Study|Physician Decision|1|||
160805781|NCT02141672|580676590|FG001|Overall Study|Physician Decision|2|||
160805782|NCT02141672|580676591|FG002|Overall Study|Physician Decision|5|||
160805783|NCT02141672|580676589|FG000|Overall Study|Protocol Violation|0|||
160805784|NCT02141672|580676590|FG001|Overall Study|Protocol Violation|0|||
160805785|NCT02141672|580676591|FG002|Overall Study|Protocol Violation|1|||
160805786|NCT02141672|580676589|FG000|Overall Study|Withdrawal by Subject|3|||
160805787|NCT02141672|580676590|FG001|Overall Study|Withdrawal by Subject|2|||
160805788|NCT02141672|580676591|FG002|Overall Study|Withdrawal by Subject|5|||
160805789|NCT02141672|580676589|FG000|Overall Study|refused to follow-up|1|||
160805790|NCT02141672|580676590|FG001|Overall Study|refused to follow-up|0|||
160805791|NCT02141672|580676591|FG002|Overall Study|refused to follow-up|1|||
160805792|NCT02688192|580676592|FG000|Overall Study|Lost to Follow-up|11|||
160805793|NCT02688192|580676593|FG001|Overall Study|Lost to Follow-up|5|||
160805794|NCT02688192|580676592|FG000|Overall Study|Physician Decision|1|||
160805795|NCT02688192|580676593|FG001|Overall Study|Physician Decision|0|||
160805796|NCT01773967|580676594|FG000|Overall Study|Lost to Follow-up|15|||
160805797|NCT01773967|580676595|FG001|Overall Study|Lost to Follow-up|13|||
160805798|NCT02803203|580676600|FG000|Overall Study|Adverse Event|4|||
160805799|NCT02803203|580676600|FG000|Overall Study|Death|4|||
160805800|NCT02803203|580676600|FG000|Overall Study|Progressive disease|29|||
160898182|NCT01543698|581023388|FG014|Phase 2|Administrative problems|1|||
161237930|NCT00440518|582252035|FG000|Randomized /Titration Period|Other|1|||
161237931|NCT00440518|582252036|FG001|Randomized /Titration Period|Other|0|||
161237932|NCT00440518|582252037|FG002|Randomized /Titration Period|Other|0|||
161237933|NCT00440518|582252035|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
161237934|NCT00440518|582252036|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
161237935|NCT00440518|582252037|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
161237936|NCT00440518|582252035|FG000|Randomized /Titration Period|Adverse Event|2|||
161237937|NCT00440518|582252036|FG001|Randomized /Titration Period|Adverse Event|3|||
161237938|NCT00440518|582252037|FG002|Randomized /Titration Period|Adverse Event|0|||
161237939|NCT00440518|582252035|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
161237940|NCT00440518|582252036|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
161237941|NCT00440518|582252037|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
161237942|NCT00440518|582252035|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
161237943|NCT00440518|582252036|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
161237944|NCT00440518|582252037|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
161237945|NCT00440518|582252035|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
161237946|NCT00440518|582252036|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
161237947|NCT00440518|582252037|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
161237948|NCT00440518|582252035|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
161237949|NCT00440518|582252036|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
161237950|NCT00440518|582252037|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
161237951|NCT00440518|582252035|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
161237952|NCT00440518|582252036|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
161237953|NCT00440518|582252037|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
161237954|NCT00440518|582252035|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
161237955|NCT00440518|582252036|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
161237956|NCT00440518|582252037|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
161237957|NCT02146105|582252038|FG000|Overall Study|Adverse Event|1|||
161237958|NCT02146105|582252038|FG000|Overall Study|Withdrawal by Subject|5|||
161237959|NCT01319383|582252039|FG000|Overall Study|No ex vivo or in vivo response|4|||
161237960|NCT01319383|582252040|FG001|Overall Study|No ex vivo or in vivo response|0|||
161237961|NCT01319383|582252039|FG000|Overall Study|Physician Decision|3|||
161237962|NCT01319383|582252040|FG001|Overall Study|Physician Decision|0|||
161237963|NCT01319383|582252039|FG000|Overall Study|Lack of Efficacy|5|||
161237964|NCT01319383|582252040|FG001|Overall Study|Lack of Efficacy|9|||
161237965|NCT01319383|582252039|FG000|Overall Study|No in vivo response to interval doses|0|||
161237966|NCT01319383|582252040|FG001|Overall Study|No in vivo response to interval doses|1|||
161237967|NCT03086460|582252043|FG000|Study Participants|Lost to Follow-up|2|||
161237968|NCT03086460|582252043|FG000|Study Participants|Protocol Violation|1|||
161237969|NCT03086460|582252043|FG000|Study Participants|Withdrawal by Subject|6|||
161237970|NCT03086460|582252043|FG000|Treatment A|Lost to Follow-up|1|||
161237971|NCT03086460|582252043|FG000|Treatment A|Protocol Violation|1|||
161237972|NCT03086460|582252043|FG000|Treatment A|Withdrawal by Subject|2|||
161237973|NCT03086460|582252043|FG000|Treatment C|Withdrawal by Subject|2|||
161237974|NCT03086460|582252043|FG000|Treatment E|Lost to Follow-up|1|||
161237975|NCT03086460|582252043|FG000|Treatment E|Withdrawal by Subject|3|||
161237976|NCT02718326|582252046|FG000|Overall Study|Adverse Event|4|||
161237977|NCT02718326|582252047|FG001|Overall Study|Adverse Event|9|||
161237978|NCT02718326|582252048|FG002|Overall Study|Adverse Event|0|||
161237979|NCT02718326|582252046|FG000|Overall Study|Death|8|||
161237980|NCT02718326|582252047|FG001|Overall Study|Death|1|||
161237981|NCT02718326|582252048|FG002|Overall Study|Death|2|||
161237982|NCT02718326|582252046|FG000|Overall Study|Withdrawal by Subject|4|||
161237983|NCT02718326|582252047|FG001|Overall Study|Withdrawal by Subject|9|||
161237984|NCT02718326|582252048|FG002|Overall Study|Withdrawal by Subject|6|||
161237985|NCT02718326|582252046|FG000|Overall Study|Lost to Follow-up|18|||
161237986|NCT02718326|582252047|FG001|Overall Study|Lost to Follow-up|5|||
161237987|NCT02718326|582252048|FG002|Overall Study|Lost to Follow-up|14|||
161237988|NCT02718326|582252046|FG000|Overall Study|Protocol Deviation|1|||
161237989|NCT02718326|582252047|FG001|Overall Study|Protocol Deviation|0|||
161237990|NCT02718326|582252048|FG002|Overall Study|Protocol Deviation|0|||
161332317|NCT00748241|582603584|FG000|Overall Study|Implant failure|1|||
160805801|NCT02803203|580676600|FG000|Overall Study|Withdrawal by Subject|8|||
160805802|NCT02803203|580676600|FG000|Overall Study|Complete resection of target disease|2|||
160805803|NCT02803203|580676600|FG000|Overall Study|Switched to commercial Osi|1|||
160805804|NCT02803203|580676600|FG000|Overall Study|Participant moved away|1|||
160805805|NCT00590967|580676601|FG000|Overall Study|Withdrawal by Subject|1|||
161237991|NCT02718326|582252046|FG000|Overall Study|Pregnancy|1|||
161237992|NCT02718326|582252047|FG001|Overall Study|Pregnancy|0|||
161237993|NCT02718326|582252048|FG002|Overall Study|Pregnancy|0|||
161237994|NCT06195579|582252052|FG000|Overall Study|Withdrawal by Subject|1|||
161237995|NCT02545283|582252053|FG000|Overall Study|Lost to Follow-up|2|||
161237996|NCT02545283|582252054|FG001|Overall Study|Lost to Follow-up|4|||
160805806|NCT00590967|580676602|FG001|Overall Study|Withdrawal by Subject|1|||
160805807|NCT00590967|580676601|FG000|Overall Study|Ineligible|1|||
160805808|NCT00590967|580676602|FG001|Overall Study|Ineligible|0|||
160805809|NCT00590967|580676601|FG000|Overall Study|Poor performance status|0|||
160805810|NCT00590967|580676602|FG001|Overall Study|Poor performance status|1|||
160805811|NCT00590967|580676601|FG000|Overall Study|Non-compliant|0|||
160805812|NCT00590967|580676602|FG001|Overall Study|Non-compliant|2|||
160805813|NCT00590967|580676601|FG000|Overall Study|Did not sign consent form|0|||
160805814|NCT00590967|580676602|FG001|Overall Study|Did not sign consent form|1|||
160805815|NCT00590967|580676601|FG000|Overall Study|Did not receive chemo per protocol|1|||
160805816|NCT00590967|580676602|FG001|Overall Study|Did not receive chemo per protocol|0|||
160805817|NCT01881789|580676603|FG000|Overall Study|Withdrawal by Subject|0|||
160898183|NCT01543698|581023374|FG000|Phase 2|Withdrawal by Subject|0|||
160898184|NCT01543698|581023375|FG001|Phase 2|Withdrawal by Subject|0|||
160898185|NCT01543698|581023376|FG002|Phase 2|Withdrawal by Subject|0|||
160898186|NCT01543698|581023377|FG003|Phase 2|Withdrawal by Subject|0|||
160898187|NCT01543698|581023378|FG004|Phase 2|Withdrawal by Subject|0|||
160898188|NCT01543698|581023379|FG005|Phase 2|Withdrawal by Subject|0|||
161130198|NCT00944034|581863373|FG004|Overall Study|Protocol Violation|2|||
161130199|NCT00944034|581863374|FG005|Overall Study|Protocol Violation|3|||
161130200|NCT00944034|581863375|FG006|Overall Study|Protocol Violation|0|||
161130201|NCT00944034|581863376|FG007|Overall Study|Protocol Violation|1|||
161130202|NCT00944034|581863377|FG008|Overall Study|Protocol Violation|1|||
161130203|NCT00944034|581863378|FG009|Overall Study|Protocol Violation|4|||
161130204|NCT00944034|581863379|FG010|Overall Study|Protocol Violation|0|||
161130205|NCT00944034|581863380|FG011|Overall Study|Protocol Violation|0|||
161130206|NCT00944034|581863369|FG000|Overall Study|Unable to classify|0|||
161130207|NCT00944034|581863370|FG001|Overall Study|Unable to classify|0|||
161130208|NCT00944034|581863371|FG002|Overall Study|Unable to classify|0|||
161130209|NCT00944034|581863372|FG003|Overall Study|Unable to classify|0|||
161130210|NCT00944034|581863373|FG004|Overall Study|Unable to classify|0|||
161130211|NCT00944034|581863374|FG005|Overall Study|Unable to classify|1|||
161130212|NCT00944034|581863375|FG006|Overall Study|Unable to classify|1|||
161130213|NCT00944034|581863376|FG007|Overall Study|Unable to classify|1|||
161130214|NCT00944034|581863377|FG008|Overall Study|Unable to classify|0|||
161130215|NCT00944034|581863378|FG009|Overall Study|Unable to classify|0|||
161130216|NCT00944034|581863379|FG010|Overall Study|Unable to classify|0|||
161130217|NCT00944034|581863380|FG011|Overall Study|Unable to classify|0|||
161130218|NCT00944034|581863369|FG000|Overall Study|Administrative reason|0|||
161130219|NCT00944034|581863370|FG001|Overall Study|Administrative reason|0|||
161130220|NCT00944034|581863371|FG002|Overall Study|Administrative reason|0|||
161130221|NCT00944034|581863372|FG003|Overall Study|Administrative reason|0|||
161130222|NCT00944034|581863373|FG004|Overall Study|Administrative reason|0|||
161130223|NCT00944034|581863374|FG005|Overall Study|Administrative reason|0|||
161130224|NCT00944034|581863375|FG006|Overall Study|Administrative reason|1|||
161130225|NCT00944034|581863376|FG007|Overall Study|Administrative reason|0|||
161130226|NCT00944034|581863377|FG008|Overall Study|Administrative reason|0|||
161130227|NCT00944034|581863378|FG009|Overall Study|Administrative reason|0|||
161130228|NCT00944034|581863379|FG010|Overall Study|Administrative reason|0|||
161130229|NCT00944034|581863380|FG011|Overall Study|Administrative reason|0|||
161130230|NCT01570244|581863384|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
161130231|NCT03486392|581863385|FG000|Overall Study|Lost to Follow-up|0|||
161130232|NCT03486392|581863386|FG001|Overall Study|Lost to Follow-up|0|||
161130233|NCT03486392|581863387|FG002|Overall Study|Lost to Follow-up|8|||
161130234|NCT03486392|581863388|FG003|Overall Study|Lost to Follow-up|5|||
161130235|NCT03486392|581863389|FG004|Overall Study|Lost to Follow-up|2|||
161130236|NCT03486392|581863385|FG000|Overall Study|Withdrawal by Subject|3|||
161130237|NCT03486392|581863386|FG001|Overall Study|Withdrawal by Subject|0|||
161130238|NCT03486392|581863387|FG002|Overall Study|Withdrawal by Subject|6|||
160898189|NCT01543698|581023380|FG006|Phase 2|Withdrawal by Subject|0|||
161130239|NCT03486392|581863388|FG003|Overall Study|Withdrawal by Subject|4|||
161130240|NCT03486392|581863389|FG004|Overall Study|Withdrawal by Subject|1|||
161130241|NCT03486392|581863385|FG000|Overall Study|Death|0|||
161130242|NCT03486392|581863386|FG001|Overall Study|Death|0|||
161130243|NCT03486392|581863387|FG002|Overall Study|Death|0|||
161130244|NCT03486392|581863388|FG003|Overall Study|Death|0|||
161130245|NCT03486392|581863389|FG004|Overall Study|Death|1|||
161130246|NCT02347631|581863390|FG000|First Intervention (2 Months)|Adverse Event|1|||
161130247|NCT02347631|581863391|FG001|First Intervention (2 Months)|Adverse Event|1|||
161130248|NCT02347631|581863390|FG000|First Intervention (2 Months)|Pregnancy|1|||
161130249|NCT02347631|581863391|FG001|First Intervention (2 Months)|Pregnancy|0|||
161130250|NCT02347631|581863390|FG000|First Intervention (2 Months)|Moved out of area|0|||
161130251|NCT02347631|581863391|FG001|First Intervention (2 Months)|Moved out of area|2|||
161130252|NCT02347631|581863390|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
160805818|NCT01881789|580676604|FG001|Overall Study|Withdrawal by Subject|2|||
160805819|NCT01881789|580676605|FG002|Overall Study|Withdrawal by Subject|1|||
160805820|NCT01881789|580676606|FG003|Overall Study|Withdrawal by Subject|0|||
160898190|NCT01543698|581023381|FG007|Phase 2|Withdrawal by Subject|0|||
160805821|NCT01881789|580676607|FG004|Overall Study|Withdrawal by Subject|1|||
160805822|NCT01881789|580676608|FG005|Overall Study|Withdrawal by Subject|1|||
160805823|NCT01881789|580676603|FG000|Overall Study|Study Terminated by Sponsor|0|||
160805824|NCT01881789|580676604|FG001|Overall Study|Study Terminated by Sponsor|0|||
160805825|NCT01881789|580676605|FG002|Overall Study|Study Terminated by Sponsor|0|||
160805826|NCT01881789|580676606|FG003|Overall Study|Study Terminated by Sponsor|0|||
160805827|NCT01881789|580676607|FG004|Overall Study|Study Terminated by Sponsor|0|||
160805828|NCT01881789|580676608|FG005|Overall Study|Study Terminated by Sponsor|1|||
160805829|NCT01881789|580676603|FG000|Overall Study|Other|3|||
160805830|NCT01881789|580676604|FG001|Overall Study|Other|5|||
160805831|NCT01881789|580676605|FG002|Overall Study|Other|2|||
160805832|NCT01881789|580676606|FG003|Overall Study|Other|3|||
160805833|NCT01881789|580676607|FG004|Overall Study|Other|1|||
160805834|NCT01881789|580676608|FG005|Overall Study|Other|1|||
160805835|NCT00920556|580676609|FG000|Overall Study|Adverse Event|16|||
160805836|NCT00920556|580676609|FG000|Overall Study|Physician Decision|7|||
161130253|NCT02347631|581863391|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
161130254|NCT02347631|581863390|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
161130255|NCT02347631|581863391|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
161130256|NCT02347631|581863390|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
161130257|NCT02347631|581863391|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
161130258|NCT02347631|581863390|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
161130259|NCT02347631|581863391|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
161130260|NCT02347631|581863390|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
161130261|NCT02347631|581863391|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
161130262|NCT02304926|581863393|FG000|Overall Study|Lost to Follow-up|2|||
161130263|NCT02304926|581863394|FG001|Overall Study|Lost to Follow-up|1|||
161130264|NCT04258579|581863395|FG000|Overall Study|Withdrawal by Subject|7|||
161130265|NCT04258579|581863395|FG000|Overall Study|Lost to Follow-up|3|||
161130266|NCT04258579|581863395|FG000|Overall Study|Protocol Violation|2|||
161130267|NCT04258579|581863395|FG000|Overall Study|Adverse Event|1|||
161130268|NCT04007159|581863396|FG000|Induction Phase|(missed study visits)|16|||
161130269|NCT04007159|581863396|FG000|Induction Phase|Withdrawal by Subject|4|||
161130270|NCT04007159|581863396|FG000|Induction Phase|Adverse Event|2|||
161130271|NCT04007159|581863396|FG000|Challenge Phase|missed study visits|3|||
161130272|NCT02076165|581863398|FG000|Overall Study|Lost to Follow-up|7|||
161130273|NCT02076165|581863399|FG001|Overall Study|Lost to Follow-up|5|||
161130274|NCT02076165|581863398|FG000|Overall Study|Refused follow-up assessment|1|||
161130275|NCT02076165|581863399|FG001|Overall Study|Refused follow-up assessment|1|||
161130276|NCT03804684|581863400|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
161130277|NCT03804684|581863401|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
161130278|NCT01950819|581863402|FG000|Overall Study|Graft Loss|35|||
161130279|NCT01950819|581863403|FG001|Overall Study|Graft Loss|30|||
161130280|NCT01950819|581863402|FG000|Overall Study|Death|29|||
161130281|NCT01950819|581863403|FG001|Overall Study|Death|34|||
161130282|NCT01950819|581863402|FG000|Overall Study|Subject / Gardian decision|54|||
161130283|NCT01950819|581863403|FG001|Overall Study|Subject / Gardian decision|51|||
161130284|NCT01950819|581863402|FG000|Overall Study|technical problems|2|||
161130285|NCT01950819|581863403|FG001|Overall Study|technical problems|0|||
161130286|NCT01950819|581863402|FG000|Overall Study|Pregnancy|0|||
161130287|NCT01950819|581863403|FG001|Overall Study|Pregnancy|2|||
161130288|NCT01950819|581863402|FG000|Overall Study|Lost to Follow-up|9|||
161130289|NCT01950819|581863403|FG001|Overall Study|Lost to Follow-up|17|||
161130290|NCT01360645|581863408|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
161130291|NCT01360645|581863409|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161130292|NCT01360645|581863410|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161130293|NCT01360645|581863411|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
161130294|NCT01360645|581863408|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
161130295|NCT01360645|581863409|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161130296|NCT01360645|581863410|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161130297|NCT01360645|581863411|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
161130298|NCT01360645|581863408|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
161130299|NCT01360645|581863409|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161130300|NCT01360645|581863410|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
161130301|NCT01360645|581863411|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
160898191|NCT01543698|581023382|FG008|Phase 2|Withdrawal by Subject|0|||
161130302|NCT01360645|581863408|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
161130303|NCT01360645|581863409|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161130304|NCT01360645|581863410|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
161130305|NCT01360645|581863411|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
160805837|NCT00920556|580676609|FG000|Overall Study|Withdrawal by Subject|1|||
160805838|NCT02834819|580676610|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
160898192|NCT01543698|581023383|FG009|Phase 2|Withdrawal by Subject|0|||
160985325|NCT02550873|581335427|FG000|Randomized Double Blind|Adverse Event|3|||
160985326|NCT02550873|581335428|FG001|Randomized Double Blind|Adverse Event|1|||
160985327|NCT02550873|581335429|FG002|Randomized Double Blind|Adverse Event|0|||
160985328|NCT02550873|581335427|FG000|Randomized Double Blind|Disease progression|1|||
160985329|NCT02550873|581335428|FG001|Randomized Double Blind|Disease progression|1|||
161237997|NCT02545283|582252053|FG000|Overall Study|Withdrawal by Subject|5|||
161237998|NCT02545283|582252054|FG001|Overall Study|Withdrawal by Subject|9|||
161237999|NCT02545283|582252053|FG000|Overall Study|Death|109|||
161238000|NCT02545283|582252054|FG001|Overall Study|Death|211|||
161238001|NCT02545283|582252053|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
161238002|NCT02545283|582252054|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
161238003|NCT02545283|582252053|FG000|Overall Study|Study Terminated By Sponsor|33|||
161238004|NCT02545283|582252054|FG001|Overall Study|Study Terminated By Sponsor|71|||
161238005|NCT00583453|582252055|FG000|Overall Study|discontinued intervention|0|||
161238006|NCT00583453|582252056|FG001|Overall Study|discontinued intervention|2|||
161238007|NCT02436005|582252057|FG000|Second Intervention|Adverse Event|0|||
161238008|NCT02436005|582252058|FG001|Second Intervention|Adverse Event|1|||
161238009|NCT00905606|582252059|FG000|Period 1|Adverse Event|0|||
161238010|NCT00905606|582252060|FG001|Period 1|Adverse Event|1|||
161238011|NCT00905606|582252059|FG000|Washout|Withdrawal by Subject|1|||
161238012|NCT00905606|582252060|FG001|Washout|Withdrawal by Subject|0|||
161238013|NCT03868891|582252063|FG000|Overall Study|Adverse Event|1|||
161238014|NCT03868891|582252064|FG001|Overall Study|Adverse Event|0|||
161238015|NCT03868891|582252063|FG000|Overall Study|Lost to Follow-up|2|||
161238016|NCT03868891|582252064|FG001|Overall Study|Lost to Follow-up|1|||
161238017|NCT03868891|582252063|FG000|Overall Study|COVID-19 Restrictions|1|||
161238018|NCT03868891|582252064|FG001|Overall Study|COVID-19 Restrictions|2|||
161238019|NCT02246920|582252065|FG000|Overall Study|Adverse Event|3|||
161238020|NCT02246920|582252066|FG001|Overall Study|Adverse Event|1|||
160985330|NCT02550873|581335429|FG002|Randomized Double Blind|Disease progression|0|||
161238021|NCT02246920|582252067|FG002|Overall Study|Adverse Event|1|||
161238022|NCT02246920|582252065|FG000|Overall Study|Lost to Follow-up|2|||
161238023|NCT02246920|582252066|FG001|Overall Study|Lost to Follow-up|1|||
161238024|NCT02246920|582252067|FG002|Overall Study|Lost to Follow-up|0|||
161238025|NCT02246920|582252065|FG000|Overall Study|Protocol Violation|2|||
161238026|NCT02246920|582252066|FG001|Overall Study|Protocol Violation|5|||
160805839|NCT02834819|580676611|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
160805840|NCT00087698|580676618|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
160805841|NCT00087698|580676618|FG000|Overall Study|Death from Other Causes|3|||
160805842|NCT00087698|580676618|FG000|Overall Study|Adverse Event|4|||
160805843|NCT00087698|580676618|FG000|Overall Study|Withdrawal by Subject|4|||
160805844|NCT00087698|580676618|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
160805845|NCT00087698|580676618|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
160805846|NCT00087698|580676618|FG000|Overall Study|Clinical Relapse|1|||
160805847|NCT00087698|580676618|FG000|Overall Study|Death from Study Disease|2|||
160805848|NCT00087698|580676618|FG000|Overall Study|Death from Study Drug Toxicity|2|||
160805849|NCT00087698|580676618|FG000|Overall Study|Protocol Violation|1|||
160805850|NCT00657267|580676625|FG000|Overall Study|Progressive disease|45|||
160805851|NCT00657267|580676625|FG000|Overall Study|Adverse Event|9|||
160805852|NCT02737501|580676626|FG000|Randomized Phase|Died|41|||
160805853|NCT02737501|580676627|FG001|Randomized Phase|Died|29|||
160805854|NCT02737501|580676628|FG002|Randomized Phase|Died|0|||
160805855|NCT02737501|580676626|FG000|Randomized Phase|Withdrawal by Subject|16|||
160805856|NCT02737501|580676627|FG001|Randomized Phase|Withdrawal by Subject|6|||
160805857|NCT02737501|580676628|FG002|Randomized Phase|Withdrawal by Subject|0|||
160805858|NCT02737501|580676626|FG000|Randomized Phase|Lost to Follow-up|0|||
160805859|NCT02737501|580676627|FG001|Randomized Phase|Lost to Follow-up|1|||
160805860|NCT02737501|580676628|FG002|Randomized Phase|Lost to Follow-up|0|||
160805861|NCT02737501|580676626|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
160805862|NCT02737501|580676627|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
160805863|NCT02737501|580676628|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
160805864|NCT02737501|580676626|FG000|Randomized Phase|Reason not Specified|1|||
160805865|NCT02737501|580676627|FG001|Randomized Phase|Reason not Specified|1|||
160805866|NCT02737501|580676628|FG002|Randomized Phase|Reason not Specified|0|||
160805867|NCT02737501|580676626|FG000|Randomized Phase|Never Treated|1|||
161238027|NCT02246920|582252067|FG002|Overall Study|Protocol Violation|1|||
161238028|NCT02246920|582252065|FG000|Overall Study|Withdrawal by Subject|0|||
161238029|NCT02246920|582252066|FG001|Overall Study|Withdrawal by Subject|0|||
161238030|NCT02246920|582252067|FG002|Overall Study|Withdrawal by Subject|1|||
161238031|NCT01363765|582252068|FG000|Overall Study|non-diagnostic|2621|||
161332318|NCT00748241|582603584|FG000|Overall Study|Lost to Follow-up|5|||
160805868|NCT02737501|580676627|FG001|Randomized Phase|Never Treated|1|||
160805869|NCT02737501|580676628|FG002|Randomized Phase|Never Treated|0|||
160805870|NCT02737501|580676626|FG000|Crossover Phase|Died|0|||
160805871|NCT02737501|580676627|FG001|Crossover Phase|Died|0|||
160985331|NCT02550873|581335427|FG000|Open Label Extension|Study ongoing|0|||
161238032|NCT01363765|582252069|FG001|Overall Study|non-diagnostic|1124|||
161238033|NCT01363765|582252068|FG000|Overall Study|duplicate records|736|||
161238034|NCT01363765|582252069|FG001|Overall Study|duplicate records|3177|||
161238035|NCT01363765|582252068|FG000|Overall Study|non-resident|156|||
161238036|NCT01363765|582252069|FG001|Overall Study|non-resident|76|||
161238037|NCT01363765|582252068|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
161238038|NCT01363765|582252069|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
161238039|NCT01363765|582252068|FG000|Overall Study|smear during intervention|2170|||
161238040|NCT01363765|582252069|FG001|Overall Study|smear during intervention|0|||
161238041|NCT03247972|582252070|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
161238042|NCT03247972|582252070|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
161238043|NCT00609674|582252071|FG000|Overall Study|Adverse Event|1|||
161238044|NCT00609674|582252072|FG001|Overall Study|Adverse Event|1|||
161238045|NCT00609674|582252071|FG000|Overall Study|Protocol Violation|3|||
161238046|NCT00609674|582252072|FG001|Overall Study|Protocol Violation|5|||
161238047|NCT00609674|582252071|FG000|Overall Study|Lost to Follow-up|1|||
161238048|NCT00609674|582252072|FG001|Overall Study|Lost to Follow-up|0|||
161238049|NCT00609674|582252071|FG000|Overall Study|Withdrew consent|2|||
161238050|NCT00609674|582252072|FG001|Overall Study|Withdrew consent|1|||
161238051|NCT03285594|582252076|FG000|Overall Study|At the Participant's Own Request|10|||
161238052|NCT03285594|582252077|FG001|Overall Study|At the Participant's Own Request|5|||
161238053|NCT03285594|582252078|FG002|Overall Study|At the Participant's Own Request|21|||
161238054|NCT03285594|582252076|FG000|Overall Study|Adverse Event|2|||
161238055|NCT03285594|582252077|FG001|Overall Study|Adverse Event|2|||
161238056|NCT03285594|582252078|FG002|Overall Study|Adverse Event|6|||
161238057|NCT03285594|582252076|FG000|Overall Study|Poor Compliance to Protocol|0|||
161238058|NCT03285594|582252077|FG001|Overall Study|Poor Compliance to Protocol|0|||
161238059|NCT03285594|582252078|FG002|Overall Study|Poor Compliance to Protocol|1|||
161238060|NCT03285594|582252076|FG000|Overall Study|Lost to Follow-up|0|||
161238061|NCT03285594|582252077|FG001|Overall Study|Lost to Follow-up|0|||
161238062|NCT03285594|582252078|FG002|Overall Study|Lost to Follow-up|1|||
161238063|NCT03285594|582252076|FG000|Overall Study|Reason Not Specified|3|||
161238064|NCT03285594|582252077|FG001|Overall Study|Reason Not Specified|4|||
161238065|NCT03285594|582252078|FG002|Overall Study|Reason Not Specified|8|||
161238066|NCT00834431|582252081|FG000|First Intervention|Adverse Event|0|||
161238067|NCT00834431|582252082|FG001|First Intervention|Adverse Event|1|||
161238068|NCT00834431|582252081|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161238069|NCT00834431|582252082|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161238070|NCT00556322|582252085|FG000|Overall Study|Insufficient therapeutic response|158|||
161238071|NCT00556322|582252086|FG001|Overall Study|Insufficient therapeutic response|168|||
161238072|NCT00556322|582252085|FG000|Overall Study|Adverse Event|7|||
161238073|NCT00556322|582252086|FG001|Overall Study|Adverse Event|4|||
161238074|NCT00556322|582252085|FG000|Overall Study|Other|4|||
161238075|NCT00556322|582252086|FG001|Overall Study|Other|1|||
161238076|NCT00556322|582252085|FG000|Overall Study|Lost to Follow-up|5|||
161238077|NCT00556322|582252086|FG001|Overall Study|Lost to Follow-up|3|||
161238078|NCT00556322|582252085|FG000|Overall Study|Withdrawal by Subject|19|||
161238079|NCT00556322|582252086|FG001|Overall Study|Withdrawal by Subject|7|||
161238080|NCT00556322|582252085|FG000|Overall Study|Protocol Violation|5|||
161238081|NCT00556322|582252086|FG001|Overall Study|Protocol Violation|1|||
161238082|NCT00556322|582252085|FG000|Overall Study|Ongoing at data cutoff|3|||
161238083|NCT00556322|582252086|FG001|Overall Study|Ongoing at data cutoff|5|||
161238084|NCT00556322|582252085|FG000|Overall Study|Death|20|||
161238085|NCT00556322|582252086|FG001|Overall Study|Death|14|||
161238086|NCT03733444|582252087|FG000|Overall Study|Adverse Event|8|||
161238087|NCT03733444|582252088|FG001|Overall Study|Adverse Event|10|||
161238088|NCT03733444|582252089|FG002|Overall Study|Adverse Event|5|||
161238089|NCT03733444|582252087|FG000|Overall Study|Death|20|||
161238090|NCT03733444|582252088|FG001|Overall Study|Death|19|||
161238091|NCT03733444|582252089|FG002|Overall Study|Death|11|||
161238092|NCT03733444|582252087|FG000|Overall Study|Lost to Follow-up|3|||
160805872|NCT02737501|580676628|FG002|Crossover Phase|Died|22|||
160805873|NCT02737501|580676626|FG000|Crossover Phase|Withdrew Consent|0|||
160805874|NCT02737501|580676627|FG001|Crossover Phase|Withdrew Consent|0|||
160805875|NCT02737501|580676628|FG002|Crossover Phase|Withdrew Consent|9|||
160805876|NCT02737501|580676626|FG000|Crossover Phase|Physician Decision|0|||
160805877|NCT02737501|580676627|FG001|Crossover Phase|Physician Decision|0|||
161238093|NCT03733444|582252088|FG001|Overall Study|Lost to Follow-up|0|||
161238094|NCT03733444|582252089|FG002|Overall Study|Lost to Follow-up|1|||
161238095|NCT03733444|582252087|FG000|Overall Study|Lack of Efficacy|0|||
161238096|NCT03733444|582252088|FG001|Overall Study|Lack of Efficacy|1|||
161238097|NCT03733444|582252089|FG002|Overall Study|Lack of Efficacy|1|||
161238098|NCT03733444|582252087|FG000|Overall Study|Physician Decision|2|||
161238099|NCT03733444|582252088|FG001|Overall Study|Physician Decision|1|||
161238100|NCT03733444|582252089|FG002|Overall Study|Physician Decision|0|||
161238101|NCT03733444|582252087|FG000|Overall Study|Protocol Violation|2|||
161238102|NCT03733444|582252088|FG001|Overall Study|Protocol Violation|1|||
161238103|NCT03733444|582252089|FG002|Overall Study|Protocol Violation|0|||
161238104|NCT03733444|582252087|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
160898193|NCT01543698|581023384|FG010|Phase 2|Withdrawal by Subject|0|||
160898194|NCT01543698|581023385|FG011|Phase 2|Withdrawal by Subject|0|||
160898195|NCT01543698|581023386|FG012|Phase 2|Withdrawal by Subject|0|||
160898196|NCT01543698|581023387|FG013|Phase 2|Withdrawal by Subject|3|||
160898197|NCT01543698|581023388|FG014|Phase 2|Withdrawal by Subject|1|||
160898198|NCT01543698|581023374|FG000|Phase 2|Adverse Event|0|||
160898199|NCT01543698|581023375|FG001|Phase 2|Adverse Event|0|||
160898200|NCT01543698|581023376|FG002|Phase 2|Adverse Event|0|||
160898201|NCT01543698|581023377|FG003|Phase 2|Adverse Event|0|||
161130306|NCT01360645|581863408|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
161130307|NCT01360645|581863409|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161130308|NCT01360645|581863410|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161130309|NCT01360645|581863411|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
161130310|NCT01360645|581863408|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
161130311|NCT01360645|581863409|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161130312|NCT01360645|581863410|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161130313|NCT01360645|581863411|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
161130314|NCT01360645|581863408|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
161130315|NCT01360645|581863409|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
161130316|NCT01360645|581863410|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
161130317|NCT01360645|581863411|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
161130318|NCT01360645|581863408|FG000|Phase B (6 Weeks)|Adverse Event|0|||
161130319|NCT01360645|581863409|FG001|Phase B (6 Weeks)|Adverse Event|6|||
161130320|NCT01360645|581863410|FG002|Phase B (6 Weeks)|Adverse Event|0|||
161130321|NCT01360645|581863411|FG003|Phase B (6 Weeks)|Adverse Event|0|||
161130322|NCT01360645|581863408|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161130323|NCT01360645|581863409|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
161130324|NCT01360645|581863410|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
161130325|NCT01360645|581863411|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
161130326|NCT01360645|581863408|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161130327|NCT01360645|581863409|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
161130328|NCT01360645|581863410|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
161130329|NCT01360645|581863411|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
161130330|NCT01360645|581863408|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
161130331|NCT01360645|581863409|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
161130332|NCT01360645|581863410|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
161130333|NCT01360645|581863411|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
161130334|NCT01360645|581863408|FG000|Phase A+|Lost to Follow-up|0|||
161130335|NCT01360645|581863409|FG001|Phase A+|Lost to Follow-up|0|||
161130336|NCT01360645|581863410|FG002|Phase A+|Lost to Follow-up|0|||
161130337|NCT01360645|581863411|FG003|Phase A+|Lost to Follow-up|7|||
161130338|NCT01360645|581863408|FG000|Phase A+|Adverse Event|0|||
161130339|NCT01360645|581863409|FG001|Phase A+|Adverse Event|0|||
161130340|NCT01360645|581863410|FG002|Phase A+|Adverse Event|0|||
161130341|NCT01360645|581863411|FG003|Phase A+|Adverse Event|2|||
161130342|NCT01360645|581863408|FG000|Phase A+|Met Withdrawal Criteria|0|||
161130343|NCT01360645|581863409|FG001|Phase A+|Met Withdrawal Criteria|0|||
161130344|NCT01360645|581863410|FG002|Phase A+|Met Withdrawal Criteria|0|||
161130345|NCT01360645|581863411|FG003|Phase A+|Met Withdrawal Criteria|4|||
161130346|NCT01360645|581863408|FG000|Phase A+|Physician Decision|0|||
161130347|NCT01360645|581863409|FG001|Phase A+|Physician Decision|0|||
161130348|NCT01360645|581863410|FG002|Phase A+|Physician Decision|0|||
161130349|NCT01360645|581863411|FG003|Phase A+|Physician Decision|2|||
161130350|NCT01360645|581863408|FG000|Phase A+|Withdrawal by Subject|0|||
161130351|NCT01360645|581863409|FG001|Phase A+|Withdrawal by Subject|0|||
161130352|NCT01360645|581863410|FG002|Phase A+|Withdrawal by Subject|0|||
161130353|NCT01360645|581863411|FG003|Phase A+|Withdrawal by Subject|5|||
161130354|NCT01360645|581863408|FG000|Phase A+|Protocol Deviation|0|||
161130355|NCT01360645|581863409|FG001|Phase A+|Protocol Deviation|0|||
161130356|NCT01360645|581863410|FG002|Phase A+|Protocol Deviation|0|||
161130357|NCT01360645|581863411|FG003|Phase A+|Protocol Deviation|4|||
161130358|NCT00713219|581863412|FG000|Overall Study|Death|1|||
161130359|NCT00713219|581863412|FG000|Overall Study|Protocol Violation|1|||
161130360|NCT00348140|581863415|FG000|Overall Study|Adverse Event|46|||
161130361|NCT00348140|581863416|FG001|Overall Study|Adverse Event|49|||
161130362|NCT00348140|581863417|FG002|Overall Study|Adverse Event|78|||
161130363|NCT00348140|581863415|FG000|Overall Study|Lost to Follow-up|4|||
161130364|NCT00348140|581863416|FG001|Overall Study|Lost to Follow-up|4|||
161130365|NCT00348140|581863417|FG002|Overall Study|Lost to Follow-up|4|||
161130366|NCT00348140|581863415|FG000|Overall Study|Protocol Violation|12|||
161130367|NCT00348140|581863416|FG001|Overall Study|Protocol Violation|13|||
161130368|NCT00348140|581863417|FG002|Overall Study|Protocol Violation|14|||
161238105|NCT03733444|582252088|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
161238106|NCT03733444|582252089|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
161238107|NCT03733444|582252087|FG000|Overall Study|Study Terminated by Sponsor|203|||
161130369|NCT00348140|581863415|FG000|Overall Study|Withdrawal by Subject|32|||
161130370|NCT00348140|581863416|FG001|Overall Study|Withdrawal by Subject|40|||
160805878|NCT02737501|580676628|FG002|Crossover Phase|Physician Decision|1|||
160805879|NCT02737501|580676626|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
160805880|NCT02737501|580676627|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
160805881|NCT02737501|580676628|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
160805882|NCT02012218|580676631|FG000|Overall Study|Withdrawal by Subject|1|||
160805883|NCT02012218|580676632|FG001|Overall Study|Withdrawal by Subject|0|||
160805884|NCT02012218|580676633|FG002|Overall Study|Withdrawal by Subject|1|||
160805885|NCT02012218|580676634|FG003|Overall Study|Withdrawal by Subject|1|||
160805886|NCT02012218|580676635|FG004|Overall Study|Withdrawal by Subject|1|||
160805887|NCT02012218|580676631|FG000|Overall Study|Adverse Event|1|||
160805888|NCT02012218|580676632|FG001|Overall Study|Adverse Event|0|||
160805889|NCT02012218|580676633|FG002|Overall Study|Adverse Event|0|||
160805890|NCT02012218|580676634|FG003|Overall Study|Adverse Event|1|||
160805891|NCT02012218|580676635|FG004|Overall Study|Adverse Event|0|||
160805892|NCT02012218|580676631|FG000|Overall Study|Lost to Follow-up|0|||
160805893|NCT02012218|580676632|FG001|Overall Study|Lost to Follow-up|1|||
160805894|NCT02012218|580676633|FG002|Overall Study|Lost to Follow-up|1|||
160805895|NCT02012218|580676634|FG003|Overall Study|Lost to Follow-up|0|||
160805896|NCT02012218|580676635|FG004|Overall Study|Lost to Follow-up|0|||
160805897|NCT02012218|580676631|FG000|Overall Study|Protocol Specified|1|||
160805898|NCT02012218|580676632|FG001|Overall Study|Protocol Specified|0|||
160805899|NCT02012218|580676633|FG002|Overall Study|Protocol Specified|0|||
160805900|NCT02012218|580676634|FG003|Overall Study|Protocol Specified|0|||
160805901|NCT02012218|580676635|FG004|Overall Study|Protocol Specified|0|||
160805902|NCT02012218|580676631|FG000|Overall Study|Protocol Deviation|1|||
161130371|NCT00348140|581863417|FG002|Overall Study|Withdrawal by Subject|40|||
161130372|NCT00348140|581863415|FG000|Overall Study|Non-compliance|8|||
161130373|NCT00348140|581863416|FG001|Overall Study|Non-compliance|13|||
161130374|NCT00348140|581863417|FG002|Overall Study|Non-compliance|5|||
161130375|NCT00348140|581863415|FG000|Overall Study|Participant at risk due to study drug|2|||
160805903|NCT02012218|580676632|FG001|Overall Study|Protocol Deviation|0|||
160805904|NCT02012218|580676633|FG002|Overall Study|Protocol Deviation|0|||
160805905|NCT02012218|580676634|FG003|Overall Study|Protocol Deviation|0|||
161130376|NCT00348140|581863416|FG001|Overall Study|Participant at risk due to study drug|0|||
161130377|NCT00348140|581863417|FG002|Overall Study|Participant at risk due to study drug|0|||
161130378|NCT00348140|581863415|FG000|Overall Study|Conditional medication increased dose|1|||
161130379|NCT00348140|581863416|FG001|Overall Study|Conditional medication increased dose|0|||
161130380|NCT00348140|581863417|FG002|Overall Study|Conditional medication increased dose|0|||
161130381|NCT00348140|581863415|FG000|Overall Study|Caregiver related|4|||
161130382|NCT00348140|581863416|FG001|Overall Study|Caregiver related|7|||
161130383|NCT00348140|581863417|FG002|Overall Study|Caregiver related|3|||
161130384|NCT00348140|581863415|FG000|Overall Study|Participant hospitalised|3|||
161130385|NCT00348140|581863416|FG001|Overall Study|Participant hospitalised|0|||
161130386|NCT00348140|581863417|FG002|Overall Study|Participant hospitalised|0|||
161130387|NCT00348140|581863415|FG000|Overall Study|Efficacy related|1|||
161130388|NCT00348140|581863416|FG001|Overall Study|Efficacy related|1|||
161130389|NCT00348140|581863417|FG002|Overall Study|Efficacy related|0|||
161130390|NCT00348140|581863415|FG000|Overall Study|Administration related|3|||
161130391|NCT00348140|581863416|FG001|Overall Study|Administration related|1|||
161130392|NCT00348140|581863417|FG002|Overall Study|Administration related|1|||
161130393|NCT00348140|581863415|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
161130394|NCT00348140|581863416|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
161130395|NCT00348140|581863417|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
161130396|NCT00348140|581863415|FG000|Overall Study|Participant unwell|1|||
161130397|NCT00348140|581863416|FG001|Overall Study|Participant unwell|0|||
161130398|NCT00348140|581863417|FG002|Overall Study|Participant unwell|0|||
161130399|NCT00348140|581863415|FG000|Overall Study|Screen failure|1|||
161332319|NCT00748241|582603584|FG000|Overall Study|Death|2|||
161332320|NCT01240382|582603585|FG000|Overall Study|Adverse Event|2|||
160805906|NCT02012218|580676635|FG004|Overall Study|Protocol Deviation|0|||
160805907|NCT01070979|580676636|FG000|Overall Study|Adverse Event|2|||
160805908|NCT01070979|580676637|FG001|Overall Study|Adverse Event|3|||
160805909|NCT01070979|580676638|FG002|Overall Study|Adverse Event|3|||
160805910|NCT01070979|580676636|FG000|Overall Study|Lost to Follow-up|2|||
160805911|NCT01070979|580676637|FG001|Overall Study|Lost to Follow-up|1|||
160805912|NCT01070979|580676638|FG002|Overall Study|Lost to Follow-up|1|||
160805913|NCT01070979|580676636|FG000|Overall Study|Protocol Violation|0|||
160805914|NCT01070979|580676637|FG001|Overall Study|Protocol Violation|2|||
160805915|NCT01070979|580676638|FG002|Overall Study|Protocol Violation|6|||
160805916|NCT01070979|580676636|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
160805917|NCT01070979|580676637|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
160898202|NCT01543698|581023378|FG004|Phase 2|Adverse Event|0|||
161130400|NCT00348140|581863416|FG001|Overall Study|Screen failure|0|||
161130401|NCT00348140|581863417|FG002|Overall Study|Screen failure|0|||
161130402|NCT00348140|581863415|FG000|Overall Study|Investigator decided to discontinue|4|||
161130403|NCT00348140|581863416|FG001|Overall Study|Investigator decided to discontinue|1|||
160898203|NCT01543698|581023379|FG005|Phase 2|Adverse Event|0|||
160985332|NCT02550873|581335428|FG001|Open Label Extension|Study ongoing|0|||
160985333|NCT02550873|581335429|FG002|Open Label Extension|Study ongoing|111|||
160985334|NCT01857323|581335430|FG000|Overall Study|Adverse Event|1|||
160985335|NCT01857323|581335430|FG000|Overall Study|Withdrawal by Subject|3|||
160985336|NCT01857323|581335430|FG000|Overall Study|Non-compliance|1|||
160805918|NCT01070979|580676638|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
160805919|NCT01070979|580676636|FG000|Overall Study|Withdrawal by Subject|3|||
160805920|NCT01070979|580676637|FG001|Overall Study|Withdrawal by Subject|1|||
160805921|NCT01070979|580676638|FG002|Overall Study|Withdrawal by Subject|1|||
160805922|NCT01070979|580676636|FG000|Overall Study|No study drug taken|0|||
160805923|NCT01070979|580676637|FG001|Overall Study|No study drug taken|1|||
160985337|NCT01857323|581335430|FG000|Overall Study|Protocol Violation|6|||
160805924|NCT01070979|580676638|FG002|Overall Study|No study drug taken|0|||
160805925|NCT00142792|580676639|FG000|Overall Study|Death|0|||
160805926|NCT00142792|580676640|FG001|Overall Study|Death|0|||
160805927|NCT00142792|580676641|FG002|Overall Study|Death|1|||
160805928|NCT00142792|580676639|FG000|Overall Study|Withdrawal by Subject|3|||
160805929|NCT00142792|580676640|FG001|Overall Study|Withdrawal by Subject|2|||
160805930|NCT00142792|580676641|FG002|Overall Study|Withdrawal by Subject|3|||
160805931|NCT00142792|580676639|FG000|Overall Study|Lost to Follow-up|8|||
160805932|NCT00142792|580676640|FG001|Overall Study|Lost to Follow-up|11|||
160898204|NCT01543698|581023380|FG006|Phase 2|Adverse Event|0|||
160898205|NCT01543698|581023381|FG007|Phase 2|Adverse Event|0|||
160898206|NCT01543698|581023382|FG008|Phase 2|Adverse Event|0|||
160898207|NCT01543698|581023383|FG009|Phase 2|Adverse Event|0|||
160898208|NCT01543698|581023384|FG010|Phase 2|Adverse Event|0|||
160898209|NCT01543698|581023385|FG011|Phase 2|Adverse Event|1|||
160898210|NCT01543698|581023386|FG012|Phase 2|Adverse Event|3|||
160898211|NCT01543698|581023387|FG013|Phase 2|Adverse Event|5|||
160898212|NCT01543698|581023388|FG014|Phase 2|Adverse Event|14|||
160898213|NCT04195906|581023394|FG000|Part 1|Adverse Event|3|||
160985338|NCT01857323|581335430|FG000|Overall Study|Lost to Follow-up|1|||
160985339|NCT01857323|581335430|FG000|Overall Study|Other|4|||
160985340|NCT01857323|581335430|FG000|Overall Study|Did not complete 180 doses|48|||
160985341|NCT02107443|581335431|FG000|Overall Study|Death|42|||
160985342|NCT02107443|581335432|FG001|Overall Study|Death|30|||
160985343|NCT02107443|581335431|FG000|Overall Study|Study Protocol Violation|3|||
160985344|NCT02107443|581335432|FG001|Overall Study|Study Protocol Violation|1|||
160985345|NCT02107443|581335431|FG000|Overall Study|Registered but Not Eligible|0|||
160985346|NCT02107443|581335432|FG001|Overall Study|Registered but Not Eligible|1|||
160985347|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
160985348|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
160985349|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
160985350|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
160985351|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Changed Mind|2|||
160985352|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Changed Mind|0|||
161130404|NCT00348140|581863417|FG002|Overall Study|Investigator decided to discontinue|4|||
161130405|NCT00348140|581863415|FG000|Overall Study|Decided to discontinue on their own|1|||
161130406|NCT00348140|581863416|FG001|Overall Study|Decided to discontinue on their own|4|||
161130407|NCT00348140|581863417|FG002|Overall Study|Decided to discontinue on their own|1|||
161130408|NCT00348140|581863415|FG000|Overall Study|Use of prohibited drug|1|||
161130409|NCT00348140|581863416|FG001|Overall Study|Use of prohibited drug|0|||
161130410|NCT00348140|581863417|FG002|Overall Study|Use of prohibited drug|2|||
161130411|NCT00348140|581863415|FG000|Overall Study|Disease progression|1|||
161130412|NCT00348140|581863416|FG001|Overall Study|Disease progression|2|||
161130413|NCT00348140|581863417|FG002|Overall Study|Disease progression|5|||
161130414|NCT00348140|581863415|FG000|Overall Study|Increased risk of cardiac infarction|0|||
161130415|NCT00348140|581863416|FG001|Overall Study|Increased risk of cardiac infarction|1|||
161130416|NCT00348140|581863417|FG002|Overall Study|Increased risk of cardiac infarction|0|||
161130417|NCT00348140|581863415|FG000|Overall Study|Serious adverse event|0|||
161130418|NCT00348140|581863416|FG001|Overall Study|Serious adverse event|1|||
160805933|NCT00142792|580676641|FG002|Overall Study|Lost to Follow-up|7|||
160805934|NCT00142792|580676639|FG000|Overall Study|No category|1|||
160898214|NCT04195906|581023395|FG001|Part 1|Adverse Event|7|||
160898215|NCT04195906|581023394|FG000|Part 1|Withdrawal by Subject|0|||
160898216|NCT04195906|581023395|FG001|Part 1|Withdrawal by Subject|1|||
161130419|NCT00348140|581863417|FG002|Overall Study|Serious adverse event|0|||
161332321|NCT01240382|582603586|FG001|Overall Study|Adverse Event|1|||
160805935|NCT00142792|580676640|FG001|Overall Study|No category|2|||
160898217|NCT04195906|581023394|FG000|Part 2|Adverse Event|1|||
160898218|NCT04195906|581023395|FG001|Part 2|Adverse Event|1|||
161130420|NCT00348140|581863415|FG000|Overall Study|Abnormal ECG|0|||
160805936|NCT00142792|580676641|FG002|Overall Study|No category|1|||
160805937|NCT04819113|580676642|FG000|Overall Study|Withdrawal by parent/guardian|3|||
160805938|NCT04819113|580676642|FG000|Overall Study|Lost to Follow-up|1|||
160898219|NCT04195906|581023394|FG000|Part 2|Withdrawal by Subject|0|||
160898220|NCT04195906|581023395|FG001|Part 2|Withdrawal by Subject|3|||
160985353|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
160985354|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
160985355|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
160985356|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
160985357|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
160985358|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
160985359|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
161238108|NCT03733444|582252088|FG001|Overall Study|Study Terminated by Sponsor|209|||
161238109|NCT03733444|582252089|FG002|Overall Study|Study Terminated by Sponsor|221|||
161238110|NCT03733444|582252087|FG000|Overall Study|Withdrawal by Subject|19|||
161238111|NCT03733444|582252088|FG001|Overall Study|Withdrawal by Subject|18|||
161238112|NCT03733444|582252089|FG002|Overall Study|Withdrawal by Subject|16|||
161238113|NCT03733444|582252087|FG000|Overall Study|Miscellaneous|1|||
161238114|NCT03733444|582252088|FG001|Overall Study|Miscellaneous|0|||
161238115|NCT03733444|582252089|FG002|Overall Study|Miscellaneous|1|||
161238116|NCT03733444|582252087|FG000|Overall Study|Not Treated|1|||
161238117|NCT03733444|582252088|FG001|Overall Study|Not Treated|2|||
161238118|NCT03733444|582252089|FG002|Overall Study|Not Treated|1|||
161238119|NCT01788423|582252090|FG000|Overall Study|See Comments in Completed (above)|0|||
161238120|NCT01788423|582252091|FG001|Overall Study|See Comments in Completed (above)|4|||
161238121|NCT01788423|582252092|FG002|Overall Study|See Comments in Completed (above)|5|||
161238122|NCT01913405|582252093|FG000|Overall Study|Withdrawal by Subject|1|||
161238123|NCT01913405|582252093|FG000|Overall Study|Adverse Event|1|||
161238124|NCT03987191|582252096|FG000|Overall Study|COVID-19 related research disruption|0|||
161238125|NCT03987191|582252097|FG001|Overall Study|COVID-19 related research disruption|2|||
161238126|NCT02689505|582252100|FG000|Overall Study|Progressive disease|2|||
161238127|NCT02689505|582252101|FG001|Overall Study|Progressive disease|2|||
161238128|NCT02689505|582252102|FG002|Overall Study|Progressive disease|3|||
161238129|NCT02689505|582252103|FG003|Overall Study|Progressive disease|9|||
161238130|NCT02689505|582252104|FG004|Overall Study|Progressive disease|1|||
161238131|NCT02689505|582252100|FG000|Overall Study|Dose Limiting Toxicity|0|||
161238132|NCT02689505|582252101|FG001|Overall Study|Dose Limiting Toxicity|1|||
161238133|NCT02689505|582252102|FG002|Overall Study|Dose Limiting Toxicity|0|||
161238134|NCT02689505|582252103|FG003|Overall Study|Dose Limiting Toxicity|0|||
161238135|NCT02689505|582252104|FG004|Overall Study|Dose Limiting Toxicity|2|||
161238136|NCT02689505|582252100|FG000|Overall Study|Other AE or clinical progression|0|||
161238137|NCT02689505|582252101|FG001|Overall Study|Other AE or clinical progression|2|||
161238138|NCT02689505|582252102|FG002|Overall Study|Other AE or clinical progression|0|||
161238139|NCT02689505|582252103|FG003|Overall Study|Other AE or clinical progression|2|||
161238140|NCT02689505|582252104|FG004|Overall Study|Other AE or clinical progression|0|||
161238141|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
161238142|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
161238143|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
161238144|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
161238145|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
161238146|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
161238147|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161238148|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
161238149|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
161238150|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
161238151|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
161238152|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
161238153|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
161238154|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
161238155|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161238156|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
161238157|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
161238158|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
161238159|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
161238160|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
161238161|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Death|0|||
161238162|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Death|1|||
161238163|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Death|0|||
161238164|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Death|0|||
161238165|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
161238166|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
161238167|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
161238168|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
161238169|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
161238170|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161238171|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161332322|NCT01240382|582603585|FG000|Overall Study|Lack of Efficacy|0|||
160985360|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
160805939|NCT04819113|580676642|FG000|Overall Study|Withdrawn before vaccination|2|||
160805940|NCT00833027|580676647|FG000|Overall Study|Adverse Event|33|||
160805941|NCT00833027|580676647|FG000|Overall Study|Death|1|||
160805942|NCT00833027|580676647|FG000|Overall Study|Lack of Efficacy|12|||
160805943|NCT00833027|580676647|FG000|Overall Study|Lost to Follow-up|24|||
160805944|NCT00833027|580676647|FG000|Overall Study|Protocol Violation|115|||
160805945|NCT00833027|580676647|FG000|Overall Study|Withdrawal by Subject|16|||
160805946|NCT00833027|580676647|FG000|Overall Study|Missing|10|||
160805947|NCT00444925|580676648|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
160805948|NCT00444925|580676649|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
160805949|NCT00444925|580676650|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
160805950|NCT00444925|580676648|FG000|Double-blind Treatment Period|Death|2|||
160805951|NCT00444925|580676649|FG001|Double-blind Treatment Period|Death|0|||
160805952|NCT00444925|580676650|FG002|Double-blind Treatment Period|Death|0|||
160805953|NCT00444925|580676648|FG000|Double-blind Treatment Period|Adverse Event|6|||
160805954|NCT00444925|580676649|FG001|Double-blind Treatment Period|Adverse Event|28|||
160805955|NCT00444925|580676650|FG002|Double-blind Treatment Period|Adverse Event|44|||
160805956|NCT00444925|580676648|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
160805957|NCT00444925|580676649|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
160805958|NCT00444925|580676650|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
160805959|NCT00444925|580676648|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
160805960|NCT00444925|580676649|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
160805961|NCT00444925|580676650|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
160805962|NCT00444925|580676648|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
160805963|NCT00444925|580676649|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
160805964|NCT00444925|580676650|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
160805965|NCT00444925|580676648|FG000|Double-blind Treatment Period|Other|7|||
160805966|NCT00444925|580676649|FG001|Double-blind Treatment Period|Other|7|||
160805967|NCT00444925|580676650|FG002|Double-blind Treatment Period|Other|12|||
160805968|NCT04417257|580676651|FG000|Pilot Phase 2|Adverse Event|2|||
160805969|NCT04417257|580676652|FG001|Pilot Phase 2|Adverse Event|0|||
160805970|NCT04417257|580676651|FG000|Pilot Phase 2|Death|14|||
160805971|NCT04417257|580676652|FG001|Pilot Phase 2|Death|11|||
160805972|NCT04417257|580676651|FG000|Pilot Phase 2|Lost to Follow-up|3|||
160805973|NCT04417257|580676652|FG001|Pilot Phase 2|Lost to Follow-up|5|||
160805974|NCT04417257|580676651|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
160805975|NCT04417257|580676652|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
160805976|NCT04417257|580676651|FG000|Pilot Phase 2|Hepatic impairment|1|||
160805977|NCT04417257|580676652|FG001|Pilot Phase 2|Hepatic impairment|0|||
160805978|NCT04417257|580676651|FG000|Pilot Phase 2|Unblinding|1|||
160805979|NCT04417257|580676652|FG001|Pilot Phase 2|Unblinding|0|||
160805980|NCT04417257|580676651|FG000|Pilot Phase 2|All other|0|||
160805981|NCT04417257|580676652|FG001|Pilot Phase 2|All other|2|||
160805982|NCT04417257|580676651|FG000|Phase 3 Extension|Death|3|||
160805983|NCT04417257|580676652|FG001|Phase 3 Extension|Death|1|||
160805984|NCT04417257|580676651|FG000|Phase 3 Extension|Lost to Follow-up|4|||
160805985|NCT04417257|580676652|FG001|Phase 3 Extension|Lost to Follow-up|2|||
160805986|NCT04417257|580676651|FG000|Phase 3 Extension|Patient withdrawal|2|||
160805987|NCT04417257|580676652|FG001|Phase 3 Extension|Patient withdrawal|2|||
160805988|NCT04417257|580676651|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
160805989|NCT04417257|580676652|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
160805990|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Death|2|||
160805991|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
160805992|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
160805993|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Physician Decision|1|||
160805994|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
160805995|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
160805996|NCT00786422|580676654|FG000|Rivaroxaban Treatment|Adverse Event|2|||
160805997|NCT00786422|580676654|FG000|Follow-up Period|Death|1|||
160805998|NCT00786422|580676654|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
160805999|NCT03484429|580676655|FG000|Overall Study|Withdrawal by Subject|1|||
160806000|NCT03484429|580676656|FG001|Overall Study|Withdrawal by Subject|0|||
160806001|NCT03484429|580676655|FG000|Overall Study|Adverse Event|2|||
160898221|NCT04195906|581023394|FG000|Part 2|Other|1|||
160898222|NCT04195906|581023395|FG001|Part 2|Other|3|||
160898223|NCT02699697|581023397|FG000|Overall Study|Death|18|||
160806002|NCT03484429|580676656|FG001|Overall Study|Adverse Event|0|||
160806003|NCT04466384|580676657|FG000|First Phase|Protocol Violation|1|||
160806004|NCT04466384|580676658|FG001|First Phase|Protocol Violation|0|||
160806005|NCT04466384|580676657|FG000|First Phase|Missing data|1|||
160806006|NCT04466384|580676658|FG001|First Phase|Missing data|0|||
160806007|NCT04466384|580676657|FG000|Cross Over Phase|Physician Decision|1|||
160806008|NCT04466384|580676658|FG001|Cross Over Phase|Physician Decision|0|||
160806009|NCT04466384|580676657|FG000|Cross Over Phase|Withdrawal by Subject|0|||
160806010|NCT04466384|580676658|FG001|Cross Over Phase|Withdrawal by Subject|1|||
160898224|NCT02699697|581023398|FG001|Overall Study|Death|15|||
160806011|NCT03761056|580676659|FG000|Overall Study|Death|8|||
160806012|NCT03761056|580676659|FG000|Overall Study|Enrolled but never treated|2|||
160806013|NCT03761056|580676659|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
160806014|NCT03761056|580676659|FG000|Overall Study|Investigator decision|1|||
160806015|NCT04267926|580678127|FG000|Overall Study|abnormal labs. No longer eligible|0|||
160806016|NCT04267926|580678128|FG001|Overall Study|abnormal labs. No longer eligible|0|||
160806017|NCT04267926|580678129|FG002|Overall Study|abnormal labs. No longer eligible|1|||
160806018|NCT04267926|580678127|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
160806019|NCT04267926|580678128|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
160806020|NCT04267926|580678129|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
160806021|NCT02595879|580678130|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
160806022|NCT02595879|580678131|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
160806023|NCT03145064|580678132|FG000|Overall Study|Death|24|||
160806024|NCT03145064|580678132|FG000|Overall Study|Lost to Follow-up|3|||
160806025|NCT03145064|580678132|FG000|Overall Study|Withdrawal by Subject|6|||
160806026|NCT03145064|580678132|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
160806027|NCT03145064|580678132|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
160806028|NCT00661830|580678133|FG000|Overall Study|Death|37|||
160806029|NCT00661830|580678134|FG001|Overall Study|Death|33|||
160806030|NCT00661830|580678133|FG000|Overall Study|Lost to Follow-up|1|||
160806031|NCT00661830|580678134|FG001|Overall Study|Lost to Follow-up|3|||
160806032|NCT00661830|580678133|FG000|Overall Study|Withdrawal by Subject|1|||
160806033|NCT00661830|580678134|FG001|Overall Study|Withdrawal by Subject|1|||
160806034|NCT00661830|580678133|FG000|Overall Study|Other reason|1|||
160806035|NCT00661830|580678134|FG001|Overall Study|Other reason|5|||
160806036|NCT01396187|580678135|FG000|Overall Study|Adverse Event|0|||
160806037|NCT01396187|580678136|FG001|Overall Study|Adverse Event|1|||
160806038|NCT01396187|580678137|FG002|Overall Study|Adverse Event|0|||
160806039|NCT01396187|580678138|FG003|Overall Study|Adverse Event|0|||
160806040|NCT01396187|580678139|FG004|Overall Study|Adverse Event|0|||
160806041|NCT01396187|580678135|FG000|Overall Study|Withdrawal by Subject|0|||
160806042|NCT01396187|580678136|FG001|Overall Study|Withdrawal by Subject|1|||
160806043|NCT01396187|580678137|FG002|Overall Study|Withdrawal by Subject|1|||
160806044|NCT01396187|580678138|FG003|Overall Study|Withdrawal by Subject|0|||
160806045|NCT01396187|580678139|FG004|Overall Study|Withdrawal by Subject|0|||
160806046|NCT01396187|580678135|FG000|Overall Study|Other|1|||
160806047|NCT01396187|580678136|FG001|Overall Study|Other|1|||
160806048|NCT01396187|580678137|FG002|Overall Study|Other|0|||
160806049|NCT01396187|580678138|FG003|Overall Study|Other|0|||
160806050|NCT01396187|580678139|FG004|Overall Study|Other|1|||
160806051|NCT01898286|580678140|FG000|Overall Study|Withdrawal by Subject|1|||
160806052|NCT01898286|580678140|FG000|Overall Study|Protocol Violation|1|||
160806053|NCT01898286|580678140|FG000|Overall Study|Lost to Follow-up|1|||
160898225|NCT02699697|581023397|FG000|Overall Study|Physician Decision|0|||
160898226|NCT02699697|581023398|FG001|Overall Study|Physician Decision|1|||
160898227|NCT02699697|581023397|FG000|Overall Study|Lost to Follow-up|2|||
160898228|NCT02699697|581023398|FG001|Overall Study|Lost to Follow-up|3|||
160898229|NCT02699697|581023397|FG000|Overall Study|Refused to follow up|1|||
160898230|NCT02699697|581023398|FG001|Overall Study|Refused to follow up|1|||
160898231|NCT02699697|581023397|FG000|Overall Study|Entered hospice care|5|||
160898232|NCT02699697|581023398|FG001|Overall Study|Entered hospice care|2|||
160898233|NCT02699697|581023397|FG000|Overall Study|Missing reason for discontinuation|6|||
160898234|NCT02699697|581023398|FG001|Overall Study|Missing reason for discontinuation|5|||
160898235|NCT02362035|581023399|FG000|Overall Study|Death|67|||
160898236|NCT02362035|581023399|FG000|Overall Study|Lost to Follow-up|3|||
160898237|NCT02362035|581023399|FG000|Overall Study|Adverse Event|1|||
160898238|NCT02362035|581023399|FG000|Overall Study|Physician Decision|1|||
160985361|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Other Medical|9|||
161238172|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
161238173|NCT01940341|582252108|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161238174|NCT01940341|582252109|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
161238175|NCT01940341|582252110|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161238176|NCT01940341|582252111|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
161332323|NCT01240382|582603586|FG001|Overall Study|Lack of Efficacy|2|||
160806054|NCT01650831|580678141|FG000|Overall Study|Screen failure|1|||
160806055|NCT05554146|580678144|FG000|Overall Study|Adverse Event|0|||
160806056|NCT05554146|580678145|FG001|Overall Study|Adverse Event|1|||
160806057|NCT05554146|580678146|FG002|Overall Study|Adverse Event|0|||
160898239|NCT02362035|581023399|FG000|Overall Study|Subject started another cancer therapy|10|||
160985362|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Other Medical|5|||
160806058|NCT05554146|580678147|FG003|Overall Study|Adverse Event|0|||
160985363|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Disease Progression|4|||
160806059|NCT05554146|580678144|FG000|Overall Study|Protocol Violation|0|||
160806060|NCT05554146|580678145|FG001|Overall Study|Protocol Violation|1|||
160806061|NCT05554146|580678146|FG002|Overall Study|Protocol Violation|0|||
160806062|NCT05554146|580678147|FG003|Overall Study|Protocol Violation|0|||
160806063|NCT05554146|580678144|FG000|Overall Study|No longer interested in participating|0|||
160806064|NCT05554146|580678145|FG001|Overall Study|No longer interested in participating|0|||
160806065|NCT05554146|580678146|FG002|Overall Study|No longer interested in participating|1|||
160806066|NCT05554146|580678147|FG003|Overall Study|No longer interested in participating|0|||
160806067|NCT05554146|580678144|FG000|Overall Study|Lost to Follow-up|1|||
160806068|NCT05554146|580678145|FG001|Overall Study|Lost to Follow-up|0|||
160806069|NCT05554146|580678146|FG002|Overall Study|Lost to Follow-up|0|||
160806070|NCT05554146|580678147|FG003|Overall Study|Lost to Follow-up|0|||
160806071|NCT02477527|580678148|FG000|Overall Study|Lost to Follow-up|2|||
160806072|NCT02477527|580678148|FG000|Overall Study|Withdrawal by Subject|1|||
160806073|NCT02477527|580678148|FG000|Overall Study|Screen Failure|3|||
160806074|NCT03692403|580678149|FG000|Overall Study|Withdrawal by Subject|1|||
160806075|NCT03692403|580678150|FG001|Overall Study|Withdrawal by Subject|0|||
160806076|NCT03692403|580678151|FG002|Overall Study|Withdrawal by Subject|1|||
160806077|NCT03692403|580678152|FG003|Overall Study|Withdrawal by Subject|0|||
160806078|NCT03692403|580678149|FG000|Overall Study|Adverse Event|0|||
160806079|NCT03692403|580678150|FG001|Overall Study|Adverse Event|0|||
160806080|NCT03692403|580678151|FG002|Overall Study|Adverse Event|0|||
160806081|NCT03692403|580678152|FG003|Overall Study|Adverse Event|1|||
160806082|NCT03692403|580678149|FG000|Overall Study|Pregnancy|0|||
160806083|NCT03692403|580678150|FG001|Overall Study|Pregnancy|1|||
160806084|NCT03692403|580678151|FG002|Overall Study|Pregnancy|0|||
160806085|NCT03692403|580678152|FG003|Overall Study|Pregnancy|0|||
160806086|NCT03692403|580678149|FG000|Overall Study|Other|0|||
160806087|NCT03692403|580678150|FG001|Overall Study|Other|0|||
160806088|NCT03692403|580678151|FG002|Overall Study|Other|1|||
160806089|NCT03692403|580678152|FG003|Overall Study|Other|0|||
160806090|NCT00856635|580678153|FG000|Overall Study|Lost to Follow-up|2|||
160806091|NCT00856635|580678154|FG001|Overall Study|Lost to Follow-up|5|||
160806092|NCT00856635|580678153|FG000|Overall Study|Pregnancy|1|||
160806093|NCT00856635|580678154|FG001|Overall Study|Pregnancy|0|||
160806094|NCT00856635|580678153|FG000|Overall Study|Withdrawal by Subject|3|||
160806095|NCT00856635|580678154|FG001|Overall Study|Withdrawal by Subject|1|||
160806096|NCT00856635|580678153|FG000|Overall Study|Serious Adverse Event|1|||
160806097|NCT00856635|580678154|FG001|Overall Study|Serious Adverse Event|0|||
160806098|NCT00856635|580678153|FG000|Overall Study|Other|1|||
160806099|NCT00856635|580678154|FG001|Overall Study|Other|0|||
160806100|NCT00856635|580678153|FG000|Overall Study|Discontinued at Randomization|2|||
160806101|NCT00856635|580678154|FG001|Overall Study|Discontinued at Randomization|2|||
160806102|NCT01349673|580678155|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
160806103|NCT01349673|580678155|FG000|Overall Study|No Longer Qualified For Study|1|||
160806104|NCT01349673|580678155|FG000|Overall Study|Site Closure|10|||
161130421|NCT00348140|581863416|FG001|Overall Study|Abnormal ECG|1|||
161130422|NCT00348140|581863417|FG002|Overall Study|Abnormal ECG|3|||
161130423|NCT00348140|581863415|FG000|Overall Study|Participant died|0|||
161130424|NCT00348140|581863416|FG001|Overall Study|Participant died|1|||
161130425|NCT00348140|581863417|FG002|Overall Study|Participant died|0|||
161130426|NCT00348140|581863415|FG000|Overall Study|Exclusion criteria met|0|||
161130427|NCT00348140|581863416|FG001|Overall Study|Exclusion criteria met|0|||
161130428|NCT00348140|581863417|FG002|Overall Study|Exclusion criteria met|1|||
161130429|NCT00348140|581863415|FG000|Overall Study|Memory declined|0|||
161130430|NCT00348140|581863416|FG001|Overall Study|Memory declined|0|||
161130431|NCT00348140|581863417|FG002|Overall Study|Memory declined|1|||
161130432|NCT01273064|581863418|FG000|Overall Study|Adverse Event|5|||
161130433|NCT01273064|581863419|FG001|Overall Study|Adverse Event|1|||
161130434|NCT01273064|581863420|FG002|Overall Study|Adverse Event|3|||
161130435|NCT01273064|581863421|FG003|Overall Study|Adverse Event|2|||
161130436|NCT01273064|581863422|FG004|Overall Study|Adverse Event|1|||
161130437|NCT01273064|581863418|FG000|Overall Study|Withdrawal by Subject|4|||
161130438|NCT01273064|581863419|FG001|Overall Study|Withdrawal by Subject|2|||
161130439|NCT01273064|581863420|FG002|Overall Study|Withdrawal by Subject|2|||
161130440|NCT01273064|581863421|FG003|Overall Study|Withdrawal by Subject|2|||
161130441|NCT01273064|581863422|FG004|Overall Study|Withdrawal by Subject|0|||
161130442|NCT01273064|581863418|FG000|Overall Study|Study Termination|13|||
160806105|NCT01349673|580678155|FG000|Overall Study|Withdrawal by Subject|21|||
160806106|NCT01349673|580678155|FG000|Overall Study|Lost to Follow-up|6|||
160806107|NCT01349673|580678155|FG000|Overall Study|Adverse Event|17|||
160806108|NCT01349673|580678155|FG000|Overall Study|Study Terminated By Sponsor|50|||
160806109|NCT01349673|580678155|FG000|Overall Study|Lack of Efficacy|8|||
160806110|NCT02383862|580678156|FG000|3 Month Follow up|Lost to Follow-up|23|||
160806111|NCT02383862|580678157|FG001|3 Month Follow up|Lost to Follow-up|21|||
161238177|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
161238178|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
160806112|NCT01724216|580678158|FG000|Overall Study|Scan was not completed|1|||
160806113|NCT00564733|580678159|FG000|Overall Study|Withdrawal by Subject|4|||
161130443|NCT01273064|581863419|FG001|Overall Study|Study Termination|27|||
160806114|NCT00564733|580678159|FG000|Overall Study|Ineligible|5|||
160806115|NCT03198767|580678164|FG000|Overall Study|Protocol Violation|0|||
160806116|NCT03198767|580678165|FG001|Overall Study|Protocol Violation|0|||
160806117|NCT03198767|580678166|FG002|Overall Study|Protocol Violation|0|||
160806118|NCT03198767|580678167|FG003|Overall Study|Protocol Violation|6|||
160806119|NCT03198767|580678168|FG004|Overall Study|Protocol Violation|0|||
160806120|NCT03198767|580678169|FG005|Overall Study|Protocol Violation|0|||
160806121|NCT03198767|580678170|FG006|Overall Study|Protocol Violation|0|||
160806122|NCT00579553|580678174|FG000|Overall Study|Lost to Follow-up|16|||
160806123|NCT00579553|580678175|FG001|Overall Study|Lost to Follow-up|13|||
160806124|NCT04860869|580678180|FG000|Overall Study|Withdrawal by Subject|1|||
160806125|NCT04860869|580678181|FG001|Overall Study|Withdrawal by Subject|0|||
160806126|NCT02651116|580678182|FG000|Overall Study|Adverse Event|0|||
160806127|NCT02651116|580678183|FG001|Overall Study|Adverse Event|1|||
160806128|NCT02651116|580678182|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
160806129|NCT02651116|580678183|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
160806130|NCT01775553|580678184|FG000|Overall Study|Adverse Event|1|||
160806131|NCT01775553|580678184|FG000|Overall Study|Disease Progression|12|||
160806132|NCT02041299|580678195|FG000|Overall Study|Adverse Event|9|||
160806133|NCT02041299|580678196|FG001|Overall Study|Adverse Event|3|||
160806134|NCT02041299|580678195|FG000|Overall Study|Lost to Follow-up|4|||
160806135|NCT02041299|580678196|FG001|Overall Study|Lost to Follow-up|1|||
160806136|NCT02041299|580678195|FG000|Overall Study|Physician Decision|1|||
160806137|NCT02041299|580678196|FG001|Overall Study|Physician Decision|1|||
160806138|NCT02041299|580678195|FG000|Overall Study|Withdrawal by Subject|13|||
160806139|NCT02041299|580678196|FG001|Overall Study|Withdrawal by Subject|7|||
160806140|NCT02041299|580678195|FG000|Overall Study|Protocol Violation|11|||
160806141|NCT02041299|580678196|FG001|Overall Study|Protocol Violation|4|||
160806142|NCT02041299|580678195|FG000|Overall Study|Termination of the study|7|||
160806143|NCT02041299|580678196|FG001|Overall Study|Termination of the study|3|||
160806144|NCT02041299|580678195|FG000|Overall Study|Required bone marrow transplant|0|||
160806145|NCT02041299|580678196|FG001|Overall Study|Required bone marrow transplant|1|||
160806146|NCT02041299|580678195|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
160806147|NCT02041299|580678196|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
160806148|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160806149|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160806150|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160806151|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
160806152|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
160806153|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
160806154|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161130444|NCT01273064|581863420|FG002|Overall Study|Study Termination|26|||
161130445|NCT01273064|581863421|FG003|Overall Study|Study Termination|16|||
161130446|NCT01273064|581863422|FG004|Overall Study|Study Termination|8|||
161130447|NCT01273064|581863418|FG000|Overall Study|Lost to Follow-up|1|||
161130448|NCT01273064|581863419|FG001|Overall Study|Lost to Follow-up|0|||
161130449|NCT01273064|581863420|FG002|Overall Study|Lost to Follow-up|0|||
161130450|NCT01273064|581863421|FG003|Overall Study|Lost to Follow-up|0|||
161130451|NCT01273064|581863422|FG004|Overall Study|Lost to Follow-up|0|||
161130452|NCT01273064|581863418|FG000|Overall Study|Physician Decision|0|||
161130453|NCT01273064|581863419|FG001|Overall Study|Physician Decision|0|||
161130454|NCT01273064|581863420|FG002|Overall Study|Physician Decision|0|||
161130455|NCT01273064|581863421|FG003|Overall Study|Physician Decision|0|||
161130456|NCT01273064|581863422|FG004|Overall Study|Physician Decision|1|||
161130457|NCT04666038|581863423|FG000|Overall Study|Progressive Disease|2|||
161130458|NCT04666038|581863424|FG001|Overall Study|Progressive Disease|0|||
161130459|NCT04666038|581863423|FG000|Overall Study|Death|38|||
161130460|NCT04666038|581863424|FG001|Overall Study|Death|32|||
161130461|NCT04666038|581863423|FG000|Overall Study|Withdrawal by Subject|10|||
161130462|NCT04666038|581863424|FG001|Overall Study|Withdrawal by Subject|19|||
161130463|NCT04666038|581863423|FG000|Overall Study|Lost to Follow-up|0|||
161130464|NCT04666038|581863424|FG001|Overall Study|Lost to Follow-up|2|||
161130465|NCT04666038|581863423|FG000|Overall Study|On Study Treatment|46|||
161130466|NCT04666038|581863424|FG001|Overall Study|On Study Treatment|5|||
161130467|NCT04666038|581863423|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
161130468|NCT04666038|581863424|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
160806155|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
160985364|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Disease Progression|2|||
161130469|NCT02867761|581863430|FG000|Overall Study|Participant withdrawn by investigator|0|||
161130470|NCT02867761|581863431|FG001|Overall Study|Participant withdrawn by investigator|1|||
161130471|NCT02867761|581863430|FG000|Overall Study|Lost to Follow-up|25|||
161130472|NCT02867761|581863431|FG001|Overall Study|Lost to Follow-up|18|||
161130473|NCT02867761|581863430|FG000|Overall Study|Unable to complete protocol|3|||
160806156|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
161130474|NCT02867761|581863431|FG001|Overall Study|Unable to complete protocol|7|||
161130475|NCT03595280|581863432|FG000|Overall Study|Lost to Follow-up|6|||
161130476|NCT03595280|581863433|FG001|Overall Study|Lost to Follow-up|9|||
160806157|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
160806158|NCT01925768|580678197|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
160806159|NCT01925768|580678198|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
160806160|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
160806161|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
160806162|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
160806163|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
160806164|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
160806165|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
160806166|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
160806167|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
160806168|NCT01925768|580678197|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
160806169|NCT01925768|580678198|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
160806170|NCT04339413|580678199|FG000|Overall Study|Reason Not Specified|2|||
160806171|NCT04339413|580678200|FG001|Overall Study|Reason Not Specified|7|||
161238179|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
161238180|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
161238181|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161238182|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
161238183|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
161238184|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
161238185|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161238186|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161238187|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
161238188|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
161238189|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
161238190|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
161238191|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
161238192|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
161238193|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161238194|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161238195|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
161238196|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
161238197|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
161238198|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
161238199|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
161238200|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
161238201|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161238202|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161238203|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
161238204|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
161238205|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161238206|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161238207|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
161238208|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
161238209|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161238210|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161238211|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
161238212|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
161238213|NCT01940341|582252108|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161238214|NCT01940341|582252109|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161238215|NCT01940341|582252110|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
161238216|NCT01940341|582252111|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
161238217|NCT03792477|582252116|FG000|Overall Study|Adverse Event|0|||
161238218|NCT03792477|582252117|FG001|Overall Study|Adverse Event|0|||
161238219|NCT03792477|582252118|FG002|Overall Study|Adverse Event|0|||
161238220|NCT03792477|582252119|FG003|Overall Study|Adverse Event|1|||
161238221|NCT03792477|582252120|FG004|Overall Study|Adverse Event|0|||
160806172|NCT04339413|580678199|FG000|Overall Study|Study Terminated by Sponsor|30|||
160806173|NCT04339413|580678200|FG001|Overall Study|Study Terminated by Sponsor|33|||
160806174|NCT04339413|580678199|FG000|Overall Study|Progressive Disease|9|||
160806175|NCT04339413|580678200|FG001|Overall Study|Progressive Disease|6|||
160806176|NCT04339413|580678199|FG000|Overall Study|Withdrawal by Subject|9|||
160806177|NCT04339413|580678200|FG001|Overall Study|Withdrawal by Subject|10|||
161238222|NCT03792477|582252116|FG000|Overall Study|Lost to Follow-up|0|||
161238223|NCT03792477|582252117|FG001|Overall Study|Lost to Follow-up|0|||
161238224|NCT03792477|582252118|FG002|Overall Study|Lost to Follow-up|2|||
161238225|NCT03792477|582252119|FG003|Overall Study|Lost to Follow-up|0|||
161238226|NCT03792477|582252120|FG004|Overall Study|Lost to Follow-up|0|||
161238227|NCT03792477|582252116|FG000|Overall Study|Other|0|||
161238228|NCT03792477|582252117|FG001|Overall Study|Other|0|||
161238229|NCT03792477|582252118|FG002|Overall Study|Other|0|||
160806178|NCT04339413|580678199|FG000|Overall Study|Physician Decision|3|||
160806179|NCT04339413|580678200|FG001|Overall Study|Physician Decision|1|||
160806180|NCT04339413|580678199|FG000|Overall Study|Death|2|||
160806181|NCT04339413|580678200|FG001|Overall Study|Death|0|||
160806182|NCT04339413|580678199|FG000|Overall Study|Adverse Event|3|||
160806183|NCT04339413|580678200|FG001|Overall Study|Adverse Event|0|||
160806184|NCT01964378|580678205|FG000|Overall Study|Disc. due to death before first dosing|0|||
160806185|NCT01964378|580678206|FG001|Overall Study|Disc. due to death before first dosing|1|||
160806186|NCT01964378|580678205|FG000|Overall Study|Disc. due to AE before first dosing|1|||
160806187|NCT01964378|580678206|FG001|Overall Study|Disc. due to AE before first dosing|0|||
160806188|NCT01964378|580678205|FG000|Overall Study|Death|3|||
160806189|NCT01964378|580678206|FG001|Overall Study|Death|2|||
160806190|NCT01964378|580678205|FG000|Overall Study|Adverse Event|12|||
160806191|NCT01964378|580678206|FG001|Overall Study|Adverse Event|5|||
160806192|NCT01964378|580678205|FG000|Overall Study|Lack of Efficacy|0|||
160806193|NCT01964378|580678206|FG001|Overall Study|Lack of Efficacy|1|||
160806194|NCT01964378|580678205|FG000|Overall Study|Protocol Violation|0|||
160806195|NCT01964378|580678206|FG001|Overall Study|Protocol Violation|1|||
160806196|NCT01964378|580678205|FG000|Overall Study|Lost to Follow-up|0|||
160806197|NCT01964378|580678206|FG001|Overall Study|Lost to Follow-up|1|||
160806198|NCT01964378|580678205|FG000|Overall Study|Withdrawal by Subject|7|||
160806199|NCT01964378|580678206|FG001|Overall Study|Withdrawal by Subject|5|||
160806200|NCT01964378|580678205|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
160806201|NCT01964378|580678206|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
160806202|NCT01964378|580678205|FG000|Overall Study|Other|1|||
160806203|NCT01964378|580678206|FG001|Overall Study|Other|2|||
160806204|NCT03542266|580678207|FG000|Treatment Phase|Withdrawal by Subject|1|||
160806205|NCT03542266|580678207|FG000|Treatment Phase|Adverse Event|1|||
160806206|NCT03542266|580678207|FG000|Treatment Phase|PD|1|||
160806207|NCT03069716|580678224|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
160806208|NCT03069716|580678225|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
160898240|NCT02362035|581023399|FG000|Overall Study|Study terminated by sponsor|45|||
160898241|NCT02362035|581023399|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
160898242|NCT02362035|581023399|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
161130477|NCT03595280|581863434|FG002|Overall Study|Lost to Follow-up|15|||
161130478|NCT01512264|581863435|FG000|Overall Study|Lost to Follow-up|0|||
161130479|NCT01512264|581863436|FG001|Overall Study|Lost to Follow-up|0|||
161130480|NCT01512264|581863437|FG002|Overall Study|Lost to Follow-up|0|||
161130481|NCT01512264|581863438|FG003|Overall Study|Lost to Follow-up|1|||
161130482|NCT01931059|581863439|FG000|Day 1|Pregnancy|0|||
161130483|NCT01931059|581863440|FG001|Day 1|Pregnancy|1|||
161130484|NCT01931059|581863439|FG000|Day3|Lost to Follow-up|1|||
161130485|NCT01931059|581863440|FG001|Day3|Lost to Follow-up|0|||
161130486|NCT02292212|581863450|FG000|ViE Phase|Withdrawal by Subject|1|||
161130487|NCT02292212|581863450|FG000|ViE Phase|Protocol Violation|2|||
161130488|NCT02675075|581863451|FG000|Overall Study|Lost to Follow-up|3|||
161130489|NCT02675075|581863452|FG001|Overall Study|Lost to Follow-up|0|||
161130490|NCT04957290|581863453|FG000|Overall Study|Progressive disease|3|||
161130491|NCT04957290|581863454|FG001|Overall Study|Progressive disease|3|||
161130492|NCT04957290|581863455|FG002|Overall Study|Progressive disease|2|||
161130493|NCT04957290|581863456|FG003|Overall Study|Progressive disease|0|||
161130494|NCT04957290|581863457|FG004|Overall Study|Progressive disease|0|||
161130495|NCT04957290|581863458|FG005|Overall Study|Progressive disease|0|||
161130496|NCT04957290|581863453|FG000|Overall Study|Withdrawal by Subject|1|||
161130497|NCT04957290|581863454|FG001|Overall Study|Withdrawal by Subject|0|||
161130498|NCT04957290|581863455|FG002|Overall Study|Withdrawal by Subject|1|||
161130499|NCT04957290|581863456|FG003|Overall Study|Withdrawal by Subject|0|||
161130500|NCT04957290|581863457|FG004|Overall Study|Withdrawal by Subject|0|||
161130501|NCT04957290|581863458|FG005|Overall Study|Withdrawal by Subject|0|||
161130502|NCT04957290|581863453|FG000|Overall Study|Death|0|||
160806209|NCT03069716|580678226|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
160806210|NCT03069716|580678224|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
160806211|NCT03069716|580678225|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
160806212|NCT03069716|580678226|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
160806213|NCT03069716|580678224|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
160806214|NCT03069716|580678225|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
160806215|NCT03069716|580678226|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
160806216|NCT03069716|580678224|FG000|Randomized Treatment|Withdrawal by Subject|0|||
161238230|NCT03792477|582252119|FG003|Overall Study|Other|0|||
161238231|NCT03792477|582252120|FG004|Overall Study|Other|1|||
160806217|NCT03069716|580678225|FG001|Randomized Treatment|Withdrawal by Subject|2|||
160806218|NCT03069716|580678226|FG002|Randomized Treatment|Withdrawal by Subject|0|||
160806219|NCT00714948|580678227|FG000|Overall Study|Adverse Event|2|||
160806220|NCT01673126|580678228|FG000|Overall Study|change of diagnosis|4|||
160806221|NCT01673126|580678229|FG001|Overall Study|change of diagnosis|3|||
160806222|NCT00237042|580678232|FG000|Treatment|Became ineligible post-randomization|0|||
160806223|NCT00237042|580678233|FG001|Treatment|Became ineligible post-randomization|1|||
160806224|NCT00237042|580678234|FG002|Treatment|Became ineligible post-randomization|16|||
160806225|NCT00237042|580678232|FG000|Treatment|Moved out of state|1|||
160806226|NCT00237042|580678233|FG001|Treatment|Moved out of state|1|||
160806227|NCT00237042|580678234|FG002|Treatment|Moved out of state|1|||
160806228|NCT00237042|580678232|FG000|Treatment|Completed no treatment|5|||
160806229|NCT00237042|580678233|FG001|Treatment|Completed no treatment|5|||
160806230|NCT00237042|580678234|FG002|Treatment|Completed no treatment|21|||
160806231|NCT00237042|580678232|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
160806232|NCT00237042|580678233|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
160806233|NCT00237042|580678234|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
160806234|NCT00237042|580678232|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
160806235|NCT00237042|580678233|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
160806236|NCT00237042|580678234|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
160806237|NCT01913327|580678241|FG000|Overall Study|Withdrawal by Subject|0|||
160806238|NCT01913327|580678242|FG001|Overall Study|Withdrawal by Subject|1|||
160806239|NCT02454530|580678245|FG000|Overall Study|Other|8|||
160806240|NCT02454530|580678246|FG001|Overall Study|Other|13|||
160806241|NCT02454530|580678245|FG000|Overall Study|Missing information|56|||
160806242|NCT02454530|580678246|FG001|Overall Study|Missing information|69|||
160806243|NCT02454530|580678245|FG000|Overall Study|Death|2|||
160806244|NCT02454530|580678246|FG001|Overall Study|Death|41|||
160806245|NCT02454530|580678245|FG000|Overall Study|Lost to Follow-up|4|||
160806246|NCT02454530|580678246|FG001|Overall Study|Lost to Follow-up|4|||
160806247|NCT00326001|580678247|FG000|Overall Study|Adverse Event|4|||
160806248|NCT00326001|580678248|FG001|Overall Study|Adverse Event|5|||
160806249|NCT00326001|580678247|FG000|Overall Study|Physician Decision|3|||
160806250|NCT00326001|580678248|FG001|Overall Study|Physician Decision|3|||
160806251|NCT05223673|580678250|FG000|Overall Study|Protocol Violation|1|||
160806252|NCT05223673|580678250|FG000|Overall Study|Study termination|6|||
160806253|NCT02112656|580678254|FG000|Overall Study|Death|78|||
160806254|NCT02112656|580678255|FG001|Overall Study|Death|82|||
160806255|NCT02112656|580678254|FG000|Overall Study|Withdrawal by Subject|9|||
160806256|NCT02112656|580678255|FG001|Overall Study|Withdrawal by Subject|11|||
160806257|NCT02112656|580678254|FG000|Overall Study|Lost to Follow-up|2|||
160806258|NCT02112656|580678255|FG001|Overall Study|Lost to Follow-up|4|||
160806259|NCT02112656|580678254|FG000|Overall Study|Noncompliance|1|||
160806260|NCT02112656|580678255|FG001|Overall Study|Noncompliance|2|||
160806261|NCT00996658|580678256|FG000|Overall Study|Adverse Event|2|||
160806262|NCT00996658|580678257|FG001|Overall Study|Adverse Event|5|||
160806263|NCT00996658|580678256|FG000|Overall Study|Protocol Violation|0|||
160806264|NCT00996658|580678257|FG001|Overall Study|Protocol Violation|1|||
160806265|NCT00996658|580678256|FG000|Overall Study|Lost to Follow-up|2|||
161332324|NCT01240382|582603585|FG000|Overall Study|Fear of adverse events|0|||
161332325|NCT01240382|582603586|FG001|Overall Study|Fear of adverse events|1|||
160806266|NCT00996658|580678257|FG001|Overall Study|Lost to Follow-up|5|||
160806267|NCT00996658|580678256|FG000|Overall Study|Non-compliance issues|3|||
160806268|NCT00996658|580678257|FG001|Overall Study|Non-compliance issues|3|||
160806269|NCT00996658|580678256|FG000|Overall Study|Other|9|||
160806270|NCT00996658|580678257|FG001|Overall Study|Other|7|||
160806271|NCT04749745|580678258|FG000|Overall Study|Withdrawal by Subject|1|||
160806272|NCT04749745|580678259|FG001|Overall Study|Withdrawal by Subject|0|||
160806273|NCT01234480|580679725|FG000|Overall Study|Pregnancy|88|||
160806274|NCT01234480|580679725|FG000|Overall Study|>36/Normal History|50|||
160806275|NCT01234480|580679725|FG000|Overall Study|Age|3|||
160806276|NCT01234480|580679725|FG000|Overall Study|HPV Vaccine History|28|||
160806277|NCT01234480|580679725|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
160806278|NCT01234480|580679725|FG000|Overall Study|Hysterectomy|2|||
160806279|NCT01234480|580679725|FG000|Overall Study|Hysterectomy post enrollment|1|||
160806280|NCT01234480|580679725|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
160806281|NCT01234480|580679725|FG000|Overall Study|Informed Consent Form Violation|30|||
160806282|NCT01234480|580679725|FG000|Overall Study|Incorrect Visit|3|||
160806283|NCT01234480|580679725|FG000|Overall Study|No Florida Lab License|20|||
160806284|NCT01234480|580679725|FG000|Overall Study|Out of Window|42|||
160806285|NCT01234480|580679725|FG000|Overall Study|Sample Processing/Storage|92|||
160806286|NCT01234480|580679725|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
160806287|NCT01234480|580679725|FG000|Overall Study|Site/Subject non-compliance|44|||
160806288|NCT01234480|580679725|FG000|Overall Study|Missing Sample|9|||
160806289|NCT03370419|580679726|FG000|Overall Study|Lost to Follow-up|16|||
160806290|NCT00620373|580679733|FG000|Overall Study|Unverified cancer status|33|||
160806291|NCT01897727|580679734|FG000|Overall Study|Exclusion: central sleep apnea|0|||
160806292|NCT01897727|580679735|FG001|Overall Study|Exclusion: central sleep apnea|1|||
160806293|NCT04245449|580679736|FG000|Overall Study|COVID shutdown|7|||
160806294|NCT01273038|580679739|FG000|Second Intervention (14 Days)|Adverse Event|0|||
160806295|NCT01273038|580679740|FG001|Second Intervention (14 Days)|Adverse Event|1|||
160806296|NCT01273038|580679739|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160806297|NCT01273038|580679740|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160806298|NCT02197572|580679741|FG000|Overall Study|Progressive Disease|28|||
160806299|NCT02197572|580679741|FG000|Overall Study|Withdrawal by Subject|9|||
161238232|NCT02605928|582252125|FG000|Overall Study|Model tuning phase|28|||
161238233|NCT02605928|582252125|FG000|Overall Study|Lack of Efficacy|5|||
161238234|NCT05341622|582252126|FG000|Overall Study|Death|0|||
161238235|NCT05341622|582252127|FG001|Overall Study|Death|0|||
161238236|NCT05341622|582252128|FG002|Overall Study|Death|0|||
161238237|NCT05341622|582252129|FG003|Overall Study|Death|0|||
161238238|NCT05341622|582252130|FG004|Overall Study|Death|1|||
161238239|NCT05341622|582252131|FG005|Overall Study|Death|0|||
161238240|NCT05341622|582252132|FG006|Overall Study|Death|0|||
161238241|NCT05341622|582252133|FG007|Overall Study|Death|1|||
161238242|NCT05341622|582252126|FG000|Overall Study|Invalid Address|0|||
161238243|NCT05341622|582252127|FG001|Overall Study|Invalid Address|1|||
161238244|NCT05341622|582252128|FG002|Overall Study|Invalid Address|0|||
161238245|NCT05341622|582252129|FG003|Overall Study|Invalid Address|0|||
161238246|NCT05341622|582252130|FG004|Overall Study|Invalid Address|0|||
161238247|NCT05341622|582252131|FG005|Overall Study|Invalid Address|0|||
161238248|NCT05341622|582252132|FG006|Overall Study|Invalid Address|0|||
161238249|NCT05341622|582252133|FG007|Overall Study|Invalid Address|0|||
161238250|NCT05341622|582252126|FG000|Overall Study|Ineligible|26|||
161238251|NCT05341622|582252127|FG001|Overall Study|Ineligible|21|||
161238252|NCT05341622|582252128|FG002|Overall Study|Ineligible|28|||
161238253|NCT05341622|582252129|FG003|Overall Study|Ineligible|24|||
161238254|NCT05341622|582252130|FG004|Overall Study|Ineligible|29|||
161238255|NCT05341622|582252131|FG005|Overall Study|Ineligible|31|||
161238256|NCT05341622|582252132|FG006|Overall Study|Ineligible|28|||
161238257|NCT05341622|582252133|FG007|Overall Study|Ineligible|26|||
161238258|NCT02658084|582252134|FG000|Overall Study|Withdrawal by Subject|1|||
161238259|NCT02658084|582252135|FG001|Overall Study|Withdrawal by Subject|0|||
161238260|NCT02658084|582252134|FG000|Overall Study|Study Termination|1|||
161238261|NCT02658084|582252135|FG001|Overall Study|Study Termination|0|||
161238262|NCT03290781|582252136|FG000|Overall Study|Adverse Event|5|||
161238263|NCT03290781|582252137|FG001|Overall Study|Adverse Event|7|||
161238264|NCT03290781|582252138|FG002|Overall Study|Adverse Event|4|||
161238265|NCT03290781|582252139|FG003|Overall Study|Adverse Event|1|||
161238266|NCT03290781|582252140|FG004|Overall Study|Adverse Event|0|||
161238267|NCT03290781|582252141|FG005|Overall Study|Adverse Event|0|||
161238268|NCT03290781|582252142|FG006|Overall Study|Adverse Event|0|||
161238269|NCT03290781|582252136|FG000|Overall Study|Death|0|||
161238270|NCT03290781|582252137|FG001|Overall Study|Death|0|||
160806300|NCT02197572|580679741|FG000|Overall Study|Adverse Event|3|||
160806301|NCT02197572|580679741|FG000|Overall Study|Reason Not Specified|4|||
160806302|NCT01465386|580679742|FG000|Overall Study|Lack of Efficacy|3|||
160806303|NCT01465386|580679742|FG000|Overall Study|Adverse Event|1|||
160806304|NCT02479880|580679743|FG000|Overall Study|Study Terminated by Sponsor|13|||
160806305|NCT02479880|580679744|FG001|Overall Study|Study Terminated by Sponsor|12|||
160806306|NCT02479880|580679743|FG000|Overall Study|Pregnancy|0|||
160806307|NCT02479880|580679744|FG001|Overall Study|Pregnancy|1|||
160806308|NCT02840253|580679745|FG000|Overall Study|Unsuccessful block|4|||
160806309|NCT03801928|580679746|FG000|Overall Study|Adverse Event|1|||
160806310|NCT03801928|580679747|FG001|Overall Study|Adverse Event|0|||
160806311|NCT03801928|580679748|FG002|Overall Study|Adverse Event|1|||
160806312|NCT03801928|580679749|FG003|Overall Study|Adverse Event|2|||
160806313|NCT03801928|580679750|FG004|Overall Study|Adverse Event|0|||
160806314|NCT03801928|580679751|FG005|Overall Study|Adverse Event|2|||
160806315|NCT03801928|580679746|FG000|Overall Study|Lack of Efficacy|0|||
160806316|NCT03801928|580679747|FG001|Overall Study|Lack of Efficacy|0|||
160806317|NCT03801928|580679748|FG002|Overall Study|Lack of Efficacy|1|||
160806318|NCT03801928|580679749|FG003|Overall Study|Lack of Efficacy|0|||
160806319|NCT03801928|580679750|FG004|Overall Study|Lack of Efficacy|0|||
160806320|NCT03801928|580679751|FG005|Overall Study|Lack of Efficacy|0|||
160806321|NCT03801928|580679746|FG000|Overall Study|Lost to Follow-up|5|||
160806322|NCT03801928|580679747|FG001|Overall Study|Lost to Follow-up|1|||
160806323|NCT03801928|580679748|FG002|Overall Study|Lost to Follow-up|1|||
160806324|NCT03801928|580679749|FG003|Overall Study|Lost to Follow-up|4|||
160806325|NCT03801928|580679750|FG004|Overall Study|Lost to Follow-up|4|||
160806326|NCT03801928|580679751|FG005|Overall Study|Lost to Follow-up|2|||
160806327|NCT03801928|580679746|FG000|Overall Study|Withdrawal by Subject|0|||
160806328|NCT03801928|580679747|FG001|Overall Study|Withdrawal by Subject|0|||
160898243|NCT02362035|581023399|FG000|Overall Study|Disease progression|11|||
161238271|NCT03290781|582252138|FG002|Overall Study|Death|1|||
161238272|NCT03290781|582252139|FG003|Overall Study|Death|0|||
161238273|NCT03290781|582252140|FG004|Overall Study|Death|1|||
161238274|NCT03290781|582252141|FG005|Overall Study|Death|0|||
161238275|NCT03290781|582252142|FG006|Overall Study|Death|0|||
161238276|NCT03290781|582252136|FG000|Overall Study|Withdrawal by Subject|6|||
161238277|NCT03290781|582252137|FG001|Overall Study|Withdrawal by Subject|5|||
161238278|NCT03290781|582252138|FG002|Overall Study|Withdrawal by Subject|9|||
161238279|NCT03290781|582252139|FG003|Overall Study|Withdrawal by Subject|10|||
161238280|NCT03290781|582252140|FG004|Overall Study|Withdrawal by Subject|1|||
161238281|NCT03290781|582252141|FG005|Overall Study|Withdrawal by Subject|2|||
161238282|NCT03290781|582252142|FG006|Overall Study|Withdrawal by Subject|0|||
161238283|NCT03290781|582252136|FG000|Overall Study|Physician Decision|0|||
161238284|NCT03290781|582252137|FG001|Overall Study|Physician Decision|1|||
161238285|NCT03290781|582252138|FG002|Overall Study|Physician Decision|0|||
161238286|NCT03290781|582252139|FG003|Overall Study|Physician Decision|0|||
161238287|NCT03290781|582252140|FG004|Overall Study|Physician Decision|0|||
161238288|NCT03290781|582252141|FG005|Overall Study|Physician Decision|0|||
161238289|NCT03290781|582252142|FG006|Overall Study|Physician Decision|0|||
161238290|NCT03290781|582252136|FG000|Overall Study|Site Terminated by Sponsor|1|||
161238291|NCT03290781|582252137|FG001|Overall Study|Site Terminated by Sponsor|0|||
161238292|NCT03290781|582252138|FG002|Overall Study|Site Terminated by Sponsor|2|||
161238293|NCT03290781|582252139|FG003|Overall Study|Site Terminated by Sponsor|1|||
161238294|NCT03290781|582252140|FG004|Overall Study|Site Terminated by Sponsor|0|||
161238295|NCT03290781|582252141|FG005|Overall Study|Site Terminated by Sponsor|0|||
161238296|NCT03290781|582252142|FG006|Overall Study|Site Terminated by Sponsor|0|||
161238297|NCT03290781|582252136|FG000|Overall Study|Lost to Follow-up|0|||
161238298|NCT03290781|582252137|FG001|Overall Study|Lost to Follow-up|0|||
161238299|NCT03290781|582252138|FG002|Overall Study|Lost to Follow-up|0|||
161238300|NCT03290781|582252139|FG003|Overall Study|Lost to Follow-up|1|||
161238301|NCT03290781|582252140|FG004|Overall Study|Lost to Follow-up|0|||
161238302|NCT03290781|582252141|FG005|Overall Study|Lost to Follow-up|0|||
161238303|NCT03290781|582252142|FG006|Overall Study|Lost to Follow-up|0|||
161238304|NCT03290781|582252136|FG000|Overall Study|Protocol Deviation|2|||
161238305|NCT03290781|582252137|FG001|Overall Study|Protocol Deviation|0|||
161238306|NCT03290781|582252138|FG002|Overall Study|Protocol Deviation|0|||
161238307|NCT03290781|582252139|FG003|Overall Study|Protocol Deviation|1|||
161238308|NCT03290781|582252140|FG004|Overall Study|Protocol Deviation|0|||
161238309|NCT03290781|582252141|FG005|Overall Study|Protocol Deviation|0|||
161238310|NCT03290781|582252142|FG006|Overall Study|Protocol Deviation|0|||
161238311|NCT03290781|582252136|FG000|Overall Study|Disease Relapse|32|||
161238312|NCT03290781|582252137|FG001|Overall Study|Disease Relapse|5|||
161238313|NCT03290781|582252138|FG002|Overall Study|Disease Relapse|38|||
161238314|NCT03290781|582252139|FG003|Overall Study|Disease Relapse|7|||
161238315|NCT03290781|582252140|FG004|Overall Study|Disease Relapse|3|||
161238316|NCT03290781|582252141|FG005|Overall Study|Disease Relapse|1|||
161238317|NCT03290781|582252142|FG006|Overall Study|Disease Relapse|4|||
160898244|NCT02362035|581023399|FG000|Overall Study|Withdrawal by Subject|20|||
160985365|NCT02107443|581335431|FG000|Overall Study|Withdrawal: Personal Issues|0|||
160985366|NCT02107443|581335432|FG001|Overall Study|Withdrawal: Personal Issues|3|||
160985367|NCT00885495|581335433|FG000|Overall Study|Adverse Event|1|||
160985368|NCT00885495|581335434|FG001|Overall Study|Adverse Event|2|||
160985369|NCT00885495|581335433|FG000|Overall Study|Protocol Violation|0|||
160985370|NCT00885495|581335434|FG001|Overall Study|Protocol Violation|1|||
160985371|NCT00885495|581335433|FG000|Overall Study|Withdrawal by Subject|1|||
160985372|NCT00885495|581335434|FG001|Overall Study|Withdrawal by Subject|0|||
160985373|NCT01400893|581335435|FG000|Overall Study|Death|27|||
160985374|NCT01400893|581335436|FG001|Overall Study|Death|21|||
160985375|NCT01400893|581335435|FG000|Overall Study|Lost to Follow-up|0|||
160898245|NCT02024529|581023400|FG000|Overall Study|Withdrawal by Subject|11|||
160898246|NCT02024529|581023401|FG001|Overall Study|Withdrawal by Subject|21|||
160898247|NCT02024529|581023400|FG000|Overall Study|Lost to Follow-up|2|||
160898248|NCT02024529|581023401|FG001|Overall Study|Lost to Follow-up|4|||
160898249|NCT00354614|581023402|FG000|Overall Study|Lack of Efficacy|28|||
160898250|NCT00691301|581023403|FG000|Overall Study|Adverse Event|10|||
160898251|NCT00691301|581023403|FG000|Overall Study|Death|2|||
160898252|NCT00691301|581023403|FG000|Overall Study|Lack of Efficacy|32|||
160898253|NCT00691301|581023403|FG000|Overall Study|Withdrawal by Subject|4|||
160898254|NCT00691301|581023403|FG000|Overall Study|Concurrent illness|2|||
160898255|NCT00691301|581023403|FG000|Overall Study|other reason|3|||
160898256|NCT00691301|581023403|FG000|Overall Study|Did not initiate study treatment|1|||
160898257|NCT02642029|581023404|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
160898258|NCT02642029|581023405|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898259|NCT02642029|581023406|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898260|NCT02642029|581023407|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898261|NCT02642029|581023408|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160898262|NCT02642029|581023409|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
160985376|NCT01400893|581335436|FG001|Overall Study|Lost to Follow-up|6|||
160985377|NCT00519636|581335437|FG000|Treatment Period 1|Adverse Event|1|||
160985378|NCT00519636|581335438|FG001|Treatment Period 1|Adverse Event|0|||
161238318|NCT03290781|582252136|FG000|Overall Study|Other|3|||
161238319|NCT03290781|582252137|FG001|Overall Study|Other|0|||
161238320|NCT03290781|582252138|FG002|Overall Study|Other|2|||
161238321|NCT03290781|582252139|FG003|Overall Study|Other|2|||
160898263|NCT02642029|581023404|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160985379|NCT00519636|581335439|FG002|Treatment Period 1|Adverse Event|1|||
160985380|NCT00519636|581335440|FG003|Treatment Period 1|Adverse Event|0|||
160985381|NCT00519636|581335437|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
161130503|NCT04957290|581863454|FG001|Overall Study|Death|2|||
161130504|NCT04957290|581863455|FG002|Overall Study|Death|1|||
161130505|NCT04957290|581863456|FG003|Overall Study|Death|0|||
161130506|NCT04957290|581863457|FG004|Overall Study|Death|0|||
161130507|NCT04957290|581863458|FG005|Overall Study|Death|0|||
161130508|NCT04957290|581863453|FG000|Overall Study|non compliance with study drug|0|||
161130509|NCT04957290|581863454|FG001|Overall Study|non compliance with study drug|1|||
161130510|NCT04957290|581863455|FG002|Overall Study|non compliance with study drug|0|||
161130511|NCT04957290|581863456|FG003|Overall Study|non compliance with study drug|0|||
161130512|NCT04957290|581863457|FG004|Overall Study|non compliance with study drug|0|||
161130513|NCT04957290|581863458|FG005|Overall Study|non compliance with study drug|0|||
161130514|NCT04957290|581863453|FG000|Overall Study|none specified.|0|||
161130515|NCT04957290|581863454|FG001|Overall Study|none specified.|1|||
161130516|NCT04957290|581863455|FG002|Overall Study|none specified.|2|||
161130517|NCT04957290|581863456|FG003|Overall Study|none specified.|0|||
161130518|NCT04957290|581863457|FG004|Overall Study|none specified.|0|||
161130519|NCT04957290|581863458|FG005|Overall Study|none specified.|0|||
161130520|NCT04957290|581863453|FG000|Overall Study|unacceptable toxicity|0|||
161130521|NCT04957290|581863454|FG001|Overall Study|unacceptable toxicity|0|||
161130522|NCT04957290|581863455|FG002|Overall Study|unacceptable toxicity|1|||
161130523|NCT04957290|581863456|FG003|Overall Study|unacceptable toxicity|0|||
161130524|NCT04957290|581863457|FG004|Overall Study|unacceptable toxicity|0|||
161130525|NCT04957290|581863458|FG005|Overall Study|unacceptable toxicity|0|||
161130526|NCT04957290|581863453|FG000|Overall Study|Adverse Event|0|||
161130527|NCT04957290|581863454|FG001|Overall Study|Adverse Event|0|||
161130528|NCT04957290|581863455|FG002|Overall Study|Adverse Event|1|||
161130529|NCT04957290|581863456|FG003|Overall Study|Adverse Event|0|||
161130530|NCT04957290|581863457|FG004|Overall Study|Adverse Event|0|||
161130531|NCT04957290|581863458|FG005|Overall Study|Adverse Event|0|||
161130532|NCT04957290|581863453|FG000|Overall Study|study terminated by sponsor|0|||
161130533|NCT04957290|581863454|FG001|Overall Study|study terminated by sponsor|0|||
161130534|NCT04957290|581863455|FG002|Overall Study|study terminated by sponsor|2|||
161130535|NCT04957290|581863456|FG003|Overall Study|study terminated by sponsor|0|||
161130536|NCT04957290|581863457|FG004|Overall Study|study terminated by sponsor|0|||
161130537|NCT04957290|581863458|FG005|Overall Study|study terminated by sponsor|0|||
161130538|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130539|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130540|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130541|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
161130542|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130543|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
161130544|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130545|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130546|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130547|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130548|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130549|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130550|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130551|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130552|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130553|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130554|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130555|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130556|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130557|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130558|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130559|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130560|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
161130561|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161130562|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
161130563|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161130564|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
161130565|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161130566|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161130567|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
161130568|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161238322|NCT03290781|582252140|FG004|Overall Study|Other|0|||
160806329|NCT03801928|580679748|FG002|Overall Study|Withdrawal by Subject|2|||
160806330|NCT03801928|580679749|FG003|Overall Study|Withdrawal by Subject|1|||
160806331|NCT03801928|580679750|FG004|Overall Study|Withdrawal by Subject|0|||
160806332|NCT03801928|580679751|FG005|Overall Study|Withdrawal by Subject|0|||
160806333|NCT03801928|580679746|FG000|Overall Study|Other|0|||
160806334|NCT03801928|580679747|FG001|Overall Study|Other|2|||
160806335|NCT03801928|580679748|FG002|Overall Study|Other|0|||
160806336|NCT03801928|580679749|FG003|Overall Study|Other|1|||
160806337|NCT03801928|580679750|FG004|Overall Study|Other|0|||
160806338|NCT03801928|580679751|FG005|Overall Study|Other|1|||
160806339|NCT03688919|580679752|FG000|Overall Study|Lost to Follow-up|2|||
160806340|NCT03688919|580679753|FG001|Overall Study|Lost to Follow-up|1|||
160806341|NCT03688919|580679752|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
160898264|NCT02642029|581023405|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
160898265|NCT02642029|581023406|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898266|NCT02642029|581023407|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898267|NCT02642029|581023408|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898268|NCT02642029|581023409|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
160898269|NCT02642029|581023404|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898270|NCT02642029|581023405|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898271|NCT02642029|581023406|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898272|NCT02642029|581023407|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898273|NCT02642029|581023408|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
160898274|NCT02642029|581023409|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
160898275|NCT02642029|581023404|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
160898276|NCT02642029|581023405|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
160898277|NCT02642029|581023406|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
160898278|NCT02642029|581023407|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
160898279|NCT02642029|581023408|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
160898280|NCT02642029|581023409|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
160898281|NCT02642029|581023404|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
160898282|NCT02642029|581023405|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898283|NCT02642029|581023406|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898284|NCT02642029|581023407|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898285|NCT02642029|581023408|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898286|NCT02642029|581023409|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
160898287|NCT02642029|581023404|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
160898288|NCT02642029|581023405|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898289|NCT02642029|581023406|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898290|NCT02642029|581023407|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898291|NCT02642029|581023408|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898292|NCT02642029|581023409|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
160898293|NCT00463580|581023412|FG000|Overall Study|Lost to Follow-up|1|||
160898294|NCT00463580|581023413|FG001|Overall Study|Lost to Follow-up|0|||
160898295|NCT00463580|581023412|FG000|Overall Study|Schedule conflict|2|||
160898296|NCT00463580|581023413|FG001|Overall Study|Schedule conflict|0|||
160898297|NCT00463580|581023412|FG000|Overall Study|Medical/psychiatric complications|0|||
160898298|NCT00463580|581023413|FG001|Overall Study|Medical/psychiatric complications|2|||
160898299|NCT01426438|581023414|FG000|Overall Study|Lost to Follow-up|1|||
160898300|NCT01426438|581023415|FG001|Overall Study|Lost to Follow-up|3|||
160898301|NCT01426438|581023414|FG000|Overall Study|Off study Treatment|9|||
160898302|NCT01426438|581023415|FG001|Overall Study|Off study Treatment|3|||
160898303|NCT01426438|581023414|FG000|Overall Study|Poor scan quality|3|||
160898304|NCT01426438|581023415|FG001|Overall Study|Poor scan quality|2|||
160898305|NCT01426438|581023414|FG000|Overall Study|Missed Scan|2|||
160898306|NCT01426438|581023415|FG001|Overall Study|Missed Scan|2|||
160898307|NCT01495975|581023418|FG000|Overall Study|Lost to Follow-up|1|||
160898308|NCT01495975|581023419|FG001|Overall Study|Lost to Follow-up|0|||
160898309|NCT00808483|581023422|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
160898310|NCT00808483|581023423|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
160898311|NCT00808483|581023422|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
160898312|NCT00808483|581023423|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
160898313|NCT00808483|581023422|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
160898314|NCT00808483|581023423|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
160898315|NCT02038881|581023424|FG000|Overall Study|Withdrawal by Subject|0|||
160898316|NCT02038881|581023425|FG001|Overall Study|Withdrawal by Subject|0|||
160898317|NCT02038881|581023426|FG002|Overall Study|Withdrawal by Subject|1|||
160898318|NCT02038881|581023424|FG000|Overall Study|Lost to Follow-up|2|||
160806342|NCT03688919|580679753|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
160806343|NCT04423939|580679758|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
160985382|NCT00519636|581335438|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
160985383|NCT00519636|581335439|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
160985384|NCT00519636|581335440|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
160985385|NCT00519636|581335437|FG000|Washout Period|Adverse Event|2|||
160985386|NCT00519636|581335438|FG001|Washout Period|Adverse Event|1|||
160985387|NCT00519636|581335439|FG002|Washout Period|Adverse Event|1|||
160985388|NCT00519636|581335440|FG003|Washout Period|Adverse Event|0|||
160985389|NCT00519636|581335437|FG000|Washout Period|Lost to Follow-up|1|||
160985390|NCT00519636|581335438|FG001|Washout Period|Lost to Follow-up|0|||
160985391|NCT00519636|581335439|FG002|Washout Period|Lost to Follow-up|0|||
160985392|NCT00519636|581335440|FG003|Washout Period|Lost to Follow-up|0|||
161238323|NCT03290781|582252141|FG005|Overall Study|Other|0|||
161238324|NCT03290781|582252142|FG006|Overall Study|Other|0|||
161238325|NCT04611789|582252143|FG000|Overall Study|Lost to Follow-up|1|||
161238326|NCT04611789|582252144|FG001|Overall Study|Lost to Follow-up|0|||
161238327|NCT04611789|582252145|FG002|Overall Study|Lost to Follow-up|0|||
161238328|NCT05152576|582252146|FG000|Overall Study|Lost to Follow-up|3|||
161238329|NCT05152576|582252147|FG001|Overall Study|Lost to Follow-up|0|||
161238330|NCT05152576|582252148|FG002|Overall Study|Lost to Follow-up|0|||
161238331|NCT05152576|582252149|FG003|Overall Study|Lost to Follow-up|1|||
161238332|NCT05152576|582252146|FG000|Overall Study|Withdrawal by Subject|0|||
161238333|NCT05152576|582252147|FG001|Overall Study|Withdrawal by Subject|1|||
161238334|NCT05152576|582252148|FG002|Overall Study|Withdrawal by Subject|0|||
161238335|NCT05152576|582252149|FG003|Overall Study|Withdrawal by Subject|1|||
161238336|NCT05152576|582252146|FG000|Overall Study|Other|2|||
161238337|NCT05152576|582252147|FG001|Overall Study|Other|0|||
161238338|NCT05152576|582252148|FG002|Overall Study|Other|0|||
161238339|NCT05152576|582252149|FG003|Overall Study|Other|0|||
161238340|NCT00859430|582252150|FG000|First Intervention|Withdrawal by Subject|0|||
161238341|NCT00859430|582252151|FG001|First Intervention|Withdrawal by Subject|1|||
161238342|NCT02286739|582253709|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
161238343|NCT02286739|582253710|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
161238344|NCT02286739|582253709|FG000|Overall Study|No Verasense type documented|0|||
161238345|NCT02286739|582253710|FG001|Overall Study|No Verasense type documented|23|||
161238346|NCT02286739|582253709|FG000|Overall Study|Adverse Event|1|||
161238347|NCT02286739|582253710|FG001|Overall Study|Adverse Event|2|||
161238348|NCT02286739|582253709|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
161238349|NCT02286739|582253710|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
161238350|NCT00834795|582253711|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
161238351|NCT00834795|582253712|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
161238352|NCT00834795|582253711|FG000|Second Intervention|Adverse Event|1|||
161238353|NCT00834795|582253712|FG001|Second Intervention|Adverse Event|0|||
161238354|NCT03697109|582253720|FG000|Open-label (OL) Phase|Adverse Event|24|||
161238355|NCT03697109|582253721|FG001|Open-label (OL) Phase|Adverse Event|0|||
161238356|NCT03697109|582253722|FG002|Open-label (OL) Phase|Adverse Event|0|||
161238357|NCT03697109|582253720|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
161238358|NCT03697109|582253721|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
161238359|NCT03697109|582253722|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
161238360|NCT03697109|582253720|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
161238361|NCT03697109|582253721|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
161238362|NCT03697109|582253722|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
161238363|NCT03697109|582253720|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
161238364|NCT03697109|582253721|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
161238365|NCT03697109|582253722|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
161238366|NCT03697109|582253720|FG000|Open-label (OL) Phase|Physician Decision|2|||
161238367|NCT03697109|582253721|FG001|Open-label (OL) Phase|Physician Decision|0|||
161238368|NCT03697109|582253722|FG002|Open-label (OL) Phase|Physician Decision|0|||
161238369|NCT03697109|582253720|FG000|Open-label (OL) Phase|Death|2|||
161238370|NCT03697109|582253721|FG001|Open-label (OL) Phase|Death|0|||
161238371|NCT03697109|582253722|FG002|Open-label (OL) Phase|Death|0|||
161238372|NCT03697109|582253720|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
161238373|NCT03697109|582253721|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
161332326|NCT02643693|582603587|FG000|Overall Study|Physician Decision|0|||
160985393|NCT00519636|581335437|FG000|Washout Period|Protocol Violation|0|||
160985394|NCT00519636|581335438|FG001|Washout Period|Protocol Violation|0|||
160985395|NCT00519636|581335439|FG002|Washout Period|Protocol Violation|1|||
160985396|NCT00519636|581335440|FG003|Washout Period|Protocol Violation|2|||
161238374|NCT03697109|582253722|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
161238375|NCT03697109|582253720|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
161238376|NCT03697109|582253721|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
161238377|NCT03697109|582253722|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
160985397|NCT00519636|581335437|FG000|Washout Period|Withdrawal by Subject|1|||
160985398|NCT00519636|581335438|FG001|Washout Period|Withdrawal by Subject|0|||
161238378|NCT03697109|582253720|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
161238379|NCT03697109|582253721|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
160985399|NCT00519636|581335439|FG002|Washout Period|Withdrawal by Subject|1|||
160985400|NCT00519636|581335440|FG003|Washout Period|Withdrawal by Subject|0|||
160985401|NCT00519636|581335437|FG000|Washout Period|Failed to meet continuation criteria|14|||
160985402|NCT00519636|581335438|FG001|Washout Period|Failed to meet continuation criteria|11|||
160985403|NCT00519636|581335439|FG002|Washout Period|Failed to meet continuation criteria|9|||
160985404|NCT00519636|581335440|FG003|Washout Period|Failed to meet continuation criteria|3|||
160985405|NCT00519636|581335437|FG000|Washout Period|Out of pollen area > 48 hours|1|||
160985406|NCT00519636|581335438|FG001|Washout Period|Out of pollen area > 48 hours|0|||
160985407|NCT00519636|581335439|FG002|Washout Period|Out of pollen area > 48 hours|0|||
160985408|NCT00519636|581335440|FG003|Washout Period|Out of pollen area > 48 hours|0|||
160985409|NCT00519636|581335437|FG000|Washout Period|Participating in study at another site|1|||
160985410|NCT00519636|581335438|FG001|Washout Period|Participating in study at another site|0|||
160985411|NCT00519636|581335439|FG002|Washout Period|Participating in study at another site|0|||
160985412|NCT00519636|581335440|FG003|Washout Period|Participating in study at another site|0|||
160985413|NCT00519636|581335437|FG000|Washout Period|Non-compliant|0|||
160985414|NCT00519636|581335438|FG001|Washout Period|Non-compliant|1|||
160985415|NCT00519636|581335439|FG002|Washout Period|Non-compliant|0|||
160985416|NCT00519636|581335440|FG003|Washout Period|Non-compliant|0|||
160985417|NCT00519636|581335437|FG000|Washout Period|Per doctors request|0|||
160985418|NCT00519636|581335438|FG001|Washout Period|Per doctors request|1|||
160985419|NCT00519636|581335439|FG002|Washout Period|Per doctors request|0|||
160985420|NCT00519636|581335440|FG003|Washout Period|Per doctors request|0|||
160985421|NCT00519636|581335437|FG000|Washout Period|Subject randomized in error|0|||
160985422|NCT00519636|581335438|FG001|Washout Period|Subject randomized in error|0|||
160985423|NCT00519636|581335439|FG002|Washout Period|Subject randomized in error|1|||
160985424|NCT00519636|581335440|FG003|Washout Period|Subject randomized in error|0|||
160985425|NCT00519636|581335437|FG000|Washout Period|Prohibited medications|0|||
160985426|NCT00519636|581335438|FG001|Washout Period|Prohibited medications|0|||
160985427|NCT00519636|581335439|FG002|Washout Period|Prohibited medications|1|||
160985428|NCT00519636|581335440|FG003|Washout Period|Prohibited medications|0|||
160985429|NCT00519636|581335437|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
160985430|NCT00519636|581335438|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
160985431|NCT00519636|581335439|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
160985432|NCT00519636|581335440|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
160985433|NCT00519636|581335437|FG000|Treatment Period 2|Subject randomized in error|0|||
160985434|NCT00519636|581335438|FG001|Treatment Period 2|Subject randomized in error|1|||
160985435|NCT00519636|581335439|FG002|Treatment Period 2|Subject randomized in error|0|||
160985436|NCT00519636|581335440|FG003|Treatment Period 2|Subject randomized in error|0|||
160985437|NCT00519636|581335437|FG000|Treatment Period 2|Per doctors request|0|||
160985438|NCT00519636|581335438|FG001|Treatment Period 2|Per doctors request|0|||
160985439|NCT00519636|581335439|FG002|Treatment Period 2|Per doctors request|1|||
160985440|NCT00519636|581335440|FG003|Treatment Period 2|Per doctors request|0|||
160985441|NCT00519636|581335437|FG000|Treatment Period 2|Subject misrandomized|0|||
160985442|NCT00519636|581335438|FG001|Treatment Period 2|Subject misrandomized|0|||
160985443|NCT00519636|581335439|FG002|Treatment Period 2|Subject misrandomized|0|||
160985444|NCT00519636|581335440|FG003|Treatment Period 2|Subject misrandomized|1|||
160985445|NCT00519636|581335437|FG000|Post Study Period|Subject randomized in error|0|||
160985446|NCT00519636|581335438|FG001|Post Study Period|Subject randomized in error|0|||
160985447|NCT00519636|581335439|FG002|Post Study Period|Subject randomized in error|0|||
160985448|NCT00519636|581335440|FG003|Post Study Period|Subject randomized in error|1|||
160985449|NCT04504916|581335441|FG000|Overall Study|Study terminated|7|||
160985450|NCT04504916|581335442|FG001|Overall Study|Study terminated|8|||
160985451|NCT04504916|581335441|FG000|Overall Study|Death|54|||
160806344|NCT04423939|580679759|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
160806345|NCT04423939|580679758|FG000|Overall Study|Death|3|||
160806346|NCT04423939|580679759|FG001|Overall Study|Death|0|||
160806347|NCT04423939|580679758|FG000|Overall Study|Withdrawal by Subject|3|||
160806348|NCT04423939|580679759|FG001|Overall Study|Withdrawal by Subject|0|||
160806349|NCT04423939|580679758|FG000|Overall Study|Caregiver to patient who died|0|||
160806350|NCT04423939|580679759|FG001|Overall Study|Caregiver to patient who died|3|||
160806351|NCT04423939|580679758|FG000|Overall Study|Caregiver to patient who withdrew|0|||
160806352|NCT04423939|580679759|FG001|Overall Study|Caregiver to patient who withdrew|3|||
160806353|NCT01456130|580679761|FG000|Overall Study|Adverse Event|4|||
160806354|NCT01456130|580679761|FG000|Overall Study|Voluntary Withdrawal|1|||
160806355|NCT01456130|580679761|FG000|Overall Study|Lack of Efficacy|4|||
160806356|NCT01456130|580679761|FG000|Overall Study|Other|1|||
160985452|NCT04504916|581335442|FG001|Overall Study|Death|18|||
160985453|NCT04504916|581335441|FG000|Overall Study|Lost to Follow-up|1|||
160985454|NCT04504916|581335442|FG001|Overall Study|Lost to Follow-up|1|||
160985455|NCT04504916|581335441|FG000|Overall Study|Withdrawal by Subject|8|||
160985456|NCT04504916|581335442|FG001|Overall Study|Withdrawal by Subject|4|||
160985457|NCT04504916|581335441|FG000|Overall Study|Did not agree to follow-up|0|||
160985458|NCT04504916|581335442|FG001|Overall Study|Did not agree to follow-up|1|||
160985459|NCT03057834|581335443|FG000|Overall Study|Withdrawal by Subject|25|||
160985460|NCT03057834|581335444|FG001|Overall Study|Withdrawal by Subject|29|||
160985461|NCT00003509|581335445|FG000|Overall Study|Not evaluable|5|||
160985462|NCT03077620|581335450|FG000|Overall Study|Unable to place lumbar catheter|1|||
160985463|NCT03077620|581335451|FG001|Overall Study|Unable to place lumbar catheter|0|||
160985464|NCT03077620|581335452|FG002|Overall Study|Unable to place lumbar catheter|1|||
160985465|NCT03077620|581335453|FG003|Overall Study|Unable to place lumbar catheter|0|||
160985466|NCT03077620|581335450|FG000|Overall Study|Withdrawal by Subject|0|||
160985467|NCT03077620|581335451|FG001|Overall Study|Withdrawal by Subject|1|||
160985468|NCT03077620|581335452|FG002|Overall Study|Withdrawal by Subject|0|||
160985469|NCT03077620|581335453|FG003|Overall Study|Withdrawal by Subject|0|||
160985470|NCT03077620|581335450|FG000|Overall Study|Physician Decision|0|||
160985471|NCT03077620|581335451|FG001|Overall Study|Physician Decision|0|||
160985472|NCT03077620|581335452|FG002|Overall Study|Physician Decision|1|||
160985473|NCT03077620|581335453|FG003|Overall Study|Physician Decision|0|||
160985474|NCT00245011|581335455|FG000|Overall Study|Lack of Efficacy|1|||
160985475|NCT00550173|581335456|FG000|Overall Study|Death|45|||
160985476|NCT00550173|581335457|FG001|Overall Study|Death|38|||
160985477|NCT00550173|581335458|FG002|Overall Study|Death|50|||
160985478|NCT00550173|581335456|FG000|Overall Study|Physician Decision|1|||
160985479|NCT00550173|581335457|FG001|Overall Study|Physician Decision|2|||
160985480|NCT00550173|581335458|FG002|Overall Study|Physician Decision|2|||
160985481|NCT00550173|581335456|FG000|Overall Study|Withdrawal by Subject|9|||
160985482|NCT00550173|581335457|FG001|Overall Study|Withdrawal by Subject|12|||
160985483|NCT00550173|581335458|FG002|Overall Study|Withdrawal by Subject|17|||
160985484|NCT00550173|581335456|FG000|Overall Study|Sponsor Decision|13|||
160985485|NCT00550173|581335457|FG001|Overall Study|Sponsor Decision|7|||
160985486|NCT00550173|581335458|FG002|Overall Study|Sponsor Decision|1|||
160985487|NCT00550173|581335456|FG000|Overall Study|Lost to Follow-up|4|||
160985488|NCT00550173|581335457|FG001|Overall Study|Lost to Follow-up|4|||
160985489|NCT00550173|581335458|FG002|Overall Study|Lost to Follow-up|3|||
160985490|NCT04034238|581336930|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
160985491|NCT04034238|581336931|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160985492|NCT04034238|581336932|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160985493|NCT04034238|581336933|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160985494|NCT04034238|581336930|FG000|Dose Escalation Phase|Screen failures|0|||
160985495|NCT04034238|581336931|FG001|Dose Escalation Phase|Screen failures|0|||
160985496|NCT04034238|581336932|FG002|Dose Escalation Phase|Screen failures|0|||
160985497|NCT04034238|581336933|FG003|Dose Escalation Phase|Screen failures|2|||
160985498|NCT04034238|581336930|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
160985499|NCT04034238|581336931|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
160985500|NCT04034238|581336932|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
160985501|NCT04034238|581336933|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
160985502|NCT04034238|581336930|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
160985503|NCT04034238|581336931|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
160985504|NCT04034238|581336932|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
160985505|NCT04034238|581336933|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
160985506|NCT02153788|581336936|FG000|Overall Study|Physician Decision|2|||
160985507|NCT02153788|581336937|FG001|Overall Study|Physician Decision|1|||
160985508|NCT01106287|581336938|FG000|Overall Study|Adverse Event|1|||
160985509|NCT01106287|581336939|FG001|Overall Study|Adverse Event|0|||
160985510|NCT01106287|581336940|FG002|Overall Study|Adverse Event|0|||
160985511|NCT01106287|581336941|FG003|Overall Study|Adverse Event|0|||
160985512|NCT01450943|581336944|FG000|Overall Study|Screen failure, loss to follow-up|2|||
160985513|NCT01450943|581336945|FG001|Overall Study|Screen failure, loss to follow-up|7|||
160985514|NCT01450943|581336946|FG002|Overall Study|Screen failure, loss to follow-up|6|||
160985515|NCT01345292|581336947|FG000|Overall Study|Withdrawal by Subject|2|||
160985516|NCT01345292|581336948|FG001|Overall Study|Withdrawal by Subject|0|||
160985517|NCT01345292|581336949|FG002|Overall Study|Withdrawal by Subject|1|||
160985518|NCT04822298|581336953|FG000|Overall Study|Death|3|||
160985519|NCT00465361|581336956|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
160985520|NCT05406791|581336957|FG000|Overall Study|Lost to Follow-up|13|||
160985521|NCT05406791|581336958|FG001|Overall Study|Lost to Follow-up|10|||
160985522|NCT01625338|581336959|FG000|Overall Study|Enrolled but not Treated|0|||
160985523|NCT01625338|581336960|FG001|Overall Study|Enrolled but not Treated|0|||
160985524|NCT01625338|581336961|FG002|Overall Study|Enrolled but not Treated|1|||
160985525|NCT01625338|581336959|FG000|Overall Study|Efficacy Failure|27|||
160985526|NCT01625338|581336960|FG001|Overall Study|Efficacy Failure|39|||
160985527|NCT01625338|581336961|FG002|Overall Study|Efficacy Failure|31|||
160985528|NCT01625338|581336959|FG000|Overall Study|Lost to Follow-up|3|||
160985529|NCT01625338|581336960|FG001|Overall Study|Lost to Follow-up|3|||
160985530|NCT01625338|581336961|FG002|Overall Study|Lost to Follow-up|2|||
160985531|NCT01625338|581336959|FG000|Overall Study|Investigator Decision|0|||
160985532|NCT01625338|581336960|FG001|Overall Study|Investigator Decision|2|||
160985533|NCT01625338|581336961|FG002|Overall Study|Investigator Decision|1|||
160806357|NCT03369665|580679766|FG000|Overall Study|Adverse Event|3|||
160806358|NCT03369665|580679766|FG000|Overall Study|Lost to Follow-up|7|||
160806359|NCT03369665|580679766|FG000|Overall Study|Withdrawal by Subject|15|||
160806360|NCT03369665|580679766|FG000|Overall Study|Progression Disease|2|||
160806361|NCT03369665|580679766|FG000|Overall Study|Not classified|3|||
160806362|NCT03230318|580679770|FG000|Overall Study|Radiographic disease progression|72|||
160806363|NCT03230318|580679771|FG001|Overall Study|Radiographic disease progression|19|||
160806364|NCT03230318|580679770|FG000|Overall Study|Clinical progression|17|||
160806365|NCT03230318|580679771|FG001|Overall Study|Clinical progression|7|||
160806366|NCT03230318|580679770|FG000|Overall Study|Adverse Event|5|||
160806367|NCT03230318|580679771|FG001|Overall Study|Adverse Event|3|||
160806368|NCT03230318|580679770|FG000|Overall Study|Physician Decision|2|||
160806369|NCT03230318|580679771|FG001|Overall Study|Physician Decision|3|||
160806370|NCT03230318|580679770|FG000|Overall Study|Death|3|||
160806371|NCT03230318|580679771|FG001|Overall Study|Death|2|||
160806372|NCT03230318|580679770|FG000|Overall Study|Lost to Follow-up|1|||
160806373|NCT03230318|580679771|FG001|Overall Study|Lost to Follow-up|0|||
160806374|NCT03230318|580679770|FG000|Overall Study|Withdrawal by Subject|1|||
160806375|NCT03230318|580679771|FG001|Overall Study|Withdrawal by Subject|3|||
160898319|NCT02038881|581023425|FG001|Overall Study|Lost to Follow-up|0|||
160898320|NCT02038881|581023426|FG002|Overall Study|Lost to Follow-up|0|||
160898321|NCT02038881|581023424|FG000|Overall Study|incarcerated|1|||
160898322|NCT02038881|581023425|FG001|Overall Study|incarcerated|0|||
160898323|NCT02038881|581023426|FG002|Overall Study|incarcerated|0|||
160898324|NCT00333840|581023427|FG000|First-line Treatment Period|Adverse Event|38|||
160898325|NCT00333840|581023428|FG001|First-line Treatment Period|Adverse Event|37|||
160898326|NCT00333840|581023429|FG002|First-line Treatment Period|Adverse Event|0|||
160898327|NCT00333840|581023430|FG003|First-line Treatment Period|Adverse Event|0|||
160898328|NCT00333840|581023427|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
160898329|NCT00333840|581023428|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
160898330|NCT00333840|581023429|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
160898331|NCT00333840|581023430|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
160898332|NCT00333840|581023427|FG000|First-line Treatment Period|Abnormal procedure|2|||
160898333|NCT00333840|581023428|FG001|First-line Treatment Period|Abnormal procedure|0|||
160898334|NCT00333840|581023429|FG002|First-line Treatment Period|Abnormal procedure|0|||
160898335|NCT00333840|581023430|FG003|First-line Treatment Period|Abnormal procedure|0|||
160898336|NCT00333840|581023427|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
160898337|NCT00333840|581023428|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
160898338|NCT00333840|581023429|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898339|NCT00333840|581023430|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898340|NCT00333840|581023427|FG000|First-line Treatment Period|No longer required study drug|21|||
160898341|NCT00333840|581023428|FG001|First-line Treatment Period|No longer required study drug|8|||
160898342|NCT00333840|581023429|FG002|First-line Treatment Period|No longer required study drug|0|||
160898343|NCT00333840|581023430|FG003|First-line Treatment Period|No longer required study drug|0|||
160898344|NCT00333840|581023427|FG000|First-line Treatment Period|Protocol Violation|17|||
160898345|NCT00333840|581023428|FG001|First-line Treatment Period|Protocol Violation|17|||
160898346|NCT00333840|581023429|FG002|First-line Treatment Period|Protocol Violation|0|||
160898347|NCT00333840|581023430|FG003|First-line Treatment Period|Protocol Violation|0|||
160898348|NCT00333840|581023427|FG000|First-line Treatment Period|Subject withdrew consent|57|||
160898349|NCT00333840|581023428|FG001|First-line Treatment Period|Subject withdrew consent|77|||
160898350|NCT00333840|581023429|FG002|First-line Treatment Period|Subject withdrew consent|0|||
160898351|NCT00333840|581023430|FG003|First-line Treatment Period|Subject withdrew consent|0|||
160898352|NCT00333840|581023427|FG000|First-line Treatment Period|Lost to Follow-up|15|||
160898353|NCT00333840|581023428|FG001|First-line Treatment Period|Lost to Follow-up|6|||
160898354|NCT00333840|581023429|FG002|First-line Treatment Period|Lost to Follow-up|0|||
160898355|NCT00333840|581023430|FG003|First-line Treatment Period|Lost to Follow-up|0|||
160898356|NCT00333840|581023427|FG000|First-line Treatment Period|Administrative problems|12|||
160898357|NCT00333840|581023428|FG001|First-line Treatment Period|Administrative problems|6|||
160898358|NCT00333840|581023429|FG002|First-line Treatment Period|Administrative problems|0|||
160898359|NCT00333840|581023430|FG003|First-line Treatment Period|Administrative problems|0|||
160898360|NCT00333840|581023427|FG000|First-line Treatment Period|Death|19|||
160898361|NCT00333840|581023428|FG001|First-line Treatment Period|Death|2|||
160898362|NCT00333840|581023429|FG002|First-line Treatment Period|Death|0|||
160898363|NCT00333840|581023430|FG003|First-line Treatment Period|Death|0|||
160898364|NCT00333840|581023427|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
160898365|NCT00333840|581023428|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
160898366|NCT00333840|581023429|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
160898367|NCT00333840|581023430|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
160898368|NCT00333840|581023427|FG000|Second-line Treatment Period|Adverse Event|0|||
160898369|NCT00333840|581023428|FG001|Second-line Treatment Period|Adverse Event|0|||
160806376|NCT03230318|580679770|FG000|Overall Study|Other|3|||
160806377|NCT03230318|580679771|FG001|Overall Study|Other|7|||
160806378|NCT01722994|580679772|FG000|Overall Study|Missing data|25|||
160806379|NCT01722994|580679773|FG001|Overall Study|Missing data|17|||
160806380|NCT01206140|580679777|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
160806381|NCT01206140|580679778|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
160806382|NCT00075764|580679779|FG000|Overall Study|Adverse Event|5|||
160806383|NCT00075764|580679780|FG001|Overall Study|Adverse Event|12|||
160806384|NCT00075764|580679779|FG000|Overall Study|Death|4|||
160806385|NCT00075764|580679780|FG001|Overall Study|Death|8|||
160806386|NCT00075764|580679779|FG000|Overall Study|Withdrawal by Subject|28|||
160806387|NCT00075764|580679780|FG001|Overall Study|Withdrawal by Subject|18|||
160806388|NCT00075764|580679779|FG000|Overall Study|Progression|269|||
160806389|NCT00075764|580679780|FG001|Overall Study|Progression|274|||
160806390|NCT00075764|580679779|FG000|Overall Study|Still on treatment|8|||
160806391|NCT00075764|580679780|FG001|Overall Study|Still on treatment|15|||
160985534|NCT01625338|581336959|FG000|Overall Study|Subject Withdrew Consent|1|||
160985535|NCT01625338|581336960|FG001|Overall Study|Subject Withdrew Consent|0|||
160985536|NCT01625338|581336961|FG002|Overall Study|Subject Withdrew Consent|2|||
160985537|NCT01625338|581336959|FG000|Overall Study|Adverse Event|1|||
160985538|NCT01625338|581336960|FG001|Overall Study|Adverse Event|0|||
160985539|NCT01625338|581336961|FG002|Overall Study|Adverse Event|1|||
160985540|NCT01625338|581336959|FG000|Overall Study|Study Discontinued by Sponsor|0|||
160985541|NCT01625338|581336960|FG001|Overall Study|Study Discontinued by Sponsor|0|||
160985542|NCT01625338|581336961|FG002|Overall Study|Study Discontinued by Sponsor|1|||
160985543|NCT01789203|581336962|FG000|Overall Study|Adverse Event|2|||
160985544|NCT01789203|581336963|FG001|Overall Study|Adverse Event|2|||
160985545|NCT01789203|581336962|FG000|Overall Study|Withdrawal by Subject|1|||
160985546|NCT01789203|581336963|FG001|Overall Study|Withdrawal by Subject|0|||
160985547|NCT01789203|581336962|FG000|Overall Study|Death|1|||
160985548|NCT01789203|581336963|FG001|Overall Study|Death|0|||
160985549|NCT01789203|581336962|FG000|Overall Study|Protocol Violation|2|||
160985550|NCT01789203|581336963|FG001|Overall Study|Protocol Violation|1|||
160806392|NCT00075764|580679779|FG000|Overall Study|Delinquent|4|||
160806393|NCT00075764|580679780|FG001|Overall Study|Delinquent|2|||
160806394|NCT00075764|580679779|FG000|Overall Study|Not protocol specified|27|||
160985551|NCT01789203|581336962|FG000|Overall Study|Other|1|||
160806395|NCT00075764|580679780|FG001|Overall Study|Not protocol specified|19|||
161332327|NCT02643693|582603588|FG001|Overall Study|Physician Decision|1|||
160806396|NCT00075764|580679779|FG000|Overall Study|Under review|0|||
160806397|NCT00075764|580679780|FG001|Overall Study|Under review|1|||
160806398|NCT02817594|580679784|FG000|Overall Study|Withdrawal by Subject|1|||
160806399|NCT02817594|580679784|FG000|Overall Study|Other|1|||
160806400|NCT02817594|580679784|FG000|Overall Study|Did Not Receive Treatment|1|||
160806401|NCT01135459|580679785|FG000|Overall Study|Adverse Event|8|||
160806402|NCT01135459|580679786|FG001|Overall Study|Adverse Event|10|||
160806403|NCT01135459|580679785|FG000|Overall Study|Lack of Efficacy|3|||
160806404|NCT01135459|580679786|FG001|Overall Study|Lack of Efficacy|1|||
160806405|NCT01135459|580679785|FG000|Overall Study|Withdrawal by Subject|2|||
160806406|NCT01135459|580679786|FG001|Overall Study|Withdrawal by Subject|3|||
160806407|NCT01135459|580679785|FG000|Overall Study|Protocol Violation|5|||
160806408|NCT01135459|580679786|FG001|Overall Study|Protocol Violation|3|||
160806409|NCT01135459|580679785|FG000|Overall Study|Lost to Follow-up|2|||
160806410|NCT01135459|580679786|FG001|Overall Study|Lost to Follow-up|1|||
160806411|NCT01135459|580679785|FG000|Overall Study|Non-compliance to study procedures|0|||
160806412|NCT01135459|580679786|FG001|Overall Study|Non-compliance to study procedures|1|||
160806413|NCT01135459|580679785|FG000|Overall Study|Other than specified|1|||
160806414|NCT01135459|580679786|FG001|Overall Study|Other than specified|1|||
160806415|NCT01803880|580679787|FG000|Overall Study|Adverse Event|1|||
160806416|NCT01803880|580679788|FG001|Overall Study|Adverse Event|0|||
160806417|NCT01803880|580679789|FG002|Overall Study|Adverse Event|0|||
160806418|NCT01803880|580679787|FG000|Overall Study|Withdrawal by Subject|1|||
160806419|NCT01803880|580679788|FG001|Overall Study|Withdrawal by Subject|1|||
160806420|NCT01803880|580679789|FG002|Overall Study|Withdrawal by Subject|4|||
160806421|NCT01803880|580679787|FG000|Overall Study|Physician Decision|0|||
160806422|NCT01803880|580679788|FG001|Overall Study|Physician Decision|0|||
160806423|NCT01803880|580679789|FG002|Overall Study|Physician Decision|1|||
160806424|NCT01803880|580679787|FG000|Overall Study|Unable to return for follow-up visits|0|||
160806425|NCT01803880|580679788|FG001|Overall Study|Unable to return for follow-up visits|1|||
160806426|NCT01803880|580679789|FG002|Overall Study|Unable to return for follow-up visits|2|||
160806427|NCT01803880|580679787|FG000|Overall Study|Lost to Follow-up|1|||
160806428|NCT01803880|580679788|FG001|Overall Study|Lost to Follow-up|2|||
160806429|NCT01803880|580679789|FG002|Overall Study|Lost to Follow-up|3|||
160806430|NCT01803880|580679787|FG000|Overall Study|Protocol Violation|1|||
160806431|NCT01803880|580679788|FG001|Overall Study|Protocol Violation|0|||
160806432|NCT01803880|580679789|FG002|Overall Study|Protocol Violation|0|||
160806433|NCT01803880|580679787|FG000|Overall Study|Early study termination|0|||
160806434|NCT01803880|580679788|FG001|Overall Study|Early study termination|6|||
160985552|NCT01789203|581336963|FG001|Overall Study|Other|1|||
160985553|NCT01789203|581336962|FG000|Overall Study|patient non-adherent|2|||
160898370|NCT00333840|581023429|FG002|Second-line Treatment Period|Adverse Event|3|||
160898371|NCT00333840|581023430|FG003|Second-line Treatment Period|Adverse Event|34|||
160898372|NCT00333840|581023427|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
160898373|NCT00333840|581023428|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
160898374|NCT00333840|581023429|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
160898375|NCT00333840|581023430|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
160898376|NCT00333840|581023427|FG000|Second-line Treatment Period|Abnormal procedure|0|||
160898377|NCT00333840|581023428|FG001|Second-line Treatment Period|Abnormal procedure|0|||
160898378|NCT00333840|581023429|FG002|Second-line Treatment Period|Abnormal procedure|0|||
160898379|NCT00333840|581023430|FG003|Second-line Treatment Period|Abnormal procedure|1|||
160898380|NCT00333840|581023427|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898381|NCT00333840|581023428|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
160898382|NCT00333840|581023429|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
160898383|NCT00333840|581023430|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
160898384|NCT00333840|581023427|FG000|Second-line Treatment Period|No longer required study drug|0|||
160898385|NCT00333840|581023428|FG001|Second-line Treatment Period|No longer required study drug|0|||
161130569|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130570|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130571|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130572|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130573|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130574|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130575|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130576|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130577|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130578|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130579|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130580|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130581|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130582|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130583|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
161130584|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161130585|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
161130586|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161130587|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
161130588|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
161130589|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
161130590|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161130591|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
161130592|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130593|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130594|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130595|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130596|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130597|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130598|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130599|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130600|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130601|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130602|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130603|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130604|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130605|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130606|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
161130607|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130608|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130609|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
161130610|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130611|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
161130612|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130613|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130614|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130615|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161332328|NCT02643693|582603589|FG002|Overall Study|Physician Decision|0|||
160985554|NCT01789203|581336963|FG001|Overall Study|patient non-adherent|0|||
160985555|NCT00515086|581336970|FG000|Overall Study|Adverse Event|1|||
160985556|NCT00515086|581336971|FG001|Overall Study|Adverse Event|1|||
160985557|NCT00515086|581336972|FG002|Overall Study|Adverse Event|2|||
160985558|NCT00515086|581336973|FG003|Overall Study|Adverse Event|3|||
160985559|NCT00515086|581336970|FG000|Overall Study|Administrative|1|||
160985560|NCT00515086|581336971|FG001|Overall Study|Administrative|1|||
160985561|NCT00515086|581336972|FG002|Overall Study|Administrative|0|||
160985562|NCT00515086|581336973|FG003|Overall Study|Administrative|0|||
160985563|NCT00515086|581336970|FG000|Overall Study|Withdrawal by Subject|1|||
160985564|NCT00515086|581336971|FG001|Overall Study|Withdrawal by Subject|0|||
160985565|NCT00515086|581336972|FG002|Overall Study|Withdrawal by Subject|0|||
160985566|NCT00515086|581336973|FG003|Overall Study|Withdrawal by Subject|1|||
160985567|NCT00515086|581336970|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
160985568|NCT00515086|581336971|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160985569|NCT00515086|581336972|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
160985570|NCT00515086|581336973|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
160985571|NCT00515086|581336970|FG000|Overall Study|Lost to Follow-up|1|||
160985572|NCT00515086|581336971|FG001|Overall Study|Lost to Follow-up|0|||
160985573|NCT00515086|581336972|FG002|Overall Study|Lost to Follow-up|0|||
160985574|NCT00515086|581336973|FG003|Overall Study|Lost to Follow-up|0|||
160985575|NCT00515086|581336970|FG000|Overall Study|Study drug no longer required|0|||
160985576|NCT00515086|581336971|FG001|Overall Study|Study drug no longer required|1|||
160985577|NCT00515086|581336972|FG002|Overall Study|Study drug no longer required|0|||
160985578|NCT00515086|581336973|FG003|Overall Study|Study drug no longer required|0|||
160985579|NCT00515086|581336970|FG000|Overall Study|Death|2|||
160985580|NCT00515086|581336971|FG001|Overall Study|Death|0|||
160985581|NCT00515086|581336972|FG002|Overall Study|Death|0|||
160985582|NCT00515086|581336973|FG003|Overall Study|Death|0|||
160985583|NCT02403674|581336976|FG000|Base Study|Death|1|||
160985584|NCT02403674|581336977|FG001|Base Study|Death|4|||
160985585|NCT02403674|581336976|FG000|Base Study|Adverse Event|11|||
160985586|NCT02403674|581336977|FG001|Base Study|Adverse Event|26|||
160985587|NCT02403674|581336976|FG000|Base Study|Lack of Efficacy|31|||
160985588|NCT02403674|581336977|FG001|Base Study|Lack of Efficacy|23|||
160985589|NCT02403674|581336976|FG000|Base Study|Lost to Follow-up|6|||
160985590|NCT02403674|581336977|FG001|Base Study|Lost to Follow-up|8|||
160985591|NCT02403674|581336976|FG000|Base Study|Withdrawal by Subject|10|||
160985592|NCT02403674|581336977|FG001|Base Study|Withdrawal by Subject|17|||
160985593|NCT02403674|581336976|FG000|Base Study|Physician Decision|2|||
160985594|NCT02403674|581336977|FG001|Base Study|Physician Decision|2|||
160985595|NCT02403674|581336976|FG000|Base Study|Pregnancy|2|||
160985596|NCT02403674|581336977|FG001|Base Study|Pregnancy|2|||
160985597|NCT02403674|581336976|FG000|Base Study|Protocol Violation|8|||
160985598|NCT02403674|581336977|FG001|Base Study|Protocol Violation|4|||
160806435|NCT01803880|580679789|FG002|Overall Study|Early study termination|5|||
160806436|NCT01803880|580679787|FG000|Overall Study|Incomplete data entry by sites|2|||
160806437|NCT01803880|580679788|FG001|Overall Study|Incomplete data entry by sites|0|||
160806438|NCT01803880|580679789|FG002|Overall Study|Incomplete data entry by sites|0|||
160806439|NCT04158375|580679796|FG000|Overall Study|Withdrawal by Subject|0|||
160806440|NCT04158375|580679797|FG001|Overall Study|Withdrawal by Subject|3|||
160806441|NCT04158375|580679798|FG002|Overall Study|Withdrawal by Subject|0|||
160806442|NCT04847843|580679799|FG000|Overall Study|Scheduling Conflicts|6|||
160806443|NCT04847843|580679800|FG001|Overall Study|Scheduling Conflicts|9|||
160806444|NCT04847843|580679799|FG000|Overall Study|Withdrawal by Subject|1|||
160806445|NCT04847843|580679800|FG001|Overall Study|Withdrawal by Subject|0|||
160806446|NCT04847843|580679799|FG000|Overall Study|Lost to Follow-up|1|||
160806447|NCT04847843|580679800|FG001|Overall Study|Lost to Follow-up|1|||
160806448|NCT04847843|580679799|FG000|Overall Study|Pregnancy|0|||
160806449|NCT04847843|580679800|FG001|Overall Study|Pregnancy|2|||
160806450|NCT04847843|580679799|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
160806451|NCT04847843|580679800|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
160806452|NCT02734004|580679801|FG000|Overall Study|Death|36|||
160985599|NCT02403674|581336976|FG000|Base Study|Non-Compliance with study drug|1|||
160985600|NCT02403674|581336977|FG001|Base Study|Non-Compliance with study drug|4|||
160985601|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
160985602|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
160985603|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
160806453|NCT02734004|580679802|FG001|Overall Study|Death|24|||
160806454|NCT02734004|580679803|FG002|Overall Study|Death|26|||
160985604|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
160985605|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
160985606|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
160985607|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
160806455|NCT02734004|580679804|FG003|Overall Study|Death|35|||
160806456|NCT02734004|580679805|FG004|Overall Study|Death|13|||
160985608|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
160985609|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
160806457|NCT02734004|580679806|FG005|Overall Study|Death|17|||
160806458|NCT02734004|580679807|FG006|Overall Study|Death|20|||
160806459|NCT02734004|580679801|FG000|Overall Study|Lost to Follow-up|1|||
160806460|NCT02734004|580679802|FG001|Overall Study|Lost to Follow-up|1|||
160806461|NCT02734004|580679803|FG002|Overall Study|Lost to Follow-up|0|||
160806462|NCT02734004|580679804|FG003|Overall Study|Lost to Follow-up|0|||
160806463|NCT02734004|580679805|FG004|Overall Study|Lost to Follow-up|1|||
160806464|NCT02734004|580679806|FG005|Overall Study|Lost to Follow-up|0|||
160806465|NCT02734004|580679807|FG006|Overall Study|Lost to Follow-up|0|||
160806466|NCT02734004|580679801|FG000|Overall Study|Withdrawal by Subject|3|||
160806467|NCT02734004|580679802|FG001|Overall Study|Withdrawal by Subject|1|||
160806468|NCT02734004|580679803|FG002|Overall Study|Withdrawal by Subject|1|||
160985610|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
160985611|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
160985612|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
160985613|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Death|1|||
160985614|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Death|0|||
160985615|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
160985616|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
160985617|NCT02403674|581336976|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
160985618|NCT02403674|581336977|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
160985619|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
160985620|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
160985621|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
160985622|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
160985623|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
160985624|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
160985625|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
160985626|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
160985627|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
160985628|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
160985629|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Death|2|||
160985630|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Death|2|||
160985631|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
160985632|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
160985633|NCT02403674|581336976|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
160985634|NCT02403674|581336977|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
160985635|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
160985636|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
160985637|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
160985638|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
160985639|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
160985640|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
160985641|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
160806469|NCT02734004|580679804|FG003|Overall Study|Withdrawal by Subject|1|||
160806470|NCT02734004|580679805|FG004|Overall Study|Withdrawal by Subject|3|||
160806471|NCT02734004|580679806|FG005|Overall Study|Withdrawal by Subject|0|||
160806472|NCT02734004|580679807|FG006|Overall Study|Withdrawal by Subject|2|||
160806473|NCT02734004|580679801|FG000|Overall Study|Other|0|||
160985642|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
160985643|NCT02403674|581336976|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
160985644|NCT02403674|581336977|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
160985645|NCT03487666|581336980|FG000|Overall Study|Disease progression|4|||
160985646|NCT03487666|581336981|FG001|Overall Study|Disease progression|2|||
160985647|NCT03487666|581336982|FG002|Overall Study|Disease progression|0|||
160985648|NCT03487666|581336980|FG000|Overall Study|Adverse Event|0|||
160985649|NCT03487666|581336981|FG001|Overall Study|Adverse Event|0|||
160985650|NCT03487666|581336982|FG002|Overall Study|Adverse Event|1|||
160985651|NCT03201757|581336983|FG000|Overall Study|Withdrawal by Subject|133|||
160985652|NCT03201757|581336983|FG000|Overall Study|Adverse Event|44|||
160985653|NCT03201757|581336983|FG000|Overall Study|Lost to Follow-up|37|||
160985654|NCT03201757|581336983|FG000|Overall Study|Pregnancy|2|||
161332329|NCT02643693|582603590|FG003|Overall Study|Physician Decision|0|||
161332330|NCT02643693|582603591|FG004|Overall Study|Physician Decision|0|||
160806474|NCT02734004|580679802|FG001|Overall Study|Other|8|||
160806475|NCT02734004|580679803|FG002|Overall Study|Other|7|||
160806476|NCT02734004|580679804|FG003|Overall Study|Other|4|||
160806477|NCT02734004|580679805|FG004|Overall Study|Other|34|||
160985655|NCT03201757|581336983|FG000|Overall Study|Lack of Efficacy|1|||
160985656|NCT03201757|581336983|FG000|Overall Study|Protocol Violation|20|||
160985657|NCT03201757|581336983|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
160985658|NCT03201757|581336983|FG000|Overall Study|Not Yet Determined|5|||
160806478|NCT02734004|580679806|FG005|Overall Study|Other|14|||
160806479|NCT02734004|580679807|FG006|Overall Study|Other|10|||
161332331|NCT02643693|582603592|FG005|Overall Study|Physician Decision|0|||
160806480|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
160806481|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
160806482|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
160806483|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
160806484|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
160806485|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
160806486|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
160806487|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
160806488|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
160806489|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
160806490|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
160806491|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
160806492|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
160806493|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
160806494|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
160806495|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
160806496|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
160806497|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
160806498|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
160806499|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
160806500|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
160806501|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
160806502|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
160806503|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
161130616|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130617|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130618|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130619|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130620|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130621|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130622|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130623|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130624|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130625|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130626|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130627|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130628|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130629|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
161130630|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
161130631|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130632|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130633|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
161130634|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130635|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130636|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130637|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130638|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130639|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130640|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130641|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130642|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130643|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130644|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130645|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130646|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130647|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130648|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130649|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130650|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130651|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130652|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
161130653|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130654|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160806504|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Other|6|||
160806505|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Other|0|||
160806506|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Other|0|||
160806507|NCT05615220|580679808|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
160806508|NCT05615220|580679809|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
160806509|NCT05615220|580679810|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
160806510|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
160806511|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
160806512|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
160806513|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
160806514|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
160806515|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
160806516|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
160806517|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
160806518|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
160806519|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
160806520|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
160806521|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
160806522|NCT05615220|580679808|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
160806523|NCT05615220|580679809|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
160806524|NCT05615220|580679810|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
160806525|NCT01459666|580679811|FG000|Overall Study|PI left institution|5|||
160806526|NCT01459666|580679812|FG001|Overall Study|PI left institution|4|||
160806527|NCT01061385|580679813|FG000|Overall Study|Lost to Follow-up|1|||
160985659|NCT03201757|581336983|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
160985660|NCT03201757|581336983|FG000|Overall Study|Other|20|||
160985661|NCT01254305|581336987|FG000|Overall Study|Adverse Event|6|||
160985662|NCT01254305|581336988|FG001|Overall Study|Adverse Event|3|||
160985663|NCT01254305|581336989|FG002|Overall Study|Adverse Event|2|||
160985664|NCT01254305|581336987|FG000|Overall Study|Lack of Efficacy|1|||
160985665|NCT01254305|581336988|FG001|Overall Study|Lack of Efficacy|0|||
160985666|NCT01254305|581336989|FG002|Overall Study|Lack of Efficacy|1|||
160985667|NCT01254305|581336987|FG000|Overall Study|Protocol Violation|1|||
160985668|NCT01254305|581336988|FG001|Overall Study|Protocol Violation|7|||
160985669|NCT01254305|581336989|FG002|Overall Study|Protocol Violation|3|||
160985670|NCT01254305|581336987|FG000|Overall Study|Withdrawal by Subject|4|||
160985671|NCT01254305|581336988|FG001|Overall Study|Withdrawal by Subject|2|||
160985672|NCT01254305|581336989|FG002|Overall Study|Withdrawal by Subject|4|||
160985673|NCT01254305|581336987|FG000|Overall Study|Lost to Follow-up|10|||
160985674|NCT01254305|581336988|FG001|Overall Study|Lost to Follow-up|6|||
160985675|NCT01254305|581336989|FG002|Overall Study|Lost to Follow-up|5|||
160985676|NCT01254305|581336987|FG000|Overall Study|Other Reasons|0|||
160985677|NCT01254305|581336988|FG001|Overall Study|Other Reasons|0|||
160985678|NCT01254305|581336989|FG002|Overall Study|Other Reasons|2|||
160985679|NCT03930186|581336990|FG000|Weeks 0 to 16|Adverse Event|6|||
160985680|NCT03930186|581336990|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
160985681|NCT03930186|581336990|FG000|Weeks 16 to 32|Adverse Event|1|||
160985682|NCT03930186|581336990|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
160985683|NCT00557505|581336993|FG000|Overall Study|Death|0|||
160985684|NCT00557505|581336994|FG001|Overall Study|Death|0|||
160985685|NCT00557505|581336995|FG002|Overall Study|Death|0|||
160985686|NCT00557505|581336996|FG003|Overall Study|Death|0|||
160985687|NCT00557505|581336997|FG004|Overall Study|Death|0|||
160985688|NCT00557505|581336998|FG005|Overall Study|Death|0|||
160985689|NCT00557505|581336999|FG006|Overall Study|Death|0|||
160985690|NCT00557505|581337000|FG007|Overall Study|Death|0|||
160985691|NCT00557505|581337001|FG008|Overall Study|Death|1|||
160985692|NCT00557505|581336993|FG000|Overall Study|Adverse Event|0|||
160985693|NCT00557505|581336994|FG001|Overall Study|Adverse Event|0|||
160985694|NCT00557505|581336995|FG002|Overall Study|Adverse Event|1|||
160985695|NCT00557505|581336996|FG003|Overall Study|Adverse Event|0|||
160985696|NCT00557505|581336997|FG004|Overall Study|Adverse Event|0|||
161130655|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
161130656|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160985697|NCT00557505|581336998|FG005|Overall Study|Adverse Event|0|||
160985698|NCT00557505|581336999|FG006|Overall Study|Adverse Event|1|||
161130657|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130658|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160985699|NCT00557505|581337000|FG007|Overall Study|Adverse Event|0|||
160985700|NCT00557505|581337001|FG008|Overall Study|Adverse Event|0|||
160985701|NCT00557505|581336993|FG000|Overall Study|Global deterioration of health|1|||
160985702|NCT00557505|581336994|FG001|Overall Study|Global deterioration of health|0|||
160985703|NCT00557505|581336995|FG002|Overall Study|Global deterioration of health|0|||
160985704|NCT00557505|581336996|FG003|Overall Study|Global deterioration of health|0|||
160806528|NCT01061385|580679814|FG001|Overall Study|Lost to Follow-up|0|||
160806529|NCT01061385|580679813|FG000|Overall Study|subject decision not related to AE|0|||
160806530|NCT01061385|580679814|FG001|Overall Study|subject decision not related to AE|1|||
160806531|NCT00533429|580679816|FG000|Overall Study|Adverse Event|3|||
160806532|NCT00533429|580679817|FG001|Overall Study|Adverse Event|1|||
160806533|NCT00533429|580679816|FG000|Overall Study|Death|1|||
160806534|NCT00533429|580679817|FG001|Overall Study|Death|0|||
160806535|NCT00533429|580679816|FG000|Overall Study|Withdrawal by Subject|2|||
160806536|NCT00533429|580679817|FG001|Overall Study|Withdrawal by Subject|0|||
160806537|NCT00533429|580679816|FG000|Overall Study|Progressive Disease|12|||
160806538|NCT00533429|580679817|FG001|Overall Study|Progressive Disease|13|||
160806539|NCT00533429|580679816|FG000|Overall Study|Symptomatic deterioration|1|||
160806540|NCT00533429|580679817|FG001|Overall Study|Symptomatic deterioration|2|||
160806541|NCT02655887|580679818|FG000|Overall Study|Lost to Follow-up|3|||
160806542|NCT02655887|580679818|FG000|Overall Study|Death|4|||
160806543|NCT02655887|580679818|FG000|Overall Study|Withdrawal by Subject|3|||
160806544|NCT02655887|580679818|FG000|Overall Study|Missed 12-month follow-up visit|4|||
160806545|NCT04245709|580679821|FG000|Overall Study|Adverse Event|13|||
160806546|NCT04245709|580679821|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
160806547|NCT02389465|580679825|FG000|Overall Study|Lost to Follow-up|1|||
160806548|NCT02389465|580679826|FG001|Overall Study|Lost to Follow-up|3|||
160806549|NCT02389465|580679827|FG002|Overall Study|Lost to Follow-up|3|||
160806550|NCT02389465|580679828|FG003|Overall Study|Lost to Follow-up|0|||
160806551|NCT02389465|580679825|FG000|Overall Study|Physician Decision|0|||
160806552|NCT02389465|580679826|FG001|Overall Study|Physician Decision|0|||
160806553|NCT02389465|580679827|FG002|Overall Study|Physician Decision|0|||
160806554|NCT02389465|580679828|FG003|Overall Study|Physician Decision|1|||
160806555|NCT02389465|580679825|FG000|Overall Study|Withdrawal by Subject|0|||
160806556|NCT02389465|580679826|FG001|Overall Study|Withdrawal by Subject|1|||
160806557|NCT02389465|580679827|FG002|Overall Study|Withdrawal by Subject|2|||
160806558|NCT02389465|580679828|FG003|Overall Study|Withdrawal by Subject|2|||
160806559|NCT04721158|580679833|FG000|Overall Study|Lost to Follow-up|4|||
160806560|NCT04721158|580679833|FG000|Overall Study|Device did not connect|1|||
160806561|NCT02382991|580679839|FG000|Overall Study|Adverse Event|1|||
160806562|NCT02382991|580679840|FG001|Overall Study|Adverse Event|2|||
160806563|NCT02382991|580679839|FG000|Overall Study|Lost to Follow-up|1|||
160806564|NCT02382991|580679840|FG001|Overall Study|Lost to Follow-up|0|||
160806565|NCT02382991|580679839|FG000|Overall Study|Withdrawal by Subject|0|||
160806566|NCT02382991|580679840|FG001|Overall Study|Withdrawal by Subject|1|||
160806567|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
160806568|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
160806569|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
160806570|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806571|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806572|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806573|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806574|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806575|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806576|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806577|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806578|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806579|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806580|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806581|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806582|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
160806583|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
160806584|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
160806585|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160898386|NCT00333840|581023429|FG002|Second-line Treatment Period|No longer required study drug|1|||
160898387|NCT00333840|581023430|FG003|Second-line Treatment Period|No longer required study drug|14|||
160898388|NCT00333840|581023427|FG000|Second-line Treatment Period|Protocol Violation|0|||
160898389|NCT00333840|581023428|FG001|Second-line Treatment Period|Protocol Violation|0|||
160898390|NCT00333840|581023429|FG002|Second-line Treatment Period|Protocol Violation|1|||
160898391|NCT00333840|581023430|FG003|Second-line Treatment Period|Protocol Violation|10|||
160898392|NCT00333840|581023427|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
160898393|NCT00333840|581023428|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
160898394|NCT00333840|581023429|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
160806586|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806587|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806588|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806589|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806590|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806591|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806592|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806593|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806594|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806595|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806596|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806597|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806598|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
160806599|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806600|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806601|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806602|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
160806603|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806604|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806605|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806606|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806607|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806608|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806609|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806610|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806611|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806612|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806613|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806614|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
160806615|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806616|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806617|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
160806618|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806619|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806620|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160985705|NCT00557505|581336997|FG004|Overall Study|Global deterioration of health|0|||
160806621|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806622|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806623|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806624|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806625|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806626|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806627|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806628|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806629|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806630|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
160806631|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806632|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806633|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806634|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
160806635|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806636|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806637|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806638|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806639|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806640|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806641|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806642|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160898395|NCT00333840|581023430|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
160898396|NCT00333840|581023427|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
160898397|NCT00333840|581023428|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
160898398|NCT00333840|581023429|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
160898399|NCT00333840|581023430|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
160898400|NCT00333840|581023427|FG000|Second-line Treatment Period|Administrative problems|0|||
160898401|NCT00333840|581023428|FG001|Second-line Treatment Period|Administrative problems|0|||
160898402|NCT00333840|581023429|FG002|Second-line Treatment Period|Administrative problems|0|||
160898403|NCT00333840|581023430|FG003|Second-line Treatment Period|Administrative problems|7|||
160898404|NCT00333840|581023427|FG000|Second-line Treatment Period|Death|0|||
160898405|NCT00333840|581023428|FG001|Second-line Treatment Period|Death|0|||
160898406|NCT00333840|581023429|FG002|Second-line Treatment Period|Death|0|||
160898407|NCT00333840|581023430|FG003|Second-line Treatment Period|Death|9|||
160898408|NCT02357979|581023431|FG000|Overall Study|Lost to Follow-up|5|||
160806643|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806644|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806645|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806646|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
160806647|NCT02891226|580679844|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806648|NCT02891226|580679845|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160898409|NCT02357979|581023432|FG001|Overall Study|Lost to Follow-up|5|||
160985706|NCT00557505|581336998|FG005|Overall Study|Global deterioration of health|0|||
160985707|NCT00557505|581336999|FG006|Overall Study|Global deterioration of health|0|||
160985708|NCT00557505|581337000|FG007|Overall Study|Global deterioration of health|0|||
160985709|NCT00557505|581337001|FG008|Overall Study|Global deterioration of health|0|||
160985710|NCT00557505|581336993|FG000|Overall Study|Objective progression or relapse|2|||
160985711|NCT00557505|581336994|FG001|Overall Study|Objective progression or relapse|3|||
160985712|NCT00557505|581336995|FG002|Overall Study|Objective progression or relapse|3|||
160985713|NCT00557505|581336996|FG003|Overall Study|Objective progression or relapse|2|||
160985714|NCT00557505|581336997|FG004|Overall Study|Objective progression or relapse|2|||
160985715|NCT00557505|581336998|FG005|Overall Study|Objective progression or relapse|3|||
160985716|NCT00557505|581336999|FG006|Overall Study|Objective progression or relapse|2|||
160985717|NCT00557505|581337000|FG007|Overall Study|Objective progression or relapse|5|||
160985718|NCT00557505|581337001|FG008|Overall Study|Objective progression or relapse|15|||
160985719|NCT00557505|581336993|FG000|Overall Study|Withdrawal by Subject|0|||
160985720|NCT00557505|581336994|FG001|Overall Study|Withdrawal by Subject|0|||
160985721|NCT00557505|581336995|FG002|Overall Study|Withdrawal by Subject|0|||
160985722|NCT00557505|581336996|FG003|Overall Study|Withdrawal by Subject|1|||
160985723|NCT00557505|581336997|FG004|Overall Study|Withdrawal by Subject|0|||
160985724|NCT00557505|581336998|FG005|Overall Study|Withdrawal by Subject|0|||
160985725|NCT00557505|581336999|FG006|Overall Study|Withdrawal by Subject|0|||
160985726|NCT00557505|581337000|FG007|Overall Study|Withdrawal by Subject|0|||
161332332|NCT02643693|582603587|FG000|Overall Study|Withdrawal by Subject|0|||
161332333|NCT02643693|582603588|FG001|Overall Study|Withdrawal by Subject|1|||
161332334|NCT02643693|582603589|FG002|Overall Study|Withdrawal by Subject|0|||
161332335|NCT02643693|582603590|FG003|Overall Study|Withdrawal by Subject|0|||
161332336|NCT02643693|582603591|FG004|Overall Study|Withdrawal by Subject|0|||
161332337|NCT02643693|582603592|FG005|Overall Study|Withdrawal by Subject|0|||
160985727|NCT00557505|581337001|FG008|Overall Study|Withdrawal by Subject|1|||
160985728|NCT03019458|581337002|FG000|Overall Study|Death|0|||
160985729|NCT03019458|581337003|FG001|Overall Study|Death|1|||
160985730|NCT00031447|581337004|FG000|Overall Study|Lost to Follow-up|0|||
160985731|NCT00031447|581337005|FG001|Overall Study|Lost to Follow-up|1|||
160985732|NCT00031447|581337004|FG000|Overall Study|Non-compliant|1|||
160985733|NCT00031447|581337005|FG001|Overall Study|Non-compliant|1|||
160985734|NCT00031447|581337004|FG000|Overall Study|Re-activation of Disease|2|||
160985735|NCT00031447|581337005|FG001|Overall Study|Re-activation of Disease|1|||
160985736|NCT00031447|581337004|FG000|Overall Study|Disruption of blinded study drug supply|7|||
160985737|NCT00031447|581337005|FG001|Overall Study|Disruption of blinded study drug supply|4|||
160985738|NCT01636362|581337009|FG000|Overall Study|Physician Decision|6|||
160985739|NCT01636362|581337009|FG000|Overall Study|Subject healed, not returning|1|||
160985740|NCT01636362|581337009|FG000|Overall Study|Withdrawal by Subject|1|||
160985741|NCT01244763|581337010|FG000|Overall Study|Adverse Event|1|||
160985742|NCT01244763|581337011|FG001|Overall Study|Adverse Event|0|||
160985743|NCT01244763|581337012|FG002|Overall Study|Adverse Event|0|||
160985744|NCT01244763|581337013|FG003|Overall Study|Adverse Event|0|||
160985745|NCT01244763|581337014|FG004|Overall Study|Adverse Event|0|||
160985746|NCT01244763|581337015|FG005|Overall Study|Adverse Event|1|||
160985747|NCT01244763|581337010|FG000|Overall Study|Death|1|||
160985748|NCT01244763|581337011|FG001|Overall Study|Death|0|||
160985749|NCT01244763|581337012|FG002|Overall Study|Death|1|||
161238380|NCT03697109|582253722|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
161238381|NCT04516967|582253724|FG000|Core Phase|Adverse Event|2|||
161238382|NCT04516967|582253725|FG001|Core Phase|Adverse Event|1|||
161238383|NCT04516967|582253726|FG002|Core Phase|Adverse Event|0|||
161238384|NCT04516967|582253724|FG000|Core Phase|Physician Decision|1|||
161238385|NCT04516967|582253725|FG001|Core Phase|Physician Decision|1|||
161238386|NCT04516967|582253726|FG002|Core Phase|Physician Decision|0|||
161238387|NCT04516967|582253724|FG000|Core Phase|Lack of Efficacy|7|||
161238388|NCT04516967|582253725|FG001|Core Phase|Lack of Efficacy|18|||
161238389|NCT04516967|582253726|FG002|Core Phase|Lack of Efficacy|0|||
161238390|NCT02301975|582253727|FG000|Overall Study|Adverse Event|8|||
161238391|NCT02301975|582253728|FG001|Overall Study|Adverse Event|3|||
161238392|NCT02301975|582253729|FG002|Overall Study|Adverse Event|2|||
161238393|NCT02301975|582253727|FG000|Overall Study|Lack of Efficacy|1|||
161238394|NCT02301975|582253728|FG001|Overall Study|Lack of Efficacy|1|||
161238395|NCT02301975|582253729|FG002|Overall Study|Lack of Efficacy|1|||
161238396|NCT02301975|582253727|FG000|Overall Study|Protocol Violation|3|||
161238397|NCT02301975|582253728|FG001|Overall Study|Protocol Violation|5|||
160985750|NCT01244763|581337013|FG003|Overall Study|Death|0|||
160985751|NCT01244763|581337014|FG004|Overall Study|Death|2|||
160985752|NCT01244763|581337015|FG005|Overall Study|Death|0|||
160985753|NCT01244763|581337010|FG000|Overall Study|Physician Decision|0|||
160985754|NCT01244763|581337011|FG001|Overall Study|Physician Decision|0|||
160985755|NCT01244763|581337012|FG002|Overall Study|Physician Decision|1|||
160985756|NCT01244763|581337013|FG003|Overall Study|Physician Decision|0|||
161238398|NCT02301975|582253729|FG002|Overall Study|Protocol Violation|3|||
161238399|NCT02301975|582253727|FG000|Overall Study|Lost to Follow-up|0|||
161238400|NCT02301975|582253728|FG001|Overall Study|Lost to Follow-up|2|||
161238401|NCT02301975|582253729|FG002|Overall Study|Lost to Follow-up|2|||
161238402|NCT02301975|582253727|FG000|Overall Study|Physician Decision|4|||
161238403|NCT02301975|582253728|FG001|Overall Study|Physician Decision|2|||
161238404|NCT02301975|582253729|FG002|Overall Study|Physician Decision|3|||
160985757|NCT01244763|581337014|FG004|Overall Study|Physician Decision|0|||
160985758|NCT01244763|581337015|FG005|Overall Study|Physician Decision|0|||
160985759|NCT01244763|581337010|FG000|Overall Study|Withdrawal by Subject|1|||
160985760|NCT01244763|581337011|FG001|Overall Study|Withdrawal by Subject|2|||
160985761|NCT01244763|581337012|FG002|Overall Study|Withdrawal by Subject|0|||
161238405|NCT02301975|582253727|FG000|Overall Study|Withdrawal by Subject|15|||
161238406|NCT02301975|582253728|FG001|Overall Study|Withdrawal by Subject|12|||
161238407|NCT02301975|582253729|FG002|Overall Study|Withdrawal by Subject|11|||
161238408|NCT00163657|582253730|FG000|Overall Study|Death|12|||
161238409|NCT00163657|582253731|FG001|Overall Study|Death|14|||
161238410|NCT00163657|582253732|FG002|Overall Study|Death|19|||
161238411|NCT00163657|582253730|FG000|Overall Study|graft loss|4|||
161238412|NCT00163657|582253731|FG001|Overall Study|graft loss|1|||
161238413|NCT00163657|582253732|FG002|Overall Study|graft loss|2|||
161238414|NCT00163657|582253730|FG000|Overall Study|Withdrawal by Subject|2|||
161238415|NCT00163657|582253731|FG001|Overall Study|Withdrawal by Subject|3|||
161238416|NCT00163657|582253732|FG002|Overall Study|Withdrawal by Subject|2|||
161238417|NCT00163657|582253730|FG000|Overall Study|Physician Decision|0|||
161238418|NCT00163657|582253731|FG001|Overall Study|Physician Decision|1|||
161238419|NCT00163657|582253732|FG002|Overall Study|Physician Decision|1|||
161238420|NCT00163657|582253730|FG000|Overall Study|Non Compliance|1|||
161238421|NCT00163657|582253731|FG001|Overall Study|Non Compliance|0|||
161238422|NCT00163657|582253732|FG002|Overall Study|Non Compliance|0|||
161238423|NCT00163657|582253730|FG000|Overall Study|Lost to Follow-up|1|||
161238424|NCT00163657|582253731|FG001|Overall Study|Lost to Follow-up|3|||
161238425|NCT00163657|582253732|FG002|Overall Study|Lost to Follow-up|10|||
161238426|NCT00163657|582253730|FG000|Overall Study|Other reason|0|||
161238427|NCT00163657|582253731|FG001|Overall Study|Other reason|1|||
161238428|NCT00163657|582253732|FG002|Overall Study|Other reason|3|||
161238429|NCT01531894|582253733|FG000|Overall Study|Physician Decision|8|||
161238430|NCT01531894|582253733|FG000|Overall Study|Death|1|||
161238431|NCT03635320|582253734|FG000|Overall Study|not implanted the device|1|||
161238432|NCT03635320|582253735|FG001|Overall Study|not implanted the device|2|||
161238433|NCT03635320|582253734|FG000|Overall Study|Withdrawal by Subject|11|||
161238434|NCT03635320|582253735|FG001|Overall Study|Withdrawal by Subject|6|||
161238435|NCT01558635|582253736|FG000|Overall Study|Death|1|||
161238436|NCT01558635|582253736|FG000|Overall Study|Withdrawal by Subject|2|||
161238437|NCT01558635|582253736|FG000|Overall Study|Physician Decision|1|||
161238438|NCT01558635|582253736|FG000|Overall Study|Subject received other treatment|1|||
161238439|NCT01558635|582253736|FG000|Overall Study|Reveal XT was explanted|1|||
161238440|NCT03049748|582253737|FG000|Overall Study|Lost to Follow-up|1|||
161238441|NCT03049748|582253738|FG001|Overall Study|Lost to Follow-up|0|||
161238442|NCT03049748|582253737|FG000|Overall Study|Death|3|||
161238443|NCT03049748|582253738|FG001|Overall Study|Death|0|||
161238444|NCT03049748|582253737|FG000|Overall Study|Withdrawal by Subject|0|||
161238445|NCT03049748|582253738|FG001|Overall Study|Withdrawal by Subject|3|||
161238446|NCT03049748|582253737|FG000|Overall Study|Protocol Violation|0|||
161238447|NCT03049748|582253738|FG001|Overall Study|Protocol Violation|2|||
161238448|NCT03049748|582253737|FG000|Overall Study|Moved out of state (relocation)|0|||
161238449|NCT03049748|582253738|FG001|Overall Study|Moved out of state (relocation)|1|||
161238450|NCT01735994|582253739|FG000|Overall Study|Withdrawal by Subject|6|||
161238451|NCT01735994|582253740|FG001|Overall Study|Withdrawal by Subject|4|||
161238452|NCT01735994|582253739|FG000|Overall Study|Injury|2|||
161238453|NCT01735994|582253740|FG001|Overall Study|Injury|0|||
161238454|NCT01735994|582253739|FG000|Overall Study|Kicked off team|5|||
161238455|NCT01735994|582253740|FG001|Overall Study|Kicked off team|0|||
161238456|NCT01735994|582253739|FG000|Overall Study|Lost to Follow-up|50|||
161238457|NCT01735994|582253740|FG001|Overall Study|Lost to Follow-up|62|||
161238458|NCT01158118|582253741|FG000|Overall Study|Screen failure|1|||
161238459|NCT01158118|582253742|FG001|Overall Study|Screen failure|0|||
161238460|NCT01158118|582253741|FG000|Overall Study|Donor match was a screen failure|0|||
161238461|NCT01158118|582253742|FG001|Overall Study|Donor match was a screen failure|1|||
160985762|NCT01244763|581337013|FG003|Overall Study|Withdrawal by Subject|1|||
161238462|NCT01158118|582253741|FG000|Overall Study|Suffered stroke prior to transplant|0|||
161238463|NCT01158118|582253742|FG001|Overall Study|Suffered stroke prior to transplant|1|||
161238464|NCT01158118|582253741|FG000|Overall Study|Death|0|||
161238465|NCT01158118|582253742|FG001|Overall Study|Death|1|||
161238466|NCT04994535|582253743|FG000|Overall Study|Lost to Follow-up|7|||
161238467|NCT04994535|582253744|FG001|Overall Study|Lost to Follow-up|7|||
161238468|NCT04994535|582253743|FG000|Overall Study|Withdrawal by Subject|10|||
161238469|NCT04994535|582253744|FG001|Overall Study|Withdrawal by Subject|7|||
161238470|NCT04994535|582253743|FG000|Overall Study|Other|1|||
161238471|NCT04994535|582253744|FG001|Overall Study|Other|1|||
161238472|NCT00604162|582253745|FG000|Overall Study|Physician Decision|3|||
161238473|NCT00604162|582253745|FG000|Overall Study|Withdrawal by Subject|1|||
161238474|NCT00960297|582253757|FG000|Overall Study|Physician Decision|1|||
160806649|NCT02891226|580679846|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806650|NCT02891226|580679847|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
160806651|NCT02891226|580679848|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806652|NCT02891226|580679849|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806653|NCT02891226|580679850|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806654|NCT02891226|580679851|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806655|NCT02891226|580679852|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806656|NCT02891226|580679853|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806657|NCT02891226|580679854|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806658|NCT02891226|580679855|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806659|NCT02891226|580679856|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806660|NCT02891226|580679857|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806661|NCT02891226|580679858|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806662|NCT02891226|580679859|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
160806663|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806664|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806665|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806666|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806667|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806668|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806669|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
160806670|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
160806671|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
160806672|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
160806673|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806674|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806675|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806676|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806677|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806678|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
160806679|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806680|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806681|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806682|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806683|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806684|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
160806685|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806686|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806687|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806688|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
160806689|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806690|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806691|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806692|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806693|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806694|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
160806695|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806696|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806697|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806698|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806699|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806700|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806701|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
160806702|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
160806703|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
160806704|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
160806705|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806706|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806707|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806708|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806709|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806710|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
160806711|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806712|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806713|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806714|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806715|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
160806716|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806717|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806718|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160985763|NCT01244763|581337014|FG004|Overall Study|Withdrawal by Subject|1|||
160806719|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806720|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806721|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806722|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806723|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806724|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806725|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806726|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
160806727|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806728|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806729|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806730|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806731|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806732|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806733|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
160806734|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806735|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806736|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806737|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806738|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806739|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806740|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806741|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806742|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
160806743|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806744|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806745|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806746|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806747|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806748|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806749|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806750|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
160806751|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
160806752|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
160806753|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806754|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160985764|NCT01244763|581337015|FG005|Overall Study|Withdrawal by Subject|2|||
161130659|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160806755|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806756|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806757|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806758|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
160806759|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806760|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806761|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806762|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806763|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806764|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806765|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806766|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
160806767|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806768|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806769|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806770|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806771|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806772|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806773|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806774|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
160806775|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806776|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806777|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806778|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
161130660|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130661|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130662|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160806779|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806780|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806781|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806782|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806783|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
160806784|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806785|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806786|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806787|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806788|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806789|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806790|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
160806791|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806792|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806793|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806794|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806795|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806796|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806797|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806798|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806799|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806800|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
160806801|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806802|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806803|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806804|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806805|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806806|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
160806807|NCT02891226|580679844|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806808|NCT02891226|580679845|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806809|NCT02891226|580679846|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806810|NCT02891226|580679847|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806811|NCT02891226|580679848|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806812|NCT02891226|580679849|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806813|NCT02891226|580679850|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806814|NCT02891226|580679851|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806815|NCT02891226|580679852|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806816|NCT02891226|580679853|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
160806817|NCT02891226|580679854|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806818|NCT02891226|580679855|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806819|NCT02891226|580679856|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806820|NCT02891226|580679857|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806821|NCT02891226|580679858|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806822|NCT02891226|580679859|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
160806823|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806824|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806825|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806826|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806827|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806828|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806829|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806830|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806831|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806832|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
161130663|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161332338|NCT02643693|582603587|FG000|Overall Study|Protocol Adherence Issues|2|||
160806833|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
160806834|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806835|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806836|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160898410|NCT01453725|581023433|FG000|Overall Study|Adverse Event|3|||
160898411|NCT01453725|581023434|FG001|Overall Study|Adverse Event|3|||
160898412|NCT01453725|581023433|FG000|Overall Study|Lost to Follow-up|4|||
160898413|NCT01453725|581023434|FG001|Overall Study|Lost to Follow-up|0|||
160806837|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806838|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
160806839|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806840|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806841|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806842|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806843|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806844|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806845|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806846|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806847|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806848|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806849|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
160806850|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806851|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806852|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806853|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806854|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
160806855|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806856|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806857|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806858|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806859|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806860|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806861|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806862|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806863|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806864|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806865|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
160806866|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806867|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806868|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806869|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806870|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
160806871|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806872|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806873|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806874|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806875|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806876|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806877|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806878|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160898414|NCT01453725|581023433|FG000|Overall Study|Non-compliance With Protocol|1|||
160898415|NCT01453725|581023434|FG001|Overall Study|Non-compliance With Protocol|2|||
160806879|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160898416|NCT01453725|581023433|FG000|Overall Study|Protocol Violation|1|||
160898417|NCT01453725|581023434|FG001|Overall Study|Protocol Violation|0|||
160898418|NCT01453725|581023433|FG000|Overall Study|Withdrawal by Subject|2|||
160898419|NCT01453725|581023434|FG001|Overall Study|Withdrawal by Subject|3|||
160898420|NCT01453725|581023433|FG000|Overall Study|Pregnancy Wish|0|||
160898421|NCT01453725|581023434|FG001|Overall Study|Pregnancy Wish|2|||
160898422|NCT01453725|581023433|FG000|Overall Study|Pregnancy|1|||
160898423|NCT01453725|581023434|FG001|Overall Study|Pregnancy|0|||
160898424|NCT01453725|581023433|FG000|Overall Study|Physician Decision|1|||
160898425|NCT01453725|581023434|FG001|Overall Study|Physician Decision|1|||
160898426|NCT03449901|581023438|FG000|Overall Study|Progression|57|||
160898427|NCT03449901|581023439|FG001|Overall Study|Progression|12|||
160898428|NCT03449901|581023438|FG000|Overall Study|Adverse Event|3|||
161130664|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130665|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130666|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130667|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130668|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130669|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161332339|NCT02643693|582603588|FG001|Overall Study|Protocol Adherence Issues|0|||
160806880|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806881|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
160806882|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806883|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160898429|NCT03449901|581023439|FG001|Overall Study|Adverse Event|0|||
160898430|NCT03449901|581023438|FG000|Overall Study|Death|6|||
160898431|NCT03449901|581023439|FG001|Overall Study|Death|2|||
160806884|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806885|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806886|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
160806887|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806888|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806889|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806890|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806891|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806892|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806893|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806894|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806895|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806896|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160898432|NCT03449901|581023438|FG000|Overall Study|Withdrawal by Subject|12|||
160898433|NCT03449901|581023439|FG001|Overall Study|Withdrawal by Subject|1|||
160898434|NCT03449901|581023438|FG000|Overall Study|Physician Decision|1|||
160898435|NCT03449901|581023439|FG001|Overall Study|Physician Decision|0|||
160898436|NCT03449901|581023438|FG000|Overall Study|Patient elected for surgical intervention|1|||
160898437|NCT03449901|581023439|FG001|Overall Study|Patient elected for surgical intervention|0|||
160898438|NCT03449901|581023438|FG000|Overall Study|Patient off for other complicating disease|1|||
160898439|NCT03449901|581023439|FG001|Overall Study|Patient off for other complicating disease|0|||
160898440|NCT03150173|581023440|FG000|Overall Study|Lost to Follow-up|13|||
160898441|NCT03150173|581023441|FG001|Overall Study|Lost to Follow-up|5|||
160898442|NCT03605212|581023447|FG000|Treatment Period|Adverse Event|1|||
160898443|NCT03605212|581023448|FG001|Treatment Period|Adverse Event|0|||
160898444|NCT03605212|581023449|FG002|Treatment Period|Adverse Event|0|||
160898445|NCT03605212|581023450|FG003|Treatment Period|Adverse Event|0|||
160898446|NCT03605212|581023451|FG004|Treatment Period|Adverse Event|0|||
160898447|NCT03605212|581023447|FG000|Treatment Period|Physician Decision|0|||
160898448|NCT03605212|581023448|FG001|Treatment Period|Physician Decision|0|||
160898449|NCT03605212|581023449|FG002|Treatment Period|Physician Decision|0|||
160898450|NCT03605212|581023450|FG003|Treatment Period|Physician Decision|0|||
160898451|NCT03605212|581023451|FG004|Treatment Period|Physician Decision|1|||
160898452|NCT01756053|581023452|FG000|Period 1 (10 Days)|Protocol Violation|1|||
160898453|NCT01756053|581023453|FG001|Period 1 (10 Days)|Protocol Violation|1|||
160898454|NCT01756053|581023452|FG000|Period 2 (10 Days)|Protocol Violation|0|||
160898455|NCT01756053|581023453|FG001|Period 2 (10 Days)|Protocol Violation|2|||
160898456|NCT01254292|581023454|FG000|Comparative Phase|Adverse Event|25|||
160898457|NCT01254292|581023455|FG001|Comparative Phase|Adverse Event|25|||
160898458|NCT01254292|581023454|FG000|Comparative Phase|Lost to Follow-up|3|||
160898459|NCT01254292|581023455|FG001|Comparative Phase|Lost to Follow-up|21|||
160898460|NCT01254292|581023454|FG000|Comparative Phase|Pregnancy|2|||
160898461|NCT01254292|581023455|FG001|Comparative Phase|Pregnancy|6|||
160898462|NCT01254292|581023454|FG000|Comparative Phase|Withdrawal by Subject|20|||
160898463|NCT01254292|581023455|FG001|Comparative Phase|Withdrawal by Subject|21|||
160898464|NCT01254292|581023454|FG000|Comparative Phase|Protocol Violation|1|||
160898465|NCT01254292|581023455|FG001|Comparative Phase|Protocol Violation|2|||
160898466|NCT01254292|581023454|FG000|Comparative Phase|Wish for pregnancy|4|||
160898467|NCT01254292|581023455|FG001|Comparative Phase|Wish for pregnancy|6|||
160898468|NCT01254292|581023454|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
160898469|NCT01254292|581023455|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
160898470|NCT01254292|581023454|FG000|LCS12 Extension Phase|Adverse Event|9|||
160898471|NCT01254292|581023455|FG001|LCS12 Extension Phase|Adverse Event|0|||
160898472|NCT01254292|581023454|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
160898473|NCT01254292|581023455|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
160985765|NCT01244763|581337010|FG000|Overall Study|Lost to Follow-up|0|||
160985766|NCT01244763|581337011|FG001|Overall Study|Lost to Follow-up|1|||
160985767|NCT01244763|581337012|FG002|Overall Study|Lost to Follow-up|0|||
160985768|NCT01244763|581337013|FG003|Overall Study|Lost to Follow-up|0|||
160898474|NCT01254292|581023454|FG000|LCS12 Extension Phase|Other unknown|4|||
160898475|NCT01254292|581023455|FG001|LCS12 Extension Phase|Other unknown|0|||
160898476|NCT01254292|581023454|FG000|LCS12 Extension Phase|Pregnancy|2|||
160898477|NCT01254292|581023455|FG001|LCS12 Extension Phase|Pregnancy|0|||
160898478|NCT01254292|581023454|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
160898479|NCT01254292|581023455|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
160898480|NCT00285818|581023456|FG000|Overall Study|Withdrawal by Subject|3|||
160898481|NCT00285818|581023457|FG001|Overall Study|Withdrawal by Subject|2|||
160898482|NCT00285818|581023456|FG000|Overall Study|Lost to Follow-up|1|||
160898483|NCT00285818|581023457|FG001|Overall Study|Lost to Follow-up|0|||
160898484|NCT01268150|581023463|FG000|Treatment Phase|Progression of disease|18|||
161130670|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160806897|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
160806898|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806899|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806900|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806901|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806902|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
160806903|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806904|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806905|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806906|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806907|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806908|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806909|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806910|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806911|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806912|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806913|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
160806914|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806915|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806916|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806917|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806918|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
160806919|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806920|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806921|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806922|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806923|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806924|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806925|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806926|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806927|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806928|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806929|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
160806930|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806931|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806932|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806933|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806934|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
160806935|NCT02891226|580679844|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806936|NCT02891226|580679845|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806937|NCT02891226|580679846|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806938|NCT02891226|580679847|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806939|NCT02891226|580679848|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806940|NCT02891226|580679849|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806941|NCT02891226|580679850|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806942|NCT02891226|580679851|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806943|NCT02891226|580679852|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806944|NCT02891226|580679853|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806945|NCT02891226|580679854|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
160806946|NCT02891226|580679855|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160898485|NCT01268150|581023463|FG000|Treatment Phase|Adverse Event|3|||
160898486|NCT01268150|581023463|FG000|Treatment Phase|Withdrawal by Subject|3|||
160898487|NCT01268150|581023463|FG000|Treatment Phase|Other|4|||
160898488|NCT01268150|581023463|FG000|Extension Phase|Adverse Event|3|||
160898489|NCT01268150|581023463|FG000|Extension Phase|Disease progression|18|||
160898490|NCT01268150|581023463|FG000|Extension Phase|Other|6|||
160898491|NCT01672736|581023465|FG000|Overall Study|Available drug expired on 31 May 16|3|||
160898492|NCT02913612|581023466|FG000|Overall Study|Lost to Follow-up|6|||
160898493|NCT02913612|581023467|FG001|Overall Study|Lost to Follow-up|5|||
160898494|NCT02913612|581023468|FG002|Overall Study|Lost to Follow-up|2|||
160898495|NCT02913612|581023469|FG003|Overall Study|Lost to Follow-up|0|||
160898496|NCT02913612|581023466|FG000|Overall Study|Physician Decision|1|||
160898497|NCT02913612|581023467|FG001|Overall Study|Physician Decision|4|||
161130671|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130672|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161332340|NCT02643693|582603589|FG002|Overall Study|Protocol Adherence Issues|1|||
161332341|NCT02643693|582603590|FG003|Overall Study|Protocol Adherence Issues|0|||
160806947|NCT02891226|580679856|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806948|NCT02891226|580679857|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806949|NCT02891226|580679858|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806950|NCT02891226|580679859|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
160806951|NCT02891226|580679844|FG000|Follow-up Period|Withdrawal by Subject|0|||
160806952|NCT02891226|580679845|FG001|Follow-up Period|Withdrawal by Subject|0|||
161130673|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130674|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
160806953|NCT02891226|580679846|FG002|Follow-up Period|Withdrawal by Subject|0|||
160806954|NCT02891226|580679847|FG003|Follow-up Period|Withdrawal by Subject|0|||
160806955|NCT02891226|580679848|FG004|Follow-up Period|Withdrawal by Subject|0|||
160806956|NCT02891226|580679849|FG005|Follow-up Period|Withdrawal by Subject|0|||
160806957|NCT02891226|580679850|FG006|Follow-up Period|Withdrawal by Subject|0|||
160806958|NCT02891226|580679851|FG007|Follow-up Period|Withdrawal by Subject|0|||
160806959|NCT02891226|580679852|FG008|Follow-up Period|Withdrawal by Subject|0|||
160806960|NCT02891226|580679853|FG009|Follow-up Period|Withdrawal by Subject|0|||
160806961|NCT02891226|580679854|FG010|Follow-up Period|Withdrawal by Subject|0|||
160806962|NCT02891226|580679855|FG011|Follow-up Period|Withdrawal by Subject|1|||
160806963|NCT02891226|580679856|FG012|Follow-up Period|Withdrawal by Subject|0|||
160806964|NCT02891226|580679857|FG013|Follow-up Period|Withdrawal by Subject|0|||
160806965|NCT02891226|580679858|FG014|Follow-up Period|Withdrawal by Subject|1|||
160806966|NCT02891226|580679859|FG015|Follow-up Period|Withdrawal by Subject|1|||
160806967|NCT01445847|580679862|FG000|Overall Study|Protocol Violation|13|||
160806968|NCT01445847|580679863|FG001|Overall Study|Protocol Violation|14|||
160806969|NCT01445847|580679862|FG000|Overall Study|Missed Data|1|||
160806970|NCT01445847|580679863|FG001|Overall Study|Missed Data|0|||
160806971|NCT03654274|580679866|FG000|Overall Study|Adverse Event|19|||
160806972|NCT03654274|580679867|FG001|Overall Study|Adverse Event|23|||
160806973|NCT03654274|580679868|FG002|Overall Study|Adverse Event|24|||
160806974|NCT03654274|580679866|FG000|Overall Study|Protocol Deviation|0|||
160806975|NCT03654274|580679867|FG001|Overall Study|Protocol Deviation|2|||
160806976|NCT03654274|580679868|FG002|Overall Study|Protocol Deviation|0|||
160806977|NCT03654274|580679866|FG000|Overall Study|Lost to Follow-up|8|||
160806978|NCT03654274|580679867|FG001|Overall Study|Lost to Follow-up|6|||
160806979|NCT03654274|580679868|FG002|Overall Study|Lost to Follow-up|5|||
160806980|NCT03654274|580679866|FG000|Overall Study|Withdrawal by Subject|46|||
160806981|NCT03654274|580679867|FG001|Overall Study|Withdrawal by Subject|25|||
160806982|NCT03654274|580679868|FG002|Overall Study|Withdrawal by Subject|33|||
160806983|NCT03654274|580679866|FG000|Overall Study|Lack of Efficacy|4|||
160806984|NCT03654274|580679867|FG001|Overall Study|Lack of Efficacy|5|||
160806985|NCT03654274|580679868|FG002|Overall Study|Lack of Efficacy|7|||
160806986|NCT03654274|580679866|FG000|Overall Study|Pregnancy|2|||
160806987|NCT03654274|580679867|FG001|Overall Study|Pregnancy|2|||
160898498|NCT02913612|581023468|FG002|Overall Study|Physician Decision|1|||
160898499|NCT02913612|581023469|FG003|Overall Study|Physician Decision|0|||
160898500|NCT02913612|581023466|FG000|Overall Study|Withdrawal by Subject|2|||
160898501|NCT02913612|581023467|FG001|Overall Study|Withdrawal by Subject|4|||
160898502|NCT02913612|581023468|FG002|Overall Study|Withdrawal by Subject|0|||
161130675|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
161130676|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130677|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130678|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
161130679|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130680|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130681|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130682|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130683|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130684|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161332342|NCT02643693|582603591|FG004|Overall Study|Protocol Adherence Issues|0|||
160806988|NCT03654274|580679868|FG002|Overall Study|Pregnancy|1|||
160806989|NCT03654274|580679866|FG000|Overall Study|Other|27|||
160806990|NCT03654274|580679867|FG001|Overall Study|Other|29|||
160806991|NCT03654274|580679868|FG002|Overall Study|Other|32|||
160806992|NCT03654274|580679866|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
160806993|NCT03654274|580679867|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
160806994|NCT03654274|580679868|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
160806995|NCT01102491|580679869|FG000|Overall Study|Protocol Violation|11|||
160806996|NCT01102491|580679870|FG001|Overall Study|Protocol Violation|12|||
160806997|NCT01265992|580679871|FG000|Overall Study|Lost to Follow-up|1|||
160806998|NCT01265992|580679871|FG000|Overall Study|Withdrawal by Subject|1|||
160806999|NCT01265992|580679871|FG000|Overall Study|Adverse Event|1|||
160807000|NCT01265992|580679871|FG000|Overall Study|Administrative reasons|2|||
160807001|NCT01265992|580679871|FG000|Overall Study|Stopped treatment|3|||
160807002|NCT01265992|580679871|FG000|Overall Study|Did not receive treatment|1|||
160807003|NCT02137070|580679889|FG000|Overall Study|Adverse Event|12|||
160807004|NCT02137070|580679890|FG001|Overall Study|Adverse Event|3|||
160807005|NCT02137070|580679889|FG000|Overall Study|Death|2|||
160807006|NCT02137070|580679890|FG001|Overall Study|Death|0|||
160807007|NCT02137070|580679889|FG000|Overall Study|Lost to Follow-up|24|||
160807008|NCT02137070|580679890|FG001|Overall Study|Lost to Follow-up|9|||
160807009|NCT02137070|580679889|FG000|Overall Study|Physician Decision|0|||
160807010|NCT02137070|580679890|FG001|Overall Study|Physician Decision|1|||
160807011|NCT02137070|580679889|FG000|Overall Study|Protocol Violation|18|||
160807012|NCT02137070|580679890|FG001|Overall Study|Protocol Violation|4|||
160807013|NCT02137070|580679889|FG000|Overall Study|Withdrawal by Subject|18|||
160807014|NCT02137070|580679890|FG001|Overall Study|Withdrawal by Subject|1|||
160807015|NCT02151786|580679891|FG000|Overall Study|Unavailability of Case Report Form|26|||
160807016|NCT02151786|580679891|FG000|Overall Study|Outside the Contract Period|1|||
160807017|NCT02151786|580679891|FG000|Overall Study|Randomized, not Treated|1|||
160807018|NCT02151786|580679891|FG000|Overall Study|Unavailability of Information|8|||
160861922|NCT01033019|580887883|FG000|Overall Study|Withdrawal by Subject|1|||
160861923|NCT01033019|580887884|FG001|Overall Study|Withdrawal by Subject|0|||
160861924|NCT01339832|580887885|FG000|Overall Study|Lost to Follow-up|3|||
160861925|NCT01339832|580887885|FG000|Overall Study|Death|11|||
160861926|NCT01052493|580887886|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
160861927|NCT01052493|580887887|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
160861928|NCT01052493|580887888|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
160861929|NCT01075243|580887894|FG000|Overall Study|Lost to Follow-up|5|||
160861930|NCT01075243|580887895|FG001|Overall Study|Lost to Follow-up|2|||
160861931|NCT01075243|580887896|FG002|Overall Study|Lost to Follow-up|0|||
160861932|NCT01075243|580887894|FG000|Overall Study|Withdrawal by Subject|1|||
160861933|NCT01075243|580887895|FG001|Overall Study|Withdrawal by Subject|1|||
160861934|NCT01075243|580887896|FG002|Overall Study|Withdrawal by Subject|0|||
160861935|NCT00551642|580887897|FG000|Treatment Period|Protocol Deviation|6|||
160861936|NCT00551642|580887898|FG001|Treatment Period|Protocol Deviation|11|||
160861937|NCT00551642|580887897|FG000|Treatment Period|Delivery device failure|1|||
160861938|NCT00551642|580887898|FG001|Treatment Period|Delivery device failure|3|||
160861939|NCT00551642|580887897|FG000|Treatment Period|Physician Decision|0|||
160861940|NCT00551642|580887898|FG001|Treatment Period|Physician Decision|1|||
160861941|NCT00551642|580887897|FG000|Treatment Period|Death|33|||
160861942|NCT00551642|580887898|FG001|Treatment Period|Death|31|||
160861943|NCT00551642|580887897|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
160861944|NCT00551642|580887898|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
160861945|NCT00551642|580887897|FG000|Treatment Period|Adverse Event|15|||
160861946|NCT00551642|580887898|FG001|Treatment Period|Adverse Event|12|||
160861947|NCT00551642|580887897|FG000|Treatment Period|Withdrawal by Subject|2|||
160861948|NCT00551642|580887898|FG001|Treatment Period|Withdrawal by Subject|1|||
160861949|NCT05386329|580887899|FG000|Overall Study|Lost to Follow-up|3|||
160861950|NCT00888134|580887900|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
160861951|NCT00888134|580887900|FG000|Follow-up|being followed for long-term survival|1|||
160861952|NCT04973449|580887905|FG000|Overall Study|Withdrawal by Subject|3|||
160861953|NCT04973449|580887906|FG001|Overall Study|Withdrawal by Subject|3|||
160861954|NCT04973449|580887907|FG002|Overall Study|Withdrawal by Subject|2|||
160861955|NCT04973449|580887908|FG003|Overall Study|Withdrawal by Subject|5|||
160861956|NCT04973449|580887909|FG004|Overall Study|Withdrawal by Subject|5|||
160861957|NCT04973449|580887910|FG005|Overall Study|Withdrawal by Subject|4|||
160861958|NCT04973449|580887911|FG006|Overall Study|Withdrawal by Subject|7|||
160861959|NCT04973449|580887912|FG007|Overall Study|Withdrawal by Subject|5|||
160861960|NCT04973449|580887905|FG000|Overall Study|Lost to Follow-up|15|||
160861961|NCT04973449|580887906|FG001|Overall Study|Lost to Follow-up|16|||
160861962|NCT04973449|580887907|FG002|Overall Study|Lost to Follow-up|16|||
160861963|NCT04973449|580887908|FG003|Overall Study|Lost to Follow-up|13|||
160861964|NCT04973449|580887909|FG004|Overall Study|Lost to Follow-up|5|||
160861965|NCT04973449|580887910|FG005|Overall Study|Lost to Follow-up|6|||
160861966|NCT04973449|580887911|FG006|Overall Study|Lost to Follow-up|10|||
160861967|NCT04973449|580887912|FG007|Overall Study|Lost to Follow-up|6|||
160861968|NCT04973449|580887905|FG000|Overall Study|Death|1|||
160861969|NCT04973449|580887906|FG001|Overall Study|Death|0|||
160861970|NCT04973449|580887907|FG002|Overall Study|Death|0|||
160985769|NCT01244763|581337014|FG004|Overall Study|Lost to Follow-up|0|||
160861971|NCT04973449|580887908|FG003|Overall Study|Death|0|||
160861972|NCT04973449|580887909|FG004|Overall Study|Death|0|||
160861973|NCT04973449|580887910|FG005|Overall Study|Death|1|||
160861974|NCT04973449|580887911|FG006|Overall Study|Death|0|||
160861975|NCT04973449|580887912|FG007|Overall Study|Death|0|||
160861976|NCT04973449|580887905|FG000|Overall Study|Other|1|||
160861977|NCT04973449|580887906|FG001|Overall Study|Other|1|||
161130685|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130686|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130687|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130688|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130689|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130690|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130691|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130692|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130693|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130694|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130695|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130696|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130697|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130698|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
161130699|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130700|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130701|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130702|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
161130703|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130704|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130705|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130706|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130707|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130708|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130709|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130710|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130711|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130712|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130713|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130714|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130715|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130716|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130717|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130718|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130719|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130720|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130721|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
161130722|NCT00896532|581863459|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130723|NCT00896532|581863460|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161130724|NCT00896532|581863461|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130725|NCT00896532|581863462|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161130726|NCT00896532|581863463|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
161130727|NCT00896532|581863464|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130728|NCT00896532|581863465|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130729|NCT00896532|581863466|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130730|NCT00896532|581863467|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130731|NCT00896532|581863468|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
160807019|NCT03718325|580681280|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
160807020|NCT03718325|580681281|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
160807021|NCT03718325|580681282|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
160807022|NCT03718325|580681280|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
160807023|NCT03718325|580681281|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
160807024|NCT03718325|580681282|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
160807025|NCT01147965|580681287|FG000|Overall Study|Progressive Disease|3|||
160807026|NCT01147965|580681288|FG001|Overall Study|Progressive Disease|3|||
160807027|NCT01147965|580681289|FG002|Overall Study|Progressive Disease|5|||
160807028|NCT01147965|580681290|FG003|Overall Study|Progressive Disease|9|||
160807029|NCT01147965|580681291|FG004|Overall Study|Progressive Disease|5|||
160807030|NCT01147965|580681292|FG005|Overall Study|Progressive Disease|5|||
160807031|NCT01147965|580681287|FG000|Overall Study|Death|0|||
160807032|NCT01147965|580681288|FG001|Overall Study|Death|0|||
160807033|NCT01147965|580681289|FG002|Overall Study|Death|1|||
160807034|NCT01147965|580681290|FG003|Overall Study|Death|1|||
161332343|NCT02643693|582603592|FG005|Overall Study|Protocol Adherence Issues|1|||
161332344|NCT01319565|582603593|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
161130732|NCT00896532|581863469|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130733|NCT00896532|581863470|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130734|NCT00896532|581863471|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130735|NCT00896532|581863472|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130736|NCT00896532|581863473|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130737|NCT00896532|581863474|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130738|NCT00896532|581863475|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130739|NCT00896532|581863476|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130740|NCT00896532|581863477|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130741|NCT00896532|581863478|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130742|NCT00896532|581863479|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130743|NCT00896532|581863480|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130744|NCT00896532|581863481|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
161130745|NCT00896532|581863459|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130746|NCT00896532|581863460|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130747|NCT00896532|581863461|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130748|NCT00896532|581863462|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130749|NCT00896532|581863463|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130750|NCT00896532|581863464|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130751|NCT00896532|581863465|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130752|NCT00896532|581863466|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130753|NCT00896532|581863467|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
161130754|NCT00896532|581863468|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130755|NCT00896532|581863469|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130756|NCT00896532|581863470|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130757|NCT00896532|581863471|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130758|NCT00896532|581863472|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130759|NCT00896532|581863473|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130760|NCT00896532|581863474|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130761|NCT00896532|581863475|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130762|NCT00896532|581863476|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130763|NCT00896532|581863477|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130764|NCT00896532|581863478|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130765|NCT00896532|581863479|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130766|NCT00896532|581863480|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130767|NCT00896532|581863481|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
161130768|NCT00896532|581863459|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130769|NCT00896532|581863460|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130770|NCT00896532|581863461|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130771|NCT00896532|581863462|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130772|NCT00896532|581863463|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130773|NCT00896532|581863464|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130774|NCT00896532|581863465|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130775|NCT00896532|581863466|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161332345|NCT01319565|582603594|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
161332346|NCT01319565|582603595|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
161332347|NCT00698815|582603597|FG000|Overall Study|Death|1|||
161332348|NCT00698815|582603598|FG001|Overall Study|Death|2|||
161332349|NCT00698815|582603599|FG002|Overall Study|Death|4|||
161130776|NCT00896532|581863467|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130777|NCT00896532|581863468|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130778|NCT00896532|581863469|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130779|NCT00896532|581863470|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130780|NCT00896532|581863471|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
161130781|NCT00896532|581863472|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130782|NCT00896532|581863473|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130783|NCT00896532|581863474|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130784|NCT00896532|581863475|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130785|NCT00896532|581863476|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130786|NCT00896532|581863477|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130787|NCT00896532|581863478|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130788|NCT00896532|581863479|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161332350|NCT00698815|582603597|FG000|Overall Study|Withdrawal by Subject|6|||
161332351|NCT00698815|582603598|FG001|Overall Study|Withdrawal by Subject|3|||
160807035|NCT01147965|580681291|FG004|Overall Study|Death|0|||
160807036|NCT01147965|580681292|FG005|Overall Study|Death|2|||
160807037|NCT01147965|580681287|FG000|Overall Study|Withdrawal by Subject|0|||
160807038|NCT01147965|580681288|FG001|Overall Study|Withdrawal by Subject|0|||
160807039|NCT01147965|580681289|FG002|Overall Study|Withdrawal by Subject|1|||
160807040|NCT01147965|580681290|FG003|Overall Study|Withdrawal by Subject|1|||
160807041|NCT01147965|580681291|FG004|Overall Study|Withdrawal by Subject|0|||
160807042|NCT01147965|580681292|FG005|Overall Study|Withdrawal by Subject|0|||
160807043|NCT01147965|580681287|FG000|Overall Study|Administration Of Alternative Therapy|0|||
160807044|NCT01147965|580681288|FG001|Overall Study|Administration Of Alternative Therapy|0|||
160807045|NCT01147965|580681289|FG002|Overall Study|Administration Of Alternative Therapy|0|||
160807046|NCT01147965|580681290|FG003|Overall Study|Administration Of Alternative Therapy|0|||
160807047|NCT01147965|580681291|FG004|Overall Study|Administration Of Alternative Therapy|0|||
160807048|NCT01147965|580681292|FG005|Overall Study|Administration Of Alternative Therapy|1|||
160807049|NCT01147965|580681287|FG000|Overall Study|Other|0|||
160807050|NCT01147965|580681288|FG001|Overall Study|Other|0|||
160807051|NCT01147965|580681289|FG002|Overall Study|Other|0|||
160807052|NCT01147965|580681290|FG003|Overall Study|Other|3|||
160807053|NCT01147965|580681291|FG004|Overall Study|Other|1|||
160807054|NCT01147965|580681292|FG005|Overall Study|Other|0|||
160807055|NCT01279044|580681295|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
160807056|NCT01279044|580681296|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
160807057|NCT01279044|580681297|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
160807058|NCT01279044|580681295|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
161238475|NCT00960297|582253757|FG000|Overall Study|Venous port infection|1|||
161238476|NCT00960297|582253757|FG000|Overall Study|Disease progression|1|||
161238477|NCT00968812|582253762|FG000|Overall Study|Adverse Event|30|||
161238478|NCT00968812|582253763|FG001|Overall Study|Adverse Event|46|||
161238479|NCT00968812|582253764|FG002|Overall Study|Adverse Event|33|||
161238480|NCT00968812|582253762|FG000|Overall Study|Death|2|||
161238481|NCT00968812|582253763|FG001|Overall Study|Death|2|||
160807059|NCT01279044|580681296|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
160807060|NCT01279044|580681297|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
160807061|NCT01279044|580681295|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
160807062|NCT01279044|580681296|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
160807063|NCT01279044|580681297|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
160807064|NCT01408277|580681300|FG000|Overall Study|Adverse Event|3|||
160807065|NCT01408277|580681301|FG001|Overall Study|Adverse Event|4|||
160807066|NCT01408277|580681300|FG000|Overall Study|Lost to Follow-up|1|||
160807067|NCT01408277|580681301|FG001|Overall Study|Lost to Follow-up|0|||
160807068|NCT01408277|580681300|FG000|Overall Study|Withdrawal by Subject|2|||
160807069|NCT01408277|580681301|FG001|Overall Study|Withdrawal by Subject|0|||
160807070|NCT01408277|580681300|FG000|Overall Study|Protocol Violation|2|||
160807071|NCT01408277|580681301|FG001|Overall Study|Protocol Violation|0|||
160807072|NCT02630693|580681308|FG000|Overall Study|No receive treatment|0|||
160807073|NCT02630693|580681309|FG001|Overall Study|No receive treatment|1|||
160807074|NCT02763059|580681310|FG000|Overall Study|Lost to Follow-up|4|||
160807075|NCT02763059|580681311|FG001|Overall Study|Lost to Follow-up|1|||
160807076|NCT02763059|580681312|FG002|Overall Study|Lost to Follow-up|6|||
160807077|NCT02763059|580681310|FG000|Overall Study|Withdrawal by Subject|1|||
160807078|NCT02763059|580681311|FG001|Overall Study|Withdrawal by Subject|0|||
160807079|NCT02763059|580681312|FG002|Overall Study|Withdrawal by Subject|3|||
160807080|NCT02370368|580681313|FG000|Overall Study|Adverse Event|1|||
160807081|NCT02370368|580681314|FG001|Overall Study|Adverse Event|2|||
160807082|NCT02370368|580681313|FG000|Overall Study|Withdrawal by Subject|5|||
160807083|NCT02370368|580681314|FG001|Overall Study|Withdrawal by Subject|4|||
160807084|NCT00175916|580681315|FG000|Overall Study|Death|19|||
160807085|NCT00175916|580681315|FG000|Overall Study|Adverse Event|81|||
160807086|NCT00175916|580681315|FG000|Overall Study|Lack of Efficacy|354|||
160807087|NCT00175916|580681315|FG000|Overall Study|Lost to Follow-up|17|||
160807088|NCT00175916|580681315|FG000|Overall Study|Subject Choice|98|||
160807089|NCT00175916|580681315|FG000|Overall Study|Lack of compliance|8|||
160807090|NCT00175916|580681315|FG000|Overall Study|Patient cannot record seizures|1|||
160807091|NCT00175916|580681315|FG000|Overall Study|Sponsor decision|17|||
160807092|NCT00175916|580681315|FG000|Overall Study|Vigabatrin intake|1|||
160807093|NCT00175916|580681315|FG000|Overall Study|Suicidal behaviour|1|||
160898503|NCT02913612|581023469|FG003|Overall Study|Withdrawal by Subject|0|||
160898504|NCT02913612|581023466|FG000|Overall Study|Hemangioma resolved|1|||
160898505|NCT02913612|581023467|FG001|Overall Study|Hemangioma resolved|0|||
160807094|NCT00175916|580681315|FG000|Overall Study|Withdrawal by Subject|1|||
160898506|NCT02913612|581023468|FG002|Overall Study|Hemangioma resolved|0|||
160807095|NCT00175916|580681315|FG000|Overall Study|Seizure - free|4|||
160807096|NCT00175916|580681315|FG000|Overall Study|Administrative reason|1|||
160898507|NCT02913612|581023469|FG003|Overall Study|Hemangioma resolved|0|||
160807097|NCT00175916|580681315|FG000|Overall Study|Pregnancy|1|||
160807098|NCT00175916|580681315|FG000|Overall Study|Patient's request|2|||
161238482|NCT00968812|582253764|FG002|Overall Study|Death|1|||
160807099|NCT00175916|580681315|FG000|Overall Study|Treating physiciant's choice|1|||
160807100|NCT00175916|580681315|FG000|Overall Study|Moved overseas|1|||
160807101|NCT00175916|580681315|FG000|Overall Study|Loss of job and economic burden|1|||
160807102|NCT00175916|580681315|FG000|Overall Study|Site was closed|9|||
160807103|NCT00175916|580681315|FG000|Overall Study|Patient went to prison|1|||
160807104|NCT02236572|580681316|FG000|Overall Study|Withdrawal by Subject|1|||
160807105|NCT02236572|580681316|FG000|Overall Study|Protocol Violation|1|||
160807106|NCT02236572|580681316|FG000|Overall Study|Lost to Follow-up|1|||
160807107|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
160807108|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
160807109|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
160807110|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
160807111|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
160807112|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
160807113|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
160807114|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
160807115|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
160807116|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
160807117|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
160807118|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
160807119|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
160807120|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
160807121|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
160807122|NCT01057693|580681317|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
160807123|NCT01057693|580681318|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
160807124|NCT01057693|580681319|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
160807125|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
160807126|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
160807127|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
160807128|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
160807129|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
160807130|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
160807131|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
160807132|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
160807133|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
160807134|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
160807135|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
160807136|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
160807137|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
160807138|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
160807139|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
160807140|NCT01057693|580681317|FG000|Between Single-Blind and Double-Blind|Other|6|||
160807141|NCT01057693|580681318|FG001|Between Single-Blind and Double-Blind|Other|0|||
160807142|NCT01057693|580681319|FG002|Between Single-Blind and Double-Blind|Other|0|||
160807143|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
160807144|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
160807145|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
160807146|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
160807147|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
160807148|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
160807149|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
160807150|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
160807151|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
160807152|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
160807153|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
160807154|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
160807155|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
160807156|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
160807157|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
160807158|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
160807159|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
160807160|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
160807161|NCT01057693|580681317|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
160807162|NCT01057693|580681318|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
160807163|NCT01057693|580681319|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
160985770|NCT01244763|581337015|FG005|Overall Study|Lost to Follow-up|0|||
160985771|NCT01244763|581337010|FG000|Overall Study|Enrolled into the Extension Study|0|||
161130789|NCT00896532|581863480|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130790|NCT00896532|581863481|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
161130791|NCT00896532|581863459|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130792|NCT00896532|581863460|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130793|NCT00896532|581863461|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130794|NCT00896532|581863462|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130795|NCT00896532|581863463|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130796|NCT00896532|581863464|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130797|NCT00896532|581863465|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130798|NCT00896532|581863466|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130799|NCT00896532|581863467|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130800|NCT00896532|581863468|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130801|NCT00896532|581863469|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
161130802|NCT00896532|581863470|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130803|NCT00896532|581863471|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
161130804|NCT00896532|581863472|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130805|NCT00896532|581863473|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130806|NCT00896532|581863474|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160807164|NCT02959463|580681320|FG000|Overall Study|Adverse Event|1|||
160807165|NCT02959463|580681321|FG001|Overall Study|Adverse Event|1|||
160807166|NCT02959463|580681320|FG000|Overall Study|Death|1|||
160807167|NCT02959463|580681321|FG001|Overall Study|Death|0|||
160807168|NCT02959463|580681320|FG000|Overall Study|Withdrawal by Subject|1|||
160807169|NCT02959463|580681321|FG001|Overall Study|Withdrawal by Subject|0|||
160807170|NCT02413996|580681322|FG000|Overall Study|not comfortable with the intervention|9|||
160807171|NCT02413996|580681323|FG001|Overall Study|not comfortable with the intervention|2|||
160807172|NCT00709319|580681324|FG000|Overall Study|Death|4|||
160807173|NCT00709319|580681324|FG000|Overall Study|Withdrawal by Subject|2|||
160807174|NCT00090779|580681325|FG000|Step 1|Withdrawal by Subject|4|||
160807175|NCT00090779|580681326|FG001|Step 1|Withdrawal by Subject|2|||
160807176|NCT00090779|580681325|FG000|Step 1|Lost to Follow-up|3|||
160807177|NCT00090779|580681326|FG001|Step 1|Lost to Follow-up|2|||
160807178|NCT00090779|580681325|FG000|Step 1|Death|0|||
160807179|NCT00090779|580681326|FG001|Step 1|Death|2|||
160807180|NCT00090779|580681325|FG000|Step 1|Physician Decision|1|||
160807181|NCT00090779|580681326|FG001|Step 1|Physician Decision|0|||
160807182|NCT00090779|580681325|FG000|Step 1|Pregnancy|1|||
160807183|NCT00090779|580681326|FG001|Step 1|Pregnancy|0|||
160807184|NCT00090779|580681325|FG000|Step 1|Non-compliance to study requirements|0|||
160807185|NCT00090779|580681326|FG001|Step 1|Non-compliance to study requirements|1|||
160807186|NCT00090779|580681325|FG000|Step 1|Subject relocated|2|||
160807187|NCT00090779|580681326|FG001|Step 1|Subject relocated|8|||
160807188|NCT00090779|580681325|FG000|Step 2|Off study per study closure|6|||
160807189|NCT00090779|580681326|FG001|Step 2|Off study per study closure|16|||
160807190|NCT00090779|580681325|FG000|Step 2|Subject relocated|0|||
160807191|NCT00090779|580681326|FG001|Step 2|Subject relocated|1|||
160807192|NCT00090779|580681325|FG000|Step 2|Non-compliance to study requirements|0|||
160807193|NCT00090779|580681326|FG001|Step 2|Non-compliance to study requirements|1|||
160807194|NCT00090779|580681325|FG000|Step 3|Initiation of ART and off extended study|3|||
160807195|NCT00090779|580681326|FG001|Step 3|Initiation of ART and off extended study|2|||
160807196|NCT00090779|580681325|FG000|Step 3|Off extended study due to study closure|4|||
160807197|NCT00090779|580681326|FG001|Step 3|Off extended study due to study closure|3|||
160807198|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
160807199|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
160807200|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
160807201|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
160807202|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
160807203|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
160807204|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
160807205|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
160807206|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
160807207|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
160807208|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
161130807|NCT00896532|581863475|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130808|NCT00896532|581863476|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130809|NCT00896532|581863477|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130810|NCT00896532|581863478|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
161130811|NCT00896532|581863479|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160807209|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
160807210|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
161130812|NCT00896532|581863480|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160807211|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
160807212|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
160807213|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
160807214|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
160807215|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
160807216|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
160807217|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
160807218|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
161238483|NCT00968812|582253762|FG000|Overall Study|Lack of Efficacy|9|||
161238484|NCT00968812|582253763|FG001|Overall Study|Lack of Efficacy|7|||
160807219|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
160807220|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
160807221|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
160807222|NCT01672879|580681329|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
160807223|NCT01672879|580681330|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
160807224|NCT01672879|580681331|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
160807225|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
160807226|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
160807227|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
160807228|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
160807229|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
160807230|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
160807231|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
160807232|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
160807233|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
160807234|NCT01672879|580681329|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
160807235|NCT01672879|580681330|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
161238485|NCT00968812|582253764|FG002|Overall Study|Lack of Efficacy|16|||
161238486|NCT00968812|582253762|FG000|Overall Study|Lost to Follow-up|17|||
161238487|NCT00968812|582253763|FG001|Overall Study|Lost to Follow-up|12|||
161238488|NCT00968812|582253764|FG002|Overall Study|Lost to Follow-up|11|||
161238489|NCT00968812|582253762|FG000|Overall Study|Physician Decision|8|||
161238490|NCT00968812|582253763|FG001|Overall Study|Physician Decision|5|||
161238491|NCT00968812|582253764|FG002|Overall Study|Physician Decision|9|||
161238492|NCT00968812|582253762|FG000|Overall Study|Protocol Violation|7|||
161238493|NCT00968812|582253763|FG001|Overall Study|Protocol Violation|4|||
161238494|NCT00968812|582253764|FG002|Overall Study|Protocol Violation|3|||
161238495|NCT00968812|582253762|FG000|Overall Study|Withdrawal by Subject|17|||
161332352|NCT00698815|582603599|FG002|Overall Study|Withdrawal by Subject|2|||
160807236|NCT01672879|580681331|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
160807237|NCT03951766|580681340|FG000|Treatment Phase|Lost to Follow-up|1|||
160898508|NCT02913612|581023466|FG000|Overall Study|Local IRB decision|1|||
160898509|NCT02913612|581023467|FG001|Overall Study|Local IRB decision|0|||
160898510|NCT02913612|581023468|FG002|Overall Study|Local IRB decision|0|||
160898511|NCT02913612|581023469|FG003|Overall Study|Local IRB decision|0|||
160898512|NCT02913612|581023466|FG000|Overall Study|Study drug non-compliance|1|||
160898513|NCT02913612|581023467|FG001|Overall Study|Study drug non-compliance|1|||
160898514|NCT02913612|581023468|FG002|Overall Study|Study drug non-compliance|0|||
160898515|NCT02913612|581023469|FG003|Overall Study|Study drug non-compliance|0|||
160898516|NCT02913612|581023466|FG000|Overall Study|Insurance issues|0|||
160898517|NCT02913612|581023467|FG001|Overall Study|Insurance issues|1|||
160898518|NCT02913612|581023468|FG002|Overall Study|Insurance issues|0|||
160898519|NCT02913612|581023469|FG003|Overall Study|Insurance issues|0|||
160898520|NCT02913612|581023466|FG000|Overall Study|Needed to treat second hemangioma|0|||
160898521|NCT02913612|581023467|FG001|Overall Study|Needed to treat second hemangioma|1|||
160898522|NCT02913612|581023468|FG002|Overall Study|Needed to treat second hemangioma|0|||
160898523|NCT02913612|581023469|FG003|Overall Study|Needed to treat second hemangioma|0|||
160898524|NCT02913612|581023466|FG000|Overall Study|Study completion criteria not met|0|||
160898525|NCT02913612|581023467|FG001|Overall Study|Study completion criteria not met|1|||
160898526|NCT02913612|581023468|FG002|Overall Study|Study completion criteria not met|0|||
160898527|NCT02913612|581023469|FG003|Overall Study|Study completion criteria not met|0|||
160898528|NCT02913612|581023466|FG000|Overall Study|Ineligible|0|||
160898529|NCT02913612|581023467|FG001|Overall Study|Ineligible|1|||
160898530|NCT02913612|581023468|FG002|Overall Study|Ineligible|0|||
160898531|NCT02913612|581023469|FG003|Overall Study|Ineligible|0|||
160898532|NCT04251273|581023470|FG000|Overall Study|Lost to Follow-up|331|||
160898533|NCT04251273|581023471|FG001|Overall Study|Lost to Follow-up|290|||
160898534|NCT04402060|581023472|FG000|Overall Study|Death|1|||
160898535|NCT04402060|581023473|FG001|Overall Study|Death|12|||
160898536|NCT04402060|581023474|FG002|Overall Study|Death|7|||
160898537|NCT04402060|581023472|FG000|Overall Study|Adverse Event|0|||
160898538|NCT04402060|581023473|FG001|Overall Study|Adverse Event|0|||
161238496|NCT00968812|582253763|FG001|Overall Study|Withdrawal by Subject|23|||
161238497|NCT00968812|582253764|FG002|Overall Study|Withdrawal by Subject|25|||
161238498|NCT00968812|582253762|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
160807238|NCT03951766|580681340|FG000|Follow-up Phase|Lost to Follow-up|10|||
160807239|NCT00041470|580681341|FG000|Overall Study|Loss of Funding|38|||
160807240|NCT02379052|580681357|FG000|Overall Study|Protocol Violation|0|||
160807241|NCT02379052|580681358|FG001|Overall Study|Protocol Violation|1|||
160807242|NCT02379052|580681357|FG000|Overall Study|Adverse Event|0|||
160807243|NCT02379052|580681358|FG001|Overall Study|Adverse Event|1|||
160807244|NCT02379052|580681357|FG000|Overall Study|Physician Decision|1|||
160807245|NCT02379052|580681358|FG001|Overall Study|Physician Decision|1|||
160807246|NCT02379052|580681357|FG000|Overall Study|Withdrawal by Subject|2|||
160807247|NCT02379052|580681358|FG001|Overall Study|Withdrawal by Subject|0|||
160807248|NCT02379052|580681357|FG000|Overall Study|Lost to Follow-up|2|||
160807249|NCT02379052|580681358|FG001|Overall Study|Lost to Follow-up|1|||
160807250|NCT02379052|580681357|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
160807251|NCT02379052|580681358|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
160807252|NCT02379052|580681357|FG000|Overall Study|Subject was Incarcerated|0|||
160807253|NCT02379052|580681358|FG001|Overall Study|Subject was Incarcerated|1|||
160807254|NCT00127855|580681359|FG000|Primary Vaccination Course|Adverse Event|0|||
160807255|NCT00127855|580681360|FG001|Primary Vaccination Course|Adverse Event|0|||
160807256|NCT00127855|580681361|FG002|Primary Vaccination Course|Adverse Event|1|||
160807257|NCT00127855|580681362|FG003|Primary Vaccination Course|Adverse Event|0|||
160807258|NCT00127855|580681363|FG004|Primary Vaccination Course|Adverse Event|0|||
160807259|NCT00127855|580681359|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
160807260|NCT00127855|580681360|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
160807261|NCT00127855|580681361|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
160807262|NCT00127855|580681362|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
160807263|NCT00127855|580681363|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
160807264|NCT00127855|580681359|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
160807265|NCT00127855|580681360|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
160807266|NCT00127855|580681361|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
160807267|NCT00127855|580681362|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
160807268|NCT00127855|580681363|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
160807269|NCT00127855|580681359|FG000|Primary Vaccination Course|Other|0|||
160807270|NCT00127855|580681360|FG001|Primary Vaccination Course|Other|0|||
160807271|NCT00127855|580681361|FG002|Primary Vaccination Course|Other|0|||
160807272|NCT00127855|580681362|FG003|Primary Vaccination Course|Other|0|||
160807273|NCT00127855|580681363|FG004|Primary Vaccination Course|Other|1|||
160807274|NCT02343302|580681364|FG000|Overall Study|Physician Decision|1|||
160807275|NCT02343302|580681365|FG001|Overall Study|Physician Decision|1|||
160807276|NCT00003869|580681373|FG000|Overall Study|Adverse Event|14|||
160807277|NCT00003869|580681374|FG001|Overall Study|Adverse Event|3|||
160807278|NCT00003869|580681373|FG000|Overall Study|Withdrawal by Subject|21|||
160807279|NCT00003869|580681374|FG001|Overall Study|Withdrawal by Subject|3|||
160807280|NCT00003869|580681373|FG000|Overall Study|Death|1|||
160807281|NCT00003869|580681374|FG001|Overall Study|Death|2|||
160807282|NCT00003869|580681373|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
160807283|NCT00003869|580681374|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
160807284|NCT01272037|580681379|FG000|Overall Study|Death|25|||
160807285|NCT01272037|580681380|FG001|Overall Study|Death|28|||
160807286|NCT01272037|580681379|FG000|Overall Study|Adverse Event|12|||
160807287|NCT01272037|580681380|FG001|Overall Study|Adverse Event|7|||
160807288|NCT01272037|580681379|FG000|Overall Study|Withdrawal by Subject|175|||
160807289|NCT01272037|580681380|FG001|Overall Study|Withdrawal by Subject|93|||
160807290|NCT01272037|580681379|FG000|Overall Study|Disease progression|70|||
160807291|NCT01272037|580681380|FG001|Overall Study|Disease progression|111|||
160807292|NCT01272037|580681379|FG000|Overall Study|Other reason|42|||
160807293|NCT01272037|580681380|FG001|Overall Study|Other reason|41|||
160807294|NCT01272037|580681379|FG000|Overall Study|Delinquent data|24|||
160807295|NCT01272037|580681380|FG001|Overall Study|Delinquent data|19|||
160807296|NCT01272037|580681379|FG000|Overall Study|Reason under review|33|||
160807297|NCT01272037|580681380|FG001|Overall Study|Reason under review|29|||
160807298|NCT01272037|580681379|FG000|Overall Study|On treatment|626|||
160898539|NCT04402060|581023474|FG002|Overall Study|Adverse Event|1|||
160898540|NCT04402060|581023472|FG000|Overall Study|Withdrawal by Subject|0|||
160807299|NCT01272037|580681380|FG001|Overall Study|On treatment|632|||
160898541|NCT04402060|581023473|FG001|Overall Study|Withdrawal by Subject|1|||
160898542|NCT04402060|581023474|FG002|Overall Study|Withdrawal by Subject|2|||
160807300|NCT02534883|580681381|FG000|Overall Study|Early Termination|8|||
160807301|NCT02534883|580681382|FG001|Overall Study|Early Termination|3|||
160807302|NCT03328832|580681383|FG000|Overall Study|Lost to Follow-up|0|||
160807303|NCT03328832|580681384|FG001|Overall Study|Lost to Follow-up|1|||
160807304|NCT00886769|580681385|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160807305|NCT00886769|580681386|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
160807306|NCT00049257|580681387|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
160807307|NCT00049257|580681387|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
160807308|NCT00049257|580681387|FG000|Carboplatin, Paclitaxel|Death|2|||
160807309|NCT00049257|580681387|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
160807310|NCT04872569|580681390|FG000|Overall Study|Withdrawal by Subject|2|||
160807311|NCT01890265|580681391|FG000|Overall Study|Other (Unspecified reason)|0|||
160807312|NCT01890265|580681392|FG001|Overall Study|Other (Unspecified reason)|1|||
160807313|NCT01890265|580681393|FG002|Overall Study|Other (Unspecified reason)|0|||
160807314|NCT01890265|580681394|FG003|Overall Study|Other (Unspecified reason)|0|||
160807315|NCT01890265|580681395|FG004|Overall Study|Other (Unspecified reason)|0|||
160807316|NCT01890265|580681396|FG005|Overall Study|Other (Unspecified reason)|0|||
160807317|NCT01890265|580681391|FG000|Overall Study|Progressive disease|6|||
160807318|NCT01890265|580681392|FG001|Overall Study|Progressive disease|6|||
160807319|NCT01890265|580681393|FG002|Overall Study|Progressive disease|0|||
160807320|NCT01890265|580681394|FG003|Overall Study|Progressive disease|0|||
160807321|NCT01890265|580681395|FG004|Overall Study|Progressive disease|0|||
160807322|NCT01890265|580681396|FG005|Overall Study|Progressive disease|0|||
160807323|NCT01890265|580681391|FG000|Overall Study|Adverse Event|2|||
160807324|NCT01890265|580681392|FG001|Overall Study|Adverse Event|1|||
160807325|NCT01890265|580681393|FG002|Overall Study|Adverse Event|0|||
160807326|NCT01890265|580681394|FG003|Overall Study|Adverse Event|0|||
160807327|NCT01890265|580681395|FG004|Overall Study|Adverse Event|0|||
160807328|NCT01890265|580681396|FG005|Overall Study|Adverse Event|0|||
160807329|NCT01890265|580681391|FG000|Overall Study|Death|2|||
160807330|NCT01890265|580681392|FG001|Overall Study|Death|3|||
160807331|NCT01890265|580681393|FG002|Overall Study|Death|1|||
160807332|NCT01890265|580681394|FG003|Overall Study|Death|0|||
160807333|NCT01890265|580681395|FG004|Overall Study|Death|0|||
160807334|NCT01890265|580681396|FG005|Overall Study|Death|0|||
160807335|NCT01890265|580681391|FG000|Overall Study|Withdrawal by Subject|0|||
160807336|NCT01890265|580681392|FG001|Overall Study|Withdrawal by Subject|2|||
160807337|NCT01890265|580681393|FG002|Overall Study|Withdrawal by Subject|3|||
160807338|NCT01890265|580681394|FG003|Overall Study|Withdrawal by Subject|0|||
160807339|NCT01890265|580681395|FG004|Overall Study|Withdrawal by Subject|2|||
160807340|NCT01890265|580681396|FG005|Overall Study|Withdrawal by Subject|0|||
160807341|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
160807342|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
160807343|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
160807344|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
160807345|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
160807346|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
160807347|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
160807348|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
160807349|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
160807350|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
160807351|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
160807352|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
160807353|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
160807354|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
160807355|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
160807356|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807357|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
160807358|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807359|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807360|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
160807361|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
160807362|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
160807363|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
160807364|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
160807365|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
160807366|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807367|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
160807368|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807369|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807370|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
160807371|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
160807372|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807373|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807374|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807375|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
160807376|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
160807377|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807378|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807379|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807380|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
160807381|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
160861978|NCT04973449|580887907|FG002|Overall Study|Other|2|||
161238499|NCT00968812|582253763|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
161238500|NCT00968812|582253764|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
161238501|NCT00968812|582253762|FG000|Overall Study|Noncompliance with study drug|4|||
161238502|NCT00968812|582253763|FG001|Overall Study|Noncompliance with study drug|1|||
161238503|NCT00968812|582253764|FG002|Overall Study|Noncompliance with study drug|6|||
161238504|NCT00968812|582253762|FG000|Overall Study|Unable to take rescue therapy|12|||
161238505|NCT00968812|582253763|FG001|Overall Study|Unable to take rescue therapy|12|||
161238506|NCT00968812|582253764|FG002|Overall Study|Unable to take rescue therapy|17|||
160807382|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807383|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807384|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807385|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
160807386|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807387|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
160807388|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807389|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807390|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
160807391|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
160807392|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807393|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807394|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807395|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
160807396|NCT04951622|580681397|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807397|NCT04951622|580681398|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
160807398|NCT04951622|580681399|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807399|NCT04951622|580681400|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807400|NCT04951622|580681401|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
160807401|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
160807402|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
160807403|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
160807404|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
160807405|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
160807406|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
160807407|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
160807408|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
160807409|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
160807410|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
160807411|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
160807412|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
160807413|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
160807414|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
160807415|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
160861979|NCT04973449|580887908|FG003|Overall Study|Other|1|||
160861980|NCT04973449|580887909|FG004|Overall Study|Other|4|||
160861981|NCT04973449|580887910|FG005|Overall Study|Other|0|||
161238507|NCT00968812|582253762|FG000|Overall Study|Other|25|||
160861982|NCT04973449|580887911|FG006|Overall Study|Other|2|||
160861983|NCT04973449|580887912|FG007|Overall Study|Other|2|||
160861984|NCT01488890|580887913|FG000|Overall Study|Serious adverse event|2|||
160861985|NCT01488890|580887914|FG001|Overall Study|Serious adverse event|0|||
160861986|NCT01488890|580887915|FG002|Overall Study|Serious adverse event|0|||
160861987|NCT01488890|580887916|FG003|Overall Study|Serious adverse event|0|||
160861988|NCT01488890|580887913|FG000|Overall Study|Protocol Violation|3|||
160861989|NCT01488890|580887914|FG001|Overall Study|Protocol Violation|0|||
160861990|NCT01488890|580887915|FG002|Overall Study|Protocol Violation|4|||
160861991|NCT01488890|580887916|FG003|Overall Study|Protocol Violation|0|||
160861992|NCT01488890|580887913|FG000|Overall Study|Lost to Follow-up|13|||
160861993|NCT01488890|580887914|FG001|Overall Study|Lost to Follow-up|10|||
160861994|NCT01488890|580887915|FG002|Overall Study|Lost to Follow-up|20|||
160861995|NCT01488890|580887916|FG003|Overall Study|Lost to Follow-up|3|||
160861996|NCT01488890|580887913|FG000|Overall Study|Withdrawal by Subject|14|||
160861997|NCT01488890|580887914|FG001|Overall Study|Withdrawal by Subject|10|||
160861998|NCT01488890|580887915|FG002|Overall Study|Withdrawal by Subject|11|||
160861999|NCT01488890|580887916|FG003|Overall Study|Withdrawal by Subject|2|||
160862000|NCT02532517|580887917|FG000|Overall Study|Did not complete 24-Month visit|4|||
160862001|NCT02532517|580887917|FG000|Overall Study|Failed Angiographic eligibility|1|||
160862002|NCT02532517|580887917|FG000|Overall Study|Lost to Follow-up|4|||
160862003|NCT02532517|580887917|FG000|Overall Study|Withdrawal by Subject|4|||
160862004|NCT02532517|580887917|FG000|Overall Study|Death|4|||
160807416|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
160807417|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
160807418|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
160807419|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
160807420|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
160807421|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807422|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807423|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
160807424|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807425|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
160807426|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
160807427|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
160807428|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
160807429|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
160807430|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
160807431|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
160807432|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
160807433|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
160807434|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
160807435|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
160807436|NCT04951622|580681397|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807437|NCT04951622|580681398|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807438|NCT04951622|580681399|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807439|NCT04951622|580681400|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
160807440|NCT04951622|580681401|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
160807441|NCT04570384|580681407|FG000|Overall Study|Adverse Event|2|||
160807442|NCT04570384|580681408|FG001|Overall Study|Adverse Event|1|||
160807443|NCT04570384|580681407|FG000|Overall Study|Death|2|||
160807444|NCT04570384|580681408|FG001|Overall Study|Death|5|||
160807445|NCT04570384|580681407|FG000|Overall Study|Lost to Follow-up|1|||
160807446|NCT04570384|580681408|FG001|Overall Study|Lost to Follow-up|0|||
160807447|NCT04570384|580681407|FG000|Overall Study|Other|1|||
160807448|NCT04570384|580681408|FG001|Overall Study|Other|0|||
160807449|NCT04570384|580681407|FG000|Overall Study|Protocol Violation|0|||
160807450|NCT04570384|580681408|FG001|Overall Study|Protocol Violation|1|||
160807451|NCT04570384|580681407|FG000|Overall Study|Sponsor Decision|1|||
160807452|NCT04570384|580681408|FG001|Overall Study|Sponsor Decision|0|||
160807453|NCT04570384|580681407|FG000|Overall Study|Withdrawal by Subject|4|||
160807454|NCT04570384|580681408|FG001|Overall Study|Withdrawal by Subject|2|||
160807455|NCT02573948|580681409|FG000|Longitudinal Cohort|Death|9|||
160807456|NCT02573948|580681409|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
160807457|NCT02573948|580681409|FG000|Longitudinal Cohort|Incarcerated|25|||
160807458|NCT00707993|580681410|FG000|Overall Study|Adverse Event|16|||
160807459|NCT00707993|580681411|FG001|Overall Study|Adverse Event|20|||
160807460|NCT00707993|580681410|FG000|Overall Study|Protocol Violation|4|||
160807461|NCT00707993|580681411|FG001|Overall Study|Protocol Violation|7|||
160807462|NCT00707993|580681410|FG000|Overall Study|Lost to Follow-up|0|||
160807463|NCT00707993|580681411|FG001|Overall Study|Lost to Follow-up|4|||
160807464|NCT00707993|580681410|FG000|Overall Study|Withdrawal by Subject|12|||
160807465|NCT00707993|580681411|FG001|Overall Study|Withdrawal by Subject|16|||
160807466|NCT00707993|580681410|FG000|Overall Study|Hyperglycemic Rescue|55|||
160807467|NCT00707993|580681411|FG001|Overall Study|Hyperglycemic Rescue|47|||
160807468|NCT00707993|580681410|FG000|Overall Study|Other|2|||
160807469|NCT00707993|580681411|FG001|Overall Study|Other|0|||
160807470|NCT00436436|580681414|FG000|Overall Study|Progression|4|||
160807471|NCT00436436|580681414|FG000|Overall Study|Adverse Event|2|||
160807472|NCT00436436|580681414|FG000|Overall Study|Death|6|||
160807473|NCT03265145|580681415|FG000|Overall Study|Protocol Violation|2|||
160807474|NCT03265145|580681416|FG001|Overall Study|Protocol Violation|0|||
160807475|NCT03265145|580681415|FG000|Overall Study|Adverse Event|1|||
160807476|NCT03265145|580681416|FG001|Overall Study|Adverse Event|0|||
160807477|NCT03265145|580681415|FG000|Overall Study|Withdrawal by Subject|23|||
160807478|NCT03265145|580681416|FG001|Overall Study|Withdrawal by Subject|19|||
160807479|NCT03265145|580681415|FG000|Overall Study|Death|12|||
160807480|NCT03265145|580681416|FG001|Overall Study|Death|12|||
160807481|NCT03265145|580681415|FG000|Overall Study|Lost to Follow-up|13|||
160807482|NCT03265145|580681416|FG001|Overall Study|Lost to Follow-up|9|||
160807483|NCT03265145|580681415|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
160807484|NCT03265145|580681416|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
160807485|NCT03265145|580681415|FG000|Overall Study|Switched back to previous medication|1|||
160807486|NCT03265145|580681416|FG001|Overall Study|Switched back to previous medication|0|||
160807487|NCT03265145|580681415|FG000|Overall Study|Did not want to take medication|1|||
160807488|NCT03265145|580681416|FG001|Overall Study|Did not want to take medication|0|||
160807489|NCT03265145|580681415|FG000|Overall Study|Subject could not afford medication|0|||
160807490|NCT03265145|580681416|FG001|Overall Study|Subject could not afford medication|1|||
160807491|NCT03265145|580681415|FG000|Overall Study|Site closed|2|||
160807492|NCT03265145|580681416|FG001|Overall Study|Site closed|3|||
160807493|NCT03265145|580681415|FG000|Overall Study|Incorrectly randomized|16|||
160807494|NCT03265145|580681416|FG001|Overall Study|Incorrectly randomized|6|||
160807495|NCT03265145|580681415|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
160807496|NCT03265145|580681416|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
160807497|NCT03265145|580681415|FG000|Overall Study|Physician Decision|0|||
160807498|NCT03265145|580681416|FG001|Overall Study|Physician Decision|3|||
160807499|NCT03265145|580681415|FG000|Overall Study|Subject transferred to another facility|0|||
160807500|NCT03265145|580681416|FG001|Overall Study|Subject transferred to another facility|1|||
160807501|NCT03941483|580681417|FG000|Overall Study|Miscellaneous|2|||
160807502|NCT03941483|580681418|FG001|Overall Study|Miscellaneous|3|||
160807503|NCT03941483|580681419|FG002|Overall Study|Miscellaneous|0|||
160807504|NCT03941483|580681417|FG000|Overall Study|Study Terminated by Sponsor|1|||
160807505|NCT03941483|580681418|FG001|Overall Study|Study Terminated by Sponsor|0|||
160807506|NCT03941483|580681419|FG002|Overall Study|Study Terminated by Sponsor|0|||
160807507|NCT03941483|580681417|FG000|Overall Study|Withdrawal by Subject|1|||
160807508|NCT03941483|580681418|FG001|Overall Study|Withdrawal by Subject|4|||
160807509|NCT03941483|580681419|FG002|Overall Study|Withdrawal by Subject|1|||
160807510|NCT03941483|580681417|FG000|Overall Study|Lost to Follow-up|2|||
160807511|NCT03941483|580681418|FG001|Overall Study|Lost to Follow-up|1|||
160807512|NCT03941483|580681419|FG002|Overall Study|Lost to Follow-up|8|||
160807513|NCT03941483|580681417|FG000|Overall Study|Death|3|||
160807514|NCT03941483|580681418|FG001|Overall Study|Death|2|||
160807515|NCT03941483|580681419|FG002|Overall Study|Death|6|||
160807516|NCT02685826|580681424|FG000|Overall Study|Adverse Event|2|||
160807517|NCT02685826|580681425|FG001|Overall Study|Adverse Event|0|||
160807518|NCT02685826|580681426|FG002|Overall Study|Adverse Event|1|||
160807519|NCT02685826|580681424|FG000|Overall Study|Progressive Disease|2|||
160807520|NCT02685826|580681425|FG001|Overall Study|Progressive Disease|1|||
160807521|NCT02685826|580681426|FG002|Overall Study|Progressive Disease|0|||
160807522|NCT02685826|580681424|FG000|Overall Study|Withdrawal by Subject|2|||
160807523|NCT02685826|580681425|FG001|Overall Study|Withdrawal by Subject|0|||
160807524|NCT02685826|580681426|FG002|Overall Study|Withdrawal by Subject|0|||
160807525|NCT02685826|580681424|FG000|Overall Study|Full Clinical Hold by FDA|19|||
160807526|NCT02685826|580681425|FG001|Overall Study|Full Clinical Hold by FDA|9|||
160807527|NCT02685826|580681426|FG002|Overall Study|Full Clinical Hold by FDA|20|||
160807528|NCT03154476|580681427|FG000|Overall Study|Lost to Follow-up|4|||
160807529|NCT03154476|580681428|FG001|Overall Study|Lost to Follow-up|4|||
160807530|NCT01444430|580681430|FG000|Overall Study|Withdrawal by Subject|53|||
160807531|NCT01444430|580681431|FG001|Overall Study|Withdrawal by Subject|72|||
160807532|NCT01444430|580681430|FG000|Overall Study|Death|6|||
160807533|NCT01444430|580681431|FG001|Overall Study|Death|8|||
160807534|NCT01444430|580681430|FG000|Overall Study|Lost to Follow-up|2|||
160807535|NCT01444430|580681431|FG001|Overall Study|Lost to Follow-up|0|||
160807536|NCT01444430|580681430|FG000|Overall Study|CRF termination module not completed.|0|||
160807537|NCT01444430|580681431|FG001|Overall Study|CRF termination module not completed.|1|||
161332353|NCT00698815|582603597|FG000|Overall Study|MD discretion|2|||
161332354|NCT00698815|582603598|FG001|Overall Study|MD discretion|7|||
161332355|NCT00698815|582603599|FG002|Overall Study|MD discretion|2|||
161332356|NCT00698815|582603597|FG000|Overall Study|Did not receive protocol treatment|1|||
161332357|NCT00698815|582603598|FG001|Overall Study|Did not receive protocol treatment|2|||
161332358|NCT00698815|582603599|FG002|Overall Study|Did not receive protocol treatment|2|||
161332359|NCT03575702|582603600|FG000|Overall Study|Withdrawal by Subject|1|||
161332360|NCT03575702|582603601|FG001|Overall Study|Withdrawal by Subject|1|||
161332361|NCT03575702|582603600|FG000|Overall Study|Lost to Follow-up|1|||
161332362|NCT03575702|582603601|FG001|Overall Study|Lost to Follow-up|2|||
161332363|NCT03575702|582603600|FG000|Overall Study|Protocol Violation|0|||
161332364|NCT03575702|582603601|FG001|Overall Study|Protocol Violation|1|||
161332365|NCT03575702|582603600|FG000|Overall Study|Patient non compliance|4|||
161332366|NCT03575702|582603601|FG001|Overall Study|Patient non compliance|0|||
161332367|NCT00490035|582603606|FG000|Overall Study|AE, non-serious non-fatal|3|||
161332368|NCT00490035|582603607|FG001|Overall Study|AE, non-serious non-fatal|4|||
161332369|NCT00490035|582603608|FG002|Overall Study|AE, non-serious non-fatal|4|||
161332370|NCT00490035|582603609|FG003|Overall Study|AE, non-serious non-fatal|5|||
161332371|NCT00490035|582603606|FG000|Overall Study|Lost to Follow-up|2|||
160807538|NCT01142388|580682825|FG000|Overall Study|Lack of Efficacy|21|||
160807539|NCT01142388|580682826|FG001|Overall Study|Lack of Efficacy|31|||
160807540|NCT01142388|580682825|FG000|Overall Study|Adverse Event|9|||
160807541|NCT01142388|580682826|FG001|Overall Study|Adverse Event|5|||
161332372|NCT00490035|582603607|FG001|Overall Study|Lost to Follow-up|0|||
161332373|NCT00490035|582603608|FG002|Overall Study|Lost to Follow-up|1|||
160807542|NCT01142388|580682825|FG000|Overall Study|Death|3|||
160807543|NCT01142388|580682826|FG001|Overall Study|Death|2|||
160807544|NCT01142388|580682825|FG000|Overall Study|Withdrawal by Subject|5|||
160807545|NCT01142388|580682826|FG001|Overall Study|Withdrawal by Subject|3|||
160807546|NCT01142388|580682825|FG000|Overall Study|Alternative therapy|1|||
160807547|NCT01142388|580682826|FG001|Overall Study|Alternative therapy|0|||
160807548|NCT01142388|580682825|FG000|Overall Study|Other complications|0|||
160807549|NCT01142388|580682826|FG001|Overall Study|Other complications|2|||
160807550|NCT01142388|580682825|FG000|Overall Study|Other|1|||
160807551|NCT01142388|580682826|FG001|Overall Study|Other|1|||
160807552|NCT01142388|580682825|FG000|Overall Study|Never started therapy|7|||
160807553|NCT01142388|580682826|FG001|Overall Study|Never started therapy|3|||
160898543|NCT04402060|581023472|FG000|Overall Study|Sponsor Request|0|||
160898544|NCT04402060|581023473|FG001|Overall Study|Sponsor Request|2|||
160898545|NCT04402060|581023474|FG002|Overall Study|Sponsor Request|0|||
160898546|NCT04402060|581023472|FG000|Overall Study|Physician Decision|0|||
160898547|NCT04402060|581023473|FG001|Overall Study|Physician Decision|0|||
160898548|NCT04402060|581023474|FG002|Overall Study|Physician Decision|1|||
160898549|NCT04402060|581023472|FG000|Overall Study|Other|0|||
160898550|NCT04402060|581023473|FG001|Overall Study|Other|1|||
160898551|NCT04402060|581023474|FG002|Overall Study|Other|0|||
160898552|NCT00936611|581023475|FG000|Overall Study|Progressive Disease|3|||
160898553|NCT00936611|581023475|FG000|Overall Study|New Systemic Therapy|22|||
160898554|NCT00936611|581023475|FG000|Overall Study|Lost to Follow-up|1|||
160898555|NCT00936611|581023475|FG000|Overall Study|Withdrawal by Subject|2|||
160898556|NCT00936611|581023475|FG000|Overall Study|Still on Follow-up|1|||
160898557|NCT00936611|581023475|FG000|Overall Study|Still on Active Therapy|7|||
160898558|NCT00936611|581023475|FG000|Overall Study|Ineligible for Study Drug|3|||
160898559|NCT02282358|581023484|FG000|Overall Study|Nonevaluable|1|||
160898560|NCT01898208|581023485|FG000|Overall Study|Positive blood culture|17|||
160898561|NCT01898208|581023486|FG001|Overall Study|Positive blood culture|23|||
160898562|NCT01898208|581023487|FG002|Overall Study|Positive blood culture|15|||
160898563|NCT01898208|581023485|FG000|Overall Study|Death/comfort care within 24 hours|10|||
160898564|NCT01898208|581023486|FG001|Overall Study|Death/comfort care within 24 hours|9|||
160898565|NCT01898208|581023487|FG002|Overall Study|Death/comfort care within 24 hours|8|||
160898566|NCT01898208|581023485|FG000|Overall Study|Negative Gram Stain|6|||
160898567|NCT01898208|581023486|FG001|Overall Study|Negative Gram Stain|9|||
160898568|NCT01898208|581023487|FG002|Overall Study|Negative Gram Stain|6|||
160898569|NCT01898208|581023485|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
160898570|NCT01898208|581023486|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
160898571|NCT01898208|581023487|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
160898572|NCT01898208|581023485|FG000|Overall Study|System/Technical Error|1|||
160898573|NCT01898208|581023486|FG001|Overall Study|System/Technical Error|2|||
160898574|NCT01898208|581023487|FG002|Overall Study|System/Technical Error|3|||
160898575|NCT01898208|581023485|FG000|Overall Study|Lost to Follow-up|3|||
160898576|NCT01898208|581023486|FG001|Overall Study|Lost to Follow-up|1|||
160898577|NCT01898208|581023487|FG002|Overall Study|Lost to Follow-up|1|||
160898578|NCT00961649|581023488|FG000|Overall Study|Adverse Event|4|||
160898579|NCT00961649|581023489|FG001|Overall Study|Adverse Event|0|||
160898580|NCT00961649|581023490|FG002|Overall Study|Adverse Event|0|||
160898581|NCT00961649|581023491|FG003|Overall Study|Adverse Event|2|||
160898582|NCT00961649|581023488|FG000|Overall Study|Inadequate control of IOP|0|||
160898583|NCT00961649|581023489|FG001|Overall Study|Inadequate control of IOP|0|||
160898584|NCT00961649|581023490|FG002|Overall Study|Inadequate control of IOP|0|||
160898585|NCT00961649|581023491|FG003|Overall Study|Inadequate control of IOP|1|||
160898586|NCT00961649|581023488|FG000|Overall Study|Patient has travel plans during holidays|0|||
160898587|NCT00961649|581023489|FG001|Overall Study|Patient has travel plans during holidays|0|||
160898588|NCT00961649|581023490|FG002|Overall Study|Patient has travel plans during holidays|1|||
160898589|NCT00961649|581023491|FG003|Overall Study|Patient has travel plans during holidays|0|||
160898590|NCT00961649|581023488|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
160898591|NCT00961649|581023489|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
160898592|NCT00961649|581023490|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
160898593|NCT00961649|581023491|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
160898594|NCT00961649|581023488|FG000|Overall Study|Study terminated by sponsor|4|||
160898595|NCT00961649|581023489|FG001|Overall Study|Study terminated by sponsor|4|||
160898596|NCT00961649|581023490|FG002|Overall Study|Study terminated by sponsor|4|||
160898597|NCT00961649|581023491|FG003|Overall Study|Study terminated by sponsor|1|||
160898598|NCT02155881|581023492|FG000|Overall Study|Withdrawal by Subject|0|||
160898599|NCT02155881|581023493|FG001|Overall Study|Withdrawal by Subject|2|||
160898600|NCT02155881|581023492|FG000|Overall Study|Inappropriately randomized|2|||
160807554|NCT03640325|580682832|FG000|Overall Study|Withdrawal by Subject|4|||
160807555|NCT03640325|580682833|FG001|Overall Study|Withdrawal by Subject|1|||
160807556|NCT03640325|580682834|FG002|Overall Study|Withdrawal by Subject|0|||
160807557|NCT03640325|580682832|FG000|Overall Study|Lost to Follow-up|4|||
160807558|NCT03640325|580682833|FG001|Overall Study|Lost to Follow-up|5|||
160807559|NCT03640325|580682834|FG002|Overall Study|Lost to Follow-up|21|||
160807560|NCT03640325|580682832|FG000|Overall Study|Death|5|||
160898601|NCT02155881|581023493|FG001|Overall Study|Inappropriately randomized|2|||
160898602|NCT02711345|581023494|FG000|Overall Study|Adverse Event|0|||
160898603|NCT02711345|581023495|FG001|Overall Study|Adverse Event|0|||
160898604|NCT02711345|581023496|FG002|Overall Study|Adverse Event|0|||
160898605|NCT02711345|581023497|FG003|Overall Study|Adverse Event|1|||
160898606|NCT02711345|581023498|FG004|Overall Study|Adverse Event|1|||
160898607|NCT02711345|581023499|FG005|Overall Study|Adverse Event|2|||
160898608|NCT02711345|581023500|FG006|Overall Study|Adverse Event|1|||
160898609|NCT02711345|581023501|FG007|Overall Study|Adverse Event|0|||
160898610|NCT02711345|581023502|FG008|Overall Study|Adverse Event|0|||
160898611|NCT02711345|581023503|FG009|Overall Study|Adverse Event|2|||
160898612|NCT02711345|581023494|FG000|Overall Study|Physician Decision|0|||
160898613|NCT02711345|581023495|FG001|Overall Study|Physician Decision|0|||
160898614|NCT02711345|581023496|FG002|Overall Study|Physician Decision|1|||
160898615|NCT02711345|581023497|FG003|Overall Study|Physician Decision|0|||
160898616|NCT02711345|581023498|FG004|Overall Study|Physician Decision|0|||
160898617|NCT02711345|581023499|FG005|Overall Study|Physician Decision|0|||
160898618|NCT02711345|581023500|FG006|Overall Study|Physician Decision|0|||
160898619|NCT02711345|581023501|FG007|Overall Study|Physician Decision|0|||
160898620|NCT02711345|581023502|FG008|Overall Study|Physician Decision|1|||
160898621|NCT02711345|581023503|FG009|Overall Study|Physician Decision|0|||
160898622|NCT02711345|581023494|FG000|Overall Study|Progressive disease|1|||
160898623|NCT02711345|581023495|FG001|Overall Study|Progressive disease|3|||
160898624|NCT02711345|581023496|FG002|Overall Study|Progressive disease|5|||
160898625|NCT02711345|581023497|FG003|Overall Study|Progressive disease|3|||
160898626|NCT02711345|581023498|FG004|Overall Study|Progressive disease|7|||
160898627|NCT02711345|581023499|FG005|Overall Study|Progressive disease|2|||
160898628|NCT02711345|581023500|FG006|Overall Study|Progressive disease|8|||
160898629|NCT02711345|581023501|FG007|Overall Study|Progressive disease|4|||
160898630|NCT02711345|581023502|FG008|Overall Study|Progressive disease|5|||
160898631|NCT02711345|581023503|FG009|Overall Study|Progressive disease|6|||
160898632|NCT02711345|581023494|FG000|Overall Study|Subject/guardian decision|0|||
160898633|NCT02711345|581023495|FG001|Overall Study|Subject/guardian decision|0|||
160898634|NCT02711345|581023496|FG002|Overall Study|Subject/guardian decision|0|||
160898635|NCT02711345|581023497|FG003|Overall Study|Subject/guardian decision|0|||
160898636|NCT02711345|581023498|FG004|Overall Study|Subject/guardian decision|0|||
160898637|NCT02711345|581023499|FG005|Overall Study|Subject/guardian decision|2|||
160898638|NCT02711345|581023500|FG006|Overall Study|Subject/guardian decision|3|||
160898639|NCT02711345|581023501|FG007|Overall Study|Subject/guardian decision|1|||
160898640|NCT02711345|581023502|FG008|Overall Study|Subject/guardian decision|0|||
160898641|NCT02711345|581023503|FG009|Overall Study|Subject/guardian decision|4|||
160898642|NCT02711345|581023494|FG000|Overall Study|Death|1|||
160898643|NCT02711345|581023495|FG001|Overall Study|Death|0|||
160898644|NCT02711345|581023496|FG002|Overall Study|Death|0|||
160898645|NCT02711345|581023497|FG003|Overall Study|Death|0|||
160898646|NCT02711345|581023498|FG004|Overall Study|Death|0|||
160898647|NCT02711345|581023499|FG005|Overall Study|Death|0|||
160898648|NCT02711345|581023500|FG006|Overall Study|Death|0|||
160898649|NCT02711345|581023501|FG007|Overall Study|Death|1|||
160898650|NCT02711345|581023502|FG008|Overall Study|Death|0|||
160898651|NCT02711345|581023503|FG009|Overall Study|Death|0|||
160898652|NCT04357782|581023504|FG000|Overall Study|Discharged from hospital|1|||
160898653|NCT04357782|581023505|FG001|Overall Study|Discharged from hospital|0|||
160898654|NCT04357782|581023504|FG000|Overall Study|Death|0|||
160898655|NCT04357782|581023505|FG001|Overall Study|Death|2|||
160898656|NCT01786148|581023506|FG000|Overall Study|Lost to Follow-up|21|||
160898657|NCT01786148|581023507|FG001|Overall Study|Lost to Follow-up|13|||
160898658|NCT01786148|581023506|FG000|Overall Study|Death|0|||
160898659|NCT01786148|581023507|FG001|Overall Study|Death|1|||
160898660|NCT01786148|581023506|FG000|Overall Study|Withdrawal by Subject|0|||
160898661|NCT01786148|581023507|FG001|Overall Study|Withdrawal by Subject|7|||
161130813|NCT00896532|581863481|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
160898662|NCT01786148|581023506|FG000|Overall Study|Incarceration|1|||
160898663|NCT01786148|581023507|FG001|Overall Study|Incarceration|1|||
160898664|NCT03780543|581023509|FG000|Overall Study|Adverse Event|1|||
161130814|NCT00896532|581863459|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130815|NCT00896532|581863460|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130816|NCT00896532|581863461|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160898665|NCT03780543|581023510|FG001|Overall Study|Adverse Event|0|||
160898666|NCT03780543|581023511|FG002|Overall Study|Adverse Event|2|||
160898667|NCT03780543|581023509|FG000|Overall Study|Lost to Follow-up|2|||
160898668|NCT03780543|581023510|FG001|Overall Study|Lost to Follow-up|0|||
160898669|NCT03780543|581023511|FG002|Overall Study|Lost to Follow-up|1|||
160898670|NCT03780543|581023509|FG000|Overall Study|Study terminated by Sponsor|8|||
160898671|NCT03780543|581023510|FG001|Overall Study|Study terminated by Sponsor|7|||
160898672|NCT03780543|581023511|FG002|Overall Study|Study terminated by Sponsor|13|||
160898673|NCT03780543|581023509|FG000|Overall Study|Withdrawal by Subject|1|||
160898674|NCT03780543|581023510|FG001|Overall Study|Withdrawal by Subject|8|||
160898675|NCT03780543|581023511|FG002|Overall Study|Withdrawal by Subject|1|||
160985772|NCT01244763|581337011|FG001|Overall Study|Enrolled into the Extension Study|0|||
160985773|NCT01244763|581337012|FG002|Overall Study|Enrolled into the Extension Study|0|||
160985774|NCT01244763|581337013|FG003|Overall Study|Enrolled into the Extension Study|0|||
160985775|NCT01244763|581337014|FG004|Overall Study|Enrolled into the Extension Study|0|||
160985776|NCT01244763|581337015|FG005|Overall Study|Enrolled into the Extension Study|1|||
160985777|NCT02271594|581337016|FG000|Overall Study|Study closed; recruiting failure|19|||
160985778|NCT02271594|581337017|FG001|Overall Study|Study closed; recruiting failure|12|||
160985779|NCT03330119|581337020|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
160985780|NCT03330119|581337021|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
160985781|NCT01561079|581337022|FG000|Overall Study|Physician Decision|17|||
160985782|NCT01561079|581337022|FG000|Overall Study|Withdrawal by Subject|59|||
160985783|NCT01561079|581337022|FG000|Overall Study|Protocol Violation|2|||
160985784|NCT00550732|581337033|FG000|Overall Study|Death|4|||
160985785|NCT00550732|581337033|FG000|Overall Study|Withdrawal by Subject|2|||
160985786|NCT00550732|581337033|FG000|Overall Study|Physician Decision|2|||
160985787|NCT00550732|581337033|FG000|Overall Study|Lost to Follow-up|1|||
160985788|NCT00550732|581337033|FG000|Overall Study|Palliative care|1|||
160985789|NCT00550732|581337033|FG000|Overall Study|Adverse Event|1|||
160985790|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
160985791|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160985792|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
160985793|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160985794|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
160985795|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
160985796|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
160985797|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
160985798|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
160985799|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
160985800|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
160985801|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
160985802|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160985803|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
160985804|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160985805|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160985806|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
160985807|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
160985808|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985809|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985810|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985811|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985812|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
160985813|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
160985814|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985815|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985816|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985817|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985818|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
160985819|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160985820|NCT01323660|581337035|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
160985821|NCT01323660|581337036|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160985822|NCT01323660|581337037|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160985823|NCT01323660|581337038|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160985824|NCT01323660|581337039|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
160985825|NCT01323660|581337040|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160985826|NCT01323660|581337035|FG000|Washout Period (14 Days)|Adverse Event|0|||
160985827|NCT01323660|581337036|FG001|Washout Period (14 Days)|Adverse Event|0|||
160985828|NCT01323660|581337037|FG002|Washout Period (14 Days)|Adverse Event|0|||
160985829|NCT01323660|581337038|FG003|Washout Period (14 Days)|Adverse Event|0|||
160985830|NCT01323660|581337039|FG004|Washout Period (14 Days)|Adverse Event|1|||
160985831|NCT01323660|581337040|FG005|Washout Period (14 Days)|Adverse Event|0|||
160985832|NCT01323660|581337035|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
160985833|NCT01323660|581337036|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
160985834|NCT01323660|581337037|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
160985835|NCT01323660|581337038|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
160985836|NCT01323660|581337039|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
160985837|NCT01323660|581337040|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
160985838|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160985839|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
160985840|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161238508|NCT00968812|582253763|FG001|Overall Study|Other|37|||
160898676|NCT03780543|581023509|FG000|Overall Study|Noncompliance with study drug|1|||
160898677|NCT03780543|581023510|FG001|Overall Study|Noncompliance with study drug|0|||
160898678|NCT03780543|581023511|FG002|Overall Study|Noncompliance with study drug|0|||
160898679|NCT01033851|581023512|FG000|Overall Study|Withdrawal by Subject|3|||
160898680|NCT01033851|581023513|FG001|Overall Study|Withdrawal by Subject|7|||
160898681|NCT00338104|581023514|FG000|Overall Study|Protocol Violation|2|||
160898682|NCT00338104|581023515|FG001|Overall Study|Protocol Violation|1|||
160898683|NCT00338104|581023516|FG002|Overall Study|Protocol Violation|3|||
160898684|NCT02362269|581023519|FG000|Overall Study|Moved|1|||
160898685|NCT02362269|581023520|FG001|Overall Study|Moved|0|||
160898686|NCT02362269|581023519|FG000|Overall Study|Lost to Follow-up|0|||
160898687|NCT02362269|581023520|FG001|Overall Study|Lost to Follow-up|6|||
160898688|NCT03841448|581023521|FG000|Double-blind Treatment (DBT) Period|Death|1|||
160898689|NCT03841448|581023522|FG001|Double-blind Treatment (DBT) Period|Death|1|||
160898690|NCT03841448|581023523|FG002|Double-blind Treatment (DBT) Period|Death|0|||
160898691|NCT03841448|581023524|FG003|Double-blind Treatment (DBT) Period|Death|0|||
160898692|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
160898693|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
160898694|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
160898695|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
160898696|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Death|0|||
160898697|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Death|0|||
160898698|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Death|0|||
160898699|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Death|1|||
160898700|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
160898701|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
160898702|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
160898703|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
160898704|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
160898705|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
160898706|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
160898707|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
160898708|NCT03841448|581023521|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
160898709|NCT03841448|581023522|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
160898710|NCT03841448|581023523|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
160898711|NCT03841448|581023524|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
160898712|NCT04068610|581023525|FG000|Overall Study|Death|4|||
160898713|NCT04068610|581023526|FG001|Overall Study|Death|8|||
160898714|NCT04068610|581023527|FG002|Overall Study|Death|13|||
160898715|NCT04068610|581023525|FG000|Overall Study|Lost to Follow-up|0|||
160898716|NCT04068610|581023526|FG001|Overall Study|Lost to Follow-up|2|||
160898717|NCT04068610|581023527|FG002|Overall Study|Lost to Follow-up|0|||
160898718|NCT04068610|581023525|FG000|Overall Study|Withdrawal by Subject|0|||
160898719|NCT04068610|581023526|FG001|Overall Study|Withdrawal by Subject|4|||
160898720|NCT04068610|581023527|FG002|Overall Study|Withdrawal by Subject|2|||
160898721|NCT04068610|581023525|FG000|Overall Study|Other|3|||
160898722|NCT04068610|581023526|FG001|Overall Study|Other|12|||
160898723|NCT04068610|581023527|FG002|Overall Study|Other|11|||
160898724|NCT00072176|581023528|FG000|Overall Study|Withdrawal by Subject|1|||
160898725|NCT00072176|581023529|FG001|Overall Study|Withdrawal by Subject|0|||
160898726|NCT00072176|581023528|FG000|Overall Study|Protocol Violation|0|||
160898727|NCT00072176|581023529|FG001|Overall Study|Protocol Violation|1|||
160898728|NCT02586064|581023530|FG000|Overall Study|Other Obligations|6|||
160898729|NCT02586064|581023531|FG001|Overall Study|Other Obligations|6|||
160898730|NCT02586064|581023530|FG000|Overall Study|Other|3|||
160898731|NCT02586064|581023531|FG001|Overall Study|Other|7|||
160898732|NCT02586064|581023530|FG000|Overall Study|Never Started|3|||
160898733|NCT02586064|581023531|FG001|Overall Study|Never Started|3|||
160985841|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160985842|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
160985843|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
160985844|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
160985845|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
160985846|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
160985847|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
160985848|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
160985849|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
160898734|NCT02586064|581023530|FG000|Overall Study|Lost Interest|1|||
160898735|NCT02586064|581023531|FG001|Overall Study|Lost Interest|4|||
160898736|NCT02586064|581023530|FG000|Overall Study|Miscellaneous Life Issues|0|||
160898737|NCT02586064|581023531|FG001|Overall Study|Miscellaneous Life Issues|5|||
160985850|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160985851|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160898738|NCT02586064|581023530|FG000|Overall Study|Infrequent Attendance|2|||
161238509|NCT00968812|582253764|FG002|Overall Study|Other|40|||
161238510|NCT00834340|582253765|FG000|Washout|Adverse Event|1|||
161238511|NCT00834340|582253766|FG001|Washout|Adverse Event|0|||
161238512|NCT00834340|582253765|FG000|Washout|Withdrawal by Subject|1|||
161238513|NCT00834340|582253766|FG001|Washout|Withdrawal by Subject|0|||
161238514|NCT00395694|582253769|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
160807561|NCT03640325|580682833|FG001|Overall Study|Death|5|||
160807562|NCT03640325|580682834|FG002|Overall Study|Death|0|||
160807563|NCT05265728|580682835|FG000|Overall Study|Adverse Event|1|||
160807564|NCT05265728|580682835|FG000|Overall Study|Study Terminated by Sponsor|5|||
160807565|NCT05265728|580682835|FG000|Overall Study|Withdrawal by Subject|2|||
160807566|NCT03493451|580682836|FG000|Overall Study|Death|11|||
160807567|NCT03493451|580682837|FG001|Overall Study|Death|26|||
160807568|NCT03493451|580682838|FG002|Overall Study|Death|3|||
160807569|NCT03493451|580682836|FG000|Overall Study|Lost to Follow-up|1|||
160807570|NCT03493451|580682837|FG001|Overall Study|Lost to Follow-up|4|||
160807571|NCT03493451|580682838|FG002|Overall Study|Lost to Follow-up|1|||
160807572|NCT03493451|580682836|FG000|Overall Study|Withdrawal by Subject|1|||
160807573|NCT03493451|580682837|FG001|Overall Study|Withdrawal by Subject|1|||
160807574|NCT03493451|580682838|FG002|Overall Study|Withdrawal by Subject|2|||
160807575|NCT03493451|580682836|FG000|Overall Study|Progressive Disease|1|||
160807576|NCT03493451|580682837|FG001|Overall Study|Progressive Disease|0|||
160807577|NCT03493451|580682838|FG002|Overall Study|Progressive Disease|0|||
160807578|NCT03493451|580682836|FG000|Overall Study|Transferred to long term extension study|8|||
160807579|NCT03493451|580682837|FG001|Overall Study|Transferred to long term extension study|13|||
160807580|NCT03493451|580682838|FG002|Overall Study|Transferred to long term extension study|5|||
160807581|NCT01566149|580682841|FG000|Overall Study|Adverse Event|0|||
160898739|NCT02586064|581023531|FG001|Overall Study|Infrequent Attendance|1|||
160898740|NCT02586064|581023530|FG000|Overall Study|Timed Out|2|||
160898741|NCT02586064|581023531|FG001|Overall Study|Timed Out|0|||
160898742|NCT02586064|581023530|FG000|Overall Study|AUD relapse|0|||
160898743|NCT02586064|581023531|FG001|Overall Study|AUD relapse|2|||
160898744|NCT02586064|581023530|FG000|Overall Study|Legal Issue|1|||
160898745|NCT02586064|581023531|FG001|Overall Study|Legal Issue|0|||
160898746|NCT02158975|581023532|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
160898747|NCT00484094|581023533|FG000|Overall Study|Discontinued|39|||
160898748|NCT00484094|581023533|FG000|Overall Study|Other|3|||
160898749|NCT02728596|581023534|FG000|Overall Study|Refusal unrelated to adverse event|3|||
160898750|NCT02728596|581023535|FG001|Overall Study|Refusal unrelated to adverse event|6|||
160898751|NCT02728596|581023536|FG002|Overall Study|Refusal unrelated to adverse event|7|||
160898752|NCT02728596|581023537|FG003|Overall Study|Refusal unrelated to adverse event|7|||
160898753|NCT02728596|581023534|FG000|Overall Study|Death|44|||
160898754|NCT02728596|581023535|FG001|Overall Study|Death|42|||
160898755|NCT02728596|581023536|FG002|Overall Study|Death|123|||
160898756|NCT02728596|581023537|FG003|Overall Study|Death|68|||
160898757|NCT00309985|581023538|FG000|Overall Study|Disease progression|12|||
160898758|NCT00309985|581023539|FG001|Overall Study|Disease progression|0|||
160898759|NCT00309985|581023538|FG000|Overall Study|Adverse Event|30|||
160898760|NCT00309985|581023539|FG001|Overall Study|Adverse Event|0|||
160985852|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160807582|NCT01566149|580682842|FG001|Overall Study|Adverse Event|1|||
160807583|NCT01566149|580682841|FG000|Overall Study|Non-compliance with study medication|2|||
160807584|NCT01566149|580682842|FG001|Overall Study|Non-compliance with study medication|0|||
160807585|NCT01566149|580682841|FG000|Overall Study|Protocol Violation|0|||
160807586|NCT01566149|580682842|FG001|Overall Study|Protocol Violation|1|||
160807587|NCT01566149|580682841|FG000|Overall Study|Withdrawal by Subject|1|||
160807588|NCT01566149|580682842|FG001|Overall Study|Withdrawal by Subject|0|||
160807589|NCT03687957|580682847|FG000|Overall Study|Withdrawal by Subject|0|||
160807590|NCT03687957|580682848|FG001|Overall Study|Withdrawal by Subject|0|||
160807591|NCT03687957|580682849|FG002|Overall Study|Withdrawal by Subject|0|||
160807592|NCT03687957|580682850|FG003|Overall Study|Withdrawal by Subject|2|||
160807593|NCT03687957|580682851|FG004|Overall Study|Withdrawal by Subject|0|||
160807594|NCT03687957|580682852|FG005|Overall Study|Withdrawal by Subject|0|||
160898761|NCT00309985|581023538|FG000|Overall Study|Death|2|||
160898762|NCT00309985|581023539|FG001|Overall Study|Death|0|||
160985853|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160807595|NCT03687957|580682853|FG006|Overall Study|Withdrawal by Subject|3|||
160807596|NCT03687957|580682854|FG007|Overall Study|Withdrawal by Subject|1|||
160807597|NCT03687957|580682855|FG008|Overall Study|Withdrawal by Subject|1|||
160898763|NCT00309985|581023538|FG000|Overall Study|Withdrawal by Subject|5|||
161238515|NCT00395694|582253770|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
161238516|NCT00395694|582253769|FG000|Continuation Phase|Adverse Event|1|||
160898764|NCT00309985|581023539|FG001|Overall Study|Withdrawal by Subject|1|||
160898765|NCT00309985|581023538|FG000|Overall Study|Physician Decision|3|||
160898766|NCT00309985|581023539|FG001|Overall Study|Physician Decision|0|||
160898767|NCT00309985|581023538|FG000|Overall Study|Never started treatment|7|||
160898768|NCT00309985|581023539|FG001|Overall Study|Never started treatment|0|||
160898769|NCT00309985|581023538|FG000|Overall Study|Complicating disease|1|||
160985854|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
160985855|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
161130817|NCT00896532|581863462|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161332374|NCT00490035|582603609|FG003|Overall Study|Lost to Follow-up|0|||
161332375|NCT00490035|582603606|FG000|Overall Study|Withdrawal by Subject|2|||
161332376|NCT00490035|582603607|FG001|Overall Study|Withdrawal by Subject|1|||
161332377|NCT00490035|582603608|FG002|Overall Study|Withdrawal by Subject|1|||
161332378|NCT00490035|582603609|FG003|Overall Study|Withdrawal by Subject|0|||
161332379|NCT00490035|582603606|FG000|Overall Study|Other reason|0|||
161332380|NCT00490035|582603607|FG001|Overall Study|Other reason|1|||
161332381|NCT00490035|582603608|FG002|Overall Study|Other reason|3|||
161332382|NCT00490035|582603609|FG003|Overall Study|Other reason|1|||
160807598|NCT03687957|580682856|FG009|Overall Study|Withdrawal by Subject|0|||
160807599|NCT03687957|580682847|FG000|Overall Study|Disease progression|0|||
160807600|NCT03687957|580682848|FG001|Overall Study|Disease progression|1|||
160807601|NCT03687957|580682849|FG002|Overall Study|Disease progression|1|||
160807602|NCT03687957|580682850|FG003|Overall Study|Disease progression|2|||
160807603|NCT03687957|580682851|FG004|Overall Study|Disease progression|2|||
160807604|NCT03687957|580682852|FG005|Overall Study|Disease progression|0|||
160807605|NCT03687957|580682853|FG006|Overall Study|Disease progression|2|||
160807606|NCT03687957|580682854|FG007|Overall Study|Disease progression|1|||
160807607|NCT03687957|580682855|FG008|Overall Study|Disease progression|0|||
160807608|NCT03687957|580682856|FG009|Overall Study|Disease progression|0|||
160807609|NCT03687957|580682847|FG000|Overall Study|Physician Decision|0|||
160807610|NCT03687957|580682848|FG001|Overall Study|Physician Decision|0|||
160807611|NCT03687957|580682849|FG002|Overall Study|Physician Decision|0|||
160807612|NCT03687957|580682850|FG003|Overall Study|Physician Decision|2|||
160807613|NCT03687957|580682851|FG004|Overall Study|Physician Decision|1|||
160807614|NCT03687957|580682852|FG005|Overall Study|Physician Decision|0|||
160807615|NCT03687957|580682853|FG006|Overall Study|Physician Decision|1|||
160807616|NCT03687957|580682854|FG007|Overall Study|Physician Decision|0|||
160807617|NCT03687957|580682855|FG008|Overall Study|Physician Decision|0|||
160807618|NCT03687957|580682856|FG009|Overall Study|Physician Decision|0|||
160807619|NCT03687957|580682847|FG000|Overall Study|New malignancy|0|||
160807620|NCT03687957|580682848|FG001|Overall Study|New malignancy|0|||
160807621|NCT03687957|580682849|FG002|Overall Study|New malignancy|0|||
160807622|NCT03687957|580682850|FG003|Overall Study|New malignancy|0|||
160807623|NCT03687957|580682851|FG004|Overall Study|New malignancy|1|||
160807624|NCT03687957|580682852|FG005|Overall Study|New malignancy|0|||
160807625|NCT03687957|580682853|FG006|Overall Study|New malignancy|0|||
160807626|NCT03687957|580682854|FG007|Overall Study|New malignancy|0|||
160807627|NCT03687957|580682855|FG008|Overall Study|New malignancy|0|||
160807628|NCT03687957|580682856|FG009|Overall Study|New malignancy|0|||
160807629|NCT03687957|580682847|FG000|Overall Study|Adverse Event|0|||
160807630|NCT03687957|580682848|FG001|Overall Study|Adverse Event|0|||
160807631|NCT03687957|580682849|FG002|Overall Study|Adverse Event|0|||
160807632|NCT03687957|580682850|FG003|Overall Study|Adverse Event|0|||
160807633|NCT03687957|580682851|FG004|Overall Study|Adverse Event|0|||
160807634|NCT03687957|580682852|FG005|Overall Study|Adverse Event|2|||
160807635|NCT03687957|580682853|FG006|Overall Study|Adverse Event|0|||
160807636|NCT03687957|580682854|FG007|Overall Study|Adverse Event|3|||
160807637|NCT03687957|580682855|FG008|Overall Study|Adverse Event|0|||
160807638|NCT03687957|580682856|FG009|Overall Study|Adverse Event|0|||
160807639|NCT03687957|580682847|FG000|Overall Study|Patient went on hospice|0|||
160807640|NCT03687957|580682848|FG001|Overall Study|Patient went on hospice|0|||
160807641|NCT03687957|580682849|FG002|Overall Study|Patient went on hospice|0|||
160807642|NCT03687957|580682850|FG003|Overall Study|Patient went on hospice|0|||
160807643|NCT03687957|580682851|FG004|Overall Study|Patient went on hospice|0|||
160807644|NCT03687957|580682852|FG005|Overall Study|Patient went on hospice|0|||
160807645|NCT03687957|580682853|FG006|Overall Study|Patient went on hospice|1|||
160807646|NCT03687957|580682854|FG007|Overall Study|Patient went on hospice|0|||
160807647|NCT03687957|580682855|FG008|Overall Study|Patient went on hospice|0|||
160807648|NCT03687957|580682856|FG009|Overall Study|Patient went on hospice|0|||
160807649|NCT03687957|580682847|FG000|Overall Study|Death|0|||
160807650|NCT03687957|580682848|FG001|Overall Study|Death|0|||
160807651|NCT03687957|580682849|FG002|Overall Study|Death|0|||
160807652|NCT03687957|580682850|FG003|Overall Study|Death|0|||
160807653|NCT03687957|580682851|FG004|Overall Study|Death|0|||
160807654|NCT03687957|580682852|FG005|Overall Study|Death|0|||
160807655|NCT03687957|580682853|FG006|Overall Study|Death|0|||
160807656|NCT03687957|580682854|FG007|Overall Study|Death|1|||
160807657|NCT03687957|580682855|FG008|Overall Study|Death|0|||
160807658|NCT03687957|580682856|FG009|Overall Study|Death|0|||
160807659|NCT00617084|580682857|FG000|Overall Study|Withdrawal by Subject|5|||
160807660|NCT00617084|580682858|FG001|Overall Study|Withdrawal by Subject|7|||
160985856|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160807661|NCT00617084|580682857|FG000|Overall Study|Missed 12 Months visit|16|||
160807662|NCT00617084|580682858|FG001|Overall Study|Missed 12 Months visit|19|||
160807663|NCT01693250|580682859|FG000|Overall Study|Lost to Follow-up|2|||
160898770|NCT00309985|581023539|FG001|Overall Study|Complicating disease|0|||
160898771|NCT00309985|581023538|FG000|Overall Study|Non-compliance|1|||
160898772|NCT00309985|581023539|FG001|Overall Study|Non-compliance|0|||
160898773|NCT00309985|581023538|FG000|Overall Study|Chemotherapy discontinued only|1|||
160898774|NCT00309985|581023539|FG001|Overall Study|Chemotherapy discontinued only|0|||
160898775|NCT03672643|581023540|FG000|Overall Study|Adverse Event|3|||
160898776|NCT03672643|581023540|FG000|Overall Study|Death|2|||
160898777|NCT03672643|581023540|FG000|Overall Study|Withdrawal by Subject|1|||
160898778|NCT03672643|581023540|FG000|Overall Study|Progressive disease|11|||
160898779|NCT03672643|581023540|FG000|Overall Study|Global deterioration of health status|1|||
160898780|NCT03672643|581023540|FG000|Overall Study|Refused further treatment|7|||
160898781|NCT03672643|581023540|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
160898782|NCT04102189|581023541|FG000|Overall Study|Withdrawal by Subject|1|||
160898783|NCT04102189|581023542|FG001|Overall Study|Withdrawal by Subject|2|||
160898784|NCT04102189|581023541|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160898785|NCT04102189|581023542|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160898786|NCT04102189|581023541|FG000|Overall Study|Lost to Follow-up|1|||
160898787|NCT04102189|581023542|FG001|Overall Study|Lost to Follow-up|0|||
160898788|NCT00217620|581024702|FG000|Overall Study|Adverse Event|2|||
160898789|NCT00217620|581024702|FG000|Overall Study|Progression|31|||
160898790|NCT00217620|581024702|FG000|Overall Study|Not Protocol Specified|4|||
160898791|NCT00217620|581024702|FG000|Overall Study|Ineligible|13|||
160898792|NCT00217620|581024702|FG000|Overall Study|Never received treatment|1|||
160898793|NCT01314703|581024712|FG000|Overall Study|screen failure and closed enrollment|8|||
160898794|NCT01863953|581024713|FG000|Overall Study|Adverse Event|0|||
160898795|NCT01863953|581024714|FG001|Overall Study|Adverse Event|0|||
160898796|NCT01863953|581024715|FG002|Overall Study|Adverse Event|1|||
160898797|NCT02008318|581024721|FG000|Overall Study|Adverse Event|4|||
160898798|NCT02008318|581024722|FG001|Overall Study|Adverse Event|0|||
160898799|NCT02008318|581024721|FG000|Overall Study|Physician Decision|2|||
160898800|NCT02008318|581024722|FG001|Overall Study|Physician Decision|0|||
160898801|NCT02008318|581024721|FG000|Overall Study|Progressive Disease|2|||
160898802|NCT02008318|581024722|FG001|Overall Study|Progressive Disease|0|||
160898803|NCT02008318|581024721|FG000|Overall Study|Protocol Violation|1|||
160898804|NCT02008318|581024722|FG001|Overall Study|Protocol Violation|1|||
160898805|NCT02008318|581024721|FG000|Overall Study|Withdrawal by Subject|3|||
160898806|NCT02008318|581024722|FG001|Overall Study|Withdrawal by Subject|0|||
160898807|NCT02281773|581024723|FG000|Overall Study|Adverse Event|6|||
160898808|NCT02281773|581024724|FG001|Overall Study|Adverse Event|1|||
160898809|NCT02281773|581024725|FG002|Overall Study|Adverse Event|4|||
160898810|NCT02281773|581024726|FG003|Overall Study|Adverse Event|8|||
160898811|NCT02281773|581024727|FG004|Overall Study|Adverse Event|9|||
160898812|NCT02281773|581024723|FG000|Overall Study|Protocol Violation|1|||
160898813|NCT02281773|581024724|FG001|Overall Study|Protocol Violation|0|||
160898814|NCT02281773|581024725|FG002|Overall Study|Protocol Violation|0|||
160898815|NCT02281773|581024726|FG003|Overall Study|Protocol Violation|2|||
160898816|NCT02281773|581024727|FG004|Overall Study|Protocol Violation|2|||
160898817|NCT02281773|581024723|FG000|Overall Study|Lost to Follow-up|2|||
160898818|NCT02281773|581024724|FG001|Overall Study|Lost to Follow-up|2|||
160898819|NCT02281773|581024725|FG002|Overall Study|Lost to Follow-up|6|||
160898820|NCT02281773|581024726|FG003|Overall Study|Lost to Follow-up|2|||
160898821|NCT02281773|581024727|FG004|Overall Study|Lost to Follow-up|10|||
160898822|NCT02281773|581024723|FG000|Overall Study|Withdrawal by Subject|2|||
160898823|NCT02281773|581024724|FG001|Overall Study|Withdrawal by Subject|8|||
160898824|NCT02281773|581024725|FG002|Overall Study|Withdrawal by Subject|6|||
160898825|NCT02281773|581024726|FG003|Overall Study|Withdrawal by Subject|6|||
160898826|NCT02281773|581024727|FG004|Overall Study|Withdrawal by Subject|8|||
160898827|NCT02281773|581024723|FG000|Overall Study|Other Reason|0|||
160898828|NCT02281773|581024724|FG001|Overall Study|Other Reason|4|||
160898829|NCT02281773|581024725|FG002|Overall Study|Other Reason|2|||
160898830|NCT02281773|581024726|FG003|Overall Study|Other Reason|3|||
160898831|NCT02281773|581024727|FG004|Overall Study|Other Reason|1|||
160898832|NCT00385762|581024728|FG000|Overall Study|Adverse Event|1|||
160985857|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160898833|NCT00385762|581024728|FG000|Overall Study|Lost to Follow-up|1|||
160898834|NCT05439941|581024729|FG000|Overall Study|Lack of Efficacy|8|||
160898835|NCT05439941|581024730|FG001|Overall Study|Lack of Efficacy|5|||
160898836|NCT05439941|581024731|FG002|Overall Study|Lack of Efficacy|3|||
160898837|NCT05439941|581024729|FG000|Overall Study|Treatment Failure|0|||
160898838|NCT05439941|581024730|FG001|Overall Study|Treatment Failure|1|||
160898839|NCT05439941|581024731|FG002|Overall Study|Treatment Failure|0|||
160898840|NCT05439941|581024729|FG000|Overall Study|Adverse Event|1|||
160898841|NCT05439941|581024730|FG001|Overall Study|Adverse Event|3|||
160898842|NCT05439941|581024731|FG002|Overall Study|Adverse Event|0|||
160898843|NCT05439941|581024729|FG000|Overall Study|Adverse Event - Parent Study|1|||
160898844|NCT05439941|581024730|FG001|Overall Study|Adverse Event - Parent Study|0|||
160898845|NCT05439941|581024731|FG002|Overall Study|Adverse Event - Parent Study|0|||
160898846|NCT05439941|581024729|FG000|Overall Study|Pregnancy|1|||
160898847|NCT05439941|581024730|FG001|Overall Study|Pregnancy|0|||
160898848|NCT05439941|581024731|FG002|Overall Study|Pregnancy|0|||
160898849|NCT05439941|581024729|FG000|Overall Study|Withdrawal by Subject|9|||
160898850|NCT05439941|581024730|FG001|Overall Study|Withdrawal by Subject|6|||
160898851|NCT05439941|581024731|FG002|Overall Study|Withdrawal by Subject|10|||
160898852|NCT05439941|581024729|FG000|Overall Study|Non-Compliance|1|||
160898853|NCT05439941|581024730|FG001|Overall Study|Non-Compliance|1|||
160898854|NCT05439941|581024731|FG002|Overall Study|Non-Compliance|1|||
160898855|NCT05439941|581024729|FG000|Overall Study|Lost to Follow-up|2|||
160898856|NCT05439941|581024730|FG001|Overall Study|Lost to Follow-up|2|||
160898857|NCT05439941|581024731|FG002|Overall Study|Lost to Follow-up|0|||
160898858|NCT05439941|581024729|FG000|Overall Study|Physician Decision|1|||
160898859|NCT05439941|581024730|FG001|Overall Study|Physician Decision|0|||
160898860|NCT05439941|581024731|FG002|Overall Study|Physician Decision|0|||
160898861|NCT05439941|581024729|FG000|Overall Study|Trial Termination by Sponsor|78|||
160898862|NCT05439941|581024730|FG001|Overall Study|Trial Termination by Sponsor|83|||
160898863|NCT05439941|581024731|FG002|Overall Study|Trial Termination by Sponsor|65|||
160898864|NCT05439941|581024729|FG000|Overall Study|Other than Reasons Listed|2|||
160898865|NCT05439941|581024730|FG001|Overall Study|Other than Reasons Listed|1|||
160898866|NCT05439941|581024731|FG002|Overall Study|Other than Reasons Listed|0|||
160898867|NCT00573183|581024732|FG000|Overall Study|Lost to Follow-up|52|||
160898868|NCT00573183|581024733|FG001|Overall Study|Lost to Follow-up|50|||
160898869|NCT00573183|581024732|FG000|Overall Study|Withdrawal by Subject|8|||
160898870|NCT00573183|581024733|FG001|Overall Study|Withdrawal by Subject|2|||
160898871|NCT00573183|581024732|FG000|Overall Study|Death|0|||
160898872|NCT00573183|581024733|FG001|Overall Study|Death|1|||
160898873|NCT00573183|581024732|FG000|Overall Study|Adverse Event|2|||
160898874|NCT00573183|581024733|FG001|Overall Study|Adverse Event|0|||
160898875|NCT00573183|581024732|FG000|Overall Study|Incarceration|5|||
160898876|NCT00573183|581024733|FG001|Overall Study|Incarceration|8|||
160898877|NCT00573183|581024732|FG000|Overall Study|Other|5|||
160898878|NCT00573183|581024733|FG001|Overall Study|Other|2|||
160898879|NCT02336373|581024736|FG000|Overall Study|Protocol closed early|4|||
160898880|NCT02336373|581024736|FG000|Overall Study|Physician Decision|14|||
160898881|NCT04798781|581024741|FG000|Overall Study|Withdrawal by Subject|1|||
160898882|NCT00615108|581024744|FG000|Overall Study|Adverse Event|122|||
160898883|NCT00615108|581024744|FG000|Overall Study|Other|370|||
160898884|NCT00615108|581024744|FG000|Overall Study|Lost to Follow-up|15|||
160898885|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
160898886|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
160898887|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
160898888|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
160898889|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
160898890|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
160898891|NCT00875979|581024745|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
160898892|NCT00875979|581024746|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
160898893|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
160898894|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
160898895|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
160898896|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
160898897|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
160898898|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
160898899|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
160898900|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
160898901|NCT00875979|581024745|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
160898902|NCT00875979|581024746|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
160898903|NCT04041375|581024747|FG000|Intervention Phase|Withdrawal by Subject|2|||
160898904|NCT04041375|581024748|FG001|Intervention Phase|Withdrawal by Subject|2|||
160898905|NCT04041375|581024747|FG000|Follow-up Phase|Death|2|||
160898906|NCT04041375|581024748|FG001|Follow-up Phase|Death|0|||
160898907|NCT04041375|581024747|FG000|Follow-up Phase|Lost to Follow-up|2|||
160898908|NCT04041375|581024748|FG001|Follow-up Phase|Lost to Follow-up|1|||
160898909|NCT04041375|581024747|FG000|Follow-up Phase|Too ill|3|||
160898910|NCT04041375|581024748|FG001|Follow-up Phase|Too ill|0|||
160898911|NCT02404220|581024754|FG000|Overall Study|Adverse Event|0|||
160898912|NCT02404220|581024755|FG001|Overall Study|Adverse Event|0|||
160898913|NCT02404220|581024756|FG002|Overall Study|Adverse Event|1|||
160898914|NCT02404220|581024757|FG003|Overall Study|Adverse Event|0|||
160898915|NCT02404220|581024754|FG000|Overall Study|Death|5|||
160898916|NCT02404220|581024755|FG001|Overall Study|Death|5|||
160898917|NCT02404220|581024756|FG002|Overall Study|Death|3|||
160898918|NCT02404220|581024757|FG003|Overall Study|Death|8|||
160898919|NCT02404220|581024754|FG000|Overall Study|Progressive Disease|0|||
160898920|NCT02404220|581024755|FG001|Overall Study|Progressive Disease|0|||
160898921|NCT02404220|581024756|FG002|Overall Study|Progressive Disease|1|||
160898922|NCT02404220|581024757|FG003|Overall Study|Progressive Disease|1|||
160898923|NCT02404220|581024754|FG000|Overall Study|Study Terminated by Sponsor|0|||
160898924|NCT02404220|581024755|FG001|Overall Study|Study Terminated by Sponsor|0|||
160898925|NCT02404220|581024756|FG002|Overall Study|Study Terminated by Sponsor|2|||
160898926|NCT02404220|581024757|FG003|Overall Study|Study Terminated by Sponsor|1|||
160898927|NCT02404220|581024754|FG000|Overall Study|Withdrawal by Subject|0|||
160898928|NCT02404220|581024755|FG001|Overall Study|Withdrawal by Subject|1|||
160898929|NCT02404220|581024756|FG002|Overall Study|Withdrawal by Subject|0|||
160898930|NCT02404220|581024757|FG003|Overall Study|Withdrawal by Subject|0|||
160898931|NCT02404220|581024754|FG000|Overall Study|Enrolled but Never Treated|0|||
160898932|NCT02404220|581024755|FG001|Overall Study|Enrolled but Never Treated|2|||
160898933|NCT02404220|581024756|FG002|Overall Study|Enrolled but Never Treated|0|||
160898934|NCT02404220|581024757|FG003|Overall Study|Enrolled but Never Treated|0|||
160898935|NCT00395733|581024758|FG000|Period 2|Withdrawal by Subject|1|||
160898936|NCT00395733|581024759|FG001|Period 2|Withdrawal by Subject|2|||
160898937|NCT00395733|581024758|FG000|Period 2|Protocol Violation|0|||
160898938|NCT00395733|581024759|FG001|Period 2|Protocol Violation|1|||
160898939|NCT00395733|581024758|FG000|Period 2|Adverse Event|0|||
160898940|NCT00395733|581024759|FG001|Period 2|Adverse Event|2|||
160898941|NCT00395733|581024758|FG000|Period 2|Technical problems|1|||
160898942|NCT00395733|581024759|FG001|Period 2|Technical problems|0|||
160898943|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
160898944|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
160898945|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Death|1|||
160898946|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Death|0|||
160898947|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
160898948|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
160898949|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
160898950|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
160898951|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
160898952|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
160898953|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
160898954|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
160898955|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
160898956|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
160898957|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
160898958|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
160898959|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
160898960|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
160898961|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
160898962|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
160898963|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
160898964|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
160898965|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
160898966|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
160898967|NCT02927262|581024762|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
160898968|NCT02927262|581024763|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
160898969|NCT02927262|581024762|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
160898970|NCT02927262|581024763|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
160898971|NCT02927262|581024762|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
160898972|NCT02927262|581024763|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
160898973|NCT02927262|581024762|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
160898974|NCT02927262|581024763|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
160898975|NCT02345226|581024768|FG000|Double-Blind Phase|Adverse Event|5|||
160898976|NCT02345226|581024769|FG001|Double-Blind Phase|Adverse Event|6|||
160898977|NCT02345226|581024768|FG000|Double-Blind Phase|Death|3|||
160898978|NCT02345226|581024769|FG001|Double-Blind Phase|Death|0|||
160898979|NCT02345226|581024768|FG000|Double-Blind Phase|Pregnancy|0|||
160898980|NCT02345226|581024769|FG001|Double-Blind Phase|Pregnancy|1|||
160898981|NCT02345226|581024768|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160898982|NCT02345226|581024769|FG001|Double-Blind Phase|Lack of Efficacy|0|||
160898983|NCT02345226|581024768|FG000|Double-Blind Phase|Investigator's Discretion|4|||
160898984|NCT02345226|581024769|FG001|Double-Blind Phase|Investigator's Discretion|3|||
160898985|NCT02345226|581024768|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
160985858|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161130818|NCT00896532|581863463|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160898986|NCT02345226|581024769|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
160898987|NCT02345226|581024768|FG000|Double-Blind Phase|Withdrew Consent|41|||
160985859|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
161130819|NCT00896532|581863464|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130820|NCT00896532|581863465|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130821|NCT00896532|581863466|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130822|NCT00896532|581863467|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130823|NCT00896532|581863468|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130824|NCT00896532|581863469|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160898988|NCT02345226|581024769|FG001|Double-Blind Phase|Withdrew Consent|39|||
160898989|NCT02345226|581024768|FG000|Double-Blind Phase|Lost to Follow-up|12|||
161130825|NCT00896532|581863470|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160898990|NCT02345226|581024769|FG001|Double-Blind Phase|Lost to Follow-up|16|||
160898991|NCT02345226|581024768|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
160898992|NCT02345226|581024769|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
160898993|NCT02345226|581024768|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160898994|NCT02345226|581024769|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
160898995|NCT03386474|581024770|FG000|Overall Study|Death|1|||
160898996|NCT03386474|581024771|FG001|Overall Study|Death|0|||
160898997|NCT03386474|581024770|FG000|Overall Study|Adverse Event|0|||
160898998|NCT03386474|581024771|FG001|Overall Study|Adverse Event|1|||
160898999|NCT03896165|581024774|FG000|Overall Study|Withdrawal by Subject|2|||
160899000|NCT01163266|581024775|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
160899001|NCT01163266|581024776|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
160899002|NCT01163266|581024777|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
160899003|NCT01163266|581024775|FG000|Overall Study|Lack of Efficacy|1|||
160899004|NCT01163266|581024776|FG001|Overall Study|Lack of Efficacy|3|||
160899005|NCT01163266|581024777|FG002|Overall Study|Lack of Efficacy|1|||
160899006|NCT01163266|581024775|FG000|Overall Study|Noncompliance with Study Drug|0|||
160899007|NCT01163266|581024776|FG001|Overall Study|Noncompliance with Study Drug|2|||
160899008|NCT01163266|581024777|FG002|Overall Study|Noncompliance with Study Drug|0|||
160899009|NCT01163266|581024775|FG000|Overall Study|Protocol Deviations|2|||
160899010|NCT01163266|581024776|FG001|Overall Study|Protocol Deviations|2|||
160899011|NCT01163266|581024777|FG002|Overall Study|Protocol Deviations|5|||
160899012|NCT01163266|581024775|FG000|Overall Study|Withdrawal of Consent|5|||
160899013|NCT01163266|581024776|FG001|Overall Study|Withdrawal of Consent|7|||
160899014|NCT01163266|581024777|FG002|Overall Study|Withdrawal of Consent|3|||
160899015|NCT01163266|581024775|FG000|Overall Study|Lost to Follow-up|7|||
160899016|NCT01163266|581024776|FG001|Overall Study|Lost to Follow-up|7|||
160899017|NCT01163266|581024777|FG002|Overall Study|Lost to Follow-up|10|||
160899018|NCT01163266|581024775|FG000|Overall Study|Other|1|||
160899019|NCT01163266|581024776|FG001|Overall Study|Other|1|||
160899020|NCT01163266|581024777|FG002|Overall Study|Other|2|||
160899021|NCT02919696|581024778|FG000|Overall Study|Adverse Event|1|||
160899022|NCT02919696|581024779|FG001|Overall Study|Adverse Event|2|||
160899023|NCT02919696|581024778|FG000|Overall Study|Withdrawal by Subject|2|||
160899024|NCT02919696|581024779|FG001|Overall Study|Withdrawal by Subject|1|||
160899025|NCT02919696|581024778|FG000|Overall Study|Sponsor Decision|1|||
160899026|NCT02919696|581024779|FG001|Overall Study|Sponsor Decision|1|||
160899027|NCT02919696|581024778|FG000|Overall Study|Never Treated|0|||
160899028|NCT02919696|581024779|FG001|Overall Study|Never Treated|1|||
160899029|NCT03181893|581024780|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899030|NCT03181893|581024781|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
160899031|NCT03181893|581024782|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899032|NCT03181893|581024783|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899033|NCT03181893|581024784|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899034|NCT03181893|581024785|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899035|NCT03181893|581024786|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899036|NCT03181893|581024787|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899037|NCT03181893|581024788|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899038|NCT03181893|581024789|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899039|NCT03181893|581024790|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
160899040|NCT03181893|581024780|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
160899041|NCT03181893|581024781|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
160899042|NCT03181893|581024782|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
161130826|NCT00896532|581863471|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
161130827|NCT00896532|581863472|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
160899043|NCT03181893|581024783|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899044|NCT03181893|581024784|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899045|NCT03181893|581024785|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899046|NCT03181893|581024786|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899047|NCT03181893|581024787|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899048|NCT03181893|581024788|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899049|NCT03181893|581024789|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899050|NCT03181893|581024790|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
160899051|NCT03181893|581024780|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899052|NCT03181893|581024781|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899053|NCT03181893|581024782|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899054|NCT03181893|581024783|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899055|NCT03181893|581024784|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899056|NCT03181893|581024785|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899057|NCT03181893|581024786|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899058|NCT03181893|581024787|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
160899059|NCT03181893|581024788|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
160899060|NCT03181893|581024789|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899061|NCT03181893|581024790|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
160899062|NCT03181893|581024780|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899063|NCT03181893|581024781|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899064|NCT03181893|581024782|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899065|NCT03181893|581024783|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899066|NCT03181893|581024784|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899067|NCT03181893|581024785|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899068|NCT03181893|581024786|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899069|NCT03181893|581024787|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899070|NCT03181893|581024788|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899071|NCT03181893|581024789|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
160899072|NCT03181893|581024790|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
160899073|NCT03181893|581024780|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899074|NCT03181893|581024781|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160807664|NCT01693250|580682860|FG001|Overall Study|Lost to Follow-up|2|||
160807665|NCT03783962|580682863|FG000|Overall Study|Lost to Follow-up|3|||
160807666|NCT03783962|580682864|FG001|Overall Study|Lost to Follow-up|6|||
160807667|NCT03783962|580682863|FG000|Overall Study|Protocol Violation|0|||
160807668|NCT03783962|580682864|FG001|Overall Study|Protocol Violation|1|||
160807669|NCT03458325|580682865|FG000|Overall Study|Withdrawal by Subject|1|||
160807670|NCT01766037|580682866|FG000|Overall Study|Adverse Event|1|||
160807671|NCT01766037|580682867|FG001|Overall Study|Adverse Event|0|||
160807672|NCT01766037|580682866|FG000|Overall Study|Lack of Efficacy|1|||
160807673|NCT01766037|580682867|FG001|Overall Study|Lack of Efficacy|0|||
160807674|NCT01766037|580682866|FG000|Overall Study|Lost to Follow-up|0|||
160807675|NCT01766037|580682867|FG001|Overall Study|Lost to Follow-up|10|||
160899075|NCT03181893|581024782|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899076|NCT03181893|581024783|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899077|NCT03181893|581024784|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899078|NCT03181893|581024785|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899079|NCT03181893|581024786|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899080|NCT03181893|581024787|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899081|NCT03181893|581024788|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899082|NCT03181893|581024789|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
160899083|NCT03181893|581024790|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
160807676|NCT01766037|580682866|FG000|Overall Study|Physician Decision|0|||
160807677|NCT01766037|580682867|FG001|Overall Study|Physician Decision|1|||
160807678|NCT01766037|580682866|FG000|Overall Study|Withdrawal by Subject|18|||
160899084|NCT03021304|581024794|FG000|Overall Study|Lack of Efficacy|1|||
160899085|NCT04815031|581024795|FG000|Overall Study|No adverse event information (missing information)|33|||
160899086|NCT03594994|581024798|FG000|Overall Study|Adverse Event|1|||
160899087|NCT03594994|581024799|FG001|Overall Study|Adverse Event|0|||
160899088|NCT03594994|581024798|FG000|Overall Study|Withdrawal by Subject|0|||
160899089|NCT03594994|581024799|FG001|Overall Study|Withdrawal by Subject|1|||
160899090|NCT03774082|581024805|FG000|Overall Study|Death|6|||
160899091|NCT03774082|581024806|FG001|Overall Study|Death|3|||
160899092|NCT03774082|581024807|FG002|Overall Study|Death|2|||
160899093|NCT03774082|581024805|FG000|Overall Study|Subject decision|0|||
160899094|NCT03774082|581024806|FG001|Overall Study|Subject decision|3|||
160899095|NCT03774082|581024807|FG002|Overall Study|Subject decision|0|||
160899096|NCT03774082|581024805|FG000|Overall Study|Lost to Follow-up|2|||
160899097|NCT03774082|581024806|FG001|Overall Study|Lost to Follow-up|0|||
160899098|NCT03774082|581024807|FG002|Overall Study|Lost to Follow-up|0|||
161130828|NCT00896532|581863473|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130829|NCT00896532|581863474|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160807679|NCT01766037|580682867|FG001|Overall Study|Withdrawal by Subject|16|||
160899099|NCT03774082|581024805|FG000|Overall Study|Guardian decision|0|||
160899100|NCT03774082|581024806|FG001|Overall Study|Guardian decision|0|||
160899101|NCT03774082|581024807|FG002|Overall Study|Guardian decision|1|||
160807680|NCT01766037|580682866|FG000|Overall Study|Moved from area|5|||
160807681|NCT01766037|580682867|FG001|Overall Study|Moved from area|0|||
160807682|NCT01766037|580682866|FG000|Overall Study|medical - unrelated|1|||
160807683|NCT01766037|580682867|FG001|Overall Study|medical - unrelated|2|||
160807684|NCT01766037|580682866|FG000|Overall Study|nausea / discomfort|3|||
160807685|NCT01766037|580682867|FG001|Overall Study|nausea / discomfort|0|||
160807686|NCT05226598|580682868|FG000|Overall Study|Death|186|||
160807687|NCT05226598|580682869|FG001|Overall Study|Death|191|||
160807688|NCT05226598|580682868|FG000|Overall Study|Withdrawal by Subject|6|||
160807689|NCT05226598|580682869|FG001|Overall Study|Withdrawal by Subject|6|||
160807690|NCT05226598|580682868|FG000|Overall Study|Ongoing|174|||
160807691|NCT05226598|580682869|FG001|Overall Study|Ongoing|176|||
160807692|NCT01282866|580682871|FG000|Overall Study|Adverse Event|1|||
160807693|NCT04834726|580682872|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
160807694|NCT04834726|580682873|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
160807695|NCT04834726|580682874|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
160807696|NCT04834726|580682875|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
161130830|NCT00896532|581863475|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160807697|NCT04834726|580682876|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
160807698|NCT04834726|580682877|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
160807699|NCT04834726|580682878|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
161130831|NCT00896532|581863476|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130832|NCT00896532|581863477|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130833|NCT00896532|581863478|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
160807700|NCT04834726|580682879|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
160807701|NCT04834726|580682880|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
160807702|NCT03465722|580682882|FG000|Overall Study|Withdrawal by Subject|21|||
160807703|NCT03465722|580682883|FG001|Overall Study|Withdrawal by Subject|14|||
160807704|NCT03465722|580682882|FG000|Overall Study|Death|89|||
160807705|NCT03465722|580682883|FG001|Overall Study|Death|87|||
160807706|NCT03465722|580682882|FG000|Overall Study|Lost to Follow-up|5|||
160807707|NCT03465722|580682883|FG001|Overall Study|Lost to Follow-up|3|||
160807708|NCT03465722|580682882|FG000|Overall Study|Administrative/Other|33|||
160807709|NCT03465722|580682883|FG001|Overall Study|Administrative/Other|32|||
160807710|NCT03465722|580682882|FG000|Overall Study|Not treated|1|||
160807711|NCT03465722|580682883|FG001|Overall Study|Not treated|2|||
160807712|NCT03465722|580682882|FG000|Overall Study|Sponsor decision|91|||
160807713|NCT03465722|580682883|FG001|Overall Study|Sponsor decision|98|||
160807714|NCT02948582|580682886|FG000|Washout Period 1|Adverse Event|0|||
160807715|NCT02948582|580682887|FG001|Washout Period 1|Adverse Event|2|||
160807716|NCT02948582|580682888|FG002|Washout Period 1|Adverse Event|0|||
160807717|NCT02948582|580682889|FG003|Washout Period 1|Adverse Event|0|||
160807718|NCT02948582|580682890|FG004|Washout Period 1|Adverse Event|0|||
160807719|NCT02948582|580682891|FG005|Washout Period 1|Adverse Event|0|||
160807720|NCT02948582|580682886|FG000|Washout Period 1|Protocol Violation|0|||
160807721|NCT02948582|580682887|FG001|Washout Period 1|Protocol Violation|0|||
160807722|NCT02948582|580682888|FG002|Washout Period 1|Protocol Violation|0|||
160807723|NCT02948582|580682889|FG003|Washout Period 1|Protocol Violation|0|||
160807724|NCT02948582|580682890|FG004|Washout Period 1|Protocol Violation|0|||
160807725|NCT02948582|580682891|FG005|Washout Period 1|Protocol Violation|1|||
160807726|NCT02948582|580682886|FG000|Washout Period 2|Adverse Event|0|||
160807727|NCT02948582|580682887|FG001|Washout Period 2|Adverse Event|1|||
160807728|NCT02948582|580682888|FG002|Washout Period 2|Adverse Event|0|||
160807729|NCT02948582|580682889|FG003|Washout Period 2|Adverse Event|0|||
160807730|NCT02948582|580682890|FG004|Washout Period 2|Adverse Event|0|||
160807731|NCT02948582|580682891|FG005|Washout Period 2|Adverse Event|0|||
160807732|NCT02948582|580682886|FG000|Washout Period 2|personal reasons|0|||
160899102|NCT03774082|581024805|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
160899103|NCT03774082|581024806|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
160899104|NCT03774082|581024807|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
160899105|NCT01950390|581024808|FG000|Overall Study|Never started treatment|3|||
161130834|NCT00896532|581863479|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130835|NCT00896532|581863480|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130836|NCT00896532|581863481|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
161130837|NCT00896532|581863459|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
161130838|NCT00896532|581863460|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
161130839|NCT00896532|581863461|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
161130840|NCT00896532|581863462|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
161130841|NCT00896532|581863463|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
161130842|NCT00896532|581863464|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
161130843|NCT00896532|581863465|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
160807733|NCT02948582|580682887|FG001|Washout Period 2|personal reasons|0|||
160807734|NCT02948582|580682888|FG002|Washout Period 2|personal reasons|0|||
160807735|NCT02948582|580682889|FG003|Washout Period 2|personal reasons|1|||
160807736|NCT02948582|580682890|FG004|Washout Period 2|personal reasons|0|||
160807737|NCT02948582|580682891|FG005|Washout Period 2|personal reasons|0|||
160807738|NCT02948582|580682886|FG000|Washout Period 4|Adverse Event|1|||
160807739|NCT02948582|580682887|FG001|Washout Period 4|Adverse Event|0|||
160807740|NCT02948582|580682888|FG002|Washout Period 4|Adverse Event|1|||
160807741|NCT02948582|580682889|FG003|Washout Period 4|Adverse Event|0|||
160807742|NCT02948582|580682890|FG004|Washout Period 4|Adverse Event|0|||
160807743|NCT02948582|580682891|FG005|Washout Period 4|Adverse Event|0|||
160807744|NCT03810014|580682892|FG000|Overall Study|Pregnancy|2|||
160807745|NCT03810014|580682893|FG001|Overall Study|Pregnancy|2|||
160807746|NCT03810014|580682894|FG002|Overall Study|Pregnancy|0|||
160807747|NCT03810014|580682895|FG003|Overall Study|Pregnancy|2|||
160807748|NCT03606486|580682901|FG000|Overall Study|Unable to collect sample|5|||
160807749|NCT00442416|580682908|FG000|Overall Study|Adverse Event|4|||
160807750|NCT00442416|580682909|FG001|Overall Study|Adverse Event|1|||
160807751|NCT00442416|580682908|FG000|Overall Study|Death|1|||
160807752|NCT00442416|580682909|FG001|Overall Study|Death|0|||
160807753|NCT00442416|580682908|FG000|Overall Study|Lack of Efficacy|2|||
160807754|NCT00442416|580682909|FG001|Overall Study|Lack of Efficacy|0|||
160807755|NCT00442416|580682908|FG000|Overall Study|Protocol Violation|2|||
160807756|NCT00442416|580682909|FG001|Overall Study|Protocol Violation|3|||
160807757|NCT00442416|580682908|FG000|Overall Study|Withdrew consent|1|||
160807758|NCT00442416|580682909|FG001|Overall Study|Withdrew consent|2|||
160807759|NCT00442416|580682908|FG000|Overall Study|Administrative/Other|27|||
160807760|NCT00442416|580682909|FG001|Overall Study|Administrative/Other|33|||
160807761|NCT00955474|580682921|FG000|Overall Study|Physician Decision|7|||
160807762|NCT00955474|580682922|FG001|Overall Study|Physician Decision|5|||
160807763|NCT00132301|580682925|FG000|Overall Study|Death|7|||
160807764|NCT00132301|580682926|FG001|Overall Study|Death|6|||
160807765|NCT00132301|580682925|FG000|Overall Study|Withdrawal by Subject|5|||
160807766|NCT00132301|580682926|FG001|Overall Study|Withdrawal by Subject|2|||
160807767|NCT00132301|580682925|FG000|Overall Study|Physician Decision|1|||
160807768|NCT00132301|580682926|FG001|Overall Study|Physician Decision|1|||
160807769|NCT00132301|580682925|FG000|Overall Study|Lost to Follow-up|5|||
160807770|NCT00132301|580682926|FG001|Overall Study|Lost to Follow-up|3|||
160807771|NCT00132301|580682925|FG000|Overall Study|Other|1|||
160807772|NCT00132301|580682926|FG001|Overall Study|Other|1|||
160807773|NCT00132301|580682925|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
160807774|NCT00132301|580682926|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
160807775|NCT03517436|580682928|FG000|Overall Study|Death|3|||
160807776|NCT03517436|580682928|FG000|Overall Study|Withdrawal by Subject|4|||
160807777|NCT03517436|580682928|FG000|Overall Study|Did not receive study valve.|1|||
160807778|NCT04271540|580682929|FG000|Overall Study|Lost to Follow-up|1|||
160807779|NCT04271540|580682929|FG000|Overall Study|Screen Fail|5|||
160807780|NCT04587869|580682932|FG000|Overall Study|Death|1|||
160807781|NCT04587869|580682933|FG001|Overall Study|Death|0|||
160807782|NCT04587869|580682932|FG000|Overall Study|Lost to Follow-up|27|||
160807783|NCT04587869|580682933|FG001|Overall Study|Lost to Follow-up|34|||
160807784|NCT04587869|580682932|FG000|Overall Study|Grant Termination|13|||
160807785|NCT04587869|580682933|FG001|Overall Study|Grant Termination|25|||
160807786|NCT04587869|580682932|FG000|Overall Study|too busy|2|||
160807787|NCT04587869|580682933|FG001|Overall Study|too busy|0|||
160807788|NCT04587869|580682932|FG000|Overall Study|Withdrawal by Subject|2|||
160807789|NCT04587869|580682933|FG001|Overall Study|Withdrawal by Subject|2|||
160807790|NCT04587869|580682932|FG000|Overall Study|Other|1|||
160807791|NCT04587869|580682933|FG001|Overall Study|Other|0|||
160807792|NCT02268383|580682934|FG000|Overall Study|Death|12|||
160807793|NCT02268383|580682934|FG000|Overall Study|Lost to Follow-up|2|||
160807794|NCT02268383|580682934|FG000|Overall Study|Withdrawal by Subject|9|||
160807795|NCT02268383|580682934|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
160807796|NCT02268383|580682934|FG000|Overall Study|Protocol deviation|3|||
160807797|NCT02268383|580682934|FG000|Overall Study|Sponsor decision|22|||
160807798|NCT02268383|580682934|FG000|Overall Study|Not reported|12|||
160807799|NCT00943761|580682935|FG000|Overall Study|Lost to Follow-up|2|||
160899106|NCT01950390|581024809|FG001|Overall Study|Never started treatment|2|||
160807800|NCT00943761|580682936|FG001|Overall Study|Lost to Follow-up|0|||
160807801|NCT00943761|580682935|FG000|Overall Study|Withdrawal by Subject|2|||
160807802|NCT00943761|580682936|FG001|Overall Study|Withdrawal by Subject|1|||
160899107|NCT01950390|581024808|FG000|Overall Study|Disease progression|45|||
161238517|NCT00395694|582253770|FG001|Continuation Phase|Adverse Event|0|||
161238518|NCT00395694|582253769|FG000|Continuation Phase|Lack of Efficacy|12|||
160807803|NCT03382912|580682937|FG000|Overall Study|Physician Decision|0|||
160807804|NCT03382912|580682938|FG001|Overall Study|Physician Decision|1|||
160807805|NCT03382912|580682937|FG000|Overall Study|Sponsor Decision|6|||
160807806|NCT03382912|580682938|FG001|Overall Study|Sponsor Decision|6|||
160807807|NCT03382912|580682937|FG000|Overall Study|Withdrawal by Subject|0|||
160807808|NCT03382912|580682938|FG001|Overall Study|Withdrawal by Subject|5|||
160807809|NCT05526521|580682943|FG000|Overall Study|Withdrawal by Subject|0|||
160807810|NCT05526521|580682944|FG001|Overall Study|Withdrawal by Subject|1|||
160899108|NCT01950390|581024809|FG001|Overall Study|Disease progression|52|||
161238519|NCT00395694|582253770|FG001|Continuation Phase|Lack of Efficacy|11|||
160807811|NCT05526521|580682945|FG002|Overall Study|Withdrawal by Subject|0|||
160807812|NCT05526521|580682946|FG003|Overall Study|Withdrawal by Subject|0|||
160807813|NCT03929913|580682947|FG000|Overall Study|Death|4|||
160807814|NCT03929913|580682947|FG000|Overall Study|Lost to Follow-up|1|||
160807815|NCT03929913|580682947|FG000|Overall Study|Failed Procedure|2|||
160807816|NCT03919929|580682950|FG000|Overall Study|Withdrawal by Subject|0|||
160807817|NCT03919929|580682951|FG001|Overall Study|Withdrawal by Subject|4|||
160807818|NCT03919929|580682950|FG000|Overall Study|Screen Failure|0|||
160807819|NCT03919929|580682951|FG001|Overall Study|Screen Failure|5|||
160807820|NCT01402869|580682952|FG000|Overall Study|Required Tooth Extraction|0|||
160807821|NCT01402869|580682953|FG001|Overall Study|Required Tooth Extraction|0|||
160807822|NCT01402869|580682954|FG002|Overall Study|Required Tooth Extraction|1|||
160807823|NCT01544348|580682955|FG000|Overall Study|Lost to Follow-up|1|||
160807824|NCT01544348|580682956|FG001|Overall Study|Lost to Follow-up|0|||
160807825|NCT01544348|580682957|FG002|Overall Study|Lost to Follow-up|0|||
160807826|NCT01544348|580682958|FG003|Overall Study|Lost to Follow-up|0|||
160807827|NCT01544348|580682959|FG004|Overall Study|Lost to Follow-up|0|||
160807828|NCT01544348|580682960|FG005|Overall Study|Lost to Follow-up|0|||
160807829|NCT01544348|580682961|FG006|Overall Study|Lost to Follow-up|1|||
160807830|NCT01544348|580682962|FG007|Overall Study|Lost to Follow-up|0|||
160807831|NCT01544348|580682955|FG000|Overall Study|Withdrawal by Subject|1|||
160807832|NCT01544348|580682956|FG001|Overall Study|Withdrawal by Subject|0|||
160807833|NCT01544348|580682957|FG002|Overall Study|Withdrawal by Subject|0|||
160807834|NCT01544348|580682958|FG003|Overall Study|Withdrawal by Subject|0|||
160807835|NCT01544348|580682959|FG004|Overall Study|Withdrawal by Subject|1|||
160807836|NCT01544348|580682960|FG005|Overall Study|Withdrawal by Subject|2|||
160807837|NCT01544348|580682961|FG006|Overall Study|Withdrawal by Subject|1|||
160807838|NCT01544348|580682962|FG007|Overall Study|Withdrawal by Subject|0|||
160807839|NCT01544348|580682955|FG000|Overall Study|Physician Decision|0|||
160807840|NCT01544348|580682956|FG001|Overall Study|Physician Decision|0|||
160807841|NCT01544348|580682957|FG002|Overall Study|Physician Decision|0|||
160807842|NCT01544348|580682958|FG003|Overall Study|Physician Decision|0|||
160807843|NCT01544348|580682959|FG004|Overall Study|Physician Decision|0|||
160807844|NCT01544348|580682960|FG005|Overall Study|Physician Decision|1|||
160807845|NCT01544348|580682961|FG006|Overall Study|Physician Decision|0|||
160807846|NCT01544348|580682962|FG007|Overall Study|Physician Decision|0|||
160807847|NCT00642707|580682963|FG000|Overall Study|Adverse Event|0|||
160807848|NCT00642707|580682964|FG001|Overall Study|Adverse Event|0|||
160807849|NCT00642707|580682965|FG002|Overall Study|Adverse Event|0|||
160807850|NCT00642707|580682966|FG003|Overall Study|Adverse Event|2|||
160807851|NCT00642707|580682963|FG000|Overall Study|Withdrawal by Subject|1|||
160807852|NCT00642707|580682964|FG001|Overall Study|Withdrawal by Subject|0|||
160807853|NCT00642707|580682965|FG002|Overall Study|Withdrawal by Subject|0|||
160807854|NCT00642707|580682966|FG003|Overall Study|Withdrawal by Subject|0|||
160807855|NCT01837680|580682972|FG000|Overall Study|Lost to Follow-up|2|||
160807856|NCT01837680|580682973|FG001|Overall Study|Lost to Follow-up|2|||
160807857|NCT01837680|580682972|FG000|Overall Study|lack of insurance|0|||
160807858|NCT01837680|580682973|FG001|Overall Study|lack of insurance|2|||
160807859|NCT01837680|580682972|FG000|Overall Study|allergic reaction|6|||
160807860|NCT01837680|580682973|FG001|Overall Study|allergic reaction|0|||
160807861|NCT01837680|580682972|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
160807862|NCT01837680|580682973|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
160807863|NCT03008070|580682974|FG000|Overall Study|Adverse Event|3|||
160807864|NCT03008070|580682975|FG001|Overall Study|Adverse Event|3|||
160807865|NCT03008070|580682976|FG002|Overall Study|Adverse Event|3|||
160807866|NCT03008070|580682974|FG000|Overall Study|Lost to Follow-up|1|||
160807867|NCT03008070|580682975|FG001|Overall Study|Lost to Follow-up|1|||
160807868|NCT03008070|580682976|FG002|Overall Study|Lost to Follow-up|0|||
160807869|NCT03008070|580682974|FG000|Overall Study|Non compliance|0|||
160807870|NCT03008070|580682975|FG001|Overall Study|Non compliance|1|||
160807871|NCT03008070|580682976|FG002|Overall Study|Non compliance|1|||
160899109|NCT01950390|581024808|FG000|Overall Study|Adverse Event|22|||
160899110|NCT01950390|581024809|FG001|Overall Study|Adverse Event|16|||
160807872|NCT03008070|580682974|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
160807873|NCT03008070|580682975|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
160807874|NCT03008070|580682976|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
160807875|NCT03008070|580682974|FG000|Overall Study|Withdrawal by Subject|2|||
160807876|NCT03008070|580682975|FG001|Overall Study|Withdrawal by Subject|0|||
160807877|NCT03008070|580682976|FG002|Overall Study|Withdrawal by Subject|1|||
160807878|NCT03008070|580682974|FG000|Overall Study|Use of prohibited drug|0|||
160807879|NCT03008070|580682975|FG001|Overall Study|Use of prohibited drug|0|||
160899111|NCT01950390|581024808|FG000|Overall Study|Death|5|||
160807880|NCT03008070|580682976|FG002|Overall Study|Use of prohibited drug|2|||
160807881|NCT05005273|580682977|FG000|Overall Study|Study Terminated|1|||
160807882|NCT05005273|580682978|FG001|Overall Study|Study Terminated|0|||
160807883|NCT04409834|580682979|FG000|Overall Study|Death|55|||
160807884|NCT04409834|580682980|FG001|Overall Study|Death|62|||
160899112|NCT01950390|581024809|FG001|Overall Study|Death|3|||
160807885|NCT03960684|580682982|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
160807886|NCT03533660|580682983|FG000|Overall Study|Withdrawal by Subject|2|||
160807887|NCT03533660|580682984|FG001|Overall Study|Withdrawal by Subject|2|||
160807888|NCT03533660|580682983|FG000|Overall Study|Death|2|||
160807889|NCT03533660|580682984|FG001|Overall Study|Death|4|||
161238520|NCT00395694|582253769|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
161238521|NCT00395694|582253770|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
161238522|NCT00395694|582253769|FG000|Continuation Phase|Poor Compliance|1|||
161238523|NCT00395694|582253770|FG001|Continuation Phase|Poor Compliance|0|||
161238524|NCT00395694|582253769|FG000|Continuation Phase|Withdrawal by Subject|0|||
161238525|NCT00395694|582253770|FG001|Continuation Phase|Withdrawal by Subject|2|||
161238526|NCT04238754|582253772|FG000|Washout - 1 Week|Lost to Follow-up|1|||
161238527|NCT04238754|582253773|FG001|Washout - 1 Week|Lost to Follow-up|0|||
161238528|NCT01175018|582253782|FG000|Overall Study|Adverse Event|3|||
161238529|NCT01175018|582253783|FG001|Overall Study|Adverse Event|1|||
161238530|NCT00835263|582253789|FG000|Second Intervention|Adverse Event|1|||
161238531|NCT00835263|582253790|FG001|Second Intervention|Adverse Event|0|||
161238532|NCT03249454|582253791|FG000|Overall Study|Withdrawal by Subject|0|||
161238533|NCT03249454|582253792|FG001|Overall Study|Withdrawal by Subject|0|||
161238534|NCT03249454|582253793|FG002|Overall Study|Withdrawal by Subject|0|||
161238535|NCT03249454|582253794|FG003|Overall Study|Withdrawal by Subject|0|||
161238536|NCT03249454|582253795|FG004|Overall Study|Withdrawal by Subject|0|||
161238537|NCT03249454|582253796|FG005|Overall Study|Withdrawal by Subject|0|||
161238538|NCT03249454|582253797|FG006|Overall Study|Withdrawal by Subject|0|||
161238539|NCT03249454|582253798|FG007|Overall Study|Withdrawal by Subject|0|||
161238540|NCT03249454|582253799|FG008|Overall Study|Withdrawal by Subject|0|||
161238541|NCT03249454|582253800|FG009|Overall Study|Withdrawal by Subject|1|||
161238542|NCT03249454|582253801|FG010|Overall Study|Withdrawal by Subject|1|||
161238543|NCT01020474|582253802|FG000|Overall Study|Adverse Event|4|||
161238544|NCT01020474|582253803|FG001|Overall Study|Adverse Event|4|||
161238545|NCT01020474|582253802|FG000|Overall Study|Protocol Violation|0|||
161238546|NCT01020474|582253803|FG001|Overall Study|Protocol Violation|2|||
161238547|NCT01020474|582253802|FG000|Overall Study|Withdrawal by Subject|5|||
161238548|NCT01020474|582253803|FG001|Overall Study|Withdrawal by Subject|7|||
161238549|NCT01020474|582253802|FG000|Overall Study|Other Reasons|1|||
161238550|NCT01020474|582253803|FG001|Overall Study|Other Reasons|1|||
161238551|NCT01020474|582253802|FG000|Overall Study|Insufficient Clinical Response|0|||
161238552|NCT01020474|582253803|FG001|Overall Study|Insufficient Clinical Response|3|||
161238553|NCT03256695|582253804|FG000|Overall Study|Adverse Event|8|||
161238554|NCT03256695|582253804|FG000|Overall Study|Death|2|||
161238555|NCT03256695|582253804|FG000|Overall Study|Withdrawal by Subject|14|||
161238556|NCT03256695|582253804|FG000|Overall Study|Non-compliance with study drug|1|||
161238557|NCT03256695|582253804|FG000|Overall Study|Lost to Follow-up|3|||
161238558|NCT03256695|582253804|FG000|Overall Study|Lack of Efficacy|3|||
161238559|NCT03256695|582253804|FG000|Overall Study|Protocol Violation|5|||
161238560|NCT03256695|582253804|FG000|Overall Study|Other than specified|3|||
161238561|NCT01103713|582253809|FG000|Overall Study|Lost to Follow-up|2|||
161238562|NCT01103713|582253809|FG000|Overall Study|Withdrawal by Subject|8|||
161238563|NCT01103713|582253809|FG000|Overall Study|Study terminated by sponsor|2|||
161238564|NCT01103713|582253809|FG000|Overall Study|Other|1|||
161238565|NCT02645409|582253810|FG000|Overall Study|Withdrawal by Subject|3|||
161238566|NCT02645409|582253811|FG001|Overall Study|Withdrawal by Subject|0|||
161238567|NCT02645409|582253810|FG000|Overall Study|Physician Decision|1|||
161238568|NCT02645409|582253811|FG001|Overall Study|Physician Decision|0|||
161238569|NCT02089685|582253812|FG000|Overall Study|Adverse Event|1|||
161238570|NCT02089685|582253813|FG001|Overall Study|Adverse Event|0|||
161238571|NCT02089685|582253814|FG002|Overall Study|Adverse Event|0|||
161238572|NCT02089685|582253815|FG003|Overall Study|Adverse Event|0|||
161238573|NCT02089685|582253816|FG004|Overall Study|Adverse Event|1|||
161238574|NCT02089685|582253817|FG005|Overall Study|Adverse Event|0|||
161238575|NCT02089685|582253812|FG000|Overall Study|Clinical Progression|4|||
161238576|NCT02089685|582253813|FG001|Overall Study|Clinical Progression|0|||
161238577|NCT02089685|582253814|FG002|Overall Study|Clinical Progression|0|||
161238578|NCT02089685|582253815|FG003|Overall Study|Clinical Progression|5|||
161238579|NCT02089685|582253816|FG004|Overall Study|Clinical Progression|1|||
161238580|NCT02089685|582253817|FG005|Overall Study|Clinical Progression|2|||
161238581|NCT02089685|582253812|FG000|Overall Study|Excluded Medication|1|||
161238582|NCT02089685|582253813|FG001|Overall Study|Excluded Medication|0|||
161238583|NCT02089685|582253814|FG002|Overall Study|Excluded Medication|0|||
161238584|NCT02089685|582253815|FG003|Overall Study|Excluded Medication|11|||
161238585|NCT02089685|582253816|FG004|Overall Study|Excluded Medication|2|||
161238586|NCT02089685|582253817|FG005|Overall Study|Excluded Medication|1|||
161238587|NCT02089685|582253812|FG000|Overall Study|Progressive disease|13|||
160807890|NCT03533660|580682983|FG000|Overall Study|Adverse Event|0|||
161238588|NCT02089685|582253813|FG001|Overall Study|Progressive disease|10|||
161238589|NCT02089685|582253814|FG002|Overall Study|Progressive disease|3|||
161238590|NCT02089685|582253815|FG003|Overall Study|Progressive disease|51|||
161238591|NCT02089685|582253816|FG004|Overall Study|Progressive disease|17|||
160807891|NCT03533660|580682984|FG001|Overall Study|Adverse Event|2|||
160807892|NCT03941873|580684497|FG000|Overall Study|Death|0|||
160807893|NCT03941873|580684498|FG001|Overall Study|Death|12|||
160807894|NCT03941873|580684499|FG002|Overall Study|Death|2|||
160807895|NCT03941873|580684500|FG003|Overall Study|Death|53|||
160807896|NCT03941873|580684497|FG000|Overall Study|Withdrawal by Subject|1|||
160807897|NCT03941873|580684498|FG001|Overall Study|Withdrawal by Subject|1|||
160807898|NCT03941873|580684499|FG002|Overall Study|Withdrawal by Subject|0|||
160807899|NCT03941873|580684500|FG003|Overall Study|Withdrawal by Subject|5|||
160807900|NCT03941873|580684497|FG000|Overall Study|Lost to Follow-up|1|||
160807901|NCT03941873|580684498|FG001|Overall Study|Lost to Follow-up|2|||
160807902|NCT03941873|580684499|FG002|Overall Study|Lost to Follow-up|0|||
160807903|NCT03941873|580684500|FG003|Overall Study|Lost to Follow-up|0|||
160807904|NCT03941873|580684497|FG000|Overall Study|Sponsor Decision|0|||
160807905|NCT03941873|580684498|FG001|Overall Study|Sponsor Decision|6|||
160807906|NCT03941873|580684499|FG002|Overall Study|Sponsor Decision|0|||
160807907|NCT03941873|580684500|FG003|Overall Study|Sponsor Decision|15|||
160807908|NCT03276728|580684503|FG000|Overall Study|Lost to Follow-up|0|||
160807909|NCT03276728|580684504|FG001|Overall Study|Lost to Follow-up|0|||
160807910|NCT03276728|580684505|FG002|Overall Study|Lost to Follow-up|2|||
160807911|NCT03276728|580684506|FG003|Overall Study|Lost to Follow-up|2|||
160807912|NCT03276728|580684507|FG004|Overall Study|Lost to Follow-up|0|||
160807913|NCT03276728|580684508|FG005|Overall Study|Lost to Follow-up|0|||
160807914|NCT03276728|580684509|FG006|Overall Study|Lost to Follow-up|0|||
160807915|NCT03276728|580684510|FG007|Overall Study|Lost to Follow-up|0|||
160807916|NCT03276728|580684503|FG000|Overall Study|Withdrawal by Subject|0|||
160807917|NCT03276728|580684504|FG001|Overall Study|Withdrawal by Subject|0|||
160899113|NCT01950390|581024808|FG000|Overall Study|Withdrawal by Subject|5|||
160899114|NCT01950390|581024809|FG001|Overall Study|Withdrawal by Subject|1|||
160899115|NCT01950390|581024808|FG000|Overall Study|Alternative therapy|0|||
160985860|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
160985861|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
160985862|NCT01323660|581337035|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160985863|NCT01323660|581337036|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160985864|NCT01323660|581337037|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160985865|NCT01323660|581337038|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160985866|NCT01323660|581337039|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
160985867|NCT01323660|581337040|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160985868|NCT00926393|581337043|FG000|Overall Study|Withdrawal by Subject|1|||
160985869|NCT00926393|581337044|FG001|Overall Study|Withdrawal by Subject|2|||
160899116|NCT01950390|581024809|FG001|Overall Study|Alternative therapy|3|||
160899117|NCT01950390|581024808|FG000|Overall Study|Complicating disease|1|||
160899118|NCT01950390|581024809|FG001|Overall Study|Complicating disease|0|||
160899119|NCT01950390|581024808|FG000|Overall Study|On treatment|1|||
160899120|NCT01950390|581024809|FG001|Overall Study|On treatment|0|||
160899121|NCT01950390|581024808|FG000|Overall Study|Symptomatic deterioration|2|||
160899122|NCT01950390|581024809|FG001|Overall Study|Symptomatic deterioration|1|||
160899123|NCT01950390|581024808|FG000|Overall Study|Physician Decision|0|||
160899124|NCT01950390|581024809|FG001|Overall Study|Physician Decision|4|||
160899125|NCT01950390|581024808|FG000|Overall Study|Lack of clinical benefit|0|||
160899126|NCT01950390|581024809|FG001|Overall Study|Lack of clinical benefit|1|||
160899127|NCT01950390|581024808|FG000|Overall Study|Maintained PR and moved to observation only|0|||
160899128|NCT01950390|581024809|FG001|Overall Study|Maintained PR and moved to observation only|1|||
160899129|NCT05938920|581024810|FG000|Overall Study|Adverse Event|1|||
160899130|NCT05938920|581024811|FG001|Overall Study|Adverse Event|3|||
160899131|NCT05938920|581024812|FG002|Overall Study|Adverse Event|2|||
160899132|NCT05938920|581024813|FG003|Overall Study|Adverse Event|1|||
160899133|NCT05938920|581024810|FG000|Overall Study|Death|0|||
160899134|NCT05938920|581024811|FG001|Overall Study|Death|1|||
160899135|NCT05938920|581024812|FG002|Overall Study|Death|0|||
160899136|NCT05938920|581024813|FG003|Overall Study|Death|0|||
160899137|NCT05938920|581024810|FG000|Overall Study|Lost to Follow-up|0|||
161130844|NCT00896532|581863466|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
161130845|NCT00896532|581863467|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
161130846|NCT00896532|581863468|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
160899138|NCT05938920|581024811|FG001|Overall Study|Lost to Follow-up|0|||
161130847|NCT00896532|581863469|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
161332383|NCT00490035|582603606|FG000|Overall Study|AE, serious fatal|1|||
160807918|NCT03276728|580684505|FG002|Overall Study|Withdrawal by Subject|0|||
160807919|NCT03276728|580684506|FG003|Overall Study|Withdrawal by Subject|3|||
160899139|NCT05938920|581024812|FG002|Overall Study|Lost to Follow-up|1|||
160899140|NCT05938920|581024813|FG003|Overall Study|Lost to Follow-up|0|||
160899141|NCT05938920|581024810|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
160899142|NCT05938920|581024811|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
160899143|NCT05938920|581024812|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
160807920|NCT03276728|580684507|FG004|Overall Study|Withdrawal by Subject|0|||
160899144|NCT05938920|581024813|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
160985870|NCT00926393|581337043|FG000|Overall Study|Adverse Event|1|||
160985871|NCT00926393|581337044|FG001|Overall Study|Adverse Event|1|||
160985872|NCT01403987|581337046|FG000|Overall Study|Residents forgot their secret PIN|18|||
160985873|NCT01403987|581337047|FG001|Overall Study|Residents forgot their secret PIN|17|||
160985874|NCT01403987|581337048|FG002|Overall Study|Residents forgot their secret PIN|18|||
160985875|NCT00751790|581337053|FG000|Overall Study|Lost to Follow-up|1|||
160985876|NCT00751790|581337053|FG000|Overall Study|Death|3|||
160985877|NCT00751790|581337053|FG000|Overall Study|Withdrawal by Subject|1|||
160985878|NCT00180674|581337055|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
160985879|NCT00180674|581337055|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
160985880|NCT03302910|581337056|FG000|Overall Study|Protocol Violation|1|||
160985881|NCT03302910|581337057|FG001|Overall Study|Protocol Violation|0|||
160985882|NCT01106976|581337058|FG000|Overall Study|Lost to Follow-up|8|||
160985883|NCT01477749|581337059|FG000|Overall Study|Physician Decision|4|||
160985884|NCT04004208|581337062|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160985885|NCT04004208|581337063|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160985886|NCT04004208|581337062|FG000|Overall Study|Death|3|||
160985887|NCT04004208|581337063|FG001|Overall Study|Death|0|||
160985888|NCT04004208|581337062|FG000|Overall Study|COVID-19 pandemic|1|||
160985889|NCT04004208|581337063|FG001|Overall Study|COVID-19 pandemic|0|||
160985890|NCT04004208|581337062|FG000|Overall Study|Physician Decision|1|||
160985891|NCT04004208|581337063|FG001|Overall Study|Physician Decision|0|||
160985892|NCT04004208|581337062|FG000|Overall Study|Adverse Event|1|||
160985893|NCT04004208|581337063|FG001|Overall Study|Adverse Event|1|||
160985894|NCT04990440|581337064|FG000|Overall Study|Sponsor's Decision|0|||
160985895|NCT04990440|581337065|FG001|Overall Study|Sponsor's Decision|0|||
160985896|NCT04990440|581337066|FG002|Overall Study|Sponsor's Decision|1|||
160985897|NCT02118714|581337067|FG000|Overall Study|Lost to Follow-up|2|||
160985898|NCT02118714|581337067|FG000|Overall Study|Protocol Violation|1|||
160985899|NCT02300311|581337073|FG000|Overall Study|Other than the reason specified|1|||
160985900|NCT02300311|581337074|FG001|Overall Study|Other than the reason specified|0|||
160985901|NCT02300311|581337073|FG000|Overall Study|Refused to continue taking medication|18|||
160985902|NCT02300311|581337074|FG001|Overall Study|Refused to continue taking medication|0|||
160985903|NCT02687919|581337075|FG000|Overall Study|Withdrawal by Subject|6|||
160985904|NCT02687919|581337076|FG001|Overall Study|Withdrawal by Subject|6|||
160985905|NCT02687919|581337075|FG000|Overall Study|Protocol Violation|2|||
160985906|NCT02687919|581337076|FG001|Overall Study|Protocol Violation|0|||
160985907|NCT00419003|581337077|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
160985908|NCT00419003|581337078|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
160985909|NCT00419003|581337077|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
160985910|NCT00419003|581337078|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
160899145|NCT05938920|581024810|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
160899146|NCT05938920|581024811|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
160899147|NCT05938920|581024812|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
160899148|NCT05938920|581024813|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
160899149|NCT05938920|581024810|FG000|Overall Study|Participant Refused to Come In|0|||
160899150|NCT05938920|581024811|FG001|Overall Study|Participant Refused to Come In|0|||
160899151|NCT05938920|581024812|FG002|Overall Study|Participant Refused to Come In|1|||
160899152|NCT05938920|581024813|FG003|Overall Study|Participant Refused to Come In|0|||
160899153|NCT01251861|581024814|FG000|Overall Study|Disease progression|6|||
160899154|NCT01251861|581024815|FG001|Overall Study|Disease progression|6|||
160899155|NCT01251861|581024814|FG000|Overall Study|Adverse Event|2|||
160899156|NCT01251861|581024815|FG001|Overall Study|Adverse Event|17|||
160899157|NCT01251861|581024814|FG000|Overall Study|Withdrawal by Subject|2|||
160899158|NCT01251861|581024815|FG001|Overall Study|Withdrawal by Subject|2|||
160899159|NCT01251861|581024814|FG000|Overall Study|Alternative therapy|1|||
160899160|NCT01251861|581024815|FG001|Overall Study|Alternative therapy|0|||
160899161|NCT01251861|581024814|FG000|Overall Study|Other complicating disease|0|||
160985911|NCT01653847|581337079|FG000|Overall Study|Withdrawal by Subject|1|||
160985912|NCT01653847|581337080|FG001|Overall Study|Withdrawal by Subject|0|||
160985913|NCT02554513|581337082|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
161238592|NCT02089685|582253817|FG005|Overall Study|Progressive disease|12|||
161238593|NCT02089685|582253812|FG000|Overall Study|Follow up ended by sponsor|2|||
161238594|NCT02089685|582253813|FG001|Overall Study|Follow up ended by sponsor|2|||
161238595|NCT02089685|582253814|FG002|Overall Study|Follow up ended by sponsor|0|||
160985914|NCT02554513|581337083|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
160985915|NCT01094743|581338519|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
160985916|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
160985917|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
160985918|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
161238596|NCT02089685|582253815|FG003|Overall Study|Follow up ended by sponsor|70|||
161238597|NCT02089685|582253816|FG004|Overall Study|Follow up ended by sponsor|26|||
160807921|NCT03276728|580684508|FG005|Overall Study|Withdrawal by Subject|0|||
160807922|NCT03276728|580684509|FG006|Overall Study|Withdrawal by Subject|0|||
160807923|NCT03276728|580684510|FG007|Overall Study|Withdrawal by Subject|0|||
160807924|NCT03276728|580684503|FG000|Overall Study|Decision by sponsor|0|||
160807925|NCT03276728|580684504|FG001|Overall Study|Decision by sponsor|0|||
160807926|NCT03276728|580684505|FG002|Overall Study|Decision by sponsor|0|||
160807927|NCT03276728|580684506|FG003|Overall Study|Decision by sponsor|0|||
160807928|NCT03276728|580684507|FG004|Overall Study|Decision by sponsor|1|||
160807929|NCT03276728|580684508|FG005|Overall Study|Decision by sponsor|0|||
160807930|NCT03276728|580684509|FG006|Overall Study|Decision by sponsor|2|||
160807931|NCT03276728|580684510|FG007|Overall Study|Decision by sponsor|1|||
160807932|NCT02257242|580684511|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
160807933|NCT02257242|580684512|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807934|NCT02257242|580684513|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807935|NCT02257242|580684514|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807936|NCT02257242|580684515|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807937|NCT02257242|580684516|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807938|NCT02257242|580684517|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807939|NCT02257242|580684518|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807940|NCT02257242|580684519|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
160807941|NCT00600106|580684520|FG000|Overall Study|Withdrawal by Subject|1|||
160807942|NCT00600106|580684521|FG001|Overall Study|Withdrawal by Subject|1|||
161130848|NCT00896532|581863470|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
161130849|NCT00896532|581863471|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
161130850|NCT00896532|581863472|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
161130851|NCT00896532|581863473|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
161130852|NCT00896532|581863474|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
161130853|NCT00896532|581863475|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
161130854|NCT00896532|581863476|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
161130855|NCT00896532|581863477|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
160807951|NCT02213926|580684526|FG000|Overall Study|Death|59|||
160807952|NCT02213926|580684526|FG000|Overall Study|Withdrawal by Subject|10|||
160807953|NCT02213926|580684526|FG000|Overall Study|study terminated by sponsor|51|||
160807954|NCT02213926|580684526|FG000|Overall Study|Lost to Follow-up|3|||
160807955|NCT02213926|580684526|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
160807956|NCT01188551|580684527|FG000|Overall Study|Pharmacy issues|1|||
160807957|NCT01188551|580684528|FG001|Overall Study|Pharmacy issues|0|||
160807958|NCT01188551|580684529|FG002|Overall Study|Pharmacy issues|0|||
160807959|NCT01188551|580684530|FG003|Overall Study|Pharmacy issues|0|||
160807960|NCT01306643|580684535|FG000|Overall Study|Adverse Event|5|||
160807961|NCT01306643|580684535|FG000|Overall Study|Disease Progression|7|||
160807962|NCT01306643|580684535|FG000|Overall Study|Other: Change in Eligibility Status|1|||
160807963|NCT04024436|580684537|FG000|Overall Study|Death|10|||
160807964|NCT04024436|580684538|FG001|Overall Study|Death|14|||
160807965|NCT04024436|580684539|FG002|Overall Study|Death|2|||
160807966|NCT04024436|580684540|FG003|Overall Study|Death|7|||
160807967|NCT04024436|580684537|FG000|Overall Study|Loss to follow up|1|||
160807968|NCT04024436|580684538|FG001|Overall Study|Loss to follow up|0|||
160807969|NCT04024436|580684539|FG002|Overall Study|Loss to follow up|0|||
160807970|NCT04024436|580684540|FG003|Overall Study|Loss to follow up|1|||
160807971|NCT04024436|580684537|FG000|Overall Study|Withdrawal of consent|2|||
160807972|NCT04024436|580684538|FG001|Overall Study|Withdrawal of consent|0|||
160807973|NCT04024436|580684539|FG002|Overall Study|Withdrawal of consent|0|||
160807974|NCT04024436|580684540|FG003|Overall Study|Withdrawal of consent|1|||
160807975|NCT04024436|580684537|FG000|Overall Study|Study termination by sponsor|4|||
160807976|NCT04024436|580684538|FG001|Overall Study|Study termination by sponsor|6|||
160807977|NCT04024436|580684539|FG002|Overall Study|Study termination by sponsor|2|||
161130856|NCT00896532|581863478|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
161130857|NCT00896532|581863479|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
161130858|NCT00896532|581863480|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
161130859|NCT00896532|581863481|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
161130860|NCT00896532|581863459|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160807978|NCT04024436|580684540|FG003|Overall Study|Study termination by sponsor|11|||
160807979|NCT04024436|580684537|FG000|Overall Study|Reason Not Specified|0|||
160807980|NCT04024436|580684538|FG001|Overall Study|Reason Not Specified|1|||
160807981|NCT04024436|580684539|FG002|Overall Study|Reason Not Specified|0|||
160807982|NCT04024436|580684540|FG003|Overall Study|Reason Not Specified|2|||
160807983|NCT01169337|580684541|FG000|Overall Study|Lack of Efficacy|5|||
160807984|NCT01169337|580684542|FG001|Overall Study|Lack of Efficacy|7|||
160807985|NCT01169337|580684543|FG002|Overall Study|Lack of Efficacy|0|||
160807986|NCT01169337|580684541|FG000|Overall Study|Adverse Event|12|||
160807987|NCT01169337|580684542|FG001|Overall Study|Adverse Event|18|||
160807988|NCT01169337|580684543|FG002|Overall Study|Adverse Event|0|||
160807989|NCT01169337|580684541|FG000|Overall Study|Death|2|||
160807990|NCT01169337|580684542|FG001|Overall Study|Death|0|||
160807991|NCT01169337|580684543|FG002|Overall Study|Death|0|||
160807992|NCT01169337|580684541|FG000|Overall Study|Withdrawal by Subject|11|||
160807993|NCT01169337|580684542|FG001|Overall Study|Withdrawal by Subject|11|||
160807994|NCT01169337|580684543|FG002|Overall Study|Withdrawal by Subject|6|||
160807995|NCT01169337|580684541|FG000|Overall Study|Noncompliance|2|||
160807996|NCT01169337|580684542|FG001|Overall Study|Noncompliance|0|||
160807997|NCT01169337|580684543|FG002|Overall Study|Noncompliance|0|||
160807998|NCT01169337|580684541|FG000|Overall Study|Other complicating disease|1|||
160807999|NCT01169337|580684542|FG001|Overall Study|Other complicating disease|1|||
160808000|NCT01169337|580684543|FG002|Overall Study|Other complicating disease|0|||
160808001|NCT01169337|580684541|FG000|Overall Study|Physician Decision|1|||
160808002|NCT01169337|580684542|FG001|Overall Study|Physician Decision|5|||
160808003|NCT01169337|580684543|FG002|Overall Study|Physician Decision|0|||
160808004|NCT01169337|580684541|FG000|Overall Study|Alternative therapy|0|||
160808005|NCT01169337|580684542|FG001|Overall Study|Alternative therapy|2|||
160808006|NCT01169337|580684543|FG002|Overall Study|Alternative therapy|0|||
160808007|NCT01169337|580684541|FG000|Overall Study|Changed hospital|0|||
160808008|NCT01169337|580684542|FG001|Overall Study|Changed hospital|1|||
160808009|NCT01169337|580684543|FG002|Overall Study|Changed hospital|0|||
160808010|NCT01169337|580684541|FG000|Overall Study|Never started treatment|0|||
160808011|NCT01169337|580684542|FG001|Overall Study|Never started treatment|2|||
160808012|NCT01169337|580684543|FG002|Overall Study|Never started treatment|0|||
160808013|NCT01169337|580684541|FG000|Overall Study|Reason not reported|1|||
160808014|NCT01169337|580684542|FG001|Overall Study|Reason not reported|0|||
160808015|NCT01169337|580684543|FG002|Overall Study|Reason not reported|0|||
160808016|NCT01169337|580684541|FG000|Overall Study|Continuing lenalidomide|9|||
160808017|NCT01169337|580684542|FG001|Overall Study|Continuing lenalidomide|43|||
160808018|NCT01169337|580684543|FG002|Overall Study|Continuing lenalidomide|0|||
160808019|NCT05507567|580684545|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
160808020|NCT05507567|580684546|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
160808021|NCT05507567|580684547|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
160808022|NCT05507567|580684545|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
160808023|NCT05507567|580684546|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
160808024|NCT05507567|580684547|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
160808025|NCT05507567|580684545|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
160899162|NCT01251861|581024815|FG001|Overall Study|Other complicating disease|1|||
160899163|NCT01251861|581024814|FG000|Overall Study|Physician Decision|1|||
160899164|NCT01251861|581024815|FG001|Overall Study|Physician Decision|0|||
160899165|NCT01251861|581024814|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
160899166|NCT01251861|581024815|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
160899167|NCT01251861|581024814|FG000|Overall Study|Other|1|||
160899168|NCT01251861|581024815|FG001|Overall Study|Other|0|||
160899169|NCT01251861|581024814|FG000|Overall Study|Never started therapy|4|||
160899170|NCT01251861|581024815|FG001|Overall Study|Never started therapy|1|||
160899171|NCT01251861|581024814|FG000|Overall Study|Potential interaction of drugs|0|||
160899172|NCT01251861|581024815|FG001|Overall Study|Potential interaction of drugs|1|||
160899173|NCT00316719|581026261|FG000|Overall Study|Adverse Event|0|||
160899174|NCT00316719|581026262|FG001|Overall Study|Adverse Event|6|||
160899175|NCT00316719|581026261|FG000|Overall Study|Consent withdrawn|2|||
160899176|NCT00316719|581026262|FG001|Overall Study|Consent withdrawn|0|||
160899177|NCT00676338|581026263|FG000|Overall Study|Adverse Event|6|||
160899178|NCT00676338|581026264|FG001|Overall Study|Adverse Event|6|||
160899179|NCT00676338|581026265|FG002|Overall Study|Adverse Event|5|||
160899180|NCT00676338|581026266|FG003|Overall Study|Adverse Event|1|||
160899181|NCT00676338|581026263|FG000|Overall Study|Lost to Follow-up|4|||
160899182|NCT00676338|581026264|FG001|Overall Study|Lost to Follow-up|1|||
160899183|NCT00676338|581026265|FG002|Overall Study|Lost to Follow-up|3|||
160899184|NCT00676338|581026266|FG003|Overall Study|Lost to Follow-up|4|||
160899185|NCT00676338|581026263|FG000|Overall Study|Physician Decision|3|||
160899186|NCT00676338|581026264|FG001|Overall Study|Physician Decision|3|||
160899187|NCT00676338|581026265|FG002|Overall Study|Physician Decision|2|||
160899188|NCT00676338|581026266|FG003|Overall Study|Physician Decision|3|||
160899189|NCT00676338|581026263|FG000|Overall Study|Protocol Violation|5|||
160899190|NCT00676338|581026264|FG001|Overall Study|Protocol Violation|9|||
160899191|NCT00676338|581026265|FG002|Overall Study|Protocol Violation|2|||
160899192|NCT00676338|581026266|FG003|Overall Study|Protocol Violation|5|||
160899193|NCT00676338|581026263|FG000|Overall Study|Withdrawal by Subject|17|||
160899194|NCT00676338|581026264|FG001|Overall Study|Withdrawal by Subject|9|||
160899195|NCT00676338|581026265|FG002|Overall Study|Withdrawal by Subject|12|||
161130861|NCT00896532|581863460|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160899196|NCT00676338|581026266|FG003|Overall Study|Withdrawal by Subject|6|||
160899197|NCT00676338|581026263|FG000|Overall Study|Entry Criteria Not Met|0|||
161238598|NCT02089685|582253817|FG005|Overall Study|Follow up ended by sponsor|26|||
160808026|NCT05507567|580684546|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
160808027|NCT05507567|580684547|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
160808028|NCT05507567|580684545|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
160808029|NCT05507567|580684546|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
160808030|NCT05507567|580684547|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
160808031|NCT01485796|580684548|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
160808032|NCT01485796|580684548|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
160808033|NCT01485796|580684548|FG000|Period 2: Epoch 2|Adverse Event|3|||
160808034|NCT01485796|580684548|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
160808035|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
160808036|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
160808037|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
160808038|NCT01485796|580684548|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
160808039|NCT04830215|580684549|FG000|Overall Study|Adverse Event|6|||
160808040|NCT04830215|580684549|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
160808041|NCT04830215|580684549|FG000|Overall Study|Withdrawal by Subject|3|||
160808042|NCT04830215|580684549|FG000|Overall Study|Protocol Deviation|1|||
160808043|NCT01643408|580684551|FG000|Overall Study|Adverse Event|12|||
160808044|NCT01643408|580684551|FG000|Overall Study|Other|2|||
160808045|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
160808046|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
160808047|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808048|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808049|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808050|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808051|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808052|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808053|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808054|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
160808055|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
160808056|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
160808057|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808058|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808059|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808060|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808061|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808062|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808063|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808064|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
160808065|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
160808066|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808067|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808068|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808069|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808070|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808071|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808072|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808073|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808074|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
160808075|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
160808076|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
160808077|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808078|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808079|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808080|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808081|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808082|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
161238599|NCT02089685|582253812|FG000|Overall Study|Withdrawal by Subject|0|||
161238600|NCT02089685|582253813|FG001|Overall Study|Withdrawal by Subject|2|||
161238601|NCT02089685|582253814|FG002|Overall Study|Withdrawal by Subject|0|||
161238602|NCT02089685|582253815|FG003|Overall Study|Withdrawal by Subject|8|||
161238603|NCT02089685|582253816|FG004|Overall Study|Withdrawal by Subject|1|||
161238604|NCT02089685|582253817|FG005|Overall Study|Withdrawal by Subject|1|||
161238605|NCT02089685|582253812|FG000|Overall Study|Status not recorded|1|||
161238606|NCT02089685|582253813|FG001|Overall Study|Status not recorded|0|||
161238607|NCT02089685|582253814|FG002|Overall Study|Status not recorded|0|||
161238608|NCT02089685|582253815|FG003|Overall Study|Status not recorded|0|||
161130862|NCT00896532|581863461|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130863|NCT00896532|581863462|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160808083|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808084|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
160808085|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808086|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
160808087|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808088|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808089|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808090|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808091|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808092|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808093|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808094|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
160808095|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
160808096|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
160808097|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808098|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808099|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808100|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808101|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808102|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808103|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808104|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
160808105|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
160808106|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
160808107|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808108|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808109|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808110|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808111|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808112|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808113|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808114|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
160808115|NCT01194219|580684552|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
160808116|NCT01194219|580684553|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
160808117|NCT01194219|580684554|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808118|NCT01194219|580684555|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808119|NCT01194219|580684556|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808120|NCT01194219|580684557|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808121|NCT01194219|580684558|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808122|NCT01194219|580684559|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808123|NCT01194219|580684560|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808124|NCT01194219|580684561|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
160808125|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808126|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808127|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
160808128|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
160808129|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808130|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808131|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808132|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808133|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808134|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
160808135|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808136|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808137|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
160808138|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
160808139|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808140|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808141|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161130864|NCT00896532|581863463|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130865|NCT00896532|581863464|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130866|NCT00896532|581863465|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130867|NCT00896532|581863466|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130868|NCT00896532|581863467|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130869|NCT00896532|581863468|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161238609|NCT02089685|582253816|FG004|Overall Study|Status not recorded|1|||
160808142|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
161130870|NCT00896532|581863469|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130871|NCT00896532|581863470|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130872|NCT00896532|581863471|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130873|NCT00896532|581863472|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130874|NCT00896532|581863473|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130875|NCT00896532|581863474|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
161130876|NCT00896532|581863475|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
161238610|NCT02089685|582253817|FG005|Overall Study|Status not recorded|0|||
161238611|NCT02089685|582253812|FG000|Overall Study|Death|0|||
161238612|NCT02089685|582253813|FG001|Overall Study|Death|0|||
161238613|NCT02089685|582253814|FG002|Overall Study|Death|0|||
161238614|NCT02089685|582253815|FG003|Overall Study|Death|7|||
161238615|NCT02089685|582253816|FG004|Overall Study|Death|2|||
161238616|NCT02089685|582253817|FG005|Overall Study|Death|5|||
161238617|NCT02089685|582253812|FG000|Overall Study|Lost to Follow-up|0|||
161238618|NCT02089685|582253813|FG001|Overall Study|Lost to Follow-up|0|||
161332384|NCT00490035|582603607|FG001|Overall Study|AE, serious fatal|0|||
161332385|NCT00490035|582603608|FG002|Overall Study|AE, serious fatal|0|||
161332386|NCT00490035|582603609|FG003|Overall Study|AE, serious fatal|0|||
161332387|NCT00490035|582603606|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161332388|NCT00490035|582603607|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161332389|NCT00490035|582603608|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
161332390|NCT00490035|582603609|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
161332391|NCT00490035|582603606|FG000|Overall Study|AE of unknown type|0|||
161332392|NCT00490035|582603607|FG001|Overall Study|AE of unknown type|0|||
161332393|NCT00490035|582603608|FG002|Overall Study|AE of unknown type|2|||
161332394|NCT00490035|582603609|FG003|Overall Study|AE of unknown type|0|||
161332395|NCT05559905|582603610|FG000|Overall Study|Withdrawal by Subject|1|||
161332396|NCT05559905|582603611|FG001|Overall Study|Withdrawal by Subject|0|||
161332397|NCT05559905|582603612|FG002|Overall Study|Withdrawal by Subject|0|||
161332398|NCT05559905|582603610|FG000|Overall Study|Not Reported|1|||
161332399|NCT05559905|582603611|FG001|Overall Study|Not Reported|0|||
161332400|NCT05559905|582603612|FG002|Overall Study|Not Reported|0|||
161332401|NCT05276973|582603613|FG000|Overall Study|Treated and DLT unevaluable|1|||
161332402|NCT05276973|582603614|FG001|Overall Study|Treated and DLT unevaluable|1|||
161332403|NCT05276973|582603615|FG002|Overall Study|Treated and DLT unevaluable|0|||
161332404|NCT03160716|582603620|FG000|Overall Study|Lost to Follow-up|1|||
161332405|NCT01628848|582603621|FG000|Overall Study|Adverse Event|9|||
161332406|NCT01628848|582603622|FG001|Overall Study|Adverse Event|7|||
161332407|NCT01628848|582603621|FG000|Overall Study|Lack of Efficacy|0|||
161332408|NCT01628848|582603622|FG001|Overall Study|Lack of Efficacy|4|||
161332409|NCT01628848|582603621|FG000|Overall Study|Withdrawal by Subject|0|||
161332410|NCT01628848|582603622|FG001|Overall Study|Withdrawal by Subject|2|||
161332411|NCT01628848|582603621|FG000|Overall Study|Physician Decision|3|||
161332412|NCT01628848|582603622|FG001|Overall Study|Physician Decision|1|||
161332413|NCT00689338|582603624|FG000|Overall Study|Death|65|||
161332414|NCT00689338|582603624|FG000|Overall Study|Adverse Event|13|||
161332415|NCT00689338|582603624|FG000|Overall Study|Insufficient Clinical Response|1|||
161332416|NCT00689338|582603624|FG000|Overall Study|Lack of Efficacy|6|||
161332417|NCT00689338|582603624|FG000|Overall Study|Other|8|||
161332418|NCT00689338|582603624|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
161332419|NCT00689338|582603624|FG000|Overall Study|Lost to Follow-up|5|||
161332420|NCT00689338|582603624|FG000|Overall Study|Withdrawal by Subject|3|||
161332421|NCT00689338|582603624|FG000|Overall Study|Protocol Violation|15|||
161332422|NCT02104895|582603627|FG000|Overall Study|Withdrawal by Subject|0|||
161332423|NCT02104895|582603628|FG001|Overall Study|Withdrawal by Subject|14|||
161332424|NCT00969228|582603629|FG000|Overall Study|Adverse Event|1|||
161332425|NCT00969228|582603630|FG001|Overall Study|Adverse Event|0|||
161332426|NCT00969228|582603629|FG000|Overall Study|Withdrawal by Subject|4|||
161238619|NCT02089685|582253814|FG002|Overall Study|Lost to Follow-up|0|||
161238620|NCT02089685|582253815|FG003|Overall Study|Lost to Follow-up|1|||
161238621|NCT02089685|582253816|FG004|Overall Study|Lost to Follow-up|0|||
161238622|NCT02089685|582253817|FG005|Overall Study|Lost to Follow-up|0|||
161238623|NCT02089685|582253812|FG000|Overall Study|Physician Decision|0|||
161238624|NCT02089685|582253813|FG001|Overall Study|Physician Decision|0|||
161238625|NCT02089685|582253814|FG002|Overall Study|Physician Decision|0|||
161238626|NCT02089685|582253815|FG003|Overall Study|Physician Decision|0|||
161238627|NCT02089685|582253816|FG004|Overall Study|Physician Decision|0|||
161238628|NCT02089685|582253817|FG005|Overall Study|Physician Decision|4|||
161238629|NCT02089685|582253812|FG000|Overall Study|Screen failure|1|||
161238630|NCT02089685|582253813|FG001|Overall Study|Screen failure|0|||
161332427|NCT00969228|582603630|FG001|Overall Study|Withdrawal by Subject|0|||
161332428|NCT00969228|582603629|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
161238631|NCT02089685|582253814|FG002|Overall Study|Screen failure|0|||
161238632|NCT02089685|582253815|FG003|Overall Study|Screen failure|0|||
161332429|NCT00969228|582603630|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
161332430|NCT02895295|582603632|FG000|Overall Study|Survey Non-response|71|||
160808143|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808144|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
160808145|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808146|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808147|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
160808148|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
160808149|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808150|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808151|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808152|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808153|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808154|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
160808155|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808156|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808157|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
160808158|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
160808159|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808160|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808161|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808162|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808163|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808164|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
160808165|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808166|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808167|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
160808168|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808169|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808170|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808171|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808172|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808173|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808174|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
160808175|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808176|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808177|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808178|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
160808179|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808180|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808181|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808182|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808183|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808184|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
160808185|NCT01194219|580684552|FG000|Maintenance Phase Weeks16-32|Other|0|||
160808186|NCT01194219|580684553|FG001|Maintenance Phase Weeks16-32|Other|0|||
160808187|NCT01194219|580684554|FG002|Maintenance Phase Weeks16-32|Other|2|||
160808188|NCT01194219|580684555|FG003|Maintenance Phase Weeks16-32|Other|1|||
160808189|NCT01194219|580684556|FG004|Maintenance Phase Weeks16-32|Other|0|||
160808190|NCT01194219|580684557|FG005|Maintenance Phase Weeks16-32|Other|0|||
160808191|NCT01194219|580684558|FG006|Maintenance Phase Weeks16-32|Other|0|||
160808192|NCT01194219|580684559|FG007|Maintenance Phase Weeks16-32|Other|0|||
161238633|NCT02089685|582253816|FG004|Overall Study|Screen failure|0|||
161238634|NCT02089685|582253817|FG005|Overall Study|Screen failure|0|||
161238635|NCT04887415|582253820|FG000|Overall Study|Lost to Follow-up|2|||
161238636|NCT05646251|582253821|FG000|Overall Study|Physician Decision|1|||
161238637|NCT05646251|582253822|FG001|Overall Study|Physician Decision|0|||
161238638|NCT05646251|582253823|FG002|Overall Study|Physician Decision|2|||
160808193|NCT01194219|580684560|FG008|Maintenance Phase Weeks16-32|Other|0|||
160808194|NCT01194219|580684561|FG009|Maintenance Phase Weeks16-32|Other|0|||
160808195|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808196|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160985919|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
161238639|NCT00840411|582253824|FG000|First Intervention|Adverse Event|1|||
161238640|NCT00840411|582253825|FG001|First Intervention|Adverse Event|0|||
160808197|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808198|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808199|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808200|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
160985920|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
161238641|NCT00840411|582253824|FG000|Washout|Withdrawal by Subject|1|||
161332431|NCT02895295|582603633|FG001|Overall Study|Survey Non-response|94|||
161332432|NCT02895295|582603634|FG002|Overall Study|Survey Non-response|92|||
161332433|NCT02532283|582603635|FG000|Overall Study|Adverse Event|0|||
161332434|NCT02532283|582603636|FG001|Overall Study|Adverse Event|1|||
161332435|NCT02532283|582603635|FG000|Overall Study|Death|1|||
161332436|NCT02532283|582603636|FG001|Overall Study|Death|0|||
161332437|NCT02532283|582603635|FG000|Overall Study|Lost to Follow-up|0|||
161332438|NCT02532283|582603636|FG001|Overall Study|Lost to Follow-up|1|||
161332439|NCT02532283|582603635|FG000|Overall Study|Withdrawal by Subject|8|||
161332440|NCT02532283|582603636|FG001|Overall Study|Withdrawal by Subject|3|||
161332441|NCT01945944|582603637|FG000|Overall Study|Adverse Event|0|||
161332442|NCT01945944|582603638|FG001|Overall Study|Adverse Event|2|||
161332443|NCT01945944|582603637|FG000|Overall Study|Physician Decision|1|||
161332444|NCT01945944|582603638|FG001|Overall Study|Physician Decision|0|||
161332445|NCT01945944|582603637|FG000|Overall Study|Withdrawal by Subject|0|||
161332446|NCT01945944|582603638|FG001|Overall Study|Withdrawal by Subject|1|||
161332447|NCT04376515|582603639|FG000|Overall Study|Found to have been vaccinated before study start|6|||
161332448|NCT04376515|582603640|FG001|Overall Study|Found to have been vaccinated before study start|6|||
161332449|NCT03811821|582603641|FG000|Overall Study|Adverse Event|1|||
161332450|NCT03811821|582603642|FG001|Overall Study|Adverse Event|1|||
161332451|NCT03811821|582603641|FG000|Overall Study|Withdrawal by Subject|5|||
161332452|NCT03811821|582603642|FG001|Overall Study|Withdrawal by Subject|4|||
161332453|NCT03811821|582603641|FG000|Overall Study|Lost to Follow-up|2|||
161332454|NCT03811821|582603642|FG001|Overall Study|Lost to Follow-up|2|||
161332455|NCT03811821|582603641|FG000|Overall Study|Contraindication for treatment|0|||
161332456|NCT03811821|582603642|FG001|Overall Study|Contraindication for treatment|1|||
161332457|NCT03811821|582603641|FG000|Overall Study|Tolerability|0|||
161332458|NCT03811821|582603642|FG001|Overall Study|Tolerability|3|||
161332459|NCT03811821|582603641|FG000|Overall Study|Comorbidities|0|||
161332460|NCT03811821|582603642|FG001|Overall Study|Comorbidities|2|||
161332461|NCT03433898|582603645|FG000|Overall Study|Progressive disease|6|||
161332462|NCT03433898|582603646|FG001|Overall Study|Progressive disease|3|||
161332463|NCT03433898|582603647|FG002|Overall Study|Progressive disease|3|||
161332464|NCT03433898|582603648|FG003|Overall Study|Progressive disease|2|||
161332465|NCT03433898|582603649|FG004|Overall Study|Progressive disease|30|||
161332466|NCT03433898|582603650|FG005|Overall Study|Progressive disease|29|||
161332467|NCT03433898|582603651|FG006|Overall Study|Progressive disease|17|||
161332468|NCT03433898|582603652|FG007|Overall Study|Progressive disease|30|||
161332469|NCT03433898|582603645|FG000|Overall Study|Not treated|1|||
161332470|NCT03433898|582603646|FG001|Overall Study|Not treated|0|||
161332471|NCT03433898|582603647|FG002|Overall Study|Not treated|0|||
161332472|NCT03433898|582603648|FG003|Overall Study|Not treated|0|||
161332473|NCT03433898|582603649|FG004|Overall Study|Not treated|1|||
161332474|NCT03433898|582603650|FG005|Overall Study|Not treated|0|||
161332475|NCT03433898|582603651|FG006|Overall Study|Not treated|0|||
161332476|NCT03433898|582603652|FG007|Overall Study|Not treated|0|||
161332477|NCT03433898|582603645|FG000|Overall Study|Death|0|||
161332478|NCT03433898|582603646|FG001|Overall Study|Death|0|||
161332479|NCT03433898|582603647|FG002|Overall Study|Death|0|||
161332480|NCT03433898|582603648|FG003|Overall Study|Death|0|||
161332481|NCT03433898|582603649|FG004|Overall Study|Death|0|||
161332482|NCT03433898|582603650|FG005|Overall Study|Death|0|||
161332483|NCT03433898|582603651|FG006|Overall Study|Death|1|||
161332484|NCT03433898|582603652|FG007|Overall Study|Death|1|||
161332485|NCT03433898|582603645|FG000|Overall Study|Withdrawal by Subject|0|||
161332486|NCT03433898|582603646|FG001|Overall Study|Withdrawal by Subject|0|||
161332487|NCT03433898|582603647|FG002|Overall Study|Withdrawal by Subject|0|||
161332488|NCT03433898|582603648|FG003|Overall Study|Withdrawal by Subject|0|||
161332489|NCT03433898|582603649|FG004|Overall Study|Withdrawal by Subject|2|||
161332490|NCT03433898|582603650|FG005|Overall Study|Withdrawal by Subject|0|||
161332491|NCT03433898|582603651|FG006|Overall Study|Withdrawal by Subject|0|||
161332492|NCT03433898|582603652|FG007|Overall Study|Withdrawal by Subject|0|||
161332493|NCT03433898|582603645|FG000|Overall Study|Adverse Event|0|||
161332494|NCT03433898|582603646|FG001|Overall Study|Adverse Event|0|||
161332495|NCT03433898|582603647|FG002|Overall Study|Adverse Event|0|||
161332496|NCT03433898|582603648|FG003|Overall Study|Adverse Event|0|||
161332497|NCT03433898|582603649|FG004|Overall Study|Adverse Event|0|||
161332498|NCT03433898|582603650|FG005|Overall Study|Adverse Event|5|||
160899198|NCT00676338|581026264|FG001|Overall Study|Entry Criteria Not Met|2|||
160899199|NCT00676338|581026265|FG002|Overall Study|Entry Criteria Not Met|1|||
161332499|NCT03433898|582603651|FG006|Overall Study|Adverse Event|2|||
161332500|NCT03433898|582603652|FG007|Overall Study|Adverse Event|2|||
161332501|NCT03433898|582603645|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160899200|NCT00676338|581026266|FG003|Overall Study|Entry Criteria Not Met|1|||
161332502|NCT03433898|582603646|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161332503|NCT03433898|582603647|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161332504|NCT03433898|582603648|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161332505|NCT03433898|582603649|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
161332506|NCT03433898|582603650|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
160808201|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
160808202|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
160808203|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808204|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
160808205|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808206|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808207|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808208|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808209|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
160808210|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
160808211|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
160808212|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
160808213|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808214|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
160808215|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808216|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808217|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808218|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808219|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
160808220|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808221|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
160808222|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808223|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808224|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
160808225|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808226|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808227|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808228|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808229|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
160808230|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808231|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
160808232|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
160808233|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808234|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
160808235|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808236|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808237|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808238|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808239|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
160808240|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
160808241|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
160808242|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808243|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808244|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
160808245|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808246|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808247|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808248|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808249|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808250|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808251|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808252|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
160808253|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808254|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
160808255|NCT01194219|580684552|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808256|NCT01194219|580684553|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808257|NCT01194219|580684554|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808258|NCT01194219|580684555|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808259|NCT01194219|580684556|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
161238642|NCT00840411|582253825|FG001|Washout|Withdrawal by Subject|0|||
161238643|NCT00651820|582253828|FG000|Overall Study|Lost to Follow-up|2|||
161238644|NCT00657553|582253832|FG000|Overall Study|low accrual, no analysis run|5|||
161238645|NCT00657553|582253833|FG001|Overall Study|low accrual, no analysis run|5|||
161238646|NCT01566721|582253834|FG000|Treatment Period|Withdrawal by Subject|35|||
161238647|NCT01566721|582253835|FG001|Treatment Period|Withdrawal by Subject|9|||
161238648|NCT01566721|582253834|FG000|Treatment Period|Disease Progression/Recurrence|37|||
161238649|NCT01566721|582253835|FG001|Treatment Period|Disease Progression/Recurrence|13|||
161238650|NCT01566721|582253834|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
161238651|NCT01566721|582253835|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
161238652|NCT01566721|582253834|FG000|Treatment Period|Other|13|||
161238653|NCT01566721|582253835|FG001|Treatment Period|Other|2|||
161238654|NCT01566721|582253834|FG000|Treatment Period|Lack of Compliance|5|||
161238655|NCT01566721|582253835|FG001|Treatment Period|Lack of Compliance|1|||
161238656|NCT01566721|582253834|FG000|Treatment Period|Adverse Event|100|||
161238657|NCT01566721|582253835|FG001|Treatment Period|Adverse Event|30|||
161238658|NCT01566721|582253834|FG000|Treatment Period|Pregnancy|1|||
161238659|NCT01566721|582253835|FG001|Treatment Period|Pregnancy|0|||
161238660|NCT01566721|582253834|FG000|Safety Follow-up|Physician Decision|6|||
161238661|NCT01566721|582253835|FG001|Safety Follow-up|Physician Decision|4|||
161238662|NCT01566721|582253834|FG000|Safety Follow-up|Lost to Follow-up|101|||
161238663|NCT01566721|582253835|FG001|Safety Follow-up|Lost to Follow-up|48|||
161238664|NCT01566721|582253834|FG000|Safety Follow-up|Withdrawal by Subject|155|||
161238665|NCT01566721|582253835|FG001|Safety Follow-up|Withdrawal by Subject|49|||
161238666|NCT01566721|582253834|FG000|Safety Follow-up|Death|28|||
161238667|NCT01566721|582253835|FG001|Safety Follow-up|Death|4|||
161238668|NCT01566721|582253834|FG000|Safety Follow-up|Non-compliance|7|||
161238669|NCT01566721|582253835|FG001|Safety Follow-up|Non-compliance|3|||
161238670|NCT01566721|582253834|FG000|Safety Follow-up|Protocol Violation|7|||
161238671|NCT01566721|582253835|FG001|Safety Follow-up|Protocol Violation|0|||
161238672|NCT01566721|582253834|FG000|Safety Follow-up|Site closure|2|||
161238673|NCT01566721|582253835|FG001|Safety Follow-up|Site closure|3|||
160808260|NCT01194219|580684557|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808261|NCT01194219|580684558|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
160808262|NCT01194219|580684559|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808263|NCT01194219|580684560|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160985921|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
160985922|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
161238674|NCT01566721|582253834|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
160808264|NCT01194219|580684561|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
160808265|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808266|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808267|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808268|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808269|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808270|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160899201|NCT00676338|581026263|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
160899202|NCT00676338|581026264|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
160899203|NCT00676338|581026265|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
160899204|NCT00676338|581026266|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
160899205|NCT02122458|581026267|FG000|Overall Study|Withdrawal by Subject|0|||
160899206|NCT02122458|581026268|FG001|Overall Study|Withdrawal by Subject|0|||
160899207|NCT02122458|581026269|FG002|Overall Study|Withdrawal by Subject|0|||
160899208|NCT02122458|581026270|FG003|Overall Study|Withdrawal by Subject|4|||
160899209|NCT02122458|581026271|FG004|Overall Study|Withdrawal by Subject|4|||
160899210|NCT02122458|581026272|FG005|Overall Study|Withdrawal by Subject|4|||
160899211|NCT02122458|581026273|FG006|Overall Study|Withdrawal by Subject|0|||
160899212|NCT02122458|581026267|FG000|Overall Study|Lost to Follow-up|1|||
160899213|NCT02122458|581026268|FG001|Overall Study|Lost to Follow-up|3|||
160899214|NCT02122458|581026269|FG002|Overall Study|Lost to Follow-up|0|||
160899215|NCT02122458|581026270|FG003|Overall Study|Lost to Follow-up|7|||
160899216|NCT02122458|581026271|FG004|Overall Study|Lost to Follow-up|5|||
160899217|NCT02122458|581026272|FG005|Overall Study|Lost to Follow-up|15|||
160899218|NCT02122458|581026273|FG006|Overall Study|Lost to Follow-up|1|||
160899219|NCT02122458|581026267|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
160899220|NCT02122458|581026268|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899221|NCT02122458|581026269|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899222|NCT02122458|581026270|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899223|NCT02122458|581026271|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899224|NCT02122458|581026272|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
160899225|NCT02122458|581026273|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
161238675|NCT01566721|582253835|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
161238676|NCT01566721|582253834|FG000|Safety Follow-up|Missing|7|||
161238677|NCT01566721|582253835|FG001|Safety Follow-up|Missing|2|||
161238678|NCT01566721|582253834|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
160808271|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160985923|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
160808272|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
160808273|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
160808274|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
160808275|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808276|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808277|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808278|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808279|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808280|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808281|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808282|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
160808283|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
160808284|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
160808285|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808286|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808287|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808288|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808289|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808290|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808291|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808292|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
160808293|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
160808294|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
160808295|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808296|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808297|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808298|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808299|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808300|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808301|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808302|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
160808303|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
160808304|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
160808305|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
160808306|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
160808307|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
160808308|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
160808309|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
160808310|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
160808311|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
160808312|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
160808313|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
160808314|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
160808315|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808316|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808317|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808318|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808319|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808320|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808321|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808322|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
160808323|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
160808324|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
160808325|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808326|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808327|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808328|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808329|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808330|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808331|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808332|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
161238679|NCT01566721|582253835|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
160808333|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
160808334|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
160808335|NCT01194219|580684552|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808336|NCT01194219|580684553|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808337|NCT01194219|580684554|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
161332507|NCT03433898|582603651|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161332508|NCT03433898|582603652|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
161332509|NCT01496976|582605229|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
161332510|NCT00870727|582605230|FG000|Overall Study|Lost to Follow-up|0|||
161332511|NCT00870727|582605231|FG001|Overall Study|Lost to Follow-up|1|||
161332512|NCT00870727|582605230|FG000|Overall Study|Lack of Efficacy|1|||
161332513|NCT00870727|582605231|FG001|Overall Study|Lack of Efficacy|3|||
161332514|NCT00870727|582605230|FG000|Overall Study|Adverse Event|0|||
161332515|NCT00870727|582605231|FG001|Overall Study|Adverse Event|1|||
161332516|NCT01811732|582605239|FG000|Overall Study|Lost to Follow-up|24|||
161332517|NCT01811732|582605240|FG001|Overall Study|Lost to Follow-up|30|||
161332518|NCT01811732|582605239|FG000|Overall Study|Withdrawal by Subject|16|||
161332519|NCT01811732|582605240|FG001|Overall Study|Withdrawal by Subject|10|||
161332520|NCT01811732|582605239|FG000|Overall Study|Adverse Event|3|||
161332521|NCT01811732|582605240|FG001|Overall Study|Adverse Event|9|||
161332522|NCT01811732|582605239|FG000|Overall Study|Lack of Efficacy|3|||
161332523|NCT01811732|582605240|FG001|Overall Study|Lack of Efficacy|1|||
161332524|NCT01811732|582605239|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
161332525|NCT01811732|582605240|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
161332526|NCT01811732|582605239|FG000|Overall Study|Physician Decision|2|||
161332527|NCT01811732|582605240|FG001|Overall Study|Physician Decision|0|||
161332528|NCT01811732|582605239|FG000|Overall Study|Death|1|||
161332529|NCT01811732|582605240|FG001|Overall Study|Death|1|||
161332530|NCT01811732|582605239|FG000|Overall Study|Insufficient venous access|0|||
161332531|NCT01811732|582605240|FG001|Overall Study|Insufficient venous access|1|||
161332532|NCT01811732|582605239|FG000|Overall Study|Protocol Violation|0|||
161332533|NCT01811732|582605240|FG001|Overall Study|Protocol Violation|1|||
160808338|NCT01194219|580684555|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808339|NCT01194219|580684556|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808340|NCT01194219|580684557|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808341|NCT01194219|580684558|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808342|NCT01194219|580684559|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
160808343|NCT01194219|580684560|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
160808344|NCT01194219|580684561|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
160808345|NCT03726658|580684562|FG000|Overall Study|Lost to Follow-up|0|||
160808346|NCT03726658|580684563|FG001|Overall Study|Lost to Follow-up|0|||
160808347|NCT03726658|580684564|FG002|Overall Study|Lost to Follow-up|2|||
160808348|NCT03726658|580684565|FG003|Overall Study|Lost to Follow-up|0|||
160808349|NCT03726658|580684566|FG004|Overall Study|Lost to Follow-up|0|||
160808350|NCT03726658|580684567|FG005|Overall Study|Lost to Follow-up|1|||
160808351|NCT03726658|580684568|FG006|Overall Study|Lost to Follow-up|1|||
160808352|NCT03726658|580684562|FG000|Overall Study|Withdrawal by Subject|1|||
160808353|NCT03726658|580684563|FG001|Overall Study|Withdrawal by Subject|0|||
160808354|NCT03726658|580684564|FG002|Overall Study|Withdrawal by Subject|0|||
160808355|NCT03726658|580684565|FG003|Overall Study|Withdrawal by Subject|0|||
160808356|NCT03726658|580684566|FG004|Overall Study|Withdrawal by Subject|6|||
160808357|NCT03726658|580684567|FG005|Overall Study|Withdrawal by Subject|4|||
160808358|NCT03726658|580684568|FG006|Overall Study|Withdrawal by Subject|2|||
160808359|NCT03726658|580684562|FG000|Overall Study|Pregnancy|0|||
160808360|NCT03726658|580684563|FG001|Overall Study|Pregnancy|0|||
160808361|NCT03726658|580684564|FG002|Overall Study|Pregnancy|0|||
160808362|NCT03726658|580684565|FG003|Overall Study|Pregnancy|0|||
160808363|NCT03726658|580684566|FG004|Overall Study|Pregnancy|0|||
160808364|NCT03726658|580684567|FG005|Overall Study|Pregnancy|0|||
160808365|NCT03726658|580684568|FG006|Overall Study|Pregnancy|1|||
160808366|NCT03726658|580684562|FG000|Overall Study|Not Reported|0|||
160808367|NCT03726658|580684563|FG001|Overall Study|Not Reported|0|||
160899226|NCT02122458|581026267|FG000|Overall Study|Adverse Event|1|||
160899227|NCT02122458|581026268|FG001|Overall Study|Adverse Event|0|||
160899228|NCT02122458|581026269|FG002|Overall Study|Adverse Event|0|||
160899229|NCT02122458|581026270|FG003|Overall Study|Adverse Event|0|||
161332534|NCT01811732|582605239|FG000|Overall Study|Subject incarcerated|1|||
161332535|NCT01811732|582605240|FG001|Overall Study|Subject incarcerated|2|||
161332536|NCT01811732|582605239|FG000|Overall Study|Admitted to another facility|1|||
161332537|NCT01811732|582605240|FG001|Overall Study|Admitted to another facility|0|||
160808368|NCT03726658|580684564|FG002|Overall Study|Not Reported|0|||
160808369|NCT03726658|580684565|FG003|Overall Study|Not Reported|0|||
160899230|NCT02122458|581026271|FG004|Overall Study|Adverse Event|0|||
160808370|NCT03726658|580684566|FG004|Overall Study|Not Reported|0|||
160808371|NCT03726658|580684567|FG005|Overall Study|Not Reported|0|||
160808372|NCT03726658|580684568|FG006|Overall Study|Not Reported|1|||
160808373|NCT05710640|580684569|FG000|Overall Study|Physician Decision|0|||
160808374|NCT05710640|580684570|FG001|Overall Study|Physician Decision|1|||
160808375|NCT05710640|580684569|FG000|Overall Study|Withdrawal by Subject|1|||
161332538|NCT01811732|582605239|FG000|Overall Study|Correct study drug not available on site|1|||
161332539|NCT01811732|582605240|FG001|Overall Study|Correct study drug not available on site|0|||
161332540|NCT00896493|582605243|FG000|Overall Study|Early disease relapse|3|||
161332541|NCT03102762|582605244|FG000|Overall Study|Lost to Follow-up|1|||
160985924|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
160985925|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
160985926|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
160985927|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
160985928|NCT02851511|581338520|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
160985929|NCT02851511|581338521|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
160985930|NCT02851511|581338522|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
160985931|NCT02851511|581338523|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
160985932|NCT02851511|581338520|FG000|Phase I|Physician Decision|0|||
160985933|NCT02851511|581338521|FG001|Phase I|Physician Decision|0|||
160985934|NCT02851511|581338522|FG002|Phase I|Physician Decision|0|||
160985935|NCT02851511|581338523|FG003|Phase I|Physician Decision|1|||
160985936|NCT02851511|581338520|FG000|Phase I|Withdrawal by Subject|2|||
160985937|NCT02851511|581338521|FG001|Phase I|Withdrawal by Subject|1|||
160985938|NCT02851511|581338522|FG002|Phase I|Withdrawal by Subject|0|||
160985939|NCT02851511|581338523|FG003|Phase I|Withdrawal by Subject|3|||
160985940|NCT02851511|581338520|FG000|Phase II|Physician Decision|18|||
160985941|NCT02851511|581338521|FG001|Phase II|Physician Decision|16|||
160985942|NCT02851511|581338522|FG002|Phase II|Physician Decision|0|||
160985943|NCT02851511|581338523|FG003|Phase II|Physician Decision|0|||
160985944|NCT02851511|581338520|FG000|Phase II|Withdrawal by Subject|18|||
160985945|NCT02851511|581338521|FG001|Phase II|Withdrawal by Subject|16|||
160985946|NCT02851511|581338522|FG002|Phase II|Withdrawal by Subject|0|||
160985947|NCT02851511|581338523|FG003|Phase II|Withdrawal by Subject|0|||
160985948|NCT02851511|581338520|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
160985949|NCT02851511|581338521|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
160985950|NCT02851511|581338522|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
160985951|NCT02851511|581338523|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
160985952|NCT02851511|581338520|FG000|Phase II|Lost to Follow-up|0|||
160985953|NCT02851511|581338521|FG001|Phase II|Lost to Follow-up|1|||
160985954|NCT02851511|581338522|FG002|Phase II|Lost to Follow-up|0|||
160985955|NCT02851511|581338523|FG003|Phase II|Lost to Follow-up|0|||
160985956|NCT00051311|581338526|FG000|Overall Study|Starting new study|0|||
160985957|NCT00051311|581338527|FG001|Overall Study|Starting new study|1|||
160985958|NCT00051311|581338526|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
160985959|NCT00051311|581338527|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
160985960|NCT00051311|581338526|FG000|Overall Study|Death of recipient|8|||
160985961|NCT00051311|581338527|FG001|Overall Study|Death of recipient|8|||
160985962|NCT00051311|581338526|FG000|Overall Study|Recipient taken off study|4|||
160985963|NCT00051311|581338527|FG001|Overall Study|Recipient taken off study|4|||
160985964|NCT04170023|581338528|FG000|LTE Period|Withdrawal by Subject|1|||
160985965|NCT04170023|581338529|FG001|LTE Period|Withdrawal by Subject|0|||
160985966|NCT04170023|581338530|FG002|LTE Period|Withdrawal by Subject|0|||
160985967|NCT04170023|581338528|FG000|LTE Period|Study Termination|11|||
160808376|NCT05710640|580684570|FG001|Overall Study|Withdrawal by Subject|0|||
160808377|NCT05710640|580684569|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
160808378|NCT05710640|580684570|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
160808379|NCT04188509|580684571|FG000|Overall Study|Adverse Event|2|||
160985968|NCT04170023|581338529|FG001|LTE Period|Study Termination|11|||
160985969|NCT04170023|581338530|FG002|LTE Period|Study Termination|5|||
160985970|NCT03712098|581338531|FG000|Overall Study|Lost to Follow-up|3|||
160985971|NCT03712098|581338532|FG001|Overall Study|Lost to Follow-up|7|||
160985972|NCT03712098|581338531|FG000|Overall Study|Withdrawal by Subject|9|||
160985973|NCT03712098|581338532|FG001|Overall Study|Withdrawal by Subject|4|||
160985974|NCT03712098|581338531|FG000|Overall Study|Protocol Violation|2|||
160985975|NCT03712098|581338532|FG001|Overall Study|Protocol Violation|1|||
161130877|NCT00896532|581863476|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160808380|NCT04188509|580684571|FG000|Overall Study|Lost to Follow-up|1|||
160985976|NCT02256969|581338533|FG000|Overall Study|Screenfailed or withdrew|2|||
160985977|NCT02256969|581338534|FG001|Overall Study|Screenfailed or withdrew|1|||
160985978|NCT02256969|581338535|FG002|Overall Study|Screenfailed or withdrew|1|||
160985979|NCT00372567|581338536|FG000|Phase 3 Study|Adverse Event|5|||
161130878|NCT00896532|581863477|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130879|NCT00896532|581863478|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160985980|NCT00372567|581338537|FG001|Phase 3 Study|Adverse Event|1|||
160985981|NCT00372567|581338538|FG002|Phase 3 Study|Adverse Event|1|||
160985982|NCT00372567|581338536|FG000|Phase 3 Study|Death|1|||
160985983|NCT00372567|581338537|FG001|Phase 3 Study|Death|1|||
160985984|NCT00372567|581338538|FG002|Phase 3 Study|Death|0|||
160985985|NCT00372567|581338536|FG000|Phase 3 Study|Protocol Violation|0|||
160985986|NCT00372567|581338537|FG001|Phase 3 Study|Protocol Violation|0|||
160985987|NCT00372567|581338538|FG002|Phase 3 Study|Protocol Violation|1|||
160985988|NCT00372567|581338536|FG000|Phase 3 Study|Objective progression or relapse|10|||
161130880|NCT00896532|581863479|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130881|NCT00896532|581863480|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
160808381|NCT04188509|580684571|FG000|Overall Study|Withdrawal of Consent|1|||
160808382|NCT04188509|580684571|FG000|Overall Study|Discretion of Investigator|1|||
160808383|NCT04188509|580684571|FG000|Overall Study|Noncompliance|3|||
160808384|NCT04188509|580684571|FG000|Overall Study|Sponsor Decision|127|||
160808385|NCT04188509|580684571|FG000|Overall Study|Other|2|||
160808386|NCT00049322|580684581|FG000|Overall Study|disease burden|0|||
160808387|NCT00049322|580684582|FG001|Overall Study|disease burden|3|||
160808388|NCT00049322|580684581|FG000|Overall Study|Adverse Event|1|||
160808389|NCT00049322|580684582|FG001|Overall Study|Adverse Event|0|||
160808390|NCT00049322|580684581|FG000|Overall Study|refused angio|0|||
160808391|NCT00049322|580684582|FG001|Overall Study|refused angio|3|||
160808392|NCT00703963|580684583|FG000|Overall Study|Withdrawal by Subject|7|||
160808393|NCT00703963|580684584|FG001|Overall Study|Withdrawal by Subject|13|||
160808394|NCT00703963|580684583|FG000|Overall Study|Physician Decision|0|||
160808395|NCT00703963|580684584|FG001|Overall Study|Physician Decision|1|||
160808396|NCT03994211|580684585|FG000|Core Phase|Adverse Event|0|||
160808397|NCT03994211|580684586|FG001|Core Phase|Adverse Event|1|||
160808398|NCT03994211|580684587|FG002|Core Phase|Adverse Event|0|||
160808399|NCT03994211|580684585|FG000|Extension Phase|Adverse Event|0|||
160808400|NCT03994211|580684586|FG001|Extension Phase|Adverse Event|0|||
160808401|NCT03994211|580684587|FG002|Extension Phase|Adverse Event|1|||
160808402|NCT03994211|580684585|FG000|Extension Phase|Physician Decision|0|||
160808403|NCT03994211|580684586|FG001|Extension Phase|Physician Decision|0|||
160808404|NCT03994211|580684587|FG002|Extension Phase|Physician Decision|1|||
160808405|NCT03994211|580684585|FG000|Extension Phase|Progressive Disease|0|||
160808406|NCT03994211|580684586|FG001|Extension Phase|Progressive Disease|0|||
160808407|NCT03994211|580684587|FG002|Extension Phase|Progressive Disease|20|||
160808408|NCT03994211|580684585|FG000|Extension Phase|Withdrawal by Subject|0|||
160808409|NCT03994211|580684586|FG001|Extension Phase|Withdrawal by Subject|0|||
160808410|NCT03994211|580684587|FG002|Extension Phase|Withdrawal by Subject|2|||
160808411|NCT00503425|580684588|FG000|Overall Study|Participant files lost|6|||
160808412|NCT00503425|580684588|FG000|Overall Study|Adverse Event|5|||
160808413|NCT00503425|580684588|FG000|Overall Study|Lack of Efficacy|25|||
160808414|NCT00503425|580684588|FG000|Overall Study|Withdrawal by Subject|8|||
160808415|NCT00503425|580684588|FG000|Overall Study|Lost to Follow-up|3|||
160808416|NCT00503425|580684588|FG000|Overall Study|Death|3|||
160808417|NCT00503425|580684588|FG000|Overall Study|Missing Data/Unknown|4|||
160808418|NCT02148263|580684589|FG000|Overall Study|Withdrawal by Subject|3|||
160808419|NCT02148263|580684590|FG001|Overall Study|Withdrawal by Subject|2|||
160808420|NCT03900728|580684591|FG000|Overall Study|No text responses|0|||
160808421|NCT03900728|580684592|FG001|Overall Study|No text responses|0|||
160808422|NCT03900728|580684593|FG002|Overall Study|No text responses|4|||
160808423|NCT00763256|580684595|FG000|Overall Study|Didn't return for appointments|7|||
160808424|NCT00763256|580684596|FG001|Overall Study|Didn't return for appointments|10|||
160808425|NCT03364231|580684597|FG000|Overall Study|Adverse Event|1|||
160808426|NCT03364231|580684598|FG001|Overall Study|Adverse Event|4|||
160808427|NCT03364231|580684597|FG000|Overall Study|Death|1|||
160808428|NCT03364231|580684598|FG001|Overall Study|Death|0|||
160808429|NCT03364231|580684597|FG000|Overall Study|Investigator Decision|2|||
160808430|NCT03364231|580684598|FG001|Overall Study|Investigator Decision|2|||
160808431|NCT03364231|580684597|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
160808432|NCT03364231|580684598|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
160808433|NCT03364231|580684597|FG000|Overall Study|Withdrawal of Subject Consent|1|||
160808434|NCT03364231|580684598|FG001|Overall Study|Withdrawal of Subject Consent|0|||
160808435|NCT03364231|580684597|FG000|Overall Study|Reason Not Specified|1|||
160808436|NCT03364231|580684598|FG001|Overall Study|Reason Not Specified|0|||
160808437|NCT03364231|580684597|FG000|Overall Study|Disease Progression|0|||
160808438|NCT03364231|580684598|FG001|Overall Study|Disease Progression|6|||
160808439|NCT01393899|580684605|FG000|Overall Study|Study terminated by sponsor|1|||
160808440|NCT01393899|580684606|FG001|Overall Study|Study terminated by sponsor|0|||
160808441|NCT01393899|580684607|FG002|Overall Study|Study terminated by sponsor|1|||
160808442|NCT01393899|580684605|FG000|Overall Study|Other|1|||
160808443|NCT01393899|580684606|FG001|Overall Study|Other|0|||
160808444|NCT01393899|580684607|FG002|Overall Study|Other|0|||
160808445|NCT01393899|580684605|FG000|Overall Study|Withdrawal by Subject|2|||
160808446|NCT01393899|580684606|FG001|Overall Study|Withdrawal by Subject|2|||
160808447|NCT01393899|580684607|FG002|Overall Study|Withdrawal by Subject|1|||
160808448|NCT01393899|580684605|FG000|Overall Study|Lost to Follow-up|0|||
160808449|NCT01393899|580684606|FG001|Overall Study|Lost to Follow-up|0|||
160808450|NCT01393899|580684607|FG002|Overall Study|Lost to Follow-up|1|||
160808451|NCT01393899|580684605|FG000|Overall Study|Does not meet entrance criteria|1|||
160808452|NCT01393899|580684606|FG001|Overall Study|Does not meet entrance criteria|0|||
160808453|NCT01393899|580684607|FG002|Overall Study|Does not meet entrance criteria|1|||
160808454|NCT01393899|580684605|FG000|Overall Study|Lack of Efficacy|26|||
160808455|NCT01393899|580684606|FG001|Overall Study|Lack of Efficacy|21|||
160808456|NCT01393899|580684607|FG002|Overall Study|Lack of Efficacy|16|||
160808457|NCT01393899|580684605|FG000|Overall Study|Adverse Event|1|||
160808458|NCT01393899|580684606|FG001|Overall Study|Adverse Event|5|||
160808459|NCT01393899|580684607|FG002|Overall Study|Adverse Event|3|||
160808460|NCT02503085|580684608|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
160808461|NCT02503085|580684609|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
160808462|NCT02503085|580684610|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
160808463|NCT02503085|580684611|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
160808464|NCT01162473|580684615|FG000|Overall Study|Adverse Event|2|||
160808465|NCT01162473|580684616|FG001|Overall Study|Adverse Event|1|||
160808466|NCT01162473|580684615|FG000|Overall Study|Withdrawal by Subject|0|||
160808467|NCT01162473|580684616|FG001|Overall Study|Withdrawal by Subject|4|||
160808468|NCT01144416|580684617|FG000|Intervention Period|Adverse Event|5|||
160808469|NCT01144416|580684618|FG001|Intervention Period|Adverse Event|6|||
160808470|NCT01144416|580684617|FG000|Intervention Period|Insufficient ovarian response|11|||
160808471|NCT01144416|580684618|FG001|Intervention Period|Insufficient ovarian response|17|||
160808472|NCT01144416|580684617|FG000|Intervention Period|Risk of OHSS|0|||
160808473|NCT01144416|580684618|FG001|Intervention Period|Risk of OHSS|1|||
160808474|NCT01144416|580684617|FG000|Intervention Period|Too high ovarian response|4|||
160808475|NCT01144416|580684618|FG001|Intervention Period|Too high ovarian response|2|||
160808476|NCT01144416|580684617|FG000|Intervention Period|No/too few/bad oocytes|7|||
160808477|NCT01144416|580684618|FG001|Intervention Period|No/too few/bad oocytes|5|||
160808478|NCT01144416|580684617|FG000|Intervention Period|No or abnormal fertilization|25|||
160808479|NCT01144416|580684618|FG001|Intervention Period|No or abnormal fertilization|10|||
160808480|NCT01144416|580684617|FG000|Intervention Period|No/too few/bad quality embryos|3|||
160808481|NCT01144416|580684618|FG001|Intervention Period|No/too few/bad quality embryos|3|||
160808482|NCT01144416|580684617|FG000|Intervention Period|Other|7|||
160808483|NCT01144416|580684618|FG001|Intervention Period|Other|5|||
160808484|NCT00124072|580684619|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
160808485|NCT00124072|580684620|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
160985989|NCT00372567|581338537|FG001|Phase 3 Study|Objective progression or relapse|13|||
160985990|NCT00372567|581338538|FG002|Phase 3 Study|Objective progression or relapse|4|||
160985991|NCT00372567|581338536|FG000|Phase 3 Study|Global deterioration of health status|0|||
160985992|NCT00372567|581338537|FG001|Phase 3 Study|Global deterioration of health status|1|||
160985993|NCT00372567|581338538|FG002|Phase 3 Study|Global deterioration of health status|0|||
160985994|NCT00372567|581338536|FG000|Phase 3 Study|Other|2|||
160985995|NCT00372567|581338537|FG001|Phase 3 Study|Other|2|||
160985996|NCT00372567|581338538|FG002|Phase 3 Study|Other|1|||
160985997|NCT00372567|581338536|FG000|Phase 3 Study|study terminated by sponsor|13|||
160985998|NCT00372567|581338537|FG001|Phase 3 Study|study terminated by sponsor|8|||
160985999|NCT00372567|581338538|FG002|Phase 3 Study|study terminated by sponsor|5|||
160986000|NCT00953160|581338543|FG000|Overall Study|Lost to Follow-up|23|||
160986001|NCT00953160|581338543|FG000|Overall Study|Withdrawal by Subject|4|||
160986002|NCT03836664|581338556|FG000|Overall Study|Didn't complete forms and lost drug|3|||
160986003|NCT03836664|581338557|FG001|Overall Study|Didn't complete forms and lost drug|3|||
160986004|NCT01427907|581338558|FG000|Overall Study|Withdrawal by Subject|3|||
160986005|NCT01427907|581338559|FG001|Overall Study|Withdrawal by Subject|4|||
160986006|NCT00425503|581338562|FG000|Overall Study|Adverse Event|2|||
160986007|NCT00425503|581338562|FG000|Overall Study|Protocol Violation|1|||
160986008|NCT03278028|581338564|FG000|Overall Study|Lost to Follow-up|1|||
160986009|NCT03278028|581338565|FG001|Overall Study|Lost to Follow-up|0|||
160986010|NCT03278028|581338564|FG000|Overall Study|Withdrawal by Subject|3|||
160986011|NCT03278028|581338565|FG001|Overall Study|Withdrawal by Subject|1|||
160986012|NCT03278028|581338564|FG000|Overall Study|Pregnancy|0|||
160986013|NCT03278028|581338565|FG001|Overall Study|Pregnancy|1|||
160986014|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
160808486|NCT00124072|580684621|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
161238680|NCT01566721|582253834|FG000|Safety Follow-up|Sponsor decision|1|||
161238681|NCT01566721|582253835|FG001|Safety Follow-up|Sponsor decision|0|||
161238682|NCT01566721|582253834|FG000|Safety Follow-up|Adverse Event|8|||
161238683|NCT01566721|582253835|FG001|Safety Follow-up|Adverse Event|4|||
161238684|NCT00811655|582253840|FG000|Overall Study|Physician Decision|1|||
161238685|NCT00787254|582253842|FG000|Overall Study|Adverse Event|24|||
161238686|NCT00787254|582253843|FG001|Overall Study|Adverse Event|23|||
161238687|NCT00787254|582253842|FG000|Overall Study|Protocol Violation|26|||
160808487|NCT00124072|580684622|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
160808488|NCT00124072|580684619|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
160808489|NCT00124072|580684620|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
160808490|NCT00124072|580684621|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
160986015|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
160986016|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
160986017|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
160986018|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
160986019|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
160986020|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
161238688|NCT00787254|582253843|FG001|Overall Study|Protocol Violation|23|||
161332542|NCT03102762|582605245|FG001|Overall Study|Lost to Follow-up|0|||
161130882|NCT00896532|581863481|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
161130883|NCT00896532|581863459|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130884|NCT00896532|581863460|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130885|NCT00896532|581863461|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130886|NCT00896532|581863462|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130887|NCT00896532|581863463|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130888|NCT00896532|581863464|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130889|NCT00896532|581863465|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130890|NCT00896532|581863466|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130891|NCT00896532|581863467|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130892|NCT00896532|581863468|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130893|NCT00896532|581863469|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130894|NCT00896532|581863470|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130895|NCT00896532|581863471|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130896|NCT00896532|581863472|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130897|NCT00896532|581863473|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130898|NCT00896532|581863474|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
161130899|NCT00896532|581863475|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
161130900|NCT00896532|581863476|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
161130901|NCT00896532|581863477|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130902|NCT00896532|581863478|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130903|NCT00896532|581863479|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161130904|NCT00896532|581863480|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
161332543|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
161332544|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161332545|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161332546|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161332547|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
161332548|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
161332549|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161332550|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161332551|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161332552|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
161332553|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
161332554|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161332555|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161332556|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161332557|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
161332558|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
161332559|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161332560|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161332561|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161332562|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
161332563|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
161332564|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161332565|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161332566|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161332567|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
161332568|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
161332569|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161332570|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161332571|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161332572|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
161332573|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
161332574|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161332575|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161332576|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161332577|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
161332578|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
161332579|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161332580|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161332581|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
160808491|NCT00124072|580684622|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
160808492|NCT00124072|580684619|FG000|Overall Study|Death|499|||
160808493|NCT00124072|580684620|FG001|Overall Study|Death|484|||
160808494|NCT00124072|580684621|FG002|Overall Study|Death|471|||
160808495|NCT00124072|580684622|FG003|Overall Study|Death|480|||
160808496|NCT00414076|580684623|FG000|Overall Study|Progression|1|||
160808497|NCT00414076|580684624|FG001|Overall Study|Progression|2|||
160808498|NCT00414076|580684623|FG000|Overall Study|Withdrawal by Subject|1|||
160808499|NCT00414076|580684624|FG001|Overall Study|Withdrawal by Subject|3|||
160808500|NCT00414076|580684623|FG000|Overall Study|Adverse Event|1|||
160808501|NCT00414076|580684624|FG001|Overall Study|Adverse Event|0|||
160808502|NCT03670355|580684632|FG000|Overall Study|Adverse Event|1|||
160808503|NCT03670355|580684633|FG001|Overall Study|Adverse Event|0|||
160808504|NCT03670355|580684632|FG000|Overall Study|Unable to comply with study procedures|0|||
160808505|NCT03670355|580684633|FG001|Overall Study|Unable to comply with study procedures|1|||
160808506|NCT03670355|580684632|FG000|Overall Study|Participant refused|0|||
160808507|NCT03670355|580684633|FG001|Overall Study|Participant refused|1|||
160808508|NCT02708680|580684638|FG000|Overall Study|Withdrawal by Subject|4|||
160808509|NCT02708680|580684639|FG001|Overall Study|Withdrawal by Subject|12|||
160808510|NCT02708680|580684640|FG002|Overall Study|Withdrawal by Subject|12|||
160808511|NCT02708680|580684638|FG000|Overall Study|Death|4|||
160808512|NCT02708680|580684639|FG001|Overall Study|Death|19|||
160808513|NCT02708680|580684640|FG002|Overall Study|Death|21|||
160808514|NCT02708680|580684638|FG000|Overall Study|Lost to Follow-up|0|||
160808515|NCT02708680|580684639|FG001|Overall Study|Lost to Follow-up|3|||
160808516|NCT02708680|580684640|FG002|Overall Study|Lost to Follow-up|3|||
160808517|NCT02708680|580684638|FG000|Overall Study|Study Terminated By Sponsor|0|||
160808518|NCT02708680|580684639|FG001|Overall Study|Study Terminated By Sponsor|5|||
160808519|NCT02708680|580684640|FG002|Overall Study|Study Terminated By Sponsor|4|||
160808520|NCT02708680|580684638|FG000|Overall Study|Other than Specified|0|||
160808521|NCT02708680|580684639|FG001|Overall Study|Other than Specified|0|||
160808522|NCT02708680|580684640|FG002|Overall Study|Other than Specified|1|||
160808523|NCT02708680|580684638|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
160808524|NCT02708680|580684639|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
160808525|NCT02708680|580684640|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
160808526|NCT01342926|580684641|FG000|Overall Study|Adverse Event|5|||
160808527|NCT01342926|580684642|FG001|Overall Study|Adverse Event|8|||
160808528|NCT01342926|580684643|FG002|Overall Study|Adverse Event|10|||
160808529|NCT01342926|580684644|FG003|Overall Study|Adverse Event|7|||
160808530|NCT01342926|580684641|FG000|Overall Study|Lost to Follow-up|0|||
160808531|NCT01342926|580684642|FG001|Overall Study|Lost to Follow-up|1|||
160808532|NCT01342926|580684643|FG002|Overall Study|Lost to Follow-up|1|||
160808533|NCT01342926|580684644|FG003|Overall Study|Lost to Follow-up|0|||
160808534|NCT01342926|580684641|FG000|Overall Study|Investigator Discretion|2|||
161238689|NCT00787254|582253842|FG000|Overall Study|Withdrawal by Subject|16|||
161238690|NCT00787254|582253843|FG001|Overall Study|Withdrawal by Subject|11|||
161238691|NCT00787254|582253842|FG000|Overall Study|Lack of Efficacy|4|||
161238692|NCT00787254|582253843|FG001|Overall Study|Lack of Efficacy|15|||
161238693|NCT00787254|582253842|FG000|Overall Study|NSAIDs discontinuation|1|||
161238694|NCT00787254|582253843|FG001|Overall Study|NSAIDs discontinuation|2|||
161238695|NCT00787254|582253842|FG000|Overall Study|Institution closed|1|||
161238696|NCT00787254|582253843|FG001|Overall Study|Institution closed|0|||
161238697|NCT00787254|582253842|FG000|Overall Study|Physician Decision|4|||
161238698|NCT00787254|582253843|FG001|Overall Study|Physician Decision|8|||
161238699|NCT00119015|582253846|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
161238700|NCT00119015|582253847|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
161238701|NCT00119015|582253848|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
161238702|NCT00316186|582253849|FG000|Overall Study|Adverse Event|6|||
161238703|NCT00316186|582253849|FG000|Overall Study|Disease Progression|4|||
160808535|NCT01342926|580684642|FG001|Overall Study|Investigator Discretion|2|||
160808536|NCT01342926|580684643|FG002|Overall Study|Investigator Discretion|0|||
160808537|NCT01342926|580684644|FG003|Overall Study|Investigator Discretion|0|||
160808538|NCT01342926|580684641|FG000|Overall Study|Withdrawal by Subject|2|||
160808539|NCT01342926|580684642|FG001|Overall Study|Withdrawal by Subject|4|||
161238704|NCT00316186|582253849|FG000|Overall Study|Lost to Follow-up|1|||
160808540|NCT01342926|580684643|FG002|Overall Study|Withdrawal by Subject|3|||
160808541|NCT01342926|580684644|FG003|Overall Study|Withdrawal by Subject|5|||
160808542|NCT04162470|580684645|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
160808543|NCT01671956|580684646|FG000|Overall Study|Disease progression|0|||
160808544|NCT01671956|580684647|FG001|Overall Study|Disease progression|1|||
160808545|NCT01671956|580684646|FG000|Overall Study|Withdrawal by Subject|1|||
161238705|NCT00316186|582253849|FG000|Overall Study|Other|1|||
161238706|NCT01802320|582253852|FG000|Overall Study|Death|1|||
161238707|NCT01802320|582253852|FG000|Overall Study|Withdrawal by Subject|1|||
161238708|NCT05265624|582255733|FG000|Overall Study|Lost to Follow-up|3|||
160808546|NCT01671956|580684647|FG001|Overall Study|Withdrawal by Subject|1|||
160808547|NCT01671956|580684646|FG000|Overall Study|Adverse Event|1|||
161238709|NCT05265624|582255734|FG001|Overall Study|Lost to Follow-up|0|||
160899231|NCT02122458|581026272|FG005|Overall Study|Adverse Event|0|||
160899232|NCT02122458|581026273|FG006|Overall Study|Adverse Event|0|||
160899233|NCT02122458|581026267|FG000|Overall Study|Experimental Error|0|||
160899234|NCT02122458|581026268|FG001|Overall Study|Experimental Error|0|||
160899235|NCT02122458|581026269|FG002|Overall Study|Experimental Error|0|||
160899236|NCT02122458|581026270|FG003|Overall Study|Experimental Error|0|||
160899237|NCT02122458|581026271|FG004|Overall Study|Experimental Error|3|||
160899238|NCT02122458|581026272|FG005|Overall Study|Experimental Error|0|||
160899239|NCT02122458|581026273|FG006|Overall Study|Experimental Error|0|||
161332582|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
161332583|NCT02709746|582605246|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
161332584|NCT02709746|582605247|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161332585|NCT02709746|582605248|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161332586|NCT02709746|582605249|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161332587|NCT02709746|582605250|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
161332588|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161332589|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
161332590|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161332591|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
161332592|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
161332593|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
161332594|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
161332595|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
161332596|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
161332597|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
161332598|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
161332599|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
161332600|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
161332601|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
161332602|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
161332603|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
161332604|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
161332605|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
161332606|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
161332607|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
161332608|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
161332609|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
161332610|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
161332611|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
161332612|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
161332613|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
161332614|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161332615|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161332616|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
161332617|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
161332618|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161332619|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161332620|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
161332621|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161332622|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
161332623|NCT02709746|582605246|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
161332624|NCT02709746|582605247|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
161332625|NCT02709746|582605248|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
161332626|NCT02709746|582605249|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
161332627|NCT02709746|582605250|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
161332628|NCT01774981|582605255|FG000|Overall Study|Adverse Event|0|||
161332629|NCT01774981|582605256|FG001|Overall Study|Adverse Event|0|||
161332630|NCT01774981|582605257|FG002|Overall Study|Adverse Event|0|||
161332631|NCT01774981|582605258|FG003|Overall Study|Adverse Event|0|||
161332632|NCT01774981|582605259|FG004|Overall Study|Adverse Event|0|||
161332633|NCT01774981|582605260|FG005|Overall Study|Adverse Event|1|||
161332634|NCT01774981|582605261|FG006|Overall Study|Adverse Event|0|||
161332635|NCT01774981|582605262|FG007|Overall Study|Adverse Event|0|||
161332636|NCT01774981|582605255|FG000|Overall Study|Withdrawal by Subject|0|||
161332637|NCT01774981|582605256|FG001|Overall Study|Withdrawal by Subject|0|||
160899240|NCT02122458|581026267|FG000|Overall Study|Deployed or Moved|0|||
161130905|NCT00896532|581863481|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
160808548|NCT01671956|580684647|FG001|Overall Study|Adverse Event|0|||
160808549|NCT04266912|580684651|FG000|Overall Study|Withdrawal by Subject|1|||
160808550|NCT04266912|580684652|FG001|Overall Study|Withdrawal by Subject|0|||
160808551|NCT04266912|580684653|FG002|Overall Study|Withdrawal by Subject|0|||
160808552|NCT04266912|580684654|FG003|Overall Study|Withdrawal by Subject|0|||
160808553|NCT04266912|580684651|FG000|Overall Study|Progression|6|||
160808554|NCT04266912|580684652|FG001|Overall Study|Progression|6|||
160808555|NCT04266912|580684653|FG002|Overall Study|Progression|0|||
160808556|NCT04266912|580684654|FG003|Overall Study|Progression|10|||
160808557|NCT03816176|580684661|FG000|Overall Study|Miscellaneous|5|||
160808558|NCT03816176|580684661|FG000|Overall Study|Lack of Efficacy|4|||
160808559|NCT03816176|580684661|FG000|Overall Study|Adverse Event|3|||
160808560|NCT05200572|580684662|FG000|Overall Study|Withdrawal by Subject|14|||
160808561|NCT07214935|580684663|FG000|Overall Study|Adverse Event|1|||
160808562|NCT07214935|580684664|FG001|Overall Study|Adverse Event|1|||
160808563|NCT07214935|580684665|FG002|Overall Study|Adverse Event|1|||
160808564|NCT07214935|580684666|FG003|Overall Study|Adverse Event|0|||
160808565|NCT07214935|580684663|FG000|Overall Study|Lost to Follow-up|0|||
160808566|NCT07214935|580684664|FG001|Overall Study|Lost to Follow-up|1|||
160808567|NCT07214935|580684665|FG002|Overall Study|Lost to Follow-up|0|||
160808568|NCT07214935|580684666|FG003|Overall Study|Lost to Follow-up|0|||
160808569|NCT07214935|580684663|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
160808570|NCT07214935|580684664|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
160808571|NCT07214935|580684665|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
160808572|NCT07214935|580684666|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
161130906|NCT00896532|581863459|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160986021|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
160986022|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
160986023|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
160986024|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
161130907|NCT00896532|581863460|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130908|NCT00896532|581863461|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130909|NCT00896532|581863462|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160808573|NCT07214935|580684663|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
160808574|NCT07214935|580684664|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
160808575|NCT07214935|580684665|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
161130910|NCT00896532|581863463|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130911|NCT00896532|581863464|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130912|NCT00896532|581863465|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130913|NCT00896532|581863466|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130914|NCT00896532|581863467|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130915|NCT00896532|581863468|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130916|NCT00896532|581863469|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130917|NCT00896532|581863470|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130918|NCT00896532|581863471|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
160808576|NCT07214935|580684666|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
160808577|NCT05823974|580686475|FG000|Overall Study|Lost to Follow-up|0|||
160808578|NCT05823974|580686476|FG001|Overall Study|Lost to Follow-up|3|||
160808579|NCT05823974|580686477|FG002|Overall Study|Lost to Follow-up|1|||
160808580|NCT05823974|580686478|FG003|Overall Study|Lost to Follow-up|0|||
160808581|NCT05823974|580686479|FG004|Overall Study|Lost to Follow-up|1|||
160808582|NCT05823974|580686480|FG005|Overall Study|Lost to Follow-up|0|||
160808583|NCT05823974|580686481|FG006|Overall Study|Lost to Follow-up|1|||
160808584|NCT05823974|580686482|FG007|Overall Study|Lost to Follow-up|0|||
160808585|NCT05823974|580686483|FG008|Overall Study|Lost to Follow-up|0|||
160808586|NCT05823974|580686484|FG009|Overall Study|Lost to Follow-up|1|||
160808587|NCT05823974|580686485|FG010|Overall Study|Lost to Follow-up|1|||
160808588|NCT05823974|580686486|FG011|Overall Study|Lost to Follow-up|0|||
160808589|NCT05823974|580686487|FG012|Overall Study|Lost to Follow-up|1|||
160808590|NCT05823974|580686488|FG013|Overall Study|Lost to Follow-up|2|||
160808591|NCT05823974|580686489|FG014|Overall Study|Lost to Follow-up|1|||
160808592|NCT05823974|580686490|FG015|Overall Study|Lost to Follow-up|1|||
160808593|NCT05823974|580686491|FG016|Overall Study|Lost to Follow-up|1|||
160808594|NCT05823974|580686492|FG017|Overall Study|Lost to Follow-up|0|||
160808595|NCT05823974|580686493|FG018|Overall Study|Lost to Follow-up|0|||
160808596|NCT05823974|580686494|FG019|Overall Study|Lost to Follow-up|2|||
160808597|NCT05823974|580686495|FG020|Overall Study|Lost to Follow-up|0|||
160808598|NCT05823974|580686475|FG000|Overall Study|Physician Decision|0|||
160808599|NCT05823974|580686476|FG001|Overall Study|Physician Decision|0|||
160808600|NCT05823974|580686477|FG002|Overall Study|Physician Decision|0|||
160808601|NCT05823974|580686478|FG003|Overall Study|Physician Decision|0|||
160808602|NCT05823974|580686479|FG004|Overall Study|Physician Decision|0|||
160986025|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
160986026|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
160986027|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
160986028|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
160986029|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
160986030|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
160986031|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
161130919|NCT00896532|581863472|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130920|NCT00896532|581863473|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130921|NCT00896532|581863474|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130922|NCT00896532|581863475|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
161130923|NCT00896532|581863476|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130924|NCT00896532|581863477|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130925|NCT00896532|581863478|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130926|NCT00896532|581863479|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130927|NCT00896532|581863480|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130928|NCT00896532|581863481|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
161130929|NCT00896532|581863459|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
161130930|NCT00896532|581863460|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
161130931|NCT00896532|581863461|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
161238710|NCT05265624|582255733|FG000|Overall Study|Withdrawal by Subject|1|||
161238711|NCT05265624|582255734|FG001|Overall Study|Withdrawal by Subject|0|||
161238712|NCT00001703|582255735|FG000|Overall Study|progressed disease|2|||
161238713|NCT00001703|582255735|FG000|Overall Study|No evidence of disease|1|||
161238714|NCT00001703|582255735|FG000|Overall Study|recurrent disease|2|||
161238715|NCT00665925|582255736|FG000|Overall Study|Lack of Efficacy|10|||
161238716|NCT00665925|582255737|FG001|Overall Study|Lack of Efficacy|8|||
161238717|NCT00665925|582255738|FG002|Overall Study|Lack of Efficacy|9|||
161332638|NCT01774981|582605257|FG002|Overall Study|Withdrawal by Subject|0|||
161332639|NCT01774981|582605258|FG003|Overall Study|Withdrawal by Subject|0|||
161332640|NCT01774981|582605259|FG004|Overall Study|Withdrawal by Subject|0|||
161332641|NCT01774981|582605260|FG005|Overall Study|Withdrawal by Subject|0|||
161332642|NCT01774981|582605261|FG006|Overall Study|Withdrawal by Subject|0|||
161332643|NCT01774981|582605262|FG007|Overall Study|Withdrawal by Subject|1|||
161332644|NCT01774981|582605255|FG000|Overall Study|Death|0|||
161332645|NCT01774981|582605256|FG001|Overall Study|Death|0|||
161332646|NCT01774981|582605257|FG002|Overall Study|Death|0|||
161332647|NCT01774981|582605258|FG003|Overall Study|Death|0|||
161332648|NCT01774981|582605259|FG004|Overall Study|Death|1|||
161332649|NCT01774981|582605260|FG005|Overall Study|Death|0|||
161332650|NCT01774981|582605261|FG006|Overall Study|Death|0|||
161332651|NCT01774981|582605262|FG007|Overall Study|Death|0|||
161332652|NCT00001566|582605265|FG000|Overall Study|patients' choice to discontinue protocol|3|||
161332653|NCT00001566|582605265|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
161332654|NCT00001566|582605265|FG000|Overall Study|Death|13|||
161332655|NCT00001566|582605265|FG000|Overall Study|Lost to Follow-up|1|||
161332656|NCT00001566|582605265|FG000|Overall Study|unable to complete initial apheresis|1|||
161332657|NCT02915835|582605266|FG000|Overall Study|Physician Decision|1|||
161332658|NCT02915835|582605267|FG001|Overall Study|Physician Decision|0|||
161332659|NCT02915835|582605266|FG000|Overall Study|Withdrawal by Subject|0|||
161332660|NCT02915835|582605267|FG001|Overall Study|Withdrawal by Subject|1|||
161332661|NCT00433836|582605268|FG000|Overall Study|Adverse Event|7|||
161332662|NCT00433836|582605269|FG001|Overall Study|Adverse Event|0|||
161332663|NCT00433836|582605268|FG000|Overall Study|Lost to Follow-up|3|||
161332664|NCT00433836|582605269|FG001|Overall Study|Lost to Follow-up|0|||
161332665|NCT00433836|582605268|FG000|Overall Study|Withdrawal by Subject|2|||
161332666|NCT00433836|582605269|FG001|Overall Study|Withdrawal by Subject|1|||
161332667|NCT00433836|582605268|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161332668|NCT00433836|582605269|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161332669|NCT00433836|582605268|FG000|Overall Study|Protocol Violation|0|||
161332670|NCT00433836|582605269|FG001|Overall Study|Protocol Violation|2|||
161332671|NCT00433836|582605268|FG000|Overall Study|Condition no longer requires study drug|0|||
161332672|NCT00433836|582605269|FG001|Overall Study|Condition no longer requires study drug|1|||
161332673|NCT00433836|582605268|FG000|Overall Study|Abnormal laboratory values|0|||
161332674|NCT00433836|582605269|FG001|Overall Study|Abnormal laboratory values|1|||
161332675|NCT00113607|582605270|FG000|Overall Study|Adverse Event|40|||
161332676|NCT00113607|582605271|FG001|Overall Study|Adverse Event|71|||
161332677|NCT00113607|582605270|FG000|Overall Study|Death|8|||
161332678|NCT00113607|582605271|FG001|Overall Study|Death|8|||
161332679|NCT00113607|582605270|FG000|Overall Study|Withdrawal by Subject|50|||
161332680|NCT00113607|582605271|FG001|Overall Study|Withdrawal by Subject|58|||
161332681|NCT00113607|582605270|FG000|Overall Study|Lost to Follow-up|0|||
161332682|NCT00113607|582605271|FG001|Overall Study|Lost to Follow-up|2|||
161130932|NCT00896532|581863462|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
160986032|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
160986033|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
160986034|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
160986035|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
160986036|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
160986037|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
161332683|NCT00113607|582605270|FG000|Overall Study|Disease Progression|180|||
161332684|NCT00113607|582605271|FG001|Overall Study|Disease Progression|142|||
161332685|NCT00113607|582605270|FG000|Overall Study|Complete Response (Confirmed)|14|||
161332686|NCT00113607|582605271|FG001|Overall Study|Complete Response (Confirmed)|24|||
161332687|NCT00113607|582605270|FG000|Overall Study|Other|43|||
161332688|NCT00113607|582605271|FG001|Overall Study|Other|32|||
161332689|NCT03669549|582605272|FG000|Overall Study|Adverse Event|4|||
161332690|NCT03669549|582605272|FG000|Overall Study|Withdrawal by Subject|1|||
161332691|NCT03669549|582605272|FG000|Overall Study|Study terminated by the Sponsor|1|||
161332692|NCT00909844|582605273|FG000|Overall Study|Adverse Event|1|||
161332693|NCT00909844|582605273|FG000|Overall Study|Withdrawal by Subject|1|||
161332694|NCT00909844|582605273|FG000|Overall Study|Lost to Follow-up|2|||
161332695|NCT00706004|582605274|FG000|Overall Study|Did not meet eligibility criteria|2|||
161332696|NCT02674516|582605275|FG000|Overall Study|Lost to Follow-up|3|||
161332697|NCT02674516|582605276|FG001|Overall Study|Lost to Follow-up|0|||
161332698|NCT02674516|582605275|FG000|Overall Study|Protocol Violation|0|||
161332699|NCT02674516|582605276|FG001|Overall Study|Protocol Violation|4|||
161332700|NCT02674516|582605275|FG000|Overall Study|Knowledge of study hypothesis|1|||
161332701|NCT02674516|582605276|FG001|Overall Study|Knowledge of study hypothesis|0|||
161332702|NCT01064479|582605277|FG000|Overall Study|Death|10|||
161332703|NCT01064479|582605278|FG001|Overall Study|Death|11|||
161332704|NCT01064479|582605277|FG000|Overall Study|Withdrawal by Subject|2|||
161332705|NCT01064479|582605278|FG001|Overall Study|Withdrawal by Subject|2|||
161332706|NCT01064479|582605277|FG000|Overall Study|Disease progression|1|||
161332707|NCT01064479|582605278|FG001|Overall Study|Disease progression|1|||
161332708|NCT01064479|582605277|FG000|Overall Study|Toxicity|1|||
161332709|NCT01064479|582605278|FG001|Overall Study|Toxicity|1|||
161332710|NCT01064479|582605277|FG000|Overall Study|Other|1|||
161332711|NCT01064479|582605278|FG001|Overall Study|Other|2|||
161332712|NCT05696392|582605285|FG000|Overall Study|Lost to Follow-up|3|||
161332713|NCT05696392|582605285|FG000|Overall Study|Protocol Violation|1|||
161332714|NCT05696392|582605285|FG000|Overall Study|Withdrawal by Subject|1|||
161332715|NCT03180736|582605286|FG000|Overall Study|Adverse Event|3|||
161332716|NCT03180736|582605287|FG001|Overall Study|Adverse Event|4|||
161332717|NCT03180736|582605286|FG000|Overall Study|Death|10|||
161332718|NCT03180736|582605287|FG001|Overall Study|Death|7|||
161332719|NCT03180736|582605286|FG000|Overall Study|Withdrawal by Subject|5|||
161332720|NCT03180736|582605287|FG001|Overall Study|Withdrawal by Subject|12|||
161332721|NCT03180736|582605286|FG000|Overall Study|Lost to Follow-up|1|||
161332722|NCT03180736|582605287|FG001|Overall Study|Lost to Follow-up|0|||
161332723|NCT03180736|582605286|FG000|Overall Study|Lack of Efficacy|66|||
161332724|NCT03180736|582605287|FG001|Overall Study|Lack of Efficacy|87|||
161332725|NCT03180736|582605286|FG000|Overall Study|Physician Decision|4|||
161332726|NCT03180736|582605287|FG001|Overall Study|Physician Decision|7|||
161332727|NCT03180736|582605286|FG000|Overall Study|randomized but not treated|2|||
161332728|NCT03180736|582605287|FG001|Overall Study|randomized but not treated|3|||
161332729|NCT03258593|582605288|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
161332730|NCT03258593|582605289|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
161332731|NCT03258593|582605290|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
161332732|NCT03258593|582605291|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
161332733|NCT03258593|582605288|FG000|Run-In Maintenance Phase|Disease progression|3|||
161332734|NCT03258593|582605289|FG001|Run-In Maintenance Phase|Disease progression|0|||
161332735|NCT03258593|582605290|FG002|Run-In Maintenance Phase|Disease progression|0|||
161332736|NCT03258593|582605291|FG003|Run-In Maintenance Phase|Disease progression|0|||
161332737|NCT03258593|582605288|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161332738|NCT03258593|582605289|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
161332739|NCT03258593|582605290|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161332740|NCT03258593|582605291|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
161332741|NCT03258593|582605288|FG000|Expansion Maintenance Phase|Physician Decision|0|||
161332742|NCT03258593|582605289|FG001|Expansion Maintenance Phase|Physician Decision|1|||
161332743|NCT03258593|582605290|FG002|Expansion Maintenance Phase|Physician Decision|0|||
161332744|NCT03258593|582605291|FG003|Expansion Maintenance Phase|Physician Decision|0|||
161332745|NCT05457257|582605299|FG000|Overall Study|Withdrawal by Subject|0|||
161332746|NCT05457257|582605300|FG001|Overall Study|Withdrawal by Subject|2|||
161332747|NCT05457257|582605299|FG000|Overall Study|Death|10|||
161332748|NCT05457257|582605300|FG001|Overall Study|Death|3|||
161332749|NCT05457257|582605299|FG000|Overall Study|Ongoing|19|||
161332750|NCT05457257|582605300|FG001|Overall Study|Ongoing|9|||
161332751|NCT04464707|582605303|FG000|Overall Study|Adverse Event|1|||
161332752|NCT04464707|582605304|FG001|Overall Study|Adverse Event|0|||
160808603|NCT05823974|580686480|FG005|Overall Study|Physician Decision|0|||
160808604|NCT05823974|580686481|FG006|Overall Study|Physician Decision|0|||
160808605|NCT05823974|580686482|FG007|Overall Study|Physician Decision|0|||
160808606|NCT05823974|580686483|FG008|Overall Study|Physician Decision|0|||
160808607|NCT05823974|580686484|FG009|Overall Study|Physician Decision|0|||
160808608|NCT05823974|580686485|FG010|Overall Study|Physician Decision|0|||
160808609|NCT05823974|580686486|FG011|Overall Study|Physician Decision|0|||
160808610|NCT05823974|580686487|FG012|Overall Study|Physician Decision|0|||
160808611|NCT05823974|580686488|FG013|Overall Study|Physician Decision|0|||
160808612|NCT05823974|580686489|FG014|Overall Study|Physician Decision|0|||
160808613|NCT05823974|580686490|FG015|Overall Study|Physician Decision|1|||
160808614|NCT05823974|580686491|FG016|Overall Study|Physician Decision|0|||
160808615|NCT05823974|580686492|FG017|Overall Study|Physician Decision|1|||
160808616|NCT05823974|580686493|FG018|Overall Study|Physician Decision|1|||
160808617|NCT05823974|580686494|FG019|Overall Study|Physician Decision|0|||
160808618|NCT05823974|580686495|FG020|Overall Study|Physician Decision|0|||
160808619|NCT05823974|580686475|FG000|Overall Study|Withdrawal by Subject|1|||
160808620|NCT05823974|580686476|FG001|Overall Study|Withdrawal by Subject|1|||
160808621|NCT05823974|580686477|FG002|Overall Study|Withdrawal by Subject|2|||
160808622|NCT05823974|580686478|FG003|Overall Study|Withdrawal by Subject|0|||
160808623|NCT05823974|580686479|FG004|Overall Study|Withdrawal by Subject|2|||
160808624|NCT05823974|580686480|FG005|Overall Study|Withdrawal by Subject|3|||
160808625|NCT05823974|580686481|FG006|Overall Study|Withdrawal by Subject|1|||
160808626|NCT05823974|580686482|FG007|Overall Study|Withdrawal by Subject|1|||
160808627|NCT05823974|580686483|FG008|Overall Study|Withdrawal by Subject|2|||
160808628|NCT05823974|580686484|FG009|Overall Study|Withdrawal by Subject|1|||
160808629|NCT05823974|580686485|FG010|Overall Study|Withdrawal by Subject|1|||
160808630|NCT05823974|580686486|FG011|Overall Study|Withdrawal by Subject|0|||
160808631|NCT05823974|580686487|FG012|Overall Study|Withdrawal by Subject|0|||
160808632|NCT05823974|580686488|FG013|Overall Study|Withdrawal by Subject|1|||
160808633|NCT05823974|580686489|FG014|Overall Study|Withdrawal by Subject|1|||
160808634|NCT05823974|580686490|FG015|Overall Study|Withdrawal by Subject|3|||
160808635|NCT05823974|580686491|FG016|Overall Study|Withdrawal by Subject|0|||
160808636|NCT05823974|580686492|FG017|Overall Study|Withdrawal by Subject|2|||
160808637|NCT05823974|580686493|FG018|Overall Study|Withdrawal by Subject|2|||
160808638|NCT05823974|580686494|FG019|Overall Study|Withdrawal by Subject|0|||
160808639|NCT05823974|580686495|FG020|Overall Study|Withdrawal by Subject|1|||
160808640|NCT05823974|580686475|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808641|NCT05823974|580686476|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808642|NCT05823974|580686477|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160808643|NCT05823974|580686478|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808644|NCT05823974|580686479|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808645|NCT05823974|580686480|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808646|NCT05823974|580686481|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808647|NCT05823974|580686482|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808648|NCT05823974|580686483|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808649|NCT05823974|580686484|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808650|NCT05823974|580686485|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808651|NCT05823974|580686486|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808652|NCT05823974|580686487|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808653|NCT05823974|580686488|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808654|NCT05823974|580686489|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160808655|NCT05823974|580686490|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808656|NCT05823974|580686491|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808657|NCT05823974|580686492|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808658|NCT05823974|580686493|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808659|NCT05823974|580686494|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808660|NCT05823974|580686495|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160808661|NCT05823974|580686475|FG000|Overall Study|Other|0|||
160808662|NCT05823974|580686476|FG001|Overall Study|Other|1|||
160808663|NCT05823974|580686477|FG002|Overall Study|Other|1|||
160808664|NCT05823974|580686478|FG003|Overall Study|Other|1|||
161130933|NCT00896532|581863463|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
161130934|NCT00896532|581863464|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
161130935|NCT00896532|581863465|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
161130936|NCT00896532|581863466|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
160808665|NCT05823974|580686479|FG004|Overall Study|Other|0|||
160808666|NCT05823974|580686480|FG005|Overall Study|Other|1|||
160808667|NCT05823974|580686481|FG006|Overall Study|Other|1|||
160808668|NCT05823974|580686482|FG007|Overall Study|Other|1|||
160808669|NCT05823974|580686483|FG008|Overall Study|Other|1|||
160808670|NCT05823974|580686484|FG009|Overall Study|Other|0|||
161130937|NCT00896532|581863467|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
161130938|NCT00896532|581863468|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
160808671|NCT05823974|580686485|FG010|Overall Study|Other|0|||
160808672|NCT05823974|580686486|FG011|Overall Study|Other|0|||
160808673|NCT05823974|580686487|FG012|Overall Study|Other|2|||
160808674|NCT05823974|580686488|FG013|Overall Study|Other|1|||
160808675|NCT05823974|580686489|FG014|Overall Study|Other|0|||
160808676|NCT05823974|580686490|FG015|Overall Study|Other|1|||
160808677|NCT05823974|580686491|FG016|Overall Study|Other|0|||
160808678|NCT05823974|580686492|FG017|Overall Study|Other|0|||
160808679|NCT05823974|580686493|FG018|Overall Study|Other|0|||
160808680|NCT05823974|580686494|FG019|Overall Study|Other|0|||
160808681|NCT05823974|580686495|FG020|Overall Study|Other|0|||
160808682|NCT02744612|580686496|FG000|Overall Study|Withdrawal by Subject|0|||
160808683|NCT02744612|580686497|FG001|Overall Study|Withdrawal by Subject|2|||
160808684|NCT00316706|580686498|FG000|Overall Study|Lost to Follow-up|38|||
160808685|NCT00316706|580686499|FG001|Overall Study|Lost to Follow-up|48|||
160808686|NCT01133756|580686502|FG000|Overall Study|Adverse Event|1|||
160808687|NCT01133756|580686503|FG001|Overall Study|Adverse Event|2|||
160808688|NCT01133756|580686504|FG002|Overall Study|Adverse Event|1|||
160808689|NCT01133756|580686502|FG000|Overall Study|Investigator Decision|1|||
160808690|NCT01133756|580686503|FG001|Overall Study|Investigator Decision|0|||
160808691|NCT01133756|580686504|FG002|Overall Study|Investigator Decision|0|||
160808692|NCT01133756|580686502|FG000|Overall Study|Withdrawal by Subject|0|||
160808693|NCT01133756|580686503|FG001|Overall Study|Withdrawal by Subject|1|||
160808694|NCT01133756|580686504|FG002|Overall Study|Withdrawal by Subject|0|||
160808695|NCT01133756|580686502|FG000|Overall Study|Progression of Disease|0|||
160808696|NCT01133756|580686503|FG001|Overall Study|Progression of Disease|0|||
160808697|NCT01133756|580686504|FG002|Overall Study|Progression of Disease|1|||
160808698|NCT02574078|580686516|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808699|NCT02574078|580686517|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808700|NCT02574078|580686518|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808701|NCT02574078|580686519|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808702|NCT02574078|580686520|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808703|NCT02574078|580686521|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160808704|NCT02574078|580686522|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
160808705|NCT02574078|580686523|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808706|NCT02574078|580686524|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
160808707|NCT02574078|580686525|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808708|NCT02574078|580686526|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808709|NCT02574078|580686527|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808710|NCT02574078|580686528|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
160808711|NCT02574078|580686516|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
160808712|NCT02574078|580686517|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
160808713|NCT02574078|580686518|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
160808714|NCT02574078|580686519|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
160808715|NCT02574078|580686520|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
160808716|NCT02574078|580686521|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
160899241|NCT02122458|581026268|FG001|Overall Study|Deployed or Moved|0|||
160899242|NCT02122458|581026269|FG002|Overall Study|Deployed or Moved|0|||
160899243|NCT02122458|581026270|FG003|Overall Study|Deployed or Moved|0|||
160899244|NCT02122458|581026271|FG004|Overall Study|Deployed or Moved|1|||
160899245|NCT02122458|581026272|FG005|Overall Study|Deployed or Moved|0|||
160899246|NCT02122458|581026273|FG006|Overall Study|Deployed or Moved|0|||
160899247|NCT02122458|581026267|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
160899248|NCT02122458|581026268|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
160899249|NCT02122458|581026269|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
160899250|NCT02122458|581026270|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
160899251|NCT02122458|581026271|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
160899252|NCT02122458|581026272|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
160899253|NCT02122458|581026273|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
160899254|NCT02122458|581026267|FG000|Overall Study|Noncompliance|0|||
160899255|NCT02122458|581026268|FG001|Overall Study|Noncompliance|1|||
160899256|NCT02122458|581026269|FG002|Overall Study|Noncompliance|0|||
160899257|NCT02122458|581026270|FG003|Overall Study|Noncompliance|0|||
160899258|NCT02122458|581026271|FG004|Overall Study|Noncompliance|0|||
160899259|NCT02122458|581026272|FG005|Overall Study|Noncompliance|0|||
160899260|NCT02122458|581026273|FG006|Overall Study|Noncompliance|0|||
160899261|NCT00412542|581026274|FG000|Overall Study|Withdrawal by Subject|0|||
160899262|NCT00412542|581026275|FG001|Overall Study|Withdrawal by Subject|2|||
160899263|NCT00412542|581026274|FG000|Overall Study|Not Eligible|0|||
160899264|NCT00412542|581026275|FG001|Overall Study|Not Eligible|1|||
160899265|NCT02833350|581026276|FG000|Overall Study|Adverse Event|0|||
160899266|NCT02833350|581026277|FG001|Overall Study|Adverse Event|3|||
160899267|NCT02833350|581026278|FG002|Overall Study|Adverse Event|4|||
160899268|NCT02833350|581026279|FG003|Overall Study|Adverse Event|4|||
161130939|NCT00896532|581863469|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
161130940|NCT00896532|581863470|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
161130941|NCT00896532|581863471|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
161130942|NCT00896532|581863472|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
160808717|NCT02574078|580686522|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
161130943|NCT00896532|581863473|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
160808718|NCT02574078|580686523|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
160808719|NCT02574078|580686524|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
160808720|NCT02574078|580686525|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
160808721|NCT02574078|580686526|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
160808722|NCT02574078|580686527|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
160808723|NCT02574078|580686528|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
160808724|NCT02574078|580686516|FG000|Pre-Treatment Period|Other reasons|0|||
160808725|NCT02574078|580686517|FG001|Pre-Treatment Period|Other reasons|0|||
160808726|NCT02574078|580686518|FG002|Pre-Treatment Period|Other reasons|0|||
160808727|NCT02574078|580686519|FG003|Pre-Treatment Period|Other reasons|0|||
161130944|NCT00896532|581863474|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
161130945|NCT00896532|581863475|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
161130946|NCT00896532|581863476|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
161130947|NCT00896532|581863477|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
161130948|NCT00896532|581863478|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
161130949|NCT00896532|581863479|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
161130950|NCT00896532|581863480|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
161130951|NCT00896532|581863481|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
161130952|NCT00896532|581863459|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130953|NCT00896532|581863460|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130954|NCT00896532|581863461|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130955|NCT00896532|581863462|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130956|NCT00896532|581863463|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130957|NCT00896532|581863464|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130958|NCT00896532|581863465|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130959|NCT00896532|581863466|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130960|NCT00896532|581863467|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130961|NCT00896532|581863468|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161238718|NCT00665925|582255739|FG003|Overall Study|Lack of Efficacy|8|||
161238719|NCT00665925|582255736|FG000|Overall Study|Lost to Follow-up|1|||
161238720|NCT00665925|582255737|FG001|Overall Study|Lost to Follow-up|2|||
161238721|NCT00665925|582255738|FG002|Overall Study|Lost to Follow-up|2|||
161238722|NCT00665925|582255739|FG003|Overall Study|Lost to Follow-up|2|||
160808728|NCT02574078|580686520|FG004|Pre-Treatment Period|Other reasons|0|||
160808729|NCT02574078|580686521|FG005|Pre-Treatment Period|Other reasons|0|||
160808730|NCT02574078|580686522|FG006|Pre-Treatment Period|Other reasons|2|||
160808731|NCT02574078|580686523|FG007|Pre-Treatment Period|Other reasons|0|||
160808732|NCT02574078|580686524|FG008|Pre-Treatment Period|Other reasons|0|||
160808733|NCT02574078|580686525|FG009|Pre-Treatment Period|Other reasons|0|||
160808734|NCT02574078|580686526|FG010|Pre-Treatment Period|Other reasons|2|||
160808735|NCT02574078|580686527|FG011|Pre-Treatment Period|Other reasons|0|||
161130962|NCT00896532|581863469|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130963|NCT00896532|581863470|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130964|NCT00896532|581863471|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130965|NCT00896532|581863472|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130966|NCT00896532|581863473|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130967|NCT00896532|581863474|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130968|NCT00896532|581863475|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
161130969|NCT00896532|581863476|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130970|NCT00896532|581863477|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130971|NCT00896532|581863478|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130972|NCT00896532|581863479|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161238723|NCT00665925|582255736|FG000|Overall Study|Withdrawal by Subject|2|||
161238724|NCT00665925|582255737|FG001|Overall Study|Withdrawal by Subject|2|||
161238725|NCT00665925|582255738|FG002|Overall Study|Withdrawal by Subject|3|||
161238726|NCT00665925|582255739|FG003|Overall Study|Withdrawal by Subject|2|||
161238727|NCT00665925|582255736|FG000|Overall Study|Physician Decision|0|||
161238728|NCT00665925|582255737|FG001|Overall Study|Physician Decision|0|||
161238729|NCT00665925|582255738|FG002|Overall Study|Physician Decision|1|||
161238730|NCT00665925|582255739|FG003|Overall Study|Physician Decision|2|||
161238731|NCT00665925|582255736|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
161238732|NCT00665925|582255737|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
160808736|NCT02574078|580686528|FG012|Pre-Treatment Period|Other reasons|0|||
160808737|NCT02574078|580686516|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
160808738|NCT02574078|580686517|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
160808739|NCT02574078|580686518|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
160808740|NCT02574078|580686519|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
160808741|NCT02574078|580686520|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
160808742|NCT02574078|580686521|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
160808743|NCT02574078|580686522|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
160808744|NCT02574078|580686523|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
160808745|NCT02574078|580686524|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
160808746|NCT02574078|580686525|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
160808747|NCT02574078|580686526|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
160808748|NCT02574078|580686527|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
160808749|NCT02574078|580686528|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
160808750|NCT02574078|580686516|FG000|Treatment Period|Disease progression|6|||
160808751|NCT02574078|580686517|FG001|Treatment Period|Disease progression|4|||
160808752|NCT02574078|580686518|FG002|Treatment Period|Disease progression|7|||
160808753|NCT02574078|580686519|FG003|Treatment Period|Disease progression|18|||
160808754|NCT02574078|580686520|FG004|Treatment Period|Disease progression|16|||
160808755|NCT02574078|580686521|FG005|Treatment Period|Disease progression|26|||
160808756|NCT02574078|580686522|FG006|Treatment Period|Disease progression|5|||
160808757|NCT02574078|580686523|FG007|Treatment Period|Disease progression|9|||
160808758|NCT02574078|580686524|FG008|Treatment Period|Disease progression|8|||
160808759|NCT02574078|580686525|FG009|Treatment Period|Disease progression|5|||
160808760|NCT02574078|580686526|FG010|Treatment Period|Disease progression|20|||
160808761|NCT02574078|580686527|FG011|Treatment Period|Disease progression|29|||
160808762|NCT02574078|580686528|FG012|Treatment Period|Disease progression|2|||
160808763|NCT02574078|580686516|FG000|Treatment Period|Study drug toxicity|1|||
160808764|NCT02574078|580686517|FG001|Treatment Period|Study drug toxicity|1|||
160808765|NCT02574078|580686518|FG002|Treatment Period|Study drug toxicity|0|||
160808766|NCT02574078|580686519|FG003|Treatment Period|Study drug toxicity|5|||
160808767|NCT02574078|580686520|FG004|Treatment Period|Study drug toxicity|3|||
160808768|NCT02574078|580686521|FG005|Treatment Period|Study drug toxicity|1|||
160808769|NCT02574078|580686522|FG006|Treatment Period|Study drug toxicity|2|||
160808770|NCT02574078|580686523|FG007|Treatment Period|Study drug toxicity|0|||
160808771|NCT02574078|580686524|FG008|Treatment Period|Study drug toxicity|2|||
160808772|NCT02574078|580686525|FG009|Treatment Period|Study drug toxicity|1|||
160808773|NCT02574078|580686526|FG010|Treatment Period|Study drug toxicity|16|||
160808774|NCT02574078|580686527|FG011|Treatment Period|Study drug toxicity|2|||
160808775|NCT02574078|580686528|FG012|Treatment Period|Study drug toxicity|4|||
160808776|NCT02574078|580686516|FG000|Treatment Period|Death|2|||
160808777|NCT02574078|580686517|FG001|Treatment Period|Death|0|||
160808778|NCT02574078|580686518|FG002|Treatment Period|Death|0|||
160808779|NCT02574078|580686519|FG003|Treatment Period|Death|0|||
160808780|NCT02574078|580686520|FG004|Treatment Period|Death|1|||
160808781|NCT02574078|580686521|FG005|Treatment Period|Death|1|||
160808782|NCT02574078|580686522|FG006|Treatment Period|Death|1|||
160808783|NCT02574078|580686523|FG007|Treatment Period|Death|1|||
160808784|NCT02574078|580686524|FG008|Treatment Period|Death|7|||
160808785|NCT02574078|580686525|FG009|Treatment Period|Death|1|||
160808786|NCT02574078|580686526|FG010|Treatment Period|Death|0|||
160808787|NCT02574078|580686527|FG011|Treatment Period|Death|2|||
160808788|NCT02574078|580686528|FG012|Treatment Period|Death|1|||
160808789|NCT02574078|580686516|FG000|Treatment Period|Adverse event unrelated to drug|0|||
160808790|NCT02574078|580686517|FG001|Treatment Period|Adverse event unrelated to drug|0|||
160808791|NCT02574078|580686518|FG002|Treatment Period|Adverse event unrelated to drug|1|||
160808792|NCT02574078|580686519|FG003|Treatment Period|Adverse event unrelated to drug|0|||
160808793|NCT02574078|580686520|FG004|Treatment Period|Adverse event unrelated to drug|2|||
160808794|NCT02574078|580686521|FG005|Treatment Period|Adverse event unrelated to drug|3|||
160808795|NCT02574078|580686522|FG006|Treatment Period|Adverse event unrelated to drug|0|||
160808796|NCT02574078|580686523|FG007|Treatment Period|Adverse event unrelated to drug|0|||
160808797|NCT02574078|580686524|FG008|Treatment Period|Adverse event unrelated to drug|1|||
160808798|NCT02574078|580686525|FG009|Treatment Period|Adverse event unrelated to drug|2|||
160808799|NCT02574078|580686526|FG010|Treatment Period|Adverse event unrelated to drug|4|||
160808800|NCT02574078|580686527|FG011|Treatment Period|Adverse event unrelated to drug|1|||
160808801|NCT02574078|580686528|FG012|Treatment Period|Adverse event unrelated to drug|0|||
160808802|NCT02574078|580686516|FG000|Treatment Period|Administrative reason by Sponsor|0|||
160808803|NCT02574078|580686517|FG001|Treatment Period|Administrative reason by Sponsor|1|||
160808804|NCT02574078|580686518|FG002|Treatment Period|Administrative reason by Sponsor|0|||
160808805|NCT02574078|580686519|FG003|Treatment Period|Administrative reason by Sponsor|0|||
160808806|NCT02574078|580686520|FG004|Treatment Period|Administrative reason by Sponsor|0|||
160808807|NCT02574078|580686521|FG005|Treatment Period|Administrative reason by Sponsor|0|||
160808808|NCT02574078|580686522|FG006|Treatment Period|Administrative reason by Sponsor|1|||
160808809|NCT02574078|580686523|FG007|Treatment Period|Administrative reason by Sponsor|0|||
160808810|NCT02574078|580686524|FG008|Treatment Period|Administrative reason by Sponsor|0|||
160899269|NCT02833350|581026280|FG004|Overall Study|Adverse Event|1|||
160808811|NCT02574078|580686525|FG009|Treatment Period|Administrative reason by Sponsor|0|||
160808812|NCT02574078|580686526|FG010|Treatment Period|Administrative reason by Sponsor|0|||
160808813|NCT02574078|580686527|FG011|Treatment Period|Administrative reason by Sponsor|0|||
160808814|NCT02574078|580686528|FG012|Treatment Period|Administrative reason by Sponsor|3|||
160808815|NCT02574078|580686516|FG000|Treatment Period|Other reasons|1|||
160808816|NCT02574078|580686517|FG001|Treatment Period|Other reasons|0|||
160808817|NCT02574078|580686518|FG002|Treatment Period|Other reasons|1|||
160808818|NCT02574078|580686519|FG003|Treatment Period|Other reasons|3|||
160808819|NCT02574078|580686520|FG004|Treatment Period|Other reasons|3|||
160808820|NCT02574078|580686521|FG005|Treatment Period|Other reasons|1|||
160808821|NCT02574078|580686522|FG006|Treatment Period|Other reasons|2|||
160808822|NCT02574078|580686523|FG007|Treatment Period|Other reasons|1|||
160808823|NCT02574078|580686524|FG008|Treatment Period|Other reasons|3|||
160808824|NCT02574078|580686525|FG009|Treatment Period|Other reasons|1|||
160808825|NCT02574078|580686526|FG010|Treatment Period|Other reasons|1|||
160808826|NCT02574078|580686527|FG011|Treatment Period|Other reasons|3|||
160808827|NCT02574078|580686528|FG012|Treatment Period|Other reasons|1|||
160808828|NCT02574078|580686516|FG000|Treatment Period|Participant request to stop drug|0|||
160808829|NCT02574078|580686517|FG001|Treatment Period|Participant request to stop drug|0|||
160808830|NCT02574078|580686518|FG002|Treatment Period|Participant request to stop drug|0|||
160808831|NCT02574078|580686519|FG003|Treatment Period|Participant request to stop drug|2|||
160808832|NCT02574078|580686520|FG004|Treatment Period|Participant request to stop drug|4|||
160808833|NCT02574078|580686521|FG005|Treatment Period|Participant request to stop drug|0|||
160808834|NCT02574078|580686522|FG006|Treatment Period|Participant request to stop drug|1|||
160808835|NCT02574078|580686523|FG007|Treatment Period|Participant request to stop drug|0|||
160808836|NCT02574078|580686524|FG008|Treatment Period|Participant request to stop drug|3|||
160808837|NCT02574078|580686525|FG009|Treatment Period|Participant request to stop drug|2|||
160808838|NCT02574078|580686526|FG010|Treatment Period|Participant request to stop drug|2|||
160808839|NCT02574078|580686527|FG011|Treatment Period|Participant request to stop drug|4|||
160808840|NCT02574078|580686528|FG012|Treatment Period|Participant request to stop drug|1|||
160808841|NCT02574078|580686516|FG000|Treatment Period|Participant withdrew consent|0|||
160808842|NCT02574078|580686517|FG001|Treatment Period|Participant withdrew consent|0|||
160899270|NCT02833350|581026281|FG005|Overall Study|Adverse Event|0|||
161332753|NCT04464707|582605305|FG002|Overall Study|Adverse Event|0|||
161332754|NCT04464707|582605303|FG000|Overall Study|Withdrawal by Subject|0|||
161332755|NCT04464707|582605304|FG001|Overall Study|Withdrawal by Subject|0|||
161332756|NCT04464707|582605305|FG002|Overall Study|Withdrawal by Subject|2|||
161332757|NCT04464707|582605303|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161332758|NCT04464707|582605304|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161332759|NCT04464707|582605305|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161332760|NCT04464707|582605303|FG000|Overall Study|Protocol Deviation|1|||
161332761|NCT04464707|582605304|FG001|Overall Study|Protocol Deviation|0|||
161332762|NCT04464707|582605305|FG002|Overall Study|Protocol Deviation|0|||
161332763|NCT04464707|582605303|FG000|Overall Study|Lost to Follow-up|2|||
161332764|NCT04464707|582605304|FG001|Overall Study|Lost to Follow-up|0|||
161332765|NCT04464707|582605305|FG002|Overall Study|Lost to Follow-up|1|||
161332766|NCT02131064|582605306|FG000|Overall Study|Death|5|||
161332767|NCT02131064|582605307|FG001|Overall Study|Death|6|||
161332768|NCT02131064|582605306|FG000|Overall Study|Lost to Follow-up|4|||
161332769|NCT02131064|582605307|FG001|Overall Study|Lost to Follow-up|8|||
161332770|NCT02131064|582605306|FG000|Overall Study|Withdrawal by Subject|14|||
161332771|NCT02131064|582605307|FG001|Overall Study|Withdrawal by Subject|18|||
161332772|NCT02131064|582605306|FG000|Overall Study|Other|2|||
161332773|NCT02131064|582605307|FG001|Overall Study|Other|2|||
161332774|NCT04831138|582605310|FG000|Overall Study|Lost to Follow-up|2|||
161332775|NCT04831138|582605311|FG001|Overall Study|Lost to Follow-up|0|||
161332776|NCT00593918|582605312|FG000|Overall Study|Withdrawal by Subject|5|||
161332777|NCT00593918|582605313|FG001|Overall Study|Withdrawal by Subject|24|||
161332778|NCT00871234|582605327|FG000|Overall Study|Adverse Event|2|||
161332779|NCT00871234|582605327|FG000|Overall Study|Lost to Follow-up|3|||
161332780|NCT04202497|582605329|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
161332781|NCT04202497|582605330|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161332782|NCT04202497|582605331|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161332783|NCT04202497|582605332|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
161332784|NCT04344301|582605333|FG000|Overall Study|Withdrawal by Subject|1|||
161332785|NCT04344301|582605334|FG001|Overall Study|Withdrawal by Subject|0|||
161332786|NCT04344301|582605333|FG000|Overall Study|Death|0|||
161332787|NCT04344301|582605334|FG001|Overall Study|Death|1|||
161332788|NCT00072410|582605335|FG000|Overall Study|Progressive disease|0|||
160808843|NCT02574078|580686518|FG002|Treatment Period|Participant withdrew consent|0|||
160808844|NCT02574078|580686519|FG003|Treatment Period|Participant withdrew consent|0|||
160808845|NCT02574078|580686520|FG004|Treatment Period|Participant withdrew consent|1|||
160808846|NCT02574078|580686521|FG005|Treatment Period|Participant withdrew consent|1|||
160808847|NCT02574078|580686522|FG006|Treatment Period|Participant withdrew consent|0|||
160808848|NCT02574078|580686523|FG007|Treatment Period|Participant withdrew consent|1|||
160808849|NCT02574078|580686524|FG008|Treatment Period|Participant withdrew consent|0|||
160808850|NCT02574078|580686525|FG009|Treatment Period|Participant withdrew consent|2|||
160808851|NCT02574078|580686526|FG010|Treatment Period|Participant withdrew consent|1|||
160808852|NCT02574078|580686527|FG011|Treatment Period|Participant withdrew consent|4|||
160808853|NCT02574078|580686528|FG012|Treatment Period|Participant withdrew consent|1|||
160808854|NCT02574078|580686516|FG000|Treatment Period|Participant no longer meets criteria|0|||
160808855|NCT02574078|580686517|FG001|Treatment Period|Participant no longer meets criteria|0|||
160808856|NCT02574078|580686518|FG002|Treatment Period|Participant no longer meets criteria|0|||
160808857|NCT02574078|580686519|FG003|Treatment Period|Participant no longer meets criteria|0|||
160808858|NCT02574078|580686520|FG004|Treatment Period|Participant no longer meets criteria|1|||
160808859|NCT02574078|580686521|FG005|Treatment Period|Participant no longer meets criteria|0|||
160808860|NCT02574078|580686522|FG006|Treatment Period|Participant no longer meets criteria|0|||
160808861|NCT02574078|580686523|FG007|Treatment Period|Participant no longer meets criteria|0|||
160808862|NCT02574078|580686524|FG008|Treatment Period|Participant no longer meets criteria|0|||
160808863|NCT02574078|580686525|FG009|Treatment Period|Participant no longer meets criteria|1|||
160808864|NCT02574078|580686526|FG010|Treatment Period|Participant no longer meets criteria|1|||
160808865|NCT02574078|580686527|FG011|Treatment Period|Participant no longer meets criteria|1|||
160808866|NCT02574078|580686528|FG012|Treatment Period|Participant no longer meets criteria|0|||
160808867|NCT02574078|580686516|FG000|Treatment Period|Lost to Follow-up|0|||
160808868|NCT02574078|580686517|FG001|Treatment Period|Lost to Follow-up|0|||
160808869|NCT02574078|580686518|FG002|Treatment Period|Lost to Follow-up|0|||
160808870|NCT02574078|580686519|FG003|Treatment Period|Lost to Follow-up|0|||
160808871|NCT02574078|580686520|FG004|Treatment Period|Lost to Follow-up|0|||
160808872|NCT02574078|580686521|FG005|Treatment Period|Lost to Follow-up|0|||
160808873|NCT02574078|580686522|FG006|Treatment Period|Lost to Follow-up|0|||
160808874|NCT02574078|580686523|FG007|Treatment Period|Lost to Follow-up|0|||
160808875|NCT02574078|580686524|FG008|Treatment Period|Lost to Follow-up|0|||
160808876|NCT02574078|580686525|FG009|Treatment Period|Lost to Follow-up|1|||
160808877|NCT02574078|580686526|FG010|Treatment Period|Lost to Follow-up|0|||
160808878|NCT02574078|580686527|FG011|Treatment Period|Lost to Follow-up|1|||
160808879|NCT02574078|580686528|FG012|Treatment Period|Lost to Follow-up|0|||
160808880|NCT02574078|580686516|FG000|Treatment Period|Maximum clinical benefit|0|||
160808881|NCT02574078|580686517|FG001|Treatment Period|Maximum clinical benefit|0|||
160808882|NCT02574078|580686518|FG002|Treatment Period|Maximum clinical benefit|0|||
160808883|NCT02574078|580686519|FG003|Treatment Period|Maximum clinical benefit|0|||
160808884|NCT02574078|580686520|FG004|Treatment Period|Maximum clinical benefit|0|||
160808885|NCT02574078|580686521|FG005|Treatment Period|Maximum clinical benefit|0|||
160808886|NCT02574078|580686522|FG006|Treatment Period|Maximum clinical benefit|0|||
160808887|NCT02574078|580686523|FG007|Treatment Period|Maximum clinical benefit|0|||
160899271|NCT02833350|581026282|FG006|Overall Study|Adverse Event|1|||
160899272|NCT02833350|581026276|FG000|Overall Study|Death|0|||
160899273|NCT02833350|581026277|FG001|Overall Study|Death|0|||
160899274|NCT02833350|581026278|FG002|Overall Study|Death|1|||
161130973|NCT00896532|581863480|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130974|NCT00896532|581863481|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
161130975|NCT00896532|581863459|FG000|Months 48-72: Follow-on Phase|Death|0|||
161130976|NCT00896532|581863460|FG001|Months 48-72: Follow-on Phase|Death|0|||
161130977|NCT00896532|581863461|FG002|Months 48-72: Follow-on Phase|Death|0|||
161130978|NCT00896532|581863462|FG003|Months 48-72: Follow-on Phase|Death|0|||
161130979|NCT00896532|581863463|FG004|Months 48-72: Follow-on Phase|Death|0|||
161130980|NCT00896532|581863464|FG005|Months 48-72: Follow-on Phase|Death|0|||
161130981|NCT00896532|581863465|FG006|Months 48-72: Follow-on Phase|Death|0|||
161130982|NCT00896532|581863466|FG007|Months 48-72: Follow-on Phase|Death|0|||
161130983|NCT00896532|581863467|FG008|Months 48-72: Follow-on Phase|Death|0|||
161130984|NCT00896532|581863468|FG009|Months 48-72: Follow-on Phase|Death|0|||
161130985|NCT00896532|581863469|FG010|Months 48-72: Follow-on Phase|Death|0|||
161130986|NCT00896532|581863470|FG011|Months 48-72: Follow-on Phase|Death|0|||
161130987|NCT00896532|581863471|FG012|Months 48-72: Follow-on Phase|Death|0|||
160808888|NCT02574078|580686524|FG008|Treatment Period|Maximum clinical benefit|0|||
160808889|NCT02574078|580686525|FG009|Treatment Period|Maximum clinical benefit|1|||
160808890|NCT02574078|580686526|FG010|Treatment Period|Maximum clinical benefit|0|||
160808891|NCT02574078|580686527|FG011|Treatment Period|Maximum clinical benefit|0|||
160808892|NCT02574078|580686528|FG012|Treatment Period|Maximum clinical benefit|0|||
160808893|NCT02222688|580686529|FG000|Overall Study|Withdrawal by Subject|0|||
160808894|NCT02222688|580686530|FG001|Overall Study|Withdrawal by Subject|0|||
160808895|NCT02222688|580686531|FG002|Overall Study|Withdrawal by Subject|0|||
160808896|NCT02222688|580686532|FG003|Overall Study|Withdrawal by Subject|2|||
160808897|NCT02222688|580686533|FG004|Overall Study|Withdrawal by Subject|1|||
160899275|NCT02833350|581026279|FG003|Overall Study|Death|0|||
160899276|NCT02833350|581026280|FG004|Overall Study|Death|0|||
161130988|NCT00896532|581863472|FG013|Months 48-72: Follow-on Phase|Death|0|||
161130989|NCT00896532|581863473|FG014|Months 48-72: Follow-on Phase|Death|0|||
161130990|NCT00896532|581863474|FG015|Months 48-72: Follow-on Phase|Death|0|||
160808898|NCT02222688|580686534|FG005|Overall Study|Withdrawal by Subject|0|||
160808899|NCT02222688|580686535|FG006|Overall Study|Withdrawal by Subject|1|||
160808900|NCT02222688|580686529|FG000|Overall Study|Disease progression|1|||
160808901|NCT02222688|580686530|FG001|Overall Study|Disease progression|0|||
160808902|NCT02222688|580686531|FG002|Overall Study|Disease progression|0|||
160808903|NCT02222688|580686532|FG003|Overall Study|Disease progression|0|||
160808904|NCT02222688|580686533|FG004|Overall Study|Disease progression|0|||
160808905|NCT02222688|580686534|FG005|Overall Study|Disease progression|0|||
160808906|NCT02222688|580686535|FG006|Overall Study|Disease progression|0|||
160808907|NCT05935878|580686536|FG000|Overall Study|Death|1|||
160808908|NCT05935878|580686537|FG001|Overall Study|Death|2|||
160808909|NCT05935878|580686536|FG000|Overall Study|Withdrawal by Subject|5|||
160808910|NCT05935878|580686537|FG001|Overall Study|Withdrawal by Subject|5|||
160808911|NCT05935878|580686536|FG000|Overall Study|Revision of implant|1|||
160808912|NCT05935878|580686537|FG001|Overall Study|Revision of implant|1|||
160808913|NCT05935878|580686536|FG000|Overall Study|Mobile bearing dislocation|0|||
160808914|NCT05935878|580686537|FG001|Overall Study|Mobile bearing dislocation|1|||
160808915|NCT01734785|580686546|FG000|Open-Label Period|Adverse Event|0|||
160808916|NCT01734785|580686547|FG001|Open-Label Period|Adverse Event|0|||
160808917|NCT01734785|580686548|FG002|Open-Label Period|Adverse Event|0|||
160808918|NCT01734785|580686549|FG003|Open-Label Period|Adverse Event|9|||
160808919|NCT01734785|580686546|FG000|Open-Label Period|Lack of Efficacy|0|||
160808920|NCT01734785|580686547|FG001|Open-Label Period|Lack of Efficacy|0|||
160808921|NCT01734785|580686548|FG002|Open-Label Period|Lack of Efficacy|0|||
160808922|NCT01734785|580686549|FG003|Open-Label Period|Lack of Efficacy|1|||
160808923|NCT01734785|580686546|FG000|Open-Label Period|Protocol Violation|0|||
160808924|NCT01734785|580686547|FG001|Open-Label Period|Protocol Violation|0|||
160808925|NCT01734785|580686548|FG002|Open-Label Period|Protocol Violation|0|||
160808926|NCT01734785|580686549|FG003|Open-Label Period|Protocol Violation|13|||
160808927|NCT01734785|580686546|FG000|Open-Label Period|Lost to Follow-up|0|||
160808928|NCT01734785|580686547|FG001|Open-Label Period|Lost to Follow-up|0|||
160808929|NCT01734785|580686548|FG002|Open-Label Period|Lost to Follow-up|0|||
161332789|NCT00072410|582605336|FG001|Overall Study|Progressive disease|3|||
161332790|NCT05590377|582605339|FG000|Overall Study|Death|1|||
161332791|NCT05590377|582605340|FG001|Overall Study|Death|1|||
161332792|NCT05590377|582605341|FG002|Overall Study|Death|2|||
161332793|NCT05590377|582605342|FG003|Overall Study|Death|0|||
161332794|NCT05590377|582605343|FG004|Overall Study|Death|0|||
161332795|NCT05590377|582605339|FG000|Overall Study|Study Terminated by Sponsor|1|||
161332796|NCT05590377|582605340|FG001|Overall Study|Study Terminated by Sponsor|5|||
161332797|NCT05590377|582605341|FG002|Overall Study|Study Terminated by Sponsor|4|||
161332798|NCT05590377|582605342|FG003|Overall Study|Study Terminated by Sponsor|0|||
161332799|NCT05590377|582605343|FG004|Overall Study|Study Terminated by Sponsor|0|||
161332800|NCT05590377|582605339|FG000|Overall Study|Withdrawal by Subject|1|||
161332801|NCT05590377|582605340|FG001|Overall Study|Withdrawal by Subject|0|||
161332802|NCT05590377|582605341|FG002|Overall Study|Withdrawal by Subject|0|||
161332803|NCT05590377|582605342|FG003|Overall Study|Withdrawal by Subject|0|||
161332804|NCT05590377|582605343|FG004|Overall Study|Withdrawal by Subject|0|||
161332805|NCT03389620|582605344|FG000|Overall Study|Lost to Follow-up|5|||
161332806|NCT03389620|582605345|FG001|Overall Study|Lost to Follow-up|1|||
161332807|NCT04782180|582605352|FG000|Overall Study|Withdrawal by Subject|2|||
161332808|NCT04782180|582605352|FG000|Overall Study|Lost to Follow-up|2|||
161332809|NCT05852353|582605353|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
161332810|NCT05852353|582605353|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
161332811|NCT05852353|582605353|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
160808930|NCT01734785|580686549|FG003|Open-Label Period|Lost to Follow-up|14|||
160808931|NCT01734785|580686546|FG000|Open-Label Period|Withdrawal by Subject|0|||
160808932|NCT01734785|580686547|FG001|Open-Label Period|Withdrawal by Subject|0|||
160808933|NCT01734785|580686548|FG002|Open-Label Period|Withdrawal by Subject|0|||
160808934|NCT01734785|580686549|FG003|Open-Label Period|Withdrawal by Subject|12|||
160808935|NCT01734785|580686546|FG000|Open-Label Period|Other Reasons|0|||
161332812|NCT05852353|582605353|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
160808936|NCT01734785|580686547|FG001|Open-Label Period|Other Reasons|0|||
160808937|NCT01734785|580686548|FG002|Open-Label Period|Other Reasons|0|||
160808938|NCT01734785|580686549|FG003|Open-Label Period|Other Reasons|224|||
160808939|NCT01734785|580686546|FG000|Double-Blind Period|Adverse Event|0|||
160899277|NCT02833350|581026281|FG005|Overall Study|Death|0|||
161332813|NCT01005745|582605354|FG000|Overall Study|No TIL growth|1|||
161332814|NCT01005745|582605354|FG000|Overall Study|Disease progressed during TIL growth|3|||
161332815|NCT01005745|582605354|FG000|Overall Study|Death prior to treatment|1|||
161332816|NCT01005745|582605354|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
161332817|NCT06077773|582605355|FG000|Overall Study|Withdrawal by Subject|1|||
160808940|NCT01734785|580686547|FG001|Double-Blind Period|Adverse Event|3|||
160808941|NCT01734785|580686548|FG002|Double-Blind Period|Adverse Event|2|||
160808942|NCT01734785|580686549|FG003|Double-Blind Period|Adverse Event|0|||
160808943|NCT01734785|580686546|FG000|Double-Blind Period|Lack of Efficacy|0|||
160808944|NCT01734785|580686547|FG001|Double-Blind Period|Lack of Efficacy|1|||
160808945|NCT01734785|580686548|FG002|Double-Blind Period|Lack of Efficacy|0|||
160808946|NCT01734785|580686549|FG003|Double-Blind Period|Lack of Efficacy|0|||
160808947|NCT01734785|580686546|FG000|Double-Blind Period|Protocol Violation|0|||
160808948|NCT01734785|580686547|FG001|Double-Blind Period|Protocol Violation|1|||
160808949|NCT01734785|580686548|FG002|Double-Blind Period|Protocol Violation|1|||
160808950|NCT01734785|580686549|FG003|Double-Blind Period|Protocol Violation|0|||
160808951|NCT01734785|580686546|FG000|Double-Blind Period|Lost to Follow-up|2|||
160808952|NCT01734785|580686547|FG001|Double-Blind Period|Lost to Follow-up|4|||
160808953|NCT01734785|580686548|FG002|Double-Blind Period|Lost to Follow-up|2|||
160808954|NCT01734785|580686549|FG003|Double-Blind Period|Lost to Follow-up|0|||
160808955|NCT01734785|580686546|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160808956|NCT01734785|580686547|FG001|Double-Blind Period|Withdrawal by Subject|0|||
160808957|NCT01734785|580686548|FG002|Double-Blind Period|Withdrawal by Subject|0|||
160808958|NCT01734785|580686549|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160899278|NCT02833350|581026282|FG006|Overall Study|Death|0|||
160899279|NCT02833350|581026276|FG000|Overall Study|Lack of Efficacy|0|||
160899280|NCT02833350|581026277|FG001|Overall Study|Lack of Efficacy|2|||
160899281|NCT02833350|581026278|FG002|Overall Study|Lack of Efficacy|1|||
160899282|NCT02833350|581026279|FG003|Overall Study|Lack of Efficacy|4|||
160899283|NCT02833350|581026280|FG004|Overall Study|Lack of Efficacy|0|||
160899284|NCT02833350|581026281|FG005|Overall Study|Lack of Efficacy|1|||
160899285|NCT02833350|581026282|FG006|Overall Study|Lack of Efficacy|1|||
160899286|NCT02833350|581026276|FG000|Overall Study|Lost to Follow-up|0|||
160899287|NCT02833350|581026277|FG001|Overall Study|Lost to Follow-up|1|||
160899288|NCT02833350|581026278|FG002|Overall Study|Lost to Follow-up|0|||
160899289|NCT02833350|581026279|FG003|Overall Study|Lost to Follow-up|0|||
160899290|NCT02833350|581026280|FG004|Overall Study|Lost to Follow-up|0|||
160899291|NCT02833350|581026281|FG005|Overall Study|Lost to Follow-up|0|||
160899292|NCT02833350|581026282|FG006|Overall Study|Lost to Follow-up|1|||
160899293|NCT02833350|581026276|FG000|Overall Study|Withdrawal by Subject|3|||
160899294|NCT02833350|581026277|FG001|Overall Study|Withdrawal by Subject|3|||
160899295|NCT02833350|581026278|FG002|Overall Study|Withdrawal by Subject|2|||
160899296|NCT02833350|581026279|FG003|Overall Study|Withdrawal by Subject|0|||
160899297|NCT02833350|581026280|FG004|Overall Study|Withdrawal by Subject|2|||
160899298|NCT02833350|581026281|FG005|Overall Study|Withdrawal by Subject|0|||
160899299|NCT02833350|581026282|FG006|Overall Study|Withdrawal by Subject|2|||
160899300|NCT01500031|581026285|FG000|Overall Study|Death|1|||
160899301|NCT01500031|581026285|FG000|Overall Study|Withdrawal by Subject|4|||
160899302|NCT01147640|581026286|FG000|Overall Study|Adverse Event|2|||
160899303|NCT01147640|581026287|FG001|Overall Study|Adverse Event|0|||
160899304|NCT01147640|581026286|FG000|Overall Study|Physician Decision|1|||
160899305|NCT01147640|581026287|FG001|Overall Study|Physician Decision|0|||
160899306|NCT01147640|581026286|FG000|Overall Study|Withdrawal by Subject|1|||
160899307|NCT01147640|581026287|FG001|Overall Study|Withdrawal by Subject|0|||
160899308|NCT01147640|581026286|FG000|Overall Study|Lost to Follow-up|0|||
160899309|NCT01147640|581026287|FG001|Overall Study|Lost to Follow-up|1|||
160899310|NCT01147640|581026286|FG000|Overall Study|Didn't meet eligibility criteria|1|||
160899311|NCT01147640|581026287|FG001|Overall Study|Didn't meet eligibility criteria|0|||
160899312|NCT01856907|581026290|FG000|Overall Study|Pregnancy|0|||
160899313|NCT01856907|581026291|FG001|Overall Study|Pregnancy|1|||
160899314|NCT01856907|581026292|FG002|Overall Study|Pregnancy|0|||
160899315|NCT01856907|581026290|FG000|Overall Study|Pregnancy|0|||
160899316|NCT01856907|581026291|FG001|Overall Study|Pregnancy|1|||
160899317|NCT01856907|581026292|FG002|Overall Study|Pregnancy|0|||
160899318|NCT01856907|581026290|FG000|Overall Study|Withdrawal by Subject|0|||
160899319|NCT01856907|581026291|FG001|Overall Study|Withdrawal by Subject|1|||
160899320|NCT01856907|581026292|FG002|Overall Study|Withdrawal by Subject|0|||
160899321|NCT00091442|581026293|FG000|Overall Study|Progressive Disease|220|||
160899322|NCT00091442|581026294|FG001|Overall Study|Progressive Disease|189|||
160899323|NCT00091442|581026293|FG000|Overall Study|Physician Decision|61|||
160899324|NCT00091442|581026294|FG001|Overall Study|Physician Decision|58|||
160899325|NCT00091442|581026293|FG000|Overall Study|Withdrawal by Subject|38|||
160899326|NCT00091442|581026294|FG001|Overall Study|Withdrawal by Subject|46|||
160899327|NCT00091442|581026293|FG000|Overall Study|Adverse Event|29|||
160899328|NCT00091442|581026294|FG001|Overall Study|Adverse Event|48|||
160899329|NCT00091442|581026293|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
160808959|NCT01734785|580686546|FG000|Double-Blind Period|Not treated|1|||
160808960|NCT01734785|580686547|FG001|Double-Blind Period|Not treated|0|||
160899330|NCT00091442|581026294|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
160899331|NCT00091442|581026293|FG000|Overall Study|Death|9|||
160899332|NCT00091442|581026294|FG001|Overall Study|Death|7|||
160899333|NCT00091442|581026293|FG000|Overall Study|Lost to Follow-up|1|||
160899334|NCT00091442|581026294|FG001|Overall Study|Lost to Follow-up|3|||
160899335|NCT00091442|581026293|FG000|Overall Study|Other|2|||
160899336|NCT00091442|581026294|FG001|Overall Study|Other|6|||
160899337|NCT00917501|581026295|FG000|Overall Study|Lost to Follow-up|4|||
160899338|NCT00917501|581026296|FG001|Overall Study|Lost to Follow-up|1|||
160899339|NCT00917501|581026295|FG000|Overall Study|Withdrawal by Subject|3|||
160899340|NCT00917501|581026296|FG001|Overall Study|Withdrawal by Subject|1|||
160808961|NCT01734785|580686548|FG002|Double-Blind Period|Not treated|0|||
160808962|NCT01734785|580686549|FG003|Double-Blind Period|Not treated|0|||
160808963|NCT02397915|580686550|FG000|Period 1|Protocol Violation|0|||
160808964|NCT02397915|580686551|FG001|Period 1|Protocol Violation|1|||
160808965|NCT02397915|580686552|FG002|Period 1|Protocol Violation|0|||
160808966|NCT02397915|580686553|FG003|Period 1|Protocol Violation|0|||
160808967|NCT02397915|580686550|FG000|Period 1|Physician Decision|1|||
160808968|NCT02397915|580686551|FG001|Period 1|Physician Decision|0|||
160808969|NCT02397915|580686552|FG002|Period 1|Physician Decision|0|||
160808970|NCT02397915|580686553|FG003|Period 1|Physician Decision|0|||
160808971|NCT00368745|580686554|FG000|Double-blind Treatment Period|Adverse Event|6|||
160808972|NCT00368745|580686555|FG001|Double-blind Treatment Period|Adverse Event|6|||
160808973|NCT00368745|580686554|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
160808974|NCT00368745|580686555|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
160808975|NCT00368745|580686554|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
160808976|NCT00368745|580686555|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
160808977|NCT00368745|580686554|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
160808978|NCT00368745|580686555|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
160808979|NCT00368745|580686554|FG000|Double-blind Treatment Period|Other|7|||
160808980|NCT00368745|580686555|FG001|Double-blind Treatment Period|Other|6|||
160808981|NCT00293813|580686559|FG000|Overall Study|Physician Decision|0|||
160808982|NCT00293813|580686560|FG001|Overall Study|Physician Decision|1|||
160808983|NCT00293813|580686561|FG002|Overall Study|Physician Decision|0|||
160808984|NCT00293813|580686559|FG000|Overall Study|Adverse Event|3|||
160808985|NCT00293813|580686560|FG001|Overall Study|Adverse Event|1|||
160808986|NCT00293813|580686561|FG002|Overall Study|Adverse Event|1|||
160808987|NCT00293813|580686559|FG000|Overall Study|Withdrawal by Subject|7|||
160808988|NCT00293813|580686560|FG001|Overall Study|Withdrawal by Subject|4|||
160808989|NCT00293813|580686561|FG002|Overall Study|Withdrawal by Subject|4|||
160808990|NCT00293813|580686559|FG000|Overall Study|Lost to Follow-up|3|||
160808991|NCT00293813|580686560|FG001|Overall Study|Lost to Follow-up|2|||
160808992|NCT00293813|580686561|FG002|Overall Study|Lost to Follow-up|3|||
160808993|NCT00293813|580686559|FG000|Overall Study|Noncompliance|0|||
161332818|NCT06077773|582605356|FG001|Overall Study|Withdrawal by Subject|0|||
161332819|NCT06077773|582605357|FG002|Overall Study|Withdrawal by Subject|1|||
161332820|NCT06077773|582605355|FG000|Overall Study|Lost to Follow-up|0|||
161332821|NCT06077773|582605356|FG001|Overall Study|Lost to Follow-up|1|||
161332822|NCT06077773|582605357|FG002|Overall Study|Lost to Follow-up|0|||
161332823|NCT06077773|582605355|FG000|Overall Study|Adverse Event|0|||
161332824|NCT06077773|582605356|FG001|Overall Study|Adverse Event|0|||
161332825|NCT06077773|582605357|FG002|Overall Study|Adverse Event|2|||
161332826|NCT03834506|582605358|FG000|Overall Study|Death|336|||
161332827|NCT03834506|582605359|FG001|Overall Study|Death|326|||
161332828|NCT03834506|582605358|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161332829|NCT03834506|582605359|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161332830|NCT03834506|582605358|FG000|Overall Study|Withdrawal by Subject|10|||
161332831|NCT03834506|582605359|FG001|Overall Study|Withdrawal by Subject|8|||
161332832|NCT03834506|582605358|FG000|Overall Study|Sponsor decision|165|||
161332833|NCT03834506|582605359|FG001|Overall Study|Sponsor decision|178|||
161332834|NCT03834506|582605358|FG000|Overall Study|Physician Decision|3|||
161332835|NCT03834506|582605359|FG001|Overall Study|Physician Decision|1|||
161332836|NCT03834506|582605358|FG000|Overall Study|Lost to Follow-up|0|||
161332837|NCT03834506|582605359|FG001|Overall Study|Lost to Follow-up|1|||
161332838|NCT04414787|582605361|FG000|Overall Study|Patient Death|18|||
160808994|NCT00293813|580686560|FG001|Overall Study|Noncompliance|1|||
160808995|NCT00293813|580686561|FG002|Overall Study|Noncompliance|0|||
160808996|NCT01582009|580686564|FG000|Overall Study|Withdrawal by Subject|1|||
160808997|NCT01582009|580686564|FG000|Overall Study|Physician Decision|1|||
160808998|NCT00310375|580686565|FG000|Primary Reporting Phase|Adverse Event|28|||
160808999|NCT00310375|580686566|FG001|Primary Reporting Phase|Adverse Event|22|||
160809000|NCT00310375|580686567|FG002|Primary Reporting Phase|Adverse Event|0|||
160809001|NCT00310375|580686565|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
160809002|NCT00310375|580686566|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
160809003|NCT00310375|580686567|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
160809004|NCT00310375|580686565|FG000|Primary Reporting Phase|Pregnancy|2|||
160809005|NCT00310375|580686566|FG001|Primary Reporting Phase|Pregnancy|2|||
161130991|NCT00896532|581863475|FG016|Months 48-72: Follow-on Phase|Death|0|||
161332839|NCT04414787|582605362|FG001|Overall Study|Patient Death|18|||
161332840|NCT04414787|582605363|FG002|Overall Study|Patient Death|15|||
161332841|NCT04414787|582605364|FG003|Overall Study|Patient Death|15|||
161332842|NCT04414787|582605361|FG000|Overall Study|Patient Hospitalization|1|||
160809006|NCT00310375|580686567|FG002|Primary Reporting Phase|Pregnancy|0|||
160809007|NCT00310375|580686565|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
160809008|NCT00310375|580686566|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
160809009|NCT00310375|580686567|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
160809010|NCT00310375|580686565|FG000|Primary Reporting Phase|Protocol Violation|8|||
161130992|NCT00896532|581863476|FG017|Months 48-72: Follow-on Phase|Death|0|||
160809011|NCT00310375|580686566|FG001|Primary Reporting Phase|Protocol Violation|5|||
160809012|NCT00310375|580686567|FG002|Primary Reporting Phase|Protocol Violation|0|||
160809013|NCT00310375|580686565|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
160809014|NCT00310375|580686566|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
160809015|NCT00310375|580686567|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
160809016|NCT00310375|580686565|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
160809017|NCT00310375|580686566|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
160809018|NCT00310375|580686567|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
160809019|NCT00310375|580686565|FG000|Primary Reporting Phase|Physician Decision|5|||
160809020|NCT00310375|580686566|FG001|Primary Reporting Phase|Physician Decision|3|||
160809021|NCT00310375|580686567|FG002|Primary Reporting Phase|Physician Decision|0|||
160809022|NCT00310375|580686565|FG000|Primary Reporting Phase|Request of the sponsor|2|||
160809023|NCT00310375|580686566|FG001|Primary Reporting Phase|Request of the sponsor|2|||
160809024|NCT00310375|580686567|FG002|Primary Reporting Phase|Request of the sponsor|0|||
160809025|NCT00310375|580686565|FG000|Primary Reporting Phase|Failed to return|1|||
160809026|NCT00310375|580686566|FG001|Primary Reporting Phase|Failed to return|3|||
160809027|NCT00310375|580686567|FG002|Primary Reporting Phase|Failed to return|0|||
160809028|NCT00310375|580686565|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
160809029|NCT00310375|580686566|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
160809030|NCT00310375|580686567|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
160809031|NCT00310375|580686565|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
160809032|NCT00310375|580686566|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
160809033|NCT00310375|580686567|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
160809034|NCT00310375|580686565|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
160809035|NCT00310375|580686566|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
160809036|NCT00310375|580686567|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
160809037|NCT00310375|580686565|FG000|Primary Reporting Phase|Site closure|3|||
160809038|NCT00310375|580686566|FG001|Primary Reporting Phase|Site closure|0|||
160809039|NCT00310375|580686567|FG002|Primary Reporting Phase|Site closure|0|||
160809040|NCT00310375|580686565|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
160809041|NCT00310375|580686566|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
160809042|NCT00310375|580686567|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
160809043|NCT00310375|580686565|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
160809044|NCT00310375|580686566|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
160809045|NCT00310375|580686567|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
160809046|NCT00310375|580686565|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
160809047|NCT00310375|580686566|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
160809048|NCT00310375|580686567|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
160809049|NCT00310375|580686565|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
160809050|NCT00310375|580686566|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
160809051|NCT00310375|580686567|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
160809052|NCT01134614|580686568|FG000|Overall Study|Still on treatment as of March 2013|21|||
160809053|NCT01134614|580686569|FG001|Overall Study|Still on treatment as of March 2013|13|||
160809054|NCT01134614|580686568|FG000|Overall Study|Progressive disease|60|||
160809055|NCT01134614|580686569|FG001|Overall Study|Progressive disease|54|||
160809056|NCT01134614|580686568|FG000|Overall Study|Adverse Event|26|||
160809057|NCT01134614|580686569|FG001|Overall Study|Adverse Event|39|||
160809058|NCT01134614|580686568|FG000|Overall Study|Death|5|||
160809059|NCT01134614|580686569|FG001|Overall Study|Death|8|||
160809060|NCT01134614|580686568|FG000|Overall Study|Withdrawal by Subject|3|||
160809061|NCT01134614|580686569|FG001|Overall Study|Withdrawal by Subject|2|||
160809062|NCT01134614|580686568|FG000|Overall Study|Alternative therapy|2|||
160809063|NCT01134614|580686569|FG001|Overall Study|Alternative therapy|0|||
160809064|NCT01134614|580686568|FG000|Overall Study|Complicating disease|2|||
160809065|NCT01134614|580686569|FG001|Overall Study|Complicating disease|1|||
160809066|NCT01134614|580686568|FG000|Overall Study|Physician's decision|0|||
160809067|NCT01134614|580686569|FG001|Overall Study|Physician's decision|1|||
160809068|NCT01134614|580686568|FG000|Overall Study|Never started treatment|4|||
160899341|NCT00917501|581026295|FG000|Overall Study|Lack of Efficacy|1|||
160899342|NCT00917501|581026296|FG001|Overall Study|Lack of Efficacy|2|||
160899343|NCT00917501|581026295|FG000|Overall Study|trouble swollowing capsules|0|||
160899344|NCT00917501|581026296|FG001|Overall Study|trouble swollowing capsules|1|||
160809069|NCT01134614|580686569|FG001|Overall Study|Never started treatment|1|||
160809070|NCT01134614|580686568|FG000|Overall Study|Pt received tx not allowed on study|0|||
160809071|NCT01134614|580686569|FG001|Overall Study|Pt received tx not allowed on study|1|||
160809072|NCT01134614|580686568|FG000|Overall Study|Symptomatic deterioration|0|||
160809073|NCT01134614|580686569|FG001|Overall Study|Symptomatic deterioration|1|||
160809074|NCT01134614|580686568|FG000|Overall Study|Patient in hospice care|0|||
160809075|NCT01134614|580686569|FG001|Overall Study|Patient in hospice care|1|||
160899345|NCT00075218|581026297|FG000|Double-Blind Treatment|Adverse Event|23|||
160899346|NCT00075218|581026298|FG001|Double-Blind Treatment|Adverse Event|4|||
160809076|NCT02553928|580686570|FG000|Overall Study|Adverse Event|2|||
160809077|NCT02553928|580686571|FG001|Overall Study|Adverse Event|1|||
160809078|NCT02553928|580686570|FG000|Overall Study|Lost to Follow-up|0|||
160809079|NCT02553928|580686571|FG001|Overall Study|Lost to Follow-up|1|||
160809080|NCT02553928|580686570|FG000|Overall Study|Administrative reason(s)|0|||
160809081|NCT02553928|580686571|FG001|Overall Study|Administrative reason(s)|1|||
160809082|NCT00770562|580686576|FG000|Overall Study|Did not take treatment|1|||
160809083|NCT00770562|580686577|FG001|Overall Study|Did not take treatment|1|||
160809084|NCT05338710|580686581|FG000|Overall Study|Withdrawal by Subject|3|||
160809085|NCT01081951|580686582|FG000|Overall Study|Death|54|||
160809086|NCT01081951|580686583|FG001|Overall Study|Death|47|||
160809087|NCT01081951|580686582|FG000|Overall Study|Withdrawal by Subject|2|||
160809088|NCT01081951|580686583|FG001|Overall Study|Withdrawal by Subject|6|||
160809089|NCT01081951|580686582|FG000|Overall Study|Allocated treatment but did not take it|0|||
160809090|NCT01081951|580686583|FG001|Overall Study|Allocated treatment but did not take it|1|||
160809091|NCT01081951|580686582|FG000|Overall Study|Lost to Follow-up|0|||
160809092|NCT01081951|580686583|FG001|Overall Study|Lost to Follow-up|1|||
160809093|NCT00292045|580686586|FG000|Core Study (Through Week 13)|Adverse Event|1|||
160809094|NCT00292045|580686586|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
160809095|NCT00606411|580686587|FG000|Overall Study|Adverse Event|1|||
160809096|NCT00606411|580686588|FG001|Overall Study|Adverse Event|2|||
160809097|NCT00606411|580686587|FG000|Overall Study|Lack of Adherence|1|||
160809098|NCT00606411|580686588|FG001|Overall Study|Lack of Adherence|1|||
160809099|NCT00606411|580686587|FG000|Overall Study|Lack of Efficacy|1|||
160809100|NCT00606411|580686588|FG001|Overall Study|Lack of Efficacy|1|||
160809101|NCT00606411|580686587|FG000|Overall Study|Withdrawal by Subject|2|||
160809102|NCT00606411|580686588|FG001|Overall Study|Withdrawal by Subject|0|||
160809103|NCT00606411|580686587|FG000|Overall Study|Lost to Follow-up|1|||
160809104|NCT00606411|580686588|FG001|Overall Study|Lost to Follow-up|2|||
160809105|NCT00606411|580686587|FG000|Overall Study|Move out of state|0|||
160809106|NCT00606411|580686588|FG001|Overall Study|Move out of state|1|||
160809107|NCT04503551|580686589|FG000|Overall Study|Withdrawal by Subject|5|||
160809108|NCT04503551|580686590|FG001|Overall Study|Withdrawal by Subject|3|||
160809109|NCT04503551|580686589|FG000|Overall Study|Physician Decision|1|||
160809110|NCT04503551|580686590|FG001|Overall Study|Physician Decision|0|||
160809111|NCT04503551|580686589|FG000|Overall Study|Death|0|||
160809112|NCT04503551|580686590|FG001|Overall Study|Death|1|||
160809113|NCT04503551|580686589|FG000|Overall Study|Lost to Follow-up|1|||
160809114|NCT04503551|580686590|FG001|Overall Study|Lost to Follow-up|2|||
160809115|NCT04503551|580686589|FG000|Overall Study|Ongoing at Week 52|99|||
160809116|NCT04503551|580686590|FG001|Overall Study|Ongoing at Week 52|62|||
160809117|NCT00412958|580686591|FG000|Overall Study|Withdrawal by Subject|3|||
160809118|NCT00412958|580686592|FG001|Overall Study|Withdrawal by Subject|0|||
160809119|NCT00412958|580686593|FG002|Overall Study|Withdrawal by Subject|0|||
160809120|NCT00412958|580686594|FG003|Overall Study|Withdrawal by Subject|1|||
160809121|NCT00412958|580686591|FG000|Overall Study|Adverse Event|0|||
160809122|NCT00412958|580686592|FG001|Overall Study|Adverse Event|1|||
160809123|NCT00412958|580686593|FG002|Overall Study|Adverse Event|0|||
160809124|NCT00412958|580686594|FG003|Overall Study|Adverse Event|0|||
160809125|NCT00412958|580686591|FG000|Overall Study|Lost to Follow-up|0|||
160809126|NCT00412958|580686592|FG001|Overall Study|Lost to Follow-up|1|||
160809127|NCT00412958|580686593|FG002|Overall Study|Lost to Follow-up|0|||
160809128|NCT00412958|580686594|FG003|Overall Study|Lost to Follow-up|0|||
160809129|NCT00412958|580686591|FG000|Overall Study|Death|0|||
160809130|NCT00412958|580686592|FG001|Overall Study|Death|1|||
160809131|NCT00412958|580686593|FG002|Overall Study|Death|0|||
160809132|NCT00412958|580686594|FG003|Overall Study|Death|0|||
160809133|NCT00412958|580686591|FG000|Overall Study|Transport issue|0|||
160809134|NCT00412958|580686592|FG001|Overall Study|Transport issue|1|||
160809135|NCT00412958|580686593|FG002|Overall Study|Transport issue|0|||
160809136|NCT00412958|580686594|FG003|Overall Study|Transport issue|0|||
160809137|NCT01318135|580686595|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
160809138|NCT01318135|580686596|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809139|NCT01318135|580686597|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809140|NCT01318135|580686598|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809141|NCT01318135|580686599|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809142|NCT01318135|580686600|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809143|NCT01318135|580686601|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809144|NCT01318135|580686602|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
160809145|NCT01318135|580686595|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
160809146|NCT01318135|580686596|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809147|NCT01318135|580686597|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809148|NCT01318135|580686598|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809149|NCT01318135|580686599|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809150|NCT01318135|580686600|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809151|NCT01318135|580686601|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809152|NCT01318135|580686602|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
160809153|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
160809154|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
160809155|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
160809156|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
160809157|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
160809158|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
160809159|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
160809160|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
160809161|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
160809162|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
160809163|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809164|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809165|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
160809166|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809167|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809168|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
160809169|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809170|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809171|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809172|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160809173|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
160809174|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160809175|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
160809176|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
160809177|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
160809178|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
160809179|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160809180|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
160809181|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160809182|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
160809183|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160809184|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
160809185|NCT01318135|580686595|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809186|NCT01318135|580686596|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809187|NCT01318135|580686597|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809188|NCT01318135|580686598|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809189|NCT01318135|580686599|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809190|NCT01318135|580686600|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809191|NCT01318135|580686601|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
160809192|NCT01318135|580686602|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
160809193|NCT05384834|580686606|FG000|Overall Study|Lost to Follow-up|43|||
160809194|NCT05384834|580686606|FG000|Overall Study|Withdrawal by Subject|5|||
160809195|NCT01871545|580686607|FG000|Overall Study|Death|2|||
160809196|NCT01871545|580686608|FG001|Overall Study|Death|0|||
160809197|NCT01871545|580686607|FG000|Overall Study|Lack of Efficacy|11|||
160809198|NCT01871545|580686608|FG001|Overall Study|Lack of Efficacy|2|||
160809199|NCT01871545|580686607|FG000|Overall Study|Physician Decision|4|||
160809200|NCT01871545|580686608|FG001|Overall Study|Physician Decision|0|||
160809201|NCT01871545|580686607|FG000|Overall Study|Withdrawal by Subject|0|||
160809202|NCT01871545|580686608|FG001|Overall Study|Withdrawal by Subject|1|||
160809203|NCT02569476|580686609|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
160809204|NCT02569476|580686609|FG000|Overall Study|Death|33|||
160809205|NCT02569476|580686609|FG000|Overall Study|Withdrawal by Subject|9|||
160809206|NCT02569476|580686609|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
160809207|NCT02569476|580686609|FG000|Overall Study|Palliative care|1|||
160986038|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
160986039|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
160986040|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
160986041|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
160986042|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
160986043|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
160986044|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
160986045|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
160986046|NCT03890120|581338569|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
161130993|NCT00896532|581863477|FG018|Months 48-72: Follow-on Phase|Death|1|||
160809208|NCT02569476|580686609|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
161130994|NCT00896532|581863478|FG019|Months 48-72: Follow-on Phase|Death|0|||
160809209|NCT02569476|580686609|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
160809210|NCT01152788|580686610|FG000|Overall Study|Withdrawal by Subject|0|||
160809211|NCT01152788|580686611|FG001|Overall Study|Withdrawal by Subject|3|||
160809212|NCT01152788|580686610|FG000|Overall Study|No treatment|0|||
160809213|NCT01152788|580686611|FG001|Overall Study|No treatment|1|||
160809214|NCT01541865|580686612|FG000|Overall Study|Lost to Follow-up|11|||
160809215|NCT01541865|580686612|FG000|Overall Study|Withdrawal by Subject|9|||
160809216|NCT01541865|580686612|FG000|Overall Study|Adverse Event|1|||
160809217|NCT01541865|580686612|FG000|Overall Study|Protocol Violation|1|||
160809218|NCT01140867|580686613|FG000|Overall Study|Adverse Event|22|||
160809219|NCT01140867|580686613|FG000|Overall Study|Lack of Efficacy|3|||
160809220|NCT01140867|580686613|FG000|Overall Study|Lost to Follow-up|2|||
160809221|NCT01140867|580686613|FG000|Overall Study|Withdrawal by Subject|1|||
160809222|NCT01140867|580686613|FG000|Overall Study|Protocol Violation|1|||
160809223|NCT01140867|580686613|FG000|Overall Study|Uncooperative patient|2|||
160809224|NCT01140867|580686613|FG000|Overall Study|Medication Noncompliance|2|||
160809225|NCT00881530|580686614|FG000|Overall Study|Adverse Event|5|||
160809226|NCT00881530|580686615|FG001|Overall Study|Adverse Event|1|||
160809227|NCT00881530|580686616|FG002|Overall Study|Adverse Event|1|||
160809228|NCT00881530|580686617|FG003|Overall Study|Adverse Event|4|||
160809229|NCT00881530|580686618|FG004|Overall Study|Adverse Event|10|||
160809230|NCT00881530|580686619|FG005|Overall Study|Adverse Event|2|||
160809231|NCT00881530|580686614|FG000|Overall Study|Lack of Efficacy|1|||
160809232|NCT00881530|580686615|FG001|Overall Study|Lack of Efficacy|0|||
160809233|NCT00881530|580686616|FG002|Overall Study|Lack of Efficacy|0|||
160809234|NCT00881530|580686617|FG003|Overall Study|Lack of Efficacy|0|||
160809235|NCT00881530|580686618|FG004|Overall Study|Lack of Efficacy|1|||
160809236|NCT00881530|580686619|FG005|Overall Study|Lack of Efficacy|1|||
160809237|NCT00881530|580686614|FG000|Overall Study|Not compliant with the protocol|0|||
160809238|NCT00881530|580686615|FG001|Overall Study|Not compliant with the protocol|0|||
160809239|NCT00881530|580686616|FG002|Overall Study|Not compliant with the protocol|0|||
160809240|NCT00881530|580686617|FG003|Overall Study|Not compliant with the protocol|0|||
160809241|NCT00881530|580686618|FG004|Overall Study|Not compliant with the protocol|2|||
160809242|NCT00881530|580686619|FG005|Overall Study|Not compliant with the protocol|0|||
160809243|NCT00881530|580686614|FG000|Overall Study|Lost to Follow-up|0|||
160809244|NCT00881530|580686615|FG001|Overall Study|Lost to Follow-up|1|||
160809245|NCT00881530|580686616|FG002|Overall Study|Lost to Follow-up|1|||
160809246|NCT00881530|580686617|FG003|Overall Study|Lost to Follow-up|3|||
160809247|NCT00881530|580686618|FG004|Overall Study|Lost to Follow-up|1|||
160809248|NCT00881530|580686619|FG005|Overall Study|Lost to Follow-up|0|||
160809249|NCT00881530|580686614|FG000|Overall Study|Refused to continue medication|7|||
160809250|NCT00881530|580686615|FG001|Overall Study|Refused to continue medication|2|||
160809251|NCT00881530|580686616|FG002|Overall Study|Refused to continue medication|1|||
160809252|NCT00881530|580686617|FG003|Overall Study|Refused to continue medication|2|||
160809253|NCT00881530|580686618|FG004|Overall Study|Refused to continue medication|0|||
160809254|NCT00881530|580686619|FG005|Overall Study|Refused to continue medication|0|||
160809255|NCT00881530|580686614|FG000|Overall Study|Other reason not defined above|1|||
160809256|NCT00881530|580686615|FG001|Overall Study|Other reason not defined above|1|||
160809257|NCT00881530|580686616|FG002|Overall Study|Other reason not defined above|2|||
160809258|NCT00881530|580686617|FG003|Overall Study|Other reason not defined above|0|||
160809259|NCT00881530|580686618|FG004|Overall Study|Other reason not defined above|0|||
160809260|NCT00881530|580686619|FG005|Overall Study|Other reason not defined above|2|||
160809261|NCT00778336|580686620|FG000|Index Procedure-Discharge|Death|6|||
160809262|NCT00778336|580686621|FG001|Index Procedure-Discharge|Death|3|||
160809263|NCT00778336|580686622|FG002|Index Procedure-Discharge|Death|2|||
160809264|NCT00778336|580686623|FG003|Index Procedure-Discharge|Death|0|||
160809265|NCT00778336|580686620|FG000|3 Month Follow Up|Lost to Follow-up|15|||
160809266|NCT00778336|580686621|FG001|3 Month Follow Up|Lost to Follow-up|20|||
160809267|NCT00778336|580686622|FG002|3 Month Follow Up|Lost to Follow-up|3|||
160809268|NCT00778336|580686623|FG003|3 Month Follow Up|Lost to Follow-up|0|||
160809269|NCT00778336|580686620|FG000|3 Month Follow Up|Death|8|||
160809270|NCT00778336|580686621|FG001|3 Month Follow Up|Death|3|||
160809271|NCT00778336|580686622|FG002|3 Month Follow Up|Death|2|||
160809272|NCT00778336|580686623|FG003|3 Month Follow Up|Death|0|||
160809273|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809274|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809275|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
160809276|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
160809277|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809278|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809279|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
160809280|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
160809281|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809282|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809283|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809284|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809285|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809286|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
160809287|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
160809288|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809289|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809290|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809291|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809292|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809293|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
160809294|NCT02720523|580686624|FG000|Period 1: Placebo-controlled Period|Other|0|||
160809295|NCT02720523|580686625|FG001|Period 1: Placebo-controlled Period|Other|0|||
160809296|NCT02720523|580686626|FG002|Period 1: Placebo-controlled Period|Other|1|||
160809297|NCT02720523|580686627|FG003|Period 1: Placebo-controlled Period|Other|1|||
161130995|NCT00896532|581863479|FG020|Months 48-72: Follow-on Phase|Death|0|||
161130996|NCT00896532|581863480|FG021|Months 48-72: Follow-on Phase|Death|0|||
161130997|NCT00896532|581863481|FG022|Months 48-72: Follow-on Phase|Death|0|||
161130998|NCT00896532|581863459|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
160809298|NCT02720523|580686628|FG004|Period 1: Placebo-controlled Period|Other|0|||
160809299|NCT02720523|580686629|FG005|Period 1: Placebo-controlled Period|Other|0|||
160809300|NCT02720523|580686630|FG006|Period 1: Placebo-controlled Period|Other|0|||
160809301|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
161130999|NCT00896532|581863460|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131000|NCT00896532|581863461|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131001|NCT00896532|581863462|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131002|NCT00896532|581863463|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131003|NCT00896532|581863464|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131004|NCT00896532|581863465|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131005|NCT00896532|581863466|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131006|NCT00896532|581863467|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131007|NCT00896532|581863468|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131008|NCT00896532|581863469|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131009|NCT00896532|581863470|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131010|NCT00896532|581863471|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131011|NCT00896532|581863472|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131012|NCT00896532|581863473|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131013|NCT00896532|581863474|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131014|NCT00896532|581863475|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131015|NCT00896532|581863476|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131016|NCT00896532|581863477|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131017|NCT00896532|581863478|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131018|NCT00896532|581863479|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131019|NCT00896532|581863480|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
161131020|NCT00896532|581863481|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
161131021|NCT00896532|581863459|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131022|NCT00896532|581863460|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131023|NCT00896532|581863461|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131024|NCT00896532|581863462|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131025|NCT00896532|581863463|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131026|NCT00896532|581863464|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131027|NCT00896532|581863465|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131028|NCT00896532|581863466|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131029|NCT00896532|581863467|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131030|NCT00896532|581863468|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131031|NCT00896532|581863469|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131032|NCT00896532|581863470|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131033|NCT00896532|581863471|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131034|NCT00896532|581863472|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131035|NCT00896532|581863473|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160809302|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
160809303|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
160809304|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
161131036|NCT00896532|581863474|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131037|NCT00896532|581863475|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131038|NCT00896532|581863476|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131039|NCT00896532|581863477|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131040|NCT00896532|581863478|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
160809305|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
160809306|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
160809307|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
160809308|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
160809309|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
160809310|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
160809311|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
160809312|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
160809313|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
160809314|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
160809315|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809316|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809317|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809318|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
160809319|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
160809320|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
160809321|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
160809322|NCT02720523|580686624|FG000|Period 2: Long-term Extension Period|Other|0|||
160809323|NCT02720523|580686625|FG001|Period 2: Long-term Extension Period|Other|0|||
161238733|NCT00665925|582255738|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161238734|NCT00665925|582255739|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
161238735|NCT00665925|582255736|FG000|Overall Study|Adverse Event|1|||
161238736|NCT00665925|582255737|FG001|Overall Study|Adverse Event|5|||
160809324|NCT02720523|580686626|FG002|Period 2: Long-term Extension Period|Other|0|||
160809325|NCT02720523|580686627|FG003|Period 2: Long-term Extension Period|Other|0|||
160809326|NCT02720523|580686628|FG004|Period 2: Long-term Extension Period|Other|2|||
160809327|NCT02720523|580686629|FG005|Period 2: Long-term Extension Period|Other|0|||
160809328|NCT02720523|580686630|FG006|Period 2: Long-term Extension Period|Other|3|||
160809329|NCT03146663|580686631|FG000|Overall Study|Did not receive study treatment|1|||
160809330|NCT03146663|580686632|FG001|Overall Study|Did not receive study treatment|1|||
160809331|NCT03581292|580686633|FG000|Overall Study|Physician Decision|9|||
160809332|NCT03581292|580686634|FG001|Overall Study|Physician Decision|5|||
160809333|NCT03581292|580686633|FG000|Overall Study|Withdrawal by Subject|3|||
160809334|NCT03581292|580686634|FG001|Overall Study|Withdrawal by Subject|0|||
160809335|NCT03581292|580686633|FG000|Overall Study|Withdrawal before Therapy Start|1|||
160809336|NCT03581292|580686634|FG001|Overall Study|Withdrawal before Therapy Start|0|||
160809337|NCT02524145|580686638|FG000|Overall Study|Withdrawal by Subject|2|||
160809338|NCT02524145|580686639|FG001|Overall Study|Withdrawal by Subject|2|||
160809339|NCT02524145|580686640|FG002|Overall Study|Withdrawal by Subject|3|||
160809340|NCT00283803|580689263|FG000|Overall Study|Physician Decision|9|||
160809341|NCT00283803|580689263|FG000|Overall Study|Withdrawal by Subject|4|||
160809342|NCT01127607|580689264|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
160809343|NCT01127607|580689265|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
160809344|NCT01127607|580689264|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
160809345|NCT01127607|580689265|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
160809346|NCT02220855|580689266|FG000|Overall Study|Adverse Event|8|||
160809347|NCT02220855|580689266|FG000|Overall Study|Disease Progression|5|||
160809348|NCT02220855|580689266|FG000|Overall Study|Withdrawal by Subject|1|||
160809349|NCT03419897|580689267|FG000|Overall Study|Death|180|||
160809350|NCT03419897|580689267|FG000|Overall Study|Lost to Follow-up|1|||
160809351|NCT03419897|580689267|FG000|Overall Study|Withdrawal by Subject|6|||
160809352|NCT03419897|580689267|FG000|Overall Study|Sponsor Decision|61|||
160809353|NCT03419897|580689267|FG000|Overall Study|Physician Decision|1|||
160809354|NCT05730725|580689270|FG000|Overall Study|Withdrawal by Subject|3|||
160809355|NCT05730725|580689271|FG001|Overall Study|Withdrawal by Subject|0|||
160809356|NCT05730725|580689272|FG002|Overall Study|Withdrawal by Subject|0|||
160809357|NCT05730725|580689273|FG003|Overall Study|Withdrawal by Subject|1|||
160809358|NCT05730725|580689270|FG000|Overall Study|Not Reported|1|||
160809359|NCT05730725|580689271|FG001|Overall Study|Not Reported|1|||
160809360|NCT05730725|580689272|FG002|Overall Study|Not Reported|1|||
160809361|NCT05730725|580689273|FG003|Overall Study|Not Reported|1|||
160809362|NCT01945216|580689276|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
160809363|NCT01945216|580689276|FG000|Overall Study|Protocol Violation|42|||
160809364|NCT01945216|580689276|FG000|Overall Study|CRF not assured by investigators|5|||
160809365|NCT02982772|580689278|FG000|Intervention|Lost to Follow-up|19|||
160809366|NCT02982772|580689279|FG001|Intervention|Lost to Follow-up|13|||
160809367|NCT02982772|580689278|FG000|1M Follow-Up|Lost to Follow-up|21|||
160809368|NCT02982772|580689279|FG001|1M Follow-Up|Lost to Follow-up|18|||
160809369|NCT02982772|580689278|FG000|3M Follow-Up|Lost to Follow-up|17|||
160809370|NCT02982772|580689279|FG001|3M Follow-Up|Lost to Follow-up|11|||
160809371|NCT02982772|580689278|FG000|6M Follow-Up|Lost to Follow-up|11|||
161238737|NCT00665925|582255738|FG002|Overall Study|Adverse Event|10|||
161238738|NCT00665925|582255739|FG003|Overall Study|Adverse Event|5|||
161131041|NCT00896532|581863479|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131042|NCT00896532|581863480|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
161131043|NCT00896532|581863481|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
161131044|NCT01176916|581863482|FG000|Overall Study|Adverse Event|61|||
161131045|NCT01176916|581863482|FG000|Overall Study|Death|1|||
161131046|NCT01176916|581863482|FG000|Overall Study|Lost to Follow-up|15|||
161131047|NCT01176916|581863482|FG000|Overall Study|Objective progression or relapse|17|||
161131048|NCT01176916|581863482|FG000|Overall Study|Protocol Violation|24|||
161131049|NCT01176916|581863482|FG000|Overall Study|Withdrawal by Subject|37|||
161131050|NCT01176916|581863482|FG000|Overall Study|Other|6|||
161238739|NCT00665925|582255736|FG000|Overall Study|Enrolled by mistake|0|||
161238740|NCT00665925|582255737|FG001|Overall Study|Enrolled by mistake|0|||
160809372|NCT02982772|580689279|FG001|6M Follow-Up|Lost to Follow-up|9|||
160809373|NCT02982772|580689278|FG000|12M Follow-Up|Lost to Follow-up|11|||
160809374|NCT02982772|580689279|FG001|12M Follow-Up|Lost to Follow-up|5|||
160809375|NCT01905943|580689280|FG000|Overall Study|Withdrawal of consent|90|||
160809376|NCT01905943|580689280|FG000|Overall Study|Lost to Follow-up|16|||
160809377|NCT01905943|580689280|FG000|Overall Study|Investigator discretion|7|||
160809378|NCT01905943|580689280|FG000|Overall Study|Death|186|||
160809379|NCT01905943|580689280|FG000|Overall Study|Adverse Event|3|||
160809380|NCT01905943|580689280|FG000|Overall Study|Other|12|||
160809381|NCT02974140|580689281|FG000|Overall Study|Adverse Event|2|||
160809382|NCT02974140|580689281|FG000|Overall Study|Lost to Follow-up|1|||
160809383|NCT02974140|580689281|FG000|Overall Study|Study Terminated by Sponsor|36|||
160809384|NCT01238991|580689284|FG000|Overall Study|Adverse Event|1|||
160809385|NCT01238991|580689285|FG001|Overall Study|Adverse Event|0|||
160809386|NCT01238991|580689286|FG002|Overall Study|Adverse Event|3|||
160809387|NCT01238991|580689287|FG003|Overall Study|Adverse Event|1|||
160809388|NCT01238991|580689288|FG004|Overall Study|Adverse Event|1|||
160809389|NCT01238991|580689289|FG005|Overall Study|Adverse Event|0|||
160809390|NCT01238991|580689290|FG006|Overall Study|Adverse Event|1|||
160809391|NCT01238991|580689291|FG007|Overall Study|Adverse Event|1|||
160809392|NCT01238991|580689292|FG008|Overall Study|Adverse Event|0|||
160809393|NCT01238991|580689293|FG009|Overall Study|Adverse Event|0|||
160809394|NCT01238991|580689284|FG000|Overall Study|Death|0|||
160809395|NCT01238991|580689285|FG001|Overall Study|Death|0|||
160809396|NCT01238991|580689286|FG002|Overall Study|Death|0|||
160809397|NCT01238991|580689287|FG003|Overall Study|Death|1|||
160809398|NCT01238991|580689288|FG004|Overall Study|Death|0|||
160809399|NCT01238991|580689289|FG005|Overall Study|Death|0|||
160809400|NCT01238991|580689290|FG006|Overall Study|Death|0|||
160809401|NCT01238991|580689291|FG007|Overall Study|Death|0|||
160809402|NCT01238991|580689292|FG008|Overall Study|Death|0|||
160809403|NCT01238991|580689293|FG009|Overall Study|Death|0|||
160809404|NCT01238991|580689284|FG000|Overall Study|Lack of Efficacy|0|||
160809405|NCT01238991|580689285|FG001|Overall Study|Lack of Efficacy|0|||
160809406|NCT01238991|580689286|FG002|Overall Study|Lack of Efficacy|1|||
160809407|NCT01238991|580689287|FG003|Overall Study|Lack of Efficacy|0|||
160809408|NCT01238991|580689288|FG004|Overall Study|Lack of Efficacy|0|||
160809409|NCT01238991|580689289|FG005|Overall Study|Lack of Efficacy|0|||
160809410|NCT01238991|580689290|FG006|Overall Study|Lack of Efficacy|0|||
160809411|NCT01238991|580689291|FG007|Overall Study|Lack of Efficacy|0|||
160809412|NCT01238991|580689292|FG008|Overall Study|Lack of Efficacy|1|||
160809413|NCT01238991|580689293|FG009|Overall Study|Lack of Efficacy|0|||
160809414|NCT01238991|580689284|FG000|Overall Study|Withdrawal by Subject|0|||
160809415|NCT01238991|580689285|FG001|Overall Study|Withdrawal by Subject|0|||
160809416|NCT01238991|580689286|FG002|Overall Study|Withdrawal by Subject|1|||
160809417|NCT01238991|580689287|FG003|Overall Study|Withdrawal by Subject|0|||
161131051|NCT01176916|581863482|FG000|Overall Study|Withdrawal prior to Treatment|6|||
161131052|NCT03158220|581863485|FG000|Overall Study|Screen Failure|0|||
161131053|NCT03158220|581863486|FG001|Overall Study|Screen Failure|1|||
161238741|NCT00665925|582255738|FG002|Overall Study|Enrolled by mistake|0|||
161238742|NCT00665925|582255739|FG003|Overall Study|Enrolled by mistake|1|||
161238743|NCT00665925|582255736|FG000|Overall Study|Due to exclusion criteria|1|||
161238744|NCT00665925|582255737|FG001|Overall Study|Due to exclusion criteria|0|||
160809418|NCT01238991|580689288|FG004|Overall Study|Withdrawal by Subject|0|||
160809419|NCT01238991|580689289|FG005|Overall Study|Withdrawal by Subject|0|||
160809420|NCT01238991|580689290|FG006|Overall Study|Withdrawal by Subject|0|||
160809421|NCT01238991|580689291|FG007|Overall Study|Withdrawal by Subject|0|||
160809422|NCT01238991|580689292|FG008|Overall Study|Withdrawal by Subject|0|||
160809423|NCT01238991|580689293|FG009|Overall Study|Withdrawal by Subject|0|||
160809424|NCT01238991|580689284|FG000|Overall Study|Study Terminated by Sponsor|0|||
160809425|NCT01238991|580689285|FG001|Overall Study|Study Terminated by Sponsor|0|||
160809426|NCT01238991|580689286|FG002|Overall Study|Study Terminated by Sponsor|0|||
160809427|NCT01238991|580689287|FG003|Overall Study|Study Terminated by Sponsor|0|||
160809428|NCT01238991|580689288|FG004|Overall Study|Study Terminated by Sponsor|1|||
160809429|NCT01238991|580689289|FG005|Overall Study|Study Terminated by Sponsor|0|||
161131054|NCT03158220|581863485|FG000|Overall Study|Withdrawal by Subject|8|||
161238745|NCT00665925|582255738|FG002|Overall Study|Due to exclusion criteria|0|||
160809430|NCT01238991|580689290|FG006|Overall Study|Study Terminated by Sponsor|7|||
160809431|NCT01238991|580689291|FG007|Overall Study|Study Terminated by Sponsor|4|||
160809432|NCT01238991|580689292|FG008|Overall Study|Study Terminated by Sponsor|2|||
160809433|NCT01238991|580689293|FG009|Overall Study|Study Terminated by Sponsor|2|||
160809434|NCT01238991|580689284|FG000|Overall Study|Caregiver's request|0|||
160809435|NCT01238991|580689285|FG001|Overall Study|Caregiver's request|0|||
160809436|NCT01238991|580689286|FG002|Overall Study|Caregiver's request|0|||
160809437|NCT01238991|580689287|FG003|Overall Study|Caregiver's request|0|||
160809438|NCT01238991|580689288|FG004|Overall Study|Caregiver's request|0|||
160809439|NCT01238991|580689289|FG005|Overall Study|Caregiver's request|0|||
160809440|NCT01238991|580689290|FG006|Overall Study|Caregiver's request|0|||
160809441|NCT01238991|580689291|FG007|Overall Study|Caregiver's request|0|||
160809442|NCT01238991|580689292|FG008|Overall Study|Caregiver's request|1|||
160809443|NCT01238991|580689293|FG009|Overall Study|Caregiver's request|0|||
160809444|NCT01238991|580689284|FG000|Overall Study|Admission to a nursing home|1|||
160809445|NCT01238991|580689285|FG001|Overall Study|Admission to a nursing home|0|||
160809446|NCT01238991|580689286|FG002|Overall Study|Admission to a nursing home|1|||
160809447|NCT01238991|580689287|FG003|Overall Study|Admission to a nursing home|0|||
160809448|NCT01238991|580689288|FG004|Overall Study|Admission to a nursing home|0|||
160809449|NCT01238991|580689289|FG005|Overall Study|Admission to a nursing home|0|||
160809450|NCT01238991|580689290|FG006|Overall Study|Admission to a nursing home|0|||
160809451|NCT01238991|580689291|FG007|Overall Study|Admission to a nursing home|0|||
160809452|NCT01238991|580689292|FG008|Overall Study|Admission to a nursing home|0|||
160809453|NCT01238991|580689293|FG009|Overall Study|Admission to a nursing home|0|||
160809454|NCT02297815|580689314|FG000|Overall Study|Lost to Follow-up|236|||
160809455|NCT02297815|580689315|FG001|Overall Study|Lost to Follow-up|140|||
160809456|NCT00662831|580689316|FG000|Overall Study|Death|4|||
160809457|NCT00662831|580689317|FG001|Overall Study|Death|1|||
160809458|NCT00662831|580689316|FG000|Overall Study|Lack of Efficacy|6|||
160809459|NCT00662831|580689317|FG001|Overall Study|Lack of Efficacy|6|||
160809460|NCT00662831|580689316|FG000|Overall Study|Lost to Follow-up|1|||
160809461|NCT00662831|580689317|FG001|Overall Study|Lost to Follow-up|0|||
161238746|NCT00665925|582255739|FG003|Overall Study|Due to exclusion criteria|0|||
161238747|NCT04035187|582255742|FG000|Overall Study|Withdrawal by Subject|2|||
161238748|NCT04035187|582255743|FG001|Overall Study|Withdrawal by Subject|1|||
161238749|NCT04035187|582255744|FG002|Overall Study|Withdrawal by Subject|0|||
161238750|NCT04035187|582255745|FG003|Overall Study|Withdrawal by Subject|0|||
161238751|NCT04035187|582255742|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
161238752|NCT04035187|582255743|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
161238753|NCT04035187|582255744|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
161238754|NCT04035187|582255745|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
161238755|NCT03165994|582255758|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
161238756|NCT03165994|582255758|FG000|Overall Study|Death|2|||
161238757|NCT03165994|582255758|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
160809462|NCT00662831|580689316|FG000|Overall Study|Withdrawal by Subject|2|||
160809463|NCT00662831|580689317|FG001|Overall Study|Withdrawal by Subject|1|||
160809464|NCT00662831|580689316|FG000|Overall Study|Other|62|||
160809465|NCT00662831|580689317|FG001|Overall Study|Other|31|||
160809466|NCT00662831|580689316|FG000|Overall Study|Protocol Violation|8|||
160809467|NCT00662831|580689317|FG001|Overall Study|Protocol Violation|4|||
160809468|NCT00662831|580689316|FG000|Overall Study|Adverse Event|23|||
160809469|NCT00662831|580689317|FG001|Overall Study|Adverse Event|16|||
160809470|NCT02522429|580689318|FG000|Overall Study|Lost to Follow-up|8|||
160809471|NCT02522429|580689318|FG000|Overall Study|Adverse Event|2|||
160809472|NCT02522429|580689318|FG000|Overall Study|Death|1|||
160809473|NCT02522429|580689318|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
160809474|NCT00294671|580689319|FG000|Overall Study|Lack of Efficacy|11|||
161131055|NCT03158220|581863486|FG001|Overall Study|Withdrawal by Subject|9|||
161131056|NCT03158220|581863485|FG000|Overall Study|Status unknown|0|||
160809475|NCT00294671|580689320|FG001|Overall Study|Lack of Efficacy|23|||
160809476|NCT00294671|580689319|FG000|Overall Study|Liver transplant|7|||
160809477|NCT00294671|580689320|FG001|Overall Study|Liver transplant|9|||
161131057|NCT03158220|581863486|FG001|Overall Study|Status unknown|1|||
161131058|NCT03158220|581863485|FG000|Overall Study|Lost to Follow-up|8|||
161131059|NCT03158220|581863486|FG001|Overall Study|Lost to Follow-up|5|||
161131060|NCT03158220|581863485|FG000|Overall Study|Physician Decision|1|||
161131061|NCT03158220|581863486|FG001|Overall Study|Physician Decision|0|||
161131062|NCT01961115|581863498|FG000|Overall Study|Disease Progression|1|||
161131063|NCT01961115|581863499|FG001|Overall Study|Disease Progression|0|||
161131064|NCT01961115|581863500|FG002|Overall Study|Disease Progression|3|||
161131065|NCT01961115|581863498|FG000|Overall Study|Adverse Event|1|||
161131066|NCT01961115|581863499|FG001|Overall Study|Adverse Event|0|||
161131067|NCT01961115|581863500|FG002|Overall Study|Adverse Event|1|||
161332843|NCT04414787|582605362|FG001|Overall Study|Patient Hospitalization|1|||
161131068|NCT01439945|581863501|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
160809478|NCT00294671|580689319|FG000|Overall Study|Drug related adverse event (AE)|4|||
160809479|NCT00294671|580689320|FG001|Overall Study|Drug related adverse event (AE)|2|||
160809480|NCT00294671|580689319|FG000|Overall Study|Non-drug related AE|3|||
160809481|NCT00294671|580689320|FG001|Overall Study|Non-drug related AE|2|||
160809482|NCT00294671|580689319|FG000|Overall Study|Lost to Follow-up|1|||
160809483|NCT00294671|580689320|FG001|Overall Study|Lost to Follow-up|3|||
160809484|NCT00294671|580689319|FG000|Overall Study|Non-compliance|1|||
160809485|NCT00294671|580689320|FG001|Overall Study|Non-compliance|0|||
160809486|NCT00294671|580689319|FG000|Overall Study|Death|0|||
160809487|NCT00294671|580689320|FG001|Overall Study|Death|1|||
160809488|NCT03015363|580689325|FG000|Overall Study|Physician Decision|14|||
160809489|NCT03015363|580689325|FG000|Overall Study|Withdrawal by Subject|3|||
160809490|NCT00958360|580689326|FG000|Overall Study|Withdrawal by Subject|3|||
160809491|NCT00958360|580689327|FG001|Overall Study|Withdrawal by Subject|1|||
160809492|NCT00958360|580689326|FG000|Overall Study|Death|6|||
160809493|NCT00958360|580689327|FG001|Overall Study|Death|7|||
160809494|NCT00958360|580689326|FG000|Overall Study|Physician Decision|2|||
160809495|NCT00958360|580689327|FG001|Overall Study|Physician Decision|1|||
160809496|NCT00958360|580689326|FG000|Overall Study|Lost to Follow-up|0|||
160809497|NCT00958360|580689327|FG001|Overall Study|Lost to Follow-up|1|||
160809498|NCT03107052|580689328|FG000|Overall Study|Adverse Event|6|||
160809499|NCT03107052|580689329|FG001|Overall Study|Adverse Event|1|||
160986047|NCT03890120|581338570|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
161238758|NCT03165994|582255758|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
161238759|NCT03165994|582255758|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
161238760|NCT03165994|582255758|FG000|Overall Study|Miscellaneous|1|||
161238761|NCT03600805|582255769|FG000|Overall Study|Adverse Event|2|||
161238762|NCT03600805|582255770|FG001|Overall Study|Adverse Event|1|||
161238763|NCT03600805|582255771|FG002|Overall Study|Adverse Event|1|||
161238764|NCT03600805|582255772|FG003|Overall Study|Adverse Event|7|||
161238765|NCT03600805|582255769|FG000|Overall Study|Lack of Efficacy|2|||
161238766|NCT03600805|582255770|FG001|Overall Study|Lack of Efficacy|1|||
161238767|NCT03600805|582255771|FG002|Overall Study|Lack of Efficacy|0|||
161238768|NCT03600805|582255772|FG003|Overall Study|Lack of Efficacy|0|||
161238769|NCT03600805|582255769|FG000|Overall Study|Withdrawal by Subject|1|||
161238770|NCT03600805|582255770|FG001|Overall Study|Withdrawal by Subject|0|||
160986048|NCT03890120|581338571|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
160986049|NCT03890120|581338572|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
160986050|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
160986051|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
160986052|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
160986053|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
160986054|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
160986055|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
160986056|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
160986057|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
160986058|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
160986059|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
160986060|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
160986061|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
160986062|NCT03890120|581338569|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
160986063|NCT03890120|581338570|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
160986064|NCT03890120|581338571|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
160986065|NCT03890120|581338572|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
160986066|NCT01052662|581338573|FG000|Overall Study|Lost to Follow-up|15|||
160986067|NCT01052662|581338574|FG001|Overall Study|Lost to Follow-up|13|||
160986068|NCT01052662|581338575|FG002|Overall Study|Lost to Follow-up|18|||
160986069|NCT01052662|581338573|FG000|Overall Study|Withdrawal by Subject|3|||
160986070|NCT01052662|581338574|FG001|Overall Study|Withdrawal by Subject|2|||
160986071|NCT01052662|581338575|FG002|Overall Study|Withdrawal by Subject|1|||
160986072|NCT01052662|581338573|FG000|Overall Study|Pharmacy issue|1|||
161238771|NCT03600805|582255771|FG002|Overall Study|Withdrawal by Subject|0|||
161238772|NCT03600805|582255772|FG003|Overall Study|Withdrawal by Subject|1|||
161238773|NCT03600805|582255769|FG000|Overall Study|Other unspecified|14|||
160809500|NCT03107052|580689330|FG002|Overall Study|Adverse Event|2|||
160809501|NCT03107052|580689328|FG000|Overall Study|Withdrawal by Subject|9|||
160809502|NCT03107052|580689329|FG001|Overall Study|Withdrawal by Subject|5|||
160809503|NCT03107052|580689330|FG002|Overall Study|Withdrawal by Subject|8|||
160809504|NCT03107052|580689328|FG000|Overall Study|Protocol Violation|6|||
160809505|NCT03107052|580689329|FG001|Overall Study|Protocol Violation|0|||
160809506|NCT03107052|580689330|FG002|Overall Study|Protocol Violation|3|||
160809507|NCT03107052|580689328|FG000|Overall Study|Lost to Follow-up|4|||
160809508|NCT03107052|580689329|FG001|Overall Study|Lost to Follow-up|0|||
160809509|NCT03107052|580689330|FG002|Overall Study|Lost to Follow-up|1|||
160986073|NCT01052662|581338574|FG001|Overall Study|Pharmacy issue|3|||
160899347|NCT00075218|581026299|FG002|Double-Blind Treatment|Adverse Event|0|||
160899348|NCT00075218|581026297|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
160899349|NCT00075218|581026298|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
160899350|NCT00075218|581026299|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
160899351|NCT00075218|581026297|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
160899352|NCT00075218|581026298|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
160899353|NCT00075218|581026299|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
160899354|NCT00075218|581026297|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
160899355|NCT00075218|581026298|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
160899356|NCT00075218|581026299|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
160899357|NCT00075218|581026297|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
160899358|NCT00075218|581026298|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
160899359|NCT00075218|581026299|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
160899360|NCT00075218|581026297|FG000|Double-Blind Treatment|No study medication taken|2|||
160899361|NCT00075218|581026298|FG001|Double-Blind Treatment|No study medication taken|0|||
160899362|NCT00075218|581026299|FG002|Double-Blind Treatment|No study medication taken|0|||
161238774|NCT03600805|582255770|FG001|Overall Study|Other unspecified|6|||
161238775|NCT03600805|582255771|FG002|Overall Study|Other unspecified|7|||
161238776|NCT03600805|582255772|FG003|Overall Study|Other unspecified|11|||
161238777|NCT00804856|582255778|FG000|Overall Study|Progressive Disease|3|||
161238778|NCT00804856|582255779|FG001|Overall Study|Progressive Disease|2|||
161238779|NCT00804856|582255780|FG002|Overall Study|Progressive Disease|4|||
161238780|NCT00804856|582255781|FG003|Overall Study|Progressive Disease|6|||
161238781|NCT00804856|582255782|FG004|Overall Study|Progressive Disease|4|||
161238782|NCT00804856|582255783|FG005|Overall Study|Progressive Disease|1|||
161238783|NCT00804856|582255784|FG006|Overall Study|Progressive Disease|8|||
161238784|NCT00804856|582255785|FG007|Overall Study|Progressive Disease|2|||
161238785|NCT00804856|582255786|FG008|Overall Study|Progressive Disease|4|||
161238786|NCT00804856|582255787|FG009|Overall Study|Progressive Disease|5|||
161238787|NCT00804856|582255788|FG010|Overall Study|Progressive Disease|12|||
161238788|NCT00804856|582255789|FG011|Overall Study|Progressive Disease|2|||
161238789|NCT00804856|582255790|FG012|Overall Study|Progressive Disease|2|||
161238790|NCT00804856|582255791|FG013|Overall Study|Progressive Disease|26|||
161238791|NCT00804856|582255792|FG014|Overall Study|Progressive Disease|20|||
161238792|NCT00804856|582255778|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238793|NCT00804856|582255779|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238794|NCT00804856|582255780|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238795|NCT00804856|582255781|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161332844|NCT04414787|582605363|FG002|Overall Study|Patient Hospitalization|2|||
160899363|NCT00075218|581026297|FG000|Open-Label Treatment|Lack of Efficacy|0|||
160899364|NCT00075218|581026298|FG001|Open-Label Treatment|Lack of Efficacy|0|||
160899365|NCT00075218|581026299|FG002|Open-Label Treatment|Lack of Efficacy|174|||
160986074|NCT01052662|581338575|FG002|Overall Study|Pharmacy issue|3|||
160986075|NCT01052662|581338573|FG000|Overall Study|Adverse Event|1|||
160986076|NCT01052662|581338574|FG001|Overall Study|Adverse Event|1|||
160986077|NCT01052662|581338575|FG002|Overall Study|Adverse Event|0|||
160986078|NCT01052662|581338573|FG000|Overall Study|Legal Problem|2|||
160986079|NCT01052662|581338574|FG001|Overall Study|Legal Problem|0|||
160986080|NCT01052662|581338575|FG002|Overall Study|Legal Problem|0|||
160986081|NCT01052662|581338573|FG000|Overall Study|Administrative|0|||
160986082|NCT01052662|581338574|FG001|Overall Study|Administrative|3|||
160899366|NCT00075218|581026297|FG000|Open-Label Treatment|Adverse Event|0|||
160899367|NCT00075218|581026298|FG001|Open-Label Treatment|Adverse Event|0|||
160899368|NCT00075218|581026299|FG002|Open-Label Treatment|Adverse Event|51|||
160899369|NCT00075218|581026297|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
160899370|NCT00075218|581026298|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
160986083|NCT01052662|581338575|FG002|Overall Study|Administrative|0|||
160986084|NCT00479674|581338576|FG000|Overall Study|Adverse Event|18|||
160986085|NCT00479674|581338576|FG000|Overall Study|Withdrawal by Subject|6|||
160986086|NCT00479674|581338576|FG000|Overall Study|Physician Decision|14|||
160986087|NCT00479674|581338576|FG000|Overall Study|none provided|3|||
160986088|NCT02478359|581338578|FG000|Overall Study|Disenrolled from health plan|106|||
160986089|NCT02478359|581338579|FG001|Overall Study|Disenrolled from health plan|65|||
161238796|NCT00804856|582255782|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161238797|NCT00804856|582255783|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160899371|NCT00075218|581026299|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
160899372|NCT00075218|581026297|FG000|Open-Label Treatment|Decision of Sponsor|0|||
160899373|NCT00075218|581026298|FG001|Open-Label Treatment|Decision of Sponsor|0|||
160899374|NCT00075218|581026299|FG002|Open-Label Treatment|Decision of Sponsor|8|||
160899375|NCT00075218|581026297|FG000|Open-Label Treatment|Protocol Violation|0|||
160986090|NCT03293485|581338583|FG000|Overall Study|Death|1|||
160986091|NCT03293485|581338583|FG000|Overall Study|Screen Failure|2|||
160986092|NCT03293485|581338583|FG000|Overall Study|Withdrawal by Subject|2|||
160986093|NCT03023332|581338584|FG000|Overall Study|Withdrawal by Subject|10|||
161238798|NCT00804856|582255784|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238799|NCT00804856|582255785|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160809510|NCT03107052|580689328|FG000|Overall Study|Lack of Efficacy|23|||
160809511|NCT03107052|580689329|FG001|Overall Study|Lack of Efficacy|7|||
160809512|NCT03107052|580689330|FG002|Overall Study|Lack of Efficacy|4|||
160809513|NCT03107052|580689328|FG000|Overall Study|Other than specified|4|||
160809514|NCT03107052|580689329|FG001|Overall Study|Other than specified|2|||
160809515|NCT03107052|580689330|FG002|Overall Study|Other than specified|0|||
160809516|NCT03107052|580689328|FG000|Overall Study|Study terminated due to futility|67|||
160809517|NCT03107052|580689329|FG001|Overall Study|Study terminated due to futility|31|||
160809518|NCT03107052|580689330|FG002|Overall Study|Study terminated due to futility|23|||
160809519|NCT00500357|580689331|FG000|Overall Study|Death|1|||
161131069|NCT01439945|581863502|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161131070|NCT01439945|581863503|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
161131071|NCT01439945|581863504|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161131072|NCT01439945|581863501|FG000|Double-Blind Treatment Phase|Ineligible|1|||
161131073|NCT01439945|581863502|FG001|Double-Blind Treatment Phase|Ineligible|2|||
161131074|NCT01439945|581863503|FG002|Double-Blind Treatment Phase|Ineligible|0|||
161131075|NCT01439945|581863504|FG003|Double-Blind Treatment Phase|Ineligible|1|||
161131076|NCT04082663|581863505|FG000|Overall Study|Adverse Event|6|||
161131077|NCT04082663|581863505|FG000|Overall Study|Lost to Follow-up|1|||
161131078|NCT02542072|581863506|FG000|First Intervention (1 Month)|Adverse Event|1|||
161131079|NCT02542072|581863507|FG001|First Intervention (1 Month)|Adverse Event|1|||
161131080|NCT02542072|581863506|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
161131081|NCT02542072|581863507|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
161131082|NCT02542072|581863506|FG000|First Intervention (1 Month)|Lens discomfort|1|||
161131083|NCT02542072|581863507|FG001|First Intervention (1 Month)|Lens discomfort|2|||
161131084|NCT02542072|581863506|FG000|First Intervention (1 Month)|Protocol Violation|1|||
161131085|NCT02542072|581863507|FG001|First Intervention (1 Month)|Protocol Violation|0|||
161131086|NCT02542072|581863506|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
161131087|NCT02542072|581863507|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
160809520|NCT02263326|580689332|FG000|Overall Study|Lost to Follow-up|1|||
160809521|NCT02263326|580689333|FG001|Overall Study|Lost to Follow-up|1|||
160809522|NCT01061723|580689334|FG000|Overall Study|Adverse Event|0|||
160809523|NCT01061723|580689335|FG001|Overall Study|Adverse Event|2|||
160809524|NCT01061723|580689336|FG002|Overall Study|Adverse Event|5|||
161131088|NCT02542072|581863506|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
160809525|NCT01061723|580689337|FG003|Overall Study|Adverse Event|5|||
160809526|NCT01061723|580689338|FG004|Overall Study|Adverse Event|2|||
160809527|NCT01061723|580689339|FG005|Overall Study|Adverse Event|6|||
160809528|NCT01061723|580689334|FG000|Overall Study|Lack of Efficacy|2|||
160809529|NCT01061723|580689335|FG001|Overall Study|Lack of Efficacy|3|||
160809530|NCT01061723|580689336|FG002|Overall Study|Lack of Efficacy|4|||
160809531|NCT01061723|580689337|FG003|Overall Study|Lack of Efficacy|2|||
160809532|NCT01061723|580689338|FG004|Overall Study|Lack of Efficacy|1|||
160809533|NCT01061723|580689339|FG005|Overall Study|Lack of Efficacy|1|||
160809534|NCT01061723|580689334|FG000|Overall Study|Randomized but not treated|0|||
160809535|NCT01061723|580689335|FG001|Overall Study|Randomized but not treated|0|||
160809536|NCT01061723|580689336|FG002|Overall Study|Randomized but not treated|0|||
160809537|NCT01061723|580689337|FG003|Overall Study|Randomized but not treated|0|||
160809538|NCT01061723|580689338|FG004|Overall Study|Randomized but not treated|0|||
160809539|NCT01061723|580689339|FG005|Overall Study|Randomized but not treated|1|||
160809540|NCT01061723|580689334|FG000|Overall Study|Other than specified above|2|||
160809541|NCT01061723|580689335|FG001|Overall Study|Other than specified above|1|||
160809542|NCT01061723|580689336|FG002|Overall Study|Other than specified above|1|||
160809543|NCT01061723|580689337|FG003|Overall Study|Other than specified above|1|||
160809544|NCT01061723|580689338|FG004|Overall Study|Other than specified above|0|||
160809545|NCT01061723|580689339|FG005|Overall Study|Other than specified above|1|||
160809546|NCT03292874|580689340|FG000|Overall Study|Due to pandemic|5|||
160809547|NCT01961297|580689343|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
160809548|NCT01961297|580689344|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
160809549|NCT02482298|580689345|FG000|Overall Study|Withdrawal by Subject|2|||
160809550|NCT02482298|580689346|FG001|Overall Study|Withdrawal by Subject|1|||
160809551|NCT02482298|580689347|FG002|Overall Study|Withdrawal by Subject|2|||
160809552|NCT02482298|580689345|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
160809553|NCT02482298|580689346|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
160809554|NCT02482298|580689347|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
160809555|NCT02482298|580689345|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
160809556|NCT02482298|580689346|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
160809557|NCT02482298|580689347|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
160809558|NCT02482298|580689345|FG000|Overall Study|Lost to Follow-up|0|||
160809559|NCT02482298|580689346|FG001|Overall Study|Lost to Follow-up|1|||
160809560|NCT02482298|580689347|FG002|Overall Study|Lost to Follow-up|0|||
160809561|NCT00540592|580689355|FG000|Overall Study|Adverse Event|0|||
160809562|NCT00540592|580689356|FG001|Overall Study|Adverse Event|1|||
160809563|NCT00540592|580689357|FG002|Overall Study|Adverse Event|0|||
161131089|NCT02542072|581863507|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
161238800|NCT00804856|582255786|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238801|NCT00804856|582255787|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238802|NCT00804856|582255788|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238803|NCT00804856|582255789|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238804|NCT00804856|582255790|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238805|NCT00804856|582255791|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161238806|NCT00804856|582255792|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161238807|NCT00804856|582255778|FG000|Overall Study|Other Adverse Event|1|||
161238808|NCT00804856|582255779|FG001|Overall Study|Other Adverse Event|1|||
161238809|NCT00804856|582255780|FG002|Overall Study|Other Adverse Event|1|||
161238810|NCT00804856|582255781|FG003|Overall Study|Other Adverse Event|2|||
161238811|NCT00804856|582255782|FG004|Overall Study|Other Adverse Event|2|||
161238812|NCT00804856|582255783|FG005|Overall Study|Other Adverse Event|1|||
161238813|NCT00804856|582255784|FG006|Overall Study|Other Adverse Event|3|||
161238814|NCT00804856|582255785|FG007|Overall Study|Other Adverse Event|0|||
161238815|NCT00804856|582255786|FG008|Overall Study|Other Adverse Event|0|||
161238816|NCT00804856|582255787|FG009|Overall Study|Other Adverse Event|1|||
161238817|NCT00804856|582255788|FG010|Overall Study|Other Adverse Event|5|||
161238818|NCT00804856|582255789|FG011|Overall Study|Other Adverse Event|2|||
161238819|NCT00804856|582255790|FG012|Overall Study|Other Adverse Event|0|||
161238820|NCT00804856|582255791|FG013|Overall Study|Other Adverse Event|6|||
161238821|NCT00804856|582255792|FG014|Overall Study|Other Adverse Event|13|||
161238822|NCT00804856|582255778|FG000|Overall Study|Non compliance with protocol|0|||
161238823|NCT00804856|582255779|FG001|Overall Study|Non compliance with protocol|0|||
161238824|NCT00804856|582255780|FG002|Overall Study|Non compliance with protocol|0|||
161238825|NCT00804856|582255781|FG003|Overall Study|Non compliance with protocol|0|||
161238826|NCT00804856|582255782|FG004|Overall Study|Non compliance with protocol|0|||
161238827|NCT00804856|582255783|FG005|Overall Study|Non compliance with protocol|0|||
161238828|NCT00804856|582255784|FG006|Overall Study|Non compliance with protocol|0|||
161238829|NCT00804856|582255785|FG007|Overall Study|Non compliance with protocol|0|||
161238830|NCT00804856|582255786|FG008|Overall Study|Non compliance with protocol|0|||
161238831|NCT00804856|582255787|FG009|Overall Study|Non compliance with protocol|0|||
161238832|NCT00804856|582255788|FG010|Overall Study|Non compliance with protocol|0|||
161238833|NCT00804856|582255789|FG011|Overall Study|Non compliance with protocol|0|||
161238834|NCT00804856|582255790|FG012|Overall Study|Non compliance with protocol|0|||
161238835|NCT00804856|582255791|FG013|Overall Study|Non compliance with protocol|2|||
161238836|NCT00804856|582255792|FG014|Overall Study|Non compliance with protocol|0|||
161238837|NCT00804856|582255778|FG000|Overall Study|Refused to continue medication|0|||
161238838|NCT00804856|582255779|FG001|Overall Study|Refused to continue medication|0|||
161238839|NCT00804856|582255780|FG002|Overall Study|Refused to continue medication|0|||
161238840|NCT00804856|582255781|FG003|Overall Study|Refused to continue medication|1|||
161238841|NCT00804856|582255782|FG004|Overall Study|Refused to continue medication|1|||
161238842|NCT00804856|582255783|FG005|Overall Study|Refused to continue medication|0|||
161238843|NCT00804856|582255784|FG006|Overall Study|Refused to continue medication|0|||
161238844|NCT00804856|582255785|FG007|Overall Study|Refused to continue medication|0|||
161238845|NCT00804856|582255786|FG008|Overall Study|Refused to continue medication|0|||
161238846|NCT00804856|582255787|FG009|Overall Study|Refused to continue medication|0|||
161238847|NCT00804856|582255788|FG010|Overall Study|Refused to continue medication|3|||
161238848|NCT00804856|582255789|FG011|Overall Study|Refused to continue medication|0|||
161238849|NCT00804856|582255790|FG012|Overall Study|Refused to continue medication|1|||
161238850|NCT00804856|582255791|FG013|Overall Study|Refused to continue medication|1|||
161238851|NCT00804856|582255792|FG014|Overall Study|Refused to continue medication|5|||
161238852|NCT00804856|582255778|FG000|Overall Study|Other reason than listed above|0|||
161238853|NCT00804856|582255779|FG001|Overall Study|Other reason than listed above|0|||
161238854|NCT00804856|582255780|FG002|Overall Study|Other reason than listed above|0|||
161238855|NCT00804856|582255781|FG003|Overall Study|Other reason than listed above|0|||
161238856|NCT00804856|582255782|FG004|Overall Study|Other reason than listed above|0|||
161238857|NCT00804856|582255783|FG005|Overall Study|Other reason than listed above|1|||
161238858|NCT00804856|582255784|FG006|Overall Study|Other reason than listed above|0|||
161238859|NCT00804856|582255785|FG007|Overall Study|Other reason than listed above|0|||
161238860|NCT00804856|582255786|FG008|Overall Study|Other reason than listed above|1|||
161238861|NCT00804856|582255787|FG009|Overall Study|Other reason than listed above|0|||
161238862|NCT00804856|582255788|FG010|Overall Study|Other reason than listed above|3|||
161238863|NCT00804856|582255789|FG011|Overall Study|Other reason than listed above|1|||
161238864|NCT00804856|582255790|FG012|Overall Study|Other reason than listed above|1|||
161238865|NCT00804856|582255791|FG013|Overall Study|Other reason than listed above|10|||
161238866|NCT00804856|582255792|FG014|Overall Study|Other reason than listed above|3|||
161238867|NCT03343535|582255795|FG000|Overall Study|Lost to Follow-up|1|||
161238868|NCT03343535|582255795|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
161238869|NCT03343535|582255795|FG000|Overall Study|Death|12|||
161238870|NCT02682238|582255801|FG000|Overall Study|Lost to Follow-up|0|||
161238871|NCT02682238|582255802|FG001|Overall Study|Lost to Follow-up|2|||
160809564|NCT00540592|580689358|FG003|Overall Study|Adverse Event|0|||
160809565|NCT00540592|580689359|FG004|Overall Study|Adverse Event|1|||
160809566|NCT00540592|580689360|FG005|Overall Study|Adverse Event|0|||
160809567|NCT00540592|580689361|FG006|Overall Study|Adverse Event|0|||
160809568|NCT00540592|580689362|FG007|Overall Study|Adverse Event|1|||
160809569|NCT00540592|580689363|FG008|Overall Study|Adverse Event|1|||
161238872|NCT02682238|582255801|FG000|Overall Study|Withdrawal by Subject|1|||
160809570|NCT00540592|580689364|FG009|Overall Study|Adverse Event|2|||
160809571|NCT00540592|580689355|FG000|Overall Study|Lost to Follow-up|2|||
160809572|NCT00540592|580689356|FG001|Overall Study|Lost to Follow-up|0|||
160809573|NCT00540592|580689357|FG002|Overall Study|Lost to Follow-up|0|||
160809574|NCT00540592|580689358|FG003|Overall Study|Lost to Follow-up|0|||
160809575|NCT00540592|580689359|FG004|Overall Study|Lost to Follow-up|0|||
160809576|NCT00540592|580689360|FG005|Overall Study|Lost to Follow-up|0|||
160809577|NCT00540592|580689361|FG006|Overall Study|Lost to Follow-up|0|||
160809578|NCT00540592|580689362|FG007|Overall Study|Lost to Follow-up|0|||
160809579|NCT00540592|580689363|FG008|Overall Study|Lost to Follow-up|0|||
160809580|NCT00540592|580689364|FG009|Overall Study|Lost to Follow-up|0|||
160809581|NCT00540592|580689355|FG000|Overall Study|Withdrawal by Subject|0|||
160809582|NCT00540592|580689356|FG001|Overall Study|Withdrawal by Subject|0|||
160809583|NCT00540592|580689357|FG002|Overall Study|Withdrawal by Subject|1|||
160809584|NCT00540592|580689358|FG003|Overall Study|Withdrawal by Subject|1|||
160809585|NCT00540592|580689359|FG004|Overall Study|Withdrawal by Subject|0|||
160809586|NCT00540592|580689360|FG005|Overall Study|Withdrawal by Subject|0|||
160809587|NCT00540592|580689361|FG006|Overall Study|Withdrawal by Subject|0|||
160809588|NCT00540592|580689362|FG007|Overall Study|Withdrawal by Subject|0|||
160809589|NCT00540592|580689363|FG008|Overall Study|Withdrawal by Subject|0|||
160809590|NCT00540592|580689364|FG009|Overall Study|Withdrawal by Subject|0|||
160809591|NCT04908683|580689365|FG000|Overall Study|Failure to meet continuation criteria|34|||
160809592|NCT04908683|580689366|FG001|Overall Study|Failure to meet continuation criteria|22|||
160809593|NCT04908683|580689365|FG000|Overall Study|Initiated prohibited medication|3|||
160809594|NCT04908683|580689366|FG001|Overall Study|Initiated prohibited medication|0|||
160809595|NCT04908683|580689365|FG000|Overall Study|Randomized by mistake|1|||
160809596|NCT04908683|580689366|FG001|Overall Study|Randomized by mistake|0|||
160809597|NCT04908683|580689365|FG000|Overall Study|Lost to Follow-up|679|||
160809598|NCT04908683|580689366|FG001|Overall Study|Lost to Follow-up|341|||
160809599|NCT04908683|580689365|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
160809600|NCT04908683|580689366|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
160809601|NCT04908683|580689365|FG000|Overall Study|Physician Decision|44|||
160809602|NCT04908683|580689366|FG001|Overall Study|Physician Decision|35|||
160809603|NCT04908683|580689365|FG000|Overall Study|Technical problems|12|||
160809604|NCT04908683|580689366|FG001|Overall Study|Technical problems|9|||
160809605|NCT04908683|580689365|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
160809606|NCT04908683|580689366|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
160809607|NCT04908683|580689365|FG000|Overall Study|Protocol Violation|2|||
160809608|NCT04908683|580689366|FG001|Overall Study|Protocol Violation|0|||
160809609|NCT04908683|580689365|FG000|Overall Study|Withdrawal by Subject|1188|||
160809610|NCT04908683|580689366|FG001|Overall Study|Withdrawal by Subject|570|||
160809611|NCT04908683|580689365|FG000|Overall Study|Site Closure by Sponsor|6|||
160809612|NCT04908683|580689366|FG001|Overall Study|Site Closure by Sponsor|3|||
160809613|NCT04908683|580689365|FG000|Overall Study|Adverse Event|21|||
160809614|NCT04908683|580689366|FG001|Overall Study|Adverse Event|11|||
160809615|NCT04908683|580689365|FG000|Overall Study|Death|101|||
160809616|NCT04908683|580689366|FG001|Overall Study|Death|61|||
160809617|NCT04908683|580689365|FG000|Overall Study|Sponsor's decision|14398|||
160809618|NCT04908683|580689366|FG001|Overall Study|Sponsor's decision|7205|||
160809619|NCT04908683|580689365|FG000|Overall Study|Other|92|||
160809620|NCT04908683|580689366|FG001|Overall Study|Other|50|||
160809621|NCT04908683|580689365|FG000|Overall Study|Randomized not vaccinated|108|||
160809622|NCT04908683|580689366|FG001|Overall Study|Randomized not vaccinated|52|||
160809623|NCT00910910|580689367|FG000|Overall Study|Adverse Event|63|||
160809624|NCT00910910|580689368|FG001|Overall Study|Adverse Event|35|||
160809625|NCT00910910|580689367|FG000|Overall Study|PD without histologic change|27|||
160809626|NCT00910910|580689368|FG001|Overall Study|PD without histologic change|23|||
160809627|NCT00910910|580689367|FG000|Overall Study|PD with histologic change|0|||
160809628|NCT00910910|580689368|FG001|Overall Study|PD with histologic change|2|||
160809629|NCT00910910|580689367|FG000|Overall Study|Withdrawal by Subject|7|||
160809630|NCT00910910|580689368|FG001|Overall Study|Withdrawal by Subject|5|||
160809631|NCT00910910|580689367|FG000|Overall Study|Lost to Follow-up|2|||
160809632|NCT00910910|580689368|FG001|Overall Study|Lost to Follow-up|2|||
160809633|NCT00910910|580689367|FG000|Overall Study|Death|9|||
160809634|NCT00910910|580689368|FG001|Overall Study|Death|3|||
160809635|NCT00910910|580689367|FG000|Overall Study|Protocol Violation|2|||
160809636|NCT00910910|580689368|FG001|Overall Study|Protocol Violation|2|||
160809637|NCT00910910|580689367|FG000|Overall Study|Completed 13 cycles of treatment|0|||
160809638|NCT00910910|580689368|FG001|Overall Study|Completed 13 cycles of treatment|118|||
160809639|NCT00910910|580689367|FG000|Overall Study|Other|114|||
160809640|NCT00910910|580689368|FG001|Overall Study|Other|32|||
160809641|NCT00910910|580689367|FG000|Overall Study|Untreated before cycle 1|1|||
160809642|NCT00910910|580689368|FG001|Overall Study|Untreated before cycle 1|2|||
160809643|NCT01973231|580689369|FG000|Overall Study|Protocol Violation|1|||
160809644|NCT01973231|580689370|FG001|Overall Study|Protocol Violation|1|||
160809645|NCT01973231|580689369|FG000|Overall Study|Lost to Follow-up|1|||
160809646|NCT01973231|580689370|FG001|Overall Study|Lost to Follow-up|1|||
160809647|NCT01973231|580689369|FG000|Overall Study|unclassified|2|||
161238873|NCT02682238|582255802|FG001|Overall Study|Withdrawal by Subject|0|||
161238874|NCT02682238|582255801|FG000|Overall Study|Adverse Event|1|||
161238875|NCT02682238|582255802|FG001|Overall Study|Adverse Event|0|||
161238876|NCT02682238|582255801|FG000|Overall Study|Non-compliance with Study Drug|1|||
161238877|NCT02682238|582255802|FG001|Overall Study|Non-compliance with Study Drug|0|||
161238878|NCT02682238|582255801|FG000|Overall Study|Non-compliance with Protocol|0|||
161238879|NCT02682238|582255802|FG001|Overall Study|Non-compliance with Protocol|2|||
161238880|NCT00123734|582255806|FG000|Overall Study|Death|3|||
161238881|NCT00123734|582255806|FG000|Overall Study|Lost to Follow-up|3|||
161238882|NCT00123734|582255806|FG000|Overall Study|Dropout|1|||
161238883|NCT00123734|582255806|FG000|Overall Study|Withdrawal by Subject|1|||
161238884|NCT00113386|582255807|FG000|Overall Study|Withdrawal by Subject|1|||
161238885|NCT00113386|582255808|FG001|Overall Study|Withdrawal by Subject|0|||
161238886|NCT00113386|582255807|FG000|Overall Study|Physician Decision|0|||
161238887|NCT00113386|582255808|FG001|Overall Study|Physician Decision|1|||
161238888|NCT00113386|582255807|FG000|Overall Study|Toxicity|3|||
161238889|NCT00113386|582255808|FG001|Overall Study|Toxicity|0|||
161238890|NCT00113386|582255807|FG000|Overall Study|Ineligible|1|||
161238891|NCT00113386|582255808|FG001|Overall Study|Ineligible|2|||
161238892|NCT00113386|582255807|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
161238893|NCT00113386|582255808|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
161238894|NCT02849457|582255809|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161238895|NCT02849457|582255810|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161238896|NCT02849457|582255811|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
161238897|NCT02849457|582255812|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
161238898|NCT03437265|582255818|FG000|Overall Study|Protocol Violation|6|||
161238899|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
161238900|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
161238901|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
161238902|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
161238903|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
161238904|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
161238905|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
161238906|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
161238907|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
161238908|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
161238909|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
161238910|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
161238911|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
161238912|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
161238913|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
161238914|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
161238915|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
161238916|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
161238917|NCT01667679|582255823|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
161238918|NCT01667679|582255824|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
161238919|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
161238920|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
161238921|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
161238922|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
161238923|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
161238924|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
161238925|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
160809648|NCT01973231|580689370|FG001|Overall Study|unclassified|1|||
160809649|NCT01973231|580689369|FG000|Overall Study|Withdrawal by Subject|7|||
160809650|NCT01973231|580689370|FG001|Overall Study|Withdrawal by Subject|9|||
160809651|NCT01071954|580689375|FG000|Overall Study|Noncompliance|4|||
160809652|NCT01071954|580689375|FG000|Overall Study|Adverse Event|1|||
160809653|NCT01071954|580689375|FG000|Overall Study|Withdrawal by Subject|11|||
160809654|NCT01071954|580689375|FG000|Overall Study|Requirement for Alternative Therapy|5|||
160809655|NCT01071954|580689375|FG000|Overall Study|Administrative Decision|5|||
160809656|NCT01071954|580689375|FG000|Overall Study|Protocol Specified Criteria|1|||
160809657|NCT01434654|580689376|FG000|Overall Study|Withdrawal by Subject|1|||
160809658|NCT01434654|580689377|FG001|Overall Study|Withdrawal by Subject|0|||
160809659|NCT01434654|580689376|FG000|Overall Study|Lost to Follow-up|1|||
160809660|NCT01434654|580689377|FG001|Overall Study|Lost to Follow-up|0|||
160809661|NCT01823198|580689378|FG000|Overall Study|Physician Decision|0|||
160809662|NCT01823198|580689379|FG001|Overall Study|Physician Decision|1|||
160809663|NCT01823198|580689380|FG002|Overall Study|Physician Decision|0|||
160809664|NCT01823198|580689381|FG003|Overall Study|Physician Decision|0|||
160809665|NCT01823198|580689382|FG004|Overall Study|Physician Decision|0|||
160809666|NCT01823198|580689383|FG005|Overall Study|Physician Decision|3|||
160809667|NCT01823198|580689384|FG006|Overall Study|Physician Decision|3|||
160809668|NCT01926444|580689385|FG000|Overall Study|Colonoscopy not performed|0|||
160809669|NCT01926444|580689386|FG001|Overall Study|Colonoscopy not performed|0|||
160809670|NCT01926444|580689387|FG002|Overall Study|Colonoscopy not performed|4|||
160809671|NCT01926444|580689388|FG003|Overall Study|Colonoscopy not performed|2|||
160809672|NCT02243371|580689398|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
160809673|NCT02243371|580689399|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
160809674|NCT02243371|580689398|FG000|Overall Study|Death (unrelated)|2|||
160809675|NCT02243371|580689399|FG001|Overall Study|Death (unrelated)|4|||
160809676|NCT02243371|580689398|FG000|Overall Study|Adverse Event (unrelated)|0|||
160809677|NCT02243371|580689399|FG001|Overall Study|Adverse Event (unrelated)|1|||
160809678|NCT02243371|580689398|FG000|Overall Study|Lack of Clinical Benefit|0|||
160809679|NCT02243371|580689399|FG001|Overall Study|Lack of Clinical Benefit|1|||
160809680|NCT02243371|580689398|FG000|Overall Study|Withdrawal by Subject|0|||
160809681|NCT02243371|580689399|FG001|Overall Study|Withdrawal by Subject|2|||
160809682|NCT04585269|580689402|FG000|Intervention|Withdrawal by Subject|9|||
160809683|NCT04585269|580689403|FG001|Intervention|Withdrawal by Subject|0|||
160809684|NCT04585269|580689402|FG000|Intervention|Unable to schedule|15|||
160809685|NCT04585269|580689403|FG001|Intervention|Unable to schedule|0|||
160809686|NCT04585269|580689402|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
160809687|NCT04585269|580689403|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
160809688|NCT04585269|580689402|FG000|FU Time 2 (3 months)|Death|2|||
160809689|NCT04585269|580689403|FG001|FU Time 2 (3 months)|Death|2|||
160809690|NCT04585269|580689402|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
160809691|NCT04585269|580689403|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
160809692|NCT04585269|580689402|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
160809693|NCT04585269|580689403|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
160809694|NCT04585269|580689402|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
160809695|NCT04585269|580689403|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
160809696|NCT04585269|580689402|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
160809697|NCT04585269|580689403|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
160809698|NCT04585269|580689402|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
160809699|NCT04585269|580689403|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
160809700|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
160809701|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809702|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809703|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809704|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809705|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809706|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809707|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809708|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809709|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809710|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809711|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809712|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
160809713|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
160809714|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
160809715|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809716|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809717|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809718|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809719|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
161131090|NCT01990261|581863508|FG000|Overall Study|Death Before Treatment Start|2|||
161131091|NCT01990261|581863508|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
161131092|NCT01990261|581863508|FG000|Overall Study|Death From other Causes|1|||
161131093|NCT01990261|581863508|FG000|Overall Study|Disease Progression (PD)|8|||
161131094|NCT01990261|581863508|FG000|Overall Study|PD Before Treatment Start|1|||
161131095|NCT01990261|581863508|FG000|Overall Study|Dossier not Approved|1|||
161131096|NCT01990261|581863508|FG000|Overall Study|Lost to Follow-up|2|||
160809720|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809721|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809722|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809723|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809724|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809725|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
160809726|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
161238926|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
161238927|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
161238928|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
161238929|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
161238930|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
161238931|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
161238932|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
161238933|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
161238934|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
161238935|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
161238936|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
161238937|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
161238938|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
161238939|NCT01667679|582255823|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
161238940|NCT01667679|582255824|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
161332845|NCT04414787|582605364|FG003|Overall Study|Patient Hospitalization|2|||
161332846|NCT04414787|582605361|FG000|Overall Study|Lost to Follow-up|7|||
161332847|NCT04414787|582605362|FG001|Overall Study|Lost to Follow-up|7|||
161332848|NCT04414787|582605363|FG002|Overall Study|Lost to Follow-up|5|||
161332849|NCT04414787|582605364|FG003|Overall Study|Lost to Follow-up|5|||
161332850|NCT04414787|582605361|FG000|Overall Study|Residence in post-acute care facility|3|||
161332851|NCT04414787|582605362|FG001|Overall Study|Residence in post-acute care facility|3|||
160809727|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
161238941|NCT01444378|582255831|FG000|Overall Study|Lost to Follow-up|1|||
161238942|NCT01444378|582255831|FG000|Overall Study|Withdrawal by Subject|1|||
161238943|NCT01444378|582255831|FG000|Overall Study|Death|3|||
161238944|NCT01444378|582255831|FG000|Overall Study|Administrative Closure Of The Study|2|||
161332852|NCT04414787|582605363|FG002|Overall Study|Residence in post-acute care facility|5|||
160809728|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
160899376|NCT00075218|581026298|FG001|Open-Label Treatment|Protocol Violation|0|||
160899377|NCT00075218|581026299|FG002|Open-Label Treatment|Protocol Violation|1|||
160899378|NCT00075218|581026297|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
160899379|NCT00075218|581026298|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
160899380|NCT00075218|581026299|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
160899381|NCT03643575|581026300|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
160899382|NCT03643575|581026301|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
160899383|NCT03643575|581026302|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
160899384|NCT03643575|581026303|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
160899385|NCT03643575|581026304|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
160899386|NCT03643575|581026305|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
160899387|NCT03643575|581026300|FG000|Washout: 7 Days|Adverse Event|1|||
160899388|NCT03643575|581026301|FG001|Washout: 7 Days|Adverse Event|0|||
160899389|NCT03643575|581026302|FG002|Washout: 7 Days|Adverse Event|0|||
160899390|NCT03643575|581026303|FG003|Washout: 7 Days|Adverse Event|0|||
160899391|NCT03643575|581026304|FG004|Washout: 7 Days|Adverse Event|0|||
160899392|NCT03643575|581026305|FG005|Washout: 7 Days|Adverse Event|0|||
160899393|NCT03643575|581026300|FG000|Washout: 7 Days|Non compliance check in|0|||
160899394|NCT03643575|581026301|FG001|Washout: 7 Days|Non compliance check in|1|||
160899395|NCT03643575|581026302|FG002|Washout: 7 Days|Non compliance check in|0|||
160899396|NCT03643575|581026303|FG003|Washout: 7 Days|Non compliance check in|0|||
160899397|NCT03643575|581026304|FG004|Washout: 7 Days|Non compliance check in|0|||
160899398|NCT03643575|581026305|FG005|Washout: 7 Days|Non compliance check in|0|||
160899399|NCT00131508|581026306|FG000|Overall Study|Disease progression|0|||
160899400|NCT00131508|581026307|FG001|Overall Study|Disease progression|2|||
160899401|NCT00131508|581026306|FG000|Overall Study|Non-Compliance|2|||
160899402|NCT00131508|581026307|FG001|Overall Study|Non-Compliance|4|||
160899403|NCT00131508|581026306|FG000|Overall Study|Withdrawal by Subject|1|||
160899404|NCT00131508|581026307|FG001|Overall Study|Withdrawal by Subject|2|||
160899405|NCT00986830|581026308|FG000|Overall Study|Death|1|||
160899406|NCT00986830|581026308|FG000|Overall Study|Lost to Follow-up|1|||
160899407|NCT00986830|581026308|FG000|Overall Study|Lack of Efficacy|1|||
160899408|NCT00986830|581026308|FG000|Overall Study|Unable to access sinus with device|5|||
160899409|NCT00845858|581026309|FG000|Overall Study|Withdrawal by Subject|5|||
161238945|NCT01444378|582255831|FG000|Overall Study|Missed Visits|10|||
160899410|NCT00845858|581026310|FG001|Overall Study|Withdrawal by Subject|1|||
160899411|NCT00845858|581026311|FG002|Overall Study|Withdrawal by Subject|1|||
160899412|NCT00845858|581026309|FG000|Overall Study|Adverse Event|3|||
160899413|NCT00845858|581026310|FG001|Overall Study|Adverse Event|8|||
160899414|NCT00845858|581026311|FG002|Overall Study|Adverse Event|4|||
160899415|NCT00845858|581026309|FG000|Overall Study|Protocol Violation|0|||
160899416|NCT00845858|581026310|FG001|Overall Study|Protocol Violation|0|||
160899417|NCT00845858|581026311|FG002|Overall Study|Protocol Violation|1|||
160899418|NCT00845858|581026309|FG000|Overall Study|not eligible|0|||
160899419|NCT00845858|581026310|FG001|Overall Study|not eligible|3|||
160899420|NCT00845858|581026311|FG002|Overall Study|not eligible|2|||
160899421|NCT01436396|581026312|FG000|Overall Study|Protocol Violation|7|||
160899422|NCT01436396|581026313|FG001|Overall Study|Protocol Violation|5|||
160899423|NCT01436396|581026312|FG000|Overall Study|Adverse Event|1|||
160899424|NCT01436396|581026313|FG001|Overall Study|Adverse Event|2|||
160899425|NCT01436396|581026312|FG000|Overall Study|Withdrawal by Subject|19|||
160899426|NCT01436396|581026313|FG001|Overall Study|Withdrawal by Subject|29|||
160899427|NCT01436396|581026312|FG000|Overall Study|Serious adverse event|2|||
160899428|NCT01436396|581026313|FG001|Overall Study|Serious adverse event|3|||
160899429|NCT01436396|581026312|FG000|Overall Study|Lost to Follow-up|3|||
160899430|NCT01436396|581026313|FG001|Overall Study|Lost to Follow-up|3|||
160899431|NCT00216476|581026315|FG000|Overall Study|Withdrawal by Subject|59|||
160899432|NCT00216476|581026316|FG001|Overall Study|Withdrawal by Subject|72|||
160899433|NCT00216476|581026317|FG002|Overall Study|Withdrawal by Subject|9|||
160899434|NCT00216476|581026315|FG000|Overall Study|Lost to Follow-up|10|||
160899435|NCT00216476|581026316|FG001|Overall Study|Lost to Follow-up|9|||
160899436|NCT00216476|581026317|FG002|Overall Study|Lost to Follow-up|1|||
160899437|NCT00216476|581026315|FG000|Overall Study|Adverse Event|6|||
160899438|NCT00216476|581026316|FG001|Overall Study|Adverse Event|10|||
160899439|NCT00216476|581026317|FG002|Overall Study|Adverse Event|1|||
160899440|NCT00216476|581026315|FG000|Overall Study|Lack of Efficacy|4|||
160899441|NCT00216476|581026316|FG001|Overall Study|Lack of Efficacy|3|||
160899442|NCT00216476|581026317|FG002|Overall Study|Lack of Efficacy|0|||
160899443|NCT00216476|581026315|FG000|Overall Study|Death|2|||
160899444|NCT00216476|581026316|FG001|Overall Study|Death|0|||
160899445|NCT00216476|581026317|FG002|Overall Study|Death|0|||
160899446|NCT00216476|581026315|FG000|Overall Study|Pregnancy|0|||
160899447|NCT00216476|581026316|FG001|Overall Study|Pregnancy|1|||
160899448|NCT00216476|581026317|FG002|Overall Study|Pregnancy|1|||
160899449|NCT00216476|581026315|FG000|Overall Study|Other|0|||
160899450|NCT00216476|581026316|FG001|Overall Study|Other|0|||
160899451|NCT00216476|581026317|FG002|Overall Study|Other|1|||
160899452|NCT00216476|581026315|FG000|Overall Study|Refuses Injection|11|||
160899453|NCT00216476|581026316|FG001|Overall Study|Refuses Injection|0|||
160899454|NCT00216476|581026317|FG002|Overall Study|Refuses Injection|0|||
160899455|NCT00216476|581026315|FG000|Overall Study|No Further Need for Treatment|3|||
160899456|NCT00216476|581026316|FG001|Overall Study|No Further Need for Treatment|4|||
160899457|NCT00216476|581026317|FG002|Overall Study|No Further Need for Treatment|1|||
160899458|NCT00216476|581026315|FG000|Overall Study|Non-compliance|0|||
160899459|NCT00216476|581026316|FG001|Overall Study|Non-compliance|4|||
160899460|NCT00216476|581026317|FG002|Overall Study|Non-compliance|1|||
160899461|NCT00216476|581026315|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
160899462|NCT00216476|581026316|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
160899463|NCT00216476|581026317|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
160899464|NCT00216476|581026315|FG000|Overall Study|Administrative Reasons|1|||
160899465|NCT00216476|581026316|FG001|Overall Study|Administrative Reasons|1|||
160899466|NCT00216476|581026317|FG002|Overall Study|Administrative Reasons|0|||
160899467|NCT00216476|581026315|FG000|Overall Study|Protocol Deviation|5|||
160899468|NCT00216476|581026316|FG001|Overall Study|Protocol Deviation|1|||
160899469|NCT00216476|581026317|FG002|Overall Study|Protocol Deviation|0|||
160899470|NCT00216476|581026315|FG000|Overall Study|Patient Moved|2|||
160899471|NCT00216476|581026316|FG001|Overall Study|Patient Moved|2|||
160899472|NCT00216476|581026317|FG002|Overall Study|Patient Moved|0|||
160899473|NCT02191137|581026320|FG000|Treatment|Death|4|||
160899474|NCT02191137|581026320|FG000|Treatment|Withdrawal by Subject|3|||
160899475|NCT02191137|581026320|FG000|Treatment|Adverse Event|2|||
160899476|NCT02191137|581026320|FG000|Treatment|Other|1|||
160899477|NCT02191137|581026320|FG000|Follow-up|Lost to Follow-up|2|||
160899478|NCT02191137|581026320|FG000|Follow-up|Ongoing/unknown|2|||
160899479|NCT02191137|581026320|FG000|Follow-up|Adverse Event|1|||
160899480|NCT00538291|581026321|FG000|Overall Study|Adverse Event|2|||
160899481|NCT00538291|581026321|FG000|Overall Study|Withdrawal by Subject|1|||
160899482|NCT00694707|581026322|FG000|Overall Study|Did Not Receive Treatment|0|||
160899483|NCT00694707|581026323|FG001|Overall Study|Did Not Receive Treatment|0|||
160899484|NCT00694707|581026324|FG002|Overall Study|Did Not Receive Treatment|1|||
160899485|NCT00694707|581026325|FG003|Overall Study|Did Not Receive Treatment|1|||
161238946|NCT02911792|582255832|FG000|Overall Study|Lost to Follow-up|3|||
160899486|NCT00694707|581026326|FG004|Overall Study|Did Not Receive Treatment|1|||
160899487|NCT00694707|581026322|FG000|Overall Study|Adverse Event|22|||
160809729|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809730|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809731|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809732|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809733|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809734|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809735|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809736|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809737|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809738|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
160809739|NCT03307785|580689406|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
160809740|NCT03307785|580689407|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
160809741|NCT03307785|580689408|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809742|NCT03307785|580689409|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809743|NCT03307785|580689410|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809744|NCT03307785|580689411|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809745|NCT03307785|580689412|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809746|NCT03307785|580689413|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809747|NCT03307785|580689414|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809748|NCT03307785|580689415|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809749|NCT03307785|580689416|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809750|NCT03307785|580689417|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809751|NCT03307785|580689418|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
160809752|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809753|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809754|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
160809755|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809756|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809757|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809758|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809759|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809760|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809761|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809762|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809763|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809764|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
160809765|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809766|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809767|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
160809768|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809769|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809770|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809771|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809772|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809773|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809774|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809775|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809776|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809777|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
160809778|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809779|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809780|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
160809781|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809782|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809783|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809784|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809785|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809786|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809787|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809788|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809789|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809790|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
160809791|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809792|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809793|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
160986094|NCT03023332|581338585|FG001|Overall Study|Withdrawal by Subject|5|||
160986095|NCT03023332|581338586|FG002|Overall Study|Withdrawal by Subject|4|||
160986096|NCT03023332|581338587|FG003|Overall Study|Withdrawal by Subject|7|||
160986097|NCT03023332|581338584|FG000|Overall Study|Lost to Follow-up|13|||
160986098|NCT03023332|581338585|FG001|Overall Study|Lost to Follow-up|16|||
160986099|NCT03023332|581338586|FG002|Overall Study|Lost to Follow-up|8|||
160986100|NCT03023332|581338587|FG003|Overall Study|Lost to Follow-up|13|||
160986101|NCT03023332|581338584|FG000|Overall Study|Death|1|||
160986102|NCT03023332|581338585|FG001|Overall Study|Death|0|||
160986103|NCT03023332|581338586|FG002|Overall Study|Death|0|||
160986104|NCT03023332|581338587|FG003|Overall Study|Death|0|||
160986105|NCT02412761|581338588|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160986106|NCT02412761|581338589|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160809794|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809795|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809796|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809797|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809798|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809799|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809800|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809801|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809802|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809803|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
160809804|NCT03307785|580689406|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809805|NCT03307785|580689407|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809806|NCT03307785|580689408|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
160809807|NCT03307785|580689409|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809808|NCT03307785|580689410|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809809|NCT03307785|580689411|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809810|NCT03307785|580689412|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809811|NCT03307785|580689413|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809812|NCT03307785|580689414|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809813|NCT03307785|580689415|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809814|NCT03307785|580689416|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809815|NCT03307785|580689417|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809816|NCT03307785|580689418|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
160809817|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809818|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809819|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809820|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
160809821|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
160809822|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809823|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809824|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160899488|NCT00694707|581026323|FG001|Overall Study|Adverse Event|14|||
160899489|NCT00694707|581026324|FG002|Overall Study|Adverse Event|8|||
160899490|NCT00694707|581026325|FG003|Overall Study|Adverse Event|12|||
160899491|NCT00694707|581026326|FG004|Overall Study|Adverse Event|13|||
160899492|NCT00694707|581026322|FG000|Overall Study|Insufficient Therapeutic Response|33|||
160899493|NCT00694707|581026323|FG001|Overall Study|Insufficient Therapeutic Response|18|||
160899494|NCT00694707|581026324|FG002|Overall Study|Insufficient Therapeutic Response|17|||
160899495|NCT00694707|581026325|FG003|Overall Study|Insufficient Therapeutic Response|15|||
160899496|NCT00694707|581026326|FG004|Overall Study|Insufficient Therapeutic Response|10|||
160899497|NCT00694707|581026322|FG000|Overall Study|Protocol Violation|1|||
160899498|NCT00694707|581026323|FG001|Overall Study|Protocol Violation|2|||
160899499|NCT00694707|581026324|FG002|Overall Study|Protocol Violation|1|||
160899500|NCT00694707|581026325|FG003|Overall Study|Protocol Violation|3|||
160986107|NCT02412761|581338590|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160986108|NCT02412761|581338591|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160986109|NCT02412761|581338592|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160986110|NCT02412761|581338593|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160986111|NCT01818700|581338594|FG000|Overall Study|Adverse Event|67|||
160899501|NCT00694707|581026326|FG004|Overall Study|Protocol Violation|1|||
160899502|NCT00694707|581026322|FG000|Overall Study|Withdrawal of Consent|14|||
160899503|NCT00694707|581026323|FG001|Overall Study|Withdrawal of Consent|18|||
160986112|NCT01818700|581338594|FG000|Overall Study|Lack of Efficacy|2|||
160986113|NCT01818700|581338594|FG000|Overall Study|Lost to Follow-up|5|||
160986114|NCT01818700|581338594|FG000|Overall Study|Withdrawal by Subject|27|||
160986115|NCT01818700|581338594|FG000|Overall Study|Protocol Violation|2|||
161131097|NCT01078805|581863509|FG000|Overall Study|Clinically significant abnormal lab|5|||
161131098|NCT01078805|581863509|FG000|Overall Study|Death|134|||
161131099|NCT01078805|581863509|FG000|Overall Study|Lost to Follow-up|676|||
161131100|NCT01078805|581863509|FG000|Overall Study|Physician Decision|169|||
161131101|NCT01078805|581863509|FG000|Overall Study|Serious adverse event|26|||
161131102|NCT01078805|581863509|FG000|Overall Study|Sponsor decision|46|||
161131103|NCT01078805|581863509|FG000|Overall Study|Withdrawal by Subject|739|||
161131104|NCT01078805|581863509|FG000|Overall Study|Other|173|||
161131105|NCT01078805|581863509|FG000|Overall Study|Didn't take study drug|82|||
161131106|NCT04722991|581863510|FG000|Overall Study|Adverse Event|12|||
161131107|NCT04722991|581863511|FG001|Overall Study|Adverse Event|4|||
161131108|NCT04722991|581863510|FG000|Overall Study|Death|2|||
161131109|NCT04722991|581863511|FG001|Overall Study|Death|0|||
161131110|NCT04722991|581863510|FG000|Overall Study|Lost to Follow-up|1|||
160809825|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809826|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809827|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809828|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809829|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
160809830|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809831|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809832|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809833|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
160809834|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
160809835|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809836|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809837|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809838|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809839|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809840|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809841|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809842|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
160809843|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809844|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809845|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809846|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
160809847|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809848|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809849|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809850|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809851|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809852|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809853|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809854|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809855|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
160809856|NCT03307785|580689406|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809857|NCT03307785|580689407|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809858|NCT03307785|580689408|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809859|NCT03307785|580689409|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809860|NCT03307785|580689410|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
160809861|NCT03307785|580689411|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809862|NCT03307785|580689412|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809863|NCT03307785|580689413|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809864|NCT03307785|580689414|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809865|NCT03307785|580689415|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809866|NCT03307785|580689416|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809867|NCT03307785|580689417|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809868|NCT03307785|580689418|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
160809869|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809870|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
161131111|NCT04722991|581863511|FG001|Overall Study|Lost to Follow-up|1|||
161131112|NCT04722991|581863510|FG000|Overall Study|Withdrawal cirterion met|2|||
161131113|NCT04722991|581863511|FG001|Overall Study|Withdrawal cirterion met|2|||
161131114|NCT04722991|581863510|FG000|Overall Study|Other|1|||
161238947|NCT02911792|582255833|FG001|Overall Study|Lost to Follow-up|3|||
161238948|NCT02911792|582255834|FG002|Overall Study|Lost to Follow-up|3|||
161238949|NCT02911792|582255835|FG003|Overall Study|Lost to Follow-up|3|||
161238950|NCT00840073|582255838|FG000|Second Intervention|Missed 72 hour blood draw|1|||
160986116|NCT01818700|581338594|FG000|Overall Study|Other|1|||
160986117|NCT02013687|581338597|FG000|Overall Study|Lost to Follow-up|0|||
160986118|NCT02013687|581338598|FG001|Overall Study|Lost to Follow-up|0|||
160986119|NCT02013687|581338599|FG002|Overall Study|Lost to Follow-up|1|||
160986120|NCT02013687|581338600|FG003|Overall Study|Lost to Follow-up|0|||
160986121|NCT02013687|581338597|FG000|Overall Study|Protocol Violation|0|||
160986122|NCT02013687|581338598|FG001|Overall Study|Protocol Violation|0|||
160986123|NCT02013687|581338599|FG002|Overall Study|Protocol Violation|0|||
160986124|NCT02013687|581338600|FG003|Overall Study|Protocol Violation|1|||
160809871|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160986125|NCT02013687|581338597|FG000|Overall Study|Withdrawal by Subject|0|||
160986126|NCT02013687|581338598|FG001|Overall Study|Withdrawal by Subject|0|||
160986127|NCT02013687|581338599|FG002|Overall Study|Withdrawal by Subject|0|||
160986128|NCT02013687|581338600|FG003|Overall Study|Withdrawal by Subject|1|||
160986129|NCT02013687|581338597|FG000|Overall Study|Missed visits due to patient travel|0|||
160986130|NCT02013687|581338598|FG001|Overall Study|Missed visits due to patient travel|0|||
160986131|NCT02013687|581338599|FG002|Overall Study|Missed visits due to patient travel|1|||
160986132|NCT02013687|581338600|FG003|Overall Study|Missed visits due to patient travel|0|||
160986133|NCT01272011|581338601|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
160986134|NCT01272011|581338602|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
160986135|NCT01272011|581338603|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
160986136|NCT01627340|581338604|FG000|Overall Study|Adverse Event|1|||
160986137|NCT01627340|581338605|FG001|Overall Study|Adverse Event|0|||
160986138|NCT01627340|581338604|FG000|Overall Study|Lost to Follow-up|8|||
160986139|NCT01627340|581338605|FG001|Overall Study|Lost to Follow-up|4|||
160986140|NCT01627340|581338604|FG000|Overall Study|Pregnancy|1|||
160986141|NCT01627340|581338605|FG001|Overall Study|Pregnancy|0|||
160986142|NCT01627340|581338604|FG000|Overall Study|Withdrawal by Subject|2|||
160986143|NCT01627340|581338605|FG001|Overall Study|Withdrawal by Subject|0|||
160986144|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
160986145|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
160986146|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
160986147|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
160986148|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
160986149|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
160986150|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
160986151|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
160986152|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
160986153|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
160986154|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
160986155|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
160986156|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
160986157|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
160986158|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
160986159|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
160986160|NCT02240680|581338608|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
160809872|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809873|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809874|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
160809875|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809876|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809877|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809878|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809879|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809880|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160809881|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
160986161|NCT02240680|581338609|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
160809882|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160986162|NCT02240680|581338610|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
160986163|NCT02240680|581338611|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
160986164|NCT02240680|581338608|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
160986165|NCT02240680|581338609|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
160986166|NCT02240680|581338610|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
160986167|NCT02240680|581338611|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
161332853|NCT04414787|582605364|FG003|Overall Study|Residence in post-acute care facility|5|||
160986168|NCT02240680|581338608|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
160986169|NCT02240680|581338609|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
160986170|NCT02240680|581338610|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
160986171|NCT02240680|581338611|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
160986172|NCT02240680|581338608|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
160986173|NCT02240680|581338609|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
160986174|NCT02240680|581338610|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
160986175|NCT02240680|581338611|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
160986176|NCT01657032|581338612|FG000|Overall Study|Lost to Follow-up|0|||
160986177|NCT01657032|581338613|FG001|Overall Study|Lost to Follow-up|7|||
160986178|NCT01782326|581338614|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
160986179|NCT01782326|581338615|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
160986180|NCT01782326|581338614|FG000|Planned Treatment Epoch|Death|29|||
160986181|NCT01782326|581338615|FG001|Planned Treatment Epoch|Death|30|||
160986182|NCT01782326|581338614|FG000|Planned Treatment Epoch|Physician Decision|18|||
160986183|NCT01782326|581338615|FG001|Planned Treatment Epoch|Physician Decision|16|||
160986184|NCT01782326|581338614|FG000|Planned Treatment Epoch|Protocol deviation|2|||
160986185|NCT01782326|581338615|FG001|Planned Treatment Epoch|Protocol deviation|3|||
160986186|NCT01782326|581338614|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
160986187|NCT01782326|581338615|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
160986188|NCT01782326|581338614|FG000|Planned Treatment Epoch|Technical problems|0|||
160986189|NCT01782326|581338615|FG001|Planned Treatment Epoch|Technical problems|4|||
160986190|NCT01782326|581338614|FG000|Double-blind Treatment|Adverse Event|129|||
160986191|NCT01782326|581338615|FG001|Double-blind Treatment|Adverse Event|145|||
160986192|NCT01782326|581338614|FG000|Double-blind Treatment|Subject/guardian decision|111|||
160986193|NCT01782326|581338615|FG001|Double-blind Treatment|Subject/guardian decision|125|||
160986194|NCT01782326|581338614|FG000|Double-blind Treatment|Lack of Efficacy|17|||
160986195|NCT01782326|581338615|FG001|Double-blind Treatment|Lack of Efficacy|22|||
160986196|NCT01782326|581338614|FG000|Double-blind Treatment|Physician Decision|13|||
160986197|NCT01782326|581338615|FG001|Double-blind Treatment|Physician Decision|16|||
160986198|NCT01782326|581338614|FG000|Double-blind Treatment|Protocol deviation|8|||
160986199|NCT01782326|581338615|FG001|Double-blind Treatment|Protocol deviation|7|||
160986200|NCT01782326|581338614|FG000|Double-blind Treatment|Technical problems|0|||
160986201|NCT01782326|581338615|FG001|Double-blind Treatment|Technical problems|5|||
160809883|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809884|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809885|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809886|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809887|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
160809888|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809889|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809890|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809891|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809892|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809893|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809894|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
160809895|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809896|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809897|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809898|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809899|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160986202|NCT03633903|581338616|FG000|Overall Study|Withdrawal by Subject|1|||
160986203|NCT03633903|581338617|FG001|Overall Study|Withdrawal by Subject|2|||
160986204|NCT03633903|581338616|FG000|Overall Study|Lost to Follow-up|5|||
160986205|NCT03633903|581338617|FG001|Overall Study|Lost to Follow-up|5|||
160986206|NCT05968482|581338618|FG000|First Crossover Period|Withdrawal by Subject|0|||
160986207|NCT05968482|581338619|FG001|First Crossover Period|Withdrawal by Subject|0|||
160986208|NCT05968482|581338620|FG002|First Crossover Period|Withdrawal by Subject|1|||
160986209|NCT05968482|581338621|FG003|First Crossover Period|Withdrawal by Subject|0|||
160986210|NCT05968482|581338622|FG004|First Crossover Period|Withdrawal by Subject|0|||
160986211|NCT05968482|581338623|FG005|First Crossover Period|Withdrawal by Subject|0|||
160986212|NCT05968482|581338618|FG000|First Crossover Period|Adverse Event|0|||
160809900|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
160809901|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809902|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160986213|NCT05968482|581338619|FG001|First Crossover Period|Adverse Event|0|||
160986214|NCT05968482|581338620|FG002|First Crossover Period|Adverse Event|0|||
160986215|NCT05968482|581338621|FG003|First Crossover Period|Adverse Event|0|||
160986216|NCT05968482|581338622|FG004|First Crossover Period|Adverse Event|0|||
160986217|NCT05968482|581338623|FG005|First Crossover Period|Adverse Event|1|||
160986218|NCT05968482|581338618|FG000|Second Crossover Period|Withdrawal by Subject|0|||
160986219|NCT05968482|581338619|FG001|Second Crossover Period|Withdrawal by Subject|0|||
160986220|NCT05968482|581338620|FG002|Second Crossover Period|Withdrawal by Subject|0|||
160986221|NCT05968482|581338621|FG003|Second Crossover Period|Withdrawal by Subject|0|||
160809903|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809904|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809905|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809906|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809907|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
160809908|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809909|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809910|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809911|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809912|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809913|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
160809914|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809915|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809916|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809917|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809918|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809919|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809920|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
160809921|NCT03307785|580689406|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809922|NCT03307785|580689407|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809923|NCT03307785|580689408|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809924|NCT03307785|580689409|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809925|NCT03307785|580689410|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809926|NCT03307785|580689411|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
160809927|NCT03307785|580689412|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809928|NCT03307785|580689413|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809929|NCT03307785|580689414|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809930|NCT03307785|580689415|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809931|NCT03307785|580689416|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809932|NCT03307785|580689417|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809933|NCT03307785|580689418|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
160809934|NCT03307785|580689406|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809935|NCT03307785|580689407|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809936|NCT03307785|580689408|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809937|NCT03307785|580689409|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809938|NCT03307785|580689410|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809939|NCT03307785|580689411|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809940|NCT03307785|580689412|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
160809941|NCT03307785|580689413|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809942|NCT03307785|580689414|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809943|NCT03307785|580689415|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809944|NCT03307785|580689416|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809945|NCT03307785|580689417|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809946|NCT03307785|580689418|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
160809947|NCT03307785|580689406|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809948|NCT03307785|580689407|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809949|NCT03307785|580689408|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809950|NCT03307785|580689409|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809951|NCT03307785|580689410|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809952|NCT03307785|580689411|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809953|NCT03307785|580689412|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
160809954|NCT03307785|580689413|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809955|NCT03307785|580689414|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809956|NCT03307785|580689415|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809957|NCT03307785|580689416|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160899504|NCT00694707|581026324|FG002|Overall Study|Withdrawal of Consent|22|||
160899505|NCT00694707|581026325|FG003|Overall Study|Withdrawal of Consent|16|||
160899506|NCT00694707|581026326|FG004|Overall Study|Withdrawal of Consent|15|||
160899507|NCT00694707|581026322|FG000|Overall Study|Lost to Follow-up|0|||
160899508|NCT00694707|581026323|FG001|Overall Study|Lost to Follow-up|1|||
160899509|NCT00694707|581026324|FG002|Overall Study|Lost to Follow-up|2|||
160899510|NCT00694707|581026325|FG003|Overall Study|Lost to Follow-up|0|||
160899511|NCT00694707|581026326|FG004|Overall Study|Lost to Follow-up|0|||
160899512|NCT00694707|581026322|FG000|Overall Study|Jeopardizing Parole Status|1|||
160809958|NCT03307785|580689417|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809959|NCT03307785|580689418|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
160809960|NCT03307785|580689406|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809961|NCT03307785|580689407|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160986222|NCT05968482|581338622|FG004|Second Crossover Period|Withdrawal by Subject|1|||
160986223|NCT05968482|581338623|FG005|Second Crossover Period|Withdrawal by Subject|0|||
160986224|NCT05968482|581338618|FG000|Third Crossover Period|Adverse Event|0|||
160986225|NCT05968482|581338619|FG001|Third Crossover Period|Adverse Event|0|||
160986226|NCT05968482|581338620|FG002|Third Crossover Period|Adverse Event|0|||
160986227|NCT05968482|581338621|FG003|Third Crossover Period|Adverse Event|0|||
160986228|NCT05968482|581338622|FG004|Third Crossover Period|Adverse Event|1|||
160986229|NCT05968482|581338623|FG005|Third Crossover Period|Adverse Event|0|||
160809962|NCT03307785|580689408|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809963|NCT03307785|580689409|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809964|NCT03307785|580689410|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809965|NCT03307785|580689411|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809966|NCT03307785|580689412|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809967|NCT03307785|580689413|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
160809968|NCT03307785|580689414|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809969|NCT03307785|580689415|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809970|NCT03307785|580689416|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809971|NCT03307785|580689417|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809972|NCT03307785|580689418|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
160809973|NCT03307785|580689406|FG000|PACT Phase: Up to 19 Months|Death|0|||
160809974|NCT03307785|580689407|FG001|PACT Phase: Up to 19 Months|Death|0|||
160809975|NCT03307785|580689408|FG002|PACT Phase: Up to 19 Months|Death|0|||
160809976|NCT03307785|580689409|FG003|PACT Phase: Up to 19 Months|Death|0|||
160809977|NCT03307785|580689410|FG004|PACT Phase: Up to 19 Months|Death|0|||
160809978|NCT03307785|580689411|FG005|PACT Phase: Up to 19 Months|Death|0|||
160809979|NCT03307785|580689412|FG006|PACT Phase: Up to 19 Months|Death|0|||
160809980|NCT03307785|580689413|FG007|PACT Phase: Up to 19 Months|Death|0|||
160809981|NCT03307785|580689414|FG008|PACT Phase: Up to 19 Months|Death|0|||
160809982|NCT03307785|580689415|FG009|PACT Phase: Up to 19 Months|Death|0|||
160809983|NCT03307785|580689416|FG010|PACT Phase: Up to 19 Months|Death|0|||
160809984|NCT03307785|580689417|FG011|PACT Phase: Up to 19 Months|Death|0|||
160809985|NCT03307785|580689418|FG012|PACT Phase: Up to 19 Months|Death|1|||
160809986|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809987|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
160809988|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
160809989|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809990|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809991|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
160809992|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Other|0|||
160809993|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Other|1|||
160809994|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Other|1|||
160809995|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Other|0|||
160899513|NCT00694707|581026323|FG001|Overall Study|Jeopardizing Parole Status|0|||
160899514|NCT00694707|581026324|FG002|Overall Study|Jeopardizing Parole Status|0|||
160899515|NCT00694707|581026325|FG003|Overall Study|Jeopardizing Parole Status|0|||
160899516|NCT00694707|581026326|FG004|Overall Study|Jeopardizing Parole Status|0|||
160899517|NCT00694707|581026322|FG000|Overall Study|Death in the Family|1|||
160899518|NCT00694707|581026323|FG001|Overall Study|Death in the Family|0|||
160899519|NCT00694707|581026324|FG002|Overall Study|Death in the Family|0|||
160899520|NCT00694707|581026325|FG003|Overall Study|Death in the Family|0|||
160899521|NCT00694707|581026326|FG004|Overall Study|Death in the Family|0|||
160986230|NCT05968482|581338618|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
160986231|NCT05968482|581338619|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
160986232|NCT05968482|581338620|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
160986233|NCT05968482|581338621|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
160986234|NCT05968482|581338622|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
160986235|NCT05968482|581338623|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
160809996|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Other|0|||
160809997|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Other|0|||
160809998|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
160809999|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
160810000|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
160899522|NCT00694707|581026322|FG000|Overall Study|Arrest by Police|0|||
160899523|NCT00694707|581026323|FG001|Overall Study|Arrest by Police|1|||
160986236|NCT02559817|581338630|FG000|Treatment Period|Adverse Event|1|||
160810001|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
160810002|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
160810003|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
160899524|NCT00694707|581026324|FG002|Overall Study|Arrest by Police|0|||
160986237|NCT02559817|581338631|FG001|Treatment Period|Adverse Event|0|||
160986238|NCT02559817|581338632|FG002|Treatment Period|Adverse Event|1|||
160986239|NCT02559817|581338633|FG003|Treatment Period|Adverse Event|0|||
161131115|NCT04722991|581863511|FG001|Overall Study|Other|0|||
161131116|NCT04722991|581863510|FG000|Overall Study|Non-compliance|0|||
161131117|NCT04722991|581863511|FG001|Overall Study|Non-compliance|1|||
161131118|NCT04722991|581863510|FG000|Overall Study|Withdrawal by Subject|0|||
161131119|NCT04722991|581863511|FG001|Overall Study|Withdrawal by Subject|1|||
161131120|NCT03186989|581863512|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131121|NCT03186989|581863513|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131122|NCT03186989|581863514|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161131123|NCT03186989|581863515|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161131124|NCT03186989|581863516|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
161131125|NCT03186989|581863517|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131126|NCT03186989|581863518|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131127|NCT03186989|581863519|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131128|NCT03186989|581863520|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131129|NCT03186989|581863521|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131130|NCT03186989|581863522|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
161131131|NCT03186989|581863512|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131132|NCT03186989|581863513|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131133|NCT03186989|581863514|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131134|NCT03186989|581863515|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131135|NCT03186989|581863516|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160810004|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
160986240|NCT02559817|581338634|FG004|Treatment Period|Adverse Event|0|||
160986241|NCT02559817|581338630|FG000|Treatment Period|Lack of Efficacy|0|||
160986242|NCT02559817|581338631|FG001|Treatment Period|Lack of Efficacy|1|||
160986243|NCT02559817|581338632|FG002|Treatment Period|Lack of Efficacy|0|||
160986244|NCT02559817|581338633|FG003|Treatment Period|Lack of Efficacy|0|||
160986245|NCT02559817|581338634|FG004|Treatment Period|Lack of Efficacy|0|||
160986246|NCT02559817|581338630|FG000|Treatment Period|Lost to Follow-up|0|||
160986247|NCT02559817|581338631|FG001|Treatment Period|Lost to Follow-up|1|||
160986248|NCT02559817|581338632|FG002|Treatment Period|Lost to Follow-up|0|||
160986249|NCT02559817|581338633|FG003|Treatment Period|Lost to Follow-up|1|||
160986250|NCT02559817|581338634|FG004|Treatment Period|Lost to Follow-up|0|||
160986251|NCT02559817|581338630|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
160986252|NCT02559817|581338631|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
160986253|NCT02559817|581338632|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
160986254|NCT02559817|581338633|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
160986255|NCT02559817|581338634|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
160986256|NCT02559817|581338630|FG000|Treatment Period|Protocol Violation|0|||
160986257|NCT02559817|581338631|FG001|Treatment Period|Protocol Violation|0|||
160986258|NCT02559817|581338632|FG002|Treatment Period|Protocol Violation|0|||
160986259|NCT02559817|581338633|FG003|Treatment Period|Protocol Violation|1|||
160986260|NCT02559817|581338634|FG004|Treatment Period|Protocol Violation|0|||
160986261|NCT02303574|581338639|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986262|NCT02303574|581338640|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986263|NCT02303574|581338641|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
160986264|NCT02303574|581338642|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986265|NCT02303574|581338643|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986266|NCT02303574|581338644|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986267|NCT02303574|581338645|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986268|NCT02303574|581338646|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986269|NCT02303574|581338647|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986270|NCT02303574|581338648|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
160986271|NCT02303574|581338639|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986272|NCT02303574|581338640|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986273|NCT02303574|581338641|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160810005|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
160986274|NCT02303574|581338642|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986275|NCT02303574|581338643|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986276|NCT02303574|581338644|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986277|NCT02303574|581338645|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986278|NCT02303574|581338646|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
160986279|NCT02303574|581338647|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
160986280|NCT02303574|581338648|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
161131136|NCT03186989|581863517|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
161131137|NCT03186989|581863518|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131138|NCT03186989|581863519|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131139|NCT03186989|581863520|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
160810006|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
160810007|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
160810008|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
160810009|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
160810010|NCT03666988|580689419|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
160810011|NCT03666988|580689420|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810012|NCT03666988|580689421|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810013|NCT03666988|580689422|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810014|NCT03666988|580689423|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810015|NCT03666988|580689424|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
160810016|NCT02517398|580689425|FG000|Overall Study|Death|2|||
160810017|NCT02517398|580689426|FG001|Overall Study|Death|3|||
160810018|NCT02517398|580689427|FG002|Overall Study|Death|4|||
160810019|NCT02517398|580689428|FG003|Overall Study|Death|2|||
160810020|NCT02517398|580689429|FG004|Overall Study|Death|3|||
160810021|NCT02517398|580689430|FG005|Overall Study|Death|8|||
160810022|NCT02517398|580689431|FG006|Overall Study|Death|3|||
160810023|NCT02517398|580689432|FG007|Overall Study|Death|2|||
160810024|NCT02517398|580689433|FG008|Overall Study|Death|6|||
160810025|NCT02517398|580689434|FG009|Overall Study|Death|24|||
160810026|NCT02517398|580689435|FG010|Overall Study|Death|53|||
160810027|NCT02517398|580689436|FG011|Overall Study|Death|25|||
160810028|NCT02517398|580689437|FG012|Overall Study|Death|73|||
160810029|NCT02517398|580689438|FG013|Overall Study|Death|29|||
160810030|NCT02517398|580689439|FG014|Overall Study|Death|26|||
160810031|NCT02517398|580689440|FG015|Overall Study|Death|23|||
160810032|NCT02517398|580689441|FG016|Overall Study|Death|26|||
160810033|NCT02517398|580689442|FG017|Overall Study|Death|25|||
160810034|NCT02517398|580689443|FG018|Overall Study|Death|22|||
160810035|NCT02517398|580689444|FG019|Overall Study|Death|7|||
160899525|NCT00694707|581026325|FG003|Overall Study|Arrest by Police|0|||
160899526|NCT00694707|581026326|FG004|Overall Study|Arrest by Police|0|||
160899527|NCT00694707|581026322|FG000|Overall Study|Administrative Reasons|0|||
160899528|NCT00694707|581026323|FG001|Overall Study|Administrative Reasons|1|||
160899529|NCT00694707|581026324|FG002|Overall Study|Administrative Reasons|0|||
160899530|NCT00694707|581026325|FG003|Overall Study|Administrative Reasons|2|||
160899531|NCT00694707|581026326|FG004|Overall Study|Administrative Reasons|0|||
160899532|NCT00694707|581026322|FG000|Overall Study|Notification of Past Head Injury|0|||
160899533|NCT00694707|581026323|FG001|Overall Study|Notification of Past Head Injury|0|||
160899534|NCT00694707|581026324|FG002|Overall Study|Notification of Past Head Injury|0|||
160899535|NCT00694707|581026325|FG003|Overall Study|Notification of Past Head Injury|1|||
160899536|NCT00694707|581026326|FG004|Overall Study|Notification of Past Head Injury|0|||
160899537|NCT01696695|581026327|FG000|Overall Study|Disease progression|373|||
160899538|NCT01696695|581026327|FG000|Overall Study|Death|29|||
160899539|NCT01696695|581026327|FG000|Overall Study|Adverse Event|74|||
160899540|NCT01696695|581026327|FG000|Overall Study|Withdrawal by Subject|92|||
160899541|NCT01696695|581026327|FG000|Overall Study|Lost to Follow-up|48|||
160899542|NCT01696695|581026327|FG000|Overall Study|Other|74|||
160899543|NCT01696695|581026327|FG000|Overall Study|Major Protocol Violation|192|||
160899544|NCT01904058|581026334|FG000|Overall Study|Adverse Event|2|||
160899545|NCT01904058|581026335|FG001|Overall Study|Adverse Event|0|||
160899546|NCT01904058|581026336|FG002|Overall Study|Adverse Event|0|||
160899547|NCT01904058|581026337|FG003|Overall Study|Adverse Event|0|||
160899548|NCT01904058|581026334|FG000|Overall Study|Withdrawal by Subject|1|||
160899549|NCT01904058|581026335|FG001|Overall Study|Withdrawal by Subject|0|||
160899550|NCT01904058|581026336|FG002|Overall Study|Withdrawal by Subject|1|||
160899551|NCT01904058|581026337|FG003|Overall Study|Withdrawal by Subject|0|||
160899552|NCT01904058|581026334|FG000|Overall Study|Pregnancy|0|||
160899553|NCT01904058|581026335|FG001|Overall Study|Pregnancy|0|||
160899554|NCT01904058|581026336|FG002|Overall Study|Pregnancy|0|||
160899555|NCT01904058|581026337|FG003|Overall Study|Pregnancy|1|||
160899556|NCT03096483|581026341|FG000|Overall Study|Withdrawal by site|1|||
160899557|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
160899558|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
160810036|NCT02517398|580689445|FG020|Overall Study|Death|26|||
160810037|NCT02517398|580689446|FG021|Overall Study|Death|30|||
160810038|NCT02517398|580689447|FG022|Overall Study|Death|20|||
160810039|NCT02517398|580689425|FG000|Overall Study|Other|0|||
160810040|NCT02517398|580689426|FG001|Overall Study|Other|0|||
160810041|NCT02517398|580689427|FG002|Overall Study|Other|0|||
160810042|NCT02517398|580689428|FG003|Overall Study|Other|1|||
160810043|NCT02517398|580689429|FG004|Overall Study|Other|0|||
160810044|NCT02517398|580689430|FG005|Overall Study|Other|0|||
160810045|NCT02517398|580689431|FG006|Overall Study|Other|0|||
160810046|NCT02517398|580689432|FG007|Overall Study|Other|0|||
160810047|NCT02517398|580689433|FG008|Overall Study|Other|0|||
160899559|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
160899560|NCT00369707|581026342|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
160899561|NCT00369707|581026342|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
161131140|NCT03186989|581863521|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131141|NCT03186989|581863522|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
161131142|NCT03186989|581863512|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131143|NCT03186989|581863513|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131144|NCT03186989|581863514|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131145|NCT03186989|581863515|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131146|NCT03186989|581863516|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131147|NCT03186989|581863517|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131148|NCT03186989|581863518|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
161131149|NCT03186989|581863519|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131150|NCT03186989|581863520|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161238951|NCT00840073|582255839|FG001|Second Intervention|Missed 72 hour blood draw|1|||
161238952|NCT02558491|582255840|FG000|First Invention|Withdrawal by Subject|3|||
161238953|NCT02558491|582255841|FG001|First Invention|Withdrawal by Subject|1|||
161238954|NCT02558491|582255840|FG000|First Invention|Data collection issues|1|||
161131151|NCT03186989|581863521|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131152|NCT03186989|581863522|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
161131153|NCT03186989|581863512|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131154|NCT03186989|581863513|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131155|NCT03186989|581863514|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131156|NCT03186989|581863515|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131157|NCT03186989|581863516|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131158|NCT03186989|581863517|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161131159|NCT03186989|581863518|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161131160|NCT03186989|581863519|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131161|NCT03186989|581863520|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
161131162|NCT03186989|581863521|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161238955|NCT02558491|582255841|FG001|First Invention|Data collection issues|0|||
161238956|NCT02558491|582255840|FG000|First Invention|Stopping criteria|0|||
161238957|NCT02558491|582255841|FG001|First Invention|Stopping criteria|1|||
161238958|NCT02558491|582255840|FG000|First Invention|Changed parameters during trial|1|||
161238959|NCT02558491|582255841|FG001|First Invention|Changed parameters during trial|0|||
161238960|NCT02558491|582255840|FG000|Second Intervention|Withdrawal by Subject|1|||
161238961|NCT02558491|582255841|FG001|Second Intervention|Withdrawal by Subject|0|||
161238962|NCT02558491|582255840|FG000|Second Intervention|Stopping Criteria|1|||
161238963|NCT02558491|582255841|FG001|Second Intervention|Stopping Criteria|0|||
161238964|NCT00107991|582255842|FG000|Eligibility Assessment|Disease not severe enough|7|||
161238965|NCT00107991|582255842|FG000|Eligibility Assessment|Unwilling to participate|7|||
161238966|NCT00107991|582255842|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
161238967|NCT00107991|582255842|FG000|Eligibility Assessment|Abnormal labs|2|||
161238968|NCT00107991|582255842|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
161238969|NCT00107991|582255842|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
161238970|NCT00107991|582255842|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
161238971|NCT00107991|582255842|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
161238972|NCT00107991|582255842|FG000|12 Week Treatment Period|Adverse Event|1|||
161238973|NCT00107991|582255842|FG000|12 Week Treatment Period|Protocol Violation|1|||
161238974|NCT00107991|582255842|FG000|12 Week Treatment Period|Incarcerated|1|||
161238975|NCT00107991|582255842|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
161238976|NCT03669861|582255843|FG000|Overall Study|Disease Flare|5|||
161238977|NCT03669861|582255843|FG000|Overall Study|Lack of Efficacy|2|||
161238978|NCT02760927|582255844|FG000|Overall Study|Tube Slippage from Device|1|||
161238979|NCT00705666|582255845|FG000|Overall Study|No post-treatment questionnaire|279|||
161238980|NCT00705666|582255845|FG000|Overall Study|Withdrawal by Subject|21|||
161238981|NCT00705666|582255845|FG000|Overall Study|Physician Decision|7|||
161238982|NCT00705666|582255845|FG000|Overall Study|Lost to Follow-up|5|||
161238983|NCT00705666|582255845|FG000|Overall Study|Death|1|||
161238984|NCT00705666|582255845|FG000|Overall Study|Adverse Event|4|||
161238985|NCT00705666|582255845|FG000|Overall Study|Other|12|||
161238986|NCT00705666|582255845|FG000|Overall Study|Other|2|||
161238987|NCT00705666|582255845|FG000|Overall Study|Lack of data|3|||
161238988|NCT00705666|582255845|FG000|Overall Study|Untreated|5|||
161238989|NCT02964039|582255847|FG000|Overall Study|Medical reason unrelated to study participation|1|||
161238990|NCT02964039|582255848|FG001|Overall Study|Medical reason unrelated to study participation|0|||
161238991|NCT02964039|582255849|FG002|Overall Study|Medical reason unrelated to study participation|3|||
161238992|NCT02964039|582255847|FG000|Overall Study|Research shutdown due to pandemic|2|||
161238993|NCT02964039|582255848|FG001|Overall Study|Research shutdown due to pandemic|0|||
161238994|NCT02964039|582255849|FG002|Overall Study|Research shutdown due to pandemic|1|||
161238995|NCT02964039|582255847|FG000|Overall Study|Withdrawal by Subject|0|||
160986281|NCT00994279|581338653|FG000|Overall Study|Withdrawal by Subject|2|||
160986282|NCT00994279|581338654|FG001|Overall Study|Withdrawal by Subject|2|||
160986283|NCT00994279|581338653|FG000|Overall Study|Toxicity|1|||
160986284|NCT00994279|581338654|FG001|Overall Study|Toxicity|0|||
160986285|NCT00994279|581338653|FG000|Overall Study|Multiple reasons|1|||
160986286|NCT00994279|581338654|FG001|Overall Study|Multiple reasons|3|||
160986287|NCT01606189|581338655|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986288|NCT01606189|581338656|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986289|NCT01606189|581338657|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986290|NCT01606189|581338658|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
160986291|NCT01606189|581338659|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
161238996|NCT02964039|582255848|FG001|Overall Study|Withdrawal by Subject|1|||
161238997|NCT02964039|582255849|FG002|Overall Study|Withdrawal by Subject|0|||
161238998|NCT02964039|582255847|FG000|Overall Study|Lost to Follow-up|1|||
161238999|NCT02964039|582255848|FG001|Overall Study|Lost to Follow-up|0|||
161239000|NCT02964039|582255849|FG002|Overall Study|Lost to Follow-up|1|||
161239001|NCT03552393|582255852|FG000|Core Period|Kidney Transplant|1|||
161239002|NCT03552393|582255852|FG000|Core Period|Prohibited Medication|1|||
161239003|NCT03552393|582255852|FG000|Safety Extension Period|Kidney Transplant|4|||
161239004|NCT01576042|582255856|FG000|Overall Study|Physician Decision|2|||
161239005|NCT01576042|582255857|FG001|Overall Study|Physician Decision|0|||
161239006|NCT00465270|582255858|FG000|Overall Study|Death|7|||
161239007|NCT00465270|582255859|FG001|Overall Study|Death|11|||
160810048|NCT02517398|580689434|FG009|Overall Study|Other|1|||
160810049|NCT02517398|580689435|FG010|Overall Study|Other|0|||
160810050|NCT02517398|580689436|FG011|Overall Study|Other|0|||
160810051|NCT02517398|580689437|FG012|Overall Study|Other|0|||
160810052|NCT02517398|580689438|FG013|Overall Study|Other|1|||
160810053|NCT02517398|580689439|FG014|Overall Study|Other|0|||
160810054|NCT02517398|580689440|FG015|Overall Study|Other|1|||
160810055|NCT02517398|580689441|FG016|Overall Study|Other|1|||
160810056|NCT02517398|580689442|FG017|Overall Study|Other|0|||
160810057|NCT02517398|580689443|FG018|Overall Study|Other|0|||
160810058|NCT02517398|580689444|FG019|Overall Study|Other|1|||
160810059|NCT02517398|580689445|FG020|Overall Study|Other|0|||
160810060|NCT02517398|580689446|FG021|Overall Study|Other|0|||
160810061|NCT02517398|580689447|FG022|Overall Study|Other|0|||
160810062|NCT02517398|580689425|FG000|Overall Study|Lost to Follow-up|0|||
160810063|NCT02517398|580689426|FG001|Overall Study|Lost to Follow-up|0|||
160810064|NCT02517398|580689427|FG002|Overall Study|Lost to Follow-up|0|||
160810065|NCT02517398|580689428|FG003|Overall Study|Lost to Follow-up|0|||
160810066|NCT02517398|580689429|FG004|Overall Study|Lost to Follow-up|0|||
160810067|NCT02517398|580689430|FG005|Overall Study|Lost to Follow-up|0|||
160810068|NCT02517398|580689431|FG006|Overall Study|Lost to Follow-up|0|||
160810069|NCT02517398|580689432|FG007|Overall Study|Lost to Follow-up|0|||
160810070|NCT02517398|580689433|FG008|Overall Study|Lost to Follow-up|0|||
160899562|NCT00369707|581026342|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
160899563|NCT00369707|581026342|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
160899564|NCT00369707|581026342|FG000|Follow up for 2 Years After Treatment|Death|1|||
160899565|NCT00369707|581026342|FG000|Follow up for 2 Years After Treatment|Other|2|||
160899566|NCT02046733|581026343|FG000|Overall Study|never initiated 'treatment visits'|6|||
160899567|NCT02046733|581026344|FG001|Overall Study|never initiated 'treatment visits'|0|||
160899568|NCT04515394|581026346|FG000|Overall Study|Participant did not receive treatment|1|||
160899569|NCT00199875|581026347|FG000|Overall Study|Withdrawal by Subject|0|||
160899570|NCT00199875|581026348|FG001|Overall Study|Withdrawal by Subject|0|||
160899571|NCT00199875|581026349|FG002|Overall Study|Withdrawal by Subject|0|||
160899572|NCT00199875|581026350|FG003|Overall Study|Withdrawal by Subject|0|||
160899573|NCT00199875|581026351|FG004|Overall Study|Withdrawal by Subject|1|||
160899574|NCT01024231|581026353|FG000|Overall Study|Other Reasons|1|||
160899575|NCT01024231|581026354|FG001|Overall Study|Other Reasons|2|||
160899576|NCT01024231|581026355|FG002|Overall Study|Other Reasons|0|||
160899577|NCT01024231|581026356|FG003|Overall Study|Other Reasons|0|||
160899578|NCT01024231|581026357|FG004|Overall Study|Other Reasons|2|||
160899579|NCT01024231|581026358|FG005|Overall Study|Other Reasons|0|||
160899580|NCT01024231|581026359|FG006|Overall Study|Other Reasons|1|||
160899581|NCT01024231|581026353|FG000|Overall Study|Maximum Clinical Benefit|1|||
160899582|NCT01024231|581026354|FG001|Overall Study|Maximum Clinical Benefit|2|||
160899583|NCT01024231|581026355|FG002|Overall Study|Maximum Clinical Benefit|0|||
160899584|NCT01024231|581026356|FG003|Overall Study|Maximum Clinical Benefit|1|||
160899585|NCT01024231|581026357|FG004|Overall Study|Maximum Clinical Benefit|1|||
160899586|NCT01024231|581026358|FG005|Overall Study|Maximum Clinical Benefit|0|||
160986292|NCT01606189|581338660|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
161239008|NCT00465270|582255858|FG000|Overall Study|Withdrawal by Subject|34|||
160810071|NCT02517398|580689434|FG009|Overall Study|Lost to Follow-up|1|||
160810072|NCT02517398|580689435|FG010|Overall Study|Lost to Follow-up|0|||
160810073|NCT02517398|580689436|FG011|Overall Study|Lost to Follow-up|2|||
160810074|NCT02517398|580689437|FG012|Overall Study|Lost to Follow-up|2|||
160810075|NCT02517398|580689438|FG013|Overall Study|Lost to Follow-up|0|||
160810076|NCT02517398|580689439|FG014|Overall Study|Lost to Follow-up|1|||
160810077|NCT02517398|580689440|FG015|Overall Study|Lost to Follow-up|1|||
160810078|NCT02517398|580689441|FG016|Overall Study|Lost to Follow-up|0|||
160810079|NCT02517398|580689442|FG017|Overall Study|Lost to Follow-up|3|||
160810080|NCT02517398|580689443|FG018|Overall Study|Lost to Follow-up|1|||
160810081|NCT02517398|580689444|FG019|Overall Study|Lost to Follow-up|0|||
160810082|NCT02517398|580689445|FG020|Overall Study|Lost to Follow-up|1|||
160899587|NCT01024231|581026359|FG006|Overall Study|Maximum Clinical Benefit|0|||
160899588|NCT01024231|581026353|FG000|Overall Study|Disease Progression|3|||
160899589|NCT01024231|581026354|FG001|Overall Study|Disease Progression|1|||
160899590|NCT01024231|581026355|FG002|Overall Study|Disease Progression|3|||
160810083|NCT02517398|580689446|FG021|Overall Study|Lost to Follow-up|0|||
160899591|NCT01024231|581026356|FG003|Overall Study|Disease Progression|0|||
160899592|NCT01024231|581026357|FG004|Overall Study|Disease Progression|4|||
160899593|NCT01024231|581026358|FG005|Overall Study|Disease Progression|11|||
160810084|NCT02517398|580689447|FG022|Overall Study|Lost to Follow-up|2|||
160810085|NCT02517398|580689425|FG000|Overall Study|Withdrew Consent|0|||
160810086|NCT02517398|580689426|FG001|Overall Study|Withdrew Consent|0|||
160810087|NCT02517398|580689427|FG002|Overall Study|Withdrew Consent|0|||
160810088|NCT02517398|580689428|FG003|Overall Study|Withdrew Consent|0|||
160810089|NCT02517398|580689429|FG004|Overall Study|Withdrew Consent|0|||
160810090|NCT02517398|580689430|FG005|Overall Study|Withdrew Consent|0|||
160810091|NCT02517398|580689431|FG006|Overall Study|Withdrew Consent|1|||
160810092|NCT02517398|580689432|FG007|Overall Study|Withdrew Consent|0|||
160810093|NCT02517398|580689433|FG008|Overall Study|Withdrew Consent|0|||
160810094|NCT02517398|580689434|FG009|Overall Study|Withdrew Consent|2|||
160810095|NCT02517398|580689435|FG010|Overall Study|Withdrew Consent|7|||
160810096|NCT02517398|580689436|FG011|Overall Study|Withdrew Consent|1|||
160810097|NCT02517398|580689437|FG012|Overall Study|Withdrew Consent|5|||
160810098|NCT02517398|580689438|FG013|Overall Study|Withdrew Consent|4|||
160810099|NCT02517398|580689439|FG014|Overall Study|Withdrew Consent|2|||
160810100|NCT02517398|580689440|FG015|Overall Study|Withdrew Consent|5|||
160986293|NCT01606189|581338655|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986294|NCT01606189|581338656|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986295|NCT01606189|581338657|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986296|NCT01606189|581338658|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986297|NCT01606189|581338659|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
160986298|NCT01606189|581338660|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
160986299|NCT00859014|581338661|FG000|Overall Study|Death|4|||
160986300|NCT00859014|581338661|FG000|Overall Study|Lost to Follow-up|1|||
160986301|NCT04796935|581338662|FG000|Overall Study|Withdrawal by Subject|0|||
160986302|NCT04796935|581338663|FG001|Overall Study|Withdrawal by Subject|1|||
160986303|NCT04796935|581338662|FG000|Overall Study|Physician Decision|0|||
160986304|NCT04796935|581338663|FG001|Overall Study|Physician Decision|1|||
160986305|NCT04796935|581338662|FG000|Overall Study|Device not available|1|||
160986306|NCT04796935|581338663|FG001|Overall Study|Device not available|0|||
160986307|NCT04796935|581338662|FG000|Overall Study|Trained provider not available|1|||
160986308|NCT04796935|581338663|FG001|Overall Study|Trained provider not available|0|||
160986309|NCT04640571|581338664|FG000|Overall Study|Withdrawal by Subject|0|||
160986310|NCT04640571|581338665|FG001|Overall Study|Withdrawal by Subject|0|||
160986311|NCT04640571|581338666|FG002|Overall Study|Withdrawal by Subject|0|||
160986312|NCT04640571|581338667|FG003|Overall Study|Withdrawal by Subject|0|||
160986313|NCT04640571|581338668|FG004|Overall Study|Withdrawal by Subject|0|||
160986314|NCT04640571|581338669|FG005|Overall Study|Withdrawal by Subject|2|||
160986315|NCT03658811|581338672|FG000|Overall Study|Lost to Follow-up|3|||
161239009|NCT00465270|582255859|FG001|Overall Study|Withdrawal by Subject|78|||
160899594|NCT01024231|581026359|FG006|Overall Study|Disease Progression|6|||
160899595|NCT01024231|581026353|FG000|Overall Study|AE unrelated to Study Drug|0|||
160899596|NCT01024231|581026354|FG001|Overall Study|AE unrelated to Study Drug|1|||
160899597|NCT01024231|581026355|FG002|Overall Study|AE unrelated to Study Drug|0|||
160899598|NCT01024231|581026356|FG003|Overall Study|AE unrelated to Study Drug|0|||
160899599|NCT01024231|581026357|FG004|Overall Study|AE unrelated to Study Drug|0|||
160899600|NCT01024231|581026358|FG005|Overall Study|AE unrelated to Study Drug|0|||
160899601|NCT01024231|581026359|FG006|Overall Study|AE unrelated to Study Drug|0|||
160899602|NCT01024231|581026353|FG000|Overall Study|No longer meets criteria|0|||
160899603|NCT01024231|581026354|FG001|Overall Study|No longer meets criteria|0|||
160899604|NCT01024231|581026355|FG002|Overall Study|No longer meets criteria|0|||
160899605|NCT01024231|581026356|FG003|Overall Study|No longer meets criteria|0|||
160899606|NCT01024231|581026357|FG004|Overall Study|No longer meets criteria|1|||
160899607|NCT01024231|581026358|FG005|Overall Study|No longer meets criteria|0|||
160986316|NCT04060680|581338674|FG000|Overall Study|Unsuccessful implant|17|||
160810101|NCT02517398|580689441|FG016|Overall Study|Withdrew Consent|4|||
160810102|NCT02517398|580689442|FG017|Overall Study|Withdrew Consent|2|||
160810103|NCT02517398|580689443|FG018|Overall Study|Withdrew Consent|3|||
160810104|NCT02517398|580689444|FG019|Overall Study|Withdrew Consent|2|||
160810105|NCT02517398|580689445|FG020|Overall Study|Withdrew Consent|9|||
160810106|NCT02517398|580689446|FG021|Overall Study|Withdrew Consent|3|||
160810107|NCT02517398|580689447|FG022|Overall Study|Withdrew Consent|1|||
160810108|NCT05588440|580689458|FG000|Overall Study|Sponsor Decision|2|||
160810109|NCT05588440|580689459|FG001|Overall Study|Sponsor Decision|0|||
160810110|NCT05588440|580689460|FG002|Overall Study|Sponsor Decision|1|||
160810111|NCT05588440|580689458|FG000|Overall Study|Death|1|||
160810112|NCT05588440|580689459|FG001|Overall Study|Death|1|||
160810113|NCT05588440|580689460|FG002|Overall Study|Death|1|||
160810114|NCT05588440|580689458|FG000|Overall Study|Screen Fail|0|||
160810115|NCT05588440|580689459|FG001|Overall Study|Screen Fail|1|||
160810116|NCT05588440|580689460|FG002|Overall Study|Screen Fail|1|||
160810117|NCT05588440|580689458|FG000|Overall Study|Withdrawal by Subject|0|||
160810118|NCT05588440|580689459|FG001|Overall Study|Withdrawal by Subject|0|||
160810119|NCT05588440|580689460|FG002|Overall Study|Withdrawal by Subject|1|||
160810120|NCT01154452|580689461|FG000|Phase Ib|Not Treated|1|||
160810121|NCT01154452|580689462|FG001|Phase Ib|Not Treated|0|||
160810122|NCT01154452|580689463|FG002|Phase Ib|Not Treated|0|||
160810123|NCT01154452|580689464|FG003|Phase Ib|Not Treated|0|||
160810124|NCT01154452|580689461|FG000|Phase Ib|Adverse Event|2|||
160810125|NCT01154452|580689462|FG001|Phase Ib|Adverse Event|1|||
160810126|NCT01154452|580689463|FG002|Phase Ib|Adverse Event|0|||
160810127|NCT01154452|580689464|FG003|Phase Ib|Adverse Event|0|||
160810128|NCT01154452|580689461|FG000|Phase II|Withdrawal by Subject|0|||
160810129|NCT01154452|580689462|FG001|Phase II|Withdrawal by Subject|0|||
160810130|NCT01154452|580689463|FG002|Phase II|Withdrawal by Subject|1|||
160810131|NCT01154452|580689464|FG003|Phase II|Withdrawal by Subject|2|||
160810132|NCT01154452|580689461|FG000|Phase II|Adverse Event|0|||
160810133|NCT01154452|580689462|FG001|Phase II|Adverse Event|0|||
160810134|NCT01154452|580689463|FG002|Phase II|Adverse Event|4|||
160810135|NCT01154452|580689464|FG003|Phase II|Adverse Event|4|||
160810136|NCT00590122|580690837|FG000|Overall Study|swallowed oral dissolving dose|1|||
160810137|NCT00590122|580690838|FG001|Overall Study|swallowed oral dissolving dose|0|||
160810138|NCT03050450|580690839|FG000|Overall Study|Physician Decision|1|||
160810139|NCT03050450|580690840|FG001|Overall Study|Physician Decision|0|||
160810140|NCT03050450|580690841|FG002|Overall Study|Physician Decision|0|||
160810141|NCT03050450|580690842|FG003|Overall Study|Physician Decision|0|||
160810142|NCT03050450|580690843|FG004|Overall Study|Physician Decision|0|||
160810143|NCT03592771|580690847|FG000|Overall Study|Adverse Event|2|||
160810144|NCT03592771|580690848|FG001|Overall Study|Adverse Event|0|||
160810145|NCT03592771|580690849|FG002|Overall Study|Adverse Event|1|||
160810146|NCT03592771|580690847|FG000|Overall Study|Death|0|||
160810147|NCT03592771|580690848|FG001|Overall Study|Death|1|||
160810148|NCT03592771|580690849|FG002|Overall Study|Death|1|||
160810149|NCT03592771|580690847|FG000|Overall Study|Lost to Follow-up|5|||
160810150|NCT03592771|580690848|FG001|Overall Study|Lost to Follow-up|11|||
160810151|NCT03592771|580690849|FG002|Overall Study|Lost to Follow-up|15|||
160810152|NCT03592771|580690847|FG000|Overall Study|Withdrawal by Subject|0|||
160810153|NCT03592771|580690848|FG001|Overall Study|Withdrawal by Subject|2|||
160810154|NCT03592771|580690849|FG002|Overall Study|Withdrawal by Subject|0|||
160810155|NCT01642901|580690850|FG000|12-month Follow-up|Withdrawal by Subject|1|||
160810156|NCT01642901|580690851|FG001|12-month Follow-up|Withdrawal by Subject|0|||
160810157|NCT05069597|580690852|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
160810158|NCT05069597|580690853|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
160810159|NCT00735553|580690854|FG000|Overall Study|Study prematurely terminated|77|||
160810160|NCT02705105|580690855|FG000|Treatment|Objective Disease Progression|1|||
160810161|NCT02705105|580690856|FG001|Treatment|Objective Disease Progression|50|||
160810162|NCT02705105|580690855|FG000|Treatment|Withdrawal by Subject|3|||
160810163|NCT02705105|580690856|FG001|Treatment|Withdrawal by Subject|5|||
160810164|NCT02705105|580690855|FG000|Treatment|Adverse Event|0|||
160810165|NCT02705105|580690856|FG001|Treatment|Adverse Event|17|||
160810166|NCT02705105|580690855|FG000|Treatment|Clinical Disease Progression|0|||
160810167|NCT02705105|580690856|FG001|Treatment|Clinical Disease Progression|32|||
160810168|NCT02705105|580690855|FG000|Treatment|Physician Decision|0|||
160810169|NCT02705105|580690856|FG001|Treatment|Physician Decision|3|||
160810170|NCT02705105|580690855|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
160810171|NCT02705105|580690856|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
160810172|NCT02705105|580690855|FG000|Follow-Up|Death|3|||
160810173|NCT02705105|580690856|FG001|Follow-Up|Death|68|||
160810174|NCT02705105|580690855|FG000|Follow-Up|Withdrawal by Subject|1|||
160810175|NCT02705105|580690856|FG001|Follow-Up|Withdrawal by Subject|14|||
160810176|NCT02705105|580690855|FG000|Follow-Up|Study Terminated|0|||
160810177|NCT02705105|580690856|FG001|Follow-Up|Study Terminated|26|||
160810178|NCT02705105|580690855|FG000|Follow-Up|Discontinued per Amendment 3|0|||
160810179|NCT02705105|580690856|FG001|Follow-Up|Discontinued per Amendment 3|2|||
160810180|NCT02707965|580690857|FG000|Overall Study|Withdrawal by Subject|0|||
160810181|NCT02707965|580690858|FG001|Overall Study|Withdrawal by Subject|0|||
160810182|NCT02707965|580690859|FG002|Overall Study|Withdrawal by Subject|1|||
160810183|NCT02707965|580690860|FG003|Overall Study|Withdrawal by Subject|0|||
160810184|NCT02707965|580690861|FG004|Overall Study|Withdrawal by Subject|0|||
160810185|NCT02707965|580690862|FG005|Overall Study|Withdrawal by Subject|0|||
160810186|NCT02707965|580690863|FG006|Overall Study|Withdrawal by Subject|0|||
160810187|NCT02707965|580690864|FG007|Overall Study|Withdrawal by Subject|2|||
160810188|NCT02707965|580690865|FG008|Overall Study|Withdrawal by Subject|0|||
160810189|NCT02707965|580690866|FG009|Overall Study|Withdrawal by Subject|0|||
160810190|NCT02707965|580690867|FG010|Overall Study|Withdrawal by Subject|0|||
160810191|NCT02707965|580690868|FG011|Overall Study|Withdrawal by Subject|0|||
160810192|NCT02707965|580690869|FG012|Overall Study|Withdrawal by Subject|0|||
160810193|NCT02707965|580690870|FG013|Overall Study|Withdrawal by Subject|0|||
160810194|NCT02707965|580690871|FG014|Overall Study|Withdrawal by Subject|0|||
160810195|NCT02707965|580690872|FG015|Overall Study|Withdrawal by Subject|0|||
161131163|NCT03186989|581863522|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
161131164|NCT02246621|581863526|FG000|Overall Study|Withdrawal by Subject|28|||
160810196|NCT02707965|580690857|FG000|Overall Study|PI decisions|0|||
160810197|NCT02707965|580690858|FG001|Overall Study|PI decisions|0|||
160810198|NCT02707965|580690859|FG002|Overall Study|PI decisions|0|||
160810199|NCT02707965|580690860|FG003|Overall Study|PI decisions|0|||
160810200|NCT02707965|580690861|FG004|Overall Study|PI decisions|0|||
160810201|NCT02707965|580690862|FG005|Overall Study|PI decisions|0|||
160810202|NCT02707965|580690863|FG006|Overall Study|PI decisions|0|||
160810203|NCT02707965|580690864|FG007|Overall Study|PI decisions|0|||
160810204|NCT02707965|580690865|FG008|Overall Study|PI decisions|0|||
160810205|NCT02707965|580690866|FG009|Overall Study|PI decisions|0|||
160810206|NCT02707965|580690867|FG010|Overall Study|PI decisions|0|||
160810207|NCT02707965|580690868|FG011|Overall Study|PI decisions|0|||
160810208|NCT02707965|580690869|FG012|Overall Study|PI decisions|0|||
160810209|NCT02707965|580690870|FG013|Overall Study|PI decisions|0|||
160810210|NCT02707965|580690871|FG014|Overall Study|PI decisions|2|||
160810211|NCT02707965|580690872|FG015|Overall Study|PI decisions|0|||
160810212|NCT02707965|580690857|FG000|Overall Study|Protocol deviation|1|||
160810213|NCT02707965|580690858|FG001|Overall Study|Protocol deviation|1|||
160810214|NCT02707965|580690859|FG002|Overall Study|Protocol deviation|0|||
160810215|NCT02707965|580690860|FG003|Overall Study|Protocol deviation|0|||
160810216|NCT02707965|580690861|FG004|Overall Study|Protocol deviation|0|||
160810217|NCT02707965|580690862|FG005|Overall Study|Protocol deviation|0|||
160810218|NCT02707965|580690863|FG006|Overall Study|Protocol deviation|0|||
160810219|NCT02707965|580690864|FG007|Overall Study|Protocol deviation|1|||
160810220|NCT02707965|580690865|FG008|Overall Study|Protocol deviation|0|||
160810221|NCT02707965|580690866|FG009|Overall Study|Protocol deviation|0|||
160810222|NCT02707965|580690867|FG010|Overall Study|Protocol deviation|0|||
160810223|NCT02707965|580690868|FG011|Overall Study|Protocol deviation|0|||
160810224|NCT02707965|580690869|FG012|Overall Study|Protocol deviation|0|||
160810225|NCT02707965|580690870|FG013|Overall Study|Protocol deviation|0|||
160810226|NCT02707965|580690871|FG014|Overall Study|Protocol deviation|0|||
160810227|NCT02707965|580690872|FG015|Overall Study|Protocol deviation|0|||
160810228|NCT03650413|580690873|FG000|Overall Study|Adverse Event|1|||
160810229|NCT03650413|580690873|FG000|Overall Study|Lack of Efficacy|17|||
160810230|NCT03650413|580690873|FG000|Overall Study|Other|9|||
160810231|NCT03650413|580690873|FG000|Overall Study|Physician Decision|2|||
160810232|NCT03650413|580690873|FG000|Overall Study|Study Terminated By Sponsor|16|||
160810233|NCT03650413|580690873|FG000|Overall Study|Withdrawal by Subject|16|||
160810234|NCT00485758|580690878|FG000|Overall Study|Adverse Event|102|||
160810235|NCT00485758|580690879|FG001|Overall Study|Adverse Event|31|||
160810236|NCT00485758|580690878|FG000|Overall Study|Death|0|||
160810237|NCT00485758|580690879|FG001|Overall Study|Death|1|||
160810238|NCT00485758|580690878|FG000|Overall Study|Lost to Follow-up|5|||
160810239|NCT00485758|580690879|FG001|Overall Study|Lost to Follow-up|1|||
160810240|NCT00485758|580690878|FG000|Overall Study|Physician Decision|3|||
160810241|NCT00485758|580690879|FG001|Overall Study|Physician Decision|3|||
160810242|NCT00485758|580690878|FG000|Overall Study|Protocol Violation|11|||
160810243|NCT00485758|580690879|FG001|Overall Study|Protocol Violation|2|||
160810244|NCT00485758|580690878|FG000|Overall Study|Withdrawal by Subject|32|||
160810245|NCT00485758|580690879|FG001|Overall Study|Withdrawal by Subject|27|||
160810246|NCT00485758|580690878|FG000|Overall Study|Study Terminated by Sponsor|3|||
160810247|NCT00485758|580690879|FG001|Overall Study|Study Terminated by Sponsor|0|||
160810248|NCT03332173|580690880|FG000|Overall Study|Death|7|||
160810249|NCT03332173|580690880|FG000|Overall Study|Withdrawal by Subject|6|||
160810250|NCT03332173|580690880|FG000|Overall Study|Lost to Follow-up|2|||
160810251|NCT03332173|580690880|FG000|Overall Study|Transferred to long-term extension study|29|||
160810252|NCT00131352|580690881|FG000|Initial Treatment Period|Adverse Event|1|||
160810253|NCT00131352|580690882|FG001|Initial Treatment Period|Adverse Event|3|||
160810254|NCT00131352|580690881|FG000|Initial Treatment Period|Non-compliant|1|||
160810255|NCT00131352|580690882|FG001|Initial Treatment Period|Non-compliant|2|||
160810256|NCT00131352|580690881|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
160810257|NCT00131352|580690882|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
160810258|NCT00131352|580690881|FG000|Initial Treatment Period|Lack of Efficacy|6|||
160810259|NCT00131352|580690882|FG001|Initial Treatment Period|Lack of Efficacy|4|||
160810260|NCT00131352|580690881|FG000|Initial Treatment Period|Other|0|||
160810261|NCT00131352|580690882|FG001|Initial Treatment Period|Other|2|||
160810262|NCT00131352|580690881|FG000|Repeat Treatment Period|Adverse Event|1|||
161131165|NCT02246621|581863527|FG001|Overall Study|Withdrawal by Subject|16|||
161131166|NCT02246621|581863526|FG000|Overall Study|Lost to Follow-up|1|||
160810263|NCT00131352|580690882|FG001|Repeat Treatment Period|Adverse Event|0|||
160810264|NCT00131352|580690881|FG000|Repeat Treatment Period|Other|1|||
160810265|NCT00131352|580690882|FG001|Repeat Treatment Period|Other|0|||
160810266|NCT00383331|580690883|FG000|Overall Study|Protocol Violation|0|||
160810267|NCT00383331|580690884|FG001|Overall Study|Protocol Violation|1|||
160810268|NCT00211172|580690886|FG000|Overall Study|Died or lost health plan eligibility|39|||
160810269|NCT00211172|580690887|FG001|Overall Study|Died or lost health plan eligibility|32|||
160810270|NCT02253433|580690888|FG000|Overall Study|Unable to Contact|9|||
160810271|NCT02253433|580690889|FG001|Overall Study|Unable to Contact|16|||
160810272|NCT02253433|580690888|FG000|Overall Study|Death|1|||
160810273|NCT02253433|580690889|FG001|Overall Study|Death|1|||
160810274|NCT02253433|580690888|FG000|Overall Study|No Longer Interested|3|||
160899608|NCT01024231|581026359|FG006|Overall Study|No longer meets criteria|1|||
160899609|NCT01024231|581026353|FG000|Overall Study|Study Drug Toxicity|1|||
160899610|NCT01024231|581026354|FG001|Overall Study|Study Drug Toxicity|6|||
160899611|NCT01024231|581026355|FG002|Overall Study|Study Drug Toxicity|6|||
160899612|NCT01024231|581026356|FG003|Overall Study|Study Drug Toxicity|4|||
160899613|NCT01024231|581026357|FG004|Overall Study|Study Drug Toxicity|2|||
160899614|NCT01024231|581026358|FG005|Overall Study|Study Drug Toxicity|0|||
160899615|NCT01024231|581026359|FG006|Overall Study|Study Drug Toxicity|7|||
160899616|NCT01024231|581026353|FG000|Overall Study|Death|6|||
160899617|NCT01024231|581026354|FG001|Overall Study|Death|2|||
160899618|NCT01024231|581026355|FG002|Overall Study|Death|1|||
160899619|NCT01024231|581026356|FG003|Overall Study|Death|0|||
160899620|NCT01024231|581026357|FG004|Overall Study|Death|4|||
160899621|NCT01024231|581026358|FG005|Overall Study|Death|3|||
160899622|NCT01024231|581026359|FG006|Overall Study|Death|5|||
160899623|NCT01024231|581026353|FG000|Overall Study|Lost to Follow-up|0|||
160899624|NCT01024231|581026354|FG001|Overall Study|Lost to Follow-up|0|||
160899625|NCT01024231|581026355|FG002|Overall Study|Lost to Follow-up|0|||
160899626|NCT01024231|581026356|FG003|Overall Study|Lost to Follow-up|0|||
160899627|NCT01024231|581026357|FG004|Overall Study|Lost to Follow-up|0|||
160899628|NCT01024231|581026358|FG005|Overall Study|Lost to Follow-up|0|||
160899629|NCT01024231|581026359|FG006|Overall Study|Lost to Follow-up|1|||
160899630|NCT01024231|581026353|FG000|Overall Study|Withdrew Consent|0|||
160899631|NCT01024231|581026354|FG001|Overall Study|Withdrew Consent|1|||
160899632|NCT01024231|581026355|FG002|Overall Study|Withdrew Consent|0|||
160899633|NCT01024231|581026356|FG003|Overall Study|Withdrew Consent|0|||
160899634|NCT01024231|581026357|FG004|Overall Study|Withdrew Consent|0|||
160899635|NCT01024231|581026358|FG005|Overall Study|Withdrew Consent|0|||
160899636|NCT01024231|581026359|FG006|Overall Study|Withdrew Consent|0|||
160899637|NCT01024231|581026353|FG000|Overall Study|Continuing on Treatment|0|||
160899638|NCT01024231|581026354|FG001|Overall Study|Continuing on Treatment|0|||
160899639|NCT01024231|581026355|FG002|Overall Study|Continuing on Treatment|0|||
160899640|NCT01024231|581026356|FG003|Overall Study|Continuing on Treatment|0|||
160899641|NCT01024231|581026357|FG004|Overall Study|Continuing on Treatment|3|||
160899642|NCT01024231|581026358|FG005|Overall Study|Continuing on Treatment|2|||
160899643|NCT01024231|581026359|FG006|Overall Study|Continuing on Treatment|0|||
160986317|NCT04060680|581338675|FG001|Overall Study|Unsuccessful implant|2|||
160986318|NCT04060680|581338674|FG000|Overall Study|Adverse Event|3|||
160986319|NCT04060680|581338675|FG001|Overall Study|Adverse Event|0|||
160986320|NCT04060680|581338674|FG000|Overall Study|Death|2|||
160986321|NCT04060680|581338675|FG001|Overall Study|Death|0|||
160986322|NCT04060680|581338674|FG000|Overall Study|Study product no longer in use|1|||
160986323|NCT04060680|581338675|FG001|Overall Study|Study product no longer in use|0|||
160986324|NCT04060680|581338674|FG000|Overall Study|Withdrawal by Subject|1|||
160986325|NCT04060680|581338675|FG001|Overall Study|Withdrawal by Subject|0|||
160986326|NCT03803774|581338676|FG000|Dose Escalation|Withdrawal by Subject|0|||
160986327|NCT03803774|581338677|FG001|Dose Escalation|Withdrawal by Subject|0|||
160986328|NCT03803774|581338678|FG002|Dose Escalation|Withdrawal by Subject|0|||
160899644|NCT01147172|581026362|FG000|Overall Study|Withdrawal by Subject|2|||
160986329|NCT03803774|581338679|FG003|Dose Escalation|Withdrawal by Subject|1|||
160986330|NCT03803774|581338680|FG004|Dose Escalation|Withdrawal by Subject|0|||
160986331|NCT05194735|581340969|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
161131167|NCT02246621|581863527|FG001|Overall Study|Lost to Follow-up|0|||
161131168|NCT02246621|581863526|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
161131169|NCT02246621|581863527|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
161131170|NCT00821678|581863528|FG000|Overall Study|Withdrawal by Subject|8|||
160986332|NCT05194735|581340970|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
161131171|NCT00821678|581863529|FG001|Overall Study|Withdrawal by Subject|0|||
161131172|NCT00821678|581863528|FG000|Overall Study|Lost to Follow-up|13|||
161131173|NCT00821678|581863529|FG001|Overall Study|Lost to Follow-up|12|||
161131174|NCT00821678|581863528|FG000|Overall Study|Death|0|||
161131175|NCT00821678|581863529|FG001|Overall Study|Death|2|||
161131176|NCT03641560|581863535|FG000|Overall Study|Withdrawal by Subject|6|||
161131177|NCT03641560|581863535|FG000|Overall Study|Progressive disease|40|||
161131178|NCT03641560|581863535|FG000|Overall Study|Death|6|||
160899645|NCT01147172|581026362|FG000|Overall Study|Lost to Follow-up|2|||
160810275|NCT02253433|580690889|FG001|Overall Study|No Longer Interested|15|||
160810276|NCT02253433|580690888|FG000|Overall Study|Out of Study Area|2|||
160810277|NCT02253433|580690889|FG001|Overall Study|Out of Study Area|7|||
160810278|NCT02253433|580690888|FG000|Overall Study|Uncomfortable with home visitors|0|||
160810279|NCT02253433|580690889|FG001|Overall Study|Uncomfortable with home visitors|3|||
160810280|NCT02253433|580690888|FG000|Overall Study|Unstable Housing/Homeless|0|||
160810281|NCT02253433|580690889|FG001|Overall Study|Unstable Housing/Homeless|7|||
160810282|NCT02253433|580690888|FG000|Overall Study|Too Busy|0|||
160810283|NCT02253433|580690889|FG001|Overall Study|Too Busy|4|||
160810284|NCT02253433|580690888|FG000|Overall Study|Medical or Other Concerns|1|||
160810285|NCT02253433|580690889|FG001|Overall Study|Medical or Other Concerns|2|||
160810286|NCT02229825|580690890|FG000|Overall Study|Personal Reasons|0|||
160810287|NCT02229825|580690891|FG001|Overall Study|Personal Reasons|1|||
160810288|NCT02229825|580690890|FG000|Overall Study|Refused continuing medication|7|||
160810289|NCT02229825|580690891|FG001|Overall Study|Refused continuing medication|6|||
160810290|NCT02229825|580690890|FG000|Overall Study|Lost to Follow-up|1|||
160810291|NCT02229825|580690891|FG001|Overall Study|Lost to Follow-up|2|||
160810292|NCT02229825|580690890|FG000|Overall Study|Protocol Violation|1|||
160810293|NCT02229825|580690891|FG001|Overall Study|Protocol Violation|1|||
160810294|NCT02229825|580690890|FG000|Overall Study|Lack of Efficacy|4|||
160810295|NCT02229825|580690891|FG001|Overall Study|Lack of Efficacy|10|||
160810296|NCT02229825|580690890|FG000|Overall Study|Adverse Event|11|||
160810297|NCT02229825|580690891|FG001|Overall Study|Adverse Event|9|||
160810298|NCT02229825|580690890|FG000|Overall Study|Not treated|0|||
160810299|NCT02229825|580690891|FG001|Overall Study|Not treated|1|||
160810300|NCT02443337|580690892|FG000|Overall Study|Adverse Event|0|||
160810301|NCT02443337|580690893|FG001|Overall Study|Adverse Event|1|||
160810302|NCT02443337|580690892|FG000|Overall Study|Clinical Progressive Disease|3|||
160810303|NCT02443337|580690893|FG001|Overall Study|Clinical Progressive Disease|0|||
160810304|NCT02443337|580690892|FG000|Overall Study|Withdrawal by Subject|2|||
160810305|NCT02443337|580690893|FG001|Overall Study|Withdrawal by Subject|1|||
160810306|NCT00372619|580690894|FG000|Overall Study|Ineligible|0|||
160810307|NCT00372619|580690895|FG001|Overall Study|Ineligible|0|||
160810308|NCT00372619|580690896|FG002|Overall Study|Ineligible|0|||
160810309|NCT00372619|580690897|FG003|Overall Study|Ineligible|0|||
160810310|NCT00372619|580690898|FG004|Overall Study|Ineligible|0|||
160810311|NCT00372619|580690899|FG005|Overall Study|Ineligible|2|||
160810312|NCT00372619|580690900|FG006|Overall Study|Ineligible|0|||
160810313|NCT00372619|580690894|FG000|Overall Study|Inevaluable|0|||
160810314|NCT00372619|580690895|FG001|Overall Study|Inevaluable|0|||
160810315|NCT00372619|580690896|FG002|Overall Study|Inevaluable|0|||
160810316|NCT00372619|580690897|FG003|Overall Study|Inevaluable|0|||
160810317|NCT00372619|580690898|FG004|Overall Study|Inevaluable|0|||
160810318|NCT00372619|580690899|FG005|Overall Study|Inevaluable|1|||
160810319|NCT00372619|580690900|FG006|Overall Study|Inevaluable|0|||
160810320|NCT01523743|580690901|FG000|Period 1|Adverse Event|1|||
160986333|NCT05194735|581340971|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
160986334|NCT05194735|581340969|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
160986335|NCT05194735|581340970|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
160986336|NCT05194735|581340971|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
160986337|NCT05194735|581340969|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
160986338|NCT05194735|581340970|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
160986339|NCT05194735|581340971|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
160986340|NCT05194735|581340969|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
160986341|NCT05194735|581340970|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
160986342|NCT05194735|581340971|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
160986343|NCT00731042|581340972|FG000|Second Intervention|Did not meet inclusion criteria|0|||
160986344|NCT00731042|581340973|FG001|Second Intervention|Did not meet inclusion criteria|2|||
160986345|NCT01256476|581340974|FG000|Overall Study|Adverse Event|2|||
160986346|NCT01256476|581340975|FG001|Overall Study|Adverse Event|1|||
160986347|NCT01256476|581340974|FG000|Overall Study|Withdrawal by Subject|2|||
160986348|NCT01256476|581340975|FG001|Overall Study|Withdrawal by Subject|1|||
160810321|NCT01523743|580690902|FG001|Period 1|Adverse Event|0|||
160810322|NCT01523743|580690901|FG000|Period 1|Withdrawal by Subject|6|||
160810323|NCT01523743|580690902|FG001|Period 1|Withdrawal by Subject|2|||
160810324|NCT01523743|580690901|FG000|Period 1|Lost to Follow-up|1|||
160810325|NCT01523743|580690902|FG001|Period 1|Lost to Follow-up|0|||
160810326|NCT01523743|580690901|FG000|Period 1|Lack of Efficacy|1|||
160810327|NCT01523743|580690902|FG001|Period 1|Lack of Efficacy|0|||
160810328|NCT01523743|580690901|FG000|Period 1|Felt unable to empty bladder|1|||
160810329|NCT01523743|580690902|FG001|Period 1|Felt unable to empty bladder|0|||
160810330|NCT01523743|580690901|FG000|Period 2|Withdrawal by Subject|0|||
160810331|NCT01523743|580690902|FG001|Period 2|Withdrawal by Subject|2|||
160810332|NCT01523743|580690901|FG000|Period 2|Adverse Event|1|||
160810333|NCT01523743|580690902|FG001|Period 2|Adverse Event|0|||
160810334|NCT03782064|580690903|FG000|Overall Study|Lack of Efficacy|2|||
160810335|NCT03782064|580690903|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
160810336|NCT00363142|580690904|FG000|Overall Study|Adverse Event|2|||
160810337|NCT00363142|580690905|FG001|Overall Study|Adverse Event|0|||
160810338|NCT00363142|580690904|FG000|Overall Study|Lack of Efficacy|0|||
160810339|NCT00363142|580690905|FG001|Overall Study|Lack of Efficacy|1|||
160810340|NCT00363142|580690904|FG000|Overall Study|Lost to Follow-up|1|||
160810341|NCT00363142|580690905|FG001|Overall Study|Lost to Follow-up|0|||
160810342|NCT00363142|580690904|FG000|Overall Study|Non-compliance|1|||
160810343|NCT00363142|580690905|FG001|Overall Study|Non-compliance|1|||
160810344|NCT00363142|580690904|FG000|Overall Study|Withdrawal by Subject|3|||
160810345|NCT00363142|580690905|FG001|Overall Study|Withdrawal by Subject|1|||
160810346|NCT02446769|580690908|FG000|Screening Period|Screen Failure|11|||
160810347|NCT02446769|580690909|FG001|Screening Period|Screen Failure|0|||
160810348|NCT02446769|580690910|FG002|Screening Period|Screen Failure|0|||
160810349|NCT02446769|580690908|FG000|Study Period|Randomized in Error|0|||
160810350|NCT02446769|580690909|FG001|Study Period|Randomized in Error|2|||
160810351|NCT02446769|580690910|FG002|Study Period|Randomized in Error|0|||
160810352|NCT01340664|580690913|FG000|Overall Study|Adverse Event|0|||
160810353|NCT01340664|580690914|FG001|Overall Study|Adverse Event|1|||
160810354|NCT01340664|580690915|FG002|Overall Study|Adverse Event|7|||
160810355|NCT01340664|580690913|FG000|Overall Study|Lost to Follow-up|2|||
160810356|NCT01340664|580690914|FG001|Overall Study|Lost to Follow-up|0|||
160810357|NCT01340664|580690915|FG002|Overall Study|Lost to Follow-up|2|||
160810358|NCT01340664|580690913|FG000|Overall Study|Withdrawal by Subject|2|||
160810359|NCT01340664|580690914|FG001|Overall Study|Withdrawal by Subject|4|||
160810360|NCT01340664|580690915|FG002|Overall Study|Withdrawal by Subject|0|||
160810361|NCT01340664|580690913|FG000|Overall Study|Glycemic withdrawal criteria|2|||
160810362|NCT01340664|580690914|FG001|Overall Study|Glycemic withdrawal criteria|0|||
160810363|NCT01340664|580690915|FG002|Overall Study|Glycemic withdrawal criteria|0|||
160810364|NCT01340664|580690913|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
160810365|NCT01340664|580690914|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
160810366|NCT01340664|580690915|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
160810367|NCT01340664|580690913|FG000|Overall Study|Other|1|||
160810368|NCT01340664|580690914|FG001|Overall Study|Other|2|||
160810369|NCT01340664|580690915|FG002|Overall Study|Other|2|||
160810370|NCT02441101|580690917|FG000|Overall Study|Withdrawal by Subject|1|||
160810371|NCT02441101|580690918|FG001|Overall Study|Withdrawal by Subject|0|||
160810372|NCT02441101|580690917|FG000|Overall Study|Lost to Follow-up|1|||
160810373|NCT02441101|580690918|FG001|Overall Study|Lost to Follow-up|0|||
160810374|NCT02441101|580690917|FG000|Overall Study|PI relocated and study terminated|1|||
160986349|NCT01256476|581340974|FG000|Overall Study|Lost to Follow-up|1|||
160986350|NCT01256476|581340975|FG001|Overall Study|Lost to Follow-up|2|||
160986351|NCT01256476|581340974|FG000|Overall Study|Persistent ALT or AST elevation|1|||
160986352|NCT01256476|581340975|FG001|Overall Study|Persistent ALT or AST elevation|0|||
160986353|NCT01256476|581340974|FG000|Overall Study|Physician Decision|0|||
160986354|NCT01256476|581340975|FG001|Overall Study|Physician Decision|1|||
160986355|NCT01256476|581340974|FG000|Overall Study|Subject non-compliance|0|||
160986356|NCT01256476|581340975|FG001|Overall Study|Subject non-compliance|1|||
160986357|NCT01256476|581340974|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
160986358|NCT01256476|581340975|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
160986359|NCT02491411|581340978|FG000|Overall Study|Physician Decision|4|||
160986360|NCT00852475|581340980|FG000|Overall Study|Lost to Follow-up|3|||
160986361|NCT00852475|581340981|FG001|Overall Study|Lost to Follow-up|4|||
160986362|NCT00495469|581340982|FG000|Overall Study|Adverse Event|0|||
160986363|NCT00495469|581340983|FG001|Overall Study|Adverse Event|1|||
160986364|NCT00495469|581340984|FG002|Overall Study|Adverse Event|3|||
160986365|NCT00495469|581340985|FG003|Overall Study|Adverse Event|0|||
160986366|NCT00495469|581340986|FG004|Overall Study|Adverse Event|1|||
160986367|NCT00495469|581340987|FG005|Overall Study|Adverse Event|1|||
160986368|NCT00495469|581340988|FG006|Overall Study|Adverse Event|1|||
160986369|NCT00495469|581340982|FG000|Overall Study|Lost to Follow-up|1|||
160986370|NCT00495469|581340983|FG001|Overall Study|Lost to Follow-up|1|||
160810375|NCT02441101|580690918|FG001|Overall Study|PI relocated and study terminated|0|||
160810376|NCT02528942|580690921|FG000|Overall Study|Did not meet imaging criteria|9|||
160810377|NCT02528942|580690921|FG000|Overall Study|Lost to Follow-up|25|||
160810378|NCT00271856|580690922|FG000|Overall Study|Withdrawal by Subject|1|||
160810379|NCT00271856|580690923|FG001|Overall Study|Withdrawal by Subject|7|||
160810380|NCT00271856|580690922|FG000|Overall Study|Lost to Follow-up|10|||
160810381|NCT00271856|580690923|FG001|Overall Study|Lost to Follow-up|11|||
160810382|NCT04599803|580690924|FG000|Overall Study|Withdrawal by Subject|5|||
160810383|NCT04599803|580690924|FG000|Overall Study|Lost to Follow-up|26|||
160810384|NCT02544750|580690925|FG000|Overall Study|Physician Decision|3|||
160986371|NCT00495469|581340984|FG002|Overall Study|Lost to Follow-up|3|||
160986372|NCT00495469|581340985|FG003|Overall Study|Lost to Follow-up|1|||
160986373|NCT00495469|581340986|FG004|Overall Study|Lost to Follow-up|0|||
160986374|NCT00495469|581340987|FG005|Overall Study|Lost to Follow-up|0|||
160810385|NCT02544750|580690926|FG001|Overall Study|Physician Decision|1|||
160810386|NCT02544750|580690925|FG000|Overall Study|Other reasons|69|||
160810387|NCT02544750|580690926|FG001|Overall Study|Other reasons|39|||
160810388|NCT02544750|580690925|FG000|Overall Study|Met withdrawal criteria|2|||
160810389|NCT02544750|580690926|FG001|Overall Study|Met withdrawal criteria|2|||
160810390|NCT02544750|580690925|FG000|Overall Study|Transition To Commercial Product|1|||
160810391|NCT02544750|580690926|FG001|Overall Study|Transition To Commercial Product|0|||
160810392|NCT02544750|580690925|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
160810393|NCT02544750|580690926|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
160810394|NCT02544750|580690925|FG000|Overall Study|Adverse Event|8|||
160810395|NCT02544750|580690926|FG001|Overall Study|Adverse Event|10|||
160810396|NCT02544750|580690925|FG000|Overall Study|Withdrawal by Subject|10|||
160810397|NCT02544750|580690926|FG001|Overall Study|Withdrawal by Subject|4|||
160810398|NCT02544750|580690925|FG000|Overall Study|Lost to Follow-up|1|||
160810399|NCT02544750|580690926|FG001|Overall Study|Lost to Follow-up|0|||
160810400|NCT01392573|580690927|FG000|Overall Study|Adverse Event|1|||
160810401|NCT01392573|580690928|FG001|Overall Study|Adverse Event|3|||
160810402|NCT01392573|580690927|FG000|Overall Study|Lack of Efficacy|1|||
160810403|NCT01392573|580690928|FG001|Overall Study|Lack of Efficacy|2|||
160810404|NCT01392573|580690927|FG000|Overall Study|Protocol Violation|0|||
160810405|NCT01392573|580690928|FG001|Overall Study|Protocol Violation|2|||
160810406|NCT01392573|580690927|FG000|Overall Study|Withdrawal Criteria|13|||
160810407|NCT01392573|580690928|FG001|Overall Study|Withdrawal Criteria|15|||
160810408|NCT01392573|580690927|FG000|Overall Study|Site closure|8|||
160810409|NCT01392573|580690928|FG001|Overall Study|Site closure|7|||
160810410|NCT01392573|580690927|FG000|Overall Study|Unclassified|9|||
160810411|NCT01392573|580690928|FG001|Overall Study|Unclassified|6|||
160810412|NCT03381287|580690930|FG000|Overall Study|Withdrawal by Subject|0|||
160810413|NCT03381287|580690931|FG001|Overall Study|Withdrawal by Subject|1|||
160899646|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
160899647|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
160899648|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
160899649|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
160899650|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
160899651|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
160899652|NCT01697358|581026364|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
160899653|NCT01697358|581026365|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
160899654|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
160899655|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
160899656|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
160899657|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
160899658|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
160899659|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
160899660|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
160899661|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
160899662|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
160899663|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
160899664|NCT01697358|581026364|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
160899665|NCT01697358|581026365|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
160899666|NCT00669396|581026366|FG000|Overall Study|Lost to Follow-up|10|||
160899667|NCT00669396|581026367|FG001|Overall Study|Lost to Follow-up|12|||
160899668|NCT01262573|581026368|FG000|Overall Study|Withdrawal by Subject|0|||
160899669|NCT01262573|581026369|FG001|Overall Study|Withdrawal by Subject|1|||
160899670|NCT00810693|581026370|FG000|Treatment Period|Adverse Event|8|||
160899671|NCT00810693|581026371|FG001|Treatment Period|Adverse Event|1|||
160899672|NCT00810693|581026372|FG002|Treatment Period|Adverse Event|7|||
160899673|NCT00810693|581026370|FG000|Treatment Period|Death|0|||
160899674|NCT00810693|581026371|FG001|Treatment Period|Death|1|||
160899675|NCT00810693|581026372|FG002|Treatment Period|Death|2|||
160899676|NCT00810693|581026370|FG000|Treatment Period|Lack of Efficacy|0|||
160899677|NCT00810693|581026371|FG001|Treatment Period|Lack of Efficacy|0|||
160899678|NCT00810693|581026372|FG002|Treatment Period|Lack of Efficacy|1|||
160899679|NCT00810693|581026370|FG000|Treatment Period|Lost to Follow-up|1|||
160899680|NCT00810693|581026371|FG001|Treatment Period|Lost to Follow-up|0|||
160810414|NCT03381287|580690932|FG002|Overall Study|Withdrawal by Subject|0|||
160810415|NCT03381287|580690933|FG003|Overall Study|Withdrawal by Subject|0|||
160810416|NCT03381287|580690930|FG000|Overall Study|Adverse Event|0|||
160810417|NCT03381287|580690931|FG001|Overall Study|Adverse Event|0|||
160810418|NCT03381287|580690932|FG002|Overall Study|Adverse Event|0|||
160899681|NCT00810693|581026372|FG002|Treatment Period|Lost to Follow-up|0|||
160810419|NCT03381287|580690933|FG003|Overall Study|Adverse Event|1|||
160810420|NCT03381287|580690930|FG000|Overall Study|Physician Decision|0|||
160810421|NCT03381287|580690931|FG001|Overall Study|Physician Decision|0|||
160810422|NCT03381287|580690932|FG002|Overall Study|Physician Decision|0|||
160810423|NCT03381287|580690933|FG003|Overall Study|Physician Decision|1|||
160810424|NCT00325130|580690973|FG000|Overall Study|Lost to Follow-up|6|||
160810425|NCT00325130|580690974|FG001|Overall Study|Lost to Follow-up|14|||
160810426|NCT00325130|580690973|FG000|Overall Study|Withdrawal by Subject|12|||
160810427|NCT00325130|580690974|FG001|Overall Study|Withdrawal by Subject|14|||
160810428|NCT00325130|580690973|FG000|Overall Study|Protocol Deviation|0|||
160810429|NCT00325130|580690974|FG001|Overall Study|Protocol Deviation|1|||
160810430|NCT00325130|580690973|FG000|Overall Study|Moved|0|||
160810431|NCT00325130|580690974|FG001|Overall Study|Moved|1|||
160899682|NCT00810693|581026370|FG000|Treatment Period|Non-compliance|1|||
160810432|NCT00325130|580690973|FG000|Overall Study|Patient Discontinued for Other|1|||
160899683|NCT00810693|581026371|FG001|Treatment Period|Non-compliance|0|||
160899684|NCT00810693|581026372|FG002|Treatment Period|Non-compliance|0|||
160899685|NCT00810693|581026370|FG000|Treatment Period|Protocol Violation|1|||
160899686|NCT00810693|581026371|FG001|Treatment Period|Protocol Violation|2|||
160899687|NCT00810693|581026372|FG002|Treatment Period|Protocol Violation|2|||
160899688|NCT00810693|581026370|FG000|Treatment Period|Withdrawal by Subject|6|||
160899689|NCT00810693|581026371|FG001|Treatment Period|Withdrawal by Subject|2|||
160899690|NCT00810693|581026372|FG002|Treatment Period|Withdrawal by Subject|3|||
160899691|NCT00810693|581026370|FG000|Treatment Period|Not treated|0|||
160899692|NCT00810693|581026371|FG001|Treatment Period|Not treated|1|||
160899693|NCT00810693|581026372|FG002|Treatment Period|Not treated|1|||
160899694|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Adverse Event|3|||
160899695|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Adverse Event|1|||
160899696|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Adverse Event|1|||
160899697|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Death|2|||
160899698|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Death|0|||
160899699|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Death|1|||
160899700|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
160899701|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
160899702|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
160899703|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
160899704|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
160899705|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
160899706|NCT00810693|581026370|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
160899707|NCT00810693|581026371|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
160899708|NCT00810693|581026372|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
160899709|NCT02507973|581026373|FG000|Overall Study|Adverse Event|1|||
160899710|NCT04295772|581026374|FG000|Overall Study|Protocol Violation|1|||
160899711|NCT04295772|581026375|FG001|Overall Study|Protocol Violation|0|||
160899712|NCT04295772|581026374|FG000|Overall Study|Ongoing for safety monitoring|14|||
160899713|NCT04295772|581026375|FG001|Overall Study|Ongoing for safety monitoring|1|||
160899714|NCT04295772|581026374|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
160899715|NCT04295772|581026375|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
160899716|NCT00331422|581026376|FG000|Overall Study|Did not receive entire study regimen|5|||
160899717|NCT00066729|581026385|FG000|Overall Study|Lost to Follow-up|1|||
160899718|NCT00066729|581026385|FG000|Overall Study|Disease progression|1|||
160899719|NCT02349542|581026388|FG000|Overall Study|Withdrawal by Subject|5|||
160899720|NCT04128371|581026389|FG000|Overall Study|Lack of Efficacy|1|||
160899721|NCT01361568|581026390|FG000|Overall Study|Adverse Event|0|||
160899722|NCT01361568|581026391|FG001|Overall Study|Adverse Event|0|||
160899723|NCT01361568|581026392|FG002|Overall Study|Adverse Event|0|||
160899724|NCT01361568|581026393|FG003|Overall Study|Adverse Event|0|||
160899725|NCT01361568|581026394|FG004|Overall Study|Adverse Event|1|||
160899726|NCT01361568|581026395|FG005|Overall Study|Adverse Event|0|||
160899727|NCT01361568|581026390|FG000|Overall Study|Physician Decision|0|||
160899728|NCT01361568|581026391|FG001|Overall Study|Physician Decision|0|||
160899729|NCT01361568|581026392|FG002|Overall Study|Physician Decision|0|||
160899730|NCT01361568|581026393|FG003|Overall Study|Physician Decision|0|||
160899731|NCT01361568|581026394|FG004|Overall Study|Physician Decision|0|||
160899732|NCT01361568|581026395|FG005|Overall Study|Physician Decision|1|||
160810433|NCT00325130|580690974|FG001|Overall Study|Patient Discontinued for Other|0|||
160810434|NCT00980460|580690981|FG000|Overall Study|Death|0|||
160810435|NCT00980460|580690982|FG001|Overall Study|Death|0|||
160810436|NCT00980460|580690983|FG002|Overall Study|Death|1|||
160810437|NCT00980460|580690984|FG003|Overall Study|Death|2|||
160899733|NCT01361568|581026390|FG000|Overall Study|Withdrawal by Subject|2|||
160899734|NCT01361568|581026391|FG001|Overall Study|Withdrawal by Subject|1|||
160899735|NCT01361568|581026392|FG002|Overall Study|Withdrawal by Subject|0|||
160899736|NCT01361568|581026393|FG003|Overall Study|Withdrawal by Subject|0|||
160899737|NCT01361568|581026394|FG004|Overall Study|Withdrawal by Subject|0|||
160899738|NCT01361568|581026395|FG005|Overall Study|Withdrawal by Subject|1|||
160899739|NCT03308786|581026396|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
160899740|NCT01999868|581026397|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
160899741|NCT01999868|581026398|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
160899742|NCT01999868|581026399|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
160899743|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
160810438|NCT00980460|580690985|FG004|Overall Study|Death|1|||
160810439|NCT00980460|580690981|FG000|Overall Study|Lack of Efficacy|0|||
160810440|NCT00980460|580690982|FG001|Overall Study|Lack of Efficacy|0|||
160810441|NCT00980460|580690983|FG002|Overall Study|Lack of Efficacy|10|||
160810442|NCT00980460|580690984|FG003|Overall Study|Lack of Efficacy|6|||
160810443|NCT00980460|580690985|FG004|Overall Study|Lack of Efficacy|8|||
160810444|NCT00980460|580690981|FG000|Overall Study|Lost to Follow-up|0|||
160810445|NCT00980460|580690982|FG001|Overall Study|Lost to Follow-up|0|||
160810446|NCT00980460|580690983|FG002|Overall Study|Lost to Follow-up|0|||
160810447|NCT00980460|580690984|FG003|Overall Study|Lost to Follow-up|1|||
160810448|NCT00980460|580690985|FG004|Overall Study|Lost to Follow-up|0|||
160810449|NCT00980460|580690981|FG000|Overall Study|Physician Decision|0|||
160810450|NCT00980460|580690982|FG001|Overall Study|Physician Decision|0|||
160810451|NCT00980460|580690983|FG002|Overall Study|Physician Decision|11|||
160810452|NCT00980460|580690984|FG003|Overall Study|Physician Decision|5|||
160810453|NCT00980460|580690985|FG004|Overall Study|Physician Decision|3|||
160810454|NCT00980460|580690981|FG000|Overall Study|Withdrawal by Subject|0|||
160810455|NCT00980460|580690982|FG001|Overall Study|Withdrawal by Subject|0|||
160810456|NCT00980460|580690983|FG002|Overall Study|Withdrawal by Subject|1|||
160810457|NCT00980460|580690984|FG003|Overall Study|Withdrawal by Subject|0|||
160810458|NCT00980460|580690985|FG004|Overall Study|Withdrawal by Subject|0|||
160810459|NCT00980460|580690981|FG000|Overall Study|Ineligible|0|||
160810460|NCT00980460|580690982|FG001|Overall Study|Ineligible|2|||
160810461|NCT00980460|580690983|FG002|Overall Study|Ineligible|3|||
160899744|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
160899745|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
161131179|NCT01974817|581865205|FG000|Overall Study|Death|4|||
161131180|NCT01974817|581865205|FG000|Overall Study|Lost to Follow-up|2|||
161131181|NCT01974817|581865205|FG000|Overall Study|Protocol Violation|2|||
161131182|NCT05047523|581865206|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161131183|NCT05047523|581865207|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161131184|NCT05047523|581865208|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
161131185|NCT05047523|581865209|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161131186|NCT05047523|581865210|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161131187|NCT05047523|581865211|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
161131188|NCT05047523|581865206|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161131189|NCT05047523|581865207|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
161131190|NCT05047523|581865208|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161131191|NCT05047523|581865209|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161131192|NCT05047523|581865210|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161131193|NCT05047523|581865211|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
161131194|NCT05047523|581865206|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
161131195|NCT05047523|581865207|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
161131196|NCT05047523|581865208|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
161131197|NCT05047523|581865209|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
160899746|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
160899747|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
161131198|NCT05047523|581865210|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
161131199|NCT05047523|581865211|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
161131200|NCT05047523|581865206|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
161131201|NCT05047523|581865207|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161131202|NCT05047523|581865208|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161131203|NCT05047523|581865209|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161131204|NCT05047523|581865210|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161131205|NCT05047523|581865211|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
161131206|NCT05047523|581865206|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161131207|NCT05047523|581865207|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161131208|NCT05047523|581865208|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161131209|NCT05047523|581865209|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
161131210|NCT05047523|581865210|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
160810462|NCT00980460|580690984|FG003|Overall Study|Ineligible|1|||
160810463|NCT00980460|580690985|FG004|Overall Study|Ineligible|4|||
160810464|NCT00980460|580690981|FG000|Overall Study|Refusal of further therapy|0|||
160810465|NCT00980460|580690982|FG001|Overall Study|Refusal of further therapy|2|||
160810466|NCT00980460|580690983|FG002|Overall Study|Refusal of further therapy|3|||
160810467|NCT00980460|580690984|FG003|Overall Study|Refusal of further therapy|2|||
160810468|NCT00980460|580690985|FG004|Overall Study|Refusal of further therapy|0|||
160899748|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
160899749|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
160986375|NCT00495469|581340988|FG006|Overall Study|Lost to Follow-up|0|||
161131211|NCT05047523|581865211|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
160810469|NCT00980460|580690981|FG000|Overall Study|No therapy within 42 days of resection|0|||
160810470|NCT00980460|580690982|FG001|Overall Study|No therapy within 42 days of resection|0|||
160810471|NCT00980460|580690983|FG002|Overall Study|No therapy within 42 days of resection|3|||
160810472|NCT00980460|580690984|FG003|Overall Study|No therapy within 42 days of resection|1|||
160810473|NCT00980460|580690985|FG004|Overall Study|No therapy within 42 days of resection|0|||
160810474|NCT00980460|580690981|FG000|Overall Study|No transplant by protocol timepoints|0|||
160810475|NCT00980460|580690982|FG001|Overall Study|No transplant by protocol timepoints|0|||
160810476|NCT00980460|580690983|FG002|Overall Study|No transplant by protocol timepoints|3|||
160810477|NCT00980460|580690984|FG003|Overall Study|No transplant by protocol timepoints|0|||
160810478|NCT00980460|580690985|FG004|Overall Study|No transplant by protocol timepoints|0|||
160810479|NCT02842086|580690986|FG000|Overall Study|Randomized but Never Treated|6|||
160810480|NCT02842086|580690987|FG001|Overall Study|Randomized but Never Treated|6|||
160810481|NCT02842086|580690986|FG000|Overall Study|Still in Double-Blind Phase|7|||
160810482|NCT02842086|580690987|FG001|Overall Study|Still in Double-Blind Phase|3|||
160810483|NCT02842086|580690986|FG000|Overall Study|Adverse Event|18|||
160810484|NCT02842086|580690987|FG001|Overall Study|Adverse Event|20|||
160810485|NCT02842086|580690986|FG000|Overall Study|Death|3|||
160810486|NCT02842086|580690987|FG001|Overall Study|Death|3|||
160810487|NCT02842086|580690986|FG000|Overall Study|Investigator's Discretion|9|||
160810488|NCT02842086|580690987|FG001|Overall Study|Investigator's Discretion|13|||
160810489|NCT02842086|580690986|FG000|Overall Study|Non-Compliance with Study Drug|9|||
160810490|NCT02842086|580690987|FG001|Overall Study|Non-Compliance with Study Drug|8|||
160810491|NCT02842086|580690986|FG000|Overall Study|Protocol Violation|8|||
160810492|NCT02842086|580690987|FG001|Overall Study|Protocol Violation|4|||
160810493|NCT02842086|580690986|FG000|Overall Study|Withdrew Consent|205|||
160810494|NCT02842086|580690987|FG001|Overall Study|Withdrew Consent|194|||
160810495|NCT02842086|580690986|FG000|Overall Study|Lost to Follow-up|274|||
160810496|NCT02842086|580690987|FG001|Overall Study|Lost to Follow-up|236|||
160810497|NCT02842086|580690986|FG000|Overall Study|HIV-1 Infection|5|||
160810498|NCT02842086|580690987|FG001|Overall Study|HIV-1 Infection|6|||
160810499|NCT00928187|580690988|FG000|Overall Study|Death|1|||
160810500|NCT00928187|580690989|FG001|Overall Study|Death|2|||
160810501|NCT00928187|580690990|FG002|Overall Study|Death|3|||
160810502|NCT00928187|580690988|FG000|Overall Study|Lost to Follow-up|1|||
160810503|NCT00928187|580690989|FG001|Overall Study|Lost to Follow-up|2|||
160810504|NCT00928187|580690990|FG002|Overall Study|Lost to Follow-up|1|||
160810505|NCT00928187|580690988|FG000|Overall Study|Withdrawal by Subject|0|||
160810506|NCT00928187|580690989|FG001|Overall Study|Withdrawal by Subject|1|||
160810507|NCT00928187|580690990|FG002|Overall Study|Withdrawal by Subject|1|||
160810508|NCT00928187|580690988|FG000|Overall Study|Protocol Violation|0|||
160810509|NCT00928187|580690989|FG001|Overall Study|Protocol Violation|1|||
160986376|NCT00495469|581340982|FG000|Overall Study|Protocol Violation|0|||
160986377|NCT00495469|581340983|FG001|Overall Study|Protocol Violation|0|||
160986378|NCT00495469|581340984|FG002|Overall Study|Protocol Violation|0|||
160986379|NCT00495469|581340985|FG003|Overall Study|Protocol Violation|0|||
160986380|NCT00495469|581340986|FG004|Overall Study|Protocol Violation|1|||
160986381|NCT00495469|581340987|FG005|Overall Study|Protocol Violation|2|||
160986382|NCT00495469|581340988|FG006|Overall Study|Protocol Violation|0|||
160986383|NCT00495469|581340982|FG000|Overall Study|Withdrawal by Subject|5|||
160810510|NCT00928187|580690990|FG002|Overall Study|Protocol Violation|0|||
160810511|NCT05696444|580690991|FG000|Treatment|Physician Decision|0|||
160810512|NCT05696444|580690992|FG001|Treatment|Physician Decision|1|||
160810513|NCT05696444|580690993|FG002|Treatment|Physician Decision|0|||
160810514|NCT05696444|580690991|FG000|30 Days|Death|1|||
160810515|NCT05696444|580690992|FG001|30 Days|Death|1|||
160810516|NCT05696444|580690993|FG002|30 Days|Death|0|||
160810517|NCT05696444|580690991|FG000|30 Days|Missed Visit|1|||
160810518|NCT05696444|580690992|FG001|30 Days|Missed Visit|1|||
160810519|NCT05696444|580690993|FG002|30 Days|Missed Visit|1|||
160810520|NCT05959447|580692237|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
160810521|NCT05959447|580692238|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
160810522|NCT05959447|580692237|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
160810523|NCT05959447|580692238|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
160810524|NCT05959447|580692237|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
160986384|NCT00495469|581340983|FG001|Overall Study|Withdrawal by Subject|3|||
160810525|NCT05959447|580692238|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
160810526|NCT05959447|580692237|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
160810527|NCT05959447|580692238|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
160810528|NCT01893411|580692243|FG000|Overall Study|Protocol Violation|1|||
160810529|NCT01893411|580692244|FG001|Overall Study|Protocol Violation|0|||
160986385|NCT00495469|581340984|FG002|Overall Study|Withdrawal by Subject|1|||
160810530|NCT01893411|580692245|FG002|Overall Study|Protocol Violation|0|||
160810531|NCT01893411|580692243|FG000|Overall Study|Physician Decision|1|||
160810532|NCT01893411|580692244|FG001|Overall Study|Physician Decision|1|||
160810533|NCT01893411|580692245|FG002|Overall Study|Physician Decision|2|||
160986386|NCT00495469|581340985|FG003|Overall Study|Withdrawal by Subject|3|||
161332854|NCT05069259|582605368|FG000|Overall Study|Withdrawal by Subject|1|||
161131212|NCT05047523|581865206|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
161131213|NCT05047523|581865207|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
161131214|NCT05047523|581865208|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
161131215|NCT05047523|581865209|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
161131216|NCT05047523|581865210|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
160810534|NCT01893411|580692243|FG000|Overall Study|Lack of Efficacy|2|||
160810535|NCT01893411|580692244|FG001|Overall Study|Lack of Efficacy|1|||
160810536|NCT01893411|580692245|FG002|Overall Study|Lack of Efficacy|0|||
160810537|NCT01893411|580692243|FG000|Overall Study|Other|3|||
160810538|NCT01893411|580692244|FG001|Overall Study|Other|1|||
160810539|NCT01893411|580692245|FG002|Overall Study|Other|3|||
160810540|NCT01893411|580692243|FG000|Overall Study|Adverse Event|1|||
160810541|NCT01893411|580692244|FG001|Overall Study|Adverse Event|0|||
160810542|NCT01893411|580692245|FG002|Overall Study|Adverse Event|0|||
160810543|NCT01893411|580692243|FG000|Overall Study|Withdrawal by Subject|7|||
160810544|NCT01893411|580692244|FG001|Overall Study|Withdrawal by Subject|4|||
161131217|NCT05047523|581865211|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
161131218|NCT01805180|581865214|FG000|Lead-in Donor Phase|screen failure|1|||
161332855|NCT05069259|582605368|FG000|Overall Study|Sponsor decision|1|||
160810545|NCT01893411|580692245|FG002|Overall Study|Withdrawal by Subject|3|||
160810546|NCT01893411|580692243|FG000|Overall Study|Lost to Follow-up|2|||
160810547|NCT01893411|580692244|FG001|Overall Study|Lost to Follow-up|0|||
160810548|NCT01893411|580692245|FG002|Overall Study|Lost to Follow-up|1|||
160810549|NCT00566982|580692246|FG000|Overall Study|Adverse Event|6|||
160810550|NCT00566982|580692247|FG001|Overall Study|Adverse Event|48|||
160810551|NCT00566982|580692246|FG000|Overall Study|Withdrawal by Subject|1|||
160810552|NCT00566982|580692247|FG001|Overall Study|Withdrawal by Subject|14|||
160810553|NCT00566982|580692246|FG000|Overall Study|Protocol Violation|1|||
160810554|NCT00566982|580692247|FG001|Overall Study|Protocol Violation|4|||
160810555|NCT00566982|580692246|FG000|Overall Study|Lost to Follow-up|0|||
160810556|NCT00566982|580692247|FG001|Overall Study|Lost to Follow-up|1|||
160810557|NCT00566982|580692246|FG000|Overall Study|Other-family problems & doctor's request|0|||
160810558|NCT00566982|580692247|FG001|Overall Study|Other-family problems & doctor's request|2|||
160810559|NCT03053440|580692250|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
160810560|NCT03053440|580692251|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
160810561|NCT03053440|580692250|FG000|Overall Study|Death|18|||
160810562|NCT03053440|580692251|FG001|Overall Study|Death|14|||
160810563|NCT03053440|580692250|FG000|Overall Study|Withdrawal by Subject|9|||
160810564|NCT03053440|580692251|FG001|Overall Study|Withdrawal by Subject|8|||
160810565|NCT03053440|580692250|FG000|Overall Study|Lost to Follow-up|1|||
160810566|NCT03053440|580692251|FG001|Overall Study|Lost to Follow-up|0|||
160810567|NCT03053440|580692250|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
160810568|NCT03053440|580692251|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
160810569|NCT03053440|580692250|FG000|Overall Study|Physician Decision|2|||
160810570|NCT03053440|580692251|FG001|Overall Study|Physician Decision|1|||
160810571|NCT03053440|580692250|FG000|Overall Study|Participant Randomized but died before dosing|1|||
160810572|NCT03053440|580692251|FG001|Overall Study|Participant Randomized but died before dosing|0|||
160899750|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
160899751|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
160899752|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
160899753|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
160899754|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
160899755|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
160899756|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
160899757|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
160899758|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
160899759|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
160899760|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
161131219|NCT01805180|581865215|FG001|Lead-in Donor Phase|screen failure|0|||
160899761|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
160899762|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
160899763|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
161131220|NCT01805180|581865216|FG002|Lead-in Donor Phase|screen failure|0|||
161131221|NCT04684420|581865221|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
160810573|NCT00391053|580692257|FG000|Overall Study|Serious Adverse Events|1|||
160810574|NCT00391053|580692258|FG001|Overall Study|Serious Adverse Events|0|||
160810575|NCT00391053|580692259|FG002|Overall Study|Serious Adverse Events|1|||
160810576|NCT00391053|580692260|FG003|Overall Study|Serious Adverse Events|4|||
160810577|NCT00391053|580692257|FG000|Overall Study|Protocol Violation|2|||
160810578|NCT00391053|580692258|FG001|Overall Study|Protocol Violation|0|||
160810579|NCT00391053|580692259|FG002|Overall Study|Protocol Violation|0|||
160810580|NCT00391053|580692260|FG003|Overall Study|Protocol Violation|0|||
160810581|NCT00391053|580692257|FG000|Overall Study|Lost to Follow-up|1|||
160810582|NCT00391053|580692258|FG001|Overall Study|Lost to Follow-up|0|||
160810583|NCT00391053|580692259|FG002|Overall Study|Lost to Follow-up|0|||
160810584|NCT00391053|580692260|FG003|Overall Study|Lost to Follow-up|5|||
160810585|NCT00391053|580692257|FG000|Overall Study|Withdrawal by Subject|5|||
160810586|NCT00391053|580692258|FG001|Overall Study|Withdrawal by Subject|1|||
160810587|NCT00391053|580692259|FG002|Overall Study|Withdrawal by Subject|1|||
160810588|NCT00391053|580692260|FG003|Overall Study|Withdrawal by Subject|1|||
160810589|NCT00473889|580692262|FG000|Overall Study|Did not receive study medication|1|||
160810590|NCT00473889|580692263|FG001|Overall Study|Did not receive study medication|4|||
160810591|NCT00473889|580692262|FG000|Overall Study|Adverse Event|30|||
160810592|NCT00473889|580692263|FG001|Overall Study|Adverse Event|17|||
160810593|NCT00473889|580692262|FG000|Overall Study|Protocol Violation|4|||
160810594|NCT00473889|580692263|FG001|Overall Study|Protocol Violation|2|||
160810595|NCT00473889|580692262|FG000|Overall Study|Lack of Efficacy|28|||
160810596|NCT00473889|580692263|FG001|Overall Study|Lack of Efficacy|29|||
160810597|NCT00473889|580692262|FG000|Overall Study|Lost to Follow-up|2|||
160810598|NCT00473889|580692263|FG001|Overall Study|Lost to Follow-up|1|||
160810599|NCT00473889|580692262|FG000|Overall Study|Physician Decision|10|||
160810600|NCT00473889|580692263|FG001|Overall Study|Physician Decision|5|||
160810601|NCT00473889|580692262|FG000|Overall Study|Trial Terminated|3|||
160810602|NCT00473889|580692263|FG001|Overall Study|Trial Terminated|6|||
160810603|NCT00473889|580692262|FG000|Overall Study|Withdrawal by Subject|5|||
160810604|NCT00473889|580692263|FG001|Overall Study|Withdrawal by Subject|0|||
160810605|NCT02140970|580692264|FG000|Overall Study|Lost to Follow-up|1|||
160810606|NCT02140970|580692265|FG001|Overall Study|Lost to Follow-up|2|||
160810607|NCT02140970|580692264|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
160810608|NCT02140970|580692265|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
160810609|NCT02140970|580692264|FG000|Overall Study|Did not meet inclusion criteria|0|||
160810610|NCT02140970|580692265|FG001|Overall Study|Did not meet inclusion criteria|1|||
160810611|NCT01498692|580692269|FG000|Overall Study|Death|4|||
160810612|NCT01498692|580692269|FG000|Overall Study|Withdrawal by Subject|1|||
160810613|NCT01498692|580692269|FG000|Overall Study|Missed 12-month visit|3|||
160810614|NCT01947283|580692270|FG000|Overall Study|Death|1|||
160810615|NCT01947283|580692271|FG001|Overall Study|Death|1|||
160810616|NCT01947283|580692272|FG002|Overall Study|Death|1|||
160810617|NCT01947283|580692273|FG003|Overall Study|Death|0|||
160810618|NCT01947283|580692274|FG004|Overall Study|Death|0|||
160810619|NCT01947283|580692275|FG005|Overall Study|Death|0|||
161131222|NCT04684420|581865222|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161131223|NCT04684420|581865223|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
161131224|NCT04684420|581865224|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161131225|NCT04684420|581865221|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
161131226|NCT04684420|581865222|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
160810620|NCT01947283|580692276|FG006|Overall Study|Death|0|||
160810621|NCT01947283|580692270|FG000|Overall Study|Lost to Follow-up|4|||
160810622|NCT01947283|580692271|FG001|Overall Study|Lost to Follow-up|6|||
160810623|NCT01947283|580692272|FG002|Overall Study|Lost to Follow-up|5|||
160810624|NCT01947283|580692273|FG003|Overall Study|Lost to Follow-up|5|||
160810625|NCT01947283|580692274|FG004|Overall Study|Lost to Follow-up|0|||
160810626|NCT01947283|580692275|FG005|Overall Study|Lost to Follow-up|2|||
160810627|NCT01947283|580692276|FG006|Overall Study|Lost to Follow-up|5|||
160810628|NCT01947283|580692270|FG000|Overall Study|Withdrawal by Subject|10|||
160810629|NCT01947283|580692271|FG001|Overall Study|Withdrawal by Subject|8|||
160810630|NCT01947283|580692272|FG002|Overall Study|Withdrawal by Subject|4|||
160810631|NCT01947283|580692273|FG003|Overall Study|Withdrawal by Subject|1|||
160810632|NCT01947283|580692274|FG004|Overall Study|Withdrawal by Subject|0|||
161131227|NCT04684420|581865223|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
161131228|NCT04684420|581865224|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
161131229|NCT00463476|581865225|FG000|Overall Study|Withdrawal by Subject|1|||
160810633|NCT01947283|580692275|FG005|Overall Study|Withdrawal by Subject|0|||
160810634|NCT01947283|580692276|FG006|Overall Study|Withdrawal by Subject|2|||
160810635|NCT01947283|580692270|FG000|Overall Study|No Clinical Recording|12|||
161131230|NCT00463476|581865226|FG001|Overall Study|Withdrawal by Subject|2|||
161131231|NCT00463476|581865225|FG000|Overall Study|Lost to Follow-up|1|||
161332856|NCT00922636|582606474|FG000|Overall Study|Adverse Event|3|||
160810636|NCT01947283|580692271|FG001|Overall Study|No Clinical Recording|6|||
160810637|NCT01947283|580692272|FG002|Overall Study|No Clinical Recording|8|||
160810638|NCT01947283|580692273|FG003|Overall Study|No Clinical Recording|10|||
160810639|NCT01947283|580692274|FG004|Overall Study|No Clinical Recording|0|||
160810640|NCT01947283|580692275|FG005|Overall Study|No Clinical Recording|0|||
160810641|NCT01947283|580692276|FG006|Overall Study|No Clinical Recording|0|||
160810642|NCT01947283|580692270|FG000|Overall Study|Non-coding Clinical Recording language|0|||
160810643|NCT01947283|580692271|FG001|Overall Study|Non-coding Clinical Recording language|0|||
160810644|NCT01947283|580692272|FG002|Overall Study|Non-coding Clinical Recording language|0|||
160810645|NCT01947283|580692273|FG003|Overall Study|Non-coding Clinical Recording language|1|||
161131232|NCT00463476|581865226|FG001|Overall Study|Lost to Follow-up|1|||
160810646|NCT01947283|580692274|FG004|Overall Study|Non-coding Clinical Recording language|0|||
160810647|NCT01947283|580692275|FG005|Overall Study|Non-coding Clinical Recording language|0|||
160810648|NCT01947283|580692276|FG006|Overall Study|Non-coding Clinical Recording language|0|||
160810649|NCT01947283|580692270|FG000|Overall Study|Missing Follow-up Assessment|2|||
160810650|NCT01947283|580692271|FG001|Overall Study|Missing Follow-up Assessment|2|||
160810651|NCT01947283|580692272|FG002|Overall Study|Missing Follow-up Assessment|3|||
160810652|NCT01947283|580692273|FG003|Overall Study|Missing Follow-up Assessment|0|||
160810653|NCT01947283|580692274|FG004|Overall Study|Missing Follow-up Assessment|0|||
160810654|NCT01947283|580692275|FG005|Overall Study|Missing Follow-up Assessment|2|||
160810655|NCT01947283|580692276|FG006|Overall Study|Missing Follow-up Assessment|0|||
160810656|NCT01947283|580692270|FG000|Overall Study|No patients were enrolled in study|0|||
160810657|NCT01947283|580692271|FG001|Overall Study|No patients were enrolled in study|0|||
160810658|NCT01947283|580692272|FG002|Overall Study|No patients were enrolled in study|0|||
160810659|NCT01947283|580692273|FG003|Overall Study|No patients were enrolled in study|0|||
160810660|NCT01947283|580692274|FG004|Overall Study|No patients were enrolled in study|0|||
160810661|NCT01947283|580692275|FG005|Overall Study|No patients were enrolled in study|3|||
160810662|NCT01947283|580692276|FG006|Overall Study|No patients were enrolled in study|1|||
160810663|NCT04729972|580692277|FG000|Overall Study|Adverse Event|1|||
160810664|NCT00430989|580692278|FG000|Overall Study|Lost to Follow-up|2|||
160810665|NCT00430989|580692279|FG001|Overall Study|Lost to Follow-up|3|||
160810666|NCT00430989|580692278|FG000|Overall Study|Withdrawal by Subject|15|||
160810667|NCT00430989|580692279|FG001|Overall Study|Withdrawal by Subject|14|||
160810668|NCT00430989|580692278|FG000|Overall Study|Protocol Violation|30|||
160810669|NCT00430989|580692279|FG001|Overall Study|Protocol Violation|37|||
160810670|NCT00430989|580692278|FG000|Overall Study|Not eligible|13|||
160810671|NCT00430989|580692279|FG001|Overall Study|Not eligible|6|||
160810672|NCT05002985|580692280|FG000|Overall Study|Withdrawal by Subject|1|||
160810673|NCT00460655|580692281|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
160810674|NCT00460655|580692282|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160810675|NCT00460655|580692283|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160810676|NCT00460655|580692284|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
160810677|NCT00460655|580692281|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
160810678|NCT00460655|580692282|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160810679|NCT00460655|580692283|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160810680|NCT00460655|580692284|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
160810681|NCT00460655|580692281|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
160810682|NCT00460655|580692282|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
160810683|NCT00460655|580692283|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
160810684|NCT00460655|580692284|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
160810685|NCT00460655|580692281|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160810686|NCT00460655|580692282|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
160810687|NCT00460655|580692283|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
160810688|NCT00460655|580692284|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
160986387|NCT00495469|581340986|FG004|Overall Study|Withdrawal by Subject|3|||
160986388|NCT00495469|581340987|FG005|Overall Study|Withdrawal by Subject|2|||
160986389|NCT00495469|581340988|FG006|Overall Study|Withdrawal by Subject|3|||
160986390|NCT00495469|581340982|FG000|Overall Study|Lack of Efficacy|0|||
160986391|NCT00495469|581340983|FG001|Overall Study|Lack of Efficacy|0|||
161239010|NCT00465270|582255858|FG000|Overall Study|Lost to Follow-up|60|||
161239011|NCT00465270|582255859|FG001|Overall Study|Lost to Follow-up|67|||
161239012|NCT00465270|582255858|FG000|Overall Study|Investigator request|3|||
161239013|NCT00465270|582255859|FG001|Overall Study|Investigator request|4|||
160810689|NCT00460655|580692281|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160810690|NCT00460655|580692282|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
160810691|NCT00460655|580692283|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
160810692|NCT00460655|580692284|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
160810693|NCT00460655|580692281|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
160810694|NCT00460655|580692282|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
160810695|NCT00460655|580692283|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
160810696|NCT00460655|580692284|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
160810697|NCT03782259|580692285|FG000|Overall Study|Lost to Follow-up|1|||
160810698|NCT03782259|580692286|FG001|Overall Study|Lost to Follow-up|1|||
160810699|NCT03782259|580692285|FG000|Overall Study|Moved out of state|0|||
160810700|NCT03782259|580692286|FG001|Overall Study|Moved out of state|2|||
161239014|NCT03233724|582255860|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
160810701|NCT03782259|580692285|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
160810702|NCT03782259|580692286|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
160810703|NCT03782259|580692285|FG000|Overall Study|Subject discontinued intervention|1|||
160986392|NCT00495469|581340984|FG002|Overall Study|Lack of Efficacy|0|||
161239015|NCT03233724|582255861|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161131233|NCT00928070|581865231|FG000|Overall Study|Lost to Follow-up|1|||
161131234|NCT00928070|581865232|FG001|Overall Study|Lost to Follow-up|2|||
161131235|NCT00928070|581865231|FG000|Overall Study|Withdrawal by Subject|10|||
161131236|NCT00928070|581865232|FG001|Overall Study|Withdrawal by Subject|3|||
160810704|NCT03782259|580692286|FG001|Overall Study|Subject discontinued intervention|0|||
160810705|NCT00603941|580692287|FG000|Overall Study|Disease progression|6|||
160810706|NCT00603941|580692288|FG001|Overall Study|Disease progression|7|||
161131237|NCT00928070|581865231|FG000|Overall Study|Adverse Event|14|||
161131238|NCT00928070|581865232|FG001|Overall Study|Adverse Event|26|||
161131239|NCT00928070|581865231|FG000|Overall Study|Lack of Efficacy|9|||
161131240|NCT00928070|581865232|FG001|Overall Study|Lack of Efficacy|5|||
161131241|NCT00928070|581865231|FG000|Overall Study|Did not meet entrance criteria|16|||
161131242|NCT00928070|581865232|FG001|Overall Study|Did not meet entrance criteria|9|||
161131243|NCT00928070|581865231|FG000|Overall Study|Protocol Violation|6|||
161131244|NCT00928070|581865232|FG001|Overall Study|Protocol Violation|5|||
161131245|NCT00928070|581865231|FG000|Overall Study|Randomized but not treated|2|||
161131246|NCT00928070|581865232|FG001|Overall Study|Randomized but not treated|2|||
161131247|NCT00928070|581865231|FG000|Overall Study|Other|5|||
161131248|NCT00928070|581865232|FG001|Overall Study|Other|5|||
161131249|NCT00556426|581865240|FG000|Overall Study|Withdrawal by Subject|3|||
161131250|NCT00556426|581865240|FG000|Overall Study|Death|6|||
161131251|NCT03049449|581865241|FG000|Overall Study|Did not receive treatment.|0|||
160810707|NCT00603941|580692289|FG002|Overall Study|Disease progression|1|||
160810708|NCT00603941|580692287|FG000|Overall Study|Adverse Event|1|||
160810709|NCT00603941|580692288|FG001|Overall Study|Adverse Event|0|||
161131252|NCT03049449|581865242|FG001|Overall Study|Did not receive treatment.|0|||
161131253|NCT03049449|581865243|FG002|Overall Study|Did not receive treatment.|0|||
161131254|NCT03049449|581865244|FG003|Overall Study|Did not receive treatment.|0|||
161131255|NCT03049449|581865245|FG004|Overall Study|Did not receive treatment.|0|||
161131256|NCT03049449|581865246|FG005|Overall Study|Did not receive treatment.|0|||
161131257|NCT03049449|581865247|FG006|Overall Study|Did not receive treatment.|0|||
161131258|NCT03049449|581865248|FG007|Overall Study|Did not receive treatment.|0|||
161131259|NCT03049449|581865249|FG008|Overall Study|Did not receive treatment.|1|||
161131260|NCT03049449|581865250|FG009|Overall Study|Did not receive treatment.|0|||
161131261|NCT03049449|581865241|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
161131262|NCT03049449|581865242|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
161131263|NCT03049449|581865243|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
161131264|NCT03049449|581865244|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
161131265|NCT03049449|581865245|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
161131266|NCT03049449|581865246|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
161131267|NCT03049449|581865247|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
161131268|NCT03049449|581865248|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
161131269|NCT03049449|581865249|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
161131270|NCT03049449|581865250|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
161131271|NCT03049449|581865241|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131272|NCT03049449|581865242|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131273|NCT03049449|581865243|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131274|NCT03049449|581865244|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131275|NCT03049449|581865245|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131276|NCT03049449|581865246|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131277|NCT03049449|581865247|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131278|NCT03049449|581865248|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
161131279|NCT03049449|581865249|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
161131280|NCT03049449|581865250|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
161131281|NCT02388295|581865265|FG000|Dose Escalation Week 1|Adverse Event|1|||
161131282|NCT02388295|581865266|FG001|Dose Escalation Week 1|Adverse Event|2|||
161131283|NCT02388295|581865267|FG002|Dose Escalation Week 1|Adverse Event|1|||
161131284|NCT02388295|581865265|FG000|Dose Escalation Week 1|Determined not eligible|1|||
161131285|NCT02388295|581865266|FG001|Dose Escalation Week 1|Determined not eligible|1|||
161131286|NCT02388295|581865267|FG002|Dose Escalation Week 1|Determined not eligible|1|||
161131287|NCT02388295|581865265|FG000|Dose Escalation Week 2|Protocol Violation|0|||
161131288|NCT02388295|581865266|FG001|Dose Escalation Week 2|Protocol Violation|1|||
161131289|NCT02388295|581865267|FG002|Dose Escalation Week 2|Protocol Violation|0|||
161257896|NCT03756883|582323518|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
160810710|NCT00603941|580692289|FG002|Overall Study|Adverse Event|1|||
161131290|NCT02388295|581865265|FG000|Dose Escalation Week 2|Determined not eligible|1|||
161257897|NCT03756883|582323519|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
160810711|NCT00603941|580692287|FG000|Overall Study|Physician Decision|0|||
160810712|NCT00603941|580692288|FG001|Overall Study|Physician Decision|1|||
160810713|NCT00603941|580692289|FG002|Overall Study|Physician Decision|0|||
160810714|NCT00603941|580692287|FG000|Overall Study|Withdrawal by Subject|0|||
160810715|NCT00603941|580692288|FG001|Overall Study|Withdrawal by Subject|2|||
160986393|NCT00495469|581340985|FG003|Overall Study|Lack of Efficacy|0|||
160986394|NCT00495469|581340986|FG004|Overall Study|Lack of Efficacy|0|||
161239016|NCT03233724|582255862|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161239017|NCT03233724|582255863|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
161239018|NCT03233724|582255864|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
161239019|NCT03233724|582255860|FG000|Phase I Dose Escalation|Best interest of participant|1|||
161239020|NCT03233724|582255861|FG001|Phase I Dose Escalation|Best interest of participant|1|||
161239021|NCT03233724|582255862|FG002|Phase I Dose Escalation|Best interest of participant|1|||
161239022|NCT03233724|582255863|FG003|Phase I Dose Escalation|Best interest of participant|0|||
161239023|NCT03233724|582255864|FG004|Phase I Dose Escalation|Best interest of participant|0|||
161239024|NCT03233724|582255860|FG000|Phase I Dose Escalation|Physician Decision|0|||
161239025|NCT03233724|582255861|FG001|Phase I Dose Escalation|Physician Decision|0|||
161239026|NCT03233724|582255862|FG002|Phase I Dose Escalation|Physician Decision|1|||
161239027|NCT03233724|582255863|FG003|Phase I Dose Escalation|Physician Decision|0|||
160986395|NCT00495469|581340987|FG005|Overall Study|Lack of Efficacy|0|||
160986396|NCT00495469|581340988|FG006|Overall Study|Lack of Efficacy|1|||
160986397|NCT00495469|581340982|FG000|Overall Study|Liver function test abnormality|0|||
160986398|NCT00495469|581340983|FG001|Overall Study|Liver function test abnormality|1|||
160986399|NCT00495469|581340984|FG002|Overall Study|Liver function test abnormality|0|||
160986400|NCT00495469|581340985|FG003|Overall Study|Liver function test abnormality|0|||
160986401|NCT00495469|581340986|FG004|Overall Study|Liver function test abnormality|0|||
160986402|NCT00495469|581340987|FG005|Overall Study|Liver function test abnormality|0|||
160986403|NCT00495469|581340988|FG006|Overall Study|Liver function test abnormality|0|||
160986404|NCT00495469|581340982|FG000|Overall Study|ST depression at randomisation in ECG|0|||
160986405|NCT00495469|581340983|FG001|Overall Study|ST depression at randomisation in ECG|1|||
160986406|NCT00495469|581340984|FG002|Overall Study|ST depression at randomisation in ECG|0|||
160986407|NCT00495469|581340985|FG003|Overall Study|ST depression at randomisation in ECG|0|||
160986408|NCT00495469|581340986|FG004|Overall Study|ST depression at randomisation in ECG|0|||
160986409|NCT00495469|581340987|FG005|Overall Study|ST depression at randomisation in ECG|0|||
160986410|NCT00495469|581340988|FG006|Overall Study|ST depression at randomisation in ECG|0|||
160986411|NCT00664521|581340992|FG000|Overall Study|Adverse Event|4|||
160986412|NCT00664521|581340993|FG001|Overall Study|Adverse Event|1|||
161239028|NCT03233724|582255864|FG004|Phase I Dose Escalation|Physician Decision|0|||
161239029|NCT03233724|582255860|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
160986413|NCT00664521|581340992|FG000|Overall Study|Lost to Follow-up|1|||
160986414|NCT00664521|581340993|FG001|Overall Study|Lost to Follow-up|0|||
161239030|NCT03233724|582255861|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161239031|NCT03233724|582255862|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
161239032|NCT03233724|582255863|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161239033|NCT03233724|582255864|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
161239034|NCT02388191|582255865|FG000|Overall Study|Patient did not receive IUD|1|||
161239035|NCT02388191|582255866|FG001|Overall Study|Patient did not receive IUD|0|||
161239036|NCT01911676|582255867|FG000|Period 1 of Study|Withdrawal by Subject|4|||
161239037|NCT01911676|582255868|FG001|Period 1 of Study|Withdrawal by Subject|2|||
161239038|NCT01911676|582255869|FG002|Period 1 of Study|Withdrawal by Subject|1|||
161239039|NCT01911676|582255870|FG003|Period 1 of Study|Withdrawal by Subject|2|||
161239040|NCT01911676|582255867|FG000|Period 1 of Study|Physician Decision|2|||
161239041|NCT01911676|582255868|FG001|Period 1 of Study|Physician Decision|0|||
160810716|NCT00603941|580692289|FG002|Overall Study|Withdrawal by Subject|0|||
160986415|NCT00664521|581340992|FG000|Overall Study|Other|1|||
160986416|NCT00664521|581340993|FG001|Overall Study|Other|0|||
160986417|NCT01657682|581340994|FG000|Overall Study|Lost to Follow-up|1|||
160986418|NCT01657682|581340995|FG001|Overall Study|Lost to Follow-up|0|||
160986419|NCT01657682|581340996|FG002|Overall Study|Lost to Follow-up|0|||
160986420|NCT01657682|581340994|FG000|Overall Study|Withdrawal by Subject|0|||
160986421|NCT01657682|581340995|FG001|Overall Study|Withdrawal by Subject|1|||
160986422|NCT01657682|581340996|FG002|Overall Study|Withdrawal by Subject|1|||
160986423|NCT01657682|581340994|FG000|Overall Study|Adverse Event|0|||
160986424|NCT01657682|581340995|FG001|Overall Study|Adverse Event|1|||
160810717|NCT00249808|580692291|FG000|Overall Study|Other|27|||
160810718|NCT00249808|580692291|FG000|Overall Study|Protocol Violation|3|||
160986425|NCT01657682|581340996|FG002|Overall Study|Adverse Event|0|||
160986426|NCT03379233|581341003|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
160986427|NCT03379233|581341004|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
160986428|NCT02531438|581341005|FG000|Overall Study|Adverse Event|7|||
160986429|NCT02531438|581341006|FG001|Overall Study|Adverse Event|9|||
160899764|NCT01999868|581026397|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
160899765|NCT01999868|581026398|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
160899766|NCT01999868|581026399|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
160899767|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
160899768|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
160899769|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
160899770|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
160899771|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
160899772|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
161131291|NCT02388295|581865266|FG001|Dose Escalation Week 2|Determined not eligible|1|||
161131292|NCT02388295|581865267|FG002|Dose Escalation Week 2|Determined not eligible|1|||
161131293|NCT02388295|581865265|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
161131294|NCT02388295|581865266|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
160899773|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
160899774|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
160899775|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
160899776|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
160899777|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
160899778|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
160899779|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
160899780|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
161131295|NCT02388295|581865267|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
161131296|NCT02429856|581865269|FG000|Overall Study|Death|12|||
161131297|NCT02429856|581865270|FG001|Overall Study|Death|13|||
161131298|NCT02429856|581865269|FG000|Overall Study|Lost to Follow-up|6|||
160899781|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
160899782|NCT01999868|581026397|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
160899783|NCT01999868|581026398|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
160899784|NCT01999868|581026399|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
160899785|NCT00289016|581026400|FG000|Overall Study|Disease Progression|29|||
160899786|NCT00289016|581026400|FG000|Overall Study|Death|2|||
160899787|NCT00289016|581026400|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
160899788|NCT00289016|581026400|FG000|Overall Study|Withdrawal by Subject|2|||
160899789|NCT00289016|581026400|FG000|Overall Study|Adverse Event|1|||
161131299|NCT02429856|581865270|FG001|Overall Study|Lost to Follow-up|5|||
161239042|NCT01911676|582255869|FG002|Period 1 of Study|Physician Decision|0|||
161239043|NCT01911676|582255870|FG003|Period 1 of Study|Physician Decision|1|||
161239044|NCT01911676|582255867|FG000|Period 2 of Study|Physician Decision|2|||
161239045|NCT01911676|582255868|FG001|Period 2 of Study|Physician Decision|0|||
161239046|NCT01911676|582255869|FG002|Period 2 of Study|Physician Decision|0|||
161239047|NCT01911676|582255870|FG003|Period 2 of Study|Physician Decision|1|||
161239048|NCT01911676|582255867|FG000|Period 2 of Study|Lost to Follow-up|0|||
161239049|NCT01911676|582255868|FG001|Period 2 of Study|Lost to Follow-up|0|||
161239050|NCT01911676|582255869|FG002|Period 2 of Study|Lost to Follow-up|0|||
161332857|NCT00922636|582606475|FG001|Overall Study|Adverse Event|3|||
161332858|NCT00922636|582606476|FG002|Overall Study|Adverse Event|2|||
161332859|NCT00922636|582606477|FG003|Overall Study|Adverse Event|3|||
161332860|NCT00922636|582606478|FG004|Overall Study|Adverse Event|2|||
161332861|NCT00922636|582606474|FG000|Overall Study|Lack of Efficacy|1|||
161332862|NCT00922636|582606475|FG001|Overall Study|Lack of Efficacy|7|||
161332863|NCT00922636|582606476|FG002|Overall Study|Lack of Efficacy|3|||
161332864|NCT00922636|582606477|FG003|Overall Study|Lack of Efficacy|2|||
161332865|NCT00922636|582606478|FG004|Overall Study|Lack of Efficacy|4|||
161332866|NCT00922636|582606474|FG000|Overall Study|Sponsor Decision|0|||
161332867|NCT00922636|582606475|FG001|Overall Study|Sponsor Decision|0|||
161332868|NCT00922636|582606476|FG002|Overall Study|Sponsor Decision|2|||
161332869|NCT00922636|582606477|FG003|Overall Study|Sponsor Decision|0|||
161332870|NCT00922636|582606478|FG004|Overall Study|Sponsor Decision|0|||
161332871|NCT00922636|582606474|FG000|Overall Study|Withdrawal by Subject|0|||
161332872|NCT00922636|582606475|FG001|Overall Study|Withdrawal by Subject|0|||
161332873|NCT00922636|582606476|FG002|Overall Study|Withdrawal by Subject|5|||
161332874|NCT00922636|582606477|FG003|Overall Study|Withdrawal by Subject|2|||
161332875|NCT00922636|582606478|FG004|Overall Study|Withdrawal by Subject|4|||
161332876|NCT00922636|582606474|FG000|Overall Study|Protocol Violation|0|||
161332877|NCT00922636|582606475|FG001|Overall Study|Protocol Violation|0|||
161332878|NCT00922636|582606476|FG002|Overall Study|Protocol Violation|2|||
160899790|NCT00289016|581026400|FG000|Overall Study|Other|1|||
161131300|NCT02429856|581865269|FG000|Overall Study|Withdrawal by Subject|1|||
161131301|NCT02429856|581865270|FG001|Overall Study|Withdrawal by Subject|1|||
161239051|NCT01911676|582255870|FG003|Period 2 of Study|Lost to Follow-up|1|||
161332879|NCT00922636|582606477|FG003|Overall Study|Protocol Violation|2|||
161332880|NCT00922636|582606478|FG004|Overall Study|Protocol Violation|0|||
160810719|NCT00249808|580692291|FG000|Overall Study|Lost to Follow-up|8|||
160810720|NCT00249808|580692291|FG000|Overall Study|Adverse Event|81|||
160810721|NCT00249808|580692291|FG000|Overall Study|Lack of Efficacy|52|||
160810722|NCT00249808|580692291|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
160810723|NCT00711594|580692292|FG000|Overall Study|Progressive disease|2|||
160810724|NCT00711594|580692293|FG001|Overall Study|Progressive disease|2|||
160810725|NCT00711594|580692294|FG002|Overall Study|Progressive disease|6|||
160810726|NCT00711594|580692295|FG003|Overall Study|Progressive disease|44|||
160986430|NCT02531438|581341005|FG000|Overall Study|Lost to Follow-up|0|||
160986431|NCT02531438|581341006|FG001|Overall Study|Lost to Follow-up|3|||
160986432|NCT02531438|581341005|FG000|Overall Study|Withdrawal by Subject|7|||
160986433|NCT02531438|581341006|FG001|Overall Study|Withdrawal by Subject|8|||
160986434|NCT02531438|581341005|FG000|Overall Study|Physician Decision|0|||
160986435|NCT02531438|581341006|FG001|Overall Study|Physician Decision|1|||
160986436|NCT02531438|581341005|FG000|Overall Study|Death|6|||
160986437|NCT02531438|581341006|FG001|Overall Study|Death|3|||
160986438|NCT02531438|581341005|FG000|Overall Study|Randomized, but Not Treated|4|||
160986439|NCT02531438|581341006|FG001|Overall Study|Randomized, but Not Treated|0|||
160986440|NCT02531438|581341005|FG000|Overall Study|Missed EOT/PTE Visit|5|||
160986441|NCT02531438|581341006|FG001|Overall Study|Missed EOT/PTE Visit|2|||
160986442|NCT02531438|581341005|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
160986443|NCT02531438|581341006|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
160986444|NCT01813422|581341008|FG000|Overall Study|Withdrawal by Subject|14|||
160986445|NCT01813422|581341009|FG001|Overall Study|Withdrawal by Subject|8|||
160986446|NCT01813422|581341008|FG000|Overall Study|Death|2|||
160986447|NCT01813422|581341009|FG001|Overall Study|Death|3|||
160986448|NCT01813422|581341008|FG000|Overall Study|Sponsor Decision|2|||
160986449|NCT01813422|581341009|FG001|Overall Study|Sponsor Decision|1|||
160986450|NCT01813422|581341008|FG000|Overall Study|Lost to Follow-up|2|||
160986451|NCT01813422|581341009|FG001|Overall Study|Lost to Follow-up|4|||
160986452|NCT01653743|581341012|FG000|Overall Study|Withdrawal by Subject|1|||
160986453|NCT01653743|581341013|FG001|Overall Study|Withdrawal by Subject|0|||
160986454|NCT01653743|581341012|FG000|Overall Study|Investigator discretion|3|||
160986455|NCT01653743|581341013|FG001|Overall Study|Investigator discretion|0|||
160986456|NCT02015195|581341016|FG000|Overall Study|Adverse Event|0|||
161131302|NCT04134494|581865274|FG000|Overall Study|Lost to Follow-up|2|||
161131303|NCT00781365|581865275|FG000|Overall Study|Withdrawal by Subject|13|||
161131304|NCT00781365|581865276|FG001|Overall Study|Withdrawal by Subject|8|||
161131305|NCT00781365|581865275|FG000|Overall Study|Did Not Attend Visit|20|||
161131306|NCT00781365|581865276|FG001|Overall Study|Did Not Attend Visit|28|||
161131307|NCT00781365|581865275|FG000|Overall Study|Language barrier|1|||
161131308|NCT00781365|581865276|FG001|Overall Study|Language barrier|0|||
161131309|NCT02978222|581865277|FG000|Overall Study|Withdrawal by Subject|2|||
161131310|NCT02978222|581865278|FG001|Overall Study|Withdrawal by Subject|2|||
161131311|NCT02978222|581865277|FG000|Overall Study|Physician Decision|2|||
161131312|NCT02978222|581865278|FG001|Overall Study|Physician Decision|0|||
161131313|NCT02978222|581865277|FG000|Overall Study|Adverse Event|0|||
161131314|NCT02978222|581865278|FG001|Overall Study|Adverse Event|1|||
161131315|NCT02978222|581865277|FG000|Overall Study|Death|1|||
161131316|NCT02978222|581865278|FG001|Overall Study|Death|0|||
161131317|NCT02978222|581865277|FG000|Overall Study|Disease Progression|32|||
161131318|NCT02978222|581865278|FG001|Overall Study|Disease Progression|32|||
161131319|NCT02978222|581865277|FG000|Overall Study|Early Study Termination|24|||
161131320|NCT02978222|581865278|FG001|Overall Study|Early Study Termination|21|||
161131321|NCT03258814|581865279|FG000|Overall Study|Early Termination|4|||
161131322|NCT03258814|581865280|FG001|Overall Study|Early Termination|3|||
161131323|NCT03258814|581865281|FG002|Overall Study|Early Termination|10|||
161131324|NCT01900002|581865282|FG000|Overall Study|Withdrawal by Subject|2|||
161131325|NCT01900002|581865282|FG000|Overall Study|ineligible for Y-90|4|||
161131326|NCT01662648|581865285|FG000|Overall Study|Death|1|||
161131327|NCT01662648|581865286|FG001|Overall Study|Death|3|||
161131328|NCT01662648|581865285|FG000|Overall Study|Adverse Event|40|||
161131329|NCT01662648|581865286|FG001|Overall Study|Adverse Event|37|||
161131330|NCT01662648|581865285|FG000|Overall Study|Lack of Efficacy|17|||
161131331|NCT01662648|581865286|FG001|Overall Study|Lack of Efficacy|16|||
161131332|NCT01662648|581865285|FG000|Overall Study|Participant ineligible to continue trial|1|||
161131333|NCT01662648|581865286|FG001|Overall Study|Participant ineligible to continue trial|1|||
161131334|NCT01662648|581865285|FG000|Overall Study|Lost to Follow-up|24|||
161131335|NCT01662648|581865286|FG001|Overall Study|Lost to Follow-up|36|||
161131336|NCT01662648|581865285|FG000|Overall Study|Withdrawal by Subject|36|||
160810727|NCT00711594|580692292|FG000|Overall Study|Other Adverse Event|1|||
160986457|NCT02015195|581341017|FG001|Overall Study|Adverse Event|0|||
160986458|NCT02015195|581341018|FG002|Overall Study|Adverse Event|0|||
160986459|NCT02015195|581341019|FG003|Overall Study|Adverse Event|1|||
160986460|NCT02015195|581341020|FG004|Overall Study|Adverse Event|0|||
160986461|NCT02015195|581341021|FG005|Overall Study|Adverse Event|0|||
160986462|NCT02015195|581341022|FG006|Overall Study|Adverse Event|0|||
160986463|NCT01318811|581341023|FG000|Overall Study|Physician Decision|1|||
160986464|NCT01318811|581341024|FG001|Overall Study|Physician Decision|1|||
160810728|NCT00711594|580692293|FG001|Overall Study|Other Adverse Event|0|||
160810729|NCT00711594|580692294|FG002|Overall Study|Other Adverse Event|0|||
160810730|NCT00711594|580692295|FG003|Overall Study|Other Adverse Event|16|||
160810731|NCT00711594|580692292|FG000|Overall Study|Withdrawal by Subject|0|||
160810732|NCT00711594|580692293|FG001|Overall Study|Withdrawal by Subject|1|||
160810733|NCT00711594|580692294|FG002|Overall Study|Withdrawal by Subject|0|||
160810734|NCT00711594|580692295|FG003|Overall Study|Withdrawal by Subject|2|||
160810735|NCT04556591|580692300|FG000|Overall Study|Lost to Follow-up|1|||
160810736|NCT04556591|580692301|FG001|Overall Study|Lost to Follow-up|0|||
160810737|NCT04556591|580692300|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
160810738|NCT04556591|580692301|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
160986465|NCT01318811|581341023|FG000|Overall Study|CRRT stopped for head CT|0|||
160986466|NCT01318811|581341024|FG001|Overall Study|CRRT stopped for head CT|1|||
160986467|NCT01318811|581341023|FG000|Overall Study|Death|0|||
160986468|NCT01318811|581341024|FG001|Overall Study|Death|1|||
160986469|NCT01318811|581341023|FG000|Overall Study|CRRT stopped for head MRI|0|||
160986470|NCT01318811|581341024|FG001|Overall Study|CRRT stopped for head MRI|1|||
160986471|NCT00811187|581341025|FG000|Overall Study|Unable to place device / procedure abort|3|||
160986472|NCT00811187|581341026|FG001|Overall Study|Unable to place device / procedure abort|3|||
160986473|NCT00131911|581341027|FG000|Overall Study|Withdrawal by Subject|1|||
160986474|NCT00131911|581341028|FG001|Overall Study|Withdrawal by Subject|0|||
160986475|NCT02825043|581341029|FG000|Overall Study|Lost to Follow-up|4|||
160986476|NCT00329303|581341030|FG000|Overall Study|Lack of Efficacy|1|||
160986477|NCT00329303|581341031|FG001|Overall Study|Lack of Efficacy|0|||
160986478|NCT00329303|581341030|FG000|Overall Study|Decision of the sponsor|0|||
160986479|NCT00329303|581341031|FG001|Overall Study|Decision of the sponsor|1|||
160986480|NCT00329303|581341030|FG000|Overall Study|Patient no longer available|1|||
160986481|NCT00329303|581341031|FG001|Overall Study|Patient no longer available|0|||
160986482|NCT00329303|581341030|FG000|Overall Study|Patient relocated|0|||
161131337|NCT01662648|581865286|FG001|Overall Study|Withdrawal by Subject|53|||
161131338|NCT01662648|581865285|FG000|Overall Study|Participant non-compliant|16|||
160810739|NCT00135330|580692303|FG000|Overall Study|Adverse Event|2|||
160810740|NCT00135330|580692304|FG001|Overall Study|Adverse Event|5|||
161131339|NCT01662648|581865286|FG001|Overall Study|Participant non-compliant|20|||
161131340|NCT01662648|581865285|FG000|Overall Study|Other|8|||
160810741|NCT00135330|580692305|FG002|Overall Study|Adverse Event|1|||
160810742|NCT00135330|580692303|FG000|Overall Study|Lost to Follow-up|0|||
160810743|NCT00135330|580692304|FG001|Overall Study|Lost to Follow-up|2|||
160810744|NCT00135330|580692305|FG002|Overall Study|Lost to Follow-up|3|||
160810745|NCT00135330|580692303|FG000|Overall Study|Physician Decision|1|||
160810746|NCT00135330|580692304|FG001|Overall Study|Physician Decision|1|||
160810747|NCT00135330|580692305|FG002|Overall Study|Physician Decision|0|||
160810748|NCT00135330|580692303|FG000|Overall Study|Protocol Violation|4|||
160810749|NCT00135330|580692304|FG001|Overall Study|Protocol Violation|3|||
160810750|NCT00135330|580692305|FG002|Overall Study|Protocol Violation|3|||
160810751|NCT00135330|580692303|FG000|Overall Study|Patient Decision|5|||
160810752|NCT00135330|580692304|FG001|Overall Study|Patient Decision|1|||
160810753|NCT00135330|580692305|FG002|Overall Study|Patient Decision|4|||
160810754|NCT00135330|580692303|FG000|Overall Study|Sponsor Decision|0|||
160810755|NCT00135330|580692304|FG001|Overall Study|Sponsor Decision|1|||
160810756|NCT00135330|580692305|FG002|Overall Study|Sponsor Decision|0|||
160810757|NCT02526212|580692315|FG000|Overall Study|Incarceration|1|||
160810758|NCT02526212|580692316|FG001|Overall Study|Incarceration|0|||
160810759|NCT02526212|580692315|FG000|Overall Study|Lost to Follow-up|1|||
160810760|NCT02526212|580692316|FG001|Overall Study|Lost to Follow-up|0|||
160810761|NCT02526212|580692315|FG000|Overall Study|Death|0|||
160810762|NCT02526212|580692316|FG001|Overall Study|Death|1|||
160810763|NCT02096952|580692318|FG000|Overall Study|Adverse Event|1|||
160810764|NCT00040742|580692319|FG000|Overall Study|Death|0|||
160810765|NCT00040742|580692320|FG001|Overall Study|Death|0|||
160810766|NCT00040742|580692321|FG002|Overall Study|Death|1|||
160810767|NCT00040742|580692322|FG003|Overall Study|Death|0|||
160810768|NCT00040742|580692319|FG000|Overall Study|Adverse Event|15|||
160810769|NCT00040742|580692320|FG001|Overall Study|Adverse Event|16|||
160810770|NCT00040742|580692321|FG002|Overall Study|Adverse Event|21|||
160810771|NCT00040742|580692322|FG003|Overall Study|Adverse Event|9|||
160810772|NCT00040742|580692319|FG000|Overall Study|Withdrawal by Subject|7|||
160810773|NCT00040742|580692320|FG001|Overall Study|Withdrawal by Subject|15|||
160810774|NCT00040742|580692321|FG002|Overall Study|Withdrawal by Subject|10|||
160810775|NCT00040742|580692322|FG003|Overall Study|Withdrawal by Subject|13|||
160810776|NCT00040742|580692319|FG000|Overall Study|Chemotoxicity|4|||
160986483|NCT00329303|581341031|FG001|Overall Study|Patient relocated|1|||
160986484|NCT03582137|581341037|FG000|Overall Study|Adverse Event|1|||
160986485|NCT03582137|581341038|FG001|Overall Study|Adverse Event|0|||
160986486|NCT03704298|581341043|FG000|Overall Study|Death|3|||
161131341|NCT01662648|581865286|FG001|Overall Study|Other|11|||
161131342|NCT01662648|581865285|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
161131343|NCT01662648|581865286|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
160986487|NCT03704298|581341044|FG001|Overall Study|Death|1|||
160986488|NCT03704298|581341045|FG002|Overall Study|Death|1|||
160986489|NCT03704298|581341046|FG003|Overall Study|Death|0|||
160986490|NCT03704298|581341043|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
160986491|NCT03704298|581341044|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
160986492|NCT03704298|581341045|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
160986493|NCT03704298|581341046|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
160986494|NCT03704298|581341043|FG000|Overall Study|Withdrawal by Subject|1|||
160986495|NCT03704298|581341044|FG001|Overall Study|Withdrawal by Subject|0|||
160986496|NCT03704298|581341045|FG002|Overall Study|Withdrawal by Subject|0|||
160986497|NCT03704298|581341046|FG003|Overall Study|Withdrawal by Subject|0|||
160986498|NCT03704298|581341043|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
160986499|NCT03704298|581341044|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
160986500|NCT03704298|581341045|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
160986501|NCT03704298|581341046|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
160986502|NCT00558753|581341047|FG000|Overall Study|Lost to Follow-up|5|||
160986503|NCT00558753|581341048|FG001|Overall Study|Lost to Follow-up|7|||
160986504|NCT00783718|581341053|FG000|Induction Phase|Adverse Event|4|||
160986505|NCT00783718|581341054|FG001|Induction Phase|Adverse Event|0|||
160986506|NCT00783718|581341055|FG002|Induction Phase|Adverse Event|7|||
160986507|NCT00783718|581341056|FG003|Induction Phase|Adverse Event|0|||
160986508|NCT00783718|581341057|FG004|Induction Phase|Adverse Event|0|||
160986509|NCT00783718|581341058|FG005|Induction Phase|Adverse Event|0|||
160986510|NCT00783718|581341059|FG006|Induction Phase|Adverse Event|0|||
160810777|NCT00040742|580692320|FG001|Overall Study|Chemotoxicity|3|||
160810778|NCT00040742|580692321|FG002|Overall Study|Chemotoxicity|5|||
160810779|NCT00040742|580692322|FG003|Overall Study|Chemotoxicity|2|||
160810780|NCT00040742|580692319|FG000|Overall Study|Incomplete Forms|6|||
160810781|NCT00040742|580692320|FG001|Overall Study|Incomplete Forms|10|||
160810782|NCT00040742|580692321|FG002|Overall Study|Incomplete Forms|4|||
160810783|NCT00040742|580692322|FG003|Overall Study|Incomplete Forms|5|||
160810784|NCT00040742|580692319|FG000|Overall Study|Other medical|7|||
160810785|NCT00040742|580692320|FG001|Overall Study|Other medical|5|||
160810786|NCT00040742|580692321|FG002|Overall Study|Other medical|5|||
160810787|NCT00040742|580692322|FG003|Overall Study|Other medical|5|||
160810788|NCT00624468|580692323|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
160810789|NCT00624468|580692324|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
160810790|NCT00624468|580692325|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
160810791|NCT00624468|580692326|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
160810792|NCT00624468|580692323|FG000|Double-blind Period|Withdrew Prematurely|1|||
160810793|NCT00624468|580692324|FG001|Double-blind Period|Withdrew Prematurely|1|||
160810794|NCT00624468|580692325|FG002|Double-blind Period|Withdrew Prematurely|0|||
160810795|NCT00624468|580692326|FG003|Double-blind Period|Withdrew Prematurely|0|||
160810796|NCT00624468|580692323|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
160810797|NCT00624468|580692324|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
160810798|NCT00624468|580692325|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
160899791|NCT03553927|581026401|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
160899792|NCT03553927|581026402|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
160899793|NCT03553927|581026401|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
160899794|NCT03553927|581026402|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
160899795|NCT03350620|581026404|FG000|Stage 2|Adverse Event|0|||
160899796|NCT03350620|581026405|FG001|Stage 2|Adverse Event|1|||
160986511|NCT00783718|581341053|FG000|Induction Phase|Protocol Violation|1|||
160986512|NCT00783718|581341054|FG001|Induction Phase|Protocol Violation|1|||
161239052|NCT00773253|582255871|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
161239053|NCT00773253|582255872|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
160899797|NCT03350620|581026406|FG002|Stage 2|Adverse Event|1|||
160899798|NCT03350620|581026404|FG000|Stage 2|Lack of Efficacy|0|||
160899799|NCT03350620|581026405|FG001|Stage 2|Lack of Efficacy|2|||
160899800|NCT03350620|581026406|FG002|Stage 2|Lack of Efficacy|0|||
160899801|NCT03350620|581026404|FG000|Stage 2|Lost to Follow-up|1|||
160810799|NCT00624468|580692326|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
160810800|NCT00624468|580692323|FG000|Safety Follow-up (SFU) Period|Other|0|||
160810801|NCT00624468|580692324|FG001|Safety Follow-up (SFU) Period|Other|0|||
160899802|NCT03350620|581026405|FG001|Stage 2|Lost to Follow-up|2|||
160810802|NCT00624468|580692325|FG002|Safety Follow-up (SFU) Period|Other|1|||
160899803|NCT03350620|581026406|FG002|Stage 2|Lost to Follow-up|2|||
160986513|NCT00783718|581341055|FG002|Induction Phase|Protocol Violation|6|||
160986514|NCT00783718|581341056|FG003|Induction Phase|Protocol Violation|0|||
160986515|NCT00783718|581341057|FG004|Induction Phase|Protocol Violation|0|||
160986516|NCT00783718|581341058|FG005|Induction Phase|Protocol Violation|0|||
160986517|NCT00783718|581341059|FG006|Induction Phase|Protocol Violation|0|||
160986518|NCT00783718|581341053|FG000|Induction Phase|Lack of Efficacy|5|||
160986519|NCT00783718|581341054|FG001|Induction Phase|Lack of Efficacy|2|||
160986520|NCT00783718|581341055|FG002|Induction Phase|Lack of Efficacy|14|||
160986521|NCT00783718|581341056|FG003|Induction Phase|Lack of Efficacy|0|||
160986522|NCT00783718|581341057|FG004|Induction Phase|Lack of Efficacy|0|||
160986523|NCT00783718|581341058|FG005|Induction Phase|Lack of Efficacy|0|||
160986524|NCT00783718|581341059|FG006|Induction Phase|Lack of Efficacy|0|||
160986525|NCT00783718|581341053|FG000|Induction Phase|Withdrawal by Subject|3|||
160986526|NCT00783718|581341054|FG001|Induction Phase|Withdrawal by Subject|4|||
160986527|NCT00783718|581341055|FG002|Induction Phase|Withdrawal by Subject|8|||
160986528|NCT00783718|581341056|FG003|Induction Phase|Withdrawal by Subject|0|||
160986529|NCT00783718|581341057|FG004|Induction Phase|Withdrawal by Subject|0|||
160986530|NCT00783718|581341058|FG005|Induction Phase|Withdrawal by Subject|0|||
160986531|NCT00783718|581341059|FG006|Induction Phase|Withdrawal by Subject|0|||
160986532|NCT00783718|581341053|FG000|Induction Phase|Lost to Follow-up|1|||
160986533|NCT00783718|581341054|FG001|Induction Phase|Lost to Follow-up|0|||
160986534|NCT00783718|581341055|FG002|Induction Phase|Lost to Follow-up|1|||
160986535|NCT00783718|581341056|FG003|Induction Phase|Lost to Follow-up|0|||
160986536|NCT00783718|581341057|FG004|Induction Phase|Lost to Follow-up|0|||
160986537|NCT00783718|581341058|FG005|Induction Phase|Lost to Follow-up|0|||
160986538|NCT00783718|581341059|FG006|Induction Phase|Lost to Follow-up|0|||
160986539|NCT00783718|581341053|FG000|Maintenance Phase|Adverse Event|12|||
160986540|NCT00783718|581341054|FG001|Maintenance Phase|Adverse Event|0|||
160986541|NCT00783718|581341055|FG002|Maintenance Phase|Adverse Event|0|||
160986542|NCT00783718|581341056|FG003|Maintenance Phase|Adverse Event|15|||
160986543|NCT00783718|581341057|FG004|Maintenance Phase|Adverse Event|7|||
160986544|NCT00783718|581341058|FG005|Maintenance Phase|Adverse Event|6|||
160986545|NCT00783718|581341059|FG006|Maintenance Phase|Adverse Event|16|||
160986546|NCT00783718|581341053|FG000|Maintenance Phase|Protocol Violation|1|||
160986547|NCT00783718|581341054|FG001|Maintenance Phase|Protocol Violation|0|||
160986548|NCT00783718|581341055|FG002|Maintenance Phase|Protocol Violation|0|||
160986549|NCT00783718|581341056|FG003|Maintenance Phase|Protocol Violation|0|||
160986550|NCT00783718|581341057|FG004|Maintenance Phase|Protocol Violation|0|||
160986551|NCT00783718|581341058|FG005|Maintenance Phase|Protocol Violation|0|||
160986552|NCT00783718|581341059|FG006|Maintenance Phase|Protocol Violation|2|||
160986553|NCT00783718|581341053|FG000|Maintenance Phase|Lack of Efficacy|83|||
160986554|NCT00783718|581341054|FG001|Maintenance Phase|Lack of Efficacy|0|||
160986555|NCT00783718|581341055|FG002|Maintenance Phase|Lack of Efficacy|0|||
160986556|NCT00783718|581341056|FG003|Maintenance Phase|Lack of Efficacy|61|||
160986557|NCT00783718|581341057|FG004|Maintenance Phase|Lack of Efficacy|31|||
160986558|NCT00783718|581341058|FG005|Maintenance Phase|Lack of Efficacy|33|||
160986559|NCT00783718|581341059|FG006|Maintenance Phase|Lack of Efficacy|155|||
160986560|NCT00783718|581341053|FG000|Maintenance Phase|Withdrawal by Subject|6|||
160986561|NCT00783718|581341054|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160986562|NCT00783718|581341055|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160986563|NCT00783718|581341056|FG003|Maintenance Phase|Withdrawal by Subject|2|||
160986564|NCT00783718|581341057|FG004|Maintenance Phase|Withdrawal by Subject|5|||
160986565|NCT00783718|581341058|FG005|Maintenance Phase|Withdrawal by Subject|2|||
160986566|NCT00783718|581341059|FG006|Maintenance Phase|Withdrawal by Subject|20|||
160986567|NCT00783718|581341053|FG000|Maintenance Phase|Lost to Follow-up|3|||
160986568|NCT00783718|581341054|FG001|Maintenance Phase|Lost to Follow-up|0|||
160986569|NCT00783718|581341055|FG002|Maintenance Phase|Lost to Follow-up|0|||
160986570|NCT00783718|581341056|FG003|Maintenance Phase|Lost to Follow-up|0|||
160986571|NCT00783718|581341057|FG004|Maintenance Phase|Lost to Follow-up|2|||
160986572|NCT00783718|581341058|FG005|Maintenance Phase|Lost to Follow-up|0|||
161332881|NCT00922636|582606474|FG000|Overall Study|Entry Criteria Not Met|0|||
160899804|NCT03350620|581026404|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
160899805|NCT03350620|581026405|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
160899806|NCT03350620|581026406|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
160899807|NCT00566111|581026407|FG000|Overall Study|Adverse Event|0|||
160899808|NCT00566111|581026408|FG001|Overall Study|Adverse Event|2|||
160899809|NCT00531934|581028564|FG000|Overall Study|Adverse Event|4|||
160899810|NCT00531934|581028565|FG001|Overall Study|Adverse Event|8|||
160899811|NCT00531934|581028564|FG000|Overall Study|Progression|52|||
160899812|NCT00531934|581028565|FG001|Overall Study|Progression|42|||
160899813|NCT00531934|581028564|FG000|Overall Study|Death|7|||
160899814|NCT00531934|581028565|FG001|Overall Study|Death|10|||
160899815|NCT00531934|581028564|FG000|Overall Study|Withdrawal by Subject|1|||
160899816|NCT00531934|581028565|FG001|Overall Study|Withdrawal by Subject|1|||
160899817|NCT00531934|581028564|FG000|Overall Study|Other|2|||
160986573|NCT00783718|581341059|FG006|Maintenance Phase|Lost to Follow-up|2|||
160986574|NCT00577629|581341060|FG000|Treatment Period|Death|1|||
160986575|NCT00577629|581341060|FG000|Long Term Follow-Up|Death|15|||
160986576|NCT00577629|581341060|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
160986577|NCT00577629|581341060|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
160986578|NCT00577629|581341060|FG000|Long Term Follow-Up|Physician Decision|1|||
160986579|NCT02929108|581341063|FG000|Overall Study|Hospice patient death|100|||
160986580|NCT02929108|581341064|FG001|Overall Study|Hospice patient death|64|||
160810803|NCT00624468|580692326|FG003|Safety Follow-up (SFU) Period|Other|1|||
160810804|NCT03520920|580692327|FG000|Overall Study|Death|13|||
160810805|NCT03520920|580692328|FG001|Overall Study|Death|1|||
160810806|NCT03520920|580692329|FG002|Overall Study|Death|0|||
160810807|NCT03520920|580692327|FG000|Overall Study|Withdrawal by Subject|2|||
160810808|NCT03520920|580692328|FG001|Overall Study|Withdrawal by Subject|1|||
161239054|NCT03173547|582255873|FG000|Overall Study|Adverse Event|2|||
160810809|NCT03520920|580692329|FG002|Overall Study|Withdrawal by Subject|0|||
160810810|NCT03520920|580692327|FG000|Overall Study|Study Terminated by the Sponsor|5|||
160810811|NCT03520920|580692328|FG001|Overall Study|Study Terminated by the Sponsor|14|||
160810812|NCT03520920|580692329|FG002|Overall Study|Study Terminated by the Sponsor|5|||
160810813|NCT04677543|580692330|FG000|Overall Study|Withdrawal by Subject|4|||
160810814|NCT04677543|580692331|FG001|Overall Study|Withdrawal by Subject|1|||
160810815|NCT04677543|580692330|FG000|Overall Study|Physician Decision|0|||
160810816|NCT04677543|580692331|FG001|Overall Study|Physician Decision|1|||
160810817|NCT04677543|580692330|FG000|Overall Study|Adverse Event|0|||
160899818|NCT00531934|581028565|FG001|Overall Study|Other|2|||
160899819|NCT00150709|581028566|FG000|Overall Study|Protocol Violation|7|||
160899820|NCT00150709|581028567|FG001|Overall Study|Protocol Violation|8|||
160899821|NCT00150709|581028568|FG002|Overall Study|Protocol Violation|3|||
160899822|NCT00150709|581028569|FG003|Overall Study|Protocol Violation|1|||
160899823|NCT00150709|581028566|FG000|Overall Study|Adverse Event|8|||
160899824|NCT00150709|581028567|FG001|Overall Study|Adverse Event|2|||
160899825|NCT00150709|581028568|FG002|Overall Study|Adverse Event|2|||
160899826|NCT00150709|581028569|FG003|Overall Study|Adverse Event|3|||
160899827|NCT00150709|581028566|FG000|Overall Study|Lack of Efficacy|6|||
160899828|NCT00150709|581028567|FG001|Overall Study|Lack of Efficacy|11|||
160899829|NCT00150709|581028568|FG002|Overall Study|Lack of Efficacy|9|||
160899830|NCT00150709|581028569|FG003|Overall Study|Lack of Efficacy|0|||
160899831|NCT00150709|581028566|FG000|Overall Study|Withdrawal by Subject|7|||
160899832|NCT00150709|581028567|FG001|Overall Study|Withdrawal by Subject|10|||
160899833|NCT00150709|581028568|FG002|Overall Study|Withdrawal by Subject|5|||
160899834|NCT00150709|581028569|FG003|Overall Study|Withdrawal by Subject|0|||
160899835|NCT00150709|581028566|FG000|Overall Study|Lost to Follow-up|3|||
160899836|NCT00150709|581028567|FG001|Overall Study|Lost to Follow-up|2|||
160899837|NCT00150709|581028568|FG002|Overall Study|Lost to Follow-up|0|||
160899838|NCT00150709|581028569|FG003|Overall Study|Lost to Follow-up|0|||
160899839|NCT00150709|581028566|FG000|Overall Study|Sponsor decision|0|||
160899840|NCT00150709|581028567|FG001|Overall Study|Sponsor decision|0|||
160899841|NCT00150709|581028568|FG002|Overall Study|Sponsor decision|0|||
160899842|NCT00150709|581028569|FG003|Overall Study|Sponsor decision|1|||
160899843|NCT00150709|581028566|FG000|Overall Study|Site/Investigator discontinued the study|5|||
160899844|NCT00150709|581028567|FG001|Overall Study|Site/Investigator discontinued the study|5|||
160899845|NCT00150709|581028568|FG002|Overall Study|Site/Investigator discontinued the study|2|||
160899846|NCT00150709|581028569|FG003|Overall Study|Site/Investigator discontinued the study|0|||
160899847|NCT00150709|581028566|FG000|Overall Study|Decision of parent(s)|1|||
160899848|NCT00150709|581028567|FG001|Overall Study|Decision of parent(s)|2|||
160899849|NCT00150709|581028568|FG002|Overall Study|Decision of parent(s)|0|||
160899850|NCT00150709|581028569|FG003|Overall Study|Decision of parent(s)|0|||
160899851|NCT00150709|581028566|FG000|Overall Study|Decision of parent(s) and investigator|3|||
160899852|NCT00150709|581028567|FG001|Overall Study|Decision of parent(s) and investigator|0|||
160899853|NCT00150709|581028568|FG002|Overall Study|Decision of parent(s) and investigator|0|||
160899854|NCT00150709|581028569|FG003|Overall Study|Decision of parent(s) and investigator|0|||
160899855|NCT00150709|581028566|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
160899856|NCT00150709|581028567|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
160899857|NCT00150709|581028568|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
160899858|NCT00150709|581028569|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
160899859|NCT00150709|581028566|FG000|Overall Study|Investigator decision|1|||
160899860|NCT00150709|581028567|FG001|Overall Study|Investigator decision|0|||
160899861|NCT00150709|581028568|FG002|Overall Study|Investigator decision|0|||
160899862|NCT00150709|581028569|FG003|Overall Study|Investigator decision|1|||
160899863|NCT00150709|581028566|FG000|Overall Study|Subject relocated|2|||
160899864|NCT00150709|581028567|FG001|Overall Study|Subject relocated|2|||
160899865|NCT00150709|581028568|FG002|Overall Study|Subject relocated|1|||
160899866|NCT00150709|581028569|FG003|Overall Study|Subject relocated|0|||
160899867|NCT00150709|581028566|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
160899868|NCT00150709|581028567|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
160899869|NCT00150709|581028568|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
160899870|NCT00150709|581028569|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
160899871|NCT00150709|581028566|FG000|Overall Study|Convenience|0|||
160899872|NCT00150709|581028567|FG001|Overall Study|Convenience|1|||
160899873|NCT00150709|581028568|FG002|Overall Study|Convenience|0|||
160899874|NCT00150709|581028569|FG003|Overall Study|Convenience|0|||
160899875|NCT00150709|581028566|FG000|Overall Study|Subject entered new drug study|0|||
160899876|NCT00150709|581028567|FG001|Overall Study|Subject entered new drug study|1|||
161239055|NCT03173547|582255874|FG001|Overall Study|Adverse Event|0|||
160810818|NCT04677543|580692331|FG001|Overall Study|Adverse Event|1|||
160810819|NCT00995436|580692332|FG000|Overall Study|Withdrawal by Subject|2|||
160810820|NCT00995436|580692333|FG001|Overall Study|Withdrawal by Subject|5|||
160810821|NCT00995436|580692334|FG002|Overall Study|Withdrawal by Subject|0|||
160810822|NCT03035864|580692336|FG000|Treatment Period|Adverse Event|1|||
160810823|NCT03035864|580692337|FG001|Treatment Period|Adverse Event|0|||
160810824|NCT03035864|580692336|FG000|Treatment Period|Other|3|||
160810825|NCT03035864|580692337|FG001|Treatment Period|Other|1|||
160810826|NCT03035864|580692336|FG000|Follow-up Period|Adverse Event|1|||
160810827|NCT03035864|580692337|FG001|Follow-up Period|Adverse Event|0|||
160810828|NCT03035864|580692336|FG000|Follow-up Period|Lost to Follow-up|6|||
160986581|NCT02929108|581341065|FG002|Overall Study|Hospice patient death|28|||
160986582|NCT02929108|581341066|FG003|Overall Study|Hospice patient death|46|||
160986583|NCT02929108|581341067|FG004|Overall Study|Hospice patient death|55|||
160986584|NCT02929108|581341068|FG005|Overall Study|Hospice patient death|28|||
160986585|NCT02929108|581341069|FG006|Overall Study|Hospice patient death|78|||
160986586|NCT01027871|581341070|FG000|Overall Study|Physician Decision|1|||
160986587|NCT01027871|581341071|FG001|Overall Study|Physician Decision|5|||
160986588|NCT01027871|581341072|FG002|Overall Study|Physician Decision|0|||
160986589|NCT01027871|581341070|FG000|Overall Study|Protocol Violation|0|||
160986590|NCT01027871|581341071|FG001|Overall Study|Protocol Violation|2|||
160986591|NCT01027871|581341072|FG002|Overall Study|Protocol Violation|2|||
160986592|NCT01027871|581341070|FG000|Overall Study|Withdrawal by Subject|1|||
160986593|NCT01027871|581341071|FG001|Overall Study|Withdrawal by Subject|2|||
160986594|NCT01027871|581341072|FG002|Overall Study|Withdrawal by Subject|2|||
160986595|NCT01027871|581341070|FG000|Overall Study|Adverse Event|0|||
160986596|NCT01027871|581341071|FG001|Overall Study|Adverse Event|2|||
161332882|NCT00922636|582606475|FG001|Overall Study|Entry Criteria Not Met|0|||
160810829|NCT03035864|580692337|FG001|Follow-up Period|Lost to Follow-up|2|||
160810830|NCT03035864|580692336|FG000|Follow-up Period|Physician Decision|1|||
160810831|NCT03035864|580692337|FG001|Follow-up Period|Physician Decision|0|||
160810832|NCT03035864|580692336|FG000|Follow-up Period|Other|3|||
160810833|NCT03035864|580692337|FG001|Follow-up Period|Other|2|||
160810834|NCT00407602|580692340|FG000|Overall Study|Death - unrelated to device|1|||
160810835|NCT00407602|580692340|FG000|Overall Study|Device explanted|5|||
160810836|NCT00407602|580692340|FG000|Overall Study|Withdrawal by Subject|1|||
160810837|NCT00553436|580692341|FG000|Overall Study|Conversion to another procedure|1|||
160810838|NCT04188834|580692342|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
160810839|NCT00577707|580692345|FG000|Overall Study|Withdrawal by Subject|3|||
160810840|NCT03706430|580692353|FG000|Overall Study|No A-Line placed|5|||
160810841|NCT03706430|580692353|FG000|Overall Study|Subject had gel nail polish|1|||
160810842|NCT03706430|580692353|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
160810843|NCT03706430|580692353|FG000|Overall Study|Cancelled Case|6|||
160810844|NCT03706430|580692353|FG000|Overall Study|Physician Decision|2|||
160810845|NCT01928433|580692354|FG000|Overall Study|Adverse Event|5|||
160810846|NCT01928433|580692355|FG001|Overall Study|Adverse Event|2|||
160810847|NCT01928433|580692356|FG002|Overall Study|Adverse Event|5|||
160810848|NCT01928433|580692354|FG000|Overall Study|Protocol Violation|0|||
160810849|NCT01928433|580692355|FG001|Overall Study|Protocol Violation|0|||
160810850|NCT01928433|580692356|FG002|Overall Study|Protocol Violation|2|||
160810851|NCT01928433|580692354|FG000|Overall Study|Lack of Efficacy|5|||
160810852|NCT01928433|580692355|FG001|Overall Study|Lack of Efficacy|4|||
160810853|NCT01928433|580692356|FG002|Overall Study|Lack of Efficacy|4|||
160810854|NCT01928433|580692354|FG000|Overall Study|Withdrawal by Subject|0|||
160810855|NCT01928433|580692355|FG001|Overall Study|Withdrawal by Subject|4|||
160810856|NCT01928433|580692356|FG002|Overall Study|Withdrawal by Subject|0|||
160810857|NCT01928433|580692354|FG000|Overall Study|Negative screening urine culture|7|||
160810858|NCT01928433|580692355|FG001|Overall Study|Negative screening urine culture|6|||
160810859|NCT01928433|580692356|FG002|Overall Study|Negative screening urine culture|10|||
160810860|NCT01928433|580692354|FG000|Overall Study|Lost to Follow-up|0|||
160810861|NCT01928433|580692355|FG001|Overall Study|Lost to Follow-up|2|||
160810862|NCT01928433|580692356|FG002|Overall Study|Lost to Follow-up|3|||
160810863|NCT01928433|580692354|FG000|Overall Study|Other reasons|3|||
160810864|NCT01928433|580692355|FG001|Overall Study|Other reasons|3|||
160986597|NCT01027871|581341072|FG002|Overall Study|Adverse Event|2|||
160810865|NCT01928433|580692356|FG002|Overall Study|Other reasons|4|||
160810866|NCT00145626|580692357|FG000|Overall Study|Did not have NK infusions|2|||
160810867|NCT00145626|580692357|FG000|Overall Study|Turned 2 years old before treatment|1|||
160986598|NCT01027871|581341070|FG000|Overall Study|Sponsor Decision|0|||
160986599|NCT01027871|581341071|FG001|Overall Study|Sponsor Decision|2|||
160986600|NCT01027871|581341072|FG002|Overall Study|Sponsor Decision|0|||
161131344|NCT01662648|581865285|FG000|Overall Study|LOE and other reason unspecified|1|||
161131345|NCT01662648|581865286|FG001|Overall Study|LOE and other reason unspecified|0|||
161332883|NCT00922636|582606476|FG002|Overall Study|Entry Criteria Not Met|1|||
160810868|NCT00145626|580692357|FG000|Overall Study|Death|1|||
160810869|NCT00145626|580692357|FG000|Overall Study|Withdrawal by Subject|1|||
160810870|NCT00100802|580692358|FG000|Overall Study|Adverse Event|9|||
160810871|NCT00100802|580692358|FG000|Overall Study|Death|1|||
160810872|NCT00100802|580692358|FG000|Overall Study|Lack of Efficacy|47|||
160810873|NCT00100802|580692358|FG000|Overall Study|Physician Decision|5|||
160810874|NCT00100802|580692358|FG000|Overall Study|Protocol Violation|1|||
160810875|NCT00100802|580692358|FG000|Overall Study|Withdrawal by Subject|5|||
160810876|NCT00100802|580692358|FG000|Overall Study|Ineligible|12|||
160810877|NCT02709720|580692359|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
160810878|NCT02709720|580692359|FG000|Overall Study|Protocol Violation|1|||
160810879|NCT02709720|580692359|FG000|Overall Study|Not take study medication|1|||
160810880|NCT01198574|580692361|FG000|Overall Study|Resigned from schools|4|||
160810881|NCT01198574|580692362|FG001|Overall Study|Resigned from schools|1|||
160810882|NCT01198574|580692363|FG002|Overall Study|Resigned from schools|1|||
160810883|NCT01198574|580692364|FG003|Overall Study|Resigned from schools|4|||
160810884|NCT00200967|580692367|FG000|First Treatment Period|Withdrawal by Subject|5|||
160810885|NCT00200967|580692368|FG001|First Treatment Period|Withdrawal by Subject|1|||
160810886|NCT00200967|580692367|FG000|First Treatment Period|Pregnancy|1|||
160810887|NCT00200967|580692368|FG001|First Treatment Period|Pregnancy|0|||
160810888|NCT00200967|580692367|FG000|Wash-out Period|Lost to Follow-up|0|||
160810889|NCT00200967|580692368|FG001|Wash-out Period|Lost to Follow-up|1|||
160810890|NCT00200967|580692367|FG000|Second Treatment Period|Withdrawal by Subject|1|||
160810891|NCT00200967|580692368|FG001|Second Treatment Period|Withdrawal by Subject|2|||
160810892|NCT00200967|580692367|FG000|Run-out Period|Lost to Follow-up|1|||
160810893|NCT00200967|580692368|FG001|Run-out Period|Lost to Follow-up|0|||
160810894|NCT03744910|580694477|FG000|Overall Study|Withdrew Consent|1|||
160810895|NCT03744910|580694478|FG001|Overall Study|Withdrew Consent|8|||
160810896|NCT03744910|580694477|FG000|Overall Study|Physician Decision|5|||
160810897|NCT03744910|580694478|FG001|Overall Study|Physician Decision|4|||
160810898|NCT03744910|580694477|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
160810899|NCT03744910|580694478|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
160810900|NCT03744910|580694477|FG000|Overall Study|Lost to Follow-up|0|||
160810901|NCT03744910|580694478|FG001|Overall Study|Lost to Follow-up|1|||
160810902|NCT03744910|580694477|FG000|Overall Study|Other-unspecified|4|||
160810903|NCT03744910|580694478|FG001|Overall Study|Other-unspecified|1|||
160810904|NCT02712983|580694479|FG000|Treatment Phase|Adverse Event|3|||
160810905|NCT02712983|580694480|FG001|Treatment Phase|Adverse Event|1|||
160810906|NCT02712983|580694481|FG002|Treatment Phase|Adverse Event|1|||
160810907|NCT02712983|580694482|FG003|Treatment Phase|Adverse Event|4|||
160810908|NCT02712983|580694483|FG004|Treatment Phase|Adverse Event|3|||
160810909|NCT02712983|580694484|FG005|Treatment Phase|Adverse Event|0|||
160810910|NCT02712983|580694485|FG006|Treatment Phase|Adverse Event|6|||
160810911|NCT02712983|580694486|FG007|Treatment Phase|Adverse Event|6|||
160810912|NCT02712983|580694487|FG008|Treatment Phase|Adverse Event|1|||
160810913|NCT02712983|580694479|FG000|Treatment Phase|Protocol Deviation|0|||
160810914|NCT02712983|580694480|FG001|Treatment Phase|Protocol Deviation|0|||
160810915|NCT02712983|580694481|FG002|Treatment Phase|Protocol Deviation|0|||
160810916|NCT02712983|580694482|FG003|Treatment Phase|Protocol Deviation|2|||
160810917|NCT02712983|580694483|FG004|Treatment Phase|Protocol Deviation|0|||
160810918|NCT02712983|580694484|FG005|Treatment Phase|Protocol Deviation|0|||
160810919|NCT02712983|580694485|FG006|Treatment Phase|Protocol Deviation|1|||
160810920|NCT02712983|580694486|FG007|Treatment Phase|Protocol Deviation|0|||
160810921|NCT02712983|580694487|FG008|Treatment Phase|Protocol Deviation|0|||
160810922|NCT02712983|580694479|FG000|Treatment Phase|Technical Problems|0|||
160810923|NCT02712983|580694480|FG001|Treatment Phase|Technical Problems|0|||
160810924|NCT02712983|580694481|FG002|Treatment Phase|Technical Problems|0|||
160810925|NCT02712983|580694482|FG003|Treatment Phase|Technical Problems|0|||
160810926|NCT02712983|580694483|FG004|Treatment Phase|Technical Problems|0|||
160810927|NCT02712983|580694484|FG005|Treatment Phase|Technical Problems|0|||
160810928|NCT02712983|580694485|FG006|Treatment Phase|Technical Problems|1|||
160810929|NCT02712983|580694486|FG007|Treatment Phase|Technical Problems|0|||
160810930|NCT02712983|580694487|FG008|Treatment Phase|Technical Problems|0|||
160810931|NCT02712983|580694479|FG000|Treatment Phase|Physician Decision|0|||
160810932|NCT02712983|580694480|FG001|Treatment Phase|Physician Decision|0|||
160810933|NCT02712983|580694481|FG002|Treatment Phase|Physician Decision|0|||
160810934|NCT02712983|580694482|FG003|Treatment Phase|Physician Decision|0|||
161131346|NCT01662648|581865285|FG000|Overall Study|LOE and Participant non-compliant|0|||
161131347|NCT01662648|581865286|FG001|Overall Study|LOE and Participant non-compliant|1|||
160810935|NCT02712983|580694483|FG004|Treatment Phase|Physician Decision|0|||
160810936|NCT02712983|580694484|FG005|Treatment Phase|Physician Decision|0|||
160810937|NCT02712983|580694485|FG006|Treatment Phase|Physician Decision|0|||
160810938|NCT02712983|580694486|FG007|Treatment Phase|Physician Decision|1|||
160810939|NCT02712983|580694487|FG008|Treatment Phase|Physician Decision|1|||
160810940|NCT02712983|580694479|FG000|Treatment Phase|Subject Decision|2|||
160810941|NCT02712983|580694480|FG001|Treatment Phase|Subject Decision|0|||
160810942|NCT02712983|580694481|FG002|Treatment Phase|Subject Decision|0|||
160810943|NCT02712983|580694482|FG003|Treatment Phase|Subject Decision|2|||
160810944|NCT02712983|580694483|FG004|Treatment Phase|Subject Decision|1|||
161131348|NCT00868790|581865287|FG000|Period 1|Adverse Event|1|||
160986601|NCT01027871|581341070|FG000|Overall Study|Discontinued Prior to Treatment|0|||
160986602|NCT01027871|581341071|FG001|Overall Study|Discontinued Prior to Treatment|0|||
160986603|NCT01027871|581341072|FG002|Overall Study|Discontinued Prior to Treatment|1|||
160986604|NCT00052962|581341073|FG000|Overall Study|Not evaluable|0|||
160986605|NCT00052962|581341074|FG001|Overall Study|Not evaluable|2|||
160986606|NCT00052962|581341073|FG000|Overall Study|Not randomized/not evaluable|1|||
160986607|NCT00052962|581341074|FG001|Overall Study|Not randomized/not evaluable|0|||
160986608|NCT01414166|581341075|FG000|Overall Study|Adverse Event|10|||
160986609|NCT01414166|581341076|FG001|Overall Study|Adverse Event|2|||
160986610|NCT01414166|581341075|FG000|Overall Study|Lost to Follow-up|4|||
160986611|NCT01414166|581341076|FG001|Overall Study|Lost to Follow-up|1|||
161332884|NCT00922636|582606477|FG003|Overall Study|Entry Criteria Not Met|1|||
161332885|NCT00922636|582606478|FG004|Overall Study|Entry Criteria Not Met|0|||
161332886|NCT00922636|582606474|FG000|Overall Study|Parent/Caregiver Decision|2|||
161332887|NCT00922636|582606475|FG001|Overall Study|Parent/Caregiver Decision|4|||
161332888|NCT00922636|582606476|FG002|Overall Study|Parent/Caregiver Decision|3|||
160810945|NCT02712983|580694484|FG005|Treatment Phase|Subject Decision|0|||
160810946|NCT02712983|580694485|FG006|Treatment Phase|Subject Decision|1|||
160810947|NCT02712983|580694486|FG007|Treatment Phase|Subject Decision|2|||
160810948|NCT02712983|580694487|FG008|Treatment Phase|Subject Decision|0|||
160810949|NCT02712983|580694479|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810950|NCT02712983|580694480|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
160810951|NCT02712983|580694481|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810952|NCT02712983|580694482|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810953|NCT02712983|580694483|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810954|NCT02712983|580694484|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810955|NCT02712983|580694485|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
160810956|NCT02712983|580694486|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
160810957|NCT02712983|580694487|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
160810958|NCT02712983|580694479|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810959|NCT02712983|580694480|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810960|NCT02712983|580694481|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810961|NCT02712983|580694482|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
160810962|NCT02712983|580694483|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810963|NCT02712983|580694484|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810964|NCT02712983|580694485|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810965|NCT02712983|580694486|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810966|NCT02712983|580694487|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
160810967|NCT02712983|580694479|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160899877|NCT00150709|581028568|FG002|Overall Study|Subject entered new drug study|0|||
160899878|NCT00150709|581028569|FG003|Overall Study|Subject entered new drug study|0|||
160899879|NCT00150709|581028566|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
160899880|NCT00150709|581028567|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
160899881|NCT00150709|581028568|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
160899882|NCT00150709|581028569|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
160899883|NCT00150709|581028566|FG000|Overall Study|Lack of ease of swallowing|0|||
160899884|NCT00150709|581028567|FG001|Overall Study|Lack of ease of swallowing|1|||
160899885|NCT00150709|581028568|FG002|Overall Study|Lack of ease of swallowing|0|||
160899886|NCT00150709|581028569|FG003|Overall Study|Lack of ease of swallowing|0|||
160899887|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Adverse Event|16|||
160899888|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Adverse Event|17|||
160899889|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Adverse Event|13|||
160899890|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Adverse Event|18|||
160899891|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Adverse Event|0|||
160899892|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Adverse Event|0|||
160899893|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Adverse Event|0|||
160899894|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Adverse Event|0|||
160899895|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
160899896|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
160899897|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
160899898|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
160899899|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899900|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899901|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899902|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
160899903|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
160986612|NCT01414166|581341075|FG000|Overall Study|Non-compliance with study drug|2|||
161131349|NCT00868790|581865288|FG001|Period 1|Adverse Event|0|||
160810968|NCT02712983|580694480|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160810969|NCT02712983|580694481|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160899904|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
160986613|NCT01414166|581341076|FG001|Overall Study|Non-compliance with study drug|0|||
161131350|NCT00868790|581865289|FG002|Period 1|Adverse Event|0|||
160986614|NCT01414166|581341075|FG000|Overall Study|Physician Decision|2|||
160986615|NCT01414166|581341076|FG001|Overall Study|Physician Decision|0|||
160986616|NCT01414166|581341075|FG000|Overall Study|Protocol Violation|2|||
160810970|NCT02712983|580694482|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160810971|NCT02712983|580694483|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
160810972|NCT02712983|580694484|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
160810973|NCT02712983|580694485|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
160810974|NCT02712983|580694486|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
160810975|NCT02712983|580694487|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
160810976|NCT03280303|580694488|FG000|Overall Study|Death|505|||
160810977|NCT03280303|580694488|FG000|Overall Study|Study terminated by sponsor|383|||
160810978|NCT03280303|580694488|FG000|Overall Study|Other|148|||
160810979|NCT03280303|580694488|FG000|Overall Study|No longer willing to participate in study|101|||
160810980|NCT03280303|580694488|FG000|Overall Study|Lost to follow up|39|||
160810981|NCT03280303|580694488|FG000|Overall Study|Adverse Event|20|||
160810982|NCT00064259|580694489|FG000|Overall Study|Adverse Event|1|||
160810983|NCT00064259|580694490|FG001|Overall Study|Adverse Event|0|||
160810984|NCT00064259|580694491|FG002|Overall Study|Adverse Event|0|||
160986617|NCT01414166|581341076|FG001|Overall Study|Protocol Violation|0|||
160810985|NCT00064259|580694492|FG003|Overall Study|Adverse Event|1|||
160810986|NCT01132651|580694495|FG000|Overall Study|Lost to Follow-up|1|||
160810987|NCT01132651|580694496|FG001|Overall Study|Lost to Follow-up|1|||
160810988|NCT00948857|580694497|FG000|Overall Study|Lost to Follow-up|1|||
160810989|NCT00948857|580694498|FG001|Overall Study|Lost to Follow-up|0|||
160810990|NCT03430843|580694500|FG000|Overall Study|Death|233|||
160810991|NCT03430843|580694501|FG001|Overall Study|Death|233|||
160810992|NCT03430843|580694500|FG000|Overall Study|Sponsor Decision|17|||
160810993|NCT03430843|580694501|FG001|Overall Study|Sponsor Decision|6|||
160810994|NCT03430843|580694500|FG000|Overall Study|Withdrawal by Subject|5|||
160810995|NCT03430843|580694501|FG001|Overall Study|Withdrawal by Subject|14|||
160810996|NCT03430843|580694500|FG000|Overall Study|Lost to Follow-up|1|||
160810997|NCT03430843|580694501|FG001|Overall Study|Lost to Follow-up|3|||
160810998|NCT05360966|580694508|FG000|Overall Study|Adverse Event|5|||
160810999|NCT05360966|580694509|FG001|Overall Study|Adverse Event|5|||
160811000|NCT05360966|580694508|FG000|Overall Study|Withdrawal of Consent|5|||
160811001|NCT05360966|580694509|FG001|Overall Study|Withdrawal of Consent|3|||
160811002|NCT05360966|580694508|FG000|Overall Study|Noncompliance|2|||
160811003|NCT05360966|580694509|FG001|Overall Study|Noncompliance|1|||
160811004|NCT05360966|580694508|FG000|Overall Study|Lost to Follow-up|2|||
160811005|NCT05360966|580694509|FG001|Overall Study|Lost to Follow-up|3|||
160811006|NCT05360966|580694508|FG000|Overall Study|Protocol Deviation|2|||
160811007|NCT05360966|580694509|FG001|Overall Study|Protocol Deviation|1|||
160986618|NCT01414166|581341075|FG000|Overall Study|Study terminated by Sponsor|68|||
160986619|NCT01414166|581341076|FG001|Overall Study|Study terminated by Sponsor|75|||
160986620|NCT01414166|581341075|FG000|Overall Study|Withdrawal by Subject|3|||
160986621|NCT01414166|581341076|FG001|Overall Study|Withdrawal by Subject|5|||
160986622|NCT03782727|581341077|FG000|Overall Study|Lost to Follow-up|32|||
160986623|NCT05489224|581341080|FG000|Treatment Period I|Withdrawal by Subject|6|||
160986624|NCT05489224|581341081|FG001|Treatment Period I|Withdrawal by Subject|5|||
160986625|NCT05489224|581341082|FG002|Treatment Period I|Withdrawal by Subject|0|||
160986626|NCT05489224|581341080|FG000|Treatment Period I|Adverse Event|3|||
160986627|NCT05489224|581341081|FG001|Treatment Period I|Adverse Event|11|||
160986628|NCT05489224|581341082|FG002|Treatment Period I|Adverse Event|0|||
160986629|NCT05489224|581341080|FG000|Treatment Period I|Lost to Follow-up|0|||
160986630|NCT05489224|581341081|FG001|Treatment Period I|Lost to Follow-up|1|||
160986631|NCT05489224|581341082|FG002|Treatment Period I|Lost to Follow-up|0|||
160986632|NCT05489224|581341080|FG000|Treatment Period I|Physician Decision|0|||
160811008|NCT05360966|580694508|FG000|Overall Study|As specified in the Clinical Study Report|1|||
160986633|NCT05489224|581341081|FG001|Treatment Period I|Physician Decision|1|||
160986634|NCT05489224|581341082|FG002|Treatment Period I|Physician Decision|0|||
160986635|NCT05489224|581341080|FG000|Treatment Period II up to Week 32|Ongoing|222|||
160986636|NCT05489224|581341081|FG001|Treatment Period II up to Week 32|Ongoing|107|||
160986637|NCT05489224|581341082|FG002|Treatment Period II up to Week 32|Ongoing|107|||
160811009|NCT05360966|580694509|FG001|Overall Study|As specified in the Clinical Study Report|3|||
160986638|NCT05489224|581341080|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
160986639|NCT05489224|581341081|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
160986640|NCT05489224|581341082|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
160986641|NCT05489224|581341080|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
160986642|NCT05489224|581341081|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
160811010|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
160811011|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811012|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811013|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811014|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811015|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160986643|NCT05489224|581341082|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
160986644|NCT04887285|581341084|FG000|Overall Study|Lost to Follow-up|0|||
160986645|NCT04887285|581341085|FG001|Overall Study|Lost to Follow-up|2|||
160986646|NCT04887285|581341086|FG002|Overall Study|Lost to Follow-up|3|||
160986647|NCT02820051|581341090|FG000|Overall Study|Lost to Follow-up|7|||
160986648|NCT02820051|581341091|FG001|Overall Study|Lost to Follow-up|4|||
160986649|NCT00832780|581341095|FG000|Overall Study|Death|16|||
160986650|NCT00832780|581341095|FG000|Overall Study|Lost to Follow-up|4|||
160986651|NCT00832780|581341095|FG000|Overall Study|no reason given|2|||
160986652|NCT00832780|581341095|FG000|Overall Study|other complicating condition|2|||
160811016|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811017|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811018|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811019|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811020|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811021|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811022|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811023|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
160811024|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811025|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811026|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811027|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811028|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811029|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811030|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811031|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811032|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811033|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811034|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811035|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811036|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
160811037|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811038|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811039|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811040|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811041|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811042|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811043|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811044|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811045|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811046|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811047|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811048|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811049|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
160811050|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160986653|NCT00832780|581341095|FG000|Overall Study|Physician Decision|1|||
161332889|NCT00922636|582606477|FG003|Overall Study|Parent/Caregiver Decision|5|||
160811051|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811052|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
160811053|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
160811054|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811055|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811056|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811057|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811058|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811059|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811060|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811061|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811062|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811063|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811064|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811065|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811066|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
160986654|NCT05705167|581341096|FG000|Overall Study|Randomised but not Treated|0|||
160986655|NCT05705167|581341097|FG001|Overall Study|Randomised but not Treated|2|||
160986656|NCT05705167|581341098|FG002|Overall Study|Randomised but not Treated|0|||
161131351|NCT00868790|581865290|FG003|Period 1|Adverse Event|0|||
160986657|NCT05705167|581341099|FG003|Overall Study|Randomised but not Treated|7|||
160811067|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811068|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811069|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811070|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811071|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811072|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811073|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811074|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811075|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811076|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811077|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811078|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811079|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
160811080|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811081|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811082|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811083|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811084|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811085|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811086|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811087|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811088|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811089|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811090|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811091|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811092|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
160811093|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811094|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811095|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
160811096|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
160811097|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811098|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811099|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811100|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811101|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811102|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811103|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811104|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811105|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811106|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811107|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811108|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811109|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
160811110|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811111|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811112|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811113|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811114|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811115|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811116|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811117|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811118|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811119|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811120|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811121|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811122|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
160811123|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811124|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811125|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811126|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811127|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811128|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811129|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811130|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811131|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811132|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811133|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160899905|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
160986658|NCT05705167|581341100|FG004|Overall Study|Randomised but not Treated|0|||
160811134|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811135|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
160986659|NCT05705167|581341101|FG005|Overall Study|Randomised but not Treated|0|||
160986660|NCT05705167|581341102|FG006|Overall Study|Randomised but not Treated|0|||
160986661|NCT05705167|581341096|FG000|Overall Study|Death|0|||
160986662|NCT05705167|581341097|FG001|Overall Study|Death|0|||
160986663|NCT05705167|581341098|FG002|Overall Study|Death|3|||
160986664|NCT05705167|581341099|FG003|Overall Study|Death|0|||
160986665|NCT05705167|581341100|FG004|Overall Study|Death|1|||
160986666|NCT05705167|581341101|FG005|Overall Study|Death|1|||
160986667|NCT05705167|581341102|FG006|Overall Study|Death|1|||
160986668|NCT05705167|581341096|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986669|NCT05705167|581341097|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986670|NCT05705167|581341098|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
160986671|NCT05705167|581341099|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
160986672|NCT05705167|581341100|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986673|NCT05705167|581341101|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
160986674|NCT05705167|581341102|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
160811136|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811137|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811138|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
160811139|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811140|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811141|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811142|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811143|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811144|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811145|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811146|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811147|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811148|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811149|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811150|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811151|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811152|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811153|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811154|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811155|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811156|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811157|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811158|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811159|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811160|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811161|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811162|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811163|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811164|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811165|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
160811166|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811167|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160986675|NCT01670500|581341103|FG000|Overall Study|Withdrawal by Subject|1|||
160986676|NCT01670500|581341104|FG001|Overall Study|Withdrawal by Subject|0|||
160986677|NCT04955626|581341105|FG000|Blinded Period|Lost to Follow-up|28|||
160986678|NCT04955626|581341106|FG001|Blinded Period|Lost to Follow-up|28|||
160811168|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811169|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811170|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811171|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811172|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160986679|NCT04955626|581341107|FG002|Blinded Period|Lost to Follow-up|7|||
160986680|NCT04955626|581341108|FG003|Blinded Period|Lost to Follow-up|14|||
160986681|NCT04955626|581341109|FG004|Blinded Period|Lost to Follow-up|3|||
160986682|NCT04955626|581341110|FG005|Blinded Period|Lost to Follow-up|2|||
160986683|NCT04955626|581341111|FG006|Blinded Period|Lost to Follow-up|6|||
160986684|NCT04955626|581341112|FG007|Blinded Period|Lost to Follow-up|4|||
160986685|NCT04955626|581341113|FG008|Blinded Period|Lost to Follow-up|5|||
161131352|NCT00868790|581865291|FG004|Period 1|Adverse Event|0|||
161131353|NCT00868790|581865292|FG005|Period 1|Adverse Event|0|||
161131354|NCT00868790|581865293|FG006|Period 1|Adverse Event|0|||
161131355|NCT00868790|581865294|FG007|Period 1|Adverse Event|3|||
160811173|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811174|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811175|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811176|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811177|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811178|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
160811179|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811180|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811181|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
160811182|NCT05396014|580694510|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811183|NCT05396014|580694511|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811184|NCT05396014|580694512|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811185|NCT05396014|580694513|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811186|NCT05396014|580694514|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811187|NCT05396014|580694515|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811188|NCT05396014|580694516|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811189|NCT05396014|580694517|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811190|NCT05396014|580694518|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811191|NCT05396014|580694519|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811192|NCT05396014|580694520|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811193|NCT05396014|580694521|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811194|NCT05396014|580694522|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811195|NCT05396014|580694523|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811196|NCT05396014|580694524|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811197|NCT05396014|580694525|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811198|NCT05396014|580694526|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811199|NCT05396014|580694527|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811200|NCT05396014|580694528|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811201|NCT05396014|580694529|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811202|NCT05396014|580694530|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811203|NCT05396014|580694531|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811204|NCT05396014|580694532|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811205|NCT05396014|580694533|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811206|NCT05396014|580694534|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811207|NCT05396014|580694535|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811208|NCT05396014|580694536|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
160811209|NCT05396014|580694537|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811210|NCT05396014|580694538|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811211|NCT05396014|580694539|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
161131356|NCT00868790|581865295|FG008|Period 1|Adverse Event|1|||
161131357|NCT00868790|581865296|FG009|Period 1|Adverse Event|0|||
160986686|NCT04955626|581341114|FG009|Blinded Period|Lost to Follow-up|8|||
160986687|NCT04955626|581341115|FG010|Blinded Period|Lost to Follow-up|10|||
160811212|NCT05396014|580694540|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811213|NCT05396014|580694541|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811214|NCT05396014|580694542|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811215|NCT05396014|580694543|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811216|NCT05396014|580694544|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811217|NCT05396014|580694545|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811218|NCT05396014|580694546|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811219|NCT05396014|580694547|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811220|NCT05396014|580694548|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811221|NCT05396014|580694549|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811222|NCT05396014|580694550|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811223|NCT05396014|580694551|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811224|NCT05396014|580694552|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
160811225|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811226|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811227|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811228|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811229|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160986688|NCT04955626|581341116|FG011|Blinded Period|Lost to Follow-up|32|||
160986689|NCT04955626|581341117|FG012|Blinded Period|Lost to Follow-up|0|||
160986690|NCT04955626|581341118|FG013|Blinded Period|Lost to Follow-up|0|||
161131358|NCT00868790|581865297|FG010|Period 1|Adverse Event|0|||
161131359|NCT00868790|581865298|FG011|Period 1|Adverse Event|0|||
161131360|NCT00868790|581865299|FG012|Period 1|Adverse Event|0|||
161131361|NCT00868790|581865300|FG013|Period 1|Adverse Event|1|||
160811230|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811231|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811232|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811233|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811234|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811235|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811236|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811237|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811238|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
160811239|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811240|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811241|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811242|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811243|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811244|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811245|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811246|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811247|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811248|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811249|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811250|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811251|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811252|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811253|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811254|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811255|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811256|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811257|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811258|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811259|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811260|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811261|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811262|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811263|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811264|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811265|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811266|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811267|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
160811268|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
160811269|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811270|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811271|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811272|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811273|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811274|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811275|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811276|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811277|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811278|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811279|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811280|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811281|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
160811282|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811283|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811284|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811285|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811286|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811287|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811288|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811289|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811290|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811291|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160986691|NCT04955626|581341119|FG014|Blinded Period|Lost to Follow-up|0|||
160811292|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811293|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811294|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811295|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811296|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811297|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811298|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811299|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811300|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811301|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811302|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811303|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811304|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811305|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811306|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811307|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
160811308|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811309|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811310|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
160811311|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
160811312|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811313|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811314|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811315|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811316|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811317|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811318|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811319|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811320|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811321|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811322|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811323|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811324|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811325|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811326|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811327|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811328|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811329|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811330|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811331|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811332|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811333|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811334|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811335|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811336|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811337|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
160811338|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811339|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811340|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811341|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811342|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811343|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811344|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811345|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811346|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811347|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811348|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160986692|NCT04955626|581341120|FG015|Blinded Period|Lost to Follow-up|12|||
160986693|NCT04955626|581341121|FG016|Blinded Period|Lost to Follow-up|2|||
160986694|NCT04955626|581341122|FG017|Blinded Period|Lost to Follow-up|5|||
160986695|NCT04955626|581341123|FG018|Blinded Period|Lost to Follow-up|0|||
160986696|NCT04955626|581341124|FG019|Blinded Period|Lost to Follow-up|0|||
160811349|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160986697|NCT04955626|581341125|FG020|Blinded Period|Lost to Follow-up|0|||
160986698|NCT04955626|581341126|FG021|Blinded Period|Lost to Follow-up|0|||
160986699|NCT04955626|581341127|FG022|Blinded Period|Lost to Follow-up|0|||
161131362|NCT00868790|581865287|FG000|Period 1|Protocol Violation|1|||
161239056|NCT03173547|582255873|FG000|Overall Study|Withdrawal by Subject|2|||
161239057|NCT03173547|582255874|FG001|Overall Study|Withdrawal by Subject|2|||
161239058|NCT02530905|582255875|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
161239059|NCT02530905|582255876|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
161239060|NCT02530905|582255877|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
161239061|NCT01231906|582255878|FG000|Overall Study|Lack of Efficacy|75|||
161239062|NCT01231906|582255879|FG001|Overall Study|Lack of Efficacy|68|||
161239063|NCT01231906|582255878|FG000|Overall Study|Lost to Follow-up|1|||
161239064|NCT01231906|582255879|FG001|Overall Study|Lost to Follow-up|0|||
161239065|NCT01231906|582255878|FG000|Overall Study|Physician Decision|34|||
161239066|NCT01231906|582255879|FG001|Overall Study|Physician Decision|24|||
161332890|NCT00922636|582606478|FG004|Overall Study|Parent/Caregiver Decision|2|||
161332891|NCT00922636|582606474|FG000|Overall Study|Lost to Follow-up|1|||
161332892|NCT00922636|582606475|FG001|Overall Study|Lost to Follow-up|2|||
161332893|NCT00922636|582606476|FG002|Overall Study|Lost to Follow-up|2|||
161332894|NCT00922636|582606477|FG003|Overall Study|Lost to Follow-up|2|||
160811350|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811351|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811352|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811353|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
160811354|NCT05396014|580694510|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811355|NCT05396014|580694511|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811356|NCT05396014|580694512|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811357|NCT05396014|580694513|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811358|NCT05396014|580694514|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811359|NCT05396014|580694515|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811360|NCT05396014|580694516|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811361|NCT05396014|580694517|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811362|NCT05396014|580694518|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811363|NCT05396014|580694519|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811364|NCT05396014|580694520|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811365|NCT05396014|580694521|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811366|NCT05396014|580694522|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811367|NCT05396014|580694523|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
160811368|NCT05396014|580694524|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811369|NCT05396014|580694525|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811370|NCT05396014|580694526|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811371|NCT05396014|580694527|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811372|NCT05396014|580694528|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811373|NCT05396014|580694529|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811374|NCT05396014|580694530|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811375|NCT05396014|580694531|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811376|NCT05396014|580694532|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811377|NCT05396014|580694533|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986700|NCT04955626|581341128|FG023|Blinded Period|Lost to Follow-up|0|||
161239067|NCT01231906|582255878|FG000|Overall Study|Withdrawal by Subject|0|||
161332895|NCT00922636|582606478|FG004|Overall Study|Lost to Follow-up|4|||
161332896|NCT01117870|582606479|FG000|Overall Study|Inability to place needle|1|||
161332897|NCT01117870|582606480|FG001|Overall Study|Inability to place needle|0|||
161332898|NCT01309386|582606481|FG000|Overall Study|Other|2|||
161332899|NCT01309386|582606482|FG001|Overall Study|Other|0|||
161332900|NCT01309386|582606481|FG000|Overall Study|Withdrawal by Subject|2|||
161332901|NCT01309386|582606482|FG001|Overall Study|Withdrawal by Subject|0|||
161332902|NCT01309386|582606481|FG000|Overall Study|Progressive disease|9|||
161332903|NCT01309386|582606482|FG001|Overall Study|Progressive disease|11|||
161332904|NCT01309386|582606481|FG000|Overall Study|Physician Decision|1|||
161332905|NCT01309386|582606482|FG001|Overall Study|Physician Decision|1|||
161332906|NCT01309386|582606481|FG000|Overall Study|Lack of Efficacy|3|||
161332907|NCT01309386|582606482|FG001|Overall Study|Lack of Efficacy|1|||
161332908|NCT01309386|582606481|FG000|Overall Study|Adverse Event|5|||
161332909|NCT01309386|582606482|FG001|Overall Study|Adverse Event|8|||
161332910|NCT00749398|582606483|FG000|Overall Study|Lack of Efficacy|7|||
161332911|NCT00749398|582606483|FG000|Overall Study|Adverse Event|4|||
161332912|NCT00749398|582606483|FG000|Overall Study|Serious adverse event|11|||
161332913|NCT00749398|582606483|FG000|Overall Study|Withdrawal by Subject|17|||
161332914|NCT00749398|582606483|FG000|Overall Study|Lost to Follow-up|11|||
161239068|NCT01231906|582255879|FG001|Overall Study|Withdrawal by Subject|4|||
161239069|NCT01231906|582255878|FG000|Overall Study|Ineligible|10|||
161239070|NCT01231906|582255879|FG001|Overall Study|Ineligible|3|||
161332915|NCT00749398|582606483|FG000|Overall Study|Reason not specified|2|||
161239071|NCT01231906|582255878|FG000|Overall Study|No treatment|1|||
161239072|NCT01231906|582255879|FG001|Overall Study|No treatment|2|||
161332916|NCT00749398|582606483|FG000|Overall Study|Unknown reason|1|||
161131363|NCT00868790|581865288|FG001|Period 1|Protocol Violation|0|||
161131364|NCT00868790|581865289|FG002|Period 1|Protocol Violation|0|||
161131365|NCT00868790|581865290|FG003|Period 1|Protocol Violation|0|||
161131366|NCT00868790|581865291|FG004|Period 1|Protocol Violation|0|||
161131367|NCT00868790|581865292|FG005|Period 1|Protocol Violation|0|||
161131368|NCT00868790|581865293|FG006|Period 1|Protocol Violation|0|||
161131369|NCT00868790|581865294|FG007|Period 1|Protocol Violation|0|||
161131370|NCT00868790|581865295|FG008|Period 1|Protocol Violation|0|||
161131371|NCT00868790|581865296|FG009|Period 1|Protocol Violation|0|||
161131372|NCT00868790|581865297|FG010|Period 1|Protocol Violation|0|||
161131373|NCT00868790|581865298|FG011|Period 1|Protocol Violation|0|||
161131374|NCT00868790|581865299|FG012|Period 1|Protocol Violation|0|||
161131375|NCT00868790|581865300|FG013|Period 1|Protocol Violation|0|||
161131376|NCT00868790|581865287|FG000|Period 1|Withdrawal by Subject|0|||
161131377|NCT00868790|581865288|FG001|Period 1|Withdrawal by Subject|1|||
161131378|NCT00868790|581865289|FG002|Period 1|Withdrawal by Subject|0|||
161131379|NCT00868790|581865290|FG003|Period 1|Withdrawal by Subject|0|||
161131380|NCT00868790|581865291|FG004|Period 1|Withdrawal by Subject|0|||
161131381|NCT00868790|581865292|FG005|Period 1|Withdrawal by Subject|0|||
161131382|NCT00868790|581865293|FG006|Period 1|Withdrawal by Subject|0|||
161131383|NCT00868790|581865294|FG007|Period 1|Withdrawal by Subject|0|||
161131384|NCT00868790|581865295|FG008|Period 1|Withdrawal by Subject|0|||
161131385|NCT00868790|581865296|FG009|Period 1|Withdrawal by Subject|0|||
161131386|NCT00868790|581865297|FG010|Period 1|Withdrawal by Subject|0|||
161131387|NCT00868790|581865298|FG011|Period 1|Withdrawal by Subject|0|||
161131388|NCT00868790|581865299|FG012|Period 1|Withdrawal by Subject|0|||
161131389|NCT00868790|581865300|FG013|Period 1|Withdrawal by Subject|1|||
161131390|NCT00868790|581865287|FG000|Period 1|Abnormal Triglycerides|0|||
161131391|NCT00868790|581865288|FG001|Period 1|Abnormal Triglycerides|0|||
161131392|NCT00868790|581865289|FG002|Period 1|Abnormal Triglycerides|0|||
161131393|NCT00868790|581865290|FG003|Period 1|Abnormal Triglycerides|0|||
161131394|NCT00868790|581865291|FG004|Period 1|Abnormal Triglycerides|1|||
161131395|NCT00868790|581865292|FG005|Period 1|Abnormal Triglycerides|0|||
161131396|NCT00868790|581865293|FG006|Period 1|Abnormal Triglycerides|0|||
161131397|NCT00868790|581865294|FG007|Period 1|Abnormal Triglycerides|0|||
161131398|NCT00868790|581865295|FG008|Period 1|Abnormal Triglycerides|0|||
161131399|NCT00868790|581865296|FG009|Period 1|Abnormal Triglycerides|0|||
161131400|NCT00868790|581865297|FG010|Period 1|Abnormal Triglycerides|0|||
161131401|NCT00868790|581865298|FG011|Period 1|Abnormal Triglycerides|0|||
161131402|NCT00868790|581865299|FG012|Period 1|Abnormal Triglycerides|0|||
161131403|NCT00868790|581865300|FG013|Period 1|Abnormal Triglycerides|0|||
161131404|NCT00868790|581865287|FG000|Period 1|Lost to Follow-up|0|||
161131405|NCT00868790|581865288|FG001|Period 1|Lost to Follow-up|0|||
161131406|NCT00868790|581865289|FG002|Period 1|Lost to Follow-up|0|||
161131407|NCT00868790|581865290|FG003|Period 1|Lost to Follow-up|0|||
161131408|NCT00868790|581865291|FG004|Period 1|Lost to Follow-up|0|||
161131409|NCT00868790|581865292|FG005|Period 1|Lost to Follow-up|1|||
161131410|NCT00868790|581865293|FG006|Period 1|Lost to Follow-up|0|||
161131411|NCT00868790|581865294|FG007|Period 1|Lost to Follow-up|0|||
161131412|NCT00868790|581865295|FG008|Period 1|Lost to Follow-up|0|||
161131413|NCT00868790|581865296|FG009|Period 1|Lost to Follow-up|0|||
161131414|NCT00868790|581865297|FG010|Period 1|Lost to Follow-up|0|||
161131415|NCT00868790|581865298|FG011|Period 1|Lost to Follow-up|0|||
161131416|NCT00868790|581865299|FG012|Period 1|Lost to Follow-up|0|||
161131417|NCT00868790|581865300|FG013|Period 1|Lost to Follow-up|0|||
160899906|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
160899907|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
160899908|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
160899909|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
160899910|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
160899911|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
160899912|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
160899913|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
160899914|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
160899915|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
160899916|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
160986701|NCT04955626|581341129|FG024|Blinded Period|Lost to Follow-up|3|||
161131418|NCT00868790|581865287|FG000|Period 2|Adverse Event|0|||
161131419|NCT00868790|581865288|FG001|Period 2|Adverse Event|0|||
161131420|NCT00868790|581865289|FG002|Period 2|Adverse Event|0|||
161131421|NCT00868790|581865290|FG003|Period 2|Adverse Event|0|||
161131422|NCT00868790|581865291|FG004|Period 2|Adverse Event|0|||
160899917|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
161131423|NCT00868790|581865292|FG005|Period 2|Adverse Event|0|||
161131424|NCT00868790|581865293|FG006|Period 2|Adverse Event|0|||
161131425|NCT00868790|581865294|FG007|Period 2|Adverse Event|0|||
161131426|NCT00868790|581865295|FG008|Period 2|Adverse Event|1|||
161131427|NCT00868790|581865296|FG009|Period 2|Adverse Event|0|||
161131428|NCT00868790|581865297|FG010|Period 2|Adverse Event|0|||
161131429|NCT00868790|581865298|FG011|Period 2|Adverse Event|0|||
161131430|NCT00868790|581865299|FG012|Period 2|Adverse Event|0|||
161131431|NCT00868790|581865300|FG013|Period 2|Adverse Event|0|||
160899918|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
160899919|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
160899920|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899921|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
160899922|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
160899923|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899924|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899925|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899926|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
160899927|NCT02975336|581028570|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
160899928|NCT02975336|581028571|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
160899929|NCT02975336|581028572|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
160899930|NCT02975336|581028573|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
160899931|NCT02975336|581028574|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
160899932|NCT02975336|581028575|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
160899933|NCT02975336|581028576|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
160899934|NCT02975336|581028577|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
160899935|NCT02975336|581028570|FG000|LTE (104 Weeks)|Adverse Event|0|||
160899936|NCT02975336|581028571|FG001|LTE (104 Weeks)|Adverse Event|0|||
160899937|NCT02975336|581028572|FG002|LTE (104 Weeks)|Adverse Event|0|||
160899938|NCT02975336|581028573|FG003|LTE (104 Weeks)|Adverse Event|0|||
160899939|NCT02975336|581028574|FG004|LTE (104 Weeks)|Adverse Event|7|||
160899940|NCT02975336|581028575|FG005|LTE (104 Weeks)|Adverse Event|4|||
160899941|NCT02975336|581028576|FG006|LTE (104 Weeks)|Adverse Event|2|||
160899942|NCT02975336|581028577|FG007|LTE (104 Weeks)|Adverse Event|0|||
160899943|NCT02975336|581028570|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
160899944|NCT02975336|581028571|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
160899945|NCT02975336|581028572|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
160899946|NCT02975336|581028573|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
160899947|NCT02975336|581028574|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
160899948|NCT02975336|581028575|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
160899949|NCT02975336|581028576|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
160899950|NCT02975336|581028577|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
160899951|NCT02975336|581028570|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
160899952|NCT02975336|581028571|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
160899953|NCT02975336|581028572|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
160899954|NCT02975336|581028573|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
160899955|NCT02975336|581028574|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
160899956|NCT02975336|581028575|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
160899957|NCT02975336|581028576|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
160899958|NCT02975336|581028577|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
160899959|NCT02975336|581028570|FG000|LTE (104 Weeks)|Other|0|||
160899960|NCT02975336|581028571|FG001|LTE (104 Weeks)|Other|0|||
160899961|NCT02975336|581028572|FG002|LTE (104 Weeks)|Other|0|||
160899962|NCT02975336|581028573|FG003|LTE (104 Weeks)|Other|0|||
160899963|NCT02975336|581028574|FG004|LTE (104 Weeks)|Other|55|||
160899964|NCT02975336|581028575|FG005|LTE (104 Weeks)|Other|63|||
160899965|NCT02975336|581028576|FG006|LTE (104 Weeks)|Other|76|||
160986702|NCT04955626|581341130|FG025|Blinded Period|Lost to Follow-up|1|||
160986703|NCT04955626|581341131|FG026|Blinded Period|Lost to Follow-up|2|||
160986704|NCT04955626|581341132|FG027|Blinded Period|Lost to Follow-up|2|||
160986705|NCT04955626|581341133|FG028|Blinded Period|Lost to Follow-up|2|||
160986706|NCT04955626|581341134|FG029|Blinded Period|Lost to Follow-up|0|||
160986707|NCT04955626|581341135|FG030|Blinded Period|Lost to Follow-up|0|||
160986708|NCT04955626|581341136|FG031|Blinded Period|Lost to Follow-up|0|||
160986709|NCT04955626|581341137|FG032|Blinded Period|Lost to Follow-up|0|||
160986710|NCT04955626|581341138|FG033|Blinded Period|Lost to Follow-up|0|||
161239073|NCT01136174|582255880|FG000|Overall Study|Adverse Event|0|||
161239074|NCT01136174|582255881|FG001|Overall Study|Adverse Event|0|||
161239075|NCT01136174|582255882|FG002|Overall Study|Adverse Event|0|||
161239076|NCT01136174|582255883|FG003|Overall Study|Adverse Event|4|||
161239077|NCT01249651|582255887|FG000|Overall Study|Withdrawal by Subject|4|||
161239078|NCT01249651|582255887|FG000|Overall Study|Adverse Event|1|||
161239079|NCT01249651|582255887|FG000|Overall Study|Protocol Violation|1|||
161239080|NCT01249651|582255887|FG000|Overall Study|Sponsor Decision|1|||
161239081|NCT03873272|582255898|FG000|Overall Study|Withdrawal by Subject|2|||
161239082|NCT03873272|582255899|FG001|Overall Study|Withdrawal by Subject|0|||
161239083|NCT03873272|582255900|FG002|Overall Study|Withdrawal by Subject|1|||
160899966|NCT02975336|581028577|FG007|LTE (104 Weeks)|Other|72|||
160899967|NCT01816074|581028581|FG000|Phase 1|Time commitment issues|0|||
160899968|NCT01816074|581028582|FG001|Phase 1|Time commitment issues|0|||
160899969|NCT01816074|581028583|FG002|Phase 1|Time commitment issues|1|||
160986711|NCT04955626|581341139|FG034|Blinded Period|Lost to Follow-up|0|||
161239084|NCT03873272|582255898|FG000|Overall Study|Death|0|||
161239085|NCT03873272|582255899|FG001|Overall Study|Death|2|||
161239086|NCT03873272|582255900|FG002|Overall Study|Death|1|||
161239087|NCT03761173|582255901|FG000|Overall Study|Lost to Follow-up|93|||
161239088|NCT03761173|582255901|FG000|Overall Study|Withdrawal by Subject|74|||
161239089|NCT03761173|582255901|FG000|Overall Study|Death|45|||
160986712|NCT04955626|581341140|FG035|Blinded Period|Lost to Follow-up|0|||
161239090|NCT03761173|582255901|FG000|Overall Study|Withdrawal for Other Reasons|29|||
161239091|NCT03761173|582255901|FG000|Overall Study|Protocol Violation|1|||
161239092|NCT01952691|582256833|FG000|Overall Study|Lost to Follow-up|2|||
161239093|NCT00199901|582256834|FG000|Overall Study|Protocol Violation|2|||
161239094|NCT00199901|582256835|FG001|Overall Study|Protocol Violation|0|||
161239095|NCT00199901|582256834|FG000|Overall Study|Withdrawal by Subject|1|||
161332917|NCT05953363|582606486|FG000|Overall Study|Screen Failure|2|||
160811378|NCT05396014|580694534|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986713|NCT04955626|581341105|FG000|Blinded Period|Protocol Violation|5|||
160811379|NCT05396014|580694535|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811380|NCT05396014|580694536|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986714|NCT04955626|581341106|FG001|Blinded Period|Protocol Violation|14|||
160986715|NCT04955626|581341107|FG002|Blinded Period|Protocol Violation|0|||
160986716|NCT04955626|581341108|FG003|Blinded Period|Protocol Violation|1|||
160811381|NCT05396014|580694537|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811382|NCT05396014|580694538|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811383|NCT05396014|580694539|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811384|NCT05396014|580694540|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811385|NCT05396014|580694541|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811386|NCT05396014|580694542|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811387|NCT05396014|580694543|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811388|NCT05396014|580694544|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811389|NCT05396014|580694545|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
161131432|NCT00868790|581865287|FG000|Period 2|Lost to Follow-up|0|||
161131433|NCT00868790|581865288|FG001|Period 2|Lost to Follow-up|1|||
161131434|NCT00868790|581865289|FG002|Period 2|Lost to Follow-up|0|||
161131435|NCT00868790|581865290|FG003|Period 2|Lost to Follow-up|0|||
161131436|NCT00868790|581865291|FG004|Period 2|Lost to Follow-up|0|||
161131437|NCT00868790|581865292|FG005|Period 2|Lost to Follow-up|1|||
161131438|NCT00868790|581865293|FG006|Period 2|Lost to Follow-up|0|||
161131439|NCT00868790|581865294|FG007|Period 2|Lost to Follow-up|0|||
161131440|NCT00868790|581865295|FG008|Period 2|Lost to Follow-up|0|||
161131441|NCT00868790|581865296|FG009|Period 2|Lost to Follow-up|0|||
161131442|NCT00868790|581865297|FG010|Period 2|Lost to Follow-up|0|||
161131443|NCT00868790|581865298|FG011|Period 2|Lost to Follow-up|0|||
161131444|NCT00868790|581865299|FG012|Period 2|Lost to Follow-up|0|||
161131445|NCT00868790|581865300|FG013|Period 2|Lost to Follow-up|0|||
161131446|NCT00868790|581865287|FG000|Period 2|Withdrawal by Subject|0|||
161131447|NCT00868790|581865288|FG001|Period 2|Withdrawal by Subject|0|||
161131448|NCT00868790|581865289|FG002|Period 2|Withdrawal by Subject|0|||
161131449|NCT00868790|581865290|FG003|Period 2|Withdrawal by Subject|0|||
161131450|NCT00868790|581865291|FG004|Period 2|Withdrawal by Subject|0|||
161131451|NCT00868790|581865292|FG005|Period 2|Withdrawal by Subject|0|||
161131452|NCT00868790|581865293|FG006|Period 2|Withdrawal by Subject|0|||
161131453|NCT00868790|581865294|FG007|Period 2|Withdrawal by Subject|0|||
161131454|NCT00868790|581865295|FG008|Period 2|Withdrawal by Subject|1|||
161131455|NCT00868790|581865296|FG009|Period 2|Withdrawal by Subject|0|||
161131456|NCT00868790|581865297|FG010|Period 2|Withdrawal by Subject|0|||
161332918|NCT05953363|582606486|FG000|Overall Study|Withdrawal by Subject|3|||
160811390|NCT05396014|580694546|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811391|NCT05396014|580694547|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811392|NCT05396014|580694548|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986717|NCT04955626|581341109|FG004|Blinded Period|Protocol Violation|2|||
160986718|NCT04955626|581341110|FG005|Blinded Period|Protocol Violation|2|||
160811393|NCT05396014|580694549|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160986719|NCT04955626|581341111|FG006|Blinded Period|Protocol Violation|0|||
160986720|NCT04955626|581341112|FG007|Blinded Period|Protocol Violation|0|||
160986721|NCT04955626|581341113|FG008|Blinded Period|Protocol Violation|0|||
160986722|NCT04955626|581341114|FG009|Blinded Period|Protocol Violation|4|||
160986723|NCT04955626|581341115|FG010|Blinded Period|Protocol Violation|6|||
161131457|NCT00868790|581865298|FG011|Period 2|Withdrawal by Subject|0|||
161131458|NCT00868790|581865299|FG012|Period 2|Withdrawal by Subject|0|||
161131459|NCT00868790|581865300|FG013|Period 2|Withdrawal by Subject|1|||
161131460|NCT00868790|581865287|FG000|Period 3|Adverse Event|0|||
161131461|NCT00868790|581865288|FG001|Period 3|Adverse Event|0|||
161131462|NCT00868790|581865289|FG002|Period 3|Adverse Event|0|||
161131463|NCT00868790|581865290|FG003|Period 3|Adverse Event|0|||
161131464|NCT00868790|581865291|FG004|Period 3|Adverse Event|0|||
161131465|NCT00868790|581865292|FG005|Period 3|Adverse Event|0|||
161131466|NCT00868790|581865293|FG006|Period 3|Adverse Event|0|||
161131467|NCT00868790|581865294|FG007|Period 3|Adverse Event|0|||
161131468|NCT00868790|581865295|FG008|Period 3|Adverse Event|0|||
161131469|NCT00868790|581865296|FG009|Period 3|Adverse Event|1|||
161239096|NCT00199901|582256835|FG001|Overall Study|Withdrawal by Subject|0|||
161239097|NCT00199901|582256834|FG000|Overall Study|Progressive Disease|24|||
161239098|NCT00199901|582256835|FG001|Overall Study|Progressive Disease|24|||
161332919|NCT05953363|582606486|FG000|Overall Study|Surgery cancelled|2|||
160811394|NCT05396014|580694550|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811395|NCT05396014|580694551|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811396|NCT05396014|580694552|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
160811397|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811398|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811399|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811400|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811401|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811402|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811403|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811404|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811405|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811406|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811407|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811408|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811409|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811410|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811411|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811412|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811413|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160986724|NCT04955626|581341116|FG011|Blinded Period|Protocol Violation|1|||
160986725|NCT04955626|581341117|FG012|Blinded Period|Protocol Violation|0|||
160986726|NCT04955626|581341118|FG013|Blinded Period|Protocol Violation|0|||
160986727|NCT04955626|581341119|FG014|Blinded Period|Protocol Violation|2|||
160986728|NCT04955626|581341120|FG015|Blinded Period|Protocol Violation|6|||
160986729|NCT04955626|581341121|FG016|Blinded Period|Protocol Violation|4|||
160986730|NCT04955626|581341122|FG017|Blinded Period|Protocol Violation|6|||
160986731|NCT04955626|581341123|FG018|Blinded Period|Protocol Violation|0|||
160986732|NCT04955626|581341124|FG019|Blinded Period|Protocol Violation|1|||
160986733|NCT04955626|581341125|FG020|Blinded Period|Protocol Violation|0|||
160986734|NCT04955626|581341126|FG021|Blinded Period|Protocol Violation|1|||
160986735|NCT04955626|581341127|FG022|Blinded Period|Protocol Violation|0|||
160986736|NCT04955626|581341128|FG023|Blinded Period|Protocol Violation|0|||
160986737|NCT04955626|581341129|FG024|Blinded Period|Protocol Violation|4|||
160986738|NCT04955626|581341130|FG025|Blinded Period|Protocol Violation|6|||
160986739|NCT04955626|581341131|FG026|Blinded Period|Protocol Violation|5|||
160986740|NCT04955626|581341132|FG027|Blinded Period|Protocol Violation|3|||
160986741|NCT04955626|581341133|FG028|Blinded Period|Protocol Violation|4|||
160986742|NCT04955626|581341134|FG029|Blinded Period|Protocol Violation|3|||
160986743|NCT04955626|581341135|FG030|Blinded Period|Protocol Violation|0|||
160986744|NCT04955626|581341136|FG031|Blinded Period|Protocol Violation|0|||
160986745|NCT04955626|581341137|FG032|Blinded Period|Protocol Violation|0|||
160986746|NCT04955626|581341138|FG033|Blinded Period|Protocol Violation|0|||
160811414|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811415|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811416|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811417|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811418|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811419|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811420|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811421|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811422|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811423|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811424|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811425|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811426|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811427|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811428|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811429|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811430|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811431|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811432|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811433|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160986747|NCT04955626|581341139|FG034|Blinded Period|Protocol Violation|0|||
160986748|NCT04955626|581341140|FG035|Blinded Period|Protocol Violation|0|||
160986749|NCT04955626|581341105|FG000|Blinded Period|Death|0|||
160986750|NCT04955626|581341106|FG001|Blinded Period|Death|2|||
160986751|NCT04955626|581341107|FG002|Blinded Period|Death|0|||
160986752|NCT04955626|581341108|FG003|Blinded Period|Death|0|||
160986753|NCT04955626|581341109|FG004|Blinded Period|Death|0|||
160986754|NCT04955626|581341110|FG005|Blinded Period|Death|0|||
161131470|NCT00868790|581865297|FG010|Period 3|Adverse Event|0|||
160811434|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811435|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811436|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
160811437|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
160811438|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
160811439|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
160811440|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811441|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811442|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811443|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811444|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811445|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811446|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811447|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811448|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
160811449|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811450|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811451|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811452|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811453|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811454|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811455|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811456|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811457|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811458|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811459|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811460|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811461|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811462|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
160811463|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811464|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811465|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811466|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811467|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811468|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811469|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811470|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811471|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811472|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811473|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811474|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811475|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
160811476|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811477|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811478|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811479|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
160811480|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811481|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
160811482|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
160811483|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811484|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811485|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811486|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811487|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811488|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811489|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811490|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811491|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811492|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811493|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811494|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811495|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811496|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811497|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811498|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811499|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811500|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811501|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811502|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811503|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811504|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811505|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811506|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811507|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811508|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811509|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811510|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811511|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811512|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811513|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811514|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811515|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811516|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811517|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811518|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811519|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811520|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811521|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811522|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811523|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811524|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
160811525|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
160811526|NCT05396014|580694510|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811527|NCT05396014|580694511|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811528|NCT05396014|580694512|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811529|NCT05396014|580694513|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811530|NCT05396014|580694514|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811531|NCT05396014|580694515|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811532|NCT05396014|580694516|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811533|NCT05396014|580694517|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811534|NCT05396014|580694518|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811535|NCT05396014|580694519|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811536|NCT05396014|580694520|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811537|NCT05396014|580694521|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811538|NCT05396014|580694522|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811539|NCT05396014|580694523|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811540|NCT05396014|580694524|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811541|NCT05396014|580694525|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811542|NCT05396014|580694526|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811543|NCT05396014|580694527|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811544|NCT05396014|580694528|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811545|NCT05396014|580694529|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811546|NCT05396014|580694530|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811547|NCT05396014|580694531|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811548|NCT05396014|580694532|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160899970|NCT01816074|581028584|FG003|Phase 1|Time commitment issues|0|||
160899971|NCT01816074|581028581|FG000|Phase 2|Time commitment Issues|0|||
160899972|NCT01816074|581028582|FG001|Phase 2|Time commitment Issues|2|||
160899973|NCT01816074|581028583|FG002|Phase 2|Time commitment Issues|0|||
160899974|NCT01816074|581028584|FG003|Phase 2|Time commitment Issues|0|||
160899975|NCT01816074|581028581|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
160899976|NCT01816074|581028582|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
160899977|NCT01816074|581028583|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
160899978|NCT01816074|581028584|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
160899979|NCT01816074|581028581|FG000|Phase 2|Physician Decision|0|||
160899980|NCT01816074|581028582|FG001|Phase 2|Physician Decision|0|||
160899981|NCT01816074|581028583|FG002|Phase 2|Physician Decision|0|||
160899982|NCT01816074|581028584|FG003|Phase 2|Physician Decision|1|||
160899983|NCT01816074|581028581|FG000|Phase 2|Withdrawal by Subject|1|||
160899984|NCT01816074|581028582|FG001|Phase 2|Withdrawal by Subject|0|||
160811549|NCT05396014|580694533|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811550|NCT05396014|580694534|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811551|NCT05396014|580694535|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160899985|NCT01816074|581028583|FG002|Phase 2|Withdrawal by Subject|0|||
160899986|NCT01816074|581028584|FG003|Phase 2|Withdrawal by Subject|0|||
160899987|NCT03355365|581028585|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
160899988|NCT03355365|581028586|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
160811552|NCT05396014|580694536|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
160811553|NCT05396014|580694537|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
161239099|NCT05776901|582256838|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
161239100|NCT02255149|582256848|FG000|Overall Study|Lost to Follow-up|2|||
161239101|NCT02255149|582256848|FG000|Overall Study|Withdrawal by Subject|1|||
161239102|NCT02255149|582256848|FG000|Overall Study|Withdrawal by PI|1|||
161239103|NCT02255149|582256848|FG000|Overall Study|Implant Failure|1|||
160811554|NCT05396014|580694538|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811555|NCT05396014|580694539|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811556|NCT05396014|580694540|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811557|NCT05396014|580694541|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811558|NCT05396014|580694542|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811559|NCT05396014|580694543|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811560|NCT05396014|580694544|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811561|NCT05396014|580694545|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811562|NCT05396014|580694546|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811563|NCT05396014|580694547|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811564|NCT05396014|580694548|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811565|NCT05396014|580694549|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811566|NCT05396014|580694550|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811567|NCT05396014|580694551|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811568|NCT05396014|580694552|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
160811569|NCT04439539|580694553|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
160811570|NCT04439539|580694554|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
160811571|NCT04439539|580694555|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
160811572|NCT04439539|580694553|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
160811573|NCT04439539|580694554|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
160811574|NCT04439539|580694555|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
160811575|NCT04439539|580694553|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
160811576|NCT04439539|580694554|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
160811577|NCT04439539|580694555|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
160811578|NCT05258890|580694557|FG000|Overall Study|Patient withdrawal|6|||
160811579|NCT05258890|580694558|FG001|Overall Study|Patient withdrawal|7|||
160811580|NCT05258890|580694557|FG000|Overall Study|Patient lost to follow-up|10|||
160811581|NCT05258890|580694558|FG001|Overall Study|Patient lost to follow-up|3|||
160811582|NCT05258890|580694557|FG000|Overall Study|Social network member withdrawal|1|||
160811583|NCT05258890|580694558|FG001|Overall Study|Social network member withdrawal|0|||
160811584|NCT05258890|580694557|FG000|Overall Study|Social network member lost to follow-up|5|||
160811585|NCT05258890|580694558|FG001|Overall Study|Social network member lost to follow-up|0|||
160811586|NCT02013778|580694563|FG000|Overall Study|Death|4|||
160811587|NCT02013778|580694563|FG000|Overall Study|Withdrawal by Subject|1|||
160811588|NCT02013778|580694563|FG000|Overall Study|Physician Decision|1|||
160811589|NCT02013778|580694563|FG000|Overall Study|Adverse Event|1|||
160811590|NCT02719691|580694564|FG000|Overall Study|Physician Decision|0|||
160811591|NCT02719691|580694565|FG001|Overall Study|Physician Decision|0|||
160811592|NCT02719691|580694566|FG002|Overall Study|Physician Decision|1|||
160811593|NCT02719691|580694567|FG003|Overall Study|Physician Decision|0|||
160811594|NCT02719691|580694568|FG004|Overall Study|Physician Decision|0|||
160811595|NCT02719691|580694569|FG005|Overall Study|Physician Decision|0|||
160811596|NCT02719691|580694570|FG006|Overall Study|Physician Decision|0|||
160811597|NCT02719691|580694564|FG000|Overall Study|Withdrawal by Subject|0|||
160811598|NCT02719691|580694565|FG001|Overall Study|Withdrawal by Subject|0|||
160811599|NCT02719691|580694566|FG002|Overall Study|Withdrawal by Subject|0|||
160811600|NCT02719691|580694567|FG003|Overall Study|Withdrawal by Subject|0|||
160811601|NCT02719691|580694568|FG004|Overall Study|Withdrawal by Subject|0|||
160811602|NCT02719691|580694569|FG005|Overall Study|Withdrawal by Subject|1|||
160811603|NCT02719691|580694570|FG006|Overall Study|Withdrawal by Subject|0|||
160811604|NCT00861757|580694573|FG000|Overall Study|Adverse Event|1|||
160899989|NCT03355365|581028585|FG000|Year 1, First Intervention|Protocol Violation|1|||
160899990|NCT03355365|581028586|FG001|Year 1, First Intervention|Protocol Violation|0|||
160899991|NCT03355365|581028585|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
160899992|NCT03355365|581028586|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
160899993|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
160899994|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
160899995|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
161239104|NCT00373256|582256854|FG000|Overall Study|Adverse Event (AE)|1|||
161239105|NCT00373256|582256855|FG001|Overall Study|Adverse Event (AE)|5|||
161239106|NCT00373256|582256854|FG000|Overall Study|Lost to Follow-up|2|||
161239107|NCT00373256|582256855|FG001|Overall Study|Lost to Follow-up|1|||
161239108|NCT00373256|582256854|FG000|Overall Study|Death|9|||
161239109|NCT00373256|582256855|FG001|Overall Study|Death|8|||
160811605|NCT00861757|580694574|FG001|Overall Study|Adverse Event|5|||
160811606|NCT00861757|580694575|FG002|Overall Study|Adverse Event|7|||
160811607|NCT00861757|580694576|FG003|Overall Study|Adverse Event|2|||
160811608|NCT00861757|580694573|FG000|Overall Study|Entry Criteria Not Met|1|||
160811609|NCT00861757|580694574|FG001|Overall Study|Entry Criteria Not Met|2|||
160811610|NCT00861757|580694575|FG002|Overall Study|Entry Criteria Not Met|1|||
160811611|NCT00861757|580694576|FG003|Overall Study|Entry Criteria Not Met|1|||
160986755|NCT04955626|581341111|FG006|Blinded Period|Death|0|||
161239110|NCT00373256|582256854|FG000|Overall Study|Objective Progression or Relapse|111|||
161239111|NCT00373256|582256855|FG001|Overall Study|Objective Progression or Relapse|104|||
161239112|NCT00373256|582256854|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
161239113|NCT00373256|582256855|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
161239114|NCT00373256|582256854|FG000|Overall Study|Other|73|||
161239115|NCT00373256|582256855|FG001|Overall Study|Other|107|||
161239116|NCT00373256|582256854|FG000|Overall Study|Protocol Violation|0|||
161239117|NCT00373256|582256855|FG001|Overall Study|Protocol Violation|2|||
161239118|NCT00373256|582256854|FG000|Overall Study|Study Terminated by Sponsor|41|||
161239119|NCT00373256|582256855|FG001|Overall Study|Study Terminated by Sponsor|13|||
160986756|NCT04955626|581341112|FG007|Blinded Period|Death|2|||
160986757|NCT04955626|581341113|FG008|Blinded Period|Death|1|||
160986758|NCT04955626|581341114|FG009|Blinded Period|Death|1|||
160986759|NCT04955626|581341115|FG010|Blinded Period|Death|0|||
160986760|NCT04955626|581341116|FG011|Blinded Period|Death|2|||
160986761|NCT04955626|581341117|FG012|Blinded Period|Death|0|||
160986762|NCT04955626|581341118|FG013|Blinded Period|Death|0|||
160986763|NCT04955626|581341119|FG014|Blinded Period|Death|0|||
160986764|NCT04955626|581341120|FG015|Blinded Period|Death|0|||
160986765|NCT04955626|581341121|FG016|Blinded Period|Death|0|||
160986766|NCT04955626|581341122|FG017|Blinded Period|Death|0|||
160986767|NCT04955626|581341123|FG018|Blinded Period|Death|0|||
160986768|NCT04955626|581341124|FG019|Blinded Period|Death|0|||
160986769|NCT04955626|581341125|FG020|Blinded Period|Death|0|||
160986770|NCT04955626|581341126|FG021|Blinded Period|Death|0|||
160811612|NCT00861757|580694573|FG000|Overall Study|Lack of Efficacy|3|||
160811613|NCT00861757|580694574|FG001|Overall Study|Lack of Efficacy|1|||
160811614|NCT00861757|580694575|FG002|Overall Study|Lack of Efficacy|0|||
160811615|NCT00861757|580694576|FG003|Overall Study|Lack of Efficacy|1|||
160811616|NCT00861757|580694573|FG000|Overall Study|Lost to Follow-up|1|||
160811617|NCT00861757|580694574|FG001|Overall Study|Lost to Follow-up|0|||
160811618|NCT00861757|580694575|FG002|Overall Study|Lost to Follow-up|1|||
160811619|NCT00861757|580694576|FG003|Overall Study|Lost to Follow-up|1|||
160811620|NCT00861757|580694573|FG000|Overall Study|Physician Decision|0|||
160811621|NCT00861757|580694574|FG001|Overall Study|Physician Decision|0|||
160811622|NCT00861757|580694575|FG002|Overall Study|Physician Decision|0|||
160811623|NCT00861757|580694576|FG003|Overall Study|Physician Decision|1|||
160811624|NCT00861757|580694573|FG000|Overall Study|Protocol Violation|2|||
160811625|NCT00861757|580694574|FG001|Overall Study|Protocol Violation|2|||
160811626|NCT00861757|580694575|FG002|Overall Study|Protocol Violation|4|||
160811627|NCT00861757|580694576|FG003|Overall Study|Protocol Violation|1|||
160811628|NCT00861757|580694573|FG000|Overall Study|Withdrawal by Subject|1|||
160811629|NCT00861757|580694574|FG001|Overall Study|Withdrawal by Subject|5|||
160811630|NCT00861757|580694575|FG002|Overall Study|Withdrawal by Subject|5|||
160811631|NCT00861757|580694576|FG003|Overall Study|Withdrawal by Subject|2|||
160811632|NCT03037476|580694579|FG000|Overall Study|Lost to Follow-up|63|||
160811633|NCT03037476|580694580|FG001|Overall Study|Lost to Follow-up|46|||
160986771|NCT04955626|581341127|FG022|Blinded Period|Death|0|||
160986772|NCT04955626|581341128|FG023|Blinded Period|Death|1|||
160986773|NCT04955626|581341129|FG024|Blinded Period|Death|0|||
161239120|NCT05604170|582256856|FG000|Overall Study|Lack of Efficacy|5|||
161239121|NCT05604170|582256856|FG000|Overall Study|Adverse Event|6|||
160811634|NCT02403817|580694581|FG000|Overall Study|Withdrawal by Subject|5|||
160811635|NCT02403817|580694582|FG001|Overall Study|Withdrawal by Subject|0|||
160811636|NCT04908384|580694586|FG000|Overall Study|Lost to Follow-up|4|||
160811637|NCT04908384|580694587|FG001|Overall Study|Lost to Follow-up|4|||
160986774|NCT04955626|581341130|FG025|Blinded Period|Death|0|||
161239122|NCT05604170|582256856|FG000|Overall Study|Physician Decision|6|||
160811638|NCT04908384|580694588|FG002|Overall Study|Lost to Follow-up|0|||
160986775|NCT04955626|581341131|FG026|Blinded Period|Death|1|||
160986776|NCT04955626|581341132|FG027|Blinded Period|Death|1|||
160986777|NCT04955626|581341133|FG028|Blinded Period|Death|0|||
160986778|NCT04955626|581341134|FG029|Blinded Period|Death|1|||
160986779|NCT04955626|581341135|FG030|Blinded Period|Death|0|||
161239123|NCT05604170|582256856|FG000|Overall Study|Lost to Follow-up|6|||
161239124|NCT05604170|582256856|FG000|Overall Study|Withdrawal by Subject|11|||
161239125|NCT05604170|582256856|FG000|Overall Study|Early study termination by sponsor|77|||
161239126|NCT05604170|582256856|FG000|Overall Study|Other|6|||
160811639|NCT04908384|580694589|FG003|Overall Study|Lost to Follow-up|0|||
160811640|NCT00833469|580694590|FG000|Overall Study|Withdrawal by Subject|1|||
160986780|NCT04955626|581341136|FG031|Blinded Period|Death|0|||
160986781|NCT04955626|581341137|FG032|Blinded Period|Death|0|||
160986782|NCT04955626|581341138|FG033|Blinded Period|Death|0|||
160986783|NCT04955626|581341139|FG034|Blinded Period|Death|0|||
160811641|NCT00833469|580694590|FG000|Overall Study|Lost to Follow-up|1|||
160811642|NCT01208324|580694591|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
161131471|NCT00868790|581865298|FG011|Period 3|Adverse Event|0|||
161131472|NCT00868790|581865299|FG012|Period 3|Adverse Event|0|||
161131473|NCT00868790|581865300|FG013|Period 3|Adverse Event|0|||
160811643|NCT01208324|580694592|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
160811644|NCT01208324|580694593|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
160811645|NCT01208324|580694594|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
160811646|NCT00984165|580694595|FG000|Overall Study|Death on study|2|||
160811647|NCT00984165|580694596|FG001|Overall Study|Death on study|0|||
160811648|NCT00984165|580694597|FG002|Overall Study|Death on study|0|||
160811649|NCT00984165|580694598|FG003|Overall Study|Death on study|0|||
160811650|NCT00984165|580694595|FG000|Overall Study|Disease progression on study|5|||
160811651|NCT00984165|580694596|FG001|Overall Study|Disease progression on study|1|||
160811652|NCT00984165|580694597|FG002|Overall Study|Disease progression on study|0|||
160811653|NCT00984165|580694598|FG003|Overall Study|Disease progression on study|0|||
160811654|NCT00984165|580694595|FG000|Overall Study|Death of recipient|0|||
160811655|NCT00984165|580694596|FG001|Overall Study|Death of recipient|0|||
160811656|NCT00984165|580694597|FG002|Overall Study|Death of recipient|0|||
160811657|NCT00984165|580694598|FG003|Overall Study|Death of recipient|1|||
160811658|NCT00984165|580694595|FG000|Overall Study|New protocol|0|||
160811659|NCT00984165|580694596|FG001|Overall Study|New protocol|0|||
161131474|NCT00868790|581865287|FG000|Period 3|Protocol Violation|0|||
161131475|NCT00868790|581865288|FG001|Period 3|Protocol Violation|0|||
161131476|NCT00868790|581865289|FG002|Period 3|Protocol Violation|0|||
160811660|NCT00984165|580694597|FG002|Overall Study|New protocol|0|||
160811661|NCT00984165|580694598|FG003|Overall Study|New protocol|1|||
160811662|NCT00984165|580694595|FG000|Overall Study|P+/donor pair removed from protocol|0|||
160811663|NCT00984165|580694596|FG001|Overall Study|P+/donor pair removed from protocol|0|||
160811664|NCT00984165|580694597|FG002|Overall Study|P+/donor pair removed from protocol|0|||
160811665|NCT00984165|580694598|FG003|Overall Study|P+/donor pair removed from protocol|1|||
160811666|NCT00984165|580694595|FG000|Overall Study|removed with a pair recipient|0|||
160811667|NCT00984165|580694596|FG001|Overall Study|removed with a pair recipient|0|||
160811668|NCT00984165|580694597|FG002|Overall Study|removed with a pair recipient|0|||
160811669|NCT00984165|580694598|FG003|Overall Study|removed with a pair recipient|1|||
160811670|NCT00700622|580694599|FG000|Overall Study|Adverse Event|4|||
160811671|NCT00700622|580694600|FG001|Overall Study|Adverse Event|0|||
160811672|NCT00700622|580694599|FG000|Overall Study|Lost to Follow-up|0|||
160811673|NCT00700622|580694600|FG001|Overall Study|Lost to Follow-up|1|||
160811674|NCT00700622|580694599|FG000|Overall Study|Physician Decision|2|||
160811675|NCT00700622|580694600|FG001|Overall Study|Physician Decision|1|||
160811676|NCT00700622|580694599|FG000|Overall Study|Protocol Violation|0|||
160811677|NCT00700622|580694600|FG001|Overall Study|Protocol Violation|1|||
160811678|NCT00700622|580694599|FG000|Overall Study|Withdrawal by Subject|4|||
160811679|NCT00700622|580694600|FG001|Overall Study|Withdrawal by Subject|1|||
160811680|NCT00700622|580694599|FG000|Overall Study|Other|3|||
160811681|NCT00700622|580694600|FG001|Overall Study|Other|1|||
160811682|NCT01309997|580694601|FG000|Overall Study|Adverse Event|1|||
160811683|NCT01309997|580694602|FG001|Overall Study|Adverse Event|0|||
160811684|NCT01309997|580694601|FG000|Overall Study|Death|1|||
160811685|NCT01309997|580694602|FG001|Overall Study|Death|3|||
160811686|NCT01309997|580694601|FG000|Overall Study|Lack of Efficacy|2|||
160811687|NCT01309997|580694602|FG001|Overall Study|Lack of Efficacy|2|||
160811688|NCT01309997|580694601|FG000|Overall Study|Withdrawal by Subject|1|||
160899996|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
161131477|NCT00868790|581865290|FG003|Period 3|Protocol Violation|0|||
161131478|NCT00868790|581865291|FG004|Period 3|Protocol Violation|0|||
161131479|NCT00868790|581865292|FG005|Period 3|Protocol Violation|0|||
161131480|NCT00868790|581865293|FG006|Period 3|Protocol Violation|0|||
161239127|NCT03032172|582256859|FG000|Treatment Period|Adverse Event|0|||
161239128|NCT03032172|582256860|FG001|Treatment Period|Adverse Event|1|||
161131481|NCT00868790|581865294|FG007|Period 3|Protocol Violation|0|||
161131482|NCT00868790|581865295|FG008|Period 3|Protocol Violation|0|||
161239129|NCT03032172|582256861|FG002|Treatment Period|Adverse Event|0|||
161239130|NCT03032172|582256862|FG003|Treatment Period|Adverse Event|0|||
161239131|NCT03032172|582256863|FG004|Treatment Period|Adverse Event|0|||
161239132|NCT03032172|582256864|FG005|Treatment Period|Adverse Event|0|||
160811689|NCT01309997|580694602|FG001|Overall Study|Withdrawal by Subject|1|||
160811690|NCT04474197|580694603|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
160811691|NCT04474197|580694604|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
160811692|NCT04474197|580694605|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
160811693|NCT04474197|580694606|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
160811694|NCT01532921|580694607|FG000|Overall Study|Death|3|||
160811695|NCT01532921|580694607|FG000|Overall Study|Withdrawal by Subject|2|||
160811696|NCT01532921|580694607|FG000|Overall Study|Lost to Follow-up|3|||
160811697|NCT01532921|580694607|FG000|Overall Study|Physician Decision|7|||
160899997|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|severe COVID|0|||
161131483|NCT00868790|581865296|FG009|Period 3|Protocol Violation|0|||
160811698|NCT01532921|580694607|FG000|Overall Study|Device was explanted during procedure|1|||
160811699|NCT01390298|580694608|FG000|Overall Study|Death|1|||
160811700|NCT01390298|580694608|FG000|Overall Study|long term ICU admission|1|||
160811701|NCT01390298|580694608|FG000|Overall Study|Withdrawal by Subject|14|||
160811702|NCT01390298|580694608|FG000|Overall Study|Lost to Follow-up|7|||
160811703|NCT01390298|580694608|FG000|Overall Study|Surgery cancelled|1|||
160811704|NCT00066222|580694617|FG000|Overall Study|No protocol treatment received|1|||
160811705|NCT00635349|580694618|FG000|Overall Study|Other|8|||
160811706|NCT00635349|580694619|FG001|Overall Study|Other|6|||
160811707|NCT00635349|580694618|FG000|Overall Study|Protocol Violation|18|||
160811708|NCT00635349|580694619|FG001|Overall Study|Protocol Violation|22|||
160811709|NCT00635349|580694618|FG000|Overall Study|Withdrawal by Subject|3|||
160811710|NCT00635349|580694619|FG001|Overall Study|Withdrawal by Subject|8|||
160811711|NCT00635349|580694618|FG000|Overall Study|Lost to Follow-up|4|||
160811712|NCT00635349|580694619|FG001|Overall Study|Lost to Follow-up|3|||
160811713|NCT00635349|580694618|FG000|Overall Study|Adverse Event|11|||
160811714|NCT00635349|580694619|FG001|Overall Study|Adverse Event|9|||
160811715|NCT05420961|580694630|FG000|Overall Study|Withdrawal by Subject|2|||
160811716|NCT05420961|580694631|FG001|Overall Study|Withdrawal by Subject|1|||
160811717|NCT05420961|580694632|FG002|Overall Study|Withdrawal by Subject|1|||
160811718|NCT05420961|580694633|FG003|Overall Study|Withdrawal by Subject|0|||
160811719|NCT05420961|580694634|FG004|Overall Study|Withdrawal by Subject|0|||
160811720|NCT05420961|580694630|FG000|Overall Study|Lost to Follow-up|0|||
160811721|NCT05420961|580694631|FG001|Overall Study|Lost to Follow-up|0|||
160811722|NCT05420961|580694632|FG002|Overall Study|Lost to Follow-up|1|||
160811723|NCT05420961|580694633|FG003|Overall Study|Lost to Follow-up|0|||
160811724|NCT05420961|580694634|FG004|Overall Study|Lost to Follow-up|0|||
160811725|NCT05420961|580694630|FG000|Overall Study|Randomized by mistake without study treatment|0|||
160811726|NCT05420961|580694631|FG001|Overall Study|Randomized by mistake without study treatment|0|||
160811727|NCT05420961|580694632|FG002|Overall Study|Randomized by mistake without study treatment|1|||
160811728|NCT05420961|580694633|FG003|Overall Study|Randomized by mistake without study treatment|0|||
160811729|NCT05420961|580694634|FG004|Overall Study|Randomized by mistake without study treatment|1|||
160811730|NCT04283656|580694635|FG000|Overall Study|Adverse Event|1|||
160811731|NCT04283656|580694636|FG001|Overall Study|Adverse Event|0|||
160811732|NCT04283656|580694635|FG000|Overall Study|Lost to Follow-up|0|||
160811733|NCT04283656|580694636|FG001|Overall Study|Lost to Follow-up|1|||
160811734|NCT00803361|580694637|FG000|Overall Study|Adverse Event|13|||
160811735|NCT00803361|580694638|FG001|Overall Study|Adverse Event|3|||
160811736|NCT00803361|580694637|FG000|Overall Study|Lack of Efficacy|4|||
160811737|NCT00803361|580694638|FG001|Overall Study|Lack of Efficacy|13|||
160811738|NCT00803361|580694637|FG000|Overall Study|Lost to Follow-up|1|||
160811739|NCT00803361|580694638|FG001|Overall Study|Lost to Follow-up|2|||
160811740|NCT00803361|580694637|FG000|Overall Study|Physician Decision|1|||
161131484|NCT00868790|581865297|FG010|Period 3|Protocol Violation|1|||
160811741|NCT00803361|580694638|FG001|Overall Study|Physician Decision|0|||
160811742|NCT00803361|580694637|FG000|Overall Study|Protocol Violation|2|||
160811743|NCT00803361|580694638|FG001|Overall Study|Protocol Violation|4|||
160811744|NCT00803361|580694637|FG000|Overall Study|Withdrawal by Subject|5|||
160811745|NCT00803361|580694638|FG001|Overall Study|Withdrawal by Subject|6|||
160811746|NCT04445519|580694639|FG000|Overall Study|Due to adaptive design|3|||
160811747|NCT04445519|580694640|FG001|Overall Study|Due to adaptive design|0|||
160811748|NCT04445519|580694641|FG002|Overall Study|Due to adaptive design|0|||
160811749|NCT04445519|580694639|FG000|Overall Study|Lost to Follow-up|0|||
160811750|NCT04445519|580694640|FG001|Overall Study|Lost to Follow-up|1|||
160811751|NCT04445519|580694641|FG002|Overall Study|Lost to Follow-up|4|||
160811752|NCT04445519|580694639|FG000|Overall Study|Sponsor or IRB Decision|0|||
160811753|NCT04445519|580694640|FG001|Overall Study|Sponsor or IRB Decision|1|||
160811754|NCT04445519|580694641|FG002|Overall Study|Sponsor or IRB Decision|2|||
160811755|NCT04445519|580694639|FG000|Overall Study|Withdrawal by Subject|0|||
160811756|NCT04445519|580694640|FG001|Overall Study|Withdrawal by Subject|3|||
160811757|NCT04445519|580694641|FG002|Overall Study|Withdrawal by Subject|3|||
160811758|NCT04445519|580694639|FG000|Overall Study|Adverse Event|0|||
160811759|NCT04445519|580694640|FG001|Overall Study|Adverse Event|8|||
160811760|NCT04445519|580694641|FG002|Overall Study|Adverse Event|6|||
160811761|NCT04445519|580694639|FG000|Overall Study|Other Reason|0|||
160811762|NCT04445519|580694640|FG001|Overall Study|Other Reason|1|||
160811763|NCT04445519|580694641|FG002|Overall Study|Other Reason|1|||
160811764|NCT04445519|580694639|FG000|Overall Study|Protocol Violation|0|||
160811765|NCT04445519|580694640|FG001|Overall Study|Protocol Violation|0|||
160899998|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|severe COVID|1|||
160811766|NCT04445519|580694641|FG002|Overall Study|Protocol Violation|1|||
160811767|NCT04482439|580694646|FG000|Overall Study|Lost to Follow-up|1|||
160811768|NCT04482439|580694646|FG000|Overall Study|Unrelated illness|1|||
160811769|NCT03072043|580694647|FG000|Overall Study|Death|0|||
160811770|NCT03072043|580694648|FG001|Overall Study|Death|0|||
160811771|NCT03072043|580694649|FG002|Overall Study|Death|3|||
160811772|NCT03072043|580694647|FG000|Overall Study|Adverse Event|0|||
160811773|NCT03072043|580694648|FG001|Overall Study|Adverse Event|0|||
160811774|NCT03072043|580694649|FG002|Overall Study|Adverse Event|2|||
160811775|NCT03072043|580694647|FG000|Overall Study|Withdrawal by Subject|0|||
160811776|NCT03072043|580694648|FG001|Overall Study|Withdrawal by Subject|0|||
160811777|NCT03072043|580694649|FG002|Overall Study|Withdrawal by Subject|4|||
160811778|NCT00645840|580694650|FG000|Overall Study|Protocol Violation|3|||
160811779|NCT02625220|580694651|FG000|Overall Study|Adverse Event|2|||
160811780|NCT02625220|580694651|FG000|Overall Study|Lost to Follow-up|2|||
160811781|NCT02625220|580694651|FG000|Overall Study|Protocol Violation|1|||
160811782|NCT02625220|580694651|FG000|Overall Study|Study discontinued at site|2|||
160811783|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
160811784|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
160811785|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
160811786|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
160811787|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
160811788|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
160811789|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
160811790|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
160811791|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
160811792|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
160811793|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160811794|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
160811795|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
160811796|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
160811797|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
160811798|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
160811799|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
160811800|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
160811801|NCT03162796|580694654|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
160811802|NCT03162796|580694655|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
160811803|NCT03162796|580694656|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
160811804|NCT03162796|580694654|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
160811805|NCT03162796|580694655|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
160811806|NCT03162796|580694656|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
160811807|NCT03162796|580694654|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
160811808|NCT03162796|580694655|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
160811809|NCT03162796|580694656|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
160811810|NCT03162796|580694654|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
160811811|NCT03162796|580694655|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
160811812|NCT03162796|580694656|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
160811813|NCT03162796|580694654|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
160811814|NCT03162796|580694655|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
160811815|NCT03162796|580694656|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
160811816|NCT02342288|580694657|FG000|Overall Study|no protocol anesthesiologist available|3|||
160811817|NCT02342288|580694658|FG001|Overall Study|no protocol anesthesiologist available|2|||
160811818|NCT02342288|580694657|FG000|Overall Study|anesthesia leak in system|1|||
160811819|NCT02342288|580694658|FG001|Overall Study|anesthesia leak in system|0|||
160811820|NCT02342288|580694657|FG000|Overall Study|Withdrawal by Subject|1|||
160811821|NCT02342288|580694658|FG001|Overall Study|Withdrawal by Subject|0|||
160811822|NCT02342288|580694657|FG000|Overall Study|coordinator contaminated with blood|0|||
160811823|NCT02342288|580694658|FG001|Overall Study|coordinator contaminated with blood|1|||
160811824|NCT02342288|580694657|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
160811825|NCT02342288|580694658|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
160811826|NCT02342288|580694657|FG000|Overall Study|coordinator not available|0|||
160811827|NCT02342288|580694658|FG001|Overall Study|coordinator not available|2|||
160811828|NCT02375373|580694660|FG000|Overall Study|Withdrawal by Subject|11|||
160811829|NCT02725476|580694661|FG000|Overall Study|Physician Decision|2|||
160811830|NCT02725476|580694662|FG001|Overall Study|Physician Decision|0|||
160811831|NCT02725476|580694661|FG000|Overall Study|Adverse Event|1|||
160811832|NCT02725476|580694662|FG001|Overall Study|Adverse Event|1|||
160811833|NCT00289289|580694664|FG000|Overall Study|Withdrawal by Subject|5|||
160811834|NCT00289289|580694665|FG001|Overall Study|Withdrawal by Subject|3|||
160811835|NCT00289289|580694666|FG002|Overall Study|Withdrawal by Subject|15|||
160986784|NCT04955626|581341140|FG035|Blinded Period|Death|0|||
160986785|NCT04955626|581341105|FG000|Blinded Period|Adverse Event|0|||
160986786|NCT04955626|581341106|FG001|Blinded Period|Adverse Event|1|||
160811836|NCT00289289|580694664|FG000|Overall Study|Lost to Follow-up|1|||
160811837|NCT00289289|580694665|FG001|Overall Study|Lost to Follow-up|0|||
160811838|NCT00289289|580694666|FG002|Overall Study|Lost to Follow-up|1|||
160811839|NCT00289289|580694664|FG000|Overall Study|Death|4|||
160986787|NCT04955626|581341107|FG002|Blinded Period|Adverse Event|1|||
160811840|NCT00289289|580694665|FG001|Overall Study|Death|2|||
160811841|NCT00289289|580694666|FG002|Overall Study|Death|5|||
160811842|NCT00289289|580694664|FG000|Overall Study|No implant attempted|0|||
160811843|NCT00289289|580694665|FG001|Overall Study|No implant attempted|0|||
160811844|NCT00289289|580694666|FG002|Overall Study|No implant attempted|1|||
160811845|NCT00289289|580694664|FG000|Overall Study|Physician Decision|1|||
160811846|NCT00289289|580694665|FG001|Overall Study|Physician Decision|0|||
160811847|NCT00289289|580694666|FG002|Overall Study|Physician Decision|6|||
160986788|NCT04955626|581341108|FG003|Blinded Period|Adverse Event|1|||
160986789|NCT04955626|581341109|FG004|Blinded Period|Adverse Event|0|||
160986790|NCT04955626|581341110|FG005|Blinded Period|Adverse Event|0|||
160986791|NCT04955626|581341111|FG006|Blinded Period|Adverse Event|0|||
160986792|NCT04955626|581341112|FG007|Blinded Period|Adverse Event|0|||
160986793|NCT04955626|581341113|FG008|Blinded Period|Adverse Event|0|||
160986794|NCT04955626|581341114|FG009|Blinded Period|Adverse Event|1|||
160986795|NCT04955626|581341115|FG010|Blinded Period|Adverse Event|1|||
160986796|NCT04955626|581341116|FG011|Blinded Period|Adverse Event|0|||
160986797|NCT04955626|581341117|FG012|Blinded Period|Adverse Event|0|||
160986798|NCT04955626|581341118|FG013|Blinded Period|Adverse Event|0|||
160986799|NCT04955626|581341119|FG014|Blinded Period|Adverse Event|0|||
160986800|NCT04955626|581341120|FG015|Blinded Period|Adverse Event|0|||
160986801|NCT04955626|581341121|FG016|Blinded Period|Adverse Event|0|||
160986802|NCT04955626|581341122|FG017|Blinded Period|Adverse Event|0|||
160986803|NCT04955626|581341123|FG018|Blinded Period|Adverse Event|1|||
160986804|NCT04955626|581341124|FG019|Blinded Period|Adverse Event|0|||
160986805|NCT04955626|581341125|FG020|Blinded Period|Adverse Event|0|||
160986806|NCT04955626|581341126|FG021|Blinded Period|Adverse Event|0|||
160986807|NCT04955626|581341127|FG022|Blinded Period|Adverse Event|0|||
160986808|NCT04955626|581341128|FG023|Blinded Period|Adverse Event|0|||
160986809|NCT04955626|581341129|FG024|Blinded Period|Adverse Event|0|||
160986810|NCT04955626|581341130|FG025|Blinded Period|Adverse Event|0|||
160986811|NCT04955626|581341131|FG026|Blinded Period|Adverse Event|1|||
160986812|NCT04955626|581341132|FG027|Blinded Period|Adverse Event|0|||
160986813|NCT04955626|581341133|FG028|Blinded Period|Adverse Event|0|||
160986814|NCT04955626|581341134|FG029|Blinded Period|Adverse Event|0|||
160986815|NCT04955626|581341135|FG030|Blinded Period|Adverse Event|0|||
160986816|NCT04955626|581341136|FG031|Blinded Period|Adverse Event|0|||
160986817|NCT04955626|581341137|FG032|Blinded Period|Adverse Event|0|||
161239133|NCT03032172|582256865|FG006|Treatment Period|Adverse Event|0|||
161239134|NCT03032172|582256866|FG007|Treatment Period|Adverse Event|0|||
161239135|NCT03032172|582256859|FG000|Treatment Period|Lack of Efficacy|0|||
161239136|NCT03032172|582256860|FG001|Treatment Period|Lack of Efficacy|1|||
161239137|NCT03032172|582256861|FG002|Treatment Period|Lack of Efficacy|0|||
161239138|NCT03032172|582256862|FG003|Treatment Period|Lack of Efficacy|0|||
161239139|NCT03032172|582256863|FG004|Treatment Period|Lack of Efficacy|0|||
161239140|NCT03032172|582256864|FG005|Treatment Period|Lack of Efficacy|0|||
161239141|NCT03032172|582256865|FG006|Treatment Period|Lack of Efficacy|0|||
161239142|NCT03032172|582256866|FG007|Treatment Period|Lack of Efficacy|0|||
161239143|NCT03032172|582256859|FG000|Treatment Period|Non-compliance With Study Drug|0|||
161239144|NCT03032172|582256860|FG001|Treatment Period|Non-compliance With Study Drug|1|||
161239145|NCT03032172|582256861|FG002|Treatment Period|Non-compliance With Study Drug|0|||
161239146|NCT03032172|582256862|FG003|Treatment Period|Non-compliance With Study Drug|0|||
161239147|NCT03032172|582256863|FG004|Treatment Period|Non-compliance With Study Drug|0|||
161239148|NCT03032172|582256864|FG005|Treatment Period|Non-compliance With Study Drug|0|||
161239149|NCT03032172|582256865|FG006|Treatment Period|Non-compliance With Study Drug|0|||
161239150|NCT03032172|582256866|FG007|Treatment Period|Non-compliance With Study Drug|0|||
161239151|NCT03032172|582256859|FG000|Treatment Period|Reason Not Specified|0|||
161239152|NCT03032172|582256860|FG001|Treatment Period|Reason Not Specified|4|||
161239153|NCT03032172|582256861|FG002|Treatment Period|Reason Not Specified|1|||
161239154|NCT03032172|582256862|FG003|Treatment Period|Reason Not Specified|0|||
160811848|NCT00289289|580694664|FG000|Overall Study|Non-study device implanted|2|||
160811849|NCT00289289|580694665|FG001|Overall Study|Non-study device implanted|1|||
160811850|NCT00289289|580694666|FG002|Overall Study|Non-study device implanted|3|||
160811851|NCT00289289|580694664|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
160986818|NCT04955626|581341138|FG033|Blinded Period|Adverse Event|0|||
160986819|NCT04955626|581341139|FG034|Blinded Period|Adverse Event|0|||
160986820|NCT04955626|581341140|FG035|Blinded Period|Adverse Event|0|||
160986821|NCT04955626|581341105|FG000|Blinded Period|No longer meets eligibility criteria|1|||
161239155|NCT03032172|582256863|FG004|Treatment Period|Reason Not Specified|0|||
161239156|NCT03032172|582256864|FG005|Treatment Period|Reason Not Specified|0|||
161239157|NCT03032172|582256865|FG006|Treatment Period|Reason Not Specified|0|||
161332920|NCT05953363|582606486|FG000|Overall Study|Adverse Event|1|||
160811852|NCT00289289|580694665|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
160811853|NCT00289289|580694666|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
160811854|NCT00289289|580694664|FG000|Overall Study|Other Exit Reason|6|||
160986822|NCT04955626|581341106|FG001|Blinded Period|No longer meets eligibility criteria|2|||
160986823|NCT04955626|581341107|FG002|Blinded Period|No longer meets eligibility criteria|0|||
160986824|NCT04955626|581341108|FG003|Blinded Period|No longer meets eligibility criteria|1|||
161239158|NCT03032172|582256866|FG007|Treatment Period|Reason Not Specified|0|||
161239159|NCT03032172|582256859|FG000|Treatment Period|Physician Decision|0|||
161239160|NCT03032172|582256860|FG001|Treatment Period|Physician Decision|2|||
161239161|NCT03032172|582256861|FG002|Treatment Period|Physician Decision|1|||
161239162|NCT03032172|582256862|FG003|Treatment Period|Physician Decision|0|||
160811855|NCT00289289|580694665|FG001|Overall Study|Other Exit Reason|4|||
160811856|NCT00289289|580694666|FG002|Overall Study|Other Exit Reason|12|||
160811857|NCT01445613|580694667|FG000|30-day Follow-up|Withdrawal by Subject|6|||
160811858|NCT01445613|580694667|FG000|30-day Follow-up|Physician Decision|3|||
160811859|NCT01445613|580694667|FG000|30-day Follow-up|Missed visit|23|||
160811860|NCT01445613|580694667|FG000|30-day Follow-up|Death|3|||
160811861|NCT01445613|580694667|FG000|1-year Follow-up|Withdrawal by Subject|12|||
160811862|NCT01445613|580694667|FG000|1-year Follow-up|Missed visit|29|||
160811863|NCT01445613|580694667|FG000|1-year Follow-up|Lost to Follow-up|2|||
160811864|NCT01445613|580694667|FG000|1-year Follow-up|Death|30|||
160811865|NCT01445613|580694667|FG000|1-year Follow-up|Physician Decision|2|||
160811866|NCT01445613|580694667|FG000|1-year Follow-up|Received a non-study stent|2|||
161332921|NCT01701674|582606487|FG000|Overall Study|Unable to safely complete treatment|1|||
160811867|NCT01169701|580694668|FG000|Overall Study|Lost to Follow-up|1|||
160811868|NCT01169701|580694669|FG001|Overall Study|Lost to Follow-up|1|||
160811869|NCT01169701|580694668|FG000|Overall Study|Withdrawal by Subject|1|||
160811870|NCT01169701|580694669|FG001|Overall Study|Withdrawal by Subject|3|||
160811871|NCT01169701|580694668|FG000|Overall Study|Adverse Event|1|||
160811872|NCT01169701|580694669|FG001|Overall Study|Adverse Event|2|||
160811873|NCT01169701|580694668|FG000|Overall Study|Exclusion criteria|2|||
160811874|NCT01169701|580694669|FG001|Overall Study|Exclusion criteria|0|||
160811875|NCT01169701|580694668|FG000|Overall Study|Death|0|||
160811876|NCT01169701|580694669|FG001|Overall Study|Death|1|||
160811877|NCT01169701|580694668|FG000|Overall Study|Administrative problems|0|||
160811878|NCT01169701|580694669|FG001|Overall Study|Administrative problems|1|||
160811879|NCT01169701|580694668|FG000|Overall Study|Serious adverse event|0|||
160811880|NCT01169701|580694669|FG001|Overall Study|Serious adverse event|1|||
160811881|NCT01169701|580694668|FG000|Overall Study|Sponsor decision|0|||
160811882|NCT01169701|580694669|FG001|Overall Study|Sponsor decision|1|||
160811883|NCT02455336|580694672|FG000|Overall Study|Withdrawal by Subject|0|||
160811884|NCT02455336|580694673|FG001|Overall Study|Withdrawal by Subject|2|||
160811885|NCT02455336|580694672|FG000|Overall Study|Adverse Event|3|||
160811886|NCT02455336|580694673|FG001|Overall Study|Adverse Event|0|||
160811887|NCT02455336|580694672|FG000|Overall Study|Non-responder to treatment|2|||
160811888|NCT02455336|580694673|FG001|Overall Study|Non-responder to treatment|0|||
160811889|NCT00391430|580694674|FG000|Overall Study|Withdrawal by Subject|3|||
160811890|NCT00391430|580694675|FG001|Overall Study|Withdrawal by Subject|0|||
160811891|NCT00391430|580694676|FG002|Overall Study|Withdrawal by Subject|12|||
160811892|NCT03299244|580694677|FG000|Overall Study|Withdrawal by Subject|34|||
160811893|NCT03299244|580694678|FG001|Overall Study|Withdrawal by Subject|29|||
160811894|NCT03299244|580694677|FG000|Overall Study|Decision by Sponsor|4|||
160811895|NCT03299244|580694678|FG001|Overall Study|Decision by Sponsor|5|||
161239163|NCT03032172|582256863|FG004|Treatment Period|Physician Decision|0|||
161239164|NCT03032172|582256864|FG005|Treatment Period|Physician Decision|0|||
161239165|NCT03032172|582256865|FG006|Treatment Period|Physician Decision|0|||
161239166|NCT03032172|582256866|FG007|Treatment Period|Physician Decision|0|||
161239167|NCT03032172|582256859|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161239168|NCT03032172|582256860|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
161332922|NCT03509467|582606492|FG000|Overall Study|Withdrawal by Subject|5|||
160811896|NCT03299244|580694677|FG000|Overall Study|Death|9|||
160811897|NCT03299244|580694678|FG001|Overall Study|Death|4|||
160811898|NCT00130039|580694683|FG000|Overall Study|Withdrawal by Subject|15|||
160899999|NCT03355365|581028585|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
160900000|NCT03355365|581028586|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
160900001|NCT03650556|581028596|FG000|Overall Study|Death|2|||
160900002|NCT03650556|581028596|FG000|Overall Study|Withdrawal by Subject|20|||
160900003|NCT03650556|581028596|FG000|Overall Study|Physician Decision|2|||
160900004|NCT03650556|581028596|FG000|Overall Study|Lost to Follow-up|8|||
161239169|NCT03032172|582256861|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
161332923|NCT03509467|582606493|FG001|Overall Study|Withdrawal by Subject|1|||
160811899|NCT00130039|580694684|FG001|Overall Study|Withdrawal by Subject|11|||
160811900|NCT00130039|580694683|FG000|Overall Study|Lost to Follow-up|3|||
160811901|NCT00130039|580694684|FG001|Overall Study|Lost to Follow-up|1|||
160811902|NCT00130039|580694683|FG000|Overall Study|Adverse Event|4|||
160811903|NCT00130039|580694684|FG001|Overall Study|Adverse Event|2|||
160811904|NCT00130039|580694683|FG000|Overall Study|Physician Decision|3|||
160811905|NCT00130039|580694684|FG001|Overall Study|Physician Decision|0|||
160811906|NCT00130039|580694683|FG000|Overall Study|clinical events without follow up MRI|5|||
160811907|NCT00130039|580694684|FG001|Overall Study|clinical events without follow up MRI|4|||
160900005|NCT03650556|581028596|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
161239170|NCT03032172|582256862|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
161239171|NCT03032172|582256863|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161239172|NCT03032172|582256864|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161239173|NCT03032172|582256865|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161239174|NCT03032172|582256866|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
161239175|NCT03032172|582256859|FG000|Treatment Period|Withdrawal by Subject|2|||
161239176|NCT03032172|582256860|FG001|Treatment Period|Withdrawal by Subject|0|||
161239177|NCT03032172|582256861|FG002|Treatment Period|Withdrawal by Subject|3|||
161239178|NCT03032172|582256862|FG003|Treatment Period|Withdrawal by Subject|0|||
161239179|NCT03032172|582256863|FG004|Treatment Period|Withdrawal by Subject|0|||
161239180|NCT03032172|582256864|FG005|Treatment Period|Withdrawal by Subject|0|||
161239181|NCT03032172|582256865|FG006|Treatment Period|Withdrawal by Subject|0|||
161239182|NCT03032172|582256866|FG007|Treatment Period|Withdrawal by Subject|0|||
161239183|NCT03032172|582256859|FG000|Open-label Extension Period|Death|0|||
160811908|NCT01740687|580694685|FG000|Overall Study|Lost to Follow-up|11|||
160811909|NCT01740687|580694685|FG000|Overall Study|Withdrawal by Subject|2|||
160811910|NCT01740687|580694685|FG000|Overall Study|other reason|22|||
160811911|NCT01740687|580694685|FG000|Overall Study|treatment not received|2|||
160811912|NCT00078806|580696404|FG000|Part 1A|Adverse Event|2|||
160811913|NCT00078806|580696405|FG001|Part 1A|Adverse Event|0|||
160811914|NCT00078806|580696406|FG002|Part 1A|Adverse Event|0|||
160811915|NCT00078806|580696407|FG003|Part 1A|Adverse Event|0|||
160811916|NCT00078806|580696404|FG000|Part 1A|Lack of Efficacy|7|||
160811917|NCT00078806|580696405|FG001|Part 1A|Lack of Efficacy|0|||
160811918|NCT00078806|580696406|FG002|Part 1A|Lack of Efficacy|0|||
160811919|NCT00078806|580696407|FG003|Part 1A|Lack of Efficacy|0|||
160811920|NCT00078806|580696404|FG000|Part 1A|Other|1|||
160811921|NCT00078806|580696405|FG001|Part 1A|Other|0|||
160811922|NCT00078806|580696406|FG002|Part 1A|Other|0|||
160811923|NCT00078806|580696407|FG003|Part 1A|Other|0|||
161239184|NCT03032172|582256860|FG001|Open-label Extension Period|Death|0|||
161239185|NCT03032172|582256861|FG002|Open-label Extension Period|Death|0|||
160811924|NCT00078806|580696404|FG000|Part 1B|Adverse Event|1|||
160811925|NCT00078806|580696405|FG001|Part 1B|Adverse Event|0|||
160811926|NCT00078806|580696406|FG002|Part 1B|Adverse Event|0|||
160811927|NCT00078806|580696407|FG003|Part 1B|Adverse Event|0|||
160811928|NCT00078806|580696404|FG000|Part 1B|Lack of Efficacy|7|||
160811929|NCT00078806|580696405|FG001|Part 1B|Lack of Efficacy|0|||
160811930|NCT00078806|580696406|FG002|Part 1B|Lack of Efficacy|0|||
160811931|NCT00078806|580696407|FG003|Part 1B|Lack of Efficacy|0|||
160811932|NCT00078806|580696404|FG000|Part 2|Adverse Event|0|||
160811933|NCT00078806|580696405|FG001|Part 2|Adverse Event|1|||
160811934|NCT00078806|580696406|FG002|Part 2|Adverse Event|0|||
160811935|NCT00078806|580696407|FG003|Part 2|Adverse Event|0|||
160811936|NCT00161616|580696408|FG000|Overall Study|Withdrawal by Subject|6|||
160811937|NCT00161616|580696409|FG001|Overall Study|Withdrawal by Subject|5|||
160811938|NCT00161616|580696408|FG000|Overall Study|Physician Decision|1|||
160811939|NCT00161616|580696409|FG001|Overall Study|Physician Decision|0|||
160811940|NCT00161616|580696408|FG000|Overall Study|Death|1|||
160811941|NCT00161616|580696409|FG001|Overall Study|Death|1|||
160811942|NCT00161616|580696408|FG000|Overall Study|Lost to Follow-up|17|||
160811943|NCT00161616|580696409|FG001|Overall Study|Lost to Follow-up|13|||
160811944|NCT00161616|580696408|FG000|Overall Study|Protocol deviation|1|||
160811945|NCT00161616|580696409|FG001|Overall Study|Protocol deviation|0|||
160811946|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
161239186|NCT03032172|582256862|FG003|Open-label Extension Period|Death|0|||
161239187|NCT03032172|582256863|FG004|Open-label Extension Period|Death|0|||
161239188|NCT03032172|582256864|FG005|Open-label Extension Period|Death|0|||
161239189|NCT03032172|582256865|FG006|Open-label Extension Period|Death|0|||
161239190|NCT03032172|582256866|FG007|Open-label Extension Period|Death|2|||
161239191|NCT03032172|582256859|FG000|Open-label Extension Period|Reason Not Specified|0|||
160811947|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
160811948|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
160811949|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
160811950|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
160811951|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
161239192|NCT03032172|582256860|FG001|Open-label Extension Period|Reason Not Specified|0|||
161239193|NCT03032172|582256861|FG002|Open-label Extension Period|Reason Not Specified|0|||
160811952|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
160811953|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
160811954|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
160811955|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
160811956|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
160811957|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
160811958|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
160811959|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
160811960|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
160811961|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
160811962|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
160811963|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
160811964|NCT03308968|580696410|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
160811965|NCT03308968|580696411|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
160811966|NCT03308968|580696412|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
160811967|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
160811968|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
160811969|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
160811970|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
160811971|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
160811972|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
160811973|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
160811974|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
160811975|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
160811976|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
160811977|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
160811978|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
160811979|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
160811980|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
160811981|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
160811982|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
160811983|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
160811984|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
160811985|NCT03308968|580696410|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
160811986|NCT03308968|580696411|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
160811987|NCT03308968|580696412|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
160811988|NCT01521923|580696416|FG000|Overall Study|AE, serious fatal|1|||
160811989|NCT01521923|580696417|FG001|Overall Study|AE, serious fatal|0|||
160811990|NCT01521923|580696418|FG002|Overall Study|AE, serious fatal|0|||
160811991|NCT01521923|580696419|FG003|Overall Study|AE, serious fatal|0|||
160811992|NCT01521923|580696416|FG000|Overall Study|SAE, non-fatal|0|||
160811993|NCT01521923|580696417|FG001|Overall Study|SAE, non-fatal|2|||
160811994|NCT01521923|580696418|FG002|Overall Study|SAE, non-fatal|2|||
160811995|NCT01521923|580696419|FG003|Overall Study|SAE, non-fatal|0|||
160811996|NCT01521923|580696416|FG000|Overall Study|AE, non-serious, non-fatal|1|||
160811997|NCT01521923|580696417|FG001|Overall Study|AE, non-serious, non-fatal|3|||
160811998|NCT01521923|580696418|FG002|Overall Study|AE, non-serious, non-fatal|6|||
160811999|NCT01521923|580696419|FG003|Overall Study|AE, non-serious, non-fatal|2|||
160812000|NCT01521923|580696416|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
160812001|NCT01521923|580696417|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
160812002|NCT01521923|580696418|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
160812003|NCT01521923|580696419|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
160812004|NCT01521923|580696416|FG000|Overall Study|Lack of Efficacy|1|||
160812005|NCT01521923|580696417|FG001|Overall Study|Lack of Efficacy|1|||
160812006|NCT01521923|580696418|FG002|Overall Study|Lack of Efficacy|0|||
160812007|NCT01521923|580696419|FG003|Overall Study|Lack of Efficacy|0|||
160812008|NCT01521923|580696416|FG000|Overall Study|Protocol Violation|0|||
160812009|NCT01521923|580696417|FG001|Overall Study|Protocol Violation|0|||
160812010|NCT01521923|580696418|FG002|Overall Study|Protocol Violation|1|||
161131485|NCT00868790|581865298|FG011|Period 3|Protocol Violation|0|||
161131486|NCT00868790|581865299|FG012|Period 3|Protocol Violation|0|||
161131487|NCT00868790|581865300|FG013|Period 3|Protocol Violation|0|||
161131488|NCT00868790|581865287|FG000|Period 3|Study Terminated by Sponsor|0|||
161131489|NCT00868790|581865288|FG001|Period 3|Study Terminated by Sponsor|0|||
161131490|NCT00868790|581865289|FG002|Period 3|Study Terminated by Sponsor|0|||
161131491|NCT00868790|581865290|FG003|Period 3|Study Terminated by Sponsor|1|||
161131492|NCT00868790|581865291|FG004|Period 3|Study Terminated by Sponsor|0|||
161131493|NCT00868790|581865292|FG005|Period 3|Study Terminated by Sponsor|0|||
161131494|NCT00868790|581865293|FG006|Period 3|Study Terminated by Sponsor|0|||
160812011|NCT01521923|580696419|FG003|Overall Study|Protocol Violation|0|||
160812012|NCT01521923|580696416|FG000|Overall Study|Lost to Follow-up|1|||
160812013|NCT01521923|580696417|FG001|Overall Study|Lost to Follow-up|0|||
160812014|NCT01521923|580696418|FG002|Overall Study|Lost to Follow-up|2|||
160812015|NCT01521923|580696419|FG003|Overall Study|Lost to Follow-up|1|||
160812016|NCT01521923|580696416|FG000|Overall Study|Withdrawal by Subject|1|||
160900006|NCT03650556|581028596|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
161131495|NCT00868790|581865294|FG007|Period 3|Study Terminated by Sponsor|0|||
161131496|NCT00868790|581865295|FG008|Period 3|Study Terminated by Sponsor|0|||
160812017|NCT01521923|580696417|FG001|Overall Study|Withdrawal by Subject|1|||
160812018|NCT01521923|580696418|FG002|Overall Study|Withdrawal by Subject|1|||
160812019|NCT01521923|580696419|FG003|Overall Study|Withdrawal by Subject|2|||
160812020|NCT01521923|580696416|FG000|Overall Study|Other|2|||
160812021|NCT01521923|580696417|FG001|Overall Study|Other|1|||
160812022|NCT01521923|580696418|FG002|Overall Study|Other|3|||
160812023|NCT01521923|580696419|FG003|Overall Study|Other|6|||
160812024|NCT01521923|580696416|FG000|Overall Study|AE, captured in Period 1|0|||
160812025|NCT01521923|580696417|FG001|Overall Study|AE, captured in Period 1|1|||
160812026|NCT01521923|580696418|FG002|Overall Study|AE, captured in Period 1|0|||
160812027|NCT01521923|580696419|FG003|Overall Study|AE, captured in Period 1|1|||
160812028|NCT02141633|580696420|FG000|Overall Study|Physician Decision|1|||
161239194|NCT03032172|582256862|FG003|Open-label Extension Period|Reason Not Specified|0|||
160812029|NCT02141633|580696421|FG001|Overall Study|Physician Decision|0|||
160812030|NCT02943070|580696424|FG000|Overall Study|Physician Decision|1|||
160812031|NCT02943070|580696424|FG000|Overall Study|Adverse Event|2|||
160812032|NCT02943070|580696424|FG000|Overall Study|Death|2|||
160812033|NCT02943070|580696424|FG000|Overall Study|Withdrawal by Subject|3|||
160812034|NCT02943070|580696424|FG000|Overall Study|Lost to Follow-up|4|||
160812035|NCT02943070|580696424|FG000|Overall Study|Retreatment or TURP|13|||
160812036|NCT02943070|580696424|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
160812037|NCT01701362|580696425|FG000|Overall Study|Adverse events not related to study drug|1|||
161131497|NCT00868790|581865296|FG009|Period 3|Study Terminated by Sponsor|0|||
161131498|NCT00868790|581865297|FG010|Period 3|Study Terminated by Sponsor|0|||
161131499|NCT00868790|581865298|FG011|Period 3|Study Terminated by Sponsor|0|||
161131500|NCT00868790|581865299|FG012|Period 3|Study Terminated by Sponsor|0|||
161239195|NCT03032172|582256863|FG004|Open-label Extension Period|Reason Not Specified|0|||
161239196|NCT03032172|582256864|FG005|Open-label Extension Period|Reason Not Specified|5|||
161332924|NCT03509467|582606494|FG002|Overall Study|Withdrawal by Subject|6|||
161332925|NCT03509467|582606495|FG003|Overall Study|Withdrawal by Subject|7|||
161332926|NCT03509467|582606496|FG004|Overall Study|Withdrawal by Subject|10|||
161332927|NCT03509467|582606497|FG005|Overall Study|Withdrawal by Subject|10|||
161332928|NCT03509467|582606498|FG006|Overall Study|Withdrawal by Subject|10|||
161332929|NCT03509467|582606499|FG007|Overall Study|Withdrawal by Subject|10|||
161332930|NCT03509467|582606492|FG000|Overall Study|Death|0|||
161332931|NCT03509467|582606493|FG001|Overall Study|Death|0|||
161332932|NCT03509467|582606494|FG002|Overall Study|Death|2|||
161332933|NCT03509467|582606495|FG003|Overall Study|Death|2|||
161332934|NCT03509467|582606496|FG004|Overall Study|Death|1|||
161332935|NCT03509467|582606497|FG005|Overall Study|Death|0|||
161332936|NCT03509467|582606498|FG006|Overall Study|Death|1|||
161332937|NCT03509467|582606499|FG007|Overall Study|Death|0|||
161239197|NCT03032172|582256865|FG006|Open-label Extension Period|Reason Not Specified|3|||
161239198|NCT03032172|582256866|FG007|Open-label Extension Period|Reason Not Specified|0|||
161239199|NCT03032172|582256859|FG000|Open-label Extension Period|Pregnancy|0|||
161239200|NCT03032172|582256860|FG001|Open-label Extension Period|Pregnancy|0|||
161239201|NCT03032172|582256861|FG002|Open-label Extension Period|Pregnancy|0|||
161239202|NCT03032172|582256862|FG003|Open-label Extension Period|Pregnancy|0|||
161239203|NCT03032172|582256863|FG004|Open-label Extension Period|Pregnancy|0|||
161239204|NCT03032172|582256864|FG005|Open-label Extension Period|Pregnancy|0|||
161239205|NCT03032172|582256865|FG006|Open-label Extension Period|Pregnancy|1|||
161239206|NCT03032172|582256866|FG007|Open-label Extension Period|Pregnancy|0|||
161239207|NCT03032172|582256859|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161239208|NCT03032172|582256860|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161239209|NCT03032172|582256861|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
161239210|NCT03032172|582256862|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
161239211|NCT03032172|582256863|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
161239212|NCT03032172|582256864|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
161239213|NCT03032172|582256865|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
161332938|NCT03509467|582606492|FG000|Overall Study|Proxy Withdrawal|0|||
160812038|NCT01701362|580696426|FG001|Overall Study|Adverse events not related to study drug|6|||
161131501|NCT00868790|581865300|FG013|Period 3|Study Terminated by Sponsor|0|||
161131502|NCT00868790|581865287|FG000|Period 4|Adverse Event|0|||
161239214|NCT03032172|582256866|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
161239215|NCT06144424|582256871|FG000|Overall Study|Withdrawal by Subject|2|||
161332939|NCT03509467|582606493|FG001|Overall Study|Proxy Withdrawal|0|||
161332940|NCT03509467|582606494|FG002|Overall Study|Proxy Withdrawal|0|||
160812039|NCT01701362|580696425|FG000|Overall Study|Adverse events related to study drug|12|||
160812040|NCT01701362|580696426|FG001|Overall Study|Adverse events related to study drug|10|||
161131503|NCT00868790|581865288|FG001|Period 4|Adverse Event|0|||
161131504|NCT00868790|581865289|FG002|Period 4|Adverse Event|0|||
161131505|NCT00868790|581865290|FG003|Period 4|Adverse Event|0|||
161131506|NCT00868790|581865291|FG004|Period 4|Adverse Event|0|||
161131507|NCT00868790|581865292|FG005|Period 4|Adverse Event|0|||
161239216|NCT06144424|582256872|FG001|Overall Study|Withdrawal by Subject|0|||
161332941|NCT03509467|582606495|FG003|Overall Study|Proxy Withdrawal|0|||
161332942|NCT03509467|582606496|FG004|Overall Study|Proxy Withdrawal|0|||
161332943|NCT03509467|582606497|FG005|Overall Study|Proxy Withdrawal|0|||
161332944|NCT03509467|582606498|FG006|Overall Study|Proxy Withdrawal|0|||
160812041|NCT01701362|580696425|FG000|Overall Study|Protocol Violation|5|||
161332945|NCT03509467|582606499|FG007|Overall Study|Proxy Withdrawal|1|||
161332946|NCT04275973|582606500|FG000|Overall Study|Withdrawal by Subject|2|||
161332947|NCT04275973|582606501|FG001|Overall Study|Withdrawal by Subject|1|||
161332948|NCT02499146|582606504|FG000|Overall Study|Global deterioration of health status|1|||
161332949|NCT02499146|582606504|FG000|Overall Study|Objective progression or relapse|20|||
161332950|NCT02499146|582606504|FG000|Overall Study|Other|2|||
161332951|NCT02499146|582606504|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
161332952|NCT04325828|582606505|FG000|Overall Study|Ongoing|26|||
161332953|NCT05115630|582606506|FG000|Overall Study|Due to COVID19|1|||
161332954|NCT05115630|582606506|FG000|Overall Study|Due to Bacteremia|1|||
161332955|NCT05115630|582606506|FG000|Overall Study|Due to viral infection|1|||
161332956|NCT04577794|582606509|FG000|Overall Study|Adverse Event|1|||
161332957|NCT04577794|582606510|FG001|Overall Study|Adverse Event|1|||
161332958|NCT02287038|582606511|FG000|Overall Study|Stopped attending appointments|3|||
161332959|NCT02287038|582606512|FG001|Overall Study|Stopped attending appointments|2|||
161332960|NCT02287038|582606511|FG000|Overall Study|Anxiety after starting medication|0|||
161332961|NCT02287038|582606512|FG001|Overall Study|Anxiety after starting medication|1|||
161332962|NCT02287038|582606511|FG000|Overall Study|Nausea after starting medication|1|||
161332963|NCT02287038|582606512|FG001|Overall Study|Nausea after starting medication|0|||
161332964|NCT02287038|582606511|FG000|Overall Study|Abnormal ECG after starting medication|1|||
161332965|NCT02287038|582606512|FG001|Overall Study|Abnormal ECG after starting medication|0|||
161332966|NCT05502302|582606520|FG000|Overall Study|Lost to Follow-up|6|||
161332967|NCT05502302|582606520|FG000|Overall Study|Death|2|||
161332968|NCT02998151|582606524|FG000|Overall Study|Withdrawal by Subject|3|||
161332969|NCT02998151|582606524|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
161332970|NCT02998151|582606524|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
161332971|NCT02667301|582606527|FG000|Overall Study|Adverse Event|1|||
161332972|NCT02667301|582606527|FG000|Overall Study|Lack of Efficacy|1|||
161332973|NCT01619878|582606530|FG000|6 Week Follow-up Phase|Adverse Event|1|||
161332974|NCT01619878|582606530|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
161332975|NCT01619878|582606530|FG000|Follow-up at 12 Months of Age|Death|2|||
161332976|NCT01883895|582606531|FG000|Overall Study|Lost to Follow-up|2|||
161332977|NCT05093933|582606532|FG000|Overall Study|Death|372|||
161332978|NCT05093933|582606533|FG001|Overall Study|Death|434|||
161332979|NCT05093933|582606532|FG000|Overall Study|Lost to Follow-up|13|||
161332980|NCT05093933|582606533|FG001|Overall Study|Lost to Follow-up|16|||
161332981|NCT05093933|582606532|FG000|Overall Study|Physician Decision|0|||
161332982|NCT05093933|582606533|FG001|Overall Study|Physician Decision|2|||
161332983|NCT05093933|582606532|FG000|Overall Study|Sponsor Decision|1|||
161332984|NCT05093933|582606533|FG001|Overall Study|Sponsor Decision|3|||
161332985|NCT05093933|582606532|FG000|Overall Study|Withdrawal by Guardian|1|||
161332986|NCT05093933|582606533|FG001|Overall Study|Withdrawal by Guardian|1|||
161332987|NCT05093933|582606532|FG000|Overall Study|Withdrawal by Subject|18|||
161332988|NCT05093933|582606533|FG001|Overall Study|Withdrawal by Subject|25|||
161332989|NCT04037358|582606534|FG000|Overall Study|Patient withdrew before intervention|1|||
161332990|NCT04037358|582606535|FG001|Overall Study|Patient withdrew before intervention|0|||
161332991|NCT05027815|582606538|FG000|Overall Study|Death|2|||
161332992|NCT05027815|582606539|FG001|Overall Study|Death|1|||
161332993|NCT00447902|582606540|FG000|Overall Study|Adverse Event|0|||
161332994|NCT00447902|582606541|FG001|Overall Study|Adverse Event|3|||
161332995|NCT00447902|582606540|FG000|Overall Study|Protocol Violation|1|||
161332996|NCT00447902|582606541|FG001|Overall Study|Protocol Violation|0|||
161332997|NCT00447902|582606540|FG000|Overall Study|Withdrawal by Subject|0|||
161332998|NCT00447902|582606541|FG001|Overall Study|Withdrawal by Subject|1|||
161332999|NCT00447902|582606540|FG000|Overall Study|included patients who discontinued|1|||
161333000|NCT00447902|582606541|FG001|Overall Study|included patients who discontinued|1|||
161333001|NCT00447902|582606540|FG000|Overall Study|Lack of Efficacy|2|||
161333002|NCT00447902|582606541|FG001|Overall Study|Lack of Efficacy|1|||
161333003|NCT01655901|582608583|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161333004|NCT01655901|582608584|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161333005|NCT01655901|582608585|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161333006|NCT01655901|582608586|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
161333007|NCT01655901|582608587|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
161333008|NCT01655901|582608588|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
160900007|NCT03917459|581028597|FG000|Overall Study|Adverse Event|1|||
161333009|NCT02997163|582608589|FG000|Overall Study|Adverse Event|1|||
161333010|NCT02997163|582608590|FG001|Overall Study|Adverse Event|0|||
161333011|NCT02997163|582608591|FG002|Overall Study|Adverse Event|0|||
161333012|NCT02997163|582608592|FG003|Overall Study|Adverse Event|1|||
161333013|NCT01712516|582608593|FG000|Overall Study|Technical problems|0|||
161333014|NCT01712516|582608594|FG001|Overall Study|Technical problems|0|||
161333015|NCT01712516|582608595|FG002|Overall Study|Technical problems|0|||
161333016|NCT01712516|582608596|FG003|Overall Study|Technical problems|2|||
161333017|NCT01712516|582608593|FG000|Overall Study|Lost to Follow-up|0|||
161333018|NCT01712516|582608594|FG001|Overall Study|Lost to Follow-up|0|||
161239217|NCT06144424|582256871|FG000|Overall Study|Incarceration|1|||
161239218|NCT06144424|582256872|FG001|Overall Study|Incarceration|0|||
161239219|NCT06284525|582256874|FG000|Overall Study|Withdrawal by Subject|1|||
161239220|NCT00834522|582256875|FG000|Washout|Adverse Event|1|||
161239221|NCT00834522|582256876|FG001|Washout|Adverse Event|0|||
161239222|NCT00834522|582256875|FG000|Washout|Withdrawal by Subject|2|||
161239223|NCT00834522|582256876|FG001|Washout|Withdrawal by Subject|1|||
161239224|NCT00519194|582256877|FG000|Overall Study|Withdrawal by Subject|9|||
161239225|NCT00519194|582256877|FG000|Overall Study|Death|9|||
161239226|NCT00519194|582256877|FG000|Overall Study|Lost to Follow-up|3|||
161239227|NCT01111461|582256878|FG000|Overall Study|Adverse Event|32|||
161239228|NCT01111461|582256878|FG000|Overall Study|Participant choice|11|||
161239229|NCT01111461|582256878|FG000|Overall Study|Lost to Follow-up|1|||
161239230|NCT01111461|582256878|FG000|Overall Study|Withdrawal by Subject|1|||
161239231|NCT01111461|582256878|FG000|Overall Study|Other|6|||
161239232|NCT03415308|582256889|FG000|Overall Study|Lost to Follow-up|0|||
161239233|NCT03415308|582256890|FG001|Overall Study|Lost to Follow-up|0|||
161239234|NCT03415308|582256891|FG002|Overall Study|Lost to Follow-up|1|||
161239235|NCT03415308|582256889|FG000|Overall Study|Scheduling Conflicts|0|||
161239236|NCT03415308|582256890|FG001|Overall Study|Scheduling Conflicts|0|||
161239237|NCT03415308|582256891|FG002|Overall Study|Scheduling Conflicts|7|||
161239238|NCT01471353|582256894|FG000|Overall Study|remain on study|3|||
161239239|NCT03123094|582256896|FG000|Overall Study|Withdrawal by Subject|0|||
161239240|NCT03123094|582256897|FG001|Overall Study|Withdrawal by Subject|2|||
161239241|NCT03123094|582256898|FG002|Overall Study|Withdrawal by Subject|1|||
161239242|NCT03123094|582256899|FG003|Overall Study|Withdrawal by Subject|0|||
161239243|NCT03123094|582256900|FG004|Overall Study|Withdrawal by Subject|1|||
161239244|NCT03246503|582256901|FG000|Overall Study|Lost to Follow-up|23|||
161239245|NCT03246503|582256901|FG000|Overall Study|Withdrawal by Subject|20|||
161239246|NCT03246503|582256901|FG000|Overall Study|Physician Decision|5|||
161239247|NCT03246503|582256901|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
161239248|NCT00736190|582256902|FG000|Overall Study|Pregnancy|1|||
161239249|NCT00736190|582256902|FG000|Overall Study|Withdrawal by Subject|1|||
161239250|NCT00736190|582256902|FG000|Overall Study|Adverse Event|1|||
161239251|NCT05014828|582256903|FG000|Overall Study|Study Completed by Sponsor|16|||
161239252|NCT05014828|582256904|FG001|Overall Study|Study Completed by Sponsor|16|||
161239253|NCT05014828|582256905|FG002|Overall Study|Study Completed by Sponsor|3|||
161239254|NCT05014828|582256906|FG003|Overall Study|Study Completed by Sponsor|3|||
161239255|NCT05014828|582256903|FG000|Overall Study|Death|11|||
161239256|NCT05014828|582256904|FG001|Overall Study|Death|6|||
161239257|NCT05014828|582256905|FG002|Overall Study|Death|0|||
161239258|NCT05014828|582256906|FG003|Overall Study|Death|0|||
161239259|NCT05014828|582256903|FG000|Overall Study|Lost to Follow-up|0|||
161239260|NCT05014828|582256904|FG001|Overall Study|Lost to Follow-up|0|||
161239261|NCT05014828|582256905|FG002|Overall Study|Lost to Follow-up|2|||
161239262|NCT05014828|582256906|FG003|Overall Study|Lost to Follow-up|0|||
161239263|NCT05014828|582256903|FG000|Overall Study|Miscellaneous.|0|||
161239264|NCT05014828|582256904|FG001|Overall Study|Miscellaneous.|1|||
161239265|NCT05014828|582256905|FG002|Overall Study|Miscellaneous.|0|||
161239266|NCT05014828|582256906|FG003|Overall Study|Miscellaneous.|0|||
161239267|NCT01370317|582256909|FG000|Overall Study|Participant withdrew consent|1|||
161239268|NCT01370317|582256910|FG001|Overall Study|Participant withdrew consent|0|||
161239269|NCT01370317|582256909|FG000|Overall Study|Protocol deviation|0|||
161239270|NCT01370317|582256910|FG001|Overall Study|Protocol deviation|1|||
161239271|NCT00075478|582256911|FG000|Overall Study|not eligible|1|||
161239272|NCT00075478|582256912|FG001|Overall Study|not eligible|0|||
161239273|NCT00075478|582256911|FG000|Overall Study|Physician Decision|0|||
161239274|NCT00075478|582256912|FG001|Overall Study|Physician Decision|1|||
161239275|NCT00824291|582256916|FG000|Overall Study|Adverse Event|15|||
161239276|NCT00824291|582256917|FG001|Overall Study|Adverse Event|6|||
161239277|NCT00824291|582256916|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161239278|NCT00824291|582256917|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
161239279|NCT00824291|582256916|FG000|Overall Study|Lost to Follow-up|11|||
161239280|NCT00824291|582256917|FG001|Overall Study|Lost to Follow-up|9|||
161239281|NCT00824291|582256916|FG000|Overall Study|Non-compliance|1|||
161239282|NCT00824291|582256917|FG001|Overall Study|Non-compliance|1|||
161239283|NCT00824291|582256916|FG000|Overall Study|Protocol Violation|4|||
161239284|NCT00824291|582256917|FG001|Overall Study|Protocol Violation|1|||
161239285|NCT00824291|582256916|FG000|Overall Study|Withdrawal by Subject|14|||
161239286|NCT00824291|582256917|FG001|Overall Study|Withdrawal by Subject|8|||
161239287|NCT00824291|582256916|FG000|Overall Study|Lack of Efficacy|7|||
161333019|NCT01712516|582608595|FG002|Overall Study|Lost to Follow-up|2|||
161239288|NCT00824291|582256917|FG001|Overall Study|Lack of Efficacy|8|||
161239289|NCT00824291|582256916|FG000|Overall Study|Participant on prohibited medication|1|||
161239290|NCT00824291|582256917|FG001|Overall Study|Participant on prohibited medication|0|||
161239291|NCT01778010|582256921|FG000|Overall Study|Withdrawal by Subject|2|||
161239292|NCT01778010|582256921|FG000|Overall Study|abnormal ECG before meds|1|||
161239293|NCT01778010|582256921|FG000|Overall Study|Arrested|1|||
161333020|NCT01712516|582608596|FG003|Overall Study|Lost to Follow-up|1|||
161239294|NCT01778010|582256921|FG000|Overall Study|rash while on placebo|1|||
161239295|NCT02159183|582256924|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
161239296|NCT02159183|582256925|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
161239297|NCT02159183|582256924|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
161239298|NCT02159183|582256925|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
161239299|NCT02159183|582256924|FG000|Analysis After the 36 Months Follow-up|Death|0|||
161239300|NCT02159183|582256925|FG001|Analysis After the 36 Months Follow-up|Death|1|||
161239301|NCT02159183|582256924|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
161239302|NCT02159183|582256925|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
161239303|NCT02159183|582256924|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
161239304|NCT02159183|582256925|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
161239305|NCT00429416|582256927|FG000|Overall Study|Death|1|||
161239306|NCT00415363|582256929|FG000|Overall Study|Withdrawal by Subject|4|||
161239307|NCT00415363|582256930|FG001|Overall Study|Withdrawal by Subject|4|||
161239308|NCT00415363|582256929|FG000|Overall Study|Adverse Event|4|||
161239309|NCT00415363|582256930|FG001|Overall Study|Adverse Event|4|||
161239310|NCT00415363|582256929|FG000|Overall Study|Lost to Follow-up|2|||
161239311|NCT00415363|582256930|FG001|Overall Study|Lost to Follow-up|1|||
161239312|NCT00415363|582256929|FG000|Overall Study|Physician Decision|3|||
161239313|NCT00415363|582256930|FG001|Overall Study|Physician Decision|1|||
161239314|NCT00415363|582256929|FG000|Overall Study|Death|16|||
161239315|NCT00415363|582256930|FG001|Overall Study|Death|12|||
161239316|NCT00415363|582256929|FG000|Overall Study|Progressive disease|26|||
161239317|NCT00415363|582256930|FG001|Overall Study|Progressive disease|32|||
161239318|NCT00813592|582256931|FG000|Overall Study|Disease assessment was not completed per|2|||
161239319|NCT01588236|582256936|FG000|Overall Study|Adverse Event|5|||
161239320|NCT01588236|582256937|FG001|Overall Study|Adverse Event|4|||
161239321|NCT01588236|582256938|FG002|Overall Study|Adverse Event|1|||
161239322|NCT01588236|582256936|FG000|Overall Study|Lost to Follow-up|8|||
161239323|NCT01588236|582256937|FG001|Overall Study|Lost to Follow-up|13|||
161239324|NCT01588236|582256938|FG002|Overall Study|Lost to Follow-up|6|||
161239325|NCT01588236|582256936|FG000|Overall Study|Physician Decision|1|||
161239326|NCT01588236|582256937|FG001|Overall Study|Physician Decision|2|||
161239327|NCT01588236|582256938|FG002|Overall Study|Physician Decision|0|||
161239328|NCT01588236|582256936|FG000|Overall Study|Protocol Violation|0|||
161239329|NCT01588236|582256937|FG001|Overall Study|Protocol Violation|1|||
161239330|NCT01588236|582256938|FG002|Overall Study|Protocol Violation|1|||
161239331|NCT01588236|582256936|FG000|Overall Study|Withdrawal by Subject|14|||
161239332|NCT01588236|582256937|FG001|Overall Study|Withdrawal by Subject|16|||
161239333|NCT01588236|582256938|FG002|Overall Study|Withdrawal by Subject|18|||
161239334|NCT01588236|582256936|FG000|Overall Study|Exclusion Criteria met during study|2|||
161239335|NCT01588236|582256937|FG001|Overall Study|Exclusion Criteria met during study|1|||
161239336|NCT01588236|582256938|FG002|Overall Study|Exclusion Criteria met during study|0|||
161239337|NCT01588236|582256936|FG000|Overall Study|sponsor decision|1|||
161239338|NCT01588236|582256937|FG001|Overall Study|sponsor decision|6|||
161239339|NCT01588236|582256938|FG002|Overall Study|sponsor decision|2|||
161239340|NCT01958294|582257953|FG000|Overall Study|Clinical Circumstances|2|||
161239341|NCT04825275|582257954|FG000|Overall Study|Withdrawal by Subject|1|||
161239342|NCT04825275|582257955|FG001|Overall Study|Withdrawal by Subject|0|||
161239343|NCT02566850|582257959|FG000|Overall Study|Protocol Violation|1|||
161239344|NCT00682461|582257960|FG000|Overall Study|Adverse Event|5|||
161239345|NCT00682461|582257961|FG001|Overall Study|Adverse Event|7|||
161239346|NCT00682461|582257960|FG000|Overall Study|Lost to Follow-up|8|||
161239347|NCT00682461|582257961|FG001|Overall Study|Lost to Follow-up|5|||
161239348|NCT00682461|582257960|FG000|Overall Study|Withdrawal by Subject|12|||
161239349|NCT00682461|582257961|FG001|Overall Study|Withdrawal by Subject|19|||
161239350|NCT06298396|582257969|FG000|Default MAP|Protocol Violation|1|||
161239351|NCT06137781|582257970|FG000|Baseline measurements|Lost to Follow-up|2|||
161239352|NCT06137781|582257970|FG000|Baseline measurements|Withdrawal by Subject|1|||
161239353|NCT06137781|582257970|FG000|Baseline measurements|Expedited surgery|1|||
161239354|NCT06137781|582257970|FG000|Intervention period|Lost to Follow-up|2|||
160812042|NCT01701362|580696426|FG001|Overall Study|Protocol Violation|3|||
160986825|NCT04955626|581341109|FG004|Blinded Period|No longer meets eligibility criteria|0|||
161239355|NCT06137781|582257970|FG000|Intervention period|Withdrawal by Subject|3|||
161239356|NCT06137781|582257970|FG000|Intervention period|Expedited surgery|1|||
161239357|NCT06137781|582257970|FG000|Intervention period|Adverse Event|1|||
161239358|NCT01547286|582257977|FG000|Overall Study|Did not meet all eligibility criteria|1|||
161239359|NCT01547286|582257977|FG000|Overall Study|Physician Decision|1|||
161239360|NCT00081653|582257979|FG000|Overall Study|Adverse Event|23|||
161239361|NCT00081653|582257980|FG001|Overall Study|Adverse Event|17|||
161333021|NCT01712516|582608593|FG000|Overall Study|Death|0|||
161239362|NCT00081653|582257979|FG000|Overall Study|Lost to Follow-up|2|||
161239363|NCT00081653|582257980|FG001|Overall Study|Lost to Follow-up|4|||
161239364|NCT00081653|582257979|FG000|Overall Study|Refused Treatment|18|||
161239365|NCT00081653|582257980|FG001|Overall Study|Refused Treatment|14|||
161239366|NCT00081653|582257979|FG000|Overall Study|Low bone mineral density|1|||
161333022|NCT01712516|582608594|FG001|Overall Study|Death|1|||
161239367|NCT00081653|582257980|FG001|Overall Study|Low bone mineral density|0|||
160812043|NCT01701362|580696425|FG000|Overall Study|No longer willing to participate|8|||
160812044|NCT01701362|580696426|FG001|Overall Study|No longer willing to participate|14|||
160812045|NCT01701362|580696425|FG000|Overall Study|Lost to Follow-up|6|||
160812046|NCT01701362|580696426|FG001|Overall Study|Lost to Follow-up|9|||
160812047|NCT01701362|580696425|FG000|Overall Study|Insufficient clinical response|6|||
160812048|NCT01701362|580696426|FG001|Overall Study|Insufficient clinical response|6|||
160812049|NCT01701362|580696425|FG000|Overall Study|Death|0|||
160812050|NCT01701362|580696426|FG001|Overall Study|Death|1|||
160812051|NCT01701362|580696425|FG000|Overall Study|Randomized but not treated|1|||
160812052|NCT01701362|580696426|FG001|Overall Study|Randomized but not treated|2|||
160812053|NCT01701362|580696425|FG000|Overall Study|Reasons other than those mentioned above|3|||
160812054|NCT01701362|580696426|FG001|Overall Study|Reasons other than those mentioned above|5|||
160812055|NCT00570778|580696427|FG000|Overall Study|Protocol deviation|2|||
160812056|NCT00570778|580696428|FG001|Overall Study|Protocol deviation|1|||
160812057|NCT00570778|580696429|FG002|Overall Study|Protocol deviation|2|||
160812058|NCT00570778|580696430|FG003|Overall Study|Protocol deviation|2|||
160812059|NCT00570778|580696427|FG000|Overall Study|Adverse Event|0|||
160812060|NCT00570778|580696428|FG001|Overall Study|Adverse Event|1|||
160812061|NCT00570778|580696429|FG002|Overall Study|Adverse Event|4|||
160812062|NCT00570778|580696430|FG003|Overall Study|Adverse Event|1|||
160812063|NCT00570778|580696427|FG000|Overall Study|Subject withdrew consent|0|||
160812064|NCT00570778|580696428|FG001|Overall Study|Subject withdrew consent|1|||
160812065|NCT00570778|580696429|FG002|Overall Study|Subject withdrew consent|0|||
160812066|NCT00570778|580696430|FG003|Overall Study|Subject withdrew consent|1|||
160812067|NCT00570778|580696427|FG000|Overall Study|Abnormal test procedure|1|||
160812068|NCT00570778|580696428|FG001|Overall Study|Abnormal test procedure|0|||
160812069|NCT00570778|580696429|FG002|Overall Study|Abnormal test procedure|0|||
160812070|NCT00570778|580696430|FG003|Overall Study|Abnormal test procedure|0|||
160812071|NCT00570778|580696427|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160812072|NCT00570778|580696428|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160812073|NCT00570778|580696429|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160812074|NCT00570778|580696430|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
160812075|NCT00570778|580696427|FG000|Overall Study|Lost to Follow-up|0|||
160812076|NCT00570778|580696428|FG001|Overall Study|Lost to Follow-up|0|||
160812077|NCT00570778|580696429|FG002|Overall Study|Lost to Follow-up|1|||
160812078|NCT00570778|580696430|FG003|Overall Study|Lost to Follow-up|0|||
160812079|NCT00570778|580696427|FG000|Overall Study|Subject no longer requires study drug|0|||
160812080|NCT00570778|580696428|FG001|Overall Study|Subject no longer requires study drug|1|||
160812081|NCT00570778|580696429|FG002|Overall Study|Subject no longer requires study drug|0|||
161239368|NCT00081653|582257979|FG000|Overall Study|Bone loss|2|||
161239369|NCT00081653|582257980|FG001|Overall Study|Bone loss|0|||
161239370|NCT00081653|582257979|FG000|Overall Study|Participant leaving country|1|||
161239371|NCT00081653|582257980|FG001|Overall Study|Participant leaving country|0|||
161239372|NCT00081653|582257979|FG000|Overall Study|Loss of bone mass|0|||
161239373|NCT00081653|582257980|FG001|Overall Study|Loss of bone mass|2|||
161239374|NCT00392665|582257981|FG000|Overall Study|Death|16|||
161239375|NCT00392665|582257982|FG001|Overall Study|Death|14|||
161239376|NCT00392665|582257981|FG000|Overall Study|Lost to Follow-up|1|||
161239377|NCT00392665|582257982|FG001|Overall Study|Lost to Follow-up|1|||
161239378|NCT03673670|582257983|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
161239379|NCT03673670|582257984|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161239380|NCT03673670|582257985|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161239381|NCT03673670|582257986|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161239382|NCT03673670|582257987|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161239383|NCT03673670|582257988|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
161239384|NCT03673670|582257983|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
161239385|NCT03673670|582257984|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
161239386|NCT03673670|582257985|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
161239387|NCT03673670|582257986|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
161239388|NCT03673670|582257987|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
161239389|NCT03673670|582257988|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
161239390|NCT03673670|582257983|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
160812082|NCT00570778|580696430|FG003|Overall Study|Subject no longer requires study drug|0|||
161239391|NCT03673670|582257984|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
160812083|NCT00443872|580696433|FG000|Overall Study|Protocol Violation|7|||
160812084|NCT00443872|580696433|FG000|Overall Study|Lost to Follow-up|2|||
160812085|NCT00443872|580696433|FG000|Overall Study|Adverse Event|8|||
160812086|NCT01014767|580696434|FG000|Overall Study|PI left institution, data unavailable|12|||
161239392|NCT03673670|582257985|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
161239393|NCT03673670|582257986|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
160812087|NCT01014767|580696435|FG001|Overall Study|PI left institution, data unavailable|1|||
160812088|NCT01014767|580696436|FG002|Overall Study|PI left institution, data unavailable|4|||
160812089|NCT01014767|580696437|FG003|Overall Study|PI left institution, data unavailable|1|||
160812090|NCT00282087|580696438|FG000|Overall Study|Death|1|||
161239394|NCT03673670|582257987|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
161239395|NCT03673670|582257988|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
161239396|NCT03673670|582257983|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161239397|NCT03673670|582257984|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161239398|NCT03673670|582257985|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161239399|NCT03673670|582257986|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161239400|NCT03673670|582257987|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
161239401|NCT03673670|582257988|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
161239402|NCT03673670|582257983|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
161239403|NCT03673670|582257984|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
161239404|NCT03673670|582257985|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
161239405|NCT03673670|582257986|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
161239406|NCT03673670|582257987|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
161239407|NCT03673670|582257988|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
161239408|NCT03673670|582257983|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161239409|NCT03673670|582257984|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161239410|NCT03673670|582257985|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161239411|NCT03673670|582257986|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161239412|NCT03673670|582257987|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
161239413|NCT03673670|582257988|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
161239414|NCT03673670|582257983|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
161239415|NCT03673670|582257984|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
161239416|NCT03673670|582257985|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
161239417|NCT03673670|582257986|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
161239418|NCT03673670|582257987|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
161239419|NCT03673670|582257988|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
161239420|NCT01058668|582257989|FG000|Double-blind Treatment Phase|Adverse Event|8|||
161239421|NCT01058668|582257990|FG001|Double-blind Treatment Phase|Adverse Event|15|||
161239422|NCT01058668|582257991|FG002|Double-blind Treatment Phase|Adverse Event|25|||
161239423|NCT01058668|582257989|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
161333023|NCT01712516|582608595|FG002|Overall Study|Death|0|||
160812091|NCT00588237|580696441|FG000|Overall Study|Evaluable for toxicity only|3|||
160812092|NCT00588237|580696441|FG000|Overall Study|Patien not treated|1|||
160812093|NCT00405392|580696449|FG000|Overall Study|Adverse Event|15|||
160812094|NCT00405392|580696450|FG001|Overall Study|Adverse Event|14|||
160812095|NCT00405392|580696449|FG000|Overall Study|Did not meet Eligibility criteria|7|||
160812096|NCT00405392|580696450|FG001|Overall Study|Did not meet Eligibility criteria|2|||
160812097|NCT00405392|580696449|FG000|Overall Study|Withdrawal by Subject|4|||
160812098|NCT00405392|580696450|FG001|Overall Study|Withdrawal by Subject|3|||
160812099|NCT00405392|580696449|FG000|Overall Study|Lost to Follow-up|1|||
160812100|NCT00405392|580696450|FG001|Overall Study|Lost to Follow-up|2|||
160812101|NCT00405392|580696449|FG000|Overall Study|Data missing|2|||
160812102|NCT00405392|580696450|FG001|Overall Study|Data missing|0|||
160812103|NCT00405392|580696449|FG000|Overall Study|Non-compliance|0|||
160812104|NCT00405392|580696450|FG001|Overall Study|Non-compliance|1|||
160812105|NCT00405392|580696449|FG000|Overall Study|Other|1|||
160812106|NCT00405392|580696450|FG001|Overall Study|Other|5|||
160812107|NCT00441142|580696471|FG000|Overall Study|Adverse Event|2|||
160812108|NCT00441142|580696472|FG001|Overall Study|Adverse Event|3|||
161239424|NCT01058668|582257990|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
161239425|NCT01058668|582257991|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
161239426|NCT01058668|582257989|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
161239427|NCT01058668|582257990|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
161239428|NCT01058668|582257991|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
161239429|NCT01058668|582257989|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
161239430|NCT01058668|582257990|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
161239431|NCT01058668|582257991|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
161239432|NCT01058668|582257989|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
161239433|NCT01058668|582257990|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
161239434|NCT01058668|582257991|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
161239435|NCT01058668|582257989|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
161239436|NCT01058668|582257990|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
161239437|NCT01058668|582257991|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
161239438|NCT02294786|582257994|FG000|Overall Study|Withdrawal by Subject|0|||
161239439|NCT02294786|582257995|FG001|Overall Study|Withdrawal by Subject|1|||
161239440|NCT02294786|582257994|FG000|Overall Study|Physician Decision|6|||
161239441|NCT02294786|582257995|FG001|Overall Study|Physician Decision|7|||
161239442|NCT02294786|582257994|FG000|Overall Study|Lost to Follow-up|1|||
161333024|NCT01712516|582608596|FG003|Overall Study|Death|0|||
160812109|NCT00441142|580696473|FG002|Overall Study|Adverse Event|3|||
160812110|NCT00441142|580696474|FG003|Overall Study|Adverse Event|22|||
160812111|NCT00441142|580696471|FG000|Overall Study|Lack of Efficacy|3|||
160812112|NCT00441142|580696472|FG001|Overall Study|Lack of Efficacy|3|||
160812113|NCT00441142|580696473|FG002|Overall Study|Lack of Efficacy|17|||
160812114|NCT00441142|580696474|FG003|Overall Study|Lack of Efficacy|32|||
160812115|NCT00441142|580696471|FG000|Overall Study|Withdrawal by Subject|0|||
160812116|NCT00441142|580696472|FG001|Overall Study|Withdrawal by Subject|0|||
160812117|NCT00441142|580696473|FG002|Overall Study|Withdrawal by Subject|2|||
160812118|NCT00441142|580696474|FG003|Overall Study|Withdrawal by Subject|10|||
160812119|NCT00441142|580696471|FG000|Overall Study|Patient still receiving active study tx|1|||
160812120|NCT00441142|580696472|FG001|Overall Study|Patient still receiving active study tx|0|||
160812121|NCT00441142|580696473|FG002|Overall Study|Patient still receiving active study tx|0|||
160812122|NCT00441142|580696474|FG003|Overall Study|Patient still receiving active study tx|2|||
160812123|NCT00441142|580696471|FG000|Overall Study|Physician Decision|0|||
160812124|NCT00441142|580696472|FG001|Overall Study|Physician Decision|1|||
160812125|NCT00441142|580696473|FG002|Overall Study|Physician Decision|0|||
160812126|NCT00441142|580696474|FG003|Overall Study|Physician Decision|1|||
160812127|NCT00441142|580696471|FG000|Overall Study|Death|0|||
160812128|NCT00441142|580696472|FG001|Overall Study|Death|0|||
160812129|NCT00441142|580696473|FG002|Overall Study|Death|0|||
160812130|NCT00441142|580696474|FG003|Overall Study|Death|1|||
160812131|NCT01703091|580696475|FG000|Overall Study|Adverse Event|5|||
160812132|NCT01703091|580696476|FG001|Overall Study|Adverse Event|3|||
160812133|NCT01703091|580696475|FG000|Overall Study|Physician Decision|2|||
160812134|NCT01703091|580696476|FG001|Overall Study|Physician Decision|1|||
160812135|NCT01703091|580696475|FG000|Overall Study|Withdrawal by Subject|1|||
160812136|NCT01703091|580696476|FG001|Overall Study|Withdrawal by Subject|0|||
160812137|NCT01703091|580696475|FG000|Overall Study|Sponsor Decision|1|||
160812138|NCT01703091|580696476|FG001|Overall Study|Sponsor Decision|0|||
160812139|NCT02550288|580696477|FG000|Overall Study|Adverse Event|0|||
160812140|NCT02550288|580696478|FG001|Overall Study|Adverse Event|1|||
160812141|NCT02550288|580696479|FG002|Overall Study|Adverse Event|0|||
160812142|NCT02550288|580696480|FG003|Overall Study|Adverse Event|0|||
160812143|NCT02550288|580696481|FG004|Overall Study|Adverse Event|0|||
160812144|NCT02550288|580696477|FG000|Overall Study|Physician Decision|0|||
160812145|NCT02550288|580696478|FG001|Overall Study|Physician Decision|0|||
160812146|NCT02550288|580696479|FG002|Overall Study|Physician Decision|0|||
160812147|NCT02550288|580696480|FG003|Overall Study|Physician Decision|1|||
160812148|NCT02550288|580696481|FG004|Overall Study|Physician Decision|0|||
160812149|NCT02550288|580696477|FG000|Overall Study|Protocol Violation|2|||
161131508|NCT00868790|581865293|FG006|Period 4|Adverse Event|0|||
161131509|NCT00868790|581865294|FG007|Period 4|Adverse Event|1|||
160812150|NCT02550288|580696478|FG001|Overall Study|Protocol Violation|2|||
160812151|NCT02550288|580696479|FG002|Overall Study|Protocol Violation|1|||
160812152|NCT02550288|580696480|FG003|Overall Study|Protocol Violation|0|||
160812153|NCT02550288|580696481|FG004|Overall Study|Protocol Violation|3|||
160812154|NCT02550288|580696477|FG000|Overall Study|Participant moved|0|||
160812155|NCT02550288|580696478|FG001|Overall Study|Participant moved|0|||
160812156|NCT02550288|580696479|FG002|Overall Study|Participant moved|0|||
160812157|NCT02550288|580696480|FG003|Overall Study|Participant moved|1|||
160812158|NCT02550288|580696481|FG004|Overall Study|Participant moved|0|||
160812159|NCT02550288|580696477|FG000|Overall Study|Withdrawal by Subject|0|||
160812160|NCT02550288|580696478|FG001|Overall Study|Withdrawal by Subject|0|||
160812161|NCT02550288|580696479|FG002|Overall Study|Withdrawal by Subject|0|||
160812162|NCT02550288|580696480|FG003|Overall Study|Withdrawal by Subject|1|||
160812163|NCT02550288|580696481|FG004|Overall Study|Withdrawal by Subject|0|||
160812164|NCT01524224|580696484|FG000|Overall Study|Progressive Disease|1|||
160812165|NCT01524224|580696485|FG001|Overall Study|Progressive Disease|0|||
160812166|NCT01524224|580696486|FG002|Overall Study|Progressive Disease|2|||
160812167|NCT01524224|580696487|FG003|Overall Study|Progressive Disease|1|||
161131510|NCT00868790|581865295|FG008|Period 4|Adverse Event|0|||
161131511|NCT00868790|581865296|FG009|Period 4|Adverse Event|0|||
161131512|NCT00868790|581865297|FG010|Period 4|Adverse Event|1|||
161131513|NCT00868790|581865298|FG011|Period 4|Adverse Event|0|||
161131514|NCT00868790|581865299|FG012|Period 4|Adverse Event|1|||
161131515|NCT00868790|581865300|FG013|Period 4|Adverse Event|0|||
161131516|NCT00868790|581865287|FG000|Period 4|Lost to Follow-up|0|||
160812168|NCT01524224|580696488|FG004|Overall Study|Progressive Disease|2|||
160812169|NCT01524224|580696489|FG005|Overall Study|Progressive Disease|1|||
160812170|NCT01524224|580696490|FG006|Overall Study|Progressive Disease|1|||
160812171|NCT01524224|580696491|FG007|Overall Study|Progressive Disease|5|||
160812172|NCT01524224|580696484|FG000|Overall Study|Withdrawal by Subject|2|||
160812173|NCT01524224|580696485|FG001|Overall Study|Withdrawal by Subject|0|||
160812174|NCT01524224|580696486|FG002|Overall Study|Withdrawal by Subject|0|||
160812175|NCT01524224|580696487|FG003|Overall Study|Withdrawal by Subject|0|||
160812176|NCT01524224|580696488|FG004|Overall Study|Withdrawal by Subject|0|||
160812177|NCT01524224|580696489|FG005|Overall Study|Withdrawal by Subject|0|||
160812178|NCT01524224|580696490|FG006|Overall Study|Withdrawal by Subject|2|||
160812179|NCT01524224|580696491|FG007|Overall Study|Withdrawal by Subject|0|||
160812180|NCT01524224|580696484|FG000|Overall Study|Adverse Event|0|||
160812181|NCT01524224|580696485|FG001|Overall Study|Adverse Event|1|||
160812182|NCT01524224|580696486|FG002|Overall Study|Adverse Event|0|||
160812183|NCT01524224|580696487|FG003|Overall Study|Adverse Event|0|||
160812184|NCT01524224|580696488|FG004|Overall Study|Adverse Event|0|||
160812185|NCT01524224|580696489|FG005|Overall Study|Adverse Event|1|||
160812186|NCT01524224|580696490|FG006|Overall Study|Adverse Event|0|||
160812187|NCT01524224|580696491|FG007|Overall Study|Adverse Event|0|||
160812188|NCT01524224|580696484|FG000|Overall Study|Physician Decision|0|||
160812189|NCT01524224|580696485|FG001|Overall Study|Physician Decision|0|||
160812190|NCT01524224|580696486|FG002|Overall Study|Physician Decision|0|||
160812191|NCT01524224|580696487|FG003|Overall Study|Physician Decision|1|||
160812192|NCT01524224|580696488|FG004|Overall Study|Physician Decision|1|||
160812193|NCT01524224|580696489|FG005|Overall Study|Physician Decision|0|||
160812194|NCT01524224|580696490|FG006|Overall Study|Physician Decision|0|||
160812195|NCT01524224|580696491|FG007|Overall Study|Physician Decision|1|||
160812196|NCT01524224|580696484|FG000|Overall Study|Sponsor Decision|0|||
160812197|NCT01524224|580696485|FG001|Overall Study|Sponsor Decision|0|||
160812198|NCT01524224|580696486|FG002|Overall Study|Sponsor Decision|0|||
160812199|NCT01524224|580696487|FG003|Overall Study|Sponsor Decision|0|||
160812200|NCT01524224|580696488|FG004|Overall Study|Sponsor Decision|1|||
160812201|NCT01524224|580696489|FG005|Overall Study|Sponsor Decision|0|||
160812202|NCT01524224|580696490|FG006|Overall Study|Sponsor Decision|0|||
160812203|NCT01524224|580696491|FG007|Overall Study|Sponsor Decision|0|||
160812204|NCT00988052|580696498|FG000|Overall Study|Missing|1|||
160812205|NCT00988052|580696499|FG001|Overall Study|Missing|0|||
160812206|NCT00988052|580696498|FG000|Overall Study|Teva requested subject withdrawal|3|||
160812207|NCT00988052|580696499|FG001|Overall Study|Teva requested subject withdrawal|1|||
160812208|NCT00988052|580696498|FG000|Overall Study|Death|1|||
160812209|NCT00988052|580696499|FG001|Overall Study|Death|3|||
160812210|NCT00988052|580696498|FG000|Overall Study|Protocol Violation|6|||
160812211|NCT00988052|580696499|FG001|Overall Study|Protocol Violation|5|||
160812212|NCT00988052|580696498|FG000|Overall Study|Pregnancy|6|||
160812213|NCT00988052|580696499|FG001|Overall Study|Pregnancy|6|||
160812214|NCT00988052|580696498|FG000|Overall Study|Lack of Efficacy|8|||
160812215|NCT00988052|580696499|FG001|Overall Study|Lack of Efficacy|7|||
160812216|NCT00988052|580696498|FG000|Overall Study|Lost to Follow-up|6|||
160812217|NCT00988052|580696499|FG001|Overall Study|Lost to Follow-up|11|||
160900008|NCT03917459|581028598|FG001|Overall Study|Adverse Event|0|||
160900009|NCT03917459|581028597|FG000|Overall Study|Withdrawal by Subject|0|||
160900010|NCT03917459|581028598|FG001|Overall Study|Withdrawal by Subject|1|||
160900011|NCT00736944|581028599|FG000|Induction|Death|1|||
160900012|NCT00736944|581028599|FG000|Definitive Treatment|Physician Decision|1|||
160900013|NCT00894166|581028600|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
160900014|NCT00894166|581028601|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
160900015|NCT00894166|581028602|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
160900016|NCT00894166|581028603|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
160900017|NCT00894166|581028604|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
160900018|NCT00894166|581028605|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
160900019|NCT00894166|581028606|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
160900020|NCT00894166|581028607|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
160900021|NCT00894166|581028600|FG000|Overall Study|Death|0|||
160900022|NCT00894166|581028601|FG001|Overall Study|Death|0|||
160900023|NCT00894166|581028602|FG002|Overall Study|Death|0|||
160900024|NCT00894166|581028603|FG003|Overall Study|Death|1|||
160900025|NCT00894166|581028604|FG004|Overall Study|Death|0|||
160900026|NCT00894166|581028605|FG005|Overall Study|Death|0|||
160900027|NCT00894166|581028606|FG006|Overall Study|Death|0|||
160900028|NCT00894166|581028607|FG007|Overall Study|Death|0|||
160900029|NCT01601132|581028609|FG000|Overall Study|Patient withdrew consent|1|||
160900030|NCT01601132|581028609|FG000|Overall Study|Protocol deviation|1|||
161239443|NCT02294786|582257995|FG001|Overall Study|Lost to Follow-up|2|||
161239444|NCT02294786|582257994|FG000|Overall Study|Protocol Violation|1|||
160900031|NCT00850070|581028614|FG000|Overall Study|Lack of Efficacy|1|||
160900032|NCT00850070|581028615|FG001|Overall Study|Lack of Efficacy|1|||
160900033|NCT00850070|581028614|FG000|Overall Study|Adverse Event|2|||
161239445|NCT02294786|582257995|FG001|Overall Study|Protocol Violation|0|||
161239446|NCT02294786|582257994|FG000|Overall Study|Adverse Event|1|||
161239447|NCT02294786|582257995|FG001|Overall Study|Adverse Event|1|||
161239448|NCT02294786|582257994|FG000|Overall Study|Death|2|||
160812218|NCT00988052|580696498|FG000|Overall Study|Physician Decision|27|||
160812219|NCT00988052|580696499|FG001|Overall Study|Physician Decision|28|||
160812220|NCT00988052|580696498|FG000|Overall Study|Adverse Event|35|||
160812221|NCT00988052|580696499|FG001|Overall Study|Adverse Event|28|||
160812222|NCT00988052|580696498|FG000|Overall Study|Withdrawal by Subject|90|||
160812223|NCT00988052|580696499|FG001|Overall Study|Withdrawal by Subject|91|||
160812224|NCT00988052|580696498|FG000|Overall Study|Study terminated by sponsor|240|||
160812225|NCT00988052|580696499|FG001|Overall Study|Study terminated by sponsor|236|||
160812226|NCT05312697|580696500|FG000|Overall Study|Sponsor Terminated Trial|2|||
160812227|NCT02858440|580696501|FG000|Overall Study|Lost to Follow-up|3|||
160812228|NCT02858440|580696501|FG000|Overall Study|Protocol Violation|2|||
160812229|NCT02858440|580696501|FG000|Overall Study|Consent withdrawal|3|||
160900034|NCT00850070|581028615|FG001|Overall Study|Adverse Event|0|||
160986826|NCT04955626|581341110|FG005|Blinded Period|No longer meets eligibility criteria|0|||
160986827|NCT04955626|581341111|FG006|Blinded Period|No longer meets eligibility criteria|0|||
161131517|NCT00868790|581865288|FG001|Period 4|Lost to Follow-up|0|||
161131518|NCT00868790|581865289|FG002|Period 4|Lost to Follow-up|0|||
161131519|NCT00868790|581865290|FG003|Period 4|Lost to Follow-up|0|||
161131520|NCT00868790|581865291|FG004|Period 4|Lost to Follow-up|0|||
161131521|NCT00868790|581865292|FG005|Period 4|Lost to Follow-up|0|||
161131522|NCT00868790|581865293|FG006|Period 4|Lost to Follow-up|0|||
161131523|NCT00868790|581865294|FG007|Period 4|Lost to Follow-up|1|||
161131524|NCT00868790|581865295|FG008|Period 4|Lost to Follow-up|0|||
161131525|NCT00868790|581865296|FG009|Period 4|Lost to Follow-up|0|||
161131526|NCT00868790|581865297|FG010|Period 4|Lost to Follow-up|0|||
161131527|NCT00868790|581865298|FG011|Period 4|Lost to Follow-up|0|||
161131528|NCT00868790|581865299|FG012|Period 4|Lost to Follow-up|0|||
161131529|NCT00868790|581865300|FG013|Period 4|Lost to Follow-up|0|||
161131530|NCT00868790|581865287|FG000|Period 4|Study Terminated by Sponsor|2|||
161131531|NCT00868790|581865288|FG001|Period 4|Study Terminated by Sponsor|0|||
161131532|NCT00868790|581865289|FG002|Period 4|Study Terminated by Sponsor|0|||
161131533|NCT00868790|581865290|FG003|Period 4|Study Terminated by Sponsor|0|||
161131534|NCT00868790|581865291|FG004|Period 4|Study Terminated by Sponsor|0|||
161131535|NCT00868790|581865292|FG005|Period 4|Study Terminated by Sponsor|0|||
161131536|NCT00868790|581865293|FG006|Period 4|Study Terminated by Sponsor|0|||
161131537|NCT00868790|581865294|FG007|Period 4|Study Terminated by Sponsor|1|||
161131538|NCT00868790|581865295|FG008|Period 4|Study Terminated by Sponsor|2|||
161131539|NCT00868790|581865296|FG009|Period 4|Study Terminated by Sponsor|0|||
161131540|NCT00868790|581865297|FG010|Period 4|Study Terminated by Sponsor|2|||
161131541|NCT00868790|581865298|FG011|Period 4|Study Terminated by Sponsor|1|||
161131542|NCT00868790|581865299|FG012|Period 4|Study Terminated by Sponsor|0|||
161131543|NCT00868790|581865300|FG013|Period 4|Study Terminated by Sponsor|1|||
161131544|NCT00868790|581865287|FG000|Period 4|Abnormal ALT/AST|0|||
161131545|NCT00868790|581865288|FG001|Period 4|Abnormal ALT/AST|0|||
161131546|NCT00868790|581865289|FG002|Period 4|Abnormal ALT/AST|1|||
161131547|NCT00868790|581865290|FG003|Period 4|Abnormal ALT/AST|0|||
161131548|NCT00868790|581865291|FG004|Period 4|Abnormal ALT/AST|0|||
161131549|NCT00868790|581865292|FG005|Period 4|Abnormal ALT/AST|0|||
161131550|NCT00868790|581865293|FG006|Period 4|Abnormal ALT/AST|0|||
161131551|NCT00868790|581865294|FG007|Period 4|Abnormal ALT/AST|0|||
161131552|NCT00868790|581865295|FG008|Period 4|Abnormal ALT/AST|0|||
161131553|NCT00868790|581865296|FG009|Period 4|Abnormal ALT/AST|0|||
161131554|NCT00868790|581865297|FG010|Period 4|Abnormal ALT/AST|0|||
161131555|NCT00868790|581865298|FG011|Period 4|Abnormal ALT/AST|0|||
161131556|NCT00868790|581865299|FG012|Period 4|Abnormal ALT/AST|0|||
161131557|NCT00868790|581865300|FG013|Period 4|Abnormal ALT/AST|0|||
161131558|NCT00868790|581865287|FG000|Post-study|Withdrawal by Subject|0|||
161131559|NCT00868790|581865288|FG001|Post-study|Withdrawal by Subject|0|||
161131560|NCT00868790|581865289|FG002|Post-study|Withdrawal by Subject|0|||
161131561|NCT00868790|581865290|FG003|Post-study|Withdrawal by Subject|0|||
161131562|NCT00868790|581865291|FG004|Post-study|Withdrawal by Subject|1|||
161131563|NCT00868790|581865292|FG005|Post-study|Withdrawal by Subject|0|||
161131564|NCT00868790|581865293|FG006|Post-study|Withdrawal by Subject|0|||
161131565|NCT00868790|581865294|FG007|Post-study|Withdrawal by Subject|0|||
161131566|NCT00868790|581865295|FG008|Post-study|Withdrawal by Subject|0|||
161131567|NCT00868790|581865296|FG009|Post-study|Withdrawal by Subject|0|||
161131568|NCT00868790|581865297|FG010|Post-study|Withdrawal by Subject|0|||
161131569|NCT00868790|581865298|FG011|Post-study|Withdrawal by Subject|0|||
161131570|NCT00868790|581865299|FG012|Post-study|Withdrawal by Subject|0|||
161131571|NCT00868790|581865300|FG013|Post-study|Withdrawal by Subject|0|||
161131572|NCT00868790|581865287|FG000|Post-study|Excluded Medication|0|||
161131573|NCT00868790|581865288|FG001|Post-study|Excluded Medication|0|||
161131574|NCT00868790|581865289|FG002|Post-study|Excluded Medication|0|||
161131575|NCT00868790|581865290|FG003|Post-study|Excluded Medication|0|||
161131576|NCT00868790|581865291|FG004|Post-study|Excluded Medication|0|||
161131577|NCT00868790|581865292|FG005|Post-study|Excluded Medication|0|||
161131578|NCT00868790|581865293|FG006|Post-study|Excluded Medication|0|||
161131579|NCT00868790|581865294|FG007|Post-study|Excluded Medication|2|||
161131580|NCT00868790|581865295|FG008|Post-study|Excluded Medication|0|||
161131581|NCT00868790|581865296|FG009|Post-study|Excluded Medication|1|||
161131582|NCT00868790|581865297|FG010|Post-study|Excluded Medication|0|||
161131583|NCT00868790|581865298|FG011|Post-study|Excluded Medication|0|||
161131584|NCT00868790|581865299|FG012|Post-study|Excluded Medication|0|||
161131585|NCT00868790|581865300|FG013|Post-study|Excluded Medication|0|||
161131586|NCT02909153|581865305|FG000|Overall Study|Withdrawal by Subject|0|||
161131587|NCT02909153|581865306|FG001|Overall Study|Withdrawal by Subject|1|||
161131588|NCT02909153|581865307|FG002|Overall Study|Withdrawal by Subject|0|||
161131589|NCT02909153|581865308|FG003|Overall Study|Withdrawal by Subject|0|||
161131590|NCT02909153|581865309|FG004|Overall Study|Withdrawal by Subject|0|||
161131591|NCT03040024|581865310|FG000|Overall Study|Adverse Event|0|||
161131592|NCT03040024|581865311|FG001|Overall Study|Adverse Event|1|||
161131593|NCT03040024|581865312|FG002|Overall Study|Adverse Event|0|||
161131594|NCT03040024|581865310|FG000|Overall Study|Death|0|||
161333025|NCT01712516|582608593|FG000|Overall Study|Protocol deviation|1|||
161333026|NCT01712516|582608594|FG001|Overall Study|Protocol deviation|0|||
161333027|NCT01712516|582608595|FG002|Overall Study|Protocol deviation|1|||
160812230|NCT02858440|580696501|FG000|Overall Study|Migrated/moved from study area|4|||
160812231|NCT00402324|580696502|FG000|Overall Study|Lost to Follow-up|11|||
160812232|NCT00402324|580696503|FG001|Overall Study|Lost to Follow-up|11|||
160812233|NCT00402324|580696502|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
160812234|NCT00402324|580696503|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
160812235|NCT00402324|580696502|FG000|Overall Study|Protocol Violation|8|||
160812236|NCT00402324|580696503|FG001|Overall Study|Protocol Violation|7|||
160812237|NCT00402324|580696502|FG000|Overall Study|Withdrawal by Subject|5|||
160812238|NCT00402324|580696503|FG001|Overall Study|Withdrawal by Subject|2|||
160812239|NCT00402324|580696502|FG000|Overall Study|Physician Decision|2|||
160812240|NCT00402324|580696503|FG001|Overall Study|Physician Decision|4|||
160812241|NCT00402324|580696502|FG000|Overall Study|Sponsor Decision|4|||
160812242|NCT00402324|580696503|FG001|Overall Study|Sponsor Decision|5|||
160812243|NCT00402324|580696502|FG000|Overall Study|Lack of Efficacy|1|||
160812244|NCT00402324|580696503|FG001|Overall Study|Lack of Efficacy|4|||
160812245|NCT00402324|580696502|FG000|Overall Study|Adverse Event|6|||
160812246|NCT00402324|580696503|FG001|Overall Study|Adverse Event|4|||
160812247|NCT00402324|580696502|FG000|Overall Study|Death|1|||
160812248|NCT00402324|580696503|FG001|Overall Study|Death|0|||
160812249|NCT01277822|580696504|FG000|Overall Study|Adverse Event|2|||
160812250|NCT01277822|580696505|FG001|Overall Study|Adverse Event|1|||
160812251|NCT01277822|580696504|FG000|Overall Study|Withdrawal by Subject|6|||
160812252|NCT01277822|580696505|FG001|Overall Study|Withdrawal by Subject|7|||
160812253|NCT01277822|580696504|FG000|Overall Study|Physician Decision|1|||
160812254|NCT01277822|580696505|FG001|Overall Study|Physician Decision|1|||
160812255|NCT01277822|580696504|FG000|Overall Study|Protocol Violation|1|||
160812256|NCT01277822|580696505|FG001|Overall Study|Protocol Violation|0|||
160812257|NCT01277822|580696504|FG000|Overall Study|Lost to Follow-up|2|||
160812258|NCT01277822|580696505|FG001|Overall Study|Lost to Follow-up|1|||
160812259|NCT01277822|580696504|FG000|Overall Study|Contraindicated medication used|2|||
160812260|NCT01277822|580696505|FG001|Overall Study|Contraindicated medication used|1|||
160812261|NCT01277822|580696504|FG000|Overall Study|Participant moved|1|||
160812262|NCT01277822|580696505|FG001|Overall Study|Participant moved|0|||
160812263|NCT02923531|580696506|FG000|Overall Study|Adverse Event|4|||
160812264|NCT02923531|580696506|FG000|Overall Study|Clinical Deterioration|1|||
160812265|NCT02923531|580696506|FG000|Overall Study|Disease Progression|3|||
160812266|NCT02923531|580696506|FG000|Overall Study|Study Termination|1|||
160812267|NCT00997984|580696507|FG000|Overall Study|Adverse Event|1|||
160812268|NCT00997984|580696508|FG001|Overall Study|Adverse Event|8|||
161131595|NCT03040024|581865311|FG001|Overall Study|Death|1|||
161131596|NCT03040024|581865312|FG002|Overall Study|Death|0|||
161333028|NCT01712516|582608596|FG003|Overall Study|Protocol deviation|0|||
161333029|NCT01712516|582608593|FG000|Overall Study|Physician Decision|2|||
161333030|NCT01712516|582608594|FG001|Overall Study|Physician Decision|0|||
160812269|NCT00997984|580696509|FG002|Overall Study|Adverse Event|8|||
160812270|NCT00997984|580696507|FG000|Overall Study|Protocol Violation|1|||
160812271|NCT00997984|580696508|FG001|Overall Study|Protocol Violation|3|||
160812272|NCT00997984|580696509|FG002|Overall Study|Protocol Violation|0|||
160812273|NCT00997984|580696507|FG000|Overall Study|Withdrawal by Subject|6|||
160812274|NCT00997984|580696508|FG001|Overall Study|Withdrawal by Subject|9|||
160812275|NCT00997984|580696509|FG002|Overall Study|Withdrawal by Subject|5|||
160812276|NCT00997984|580696507|FG000|Overall Study|Lost to Follow-up|8|||
160812277|NCT00997984|580696508|FG001|Overall Study|Lost to Follow-up|5|||
160812278|NCT00997984|580696509|FG002|Overall Study|Lost to Follow-up|4|||
161131597|NCT03040024|581865310|FG000|Overall Study|Physician Decision|0|||
161131598|NCT03040024|581865311|FG001|Overall Study|Physician Decision|0|||
161131599|NCT03040024|581865312|FG002|Overall Study|Physician Decision|1|||
161131600|NCT02658812|581865313|FG000|Overall Study|Disease Progression|7|||
161131601|NCT02658812|581865313|FG000|Overall Study|Unrelated to study treatment|1|||
161131602|NCT02658812|581865313|FG000|Overall Study|Adverse Event|1|||
161131603|NCT00854828|581865316|FG000|Overall Study|Death|1|||
161131604|NCT00854828|581865317|FG001|Overall Study|Death|0|||
161131605|NCT00854828|581865318|FG002|Overall Study|Death|0|||
161131606|NCT00854828|581865319|FG003|Overall Study|Death|0|||
161131607|NCT00854828|581865316|FG000|Overall Study|Withdrawal by Subject|1|||
161131608|NCT00854828|581865317|FG001|Overall Study|Withdrawal by Subject|1|||
161131609|NCT00854828|581865318|FG002|Overall Study|Withdrawal by Subject|0|||
160812279|NCT00997984|580696507|FG000|Overall Study|Lack of Efficacy|20|||
160812280|NCT00997984|580696508|FG001|Overall Study|Lack of Efficacy|6|||
160812281|NCT00997984|580696509|FG002|Overall Study|Lack of Efficacy|3|||
160812282|NCT00997984|580696507|FG000|Overall Study|Met exclusion criteria|1|||
160812283|NCT00997984|580696508|FG001|Overall Study|Met exclusion criteria|0|||
160812284|NCT00997984|580696509|FG002|Overall Study|Met exclusion criteria|0|||
160812285|NCT00997984|580696507|FG000|Overall Study|non-compliance|0|||
161131610|NCT00854828|581865319|FG003|Overall Study|Withdrawal by Subject|9|||
161131611|NCT00854828|581865316|FG000|Overall Study|Missed 24mo visit|1|||
161333031|NCT01712516|582608595|FG002|Overall Study|Physician Decision|0|||
160812286|NCT00997984|580696508|FG001|Overall Study|non-compliance|2|||
160812287|NCT00997984|580696509|FG002|Overall Study|non-compliance|3|||
160812288|NCT00997984|580696507|FG000|Overall Study|Wrong medication dispensed|0|||
160812289|NCT00997984|580696508|FG001|Overall Study|Wrong medication dispensed|1|||
160812290|NCT00997984|580696509|FG002|Overall Study|Wrong medication dispensed|0|||
160812291|NCT00997984|580696507|FG000|Overall Study|Suicidal ideation|0|||
160812292|NCT00997984|580696508|FG001|Overall Study|Suicidal ideation|0|||
160812293|NCT00997984|580696509|FG002|Overall Study|Suicidal ideation|1|||
160812294|NCT00997984|580696507|FG000|Overall Study|Work schedule|0|||
160812295|NCT00997984|580696508|FG001|Overall Study|Work schedule|0|||
160812296|NCT00997984|580696509|FG002|Overall Study|Work schedule|2|||
160812297|NCT02997865|580696511|FG000|Overall Study|Death|2|||
160812298|NCT02997865|580696512|FG001|Overall Study|Death|1|||
160812299|NCT02997865|580696511|FG000|Overall Study|Lost to Follow-up|6|||
160812300|NCT02997865|580696512|FG001|Overall Study|Lost to Follow-up|3|||
160812301|NCT02997865|580696511|FG000|Overall Study|Withdrawal by Subject|5|||
160812302|NCT02997865|580696512|FG001|Overall Study|Withdrawal by Subject|0|||
160812303|NCT01119066|580696513|FG000|Overall Study|Withdrawal by Subject|4|||
160812304|NCT01119066|580696514|FG001|Overall Study|Withdrawal by Subject|6|||
160812305|NCT01119066|580696515|FG002|Overall Study|Withdrawal by Subject|0|||
160812306|NCT01119066|580696516|FG003|Overall Study|Withdrawal by Subject|0|||
160812307|NCT01119066|580696513|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
160812308|NCT01119066|580696514|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
160812309|NCT01119066|580696515|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
160812310|NCT01119066|580696516|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
160812311|NCT01119066|580696513|FG000|Overall Study|Relapse identified before transplant|1|||
160812312|NCT01119066|580696514|FG001|Overall Study|Relapse identified before transplant|0|||
160812313|NCT01119066|580696515|FG002|Overall Study|Relapse identified before transplant|0|||
160812314|NCT01119066|580696516|FG003|Overall Study|Relapse identified before transplant|0|||
160812315|NCT01119066|580696513|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
160812316|NCT01119066|580696514|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
160812317|NCT01119066|580696515|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
160812318|NCT01119066|580696516|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
160812319|NCT01119066|580696513|FG000|Overall Study|Relapse identified before transplant|0|||
160812320|NCT01119066|580696514|FG001|Overall Study|Relapse identified before transplant|4|||
160812321|NCT01119066|580696515|FG002|Overall Study|Relapse identified before transplant|0|||
160812322|NCT01119066|580696516|FG003|Overall Study|Relapse identified before transplant|0|||
160812323|NCT00783835|580696517|FG000|Overall Study|Adverse Event|3|||
160812324|NCT00783835|580696517|FG000|Overall Study|Medical Criteria|1|||
160812325|NCT00783835|580696517|FG000|Overall Study|Withdrawal by Subject|2|||
160812326|NCT00783835|580696517|FG000|Overall Study|Lost to Follow-up|1|||
160812327|NCT00783835|580696517|FG000|Overall Study|Participant not Adherent|3|||
160812328|NCT00295646|580696518|FG000|Overall Study|Protocol Violation|18|||
160812329|NCT00295646|580696519|FG001|Overall Study|Protocol Violation|20|||
160812330|NCT00295646|580696520|FG002|Overall Study|Protocol Violation|20|||
160812331|NCT00295646|580696521|FG003|Overall Study|Protocol Violation|18|||
160812332|NCT00295646|580696518|FG000|Overall Study|Withdrawal by Subject|8|||
160812333|NCT00295646|580696519|FG001|Overall Study|Withdrawal by Subject|9|||
160812334|NCT00295646|580696520|FG002|Overall Study|Withdrawal by Subject|11|||
161239449|NCT02294786|582257995|FG001|Overall Study|Death|3|||
160812335|NCT00295646|580696521|FG003|Overall Study|Withdrawal by Subject|14|||
160812336|NCT00295646|580696518|FG000|Overall Study|Lost to Follow-up|0|||
160812337|NCT00295646|580696519|FG001|Overall Study|Lost to Follow-up|5|||
160812338|NCT00295646|580696520|FG002|Overall Study|Lost to Follow-up|1|||
160812339|NCT00295646|580696521|FG003|Overall Study|Lost to Follow-up|5|||
160812340|NCT00295646|580696518|FG000|Overall Study|Death|9|||
160812341|NCT00295646|580696519|FG001|Overall Study|Death|7|||
160812342|NCT00295646|580696520|FG002|Overall Study|Death|18|||
160812343|NCT00295646|580696521|FG003|Overall Study|Death|8|||
160812344|NCT01945996|580696522|FG000|Overall Study|Lost to Follow-up|3|||
160812345|NCT01945996|580696523|FG001|Overall Study|Lost to Follow-up|5|||
160812346|NCT04660552|580696525|FG000|Overall Study|Withdrawal by Subject|3|||
160812347|NCT04660552|580696526|FG001|Overall Study|Withdrawal by Subject|1|||
160812348|NCT03012828|580696527|FG000|Overall Study|Lost to Follow-up|1|||
160812349|NCT03012828|580696528|FG001|Overall Study|Lost to Follow-up|0|||
160812350|NCT03012828|580696529|FG002|Overall Study|Lost to Follow-up|1|||
160812351|NCT03012828|580696530|FG003|Overall Study|Lost to Follow-up|0|||
160812352|NCT03012828|580696531|FG004|Overall Study|Lost to Follow-up|1|||
161239450|NCT03261167|582257996|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
160812353|NCT03012828|580696532|FG005|Overall Study|Lost to Follow-up|0|||
160812354|NCT03012828|580696527|FG000|Overall Study|Withdrawal by Subject|0|||
160812355|NCT03012828|580696528|FG001|Overall Study|Withdrawal by Subject|0|||
160812356|NCT03012828|580696529|FG002|Overall Study|Withdrawal by Subject|1|||
160812357|NCT03012828|580696530|FG003|Overall Study|Withdrawal by Subject|0|||
160812358|NCT03012828|580696531|FG004|Overall Study|Withdrawal by Subject|0|||
160812359|NCT03012828|580696532|FG005|Overall Study|Withdrawal by Subject|1|||
160812360|NCT03012828|580696527|FG000|Overall Study|Non-compliance with protocol|0|||
160812361|NCT03012828|580696528|FG001|Overall Study|Non-compliance with protocol|0|||
160812362|NCT03012828|580696529|FG002|Overall Study|Non-compliance with protocol|0|||
160812363|NCT03012828|580696530|FG003|Overall Study|Non-compliance with protocol|0|||
160812364|NCT03012828|580696531|FG004|Overall Study|Non-compliance with protocol|1|||
160812365|NCT03012828|580696532|FG005|Overall Study|Non-compliance with protocol|0|||
160812366|NCT03012828|580696527|FG000|Overall Study|Delay to last visit would delay DBL|0|||
160812367|NCT03012828|580696528|FG001|Overall Study|Delay to last visit would delay DBL|0|||
160812368|NCT03012828|580696529|FG002|Overall Study|Delay to last visit would delay DBL|0|||
160812369|NCT03012828|580696530|FG003|Overall Study|Delay to last visit would delay DBL|0|||
160812370|NCT03012828|580696531|FG004|Overall Study|Delay to last visit would delay DBL|0|||
160812371|NCT03012828|580696532|FG005|Overall Study|Delay to last visit would delay DBL|1|||
160812372|NCT01970241|580696533|FG000|Overall Study|Withdrawal by Subject|2|||
160812373|NCT01970241|580696534|FG001|Overall Study|Withdrawal by Subject|0|||
160812374|NCT01970241|580696533|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
161239451|NCT03261167|582257997|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
161239452|NCT03261167|582257996|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
161239453|NCT03261167|582257997|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
161239454|NCT03261167|582257996|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
161333032|NCT01712516|582608596|FG003|Overall Study|Physician Decision|1|||
160812375|NCT01970241|580696534|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
160812376|NCT01107392|580696535|FG000|Overall Study|Adverse Event|2|||
160812377|NCT01107392|580696536|FG001|Overall Study|Adverse Event|0|||
160812378|NCT01107392|580696535|FG000|Overall Study|Personal Reasons|2|||
160812379|NCT01107392|580696536|FG001|Overall Study|Personal Reasons|3|||
160812380|NCT01107392|580696535|FG000|Overall Study|Administrative decision|1|||
160812381|NCT01107392|580696536|FG001|Overall Study|Administrative decision|0|||
160812382|NCT02689206|580696540|FG000|Overall Study|Adverse Event|0|||
160812383|NCT02689206|580696541|FG001|Overall Study|Adverse Event|0|||
160812384|NCT02689206|580696542|FG002|Overall Study|Adverse Event|1|||
160812385|NCT02689206|580696543|FG003|Overall Study|Adverse Event|0|||
160812386|NCT02689206|580696544|FG004|Overall Study|Adverse Event|2|||
160812387|NCT02689206|580696540|FG000|Overall Study|Protocol Violation|1|||
160812388|NCT02689206|580696541|FG001|Overall Study|Protocol Violation|0|||
160812389|NCT02689206|580696542|FG002|Overall Study|Protocol Violation|0|||
160812390|NCT02689206|580696543|FG003|Overall Study|Protocol Violation|1|||
160812391|NCT02689206|580696544|FG004|Overall Study|Protocol Violation|2|||
160812392|NCT02689206|580696540|FG000|Overall Study|Other: Reached stopping criteria|0|||
160812393|NCT02689206|580696541|FG001|Overall Study|Other: Reached stopping criteria|1|||
160812394|NCT02689206|580696542|FG002|Overall Study|Other: Reached stopping criteria|2|||
160812395|NCT02689206|580696543|FG003|Overall Study|Other: Reached stopping criteria|3|||
160812396|NCT02689206|580696544|FG004|Overall Study|Other: Reached stopping criteria|4|||
160812397|NCT02689206|580696540|FG000|Overall Study|Physician Decision|1|||
160812398|NCT02689206|580696541|FG001|Overall Study|Physician Decision|0|||
160812399|NCT02689206|580696542|FG002|Overall Study|Physician Decision|0|||
160812400|NCT02689206|580696543|FG003|Overall Study|Physician Decision|0|||
160812401|NCT02689206|580696544|FG004|Overall Study|Physician Decision|0|||
160812402|NCT02689206|580696540|FG000|Overall Study|Withdrawal by Subject|1|||
160812403|NCT02689206|580696541|FG001|Overall Study|Withdrawal by Subject|0|||
160812404|NCT02689206|580696542|FG002|Overall Study|Withdrawal by Subject|1|||
160812405|NCT02689206|580696543|FG003|Overall Study|Withdrawal by Subject|0|||
160812406|NCT02689206|580696544|FG004|Overall Study|Withdrawal by Subject|0|||
160900035|NCT01522248|581028620|FG000|Overall Study|Lost to Follow-up|1|||
160900036|NCT01522248|581028621|FG001|Overall Study|Lost to Follow-up|0|||
160900037|NCT01332331|581028623|FG000|Overall Study|Lost to Follow-up|0|||
160900038|NCT01332331|581028624|FG001|Overall Study|Lost to Follow-up|1|||
160900039|NCT01332331|581028623|FG000|Overall Study|Adverse Event|1|||
160900040|NCT01332331|581028624|FG001|Overall Study|Adverse Event|1|||
160900041|NCT01332331|581028623|FG000|Overall Study|Physician Decision|1|||
160900042|NCT01332331|581028624|FG001|Overall Study|Physician Decision|0|||
160812407|NCT02520388|580696545|FG000|Overall Study|Physician Decision|1|||
160812408|NCT02520388|580696546|FG001|Overall Study|Physician Decision|0|||
160812409|NCT02520388|580696545|FG000|Overall Study|Subject or parent/guardian request|0|||
160812410|NCT02520388|580696546|FG001|Overall Study|Subject or parent/guardian request|6|||
160900043|NCT04674644|581028633|FG000|Overall Study|with missing data|37|||
160900044|NCT03469934|581028635|FG000|Overall Study|Withdrawal by Subject|0|||
160900045|NCT03469934|581028636|FG001|Overall Study|Withdrawal by Subject|1|||
160900046|NCT01691898|581028637|FG000|Overall Study|Death|34|||
160900047|NCT01691898|581028638|FG001|Overall Study|Death|32|||
160812411|NCT02520388|580696545|FG000|Overall Study|Adverse Event|1|||
160812412|NCT02520388|580696546|FG001|Overall Study|Adverse Event|4|||
160812413|NCT02520388|580696545|FG000|Overall Study|Lost to Follow-up|3|||
160812414|NCT02520388|580696546|FG001|Overall Study|Lost to Follow-up|2|||
160900048|NCT01691898|581028639|FG002|Overall Study|Death|6|||
160900049|NCT01691898|581028640|FG003|Overall Study|Death|3|||
160812415|NCT02520388|580696545|FG000|Overall Study|Other (reason not defined)|4|||
160812416|NCT02520388|580696546|FG001|Overall Study|Other (reason not defined)|4|||
160812417|NCT01437111|580696547|FG000|Overall Study|Adverse Event|2|||
160812418|NCT01437111|580696547|FG000|Overall Study|Withdrawal by Subject|4|||
160812419|NCT01437111|580696547|FG000|Overall Study|Not reported|5|||
160812420|NCT01437111|580696547|FG000|Overall Study|Physician Decision|1|||
160812421|NCT01437111|580696547|FG000|Overall Study|Lost to Follow-up|5|||
160812422|NCT01437111|580696547|FG000|Overall Study|Protocol Violation|1|||
160812423|NCT01232127|580696548|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
160812424|NCT01232127|580696549|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
160812425|NCT01232127|580696550|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
160812426|NCT02623205|580696553|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
160812427|NCT02623205|580696554|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
160812428|NCT03062280|580697916|FG000|Overall Study|Adverse Event|1|||
160812429|NCT03062280|580697916|FG000|Overall Study|Death|1|||
160812430|NCT03062280|580697916|FG000|Overall Study|Fertility Treatment|2|||
161333033|NCT01712516|582608593|FG000|Overall Study|Withdrawal by Subject|3|||
161333034|NCT01712516|582608594|FG001|Overall Study|Withdrawal by Subject|9|||
161333035|NCT01712516|582608595|FG002|Overall Study|Withdrawal by Subject|3|||
160812431|NCT03062280|580697916|FG000|Overall Study|Physician Decision|2|||
160812432|NCT03062280|580697916|FG000|Overall Study|Pregnancy|5|||
160812433|NCT03062280|580697916|FG000|Overall Study|Withdrawal by Subject|11|||
160812434|NCT00022763|580697917|FG000|Overall Study|Adverse Event|1|||
160812435|NCT00022763|580697918|FG001|Overall Study|Adverse Event|2|||
160812436|NCT00022763|580697917|FG000|Overall Study|Injection Site Reactions|0|||
160812437|NCT00022763|580697918|FG001|Overall Study|Injection Site Reactions|2|||
160812438|NCT00022763|580697917|FG000|Overall Study|Death|0|||
160812439|NCT00022763|580697918|FG001|Overall Study|Death|1|||
160812440|NCT00022763|580697917|FG000|Overall Study|Lost to Follow-up|0|||
160812441|NCT00022763|580697918|FG001|Overall Study|Lost to Follow-up|3|||
160812442|NCT00022763|580697917|FG000|Overall Study|Withdrawal by Subject|4|||
160812443|NCT00022763|580697918|FG001|Overall Study|Withdrawal by Subject|7|||
160812444|NCT00022763|580697917|FG000|Overall Study|Insufficient Therapy|1|||
160812445|NCT00022763|580697918|FG001|Overall Study|Insufficient Therapy|0|||
160812446|NCT00022763|580697917|FG000|Overall Study|Admin|3|||
160812447|NCT00022763|580697918|FG001|Overall Study|Admin|2|||
160812448|NCT03248531|580697919|FG000|Overall Study|Adverse Event|0|||
160812449|NCT03248531|580697920|FG001|Overall Study|Adverse Event|0|||
160812450|NCT03248531|580697921|FG002|Overall Study|Adverse Event|1|||
160812451|NCT03248531|580697919|FG000|Overall Study|Lost to Follow-up|1|||
160812452|NCT03248531|580697920|FG001|Overall Study|Lost to Follow-up|0|||
160812453|NCT03248531|580697921|FG002|Overall Study|Lost to Follow-up|5|||
160812454|NCT03248531|580697919|FG000|Overall Study|Withdrawal by Subject|3|||
160812455|NCT03248531|580697920|FG001|Overall Study|Withdrawal by Subject|3|||
160812456|NCT03248531|580697921|FG002|Overall Study|Withdrawal by Subject|2|||
160812457|NCT03248531|580697919|FG000|Overall Study|Sponsor Request|0|||
160812458|NCT03248531|580697920|FG001|Overall Study|Sponsor Request|2|||
160812459|NCT03248531|580697921|FG002|Overall Study|Sponsor Request|0|||
160812460|NCT04908865|580697922|FG000|Overall Study|Adverse Event|2|||
160812461|NCT04908865|580697922|FG000|Overall Study|Lack of Efficacy|5|||
160812462|NCT04908865|580697922|FG000|Overall Study|Lost to Follow-up|1|||
160812463|NCT05286658|580697923|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
160812464|NCT05286658|580697923|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
160812465|NCT00842153|580697926|FG000|Overall Study|Adverse Event|0|||
160812466|NCT00842153|580697927|FG001|Overall Study|Adverse Event|1|||
160812467|NCT00842153|580697926|FG000|Overall Study|Lost to Follow-up|1|||
160812468|NCT00842153|580697927|FG001|Overall Study|Lost to Follow-up|2|||
160812469|NCT02201329|580697929|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
160812470|NCT02201329|580697929|FG000|Overall Study|Withdrawal by Subject|2|||
160812471|NCT00470262|580697930|FG000|Overall Study|Withdrawal by Subject|2|||
160812472|NCT00470262|580697931|FG001|Overall Study|Withdrawal by Subject|0|||
160812473|NCT01509846|580697932|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
160812474|NCT01509846|580697933|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
160812475|NCT01509846|580697934|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
160812476|NCT01509846|580697935|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
160812477|NCT01509846|580697936|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
160812478|NCT01509846|580697932|FG000|Received Vaccination 2|Illness|0|||
160812479|NCT01509846|580697933|FG001|Received Vaccination 2|Illness|0|||
160812480|NCT01509846|580697934|FG002|Received Vaccination 2|Illness|0|||
160812481|NCT01509846|580697935|FG003|Received Vaccination 2|Illness|0|||
160812482|NCT01509846|580697936|FG004|Received Vaccination 2|Illness|1|||
160812483|NCT01509846|580697932|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
160812484|NCT01509846|580697933|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
160812485|NCT01509846|580697934|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
160812486|NCT01509846|580697935|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
160900050|NCT01691898|581028641|FG004|Overall Study|Death|8|||
160900051|NCT01691898|581028642|FG005|Overall Study|Death|31|||
160900052|NCT01691898|581028637|FG000|Overall Study|Adverse Event|0|||
160900053|NCT01691898|581028638|FG001|Overall Study|Adverse Event|1|||
160986828|NCT04955626|581341112|FG007|Blinded Period|No longer meets eligibility criteria|0|||
160986829|NCT04955626|581341113|FG008|Blinded Period|No longer meets eligibility criteria|1|||
160986830|NCT04955626|581341114|FG009|Blinded Period|No longer meets eligibility criteria|0|||
160986831|NCT04955626|581341115|FG010|Blinded Period|No longer meets eligibility criteria|1|||
160986832|NCT04955626|581341116|FG011|Blinded Period|No longer meets eligibility criteria|1|||
160986833|NCT04955626|581341117|FG012|Blinded Period|No longer meets eligibility criteria|0|||
160986834|NCT04955626|581341118|FG013|Blinded Period|No longer meets eligibility criteria|0|||
160986835|NCT04955626|581341119|FG014|Blinded Period|No longer meets eligibility criteria|0|||
160986836|NCT04955626|581341120|FG015|Blinded Period|No longer meets eligibility criteria|3|||
160900054|NCT01691898|581028639|FG002|Overall Study|Adverse Event|0|||
160900055|NCT01691898|581028640|FG003|Overall Study|Adverse Event|1|||
160986837|NCT04955626|581341121|FG016|Blinded Period|No longer meets eligibility criteria|0|||
160986838|NCT04955626|581341122|FG017|Blinded Period|No longer meets eligibility criteria|2|||
160986839|NCT04955626|581341123|FG018|Blinded Period|No longer meets eligibility criteria|0|||
160986840|NCT04955626|581341124|FG019|Blinded Period|No longer meets eligibility criteria|0|||
160986841|NCT04955626|581341125|FG020|Blinded Period|No longer meets eligibility criteria|0|||
160986842|NCT04955626|581341126|FG021|Blinded Period|No longer meets eligibility criteria|0|||
160986843|NCT04955626|581341127|FG022|Blinded Period|No longer meets eligibility criteria|0|||
160986844|NCT04955626|581341128|FG023|Blinded Period|No longer meets eligibility criteria|0|||
160986845|NCT04955626|581341129|FG024|Blinded Period|No longer meets eligibility criteria|1|||
160986846|NCT04955626|581341130|FG025|Blinded Period|No longer meets eligibility criteria|0|||
161131612|NCT00854828|581865317|FG001|Overall Study|Missed 24mo visit|1|||
160900056|NCT01691898|581028641|FG004|Overall Study|Adverse Event|1|||
160900057|NCT01691898|581028642|FG005|Overall Study|Adverse Event|0|||
160900058|NCT01691898|581028637|FG000|Overall Study|Progression of Disease|1|||
160900059|NCT01691898|581028638|FG001|Overall Study|Progression of Disease|2|||
160900060|NCT01691898|581028639|FG002|Overall Study|Progression of Disease|1|||
160900061|NCT01691898|581028640|FG003|Overall Study|Progression of Disease|0|||
160900062|NCT01691898|581028641|FG004|Overall Study|Progression of Disease|0|||
160900063|NCT01691898|581028642|FG005|Overall Study|Progression of Disease|1|||
160900064|NCT01691898|581028637|FG000|Overall Study|Lost to Follow-up|3|||
160900065|NCT01691898|581028638|FG001|Overall Study|Lost to Follow-up|1|||
160900066|NCT01691898|581028639|FG002|Overall Study|Lost to Follow-up|0|||
160900067|NCT01691898|581028640|FG003|Overall Study|Lost to Follow-up|0|||
160900068|NCT01691898|581028641|FG004|Overall Study|Lost to Follow-up|1|||
160900069|NCT01691898|581028642|FG005|Overall Study|Lost to Follow-up|0|||
160900070|NCT01691898|581028637|FG000|Overall Study|Withdrawal by Subject|9|||
160900071|NCT01691898|581028638|FG001|Overall Study|Withdrawal by Subject|8|||
160900072|NCT01691898|581028639|FG002|Overall Study|Withdrawal by Subject|2|||
160900073|NCT01691898|581028640|FG003|Overall Study|Withdrawal by Subject|1|||
160900074|NCT01691898|581028641|FG004|Overall Study|Withdrawal by Subject|3|||
160900075|NCT01691898|581028642|FG005|Overall Study|Withdrawal by Subject|3|||
161131613|NCT00854828|581865318|FG002|Overall Study|Missed 24mo visit|8|||
161131614|NCT00854828|581865319|FG003|Overall Study|Missed 24mo visit|8|||
161131615|NCT01282229|581865320|FG000|Overall Study|Protocol Violation|2|||
161131616|NCT03686969|581865321|FG000|Overall Study|Study terminated|1|||
161131617|NCT03686969|581865322|FG001|Overall Study|Study terminated|0|||
161131618|NCT00848120|581865323|FG000|Overall Study|Adverse Event|1|||
161131619|NCT01988090|581865327|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
161131620|NCT01988090|581865328|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
161131621|NCT01988090|581865327|FG000|Start Treament After Randomization|Protocol Violation|0|||
161131622|NCT01988090|581865328|FG001|Start Treament After Randomization|Protocol Violation|1|||
161131623|NCT01988090|581865327|FG000|Complete Study After Start|Withdrawal by Subject|2|||
160900076|NCT01691898|581028637|FG000|Overall Study|Non-Compliance|0|||
160900077|NCT01691898|581028638|FG001|Overall Study|Non-Compliance|0|||
160900078|NCT01691898|581028639|FG002|Overall Study|Non-Compliance|0|||
160900079|NCT01691898|581028640|FG003|Overall Study|Non-Compliance|0|||
160900080|NCT01691898|581028641|FG004|Overall Study|Non-Compliance|1|||
160900081|NCT01691898|581028642|FG005|Overall Study|Non-Compliance|0|||
160900082|NCT01013350|581028643|FG000|Overall Study|Lost to Follow-up|15|||
160900083|NCT01013350|581028644|FG001|Overall Study|Lost to Follow-up|95|||
160900084|NCT01013350|581028643|FG000|Overall Study|Adverse Event|0|||
160900085|NCT01013350|581028644|FG001|Overall Study|Adverse Event|1|||
160900086|NCT01013350|581028643|FG000|Overall Study|Physician Decision|4|||
160900087|NCT01013350|581028644|FG001|Overall Study|Physician Decision|20|||
160900088|NCT01013350|581028643|FG000|Overall Study|Withdrawal by Subject|15|||
160900089|NCT01013350|581028644|FG001|Overall Study|Withdrawal by Subject|38|||
160900090|NCT01013350|581028643|FG000|Overall Study|Death|3|||
160900091|NCT01013350|581028644|FG001|Overall Study|Death|5|||
160900092|NCT01013350|581028643|FG000|Overall Study|Participant entered interventional study|0|||
160986847|NCT04955626|581341131|FG026|Blinded Period|No longer meets eligibility criteria|0|||
160986848|NCT04955626|581341132|FG027|Blinded Period|No longer meets eligibility criteria|1|||
160986849|NCT04955626|581341133|FG028|Blinded Period|No longer meets eligibility criteria|0|||
160986850|NCT04955626|581341134|FG029|Blinded Period|No longer meets eligibility criteria|0|||
160986851|NCT04955626|581341135|FG030|Blinded Period|No longer meets eligibility criteria|0|||
160986852|NCT04955626|581341136|FG031|Blinded Period|No longer meets eligibility criteria|0|||
160986853|NCT04955626|581341137|FG032|Blinded Period|No longer meets eligibility criteria|0|||
160986854|NCT04955626|581341138|FG033|Blinded Period|No longer meets eligibility criteria|0|||
160986855|NCT04955626|581341139|FG034|Blinded Period|No longer meets eligibility criteria|0|||
160986856|NCT04955626|581341140|FG035|Blinded Period|No longer meets eligibility criteria|0|||
160986857|NCT04955626|581341105|FG000|Blinded Period|Other|54|||
160986858|NCT04955626|581341106|FG001|Blinded Period|Other|3|||
160986859|NCT04955626|581341107|FG002|Blinded Period|Other|4|||
160986860|NCT04955626|581341108|FG003|Blinded Period|Other|2|||
160986861|NCT04955626|581341109|FG004|Blinded Period|Other|0|||
160986862|NCT04955626|581341110|FG005|Blinded Period|Other|0|||
160986863|NCT04955626|581341111|FG006|Blinded Period|Other|2|||
160986864|NCT04955626|581341112|FG007|Blinded Period|Other|2|||
160986865|NCT04955626|581341113|FG008|Blinded Period|Other|1|||
160986866|NCT04955626|581341114|FG009|Blinded Period|Other|0|||
160986867|NCT04955626|581341115|FG010|Blinded Period|Other|1|||
160986868|NCT04955626|581341116|FG011|Blinded Period|Other|1|||
160986869|NCT04955626|581341117|FG012|Blinded Period|Other|0|||
160986870|NCT04955626|581341118|FG013|Blinded Period|Other|0|||
160986871|NCT04955626|581341119|FG014|Blinded Period|Other|0|||
160986872|NCT04955626|581341120|FG015|Blinded Period|Other|0|||
160986873|NCT04955626|581341121|FG016|Blinded Period|Other|0|||
160986874|NCT04955626|581341122|FG017|Blinded Period|Other|1|||
160986875|NCT04955626|581341123|FG018|Blinded Period|Other|0|||
160986876|NCT04955626|581341124|FG019|Blinded Period|Other|0|||
160986877|NCT04955626|581341125|FG020|Blinded Period|Other|0|||
160986878|NCT04955626|581341126|FG021|Blinded Period|Other|0|||
160986879|NCT04955626|581341127|FG022|Blinded Period|Other|0|||
160986880|NCT04955626|581341128|FG023|Blinded Period|Other|0|||
160986881|NCT04955626|581341129|FG024|Blinded Period|Other|0|||
160986882|NCT04955626|581341130|FG025|Blinded Period|Other|0|||
160986883|NCT04955626|581341131|FG026|Blinded Period|Other|2|||
160986884|NCT04955626|581341132|FG027|Blinded Period|Other|0|||
160986885|NCT04955626|581341133|FG028|Blinded Period|Other|0|||
160986886|NCT04955626|581341134|FG029|Blinded Period|Other|0|||
160986887|NCT04955626|581341135|FG030|Blinded Period|Other|0|||
160986888|NCT04955626|581341136|FG031|Blinded Period|Other|0|||
160986889|NCT04955626|581341137|FG032|Blinded Period|Other|0|||
160986890|NCT04955626|581341138|FG033|Blinded Period|Other|0|||
160986891|NCT04955626|581341139|FG034|Blinded Period|Other|0|||
160986892|NCT04955626|581341140|FG035|Blinded Period|Other|0|||
160986893|NCT04955626|581341105|FG000|Blinded Period|Physician Decision|1|||
160986894|NCT04955626|581341106|FG001|Blinded Period|Physician Decision|1|||
160986895|NCT04955626|581341107|FG002|Blinded Period|Physician Decision|0|||
160986896|NCT04955626|581341108|FG003|Blinded Period|Physician Decision|3|||
160986897|NCT04955626|581341109|FG004|Blinded Period|Physician Decision|0|||
160986898|NCT04955626|581341110|FG005|Blinded Period|Physician Decision|0|||
160986899|NCT04955626|581341111|FG006|Blinded Period|Physician Decision|1|||
160986900|NCT04955626|581341112|FG007|Blinded Period|Physician Decision|1|||
160986901|NCT04955626|581341113|FG008|Blinded Period|Physician Decision|0|||
160986902|NCT04955626|581341114|FG009|Blinded Period|Physician Decision|0|||
160986903|NCT04955626|581341115|FG010|Blinded Period|Physician Decision|0|||
160986904|NCT04955626|581341116|FG011|Blinded Period|Physician Decision|5|||
160986905|NCT04955626|581341117|FG012|Blinded Period|Physician Decision|0|||
160986906|NCT04955626|581341118|FG013|Blinded Period|Physician Decision|0|||
161131624|NCT01988090|581865328|FG001|Complete Study After Start|Withdrawal by Subject|0|||
161131625|NCT01988090|581865327|FG000|Complete Study After Start|Protocol Violation|1|||
161131626|NCT01988090|581865328|FG001|Complete Study After Start|Protocol Violation|1|||
161131627|NCT03887130|581865333|FG000|Overall Study|Progressive disease|23|||
161131628|NCT03887130|581865334|FG001|Overall Study|Progressive disease|14|||
161131629|NCT03887130|581865335|FG002|Overall Study|Progressive disease|7|||
160986907|NCT04955626|581341119|FG014|Blinded Period|Physician Decision|0|||
160986908|NCT04955626|581341120|FG015|Blinded Period|Physician Decision|0|||
160986909|NCT04955626|581341121|FG016|Blinded Period|Physician Decision|0|||
160986910|NCT04955626|581341122|FG017|Blinded Period|Physician Decision|0|||
160986911|NCT04955626|581341123|FG018|Blinded Period|Physician Decision|0|||
160986912|NCT04955626|581341124|FG019|Blinded Period|Physician Decision|0|||
160986913|NCT04955626|581341125|FG020|Blinded Period|Physician Decision|0|||
160986914|NCT04955626|581341126|FG021|Blinded Period|Physician Decision|0|||
160986915|NCT04955626|581341127|FG022|Blinded Period|Physician Decision|0|||
160986916|NCT04955626|581341128|FG023|Blinded Period|Physician Decision|0|||
160986917|NCT04955626|581341129|FG024|Blinded Period|Physician Decision|0|||
160986918|NCT04955626|581341130|FG025|Blinded Period|Physician Decision|0|||
160986919|NCT04955626|581341131|FG026|Blinded Period|Physician Decision|0|||
161131630|NCT03887130|581865333|FG000|Overall Study|Protocol Violation|3|||
161131631|NCT03887130|581865334|FG001|Overall Study|Protocol Violation|1|||
160812487|NCT01509846|580697936|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
160812488|NCT01509846|580697932|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
160812489|NCT01509846|580697933|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
160812490|NCT01509846|580697934|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
160812491|NCT01509846|580697935|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
160812492|NCT01509846|580697936|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
161131632|NCT03887130|581865335|FG002|Overall Study|Protocol Violation|2|||
161131633|NCT03887130|581865333|FG000|Overall Study|Drug related toxicity|7|||
160812493|NCT01509846|580697932|FG000|Received Vaccination 3|Pregnancy|0|||
160812494|NCT01509846|580697933|FG001|Received Vaccination 3|Pregnancy|0|||
160812495|NCT01509846|580697934|FG002|Received Vaccination 3|Pregnancy|0|||
160812496|NCT01509846|580697935|FG003|Received Vaccination 3|Pregnancy|1|||
160812497|NCT01509846|580697936|FG004|Received Vaccination 3|Pregnancy|0|||
160812498|NCT01509846|580697932|FG000|Received Vaccination 3|Lost to Follow-up|0|||
160812499|NCT01509846|580697933|FG001|Received Vaccination 3|Lost to Follow-up|0|||
160812500|NCT01509846|580697934|FG002|Received Vaccination 3|Lost to Follow-up|1|||
160812501|NCT01509846|580697935|FG003|Received Vaccination 3|Lost to Follow-up|0|||
160812502|NCT01509846|580697936|FG004|Received Vaccination 3|Lost to Follow-up|0|||
160812503|NCT01637584|580697938|FG000|Overall Study|Withdrawal by Subject|1|||
160812504|NCT01637584|580697939|FG001|Overall Study|Withdrawal by Subject|3|||
160812505|NCT04396795|580697940|FG000|Month 1|Lost to Follow-up|2|||
160812506|NCT04396795|580697941|FG001|Month 1|Lost to Follow-up|3|||
160812507|NCT04396795|580697940|FG000|Month 3|Lost to Follow-up|1|||
160812508|NCT04396795|580697941|FG001|Month 3|Lost to Follow-up|3|||
160812509|NCT04396795|580697940|FG000|Month 6|Lost to Follow-up|3|||
160812510|NCT04396795|580697941|FG001|Month 6|Lost to Follow-up|3|||
160812511|NCT02366923|580697942|FG000|Overall Study|Withdrawal by Subject|1|||
160812512|NCT02366923|580697942|FG000|Overall Study|Positive Slit Lamp Findings|2|||
160812513|NCT02366923|580697942|FG000|Overall Study|High Astigmatism|3|||
160812514|NCT02484443|580697943|FG000|Overall Study|Lack of Efficacy|28|||
160812515|NCT02484443|580697943|FG000|Overall Study|Physician Decision|2|||
160812516|NCT02484443|580697943|FG000|Overall Study|Ineligible|2|||
160812517|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Death|0|||
160812518|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Death|1|||
160812519|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Death|1|||
160812520|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Death|0|||
160812521|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Death|0|||
160812522|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Death|0|||
160812523|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Death|0|||
160812524|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Death|0|||
160812525|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812526|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812527|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
160812528|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812529|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
160812530|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812531|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812532|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
160812533|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812534|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812535|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812536|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
160812537|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812538|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812539|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812540|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
160812541|NCT02122146|580697944|FG000|Part 1: Dose Escalation|Other|1|||
160812542|NCT02122146|580697945|FG001|Part 1: Dose Escalation|Other|0|||
160812543|NCT02122146|580697946|FG002|Part 1: Dose Escalation|Other|0|||
161131634|NCT03887130|581865334|FG001|Overall Study|Drug related toxicity|7|||
160812544|NCT02122146|580697947|FG003|Part 1: Dose Escalation|Other|0|||
160812545|NCT02122146|580697948|FG004|Part 1: Dose Escalation|Other|0|||
160812546|NCT02122146|580697949|FG005|Part 1: Dose Escalation|Other|1|||
160812547|NCT02122146|580697950|FG006|Part 1: Dose Escalation|Other|1|||
160812548|NCT02122146|580697951|FG007|Part 1: Dose Escalation|Other|2|||
160812549|NCT03472495|580697952|FG000|Overall Study|Treatment no longer indicated|1|||
160812550|NCT03472495|580697953|FG001|Overall Study|Treatment no longer indicated|2|||
160812551|NCT03472495|580697952|FG000|Overall Study|Physician Decision|0|||
160812552|NCT03472495|580697953|FG001|Overall Study|Physician Decision|2|||
160812553|NCT00992056|580697956|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
160812554|NCT00992056|580697957|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
160812555|NCT00992056|580697956|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
160812556|NCT00992056|580697957|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
160812557|NCT02595866|580697958|FG000|Overall Study|Adverse Event|2|||
160812558|NCT02595866|580697959|FG001|Overall Study|Adverse Event|5|||
160812559|NCT02595866|580697958|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
160812560|NCT02595866|580697959|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
160812561|NCT02595866|580697958|FG000|Overall Study|Death|0|||
160812562|NCT02595866|580697959|FG001|Overall Study|Death|1|||
160812563|NCT02595866|580697958|FG000|Overall Study|Incarceration|1|||
160812564|NCT02595866|580697959|FG001|Overall Study|Incarceration|0|||
160812565|NCT02595866|580697958|FG000|Overall Study|Lack of Efficacy|17|||
160812566|NCT02595866|580697959|FG001|Overall Study|Lack of Efficacy|7|||
160812567|NCT02595866|580697958|FG000|Overall Study|Physician Decision|4|||
160812568|NCT02595866|580697959|FG001|Overall Study|Physician Decision|3|||
160812569|NCT02595866|580697958|FG000|Overall Study|Switched to Alternative Treatment|1|||
160812570|NCT02595866|580697959|FG001|Overall Study|Switched to Alternative Treatment|0|||
160812571|NCT02595866|580697958|FG000|Overall Study|Study Terminated|0|||
160812572|NCT02595866|580697959|FG001|Overall Study|Study Terminated|4|||
160812573|NCT02595866|580697958|FG000|Overall Study|Withdrawal by Subject|6|||
160812574|NCT02595866|580697959|FG001|Overall Study|Withdrawal by Subject|1|||
160812575|NCT01001767|580697962|FG000|Overall Study|no baseline study performed|1|||
160812576|NCT01001767|580697963|FG001|Overall Study|no baseline study performed|0|||
160812577|NCT01001767|580697962|FG000|Overall Study|Protocol Violation|1|||
160812578|NCT01001767|580697963|FG001|Overall Study|Protocol Violation|0|||
160812579|NCT01001767|580697962|FG000|Overall Study|Lost to Follow-up|1|||
160812580|NCT01001767|580697963|FG001|Overall Study|Lost to Follow-up|0|||
160812581|NCT01001767|580697962|FG000|Overall Study|Physician Decision|1|||
160812582|NCT01001767|580697963|FG001|Overall Study|Physician Decision|0|||
160812583|NCT02584452|580697964|FG000|Overall Study|Physician Decision|1|||
160812584|NCT02584452|580697965|FG001|Overall Study|Physician Decision|1|||
160812585|NCT02584452|580697964|FG000|Overall Study|Lost to Follow-up|1|||
160812586|NCT02584452|580697965|FG001|Overall Study|Lost to Follow-up|1|||
160812587|NCT00851552|580697966|FG000|Overall Study|Death|2|||
160812588|NCT00851552|580697966|FG000|Overall Study|Adverse Event|1|||
160812589|NCT00851552|580697966|FG000|Overall Study|Disease Progression|4|||
160812590|NCT00177294|580697967|FG000|Overall Study|Withdrawal by Subject|7|||
160812591|NCT00177294|580697968|FG001|Overall Study|Withdrawal by Subject|5|||
160812592|NCT02998671|580697969|FG000|Period 1|Study Terminated By Sponsor|2|||
160812593|NCT02998671|580697970|FG001|Period 1|Study Terminated By Sponsor|1|||
160812594|NCT02998671|580697971|FG002|Period 1|Study Terminated By Sponsor|0|||
160812595|NCT02998671|580697972|FG003|Period 1|Study Terminated By Sponsor|0|||
160812596|NCT02998671|580697973|FG004|Period 1|Study Terminated By Sponsor|1|||
160812597|NCT02998671|580697969|FG000|Period 1|Withdrawal by Subject|1|||
160812598|NCT02998671|580697970|FG001|Period 1|Withdrawal by Subject|2|||
160812599|NCT02998671|580697971|FG002|Period 1|Withdrawal by Subject|0|||
160812600|NCT02998671|580697972|FG003|Period 1|Withdrawal by Subject|0|||
160812601|NCT02998671|580697973|FG004|Period 1|Withdrawal by Subject|2|||
161239455|NCT03261167|582257997|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
160812602|NCT02998671|580697969|FG000|Period 1|Pregnancy|1|||
160812603|NCT02998671|580697970|FG001|Period 1|Pregnancy|0|||
160812604|NCT02998671|580697971|FG002|Period 1|Pregnancy|0|||
160812605|NCT02998671|580697972|FG003|Period 1|Pregnancy|0|||
160812606|NCT02998671|580697973|FG004|Period 1|Pregnancy|0|||
160812607|NCT02998671|580697969|FG000|Period 1|Adverse Event|0|||
160812608|NCT02998671|580697970|FG001|Period 1|Adverse Event|0|||
160812609|NCT02998671|580697971|FG002|Period 1|Adverse Event|0|||
160812610|NCT02998671|580697972|FG003|Period 1|Adverse Event|0|||
160812611|NCT02998671|580697973|FG004|Period 1|Adverse Event|1|||
160812612|NCT02998671|580697969|FG000|Period 2|Adverse Event|0|||
160812613|NCT02998671|580697970|FG001|Period 2|Adverse Event|1|||
160812614|NCT02998671|580697971|FG002|Period 2|Adverse Event|0|||
161239456|NCT03261167|582257996|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
161239457|NCT03261167|582257997|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
161239458|NCT03261167|582257996|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
161239459|NCT03261167|582257997|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
160812615|NCT02998671|580697972|FG003|Period 2|Adverse Event|0|||
160812616|NCT02998671|580697973|FG004|Period 2|Adverse Event|0|||
160812617|NCT02998671|580697969|FG000|Period 2|Study Terminated By Sponsor|3|||
160812618|NCT02998671|580697970|FG001|Period 2|Study Terminated By Sponsor|5|||
160812619|NCT02998671|580697971|FG002|Period 2|Study Terminated By Sponsor|1|||
160812620|NCT02998671|580697972|FG003|Period 2|Study Terminated By Sponsor|3|||
160812621|NCT02998671|580697973|FG004|Period 2|Study Terminated By Sponsor|0|||
160812622|NCT02998671|580697969|FG000|Period 2|Withdrawal by Subject|0|||
160812623|NCT02998671|580697970|FG001|Period 2|Withdrawal by Subject|1|||
160812624|NCT02998671|580697971|FG002|Period 2|Withdrawal by Subject|0|||
160812625|NCT02998671|580697972|FG003|Period 2|Withdrawal by Subject|0|||
160812626|NCT02998671|580697973|FG004|Period 2|Withdrawal by Subject|0|||
160812627|NCT02998671|580697969|FG000|Period 2|Lost to Follow-up|0|||
160812628|NCT02998671|580697970|FG001|Period 2|Lost to Follow-up|0|||
160812629|NCT02998671|580697971|FG002|Period 2|Lost to Follow-up|0|||
160812630|NCT02998671|580697972|FG003|Period 2|Lost to Follow-up|1|||
160812631|NCT02998671|580697973|FG004|Period 2|Lost to Follow-up|0|||
160812632|NCT02038946|580697974|FG000|Overall Study|Death|5|||
160812633|NCT02038946|580697974|FG000|Overall Study|Withdrawal by Subject|3|||
160812634|NCT02038946|580697974|FG000|Overall Study|Lost to Follow-up|2|||
160812635|NCT02038946|580697974|FG000|Overall Study|Other reasons|2|||
160812636|NCT02131311|580697978|FG000|Overall Study|Adverse Event|2|||
160812637|NCT02131311|580697978|FG000|Overall Study|Protocol Violation|1|||
160812638|NCT02131311|580697978|FG000|Overall Study|Lost to Follow-up|1|||
160812639|NCT01479764|580697979|FG000|Randomized|Adverse Event|1|||
160812640|NCT01479764|580697980|FG001|Randomized|Adverse Event|1|||
160812641|NCT01479764|580697979|FG000|Randomized|Withdrawal by Subject|1|||
160812642|NCT01479764|580697980|FG001|Randomized|Withdrawal by Subject|0|||
160812643|NCT01479764|580697979|FG000|Treated|Lost to Follow-up|0|||
160812644|NCT01479764|580697980|FG001|Treated|Lost to Follow-up|2|||
160812645|NCT02473471|580697981|FG000|Overall Study|poor oral hygiene|2|||
160812646|NCT02473471|580697981|FG000|Overall Study|Lost to Follow-up|1|||
160812647|NCT03082677|580697982|FG000|Overall Study|Not Treated|2|||
160812648|NCT00255723|580697988|FG000|Overall Study|Adverse Event|1|||
160812649|NCT00255723|580697989|FG001|Overall Study|Adverse Event|1|||
160812650|NCT00255723|580697988|FG000|Overall Study|Death|0|||
160812651|NCT00255723|580697989|FG001|Overall Study|Death|1|||
160812652|NCT00255723|580697988|FG000|Overall Study|Response Data Not Available|1|||
160812653|NCT00255723|580697989|FG001|Overall Study|Response Data Not Available|0|||
160812654|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
160812655|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
160812656|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
160812657|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
160812658|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
160812659|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
160812660|NCT00191945|580697990|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
160812661|NCT00191945|580697991|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
160812662|NCT03711370|580697993|FG000|Overall Study|Lost to Follow-up|16|||
160812663|NCT03711370|580697994|FG001|Overall Study|Lost to Follow-up|10|||
160812664|NCT03711370|580697993|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
160812665|NCT03711370|580697994|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
160812666|NCT02063984|580697995|FG000|Overall Study|Lost to Follow-up|6|||
160812667|NCT02063984|580697996|FG001|Overall Study|Lost to Follow-up|5|||
160812668|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
160812669|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
160812670|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
160812671|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
160812672|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
160812673|NCT01536561|580698001|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
160812674|NCT01030952|580698006|FG000|Overall Study|Protocol Violation|0|||
160812675|NCT01030952|580698007|FG001|Overall Study|Protocol Violation|1|||
160812676|NCT01030952|580698006|FG000|Overall Study|Informed consent withdrawal|1|||
160812677|NCT01030952|580698007|FG001|Overall Study|Informed consent withdrawal|0|||
160812678|NCT01030952|580698006|FG000|Overall Study|Lost to Follow-up|0|||
160812679|NCT01030952|580698007|FG001|Overall Study|Lost to Follow-up|1|||
160812680|NCT01030952|580698006|FG000|Overall Study|Unexplained|1|||
160812681|NCT01030952|580698007|FG001|Overall Study|Unexplained|1|||
160812682|NCT00431444|580698010|FG000|Overall Study|Protocol Violation|1|||
160812683|NCT00431444|580698011|FG001|Overall Study|Protocol Violation|4|||
160812684|NCT00431444|580698010|FG000|Overall Study|Adverse Event|2|||
160812685|NCT00431444|580698011|FG001|Overall Study|Adverse Event|1|||
160812686|NCT00431444|580698010|FG000|Overall Study|Withdrawal by Subject|1|||
160812687|NCT00431444|580698011|FG001|Overall Study|Withdrawal by Subject|1|||
160812688|NCT00431444|580698010|FG000|Overall Study|Lost to Follow-up|1|||
160812689|NCT00431444|580698011|FG001|Overall Study|Lost to Follow-up|0|||
160812690|NCT00431444|580698010|FG000|Overall Study|Administrative Problems|0|||
160812691|NCT00431444|580698011|FG001|Overall Study|Administrative Problems|1|||
160812692|NCT03583359|580698015|FG000|Overall Study|Withdrawal by Subject|15|||
160812693|NCT03583359|580698016|FG001|Overall Study|Withdrawal by Subject|6|||
160812694|NCT03583359|580698015|FG000|Overall Study|Lost to Follow-up|12|||
160812695|NCT03583359|580698016|FG001|Overall Study|Lost to Follow-up|3|||
160812696|NCT03583359|580698015|FG000|Overall Study|Adverse Event|0|||
160812697|NCT03583359|580698016|FG001|Overall Study|Adverse Event|1|||
160812698|NCT03583359|580698015|FG000|Overall Study|Protocol Violation|0|||
160812699|NCT03583359|580698016|FG001|Overall Study|Protocol Violation|1|||
160812700|NCT03583359|580698015|FG000|Overall Study|Other|2|||
160812701|NCT03583359|580698016|FG001|Overall Study|Other|1|||
161131635|NCT03887130|581865335|FG002|Overall Study|Drug related toxicity|13|||
161131636|NCT03887130|581865333|FG000|Overall Study|Non drug related toxicity|3|||
161131637|NCT03887130|581865334|FG001|Overall Study|Non drug related toxicity|0|||
161131638|NCT03887130|581865335|FG002|Overall Study|Non drug related toxicity|0|||
161333036|NCT01712516|582608596|FG003|Overall Study|Withdrawal by Subject|9|||
160812702|NCT03497039|580698017|FG000|Overall Study|Withdrawal by Subject|1|||
160812703|NCT03497039|580698018|FG001|Overall Study|Withdrawal by Subject|0|||
160812704|NCT03497039|580698017|FG000|Overall Study|Protocol Violation|0|||
161131639|NCT03887130|581865333|FG000|Overall Study|Death|2|||
160812705|NCT03497039|580698018|FG001|Overall Study|Protocol Violation|1|||
160812706|NCT02131662|580698020|FG000|Overall Study|Protocol Violation|1|||
160812707|NCT02131662|580698021|FG001|Overall Study|Protocol Violation|0|||
160812708|NCT02131662|580698022|FG002|Overall Study|Protocol Violation|0|||
160812709|NCT02131662|580698023|FG003|Overall Study|Protocol Violation|0|||
160812710|NCT02131662|580698024|FG004|Overall Study|Protocol Violation|0|||
160812711|NCT02131662|580698020|FG000|Overall Study|Other|2|||
160812712|NCT02131662|580698021|FG001|Overall Study|Other|4|||
160812713|NCT02131662|580698022|FG002|Overall Study|Other|3|||
160812714|NCT02131662|580698023|FG003|Overall Study|Other|3|||
160812715|NCT02131662|580698024|FG004|Overall Study|Other|4|||
160812716|NCT02131662|580698020|FG000|Overall Study|Adverse Event|0|||
160812717|NCT02131662|580698021|FG001|Overall Study|Adverse Event|1|||
160812718|NCT02131662|580698022|FG002|Overall Study|Adverse Event|1|||
160812719|NCT02131662|580698023|FG003|Overall Study|Adverse Event|1|||
160812720|NCT02131662|580698024|FG004|Overall Study|Adverse Event|3|||
160812721|NCT02131662|580698020|FG000|Overall Study|Pregnancy|0|||
160812722|NCT02131662|580698021|FG001|Overall Study|Pregnancy|1|||
160812723|NCT02131662|580698022|FG002|Overall Study|Pregnancy|0|||
160812724|NCT02131662|580698023|FG003|Overall Study|Pregnancy|1|||
160812725|NCT02131662|580698024|FG004|Overall Study|Pregnancy|0|||
160812726|NCT02131662|580698020|FG000|Overall Study|Wish for pregnancy|0|||
160812727|NCT02131662|580698021|FG001|Overall Study|Wish for pregnancy|0|||
160812728|NCT02131662|580698022|FG002|Overall Study|Wish for pregnancy|0|||
160812729|NCT02131662|580698023|FG003|Overall Study|Wish for pregnancy|0|||
160812730|NCT02131662|580698024|FG004|Overall Study|Wish for pregnancy|1|||
160812731|NCT02131662|580698020|FG000|Overall Study|Lack of Efficacy|1|||
160812732|NCT02131662|580698021|FG001|Overall Study|Lack of Efficacy|0|||
160812733|NCT02131662|580698022|FG002|Overall Study|Lack of Efficacy|0|||
160812734|NCT02131662|580698023|FG003|Overall Study|Lack of Efficacy|0|||
160812735|NCT02131662|580698024|FG004|Overall Study|Lack of Efficacy|1|||
160812736|NCT02131662|580698020|FG000|Overall Study|Withdrawal by Subject|1|||
160812737|NCT02131662|580698021|FG001|Overall Study|Withdrawal by Subject|5|||
160812738|NCT02131662|580698022|FG002|Overall Study|Withdrawal by Subject|1|||
160812739|NCT02131662|580698023|FG003|Overall Study|Withdrawal by Subject|5|||
160812740|NCT02131662|580698024|FG004|Overall Study|Withdrawal by Subject|6|||
160812741|NCT02131662|580698020|FG000|Overall Study|Lost to Follow-up|1|||
160812742|NCT02131662|580698021|FG001|Overall Study|Lost to Follow-up|3|||
160812743|NCT02131662|580698022|FG002|Overall Study|Lost to Follow-up|0|||
160812744|NCT02131662|580698023|FG003|Overall Study|Lost to Follow-up|9|||
160812745|NCT02131662|580698024|FG004|Overall Study|Lost to Follow-up|0|||
160812746|NCT02131662|580698020|FG000|Overall Study|Not treated|2|||
160812747|NCT02131662|580698021|FG001|Overall Study|Not treated|0|||
160812748|NCT02131662|580698022|FG002|Overall Study|Not treated|2|||
160812749|NCT02131662|580698023|FG003|Overall Study|Not treated|2|||
160812750|NCT02131662|580698024|FG004|Overall Study|Not treated|3|||
160812751|NCT03554018|580698025|FG000|Overall Study|Lost to Follow-up|3|||
160812752|NCT03554018|580698026|FG001|Overall Study|Lost to Follow-up|7|||
160812753|NCT01016132|580698030|FG000|Overall Study|Discomfort|1|||
160812754|NCT02949024|580698031|FG000|Overall Study|Withdrawal by Subject|0|||
160812755|NCT02949024|580698032|FG001|Overall Study|Withdrawal by Subject|1|||
160812756|NCT00854724|580699987|FG000|First Intervention|Withdrawal by Subject|1|||
160812757|NCT00854724|580699988|FG001|First Intervention|Withdrawal by Subject|1|||
160812758|NCT00854724|580699987|FG000|Washout|Protocol Violation|1|||
160812759|NCT00854724|580699988|FG001|Washout|Protocol Violation|0|||
160812760|NCT00854724|580699987|FG000|Washout|Withdrawal by Subject|0|||
160812761|NCT00854724|580699988|FG001|Washout|Withdrawal by Subject|1|||
160812762|NCT00854724|580699987|FG000|Second Intervention|Protocol Violation|1|||
160812763|NCT00854724|580699988|FG001|Second Intervention|Protocol Violation|0|||
160812764|NCT00854724|580699987|FG000|Second Intervention|Physician Decision|0|||
160812765|NCT00854724|580699988|FG001|Second Intervention|Physician Decision|1|||
160812766|NCT00933608|580699990|FG000|Overall Study|Adverse Event|4|||
160812767|NCT00933608|580699991|FG001|Overall Study|Adverse Event|2|||
160812768|NCT00933608|580699990|FG000|Overall Study|Physician Decision|1|||
160812769|NCT00933608|580699991|FG001|Overall Study|Physician Decision|0|||
160812770|NCT00336284|580699996|FG000|Overall Study|Death|52|||
160812771|NCT00336284|580699997|FG001|Overall Study|Death|26|||
160812772|NCT00336284|580699996|FG000|Overall Study|Lost to Follow-up|82|||
160812773|NCT00336284|580699997|FG001|Overall Study|Lost to Follow-up|61|||
160812774|NCT00336284|580699996|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
160812775|NCT00336284|580699997|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
160812776|NCT02789345|580700000|FG000|Overall Study|Adverse Event|0|||
160812777|NCT02789345|580700001|FG001|Overall Study|Adverse Event|0|||
160812778|NCT02789345|580700002|FG002|Overall Study|Adverse Event|1|||
160812779|NCT02789345|580700000|FG000|Overall Study|Death|0|||
160812780|NCT02789345|580700001|FG001|Overall Study|Death|0|||
160812781|NCT02789345|580700002|FG002|Overall Study|Death|1|||
160812782|NCT02789345|580700000|FG000|Overall Study|Physician Decision|2|||
160812783|NCT02789345|580700001|FG001|Overall Study|Physician Decision|0|||
160812784|NCT02789345|580700002|FG002|Overall Study|Physician Decision|1|||
160812785|NCT02789345|580700000|FG000|Overall Study|Progressive Disease|1|||
160812786|NCT02789345|580700001|FG001|Overall Study|Progressive Disease|3|||
160812787|NCT02789345|580700002|FG002|Overall Study|Progressive Disease|14|||
160812788|NCT01709110|580700003|FG000|Overall Study|Adverse Event|56|||
160812789|NCT01709110|580700004|FG001|Overall Study|Adverse Event|48|||
160812790|NCT01709110|580700003|FG000|Overall Study|Death|14|||
160812791|NCT01709110|580700004|FG001|Overall Study|Death|6|||
160812792|NCT01709110|580700003|FG000|Overall Study|Lost to Follow-up|7|||
160812793|NCT01709110|580700004|FG001|Overall Study|Lost to Follow-up|5|||
160812794|NCT01709110|580700003|FG000|Overall Study|Protocol Violation|4|||
160812795|NCT01709110|580700004|FG001|Overall Study|Protocol Violation|6|||
160812796|NCT01709110|580700003|FG000|Overall Study|Withdrawal by Subject|96|||
160812797|NCT01709110|580700004|FG001|Overall Study|Withdrawal by Subject|89|||
160812798|NCT01709110|580700003|FG000|Overall Study|Physician Decision|4|||
160812799|NCT01709110|580700004|FG001|Overall Study|Physician Decision|10|||
160812800|NCT01709110|580700003|FG000|Overall Study|Sponsor Decision|2|||
160812801|NCT01709110|580700004|FG001|Overall Study|Sponsor Decision|2|||
160812802|NCT01709110|580700003|FG000|Overall Study|Lack of Efficacy|1|||
160812803|NCT01709110|580700004|FG001|Overall Study|Lack of Efficacy|1|||
160812804|NCT01709110|580700003|FG000|Overall Study|Caregiver Decision|1|||
160812805|NCT01709110|580700004|FG001|Overall Study|Caregiver Decision|1|||
160812806|NCT03645421|580700013|FG000|Overall Study|Adverse Event|0|||
160812807|NCT03645421|580700014|FG001|Overall Study|Adverse Event|0|||
160812808|NCT03645421|580700015|FG002|Overall Study|Adverse Event|4|||
160812809|NCT03645421|580700016|FG003|Overall Study|Adverse Event|1|||
160812810|NCT03645421|580700013|FG000|Overall Study|Withdrawal by patient|0|||
160812811|NCT03645421|580700014|FG001|Overall Study|Withdrawal by patient|0|||
160812812|NCT03645421|580700015|FG002|Overall Study|Withdrawal by patient|0|||
160812813|NCT03645421|580700016|FG003|Overall Study|Withdrawal by patient|3|||
160812814|NCT03645421|580700013|FG000|Overall Study|Study specific withdrawal criteria|0|||
160812815|NCT03645421|580700014|FG001|Overall Study|Study specific withdrawal criteria|0|||
160812816|NCT03645421|580700015|FG002|Overall Study|Study specific withdrawal criteria|1|||
160812817|NCT03645421|580700016|FG003|Overall Study|Study specific withdrawal criteria|0|||
160812818|NCT02120781|580700017|FG000|Overall Study|Physician Decision|2|||
160812819|NCT02120781|580700018|FG001|Overall Study|Physician Decision|0|||
160812820|NCT02120781|580700017|FG000|Overall Study|Completion not documented|2|||
160812821|NCT02120781|580700018|FG001|Overall Study|Completion not documented|1|||
160812822|NCT04123093|580700024|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
160812823|NCT04123093|580700025|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
160812824|NCT04123093|580700024|FG000|Phase 2|Physician Decision|0|||
160812825|NCT04123093|580700025|FG001|Phase 2|Physician Decision|1|||
160812826|NCT04123093|580700024|FG000|Phase 2|Withdrawal by Subject|0|||
160812827|NCT04123093|580700025|FG001|Phase 2|Withdrawal by Subject|1|||
160812828|NCT03286543|580700026|FG000|Consented|Screen failure before randomization|2|||
160812829|NCT03286543|580700027|FG001|Consented|Screen failure before randomization|0|||
160812830|NCT03286543|580700028|FG002|Consented|Screen failure before randomization|0|||
160812831|NCT03286543|580700026|FG000|Consented|Screen failure before enrollment|4|||
160812832|NCT03286543|580700027|FG001|Consented|Screen failure before enrollment|0|||
160812833|NCT03286543|580700028|FG002|Consented|Screen failure before enrollment|0|||
160812834|NCT03286543|580700026|FG000|Consented|TKA cancelled after enrollment|1|||
160812835|NCT03286543|580700027|FG001|Consented|TKA cancelled after enrollment|0|||
160812836|NCT03286543|580700028|FG002|Consented|TKA cancelled after enrollment|0|||
160812837|NCT03286543|580700026|FG000|Consented|Withdrawn from study|12|||
160812838|NCT03286543|580700027|FG001|Consented|Withdrawn from study|0|||
160812839|NCT03286543|580700028|FG002|Consented|Withdrawn from study|0|||
160812840|NCT03286543|580700026|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
160812841|NCT03286543|580700027|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
160812842|NCT03286543|580700028|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
160812843|NCT03286543|580700026|FG000|Study Enrollment|Withdrawn from study|0|||
160812844|NCT03286543|580700027|FG001|Study Enrollment|Withdrawn from study|6|||
160900093|NCT01013350|581028644|FG001|Overall Study|Participant entered interventional study|8|||
160900094|NCT01013350|581028643|FG000|Overall Study|Other|1|||
160812845|NCT03286543|580700028|FG002|Study Enrollment|Withdrawn from study|6|||
160812846|NCT03850093|580700032|FG000|Overall Study|Withdrawal by Subject|1|||
160812847|NCT03850093|580700033|FG001|Overall Study|Withdrawal by Subject|0|||
160812848|NCT03850093|580700034|FG002|Overall Study|Withdrawal by Subject|2|||
160812849|NCT02836717|580700037|FG000|Test Phase|Lack of Efficacy|14|||
160812850|NCT02836717|580700038|FG001|Test Phase|Lack of Efficacy|8|||
160812851|NCT02836717|580700039|FG002|Test Phase|Lack of Efficacy|0|||
160812852|NCT02836717|580700037|FG000|Study Phase|Adverse Event|2|||
160812853|NCT02836717|580700038|FG001|Study Phase|Adverse Event|0|||
160812854|NCT02836717|580700039|FG002|Study Phase|Adverse Event|0|||
160812855|NCT02836717|580700037|FG000|Study Phase|Lack of Efficacy|8|||
160812856|NCT02836717|580700038|FG001|Study Phase|Lack of Efficacy|6|||
160812857|NCT02836717|580700039|FG002|Study Phase|Lack of Efficacy|1|||
160812858|NCT02836717|580700037|FG000|Study Phase|Withdrawal by Subject|1|||
160812859|NCT02836717|580700038|FG001|Study Phase|Withdrawal by Subject|0|||
160812860|NCT02836717|580700039|FG002|Study Phase|Withdrawal by Subject|0|||
160900095|NCT01013350|581028644|FG001|Overall Study|Other|25|||
160812861|NCT02836717|580700037|FG000|Study Phase|Death|1|||
160812862|NCT02836717|580700038|FG001|Study Phase|Death|0|||
160812863|NCT02836717|580700039|FG002|Study Phase|Death|0|||
160812864|NCT02836717|580700037|FG000|Study Phase|abdominal surgeries|2|||
160812865|NCT02836717|580700038|FG001|Study Phase|abdominal surgeries|1|||
160812866|NCT02836717|580700039|FG002|Study Phase|abdominal surgeries|0|||
160812867|NCT03226249|580700041|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
160812868|NCT03226249|580700041|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
160812869|NCT03226249|580700041|FG000|Survival Follow-up|Patients still in follow-up.|30|||
160812870|NCT03462641|580700042|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
160812871|NCT03462641|580700043|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
160812872|NCT03462641|580700042|FG000|Visit 2|Withdrawal by Subject|0|||
160812873|NCT03462641|580700043|FG001|Visit 2|Withdrawal by Subject|1|||
160812874|NCT01804049|580700044|FG000|Overall Study|Adverse Event|2|||
160812875|NCT01804049|580700045|FG001|Overall Study|Adverse Event|10|||
160812876|NCT01804049|580700044|FG000|Overall Study|Lost to Follow-up|2|||
160812877|NCT01804049|580700045|FG001|Overall Study|Lost to Follow-up|1|||
160812878|NCT01804049|580700044|FG000|Overall Study|Decreased interest/personal|4|||
160812879|NCT01804049|580700045|FG001|Overall Study|Decreased interest/personal|5|||
160812880|NCT01804049|580700044|FG000|Overall Study|Other health concerns|2|||
160812881|NCT01804049|580700045|FG001|Overall Study|Other health concerns|7|||
160812882|NCT01804049|580700044|FG000|Overall Study|Moved out of area|0|||
160812883|NCT01804049|580700045|FG001|Overall Study|Moved out of area|7|||
160812884|NCT01804049|580700044|FG000|Overall Study|other MD recommended|1|||
160812885|NCT01804049|580700045|FG001|Overall Study|other MD recommended|1|||
160812886|NCT01804049|580700044|FG000|Overall Study|Enrollment in dual studies|0|||
160812887|NCT01804049|580700045|FG001|Overall Study|Enrollment in dual studies|1|||
160812888|NCT00070109|580700046|FG000|Overall Study|Death|1|||
160812889|NCT00070109|580700047|FG001|Overall Study|Death|1|||
160812890|NCT00070109|580700048|FG002|Overall Study|Death|0|||
160812891|NCT00070109|580700049|FG003|Overall Study|Death|0|||
160812892|NCT00070109|580700050|FG004|Overall Study|Death|1|||
160812893|NCT00070109|580700046|FG000|Overall Study|Lack of Efficacy|6|||
160812894|NCT00070109|580700047|FG001|Overall Study|Lack of Efficacy|4|||
160812895|NCT00070109|580700048|FG002|Overall Study|Lack of Efficacy|5|||
160812896|NCT00070109|580700049|FG003|Overall Study|Lack of Efficacy|15|||
160812897|NCT00070109|580700050|FG004|Overall Study|Lack of Efficacy|5|||
160812898|NCT00070109|580700046|FG000|Overall Study|Physician Decision|1|||
160812899|NCT00070109|580700047|FG001|Overall Study|Physician Decision|0|||
160812900|NCT00070109|580700048|FG002|Overall Study|Physician Decision|0|||
160812901|NCT00070109|580700049|FG003|Overall Study|Physician Decision|0|||
160812902|NCT00070109|580700050|FG004|Overall Study|Physician Decision|0|||
160812903|NCT00070109|580700046|FG000|Overall Study|Withdrawal by Subject|0|||
160812904|NCT00070109|580700047|FG001|Overall Study|Withdrawal by Subject|1|||
160812905|NCT00070109|580700048|FG002|Overall Study|Withdrawal by Subject|1|||
160812906|NCT00070109|580700049|FG003|Overall Study|Withdrawal by Subject|0|||
160812907|NCT00070109|580700050|FG004|Overall Study|Withdrawal by Subject|0|||
160812908|NCT00070109|580700046|FG000|Overall Study|Adverse Event|0|||
160812909|NCT00070109|580700047|FG001|Overall Study|Adverse Event|0|||
160812910|NCT00070109|580700048|FG002|Overall Study|Adverse Event|2|||
160812911|NCT00070109|580700049|FG003|Overall Study|Adverse Event|4|||
160812912|NCT00070109|580700050|FG004|Overall Study|Adverse Event|2|||
160812913|NCT00070109|580700046|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
160812914|NCT00070109|580700047|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
160812915|NCT00070109|580700048|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
160812916|NCT00070109|580700049|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
160812917|NCT00070109|580700050|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
160812918|NCT01164891|580700051|FG000|Overall Study|Disease Progression|5|||
160812919|NCT01164891|580700051|FG000|Overall Study|Adverse Event|1|||
160812920|NCT00338286|580700052|FG000|Overall Study|Withdrawal by Subject|50|||
160812921|NCT00338286|580700053|FG001|Overall Study|Withdrawal by Subject|54|||
160812922|NCT00338286|580700052|FG000|Overall Study|Lost to Follow-up|80|||
160812923|NCT00338286|580700053|FG001|Overall Study|Lost to Follow-up|66|||
160812924|NCT00338286|580700052|FG000|Overall Study|Other|103|||
160812925|NCT00338286|580700053|FG001|Overall Study|Other|93|||
160812926|NCT01265563|580700054|FG000|Overall Study|Withdrawal by Subject|0|||
160812927|NCT01265563|580700055|FG001|Overall Study|Withdrawal by Subject|1|||
160812928|NCT01265563|580700056|FG002|Overall Study|Withdrawal by Subject|1|||
160986920|NCT04955626|581341132|FG027|Blinded Period|Physician Decision|0|||
161333037|NCT01251952|582608597|FG000|Overall Study|Adverse Event|1|||
160812929|NCT01265563|580700057|FG003|Overall Study|Withdrawal by Subject|0|||
160812930|NCT01265563|580700058|FG004|Overall Study|Withdrawal by Subject|2|||
160812931|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
160812932|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
160812933|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
160812934|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
160812935|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
160812936|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
160812937|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
160812938|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
160812939|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
160812940|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
160812941|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
160812942|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
160812943|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812944|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812945|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
160812946|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812947|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812948|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812949|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812950|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812951|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812952|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812953|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812954|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
160812955|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
160812956|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
160812957|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
160812958|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
160812959|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
160812960|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
160812961|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
160812962|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
160812963|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
160812964|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
160812965|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
160812966|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
160812967|NCT01667133|580700062|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812968|NCT01667133|580700063|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812969|NCT01667133|580700064|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812970|NCT01667133|580700065|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
160812971|NCT01667133|580700066|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812972|NCT01667133|580700067|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812973|NCT01667133|580700068|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
161239460|NCT03406156|582258004|FG000|Overall Study|Death|9|||
160812974|NCT01667133|580700069|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812975|NCT01667133|580700070|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812976|NCT01667133|580700071|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812977|NCT01667133|580700072|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812978|NCT01667133|580700073|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
160812979|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
160812980|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
160812981|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
160812982|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
160812983|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
160812984|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
160812985|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
160812986|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
160812987|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
160812988|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
160812989|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
160812990|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
160812991|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812992|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160900096|NCT02019277|581028645|FG000|Overall Study|Withdrawal by Subject|3|||
160900097|NCT02019277|581028645|FG000|Overall Study|Death|7|||
161239461|NCT03406156|582258005|FG001|Overall Study|Death|3|||
161239462|NCT03406156|582258004|FG000|Overall Study|Withdrawal by Subject|1|||
161239463|NCT03406156|582258005|FG001|Overall Study|Withdrawal by Subject|2|||
161239464|NCT03406156|582258004|FG000|Overall Study|COVID-19 infection|1|||
160812993|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812994|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812995|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812996|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
161239465|NCT03406156|582258005|FG001|Overall Study|COVID-19 infection|0|||
161239466|NCT03406156|582258004|FG000|Overall Study|Non-compliance with study procedures|1|||
160812997|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812998|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160812999|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160900098|NCT02019277|581028645|FG000|Overall Study|Did no Cooperate|1|||
161239467|NCT03406156|582258005|FG001|Overall Study|Non-compliance with study procedures|1|||
160813000|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
160813001|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160813002|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
160813003|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
160813004|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
160813005|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
160813006|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
160813007|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
160813008|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
160813009|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
160813010|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
160813011|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
160813012|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
160813013|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
160813014|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
160813015|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813016|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813017|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813018|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813019|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813020|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813021|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813022|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813023|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813024|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
160813025|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813026|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
160813027|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Death|0|||
160813028|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Death|0|||
160813029|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Death|0|||
160813030|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Death|0|||
160813031|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Death|0|||
160813032|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Death|0|||
160813033|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Death|0|||
160813034|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Death|0|||
160813035|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Death|0|||
160813036|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Death|1|||
160813037|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Death|0|||
160813038|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Death|0|||
160813039|NCT01667133|580700062|FG000|Phase 2: Dose-expansion|Other|0|||
160813040|NCT01667133|580700063|FG001|Phase 2: Dose-expansion|Other|0|||
160813041|NCT01667133|580700064|FG002|Phase 2: Dose-expansion|Other|0|||
160813042|NCT01667133|580700065|FG003|Phase 2: Dose-expansion|Other|0|||
160813043|NCT01667133|580700066|FG004|Phase 2: Dose-expansion|Other|0|||
160813044|NCT01667133|580700067|FG005|Phase 2: Dose-expansion|Other|0|||
160813045|NCT01667133|580700068|FG006|Phase 2: Dose-expansion|Other|0|||
160813046|NCT01667133|580700069|FG007|Phase 2: Dose-expansion|Other|0|||
160813047|NCT01667133|580700070|FG008|Phase 2: Dose-expansion|Other|0|||
160813048|NCT01667133|580700071|FG009|Phase 2: Dose-expansion|Other|0|||
160813049|NCT01667133|580700072|FG010|Phase 2: Dose-expansion|Other|0|||
160986921|NCT04955626|581341133|FG028|Blinded Period|Physician Decision|0|||
160986922|NCT04955626|581341134|FG029|Blinded Period|Physician Decision|0|||
160986923|NCT04955626|581341135|FG030|Blinded Period|Physician Decision|0|||
161239468|NCT03406156|582258004|FG000|Overall Study|Lost to Follow-up|0|||
161239469|NCT03406156|582258005|FG001|Overall Study|Lost to Follow-up|2|||
161239470|NCT03406156|582258004|FG000|Overall Study|Other, not specified|72|||
160986924|NCT04955626|581341136|FG031|Blinded Period|Physician Decision|0|||
160986925|NCT04955626|581341137|FG032|Blinded Period|Physician Decision|0|||
160986926|NCT04955626|581341138|FG033|Blinded Period|Physician Decision|0|||
160986927|NCT04955626|581341139|FG034|Blinded Period|Physician Decision|0|||
161239471|NCT03406156|582258005|FG001|Overall Study|Other, not specified|28|||
161239472|NCT05479058|582258008|FG000|Overall Study|Withdrawal by Subject|1|||
161239473|NCT05479058|582258009|FG001|Overall Study|Withdrawal by Subject|1|||
161239474|NCT05479058|582258008|FG000|Overall Study|Study terminated by sponsor|10|||
160813050|NCT01667133|580700073|FG011|Phase 2: Dose-expansion|Other|1|||
160813051|NCT01916824|580700074|FG000|Overall Study|Lost to Follow-up|3|||
160813052|NCT01916824|580700075|FG001|Overall Study|Lost to Follow-up|6|||
160813053|NCT01916824|580700074|FG000|Overall Study|Physician Decision|2|||
160813054|NCT01916824|580700075|FG001|Overall Study|Physician Decision|0|||
160813055|NCT01916824|580700074|FG000|Overall Study|Withdrawal by Subject|2|||
160813056|NCT01916824|580700075|FG001|Overall Study|Withdrawal by Subject|3|||
161239475|NCT05479058|582258009|FG001|Overall Study|Study terminated by sponsor|10|||
160813057|NCT03835481|580700080|FG000|Double-blind Period|Other not stated below|0|||
160813058|NCT03835481|580700081|FG001|Double-blind Period|Other not stated below|0|||
161239476|NCT05630885|582258010|FG000|Study Completion|Took prohibited medications|2|||
160986928|NCT04955626|581341140|FG035|Blinded Period|Physician Decision|0|||
161333038|NCT00496769|582608598|FG000|Double Blind|>=1 reason assigned per patient|558|||
161333039|NCT00496769|582608599|FG001|Double Blind|>=1 reason assigned per patient|649|||
161333040|NCT00496769|582608600|FG002|Double Blind|>=1 reason assigned per patient|0|||
161333041|NCT00496769|582608598|FG000|Open Label|>=1 reason assigned per patient|0|||
161333042|NCT00496769|582608599|FG001|Open Label|>=1 reason assigned per patient|0|||
161333043|NCT00496769|582608600|FG002|Open Label|>=1 reason assigned per patient|1011|||
161333044|NCT02308046|582608601|FG000|Overall Study|Negative yeast culture at Baseline|32|||
161333045|NCT02308046|582608602|FG001|Overall Study|Negative yeast culture at Baseline|33|||
161333046|NCT02308046|582608601|FG000|Overall Study|Positive for STD at Baseline|1|||
161333047|NCT02308046|582608602|FG001|Overall Study|Positive for STD at Baseline|2|||
161333048|NCT02308046|582608601|FG000|Overall Study|Lost to Follow-up|1|||
161333049|NCT02308046|582608602|FG001|Overall Study|Lost to Follow-up|3|||
161333050|NCT02224625|582608608|FG000|Irritation|Adverse Event|6|||
161333051|NCT02224625|582608608|FG000|Sensitization|Adverse Event|55|||
161333052|NCT01181167|582608609|FG000|Overall Study|Adverse Event|11|||
161333053|NCT01181167|582608610|FG001|Overall Study|Adverse Event|21|||
160900099|NCT02019277|581028645|FG000|Overall Study|Adverse Event|1|||
160900100|NCT03725852|581028646|FG000|Overall Study|Death|1|||
161131640|NCT03887130|581865334|FG001|Overall Study|Death|2|||
161131641|NCT03887130|581865335|FG002|Overall Study|Death|1|||
161131642|NCT03887130|581865333|FG000|Overall Study|Withdrawal by Subject|7|||
161131643|NCT03887130|581865334|FG001|Overall Study|Withdrawal by Subject|6|||
161131644|NCT03887130|581865335|FG002|Overall Study|Withdrawal by Subject|11|||
161131645|NCT03887130|581865333|FG000|Overall Study|other reason|6|||
161131646|NCT03887130|581865334|FG001|Overall Study|other reason|20|||
161131647|NCT03887130|581865335|FG002|Overall Study|other reason|17|||
161131648|NCT00927563|581865339|FG000|Overall Study|Lost to Follow-up|1|||
161131649|NCT00927563|581865339|FG000|Overall Study|Withdrawal by Subject|1|||
161131650|NCT02497001|581865342|FG000|Overall Study|Lost to Follow-up|10|||
161131651|NCT02497001|581865343|FG001|Overall Study|Lost to Follow-up|2|||
161131652|NCT02497001|581865344|FG002|Overall Study|Lost to Follow-up|0|||
161131653|NCT02497001|581865345|FG003|Overall Study|Lost to Follow-up|2|||
161131654|NCT02497001|581865342|FG000|Overall Study|Adverse Event|28|||
161131655|NCT02497001|581865343|FG001|Overall Study|Adverse Event|30|||
161131656|NCT02497001|581865344|FG002|Overall Study|Adverse Event|11|||
161131657|NCT02497001|581865345|FG003|Overall Study|Adverse Event|11|||
161131658|NCT02497001|581865342|FG000|Overall Study|Withdrawal by Subject|14|||
161131659|NCT02497001|581865343|FG001|Overall Study|Withdrawal by Subject|37|||
161131660|NCT02497001|581865344|FG002|Overall Study|Withdrawal by Subject|19|||
161131661|NCT02497001|581865345|FG003|Overall Study|Withdrawal by Subject|15|||
161131662|NCT02497001|581865342|FG000|Overall Study|Physician Decision|5|||
161131663|NCT02497001|581865343|FG001|Overall Study|Physician Decision|11|||
161131664|NCT02497001|581865344|FG002|Overall Study|Physician Decision|5|||
161131665|NCT02497001|581865345|FG003|Overall Study|Physician Decision|1|||
161131666|NCT02497001|581865342|FG000|Overall Study|subjects that were not treated|1|||
161131667|NCT02497001|581865343|FG001|Overall Study|subjects that were not treated|2|||
161131668|NCT02497001|581865344|FG002|Overall Study|subjects that were not treated|2|||
161131669|NCT02497001|581865345|FG003|Overall Study|subjects that were not treated|1|||
161131670|NCT02497001|581865342|FG000|Overall Study|Major Protocol Deviation|3|||
161131671|NCT02497001|581865343|FG001|Overall Study|Major Protocol Deviation|4|||
161131672|NCT02497001|581865344|FG002|Overall Study|Major Protocol Deviation|4|||
161131673|NCT02497001|581865345|FG003|Overall Study|Major Protocol Deviation|4|||
161131674|NCT02497001|581865342|FG000|Overall Study|Lack of Efficacy|10|||
161131675|NCT02497001|581865343|FG001|Overall Study|Lack of Efficacy|16|||
161131676|NCT02497001|581865344|FG002|Overall Study|Lack of Efficacy|6|||
161131677|NCT02497001|581865345|FG003|Overall Study|Lack of Efficacy|6|||
161131678|NCT02497001|581865342|FG000|Overall Study|Protocol Violation|3|||
161131679|NCT02497001|581865343|FG001|Overall Study|Protocol Violation|1|||
161131680|NCT02497001|581865344|FG002|Overall Study|Protocol Violation|3|||
161131681|NCT02497001|581865345|FG003|Overall Study|Protocol Violation|1|||
161131682|NCT00705263|581865346|FG000|Overall Study|Withdrawal by Subject|2|||
161131683|NCT05501119|581865347|FG000|Overall Study|Withdrawal by Subject|2|||
161131684|NCT05501119|581865347|FG000|Overall Study|Lost to Follow-up|5|||
161131685|NCT01752023|581865348|FG000|Overall Study|Physician Decision|2|||
161131686|NCT01752023|581865349|FG001|Overall Study|Physician Decision|1|||
161131687|NCT02899156|581865353|FG000|Overall Study|Death|1|||
161131688|NCT02899156|581865354|FG001|Overall Study|Death|0|||
161333054|NCT01181167|582608609|FG000|Overall Study|Lost to Follow-up|1|||
160900101|NCT03725852|581028647|FG001|Overall Study|Death|0|||
161131689|NCT02899156|581865353|FG000|Overall Study|Physician Decision|0|||
161131690|NCT02899156|581865354|FG001|Overall Study|Physician Decision|1|||
161131691|NCT02440581|581865357|FG000|Overall Study|Death|0|||
161131692|NCT02440581|581865358|FG001|Overall Study|Death|0|||
161131693|NCT02440581|581865359|FG002|Overall Study|Death|7|||
161131694|NCT02440581|581865360|FG003|Overall Study|Death|5|||
161131695|NCT02440581|581865357|FG000|Overall Study|Transplanted|1|||
161131696|NCT02440581|581865358|FG001|Overall Study|Transplanted|0|||
161131697|NCT02440581|581865359|FG002|Overall Study|Transplanted|3|||
161131698|NCT02440581|581865360|FG003|Overall Study|Transplanted|2|||
160813059|NCT03835481|580700082|FG002|Double-blind Period|Other not stated below|0|||
160813060|NCT03835481|580700083|FG003|Double-blind Period|Other not stated below|1|||
161239477|NCT05630885|582258011|FG001|Study Completion|Took prohibited medications|0|||
160813061|NCT03835481|580700084|FG004|Double-blind Period|Other not stated below|1|||
160813062|NCT03835481|580700080|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
160813063|NCT03835481|580700081|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
160813064|NCT03835481|580700082|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
160813065|NCT03835481|580700083|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
160813066|NCT03835481|580700084|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
160813067|NCT03835481|580700080|FG000|Double-blind Period|Withdrawal by Subject|0|||
160813068|NCT03835481|580700081|FG001|Double-blind Period|Withdrawal by Subject|0|||
160813069|NCT03835481|580700082|FG002|Double-blind Period|Withdrawal by Subject|1|||
160813070|NCT03835481|580700083|FG003|Double-blind Period|Withdrawal by Subject|0|||
160813071|NCT03835481|580700084|FG004|Double-blind Period|Withdrawal by Subject|5|||
160813072|NCT03835481|580700080|FG000|Double-blind Period|Lost to Follow-up|0|||
160813073|NCT03835481|580700081|FG001|Double-blind Period|Lost to Follow-up|0|||
160813074|NCT03835481|580700082|FG002|Double-blind Period|Lost to Follow-up|0|||
160813075|NCT03835481|580700083|FG003|Double-blind Period|Lost to Follow-up|1|||
160813076|NCT03835481|580700084|FG004|Double-blind Period|Lost to Follow-up|0|||
160813077|NCT03835481|580700080|FG000|Double-blind Period|Protocol Violation|0|||
160813078|NCT03835481|580700081|FG001|Double-blind Period|Protocol Violation|2|||
160813079|NCT03835481|580700082|FG002|Double-blind Period|Protocol Violation|0|||
160813080|NCT03835481|580700083|FG003|Double-blind Period|Protocol Violation|1|||
160813081|NCT03835481|580700084|FG004|Double-blind Period|Protocol Violation|0|||
160813082|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
161239478|NCT05630885|582258010|FG000|Study Completion|Non-compliance with study drug|1|||
161239479|NCT05630885|582258011|FG001|Study Completion|Non-compliance with study drug|0|||
161239480|NCT05630885|582258010|FG000|Study Completion|Adverse Event|1|||
160813083|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
160813084|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
160813085|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
160813086|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
160813087|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
160813088|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
160813089|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
160813090|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
160813091|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
160813092|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
160813093|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
160813094|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
160813095|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
160813096|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
160813097|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
160813098|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
160813099|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
161239481|NCT05630885|582258011|FG001|Study Completion|Adverse Event|0|||
161239482|NCT05630885|582258010|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
161239483|NCT05630885|582258011|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
161239484|NCT05630885|582258010|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
161239485|NCT05630885|582258011|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
161239486|NCT03419403|582258014|FG000|Overall Study|Withdrawal by Subject|5|||
161239487|NCT03419403|582258015|FG001|Overall Study|Withdrawal by Subject|2|||
161239488|NCT03419403|582258016|FG002|Overall Study|Withdrawal by Subject|5|||
161239489|NCT03419403|582258017|FG003|Overall Study|Withdrawal by Subject|1|||
161239490|NCT03419403|582258014|FG000|Overall Study|Progressive disease (per protocol)|0|||
161239491|NCT03419403|582258015|FG001|Overall Study|Progressive disease (per protocol)|2|||
161239492|NCT03419403|582258016|FG002|Overall Study|Progressive disease (per protocol)|2|||
161239493|NCT03419403|582258017|FG003|Overall Study|Progressive disease (per protocol)|0|||
161333055|NCT01181167|582608610|FG001|Overall Study|Lost to Follow-up|0|||
161333056|NCT01181167|582608609|FG000|Overall Study|Physician Decision|2|||
161333057|NCT01181167|582608610|FG001|Overall Study|Physician Decision|3|||
161333058|NCT01181167|582608609|FG000|Overall Study|Protocol Violation|3|||
160813100|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
160813101|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
160813102|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
161239494|NCT03419403|582258014|FG000|Overall Study|Other, not specified|6|||
161239495|NCT03419403|582258015|FG001|Overall Study|Other, not specified|4|||
161239496|NCT03419403|582258016|FG002|Overall Study|Other, not specified|5|||
161239497|NCT03419403|582258017|FG003|Overall Study|Other, not specified|1|||
161239498|NCT03419403|582258014|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
161239499|NCT03419403|582258015|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
161239500|NCT03419403|582258016|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
161239501|NCT03419403|582258017|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
161239502|NCT00505622|582258020|FG000|Overall Study|Adverse Event|5|||
161239503|NCT00505622|582258021|FG001|Overall Study|Adverse Event|6|||
161239504|NCT00505622|582258022|FG002|Overall Study|Adverse Event|4|||
161239505|NCT00505622|582258020|FG000|Overall Study|Protocol Violation|1|||
161239506|NCT00505622|582258021|FG001|Overall Study|Protocol Violation|1|||
161239507|NCT00505622|582258022|FG002|Overall Study|Protocol Violation|0|||
161239508|NCT00505622|582258020|FG000|Overall Study|Withdrawal by Subject|0|||
161239509|NCT00505622|582258021|FG001|Overall Study|Withdrawal by Subject|3|||
161239510|NCT00505622|582258022|FG002|Overall Study|Withdrawal by Subject|2|||
161239511|NCT00505622|582258020|FG000|Overall Study|Study termination by sponsor|115|||
161239512|NCT00505622|582258021|FG001|Overall Study|Study termination by sponsor|98|||
161239513|NCT00505622|582258022|FG002|Overall Study|Study termination by sponsor|90|||
161239514|NCT03084471|582258025|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
161239515|NCT03084471|582258025|FG000|Overall Study|Condition under investigation worsened|84|||
161239516|NCT03084471|582258025|FG000|Overall Study|Lack of therapeutic response|2|||
161239517|NCT03084471|582258025|FG000|Overall Study|Protocol Violation|1|||
160813103|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160813104|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160813105|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
160813106|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
160813107|NCT03835481|580700080|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
160813108|NCT03835481|580700081|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
160813109|NCT03835481|580700082|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
160813110|NCT03835481|580700083|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
160813111|NCT03835481|580700084|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
160813112|NCT00375505|580700093|FG000|Overall Study|Adverse Event|1|||
160813113|NCT00375505|580700094|FG001|Overall Study|Adverse Event|2|||
160813114|NCT01831466|580700095|FG000|Overall Study|Protocol Violation|1|||
160813115|NCT01831466|580700096|FG001|Overall Study|Protocol Violation|1|||
160813116|NCT01831466|580700097|FG002|Overall Study|Protocol Violation|2|||
160813117|NCT01831466|580700098|FG003|Overall Study|Protocol Violation|0|||
160813118|NCT01831466|580700099|FG004|Overall Study|Protocol Violation|0|||
160813119|NCT01831466|580700100|FG005|Overall Study|Protocol Violation|1|||
160813120|NCT01831466|580700101|FG006|Overall Study|Protocol Violation|0|||
160813121|NCT01831466|580700102|FG007|Overall Study|Protocol Violation|0|||
160813122|NCT01831466|580700103|FG008|Overall Study|Protocol Violation|0|||
160813123|NCT01831466|580700104|FG009|Overall Study|Protocol Violation|0|||
160813124|NCT01831466|580700105|FG010|Overall Study|Protocol Violation|0|||
160813125|NCT01831466|580700106|FG011|Overall Study|Protocol Violation|0|||
160813126|NCT01831466|580700095|FG000|Overall Study|Other|2|||
160813127|NCT01831466|580700096|FG001|Overall Study|Other|3|||
160813128|NCT01831466|580700097|FG002|Overall Study|Other|2|||
160813129|NCT01831466|580700098|FG003|Overall Study|Other|2|||
160813130|NCT01831466|580700099|FG004|Overall Study|Other|2|||
160813131|NCT01831466|580700100|FG005|Overall Study|Other|1|||
160813132|NCT01831466|580700101|FG006|Overall Study|Other|0|||
160813133|NCT01831466|580700102|FG007|Overall Study|Other|0|||
161239518|NCT03084471|582258025|FG000|Overall Study|Adverse Event|73|||
161239519|NCT03084471|582258025|FG000|Overall Study|Withdrawal by Subject|12|||
161239520|NCT03084471|582258025|FG000|Overall Study|Disease relapse|181|||
161239521|NCT03084471|582258025|FG000|Overall Study|Subjective disease progression|359|||
160813134|NCT01831466|580700103|FG008|Overall Study|Other|0|||
160813135|NCT01831466|580700104|FG009|Overall Study|Other|0|||
160813136|NCT01831466|580700105|FG010|Overall Study|Other|0|||
161131699|NCT02440581|581865357|FG000|Overall Study|Withdrawal by Subject|4|||
161131700|NCT02440581|581865358|FG001|Overall Study|Withdrawal by Subject|11|||
161131701|NCT02440581|581865359|FG002|Overall Study|Withdrawal by Subject|3|||
161131702|NCT02440581|581865360|FG003|Overall Study|Withdrawal by Subject|7|||
161131703|NCT00654498|581865361|FG000|Overall Study|Not Treated|1|||
161131704|NCT00654498|581865362|FG001|Overall Study|Not Treated|0|||
161131705|NCT00654498|581865361|FG000|Overall Study|Adverse Event|6|||
161131706|NCT00654498|581865362|FG001|Overall Study|Adverse Event|1|||
161131707|NCT00654498|581865361|FG000|Overall Study|Protocol Violation|1|||
161131708|NCT00654498|581865362|FG001|Overall Study|Protocol Violation|1|||
161131709|NCT00654498|581865361|FG000|Overall Study|Lost to Follow-up|1|||
161131710|NCT00654498|581865362|FG001|Overall Study|Lost to Follow-up|5|||
161131711|NCT00654498|581865361|FG000|Overall Study|Withdrawal by Subject|1|||
161239522|NCT03084471|582258025|FG000|Overall Study|Other (as recorded)|33|||
160813137|NCT01831466|580700106|FG011|Overall Study|Other|0|||
161131712|NCT00654498|581865362|FG001|Overall Study|Withdrawal by Subject|0|||
160813138|NCT01831466|580700095|FG000|Overall Study|Non-compliance with study treatment|2|||
160813139|NCT01831466|580700096|FG001|Overall Study|Non-compliance with study treatment|1|||
160813140|NCT01831466|580700097|FG002|Overall Study|Non-compliance with study treatment|1|||
160813141|NCT01831466|580700098|FG003|Overall Study|Non-compliance with study treatment|0|||
160813142|NCT01831466|580700099|FG004|Overall Study|Non-compliance with study treatment|0|||
160813143|NCT01831466|580700100|FG005|Overall Study|Non-compliance with study treatment|1|||
160813144|NCT01831466|580700101|FG006|Overall Study|Non-compliance with study treatment|0|||
160813145|NCT01831466|580700102|FG007|Overall Study|Non-compliance with study treatment|0|||
160813146|NCT01831466|580700103|FG008|Overall Study|Non-compliance with study treatment|0|||
160813147|NCT01831466|580700104|FG009|Overall Study|Non-compliance with study treatment|0|||
160813148|NCT01831466|580700105|FG010|Overall Study|Non-compliance with study treatment|0|||
160813149|NCT01831466|580700106|FG011|Overall Study|Non-compliance with study treatment|0|||
160813150|NCT01831466|580700095|FG000|Overall Study|Death|0|||
160813151|NCT01831466|580700096|FG001|Overall Study|Death|1|||
160900102|NCT03725852|581028646|FG000|Overall Study|Withdrawal by Subject|1|||
160900103|NCT03725852|581028647|FG001|Overall Study|Withdrawal by Subject|0|||
160900104|NCT03725852|581028646|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
160900105|NCT03725852|581028647|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
160900106|NCT04738734|581028649|FG000|Overall Study|Withdrawal by Subject|2|||
160900107|NCT04738734|581028650|FG001|Overall Study|Withdrawal by Subject|4|||
160900108|NCT04738734|581028649|FG000|Overall Study|Lost to Follow-up|5|||
160900109|NCT04738734|581028650|FG001|Overall Study|Lost to Follow-up|2|||
160900110|NCT04738734|581028649|FG000|Overall Study|Physician Decision|0|||
160900111|NCT04738734|581028650|FG001|Overall Study|Physician Decision|1|||
160900112|NCT04738734|581028649|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
160900113|NCT04738734|581028650|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
160900114|NCT04093414|581028653|FG000|3 Month Follow up|Physician Decision|0|||
160900115|NCT04093414|581028654|FG001|3 Month Follow up|Physician Decision|1|||
160900116|NCT04093414|581028653|FG000|6month Follow up|Physician Decision|1|||
160900117|NCT04093414|581028654|FG001|6month Follow up|Physician Decision|3|||
160900118|NCT03452228|581028655|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160900119|NCT03452228|581028656|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
160900120|NCT03452228|581028657|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160900121|NCT03452228|581028655|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160986929|NCT04955626|581341105|FG000|Blinded Period|Withdrawal by Subject|26|||
160986930|NCT04955626|581341106|FG001|Blinded Period|Withdrawal by Subject|62|||
161131713|NCT00654498|581865361|FG000|Overall Study|Other reason not defined above|4|||
161131714|NCT00654498|581865362|FG001|Overall Study|Other reason not defined above|5|||
161131715|NCT00787787|581865363|FG000|Overall Study|Lack of Efficacy|4|||
161131716|NCT00787787|581865363|FG000|Overall Study|Adverse Event|3|||
161131717|NCT01468987|581865364|FG000|Overall Study|Adverse Event|12|||
161131718|NCT01468987|581865365|FG001|Overall Study|Adverse Event|9|||
161131719|NCT01468987|581865364|FG000|Overall Study|Death|4|||
161131720|NCT01468987|581865365|FG001|Overall Study|Death|1|||
161131721|NCT01468987|581865364|FG000|Overall Study|Lost to Follow-up|10|||
161131722|NCT01468987|581865365|FG001|Overall Study|Lost to Follow-up|5|||
161131723|NCT01468987|581865364|FG000|Overall Study|Protocol Violation|8|||
161131724|NCT01468987|581865365|FG001|Overall Study|Protocol Violation|2|||
161131725|NCT01468987|581865364|FG000|Overall Study|Withdrawal by Subject|28|||
161131726|NCT01468987|581865365|FG001|Overall Study|Withdrawal by Subject|28|||
161131727|NCT01468987|581865364|FG000|Overall Study|Physician Decision|8|||
161131728|NCT01468987|581865365|FG001|Overall Study|Physician Decision|15|||
161131729|NCT01468987|581865364|FG000|Overall Study|Sponsor Decision|1|||
161131730|NCT01468987|581865365|FG001|Overall Study|Sponsor Decision|0|||
161131731|NCT00484315|581865368|FG000|12-Month Clinical Follow-up|Death|6|||
161131732|NCT00484315|581865369|FG001|12-Month Clinical Follow-up|Death|2|||
161131733|NCT00484315|581865368|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
161131734|NCT00484315|581865369|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
161131735|NCT00484315|581865368|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
161131736|NCT00484315|581865369|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
161131737|NCT00484315|581865368|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
161131738|NCT00484315|581865369|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
161131739|NCT00484315|581865368|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
161131740|NCT00484315|581865369|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
161131741|NCT00484315|581865368|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
161131742|NCT00484315|581865369|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
161131743|NCT00484315|581865368|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
161131744|NCT00484315|581865369|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
161239523|NCT03084471|582258025|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
161239524|NCT02414152|582258030|FG000|Overall Study|Withdrawal by Subject|1|||
160813152|NCT01831466|580700097|FG002|Overall Study|Death|0|||
160813153|NCT01831466|580700098|FG003|Overall Study|Death|0|||
160813154|NCT01831466|580700099|FG004|Overall Study|Death|0|||
160813155|NCT01831466|580700100|FG005|Overall Study|Death|0|||
160813156|NCT01831466|580700101|FG006|Overall Study|Death|0|||
160813157|NCT01831466|580700102|FG007|Overall Study|Death|0|||
160813158|NCT01831466|580700103|FG008|Overall Study|Death|0|||
160813159|NCT01831466|580700104|FG009|Overall Study|Death|0|||
160813160|NCT01831466|580700105|FG010|Overall Study|Death|0|||
160813161|NCT01831466|580700106|FG011|Overall Study|Death|0|||
160813162|NCT01831466|580700095|FG000|Overall Study|Withdrawal by Subject|6|||
160813163|NCT01831466|580700096|FG001|Overall Study|Withdrawal by Subject|3|||
160813164|NCT01831466|580700097|FG002|Overall Study|Withdrawal by Subject|3|||
160813165|NCT01831466|580700098|FG003|Overall Study|Withdrawal by Subject|3|||
160813166|NCT01831466|580700099|FG004|Overall Study|Withdrawal by Subject|3|||
160813167|NCT01831466|580700100|FG005|Overall Study|Withdrawal by Subject|5|||
161333059|NCT01181167|582608610|FG001|Overall Study|Protocol Violation|0|||
161131745|NCT00943683|581865370|FG000|Overall Study|Adverse Event|3|||
161131746|NCT00943683|581865371|FG001|Overall Study|Adverse Event|3|||
161131747|NCT00943683|581865370|FG000|Overall Study|Lost to Follow-up|1|||
161131748|NCT00943683|581865371|FG001|Overall Study|Lost to Follow-up|1|||
161131749|NCT00943683|581865370|FG000|Overall Study|Protocol Violation|1|||
161131750|NCT00943683|581865371|FG001|Overall Study|Protocol Violation|2|||
161131751|NCT00943683|581865370|FG000|Overall Study|Withdrawal by Subject|1|||
161131752|NCT00943683|581865371|FG001|Overall Study|Withdrawal by Subject|0|||
161131753|NCT00943683|581865370|FG000|Overall Study|Patient Moved|1|||
161131754|NCT00943683|581865371|FG001|Overall Study|Patient Moved|0|||
161131755|NCT01245673|581865372|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
160813168|NCT01831466|580700101|FG006|Overall Study|Withdrawal by Subject|0|||
160813169|NCT01831466|580700102|FG007|Overall Study|Withdrawal by Subject|0|||
160813170|NCT01831466|580700103|FG008|Overall Study|Withdrawal by Subject|0|||
160813171|NCT01831466|580700104|FG009|Overall Study|Withdrawal by Subject|1|||
160813172|NCT01831466|580700105|FG010|Overall Study|Withdrawal by Subject|0|||
160813173|NCT01831466|580700106|FG011|Overall Study|Withdrawal by Subject|1|||
160813174|NCT01831466|580700095|FG000|Overall Study|Lost to Follow-up|0|||
160813175|NCT01831466|580700096|FG001|Overall Study|Lost to Follow-up|1|||
160813176|NCT01831466|580700097|FG002|Overall Study|Lost to Follow-up|4|||
160813177|NCT01831466|580700098|FG003|Overall Study|Lost to Follow-up|2|||
160813178|NCT01831466|580700099|FG004|Overall Study|Lost to Follow-up|0|||
160813179|NCT01831466|580700100|FG005|Overall Study|Lost to Follow-up|3|||
160813180|NCT01831466|580700101|FG006|Overall Study|Lost to Follow-up|0|||
160813181|NCT01831466|580700102|FG007|Overall Study|Lost to Follow-up|0|||
160813182|NCT01831466|580700103|FG008|Overall Study|Lost to Follow-up|0|||
160813183|NCT01831466|580700104|FG009|Overall Study|Lost to Follow-up|1|||
160813184|NCT01831466|580700105|FG010|Overall Study|Lost to Follow-up|0|||
160813185|NCT01831466|580700106|FG011|Overall Study|Lost to Follow-up|1|||
160813186|NCT01831466|580700095|FG000|Overall Study|Lack of Efficacy|5|||
160813187|NCT01831466|580700096|FG001|Overall Study|Lack of Efficacy|8|||
160813188|NCT01831466|580700097|FG002|Overall Study|Lack of Efficacy|7|||
160813189|NCT01831466|580700098|FG003|Overall Study|Lack of Efficacy|6|||
160813190|NCT01831466|580700099|FG004|Overall Study|Lack of Efficacy|9|||
160813191|NCT01831466|580700100|FG005|Overall Study|Lack of Efficacy|8|||
160813192|NCT01831466|580700101|FG006|Overall Study|Lack of Efficacy|1|||
160813193|NCT01831466|580700102|FG007|Overall Study|Lack of Efficacy|1|||
160813194|NCT01831466|580700103|FG008|Overall Study|Lack of Efficacy|2|||
160813195|NCT01831466|580700104|FG009|Overall Study|Lack of Efficacy|2|||
160813196|NCT01831466|580700105|FG010|Overall Study|Lack of Efficacy|2|||
160813197|NCT01831466|580700106|FG011|Overall Study|Lack of Efficacy|0|||
160813198|NCT01831466|580700095|FG000|Overall Study|Adverse Event|0|||
160813199|NCT01831466|580700096|FG001|Overall Study|Adverse Event|0|||
160813200|NCT01831466|580700097|FG002|Overall Study|Adverse Event|4|||
160813201|NCT01831466|580700098|FG003|Overall Study|Adverse Event|6|||
160813202|NCT01831466|580700099|FG004|Overall Study|Adverse Event|3|||
160813203|NCT01831466|580700100|FG005|Overall Study|Adverse Event|7|||
160813204|NCT01831466|580700101|FG006|Overall Study|Adverse Event|0|||
160813205|NCT01831466|580700102|FG007|Overall Study|Adverse Event|1|||
160813206|NCT01831466|580700103|FG008|Overall Study|Adverse Event|1|||
160813207|NCT01831466|580700104|FG009|Overall Study|Adverse Event|1|||
160813208|NCT01831466|580700105|FG010|Overall Study|Adverse Event|0|||
160813209|NCT01831466|580700106|FG011|Overall Study|Adverse Event|2|||
160813210|NCT00429182|580700108|FG000|Overall Study|Not evaluable, Disease Progression|2|||
160813211|NCT00429182|580700108|FG000|Overall Study|Not eligible|5|||
160813212|NCT02146131|580700109|FG000|Overall Study|Physician Decision|61|||
160813213|NCT02146131|580700110|FG001|Overall Study|Physician Decision|56|||
160813214|NCT02567799|580700111|FG000|Concurrent Chemoradiotherapy|Death|1|||
160813215|NCT02567799|580700112|FG001|Concurrent Chemoradiotherapy|Death|0|||
160813216|NCT02567799|580700113|FG002|Concurrent Chemoradiotherapy|Death|0|||
161131756|NCT01609842|581865378|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
161131757|NCT01609842|581865379|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
160813217|NCT02567799|580700111|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
160813218|NCT02567799|580700112|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
160813219|NCT02567799|580700113|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
160813220|NCT02567799|580700111|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
160813221|NCT02567799|580700112|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
160813222|NCT02567799|580700113|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
160813223|NCT02567799|580700111|FG000|Follow-up|Death|1|||
160813224|NCT02567799|580700112|FG001|Follow-up|Death|0|||
160813225|NCT02567799|580700113|FG002|Follow-up|Death|1|||
160813226|NCT02567799|580700111|FG000|Follow-up|Progressive Disease|1|||
160813227|NCT02567799|580700112|FG001|Follow-up|Progressive Disease|1|||
160813228|NCT02567799|580700113|FG002|Follow-up|Progressive Disease|3|||
160813229|NCT02142803|580700120|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
160813230|NCT02142803|580700121|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
160813231|NCT02142803|580700122|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
160813232|NCT02142803|580700123|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
160813233|NCT05111002|580700124|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
160813234|NCT05111002|580700125|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
160813235|NCT05111002|580700124|FG000|Secondary Outcome|Lost to Follow-up|1|||
160813236|NCT05111002|580700125|FG001|Secondary Outcome|Lost to Follow-up|0|||
160813237|NCT04776720|580700139|FG000|Overall Study|COVID Related|4|||
160813238|NCT04776720|580700140|FG001|Overall Study|COVID Related|2|||
160813239|NCT04776720|580700139|FG000|Overall Study|Adverse Event|2|||
160813240|NCT04776720|580700140|FG001|Overall Study|Adverse Event|0|||
160813241|NCT04776720|580700139|FG000|Overall Study|Serious Adverse Event|0|||
160813242|NCT04776720|580700140|FG001|Overall Study|Serious Adverse Event|1|||
160813243|NCT04776720|580700139|FG000|Overall Study|Too Busy|3|||
160813244|NCT04776720|580700140|FG001|Overall Study|Too Busy|1|||
160813245|NCT04776720|580700139|FG000|Overall Study|Lost to Follow-up|1|||
160813246|NCT04776720|580700140|FG001|Overall Study|Lost to Follow-up|2|||
160813247|NCT04776720|580700139|FG000|Overall Study|Family|2|||
160813248|NCT04776720|580700140|FG001|Overall Study|Family|2|||
160813249|NCT04776720|580700139|FG000|Overall Study|No remote technology access|0|||
160813250|NCT04776720|580700140|FG001|Overall Study|No remote technology access|1|||
160813251|NCT04776720|580700139|FG000|Overall Study|Withdrawal by Subject|1|||
160813252|NCT04776720|580700140|FG001|Overall Study|Withdrawal by Subject|0|||
160813253|NCT04776720|580700139|FG000|Overall Study|Cannot tolerate intervention|1|||
160813254|NCT04776720|580700140|FG001|Overall Study|Cannot tolerate intervention|0|||
160813255|NCT04776720|580700139|FG000|Overall Study|Incomplete outcome data|6|||
160813256|NCT04776720|580700140|FG001|Overall Study|Incomplete outcome data|1|||
160813257|NCT05356910|580700143|FG000|Overall Study|Lost to Follow-up|10|||
160813258|NCT05356910|580700144|FG001|Overall Study|Lost to Follow-up|19|||
160813259|NCT05356910|580700145|FG002|Overall Study|Lost to Follow-up|0|||
160813260|NCT05356910|580700146|FG003|Overall Study|Lost to Follow-up|0|||
160813261|NCT05356910|580700143|FG000|Overall Study|Withdrawal by Subject|4|||
160813262|NCT05356910|580700144|FG001|Overall Study|Withdrawal by Subject|2|||
160813263|NCT05356910|580700145|FG002|Overall Study|Withdrawal by Subject|0|||
160813264|NCT05356910|580700146|FG003|Overall Study|Withdrawal by Subject|0|||
160813265|NCT02712996|580700150|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
160813266|NCT02712996|580700151|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
160813267|NCT01451749|580700155|FG000|Overall Study|Protocol Violation|14|||
160986931|NCT04955626|581341107|FG002|Blinded Period|Withdrawal by Subject|14|||
160986932|NCT04955626|581341108|FG003|Blinded Period|Withdrawal by Subject|16|||
160986933|NCT04955626|581341109|FG004|Blinded Period|Withdrawal by Subject|1|||
160986934|NCT04955626|581341110|FG005|Blinded Period|Withdrawal by Subject|2|||
160813268|NCT01451749|580700156|FG001|Overall Study|Protocol Violation|7|||
160813269|NCT01451749|580700155|FG000|Overall Study|Lost to Follow-up|15|||
160813270|NCT01451749|580700156|FG001|Overall Study|Lost to Follow-up|5|||
160813271|NCT01451749|580700155|FG000|Overall Study|Meet the exclusion criteria,and|1|||
160813272|NCT01451749|580700156|FG001|Overall Study|Meet the exclusion criteria,and|1|||
160813273|NCT01451749|580700155|FG000|Overall Study|Adverse Event|2|||
160813274|NCT01451749|580700156|FG001|Overall Study|Adverse Event|0|||
160813275|NCT01451749|580700155|FG000|Overall Study|Withdrawal by Subject|0|||
160813276|NCT01451749|580700156|FG001|Overall Study|Withdrawal by Subject|1|||
160813277|NCT00972517|580700159|FG000|Overall Study|Adverse Event|0|||
160813278|NCT00972517|580700160|FG001|Overall Study|Adverse Event|0|||
160813279|NCT00972517|580700161|FG002|Overall Study|Adverse Event|0|||
160813280|NCT00972517|580700162|FG003|Overall Study|Adverse Event|1|||
160813281|NCT00972517|580700163|FG004|Overall Study|Adverse Event|0|||
160813282|NCT00972517|580700164|FG005|Overall Study|Adverse Event|0|||
160813283|NCT00972517|580700159|FG000|Overall Study|Withdrawal by Subject|0|||
160813284|NCT00972517|580700160|FG001|Overall Study|Withdrawal by Subject|1|||
160813285|NCT00972517|580700161|FG002|Overall Study|Withdrawal by Subject|0|||
160986935|NCT04955626|581341111|FG006|Blinded Period|Withdrawal by Subject|9|||
160813286|NCT00972517|580700162|FG003|Overall Study|Withdrawal by Subject|2|||
160813287|NCT00972517|580700163|FG004|Overall Study|Withdrawal by Subject|1|||
160813288|NCT00972517|580700164|FG005|Overall Study|Withdrawal by Subject|0|||
160813289|NCT02311881|580700165|FG000|Overall Study|Did not meet the study criteria|2|||
160813290|NCT02311881|580700166|FG001|Overall Study|Did not meet the study criteria|2|||
160813291|NCT02311881|580700167|FG002|Overall Study|Did not meet the study criteria|0|||
160813292|NCT02311881|580700165|FG000|Overall Study|Adverse Event|7|||
160813293|NCT02311881|580700166|FG001|Overall Study|Adverse Event|15|||
160813294|NCT02311881|580700167|FG002|Overall Study|Adverse Event|8|||
160813295|NCT02311881|580700165|FG000|Overall Study|Lost to Follow-up|3|||
160813296|NCT02311881|580700166|FG001|Overall Study|Lost to Follow-up|3|||
160813297|NCT02311881|580700167|FG002|Overall Study|Lost to Follow-up|2|||
160813298|NCT02311881|580700165|FG000|Overall Study|Protocol Violation|1|||
160813299|NCT02311881|580700166|FG001|Overall Study|Protocol Violation|2|||
160813300|NCT02311881|580700167|FG002|Overall Study|Protocol Violation|3|||
160813301|NCT02311881|580700165|FG000|Overall Study|Withdrawal of consent|14|||
160813302|NCT02311881|580700166|FG001|Overall Study|Withdrawal of consent|16|||
160813303|NCT02311881|580700167|FG002|Overall Study|Withdrawal of consent|17|||
160813304|NCT02311881|580700165|FG000|Overall Study|Other|0|||
160813305|NCT02311881|580700166|FG001|Overall Study|Other|0|||
160813306|NCT02311881|580700167|FG002|Overall Study|Other|1|||
160813307|NCT02311881|580700165|FG000|Overall Study|Lack of Efficacy|1|||
160813308|NCT02311881|580700166|FG001|Overall Study|Lack of Efficacy|2|||
160813309|NCT02311881|580700167|FG002|Overall Study|Lack of Efficacy|0|||
160813310|NCT02311881|580700165|FG000|Overall Study|Subject has border line pregnancy test|1|||
160813311|NCT02311881|580700166|FG001|Overall Study|Subject has border line pregnancy test|0|||
160813312|NCT02311881|580700167|FG002|Overall Study|Subject has border line pregnancy test|0|||
160813313|NCT02311881|580700165|FG000|Overall Study|Withdrawal by Subject|3|||
160813314|NCT02311881|580700166|FG001|Overall Study|Withdrawal by Subject|1|||
160813315|NCT02311881|580700167|FG002|Overall Study|Withdrawal by Subject|4|||
160813316|NCT02311881|580700165|FG000|Overall Study|Sponsor Decision|1|||
160813317|NCT02311881|580700166|FG001|Overall Study|Sponsor Decision|1|||
160813318|NCT02311881|580700167|FG002|Overall Study|Sponsor Decision|1|||
160813319|NCT02311881|580700165|FG000|Overall Study|Protocol Deviation|1|||
160813320|NCT02311881|580700166|FG001|Overall Study|Protocol Deviation|0|||
160813321|NCT02311881|580700167|FG002|Overall Study|Protocol Deviation|0|||
160813322|NCT02311881|580700165|FG000|Overall Study|Non-Compliance|1|||
160813323|NCT02311881|580700166|FG001|Overall Study|Non-Compliance|0|||
160813324|NCT02311881|580700167|FG002|Overall Study|Non-Compliance|2|||
160813325|NCT02311881|580700165|FG000|Overall Study|Physician Decision|0|||
160813326|NCT02311881|580700166|FG001|Overall Study|Physician Decision|0|||
160813327|NCT02311881|580700167|FG002|Overall Study|Physician Decision|1|||
160813328|NCT02311881|580700165|FG000|Overall Study|Medical Monitor Discretion|0|||
160813329|NCT02311881|580700166|FG001|Overall Study|Medical Monitor Discretion|0|||
160813330|NCT02311881|580700167|FG002|Overall Study|Medical Monitor Discretion|1|||
160813331|NCT02311881|580700165|FG000|Overall Study|Participant taking another medication|0|||
160813332|NCT02311881|580700166|FG001|Overall Study|Participant taking another medication|0|||
160813333|NCT02311881|580700167|FG002|Overall Study|Participant taking another medication|1|||
160813334|NCT02311881|580700165|FG000|Overall Study|Serious Adverse Event|0|||
160813335|NCT02311881|580700166|FG001|Overall Study|Serious Adverse Event|1|||
160813336|NCT02311881|580700167|FG002|Overall Study|Serious Adverse Event|0|||
160813337|NCT03306433|580700170|FG000|Overall Study|Lost to Follow-up|3|||
160813338|NCT03306433|580700170|FG000|Overall Study|Patient did not have teeth extracted|1|||
160813339|NCT03306433|580700170|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
160813340|NCT00819156|580700171|FG000|Overall Study|Adverse Event|1|||
160813341|NCT00819156|580700172|FG001|Overall Study|Adverse Event|4|||
160813342|NCT00819156|580700173|FG002|Overall Study|Adverse Event|2|||
160813343|NCT00819156|580700174|FG003|Overall Study|Adverse Event|1|||
160813344|NCT00819156|580700175|FG004|Overall Study|Adverse Event|2|||
160813345|NCT00819156|580700176|FG005|Overall Study|Adverse Event|3|||
160813346|NCT00819156|580700171|FG000|Overall Study|Withdrawal by Subject|0|||
160813347|NCT00819156|580700172|FG001|Overall Study|Withdrawal by Subject|3|||
160813348|NCT00819156|580700173|FG002|Overall Study|Withdrawal by Subject|2|||
160813349|NCT00819156|580700174|FG003|Overall Study|Withdrawal by Subject|0|||
160813350|NCT00819156|580700175|FG004|Overall Study|Withdrawal by Subject|1|||
160813351|NCT00819156|580700176|FG005|Overall Study|Withdrawal by Subject|0|||
160813352|NCT00819156|580700171|FG000|Overall Study|Protocol Violation|1|||
160813353|NCT00819156|580700172|FG001|Overall Study|Protocol Violation|0|||
160813354|NCT00819156|580700173|FG002|Overall Study|Protocol Violation|1|||
160813355|NCT00819156|580700174|FG003|Overall Study|Protocol Violation|0|||
160813356|NCT00819156|580700175|FG004|Overall Study|Protocol Violation|0|||
160813357|NCT00819156|580700176|FG005|Overall Study|Protocol Violation|1|||
160813358|NCT00819156|580700171|FG000|Overall Study|Lost to Follow-up|0|||
160813359|NCT00819156|580700172|FG001|Overall Study|Lost to Follow-up|1|||
160813360|NCT00819156|580700173|FG002|Overall Study|Lost to Follow-up|0|||
160813361|NCT00819156|580700174|FG003|Overall Study|Lost to Follow-up|0|||
160813362|NCT00819156|580700175|FG004|Overall Study|Lost to Follow-up|0|||
160813363|NCT00819156|580700176|FG005|Overall Study|Lost to Follow-up|2|||
160813364|NCT00819156|580700171|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
160813365|NCT00819156|580700172|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
160813366|NCT00819156|580700173|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
160813367|NCT00819156|580700174|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
160813368|NCT00819156|580700175|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
160813369|NCT00819156|580700176|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
160813370|NCT00819156|580700171|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
160813371|NCT00819156|580700172|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813372|NCT00819156|580700173|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813373|NCT00819156|580700174|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813374|NCT00819156|580700175|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
160813375|NCT00819156|580700176|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
160813376|NCT00819156|580700171|FG000|Overall Study|Prostate-specific antigen progression|0|||
160813377|NCT00819156|580700172|FG001|Overall Study|Prostate-specific antigen progression|0|||
160813378|NCT00819156|580700173|FG002|Overall Study|Prostate-specific antigen progression|0|||
160813379|NCT00819156|580700174|FG003|Overall Study|Prostate-specific antigen progression|0|||
160813380|NCT00819156|580700175|FG004|Overall Study|Prostate-specific antigen progression|1|||
160813381|NCT00819156|580700176|FG005|Overall Study|Prostate-specific antigen progression|0|||
160813382|NCT00790582|580700177|FG000|Overall Study|Death|14|||
160813383|NCT00790582|580700178|FG001|Overall Study|Death|32|||
160813384|NCT00790582|580700177|FG000|Overall Study|Physician Decision|7|||
160813385|NCT00790582|580700178|FG001|Overall Study|Physician Decision|1|||
160813386|NCT00790582|580700177|FG000|Overall Study|Lost to Follow-up|3|||
160813387|NCT00790582|580700178|FG001|Overall Study|Lost to Follow-up|3|||
160813388|NCT00790582|580700177|FG000|Overall Study|Withdrawal by Subject|7|||
160813389|NCT00790582|580700178|FG001|Overall Study|Withdrawal by Subject|51|||
160813390|NCT00803595|580700179|FG000|Overall Study|Adverse Event|3|||
160813391|NCT00803595|580700180|FG001|Overall Study|Adverse Event|4|||
160813392|NCT00803595|580700181|FG002|Overall Study|Adverse Event|1|||
160813393|NCT00803595|580700179|FG000|Overall Study|Protocol Violation|7|||
160813394|NCT00803595|580700180|FG001|Overall Study|Protocol Violation|2|||
160813395|NCT00803595|580700181|FG002|Overall Study|Protocol Violation|12|||
160813396|NCT00803595|580700179|FG000|Overall Study|Withdrawal by Subject|5|||
160813397|NCT00803595|580700180|FG001|Overall Study|Withdrawal by Subject|2|||
160813398|NCT00803595|580700181|FG002|Overall Study|Withdrawal by Subject|3|||
160813399|NCT00556439|580700185|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
160813400|NCT00556439|580700186|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
160813401|NCT00556439|580700187|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
160813402|NCT00556439|580700188|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
160813403|NCT00556439|580700185|FG000|Study Entry to Week 12|Physician Decision|1|||
160813404|NCT00556439|580700186|FG001|Study Entry to Week 12|Physician Decision|0|||
160813405|NCT00556439|580700187|FG002|Study Entry to Week 12|Physician Decision|0|||
160813406|NCT00556439|580700188|FG003|Study Entry to Week 12|Physician Decision|0|||
160813407|NCT00556439|580700185|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
160813408|NCT00556439|580700186|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
160813409|NCT00556439|580700187|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
160813410|NCT00556439|580700188|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
160813411|NCT00556439|580700185|FG000|Study Entry to Week 12|Recurrent infection|1|||
160813412|NCT00556439|580700186|FG001|Study Entry to Week 12|Recurrent infection|0|||
160813413|NCT00556439|580700187|FG002|Study Entry to Week 12|Recurrent infection|0|||
160813414|NCT00556439|580700188|FG003|Study Entry to Week 12|Recurrent infection|0|||
160813415|NCT00556439|580700185|FG000|Study Entry to Week 12|Malignancy|0|||
160813416|NCT00556439|580700186|FG001|Study Entry to Week 12|Malignancy|0|||
160813417|NCT00556439|580700187|FG002|Study Entry to Week 12|Malignancy|1|||
160813418|NCT00556439|580700188|FG003|Study Entry to Week 12|Malignancy|0|||
160813419|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
160813420|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
160813421|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
160813422|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
160813423|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
160813424|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
160813425|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
160813426|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
160813427|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
160813428|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
160813429|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
160900122|NCT03452228|581028656|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
161131758|NCT01445678|581865388|FG000|Overall Study|Adverse Event|12|||
161131759|NCT01445678|581865389|FG001|Overall Study|Adverse Event|8|||
161131760|NCT01445678|581865388|FG000|Overall Study|Lack of Efficacy|0|||
160813430|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
160813431|NCT00556439|580700185|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
160813432|NCT00556439|580700186|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
160813433|NCT00556439|580700187|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
160813434|NCT00556439|580700188|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
160813435|NCT02100423|580700189|FG000|Overall Study|Death|1|||
160813436|NCT02100423|580700189|FG000|Overall Study|Withdrawal by Subject|3|||
161239525|NCT02414152|582258030|FG000|Overall Study|Lack of Efficacy|1|||
161239526|NCT01757392|582258031|FG000|Overall Study|Withdrawal by Subject|1|||
161239527|NCT01757392|582258031|FG000|Overall Study|Screen Fail|3|||
161239528|NCT00841698|582258038|FG000|First Intervention|Withdrawal by Subject|1|||
161239529|NCT00841698|582258039|FG001|First Intervention|Withdrawal by Subject|0|||
161239530|NCT04078022|582258044|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
161239531|NCT04078022|582258045|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
161239532|NCT01250912|582258046|FG000|Overall Study|Lost to Follow-up|1|||
161239533|NCT01929863|582258049|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
161239534|NCT01929863|582258050|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
161239535|NCT01929863|582258049|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
161239536|NCT01929863|582258050|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
161239537|NCT01929863|582258049|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
161239538|NCT01929863|582258050|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
161239539|NCT02152163|582258053|FG000|Overall Study|Physician Decision|12|||
161239540|NCT02152163|582258054|FG001|Overall Study|Physician Decision|13|||
161239541|NCT00730691|582258055|FG000|Overall Study|Adverse Event|4|||
161239542|NCT00730691|582258056|FG001|Overall Study|Adverse Event|8|||
161239543|NCT00730691|582258057|FG002|Overall Study|Adverse Event|11|||
161239544|NCT00730691|582258058|FG003|Overall Study|Adverse Event|11|||
161239545|NCT00730691|582258059|FG004|Overall Study|Adverse Event|23|||
161239546|NCT00730691|582258055|FG000|Overall Study|Lack of Efficacy|4|||
161239547|NCT00730691|582258056|FG001|Overall Study|Lack of Efficacy|4|||
161239548|NCT00730691|582258057|FG002|Overall Study|Lack of Efficacy|2|||
161239549|NCT00730691|582258058|FG003|Overall Study|Lack of Efficacy|1|||
161239550|NCT00730691|582258059|FG004|Overall Study|Lack of Efficacy|1|||
161239551|NCT00730691|582258055|FG000|Overall Study|Non-compliance with Study Drug|6|||
161239552|NCT00730691|582258056|FG001|Overall Study|Non-compliance with Study Drug|1|||
161239553|NCT00730691|582258057|FG002|Overall Study|Non-compliance with Study Drug|6|||
161239554|NCT00730691|582258058|FG003|Overall Study|Non-compliance with Study Drug|3|||
161239555|NCT00730691|582258059|FG004|Overall Study|Non-compliance with Study Drug|3|||
161239556|NCT00730691|582258055|FG000|Overall Study|Protocol Deviations|3|||
161239557|NCT00730691|582258056|FG001|Overall Study|Protocol Deviations|5|||
161239558|NCT00730691|582258057|FG002|Overall Study|Protocol Deviations|3|||
161239559|NCT00730691|582258058|FG003|Overall Study|Protocol Deviations|7|||
161239560|NCT00730691|582258059|FG004|Overall Study|Protocol Deviations|5|||
161239561|NCT00730691|582258055|FG000|Overall Study|Withdrawal of Consent|7|||
161239562|NCT00730691|582258056|FG001|Overall Study|Withdrawal of Consent|9|||
161239563|NCT00730691|582258057|FG002|Overall Study|Withdrawal of Consent|3|||
161239564|NCT00730691|582258058|FG003|Overall Study|Withdrawal of Consent|6|||
161239565|NCT00730691|582258059|FG004|Overall Study|Withdrawal of Consent|3|||
161239566|NCT00730691|582258055|FG000|Overall Study|Lost to Follow-up|11|||
161239567|NCT00730691|582258056|FG001|Overall Study|Lost to Follow-up|8|||
161239568|NCT00730691|582258057|FG002|Overall Study|Lost to Follow-up|13|||
161239569|NCT00730691|582258058|FG003|Overall Study|Lost to Follow-up|15|||
161239570|NCT00730691|582258059|FG004|Overall Study|Lost to Follow-up|13|||
161239571|NCT00730691|582258055|FG000|Overall Study|Other|1|||
161239572|NCT00730691|582258056|FG001|Overall Study|Other|1|||
161239573|NCT00730691|582258057|FG002|Overall Study|Other|1|||
161239574|NCT00730691|582258058|FG003|Overall Study|Other|2|||
161239575|NCT00730691|582258059|FG004|Overall Study|Other|2|||
161239576|NCT05710718|582260418|FG000|Overall Study|Withdrawal by Subject|5|||
161239577|NCT05710718|582260419|FG001|Overall Study|Withdrawal by Subject|1|||
161239578|NCT05710718|582260418|FG000|Overall Study|Lost to Follow-up|0|||
161239579|NCT05710718|582260419|FG001|Overall Study|Lost to Follow-up|1|||
161239580|NCT05710718|582260418|FG000|Overall Study|Death|0|||
161239581|NCT05710718|582260419|FG001|Overall Study|Death|1|||
161239582|NCT04372238|582260420|FG000|Overall Study|Duplicate|3|||
161239583|NCT04372238|582260421|FG001|Overall Study|Duplicate|3|||
161239584|NCT04372238|582260420|FG000|Overall Study|Did not consent for data linkage|6|||
161239585|NCT04372238|582260421|FG001|Overall Study|Did not consent for data linkage|10|||
161239586|NCT02591420|582260422|FG000|Overall Study|Lost to Follow-up|0|||
161239587|NCT02591420|582260423|FG001|Overall Study|Lost to Follow-up|1|||
161239588|NCT02591420|582260424|FG002|Overall Study|Lost to Follow-up|2|||
161239589|NCT04241458|582260425|FG000|Overall Study|Withdrawal by Subject|0|||
161239590|NCT04241458|582260426|FG001|Overall Study|Withdrawal by Subject|0|||
161333060|NCT01181167|582608609|FG000|Overall Study|Withdrawal by Subject|6|||
161239591|NCT04241458|582260427|FG002|Overall Study|Withdrawal by Subject|0|||
161239592|NCT04241458|582260428|FG003|Overall Study|Withdrawal by Subject|0|||
161239593|NCT04241458|582260429|FG004|Overall Study|Withdrawal by Subject|1|||
161239594|NCT05005442|582260430|FG000|Overall Study|Death|14|||
161239595|NCT05005442|582260431|FG001|Overall Study|Death|10|||
161239596|NCT05005442|582260432|FG002|Overall Study|Death|8|||
161239597|NCT05005442|582260433|FG003|Overall Study|Death|22|||
161239598|NCT05005442|582260434|FG004|Overall Study|Death|13|||
161239599|NCT05005442|582260435|FG005|Overall Study|Death|15|||
161239600|NCT05005442|582260430|FG000|Overall Study|Lost to Follow-up|0|||
161239601|NCT05005442|582260431|FG001|Overall Study|Lost to Follow-up|2|||
160813437|NCT02100423|580700189|FG000|Overall Study|Adverse Event|1|||
160813438|NCT02100423|580700189|FG000|Overall Study|Physician Decision|1|||
160813439|NCT00703846|580700190|FG000|Overall Study|Adverse Event|8|||
160813440|NCT00703846|580700190|FG000|Overall Study|Lost to Follow-up|55|||
160813441|NCT00703846|580700190|FG000|Overall Study|Lack of Efficacy|15|||
160813442|NCT00703846|580700190|FG000|Overall Study|Noncompliance with Study Treatment|2|||
160813443|NCT00703846|580700190|FG000|Overall Study|Withdrawal by Subject|40|||
160813444|NCT00703846|580700190|FG000|Overall Study|Death|1|||
160813445|NCT00703846|580700190|FG000|Overall Study|Other|14|||
160813446|NCT00703846|580700190|FG000|Overall Study|Did Not Receive Study Drug|2|||
160813447|NCT04601532|580700191|FG000|Overall Study|Lost to Follow-up|1|||
160813448|NCT04601532|580700192|FG001|Overall Study|Lost to Follow-up|2|||
160813449|NCT04601532|580700191|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
160813450|NCT04601532|580700192|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
160813451|NCT02195700|580700193|FG000|Overall Study|Protocol Violation|0|||
160813452|NCT02195700|580700194|FG001|Overall Study|Protocol Violation|2|||
160813453|NCT02195700|580700193|FG000|Overall Study|Noncompliance|1|||
160813454|NCT02195700|580700194|FG001|Overall Study|Noncompliance|0|||
160813455|NCT02195700|580700193|FG000|Overall Study|Adverse Event|1|||
160813456|NCT02195700|580700194|FG001|Overall Study|Adverse Event|2|||
161131761|NCT01445678|581865389|FG001|Overall Study|Lack of Efficacy|2|||
161131762|NCT01445678|581865388|FG000|Overall Study|Lost to Follow-up|8|||
161131763|NCT01445678|581865389|FG001|Overall Study|Lost to Follow-up|5|||
161131764|NCT01445678|581865388|FG000|Overall Study|Protocol Violation|1|||
161131765|NCT01445678|581865389|FG001|Overall Study|Protocol Violation|1|||
161131766|NCT01445678|581865388|FG000|Overall Study|Withdrawal by Subject|9|||
161131767|NCT01445678|581865389|FG001|Overall Study|Withdrawal by Subject|5|||
161131768|NCT01459614|581865392|FG000|Overall Study|Adverse Event|1|||
161131769|NCT01459614|581865393|FG001|Overall Study|Adverse Event|0|||
161131770|NCT01565980|581865394|FG000|Overall Study|Death|1|||
161131771|NCT01565980|581865395|FG001|Overall Study|Death|0|||
161131772|NCT01565980|581865394|FG000|Overall Study|Lost to Follow-up|1|||
161131773|NCT01565980|581865395|FG001|Overall Study|Lost to Follow-up|0|||
161131774|NCT01565980|581865394|FG000|Overall Study|health complications|1|||
161131775|NCT01565980|581865395|FG001|Overall Study|health complications|1|||
161131776|NCT01565980|581865394|FG000|Overall Study|stopped medical treatment|1|||
161131777|NCT01565980|581865395|FG001|Overall Study|stopped medical treatment|0|||
161131778|NCT01565980|581865394|FG000|Overall Study|Withdrawal by Subject|0|||
161131779|NCT01565980|581865395|FG001|Overall Study|Withdrawal by Subject|3|||
161131780|NCT02078219|581865398|FG000|Overall Study|Other|2|||
161131781|NCT02078219|581865399|FG001|Overall Study|Other|2|||
161131782|NCT02078219|581865400|FG002|Overall Study|Other|3|||
161131783|NCT02078219|581865401|FG003|Overall Study|Other|0|||
161131784|NCT02078219|581865402|FG004|Overall Study|Other|1|||
161131785|NCT02078219|581865398|FG000|Overall Study|Withdrawal by Subject|0|||
161131786|NCT02078219|581865399|FG001|Overall Study|Withdrawal by Subject|1|||
161131787|NCT02078219|581865400|FG002|Overall Study|Withdrawal by Subject|0|||
161131788|NCT02078219|581865401|FG003|Overall Study|Withdrawal by Subject|1|||
161131789|NCT02078219|581865402|FG004|Overall Study|Withdrawal by Subject|1|||
161131790|NCT02078219|581865398|FG000|Overall Study|Protocol Violation|0|||
161131791|NCT02078219|581865399|FG001|Overall Study|Protocol Violation|0|||
161131792|NCT02078219|581865400|FG002|Overall Study|Protocol Violation|0|||
161131793|NCT02078219|581865401|FG003|Overall Study|Protocol Violation|1|||
161131794|NCT02078219|581865402|FG004|Overall Study|Protocol Violation|0|||
161131795|NCT02078219|581865398|FG000|Overall Study|Death|0|||
161131796|NCT02078219|581865399|FG001|Overall Study|Death|0|||
161131797|NCT02078219|581865400|FG002|Overall Study|Death|0|||
161131798|NCT02078219|581865401|FG003|Overall Study|Death|1|||
161131799|NCT02078219|581865402|FG004|Overall Study|Death|0|||
161131800|NCT02078219|581865398|FG000|Overall Study|Adverse Event|1|||
161131801|NCT02078219|581865399|FG001|Overall Study|Adverse Event|1|||
161131802|NCT02078219|581865400|FG002|Overall Study|Adverse Event|3|||
161131803|NCT02078219|581865401|FG003|Overall Study|Adverse Event|1|||
161131804|NCT02078219|581865402|FG004|Overall Study|Adverse Event|0|||
161131805|NCT00891202|581865403|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
161131806|NCT00891202|581865404|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161131807|NCT00891202|581865405|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161131808|NCT00891202|581865406|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
161131809|NCT00891202|581865403|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161131810|NCT00891202|581865404|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161131811|NCT00891202|581865405|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
160813457|NCT02195700|580700193|FG000|Overall Study|Withdrawal by Subject|3|||
160813458|NCT02195700|580700194|FG001|Overall Study|Withdrawal by Subject|2|||
160813459|NCT02195700|580700193|FG000|Overall Study|Lost to Follow-up|1|||
160813460|NCT02195700|580700194|FG001|Overall Study|Lost to Follow-up|1|||
161131812|NCT00891202|581865406|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
161131813|NCT00891202|581865403|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161131814|NCT00891202|581865404|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
160813461|NCT01352221|580700195|FG000|Double-blind Phase|Adverse Event|6|||
160813462|NCT01352221|580700196|FG001|Double-blind Phase|Adverse Event|4|||
160813463|NCT01352221|580700197|FG002|Double-blind Phase|Adverse Event|0|||
160813464|NCT01352221|580700198|FG003|Double-blind Phase|Adverse Event|0|||
160813465|NCT01352221|580700195|FG000|Double-blind Phase|Withdrawal by Subject|3|||
160813466|NCT01352221|580700196|FG001|Double-blind Phase|Withdrawal by Subject|5|||
160813467|NCT01352221|580700197|FG002|Double-blind Phase|Withdrawal by Subject|0|||
160813468|NCT01352221|580700198|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160813469|NCT01352221|580700195|FG000|Double-blind Phase|Lost to Follow-up|0|||
160813470|NCT01352221|580700196|FG001|Double-blind Phase|Lost to Follow-up|1|||
160813471|NCT01352221|580700197|FG002|Double-blind Phase|Lost to Follow-up|0|||
160813472|NCT01352221|580700198|FG003|Double-blind Phase|Lost to Follow-up|0|||
160813473|NCT01352221|580700195|FG000|Double-blind Phase|Protocol Violation|0|||
160813474|NCT01352221|580700196|FG001|Double-blind Phase|Protocol Violation|1|||
160813475|NCT01352221|580700197|FG002|Double-blind Phase|Protocol Violation|0|||
160813476|NCT01352221|580700198|FG003|Double-blind Phase|Protocol Violation|0|||
160813477|NCT01352221|580700195|FG000|Open-label Phase|Physician Decision|0|||
160813478|NCT01352221|580700196|FG001|Open-label Phase|Physician Decision|0|||
160813479|NCT01352221|580700197|FG002|Open-label Phase|Physician Decision|2|||
160813480|NCT01352221|580700198|FG003|Open-label Phase|Physician Decision|1|||
160813481|NCT01352221|580700195|FG000|Open-label Phase|Pregnancy|0|||
160813482|NCT01352221|580700196|FG001|Open-label Phase|Pregnancy|0|||
160813483|NCT01352221|580700197|FG002|Open-label Phase|Pregnancy|1|||
160813484|NCT01352221|580700198|FG003|Open-label Phase|Pregnancy|0|||
160813485|NCT01352221|580700195|FG000|Open-label Phase|Adverse Event|0|||
160813486|NCT01352221|580700196|FG001|Open-label Phase|Adverse Event|0|||
160813487|NCT01352221|580700197|FG002|Open-label Phase|Adverse Event|8|||
160813488|NCT01352221|580700198|FG003|Open-label Phase|Adverse Event|4|||
160813489|NCT01352221|580700195|FG000|Open-label Phase|Withdrawal by Subject|0|||
160813490|NCT01352221|580700196|FG001|Open-label Phase|Withdrawal by Subject|0|||
160813491|NCT01352221|580700197|FG002|Open-label Phase|Withdrawal by Subject|1|||
160813492|NCT01352221|580700198|FG003|Open-label Phase|Withdrawal by Subject|6|||
160813493|NCT01352221|580700195|FG000|Open-label Phase|Worsening of IBD|0|||
160813494|NCT01352221|580700196|FG001|Open-label Phase|Worsening of IBD|0|||
160813495|NCT01352221|580700197|FG002|Open-label Phase|Worsening of IBD|1|||
160813496|NCT01352221|580700198|FG003|Open-label Phase|Worsening of IBD|0|||
160813497|NCT02566785|580700199|FG000|Overall Study|Lost to Follow-up|0|||
160813498|NCT02566785|580700200|FG001|Overall Study|Lost to Follow-up|2|||
160813499|NCT02566785|580700199|FG000|Overall Study|Worsening condition|1|||
160813500|NCT02566785|580700200|FG001|Overall Study|Worsening condition|1|||
160813501|NCT01597908|580700201|FG000|Randomized Phase|Death|217|||
160813502|NCT01597908|580700202|FG001|Randomized Phase|Death|238|||
160813503|NCT01597908|580700203|FG002|Randomized Phase|Death|0|||
160813504|NCT01597908|580700201|FG000|Randomized Phase|Sponsor Decision|93|||
160813505|NCT01597908|580700202|FG001|Randomized Phase|Sponsor Decision|39|||
160813506|NCT01597908|580700203|FG002|Randomized Phase|Sponsor Decision|0|||
160813507|NCT01597908|580700201|FG000|Randomized Phase|Lost to Follow-up|9|||
160813508|NCT01597908|580700202|FG001|Randomized Phase|Lost to Follow-up|16|||
160813509|NCT01597908|580700203|FG002|Randomized Phase|Lost to Follow-up|0|||
160813510|NCT01597908|580700201|FG000|Randomized Phase|Physician Decision|6|||
160813511|NCT01597908|580700202|FG001|Randomized Phase|Physician Decision|3|||
160813512|NCT01597908|580700203|FG002|Randomized Phase|Physician Decision|0|||
160813513|NCT01597908|580700201|FG000|Randomized Phase|Withdrawal by Subject|26|||
160813514|NCT01597908|580700202|FG001|Randomized Phase|Withdrawal by Subject|22|||
160813515|NCT01597908|580700203|FG002|Randomized Phase|Withdrawal by Subject|0|||
160813516|NCT01597908|580700201|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
160813517|NCT01597908|580700202|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
160813518|NCT01597908|580700203|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
160813519|NCT01597908|580700201|FG000|Crossover Phase|Death|0|||
160813520|NCT01597908|580700202|FG001|Crossover Phase|Death|0|||
160813521|NCT01597908|580700203|FG002|Crossover Phase|Death|11|||
161239602|NCT05005442|582260432|FG002|Overall Study|Lost to Follow-up|0|||
160813522|NCT01597908|580700201|FG000|Crossover Phase|Withdrawal by Subject|0|||
160813523|NCT01597908|580700202|FG001|Crossover Phase|Withdrawal by Subject|0|||
160813524|NCT01597908|580700203|FG002|Crossover Phase|Withdrawal by Subject|3|||
160813525|NCT01597908|580700201|FG000|Crossover Phase|Sponsor Decision|0|||
160813526|NCT01597908|580700202|FG001|Crossover Phase|Sponsor Decision|0|||
160813527|NCT01597908|580700203|FG002|Crossover Phase|Sponsor Decision|20|||
160813528|NCT02547038|580701760|FG000|Overall Study|Lost to Follow-up|3|||
160813529|NCT02547038|580701761|FG001|Overall Study|Lost to Follow-up|2|||
160813530|NCT01340625|580701764|FG000|First Intervention|Adverse Event|1|||
160813531|NCT01340625|580701765|FG001|First Intervention|Adverse Event|0|||
160813532|NCT01340625|580701764|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
160813533|NCT01340625|580701765|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
160813534|NCT05160415|580701766|FG000|Overall Study|Withdrawal by Subject|3|||
160813535|NCT00623233|580701767|FG000|Overall Study|Adverse Event|10|||
160813536|NCT00623233|580701767|FG000|Overall Study|Physician Decision|10|||
160813537|NCT00623233|580701767|FG000|Overall Study|Lost to Follow-up|1|||
160813538|NCT00623233|580701767|FG000|Overall Study|Withdrawal by Subject|3|||
160813539|NCT00459875|580701768|FG000|Overall Study|Ineligible participant|1|||
160813540|NCT00459875|580701768|FG000|Overall Study|Adverse Event|2|||
160813541|NCT00576628|580701771|FG000|Overall Study|Adverse Event|11|||
160813542|NCT00576628|580701771|FG000|Overall Study|Death|2|||
160813543|NCT00576628|580701771|FG000|Overall Study|Failure to return|1|||
160813544|NCT00576628|580701771|FG000|Overall Study|Refused Treatment|8|||
160813545|NCT00576628|580701771|FG000|Overall Study|Pregnancy|1|||
160813546|NCT00576628|580701771|FG000|Overall Study|RBC transfusion|1|||
160813547|NCT00576628|580701771|FG000|Overall Study|Progression of Kidney Disease|1|||
160813548|NCT00576628|580701771|FG000|Overall Study|Progression of Renal Failure|1|||
160813549|NCT00576628|580701771|FG000|Overall Study|The patient move into other town|1|||
160813550|NCT00576628|580701771|FG000|Overall Study|Transplantation|1|||
160813551|NCT00576628|580701771|FG000|Overall Study|Dialysis|15|||
160813552|NCT03206970|580701772|FG000|Overall Study|Death|21|||
160813553|NCT03206970|580701772|FG000|Overall Study|Withdrawal by Subject|13|||
160813554|NCT03206970|580701772|FG000|Overall Study|Lost to Follow-up|3|||
160813555|NCT03206970|580701772|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
160813556|NCT03654040|580701779|FG000|Overall Study|Death|1|||
160813557|NCT03654040|580701780|FG001|Overall Study|Death|0|||
160813558|NCT03654040|580701779|FG000|Overall Study|Withdrawal by Subject|1|||
160813559|NCT03654040|580701780|FG001|Overall Study|Withdrawal by Subject|0|||
160813560|NCT03654040|580701779|FG000|Overall Study|Study terminated by sponsor|8|||
160813561|NCT03654040|580701780|FG001|Overall Study|Study terminated by sponsor|2|||
160813562|NCT03654040|580701779|FG000|Overall Study|Failure to initiate study therapy|2|||
160813563|NCT03654040|580701780|FG001|Overall Study|Failure to initiate study therapy|0|||
160813564|NCT03654040|580701779|FG000|Overall Study|Transplanted at another center|2|||
160813565|NCT03654040|580701780|FG001|Overall Study|Transplanted at another center|0|||
160813566|NCT03654040|580701779|FG000|Overall Study|Failure to meet eligibility criteria|14|||
160813567|NCT03654040|580701780|FG001|Overall Study|Failure to meet eligibility criteria|2|||
160813568|NCT03654040|580701779|FG000|Overall Study|No longer transplant candidate|1|||
160813569|NCT03654040|580701780|FG001|Overall Study|No longer transplant candidate|0|||
160813570|NCT03654040|580701779|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
160813571|NCT03654040|580701780|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
160813572|NCT03654040|580701779|FG000|Overall Study|Recipient ineligible|0|||
160813573|NCT03654040|580701780|FG001|Overall Study|Recipient ineligible|2|||
160813574|NCT03654040|580701779|FG000|Overall Study|Received deceased liver|0|||
160813575|NCT03654040|580701780|FG001|Overall Study|Received deceased liver|1|||
160813576|NCT01951586|580701785|FG000|Overall Study|Death|61|||
160813577|NCT01951586|580701786|FG001|Overall Study|Death|120|||
160813578|NCT01951586|580701785|FG000|Overall Study|Withdrawal by Subject|8|||
160813579|NCT01951586|580701786|FG001|Overall Study|Withdrawal by Subject|17|||
160813580|NCT01951586|580701785|FG000|Overall Study|Lost to Follow-up|0|||
160813581|NCT01951586|580701786|FG001|Overall Study|Lost to Follow-up|1|||
160813582|NCT01951586|580701785|FG000|Overall Study|Sponsor Decision|9|||
160813583|NCT01951586|580701786|FG001|Overall Study|Sponsor Decision|10|||
160813584|NCT05332392|580701787|FG000|Overall Study|Did not meet inclusion criteria|25|||
160813585|NCT05332392|580701787|FG000|Overall Study|Principal Investigator's decision|17|||
160813586|NCT05332392|580701787|FG000|Overall Study|Adverse Event|1|||
160813587|NCT05332392|580701787|FG000|Overall Study|Subject's decision|1|||
160813588|NCT00224120|580701788|FG000|Overall Study|Adverse Event|10|||
160813589|NCT00224120|580701789|FG001|Overall Study|Adverse Event|4|||
160813590|NCT00224120|580701788|FG000|Overall Study|Protocol Violation|1|||
160813591|NCT00224120|580701789|FG001|Overall Study|Protocol Violation|0|||
160813592|NCT00224120|580701788|FG000|Overall Study|Withdrawal by Subject|5|||
161131815|NCT00891202|581865405|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
161131816|NCT00891202|581865406|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
161131817|NCT00891202|581865403|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
161131818|NCT00891202|581865404|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
161131819|NCT00891202|581865405|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
161131820|NCT00891202|581865406|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
161131821|NCT04439279|581867232|FG000|Overall Study|Adverse Event|7|||
161131822|NCT04439279|581867232|FG000|Overall Study|Death|4|||
161131823|NCT04439279|581867232|FG000|Overall Study|Disease progression|17|||
161131824|NCT04439279|581867232|FG000|Overall Study|Complicating disease|3|||
160813593|NCT00224120|580701789|FG001|Overall Study|Withdrawal by Subject|10|||
160813594|NCT00224120|580701788|FG000|Overall Study|Lack of Efficacy|0|||
160813595|NCT00224120|580701789|FG001|Overall Study|Lack of Efficacy|2|||
160813596|NCT00224120|580701788|FG000|Overall Study|Lost to Follow-up|2|||
160813597|NCT00224120|580701789|FG001|Overall Study|Lost to Follow-up|3|||
160813598|NCT00224120|580701788|FG000|Overall Study|Other|4|||
160813599|NCT00224120|580701789|FG001|Overall Study|Other|5|||
161131825|NCT04439279|581867232|FG000|Overall Study|Withdrawal by Subject|2|||
161131826|NCT04439279|581867232|FG000|Overall Study|Ineligible|1|||
161131827|NCT04439279|581867232|FG000|Overall Study|Treatment still ongoing|1|||
160813600|NCT00104416|580701792|FG000|Double-Blind Phase|Adverse Event|2|||
160813601|NCT00104416|580701793|FG001|Double-Blind Phase|Adverse Event|1|||
160813602|NCT00104416|580701794|FG002|Double-Blind Phase|Adverse Event|0|||
160813603|NCT00104416|580701795|FG003|Double-Blind Phase|Adverse Event|0|||
160813604|NCT00104416|580701796|FG004|Double-Blind Phase|Adverse Event|0|||
160813605|NCT00104416|580701792|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160813606|NCT00104416|580701793|FG001|Double-Blind Phase|Lost to Follow-up|1|||
160813607|NCT00104416|580701794|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160813608|NCT00104416|580701795|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160813609|NCT00104416|580701796|FG004|Double-Blind Phase|Lost to Follow-up|0|||
160813610|NCT00104416|580701792|FG000|Double-Blind Phase|Protocol Violation|0|||
160813611|NCT00104416|580701793|FG001|Double-Blind Phase|Protocol Violation|1|||
160813612|NCT00104416|580701794|FG002|Double-Blind Phase|Protocol Violation|0|||
160813613|NCT00104416|580701795|FG003|Double-Blind Phase|Protocol Violation|0|||
160813614|NCT00104416|580701796|FG004|Double-Blind Phase|Protocol Violation|0|||
160813615|NCT00104416|580701792|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
160813616|NCT00104416|580701793|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
160813617|NCT00104416|580701794|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160813618|NCT00104416|580701795|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160813619|NCT00104416|580701796|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160813620|NCT00104416|580701792|FG000|Double-Blind Phase|Pregnancy|1|||
160813621|NCT00104416|580701793|FG001|Double-Blind Phase|Pregnancy|0|||
160813622|NCT00104416|580701794|FG002|Double-Blind Phase|Pregnancy|0|||
160813623|NCT00104416|580701795|FG003|Double-Blind Phase|Pregnancy|0|||
160813624|NCT00104416|580701796|FG004|Double-Blind Phase|Pregnancy|0|||
160813625|NCT00104416|580701792|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
160813626|NCT00104416|580701793|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
160813627|NCT00104416|580701794|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
160813628|NCT00104416|580701795|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
160813629|NCT00104416|580701796|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
160813630|NCT00104416|580701792|FG000|Continuation Phase|Adverse Event|0|||
160813631|NCT00104416|580701793|FG001|Continuation Phase|Adverse Event|0|||
160813632|NCT00104416|580701794|FG002|Continuation Phase|Adverse Event|2|||
160813633|NCT00104416|580701795|FG003|Continuation Phase|Adverse Event|0|||
160813634|NCT00104416|580701796|FG004|Continuation Phase|Adverse Event|2|||
160813635|NCT00104416|580701792|FG000|Continuation Phase|Lost to Follow-up|0|||
160813636|NCT00104416|580701793|FG001|Continuation Phase|Lost to Follow-up|0|||
160813637|NCT00104416|580701794|FG002|Continuation Phase|Lost to Follow-up|1|||
160813638|NCT00104416|580701795|FG003|Continuation Phase|Lost to Follow-up|0|||
160813639|NCT00104416|580701796|FG004|Continuation Phase|Lost to Follow-up|1|||
160813640|NCT00104416|580701792|FG000|Continuation Phase|Withdrawal by Subject|0|||
160813641|NCT00104416|580701793|FG001|Continuation Phase|Withdrawal by Subject|0|||
160813642|NCT00104416|580701794|FG002|Continuation Phase|Withdrawal by Subject|2|||
160813643|NCT00104416|580701795|FG003|Continuation Phase|Withdrawal by Subject|1|||
160813644|NCT00104416|580701796|FG004|Continuation Phase|Withdrawal by Subject|1|||
160813645|NCT00104416|580701792|FG000|Continuation Phase|Pregnancy|0|||
160813646|NCT00104416|580701793|FG001|Continuation Phase|Pregnancy|0|||
160813647|NCT00104416|580701794|FG002|Continuation Phase|Pregnancy|1|||
160813648|NCT00104416|580701795|FG003|Continuation Phase|Pregnancy|1|||
160813649|NCT00104416|580701796|FG004|Continuation Phase|Pregnancy|0|||
160813650|NCT00104416|580701792|FG000|Continuation Phase|Non-compliance|0|||
160813651|NCT00104416|580701793|FG001|Continuation Phase|Non-compliance|0|||
160813652|NCT00104416|580701794|FG002|Continuation Phase|Non-compliance|0|||
160813653|NCT00104416|580701795|FG003|Continuation Phase|Non-compliance|0|||
160813654|NCT00104416|580701796|FG004|Continuation Phase|Non-compliance|1|||
160813655|NCT00438360|580701797|FG000|Overall Study|Adverse Event|6|||
160813656|NCT00438360|580701798|FG001|Overall Study|Adverse Event|1|||
160813657|NCT00438360|580701797|FG000|Overall Study|Lack of Efficacy|42|||
160813658|NCT00438360|580701798|FG001|Overall Study|Lack of Efficacy|27|||
160813659|NCT00438360|580701797|FG000|Overall Study|Other|24|||
160813660|NCT00438360|580701798|FG001|Overall Study|Other|15|||
160813661|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813662|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
161131828|NCT02689492|581867233|FG000|Overall Study|Lost to Follow-up|61|||
161131829|NCT02689492|581867233|FG000|Overall Study|Withdrawal by Subject|11|||
160813663|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813664|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
160813665|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813666|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
160813667|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813668|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813669|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
160813670|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
160813671|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161131830|NCT02689492|581867233|FG000|Overall Study|Death|9|||
160813672|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
161131831|NCT02689492|581867233|FG000|Overall Study|Physician Decision|2|||
160813673|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813674|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
160813675|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813676|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813677|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813678|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
160813679|NCT03629223|580701799|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813680|NCT03629223|580701800|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
160813681|NCT03629223|580701801|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813682|NCT03629223|580701802|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813683|NCT03629223|580701803|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813684|NCT03629223|580701804|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
160813685|NCT03629223|580701799|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
160813686|NCT03629223|580701800|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813687|NCT03629223|580701801|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813688|NCT03629223|580701802|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813689|NCT03629223|580701803|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813690|NCT03629223|580701804|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
160813691|NCT01534351|580701805|FG000|Overall Study|Study Terminated Early|1|||
160813692|NCT01534351|580701806|FG001|Overall Study|Study Terminated Early|0|||
160813693|NCT01534351|580701807|FG002|Overall Study|Study Terminated Early|0|||
160813694|NCT02702609|580701808|FG000|Overall Study|Lost to Follow-up|8|||
160813695|NCT02702609|580701809|FG001|Overall Study|Lost to Follow-up|4|||
160813696|NCT02702609|580701808|FG000|Overall Study|Physician Decision|1|||
160813697|NCT02702609|580701809|FG001|Overall Study|Physician Decision|0|||
160813698|NCT02674464|580701810|FG000|Overall Study|Death|10|||
160813699|NCT02674464|580701811|FG001|Overall Study|Death|21|||
160813700|NCT02674464|580701810|FG000|Overall Study|Withdrawal by Subject|24|||
160813701|NCT02674464|580701811|FG001|Overall Study|Withdrawal by Subject|44|||
160813702|NCT02674464|580701810|FG000|Overall Study|Lost to Follow-up|97|||
160813703|NCT02674464|580701811|FG001|Overall Study|Lost to Follow-up|92|||
160813704|NCT02674464|580701810|FG000|Overall Study|Outside survey window|6|||
160813705|NCT02674464|580701811|FG001|Overall Study|Outside survey window|3|||
160813706|NCT04153981|580701812|FG000|Overall Study|Death|1|||
160813707|NCT04153981|580701812|FG000|Overall Study|Withdrawal by Subject|24|||
160813708|NCT04153981|580701812|FG000|Overall Study|Lost to Follow-up|1|||
160813709|NCT04153981|580701812|FG000|Overall Study|Physician Decision|1|||
161131832|NCT02689492|581867233|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
161131833|NCT02689492|581867233|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
161131834|NCT02689492|581867233|FG000|Overall Study|Other than listed|1|||
161131835|NCT01750918|581867234|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
161131836|NCT01750918|581867235|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
161131837|NCT01750918|581867236|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
161131838|NCT01750918|581867237|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
161131839|NCT01750918|581867238|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
161131840|NCT01750918|581867239|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
161131841|NCT01750918|581867240|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
161131842|NCT01750918|581867241|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
161131843|NCT01750918|581867234|FG000|Overall Study|Lost to Follow-up|0|||
161131844|NCT01750918|581867235|FG001|Overall Study|Lost to Follow-up|0|||
161131845|NCT01750918|581867236|FG002|Overall Study|Lost to Follow-up|2|||
161131846|NCT01750918|581867237|FG003|Overall Study|Lost to Follow-up|2|||
161131847|NCT01750918|581867238|FG004|Overall Study|Lost to Follow-up|0|||
161131848|NCT01750918|581867239|FG005|Overall Study|Lost to Follow-up|0|||
161131849|NCT01750918|581867240|FG006|Overall Study|Lost to Follow-up|0|||
161131850|NCT01750918|581867241|FG007|Overall Study|Lost to Follow-up|1|||
161131851|NCT01750918|581867234|FG000|Overall Study|Withdrawal by Subject|0|||
161131852|NCT01750918|581867235|FG001|Overall Study|Withdrawal by Subject|0|||
161131853|NCT01750918|581867236|FG002|Overall Study|Withdrawal by Subject|1|||
161131854|NCT01750918|581867237|FG003|Overall Study|Withdrawal by Subject|2|||
161131855|NCT01750918|581867238|FG004|Overall Study|Withdrawal by Subject|1|||
161131856|NCT01750918|581867239|FG005|Overall Study|Withdrawal by Subject|1|||
161131857|NCT01750918|581867240|FG006|Overall Study|Withdrawal by Subject|2|||
161131858|NCT01750918|581867241|FG007|Overall Study|Withdrawal by Subject|2|||
161131859|NCT02031679|581867244|FG000|Overall Study|Protocol Violation|0|||
161131860|NCT02031679|581867245|FG001|Overall Study|Protocol Violation|1|||
161131861|NCT02031679|581867244|FG000|Overall Study|Lack of Efficacy|0|||
161131862|NCT02031679|581867245|FG001|Overall Study|Lack of Efficacy|1|||
161131863|NCT02338843|581867249|FG000|Overall Study|Adverse Event|2|||
161131864|NCT02338843|581867250|FG001|Overall Study|Adverse Event|1|||
161131865|NCT02338843|581867249|FG000|Overall Study|Death|40|||
161333061|NCT01181167|582608610|FG001|Overall Study|Withdrawal by Subject|8|||
161333062|NCT01573000|582608611|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
160813710|NCT04153981|580701812|FG000|Overall Study|Due to Unavailable Glucometer|1|||
160813711|NCT04153981|580701812|FG000|Overall Study|Covid 19|52|||
160813712|NCT04153981|580701812|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
160813713|NCT04153981|580701812|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
160813714|NCT01262638|580701813|FG000|Overall Study|Adverse Event|3|||
160813715|NCT01262638|580701814|FG001|Overall Study|Adverse Event|4|||
160813716|NCT01262638|580701815|FG002|Overall Study|Adverse Event|3|||
160813717|NCT01262638|580701816|FG003|Overall Study|Adverse Event|4|||
160813718|NCT01262638|580701813|FG000|Overall Study|Protocol Violation|1|||
160813719|NCT01262638|580701814|FG001|Overall Study|Protocol Violation|0|||
160813720|NCT01262638|580701815|FG002|Overall Study|Protocol Violation|0|||
160813721|NCT01262638|580701816|FG003|Overall Study|Protocol Violation|1|||
160813722|NCT01262638|580701813|FG000|Overall Study|Withdrawal by Subject|2|||
160813723|NCT01262638|580701814|FG001|Overall Study|Withdrawal by Subject|1|||
160813724|NCT01262638|580701815|FG002|Overall Study|Withdrawal by Subject|0|||
160813725|NCT01262638|580701816|FG003|Overall Study|Withdrawal by Subject|1|||
160813726|NCT01262638|580701813|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160813727|NCT01262638|580701814|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160813728|NCT01262638|580701815|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
160813729|NCT01262638|580701816|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160813730|NCT01262638|580701813|FG000|Overall Study|Lost to Follow-up|1|||
160813731|NCT01262638|580701814|FG001|Overall Study|Lost to Follow-up|1|||
160813732|NCT01262638|580701815|FG002|Overall Study|Lost to Follow-up|1|||
160813733|NCT01262638|580701816|FG003|Overall Study|Lost to Follow-up|1|||
160813734|NCT01262638|580701813|FG000|Overall Study|Participant Went Out of Town|0|||
160813735|NCT01262638|580701814|FG001|Overall Study|Participant Went Out of Town|0|||
160813736|NCT01262638|580701815|FG002|Overall Study|Participant Went Out of Town|1|||
160813737|NCT01262638|580701816|FG003|Overall Study|Participant Went Out of Town|0|||
160813738|NCT01369199|580701819|FG000|Overall Study|Withdrawal by Subject|1|||
160813739|NCT01369199|580701819|FG000|Overall Study|Lost to Follow-up|2|||
160813740|NCT01071252|580701820|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
160813741|NCT01071252|580701821|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
160813742|NCT01071252|580701822|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
160813743|NCT01071252|580701823|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
160813744|NCT01071252|580701824|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
160813745|NCT01071252|580701820|FG000|Overall Study|Withdrawal by Subject|8|||
160813746|NCT01071252|580701821|FG001|Overall Study|Withdrawal by Subject|2|||
160813747|NCT01071252|580701822|FG002|Overall Study|Withdrawal by Subject|1|||
160813748|NCT01071252|580701823|FG003|Overall Study|Withdrawal by Subject|2|||
160813749|NCT01071252|580701824|FG004|Overall Study|Withdrawal by Subject|3|||
160813750|NCT01071252|580701820|FG000|Overall Study|administrative problems|1|||
161131866|NCT02338843|581867250|FG001|Overall Study|Death|53|||
161131867|NCT02338843|581867249|FG000|Overall Study|Physician Decision|1|||
161239603|NCT05005442|582260433|FG003|Overall Study|Lost to Follow-up|0|||
161239604|NCT05005442|582260434|FG004|Overall Study|Lost to Follow-up|1|||
161239605|NCT05005442|582260435|FG005|Overall Study|Lost to Follow-up|0|||
161239606|NCT05005442|582260430|FG000|Overall Study|Physician Decision|0|||
161239607|NCT05005442|582260431|FG001|Overall Study|Physician Decision|0|||
160813751|NCT01071252|580701821|FG001|Overall Study|administrative problems|1|||
161131868|NCT02338843|581867250|FG001|Overall Study|Physician Decision|0|||
161131869|NCT02338843|581867249|FG000|Overall Study|Withdrawal by Subject|0|||
161131870|NCT02338843|581867250|FG001|Overall Study|Withdrawal by Subject|2|||
161131871|NCT02338843|581867249|FG000|Overall Study|Subject Recovered|0|||
161131872|NCT02338843|581867250|FG001|Overall Study|Subject Recovered|2|||
161131873|NCT02338843|581867249|FG000|Overall Study|Discontinued prior to randomizat|1|||
161131874|NCT02338843|581867250|FG001|Overall Study|Discontinued prior to randomizat|0|||
161131875|NCT00110305|581867251|FG000|Overall Study|Adverse Event|46|||
161131876|NCT00110305|581867252|FG001|Overall Study|Adverse Event|13|||
161131877|NCT00110305|581867251|FG000|Overall Study|Sponsors Decision|1|||
161131878|NCT00110305|581867252|FG001|Overall Study|Sponsors Decision|0|||
161131879|NCT00110305|581867251|FG000|Overall Study|Subject Non-Compliant|9|||
160813752|NCT01071252|580701822|FG002|Overall Study|administrative problems|0|||
160813753|NCT01071252|580701823|FG003|Overall Study|administrative problems|2|||
160813754|NCT01071252|580701824|FG004|Overall Study|administrative problems|1|||
160813755|NCT01071252|580701820|FG000|Overall Study|Lost to Follow-up|1|||
160813756|NCT01071252|580701821|FG001|Overall Study|Lost to Follow-up|0|||
160813757|NCT01071252|580701822|FG002|Overall Study|Lost to Follow-up|1|||
161131880|NCT00110305|581867252|FG001|Overall Study|Subject Non-Compliant|2|||
161131881|NCT00110305|581867251|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161239608|NCT05005442|582260432|FG002|Overall Study|Physician Decision|1|||
160813758|NCT01071252|580701823|FG003|Overall Study|Lost to Follow-up|2|||
160813759|NCT01071252|580701824|FG004|Overall Study|Lost to Follow-up|0|||
160813760|NCT01071252|580701820|FG000|Overall Study|Adverse Event|1|||
160813761|NCT01071252|580701821|FG001|Overall Study|Adverse Event|1|||
160813762|NCT01071252|580701822|FG002|Overall Study|Adverse Event|0|||
160813763|NCT01071252|580701823|FG003|Overall Study|Adverse Event|1|||
161131882|NCT00110305|581867252|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
161131883|NCT00110305|581867251|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
161131884|NCT00110305|581867252|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
161131885|NCT00110305|581867251|FG000|Overall Study|Protocol Violation|0|||
161131886|NCT00110305|581867252|FG001|Overall Study|Protocol Violation|1|||
161131887|NCT00110305|581867251|FG000|Overall Study|Withdrawal by Subject|7|||
161131888|NCT00110305|581867252|FG001|Overall Study|Withdrawal by Subject|7|||
161131889|NCT00110305|581867251|FG000|Overall Study|Lost to Follow-up|20|||
161131890|NCT00110305|581867252|FG001|Overall Study|Lost to Follow-up|3|||
161131891|NCT00110305|581867251|FG000|Overall Study|Other|8|||
161131892|NCT00110305|581867252|FG001|Overall Study|Other|2|||
161131893|NCT00224016|581867256|FG000|Titration Period|Withdrawal by Subject|0|||
161131894|NCT00224016|581867257|FG001|Titration Period|Withdrawal by Subject|1|||
161131895|NCT00224016|581867256|FG000|Titration Period|Lost to Follow-up|1|||
161131896|NCT00224016|581867257|FG001|Titration Period|Lost to Follow-up|0|||
161131897|NCT00224016|581867256|FG000|Maintenance Period|Withdrawal by Subject|2|||
161131898|NCT00224016|581867257|FG001|Maintenance Period|Withdrawal by Subject|0|||
161131899|NCT00224016|581867256|FG000|Maintenance Period|Lost to Follow-up|0|||
161131900|NCT00224016|581867257|FG001|Maintenance Period|Lost to Follow-up|1|||
161131901|NCT01609933|581867258|FG000|Overall Study|Adverse Event|1|||
161131902|NCT01609933|581867258|FG000|Overall Study|Withdrawal by Subject|3|||
161131903|NCT01252966|581867259|FG000|Overall Study|Lost to Follow-up|16|||
161131904|NCT01252966|581867260|FG001|Overall Study|Lost to Follow-up|10|||
161131905|NCT01252966|581867259|FG000|Overall Study|Withdrawal by Subject|7|||
161131906|NCT01252966|581867260|FG001|Overall Study|Withdrawal by Subject|3|||
161131907|NCT00522392|581867284|FG000|Overall Study|Disease progression|0|||
161131908|NCT00522392|581867285|FG001|Overall Study|Disease progression|3|||
161333063|NCT01573000|582608612|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
161333064|NCT01573000|582608611|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
161333065|NCT01573000|582608612|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
161333066|NCT01573000|582608611|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
161333067|NCT01573000|582608612|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
161333068|NCT01573000|582608611|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
161333069|NCT01573000|582608612|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
161333070|NCT01573000|582608611|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
161333071|NCT01573000|582608612|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
161333072|NCT01573000|582608611|FG000|Crossover Phase|Lack of Efficacy|0|||
161333073|NCT01573000|582608612|FG001|Crossover Phase|Lack of Efficacy|13|||
161333074|NCT01573000|582608611|FG000|Crossover Phase|Lost to Follow-up|0|||
161333075|NCT01573000|582608612|FG001|Crossover Phase|Lost to Follow-up|2|||
161333076|NCT01573000|582608611|FG000|Crossover Phase|Death|0|||
161333077|NCT01573000|582608612|FG001|Crossover Phase|Death|3|||
161333078|NCT01573000|582608611|FG000|Long-Term Follow-Up|Death|3|||
161333079|NCT01573000|582608612|FG001|Long-Term Follow-Up|Death|0|||
161333080|NCT01573000|582608611|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
161333081|NCT01573000|582608612|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
161333082|NCT01433159|582608616|FG000|Overall Study|Adverse Event|1|||
161333083|NCT01433159|582608617|FG001|Overall Study|Adverse Event|0|||
161333084|NCT01433159|582608616|FG000|Overall Study|Physician Decision|1|||
161333085|NCT01433159|582608617|FG001|Overall Study|Physician Decision|0|||
161333086|NCT01433159|582608616|FG000|Overall Study|Protocol Violation|0|||
161333087|NCT01433159|582608617|FG001|Overall Study|Protocol Violation|1|||
161333088|NCT01100853|582608618|FG000|Overall Study|Lost to Follow-up|11|||
161333089|NCT01100853|582608619|FG001|Overall Study|Lost to Follow-up|6|||
161333090|NCT01100853|582608618|FG000|Overall Study|Received <4 study injections|10|||
161333091|NCT01100853|582608619|FG001|Overall Study|Received <4 study injections|13|||
161333092|NCT01100853|582608618|FG000|Overall Study|Withdrawal by Subject|6|||
161333093|NCT01100853|582608619|FG001|Overall Study|Withdrawal by Subject|4|||
161333094|NCT01384877|582608620|FG000|Treatment 2|Lost to Follow-up|2|||
161333095|NCT01384877|582608621|FG001|Treatment 2|Lost to Follow-up|2|||
161333096|NCT01930539|582608634|FG000|Overall Study|Withdrawal by Subject|2|||
161333097|NCT01930539|582608635|FG001|Overall Study|Withdrawal by Subject|2|||
161333098|NCT01548404|582608636|FG000|Overall Study|Adverse Event|3|||
161333099|NCT01548404|582608637|FG001|Overall Study|Adverse Event|1|||
161333100|NCT01548404|582608636|FG000|Overall Study|Physician Decision|2|||
161333101|NCT01548404|582608637|FG001|Overall Study|Physician Decision|1|||
161333102|NCT01548404|582608636|FG000|Overall Study|Inadequate response to study treatment|23|||
161333103|NCT01548404|582608637|FG001|Overall Study|Inadequate response to study treatment|7|||
161333104|NCT01548404|582608636|FG000|Overall Study|Lost to Follow-up|2|||
161333105|NCT01548404|582608637|FG001|Overall Study|Lost to Follow-up|0|||
161333106|NCT01548404|582608636|FG000|Overall Study|Withdrawal by Subject|0|||
161333107|NCT01548404|582608637|FG001|Overall Study|Withdrawal by Subject|3|||
161131909|NCT00522392|581867284|FG000|Overall Study|Adverse Event|7|||
161131910|NCT00522392|581867285|FG001|Overall Study|Adverse Event|7|||
161131911|NCT00522392|581867284|FG000|Overall Study|Withdrawal by Subject|1|||
161333108|NCT01548404|582608636|FG000|Overall Study|Other than specified above|0|||
160813764|NCT01071252|580701824|FG004|Overall Study|Adverse Event|0|||
160813765|NCT01071252|580701820|FG000|Overall Study|Death|0|||
160813766|NCT01071252|580701821|FG001|Overall Study|Death|0|||
160813767|NCT01071252|580701822|FG002|Overall Study|Death|0|||
160813768|NCT01071252|580701823|FG003|Overall Study|Death|0|||
160813769|NCT01071252|580701824|FG004|Overall Study|Death|1|||
160813770|NCT01066104|580701825|FG000|Overall Study|Adverse Event|1|||
160813771|NCT01066104|580701826|FG001|Overall Study|Adverse Event|1|||
160813772|NCT01066104|580701825|FG000|Overall Study|Protocol Violation|1|||
160813773|NCT01066104|580701826|FG001|Overall Study|Protocol Violation|0|||
160813774|NCT03902392|580701829|FG000|Overall Study|Lost to Follow-up|7|||
160813775|NCT03902392|580701830|FG001|Overall Study|Lost to Follow-up|7|||
160813776|NCT03248167|580701833|FG000|Overall Study|Withdrawal by Subject|2|||
160813777|NCT03248167|580701834|FG001|Overall Study|Withdrawal by Subject|2|||
160813778|NCT03248167|580701833|FG000|Overall Study|Physician Decision|0|||
160813779|NCT03248167|580701834|FG001|Overall Study|Physician Decision|1|||
160813780|NCT03248167|580701833|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
160813781|NCT03248167|580701834|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
160813782|NCT03248167|580701833|FG000|Overall Study|Lost to Follow-up|1|||
160813783|NCT03248167|580701834|FG001|Overall Study|Lost to Follow-up|0|||
160813784|NCT01558596|580701838|FG000|Overall Study|Withdrawal by Subject|1|||
160813785|NCT01558596|580701839|FG001|Overall Study|Withdrawal by Subject|0|||
160813786|NCT01558596|580701838|FG000|Overall Study|surgery elsewhere or cancelled|1|||
161131912|NCT00522392|581867285|FG001|Overall Study|Withdrawal by Subject|1|||
161131913|NCT00522392|581867284|FG000|Overall Study|Physician Decision|0|||
161131914|NCT00522392|581867285|FG001|Overall Study|Physician Decision|1|||
161131915|NCT00522392|581867284|FG000|Overall Study|Non-compliance|0|||
161131916|NCT00522392|581867285|FG001|Overall Study|Non-compliance|1|||
161131917|NCT00430755|581867288|FG000|Overall Study|Withdrawal by Subject|53|||
161131918|NCT01154101|581867289|FG000|Overall Study|Adverse Event|0|||
161131919|NCT01154101|581867290|FG001|Overall Study|Adverse Event|2|||
161131920|NCT01154101|581867291|FG002|Overall Study|Adverse Event|1|||
161131921|NCT01154101|581867292|FG003|Overall Study|Adverse Event|1|||
161131922|NCT01154101|581867293|FG004|Overall Study|Adverse Event|0|||
161131923|NCT01154101|581867289|FG000|Overall Study|Lost to Follow-up|0|||
161131924|NCT01154101|581867290|FG001|Overall Study|Lost to Follow-up|1|||
161131925|NCT01154101|581867291|FG002|Overall Study|Lost to Follow-up|0|||
161131926|NCT01154101|581867292|FG003|Overall Study|Lost to Follow-up|1|||
161131927|NCT01154101|581867293|FG004|Overall Study|Lost to Follow-up|0|||
161131928|NCT01154101|581867289|FG000|Overall Study|Withdrawal by Subject|0|||
161131929|NCT01154101|581867290|FG001|Overall Study|Withdrawal by Subject|1|||
161131930|NCT01154101|581867291|FG002|Overall Study|Withdrawal by Subject|2|||
161131931|NCT01154101|581867292|FG003|Overall Study|Withdrawal by Subject|0|||
161131932|NCT01154101|581867293|FG004|Overall Study|Withdrawal by Subject|1|||
161131933|NCT05019131|581867294|FG000|Overall Study|Lost to Follow-up|0|||
161131934|NCT05019131|581867295|FG001|Overall Study|Lost to Follow-up|3|||
161131935|NCT03575104|581867296|FG000|Overall Study|Adverse Event|4|||
161131936|NCT03575104|581867297|FG001|Overall Study|Adverse Event|3|||
161131937|NCT03575104|581867298|FG002|Overall Study|Adverse Event|4|||
161131938|NCT03575104|581867296|FG000|Overall Study|Withdrawal by Subject|13|||
161131939|NCT03575104|581867297|FG001|Overall Study|Withdrawal by Subject|16|||
161131940|NCT03575104|581867298|FG002|Overall Study|Withdrawal by Subject|11|||
161131941|NCT03575104|581867296|FG000|Overall Study|Other reasons|6|||
161131942|NCT03575104|581867297|FG001|Overall Study|Other reasons|8|||
161131943|NCT03575104|581867298|FG002|Overall Study|Other reasons|6|||
161131944|NCT03575104|581867296|FG000|Overall Study|Lost to Follow-up|1|||
161131945|NCT03575104|581867297|FG001|Overall Study|Lost to Follow-up|2|||
161131946|NCT03575104|581867298|FG002|Overall Study|Lost to Follow-up|1|||
161131947|NCT02360098|581867299|FG000|Overall Study|Physician Decision|7|||
161131948|NCT01919307|581867302|FG000|Overall Study|Withdrawal by Subject|9|||
161131949|NCT05052723|581867304|FG000|Overall Study|Death|19|||
161131950|NCT02771522|581867305|FG000|Overall Study|Lost to Follow-up|3|||
161131951|NCT02771522|581867305|FG000|Overall Study|Withdrawal by Subject|2|||
161131952|NCT02771522|581867305|FG000|Overall Study|No white spot lesions|3|||
161131953|NCT02054702|581867310|FG000|Overall Study|Lost to Follow-up|3|||
161131954|NCT02054702|581867311|FG001|Overall Study|Lost to Follow-up|5|||
161131955|NCT02054702|581867310|FG000|Overall Study|Adverse Event|3|||
161131956|NCT02054702|581867311|FG001|Overall Study|Adverse Event|1|||
161131957|NCT02054702|581867310|FG000|Overall Study|Met Withdrawal Criteria|4|||
160813787|NCT01558596|580701839|FG001|Overall Study|surgery elsewhere or cancelled|1|||
160813788|NCT01558596|580701838|FG000|Overall Study|Protocol Violation|1|||
160813789|NCT01558596|580701839|FG001|Overall Study|Protocol Violation|0|||
160813790|NCT00260832|580701840|FG000|Overall Study|Adverse Event|26|||
160813791|NCT00260832|580701841|FG001|Overall Study|Adverse Event|19|||
160813792|NCT00260832|580701840|FG000|Overall Study|Progression|116|||
160813793|NCT00260832|580701841|FG001|Overall Study|Progression|96|||
161131958|NCT02054702|581867311|FG001|Overall Study|Met Withdrawal Criteria|1|||
161131959|NCT02054702|581867310|FG000|Overall Study|Physician Decision|0|||
161131960|NCT02054702|581867311|FG001|Overall Study|Physician Decision|1|||
160813794|NCT00260832|580701840|FG000|Overall Study|Withdrawal by Subject|15|||
160813795|NCT00260832|580701841|FG001|Overall Study|Withdrawal by Subject|17|||
160813796|NCT00260832|580701840|FG000|Overall Study|Physician Decision|15|||
160813797|NCT00260832|580701841|FG001|Overall Study|Physician Decision|9|||
160813798|NCT00260832|580701840|FG000|Overall Study|Death|43|||
160813799|NCT00260832|580701841|FG001|Overall Study|Death|62|||
160813800|NCT00260832|580701840|FG000|Overall Study|Other|10|||
160813801|NCT00260832|580701841|FG001|Overall Study|Other|7|||
160813802|NCT00260832|580701840|FG000|Overall Study|Protocol Violation|3|||
160813803|NCT00260832|580701841|FG001|Overall Study|Protocol Violation|1|||
160813804|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
160813805|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
160813806|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
160813807|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813808|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813809|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813810|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
160813811|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
160813812|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161239609|NCT05005442|582260433|FG003|Overall Study|Physician Decision|0|||
161239610|NCT05005442|582260434|FG004|Overall Study|Physician Decision|2|||
161239611|NCT05005442|582260435|FG005|Overall Study|Physician Decision|0|||
161239612|NCT05005442|582260430|FG000|Overall Study|Sponsor decision|26|||
161239613|NCT05005442|582260431|FG001|Overall Study|Sponsor decision|26|||
161239614|NCT05005442|582260432|FG002|Overall Study|Sponsor decision|10|||
161239615|NCT05005442|582260433|FG003|Overall Study|Sponsor decision|5|||
161239616|NCT05005442|582260434|FG004|Overall Study|Sponsor decision|9|||
161239617|NCT05005442|582260435|FG005|Overall Study|Sponsor decision|12|||
161239618|NCT05005442|582260430|FG000|Overall Study|Withdrawal by Subject|2|||
161239619|NCT05005442|582260431|FG001|Overall Study|Withdrawal by Subject|2|||
161239620|NCT05005442|582260432|FG002|Overall Study|Withdrawal by Subject|1|||
161239621|NCT05005442|582260433|FG003|Overall Study|Withdrawal by Subject|3|||
161239622|NCT05005442|582260434|FG004|Overall Study|Withdrawal by Subject|0|||
161239623|NCT05005442|582260435|FG005|Overall Study|Withdrawal by Subject|5|||
161239624|NCT05005442|582260430|FG000|Overall Study|Site terminated by sponsor|0|||
161239625|NCT05005442|582260431|FG001|Overall Study|Site terminated by sponsor|2|||
161239626|NCT05005442|582260432|FG002|Overall Study|Site terminated by sponsor|0|||
161239627|NCT05005442|582260433|FG003|Overall Study|Site terminated by sponsor|0|||
161239628|NCT05005442|582260434|FG004|Overall Study|Site terminated by sponsor|0|||
161239629|NCT05005442|582260435|FG005|Overall Study|Site terminated by sponsor|1|||
161239630|NCT03696160|582260438|FG000|Overall Study|Withdrew before IMP dosing|2|||
161239631|NCT03696160|582260439|FG001|Overall Study|Withdrew before IMP dosing|3|||
161239632|NCT00334815|582260440|FG000|Overall Study|Adverse Event|3|||
161239633|NCT00334815|582260441|FG001|Overall Study|Adverse Event|2|||
161239634|NCT00334815|582260440|FG000|Overall Study|Death|0|||
161239635|NCT00334815|582260441|FG001|Overall Study|Death|2|||
161239636|NCT00334815|582260440|FG000|Overall Study|Progression|1|||
161239637|NCT00334815|582260441|FG001|Overall Study|Progression|0|||
161239638|NCT00334815|582260440|FG000|Overall Study|ineligible|1|||
161239639|NCT00334815|582260441|FG001|Overall Study|ineligible|1|||
161239640|NCT00334815|582260440|FG000|Overall Study|patient refused treatment|0|||
161239641|NCT00334815|582260441|FG001|Overall Study|patient refused treatment|1|||
161239642|NCT00334815|582260440|FG000|Overall Study|Physician Decision|2|||
161239643|NCT00334815|582260441|FG001|Overall Study|Physician Decision|4|||
161239644|NCT04970810|582260442|FG000|Overall Study|deemed ineligible after randomization|3|||
161239645|NCT04970810|582260443|FG001|Overall Study|deemed ineligible after randomization|0|||
161239646|NCT04970810|582260444|FG002|Overall Study|deemed ineligible after randomization|4|||
161239647|NCT04742491|582260447|FG000|Overall Study|Death|2|||
161239648|NCT04742491|582260448|FG001|Overall Study|Death|0|||
161239649|NCT04742491|582260447|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
161239650|NCT04742491|582260448|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
160813813|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813814|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813815|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813816|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160813817|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
161239651|NCT04742491|582260447|FG000|Overall Study|Lost to Follow-up|6|||
161239652|NCT04742491|582260448|FG001|Overall Study|Lost to Follow-up|8|||
161239653|NCT04742491|582260447|FG000|Overall Study|Withdrawal by Subject|4|||
161239654|NCT04742491|582260448|FG001|Overall Study|Withdrawal by Subject|2|||
161239655|NCT04742491|582260447|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
161239656|NCT04742491|582260448|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
161239657|NCT04742491|582260447|FG000|Overall Study|Participant refused further participation|2|||
161239658|NCT04742491|582260448|FG001|Overall Study|Participant refused further participation|7|||
161333109|NCT01548404|582608637|FG001|Overall Study|Other than specified above|2|||
161333110|NCT00883181|582608638|FG000|Overall Study|Hematological Adverse Event|26|||
161333111|NCT00883181|582608638|FG000|Overall Study|Non-hematological Adverse Event|55|||
161333112|NCT00883181|582608638|FG000|Overall Study|Disease Progression|94|||
161333113|NCT00883181|582608638|FG000|Overall Study|Administrative Reason|24|||
161333114|NCT00883181|582608638|FG000|Overall Study|Withdrawal by Subject|4|||
161333115|NCT00883181|582608638|FG000|Overall Study|Death|31|||
161333116|NCT00883181|582608638|FG000|Overall Study|Other|38|||
161333117|NCT00883181|582608638|FG000|Overall Study|Protocol Deviation|3|||
161333118|NCT00883181|582608638|FG000|Overall Study|Noncompliance|3|||
161333119|NCT04040439|582608639|FG000|Overall Study|Invalid registration|11|||
161333120|NCT04040439|582608639|FG000|Overall Study|No IC* on publication of study results|2|||
161333121|NCT00426270|582608640|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
161333122|NCT00426270|582608640|FG000|Overall Study|Adverse Event|5|||
161333123|NCT01450813|582608641|FG000|Overall Study|Physician Decision|1|||
161333124|NCT01450813|582608642|FG001|Overall Study|Physician Decision|1|||
161333125|NCT01450813|582608643|FG002|Overall Study|Physician Decision|0|||
161333126|NCT01450813|582608644|FG003|Overall Study|Physician Decision|3|||
161333127|NCT02062437|582608647|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
161333128|NCT02062437|582608647|FG000|Overall Study|Patient not available for the 2y visit|18|||
161333129|NCT02062437|582608647|FG000|Overall Study|Death|2|||
161333130|NCT02062437|582608647|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
161333131|NCT00960193|582608648|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
161333132|NCT01324102|582608649|FG000|Overall Study|illness|1|||
161333133|NCT01324102|582608650|FG001|Overall Study|illness|6|||
161333134|NCT00728494|582608651|FG000|Overall Study|Adverse Event|7|||
161333135|NCT00728494|582608652|FG001|Overall Study|Adverse Event|0|||
161333136|NCT00728494|582608651|FG000|Overall Study|Withdrawal by Subject|0|||
161333137|NCT00728494|582608652|FG001|Overall Study|Withdrawal by Subject|2|||
161333138|NCT00728494|582608651|FG000|Overall Study|Lack of Efficacy|2|||
161333139|NCT00728494|582608652|FG001|Overall Study|Lack of Efficacy|4|||
161333140|NCT00728494|582608651|FG000|Overall Study|No data available|0|||
161333141|NCT00728494|582608652|FG001|Overall Study|No data available|1|||
161333142|NCT02089347|582608653|FG000|Overall Study|Protocol Violation|1|||
161333143|NCT02089347|582608654|FG001|Overall Study|Protocol Violation|0|||
161333144|NCT01249131|582608655|FG000|Washout Period of 10 Days|Adverse Event|0|||
161333145|NCT01249131|582608656|FG001|Washout Period of 10 Days|Adverse Event|0|||
161333146|NCT01249131|582608657|FG002|Washout Period of 10 Days|Adverse Event|0|||
161333147|NCT01249131|582608658|FG003|Washout Period of 10 Days|Adverse Event|0|||
161333148|NCT01249131|582608659|FG004|Washout Period of 10 Days|Adverse Event|1|||
161333149|NCT01249131|582608660|FG005|Washout Period of 10 Days|Adverse Event|0|||
161333150|NCT01225549|582608661|FG000|Period 4 - Washout|Disallowed medication|0|||
160813818|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
160813819|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
160813820|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
160813821|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813822|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813823|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813824|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160813825|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
160813826|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
160813827|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813828|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813829|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813830|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813831|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
160813832|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
160813833|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813834|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813835|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813836|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160900123|NCT03452228|581028657|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
161333151|NCT01225549|582608662|FG001|Period 4 - Washout|Disallowed medication|1|||
161333152|NCT01225549|582608663|FG002|Period 4 - Washout|Disallowed medication|0|||
161333153|NCT01225549|582608664|FG003|Period 4 - Washout|Disallowed medication|0|||
161333154|NCT01225549|582608665|FG004|Period 4 - Washout|Disallowed medication|0|||
161333155|NCT01225549|582608666|FG005|Period 4 - Washout|Disallowed medication|0|||
161333156|NCT01225549|582608667|FG006|Period 4 - Washout|Disallowed medication|0|||
161333157|NCT01225549|582608668|FG007|Period 4 - Washout|Disallowed medication|0|||
161333158|NCT01225549|582608669|FG008|Period 4 - Washout|Disallowed medication|0|||
161333159|NCT01225549|582608670|FG009|Period 4 - Washout|Disallowed medication|0|||
161333160|NCT01225549|582608661|FG000|Period 6 - Washout|Disallowed medication|0|||
160813837|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813838|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
160813839|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813840|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
160813841|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813842|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813843|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813844|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813845|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
160813846|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
160813847|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
160813848|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
160813849|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813850|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813851|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813852|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160813853|NCT03745638|580701842|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
160813854|NCT03745638|580701843|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
160813855|NCT03745638|580701844|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813856|NCT03745638|580701845|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160900124|NCT03452228|581028655|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
160900125|NCT03452228|581028656|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
161131961|NCT02054702|581867310|FG000|Overall Study|Withdrawal by Subject|14|||
161131962|NCT02054702|581867311|FG001|Overall Study|Withdrawal by Subject|4|||
161131963|NCT01262898|581867312|FG000|Overall Study|Protocol Violation|1|||
161131964|NCT01262898|581867313|FG001|Overall Study|Protocol Violation|1|||
161131965|NCT01262898|581867314|FG002|Overall Study|Protocol Violation|0|||
161131966|NCT01262898|581867315|FG003|Overall Study|Protocol Violation|0|||
161131967|NCT01262898|581867312|FG000|Overall Study|Lost to Follow-up|1|||
161131968|NCT01262898|581867313|FG001|Overall Study|Lost to Follow-up|0|||
161131969|NCT01262898|581867314|FG002|Overall Study|Lost to Follow-up|0|||
161131970|NCT01262898|581867315|FG003|Overall Study|Lost to Follow-up|0|||
161131971|NCT01262898|581867312|FG000|Overall Study|Withdrawal by Subject|1|||
161131972|NCT01262898|581867313|FG001|Overall Study|Withdrawal by Subject|1|||
161131973|NCT01262898|581867314|FG002|Overall Study|Withdrawal by Subject|0|||
161131974|NCT01262898|581867315|FG003|Overall Study|Withdrawal by Subject|0|||
161131975|NCT01551693|581867316|FG000|Overall Study|Disease Progression|1|||
161131976|NCT01551693|581867317|FG001|Overall Study|Disease Progression|0|||
161131977|NCT01551693|581867316|FG000|Overall Study|Adverse Event|0|||
161131978|NCT01551693|581867317|FG001|Overall Study|Adverse Event|1|||
161131979|NCT01551693|581867316|FG000|Overall Study|Withdrawal by Subject|0|||
161131980|NCT01551693|581867317|FG001|Overall Study|Withdrawal by Subject|1|||
161131981|NCT00802360|581867321|FG000|Overall Study|Stimulation failure|4|||
161131982|NCT00802360|581867322|FG001|Overall Study|Stimulation failure|0|||
161131983|NCT00802360|581867323|FG002|Overall Study|Stimulation failure|3|||
161131984|NCT00802360|581867324|FG003|Overall Study|Stimulation failure|3|||
161131985|NCT00802360|581867321|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
161131986|NCT00802360|581867322|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
161131987|NCT00802360|581867323|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
161131988|NCT00802360|581867324|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
161131989|NCT00802360|581867321|FG000|Overall Study|Cycle cancelled|0|||
161131990|NCT00802360|581867322|FG001|Overall Study|Cycle cancelled|1|||
161131991|NCT00802360|581867323|FG002|Overall Study|Cycle cancelled|1|||
161131992|NCT00802360|581867324|FG003|Overall Study|Cycle cancelled|1|||
161131993|NCT00802360|581867321|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161131994|NCT00802360|581867322|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161131995|NCT00802360|581867323|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
161131996|NCT00802360|581867324|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
161131997|NCT00802360|581867321|FG000|Overall Study|No positive serum pregnancy|17|||
161131998|NCT00802360|581867322|FG001|Overall Study|No positive serum pregnancy|20|||
161131999|NCT00802360|581867323|FG002|Overall Study|No positive serum pregnancy|14|||
161132000|NCT00802360|581867324|FG003|Overall Study|No positive serum pregnancy|10|||
161132001|NCT00802360|581867321|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161132002|NCT00802360|581867322|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161132003|NCT00802360|581867323|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
161132004|NCT00802360|581867324|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
161132005|NCT00802360|581867321|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
161132006|NCT00802360|581867322|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
161132007|NCT00802360|581867323|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
161132008|NCT00802360|581867324|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
160813857|NCT03745638|580701846|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813858|NCT03745638|580701847|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813859|NCT03745638|580701848|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
160813860|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813861|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813862|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813863|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
160813864|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161239659|NCT04742491|582260447|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
161239660|NCT04742491|582260448|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
161239661|NCT04742491|582260447|FG000|Overall Study|Other reasons|3|||
161239662|NCT04742491|582260448|FG001|Overall Study|Other reasons|4|||
161239663|NCT03317899|582260452|FG000|Overall Study|Death|6|||
161239664|NCT03317899|582260453|FG001|Overall Study|Death|9|||
161239665|NCT01528696|582260457|FG000|Overall Study|See detailed description|18|||
161239666|NCT01528696|582260458|FG001|Overall Study|See detailed description|19|||
161239667|NCT00446966|582260459|FG000|Overall Study|Lost to Follow-up|10|||
161239668|NCT00446966|582260460|FG001|Overall Study|Lost to Follow-up|7|||
161239669|NCT00836472|582260462|FG000|Washout|Adverse Event|1|||
161239670|NCT00836472|582260463|FG001|Washout|Adverse Event|2|||
161239671|NCT00836472|582260462|FG000|Washout|Withdrawal by Subject|1|||
161239672|NCT00836472|582260463|FG001|Washout|Withdrawal by Subject|1|||
161239673|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
161239674|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
161239675|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
161239676|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
161239677|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239678|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239679|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239680|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239681|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239682|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160813865|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
160813866|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
160813867|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813868|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813869|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813870|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
160813871|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160813872|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
160813873|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
160813874|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160813875|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160813876|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160813877|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
160813878|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
160813879|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
160813880|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
160813881|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813882|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813883|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813884|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813885|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
160813886|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
160813887|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
160813888|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813889|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161239683|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239684|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239685|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
160813890|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161239686|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
161239687|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161239688|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161239689|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
161239690|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
161333161|NCT01225549|582608662|FG001|Period 6 - Washout|Disallowed medication|0|||
160813891|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813892|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813893|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
160813894|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
160813895|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160813896|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160813897|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160813898|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
160813899|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
160813900|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
160813901|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
160813902|NCT03745638|580701842|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813903|NCT03745638|580701843|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813904|NCT03745638|580701844|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813905|NCT03745638|580701845|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813906|NCT03745638|580701846|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
160813907|NCT03745638|580701847|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
160813908|NCT03745638|580701848|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
160813909|NCT00771927|580701851|FG000|Overall Study|Adverse Event|100|||
160813910|NCT00771927|580701852|FG001|Overall Study|Adverse Event|105|||
160813911|NCT00771927|580701851|FG000|Overall Study|Lack of Efficacy|70|||
160813912|NCT00771927|580701852|FG001|Overall Study|Lack of Efficacy|42|||
160813913|NCT00771927|580701851|FG000|Overall Study|Lost to Follow-up|46|||
160813914|NCT00771927|580701852|FG001|Overall Study|Lost to Follow-up|46|||
160813915|NCT00771927|580701851|FG000|Overall Study|Withdrawal by Subject|16|||
160813916|NCT00771927|580701852|FG001|Overall Study|Withdrawal by Subject|17|||
160813917|NCT00771927|580701851|FG000|Overall Study|Other reason|23|||
160813918|NCT00771927|580701852|FG001|Overall Study|Other reason|27|||
160813919|NCT04222699|580701858|FG000|Overall Study|Lost to Follow-up|2|||
160813920|NCT02467192|580701862|FG000|Overall Study|Death|1|||
160813921|NCT02467192|580701862|FG000|Overall Study|revealed to have pneumonia before|2|||
160813922|NCT03213938|580701863|FG000|Overall Study|Lost to Follow-up|4|||
160813923|NCT03213938|580701864|FG001|Overall Study|Lost to Follow-up|3|||
160813924|NCT03213938|580701863|FG000|Overall Study|Lack of Efficacy|1|||
160813925|NCT03213938|580701864|FG001|Overall Study|Lack of Efficacy|0|||
160813926|NCT03213938|580701863|FG000|Overall Study|Decline to participate|5|||
160813927|NCT03213938|580701864|FG001|Overall Study|Decline to participate|4|||
160813928|NCT03213938|580701863|FG000|Overall Study|Without reason|4|||
160813929|NCT03213938|580701864|FG001|Overall Study|Without reason|5|||
160813930|NCT00005947|580701879|FG000|Overall Study|Death|54|||
160813931|NCT00005947|580701880|FG001|Overall Study|Death|40|||
160813932|NCT00005947|580701879|FG000|Overall Study|Patient Refused to Continue|2|||
160813933|NCT00005947|580701880|FG001|Overall Study|Patient Refused to Continue|1|||
160813934|NCT00005947|580701879|FG000|Overall Study|Site Closure|1|||
160813935|NCT00005947|580701880|FG001|Overall Study|Site Closure|0|||
160813936|NCT03335150|580701883|FG000|Overall Study|Withdrawal by Subject|10|||
160813937|NCT03335150|580701884|FG001|Overall Study|Withdrawal by Subject|4|||
160813938|NCT03335150|580701883|FG000|Overall Study|Adverse Event|0|||
160813939|NCT03335150|580701884|FG001|Overall Study|Adverse Event|1|||
160813940|NCT02218697|580701885|FG000|Overall Study|Adverse Event|0|||
160813941|NCT02218697|580701886|FG001|Overall Study|Adverse Event|2|||
160813942|NCT02218697|580701885|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
160813943|NCT02218697|580701886|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
160813944|NCT02218697|580701885|FG000|Overall Study|Withdrawal by Subject|2|||
161132009|NCT00802360|581867321|FG000|Overall Study|Other|2|||
161132010|NCT00802360|581867322|FG001|Overall Study|Other|3|||
161132011|NCT00802360|581867323|FG002|Overall Study|Other|6|||
161132012|NCT00802360|581867324|FG003|Overall Study|Other|3|||
161132013|NCT03838484|581867335|FG000|Overall Study|Lost to Follow-up|0|||
161132014|NCT03838484|581867336|FG001|Overall Study|Lost to Follow-up|1|||
160900126|NCT03452228|581028657|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
160900127|NCT03452228|581028655|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160813945|NCT02218697|580701886|FG001|Overall Study|Withdrawal by Subject|3|||
160813946|NCT04380753|580701891|FG000|Overall Study|Participants continuing study|4|||
160813947|NCT04380753|580701891|FG000|Overall Study|Death|2|||
160813948|NCT00809926|580701892|FG000|Overall Study|Adverse Event|18|||
160813949|NCT00809926|580701893|FG001|Overall Study|Adverse Event|10|||
160813950|NCT00809926|580701892|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160813951|NCT00809926|580701893|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160813952|NCT00809926|580701892|FG000|Overall Study|Patient withdrew consent|8|||
161132015|NCT03838484|581867337|FG002|Overall Study|Lost to Follow-up|0|||
161132016|NCT03838484|581867338|FG003|Overall Study|Lost to Follow-up|0|||
161132017|NCT01614964|581867339|FG000|Overall Study|Withdrawal by Subject|2|||
161333162|NCT01225549|582608663|FG002|Period 6 - Washout|Disallowed medication|0|||
160813953|NCT00809926|580701893|FG001|Overall Study|Patient withdrew consent|6|||
160813954|NCT00809926|580701892|FG000|Overall Study|Lost to Follow-up|2|||
160813955|NCT00809926|580701893|FG001|Overall Study|Lost to Follow-up|1|||
160813956|NCT00809926|580701892|FG000|Overall Study|Administrative Problems|0|||
160813957|NCT00809926|580701893|FG001|Overall Study|Administrative Problems|1|||
160813958|NCT00809926|580701892|FG000|Overall Study|Protocol deviation|0|||
160813959|NCT00809926|580701893|FG001|Overall Study|Protocol deviation|2|||
160813960|NCT00837161|580701900|FG000|Overall Study|refused hysterectomy|2|||
160813961|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Adverse Event|21|||
160813962|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Adverse Event|34|||
160813963|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Adverse Event|14|||
160813964|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Adverse Event|17|||
160813965|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Adverse Event|0|||
160813966|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
160813967|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
160813968|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
160813969|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
160813970|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
160813971|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
160813972|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
160813973|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
160813974|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
160813975|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
160813976|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Physician Decision|2|||
160813977|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Physician Decision|4|||
160813978|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Physician Decision|4|||
160813979|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Physician Decision|4|||
160813980|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Physician Decision|0|||
160813981|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
160813982|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
160813983|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
160813984|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
160813985|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
160813986|NCT00451958|580701901|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
160813987|NCT00451958|580701902|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
160813988|NCT00451958|580701903|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
160813989|NCT00451958|580701904|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
160813990|NCT00451958|580701905|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
160813991|NCT01027650|580701908|FG000|Overall Study|Personal Reasons|0|||
160813992|NCT01027650|580701909|FG001|Overall Study|Personal Reasons|0|||
161132018|NCT01614964|581867340|FG001|Overall Study|Withdrawal by Subject|0|||
161132019|NCT01614964|581867339|FG000|Overall Study|Lost to Follow-up|3|||
161132020|NCT01614964|581867340|FG001|Overall Study|Lost to Follow-up|0|||
161132021|NCT00860470|581867349|FG000|Overall Study|Death|6|||
161132022|NCT00860470|581867350|FG001|Overall Study|Death|10|||
161132023|NCT00860470|581867349|FG000|Overall Study|Moved away|8|||
161132024|NCT00860470|581867350|FG001|Overall Study|Moved away|10|||
161132025|NCT00860470|581867349|FG000|Overall Study|Lost to Follow-up|34|||
161132026|NCT00860470|581867350|FG001|Overall Study|Lost to Follow-up|39|||
161132027|NCT01032629|581867352|FG000|Overall Study|Closed Site|21|||
161132028|NCT01032629|581867353|FG001|Overall Study|Closed Site|18|||
161132029|NCT01032629|581867354|FG002|Overall Study|Closed Site|16|||
161132030|NCT01032629|581867352|FG000|Overall Study|Withdrawal by Subject|50|||
161132031|NCT01032629|581867353|FG001|Overall Study|Withdrawal by Subject|36|||
161132032|NCT01032629|581867354|FG002|Overall Study|Withdrawal by Subject|35|||
161132033|NCT01032629|581867352|FG000|Overall Study|Lost to Follow-up|74|||
161132034|NCT01032629|581867353|FG001|Overall Study|Lost to Follow-up|47|||
161132035|NCT01032629|581867354|FG002|Overall Study|Lost to Follow-up|37|||
161132036|NCT03371355|581867357|FG000|Overall Study|Investigator judgment|0|||
161132037|NCT03371355|581867358|FG001|Overall Study|Investigator judgment|0|||
161132038|NCT03371355|581867359|FG002|Overall Study|Investigator judgment|1|||
161132039|NCT03371355|581867360|FG003|Overall Study|Investigator judgment|1|||
161333163|NCT01225549|582608664|FG003|Period 6 - Washout|Disallowed medication|1|||
160813993|NCT01027650|580701910|FG002|Overall Study|Personal Reasons|0|||
161132040|NCT03371355|581867357|FG000|Overall Study|Voluntary withdrawal|1|||
160813994|NCT01027650|580701911|FG003|Overall Study|Personal Reasons|0|||
160813995|NCT01027650|580701912|FG004|Overall Study|Personal Reasons|2|||
160813996|NCT01027650|580701913|FG005|Overall Study|Personal Reasons|1|||
160813997|NCT01027650|580701914|FG006|Overall Study|Personal Reasons|0|||
160813998|NCT01027650|580701915|FG007|Overall Study|Personal Reasons|0|||
160813999|NCT01027650|580701908|FG000|Overall Study|Lost to Follow-up|0|||
160814000|NCT01027650|580701909|FG001|Overall Study|Lost to Follow-up|0|||
160814001|NCT01027650|580701910|FG002|Overall Study|Lost to Follow-up|0|||
160814002|NCT01027650|580701911|FG003|Overall Study|Lost to Follow-up|0|||
161132041|NCT03371355|581867358|FG001|Overall Study|Voluntary withdrawal|0|||
161132042|NCT03371355|581867359|FG002|Overall Study|Voluntary withdrawal|1|||
161132043|NCT03371355|581867360|FG003|Overall Study|Voluntary withdrawal|2|||
160814003|NCT01027650|580701912|FG004|Overall Study|Lost to Follow-up|0|||
160814004|NCT01027650|580701913|FG005|Overall Study|Lost to Follow-up|0|||
160814005|NCT01027650|580701914|FG006|Overall Study|Lost to Follow-up|1|||
160814006|NCT01027650|580701915|FG007|Overall Study|Lost to Follow-up|0|||
160814007|NCT01027650|580701908|FG000|Overall Study|Lack of Efficacy|0|||
160814008|NCT01027650|580701909|FG001|Overall Study|Lack of Efficacy|0|||
161333164|NCT01225549|582608665|FG004|Period 6 - Washout|Disallowed medication|0|||
161333165|NCT01225549|582608666|FG005|Period 6 - Washout|Disallowed medication|0|||
161333166|NCT01225549|582608667|FG006|Period 6 - Washout|Disallowed medication|0|||
161333167|NCT01225549|582608668|FG007|Period 6 - Washout|Disallowed medication|0|||
161333168|NCT01225549|582608669|FG008|Period 6 - Washout|Disallowed medication|0|||
161333169|NCT01225549|582608670|FG009|Period 6 - Washout|Disallowed medication|0|||
161333170|NCT03426345|582608671|FG000|Overall Study|Adverse Event|4|||
161333171|NCT03426345|582608672|FG001|Overall Study|Adverse Event|4|||
161333172|NCT03426345|582608671|FG000|Overall Study|Lack of Efficacy|1|||
161333173|NCT03426345|582608672|FG001|Overall Study|Lack of Efficacy|0|||
161333174|NCT03426345|582608671|FG000|Overall Study|Withdrawal by Subject|5|||
161333175|NCT03426345|582608672|FG001|Overall Study|Withdrawal by Subject|6|||
161333176|NCT03426345|582608671|FG000|Overall Study|Lost to Follow-up|3|||
161333177|NCT03426345|582608672|FG001|Overall Study|Lost to Follow-up|1|||
161333178|NCT03426345|582608671|FG000|Overall Study|Protocol Deviation|3|||
161333179|NCT03426345|582608672|FG001|Overall Study|Protocol Deviation|4|||
161333180|NCT03426345|582608671|FG000|Overall Study|Reason Not Specified|1|||
161333181|NCT03426345|582608672|FG001|Overall Study|Reason Not Specified|2|||
161333182|NCT03426345|582608671|FG000|Overall Study|Missing Completion Status|1|||
161333183|NCT03426345|582608672|FG001|Overall Study|Missing Completion Status|0|||
161333184|NCT02456727|582608673|FG000|Overall Study|Lost to Follow-up|63|||
161333185|NCT02456727|582608674|FG001|Overall Study|Lost to Follow-up|65|||
161333186|NCT02456727|582608673|FG000|Overall Study|Death|2|||
160814009|NCT01027650|580701910|FG002|Overall Study|Lack of Efficacy|0|||
160814010|NCT01027650|580701911|FG003|Overall Study|Lack of Efficacy|0|||
160814011|NCT01027650|580701912|FG004|Overall Study|Lack of Efficacy|0|||
160814012|NCT01027650|580701913|FG005|Overall Study|Lack of Efficacy|1|||
161239691|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239692|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239693|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239694|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239695|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239696|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239697|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239698|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239699|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239700|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
161239701|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
161239702|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239703|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
161239704|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239705|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239706|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239707|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239708|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239709|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239710|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239711|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239712|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239713|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239714|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
161239715|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161239716|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161239717|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161239718|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239719|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239720|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239721|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161333187|NCT02456727|582608674|FG001|Overall Study|Death|1|||
161333188|NCT02456727|582608673|FG000|Overall Study|Withdrawal by Subject|1|||
161333189|NCT02456727|582608674|FG001|Overall Study|Withdrawal by Subject|10|||
161333190|NCT02456727|582608673|FG000|Overall Study|Never Initiated Treatment|43|||
160814013|NCT01027650|580701914|FG006|Overall Study|Lack of Efficacy|0|||
160814014|NCT01027650|580701915|FG007|Overall Study|Lack of Efficacy|0|||
160814015|NCT02175277|580701916|FG000|Overall Study|Protocol-specified Criteria|1|||
160814016|NCT00670930|580701917|FG000|Overall Study|Adminstrative Problem|0|||
160814017|NCT00670930|580701918|FG001|Overall Study|Adminstrative Problem|1|||
160814018|NCT00670930|580701917|FG000|Overall Study|Lost to Follow-up|1|||
160814019|NCT00670930|580701918|FG001|Overall Study|Lost to Follow-up|0|||
160814020|NCT01042158|580701919|FG000|Overall Study|Physician Decision|1|||
160814021|NCT00875485|580703718|FG000|Challenge Dose Epoch|Pregnancy|1|||
160814022|NCT00875485|580703719|FG001|Challenge Dose Epoch|Pregnancy|0|||
160814023|NCT01271010|580703720|FG000|Overall Study|Reason not specified|11|||
160814024|NCT01271010|580703720|FG000|Overall Study|Start of new CLL therapy|1|||
161239722|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239723|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239724|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239725|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239726|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239727|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239728|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161239729|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
161239730|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239731|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
161239732|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239733|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239734|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239735|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239736|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239737|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239738|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239739|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239740|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239741|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239742|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
161239743|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
160814025|NCT01271010|580703720|FG000|Overall Study|Protocol Violation|1|||
160814026|NCT01271010|580703720|FG000|Overall Study|Death|2|||
161239744|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239745|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161239746|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239747|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239748|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239749|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239750|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239751|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239752|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239753|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
160814027|NCT01271010|580703720|FG000|Overall Study|Progression and relapse of disease|1|||
160814028|NCT01271010|580703720|FG000|Overall Study|Withdrawal by Subject|18|||
160814029|NCT01271010|580703720|FG000|Overall Study|Disease progression|27|||
160814030|NCT01631747|580703721|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
160814031|NCT01631747|580703722|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
160814032|NCT01631747|580703721|FG000|Live Birth|Pregnancy Termination|1|||
160814033|NCT01631747|580703722|FG001|Live Birth|Pregnancy Termination|0|||
160814034|NCT01631747|580703721|FG000|Live Birth|MIscarriage|2|||
160814035|NCT01631747|580703722|FG001|Live Birth|MIscarriage|0|||
160814036|NCT01631747|580703721|FG000|Live Birth|Stillbirth|1|||
160814037|NCT01631747|580703722|FG001|Live Birth|Stillbirth|1|||
160814038|NCT01631747|580703721|FG000|One Year Infant Outcomes|Patient Refused|13|||
160814039|NCT01631747|580703722|FG001|One Year Infant Outcomes|Patient Refused|9|||
160814040|NCT02908685|580703723|FG000|Part 1 OLE|Withdrawal by Subject|0|||
160814041|NCT02908685|580703724|FG001|Part 1 OLE|Withdrawal by Subject|0|||
160814042|NCT02908685|580703725|FG002|Part 1 OLE|Withdrawal by Subject|0|||
160814043|NCT02908685|580703726|FG003|Part 1 OLE|Withdrawal by Subject|0|||
160814044|NCT02908685|580703727|FG004|Part 1 OLE|Withdrawal by Subject|0|||
160814045|NCT02908685|580703728|FG005|Part 1 OLE|Withdrawal by Subject|0|||
160814046|NCT02908685|580703729|FG006|Part 1 OLE|Withdrawal by Subject|0|||
160814047|NCT02908685|580703730|FG007|Part 1 OLE|Withdrawal by Subject|0|||
160814048|NCT02908685|580703731|FG008|Part 1 OLE|Withdrawal by Subject|0|||
160814049|NCT02908685|580703732|FG009|Part 1 OLE|Withdrawal by Subject|0|||
160814050|NCT02908685|580703733|FG010|Part 1 OLE|Withdrawal by Subject|2|||
161333191|NCT02456727|582608674|FG001|Overall Study|Never Initiated Treatment|30|||
160814051|NCT02908685|580703734|FG011|Part 1 OLE|Withdrawal by Subject|1|||
160814052|NCT02908685|580703735|FG012|Part 1 OLE|Withdrawal by Subject|0|||
160814053|NCT02908685|580703736|FG013|Part 1 OLE|Withdrawal by Subject|0|||
160814054|NCT02908685|580703723|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814055|NCT02908685|580703724|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814056|NCT02908685|580703725|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
161239754|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239755|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239756|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161239757|NCT01695239|582260464|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
161239758|NCT01695239|582260465|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239759|NCT01695239|582260466|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239760|NCT01695239|582260467|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239761|NCT01695239|582260468|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239762|NCT01695239|582260469|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239763|NCT01695239|582260470|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239764|NCT01695239|582260471|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239765|NCT01695239|582260472|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
160814057|NCT02908685|580703726|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814058|NCT02908685|580703727|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814059|NCT02908685|580703728|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814060|NCT02908685|580703729|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814061|NCT02908685|580703730|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814062|NCT02908685|580703731|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814063|NCT02908685|580703732|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814064|NCT02908685|580703733|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814065|NCT02908685|580703734|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
160814066|NCT02908685|580703735|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
160814067|NCT02908685|580703736|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
160814068|NCT02908685|580703723|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814069|NCT02908685|580703724|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814070|NCT02908685|580703725|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814071|NCT02908685|580703726|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814072|NCT02908685|580703727|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814073|NCT02908685|580703728|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814074|NCT02908685|580703729|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814075|NCT02908685|580703730|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814076|NCT02908685|580703731|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814077|NCT02908685|580703732|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814078|NCT02908685|580703733|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814079|NCT02908685|580703734|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814080|NCT02908685|580703735|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
161239766|NCT01695239|582260473|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239767|NCT01695239|582260474|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239768|NCT01695239|582260475|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239769|NCT01695239|582260476|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239770|NCT01695239|582260477|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
161239771|NCT01695239|582260464|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239772|NCT01695239|582260465|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239773|NCT01695239|582260466|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239774|NCT01695239|582260467|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239775|NCT01695239|582260468|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239776|NCT01695239|582260469|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239777|NCT01695239|582260470|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239778|NCT01695239|582260471|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
161239779|NCT01695239|582260472|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161333192|NCT00492297|582608675|FG000|Treatment|Death|2|||
161333193|NCT00492297|582608675|FG000|Treatment|Study terminated by sponsor|3|||
161333194|NCT00492297|582608675|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
161333195|NCT00492297|582608675|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
161333196|NCT00492297|582608675|FG000|Survival Only Follow-up|Death|46|||
161333197|NCT00492297|582608675|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
161333198|NCT00492297|582608675|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
161333199|NCT03885908|582608676|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
161333200|NCT03885908|582608677|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
161333201|NCT03885908|582608676|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
161333202|NCT03885908|582608677|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
161333203|NCT03885908|582608676|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
161333204|NCT03885908|582608677|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
161333205|NCT03885908|582608676|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
160814081|NCT02908685|580703736|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
160814082|NCT02908685|580703723|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814083|NCT02908685|580703724|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814084|NCT02908685|580703725|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814085|NCT02908685|580703726|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814086|NCT02908685|580703727|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814087|NCT02908685|580703728|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
161239780|NCT01695239|582260473|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
160814088|NCT02908685|580703729|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814089|NCT02908685|580703730|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814090|NCT02908685|580703731|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814091|NCT02908685|580703732|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814092|NCT02908685|580703733|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814093|NCT02908685|580703734|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814094|NCT02908685|580703735|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
160814095|NCT02908685|580703736|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
160814096|NCT02908685|580703723|FG000|Part 2 OLE: > Month 24|Death|0|||
160814097|NCT02908685|580703724|FG001|Part 2 OLE: > Month 24|Death|0|||
160814098|NCT02908685|580703725|FG002|Part 2 OLE: > Month 24|Death|0|||
160900128|NCT03452228|581028656|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
160900129|NCT03452228|581028657|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
161239781|NCT01695239|582260474|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239782|NCT01695239|582260475|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239783|NCT01695239|582260476|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239784|NCT01695239|582260477|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
161239785|NCT01695239|582260464|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239786|NCT01695239|582260465|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239787|NCT01695239|582260466|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
160900130|NCT02761733|581028658|FG000|Overall Study|Death|3|||
160900131|NCT02761733|581028659|FG001|Overall Study|Death|5|||
160900132|NCT02761733|581028660|FG002|Overall Study|Death|1|||
160900133|NCT02761733|581028661|FG003|Overall Study|Death|1|||
160900134|NCT02761733|581028658|FG000|Overall Study|Lost to Follow-up|6|||
160900135|NCT02761733|581028659|FG001|Overall Study|Lost to Follow-up|7|||
161132044|NCT03371355|581867357|FG000|Overall Study|Adverse Event|0|||
161132045|NCT03371355|581867358|FG001|Overall Study|Adverse Event|1|||
161132046|NCT03371355|581867359|FG002|Overall Study|Adverse Event|2|||
161132047|NCT03371355|581867360|FG003|Overall Study|Adverse Event|3|||
161132048|NCT03371355|581867357|FG000|Overall Study|Reason not Specified|0|||
161132049|NCT03371355|581867358|FG001|Overall Study|Reason not Specified|1|||
161132050|NCT03371355|581867359|FG002|Overall Study|Reason not Specified|0|||
161132051|NCT03371355|581867360|FG003|Overall Study|Reason not Specified|1|||
161132052|NCT01264939|581867364|FG000|Overall Study|Adverse Event|1|||
161132053|NCT01264939|581867365|FG001|Overall Study|Adverse Event|3|||
161132054|NCT01264939|581867364|FG000|Overall Study|Lost to Follow-up|0|||
161132055|NCT01264939|581867365|FG001|Overall Study|Lost to Follow-up|3|||
161132056|NCT01264939|581867364|FG000|Overall Study|Physician Decision|1|||
161132057|NCT01264939|581867365|FG001|Overall Study|Physician Decision|1|||
161132058|NCT01264939|581867364|FG000|Overall Study|Patient/Guardian Decision|8|||
161132059|NCT01264939|581867365|FG001|Overall Study|Patient/Guardian Decision|10|||
161132060|NCT01264939|581867364|FG000|Overall Study|Disease Progression|8|||
161132061|NCT01264939|581867365|FG001|Overall Study|Disease Progression|11|||
161132062|NCT01171612|581867367|FG000|Overall Study|Lost to Follow-up|51|||
161132063|NCT01526148|581867373|FG000|Overall Study|Adverse Event|6|||
161132064|NCT01526148|581867374|FG001|Overall Study|Adverse Event|5|||
161132065|NCT01526148|581867373|FG000|Overall Study|Lost to Follow-up|3|||
161132066|NCT01526148|581867374|FG001|Overall Study|Lost to Follow-up|6|||
161132067|NCT01526148|581867373|FG000|Overall Study|Withdrawal by Subject|2|||
161132068|NCT01526148|581867374|FG001|Overall Study|Withdrawal by Subject|0|||
161132069|NCT01526148|581867373|FG000|Overall Study|Unstable Medical Condition|1|||
161132070|NCT01526148|581867374|FG001|Overall Study|Unstable Medical Condition|0|||
161132071|NCT01526148|581867373|FG000|Overall Study|Unable to discontinue concomitant med|1|||
161132072|NCT01526148|581867374|FG001|Overall Study|Unable to discontinue concomitant med|0|||
161132073|NCT01526148|581867373|FG000|Overall Study|Moved out of state|1|||
161132074|NCT01526148|581867374|FG001|Overall Study|Moved out of state|0|||
161132075|NCT01526148|581867373|FG000|Overall Study|Incarcerated|0|||
161132076|NCT01526148|581867374|FG001|Overall Study|Incarcerated|2|||
160814099|NCT02908685|580703726|FG003|Part 2 OLE: > Month 24|Death|0|||
160814100|NCT02908685|580703727|FG004|Part 2 OLE: > Month 24|Death|0|||
160900136|NCT02761733|581028660|FG002|Overall Study|Lost to Follow-up|0|||
160900137|NCT02761733|581028661|FG003|Overall Study|Lost to Follow-up|3|||
161132077|NCT01173653|581867375|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
161132078|NCT01173653|581867376|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
161132079|NCT01671280|581867379|FG000|Overall Study|Withdrawal by Subject|2|||
161132080|NCT00996203|581867380|FG000|Overall Study|Adverse Event|3|||
160814101|NCT02908685|580703728|FG005|Part 2 OLE: > Month 24|Death|0|||
160814102|NCT02908685|580703729|FG006|Part 2 OLE: > Month 24|Death|0|||
160814103|NCT02908685|580703730|FG007|Part 2 OLE: > Month 24|Death|0|||
160814104|NCT02908685|580703731|FG008|Part 2 OLE: > Month 24|Death|0|||
160814105|NCT02908685|580703732|FG009|Part 2 OLE: > Month 24|Death|0|||
160814106|NCT02908685|580703733|FG010|Part 2 OLE: > Month 24|Death|0|||
160814107|NCT02908685|580703734|FG011|Part 2 OLE: > Month 24|Death|0|||
160814108|NCT02908685|580703735|FG012|Part 2 OLE: > Month 24|Death|1|||
160814109|NCT02908685|580703736|FG013|Part 2 OLE: > Month 24|Death|0|||
160814110|NCT02908685|580703723|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
160814111|NCT02908685|580703724|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
160814112|NCT02908685|580703725|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
160814113|NCT02908685|580703726|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
160814114|NCT02908685|580703727|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
160814115|NCT02908685|580703728|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
160814116|NCT02908685|580703729|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
160814117|NCT02908685|580703730|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
160814118|NCT02908685|580703731|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
160814119|NCT02908685|580703732|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
160814120|NCT02908685|580703733|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
160814121|NCT02908685|580703734|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
160814122|NCT02908685|580703735|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
160814123|NCT02908685|580703736|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
160814124|NCT02908685|580703723|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814125|NCT02908685|580703724|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814126|NCT02908685|580703725|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814127|NCT02908685|580703726|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814128|NCT02908685|580703727|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814129|NCT02908685|580703728|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814130|NCT02908685|580703729|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
161239788|NCT01695239|582260467|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239789|NCT01695239|582260468|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239790|NCT01695239|582260469|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239791|NCT01695239|582260470|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239792|NCT01695239|582260471|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
161239793|NCT01695239|582260472|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239794|NCT01695239|582260473|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239795|NCT01695239|582260474|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239796|NCT01695239|582260475|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239797|NCT01695239|582260476|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239798|NCT01695239|582260477|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
161239799|NCT01695239|582260464|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239800|NCT01695239|582260465|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239801|NCT01695239|582260466|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239802|NCT01695239|582260467|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239803|NCT01695239|582260468|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239804|NCT01695239|582260469|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239805|NCT01695239|582260470|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239806|NCT01695239|582260471|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
161239807|NCT01695239|582260472|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239808|NCT01695239|582260473|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239809|NCT01695239|582260474|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
160814131|NCT02908685|580703730|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814132|NCT02908685|580703731|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814133|NCT02908685|580703732|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160900138|NCT02761733|581028658|FG000|Overall Study|Physician Decision|4|||
161239810|NCT01695239|582260475|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239811|NCT01695239|582260476|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239812|NCT01695239|582260477|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
161239813|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239814|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239815|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
160814134|NCT02908685|580703733|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814135|NCT02908685|580703734|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
160814136|NCT02908685|580703735|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
160814137|NCT02908685|580703736|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
160814138|NCT02954406|580703737|FG000|Overall Study|Adverse Event|0|||
160814139|NCT02954406|580703738|FG001|Overall Study|Adverse Event|1|||
160814140|NCT02954406|580703739|FG002|Overall Study|Adverse Event|0|||
160814141|NCT02954406|580703740|FG003|Overall Study|Adverse Event|0|||
160814142|NCT02954406|580703741|FG004|Overall Study|Adverse Event|1|||
160814143|NCT02954406|580703742|FG005|Overall Study|Adverse Event|0|||
160814144|NCT02954406|580703743|FG006|Overall Study|Adverse Event|0|||
160814145|NCT02954406|580703744|FG007|Overall Study|Adverse Event|0|||
160814146|NCT02954406|580703745|FG008|Overall Study|Adverse Event|1|||
160814147|NCT02954406|580703746|FG009|Overall Study|Adverse Event|1|||
160814148|NCT02954406|580703747|FG010|Overall Study|Adverse Event|0|||
160814149|NCT02954406|580703737|FG000|Overall Study|Progressive Disease|3|||
160814150|NCT02954406|580703738|FG001|Overall Study|Progressive Disease|4|||
160814151|NCT02954406|580703739|FG002|Overall Study|Progressive Disease|3|||
160814152|NCT02954406|580703740|FG003|Overall Study|Progressive Disease|4|||
160814153|NCT02954406|580703741|FG004|Overall Study|Progressive Disease|3|||
160814154|NCT02954406|580703742|FG005|Overall Study|Progressive Disease|3|||
160814155|NCT02954406|580703743|FG006|Overall Study|Progressive Disease|2|||
160814156|NCT02954406|580703744|FG007|Overall Study|Progressive Disease|2|||
160814157|NCT02954406|580703745|FG008|Overall Study|Progressive Disease|1|||
160814158|NCT02954406|580703746|FG009|Overall Study|Progressive Disease|1|||
160814159|NCT02954406|580703747|FG010|Overall Study|Progressive Disease|0|||
160814160|NCT02954406|580703737|FG000|Overall Study|Symptomatic Deterioration|0|||
160814161|NCT02954406|580703738|FG001|Overall Study|Symptomatic Deterioration|1|||
160814162|NCT02954406|580703739|FG002|Overall Study|Symptomatic Deterioration|0|||
160814163|NCT02954406|580703740|FG003|Overall Study|Symptomatic Deterioration|0|||
160814164|NCT02954406|580703741|FG004|Overall Study|Symptomatic Deterioration|0|||
160814165|NCT02954406|580703742|FG005|Overall Study|Symptomatic Deterioration|0|||
160814166|NCT02954406|580703743|FG006|Overall Study|Symptomatic Deterioration|0|||
160814167|NCT02954406|580703744|FG007|Overall Study|Symptomatic Deterioration|0|||
160814168|NCT02954406|580703745|FG008|Overall Study|Symptomatic Deterioration|0|||
160814169|NCT02954406|580703746|FG009|Overall Study|Symptomatic Deterioration|0|||
160814170|NCT02954406|580703747|FG010|Overall Study|Symptomatic Deterioration|0|||
160814171|NCT02954406|580703737|FG000|Overall Study|Death|0|||
160814172|NCT02954406|580703738|FG001|Overall Study|Death|0|||
160814173|NCT02954406|580703739|FG002|Overall Study|Death|0|||
160814174|NCT02954406|580703740|FG003|Overall Study|Death|0|||
160814175|NCT02954406|580703741|FG004|Overall Study|Death|1|||
160814176|NCT02954406|580703742|FG005|Overall Study|Death|0|||
160814177|NCT02954406|580703743|FG006|Overall Study|Death|0|||
160814178|NCT02954406|580703744|FG007|Overall Study|Death|0|||
160814179|NCT02954406|580703745|FG008|Overall Study|Death|1|||
160814180|NCT02954406|580703746|FG009|Overall Study|Death|1|||
160814181|NCT02954406|580703747|FG010|Overall Study|Death|0|||
160814182|NCT02954406|580703737|FG000|Overall Study|Reason Not Specified|0|||
160814183|NCT02954406|580703738|FG001|Overall Study|Reason Not Specified|0|||
160814184|NCT02954406|580703739|FG002|Overall Study|Reason Not Specified|3|||
160814185|NCT02954406|580703740|FG003|Overall Study|Reason Not Specified|2|||
160814186|NCT02954406|580703741|FG004|Overall Study|Reason Not Specified|2|||
160814187|NCT02954406|580703742|FG005|Overall Study|Reason Not Specified|0|||
160814188|NCT02954406|580703743|FG006|Overall Study|Reason Not Specified|1|||
160814189|NCT02954406|580703744|FG007|Overall Study|Reason Not Specified|0|||
160814190|NCT02954406|580703745|FG008|Overall Study|Reason Not Specified|1|||
160814191|NCT02954406|580703746|FG009|Overall Study|Reason Not Specified|0|||
160814192|NCT02954406|580703747|FG010|Overall Study|Reason Not Specified|0|||
160814193|NCT00782171|580703748|FG000|Overall Study|Lost to Follow-up|2|||
160814194|NCT00782171|580703749|FG001|Overall Study|Lost to Follow-up|2|||
160814195|NCT00782171|580703748|FG000|Overall Study|Withdrawal by Subject|2|||
160814196|NCT00782171|580703749|FG001|Overall Study|Withdrawal by Subject|1|||
160814197|NCT00782171|580703748|FG000|Overall Study|complications|3|||
160814198|NCT00782171|580703749|FG001|Overall Study|complications|1|||
160814199|NCT00782171|580703748|FG000|Overall Study|others|7|||
160814200|NCT00782171|580703749|FG001|Overall Study|others|9|||
160814201|NCT00782171|580703748|FG000|Overall Study|not eligible|8|||
160814202|NCT00782171|580703749|FG001|Overall Study|not eligible|6|||
160814203|NCT01691014|580703750|FG000|Overall Study|Premature Termination|1|||
160814204|NCT01691014|580703751|FG001|Overall Study|Premature Termination|6|||
160814205|NCT01691014|580703752|FG002|Overall Study|Premature Termination|0|||
160814206|NCT01691014|580703753|FG003|Overall Study|Premature Termination|3|||
160814207|NCT01691014|580703750|FG000|Overall Study|Other|0|||
160814208|NCT01691014|580703751|FG001|Overall Study|Other|0|||
160814209|NCT01691014|580703752|FG002|Overall Study|Other|2|||
160814210|NCT01691014|580703753|FG003|Overall Study|Other|0|||
160814211|NCT01691014|580703750|FG000|Overall Study|Withdrawal by Subject|0|||
160814212|NCT01691014|580703751|FG001|Overall Study|Withdrawal by Subject|1|||
160814213|NCT01691014|580703752|FG002|Overall Study|Withdrawal by Subject|1|||
160814214|NCT01691014|580703753|FG003|Overall Study|Withdrawal by Subject|1|||
160814215|NCT01691014|580703750|FG000|Overall Study|Adverse Event|0|||
160814216|NCT01691014|580703751|FG001|Overall Study|Adverse Event|5|||
160814217|NCT01691014|580703752|FG002|Overall Study|Adverse Event|1|||
160814218|NCT01691014|580703753|FG003|Overall Study|Adverse Event|1|||
160814219|NCT01691014|580703750|FG000|Overall Study|Lack of Efficacy|2|||
160814220|NCT01691014|580703751|FG001|Overall Study|Lack of Efficacy|3|||
160814221|NCT01691014|580703752|FG002|Overall Study|Lack of Efficacy|7|||
160814222|NCT01691014|580703753|FG003|Overall Study|Lack of Efficacy|0|||
160814223|NCT05897242|580703756|FG000|Overall Study|Lost to Follow-up|6|||
160814224|NCT05897242|580703757|FG001|Overall Study|Lost to Follow-up|1|||
160814225|NCT05897242|580703756|FG000|Overall Study|Incomplete|1|||
160814226|NCT05897242|580703757|FG001|Overall Study|Incomplete|0|||
160814227|NCT05897242|580703756|FG000|Overall Study|Withdrawal by Subject|1|||
160814228|NCT05897242|580703757|FG001|Overall Study|Withdrawal by Subject|0|||
160814229|NCT03522246|580703758|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
160814230|NCT03522246|580703759|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
160814231|NCT03522246|580703760|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
160814232|NCT03522246|580703761|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
160814233|NCT03522246|580703762|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
161239816|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239817|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239818|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239819|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239820|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239821|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
161239822|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
161239823|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239824|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239825|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239826|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
161239827|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
161239828|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
161239829|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
161239830|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
161239831|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
161239832|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
161239833|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
161239834|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
161239835|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
161239836|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
161239837|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
161333206|NCT03885908|582608677|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
161333207|NCT02974868|582608678|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
160814234|NCT00814580|580703763|FG000|Overall Study|Adverse Event|6|||
160814235|NCT00814580|580703764|FG001|Overall Study|Adverse Event|15|||
160814236|NCT00814580|580703763|FG000|Overall Study|Lack of Efficacy|18|||
160814237|NCT00814580|580703764|FG001|Overall Study|Lack of Efficacy|25|||
160814238|NCT00814580|580703763|FG000|Overall Study|Protocol Violation|2|||
160814239|NCT00814580|580703764|FG001|Overall Study|Protocol Violation|0|||
160814240|NCT00814580|580703763|FG000|Overall Study|Withdrawal by Subject|2|||
160814241|NCT00814580|580703764|FG001|Overall Study|Withdrawal by Subject|2|||
160814242|NCT00814580|580703763|FG000|Overall Study|Other|1|||
160814243|NCT00814580|580703764|FG001|Overall Study|Other|3|||
160814244|NCT00814580|580703763|FG000|Overall Study|Did Not Take Drug|2|||
160814245|NCT00814580|580703764|FG001|Overall Study|Did Not Take Drug|2|||
160814246|NCT02482428|580703765|FG000|Overall Study|Lost to Follow-up|4|||
160814247|NCT02482428|580703766|FG001|Overall Study|Lost to Follow-up|9|||
160814248|NCT02482428|580703767|FG002|Overall Study|Lost to Follow-up|1|||
160814249|NCT02482428|580703768|FG003|Overall Study|Lost to Follow-up|2|||
160814250|NCT02482428|580703769|FG004|Overall Study|Lost to Follow-up|4|||
160814251|NCT02482428|580703765|FG000|Overall Study|Physician Decision|0|||
160814252|NCT02482428|580703766|FG001|Overall Study|Physician Decision|0|||
160814253|NCT02482428|580703767|FG002|Overall Study|Physician Decision|0|||
160814254|NCT02482428|580703768|FG003|Overall Study|Physician Decision|0|||
160814255|NCT02482428|580703769|FG004|Overall Study|Physician Decision|1|||
160814256|NCT02482428|580703765|FG000|Overall Study|protocol deviation|1|||
161333208|NCT02974868|582608679|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
160814257|NCT02482428|580703766|FG001|Overall Study|protocol deviation|1|||
160814258|NCT02482428|580703767|FG002|Overall Study|protocol deviation|0|||
160814259|NCT02482428|580703768|FG003|Overall Study|protocol deviation|0|||
160814260|NCT02482428|580703769|FG004|Overall Study|protocol deviation|0|||
160814261|NCT02482428|580703765|FG000|Overall Study|subject/guardian decision|4|||
160814262|NCT02482428|580703766|FG001|Overall Study|subject/guardian decision|2|||
160814263|NCT02482428|580703767|FG002|Overall Study|subject/guardian decision|0|||
160814264|NCT02482428|580703768|FG003|Overall Study|subject/guardian decision|0|||
161239838|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
161239839|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
160900139|NCT02761733|581028659|FG001|Overall Study|Physician Decision|0|||
160814265|NCT02482428|580703769|FG004|Overall Study|subject/guardian decision|2|||
160814266|NCT00809835|580703772|FG000|Overall Study|Lost to Follow-up|7|||
160814267|NCT00809835|580703773|FG001|Overall Study|Lost to Follow-up|6|||
160814268|NCT00809835|580703774|FG002|Overall Study|Lost to Follow-up|10|||
161132081|NCT00996203|581867380|FG000|Overall Study|Lost to Follow-up|1|||
160814269|NCT00809835|580703775|FG003|Overall Study|Lost to Follow-up|2|||
160814270|NCT00809835|580703772|FG000|Overall Study|Withdrawal by Subject|1|||
160814271|NCT00809835|580703773|FG001|Overall Study|Withdrawal by Subject|1|||
160814272|NCT00809835|580703774|FG002|Overall Study|Withdrawal by Subject|1|||
160814273|NCT00809835|580703775|FG003|Overall Study|Withdrawal by Subject|0|||
160814274|NCT00516893|580703776|FG000|Overall Study|Lost to Follow-up|4|||
160814275|NCT00516893|580703776|FG000|Overall Study|Adverse Event|3|||
160814276|NCT00516893|580703776|FG000|Overall Study|Withdrawal by Subject|2|||
160814277|NCT00516893|580703776|FG000|Overall Study|Noncompliance|2|||
160814278|NCT00516893|580703776|FG000|Overall Study|Death|1|||
160814279|NCT00516893|580703776|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
160900140|NCT02761733|581028660|FG002|Overall Study|Physician Decision|0|||
160900141|NCT02761733|581028661|FG003|Overall Study|Physician Decision|0|||
160900142|NCT02761733|581028658|FG000|Overall Study|Withdrawal by Subject|2|||
160900143|NCT02761733|581028659|FG001|Overall Study|Withdrawal by Subject|0|||
160900144|NCT02761733|581028660|FG002|Overall Study|Withdrawal by Subject|0|||
160900145|NCT02761733|581028661|FG003|Overall Study|Withdrawal by Subject|0|||
160900146|NCT02761733|581028658|FG000|Overall Study|Discharged from Study Site|10|||
160900147|NCT02761733|581028659|FG001|Overall Study|Discharged from Study Site|9|||
160900148|NCT02761733|581028660|FG002|Overall Study|Discharged from Study Site|25|||
160900149|NCT02761733|581028661|FG003|Overall Study|Discharged from Study Site|11|||
160900150|NCT02761733|581028658|FG000|Overall Study|Cognitive Impairment|5|||
160900151|NCT02761733|581028659|FG001|Overall Study|Cognitive Impairment|0|||
160900152|NCT02761733|581028660|FG002|Overall Study|Cognitive Impairment|1|||
160900153|NCT02761733|581028661|FG003|Overall Study|Cognitive Impairment|0|||
160900154|NCT01297920|581028664|FG000|Overall Study|Adverse Event|42|||
160900155|NCT01297920|581028665|FG001|Overall Study|Adverse Event|10|||
160900156|NCT01297920|581028666|FG002|Overall Study|Adverse Event|38|||
161132082|NCT00996203|581867380|FG000|Overall Study|Lack of Efficacy|1|||
161132083|NCT00996203|581867380|FG000|Overall Study|Protocol Violation|2|||
161132084|NCT01959165|581867381|FG000|Overall Study|Adverse Event|0|||
161132085|NCT01959165|581867382|FG001|Overall Study|Adverse Event|0|||
161132086|NCT01959165|581867383|FG002|Overall Study|Adverse Event|0|||
161132087|NCT01959165|581867384|FG003|Overall Study|Adverse Event|1|||
161132088|NCT01959165|581867381|FG000|Overall Study|Lack of Efficacy|1|||
161132089|NCT01959165|581867382|FG001|Overall Study|Lack of Efficacy|0|||
161132090|NCT01959165|581867383|FG002|Overall Study|Lack of Efficacy|0|||
161132091|NCT01959165|581867384|FG003|Overall Study|Lack of Efficacy|0|||
161132092|NCT01959165|581867381|FG000|Overall Study|overdose|0|||
161132093|NCT01959165|581867382|FG001|Overall Study|overdose|0|||
161132094|NCT01959165|581867383|FG002|Overall Study|overdose|0|||
161132095|NCT01959165|581867384|FG003|Overall Study|overdose|1|||
161132096|NCT01959165|581867381|FG000|Overall Study|Welfare recipient|0|||
161132097|NCT01959165|581867382|FG001|Overall Study|Welfare recipient|1|||
161132098|NCT01959165|581867383|FG002|Overall Study|Welfare recipient|0|||
161132099|NCT01959165|581867384|FG003|Overall Study|Welfare recipient|0|||
161132100|NCT03898063|581867387|FG000|Overall Study|Withdrawal by Subject|10|||
161132101|NCT03898063|581867388|FG001|Overall Study|Withdrawal by Subject|8|||
161132102|NCT03430986|581867391|FG000|24-week Control Period|Adverse Event|1|||
161132103|NCT03430986|581867392|FG001|24-week Control Period|Adverse Event|0|||
161132104|NCT03430986|581867391|FG000|24-week Control Period|Lost to Follow-up|2|||
161132105|NCT03430986|581867392|FG001|24-week Control Period|Lost to Follow-up|2|||
161132106|NCT03430986|581867391|FG000|24-week Control Period|Withdrawal by Participant|5|||
161132107|NCT03430986|581867392|FG001|24-week Control Period|Withdrawal by Participant|0|||
161132108|NCT03430986|581867391|FG000|24-week Control Period|Protocol Deviation|0|||
161132109|NCT03430986|581867392|FG001|24-week Control Period|Protocol Deviation|2|||
161132110|NCT03430986|581867391|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
161132111|NCT03430986|581867392|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
161239840|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
160814280|NCT00516893|580703776|FG000|Overall Study|Relocated|1|||
160814281|NCT00516893|580703776|FG000|Overall Study|Pregnancy|1|||
160814282|NCT00516893|580703776|FG000|Overall Study|Received Medication From Another Study|1|||
160814283|NCT01519791|580703778|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
160900157|NCT01297920|581028664|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
160900158|NCT01297920|581028665|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
160900159|NCT01297920|581028666|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
160900160|NCT01297920|581028664|FG000|Overall Study|Noncompliance|1|||
161132112|NCT03430986|581867391|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
161132113|NCT03430986|581867392|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
161132114|NCT01889602|581867395|FG000|First Intervention|Adverse Event|1|||
161132115|NCT01889602|581867396|FG001|First Intervention|Adverse Event|1|||
161132116|NCT01889602|581867397|FG002|First Intervention|Adverse Event|1|||
160814284|NCT01519791|580703779|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
160814285|NCT01519791|580703778|FG000|Overall Study|Protocol Violation|6|||
160814286|NCT01519791|580703779|FG001|Overall Study|Protocol Violation|19|||
160814287|NCT01519791|580703778|FG000|Overall Study|Other Reason|87|||
160814288|NCT01519791|580703779|FG001|Overall Study|Other Reason|222|||
160814289|NCT01519791|580703778|FG000|Overall Study|subjects randomized in error|2|||
161239841|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239842|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160814290|NCT01519791|580703779|FG001|Overall Study|subjects randomized in error|0|||
160814291|NCT01519791|580703778|FG000|Overall Study|Lack of Efficacy|16|||
160814292|NCT01519791|580703779|FG001|Overall Study|Lack of Efficacy|20|||
160814293|NCT01519791|580703778|FG000|Overall Study|SAE, non-fatal|6|||
160814294|NCT01519791|580703779|FG001|Overall Study|SAE, non-fatal|22|||
160814295|NCT01519791|580703778|FG000|Overall Study|AE, serious fatal|0|||
160814296|NCT01519791|580703779|FG001|Overall Study|AE, serious fatal|1|||
160814297|NCT01519791|580703778|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
160814298|NCT01519791|580703779|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
160814299|NCT01519791|580703778|FG000|Overall Study|AE, non-serious non-fatal|12|||
160814300|NCT01519791|580703779|FG001|Overall Study|AE, non-serious non-fatal|31|||
160814301|NCT01519791|580703778|FG000|Overall Study|Withdrawal by Subject|15|||
160814302|NCT01519791|580703779|FG001|Overall Study|Withdrawal by Subject|37|||
160814303|NCT01519791|580703778|FG000|Overall Study|Lost to Follow-up|6|||
160814304|NCT01519791|580703779|FG001|Overall Study|Lost to Follow-up|14|||
161132117|NCT01889602|581867395|FG000|First Intervention|Protocol Violation|0|||
161132118|NCT01889602|581867396|FG001|First Intervention|Protocol Violation|1|||
161132119|NCT01889602|581867397|FG002|First Intervention|Protocol Violation|1|||
161132120|NCT01889602|581867395|FG000|First Intervention|Study ending|0|||
161132121|NCT01889602|581867396|FG001|First Intervention|Study ending|1|||
161132122|NCT01889602|581867397|FG002|First Intervention|Study ending|0|||
161132123|NCT01889602|581867395|FG000|Second Intervention|Adverse Event|0|||
161132124|NCT01889602|581867396|FG001|Second Intervention|Adverse Event|0|||
161132125|NCT01889602|581867397|FG002|Second Intervention|Adverse Event|1|||
161132126|NCT01889602|581867395|FG000|Second Intervention|Study ending|1|||
161132127|NCT01889602|581867396|FG001|Second Intervention|Study ending|0|||
161132128|NCT01889602|581867397|FG002|Second Intervention|Study ending|0|||
161132129|NCT01889602|581867395|FG000|Second Intervention|Withdrawal by Subject|0|||
161132130|NCT01889602|581867396|FG001|Second Intervention|Withdrawal by Subject|0|||
161132131|NCT01889602|581867397|FG002|Second Intervention|Withdrawal by Subject|1|||
161132132|NCT01889602|581867395|FG000|Third Intervention|Protocol Violation|1|||
161132133|NCT01889602|581867396|FG001|Third Intervention|Protocol Violation|0|||
161132134|NCT01889602|581867397|FG002|Third Intervention|Protocol Violation|0|||
161132135|NCT01889602|581867395|FG000|Third Intervention|Withdrawal by Subject|2|||
161239843|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239844|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239845|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239846|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239847|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160814305|NCT00559845|580703780|FG000|Overall Study|Withdrew Consent|1|||
160814306|NCT00559845|580703780|FG000|Overall Study|Disease Progression|1|||
160814307|NCT00559845|580703780|FG000|Overall Study|Adverse Event|3|||
160814308|NCT00559845|580703780|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
160814309|NCT00559845|580703780|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
160814310|NCT05791565|580703781|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
160814311|NCT05791565|580703782|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
160814312|NCT00880269|580703783|FG000|Overall Study|Protocol Violation|1|||
160814313|NCT00880269|580703784|FG001|Overall Study|Protocol Violation|0|||
160814314|NCT00880269|580703783|FG000|Overall Study|Disease Progression|13|||
160814315|NCT00880269|580703784|FG001|Overall Study|Disease Progression|11|||
160814316|NCT00880269|580703783|FG000|Overall Study|New Cancer Therapy|1|||
160814317|NCT00880269|580703784|FG001|Overall Study|New Cancer Therapy|0|||
160814318|NCT00880269|580703783|FG000|Overall Study|Death|4|||
161239848|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
160814319|NCT00880269|580703784|FG001|Overall Study|Death|2|||
160814320|NCT00880269|580703783|FG000|Overall Study|Lost to Follow-up|0|||
160814321|NCT00880269|580703784|FG001|Overall Study|Lost to Follow-up|1|||
160986936|NCT04955626|581341112|FG007|Blinded Period|Withdrawal by Subject|5|||
161239849|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
161132136|NCT01889602|581867396|FG001|Third Intervention|Withdrawal by Subject|2|||
161132137|NCT01889602|581867397|FG002|Third Intervention|Withdrawal by Subject|0|||
160814322|NCT00880269|580703783|FG000|Overall Study|Withdrawal by Subject|3|||
160814323|NCT00880269|580703784|FG001|Overall Study|Withdrawal by Subject|4|||
160814324|NCT00880269|580703783|FG000|Overall Study|Adverse Event|10|||
160814325|NCT00880269|580703784|FG001|Overall Study|Adverse Event|9|||
161132138|NCT00961961|581867398|FG000|Phase I|Withdrawal by Subject|7|||
161132139|NCT00961961|581867399|FG001|Phase I|Withdrawal by Subject|0|||
160814326|NCT02516982|580703785|FG000|Overall Study|Called in to antenatal appointment|32|||
160814327|NCT02516982|580703786|FG001|Overall Study|Called in to antenatal appointment|35|||
160814328|NCT02516982|580703787|FG002|Overall Study|Called in to antenatal appointment|0|||
160814329|NCT02516982|580703788|FG003|Overall Study|Called in to antenatal appointment|0|||
160814330|NCT02516982|580703785|FG000|Overall Study|Withdrawal by Subject|0|||
160814331|NCT02516982|580703786|FG001|Overall Study|Withdrawal by Subject|0|||
160814332|NCT02516982|580703787|FG002|Overall Study|Withdrawal by Subject|1|||
160814333|NCT02516982|580703788|FG003|Overall Study|Withdrawal by Subject|2|||
160814334|NCT02516982|580703785|FG000|Overall Study|Protocol Violation|0|||
160814335|NCT02516982|580703786|FG001|Overall Study|Protocol Violation|0|||
160814336|NCT02516982|580703787|FG002|Overall Study|Protocol Violation|1|||
160814337|NCT02516982|580703788|FG003|Overall Study|Protocol Violation|1|||
160814338|NCT02516982|580703785|FG000|Overall Study|Did not install the app|0|||
160814339|NCT02516982|580703786|FG001|Overall Study|Did not install the app|0|||
160814340|NCT02516982|580703787|FG002|Overall Study|Did not install the app|46|||
160814341|NCT02516982|580703788|FG003|Overall Study|Did not install the app|47|||
160814342|NCT03379259|580703790|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
160814343|NCT03379259|580703791|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
160814344|NCT03379259|580703792|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
160814345|NCT03379259|580703793|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
160814346|NCT03379259|580703794|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
160814347|NCT03379259|580703795|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
160814348|NCT03379259|580703790|FG000|Overall Study|Death|0|||
160814349|NCT03379259|580703791|FG001|Overall Study|Death|1|||
160814350|NCT03379259|580703792|FG002|Overall Study|Death|2|||
160814351|NCT03379259|580703793|FG003|Overall Study|Death|1|||
160814352|NCT03379259|580703794|FG004|Overall Study|Death|4|||
160814353|NCT03379259|580703795|FG005|Overall Study|Death|2|||
160814354|NCT03379259|580703790|FG000|Overall Study|Withdrawal by Subject|0|||
160814355|NCT03379259|580703791|FG001|Overall Study|Withdrawal by Subject|0|||
160814356|NCT03379259|580703792|FG002|Overall Study|Withdrawal by Subject|1|||
160814357|NCT03379259|580703793|FG003|Overall Study|Withdrawal by Subject|0|||
160814358|NCT03379259|580703794|FG004|Overall Study|Withdrawal by Subject|2|||
160814359|NCT03379259|580703795|FG005|Overall Study|Withdrawal by Subject|0|||
160814360|NCT03379259|580703790|FG000|Overall Study|Study terminated by sponsor|0|||
160814361|NCT03379259|580703791|FG001|Overall Study|Study terminated by sponsor|0|||
160814362|NCT03379259|580703792|FG002|Overall Study|Study terminated by sponsor|0|||
160814363|NCT03379259|580703793|FG003|Overall Study|Study terminated by sponsor|1|||
160814364|NCT03379259|580703794|FG004|Overall Study|Study terminated by sponsor|1|||
160814365|NCT03379259|580703795|FG005|Overall Study|Study terminated by sponsor|4|||
160814366|NCT03379259|580703790|FG000|Overall Study|Disease progression|0|||
160814367|NCT03379259|580703791|FG001|Overall Study|Disease progression|0|||
160814368|NCT03379259|580703792|FG002|Overall Study|Disease progression|0|||
160814369|NCT03379259|580703793|FG003|Overall Study|Disease progression|1|||
160814370|NCT03379259|580703794|FG004|Overall Study|Disease progression|0|||
160814371|NCT03379259|580703795|FG005|Overall Study|Disease progression|1|||
160814372|NCT03379259|580703790|FG000|Overall Study|Lost to Follow-up|0|||
160814373|NCT03379259|580703791|FG001|Overall Study|Lost to Follow-up|0|||
160814374|NCT03379259|580703792|FG002|Overall Study|Lost to Follow-up|0|||
160814375|NCT03379259|580703793|FG003|Overall Study|Lost to Follow-up|0|||
160814376|NCT03379259|580703794|FG004|Overall Study|Lost to Follow-up|1|||
160814377|NCT03379259|580703795|FG005|Overall Study|Lost to Follow-up|0|||
160814378|NCT03379259|580703790|FG000|Overall Study|Deteriorating condition|0|||
160814379|NCT03379259|580703791|FG001|Overall Study|Deteriorating condition|0|||
160814380|NCT03379259|580703792|FG002|Overall Study|Deteriorating condition|0|||
160814381|NCT03379259|580703793|FG003|Overall Study|Deteriorating condition|0|||
160900161|NCT01297920|581028665|FG001|Overall Study|Noncompliance|0|||
160900162|NCT01297920|581028666|FG002|Overall Study|Noncompliance|0|||
160900163|NCT01297920|581028664|FG000|Overall Study|Protocol Violation|1|||
161239850|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
161239851|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239852|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239853|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239854|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
161239855|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
161239856|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
160814382|NCT03379259|580703794|FG004|Overall Study|Deteriorating condition|1|||
160814383|NCT03379259|580703795|FG005|Overall Study|Deteriorating condition|0|||
160814384|NCT03195660|580703796|FG000|Overall Study|The study was terminated|2|||
160814385|NCT00375427|580703797|FG000|Overall Study|Adverse Event|21|||
160814386|NCT00375427|580703798|FG001|Overall Study|Adverse Event|27|||
160814387|NCT00375427|580703797|FG000|Overall Study|Abnormal test procedure result(s)|0|||
160814388|NCT00375427|580703798|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160814389|NCT00375427|580703797|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160900164|NCT01297920|581028665|FG001|Overall Study|Protocol Violation|3|||
161239857|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
161239858|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
161239859|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
161239860|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
161239861|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
161239862|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
161239863|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
161239864|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
161239865|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
161239866|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
161239867|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
161239868|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
161239869|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239870|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239871|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239872|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239873|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239874|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239875|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239876|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239877|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
161239878|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
161239879|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239880|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239881|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239882|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
161239883|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239884|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239885|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239886|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239887|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
160814390|NCT00375427|580703798|FG001|Overall Study|Abnormal laboratory value(s)|2|||
160814391|NCT00375427|580703797|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
160814392|NCT00375427|580703798|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160814393|NCT00375427|580703797|FG000|Overall Study|Patient no longer requires study drug|3|||
160814394|NCT00375427|580703798|FG001|Overall Study|Patient no longer requires study drug|7|||
160814395|NCT00375427|580703797|FG000|Overall Study|Protocol Violation|10|||
160814396|NCT00375427|580703798|FG001|Overall Study|Protocol Violation|8|||
160814397|NCT00375427|580703797|FG000|Overall Study|Withdrawal by Subject|9|||
160814398|NCT00375427|580703798|FG001|Overall Study|Withdrawal by Subject|13|||
160814399|NCT00375427|580703797|FG000|Overall Study|Lost to Follow-up|1|||
160814400|NCT00375427|580703798|FG001|Overall Study|Lost to Follow-up|1|||
160814401|NCT00375427|580703797|FG000|Overall Study|Administrative reasons|0|||
160814402|NCT00375427|580703798|FG001|Overall Study|Administrative reasons|1|||
160814403|NCT00375427|580703797|FG000|Overall Study|Death|11|||
160814404|NCT00375427|580703798|FG001|Overall Study|Death|10|||
160814405|NCT01977729|580703804|FG000|Overall Study|Study terminated|1|||
160814406|NCT01268046|580703805|FG000|Overall Study|Withdrawal by Subject|1|||
160814407|NCT01268046|580703806|FG001|Overall Study|Withdrawal by Subject|0|||
160814408|NCT01268046|580703807|FG002|Overall Study|Withdrawal by Subject|0|||
160814409|NCT01268046|580703808|FG003|Overall Study|Withdrawal by Subject|1|||
160814410|NCT01268046|580703805|FG000|Overall Study|Lost to Follow-up|0|||
160814411|NCT01268046|580703806|FG001|Overall Study|Lost to Follow-up|0|||
160814412|NCT01268046|580703807|FG002|Overall Study|Lost to Follow-up|1|||
160814413|NCT01268046|580703808|FG003|Overall Study|Lost to Follow-up|0|||
160814414|NCT03636893|580703809|FG000|Overall Study|Death|0|||
160814415|NCT03636893|580703810|FG001|Overall Study|Death|1|||
160814416|NCT03636893|580703809|FG000|Overall Study|Protocol Violation|0|||
160814417|NCT03636893|580703810|FG001|Overall Study|Protocol Violation|3|||
160814418|NCT03636893|580703809|FG000|Overall Study|Withdrawal by Subject|1|||
160986937|NCT04955626|581341113|FG008|Blinded Period|Withdrawal by Subject|3|||
160814419|NCT03636893|580703810|FG001|Overall Study|Withdrawal by Subject|2|||
160814420|NCT03636893|580703809|FG000|Overall Study|Refusal to surgery|4|||
160814421|NCT03636893|580703810|FG001|Overall Study|Refusal to surgery|3|||
160814422|NCT03636893|580703809|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
160986938|NCT04955626|581341114|FG009|Blinded Period|Withdrawal by Subject|15|||
160986939|NCT04955626|581341115|FG010|Blinded Period|Withdrawal by Subject|11|||
160986940|NCT04955626|581341116|FG011|Blinded Period|Withdrawal by Subject|7|||
160986941|NCT04955626|581341117|FG012|Blinded Period|Withdrawal by Subject|2|||
160986942|NCT04955626|581341118|FG013|Blinded Period|Withdrawal by Subject|0|||
160986943|NCT04955626|581341119|FG014|Blinded Period|Withdrawal by Subject|1|||
160814423|NCT03636893|580703810|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
160814424|NCT03636893|580703809|FG000|Overall Study|Adverse Event|1|||
160814425|NCT03636893|580703810|FG001|Overall Study|Adverse Event|1|||
160814426|NCT02314156|580703811|FG000|Overall Study|Adverse Event|1|||
160814427|NCT02314156|580703812|FG001|Overall Study|Adverse Event|0|||
160814428|NCT02314156|580703811|FG000|Overall Study|Withdrawal by Subject|1|||
160814429|NCT02314156|580703812|FG001|Overall Study|Withdrawal by Subject|0|||
160814430|NCT00758069|580703815|FG000|Overall Study|Lack of Efficacy|0|||
160814431|NCT00758069|580703816|FG001|Overall Study|Lack of Efficacy|0|||
160814432|NCT00758069|580703817|FG002|Overall Study|Lack of Efficacy|1|||
160814433|NCT00758069|580703815|FG000|Overall Study|Incorrect Study Drug|1|||
160814434|NCT00758069|580703816|FG001|Overall Study|Incorrect Study Drug|0|||
160814435|NCT00758069|580703817|FG002|Overall Study|Incorrect Study Drug|0|||
160814436|NCT04560816|580703818|FG000|Overall Study|Withdrawal by Subject|1|||
160814437|NCT04560816|580703819|FG001|Overall Study|Withdrawal by Subject|1|||
160814438|NCT04560816|580703820|FG002|Overall Study|Withdrawal by Subject|1|||
160814439|NCT04560816|580703821|FG003|Overall Study|Withdrawal by Subject|0|||
160814440|NCT04560816|580703822|FG004|Overall Study|Withdrawal by Subject|3|||
160814441|NCT04560816|580703823|FG005|Overall Study|Withdrawal by Subject|0|||
160814442|NCT04560816|580703818|FG000|Overall Study|Lost to Follow-up|1|||
160814443|NCT04560816|580703819|FG001|Overall Study|Lost to Follow-up|0|||
160814444|NCT04560816|580703820|FG002|Overall Study|Lost to Follow-up|0|||
160814445|NCT04560816|580703821|FG003|Overall Study|Lost to Follow-up|0|||
160814446|NCT04560816|580703822|FG004|Overall Study|Lost to Follow-up|0|||
160814447|NCT04560816|580703823|FG005|Overall Study|Lost to Follow-up|0|||
160814448|NCT04560816|580703818|FG000|Overall Study|Protocol Violation|1|||
160814449|NCT04560816|580703819|FG001|Overall Study|Protocol Violation|0|||
160814450|NCT04560816|580703820|FG002|Overall Study|Protocol Violation|0|||
160814451|NCT04560816|580703821|FG003|Overall Study|Protocol Violation|0|||
160814452|NCT04560816|580703822|FG004|Overall Study|Protocol Violation|0|||
160814453|NCT04560816|580703823|FG005|Overall Study|Protocol Violation|0|||
160814454|NCT02277691|580703824|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
160814455|NCT02277691|580703824|FG000|Overall Study|Voluntary Withdrawal|7|||
160814456|NCT02277691|580703824|FG000|Overall Study|Lack of Efficacy|5|||
160814457|NCT02277691|580703824|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
160814458|NCT02846389|580703827|FG000|Overall Study|Withdrawal by Subject|1|||
160814459|NCT02846389|580703828|FG001|Overall Study|Withdrawal by Subject|1|||
160814460|NCT03818607|580703831|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
160814461|NCT03818607|580703832|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
160814462|NCT03818607|580703831|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
160814463|NCT03818607|580703832|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
160814464|NCT03818607|580703831|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
160814465|NCT03818607|580703832|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
160814466|NCT01147250|580703836|FG000|Overall Study|Lost to Follow-up|14|||
160814467|NCT01147250|580703837|FG001|Overall Study|Lost to Follow-up|11|||
160814468|NCT01147250|580703836|FG000|Overall Study|Withdrawal by Subject|83|||
160814469|NCT01147250|580703837|FG001|Overall Study|Withdrawal by Subject|88|||
160814470|NCT01147250|580703836|FG000|Overall Study|Site termination by sponsor|13|||
160814471|NCT01147250|580703837|FG001|Overall Study|Site termination by sponsor|5|||
160814472|NCT01147250|580703836|FG000|Overall Study|Other than specified|0|||
160814473|NCT01147250|580703837|FG001|Overall Study|Other than specified|1|||
160814474|NCT02249091|580703839|FG000|Overall Study|Lack of Efficacy|8|||
160814475|NCT02249091|580703840|FG001|Overall Study|Lack of Efficacy|3|||
160814476|NCT02249091|580703839|FG000|Overall Study|Physician Decision|4|||
160814477|NCT02249091|580703840|FG001|Overall Study|Physician Decision|1|||
160814478|NCT02249091|580703839|FG000|Overall Study|Withdrawal by Subject|2|||
160814479|NCT02249091|580703840|FG001|Overall Study|Withdrawal by Subject|2|||
160814480|NCT02249091|580703839|FG000|Overall Study|Death|3|||
160814481|NCT02249091|580703840|FG001|Overall Study|Death|4|||
160814482|NCT02249091|580703839|FG000|Overall Study|Adverse Event|1|||
160814483|NCT02249091|580703840|FG001|Overall Study|Adverse Event|0|||
160814484|NCT02249091|580703839|FG000|Overall Study|Stable disease with following SCT|0|||
160814485|NCT02249091|580703840|FG001|Overall Study|Stable disease with following SCT|1|||
160814486|NCT02249091|580703839|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
160814487|NCT02249091|580703840|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
160814488|NCT02249091|580703839|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
160814489|NCT02249091|580703840|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
160814490|NCT02249091|580703839|FG000|Overall Study|Refractory AML|1|||
160814491|NCT02249091|580703840|FG001|Overall Study|Refractory AML|1|||
160814492|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814493|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
160814494|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814495|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814496|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814497|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
160814498|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
160814499|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
160814500|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814501|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814502|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814503|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160814504|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
160814505|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
160814506|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814507|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814508|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814509|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160814510|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
160814511|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
160814512|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814513|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814514|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
160814515|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
161132140|NCT00961961|581867400|FG002|Phase I|Withdrawal by Subject|0|||
161132141|NCT00961961|581867401|FG003|Phase I|Withdrawal by Subject|0|||
160814516|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814517|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
160814518|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814519|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814520|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814521|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160814522|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
160814523|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
160814524|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814525|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814526|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814527|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
160814528|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814529|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
160814530|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814531|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814532|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814533|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
160814534|NCT03985943|580703844|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814535|NCT03985943|580703845|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
160900165|NCT01297920|581028666|FG002|Overall Study|Protocol Violation|0|||
160900166|NCT01297920|581028664|FG000|Overall Study|Inadequate Control of IOP|7|||
160900167|NCT01297920|581028665|FG001|Overall Study|Inadequate Control of IOP|9|||
160900168|NCT01297920|581028666|FG002|Overall Study|Inadequate Control of IOP|17|||
160900169|NCT01297920|581028664|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
160900170|NCT01297920|581028665|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
160900171|NCT01297920|581028666|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
160900172|NCT01710046|581028667|FG000|Overall Study|Lost to Follow-up|1|||
160900173|NCT01710046|581028668|FG001|Overall Study|Lost to Follow-up|0|||
160900174|NCT02215096|581028669|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
160900175|NCT02215096|581028670|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900176|NCT02215096|581028671|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900177|NCT02215096|581028672|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900178|NCT02215096|581028673|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
160900179|NCT02215096|581028669|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900180|NCT02215096|581028670|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900181|NCT02215096|581028671|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900182|NCT02215096|581028672|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
160900183|NCT02215096|581028673|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
160986944|NCT04955626|581341120|FG015|Blinded Period|Withdrawal by Subject|11|||
160986945|NCT04955626|581341121|FG016|Blinded Period|Withdrawal by Subject|2|||
161132142|NCT00961961|581867398|FG000|Phase I|Lost to Follow-up|10|||
161132143|NCT00961961|581867399|FG001|Phase I|Lost to Follow-up|0|||
161132144|NCT00961961|581867400|FG002|Phase I|Lost to Follow-up|0|||
161333209|NCT02974868|582608680|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
160814536|NCT03985943|580703846|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814537|NCT03985943|580703847|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814538|NCT03985943|580703848|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814539|NCT03985943|580703849|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
160814540|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160814541|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160814542|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
160814543|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
160814544|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
160814545|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
160814546|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160814547|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160814548|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
160986946|NCT04955626|581341122|FG017|Blinded Period|Withdrawal by Subject|5|||
160986947|NCT04955626|581341123|FG018|Blinded Period|Withdrawal by Subject|0|||
160986948|NCT04955626|581341124|FG019|Blinded Period|Withdrawal by Subject|0|||
160986949|NCT04955626|581341125|FG020|Blinded Period|Withdrawal by Subject|1|||
160814549|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
160814550|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
160814551|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
160814552|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
160814553|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
160814554|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
160814555|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
160814556|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
160814557|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
160814558|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160986950|NCT04955626|581341126|FG021|Blinded Period|Withdrawal by Subject|0|||
160986951|NCT04955626|581341127|FG022|Blinded Period|Withdrawal by Subject|0|||
160986952|NCT04955626|581341128|FG023|Blinded Period|Withdrawal by Subject|0|||
160986953|NCT04955626|581341129|FG024|Blinded Period|Withdrawal by Subject|5|||
160986954|NCT04955626|581341130|FG025|Blinded Period|Withdrawal by Subject|1|||
160986955|NCT04955626|581341131|FG026|Blinded Period|Withdrawal by Subject|5|||
160814559|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160814560|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160986956|NCT04955626|581341132|FG027|Blinded Period|Withdrawal by Subject|1|||
160986957|NCT04955626|581341133|FG028|Blinded Period|Withdrawal by Subject|4|||
160986958|NCT04955626|581341134|FG029|Blinded Period|Withdrawal by Subject|2|||
160986959|NCT04955626|581341135|FG030|Blinded Period|Withdrawal by Subject|0|||
160986960|NCT04955626|581341136|FG031|Blinded Period|Withdrawal by Subject|0|||
160986961|NCT04955626|581341137|FG032|Blinded Period|Withdrawal by Subject|0|||
160986962|NCT04955626|581341138|FG033|Blinded Period|Withdrawal by Subject|0|||
160986963|NCT04955626|581341139|FG034|Blinded Period|Withdrawal by Subject|0|||
160986964|NCT04955626|581341140|FG035|Blinded Period|Withdrawal by Subject|0|||
160986965|NCT04955626|581341105|FG000|Blinded Period|Refused further study procedures|0|||
160986966|NCT04955626|581341106|FG001|Blinded Period|Refused further study procedures|0|||
160986967|NCT04955626|581341107|FG002|Blinded Period|Refused further study procedures|0|||
160986968|NCT04955626|581341108|FG003|Blinded Period|Refused further study procedures|0|||
160986969|NCT04955626|581341109|FG004|Blinded Period|Refused further study procedures|0|||
160986970|NCT04955626|581341110|FG005|Blinded Period|Refused further study procedures|0|||
160986971|NCT04955626|581341111|FG006|Blinded Period|Refused further study procedures|1|||
160986972|NCT04955626|581341112|FG007|Blinded Period|Refused further study procedures|0|||
160986973|NCT04955626|581341113|FG008|Blinded Period|Refused further study procedures|0|||
160986974|NCT04955626|581341114|FG009|Blinded Period|Refused further study procedures|0|||
160986975|NCT04955626|581341115|FG010|Blinded Period|Refused further study procedures|0|||
160986976|NCT04955626|581341116|FG011|Blinded Period|Refused further study procedures|2|||
160814561|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160814562|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160814563|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160814564|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160986977|NCT04955626|581341117|FG012|Blinded Period|Refused further study procedures|0|||
160986978|NCT04955626|581341118|FG013|Blinded Period|Refused further study procedures|0|||
160986979|NCT04955626|581341119|FG014|Blinded Period|Refused further study procedures|0|||
160986980|NCT04955626|581341120|FG015|Blinded Period|Refused further study procedures|0|||
160986981|NCT04955626|581341121|FG016|Blinded Period|Refused further study procedures|0|||
160986982|NCT04955626|581341122|FG017|Blinded Period|Refused further study procedures|0|||
160986983|NCT04955626|581341123|FG018|Blinded Period|Refused further study procedures|0|||
160986984|NCT04955626|581341124|FG019|Blinded Period|Refused further study procedures|0|||
160986985|NCT04955626|581341125|FG020|Blinded Period|Refused further study procedures|0|||
160814565|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160814566|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
160814567|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160814568|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
160814569|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
160814570|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
160814571|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
160814572|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
160814573|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
160814574|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
160814575|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
160814576|NCT03985943|580703844|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
160814577|NCT03985943|580703845|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
160814578|NCT03985943|580703846|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
160814579|NCT03985943|580703847|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
160814580|NCT03985943|580703848|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
160814581|NCT03985943|580703849|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
160814582|NCT00716482|580703850|FG000|Overall Study|Lost to Follow-up|6|||
160814583|NCT00716482|580703850|FG000|Overall Study|Inadequate acquisition or analysis|50|||
160814584|NCT00716482|580703850|FG000|Overall Study|no pathology obtained|10|||
160814585|NCT00716482|580703850|FG000|Overall Study|technical/machine error|28|||
160814586|NCT00716482|580703850|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
160814587|NCT04075513|580703853|FG000|Overall Study|Withdrawal by Subject|2|||
160814588|NCT04075513|580703854|FG001|Overall Study|Withdrawal by Subject|2|||
160814589|NCT04075513|580703853|FG000|Overall Study|Lack of Efficacy|1|||
160814590|NCT04075513|580703854|FG001|Overall Study|Lack of Efficacy|0|||
160814591|NCT04075513|580703853|FG000|Overall Study|Lost to Follow-up|4|||
160814592|NCT04075513|580703854|FG001|Overall Study|Lost to Follow-up|2|||
160814593|NCT04075513|580703853|FG000|Overall Study|Switch to insulin pump|1|||
160814594|NCT04075513|580703854|FG001|Overall Study|Switch to insulin pump|0|||
160814595|NCT05730335|580703855|FG000|Overall Study|Lost to Follow-up|8|||
160814596|NCT05730335|580703855|FG000|Overall Study|Withdrawal by Subject|6|||
160814597|NCT03249909|580703856|FG000|Overall Study|Withdrawal by Subject|3|||
160814598|NCT03249909|580703857|FG001|Overall Study|Withdrawal by Subject|0|||
160814599|NCT03249909|580703858|FG002|Overall Study|Withdrawal by Subject|0|||
160814600|NCT03249909|580703856|FG000|Overall Study|Adverse Event|3|||
160814601|NCT03249909|580703857|FG001|Overall Study|Adverse Event|0|||
160814602|NCT03249909|580703858|FG002|Overall Study|Adverse Event|0|||
160814603|NCT03249909|580703856|FG000|Overall Study|Lost to Follow-up|0|||
160814604|NCT03249909|580703857|FG001|Overall Study|Lost to Follow-up|1|||
160814605|NCT03249909|580703858|FG002|Overall Study|Lost to Follow-up|0|||
160814606|NCT03517371|580703859|FG000|Overall Study|Adverse Event|8|||
160814607|NCT03517371|580703860|FG001|Overall Study|Adverse Event|9|||
160814608|NCT03517371|580703859|FG000|Overall Study|Lost to Follow-up|1|||
160814609|NCT03517371|580703860|FG001|Overall Study|Lost to Follow-up|2|||
160814610|NCT03517371|580703859|FG000|Overall Study|Withdrawal by Subject|4|||
160814611|NCT03517371|580703860|FG001|Overall Study|Withdrawal by Subject|4|||
160814612|NCT03517371|580703859|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
160814613|NCT03517371|580703860|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
160814614|NCT03517371|580703859|FG000|Overall Study|COVID restrictions|2|||
160814615|NCT03517371|580703860|FG001|Overall Study|COVID restrictions|0|||
160814616|NCT03517371|580703859|FG000|Overall Study|Receiving DBS Surgery|0|||
160814617|NCT03517371|580703860|FG001|Overall Study|Receiving DBS Surgery|1|||
160814618|NCT05411822|580703861|FG000|Overall Study|Withdrawal by Subject|2|||
160814619|NCT05411822|580703862|FG001|Overall Study|Withdrawal by Subject|1|||
160814620|NCT01345929|580703863|FG000|Overall Study|Withdrawal by Subject|9|||
160814621|NCT01345929|580703864|FG001|Overall Study|Withdrawal by Subject|8|||
160814622|NCT01345929|580703863|FG000|Overall Study|Lost to Follow-up|9|||
160814623|NCT01345929|580703864|FG001|Overall Study|Lost to Follow-up|9|||
160814624|NCT01345929|580703863|FG000|Overall Study|Adverse Event|0|||
160814625|NCT01345929|580703864|FG001|Overall Study|Adverse Event|1|||
160814626|NCT01345929|580703863|FG000|Overall Study|Didn't meet eligibility criteria|2|||
160814627|NCT01345929|580703864|FG001|Overall Study|Didn't meet eligibility criteria|0|||
160814628|NCT01345929|580703863|FG000|Overall Study|40,000 CFU/ML|1|||
160814629|NCT01345929|580703864|FG001|Overall Study|40,000 CFU/ML|0|||
160814630|NCT01345929|580703863|FG000|Overall Study|Patient withdrawal|0|||
160814631|NCT01345929|580703864|FG001|Overall Study|Patient withdrawal|1|||
160814632|NCT02819297|580703865|FG000|Overall Study|Withdrawal by Subject|25|||
160900184|NCT02215096|581028669|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160814633|NCT02819297|580703866|FG001|Overall Study|Withdrawal by Subject|13|||
160814634|NCT02819297|580703865|FG000|Overall Study|Lost to Follow-up|12|||
160814635|NCT02819297|580703866|FG001|Overall Study|Lost to Follow-up|14|||
160814636|NCT02819297|580703865|FG000|Overall Study|Adverse Event|12|||
160900185|NCT02215096|581028670|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160814637|NCT02819297|580703866|FG001|Overall Study|Adverse Event|10|||
160814638|NCT02819297|580703865|FG000|Overall Study|Physician Decision|5|||
160814639|NCT02819297|580703866|FG001|Overall Study|Physician Decision|5|||
160814640|NCT02819297|580703865|FG000|Overall Study|Lack of Efficacy|5|||
160814641|NCT02819297|580703866|FG001|Overall Study|Lack of Efficacy|8|||
160814642|NCT02819297|580703865|FG000|Overall Study|Protocol Violation|1|||
160814643|NCT02819297|580703866|FG001|Overall Study|Protocol Violation|2|||
160814644|NCT02318368|580703867|FG000|Overall Study|Withdrawal by Subject|2|||
160814645|NCT02318368|580703868|FG001|Overall Study|Withdrawal by Subject|0|||
160814646|NCT02318368|580703867|FG000|Overall Study|Study terminated by the sponsor|5|||
160814647|NCT02318368|580703868|FG001|Overall Study|Study terminated by the sponsor|2|||
160814648|NCT02318368|580703867|FG000|Overall Study|Death|0|||
160814649|NCT02318368|580703868|FG001|Overall Study|Death|1|||
160814650|NCT01901614|580703869|FG000|Overall Study|Adverse Event|0|||
160814651|NCT01901614|580703870|FG001|Overall Study|Adverse Event|1|||
160814652|NCT01901614|580703869|FG000|Overall Study|Lost to Follow-up|1|||
160814653|NCT01901614|580703870|FG001|Overall Study|Lost to Follow-up|0|||
160814654|NCT01901614|580703869|FG000|Overall Study|Screen Fail|1|||
160814655|NCT01901614|580703870|FG001|Overall Study|Screen Fail|0|||
160814656|NCT01814046|580703876|FG000|Drug Administration|Death due to complications of RSV|1|||
160814657|NCT01814046|580703877|FG001|Drug Administration|Death due to complications of RSV|0|||
160814658|NCT01814046|580703878|FG002|Drug Administration|Death due to complications of RSV|0|||
160814659|NCT00564902|580703879|FG000|Overall Study|Withdrawal by Subject|0|||
160814660|NCT00564902|580703880|FG001|Overall Study|Withdrawal by Subject|3|||
160814661|NCT00564902|580703881|FG002|Overall Study|Withdrawal by Subject|4|||
160814662|NCT00564902|580703879|FG000|Overall Study|Death|1|||
160814663|NCT00564902|580703880|FG001|Overall Study|Death|1|||
160814664|NCT00564902|580703881|FG002|Overall Study|Death|0|||
160814665|NCT00958347|580703882|FG000|Overall Study|Death|43|||
160814666|NCT00958347|580703882|FG000|Overall Study|Withdrawal by Subject|23|||
160814667|NCT00958347|580703882|FG000|Overall Study|Lost to Follow-up|15|||
160814668|NCT00958347|580703882|FG000|Overall Study|revision/removal|10|||
160814669|NCT00958347|580703882|FG000|Overall Study|study termination|135|||
160814670|NCT04552288|580703885|FG000|Overall Study|Death|3|||
160814671|NCT04552288|580703885|FG000|Overall Study|Lost to Follow-up|6|||
160814672|NCT04552288|580703885|FG000|Overall Study|Physician Decision|3|||
160814673|NCT04552288|580703885|FG000|Overall Study|Protocol Violation|9|||
160814674|NCT04552288|580703885|FG000|Overall Study|Withdrawal by Subject|6|||
160814675|NCT04552288|580703885|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
160814676|NCT01603043|580703886|FG000|Overall Study|Study Futility|7|||
160814677|NCT01603043|580703887|FG001|Overall Study|Study Futility|3|||
160814678|NCT01917929|580703888|FG000|Overall Study|Death|8|||
160814679|NCT01917929|580703888|FG000|Overall Study|Lost to Follow-up|19|||
160814680|NCT01917929|580703888|FG000|Overall Study|Withdrawal by Subject|33|||
160814681|NCT01917929|580703888|FG000|Overall Study|Adverse Event|6|||
160814682|NCT01917929|580703888|FG000|Overall Study|Investigative Site Terminated|35|||
160814683|NCT01917929|580703888|FG000|Overall Study|Censored because study device not implanted|6|||
160814684|NCT01917929|580703888|FG000|Overall Study|Censored because surgery not performed|3|||
160814685|NCT01917929|580703888|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
160814686|NCT01917929|580703888|FG000|Overall Study|Sponsor terminated study|175|||
160814687|NCT04532294|580703889|FG000|Overall Study|Withdrawal by Subject|0|||
160814688|NCT04532294|580703890|FG001|Overall Study|Withdrawal by Subject|0|||
160814689|NCT04532294|580703891|FG002|Overall Study|Withdrawal by Subject|1|||
160814690|NCT04532294|580703889|FG000|Overall Study|Participants Not Dosed|0|||
160814691|NCT04532294|580703890|FG001|Overall Study|Participants Not Dosed|0|||
160814692|NCT04532294|580703891|FG002|Overall Study|Participants Not Dosed|2|||
160814693|NCT03089047|580703892|FG000|Overall Study|Lost to Follow-up|1|||
160814694|NCT03089047|580703893|FG001|Overall Study|Lost to Follow-up|0|||
160814695|NCT03599518|580703894|FG000|Overall Study|Clinical progression|0|||
160814696|NCT03599518|580703895|FG001|Overall Study|Clinical progression|0|||
160814697|NCT03599518|580703896|FG002|Overall Study|Clinical progression|0|||
160814698|NCT03599518|580703897|FG003|Overall Study|Clinical progression|0|||
160814699|NCT03599518|580703898|FG004|Overall Study|Clinical progression|1|||
160814700|NCT03599518|580703894|FG000|Overall Study|Adverse Event|0|||
160814701|NCT03599518|580703895|FG001|Overall Study|Adverse Event|0|||
160814702|NCT03599518|580703896|FG002|Overall Study|Adverse Event|0|||
160814703|NCT03599518|580703897|FG003|Overall Study|Adverse Event|0|||
160814704|NCT03599518|580703898|FG004|Overall Study|Adverse Event|1|||
160814705|NCT03599518|580703894|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
160814706|NCT03599518|580703895|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
160814707|NCT03599518|580703896|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
160814708|NCT03599518|580703897|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
160814709|NCT03599518|580703898|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
160814710|NCT03599518|580703894|FG000|Overall Study|Participant withdrawal from study treatment|0|||
160900186|NCT02215096|581028671|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160900187|NCT02215096|581028672|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
160814711|NCT03599518|580703895|FG001|Overall Study|Participant withdrawal from study treatment|0|||
160814712|NCT03599518|580703896|FG002|Overall Study|Participant withdrawal from study treatment|1|||
160814713|NCT03599518|580703897|FG003|Overall Study|Participant withdrawal from study treatment|0|||
160814714|NCT03599518|580703898|FG004|Overall Study|Participant withdrawal from study treatment|0|||
160814715|NCT06899737|580703899|FG000|Overall Study|Lost to Follow-up|19|||
160814716|NCT06899737|580703900|FG001|Overall Study|Lost to Follow-up|7|||
160814717|NCT01082081|580703901|FG000|Overall Study|Lost to Follow-up|0|||
160814718|NCT01082081|580703902|FG001|Overall Study|Lost to Follow-up|0|||
160814719|NCT01082081|580703903|FG002|Overall Study|Lost to Follow-up|1|||
160814720|NCT01082081|580703901|FG000|Overall Study|Withdrawal by Subject|0|||
160814721|NCT01082081|580703902|FG001|Overall Study|Withdrawal by Subject|0|||
160814722|NCT01082081|580703903|FG002|Overall Study|Withdrawal by Subject|1|||
160814723|NCT01082081|580703901|FG000|Overall Study|Other Reason|0|||
160814724|NCT01082081|580703902|FG001|Overall Study|Other Reason|1|||
160814725|NCT01082081|580703903|FG002|Overall Study|Other Reason|0|||
160814726|NCT01575808|580703904|FG000|Overall Study|Death|2|||
160814727|NCT01575808|580703905|FG001|Overall Study|Death|0|||
160814728|NCT01575808|580703904|FG000|Overall Study|Withdrawal by Subject|1|||
160814729|NCT01575808|580703905|FG001|Overall Study|Withdrawal by Subject|0|||
160814730|NCT03159468|580703906|FG000|Overall Study|Withdrawal by Subject|0|||
160814731|NCT03159468|580703907|FG001|Overall Study|Withdrawal by Subject|0|||
160814732|NCT03159468|580703908|FG002|Overall Study|Withdrawal by Subject|3|||
160814733|NCT03159468|580703909|FG003|Overall Study|Withdrawal by Subject|0|||
160814734|NCT03159468|580703910|FG004|Overall Study|Withdrawal by Subject|0|||
160814735|NCT03159468|580703911|FG005|Overall Study|Withdrawal by Subject|0|||
160814736|NCT04308239|580705493|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
160814737|NCT04308239|580705494|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
160814738|NCT04308239|580705493|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
160814739|NCT04308239|580705494|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
160814740|NCT04308239|580705493|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
160814741|NCT04308239|580705494|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
160814742|NCT04308239|580705493|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
160814743|NCT04308239|580705494|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
160814744|NCT01670279|580705497|FG000|Overall Study|Adverse Event|0|||
160814745|NCT01670279|580705498|FG001|Overall Study|Adverse Event|1|||
160814746|NCT01670279|580705499|FG002|Overall Study|Adverse Event|0|||
160814747|NCT01670279|580705500|FG003|Overall Study|Adverse Event|0|||
160814748|NCT01670279|580705497|FG000|Overall Study|Physician Decision|0|||
160814749|NCT01670279|580705498|FG001|Overall Study|Physician Decision|1|||
160814750|NCT01670279|580705499|FG002|Overall Study|Physician Decision|0|||
160814751|NCT01670279|580705500|FG003|Overall Study|Physician Decision|0|||
160814752|NCT01670279|580705497|FG000|Overall Study|Participant met withdrawal criteria|0|||
160814753|NCT01670279|580705498|FG001|Overall Study|Participant met withdrawal criteria|0|||
160814754|NCT01670279|580705499|FG002|Overall Study|Participant met withdrawal criteria|0|||
160814755|NCT01670279|580705500|FG003|Overall Study|Participant met withdrawal criteria|1|||
160814756|NCT01555073|580705501|FG000|Overall Study|Lost to Follow-up|1|||
160814757|NCT01555073|580705502|FG001|Overall Study|Lost to Follow-up|2|||
160814758|NCT01555073|580705503|FG002|Overall Study|Lost to Follow-up|0|||
160814759|NCT01555073|580705504|FG003|Overall Study|Lost to Follow-up|5|||
160814760|NCT02125838|580705505|FG000|Overall Study|Lost to Follow-up|4|||
160814761|NCT02125838|580705506|FG001|Overall Study|Lost to Follow-up|4|||
160814762|NCT02565147|580705507|FG000|Overall Study|Withdrawal by Subject|5|||
160814763|NCT02565147|580705508|FG001|Overall Study|Withdrawal by Subject|1|||
160814764|NCT02565147|580705507|FG000|Overall Study|Lost to Follow-up|0|||
160814765|NCT02565147|580705508|FG001|Overall Study|Lost to Follow-up|1|||
160814766|NCT02565147|580705507|FG000|Overall Study|Death|1|||
160814767|NCT02565147|580705508|FG001|Overall Study|Death|1|||
160814768|NCT00787839|580705509|FG000|Overall Study|Failure to have the OGTT was most common|404|||
160814769|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
160814770|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
160814771|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
160814772|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
160814773|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Death|58|||
160814774|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Death|65|||
160900188|NCT02215096|581028673|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
160814775|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Adverse Event|28|||
160814776|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Adverse Event|40|||
160814777|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Disease Progression|22|||
160814778|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Disease Progression|35|||
160814779|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Other|25|||
160814780|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Other|33|||
160814781|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
160900189|NCT02215096|581028669|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
160814782|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
160814783|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Noncompliance|8|||
160814784|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Noncompliance|8|||
160814785|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
160814786|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
160814787|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
160814788|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
160814789|NCT00286091|580705517|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
160814790|NCT00286091|580705518|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
160814791|NCT00286091|580705517|FG000|Open-label Treatment Phase|Physician Decision|24|||
160814792|NCT00286091|580705518|FG001|Open-label Treatment Phase|Physician Decision|21|||
160814793|NCT00286091|580705517|FG000|Open-label Treatment Phase|Adverse Event|5|||
160814794|NCT00286091|580705518|FG001|Open-label Treatment Phase|Adverse Event|16|||
160814795|NCT00286091|580705517|FG000|Open-label Treatment Phase|Other|11|||
160814796|NCT00286091|580705518|FG001|Open-label Treatment Phase|Other|11|||
160814797|NCT00286091|580705517|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
160814798|NCT00286091|580705518|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
160814799|NCT00286091|580705517|FG000|Open-label Treatment Phase|Death|10|||
160814800|NCT00286091|580705518|FG001|Open-label Treatment Phase|Death|7|||
160814801|NCT00286091|580705517|FG000|Open-label Treatment Phase|Disease Progression|9|||
160814802|NCT00286091|580705518|FG001|Open-label Treatment Phase|Disease Progression|3|||
160814803|NCT00286091|580705517|FG000|Open-label Treatment Phase|Noncompliance|3|||
160814804|NCT00286091|580705518|FG001|Open-label Treatment Phase|Noncompliance|1|||
160814805|NCT00286091|580705517|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
160814806|NCT00286091|580705518|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
160814807|NCT00286091|580705517|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
160814808|NCT00286091|580705518|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
160814809|NCT00286091|580705517|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
160814810|NCT00286091|580705518|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
160814811|NCT00244725|580705521|FG000|Overall Study|Lost to Follow-up|3|||
160814812|NCT00244725|580705522|FG001|Overall Study|Lost to Follow-up|4|||
160814813|NCT00244725|580705523|FG002|Overall Study|Lost to Follow-up|9|||
160814814|NCT00244725|580705524|FG003|Overall Study|Lost to Follow-up|2|||
160814815|NCT00244725|580705521|FG000|Overall Study|Withdrawal by Subject|9|||
160814816|NCT00244725|580705522|FG001|Overall Study|Withdrawal by Subject|7|||
160814817|NCT00244725|580705523|FG002|Overall Study|Withdrawal by Subject|7|||
160814818|NCT00244725|580705524|FG003|Overall Study|Withdrawal by Subject|8|||
160814819|NCT00244725|580705521|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
160814820|NCT00244725|580705522|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
160986986|NCT04955626|581341126|FG021|Blinded Period|Refused further study procedures|0|||
160986987|NCT04955626|581341127|FG022|Blinded Period|Refused further study procedures|0|||
160986988|NCT04955626|581341128|FG023|Blinded Period|Refused further study procedures|0|||
160986989|NCT04955626|581341129|FG024|Blinded Period|Refused further study procedures|0|||
160986990|NCT04955626|581341130|FG025|Blinded Period|Refused further study procedures|0|||
160986991|NCT04955626|581341131|FG026|Blinded Period|Refused further study procedures|0|||
160986992|NCT04955626|581341132|FG027|Blinded Period|Refused further study procedures|0|||
160986993|NCT04955626|581341133|FG028|Blinded Period|Refused further study procedures|0|||
160986994|NCT04955626|581341134|FG029|Blinded Period|Refused further study procedures|0|||
160986995|NCT04955626|581341135|FG030|Blinded Period|Refused further study procedures|0|||
160986996|NCT04955626|581341136|FG031|Blinded Period|Refused further study procedures|0|||
160986997|NCT04955626|581341137|FG032|Blinded Period|Refused further study procedures|0|||
160986998|NCT04955626|581341138|FG033|Blinded Period|Refused further study procedures|0|||
160986999|NCT04955626|581341139|FG034|Blinded Period|Refused further study procedures|0|||
160987000|NCT04955626|581341140|FG035|Blinded Period|Refused further study procedures|0|||
160987001|NCT04955626|581341105|FG000|Blinded Period|Participants entered open label period|4544|||
160987002|NCT04955626|581341106|FG001|Blinded Period|Participants entered open label period|4906|||
160987003|NCT04955626|581341107|FG002|Blinded Period|Participants entered open label period|0|||
160987004|NCT04955626|581341108|FG003|Blinded Period|Participants entered open label period|0|||
160814821|NCT00244725|580705523|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
160814822|NCT00244725|580705524|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
160814823|NCT00244725|580705521|FG000|Overall Study|Physician Decision|3|||
160814824|NCT00244725|580705522|FG001|Overall Study|Physician Decision|0|||
160814825|NCT00244725|580705523|FG002|Overall Study|Physician Decision|1|||
160814826|NCT00244725|580705524|FG003|Overall Study|Physician Decision|2|||
160814827|NCT00244725|580705521|FG000|Overall Study|Adverse Events|3|||
160987005|NCT04955626|581341109|FG004|Blinded Period|Participants entered open label period|0|||
160814828|NCT00244725|580705522|FG001|Overall Study|Adverse Events|1|||
160814829|NCT00244725|580705523|FG002|Overall Study|Adverse Events|4|||
160814830|NCT00244725|580705524|FG003|Overall Study|Adverse Events|4|||
161132145|NCT00961961|581867401|FG003|Phase I|Lost to Follow-up|0|||
160814831|NCT00244725|580705521|FG000|Overall Study|Withdrwal by participant|1|||
160814832|NCT00244725|580705522|FG001|Overall Study|Withdrwal by participant|0|||
160814833|NCT00244725|580705523|FG002|Overall Study|Withdrwal by participant|0|||
160814834|NCT00244725|580705524|FG003|Overall Study|Withdrwal by participant|1|||
160814835|NCT00244725|580705521|FG000|Overall Study|Liver function test abnormality|2|||
160814836|NCT00244725|580705522|FG001|Overall Study|Liver function test abnormality|0|||
160814837|NCT00244725|580705523|FG002|Overall Study|Liver function test abnormality|0|||
160814838|NCT00244725|580705524|FG003|Overall Study|Liver function test abnormality|1|||
160814839|NCT00244725|580705521|FG000|Overall Study|Sponsor withdrew the participant|1|||
160814840|NCT00244725|580705522|FG001|Overall Study|Sponsor withdrew the participant|0|||
160987006|NCT04955626|581341110|FG005|Blinded Period|Participants entered open label period|0|||
161132146|NCT00961961|581867398|FG000|Phase I|Lack of Efficacy|94|||
161132147|NCT00961961|581867399|FG001|Phase I|Lack of Efficacy|0|||
161132148|NCT00961961|581867400|FG002|Phase I|Lack of Efficacy|0|||
161132149|NCT00961961|581867401|FG003|Phase I|Lack of Efficacy|0|||
161132150|NCT00961961|581867398|FG000|Phase I|Adverse Event|7|||
161132151|NCT00961961|581867399|FG001|Phase I|Adverse Event|0|||
161132152|NCT00961961|581867400|FG002|Phase I|Adverse Event|0|||
161132153|NCT00961961|581867401|FG003|Phase I|Adverse Event|0|||
161132154|NCT00961961|581867398|FG000|Phase I|Physician Decision|8|||
161132155|NCT00961961|581867399|FG001|Phase I|Physician Decision|0|||
161132156|NCT00961961|581867400|FG002|Phase I|Physician Decision|0|||
161132157|NCT00961961|581867401|FG003|Phase I|Physician Decision|0|||
161132158|NCT00961961|581867398|FG000|Phase II|Lost to Follow-up|0|||
161132159|NCT00961961|581867399|FG001|Phase II|Lost to Follow-up|0|||
161132160|NCT00961961|581867400|FG002|Phase II|Lost to Follow-up|10|||
160987007|NCT04955626|581341111|FG006|Blinded Period|Participants entered open label period|0|||
160987008|NCT04955626|581341112|FG007|Blinded Period|Participants entered open label period|0|||
160987009|NCT04955626|581341113|FG008|Blinded Period|Participants entered open label period|0|||
160987010|NCT04955626|581341114|FG009|Blinded Period|Participants entered open label period|0|||
160987011|NCT04955626|581341115|FG010|Blinded Period|Participants entered open label period|0|||
160987012|NCT04955626|581341116|FG011|Blinded Period|Participants entered open label period|0|||
160987013|NCT04955626|581341117|FG012|Blinded Period|Participants entered open label period|0|||
160987014|NCT04955626|581341118|FG013|Blinded Period|Participants entered open label period|0|||
160987015|NCT04955626|581341119|FG014|Blinded Period|Participants entered open label period|0|||
160987016|NCT04955626|581341120|FG015|Blinded Period|Participants entered open label period|0|||
160987017|NCT04955626|581341121|FG016|Blinded Period|Participants entered open label period|0|||
160987018|NCT04955626|581341122|FG017|Blinded Period|Participants entered open label period|0|||
160987019|NCT04955626|581341123|FG018|Blinded Period|Participants entered open label period|0|||
160987020|NCT04955626|581341124|FG019|Blinded Period|Participants entered open label period|0|||
160987021|NCT04955626|581341125|FG020|Blinded Period|Participants entered open label period|0|||
160987022|NCT04955626|581341126|FG021|Blinded Period|Participants entered open label period|0|||
160987023|NCT04955626|581341127|FG022|Blinded Period|Participants entered open label period|0|||
160987024|NCT04955626|581341128|FG023|Blinded Period|Participants entered open label period|0|||
160987025|NCT04955626|581341129|FG024|Blinded Period|Participants entered open label period|0|||
160987026|NCT04955626|581341130|FG025|Blinded Period|Participants entered open label period|0|||
160987027|NCT04955626|581341131|FG026|Blinded Period|Participants entered open label period|0|||
160987028|NCT04955626|581341132|FG027|Blinded Period|Participants entered open label period|0|||
160987029|NCT04955626|581341133|FG028|Blinded Period|Participants entered open label period|0|||
160987030|NCT04955626|581341134|FG029|Blinded Period|Participants entered open label period|0|||
160987031|NCT04955626|581341135|FG030|Blinded Period|Participants entered open label period|0|||
160987032|NCT04955626|581341136|FG031|Blinded Period|Participants entered open label period|0|||
160987033|NCT04955626|581341137|FG032|Blinded Period|Participants entered open label period|0|||
160987034|NCT04955626|581341138|FG033|Blinded Period|Participants entered open label period|0|||
160987035|NCT04955626|581341139|FG034|Blinded Period|Participants entered open label period|0|||
160987036|NCT04955626|581341140|FG035|Blinded Period|Participants entered open label period|0|||
161132161|NCT00961961|581867401|FG003|Phase II|Lost to Follow-up|7|||
161132162|NCT00961961|581867398|FG000|Phase II|Adverse Event|0|||
161239888|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239889|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239890|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239891|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
161239892|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
161239893|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239894|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239895|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239896|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
161239897|NCT01695239|582260464|FG000|Extension Long-Term Extension Periods|Death|0|||
161239898|NCT01695239|582260465|FG001|Extension Long-Term Extension Periods|Death|0|||
161239899|NCT01695239|582260466|FG002|Extension Long-Term Extension Periods|Death|0|||
161132163|NCT00961961|581867399|FG001|Phase II|Adverse Event|0|||
161132164|NCT00961961|581867400|FG002|Phase II|Adverse Event|0|||
161132165|NCT00961961|581867401|FG003|Phase II|Adverse Event|1|||
161239900|NCT01695239|582260467|FG003|Extension Long-Term Extension Periods|Death|0|||
161239901|NCT01695239|582260468|FG004|Extension Long-Term Extension Periods|Death|0|||
161239902|NCT01695239|582260469|FG005|Extension Long-Term Extension Periods|Death|0|||
161239903|NCT01695239|582260470|FG006|Extension Long-Term Extension Periods|Death|0|||
160987037|NCT04955626|581341105|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
160987038|NCT04955626|581341106|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
160987039|NCT04955626|581341107|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
160987040|NCT04955626|581341108|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
160987041|NCT04955626|581341109|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
160987042|NCT04955626|581341110|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
160987043|NCT04955626|581341111|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
160987044|NCT04955626|581341112|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
160987045|NCT04955626|581341113|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
160987046|NCT04955626|581341114|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
160987047|NCT04955626|581341115|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
160987048|NCT04955626|581341116|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
160987049|NCT04955626|581341117|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
160814841|NCT00244725|580705523|FG002|Overall Study|Sponsor withdrew the participant|0|||
160814842|NCT00244725|580705524|FG003|Overall Study|Sponsor withdrew the participant|1|||
160814843|NCT00244725|580705521|FG000|Overall Study|Mediciation Error|0|||
160814844|NCT00244725|580705522|FG001|Overall Study|Mediciation Error|1|||
160987050|NCT04955626|581341118|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
161132166|NCT00961961|581867398|FG000|Phase II|Physician Decision|0|||
161132167|NCT00961961|581867399|FG001|Phase II|Physician Decision|0|||
161132168|NCT00961961|581867400|FG002|Phase II|Physician Decision|1|||
161132169|NCT00961961|581867401|FG003|Phase II|Physician Decision|0|||
161132170|NCT00961961|581867398|FG000|Phase II|Withdrawal by Subject|0|||
161132171|NCT00961961|581867399|FG001|Phase II|Withdrawal by Subject|0|||
161132172|NCT00961961|581867400|FG002|Phase II|Withdrawal by Subject|1|||
161132173|NCT00961961|581867401|FG003|Phase II|Withdrawal by Subject|0|||
161132174|NCT01412957|581867402|FG000|Overall Study|Withdrawal by Subject|6|||
161132175|NCT01412957|581867403|FG001|Overall Study|Withdrawal by Subject|22|||
161132176|NCT01412957|581867402|FG000|Overall Study|Lost to Follow-up|7|||
161132177|NCT01412957|581867403|FG001|Overall Study|Lost to Follow-up|2|||
161132178|NCT01412957|581867402|FG000|Overall Study|Death|136|||
161132179|NCT01412957|581867403|FG001|Overall Study|Death|133|||
161132180|NCT02425098|581867409|FG000|Overall Study|Lost to Follow-up|7|||
161132181|NCT02425098|581867410|FG001|Overall Study|Lost to Follow-up|7|||
161132182|NCT02425098|581867409|FG000|Overall Study|Withdrawal by Subject|4|||
161132183|NCT02425098|581867410|FG001|Overall Study|Withdrawal by Subject|8|||
161132184|NCT02425098|581867409|FG000|Overall Study|Pregnancy|2|||
161132185|NCT02425098|581867410|FG001|Overall Study|Pregnancy|0|||
161132186|NCT02425098|581867409|FG000|Overall Study|Reason not Specified|0|||
161132187|NCT02425098|581867410|FG001|Overall Study|Reason not Specified|1|||
161132188|NCT03636906|581867413|FG000|Overall Study|Adverse Event|0|||
161132189|NCT03636906|581867414|FG001|Overall Study|Adverse Event|0|||
161132190|NCT03636906|581867415|FG002|Overall Study|Adverse Event|1|||
161132191|NCT03636906|581867413|FG000|Overall Study|Lost to Follow-up|1|||
161132192|NCT03636906|581867414|FG001|Overall Study|Lost to Follow-up|0|||
161132193|NCT03636906|581867415|FG002|Overall Study|Lost to Follow-up|0|||
161132194|NCT03636906|581867413|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
161132195|NCT03636906|581867414|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
161132196|NCT03636906|581867415|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
161132197|NCT03636906|581867413|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161132198|NCT03636906|581867414|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161132199|NCT03636906|581867415|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
161132200|NCT03636906|581867413|FG000|Overall Study|Other|0|||
161132201|NCT03636906|581867414|FG001|Overall Study|Other|0|||
161132202|NCT03636906|581867415|FG002|Overall Study|Other|1|||
161132203|NCT04280081|581867419|FG000|Overall Study|Adverse Event|4|||
161132204|NCT04280081|581867419|FG000|Overall Study|Death|2|||
161132205|NCT04280081|581867419|FG000|Overall Study|Progressive Disease|6|||
161132206|NCT01468311|581867420|FG000|Overall Study|mobilization failure|1|||
161132207|NCT01468311|581867420|FG000|Overall Study|Withdrawal by Subject|1|||
160814845|NCT00244725|580705523|FG002|Overall Study|Mediciation Error|0|||
160814846|NCT00244725|580705524|FG003|Overall Study|Mediciation Error|0|||
161132208|NCT04854499|581868893|FG000|Overall Study|Study Terminated by Sponsor|5|||
161132209|NCT04854499|581868894|FG001|Overall Study|Study Terminated by Sponsor|27|||
161132210|NCT04854499|581868895|FG002|Overall Study|Study Terminated by Sponsor|28|||
161132211|NCT04854499|581868896|FG003|Overall Study|Study Terminated by Sponsor|19|||
161132212|NCT04854499|581868897|FG004|Overall Study|Study Terminated by Sponsor|1|||
161132213|NCT04854499|581868898|FG005|Overall Study|Study Terminated by Sponsor|10|||
160987051|NCT04955626|581341119|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
161132214|NCT04854499|581868893|FG000|Overall Study|Death|1|||
161132215|NCT04854499|581868894|FG001|Overall Study|Death|23|||
160814847|NCT00244725|580705521|FG000|Overall Study|Rehab Refused to allow participantion|0|||
160814848|NCT00244725|580705522|FG001|Overall Study|Rehab Refused to allow participantion|1|||
160814849|NCT00244725|580705523|FG002|Overall Study|Rehab Refused to allow participantion|0|||
160814850|NCT00244725|580705524|FG003|Overall Study|Rehab Refused to allow participantion|0|||
160814851|NCT00244725|580705521|FG000|Overall Study|Headache|0|||
160814852|NCT00244725|580705522|FG001|Overall Study|Headache|1|||
160814853|NCT00244725|580705523|FG002|Overall Study|Headache|0|||
160814854|NCT00244725|580705524|FG003|Overall Study|Headache|0|||
160814855|NCT00244725|580705521|FG000|Overall Study|Received prohibited medication|0|||
160814856|NCT00244725|580705522|FG001|Overall Study|Received prohibited medication|1|||
160814857|NCT00244725|580705523|FG002|Overall Study|Received prohibited medication|0|||
160987052|NCT04955626|581341120|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
160987053|NCT04955626|581341121|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
160987054|NCT04955626|581341122|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
160987055|NCT04955626|581341123|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
160814858|NCT00244725|580705524|FG003|Overall Study|Received prohibited medication|1|||
160814859|NCT00244725|580705521|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
160814860|NCT00244725|580705522|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
160814861|NCT00244725|580705523|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
160814862|NCT00244725|580705524|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
160814863|NCT00244725|580705521|FG000|Overall Study|Administrative reason|0|||
160814864|NCT00244725|580705522|FG001|Overall Study|Administrative reason|0|||
160814865|NCT00244725|580705523|FG002|Overall Study|Administrative reason|1|||
160900190|NCT02215096|581028670|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
160900191|NCT02215096|581028671|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
160900192|NCT02215096|581028672|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
160900193|NCT02215096|581028673|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
160900194|NCT03439657|581028674|FG000|Overall Study|Adverse Event|2|||
160987056|NCT04955626|581341124|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
160987057|NCT04955626|581341125|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
160987058|NCT04955626|581341126|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
160987059|NCT04955626|581341127|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
160987060|NCT04955626|581341128|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
160987061|NCT04955626|581341129|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
160987062|NCT04955626|581341130|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
160987063|NCT04955626|581341131|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
160987064|NCT04955626|581341132|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
160987065|NCT04955626|581341133|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
160987066|NCT04955626|581341134|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
160987067|NCT04955626|581341135|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
160987068|NCT04955626|581341136|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
160987069|NCT04955626|581341137|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
160987070|NCT04955626|581341138|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
160987071|NCT04955626|581341139|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
160987072|NCT04955626|581341140|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
160987073|NCT04955626|581341105|FG000|Blinded Period|Medication error|0|||
160987074|NCT04955626|581341106|FG001|Blinded Period|Medication error|0|||
160987075|NCT04955626|581341107|FG002|Blinded Period|Medication error|0|||
160987076|NCT04955626|581341108|FG003|Blinded Period|Medication error|0|||
160987077|NCT04955626|581341109|FG004|Blinded Period|Medication error|0|||
160987078|NCT04955626|581341110|FG005|Blinded Period|Medication error|0|||
160987079|NCT04955626|581341111|FG006|Blinded Period|Medication error|0|||
160987080|NCT04955626|581341112|FG007|Blinded Period|Medication error|0|||
160987081|NCT04955626|581341113|FG008|Blinded Period|Medication error|0|||
160987082|NCT04955626|581341114|FG009|Blinded Period|Medication error|0|||
160987083|NCT04955626|581341115|FG010|Blinded Period|Medication error|2|||
160987084|NCT04955626|581341116|FG011|Blinded Period|Medication error|0|||
160987085|NCT04955626|581341117|FG012|Blinded Period|Medication error|0|||
160987086|NCT04955626|581341118|FG013|Blinded Period|Medication error|0|||
160987087|NCT04955626|581341119|FG014|Blinded Period|Medication error|0|||
160987088|NCT04955626|581341120|FG015|Blinded Period|Medication error|0|||
160987089|NCT04955626|581341121|FG016|Blinded Period|Medication error|0|||
160987090|NCT04955626|581341122|FG017|Blinded Period|Medication error|0|||
160814866|NCT00244725|580705524|FG003|Overall Study|Administrative reason|0|||
160814867|NCT00244725|580705521|FG000|Overall Study|Vomit|0|||
160814868|NCT00244725|580705522|FG001|Overall Study|Vomit|0|||
160987091|NCT04955626|581341123|FG018|Blinded Period|Medication error|0|||
160987092|NCT04955626|581341124|FG019|Blinded Period|Medication error|0|||
160987093|NCT04955626|581341125|FG020|Blinded Period|Medication error|0|||
161239904|NCT01695239|582260471|FG007|Extension Long-Term Extension Periods|Death|0|||
161239905|NCT01695239|582260472|FG008|Extension Long-Term Extension Periods|Death|1|||
160900195|NCT03439657|581028675|FG001|Overall Study|Adverse Event|3|||
160900196|NCT03439657|581028674|FG000|Overall Study|Lost to Follow-up|1|||
160900197|NCT03439657|581028675|FG001|Overall Study|Lost to Follow-up|0|||
160814869|NCT00244725|580705523|FG002|Overall Study|Vomit|1|||
160814870|NCT00244725|580705524|FG003|Overall Study|Vomit|0|||
160814871|NCT00244725|580705521|FG000|Overall Study|Failed to follow-up|0|||
160814872|NCT00244725|580705522|FG001|Overall Study|Failed to follow-up|0|||
160814873|NCT00244725|580705523|FG002|Overall Study|Failed to follow-up|1|||
160814874|NCT00244725|580705524|FG003|Overall Study|Failed to follow-up|1|||
160814875|NCT02936869|580705525|FG000|Overall Study|Lost to Follow-up|1|||
160814876|NCT02936869|580705526|FG001|Overall Study|Lost to Follow-up|3|||
160814877|NCT02936869|580705525|FG000|Overall Study|Death|0|||
160814878|NCT02936869|580705526|FG001|Overall Study|Death|1|||
160814879|NCT02936869|580705525|FG000|Overall Study|Legal Case|0|||
160814880|NCT02936869|580705526|FG001|Overall Study|Legal Case|1|||
161333210|NCT02974868|582608681|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
161333211|NCT02974868|582608678|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
161333212|NCT02974868|582608679|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
161333213|NCT02974868|582608680|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
161333214|NCT02974868|582608681|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
161333215|NCT02974868|582608678|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
161333216|NCT02974868|582608679|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
161333217|NCT02974868|582608680|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
161333218|NCT02974868|582608681|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
161333219|NCT02974868|582608678|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
161333220|NCT02974868|582608679|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
161333221|NCT02974868|582608680|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
161333222|NCT02974868|582608681|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
161333223|NCT01663402|582608682|FG000|Overall Study|Randomized but not treated|19|||
161333224|NCT01663402|582608683|FG001|Overall Study|Randomized but not treated|11|||
161333225|NCT01663402|582608682|FG000|Overall Study|Adverse Event|347|||
161333226|NCT01663402|582608683|FG001|Overall Study|Adverse Event|362|||
161333227|NCT01663402|582608682|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
161333228|NCT01663402|582608683|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
161333229|NCT01663402|582608682|FG000|Overall Study|Poor compliance to protocol|529|||
160814881|NCT02936869|580705525|FG000|Overall Study|Protocol Violation|1|||
160814882|NCT02936869|580705526|FG001|Overall Study|Protocol Violation|0|||
160814883|NCT03799952|580705527|FG000|Overall Study|Program was too easy, discontinued|1|||
160814884|NCT03799952|580705528|FG001|Overall Study|Program was too easy, discontinued|0|||
160814885|NCT03799952|580705527|FG000|Overall Study|Lost to Follow-up|0|||
160814886|NCT03799952|580705528|FG001|Overall Study|Lost to Follow-up|2|||
160814887|NCT00335738|580705529|FG000|Overall Study|Physician Decision|6|||
160814888|NCT00335738|580705530|FG001|Overall Study|Physician Decision|0|||
160814889|NCT00335738|580705529|FG000|Overall Study|Withdrawal by Subject|2|||
160814890|NCT00335738|580705530|FG001|Overall Study|Withdrawal by Subject|0|||
160814891|NCT00335738|580705529|FG000|Overall Study|Ineligible|3|||
160814892|NCT00335738|580705530|FG001|Overall Study|Ineligible|4|||
160814893|NCT04004221|580705535|FG000|Overall Study|Death|89|||
160814894|NCT04004221|580705535|FG000|Overall Study|Withdrawal by Subject|5|||
160814895|NCT04004221|580705535|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
160814896|NCT04004221|580705535|FG000|Overall Study|Sponsor Decision|9|||
160814897|NCT04004221|580705535|FG000|Overall Study|Participant refused to enter LTE|1|||
160814898|NCT03423238|580705536|FG000|Overall Study|Lost to Follow-up|1|||
160814899|NCT03423238|580705537|FG001|Overall Study|Lost to Follow-up|0|||
160814900|NCT03423238|580705536|FG000|Overall Study|Withdrawal by Subject|1|||
160814901|NCT03423238|580705537|FG001|Overall Study|Withdrawal by Subject|0|||
160814902|NCT02036580|580705539|FG000|Overall Study|Withdrawal by Subject|0|||
160814903|NCT02036580|580705540|FG001|Overall Study|Withdrawal by Subject|1|||
160814904|NCT02036580|580705541|FG002|Overall Study|Withdrawal by Subject|0|||
160814905|NCT02036580|580705539|FG000|Overall Study|Adverse Event|1|||
160814906|NCT02036580|580705540|FG001|Overall Study|Adverse Event|0|||
160814907|NCT02036580|580705541|FG002|Overall Study|Adverse Event|0|||
160814908|NCT00506454|580705542|FG000|Overall Study|Withdrawal by Subject|1|||
160814909|NCT00506454|580705543|FG001|Overall Study|Withdrawal by Subject|1|||
160814910|NCT01104545|580705544|FG000|Overall Study|Adverse Event|0|||
161333230|NCT01663402|582608683|FG001|Overall Study|Poor compliance to protocol|454|||
160814911|NCT01104545|580705545|FG001|Overall Study|Adverse Event|1|||
160814912|NCT01104545|580705546|FG002|Overall Study|Adverse Event|2|||
160814913|NCT00976716|580705547|FG000|Overall Study|Adverse Event|1|||
160814914|NCT02993822|580705555|FG000|Overall Study|Lack of Efficacy|1|||
160814915|NCT02993822|580705556|FG001|Overall Study|Lack of Efficacy|1|||
160814916|NCT02993822|580705557|FG002|Overall Study|Lack of Efficacy|0|||
160814917|NCT02993822|580705558|FG003|Overall Study|Lack of Efficacy|0|||
160814918|NCT02993822|580705555|FG000|Overall Study|Protocol Violation|1|||
160814919|NCT02993822|580705556|FG001|Overall Study|Protocol Violation|0|||
160814920|NCT02993822|580705557|FG002|Overall Study|Protocol Violation|0|||
160814921|NCT02993822|580705558|FG003|Overall Study|Protocol Violation|0|||
160814922|NCT02993822|580705555|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
160814923|NCT02993822|580705556|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
160987094|NCT04955626|581341126|FG021|Blinded Period|Medication error|0|||
160987095|NCT04955626|581341127|FG022|Blinded Period|Medication error|0|||
160987096|NCT04955626|581341128|FG023|Blinded Period|Medication error|0|||
160987097|NCT04955626|581341129|FG024|Blinded Period|Medication error|0|||
160987098|NCT04955626|581341130|FG025|Blinded Period|Medication error|0|||
160987099|NCT04955626|581341131|FG026|Blinded Period|Medication error|0|||
160987100|NCT04955626|581341132|FG027|Blinded Period|Medication error|0|||
160987101|NCT04955626|581341133|FG028|Blinded Period|Medication error|4|||
160987102|NCT04955626|581341134|FG029|Blinded Period|Medication error|0|||
160987103|NCT04955626|581341135|FG030|Blinded Period|Medication error|0|||
160987104|NCT04955626|581341136|FG031|Blinded Period|Medication error|0|||
160987105|NCT04955626|581341137|FG032|Blinded Period|Medication error|0|||
160987106|NCT04955626|581341138|FG033|Blinded Period|Medication error|0|||
160987107|NCT04955626|581341139|FG034|Blinded Period|Medication error|0|||
160987108|NCT04955626|581341140|FG035|Blinded Period|Medication error|0|||
160987109|NCT04955626|581341105|FG000|Open-Label Period|Lost to Follow-up|109|||
160987110|NCT04955626|581341106|FG001|Open-Label Period|Lost to Follow-up|41|||
160987111|NCT04955626|581341107|FG002|Open-Label Period|Lost to Follow-up|0|||
160987112|NCT04955626|581341108|FG003|Open-Label Period|Lost to Follow-up|0|||
160987113|NCT04955626|581341109|FG004|Open-Label Period|Lost to Follow-up|0|||
160987114|NCT04955626|581341110|FG005|Open-Label Period|Lost to Follow-up|0|||
160987115|NCT04955626|581341111|FG006|Open-Label Period|Lost to Follow-up|0|||
160987116|NCT04955626|581341112|FG007|Open-Label Period|Lost to Follow-up|0|||
161239906|NCT01695239|582260473|FG009|Extension Long-Term Extension Periods|Death|0|||
161239907|NCT01695239|582260474|FG010|Extension Long-Term Extension Periods|Death|0|||
160814924|NCT02993822|580705557|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
160814925|NCT02993822|580705558|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
160814926|NCT02993822|580705555|FG000|Overall Study|Adverse Event|3|||
160814927|NCT02993822|580705556|FG001|Overall Study|Adverse Event|1|||
160814928|NCT02993822|580705557|FG002|Overall Study|Adverse Event|7|||
160814929|NCT02993822|580705558|FG003|Overall Study|Adverse Event|0|||
160814930|NCT02993822|580705555|FG000|Overall Study|Withdrawal by Subject|4|||
160814931|NCT02993822|580705556|FG001|Overall Study|Withdrawal by Subject|2|||
160814932|NCT02993822|580705557|FG002|Overall Study|Withdrawal by Subject|2|||
160814933|NCT02993822|580705558|FG003|Overall Study|Withdrawal by Subject|3|||
161239908|NCT01695239|582260475|FG011|Extension Long-Term Extension Periods|Death|0|||
160814934|NCT02993822|580705555|FG000|Overall Study|Lost to Follow-up|1|||
160814935|NCT02993822|580705556|FG001|Overall Study|Lost to Follow-up|0|||
160814936|NCT02993822|580705557|FG002|Overall Study|Lost to Follow-up|1|||
160814937|NCT02993822|580705558|FG003|Overall Study|Lost to Follow-up|0|||
160814938|NCT01221753|580705562|FG000|Overall Study|Adverse Event|1|||
160814939|NCT01939977|580705563|FG000|Overall Study|Adverse Event|4|||
160814940|NCT01939977|580705564|FG001|Overall Study|Adverse Event|3|||
160814941|NCT01939977|580705563|FG000|Overall Study|Lack of Efficacy|3|||
160814942|NCT01939977|580705564|FG001|Overall Study|Lack of Efficacy|0|||
160814943|NCT01939977|580705563|FG000|Overall Study|Physician Decision|1|||
160814944|NCT01939977|580705564|FG001|Overall Study|Physician Decision|1|||
160814945|NCT01939977|580705563|FG000|Overall Study|Withdrawal by Subject|0|||
160814946|NCT01939977|580705564|FG001|Overall Study|Withdrawal by Subject|2|||
160814947|NCT01939977|580705563|FG000|Overall Study|Did not meet inclusion criteria|1|||
160814948|NCT01939977|580705564|FG001|Overall Study|Did not meet inclusion criteria|0|||
160814949|NCT01939977|580705563|FG000|Overall Study|Did not receive study medication|0|||
160814950|NCT01939977|580705564|FG001|Overall Study|Did not receive study medication|1|||
160814951|NCT01696981|580705568|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
160814952|NCT01696981|580705569|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
160814953|NCT01696981|580705568|FG000|Overall Study|Died Before Randomization|3|||
160814954|NCT01696981|580705569|FG001|Overall Study|Died Before Randomization|8|||
160814955|NCT01696981|580705568|FG000|Overall Study|Died Before ASU (Control)|278|||
160987117|NCT04955626|581341113|FG008|Open-Label Period|Lost to Follow-up|0|||
160987118|NCT04955626|581341114|FG009|Open-Label Period|Lost to Follow-up|0|||
160987119|NCT04955626|581341115|FG010|Open-Label Period|Lost to Follow-up|0|||
160987120|NCT04955626|581341116|FG011|Open-Label Period|Lost to Follow-up|0|||
160987121|NCT04955626|581341117|FG012|Open-Label Period|Lost to Follow-up|0|||
160987122|NCT04955626|581341118|FG013|Open-Label Period|Lost to Follow-up|0|||
160987123|NCT04955626|581341119|FG014|Open-Label Period|Lost to Follow-up|0|||
160987124|NCT04955626|581341120|FG015|Open-Label Period|Lost to Follow-up|0|||
160987125|NCT04955626|581341121|FG016|Open-Label Period|Lost to Follow-up|0|||
160987126|NCT04955626|581341122|FG017|Open-Label Period|Lost to Follow-up|0|||
160987127|NCT04955626|581341123|FG018|Open-Label Period|Lost to Follow-up|0|||
160987128|NCT04955626|581341124|FG019|Open-Label Period|Lost to Follow-up|0|||
160987129|NCT04955626|581341125|FG020|Open-Label Period|Lost to Follow-up|0|||
160987130|NCT04955626|581341126|FG021|Open-Label Period|Lost to Follow-up|0|||
160987131|NCT04955626|581341127|FG022|Open-Label Period|Lost to Follow-up|0|||
160987132|NCT04955626|581341128|FG023|Open-Label Period|Lost to Follow-up|0|||
160987133|NCT04955626|581341129|FG024|Open-Label Period|Lost to Follow-up|0|||
160987134|NCT04955626|581341130|FG025|Open-Label Period|Lost to Follow-up|0|||
160814956|NCT01696981|580705569|FG001|Overall Study|Died Before ASU (Control)|0|||
160814957|NCT01696981|580705568|FG000|Overall Study|Refused ASU (Control)|920|||
160814958|NCT01696981|580705569|FG001|Overall Study|Refused ASU (Control)|0|||
160814959|NCT01696981|580705568|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
160814960|NCT01696981|580705569|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
160814961|NCT02798315|580705572|FG000|Overall Study|Failure to return|1|||
160814962|NCT00465972|580705573|FG000|Overall Study|Withdrawal by Subject|2|||
160814963|NCT00465972|580705574|FG001|Overall Study|Withdrawal by Subject|1|||
160814964|NCT02097719|580705575|FG000|Overall Study|Subject Withdrew Consent|1|||
160814965|NCT02097719|580705576|FG001|Overall Study|Subject Withdrew Consent|0|||
160814966|NCT02097719|580705575|FG000|Overall Study|Lost to Follow-up|0|||
160814967|NCT02097719|580705576|FG001|Overall Study|Lost to Follow-up|1|||
160814968|NCT02097719|580705575|FG000|Overall Study|Adverse Event|2|||
160814969|NCT02097719|580705576|FG001|Overall Study|Adverse Event|0|||
160814970|NCT03292640|580705577|FG000|Overall Study|Withdrawal by Subject|17|||
160814971|NCT03292640|580705578|FG001|Overall Study|Withdrawal by Subject|16|||
160814972|NCT03292640|580705577|FG000|Overall Study|Adverse Event|20|||
160814973|NCT03292640|580705578|FG001|Overall Study|Adverse Event|2|||
160814974|NCT03292640|580705577|FG000|Overall Study|Lost to Follow-up|24|||
160814975|NCT03292640|580705578|FG001|Overall Study|Lost to Follow-up|24|||
160814976|NCT01108731|580705586|FG000|Overall Study|Withdrawal by Subject|1|||
160814977|NCT01108731|580705587|FG001|Overall Study|Withdrawal by Subject|1|||
160814978|NCT01108731|580705586|FG000|Overall Study|Adverse Event|3|||
160814979|NCT01108731|580705587|FG001|Overall Study|Adverse Event|3|||
160814980|NCT00984594|580705588|FG000|Overall Study|Lost to Follow-up|1|||
160814981|NCT00984594|580705589|FG001|Overall Study|Lost to Follow-up|0|||
160814982|NCT00984594|580705588|FG000|Overall Study|Withdrawal by Subject|0|||
160814983|NCT00984594|580705589|FG001|Overall Study|Withdrawal by Subject|1|||
160814984|NCT00851890|580705590|FG000|Overall Study|Lost to Follow-up|0|||
160814985|NCT00851890|580705591|FG001|Overall Study|Lost to Follow-up|1|||
160814986|NCT00851890|580705592|FG002|Overall Study|Lost to Follow-up|0|||
160814987|NCT00851890|580705593|FG003|Overall Study|Lost to Follow-up|1|||
160814988|NCT03135431|580705594|FG000|Overall Study|Study Surgeon not available|2|||
160814989|NCT03135431|580705595|FG001|Overall Study|Study Surgeon not available|0|||
160814990|NCT01063062|580705596|FG000|Overall Study|Patient withdrew consent|0|||
160814991|NCT01063062|580705597|FG001|Overall Study|Patient withdrew consent|1|||
160814992|NCT01063062|580705596|FG000|Overall Study|Adverse Event|2|||
160814993|NCT01063062|580705597|FG001|Overall Study|Adverse Event|4|||
160814994|NCT01063062|580705596|FG000|Overall Study|Protocol Violation|5|||
160814995|NCT01063062|580705597|FG001|Overall Study|Protocol Violation|4|||
160987135|NCT04955626|581341131|FG026|Open-Label Period|Lost to Follow-up|0|||
161132216|NCT04854499|581868895|FG002|Overall Study|Death|21|||
160814996|NCT01063062|580705596|FG000|Overall Study|Investigator's request|1|||
160814997|NCT01063062|580705597|FG001|Overall Study|Investigator's request|0|||
160814998|NCT01063062|580705596|FG000|Overall Study|Lost to Follow-up|0|||
160814999|NCT01063062|580705597|FG001|Overall Study|Lost to Follow-up|2|||
160815000|NCT01063062|580705596|FG000|Overall Study|Miscellaneous reason|0|||
160815001|NCT01063062|580705597|FG001|Overall Study|Miscellaneous reason|1|||
161132217|NCT04854499|581868896|FG003|Overall Study|Death|7|||
161132218|NCT04854499|581868897|FG004|Overall Study|Death|6|||
161132219|NCT04854499|581868898|FG005|Overall Study|Death|24|||
161132220|NCT04854499|581868893|FG000|Overall Study|Investigator's Discretion|0|||
161132221|NCT04854499|581868894|FG001|Overall Study|Investigator's Discretion|1|||
161132222|NCT04854499|581868895|FG002|Overall Study|Investigator's Discretion|3|||
161132223|NCT04854499|581868896|FG003|Overall Study|Investigator's Discretion|4|||
161132224|NCT04854499|581868897|FG004|Overall Study|Investigator's Discretion|1|||
161132225|NCT04854499|581868898|FG005|Overall Study|Investigator's Discretion|5|||
161132226|NCT04854499|581868893|FG000|Overall Study|Withdrew Consent|0|||
161132227|NCT04854499|581868894|FG001|Overall Study|Withdrew Consent|1|||
161132228|NCT04854499|581868895|FG002|Overall Study|Withdrew Consent|2|||
161132229|NCT04854499|581868896|FG003|Overall Study|Withdrew Consent|2|||
161132230|NCT04854499|581868897|FG004|Overall Study|Withdrew Consent|0|||
161132231|NCT04854499|581868898|FG005|Overall Study|Withdrew Consent|1|||
161132232|NCT04854499|581868893|FG000|Overall Study|Lost to Follow-up|0|||
161132233|NCT04854499|581868894|FG001|Overall Study|Lost to Follow-up|0|||
161132234|NCT04854499|581868895|FG002|Overall Study|Lost to Follow-up|0|||
161132235|NCT04854499|581868896|FG003|Overall Study|Lost to Follow-up|0|||
161132236|NCT04854499|581868897|FG004|Overall Study|Lost to Follow-up|0|||
161132237|NCT04854499|581868898|FG005|Overall Study|Lost to Follow-up|1|||
161132238|NCT00398112|581868899|FG000|Overall Study|Adverse Event|4|||
160987136|NCT04955626|581341132|FG027|Open-Label Period|Lost to Follow-up|0|||
160987137|NCT04955626|581341133|FG028|Open-Label Period|Lost to Follow-up|0|||
161132239|NCT00398112|581868899|FG000|Overall Study|Disease progression|9|||
160815002|NCT02015481|580705598|FG000|Overall Study|Death|1|||
160815003|NCT02597452|580705600|FG000|Overall Study|testing incomplete|30|||
160815004|NCT03122145|580705603|FG000|Overall Study|Concurrent respiratory disease|3|||
160815005|NCT03122145|580705604|FG001|Overall Study|Concurrent respiratory disease|0|||
160987138|NCT04955626|581341134|FG029|Open-Label Period|Lost to Follow-up|0|||
160815006|NCT02016716|580705609|FG000|Overall Study|Withdrawal by Subject|5|||
160987139|NCT04955626|581341135|FG030|Open-Label Period|Lost to Follow-up|0|||
160987140|NCT04955626|581341136|FG031|Open-Label Period|Lost to Follow-up|0|||
160987141|NCT04955626|581341137|FG032|Open-Label Period|Lost to Follow-up|0|||
160987142|NCT04955626|581341138|FG033|Open-Label Period|Lost to Follow-up|0|||
160987143|NCT04955626|581341139|FG034|Open-Label Period|Lost to Follow-up|0|||
160987144|NCT04955626|581341140|FG035|Open-Label Period|Lost to Follow-up|0|||
160987145|NCT04955626|581341105|FG000|Open-Label Period|Protocol Violation|377|||
160987146|NCT04955626|581341106|FG001|Open-Label Period|Protocol Violation|48|||
160987147|NCT04955626|581341107|FG002|Open-Label Period|Protocol Violation|0|||
160987148|NCT04955626|581341108|FG003|Open-Label Period|Protocol Violation|0|||
161239909|NCT01695239|582260476|FG012|Extension Long-Term Extension Periods|Death|0|||
161239910|NCT01695239|582260477|FG013|Extension Long-Term Extension Periods|Death|0|||
161239911|NCT01695239|582260464|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239912|NCT01695239|582260465|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160815007|NCT02016716|580705610|FG001|Overall Study|Withdrawal by Subject|5|||
160987149|NCT04955626|581341109|FG004|Open-Label Period|Protocol Violation|0|||
160987150|NCT04955626|581341110|FG005|Open-Label Period|Protocol Violation|0|||
160987151|NCT04955626|581341111|FG006|Open-Label Period|Protocol Violation|0|||
160987152|NCT04955626|581341112|FG007|Open-Label Period|Protocol Violation|0|||
160987153|NCT04955626|581341113|FG008|Open-Label Period|Protocol Violation|0|||
160987154|NCT04955626|581341114|FG009|Open-Label Period|Protocol Violation|0|||
160987155|NCT04955626|581341115|FG010|Open-Label Period|Protocol Violation|0|||
160987156|NCT04955626|581341116|FG011|Open-Label Period|Protocol Violation|0|||
160987157|NCT04955626|581341117|FG012|Open-Label Period|Protocol Violation|0|||
160987158|NCT04955626|581341118|FG013|Open-Label Period|Protocol Violation|0|||
160987159|NCT04955626|581341119|FG014|Open-Label Period|Protocol Violation|0|||
160987160|NCT04955626|581341120|FG015|Open-Label Period|Protocol Violation|0|||
160987161|NCT04955626|581341121|FG016|Open-Label Period|Protocol Violation|0|||
160987162|NCT04955626|581341122|FG017|Open-Label Period|Protocol Violation|0|||
160987163|NCT04955626|581341123|FG018|Open-Label Period|Protocol Violation|0|||
160815008|NCT02016716|580705611|FG002|Overall Study|Withdrawal by Subject|5|||
160815009|NCT02016716|580705609|FG000|Overall Study|Protocol-specified Criteria|0|||
160815010|NCT02016716|580705610|FG001|Overall Study|Protocol-specified Criteria|1|||
160815011|NCT02016716|580705611|FG002|Overall Study|Protocol-specified Criteria|0|||
160815012|NCT02016716|580705609|FG000|Overall Study|Lost to Follow-up|1|||
160815013|NCT02016716|580705610|FG001|Overall Study|Lost to Follow-up|2|||
160815014|NCT02016716|580705611|FG002|Overall Study|Lost to Follow-up|1|||
160815015|NCT00079391|580705612|FG000|Overall Study|Withdrawal by Subject|1|||
160815016|NCT00281099|580705613|FG000|Overall Study|Death|46|||
160815017|NCT00281099|580705614|FG001|Overall Study|Death|57|||
160815018|NCT00281099|580705613|FG000|Overall Study|Lost to Follow-up|10|||
160987164|NCT04955626|581341124|FG019|Open-Label Period|Protocol Violation|0|||
160987165|NCT04955626|581341125|FG020|Open-Label Period|Protocol Violation|0|||
160987166|NCT04955626|581341126|FG021|Open-Label Period|Protocol Violation|0|||
161132240|NCT00398112|581868899|FG000|Overall Study|Alternative treatment|1|||
161132241|NCT00398112|581868899|FG000|Overall Study|Withdrawal by Subject|3|||
161132242|NCT00398112|581868899|FG000|Overall Study|Death|1|||
161132243|NCT00582556|581868900|FG000|Overall Study|Withdrawal by Subject|0|||
161132244|NCT00582556|581868901|FG001|Overall Study|Withdrawal by Subject|1|||
161132245|NCT00582556|581868902|FG002|Overall Study|Withdrawal by Subject|1|||
161132246|NCT00582556|581868900|FG000|Overall Study|Physician Decision|0|||
161132247|NCT00582556|581868901|FG001|Overall Study|Physician Decision|0|||
161132248|NCT00582556|581868902|FG002|Overall Study|Physician Decision|1|||
161132249|NCT01993888|581868903|FG000|Overall Study|Death|1|||
161132250|NCT01993888|581868904|FG001|Overall Study|Death|1|||
161132251|NCT01993888|581868903|FG000|Overall Study|Lost to Follow-up|1|||
161132252|NCT01993888|581868904|FG001|Overall Study|Lost to Follow-up|1|||
161132253|NCT01993888|581868903|FG000|Overall Study|Withdrawal by Subject|0|||
161132254|NCT01993888|581868904|FG001|Overall Study|Withdrawal by Subject|1|||
161132255|NCT03124459|581868907|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
160987167|NCT04955626|581341127|FG022|Open-Label Period|Protocol Violation|0|||
160987168|NCT04955626|581341128|FG023|Open-Label Period|Protocol Violation|0|||
160987169|NCT04955626|581341129|FG024|Open-Label Period|Protocol Violation|0|||
160987170|NCT04955626|581341130|FG025|Open-Label Period|Protocol Violation|0|||
160987171|NCT04955626|581341131|FG026|Open-Label Period|Protocol Violation|0|||
160987172|NCT04955626|581341132|FG027|Open-Label Period|Protocol Violation|0|||
160987173|NCT04955626|581341133|FG028|Open-Label Period|Protocol Violation|0|||
160987174|NCT04955626|581341134|FG029|Open-Label Period|Protocol Violation|0|||
160987175|NCT04955626|581341135|FG030|Open-Label Period|Protocol Violation|0|||
160987176|NCT04955626|581341136|FG031|Open-Label Period|Protocol Violation|0|||
160987177|NCT04955626|581341137|FG032|Open-Label Period|Protocol Violation|0|||
160815019|NCT00281099|580705614|FG001|Overall Study|Lost to Follow-up|19|||
160815020|NCT00281099|580705613|FG000|Overall Study|Withdrawal by Subject|65|||
160815021|NCT00281099|580705614|FG001|Overall Study|Withdrawal by Subject|70|||
160815022|NCT00281099|580705613|FG000|Overall Study|Physician Decision|79|||
160987178|NCT04955626|581341138|FG033|Open-Label Period|Protocol Violation|0|||
160987179|NCT04955626|581341139|FG034|Open-Label Period|Protocol Violation|0|||
160987180|NCT04955626|581341140|FG035|Open-Label Period|Protocol Violation|0|||
160987181|NCT04955626|581341105|FG000|Open-Label Period|Death|5|||
160987182|NCT04955626|581341106|FG001|Open-Label Period|Death|5|||
160987183|NCT04955626|581341107|FG002|Open-Label Period|Death|0|||
160987184|NCT04955626|581341108|FG003|Open-Label Period|Death|0|||
160987185|NCT04955626|581341109|FG004|Open-Label Period|Death|0|||
160987186|NCT04955626|581341110|FG005|Open-Label Period|Death|0|||
160987187|NCT04955626|581341111|FG006|Open-Label Period|Death|0|||
160987188|NCT04955626|581341112|FG007|Open-Label Period|Death|0|||
160987189|NCT04955626|581341113|FG008|Open-Label Period|Death|0|||
160987190|NCT04955626|581341114|FG009|Open-Label Period|Death|0|||
160987191|NCT04955626|581341115|FG010|Open-Label Period|Death|0|||
160987192|NCT04955626|581341116|FG011|Open-Label Period|Death|0|||
161239913|NCT01695239|582260466|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239914|NCT01695239|582260467|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239915|NCT01695239|582260468|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239916|NCT01695239|582260469|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239917|NCT01695239|582260470|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239918|NCT01695239|582260471|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160815023|NCT00281099|580705614|FG001|Overall Study|Physician Decision|72|||
160815024|NCT00281099|580705613|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
160815025|NCT00281099|580705614|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
160815026|NCT02931838|580705615|FG000|Overall Study|Reason not provided by investigator|1|||
160815027|NCT02931838|580705616|FG001|Overall Study|Reason not provided by investigator|0|||
160815028|NCT02931838|580705617|FG002|Overall Study|Reason not provided by investigator|1|||
160815029|NCT02931838|580705618|FG003|Overall Study|Reason not provided by investigator|0|||
160815030|NCT02931838|580705619|FG004|Overall Study|Reason not provided by investigator|0|||
160815031|NCT02931838|580705620|FG005|Overall Study|Reason not provided by investigator|0|||
160815032|NCT02931838|580705615|FG000|Overall Study|Poor/non-compliance|0|||
160815033|NCT02931838|580705616|FG001|Overall Study|Poor/non-compliance|0|||
160815034|NCT02931838|580705617|FG002|Overall Study|Poor/non-compliance|1|||
160815035|NCT02931838|580705618|FG003|Overall Study|Poor/non-compliance|0|||
160815036|NCT02931838|580705619|FG004|Overall Study|Poor/non-compliance|0|||
160815037|NCT02931838|580705620|FG005|Overall Study|Poor/non-compliance|0|||
160815038|NCT02931838|580705615|FG000|Overall Study|Lack of Efficacy|5|||
160815039|NCT02931838|580705616|FG001|Overall Study|Lack of Efficacy|4|||
160815040|NCT02931838|580705617|FG002|Overall Study|Lack of Efficacy|0|||
160815041|NCT02931838|580705618|FG003|Overall Study|Lack of Efficacy|0|||
160815042|NCT02931838|580705619|FG004|Overall Study|Lack of Efficacy|0|||
160815043|NCT02931838|580705620|FG005|Overall Study|Lack of Efficacy|1|||
160815044|NCT02931838|580705615|FG000|Overall Study|Lost to Follow-up|1|||
160815045|NCT02931838|580705616|FG001|Overall Study|Lost to Follow-up|0|||
160815046|NCT02931838|580705617|FG002|Overall Study|Lost to Follow-up|1|||
160815047|NCT02931838|580705618|FG003|Overall Study|Lost to Follow-up|1|||
160815048|NCT02931838|580705619|FG004|Overall Study|Lost to Follow-up|2|||
160815049|NCT02931838|580705620|FG005|Overall Study|Lost to Follow-up|0|||
160815050|NCT02931838|580705615|FG000|Overall Study|Subject request to discontinue treatment|4|||
160815051|NCT02931838|580705616|FG001|Overall Study|Subject request to discontinue treatment|3|||
160815052|NCT02931838|580705617|FG002|Overall Study|Subject request to discontinue treatment|3|||
160815053|NCT02931838|580705618|FG003|Overall Study|Subject request to discontinue treatment|0|||
160815054|NCT02931838|580705619|FG004|Overall Study|Subject request to discontinue treatment|1|||
160815055|NCT02931838|580705620|FG005|Overall Study|Subject request to discontinue treatment|0|||
160815056|NCT02931838|580705615|FG000|Overall Study|Withdrawal by Subject|1|||
160815057|NCT02931838|580705616|FG001|Overall Study|Withdrawal by Subject|2|||
160815058|NCT02931838|580705617|FG002|Overall Study|Withdrawal by Subject|0|||
160815059|NCT02931838|580705618|FG003|Overall Study|Withdrawal by Subject|1|||
160815060|NCT02931838|580705619|FG004|Overall Study|Withdrawal by Subject|0|||
160815061|NCT02931838|580705620|FG005|Overall Study|Withdrawal by Subject|0|||
161333231|NCT01663402|582608682|FG000|Overall Study|Physician Decision|77|||
160815062|NCT02931838|580705615|FG000|Overall Study|Adverse Event|2|||
160815063|NCT02931838|580705616|FG001|Overall Study|Adverse Event|1|||
160815064|NCT02931838|580705617|FG002|Overall Study|Adverse Event|2|||
160815065|NCT02931838|580705618|FG003|Overall Study|Adverse Event|1|||
160815066|NCT02931838|580705619|FG004|Overall Study|Adverse Event|3|||
160815067|NCT02931838|580705620|FG005|Overall Study|Adverse Event|1|||
160815068|NCT00104728|580705621|FG000|Overall Study|screen failures|19|||
160815069|NCT01963767|580705622|FG000|Overall Study|Withdrawal by Subject|4|||
160815070|NCT01963767|580705623|FG001|Overall Study|Withdrawal by Subject|2|||
160987193|NCT04955626|581341117|FG012|Open-Label Period|Death|0|||
160987194|NCT04955626|581341118|FG013|Open-Label Period|Death|0|||
160987195|NCT04955626|581341119|FG014|Open-Label Period|Death|0|||
160987196|NCT04955626|581341120|FG015|Open-Label Period|Death|0|||
160987197|NCT04955626|581341121|FG016|Open-Label Period|Death|0|||
160987198|NCT04955626|581341122|FG017|Open-Label Period|Death|0|||
160987199|NCT04955626|581341123|FG018|Open-Label Period|Death|0|||
160987200|NCT04955626|581341124|FG019|Open-Label Period|Death|0|||
160815071|NCT01963767|580705622|FG000|Overall Study|Adverse Event|2|||
160815072|NCT01963767|580705623|FG001|Overall Study|Adverse Event|0|||
160815073|NCT01659996|580705624|FG000|Overall Study|Protocol Violation|3|||
160815074|NCT01659996|580705625|FG001|Overall Study|Protocol Violation|3|||
160815075|NCT01659996|580705626|FG002|Overall Study|Protocol Violation|3|||
160815076|NCT01659996|580705624|FG000|Overall Study|Lost to Follow-up|1|||
160815077|NCT01659996|580705625|FG001|Overall Study|Lost to Follow-up|3|||
160815078|NCT01659996|580705626|FG002|Overall Study|Lost to Follow-up|2|||
160815079|NCT01659996|580705624|FG000|Overall Study|Adverse Event|0|||
160815080|NCT01659996|580705625|FG001|Overall Study|Adverse Event|0|||
160815081|NCT01659996|580705626|FG002|Overall Study|Adverse Event|1|||
160815082|NCT01659996|580705624|FG000|Overall Study|Withdrawal by Subject|4|||
160815083|NCT01659996|580705625|FG001|Overall Study|Withdrawal by Subject|1|||
160815084|NCT01659996|580705626|FG002|Overall Study|Withdrawal by Subject|5|||
160815085|NCT03206918|580705627|FG000|Overall Study|Death|11|||
160815086|NCT03206918|580705627|FG000|Overall Study|Withdrawal by Subject|5|||
160815087|NCT03206918|580705627|FG000|Overall Study|Study terminated by sponsor|12|||
160815088|NCT03206918|580705627|FG000|Overall Study|Lost to Follow-up|3|||
160815089|NCT03206918|580705627|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
160815090|NCT02709577|580705628|FG000|Overall Study|non-accommodating anatomy|0|||
160815091|NCT02709577|580705629|FG001|Overall Study|non-accommodating anatomy|1|||
160815092|NCT02709577|580705630|FG002|Overall Study|non-accommodating anatomy|0|||
160815093|NCT02709577|580705631|FG003|Overall Study|non-accommodating anatomy|0|||
160815094|NCT02709577|580705628|FG000|Overall Study|procedural complication|0|||
160815095|NCT02709577|580705629|FG001|Overall Study|procedural complication|1|||
160815096|NCT02709577|580705630|FG002|Overall Study|procedural complication|0|||
160815097|NCT02709577|580705631|FG003|Overall Study|procedural complication|0|||
160815098|NCT02709577|580705628|FG000|Overall Study|Withdrawal by Subject|2|||
160815099|NCT02709577|580705629|FG001|Overall Study|Withdrawal by Subject|3|||
160815100|NCT02709577|580705630|FG002|Overall Study|Withdrawal by Subject|2|||
160815101|NCT02709577|580705631|FG003|Overall Study|Withdrawal by Subject|0|||
160815102|NCT02701764|580705632|FG000|Overall Study|Lost to Follow-up|0|||
160815103|NCT02701764|580705633|FG001|Overall Study|Lost to Follow-up|1|||
160815104|NCT00375674|580705638|FG000|Overall Study|Other|26|||
160815105|NCT00375674|580705639|FG001|Overall Study|Other|18|||
160815106|NCT00375674|580705638|FG000|Overall Study|Death|67|||
160815107|NCT00375674|580705639|FG001|Overall Study|Death|76|||
160815108|NCT00375674|580705638|FG000|Overall Study|Participants refused further follow-up|31|||
160815109|NCT00375674|580705639|FG001|Overall Study|Participants refused further follow-up|30|||
160815110|NCT00375674|580705638|FG000|Overall Study|Lost to Follow-up|17|||
160815111|NCT00375674|580705639|FG001|Overall Study|Lost to Follow-up|15|||
160815112|NCT00375674|580705638|FG000|Overall Study|Enrolled but not treated|3|||
160815113|NCT00375674|580705639|FG001|Overall Study|Enrolled but not treated|2|||
160815114|NCT00912782|580705640|FG000|Overall Study|Death|2|||
160815115|NCT00912782|580705641|FG001|Overall Study|Death|1|||
160815116|NCT00912782|580705640|FG000|Overall Study|Lost to Follow-up|0|||
160815117|NCT00912782|580705641|FG001|Overall Study|Lost to Follow-up|1|||
160815118|NCT00912782|580705640|FG000|Overall Study|Did not receive vascular access type|1|||
160815119|NCT00912782|580705641|FG001|Overall Study|Did not receive vascular access type|2|||
160815120|NCT00912782|580705640|FG000|Overall Study|Relocated before study completion|0|||
160815121|NCT00912782|580705641|FG001|Overall Study|Relocated before study completion|1|||
160815122|NCT05924165|580707286|FG000|Overall Study|Physician Decision|2|||
160815123|NCT05924165|580707287|FG001|Overall Study|Physician Decision|3|||
160815124|NCT01681186|580707288|FG000|Washout Period From Second Intervention|Adverse Event|0|||
160815125|NCT01681186|580707289|FG001|Washout Period From Second Intervention|Adverse Event|0|||
160815126|NCT01681186|580707290|FG002|Washout Period From Second Intervention|Adverse Event|0|||
160815127|NCT01681186|580707291|FG003|Washout Period From Second Intervention|Adverse Event|0|||
160815128|NCT01681186|580707292|FG004|Washout Period From Second Intervention|Adverse Event|0|||
160815129|NCT01681186|580707293|FG005|Washout Period From Second Intervention|Adverse Event|0|||
160815130|NCT01681186|580707294|FG006|Washout Period From Second Intervention|Adverse Event|1|||
160900198|NCT03439657|581028674|FG000|Overall Study|Protocol Violation|1|||
160900199|NCT03439657|581028675|FG001|Overall Study|Protocol Violation|1|||
160900200|NCT03439657|581028674|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
160900201|NCT03439657|581028675|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
160900202|NCT00761631|581028676|FG000|Overall Study|Parent/legal guardian request|8|||
160900203|NCT00761631|581028677|FG001|Overall Study|Parent/legal guardian request|3|||
160900204|NCT00761631|581028678|FG002|Overall Study|Parent/legal guardian request|8|||
160900205|NCT00761631|581028679|FG003|Overall Study|Parent/legal guardian request|0|||
160900206|NCT00761631|581028680|FG004|Overall Study|Parent/legal guardian request|5|||
160900207|NCT00761631|581028681|FG005|Overall Study|Parent/legal guardian request|0|||
160900208|NCT00761631|581028676|FG000|Overall Study|Lost to Follow-up|2|||
160900209|NCT00761631|581028677|FG001|Overall Study|Lost to Follow-up|4|||
160900210|NCT00761631|581028678|FG002|Overall Study|Lost to Follow-up|7|||
160900211|NCT00761631|581028679|FG003|Overall Study|Lost to Follow-up|1|||
160900212|NCT00761631|581028680|FG004|Overall Study|Lost to Follow-up|6|||
160815131|NCT01681186|580707295|FG007|Washout Period From Second Intervention|Adverse Event|0|||
160815132|NCT01681186|580707288|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
160815133|NCT01681186|580707289|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
160815134|NCT01681186|580707290|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
160815135|NCT01681186|580707291|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
161132256|NCT03124459|581868908|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161132257|NCT03124459|581868909|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161333232|NCT01663402|582608683|FG001|Overall Study|Physician Decision|62|||
161333233|NCT01663402|582608682|FG000|Overall Study|Site terminated by sponsor|1|||
161333234|NCT01663402|582608683|FG001|Overall Study|Site terminated by sponsor|3|||
161333235|NCT01663402|582608682|FG000|Overall Study|Participant moved|139|||
161333236|NCT01663402|582608683|FG001|Overall Study|Participant moved|104|||
161333237|NCT01663402|582608682|FG000|Overall Study|Withdrawal by Subject|118|||
161333238|NCT01663402|582608683|FG001|Overall Study|Withdrawal by Subject|91|||
161333239|NCT01663402|582608682|FG000|Overall Study|Related to study drug administration|96|||
161333240|NCT01663402|582608683|FG001|Overall Study|Related to study drug administration|105|||
161333241|NCT01663402|582608682|FG000|Overall Study|Lost to Follow-up|17|||
161333242|NCT01663402|582608683|FG001|Overall Study|Lost to Follow-up|15|||
161333243|NCT01663402|582608682|FG000|Overall Study|Other than specified above|172|||
161333244|NCT01663402|582608683|FG001|Overall Study|Other than specified above|147|||
161333245|NCT01900444|582608686|FG000|Overall Study|Protocol Violation|2|||
161333246|NCT01900444|582608686|FG000|Overall Study|Lost to Follow-up|1|||
161333247|NCT00072384|582608687|FG000|Overall Study|Physician Decision|1|||
161333248|NCT00072384|582608687|FG000|Overall Study|Ineligible|8|||
161333249|NCT01825200|582608688|FG000|Overall Study|Lost to Follow-up|5|||
161333250|NCT01825200|582608689|FG001|Overall Study|Lost to Follow-up|6|||
161333251|NCT01825200|582608688|FG000|Overall Study|Withdrawal by Subject|0|||
161333252|NCT01825200|582608689|FG001|Overall Study|Withdrawal by Subject|1|||
161333253|NCT04219189|582608691|FG000|Overall Study|Withdrawal by Subject|1|||
161333254|NCT04219189|582608692|FG001|Overall Study|Withdrawal by Subject|2|||
161333255|NCT04219189|582608691|FG000|Overall Study|Protocol Violation|0|||
161333256|NCT04219189|582608692|FG001|Overall Study|Protocol Violation|1|||
161333257|NCT04219189|582608691|FG000|Overall Study|Lost to Follow-up|0|||
161333258|NCT04219189|582608692|FG001|Overall Study|Lost to Follow-up|1|||
161333259|NCT04219189|582608691|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
161333260|NCT04219189|582608692|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
161333261|NCT06058390|582608693|FG000|Overall Study|Lost to Follow-up|0|||
161333262|NCT06058390|582608694|FG001|Overall Study|Lost to Follow-up|0|||
161333263|NCT06058390|582608695|FG002|Overall Study|Lost to Follow-up|2|||
161333264|NCT06058390|582608696|FG003|Overall Study|Lost to Follow-up|1|||
161333265|NCT06058390|582608693|FG000|Overall Study|Physician Decision|0|||
161333266|NCT06058390|582608694|FG001|Overall Study|Physician Decision|0|||
161333267|NCT06058390|582608695|FG002|Overall Study|Physician Decision|0|||
161333268|NCT06058390|582608696|FG003|Overall Study|Physician Decision|1|||
161333269|NCT06058390|582608693|FG000|Overall Study|Participants did not receive any study intervention|0|||
161333270|NCT06058390|582608694|FG001|Overall Study|Participants did not receive any study intervention|0|||
161333271|NCT06058390|582608695|FG002|Overall Study|Participants did not receive any study intervention|0|||
161333272|NCT06058390|582608696|FG003|Overall Study|Participants did not receive any study intervention|1|||
161333273|NCT03585270|582608697|FG000|Overall Study|Withdrawal by Subject|2|||
161333274|NCT03585270|582608698|FG001|Overall Study|Withdrawal by Subject|6|||
161333275|NCT03585270|582608697|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
161333276|NCT03585270|582608698|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
161333277|NCT03585270|582608697|FG000|Overall Study|Adverse Event|5|||
161333278|NCT03585270|582608698|FG001|Overall Study|Adverse Event|2|||
161333279|NCT03585270|582608697|FG000|Overall Study|Lost to Follow-up|1|||
161333280|NCT03585270|582608698|FG001|Overall Study|Lost to Follow-up|4|||
161333281|NCT03585270|582608697|FG000|Overall Study|Death|5|||
161333282|NCT03585270|582608698|FG001|Overall Study|Death|3|||
161333283|NCT03585270|582608697|FG000|Overall Study|Other reasons|2|||
161333284|NCT03585270|582608698|FG001|Overall Study|Other reasons|2|||
161333285|NCT03292016|582608699|FG000|Second Washout|Adverse Event|0|||
161333286|NCT03292016|582608700|FG001|Second Washout|Adverse Event|1|||
161333287|NCT03292016|582608701|FG002|Second Washout|Adverse Event|0|||
161333288|NCT03292016|582608702|FG003|Second Washout|Adverse Event|0|||
161333289|NCT03292016|582608703|FG004|Second Washout|Adverse Event|0|||
161333290|NCT03292016|582608704|FG005|Second Washout|Adverse Event|0|||
161333291|NCT03904693|582608705|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161333292|NCT03904693|582608706|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161333293|NCT03904693|582608707|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
160815136|NCT01681186|580707292|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
161333294|NCT03904693|582608708|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161333295|NCT03904693|582608709|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161333296|NCT03904693|582608710|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
161333297|NCT03904693|582608705|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
160900213|NCT00761631|581028681|FG005|Overall Study|Lost to Follow-up|1|||
160900214|NCT00761631|581028676|FG000|Overall Study|Protocol Violation|2|||
160900215|NCT00761631|581028677|FG001|Overall Study|Protocol Violation|0|||
160900216|NCT00761631|581028678|FG002|Overall Study|Protocol Violation|0|||
160900217|NCT00761631|581028679|FG003|Overall Study|Protocol Violation|1|||
160900218|NCT00761631|581028680|FG004|Overall Study|Protocol Violation|5|||
160900219|NCT00761631|581028681|FG005|Overall Study|Protocol Violation|1|||
160900220|NCT00761631|581028676|FG000|Overall Study|Randomized, not treated|1|||
160900221|NCT00761631|581028677|FG001|Overall Study|Randomized, not treated|0|||
160900222|NCT00761631|581028678|FG002|Overall Study|Randomized, not treated|0|||
160900223|NCT00761631|581028679|FG003|Overall Study|Randomized, not treated|0|||
160900224|NCT00761631|581028680|FG004|Overall Study|Randomized, not treated|0|||
160900225|NCT00761631|581028681|FG005|Overall Study|Randomized, not treated|0|||
160900226|NCT00761631|581028676|FG000|Overall Study|Failed to return|1|||
160900227|NCT00761631|581028677|FG001|Overall Study|Failed to return|0|||
160900228|NCT00761631|581028678|FG002|Overall Study|Failed to return|1|||
160900229|NCT00761631|581028679|FG003|Overall Study|Failed to return|1|||
160900230|NCT00761631|581028680|FG004|Overall Study|Failed to return|5|||
160900231|NCT00761631|581028681|FG005|Overall Study|Failed to return|2|||
160900232|NCT00761631|581028676|FG000|Overall Study|Physician Decision|1|||
160900233|NCT00761631|581028677|FG001|Overall Study|Physician Decision|0|||
160900234|NCT00761631|581028678|FG002|Overall Study|Physician Decision|0|||
160900235|NCT00761631|581028679|FG003|Overall Study|Physician Decision|0|||
160987201|NCT04955626|581341125|FG020|Open-Label Period|Death|0|||
160987202|NCT04955626|581341126|FG021|Open-Label Period|Death|0|||
160987203|NCT04955626|581341127|FG022|Open-Label Period|Death|0|||
160987204|NCT04955626|581341128|FG023|Open-Label Period|Death|0|||
160987205|NCT04955626|581341129|FG024|Open-Label Period|Death|0|||
160987206|NCT04955626|581341130|FG025|Open-Label Period|Death|0|||
161132258|NCT03124459|581868910|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161132259|NCT03124459|581868911|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
161132260|NCT03124459|581868912|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
161132261|NCT03124459|581868907|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161132262|NCT03124459|581868908|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161132263|NCT03124459|581868909|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161132264|NCT03124459|581868910|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161132265|NCT03124459|581868911|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
161132266|NCT03124459|581868912|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
161132267|NCT03124459|581868907|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161132268|NCT03124459|581868908|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161132269|NCT03124459|581868909|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161132270|NCT03124459|581868910|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
161132271|NCT03124459|581868911|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
161132272|NCT03124459|581868912|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
161132273|NCT03124459|581868907|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161132274|NCT03124459|581868908|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161132275|NCT03124459|581868909|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161132276|NCT03124459|581868910|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
161132277|NCT03124459|581868911|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
161132278|NCT03124459|581868912|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
161132279|NCT03124459|581868907|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161132280|NCT03124459|581868908|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161132281|NCT03124459|581868909|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161132282|NCT03124459|581868910|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161132283|NCT03124459|581868911|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
161132284|NCT03124459|581868912|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
161132285|NCT03124459|581868907|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161132286|NCT03124459|581868908|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161132287|NCT03124459|581868909|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161132288|NCT03124459|581868910|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161132289|NCT03124459|581868911|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
161132290|NCT03124459|581868912|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
161132291|NCT00450580|581868914|FG000|Overall Study|Adverse Event|5|||
161132292|NCT00450580|581868915|FG001|Overall Study|Adverse Event|7|||
161132293|NCT00450580|581868914|FG000|Overall Study|Lost to Follow-up|4|||
161132294|NCT00450580|581868915|FG001|Overall Study|Lost to Follow-up|5|||
161132295|NCT00450580|581868914|FG000|Overall Study|Withdrawal by Subject|2|||
160900236|NCT00761631|581028680|FG004|Overall Study|Physician Decision|0|||
160900237|NCT00761631|581028681|FG005|Overall Study|Physician Decision|0|||
160900238|NCT00761631|581028676|FG000|Overall Study|Other|0|||
160900239|NCT00761631|581028677|FG001|Overall Study|Other|0|||
160987207|NCT04955626|581341131|FG026|Open-Label Period|Death|0|||
160987208|NCT04955626|581341132|FG027|Open-Label Period|Death|0|||
160987209|NCT04955626|581341133|FG028|Open-Label Period|Death|0|||
160987210|NCT04955626|581341134|FG029|Open-Label Period|Death|0|||
160987211|NCT04955626|581341135|FG030|Open-Label Period|Death|0|||
160987212|NCT04955626|581341136|FG031|Open-Label Period|Death|0|||
160987213|NCT04955626|581341137|FG032|Open-Label Period|Death|0|||
160987214|NCT04955626|581341138|FG033|Open-Label Period|Death|0|||
160987215|NCT04955626|581341139|FG034|Open-Label Period|Death|0|||
160815137|NCT01681186|580707293|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
160815138|NCT01681186|580707294|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
160815139|NCT01681186|580707295|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
160815140|NCT01681186|580707288|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
160987216|NCT04955626|581341140|FG035|Open-Label Period|Death|0|||
160987217|NCT04955626|581341105|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
160987218|NCT04955626|581341106|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
160987219|NCT04955626|581341107|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
160987220|NCT04955626|581341108|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
160987221|NCT04955626|581341109|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
160987222|NCT04955626|581341110|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
160987223|NCT04955626|581341111|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
160987224|NCT04955626|581341112|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
160987225|NCT04955626|581341113|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
160987226|NCT04955626|581341114|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
160987227|NCT04955626|581341115|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
160987228|NCT04955626|581341116|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
160987229|NCT04955626|581341117|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
160987230|NCT04955626|581341118|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
160987231|NCT04955626|581341119|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
160987232|NCT04955626|581341120|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
160987233|NCT04955626|581341121|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
160987234|NCT04955626|581341122|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
160987235|NCT04955626|581341123|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
160987236|NCT04955626|581341124|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
160987237|NCT04955626|581341125|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
160987238|NCT04955626|581341126|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
160987239|NCT04955626|581341127|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
160987240|NCT04955626|581341128|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
160987241|NCT04955626|581341129|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
160987242|NCT04955626|581341130|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
160987243|NCT04955626|581341131|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
160987244|NCT04955626|581341132|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
160987245|NCT04955626|581341133|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
160987246|NCT04955626|581341134|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
160987247|NCT04955626|581341135|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
160987248|NCT04955626|581341136|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
160987249|NCT04955626|581341137|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
160987250|NCT04955626|581341138|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
160987251|NCT04955626|581341139|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
160987252|NCT04955626|581341140|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
160987253|NCT04955626|581341105|FG000|Open-Label Period|Other|621|||
161239919|NCT01695239|582260472|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239920|NCT01695239|582260473|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239921|NCT01695239|582260474|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161239922|NCT01695239|582260475|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
161239923|NCT01695239|582260476|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
161239924|NCT01695239|582260477|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
161239925|NCT01695239|582260464|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239926|NCT01695239|582260465|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239927|NCT01695239|582260466|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239928|NCT01695239|582260467|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239929|NCT01695239|582260468|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239930|NCT01695239|582260469|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239931|NCT01695239|582260470|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239932|NCT01695239|582260471|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239933|NCT01695239|582260472|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239934|NCT01695239|582260473|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160987254|NCT04955626|581341106|FG001|Open-Label Period|Other|429|||
160987255|NCT04955626|581341107|FG002|Open-Label Period|Other|0|||
160987256|NCT04955626|581341108|FG003|Open-Label Period|Other|0|||
160987257|NCT04955626|581341109|FG004|Open-Label Period|Other|0|||
160987258|NCT04955626|581341110|FG005|Open-Label Period|Other|0|||
161333298|NCT03904693|582608706|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161333299|NCT03904693|582608707|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
161333300|NCT03904693|582608708|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161333301|NCT03904693|582608709|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161333302|NCT03904693|582608710|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
161333303|NCT03904693|582608705|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161333304|NCT03904693|582608706|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
161333305|NCT03904693|582608707|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
161333306|NCT03904693|582608708|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161333307|NCT03904693|582608709|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161333308|NCT03904693|582608710|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
161333309|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161333310|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161333311|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
161333312|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
161333313|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
161333314|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
161333315|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
161333316|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
161333317|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
161333318|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
161333319|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
161333320|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
161333321|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161333322|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161333323|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161333324|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
161333325|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161333326|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
161333327|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161333328|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160815141|NCT01681186|580707289|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815142|NCT01681186|580707290|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815143|NCT01681186|580707291|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815144|NCT01681186|580707292|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815145|NCT01681186|580707293|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815146|NCT01681186|580707294|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
160815147|NCT01681186|580707295|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
160815148|NCT01681186|580707288|FG000|Fourth Intervention|Protocol Violation|0|||
160815149|NCT01681186|580707289|FG001|Fourth Intervention|Protocol Violation|0|||
160815150|NCT01681186|580707290|FG002|Fourth Intervention|Protocol Violation|0|||
160815151|NCT01681186|580707291|FG003|Fourth Intervention|Protocol Violation|0|||
160815152|NCT01681186|580707292|FG004|Fourth Intervention|Protocol Violation|0|||
160815153|NCT01681186|580707293|FG005|Fourth Intervention|Protocol Violation|0|||
160815154|NCT01681186|580707294|FG006|Fourth Intervention|Protocol Violation|0|||
160815155|NCT01681186|580707295|FG007|Fourth Intervention|Protocol Violation|1|||
160815156|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Adverse Event|1|||
160815157|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Adverse Event|0|||
160815158|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
160815159|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
160815160|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
160815161|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
160815162|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
160815163|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
160815164|NCT00301262|580707302|FG000|Double Blind Phase (DB)|Other|1|||
160815165|NCT00301262|580707303|FG001|Double Blind Phase (DB)|Other|4|||
160815166|NCT00301262|580707302|FG000|Open Label Phase (OL)|Adverse Event|1|||
160815167|NCT00301262|580707303|FG001|Open Label Phase (OL)|Adverse Event|0|||
160815168|NCT00301262|580707302|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
160815169|NCT00301262|580707303|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
161333329|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161333330|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
160815170|NCT00301262|580707302|FG000|Open Label Phase (OL)|Other|2|||
160815171|NCT00301262|580707303|FG001|Open Label Phase (OL)|Other|0|||
160815172|NCT03530995|580707304|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
160815173|NCT03530995|580707305|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
160900240|NCT00761631|581028678|FG002|Overall Study|Other|0|||
160900241|NCT00761631|581028679|FG003|Overall Study|Other|0|||
160815174|NCT03530995|580707304|FG000|Part 1 Period 3|Protocol Violation|1|||
160815175|NCT03530995|580707305|FG001|Part 1 Period 3|Protocol Violation|0|||
160815176|NCT03530995|580707304|FG000|Part 1 Period 4|Physician Decision|1|||
160815177|NCT03530995|580707305|FG001|Part 1 Period 4|Physician Decision|0|||
160815178|NCT03530995|580707304|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
160815179|NCT03530995|580707305|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
160815180|NCT01443364|580707313|FG000|Overall Study|Lack of Efficacy|14|||
160815181|NCT01443364|580707313|FG000|Overall Study|Lost to Follow-up|3|||
160815182|NCT01443364|580707313|FG000|Overall Study|Withdrawal by Subject|5|||
160815183|NCT01443364|580707313|FG000|Overall Study|Other Reason|4|||
160815184|NCT01443364|580707313|FG000|Overall Study|SAE, non-fatal|6|||
160815185|NCT01443364|580707313|FG000|Overall Study|AE, non-serious non-fatal|8|||
160815186|NCT01443364|580707313|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160815187|NCT02650804|580707314|FG000|Overall Study|Adverse Event|3|||
160815188|NCT02650804|580707315|FG001|Overall Study|Adverse Event|2|||
160815189|NCT02650804|580707314|FG000|Overall Study|Death|1|||
160815190|NCT02650804|580707315|FG001|Overall Study|Death|2|||
160815191|NCT02650804|580707314|FG000|Overall Study|Progressive Disease|7|||
160815192|NCT02650804|580707315|FG001|Overall Study|Progressive Disease|10|||
160815193|NCT02650804|580707314|FG000|Overall Study|Physician Decision|0|||
160815194|NCT02650804|580707315|FG001|Overall Study|Physician Decision|2|||
160815195|NCT02650804|580707314|FG000|Overall Study|Withdrawal by Subject|1|||
160815196|NCT02650804|580707315|FG001|Overall Study|Withdrawal by Subject|4|||
160815197|NCT02650804|580707314|FG000|Overall Study|Symptomatic deterioration|5|||
160815198|NCT02650804|580707315|FG001|Overall Study|Symptomatic deterioration|7|||
160815199|NCT02650804|580707314|FG000|Overall Study|Protocol Violation|0|||
160815200|NCT02650804|580707315|FG001|Overall Study|Protocol Violation|1|||
160815201|NCT01986231|580707320|FG000|Overall Study|Adverse Event|1|||
160815202|NCT04848220|580707321|FG000|Overall Study|Unable to proceed to study procedure|0|||
160815203|NCT04848220|580707322|FG001|Overall Study|Unable to proceed to study procedure|1|||
160815204|NCT04848220|580707323|FG002|Overall Study|Unable to proceed to study procedure|0|||
160815205|NCT04848220|580707321|FG000|Overall Study|Fractional flow not significant|0|||
160815206|NCT04848220|580707322|FG001|Overall Study|Fractional flow not significant|1|||
160815207|NCT04848220|580707323|FG002|Overall Study|Fractional flow not significant|0|||
160815208|NCT02150057|580707326|FG000|Overall Study|Lost to Follow-up|6|||
160815209|NCT02150057|580707327|FG001|Overall Study|Lost to Follow-up|4|||
160815210|NCT02388165|580707330|FG000|Overall Study|Study terminated by sponsor|5|||
160815211|NCT02388165|580707331|FG001|Overall Study|Study terminated by sponsor|5|||
160815212|NCT02388165|580707330|FG000|Overall Study|Other|11|||
160815213|NCT02388165|580707331|FG001|Overall Study|Other|13|||
160815214|NCT02388165|580707330|FG000|Overall Study|No longer meet eligibility criteria|40|||
160815215|NCT02388165|580707331|FG001|Overall Study|No longer meet eligibility criteria|43|||
160815216|NCT02388165|580707330|FG000|Overall Study|Withdrawal of consent|31|||
160815217|NCT02388165|580707331|FG001|Overall Study|Withdrawal of consent|32|||
160815218|NCT02388165|580707330|FG000|Overall Study|Lost to Follow-up|19|||
160815219|NCT02388165|580707331|FG001|Overall Study|Lost to Follow-up|20|||
160815220|NCT02388165|580707330|FG000|Overall Study|Death|13|||
160815221|NCT02388165|580707331|FG001|Overall Study|Death|10|||
160815222|NCT02388165|580707330|FG000|Overall Study|Adverse Event|3|||
160815223|NCT02388165|580707331|FG001|Overall Study|Adverse Event|5|||
160987259|NCT04955626|581341111|FG006|Open-Label Period|Other|0|||
160987260|NCT04955626|581341112|FG007|Open-Label Period|Other|0|||
160987261|NCT04955626|581341113|FG008|Open-Label Period|Other|0|||
160987262|NCT04955626|581341114|FG009|Open-Label Period|Other|0|||
160987263|NCT04955626|581341115|FG010|Open-Label Period|Other|0|||
160987264|NCT04955626|581341116|FG011|Open-Label Period|Other|0|||
160987265|NCT04955626|581341117|FG012|Open-Label Period|Other|0|||
160987266|NCT04955626|581341118|FG013|Open-Label Period|Other|0|||
160987267|NCT04955626|581341119|FG014|Open-Label Period|Other|0|||
161239935|NCT01695239|582260474|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161239936|NCT01695239|582260475|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
160987268|NCT04955626|581341120|FG015|Open-Label Period|Other|0|||
160987269|NCT04955626|581341121|FG016|Open-Label Period|Other|0|||
160987270|NCT04955626|581341122|FG017|Open-Label Period|Other|0|||
160987271|NCT04955626|581341123|FG018|Open-Label Period|Other|0|||
160987272|NCT04955626|581341124|FG019|Open-Label Period|Other|0|||
160987273|NCT04955626|581341125|FG020|Open-Label Period|Other|0|||
160987274|NCT04955626|581341126|FG021|Open-Label Period|Other|0|||
160987275|NCT04955626|581341127|FG022|Open-Label Period|Other|0|||
160987276|NCT04955626|581341128|FG023|Open-Label Period|Other|0|||
160987277|NCT04955626|581341129|FG024|Open-Label Period|Other|0|||
160987278|NCT04955626|581341130|FG025|Open-Label Period|Other|0|||
161239937|NCT01695239|582260476|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161239938|NCT01695239|582260477|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
160815224|NCT02388165|580707330|FG000|Overall Study|Did not meet entrance criteria|5|||
160815225|NCT02388165|580707331|FG001|Overall Study|Did not meet entrance criteria|2|||
160815226|NCT01406938|580707332|FG000|Induction Period|Subject/guardian decision|6|||
160815227|NCT01406938|580707333|FG001|Induction Period|Subject/guardian decision|8|||
160987279|NCT04955626|581341131|FG026|Open-Label Period|Other|0|||
161239939|NCT01695239|582260464|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239940|NCT01695239|582260465|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239941|NCT01695239|582260466|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239942|NCT01695239|582260467|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239943|NCT01695239|582260468|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239944|NCT01695239|582260469|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239945|NCT01695239|582260470|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239946|NCT01695239|582260471|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239947|NCT01695239|582260472|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239948|NCT01695239|582260473|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
161239949|NCT01695239|582260474|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
160815228|NCT01406938|580707334|FG002|Induction Period|Subject/guardian decision|0|||
160815229|NCT01406938|580707335|FG003|Induction Period|Subject/guardian decision|0|||
160815230|NCT01406938|580707336|FG004|Induction Period|Subject/guardian decision|0|||
160815231|NCT01406938|580707337|FG005|Induction Period|Subject/guardian decision|0|||
160815232|NCT01406938|580707332|FG000|Induction Period|Protocol deviation|1|||
160815233|NCT01406938|580707333|FG001|Induction Period|Protocol deviation|0|||
160815234|NCT01406938|580707334|FG002|Induction Period|Protocol deviation|0|||
160815235|NCT01406938|580707335|FG003|Induction Period|Protocol deviation|0|||
160815236|NCT01406938|580707336|FG004|Induction Period|Protocol deviation|0|||
160815237|NCT01406938|580707337|FG005|Induction Period|Protocol deviation|0|||
160815238|NCT01406938|580707332|FG000|Induction Period|Adverse Event|8|||
160815239|NCT01406938|580707333|FG001|Induction Period|Adverse Event|9|||
160815240|NCT01406938|580707334|FG002|Induction Period|Adverse Event|0|||
161239950|NCT01695239|582260475|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
160815241|NCT01406938|580707335|FG003|Induction Period|Adverse Event|0|||
160815242|NCT01406938|580707336|FG004|Induction Period|Adverse Event|0|||
160815243|NCT01406938|580707337|FG005|Induction Period|Adverse Event|0|||
160815244|NCT01406938|580707332|FG000|Induction Period|Lack of Efficacy|1|||
160815245|NCT01406938|580707333|FG001|Induction Period|Lack of Efficacy|0|||
160815246|NCT01406938|580707334|FG002|Induction Period|Lack of Efficacy|0|||
160815247|NCT01406938|580707335|FG003|Induction Period|Lack of Efficacy|0|||
160815248|NCT01406938|580707336|FG004|Induction Period|Lack of Efficacy|0|||
160815249|NCT01406938|580707337|FG005|Induction Period|Lack of Efficacy|0|||
160815250|NCT01406938|580707332|FG000|Induction Period|Lost to Follow-up|2|||
160815251|NCT01406938|580707333|FG001|Induction Period|Lost to Follow-up|3|||
160815252|NCT01406938|580707334|FG002|Induction Period|Lost to Follow-up|0|||
160815253|NCT01406938|580707335|FG003|Induction Period|Lost to Follow-up|0|||
160815254|NCT01406938|580707336|FG004|Induction Period|Lost to Follow-up|0|||
160815255|NCT01406938|580707337|FG005|Induction Period|Lost to Follow-up|0|||
160815256|NCT01406938|580707332|FG000|Maintenance Period|Adverse Event|0|||
160815257|NCT01406938|580707333|FG001|Maintenance Period|Adverse Event|0|||
160815258|NCT01406938|580707334|FG002|Maintenance Period|Adverse Event|2|||
160815259|NCT01406938|580707335|FG003|Maintenance Period|Adverse Event|8|||
160815260|NCT01406938|580707336|FG004|Maintenance Period|Adverse Event|4|||
160815261|NCT01406938|580707337|FG005|Maintenance Period|Adverse Event|2|||
160815262|NCT01406938|580707332|FG000|Maintenance Period|Death|0|||
160815263|NCT01406938|580707333|FG001|Maintenance Period|Death|0|||
160815264|NCT01406938|580707334|FG002|Maintenance Period|Death|0|||
160815265|NCT01406938|580707335|FG003|Maintenance Period|Death|0|||
160815266|NCT01406938|580707336|FG004|Maintenance Period|Death|1|||
160815267|NCT01406938|580707337|FG005|Maintenance Period|Death|0|||
160815268|NCT01406938|580707332|FG000|Maintenance Period|Subject/guardian decision|0|||
160815269|NCT01406938|580707333|FG001|Maintenance Period|Subject/guardian decision|0|||
160815270|NCT01406938|580707334|FG002|Maintenance Period|Subject/guardian decision|11|||
160815271|NCT01406938|580707335|FG003|Maintenance Period|Subject/guardian decision|7|||
160815272|NCT01406938|580707336|FG004|Maintenance Period|Subject/guardian decision|10|||
160815273|NCT01406938|580707337|FG005|Maintenance Period|Subject/guardian decision|7|||
160815274|NCT01406938|580707332|FG000|Maintenance Period|Protocol Violation|0|||
160900242|NCT00761631|581028680|FG004|Overall Study|Other|1|||
160900243|NCT00761631|581028681|FG005|Overall Study|Other|1|||
160900244|NCT00319501|581028686|FG000|Double-blind Period|Withdrawal by Subject|0|||
161239951|NCT01695239|582260476|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
161239952|NCT01695239|582260477|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
161333331|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
160815275|NCT01406938|580707333|FG001|Maintenance Period|Protocol Violation|0|||
160815276|NCT01406938|580707334|FG002|Maintenance Period|Protocol Violation|2|||
160815277|NCT01406938|580707335|FG003|Maintenance Period|Protocol Violation|2|||
160900245|NCT00319501|581028687|FG001|Double-blind Period|Withdrawal by Subject|3|||
160815278|NCT01406938|580707336|FG004|Maintenance Period|Protocol Violation|2|||
160815279|NCT01406938|580707337|FG005|Maintenance Period|Protocol Violation|2|||
160815280|NCT01406938|580707332|FG000|Maintenance Period|Pregnancy|0|||
160815281|NCT01406938|580707333|FG001|Maintenance Period|Pregnancy|0|||
160815282|NCT01406938|580707334|FG002|Maintenance Period|Pregnancy|0|||
160815283|NCT01406938|580707335|FG003|Maintenance Period|Pregnancy|0|||
160815284|NCT01406938|580707336|FG004|Maintenance Period|Pregnancy|1|||
160815285|NCT01406938|580707337|FG005|Maintenance Period|Pregnancy|0|||
160815286|NCT01406938|580707332|FG000|Maintenance Period|Lost to Follow-up|0|||
160815287|NCT01406938|580707333|FG001|Maintenance Period|Lost to Follow-up|0|||
160815288|NCT01406938|580707334|FG002|Maintenance Period|Lost to Follow-up|0|||
160815289|NCT01406938|580707335|FG003|Maintenance Period|Lost to Follow-up|0|||
160815290|NCT01406938|580707336|FG004|Maintenance Period|Lost to Follow-up|4|||
160815291|NCT01406938|580707337|FG005|Maintenance Period|Lost to Follow-up|0|||
160815292|NCT01406938|580707332|FG000|Maintenance Period|Lack of Efficacy|0|||
160815293|NCT01406938|580707333|FG001|Maintenance Period|Lack of Efficacy|0|||
160815294|NCT01406938|580707334|FG002|Maintenance Period|Lack of Efficacy|2|||
160815295|NCT01406938|580707335|FG003|Maintenance Period|Lack of Efficacy|1|||
160815296|NCT01406938|580707336|FG004|Maintenance Period|Lack of Efficacy|3|||
160815297|NCT01406938|580707337|FG005|Maintenance Period|Lack of Efficacy|5|||
160815298|NCT01406938|580707332|FG000|Follow up|Lack of Efficacy|3|||
160815299|NCT01406938|580707333|FG001|Follow up|Lack of Efficacy|2|||
160815300|NCT01406938|580707334|FG002|Follow up|Lack of Efficacy|1|||
160815301|NCT01406938|580707335|FG003|Follow up|Lack of Efficacy|0|||
160815302|NCT01406938|580707336|FG004|Follow up|Lack of Efficacy|0|||
160815303|NCT01406938|580707337|FG005|Follow up|Lack of Efficacy|0|||
160815304|NCT01406938|580707332|FG000|Follow up|Patient/guardian decision|4|||
160815305|NCT01406938|580707333|FG001|Follow up|Patient/guardian decision|2|||
160815306|NCT01406938|580707334|FG002|Follow up|Patient/guardian decision|4|||
160815307|NCT01406938|580707335|FG003|Follow up|Patient/guardian decision|2|||
160815308|NCT01406938|580707336|FG004|Follow up|Patient/guardian decision|4|||
160815309|NCT01406938|580707337|FG005|Follow up|Patient/guardian decision|1|||
160815310|NCT01406938|580707332|FG000|Follow up|Protocol Violation|0|||
160815311|NCT01406938|580707333|FG001|Follow up|Protocol Violation|0|||
160815312|NCT01406938|580707334|FG002|Follow up|Protocol Violation|1|||
160815313|NCT01406938|580707335|FG003|Follow up|Protocol Violation|0|||
160815314|NCT01406938|580707336|FG004|Follow up|Protocol Violation|0|||
160815315|NCT01406938|580707337|FG005|Follow up|Protocol Violation|0|||
160815316|NCT01406938|580707332|FG000|Follow up|Physician Decision|0|||
160815317|NCT01406938|580707333|FG001|Follow up|Physician Decision|0|||
160815318|NCT01406938|580707334|FG002|Follow up|Physician Decision|2|||
160815319|NCT01406938|580707335|FG003|Follow up|Physician Decision|0|||
160815320|NCT01406938|580707336|FG004|Follow up|Physician Decision|3|||
160815321|NCT01406938|580707337|FG005|Follow up|Physician Decision|1|||
160815322|NCT01406938|580707332|FG000|Follow up|Lost to Follow-up|1|||
160815323|NCT01406938|580707333|FG001|Follow up|Lost to Follow-up|1|||
160815324|NCT01406938|580707334|FG002|Follow up|Lost to Follow-up|0|||
160815325|NCT01406938|580707335|FG003|Follow up|Lost to Follow-up|1|||
160815326|NCT01406938|580707336|FG004|Follow up|Lost to Follow-up|2|||
160815327|NCT01406938|580707337|FG005|Follow up|Lost to Follow-up|1|||
160815328|NCT00962741|580707342|FG000|Overall Study|Failed to return|3|||
160900246|NCT00319501|581028686|FG000|Double-blind Period|Sponsor Request|1|||
160900247|NCT00319501|581028687|FG001|Double-blind Period|Sponsor Request|0|||
161239953|NCT01695239|582260464|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239954|NCT01695239|582260465|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239955|NCT01695239|582260466|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239956|NCT01695239|582260467|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239957|NCT01695239|582260468|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239958|NCT01695239|582260469|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160815329|NCT00962741|580707342|FG000|Overall Study|Lost to Follow-up|2|||
160815330|NCT00962741|580707342|FG000|Overall Study|Withdrawal by Subject|1|||
160815331|NCT00962741|580707342|FG000|Overall Study|Lack of Efficacy|1|||
160815332|NCT00962741|580707342|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
160815333|NCT02141399|580707346|FG000|Overall Study|Adverse Event|158|||
160815334|NCT02141399|580707346|FG000|Overall Study|Lack of Efficacy|62|||
160815335|NCT02141399|580707346|FG000|Overall Study|Lost to Follow-up|151|||
160815336|NCT02141399|580707346|FG000|Overall Study|Non-compliance with study drug|18|||
160815337|NCT02141399|580707346|FG000|Overall Study|Other|45|||
160815338|NCT02141399|580707346|FG000|Overall Study|Physician Decision|17|||
160815339|NCT02141399|580707346|FG000|Overall Study|Pregnancy|3|||
160815340|NCT02141399|580707346|FG000|Overall Study|Protocol Violation|38|||
160815341|NCT02141399|580707346|FG000|Overall Study|Withdrawal by Subject|238|||
160815342|NCT02141399|580707346|FG000|Overall Study|Failure to meet eligibility criteria|14|||
160815343|NCT00606034|580707353|FG000|Overall Study|incarceration|1|||
160815344|NCT02516098|580707357|FG000|Period 1|Protocol Violation|1|||
160815345|NCT02516098|580707358|FG001|Period 1|Protocol Violation|0|||
160900248|NCT00319501|581028686|FG000|Double-blind Period|Did not receive treatment|42|||
160900249|NCT00319501|581028687|FG001|Double-blind Period|Did not receive treatment|29|||
160900250|NCT00319501|581028686|FG000|Open-label Period|Adverse Event|5|||
160900251|NCT00319501|581028687|FG001|Open-label Period|Adverse Event|0|||
160900252|NCT00319501|581028686|FG000|Open-label Period|Protocol Violation|6|||
160900253|NCT00319501|581028687|FG001|Open-label Period|Protocol Violation|0|||
161333332|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
161333333|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161333334|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161333335|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161333336|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161333337|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
161333338|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
161333339|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
160900254|NCT00319501|581028686|FG000|Open-label Period|Withdrawal by Subject|38|||
160900255|NCT00319501|581028687|FG001|Open-label Period|Withdrawal by Subject|0|||
160900256|NCT00319501|581028686|FG000|Open-label Period|Principal Investigator decision|6|||
160900257|NCT00319501|581028687|FG001|Open-label Period|Principal Investigator decision|0|||
161333340|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161333341|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161333342|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161333343|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
161333344|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
161333345|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161333346|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161333347|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161333348|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161333349|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
161333350|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
161333351|NCT03904693|582608705|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161333352|NCT03904693|582608706|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
160900258|NCT00319501|581028686|FG000|Open-label Period|Sponsor request|12|||
160900259|NCT00319501|581028687|FG001|Open-label Period|Sponsor request|0|||
160900260|NCT00319501|581028686|FG000|Open-label Period|Lost to Follow-up|5|||
160900261|NCT00319501|581028687|FG001|Open-label Period|Lost to Follow-up|0|||
160900262|NCT00319501|581028686|FG000|Open-label Period|Did not receive treatment|33|||
160900263|NCT00319501|581028687|FG001|Open-label Period|Did not receive treatment|0|||
160900264|NCT00319501|581028686|FG000|Open-label Period|Other|11|||
160900265|NCT00319501|581028687|FG001|Open-label Period|Other|0|||
160900266|NCT00319501|581028686|FG000|Open-label Extension Period|Adverse Event|2|||
160900267|NCT00319501|581028687|FG001|Open-label Extension Period|Adverse Event|0|||
160900268|NCT00319501|581028686|FG000|Open-label Extension Period|Did not receive treatment|18|||
160900269|NCT00319501|581028687|FG001|Open-label Extension Period|Did not receive treatment|0|||
160900270|NCT00319501|581028686|FG000|Open-label Extension Period|Other|1|||
160900271|NCT00319501|581028687|FG001|Open-label Extension Period|Other|0|||
160900272|NCT00319501|581028686|FG000|Open-label Extension Period|Principal investigator decision|2|||
160900273|NCT00319501|581028687|FG001|Open-label Extension Period|Principal investigator decision|0|||
160900274|NCT00319501|581028686|FG000|Open-label Extension Period|Sponsor request|26|||
160900275|NCT00319501|581028687|FG001|Open-label Extension Period|Sponsor request|0|||
160900276|NCT00319501|581028686|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
160900277|NCT00319501|581028687|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
160900278|NCT00667875|581028688|FG000|Overall Study|Adverse Event|0|||
160900279|NCT00667875|581028689|FG001|Overall Study|Adverse Event|2|||
160900280|NCT00667875|581028690|FG002|Overall Study|Adverse Event|6|||
160900281|NCT00667875|581028688|FG000|Overall Study|Withdrawal by Subject|10|||
160900282|NCT00667875|581028689|FG001|Overall Study|Withdrawal by Subject|9|||
160900283|NCT00667875|581028690|FG002|Overall Study|Withdrawal by Subject|7|||
160900284|NCT00450255|581028691|FG000|Overall Study|Prior RFA ablation of liver|1|||
160900285|NCT02764697|581028692|FG000|Overall Study|Lack of Efficacy|3|||
160900286|NCT02612129|581028695|FG000|Single Dose Treatment Period|Screening Failure|1|||
160900287|NCT02612129|581028696|FG001|Single Dose Treatment Period|Screening Failure|0|||
160900288|NCT02612129|581028697|FG002|Single Dose Treatment Period|Screening Failure|0|||
160900289|NCT02612129|581028695|FG000|Continuous Treatment Period|Early Escape|0|||
160900290|NCT02612129|581028696|FG001|Continuous Treatment Period|Early Escape|2|||
160900291|NCT02612129|581028697|FG002|Continuous Treatment Period|Early Escape|0|||
160900292|NCT02612129|581028695|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
160900293|NCT02612129|581028696|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
160900294|NCT02612129|581028697|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
160900295|NCT02612129|581028695|FG000|Continuous Treatment Period|Safety Reasons|0|||
160900296|NCT02612129|581028696|FG001|Continuous Treatment Period|Safety Reasons|3|||
160900297|NCT02612129|581028697|FG002|Continuous Treatment Period|Safety Reasons|0|||
160900298|NCT02612129|581028695|FG000|Continuous Treatment Period|Death|0|||
160815346|NCT02516098|580707357|FG000|Washout After Period 1|Adverse Event|0|||
160815347|NCT02516098|580707358|FG001|Washout After Period 1|Adverse Event|1|||
160815348|NCT02516098|580707357|FG000|Period 2|Withdrawal by Subject|0|||
160815349|NCT02516098|580707358|FG001|Period 2|Withdrawal by Subject|1|||
160815350|NCT01734395|580707359|FG000|Overall Study|Other|65|||
160815351|NCT01734395|580707359|FG000|Overall Study|Lost to Follow-up|287|||
160815352|NCT01734395|580707359|FG000|Overall Study|Lack of Efficacy|5|||
160815353|NCT01734395|580707359|FG000|Overall Study|Adverse Event|40|||
160815354|NCT01734395|580707359|FG000|Overall Study|Withdrawal by Subject|10|||
160815355|NCT01734395|580707359|FG000|Overall Study|Missing the reasons for not completed|3|||
160815356|NCT01092780|580707360|FG000|Washout Period 1|Adverse Event|0|||
160815357|NCT01092780|580707361|FG001|Washout Period 1|Adverse Event|1|||
160815358|NCT01092780|580707362|FG002|Washout Period 1|Adverse Event|0|||
160815359|NCT01092780|580707363|FG003|Washout Period 1|Adverse Event|0|||
160815360|NCT01092780|580707360|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
160815361|NCT01092780|580707361|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
160815362|NCT01092780|580707362|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
160815363|NCT01092780|580707363|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
160815364|NCT01092780|580707360|FG000|Washout Period 2|Adverse Event|0|||
160815365|NCT01092780|580707361|FG001|Washout Period 2|Adverse Event|1|||
160815366|NCT01092780|580707362|FG002|Washout Period 2|Adverse Event|1|||
160815367|NCT01092780|580707363|FG003|Washout Period 2|Adverse Event|0|||
160815368|NCT01257230|580707364|FG000|Overall Study|Not Treated|0|||
160815369|NCT01257230|580707365|FG001|Overall Study|Not Treated|0|||
160815370|NCT01257230|580707366|FG002|Overall Study|Not Treated|1|||
160815371|NCT01257230|580707364|FG000|Overall Study|Adverse Event|2|||
160815372|NCT01257230|580707365|FG001|Overall Study|Adverse Event|0|||
160815373|NCT01257230|580707366|FG002|Overall Study|Adverse Event|0|||
160815374|NCT01257230|580707364|FG000|Overall Study|Lack of Efficacy|0|||
160815375|NCT01257230|580707365|FG001|Overall Study|Lack of Efficacy|1|||
160815376|NCT01257230|580707366|FG002|Overall Study|Lack of Efficacy|0|||
160815377|NCT01257230|580707364|FG000|Overall Study|Protocol Violation|3|||
160815378|NCT01257230|580707365|FG001|Overall Study|Protocol Violation|0|||
160815379|NCT01257230|580707366|FG002|Overall Study|Protocol Violation|1|||
160987280|NCT04955626|581341132|FG027|Open-Label Period|Other|0|||
160987281|NCT04955626|581341133|FG028|Open-Label Period|Other|0|||
160987282|NCT04955626|581341134|FG029|Open-Label Period|Other|0|||
160987283|NCT04955626|581341135|FG030|Open-Label Period|Other|0|||
161239959|NCT01695239|582260470|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
160815380|NCT01257230|580707364|FG000|Overall Study|Withdrawal by Subject|0|||
160815381|NCT01257230|580707365|FG001|Overall Study|Withdrawal by Subject|4|||
160815382|NCT01257230|580707366|FG002|Overall Study|Withdrawal by Subject|1|||
160815383|NCT01257230|580707364|FG000|Overall Study|Other reason not defined above|1|||
160815384|NCT01257230|580707365|FG001|Overall Study|Other reason not defined above|5|||
160815385|NCT01257230|580707366|FG002|Overall Study|Other reason not defined above|3|||
160815386|NCT00765037|580707372|FG000|Overall Study|Lost to Follow-up|5|||
160815387|NCT00765037|580707372|FG000|Overall Study|Adverse Event|1|||
160815388|NCT00615719|580707373|FG000|Overall Study|Physician Decision|5|||
160815389|NCT02300558|580707374|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
160815390|NCT02300558|580707374|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
160815391|NCT02300558|580707374|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
160815392|NCT02300558|580707374|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
160815393|NCT01471028|580707375|FG000|VTI-208|Adverse Event|39|||
160815394|NCT01471028|580707376|FG001|VTI-208|Adverse Event|41|||
160900299|NCT02612129|581028696|FG001|Continuous Treatment Period|Death|1|||
160900300|NCT02612129|581028697|FG002|Continuous Treatment Period|Death|0|||
160900301|NCT02612129|581028695|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
160900302|NCT02612129|581028696|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
160900303|NCT02612129|581028697|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
160900304|NCT02557295|581028698|FG000|Overall Study|Withdrawal by Subject|9|||
160900305|NCT02557295|581028699|FG001|Overall Study|Withdrawal by Subject|2|||
160900306|NCT02557295|581028700|FG002|Overall Study|Withdrawal by Subject|4|||
160900307|NCT02557295|581028701|FG003|Overall Study|Withdrawal by Subject|0|||
160900308|NCT02557295|581028702|FG004|Overall Study|Withdrawal by Subject|0|||
160900309|NCT02557295|581028703|FG005|Overall Study|Withdrawal by Subject|0|||
160987284|NCT04955626|581341136|FG031|Open-Label Period|Other|0|||
160815395|NCT01471028|580707375|FG000|VTI-208|Withdrawal by Subject|0|||
160815396|NCT01471028|580707376|FG001|VTI-208|Withdrawal by Subject|2|||
160815397|NCT01471028|580707375|FG000|VTI-208|Lost to Follow-up|1|||
160815398|NCT01471028|580707376|FG001|VTI-208|Lost to Follow-up|1|||
160815399|NCT01471028|580707375|FG000|VTI-208E|Death|7|||
160815400|NCT01471028|580707376|FG001|VTI-208E|Death|10|||
160815401|NCT01471028|580707375|FG000|VTI-208E|Withdrawal by Subject|1|||
160815402|NCT01471028|580707376|FG001|VTI-208E|Withdrawal by Subject|0|||
160815403|NCT01471028|580707375|FG000|VTI-208E|Lost to Follow-up|0|||
160815404|NCT01471028|580707376|FG001|VTI-208E|Lost to Follow-up|2|||
160815405|NCT00935493|580707379|FG000|Overall Study|Lost to Follow-up|1|||
160900310|NCT02557295|581028704|FG006|Overall Study|Withdrawal by Subject|15|||
160900311|NCT02557295|581028705|FG007|Overall Study|Withdrawal by Subject|1|||
161333353|NCT03904693|582608707|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161333354|NCT03904693|582608708|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161333355|NCT03904693|582608709|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
161333356|NCT03904693|582608710|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
161333357|NCT01172873|582608711|FG000|Overall Study|Withdrawal by Subject|3|||
161333358|NCT01172873|582608712|FG001|Overall Study|Withdrawal by Subject|2|||
161333359|NCT05518539|582608713|FG000|Overall Study|Lost to Follow-up|6|||
161333360|NCT04613518|582608714|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161333361|NCT04613518|582608715|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
161333362|NCT04613518|582608716|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161333363|NCT04613518|582608714|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161333364|NCT04613518|582608715|FG001|Double-Blind Treatment Period|Adverse Event|0|||
161333365|NCT04613518|582608716|FG002|Double-Blind Treatment Period|Adverse Event|1|||
161333366|NCT04613518|582608714|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
161333367|NCT04613518|582608715|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
161333368|NCT04613518|582608716|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
161333369|NCT04613518|582608714|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
161333370|NCT04613518|582608715|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
161333371|NCT04613518|582608716|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
161333372|NCT04613518|582608714|FG000|Double-Blind Treatment Period|Other Reasons|2|||
161333373|NCT04613518|582608715|FG001|Double-Blind Treatment Period|Other Reasons|0|||
161333374|NCT04613518|582608716|FG002|Double-Blind Treatment Period|Other Reasons|0|||
161333375|NCT04613518|582608714|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
161333376|NCT04613518|582608715|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
161333377|NCT04613518|582608716|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161333378|NCT04613518|582608714|FG000|Open-Label Treatment Period|Adverse Event|1|||
161333379|NCT04613518|582608715|FG001|Open-Label Treatment Period|Adverse Event|0|||
161333380|NCT04613518|582608716|FG002|Open-Label Treatment Period|Adverse Event|3|||
161333381|NCT04613518|582608714|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
161333382|NCT04613518|582608715|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
161333383|NCT04613518|582608716|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
161333384|NCT04613518|582608714|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
161333385|NCT04613518|582608715|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
161333386|NCT04613518|582608716|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
161333387|NCT04613518|582608714|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
161333388|NCT04613518|582608715|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
161333389|NCT04613518|582608716|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
161333390|NCT04613518|582608714|FG000|Open-Label Treatment Period|Other reasons|1|||
161333391|NCT04613518|582608715|FG001|Open-Label Treatment Period|Other reasons|0|||
161333392|NCT04613518|582608716|FG002|Open-Label Treatment Period|Other reasons|0|||
161333393|NCT03589807|582608717|FG000|Overall Study|Lost to Follow-up|0|||
161333394|NCT03589807|582608718|FG001|Overall Study|Lost to Follow-up|2|||
161333395|NCT03589807|582608719|FG002|Overall Study|Lost to Follow-up|2|||
161333396|NCT03589807|582608720|FG003|Overall Study|Lost to Follow-up|3|||
161333397|NCT03589807|582608721|FG004|Overall Study|Lost to Follow-up|1|||
161333398|NCT03589807|582608722|FG005|Overall Study|Lost to Follow-up|1|||
161333399|NCT03589807|582608717|FG000|Overall Study|Withdrawal by Subject|0|||
161333400|NCT03589807|582608718|FG001|Overall Study|Withdrawal by Subject|5|||
161333401|NCT03589807|582608719|FG002|Overall Study|Withdrawal by Subject|0|||
161333402|NCT03589807|582608720|FG003|Overall Study|Withdrawal by Subject|0|||
161333403|NCT03589807|582608721|FG004|Overall Study|Withdrawal by Subject|0|||
161333404|NCT03589807|582608722|FG005|Overall Study|Withdrawal by Subject|0|||
161333405|NCT03589807|582608717|FG000|Overall Study|Protocol Violation|0|||
161333406|NCT03589807|582608718|FG001|Overall Study|Protocol Violation|0|||
161333407|NCT03589807|582608719|FG002|Overall Study|Protocol Violation|0|||
161333408|NCT03589807|582608720|FG003|Overall Study|Protocol Violation|1|||
161333409|NCT03589807|582608721|FG004|Overall Study|Protocol Violation|0|||
161333410|NCT03589807|582608722|FG005|Overall Study|Protocol Violation|0|||
161333411|NCT03589807|582608717|FG000|Overall Study|Enrolled but treatment not administered|0|||
161333412|NCT03589807|582608718|FG001|Overall Study|Enrolled but treatment not administered|0|||
161333413|NCT03589807|582608719|FG002|Overall Study|Enrolled but treatment not administered|0|||
161333414|NCT03589807|582608720|FG003|Overall Study|Enrolled but treatment not administered|0|||
161333415|NCT03589807|582608721|FG004|Overall Study|Enrolled but treatment not administered|1|||
161333416|NCT03589807|582608722|FG005|Overall Study|Enrolled but treatment not administered|0|||
161333417|NCT01211145|582608723|FG000|Overall Study|Reason not specified|3|||
161333418|NCT01211145|582608724|FG001|Overall Study|Reason not specified|2|||
161333419|NCT01211145|582608725|FG002|Overall Study|Reason not specified|2|||
160900312|NCT02557295|581028706|FG008|Overall Study|Withdrawal by Subject|3|||
160815406|NCT00935493|580707380|FG001|Overall Study|Lost to Follow-up|1|||
160815407|NCT00935493|580707381|FG002|Overall Study|Lost to Follow-up|1|||
160815408|NCT00935493|580707379|FG000|Overall Study|Treatment Discontinued|0|||
160815409|NCT00935493|580707380|FG001|Overall Study|Treatment Discontinued|1|||
160815410|NCT00935493|580707381|FG002|Overall Study|Treatment Discontinued|0|||
160815411|NCT03823287|580707382|FG000|Overall Study|Withdrawal by Subject|25|||
160815412|NCT03823287|580707383|FG001|Overall Study|Withdrawal by Subject|17|||
160815413|NCT03823287|580707382|FG000|Overall Study|Death|13|||
160815414|NCT03823287|580707383|FG001|Overall Study|Death|7|||
160815415|NCT03823287|580707382|FG000|Overall Study|Lost to Follow-up|7|||
160815416|NCT03823287|580707383|FG001|Overall Study|Lost to Follow-up|8|||
160815417|NCT03823287|580707382|FG000|Overall Study|Adverse Event|6|||
160815418|NCT03823287|580707383|FG001|Overall Study|Adverse Event|8|||
160815419|NCT03823287|580707382|FG000|Overall Study|Physician Decision|5|||
160815420|NCT03823287|580707383|FG001|Overall Study|Physician Decision|2|||
160815421|NCT03823287|580707382|FG000|Overall Study|Lack of Efficacy|2|||
160815422|NCT03823287|580707383|FG001|Overall Study|Lack of Efficacy|0|||
160815423|NCT03823287|580707382|FG000|Overall Study|Other|2|||
160815424|NCT03823287|580707383|FG001|Overall Study|Other|4|||
160815425|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Adverse Event|7|||
160815426|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Adverse Event|0|||
160815427|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Adverse Event|0|||
160815428|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
160815429|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
160815430|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
160815431|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
160815432|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
160815433|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
160815434|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
160815435|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
160815436|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
160815437|NCT01059864|580707386|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
160815438|NCT01059864|580707387|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
160815439|NCT01059864|580707388|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
160815440|NCT01059864|580707386|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160815441|NCT01059864|580707387|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
160815442|NCT01059864|580707388|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
160815443|NCT03108521|580707389|FG000|Overall Study|Lost to Follow-up|3|||
160815444|NCT03108521|580707390|FG001|Overall Study|Lost to Follow-up|0|||
160815445|NCT03108521|580707389|FG000|Overall Study|Lack of Efficacy|2|||
160815446|NCT03108521|580707390|FG001|Overall Study|Lack of Efficacy|0|||
160815447|NCT03108521|580707389|FG000|Overall Study|Physician Decision|4|||
160815448|NCT03108521|580707390|FG001|Overall Study|Physician Decision|0|||
160815449|NCT03108521|580707389|FG000|Overall Study|Adverse Event|3|||
160815450|NCT03108521|580707390|FG001|Overall Study|Adverse Event|0|||
160815451|NCT03281629|580707397|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
160815452|NCT03281629|580707398|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
160815453|NCT03281629|580707397|FG000|Overall Study|Death|0|||
160815454|NCT03281629|580707398|FG001|Overall Study|Death|1|||
160815455|NCT03281629|580707397|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
160815456|NCT03281629|580707398|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
160815457|NCT01170273|580707404|FG000|Overall Study|Lost to Follow-up|6|||
160815458|NCT01170273|580707405|FG001|Overall Study|Lost to Follow-up|8|||
160815459|NCT01170273|580707404|FG000|Overall Study|Protocol Violation|1|||
160815460|NCT01170273|580707405|FG001|Overall Study|Protocol Violation|0|||
160815461|NCT01170273|580707404|FG000|Overall Study|Death|1|||
161132296|NCT00450580|581868915|FG001|Overall Study|Withdrawal by Subject|2|||
161132297|NCT00450580|581868914|FG000|Overall Study|Protocol Violation|1|||
161132298|NCT00450580|581868915|FG001|Overall Study|Protocol Violation|1|||
161132299|NCT00450580|581868914|FG000|Overall Study|Protocol-defined virologic failure|1|||
161132300|NCT00450580|581868915|FG001|Overall Study|Protocol-defined virologic failure|0|||
161132301|NCT00450580|581868914|FG000|Overall Study|Could not comply with scheduled visits|1|||
161132302|NCT00450580|581868915|FG001|Overall Study|Could not comply with scheduled visits|0|||
160815462|NCT01170273|580707405|FG001|Overall Study|Death|0|||
160815463|NCT01170273|580707404|FG000|Overall Study|Adverse Event|0|||
160815464|NCT01170273|580707405|FG001|Overall Study|Adverse Event|1|||
160815465|NCT01456195|580709260|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160815466|NCT01456195|580709261|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
160815467|NCT01456195|580709262|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
160815468|NCT01456195|580709260|FG000|Overall Study|Lost to Follow-up|3|||
160815469|NCT01456195|580709261|FG001|Overall Study|Lost to Follow-up|1|||
160815470|NCT01456195|580709262|FG002|Overall Study|Lost to Follow-up|3|||
160815471|NCT01456195|580709260|FG000|Overall Study|Voluntary Withdrawal|5|||
160815472|NCT01456195|580709261|FG001|Overall Study|Voluntary Withdrawal|3|||
160815473|NCT01456195|580709262|FG002|Overall Study|Voluntary Withdrawal|7|||
161132303|NCT00450580|581868914|FG000|Overall Study|Patient went to Brazil|1|||
160815474|NCT01456195|580709260|FG000|Overall Study|Lack of Efficacy|0|||
160815475|NCT01456195|580709261|FG001|Overall Study|Lack of Efficacy|1|||
160815476|NCT01456195|580709262|FG002|Overall Study|Lack of Efficacy|0|||
160815477|NCT01456195|580709260|FG000|Overall Study|Other Reasons|2|||
160815478|NCT01456195|580709261|FG001|Overall Study|Other Reasons|1|||
160815479|NCT01456195|580709262|FG002|Overall Study|Other Reasons|3|||
160815480|NCT02109432|580709263|FG000|Overall Study|Withdrawal by Subject|1|||
160815481|NCT03372551|580709270|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
160815482|NCT03372551|580709271|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
160815483|NCT04683029|580709284|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
160815484|NCT04683029|580709285|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
160815485|NCT04683029|580709286|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
160815486|NCT04683029|580709287|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
160815487|NCT04683029|580709284|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
160815488|NCT04683029|580709285|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
160815489|NCT04683029|580709286|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
160815490|NCT04683029|580709287|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
160815491|NCT04683029|580709284|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
160815492|NCT04683029|580709285|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
160815493|NCT04683029|580709286|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
160815494|NCT04683029|580709287|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
160815495|NCT04299308|580709288|FG000|Overall Study|Withdrawal by Subject|1|||
160815496|NCT04299308|580709289|FG001|Overall Study|Withdrawal by Subject|0|||
160815497|NCT04299308|580709288|FG000|Overall Study|issue with PET image (1)|1|||
160815498|NCT04299308|580709289|FG001|Overall Study|issue with PET image (1)|0|||
160815499|NCT02920528|580709292|FG000|Overall Study|Incomplete Data|1|||
160815500|NCT02920528|580709293|FG001|Overall Study|Incomplete Data|1|||
160815501|NCT02920528|580709294|FG002|Overall Study|Incomplete Data|1|||
160815502|NCT02920528|580709292|FG000|Overall Study|Adverse Event|0|||
160815503|NCT02920528|580709293|FG001|Overall Study|Adverse Event|0|||
160815504|NCT02920528|580709294|FG002|Overall Study|Adverse Event|3|||
160815505|NCT02920528|580709292|FG000|Overall Study|Did not meet inclusion criteria|2|||
160815506|NCT02920528|580709293|FG001|Overall Study|Did not meet inclusion criteria|0|||
160815507|NCT02920528|580709294|FG002|Overall Study|Did not meet inclusion criteria|1|||
160815508|NCT03596047|580709296|FG000|Overall Study|Withdrawal by Subject|7|||
160815509|NCT03596047|580709297|FG001|Overall Study|Withdrawal by Subject|4|||
160815510|NCT03596047|580709296|FG000|Overall Study|Lost to Follow-up|0|||
160815511|NCT03596047|580709297|FG001|Overall Study|Lost to Follow-up|2|||
160815512|NCT00066703|580709298|FG000|Overall Study|Adverse Event|80|||
160815513|NCT00066703|580709299|FG001|Overall Study|Adverse Event|111|||
160815514|NCT00066703|580709298|FG000|Overall Study|Death|3|||
160815515|NCT00066703|580709299|FG001|Overall Study|Death|0|||
160815516|NCT00066703|580709298|FG000|Overall Study|Lack of Efficacy|114|||
160815517|NCT00066703|580709299|FG001|Overall Study|Lack of Efficacy|69|||
160815518|NCT00066703|580709298|FG000|Overall Study|Lost to Follow-up|31|||
160815519|NCT00066703|580709299|FG001|Overall Study|Lost to Follow-up|28|||
160815520|NCT00066703|580709298|FG000|Overall Study|Withdrawal by Subject|38|||
160815521|NCT00066703|580709299|FG001|Overall Study|Withdrawal by Subject|63|||
160815522|NCT00066703|580709298|FG000|Overall Study|Treatment ongoing|346|||
160815523|NCT00066703|580709299|FG001|Overall Study|Treatment ongoing|311|||
160815524|NCT01696968|580709300|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
160900313|NCT02557295|581028698|FG000|Overall Study|Disease Progression|0|||
160900314|NCT02557295|581028699|FG001|Overall Study|Disease Progression|0|||
160900315|NCT02557295|581028700|FG002|Overall Study|Disease Progression|0|||
160900316|NCT02557295|581028701|FG003|Overall Study|Disease Progression|0|||
160900317|NCT02557295|581028702|FG004|Overall Study|Disease Progression|0|||
160900318|NCT02557295|581028703|FG005|Overall Study|Disease Progression|0|||
160900319|NCT02557295|581028704|FG006|Overall Study|Disease Progression|1|||
160900320|NCT02557295|581028705|FG007|Overall Study|Disease Progression|0|||
161132304|NCT00450580|581868915|FG001|Overall Study|Patient went to Brazil|0|||
161132305|NCT00450580|581868914|FG000|Overall Study|Patient could not swallow Norvir|1|||
161132306|NCT00450580|581868915|FG001|Overall Study|Patient could not swallow Norvir|0|||
161132307|NCT00450580|581868914|FG000|Overall Study|Withdrawal due to pregnancy|0|||
161132308|NCT00450580|581868915|FG001|Overall Study|Withdrawal due to pregnancy|1|||
161132309|NCT03932812|581868920|FG000|Overall Study|Lost to Follow-up|12|||
161132310|NCT03932812|581868921|FG001|Overall Study|Lost to Follow-up|14|||
160815525|NCT01696968|580709301|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
160815526|NCT01696968|580709300|FG000|Overall Study|Died Before Randomization|3|||
160815527|NCT01696968|580709301|FG001|Overall Study|Died Before Randomization|8|||
160815528|NCT01696968|580709300|FG000|Overall Study|Died Before ASU (Control)|278|||
160815529|NCT01696968|580709301|FG001|Overall Study|Died Before ASU (Control)|0|||
160815530|NCT01696968|580709300|FG000|Overall Study|Refused ASU (Control)|920|||
160815531|NCT01696968|580709301|FG001|Overall Study|Refused ASU (Control)|0|||
160815532|NCT01696968|580709300|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
160900321|NCT02557295|581028706|FG008|Overall Study|Disease Progression|0|||
161132311|NCT03932812|581868920|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
161132312|NCT03932812|581868921|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
161132313|NCT00332709|581868926|FG000|Overall Study|Adverse Event|11|||
161132314|NCT00332709|581868927|FG001|Overall Study|Adverse Event|14|||
161333420|NCT01211145|582608726|FG003|Overall Study|Reason not specified|1|||
161333421|NCT01211145|582608723|FG000|Overall Study|Lost to Follow-up|3|||
161333422|NCT01211145|582608724|FG001|Overall Study|Lost to Follow-up|2|||
161333423|NCT01211145|582608725|FG002|Overall Study|Lost to Follow-up|1|||
161333424|NCT01211145|582608726|FG003|Overall Study|Lost to Follow-up|2|||
161333425|NCT01211145|582608723|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161333426|NCT01211145|582608724|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161333427|NCT01211145|582608725|FG002|Overall Study|Study-specific withdrawal criteria|0|||
161333428|NCT01211145|582608726|FG003|Overall Study|Study-specific withdrawal criteria|0|||
161333429|NCT01211145|582608723|FG000|Overall Study|Severe noncompliance to protocol|1|||
161333430|NCT01211145|582608724|FG001|Overall Study|Severe noncompliance to protocol|0|||
161333431|NCT01211145|582608725|FG002|Overall Study|Severe noncompliance to protocol|0|||
161333432|NCT01211145|582608726|FG003|Overall Study|Severe noncompliance to protocol|0|||
161333433|NCT01211145|582608723|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
161333434|NCT01211145|582608724|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
161333435|NCT01211145|582608725|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
161333436|NCT01211145|582608726|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
161333437|NCT01211145|582608723|FG000|Overall Study|Patient decision|2|||
161333438|NCT01211145|582608724|FG001|Overall Study|Patient decision|1|||
161333439|NCT01211145|582608725|FG002|Overall Study|Patient decision|0|||
161333440|NCT01211145|582608726|FG003|Overall Study|Patient decision|2|||
161333441|NCT00249834|582608729|FG000|Overall Study|Ovarian stimulation failed|1|||
161333442|NCT00249834|582608730|FG001|Overall Study|Ovarian stimulation failed|0|||
161333443|NCT00249834|582608731|FG002|Overall Study|Ovarian stimulation failed|0|||
161333444|NCT00249834|582608732|FG003|Overall Study|Ovarian stimulation failed|0|||
161333445|NCT00249834|582608733|FG004|Overall Study|Ovarian stimulation failed|0|||
161333446|NCT00249834|582608734|FG005|Overall Study|Ovarian stimulation failed|0|||
161333447|NCT00249834|582608735|FG006|Overall Study|Ovarian stimulation failed|0|||
161333448|NCT00249834|582608736|FG007|Overall Study|Ovarian stimulation failed|0|||
161333449|NCT00249834|582608729|FG000|Overall Study|Failure of down-regulation|0|||
161333450|NCT00249834|582608730|FG001|Overall Study|Failure of down-regulation|0|||
161333451|NCT00249834|582608731|FG002|Overall Study|Failure of down-regulation|0|||
161333452|NCT00249834|582608732|FG003|Overall Study|Failure of down-regulation|0|||
161333453|NCT00249834|582608733|FG004|Overall Study|Failure of down-regulation|0|||
161333454|NCT00249834|582608734|FG005|Overall Study|Failure of down-regulation|0|||
161333455|NCT00249834|582608735|FG006|Overall Study|Failure of down-regulation|1|||
161333456|NCT00249834|582608736|FG007|Overall Study|Failure of down-regulation|0|||
161333457|NCT00249834|582608729|FG000|Overall Study|Protocol Violation|0|||
161333458|NCT00249834|582608730|FG001|Overall Study|Protocol Violation|19|||
161333459|NCT00249834|582608731|FG002|Overall Study|Protocol Violation|14|||
161333460|NCT00249834|582608732|FG003|Overall Study|Protocol Violation|8|||
161333461|NCT00249834|582608733|FG004|Overall Study|Protocol Violation|5|||
161333462|NCT00249834|582608734|FG005|Overall Study|Protocol Violation|2|||
161333463|NCT00249834|582608735|FG006|Overall Study|Protocol Violation|0|||
161333464|NCT00249834|582608736|FG007|Overall Study|Protocol Violation|0|||
161333465|NCT02688933|582608739|FG000|Overall Study|Adverse Event|3|||
161333466|NCT02688933|582608740|FG001|Overall Study|Adverse Event|1|||
161333467|NCT02688933|582608739|FG000|Overall Study|Lack of Efficacy|2|||
160815533|NCT01696968|580709301|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
161132315|NCT00332709|581868926|FG000|Overall Study|Withdrawal by Subject|2|||
161132316|NCT00332709|581868927|FG001|Overall Study|Withdrawal by Subject|3|||
161132317|NCT00332709|581868926|FG000|Overall Study|Lost to Follow-up|2|||
161132318|NCT00332709|581868927|FG001|Overall Study|Lost to Follow-up|0|||
161132319|NCT00332709|581868926|FG000|Overall Study|Administrative Problems|0|||
161132320|NCT00332709|581868927|FG001|Overall Study|Administrative Problems|3|||
161132321|NCT00332709|581868926|FG000|Overall Study|Abnormal test procedure result|1|||
161132322|NCT00332709|581868927|FG001|Overall Study|Abnormal test procedure result|0|||
161132323|NCT01409928|581868928|FG000|Overall Study|Physician Decision|12|||
161132324|NCT00988247|581868929|FG000|Overall Study|Adverse Event|17|||
161132325|NCT00988247|581868930|FG001|Overall Study|Adverse Event|3|||
161132326|NCT00988247|581868929|FG000|Overall Study|Withdrawal by Subject|44|||
161132327|NCT00988247|581868930|FG001|Overall Study|Withdrawal by Subject|13|||
161333468|NCT02688933|582608740|FG001|Overall Study|Lack of Efficacy|2|||
161333469|NCT02688933|582608739|FG000|Overall Study|Poor compliance to protocol|7|||
161333470|NCT02688933|582608740|FG001|Overall Study|Poor compliance to protocol|4|||
161333471|NCT02688933|582608739|FG000|Overall Study|Hypoglycemia|2|||
161333472|NCT02688933|582608740|FG001|Overall Study|Hypoglycemia|0|||
161333473|NCT02688933|582608739|FG000|Overall Study|Other than Specified|14|||
161132328|NCT00988247|581868929|FG000|Overall Study|Pregnancy|1|||
161333474|NCT02688933|582608740|FG001|Overall Study|Other than Specified|25|||
161132329|NCT00988247|581868930|FG001|Overall Study|Pregnancy|2|||
161333475|NCT02688933|582608739|FG000|Overall Study|Lost to Follow-up|1|||
160815534|NCT03350035|580709302|FG000|Overall Study|Lack of Efficacy|2|||
160815535|NCT03350035|580709303|FG001|Overall Study|Lack of Efficacy|0|||
160815536|NCT03350035|580709304|FG002|Overall Study|Lack of Efficacy|0|||
160815537|NCT03350035|580709302|FG000|Overall Study|Subject discharged to hospice|0|||
160815538|NCT03350035|580709303|FG001|Overall Study|Subject discharged to hospice|0|||
160815539|NCT03350035|580709304|FG002|Overall Study|Subject discharged to hospice|1|||
160815540|NCT01811485|580709305|FG000|Overall Study|Adverse Event|1|||
160815541|NCT01811485|580709306|FG001|Overall Study|Adverse Event|3|||
160815542|NCT01811485|580709307|FG002|Overall Study|Adverse Event|2|||
160815543|NCT01811485|580709305|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160815544|NCT01811485|580709306|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160815545|NCT01811485|580709307|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
160815546|NCT01811485|580709305|FG000|Overall Study|Administrative problems|1|||
160815547|NCT01811485|580709306|FG001|Overall Study|Administrative problems|0|||
160815548|NCT01811485|580709307|FG002|Overall Study|Administrative problems|0|||
160815549|NCT01811485|580709305|FG000|Overall Study|Protocol Deviation|0|||
160815550|NCT01811485|580709306|FG001|Overall Study|Protocol Deviation|1|||
160815551|NCT01811485|580709307|FG002|Overall Study|Protocol Deviation|0|||
160815552|NCT03654404|580709308|FG000|Overall Study|Death|1|||
160815553|NCT03654404|580709308|FG000|Overall Study|Lost to Follow-up|2|||
160815554|NCT03654404|580709308|FG000|Overall Study|Withdrawal by Subject|5|||
160815555|NCT00654745|580709309|FG000|Overall Study|Adverse Event|12|||
160815556|NCT00654745|580709309|FG000|Overall Study|Lost to Follow-up|7|||
160815557|NCT00654745|580709309|FG000|Overall Study|Protocol Violation|11|||
160815558|NCT00654745|580709309|FG000|Overall Study|Withdrawal by Subject|10|||
160815559|NCT00654745|580709309|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
160815560|NCT04551963|580709310|FG000|Overall Study|Physician Decision|1|||
160815561|NCT04551963|580709311|FG001|Overall Study|Physician Decision|1|||
160815562|NCT04551963|580709310|FG000|Overall Study|Death|1|||
160815563|NCT04551963|580709311|FG001|Overall Study|Death|0|||
160815564|NCT02974855|580709312|FG000|Overall Study|Adverse Event|0|||
160815565|NCT02974855|580709313|FG001|Overall Study|Adverse Event|1|||
160815566|NCT02974855|580709314|FG002|Overall Study|Adverse Event|0|||
160815567|NCT02974855|580709315|FG003|Overall Study|Adverse Event|1|||
160815568|NCT01474772|580709316|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
160815569|NCT01474772|580709317|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
160815570|NCT01474772|580709316|FG000|Period 1|AE not Related to Study Drug|1|||
160815571|NCT01474772|580709317|FG001|Period 1|AE not Related to Study Drug|0|||
160815572|NCT01474772|580709316|FG000|Period 1|Withdrawal by Subject|3|||
160815573|NCT01474772|580709317|FG001|Period 1|Withdrawal by Subject|1|||
160815574|NCT01474772|580709316|FG000|Period 1|Lost to Follow-up|1|||
160815575|NCT01474772|580709317|FG001|Period 1|Lost to Follow-up|0|||
160815576|NCT01474772|580709316|FG000|Period 1|Reason not Specified|1|||
160815577|NCT01474772|580709317|FG001|Period 1|Reason not Specified|1|||
160815578|NCT01474772|580709316|FG000|Washout|AE not Related to Study Drug|2|||
160815579|NCT01474772|580709317|FG001|Washout|AE not Related to Study Drug|0|||
160815580|NCT01474772|580709316|FG000|Washout|Withdrawal by Subject|1|||
160815581|NCT01474772|580709317|FG001|Washout|Withdrawal by Subject|0|||
160815582|NCT01474772|580709316|FG000|Washout|Lost to Follow-up|0|||
160815583|NCT01474772|580709317|FG001|Washout|Lost to Follow-up|1|||
160815584|NCT01474772|580709316|FG000|Washout|Reason not Specified|0|||
160815585|NCT01474772|580709317|FG001|Washout|Reason not Specified|1|||
160815586|NCT01474772|580709316|FG000|Period 2|Death|0|||
160815587|NCT01474772|580709317|FG001|Period 2|Death|1|||
160815588|NCT01474772|580709316|FG000|Period 2|AE Related to Study Drug|0|||
161333476|NCT02688933|582608740|FG001|Overall Study|Lost to Follow-up|5|||
160987285|NCT04955626|581341137|FG032|Open-Label Period|Other|0|||
160987286|NCT04955626|581341138|FG033|Open-Label Period|Other|0|||
160987287|NCT04955626|581341139|FG034|Open-Label Period|Other|0|||
160987288|NCT04955626|581341140|FG035|Open-Label Period|Other|0|||
160815589|NCT01474772|580709317|FG001|Period 2|AE Related to Study Drug|1|||
160815590|NCT01474772|580709316|FG000|Period 2|AE not Related to Study Drug|4|||
160987289|NCT04955626|581341105|FG000|Open-Label Period|Physician Decision|2|||
160987290|NCT04955626|581341106|FG001|Open-Label Period|Physician Decision|0|||
160815591|NCT01474772|580709317|FG001|Period 2|AE not Related to Study Drug|1|||
160815592|NCT01474772|580709316|FG000|Period 2|Lack of Efficacy|1|||
160815593|NCT01474772|580709317|FG001|Period 2|Lack of Efficacy|0|||
160815594|NCT01474772|580709316|FG000|Period 2|Withdrawal by Subject|3|||
160815595|NCT01474772|580709317|FG001|Period 2|Withdrawal by Subject|4|||
160815596|NCT01474772|580709316|FG000|Period 2|Lost to Follow-up|1|||
160815597|NCT01474772|580709317|FG001|Period 2|Lost to Follow-up|1|||
160815598|NCT01474772|580709316|FG000|Period 2|Reason not Specified|0|||
160815599|NCT01474772|580709317|FG001|Period 2|Reason not Specified|2|||
160815600|NCT01474772|580709316|FG000|Follow-up|AE not Related to Study Drug|0|||
160815601|NCT01474772|580709317|FG001|Follow-up|AE not Related to Study Drug|1|||
160815602|NCT00633074|580709318|FG000|Overall Study|Adverse Event|1|||
160815603|NCT00633074|580709319|FG001|Overall Study|Adverse Event|0|||
160815604|NCT00365105|580709320|FG000|Overall Study|Protocol Violation|5|||
160815605|NCT00365105|580709321|FG001|Overall Study|Protocol Violation|8|||
160987291|NCT04955626|581341107|FG002|Open-Label Period|Physician Decision|0|||
160815606|NCT00748618|580709322|FG000|Overall Study|Adverse Event|1|||
160815607|NCT00748618|580709323|FG001|Overall Study|Adverse Event|0|||
160815608|NCT06004895|580709324|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
160815609|NCT06004895|580709324|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
160815610|NCT00466947|580709325|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
160815611|NCT00466947|580709326|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
160815612|NCT00466947|580709325|FG000|Study End Analysis Period|Adverse Event|35|||
160815613|NCT00466947|580709326|FG001|Study End Analysis Period|Adverse Event|43|||
160815614|NCT00466947|580709325|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
160815615|NCT00466947|580709326|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
160815616|NCT00466947|580709325|FG000|Study End Analysis Period|Physician Decision|29|||
160815617|NCT00466947|580709326|FG001|Study End Analysis Period|Physician Decision|29|||
160815618|NCT00466947|580709325|FG000|Study End Analysis Period|Protocol Violation|9|||
160815619|NCT00466947|580709326|FG001|Study End Analysis Period|Protocol Violation|17|||
160815620|NCT00466947|580709325|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
160815621|NCT00466947|580709326|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
160815622|NCT00466947|580709325|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
160815623|NCT00466947|580709326|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
160815624|NCT00466947|580709325|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
160815625|NCT00466947|580709326|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
160815626|NCT00466947|580709325|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
160815627|NCT00466947|580709326|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
160815628|NCT00878254|580709327|FG000|Overall Study|Physician Decision|1|||
160815629|NCT00878254|580709327|FG000|Overall Study|Death|1|||
160815630|NCT00878254|580709327|FG000|Overall Study|Withdrawal by Subject|1|||
160815631|NCT01995526|580709328|FG000|Overall Study|Physician Decision|1|||
160815632|NCT03367403|580709334|FG000|Overall Study|Adverse Event|20|||
160815633|NCT03367403|580709335|FG001|Overall Study|Adverse Event|6|||
160815634|NCT03367403|580709336|FG002|Overall Study|Adverse Event|2|||
160815635|NCT03367403|580709334|FG000|Overall Study|Withdrawal by Subject|12|||
160815636|NCT03367403|580709335|FG001|Overall Study|Withdrawal by Subject|13|||
160815637|NCT03367403|580709336|FG002|Overall Study|Withdrawal by Subject|1|||
160815638|NCT03367403|580709334|FG000|Overall Study|Death|1|||
160815639|NCT03367403|580709335|FG001|Overall Study|Death|2|||
160815640|NCT03367403|580709336|FG002|Overall Study|Death|0|||
160815641|NCT03367403|580709334|FG000|Overall Study|Physician Decision|0|||
160815642|NCT03367403|580709335|FG001|Overall Study|Physician Decision|1|||
160815643|NCT03367403|580709336|FG002|Overall Study|Physician Decision|0|||
160815644|NCT03367403|580709334|FG000|Overall Study|Protocol Violation|1|||
160815645|NCT03367403|580709335|FG001|Overall Study|Protocol Violation|1|||
160815646|NCT03367403|580709336|FG002|Overall Study|Protocol Violation|0|||
160815647|NCT03367403|580709334|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160815648|NCT03367403|580709335|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
160815649|NCT03367403|580709336|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
160987292|NCT04955626|581341108|FG003|Open-Label Period|Physician Decision|0|||
160987293|NCT04955626|581341109|FG004|Open-Label Period|Physician Decision|0|||
160987294|NCT04955626|581341110|FG005|Open-Label Period|Physician Decision|0|||
160987295|NCT04955626|581341111|FG006|Open-Label Period|Physician Decision|0|||
160987296|NCT04955626|581341112|FG007|Open-Label Period|Physician Decision|0|||
160987297|NCT04955626|581341113|FG008|Open-Label Period|Physician Decision|0|||
160815650|NCT03367403|580709334|FG000|Overall Study|COVID-19|3|||
160815651|NCT03367403|580709335|FG001|Overall Study|COVID-19|6|||
160815652|NCT03367403|580709336|FG002|Overall Study|COVID-19|0|||
160815653|NCT03367403|580709334|FG000|Overall Study|Abuse of Alcohol Intake|0|||
160815654|NCT03367403|580709335|FG001|Overall Study|Abuse of Alcohol Intake|1|||
160815655|NCT03367403|580709336|FG002|Overall Study|Abuse of Alcohol Intake|0|||
160815656|NCT03367403|580709334|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
160815657|NCT03367403|580709335|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
160815658|NCT03367403|580709336|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
160987298|NCT04955626|581341114|FG009|Open-Label Period|Physician Decision|0|||
160987299|NCT04955626|581341115|FG010|Open-Label Period|Physician Decision|0|||
160987300|NCT04955626|581341116|FG011|Open-Label Period|Physician Decision|0|||
160815659|NCT00194077|580709337|FG000|Overall Study|Lack of Efficacy|22|||
160815660|NCT00194077|580709338|FG001|Overall Study|Lack of Efficacy|29|||
160815661|NCT00194077|580709337|FG000|Overall Study|Study nonadherence|1|||
160815662|NCT00194077|580709338|FG001|Overall Study|Study nonadherence|0|||
160815663|NCT00194077|580709337|FG000|Overall Study|Withdrawal by Subject|1|||
160815664|NCT00194077|580709338|FG001|Overall Study|Withdrawal by Subject|1|||
160987301|NCT04955626|581341117|FG012|Open-Label Period|Physician Decision|0|||
160987302|NCT04955626|581341118|FG013|Open-Label Period|Physician Decision|0|||
160987303|NCT04955626|581341119|FG014|Open-Label Period|Physician Decision|0|||
160815665|NCT03470194|580709341|FG000|Overall Study|Lost to Follow-up|11|||
160815666|NCT03470194|580709342|FG001|Overall Study|Lost to Follow-up|17|||
160815667|NCT01822899|580709343|FG000|Overall Study|Adverse Event|6|||
160815668|NCT01822899|580709344|FG001|Overall Study|Adverse Event|5|||
160815669|NCT01822899|580709343|FG000|Overall Study|Lack of Efficacy|6|||
160815670|NCT01822899|580709344|FG001|Overall Study|Lack of Efficacy|3|||
160815671|NCT01822899|580709343|FG000|Overall Study|Protocol Violation|6|||
160815672|NCT01822899|580709344|FG001|Overall Study|Protocol Violation|3|||
160815673|NCT01822899|580709343|FG000|Overall Study|Lost to Follow-up|1|||
160815674|NCT01822899|580709344|FG001|Overall Study|Lost to Follow-up|0|||
160815675|NCT01822899|580709343|FG000|Overall Study|Withdrawal by Subject|5|||
160815676|NCT01822899|580709344|FG001|Overall Study|Withdrawal by Subject|7|||
160815677|NCT00759876|580709346|FG000|Overall Study|Sponsor terminated study early|36|||
160815678|NCT01450696|580709348|FG000|Overall Study|Never Treated|1|||
160815679|NCT01450696|580709349|FG001|Overall Study|Never Treated|1|||
160815680|NCT01450696|580709348|FG000|Overall Study|Death|77|||
160815681|NCT01450696|580709349|FG001|Overall Study|Death|84|||
160815682|NCT01450696|580709348|FG000|Overall Study|Lost to Follow-up|3|||
160815683|NCT01450696|580709349|FG001|Overall Study|Lost to Follow-up|3|||
160815684|NCT01450696|580709348|FG000|Overall Study|Non-Compliance|1|||
160815685|NCT01450696|580709349|FG001|Overall Study|Non-Compliance|0|||
160815686|NCT01450696|580709348|FG000|Overall Study|Withdrawal by Subject|13|||
160815687|NCT01450696|580709349|FG001|Overall Study|Withdrawal by Subject|2|||
160815688|NCT01450696|580709348|FG000|Overall Study|Study Terminated by Sponsor|53|||
160815689|NCT01450696|580709349|FG001|Overall Study|Study Terminated by Sponsor|58|||
160815690|NCT02321319|580709351|FG000|Overall Study|Product discontinued|5|||
160815691|NCT02570152|580709354|FG000|Overall Study|Protocol Violation|2|||
160815692|NCT02570152|580709354|FG000|Overall Study|Migrated/moved from study area|13|||
160815693|NCT02684617|580709355|FG000|Overall Study|Adverse Event|1|||
160815694|NCT02684617|580709356|FG001|Overall Study|Adverse Event|0|||
160815695|NCT02684617|580709357|FG002|Overall Study|Adverse Event|1|||
160815696|NCT02684617|580709355|FG000|Overall Study|Death|8|||
160815697|NCT02684617|580709356|FG001|Overall Study|Death|16|||
160815698|NCT02684617|580709357|FG002|Overall Study|Death|28|||
160815699|NCT02684617|580709355|FG000|Overall Study|Withdrawal by Subject|2|||
160815700|NCT02684617|580709356|FG001|Overall Study|Withdrawal by Subject|0|||
160815701|NCT02684617|580709357|FG002|Overall Study|Withdrawal by Subject|4|||
160815702|NCT02684617|580709355|FG000|Overall Study|Screen Failure|1|||
160815703|NCT02684617|580709356|FG001|Overall Study|Screen Failure|0|||
160815704|NCT02684617|580709357|FG002|Overall Study|Screen Failure|2|||
160815705|NCT02684617|580709355|FG000|Overall Study|Study Terminated by Sponsor|6|||
160815706|NCT02684617|580709356|FG001|Overall Study|Study Terminated by Sponsor|1|||
160815707|NCT02684617|580709357|FG002|Overall Study|Study Terminated by Sponsor|5|||
160815708|NCT00853242|580709358|FG000|Overall Study|Adverse Event|0|||
160815709|NCT00853242|580709359|FG001|Overall Study|Adverse Event|1|||
160815710|NCT00853242|580709360|FG002|Overall Study|Adverse Event|1|||
160815711|NCT00853242|580709361|FG003|Overall Study|Adverse Event|0|||
160815712|NCT00853242|580709362|FG004|Overall Study|Adverse Event|3|||
160815713|NCT00853242|580709363|FG005|Overall Study|Adverse Event|1|||
160815714|NCT00853242|580709364|FG006|Overall Study|Adverse Event|1|||
160815715|NCT00853242|580709358|FG000|Overall Study|Noncompliant|0|||
160815716|NCT00853242|580709359|FG001|Overall Study|Noncompliant|0|||
160815717|NCT00853242|580709360|FG002|Overall Study|Noncompliant|0|||
160815718|NCT00853242|580709361|FG003|Overall Study|Noncompliant|0|||
160815719|NCT00853242|580709362|FG004|Overall Study|Noncompliant|1|||
160815720|NCT00853242|580709363|FG005|Overall Study|Noncompliant|0|||
160900322|NCT02557295|581028698|FG000|Overall Study|Lack of Efficacy|24|||
160900323|NCT02557295|581028699|FG001|Overall Study|Lack of Efficacy|1|||
160900324|NCT02557295|581028700|FG002|Overall Study|Lack of Efficacy|3|||
160900325|NCT02557295|581028701|FG003|Overall Study|Lack of Efficacy|0|||
160900326|NCT02557295|581028702|FG004|Overall Study|Lack of Efficacy|0|||
161132330|NCT00988247|581868929|FG000|Overall Study|Lost to Follow-up|11|||
161132331|NCT00988247|581868930|FG001|Overall Study|Lost to Follow-up|2|||
160815721|NCT00853242|580709364|FG006|Overall Study|Noncompliant|0|||
160815722|NCT00853242|580709358|FG000|Overall Study|Withdrawal by Subject|1|||
160815723|NCT00853242|580709359|FG001|Overall Study|Withdrawal by Subject|2|||
160815724|NCT00853242|580709360|FG002|Overall Study|Withdrawal by Subject|0|||
160815725|NCT00853242|580709361|FG003|Overall Study|Withdrawal by Subject|4|||
160815726|NCT00853242|580709362|FG004|Overall Study|Withdrawal by Subject|0|||
160815727|NCT00853242|580709363|FG005|Overall Study|Withdrawal by Subject|0|||
160815728|NCT00853242|580709364|FG006|Overall Study|Withdrawal by Subject|2|||
160815729|NCT00853242|580709358|FG000|Overall Study|Other|2|||
160815730|NCT00853242|580709359|FG001|Overall Study|Other|0|||
160815731|NCT00853242|580709360|FG002|Overall Study|Other|2|||
160815732|NCT00853242|580709361|FG003|Overall Study|Other|0|||
160815733|NCT00853242|580709362|FG004|Overall Study|Other|0|||
160815734|NCT00853242|580709363|FG005|Overall Study|Other|1|||
160815735|NCT00853242|580709364|FG006|Overall Study|Other|2|||
160815736|NCT03497975|580709365|FG000|Overall Study|Withdrew Consent|34|||
160815737|NCT03497975|580709366|FG001|Overall Study|Withdrew Consent|35|||
160987304|NCT04955626|581341120|FG015|Open-Label Period|Physician Decision|0|||
160987305|NCT04955626|581341121|FG016|Open-Label Period|Physician Decision|0|||
160987306|NCT04955626|581341122|FG017|Open-Label Period|Physician Decision|0|||
160987307|NCT04955626|581341123|FG018|Open-Label Period|Physician Decision|0|||
160987308|NCT04955626|581341124|FG019|Open-Label Period|Physician Decision|0|||
161239960|NCT01695239|582260471|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239961|NCT01695239|582260472|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239962|NCT01695239|582260473|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239963|NCT01695239|582260474|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239964|NCT01695239|582260475|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239965|NCT01695239|582260476|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161239966|NCT01695239|582260477|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
161239967|NCT03502811|582260478|FG000|Overall Study|Death|157|||
161333477|NCT06110754|582608745|FG000|Overall Study|Withdrawal by Subject|0|||
161333478|NCT06110754|582608746|FG001|Overall Study|Withdrawal by Subject|0|||
160987309|NCT04955626|581341125|FG020|Open-Label Period|Physician Decision|0|||
160987310|NCT04955626|581341126|FG021|Open-Label Period|Physician Decision|0|||
160987311|NCT04955626|581341127|FG022|Open-Label Period|Physician Decision|0|||
160987312|NCT04955626|581341128|FG023|Open-Label Period|Physician Decision|0|||
160987313|NCT04955626|581341129|FG024|Open-Label Period|Physician Decision|0|||
160987314|NCT04955626|581341130|FG025|Open-Label Period|Physician Decision|0|||
160987315|NCT04955626|581341131|FG026|Open-Label Period|Physician Decision|0|||
160987316|NCT04955626|581341132|FG027|Open-Label Period|Physician Decision|0|||
160987317|NCT04955626|581341133|FG028|Open-Label Period|Physician Decision|0|||
160987318|NCT04955626|581341134|FG029|Open-Label Period|Physician Decision|0|||
160987319|NCT04955626|581341135|FG030|Open-Label Period|Physician Decision|0|||
160987320|NCT04955626|581341136|FG031|Open-Label Period|Physician Decision|0|||
160987321|NCT04955626|581341137|FG032|Open-Label Period|Physician Decision|0|||
160987322|NCT04955626|581341138|FG033|Open-Label Period|Physician Decision|0|||
160987323|NCT04955626|581341139|FG034|Open-Label Period|Physician Decision|0|||
160987324|NCT04955626|581341140|FG035|Open-Label Period|Physician Decision|0|||
161333479|NCT06110754|582608747|FG002|Overall Study|Withdrawal by Subject|1|||
161333480|NCT06110754|582608748|FG003|Overall Study|Withdrawal by Subject|0|||
161333481|NCT00846586|582608750|FG000|Overall Study|Adverse Event|20|||
161333482|NCT00846586|582608751|FG001|Overall Study|Adverse Event|10|||
161333483|NCT00846586|582608750|FG000|Overall Study|Subject withdrew consent|8|||
161333484|NCT00846586|582608751|FG001|Overall Study|Subject withdrew consent|10|||
161333485|NCT00846586|582608750|FG000|Overall Study|Administrative problems|5|||
161333486|NCT00846586|582608751|FG001|Overall Study|Administrative problems|4|||
161333487|NCT00846586|582608750|FG000|Overall Study|Death|2|||
161333488|NCT00846586|582608751|FG001|Overall Study|Death|0|||
161333489|NCT00846586|582608750|FG000|Overall Study|Protocol deviation|2|||
161333490|NCT00846586|582608751|FG001|Overall Study|Protocol deviation|6|||
161333491|NCT00846586|582608750|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161333492|NCT00846586|582608751|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161333493|NCT00846586|582608750|FG000|Overall Study|Lost to Follow-up|1|||
161333494|NCT00846586|582608751|FG001|Overall Study|Lost to Follow-up|4|||
161333495|NCT00846586|582608750|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161333496|NCT00846586|582608751|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161333497|NCT01949142|582608754|FG000|Overall Study|Withdrawal of consent|1|||
161333498|NCT01949142|582608755|FG001|Overall Study|Withdrawal of consent|0|||
161333499|NCT01949142|582608754|FG000|Overall Study|Lost to Follow-up|1|||
161333500|NCT01949142|582608755|FG001|Overall Study|Lost to Follow-up|1|||
161333501|NCT01949142|582608754|FG000|Overall Study|Parent changed their mind|1|||
161333502|NCT01949142|582608755|FG001|Overall Study|Parent changed their mind|0|||
161333503|NCT04802161|582608757|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
161333504|NCT04802161|582608758|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
161333505|NCT04802161|582608759|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
161333506|NCT04802161|582608760|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
161333507|NCT04802161|582608757|FG000|Overall Study|Clinical Instability|0|||
161333508|NCT04802161|582608758|FG001|Overall Study|Clinical Instability|0|||
161333509|NCT04802161|582608759|FG002|Overall Study|Clinical Instability|1|||
161333510|NCT04802161|582608760|FG003|Overall Study|Clinical Instability|0|||
161333511|NCT04802161|582608757|FG000|Overall Study|Adverse Event|0|||
161333512|NCT04802161|582608758|FG001|Overall Study|Adverse Event|0|||
161333513|NCT04802161|582608759|FG002|Overall Study|Adverse Event|1|||
161333514|NCT04802161|582608760|FG003|Overall Study|Adverse Event|0|||
161333515|NCT04802161|582608757|FG000|Overall Study|Death|0|||
161333516|NCT04802161|582608758|FG001|Overall Study|Death|0|||
161333517|NCT04802161|582608759|FG002|Overall Study|Death|1|||
161333518|NCT04802161|582608760|FG003|Overall Study|Death|0|||
160987325|NCT04955626|581341105|FG000|Open-Label Period|Withdrawal by Subject|135|||
160987326|NCT04955626|581341106|FG001|Open-Label Period|Withdrawal by Subject|25|||
161333519|NCT00352118|582610497|FG000|Overall Study|Physician Decision|4|||
161333520|NCT00557466|582610501|FG000|Overall Study|Adverse Event|3|||
161333521|NCT00557466|582610502|FG001|Overall Study|Adverse Event|1|||
161333522|NCT00557466|582610503|FG002|Overall Study|Adverse Event|4|||
161333523|NCT00557466|582610504|FG003|Overall Study|Adverse Event|1|||
161333524|NCT00557466|582610505|FG004|Overall Study|Adverse Event|2|||
161333525|NCT00557466|582610506|FG005|Overall Study|Adverse Event|4|||
161333526|NCT00557466|582610501|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161333527|NCT00557466|582610502|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161333528|NCT00557466|582610503|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161333529|NCT00557466|582610504|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161333530|NCT00557466|582610505|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161333531|NCT00557466|582610506|FG005|Overall Study|Abnormal laboratory value(s)|0|||
161333532|NCT00557466|582610501|FG000|Overall Study|Protocol deviation|0|||
161333533|NCT00557466|582610502|FG001|Overall Study|Protocol deviation|1|||
161333534|NCT00557466|582610503|FG002|Overall Study|Protocol deviation|0|||
161333535|NCT00557466|582610504|FG003|Overall Study|Protocol deviation|2|||
161333536|NCT00557466|582610505|FG004|Overall Study|Protocol deviation|0|||
161333537|NCT00557466|582610506|FG005|Overall Study|Protocol deviation|0|||
161333538|NCT00557466|582610501|FG000|Overall Study|Subject withdrew consent|0|||
161333539|NCT00557466|582610502|FG001|Overall Study|Subject withdrew consent|0|||
161333540|NCT00557466|582610503|FG002|Overall Study|Subject withdrew consent|0|||
161333541|NCT00557466|582610504|FG003|Overall Study|Subject withdrew consent|0|||
161333542|NCT00557466|582610505|FG004|Overall Study|Subject withdrew consent|1|||
160987327|NCT04955626|581341107|FG002|Open-Label Period|Withdrawal by Subject|0|||
160987328|NCT04955626|581341108|FG003|Open-Label Period|Withdrawal by Subject|0|||
160987329|NCT04955626|581341109|FG004|Open-Label Period|Withdrawal by Subject|0|||
160987330|NCT04955626|581341110|FG005|Open-Label Period|Withdrawal by Subject|0|||
160987331|NCT04955626|581341111|FG006|Open-Label Period|Withdrawal by Subject|0|||
160987332|NCT04955626|581341112|FG007|Open-Label Period|Withdrawal by Subject|0|||
160987333|NCT04955626|581341113|FG008|Open-Label Period|Withdrawal by Subject|0|||
160987334|NCT04955626|581341114|FG009|Open-Label Period|Withdrawal by Subject|0|||
160987335|NCT04955626|581341115|FG010|Open-Label Period|Withdrawal by Subject|0|||
160987336|NCT04955626|581341116|FG011|Open-Label Period|Withdrawal by Subject|0|||
160987337|NCT04955626|581341117|FG012|Open-Label Period|Withdrawal by Subject|0|||
160987338|NCT04955626|581341118|FG013|Open-Label Period|Withdrawal by Subject|0|||
160987339|NCT04955626|581341119|FG014|Open-Label Period|Withdrawal by Subject|0|||
160987340|NCT04955626|581341120|FG015|Open-Label Period|Withdrawal by Subject|0|||
160987341|NCT04955626|581341121|FG016|Open-Label Period|Withdrawal by Subject|0|||
160987342|NCT04955626|581341122|FG017|Open-Label Period|Withdrawal by Subject|0|||
160987343|NCT04955626|581341123|FG018|Open-Label Period|Withdrawal by Subject|0|||
160987344|NCT04955626|581341124|FG019|Open-Label Period|Withdrawal by Subject|0|||
160987345|NCT04955626|581341125|FG020|Open-Label Period|Withdrawal by Subject|0|||
160987346|NCT04955626|581341126|FG021|Open-Label Period|Withdrawal by Subject|0|||
160987347|NCT04955626|581341127|FG022|Open-Label Period|Withdrawal by Subject|0|||
160987348|NCT04955626|581341128|FG023|Open-Label Period|Withdrawal by Subject|0|||
160987349|NCT04955626|581341129|FG024|Open-Label Period|Withdrawal by Subject|0|||
160987350|NCT04955626|581341130|FG025|Open-Label Period|Withdrawal by Subject|0|||
160987351|NCT04955626|581341131|FG026|Open-Label Period|Withdrawal by Subject|0|||
160987352|NCT04955626|581341132|FG027|Open-Label Period|Withdrawal by Subject|0|||
160987353|NCT04955626|581341133|FG028|Open-Label Period|Withdrawal by Subject|0|||
160987354|NCT04955626|581341134|FG029|Open-Label Period|Withdrawal by Subject|0|||
160987355|NCT04955626|581341135|FG030|Open-Label Period|Withdrawal by Subject|0|||
160987356|NCT04955626|581341136|FG031|Open-Label Period|Withdrawal by Subject|0|||
160987357|NCT04955626|581341137|FG032|Open-Label Period|Withdrawal by Subject|0|||
160987358|NCT04955626|581341138|FG033|Open-Label Period|Withdrawal by Subject|0|||
160987359|NCT04955626|581341139|FG034|Open-Label Period|Withdrawal by Subject|0|||
160987360|NCT04955626|581341140|FG035|Open-Label Period|Withdrawal by Subject|0|||
161333543|NCT00557466|582610506|FG005|Overall Study|Subject withdrew consent|2|||
161333544|NCT00557466|582610501|FG000|Overall Study|Administrative problems|0|||
160815738|NCT03497975|580709365|FG000|Overall Study|Lost to Follow-up|7|||
160815739|NCT03497975|580709366|FG001|Overall Study|Lost to Follow-up|7|||
160815740|NCT03497975|580709365|FG000|Overall Study|Physician Decision|4|||
160815741|NCT03497975|580709366|FG001|Overall Study|Physician Decision|5|||
160987361|NCT04955626|581341105|FG000|Open-Label Period|Refused further study procedures|1|||
160987362|NCT04955626|581341106|FG001|Open-Label Period|Refused further study procedures|0|||
160987363|NCT04955626|581341107|FG002|Open-Label Period|Refused further study procedures|0|||
160987364|NCT04955626|581341108|FG003|Open-Label Period|Refused further study procedures|0|||
160987365|NCT04955626|581341109|FG004|Open-Label Period|Refused further study procedures|0|||
160987366|NCT04955626|581341110|FG005|Open-Label Period|Refused further study procedures|0|||
160987367|NCT04955626|581341111|FG006|Open-Label Period|Refused further study procedures|0|||
160987368|NCT04955626|581341112|FG007|Open-Label Period|Refused further study procedures|0|||
160987369|NCT04955626|581341113|FG008|Open-Label Period|Refused further study procedures|0|||
161132332|NCT00988247|581868929|FG000|Overall Study|Protocol Violation|4|||
161333545|NCT00557466|582610502|FG001|Overall Study|Administrative problems|1|||
160815742|NCT03497975|580709365|FG000|Overall Study|Discontinued|42|||
160815743|NCT03497975|580709366|FG001|Overall Study|Discontinued|39|||
160987370|NCT04955626|581341114|FG009|Open-Label Period|Refused further study procedures|0|||
160987371|NCT04955626|581341115|FG010|Open-Label Period|Refused further study procedures|0|||
160987372|NCT04955626|581341116|FG011|Open-Label Period|Refused further study procedures|0|||
160987373|NCT04955626|581341117|FG012|Open-Label Period|Refused further study procedures|0|||
160987374|NCT04955626|581341118|FG013|Open-Label Period|Refused further study procedures|0|||
160987375|NCT04955626|581341119|FG014|Open-Label Period|Refused further study procedures|0|||
160987376|NCT04955626|581341120|FG015|Open-Label Period|Refused further study procedures|0|||
160987377|NCT04955626|581341121|FG016|Open-Label Period|Refused further study procedures|0|||
160987378|NCT04955626|581341122|FG017|Open-Label Period|Refused further study procedures|0|||
160987379|NCT04955626|581341123|FG018|Open-Label Period|Refused further study procedures|0|||
160987380|NCT04955626|581341124|FG019|Open-Label Period|Refused further study procedures|0|||
160987381|NCT04955626|581341125|FG020|Open-Label Period|Refused further study procedures|0|||
160987382|NCT04955626|581341126|FG021|Open-Label Period|Refused further study procedures|0|||
160987383|NCT04955626|581341127|FG022|Open-Label Period|Refused further study procedures|0|||
160987384|NCT04955626|581341128|FG023|Open-Label Period|Refused further study procedures|0|||
160987385|NCT04955626|581341129|FG024|Open-Label Period|Refused further study procedures|0|||
160987386|NCT04955626|581341130|FG025|Open-Label Period|Refused further study procedures|0|||
160987387|NCT04955626|581341131|FG026|Open-Label Period|Refused further study procedures|0|||
160987388|NCT04955626|581341132|FG027|Open-Label Period|Refused further study procedures|0|||
160987389|NCT04955626|581341133|FG028|Open-Label Period|Refused further study procedures|0|||
160987390|NCT04955626|581341134|FG029|Open-Label Period|Refused further study procedures|0|||
160987391|NCT04955626|581341135|FG030|Open-Label Period|Refused further study procedures|0|||
160987392|NCT04955626|581341136|FG031|Open-Label Period|Refused further study procedures|0|||
160987393|NCT04955626|581341137|FG032|Open-Label Period|Refused further study procedures|0|||
161239968|NCT03502811|582260478|FG000|Overall Study|Withdrawal by Subject|105|||
161239969|NCT03502811|582260478|FG000|Overall Study|Lost to Follow-up|26|||
161239970|NCT03502811|582260478|FG000|Overall Study|No Visits (Missed)|31|||
161239971|NCT03913377|582260479|FG000|Period 1|Test Article no longer available|0|||
161239972|NCT03913377|582260480|FG001|Period 1|Test Article no longer available|1|||
161239973|NCT03913377|582260481|FG002|Period 1|Test Article no longer available|0|||
161239974|NCT03913377|582260479|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
160987394|NCT04955626|581341138|FG033|Open-Label Period|Refused further study procedures|0|||
160987395|NCT04955626|581341139|FG034|Open-Label Period|Refused further study procedures|0|||
160987396|NCT04955626|581341140|FG035|Open-Label Period|Refused further study procedures|0|||
160987397|NCT04955626|581341105|FG000|Open-Label Period|Adverse Event|1|||
160987398|NCT04955626|581341106|FG001|Open-Label Period|Adverse Event|0|||
160987399|NCT04955626|581341107|FG002|Open-Label Period|Adverse Event|0|||
160987400|NCT04955626|581341108|FG003|Open-Label Period|Adverse Event|0|||
160987401|NCT04955626|581341109|FG004|Open-Label Period|Adverse Event|0|||
160987402|NCT04955626|581341110|FG005|Open-Label Period|Adverse Event|0|||
160987403|NCT04955626|581341111|FG006|Open-Label Period|Adverse Event|0|||
160987404|NCT04955626|581341112|FG007|Open-Label Period|Adverse Event|0|||
160987405|NCT04955626|581341113|FG008|Open-Label Period|Adverse Event|0|||
160987406|NCT04955626|581341114|FG009|Open-Label Period|Adverse Event|0|||
161239975|NCT03913377|582260480|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
161239976|NCT03913377|582260481|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
161239977|NCT05239195|582260482|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
161239978|NCT05239195|582260483|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
161239979|NCT00933686|582260484|FG000|Overall Study|Protocol Violation|0|||
161239980|NCT00933686|582260485|FG001|Overall Study|Protocol Violation|1|||
161239981|NCT00933686|582260484|FG000|Overall Study|Lost to Follow-up|2|||
161239982|NCT00933686|582260485|FG001|Overall Study|Lost to Follow-up|2|||
161239983|NCT00933686|582260484|FG000|Overall Study|Withdrawal by Subject|6|||
161239984|NCT00933686|582260485|FG001|Overall Study|Withdrawal by Subject|5|||
161239985|NCT00933686|582260484|FG000|Overall Study|Adverse Event|1|||
161239986|NCT00933686|582260485|FG001|Overall Study|Adverse Event|1|||
161239987|NCT00933686|582260484|FG000|Overall Study|Physician Decision|1|||
161239988|NCT00933686|582260485|FG001|Overall Study|Physician Decision|0|||
161239989|NCT00933686|582260484|FG000|Overall Study|Failure to show up at endpoint visits|0|||
161239990|NCT00933686|582260485|FG001|Overall Study|Failure to show up at endpoint visits|2|||
161239991|NCT01244620|582260488|FG000|Overall Study|Study terminated|4|||
161239992|NCT01244620|582260489|FG001|Overall Study|Study terminated|4|||
161239993|NCT01244620|582260490|FG002|Overall Study|Study terminated|4|||
161239994|NCT01244620|582260491|FG003|Overall Study|Study terminated|4|||
161239995|NCT02321098|582260492|FG000|12 Weeks Treament|Lost to Follow-up|1|||
161239996|NCT02321098|582260493|FG001|12 Weeks Treament|Lost to Follow-up|1|||
161239997|NCT02321098|582260494|FG002|12 Weeks Treament|Lost to Follow-up|0|||
161239998|NCT02321098|582260492|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
161239999|NCT02321098|582260493|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
161240000|NCT02321098|582260494|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
161240001|NCT02321098|582260492|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
160987407|NCT04955626|581341115|FG010|Open-Label Period|Adverse Event|0|||
160987408|NCT04955626|581341116|FG011|Open-Label Period|Adverse Event|0|||
160987409|NCT04955626|581341117|FG012|Open-Label Period|Adverse Event|0|||
160987410|NCT04955626|581341118|FG013|Open-Label Period|Adverse Event|0|||
160987411|NCT04955626|581341119|FG014|Open-Label Period|Adverse Event|0|||
160987412|NCT04955626|581341120|FG015|Open-Label Period|Adverse Event|0|||
160987413|NCT04955626|581341121|FG016|Open-Label Period|Adverse Event|0|||
161333546|NCT00557466|582610503|FG002|Overall Study|Administrative problems|1|||
161333547|NCT00557466|582610504|FG003|Overall Study|Administrative problems|0|||
161333548|NCT00557466|582610505|FG004|Overall Study|Administrative problems|0|||
161333549|NCT00557466|582610506|FG005|Overall Study|Administrative problems|0|||
161333550|NCT00557466|582610501|FG000|Overall Study|Abnormal test procedure results|0|||
161333551|NCT00557466|582610502|FG001|Overall Study|Abnormal test procedure results|0|||
161333552|NCT00557466|582610503|FG002|Overall Study|Abnormal test procedure results|1|||
161333553|NCT00557466|582610504|FG003|Overall Study|Abnormal test procedure results|0|||
161333554|NCT00557466|582610505|FG004|Overall Study|Abnormal test procedure results|0|||
161333555|NCT00557466|582610506|FG005|Overall Study|Abnormal test procedure results|0|||
161333556|NCT00557466|582610501|FG000|Overall Study|Lost to Follow-up|0|||
161333557|NCT00557466|582610502|FG001|Overall Study|Lost to Follow-up|0|||
161333558|NCT00557466|582610503|FG002|Overall Study|Lost to Follow-up|0|||
161333559|NCT00557466|582610504|FG003|Overall Study|Lost to Follow-up|1|||
161333560|NCT00557466|582610505|FG004|Overall Study|Lost to Follow-up|0|||
161333561|NCT00557466|582610506|FG005|Overall Study|Lost to Follow-up|0|||
161333562|NCT03342001|582610513|FG000|Overall Study|Adverse Event|1|||
161333563|NCT03342001|582610513|FG000|Overall Study|Lost to Follow-up|1|||
161333564|NCT00752089|582610516|FG000|Overall Study|Adverse Event|1|||
161333565|NCT00752089|582610516|FG000|Overall Study|Protocol Deviation|2|||
161333566|NCT00752089|582610516|FG000|Overall Study|Could not attend visit 9|1|||
161333567|NCT00752089|582610516|FG000|Overall Study|Not capable of wearing partial denture|1|||
161333568|NCT00752089|582610516|FG000|Overall Study|Cannot continue the study|1|||
161333569|NCT00386334|582610519|FG000|Double Blind Period|Adverse Event|9|||
161333570|NCT00386334|582610520|FG001|Double Blind Period|Adverse Event|14|||
161333571|NCT00386334|582610519|FG000|Double Blind Period|Protocol Violation|1|||
161333572|NCT00386334|582610520|FG001|Double Blind Period|Protocol Violation|1|||
161333573|NCT00386334|582610519|FG000|Double Blind Period|Withdrawal by Subject|9|||
161333574|NCT00386334|582610520|FG001|Double Blind Period|Withdrawal by Subject|13|||
161333575|NCT00386334|582610519|FG000|Double Blind Period|Lack of Efficacy|20|||
161333576|NCT00386334|582610520|FG001|Double Blind Period|Lack of Efficacy|11|||
161333577|NCT00386334|582610519|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
161333578|NCT00386334|582610520|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
161333579|NCT00386334|582610519|FG000|Double Blind Period|Other|3|||
161333580|NCT00386334|582610520|FG001|Double Blind Period|Other|3|||
161333581|NCT00386334|582610519|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
161333582|NCT00386334|582610520|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
161333583|NCT03238417|582610521|FG000|Overall|non-response|955|||
161333584|NCT03238417|582610522|FG001|Overall|non-response|1920|||
161333585|NCT03238417|582610521|FG000|Overall|partial completion|48|||
161333586|NCT03238417|582610522|FG001|Overall|partial completion|68|||
161333587|NCT03238417|582610521|FG000|Baseline|Partial completion|17|||
161333588|NCT03238417|582610522|FG001|Baseline|Partial completion|48|||
161333589|NCT03238417|582610521|FG000|Baseline|non-response|372|||
161333590|NCT03238417|582610522|FG001|Baseline|non-response|669|||
161333591|NCT03238417|582610521|FG000|12-month|non-response|296|||
161333592|NCT03238417|582610522|FG001|12-month|non-response|669|||
161333593|NCT03238417|582610521|FG000|12-month|partial completion|23|||
161333594|NCT03238417|582610522|FG001|12-month|partial completion|37|||
161333595|NCT03238417|582610521|FG000|24-month|non-response|287|||
161333596|NCT03238417|582610522|FG001|24-month|non-response|594|||
161333597|NCT03238417|582610521|FG000|24-month|partial completion|8|||
161333598|NCT03238417|582610522|FG001|24-month|partial completion|31|||
161333599|NCT02914834|582610526|FG000|Overall Study|Study halted due to COVID|1|||
161333600|NCT02914834|582610527|FG001|Overall Study|Study halted due to COVID|1|||
161333601|NCT02914834|582610526|FG000|Overall Study|1 subject withdrew|0|||
161333602|NCT02914834|582610527|FG001|Overall Study|1 subject withdrew|1|||
161333603|NCT00975416|582610534|FG000|Overall Study|early discharge from tx|3|||
161333604|NCT00975416|582610535|FG001|Overall Study|early discharge from tx|5|||
161333605|NCT01245101|582610536|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
161333606|NCT01245101|582610537|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
161333607|NCT01245101|582610536|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
161333608|NCT01245101|582610537|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
160987414|NCT04955626|581341122|FG017|Open-Label Period|Adverse Event|0|||
160987415|NCT04955626|581341123|FG018|Open-Label Period|Adverse Event|0|||
161333609|NCT01245101|582610536|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
160987416|NCT04955626|581341124|FG019|Open-Label Period|Adverse Event|0|||
161333610|NCT01245101|582610537|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
161333611|NCT00473083|582610540|FG000|Overall Study|Adverse Event|1|||
161333612|NCT00473083|582610541|FG001|Overall Study|Adverse Event|0|||
160815744|NCT03497975|580709365|FG000|Overall Study|Reason Not Specified|15|||
160815745|NCT03497975|580709366|FG001|Overall Study|Reason Not Specified|14|||
160815746|NCT02957747|580709367|FG000|Overall Study|Withdrawal by Subject|0|||
160815747|NCT02957747|580709368|FG001|Overall Study|Withdrawal by Subject|3|||
160815748|NCT02957747|580709367|FG000|Overall Study|Lost to Follow-up|10|||
160815749|NCT02957747|580709368|FG001|Overall Study|Lost to Follow-up|5|||
160815750|NCT00888329|580709369|FG000|Overall Study|Physician Decision|6|||
160815751|NCT00888329|580709370|FG001|Overall Study|Physician Decision|9|||
160815752|NCT01355679|580709374|FG000|Overall Study|benign tumor types found at biopsy|2|||
160815753|NCT02027311|580709375|FG000|Overall Study|Protocol Violation|3|||
160815754|NCT02027311|580709376|FG001|Overall Study|Protocol Violation|2|||
160815755|NCT03928418|580709377|FG000|Overall Study|Lost to Follow-up|5|||
160815756|NCT03928418|580709378|FG001|Overall Study|Lost to Follow-up|3|||
160815757|NCT03928418|580709379|FG002|Overall Study|Lost to Follow-up|5|||
160815758|NCT03928418|580709377|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
160815759|NCT03928418|580709378|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
160815760|NCT03928418|580709379|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
160815761|NCT00964002|580709381|FG000|Overall Study|Protocol Violation|8|||
160815762|NCT03768089|580709389|FG000|Part A|Lost to Follow-up|0|||
160815763|NCT03768089|580709390|FG001|Part A|Lost to Follow-up|0|||
160815764|NCT03768089|580709391|FG002|Part A|Lost to Follow-up|0|||
160815765|NCT03768089|580709392|FG003|Part A|Lost to Follow-up|0|||
160815766|NCT03768089|580709393|FG004|Part A|Lost to Follow-up|1|||
160815767|NCT03768089|580709394|FG005|Part A|Lost to Follow-up|0|||
160815768|NCT03768089|580709395|FG006|Part A|Lost to Follow-up|0|||
160815769|NCT03768089|580709396|FG007|Part A|Lost to Follow-up|0|||
160815770|NCT03768089|580709397|FG008|Part A|Lost to Follow-up|0|||
160815771|NCT03768089|580709398|FG009|Part A|Lost to Follow-up|0|||
160815772|NCT03768089|580709399|FG010|Part A|Lost to Follow-up|0|||
160815773|NCT03768089|580709400|FG011|Part A|Lost to Follow-up|0|||
160815774|NCT03768089|580709401|FG012|Part A|Lost to Follow-up|0|||
160815775|NCT03768089|580709402|FG013|Part A|Lost to Follow-up|0|||
160815776|NCT03768089|580709403|FG014|Part A|Lost to Follow-up|0|||
160815777|NCT03768089|580709404|FG015|Part A|Lost to Follow-up|0|||
160815778|NCT03768089|580709405|FG016|Part A|Lost to Follow-up|0|||
160815779|NCT03768089|580709406|FG017|Part A|Lost to Follow-up|0|||
160815780|NCT03768089|580709389|FG000|Part C|Randomized, Never Dosed|0|||
160815781|NCT03768089|580709390|FG001|Part C|Randomized, Never Dosed|0|||
160815782|NCT03768089|580709391|FG002|Part C|Randomized, Never Dosed|0|||
160815783|NCT03768089|580709392|FG003|Part C|Randomized, Never Dosed|0|||
160815784|NCT03768089|580709393|FG004|Part C|Randomized, Never Dosed|0|||
160815785|NCT03768089|580709394|FG005|Part C|Randomized, Never Dosed|0|||
160815786|NCT03768089|580709395|FG006|Part C|Randomized, Never Dosed|0|||
160815787|NCT03768089|580709396|FG007|Part C|Randomized, Never Dosed|0|||
160815788|NCT03768089|580709397|FG008|Part C|Randomized, Never Dosed|0|||
160815789|NCT03768089|580709398|FG009|Part C|Randomized, Never Dosed|0|||
161240002|NCT02321098|582260493|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
161240003|NCT02321098|582260494|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
161240004|NCT02321098|582260492|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
161240005|NCT02321098|582260493|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
161240006|NCT02321098|582260494|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
160987417|NCT04955626|581341125|FG020|Open-Label Period|Adverse Event|0|||
160987418|NCT04955626|581341126|FG021|Open-Label Period|Adverse Event|0|||
160987419|NCT04955626|581341127|FG022|Open-Label Period|Adverse Event|0|||
161240007|NCT01663233|582260495|FG000|Overall Study|Withdrawal by Subject|3|||
161240008|NCT01663233|582260496|FG001|Overall Study|Withdrawal by Subject|2|||
161240009|NCT01663233|582260495|FG000|Overall Study|Protocol Deviation|1|||
161240010|NCT01663233|582260496|FG001|Overall Study|Protocol Deviation|4|||
161240011|NCT01663233|582260495|FG000|Overall Study|Lost to Follow-up|0|||
161240012|NCT01663233|582260496|FG001|Overall Study|Lost to Follow-up|1|||
160815790|NCT03768089|580709399|FG010|Part C|Randomized, Never Dosed|0|||
160815791|NCT03768089|580709400|FG011|Part C|Randomized, Never Dosed|0|||
160815792|NCT03768089|580709401|FG012|Part C|Randomized, Never Dosed|0|||
160815793|NCT03768089|580709402|FG013|Part C|Randomized, Never Dosed|0|||
160815794|NCT03768089|580709403|FG014|Part C|Randomized, Never Dosed|1|||
160815795|NCT03768089|580709404|FG015|Part C|Randomized, Never Dosed|0|||
161240013|NCT00796328|582260499|FG000|Overall Study|experienced hypotension requiring tx|6|||
161240014|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Adverse Event|11|||
160815796|NCT03768089|580709405|FG016|Part C|Randomized, Never Dosed|0|||
160815797|NCT03768089|580709406|FG017|Part C|Randomized, Never Dosed|0|||
160815798|NCT02091362|580709411|FG000|Period 1|Protocol Violation|1|||
160815799|NCT02091362|580709412|FG001|Period 1|Protocol Violation|0|||
160815800|NCT02091362|580709411|FG000|Period 1|Withdrawal by Subject|2|||
160815801|NCT02091362|580709412|FG001|Period 1|Withdrawal by Subject|3|||
160815802|NCT02091362|580709411|FG000|Period 1|Lost to Follow-up|0|||
160815803|NCT02091362|580709412|FG001|Period 1|Lost to Follow-up|1|||
160815804|NCT02091362|580709411|FG000|Period 1|Adverse Event|2|||
160815805|NCT02091362|580709412|FG001|Period 1|Adverse Event|0|||
160815806|NCT02091362|580709411|FG000|Wash-out|Lost to Follow-up|1|||
160815807|NCT02091362|580709412|FG001|Wash-out|Lost to Follow-up|1|||
160815808|NCT02091362|580709411|FG000|Wash-out|Withdrawal by Subject|0|||
160815809|NCT02091362|580709412|FG001|Wash-out|Withdrawal by Subject|2|||
160815810|NCT02091362|580709411|FG000|Period 2|Adverse Event|1|||
160815811|NCT02091362|580709412|FG001|Period 2|Adverse Event|0|||
160815812|NCT02091362|580709411|FG000|Period 2|Lost to Follow-up|0|||
160815813|NCT02091362|580709412|FG001|Period 2|Lost to Follow-up|1|||
160815814|NCT02091362|580709411|FG000|Period 2|Withdrawal by Subject|1|||
160815815|NCT02091362|580709412|FG001|Period 2|Withdrawal by Subject|1|||
160815816|NCT02466425|580709413|FG000|Overall Study|Adverse Event|3|||
160815817|NCT02466425|580709414|FG001|Overall Study|Adverse Event|11|||
160815818|NCT02466425|580709413|FG000|Overall Study|Lack of Efficacy|4|||
160815819|NCT02466425|580709414|FG001|Overall Study|Lack of Efficacy|1|||
160815820|NCT02466425|580709413|FG000|Overall Study|Lost to Follow-up|3|||
160815821|NCT02466425|580709414|FG001|Overall Study|Lost to Follow-up|0|||
160815822|NCT02466425|580709413|FG000|Overall Study|Protocol Violation|1|||
160815823|NCT02466425|580709414|FG001|Overall Study|Protocol Violation|0|||
160815824|NCT02466425|580709413|FG000|Overall Study|Withdrawal by Subject|0|||
160815825|NCT02466425|580709414|FG001|Overall Study|Withdrawal by Subject|1|||
160815826|NCT02466425|580709413|FG000|Overall Study|Other|1|||
160815827|NCT02466425|580709414|FG001|Overall Study|Other|3|||
160815828|NCT02466425|580709413|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160815829|NCT02466425|580709414|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160815830|NCT05141175|580709423|FG000|Overall Study|Withdrawal by Subject|1|||
160815831|NCT00902850|580709426|FG000|Overall Study|Physician Decision|2|||
160815832|NCT00902850|580709427|FG001|Overall Study|Physician Decision|2|||
160815833|NCT04470050|580709432|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160815834|NCT04470050|580709433|FG001|Double-blind Treatment Phase|Adverse Event|0|||
160815835|NCT04470050|580709434|FG002|Double-blind Treatment Phase|Adverse Event|0|||
160815836|NCT04470050|580709435|FG003|Double-blind Treatment Phase|Adverse Event|1|||
160815837|NCT04470050|580709436|FG004|Double-blind Treatment Phase|Adverse Event|0|||
160815838|NCT04470050|580709437|FG005|Double-blind Treatment Phase|Adverse Event|0|||
160815839|NCT04470050|580709438|FG006|Double-blind Treatment Phase|Adverse Event|0|||
160815840|NCT04470050|580709432|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815841|NCT04470050|580709433|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815842|NCT04470050|580709434|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815843|NCT04470050|580709435|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815844|NCT04470050|580709436|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
160815845|NCT04470050|580709437|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815846|NCT04470050|580709438|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
160815847|NCT04470050|580709432|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
160815848|NCT04470050|580709433|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
160815849|NCT04470050|580709434|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
160815850|NCT04470050|580709435|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
160815851|NCT04470050|580709436|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
160815852|NCT04470050|580709437|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
160815853|NCT04470050|580709438|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
160815854|NCT03098433|580709439|FG000|Overall Study|Withdrawal by Subject|10|||
160815855|NCT01813058|580709440|FG000|Overall Study|Withdrawal by Subject|5|||
160815856|NCT01813058|580709441|FG001|Overall Study|Withdrawal by Subject|4|||
160815857|NCT03585764|580709442|FG000|Overall Study|Death|3|||
160815858|NCT03585764|580709443|FG001|Overall Study|Death|2|||
160815859|NCT03585764|580709444|FG002|Overall Study|Death|3|||
160815860|NCT03585764|580709445|FG003|Overall Study|Death|0|||
160815861|NCT03585764|580709442|FG000|Overall Study|Lost to Follow-up|0|||
160815862|NCT03585764|580709443|FG001|Overall Study|Lost to Follow-up|1|||
160815863|NCT03585764|580709444|FG002|Overall Study|Lost to Follow-up|0|||
160815864|NCT03585764|580709445|FG003|Overall Study|Lost to Follow-up|0|||
160815865|NCT03585764|580709442|FG000|Overall Study|Physician Decision|0|||
160815866|NCT03585764|580709443|FG001|Overall Study|Physician Decision|0|||
160815867|NCT03585764|580709444|FG002|Overall Study|Physician Decision|2|||
160815868|NCT03585764|580709445|FG003|Overall Study|Physician Decision|0|||
160815869|NCT01581021|580709447|FG000|Overall Study|Lost to Follow-up|4|||
160815870|NCT01581021|580709448|FG001|Overall Study|Lost to Follow-up|6|||
161132333|NCT00988247|581868930|FG001|Overall Study|Protocol Violation|5|||
160815871|NCT01581021|580709447|FG000|Overall Study|More than 2 hooks in thoracic|3|||
160815872|NCT01581021|580709448|FG001|Overall Study|More than 2 hooks in thoracic|0|||
160815873|NCT01581021|580709447|FG000|Overall Study|Neuromuscular|2|||
160815874|NCT01581021|580709448|FG001|Overall Study|Neuromuscular|1|||
161132334|NCT00988247|581868929|FG000|Overall Study|Sponsor requested withdrawal|3|||
160815875|NCT01581021|580709447|FG000|Overall Study|Not Randomized|1|||
160815876|NCT01581021|580709448|FG001|Overall Study|Not Randomized|2|||
160815877|NCT01581021|580709447|FG000|Overall Study|Lenke 6 Classification|0|||
160815878|NCT01581021|580709448|FG001|Overall Study|Lenke 6 Classification|1|||
160815879|NCT01581021|580709447|FG000|Overall Study|Lack of Efficacy|0|||
160815880|NCT01581021|580709448|FG001|Overall Study|Lack of Efficacy|1|||
160815881|NCT03604172|580709451|FG000|Overall Study|Lost to Follow-up|1|||
160815882|NCT03604172|580709452|FG001|Overall Study|Lost to Follow-up|2|||
160815883|NCT00054327|580709453|FG000|Overall Study|Engraftment failure|1|||
160815884|NCT00054327|580709454|FG001|Overall Study|Engraftment failure|0|||
160815885|NCT00054327|580709455|FG002|Overall Study|Engraftment failure|0|||
160815886|NCT00054327|580709456|FG003|Overall Study|Engraftment failure|0|||
160815887|NCT00054327|580709457|FG004|Overall Study|Engraftment failure|0|||
160815888|NCT00054327|580709458|FG005|Overall Study|Engraftment failure|0|||
160815889|NCT03028129|580709461|FG000|Overall Study|Adverse Event|13|||
160815890|NCT03028129|580709462|FG001|Overall Study|Adverse Event|2|||
160815891|NCT03028129|580709461|FG000|Overall Study|Lost to Follow-up|50|||
160815892|NCT03028129|580709462|FG001|Overall Study|Lost to Follow-up|38|||
160815893|NCT03028129|580709461|FG000|Overall Study|Physician Decision|0|||
160815894|NCT03028129|580709462|FG001|Overall Study|Physician Decision|1|||
160815895|NCT03028129|580709461|FG000|Overall Study|Protocol Violation|1|||
160815896|NCT03028129|580709462|FG001|Overall Study|Protocol Violation|1|||
160815897|NCT03028129|580709461|FG000|Overall Study|Withdrawal by Subject|62|||
160815898|NCT03028129|580709462|FG001|Overall Study|Withdrawal by Subject|45|||
160815899|NCT00923351|580709463|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
160815900|NCT00923351|580709464|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
160815901|NCT00923351|580709465|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
160815902|NCT00395486|580709470|FG000|Overall Study|Adverse Event|1|||
160815903|NCT00395486|580709471|FG001|Overall Study|Adverse Event|2|||
160815904|NCT00395486|580709470|FG000|Overall Study|Withdrawal by Subject|5|||
160815905|NCT00395486|580709471|FG001|Overall Study|Withdrawal by Subject|2|||
160815906|NCT00395486|580709470|FG000|Overall Study|Lost to Follow-up|0|||
160815907|NCT00395486|580709471|FG001|Overall Study|Lost to Follow-up|1|||
160815908|NCT00734604|580711906|FG000|Overall Study|Adverse Event|0|||
160815909|NCT00734604|580711907|FG001|Overall Study|Adverse Event|2|||
160815910|NCT00734604|580711908|FG002|Overall Study|Adverse Event|0|||
160815911|NCT00734604|580711909|FG003|Overall Study|Adverse Event|2|||
160815912|NCT00734604|580711910|FG004|Overall Study|Adverse Event|1|||
160815913|NCT00734604|580711911|FG005|Overall Study|Adverse Event|1|||
160815914|NCT00734604|580711906|FG000|Overall Study|Serious Adverse Event|1|||
160815915|NCT00734604|580711907|FG001|Overall Study|Serious Adverse Event|0|||
160815916|NCT00734604|580711908|FG002|Overall Study|Serious Adverse Event|1|||
160815917|NCT00734604|580711909|FG003|Overall Study|Serious Adverse Event|2|||
160815918|NCT00734604|580711910|FG004|Overall Study|Serious Adverse Event|0|||
160815919|NCT00734604|580711911|FG005|Overall Study|Serious Adverse Event|1|||
160815920|NCT00734604|580711906|FG000|Overall Study|Lost to Follow-up|1|||
160815921|NCT00734604|580711907|FG001|Overall Study|Lost to Follow-up|2|||
160815922|NCT00734604|580711908|FG002|Overall Study|Lost to Follow-up|2|||
160815923|NCT00734604|580711909|FG003|Overall Study|Lost to Follow-up|4|||
160815924|NCT00734604|580711910|FG004|Overall Study|Lost to Follow-up|2|||
160815925|NCT00734604|580711911|FG005|Overall Study|Lost to Follow-up|3|||
160815926|NCT00734604|580711906|FG000|Overall Study|Physician Decision|0|||
160815927|NCT00734604|580711907|FG001|Overall Study|Physician Decision|1|||
160815928|NCT00734604|580711908|FG002|Overall Study|Physician Decision|1|||
160815929|NCT00734604|580711909|FG003|Overall Study|Physician Decision|0|||
160815930|NCT00734604|580711910|FG004|Overall Study|Physician Decision|0|||
160815931|NCT00734604|580711911|FG005|Overall Study|Physician Decision|0|||
160815932|NCT00734604|580711906|FG000|Overall Study|Protocol Violation|0|||
160815933|NCT00734604|580711907|FG001|Overall Study|Protocol Violation|2|||
160815934|NCT00734604|580711908|FG002|Overall Study|Protocol Violation|0|||
160815935|NCT00734604|580711909|FG003|Overall Study|Protocol Violation|0|||
160815936|NCT00734604|580711910|FG004|Overall Study|Protocol Violation|1|||
160815937|NCT00734604|580711911|FG005|Overall Study|Protocol Violation|0|||
160815938|NCT00734604|580711906|FG000|Overall Study|Sponsor Decision|1|||
160815939|NCT00734604|580711907|FG001|Overall Study|Sponsor Decision|2|||
160815940|NCT00734604|580711908|FG002|Overall Study|Sponsor Decision|1|||
160815941|NCT00734604|580711909|FG003|Overall Study|Sponsor Decision|0|||
160815942|NCT00734604|580711910|FG004|Overall Study|Sponsor Decision|2|||
161132335|NCT00988247|581868930|FG001|Overall Study|Sponsor requested withdrawal|1|||
161132336|NCT00988247|581868929|FG000|Overall Study|Other|3|||
160815943|NCT00734604|580711911|FG005|Overall Study|Sponsor Decision|0|||
160815944|NCT00734604|580711906|FG000|Overall Study|Withdrawal by Subject|0|||
160815945|NCT00734604|580711907|FG001|Overall Study|Withdrawal by Subject|2|||
160815946|NCT00734604|580711908|FG002|Overall Study|Withdrawal by Subject|0|||
160815947|NCT00734604|580711909|FG003|Overall Study|Withdrawal by Subject|1|||
160815948|NCT00734604|580711910|FG004|Overall Study|Withdrawal by Subject|2|||
160815949|NCT00734604|580711911|FG005|Overall Study|Withdrawal by Subject|1|||
160815950|NCT00734604|580711906|FG000|Overall Study|Lack of Efficacy|0|||
160815951|NCT00734604|580711907|FG001|Overall Study|Lack of Efficacy|1|||
160815952|NCT00734604|580711908|FG002|Overall Study|Lack of Efficacy|1|||
160815953|NCT00734604|580711909|FG003|Overall Study|Lack of Efficacy|0|||
160815954|NCT00734604|580711910|FG004|Overall Study|Lack of Efficacy|0|||
160815955|NCT00734604|580711911|FG005|Overall Study|Lack of Efficacy|0|||
160815956|NCT02199314|580711912|FG000|Overall Study|Withdrawal by Subject|6|||
160815957|NCT02199314|580711912|FG000|Overall Study|Physician Decision|10|||
160815958|NCT02242435|580711915|FG000|Overall Study|Lost to Follow-up|3|||
160815959|NCT02242435|580711916|FG001|Overall Study|Lost to Follow-up|4|||
160815960|NCT02242435|580711915|FG000|Overall Study|Adverse Event|3|||
160815961|NCT02242435|580711916|FG001|Overall Study|Adverse Event|2|||
160815962|NCT02242435|580711915|FG000|Overall Study|Withdrawal by Subject|13|||
160815963|NCT02242435|580711916|FG001|Overall Study|Withdrawal by Subject|8|||
160815964|NCT02242435|580711915|FG000|Overall Study|Death|0|||
160815965|NCT02242435|580711916|FG001|Overall Study|Death|1|||
160815966|NCT02242435|580711915|FG000|Overall Study|Protocol Violation|1|||
160815967|NCT02242435|580711916|FG001|Overall Study|Protocol Violation|0|||
160815968|NCT02242435|580711915|FG000|Overall Study|Physician Decision|0|||
160815969|NCT02242435|580711916|FG001|Overall Study|Physician Decision|1|||
160900327|NCT02557295|581028703|FG005|Overall Study|Lack of Efficacy|0|||
160900328|NCT02557295|581028704|FG006|Overall Study|Lack of Efficacy|12|||
160900329|NCT02557295|581028705|FG007|Overall Study|Lack of Efficacy|1|||
160900330|NCT02557295|581028706|FG008|Overall Study|Lack of Efficacy|0|||
160900331|NCT02557295|581028698|FG000|Overall Study|Adverse Event|16|||
160900332|NCT02557295|581028699|FG001|Overall Study|Adverse Event|2|||
160900333|NCT02557295|581028700|FG002|Overall Study|Adverse Event|3|||
160900334|NCT02557295|581028701|FG003|Overall Study|Adverse Event|0|||
160900335|NCT02557295|581028702|FG004|Overall Study|Adverse Event|0|||
160900336|NCT02557295|581028703|FG005|Overall Study|Adverse Event|0|||
160900337|NCT02557295|581028704|FG006|Overall Study|Adverse Event|2|||
160900338|NCT02557295|581028705|FG007|Overall Study|Adverse Event|1|||
160900339|NCT02557295|581028706|FG008|Overall Study|Adverse Event|1|||
160900340|NCT02557295|581028698|FG000|Overall Study|Lost to Follow-up|4|||
160900341|NCT02557295|581028699|FG001|Overall Study|Lost to Follow-up|0|||
160900342|NCT02557295|581028700|FG002|Overall Study|Lost to Follow-up|0|||
160900343|NCT02557295|581028701|FG003|Overall Study|Lost to Follow-up|0|||
161132337|NCT00988247|581868930|FG001|Overall Study|Other|0|||
161132338|NCT02661594|581868931|FG000|Overall Study|Protocol Violation|1|||
161132339|NCT02661594|581868932|FG001|Overall Study|Protocol Violation|0|||
161132340|NCT02661594|581868933|FG002|Overall Study|Protocol Violation|1|||
161333613|NCT00473083|582610542|FG002|Overall Study|Adverse Event|0|||
161132341|NCT02661594|581868934|FG003|Overall Study|Protocol Violation|0|||
161132342|NCT01169779|581868937|FG000|Overall Study|Adverse Event|3|||
161132343|NCT01169779|581868938|FG001|Overall Study|Adverse Event|11|||
161132344|NCT01169779|581868937|FG000|Overall Study|Lack of Efficacy|1|||
161132345|NCT01169779|581868938|FG001|Overall Study|Lack of Efficacy|0|||
161132346|NCT01169779|581868937|FG000|Overall Study|Protocol Violation|1|||
161132347|NCT01169779|581868938|FG001|Overall Study|Protocol Violation|1|||
161132348|NCT01169779|581868937|FG000|Overall Study|Withdrawal by Subject|3|||
161132349|NCT01169779|581868938|FG001|Overall Study|Withdrawal by Subject|2|||
161132350|NCT01169779|581868937|FG000|Overall Study|Familial and personal reasons|3|||
161132351|NCT01169779|581868938|FG001|Overall Study|Familial and personal reasons|3|||
161132352|NCT00432237|581868941|FG000|Overall Study|Adverse Event|0|||
161132353|NCT00432237|581868942|FG001|Overall Study|Adverse Event|0|||
161333614|NCT01184872|582610543|FG000|Overall Study|Adverse Event|3|||
161333615|NCT01184872|582610544|FG001|Overall Study|Adverse Event|4|||
161333616|NCT01184872|582610543|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161333617|NCT01184872|582610544|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161333618|NCT01184872|582610543|FG000|Overall Study|Withdrawal by Subject|2|||
161333619|NCT01184872|582610544|FG001|Overall Study|Withdrawal by Subject|0|||
161333620|NCT01184872|582610543|FG000|Overall Study|Lost to Follow-up|0|||
161333621|NCT01184872|582610544|FG001|Overall Study|Lost to Follow-up|1|||
161333622|NCT01184872|582610543|FG000|Overall Study|Administrative problems|1|||
161333623|NCT01184872|582610544|FG001|Overall Study|Administrative problems|1|||
161333624|NCT01184872|582610543|FG000|Overall Study|Protocol deviation|1|||
161333625|NCT01184872|582610544|FG001|Overall Study|Protocol deviation|0|||
161333626|NCT02446691|582610551|FG000|Overall Study|Withdrawal by Subject|2|||
161333627|NCT02446691|582610551|FG000|Overall Study|Lost to Follow-up|8|||
161333628|NCT02446691|582610551|FG000|Overall Study|Protocol Violation|1|||
161333629|NCT00192114|582610552|FG000|Overall Study|Objective Tumor Progression|19|||
161333630|NCT00192114|582610552|FG000|Overall Study|Adverse Event|2|||
161333631|NCT00192114|582610552|FG000|Overall Study|Clinical Progression|2|||
161333632|NCT00192114|582610552|FG000|Overall Study|Death|1|||
161333633|NCT03903172|582610562|FG000|Overall Study|screen fail|4|||
161333634|NCT03903172|582610563|FG001|Overall Study|screen fail|1|||
161333635|NCT01545388|582610564|FG000|Overall Study|Adverse Event|2|||
161333636|NCT01545388|582610565|FG001|Overall Study|Adverse Event|4|||
160815970|NCT02557100|580711927|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
160815971|NCT02557100|580711928|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
160815972|NCT02557100|580711929|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
160900344|NCT02557295|581028702|FG004|Overall Study|Lost to Follow-up|0|||
160900345|NCT02557295|581028703|FG005|Overall Study|Lost to Follow-up|0|||
160900346|NCT02557295|581028704|FG006|Overall Study|Lost to Follow-up|9|||
160900347|NCT02557295|581028705|FG007|Overall Study|Lost to Follow-up|0|||
161132354|NCT00432237|581868943|FG002|Overall Study|Adverse Event|0|||
161132355|NCT00432237|581868944|FG003|Overall Study|Adverse Event|1|||
161132356|NCT00432237|581868941|FG000|Overall Study|Lack of Efficacy|0|||
161333637|NCT01545388|582610566|FG002|Overall Study|Adverse Event|1|||
160987420|NCT04955626|581341128|FG023|Open-Label Period|Adverse Event|0|||
160987421|NCT04955626|581341129|FG024|Open-Label Period|Adverse Event|0|||
160987422|NCT04955626|581341130|FG025|Open-Label Period|Adverse Event|0|||
160987423|NCT04955626|581341131|FG026|Open-Label Period|Adverse Event|0|||
160987424|NCT04955626|581341132|FG027|Open-Label Period|Adverse Event|0|||
160987425|NCT04955626|581341133|FG028|Open-Label Period|Adverse Event|0|||
160987426|NCT04955626|581341134|FG029|Open-Label Period|Adverse Event|0|||
160987427|NCT04955626|581341135|FG030|Open-Label Period|Adverse Event|0|||
160987428|NCT04955626|581341136|FG031|Open-Label Period|Adverse Event|0|||
160987429|NCT04955626|581341137|FG032|Open-Label Period|Adverse Event|0|||
160987430|NCT04955626|581341138|FG033|Open-Label Period|Adverse Event|0|||
160815973|NCT02557100|580711927|FG000|Single Blind Treatment Period|Death|0|||
160815974|NCT02557100|580711928|FG001|Single Blind Treatment Period|Death|1|||
160815975|NCT02557100|580711929|FG002|Single Blind Treatment Period|Death|0|||
160815976|NCT02557100|580711927|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
160815977|NCT02557100|580711928|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
160815978|NCT02557100|580711929|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
160815979|NCT02557100|580711927|FG000|Single Blind Treatment Period|Adverse Event|0|||
160815980|NCT02557100|580711928|FG001|Single Blind Treatment Period|Adverse Event|1|||
160815981|NCT02557100|580711929|FG002|Single Blind Treatment Period|Adverse Event|0|||
160815982|NCT02557100|580711927|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
160815983|NCT02557100|580711928|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
160815984|NCT02557100|580711929|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
160815985|NCT02557100|580711927|FG000|Cumulative Abatacept Period|Other Reasons|0|||
160815986|NCT02557100|580711928|FG001|Cumulative Abatacept Period|Other Reasons|0|||
160815987|NCT02557100|580711929|FG002|Cumulative Abatacept Period|Other Reasons|1|||
160815988|NCT02557100|580711927|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
160815989|NCT02557100|580711928|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
160815990|NCT02557100|580711929|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
160815991|NCT02557100|580711927|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
160815992|NCT02557100|580711928|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
160815993|NCT02557100|580711929|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
160815994|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
160815995|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
160815996|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
160815997|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
160815998|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
160815999|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
160816000|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
160816001|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
160816002|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
160816003|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
160816004|NCT00510718|580711932|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
160816005|NCT00510718|580711933|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
160816006|NCT02513485|580711935|FG000|Overall Study|Adverse Event|1|||
160816007|NCT02513485|580711936|FG001|Overall Study|Adverse Event|0|||
160816008|NCT00489424|580711950|FG000|Overall Study|Adverse Event|3|||
160816009|NCT00489424|580711951|FG001|Overall Study|Adverse Event|3|||
160816010|NCT00489424|580711952|FG002|Overall Study|Adverse Event|4|||
160816011|NCT00489424|580711950|FG000|Overall Study|Lack of Efficacy|1|||
160816012|NCT00489424|580711951|FG001|Overall Study|Lack of Efficacy|0|||
160816013|NCT00489424|580711952|FG002|Overall Study|Lack of Efficacy|0|||
160816014|NCT00489424|580711950|FG000|Overall Study|Administrative problems|0|||
160816015|NCT00489424|580711951|FG001|Overall Study|Administrative problems|2|||
160816016|NCT00489424|580711952|FG002|Overall Study|Administrative problems|1|||
160816017|NCT00394251|580711953|FG000|Overall Study|Adverse Event|7|||
160816018|NCT00394251|580711954|FG001|Overall Study|Adverse Event|5|||
160816019|NCT00394251|580711953|FG000|Overall Study|Unacceptable Toxicity|20|||
160987431|NCT04955626|581341139|FG034|Open-Label Period|Adverse Event|0|||
160987432|NCT04955626|581341140|FG035|Open-Label Period|Adverse Event|0|||
160987433|NCT04955626|581341105|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
161132357|NCT00432237|581868942|FG001|Overall Study|Lack of Efficacy|0|||
161132358|NCT00432237|581868943|FG002|Overall Study|Lack of Efficacy|0|||
160816020|NCT00394251|580711954|FG001|Overall Study|Unacceptable Toxicity|18|||
160816021|NCT00394251|580711953|FG000|Overall Study|Physician Decision|1|||
160816022|NCT00394251|580711954|FG001|Overall Study|Physician Decision|1|||
160816023|NCT00394251|580711953|FG000|Overall Study|Protocol Violation|0|||
160816024|NCT00394251|580711954|FG001|Overall Study|Protocol Violation|1|||
160816025|NCT00394251|580711953|FG000|Overall Study|Withdrawal by Subject|7|||
160816026|NCT00394251|580711954|FG001|Overall Study|Withdrawal by Subject|11|||
160816027|NCT00394251|580711953|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
160816028|NCT00394251|580711954|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
160987434|NCT04955626|581341106|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
160816029|NCT01558115|580711955|FG000|Overall Study|Withdrawal by Subject|3|||
160816030|NCT01558115|580711955|FG000|Overall Study|Study closed due to poor enrollment|4|||
160816031|NCT01436656|580711956|FG000|Dose Escalation|Death|1|||
160816032|NCT01436656|580711957|FG001|Dose Escalation|Death|3|||
160816033|NCT01436656|580711958|FG002|Dose Escalation|Death|1|||
160816034|NCT01436656|580711959|FG003|Dose Escalation|Death|0|||
160816035|NCT01436656|580711960|FG004|Dose Escalation|Death|2|||
160816036|NCT01436656|580711961|FG005|Dose Escalation|Death|1|||
160816037|NCT01436656|580711962|FG006|Dose Escalation|Death|1|||
160816038|NCT01436656|580711963|FG007|Dose Escalation|Death|1|||
160816039|NCT01436656|580711964|FG008|Dose Escalation|Death|1|||
160816040|NCT01436656|580711965|FG009|Dose Escalation|Death|0|||
160816041|NCT01436656|580711966|FG010|Dose Escalation|Death|0|||
160816042|NCT01436656|580711967|FG011|Dose Escalation|Death|0|||
160816043|NCT01436656|580711968|FG012|Dose Escalation|Death|0|||
160816044|NCT01436656|580711969|FG013|Dose Escalation|Death|0|||
160816045|NCT01436656|580711970|FG014|Dose Escalation|Death|0|||
160816046|NCT01436656|580711971|FG015|Dose Escalation|Death|0|||
160816047|NCT01436656|580711972|FG016|Dose Escalation|Death|0|||
160816048|NCT01436656|580711973|FG017|Dose Escalation|Death|0|||
160816049|NCT01436656|580711956|FG000|Dose Escalation|Protocol Violation|0|||
160816050|NCT01436656|580711957|FG001|Dose Escalation|Protocol Violation|0|||
160816051|NCT01436656|580711958|FG002|Dose Escalation|Protocol Violation|0|||
160816052|NCT01436656|580711959|FG003|Dose Escalation|Protocol Violation|0|||
160816053|NCT01436656|580711960|FG004|Dose Escalation|Protocol Violation|0|||
160816054|NCT01436656|580711961|FG005|Dose Escalation|Protocol Violation|1|||
160816055|NCT01436656|580711962|FG006|Dose Escalation|Protocol Violation|0|||
160816056|NCT01436656|580711963|FG007|Dose Escalation|Protocol Violation|0|||
160816057|NCT01436656|580711964|FG008|Dose Escalation|Protocol Violation|0|||
160816058|NCT01436656|580711965|FG009|Dose Escalation|Protocol Violation|0|||
160816059|NCT01436656|580711966|FG010|Dose Escalation|Protocol Violation|0|||
160816060|NCT01436656|580711967|FG011|Dose Escalation|Protocol Violation|0|||
160816061|NCT01436656|580711968|FG012|Dose Escalation|Protocol Violation|0|||
160816062|NCT01436656|580711969|FG013|Dose Escalation|Protocol Violation|0|||
160816063|NCT01436656|580711970|FG014|Dose Escalation|Protocol Violation|0|||
160816064|NCT01436656|580711971|FG015|Dose Escalation|Protocol Violation|0|||
160816065|NCT01436656|580711972|FG016|Dose Escalation|Protocol Violation|0|||
160816066|NCT01436656|580711973|FG017|Dose Escalation|Protocol Violation|0|||
160816067|NCT01436656|580711956|FG000|Dose Escalation|Withdrawal by Subject|0|||
160816068|NCT01436656|580711957|FG001|Dose Escalation|Withdrawal by Subject|0|||
160816069|NCT01436656|580711958|FG002|Dose Escalation|Withdrawal by Subject|0|||
160816070|NCT01436656|580711959|FG003|Dose Escalation|Withdrawal by Subject|0|||
160816071|NCT01436656|580711960|FG004|Dose Escalation|Withdrawal by Subject|1|||
160816072|NCT01436656|580711961|FG005|Dose Escalation|Withdrawal by Subject|0|||
160816073|NCT01436656|580711962|FG006|Dose Escalation|Withdrawal by Subject|0|||
160816074|NCT01436656|580711963|FG007|Dose Escalation|Withdrawal by Subject|2|||
160816075|NCT01436656|580711964|FG008|Dose Escalation|Withdrawal by Subject|0|||
160816076|NCT01436656|580711965|FG009|Dose Escalation|Withdrawal by Subject|1|||
160816077|NCT01436656|580711966|FG010|Dose Escalation|Withdrawal by Subject|1|||
160816078|NCT01436656|580711967|FG011|Dose Escalation|Withdrawal by Subject|0|||
160816079|NCT01436656|580711968|FG012|Dose Escalation|Withdrawal by Subject|0|||
161132359|NCT00432237|581868944|FG003|Overall Study|Lack of Efficacy|1|||
161132360|NCT00432237|581868941|FG000|Overall Study|Lost to Follow-up|10|||
161132361|NCT00432237|581868942|FG001|Overall Study|Lost to Follow-up|10|||
161132362|NCT00432237|581868943|FG002|Overall Study|Lost to Follow-up|18|||
161132363|NCT00432237|581868944|FG003|Overall Study|Lost to Follow-up|18|||
161132364|NCT00432237|581868941|FG000|Overall Study|Physician Decision|1|||
161132365|NCT00432237|581868942|FG001|Overall Study|Physician Decision|3|||
160816080|NCT01436656|580711969|FG013|Dose Escalation|Withdrawal by Subject|0|||
161132366|NCT00432237|581868943|FG002|Overall Study|Physician Decision|2|||
161333638|NCT01545388|582610564|FG000|Overall Study|Lack of Efficacy|3|||
160816081|NCT01436656|580711970|FG014|Dose Escalation|Withdrawal by Subject|0|||
160816082|NCT01436656|580711971|FG015|Dose Escalation|Withdrawal by Subject|0|||
160816083|NCT01436656|580711972|FG016|Dose Escalation|Withdrawal by Subject|0|||
160816084|NCT01436656|580711973|FG017|Dose Escalation|Withdrawal by Subject|0|||
160816085|NCT01436656|580711956|FG000|Dose Escalation|Administrative problems|0|||
160816086|NCT01436656|580711957|FG001|Dose Escalation|Administrative problems|1|||
160816087|NCT01436656|580711958|FG002|Dose Escalation|Administrative problems|0|||
160816088|NCT01436656|580711959|FG003|Dose Escalation|Administrative problems|0|||
160816089|NCT01436656|580711960|FG004|Dose Escalation|Administrative problems|0|||
160816090|NCT01436656|580711961|FG005|Dose Escalation|Administrative problems|0|||
160816091|NCT01436656|580711962|FG006|Dose Escalation|Administrative problems|0|||
160816092|NCT01436656|580711963|FG007|Dose Escalation|Administrative problems|0|||
160816093|NCT01436656|580711964|FG008|Dose Escalation|Administrative problems|0|||
160816094|NCT01436656|580711965|FG009|Dose Escalation|Administrative problems|0|||
160900348|NCT02557295|581028706|FG008|Overall Study|Lost to Follow-up|0|||
160900349|NCT02557295|581028698|FG000|Overall Study|Study Close|54|||
160900350|NCT02557295|581028699|FG001|Overall Study|Study Close|3|||
160900351|NCT02557295|581028700|FG002|Overall Study|Study Close|5|||
160816095|NCT01436656|580711966|FG010|Dose Escalation|Administrative problems|0|||
160816096|NCT01436656|580711967|FG011|Dose Escalation|Administrative problems|0|||
160816097|NCT01436656|580711968|FG012|Dose Escalation|Administrative problems|0|||
160816098|NCT01436656|580711969|FG013|Dose Escalation|Administrative problems|0|||
160816099|NCT01436656|580711970|FG014|Dose Escalation|Administrative problems|0|||
160816100|NCT01436656|580711971|FG015|Dose Escalation|Administrative problems|0|||
160816101|NCT01436656|580711972|FG016|Dose Escalation|Administrative problems|0|||
160816102|NCT01436656|580711973|FG017|Dose Escalation|Administrative problems|0|||
160816103|NCT01436656|580711956|FG000|Dose Escalation|Lost to Follow-up|1|||
160816104|NCT01436656|580711957|FG001|Dose Escalation|Lost to Follow-up|0|||
160816105|NCT01436656|580711958|FG002|Dose Escalation|Lost to Follow-up|0|||
160816106|NCT01436656|580711959|FG003|Dose Escalation|Lost to Follow-up|0|||
160816107|NCT01436656|580711960|FG004|Dose Escalation|Lost to Follow-up|1|||
160816108|NCT01436656|580711961|FG005|Dose Escalation|Lost to Follow-up|0|||
160816109|NCT01436656|580711962|FG006|Dose Escalation|Lost to Follow-up|0|||
160816110|NCT01436656|580711963|FG007|Dose Escalation|Lost to Follow-up|0|||
160816111|NCT01436656|580711964|FG008|Dose Escalation|Lost to Follow-up|0|||
160816112|NCT01436656|580711965|FG009|Dose Escalation|Lost to Follow-up|0|||
160816113|NCT01436656|580711966|FG010|Dose Escalation|Lost to Follow-up|0|||
160816114|NCT01436656|580711967|FG011|Dose Escalation|Lost to Follow-up|0|||
160816115|NCT01436656|580711968|FG012|Dose Escalation|Lost to Follow-up|0|||
160816116|NCT01436656|580711969|FG013|Dose Escalation|Lost to Follow-up|0|||
161240015|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Adverse Event|23|||
161240016|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Adverse Event|29|||
161240017|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Adverse Event|2|||
161240018|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Adverse Event|8|||
161240019|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
161240020|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
161240021|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
161240022|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
161240023|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
161240024|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
161240025|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
161240026|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
161240027|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
161240028|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
161240029|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
161240030|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
161240031|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
161240032|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
161240033|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
161240034|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
160816117|NCT01436656|580711970|FG014|Dose Escalation|Lost to Follow-up|0|||
160816118|NCT01436656|580711971|FG015|Dose Escalation|Lost to Follow-up|0|||
160816119|NCT01436656|580711972|FG016|Dose Escalation|Lost to Follow-up|0|||
160816120|NCT01436656|580711973|FG017|Dose Escalation|Lost to Follow-up|0|||
160816121|NCT01436656|580711956|FG000|Dose Escalation|New anti-cancer therapy|1|||
160816122|NCT01436656|580711957|FG001|Dose Escalation|New anti-cancer therapy|0|||
160816123|NCT01436656|580711958|FG002|Dose Escalation|New anti-cancer therapy|0|||
160816124|NCT01436656|580711959|FG003|Dose Escalation|New anti-cancer therapy|0|||
160900352|NCT02557295|581028701|FG003|Overall Study|Study Close|3|||
160816125|NCT01436656|580711960|FG004|Dose Escalation|New anti-cancer therapy|0|||
160816126|NCT01436656|580711961|FG005|Dose Escalation|New anti-cancer therapy|0|||
160816127|NCT01436656|580711962|FG006|Dose Escalation|New anti-cancer therapy|0|||
160816128|NCT01436656|580711963|FG007|Dose Escalation|New anti-cancer therapy|0|||
160816129|NCT01436656|580711964|FG008|Dose Escalation|New anti-cancer therapy|1|||
160816130|NCT01436656|580711965|FG009|Dose Escalation|New anti-cancer therapy|1|||
160816131|NCT01436656|580711966|FG010|Dose Escalation|New anti-cancer therapy|0|||
160816132|NCT01436656|580711967|FG011|Dose Escalation|New anti-cancer therapy|0|||
160816133|NCT01436656|580711968|FG012|Dose Escalation|New anti-cancer therapy|0|||
160900353|NCT02557295|581028702|FG004|Overall Study|Study Close|0|||
160900354|NCT02557295|581028703|FG005|Overall Study|Study Close|0|||
160900355|NCT02557295|581028704|FG006|Overall Study|Study Close|37|||
160900356|NCT02557295|581028705|FG007|Overall Study|Study Close|3|||
160900357|NCT02557295|581028706|FG008|Overall Study|Study Close|19|||
160900358|NCT02557295|581028698|FG000|Overall Study|except for study close|4|||
160900359|NCT02557295|581028699|FG001|Overall Study|except for study close|0|||
160900360|NCT02557295|581028700|FG002|Overall Study|except for study close|0|||
160900361|NCT02557295|581028701|FG003|Overall Study|except for study close|0|||
160900362|NCT02557295|581028702|FG004|Overall Study|except for study close|0|||
160900363|NCT02557295|581028703|FG005|Overall Study|except for study close|0|||
160900364|NCT02557295|581028704|FG006|Overall Study|except for study close|5|||
160900365|NCT02557295|581028705|FG007|Overall Study|except for study close|1|||
160900366|NCT02557295|581028706|FG008|Overall Study|except for study close|0|||
160900367|NCT01066000|581028707|FG000|Overall Study|Protocol Violation|4|||
160900368|NCT01066000|581028707|FG000|Overall Study|Death|3|||
160900369|NCT01066000|581028707|FG000|Overall Study|Withdrawal by Subject|1|||
160987435|NCT04955626|581341107|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
160987436|NCT04955626|581341108|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
160987437|NCT04955626|581341109|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
160987438|NCT04955626|581341110|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
160987439|NCT04955626|581341111|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
160987440|NCT04955626|581341112|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
160987441|NCT04955626|581341113|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
160987442|NCT04955626|581341114|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
160987443|NCT04955626|581341115|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
160987444|NCT04955626|581341116|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
160987445|NCT04955626|581341117|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
160987446|NCT04955626|581341118|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
161333639|NCT01545388|582610565|FG001|Overall Study|Lack of Efficacy|2|||
161333640|NCT01545388|582610566|FG002|Overall Study|Lack of Efficacy|5|||
161333641|NCT01545388|582610564|FG000|Overall Study|Participant moved or relocated|1|||
161333642|NCT01545388|582610565|FG001|Overall Study|Participant moved or relocated|0|||
161333643|NCT01545388|582610566|FG002|Overall Study|Participant moved or relocated|0|||
161333644|NCT01545388|582610564|FG000|Overall Study|Withdrawal by Subject|1|||
161333645|NCT01545388|582610565|FG001|Overall Study|Withdrawal by Subject|4|||
161333646|NCT01545388|582610566|FG002|Overall Study|Withdrawal by Subject|2|||
161333647|NCT01545388|582610564|FG000|Overall Study|Other|1|||
161333648|NCT01545388|582610565|FG001|Overall Study|Other|1|||
161333649|NCT01545388|582610566|FG002|Overall Study|Other|0|||
161333650|NCT01474486|582610569|FG000|Overall Study|Death|2|||
161333651|NCT01474486|582610569|FG000|Overall Study|Withdrawal by Subject|4|||
161333652|NCT01474486|582610569|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
161333653|NCT01255163|582610570|FG000|Overall Study|Withdrawal by Subject|1|||
161333654|NCT01255163|582610571|FG001|Overall Study|Withdrawal by Subject|0|||
161333655|NCT01255163|582610570|FG000|Overall Study|Lost to Follow-up|2|||
161333656|NCT01255163|582610571|FG001|Overall Study|Lost to Follow-up|0|||
161333657|NCT01255163|582610570|FG000|Overall Study|Adverse Event|0|||
161333658|NCT01255163|582610571|FG001|Overall Study|Adverse Event|2|||
161333659|NCT01255163|582610570|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
161333660|NCT01255163|582610571|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
161333661|NCT02495389|582610572|FG000|Overall Study|Withdrawal by Subject|40|||
161333662|NCT01924533|582610573|FG000|Overall Study|Death|181|||
161333663|NCT01924533|582610574|FG001|Overall Study|Death|200|||
161333664|NCT01924533|582610573|FG000|Overall Study|Lost to Follow-up|0|||
161333665|NCT01924533|582610574|FG001|Overall Study|Lost to Follow-up|1|||
161333666|NCT01924533|582610573|FG000|Overall Study|Withdrawal by Subject|7|||
161333667|NCT01924533|582610574|FG001|Overall Study|Withdrawal by Subject|3|||
161333668|NCT01924533|582610573|FG000|Overall Study|Other Eligibility criteria|1|||
161333669|NCT01924533|582610574|FG001|Overall Study|Other Eligibility criteria|1|||
161333670|NCT05817669|582610575|FG000|Overall Study|Prohibited medication used|1|||
161333671|NCT05817669|582610576|FG001|Overall Study|Prohibited medication used|2|||
160816134|NCT01436656|580711969|FG013|Dose Escalation|New anti-cancer therapy|0|||
160816135|NCT01436656|580711970|FG014|Dose Escalation|New anti-cancer therapy|0|||
160816136|NCT01436656|580711971|FG015|Dose Escalation|New anti-cancer therapy|0|||
160816137|NCT01436656|580711972|FG016|Dose Escalation|New anti-cancer therapy|0|||
160816138|NCT01436656|580711973|FG017|Dose Escalation|New anti-cancer therapy|0|||
160816139|NCT01436656|580711956|FG000|Dose Expansion|Adverse Event|0|||
160816140|NCT01436656|580711957|FG001|Dose Expansion|Adverse Event|0|||
160816141|NCT01436656|580711958|FG002|Dose Expansion|Adverse Event|0|||
160816142|NCT01436656|580711959|FG003|Dose Expansion|Adverse Event|0|||
160816143|NCT01436656|580711960|FG004|Dose Expansion|Adverse Event|0|||
160816144|NCT01436656|580711961|FG005|Dose Expansion|Adverse Event|0|||
160816145|NCT01436656|580711962|FG006|Dose Expansion|Adverse Event|0|||
160816146|NCT01436656|580711963|FG007|Dose Expansion|Adverse Event|0|||
160816147|NCT01436656|580711964|FG008|Dose Expansion|Adverse Event|0|||
160816148|NCT01436656|580711965|FG009|Dose Expansion|Adverse Event|0|||
160816149|NCT01436656|580711966|FG010|Dose Expansion|Adverse Event|0|||
160816150|NCT01436656|580711967|FG011|Dose Expansion|Adverse Event|1|||
160816151|NCT01436656|580711968|FG012|Dose Expansion|Adverse Event|0|||
160816152|NCT01436656|580711969|FG013|Dose Expansion|Adverse Event|0|||
160816153|NCT01436656|580711970|FG014|Dose Expansion|Adverse Event|0|||
160816154|NCT01436656|580711971|FG015|Dose Expansion|Adverse Event|0|||
160816155|NCT01436656|580711972|FG016|Dose Expansion|Adverse Event|0|||
160816156|NCT01436656|580711973|FG017|Dose Expansion|Adverse Event|0|||
161333672|NCT05817669|582610575|FG000|Overall Study|Adverse Event|1|||
160816157|NCT01436656|580711956|FG000|Dose Expansion|Withdrawal by Subject|0|||
160816158|NCT01436656|580711957|FG001|Dose Expansion|Withdrawal by Subject|0|||
160816159|NCT01436656|580711958|FG002|Dose Expansion|Withdrawal by Subject|0|||
160816160|NCT01436656|580711959|FG003|Dose Expansion|Withdrawal by Subject|0|||
160816161|NCT01436656|580711960|FG004|Dose Expansion|Withdrawal by Subject|0|||
161333673|NCT05817669|582610576|FG001|Overall Study|Adverse Event|0|||
161333674|NCT05817669|582610575|FG000|Overall Study|Withdrawal by Subject|1|||
160816162|NCT01436656|580711961|FG005|Dose Expansion|Withdrawal by Subject|0|||
160816163|NCT01436656|580711962|FG006|Dose Expansion|Withdrawal by Subject|0|||
160816164|NCT01436656|580711963|FG007|Dose Expansion|Withdrawal by Subject|0|||
160816165|NCT01436656|580711964|FG008|Dose Expansion|Withdrawal by Subject|0|||
160816166|NCT01436656|580711965|FG009|Dose Expansion|Withdrawal by Subject|0|||
160816167|NCT01436656|580711966|FG010|Dose Expansion|Withdrawal by Subject|0|||
160816168|NCT01436656|580711967|FG011|Dose Expansion|Withdrawal by Subject|1|||
160816169|NCT01436656|580711968|FG012|Dose Expansion|Withdrawal by Subject|3|||
160816170|NCT01436656|580711969|FG013|Dose Expansion|Withdrawal by Subject|1|||
160816171|NCT01436656|580711970|FG014|Dose Expansion|Withdrawal by Subject|2|||
160816172|NCT01436656|580711971|FG015|Dose Expansion|Withdrawal by Subject|0|||
160816173|NCT01436656|580711972|FG016|Dose Expansion|Withdrawal by Subject|1|||
160816174|NCT01436656|580711973|FG017|Dose Expansion|Withdrawal by Subject|1|||
160816175|NCT01436656|580711956|FG000|Dose Expansion|Death|0|||
160816176|NCT01436656|580711957|FG001|Dose Expansion|Death|0|||
160816177|NCT01436656|580711958|FG002|Dose Expansion|Death|0|||
160816178|NCT01436656|580711959|FG003|Dose Expansion|Death|0|||
160987447|NCT04955626|581341119|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
160816179|NCT01436656|580711960|FG004|Dose Expansion|Death|0|||
160816180|NCT01436656|580711961|FG005|Dose Expansion|Death|0|||
160816181|NCT01436656|580711962|FG006|Dose Expansion|Death|0|||
160816182|NCT01436656|580711963|FG007|Dose Expansion|Death|0|||
160816183|NCT01436656|580711964|FG008|Dose Expansion|Death|0|||
160816184|NCT01436656|580711965|FG009|Dose Expansion|Death|0|||
160816185|NCT01436656|580711966|FG010|Dose Expansion|Death|0|||
160816186|NCT01436656|580711967|FG011|Dose Expansion|Death|0|||
160816187|NCT01436656|580711968|FG012|Dose Expansion|Death|1|||
160816188|NCT01436656|580711969|FG013|Dose Expansion|Death|0|||
160816189|NCT01436656|580711970|FG014|Dose Expansion|Death|3|||
160816190|NCT01436656|580711971|FG015|Dose Expansion|Death|0|||
160816191|NCT01436656|580711972|FG016|Dose Expansion|Death|3|||
160816192|NCT01436656|580711973|FG017|Dose Expansion|Death|3|||
160816193|NCT01436656|580711956|FG000|Dose Expansion|Lost to Follow-up|0|||
160816194|NCT01436656|580711957|FG001|Dose Expansion|Lost to Follow-up|0|||
160816195|NCT01436656|580711958|FG002|Dose Expansion|Lost to Follow-up|0|||
160816196|NCT01436656|580711959|FG003|Dose Expansion|Lost to Follow-up|0|||
160816197|NCT01436656|580711960|FG004|Dose Expansion|Lost to Follow-up|0|||
160816198|NCT01436656|580711961|FG005|Dose Expansion|Lost to Follow-up|0|||
160816199|NCT01436656|580711962|FG006|Dose Expansion|Lost to Follow-up|0|||
160816200|NCT01436656|580711963|FG007|Dose Expansion|Lost to Follow-up|0|||
160816201|NCT01436656|580711964|FG008|Dose Expansion|Lost to Follow-up|0|||
160816202|NCT01436656|580711965|FG009|Dose Expansion|Lost to Follow-up|0|||
160816203|NCT01436656|580711966|FG010|Dose Expansion|Lost to Follow-up|0|||
160816204|NCT01436656|580711967|FG011|Dose Expansion|Lost to Follow-up|0|||
160816205|NCT01436656|580711968|FG012|Dose Expansion|Lost to Follow-up|0|||
160816206|NCT01436656|580711969|FG013|Dose Expansion|Lost to Follow-up|0|||
160816207|NCT01436656|580711970|FG014|Dose Expansion|Lost to Follow-up|0|||
160816208|NCT01436656|580711971|FG015|Dose Expansion|Lost to Follow-up|0|||
160816209|NCT01436656|580711972|FG016|Dose Expansion|Lost to Follow-up|0|||
160816210|NCT01436656|580711973|FG017|Dose Expansion|Lost to Follow-up|3|||
160816211|NCT01436656|580711956|FG000|Dose Expansion|Disease progression|0|||
160816212|NCT01436656|580711957|FG001|Dose Expansion|Disease progression|0|||
160816213|NCT01436656|580711958|FG002|Dose Expansion|Disease progression|0|||
160816214|NCT01436656|580711959|FG003|Dose Expansion|Disease progression|0|||
160816215|NCT01436656|580711960|FG004|Dose Expansion|Disease progression|0|||
160816216|NCT01436656|580711961|FG005|Dose Expansion|Disease progression|0|||
160816217|NCT01436656|580711962|FG006|Dose Expansion|Disease progression|0|||
160816218|NCT01436656|580711963|FG007|Dose Expansion|Disease progression|0|||
160816219|NCT01436656|580711964|FG008|Dose Expansion|Disease progression|0|||
160816220|NCT01436656|580711965|FG009|Dose Expansion|Disease progression|0|||
160816221|NCT01436656|580711966|FG010|Dose Expansion|Disease progression|0|||
160816222|NCT01436656|580711967|FG011|Dose Expansion|Disease progression|3|||
160816223|NCT01436656|580711968|FG012|Dose Expansion|Disease progression|1|||
160816224|NCT01436656|580711969|FG013|Dose Expansion|Disease progression|0|||
160816225|NCT01436656|580711970|FG014|Dose Expansion|Disease progression|1|||
160816226|NCT01436656|580711971|FG015|Dose Expansion|Disease progression|0|||
160987448|NCT04955626|581341120|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
160987449|NCT04955626|581341121|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
160816227|NCT01436656|580711972|FG016|Dose Expansion|Disease progression|0|||
160816228|NCT01436656|580711973|FG017|Dose Expansion|Disease progression|1|||
160816229|NCT01436656|580711956|FG000|Dose Expansion|New cancer therapy|0|||
160816230|NCT01436656|580711957|FG001|Dose Expansion|New cancer therapy|0|||
160816231|NCT01436656|580711958|FG002|Dose Expansion|New cancer therapy|0|||
160816232|NCT01436656|580711959|FG003|Dose Expansion|New cancer therapy|0|||
160816233|NCT01436656|580711960|FG004|Dose Expansion|New cancer therapy|0|||
160816234|NCT01436656|580711961|FG005|Dose Expansion|New cancer therapy|0|||
160816235|NCT01436656|580711962|FG006|Dose Expansion|New cancer therapy|0|||
160816236|NCT01436656|580711963|FG007|Dose Expansion|New cancer therapy|0|||
160816237|NCT01436656|580711964|FG008|Dose Expansion|New cancer therapy|0|||
160816238|NCT01436656|580711965|FG009|Dose Expansion|New cancer therapy|0|||
160987450|NCT04955626|581341122|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
160987451|NCT04955626|581341123|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
160987452|NCT04955626|581341124|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
160987453|NCT04955626|581341125|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
160987454|NCT04955626|581341126|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
160987455|NCT04955626|581341127|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
160987456|NCT04955626|581341128|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
160987457|NCT04955626|581341129|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
160987458|NCT04955626|581341130|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
160987459|NCT04955626|581341131|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
160987460|NCT04955626|581341132|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
160987461|NCT04955626|581341133|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
160987462|NCT04955626|581341134|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
160987463|NCT04955626|581341135|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
160987464|NCT04955626|581341136|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
160987465|NCT04955626|581341137|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
160987466|NCT04955626|581341138|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
160987467|NCT04955626|581341139|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
161240035|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
161240036|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161240037|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161240038|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
161240039|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
161240040|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
161240041|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
160987468|NCT04955626|581341140|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
160987469|NCT04955626|581341105|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987470|NCT04955626|581341106|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
160987471|NCT04955626|581341107|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987472|NCT04955626|581341108|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987473|NCT04955626|581341109|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161333675|NCT05817669|582610576|FG001|Overall Study|Withdrawal by Subject|2|||
161333676|NCT04233879|582610577|FG000|Overall Study|Death|2|||
161333677|NCT04233879|582610578|FG001|Overall Study|Death|0|||
161333678|NCT04233879|582610577|FG000|Overall Study|Lost to Follow-up|3|||
161333679|NCT04233879|582610578|FG001|Overall Study|Lost to Follow-up|8|||
161333680|NCT04233879|582610577|FG000|Overall Study|Physician Decision|4|||
161333681|NCT04233879|582610578|FG001|Overall Study|Physician Decision|4|||
161333682|NCT04233879|582610577|FG000|Overall Study|Withdrawal by Subject|7|||
160816239|NCT01436656|580711966|FG010|Dose Expansion|New cancer therapy|0|||
160816240|NCT01436656|580711967|FG011|Dose Expansion|New cancer therapy|1|||
160987474|NCT04955626|581341110|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
161240042|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
161240043|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
161240044|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
161240045|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
161240046|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
161240047|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
161240048|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
161240049|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Move|0|||
161240050|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Move|1|||
161240051|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Move|0|||
161240052|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Move|0|||
161240053|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Move|0|||
161240054|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161240055|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161240056|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161240057|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
161240058|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
161240059|NCT00318461|582260502|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
161240060|NCT00318461|582260503|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161240061|NCT00318461|582260504|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161240062|NCT00318461|582260505|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
161240063|NCT00318461|582260506|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
161240064|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Work commitment|0|||
161240065|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Work commitment|0|||
161240066|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Work commitment|0|||
161240067|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Work commitment|0|||
161240068|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Work commitment|1|||
161333683|NCT04233879|582610578|FG001|Overall Study|Withdrawal by Subject|10|||
160816241|NCT01436656|580711968|FG012|Dose Expansion|New cancer therapy|1|||
160816242|NCT01436656|580711969|FG013|Dose Expansion|New cancer therapy|0|||
160816243|NCT01436656|580711970|FG014|Dose Expansion|New cancer therapy|2|||
160816244|NCT01436656|580711971|FG015|Dose Expansion|New cancer therapy|0|||
160816245|NCT01436656|580711972|FG016|Dose Expansion|New cancer therapy|0|||
160816246|NCT01436656|580711973|FG017|Dose Expansion|New cancer therapy|0|||
160816247|NCT01696994|580711974|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
160816248|NCT01696994|580711975|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
160816249|NCT01696994|580711974|FG000|Overall Study|Died Before Randomization|1|||
160816250|NCT01696994|580711975|FG001|Overall Study|Died Before Randomization|2|||
160816251|NCT01696994|580711974|FG000|Overall Study|Died Before ASU (Control)|73|||
160816252|NCT01696994|580711975|FG001|Overall Study|Died Before ASU (Control)|0|||
160816253|NCT01696994|580711974|FG000|Overall Study|No Ovaries at Baseline|4807|||
160816254|NCT01696994|580711975|FG001|Overall Study|No Ovaries at Baseline|4851|||
160816255|NCT01696994|580711974|FG000|Overall Study|Refused ASU (Control)|311|||
160816256|NCT01696994|580711975|FG001|Overall Study|Refused ASU (Control)|0|||
160816257|NCT01696994|580711974|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
160816258|NCT01696994|580711975|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
160816259|NCT04644276|580711976|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
160816260|NCT04644276|580711977|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
160816261|NCT04644276|580711978|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
160816262|NCT00705250|580711979|FG000|Overall Study|Withdrawal by Subject|1|||
160816263|NCT00705250|580711979|FG000|Overall Study|Patient died in car accident|1|||
160816264|NCT01576146|580711982|FG000|Extension Period 1|Adverse Event|2|||
160816265|NCT01576146|580711982|FG000|Extension Period 1|Death|2|||
160816266|NCT01576146|580711982|FG000|Extension Period 1|Physician Decision|2|||
160816267|NCT01576146|580711982|FG000|Extension Period 1|Withdrawal by Subject|1|||
160816268|NCT01576146|580711982|FG000|Extension Period 1|Lost to Follow-up|1|||
160816269|NCT01576146|580711982|FG000|Extension Period 1|Parathyroidectomy|1|||
160816270|NCT01576146|580711982|FG000|Extension Period 1|Renal Transplant|1|||
160816271|NCT01576146|580711982|FG000|Extension Period 2|Sponsor Decision|13|||
160816272|NCT01576146|580711982|FG000|Extension Period 2|Death|1|||
160816273|NCT01576146|580711982|FG000|Extension Period 2|Adverse Event|1|||
160816274|NCT01576146|580711982|FG000|Extension Period 2|Renal Transplant|1|||
160816275|NCT01576146|580711982|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
160816276|NCT01667224|580711984|FG000|Overall Study|Withdrawal by Subject|3|||
160816277|NCT01667224|580711985|FG001|Overall Study|Withdrawal by Subject|1|||
160816278|NCT01667224|580711984|FG000|Overall Study|Protocol Violation|1|||
160816279|NCT01667224|580711985|FG001|Overall Study|Protocol Violation|1|||
160816280|NCT00316225|580711986|FG000|Overall Study|Adverse Event|2|||
160816281|NCT00316225|580711986|FG000|Overall Study|Physician Decision|3|||
160816282|NCT00316225|580711986|FG000|Overall Study|Progressive Disease|15|||
160816283|NCT00316225|580711986|FG000|Overall Study|Withdrawal by Subject|3|||
160816284|NCT00316225|580711986|FG000|Overall Study|Death|2|||
160816285|NCT01814878|580711987|FG000|Overall Study|Adverse Event|16|||
160816286|NCT01814878|580711988|FG001|Overall Study|Adverse Event|5|||
160816287|NCT01814878|580711987|FG000|Overall Study|Withdrawal by Subject|20|||
160816288|NCT01814878|580711988|FG001|Overall Study|Withdrawal by Subject|16|||
160816289|NCT01814878|580711987|FG000|Overall Study|Protocol Violation|5|||
160816290|NCT01814878|580711988|FG001|Overall Study|Protocol Violation|5|||
160816291|NCT01814878|580711987|FG000|Overall Study|Physician Decision|3|||
160816292|NCT01814878|580711988|FG001|Overall Study|Physician Decision|1|||
160816293|NCT01814878|580711987|FG000|Overall Study|Screening failure (drop-out)|0|||
160816294|NCT01814878|580711988|FG001|Overall Study|Screening failure (drop-out)|3|||
160816295|NCT01814878|580711987|FG000|Overall Study|Other|2|||
160816296|NCT01814878|580711988|FG001|Overall Study|Other|0|||
160816297|NCT01545934|580711989|FG000|Overall Study|Withdrawal by Subject|4|||
160816298|NCT01545934|580711990|FG001|Overall Study|Withdrawal by Subject|3|||
160816299|NCT01545934|580711989|FG000|Overall Study|Lost to Follow-up|1|||
160816300|NCT01545934|580711990|FG001|Overall Study|Lost to Follow-up|0|||
160816301|NCT01843673|580711991|FG000|Overall Study|Lack of Efficacy|2|||
160816302|NCT01843673|580711991|FG000|Overall Study|Withdrawal by Subject|4|||
160816303|NCT00425698|580711992|FG000|Overall Study|Adverse Event|3|||
160816304|NCT00425698|580711993|FG001|Overall Study|Adverse Event|1|||
160816305|NCT00425698|580711992|FG000|Overall Study|Withdrawal by Subject|0|||
160816306|NCT00425698|580711993|FG001|Overall Study|Withdrawal by Subject|1|||
160816307|NCT01205061|580711994|FG000|Overall Study|Adverse Event|4|||
160816308|NCT01205061|580711994|FG000|Overall Study|Withdrawal by Subject|11|||
160816309|NCT01205061|580711994|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
160816310|NCT01205061|580711994|FG000|Overall Study|Lost to Follow-up|9|||
160816311|NCT01205061|580711994|FG000|Overall Study|Other|1|||
160816312|NCT04026009|580711999|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160816313|NCT04026009|580712000|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160816314|NCT04026009|580712001|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160816315|NCT04026009|580712002|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160816316|NCT04026009|580712003|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160816317|NCT04026009|580711999|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816318|NCT04026009|580712000|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816319|NCT04026009|580712001|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816320|NCT04026009|580712002|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
160816321|NCT04026009|580712003|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
160816322|NCT01988662|580712004|FG000|Overall Study|Subject/guardian decision|1|||
160816323|NCT01988662|580712005|FG001|Overall Study|Subject/guardian decision|1|||
160816324|NCT01988662|580712004|FG000|Overall Study|Adverse Event|3|||
160816325|NCT01988662|580712005|FG001|Overall Study|Adverse Event|1|||
160816326|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
160816327|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
160816328|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
160816329|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
160816330|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
160816331|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
160816332|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
160816333|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
160816334|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
160816335|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
160816336|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
160816337|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
160816338|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
160816339|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
160816340|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
160816341|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
160816342|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
160816343|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816344|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816345|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816346|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816347|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816348|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816349|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816350|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816351|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816352|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816353|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816354|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816355|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
160816356|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
160816357|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
160816358|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
160816359|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
160816360|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
160816361|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
160816362|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
160816363|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
160816364|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
160816365|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
160816366|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
160816367|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
160816368|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
160816369|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
160816370|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
160816371|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
160816372|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
160816373|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
160987475|NCT04955626|581341111|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987476|NCT04955626|581341112|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987477|NCT04955626|581341113|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987478|NCT04955626|581341114|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816374|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
160816375|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
160816376|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
160816377|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
160987479|NCT04955626|581341115|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987480|NCT04955626|581341116|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816378|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
160816379|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
160816380|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
160816381|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
160816382|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
160816383|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
160816384|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
160816385|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
160816386|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
160816387|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
160816388|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
160816389|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
160816390|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816391|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816392|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816393|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816394|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816395|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816396|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816397|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816398|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816399|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816400|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160816401|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
160816402|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
160816403|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
160816404|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
160816405|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816406|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816407|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816408|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816409|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816410|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816411|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816412|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816413|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816414|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816415|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
160816416|NCT03831191|580712008|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816417|NCT03831191|580712009|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816418|NCT03831191|580712010|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816419|NCT03831191|580712011|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
160816420|NCT03831191|580712012|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816421|NCT03831191|580712013|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816422|NCT03831191|580712014|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816423|NCT03831191|580712015|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816424|NCT03831191|580712016|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816425|NCT03831191|580712017|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816426|NCT03831191|580712018|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816427|NCT03831191|580712019|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816428|NCT03831191|580712020|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816429|NCT03831191|580712021|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816430|NCT03831191|580712022|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
160816431|NCT03831191|580712008|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160816432|NCT03831191|580712009|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160987481|NCT04955626|581341117|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987482|NCT04955626|581341118|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987483|NCT04955626|581341119|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987484|NCT04955626|581341120|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987485|NCT04955626|581341121|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987486|NCT04955626|581341122|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987487|NCT04955626|581341123|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987488|NCT04955626|581341124|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816433|NCT03831191|580712010|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160816434|NCT03831191|580712011|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
160816435|NCT03831191|580712012|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
160816436|NCT03831191|580712013|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
160987489|NCT04955626|581341125|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816437|NCT03831191|580712014|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
160816438|NCT03831191|580712015|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
160816439|NCT03831191|580712016|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
160816440|NCT03831191|580712017|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
160816441|NCT03831191|580712018|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
160816442|NCT03831191|580712019|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
160816443|NCT03831191|580712020|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
160816444|NCT03831191|580712021|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
160816445|NCT03831191|580712022|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
160816446|NCT03831191|580712008|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816447|NCT03831191|580712009|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816448|NCT03831191|580712010|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816449|NCT03831191|580712011|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816450|NCT03831191|580712012|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816451|NCT03831191|580712013|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816452|NCT03831191|580712014|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816453|NCT03831191|580712015|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816454|NCT03831191|580712016|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816455|NCT03831191|580712017|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816456|NCT03831191|580712018|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816457|NCT03831191|580712019|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816458|NCT03831191|580712020|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816459|NCT03831191|580712021|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160816460|NCT03831191|580712022|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
160816461|NCT03831191|580712008|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816462|NCT03831191|580712009|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816463|NCT03831191|580712010|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816464|NCT03831191|580712011|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816465|NCT03831191|580712012|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816466|NCT03831191|580712013|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816467|NCT03831191|580712014|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816468|NCT03831191|580712015|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816469|NCT03831191|580712016|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816470|NCT03831191|580712017|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816471|NCT03831191|580712018|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816472|NCT03831191|580712019|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816473|NCT03831191|580712020|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816474|NCT03831191|580712021|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160816475|NCT03831191|580712022|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
160816476|NCT00695955|580712023|FG000|Cohort 1|Adverse Event|26|||
160816477|NCT00695955|580712023|FG000|Cohort 1|Protocol Violation|2|||
160816478|NCT00695955|580712023|FG000|Cohort 1|Lost to Follow-up|30|||
160816479|NCT00695955|580712023|FG000|Cohort 1|Withdrawal by Subject|25|||
160816480|NCT00695955|580712023|FG000|Cohort 1|Lack of Efficacy|3|||
160816481|NCT00695955|580712023|FG000|Cohort 1|Other|16|||
160816482|NCT00695955|580712023|FG000|Cohort 2|Adverse Event|24|||
160816483|NCT00695955|580712023|FG000|Cohort 2|Protocol Violation|5|||
160816484|NCT00695955|580712023|FG000|Cohort 2|Lost to Follow-up|38|||
160816485|NCT00695955|580712023|FG000|Cohort 2|Withdrawal by Subject|28|||
160816486|NCT00695955|580712023|FG000|Cohort 2|Lack of Efficacy|4|||
160816487|NCT00695955|580712023|FG000|Cohort 2|Other|5|||
160816488|NCT01177553|580712024|FG000|Overall Study|babies not yet 6 months of age|1|||
160816489|NCT01177553|580712025|FG001|Overall Study|babies not yet 6 months of age|0|||
160816490|NCT04826094|580712027|FG000|Overall Study|Lost to Follow-up|2|||
160816491|NCT04826094|580712028|FG001|Overall Study|Lost to Follow-up|1|||
160816492|NCT04826094|580712029|FG002|Overall Study|Lost to Follow-up|0|||
160816493|NCT04826094|580712030|FG003|Overall Study|Lost to Follow-up|0|||
160816494|NCT04826094|580712031|FG004|Overall Study|Lost to Follow-up|1|||
160816495|NCT04826094|580712032|FG005|Overall Study|Lost to Follow-up|3|||
160816496|NCT04826094|580712033|FG006|Overall Study|Lost to Follow-up|1|||
160816497|NCT04826094|580712034|FG007|Overall Study|Lost to Follow-up|1|||
160816498|NCT04826094|580712027|FG000|Overall Study|Participant withdrew consent|1|||
160816499|NCT04826094|580712028|FG001|Overall Study|Participant withdrew consent|0|||
160816500|NCT04826094|580712029|FG002|Overall Study|Participant withdrew consent|0|||
160816501|NCT04826094|580712030|FG003|Overall Study|Participant withdrew consent|1|||
160816502|NCT04826094|580712031|FG004|Overall Study|Participant withdrew consent|1|||
160900370|NCT01066000|581028707|FG000|Overall Study|Adverse Event|1|||
161132367|NCT00432237|581868944|FG003|Overall Study|Physician Decision|1|||
160816503|NCT04826094|580712032|FG005|Overall Study|Participant withdrew consent|1|||
160816504|NCT04826094|580712033|FG006|Overall Study|Participant withdrew consent|0|||
161132368|NCT00432237|581868941|FG000|Overall Study|Pregnancy|0|||
160816505|NCT04826094|580712034|FG007|Overall Study|Participant withdrew consent|1|||
160816506|NCT04826094|580712027|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
160816507|NCT04826094|580712028|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
160816508|NCT04826094|580712029|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
160816509|NCT04826094|580712030|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
160816510|NCT04826094|580712031|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
160816511|NCT04826094|580712032|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
160816512|NCT04826094|580712033|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
160816513|NCT04826094|580712034|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
160816514|NCT04826094|580712027|FG000|Overall Study|Withdrawn by Investigator|0|||
160816515|NCT04826094|580712028|FG001|Overall Study|Withdrawn by Investigator|0|||
160816516|NCT04826094|580712029|FG002|Overall Study|Withdrawn by Investigator|0|||
160816517|NCT04826094|580712030|FG003|Overall Study|Withdrawn by Investigator|0|||
160816518|NCT04826094|580712031|FG004|Overall Study|Withdrawn by Investigator|0|||
160816519|NCT04826094|580712032|FG005|Overall Study|Withdrawn by Investigator|1|||
160816520|NCT04826094|580712033|FG006|Overall Study|Withdrawn by Investigator|0|||
160816521|NCT04826094|580712034|FG007|Overall Study|Withdrawn by Investigator|1|||
160816522|NCT04826094|580712027|FG000|Overall Study|Other: Moved from area|1|||
160816523|NCT04826094|580712028|FG001|Overall Study|Other: Moved from area|1|||
160816524|NCT04826094|580712029|FG002|Overall Study|Other: Moved from area|1|||
160816525|NCT04826094|580712030|FG003|Overall Study|Other: Moved from area|0|||
160816526|NCT04826094|580712031|FG004|Overall Study|Other: Moved from area|0|||
160816527|NCT04826094|580712032|FG005|Overall Study|Other: Moved from area|0|||
160816528|NCT04826094|580712033|FG006|Overall Study|Other: Moved from area|0|||
160816529|NCT04826094|580712034|FG007|Overall Study|Other: Moved from area|0|||
160816530|NCT04826094|580712027|FG000|Overall Study|Other: Declined|0|||
160816531|NCT04826094|580712028|FG001|Overall Study|Other: Declined|0|||
160816532|NCT04826094|580712029|FG002|Overall Study|Other: Declined|0|||
160816533|NCT04826094|580712030|FG003|Overall Study|Other: Declined|0|||
160816534|NCT04826094|580712031|FG004|Overall Study|Other: Declined|1|||
160816535|NCT04826094|580712032|FG005|Overall Study|Other: Declined|0|||
160816536|NCT04826094|580712033|FG006|Overall Study|Other: Declined|0|||
160816537|NCT04826094|580712034|FG007|Overall Study|Other: Declined|0|||
160816538|NCT04826094|580712027|FG000|Overall Study|Other: Vaccine not administered|0|||
160816539|NCT04826094|580712028|FG001|Overall Study|Other: Vaccine not administered|0|||
160816540|NCT04826094|580712029|FG002|Overall Study|Other: Vaccine not administered|1|||
160816541|NCT04826094|580712030|FG003|Overall Study|Other: Vaccine not administered|0|||
160816542|NCT04826094|580712031|FG004|Overall Study|Other: Vaccine not administered|0|||
160816543|NCT04826094|580712032|FG005|Overall Study|Other: Vaccine not administered|1|||
160816544|NCT04826094|580712033|FG006|Overall Study|Other: Vaccine not administered|1|||
160816545|NCT04826094|580712034|FG007|Overall Study|Other: Vaccine not administered|3|||
160816546|NCT01864148|580712037|FG000|Overall Study|Other|2|||
160816547|NCT01864148|580712038|FG001|Overall Study|Other|1|||
160816548|NCT01864148|580712039|FG002|Overall Study|Other|1|||
160816549|NCT01864148|580712040|FG003|Overall Study|Other|3|||
160816550|NCT01864148|580712041|FG004|Overall Study|Other|1|||
160816551|NCT01864148|580712037|FG000|Overall Study|Death|0|||
160816552|NCT01864148|580712038|FG001|Overall Study|Death|0|||
160816553|NCT01864148|580712039|FG002|Overall Study|Death|0|||
160816554|NCT01864148|580712040|FG003|Overall Study|Death|1|||
160816555|NCT01864148|580712041|FG004|Overall Study|Death|0|||
160816556|NCT01864148|580712037|FG000|Overall Study|Investigator Decision|5|||
160816557|NCT01864148|580712038|FG001|Overall Study|Investigator Decision|0|||
160816558|NCT01864148|580712039|FG002|Overall Study|Investigator Decision|0|||
160900371|NCT01386008|581028708|FG000|Overall Study|exited w/o incident /study discontinued|17|||
160900372|NCT01386008|581028708|FG000|Overall Study|Adverse Event|3|||
160900373|NCT01067976|581028709|FG000|Overall Study|Study drug never administered|20|||
160900374|NCT01067976|581028709|FG000|Overall Study|Study prematurely discontinued|2|||
160816559|NCT01864148|580712040|FG003|Overall Study|Investigator Decision|4|||
160816560|NCT01864148|580712041|FG004|Overall Study|Investigator Decision|6|||
160816561|NCT01864148|580712037|FG000|Overall Study|Withdrawal by Subject|9|||
160816562|NCT01864148|580712038|FG001|Overall Study|Withdrawal by Subject|2|||
160816563|NCT01864148|580712039|FG002|Overall Study|Withdrawal by Subject|6|||
160816564|NCT01864148|580712040|FG003|Overall Study|Withdrawal by Subject|8|||
160900375|NCT04449861|581028710|FG000|Overall Study|Withdrawal by Subject|4|||
160816565|NCT01864148|580712041|FG004|Overall Study|Withdrawal by Subject|8|||
160816566|NCT01864148|580712037|FG000|Overall Study|Lost to Follow-up|0|||
160816567|NCT01864148|580712038|FG001|Overall Study|Lost to Follow-up|0|||
160816568|NCT01864148|580712039|FG002|Overall Study|Lost to Follow-up|0|||
160816569|NCT01864148|580712040|FG003|Overall Study|Lost to Follow-up|2|||
160816570|NCT01864148|580712041|FG004|Overall Study|Lost to Follow-up|1|||
160816571|NCT01864148|580712037|FG000|Overall Study|Adverse Event|4|||
160816572|NCT01864148|580712038|FG001|Overall Study|Adverse Event|2|||
160816573|NCT01864148|580712039|FG002|Overall Study|Adverse Event|4|||
160900376|NCT04449861|581028710|FG000|Overall Study|Lost to Follow-up|5|||
160900377|NCT04449861|581028710|FG000|Overall Study|Death|112|||
160900378|NCT00976677|581028711|FG000|Overall Study|Adverse Event|1|||
160900379|NCT00976677|581028712|FG001|Overall Study|Adverse Event|0|||
160900380|NCT00976677|581028711|FG000|Overall Study|Withdrawal by Subject|0|||
160900381|NCT00976677|581028712|FG001|Overall Study|Withdrawal by Subject|2|||
160816574|NCT01864148|580712040|FG003|Overall Study|Adverse Event|7|||
160816575|NCT01864148|580712041|FG004|Overall Study|Adverse Event|7|||
160816576|NCT01864148|580712037|FG000|Overall Study|Not Dosed|0|||
160816577|NCT01864148|580712038|FG001|Overall Study|Not Dosed|0|||
160816578|NCT01864148|580712039|FG002|Overall Study|Not Dosed|0|||
160816579|NCT01864148|580712040|FG003|Overall Study|Not Dosed|1|||
160816580|NCT01864148|580712041|FG004|Overall Study|Not Dosed|0|||
160816581|NCT01421303|580712044|FG000|Overall Study|Lost to Follow-up|13|||
160816582|NCT01421303|580712044|FG000|Overall Study|Non compliance with study procedure|1|||
160816583|NCT01421303|580712044|FG000|Overall Study|Other|7|||
160816584|NCT01421303|580712044|FG000|Overall Study|Withdrawal by Subject|1|||
160816585|NCT05319600|580712045|FG000|Overall Study|Withdrawal by Subject|1|||
160816586|NCT05319600|580712046|FG001|Overall Study|Withdrawal by Subject|0|||
160816587|NCT05319600|580712045|FG000|Overall Study|Lost to Follow-up|0|||
160816588|NCT05319600|580712046|FG001|Overall Study|Lost to Follow-up|4|||
160816589|NCT00690430|580712047|FG000|Core Phase|Abnormal Laboratory value|0|||
160816590|NCT00690430|580712048|FG001|Core Phase|Abnormal Laboratory value|1|||
160816591|NCT00690430|580712049|FG002|Core Phase|Abnormal Laboratory value|0|||
160816592|NCT00690430|580712047|FG000|Core Phase|Adverse Event|5|||
160816593|NCT00690430|580712048|FG001|Core Phase|Adverse Event|1|||
160816594|NCT00690430|580712049|FG002|Core Phase|Adverse Event|0|||
160816595|NCT00690430|580712047|FG000|Core Phase|Death|0|||
160816596|NCT00690430|580712048|FG001|Core Phase|Death|2|||
160816597|NCT00690430|580712049|FG002|Core Phase|Death|0|||
160816598|NCT00690430|580712047|FG000|Core Phase|Protocol Violation|1|||
160816599|NCT00690430|580712048|FG001|Core Phase|Protocol Violation|0|||
160987490|NCT04955626|581341126|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816600|NCT00690430|580712049|FG002|Core Phase|Protocol Violation|0|||
160816601|NCT00690430|580712047|FG000|Core Phase|Withdrawal by Subject|3|||
160816602|NCT00690430|580712048|FG001|Core Phase|Withdrawal by Subject|3|||
160816603|NCT00690430|580712049|FG002|Core Phase|Withdrawal by Subject|0|||
160816604|NCT00690430|580712047|FG000|Core Phase|Subject no longer requires study drug|1|||
160816605|NCT00690430|580712048|FG001|Core Phase|Subject no longer requires study drug|0|||
160816606|NCT00690430|580712049|FG002|Core Phase|Subject no longer requires study drug|0|||
160816607|NCT00690430|580712047|FG000|Core Phase|Lack of Efficacy|8|||
160816608|NCT00690430|580712048|FG001|Core Phase|Lack of Efficacy|10|||
160987491|NCT04955626|581341127|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987492|NCT04955626|581341128|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987493|NCT04955626|581341129|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987494|NCT04955626|581341130|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987495|NCT04955626|581341131|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987496|NCT04955626|581341132|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987497|NCT04955626|581341133|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987498|NCT04955626|581341134|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987499|NCT04955626|581341135|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987500|NCT04955626|581341136|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987501|NCT04955626|581341137|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987502|NCT04955626|581341138|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987503|NCT04955626|581341139|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160987504|NCT04955626|581341140|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
160816609|NCT00690430|580712049|FG002|Core Phase|Lack of Efficacy|0|||
160816610|NCT00690430|580712047|FG000|Core Phase|Administrative Problems|0|||
160816611|NCT00690430|580712048|FG001|Core Phase|Administrative Problems|1|||
160816612|NCT00690430|580712049|FG002|Core Phase|Administrative Problems|0|||
160816613|NCT00690430|580712047|FG000|Core Phase|Early Termination|0|||
160987505|NCT04951479|581341143|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
160987506|NCT04209790|581341144|FG000|Overall Study|Physician Decision|1|||
160987507|NCT03706690|581341145|FG000|Overall Study|Withdrawal by Subject|8|||
160816614|NCT00690430|580712048|FG001|Core Phase|Early Termination|5|||
160816615|NCT00690430|580712049|FG002|Core Phase|Early Termination|0|||
160816616|NCT00690430|580712047|FG000|Extension Phase|Lack of Efficacy|3|||
160816617|NCT00690430|580712048|FG001|Extension Phase|Lack of Efficacy|1|||
160816618|NCT00690430|580712049|FG002|Extension Phase|Lack of Efficacy|4|||
160816619|NCT00690430|580712047|FG000|Extension Phase|Abnormal Lab Values|1|||
160816620|NCT00690430|580712048|FG001|Extension Phase|Abnormal Lab Values|0|||
160987508|NCT03706690|581341146|FG001|Overall Study|Withdrawal by Subject|8|||
160987509|NCT03706690|581341145|FG000|Overall Study|Death|143|||
160816621|NCT00690430|580712049|FG002|Extension Phase|Abnormal Lab Values|0|||
160816622|NCT00690430|580712047|FG000|Extension Phase|Abnormal test procedure results|1|||
160816623|NCT00690430|580712048|FG001|Extension Phase|Abnormal test procedure results|0|||
160816624|NCT00690430|580712049|FG002|Extension Phase|Abnormal test procedure results|0|||
160816625|NCT00690430|580712047|FG000|Extension Phase|Administrative Problems|0|||
160816626|NCT00690430|580712048|FG001|Extension Phase|Administrative Problems|1|||
160816627|NCT00690430|580712049|FG002|Extension Phase|Administrative Problems|1|||
160816628|NCT00690430|580712047|FG000|Extension Phase|Adverse Event|2|||
160987510|NCT03706690|581341146|FG001|Overall Study|Death|75|||
160987511|NCT03706690|581341145|FG000|Overall Study|Ongoing at DCO|121|||
160987512|NCT03706690|581341146|FG001|Overall Study|Ongoing at DCO|52|||
160987513|NCT05617040|581341147|FG000|Overall Study|Adverse Event|0|||
160987514|NCT05617040|581341148|FG001|Overall Study|Adverse Event|1|||
160816629|NCT00690430|580712048|FG001|Extension Phase|Adverse Event|1|||
160816630|NCT00690430|580712049|FG002|Extension Phase|Adverse Event|2|||
160987515|NCT05617040|581341149|FG002|Overall Study|Adverse Event|0|||
160987516|NCT05617040|581341147|FG000|Overall Study|Death|0|||
160987517|NCT05617040|581341148|FG001|Overall Study|Death|0|||
160987518|NCT05617040|581341149|FG002|Overall Study|Death|1|||
160987519|NCT02711826|581341150|FG000|Overall Study|Physician Decision|0|||
160987520|NCT02711826|581341151|FG001|Overall Study|Physician Decision|0|||
160987521|NCT02711826|581341152|FG002|Overall Study|Physician Decision|0|||
160987522|NCT02711826|581341153|FG003|Overall Study|Physician Decision|1|||
161333684|NCT04233879|582610577|FG000|Overall Study|Other|281|||
161333685|NCT04233879|582610578|FG001|Overall Study|Other|279|||
160816631|NCT00690430|580712047|FG000|Extension Phase|Death|1|||
160816632|NCT00690430|580712048|FG001|Extension Phase|Death|1|||
160816633|NCT00690430|580712049|FG002|Extension Phase|Death|1|||
160816634|NCT00690430|580712047|FG000|Extension Phase|Withdrawal by Subject|0|||
160816635|NCT00690430|580712048|FG001|Extension Phase|Withdrawal by Subject|0|||
160816636|NCT00690430|580712049|FG002|Extension Phase|Withdrawal by Subject|2|||
160816637|NCT00690430|580712047|FG000|Extension Phase|Early Termination|10|||
160816638|NCT00690430|580712048|FG001|Extension Phase|Early Termination|1|||
160816639|NCT00690430|580712049|FG002|Extension Phase|Early Termination|3|||
160816640|NCT02120300|580712054|FG000|Overall Study|Enrolled but Never Treated|2|||
160816641|NCT02120300|580712055|FG001|Overall Study|Enrolled but Never Treated|0|||
160816642|NCT02120300|580712056|FG002|Overall Study|Enrolled but Never Treated|0|||
160816643|NCT02120300|580712057|FG003|Overall Study|Enrolled but Never Treated|0|||
160816644|NCT02120300|580712054|FG000|Overall Study|Lack of Efficacy|0|||
160816645|NCT02120300|580712055|FG001|Overall Study|Lack of Efficacy|0|||
160816646|NCT02120300|580712056|FG002|Overall Study|Lack of Efficacy|0|||
160816647|NCT02120300|580712057|FG003|Overall Study|Lack of Efficacy|1|||
160816648|NCT02120300|580712054|FG000|Overall Study|Lost to Follow-up|1|||
160816649|NCT02120300|580712055|FG001|Overall Study|Lost to Follow-up|0|||
160816650|NCT02120300|580712056|FG002|Overall Study|Lost to Follow-up|0|||
160816651|NCT02120300|580712057|FG003|Overall Study|Lost to Follow-up|0|||
160816652|NCT01721486|580712066|FG000|Overall Study|Protocol Violation|1|||
160816653|NCT01721486|580712067|FG001|Overall Study|Protocol Violation|0|||
160816654|NCT01721486|580712066|FG000|Overall Study|Physician Decision|0|||
160816655|NCT01721486|580712067|FG001|Overall Study|Physician Decision|1|||
161333686|NCT01802385|582610582|FG000|Overall Study|Death|106|||
161333687|NCT01802385|582610583|FG001|Overall Study|Death|120|||
161333688|NCT03810183|582610584|FG000|Overall Study|Study terminated by Sponsor|2|||
160816656|NCT00582712|580712068|FG000|Overall Study|Adverse Event|1|||
160816657|NCT00582712|580712068|FG000|Overall Study|Lack of Efficacy|1|||
160816658|NCT00582712|580712068|FG000|Overall Study|Withdrawal by Subject|1|||
161333689|NCT03810183|582610585|FG001|Overall Study|Study terminated by Sponsor|1|||
161333690|NCT00323063|582610587|FG000|Overall Study|Adverse Event|1|||
160816659|NCT00582712|580712068|FG000|Overall Study|Complicating disease requiring treatment|1|||
160816660|NCT02676895|580712072|FG000|Overall Study|Administrative reason|1|||
160816661|NCT02676895|580712073|FG001|Overall Study|Administrative reason|0|||
160816662|NCT02676895|580712074|FG002|Overall Study|Administrative reason|0|||
160816663|NCT02676895|580712072|FG000|Overall Study|Protocol Violation|1|||
160816664|NCT02676895|580712073|FG001|Overall Study|Protocol Violation|0|||
160816665|NCT02676895|580712074|FG002|Overall Study|Protocol Violation|0|||
160816666|NCT02676895|580712072|FG000|Overall Study|Adverse Event|0|||
160816667|NCT02676895|580712073|FG001|Overall Study|Adverse Event|3|||
160987523|NCT02711826|581341154|FG004|Overall Study|Physician Decision|0|||
160816668|NCT02676895|580712074|FG002|Overall Study|Adverse Event|1|||
160987524|NCT02711826|581341150|FG000|Overall Study|Withdrawal by Subject|0|||
160987525|NCT02711826|581341151|FG001|Overall Study|Withdrawal by Subject|1|||
160987526|NCT02711826|581341152|FG002|Overall Study|Withdrawal by Subject|0|||
160816669|NCT02676895|580712072|FG000|Overall Study|Lost to Follow-up|0|||
160816670|NCT02676895|580712073|FG001|Overall Study|Lost to Follow-up|0|||
160816671|NCT02676895|580712074|FG002|Overall Study|Lost to Follow-up|1|||
160816672|NCT02676895|580712072|FG000|Overall Study|Withdrawal by Subject|0|||
160816673|NCT02676895|580712073|FG001|Overall Study|Withdrawal by Subject|0|||
160816674|NCT02676895|580712074|FG002|Overall Study|Withdrawal by Subject|1|||
160816675|NCT01270880|580712075|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
160816676|NCT00344318|580712076|FG000|Overall Study|Adverse Event|0|||
160816677|NCT00344318|580712077|FG001|Overall Study|Adverse Event|3|||
160816678|NCT00344318|580712078|FG002|Overall Study|Adverse Event|0|||
160816679|NCT00344318|580712079|FG003|Overall Study|Adverse Event|1|||
160816680|NCT00344318|580712076|FG000|Overall Study|Withdrawal by Subject|2|||
160987527|NCT02711826|581341153|FG003|Overall Study|Withdrawal by Subject|4|||
160987528|NCT02711826|581341154|FG004|Overall Study|Withdrawal by Subject|0|||
161132369|NCT00432237|581868942|FG001|Overall Study|Pregnancy|1|||
161333691|NCT00323063|582610588|FG001|Overall Study|Adverse Event|0|||
160816681|NCT00344318|580712077|FG001|Overall Study|Withdrawal by Subject|2|||
160987529|NCT02711826|581341150|FG000|Overall Study|Failure to manufacture cellular product|0|||
160816682|NCT00344318|580712078|FG002|Overall Study|Withdrawal by Subject|0|||
160816683|NCT00344318|580712079|FG003|Overall Study|Withdrawal by Subject|2|||
160816684|NCT00344318|580712076|FG000|Overall Study|Lost to Follow-up|2|||
160816685|NCT00344318|580712077|FG001|Overall Study|Lost to Follow-up|0|||
160816686|NCT00344318|580712078|FG002|Overall Study|Lost to Follow-up|1|||
160816687|NCT00344318|580712079|FG003|Overall Study|Lost to Follow-up|0|||
160816688|NCT00182078|580712080|FG000|Overall Study|Withdrawal by Subject|1|||
160816689|NCT00182078|580712081|FG001|Overall Study|Withdrawal by Subject|0|||
160816690|NCT01076205|580712082|FG000|Overall Study|Adverse Drug Reaction|299|||
160816691|NCT01076205|580712082|FG000|Overall Study|Lack of Effectiveness|1423|||
160816692|NCT01076205|580712082|FG000|Overall Study|Other Reason|1075|||
160816693|NCT01076205|580712082|FG000|Overall Study|Unknown Reason|71|||
160816694|NCT01076205|580712082|FG000|Overall Study|Lost to Follow-up|3151|||
160816695|NCT00361231|580712083|FG000|Overall Study|Physician Decision|3|||
160816696|NCT00361231|580712083|FG000|Overall Study|Symptomatic deterioration|5|||
160816697|NCT00361231|580712083|FG000|Overall Study|Radiographic disease progression|16|||
160816698|NCT00361231|580712083|FG000|Overall Study|Withdrawal by Subject|4|||
160816699|NCT00361231|580712083|FG000|Overall Study|Adverse Event|6|||
160816700|NCT01732510|580712084|FG000|Overall Study|Adverse Event|0|||
160816701|NCT01732510|580712085|FG001|Overall Study|Adverse Event|1|||
160816702|NCT01732510|580712086|FG002|Overall Study|Adverse Event|1|||
160816703|NCT01732510|580712087|FG003|Overall Study|Adverse Event|0|||
160816704|NCT01732510|580712088|FG004|Overall Study|Adverse Event|0|||
160816705|NCT01732510|580712089|FG005|Overall Study|Adverse Event|0|||
160987530|NCT02711826|581341151|FG001|Overall Study|Failure to manufacture cellular product|0|||
160987531|NCT02711826|581341152|FG002|Overall Study|Failure to manufacture cellular product|5|||
160987532|NCT02711826|581341153|FG003|Overall Study|Failure to manufacture cellular product|0|||
160816706|NCT01732510|580712090|FG006|Overall Study|Adverse Event|1|||
160816707|NCT01732510|580712084|FG000|Overall Study|Protocol Violation|0|||
160816708|NCT01732510|580712085|FG001|Overall Study|Protocol Violation|0|||
160816709|NCT01732510|580712086|FG002|Overall Study|Protocol Violation|0|||
160816710|NCT01732510|580712087|FG003|Overall Study|Protocol Violation|1|||
160816711|NCT01732510|580712088|FG004|Overall Study|Protocol Violation|0|||
160816712|NCT01732510|580712089|FG005|Overall Study|Protocol Violation|0|||
160816713|NCT01732510|580712090|FG006|Overall Study|Protocol Violation|0|||
160816714|NCT01732510|580712084|FG000|Overall Study|Withdrawal by Subject|1|||
160816715|NCT01732510|580712085|FG001|Overall Study|Withdrawal by Subject|3|||
160816716|NCT01732510|580712086|FG002|Overall Study|Withdrawal by Subject|2|||
160816717|NCT01732510|580712087|FG003|Overall Study|Withdrawal by Subject|1|||
160816718|NCT01732510|580712088|FG004|Overall Study|Withdrawal by Subject|5|||
160816719|NCT01732510|580712089|FG005|Overall Study|Withdrawal by Subject|0|||
160816720|NCT01732510|580712090|FG006|Overall Study|Withdrawal by Subject|1|||
160816721|NCT01732510|580712084|FG000|Overall Study|Lost to Follow-up|0|||
160816722|NCT01732510|580712085|FG001|Overall Study|Lost to Follow-up|0|||
160816723|NCT01732510|580712086|FG002|Overall Study|Lost to Follow-up|1|||
160816724|NCT01732510|580712087|FG003|Overall Study|Lost to Follow-up|1|||
160816725|NCT01732510|580712088|FG004|Overall Study|Lost to Follow-up|0|||
160816726|NCT01732510|580712089|FG005|Overall Study|Lost to Follow-up|1|||
160816727|NCT01732510|580712090|FG006|Overall Study|Lost to Follow-up|0|||
160816728|NCT01732510|580712084|FG000|Overall Study|Physician Decision|0|||
160816729|NCT01732510|580712085|FG001|Overall Study|Physician Decision|1|||
160816730|NCT01732510|580712086|FG002|Overall Study|Physician Decision|0|||
160816731|NCT01732510|580712087|FG003|Overall Study|Physician Decision|0|||
160816732|NCT01732510|580712088|FG004|Overall Study|Physician Decision|0|||
160987533|NCT02711826|581341154|FG004|Overall Study|Failure to manufacture cellular product|0|||
160816733|NCT01732510|580712089|FG005|Overall Study|Physician Decision|0|||
160816734|NCT01732510|580712090|FG006|Overall Study|Physician Decision|0|||
160816735|NCT01732510|580712084|FG000|Overall Study|Pregnancy|0|||
160816736|NCT01732510|580712085|FG001|Overall Study|Pregnancy|0|||
160816737|NCT01732510|580712086|FG002|Overall Study|Pregnancy|0|||
160816738|NCT01732510|580712087|FG003|Overall Study|Pregnancy|1|||
160816739|NCT01732510|580712088|FG004|Overall Study|Pregnancy|0|||
160816740|NCT01732510|580712089|FG005|Overall Study|Pregnancy|0|||
160987534|NCT02711826|581341150|FG000|Overall Study|Infusion canceled for active infection|0|||
160987535|NCT02711826|581341151|FG001|Overall Study|Infusion canceled for active infection|1|||
160816741|NCT01732510|580712090|FG006|Overall Study|Pregnancy|0|||
160816742|NCT01732510|580712084|FG000|Overall Study|Study Terminated By Sponsor|0|||
160816743|NCT01732510|580712085|FG001|Overall Study|Study Terminated By Sponsor|0|||
160816744|NCT01732510|580712086|FG002|Overall Study|Study Terminated By Sponsor|0|||
160816745|NCT01732510|580712087|FG003|Overall Study|Study Terminated By Sponsor|1|||
160816746|NCT01732510|580712088|FG004|Overall Study|Study Terminated By Sponsor|0|||
160816747|NCT01732510|580712089|FG005|Overall Study|Study Terminated By Sponsor|12|||
160816748|NCT01732510|580712090|FG006|Overall Study|Study Terminated By Sponsor|6|||
160816749|NCT03403361|580712091|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
160816750|NCT02487654|580712093|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
160816751|NCT02487654|580712094|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
160816752|NCT02487654|580712093|FG000|Overall Study|Withdrawal by Subject|3|||
160816753|NCT02487654|580712094|FG001|Overall Study|Withdrawal by Subject|7|||
160816754|NCT02443116|580712097|FG000|Part 1|Adverse Event|2|||
160816755|NCT02443116|580712098|FG001|Part 1|Adverse Event|3|||
160816756|NCT02443116|580712099|FG002|Part 1|Adverse Event|0|||
160816757|NCT02443116|580712100|FG003|Part 1|Adverse Event|0|||
160816758|NCT02443116|580712101|FG004|Part 1|Adverse Event|0|||
160816759|NCT02443116|580712102|FG005|Part 1|Adverse Event|0|||
160816760|NCT02443116|580712103|FG006|Part 1|Adverse Event|0|||
160816761|NCT02443116|580712104|FG007|Part 1|Adverse Event|0|||
160816762|NCT02443116|580712105|FG008|Part 1|Adverse Event|0|||
160816763|NCT02443116|580712097|FG000|Part 1|Withdrew informed consent|0|||
160816764|NCT02443116|580712098|FG001|Part 1|Withdrew informed consent|1|||
160816765|NCT02443116|580712099|FG002|Part 1|Withdrew informed consent|0|||
160816766|NCT02443116|580712100|FG003|Part 1|Withdrew informed consent|0|||
160816767|NCT02443116|580712101|FG004|Part 1|Withdrew informed consent|0|||
160816768|NCT02443116|580712102|FG005|Part 1|Withdrew informed consent|0|||
160816769|NCT02443116|580712103|FG006|Part 1|Withdrew informed consent|0|||
160816770|NCT02443116|580712104|FG007|Part 1|Withdrew informed consent|0|||
160816771|NCT02443116|580712105|FG008|Part 1|Withdrew informed consent|0|||
160816772|NCT02443116|580712097|FG000|Part 1|Lost to Follow-up|0|||
160816773|NCT02443116|580712098|FG001|Part 1|Lost to Follow-up|0|||
160816774|NCT02443116|580712099|FG002|Part 1|Lost to Follow-up|2|||
160816775|NCT02443116|580712100|FG003|Part 1|Lost to Follow-up|0|||
160816776|NCT02443116|580712101|FG004|Part 1|Lost to Follow-up|0|||
160816777|NCT02443116|580712102|FG005|Part 1|Lost to Follow-up|0|||
160816778|NCT02443116|580712103|FG006|Part 1|Lost to Follow-up|0|||
160816779|NCT02443116|580712104|FG007|Part 1|Lost to Follow-up|0|||
160816780|NCT02443116|580712105|FG008|Part 1|Lost to Follow-up|0|||
160816781|NCT02443116|580712097|FG000|Part 1|Participant moved out of state|0|||
160816782|NCT02443116|580712098|FG001|Part 1|Participant moved out of state|0|||
160816783|NCT02443116|580712099|FG002|Part 1|Participant moved out of state|1|||
160816784|NCT02443116|580712100|FG003|Part 1|Participant moved out of state|0|||
160816785|NCT02443116|580712101|FG004|Part 1|Participant moved out of state|0|||
160816786|NCT02443116|580712102|FG005|Part 1|Participant moved out of state|0|||
160816787|NCT02443116|580712103|FG006|Part 1|Participant moved out of state|0|||
160816788|NCT02443116|580712104|FG007|Part 1|Participant moved out of state|0|||
160816789|NCT02443116|580712105|FG008|Part 1|Participant moved out of state|0|||
160816790|NCT02443116|580712097|FG000|Part 1|Participant enrolled in another clinical trial|0|||
160816791|NCT02443116|580712098|FG001|Part 1|Participant enrolled in another clinical trial|0|||
160816792|NCT02443116|580712099|FG002|Part 1|Participant enrolled in another clinical trial|1|||
160816793|NCT02443116|580712100|FG003|Part 1|Participant enrolled in another clinical trial|0|||
160816794|NCT02443116|580712101|FG004|Part 1|Participant enrolled in another clinical trial|0|||
160816795|NCT02443116|580712102|FG005|Part 1|Participant enrolled in another clinical trial|0|||
160816796|NCT02443116|580712103|FG006|Part 1|Participant enrolled in another clinical trial|0|||
160816797|NCT02443116|580712104|FG007|Part 1|Participant enrolled in another clinical trial|0|||
160816798|NCT02443116|580712105|FG008|Part 1|Participant enrolled in another clinical trial|0|||
160816799|NCT02443116|580712097|FG000|Part 2|Adverse Event|0|||
160816800|NCT02443116|580712098|FG001|Part 2|Adverse Event|0|||
160816801|NCT02443116|580712099|FG002|Part 2|Adverse Event|0|||
160816802|NCT02443116|580712100|FG003|Part 2|Adverse Event|0|||
160816803|NCT02443116|580712101|FG004|Part 2|Adverse Event|1|||
160816804|NCT02443116|580712102|FG005|Part 2|Adverse Event|1|||
160816805|NCT02443116|580712103|FG006|Part 2|Adverse Event|2|||
160816806|NCT02443116|580712104|FG007|Part 2|Adverse Event|0|||
160816807|NCT02443116|580712105|FG008|Part 2|Adverse Event|0|||
160816808|NCT02443116|580712097|FG000|Part 2|Withdrew informed consent|0|||
160816809|NCT02443116|580712098|FG001|Part 2|Withdrew informed consent|0|||
160816810|NCT02443116|580712099|FG002|Part 2|Withdrew informed consent|0|||
160816811|NCT02443116|580712100|FG003|Part 2|Withdrew informed consent|0|||
160816812|NCT02443116|580712101|FG004|Part 2|Withdrew informed consent|0|||
160816813|NCT02443116|580712102|FG005|Part 2|Withdrew informed consent|1|||
160816814|NCT02443116|580712103|FG006|Part 2|Withdrew informed consent|1|||
161132370|NCT00432237|581868943|FG002|Overall Study|Pregnancy|0|||
161132371|NCT00432237|581868944|FG003|Overall Study|Pregnancy|0|||
161132372|NCT00432237|581868941|FG000|Overall Study|Protocol Violation|13|||
161132373|NCT00432237|581868942|FG001|Overall Study|Protocol Violation|10|||
161132374|NCT00432237|581868943|FG002|Overall Study|Protocol Violation|11|||
161132375|NCT00432237|581868944|FG003|Overall Study|Protocol Violation|8|||
161132376|NCT00432237|581868941|FG000|Overall Study|Withdrawal by Subject|5|||
160816815|NCT02443116|580712104|FG007|Part 2|Withdrew informed consent|0|||
160816816|NCT02443116|580712105|FG008|Part 2|Withdrew informed consent|0|||
160816817|NCT02443116|580712097|FG000|Part 2|Inability to comply with protocol|0|||
160816818|NCT02443116|580712098|FG001|Part 2|Inability to comply with protocol|0|||
160816819|NCT02443116|580712099|FG002|Part 2|Inability to comply with protocol|0|||
160816820|NCT02443116|580712100|FG003|Part 2|Inability to comply with protocol|1|||
160816821|NCT02443116|580712101|FG004|Part 2|Inability to comply with protocol|0|||
161132377|NCT00432237|581868942|FG001|Overall Study|Withdrawal by Subject|6|||
160816822|NCT02443116|580712102|FG005|Part 2|Inability to comply with protocol|0|||
160816823|NCT02443116|580712103|FG006|Part 2|Inability to comply with protocol|0|||
160816824|NCT02443116|580712104|FG007|Part 2|Inability to comply with protocol|0|||
160816825|NCT02443116|580712105|FG008|Part 2|Inability to comply with protocol|0|||
160816826|NCT02443116|580712097|FG000|Part 2|Lost to Follow-up|0|||
160816827|NCT02443116|580712098|FG001|Part 2|Lost to Follow-up|0|||
160816828|NCT02443116|580712099|FG002|Part 2|Lost to Follow-up|0|||
160816829|NCT02443116|580712100|FG003|Part 2|Lost to Follow-up|1|||
160816830|NCT02443116|580712101|FG004|Part 2|Lost to Follow-up|0|||
160816831|NCT02443116|580712102|FG005|Part 2|Lost to Follow-up|0|||
160816832|NCT02443116|580712103|FG006|Part 2|Lost to Follow-up|0|||
160816833|NCT02443116|580712104|FG007|Part 2|Lost to Follow-up|0|||
160816834|NCT02443116|580712105|FG008|Part 2|Lost to Follow-up|0|||
160816835|NCT02443116|580712097|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816836|NCT02443116|580712098|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816837|NCT02443116|580712099|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816838|NCT02443116|580712100|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816839|NCT02443116|580712101|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816840|NCT02443116|580712102|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
160816841|NCT02443116|580712103|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816842|NCT02443116|580712104|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816843|NCT02443116|580712105|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
160816844|NCT02443116|580712097|FG000|Part 3|Adverse Event|0|||
160816845|NCT02443116|580712098|FG001|Part 3|Adverse Event|0|||
160816846|NCT02443116|580712099|FG002|Part 3|Adverse Event|0|||
160816847|NCT02443116|580712100|FG003|Part 3|Adverse Event|0|||
160816848|NCT02443116|580712101|FG004|Part 3|Adverse Event|0|||
160816849|NCT02443116|580712102|FG005|Part 3|Adverse Event|0|||
160816850|NCT02443116|580712103|FG006|Part 3|Adverse Event|0|||
160816851|NCT02443116|580712104|FG007|Part 3|Adverse Event|0|||
160816852|NCT02443116|580712105|FG008|Part 3|Adverse Event|1|||
160816853|NCT02443116|580712097|FG000|Part 3|Withdrew informed consent|0|||
160816854|NCT02443116|580712098|FG001|Part 3|Withdrew informed consent|0|||
160816855|NCT02443116|580712099|FG002|Part 3|Withdrew informed consent|0|||
160816856|NCT02443116|580712100|FG003|Part 3|Withdrew informed consent|0|||
160816857|NCT02443116|580712101|FG004|Part 3|Withdrew informed consent|0|||
160816858|NCT02443116|580712102|FG005|Part 3|Withdrew informed consent|0|||
161132378|NCT00432237|581868943|FG002|Overall Study|Withdrawal by Subject|9|||
161132379|NCT00432237|581868944|FG003|Overall Study|Withdrawal by Subject|11|||
160816859|NCT02443116|580712103|FG006|Part 3|Withdrew informed consent|0|||
160816860|NCT02443116|580712104|FG007|Part 3|Withdrew informed consent|3|||
160816861|NCT02443116|580712105|FG008|Part 3|Withdrew informed consent|2|||
160816862|NCT02443116|580712097|FG000|Part 3|Lost to Follow-up|0|||
160816863|NCT02443116|580712098|FG001|Part 3|Lost to Follow-up|0|||
161132380|NCT00432237|581868941|FG000|Overall Study|Lack of Qualifying Event|38|||
161132381|NCT00432237|581868942|FG001|Overall Study|Lack of Qualifying Event|71|||
161132382|NCT00432237|581868943|FG002|Overall Study|Lack of Qualifying Event|69|||
161132383|NCT00432237|581868944|FG003|Overall Study|Lack of Qualifying Event|84|||
161132384|NCT01354132|581868945|FG000|Randomization|Physician Decision|1|||
161132385|NCT01354132|581868946|FG001|Randomization|Physician Decision|0|||
161132386|NCT01354132|581868945|FG000|Randomization|Withdrawal by Subject|0|||
161132387|NCT01354132|581868946|FG001|Randomization|Withdrawal by Subject|1|||
161132388|NCT01354132|581868945|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
161132389|NCT01354132|581868946|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
161132390|NCT01354132|581868945|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
161132391|NCT01354132|581868946|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
161132392|NCT01354132|581868945|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
161132393|NCT01354132|581868946|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
161132394|NCT00191854|581868949|FG000|Overall Study|Death|26|||
161132395|NCT00191854|581868950|FG001|Overall Study|Death|23|||
161132396|NCT00191854|581868951|FG002|Overall Study|Death|29|||
161132397|NCT00191854|581868949|FG000|Overall Study|Lost to Follow-up|7|||
161132398|NCT00191854|581868950|FG001|Overall Study|Lost to Follow-up|5|||
161132399|NCT00191854|581868951|FG002|Overall Study|Lost to Follow-up|5|||
161132400|NCT00191854|581868949|FG000|Overall Study|Withdrawal by Subject|4|||
160816864|NCT02443116|580712099|FG002|Part 3|Lost to Follow-up|0|||
160816865|NCT02443116|580712100|FG003|Part 3|Lost to Follow-up|0|||
161132401|NCT00191854|581868950|FG001|Overall Study|Withdrawal by Subject|2|||
161132402|NCT00191854|581868951|FG002|Overall Study|Withdrawal by Subject|3|||
161132403|NCT00191854|581868949|FG000|Overall Study|Sponsor Decision|0|||
161132404|NCT00191854|581868950|FG001|Overall Study|Sponsor Decision|0|||
161132405|NCT00191854|581868951|FG002|Overall Study|Sponsor Decision|1|||
161132406|NCT00191854|581868949|FG000|Overall Study|Screen Failure|0|||
160816866|NCT02443116|580712101|FG004|Part 3|Lost to Follow-up|0|||
161132407|NCT00191854|581868950|FG001|Overall Study|Screen Failure|0|||
160816867|NCT02443116|580712102|FG005|Part 3|Lost to Follow-up|0|||
160816868|NCT02443116|580712103|FG006|Part 3|Lost to Follow-up|0|||
160816869|NCT02443116|580712104|FG007|Part 3|Lost to Follow-up|1|||
160816870|NCT02443116|580712105|FG008|Part 3|Lost to Follow-up|2|||
160816871|NCT00349349|580712113|FG000|Overall Study|Adverse Event|5|||
160816872|NCT00349349|580712114|FG001|Overall Study|Adverse Event|6|||
160816873|NCT00349349|580712115|FG002|Overall Study|Adverse Event|2|||
160816874|NCT00349349|580712113|FG000|Overall Study|Withdrawal by Subject|5|||
160816875|NCT00349349|580712114|FG001|Overall Study|Withdrawal by Subject|2|||
160816876|NCT00349349|580712115|FG002|Overall Study|Withdrawal by Subject|1|||
160816877|NCT00349349|580712113|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
160816878|NCT00349349|580712114|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
160816879|NCT00349349|580712115|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
160816880|NCT00349349|580712113|FG000|Overall Study|Death|13|||
160816881|NCT00349349|580712114|FG001|Overall Study|Death|10|||
160816882|NCT00349349|580712115|FG002|Overall Study|Death|1|||
160816883|NCT00349349|580712113|FG000|Overall Study|Other Treatment Selected|2|||
160816884|NCT00349349|580712114|FG001|Overall Study|Other Treatment Selected|0|||
160816885|NCT00349349|580712115|FG002|Overall Study|Other Treatment Selected|0|||
160816886|NCT00349349|580712113|FG000|Overall Study|Participant Reduced General Condition|0|||
160816887|NCT00349349|580712114|FG001|Overall Study|Participant Reduced General Condition|1|||
160816888|NCT00349349|580712115|FG002|Overall Study|Participant Reduced General Condition|0|||
160816889|NCT00349349|580712113|FG000|Overall Study|Physician Decision|1|||
160816890|NCT00349349|580712114|FG001|Overall Study|Physician Decision|2|||
160816891|NCT00349349|580712115|FG002|Overall Study|Physician Decision|1|||
160816892|NCT00349349|580712113|FG000|Overall Study|No Response|0|||
160816893|NCT00349349|580712114|FG001|Overall Study|No Response|3|||
160816894|NCT00349349|580712115|FG002|Overall Study|No Response|0|||
160816895|NCT00349349|580712113|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
160816896|NCT00349349|580712114|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
160816897|NCT00349349|580712115|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
160816898|NCT03763656|580712116|FG000|Overall Study|Physician Decision|1|||
160816899|NCT03763656|580712116|FG000|Overall Study|Protocol Violation|1|||
160816900|NCT03763656|580712116|FG000|Overall Study|Withdrawal by Subject|7|||
160816901|NCT03479541|580712117|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
160816902|NCT03479541|580712118|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
160816903|NCT03479541|580712119|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
160816904|NCT03479541|580712120|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
160816905|NCT03479541|580712117|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
160816906|NCT03479541|580712118|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
160816907|NCT03479541|580712119|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
160816908|NCT03479541|580712120|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
160816909|NCT03479541|580712117|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
160816910|NCT03479541|580712118|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
160816911|NCT03479541|580712119|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
160816912|NCT03479541|580712120|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
160816913|NCT03479541|580712117|FG000|Home Monitoring|Lost to Follow-up|0|||
160816914|NCT03479541|580712118|FG001|Home Monitoring|Lost to Follow-up|0|||
160987536|NCT02711826|581341152|FG002|Overall Study|Infusion canceled for active infection|0|||
160816915|NCT03479541|580712119|FG002|Home Monitoring|Lost to Follow-up|8|||
160816916|NCT03479541|580712120|FG003|Home Monitoring|Lost to Follow-up|12|||
160816917|NCT03479541|580712117|FG000|Home Monitoring|Withdrawal by Subject|0|||
160816918|NCT03479541|580712118|FG001|Home Monitoring|Withdrawal by Subject|0|||
160816919|NCT03479541|580712119|FG002|Home Monitoring|Withdrawal by Subject|17|||
160816920|NCT03479541|580712120|FG003|Home Monitoring|Withdrawal by Subject|30|||
160816921|NCT03479541|580712117|FG000|Home Monitoring|Early Termination - PI Decision|0|||
160816922|NCT03479541|580712118|FG001|Home Monitoring|Early Termination - PI Decision|0|||
160816923|NCT03479541|580712119|FG002|Home Monitoring|Early Termination - PI Decision|4|||
160816924|NCT03479541|580712120|FG003|Home Monitoring|Early Termination - PI Decision|6|||
160987537|NCT02711826|581341153|FG003|Overall Study|Infusion canceled for active infection|0|||
160987538|NCT02711826|581341154|FG004|Overall Study|Infusion canceled for active infection|0|||
160987539|NCT02711826|581341150|FG000|Overall Study|Screen failures|0|||
160987540|NCT02711826|581341151|FG001|Overall Study|Screen failures|0|||
160987541|NCT02711826|581341152|FG002|Overall Study|Screen failures|0|||
160987542|NCT02711826|581341153|FG003|Overall Study|Screen failures|4|||
160816925|NCT03110029|580712124|FG000|Overall Study|Withdrawal by Subject|1|||
160816926|NCT03110029|580712125|FG001|Overall Study|Withdrawal by Subject|1|||
160816927|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
160816928|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
160816929|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
160816930|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
160987543|NCT02711826|581341154|FG004|Overall Study|Screen failures|0|||
160816931|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
160816932|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
160816933|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
160816934|NCT01673854|580712127|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
160816935|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
160816936|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
160816937|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
160816938|NCT01673854|580712127|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
160816939|NCT00334737|580712128|FG000|Hospital Phase|Death|1|||
160816940|NCT00334737|580712129|FG001|Hospital Phase|Death|2|||
160816941|NCT00334737|580712130|FG002|Hospital Phase|Death|3|||
160816942|NCT00334737|580712128|FG000|Hospital Phase|Withdrawal by Subject|0|||
160816943|NCT00334737|580712129|FG001|Hospital Phase|Withdrawal by Subject|0|||
160816944|NCT00334737|580712130|FG002|Hospital Phase|Withdrawal by Subject|1|||
160816945|NCT00334737|580712128|FG000|Hospital Phase|Did not receive study drug|1|||
160816946|NCT00334737|580712129|FG001|Hospital Phase|Did not receive study drug|0|||
160816947|NCT00334737|580712130|FG002|Hospital Phase|Did not receive study drug|0|||
160816948|NCT00334737|580712128|FG000|Follow up Phase|Lost to Follow-up|5|||
160816949|NCT00334737|580712129|FG001|Follow up Phase|Lost to Follow-up|3|||
160816950|NCT00334737|580712130|FG002|Follow up Phase|Lost to Follow-up|6|||
160816951|NCT02316353|580712131|FG000|Overall Study|Pregnancy|1|||
160816952|NCT02316353|580712132|FG001|Overall Study|Pregnancy|3|||
160816953|NCT02316353|580712131|FG000|Overall Study|Adverse Event|1|||
160816954|NCT02316353|580712132|FG001|Overall Study|Adverse Event|3|||
160816955|NCT02316353|580712131|FG000|Overall Study|Withdrawal by Subject|6|||
160816956|NCT02316353|580712132|FG001|Overall Study|Withdrawal by Subject|2|||
160816957|NCT01380535|580714956|FG000|Overall Study|Adverse Event|3|||
160816958|NCT01380535|580714957|FG001|Overall Study|Adverse Event|3|||
160816959|NCT01380535|580714956|FG000|Overall Study|Death|3|||
160816960|NCT01380535|580714957|FG001|Overall Study|Death|0|||
160816961|NCT01380535|580714956|FG000|Overall Study|Study site closed|0|||
160816962|NCT01380535|580714957|FG001|Overall Study|Study site closed|5|||
160816963|NCT01380535|580714956|FG000|Overall Study|Withdrawal by Subject|1|||
160816964|NCT01380535|580714957|FG001|Overall Study|Withdrawal by Subject|2|||
160816965|NCT01380535|580714956|FG000|Overall Study|Protocol Violation|0|||
160816966|NCT01380535|580714957|FG001|Overall Study|Protocol Violation|2|||
160816967|NCT01380535|580714956|FG000|Overall Study|Lack of Efficacy|0|||
160816968|NCT01380535|580714957|FG001|Overall Study|Lack of Efficacy|3|||
160816969|NCT01579565|580714958|FG000|Randomized|Adverse Event|1|||
160816970|NCT01579565|580714959|FG001|Randomized|Adverse Event|3|||
161132408|NCT00191854|581868951|FG002|Overall Study|Screen Failure|1|||
161132409|NCT03293654|581868953|FG000|Overall Study|Lost to Follow-up|0|||
161132410|NCT03293654|581868954|FG001|Overall Study|Lost to Follow-up|1|||
161132411|NCT03293654|581868955|FG002|Overall Study|Lost to Follow-up|0|||
161132412|NCT01933932|581868957|FG000|Overall Study|Death|173|||
161132413|NCT01933932|581868958|FG001|Overall Study|Death|163|||
161132414|NCT01933932|581868957|FG000|Overall Study|Withdrawal by Subject|11|||
161132415|NCT01933932|581868958|FG001|Overall Study|Withdrawal by Subject|14|||
161132416|NCT01933932|581868957|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161132417|NCT01933932|581868958|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161132418|NCT00763009|581868963|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
161132419|NCT02013544|581868964|FG000|Overall Study|Adverse Event|5|||
161132420|NCT02013544|581868965|FG001|Overall Study|Adverse Event|5|||
161132421|NCT02013544|581868964|FG000|Overall Study|Lost to Follow-up|2|||
161132422|NCT02013544|581868965|FG001|Overall Study|Lost to Follow-up|3|||
161132423|NCT02013544|581868964|FG000|Overall Study|Withdrawal by Subject|2|||
161132424|NCT02013544|581868965|FG001|Overall Study|Withdrawal by Subject|8|||
161132425|NCT02013544|581868964|FG000|Overall Study|Physician Decision|0|||
161132426|NCT02013544|581868965|FG001|Overall Study|Physician Decision|1|||
161132427|NCT02013544|581868964|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
161132428|NCT02013544|581868965|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
161132429|NCT01295125|581868966|FG000|Overall Study|Study stopped prematurely|9|||
161132430|NCT00891735|581868967|FG000|Overall Study|Adverse Event|2|||
161132431|NCT00891735|581868968|FG001|Overall Study|Adverse Event|0|||
161132432|NCT00891735|581868969|FG002|Overall Study|Adverse Event|2|||
161132433|NCT00891735|581868970|FG003|Overall Study|Adverse Event|0|||
161132434|NCT00891735|581868967|FG000|Overall Study|Death|8|||
161132435|NCT00891735|581868968|FG001|Overall Study|Death|5|||
161132436|NCT00891735|581868969|FG002|Overall Study|Death|4|||
161132437|NCT00891735|581868970|FG003|Overall Study|Death|5|||
161132438|NCT00891735|581868967|FG000|Overall Study|Lost to Follow-up|2|||
161132439|NCT00891735|581868968|FG001|Overall Study|Lost to Follow-up|2|||
160816971|NCT01579565|580714958|FG000|Randomized|Withdrawal by Subject|3|||
160816972|NCT01579565|580714959|FG001|Randomized|Withdrawal by Subject|0|||
160816973|NCT01579565|580714958|FG000|Randomized|inadequate preoperative pupil dilation|0|||
160816974|NCT01579565|580714959|FG001|Randomized|inadequate preoperative pupil dilation|1|||
160816975|NCT01579565|580714958|FG000|Randomized|prohibited preoperative eating|1|||
160816976|NCT01579565|580714959|FG001|Randomized|prohibited preoperative eating|0|||
160816977|NCT01579565|580714958|FG000|Randomized|prohibited preoperative medication|0|||
160816978|NCT01579565|580714959|FG001|Randomized|prohibited preoperative medication|1|||
160816979|NCT01579565|580714958|FG000|Treated|Physician Decision|0|||
160816980|NCT01579565|580714959|FG001|Treated|Physician Decision|1|||
160816981|NCT01579565|580714958|FG000|Treated|Lost to Follow-up|2|||
160816982|NCT01579565|580714959|FG001|Treated|Lost to Follow-up|1|||
160816983|NCT01579565|580714958|FG000|Treated|declined to return for final visit|0|||
160816984|NCT01579565|580714959|FG001|Treated|declined to return for final visit|1|||
160816985|NCT05425732|580714965|FG000|Overall Study|Death|4|||
160816986|NCT05425732|580714966|FG001|Overall Study|Death|2|||
160816987|NCT05425732|580714967|FG002|Overall Study|Death|0|||
160816988|NCT05425732|580714968|FG003|Overall Study|Death|0|||
160816989|NCT05425732|580714965|FG000|Overall Study|Lost to Follow-up|10|||
160816990|NCT05425732|580714966|FG001|Overall Study|Lost to Follow-up|15|||
160816991|NCT05425732|580714967|FG002|Overall Study|Lost to Follow-up|5|||
160816992|NCT05425732|580714968|FG003|Overall Study|Lost to Follow-up|3|||
160816993|NCT05425732|580714965|FG000|Overall Study|Physician Decision|0|||
160816994|NCT05425732|580714966|FG001|Overall Study|Physician Decision|2|||
160816995|NCT05425732|580714967|FG002|Overall Study|Physician Decision|0|||
160816996|NCT05425732|580714968|FG003|Overall Study|Physician Decision|0|||
160816997|NCT05425732|580714965|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160816998|NCT05425732|580714966|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
160816999|NCT05425732|580714967|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160817000|NCT05425732|580714968|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160817001|NCT05425732|580714965|FG000|Overall Study|Withdrawal by Subject|4|||
160817002|NCT05425732|580714966|FG001|Overall Study|Withdrawal by Subject|8|||
160817003|NCT05425732|580714967|FG002|Overall Study|Withdrawal by Subject|1|||
160817004|NCT05425732|580714968|FG003|Overall Study|Withdrawal by Subject|1|||
160817005|NCT05425732|580714965|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
160817006|NCT05425732|580714966|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
160817007|NCT05425732|580714967|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
160817008|NCT05425732|580714968|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
160817009|NCT02582814|580714969|FG000|Overall Study|Study-specific withdrawal criteria|1|||
160817010|NCT02582814|580714970|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160817011|NCT02582814|580714969|FG000|Overall Study|Withdrawal by Subject|4|||
160817012|NCT02582814|580714970|FG001|Overall Study|Withdrawal by Subject|3|||
160817013|NCT02582814|580714969|FG000|Overall Study|Adverse Event|4|||
160817014|NCT02582814|580714970|FG001|Overall Study|Adverse Event|4|||
160817015|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
160817016|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
160817017|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
160817018|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
160817019|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
160817020|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
160817021|NCT00306293|580714971|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
160817022|NCT00306293|580714972|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
160817023|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
160817024|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
160817025|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
160817026|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
160817027|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
160817028|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
160817029|NCT00306293|580714971|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
160817030|NCT00306293|580714972|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
160817031|NCT01089413|580714978|FG000|Overall Study|Lost to Follow-up|1|||
160817032|NCT01089413|580714978|FG000|Overall Study|Progressive Disease|93|||
160987544|NCT00729690|581341155|FG000|Overall Study|IT Catheter Malfunction|0|||
160987545|NCT00729690|581341156|FG001|Overall Study|IT Catheter Malfunction|2|||
160817033|NCT01089413|580714978|FG000|Overall Study|Participant Withdrew Consent|1|||
160817034|NCT01089413|580714978|FG000|Overall Study|Unacceptable Toxicity|12|||
160817035|NCT01089413|580714978|FG000|Overall Study|Death|10|||
160817036|NCT01089413|580714978|FG000|Overall Study|Metastasectomy|13|||
160817037|NCT01089413|580714978|FG000|Overall Study|Other|71|||
160987546|NCT00729690|581341157|FG002|Overall Study|IT Catheter Malfunction|2|||
160817038|NCT01610557|580714985|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160817039|NCT01610557|580714986|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
161132440|NCT00891735|581868969|FG002|Overall Study|Lost to Follow-up|2|||
160987547|NCT02169219|581341158|FG000|Overall Study|Lack of Efficacy|6|||
161132441|NCT00891735|581868970|FG003|Overall Study|Lost to Follow-up|2|||
161132442|NCT00891735|581868967|FG000|Overall Study|Physician's decision to withdraw patient|1|||
161333692|NCT00323063|582610587|FG000|Overall Study|brain mets discovered prior to treatment|1|||
160817040|NCT01610557|580714987|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160987548|NCT04482855|581341159|FG000|Overall Study|Lost to Follow-up|1|||
160817041|NCT01610557|580714988|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160817042|NCT01610557|580714989|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
160817043|NCT01610557|580714985|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817044|NCT01610557|580714986|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817045|NCT01610557|580714987|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817046|NCT01610557|580714988|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
160817047|NCT01610557|580714989|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
161132443|NCT00891735|581868968|FG001|Overall Study|Physician's decision to withdraw patient|0|||
161132444|NCT00891735|581868969|FG002|Overall Study|Physician's decision to withdraw patient|0|||
161132445|NCT00891735|581868970|FG003|Overall Study|Physician's decision to withdraw patient|0|||
161132446|NCT00891735|581868967|FG000|Overall Study|Patient's decision to withdraw|4|||
161132447|NCT00891735|581868968|FG001|Overall Study|Patient's decision to withdraw|9|||
161132448|NCT00891735|581868969|FG002|Overall Study|Patient's decision to withdraw|4|||
161132449|NCT00891735|581868970|FG003|Overall Study|Patient's decision to withdraw|8|||
161132450|NCT01355289|581868973|FG000|Core Study|Adverse Event, Non-Fatal|1|||
161132451|NCT01355289|581868974|FG001|Core Study|Adverse Event, Non-Fatal|0|||
161132452|NCT01355289|581868975|FG002|Core Study|Adverse Event, Non-Fatal|0|||
161132453|NCT01355289|581868976|FG003|Core Study|Adverse Event, Non-Fatal|0|||
161132454|NCT01355289|581868977|FG004|Core Study|Adverse Event, Non-Fatal|0|||
160817060|NCT02003638|580714996|FG000|Overall Study|Withdrawal by Subject|1|||
160817061|NCT02003638|580714997|FG001|Overall Study|Withdrawal by Subject|0|||
160817062|NCT04115748|580715003|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
160817063|NCT04115748|580715004|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
160817064|NCT04115748|580715005|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
160817065|NCT04115748|580715006|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
160817066|NCT04115748|580715007|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817067|NCT04115748|580715008|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817068|NCT04115748|580715009|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817069|NCT04115748|580715010|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817070|NCT04115748|580715011|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817071|NCT04115748|580715012|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
160817072|NCT04115748|580715003|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817073|NCT04115748|580715004|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817074|NCT04115748|580715005|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817075|NCT04115748|580715006|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
160817076|NCT04115748|580715007|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817077|NCT04115748|580715008|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817078|NCT04115748|580715009|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817079|NCT04115748|580715010|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817080|NCT04115748|580715011|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817081|NCT04115748|580715012|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
160817082|NCT04115748|580715003|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817083|NCT04115748|580715004|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817084|NCT04115748|580715005|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817085|NCT04115748|580715006|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
160817086|NCT04115748|580715007|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
160817087|NCT04115748|580715008|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
160817088|NCT04115748|580715009|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
160817089|NCT04115748|580715010|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
160817090|NCT04115748|580715011|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
160817091|NCT04115748|580715012|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
160817092|NCT04115748|580715003|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817093|NCT04115748|580715004|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817094|NCT04115748|580715005|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817095|NCT04115748|580715006|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817096|NCT04115748|580715007|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817097|NCT04115748|580715008|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160987549|NCT04482855|581341160|FG001|Overall Study|Lost to Follow-up|0|||
161132455|NCT01355289|581868973|FG000|Core Study|Inadequate Therapeutic Effect|0|||
161132456|NCT01355289|581868974|FG001|Core Study|Inadequate Therapeutic Effect|0|||
161132457|NCT01355289|581868975|FG002|Core Study|Inadequate Therapeutic Effect|0|||
161132458|NCT01355289|581868976|FG003|Core Study|Inadequate Therapeutic Effect|1|||
161132459|NCT01355289|581868977|FG004|Core Study|Inadequate Therapeutic Effect|0|||
161132460|NCT01355289|581868973|FG000|Core Study|Other|0|||
161132461|NCT01355289|581868974|FG001|Core Study|Other|0|||
161132462|NCT01355289|581868975|FG002|Core Study|Other|0|||
161132463|NCT01355289|581868976|FG003|Core Study|Other|1|||
161132464|NCT01355289|581868977|FG004|Core Study|Other|0|||
161132465|NCT01355289|581868973|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
161132466|NCT01355289|581868974|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
160817098|NCT04115748|580715009|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817099|NCT04115748|580715010|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817100|NCT04115748|580715011|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
160987550|NCT04482855|581341159|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
160817101|NCT04115748|580715012|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
160817102|NCT01200407|580715013|FG000|Overall Study|Lost to Follow-up|56|||
160817103|NCT01200407|580715013|FG000|Overall Study|Adverse Event|3|||
160817104|NCT01200407|580715013|FG000|Overall Study|Withdrawal by Subject|4|||
160817105|NCT01200407|580715013|FG000|Overall Study|Other|19|||
160817106|NCT03299881|580715014|FG000|Overall Study|Study Termination|17|||
160817107|NCT03299881|580715015|FG001|Overall Study|Study Termination|13|||
160817108|NCT02752633|580715016|FG000|Overall Study|Withdrawal by Subject|1|||
160817109|NCT03425006|580715021|FG000|Overall Study|Withdrawal by Subject|1|||
160817110|NCT03425006|580715021|FG000|Overall Study|Physician Decision|1|||
160817111|NCT03425006|580715021|FG000|Overall Study|Death|1|||
160817112|NCT00610857|580715024|FG000|Overall Study|Not evaluable for response|2|||
160817113|NCT03931382|580715025|FG000|Overall Study|Equipment malfunction|2|||
160817114|NCT03931382|580715026|FG001|Overall Study|Equipment malfunction|0|||
160817115|NCT03931382|580715027|FG002|Overall Study|Equipment malfunction|2|||
160817116|NCT03931382|580715025|FG000|Overall Study|Withdrawal by Subject|0|||
160817117|NCT03931382|580715026|FG001|Overall Study|Withdrawal by Subject|1|||
160817118|NCT03931382|580715027|FG002|Overall Study|Withdrawal by Subject|0|||
160817119|NCT02151903|580715028|FG000|Overall Study|Withdrawal by Subject|1|||
160817120|NCT02151903|580715029|FG001|Overall Study|Withdrawal by Subject|0|||
160817121|NCT02151903|580715028|FG000|Overall Study|Progressive disease|2|||
160817122|NCT02151903|580715029|FG001|Overall Study|Progressive disease|1|||
160817123|NCT01500252|580715030|FG000|Overall Study|Death|4|||
160817124|NCT01500252|580715031|FG001|Overall Study|Death|2|||
160817125|NCT01500252|580715030|FG000|Overall Study|Lost to Follow-up|5|||
160817126|NCT01500252|580715031|FG001|Overall Study|Lost to Follow-up|4|||
160817127|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
160817128|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
160817129|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
160817130|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
160817131|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
160817132|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
160817133|NCT03490292|580715032|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
160817134|NCT03490292|580715033|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
160817135|NCT03490292|580715032|FG000|1 Year Follow Up Post Last Dose|Death|1|||
160817136|NCT03490292|580715033|FG001|1 Year Follow Up Post Last Dose|Death|1|||
160817137|NCT06003777|580715034|FG000|Period 1|Adverse Event|0|||
160817138|NCT06003777|580715035|FG001|Period 1|Adverse Event|0|||
160817139|NCT06003777|580715036|FG002|Period 1|Adverse Event|1|||
160817140|NCT06003777|580715037|FG003|Period 1|Adverse Event|0|||
160817141|NCT06003777|580715038|FG004|Period 1|Adverse Event|0|||
160817142|NCT06003777|580715039|FG005|Period 1|Adverse Event|0|||
160817143|NCT06003777|580715040|FG006|Period 1|Adverse Event|0|||
160817144|NCT06003777|580715041|FG007|Period 1|Adverse Event|0|||
160817145|NCT06003777|580715042|FG008|Period 1|Adverse Event|0|||
160987551|NCT04482855|581341160|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
160987552|NCT04482855|581341159|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
160987553|NCT04482855|581341160|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
160987554|NCT02886936|581341164|FG000|Overall Study|Lost to Follow-up|4|||
160987555|NCT02886936|581341165|FG001|Overall Study|Lost to Follow-up|3|||
160987556|NCT02886936|581341166|FG002|Overall Study|Lost to Follow-up|0|||
160987557|NCT02507219|581341167|FG000|Overall Study|Physician Decision|1|||
160987558|NCT02507219|581341168|FG001|Overall Study|Physician Decision|0|||
160987559|NCT02507219|581341169|FG002|Overall Study|Physician Decision|0|||
160987560|NCT02507219|581341170|FG003|Overall Study|Physician Decision|0|||
160987561|NCT02507219|581341171|FG004|Overall Study|Physician Decision|0|||
160817146|NCT06003777|580715043|FG009|Period 1|Adverse Event|0|||
160817147|NCT06003777|580715044|FG010|Period 1|Adverse Event|0|||
160817148|NCT06003777|580715045|FG011|Period 1|Adverse Event|0|||
160817149|NCT06003777|580715034|FG000|Period 1|Withdrawal by Subject|0|||
160817150|NCT06003777|580715035|FG001|Period 1|Withdrawal by Subject|0|||
160817151|NCT06003777|580715036|FG002|Period 1|Withdrawal by Subject|0|||
160817152|NCT06003777|580715037|FG003|Period 1|Withdrawal by Subject|0|||
160817153|NCT06003777|580715038|FG004|Period 1|Withdrawal by Subject|1|||
160817154|NCT06003777|580715039|FG005|Period 1|Withdrawal by Subject|0|||
160817155|NCT06003777|580715040|FG006|Period 1|Withdrawal by Subject|0|||
160817156|NCT06003777|580715041|FG007|Period 1|Withdrawal by Subject|0|||
160817157|NCT06003777|580715042|FG008|Period 1|Withdrawal by Subject|0|||
161132467|NCT01355289|581868975|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
160817158|NCT06003777|580715043|FG009|Period 1|Withdrawal by Subject|0|||
160817159|NCT06003777|580715044|FG010|Period 1|Withdrawal by Subject|0|||
160817160|NCT06003777|580715045|FG011|Period 1|Withdrawal by Subject|0|||
160817161|NCT06003777|580715034|FG000|Period 2|Withdrawal by Subject|0|||
160817162|NCT06003777|580715035|FG001|Period 2|Withdrawal by Subject|0|||
160817163|NCT06003777|580715036|FG002|Period 2|Withdrawal by Subject|0|||
160817164|NCT06003777|580715037|FG003|Period 2|Withdrawal by Subject|0|||
160817165|NCT06003777|580715038|FG004|Period 2|Withdrawal by Subject|0|||
160817166|NCT06003777|580715039|FG005|Period 2|Withdrawal by Subject|0|||
160817167|NCT06003777|580715040|FG006|Period 2|Withdrawal by Subject|0|||
161132468|NCT01355289|581868976|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
160817168|NCT06003777|580715041|FG007|Period 2|Withdrawal by Subject|0|||
160817169|NCT06003777|580715042|FG008|Period 2|Withdrawal by Subject|1|||
160817170|NCT06003777|580715043|FG009|Period 2|Withdrawal by Subject|0|||
160817171|NCT06003777|580715044|FG010|Period 2|Withdrawal by Subject|0|||
160817172|NCT06003777|580715045|FG011|Period 2|Withdrawal by Subject|0|||
160817173|NCT06003777|580715034|FG000|Period 3|Adverse Event|0|||
160817174|NCT06003777|580715035|FG001|Period 3|Adverse Event|0|||
160817175|NCT06003777|580715036|FG002|Period 3|Adverse Event|0|||
160817176|NCT06003777|580715037|FG003|Period 3|Adverse Event|0|||
160817177|NCT06003777|580715038|FG004|Period 3|Adverse Event|0|||
160817178|NCT06003777|580715039|FG005|Period 3|Adverse Event|0|||
160817179|NCT06003777|580715040|FG006|Period 3|Adverse Event|1|||
160817180|NCT06003777|580715041|FG007|Period 3|Adverse Event|0|||
160817181|NCT06003777|580715042|FG008|Period 3|Adverse Event|0|||
160817182|NCT06003777|580715043|FG009|Period 3|Adverse Event|0|||
160817183|NCT06003777|580715044|FG010|Period 3|Adverse Event|0|||
160817184|NCT06003777|580715045|FG011|Period 3|Adverse Event|0|||
160817185|NCT06003777|580715034|FG000|Period 4|No longer met eligibility criteria|0|||
160817186|NCT06003777|580715035|FG001|Period 4|No longer met eligibility criteria|0|||
160817187|NCT06003777|580715036|FG002|Period 4|No longer met eligibility criteria|1|||
160817188|NCT06003777|580715037|FG003|Period 4|No longer met eligibility criteria|0|||
160817189|NCT06003777|580715038|FG004|Period 4|No longer met eligibility criteria|0|||
160817190|NCT06003777|580715039|FG005|Period 4|No longer met eligibility criteria|0|||
160817191|NCT06003777|580715040|FG006|Period 4|No longer met eligibility criteria|0|||
160817192|NCT06003777|580715041|FG007|Period 4|No longer met eligibility criteria|0|||
160817193|NCT06003777|580715042|FG008|Period 4|No longer met eligibility criteria|0|||
160817194|NCT06003777|580715043|FG009|Period 4|No longer met eligibility criteria|0|||
160817195|NCT06003777|580715044|FG010|Period 4|No longer met eligibility criteria|0|||
160817196|NCT06003777|580715045|FG011|Period 4|No longer met eligibility criteria|0|||
160817197|NCT06003777|580715034|FG000|Period 4|Withdrawal by Subject|0|||
160817198|NCT06003777|580715035|FG001|Period 4|Withdrawal by Subject|1|||
160817199|NCT06003777|580715036|FG002|Period 4|Withdrawal by Subject|0|||
160817200|NCT06003777|580715037|FG003|Period 4|Withdrawal by Subject|0|||
160817201|NCT06003777|580715038|FG004|Period 4|Withdrawal by Subject|0|||
160817202|NCT06003777|580715039|FG005|Period 4|Withdrawal by Subject|0|||
160817203|NCT06003777|580715040|FG006|Period 4|Withdrawal by Subject|0|||
160817204|NCT06003777|580715041|FG007|Period 4|Withdrawal by Subject|0|||
160817205|NCT06003777|580715042|FG008|Period 4|Withdrawal by Subject|0|||
160817206|NCT06003777|580715043|FG009|Period 4|Withdrawal by Subject|0|||
160817207|NCT06003777|580715044|FG010|Period 4|Withdrawal by Subject|0|||
160817208|NCT06003777|580715045|FG011|Period 4|Withdrawal by Subject|0|||
160817209|NCT01106651|580715046|FG000|Overall Study|Adverse Event|17|||
160817210|NCT01106651|580715047|FG001|Overall Study|Adverse Event|9|||
160817211|NCT01106651|580715048|FG002|Overall Study|Adverse Event|23|||
160817212|NCT01106651|580715046|FG000|Overall Study|Lost to Follow-up|8|||
160817213|NCT01106651|580715047|FG001|Overall Study|Lost to Follow-up|2|||
160817214|NCT01106651|580715048|FG002|Overall Study|Lost to Follow-up|6|||
160817215|NCT01106651|580715046|FG000|Overall Study|Physician Decision|4|||
160817216|NCT01106651|580715047|FG001|Overall Study|Physician Decision|3|||
160900382|NCT00976677|581028711|FG000|Overall Study|Disease progression|1|||
160900383|NCT00976677|581028712|FG001|Overall Study|Disease progression|1|||
161132469|NCT01355289|581868977|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
161132470|NCT01355289|581868973|FG000|Open Label Extension|Lost to Follow-up|0|||
160900384|NCT00976677|581028711|FG000|Overall Study|Trial unblinded|2|||
160900385|NCT00976677|581028712|FG001|Overall Study|Trial unblinded|2|||
161132471|NCT01355289|581868974|FG001|Open Label Extension|Lost to Follow-up|0|||
160817217|NCT01106651|580715048|FG002|Overall Study|Physician Decision|1|||
160817218|NCT01106651|580715046|FG000|Overall Study|Protocol Violation|1|||
160817219|NCT01106651|580715047|FG001|Overall Study|Protocol Violation|2|||
160817220|NCT01106651|580715048|FG002|Overall Study|Protocol Violation|1|||
160817221|NCT01106651|580715046|FG000|Overall Study|Withdrawal by Subject|14|||
160817222|NCT01106651|580715047|FG001|Overall Study|Withdrawal by Subject|7|||
160817223|NCT01106651|580715048|FG002|Overall Study|Withdrawal by Subject|4|||
160817224|NCT01106651|580715046|FG000|Overall Study|Noncompliance with study drug|1|||
160817225|NCT01106651|580715047|FG001|Overall Study|Noncompliance with study drug|0|||
160817226|NCT01106651|580715048|FG002|Overall Study|Noncompliance with study drug|2|||
160817227|NCT01106651|580715046|FG000|Overall Study|Other|34|||
160817228|NCT01106651|580715047|FG001|Overall Study|Other|31|||
160817229|NCT01106651|580715048|FG002|Overall Study|Other|21|||
160817230|NCT01106651|580715046|FG000|Overall Study|Death|0|||
160817231|NCT01106651|580715047|FG001|Overall Study|Death|3|||
160817232|NCT01106651|580715048|FG002|Overall Study|Death|0|||
160817233|NCT00904670|580715049|FG000|Open Label Phase|Withdrawal by Subject|2|||
160817234|NCT00904670|580715050|FG001|Open Label Phase|Withdrawal by Subject|0|||
160817235|NCT00904670|580715049|FG000|Open Label Phase|Adverse Event|2|||
160817236|NCT00904670|580715050|FG001|Open Label Phase|Adverse Event|0|||
160817237|NCT00904670|580715049|FG000|Open Label Phase|Lack of Efficacy|1|||
160817238|NCT00904670|580715050|FG001|Open Label Phase|Lack of Efficacy|0|||
160817239|NCT00904670|580715049|FG000|Open Label Phase|Lost to Follow-up|1|||
160817240|NCT00904670|580715050|FG001|Open Label Phase|Lost to Follow-up|0|||
160817241|NCT00889603|580715051|FG000|Overall Study|Adverse Event|7|||
160817242|NCT00889603|580715051|FG000|Overall Study|Death|3|||
160817243|NCT00889603|580715051|FG000|Overall Study|Lost to Follow-up|19|||
160817244|NCT00889603|580715051|FG000|Overall Study|No longer willing to participant in stud|4|||
160817245|NCT00889603|580715051|FG000|Overall Study|Other|4|||
160817246|NCT03640507|580715052|FG000|Overall Study|Withdrawal by Subject|0|||
160817247|NCT03640507|580715053|FG001|Overall Study|Withdrawal by Subject|0|||
160817248|NCT03640507|580715054|FG002|Overall Study|Withdrawal by Subject|1|||
160817249|NCT03525600|580715055|FG000|Overall Study|Adverse Event|9|||
160817250|NCT03525600|580715056|FG001|Overall Study|Adverse Event|6|||
160817251|NCT03525600|580715057|FG002|Overall Study|Adverse Event|5|||
160817252|NCT03525600|580715058|FG003|Overall Study|Adverse Event|3|||
160817253|NCT03525600|580715055|FG000|Overall Study|Lost to Follow-up|2|||
160817254|NCT03525600|580715056|FG001|Overall Study|Lost to Follow-up|4|||
160817255|NCT03525600|580715057|FG002|Overall Study|Lost to Follow-up|4|||
160817256|NCT03525600|580715058|FG003|Overall Study|Lost to Follow-up|0|||
160817257|NCT03525600|580715055|FG000|Overall Study|Physician Decision|1|||
160817258|NCT03525600|580715056|FG001|Overall Study|Physician Decision|0|||
160817259|NCT03525600|580715057|FG002|Overall Study|Physician Decision|2|||
160817260|NCT03525600|580715058|FG003|Overall Study|Physician Decision|0|||
160817261|NCT03525600|580715055|FG000|Overall Study|Consent withdrawal|36|||
160817262|NCT03525600|580715056|FG001|Overall Study|Consent withdrawal|20|||
160817263|NCT03525600|580715057|FG002|Overall Study|Consent withdrawal|6|||
160817264|NCT03525600|580715058|FG003|Overall Study|Consent withdrawal|13|||
160817265|NCT03525600|580715055|FG000|Overall Study|Death|7|||
160817266|NCT03525600|580715056|FG001|Overall Study|Death|6|||
160817267|NCT03525600|580715057|FG002|Overall Study|Death|4|||
160817268|NCT03525600|580715058|FG003|Overall Study|Death|3|||
160817269|NCT03525600|580715055|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
160817270|NCT03525600|580715056|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
160817271|NCT03525600|580715057|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
160817272|NCT03525600|580715058|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
160817273|NCT03525600|580715055|FG000|Overall Study|Other|0|||
160817274|NCT03525600|580715056|FG001|Overall Study|Other|1|||
160817275|NCT03525600|580715057|FG002|Overall Study|Other|0|||
160817276|NCT03525600|580715058|FG003|Overall Study|Other|0|||
160817277|NCT00613327|580715062|FG000|Overall Study|Adverse Event|38|||
160817278|NCT00613327|580715062|FG000|Overall Study|Lost to Follow-up|8|||
160817279|NCT00613327|580715062|FG000|Overall Study|Withdrawal by Subject|6|||
160817280|NCT00613327|580715062|FG000|Overall Study|Protocol Violation|2|||
160817281|NCT00613327|580715062|FG000|Overall Study|Other|47|||
160817282|NCT01832493|580715065|FG000|Overall Study|Physician Decision|2|||
160817283|NCT01832493|580715065|FG000|Overall Study|Protocol Violation|4|||
160817284|NCT01832493|580715065|FG000|Overall Study|Unable to place LV lead|2|||
160817285|NCT00313144|580715068|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
160817286|NCT00313144|580715068|FG000|Overall Study|Death|7|||
160817287|NCT00313144|580715068|FG000|Overall Study|Lost to Follow-up|5|||
160817288|NCT00313144|580715068|FG000|Overall Study|Withdrawal by Subject|4|||
160817289|NCT00313144|580715068|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
160817290|NCT00313144|580715068|FG000|Overall Study|Physician Decision|4|||
160817291|NCT00313144|580715068|FG000|Overall Study|Adverse event - transient|5|||
160817292|NCT00313144|580715068|FG000|Overall Study|Liver transplant|1|||
160817293|NCT00313144|580715068|FG000|Overall Study|Insurance (homecare provider) change|1|||
160817294|NCT00313144|580715068|FG000|Overall Study|Change to different product|1|||
160817295|NCT00313144|580715068|FG000|Overall Study|Due to termination of the study|66|||
160817296|NCT04731298|580715069|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
160817297|NCT04731298|580715070|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
160817298|NCT01208961|580715071|FG000|High-Fat Period III|Protocol Violation|1|||
160817299|NCT01208961|580715072|FG001|High-Fat Period III|Protocol Violation|0|||
160817300|NCT01262560|580715073|FG000|Overall Study|Protocol Violation|0|||
160817301|NCT01262560|580715074|FG001|Overall Study|Protocol Violation|1|||
160817302|NCT01262560|580715075|FG002|Overall Study|Protocol Violation|2|||
160817303|NCT00350870|580715078|FG000|Overall Study|Withdrawal by Subject|21|||
160817304|NCT00350870|580715079|FG001|Overall Study|Withdrawal by Subject|17|||
160817305|NCT00350870|580715080|FG002|Overall Study|Withdrawal by Subject|15|||
160817306|NCT00350870|580715081|FG003|Overall Study|Withdrawal by Subject|14|||
160817307|NCT00350870|580715078|FG000|Overall Study|Physician Decision|1|||
160817308|NCT00350870|580715079|FG001|Overall Study|Physician Decision|0|||
160817309|NCT00350870|580715080|FG002|Overall Study|Physician Decision|1|||
160817310|NCT00350870|580715081|FG003|Overall Study|Physician Decision|1|||
160817311|NCT01932372|580715082|FG000|Overall Study|Not meeting eligibility criteria|33|||
160817312|NCT01932372|580715083|FG001|Overall Study|Not meeting eligibility criteria|179|||
160817313|NCT04382586|580715088|FG000|Overall Study|Death|3|||
160817314|NCT04382586|580715089|FG001|Overall Study|Death|4|||
160817315|NCT04382586|580715088|FG000|Overall Study|Lost to Follow-up|11|||
160817316|NCT04382586|580715089|FG001|Overall Study|Lost to Follow-up|8|||
160817317|NCT04382586|580715088|FG000|Overall Study|Withdrawal by Subject|3|||
160817318|NCT04382586|580715089|FG001|Overall Study|Withdrawal by Subject|1|||
160817319|NCT04382586|580715088|FG000|Overall Study|Physician Decision|0|||
160817320|NCT04382586|580715089|FG001|Overall Study|Physician Decision|3|||
160817321|NCT03594747|580715090|FG000|Overall Study|Death|78|||
160817322|NCT03594747|580715091|FG001|Overall Study|Death|86|||
160817323|NCT03594747|580715092|FG002|Overall Study|Death|87|||
160817324|NCT03594747|580715090|FG000|Overall Study|Withdrawal by Subject|5|||
160817325|NCT03594747|580715091|FG001|Overall Study|Withdrawal by Subject|2|||
160817326|NCT03594747|580715092|FG002|Overall Study|Withdrawal by Subject|11|||
160817327|NCT03594747|580715090|FG000|Overall Study|Lost to Follow-up|4|||
160817328|NCT03594747|580715091|FG001|Overall Study|Lost to Follow-up|1|||
160817329|NCT03594747|580715092|FG002|Overall Study|Lost to Follow-up|1|||
160817330|NCT03594747|580715090|FG000|Overall Study|Physician Decision|0|||
160817331|NCT03594747|580715091|FG001|Overall Study|Physician Decision|1|||
160817332|NCT03594747|580715092|FG002|Overall Study|Physician Decision|0|||
160817333|NCT03594747|580715090|FG000|Overall Study|Sponsor decision|23|||
160817334|NCT03594747|580715091|FG001|Overall Study|Sponsor decision|17|||
160817335|NCT03594747|580715092|FG002|Overall Study|Sponsor decision|16|||
160817336|NCT03594747|580715090|FG000|Overall Study|Did not meet inclusion criteria|0|||
160817337|NCT03594747|580715091|FG001|Overall Study|Did not meet inclusion criteria|0|||
160817338|NCT03594747|580715092|FG002|Overall Study|Did not meet inclusion criteria|1|||
160817339|NCT03594747|580715090|FG000|Overall Study|Transfer to long term extension study|10|||
160817340|NCT03594747|580715091|FG001|Overall Study|Transfer to long term extension study|12|||
160817341|NCT03594747|580715092|FG002|Overall Study|Transfer to long term extension study|5|||
160817342|NCT02265536|580715093|FG000|Overall Study|Adverse Event|1|||
160817343|NCT02265536|580715094|FG001|Overall Study|Adverse Event|0|||
160817344|NCT02265536|580715095|FG002|Overall Study|Adverse Event|0|||
160817345|NCT02265536|580715096|FG003|Overall Study|Adverse Event|0|||
160817346|NCT02265536|580715097|FG004|Overall Study|Adverse Event|1|||
160817347|NCT02265536|580715098|FG005|Overall Study|Adverse Event|0|||
160817348|NCT02265536|580715093|FG000|Overall Study|Physician Decision|0|||
160817349|NCT02265536|580715094|FG001|Overall Study|Physician Decision|0|||
160817350|NCT02265536|580715095|FG002|Overall Study|Physician Decision|0|||
160817351|NCT02265536|580715096|FG003|Overall Study|Physician Decision|0|||
160817352|NCT02265536|580715097|FG004|Overall Study|Physician Decision|2|||
160817353|NCT02265536|580715098|FG005|Overall Study|Physician Decision|0|||
160817354|NCT02265536|580715093|FG000|Overall Study|Withdrawal by Subject|0|||
160817355|NCT02265536|580715094|FG001|Overall Study|Withdrawal by Subject|3|||
160817356|NCT02265536|580715095|FG002|Overall Study|Withdrawal by Subject|0|||
160817357|NCT02265536|580715096|FG003|Overall Study|Withdrawal by Subject|0|||
160817358|NCT02265536|580715097|FG004|Overall Study|Withdrawal by Subject|0|||
160817359|NCT02265536|580715098|FG005|Overall Study|Withdrawal by Subject|0|||
160817360|NCT02907216|580715101|FG000|Overall Study|No benefit to be obtained by continuing|0|||
160817361|NCT02907216|580715102|FG001|Overall Study|No benefit to be obtained by continuing|1|||
160817362|NCT02907216|580715101|FG000|Overall Study|Withdrawal by Subject|1|||
160817363|NCT02907216|580715102|FG001|Overall Study|Withdrawal by Subject|0|||
160817364|NCT02095873|580715104|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
160817365|NCT02095873|580715105|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160817366|NCT02095873|580715104|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
160817367|NCT02095873|580715105|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
160817368|NCT02095873|580715104|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
160817369|NCT02095873|580715105|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
160817370|NCT00792740|580715109|FG000|Overall Study|Disease Worsening|3|||
160817371|NCT00792740|580715110|FG001|Overall Study|Disease Worsening|2|||
160817372|NCT00792740|580715109|FG000|Overall Study|Personal Reason|1|||
160817373|NCT00792740|580715110|FG001|Overall Study|Personal Reason|0|||
160817374|NCT00792740|580715109|FG000|Overall Study|Adverse Event|1|||
160817375|NCT00792740|580715110|FG001|Overall Study|Adverse Event|3|||
160817376|NCT00792740|580715109|FG000|Overall Study|Patient's withdrawal of consent|0|||
160817377|NCT00792740|580715110|FG001|Overall Study|Patient's withdrawal of consent|1|||
160817378|NCT00792740|580715109|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
160817379|NCT00792740|580715110|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
160817380|NCT00792740|580715109|FG000|Overall Study|Other reasons|0|||
160817381|NCT00792740|580715110|FG001|Overall Study|Other reasons|1|||
160817382|NCT02485639|580715115|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
160817383|NCT02485639|580715115|FG000|Overall Study|Early termination|4|||
160817384|NCT02485639|580715115|FG000|Overall Study|Withdrawal by Subject|4|||
160817385|NCT02640625|580716852|FG000|Overall Study|Adverse Event|1|||
160817386|NCT00197145|580716853|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
160817387|NCT00197145|580716854|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
160817388|NCT00197145|580716853|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
160817389|NCT00197145|580716854|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
160817390|NCT00197145|580716853|FG000|Period 1: Randomized Treatment Phase|Other|2|||
160817391|NCT00197145|580716854|FG001|Period 1: Randomized Treatment Phase|Other|2|||
160817392|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
160817393|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
160817394|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
160817395|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
160817396|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
160817397|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
160817398|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
160817399|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
160817400|NCT00197145|580716853|FG000|Period 2 : Open Label Phase|Other|1|||
160817401|NCT00197145|580716854|FG001|Period 2 : Open Label Phase|Other|0|||
160817402|NCT00790868|580716855|FG000|Overall Study|Withdrawal by Subject|4|||
160817403|NCT00790868|580716856|FG001|Overall Study|Withdrawal by Subject|5|||
160817404|NCT00790868|580716855|FG000|Overall Study|Lost to Follow-up|2|||
160817405|NCT00790868|580716856|FG001|Overall Study|Lost to Follow-up|12|||
160817406|NCT02867813|580716860|FG000|Overall Study|Withdrawal by Subject|57|||
160817407|NCT02867813|580716861|FG001|Overall Study|Withdrawal by Subject|56|||
160817408|NCT02867813|580716860|FG000|Overall Study|Decision by Sponsor|7|||
160817409|NCT02867813|580716861|FG001|Overall Study|Decision by Sponsor|7|||
160817410|NCT02867813|580716860|FG000|Overall Study|Lost to Follow-up|91|||
160817411|NCT02867813|580716861|FG001|Overall Study|Lost to Follow-up|78|||
160817412|NCT02867813|580716860|FG000|Overall Study|Missing|2|||
160817413|NCT02867813|580716861|FG001|Overall Study|Missing|1|||
160817414|NCT02867813|580716860|FG000|Overall Study|Death|294|||
160817415|NCT02867813|580716861|FG001|Overall Study|Death|268|||
160817416|NCT02013206|580716862|FG000|Overall Study|Progressive disease (PD)|14|||
160817417|NCT02013206|580716863|FG001|Overall Study|Progressive disease (PD)|17|||
160817418|NCT02013206|580716862|FG000|Overall Study|Symptomatic deterioration|3|||
160817419|NCT02013206|580716863|FG001|Overall Study|Symptomatic deterioration|1|||
160817420|NCT02013206|580716862|FG000|Overall Study|Adverse Event|1|||
160817421|NCT02013206|580716863|FG001|Overall Study|Adverse Event|0|||
160817422|NCT02013206|580716862|FG000|Overall Study|Patient refusal|2|||
160817423|NCT02013206|580716863|FG001|Overall Study|Patient refusal|0|||
160817424|NCT02013206|580716862|FG000|Overall Study|Patient non-compliance|1|||
160817425|NCT02013206|580716863|FG001|Overall Study|Patient non-compliance|0|||
160817426|NCT02013206|580716862|FG000|Overall Study|Death|1|||
160817427|NCT02013206|580716863|FG001|Overall Study|Death|2|||
160817428|NCT02013206|580716862|FG000|Overall Study|Other reasons off treatment|5|||
160817429|NCT02013206|580716863|FG001|Overall Study|Other reasons off treatment|2|||
160817430|NCT02370537|580716864|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
160817431|NCT02370537|580716865|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
160817432|NCT02370537|580716866|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
160817433|NCT02370537|580716864|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
160817434|NCT02370537|580716865|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
160817435|NCT02370537|580716866|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
160817436|NCT02370537|580716864|FG000|Part B|Not randomised to receive treatment|1|||
160817437|NCT02370537|580716865|FG001|Part B|Not randomised to receive treatment|2|||
160817438|NCT02370537|580716866|FG002|Part B|Not randomised to receive treatment|259|||
160817439|NCT02370537|580716864|FG000|Part B|Withdrawal by Subject|0|||
160817440|NCT02370537|580716865|FG001|Part B|Withdrawal by Subject|1|||
160817441|NCT02370537|580716866|FG002|Part B|Withdrawal by Subject|0|||
160817442|NCT02578680|580716869|FG000|Overall Study|Death|329|||
160817443|NCT02578680|580716870|FG001|Overall Study|Death|181|||
160817444|NCT02578680|580716869|FG000|Overall Study|Lost to Follow-up|3|||
160817445|NCT02578680|580716870|FG001|Overall Study|Lost to Follow-up|1|||
160817446|NCT02578680|580716869|FG000|Overall Study|Physician Decision|0|||
160817447|NCT02578680|580716870|FG001|Overall Study|Physician Decision|1|||
160817448|NCT02578680|580716869|FG000|Overall Study|Protocol Violation|1|||
160817449|NCT02578680|580716870|FG001|Overall Study|Protocol Violation|1|||
160817450|NCT02578680|580716869|FG000|Overall Study|Sponsor Decision|64|||
160987562|NCT02507219|581341172|FG005|Overall Study|Physician Decision|0|||
160987563|NCT02507219|581341167|FG000|Overall Study|Withdrawal by Subject|0|||
160987564|NCT02507219|581341168|FG001|Overall Study|Withdrawal by Subject|0|||
160817451|NCT02578680|580716870|FG001|Overall Study|Sponsor Decision|13|||
160817452|NCT02578680|580716869|FG000|Overall Study|Withdrawal by Subject|13|||
160817453|NCT02578680|580716870|FG001|Overall Study|Withdrawal by Subject|9|||
160817454|NCT02596958|580716872|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
160817455|NCT02596958|580716872|FG000|Overall Study|Cancer Progression|441|||
160987565|NCT02507219|581341169|FG002|Overall Study|Withdrawal by Subject|0|||
160817456|NCT02596958|580716872|FG000|Overall Study|Death From Cancer|112|||
161132472|NCT01355289|581868975|FG002|Open Label Extension|Lost to Follow-up|0|||
160817457|NCT02596958|580716872|FG000|Overall Study|Death From Other Cause|33|||
160817458|NCT02596958|580716872|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
160817459|NCT02596958|580716872|FG000|Overall Study|Administrative Reasons/Other|231|||
160817460|NCT02596958|580716872|FG000|Overall Study|Lost to Follow-up|33|||
161132473|NCT01355289|581868976|FG003|Open Label Extension|Lost to Follow-up|0|||
161132474|NCT01355289|581868977|FG004|Open Label Extension|Lost to Follow-up|1|||
160817461|NCT02596958|580716872|FG000|Overall Study|Missing|32|||
160817462|NCT02596958|580716872|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
160817463|NCT01559259|580716873|FG000|Overall Study|Withdrawal by Subject|0|||
160817464|NCT01559259|580716874|FG001|Overall Study|Withdrawal by Subject|0|||
160817465|NCT01559259|580716875|FG002|Overall Study|Withdrawal by Subject|0|||
160817466|NCT01559259|580716876|FG003|Overall Study|Withdrawal by Subject|1|||
160817467|NCT01559259|580716877|FG004|Overall Study|Withdrawal by Subject|0|||
160817468|NCT01559259|580716873|FG000|Overall Study|Adverse Event|0|||
160817469|NCT01559259|580716874|FG001|Overall Study|Adverse Event|1|||
160817470|NCT01559259|580716875|FG002|Overall Study|Adverse Event|1|||
160817471|NCT01559259|580716876|FG003|Overall Study|Adverse Event|0|||
160817472|NCT01559259|580716877|FG004|Overall Study|Adverse Event|0|||
160817473|NCT01995669|580716878|FG000|Overall Study|Progression|2|||
160817474|NCT01995669|580716879|FG001|Overall Study|Progression|1|||
160817475|NCT01995669|580716880|FG002|Overall Study|Progression|1|||
160817476|NCT01995669|580716881|FG003|Overall Study|Progression|13|||
160817477|NCT01995669|580716878|FG000|Overall Study|Adverse Event|0|||
160817478|NCT01995669|580716879|FG001|Overall Study|Adverse Event|0|||
160817479|NCT01995669|580716880|FG002|Overall Study|Adverse Event|0|||
160817480|NCT01995669|580716881|FG003|Overall Study|Adverse Event|3|||
160817481|NCT01995669|580716878|FG000|Overall Study|Death|0|||
160817482|NCT01995669|580716879|FG001|Overall Study|Death|0|||
160817483|NCT01995669|580716880|FG002|Overall Study|Death|0|||
160817484|NCT01995669|580716881|FG003|Overall Study|Death|6|||
160817485|NCT01995669|580716878|FG000|Overall Study|Withdrawal by Subject|0|||
160817486|NCT01995669|580716879|FG001|Overall Study|Withdrawal by Subject|0|||
160817487|NCT01995669|580716880|FG002|Overall Study|Withdrawal by Subject|0|||
160817488|NCT01995669|580716881|FG003|Overall Study|Withdrawal by Subject|6|||
160817489|NCT01995669|580716878|FG000|Overall Study|Insurance Expired|0|||
160817490|NCT01995669|580716879|FG001|Overall Study|Insurance Expired|0|||
160817491|NCT01995669|580716880|FG002|Overall Study|Insurance Expired|0|||
160817492|NCT01995669|580716881|FG003|Overall Study|Insurance Expired|1|||
160817493|NCT03727646|580716882|FG000|Overall Study|Adverse Event|1|||
160817494|NCT03727646|580716883|FG001|Overall Study|Adverse Event|0|||
160817495|NCT04753658|580716884|FG000|Overall Study|Progressive disease|7|||
160817496|NCT04753658|580716884|FG000|Overall Study|Other|7|||
161132475|NCT01355289|581868973|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
160817497|NCT04753658|580716884|FG000|Overall Study|Adverse Event|1|||
160817498|NCT05659719|580716885|FG000|Overall Study|At sponsor's request|0|||
160817499|NCT05659719|580716886|FG001|Overall Study|At sponsor's request|0|||
160817500|NCT05659719|580716887|FG002|Overall Study|At sponsor's request|0|||
160817501|NCT05659719|580716888|FG003|Overall Study|At sponsor's request|95|||
160817502|NCT05659719|580716885|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
160817503|NCT05659719|580716886|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
160817504|NCT05659719|580716887|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
160817505|NCT05659719|580716888|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
160817506|NCT05659719|580716885|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
160817507|NCT05659719|580716886|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
160817508|NCT05659719|580716887|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
160817509|NCT05659719|580716888|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
160817510|NCT05659719|580716885|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161132476|NCT01355289|581868974|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
160817511|NCT05659719|580716886|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
160817512|NCT05659719|580716887|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
161132477|NCT01355289|581868975|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
161132478|NCT01355289|581868976|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
161132479|NCT01355289|581868977|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
161132480|NCT01355289|581868973|FG000|Open Label Extension|Other|0|||
161132481|NCT01355289|581868974|FG001|Open Label Extension|Other|0|||
160817513|NCT05659719|580716888|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
160817514|NCT05659719|580716885|FG000|Overall Study|Lost to Follow-up|0|||
160817515|NCT05659719|580716886|FG001|Overall Study|Lost to Follow-up|0|||
160817516|NCT05659719|580716887|FG002|Overall Study|Lost to Follow-up|0|||
160817517|NCT05659719|580716888|FG003|Overall Study|Lost to Follow-up|2|||
160817518|NCT05659719|580716885|FG000|Overall Study|Moved to another observational study|0|||
160817519|NCT05659719|580716886|FG001|Overall Study|Moved to another observational study|0|||
160817520|NCT05659719|580716887|FG002|Overall Study|Moved to another observational study|0|||
160817521|NCT05659719|580716888|FG003|Overall Study|Moved to another observational study|1|||
160817522|NCT05659719|580716885|FG000|Overall Study|The child was enrolled in an interventional study|0|||
160817523|NCT05659719|580716886|FG001|Overall Study|The child was enrolled in an interventional study|0|||
160817524|NCT05659719|580716887|FG002|Overall Study|The child was enrolled in an interventional study|0|||
160817525|NCT05659719|580716888|FG003|Overall Study|The child was enrolled in an interventional study|55|||
160817526|NCT05659719|580716885|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
160817527|NCT05659719|580716886|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
160817528|NCT05659719|580716887|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
160817529|NCT05659719|580716888|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
160817530|NCT05659719|580716885|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
161333693|NCT00323063|582610588|FG001|Overall Study|brain mets discovered prior to treatment|0|||
161333694|NCT05002972|582610590|FG000|Overall Study|Withdrawal by Subject|2|||
160817531|NCT05659719|580716886|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
160817532|NCT05659719|580716887|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
160817533|NCT05659719|580716888|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
160817534|NCT02290691|580716892|FG000|Overall Study|Noncompliance|0|||
160817535|NCT02290691|580716893|FG001|Overall Study|Noncompliance|1|||
160817536|NCT02290691|580716892|FG000|Overall Study|Withdrawal by Subject|1|||
160817537|NCT02290691|580716893|FG001|Overall Study|Withdrawal by Subject|1|||
160817538|NCT02290691|580716892|FG000|Overall Study|Lost to Follow-up|7|||
160817539|NCT02290691|580716893|FG001|Overall Study|Lost to Follow-up|7|||
160817540|NCT00218634|580716894|FG000|Overall Study|Lost to Follow-up|8|||
160817541|NCT00218634|580716895|FG001|Overall Study|Lost to Follow-up|15|||
160817542|NCT00978380|580716898|FG000|Overall Study|Protocol Violation|2|||
160817543|NCT00978380|580716898|FG000|Overall Study|Withdrawal criteria|9|||
160817544|NCT00978380|580716898|FG000|Overall Study|Unclassified|8|||
160817545|NCT00176488|580716899|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
160817546|NCT05059301|580716900|FG000|Overall Study|Adverse Event|0|||
160817547|NCT05059301|580716901|FG001|Overall Study|Adverse Event|2|||
160817548|NCT05059301|580716902|FG002|Overall Study|Adverse Event|2|||
160817549|NCT05059301|580716900|FG000|Overall Study|Lost to Follow-up|2|||
160817550|NCT05059301|580716901|FG001|Overall Study|Lost to Follow-up|3|||
160817551|NCT05059301|580716902|FG002|Overall Study|Lost to Follow-up|3|||
160817552|NCT04952597|580716903|FG000|Overall Study|Death|12|||
160817553|NCT04952597|580716904|FG001|Overall Study|Death|13|||
160817554|NCT04952597|580716905|FG002|Overall Study|Death|14|||
160817555|NCT04952597|580716903|FG000|Overall Study|Withdrawal by Subject|1|||
160817556|NCT04952597|580716904|FG001|Overall Study|Withdrawal by Subject|0|||
160817557|NCT04952597|580716905|FG002|Overall Study|Withdrawal by Subject|3|||
160817558|NCT04952597|580716903|FG000|Overall Study|Lost to Follow-up|0|||
160817559|NCT04952597|580716904|FG001|Overall Study|Lost to Follow-up|1|||
160817560|NCT04952597|580716905|FG002|Overall Study|Lost to Follow-up|1|||
160817561|NCT01296711|580716906|FG000|Overall Study|Adverse Event|3|||
160817562|NCT01296711|580716907|FG001|Overall Study|Adverse Event|1|||
160817563|NCT01296711|580716908|FG002|Overall Study|Adverse Event|4|||
160817564|NCT01296711|580716909|FG003|Overall Study|Adverse Event|3|||
160817565|NCT01296711|580716910|FG004|Overall Study|Adverse Event|1|||
160817566|NCT01296711|580716911|FG005|Overall Study|Adverse Event|6|||
160817567|NCT01296711|580716912|FG006|Overall Study|Adverse Event|11|||
160817568|NCT01296711|580716913|FG007|Overall Study|Adverse Event|3|||
160817569|NCT01296711|580716906|FG000|Overall Study|Lack of Efficacy|1|||
160817570|NCT01296711|580716907|FG001|Overall Study|Lack of Efficacy|4|||
160817571|NCT01296711|580716908|FG002|Overall Study|Lack of Efficacy|1|||
160817572|NCT01296711|580716909|FG003|Overall Study|Lack of Efficacy|1|||
160817573|NCT01296711|580716910|FG004|Overall Study|Lack of Efficacy|1|||
160817574|NCT01296711|580716911|FG005|Overall Study|Lack of Efficacy|0|||
160817575|NCT01296711|580716912|FG006|Overall Study|Lack of Efficacy|2|||
160817576|NCT01296711|580716913|FG007|Overall Study|Lack of Efficacy|3|||
160817577|NCT01296711|580716906|FG000|Overall Study|Lost to Follow-up|0|||
160817578|NCT01296711|580716907|FG001|Overall Study|Lost to Follow-up|0|||
160817579|NCT01296711|580716908|FG002|Overall Study|Lost to Follow-up|1|||
160817580|NCT01296711|580716909|FG003|Overall Study|Lost to Follow-up|1|||
160817581|NCT01296711|580716910|FG004|Overall Study|Lost to Follow-up|2|||
160817582|NCT01296711|580716911|FG005|Overall Study|Lost to Follow-up|0|||
161333695|NCT01664091|582610591|FG000|Overall Study|Death|1|||
160817583|NCT01296711|580716912|FG006|Overall Study|Lost to Follow-up|4|||
160817584|NCT01296711|580716913|FG007|Overall Study|Lost to Follow-up|2|||
160817585|NCT01296711|580716906|FG000|Overall Study|Protocol Violation|0|||
160817586|NCT01296711|580716907|FG001|Overall Study|Protocol Violation|0|||
160817587|NCT01296711|580716908|FG002|Overall Study|Protocol Violation|0|||
160817588|NCT01296711|580716909|FG003|Overall Study|Protocol Violation|1|||
161333696|NCT01664091|582610591|FG000|Overall Study|Disease Progression|2|||
161333697|NCT01664091|582610591|FG000|Overall Study|Lost to Follow-up|2|||
161333698|NCT01664091|582610591|FG000|Overall Study|Withdrawal by Subject|1|||
161333699|NCT02053493|582610594|FG000|Overall Study|Withdrawal by Subject|1|||
161333700|NCT02053493|582610595|FG001|Overall Study|Withdrawal by Subject|1|||
161333701|NCT01076543|582610598|FG000|Overall Study|Withdrawal by Subject|2|||
161333702|NCT01076543|582610599|FG001|Overall Study|Withdrawal by Subject|0|||
161333703|NCT01076543|582610600|FG002|Overall Study|Withdrawal by Subject|0|||
161333704|NCT01076543|582610601|FG003|Overall Study|Withdrawal by Subject|0|||
161333705|NCT01076543|582610602|FG004|Overall Study|Withdrawal by Subject|0|||
161333706|NCT01076543|582610603|FG005|Overall Study|Withdrawal by Subject|0|||
161333707|NCT00338741|582610604|FG000|Overall Study|Lost to Follow-up|2|||
161333708|NCT00338741|582610605|FG001|Overall Study|Lost to Follow-up|0|||
161333709|NCT01534273|582610606|FG000|Period 1|Physician Decision|0|||
161333710|NCT01534273|582610607|FG001|Period 1|Physician Decision|0|||
161333711|NCT01534273|582610608|FG002|Period 1|Physician Decision|0|||
161333712|NCT01534273|582610609|FG003|Period 1|Physician Decision|1|||
161333713|NCT01534273|582610610|FG004|Period 1|Physician Decision|0|||
161333714|NCT01534273|582610611|FG005|Period 1|Physician Decision|0|||
161333715|NCT01534273|582610612|FG006|Period 1|Physician Decision|0|||
161333716|NCT01619865|582610613|FG000|Overall Study|Adverse Event|1|||
161333717|NCT01619865|582610613|FG000|Overall Study|Death|2|||
161333718|NCT01619865|582610613|FG000|Overall Study|subject not able to comply|1|||
161333719|NCT03586050|582610614|FG000|Overall Study|Death|3|||
161333720|NCT03586050|582610614|FG000|Overall Study|Withdrawal by Subject|2|||
161333721|NCT01494818|582610615|FG000|Overall Study|Relocation|1|||
161333722|NCT01494818|582610616|FG001|Overall Study|Relocation|2|||
161333723|NCT01494818|582610615|FG000|Overall Study|Lost to Follow-up|1|||
161333724|NCT01494818|582610616|FG001|Overall Study|Lost to Follow-up|0|||
161333725|NCT00791999|582610617|FG000|Overall Study|Protocol planed withdrawal|14|||
161333726|NCT00791999|582610618|FG001|Overall Study|Protocol planed withdrawal|11|||
161333727|NCT00791999|582610619|FG002|Overall Study|Protocol planed withdrawal|11|||
161333728|NCT00791999|582610620|FG003|Overall Study|Protocol planed withdrawal|45|||
161333729|NCT00791999|582610617|FG000|Overall Study|Withdrawal by Subject|0|||
161333730|NCT00791999|582610618|FG001|Overall Study|Withdrawal by Subject|1|||
161333731|NCT00791999|582610619|FG002|Overall Study|Withdrawal by Subject|0|||
161333732|NCT00791999|582610620|FG003|Overall Study|Withdrawal by Subject|2|||
161333733|NCT00791999|582610617|FG000|Overall Study|Protocol Violation|3|||
161333734|NCT00791999|582610618|FG001|Overall Study|Protocol Violation|0|||
161333735|NCT00791999|582610619|FG002|Overall Study|Protocol Violation|1|||
161333736|NCT00791999|582610620|FG003|Overall Study|Protocol Violation|0|||
160817589|NCT01296711|580716910|FG004|Overall Study|Protocol Violation|1|||
160817590|NCT01296711|580716911|FG005|Overall Study|Protocol Violation|0|||
160817591|NCT01296711|580716912|FG006|Overall Study|Protocol Violation|0|||
160817592|NCT01296711|580716913|FG007|Overall Study|Protocol Violation|0|||
160817593|NCT01296711|580716906|FG000|Overall Study|Withdrawal by Subject|4|||
160817594|NCT01296711|580716907|FG001|Overall Study|Withdrawal by Subject|2|||
160817595|NCT01296711|580716908|FG002|Overall Study|Withdrawal by Subject|2|||
160817596|NCT01296711|580716909|FG003|Overall Study|Withdrawal by Subject|1|||
160817597|NCT01296711|580716910|FG004|Overall Study|Withdrawal by Subject|1|||
160817598|NCT01296711|580716911|FG005|Overall Study|Withdrawal by Subject|1|||
160817599|NCT01296711|580716912|FG006|Overall Study|Withdrawal by Subject|2|||
160817600|NCT01296711|580716913|FG007|Overall Study|Withdrawal by Subject|1|||
160817601|NCT01296711|580716906|FG000|Overall Study|Study termination|8|||
160817602|NCT01296711|580716907|FG001|Overall Study|Study termination|1|||
160900386|NCT00976677|581028711|FG000|Overall Study|Unknown/Missing|1|||
160900387|NCT00976677|581028712|FG001|Overall Study|Unknown/Missing|0|||
160900388|NCT03487549|581028717|FG000|Overall Study|Protocol Violation|0|||
160900389|NCT03487549|581028718|FG001|Overall Study|Protocol Violation|1|||
160900390|NCT03487549|581028717|FG000|Overall Study|Lost to Follow-up|2|||
161132482|NCT01355289|581868975|FG002|Open Label Extension|Other|0|||
161132483|NCT01355289|581868976|FG003|Open Label Extension|Other|0|||
161333737|NCT00791999|582610617|FG000|Overall Study|Adverse Event|3|||
161333738|NCT00791999|582610618|FG001|Overall Study|Adverse Event|3|||
161333739|NCT00791999|582610619|FG002|Overall Study|Adverse Event|7|||
161333740|NCT00791999|582610620|FG003|Overall Study|Adverse Event|3|||
161333741|NCT00791999|582610617|FG000|Overall Study|Lack of Efficacy|0|||
161333742|NCT00791999|582610618|FG001|Overall Study|Lack of Efficacy|1|||
161333743|NCT00791999|582610619|FG002|Overall Study|Lack of Efficacy|0|||
161333744|NCT00791999|582610620|FG003|Overall Study|Lack of Efficacy|2|||
161333745|NCT00791999|582610617|FG000|Overall Study|Reason other than those above|1|||
160900391|NCT03487549|581028718|FG001|Overall Study|Lost to Follow-up|1|||
161333746|NCT00791999|582610618|FG001|Overall Study|Reason other than those above|0|||
160817603|NCT01296711|580716908|FG002|Overall Study|Study termination|5|||
160817604|NCT01296711|580716909|FG003|Overall Study|Study termination|4|||
160817605|NCT01296711|580716910|FG004|Overall Study|Study termination|4|||
160900392|NCT03487549|581028717|FG000|Overall Study|Withdrawal by Subject|2|||
161333747|NCT00791999|582610619|FG002|Overall Study|Reason other than those above|1|||
161333748|NCT00791999|582610620|FG003|Overall Study|Reason other than those above|0|||
160817606|NCT01296711|580716911|FG005|Overall Study|Study termination|4|||
160817607|NCT01296711|580716912|FG006|Overall Study|Study termination|8|||
160817608|NCT01296711|580716913|FG007|Overall Study|Study termination|10|||
160817609|NCT01296711|580716906|FG000|Overall Study|Continued elevated liver enzymes|0|||
160817610|NCT01296711|580716907|FG001|Overall Study|Continued elevated liver enzymes|0|||
160817611|NCT01296711|580716908|FG002|Overall Study|Continued elevated liver enzymes|0|||
160817612|NCT01296711|580716909|FG003|Overall Study|Continued elevated liver enzymes|1|||
160817613|NCT01296711|580716910|FG004|Overall Study|Continued elevated liver enzymes|0|||
160817614|NCT01296711|580716911|FG005|Overall Study|Continued elevated liver enzymes|0|||
160817615|NCT01296711|580716912|FG006|Overall Study|Continued elevated liver enzymes|0|||
160987566|NCT02507219|581341170|FG003|Overall Study|Withdrawal by Subject|0|||
160987567|NCT02507219|581341171|FG004|Overall Study|Withdrawal by Subject|1|||
160987568|NCT02507219|581341172|FG005|Overall Study|Withdrawal by Subject|0|||
160987569|NCT04562779|581341173|FG000|Overall Study|Lost to Follow-up|7|||
160987570|NCT04562779|581341174|FG001|Overall Study|Lost to Follow-up|5|||
160987571|NCT04562779|581341175|FG002|Overall Study|Lost to Follow-up|10|||
160987572|NCT04562779|581341173|FG000|Overall Study|Protocol Violation|2|||
160987573|NCT04562779|581341174|FG001|Overall Study|Protocol Violation|2|||
160987574|NCT04562779|581341175|FG002|Overall Study|Protocol Violation|0|||
161132484|NCT01355289|581868977|FG004|Open Label Extension|Other|3|||
161132485|NCT00888238|581868981|FG000|Washout Period After Period 2|Adverse Event|0|||
161132486|NCT00888238|581868982|FG001|Washout Period After Period 2|Adverse Event|0|||
160817616|NCT01296711|580716913|FG007|Overall Study|Continued elevated liver enzymes|0|||
160817617|NCT01296711|580716906|FG000|Overall Study|Methotrexate discontinued|0|||
160817618|NCT01296711|580716907|FG001|Overall Study|Methotrexate discontinued|0|||
160817619|NCT01296711|580716908|FG002|Overall Study|Methotrexate discontinued|0|||
160817620|NCT01296711|580716909|FG003|Overall Study|Methotrexate discontinued|1|||
160817621|NCT01296711|580716910|FG004|Overall Study|Methotrexate discontinued|0|||
160817622|NCT01296711|580716911|FG005|Overall Study|Methotrexate discontinued|0|||
160817623|NCT01296711|580716912|FG006|Overall Study|Methotrexate discontinued|0|||
160817624|NCT01296711|580716913|FG007|Overall Study|Methotrexate discontinued|0|||
160817625|NCT01296711|580716906|FG000|Overall Study|Investigator discretion|0|||
160817626|NCT01296711|580716907|FG001|Overall Study|Investigator discretion|0|||
160817627|NCT01296711|580716908|FG002|Overall Study|Investigator discretion|0|||
160817628|NCT01296711|580716909|FG003|Overall Study|Investigator discretion|0|||
160817629|NCT01296711|580716910|FG004|Overall Study|Investigator discretion|0|||
160817630|NCT01296711|580716911|FG005|Overall Study|Investigator discretion|0|||
160817631|NCT01296711|580716912|FG006|Overall Study|Investigator discretion|1|||
160817632|NCT01296711|580716913|FG007|Overall Study|Investigator discretion|0|||
160817633|NCT01296711|580716906|FG000|Overall Study|Other|0|||
160817634|NCT01296711|580716907|FG001|Overall Study|Other|0|||
160817635|NCT01296711|580716908|FG002|Overall Study|Other|0|||
160817636|NCT01296711|580716909|FG003|Overall Study|Other|0|||
160817637|NCT01296711|580716910|FG004|Overall Study|Other|0|||
160817638|NCT01296711|580716911|FG005|Overall Study|Other|0|||
160817639|NCT01296711|580716912|FG006|Overall Study|Other|1|||
160817640|NCT01296711|580716913|FG007|Overall Study|Other|0|||
160817641|NCT01296711|580716906|FG000|Overall Study|Required restricted steroid injections|0|||
160817642|NCT01296711|580716907|FG001|Overall Study|Required restricted steroid injections|0|||
160817643|NCT01296711|580716908|FG002|Overall Study|Required restricted steroid injections|0|||
160817644|NCT01296711|580716909|FG003|Overall Study|Required restricted steroid injections|0|||
160817645|NCT01296711|580716910|FG004|Overall Study|Required restricted steroid injections|0|||
160817646|NCT01296711|580716911|FG005|Overall Study|Required restricted steroid injections|0|||
160817647|NCT01296711|580716912|FG006|Overall Study|Required restricted steroid injections|1|||
160817648|NCT01296711|580716913|FG007|Overall Study|Required restricted steroid injections|0|||
160817649|NCT01296711|580716906|FG000|Overall Study|Ongoing missed appointments|0|||
160817650|NCT01296711|580716907|FG001|Overall Study|Ongoing missed appointments|0|||
160817651|NCT01296711|580716908|FG002|Overall Study|Ongoing missed appointments|0|||
160817652|NCT01296711|580716909|FG003|Overall Study|Ongoing missed appointments|0|||
160817653|NCT01296711|580716910|FG004|Overall Study|Ongoing missed appointments|0|||
160817654|NCT01296711|580716911|FG005|Overall Study|Ongoing missed appointments|0|||
160817655|NCT01296711|580716912|FG006|Overall Study|Ongoing missed appointments|1|||
160817656|NCT01296711|580716913|FG007|Overall Study|Ongoing missed appointments|0|||
160817657|NCT01296711|580716906|FG000|Overall Study|Failure to comply with visits|0|||
160817658|NCT01296711|580716907|FG001|Overall Study|Failure to comply with visits|0|||
161132487|NCT00888238|581868983|FG002|Washout Period After Period 2|Adverse Event|1|||
160817659|NCT01296711|580716908|FG002|Overall Study|Failure to comply with visits|0|||
160817660|NCT01296711|580716909|FG003|Overall Study|Failure to comply with visits|0|||
160817661|NCT01296711|580716910|FG004|Overall Study|Failure to comply with visits|0|||
160817662|NCT01296711|580716911|FG005|Overall Study|Failure to comply with visits|0|||
160817663|NCT01296711|580716912|FG006|Overall Study|Failure to comply with visits|0|||
160987575|NCT02320721|581341176|FG000|Overall Study|Adverse Event|6|||
160987576|NCT02320721|581341177|FG001|Overall Study|Adverse Event|6|||
161132488|NCT00619957|581868984|FG000|Month 24 Double-Blind|Adverse Event|9|||
161132489|NCT00619957|581868985|FG001|Month 24 Double-Blind|Adverse Event|7|||
160817664|NCT01296711|580716913|FG007|Overall Study|Failure to comply with visits|1|||
160817665|NCT01296711|580716906|FG000|Overall Study|Patient decision due to transport|0|||
160817666|NCT01296711|580716907|FG001|Overall Study|Patient decision due to transport|0|||
160817667|NCT01296711|580716908|FG002|Overall Study|Patient decision due to transport|0|||
160817668|NCT01296711|580716909|FG003|Overall Study|Patient decision due to transport|0|||
160817669|NCT01296711|580716910|FG004|Overall Study|Patient decision due to transport|0|||
160817670|NCT01296711|580716911|FG005|Overall Study|Patient decision due to transport|0|||
160817671|NCT01296711|580716912|FG006|Overall Study|Patient decision due to transport|0|||
160817672|NCT01296711|580716913|FG007|Overall Study|Patient decision due to transport|1|||
160817673|NCT00923975|580716919|FG000|Overall Study|Did not meet inclusion criteria|1|||
160817674|NCT01328535|580716920|FG000|Overall Study|Ineligible|1|||
160817675|NCT01005316|580716921|FG000|Overall Study|Adverse Event|0|||
160817676|NCT01005316|580716922|FG001|Overall Study|Adverse Event|0|||
160817677|NCT01005316|580716923|FG002|Overall Study|Adverse Event|0|||
160817678|NCT01005316|580716924|FG003|Overall Study|Adverse Event|1|||
160817679|NCT01005316|580716921|FG000|Overall Study|Death|20|||
160817680|NCT01005316|580716922|FG001|Overall Study|Death|5|||
160817681|NCT01005316|580716923|FG002|Overall Study|Death|1|||
160817682|NCT01005316|580716924|FG003|Overall Study|Death|15|||
160817683|NCT01005316|580716921|FG000|Overall Study|Study Termination|5|||
160817684|NCT01005316|580716922|FG001|Overall Study|Study Termination|63|||
160817685|NCT01005316|580716923|FG002|Overall Study|Study Termination|9|||
160817686|NCT01005316|580716924|FG003|Overall Study|Study Termination|85|||
160817687|NCT01005316|580716921|FG000|Overall Study|Lost to Follow-up|1|||
160817688|NCT01005316|580716922|FG001|Overall Study|Lost to Follow-up|3|||
160817689|NCT01005316|580716923|FG002|Overall Study|Lost to Follow-up|0|||
160817690|NCT01005316|580716924|FG003|Overall Study|Lost to Follow-up|2|||
160817691|NCT01005316|580716921|FG000|Overall Study|Physician Decision|6|||
160817692|NCT01005316|580716922|FG001|Overall Study|Physician Decision|0|||
160817693|NCT01005316|580716923|FG002|Overall Study|Physician Decision|0|||
160817694|NCT01005316|580716924|FG003|Overall Study|Physician Decision|0|||
160817695|NCT01005316|580716921|FG000|Overall Study|Sponsor Decision|6|||
160817696|NCT01005316|580716922|FG001|Overall Study|Sponsor Decision|3|||
160817697|NCT01005316|580716923|FG002|Overall Study|Sponsor Decision|0|||
160817698|NCT01005316|580716924|FG003|Overall Study|Sponsor Decision|0|||
160817699|NCT01005316|580716921|FG000|Overall Study|Withdrawal by Subject|1|||
160817700|NCT01005316|580716922|FG001|Overall Study|Withdrawal by Subject|1|||
160817701|NCT01005316|580716923|FG002|Overall Study|Withdrawal by Subject|0|||
160817702|NCT01005316|580716924|FG003|Overall Study|Withdrawal by Subject|2|||
160817703|NCT01005316|580716921|FG000|Overall Study|Consented to Another Study|2|||
160817704|NCT01005316|580716922|FG001|Overall Study|Consented to Another Study|0|||
160817705|NCT01005316|580716923|FG002|Overall Study|Consented to Another Study|0|||
160817706|NCT01005316|580716924|FG003|Overall Study|Consented to Another Study|0|||
160817707|NCT01005316|580716921|FG000|Overall Study|Delisted|8|||
160817708|NCT01005316|580716922|FG001|Overall Study|Delisted|0|||
160817709|NCT01005316|580716923|FG002|Overall Study|Delisted|0|||
160817710|NCT01005316|580716924|FG003|Overall Study|Delisted|0|||
160817711|NCT01005316|580716921|FG000|Overall Study|Transferred Care|1|||
160817712|NCT01005316|580716922|FG001|Overall Study|Transferred Care|0|||
160900393|NCT03487549|581028718|FG001|Overall Study|Withdrawal by Subject|0|||
160900394|NCT04092582|581030069|FG000|Overall Study|Death|1|||
160900395|NCT04092582|581030070|FG001|Overall Study|Death|1|||
160900396|NCT04092582|581030069|FG000|Overall Study|Withdrawal by Subject|4|||
160900397|NCT04092582|581030070|FG001|Overall Study|Withdrawal by Subject|1|||
160900398|NCT04092582|581030069|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
160900399|NCT04092582|581030070|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
160900400|NCT03019185|581030079|FG000|Overall Study|Lost to Follow-up|3|||
160900401|NCT03019185|581030080|FG001|Overall Study|Lost to Follow-up|0|||
160900402|NCT03019185|581030081|FG002|Overall Study|Lost to Follow-up|2|||
160987577|NCT02320721|581341176|FG000|Overall Study|Lack of Efficacy|2|||
160987578|NCT02320721|581341177|FG001|Overall Study|Lack of Efficacy|0|||
161132490|NCT00619957|581868984|FG000|Month 24 Double-Blind|Protocol Violation|1|||
161132491|NCT00619957|581868985|FG001|Month 24 Double-Blind|Protocol Violation|0|||
161132492|NCT00619957|581868984|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
160817713|NCT01005316|580716923|FG002|Overall Study|Transferred Care|1|||
160817714|NCT01005316|580716924|FG003|Overall Study|Transferred Care|3|||
160817715|NCT01005316|580716921|FG000|Overall Study|Retransplanted|0|||
160817716|NCT01005316|580716922|FG001|Overall Study|Retransplanted|1|||
160817717|NCT01005316|580716923|FG002|Overall Study|Retransplanted|0|||
160817718|NCT01005316|580716924|FG003|Overall Study|Retransplanted|0|||
160817719|NCT00632827|580716925|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
160817720|NCT00632827|580716925|FG000|Overall Study|Death|2|||
160817721|NCT00632827|580716925|FG000|Overall Study|Adverse Event|5|||
160817722|NCT00632827|580716925|FG000|Overall Study|Lost to Follow-up|1|||
160817723|NCT01035463|580716926|FG000|Overall Study|Adverse Event|0|||
160817724|NCT01035463|580716927|FG001|Overall Study|Adverse Event|0|||
160817725|NCT01035463|580716928|FG002|Overall Study|Adverse Event|4|||
160900403|NCT03019185|581030079|FG000|Overall Study|Withdrawal by Subject|1|||
161132493|NCT00619957|581868985|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
161132494|NCT00619957|581868984|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
161132495|NCT00619957|581868985|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
161132496|NCT00619957|581868984|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
161132497|NCT00619957|581868985|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
161132498|NCT00619957|581868984|FG000|Month 48 Open-Label|Adverse Event|4|||
161132499|NCT00619957|581868985|FG001|Month 48 Open-Label|Adverse Event|4|||
161132500|NCT00619957|581868984|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
161132501|NCT00619957|581868985|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
161132502|NCT00619957|581868984|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
161132503|NCT00619957|581868985|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
161132504|NCT00723957|581868986|FG000|Overall Study|Adverse event unrelated to study drug|1|||
161132505|NCT00723957|581868987|FG001|Overall Study|Adverse event unrelated to study drug|4|||
161132506|NCT00723957|581868986|FG000|Overall Study|Death|3|||
161132507|NCT00723957|581868987|FG001|Overall Study|Death|4|||
161132508|NCT00723957|581868986|FG000|Overall Study|Disease progression|27|||
161132509|NCT00723957|581868987|FG001|Overall Study|Disease progression|25|||
161132510|NCT00723957|581868986|FG000|Overall Study|Maximum clinical benefit|4|||
161132511|NCT00723957|581868987|FG001|Overall Study|Maximum clinical benefit|5|||
161132512|NCT00723957|581868986|FG000|Overall Study|Investigator decision|1|||
161132513|NCT00723957|581868987|FG001|Overall Study|Investigator decision|1|||
161132514|NCT00723957|581868986|FG000|Overall Study|Study drug toxicity|4|||
161132515|NCT00723957|581868987|FG001|Overall Study|Study drug toxicity|6|||
161132516|NCT00723957|581868986|FG000|Overall Study|Withdrawal by Subject|7|||
161132517|NCT00723957|581868987|FG001|Overall Study|Withdrawal by Subject|5|||
161132518|NCT00723957|581868986|FG000|Overall Study|Reason not analyzed|1|||
161132519|NCT00723957|581868987|FG001|Overall Study|Reason not analyzed|0|||
161132520|NCT00723957|581868986|FG000|Overall Study|Never received treatment|3|||
161132521|NCT00723957|581868987|FG001|Overall Study|Never received treatment|3|||
161132522|NCT01763164|581868989|FG000|Treatment Phase|Participant/Guardian decision|26|||
161132523|NCT01763164|581868990|FG001|Treatment Phase|Participant/Guardian decision|14|||
161132524|NCT01763164|581868989|FG000|Treatment Phase|Protocol Violation|1|||
161132525|NCT01763164|581868990|FG001|Treatment Phase|Protocol Violation|1|||
161132526|NCT01763164|581868989|FG000|Treatment Phase|Progressive Disease|142|||
161132527|NCT01763164|581868990|FG001|Treatment Phase|Progressive Disease|76|||
161132528|NCT01763164|581868989|FG000|Treatment Phase|Physician Decision|24|||
161132529|NCT01763164|581868990|FG001|Treatment Phase|Physician Decision|13|||
161132530|NCT01763164|581868989|FG000|Treatment Phase|Death|10|||
161132531|NCT01763164|581868990|FG001|Treatment Phase|Death|1|||
161132532|NCT01763164|581868989|FG000|Treatment Phase|Adverse Event|66|||
161132533|NCT01763164|581868990|FG001|Treatment Phase|Adverse Event|8|||
161132534|NCT01763164|581868989|FG000|Treatment Phase|Randomized but not Treated|0|||
161132535|NCT01763164|581868990|FG001|Treatment Phase|Randomized but not Treated|19|||
161132536|NCT01763164|581868989|FG000|Treatment Phase|Other|0|||
161132537|NCT01763164|581868990|FG001|Treatment Phase|Other|1|||
161132538|NCT01763164|581868989|FG000|Follow up Phase|New therapy for study indication|12|||
161132539|NCT01763164|581868990|FG001|Follow up Phase|New therapy for study indication|3|||
161132540|NCT01763164|581868989|FG000|Follow up Phase|Death|21|||
161132541|NCT01763164|581868990|FG001|Follow up Phase|Death|4|||
161132542|NCT01763164|581868989|FG000|Follow up Phase|Subject/guardian decision|9|||
161132543|NCT01763164|581868990|FG001|Follow up Phase|Subject/guardian decision|2|||
161132544|NCT01763164|581868989|FG000|Follow up Phase|Progressive disease|127|||
161132545|NCT01763164|581868990|FG001|Follow up Phase|Progressive disease|62|||
161132546|NCT01763164|581868989|FG000|Follow up Phase|Physician Decision|10|||
161132547|NCT01763164|581868990|FG001|Follow up Phase|Physician Decision|3|||
161132548|NCT01763164|581868989|FG000|Follow up Phase|Lost to Follow-up|1|||
161132549|NCT01763164|581868990|FG001|Follow up Phase|Lost to Follow-up|0|||
161132550|NCT01763164|581868989|FG000|Follow up Phase|Adverse Event|17|||
161132551|NCT01763164|581868990|FG001|Follow up Phase|Adverse Event|1|||
161132552|NCT04964258|581868991|FG000|Overall Study|Lost to Follow-up|1|||
161132553|NCT04964258|581868992|FG001|Overall Study|Lost to Follow-up|0|||
161132554|NCT04964258|581868993|FG002|Overall Study|Lost to Follow-up|0|||
160817726|NCT01035463|580716929|FG003|Overall Study|Adverse Event|1|||
160817727|NCT01035463|580716930|FG004|Overall Study|Adverse Event|5|||
160817728|NCT01035463|580716931|FG005|Overall Study|Adverse Event|7|||
160817729|NCT01035463|580716926|FG000|Overall Study|Withdrawal by Subject|0|||
160817730|NCT01035463|580716927|FG001|Overall Study|Withdrawal by Subject|2|||
161132555|NCT04964258|581868994|FG003|Overall Study|Lost to Follow-up|0|||
161132556|NCT04964258|581868995|FG004|Overall Study|Lost to Follow-up|0|||
161132557|NCT04964258|581868996|FG005|Overall Study|Lost to Follow-up|1|||
161132558|NCT04964258|581868997|FG006|Overall Study|Lost to Follow-up|0|||
161132559|NCT04964258|581868998|FG007|Overall Study|Lost to Follow-up|0|||
161132560|NCT04964258|581868999|FG008|Overall Study|Lost to Follow-up|0|||
161132561|NCT04964258|581869000|FG009|Overall Study|Lost to Follow-up|0|||
160817731|NCT01035463|580716928|FG002|Overall Study|Withdrawal by Subject|1|||
161132562|NCT04964258|581869001|FG010|Overall Study|Lost to Follow-up|0|||
161132563|NCT02965378|581869002|FG000|Overall Study|Progression|16|||
161132564|NCT02965378|581869003|FG001|Overall Study|Progression|4|||
160817732|NCT01035463|580716929|FG003|Overall Study|Withdrawal by Subject|0|||
160817733|NCT01035463|580716930|FG004|Overall Study|Withdrawal by Subject|1|||
160817734|NCT01035463|580716931|FG005|Overall Study|Withdrawal by Subject|4|||
160817735|NCT01035463|580716926|FG000|Overall Study|Disease progression|0|||
160817736|NCT01035463|580716927|FG001|Overall Study|Disease progression|0|||
160817737|NCT01035463|580716928|FG002|Overall Study|Disease progression|0|||
160817738|NCT01035463|580716929|FG003|Overall Study|Disease progression|0|||
160817739|NCT01035463|580716930|FG004|Overall Study|Disease progression|0|||
160817740|NCT01035463|580716931|FG005|Overall Study|Disease progression|3|||
160817741|NCT01035463|580716926|FG000|Overall Study|Other Malignancy|0|||
160817742|NCT01035463|580716927|FG001|Overall Study|Other Malignancy|0|||
160817743|NCT01035463|580716928|FG002|Overall Study|Other Malignancy|0|||
160817744|NCT01035463|580716929|FG003|Overall Study|Other Malignancy|0|||
160817745|NCT01035463|580716930|FG004|Overall Study|Other Malignancy|0|||
160817746|NCT01035463|580716931|FG005|Overall Study|Other Malignancy|2|||
160817747|NCT01035463|580716926|FG000|Overall Study|Other|0|||
160817748|NCT01035463|580716927|FG001|Overall Study|Other|0|||
160817749|NCT01035463|580716928|FG002|Overall Study|Other|0|||
160817750|NCT01035463|580716929|FG003|Overall Study|Other|1|||
160817751|NCT01035463|580716930|FG004|Overall Study|Other|0|||
160817752|NCT01035463|580716931|FG005|Overall Study|Other|2|||
160817753|NCT01126268|580716936|FG000|Overall Study|Adverse Event|1|||
160817754|NCT03070171|580716943|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
160817755|NCT03070171|580716944|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
160817756|NCT03070171|580716943|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
160817757|NCT03070171|580716944|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
160817758|NCT03655054|580716950|FG000|Overall Study|Lost to Follow-up|1|||
160817759|NCT01626118|580716951|FG000|Overall Study|Lack of Efficacy|1|||
160817760|NCT01626118|580716952|FG001|Overall Study|Lack of Efficacy|0|||
160817761|NCT01626118|580716953|FG002|Overall Study|Lack of Efficacy|1|||
160817762|NCT01626118|580716954|FG003|Overall Study|Lack of Efficacy|3|||
160817763|NCT01626118|580716951|FG000|Overall Study|Lost to Follow-up|1|||
160817764|NCT01626118|580716952|FG001|Overall Study|Lost to Follow-up|0|||
160817765|NCT01626118|580716953|FG002|Overall Study|Lost to Follow-up|0|||
160817766|NCT01626118|580716954|FG003|Overall Study|Lost to Follow-up|0|||
160817767|NCT01626118|580716951|FG000|Overall Study|Adverse Event|0|||
160817768|NCT01626118|580716952|FG001|Overall Study|Adverse Event|1|||
160817769|NCT01626118|580716953|FG002|Overall Study|Adverse Event|1|||
160817770|NCT01626118|580716954|FG003|Overall Study|Adverse Event|0|||
160817771|NCT01626118|580716951|FG000|Overall Study|Investigator Decision|0|||
160817772|NCT01626118|580716952|FG001|Overall Study|Investigator Decision|1|||
160817773|NCT01626118|580716953|FG002|Overall Study|Investigator Decision|0|||
160817774|NCT01626118|580716954|FG003|Overall Study|Investigator Decision|0|||
160817775|NCT00002540|580716955|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
160817776|NCT00002540|580716956|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
160817777|NCT00002540|580716955|FG000|Overall Study|Died Before Randomization|2|||
160817778|NCT00002540|580716956|FG001|Overall Study|Died Before Randomization|6|||
160817779|NCT00002540|580716955|FG000|Overall Study|Died Before ASU (Control)|202|||
160817780|NCT00002540|580716956|FG001|Overall Study|Died Before ASU (Control)|0|||
160817781|NCT00002540|580716955|FG000|Overall Study|Refused ASU (Control)|597|||
160817782|NCT00002540|580716956|FG001|Overall Study|Refused ASU (Control)|0|||
160817783|NCT00002540|580716955|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
160817784|NCT00002540|580716956|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
160817785|NCT00778375|580716959|FG000|Overall Study|Ineligible|3|||
160817786|NCT00712725|580716963|FG000|Overall Study|Adverse Event|1|||
160817787|NCT00712725|580716964|FG001|Overall Study|Adverse Event|0|||
160817788|NCT00712725|580716965|FG002|Overall Study|Adverse Event|0|||
160817789|NCT00712725|580716966|FG003|Overall Study|Adverse Event|1|||
160817790|NCT00712725|580716967|FG004|Overall Study|Adverse Event|0|||
160817791|NCT00712725|580716968|FG005|Overall Study|Adverse Event|0|||
160817792|NCT00712725|580716969|FG006|Overall Study|Adverse Event|0|||
160817793|NCT00712725|580716970|FG007|Overall Study|Adverse Event|0|||
160817794|NCT00712725|580716963|FG000|Overall Study|Lost to Follow-up|3|||
160817795|NCT00712725|580716964|FG001|Overall Study|Lost to Follow-up|2|||
160900404|NCT03019185|581030080|FG001|Overall Study|Withdrawal by Subject|1|||
160817796|NCT00712725|580716965|FG002|Overall Study|Lost to Follow-up|1|||
160817797|NCT00712725|580716966|FG003|Overall Study|Lost to Follow-up|1|||
160817798|NCT00712725|580716967|FG004|Overall Study|Lost to Follow-up|2|||
160817799|NCT00712725|580716968|FG005|Overall Study|Lost to Follow-up|2|||
160817800|NCT00712725|580716969|FG006|Overall Study|Lost to Follow-up|3|||
160817801|NCT00712725|580716970|FG007|Overall Study|Lost to Follow-up|1|||
160817802|NCT00712725|580716963|FG000|Overall Study|Physician Decision|2|||
160817803|NCT00712725|580716964|FG001|Overall Study|Physician Decision|0|||
160817804|NCT00712725|580716965|FG002|Overall Study|Physician Decision|0|||
160817805|NCT00712725|580716966|FG003|Overall Study|Physician Decision|0|||
160817806|NCT00712725|580716967|FG004|Overall Study|Physician Decision|1|||
160817807|NCT00712725|580716968|FG005|Overall Study|Physician Decision|0|||
160817808|NCT00712725|580716969|FG006|Overall Study|Physician Decision|2|||
160900405|NCT03019185|581030081|FG002|Overall Study|Withdrawal by Subject|0|||
160817809|NCT00712725|580716970|FG007|Overall Study|Physician Decision|0|||
160817810|NCT00712725|580716963|FG000|Overall Study|Pregnancy|0|||
160817811|NCT00712725|580716964|FG001|Overall Study|Pregnancy|1|||
160817812|NCT00712725|580716965|FG002|Overall Study|Pregnancy|0|||
160817813|NCT00712725|580716966|FG003|Overall Study|Pregnancy|0|||
160817814|NCT00712725|580716967|FG004|Overall Study|Pregnancy|1|||
160817815|NCT00712725|580716968|FG005|Overall Study|Pregnancy|0|||
160817816|NCT00712725|580716969|FG006|Overall Study|Pregnancy|2|||
160817817|NCT00712725|580716970|FG007|Overall Study|Pregnancy|0|||
160817818|NCT00712725|580716963|FG000|Overall Study|Protocol Violation|2|||
160817819|NCT00712725|580716964|FG001|Overall Study|Protocol Violation|0|||
160817820|NCT00712725|580716965|FG002|Overall Study|Protocol Violation|1|||
160817821|NCT00712725|580716966|FG003|Overall Study|Protocol Violation|3|||
160817822|NCT00712725|580716967|FG004|Overall Study|Protocol Violation|2|||
160817823|NCT00712725|580716968|FG005|Overall Study|Protocol Violation|0|||
160817824|NCT00712725|580716969|FG006|Overall Study|Protocol Violation|1|||
160817825|NCT00712725|580716970|FG007|Overall Study|Protocol Violation|1|||
160817826|NCT00712725|580716963|FG000|Overall Study|Withdrawal by Subject|2|||
160817827|NCT00712725|580716964|FG001|Overall Study|Withdrawal by Subject|1|||
160817828|NCT00712725|580716965|FG002|Overall Study|Withdrawal by Subject|1|||
160817829|NCT00712725|580716966|FG003|Overall Study|Withdrawal by Subject|2|||
160817830|NCT00712725|580716967|FG004|Overall Study|Withdrawal by Subject|1|||
160817831|NCT00712725|580716968|FG005|Overall Study|Withdrawal by Subject|1|||
160817832|NCT00712725|580716969|FG006|Overall Study|Withdrawal by Subject|1|||
160817833|NCT00712725|580716970|FG007|Overall Study|Withdrawal by Subject|2|||
160817834|NCT00712725|580716963|FG000|Overall Study|Lack of Qualifying Event|16|||
160817835|NCT00712725|580716964|FG001|Overall Study|Lack of Qualifying Event|2|||
160817836|NCT00712725|580716965|FG002|Overall Study|Lack of Qualifying Event|6|||
160817837|NCT00712725|580716966|FG003|Overall Study|Lack of Qualifying Event|8|||
160817838|NCT00712725|580716967|FG004|Overall Study|Lack of Qualifying Event|11|||
160817839|NCT00712725|580716968|FG005|Overall Study|Lack of Qualifying Event|13|||
160817840|NCT00712725|580716969|FG006|Overall Study|Lack of Qualifying Event|11|||
160817841|NCT00712725|580716970|FG007|Overall Study|Lack of Qualifying Event|6|||
160817842|NCT00712725|580716963|FG000|Overall Study|Protocol Specified Criteria|3|||
160817843|NCT00712725|580716964|FG001|Overall Study|Protocol Specified Criteria|0|||
160817844|NCT00712725|580716965|FG002|Overall Study|Protocol Specified Criteria|1|||
160817845|NCT00712725|580716966|FG003|Overall Study|Protocol Specified Criteria|2|||
160817846|NCT00712725|580716967|FG004|Overall Study|Protocol Specified Criteria|1|||
160817847|NCT00712725|580716968|FG005|Overall Study|Protocol Specified Criteria|0|||
160817848|NCT00712725|580716969|FG006|Overall Study|Protocol Specified Criteria|2|||
160817849|NCT00712725|580716970|FG007|Overall Study|Protocol Specified Criteria|1|||
160817850|NCT01901289|580716971|FG000|Overall Study|Death|32|||
160817851|NCT01901289|580716971|FG000|Overall Study|Lost to Follow-up|16|||
160817852|NCT01901289|580716971|FG000|Overall Study|Withdrawal by Subject|35|||
160817853|NCT01901289|580716971|FG000|Overall Study|Other type of endpoint met|2|||
160817854|NCT00700882|580716972|FG000|Overall Study|Never received treatment|6|||
160987579|NCT02320721|581341176|FG000|Overall Study|Poor compliance to protocol|3|||
160817855|NCT00700882|580716972|FG000|Overall Study|Ineligible|2|||
160817856|NCT00700882|580716972|FG000|Overall Study|No KIT mutation|51|||
160817857|NCT01814397|580716982|FG000|Overall Study|Adverse Event|7|||
160817858|NCT01814397|580716982|FG000|Overall Study|Withdrawal by Subject|7|||
160817859|NCT00290771|580716983|FG000|Overall Study|Disease progression|95|||
160817860|NCT00290771|580716984|FG001|Overall Study|Disease progression|73|||
160817861|NCT00290771|580716983|FG000|Overall Study|Death|11|||
160817862|NCT00290771|580716984|FG001|Overall Study|Death|10|||
160817863|NCT00290771|580716983|FG000|Overall Study|Adverse Event|12|||
160817864|NCT00290771|580716984|FG001|Overall Study|Adverse Event|6|||
160987580|NCT02320721|581341177|FG001|Overall Study|Poor compliance to protocol|7|||
160987581|NCT02320721|581341176|FG000|Overall Study|Randomized but not treated|0|||
160987582|NCT02320721|581341177|FG001|Overall Study|Randomized but not treated|1|||
160987583|NCT02320721|581341176|FG000|Overall Study|Hypoglycemia|1|||
160987584|NCT02320721|581341177|FG001|Overall Study|Hypoglycemia|0|||
160987585|NCT02320721|581341176|FG000|Overall Study|Other than specified above|15|||
161333749|NCT00617357|582610623|FG000|Overall Study|Lost to Follow-up|7|||
160817865|NCT00290771|580716983|FG000|Overall Study|Withdrawal by Subject|5|||
160817866|NCT00290771|580716984|FG001|Overall Study|Withdrawal by Subject|6|||
160817867|NCT00290771|580716983|FG000|Overall Study|Administrative problems|2|||
160817868|NCT00290771|580716984|FG001|Overall Study|Administrative problems|1|||
160817869|NCT00290771|580716983|FG000|Overall Study|Protocol Violation|2|||
160817870|NCT00290771|580716984|FG001|Overall Study|Protocol Violation|0|||
160817871|NCT00290771|580716983|FG000|Overall Study|Lost to Follow-up|0|||
160817872|NCT00290771|580716984|FG001|Overall Study|Lost to Follow-up|1|||
160817873|NCT04154293|580716987|FG000|Overall Study|Withdrawal by Subject|2|||
160817874|NCT04154293|580716988|FG001|Overall Study|Withdrawal by Subject|3|||
160817875|NCT04154293|580716989|FG002|Overall Study|Withdrawal by Subject|1|||
160817876|NCT04154293|580716987|FG000|Overall Study|Physician Decision|0|||
160817877|NCT04154293|580716988|FG001|Overall Study|Physician Decision|0|||
160987586|NCT02320721|581341177|FG001|Overall Study|Other than specified above|20|||
160817878|NCT04154293|580716989|FG002|Overall Study|Physician Decision|1|||
160817879|NCT03703817|580716990|FG000|Overall Study|Not meeting eligibility criteria|7|||
160817880|NCT03703817|580716991|FG001|Overall Study|Not meeting eligibility criteria|4|||
160817881|NCT02791516|580716992|FG000|Overall Study|Withdrawal by Subject|1|||
160817882|NCT02791516|580716993|FG001|Overall Study|Withdrawal by Subject|1|||
160817883|NCT02524275|580716994|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
160817884|NCT01439971|580716995|FG000|Overall Study|Required number in cohort dosed|0|||
160817885|NCT01439971|580716996|FG001|Overall Study|Required number in cohort dosed|1|||
160817886|NCT01439971|580716997|FG002|Overall Study|Required number in cohort dosed|2|||
160817887|NCT01439971|580716998|FG003|Overall Study|Required number in cohort dosed|0|||
160817888|NCT01439971|580716999|FG004|Overall Study|Required number in cohort dosed|1|||
160817889|NCT02628600|580717002|FG000|Overall Study|Death|2|||
160817890|NCT02628600|580717003|FG001|Overall Study|Death|1|||
160817891|NCT02628600|580717002|FG000|Overall Study|Adverse Event|3|||
160817892|NCT02628600|580717003|FG001|Overall Study|Adverse Event|20|||
160817893|NCT02628600|580717002|FG000|Overall Study|Protocol Violation|0|||
160817894|NCT02628600|580717003|FG001|Overall Study|Protocol Violation|1|||
160817895|NCT02628600|580717002|FG000|Overall Study|Lack of Efficacy|2|||
160817896|NCT02628600|580717003|FG001|Overall Study|Lack of Efficacy|0|||
160817897|NCT02628600|580717002|FG000|Overall Study|Withdrawal by Subject|13|||
160817898|NCT02628600|580717003|FG001|Overall Study|Withdrawal by Subject|8|||
160817899|NCT02628600|580717002|FG000|Overall Study|Lost to Follow-up|1|||
160817900|NCT02628600|580717003|FG001|Overall Study|Lost to Follow-up|0|||
160817901|NCT02628600|580717002|FG000|Overall Study|Physician Decision|2|||
160817902|NCT02628600|580717003|FG001|Overall Study|Physician Decision|2|||
160817903|NCT02628600|580717002|FG000|Overall Study|Other not specified|1|||
160817904|NCT02628600|580717003|FG001|Overall Study|Other not specified|0|||
160817905|NCT00107900|580717008|FG000|Overall Study|Adverse Event|3|||
160817906|NCT00107900|580717009|FG001|Overall Study|Adverse Event|2|||
160817907|NCT00107900|580717010|FG002|Overall Study|Adverse Event|10|||
160817908|NCT00107900|580717011|FG003|Overall Study|Adverse Event|3|||
160817909|NCT00107900|580717012|FG004|Overall Study|Adverse Event|5|||
160817910|NCT00107900|580717013|FG005|Overall Study|Adverse Event|3|||
160817911|NCT00107900|580717008|FG000|Overall Study|Death|0|||
160817912|NCT00107900|580717009|FG001|Overall Study|Death|0|||
160817913|NCT00107900|580717010|FG002|Overall Study|Death|0|||
160817914|NCT00107900|580717011|FG003|Overall Study|Death|0|||
160817915|NCT00107900|580717012|FG004|Overall Study|Death|1|||
160817916|NCT00107900|580717013|FG005|Overall Study|Death|0|||
160817917|NCT00107900|580717008|FG000|Overall Study|Lost to Follow-up|4|||
160817918|NCT00107900|580717009|FG001|Overall Study|Lost to Follow-up|1|||
160817919|NCT00107900|580717010|FG002|Overall Study|Lost to Follow-up|3|||
160817920|NCT00107900|580717011|FG003|Overall Study|Lost to Follow-up|2|||
160817921|NCT00107900|580717012|FG004|Overall Study|Lost to Follow-up|5|||
160817922|NCT00107900|580717013|FG005|Overall Study|Lost to Follow-up|5|||
160817923|NCT00107900|580717008|FG000|Overall Study|Protocol Violation|1|||
160817924|NCT00107900|580717009|FG001|Overall Study|Protocol Violation|0|||
160817925|NCT00107900|580717010|FG002|Overall Study|Protocol Violation|5|||
160817926|NCT00107900|580717011|FG003|Overall Study|Protocol Violation|5|||
160817927|NCT00107900|580717012|FG004|Overall Study|Protocol Violation|7|||
160817928|NCT00107900|580717013|FG005|Overall Study|Protocol Violation|0|||
160817929|NCT00107900|580717008|FG000|Overall Study|Withdrawal by Subject|1|||
160817930|NCT00107900|580717009|FG001|Overall Study|Withdrawal by Subject|0|||
160817931|NCT00107900|580717010|FG002|Overall Study|Withdrawal by Subject|5|||
160817932|NCT00107900|580717011|FG003|Overall Study|Withdrawal by Subject|0|||
160817933|NCT00107900|580717012|FG004|Overall Study|Withdrawal by Subject|1|||
160817934|NCT00107900|580717013|FG005|Overall Study|Withdrawal by Subject|1|||
160817935|NCT00107900|580717008|FG000|Overall Study|Administrative Reasons|1|||
160817936|NCT00107900|580717009|FG001|Overall Study|Administrative Reasons|0|||
160900406|NCT03019185|581030079|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
161132565|NCT02965378|581869002|FG000|Overall Study|Adverse Event|5|||
161333750|NCT00617357|582610623|FG000|Overall Study|Death|5|||
160817937|NCT00107900|580717010|FG002|Overall Study|Administrative Reasons|2|||
160817938|NCT00107900|580717011|FG003|Overall Study|Administrative Reasons|2|||
160817939|NCT00107900|580717012|FG004|Overall Study|Administrative Reasons|2|||
160817940|NCT00107900|580717013|FG005|Overall Study|Administrative Reasons|0|||
160817941|NCT03724981|580719442|FG000|First Device|Protocol Violation|1|||
160900407|NCT03019185|581030080|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
160817942|NCT03724981|580719443|FG001|First Device|Protocol Violation|1|||
160817943|NCT00511433|580719444|FG000|Overall Study|Adverse Event|5|||
160817944|NCT00511433|580719445|FG001|Overall Study|Adverse Event|0|||
160817945|NCT00511433|580719444|FG000|Overall Study|Other Reason|1|||
160817946|NCT00511433|580719445|FG001|Overall Study|Other Reason|1|||
160817947|NCT02791191|580719446|FG000|Overall Study|Adverse Event|2|||
160817948|NCT02791191|580719447|FG001|Overall Study|Adverse Event|4|||
160817949|NCT02791191|580719448|FG002|Overall Study|Adverse Event|5|||
160817950|NCT02791191|580719446|FG000|Overall Study|Lack of Efficacy|0|||
160817951|NCT02791191|580719447|FG001|Overall Study|Lack of Efficacy|1|||
160817952|NCT02791191|580719448|FG002|Overall Study|Lack of Efficacy|0|||
160817953|NCT02791191|580719446|FG000|Overall Study|Study Drug Non-Compliance|0|||
160817954|NCT02791191|580719447|FG001|Overall Study|Study Drug Non-Compliance|2|||
160817955|NCT02791191|580719448|FG002|Overall Study|Study Drug Non-Compliance|0|||
160817956|NCT02791191|580719446|FG000|Overall Study|Site Closed by Sponsor|1|||
160817957|NCT02791191|580719447|FG001|Overall Study|Site Closed by Sponsor|1|||
160817958|NCT02791191|580719448|FG002|Overall Study|Site Closed by Sponsor|3|||
160817959|NCT02791191|580719446|FG000|Overall Study|Progressive Disease|1|||
160817960|NCT02791191|580719447|FG001|Overall Study|Progressive Disease|0|||
160817961|NCT02791191|580719448|FG002|Overall Study|Progressive Disease|0|||
160817962|NCT02791191|580719446|FG000|Overall Study|Study Terminated by Sponsor|29|||
160817963|NCT02791191|580719447|FG001|Overall Study|Study Terminated by Sponsor|101|||
160817964|NCT02791191|580719448|FG002|Overall Study|Study Terminated by Sponsor|109|||
160817965|NCT02791191|580719446|FG000|Overall Study|Withdrawal by Subject|3|||
160817966|NCT02791191|580719447|FG001|Overall Study|Withdrawal by Subject|1|||
160817967|NCT02791191|580719448|FG002|Overall Study|Withdrawal by Subject|3|||
160817968|NCT02791191|580719446|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
160817969|NCT02791191|580719447|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
160817970|NCT02791191|580719448|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
160817971|NCT01952665|580719450|FG000|Overall Study|Physician Decision|3|||
160817972|NCT01952665|580719451|FG001|Overall Study|Physician Decision|2|||
161132566|NCT02965378|581869003|FG001|Overall Study|Adverse Event|2|||
161132567|NCT02965378|581869002|FG000|Overall Study|Death|2|||
160817973|NCT01952665|580719450|FG000|Overall Study|Lost to Follow-up|1|||
160817974|NCT01952665|580719451|FG001|Overall Study|Lost to Follow-up|2|||
160817975|NCT01952665|580719450|FG000|Overall Study|Adverse Event|2|||
160817976|NCT01952665|580719451|FG001|Overall Study|Adverse Event|1|||
160817977|NCT01952665|580719450|FG000|Overall Study|Protocol Violation|0|||
160817978|NCT01952665|580719451|FG001|Overall Study|Protocol Violation|1|||
160817979|NCT00185380|580719468|FG000|Overall Study|Adverse Event|41|||
160817980|NCT00185380|580719469|FG001|Overall Study|Adverse Event|43|||
160817981|NCT00185380|580719470|FG002|Overall Study|Adverse Event|48|||
160817982|NCT00185380|580719468|FG000|Overall Study|Lost to Follow-up|0|||
160817983|NCT00185380|580719469|FG001|Overall Study|Lost to Follow-up|4|||
160817984|NCT00185380|580719470|FG002|Overall Study|Lost to Follow-up|3|||
160817985|NCT00185380|580719468|FG000|Overall Study|Pregnancy|1|||
160817986|NCT00185380|580719469|FG001|Overall Study|Pregnancy|4|||
160817987|NCT00185380|580719470|FG002|Overall Study|Pregnancy|0|||
160817988|NCT00185380|580719468|FG000|Overall Study|Protocol Violation|2|||
160817989|NCT00185380|580719469|FG001|Overall Study|Protocol Violation|2|||
160817990|NCT00185380|580719470|FG002|Overall Study|Protocol Violation|1|||
160817991|NCT00185380|580719468|FG000|Overall Study|Withdrawal by Subject|1|||
160817992|NCT00185380|580719469|FG001|Overall Study|Withdrawal by Subject|2|||
160817993|NCT00185380|580719470|FG002|Overall Study|Withdrawal by Subject|0|||
160817994|NCT00185380|580719468|FG000|Overall Study|Failed insertion|1|||
160817995|NCT00185380|580719469|FG001|Overall Study|Failed insertion|1|||
160817996|NCT00185380|580719470|FG002|Overall Study|Failed insertion|2|||
160817997|NCT00185380|580719468|FG000|Overall Study|Planned pregnancy|9|||
160817998|NCT00185380|580719469|FG001|Overall Study|Planned pregnancy|12|||
160817999|NCT00185380|580719470|FG002|Overall Study|Planned pregnancy|12|||
160818000|NCT00185380|580719468|FG000|Overall Study|No need for contraception|3|||
160818001|NCT00185380|580719469|FG001|Overall Study|No need for contraception|3|||
160818002|NCT00185380|580719470|FG002|Overall Study|No need for contraception|3|||
160818003|NCT00185380|580719468|FG000|Overall Study|Could not attend visits|2|||
160818004|NCT00185380|580719469|FG001|Overall Study|Could not attend visits|0|||
160818005|NCT00185380|580719470|FG002|Overall Study|Could not attend visits|4|||
160818006|NCT00185380|580719468|FG000|Overall Study|personal reason|6|||
160818007|NCT00185380|580719469|FG001|Overall Study|personal reason|1|||
160818008|NCT00185380|580719470|FG002|Overall Study|personal reason|1|||
160818009|NCT02589665|580719471|FG000|Induction Period|Did not receive drug|0|||
160818010|NCT02589665|580719472|FG001|Induction Period|Did not receive drug|0|||
160818011|NCT02589665|580719473|FG002|Induction Period|Did not receive drug|0|||
160818012|NCT02589665|580719474|FG003|Induction Period|Did not receive drug|1|||
160818013|NCT02589665|580719475|FG004|Induction Period|Did not receive drug|0|||
160818014|NCT02589665|580719476|FG005|Induction Period|Did not receive drug|0|||
160818015|NCT02589665|580719477|FG006|Induction Period|Did not receive drug|0|||
160818016|NCT02589665|580719478|FG007|Induction Period|Did not receive drug|0|||
160818017|NCT02589665|580719479|FG008|Induction Period|Did not receive drug|0|||
160818018|NCT02589665|580719480|FG009|Induction Period|Did not receive drug|0|||
160818019|NCT02589665|580719471|FG000|Induction Period|Adverse Event|3|||
160818020|NCT02589665|580719472|FG001|Induction Period|Adverse Event|0|||
160818021|NCT02589665|580719473|FG002|Induction Period|Adverse Event|2|||
160818022|NCT02589665|580719474|FG003|Induction Period|Adverse Event|2|||
160818023|NCT02589665|580719475|FG004|Induction Period|Adverse Event|0|||
160818024|NCT02589665|580719476|FG005|Induction Period|Adverse Event|0|||
160818025|NCT02589665|580719477|FG006|Induction Period|Adverse Event|0|||
160818026|NCT02589665|580719478|FG007|Induction Period|Adverse Event|0|||
160818027|NCT02589665|580719479|FG008|Induction Period|Adverse Event|0|||
160818028|NCT02589665|580719480|FG009|Induction Period|Adverse Event|0|||
160818029|NCT02589665|580719471|FG000|Induction Period|Withdrawal by Subject|0|||
160818030|NCT02589665|580719472|FG001|Induction Period|Withdrawal by Subject|1|||
160818031|NCT02589665|580719473|FG002|Induction Period|Withdrawal by Subject|0|||
160818032|NCT02589665|580719474|FG003|Induction Period|Withdrawal by Subject|1|||
160818033|NCT02589665|580719475|FG004|Induction Period|Withdrawal by Subject|0|||
160818034|NCT02589665|580719476|FG005|Induction Period|Withdrawal by Subject|0|||
160818035|NCT02589665|580719477|FG006|Induction Period|Withdrawal by Subject|0|||
160818036|NCT02589665|580719478|FG007|Induction Period|Withdrawal by Subject|0|||
160818037|NCT02589665|580719479|FG008|Induction Period|Withdrawal by Subject|0|||
160818038|NCT02589665|580719480|FG009|Induction Period|Withdrawal by Subject|0|||
160818039|NCT02589665|580719471|FG000|Induction Period|Protocol Violation|0|||
160818040|NCT02589665|580719472|FG001|Induction Period|Protocol Violation|1|||
160818041|NCT02589665|580719473|FG002|Induction Period|Protocol Violation|0|||
160818042|NCT02589665|580719474|FG003|Induction Period|Protocol Violation|0|||
160818043|NCT02589665|580719475|FG004|Induction Period|Protocol Violation|0|||
160818044|NCT02589665|580719476|FG005|Induction Period|Protocol Violation|0|||
160818045|NCT02589665|580719477|FG006|Induction Period|Protocol Violation|0|||
160818046|NCT02589665|580719478|FG007|Induction Period|Protocol Violation|0|||
160818047|NCT02589665|580719479|FG008|Induction Period|Protocol Violation|0|||
160818048|NCT02589665|580719480|FG009|Induction Period|Protocol Violation|0|||
160818049|NCT02589665|580719471|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818050|NCT02589665|580719472|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818051|NCT02589665|580719473|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818052|NCT02589665|580719474|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818053|NCT02589665|580719475|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
160818054|NCT02589665|580719476|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
160818055|NCT02589665|580719477|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
160818056|NCT02589665|580719478|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818057|NCT02589665|580719479|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818058|NCT02589665|580719480|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818059|NCT02589665|580719471|FG000|Maintenance Period|Withdrawal by Subject|0|||
160818060|NCT02589665|580719472|FG001|Maintenance Period|Withdrawal by Subject|0|||
160818061|NCT02589665|580719473|FG002|Maintenance Period|Withdrawal by Subject|0|||
160818062|NCT02589665|580719474|FG003|Maintenance Period|Withdrawal by Subject|0|||
160818063|NCT02589665|580719475|FG004|Maintenance Period|Withdrawal by Subject|4|||
160818064|NCT02589665|580719476|FG005|Maintenance Period|Withdrawal by Subject|2|||
160818065|NCT02589665|580719477|FG006|Maintenance Period|Withdrawal by Subject|4|||
160818066|NCT02589665|580719478|FG007|Maintenance Period|Withdrawal by Subject|0|||
160818067|NCT02589665|580719479|FG008|Maintenance Period|Withdrawal by Subject|0|||
160818068|NCT02589665|580719480|FG009|Maintenance Period|Withdrawal by Subject|0|||
160818069|NCT02589665|580719471|FG000|Maintenance Period|Lack of Efficacy|0|||
160818070|NCT02589665|580719472|FG001|Maintenance Period|Lack of Efficacy|0|||
160818071|NCT02589665|580719473|FG002|Maintenance Period|Lack of Efficacy|0|||
160818072|NCT02589665|580719474|FG003|Maintenance Period|Lack of Efficacy|0|||
160818073|NCT02589665|580719475|FG004|Maintenance Period|Lack of Efficacy|2|||
160818074|NCT02589665|580719476|FG005|Maintenance Period|Lack of Efficacy|1|||
160818075|NCT02589665|580719477|FG006|Maintenance Period|Lack of Efficacy|0|||
160818076|NCT02589665|580719478|FG007|Maintenance Period|Lack of Efficacy|0|||
160818077|NCT02589665|580719479|FG008|Maintenance Period|Lack of Efficacy|0|||
160818078|NCT02589665|580719480|FG009|Maintenance Period|Lack of Efficacy|0|||
160818079|NCT02589665|580719471|FG000|Maintenance Period|Adverse Event|0|||
160818080|NCT02589665|580719472|FG001|Maintenance Period|Adverse Event|0|||
160818081|NCT02589665|580719473|FG002|Maintenance Period|Adverse Event|0|||
160818082|NCT02589665|580719474|FG003|Maintenance Period|Adverse Event|0|||
160818083|NCT02589665|580719475|FG004|Maintenance Period|Adverse Event|0|||
160818084|NCT02589665|580719476|FG005|Maintenance Period|Adverse Event|0|||
160818085|NCT02589665|580719477|FG006|Maintenance Period|Adverse Event|2|||
160900408|NCT03019185|581030081|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
160900409|NCT03019185|581030079|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
160900410|NCT03019185|581030080|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
160900411|NCT03019185|581030081|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
160900412|NCT01303861|581030089|FG000|Overall Study|Lost to Follow-up|34|||
160900413|NCT01303861|581030090|FG001|Overall Study|Lost to Follow-up|14|||
160900414|NCT01303861|581030091|FG002|Overall Study|Lost to Follow-up|27|||
160987587|NCT03173248|581341178|FG000|Overall Study|Death|28|||
160987588|NCT03173248|581341179|FG001|Overall Study|Death|46|||
160987589|NCT03173248|581341178|FG000|Overall Study|Lost to Follow-up|0|||
160987590|NCT03173248|581341179|FG001|Overall Study|Lost to Follow-up|1|||
160818086|NCT02589665|580719478|FG007|Maintenance Period|Adverse Event|0|||
160818087|NCT02589665|580719479|FG008|Maintenance Period|Adverse Event|0|||
160818088|NCT02589665|580719480|FG009|Maintenance Period|Adverse Event|0|||
160818089|NCT02589665|580719471|FG000|Maintenance Period|Lost to Follow-up|0|||
160818090|NCT02589665|580719472|FG001|Maintenance Period|Lost to Follow-up|0|||
160818091|NCT02589665|580719473|FG002|Maintenance Period|Lost to Follow-up|0|||
160818092|NCT02589665|580719474|FG003|Maintenance Period|Lost to Follow-up|0|||
160818093|NCT02589665|580719475|FG004|Maintenance Period|Lost to Follow-up|0|||
160818094|NCT02589665|580719476|FG005|Maintenance Period|Lost to Follow-up|1|||
160818095|NCT02589665|580719477|FG006|Maintenance Period|Lost to Follow-up|0|||
160818096|NCT02589665|580719478|FG007|Maintenance Period|Lost to Follow-up|0|||
160818097|NCT02589665|580719479|FG008|Maintenance Period|Lost to Follow-up|0|||
160818098|NCT02589665|580719480|FG009|Maintenance Period|Lost to Follow-up|0|||
160818099|NCT02589665|580719471|FG000|Maintenance Period|Physician Decision|0|||
160818100|NCT02589665|580719472|FG001|Maintenance Period|Physician Decision|0|||
160818101|NCT02589665|580719473|FG002|Maintenance Period|Physician Decision|0|||
160818102|NCT02589665|580719474|FG003|Maintenance Period|Physician Decision|0|||
160818103|NCT02589665|580719475|FG004|Maintenance Period|Physician Decision|0|||
160818104|NCT02589665|580719476|FG005|Maintenance Period|Physician Decision|1|||
160818105|NCT02589665|580719477|FG006|Maintenance Period|Physician Decision|0|||
160818106|NCT02589665|580719478|FG007|Maintenance Period|Physician Decision|0|||
160818107|NCT02589665|580719479|FG008|Maintenance Period|Physician Decision|0|||
160818108|NCT02589665|580719480|FG009|Maintenance Period|Physician Decision|0|||
160818109|NCT02589665|580719471|FG000|Maintenance Period|Reason Not Collected|0|||
160818110|NCT02589665|580719472|FG001|Maintenance Period|Reason Not Collected|0|||
160818111|NCT02589665|580719473|FG002|Maintenance Period|Reason Not Collected|0|||
160818112|NCT02589665|580719474|FG003|Maintenance Period|Reason Not Collected|0|||
160818113|NCT02589665|580719475|FG004|Maintenance Period|Reason Not Collected|0|||
160818114|NCT02589665|580719476|FG005|Maintenance Period|Reason Not Collected|1|||
160818115|NCT02589665|580719477|FG006|Maintenance Period|Reason Not Collected|1|||
160818116|NCT02589665|580719478|FG007|Maintenance Period|Reason Not Collected|0|||
160818117|NCT02589665|580719479|FG008|Maintenance Period|Reason Not Collected|0|||
160900415|NCT01303861|581030092|FG003|Overall Study|Lost to Follow-up|31|||
160900416|NCT01303861|581030089|FG000|Overall Study|Lack of Efficacy|3|||
160900417|NCT01303861|581030090|FG001|Overall Study|Lack of Efficacy|2|||
160900418|NCT01303861|581030091|FG002|Overall Study|Lack of Efficacy|1|||
160900419|NCT01303861|581030092|FG003|Overall Study|Lack of Efficacy|0|||
160900420|NCT01303861|581030089|FG000|Overall Study|Withdrawal by Subject|16|||
160900421|NCT01303861|581030090|FG001|Overall Study|Withdrawal by Subject|8|||
160900422|NCT01303861|581030091|FG002|Overall Study|Withdrawal by Subject|8|||
160900423|NCT01303861|581030092|FG003|Overall Study|Withdrawal by Subject|23|||
160818118|NCT02589665|580719480|FG009|Maintenance Period|Reason Not Collected|0|||
160818119|NCT02589665|580719471|FG000|Induction Extension Period|Adverse Event|0|||
160900424|NCT01303861|581030089|FG000|Overall Study|Adverse Event|4|||
160900425|NCT01303861|581030090|FG001|Overall Study|Adverse Event|1|||
160900426|NCT01303861|581030091|FG002|Overall Study|Adverse Event|0|||
160900427|NCT01303861|581030092|FG003|Overall Study|Adverse Event|5|||
160900428|NCT01303861|581030089|FG000|Overall Study|Pregnancy|1|||
160900429|NCT01303861|581030090|FG001|Overall Study|Pregnancy|0|||
160900430|NCT01303861|581030091|FG002|Overall Study|Pregnancy|0|||
161132568|NCT02965378|581869003|FG001|Overall Study|Death|0|||
161132569|NCT02965378|581869002|FG000|Overall Study|Refusal|2|||
161132570|NCT02965378|581869003|FG001|Overall Study|Refusal|1|||
161132571|NCT02965378|581869002|FG000|Overall Study|Not protocol specified|0|||
161132572|NCT02965378|581869003|FG001|Overall Study|Not protocol specified|2|||
161132573|NCT01384292|581869006|FG000|Part B|Severe non-compliance to protocol|1|||
161132574|NCT01384292|581869007|FG001|Part B|Severe non-compliance to protocol|0|||
161132575|NCT01384292|581869008|FG002|Part B|Severe non-compliance to protocol|0|||
161132576|NCT04525703|581869010|FG000|Overall Study|Lost to Follow-up|6|||
161132577|NCT04525703|581869011|FG001|Overall Study|Lost to Follow-up|15|||
161132578|NCT04525703|581869012|FG002|Overall Study|Lost to Follow-up|8|||
161132579|NCT01285349|581869013|FG000|Overall Study|Lost to Follow-up|27|||
161132580|NCT01285349|581869014|FG001|Overall Study|Lost to Follow-up|20|||
161132581|NCT01285349|581869015|FG002|Overall Study|Lost to Follow-up|27|||
161132582|NCT00565617|581869016|FG000|Overall Study|Withdrawal by Subject|1|||
161132583|NCT03529409|581869026|FG000|Randomized|Lost to Follow-up|0|||
161132584|NCT03529409|581869027|FG001|Randomized|Lost to Follow-up|0|||
161132585|NCT03529409|581869028|FG002|Randomized|Lost to Follow-up|4|||
161132586|NCT03529409|581869026|FG000|Randomized|Excluded|0|||
161132587|NCT03529409|581869027|FG001|Randomized|Excluded|0|||
161132588|NCT03529409|581869028|FG002|Randomized|Excluded|1|||
160818120|NCT02589665|580719472|FG001|Induction Extension Period|Adverse Event|0|||
160818121|NCT02589665|580719473|FG002|Induction Extension Period|Adverse Event|0|||
160900431|NCT01303861|581030092|FG003|Overall Study|Pregnancy|0|||
160900432|NCT01868503|581030104|FG000|Overall Study|Withdrawal by Subject|1|||
160900433|NCT01868503|581030104|FG000|Overall Study|Protocol Violation|1|||
160900434|NCT05224141|581030106|FG000|Overall Study|Ongoing|75|||
160900435|NCT05224141|581030107|FG001|Overall Study|Ongoing|88|||
160900436|NCT05224141|581030106|FG000|Overall Study|Withdrawal by Subject|2|||
161132589|NCT03529409|581869026|FG000|Post-treatment Assessment|Death|1|||
161132590|NCT03529409|581869027|FG001|Post-treatment Assessment|Death|0|||
161132591|NCT03529409|581869028|FG002|Post-treatment Assessment|Death|0|||
161132592|NCT03529409|581869026|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
161132593|NCT03529409|581869027|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
160818122|NCT02589665|580719474|FG003|Induction Extension Period|Adverse Event|0|||
160818123|NCT02589665|580719475|FG004|Induction Extension Period|Adverse Event|0|||
160818124|NCT02589665|580719476|FG005|Induction Extension Period|Adverse Event|0|||
160818125|NCT02589665|580719477|FG006|Induction Extension Period|Adverse Event|0|||
160818126|NCT02589665|580719478|FG007|Induction Extension Period|Adverse Event|0|||
160818127|NCT02589665|580719479|FG008|Induction Extension Period|Adverse Event|4|||
160818128|NCT02589665|580719480|FG009|Induction Extension Period|Adverse Event|0|||
160818129|NCT02589665|580719471|FG000|Induction Extension Period|Lack of Efficacy|0|||
160818130|NCT02589665|580719472|FG001|Induction Extension Period|Lack of Efficacy|0|||
160818131|NCT02589665|580719473|FG002|Induction Extension Period|Lack of Efficacy|0|||
160818132|NCT02589665|580719474|FG003|Induction Extension Period|Lack of Efficacy|0|||
160818133|NCT02589665|580719475|FG004|Induction Extension Period|Lack of Efficacy|0|||
160818134|NCT02589665|580719476|FG005|Induction Extension Period|Lack of Efficacy|0|||
160818135|NCT02589665|580719477|FG006|Induction Extension Period|Lack of Efficacy|0|||
160818136|NCT02589665|580719478|FG007|Induction Extension Period|Lack of Efficacy|0|||
160818137|NCT02589665|580719479|FG008|Induction Extension Period|Lack of Efficacy|3|||
160818138|NCT02589665|580719480|FG009|Induction Extension Period|Lack of Efficacy|0|||
160818139|NCT02589665|580719471|FG000|Induction Extension Period|Withdrawal by Subject|0|||
160818140|NCT02589665|580719472|FG001|Induction Extension Period|Withdrawal by Subject|0|||
160818141|NCT02589665|580719473|FG002|Induction Extension Period|Withdrawal by Subject|0|||
160818142|NCT02589665|580719474|FG003|Induction Extension Period|Withdrawal by Subject|0|||
160818143|NCT02589665|580719475|FG004|Induction Extension Period|Withdrawal by Subject|0|||
160818144|NCT02589665|580719476|FG005|Induction Extension Period|Withdrawal by Subject|0|||
160818145|NCT02589665|580719477|FG006|Induction Extension Period|Withdrawal by Subject|0|||
160818146|NCT02589665|580719478|FG007|Induction Extension Period|Withdrawal by Subject|2|||
160818147|NCT02589665|580719479|FG008|Induction Extension Period|Withdrawal by Subject|3|||
160818148|NCT02589665|580719480|FG009|Induction Extension Period|Withdrawal by Subject|0|||
160818149|NCT02589665|580719471|FG000|Induction Extension Period|Physician Decision|0|||
160818150|NCT02589665|580719472|FG001|Induction Extension Period|Physician Decision|0|||
160818151|NCT02589665|580719473|FG002|Induction Extension Period|Physician Decision|0|||
160818152|NCT02589665|580719474|FG003|Induction Extension Period|Physician Decision|0|||
160818153|NCT02589665|580719475|FG004|Induction Extension Period|Physician Decision|0|||
160818154|NCT02589665|580719476|FG005|Induction Extension Period|Physician Decision|0|||
160818155|NCT02589665|580719477|FG006|Induction Extension Period|Physician Decision|0|||
160818156|NCT02589665|580719478|FG007|Induction Extension Period|Physician Decision|0|||
160818157|NCT02589665|580719479|FG008|Induction Extension Period|Physician Decision|1|||
160818158|NCT02589665|580719480|FG009|Induction Extension Period|Physician Decision|0|||
160818159|NCT02589665|580719471|FG000|Induction Extension Period|Reason Not Collected|0|||
160818160|NCT02589665|580719472|FG001|Induction Extension Period|Reason Not Collected|0|||
160818161|NCT02589665|580719473|FG002|Induction Extension Period|Reason Not Collected|0|||
160818162|NCT02589665|580719474|FG003|Induction Extension Period|Reason Not Collected|0|||
160818163|NCT02589665|580719475|FG004|Induction Extension Period|Reason Not Collected|0|||
160818164|NCT02589665|580719476|FG005|Induction Extension Period|Reason Not Collected|0|||
160818165|NCT02589665|580719477|FG006|Induction Extension Period|Reason Not Collected|0|||
160818166|NCT02589665|580719478|FG007|Induction Extension Period|Reason Not Collected|0|||
160818167|NCT02589665|580719479|FG008|Induction Extension Period|Reason Not Collected|1|||
160818168|NCT02589665|580719480|FG009|Induction Extension Period|Reason Not Collected|0|||
160818169|NCT02589665|580719471|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818170|NCT02589665|580719472|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818171|NCT02589665|580719473|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818172|NCT02589665|580719474|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818173|NCT02589665|580719475|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818174|NCT02589665|580719476|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818175|NCT02589665|580719477|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818176|NCT02589665|580719478|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818177|NCT02589665|580719479|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
160818178|NCT02589665|580719480|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
160818179|NCT02589665|580719471|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
160818180|NCT02589665|580719472|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
160818181|NCT02589665|580719473|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
160818182|NCT02589665|580719474|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
160818183|NCT02589665|580719475|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
160818184|NCT02589665|580719476|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
160818185|NCT02589665|580719477|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
160818186|NCT02589665|580719478|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
160987591|NCT03173248|581341178|FG000|Overall Study|Withdrawal by Subject|6|||
160987592|NCT03173248|581341179|FG001|Overall Study|Withdrawal by Subject|4|||
161333751|NCT00617357|582610623|FG000|Overall Study|insurance concerns|2|||
160818187|NCT02589665|580719479|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
160818188|NCT02589665|580719480|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
160818189|NCT02589665|580719471|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
160818190|NCT02589665|580719472|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
160818191|NCT02589665|580719473|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
160818192|NCT02589665|580719474|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
160818193|NCT02589665|580719475|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
160818194|NCT02589665|580719476|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
160818195|NCT02589665|580719477|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
160818196|NCT02589665|580719478|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
160818197|NCT02589665|580719479|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
160818198|NCT02589665|580719480|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
160818199|NCT02589665|580719471|FG000|Maintenance Extension Period|Adverse Event|0|||
160818200|NCT02589665|580719472|FG001|Maintenance Extension Period|Adverse Event|0|||
160818201|NCT02589665|580719473|FG002|Maintenance Extension Period|Adverse Event|0|||
160818202|NCT02589665|580719474|FG003|Maintenance Extension Period|Adverse Event|0|||
160818203|NCT02589665|580719475|FG004|Maintenance Extension Period|Adverse Event|0|||
160818204|NCT02589665|580719476|FG005|Maintenance Extension Period|Adverse Event|0|||
160818205|NCT02589665|580719477|FG006|Maintenance Extension Period|Adverse Event|0|||
160818206|NCT02589665|580719478|FG007|Maintenance Extension Period|Adverse Event|0|||
160818207|NCT02589665|580719479|FG008|Maintenance Extension Period|Adverse Event|0|||
160818208|NCT02589665|580719480|FG009|Maintenance Extension Period|Adverse Event|2|||
160818209|NCT02589665|580719471|FG000|Maintenance Extension Period|Non-responder|0|||
160818210|NCT02589665|580719472|FG001|Maintenance Extension Period|Non-responder|0|||
160818211|NCT02589665|580719473|FG002|Maintenance Extension Period|Non-responder|0|||
160818212|NCT02589665|580719474|FG003|Maintenance Extension Period|Non-responder|0|||
160818213|NCT02589665|580719475|FG004|Maintenance Extension Period|Non-responder|0|||
160818214|NCT02589665|580719476|FG005|Maintenance Extension Period|Non-responder|0|||
160818215|NCT02589665|580719477|FG006|Maintenance Extension Period|Non-responder|0|||
160818216|NCT02589665|580719478|FG007|Maintenance Extension Period|Non-responder|0|||
160818217|NCT02589665|580719479|FG008|Maintenance Extension Period|Non-responder|0|||
160818218|NCT02589665|580719480|FG009|Maintenance Extension Period|Non-responder|1|||
160818219|NCT00327015|580719481|FG000|Overall Study|Lack of Efficacy|18|||
160818220|NCT00327015|580719482|FG001|Overall Study|Lack of Efficacy|18|||
160818221|NCT00327015|580719483|FG002|Overall Study|Lack of Efficacy|35|||
160818222|NCT00327015|580719484|FG003|Overall Study|Lack of Efficacy|29|||
160818223|NCT00327015|580719481|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
160818224|NCT00327015|580719482|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
160818225|NCT00327015|580719483|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
160818226|NCT00327015|580719484|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
160818227|NCT00327015|580719481|FG000|Overall Study|Lost to Follow-up|22|||
160818228|NCT00327015|580719482|FG001|Overall Study|Lost to Follow-up|23|||
160818229|NCT00327015|580719483|FG002|Overall Study|Lost to Follow-up|29|||
160818230|NCT00327015|580719484|FG003|Overall Study|Lost to Follow-up|22|||
160818231|NCT00327015|580719481|FG000|Overall Study|Adverse Event|14|||
160818232|NCT00327015|580719482|FG001|Overall Study|Adverse Event|10|||
160818233|NCT00327015|580719483|FG002|Overall Study|Adverse Event|14|||
160818234|NCT00327015|580719484|FG003|Overall Study|Adverse Event|14|||
160818235|NCT00327015|580719481|FG000|Overall Study|Subject no longer meets study criteria|4|||
160818236|NCT00327015|580719482|FG001|Overall Study|Subject no longer meets study criteria|2|||
160818237|NCT00327015|580719483|FG002|Overall Study|Subject no longer meets study criteria|8|||
160818238|NCT00327015|580719484|FG003|Overall Study|Subject no longer meets study criteria|7|||
160818239|NCT00327015|580719481|FG000|Overall Study|Poor/Noncompliance|11|||
160818240|NCT00327015|580719482|FG001|Overall Study|Poor/Noncompliance|8|||
160818241|NCT00327015|580719483|FG002|Overall Study|Poor/Noncompliance|4|||
160818242|NCT00327015|580719484|FG003|Overall Study|Poor/Noncompliance|5|||
160818243|NCT00327015|580719481|FG000|Overall Study|Physician Decision|0|||
160818244|NCT00327015|580719482|FG001|Overall Study|Physician Decision|1|||
160818245|NCT00327015|580719483|FG002|Overall Study|Physician Decision|3|||
160818246|NCT00327015|580719484|FG003|Overall Study|Physician Decision|2|||
160818247|NCT00327015|580719481|FG000|Overall Study|Death|1|||
160818248|NCT00327015|580719482|FG001|Overall Study|Death|2|||
160818249|NCT00327015|580719483|FG002|Overall Study|Death|2|||
160818250|NCT00327015|580719484|FG003|Overall Study|Death|3|||
160818251|NCT00327015|580719481|FG000|Overall Study|Pregnancy|0|||
160818252|NCT00327015|580719482|FG001|Overall Study|Pregnancy|2|||
160818253|NCT00327015|580719483|FG002|Overall Study|Pregnancy|1|||
160818254|NCT00327015|580719484|FG003|Overall Study|Pregnancy|1|||
160818255|NCT00327015|580719481|FG000|Overall Study|Administrative Reason by Sponsor|1|||
160818256|NCT00327015|580719482|FG001|Overall Study|Administrative Reason by Sponsor|2|||
160818257|NCT00327015|580719483|FG002|Overall Study|Administrative Reason by Sponsor|2|||
160818258|NCT00327015|580719484|FG003|Overall Study|Administrative Reason by Sponsor|1|||
160818259|NCT02923830|580719488|FG000|Overall Study|Physician Decision|13|||
160818260|NCT02923830|580719489|FG001|Overall Study|Physician Decision|15|||
161333752|NCT00617357|582610623|FG000|Overall Study|Withdrawal by Subject|1|||
161333753|NCT00617357|582610623|FG000|Overall Study|Physician Decision|1|||
161333754|NCT02153918|582610628|FG000|Overall Study|Refused further treatment|1|||
161333755|NCT03327324|582610629|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333756|NCT03327324|582610630|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161333757|NCT03327324|582610631|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333758|NCT03327324|582610632|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
160900437|NCT05224141|581030107|FG001|Overall Study|Withdrawal by Subject|4|||
160900438|NCT05224141|581030106|FG000|Overall Study|Death|153|||
160900439|NCT05224141|581030107|FG001|Overall Study|Death|138|||
161333759|NCT03327324|582610633|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333760|NCT03327324|582610634|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
161333761|NCT03327324|582610629|FG000|Baseline (Month 0-Month 3)|Refused|0|||
161333762|NCT03327324|582610630|FG001|Baseline (Month 0-Month 3)|Refused|0|||
161333763|NCT03327324|582610631|FG002|Baseline (Month 0-Month 3)|Refused|0|||
161333764|NCT03327324|582610632|FG003|Baseline (Month 0-Month 3)|Refused|0|||
161333765|NCT03327324|582610633|FG004|Baseline (Month 0-Month 3)|Refused|1|||
161333766|NCT03327324|582610634|FG005|Baseline (Month 0-Month 3)|Refused|0|||
160818261|NCT00837265|580719490|FG000|Pilot Phase|Withdrawal by Subject|0|||
160818262|NCT00837265|580719491|FG001|Pilot Phase|Withdrawal by Subject|2|||
160818263|NCT00837265|580719492|FG002|Pilot Phase|Withdrawal by Subject|3|||
160818264|NCT00837265|580719493|FG003|Pilot Phase|Withdrawal by Subject|2|||
160818265|NCT00837265|580719494|FG004|Pilot Phase|Withdrawal by Subject|0|||
160818266|NCT00837265|580719495|FG005|Pilot Phase|Withdrawal by Subject|0|||
160818267|NCT00837265|580719496|FG006|Pilot Phase|Withdrawal by Subject|0|||
160818268|NCT00837265|580719490|FG000|Pilot Phase|Decision of the investigator|2|||
160818269|NCT00837265|580719491|FG001|Pilot Phase|Decision of the investigator|1|||
160818270|NCT00837265|580719492|FG002|Pilot Phase|Decision of the investigator|0|||
160818271|NCT00837265|580719493|FG003|Pilot Phase|Decision of the investigator|0|||
160818272|NCT00837265|580719494|FG004|Pilot Phase|Decision of the investigator|0|||
160818273|NCT00837265|580719495|FG005|Pilot Phase|Decision of the investigator|0|||
160818274|NCT00837265|580719496|FG006|Pilot Phase|Decision of the investigator|0|||
160818275|NCT00837265|580719490|FG000|Pilot Phase|Adverse Event|1|||
160818276|NCT00837265|580719491|FG001|Pilot Phase|Adverse Event|0|||
160818277|NCT00837265|580719492|FG002|Pilot Phase|Adverse Event|0|||
160818278|NCT00837265|580719493|FG003|Pilot Phase|Adverse Event|0|||
160818279|NCT00837265|580719494|FG004|Pilot Phase|Adverse Event|0|||
160818280|NCT00837265|580719495|FG005|Pilot Phase|Adverse Event|0|||
160818281|NCT00837265|580719496|FG006|Pilot Phase|Adverse Event|0|||
160818282|NCT00837265|580719490|FG000|Pilot Phase|Disease progression|0|||
160818283|NCT00837265|580719491|FG001|Pilot Phase|Disease progression|0|||
160818284|NCT00837265|580719492|FG002|Pilot Phase|Disease progression|0|||
160818285|NCT00837265|580719493|FG003|Pilot Phase|Disease progression|1|||
160818286|NCT00837265|580719494|FG004|Pilot Phase|Disease progression|0|||
160818287|NCT00837265|580719495|FG005|Pilot Phase|Disease progression|0|||
161333767|NCT03327324|582610629|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161333768|NCT03327324|582610630|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
160818288|NCT00837265|580719496|FG006|Pilot Phase|Disease progression|0|||
160818289|NCT00837265|580719490|FG000|Pilot Phase|Participant left the city|0|||
160818290|NCT00837265|580719491|FG001|Pilot Phase|Participant left the city|0|||
160818291|NCT00837265|580719492|FG002|Pilot Phase|Participant left the city|0|||
160818292|NCT00837265|580719493|FG003|Pilot Phase|Participant left the city|1|||
160818293|NCT00837265|580719494|FG004|Pilot Phase|Participant left the city|0|||
160818294|NCT00837265|580719495|FG005|Pilot Phase|Participant left the city|0|||
160818295|NCT00837265|580719496|FG006|Pilot Phase|Participant left the city|0|||
160818296|NCT00837265|580719490|FG000|Main Phase|Withdrawal by Subject|0|||
160818297|NCT00837265|580719491|FG001|Main Phase|Withdrawal by Subject|0|||
160818298|NCT00837265|580719492|FG002|Main Phase|Withdrawal by Subject|0|||
160900440|NCT03212690|581030119|FG000|Overall Study|Protocol Violation|1|||
160900441|NCT03208127|581030121|FG000|Overall Study|Death|1|||
161132594|NCT03529409|581869028|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
161333769|NCT03327324|582610631|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161333770|NCT03327324|582610632|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160900442|NCT01254331|581030126|FG000|Initial Phase|Adverse Event|3|||
161333771|NCT03327324|582610633|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
160900443|NCT01254331|581030126|FG000|Initial Phase|Withdrawal by Subject|1|||
160818299|NCT00837265|580719493|FG003|Main Phase|Withdrawal by Subject|0|||
160900444|NCT01254331|581030126|FG000|Initial Phase|Pregnancy|1|||
160818300|NCT00837265|580719494|FG004|Main Phase|Withdrawal by Subject|4|||
160818301|NCT00837265|580719495|FG005|Main Phase|Withdrawal by Subject|2|||
160818302|NCT00837265|580719496|FG006|Main Phase|Withdrawal by Subject|1|||
160818303|NCT00837265|580719490|FG000|Main Phase|Decision of the investigator|0|||
160818304|NCT00837265|580719491|FG001|Main Phase|Decision of the investigator|0|||
160818305|NCT00837265|580719492|FG002|Main Phase|Decision of the investigator|0|||
160818306|NCT00837265|580719493|FG003|Main Phase|Decision of the investigator|0|||
160818307|NCT00837265|580719494|FG004|Main Phase|Decision of the investigator|0|||
160818308|NCT00837265|580719495|FG005|Main Phase|Decision of the investigator|2|||
160818309|NCT00837265|580719496|FG006|Main Phase|Decision of the investigator|1|||
160818310|NCT00837265|580719490|FG000|Main Phase|Adverse Event|0|||
160818311|NCT00837265|580719491|FG001|Main Phase|Adverse Event|0|||
160818312|NCT00837265|580719492|FG002|Main Phase|Adverse Event|0|||
160818313|NCT00837265|580719493|FG003|Main Phase|Adverse Event|0|||
160818314|NCT00837265|580719494|FG004|Main Phase|Adverse Event|0|||
160818315|NCT00837265|580719495|FG005|Main Phase|Adverse Event|1|||
160818316|NCT00837265|580719496|FG006|Main Phase|Adverse Event|0|||
160818317|NCT00837265|580719490|FG000|Main Phase|Death|0|||
160818318|NCT00837265|580719491|FG001|Main Phase|Death|0|||
160818319|NCT00837265|580719492|FG002|Main Phase|Death|0|||
160818320|NCT00837265|580719493|FG003|Main Phase|Death|0|||
160818321|NCT00837265|580719494|FG004|Main Phase|Death|2|||
160818322|NCT00837265|580719495|FG005|Main Phase|Death|0|||
160818323|NCT00837265|580719496|FG006|Main Phase|Death|1|||
160818324|NCT00837265|580719490|FG000|Main Phase|Lost to Follow-up|0|||
160818325|NCT00837265|580719491|FG001|Main Phase|Lost to Follow-up|0|||
160818326|NCT00837265|580719492|FG002|Main Phase|Lost to Follow-up|0|||
160818327|NCT00837265|580719493|FG003|Main Phase|Lost to Follow-up|0|||
160818328|NCT00837265|580719494|FG004|Main Phase|Lost to Follow-up|1|||
160818329|NCT00837265|580719495|FG005|Main Phase|Lost to Follow-up|0|||
160818330|NCT00837265|580719496|FG006|Main Phase|Lost to Follow-up|0|||
161240069|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Investigator decision|0|||
161240070|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Investigator decision|0|||
161240071|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Investigator decision|0|||
161240072|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Investigator decision|0|||
161240073|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Investigator decision|1|||
161240074|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Lack of time|1|||
161240075|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Lack of time|0|||
161240076|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Lack of time|0|||
161240077|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Lack of time|0|||
161240078|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Lack of time|0|||
161333772|NCT03327324|582610634|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
161333773|NCT03327324|582610629|FG000|Baseline (Month 0-Month 3)|Death|0|||
160818331|NCT00837265|580719490|FG000|Main Phase|Principal investigator resignation|0|||
160818332|NCT00837265|580719491|FG001|Main Phase|Principal investigator resignation|0|||
160818333|NCT00837265|580719492|FG002|Main Phase|Principal investigator resignation|0|||
160818334|NCT00837265|580719493|FG003|Main Phase|Principal investigator resignation|0|||
160818335|NCT00837265|580719494|FG004|Main Phase|Principal investigator resignation|2|||
160818336|NCT00837265|580719495|FG005|Main Phase|Principal investigator resignation|0|||
160818337|NCT00837265|580719496|FG006|Main Phase|Principal investigator resignation|0|||
160818338|NCT00837265|580719490|FG000|Main Phase|Participant's personal reason|0|||
160818339|NCT00837265|580719491|FG001|Main Phase|Participant's personal reason|0|||
160818340|NCT00837265|580719492|FG002|Main Phase|Participant's personal reason|0|||
160818341|NCT00837265|580719493|FG003|Main Phase|Participant's personal reason|0|||
160818342|NCT00837265|580719494|FG004|Main Phase|Participant's personal reason|1|||
160818343|NCT00837265|580719495|FG005|Main Phase|Participant's personal reason|0|||
160818344|NCT00837265|580719496|FG006|Main Phase|Participant's personal reason|0|||
160900445|NCT01254331|581030126|FG000|Extension Phase|Lack of Efficacy|1|||
160900446|NCT01254331|581030126|FG000|Extension Phase|Lost to Follow-up|3|||
160900447|NCT01011738|581030127|FG000|Overall Study|Death|12|||
160900448|NCT01011738|581030128|FG001|Overall Study|Death|3|||
160900449|NCT01011738|581030129|FG002|Overall Study|Death|0|||
160900450|NCT01011738|581030127|FG000|Overall Study|Unknown reasons|312|||
160900451|NCT01011738|581030128|FG001|Overall Study|Unknown reasons|291|||
160900452|NCT01011738|581030129|FG002|Overall Study|Unknown reasons|17|||
160900453|NCT00287365|581030130|FG000|Overall Study|sample not acquired|13|||
160900454|NCT00968864|581030131|FG000|Overall Study|Protocol exception/ not evaluable|1|||
160900455|NCT01967173|581030132|FG000|Overall Study|Lost to Follow-up|5|||
160900456|NCT01967173|581030133|FG001|Overall Study|Lost to Follow-up|3|||
160900457|NCT01967173|581030134|FG002|Overall Study|Lost to Follow-up|2|||
160900458|NCT01967173|581030135|FG003|Overall Study|Lost to Follow-up|4|||
160900459|NCT01967173|581030136|FG004|Overall Study|Lost to Follow-up|8|||
160900460|NCT01967173|581030137|FG005|Overall Study|Lost to Follow-up|12|||
160900461|NCT01967173|581030138|FG006|Overall Study|Lost to Follow-up|6|||
160900462|NCT01967173|581030139|FG007|Overall Study|Lost to Follow-up|8|||
160900463|NCT01967173|581030132|FG000|Overall Study|Physician Decision|2|||
160900464|NCT01967173|581030133|FG001|Overall Study|Physician Decision|0|||
160900465|NCT01967173|581030134|FG002|Overall Study|Physician Decision|2|||
160900466|NCT01967173|581030135|FG003|Overall Study|Physician Decision|1|||
160900467|NCT01967173|581030136|FG004|Overall Study|Physician Decision|1|||
160900468|NCT01967173|581030137|FG005|Overall Study|Physician Decision|1|||
160900469|NCT01967173|581030138|FG006|Overall Study|Physician Decision|1|||
160900470|NCT01967173|581030139|FG007|Overall Study|Physician Decision|0|||
160900471|NCT01967173|581030132|FG000|Overall Study|Lack of Efficacy|2|||
160900472|NCT01967173|581030133|FG001|Overall Study|Lack of Efficacy|0|||
160818345|NCT00733291|580719498|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
161240079|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161240080|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161240081|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161240082|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
161240083|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
161240084|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
161240085|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
161132595|NCT03529409|581869026|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
161132596|NCT03529409|581869027|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
161132597|NCT03529409|581869028|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
161132598|NCT03529409|581869026|FG000|Follow-up Assessment|Death|1|||
161240086|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
161240087|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
161132599|NCT03529409|581869027|FG001|Follow-up Assessment|Death|0|||
161132600|NCT03529409|581869028|FG002|Follow-up Assessment|Death|0|||
161132601|NCT03529409|581869026|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
161132602|NCT03529409|581869027|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
161132603|NCT03529409|581869028|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
161132604|NCT01497262|581869029|FG000|Overall Study|Abnormal Lab Values|4|||
161132605|NCT01497262|581869029|FG000|Overall Study|Abnormal Test Procedure Result|1|||
161132606|NCT01497262|581869029|FG000|Overall Study|Physician Decision|1|||
161132607|NCT01497262|581869029|FG000|Overall Study|Withdrawal by Subject|2|||
161132608|NCT01497262|581869029|FG000|Overall Study|Adverse Event|2|||
161132609|NCT01497262|581869029|FG000|Overall Study|Protocol Violation|1|||
161132610|NCT01870739|581869030|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
160818346|NCT00733291|580719499|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
160900473|NCT01967173|581030134|FG002|Overall Study|Lack of Efficacy|2|||
161132611|NCT01870739|581869031|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
161132612|NCT01870739|581869030|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
161132613|NCT01870739|581869031|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
161132614|NCT01870739|581869030|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
161132615|NCT01870739|581869031|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
161132616|NCT01870739|581869030|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
161132617|NCT01870739|581869031|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
161132618|NCT01870739|581869030|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
161132619|NCT01870739|581869031|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
161132620|NCT01870739|581869030|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
161132621|NCT01870739|581869031|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
161132622|NCT01870739|581869030|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
161132623|NCT01870739|581869031|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
161132624|NCT01926626|581869040|FG000|Overall Study|Withdrawal by Subject|15|||
161132625|NCT01926626|581869040|FG000|Overall Study|Lost to Follow-up|7|||
161132626|NCT03283085|581869041|FG000|Overall Study|Adverse Event|18|||
161132627|NCT03283085|581869042|FG001|Overall Study|Adverse Event|3|||
161132628|NCT03283085|581869043|FG002|Overall Study|Adverse Event|13|||
161132629|NCT03283085|581869044|FG003|Overall Study|Adverse Event|0|||
161132630|NCT03283085|581869045|FG004|Overall Study|Adverse Event|0|||
161132631|NCT03283085|581869046|FG005|Overall Study|Adverse Event|5|||
161132632|NCT03283085|581869041|FG000|Overall Study|Death|0|||
161132633|NCT03283085|581869042|FG001|Overall Study|Death|0|||
161132634|NCT03283085|581869043|FG002|Overall Study|Death|3|||
161132635|NCT03283085|581869044|FG003|Overall Study|Death|1|||
161132636|NCT03283085|581869045|FG004|Overall Study|Death|0|||
161132637|NCT03283085|581869046|FG005|Overall Study|Death|0|||
161240088|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
161240089|NCT00318461|582260502|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
160900474|NCT01967173|581030135|FG003|Overall Study|Lack of Efficacy|2|||
160900475|NCT01967173|581030136|FG004|Overall Study|Lack of Efficacy|0|||
160900476|NCT01967173|581030137|FG005|Overall Study|Lack of Efficacy|1|||
160900477|NCT01967173|581030138|FG006|Overall Study|Lack of Efficacy|0|||
160900478|NCT01967173|581030139|FG007|Overall Study|Lack of Efficacy|2|||
160900479|NCT01967173|581030132|FG000|Overall Study|Pregnancy|0|||
160900480|NCT01967173|581030133|FG001|Overall Study|Pregnancy|0|||
160900481|NCT01967173|581030134|FG002|Overall Study|Pregnancy|0|||
160900482|NCT01967173|581030135|FG003|Overall Study|Pregnancy|0|||
160900483|NCT01967173|581030136|FG004|Overall Study|Pregnancy|0|||
160900484|NCT01967173|581030137|FG005|Overall Study|Pregnancy|0|||
160900485|NCT01967173|581030138|FG006|Overall Study|Pregnancy|1|||
160900486|NCT01967173|581030139|FG007|Overall Study|Pregnancy|1|||
160900487|NCT01967173|581030132|FG000|Overall Study|Adverse Event|0|||
160900488|NCT01967173|581030133|FG001|Overall Study|Adverse Event|0|||
160900489|NCT01967173|581030134|FG002|Overall Study|Adverse Event|0|||
160900490|NCT01967173|581030135|FG003|Overall Study|Adverse Event|0|||
160818347|NCT00733291|580719500|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
160818348|NCT00733291|580719501|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
160818349|NCT01751906|580719508|FG000|Overall Study|Lost to Follow-up|151|||
160818350|NCT01751906|580719509|FG001|Overall Study|Lost to Follow-up|68|||
160818351|NCT01751906|580719508|FG000|Overall Study|Withdrawal by Subject|22|||
160818352|NCT01751906|580719509|FG001|Overall Study|Withdrawal by Subject|18|||
160818353|NCT01751906|580719508|FG000|Overall Study|Physician Decision|5|||
160818354|NCT01751906|580719509|FG001|Overall Study|Physician Decision|2|||
160818355|NCT01751906|580719508|FG000|Overall Study|Death|84|||
160818356|NCT01751906|580719509|FG001|Overall Study|Death|43|||
160818357|NCT01751906|580719508|FG000|Overall Study|Denied on premises for follow-up by law|1|||
160818358|NCT01751906|580719509|FG001|Overall Study|Denied on premises for follow-up by law|0|||
160818359|NCT01110330|580719514|FG000|Overall Study|Adverse Event|0|||
160818360|NCT01110330|580719515|FG001|Overall Study|Adverse Event|4|||
160818361|NCT01110330|580719516|FG002|Overall Study|Adverse Event|3|||
160818362|NCT01110330|580719514|FG000|Overall Study|Lack of Efficacy|3|||
160818363|NCT01110330|580719515|FG001|Overall Study|Lack of Efficacy|1|||
160818364|NCT01110330|580719516|FG002|Overall Study|Lack of Efficacy|1|||
160818365|NCT01110330|580719514|FG000|Overall Study|Lost to Follow-up|9|||
160818366|NCT01110330|580719515|FG001|Overall Study|Lost to Follow-up|10|||
160818367|NCT01110330|580719516|FG002|Overall Study|Lost to Follow-up|15|||
160818368|NCT01110330|580719514|FG000|Overall Study|Physician Decision|0|||
160818369|NCT01110330|580719515|FG001|Overall Study|Physician Decision|1|||
160818370|NCT01110330|580719516|FG002|Overall Study|Physician Decision|0|||
160818371|NCT01110330|580719514|FG000|Overall Study|Protocol Violation|2|||
160818372|NCT01110330|580719515|FG001|Overall Study|Protocol Violation|0|||
160818373|NCT01110330|580719516|FG002|Overall Study|Protocol Violation|4|||
160818374|NCT01110330|580719514|FG000|Overall Study|Withdrawal by Subject|0|||
160818375|NCT01110330|580719515|FG001|Overall Study|Withdrawal by Subject|6|||
160818376|NCT01110330|580719516|FG002|Overall Study|Withdrawal by Subject|2|||
160818377|NCT01110330|580719514|FG000|Overall Study|Other|1|||
160818378|NCT01110330|580719515|FG001|Overall Study|Other|1|||
160818379|NCT01110330|580719516|FG002|Overall Study|Other|1|||
160818380|NCT02759107|580719517|FG000|Overall Study|Adverse Event|0|||
160818381|NCT02759107|580719518|FG001|Overall Study|Adverse Event|0|||
160818382|NCT02759107|580719519|FG002|Overall Study|Adverse Event|0|||
160818383|NCT02759107|580719520|FG003|Overall Study|Adverse Event|0|||
160818384|NCT02759107|580719521|FG004|Overall Study|Adverse Event|0|||
160818385|NCT02759107|580719522|FG005|Overall Study|Adverse Event|0|||
160818386|NCT02759107|580719523|FG006|Overall Study|Adverse Event|0|||
160818387|NCT02759107|580719524|FG007|Overall Study|Adverse Event|0|||
160818388|NCT02759107|580719525|FG008|Overall Study|Adverse Event|0|||
160818389|NCT02759107|580719526|FG009|Overall Study|Adverse Event|0|||
160818390|NCT02759107|580719527|FG010|Overall Study|Adverse Event|0|||
160818391|NCT02759107|580719528|FG011|Overall Study|Adverse Event|0|||
160818392|NCT02759107|580719529|FG012|Overall Study|Adverse Event|2|||
160818393|NCT02759107|580719530|FG013|Overall Study|Adverse Event|0|||
160818394|NCT02759107|580719531|FG014|Overall Study|Adverse Event|0|||
160818395|NCT02759107|580719532|FG015|Overall Study|Adverse Event|1|||
160818396|NCT02759107|580719533|FG016|Overall Study|Adverse Event|0|||
160818397|NCT02759107|580719534|FG017|Overall Study|Adverse Event|2|||
160818398|NCT02759107|580719517|FG000|Overall Study|Scheduling Conflict|0|||
160818399|NCT02759107|580719518|FG001|Overall Study|Scheduling Conflict|0|||
160818400|NCT02759107|580719519|FG002|Overall Study|Scheduling Conflict|0|||
160900491|NCT01967173|581030136|FG004|Overall Study|Adverse Event|0|||
160900492|NCT01967173|581030137|FG005|Overall Study|Adverse Event|0|||
160900493|NCT01967173|581030138|FG006|Overall Study|Adverse Event|0|||
160900494|NCT01967173|581030139|FG007|Overall Study|Adverse Event|1|||
160900495|NCT01967173|581030132|FG000|Overall Study|Withdrawal by Subject|15|||
160900496|NCT01967173|581030133|FG001|Overall Study|Withdrawal by Subject|14|||
160900497|NCT01967173|581030134|FG002|Overall Study|Withdrawal by Subject|10|||
160900498|NCT01967173|581030135|FG003|Overall Study|Withdrawal by Subject|7|||
160900499|NCT01967173|581030136|FG004|Overall Study|Withdrawal by Subject|8|||
160900500|NCT01967173|581030137|FG005|Overall Study|Withdrawal by Subject|9|||
160900501|NCT01967173|581030138|FG006|Overall Study|Withdrawal by Subject|10|||
160900502|NCT01967173|581030139|FG007|Overall Study|Withdrawal by Subject|12|||
160900503|NCT01346969|581030140|FG000|Overall Study|Withdrawal by Subject|0|||
160900504|NCT01346969|581030141|FG001|Overall Study|Withdrawal by Subject|0|||
161132638|NCT03283085|581869041|FG000|Overall Study|Withdrawal by Subject|42|||
160818401|NCT02759107|580719520|FG003|Overall Study|Scheduling Conflict|0|||
160818402|NCT02759107|580719521|FG004|Overall Study|Scheduling Conflict|0|||
160818403|NCT02759107|580719522|FG005|Overall Study|Scheduling Conflict|0|||
160818404|NCT02759107|580719523|FG006|Overall Study|Scheduling Conflict|0|||
160818405|NCT02759107|580719524|FG007|Overall Study|Scheduling Conflict|0|||
160818406|NCT02759107|580719525|FG008|Overall Study|Scheduling Conflict|0|||
160818407|NCT02759107|580719526|FG009|Overall Study|Scheduling Conflict|1|||
160818408|NCT02759107|580719527|FG010|Overall Study|Scheduling Conflict|0|||
160818409|NCT02759107|580719528|FG011|Overall Study|Scheduling Conflict|0|||
160900505|NCT01346969|581030142|FG002|Overall Study|Withdrawal by Subject|1|||
160987593|NCT03173248|581341178|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
160987594|NCT03173248|581341179|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
160987595|NCT01544582|581341180|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
160987596|NCT01544582|581341181|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
160987597|NCT01544582|581341182|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
160818410|NCT02759107|580719529|FG012|Overall Study|Scheduling Conflict|0|||
160818411|NCT02759107|580719530|FG013|Overall Study|Scheduling Conflict|0|||
160818412|NCT02759107|580719531|FG014|Overall Study|Scheduling Conflict|0|||
160818413|NCT02759107|580719532|FG015|Overall Study|Scheduling Conflict|0|||
160818414|NCT02759107|580719533|FG016|Overall Study|Scheduling Conflict|0|||
160818415|NCT02759107|580719534|FG017|Overall Study|Scheduling Conflict|0|||
160818416|NCT00420004|580719541|FG000|Overall Study|Adverse Event|4|||
160818417|NCT00420004|580719542|FG001|Overall Study|Adverse Event|1|||
160818418|NCT00420004|580719543|FG002|Overall Study|Adverse Event|1|||
160818419|NCT00420004|580719541|FG000|Overall Study|Lack of Efficacy|5|||
160818420|NCT00420004|580719542|FG001|Overall Study|Lack of Efficacy|4|||
160818421|NCT00420004|580719543|FG002|Overall Study|Lack of Efficacy|1|||
160818422|NCT00420004|580719541|FG000|Overall Study|Lost to Follow-up|31|||
160818423|NCT00420004|580719542|FG001|Overall Study|Lost to Follow-up|12|||
160818424|NCT00420004|580719543|FG002|Overall Study|Lost to Follow-up|10|||
160818425|NCT00420004|580719541|FG000|Overall Study|Entry Criteria Not Met|0|||
160818426|NCT00420004|580719542|FG001|Overall Study|Entry Criteria Not Met|1|||
160818427|NCT00420004|580719543|FG002|Overall Study|Entry Criteria Not Met|0|||
160818428|NCT00420004|580719541|FG000|Overall Study|Physician Decision|14|||
160818429|NCT00420004|580719542|FG001|Overall Study|Physician Decision|4|||
160818430|NCT00420004|580719543|FG002|Overall Study|Physician Decision|2|||
160818431|NCT00420004|580719541|FG000|Overall Study|Protocol Violation|5|||
160818432|NCT00420004|580719542|FG001|Overall Study|Protocol Violation|4|||
160818433|NCT00420004|580719543|FG002|Overall Study|Protocol Violation|3|||
160818434|NCT00420004|580719541|FG000|Overall Study|Withdrawal by Subject|67|||
160818435|NCT00420004|580719542|FG001|Overall Study|Withdrawal by Subject|42|||
160818436|NCT00420004|580719543|FG002|Overall Study|Withdrawal by Subject|14|||
160818437|NCT00420004|580719541|FG000|Overall Study|Sponsor Decision|3|||
160818438|NCT00420004|580719542|FG001|Overall Study|Sponsor Decision|3|||
160818439|NCT00420004|580719543|FG002|Overall Study|Sponsor Decision|1|||
160818440|NCT00591149|580719544|FG000|Overall Study|Adverse Event|4|||
160818441|NCT00591149|580719544|FG000|Overall Study|Withdrawal by Subject|1|||
160818442|NCT03002818|580719545|FG000|Overall Study|Decision of the investigator|1|||
160818443|NCT01549886|580719546|FG000|Overall Study|Sponsor's decision|2|||
160818444|NCT01549886|580719547|FG001|Overall Study|Sponsor's decision|3|||
160818445|NCT00608023|580719548|FG000|Overall Study|Withdrawal by Subject|8|||
160818446|NCT00608023|580719549|FG001|Overall Study|Withdrawal by Subject|10|||
160818447|NCT00608023|580719550|FG002|Overall Study|Withdrawal by Subject|7|||
160818448|NCT00608023|580719548|FG000|Overall Study|Adverse Event|1|||
160818449|NCT00608023|580719549|FG001|Overall Study|Adverse Event|4|||
160818450|NCT00608023|580719550|FG002|Overall Study|Adverse Event|5|||
160818451|NCT00608023|580719548|FG000|Overall Study|Lost to Follow-up|2|||
160818452|NCT00608023|580719549|FG001|Overall Study|Lost to Follow-up|2|||
160818453|NCT00608023|580719550|FG002|Overall Study|Lost to Follow-up|1|||
160818454|NCT00608023|580719548|FG000|Overall Study|Protocol Violation|1|||
160818455|NCT00608023|580719549|FG001|Overall Study|Protocol Violation|3|||
160818456|NCT00608023|580719550|FG002|Overall Study|Protocol Violation|1|||
160818457|NCT00608023|580719548|FG000|Overall Study|Unknown reason|0|||
160818458|NCT00608023|580719549|FG001|Overall Study|Unknown reason|3|||
160818459|NCT00608023|580719550|FG002|Overall Study|Unknown reason|0|||
160818460|NCT01231321|580719553|FG000|Overall Study|Adverse Event|3|||
160818461|NCT01231321|580719553|FG000|Overall Study|Lack of Efficacy|2|||
160818462|NCT00489736|580719554|FG000|Overall Study|Lack of Efficacy|53|||
160818463|NCT00489736|580719555|FG001|Overall Study|Lack of Efficacy|14|||
160987598|NCT01544582|581341183|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
160987599|NCT01544582|581341180|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
160987600|NCT01544582|581341181|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
160987601|NCT01544582|581341182|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
160987602|NCT01544582|581341183|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
160987603|NCT01544582|581341180|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
160818464|NCT00489736|580719554|FG000|Overall Study|Adverse Event|32|||
160818465|NCT00489736|580719555|FG001|Overall Study|Adverse Event|45|||
160818466|NCT00489736|580719554|FG000|Overall Study|Poor compliance|6|||
160818467|NCT00489736|580719555|FG001|Overall Study|Poor compliance|2|||
160818468|NCT00489736|580719554|FG000|Overall Study|Not coded/ Not pre-specified|5|||
160818469|NCT00489736|580719555|FG001|Overall Study|Not coded/ Not pre-specified|8|||
160818470|NCT04021524|580719556|FG000|Overall Study|Change in surgical intervention|0|||
160818471|NCT04021524|580719557|FG001|Overall Study|Change in surgical intervention|1|||
160818472|NCT06422364|580719558|FG000|Overall Study|Withdrawn due to study closure|0|||
160818473|NCT06422364|580719559|FG001|Overall Study|Withdrawn due to study closure|2|||
160818474|NCT00245050|580719566|FG000|Overall Study|Adverse Event|3|||
160818475|NCT00245050|580719567|FG001|Overall Study|Adverse Event|2|||
160818476|NCT00152477|580719570|FG000|Chemotherapy Period|Adverse Event|9|||
160818477|NCT00152477|580719571|FG001|Chemotherapy Period|Adverse Event|4|||
160818478|NCT00152477|580719572|FG002|Chemotherapy Period|Adverse Event|5|||
160818479|NCT00152477|580719570|FG000|Chemotherapy Period|Death|1|||
160818480|NCT00152477|580719571|FG001|Chemotherapy Period|Death|3|||
160818481|NCT00152477|580719572|FG002|Chemotherapy Period|Death|3|||
160818482|NCT00152477|580719570|FG000|Chemotherapy Period|Lack of Efficacy|4|||
160818483|NCT00152477|580719571|FG001|Chemotherapy Period|Lack of Efficacy|5|||
160818484|NCT00152477|580719572|FG002|Chemotherapy Period|Lack of Efficacy|6|||
160818485|NCT00152477|580719570|FG000|Chemotherapy Period|Lost to Follow-up|1|||
160818486|NCT00152477|580719571|FG001|Chemotherapy Period|Lost to Follow-up|0|||
160818487|NCT00152477|580719572|FG002|Chemotherapy Period|Lost to Follow-up|1|||
160818488|NCT00152477|580719570|FG000|Chemotherapy Period|Protocol Violation|1|||
160818489|NCT00152477|580719571|FG001|Chemotherapy Period|Protocol Violation|1|||
160818490|NCT00152477|580719572|FG002|Chemotherapy Period|Protocol Violation|0|||
160818491|NCT00152477|580719570|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
160818492|NCT00152477|580719571|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
160818493|NCT00152477|580719572|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
160818494|NCT00152477|580719570|FG000|Chemotherapy Period|Progression of Disease|6|||
160818495|NCT00152477|580719571|FG001|Chemotherapy Period|Progression of Disease|8|||
160818496|NCT00152477|580719572|FG002|Chemotherapy Period|Progression of Disease|4|||
160818497|NCT00152477|580719570|FG000|Chemotherapy Period|Investigator decision|0|||
160818498|NCT00152477|580719571|FG001|Chemotherapy Period|Investigator decision|0|||
160818499|NCT00152477|580719572|FG002|Chemotherapy Period|Investigator decision|1|||
160818500|NCT00152477|580719570|FG000|Chemotherapy Period|Patient condition worsened|1|||
160818501|NCT00152477|580719571|FG001|Chemotherapy Period|Patient condition worsened|0|||
160818502|NCT00152477|580719572|FG002|Chemotherapy Period|Patient condition worsened|0|||
160818503|NCT00152477|580719570|FG000|Monotherapy Period|Adverse Event|1|||
160818504|NCT00152477|580719571|FG001|Monotherapy Period|Adverse Event|0|||
160818505|NCT00152477|580719572|FG002|Monotherapy Period|Adverse Event|5|||
160818506|NCT00152477|580719570|FG000|Monotherapy Period|Death|2|||
160818507|NCT00152477|580719571|FG001|Monotherapy Period|Death|0|||
160818508|NCT00152477|580719572|FG002|Monotherapy Period|Death|1|||
160818509|NCT00152477|580719570|FG000|Monotherapy Period|Lack of Efficacy|7|||
160818510|NCT00152477|580719571|FG001|Monotherapy Period|Lack of Efficacy|16|||
160818511|NCT00152477|580719572|FG002|Monotherapy Period|Lack of Efficacy|10|||
160818512|NCT00152477|580719570|FG000|Monotherapy Period|Protocol Violation|0|||
160818513|NCT00152477|580719571|FG001|Monotherapy Period|Protocol Violation|1|||
160818514|NCT00152477|580719572|FG002|Monotherapy Period|Protocol Violation|0|||
160818515|NCT00152477|580719570|FG000|Monotherapy Period|Withdrawal by Subject|0|||
160818516|NCT00152477|580719571|FG001|Monotherapy Period|Withdrawal by Subject|0|||
160818517|NCT00152477|580719572|FG002|Monotherapy Period|Withdrawal by Subject|4|||
160818518|NCT00152477|580719570|FG000|Monotherapy Period|Progression of Disease|5|||
160818519|NCT00152477|580719571|FG001|Monotherapy Period|Progression of Disease|11|||
160818520|NCT00152477|580719572|FG002|Monotherapy Period|Progression of Disease|12|||
160818521|NCT00152477|580719570|FG000|Monotherapy Period|Patient decision|0|||
160818522|NCT00152477|580719571|FG001|Monotherapy Period|Patient decision|1|||
160818523|NCT00152477|580719572|FG002|Monotherapy Period|Patient decision|1|||
160818524|NCT00152477|580719570|FG000|Monotherapy Period|Study personel decision|0|||
160818525|NCT00152477|580719571|FG001|Monotherapy Period|Study personel decision|0|||
160818526|NCT00152477|580719572|FG002|Monotherapy Period|Study personel decision|1|||
160818527|NCT03275246|580719575|FG000|Overall Study|Protocol Violation|5|||
160818528|NCT03275246|580719575|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
160818529|NCT00730041|580719576|FG000|Overall Study|Lost to Follow-up|0|||
160818530|NCT00730041|580719577|FG001|Overall Study|Lost to Follow-up|2|||
160818531|NCT02301546|580719578|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
160818532|NCT02301546|580719579|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
160818533|NCT02301546|580719578|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
160818534|NCT02301546|580719579|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
160818535|NCT02301546|580719578|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
160818536|NCT02301546|580719579|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
160818537|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
160818538|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
160818539|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
160818540|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
160818541|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
160818542|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
160818543|NCT02301546|580719578|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
160818544|NCT02301546|580719579|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
160818545|NCT00433966|580719580|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
160987604|NCT01544582|581341181|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
160818546|NCT00433966|580719581|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
160818547|NCT00433966|580719582|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
160818548|NCT00433966|580719583|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
160818549|NCT00433966|580719580|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
160818550|NCT00433966|580719581|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
160818551|NCT00433966|580719582|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
160818552|NCT00433966|580719583|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
160818553|NCT00433966|580719580|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
160818554|NCT00433966|580719581|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
160818555|NCT00433966|580719582|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
160818556|NCT00433966|580719583|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
160818557|NCT00433966|580719580|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
160818558|NCT00433966|580719581|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
160818559|NCT00433966|580719582|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
160818560|NCT00433966|580719583|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
160818561|NCT00433966|580719580|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
160818562|NCT00433966|580719581|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
160818563|NCT00433966|580719582|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
160818564|NCT00433966|580719583|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
160818565|NCT03748706|580719587|FG000|Overall Study|Lost to Follow-up|1|||
160818566|NCT01606176|580719594|FG000|Overall Study|Adverse Event|2|||
160818567|NCT01606176|580719595|FG001|Overall Study|Adverse Event|3|||
160818568|NCT01606176|580719594|FG000|Overall Study|Disease progression|1|||
160818569|NCT01606176|580719595|FG001|Overall Study|Disease progression|0|||
160818570|NCT01606176|580719594|FG000|Overall Study|Withdrawal by Subject|1|||
160818571|NCT01606176|580719595|FG001|Overall Study|Withdrawal by Subject|0|||
160818572|NCT05129449|580719608|FG000|Overall Study|Protocol Violation|1|||
160818573|NCT04238481|580719609|FG000|Overall Study|Miscellaneous|0|||
160818574|NCT04238481|580719610|FG001|Overall Study|Miscellaneous|1|||
160818575|NCT04238481|580719611|FG002|Overall Study|Miscellaneous|0|||
160818576|NCT04238481|580719612|FG003|Overall Study|Miscellaneous|0|||
160818577|NCT02247011|580719613|FG000|Overall Study|Poor quality of radiological results|125|||
160818578|NCT02152371|580719614|FG000|Overall Study|Adverse Event|6|||
160818579|NCT02152371|580719615|FG001|Overall Study|Adverse Event|2|||
160818580|NCT02152371|580719614|FG000|Overall Study|Withdrawal by Subject|3|||
160818581|NCT02152371|580719615|FG001|Overall Study|Withdrawal by Subject|7|||
160818582|NCT02152371|580719614|FG000|Overall Study|Protocol Violation|2|||
160818583|NCT02152371|580719615|FG001|Overall Study|Protocol Violation|3|||
160818584|NCT02152371|580719614|FG000|Overall Study|Lost to Follow-up|1|||
160818585|NCT02152371|580719615|FG001|Overall Study|Lost to Follow-up|0|||
160818586|NCT02152371|580719614|FG000|Overall Study|Lack of Efficacy|0|||
160818587|NCT02152371|580719615|FG001|Overall Study|Lack of Efficacy|1|||
160818588|NCT02152371|580719614|FG000|Overall Study|Physician Decision|0|||
160818589|NCT02152371|580719615|FG001|Overall Study|Physician Decision|2|||
160818590|NCT02152371|580719614|FG000|Overall Study|Reason Not Given|0|||
160818591|NCT02152371|580719615|FG001|Overall Study|Reason Not Given|1|||
160818592|NCT00656058|580719617|FG000|Overall Study|Withdrawal by Subject|2|||
160818593|NCT00656058|580719617|FG000|Overall Study|Withdrawal by Subject|4|||
160818594|NCT00616018|580719618|FG000|Overall Study|Protocol Violation|3|||
160818595|NCT01818258|580719620|FG000|Overall Study|Death|3|||
160818596|NCT01818258|580719621|FG001|Overall Study|Death|0|||
160818597|NCT01818258|580719620|FG000|Overall Study|Withdrawal by Subject|0|||
160818598|NCT01818258|580719621|FG001|Overall Study|Withdrawal by Subject|1|||
160900506|NCT01346969|581030143|FG003|Overall Study|Withdrawal by Subject|0|||
160900507|NCT01346969|581030140|FG000|Overall Study|Lost to Follow-up|1|||
160900508|NCT01346969|581030141|FG001|Overall Study|Lost to Follow-up|0|||
160900509|NCT01346969|581030142|FG002|Overall Study|Lost to Follow-up|2|||
160900510|NCT01346969|581030143|FG003|Overall Study|Lost to Follow-up|0|||
160987605|NCT01544582|581341182|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
160900511|NCT01346969|581030140|FG000|Overall Study|Physician Decision|0|||
160987606|NCT01544582|581341183|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
160987607|NCT01544582|581341180|FG000|Analysis Population|Physician Decision|0|||
160987608|NCT01544582|581341181|FG001|Analysis Population|Physician Decision|13|||
160987609|NCT01544582|581341182|FG002|Analysis Population|Physician Decision|10|||
160987610|NCT01544582|581341183|FG003|Analysis Population|Physician Decision|9|||
160987611|NCT01544582|581341180|FG000|Analysis Population|Safety Reason|0|||
160818599|NCT01818258|580719620|FG000|Overall Study|Lost to Follow-up|0|||
160818600|NCT01818258|580719621|FG001|Overall Study|Lost to Follow-up|1|||
160818601|NCT01818258|580719620|FG000|Overall Study|Unable to Travel to Clinic|0|||
160818602|NCT01818258|580719621|FG001|Overall Study|Unable to Travel to Clinic|1|||
160818603|NCT02839720|580719622|FG000|Overall Study|Adverse Event|2|||
160818604|NCT02839720|580719622|FG000|Overall Study|Non-compliance|2|||
160818605|NCT02839720|580719622|FG000|Overall Study|Intercurrent Illness|1|||
160900512|NCT01346969|581030141|FG001|Overall Study|Physician Decision|0|||
160900513|NCT01346969|581030142|FG002|Overall Study|Physician Decision|0|||
160900514|NCT01346969|581030143|FG003|Overall Study|Physician Decision|1|||
160987612|NCT01544582|581341181|FG001|Analysis Population|Safety Reason|33|||
160818606|NCT02839720|580719622|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
160818607|NCT00349921|580719623|FG000|First Spinal Injection|Physician Decision|1|||
160818608|NCT00349921|580719624|FG001|First Spinal Injection|Physician Decision|0|||
160818609|NCT00349921|580719625|FG002|First Spinal Injection|Physician Decision|0|||
160818610|NCT00349921|580719626|FG003|First Spinal Injection|Physician Decision|0|||
160818611|NCT00349921|580719623|FG000|First Spinal Injection|Adverse Event|0|||
160818612|NCT00349921|580719624|FG001|First Spinal Injection|Adverse Event|0|||
160818613|NCT00349921|580719625|FG002|First Spinal Injection|Adverse Event|1|||
160818614|NCT00349921|580719626|FG003|First Spinal Injection|Adverse Event|0|||
160818615|NCT05145322|580719627|FG000|Overall Study|Lost to Follow-up|4|||
160818616|NCT05145322|580719628|FG001|Overall Study|Lost to Follow-up|5|||
160987613|NCT01544582|581341182|FG002|Analysis Population|Safety Reason|31|||
160987614|NCT01544582|581341183|FG003|Analysis Population|Safety Reason|8|||
160987615|NCT01544582|581341180|FG000|Analysis Population|Effectiveness Reason|0|||
160987616|NCT01544582|581341181|FG001|Analysis Population|Effectiveness Reason|48|||
160987617|NCT01544582|581341182|FG002|Analysis Population|Effectiveness Reason|29|||
160987618|NCT01544582|581341183|FG003|Analysis Population|Effectiveness Reason|12|||
160987619|NCT01544582|581341180|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
160987620|NCT01544582|581341181|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
160987621|NCT01544582|581341182|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
160987622|NCT01544582|581341183|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
160818617|NCT04700540|580719629|FG000|Overall Study|Withdrawal by Subject|12|||
160818618|NCT04700540|580719630|FG001|Overall Study|Withdrawal by Subject|8|||
160818619|NCT04700540|580719629|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
160818620|NCT04700540|580719630|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
160818621|NCT03194568|580719631|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
160818622|NCT05285644|580719634|FG000|Overall Study|Adverse Event|3|||
160818623|NCT05285644|580719635|FG001|Overall Study|Adverse Event|3|||
160818624|NCT05285644|580719634|FG000|Overall Study|Withdrawal of Consent|2|||
160818625|NCT05285644|580719635|FG001|Overall Study|Withdrawal of Consent|5|||
160818626|NCT05285644|580719634|FG000|Overall Study|Noncompliance|0|||
160818627|NCT05285644|580719635|FG001|Overall Study|Noncompliance|4|||
160818628|NCT05285644|580719634|FG000|Overall Study|Lost to Follow-up|4|||
160818629|NCT05285644|580719635|FG001|Overall Study|Lost to Follow-up|6|||
160818630|NCT05285644|580719634|FG000|Overall Study|Disallowed Concurrent Medication|1|||
160818631|NCT05285644|580719635|FG001|Overall Study|Disallowed Concurrent Medication|1|||
160818632|NCT05285644|580719634|FG000|Overall Study|Investigator Decision|2|||
160818633|NCT05285644|580719635|FG001|Overall Study|Investigator Decision|0|||
160818634|NCT05285644|580719634|FG000|Overall Study|Protocol Deviation|1|||
160818635|NCT05285644|580719635|FG001|Overall Study|Protocol Deviation|0|||
160818636|NCT05285644|580719634|FG000|Overall Study|As specified in the Clinical Study Report|7|||
160818637|NCT05285644|580719635|FG001|Overall Study|As specified in the Clinical Study Report|3|||
160818638|NCT05248997|580719638|FG000|Overall Study|Lost to Follow-up|1|||
160818639|NCT05248997|580719639|FG001|Overall Study|Lost to Follow-up|1|||
160987623|NCT01544582|581341180|FG000|Analysis Population|Lost to Follow-up|0|||
160987624|NCT01544582|581341181|FG001|Analysis Population|Lost to Follow-up|6|||
160987625|NCT01544582|581341182|FG002|Analysis Population|Lost to Follow-up|6|||
160987626|NCT01544582|581341183|FG003|Analysis Population|Lost to Follow-up|5|||
160987627|NCT01544582|581341180|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
160987628|NCT01544582|581341181|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
160987629|NCT01544582|581341182|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
160987630|NCT01544582|581341183|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
160818640|NCT05248997|580719638|FG000|Overall Study|Randomized but not treated|32|||
160818641|NCT05248997|580719639|FG001|Overall Study|Randomized but not treated|25|||
160818642|NCT03515551|580719640|FG000|Overall Study|Death|4|||
160818643|NCT03515551|580719641|FG001|Overall Study|Death|1|||
160818644|NCT03515551|580719642|FG002|Overall Study|Death|2|||
160818645|NCT03515551|580719643|FG003|Overall Study|Death|2|||
160818646|NCT03515551|580719644|FG004|Overall Study|Death|2|||
160818647|NCT03515551|580719645|FG005|Overall Study|Death|4|||
160818648|NCT03515551|580719646|FG006|Overall Study|Death|1|||
160818649|NCT03515551|580719640|FG000|Overall Study|Lost to Follow-up|0|||
160818650|NCT03515551|580719641|FG001|Overall Study|Lost to Follow-up|0|||
160818651|NCT03515551|580719642|FG002|Overall Study|Lost to Follow-up|1|||
160818652|NCT03515551|580719643|FG003|Overall Study|Lost to Follow-up|0|||
160818653|NCT03515551|580719644|FG004|Overall Study|Lost to Follow-up|0|||
160818654|NCT03515551|580719645|FG005|Overall Study|Lost to Follow-up|0|||
160987631|NCT01544582|581341180|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
160987632|NCT01544582|581341181|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
160987633|NCT01544582|581341182|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
160987634|NCT01544582|581341183|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
161333774|NCT03327324|582610630|FG001|Baseline (Month 0-Month 3)|Death|0|||
160987635|NCT01544582|581341180|FG000|Analysis Population|Intolerance|0|||
161333775|NCT03327324|582610631|FG002|Baseline (Month 0-Month 3)|Death|0|||
160818655|NCT03515551|580719646|FG006|Overall Study|Lost to Follow-up|0|||
160818656|NCT03515551|580719640|FG000|Overall Study|Withdrawal by Subject|0|||
160818657|NCT03515551|580719641|FG001|Overall Study|Withdrawal by Subject|1|||
160818658|NCT03515551|580719642|FG002|Overall Study|Withdrawal by Subject|0|||
160818659|NCT03515551|580719643|FG003|Overall Study|Withdrawal by Subject|0|||
160818660|NCT03515551|580719644|FG004|Overall Study|Withdrawal by Subject|0|||
160818661|NCT03515551|580719645|FG005|Overall Study|Withdrawal by Subject|0|||
160818662|NCT03515551|580719646|FG006|Overall Study|Withdrawal by Subject|1|||
160818663|NCT03515551|580719640|FG000|Overall Study|Study ended by sponsor|0|||
160818664|NCT03515551|580719641|FG001|Overall Study|Study ended by sponsor|0|||
160818665|NCT03515551|580719642|FG002|Overall Study|Study ended by sponsor|2|||
160818666|NCT03515551|580719643|FG003|Overall Study|Study ended by sponsor|1|||
160818667|NCT03515551|580719644|FG004|Overall Study|Study ended by sponsor|3|||
160818668|NCT03515551|580719645|FG005|Overall Study|Study ended by sponsor|0|||
160818669|NCT03515551|580719646|FG006|Overall Study|Study ended by sponsor|3|||
160818670|NCT03515551|580719640|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818671|NCT03515551|580719641|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
160818672|NCT03515551|580719642|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818673|NCT03515551|580719643|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818674|NCT03515551|580719644|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818675|NCT03515551|580719645|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818676|NCT03515551|580719646|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
160818677|NCT03028415|580719650|FG000|Overall Study|Lost to Follow-up|6|||
160818678|NCT03028415|580719651|FG001|Overall Study|Lost to Follow-up|3|||
160818679|NCT03028415|580719650|FG000|Overall Study|Withdrawal by Subject|1|||
160818680|NCT03028415|580719651|FG001|Overall Study|Withdrawal by Subject|0|||
160818681|NCT03028415|580719650|FG000|Overall Study|Discontinued due to COVID-19|1|||
160818682|NCT03028415|580719651|FG001|Overall Study|Discontinued due to COVID-19|0|||
160818683|NCT01740089|580721598|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
160818684|NCT01740089|580721599|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
160818685|NCT01740089|580721600|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
160818686|NCT01740089|580721598|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
160818687|NCT01740089|580721599|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
160818688|NCT01740089|580721600|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
160818689|NCT01740089|580721598|FG000|After 12 Weeks|Lack of Efficacy|3|||
160818690|NCT01740089|580721599|FG001|After 12 Weeks|Lack of Efficacy|1|||
161132639|NCT03283085|581869042|FG001|Overall Study|Withdrawal by Subject|21|||
161132640|NCT03283085|581869043|FG002|Overall Study|Withdrawal by Subject|66|||
161132641|NCT03283085|581869044|FG003|Overall Study|Withdrawal by Subject|3|||
161132642|NCT03283085|581869045|FG004|Overall Study|Withdrawal by Subject|3|||
161132643|NCT03283085|581869046|FG005|Overall Study|Withdrawal by Subject|5|||
161132644|NCT03283085|581869041|FG000|Overall Study|Physician Decision|14|||
161132645|NCT03283085|581869042|FG001|Overall Study|Physician Decision|8|||
161132646|NCT03283085|581869043|FG002|Overall Study|Physician Decision|19|||
161132647|NCT03283085|581869044|FG003|Overall Study|Physician Decision|0|||
161132648|NCT03283085|581869045|FG004|Overall Study|Physician Decision|0|||
161132649|NCT03283085|581869046|FG005|Overall Study|Physician Decision|2|||
161132650|NCT03283085|581869041|FG000|Overall Study|Site Terminated by Sponsor|1|||
161132651|NCT03283085|581869042|FG001|Overall Study|Site Terminated by Sponsor|0|||
161132652|NCT03283085|581869043|FG002|Overall Study|Site Terminated by Sponsor|3|||
161132653|NCT03283085|581869044|FG003|Overall Study|Site Terminated by Sponsor|0|||
161132654|NCT03283085|581869045|FG004|Overall Study|Site Terminated by Sponsor|0|||
161132655|NCT03283085|581869046|FG005|Overall Study|Site Terminated by Sponsor|0|||
161132656|NCT03283085|581869041|FG000|Overall Study|Lost to Follow-up|2|||
161132657|NCT03283085|581869042|FG001|Overall Study|Lost to Follow-up|0|||
161132658|NCT03283085|581869043|FG002|Overall Study|Lost to Follow-up|2|||
161132659|NCT03283085|581869044|FG003|Overall Study|Lost to Follow-up|0|||
161132660|NCT03283085|581869045|FG004|Overall Study|Lost to Follow-up|0|||
161132661|NCT03283085|581869046|FG005|Overall Study|Lost to Follow-up|1|||
161132662|NCT03283085|581869041|FG000|Overall Study|Pregnancy|0|||
161132663|NCT03283085|581869042|FG001|Overall Study|Pregnancy|0|||
161132664|NCT03283085|581869043|FG002|Overall Study|Pregnancy|1|||
161132665|NCT03283085|581869044|FG003|Overall Study|Pregnancy|0|||
161132666|NCT03283085|581869045|FG004|Overall Study|Pregnancy|0|||
161132667|NCT03283085|581869046|FG005|Overall Study|Pregnancy|0|||
161132668|NCT03283085|581869041|FG000|Overall Study|Lack of Efficacy|12|||
161132669|NCT03283085|581869042|FG001|Overall Study|Lack of Efficacy|6|||
161132670|NCT03283085|581869043|FG002|Overall Study|Lack of Efficacy|24|||
161132671|NCT03283085|581869044|FG003|Overall Study|Lack of Efficacy|1|||
161132672|NCT03283085|581869045|FG004|Overall Study|Lack of Efficacy|1|||
161132673|NCT03283085|581869046|FG005|Overall Study|Lack of Efficacy|0|||
161132674|NCT03283085|581869041|FG000|Overall Study|Reason not Specified|0|||
161132675|NCT03283085|581869042|FG001|Overall Study|Reason not Specified|4|||
161132676|NCT03283085|581869043|FG002|Overall Study|Reason not Specified|8|||
160818691|NCT01740089|580721600|FG002|After 12 Weeks|Lack of Efficacy|4|||
161132677|NCT03283085|581869044|FG003|Overall Study|Reason not Specified|0|||
160818692|NCT01740089|580721598|FG000|After 12 Weeks|Adverse Event|2|||
160818693|NCT01740089|580721599|FG001|After 12 Weeks|Adverse Event|0|||
160818694|NCT01740089|580721600|FG002|After 12 Weeks|Adverse Event|5|||
160818695|NCT01740089|580721598|FG000|After 12 Weeks|Protocol Violation|1|||
160818696|NCT01740089|580721599|FG001|After 12 Weeks|Protocol Violation|1|||
160818697|NCT01740089|580721600|FG002|After 12 Weeks|Protocol Violation|1|||
160818698|NCT01740089|580721598|FG000|After 12 Weeks|Withdrawal by Subject|1|||
160818699|NCT01740089|580721599|FG001|After 12 Weeks|Withdrawal by Subject|1|||
160818700|NCT01740089|580721600|FG002|After 12 Weeks|Withdrawal by Subject|1|||
160818701|NCT01448824|580721605|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818702|NCT01448824|580721606|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818703|NCT01448824|580721607|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818704|NCT01448824|580721608|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818705|NCT01448824|580721609|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818706|NCT01448824|580721610|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818707|NCT01448824|580721611|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
160818708|NCT01448824|580721612|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
160818709|NCT01448824|580721605|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818710|NCT01448824|580721606|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818711|NCT01448824|580721607|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818712|NCT01448824|580721608|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
160818713|NCT01448824|580721609|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
160818714|NCT01448824|580721610|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
160818715|NCT01448824|580721611|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818716|NCT01448824|580721612|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
160818717|NCT01448824|580721605|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818718|NCT01448824|580721606|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818719|NCT01448824|580721607|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818720|NCT01448824|580721608|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818721|NCT01448824|580721609|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818722|NCT01448824|580721610|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
160818723|NCT01448824|580721611|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818724|NCT01448824|580721612|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
160818725|NCT01448824|580721605|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
160818726|NCT01448824|580721606|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
160818727|NCT01448824|580721607|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
160818728|NCT01448824|580721608|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
160818729|NCT01448824|580721609|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
160818730|NCT01448824|580721610|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
160818731|NCT01448824|580721611|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
160818732|NCT01448824|580721612|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
160818733|NCT01448824|580721605|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818734|NCT01448824|580721606|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818735|NCT01448824|580721607|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818736|NCT01448824|580721608|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818737|NCT01448824|580721609|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818738|NCT01448824|580721610|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818739|NCT01448824|580721611|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
160818740|NCT01448824|580721612|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
160818741|NCT01448824|580721605|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818742|NCT01448824|580721606|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818743|NCT01448824|580721607|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818744|NCT01448824|580721608|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818745|NCT01448824|580721609|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818746|NCT01448824|580721610|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818747|NCT01448824|580721611|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
160818748|NCT01448824|580721612|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
161132678|NCT03283085|581869045|FG004|Overall Study|Reason not Specified|0|||
161132679|NCT03283085|581869046|FG005|Overall Study|Reason not Specified|1|||
161132680|NCT02292771|581869049|FG000|Overall Study|Withdrawal by Subject|2|||
161132681|NCT02292771|581869050|FG001|Overall Study|Withdrawal by Subject|1|||
161132682|NCT02292771|581869049|FG000|Overall Study|Lost to Follow-up|2|||
161132683|NCT02292771|581869050|FG001|Overall Study|Lost to Follow-up|1|||
161132684|NCT06001307|581870713|FG000|Overall Study|Lost to Follow-up|1|||
161132685|NCT06001307|581870714|FG001|Overall Study|Lost to Follow-up|2|||
161132686|NCT03532100|581870715|FG000|Overall Study|Intervention malfunction|1|||
161132687|NCT03896581|581870716|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
161333776|NCT03327324|582610632|FG003|Baseline (Month 0-Month 3)|Death|0|||
161333777|NCT03327324|582610633|FG004|Baseline (Month 0-Month 3)|Death|1|||
160818749|NCT01448824|580721605|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818750|NCT01448824|580721606|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818751|NCT01448824|580721607|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818752|NCT01448824|580721608|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818753|NCT01448824|580721609|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818754|NCT01448824|580721610|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818755|NCT01448824|580721611|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
160818756|NCT01448824|580721612|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
160818757|NCT01448824|580721605|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818758|NCT01448824|580721606|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818759|NCT01448824|580721607|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818760|NCT01448824|580721608|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818761|NCT01448824|580721609|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818762|NCT01448824|580721610|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818763|NCT01448824|580721611|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
160818764|NCT01448824|580721612|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
160818765|NCT01537081|580721614|FG000|Overall Study|Adverse Event|5|||
160818766|NCT01537081|580721615|FG001|Overall Study|Adverse Event|2|||
160818767|NCT01537081|580721616|FG002|Overall Study|Adverse Event|2|||
160818768|NCT01537081|580721614|FG000|Overall Study|Lack of Efficacy|2|||
160818769|NCT01537081|580721615|FG001|Overall Study|Lack of Efficacy|1|||
160818770|NCT01537081|580721616|FG002|Overall Study|Lack of Efficacy|0|||
160818771|NCT01537081|580721614|FG000|Overall Study|Lost to Follow-up|17|||
160818772|NCT01537081|580721615|FG001|Overall Study|Lost to Follow-up|15|||
160818773|NCT01537081|580721616|FG002|Overall Study|Lost to Follow-up|9|||
160818774|NCT01537081|580721614|FG000|Overall Study|Protocol Violation|3|||
160818775|NCT01537081|580721615|FG001|Overall Study|Protocol Violation|2|||
160818776|NCT01537081|580721616|FG002|Overall Study|Protocol Violation|2|||
160818777|NCT01537081|580721614|FG000|Overall Study|Withdrawal by Subject|6|||
160818778|NCT01537081|580721615|FG001|Overall Study|Withdrawal by Subject|11|||
160818779|NCT01537081|580721616|FG002|Overall Study|Withdrawal by Subject|3|||
160818780|NCT01537081|580721614|FG000|Overall Study|Physician Decision|5|||
160818781|NCT01537081|580721615|FG001|Overall Study|Physician Decision|6|||
160818782|NCT01537081|580721616|FG002|Overall Study|Physician Decision|0|||
160818783|NCT01537081|580721614|FG000|Overall Study|Sponsor decision|0|||
160818784|NCT01537081|580721615|FG001|Overall Study|Sponsor decision|1|||
160818785|NCT01537081|580721616|FG002|Overall Study|Sponsor decision|0|||
160818786|NCT01537081|580721614|FG000|Overall Study|Assigned but never dosed|1|||
160818787|NCT01537081|580721615|FG001|Overall Study|Assigned but never dosed|0|||
160818788|NCT01537081|580721616|FG002|Overall Study|Assigned but never dosed|0|||
160818789|NCT01463111|580721617|FG000|Overall Study|Withdrawal by Subject|2|||
160818790|NCT01463111|580721617|FG000|Overall Study|Lost to Follow-up|5|||
160818791|NCT01463111|580721617|FG000|Overall Study|Physician Decision|2|||
160818792|NCT03100539|580721618|FG000|Overall Study|Lost to Follow-up|60|||
160818793|NCT03100539|580721619|FG001|Overall Study|Lost to Follow-up|54|||
160818794|NCT03100539|580721620|FG002|Overall Study|Lost to Follow-up|17|||
160818795|NCT03100539|580721618|FG000|Overall Study|Uncollected|8|||
160818796|NCT03100539|580721619|FG001|Overall Study|Uncollected|8|||
160818797|NCT03100539|580721620|FG002|Overall Study|Uncollected|0|||
160818798|NCT03100539|580721618|FG000|Overall Study|Ally Health|0|||
160818799|NCT03100539|580721619|FG001|Overall Study|Ally Health|0|||
160818800|NCT03100539|580721620|FG002|Overall Study|Ally Health|3|||
160818801|NCT03100539|580721618|FG000|Overall Study|Disinterest|0|||
160818802|NCT03100539|580721619|FG001|Overall Study|Disinterest|0|||
160818803|NCT03100539|580721620|FG002|Overall Study|Disinterest|22|||
160987636|NCT01544582|581341181|FG001|Analysis Population|Intolerance|1|||
160987637|NCT01544582|581341182|FG002|Analysis Population|Intolerance|0|||
160818804|NCT03100539|580721618|FG000|Overall Study|Veteran Health|0|||
160818805|NCT03100539|580721619|FG001|Overall Study|Veteran Health|0|||
160987638|NCT01544582|581341183|FG003|Analysis Population|Intolerance|0|||
160818806|NCT03100539|580721620|FG002|Overall Study|Veteran Health|8|||
160818807|NCT03100539|580721618|FG000|Overall Study|Moved|0|||
160818808|NCT03100539|580721619|FG001|Overall Study|Moved|0|||
160987639|NCT01544582|581341180|FG000|Analysis Population|Liver Transplantation|0|||
160818809|NCT03100539|580721620|FG002|Overall Study|Moved|1|||
160818810|NCT03100539|580721618|FG000|Overall Study|Scheduling Conflicts|0|||
160818811|NCT03100539|580721619|FG001|Overall Study|Scheduling Conflicts|0|||
160818812|NCT03100539|580721620|FG002|Overall Study|Scheduling Conflicts|12|||
160987640|NCT01544582|581341181|FG001|Analysis Population|Liver Transplantation|0|||
160818813|NCT00882583|580721621|FG000|Overall Study|Physician Decision|1|||
160818814|NCT00882583|580721622|FG001|Overall Study|Physician Decision|0|||
160818815|NCT00882583|580721621|FG000|Overall Study|Adverse Event|0|||
160818816|NCT00882583|580721622|FG001|Overall Study|Adverse Event|1|||
160818817|NCT01892436|580721625|FG000|Overall Study|Withdrawal by Subject|8|||
160818818|NCT01892436|580721626|FG001|Overall Study|Withdrawal by Subject|15|||
160818819|NCT01892436|580721627|FG002|Overall Study|Withdrawal by Subject|4|||
160818820|NCT01892436|580721628|FG003|Overall Study|Withdrawal by Subject|4|||
160818821|NCT01892436|580721625|FG000|Overall Study|Death|1|||
160818822|NCT01892436|580721626|FG001|Overall Study|Death|1|||
160818823|NCT01892436|580721627|FG002|Overall Study|Death|0|||
160818824|NCT01892436|580721628|FG003|Overall Study|Death|0|||
160818825|NCT01892436|580721625|FG000|Overall Study|Physician Decision|2|||
160818826|NCT01892436|580721626|FG001|Overall Study|Physician Decision|1|||
160818827|NCT01892436|580721627|FG002|Overall Study|Physician Decision|0|||
160818828|NCT01892436|580721628|FG003|Overall Study|Physician Decision|1|||
160818829|NCT01892436|580721625|FG000|Overall Study|Pregnancy|0|||
160818830|NCT01892436|580721626|FG001|Overall Study|Pregnancy|2|||
160818831|NCT01892436|580721627|FG002|Overall Study|Pregnancy|1|||
160818832|NCT01892436|580721628|FG003|Overall Study|Pregnancy|0|||
160818833|NCT01892436|580721625|FG000|Overall Study|Technical problems|2|||
160818834|NCT01892436|580721626|FG001|Overall Study|Technical problems|1|||
160818835|NCT01892436|580721627|FG002|Overall Study|Technical problems|1|||
160818836|NCT01892436|580721628|FG003|Overall Study|Technical problems|1|||
160818837|NCT01892436|580721625|FG000|Overall Study|Lack of Efficacy|1|||
160818838|NCT01892436|580721626|FG001|Overall Study|Lack of Efficacy|2|||
160818839|NCT01892436|580721627|FG002|Overall Study|Lack of Efficacy|2|||
160818840|NCT01892436|580721628|FG003|Overall Study|Lack of Efficacy|2|||
160818841|NCT01892436|580721625|FG000|Overall Study|Lost to Follow-up|1|||
160818842|NCT01892436|580721626|FG001|Overall Study|Lost to Follow-up|1|||
160818843|NCT01892436|580721627|FG002|Overall Study|Lost to Follow-up|1|||
160818844|NCT01892436|580721628|FG003|Overall Study|Lost to Follow-up|3|||
160818845|NCT01892436|580721625|FG000|Overall Study|non-compliance with treatment|1|||
160818846|NCT01892436|580721626|FG001|Overall Study|non-compliance with treatment|0|||
160818847|NCT01892436|580721627|FG002|Overall Study|non-compliance with treatment|0|||
160818848|NCT01892436|580721628|FG003|Overall Study|non-compliance with treatment|0|||
160818849|NCT01892436|580721625|FG000|Overall Study|Adverse Event|7|||
160818850|NCT01892436|580721626|FG001|Overall Study|Adverse Event|6|||
160818851|NCT01892436|580721627|FG002|Overall Study|Adverse Event|2|||
160818852|NCT01892436|580721628|FG003|Overall Study|Adverse Event|3|||
160818853|NCT02526524|580721629|FG000|Overall Study|Withdrawal by Subject|3|||
160818854|NCT02526524|580721630|FG001|Overall Study|Withdrawal by Subject|3|||
160818855|NCT02526524|580721631|FG002|Overall Study|Withdrawal by Subject|6|||
160818856|NCT02526524|580721632|FG003|Overall Study|Withdrawal by Subject|1|||
160818857|NCT02526524|580721633|FG004|Overall Study|Withdrawal by Subject|9|||
160818858|NCT02526524|580721634|FG005|Overall Study|Withdrawal by Subject|5|||
160818859|NCT02526524|580721629|FG000|Overall Study|Adverse Event|3|||
160818860|NCT02526524|580721630|FG001|Overall Study|Adverse Event|2|||
160818861|NCT02526524|580721631|FG002|Overall Study|Adverse Event|4|||
160818862|NCT02526524|580721632|FG003|Overall Study|Adverse Event|2|||
160818863|NCT02526524|580721633|FG004|Overall Study|Adverse Event|6|||
160818864|NCT02526524|580721634|FG005|Overall Study|Adverse Event|8|||
160818865|NCT02526524|580721629|FG000|Overall Study|Lost to Follow-up|2|||
160818866|NCT02526524|580721630|FG001|Overall Study|Lost to Follow-up|3|||
160818867|NCT02526524|580721631|FG002|Overall Study|Lost to Follow-up|8|||
160818868|NCT02526524|580721632|FG003|Overall Study|Lost to Follow-up|1|||
160818869|NCT02526524|580721633|FG004|Overall Study|Lost to Follow-up|2|||
160818870|NCT02526524|580721634|FG005|Overall Study|Lost to Follow-up|5|||
160818871|NCT02526524|580721629|FG000|Overall Study|Protocol Violation|3|||
160818872|NCT02526524|580721630|FG001|Overall Study|Protocol Violation|1|||
160818873|NCT02526524|580721631|FG002|Overall Study|Protocol Violation|5|||
160818874|NCT02526524|580721632|FG003|Overall Study|Protocol Violation|3|||
160818875|NCT02526524|580721633|FG004|Overall Study|Protocol Violation|4|||
160818876|NCT02526524|580721634|FG005|Overall Study|Protocol Violation|3|||
160818877|NCT02526524|580721629|FG000|Overall Study|Loss of Glucose Control|0|||
160900515|NCT01346969|581030140|FG000|Overall Study|Randomized but not treated|1|||
160818878|NCT02526524|580721630|FG001|Overall Study|Loss of Glucose Control|0|||
160818879|NCT02526524|580721631|FG002|Overall Study|Loss of Glucose Control|3|||
160818880|NCT02526524|580721632|FG003|Overall Study|Loss of Glucose Control|0|||
160818881|NCT02526524|580721633|FG004|Overall Study|Loss of Glucose Control|2|||
160818882|NCT02526524|580721634|FG005|Overall Study|Loss of Glucose Control|0|||
160818883|NCT02526524|580721629|FG000|Overall Study|Physician Decision|0|||
160818884|NCT02526524|580721630|FG001|Overall Study|Physician Decision|0|||
160818885|NCT02526524|580721631|FG002|Overall Study|Physician Decision|0|||
160818886|NCT02526524|580721632|FG003|Overall Study|Physician Decision|0|||
160818887|NCT02526524|580721633|FG004|Overall Study|Physician Decision|1|||
160818888|NCT02526524|580721634|FG005|Overall Study|Physician Decision|0|||
160818889|NCT02526524|580721629|FG000|Overall Study|Sponsor Decision|1|||
160818890|NCT02526524|580721630|FG001|Overall Study|Sponsor Decision|0|||
160818891|NCT02526524|580721631|FG002|Overall Study|Sponsor Decision|0|||
160818892|NCT02526524|580721632|FG003|Overall Study|Sponsor Decision|0|||
160818893|NCT02526524|580721633|FG004|Overall Study|Sponsor Decision|0|||
160900516|NCT01346969|581030141|FG001|Overall Study|Randomized but not treated|0|||
160900517|NCT01346969|581030142|FG002|Overall Study|Randomized but not treated|0|||
160900518|NCT01346969|581030143|FG003|Overall Study|Randomized but not treated|0|||
160900519|NCT03666624|581030145|FG000|Overall Study|participant grieving over recent death of parent|1|||
161333778|NCT03327324|582610634|FG005|Baseline (Month 0-Month 3)|Death|0|||
161333779|NCT03327324|582610629|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333780|NCT03327324|582610630|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333781|NCT03327324|582610631|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333782|NCT03327324|582610632|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333783|NCT03327324|582610633|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333784|NCT03327324|582610634|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
160818894|NCT02526524|580721634|FG005|Overall Study|Sponsor Decision|0|||
160818895|NCT01606787|580721641|FG000|Overall Study|Withdrawal by Subject|4|||
160818896|NCT01606787|580721642|FG001|Overall Study|Withdrawal by Subject|5|||
160818897|NCT01606787|580721641|FG000|Overall Study|Surgery canceled|0|||
160818898|NCT01606787|580721642|FG001|Overall Study|Surgery canceled|2|||
160818899|NCT00713349|580721644|FG000|Overall Study|Protocol Violation|1|||
160818900|NCT03764631|580721645|FG000|Overall Study|Personal Reasons|3|||
160818901|NCT03764631|580721646|FG001|Overall Study|Personal Reasons|2|||
160818902|NCT03764631|580721645|FG000|Overall Study|Switching Therapy|3|||
160818903|NCT03764631|580721646|FG001|Overall Study|Switching Therapy|3|||
160818904|NCT03764631|580721645|FG000|Overall Study|Adverse Event|0|||
160818905|NCT03764631|580721646|FG001|Overall Study|Adverse Event|1|||
160818906|NCT03764631|580721645|FG000|Overall Study|Lost to Follow-up|33|||
160818907|NCT03764631|580721646|FG001|Overall Study|Lost to Follow-up|41|||
160818908|NCT03764631|580721645|FG000|Overall Study|No data as study site was closed|2|||
160818909|NCT03764631|580721646|FG001|Overall Study|No data as study site was closed|6|||
160818910|NCT01289353|580721647|FG000|Overall Study|Lost to Follow-up|2|||
160818911|NCT00473668|580721650|FG000|Overall Study|Withdrawal by Subject|0|||
160818912|NCT00473668|580721651|FG001|Overall Study|Withdrawal by Subject|2|||
160818913|NCT00473668|580721652|FG002|Overall Study|Withdrawal by Subject|0|||
160818914|NCT00473668|580721650|FG000|Overall Study|Migrated/moved from study area|3|||
160818915|NCT00473668|580721651|FG001|Overall Study|Migrated/moved from study area|2|||
160818916|NCT00473668|580721652|FG002|Overall Study|Migrated/moved from study area|0|||
160818917|NCT00473668|580721650|FG000|Overall Study|Lost to Follow-up|0|||
160818918|NCT00473668|580721651|FG001|Overall Study|Lost to Follow-up|4|||
160818919|NCT00473668|580721652|FG002|Overall Study|Lost to Follow-up|6|||
160818920|NCT00473668|580721650|FG000|Overall Study|Other|2|||
160818921|NCT00473668|580721651|FG001|Overall Study|Other|3|||
160818922|NCT00473668|580721652|FG002|Overall Study|Other|4|||
160818923|NCT02039219|580721653|FG000|Treatment|Withdrawal by Subject|1|||
160818924|NCT02039219|580721654|FG001|Treatment|Withdrawal by Subject|0|||
160818925|NCT02039219|580721653|FG000|Treatment|Adverse Event|0|||
160818926|NCT02039219|580721654|FG001|Treatment|Adverse Event|1|||
160818927|NCT02039219|580721653|FG000|Treatment|Physician Decision|1|||
160818928|NCT02039219|580721654|FG001|Treatment|Physician Decision|0|||
160818929|NCT02039219|580721653|FG000|Treatment|Lost to Follow-up|0|||
160818930|NCT02039219|580721654|FG001|Treatment|Lost to Follow-up|1|||
160818931|NCT02039219|580721653|FG000|Treatment|Protocol Violation|1|||
160818932|NCT02039219|580721654|FG001|Treatment|Protocol Violation|0|||
160818933|NCT02039219|580721653|FG000|Treatment|Death|1|||
160818934|NCT02039219|580721654|FG001|Treatment|Death|0|||
160818935|NCT02039219|580721653|FG000|Follow up|Adverse Event|0|||
160818936|NCT02039219|580721654|FG001|Follow up|Adverse Event|1|||
160818937|NCT02226562|580721655|FG000|Overall Study|Lost to Follow-up|0|||
160818938|NCT02226562|580721656|FG001|Overall Study|Lost to Follow-up|1|||
160818939|NCT04569136|580721662|FG000|Overall Study|Lost to Follow-up|2|||
160818940|NCT04569136|580721663|FG001|Overall Study|Lost to Follow-up|0|||
160818941|NCT04569136|580721664|FG002|Overall Study|Lost to Follow-up|1|||
160818942|NCT01466660|580721670|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
160818943|NCT01466660|580721671|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
160818944|NCT01466660|580721670|FG000|Overall Study|Worsening of underlying cancer disease|5|||
160818945|NCT01466660|580721671|FG001|Overall Study|Worsening of underlying cancer disease|2|||
160818946|NCT01466660|580721670|FG000|Overall Study|Other adverse event|19|||
160818947|NCT01466660|580721671|FG001|Overall Study|Other adverse event|18|||
160818948|NCT01466660|580721670|FG000|Overall Study|Protocol Violation|2|||
160818949|NCT01466660|580721671|FG001|Overall Study|Protocol Violation|1|||
160818950|NCT01466660|580721670|FG000|Overall Study|Refused continuation of trial medication|4|||
160818951|NCT01466660|580721671|FG001|Overall Study|Refused continuation of trial medication|3|||
160818952|NCT01466660|580721670|FG000|Overall Study|Other reason not defined above|10|||
160818953|NCT01466660|580721671|FG001|Overall Study|Other reason not defined above|8|||
160818954|NCT03576066|580721672|FG000|Overall Study|Noncompliance with study drug|0|||
160818955|NCT03576066|580721673|FG001|Overall Study|Noncompliance with study drug|1|||
160818956|NCT00129701|580721674|FG000|Overall Study|Withdrawal by Subject|33|||
160818957|NCT00006164|580721675|FG000|Overall Study|Withdrew or lost to follow-up|70|||
160818958|NCT00006164|580721676|FG001|Overall Study|Withdrew or lost to follow-up|81|||
160818959|NCT02750345|580721677|FG000|Intervention 1|Adverse Event|0|||
160900520|NCT03666624|581030146|FG001|Overall Study|participant grieving over recent death of parent|0|||
161132688|NCT03896581|581870717|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
160818960|NCT02750345|580721678|FG001|Intervention 1|Adverse Event|0|||
160818961|NCT02750345|580721679|FG002|Intervention 1|Adverse Event|0|||
160818962|NCT02750345|580721680|FG003|Intervention 1|Adverse Event|0|||
160818963|NCT02750345|580721681|FG004|Intervention 1|Adverse Event|1|||
160818964|NCT02750345|580721682|FG005|Intervention 1|Adverse Event|0|||
160818965|NCT00223808|580721683|FG000|Overall Study|<5 hrs therapy before discharge|3|||
160818966|NCT00223808|580721684|FG001|Overall Study|<5 hrs therapy before discharge|5|||
160818967|NCT00223808|580721685|FG002|Overall Study|<5 hrs therapy before discharge|5|||
160818968|NCT00191724|580721688|FG000|Overall Study|Adverse Event|0|||
160818969|NCT00191724|580721689|FG001|Overall Study|Adverse Event|0|||
160818970|NCT00191724|580721690|FG002|Overall Study|Adverse Event|1|||
160818971|NCT00191724|580721691|FG003|Overall Study|Adverse Event|0|||
160818972|NCT00191724|580721692|FG004|Overall Study|Adverse Event|0|||
160818973|NCT00191724|580721688|FG000|Overall Study|Lost to Follow-up|1|||
160818974|NCT00191724|580721689|FG001|Overall Study|Lost to Follow-up|1|||
160818975|NCT00191724|580721690|FG002|Overall Study|Lost to Follow-up|0|||
160818976|NCT00191724|580721691|FG003|Overall Study|Lost to Follow-up|2|||
160818977|NCT00191724|580721692|FG004|Overall Study|Lost to Follow-up|3|||
160818978|NCT00191724|580721688|FG000|Overall Study|Withdrawal by Subject|0|||
160818979|NCT00191724|580721689|FG001|Overall Study|Withdrawal by Subject|0|||
160818980|NCT00191724|580721690|FG002|Overall Study|Withdrawal by Subject|0|||
160818981|NCT00191724|580721691|FG003|Overall Study|Withdrawal by Subject|1|||
160818982|NCT00191724|580721692|FG004|Overall Study|Withdrawal by Subject|0|||
160818983|NCT05260073|580721693|FG000|Overall Study|Physician Decision|1|||
160818984|NCT05260073|580721693|FG000|Overall Study|Withdrawal by Subject|6|||
160818985|NCT05260073|580721693|FG000|Overall Study|Lost to Follow-up|14|||
160818986|NCT03458910|580721694|FG000|Overall Study|Withdrawal by Subject|7|||
160818987|NCT03458910|580721695|FG001|Overall Study|Withdrawal by Subject|8|||
160818988|NCT03458910|580721696|FG002|Overall Study|Withdrawal by Subject|6|||
160818989|NCT03458910|580721697|FG003|Overall Study|Withdrawal by Subject|4|||
160818990|NCT03458910|580721694|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
160818991|NCT03458910|580721695|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
160818992|NCT03458910|580721696|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
160818993|NCT03458910|580721697|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
160818994|NCT05275010|580721698|FG000|Overall Study|Reason Not Specified|4|||
160818995|NCT05275010|580721699|FG001|Overall Study|Reason Not Specified|1|||
160818996|NCT05275010|580721698|FG000|Overall Study|Withdrawal by Subject|1|||
160818997|NCT05275010|580721699|FG001|Overall Study|Withdrawal by Subject|0|||
160818998|NCT05275010|580721698|FG000|Overall Study|Lost to Follow-up|0|||
160818999|NCT05275010|580721699|FG001|Overall Study|Lost to Follow-up|1|||
160819000|NCT04484649|580721702|FG000|Overall Study|Lost to Follow-up|2|||
160819001|NCT04484649|580721703|FG001|Overall Study|Lost to Follow-up|1|||
160819002|NCT04484649|580721702|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
160819003|NCT04484649|580721703|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
160819004|NCT01681069|580721704|FG000|Overall Study|Withdrawal by Subject|4|||
160819005|NCT01681069|580721705|FG001|Overall Study|Withdrawal by Subject|5|||
160819006|NCT01681069|580721704|FG000|Overall Study|Protocol Violation|1|||
160819007|NCT01681069|580721705|FG001|Overall Study|Protocol Violation|1|||
160819008|NCT01681069|580721704|FG000|Overall Study|Adverse Event|0|||
160819009|NCT01681069|580721705|FG001|Overall Study|Adverse Event|1|||
160819010|NCT03883165|580721706|FG000|Overall Study|Withdrawal by Subject|4|||
160819011|NCT03883165|580721707|FG001|Overall Study|Withdrawal by Subject|3|||
160819012|NCT00967694|580721708|FG000|Overall Study|Withdrawal by Subject|6|||
160819013|NCT03905265|580721709|FG000|Overall Study|Withdrawal by Subject|1|||
160819014|NCT03905265|580721710|FG001|Overall Study|Withdrawal by Subject|1|||
160819015|NCT03905265|580721711|FG002|Overall Study|Withdrawal by Subject|0|||
160819016|NCT03905265|580721712|FG003|Overall Study|Withdrawal by Subject|0|||
160819017|NCT04085458|580721715|FG000|Overall Study|Other|1|||
160819018|NCT04085458|580721715|FG000|Overall Study|Withdrawal by Subject|2|||
160900521|NCT05213481|581030148|FG000|Overall Study|Adverse Event|3|||
161132689|NCT03896581|581870716|FG000|Overall Study|Withdrawal by Subject|4|||
161132690|NCT03896581|581870717|FG001|Overall Study|Withdrawal by Subject|1|||
161132691|NCT03896581|581870716|FG000|Overall Study|Lost to Follow-up|1|||
161132692|NCT03896581|581870717|FG001|Overall Study|Lost to Follow-up|0|||
161132693|NCT03896581|581870716|FG000|Overall Study|Lack of Efficacy|2|||
160900522|NCT05213481|581030148|FG000|Overall Study|Lost to Follow-up|1|||
160819019|NCT04085458|580721715|FG000|Overall Study|Adverse Event|2|||
160819020|NCT03632993|580721716|FG000|Overall Study|Withdrawal by Subject|1|||
160819021|NCT03632993|580721717|FG001|Overall Study|Withdrawal by Subject|0|||
160819022|NCT03632993|580721718|FG002|Overall Study|Withdrawal by Subject|0|||
160819023|NCT03632993|580721719|FG003|Overall Study|Withdrawal by Subject|0|||
160819024|NCT03632993|580721720|FG004|Overall Study|Withdrawal by Subject|0|||
160900523|NCT00447005|581030150|FG000|Overall Study|Adverse Event|1|||
161132694|NCT03896581|581870717|FG001|Overall Study|Lack of Efficacy|1|||
160819025|NCT03632993|580721721|FG005|Overall Study|Withdrawal by Subject|0|||
160819026|NCT03632993|580721722|FG006|Overall Study|Withdrawal by Subject|0|||
160819027|NCT03632993|580721723|FG007|Overall Study|Withdrawal by Subject|0|||
160819028|NCT03632993|580721724|FG008|Overall Study|Withdrawal by Subject|0|||
160819029|NCT03632993|580721725|FG009|Overall Study|Withdrawal by Subject|1|||
160819030|NCT03632993|580721716|FG000|Overall Study|Protocol Non-compliance|0|||
160819031|NCT03632993|580721717|FG001|Overall Study|Protocol Non-compliance|1|||
160819032|NCT03632993|580721718|FG002|Overall Study|Protocol Non-compliance|0|||
160819033|NCT03632993|580721719|FG003|Overall Study|Protocol Non-compliance|0|||
160819034|NCT03632993|580721720|FG004|Overall Study|Protocol Non-compliance|0|||
160819035|NCT03632993|580721721|FG005|Overall Study|Protocol Non-compliance|0|||
160819036|NCT03632993|580721722|FG006|Overall Study|Protocol Non-compliance|0|||
160819037|NCT03632993|580721723|FG007|Overall Study|Protocol Non-compliance|0|||
160819038|NCT03632993|580721724|FG008|Overall Study|Protocol Non-compliance|0|||
160819039|NCT03632993|580721725|FG009|Overall Study|Protocol Non-compliance|0|||
160819040|NCT03632993|580721716|FG000|Overall Study|Lost to Follow-up|0|||
160819041|NCT03632993|580721717|FG001|Overall Study|Lost to Follow-up|0|||
160819042|NCT03632993|580721718|FG002|Overall Study|Lost to Follow-up|0|||
160819043|NCT03632993|580721719|FG003|Overall Study|Lost to Follow-up|0|||
160819044|NCT03632993|580721720|FG004|Overall Study|Lost to Follow-up|0|||
160819045|NCT03632993|580721721|FG005|Overall Study|Lost to Follow-up|1|||
160819046|NCT03632993|580721722|FG006|Overall Study|Lost to Follow-up|0|||
160819047|NCT03632993|580721723|FG007|Overall Study|Lost to Follow-up|1|||
160819048|NCT03632993|580721724|FG008|Overall Study|Lost to Follow-up|0|||
160819049|NCT03632993|580721725|FG009|Overall Study|Lost to Follow-up|0|||
160819050|NCT03632993|580721716|FG000|Overall Study|Adverse Event|0|||
160819051|NCT03632993|580721717|FG001|Overall Study|Adverse Event|0|||
160819052|NCT03632993|580721718|FG002|Overall Study|Adverse Event|0|||
160819053|NCT03632993|580721719|FG003|Overall Study|Adverse Event|0|||
160819054|NCT03632993|580721720|FG004|Overall Study|Adverse Event|0|||
160819055|NCT03632993|580721721|FG005|Overall Study|Adverse Event|1|||
160819056|NCT03632993|580721722|FG006|Overall Study|Adverse Event|0|||
160819057|NCT03632993|580721723|FG007|Overall Study|Adverse Event|1|||
160819058|NCT03632993|580721724|FG008|Overall Study|Adverse Event|0|||
160819059|NCT03632993|580721725|FG009|Overall Study|Adverse Event|0|||
160819060|NCT00758264|580721726|FG000|Active Phase|Withdrawal by Subject|0|||
160819061|NCT00758264|580721727|FG001|Active Phase|Withdrawal by Subject|0|||
160819062|NCT00758264|580721728|FG002|Active Phase|Withdrawal by Subject|1|||
160819063|NCT00758264|580721726|FG000|Active Phase|Lost to Follow-up|1|||
160819064|NCT00758264|580721727|FG001|Active Phase|Lost to Follow-up|0|||
160819065|NCT00758264|580721728|FG002|Active Phase|Lost to Follow-up|0|||
160819066|NCT00758264|580721726|FG000|Active Phase|Other|0|||
160819067|NCT00758264|580721727|FG001|Active Phase|Other|0|||
160819068|NCT00758264|580721728|FG002|Active Phase|Other|4|||
160819069|NCT00368836|580721730|FG000|Phase II|Screen Failure|1|||
160819070|NCT00368836|580721730|FG000|Phase II|Withdrawal by Subject|1|||
160819071|NCT00368836|580721730|FG000|Phase II|unable to collect blood and/or breath|17|||
160819072|NCT00368836|580721730|FG000|Phase II|Protocol Violation|2|||
160819073|NCT00244933|580721738|FG000|Overall Study|Not response evaluable|2|||
160819074|NCT02901054|580721744|FG000|Overall Study|Physician Decision|1|||
160819075|NCT02901054|580721744|FG000|Overall Study|Withdrawal by Subject|3|||
160819076|NCT06359028|580721748|FG000|Overall Study|Adverse Event|1|||
160819077|NCT06359028|580721749|FG001|Overall Study|Adverse Event|0|||
160819078|NCT06359028|580721748|FG000|Overall Study|Withdrawal by Subject|1|||
160819079|NCT06359028|580721749|FG001|Overall Study|Withdrawal by Subject|0|||
160819080|NCT00673231|580721750|FG000|Overall Study|Withdrawal by Subject|14|||
160819081|NCT00673231|580721751|FG001|Overall Study|Withdrawal by Subject|10|||
160819082|NCT00673231|580721752|FG002|Overall Study|Withdrawal by Subject|8|||
160987641|NCT01544582|581341182|FG002|Analysis Population|Liver Transplantation|1|||
160987642|NCT01544582|581341183|FG003|Analysis Population|Liver Transplantation|0|||
160987643|NCT01544582|581341180|FG000|Analysis Population|No Social Insurance|0|||
160987644|NCT01544582|581341181|FG001|Analysis Population|No Social Insurance|0|||
160987645|NCT01544582|581341182|FG002|Analysis Population|No Social Insurance|1|||
160819083|NCT00673231|580721753|FG003|Overall Study|Withdrawal by Subject|6|||
160819084|NCT00673231|580721750|FG000|Overall Study|Adverse Event|6|||
160819085|NCT00673231|580721751|FG001|Overall Study|Adverse Event|5|||
160819086|NCT00673231|580721752|FG002|Overall Study|Adverse Event|9|||
160819087|NCT00673231|580721753|FG003|Overall Study|Adverse Event|6|||
160819088|NCT00673231|580721750|FG000|Overall Study|Lost to Follow-up|1|||
160819089|NCT00673231|580721751|FG001|Overall Study|Lost to Follow-up|2|||
160819090|NCT00673231|580721752|FG002|Overall Study|Lost to Follow-up|1|||
160987646|NCT01544582|581341183|FG003|Analysis Population|No Social Insurance|0|||
160987647|NCT01544582|581341180|FG000|Analysis Population|Poor Adherence|0|||
160819091|NCT00673231|580721753|FG003|Overall Study|Lost to Follow-up|2|||
160987648|NCT01544582|581341181|FG001|Analysis Population|Poor Adherence|0|||
160819092|NCT00673231|580721750|FG000|Overall Study|Death|0|||
160819093|NCT00673231|580721751|FG001|Overall Study|Death|0|||
160819094|NCT00673231|580721752|FG002|Overall Study|Death|1|||
160819095|NCT00673231|580721753|FG003|Overall Study|Death|0|||
160819096|NCT00673231|580721750|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
160819097|NCT00673231|580721751|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
160819098|NCT00673231|580721752|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
160819099|NCT00673231|580721753|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
160819100|NCT02952313|580721754|FG000|Primary Endpoint|Lost to Follow-up|4|||
160819101|NCT02952313|580721754|FG000|Primary Endpoint|Withdrawal by Subject|1|||
160819102|NCT02952313|580721754|FG000|Primary Endpoint|Lack of Efficacy|1|||
160819103|NCT02952313|580721754|FG000|Primary Endpoint|Missed visit|1|||
160819104|NCT02952313|580721754|FG000|Long-term Follow-up|Lost to Follow-up|12|||
160819105|NCT02952313|580721754|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
160819106|NCT02952313|580721754|FG000|Long-term Follow-up|Lack of Efficacy|6|||
160819107|NCT02952313|580721754|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
160819108|NCT02952313|580721754|FG000|Long-term Follow-up|Physician Decision|1|||
160819109|NCT02952313|580721754|FG000|Long-term Follow-up|Death|1|||
160819110|NCT02470585|580721765|FG000|Overall Study|Death|224|||
160819111|NCT02470585|580721766|FG001|Overall Study|Death|227|||
160819112|NCT02470585|580721767|FG002|Overall Study|Death|199|||
160819113|NCT02470585|580721765|FG000|Overall Study|Withdrew consent|21|||
160819114|NCT02470585|580721766|FG001|Overall Study|Withdrew consent|22|||
160819115|NCT02470585|580721767|FG002|Overall Study|Withdrew consent|31|||
160819116|NCT02470585|580721765|FG000|Overall Study|Lost to Follow-up|8|||
160819117|NCT02470585|580721766|FG001|Overall Study|Lost to Follow-up|15|||
160819118|NCT02470585|580721767|FG002|Overall Study|Lost to Follow-up|13|||
160819119|NCT02470585|580721765|FG000|Overall Study|Sponsor discontinued study|117|||
160819120|NCT02470585|580721766|FG001|Overall Study|Sponsor discontinued study|110|||
160819121|NCT02470585|580721767|FG002|Overall Study|Sponsor discontinued study|122|||
160819122|NCT02470585|580721765|FG000|Overall Study|Other, not specified|5|||
160819123|NCT02470585|580721766|FG001|Overall Study|Other, not specified|7|||
160819124|NCT02470585|580721767|FG002|Overall Study|Other, not specified|14|||
160819125|NCT02470585|580721765|FG000|Overall Study|Missing due to site non-compliance|0|||
160819126|NCT02470585|580721766|FG001|Overall Study|Missing due to site non-compliance|2|||
160819127|NCT02470585|580721767|FG002|Overall Study|Missing due to site non-compliance|3|||
160819128|NCT02602275|580721768|FG000|Day 1|Physician Decision|0|||
160819129|NCT02602275|580721769|FG001|Day 1|Physician Decision|1|||
160819130|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
160819131|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
160819132|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
160819133|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
160819134|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
160819135|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
160819136|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
160819137|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
160819138|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
160819139|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
160819140|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
160819141|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
160819142|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
160819143|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
160819144|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
160819145|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
160819146|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
160819147|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
160819148|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
160819149|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
160819150|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
160819151|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
160819152|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
160819153|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
160987649|NCT01544582|581341182|FG002|Analysis Population|Poor Adherence|1|||
160987650|NCT01544582|581341183|FG003|Analysis Population|Poor Adherence|0|||
160987651|NCT01544582|581341180|FG000|Analysis Population|Poor Participant Compliance|0|||
160819154|NCT01866111|580721770|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
160819155|NCT01866111|580721771|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
160819156|NCT01866111|580721772|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
160819157|NCT01866111|580721773|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
160819158|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
160819159|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
160819160|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
160819161|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
160819162|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
160819163|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
160819164|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
160819165|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
160819166|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
160987652|NCT01544582|581341181|FG001|Analysis Population|Poor Participant Compliance|1|||
160987653|NCT01544582|581341182|FG002|Analysis Population|Poor Participant Compliance|0|||
160987654|NCT01544582|581341183|FG003|Analysis Population|Poor Participant Compliance|0|||
160819167|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
160819168|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
160819169|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
160819170|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
160819171|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
160819172|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
160819173|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
160819174|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Death|1|||
160819175|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Death|1|||
160819176|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Death|3|||
160819177|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Death|2|||
160819178|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
160819179|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
160819180|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
160819181|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
160819182|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
160819183|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
160819184|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
160819185|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
160819186|NCT01866111|580721770|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
160819187|NCT01866111|580721771|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
160819188|NCT01866111|580721772|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
160819189|NCT01866111|580721773|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
160819190|NCT04113018|580721776|FG000|Overall Study|Death|2|||
160819191|NCT04113018|580721776|FG000|Overall Study|Lost to Follow-up|1|||
160819192|NCT04113018|580721776|FG000|Overall Study|Still On Study (on study treatment)|24|||
160819193|NCT04113018|580721776|FG000|Overall Study|Still On Study (in follow up)|12|||
160819194|NCT05005013|580721777|FG000|Overall Study|Withdrawal by Subject|5|||
160819195|NCT05005013|580721778|FG001|Overall Study|Withdrawal by Subject|1|||
160819196|NCT05005013|580721777|FG000|Overall Study|Lost to Follow-up|3|||
160819197|NCT05005013|580721778|FG001|Overall Study|Lost to Follow-up|1|||
160819198|NCT05005013|580721777|FG000|Overall Study|Ineligibility|1|||
160819199|NCT05005013|580721778|FG001|Overall Study|Ineligibility|1|||
160819200|NCT04283994|580721779|FG000|Overall Study|Death|11|||
160819201|NCT04283994|580721780|FG001|Overall Study|Death|20|||
160819202|NCT04283994|580721781|FG002|Overall Study|Death|11|||
160819203|NCT04283994|580721782|FG003|Overall Study|Death|0|||
160819204|NCT04283994|580721783|FG004|Overall Study|Death|0|||
160819205|NCT04283994|580721784|FG005|Overall Study|Death|0|||
160819206|NCT04283994|580721785|FG006|Overall Study|Death|0|||
160819207|NCT04283994|580721779|FG000|Overall Study|Withdrawal by Subject|16|||
160819208|NCT04283994|580721780|FG001|Overall Study|Withdrawal by Subject|4|||
160819209|NCT04283994|580721781|FG002|Overall Study|Withdrawal by Subject|6|||
160987655|NCT01544582|581341180|FG000|Analysis Population|Programmed Surgery|0|||
160987656|NCT01544582|581341181|FG001|Analysis Population|Programmed Surgery|1|||
160819210|NCT04283994|580721782|FG003|Overall Study|Withdrawal by Subject|1|||
160819211|NCT04283994|580721783|FG004|Overall Study|Withdrawal by Subject|0|||
160819212|NCT04283994|580721784|FG005|Overall Study|Withdrawal by Subject|1|||
160819213|NCT04283994|580721785|FG006|Overall Study|Withdrawal by Subject|0|||
160819214|NCT00583752|580721786|FG000|Overall Study|Lost to Follow-up|5|||
160819215|NCT00583752|580721787|FG001|Overall Study|Lost to Follow-up|5|||
160819216|NCT03315793|580721788|FG000|Overall Study|Adverse Event|4|||
160819217|NCT03315793|580721789|FG001|Overall Study|Adverse Event|2|||
160819218|NCT03315793|580721788|FG000|Overall Study|Protocol Deviation|1|||
160819219|NCT03315793|580721789|FG001|Overall Study|Protocol Deviation|0|||
160819220|NCT03315793|580721788|FG000|Overall Study|Difficult for regular visit|0|||
160819221|NCT03315793|580721789|FG001|Overall Study|Difficult for regular visit|1|||
160819222|NCT00983515|580723212|FG000|Ritonavir Alone|liver panel out of range|6|||
160819223|NCT00983515|580723212|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
160819224|NCT01463696|580723217|FG000|Overall Study|Adverse Event|0|||
160819225|NCT01463696|580723218|FG001|Overall Study|Adverse Event|1|||
160819226|NCT01463696|580723219|FG002|Overall Study|Adverse Event|0|||
160819227|NCT01463696|580723220|FG003|Overall Study|Adverse Event|2|||
160819228|NCT01463696|580723221|FG004|Overall Study|Adverse Event|0|||
160987657|NCT01544582|581341182|FG002|Analysis Population|Programmed Surgery|0|||
160987658|NCT01544582|581341183|FG003|Analysis Population|Programmed Surgery|0|||
160819229|NCT01463696|580723222|FG005|Overall Study|Adverse Event|1|||
160819230|NCT01463696|580723223|FG006|Overall Study|Adverse Event|3|||
160819231|NCT01463696|580723224|FG007|Overall Study|Adverse Event|2|||
160819232|NCT01463696|580723217|FG000|Overall Study|Lost to Follow-up|0|||
160819233|NCT01463696|580723218|FG001|Overall Study|Lost to Follow-up|0|||
160819234|NCT01463696|580723219|FG002|Overall Study|Lost to Follow-up|1|||
160819235|NCT01463696|580723220|FG003|Overall Study|Lost to Follow-up|0|||
160819236|NCT01463696|580723221|FG004|Overall Study|Lost to Follow-up|0|||
160819237|NCT01463696|580723222|FG005|Overall Study|Lost to Follow-up|0|||
160819238|NCT01463696|580723223|FG006|Overall Study|Lost to Follow-up|0|||
160819239|NCT01463696|580723224|FG007|Overall Study|Lost to Follow-up|0|||
160819240|NCT01463696|580723217|FG000|Overall Study|Progressive Disease|0|||
160819241|NCT01463696|580723218|FG001|Overall Study|Progressive Disease|1|||
160819242|NCT01463696|580723219|FG002|Overall Study|Progressive Disease|0|||
160819243|NCT01463696|580723220|FG003|Overall Study|Progressive Disease|1|||
160819244|NCT01463696|580723221|FG004|Overall Study|Progressive Disease|0|||
160819245|NCT01463696|580723222|FG005|Overall Study|Progressive Disease|1|||
160819246|NCT01463696|580723223|FG006|Overall Study|Progressive Disease|4|||
160819247|NCT01463696|580723224|FG007|Overall Study|Progressive Disease|2|||
160819248|NCT01463696|580723217|FG000|Overall Study|Withdrawal by Subject|0|||
160819249|NCT01463696|580723218|FG001|Overall Study|Withdrawal by Subject|0|||
160819250|NCT01463696|580723219|FG002|Overall Study|Withdrawal by Subject|0|||
160819251|NCT01463696|580723220|FG003|Overall Study|Withdrawal by Subject|1|||
160819252|NCT01463696|580723221|FG004|Overall Study|Withdrawal by Subject|1|||
160819253|NCT01463696|580723222|FG005|Overall Study|Withdrawal by Subject|1|||
160819254|NCT01463696|580723223|FG006|Overall Study|Withdrawal by Subject|2|||
160819255|NCT01463696|580723224|FG007|Overall Study|Withdrawal by Subject|0|||
160819256|NCT01463696|580723217|FG000|Overall Study|Not Treated|0|||
160819257|NCT01463696|580723218|FG001|Overall Study|Not Treated|0|||
160819258|NCT01463696|580723219|FG002|Overall Study|Not Treated|0|||
160819259|NCT01463696|580723220|FG003|Overall Study|Not Treated|0|||
160819260|NCT01463696|580723221|FG004|Overall Study|Not Treated|0|||
160819261|NCT01463696|580723222|FG005|Overall Study|Not Treated|0|||
160819262|NCT01463696|580723223|FG006|Overall Study|Not Treated|1|||
160819263|NCT01463696|580723224|FG007|Overall Study|Not Treated|0|||
160819264|NCT05526781|580723237|FG000|Overall Study|Lost to Follow-up|1|||
160819265|NCT01801436|580723238|FG000|Overall Study|Withdrawal by Subject|3|||
160819266|NCT01801436|580723238|FG000|Overall Study|Adverse Event|2|||
160819267|NCT01801436|580723238|FG000|Overall Study|Progressive disease|4|||
160819268|NCT02447250|580723241|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
160819269|NCT02447250|580723241|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
160819270|NCT02447250|580723241|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
160819271|NCT02743949|580723242|FG000|Overall Study|Adverse Event|0|||
160819272|NCT02743949|580723243|FG001|Overall Study|Adverse Event|0|||
160819273|NCT02743949|580723244|FG002|Overall Study|Adverse Event|2|||
160819274|NCT02743949|580723242|FG000|Overall Study|Significant Protocol Deviation|2|||
160819275|NCT02743949|580723243|FG001|Overall Study|Significant Protocol Deviation|0|||
160819276|NCT02743949|580723244|FG002|Overall Study|Significant Protocol Deviation|1|||
160819277|NCT02743949|580723242|FG000|Overall Study|Voluntary Withdrawal|2|||
160819278|NCT02743949|580723243|FG001|Overall Study|Voluntary Withdrawal|1|||
160819279|NCT02743949|580723244|FG002|Overall Study|Voluntary Withdrawal|0|||
160819280|NCT01921218|580723245|FG000|Overall Study|Death|2|||
160819281|NCT01921218|580723246|FG001|Overall Study|Death|1|||
160819282|NCT01921218|580723245|FG000|Overall Study|Withdrawal by Subject|0|||
160819283|NCT01921218|580723246|FG001|Overall Study|Withdrawal by Subject|2|||
160819284|NCT01921218|580723245|FG000|Overall Study|Kidney transplant|1|||
160819285|NCT01921218|580723246|FG001|Overall Study|Kidney transplant|1|||
160819286|NCT03389555|580723247|FG000|Overall Study|Protocol Violation|1|||
160819287|NCT03389555|580723248|FG001|Overall Study|Protocol Violation|3|||
160819288|NCT03389555|580723247|FG000|Overall Study|Death|1|||
160819289|NCT03389555|580723248|FG001|Overall Study|Death|0|||
160819290|NCT01885208|580723249|FG000|Overall Study|Unclassified|32|||
160819291|NCT01885208|580723250|FG001|Overall Study|Unclassified|38|||
160819292|NCT00920218|580723251|FG000|Overall Study|Serious Adverse Event|2|||
160819293|NCT00920218|580723252|FG001|Overall Study|Serious Adverse Event|0|||
160819294|NCT00920218|580723253|FG002|Overall Study|Serious Adverse Event|2|||
160819295|NCT00920218|580723254|FG003|Overall Study|Serious Adverse Event|1|||
160819296|NCT00920218|580723251|FG000|Overall Study|Withdrawal by Subject|0|||
160819297|NCT00920218|580723252|FG001|Overall Study|Withdrawal by Subject|3|||
160819298|NCT00920218|580723253|FG002|Overall Study|Withdrawal by Subject|2|||
160819299|NCT00920218|580723254|FG003|Overall Study|Withdrawal by Subject|0|||
160819300|NCT00920218|580723251|FG000|Overall Study|Migrated/moved from study area|0|||
160819301|NCT00920218|580723252|FG001|Overall Study|Migrated/moved from study area|0|||
160819302|NCT00920218|580723253|FG002|Overall Study|Migrated/moved from study area|1|||
160819303|NCT00920218|580723254|FG003|Overall Study|Migrated/moved from study area|0|||
160819304|NCT00920218|580723251|FG000|Overall Study|Lost to Follow-up|0|||
160819305|NCT00920218|580723252|FG001|Overall Study|Lost to Follow-up|1|||
160987659|NCT01544582|581341180|FG000|Analysis Population|Participant in Jail|0|||
160987660|NCT01544582|581341181|FG001|Analysis Population|Participant in Jail|0|||
160819306|NCT00920218|580723253|FG002|Overall Study|Lost to Follow-up|0|||
160819307|NCT00920218|580723254|FG003|Overall Study|Lost to Follow-up|3|||
160819308|NCT00920218|580723251|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
160819309|NCT00920218|580723252|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
160819310|NCT00920218|580723253|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
160819311|NCT00920218|580723254|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
160819312|NCT00920218|580723251|FG000|Overall Study|Other|0|||
160819313|NCT00920218|580723252|FG001|Overall Study|Other|0|||
160819314|NCT00920218|580723253|FG002|Overall Study|Other|1|||
160819315|NCT00920218|580723254|FG003|Overall Study|Other|0|||
160819316|NCT00960011|580723255|FG000|Overall Study|Death|5|||
160819317|NCT00960011|580723256|FG001|Overall Study|Death|0|||
160819318|NCT00960011|580723255|FG000|Overall Study|Lost to Follow-up|6|||
160819319|NCT00960011|580723256|FG001|Overall Study|Lost to Follow-up|2|||
160819320|NCT04417218|580723260|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
160819321|NCT04417218|580723261|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
160819322|NCT00873041|580723262|FG000|Core Study|Adverse Event|2|||
160819323|NCT00873041|580723263|FG001|Core Study|Adverse Event|3|||
160819324|NCT00873041|580723264|FG002|Core Study|Adverse Event|1|||
160819325|NCT00873041|580723262|FG000|Core Study|Withdrawal by Subject|1|||
160819326|NCT00873041|580723263|FG001|Core Study|Withdrawal by Subject|2|||
160819327|NCT00873041|580723264|FG002|Core Study|Withdrawal by Subject|2|||
160819328|NCT00873041|580723262|FG000|Core Study|Lost to Follow-up|3|||
160819329|NCT00873041|580723263|FG001|Core Study|Lost to Follow-up|1|||
160819330|NCT00873041|580723264|FG002|Core Study|Lost to Follow-up|0|||
160819331|NCT00873041|580723262|FG000|Core Study|Abnormal laboratory value|0|||
160819332|NCT00873041|580723263|FG001|Core Study|Abnormal laboratory value|0|||
160819333|NCT00873041|580723264|FG002|Core Study|Abnormal laboratory value|1|||
160819334|NCT00873041|580723262|FG000|Core Study|Protocol deviation|1|||
160819335|NCT00873041|580723263|FG001|Core Study|Protocol deviation|0|||
160819336|NCT00873041|580723264|FG002|Core Study|Protocol deviation|1|||
160819337|NCT00873041|580723262|FG000|Extension Study|Adverse Event|1|||
160819338|NCT00873041|580723263|FG001|Extension Study|Adverse Event|0|||
160819339|NCT00873041|580723264|FG002|Extension Study|Adverse Event|1|||
160819340|NCT00873041|580723262|FG000|Extension Study|Administrative reasons|0|||
160819341|NCT00873041|580723263|FG001|Extension Study|Administrative reasons|0|||
160819342|NCT00873041|580723264|FG002|Extension Study|Administrative reasons|1|||
160819343|NCT02449889|580723267|FG000|Overall Study|Adverse Event|1|||
160819344|NCT02449889|580723268|FG001|Overall Study|Adverse Event|2|||
160819345|NCT02449889|580723269|FG002|Overall Study|Adverse Event|0|||
160819346|NCT02449889|580723267|FG000|Overall Study|Protocol Violation|0|||
160819347|NCT02449889|580723268|FG001|Overall Study|Protocol Violation|4|||
160819348|NCT02449889|580723269|FG002|Overall Study|Protocol Violation|1|||
160819349|NCT01082874|580723274|FG000|Overall Study|Lost to Follow-up|10|||
160819350|NCT01082874|580723275|FG001|Overall Study|Lost to Follow-up|10|||
160819351|NCT01082874|580723276|FG002|Overall Study|Lost to Follow-up|6|||
160819352|NCT01082874|580723277|FG003|Overall Study|Lost to Follow-up|10|||
160819353|NCT01082874|580723274|FG000|Overall Study|Withdrawal by Subject|1|||
160819354|NCT01082874|580723275|FG001|Overall Study|Withdrawal by Subject|2|||
160819355|NCT01082874|580723276|FG002|Overall Study|Withdrawal by Subject|5|||
160819356|NCT01082874|580723277|FG003|Overall Study|Withdrawal by Subject|3|||
160819357|NCT03176472|580723286|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
160819358|NCT03176472|580723287|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
160819359|NCT03176472|580723286|FG000|Double Blind Treatment Period|Adverse Event|0|||
160819360|NCT03176472|580723287|FG001|Double Blind Treatment Period|Adverse Event|5|||
160819361|NCT03176472|580723286|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
160819362|NCT03176472|580723287|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160819363|NCT03176472|580723286|FG000|Double Blind Treatment Period|Physician Decision|0|||
160819364|NCT03176472|580723287|FG001|Double Blind Treatment Period|Physician Decision|1|||
160819365|NCT03176472|580723286|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160819366|NCT03176472|580723287|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160819367|NCT03176472|580723286|FG000|Double Blind Treatment Period|Not Provided|1|||
160819368|NCT03176472|580723287|FG001|Double Blind Treatment Period|Not Provided|0|||
160819369|NCT03176472|580723286|FG000|Open Label Extension|Withdrawal by Subject|3|||
160819370|NCT03176472|580723287|FG001|Open Label Extension|Withdrawal by Subject|4|||
160819371|NCT03176472|580723286|FG000|Open Label Extension|Adverse Event|2|||
160819372|NCT03176472|580723287|FG001|Open Label Extension|Adverse Event|4|||
160819373|NCT03176472|580723286|FG000|Open Label Extension|Lost to Follow-up|1|||
160987661|NCT01544582|581341182|FG002|Analysis Population|Participant in Jail|1|||
160819374|NCT03176472|580723287|FG001|Open Label Extension|Lost to Follow-up|2|||
160819375|NCT03176472|580723286|FG000|Open Label Extension|Protocol Violation|0|||
160819376|NCT03176472|580723287|FG001|Open Label Extension|Protocol Violation|1|||
160819377|NCT03176472|580723286|FG000|Open Label Extension|Not Provided|2|||
160819378|NCT03176472|580723287|FG001|Open Label Extension|Not Provided|1|||
160819379|NCT03272828|580723288|FG000|Overall Study|Lost to Follow-up|7|||
160987662|NCT01544582|581341183|FG003|Analysis Population|Participant in Jail|0|||
160819380|NCT03272828|580723289|FG001|Overall Study|Lost to Follow-up|7|||
160819381|NCT03272828|580723288|FG000|Overall Study|Withdrawal by Subject|2|||
160819382|NCT03272828|580723289|FG001|Overall Study|Withdrawal by Subject|0|||
160819383|NCT03272828|580723288|FG000|Overall Study|Deceased|1|||
160819384|NCT03272828|580723289|FG001|Overall Study|Deceased|1|||
160819385|NCT03272828|580723288|FG000|Overall Study|Failed implant|1|||
160819386|NCT03272828|580723289|FG001|Overall Study|Failed implant|2|||
160819387|NCT01846663|580723290|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
160819388|NCT01846663|580723291|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
160819389|NCT01846663|580723290|FG000|Overall Study|Withdrawal by Subject|1|||
160819390|NCT01846663|580723291|FG001|Overall Study|Withdrawal by Subject|0|||
160819391|NCT01846663|580723290|FG000|Overall Study|Adverse Event|1|||
160819392|NCT01846663|580723291|FG001|Overall Study|Adverse Event|2|||
160819393|NCT03888235|580723297|FG000|Overall Study|Lost to Follow-up|1|||
160819394|NCT03888235|580723298|FG001|Overall Study|Lost to Follow-up|1|||
160819395|NCT03888235|580723299|FG002|Overall Study|Lost to Follow-up|0|||
160819396|NCT01054560|580723300|FG000|Overall Study|Death|10|||
160819397|NCT01054560|580723301|FG001|Overall Study|Death|21|||
160819398|NCT01054560|580723300|FG000|Overall Study|Lost to Follow-up|2|||
160819399|NCT01054560|580723301|FG001|Overall Study|Lost to Follow-up|5|||
160819400|NCT01054560|580723300|FG000|Overall Study|Withdrawal by Subject|0|||
160819401|NCT01054560|580723301|FG001|Overall Study|Withdrawal by Subject|2|||
160819402|NCT01054560|580723300|FG000|Overall Study|Physician Decision|1|||
160819403|NCT01054560|580723301|FG001|Overall Study|Physician Decision|0|||
160819404|NCT00675441|580723302|FG000|Overall Study|Withdrawal by Subject|2|||
160819405|NCT00675441|580723302|FG000|Overall Study|Death|1|||
160819406|NCT01923363|580723303|FG000|Overall Study|Protocol Violation|1|||
160819407|NCT03718884|580723306|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
160819408|NCT03718884|580723307|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
160819409|NCT03718884|580723306|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
160819410|NCT03718884|580723307|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
160819411|NCT00920387|580723312|FG000|Stage 1|Adverse Event|1|||
160819412|NCT00920387|580723313|FG001|Stage 1|Adverse Event|0|||
160819413|NCT00920387|580723314|FG002|Stage 1|Adverse Event|0|||
160819414|NCT04470908|580723315|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
160819415|NCT02241733|580723318|FG000|Overall Study|Lost to Follow-up|9|||
160819416|NCT02241733|580723319|FG001|Overall Study|Lost to Follow-up|4|||
160819417|NCT02241733|580723318|FG000|Overall Study|Physician Decision|6|||
160819418|NCT02241733|580723319|FG001|Overall Study|Physician Decision|2|||
160819419|NCT02241733|580723318|FG000|Overall Study|Withdrawal by Subject|0|||
160819420|NCT02241733|580723319|FG001|Overall Study|Withdrawal by Subject|2|||
160819421|NCT02241733|580723318|FG000|Overall Study|Death|0|||
160819422|NCT02241733|580723319|FG001|Overall Study|Death|2|||
160819423|NCT00157196|580723322|FG000|Overall Study|Ongoing at data cut-off|9|||
160819424|NCT06099223|580723323|FG000|Overall Study|Preoperative surveys missed|0|||
160819425|NCT06099223|580723324|FG001|Overall Study|Preoperative surveys missed|1|||
160819426|NCT01221623|580723325|FG000|Overall Study|Withdrawal by Subject|19|||
160819427|NCT01221623|580723326|FG001|Overall Study|Withdrawal by Subject|8|||
160819428|NCT01221623|580723325|FG000|Overall Study|Lost to Follow-up|7|||
160819429|NCT01221623|580723326|FG001|Overall Study|Lost to Follow-up|1|||
160819430|NCT01221623|580723325|FG000|Overall Study|Adverse Event|6|||
160819431|NCT01221623|580723326|FG001|Overall Study|Adverse Event|3|||
160819432|NCT01221623|580723325|FG000|Overall Study|Death|1|||
160819433|NCT01221623|580723326|FG001|Overall Study|Death|0|||
160819434|NCT01221623|580723325|FG000|Overall Study|Other|5|||
160819435|NCT01221623|580723326|FG001|Overall Study|Other|2|||
160819436|NCT00661726|580723327|FG000|Overall Study|Adverse Event|1|||
160819437|NCT02147197|580723328|FG000|Overall Study|Adverse Event|1|||
160819438|NCT02147197|580723329|FG001|Overall Study|Adverse Event|0|||
160819439|NCT02147197|580723330|FG002|Overall Study|Adverse Event|0|||
161132695|NCT03896581|581870716|FG000|Overall Study|Adverse event, non-fatal|0|||
160819440|NCT02147197|580723328|FG000|Overall Study|Withdrawal of Consent|4|||
160819441|NCT02147197|580723329|FG001|Overall Study|Withdrawal of Consent|3|||
160819442|NCT02147197|580723330|FG002|Overall Study|Withdrawal of Consent|2|||
160819443|NCT02147197|580723328|FG000|Overall Study|Lost to Follow-up|2|||
161132696|NCT03896581|581870717|FG001|Overall Study|Adverse event, non-fatal|2|||
160819444|NCT02147197|580723329|FG001|Overall Study|Lost to Follow-up|3|||
160819445|NCT02147197|580723330|FG002|Overall Study|Lost to Follow-up|1|||
160819446|NCT02147197|580723328|FG000|Overall Study|Protocol Violation|1|||
160819447|NCT02147197|580723329|FG001|Overall Study|Protocol Violation|0|||
160987663|NCT03015740|581341186|FG000|Overall Study|Adverse Event|1|||
160819448|NCT02147197|580723330|FG002|Overall Study|Protocol Violation|3|||
160819449|NCT02147197|580723328|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160819450|NCT02147197|580723329|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160819451|NCT02147197|580723330|FG002|Overall Study|Other Miscellaneous Reasons|3|||
160819452|NCT02644096|580723331|FG000|Overall Study|Withdrawal by Subject|28|||
160819453|NCT02644096|580723332|FG001|Overall Study|Withdrawal by Subject|25|||
160819454|NCT00830375|580723333|FG000|Overall Study|Lost to Follow-up|1|||
160819455|NCT01700959|580723334|FG000|Overall Study|Adverse Event|0|||
160819456|NCT01700959|580723335|FG001|Overall Study|Adverse Event|1|||
160819457|NCT01700959|580723336|FG002|Overall Study|Adverse Event|1|||
160819458|NCT01700959|580723337|FG003|Overall Study|Adverse Event|2|||
160819459|NCT01700959|580723338|FG004|Overall Study|Adverse Event|0|||
160819460|NCT01700959|580723339|FG005|Overall Study|Adverse Event|2|||
160819461|NCT01700959|580723334|FG000|Overall Study|Withdrawal by Subject|15|||
160819462|NCT01700959|580723335|FG001|Overall Study|Withdrawal by Subject|9|||
160819463|NCT01700959|580723336|FG002|Overall Study|Withdrawal by Subject|12|||
160819464|NCT01700959|580723337|FG003|Overall Study|Withdrawal by Subject|11|||
160819465|NCT01700959|580723338|FG004|Overall Study|Withdrawal by Subject|8|||
160819466|NCT01700959|580723339|FG005|Overall Study|Withdrawal by Subject|12|||
160819467|NCT01700959|580723334|FG000|Overall Study|Ineligible|2|||
160819468|NCT01700959|580723335|FG001|Overall Study|Ineligible|1|||
160819469|NCT01700959|580723336|FG002|Overall Study|Ineligible|2|||
160819470|NCT01700959|580723337|FG003|Overall Study|Ineligible|0|||
160819471|NCT01700959|580723338|FG004|Overall Study|Ineligible|0|||
160819472|NCT01700959|580723339|FG005|Overall Study|Ineligible|1|||
160819473|NCT01700959|580723334|FG000|Overall Study|Noncompliant|9|||
160819474|NCT01700959|580723335|FG001|Overall Study|Noncompliant|9|||
160819475|NCT01700959|580723336|FG002|Overall Study|Noncompliant|17|||
160819476|NCT01700959|580723337|FG003|Overall Study|Noncompliant|18|||
160819477|NCT01700959|580723338|FG004|Overall Study|Noncompliant|15|||
160819478|NCT01700959|580723339|FG005|Overall Study|Noncompliant|9|||
160819479|NCT01700959|580723334|FG000|Overall Study|Side effects|1|||
160819480|NCT01700959|580723335|FG001|Overall Study|Side effects|4|||
160819481|NCT01700959|580723336|FG002|Overall Study|Side effects|8|||
160819482|NCT01700959|580723337|FG003|Overall Study|Side effects|4|||
160819483|NCT01700959|580723338|FG004|Overall Study|Side effects|4|||
160819484|NCT01700959|580723339|FG005|Overall Study|Side effects|1|||
160819485|NCT00322452|580723340|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160819486|NCT00322452|580723341|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160819487|NCT00322452|580723340|FG000|Overall Study|Lost to Follow-up|5|||
160819488|NCT00322452|580723341|FG001|Overall Study|Lost to Follow-up|2|||
160819489|NCT00322452|580723340|FG000|Overall Study|Withdrawal by Subject|19|||
160819490|NCT00322452|580723341|FG001|Overall Study|Withdrawal by Subject|46|||
160819491|NCT00322452|580723340|FG000|Overall Study|Death|223|||
160819492|NCT00322452|580723341|FG001|Overall Study|Death|227|||
160819493|NCT00526656|580723342|FG000|Overall Study|Death|1|||
160819494|NCT00526656|580723342|FG000|Overall Study|Refused surgery|1|||
160819495|NCT04091581|580723343|FG000|Overall Study|Lost to Follow-up|0|||
160819496|NCT04091581|580723344|FG001|Overall Study|Lost to Follow-up|1|||
160819497|NCT01795495|580723345|FG000|Overall Study|Protocol Violation|1|||
160819498|NCT01795495|580723346|FG001|Overall Study|Protocol Violation|0|||
160819499|NCT01795495|580723347|FG002|Overall Study|Protocol Violation|1|||
160819500|NCT01795495|580723345|FG000|Overall Study|Physician Decision|0|||
160819501|NCT01795495|580723346|FG001|Overall Study|Physician Decision|0|||
160819502|NCT01795495|580723347|FG002|Overall Study|Physician Decision|1|||
160819503|NCT01331837|580723348|FG000|Overall Study|Death|30|||
160819504|NCT01331837|580723349|FG001|Overall Study|Death|34|||
160819505|NCT01331837|580723348|FG000|Overall Study|Lost to Follow-up|3|||
160819506|NCT01331837|580723349|FG001|Overall Study|Lost to Follow-up|1|||
160819507|NCT01331837|580723348|FG000|Overall Study|Info not recorded|10|||
160819508|NCT01331837|580723349|FG001|Overall Study|Info not recorded|16|||
160819509|NCT01331837|580723348|FG000|Overall Study|Withdrawal by Subject|13|||
160819510|NCT01331837|580723349|FG001|Overall Study|Withdrawal by Subject|16|||
160819511|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Adverse Event|76|||
160819512|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Adverse Event|0|||
160819513|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Adverse Event|0|||
160819514|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Death|3|||
160819515|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Death|0|||
160819516|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Death|0|||
160819517|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
160819518|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
160819519|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
161132697|NCT00162773|581870718|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
160819520|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Physician Decision|9|||
160819521|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Physician Decision|0|||
160819522|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Physician Decision|0|||
160819523|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
160819524|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
160819525|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
160819526|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Disease progression|45|||
160819527|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Disease progression|0|||
160819528|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Disease progression|0|||
160819529|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
160819530|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
160819531|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
160987664|NCT03015740|581341187|FG001|Overall Study|Adverse Event|0|||
160987665|NCT03015740|581341188|FG002|Overall Study|Adverse Event|0|||
160987666|NCT03015740|581341186|FG000|Overall Study|Death|3|||
160987667|NCT03015740|581341187|FG001|Overall Study|Death|5|||
160987668|NCT03015740|581341188|FG002|Overall Study|Death|0|||
160987669|NCT03015740|581341186|FG000|Overall Study|Withdrawal by Subject|2|||
160987670|NCT03015740|581341187|FG001|Overall Study|Withdrawal by Subject|0|||
160987671|NCT03015740|581341188|FG002|Overall Study|Withdrawal by Subject|0|||
160987672|NCT00231179|581343145|FG000|Overall Study|Lost to Follow-up|21|||
160987673|NCT00231179|581343146|FG001|Overall Study|Lost to Follow-up|21|||
160987674|NCT00231179|581343145|FG000|Overall Study|Withdrawal by Subject|3|||
160987675|NCT00231179|581343146|FG001|Overall Study|Withdrawal by Subject|3|||
160987676|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
160987677|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
160987678|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
160987679|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
160987680|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
160987681|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
160987682|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
160987683|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
160987684|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
160987685|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
160987686|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
160987687|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
160987688|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
160987689|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
160987690|NCT04672460|581343147|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
160987691|NCT04672460|581343148|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
160987692|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
160987693|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
160987694|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
160987695|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
160987696|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
161240090|NCT00318461|582260503|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161240091|NCT00318461|582260504|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161240092|NCT00318461|582260505|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
161240093|NCT00318461|582260506|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
161240094|NCT00318461|582260502|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161240095|NCT00318461|582260503|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
161240096|NCT00318461|582260504|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161240097|NCT00318461|582260505|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161240098|NCT00318461|582260506|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
161240099|NCT00318461|582260502|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
161240100|NCT00318461|582260503|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
161240101|NCT00318461|582260504|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
161240102|NCT00318461|582260505|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
161240103|NCT00318461|582260506|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
161240104|NCT00318461|582260502|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
160987697|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
160987698|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
160987699|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
160987700|NCT04672460|581343147|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
160987701|NCT04672460|581343148|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
160987702|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
160987703|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
160987704|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
160987705|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
160987706|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
160987707|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
160987708|NCT04672460|581343147|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
160987709|NCT04672460|581343148|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
160987710|NCT00940017|581343151|FG000|Overall Study|did not meet entrance criteria|3|||
160987711|NCT00940017|581343151|FG000|Overall Study|Adverse Event|1|||
160987712|NCT00569946|581343152|FG000|Overall Study|Adverse Event|16|||
160987713|NCT00569946|581343152|FG000|Overall Study|Objective Progression or Relapse|42|||
160987714|NCT00569946|581343152|FG000|Overall Study|Global Deterioration of Health Status|1|||
160987715|NCT02949271|581343155|FG000|Overall Study|Lack of Efficacy|5|||
160819532|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
160819533|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
160819534|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
160819535|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
160819536|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
160819537|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
160819538|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
160819539|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
160819540|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
160819541|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
160819542|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
160819543|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
160819544|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
160819545|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
160819546|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
160819547|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
160819548|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
160819549|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
160819550|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
160819551|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
160819552|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
160819553|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
160819554|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
160819555|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
160819556|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Promotor request|1|||
160819557|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Promotor request|0|||
160819558|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Promotor request|0|||
160819559|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
160819560|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
160819561|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
160819562|NCT01461928|580724844|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
160819563|NCT01461928|580724845|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
160819564|NCT01461928|580724846|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
160819565|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Death|3|||
160819566|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Death|0|||
160819567|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Death|0|||
160819568|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
160819569|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
160819570|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
160819571|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
160819572|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
160819573|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
160819574|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Diseases progression|91|||
160819575|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Diseases progression|0|||
160819576|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Diseases progression|0|||
160819577|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Adverse Event|70|||
160819578|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Adverse Event|0|||
160819579|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Adverse Event|0|||
160819580|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Physician Decision|9|||
160819581|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Physician Decision|0|||
160819582|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Physician Decision|0|||
160819583|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
160819584|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
160819585|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
160819586|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
160900524|NCT00447005|581030150|FG000|Overall Study|Lack of Efficacy|11|||
160900525|NCT00397215|581030151|FG000|Month 0 (Day 0)|Adverse Event|0|||
160900526|NCT00397215|581030152|FG001|Month 0 (Day 0)|Adverse Event|1|||
160900527|NCT00397215|581030153|FG002|Month 0 (Day 0)|Adverse Event|0|||
160900528|NCT00397215|581030154|FG003|Month 0 (Day 0)|Adverse Event|0|||
160900529|NCT00397215|581030151|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
160900530|NCT00397215|581030152|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
160900531|NCT00397215|581030153|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
160900532|NCT00397215|581030154|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
160900533|NCT00397215|581030151|FG000|Month 0 (Day 0)|Other|4|||
160900534|NCT00397215|581030152|FG001|Month 0 (Day 0)|Other|1|||
160987716|NCT02949271|581343156|FG001|Overall Study|Lack of Efficacy|4|||
161333785|NCT03327324|582610629|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
160819587|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
160819588|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
160819589|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
160819590|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
160819591|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
160819592|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Not compliant|1|||
160819593|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Not compliant|0|||
160819594|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Not compliant|0|||
160819595|NCT01461928|580724844|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
160819596|NCT01461928|580724845|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
160819597|NCT01461928|580724846|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
160819598|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Adverse Event|0|||
160819599|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Adverse Event|2|||
160819600|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Adverse Event|0|||
160819601|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Death|0|||
160819602|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Death|10|||
160819603|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Death|8|||
160819604|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Physician Decision|0|||
160819605|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Physician Decision|0|||
160819606|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Physician Decision|4|||
160819607|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
160819608|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
160819609|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
160819610|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Moved to another town|0|||
160819611|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Moved to another town|1|||
160819612|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Moved to another town|0|||
160819613|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Disease progression|0|||
160819614|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Disease progression|0|||
160819615|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Disease progression|3|||
160819616|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
160819617|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
160819618|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
160819619|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
160819620|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
160819621|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
160819622|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
160819623|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
160819624|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
160819625|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
160819626|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
160819627|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
160819628|NCT01461928|580724844|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
160819629|NCT01461928|580724845|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
160819630|NCT01461928|580724846|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
160819631|NCT01159171|580724847|FG000|Overall Study|Adverse Event|11|||
160819632|NCT01159171|580724847|FG000|Overall Study|Progression of Disease|28|||
160819633|NCT01159171|580724847|FG000|Overall Study|Protocol Violation|1|||
160819634|NCT01159171|580724847|FG000|Overall Study|Need for Surgery|5|||
160819635|NCT01159171|580724847|FG000|Overall Study|Medical Decision|4|||
160819636|NCT01159171|580724847|FG000|Overall Study|Death|1|||
160819637|NCT00470093|580724855|FG000|Overall Study|Adverse Event|2|||
160819638|NCT00539513|580724856|FG000|Overall Study|Withdrawal by Subject|2|||
160819639|NCT00539513|580724857|FG001|Overall Study|Withdrawal by Subject|1|||
160819640|NCT00539513|580724856|FG000|Overall Study|Lost to Follow-up|0|||
160819641|NCT00539513|580724857|FG001|Overall Study|Lost to Follow-up|1|||
160819642|NCT00664560|580724858|FG000|Overall Study|Adverse Event|19|||
160819643|NCT00664560|580724859|FG001|Overall Study|Adverse Event|16|||
160819644|NCT00664560|580724860|FG002|Overall Study|Adverse Event|7|||
160819645|NCT00664560|580724858|FG000|Overall Study|Withdrawal by Subject|9|||
160819646|NCT00664560|580724859|FG001|Overall Study|Withdrawal by Subject|13|||
160819647|NCT00664560|580724860|FG002|Overall Study|Withdrawal by Subject|7|||
160819648|NCT00664560|580724858|FG000|Overall Study|Lost to Follow-up|0|||
160819649|NCT00664560|580724859|FG001|Overall Study|Lost to Follow-up|2|||
160900535|NCT00397215|581030153|FG002|Month 0 (Day 0)|Other|3|||
160819650|NCT00664560|580724860|FG002|Overall Study|Lost to Follow-up|0|||
160819651|NCT00664560|580724858|FG000|Overall Study|Other|11|||
160819652|NCT00664560|580724859|FG001|Overall Study|Other|4|||
160819653|NCT00664560|580724860|FG002|Overall Study|Other|5|||
160819654|NCT01328041|580724861|FG000|Overall Study|Adverse Event|7|||
160900536|NCT00397215|581030154|FG003|Month 0 (Day 0)|Other|3|||
160819655|NCT01328041|580724861|FG000|Overall Study|Lack of Efficacy|27|||
160819656|NCT01328041|580724861|FG000|Overall Study|Protocol Violation|7|||
160900537|NCT00397215|581030151|FG000|Month 6 (Day 180)|Adverse Event|0|||
160819657|NCT01328041|580724861|FG000|Overall Study|Lost to Follow-up|7|||
160819658|NCT01328041|580724861|FG000|Overall Study|Physician Decision|2|||
160819659|NCT01328041|580724861|FG000|Overall Study|Withdrawal by Subject|7|||
160819660|NCT00711113|580724862|FG000|Overall Study|Lost to Follow-up|9|||
160819661|NCT00711113|580724862|FG000|Overall Study|Implant lost|2|||
160819662|NCT02456636|580724863|FG000|Overall Study|Death|0|||
160819663|NCT02456636|580724864|FG001|Overall Study|Death|3|||
160819664|NCT02456636|580724865|FG002|Overall Study|Death|0|||
160819665|NCT02456636|580724863|FG000|Overall Study|Pregnancy|1|||
160819666|NCT02456636|580724864|FG001|Overall Study|Pregnancy|3|||
160819667|NCT02456636|580724865|FG002|Overall Study|Pregnancy|5|||
160819668|NCT02456636|580724863|FG000|Overall Study|Physician Decision|4|||
160819669|NCT02456636|580724864|FG001|Overall Study|Physician Decision|5|||
160819670|NCT02456636|580724865|FG002|Overall Study|Physician Decision|4|||
160819671|NCT02456636|580724863|FG000|Overall Study|Withdrawal by Subject|13|||
160819672|NCT02456636|580724864|FG001|Overall Study|Withdrawal by Subject|14|||
160819673|NCT02456636|580724865|FG002|Overall Study|Withdrawal by Subject|16|||
160819674|NCT02456636|580724863|FG000|Overall Study|Lost to Follow-up|50|||
160819675|NCT02456636|580724864|FG001|Overall Study|Lost to Follow-up|44|||
160819676|NCT02456636|580724865|FG002|Overall Study|Lost to Follow-up|50|||
160819677|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819678|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
160819679|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819680|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819681|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
160819682|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819683|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
160819684|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819685|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819686|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
160819687|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819688|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
160819689|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819690|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819691|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
160819692|NCT02688088|580724868|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819693|NCT02688088|580724869|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
160819694|NCT02688088|580724870|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819695|NCT02688088|580724871|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819696|NCT02688088|580724872|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
160819697|NCT02688088|580724868|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819698|NCT02688088|580724869|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819699|NCT02688088|580724870|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
160819700|NCT02688088|580724871|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819701|NCT02688088|580724872|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
160819702|NCT02688088|580724868|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160819703|NCT02688088|580724869|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160819704|NCT02688088|580724870|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
160819705|NCT02688088|580724871|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160987717|NCT02949271|581343155|FG000|Overall Study|Lost to Follow-up|3|||
160987718|NCT02949271|581343156|FG001|Overall Study|Lost to Follow-up|6|||
160900538|NCT00397215|581030152|FG001|Month 6 (Day 180)|Adverse Event|3|||
160900539|NCT00397215|581030153|FG002|Month 6 (Day 180)|Adverse Event|2|||
160900540|NCT00397215|581030154|FG003|Month 6 (Day 180)|Adverse Event|0|||
160900541|NCT00397215|581030151|FG000|Month 6 (Day 180)|Other|2|||
160900542|NCT00397215|581030152|FG001|Month 6 (Day 180)|Other|0|||
160900543|NCT00397215|581030153|FG002|Month 6 (Day 180)|Other|3|||
160900544|NCT00397215|581030154|FG003|Month 6 (Day 180)|Other|0|||
160900545|NCT00423514|581030155|FG000|Overall Study|Ineligible|1|||
160900546|NCT00423514|581030156|FG001|Overall Study|Ineligible|0|||
160900547|NCT02128932|581030157|FG000|Overall Study|Withdrawal by Subject|11|||
160900548|NCT02128932|581030158|FG001|Overall Study|Withdrawal by Subject|7|||
160900549|NCT02128932|581030159|FG002|Overall Study|Withdrawal by Subject|8|||
160900550|NCT02128932|581030157|FG000|Overall Study|Death|2|||
160819706|NCT02688088|580724872|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
160819707|NCT02688088|580724868|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160819708|NCT02688088|580724869|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160819709|NCT02688088|580724870|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160900551|NCT02128932|581030158|FG001|Overall Study|Death|0|||
160900552|NCT02128932|581030159|FG002|Overall Study|Death|2|||
160900553|NCT02128932|581030157|FG000|Overall Study|Lost to Follow-up|2|||
160900554|NCT02128932|581030158|FG001|Overall Study|Lost to Follow-up|1|||
160900555|NCT02128932|581030159|FG002|Overall Study|Lost to Follow-up|1|||
160987719|NCT02949271|581343155|FG000|Overall Study|Physician Decision|5|||
161333786|NCT03327324|582610630|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333787|NCT03327324|582610631|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161333788|NCT03327324|582610632|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333789|NCT03327324|582610633|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161132698|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
161333790|NCT03327324|582610634|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333791|NCT03327324|582610629|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
161333792|NCT03327324|582610630|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161333793|NCT03327324|582610631|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161333794|NCT03327324|582610632|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
161333795|NCT03327324|582610633|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
161333796|NCT03327324|582610634|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
161333797|NCT03327324|582610629|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
161333798|NCT03327324|582610630|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161333799|NCT03327324|582610631|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161333800|NCT03327324|582610632|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161333801|NCT03327324|582610633|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161333802|NCT03327324|582610634|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
161333803|NCT03327324|582610629|FG000|Intervention (Month 3-Month 6)|Death|1|||
161333804|NCT03327324|582610630|FG001|Intervention (Month 3-Month 6)|Death|0|||
161333805|NCT03327324|582610631|FG002|Intervention (Month 3-Month 6)|Death|1|||
161333806|NCT03327324|582610632|FG003|Intervention (Month 3-Month 6)|Death|1|||
161132699|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
161132700|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161132701|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161132702|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
161132703|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
161132704|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
161132705|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161132706|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161132707|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
161132708|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
161132709|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161132710|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161132711|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161132712|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
161132713|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161132714|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
161132715|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161132716|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
160987720|NCT02949271|581343156|FG001|Overall Study|Physician Decision|5|||
160987721|NCT02949271|581343155|FG000|Overall Study|Protocol Violation|6|||
160987722|NCT02949271|581343156|FG001|Overall Study|Protocol Violation|3|||
160987723|NCT02949271|581343155|FG000|Overall Study|Withdrawal by Subject|1|||
160987724|NCT02949271|581343156|FG001|Overall Study|Withdrawal by Subject|0|||
160987725|NCT02949271|581343155|FG000|Overall Study|Delivered prior to intervention|7|||
160987726|NCT02949271|581343156|FG001|Overall Study|Delivered prior to intervention|9|||
160987727|NCT02949271|581343155|FG000|Overall Study|Outside the window for cervical dilation|2|||
160987728|NCT02949271|581343156|FG001|Overall Study|Outside the window for cervical dilation|3|||
160987729|NCT05458102|581343157|FG000|Overall Study|Withdrew consent|2|||
160987730|NCT05458102|581343158|FG001|Overall Study|Withdrew consent|0|||
160987731|NCT05458102|581343157|FG000|Overall Study|Adverse Event|1|||
160987732|NCT05458102|581343158|FG001|Overall Study|Adverse Event|0|||
160987733|NCT05458102|581343157|FG000|Overall Study|Enrolled but never treated|1|||
160987734|NCT05458102|581343158|FG001|Overall Study|Enrolled but never treated|0|||
160987735|NCT05458102|581343157|FG000|Overall Study|Protocol Violation|1|||
160987736|NCT05458102|581343158|FG001|Overall Study|Protocol Violation|0|||
160987737|NCT02373813|581343164|FG000|Run-In Period|Other, Not Specified|5|||
160987738|NCT02373813|581343165|FG001|Run-In Period|Other, Not Specified|0|||
160987739|NCT02373813|581343166|FG002|Run-In Period|Other, Not Specified|0|||
160987740|NCT02373813|581343167|FG003|Run-In Period|Other, Not Specified|0|||
160987741|NCT02373813|581343164|FG000|Run-In Period|Withdrawal by Subject|16|||
160987742|NCT02373813|581343165|FG001|Run-In Period|Withdrawal by Subject|0|||
160987743|NCT02373813|581343166|FG002|Run-In Period|Withdrawal by Subject|0|||
160987744|NCT02373813|581343167|FG003|Run-In Period|Withdrawal by Subject|0|||
160987745|NCT02373813|581343164|FG000|Run-In Period|Decision by Sponsor|11|||
160900556|NCT02128932|581030157|FG000|Overall Study|No reason for withdrawal|12|||
160900557|NCT02128932|581030158|FG001|Overall Study|No reason for withdrawal|11|||
160900558|NCT02128932|581030159|FG002|Overall Study|No reason for withdrawal|7|||
160900559|NCT03685123|581030164|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
160900560|NCT03685123|581030165|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
160900561|NCT03685123|581030166|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
161132717|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
161132718|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
161132719|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
161132720|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
160987746|NCT02373813|581343165|FG001|Run-In Period|Decision by Sponsor|0|||
160987747|NCT02373813|581343166|FG002|Run-In Period|Decision by Sponsor|0|||
160987748|NCT02373813|581343167|FG003|Run-In Period|Decision by Sponsor|0|||
161333807|NCT03327324|582610633|FG004|Intervention (Month 3-Month 6)|Death|1|||
161333808|NCT03327324|582610634|FG005|Intervention (Month 3-Month 6)|Death|0|||
161333809|NCT03327324|582610629|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333810|NCT03327324|582610630|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333811|NCT03327324|582610631|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333812|NCT03327324|582610632|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333813|NCT03327324|582610633|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333814|NCT03327324|582610634|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
161132721|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
160987749|NCT02373813|581343164|FG000|Run-In Period|Protocol Violation|75|||
160987750|NCT02373813|581343165|FG001|Run-In Period|Protocol Violation|0|||
160987751|NCT02373813|581343166|FG002|Run-In Period|Protocol Violation|0|||
160987752|NCT02373813|581343167|FG003|Run-In Period|Protocol Violation|0|||
160987753|NCT02373813|581343164|FG000|Run-In Period|Lost to Follow-up|2|||
160987754|NCT02373813|581343165|FG001|Run-In Period|Lost to Follow-up|0|||
160987755|NCT02373813|581343166|FG002|Run-In Period|Lost to Follow-up|0|||
160987756|NCT02373813|581343167|FG003|Run-In Period|Lost to Follow-up|0|||
160987757|NCT02373813|581343164|FG000|Run-In Period|Adverse Event|3|||
160987758|NCT02373813|581343165|FG001|Run-In Period|Adverse Event|0|||
160987759|NCT02373813|581343166|FG002|Run-In Period|Adverse Event|0|||
160987760|NCT02373813|581343167|FG003|Run-In Period|Adverse Event|0|||
160987761|NCT02373813|581343164|FG000|Run-In Period|Noncompliance|1|||
160987762|NCT02373813|581343165|FG001|Run-In Period|Noncompliance|0|||
161132722|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
161132723|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
161132724|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
161132725|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161132726|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
161132727|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
160900562|NCT03685123|581030164|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
161132728|NCT02660580|581870723|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
161132729|NCT02660580|581870724|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
161132730|NCT02660580|581870725|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161132731|NCT02660580|581870726|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161132732|NCT02660580|581870727|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
161132733|NCT02660580|581870723|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161132734|NCT02660580|581870724|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161132735|NCT02660580|581870725|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
161132736|NCT02660580|581870726|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
161132737|NCT02660580|581870727|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
161132738|NCT02660580|581870723|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161132739|NCT02660580|581870724|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
160900563|NCT03685123|581030165|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
160900564|NCT03685123|581030166|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
160900565|NCT03685123|581030164|FG000|Weight Loss Phase|Lost to Follow-up|1|||
160900566|NCT03685123|581030165|FG001|Weight Loss Phase|Lost to Follow-up|0|||
160900567|NCT03685123|581030166|FG002|Weight Loss Phase|Lost to Follow-up|0|||
160900568|NCT03685123|581030164|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
160900569|NCT03685123|581030165|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
160900570|NCT03685123|581030166|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
160900571|NCT03685123|581030164|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
160900572|NCT03685123|581030165|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
160900573|NCT03685123|581030166|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
160987763|NCT02373813|581343166|FG002|Run-In Period|Noncompliance|0|||
160987764|NCT02373813|581343167|FG003|Run-In Period|Noncompliance|0|||
160987765|NCT02373813|581343164|FG000|Run-In Period|Ineligibility Determined|3|||
160987766|NCT02373813|581343165|FG001|Run-In Period|Ineligibility Determined|0|||
160987767|NCT02373813|581343166|FG002|Run-In Period|Ineligibility Determined|0|||
161240105|NCT00318461|582260503|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
160819710|NCT02688088|580724871|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
160819711|NCT02688088|580724872|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
160819712|NCT02688088|580724868|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819713|NCT02688088|580724869|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819714|NCT02688088|580724870|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819715|NCT02688088|580724871|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
160819716|NCT02688088|580724872|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
160819717|NCT02688088|580724868|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819718|NCT02688088|580724869|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819719|NCT02688088|580724870|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819720|NCT02688088|580724871|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
160819721|NCT02688088|580724872|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
160819722|NCT03812185|580724874|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
160819723|NCT00313313|580724877|FG000|Overall Study|Lack of Efficacy|14|||
160819724|NCT00313313|580724878|FG001|Overall Study|Lack of Efficacy|9|||
160819725|NCT00313313|580724879|FG002|Overall Study|Lack of Efficacy|20|||
160819726|NCT00313313|580724877|FG000|Overall Study|Withdrawal of consent by subject|18|||
160819727|NCT00313313|580724878|FG001|Overall Study|Withdrawal of consent by subject|17|||
160819728|NCT00313313|580724879|FG002|Overall Study|Withdrawal of consent by subject|31|||
160819729|NCT00313313|580724877|FG000|Overall Study|Lost to Follow-up|10|||
160819730|NCT00313313|580724878|FG001|Overall Study|Lost to Follow-up|7|||
160819731|NCT00313313|580724879|FG002|Overall Study|Lost to Follow-up|9|||
160819732|NCT00313313|580724877|FG000|Overall Study|Adverse Event|15|||
160819733|NCT00313313|580724878|FG001|Overall Study|Adverse Event|16|||
160819734|NCT00313313|580724879|FG002|Overall Study|Adverse Event|12|||
160819735|NCT00313313|580724877|FG000|Overall Study|Physician Decision|2|||
160819736|NCT00313313|580724878|FG001|Overall Study|Physician Decision|6|||
160819737|NCT00313313|580724879|FG002|Overall Study|Physician Decision|4|||
160819738|NCT00313313|580724877|FG000|Overall Study|Poor/Noncompliance|3|||
160819739|NCT00313313|580724878|FG001|Overall Study|Poor/Noncompliance|6|||
160819740|NCT00313313|580724879|FG002|Overall Study|Poor/Noncompliance|2|||
160819741|NCT00313313|580724877|FG000|Overall Study|Pregnancy|1|||
160819742|NCT00313313|580724878|FG001|Overall Study|Pregnancy|2|||
160819743|NCT00313313|580724879|FG002|Overall Study|Pregnancy|0|||
160819744|NCT00313313|580724877|FG000|Overall Study|Death|0|||
160819745|NCT00313313|580724878|FG001|Overall Study|Death|0|||
160819746|NCT00313313|580724879|FG002|Overall Study|Death|2|||
160819747|NCT00313313|580724877|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160819748|NCT00313313|580724878|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
160819749|NCT00313313|580724879|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
160819750|NCT00090142|580724880|FG000|Treatment Period I|Lost to Follow-up|1|||
160819751|NCT00090142|580724881|FG001|Treatment Period I|Lost to Follow-up|2|||
160819752|NCT00090142|580724880|FG000|Treatment Period I|Protocol Violation|2|||
160819753|NCT00090142|580724881|FG001|Treatment Period I|Protocol Violation|0|||
160819754|NCT00090142|580724880|FG000|Treatment Period I|Withdrawal by Subject|2|||
160819755|NCT00090142|580724881|FG001|Treatment Period I|Withdrawal by Subject|0|||
160819756|NCT00090142|580724880|FG000|Treatment Period I|Other|0|||
160819757|NCT00090142|580724881|FG001|Treatment Period I|Other|1|||
160819758|NCT00090142|580724880|FG000|Treatment Period II|Other|1|||
160819759|NCT00090142|580724881|FG001|Treatment Period II|Other|0|||
160819760|NCT00006046|580724887|FG000|Overall Study|Adverse Event|3|||
160819761|NCT00006046|580724888|FG001|Overall Study|Adverse Event|0|||
160819762|NCT00006046|580724889|FG002|Overall Study|Adverse Event|0|||
160819763|NCT00006046|580724890|FG003|Overall Study|Adverse Event|0|||
161240106|NCT00318461|582260504|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
160819764|NCT00006046|580724891|FG004|Overall Study|Adverse Event|0|||
160819765|NCT00006046|580724887|FG000|Overall Study|Disease Progression|2|||
160819766|NCT00006046|580724888|FG001|Overall Study|Disease Progression|0|||
160819767|NCT00006046|580724889|FG002|Overall Study|Disease Progression|0|||
160819768|NCT00006046|580724890|FG003|Overall Study|Disease Progression|0|||
160819769|NCT00006046|580724891|FG004|Overall Study|Disease Progression|0|||
160819770|NCT04295681|580724908|FG000|Overall Study|Eligibility error|1|||
160987768|NCT02373813|581343167|FG003|Run-In Period|Ineligibility Determined|0|||
160987769|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
160987770|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
160819771|NCT04295681|580724909|FG001|Overall Study|Eligibility error|3|||
160819772|NCT02210689|580724916|FG000|Overall Study|Withdrawal by Subject|7|||
160819773|NCT02210689|580724917|FG001|Overall Study|Withdrawal by Subject|4|||
160819774|NCT02210689|580724918|FG002|Overall Study|Withdrawal by Subject|2|||
160819775|NCT02210689|580724916|FG000|Overall Study|Adverse Event|0|||
160819776|NCT02210689|580724917|FG001|Overall Study|Adverse Event|1|||
160819777|NCT02210689|580724918|FG002|Overall Study|Adverse Event|0|||
160819778|NCT02210689|580724916|FG000|Overall Study|Protocol Violation|1|||
160819779|NCT02210689|580724917|FG001|Overall Study|Protocol Violation|0|||
160819780|NCT02210689|580724918|FG002|Overall Study|Protocol Violation|0|||
160819781|NCT02210689|580724916|FG000|Overall Study|Lost to Follow-up|11|||
160819782|NCT02210689|580724917|FG001|Overall Study|Lost to Follow-up|9|||
160819783|NCT02210689|580724918|FG002|Overall Study|Lost to Follow-up|5|||
160819784|NCT02210689|580724916|FG000|Overall Study|Pregnancy|0|||
160819785|NCT02210689|580724917|FG001|Overall Study|Pregnancy|1|||
160819786|NCT02210689|580724918|FG002|Overall Study|Pregnancy|0|||
160819787|NCT02210689|580724916|FG000|Overall Study|Lack of Efficacy|0|||
160819788|NCT02210689|580724917|FG001|Overall Study|Lack of Efficacy|1|||
160819789|NCT02210689|580724918|FG002|Overall Study|Lack of Efficacy|5|||
160819790|NCT02210689|580724916|FG000|Overall Study|Prohibited medication|2|||
160819791|NCT02210689|580724917|FG001|Overall Study|Prohibited medication|8|||
160819792|NCT02210689|580724918|FG002|Overall Study|Prohibited medication|1|||
160819793|NCT02210689|580724916|FG000|Overall Study|Negative Nugent score at baseline|6|||
160819794|NCT02210689|580724917|FG001|Overall Study|Negative Nugent score at baseline|2|||
160819795|NCT02210689|580724918|FG002|Overall Study|Negative Nugent score at baseline|2|||
160819796|NCT02210689|580724916|FG000|Overall Study|Other|25|||
160819797|NCT02210689|580724917|FG001|Overall Study|Other|21|||
160819798|NCT02210689|580724918|FG002|Overall Study|Other|8|||
160819799|NCT00866047|580724919|FG000|Treatment Period|Progressive disease|13|||
160819800|NCT00866047|580724919|FG000|Treatment Period|Adverse Event|16|||
160819801|NCT00866047|580724919|FG000|Treatment Period|Physician Decision|14|||
160819802|NCT00866047|580724919|FG000|Treatment Period|Withdrawal by Subject|5|||
160819803|NCT00866047|580724919|FG000|Follow-up Period|Lost to Follow-up|5|||
160819804|NCT02928029|580724920|FG000|Overall Study|Withdrawal by Subject|0|||
160819805|NCT02928029|580724921|FG001|Overall Study|Withdrawal by Subject|1|||
160819806|NCT02928029|580724920|FG000|Overall Study|Radiological progression|1|||
160819807|NCT02928029|580724921|FG001|Overall Study|Radiological progression|0|||
160819808|NCT02928029|580724920|FG000|Overall Study|Clinical progression|1|||
160819809|NCT02928029|580724921|FG001|Overall Study|Clinical progression|2|||
160819810|NCT02928029|580724920|FG000|Overall Study|AE not related to clinical progression|1|||
160819811|NCT02928029|580724921|FG001|Overall Study|AE not related to clinical progression|1|||
160819812|NCT05427539|580724922|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
160819813|NCT05427539|580724923|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
160819814|NCT05427539|580724922|FG000|Period 1|Withdrawal by Subject|1|||
160819815|NCT05427539|580724923|FG001|Period 1|Withdrawal by Subject|0|||
160819816|NCT02099344|580724924|FG000|Overall Study|Physician Decision|1|||
160819817|NCT02099344|580724925|FG001|Overall Study|Physician Decision|0|||
160819818|NCT00404755|580724928|FG000|Phase I (Bupropion)|Adverse Event|3|||
160819819|NCT00404755|580724928|FG000|Phase I (Bupropion)|Other|1|||
160819820|NCT00404755|580724928|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
160819821|NCT01453205|580724931|FG000|Overall Study|Lost to Follow-up|3|||
160819822|NCT01453205|580724932|FG001|Overall Study|Lost to Follow-up|0|||
160819823|NCT01453205|580724933|FG002|Overall Study|Lost to Follow-up|1|||
160819824|NCT01453205|580724931|FG000|Overall Study|Withdrawal by Subject|8|||
160819825|NCT01453205|580724932|FG001|Overall Study|Withdrawal by Subject|3|||
160819826|NCT01453205|580724933|FG002|Overall Study|Withdrawal by Subject|0|||
160819827|NCT01453205|580724931|FG000|Overall Study|Death|24|||
160819828|NCT01453205|580724932|FG001|Overall Study|Death|22|||
160819829|NCT01453205|580724933|FG002|Overall Study|Death|18|||
160819830|NCT01453205|580724931|FG000|Overall Study|Other|45|||
160819831|NCT01453205|580724932|FG001|Overall Study|Other|27|||
160819832|NCT01453205|580724933|FG002|Overall Study|Other|35|||
160819833|NCT05593913|580724936|FG000|Overall Study|Insufficient image quality|39|||
160819834|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
160819835|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
160819836|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
160819837|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
160819838|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
160819839|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
160819840|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
160819841|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
160819842|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
160819843|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
160819844|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
160819845|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
160819846|NCT04376684|580724937|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
160819847|NCT04376684|580724938|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
160819848|NCT04376684|580724939|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
160819849|NCT04376684|580724940|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
160819850|NCT04376684|580724937|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
160819851|NCT04376684|580724938|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
160819852|NCT04376684|580724939|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
160819853|NCT04376684|580724940|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
160819854|NCT04376684|580724937|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
160819855|NCT04376684|580724938|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
160819856|NCT04376684|580724939|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
160819857|NCT04376684|580724940|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
160819858|NCT04376684|580724937|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
160819859|NCT04376684|580724938|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
160819860|NCT04376684|580724939|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
160819861|NCT04376684|580724940|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
160819862|NCT01666119|580724941|FG000|Overall Study|Adverse Event|6|||
160819863|NCT01666119|580724941|FG000|Overall Study|Withdrawal by Subject|16|||
160819864|NCT01666119|580724941|FG000|Overall Study|Lost to Follow-up|7|||
160819865|NCT01666119|580724941|FG000|Overall Study|non compliance with study medication, pa|18|||
160819866|NCT01666119|580724941|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
160819867|NCT00516906|580724952|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
160819868|NCT00516906|580724953|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
160819869|NCT01974206|580724954|FG000|Overall Study|Did Not Take Study Drug|0|||
160819870|NCT01974206|580724955|FG001|Overall Study|Did Not Take Study Drug|1|||
160819871|NCT01974206|580724954|FG000|Overall Study|Physician Decision|1|||
160819872|NCT01974206|580724955|FG001|Overall Study|Physician Decision|0|||
160819873|NCT01974206|580724954|FG000|Overall Study|Withdrawal by Subject|3|||
160819874|NCT01974206|580724955|FG001|Overall Study|Withdrawal by Subject|0|||
160819875|NCT01974206|580724954|FG000|Overall Study|Lost to Follow-up|1|||
160819876|NCT01974206|580724955|FG001|Overall Study|Lost to Follow-up|0|||
160819877|NCT01974206|580724954|FG000|Overall Study|Death|1|||
160819878|NCT01974206|580724955|FG001|Overall Study|Death|0|||
160819879|NCT03802630|580724956|FG000|Overall Study|Study terminated by sponsor|130|||
160819880|NCT03802630|580724957|FG001|Overall Study|Study terminated by sponsor|134|||
160819881|NCT03802630|580724956|FG000|Overall Study|Subject decision|16|||
160819882|NCT03802630|580724957|FG001|Overall Study|Subject decision|9|||
160819883|NCT03802630|580724956|FG000|Overall Study|Adverse Event|3|||
160819884|NCT03802630|580724957|FG001|Overall Study|Adverse Event|1|||
160819885|NCT03802630|580724956|FG000|Overall Study|Lost to Follow-up|2|||
160819886|NCT03802630|580724957|FG001|Overall Study|Lost to Follow-up|2|||
160819887|NCT03802630|580724956|FG000|Overall Study|Physician Decision|2|||
160819888|NCT03802630|580724957|FG001|Overall Study|Physician Decision|0|||
160819889|NCT03802630|580724956|FG000|Overall Study|Death|0|||
160819890|NCT03802630|580724957|FG001|Overall Study|Death|2|||
160819891|NCT02684058|580724962|FG000|Treatment Period|Progressive disease|4|||
160819892|NCT02684058|580724963|FG001|Treatment Period|Progressive disease|10|||
160819893|NCT02684058|580724964|FG002|Treatment Period|Progressive disease|19|||
160819894|NCT02684058|580724962|FG000|Treatment Period|Adverse Event|3|||
160819895|NCT02684058|580724963|FG001|Treatment Period|Adverse Event|8|||
160819896|NCT02684058|580724964|FG002|Treatment Period|Adverse Event|1|||
160819897|NCT02684058|580724962|FG000|Treatment Period|Physician Decision|5|||
160819898|NCT02684058|580724963|FG001|Treatment Period|Physician Decision|1|||
160819899|NCT02684058|580724964|FG002|Treatment Period|Physician Decision|2|||
160987771|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
161132740|NCT02660580|581870725|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
161132741|NCT02660580|581870726|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
161132742|NCT02660580|581870727|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
161132743|NCT02660580|581870723|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
161132744|NCT02660580|581870724|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
161132745|NCT02660580|581870725|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
161132746|NCT02660580|581870726|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
161333815|NCT03327324|582610629|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
161333816|NCT03327324|582610630|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333817|NCT03327324|582610631|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333818|NCT03327324|582610632|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333819|NCT03327324|582610633|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333820|NCT03327324|582610634|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
161333821|NCT03327324|582610629|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
160819900|NCT02684058|580724962|FG000|Treatment Period|New therapy for study indication|1|||
160819901|NCT02684058|580724963|FG001|Treatment Period|New therapy for study indication|0|||
160819902|NCT02684058|580724964|FG002|Treatment Period|New therapy for study indication|0|||
160819903|NCT02684058|580724962|FG000|Treatment Period|Protocol deviation|0|||
160819904|NCT02684058|580724963|FG001|Treatment Period|Protocol deviation|1|||
160819905|NCT02684058|580724964|FG002|Treatment Period|Protocol deviation|0|||
160819906|NCT02684058|580724962|FG000|Treatment Period|Subject/guardian decision|4|||
160819907|NCT02684058|580724963|FG001|Treatment Period|Subject/guardian decision|3|||
160819908|NCT02684058|580724964|FG002|Treatment Period|Subject/guardian decision|0|||
160819909|NCT02684058|580724962|FG000|Treatment Period|Death|0|||
160819910|NCT02684058|580724963|FG001|Treatment Period|Death|0|||
160819911|NCT02684058|580724964|FG002|Treatment Period|Death|2|||
160819912|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
160819913|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
160819914|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
160819915|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
160819916|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
160819917|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
160900574|NCT03685123|581030164|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
160900575|NCT03685123|581030165|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
160900576|NCT03685123|581030166|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
161333822|NCT03327324|582610630|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
160819918|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160900577|NCT02959983|581030167|FG000|Overall Study|Protocol Violation|0|||
160900578|NCT02959983|581030168|FG001|Overall Study|Protocol Violation|1|||
160900579|NCT02959983|581030167|FG000|Overall Study|Lack of Efficacy|0|||
160900580|NCT02959983|581030168|FG001|Overall Study|Lack of Efficacy|1|||
160900581|NCT02959983|581030167|FG000|Overall Study|Lost to Follow-up|12|||
160900582|NCT02959983|581030168|FG001|Overall Study|Lost to Follow-up|9|||
160900583|NCT02959983|581030167|FG000|Overall Study|Other|1|||
160900584|NCT02959983|581030168|FG001|Overall Study|Other|1|||
160900585|NCT02959983|581030167|FG000|Overall Study|Physician Decision|1|||
160900586|NCT02959983|581030168|FG001|Overall Study|Physician Decision|0|||
160900587|NCT02959983|581030167|FG000|Overall Study|Adverse Event|5|||
160900588|NCT02959983|581030168|FG001|Overall Study|Adverse Event|1|||
160900589|NCT02959983|581030167|FG000|Overall Study|Withdrawal by Subject|7|||
160900590|NCT02959983|581030168|FG001|Overall Study|Withdrawal by Subject|12|||
160900591|NCT01254630|581030169|FG000|Overall Study|Adverse Event|36|||
160900592|NCT01254630|581030170|FG001|Overall Study|Adverse Event|15|||
160900593|NCT01254630|581030171|FG002|Overall Study|Adverse Event|40|||
160900594|NCT01254630|581030172|FG003|Overall Study|Adverse Event|8|||
160900595|NCT01254630|581030169|FG000|Overall Study|Death|461|||
160900596|NCT01254630|581030170|FG001|Overall Study|Death|151|||
160900597|NCT01254630|581030171|FG002|Overall Study|Death|478|||
160900598|NCT01254630|581030172|FG003|Overall Study|Death|139|||
160900599|NCT01254630|581030169|FG000|Overall Study|Lost to Follow-up|80|||
160900600|NCT01254630|581030170|FG001|Overall Study|Lost to Follow-up|26|||
160900601|NCT01254630|581030171|FG002|Overall Study|Lost to Follow-up|89|||
160900602|NCT01254630|581030172|FG003|Overall Study|Lost to Follow-up|32|||
160900603|NCT01254630|581030169|FG000|Overall Study|Physician Decision|24|||
160900604|NCT01254630|581030170|FG001|Overall Study|Physician Decision|8|||
160900605|NCT01254630|581030171|FG002|Overall Study|Physician Decision|16|||
160900606|NCT01254630|581030172|FG003|Overall Study|Physician Decision|7|||
160900607|NCT01254630|581030169|FG000|Overall Study|Withdrawal by Subject|201|||
160900608|NCT01254630|581030170|FG001|Overall Study|Withdrawal by Subject|94|||
160900609|NCT01254630|581030171|FG002|Overall Study|Withdrawal by Subject|188|||
160900610|NCT01254630|581030172|FG003|Overall Study|Withdrawal by Subject|89|||
160900611|NCT01254630|581030169|FG000|Overall Study|Study terminated by sponsor|0|||
160900612|NCT01254630|581030170|FG001|Overall Study|Study terminated by sponsor|994|||
160900613|NCT01254630|581030171|FG002|Overall Study|Study terminated by sponsor|0|||
160900614|NCT01254630|581030172|FG003|Overall Study|Study terminated by sponsor|1010|||
160900615|NCT01254630|581030169|FG000|Overall Study|Status not recorded|0|||
160900616|NCT01254630|581030170|FG001|Overall Study|Status not recorded|0|||
160900617|NCT01254630|581030171|FG002|Overall Study|Status not recorded|1|||
160900618|NCT01254630|581030172|FG003|Overall Study|Status not recorded|0|||
160900619|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
160900620|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
160900621|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
160900622|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
160900623|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900624|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900625|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900626|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900627|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900628|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900629|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900630|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
160900631|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
160900632|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
160900633|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
160900634|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900635|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900636|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160819919|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
160819920|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
160819921|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|Death|0|||
160819922|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|Death|0|||
160819923|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|Death|3|||
160819924|NCT02684058|580724962|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
160819925|NCT02684058|580724963|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
160819926|NCT02684058|580724964|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
160819927|NCT02684058|580724962|FG000|Post-treatment Survival Follow-up|Death|0|||
160819928|NCT02684058|580724963|FG001|Post-treatment Survival Follow-up|Death|0|||
160819929|NCT02684058|580724964|FG002|Post-treatment Survival Follow-up|Death|7|||
160819930|NCT02684058|580724962|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
160819931|NCT02684058|580724963|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
160819932|NCT02684058|580724964|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
160819933|NCT02684058|580724962|FG000|Crossover Treatment Period|Progressive disease|0|||
160819934|NCT02684058|580724963|FG001|Crossover Treatment Period|Progressive disease|1|||
160819935|NCT02684058|580724964|FG002|Crossover Treatment Period|Progressive disease|0|||
160819936|NCT01252186|580724965|FG000|Overall Study|Adverse Event|9|||
160819937|NCT01252186|580724966|FG001|Overall Study|Adverse Event|6|||
160819938|NCT01252186|580724967|FG002|Overall Study|Adverse Event|8|||
160819939|NCT01252186|580724965|FG000|Overall Study|Withdrawal by Subject|2|||
160819940|NCT01252186|580724966|FG001|Overall Study|Withdrawal by Subject|5|||
161132747|NCT02660580|581870727|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
161132748|NCT02660580|581870723|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
161132749|NCT02660580|581870724|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
161132750|NCT02660580|581870725|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
161132751|NCT02660580|581870726|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
161132752|NCT02660580|581870727|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
161132753|NCT02660580|581870723|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
160819941|NCT01252186|580724967|FG002|Overall Study|Withdrawal by Subject|2|||
160819942|NCT01252186|580724965|FG000|Overall Study|Physician Decision|0|||
160819943|NCT01252186|580724966|FG001|Overall Study|Physician Decision|0|||
160819944|NCT01252186|580724967|FG002|Overall Study|Physician Decision|1|||
160819945|NCT01252186|580724965|FG000|Overall Study|Non-compliance|0|||
160819946|NCT01252186|580724966|FG001|Overall Study|Non-compliance|3|||
160819947|NCT01252186|580724967|FG002|Overall Study|Non-compliance|4|||
160819948|NCT01252186|580724965|FG000|Overall Study|Protocol Violation|0|||
160819949|NCT01252186|580724966|FG001|Overall Study|Protocol Violation|0|||
160819950|NCT01252186|580724967|FG002|Overall Study|Protocol Violation|1|||
160819951|NCT01252186|580724965|FG000|Overall Study|Pregnancy|2|||
160819952|NCT01252186|580724966|FG001|Overall Study|Pregnancy|2|||
160819953|NCT01252186|580724967|FG002|Overall Study|Pregnancy|0|||
160819954|NCT01252186|580724965|FG000|Overall Study|Sponsor Request|2|||
160819955|NCT01252186|580724966|FG001|Overall Study|Sponsor Request|1|||
160819956|NCT01252186|580724967|FG002|Overall Study|Sponsor Request|0|||
160819957|NCT01252186|580724965|FG000|Overall Study|Lost to Follow-up|10|||
160819958|NCT01252186|580724966|FG001|Overall Study|Lost to Follow-up|10|||
160819959|NCT01252186|580724967|FG002|Overall Study|Lost to Follow-up|11|||
160819960|NCT01252186|580724965|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
160819961|NCT01252186|580724966|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
160819962|NCT01252186|580724967|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
160819963|NCT00780143|580724968|FG000|Overall Study|Progressive disease|1|||
160819964|NCT00780143|580724968|FG000|Overall Study|Toxicity|1|||
160819965|NCT00780143|580724968|FG000|Overall Study|Adverse Event|1|||
160819966|NCT01457014|580724973|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
160819967|NCT01457014|580724974|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
160819968|NCT01457014|580724975|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
160819969|NCT01457014|580724976|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
160819970|NCT01457014|580724973|FG000|First Night|Withdrawal by Subject|3|||
160819971|NCT01457014|580724974|FG001|First Night|Withdrawal by Subject|0|||
160819972|NCT01457014|580724975|FG002|First Night|Withdrawal by Subject|0|||
160819973|NCT01457014|580724976|FG003|First Night|Withdrawal by Subject|0|||
160819974|NCT02461290|580724977|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
160819975|NCT02461290|580724977|FG000|Overall Study|Lost to Follow-up|3|||
160819976|NCT03319953|580724982|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
160900637|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
161132754|NCT02660580|581870724|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
160819977|NCT03319953|580724983|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
160819978|NCT03319953|580724984|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
160819979|NCT03319953|580724985|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
160819980|NCT03319953|580724982|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
160819981|NCT03319953|580724983|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
160900638|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160987772|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
160987773|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160987774|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
160987775|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
160819982|NCT03319953|580724984|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
160819983|NCT03319953|580724985|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
160819984|NCT02438384|580724986|FG000|Overall Study|Lost to Follow-up|8|||
160819985|NCT02438384|580724987|FG001|Overall Study|Lost to Follow-up|6|||
160819986|NCT02438384|580724988|FG002|Overall Study|Lost to Follow-up|4|||
160819987|NCT04027049|580724992|FG000|Overall Study|Withdrawn by family|1|||
160819988|NCT04027049|580724993|FG001|Overall Study|Withdrawn by family|0|||
160819989|NCT04027049|580724992|FG000|Overall Study|Participant safety|1|||
160819990|NCT04027049|580724993|FG001|Overall Study|Participant safety|0|||
160987776|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
160987777|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160987778|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
160987779|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
160819991|NCT02650128|580724994|FG000|Overall Study|Death|2|||
160819992|NCT02264665|580726989|FG000|Overall Study|Other|0|||
160819993|NCT02264665|580726990|FG001|Overall Study|Other|0|||
160819994|NCT02264665|580726991|FG002|Overall Study|Other|3|||
160819995|NCT02264665|580726992|FG003|Overall Study|Other|0|||
160819996|NCT02264665|580726993|FG004|Overall Study|Other|0|||
160819997|NCT02264665|580726994|FG005|Overall Study|Other|0|||
160819998|NCT02264665|580726995|FG006|Overall Study|Other|0|||
160819999|NCT02264665|580726989|FG000|Overall Study|Death|9|||
160820000|NCT02264665|580726990|FG001|Overall Study|Death|8|||
160820001|NCT02264665|580726991|FG002|Overall Study|Death|13|||
160820002|NCT02264665|580726992|FG003|Overall Study|Death|5|||
160820003|NCT02264665|580726993|FG004|Overall Study|Death|0|||
160820004|NCT02264665|580726994|FG005|Overall Study|Death|0|||
160820005|NCT02264665|580726995|FG006|Overall Study|Death|1|||
160820006|NCT02264665|580726989|FG000|Overall Study|Lost to Follow-up|1|||
160820007|NCT02264665|580726990|FG001|Overall Study|Lost to Follow-up|0|||
160820008|NCT02264665|580726991|FG002|Overall Study|Lost to Follow-up|2|||
160820009|NCT02264665|580726992|FG003|Overall Study|Lost to Follow-up|1|||
160820010|NCT02264665|580726993|FG004|Overall Study|Lost to Follow-up|0|||
160820011|NCT02264665|580726994|FG005|Overall Study|Lost to Follow-up|0|||
160820012|NCT02264665|580726995|FG006|Overall Study|Lost to Follow-up|0|||
160820013|NCT02264665|580726989|FG000|Overall Study|Participant decision|0|||
160820014|NCT02264665|580726990|FG001|Overall Study|Participant decision|0|||
160820015|NCT02264665|580726991|FG002|Overall Study|Participant decision|0|||
160820016|NCT02264665|580726992|FG003|Overall Study|Participant decision|1|||
160820017|NCT02264665|580726993|FG004|Overall Study|Participant decision|0|||
160820018|NCT02264665|580726994|FG005|Overall Study|Participant decision|0|||
160820019|NCT02264665|580726995|FG006|Overall Study|Participant decision|0|||
160820020|NCT02264665|580726989|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
160820021|NCT02264665|580726990|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
160820022|NCT02264665|580726991|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
160820023|NCT02264665|580726992|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
160820024|NCT02264665|580726993|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
160820025|NCT02264665|580726994|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
160820026|NCT02264665|580726995|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
160820027|NCT02264665|580726989|FG000|Overall Study|Data Missing|0|||
160820028|NCT02264665|580726990|FG001|Overall Study|Data Missing|0|||
160820029|NCT02264665|580726991|FG002|Overall Study|Data Missing|1|||
160820030|NCT02264665|580726992|FG003|Overall Study|Data Missing|0|||
160820031|NCT02264665|580726993|FG004|Overall Study|Data Missing|0|||
160820032|NCT02264665|580726994|FG005|Overall Study|Data Missing|0|||
160820033|NCT02264665|580726995|FG006|Overall Study|Data Missing|0|||
160820034|NCT00789581|580726996|FG000|AC Therapy|Adverse Event|2|||
160820035|NCT00789581|580726997|FG001|AC Therapy|Adverse Event|3|||
160820036|NCT00789581|580726996|FG000|AC Therapy|Withdrawal by Subject|4|||
160820037|NCT00789581|580726997|FG001|AC Therapy|Withdrawal by Subject|7|||
160820038|NCT00789581|580726996|FG000|AC Therapy|Disease recurrence|3|||
160820039|NCT00789581|580726997|FG001|AC Therapy|Disease recurrence|1|||
160820040|NCT00789581|580726996|FG000|AC Therapy|Intercurrent Illness|1|||
160820041|NCT00789581|580726997|FG001|AC Therapy|Intercurrent Illness|0|||
160820042|NCT00789581|580726996|FG000|AC Therapy|Never Treated|1|||
160820043|NCT00789581|580726997|FG001|AC Therapy|Never Treated|4|||
160820044|NCT00789581|580726996|FG000|AC Therapy|Other|0|||
160820045|NCT00789581|580726997|FG001|AC Therapy|Other|2|||
160820046|NCT00789581|580726996|FG000|Adjuvant Therapy|Never treated|2|||
160820047|NCT00789581|580726997|FG001|Adjuvant Therapy|Never treated|2|||
160820048|NCT00789581|580726996|FG000|Adjuvant Therapy|Adverse Event|20|||
160820049|NCT00789581|580726997|FG001|Adjuvant Therapy|Adverse Event|44|||
160820050|NCT00789581|580726996|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
160820051|NCT00789581|580726997|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
160900639|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900640|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900641|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900642|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
160900643|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
160987780|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
160987781|NCT02373813|581343164|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160987782|NCT02373813|581343165|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
160987783|NCT02373813|581343166|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
160987784|NCT02373813|581343167|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
160987785|NCT01511536|581343168|FG000|Phase 1|Other|0|||
160987786|NCT01511536|581343169|FG001|Phase 1|Other|1|||
160987787|NCT01511536|581343170|FG002|Phase 1|Other|0|||
160987788|NCT01511536|581343168|FG000|Phase 2|Other|0|||
160987789|NCT01511536|581343169|FG001|Phase 2|Other|0|||
160987790|NCT01511536|581343170|FG002|Phase 2|Other|9|||
160987791|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
160820052|NCT00789581|580726996|FG000|Adjuvant Therapy|Disease recurrence|2|||
160820053|NCT00789581|580726997|FG001|Adjuvant Therapy|Disease recurrence|1|||
160820054|NCT00789581|580726996|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
160820055|NCT00789581|580726997|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
160820056|NCT00789581|580726996|FG000|Adjuvant Therapy|Protocol Violation|1|||
160820057|NCT00789581|580726997|FG001|Adjuvant Therapy|Protocol Violation|1|||
160820058|NCT00789581|580726996|FG000|Adjuvant Therapy|Other|0|||
160820059|NCT00789581|580726997|FG001|Adjuvant Therapy|Other|1|||
160820060|NCT05312632|580726998|FG000|Overall Study|Adverse Event|12|||
160820061|NCT05312632|580726998|FG000|Overall Study|Withdrawal by Subject|10|||
160987792|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
160987793|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
160987794|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
160987795|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
160820062|NCT05312632|580726998|FG000|Overall Study|Lack of Efficacy|4|||
160820063|NCT05312632|580726998|FG000|Overall Study|Non-compliance with study procedures|9|||
160820064|NCT05312632|580726998|FG000|Overall Study|Other|4|||
160820065|NCT02379221|580726999|FG000|Overall Study|Lost to Follow-up|1|||
160820066|NCT00519376|580727000|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820067|NCT00519376|580727001|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820068|NCT00519376|580727002|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820069|NCT00519376|580727003|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820070|NCT00519376|580727004|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820071|NCT00519376|580727005|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820072|NCT00519376|580727006|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820073|NCT00519376|580727007|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820074|NCT00519376|580727008|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820075|NCT00519376|580727009|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820076|NCT00519376|580727010|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820077|NCT00519376|580727011|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820078|NCT00519376|580727012|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
160820079|NCT00519376|580727013|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820080|NCT00519376|580727014|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160987796|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
160987797|NCT01764386|581343174|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
160987798|NCT01764386|581343175|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
160987799|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
160987800|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
160987801|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
160987802|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
160987803|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
160987804|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
160900644|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
160900645|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900646|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900647|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900648|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900649|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160820081|NCT00519376|580727015|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
160820082|NCT00519376|580727000|FG000|Treatment Period 4|Lost to Follow-up|0|||
160820083|NCT00519376|580727001|FG001|Treatment Period 4|Lost to Follow-up|0|||
160900650|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900651|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160820084|NCT00519376|580727002|FG002|Treatment Period 4|Lost to Follow-up|1|||
160820085|NCT00519376|580727003|FG003|Treatment Period 4|Lost to Follow-up|0|||
160820086|NCT00519376|580727004|FG004|Treatment Period 4|Lost to Follow-up|0|||
160820087|NCT00519376|580727005|FG005|Treatment Period 4|Lost to Follow-up|0|||
160820088|NCT00519376|580727006|FG006|Treatment Period 4|Lost to Follow-up|0|||
160820089|NCT00519376|580727007|FG007|Treatment Period 4|Lost to Follow-up|0|||
160820090|NCT00519376|580727008|FG008|Treatment Period 4|Lost to Follow-up|0|||
160820091|NCT00519376|580727009|FG009|Treatment Period 4|Lost to Follow-up|0|||
160820092|NCT00519376|580727010|FG010|Treatment Period 4|Lost to Follow-up|0|||
160820093|NCT00519376|580727011|FG011|Treatment Period 4|Lost to Follow-up|0|||
160820094|NCT00519376|580727012|FG012|Treatment Period 4|Lost to Follow-up|0|||
160820095|NCT00519376|580727013|FG013|Treatment Period 4|Lost to Follow-up|0|||
160820096|NCT00519376|580727014|FG014|Treatment Period 4|Lost to Follow-up|0|||
160820097|NCT00519376|580727015|FG015|Treatment Period 4|Lost to Follow-up|0|||
160820098|NCT00908115|580727023|FG000|Overall Study|Other|14|||
160820099|NCT01973387|580727031|FG000|Overall Study|Adverse Event|14|||
160820100|NCT01973387|580727032|FG001|Overall Study|Adverse Event|4|||
160820101|NCT01973387|580727031|FG000|Overall Study|Withdrawal by Subject|7|||
160820102|NCT01973387|580727032|FG001|Overall Study|Withdrawal by Subject|4|||
160820103|NCT01973387|580727031|FG000|Overall Study|Study terminated by sponsor|63|||
160820104|NCT01973387|580727032|FG001|Overall Study|Study terminated by sponsor|0|||
160820105|NCT01973387|580727031|FG000|Overall Study|Progressive disease or relapse|16|||
160820106|NCT01973387|580727032|FG001|Overall Study|Progressive disease or relapse|5|||
160820107|NCT01973387|580727031|FG000|Overall Study|Death|4|||
160820108|NCT01973387|580727032|FG001|Overall Study|Death|3|||
160820109|NCT01973387|580727031|FG000|Overall Study|Randomized, not treated|2|||
160820110|NCT01973387|580727032|FG001|Overall Study|Randomized, not treated|2|||
160820111|NCT01498575|580727033|FG000|Overall Sample|Withdrawal by Subject|60|||
160820112|NCT01498575|580727034|FG001|Overall Sample|Withdrawal by Subject|14|||
160820113|NCT01498575|580727033|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
160820114|NCT01498575|580727034|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
160820115|NCT01498575|580727033|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
160820116|NCT01498575|580727034|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
160820117|NCT01345591|580727038|FG000|Overall Study|Lost to Follow-up|1|||
160820118|NCT01126437|580727039|FG000|Overall Study|Not treated|11|||
160820119|NCT01126437|580727040|FG001|Overall Study|Not treated|18|||
160820120|NCT01126437|580727041|FG002|Overall Study|Not treated|19|||
161132755|NCT02660580|581870725|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
161132756|NCT02660580|581870726|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
161132757|NCT02660580|581870727|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
161132758|NCT02660580|581870723|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161132759|NCT02660580|581870724|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161132760|NCT02660580|581870725|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
161132761|NCT02660580|581870726|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
161132762|NCT02660580|581870727|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
161132763|NCT05415449|581870728|FG000|Overall Study|Lost to Follow-up|2|||
161132764|NCT05415449|581870728|FG000|Overall Study|Withdrawal by Subject|4|||
161132765|NCT02185521|581870731|FG000|Overall Study|Withdrawal by Subject|1|||
161132766|NCT02185521|581870731|FG000|Overall Study|Protocol Violation|1|||
161132767|NCT01028352|581870733|FG000|Overall Study|Ineligible due to baseline average pain|5|||
161132768|NCT01028352|581870733|FG000|Overall Study|Withdrawal by Subject|1|||
161132769|NCT01903876|581870734|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
161132770|NCT01903876|581870735|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
161132771|NCT01903876|581870734|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
161132772|NCT01903876|581870735|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
161132773|NCT00826748|581870745|FG000|Overall Study|Withdrawal by Subject|0|||
161132774|NCT00826748|581870746|FG001|Overall Study|Withdrawal by Subject|0|||
161132775|NCT00826748|581870747|FG002|Overall Study|Withdrawal by Subject|2|||
161132776|NCT00826748|581870745|FG000|Overall Study|Physician Decision|0|||
161132777|NCT00826748|581870746|FG001|Overall Study|Physician Decision|0|||
161132778|NCT00826748|581870747|FG002|Overall Study|Physician Decision|1|||
161132779|NCT00826748|581870745|FG000|Overall Study|Samples Did Not pass QC|0|||
161132780|NCT00826748|581870746|FG001|Overall Study|Samples Did Not pass QC|0|||
161132781|NCT00826748|581870747|FG002|Overall Study|Samples Did Not pass QC|1|||
161132782|NCT02300129|581870749|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161132783|NCT02300129|581870750|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
161132784|NCT02300129|581870751|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
161132785|NCT02300129|581870752|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
160820121|NCT01126437|580727039|FG000|Overall Study|Sites with data irregularities/fraud|6|||
160820122|NCT01126437|580727040|FG001|Overall Study|Sites with data irregularities/fraud|6|||
160820123|NCT01126437|580727041|FG002|Overall Study|Sites with data irregularities/fraud|7|||
160820124|NCT01126437|580727039|FG000|Overall Study|Adverse Event|602|||
160820125|NCT01126437|580727040|FG001|Overall Study|Adverse Event|606|||
160820126|NCT01126437|580727041|FG002|Overall Study|Adverse Event|635|||
160820127|NCT01126437|580727039|FG000|Overall Study|Lack of Efficacy|65|||
160820128|NCT01126437|580727040|FG001|Overall Study|Lack of Efficacy|60|||
160820129|NCT01126437|580727041|FG002|Overall Study|Lack of Efficacy|59|||
160820130|NCT01126437|580727039|FG000|Overall Study|Protocol Violation|64|||
160820131|NCT01126437|580727040|FG001|Overall Study|Protocol Violation|66|||
160820132|NCT01126437|580727041|FG002|Overall Study|Protocol Violation|41|||
160820133|NCT01126437|580727039|FG000|Overall Study|Lost to Follow-up|52|||
160820134|NCT01126437|580727040|FG001|Overall Study|Lost to Follow-up|63|||
160820135|NCT01126437|580727041|FG002|Overall Study|Lost to Follow-up|55|||
160820136|NCT01126437|580727039|FG000|Overall Study|Withdrawal by Subject|331|||
160820137|NCT01126437|580727040|FG001|Overall Study|Withdrawal by Subject|335|||
160820138|NCT01126437|580727041|FG002|Overall Study|Withdrawal by Subject|319|||
160820139|NCT01126437|580727039|FG000|Overall Study|Other reason not specified|210|||
160820140|NCT01126437|580727040|FG001|Overall Study|Other reason not specified|176|||
160820141|NCT01126437|580727041|FG002|Overall Study|Other reason not specified|178|||
160820142|NCT00596154|580727042|FG000|Overall Study|Not Evaluable|2|||
160820143|NCT00642369|580727047|FG000|Overall Study|Adverse Event|2|||
160820144|NCT00642369|580727048|FG001|Overall Study|Adverse Event|3|||
160820145|NCT00642369|580727047|FG000|Overall Study|Withdrawal by Subject|1|||
160820146|NCT00642369|580727048|FG001|Overall Study|Withdrawal by Subject|0|||
160820147|NCT00642369|580727047|FG000|Overall Study|misdiagnosis|0|||
160820148|NCT00642369|580727048|FG001|Overall Study|misdiagnosis|1|||
160820149|NCT00642369|580727047|FG000|Overall Study|Lack of Efficacy|2|||
160820150|NCT00642369|580727048|FG001|Overall Study|Lack of Efficacy|2|||
160820151|NCT00996281|580727056|FG000|Overall Study|Adverse Event|75|||
160820152|NCT00996281|580727057|FG001|Overall Study|Adverse Event|37|||
160820153|NCT00996281|580727056|FG000|Overall Study|Major Protocol Deviation|6|||
160820154|NCT00996281|580727057|FG001|Overall Study|Major Protocol Deviation|7|||
160820155|NCT00996281|580727056|FG000|Overall Study|Lost to Follow-up|14|||
160820156|NCT00996281|580727057|FG001|Overall Study|Lost to Follow-up|16|||
160820157|NCT00996281|580727056|FG000|Overall Study|Withdrawal by Subject|31|||
160900652|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900653|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900654|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
160900655|NCT02925117|581030178|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
160900656|NCT02925117|581030179|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
160900657|NCT02925117|581030180|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
160900658|NCT02925117|581030181|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
160900659|NCT02925117|581030182|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
160900660|NCT02925117|581030183|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
160900661|NCT02925117|581030184|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
160900662|NCT02925117|581030185|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
160900663|NCT02925117|581030186|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
160900664|NCT02925117|581030187|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
160900665|NCT02925117|581030188|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
160900666|NCT02925117|581030189|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
160900667|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900668|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900669|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900670|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900671|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900672|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
160900673|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900674|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900675|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900676|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
160900677|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
160900678|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
160900679|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900680|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900681|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160987805|NCT01764386|581343174|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
160820158|NCT00996281|580727057|FG001|Overall Study|Withdrawal by Subject|20|||
160820159|NCT00996281|580727056|FG000|Overall Study|Lack of Efficacy|0|||
160820160|NCT00996281|580727057|FG001|Overall Study|Lack of Efficacy|2|||
160820161|NCT00996281|580727056|FG000|Overall Study|Other|5|||
160820162|NCT00996281|580727057|FG001|Overall Study|Other|7|||
160820163|NCT03466099|580727060|FG000|Overall Study|Adverse Event|1|||
160820164|NCT03466099|580727061|FG001|Overall Study|Adverse Event|1|||
160900682|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900683|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
160900684|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
160987806|NCT01764386|581343175|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
160900685|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
160900686|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
160900687|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160820165|NCT03466099|580727062|FG002|Overall Study|Adverse Event|1|||
160820166|NCT03466099|580727060|FG000|Overall Study|Withdrawal by Subject|2|||
160820167|NCT03466099|580727061|FG001|Overall Study|Withdrawal by Subject|3|||
160820168|NCT03466099|580727062|FG002|Overall Study|Withdrawal by Subject|1|||
160820169|NCT03466099|580727060|FG000|Overall Study|Use of rescue medication|8|||
160820170|NCT03466099|580727061|FG001|Overall Study|Use of rescue medication|9|||
160820171|NCT03466099|580727062|FG002|Overall Study|Use of rescue medication|13|||
160820172|NCT03466099|580727060|FG000|Overall Study|Rescued without meeting criteria|4|||
160820173|NCT03466099|580727061|FG001|Overall Study|Rescued without meeting criteria|1|||
160820174|NCT03466099|580727062|FG002|Overall Study|Rescued without meeting criteria|1|||
160820175|NCT03466099|580727060|FG000|Overall Study|Subject compliance|2|||
160820176|NCT03466099|580727061|FG001|Overall Study|Subject compliance|0|||
160820177|NCT03466099|580727062|FG002|Overall Study|Subject compliance|0|||
160820178|NCT03466099|580727060|FG000|Overall Study|Worsening disease|0|||
160820179|NCT03466099|580727061|FG001|Overall Study|Worsening disease|0|||
160820180|NCT03466099|580727062|FG002|Overall Study|Worsening disease|1|||
160820181|NCT03622112|580727063|FG000|Overall Study|Withdrawal by Subject|6|||
160820182|NCT03622112|580727064|FG001|Overall Study|Withdrawal by Subject|2|||
160820183|NCT03622112|580727065|FG002|Overall Study|Withdrawal by Subject|4|||
160820184|NCT03622112|580727066|FG003|Overall Study|Withdrawal by Subject|2|||
160820185|NCT03622112|580727067|FG004|Overall Study|Withdrawal by Subject|1|||
160820186|NCT03622112|580727068|FG005|Overall Study|Withdrawal by Subject|2|||
160820187|NCT03622112|580727069|FG006|Overall Study|Withdrawal by Subject|2|||
160820188|NCT03622112|580727063|FG000|Overall Study|Death|0|||
160820189|NCT03622112|580727064|FG001|Overall Study|Death|0|||
160820190|NCT03622112|580727065|FG002|Overall Study|Death|0|||
160820191|NCT03622112|580727066|FG003|Overall Study|Death|1|||
160820192|NCT03622112|580727067|FG004|Overall Study|Death|0|||
160820193|NCT03622112|580727068|FG005|Overall Study|Death|0|||
160820194|NCT03622112|580727069|FG006|Overall Study|Death|0|||
160820195|NCT03622112|580727063|FG000|Overall Study|Lost to Follow-up|1|||
160820196|NCT03622112|580727064|FG001|Overall Study|Lost to Follow-up|1|||
160820197|NCT03622112|580727065|FG002|Overall Study|Lost to Follow-up|0|||
160820198|NCT03622112|580727066|FG003|Overall Study|Lost to Follow-up|0|||
160820199|NCT03622112|580727067|FG004|Overall Study|Lost to Follow-up|0|||
160820200|NCT03622112|580727068|FG005|Overall Study|Lost to Follow-up|0|||
160820201|NCT03622112|580727069|FG006|Overall Study|Lost to Follow-up|0|||
160820202|NCT03622112|580727063|FG000|Overall Study|Study-specific withdrawal criteria|10|||
160820203|NCT03622112|580727064|FG001|Overall Study|Study-specific withdrawal criteria|8|||
160820204|NCT03622112|580727065|FG002|Overall Study|Study-specific withdrawal criteria|7|||
160820205|NCT03622112|580727066|FG003|Overall Study|Study-specific withdrawal criteria|6|||
160820206|NCT03622112|580727067|FG004|Overall Study|Study-specific withdrawal criteria|4|||
160820207|NCT03622112|580727068|FG005|Overall Study|Study-specific withdrawal criteria|18|||
160820208|NCT03622112|580727069|FG006|Overall Study|Study-specific withdrawal criteria|4|||
160820209|NCT03622112|580727063|FG000|Overall Study|Protocol Violation|2|||
160820210|NCT03622112|580727064|FG001|Overall Study|Protocol Violation|0|||
160820211|NCT03622112|580727065|FG002|Overall Study|Protocol Violation|1|||
160820212|NCT03622112|580727066|FG003|Overall Study|Protocol Violation|1|||
160820213|NCT03622112|580727067|FG004|Overall Study|Protocol Violation|0|||
160820214|NCT03622112|580727068|FG005|Overall Study|Protocol Violation|0|||
160820215|NCT03622112|580727069|FG006|Overall Study|Protocol Violation|0|||
160820216|NCT03622112|580727063|FG000|Overall Study|Adverse Event|6|||
160820217|NCT03622112|580727064|FG001|Overall Study|Adverse Event|8|||
160820218|NCT03622112|580727065|FG002|Overall Study|Adverse Event|4|||
160820219|NCT03622112|580727066|FG003|Overall Study|Adverse Event|11|||
160820220|NCT03622112|580727067|FG004|Overall Study|Adverse Event|4|||
160820221|NCT03622112|580727068|FG005|Overall Study|Adverse Event|20|||
160820222|NCT03622112|580727069|FG006|Overall Study|Adverse Event|2|||
160820223|NCT03622112|580727063|FG000|Overall Study|Reason not specified|0|||
160820224|NCT03622112|580727064|FG001|Overall Study|Reason not specified|1|||
160820225|NCT03622112|580727065|FG002|Overall Study|Reason not specified|0|||
160820226|NCT03622112|580727066|FG003|Overall Study|Reason not specified|1|||
160820227|NCT03622112|580727067|FG004|Overall Study|Reason not specified|1|||
160820228|NCT03622112|580727068|FG005|Overall Study|Reason not specified|2|||
160820229|NCT03622112|580727069|FG006|Overall Study|Reason not specified|1|||
160987807|NCT02703532|581343177|FG000|Overall Study|Withdrawal by Subject|0|||
160820230|NCT01165320|580727070|FG000|Overall Study|Clinical adverse experience|2|||
160820231|NCT01165320|580727071|FG001|Overall Study|Clinical adverse experience|1|||
160820232|NCT01165320|580727072|FG002|Overall Study|Clinical adverse experience|0|||
160820233|NCT01165320|580727070|FG000|Overall Study|Laboratory adverse experience|1|||
160820234|NCT01165320|580727071|FG001|Overall Study|Laboratory adverse experience|0|||
160820235|NCT01165320|580727072|FG002|Overall Study|Laboratory adverse experience|0|||
160987808|NCT02703532|581343178|FG001|Overall Study|Withdrawal by Subject|1|||
160987809|NCT02703532|581343179|FG002|Overall Study|Withdrawal by Subject|0|||
160820236|NCT01165320|580727070|FG000|Overall Study|Lack of Efficacy|0|||
160820237|NCT01165320|580727071|FG001|Overall Study|Lack of Efficacy|2|||
160820238|NCT01165320|580727072|FG002|Overall Study|Lack of Efficacy|0|||
160820239|NCT01165320|580727070|FG000|Overall Study|Reason unknown|0|||
160820240|NCT01165320|580727071|FG001|Overall Study|Reason unknown|1|||
160820241|NCT01165320|580727072|FG002|Overall Study|Reason unknown|0|||
160820242|NCT01155466|580727078|FG000|Overall Study|Adverse Event|13|||
160820243|NCT01155466|580727079|FG001|Overall Study|Adverse Event|15|||
160820244|NCT01155466|580727080|FG002|Overall Study|Adverse Event|6|||
160820245|NCT01155466|580727081|FG003|Overall Study|Adverse Event|17|||
160820246|NCT01155466|580727082|FG004|Overall Study|Adverse Event|18|||
160820247|NCT01155466|580727078|FG000|Overall Study|Lost to Follow-up|0|||
160820248|NCT01155466|580727079|FG001|Overall Study|Lost to Follow-up|0|||
160820249|NCT01155466|580727080|FG002|Overall Study|Lost to Follow-up|0|||
160820250|NCT01155466|580727081|FG003|Overall Study|Lost to Follow-up|0|||
160820251|NCT01155466|580727082|FG004|Overall Study|Lost to Follow-up|2|||
160820252|NCT01155466|580727078|FG000|Overall Study|Withdrawal by Subject|7|||
160820253|NCT01155466|580727079|FG001|Overall Study|Withdrawal by Subject|5|||
160820254|NCT01155466|580727080|FG002|Overall Study|Withdrawal by Subject|9|||
160987810|NCT02703532|581343180|FG003|Overall Study|Withdrawal by Subject|1|||
160820255|NCT01155466|580727081|FG003|Overall Study|Withdrawal by Subject|4|||
160820256|NCT01155466|580727082|FG004|Overall Study|Withdrawal by Subject|4|||
160820257|NCT01155466|580727078|FG000|Overall Study|Protocol Violation|0|||
160820258|NCT01155466|580727079|FG001|Overall Study|Protocol Violation|0|||
160820259|NCT01155466|580727080|FG002|Overall Study|Protocol Violation|2|||
160987811|NCT02703532|581343177|FG000|Overall Study|Lost to Follow-up|2|||
160987812|NCT02703532|581343178|FG001|Overall Study|Lost to Follow-up|0|||
160987813|NCT02703532|581343179|FG002|Overall Study|Lost to Follow-up|2|||
160987814|NCT02703532|581343180|FG003|Overall Study|Lost to Follow-up|0|||
160820260|NCT01155466|580727081|FG003|Overall Study|Protocol Violation|0|||
160820261|NCT01155466|580727082|FG004|Overall Study|Protocol Violation|1|||
160820262|NCT01155466|580727078|FG000|Overall Study|Administrative|0|||
160820263|NCT01155466|580727079|FG001|Overall Study|Administrative|3|||
160820264|NCT01155466|580727080|FG002|Overall Study|Administrative|0|||
160820265|NCT01155466|580727081|FG003|Overall Study|Administrative|0|||
160820266|NCT01155466|580727082|FG004|Overall Study|Administrative|0|||
160820267|NCT01155466|580727078|FG000|Overall Study|Randomized not treated|2|||
160900688|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160900689|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160900690|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
160900691|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900692|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900693|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160820268|NCT01155466|580727079|FG001|Overall Study|Randomized not treated|2|||
160820269|NCT01155466|580727080|FG002|Overall Study|Randomized not treated|3|||
160820270|NCT01155466|580727081|FG003|Overall Study|Randomized not treated|0|||
160820271|NCT01155466|580727082|FG004|Overall Study|Randomized not treated|2|||
160820272|NCT03305419|580727083|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820273|NCT03305419|580727084|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
160820274|NCT03305419|580727085|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820275|NCT03305419|580727086|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820276|NCT03305419|580727087|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820277|NCT03305419|580727088|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160900694|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900695|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900696|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
160900697|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900698|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900699|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900700|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900701|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
160900702|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
160900703|NCT02925117|581030178|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
160900704|NCT02925117|581030179|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
160900705|NCT02925117|581030180|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
160900706|NCT02925117|581030181|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
160900707|NCT02925117|581030182|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
160900708|NCT02925117|581030183|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
160900709|NCT02925117|581030184|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
160987815|NCT03738241|581343181|FG000|Overall Study|Withdrawal by Subject|0|||
160987816|NCT03738241|581343182|FG001|Overall Study|Withdrawal by Subject|0|||
160820278|NCT03305419|580727089|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820279|NCT03305419|580727090|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
160820280|NCT03305419|580727083|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
160820281|NCT03305419|580727084|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820282|NCT03305419|580727085|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820283|NCT03305419|580727086|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160900710|NCT02925117|581030185|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
160987817|NCT03738241|581343183|FG002|Overall Study|Withdrawal by Subject|0|||
160820284|NCT03305419|580727087|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820285|NCT03305419|580727088|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820286|NCT03305419|580727089|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820287|NCT03305419|580727090|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
160820288|NCT03305419|580727083|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
160820289|NCT03305419|580727084|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820290|NCT03305419|580727085|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820291|NCT03305419|580727086|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820292|NCT03305419|580727087|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820293|NCT03305419|580727088|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820294|NCT03305419|580727089|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820295|NCT03305419|580727090|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
160820296|NCT03305419|580727083|FG000|Part B (14 Days)|Adverse Event|0|||
160820297|NCT03305419|580727084|FG001|Part B (14 Days)|Adverse Event|0|||
160820298|NCT03305419|580727085|FG002|Part B (14 Days)|Adverse Event|0|||
160820299|NCT03305419|580727086|FG003|Part B (14 Days)|Adverse Event|0|||
160820300|NCT03305419|580727087|FG004|Part B (14 Days)|Adverse Event|1|||
160820301|NCT03305419|580727088|FG005|Part B (14 Days)|Adverse Event|2|||
160820302|NCT03305419|580727089|FG006|Part B (14 Days)|Adverse Event|4|||
160820303|NCT03305419|580727090|FG007|Part B (14 Days)|Adverse Event|0|||
160820304|NCT03305419|580727083|FG000|Part B (14 Days)|Physician Decision|0|||
160820305|NCT03305419|580727084|FG001|Part B (14 Days)|Physician Decision|0|||
160820306|NCT03305419|580727085|FG002|Part B (14 Days)|Physician Decision|0|||
160820307|NCT03305419|580727086|FG003|Part B (14 Days)|Physician Decision|0|||
160820308|NCT03305419|580727087|FG004|Part B (14 Days)|Physician Decision|2|||
160820309|NCT03305419|580727088|FG005|Part B (14 Days)|Physician Decision|8|||
160820310|NCT03305419|580727089|FG006|Part B (14 Days)|Physician Decision|1|||
160820311|NCT03305419|580727090|FG007|Part B (14 Days)|Physician Decision|0|||
160820312|NCT04154605|580727095|FG000|Overall Study|Procedure Canceled|1|||
160820313|NCT04154605|580727096|FG001|Overall Study|Procedure Canceled|1|||
160820314|NCT04154605|580727095|FG000|Overall Study|Missed follow up|1|||
160820315|NCT04154605|580727096|FG001|Overall Study|Missed follow up|1|||
160820316|NCT04154605|580727095|FG000|Overall Study|Withdrawal by Subject|1|||
160820317|NCT04154605|580727096|FG001|Overall Study|Withdrawal by Subject|0|||
160820318|NCT01229254|580727099|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
160820319|NCT01229254|580727100|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
160820320|NCT01229254|580727101|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
160820321|NCT01229254|580727099|FG000|Overall Study|Adverse Event|4|||
160820322|NCT01229254|580727100|FG001|Overall Study|Adverse Event|5|||
160820323|NCT01229254|580727101|FG002|Overall Study|Adverse Event|3|||
160820324|NCT01229254|580727099|FG000|Overall Study|Lost to Follow-up|3|||
160820325|NCT01229254|580727100|FG001|Overall Study|Lost to Follow-up|0|||
160820326|NCT01229254|580727101|FG002|Overall Study|Lost to Follow-up|1|||
160820327|NCT01229254|580727099|FG000|Overall Study|Physician Decision|0|||
160820328|NCT01229254|580727100|FG001|Overall Study|Physician Decision|3|||
160820329|NCT01229254|580727101|FG002|Overall Study|Physician Decision|0|||
160820330|NCT01229254|580727099|FG000|Overall Study|Protocol Violation|4|||
160820331|NCT01229254|580727100|FG001|Overall Study|Protocol Violation|6|||
160820332|NCT01229254|580727101|FG002|Overall Study|Protocol Violation|5|||
160820333|NCT01229254|580727099|FG000|Overall Study|Withdrawal by Subject|1|||
160820334|NCT01229254|580727100|FG001|Overall Study|Withdrawal by Subject|0|||
160820335|NCT01229254|580727101|FG002|Overall Study|Withdrawal by Subject|1|||
160820336|NCT01229254|580727099|FG000|Overall Study|Non-compliance with Study Drug|0|||
160820337|NCT01229254|580727100|FG001|Overall Study|Non-compliance with Study Drug|1|||
160820338|NCT01229254|580727101|FG002|Overall Study|Non-compliance with Study Drug|1|||
160820339|NCT04934800|580727102|FG000|Overall Study|Other|1|||
160820340|NCT04934800|580727102|FG000|Overall Study|Withdrawal by Subject|5|||
160820341|NCT04934800|580727102|FG000|Overall Study|Lack of Efficacy|1|||
160820342|NCT04934800|580727102|FG000|Overall Study|Adverse Event|9|||
160820343|NCT04934800|580727102|FG000|Overall Study|Lost to Follow-up|5|||
160820344|NCT04934800|580727102|FG000|Overall Study|Enrolled but not treated|1|||
160820345|NCT05596734|580727103|FG000|Substudy A|Withdrawal by Subject|1|||
160820346|NCT05596734|580727104|FG001|Substudy A|Withdrawal by Subject|0|||
160820347|NCT05596734|580727105|FG002|Substudy A|Withdrawal by Subject|0|||
160820348|NCT05596734|580727106|FG003|Substudy A|Withdrawal by Subject|0|||
160820349|NCT05596734|580727107|FG004|Substudy A|Withdrawal by Subject|0|||
160820350|NCT05596734|580727108|FG005|Substudy A|Withdrawal by Subject|0|||
160820351|NCT05596734|580727109|FG006|Substudy A|Withdrawal by Subject|1|||
160820352|NCT05596734|580727110|FG007|Substudy A|Withdrawal by Subject|0|||
160820353|NCT05596734|580727111|FG008|Substudy A|Withdrawal by Subject|0|||
160820354|NCT05596734|580727112|FG009|Substudy A|Withdrawal by Subject|0|||
160820355|NCT05596734|580727113|FG010|Substudy A|Withdrawal by Subject|0|||
160820356|NCT05596734|580727114|FG011|Substudy A|Withdrawal by Subject|0|||
160820357|NCT05596734|580727115|FG012|Substudy A|Withdrawal by Subject|0|||
160820358|NCT05596734|580727116|FG013|Substudy A|Withdrawal by Subject|0|||
160987818|NCT03738241|581343184|FG003|Overall Study|Withdrawal by Subject|0|||
160987819|NCT03738241|581343185|FG004|Overall Study|Withdrawal by Subject|0|||
160987820|NCT03738241|581343186|FG005|Overall Study|Withdrawal by Subject|0|||
160987821|NCT03738241|581343187|FG006|Overall Study|Withdrawal by Subject|0|||
160987822|NCT03738241|581343188|FG007|Overall Study|Withdrawal by Subject|0|||
160987823|NCT03738241|581343189|FG008|Overall Study|Withdrawal by Subject|0|||
160987824|NCT03738241|581343190|FG009|Overall Study|Withdrawal by Subject|1|||
160987825|NCT03738241|581343181|FG000|Overall Study|Physician Decision|0|||
160987826|NCT03738241|581343182|FG001|Overall Study|Physician Decision|0|||
160987827|NCT03738241|581343183|FG002|Overall Study|Physician Decision|0|||
160987828|NCT03738241|581343184|FG003|Overall Study|Physician Decision|0|||
160987829|NCT03738241|581343185|FG004|Overall Study|Physician Decision|0|||
160987830|NCT03738241|581343186|FG005|Overall Study|Physician Decision|0|||
160987831|NCT03738241|581343187|FG006|Overall Study|Physician Decision|0|||
160987832|NCT03738241|581343188|FG007|Overall Study|Physician Decision|0|||
160987833|NCT03738241|581343189|FG008|Overall Study|Physician Decision|1|||
160987834|NCT03738241|581343190|FG009|Overall Study|Physician Decision|0|||
160987835|NCT03738241|581343181|FG000|Overall Study|Adverse Event|1|||
160987836|NCT03738241|581343182|FG001|Overall Study|Adverse Event|0|||
160987837|NCT03738241|581343183|FG002|Overall Study|Adverse Event|0|||
160987838|NCT03738241|581343184|FG003|Overall Study|Adverse Event|0|||
160987839|NCT03738241|581343185|FG004|Overall Study|Adverse Event|0|||
160987840|NCT03738241|581343186|FG005|Overall Study|Adverse Event|0|||
160987841|NCT03738241|581343187|FG006|Overall Study|Adverse Event|0|||
160987842|NCT03738241|581343188|FG007|Overall Study|Adverse Event|0|||
160987843|NCT03738241|581343189|FG008|Overall Study|Adverse Event|0|||
160987844|NCT03738241|581343190|FG009|Overall Study|Adverse Event|0|||
160820359|NCT05596734|580727117|FG014|Substudy A|Withdrawal by Subject|0|||
160820360|NCT05596734|580727118|FG015|Substudy A|Withdrawal by Subject|0|||
160820361|NCT05596734|580727119|FG016|Substudy A|Withdrawal by Subject|0|||
160820362|NCT05596734|580727120|FG017|Substudy A|Withdrawal by Subject|0|||
160820363|NCT05596734|580727121|FG018|Substudy A|Withdrawal by Subject|0|||
160820364|NCT05596734|580727122|FG019|Substudy A|Withdrawal by Subject|0|||
160820365|NCT05596734|580727123|FG020|Substudy A|Withdrawal by Subject|0|||
160820366|NCT05596734|580727124|FG021|Substudy A|Withdrawal by Subject|0|||
160820367|NCT05596734|580727125|FG022|Substudy A|Withdrawal by Subject|0|||
160820368|NCT05596734|580727126|FG023|Substudy A|Withdrawal by Subject|0|||
160820369|NCT05596734|580727103|FG000|Substudy A|Lost to Follow-up|1|||
160820370|NCT05596734|580727104|FG001|Substudy A|Lost to Follow-up|0|||
160820371|NCT05596734|580727105|FG002|Substudy A|Lost to Follow-up|1|||
160820372|NCT05596734|580727106|FG003|Substudy A|Lost to Follow-up|0|||
160820373|NCT05596734|580727107|FG004|Substudy A|Lost to Follow-up|0|||
160820374|NCT05596734|580727108|FG005|Substudy A|Lost to Follow-up|0|||
160820375|NCT05596734|580727109|FG006|Substudy A|Lost to Follow-up|0|||
160820376|NCT05596734|580727110|FG007|Substudy A|Lost to Follow-up|0|||
160820377|NCT05596734|580727111|FG008|Substudy A|Lost to Follow-up|0|||
160820378|NCT05596734|580727112|FG009|Substudy A|Lost to Follow-up|0|||
160820379|NCT05596734|580727113|FG010|Substudy A|Lost to Follow-up|0|||
160820380|NCT05596734|580727114|FG011|Substudy A|Lost to Follow-up|0|||
160820381|NCT05596734|580727115|FG012|Substudy A|Lost to Follow-up|0|||
160820382|NCT05596734|580727116|FG013|Substudy A|Lost to Follow-up|0|||
160820383|NCT05596734|580727117|FG014|Substudy A|Lost to Follow-up|0|||
160820384|NCT05596734|580727118|FG015|Substudy A|Lost to Follow-up|0|||
160820385|NCT05596734|580727119|FG016|Substudy A|Lost to Follow-up|0|||
160820386|NCT05596734|580727120|FG017|Substudy A|Lost to Follow-up|0|||
160820387|NCT05596734|580727121|FG018|Substudy A|Lost to Follow-up|0|||
160820388|NCT05596734|580727122|FG019|Substudy A|Lost to Follow-up|0|||
160820389|NCT05596734|580727123|FG020|Substudy A|Lost to Follow-up|0|||
160820390|NCT05596734|580727124|FG021|Substudy A|Lost to Follow-up|0|||
160820391|NCT05596734|580727125|FG022|Substudy A|Lost to Follow-up|0|||
160820392|NCT05596734|580727126|FG023|Substudy A|Lost to Follow-up|0|||
160820393|NCT05596734|580727103|FG000|Substudy B|Withdrawal by Subject|0|||
160820394|NCT05596734|580727104|FG001|Substudy B|Withdrawal by Subject|0|||
160820395|NCT05596734|580727105|FG002|Substudy B|Withdrawal by Subject|0|||
160820396|NCT05596734|580727106|FG003|Substudy B|Withdrawal by Subject|0|||
160820397|NCT05596734|580727107|FG004|Substudy B|Withdrawal by Subject|0|||
160820398|NCT05596734|580727108|FG005|Substudy B|Withdrawal by Subject|0|||
160820399|NCT05596734|580727109|FG006|Substudy B|Withdrawal by Subject|0|||
160820400|NCT05596734|580727110|FG007|Substudy B|Withdrawal by Subject|0|||
160987845|NCT03169361|581343191|FG000|Overall Study|Protocol Violation|32|||
160987846|NCT02788656|581343192|FG000|Overall Study|Withdrawal by Subject|1|||
160820401|NCT05596734|580727111|FG008|Substudy B|Withdrawal by Subject|0|||
160820402|NCT05596734|580727112|FG009|Substudy B|Withdrawal by Subject|0|||
160820403|NCT05596734|580727113|FG010|Substudy B|Withdrawal by Subject|0|||
160820404|NCT05596734|580727114|FG011|Substudy B|Withdrawal by Subject|0|||
160820405|NCT05596734|580727115|FG012|Substudy B|Withdrawal by Subject|1|||
160987847|NCT02788656|581343193|FG001|Overall Study|Withdrawal by Subject|0|||
160987848|NCT02263885|581343194|FG000|Overall Study|Withdrawal by Subject|7|||
160987849|NCT02263885|581343194|FG000|Overall Study|Alternative Treatment|3|||
160987850|NCT02459964|581343203|FG000|Overall Study|Withdrawal by Subject|0|||
160820406|NCT05596734|580727116|FG013|Substudy B|Withdrawal by Subject|0|||
160820407|NCT05596734|580727117|FG014|Substudy B|Withdrawal by Subject|1|||
160820408|NCT05596734|580727118|FG015|Substudy B|Withdrawal by Subject|2|||
160820409|NCT05596734|580727119|FG016|Substudy B|Withdrawal by Subject|2|||
160820410|NCT05596734|580727120|FG017|Substudy B|Withdrawal by Subject|1|||
160820411|NCT05596734|580727121|FG018|Substudy B|Withdrawal by Subject|2|||
160820412|NCT05596734|580727122|FG019|Substudy B|Withdrawal by Subject|0|||
160820413|NCT05596734|580727123|FG020|Substudy B|Withdrawal by Subject|0|||
160820414|NCT05596734|580727124|FG021|Substudy B|Withdrawal by Subject|0|||
160820415|NCT05596734|580727125|FG022|Substudy B|Withdrawal by Subject|0|||
160820416|NCT05596734|580727126|FG023|Substudy B|Withdrawal by Subject|1|||
160820417|NCT05596734|580727103|FG000|Substudy B|Physician Decision|0|||
160820418|NCT05596734|580727104|FG001|Substudy B|Physician Decision|0|||
160820419|NCT05596734|580727105|FG002|Substudy B|Physician Decision|0|||
160820420|NCT05596734|580727106|FG003|Substudy B|Physician Decision|0|||
160820421|NCT05596734|580727107|FG004|Substudy B|Physician Decision|0|||
160820422|NCT05596734|580727108|FG005|Substudy B|Physician Decision|0|||
160820423|NCT05596734|580727109|FG006|Substudy B|Physician Decision|0|||
160820424|NCT05596734|580727110|FG007|Substudy B|Physician Decision|0|||
160820425|NCT05596734|580727111|FG008|Substudy B|Physician Decision|0|||
160820426|NCT05596734|580727112|FG009|Substudy B|Physician Decision|0|||
160820427|NCT05596734|580727113|FG010|Substudy B|Physician Decision|0|||
160820428|NCT05596734|580727114|FG011|Substudy B|Physician Decision|0|||
160820429|NCT05596734|580727115|FG012|Substudy B|Physician Decision|0|||
160820430|NCT05596734|580727116|FG013|Substudy B|Physician Decision|0|||
160820431|NCT05596734|580727117|FG014|Substudy B|Physician Decision|0|||
160820432|NCT05596734|580727118|FG015|Substudy B|Physician Decision|1|||
160820433|NCT05596734|580727119|FG016|Substudy B|Physician Decision|0|||
160820434|NCT05596734|580727120|FG017|Substudy B|Physician Decision|0|||
160820435|NCT05596734|580727121|FG018|Substudy B|Physician Decision|0|||
160820436|NCT05596734|580727122|FG019|Substudy B|Physician Decision|0|||
160820437|NCT05596734|580727123|FG020|Substudy B|Physician Decision|0|||
160820438|NCT05596734|580727124|FG021|Substudy B|Physician Decision|0|||
160820439|NCT05596734|580727125|FG022|Substudy B|Physician Decision|0|||
160820440|NCT05596734|580727126|FG023|Substudy B|Physician Decision|0|||
160820441|NCT05596734|580727103|FG000|Substudy B|Lost to Follow-up|0|||
160820442|NCT05596734|580727104|FG001|Substudy B|Lost to Follow-up|0|||
160820443|NCT05596734|580727105|FG002|Substudy B|Lost to Follow-up|0|||
160820444|NCT05596734|580727106|FG003|Substudy B|Lost to Follow-up|0|||
160820445|NCT05596734|580727107|FG004|Substudy B|Lost to Follow-up|0|||
160820446|NCT05596734|580727108|FG005|Substudy B|Lost to Follow-up|0|||
161132786|NCT02300129|581870749|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161132787|NCT02300129|581870750|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
161132788|NCT02300129|581870751|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
160820447|NCT05596734|580727109|FG006|Substudy B|Lost to Follow-up|0|||
160820448|NCT05596734|580727110|FG007|Substudy B|Lost to Follow-up|0|||
160820449|NCT05596734|580727111|FG008|Substudy B|Lost to Follow-up|0|||
160820450|NCT05596734|580727112|FG009|Substudy B|Lost to Follow-up|0|||
160820451|NCT05596734|580727113|FG010|Substudy B|Lost to Follow-up|0|||
160820452|NCT05596734|580727114|FG011|Substudy B|Lost to Follow-up|0|||
160820453|NCT05596734|580727115|FG012|Substudy B|Lost to Follow-up|1|||
160820454|NCT05596734|580727116|FG013|Substudy B|Lost to Follow-up|0|||
160820455|NCT05596734|580727117|FG014|Substudy B|Lost to Follow-up|1|||
160820456|NCT05596734|580727118|FG015|Substudy B|Lost to Follow-up|1|||
160820457|NCT05596734|580727119|FG016|Substudy B|Lost to Follow-up|0|||
160820458|NCT05596734|580727120|FG017|Substudy B|Lost to Follow-up|0|||
160820459|NCT05596734|580727121|FG018|Substudy B|Lost to Follow-up|0|||
160820460|NCT05596734|580727122|FG019|Substudy B|Lost to Follow-up|0|||
160820461|NCT05596734|580727123|FG020|Substudy B|Lost to Follow-up|0|||
160820462|NCT05596734|580727124|FG021|Substudy B|Lost to Follow-up|0|||
160820463|NCT05596734|580727125|FG022|Substudy B|Lost to Follow-up|0|||
160820464|NCT05596734|580727126|FG023|Substudy B|Lost to Follow-up|0|||
160820465|NCT02118766|580727131|FG000|Overall Study|Adverse Event|7|||
160820466|NCT02118766|580727132|FG001|Overall Study|Adverse Event|2|||
161132789|NCT02300129|581870752|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
160820467|NCT02118766|580727131|FG000|Overall Study|Withdrawal by Subject|3|||
160820468|NCT02118766|580727132|FG001|Overall Study|Withdrawal by Subject|6|||
160820469|NCT02118766|580727131|FG000|Overall Study|Lost to Follow-up|5|||
160820470|NCT02118766|580727132|FG001|Overall Study|Lost to Follow-up|4|||
160820471|NCT02118766|580727131|FG000|Overall Study|Withdrawal by parent/guardian|12|||
160820472|NCT02118766|580727132|FG001|Overall Study|Withdrawal by parent/guardian|18|||
160820473|NCT02118766|580727131|FG000|Overall Study|Other|3|||
160820474|NCT02118766|580727132|FG001|Overall Study|Other|1|||
160820475|NCT02059499|580727134|FG000|Upto Week 20|Lost to Follow-up|2|||
160820476|NCT02059499|580727135|FG001|Upto Week 20|Lost to Follow-up|6|||
160820477|NCT02059499|580727136|FG002|Upto Week 20|Lost to Follow-up|0|||
160820478|NCT02059499|580727134|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
160820479|NCT02059499|580727135|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
160900711|NCT02925117|581030186|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
160820480|NCT02059499|580727136|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
160820481|NCT02059499|580727134|FG000|Upto Week 20|Withdrawal by Subject|1|||
160820482|NCT02059499|580727135|FG001|Upto Week 20|Withdrawal by Subject|1|||
160820483|NCT02059499|580727136|FG002|Upto Week 20|Withdrawal by Subject|0|||
160820484|NCT02059499|580727134|FG000|Upto Week 20|No treatment per protocol criteria|0|||
160820485|NCT02059499|580727135|FG001|Upto Week 20|No treatment per protocol criteria|0|||
160820486|NCT02059499|580727136|FG002|Upto Week 20|No treatment per protocol criteria|5|||
160820487|NCT02059499|580727134|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
160820488|NCT02059499|580727135|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
160820489|NCT02059499|580727136|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
160820490|NCT02059499|580727134|FG000|Post-week 20|Lost to Follow-up|0|||
160820491|NCT02059499|580727135|FG001|Post-week 20|Lost to Follow-up|2|||
160820492|NCT02059499|580727136|FG002|Post-week 20|Lost to Follow-up|0|||
160820493|NCT02059499|580727134|FG000|Post-week 20|Withdrawal by Subject|0|||
160820494|NCT02059499|580727135|FG001|Post-week 20|Withdrawal by Subject|1|||
160820495|NCT02059499|580727136|FG002|Post-week 20|Withdrawal by Subject|0|||
160820496|NCT02059499|580727134|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
160820497|NCT02059499|580727135|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
160820498|NCT02059499|580727136|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
160820499|NCT04210245|580727137|FG000|Overall Study|Adverse Event|0|||
160820500|NCT04210245|580727138|FG001|Overall Study|Adverse Event|3|||
160820501|NCT04210245|580727139|FG002|Overall Study|Adverse Event|6|||
160820502|NCT04210245|580727140|FG003|Overall Study|Adverse Event|0|||
160820503|NCT04210245|580727137|FG000|Overall Study|Withdrawal by Subject|0|||
160820504|NCT04210245|580727138|FG001|Overall Study|Withdrawal by Subject|1|||
160820505|NCT04210245|580727139|FG002|Overall Study|Withdrawal by Subject|4|||
160820506|NCT04210245|580727140|FG003|Overall Study|Withdrawal by Subject|4|||
160820507|NCT04210245|580727137|FG000|Overall Study|Lost to Follow-up|0|||
160820508|NCT04210245|580727138|FG001|Overall Study|Lost to Follow-up|1|||
160820509|NCT04210245|580727139|FG002|Overall Study|Lost to Follow-up|1|||
160820510|NCT04210245|580727140|FG003|Overall Study|Lost to Follow-up|1|||
160820511|NCT04210245|580727137|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
160820512|NCT04210245|580727138|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
160820513|NCT04210245|580727139|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
160820514|NCT04210245|580727140|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
160820515|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
160820516|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820517|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820518|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820519|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820520|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
160820521|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
160820522|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
160820523|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820524|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820525|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820526|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
160820527|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
160820528|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
160820529|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820530|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820531|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820532|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
160820533|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
160820534|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
160820535|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160820536|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160820537|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160820538|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
160987851|NCT02459964|581343204|FG001|Overall Study|Withdrawal by Subject|0|||
160820539|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
160820540|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
160820541|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160820542|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160987852|NCT02459964|581343205|FG002|Overall Study|Withdrawal by Subject|1|||
160987853|NCT02459964|581343203|FG000|Overall Study|Abnormal EKG changes|0|||
160987854|NCT02459964|581343204|FG001|Overall Study|Abnormal EKG changes|0|||
160987855|NCT02459964|581343205|FG002|Overall Study|Abnormal EKG changes|1|||
160987856|NCT04531540|581343210|FG000|Overall Study|Adverse Event|1|||
160987857|NCT04531540|581343210|FG000|Overall Study|Protocol Violation|3|||
160987858|NCT04531540|581343210|FG000|Overall Study|Withdrawal by Subject|4|||
160987859|NCT04531540|581343210|FG000|Overall Study|Found to be Ineligible|1|||
160987860|NCT03239210|581343211|FG000|Overall Study|Lost to Follow-up|2|||
160987861|NCT03239210|581343212|FG001|Overall Study|Lost to Follow-up|2|||
160987862|NCT03239210|581343211|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
160987863|NCT03239210|581343212|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
160987864|NCT03239210|581343211|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
160987865|NCT03239210|581343212|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
160987866|NCT01575860|581343213|FG000|Overall Study|Withdrawal by Subject|1|||
160987867|NCT01575860|581343213|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
160987868|NCT02223793|581343215|FG000|Overall Study|Lost to Follow-up|10|||
161240107|NCT00318461|582260505|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
161240108|NCT00318461|582260506|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
161240109|NCT00318461|582260502|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
161240110|NCT00318461|582260503|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
161240111|NCT00318461|582260504|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
161240112|NCT00318461|582260505|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
161240113|NCT00318461|582260506|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
161240114|NCT00318461|582260502|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
161240115|NCT00318461|582260503|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
161240116|NCT00318461|582260504|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
161240117|NCT00318461|582260505|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
160820543|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160820544|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
160820545|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
160820546|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820547|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820548|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820549|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160900712|NCT02925117|581030187|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
160900713|NCT02925117|581030188|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
160900714|NCT02925117|581030189|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
160900715|NCT04032652|581030190|FG000|Overall Study|The study was terminated and the PI has|1|||
160900716|NCT04032652|581030191|FG001|Overall Study|The study was terminated and the PI has|1|||
160900717|NCT02663908|581030192|FG000|Overall Study|Withdrawal by Subject|8|||
160900718|NCT02663908|581030193|FG001|Overall Study|Withdrawal by Subject|5|||
160900719|NCT02663908|581030192|FG000|Overall Study|Lost to Follow-up|1|||
160900720|NCT02663908|581030193|FG001|Overall Study|Lost to Follow-up|5|||
160900721|NCT02663908|581030192|FG000|Overall Study|Adverse Event|13|||
160900722|NCT02663908|581030193|FG001|Overall Study|Adverse Event|11|||
160900723|NCT02663908|581030192|FG000|Overall Study|Protocol Violation|1|||
160900724|NCT02663908|581030193|FG001|Overall Study|Protocol Violation|2|||
160900725|NCT02663908|581030192|FG000|Overall Study|Lack of therapeutic response|2|||
160900726|NCT02663908|581030193|FG001|Overall Study|Lack of therapeutic response|0|||
160900727|NCT02663908|581030192|FG000|Overall Study|COVID-19|1|||
160900728|NCT02663908|581030193|FG001|Overall Study|COVID-19|0|||
160900729|NCT02663908|581030192|FG000|Overall Study|Site closed|1|||
160900730|NCT02663908|581030193|FG001|Overall Study|Site closed|0|||
160900731|NCT02663908|581030192|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
160900732|NCT02663908|581030193|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
160900733|NCT02663908|581030192|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
160900734|NCT02663908|581030193|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
160900735|NCT02663908|581030192|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
160900736|NCT02663908|581030193|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
160900737|NCT02663908|581030192|FG000|Overall Study|Death|1|||
160900738|NCT02663908|581030193|FG001|Overall Study|Death|0|||
160900739|NCT02663908|581030192|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
160900740|NCT02663908|581030193|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
160900741|NCT02663908|581030192|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
160900742|NCT02663908|581030193|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
160900743|NCT00370071|581030194|FG000|Overall Study|Withdrawal by Subject|2|||
160900744|NCT02004522|581030195|FG000|Overall Study|Adverse Event|55|||
160900745|NCT02004522|581030196|FG001|Overall Study|Adverse Event|6|||
160900746|NCT02004522|581030195|FG000|Overall Study|Withdrawal by Subject|13|||
160987869|NCT02223793|581343216|FG001|Overall Study|Lost to Follow-up|1|||
160987870|NCT02223793|581343217|FG002|Overall Study|Lost to Follow-up|2|||
161240118|NCT00318461|582260506|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
161240119|NCT00796653|582260507|FG000|Overall Study|Adverse Event|19|||
161240120|NCT00796653|582260508|FG001|Overall Study|Adverse Event|16|||
161240121|NCT00796653|582260509|FG002|Overall Study|Adverse Event|16|||
161240122|NCT00796653|582260510|FG003|Overall Study|Adverse Event|16|||
161240123|NCT00796653|582260507|FG000|Overall Study|Lost to Follow-up|2|||
160820550|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
160820551|NCT03989349|580727141|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
160820552|NCT03989349|580727142|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
160820553|NCT03989349|580727143|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820554|NCT03989349|580727144|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820555|NCT03989349|580727145|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820556|NCT03989349|580727146|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
160820557|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160820558|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
160820559|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
160820560|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
160900747|NCT02004522|581030196|FG001|Overall Study|Withdrawal by Subject|7|||
160900748|NCT02004522|581030195|FG000|Overall Study|Death|12|||
160900749|NCT02004522|581030196|FG001|Overall Study|Death|3|||
160900750|NCT02004522|581030195|FG000|Overall Study|Physician Decision|3|||
160900751|NCT02004522|581030196|FG001|Overall Study|Physician Decision|4|||
160900752|NCT02004522|581030195|FG000|Overall Study|Protocol Violation|1|||
160900753|NCT02004522|581030196|FG001|Overall Study|Protocol Violation|0|||
160900754|NCT02004522|581030195|FG000|Overall Study|Other is reason listed by PI|4|||
160900755|NCT02004522|581030196|FG001|Overall Study|Other is reason listed by PI|1|||
160900756|NCT02004522|581030195|FG000|Overall Study|Never Dosed|2|||
160900757|NCT02004522|581030196|FG001|Overall Study|Never Dosed|4|||
160900758|NCT02004522|581030195|FG000|Overall Study|Disease Progression|35|||
160900759|NCT02004522|581030196|FG001|Overall Study|Disease Progression|31|||
160900760|NCT02004522|581030195|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
160900761|NCT02004522|581030196|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
160900762|NCT01787331|581030197|FG000|Overall Study|Physician Decision|1|||
160900763|NCT01787331|581030197|FG000|Overall Study|Withdrawal by Subject|1|||
160900764|NCT00302107|581030201|FG000|Overall Study|Lost to Follow-up|6|||
160900765|NCT00302107|581030202|FG001|Overall Study|Lost to Follow-up|5|||
160900766|NCT00302107|581030201|FG000|Overall Study|Protocol Violation|1|||
160900767|NCT00302107|581030202|FG001|Overall Study|Protocol Violation|0|||
160900768|NCT00302107|581030201|FG000|Overall Study|Relocation|0|||
160900769|NCT00302107|581030202|FG001|Overall Study|Relocation|1|||
160900770|NCT00302107|581030201|FG000|Overall Study|Withdrawal by Subject|0|||
160900771|NCT00302107|581030202|FG001|Overall Study|Withdrawal by Subject|3|||
160900772|NCT00302107|581030201|FG000|Overall Study|Adverse Event|1|||
160900773|NCT00302107|581030202|FG001|Overall Study|Adverse Event|0|||
160900774|NCT01790932|581030203|FG000|Overall Study|Disease Progression|41|||
160900775|NCT01790932|581030203|FG000|Overall Study|Adverse Event|7|||
160900776|NCT01790932|581030203|FG000|Overall Study|Physician Decision|1|||
160900777|NCT01790932|581030203|FG000|Overall Study|Withdrawal by Subject|1|||
160900778|NCT01441180|581030209|FG000|Overall Study|Lost to Follow-up|1|||
160900779|NCT01441180|581030210|FG001|Overall Study|Lost to Follow-up|1|||
160900780|NCT01441180|581030211|FG002|Overall Study|Lost to Follow-up|1|||
160900781|NCT01441180|581030209|FG000|Overall Study|Discontinued|0|||
160900782|NCT01441180|581030210|FG001|Overall Study|Discontinued|0|||
160900783|NCT01441180|581030211|FG002|Overall Study|Discontinued|2|||
160900784|NCT06238362|581030212|FG000|Overall Study|Insufficient total sleep time|1|||
160900785|NCT06238362|581030213|FG001|Overall Study|Insufficient total sleep time|0|||
160900786|NCT06238362|581030212|FG000|Overall Study|Inadequate signal quality|1|||
160900787|NCT06238362|581030213|FG001|Overall Study|Inadequate signal quality|0|||
160900788|NCT01798004|581031822|FG000|Overall Study|Death|2|||
160900789|NCT01798004|581031822|FG000|Overall Study|Lack of Efficacy|8|||
160900790|NCT01798004|581031822|FG000|Overall Study|Physician Decision|25|||
160900791|NCT01798004|581031822|FG000|Overall Study|Withdrawal by Subject|4|||
160900792|NCT01798004|581031822|FG000|Overall Study|Ineligible|4|||
160900793|NCT01798004|581031822|FG000|Overall Study|Patient/parent refusal|7|||
160900794|NCT01798004|581031822|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
160900795|NCT01798004|581031822|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
160900796|NCT03320057|581031823|FG000|Overall Study|Lost to Follow-up|4|||
160900797|NCT03320057|581031824|FG001|Overall Study|Lost to Follow-up|17|||
160900798|NCT03320057|581031823|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
160987871|NCT02223793|581343215|FG000|Overall Study|Withdrawal by Subject|3|||
161240124|NCT00796653|582260508|FG001|Overall Study|Lost to Follow-up|1|||
161240125|NCT00796653|582260509|FG002|Overall Study|Lost to Follow-up|2|||
161240126|NCT00796653|582260510|FG003|Overall Study|Lost to Follow-up|3|||
161240127|NCT00796653|582260507|FG000|Overall Study|Withdrawal by Subject|16|||
161240128|NCT00796653|582260508|FG001|Overall Study|Withdrawal by Subject|8|||
160820561|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
160820562|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
160820563|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160820564|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
160820565|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
160820566|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
160820567|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
160820568|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
160820569|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160820570|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
160820571|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
160820572|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
160820573|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
160820574|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
160820575|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820576|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820577|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
160820578|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820579|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
160820580|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
160820581|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160820582|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160820583|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
160820584|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161240129|NCT00796653|582260509|FG002|Overall Study|Withdrawal by Subject|8|||
160820585|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
160820586|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
160820587|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
160820588|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
160820589|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
160820590|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
160820591|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
160820592|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
160820593|NCT03989349|580727141|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
160820594|NCT03989349|580727142|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
160820595|NCT03989349|580727143|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
160820596|NCT03989349|580727144|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
160820597|NCT03989349|580727145|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
160820598|NCT03989349|580727146|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
160820599|NCT02248649|580727147|FG000|Overall Study|Death|7|||
160820600|NCT02248649|580727148|FG001|Overall Study|Death|11|||
160820601|NCT02248649|580727147|FG000|Overall Study|Lost to Follow-up|14|||
160820602|NCT02248649|580727148|FG001|Overall Study|Lost to Follow-up|10|||
160820603|NCT03219034|580727151|FG000|Overall Study|Lost to Follow-up|9|||
160820604|NCT03219034|580727152|FG001|Overall Study|Lost to Follow-up|13|||
160820605|NCT03219034|580727151|FG000|Overall Study|Additional dental work needed|1|||
160820606|NCT03219034|580727152|FG001|Overall Study|Additional dental work needed|0|||
160820607|NCT03219034|580727151|FG000|Overall Study|UPPP Surgery|1|||
160820608|NCT03219034|580727152|FG001|Overall Study|UPPP Surgery|0|||
160820609|NCT03219034|580727151|FG000|Overall Study|Dental sensitivity|0|||
160820610|NCT03219034|580727152|FG001|Overall Study|Dental sensitivity|1|||
160820611|NCT03219034|580727151|FG000|Overall Study|Death in family|0|||
160820612|NCT03219034|580727152|FG001|Overall Study|Death in family|1|||
160820613|NCT01802580|580727153|FG000|Overall Study|Physician Decision|1|||
160820614|NCT01802580|580727154|FG001|Overall Study|Physician Decision|0|||
160820615|NCT01802580|580727153|FG000|Overall Study|Protocol Violation|2|||
160820616|NCT01802580|580727154|FG001|Overall Study|Protocol Violation|0|||
160820617|NCT01802580|580727153|FG000|Overall Study|Withdrawal by Subject|5|||
160820618|NCT01802580|580727154|FG001|Overall Study|Withdrawal by Subject|6|||
160820619|NCT01802580|580727153|FG000|Overall Study|Other|1|||
160820620|NCT01802580|580727154|FG001|Overall Study|Other|3|||
161240130|NCT00796653|582260510|FG003|Overall Study|Withdrawal by Subject|13|||
160987872|NCT02223793|581343216|FG001|Overall Study|Withdrawal by Subject|2|||
160987873|NCT02223793|581343217|FG002|Overall Study|Withdrawal by Subject|3|||
161240131|NCT00796653|582260507|FG000|Overall Study|Lack of Efficacy|8|||
160820621|NCT01802580|580727153|FG000|Overall Study|Lack of Efficacy|0|||
160820622|NCT01802580|580727154|FG001|Overall Study|Lack of Efficacy|2|||
160987874|NCT02223793|581343215|FG000|Overall Study|Moved/studycenter unable to participate|4|||
160987875|NCT02223793|581343216|FG001|Overall Study|Moved/studycenter unable to participate|6|||
160987876|NCT02223793|581343217|FG002|Overall Study|Moved/studycenter unable to participate|8|||
160820623|NCT03255967|580727155|FG000|Overall Study|Adverse Event|26|||
160820624|NCT03255967|580727156|FG001|Overall Study|Adverse Event|30|||
160820625|NCT03255967|580727155|FG000|Overall Study|Withdrawal by Subject|6|||
160820626|NCT03255967|580727156|FG001|Overall Study|Withdrawal by Subject|6|||
160820627|NCT03255967|580727155|FG000|Overall Study|Schedule conflict|6|||
160820628|NCT03255967|580727156|FG001|Overall Study|Schedule conflict|4|||
160820629|NCT03255967|580727155|FG000|Overall Study|POA did not sign consent form|2|||
160820630|NCT03255967|580727156|FG001|Overall Study|POA did not sign consent form|0|||
160820631|NCT01327053|580727165|FG000|Overall Study|Adverse Event|23|||
160987877|NCT00278564|581343219|FG000|Overall Study|Lack of Efficacy|4|||
160987878|NCT02321540|581343220|FG000|Overall Study|Death|0|||
160987879|NCT02321540|581343221|FG001|Overall Study|Death|1|||
160987880|NCT02321540|581343220|FG000|Overall Study|Progression|3|||
160987881|NCT02321540|581343221|FG001|Overall Study|Progression|9|||
160987882|NCT00003377|581343222|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
160987883|NCT00003377|581343223|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
160987884|NCT00003377|581343224|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
160987885|NCT00003377|581343225|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
160987886|NCT00003377|581343226|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
160987887|NCT00003377|581343222|FG000|Period II|Ureteral stent complications|0|||
160987888|NCT00003377|581343223|FG001|Period II|Ureteral stent complications|0|||
160987889|NCT00003377|581343224|FG002|Period II|Ureteral stent complications|0|||
160987890|NCT00003377|581343225|FG003|Period II|Ureteral stent complications|0|||
160987891|NCT00003377|581343226|FG004|Period II|Ureteral stent complications|1|||
160987892|NCT00480441|581343230|FG000|Screening|Not Eligible|37|||
160987893|NCT00480441|581343231|FG001|Screening|Not Eligible|0|||
161240132|NCT00796653|582260508|FG001|Overall Study|Lack of Efficacy|1|||
161240133|NCT00796653|582260509|FG002|Overall Study|Lack of Efficacy|3|||
161240134|NCT00796653|582260510|FG003|Overall Study|Lack of Efficacy|2|||
161240135|NCT00796653|582260507|FG000|Overall Study|Non compliance with protocol|2|||
161240136|NCT00796653|582260508|FG001|Overall Study|Non compliance with protocol|2|||
161240137|NCT00796653|582260509|FG002|Overall Study|Non compliance with protocol|0|||
160987894|NCT00480441|581343232|FG002|Screening|Not Eligible|0|||
160987895|NCT00480441|581343230|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
160987896|NCT00480441|581343231|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
160987897|NCT00480441|581343232|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
160987898|NCT00480441|581343230|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
160987899|NCT00480441|581343231|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
160987900|NCT00480441|581343232|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
160987901|NCT00480441|581343230|FG000|Baseline Functional MRI|physical contraindication|4|||
160987902|NCT00480441|581343231|FG001|Baseline Functional MRI|physical contraindication|0|||
160987903|NCT00480441|581343232|FG002|Baseline Functional MRI|physical contraindication|0|||
160987904|NCT00480441|581343230|FG000|Randomization|Lost to Follow-up|0|||
160987905|NCT00480441|581343231|FG001|Randomization|Lost to Follow-up|7|||
160987906|NCT00480441|581343232|FG002|Randomization|Lost to Follow-up|2|||
160987907|NCT03532178|581343233|FG000|First Period|Withdrawal by Subject|1|||
160987908|NCT03532178|581343234|FG001|First Period|Withdrawal by Subject|3|||
160987909|NCT03532178|581343233|FG000|First Period|technical issues in data collection Technical issues|0|||
160987910|NCT03532178|581343234|FG001|First Period|technical issues in data collection Technical issues|1|||
160987911|NCT03532178|581343233|FG000|Second Period|Withdrawal by Subject|1|||
160987912|NCT03532178|581343234|FG001|Second Period|Withdrawal by Subject|1|||
160987913|NCT03532178|581343233|FG000|Second Period|Technical issues|0|||
160987914|NCT03532178|581343234|FG001|Second Period|Technical issues|1|||
160987915|NCT01113463|581343238|FG000|Overall Study|Physician Decision|5|||
160987916|NCT00372528|581343239|FG000|Overall Study|Lack of Efficacy|1|||
160987917|NCT00372528|581343239|FG000|Overall Study|Adverse Event|1|||
160987918|NCT00372528|581343239|FG000|Overall Study|Study Terminated by Sponsor|18|||
160987919|NCT00372528|581343239|FG000|Overall Study|Other|1|||
160987920|NCT01417000|581343240|FG000|Overall Study|Death|59|||
160820632|NCT01327053|580727166|FG001|Overall Study|Adverse Event|57|||
160820633|NCT01327053|580727165|FG000|Overall Study|Patient/guardian decision|11|||
160987921|NCT01417000|581343241|FG001|Overall Study|Death|28|||
160987922|NCT01417000|581343240|FG000|Overall Study|Lost to Follow-up|1|||
160987923|NCT01417000|581343241|FG001|Overall Study|Lost to Follow-up|0|||
160987924|NCT01417000|581343240|FG000|Overall Study|Study Terminated by Sponsor|1|||
160987925|NCT01417000|581343241|FG001|Overall Study|Study Terminated by Sponsor|1|||
160987926|NCT00965484|581343242|FG000|Overall Study|Protocol Violation|1|||
160987927|NCT00965484|581343242|FG000|Overall Study|Withdrawal by Subject|1|||
160987928|NCT00162942|581343243|FG000|Overall Study|Adverse Event|10|||
160987929|NCT00162942|581343244|FG001|Overall Study|Adverse Event|6|||
160987930|NCT00162942|581343243|FG000|Overall Study|Death|1|||
160987931|NCT00162942|581343244|FG001|Overall Study|Death|0|||
160987932|NCT00162942|581343243|FG000|Overall Study|Withdrawal by Subject|3|||
160987933|NCT00162942|581343244|FG001|Overall Study|Withdrawal by Subject|6|||
160987934|NCT00162942|581343243|FG000|Overall Study|Physician Decision|1|||
160900799|NCT03320057|581031824|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
160900800|NCT06956170|581031825|FG000|Overall Study|Death|2|||
160900801|NCT06956170|581031826|FG001|Overall Study|Death|1|||
160900802|NCT06956170|581031825|FG000|Overall Study|Withdrawal by Subject|1|||
160900803|NCT06956170|581031826|FG001|Overall Study|Withdrawal by Subject|0|||
160900804|NCT06956170|581031825|FG000|Overall Study|Ongoing|7|||
160900805|NCT06956170|581031826|FG001|Overall Study|Ongoing|10|||
160900806|NCT02323113|581031827|FG000|Overall Study|Adverse Event|3|||
160900807|NCT02323113|581031828|FG001|Overall Study|Adverse Event|3|||
160900808|NCT02323113|581031829|FG002|Overall Study|Adverse Event|2|||
160900809|NCT02323113|581031830|FG003|Overall Study|Adverse Event|5|||
160900810|NCT02323113|581031831|FG004|Overall Study|Adverse Event|8|||
160900811|NCT02323113|581031832|FG005|Overall Study|Adverse Event|3|||
160900812|NCT02323113|581031833|FG006|Overall Study|Adverse Event|6|||
160900813|NCT02323113|581031834|FG007|Overall Study|Adverse Event|0|||
160900814|NCT02323113|581031827|FG000|Overall Study|Progressive Disease|0|||
160900815|NCT02323113|581031828|FG001|Overall Study|Progressive Disease|1|||
160900816|NCT02323113|581031829|FG002|Overall Study|Progressive Disease|1|||
160900817|NCT02323113|581031830|FG003|Overall Study|Progressive Disease|0|||
160900818|NCT02323113|581031831|FG004|Overall Study|Progressive Disease|0|||
160900819|NCT02323113|581031832|FG005|Overall Study|Progressive Disease|3|||
160900820|NCT02323113|581031833|FG006|Overall Study|Progressive Disease|0|||
160900821|NCT02323113|581031834|FG007|Overall Study|Progressive Disease|0|||
160900822|NCT02323113|581031827|FG000|Overall Study|Symptomatic Deterioration|0|||
160900823|NCT02323113|581031828|FG001|Overall Study|Symptomatic Deterioration|0|||
160900824|NCT02323113|581031829|FG002|Overall Study|Symptomatic Deterioration|1|||
160900825|NCT02323113|581031830|FG003|Overall Study|Symptomatic Deterioration|0|||
160900826|NCT02323113|581031831|FG004|Overall Study|Symptomatic Deterioration|1|||
160900827|NCT02323113|581031832|FG005|Overall Study|Symptomatic Deterioration|0|||
160900828|NCT02323113|581031833|FG006|Overall Study|Symptomatic Deterioration|0|||
160900829|NCT02323113|581031834|FG007|Overall Study|Symptomatic Deterioration|0|||
160900830|NCT02323113|581031827|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
160900831|NCT02323113|581031828|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
160900832|NCT02323113|581031829|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900833|NCT02323113|581031830|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900834|NCT02323113|581031831|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900835|NCT02323113|581031832|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
160900836|NCT02323113|581031833|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900837|NCT02323113|581031834|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
160900838|NCT02323113|581031827|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900839|NCT02323113|581031828|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
160900840|NCT02323113|581031829|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900841|NCT02323113|581031830|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160987935|NCT00162942|581343244|FG001|Overall Study|Physician Decision|0|||
160987936|NCT00162942|581343243|FG000|Overall Study|Enter Open-Label Study|76|||
160987937|NCT00162942|581343244|FG001|Overall Study|Enter Open-Label Study|35|||
160987938|NCT00162942|581343243|FG000|Overall Study|Alternate Therapy|6|||
160987939|NCT00162942|581343244|FG001|Overall Study|Alternate Therapy|2|||
160900842|NCT02323113|581031831|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900843|NCT02323113|581031832|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900844|NCT02323113|581031833|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900845|NCT02323113|581031834|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
160900846|NCT02280304|581031839|FG000|Overall Study|Lost to Follow-up|7|||
160900847|NCT02280304|581031840|FG001|Overall Study|Lost to Follow-up|8|||
160900848|NCT04805541|581031841|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
160900849|NCT00713323|581031852|FG000|Overall Study|Adverse Event|75|||
160900850|NCT00713323|581031852|FG000|Overall Study|Withdrawal by Subject|15|||
160900851|NCT00713323|581031852|FG000|Overall Study|Lost to Follow-up|11|||
160900852|NCT00713323|581031852|FG000|Overall Study|Lack of Efficacy|36|||
160900853|NCT00713323|581031852|FG000|Overall Study|Low creatine clearance at screening|1|||
160900854|NCT00713323|581031852|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
160900855|NCT00713323|581031852|FG000|Overall Study|Surgery cured allodynic pain|1|||
160900856|NCT00713323|581031852|FG000|Overall Study|Pain free|1|||
160900857|NCT00713323|581031852|FG000|Overall Study|Non-compliance|1|||
160900858|NCT00713323|581031852|FG000|Overall Study|Pain resolved|1|||
160900859|NCT00713323|581031852|FG000|Overall Study|Subject travelling to USA|1|||
160900860|NCT00713323|581031852|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
160900861|NCT00713323|581031852|FG000|Overall Study|Treatment that may interact with Sativex|1|||
160900862|NCT05154578|581031853|FG000|Overall Study|Withdrawal by Subject|2|||
160900863|NCT05154578|581031854|FG001|Overall Study|Withdrawal by Subject|3|||
160987940|NCT00162942|581343243|FG000|Overall Study|Lack of Efficacy|1|||
160900864|NCT05154578|581031855|FG002|Overall Study|Withdrawal by Subject|2|||
160900865|NCT05154578|581031856|FG003|Overall Study|Withdrawal by Subject|4|||
160900866|NCT05154578|581031857|FG004|Overall Study|Withdrawal by Subject|0|||
160900867|NCT05154578|581031853|FG000|Overall Study|Lost to Follow-up|0|||
160900868|NCT05154578|581031854|FG001|Overall Study|Lost to Follow-up|1|||
160900869|NCT05154578|581031855|FG002|Overall Study|Lost to Follow-up|0|||
160900870|NCT05154578|581031856|FG003|Overall Study|Lost to Follow-up|3|||
160900871|NCT05154578|581031857|FG004|Overall Study|Lost to Follow-up|0|||
160900872|NCT05154578|581031853|FG000|Overall Study|Adverse Event|0|||
160900873|NCT05154578|581031854|FG001|Overall Study|Adverse Event|0|||
160900874|NCT05154578|581031855|FG002|Overall Study|Adverse Event|0|||
160900875|NCT05154578|581031856|FG003|Overall Study|Adverse Event|1|||
160900876|NCT05154578|581031857|FG004|Overall Study|Adverse Event|0|||
160900877|NCT05154578|581031853|FG000|Overall Study|Relocated to another province|0|||
160900878|NCT05154578|581031854|FG001|Overall Study|Relocated to another province|0|||
160900879|NCT05154578|581031855|FG002|Overall Study|Relocated to another province|1|||
160900880|NCT05154578|581031856|FG003|Overall Study|Relocated to another province|0|||
160900881|NCT05154578|581031857|FG004|Overall Study|Relocated to another province|1|||
160900882|NCT05154578|581031853|FG000|Overall Study|Baby loss|0|||
160900883|NCT05154578|581031854|FG001|Overall Study|Baby loss|1|||
160900884|NCT05154578|581031855|FG002|Overall Study|Baby loss|0|||
160900885|NCT05154578|581031856|FG003|Overall Study|Baby loss|0|||
160900886|NCT05154578|581031857|FG004|Overall Study|Baby loss|0|||
160900887|NCT02764333|581031858|FG000|Overall Study|Ineligible|1|||
160900888|NCT01200524|581031859|FG000|Overall Study|Withdrawal by Subject|1|||
160900889|NCT01200524|581031860|FG001|Overall Study|Withdrawal by Subject|1|||
160900890|NCT01200524|581031861|FG002|Overall Study|Withdrawal by Subject|3|||
160900891|NCT01200524|581031859|FG000|Overall Study|Adverse Event|1|||
160900892|NCT01200524|581031860|FG001|Overall Study|Adverse Event|0|||
160900893|NCT01200524|581031861|FG002|Overall Study|Adverse Event|0|||
160900894|NCT01200524|581031859|FG000|Overall Study|Non availability of study nurse|0|||
160900895|NCT01200524|581031860|FG001|Overall Study|Non availability of study nurse|0|||
160900896|NCT01200524|581031861|FG002|Overall Study|Non availability of study nurse|1|||
160900897|NCT00491764|581031863|FG000|Overall Study|Adverse Event|1|||
160900898|NCT00491764|581031864|FG001|Overall Study|Adverse Event|2|||
160900899|NCT00491764|581031865|FG002|Overall Study|Adverse Event|4|||
160900900|NCT00491764|581031866|FG003|Overall Study|Adverse Event|4|||
160900901|NCT00491764|581031867|FG004|Overall Study|Adverse Event|0|||
160900902|NCT00491764|581031868|FG005|Overall Study|Adverse Event|1|||
160900903|NCT00491764|581031863|FG000|Overall Study|Lost to Follow-up|0|||
160900904|NCT00491764|581031864|FG001|Overall Study|Lost to Follow-up|1|||
160900905|NCT00491764|581031865|FG002|Overall Study|Lost to Follow-up|0|||
160900906|NCT00491764|581031866|FG003|Overall Study|Lost to Follow-up|1|||
160900907|NCT00491764|581031867|FG004|Overall Study|Lost to Follow-up|0|||
160900908|NCT00491764|581031868|FG005|Overall Study|Lost to Follow-up|3|||
160900909|NCT00491764|581031863|FG000|Overall Study|Withdrawal by Subject|2|||
160900910|NCT00491764|581031864|FG001|Overall Study|Withdrawal by Subject|3|||
160900911|NCT00491764|581031865|FG002|Overall Study|Withdrawal by Subject|1|||
160900912|NCT00491764|581031866|FG003|Overall Study|Withdrawal by Subject|2|||
160900913|NCT00491764|581031867|FG004|Overall Study|Withdrawal by Subject|2|||
160900914|NCT00491764|581031868|FG005|Overall Study|Withdrawal by Subject|4|||
160900915|NCT00491764|581031863|FG000|Overall Study|Non Compliance with the Protocol|1|||
160900916|NCT00491764|581031864|FG001|Overall Study|Non Compliance with the Protocol|0|||
160900917|NCT00491764|581031865|FG002|Overall Study|Non Compliance with the Protocol|0|||
160900918|NCT00491764|581031866|FG003|Overall Study|Non Compliance with the Protocol|0|||
160987941|NCT00162942|581343244|FG001|Overall Study|Lack of Efficacy|0|||
160987942|NCT00162942|581343243|FG000|Overall Study|Flare During Active Treatment|7|||
160987943|NCT00162942|581343244|FG001|Overall Study|Flare During Active Treatment|3|||
160987944|NCT00162942|581343243|FG000|Overall Study|2 or more consecutive treatments missed|1|||
160987945|NCT00162942|581343244|FG001|Overall Study|2 or more consecutive treatments missed|0|||
160987946|NCT01354938|581343245|FG000|Overall Study|Lost to Follow-up|1|||
160987947|NCT00410384|581343246|FG000|Overall Study|Withdrawal by Subject|28|||
160987948|NCT00410384|581343247|FG001|Overall Study|Withdrawal by Subject|17|||
160987949|NCT00410384|581343248|FG002|Overall Study|Withdrawal by Subject|20|||
160987950|NCT00410384|581343246|FG000|Overall Study|Adverse Event|23|||
160987951|NCT00410384|581343247|FG001|Overall Study|Adverse Event|18|||
160987952|NCT00410384|581343248|FG002|Overall Study|Adverse Event|23|||
161333823|NCT03327324|582610631|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
160900919|NCT00491764|581031867|FG004|Overall Study|Non Compliance with the Protocol|0|||
160900920|NCT00491764|581031868|FG005|Overall Study|Non Compliance with the Protocol|0|||
160900921|NCT00491764|581031863|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
160900922|NCT00491764|581031864|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
160900923|NCT00491764|581031865|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
160900924|NCT00491764|581031866|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
160987953|NCT00410384|581343246|FG000|Overall Study|Lack of Efficacy|20|||
160987954|NCT00410384|581343247|FG001|Overall Study|Lack of Efficacy|12|||
161132790|NCT02300129|581870749|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
161132791|NCT02300129|581870750|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161132792|NCT02300129|581870751|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161132793|NCT02300129|581870752|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
161132794|NCT01887912|581870753|FG000|Overall Study|Serious adverse event|400|||
161132795|NCT01887912|581870754|FG001|Overall Study|Serious adverse event|198|||
161132796|NCT01887912|581870753|FG000|Overall Study|Other Adverse Event|34|||
161132797|NCT01887912|581870754|FG001|Overall Study|Other Adverse Event|15|||
161132798|NCT01887912|581870753|FG000|Overall Study|Protocol Violation|67|||
161132799|NCT01887912|581870754|FG001|Overall Study|Protocol Violation|37|||
161132800|NCT01887912|581870753|FG000|Overall Study|Lost to Follow-up|163|||
161132801|NCT01887912|581870754|FG001|Overall Study|Lost to Follow-up|74|||
161132802|NCT01887912|581870753|FG000|Overall Study|Withdrawal by Subject|606|||
161132803|NCT01887912|581870754|FG001|Overall Study|Withdrawal by Subject|349|||
161132804|NCT01887912|581870753|FG000|Overall Study|Other|122|||
161132805|NCT01887912|581870754|FG001|Overall Study|Other|58|||
161132806|NCT04462536|581870755|FG000|Overall Study|Withdrawal by Subject|3|||
161132807|NCT04462536|581870756|FG001|Overall Study|Withdrawal by Subject|9|||
161132808|NCT04462536|581870755|FG000|Overall Study|Lost to Follow-up|2|||
161132809|NCT04462536|581870756|FG001|Overall Study|Lost to Follow-up|4|||
161132810|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
161132811|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
161132812|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
161132813|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
161132814|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
161132815|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
161132816|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
161132817|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
161132818|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
161132819|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
161132820|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
161132821|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
161132822|NCT02747927|581870757|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
161132823|NCT02747927|581870758|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
161132824|NCT02747927|581870757|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
161132825|NCT02747927|581870758|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
161132826|NCT02747927|581870757|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
161132827|NCT02747927|581870758|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
161132828|NCT02747927|581870757|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
161132829|NCT02747927|581870758|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
161132830|NCT02747927|581870757|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
161132831|NCT02747927|581870758|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
160820634|NCT01327053|580727166|FG001|Overall Study|Patient/guardian decision|35|||
160820635|NCT01327053|580727165|FG000|Overall Study|Physician Decision|10|||
160820636|NCT01327053|580727166|FG001|Overall Study|Physician Decision|14|||
160820637|NCT01327053|580727165|FG000|Overall Study|Death|1|||
160820638|NCT01327053|580727166|FG001|Overall Study|Death|5|||
160820639|NCT01327053|580727165|FG000|Overall Study|Lost to Follow-up|2|||
160820640|NCT01327053|580727166|FG001|Overall Study|Lost to Follow-up|4|||
160820641|NCT01327053|580727165|FG000|Overall Study|Non-compliance with study treatment|0|||
160820642|NCT01327053|580727166|FG001|Overall Study|Non-compliance with study treatment|5|||
160820643|NCT01327053|580727165|FG000|Overall Study|Study terminated by Sponsor|1|||
160900925|NCT00491764|581031867|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
160900926|NCT00491764|581031868|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
161132832|NCT02747927|581870757|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
161132833|NCT02747927|581870758|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
161132834|NCT02747927|581870757|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
161132835|NCT02747927|581870758|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
161132836|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
161132837|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
161132838|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
161132839|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
161132840|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
161132841|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
161132842|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
161132843|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
161132844|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
161333824|NCT03327324|582610632|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
160987955|NCT00410384|581343248|FG002|Overall Study|Lack of Efficacy|17|||
160987956|NCT00410384|581343246|FG000|Overall Study|Lack of Compliance|2|||
160987957|NCT00410384|581343247|FG001|Overall Study|Lack of Compliance|2|||
160987958|NCT00410384|581343248|FG002|Overall Study|Lack of Compliance|2|||
160820644|NCT01327053|580727166|FG001|Overall Study|Study terminated by Sponsor|3|||
160820645|NCT01327053|580727165|FG000|Overall Study|Progressive disease|31|||
160820646|NCT01327053|580727166|FG001|Overall Study|Progressive disease|26|||
160820647|NCT01327053|580727165|FG000|Overall Study|Protocol Violation|0|||
160820648|NCT01327053|580727166|FG001|Overall Study|Protocol Violation|1|||
160820649|NCT01327053|580727165|FG000|Overall Study|Untreated|0|||
160820650|NCT01327053|580727166|FG001|Overall Study|Untreated|1|||
160820651|NCT00778258|580727170|FG000|Overall Study|Adverse Event|1|||
160820652|NCT00778258|580727171|FG001|Overall Study|Adverse Event|0|||
160820653|NCT00778258|580727172|FG002|Overall Study|Adverse Event|0|||
160820654|NCT00778258|580727173|FG003|Overall Study|Adverse Event|0|||
160820655|NCT00778258|580727174|FG004|Overall Study|Adverse Event|0|||
160820656|NCT00778258|580727175|FG005|Overall Study|Adverse Event|1|||
160820657|NCT00778258|580727176|FG006|Overall Study|Adverse Event|0|||
160820658|NCT00778258|580727177|FG007|Overall Study|Adverse Event|0|||
160820659|NCT00778258|580727178|FG008|Overall Study|Adverse Event|0|||
160820660|NCT00778258|580727170|FG000|Overall Study|Lost to Follow-up|0|||
160820661|NCT00778258|580727171|FG001|Overall Study|Lost to Follow-up|0|||
160820662|NCT00778258|580727172|FG002|Overall Study|Lost to Follow-up|2|||
160820663|NCT00778258|580727173|FG003|Overall Study|Lost to Follow-up|0|||
160820664|NCT00778258|580727174|FG004|Overall Study|Lost to Follow-up|0|||
160820665|NCT00778258|580727175|FG005|Overall Study|Lost to Follow-up|3|||
160820666|NCT00778258|580727176|FG006|Overall Study|Lost to Follow-up|2|||
160820667|NCT00778258|580727177|FG007|Overall Study|Lost to Follow-up|2|||
160820668|NCT00778258|580727178|FG008|Overall Study|Lost to Follow-up|0|||
160820669|NCT00778258|580727170|FG000|Overall Study|Withdrawal by Subject|6|||
160820670|NCT00778258|580727171|FG001|Overall Study|Withdrawal by Subject|2|||
160820671|NCT00778258|580727172|FG002|Overall Study|Withdrawal by Subject|8|||
160820672|NCT00778258|580727173|FG003|Overall Study|Withdrawal by Subject|2|||
160820673|NCT00778258|580727174|FG004|Overall Study|Withdrawal by Subject|0|||
160820674|NCT00778258|580727175|FG005|Overall Study|Withdrawal by Subject|6|||
160820675|NCT00778258|580727176|FG006|Overall Study|Withdrawal by Subject|12|||
160820676|NCT00778258|580727177|FG007|Overall Study|Withdrawal by Subject|12|||
160820677|NCT00778258|580727178|FG008|Overall Study|Withdrawal by Subject|4|||
160820678|NCT00778258|580727170|FG000|Overall Study|New Contraindication|0|||
160820679|NCT00778258|580727171|FG001|Overall Study|New Contraindication|0|||
160820680|NCT00778258|580727172|FG002|Overall Study|New Contraindication|0|||
160820681|NCT00778258|580727173|FG003|Overall Study|New Contraindication|0|||
160820682|NCT00778258|580727174|FG004|Overall Study|New Contraindication|0|||
160820683|NCT00778258|580727175|FG005|Overall Study|New Contraindication|0|||
160820684|NCT00778258|580727176|FG006|Overall Study|New Contraindication|0|||
160820685|NCT00778258|580727177|FG007|Overall Study|New Contraindication|1|||
160820686|NCT00778258|580727178|FG008|Overall Study|New Contraindication|0|||
160820687|NCT00778258|580727170|FG000|Overall Study|Non-compliance|0|||
160820688|NCT00778258|580727171|FG001|Overall Study|Non-compliance|0|||
160820689|NCT00778258|580727172|FG002|Overall Study|Non-compliance|0|||
160820690|NCT00778258|580727173|FG003|Overall Study|Non-compliance|1|||
160820691|NCT00778258|580727174|FG004|Overall Study|Non-compliance|0|||
160820692|NCT00778258|580727175|FG005|Overall Study|Non-compliance|0|||
160820693|NCT00778258|580727176|FG006|Overall Study|Non-compliance|0|||
160820694|NCT00778258|580727177|FG007|Overall Study|Non-compliance|0|||
160820695|NCT00778258|580727178|FG008|Overall Study|Non-compliance|0|||
160820696|NCT00778258|580727170|FG000|Overall Study|Other|0|||
160820697|NCT00778258|580727171|FG001|Overall Study|Other|0|||
160820698|NCT00778258|580727172|FG002|Overall Study|Other|0|||
160820699|NCT00778258|580727173|FG003|Overall Study|Other|0|||
160820700|NCT00778258|580727174|FG004|Overall Study|Other|0|||
160820701|NCT00778258|580727175|FG005|Overall Study|Other|0|||
160987959|NCT00410384|581343246|FG000|Overall Study|Lost to Follow-up|4|||
160820702|NCT00778258|580727176|FG006|Overall Study|Other|1|||
160820703|NCT00778258|580727177|FG007|Overall Study|Other|0|||
160987960|NCT00410384|581343247|FG001|Overall Study|Lost to Follow-up|6|||
160820704|NCT00778258|580727178|FG008|Overall Study|Other|0|||
160820705|NCT04621240|580727180|FG000|Overall Study|Withdrawal by Subject|36|||
160820706|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
160820707|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
160820708|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
160820709|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
160820710|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
160820711|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
160820712|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
160820713|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
160820714|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
160987961|NCT00410384|581343248|FG002|Overall Study|Lost to Follow-up|6|||
160820715|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
160820716|NCT01263015|580729042|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
160820717|NCT01263015|580729043|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
160820718|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
160820719|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
160820720|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
160820721|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
160820722|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
160820723|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
160820724|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
160820725|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
160820726|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
160820727|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
160820728|NCT01263015|580729042|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
160820729|NCT01263015|580729043|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
160820730|NCT05599451|580729044|FG000|Overall Study|Not randomized|11|||
160820731|NCT05599451|580729045|FG001|Overall Study|Not randomized|0|||
160820732|NCT05599451|580729046|FG002|Overall Study|Not randomized|0|||
160820733|NCT05599451|580729047|FG003|Overall Study|Not randomized|0|||
160820734|NCT05599451|580729048|FG004|Overall Study|Not randomized|0|||
160820735|NCT05599451|580729044|FG000|Overall Study|Physician Decision|0|||
160820736|NCT05599451|580729045|FG001|Overall Study|Physician Decision|0|||
160820737|NCT05599451|580729046|FG002|Overall Study|Physician Decision|0|||
160820738|NCT05599451|580729047|FG003|Overall Study|Physician Decision|1|||
160820739|NCT05599451|580729048|FG004|Overall Study|Physician Decision|0|||
160820740|NCT02723006|580729049|FG000|Overall Study|Withdrawal by Subject|0|||
160820741|NCT02723006|580729050|FG001|Overall Study|Withdrawal by Subject|1|||
160900927|NCT00491764|581031863|FG000|Overall Study|Administrative|1|||
160900928|NCT00491764|581031864|FG001|Overall Study|Administrative|0|||
160900929|NCT00491764|581031865|FG002|Overall Study|Administrative|2|||
160900930|NCT00491764|581031866|FG003|Overall Study|Administrative|1|||
160900931|NCT00491764|581031867|FG004|Overall Study|Administrative|0|||
160900932|NCT00491764|581031868|FG005|Overall Study|Administrative|0|||
160900933|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Adverse Event|3|||
160900934|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Adverse Event|0|||
160900935|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
160900936|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
160900937|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
160900938|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
160900939|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Physician Decision|0|||
160900940|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Physician Decision|2|||
160900941|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
160900942|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
160900943|NCT02110238|581031869|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
160900944|NCT02110238|581031870|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
160900945|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
160900946|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
160900947|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
160900948|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
160900949|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
160900950|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
160900951|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
160900952|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
160900953|NCT02110238|581031869|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
160900954|NCT02110238|581031870|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
160900955|NCT03228433|581031875|FG000|Overall Study|Lost to Follow-up|1|||
160900956|NCT03228433|581031876|FG001|Overall Study|Lost to Follow-up|0|||
160900957|NCT03228433|581031877|FG002|Overall Study|Lost to Follow-up|0|||
160900958|NCT03228433|581031878|FG003|Overall Study|Lost to Follow-up|0|||
160900959|NCT03228433|581031879|FG004|Overall Study|Lost to Follow-up|0|||
160900960|NCT03228433|581031880|FG005|Overall Study|Lost to Follow-up|0|||
160900961|NCT03228433|581031875|FG000|Overall Study|Positive alcohol test|0|||
160900962|NCT03228433|581031876|FG001|Overall Study|Positive alcohol test|0|||
160900963|NCT03228433|581031877|FG002|Overall Study|Positive alcohol test|0|||
160900964|NCT03228433|581031878|FG003|Overall Study|Positive alcohol test|1|||
160900965|NCT03228433|581031879|FG004|Overall Study|Positive alcohol test|0|||
161132845|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
160820742|NCT02723006|580729051|FG002|Overall Study|Withdrawal by Subject|1|||
160820743|NCT02723006|580729049|FG000|Overall Study|Study Terminated by Sponsor|1|||
160900966|NCT03228433|581031880|FG005|Overall Study|Positive alcohol test|0|||
160900967|NCT03626168|581031883|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160900968|NCT03626168|581031884|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160820744|NCT02723006|580729050|FG001|Overall Study|Study Terminated by Sponsor|6|||
160820745|NCT02723006|580729051|FG002|Overall Study|Study Terminated by Sponsor|6|||
160820746|NCT00303446|580729052|FG000|Overall Study|Withdrawal by Subject|2|||
160820747|NCT00303446|580729053|FG001|Overall Study|Withdrawal by Subject|2|||
160820748|NCT00303446|580729052|FG000|Overall Study|Death|0|||
160820749|NCT00303446|580729053|FG001|Overall Study|Death|1|||
160820750|NCT00303446|580729052|FG000|Overall Study|Physician Decision|0|||
160820751|NCT00303446|580729053|FG001|Overall Study|Physician Decision|1|||
160820752|NCT03285958|580729054|FG000|Overall Study|Lost to Follow-up|1|||
160820753|NCT03285958|580729055|FG001|Overall Study|Lost to Follow-up|1|||
160820754|NCT03285958|580729054|FG000|Overall Study|Withdrawal by Subject|1|||
160820755|NCT03285958|580729055|FG001|Overall Study|Withdrawal by Subject|0|||
160820756|NCT03285958|580729054|FG000|Overall Study|Not able to attend required orientation|3|||
160820757|NCT03285958|580729055|FG001|Overall Study|Not able to attend required orientation|0|||
160820758|NCT03116828|580729057|FG000|Overall Study|Adverse Event|1|||
160820759|NCT03116828|580729058|FG001|Overall Study|Adverse Event|10|||
160820760|NCT03116828|580729057|FG000|Overall Study|Withdrawal by Subject|4|||
160820761|NCT03116828|580729058|FG001|Overall Study|Withdrawal by Subject|8|||
160820762|NCT03116828|580729057|FG000|Overall Study|OTHER|3|||
160820763|NCT03116828|580729058|FG001|Overall Study|OTHER|3|||
160820764|NCT05243745|580729061|FG000|Overall Study|Withdrawal by Subject|0|||
160820765|NCT05243745|580729062|FG001|Overall Study|Withdrawal by Subject|0|||
160820766|NCT05243745|580729063|FG002|Overall Study|Withdrawal by Subject|0|||
160820767|NCT05243745|580729064|FG003|Overall Study|Withdrawal by Subject|1|||
160820768|NCT05243745|580729061|FG000|Overall Study|Unable to Attend Visit 6|0|||
160820769|NCT05243745|580729062|FG001|Overall Study|Unable to Attend Visit 6|0|||
160820770|NCT05243745|580729063|FG002|Overall Study|Unable to Attend Visit 6|1|||
160820771|NCT05243745|580729064|FG003|Overall Study|Unable to Attend Visit 6|0|||
160820772|NCT02998203|580729065|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
160820773|NCT02998203|580729066|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
160820774|NCT02998203|580729065|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
160820775|NCT02998203|580729066|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
160820776|NCT04187144|580729079|FG000|Overall Study|Lost to Follow-up|12|||
160820777|NCT04187144|580729080|FG001|Overall Study|Lost to Follow-up|11|||
160820778|NCT04187144|580729079|FG000|Overall Study|Withdrawal by Subject|20|||
160820779|NCT04187144|580729080|FG001|Overall Study|Withdrawal by Subject|18|||
160820780|NCT04187144|580729079|FG000|Overall Study|Adverse Event|19|||
160820781|NCT04187144|580729080|FG001|Overall Study|Adverse Event|4|||
160987962|NCT00410384|581343246|FG000|Overall Study|Protocol Violation|6|||
160987963|NCT00410384|581343247|FG001|Overall Study|Protocol Violation|6|||
160987964|NCT00410384|581343248|FG002|Overall Study|Protocol Violation|6|||
160987965|NCT00410384|581343246|FG000|Overall Study|Physician Decision|3|||
160987966|NCT00410384|581343247|FG001|Overall Study|Physician Decision|3|||
160987967|NCT00410384|581343248|FG002|Overall Study|Physician Decision|4|||
160987968|NCT00410384|581343246|FG000|Overall Study|Other|3|||
160987969|NCT00410384|581343247|FG001|Overall Study|Other|8|||
160987970|NCT00410384|581343248|FG002|Overall Study|Other|4|||
160987971|NCT01167023|581343249|FG000|Overall Study|Lost to Follow-up|0|||
160987972|NCT01167023|581343250|FG001|Overall Study|Lost to Follow-up|1|||
160987973|NCT01167023|581343251|FG002|Overall Study|Lost to Follow-up|1|||
160987974|NCT01167023|581343249|FG000|Overall Study|Screen Failure|0|||
160987975|NCT01167023|581343250|FG001|Overall Study|Screen Failure|1|||
160987976|NCT01167023|581343251|FG002|Overall Study|Screen Failure|0|||
160987977|NCT01167023|581343249|FG000|Overall Study|Sponsor Decision|0|||
160987978|NCT01167023|581343250|FG001|Overall Study|Sponsor Decision|1|||
160987979|NCT01167023|581343251|FG002|Overall Study|Sponsor Decision|0|||
160987980|NCT01167023|581343249|FG000|Overall Study|Withdrawal by Subject|0|||
160987981|NCT01167023|581343250|FG001|Overall Study|Withdrawal by Subject|0|||
160987982|NCT01167023|581343251|FG002|Overall Study|Withdrawal by Subject|1|||
160987983|NCT01253200|581343252|FG000|Overall Study|Death|1|||
160987984|NCT01253200|581343253|FG001|Overall Study|Death|0|||
160987985|NCT01253200|581343254|FG002|Overall Study|Death|0|||
160987986|NCT01253200|581343255|FG003|Overall Study|Death|0|||
160987987|NCT01253200|581343256|FG004|Overall Study|Death|0|||
160820782|NCT04187144|580729079|FG000|Overall Study|Physician Decision|5|||
160820783|NCT04187144|580729080|FG001|Overall Study|Physician Decision|3|||
160820784|NCT04187144|580729079|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
160820785|NCT04187144|580729080|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
160820786|NCT04187144|580729079|FG000|Overall Study|Protocol Deviation|1|||
160820787|NCT04187144|580729080|FG001|Overall Study|Protocol Deviation|4|||
160987988|NCT01253200|581343252|FG000|Overall Study|Lost to Follow-up|1|||
160987989|NCT01253200|581343253|FG001|Overall Study|Lost to Follow-up|1|||
160987990|NCT01253200|581343254|FG002|Overall Study|Lost to Follow-up|0|||
160987991|NCT01253200|581343255|FG003|Overall Study|Lost to Follow-up|0|||
160987992|NCT01253200|581343256|FG004|Overall Study|Lost to Follow-up|0|||
160987993|NCT01253200|581343252|FG000|Overall Study|Withdrawal by Subject|2|||
160987994|NCT01253200|581343253|FG001|Overall Study|Withdrawal by Subject|0|||
160987995|NCT01253200|581343254|FG002|Overall Study|Withdrawal by Subject|0|||
160900969|NCT03626168|581031883|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
160900970|NCT03626168|581031884|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
160900971|NCT03626168|581031883|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160900972|NCT03626168|581031884|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
160900973|NCT01419626|581031885|FG000|Overall Study|Protocol Violation|3|||
160900974|NCT01419626|581031886|FG001|Overall Study|Protocol Violation|2|||
160900975|NCT01419626|581031887|FG002|Overall Study|Protocol Violation|2|||
160900976|NCT01419626|581031885|FG000|Overall Study|Withdrawal by Subject|1|||
160900977|NCT01419626|581031886|FG001|Overall Study|Withdrawal by Subject|0|||
160900978|NCT01419626|581031887|FG002|Overall Study|Withdrawal by Subject|0|||
160900979|NCT01419626|581031885|FG000|Overall Study|Lost to Follow-up|0|||
160900980|NCT01419626|581031886|FG001|Overall Study|Lost to Follow-up|1|||
160900981|NCT01419626|581031887|FG002|Overall Study|Lost to Follow-up|1|||
160900982|NCT01146912|581031888|FG000|Overall Study|Already received influenza vaccination|817|||
160900983|NCT01146912|581031889|FG001|Overall Study|Already received influenza vaccination|822|||
160900984|NCT01146912|581031890|FG002|Overall Study|Already received influenza vaccination|13|||
160900985|NCT01146912|581031891|FG003|Overall Study|Already received influenza vaccination|15|||
160900986|NCT01146912|581031892|FG004|Overall Study|Already received influenza vaccination|41|||
160900987|NCT01146912|581031893|FG005|Overall Study|Already received influenza vaccination|61|||
160900988|NCT01146912|581031894|FG006|Overall Study|Already received influenza vaccination|56|||
160900989|NCT01146912|581031895|FG007|Overall Study|Already received influenza vaccination|0|||
160900990|NCT01146912|581031888|FG000|Overall Study|< 14 weeks gestational age|0|||
160900991|NCT01146912|581031889|FG001|Overall Study|< 14 weeks gestational age|0|||
160900992|NCT01146912|581031890|FG002|Overall Study|< 14 weeks gestational age|3|||
160987996|NCT01253200|581343255|FG003|Overall Study|Withdrawal by Subject|0|||
160987997|NCT01253200|581343256|FG004|Overall Study|Withdrawal by Subject|0|||
160987998|NCT01253200|581343252|FG000|Overall Study|Protocol Violation|1|||
160987999|NCT01253200|581343253|FG001|Overall Study|Protocol Violation|4|||
160988000|NCT01253200|581343254|FG002|Overall Study|Protocol Violation|0|||
160988001|NCT01253200|581343255|FG003|Overall Study|Protocol Violation|0|||
160988002|NCT01253200|581343256|FG004|Overall Study|Protocol Violation|5|||
160988003|NCT01253200|581343252|FG000|Overall Study|intents|10|||
160988004|NCT01253200|581343253|FG001|Overall Study|intents|10|||
160988005|NCT01253200|581343254|FG002|Overall Study|intents|1|||
160988006|NCT01253200|581343255|FG003|Overall Study|intents|3|||
160988007|NCT01253200|581343256|FG004|Overall Study|intents|0|||
160988008|NCT01253200|581343252|FG000|Overall Study|Attempts|6|||
160988009|NCT01253200|581343253|FG001|Overall Study|Attempts|4|||
160988010|NCT01253200|581343254|FG002|Overall Study|Attempts|1|||
160988011|NCT01253200|581343255|FG003|Overall Study|Attempts|2|||
160988012|NCT01253200|581343256|FG004|Overall Study|Attempts|0|||
160988013|NCT02049437|581343257|FG000|Period 1|Adverse Event|1|||
160988014|NCT02049437|581343258|FG001|Period 1|Adverse Event|1|||
160988015|NCT02049437|581343257|FG000|Period 1|Adverse Event|1|||
160988016|NCT02049437|581343258|FG001|Period 1|Adverse Event|0|||
160988017|NCT01192295|581343259|FG000|Overall Study|Adverse Event|3|||
160988018|NCT01192295|581343260|FG001|Overall Study|Adverse Event|7|||
160988019|NCT01192295|581343259|FG000|Overall Study|Withdrawal by Subject|3|||
160988020|NCT01192295|581343260|FG001|Overall Study|Withdrawal by Subject|4|||
160988021|NCT01192295|581343259|FG000|Overall Study|Lost to Follow-up|0|||
160988022|NCT01192295|581343260|FG001|Overall Study|Lost to Follow-up|1|||
160988023|NCT01192295|581343259|FG000|Overall Study|Lack of Efficacy|0|||
160988024|NCT01192295|581343260|FG001|Overall Study|Lack of Efficacy|5|||
160988025|NCT01192295|581343259|FG000|Overall Study|Administrative|4|||
160988026|NCT01192295|581343260|FG001|Overall Study|Administrative|6|||
160988027|NCT00630539|581343261|FG000|Overall Study|Adverse Event|1|||
160988028|NCT00630539|581343262|FG001|Overall Study|Adverse Event|3|||
160988029|NCT00630539|581343263|FG002|Overall Study|Adverse Event|1|||
160988030|NCT00630539|581343264|FG003|Overall Study|Adverse Event|2|||
160988031|NCT00630539|581343261|FG000|Overall Study|Withdrawal by Subject|0|||
160988032|NCT00630539|581343262|FG001|Overall Study|Withdrawal by Subject|1|||
160988033|NCT00630539|581343263|FG002|Overall Study|Withdrawal by Subject|0|||
160900993|NCT01146912|581031891|FG003|Overall Study|< 14 weeks gestational age|2|||
160988034|NCT00630539|581343264|FG003|Overall Study|Withdrawal by Subject|1|||
160900994|NCT01146912|581031892|FG004|Overall Study|< 14 weeks gestational age|0|||
160900995|NCT01146912|581031893|FG005|Overall Study|< 14 weeks gestational age|0|||
160900996|NCT01146912|581031894|FG006|Overall Study|< 14 weeks gestational age|0|||
160988035|NCT00578227|581343270|FG000|Overall Study|Lost to Follow-up|0|||
160988036|NCT00578227|581343271|FG001|Overall Study|Lost to Follow-up|1|||
160988037|NCT00578227|581343272|FG002|Overall Study|Lost to Follow-up|1|||
160988038|NCT00578227|581343270|FG000|Overall Study|Withdrawal by Subject|5|||
160988039|NCT00578227|581343271|FG001|Overall Study|Withdrawal by Subject|1|||
160988040|NCT00578227|581343272|FG002|Overall Study|Withdrawal by Subject|3|||
160988041|NCT04736056|581343285|FG000|Overall Study|Death|0|||
160988042|NCT04736056|581343286|FG001|Overall Study|Death|0|||
160988043|NCT04736056|581343287|FG002|Overall Study|Death|0|||
160988044|NCT04736056|581343288|FG003|Overall Study|Death|1|||
160988045|NCT04736056|581343285|FG000|Overall Study|Lost to Follow-up|1|||
160988046|NCT04736056|581343286|FG001|Overall Study|Lost to Follow-up|0|||
160988047|NCT04736056|581343287|FG002|Overall Study|Lost to Follow-up|1|||
160988048|NCT04736056|581343288|FG003|Overall Study|Lost to Follow-up|1|||
160988049|NCT04736056|581343285|FG000|Overall Study|Withdrawal by Subject|2|||
160988050|NCT04736056|581343286|FG001|Overall Study|Withdrawal by Subject|0|||
161132846|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
161132847|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
161132848|NCT02747927|581870757|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
161132849|NCT02747927|581870758|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
161132850|NCT02747927|581870757|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
161132851|NCT02747927|581870758|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
161132852|NCT02747927|581870757|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
161132853|NCT02747927|581870758|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
161132854|NCT02747927|581870757|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
161132855|NCT02747927|581870758|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
161132856|NCT02747927|581870757|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
161132857|NCT02747927|581870758|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
161132858|NCT02747927|581870757|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
161132859|NCT02747927|581870758|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
161132860|NCT02747927|581870757|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
161132861|NCT02747927|581870758|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
161132862|NCT02747927|581870757|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
161132863|NCT02747927|581870758|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
161132864|NCT02747927|581870757|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
161132865|NCT02747927|581870758|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
161132866|NCT02747927|581870757|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
161132867|NCT02747927|581870758|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
161132868|NCT02747927|581870757|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
161132869|NCT02747927|581870758|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
161132870|NCT02747927|581870757|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
161132871|NCT02747927|581870758|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
161132872|NCT02747927|581870757|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
161132873|NCT02747927|581870758|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
161132874|NCT03480802|581870765|FG000|Overall Study|Lost to Follow-up|5|||
161132875|NCT03480802|581870766|FG001|Overall Study|Lost to Follow-up|1|||
161132876|NCT03480802|581870765|FG000|Overall Study|Withdrawal by Subject|2|||
161132877|NCT03480802|581870766|FG001|Overall Study|Withdrawal by Subject|1|||
160820788|NCT03842969|580729081|FG000|Overall Study|Participant declined follow-up visit|0|||
160820789|NCT03842969|580729082|FG001|Overall Study|Participant declined follow-up visit|1|||
160820790|NCT03842969|580729083|FG002|Overall Study|Participant declined follow-up visit|0|||
160820791|NCT03842969|580729081|FG000|Overall Study|Sponsor's decision|12|||
160820792|NCT03842969|580729082|FG001|Overall Study|Sponsor's decision|99|||
160820793|NCT03842969|580729083|FG002|Overall Study|Sponsor's decision|61|||
160988051|NCT04736056|581343287|FG002|Overall Study|Withdrawal by Subject|0|||
160988052|NCT04736056|581343288|FG003|Overall Study|Withdrawal by Subject|0|||
160988053|NCT04736056|581343285|FG000|Overall Study|Physician Decision|1|||
160988054|NCT04736056|581343286|FG001|Overall Study|Physician Decision|0|||
160988055|NCT04736056|581343287|FG002|Overall Study|Physician Decision|1|||
160988056|NCT04736056|581343288|FG003|Overall Study|Physician Decision|0|||
160988057|NCT04529538|581343289|FG000|Overall Study|Lost to Follow-up|3|||
160988058|NCT04529538|581343290|FG001|Overall Study|Lost to Follow-up|2|||
160988059|NCT04529538|581343291|FG002|Overall Study|Lost to Follow-up|1|||
160988060|NCT04529538|581343292|FG003|Overall Study|Lost to Follow-up|0|||
160988061|NCT04529538|581343293|FG004|Overall Study|Lost to Follow-up|1|||
160988062|NCT04529538|581343294|FG005|Overall Study|Lost to Follow-up|1|||
160988063|NCT04529538|581343295|FG006|Overall Study|Lost to Follow-up|2|||
160988064|NCT04529538|581343296|FG007|Overall Study|Lost to Follow-up|0|||
160988065|NCT04529538|581343289|FG000|Overall Study|Not eligible at enrollment|0|||
160988066|NCT04529538|581343290|FG001|Overall Study|Not eligible at enrollment|1|||
160988067|NCT04529538|581343291|FG002|Overall Study|Not eligible at enrollment|2|||
160988068|NCT04529538|581343292|FG003|Overall Study|Not eligible at enrollment|1|||
160988069|NCT04529538|581343293|FG004|Overall Study|Not eligible at enrollment|0|||
160988070|NCT04529538|581343294|FG005|Overall Study|Not eligible at enrollment|0|||
160988071|NCT04529538|581343295|FG006|Overall Study|Not eligible at enrollment|0|||
161132878|NCT03480802|581870765|FG000|Overall Study|Relocated|0|||
161132879|NCT03480802|581870766|FG001|Overall Study|Relocated|1|||
161132880|NCT02601950|581870771|FG000|Overall Study|Participant enrolled in rollover study|0|||
161132881|NCT02601950|581870772|FG001|Overall Study|Participant enrolled in rollover study|0|||
161132882|NCT02601950|581870773|FG002|Overall Study|Participant enrolled in rollover study|1|||
160988072|NCT04529538|581343296|FG007|Overall Study|Not eligible at enrollment|1|||
160820794|NCT03842969|580729081|FG000|Overall Study|Pregnancy|0|||
160820795|NCT03842969|580729082|FG001|Overall Study|Pregnancy|0|||
160820796|NCT03842969|580729083|FG002|Overall Study|Pregnancy|1|||
160820797|NCT03842969|580729081|FG000|Overall Study|Death|1|||
160988073|NCT04529538|581343289|FG000|Overall Study|Withdrawal by Subject|0|||
160988074|NCT04529538|581343290|FG001|Overall Study|Withdrawal by Subject|1|||
160988075|NCT04529538|581343291|FG002|Overall Study|Withdrawal by Subject|1|||
160988076|NCT04529538|581343292|FG003|Overall Study|Withdrawal by Subject|2|||
160988077|NCT04529538|581343293|FG004|Overall Study|Withdrawal by Subject|0|||
160988078|NCT04529538|581343294|FG005|Overall Study|Withdrawal by Subject|2|||
160988079|NCT04529538|581343295|FG006|Overall Study|Withdrawal by Subject|3|||
160988080|NCT04529538|581343296|FG007|Overall Study|Withdrawal by Subject|0|||
160988081|NCT04529538|581343289|FG000|Overall Study|Other|0|||
160988082|NCT04529538|581343290|FG001|Overall Study|Other|1|||
160988083|NCT04529538|581343291|FG002|Overall Study|Other|0|||
160988084|NCT04529538|581343292|FG003|Overall Study|Other|0|||
160988085|NCT04529538|581343293|FG004|Overall Study|Other|0|||
160988086|NCT04529538|581343294|FG005|Overall Study|Other|0|||
160988087|NCT04529538|581343295|FG006|Overall Study|Other|0|||
160988088|NCT04529538|581343296|FG007|Overall Study|Other|0|||
160988089|NCT04529538|581343289|FG000|Overall Study|Adverse Event|0|||
160988090|NCT04529538|581343290|FG001|Overall Study|Adverse Event|0|||
160988091|NCT04529538|581343291|FG002|Overall Study|Adverse Event|0|||
160988092|NCT04529538|581343292|FG003|Overall Study|Adverse Event|1|||
160988093|NCT04529538|581343293|FG004|Overall Study|Adverse Event|0|||
160988094|NCT04529538|581343294|FG005|Overall Study|Adverse Event|0|||
160988095|NCT04529538|581343295|FG006|Overall Study|Adverse Event|0|||
160988096|NCT04529538|581343296|FG007|Overall Study|Adverse Event|0|||
160988097|NCT04529538|581343289|FG000|Overall Study|Protocol Deviation|0|||
160988098|NCT04529538|581343290|FG001|Overall Study|Protocol Deviation|0|||
160988099|NCT04529538|581343291|FG002|Overall Study|Protocol Deviation|0|||
160988100|NCT04529538|581343292|FG003|Overall Study|Protocol Deviation|1|||
160988101|NCT04529538|581343293|FG004|Overall Study|Protocol Deviation|0|||
160988102|NCT04529538|581343294|FG005|Overall Study|Protocol Deviation|0|||
160988103|NCT04529538|581343295|FG006|Overall Study|Protocol Deviation|0|||
160988104|NCT04529538|581343296|FG007|Overall Study|Protocol Deviation|0|||
160988105|NCT04529538|581343289|FG000|Overall Study|Physician Decision|0|||
160988106|NCT04529538|581343290|FG001|Overall Study|Physician Decision|0|||
160988107|NCT04529538|581343291|FG002|Overall Study|Physician Decision|0|||
160988108|NCT04529538|581343292|FG003|Overall Study|Physician Decision|0|||
160988109|NCT04529538|581343293|FG004|Overall Study|Physician Decision|0|||
160988110|NCT04529538|581343294|FG005|Overall Study|Physician Decision|1|||
161132883|NCT02601950|581870774|FG003|Overall Study|Participant enrolled in rollover study|0|||
161132884|NCT02601950|581870775|FG004|Overall Study|Participant enrolled in rollover study|1|||
161132885|NCT02601950|581870776|FG005|Overall Study|Participant enrolled in rollover study|1|||
161132886|NCT02601950|581870777|FG006|Overall Study|Participant enrolled in rollover study|1|||
161132887|NCT02601950|581870778|FG007|Overall Study|Participant enrolled in rollover study|0|||
161132888|NCT02601950|581870771|FG000|Overall Study|Disease progression - radiological|21|||
161132889|NCT02601950|581870772|FG001|Overall Study|Disease progression - radiological|26|||
161132890|NCT02601950|581870773|FG002|Overall Study|Disease progression - radiological|22|||
161132891|NCT02601950|581870774|FG003|Overall Study|Disease progression - radiological|11|||
161132892|NCT02601950|581870775|FG004|Overall Study|Disease progression - radiological|46|||
161132893|NCT02601950|581870776|FG005|Overall Study|Disease progression - radiological|52|||
161132894|NCT02601950|581870777|FG006|Overall Study|Disease progression - radiological|7|||
161132895|NCT02601950|581870778|FG007|Overall Study|Disease progression - radiological|5|||
161132896|NCT02601950|581870771|FG000|Overall Study|Disease progression - clinical|3|||
161132897|NCT02601950|581870772|FG001|Overall Study|Disease progression - clinical|5|||
161132898|NCT02601950|581870773|FG002|Overall Study|Disease progression - clinical|4|||
161132899|NCT02601950|581870774|FG003|Overall Study|Disease progression - clinical|2|||
161132900|NCT02601950|581870775|FG004|Overall Study|Disease progression - clinical|6|||
161132901|NCT02601950|581870776|FG005|Overall Study|Disease progression - clinical|6|||
161132902|NCT02601950|581870777|FG006|Overall Study|Disease progression - clinical|5|||
161132903|NCT02601950|581870778|FG007|Overall Study|Disease progression - clinical|1|||
161132904|NCT02601950|581870771|FG000|Overall Study|Death|6|||
161132905|NCT02601950|581870772|FG001|Overall Study|Death|0|||
161132906|NCT02601950|581870773|FG002|Overall Study|Death|3|||
160988111|NCT04529538|581343295|FG006|Overall Study|Physician Decision|0|||
161132907|NCT02601950|581870774|FG003|Overall Study|Death|1|||
161132908|NCT02601950|581870775|FG004|Overall Study|Death|4|||
161132909|NCT02601950|581870776|FG005|Overall Study|Death|1|||
160988112|NCT04529538|581343296|FG007|Overall Study|Physician Decision|1|||
160988113|NCT02223182|581343298|FG000|Double-Blind Period|Adverse Event|0|||
160988114|NCT02223182|581343299|FG001|Double-Blind Period|Adverse Event|2|||
160988115|NCT02223182|581343300|FG002|Double-Blind Period|Adverse Event|1|||
160988116|NCT02223182|581343301|FG003|Double-Blind Period|Adverse Event|0|||
160988117|NCT02223182|581343298|FG000|Double-Blind Period|Withdrawal by Subject|1|||
160820798|NCT03842969|580729082|FG001|Overall Study|Death|0|||
160988118|NCT02223182|581343299|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160988119|NCT02223182|581343300|FG002|Double-Blind Period|Withdrawal by Subject|1|||
160988120|NCT02223182|581343301|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160988121|NCT02223182|581343298|FG000|Double-Blind Period|Lost to Follow-up|0|||
160988122|NCT02223182|581343299|FG001|Double-Blind Period|Lost to Follow-up|1|||
160988123|NCT02223182|581343300|FG002|Double-Blind Period|Lost to Follow-up|0|||
160988124|NCT02223182|581343301|FG003|Double-Blind Period|Lost to Follow-up|0|||
160988125|NCT02223182|581343298|FG000|Double-Blind Period|Non Compliance|0|||
160988126|NCT02223182|581343299|FG001|Double-Blind Period|Non Compliance|0|||
160988127|NCT02223182|581343300|FG002|Double-Blind Period|Non Compliance|0|||
160988128|NCT02223182|581343301|FG003|Double-Blind Period|Non Compliance|1|||
160988129|NCT02223182|581343298|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
160988130|NCT02223182|581343299|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
160988131|NCT02223182|581343300|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
160988132|NCT02223182|581343301|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
160988133|NCT02223182|581343298|FG000|Open-Label 500 Period|Adverse Event|1|||
160988134|NCT02223182|581343299|FG001|Open-Label 500 Period|Adverse Event|0|||
160988135|NCT02223182|581343300|FG002|Open-Label 500 Period|Adverse Event|2|||
160988136|NCT02223182|581343301|FG003|Open-Label 500 Period|Adverse Event|1|||
160820799|NCT03842969|580729083|FG002|Overall Study|Death|1|||
160820800|NCT03842969|580729081|FG000|Overall Study|Withdrawal by Subject|3|||
160820801|NCT03842969|580729082|FG001|Overall Study|Withdrawal by Subject|30|||
160820802|NCT03842969|580729083|FG002|Overall Study|Withdrawal by Subject|18|||
160820803|NCT03842969|580729081|FG000|Overall Study|Protocol Violation|1|||
160820804|NCT03842969|580729082|FG001|Overall Study|Protocol Violation|1|||
160820805|NCT03842969|580729083|FG002|Overall Study|Protocol Violation|0|||
160820806|NCT03842969|580729081|FG000|Overall Study|Physician Decision|0|||
160820807|NCT03842969|580729082|FG001|Overall Study|Physician Decision|3|||
160820808|NCT03842969|580729083|FG002|Overall Study|Physician Decision|0|||
160820809|NCT03842969|580729081|FG000|Overall Study|Lost to Follow-up|0|||
160820810|NCT03842969|580729082|FG001|Overall Study|Lost to Follow-up|2|||
160820811|NCT03842969|580729083|FG002|Overall Study|Lost to Follow-up|0|||
160820812|NCT03842969|580729081|FG000|Overall Study|Adverse Event|0|||
160820813|NCT03842969|580729082|FG001|Overall Study|Adverse Event|2|||
160820814|NCT03842969|580729083|FG002|Overall Study|Adverse Event|0|||
160820815|NCT01044745|580729084|FG000|Overall Study|Ineiligible|2|||
160820816|NCT01962987|580729087|FG000|Overall Study|Adverse Event|4|||
160820817|NCT01962987|580729088|FG001|Overall Study|Adverse Event|4|||
160820818|NCT01962987|580729089|FG002|Overall Study|Adverse Event|0|||
160820819|NCT01962987|580729087|FG000|Overall Study|Lost to Follow-up|0|||
160820820|NCT01962987|580729088|FG001|Overall Study|Lost to Follow-up|0|||
160820821|NCT01962987|580729089|FG002|Overall Study|Lost to Follow-up|1|||
160820822|NCT01962987|580729087|FG000|Overall Study|Non compliance with dosing requirements|4|||
160820823|NCT01962987|580729088|FG001|Overall Study|Non compliance with dosing requirements|2|||
160820824|NCT01962987|580729089|FG002|Overall Study|Non compliance with dosing requirements|0|||
160820825|NCT01962987|580729087|FG000|Overall Study|Miscellaneous|1|||
160820826|NCT01962987|580729088|FG001|Overall Study|Miscellaneous|9|||
160820827|NCT01962987|580729089|FG002|Overall Study|Miscellaneous|2|||
160820828|NCT01962987|580729087|FG000|Overall Study|Restricted medication|5|||
160820829|NCT01962987|580729088|FG001|Overall Study|Restricted medication|1|||
160820830|NCT01962987|580729089|FG002|Overall Study|Restricted medication|1|||
160820831|NCT01962987|580729087|FG000|Overall Study|Serious Adverse Event|1|||
160820832|NCT01962987|580729088|FG001|Overall Study|Serious Adverse Event|0|||
160820833|NCT01962987|580729089|FG002|Overall Study|Serious Adverse Event|0|||
160820834|NCT01962987|580729087|FG000|Overall Study|Withdrawal by Subject|11|||
160820835|NCT01962987|580729088|FG001|Overall Study|Withdrawal by Subject|10|||
160820836|NCT01962987|580729089|FG002|Overall Study|Withdrawal by Subject|6|||
160820837|NCT01962987|580729087|FG000|Overall Study|Randomized in Error|4|||
160820838|NCT01962987|580729088|FG001|Overall Study|Randomized in Error|2|||
160820839|NCT01962987|580729089|FG002|Overall Study|Randomized in Error|2|||
160820840|NCT01468207|580729090|FG000|Treatment Period 1|Adverse Event|1|||
160820841|NCT01468207|580729091|FG001|Treatment Period 1|Adverse Event|0|||
160820842|NCT01468207|580729092|FG002|Treatment Period 1|Adverse Event|0|||
160988137|NCT02223182|581343298|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
160820843|NCT01468207|580729093|FG003|Treatment Period 1|Adverse Event|0|||
160820844|NCT01468207|580729094|FG004|Treatment Period 1|Adverse Event|0|||
160820845|NCT01468207|580729095|FG005|Treatment Period 1|Adverse Event|0|||
160820846|NCT01468207|580729090|FG000|Treatment Period 1|Protocol Violation|1|||
160820847|NCT01468207|580729091|FG001|Treatment Period 1|Protocol Violation|1|||
160988138|NCT02223182|581343299|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
160820848|NCT01468207|580729092|FG002|Treatment Period 1|Protocol Violation|0|||
160820849|NCT01468207|580729093|FG003|Treatment Period 1|Protocol Violation|0|||
160820850|NCT01468207|580729094|FG004|Treatment Period 1|Protocol Violation|0|||
160820851|NCT01468207|580729095|FG005|Treatment Period 1|Protocol Violation|0|||
160820852|NCT01468207|580729090|FG000|Treatment Period 1|Withdrawal by Subject|5|||
160820853|NCT01468207|580729091|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160820854|NCT01468207|580729092|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160820855|NCT01468207|580729093|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160820856|NCT01468207|580729094|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160820857|NCT01468207|580729095|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160820858|NCT01468207|580729090|FG000|Treatment Period 1|Lost to Follow-up|2|||
160820859|NCT01468207|580729091|FG001|Treatment Period 1|Lost to Follow-up|1|||
160820860|NCT01468207|580729092|FG002|Treatment Period 1|Lost to Follow-up|0|||
160820861|NCT01468207|580729093|FG003|Treatment Period 1|Lost to Follow-up|0|||
160820862|NCT01468207|580729094|FG004|Treatment Period 1|Lost to Follow-up|0|||
160820863|NCT01468207|580729095|FG005|Treatment Period 1|Lost to Follow-up|0|||
160820864|NCT01468207|580729090|FG000|Treatment Period 1|Other|0|||
160820865|NCT01468207|580729091|FG001|Treatment Period 1|Other|2|||
160820866|NCT01468207|580729092|FG002|Treatment Period 1|Other|0|||
160820867|NCT01468207|580729093|FG003|Treatment Period 1|Other|0|||
160820868|NCT01468207|580729094|FG004|Treatment Period 1|Other|0|||
160820869|NCT01468207|580729095|FG005|Treatment Period 1|Other|0|||
160820870|NCT01468207|580729090|FG000|Treatment Period 2|Adverse Event|0|||
160820871|NCT01468207|580729091|FG001|Treatment Period 2|Adverse Event|0|||
160820872|NCT01468207|580729092|FG002|Treatment Period 2|Adverse Event|6|||
160820873|NCT01468207|580729093|FG003|Treatment Period 2|Adverse Event|1|||
160820874|NCT01468207|580729094|FG004|Treatment Period 2|Adverse Event|2|||
160820875|NCT01468207|580729095|FG005|Treatment Period 2|Adverse Event|1|||
160820876|NCT01468207|580729090|FG000|Treatment Period 2|Lack of Efficacy|0|||
160820877|NCT01468207|580729091|FG001|Treatment Period 2|Lack of Efficacy|0|||
160820878|NCT01468207|580729092|FG002|Treatment Period 2|Lack of Efficacy|1|||
160820879|NCT01468207|580729093|FG003|Treatment Period 2|Lack of Efficacy|1|||
160820880|NCT01468207|580729094|FG004|Treatment Period 2|Lack of Efficacy|0|||
160820881|NCT01468207|580729095|FG005|Treatment Period 2|Lack of Efficacy|2|||
160820882|NCT01468207|580729090|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160820883|NCT01468207|580729091|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160820884|NCT01468207|580729092|FG002|Treatment Period 2|Withdrawal by Subject|5|||
160820885|NCT01468207|580729093|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160820886|NCT01468207|580729094|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160820887|NCT01468207|580729095|FG005|Treatment Period 2|Withdrawal by Subject|2|||
160820888|NCT01468207|580729090|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
160820889|NCT01468207|580729091|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
160820890|NCT01468207|580729092|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
160820891|NCT01468207|580729093|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
160820892|NCT01468207|580729094|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
160820893|NCT01468207|580729095|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
160820894|NCT01468207|580729090|FG000|Treatment Period 2|Lost to Follow-up|0|||
160820895|NCT01468207|580729091|FG001|Treatment Period 2|Lost to Follow-up|0|||
160820896|NCT01468207|580729092|FG002|Treatment Period 2|Lost to Follow-up|5|||
160820897|NCT01468207|580729093|FG003|Treatment Period 2|Lost to Follow-up|1|||
160820898|NCT01468207|580729094|FG004|Treatment Period 2|Lost to Follow-up|0|||
160820899|NCT01468207|580729095|FG005|Treatment Period 2|Lost to Follow-up|0|||
160820900|NCT01468207|580729090|FG000|Treatment Period 2|Other|0|||
160820901|NCT01468207|580729091|FG001|Treatment Period 2|Other|0|||
160820902|NCT01468207|580729092|FG002|Treatment Period 2|Other|5|||
160820903|NCT01468207|580729093|FG003|Treatment Period 2|Other|1|||
160820904|NCT01468207|580729094|FG004|Treatment Period 2|Other|1|||
160820905|NCT01468207|580729095|FG005|Treatment Period 2|Other|2|||
160820906|NCT01967823|580729098|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
160820907|NCT00316693|580729099|FG000|Overall Study|Adverse Event|6|||
160820908|NCT00316693|580729100|FG001|Overall Study|Adverse Event|1|||
160820909|NCT00316693|580729099|FG000|Overall Study|Protocol Violation|1|||
160820910|NCT00316693|580729100|FG001|Overall Study|Protocol Violation|0|||
160820911|NCT00316693|580729099|FG000|Overall Study|Withdrawal by Subject|6|||
160820912|NCT00316693|580729100|FG001|Overall Study|Withdrawal by Subject|6|||
160820913|NCT00316693|580729099|FG000|Overall Study|Lost to Follow-up|26|||
160820914|NCT00316693|580729100|FG001|Overall Study|Lost to Follow-up|34|||
160820915|NCT00316693|580729099|FG000|Overall Study|Other|38|||
160820916|NCT00316693|580729100|FG001|Overall Study|Other|44|||
160820917|NCT00413894|580729107|FG000|Overall Study|Withdrawal by Subject|10|||
160820918|NCT00413894|580729107|FG000|Overall Study|Administrative Reasons|1|||
160820919|NCT00413894|580729107|FG000|Overall Study|Hb <10 grams/deciliter|12|||
160820920|NCT00413894|580729107|FG000|Overall Study|Adverse Event|28|||
160820921|NCT00413894|580729107|FG000|Overall Study|Protocol Violation|11|||
160820922|NCT00413894|580729107|FG000|Overall Study|Other|18|||
160820923|NCT04225676|580729108|FG000|Overall Study|Physician Decision|1|||
160820924|NCT04225676|580729108|FG000|Overall Study|Lack of Efficacy|1|||
160820925|NCT04225676|580729108|FG000|Overall Study|Study terminated by sponsor|3|||
160820926|NCT05289271|580729111|FG000|Overall Study|Mistakenly allocated, untreated|1|||
160820927|NCT05289271|580729112|FG001|Overall Study|Mistakenly allocated, untreated|0|||
160820928|NCT02019108|580729113|FG000|Overall Study|Lost to Follow-up|5|||
160820929|NCT02019108|580729114|FG001|Overall Study|Lost to Follow-up|7|||
160900997|NCT01146912|581031895|FG007|Overall Study|< 14 weeks gestational age|0|||
160900998|NCT01146912|581031888|FG000|Overall Study|Duplicate patient|0|||
160988139|NCT02223182|581343300|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
160988140|NCT02223182|581343301|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
160988141|NCT02223182|581343298|FG000|Open-Label 500 Period|Physician Decision|0|||
160988142|NCT02223182|581343299|FG001|Open-Label 500 Period|Physician Decision|0|||
160988143|NCT02223182|581343300|FG002|Open-Label 500 Period|Physician Decision|0|||
160988144|NCT02223182|581343301|FG003|Open-Label 500 Period|Physician Decision|1|||
160988145|NCT02223182|581343298|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
160988146|NCT02223182|581343299|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
160988147|NCT02223182|581343300|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
160988148|NCT02223182|581343301|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
160988149|NCT02223182|581343298|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
160988150|NCT02223182|581343299|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
160988151|NCT02223182|581343300|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
160988152|NCT02223182|581343301|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
160988153|NCT02223182|581343298|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
160988154|NCT02223182|581343299|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
160988155|NCT02223182|581343300|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
160988156|NCT02223182|581343301|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
160988157|NCT02223182|581343298|FG000|Open-Label 300 Period|Non Compliance|0|||
160988158|NCT02223182|581343299|FG001|Open-Label 300 Period|Non Compliance|2|||
160988159|NCT02223182|581343300|FG002|Open-Label 300 Period|Non Compliance|1|||
160988160|NCT02223182|581343301|FG003|Open-Label 300 Period|Non Compliance|0|||
160988161|NCT04956692|581343308|FG000|Overall Study|Death|115|||
160988162|NCT04956692|581343309|FG001|Overall Study|Death|47|||
160988163|NCT04956692|581343308|FG000|Overall Study|Lost to Follow-up|0|||
160988164|NCT04956692|581343309|FG001|Overall Study|Lost to Follow-up|1|||
160988165|NCT04956692|581343308|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
160988166|NCT04956692|581343309|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160988167|NCT04956692|581343308|FG000|Overall Study|Withdrawal by Subject|5|||
160988168|NCT04956692|581343309|FG001|Overall Study|Withdrawal by Subject|2|||
160988169|NCT04956692|581343308|FG000|Overall Study|Ongoing in Study|236|||
160988170|NCT04956692|581343309|FG001|Overall Study|Ongoing in Study|123|||
160988171|NCT02099539|581343314|FG000|Overall Study|Progressive Disease|3|||
160988172|NCT02099539|581343315|FG001|Overall Study|Progressive Disease|2|||
160988173|NCT02099539|581343316|FG002|Overall Study|Progressive Disease|2|||
160988174|NCT02099539|581343317|FG003|Overall Study|Progressive Disease|1|||
160988175|NCT02099539|581343318|FG004|Overall Study|Progressive Disease|4|||
160988176|NCT02099539|581343319|FG005|Overall Study|Progressive Disease|2|||
160988177|NCT02099539|581343320|FG006|Overall Study|Progressive Disease|0|||
160988178|NCT02099539|581343314|FG000|Overall Study|Adverse Event|0|||
160988179|NCT02099539|581343315|FG001|Overall Study|Adverse Event|0|||
160988180|NCT02099539|581343316|FG002|Overall Study|Adverse Event|1|||
160988181|NCT02099539|581343317|FG003|Overall Study|Adverse Event|1|||
160988182|NCT02099539|581343318|FG004|Overall Study|Adverse Event|0|||
160988183|NCT02099539|581343319|FG005|Overall Study|Adverse Event|0|||
160988184|NCT02099539|581343320|FG006|Overall Study|Adverse Event|0|||
160988185|NCT02099539|581343314|FG000|Overall Study|Physician Decision|0|||
160988186|NCT02099539|581343315|FG001|Overall Study|Physician Decision|0|||
160988187|NCT02099539|581343316|FG002|Overall Study|Physician Decision|0|||
160988188|NCT02099539|581343317|FG003|Overall Study|Physician Decision|0|||
160988189|NCT02099539|581343318|FG004|Overall Study|Physician Decision|0|||
160988190|NCT02099539|581343319|FG005|Overall Study|Physician Decision|1|||
160988191|NCT02099539|581343320|FG006|Overall Study|Physician Decision|0|||
160988192|NCT03473756|581343322|FG000|Overall Study|Withdrawal by Subject|1|||
160988193|NCT03473756|581343323|FG001|Overall Study|Withdrawal by Subject|4|||
160988194|NCT03473756|581343322|FG000|Overall Study|Adverse Event|6|||
160988195|NCT03473756|581343323|FG001|Overall Study|Adverse Event|7|||
160988196|NCT03473756|581343322|FG000|Overall Study|Lack of Efficacy|3|||
160988197|NCT03473756|581343323|FG001|Overall Study|Lack of Efficacy|10|||
160988198|NCT03473756|581343322|FG000|Overall Study|Physician Decision|0|||
160988199|NCT03473756|581343323|FG001|Overall Study|Physician Decision|2|||
160988200|NCT03473756|581343322|FG000|Overall Study|End of study treatment|0|||
160988201|NCT03473756|581343323|FG001|Overall Study|End of study treatment|2|||
160988202|NCT03473756|581343322|FG000|Overall Study|Lost to Follow-up|0|||
160988203|NCT03473756|581343323|FG001|Overall Study|Lost to Follow-up|1|||
160820930|NCT03392883|580729119|FG000|Overall Study|Lost to Follow-up|122|||
160988204|NCT03714022|581343324|FG000|Overall Study|Adverse Event|1|||
160988205|NCT03714022|581343325|FG001|Overall Study|Adverse Event|0|||
160988206|NCT03714022|581343324|FG000|Overall Study|Consent withdrawal|0|||
160988207|NCT03714022|581343325|FG001|Overall Study|Consent withdrawal|1|||
160988208|NCT03714022|581343324|FG000|Overall Study|Lost to Follow-up|3|||
160988209|NCT03714022|581343325|FG001|Overall Study|Lost to Follow-up|2|||
160988210|NCT02487446|581343329|FG000|Period 1|Physician Decision|0|||
160988211|NCT02487446|581343330|FG001|Period 1|Physician Decision|1|||
160988212|NCT02487446|581343329|FG000|Period 1|Lack of Efficacy|1|||
160988213|NCT02487446|581343330|FG001|Period 1|Lack of Efficacy|0|||
160988214|NCT02487446|581343329|FG000|Period 1|Protocol deviation|3|||
160988215|NCT02487446|581343330|FG001|Period 1|Protocol deviation|2|||
160988216|NCT02487446|581343329|FG000|Period 1|Lost to Follow-up|2|||
160988217|NCT02487446|581343330|FG001|Period 1|Lost to Follow-up|0|||
160988218|NCT02487446|581343329|FG000|Period 1|Withdrawal by Subject|2|||
160988219|NCT02487446|581343330|FG001|Period 1|Withdrawal by Subject|0|||
160988220|NCT02487446|581343329|FG000|Period 1|Adverse Event|5|||
160988221|NCT02487446|581343330|FG001|Period 1|Adverse Event|5|||
160988222|NCT02487446|581343329|FG000|Washout|Lost to Follow-up|0|||
160988223|NCT02487446|581343330|FG001|Washout|Lost to Follow-up|2|||
160988224|NCT02487446|581343329|FG000|Washout|Withdrawal by Subject|1|||
160988225|NCT02487446|581343330|FG001|Washout|Withdrawal by Subject|4|||
160988226|NCT02487446|581343329|FG000|Washout|Adverse Event|2|||
160988227|NCT02487446|581343330|FG001|Washout|Adverse Event|2|||
160988228|NCT02487446|581343329|FG000|Period 2|Protocol deviation|0|||
160988229|NCT02487446|581343330|FG001|Period 2|Protocol deviation|1|||
160988230|NCT02487446|581343329|FG000|Period 2|Lost to Follow-up|1|||
160988231|NCT02487446|581343330|FG001|Period 2|Lost to Follow-up|1|||
160988232|NCT02487446|581343329|FG000|Period 2|Withdrawal by Subject|1|||
160988233|NCT02487446|581343330|FG001|Period 2|Withdrawal by Subject|1|||
160988234|NCT02487446|581343329|FG000|Period 2|Adverse Event|6|||
160988235|NCT02487446|581343330|FG001|Period 2|Adverse Event|2|||
160988236|NCT02234310|581343331|FG000|Overall Study|Physician Decision|1|||
160988237|NCT02234310|581343331|FG000|Overall Study|Adverse Event|1|||
160988238|NCT02234310|581343331|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
160988239|NCT02234310|581343331|FG000|Overall Study|Withdrawal by Subject|2|||
160988240|NCT03289455|581343332|FG000|Overall Study|Death|1|||
160988241|NCT03289455|581343333|FG001|Overall Study|Death|0|||
160988242|NCT03289455|581343334|FG002|Overall Study|Death|0|||
160988243|NCT03289455|581343332|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
160988244|NCT03289455|581343333|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
160988245|NCT03289455|581343334|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
160988246|NCT03289455|581343332|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
160988247|NCT03289455|581343333|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
160988248|NCT03289455|581343334|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
160988249|NCT03289455|581343332|FG000|Overall Study|Progressive disease|3|||
160988250|NCT03289455|581343333|FG001|Overall Study|Progressive disease|4|||
160988251|NCT03289455|581343334|FG002|Overall Study|Progressive disease|5|||
160988252|NCT02624778|581345227|FG000|Overall Study|Lost to Follow-up|0|||
160988253|NCT02624778|581345228|FG001|Overall Study|Lost to Follow-up|0|||
160988254|NCT02624778|581345229|FG002|Overall Study|Lost to Follow-up|1|||
160820931|NCT03392883|580729120|FG001|Overall Study|Lost to Follow-up|13|||
160820932|NCT03392883|580729121|FG002|Overall Study|Lost to Follow-up|9|||
160820933|NCT03392883|580729119|FG000|Overall Study|Death|4|||
160820934|NCT03392883|580729120|FG001|Overall Study|Death|0|||
160820935|NCT03392883|580729121|FG002|Overall Study|Death|0|||
160820936|NCT03392883|580729119|FG000|Overall Study|Lack of Efficacy|29|||
160820937|NCT03392883|580729120|FG001|Overall Study|Lack of Efficacy|0|||
160820938|NCT03392883|580729121|FG002|Overall Study|Lack of Efficacy|0|||
160820939|NCT03392883|580729119|FG000|Overall Study|Withdrawal by Subject|180|||
160820940|NCT03392883|580729120|FG001|Overall Study|Withdrawal by Subject|0|||
160820941|NCT03392883|580729121|FG002|Overall Study|Withdrawal by Subject|0|||
160820942|NCT03392883|580729119|FG000|Overall Study|Adverse Event|1|||
160820943|NCT03392883|580729120|FG001|Overall Study|Adverse Event|0|||
160820944|NCT03392883|580729121|FG002|Overall Study|Adverse Event|0|||
161132910|NCT02601950|581870777|FG006|Overall Study|Death|0|||
161132911|NCT02601950|581870778|FG007|Overall Study|Death|0|||
161132912|NCT02601950|581870771|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132913|NCT02601950|581870772|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132914|NCT02601950|581870773|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132915|NCT02601950|581870774|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132916|NCT02601950|581870775|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132917|NCT02601950|581870776|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
161132918|NCT02601950|581870777|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132919|NCT02601950|581870778|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
161132920|NCT02601950|581870771|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
161132921|NCT02601950|581870772|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
161132922|NCT02601950|581870773|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
160820945|NCT03356977|580729124|FG000|Overall Study|Lost to Follow-up|3|||
160820946|NCT03356977|580729124|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160988255|NCT02624778|581345230|FG003|Overall Study|Lost to Follow-up|0|||
160988256|NCT02624778|581345231|FG004|Overall Study|Lost to Follow-up|0|||
160988257|NCT02624778|581345232|FG005|Overall Study|Lost to Follow-up|0|||
160988258|NCT02624778|581345233|FG006|Overall Study|Lost to Follow-up|0|||
160988259|NCT02624778|581345234|FG007|Overall Study|Lost to Follow-up|0|||
161132923|NCT02601950|581870774|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
160820947|NCT01728077|580729127|FG000|Overall Study|Lack of Efficacy|3|||
160988260|NCT02624778|581345235|FG008|Overall Study|Lost to Follow-up|0|||
160988261|NCT02624778|581345227|FG000|Overall Study|Withdrawal by Subject|0|||
160988262|NCT02624778|581345228|FG001|Overall Study|Withdrawal by Subject|1|||
160988263|NCT02624778|581345229|FG002|Overall Study|Withdrawal by Subject|0|||
160988264|NCT02624778|581345230|FG003|Overall Study|Withdrawal by Subject|0|||
160988265|NCT02624778|581345231|FG004|Overall Study|Withdrawal by Subject|0|||
161240138|NCT00796653|582260510|FG003|Overall Study|Non compliance with protocol|2|||
161240139|NCT00796653|582260507|FG000|Overall Study|Other reason not described above|4|||
161240140|NCT00796653|582260508|FG001|Overall Study|Other reason not described above|9|||
161240141|NCT00796653|582260509|FG002|Overall Study|Other reason not described above|7|||
161240142|NCT00796653|582260510|FG003|Overall Study|Other reason not described above|4|||
161240143|NCT00835692|582260512|FG000|First Intervention|Withdrawal by Subject|1|||
161240144|NCT00835692|582260513|FG001|First Intervention|Withdrawal by Subject|0|||
161240145|NCT00191815|582260516|FG000|Overall Study|Adverse Event|2|||
161240146|NCT00191815|582260516|FG000|Overall Study|Disease progression or relapse|24|||
161240147|NCT00191815|582260516|FG000|Overall Study|Death|2|||
161240148|NCT00191815|582260516|FG000|Overall Study|Protocol Violation|3|||
161240149|NCT00191815|582260516|FG000|Overall Study|Physician Decision|2|||
161240150|NCT00191815|582260516|FG000|Overall Study|Withdrawal by Subject|7|||
161240151|NCT03644550|582260517|FG000|Overall Study|Withdrawal by Subject|3|||
161240152|NCT03644550|582260517|FG000|Overall Study|Progressive disease|15|||
161240153|NCT01218867|582260518|FG000|Overall Study|Death during treatment|0|||
161240154|NCT01218867|582260519|FG001|Overall Study|Death during treatment|0|||
161240155|NCT01218867|582260520|FG002|Overall Study|Death during treatment|0|||
161240156|NCT01218867|582260521|FG003|Overall Study|Death during treatment|0|||
161240157|NCT01218867|582260522|FG004|Overall Study|Death during treatment|0|||
161240158|NCT01218867|582260523|FG005|Overall Study|Death during treatment|0|||
161240159|NCT01218867|582260524|FG006|Overall Study|Death during treatment|1|||
161240160|NCT01218867|582260525|FG007|Overall Study|Death during treatment|0|||
161240161|NCT01218867|582260526|FG008|Overall Study|Death during treatment|0|||
161240162|NCT01218867|582260527|FG009|Overall Study|Death during treatment|0|||
161240163|NCT01218867|582260528|FG010|Overall Study|Death during treatment|0|||
161240164|NCT00251979|582260529|FG000|Overall Study|Protocol Violation|3|||
161240165|NCT00251979|582260530|FG001|Overall Study|Protocol Violation|5|||
161240166|NCT00251979|582260529|FG000|Overall Study|Adverse Event|11|||
161240167|NCT00251979|582260530|FG001|Overall Study|Adverse Event|17|||
161240168|NCT00251979|582260529|FG000|Overall Study|Withdrawal by Subject|13|||
161240169|NCT00251979|582260530|FG001|Overall Study|Withdrawal by Subject|7|||
161240170|NCT00251979|582260529|FG000|Overall Study|Lost to Follow-up|8|||
161240171|NCT00251979|582260530|FG001|Overall Study|Lost to Follow-up|6|||
161240172|NCT00251979|582260529|FG000|Overall Study|Death|3|||
161240173|NCT00251979|582260530|FG001|Overall Study|Death|5|||
161240174|NCT01348789|582260540|FG000|Overall Study|Protocol Violation|2|||
161240175|NCT01348789|582260540|FG000|Overall Study|Withdrawal by Subject|2|||
161240176|NCT01878292|582260541|FG000|Randomized|Protocol Violation|1|||
161240177|NCT01878292|582260542|FG001|Randomized|Protocol Violation|0|||
161240178|NCT01878292|582260543|FG002|Randomized|Protocol Violation|0|||
161240179|NCT01878292|582260541|FG000|Randomized|Lost to Follow-up|1|||
161240180|NCT01878292|582260542|FG001|Randomized|Lost to Follow-up|0|||
161240181|NCT01878292|582260543|FG002|Randomized|Lost to Follow-up|0|||
161240182|NCT01878292|582260541|FG000|Randomized|Adverse Event|1|||
161240183|NCT01878292|582260542|FG001|Randomized|Adverse Event|0|||
161240184|NCT01878292|582260543|FG002|Randomized|Adverse Event|0|||
161240185|NCT01878292|582260541|FG000|Double-blind Treatment Period|Other Reasons|2|||
161240186|NCT01878292|582260542|FG001|Double-blind Treatment Period|Other Reasons|0|||
161240187|NCT01878292|582260543|FG002|Double-blind Treatment Period|Other Reasons|0|||
161240188|NCT01878292|582260541|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
161240189|NCT01878292|582260542|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
161240190|NCT01878292|582260543|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161240191|NCT01878292|582260541|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
161240192|NCT01878292|582260542|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
161240193|NCT01878292|582260543|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
161333825|NCT03327324|582610633|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161240194|NCT01878292|582260541|FG000|Double-blind Treatment Period|Protocol Violation|3|||
161240195|NCT01878292|582260542|FG001|Double-blind Treatment Period|Protocol Violation|4|||
161240196|NCT01878292|582260543|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161333826|NCT03327324|582610634|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
161333827|NCT03327324|582610629|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161240197|NCT01878292|582260541|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
160988266|NCT02624778|581345232|FG005|Overall Study|Withdrawal by Subject|1|||
160988267|NCT02624778|581345233|FG006|Overall Study|Withdrawal by Subject|1|||
161240198|NCT01878292|582260542|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
161333828|NCT03327324|582610630|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161333829|NCT03327324|582610631|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
161240199|NCT01878292|582260543|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
160988268|NCT02624778|581345234|FG007|Overall Study|Withdrawal by Subject|1|||
160988269|NCT02624778|581345235|FG008|Overall Study|Withdrawal by Subject|1|||
160988270|NCT02624778|581345227|FG000|Overall Study|Adverse Event|0|||
160988271|NCT02624778|581345228|FG001|Overall Study|Adverse Event|0|||
160988272|NCT02624778|581345229|FG002|Overall Study|Adverse Event|0|||
160988273|NCT02624778|581345230|FG003|Overall Study|Adverse Event|0|||
160988274|NCT02624778|581345231|FG004|Overall Study|Adverse Event|0|||
160988275|NCT02624778|581345232|FG005|Overall Study|Adverse Event|0|||
160988276|NCT02624778|581345233|FG006|Overall Study|Adverse Event|0|||
160988277|NCT02624778|581345234|FG007|Overall Study|Adverse Event|0|||
160988278|NCT02624778|581345235|FG008|Overall Study|Adverse Event|2|||
160988279|NCT02624778|581345227|FG000|Overall Study|Death|0|||
160988280|NCT02624778|581345228|FG001|Overall Study|Death|0|||
160988281|NCT02624778|581345229|FG002|Overall Study|Death|0|||
160988282|NCT02624778|581345230|FG003|Overall Study|Death|0|||
160988283|NCT02624778|581345231|FG004|Overall Study|Death|0|||
160988284|NCT02624778|581345232|FG005|Overall Study|Death|0|||
160988285|NCT02624778|581345233|FG006|Overall Study|Death|1|||
160988286|NCT02624778|581345234|FG007|Overall Study|Death|0|||
160988287|NCT02624778|581345235|FG008|Overall Study|Death|0|||
160988288|NCT02624778|581345227|FG000|Overall Study|Physician Decision|0|||
160988289|NCT02624778|581345228|FG001|Overall Study|Physician Decision|0|||
160988290|NCT02624778|581345229|FG002|Overall Study|Physician Decision|0|||
160988291|NCT02624778|581345230|FG003|Overall Study|Physician Decision|0|||
160988292|NCT02624778|581345231|FG004|Overall Study|Physician Decision|0|||
160988293|NCT02624778|581345232|FG005|Overall Study|Physician Decision|0|||
160988294|NCT02624778|581345233|FG006|Overall Study|Physician Decision|0|||
160988295|NCT02624778|581345234|FG007|Overall Study|Physician Decision|3|||
160988296|NCT02624778|581345235|FG008|Overall Study|Physician Decision|3|||
160988297|NCT04091672|581345238|FG000|Overall Study|Death|6|||
160988298|NCT04091672|581345239|FG001|Overall Study|Death|6|||
160988299|NCT04091672|581345238|FG000|Overall Study|Lost to Follow-up|7|||
160988300|NCT04091672|581345239|FG001|Overall Study|Lost to Follow-up|7|||
160988301|NCT04091672|581345238|FG000|Overall Study|Withdrawal by Subject|3|||
160988302|NCT04091672|581345239|FG001|Overall Study|Withdrawal by Subject|3|||
160988303|NCT04091672|581345238|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
160988304|NCT04091672|581345239|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
160988305|NCT05296629|581345240|FG000|Overall Study|Withdrawal by Subject|3|||
160988306|NCT05296629|581345241|FG001|Overall Study|Withdrawal by Subject|10|||
160988307|NCT05296629|581345242|FG002|Overall Study|Withdrawal by Subject|4|||
160988308|NCT05296629|581345240|FG000|Overall Study|Lost to Follow-up|2|||
160988309|NCT05296629|581345241|FG001|Overall Study|Lost to Follow-up|7|||
160988310|NCT05296629|581345242|FG002|Overall Study|Lost to Follow-up|1|||
160988311|NCT05296629|581345240|FG000|Overall Study|Adverse Event|0|||
160988312|NCT05296629|581345241|FG001|Overall Study|Adverse Event|4|||
160988313|NCT05296629|581345242|FG002|Overall Study|Adverse Event|2|||
160988314|NCT05296629|581345240|FG000|Overall Study|Protocol Violation|0|||
160988315|NCT05296629|581345241|FG001|Overall Study|Protocol Violation|2|||
160988316|NCT05296629|581345242|FG002|Overall Study|Protocol Violation|0|||
160988317|NCT04610684|581345248|FG000|Study Treatment|Withdrawal by Subject|1|||
160988318|NCT04610684|581345248|FG000|Study Treatment|Disease Progression|2|||
160988319|NCT04610684|581345248|FG000|Follow up|Death|2|||
160988320|NCT04610684|581345248|FG000|Follow up|Withdrawal by Subject|1|||
160988321|NCT00359619|581345249|FG000|Overall Study|Adverse Event|0|||
160988322|NCT00359619|581345250|FG001|Overall Study|Adverse Event|0|||
160988323|NCT00359619|581345251|FG002|Overall Study|Adverse Event|1|||
160988324|NCT00359619|581345252|FG003|Overall Study|Adverse Event|0|||
160988325|NCT00359619|581345253|FG004|Overall Study|Adverse Event|0|||
160988326|NCT00359619|581345254|FG005|Overall Study|Adverse Event|0|||
161132924|NCT02601950|581870775|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
161132925|NCT02601950|581870776|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
160820948|NCT01728077|580729128|FG001|Overall Study|Lack of Efficacy|1|||
160820949|NCT01728077|580729127|FG000|Overall Study|Lost to Follow-up|1|||
160820950|NCT01728077|580729128|FG001|Overall Study|Lost to Follow-up|0|||
160820951|NCT01728077|580729127|FG000|Overall Study|Subject choice|2|||
160820952|NCT01728077|580729128|FG001|Overall Study|Subject choice|3|||
160988327|NCT00359619|581345255|FG006|Overall Study|Adverse Event|1|||
160988328|NCT00359619|581345249|FG000|Overall Study|Withdrawal by Subject|3|||
160988329|NCT00359619|581345250|FG001|Overall Study|Withdrawal by Subject|1|||
160988330|NCT00359619|581345251|FG002|Overall Study|Withdrawal by Subject|4|||
160988331|NCT00359619|581345252|FG003|Overall Study|Withdrawal by Subject|2|||
160988332|NCT00359619|581345253|FG004|Overall Study|Withdrawal by Subject|2|||
160988333|NCT00359619|581345254|FG005|Overall Study|Withdrawal by Subject|0|||
160988334|NCT00359619|581345255|FG006|Overall Study|Withdrawal by Subject|3|||
160988335|NCT00359619|581345249|FG000|Overall Study|Other|1|||
160988336|NCT00359619|581345250|FG001|Overall Study|Other|0|||
160988337|NCT00359619|581345251|FG002|Overall Study|Other|0|||
160988338|NCT00359619|581345252|FG003|Overall Study|Other|0|||
160988339|NCT00359619|581345253|FG004|Overall Study|Other|0|||
160988340|NCT00359619|581345254|FG005|Overall Study|Other|0|||
160988341|NCT00359619|581345255|FG006|Overall Study|Other|0|||
160820953|NCT01728077|580729127|FG000|Overall Study|Death|0|||
160820954|NCT01728077|580729128|FG001|Overall Study|Death|1|||
160820955|NCT01728077|580729127|FG000|Overall Study|Patient moving|1|||
160820956|NCT01728077|580729128|FG001|Overall Study|Patient moving|0|||
160820957|NCT01728077|580729127|FG000|Overall Study|Non compliance|1|||
160820958|NCT01728077|580729128|FG001|Overall Study|Non compliance|0|||
160820959|NCT00378599|580729129|FG000|Overall Study|Adverse Event|38|||
160820960|NCT00378599|580729129|FG000|Overall Study|Protocol Violation|2|||
160820961|NCT00378599|580729129|FG000|Overall Study|Treatment failure|7|||
160820962|NCT00378599|580729129|FG000|Overall Study|Withdrawal by Subject|5|||
160820963|NCT03224507|580729132|FG000|Overall Study|Death|3|||
160820964|NCT03224507|580729133|FG001|Overall Study|Death|0|||
160820965|NCT03224507|580729132|FG000|Overall Study|Lack of Efficacy|6|||
160820966|NCT03224507|580729133|FG001|Overall Study|Lack of Efficacy|0|||
160820967|NCT03224507|580729132|FG000|Overall Study|Withdrawal by Subject|6|||
160820968|NCT03224507|580729133|FG001|Overall Study|Withdrawal by Subject|0|||
160820969|NCT02442310|580729137|FG000|Overall Study|Adverse Event|2|||
160820970|NCT02442310|580729137|FG000|Overall Study|Withdrawal by Subject|1|||
160820971|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
160820972|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
160820973|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
160820974|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
160820975|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
160820976|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
160820977|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
160900999|NCT01146912|581031889|FG001|Overall Study|Duplicate patient|0|||
160901000|NCT01146912|581031890|FG002|Overall Study|Duplicate patient|1|||
160901001|NCT01146912|581031891|FG003|Overall Study|Duplicate patient|0|||
160901002|NCT01146912|581031892|FG004|Overall Study|Duplicate patient|0|||
160901003|NCT01146912|581031893|FG005|Overall Study|Duplicate patient|0|||
160901004|NCT01146912|581031894|FG006|Overall Study|Duplicate patient|0|||
160901005|NCT01146912|581031895|FG007|Overall Study|Duplicate patient|0|||
160901006|NCT02980783|581031896|FG000|Overall Study|Lost to Follow-up|1|||
160901007|NCT00880542|581031897|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
160901008|NCT00880542|581031897|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
160901009|NCT00880542|581031897|FG000|REP: Surgical Resection|progressive disease|1|||
160901010|NCT05047770|581031898|FG000|Overall Study|Withdrawal by Subject|15|||
160901011|NCT05047770|581031899|FG001|Overall Study|Withdrawal by Subject|10|||
160901012|NCT05047770|581031900|FG002|Overall Study|Withdrawal by Subject|6|||
160901013|NCT05047770|581031901|FG003|Overall Study|Withdrawal by Subject|12|||
160901014|NCT05047770|581031898|FG000|Overall Study|Lost to Follow-up|7|||
160901015|NCT05047770|581031899|FG001|Overall Study|Lost to Follow-up|5|||
160901016|NCT05047770|581031900|FG002|Overall Study|Lost to Follow-up|12|||
160901017|NCT05047770|581031901|FG003|Overall Study|Lost to Follow-up|13|||
160901018|NCT05047770|581031898|FG000|Overall Study|Other|1|||
160901019|NCT05047770|581031899|FG001|Overall Study|Other|0|||
160901020|NCT05047770|581031900|FG002|Overall Study|Other|1|||
160901021|NCT05047770|581031901|FG003|Overall Study|Other|0|||
160901022|NCT01772160|581031902|FG000|Overall Study|Death|3|||
160901023|NCT01772160|581031902|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
160901024|NCT01772160|581031902|FG000|Overall Study|Consent withdrawal|3|||
160901025|NCT01772160|581031902|FG000|Overall Study|Migrated / moved from the study area|4|||
160901026|NCT01772160|581031902|FG000|Overall Study|Lost to Follow-up|30|||
160901027|NCT01772160|581031902|FG000|Overall Study|Other|5|||
160901028|NCT02202980|581031903|FG000|Overall Study|Lack of Efficacy|1|||
160901029|NCT02202980|581031904|FG001|Overall Study|Lack of Efficacy|0|||
160901030|NCT02202980|581031905|FG002|Overall Study|Lack of Efficacy|7|||
160988342|NCT00359619|581345249|FG000|Overall Study|Lost to Follow-up|4|||
160988343|NCT00359619|581345250|FG001|Overall Study|Lost to Follow-up|4|||
160988344|NCT00359619|581345251|FG002|Overall Study|Lost to Follow-up|2|||
160988345|NCT00359619|581345252|FG003|Overall Study|Lost to Follow-up|1|||
160988346|NCT00359619|581345253|FG004|Overall Study|Lost to Follow-up|1|||
160901031|NCT02202980|581031906|FG003|Overall Study|Lack of Efficacy|0|||
160901032|NCT02202980|581031907|FG004|Overall Study|Lack of Efficacy|3|||
160901033|NCT02202980|581031908|FG005|Overall Study|Lack of Efficacy|1|||
160820978|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
160820979|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
160820980|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
160901034|NCT02202980|581031909|FG006|Overall Study|Lack of Efficacy|11|||
160901035|NCT02202980|581031910|FG007|Overall Study|Lack of Efficacy|2|||
160901036|NCT02202980|581031911|FG008|Overall Study|Lack of Efficacy|2|||
160901037|NCT02202980|581031912|FG009|Overall Study|Lack of Efficacy|0|||
161132926|NCT02601950|581870777|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
160820981|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Other|1|||
160820982|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Other|1|||
160901038|NCT02202980|581031913|FG010|Overall Study|Lack of Efficacy|0|||
160901039|NCT02202980|581031914|FG011|Overall Study|Lack of Efficacy|3|||
160901040|NCT02202980|581031915|FG012|Overall Study|Lack of Efficacy|10|||
160988347|NCT00359619|581345254|FG005|Overall Study|Lost to Follow-up|5|||
160988348|NCT00359619|581345255|FG006|Overall Study|Lost to Follow-up|0|||
160988349|NCT00049517|581345256|FG000|Induction|Disease progression|0|||
160988350|NCT00049517|581345257|FG001|Induction|Disease progression|0|||
160988351|NCT00049517|581345258|FG002|Induction|Disease progression|0|||
160988352|NCT00049517|581345259|FG003|Induction|Disease progression|0|||
160988353|NCT00049517|581345260|FG004|Induction|Disease progression|18|||
160988354|NCT00049517|581345261|FG005|Induction|Disease progression|11|||
160988355|NCT00049517|581345256|FG000|Induction|Adverse Event|0|||
160988356|NCT00049517|581345257|FG001|Induction|Adverse Event|0|||
160988357|NCT00049517|581345258|FG002|Induction|Adverse Event|0|||
160988358|NCT00049517|581345259|FG003|Induction|Adverse Event|0|||
160988359|NCT00049517|581345260|FG004|Induction|Adverse Event|5|||
160988360|NCT00049517|581345261|FG005|Induction|Adverse Event|7|||
160988361|NCT00049517|581345256|FG000|Induction|Death|0|||
160988362|NCT00049517|581345257|FG001|Induction|Death|0|||
160988363|NCT00049517|581345258|FG002|Induction|Death|0|||
160988364|NCT00049517|581345259|FG003|Induction|Death|0|||
161240200|NCT01878292|582260541|FG000|Double-blind Treatment Period|Adverse Event|4|||
161240201|NCT01878292|582260542|FG001|Double-blind Treatment Period|Adverse Event|9|||
160988365|NCT00049517|581345260|FG004|Induction|Death|9|||
160988366|NCT00049517|581345261|FG005|Induction|Death|6|||
160988367|NCT00049517|581345256|FG000|Induction|Withdrawal by Subject|0|||
160988368|NCT00049517|581345257|FG001|Induction|Withdrawal by Subject|0|||
160988369|NCT00049517|581345258|FG002|Induction|Withdrawal by Subject|0|||
160988370|NCT00049517|581345259|FG003|Induction|Withdrawal by Subject|0|||
160988371|NCT00049517|581345260|FG004|Induction|Withdrawal by Subject|1|||
160988372|NCT00049517|581345261|FG005|Induction|Withdrawal by Subject|3|||
160988373|NCT00049517|581345256|FG000|Induction|Alternative therapy|0|||
160988374|NCT00049517|581345257|FG001|Induction|Alternative therapy|0|||
160988375|NCT00049517|581345258|FG002|Induction|Alternative therapy|0|||
160988376|NCT00049517|581345259|FG003|Induction|Alternative therapy|0|||
160988377|NCT00049517|581345260|FG004|Induction|Alternative therapy|2|||
160988378|NCT00049517|581345261|FG005|Induction|Alternative therapy|2|||
160988379|NCT00049517|581345256|FG000|Induction|Other complicating disease|0|||
160988380|NCT00049517|581345257|FG001|Induction|Other complicating disease|0|||
160988381|NCT00049517|581345258|FG002|Induction|Other complicating disease|0|||
160988382|NCT00049517|581345259|FG003|Induction|Other complicating disease|0|||
160988383|NCT00049517|581345260|FG004|Induction|Other complicating disease|3|||
160988384|NCT00049517|581345261|FG005|Induction|Other complicating disease|0|||
160988385|NCT00049517|581345256|FG000|Induction|Reasons not reported|0|||
160988386|NCT00049517|581345257|FG001|Induction|Reasons not reported|0|||
160988387|NCT00049517|581345258|FG002|Induction|Reasons not reported|0|||
160988388|NCT00049517|581345259|FG003|Induction|Reasons not reported|0|||
160988389|NCT00049517|581345260|FG004|Induction|Reasons not reported|22|||
160988390|NCT00049517|581345261|FG005|Induction|Reasons not reported|25|||
160988391|NCT00049517|581345256|FG000|Conditioning/Transplant|Disease progression|14|||
160988392|NCT00049517|581345257|FG001|Conditioning/Transplant|Disease progression|6|||
160988393|NCT00049517|581345258|FG002|Conditioning/Transplant|Disease progression|10|||
160988394|NCT00049517|581345259|FG003|Conditioning/Transplant|Disease progression|6|||
160988395|NCT00049517|581345260|FG004|Conditioning/Transplant|Disease progression|0|||
160988396|NCT00049517|581345261|FG005|Conditioning/Transplant|Disease progression|0|||
160988397|NCT00049517|581345256|FG000|Conditioning/Transplant|Adverse Event|2|||
160901041|NCT02202980|581031916|FG013|Overall Study|Lack of Efficacy|0|||
160901042|NCT02202980|581031903|FG000|Overall Study|Protocol Violation|0|||
160901043|NCT02202980|581031904|FG001|Overall Study|Protocol Violation|0|||
160901044|NCT02202980|581031905|FG002|Overall Study|Protocol Violation|0|||
160901045|NCT02202980|581031906|FG003|Overall Study|Protocol Violation|3|||
160901046|NCT02202980|581031907|FG004|Overall Study|Protocol Violation|3|||
160901047|NCT02202980|581031908|FG005|Overall Study|Protocol Violation|0|||
160901048|NCT02202980|581031909|FG006|Overall Study|Protocol Violation|0|||
160901049|NCT02202980|581031910|FG007|Overall Study|Protocol Violation|0|||
160901050|NCT02202980|581031911|FG008|Overall Study|Protocol Violation|0|||
160901051|NCT02202980|581031912|FG009|Overall Study|Protocol Violation|0|||
160901052|NCT02202980|581031913|FG010|Overall Study|Protocol Violation|0|||
160988398|NCT00049517|581345257|FG001|Conditioning/Transplant|Adverse Event|1|||
160988399|NCT00049517|581345258|FG002|Conditioning/Transplant|Adverse Event|4|||
160988400|NCT00049517|581345259|FG003|Conditioning/Transplant|Adverse Event|8|||
160988401|NCT00049517|581345260|FG004|Conditioning/Transplant|Adverse Event|0|||
160988402|NCT00049517|581345261|FG005|Conditioning/Transplant|Adverse Event|0|||
160988403|NCT00049517|581345256|FG000|Conditioning/Transplant|Death|1|||
160988404|NCT00049517|581345257|FG001|Conditioning/Transplant|Death|0|||
160988405|NCT00049517|581345258|FG002|Conditioning/Transplant|Death|0|||
160988406|NCT00049517|581345259|FG003|Conditioning/Transplant|Death|2|||
161240202|NCT01878292|582260543|FG002|Double-blind Treatment Period|Adverse Event|8|||
161240203|NCT01878292|582260541|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
161240204|NCT01878292|582260542|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
160988407|NCT00049517|581345260|FG004|Conditioning/Transplant|Death|0|||
160988408|NCT00049517|581345261|FG005|Conditioning/Transplant|Death|0|||
160988409|NCT00049517|581345256|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
160988410|NCT00049517|581345257|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
160988411|NCT00049517|581345258|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
160988412|NCT00049517|581345259|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
160988413|NCT00049517|581345260|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
160988414|NCT00049517|581345261|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
160988415|NCT00049517|581345256|FG000|Conditioning/Transplant|Alternative therapy|4|||
160988416|NCT00049517|581345257|FG001|Conditioning/Transplant|Alternative therapy|4|||
160988417|NCT00049517|581345258|FG002|Conditioning/Transplant|Alternative therapy|2|||
160988418|NCT00049517|581345259|FG003|Conditioning/Transplant|Alternative therapy|1|||
160988419|NCT00049517|581345260|FG004|Conditioning/Transplant|Alternative therapy|1|||
160988420|NCT00049517|581345261|FG005|Conditioning/Transplant|Alternative therapy|0|||
161333830|NCT03327324|582610632|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161333831|NCT03327324|582610633|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
160820983|NCT02075047|580729138|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
160820984|NCT02075047|580729139|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
160820985|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
160820986|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
160820987|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
160820988|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
160820989|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
160820990|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
160820991|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
160820992|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
160820993|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
160820994|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
160820995|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Other|1|||
160820996|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Other|2|||
160820997|NCT02075047|580729138|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
160820998|NCT02075047|580729139|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
160820999|NCT00075946|580729140|FG000|Overall Study|Path ineligible: undetermined histology|0|||
160821000|NCT00075946|580729141|FG001|Overall Study|Path ineligible: undetermined histology|0|||
160821001|NCT00075946|580729142|FG002|Overall Study|Path ineligible: undetermined histology|0|||
160821002|NCT00075946|580729143|FG003|Overall Study|Path ineligible: undetermined histology|0|||
160821003|NCT00075946|580729144|FG004|Overall Study|Path ineligible: undetermined histology|6|||
160821004|NCT00075946|580729140|FG000|Overall Study|Did not achieve response after induction|0|||
160821005|NCT00075946|580729141|FG001|Overall Study|Did not achieve response after induction|0|||
160821006|NCT00075946|580729142|FG002|Overall Study|Did not achieve response after induction|0|||
160821007|NCT00075946|580729143|FG003|Overall Study|Did not achieve response after induction|0|||
160821008|NCT00075946|580729144|FG004|Overall Study|Did not achieve response after induction|182|||
160821009|NCT00075946|580729140|FG000|Overall Study|Incorrectly randomized (no response)|5|||
160821010|NCT00075946|580729141|FG001|Overall Study|Incorrectly randomized (no response)|5|||
160821011|NCT00075946|580729142|FG002|Overall Study|Incorrectly randomized (no response)|5|||
160988421|NCT00049517|581345256|FG000|Conditioning/Transplant|Other complicating disease|2|||
160988422|NCT00049517|581345257|FG001|Conditioning/Transplant|Other complicating disease|0|||
160988423|NCT00049517|581345258|FG002|Conditioning/Transplant|Other complicating disease|0|||
160988424|NCT00049517|581345259|FG003|Conditioning/Transplant|Other complicating disease|4|||
160988425|NCT00049517|581345260|FG004|Conditioning/Transplant|Other complicating disease|0|||
160988426|NCT00049517|581345261|FG005|Conditioning/Transplant|Other complicating disease|1|||
160988427|NCT00049517|581345256|FG000|Conditioning/Transplant|Reasons not reported|25|||
160988428|NCT00049517|581345257|FG001|Conditioning/Transplant|Reasons not reported|31|||
160988429|NCT00049517|581345258|FG002|Conditioning/Transplant|Reasons not reported|18|||
160988430|NCT00049517|581345259|FG003|Conditioning/Transplant|Reasons not reported|15|||
160988431|NCT00049517|581345260|FG004|Conditioning/Transplant|Reasons not reported|5|||
160988432|NCT00049517|581345261|FG005|Conditioning/Transplant|Reasons not reported|5|||
160988433|NCT03929302|581345262|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
160988434|NCT03929302|581345263|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
160988435|NCT03929302|581345264|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
160988436|NCT03929302|581345262|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
160988437|NCT03929302|581345263|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
160988438|NCT03929302|581345264|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
160988439|NCT03929302|581345262|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
160821012|NCT00075946|580729143|FG003|Overall Study|Incorrectly randomized (no response)|1|||
160821013|NCT00075946|580729144|FG004|Overall Study|Incorrectly randomized (no response)|0|||
160821014|NCT00075946|580729140|FG000|Overall Study|Adverse Event|2|||
160988440|NCT03929302|581345263|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
160988441|NCT03929302|581345264|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
160988442|NCT04454567|581345265|FG000|Overall Study|Study Terminated by Sponsor|1|||
160988443|NCT04454567|581345266|FG001|Overall Study|Study Terminated by Sponsor|1|||
160821015|NCT00075946|580729141|FG001|Overall Study|Adverse Event|10|||
160821016|NCT00075946|580729142|FG002|Overall Study|Adverse Event|0|||
160821017|NCT00075946|580729143|FG003|Overall Study|Adverse Event|2|||
160821018|NCT00075946|580729144|FG004|Overall Study|Adverse Event|0|||
160821019|NCT00075946|580729140|FG000|Overall Study|Death|0|||
160821020|NCT00075946|580729141|FG001|Overall Study|Death|1|||
160821021|NCT00075946|580729142|FG002|Overall Study|Death|0|||
160821022|NCT00075946|580729143|FG003|Overall Study|Death|0|||
160821023|NCT00075946|580729144|FG004|Overall Study|Death|0|||
160821024|NCT00075946|580729140|FG000|Overall Study|Withdrawal by Subject|23|||
160821025|NCT00075946|580729141|FG001|Overall Study|Withdrawal by Subject|58|||
160821026|NCT00075946|580729142|FG002|Overall Study|Withdrawal by Subject|4|||
160821027|NCT00075946|580729143|FG003|Overall Study|Withdrawal by Subject|9|||
160821028|NCT00075946|580729144|FG004|Overall Study|Withdrawal by Subject|0|||
160821029|NCT00075946|580729140|FG000|Overall Study|Alternative therapy|16|||
160821030|NCT00075946|580729141|FG001|Overall Study|Alternative therapy|2|||
160821031|NCT00075946|580729142|FG002|Overall Study|Alternative therapy|5|||
160821032|NCT00075946|580729143|FG003|Overall Study|Alternative therapy|0|||
160821033|NCT00075946|580729144|FG004|Overall Study|Alternative therapy|0|||
160821034|NCT00075946|580729140|FG000|Overall Study|Other complicating disease|7|||
160821035|NCT00075946|580729141|FG001|Overall Study|Other complicating disease|13|||
160821036|NCT00075946|580729142|FG002|Overall Study|Other complicating disease|1|||
160821037|NCT00075946|580729143|FG003|Overall Study|Other complicating disease|4|||
160821038|NCT00075946|580729144|FG004|Overall Study|Other complicating disease|0|||
160821039|NCT00075946|580729140|FG000|Overall Study|No response to retreatment|23|||
160821040|NCT00075946|580729141|FG001|Overall Study|No response to retreatment|0|||
160821041|NCT00075946|580729142|FG002|Overall Study|No response to retreatment|2|||
160821042|NCT00075946|580729143|FG003|Overall Study|No response to retreatment|0|||
160821043|NCT00075946|580729144|FG004|Overall Study|No response to retreatment|0|||
160821044|NCT00075946|580729140|FG000|Overall Study|Time to progression less than 6 months|15|||
160821045|NCT00075946|580729141|FG001|Overall Study|Time to progression less than 6 months|30|||
160821046|NCT00075946|580729142|FG002|Overall Study|Time to progression less than 6 months|8|||
160821047|NCT00075946|580729143|FG003|Overall Study|Time to progression less than 6 months|3|||
160821048|NCT00075946|580729144|FG004|Overall Study|Time to progression less than 6 months|0|||
160821049|NCT00075946|580729140|FG000|Overall Study|Other|57|||
160821050|NCT00075946|580729141|FG001|Overall Study|Other|32|||
160821051|NCT00075946|580729142|FG002|Overall Study|Other|3|||
160821052|NCT00075946|580729143|FG003|Overall Study|Other|11|||
160901053|NCT02202980|581031914|FG011|Overall Study|Protocol Violation|0|||
160901054|NCT02202980|581031915|FG012|Overall Study|Protocol Violation|0|||
160901055|NCT02202980|581031916|FG013|Overall Study|Protocol Violation|0|||
160901056|NCT02202980|581031903|FG000|Overall Study|Lost to Follow-up|0|||
160901057|NCT02202980|581031904|FG001|Overall Study|Lost to Follow-up|1|||
160901058|NCT02202980|581031905|FG002|Overall Study|Lost to Follow-up|1|||
160901059|NCT02202980|581031906|FG003|Overall Study|Lost to Follow-up|1|||
160901060|NCT02202980|581031907|FG004|Overall Study|Lost to Follow-up|0|||
160901061|NCT02202980|581031908|FG005|Overall Study|Lost to Follow-up|0|||
160901062|NCT02202980|581031909|FG006|Overall Study|Lost to Follow-up|0|||
160901063|NCT02202980|581031910|FG007|Overall Study|Lost to Follow-up|1|||
160901064|NCT02202980|581031911|FG008|Overall Study|Lost to Follow-up|1|||
160901065|NCT02202980|581031912|FG009|Overall Study|Lost to Follow-up|0|||
160901066|NCT02202980|581031913|FG010|Overall Study|Lost to Follow-up|0|||
160901067|NCT02202980|581031914|FG011|Overall Study|Lost to Follow-up|0|||
160901068|NCT02202980|581031915|FG012|Overall Study|Lost to Follow-up|1|||
160901069|NCT02202980|581031916|FG013|Overall Study|Lost to Follow-up|0|||
160901070|NCT02202980|581031903|FG000|Overall Study|Withdrew Consent|0|||
160901071|NCT02202980|581031904|FG001|Overall Study|Withdrew Consent|1|||
160901072|NCT02202980|581031905|FG002|Overall Study|Withdrew Consent|2|||
160901073|NCT02202980|581031906|FG003|Overall Study|Withdrew Consent|0|||
160901074|NCT02202980|581031907|FG004|Overall Study|Withdrew Consent|0|||
160901075|NCT02202980|581031908|FG005|Overall Study|Withdrew Consent|0|||
160901076|NCT02202980|581031909|FG006|Overall Study|Withdrew Consent|0|||
160901077|NCT02202980|581031910|FG007|Overall Study|Withdrew Consent|0|||
160901078|NCT02202980|581031911|FG008|Overall Study|Withdrew Consent|1|||
160901079|NCT02202980|581031912|FG009|Overall Study|Withdrew Consent|0|||
160821053|NCT00075946|580729144|FG004|Overall Study|Other|0|||
160821054|NCT02231892|580729145|FG000|Overall Study|Lost to Follow-up|1|||
160901080|NCT02202980|581031913|FG010|Overall Study|Withdrew Consent|0|||
160901081|NCT02202980|581031914|FG011|Overall Study|Withdrew Consent|0|||
160901082|NCT02202980|581031915|FG012|Overall Study|Withdrew Consent|0|||
160901083|NCT02202980|581031916|FG013|Overall Study|Withdrew Consent|0|||
160901084|NCT01952145|581031917|FG000|Overall Study|Protocol Violation|2|||
160821055|NCT02231892|580729146|FG001|Overall Study|Lost to Follow-up|0|||
160821056|NCT02231892|580729147|FG002|Overall Study|Lost to Follow-up|3|||
160821057|NCT02231892|580729145|FG000|Overall Study|Withdrawal by Subject|4|||
160821058|NCT02231892|580729146|FG001|Overall Study|Withdrawal by Subject|3|||
160821059|NCT02231892|580729147|FG002|Overall Study|Withdrawal by Subject|15|||
160821060|NCT02231892|580729145|FG000|Overall Study|Physician Decision|0|||
160821061|NCT02231892|580729146|FG001|Overall Study|Physician Decision|2|||
161132927|NCT02601950|581870778|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
161132928|NCT02601950|581870771|FG000|Overall Study|Non-compliance|0|||
161132929|NCT02601950|581870772|FG001|Overall Study|Non-compliance|1|||
161132930|NCT02601950|581870773|FG002|Overall Study|Non-compliance|0|||
161132931|NCT02601950|581870774|FG003|Overall Study|Non-compliance|0|||
161132932|NCT02601950|581870775|FG004|Overall Study|Non-compliance|0|||
161132933|NCT02601950|581870776|FG005|Overall Study|Non-compliance|1|||
161132934|NCT02601950|581870777|FG006|Overall Study|Non-compliance|1|||
161132935|NCT02601950|581870778|FG007|Overall Study|Non-compliance|0|||
161132936|NCT02601950|581870771|FG000|Overall Study|Participant refused further study treatment|0|||
161132937|NCT02601950|581870772|FG001|Overall Study|Participant refused further study treatment|1|||
161132938|NCT02601950|581870773|FG002|Overall Study|Participant refused further study treatment|1|||
161132939|NCT02601950|581870774|FG003|Overall Study|Participant refused further study treatment|0|||
161132940|NCT02601950|581870775|FG004|Overall Study|Participant refused further study treatment|2|||
161132941|NCT02601950|581870776|FG005|Overall Study|Participant refused further study treatment|2|||
161132942|NCT02601950|581870777|FG006|Overall Study|Participant refused further study treatment|2|||
161132943|NCT02601950|581870778|FG007|Overall Study|Participant refused further study treatment|1|||
161132944|NCT02601950|581870771|FG000|Overall Study|Investigator discretion|1|||
161132945|NCT02601950|581870772|FG001|Overall Study|Investigator discretion|0|||
161132946|NCT02601950|581870773|FG002|Overall Study|Investigator discretion|1|||
161132947|NCT02601950|581870774|FG003|Overall Study|Investigator discretion|0|||
161132948|NCT02601950|581870775|FG004|Overall Study|Investigator discretion|1|||
161132949|NCT02601950|581870776|FG005|Overall Study|Investigator discretion|1|||
160821062|NCT02231892|580729147|FG002|Overall Study|Physician Decision|4|||
160821063|NCT02231892|580729145|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
160821064|NCT02231892|580729146|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
160821065|NCT02231892|580729147|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
160821066|NCT02231892|580729145|FG000|Overall Study|Participant motor threshold was >83%|0|||
160821067|NCT02231892|580729146|FG001|Overall Study|Participant motor threshold was >83%|0|||
160821068|NCT02231892|580729147|FG002|Overall Study|Participant motor threshold was >83%|9|||
160821069|NCT02231892|580729145|FG000|Overall Study|Could not find motor threshold|2|||
160821070|NCT02231892|580729146|FG001|Overall Study|Could not find motor threshold|0|||
160821071|NCT02231892|580729147|FG002|Overall Study|Could not find motor threshold|1|||
160821072|NCT02231892|580729145|FG000|Overall Study|Could not find reliable motor hotspot|0|||
160821073|NCT02231892|580729146|FG001|Overall Study|Could not find reliable motor hotspot|0|||
160821074|NCT02231892|580729147|FG002|Overall Study|Could not find reliable motor hotspot|1|||
160821075|NCT00223977|580729156|FG000|Overall Study|Adverse Event|7|||
160821076|NCT00223977|580729157|FG001|Overall Study|Adverse Event|10|||
160821077|NCT00223977|580729158|FG002|Overall Study|Adverse Event|0|||
160821078|NCT00223977|580729156|FG000|Overall Study|Protocol Violation|0|||
160821079|NCT00223977|580729157|FG001|Overall Study|Protocol Violation|0|||
160821080|NCT00223977|580729158|FG002|Overall Study|Protocol Violation|1|||
160821081|NCT00223977|580729156|FG000|Overall Study|Withdrawal by Subject|1|||
160821082|NCT00223977|580729157|FG001|Overall Study|Withdrawal by Subject|1|||
160821083|NCT00223977|580729158|FG002|Overall Study|Withdrawal by Subject|2|||
160821084|NCT00223977|580729156|FG000|Overall Study|Other|1|||
160821085|NCT00223977|580729157|FG001|Overall Study|Other|0|||
160821086|NCT00223977|580729158|FG002|Overall Study|Other|0|||
160821087|NCT02359045|580729159|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
160821088|NCT02359045|580729160|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160821089|NCT02359045|580729159|FG000|Overall Study|Lost to Follow-up|1|||
160821090|NCT02359045|580729160|FG001|Overall Study|Lost to Follow-up|1|||
160821091|NCT02359045|580729159|FG000|Overall Study|Adverse Event|0|||
160821092|NCT02359045|580729160|FG001|Overall Study|Adverse Event|1|||
160821093|NCT00503581|580729169|FG000|Overall Study|Study closed|3|||
160821094|NCT00503581|580729170|FG001|Overall Study|Study closed|4|||
160821095|NCT00503581|580729171|FG002|Overall Study|Study closed|2|||
160821096|NCT03099174|580729183|FG000|Overall Study|Withdrawal by Subject|0|||
160821097|NCT03099174|580729184|FG001|Overall Study|Withdrawal by Subject|0|||
160821098|NCT03099174|580729185|FG002|Overall Study|Withdrawal by Subject|1|||
161132950|NCT02601950|581870777|FG006|Overall Study|Investigator discretion|1|||
161132951|NCT02601950|581870778|FG007|Overall Study|Investigator discretion|0|||
161132952|NCT02601950|581870771|FG000|Overall Study|Other|0|||
161132953|NCT02601950|581870772|FG001|Overall Study|Other|0|||
161132954|NCT02601950|581870773|FG002|Overall Study|Other|0|||
161132955|NCT02601950|581870774|FG003|Overall Study|Other|0|||
161132956|NCT02601950|581870775|FG004|Overall Study|Other|2|||
160821099|NCT03099174|580729186|FG003|Overall Study|Withdrawal by Subject|0|||
160821100|NCT03099174|580729187|FG004|Overall Study|Withdrawal by Subject|2|||
160821101|NCT03099174|580729188|FG005|Overall Study|Withdrawal by Subject|2|||
160821102|NCT03099174|580729189|FG006|Overall Study|Withdrawal by Subject|1|||
161132957|NCT02601950|581870776|FG005|Overall Study|Other|2|||
161132958|NCT02601950|581870777|FG006|Overall Study|Other|1|||
161132959|NCT02601950|581870778|FG007|Overall Study|Other|0|||
161132960|NCT02157883|581870779|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
160901085|NCT01952145|581031918|FG001|Overall Study|Protocol Violation|1|||
160901086|NCT01952145|581031917|FG000|Overall Study|Death|0|||
160901087|NCT01952145|581031918|FG001|Overall Study|Death|1|||
160901088|NCT01952145|581031917|FG000|Overall Study|Adverse Event|9|||
160901089|NCT01952145|581031918|FG001|Overall Study|Adverse Event|0|||
160901090|NCT01952145|581031917|FG000|Overall Study|Withdrawal Criteria|16|||
160901091|NCT01952145|581031918|FG001|Overall Study|Withdrawal Criteria|11|||
160901092|NCT01952145|581031917|FG000|Overall Study|Unclassified|1|||
160901093|NCT01952145|581031918|FG001|Overall Study|Unclassified|1|||
160901094|NCT01540838|581031922|FG000|Overall Study|Open nasogastric tube|9|||
160901095|NCT01540838|581031923|FG001|Overall Study|Open nasogastric tube|7|||
160901096|NCT01540838|581031922|FG000|Overall Study|Treatment doses missing|8|||
160901097|NCT01540838|581031923|FG001|Overall Study|Treatment doses missing|12|||
160901098|NCT01540838|581031922|FG000|Overall Study|Additional antibiotic treatment|1|||
160901099|NCT01540838|581031923|FG001|Overall Study|Additional antibiotic treatment|2|||
160901100|NCT01540838|581031922|FG000|Overall Study|Died before treatment initiation|1|||
160901101|NCT01540838|581031923|FG001|Overall Study|Died before treatment initiation|1|||
160901102|NCT01540838|581031922|FG000|Overall Study|Not BM. Other treatment|3|||
160901103|NCT01540838|581031923|FG001|Overall Study|Not BM. Other treatment|1|||
160901104|NCT02130570|581031924|FG000|Overall Study|Death|3|||
160901105|NCT02130570|581031925|FG001|Overall Study|Death|5|||
160901106|NCT02130570|581031924|FG000|Overall Study|Withdrawal by Subject|6|||
160901107|NCT02130570|581031925|FG001|Overall Study|Withdrawal by Subject|3|||
160901108|NCT02130570|581031924|FG000|Overall Study|Part of practice that discontinued study|0|||
160901109|NCT02130570|581031925|FG001|Overall Study|Part of practice that discontinued study|5|||
160901110|NCT02808650|581031935|FG000|Overall Study|Death|0|||
160901111|NCT02808650|581031936|FG001|Overall Study|Death|0|||
160901112|NCT02808650|581031937|FG002|Overall Study|Death|0|||
160901113|NCT02808650|581031938|FG003|Overall Study|Death|0|||
160901114|NCT02808650|581031939|FG004|Overall Study|Death|1|||
160901115|NCT02808650|581031935|FG000|Overall Study|Lack of Efficacy|5|||
160901116|NCT02808650|581031936|FG001|Overall Study|Lack of Efficacy|5|||
160901117|NCT02808650|581031937|FG002|Overall Study|Lack of Efficacy|6|||
160901118|NCT02808650|581031938|FG003|Overall Study|Lack of Efficacy|5|||
160901119|NCT02808650|581031939|FG004|Overall Study|Lack of Efficacy|4|||
160901120|NCT02808650|581031935|FG000|Overall Study|Physician Decision|1|||
160901121|NCT02808650|581031936|FG001|Overall Study|Physician Decision|1|||
160901122|NCT02808650|581031937|FG002|Overall Study|Physician Decision|0|||
160901123|NCT02808650|581031938|FG003|Overall Study|Physician Decision|0|||
160901124|NCT02808650|581031939|FG004|Overall Study|Physician Decision|0|||
160901125|NCT02808650|581031935|FG000|Overall Study|Withdrawal by Subject|0|||
160901126|NCT02808650|581031936|FG001|Overall Study|Withdrawal by Subject|0|||
160901127|NCT02808650|581031937|FG002|Overall Study|Withdrawal by Subject|0|||
160901128|NCT02808650|581031938|FG003|Overall Study|Withdrawal by Subject|1|||
160901129|NCT02808650|581031939|FG004|Overall Study|Withdrawal by Subject|1|||
160901130|NCT00071396|581031947|FG000|Overall Study|Withdrawal by Subject|1|||
160901131|NCT00071396|581031947|FG000|Overall Study|Physician Decision|2|||
160901132|NCT00113087|581031948|FG000|Overall Study|Death or Transplant|14|||
160901133|NCT00113087|581031949|FG001|Overall Study|Death or Transplant|16|||
160901134|NCT00113087|581031948|FG000|Overall Study|Family or MD withdrew subject|10|||
160901135|NCT00113087|581031949|FG001|Overall Study|Family or MD withdrew subject|5|||
160901136|NCT00633750|581031951|FG000|Overall Study|Adverse Event|2|||
160901137|NCT00633750|581031951|FG000|Overall Study|Withdrawal by Subject|3|||
160901138|NCT01903031|581031952|FG000|Overall Study|Not Able to Attend Clinic|1|||
160901139|NCT01903031|581031953|FG001|Overall Study|Not Able to Attend Clinic|1|||
160901140|NCT01903031|581031954|FG002|Overall Study|Not Able to Attend Clinic|0|||
160901141|NCT01903031|581031952|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
160901142|NCT01903031|581031953|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
160901143|NCT01903031|581031954|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
160901144|NCT01903031|581031952|FG000|Overall Study|Adverse Event|0|||
160901145|NCT01903031|581031953|FG001|Overall Study|Adverse Event|1|||
160901146|NCT01903031|581031954|FG002|Overall Study|Adverse Event|0|||
160901147|NCT01903031|581031952|FG000|Overall Study|Withdrawal by Subject|0|||
160901148|NCT01903031|581031953|FG001|Overall Study|Withdrawal by Subject|1|||
160901149|NCT01903031|581031954|FG002|Overall Study|Withdrawal by Subject|1|||
160901150|NCT01903031|581031952|FG000|Overall Study|Protocol Violation|0|||
160901151|NCT01903031|581031953|FG001|Overall Study|Protocol Violation|0|||
160901152|NCT01903031|581031954|FG002|Overall Study|Protocol Violation|2|||
160901153|NCT01903031|581031952|FG000|Overall Study|Lost to Follow-up|0|||
160901154|NCT01903031|581031953|FG001|Overall Study|Lost to Follow-up|0|||
160901155|NCT01903031|581031954|FG002|Overall Study|Lost to Follow-up|1|||
160901156|NCT01903031|581031952|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
160901157|NCT01903031|581031953|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
160901158|NCT01903031|581031954|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
160901159|NCT01811225|581031955|FG000|Treatment Period 1|Adverse Event|2|||
160901160|NCT01811225|581031956|FG001|Treatment Period 1|Adverse Event|3|||
160901161|NCT01811225|581031955|FG000|Treatment Period 1|Lost to Follow-up|12|||
161240205|NCT01878292|582260543|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
161240206|NCT00323882|582260544|FG000|Overall Study|Adverse Event|2|||
161240207|NCT00323882|582260545|FG001|Overall Study|Adverse Event|1|||
160821103|NCT03099174|580729190|FG007|Overall Study|Withdrawal by Subject|4|||
160821104|NCT03099174|580729183|FG000|Overall Study|Adverse Event|0|||
160821105|NCT03099174|580729184|FG001|Overall Study|Adverse Event|1|||
160821106|NCT03099174|580729185|FG002|Overall Study|Adverse Event|1|||
160821107|NCT03099174|580729186|FG003|Overall Study|Adverse Event|2|||
160821108|NCT03099174|580729187|FG004|Overall Study|Adverse Event|5|||
160821109|NCT03099174|580729188|FG005|Overall Study|Adverse Event|3|||
160821110|NCT03099174|580729189|FG006|Overall Study|Adverse Event|6|||
160821111|NCT03099174|580729190|FG007|Overall Study|Adverse Event|4|||
160821112|NCT03099174|580729183|FG000|Overall Study|Other than listed|6|||
160821113|NCT03099174|580729184|FG001|Overall Study|Other than listed|6|||
160821114|NCT03099174|580729185|FG002|Overall Study|Other than listed|5|||
160821115|NCT03099174|580729186|FG003|Overall Study|Other than listed|6|||
160821116|NCT03099174|580729187|FG004|Overall Study|Other than listed|19|||
160821117|NCT03099174|580729188|FG005|Overall Study|Other than listed|10|||
160821118|NCT03099174|580729189|FG006|Overall Study|Other than listed|26|||
160821119|NCT03099174|580729190|FG007|Overall Study|Other than listed|23|||
160821120|NCT02438683|580729191|FG000|Overall Study|Adverse Event|1|||
160821121|NCT02438683|580729192|FG001|Overall Study|Adverse Event|0|||
160821122|NCT02438683|580729193|FG002|Overall Study|Adverse Event|0|||
160821123|NCT02438683|580729194|FG003|Overall Study|Adverse Event|0|||
160821124|NCT02438683|580729195|FG004|Overall Study|Adverse Event|0|||
160821125|NCT02438683|580729196|FG005|Overall Study|Adverse Event|0|||
160821126|NCT00721578|580729197|FG000|Overall Study|Death|1|||
160821127|NCT00721578|580729198|FG001|Overall Study|Death|1|||
160821128|NCT00721578|580729197|FG000|Overall Study|Withdrawal by Subject|1|||
160821129|NCT00721578|580729198|FG001|Overall Study|Withdrawal by Subject|1|||
160821130|NCT00211757|580729212|FG000|Overall Study|Withdrawal by Subject|1|||
160821131|NCT00211757|580729213|FG001|Overall Study|Withdrawal by Subject|1|||
161240208|NCT00323882|582260546|FG002|Overall Study|Adverse Event|1|||
161240209|NCT00323882|582260547|FG003|Overall Study|Adverse Event|1|||
161240210|NCT00323882|582260548|FG004|Overall Study|Adverse Event|3|||
161240211|NCT00323882|582260544|FG000|Overall Study|Disease Progression|6|||
161240212|NCT00323882|582260545|FG001|Overall Study|Disease Progression|4|||
161240213|NCT00323882|582260546|FG002|Overall Study|Disease Progression|10|||
161240214|NCT00323882|582260547|FG003|Overall Study|Disease Progression|5|||
161240215|NCT00323882|582260548|FG004|Overall Study|Disease Progression|22|||
161240216|NCT00323882|582260544|FG000|Overall Study|Death|0|||
161240217|NCT00323882|582260545|FG001|Overall Study|Death|1|||
161240218|NCT00323882|582260546|FG002|Overall Study|Death|1|||
161240219|NCT00323882|582260547|FG003|Overall Study|Death|0|||
161240220|NCT00323882|582260548|FG004|Overall Study|Death|5|||
161240221|NCT00323882|582260544|FG000|Overall Study|Lost to Follow-up|0|||
161240222|NCT00323882|582260545|FG001|Overall Study|Lost to Follow-up|0|||
161240223|NCT00323882|582260546|FG002|Overall Study|Lost to Follow-up|1|||
161240224|NCT00323882|582260547|FG003|Overall Study|Lost to Follow-up|0|||
161240225|NCT00323882|582260548|FG004|Overall Study|Lost to Follow-up|1|||
161240226|NCT00323882|582260544|FG000|Overall Study|Other|0|||
161240227|NCT00323882|582260545|FG001|Overall Study|Other|0|||
161240228|NCT00323882|582260546|FG002|Overall Study|Other|0|||
161240229|NCT00323882|582260547|FG003|Overall Study|Other|1|||
161240230|NCT00323882|582260548|FG004|Overall Study|Other|1|||
161240231|NCT03123471|582260557|FG000|Placebo-controlled Phase|Adverse Event|3|||
161240232|NCT03123471|582260558|FG001|Placebo-controlled Phase|Adverse Event|8|||
161240233|NCT03123471|582260557|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
161240234|NCT03123471|582260558|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
161240235|NCT03123471|582260557|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
161240236|NCT03123471|582260558|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
160821132|NCT00211757|580729212|FG000|Overall Study|Lack of Efficacy|0|||
160901162|NCT01811225|581031956|FG001|Treatment Period 1|Lost to Follow-up|8|||
160901163|NCT01811225|581031955|FG000|Treatment Period 1|transporation|1|||
160901164|NCT01811225|581031956|FG001|Treatment Period 1|transporation|0|||
160901165|NCT01811225|581031955|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
160901166|NCT01811225|581031956|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
160821133|NCT00211757|580729213|FG001|Overall Study|Lack of Efficacy|1|||
160821134|NCT02825420|580729215|FG000|Overall Study|Death|30|||
160821135|NCT02825420|580729216|FG001|Overall Study|Death|12|||
160821136|NCT02825420|580729215|FG000|Overall Study|Progressive disease|6|||
160821137|NCT02825420|580729216|FG001|Overall Study|Progressive disease|1|||
160901167|NCT01811225|581031955|FG000|Treatment Period 2|Lost to Follow-up|1|||
160901168|NCT01811225|581031956|FG001|Treatment Period 2|Lost to Follow-up|2|||
160901169|NCT01811225|581031955|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
160901170|NCT01811225|581031956|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
160901171|NCT03000569|581031957|FG000|Overall Study|Withdrawal by Subject|1|||
160901172|NCT03000569|581031958|FG001|Overall Study|Withdrawal by Subject|0|||
160901173|NCT02298023|581031959|FG000|Overall Study|Withdrawal by Subject|1|||
161240237|NCT03123471|582260557|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
161240238|NCT03123471|582260558|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
161240239|NCT03123471|582260557|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
161240240|NCT03123471|582260558|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
160821138|NCT02825420|580729215|FG000|Overall Study|Lost to Follow-up|2|||
160821139|NCT02825420|580729216|FG001|Overall Study|Lost to Follow-up|2|||
160821140|NCT02825420|580729215|FG000|Overall Study|Withdrawal by Subject|1|||
160821141|NCT02825420|580729216|FG001|Overall Study|Withdrawal by Subject|1|||
160821142|NCT02825420|580729215|FG000|Overall Study|Protocol amendment not signed|1|||
160821143|NCT02825420|580729216|FG001|Overall Study|Protocol amendment not signed|1|||
160821144|NCT02825420|580729215|FG000|Overall Study|Physician Decision|1|||
160821145|NCT02825420|580729216|FG001|Overall Study|Physician Decision|0|||
160821146|NCT02825420|580729215|FG000|Overall Study|Did not receive PLD|2|||
160821147|NCT02825420|580729216|FG001|Overall Study|Did not receive PLD|0|||
160821148|NCT02226198|580731171|FG000|Lead-in Phase|Protocol Violation|1|||
160821149|NCT02226198|580731172|FG001|Lead-in Phase|Protocol Violation|0|||
160821150|NCT02226198|580731173|FG002|Lead-in Phase|Protocol Violation|0|||
160821151|NCT02226198|580731171|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
160821152|NCT02226198|580731172|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
160821153|NCT02226198|580731173|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
160821154|NCT01440517|580731177|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
160821155|NCT01288612|580731178|FG000|Overall Study|Unable to contact|11|||
160821156|NCT01288612|580731179|FG001|Overall Study|Unable to contact|16|||
160821157|NCT01288612|580731180|FG002|Overall Study|Unable to contact|20|||
160821158|NCT01288612|580731178|FG000|Overall Study|Declined|78|||
160821159|NCT01288612|580731179|FG001|Overall Study|Declined|63|||
160821160|NCT01288612|580731180|FG002|Overall Study|Declined|62|||
160821161|NCT01288612|580731178|FG000|Overall Study|Unable to intubate|0|||
160821162|NCT01288612|580731179|FG001|Overall Study|Unable to intubate|3|||
160821163|NCT01288612|580731180|FG002|Overall Study|Unable to intubate|0|||
160821164|NCT00871923|580731181|FG000|Overall Study|Death|1|||
160821165|NCT00871923|580731181|FG000|Overall Study|Withdrawal by Subject|1|||
160821166|NCT00496483|580731187|FG000|Overall Study|Not dosed|9|||
160821167|NCT00496483|580731187|FG000|Overall Study|Adverse Event|2|||
160821168|NCT00496483|580731187|FG000|Overall Study|Lack of Efficacy|1|||
160821169|NCT04258995|580731189|FG000|Overall Study|Lost to Follow-up|1|||
160821170|NCT04258995|580731190|FG001|Overall Study|Lost to Follow-up|1|||
160821171|NCT01145352|580731194|FG000|Overall Study|Found to have been registered twice|6|||
160821172|NCT01145352|580731194|FG000|Overall Study|Treated before marketing approval|4|||
160821173|NCT01145352|580731194|FG000|Overall Study|Syringe formulation was used|1|||
160821174|NCT00847665|580731195|FG000|Overall Study|Withdrawal by Subject|1|||
160988444|NCT02757885|581345268|FG000|Overall Study|Screen Failures|4|||
160988445|NCT01175707|581345269|FG000|Overall Study|Adverse Event|4|||
160988446|NCT01175707|581345270|FG001|Overall Study|Adverse Event|6|||
160988447|NCT01456780|581345271|FG000|Overall Study|Lost to Follow-up|3|||
160988448|NCT01456780|581345272|FG001|Overall Study|Lost to Follow-up|3|||
160988449|NCT01456780|581345273|FG002|Overall Study|Lost to Follow-up|0|||
160988450|NCT02688621|581345280|FG000|Overall Study|Pregnancy|1|||
160988451|NCT02688621|581345281|FG001|Overall Study|Pregnancy|3|||
160821175|NCT00847665|580731196|FG001|Overall Study|Withdrawal by Subject|0|||
160821176|NCT00585546|580731197|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
161240241|NCT03123471|582260557|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
161240242|NCT03123471|582260558|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
160821177|NCT00585546|580731197|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
160821178|NCT02851797|580731198|FG000|Overall Study|Withdrawal by Subject|4|||
160821179|NCT02851797|580731199|FG001|Overall Study|Withdrawal by Subject|2|||
160821180|NCT02851797|580731198|FG000|Overall Study|Adverse Event|3|||
160821181|NCT02851797|580731199|FG001|Overall Study|Adverse Event|0|||
160821182|NCT03077438|580731200|FG000|Overall Study|Protocol Violation|3|||
160988452|NCT02688621|581345280|FG000|Overall Study|Lost to Follow-up|38|||
160988453|NCT02688621|581345281|FG001|Overall Study|Lost to Follow-up|15|||
160988454|NCT02688621|581345280|FG000|Overall Study|Withdrawal by Subject|1|||
160988455|NCT02688621|581345281|FG001|Overall Study|Withdrawal by Subject|0|||
160821183|NCT03077438|580731201|FG001|Overall Study|Protocol Violation|5|||
160821184|NCT03077438|580731200|FG000|Overall Study|Withdrawal by Subject|3|||
160821185|NCT03077438|580731201|FG001|Overall Study|Withdrawal by Subject|6|||
160988456|NCT05349864|581345288|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
160821186|NCT03077438|580731200|FG000|Overall Study|Lost to Follow-up|6|||
160821187|NCT03077438|580731201|FG001|Overall Study|Lost to Follow-up|3|||
160821188|NCT00813865|580731202|FG000|Overall Study|Failure to Respond|3|||
160821189|NCT00813865|580731202|FG000|Overall Study|Lost to Follow-up|3|||
160821190|NCT00813865|580731202|FG000|Overall Study|Withdrawal by Subject|1|||
160821191|NCT00624585|580731204|FG000|Overall Study|Death|3|||
161240243|NCT03123471|582260557|FG000|Placebo-controlled Phase|Miscellaneous|0|||
160988457|NCT05349864|581345289|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
160988458|NCT00984282|581345290|FG000|Double Blind Treatment|Adverse Event|40|||
160988459|NCT00984282|581345291|FG001|Double Blind Treatment|Adverse Event|6|||
160821192|NCT00624585|580731204|FG000|Overall Study|Disease Progression|6|||
160821193|NCT00624585|580731204|FG000|Overall Study|Adverse Event|3|||
160821194|NCT04686084|580731213|FG000|Overall Study|Lost to Follow-up|1|||
160821195|NCT00676520|580731214|FG000|Overall Study|Withdrawal by Subject|163|||
160821196|NCT00676520|580731214|FG000|Overall Study|Lost to Follow-up|162|||
160821197|NCT00676520|580731214|FG000|Overall Study|Death|159|||
160821198|NCT00676520|580731214|FG000|Overall Study|Physician Decision|20|||
160821199|NCT00676520|580731214|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
160821200|NCT00676520|580731214|FG000|Overall Study|Other Reason|18|||
160821201|NCT01425359|580731215|FG000|Overall Study|Randomized but Not Treated|2|||
160821202|NCT01425359|580731216|FG001|Overall Study|Randomized but Not Treated|3|||
160821203|NCT01425359|580731215|FG000|Overall Study|Adverse Event|9|||
160821204|NCT01425359|580731216|FG001|Overall Study|Adverse Event|8|||
160821205|NCT01425359|580731215|FG000|Overall Study|Revascularization|0|||
160821206|NCT01425359|580731216|FG001|Overall Study|Revascularization|1|||
160821207|NCT01425359|580731215|FG000|Overall Study|Death|0|||
160821208|NCT01425359|580731216|FG001|Overall Study|Death|1|||
160821209|NCT01425359|580731215|FG000|Overall Study|Unsatisfactory Response|1|||
160821210|NCT01425359|580731216|FG001|Overall Study|Unsatisfactory Response|0|||
160821211|NCT01425359|580731215|FG000|Overall Study|Protocol Violation|1|||
160821212|NCT01425359|580731216|FG001|Overall Study|Protocol Violation|2|||
160821213|NCT01425359|580731215|FG000|Overall Study|Subject Withdrew Consent|1|||
160821214|NCT01425359|580731216|FG001|Overall Study|Subject Withdrew Consent|2|||
160821215|NCT01425359|580731215|FG000|Overall Study|Investigator's Discretion|2|||
160821216|NCT01425359|580731216|FG001|Overall Study|Investigator's Discretion|0|||
160821217|NCT01425359|580731215|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
160821218|NCT01425359|580731216|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
160821219|NCT02135029|580731220|FG000|Overall Study|Adverse Event|2|||
160821220|NCT02135029|580731221|FG001|Overall Study|Adverse Event|2|||
160821221|NCT02135029|580731222|FG002|Overall Study|Adverse Event|2|||
160821222|NCT02135029|580731220|FG000|Overall Study|Lost to Follow-up|0|||
160821223|NCT02135029|580731221|FG001|Overall Study|Lost to Follow-up|1|||
160821224|NCT02135029|580731222|FG002|Overall Study|Lost to Follow-up|0|||
160821225|NCT02135029|580731220|FG000|Overall Study|Withdrawal by Subject|2|||
160821226|NCT02135029|580731221|FG001|Overall Study|Withdrawal by Subject|0|||
160821227|NCT02135029|580731222|FG002|Overall Study|Withdrawal by Subject|1|||
160821228|NCT02135029|580731220|FG000|Overall Study|Other|0|||
160821229|NCT02135029|580731221|FG001|Overall Study|Other|1|||
160821230|NCT02135029|580731222|FG002|Overall Study|Other|0|||
160821231|NCT02135029|580731220|FG000|Overall Study|Death|0|||
160821232|NCT02135029|580731221|FG001|Overall Study|Death|1|||
160821233|NCT02135029|580731222|FG002|Overall Study|Death|0|||
160821234|NCT04043234|580731223|FG000|Overall Study|Lost to Follow-up|1|||
160821235|NCT04043234|580731223|FG000|Overall Study|Withdrawal by Subject|1|||
160821236|NCT00744978|580731239|FG000|Period 1|Lost to Follow-up|1|||
160821237|NCT00744978|580731240|FG001|Period 1|Lost to Follow-up|0|||
160821238|NCT00744978|580731239|FG000|Period 1|Withdrawal by Subject|0|||
160821239|NCT00744978|580731240|FG001|Period 1|Withdrawal by Subject|2|||
160821240|NCT00744978|580731239|FG000|Period 1|Other|0|||
160821241|NCT00744978|580731240|FG001|Period 1|Other|2|||
160821242|NCT00744978|580731239|FG000|Period 1|Adverse Event|4|||
160821243|NCT00744978|580731240|FG001|Period 1|Adverse Event|0|||
160821244|NCT00744978|580731239|FG000|Period 1|Randomized but not Treated|1|||
160821245|NCT00744978|580731240|FG001|Period 1|Randomized but not Treated|1|||
160821246|NCT00744978|580731239|FG000|Period 2|Adverse Event|0|||
160988460|NCT00984282|581345290|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
160988461|NCT00984282|581345291|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
161333832|NCT03327324|582610634|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
161333833|NCT03327324|582610629|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333834|NCT03327324|582610630|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
160821247|NCT00744978|580731240|FG001|Period 2|Adverse Event|1|||
160821248|NCT03773133|580731241|FG000|Overall Study|Screen Failure|8|||
160821249|NCT00515294|580731242|FG000|Overall Study|Lost to Follow-up|3|||
160821250|NCT00515294|580731243|FG001|Overall Study|Lost to Follow-up|2|||
160821251|NCT00515294|580731244|FG002|Overall Study|Lost to Follow-up|3|||
160821252|NCT00515294|580731245|FG003|Overall Study|Lost to Follow-up|1|||
160821253|NCT00515294|580731242|FG000|Overall Study|Driver simulator problems|1|||
160821254|NCT00515294|580731243|FG001|Overall Study|Driver simulator problems|1|||
160821255|NCT00515294|580731244|FG002|Overall Study|Driver simulator problems|1|||
160821256|NCT00515294|580731245|FG003|Overall Study|Driver simulator problems|3|||
160821257|NCT00515294|580731242|FG000|Overall Study|Caffeine amount inaccurate|5|||
160821258|NCT00515294|580731243|FG001|Overall Study|Caffeine amount inaccurate|0|||
160821259|NCT00515294|580731244|FG002|Overall Study|Caffeine amount inaccurate|7|||
160821260|NCT00515294|580731245|FG003|Overall Study|Caffeine amount inaccurate|0|||
160821261|NCT02778555|580731248|FG000|Overall Study|Withdrawal by Subject|55|||
160821262|NCT02778555|580731249|FG001|Overall Study|Withdrawal by Subject|32|||
160821263|NCT02778555|580731250|FG002|Overall Study|Withdrawal by Subject|107|||
160821264|NCT03276026|580731253|FG000|Overall Study|Protocol Violation|1|||
160821265|NCT03276026|580731254|FG001|Overall Study|Protocol Violation|0|||
160821266|NCT01534260|580731255|FG000|Overall Study|Adverse Event|1|||
160821267|NCT01534260|580731256|FG001|Overall Study|Adverse Event|8|||
160821268|NCT01534260|580731255|FG000|Overall Study|Death|2|||
160821269|NCT01534260|580731256|FG001|Overall Study|Death|0|||
160821270|NCT01534260|580731255|FG000|Overall Study|Lack of Efficacy|1|||
160821271|NCT01534260|580731256|FG001|Overall Study|Lack of Efficacy|1|||
160821272|NCT01534260|580731255|FG000|Overall Study|Withdrawal by Subject|1|||
160821273|NCT01534260|580731256|FG001|Overall Study|Withdrawal by Subject|3|||
160821274|NCT01534260|580731255|FG000|Overall Study|Disease Progression|8|||
160821275|NCT01534260|580731256|FG001|Overall Study|Disease Progression|6|||
160821276|NCT01534260|580731255|FG000|Overall Study|Physician Decision|3|||
160821277|NCT01534260|580731256|FG001|Overall Study|Physician Decision|1|||
160821278|NCT01534260|580731255|FG000|Overall Study|No treatment, per protocol|0|||
160821279|NCT01534260|580731256|FG001|Overall Study|No treatment, per protocol|1|||
160821280|NCT00367744|580731257|FG000|Overall Study|Lost to Follow-up|4|||
160821281|NCT00367744|580731258|FG001|Overall Study|Lost to Follow-up|5|||
160821282|NCT03664674|580731259|FG000|Overall Study|Adverse Event|1|||
160821283|NCT03664674|580731260|FG001|Overall Study|Adverse Event|1|||
160821284|NCT03664674|580731259|FG000|Overall Study|Physician Decision|0|||
160821285|NCT03664674|580731260|FG001|Overall Study|Physician Decision|1|||
160821286|NCT03664674|580731259|FG000|Overall Study|Withdrawal by Subject|2|||
160821287|NCT03664674|580731260|FG001|Overall Study|Withdrawal by Subject|0|||
160821288|NCT01342965|580731264|FG000|Overall Study|Death|58|||
160821289|NCT01342965|580731265|FG001|Overall Study|Death|57|||
160821290|NCT01342965|580731264|FG000|Overall Study|Lost to Follow-up|5|||
160821291|NCT01342965|580731265|FG001|Overall Study|Lost to Follow-up|3|||
160821292|NCT01342965|580731264|FG000|Overall Study|Other Reasons- Unspecified|44|||
160821293|NCT01342965|580731265|FG001|Overall Study|Other Reasons- Unspecified|38|||
160821294|NCT01342965|580731264|FG000|Overall Study|Withdrawal by Subject|2|||
160821295|NCT01342965|580731265|FG001|Overall Study|Withdrawal by Subject|9|||
160821296|NCT00856206|580731268|FG000|Overall Study|Protocol Violation|6|||
160821297|NCT00856206|580731269|FG001|Overall Study|Protocol Violation|18|||
160821298|NCT00856206|580731268|FG000|Overall Study|Adverse Event|10|||
160821299|NCT00856206|580731269|FG001|Overall Study|Adverse Event|46|||
160821300|NCT00856206|580731268|FG000|Overall Study|Lack of Efficacy|1|||
160821301|NCT00856206|580731269|FG001|Overall Study|Lack of Efficacy|2|||
160821302|NCT00856206|580731268|FG000|Overall Study|Withdrawal by Subject|15|||
160821303|NCT00856206|580731269|FG001|Overall Study|Withdrawal by Subject|36|||
160821304|NCT00856206|580731268|FG000|Overall Study|Lost to Follow-up|13|||
160821305|NCT00856206|580731269|FG001|Overall Study|Lost to Follow-up|39|||
160821306|NCT00856206|580731268|FG000|Overall Study|Death|2|||
160821307|NCT00856206|580731269|FG001|Overall Study|Death|2|||
160821308|NCT00856206|580731268|FG000|Overall Study|Decision by the Sponsor|4|||
160821309|NCT00856206|580731269|FG001|Overall Study|Decision by the Sponsor|8|||
160821310|NCT00856206|580731268|FG000|Overall Study|Other than specified above|3|||
160821311|NCT00856206|580731269|FG001|Overall Study|Other than specified above|10|||
160821312|NCT04584346|580731275|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
160821313|NCT04584346|580731276|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
160821314|NCT02780856|580731279|FG000|Overall Study|Lost to Follow-up|1|||
160821315|NCT04262882|580731280|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
160821316|NCT04262882|580731281|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
160821317|NCT04262882|580731280|FG000|Overall Study|Lost to Follow-up|1|||
160821318|NCT04262882|580731281|FG001|Overall Study|Lost to Follow-up|0|||
160821319|NCT01301066|580731282|FG000|Overall Study|Lost to Follow-up|5|||
160821320|NCT01301066|580731283|FG001|Overall Study|Lost to Follow-up|11|||
160821321|NCT01301066|580731282|FG000|Overall Study|Protocol Violation|8|||
160821322|NCT01301066|580731283|FG001|Overall Study|Protocol Violation|7|||
160821323|NCT01301066|580731282|FG000|Overall Study|Withdrawal by Subject|4|||
160821324|NCT01301066|580731283|FG001|Overall Study|Withdrawal by Subject|9|||
160821325|NCT01301066|580731282|FG000|Overall Study|Adverse Event|6|||
160821326|NCT01301066|580731283|FG001|Overall Study|Adverse Event|6|||
160821327|NCT01301066|580731282|FG000|Overall Study|Sponsor Decision|2|||
160821328|NCT01301066|580731283|FG001|Overall Study|Sponsor Decision|1|||
160821329|NCT01301066|580731282|FG000|Overall Study|Physician Decision|0|||
160821330|NCT01301066|580731283|FG001|Overall Study|Physician Decision|1|||
160821331|NCT01301066|580731282|FG000|Overall Study|Other|2|||
160821332|NCT01301066|580731283|FG001|Overall Study|Other|0|||
160901174|NCT02298023|581031960|FG001|Overall Study|Withdrawal by Subject|0|||
161339976|NCT00042289|582633405|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160901175|NCT02298023|581031961|FG002|Overall Study|Withdrawal by Subject|0|||
160901176|NCT00492531|581031967|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
160821333|NCT04003207|580731284|FG000|Overall Study|Protocol Violation|1|||
160821334|NCT03894969|580731286|FG000|Overall Study|Adverse Event|0|||
160821335|NCT03894969|580731287|FG001|Overall Study|Adverse Event|2|||
160821336|NCT03894969|580731288|FG002|Overall Study|Adverse Event|0|||
160821337|NCT03894969|580731289|FG003|Overall Study|Adverse Event|1|||
160821338|NCT03894969|580731290|FG004|Overall Study|Adverse Event|2|||
161240244|NCT03123471|582260558|FG001|Placebo-controlled Phase|Miscellaneous|1|||
161240245|NCT03123471|582260557|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
161240246|NCT03123471|582260558|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
161240247|NCT03123471|582260557|FG000|Apremilast Extension Phase|Adverse Event|1|||
161240248|NCT03123471|582260558|FG001|Apremilast Extension Phase|Adverse Event|5|||
161240249|NCT03123471|582260557|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
161240250|NCT03123471|582260558|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
161240251|NCT03123471|582260557|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
161240252|NCT03123471|582260558|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
161240253|NCT02358538|582260559|FG000|Through Week 26|Adverse Event|0|||
161240254|NCT02358538|582260560|FG001|Through Week 26|Adverse Event|1|||
160821339|NCT03894969|580731286|FG000|Overall Study|Lost to Follow-up|3|||
160821340|NCT03894969|580731287|FG001|Overall Study|Lost to Follow-up|1|||
160821341|NCT03894969|580731288|FG002|Overall Study|Lost to Follow-up|1|||
160821342|NCT03894969|580731289|FG003|Overall Study|Lost to Follow-up|0|||
160821343|NCT03894969|580731290|FG004|Overall Study|Lost to Follow-up|0|||
160821344|NCT03894969|580731286|FG000|Overall Study|Withdrawal by Subject|2|||
160821345|NCT03894969|580731287|FG001|Overall Study|Withdrawal by Subject|1|||
160821346|NCT03894969|580731288|FG002|Overall Study|Withdrawal by Subject|3|||
160821347|NCT03894969|580731289|FG003|Overall Study|Withdrawal by Subject|4|||
160821348|NCT03894969|580731290|FG004|Overall Study|Withdrawal by Subject|8|||
160821349|NCT03894969|580731286|FG000|Overall Study|Other|0|||
160821350|NCT03894969|580731287|FG001|Overall Study|Other|0|||
160821351|NCT03894969|580731288|FG002|Overall Study|Other|0|||
160821352|NCT03894969|580731289|FG003|Overall Study|Other|0|||
160821353|NCT03894969|580731290|FG004|Overall Study|Other|3|||
160821354|NCT03894969|580731286|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
160821355|NCT03894969|580731287|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
160821356|NCT03894969|580731288|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
160821357|NCT03894969|580731289|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
160821358|NCT03894969|580731290|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
160821359|NCT03894969|580731286|FG000|Overall Study|Solicited Adverse Event|0|||
160821360|NCT03894969|580731287|FG001|Overall Study|Solicited Adverse Event|1|||
160821361|NCT03894969|580731288|FG002|Overall Study|Solicited Adverse Event|0|||
160821362|NCT03894969|580731289|FG003|Overall Study|Solicited Adverse Event|0|||
160821363|NCT03894969|580731290|FG004|Overall Study|Solicited Adverse Event|0|||
160821364|NCT00468676|580731291|FG000|Overall Study|Lost to Follow-up|14|||
160821365|NCT00468676|580731292|FG001|Overall Study|Lost to Follow-up|11|||
160901177|NCT00492531|581031968|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
160901178|NCT04122534|581031977|FG000|Overall Study|Lost to Follow-up|4|||
160901179|NCT00437983|581031985|FG000|Overall Study|Adverse Event|6|||
160901180|NCT00437983|581031986|FG001|Overall Study|Adverse Event|6|||
160901181|NCT00437983|581031985|FG000|Overall Study|Protocol Violation|2|||
160901182|NCT00437983|581031986|FG001|Overall Study|Protocol Violation|1|||
160901183|NCT00437983|581031985|FG000|Overall Study|Withdrawal by Subject|5|||
160901184|NCT00437983|581031986|FG001|Overall Study|Withdrawal by Subject|6|||
160901185|NCT01558739|581031989|FG000|Overall Study|Adverse Event|7|||
160901186|NCT01558739|581031989|FG000|Overall Study|Withdrawal by Subject|2|||
160901187|NCT01558739|581031989|FG000|Overall Study|Death|3|||
160901188|NCT01558739|581031989|FG000|Overall Study|Disease Progression|4|||
160901189|NCT01558739|581031989|FG000|Overall Study|Protocol Violation|1|||
160901190|NCT01402011|581031994|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
160901191|NCT01402011|581031995|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
160901192|NCT01402011|581031996|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
160901193|NCT01402011|581031994|FG000|Active Treatment Period|Withdrawal by Subject|1|||
160901194|NCT01402011|581031995|FG001|Active Treatment Period|Withdrawal by Subject|3|||
160901195|NCT01402011|581031996|FG002|Active Treatment Period|Withdrawal by Subject|0|||
160901196|NCT01402011|581031994|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
160901197|NCT01402011|581031995|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
160901198|NCT01402011|581031996|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
160901199|NCT00594659|581031997|FG000|Overall Study|Lost to Follow-up|13|||
160901200|NCT00594659|581031998|FG001|Overall Study|Lost to Follow-up|9|||
160901201|NCT00594659|581031999|FG002|Overall Study|Lost to Follow-up|7|||
160901202|NCT00142298|581032001|FG000|Overall Study|Adverse Event|10|||
160901203|NCT00142298|581032002|FG001|Overall Study|Adverse Event|10|||
160901204|NCT00142298|581032003|FG002|Overall Study|Adverse Event|1|||
160901205|NCT00142298|581032004|FG003|Overall Study|Adverse Event|5|||
160901206|NCT00142298|581032005|FG004|Overall Study|Adverse Event|2|||
160901207|NCT00142298|581032006|FG005|Overall Study|Adverse Event|2|||
160901208|NCT00142298|581032007|FG006|Overall Study|Adverse Event|0|||
160901209|NCT00142298|581032008|FG007|Overall Study|Adverse Event|0|||
160901210|NCT00142298|581032009|FG008|Overall Study|Adverse Event|0|||
160901211|NCT00142298|581032010|FG009|Overall Study|Adverse Event|0|||
160901212|NCT00142298|581032001|FG000|Overall Study|Clinical disease progression|1|||
160901213|NCT00142298|581032002|FG001|Overall Study|Clinical disease progression|0|||
160821366|NCT00468676|580731291|FG000|Overall Study|Death|2|||
160821367|NCT00468676|580731292|FG001|Overall Study|Death|1|||
160821368|NCT02979093|580731293|FG000|First Scan Session|Scanning data problems|1|||
160821369|NCT02979093|580731294|FG001|First Scan Session|Scanning data problems|2|||
160821370|NCT02979093|580731295|FG002|First Scan Session|Scanning data problems|2|||
160821371|NCT02979093|580731296|FG003|First Scan Session|Scanning data problems|0|||
160821372|NCT02979093|580731293|FG000|Second Scan Session|Scanning data problems|3|||
160988462|NCT00984282|581345290|FG000|Double Blind Treatment|Physician Decision|1|||
160988463|NCT00984282|581345291|FG001|Double Blind Treatment|Physician Decision|2|||
160988464|NCT00984282|581345290|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
160988465|NCT00984282|581345291|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
160988466|NCT00984282|581345290|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
160988467|NCT00984282|581345291|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
160988468|NCT00984282|581345290|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
160988469|NCT00984282|581345291|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
160988470|NCT00984282|581345290|FG000|Double Blind Treatment|Lost to Follow-up|3|||
160988471|NCT00984282|581345291|FG001|Double Blind Treatment|Lost to Follow-up|0|||
160988472|NCT00984282|581345290|FG000|Double Blind Treatment|Death|8|||
160988473|NCT00984282|581345291|FG001|Double Blind Treatment|Death|4|||
160988474|NCT00984282|581345290|FG000|Double Blind Treatment|Not treated|0|||
160988475|NCT00984282|581345291|FG001|Double Blind Treatment|Not treated|1|||
160988476|NCT00984282|581345290|FG000|Double Blind Treatment|Switched to commercial drug|6|||
160988477|NCT00984282|581345291|FG001|Double Blind Treatment|Switched to commercial drug|1|||
160988478|NCT00984282|581345290|FG000|Double Blind Treatment|protocol driven decision point|1|||
160988479|NCT00984282|581345291|FG001|Double Blind Treatment|protocol driven decision point|1|||
160988480|NCT00984282|581345290|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
160988481|NCT00984282|581345291|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
160988482|NCT00984282|581345290|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
160988483|NCT00984282|581345291|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
160988484|NCT00984282|581345290|FG000|Open-label Treatment|Adverse Event|20|||
160988485|NCT00984282|581345291|FG001|Open-label Treatment|Adverse Event|30|||
160988486|NCT00984282|581345290|FG000|Open-label Treatment|Withdrawal by Subject|6|||
160988487|NCT00984282|581345291|FG001|Open-label Treatment|Withdrawal by Subject|21|||
160988488|NCT00984282|581345290|FG000|Open-label Treatment|Death|7|||
160988489|NCT00984282|581345291|FG001|Open-label Treatment|Death|15|||
160988490|NCT00984282|581345290|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
160988491|NCT00984282|581345291|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
160988492|NCT00984282|581345290|FG000|Open-label Treatment|Lost to Follow-up|1|||
160988493|NCT00984282|581345291|FG001|Open-label Treatment|Lost to Follow-up|1|||
160988494|NCT00984282|581345290|FG000|Open-label Treatment|Patient convenience|1|||
160988495|NCT00984282|581345291|FG001|Open-label Treatment|Patient convenience|0|||
160988496|NCT00984282|581345290|FG000|Open-label Treatment|Non-compliant with study medication|1|||
160988497|NCT00984282|581345291|FG001|Open-label Treatment|Non-compliant with study medication|0|||
160988498|NCT00984282|581345290|FG000|Open-label Treatment|Target lesion removed|0|||
160988499|NCT00984282|581345291|FG001|Open-label Treatment|Target lesion removed|1|||
160988500|NCT00984282|581345290|FG000|Open-label Treatment|Protocol driven decision point|1|||
160988501|NCT00984282|581345291|FG001|Open-label Treatment|Protocol driven decision point|1|||
160988502|NCT00984282|581345290|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
160988503|NCT00984282|581345291|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
160988504|NCT00984282|581345290|FG000|Open-label Treatment|Switched to commercial drug|6|||
160988505|NCT00984282|581345291|FG001|Open-label Treatment|Switched to commercial drug|7|||
160988506|NCT00984282|581345290|FG000|Open-label Treatment|Physician Decision|1|||
160988507|NCT00984282|581345291|FG001|Open-label Treatment|Physician Decision|0|||
160988508|NCT00984282|581345290|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
160988509|NCT00984282|581345291|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
160988510|NCT00984282|581345290|FG000|Long Term Follow-up|Death|27|||
160988511|NCT00984282|581345291|FG001|Long Term Follow-up|Death|68|||
160988512|NCT00984282|581345290|FG000|Long Term Follow-up|Lost to Follow-up|3|||
161132961|NCT02157883|581870779|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
161132962|NCT02157883|581870779|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
161132963|NCT02157883|581870779|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
161132964|NCT02157883|581870779|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
161132965|NCT01701258|581870780|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
161132966|NCT01701258|581870781|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
161132967|NCT01701258|581870782|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
161132968|NCT01701258|581870783|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
161132969|NCT01701258|581870784|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
161132970|NCT01701258|581870785|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
161132971|NCT01701258|581870786|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
160821373|NCT02979093|580731294|FG001|Second Scan Session|Scanning data problems|0|||
160988513|NCT00984282|581345291|FG001|Long Term Follow-up|Lost to Follow-up|6|||
160988514|NCT00984282|581345290|FG000|Long Term Follow-up|Protocol driven decision point|25|||
160988515|NCT00984282|581345291|FG001|Long Term Follow-up|Protocol driven decision point|26|||
160988516|NCT00984282|581345290|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
160988517|NCT00984282|581345291|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
160988518|NCT00984282|581345290|FG000|Long Term Follow-up|Switched to commercial drug|4|||
160988519|NCT00984282|581345291|FG001|Long Term Follow-up|Switched to commercial drug|2|||
160988520|NCT00984282|581345290|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
160988521|NCT00984282|581345291|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
160988522|NCT03606460|581345293|FG000|Overall Study|Lost to Follow-up|1|||
160988523|NCT03606460|581345294|FG001|Overall Study|Lost to Follow-up|8|||
160988524|NCT04541186|581345298|FG000|Main Study|Adverse Event|0|||
160988525|NCT04541186|581345299|FG001|Main Study|Adverse Event|0|||
160988526|NCT04541186|581345300|FG002|Main Study|Adverse Event|4|||
160988527|NCT04541186|581345301|FG003|Main Study|Adverse Event|0|||
160988528|NCT04541186|581345302|FG004|Main Study|Adverse Event|0|||
160988529|NCT04541186|581345298|FG000|Main Study|Investigator Decision|0|||
160988530|NCT04541186|581345299|FG001|Main Study|Investigator Decision|0|||
160988531|NCT04541186|581345300|FG002|Main Study|Investigator Decision|1|||
160988532|NCT04541186|581345301|FG003|Main Study|Investigator Decision|1|||
160988533|NCT04541186|581345302|FG004|Main Study|Investigator Decision|0|||
160988534|NCT04541186|581345298|FG000|Main Study|Withdrawal by Subject|1|||
160988535|NCT04541186|581345299|FG001|Main Study|Withdrawal by Subject|1|||
160988536|NCT04541186|581345300|FG002|Main Study|Withdrawal by Subject|0|||
160988537|NCT04541186|581345301|FG003|Main Study|Withdrawal by Subject|0|||
160988538|NCT04541186|581345302|FG004|Main Study|Withdrawal by Subject|0|||
160988539|NCT04541186|581345298|FG000|Main Study|COVID-19-related Dose Interruption|0|||
160988540|NCT04541186|581345299|FG001|Main Study|COVID-19-related Dose Interruption|0|||
160988541|NCT04541186|581345300|FG002|Main Study|COVID-19-related Dose Interruption|0|||
160988542|NCT04541186|581345301|FG003|Main Study|COVID-19-related Dose Interruption|0|||
160988543|NCT04541186|581345302|FG004|Main Study|COVID-19-related Dose Interruption|1|||
160988544|NCT04541186|581345298|FG000|Main Study|Randomized in Error Not Treated|0|||
160988545|NCT04541186|581345299|FG001|Main Study|Randomized in Error Not Treated|0|||
160988546|NCT04541186|581345300|FG002|Main Study|Randomized in Error Not Treated|1|||
160988547|NCT04541186|581345301|FG003|Main Study|Randomized in Error Not Treated|0|||
160988548|NCT04541186|581345302|FG004|Main Study|Randomized in Error Not Treated|0|||
161240255|NCT02358538|582260561|FG002|Through Week 26|Adverse Event|1|||
161240256|NCT02358538|582260562|FG003|Through Week 26|Adverse Event|2|||
160988549|NCT04541186|581345298|FG000|Fibrate Expansion Study|Other than Specified|0|||
160988550|NCT04541186|581345299|FG001|Fibrate Expansion Study|Other than Specified|0|||
160988551|NCT04541186|581345300|FG002|Fibrate Expansion Study|Other than Specified|0|||
160988552|NCT04541186|581345301|FG003|Fibrate Expansion Study|Other than Specified|0|||
161240257|NCT02358538|582260559|FG000|Through Week 26|Lack of Efficacy|1|||
161240258|NCT02358538|582260560|FG001|Through Week 26|Lack of Efficacy|1|||
160988553|NCT04541186|581345302|FG004|Fibrate Expansion Study|Other than Specified|1|||
160988554|NCT00303303|581345303|FG000|Overall Study|Withdrawal by Subject|0|||
160988555|NCT00303303|581345304|FG001|Overall Study|Withdrawal by Subject|0|||
160988556|NCT00303303|581345305|FG002|Overall Study|Withdrawal by Subject|1|||
160988557|NCT03085017|581345306|FG000|Overall Study|Death|0|||
160988558|NCT03085017|581345307|FG001|Overall Study|Death|3|||
160988559|NCT00058058|581345308|FG000|Overall Study|Withdrawal by Subject|4|||
160988560|NCT00058058|581345308|FG000|Overall Study|Ineligible|20|||
160988561|NCT00058058|581345308|FG000|Overall Study|Claustrophobic|5|||
160988562|NCT00058058|581345308|FG000|Overall Study|technical issues|6|||
160988563|NCT00058058|581345308|FG000|Overall Study|Poor positioning, illness,pain|3|||
160988564|NCT00582790|581345309|FG000|Overall Study|Rapid progression of disease|1|||
160988565|NCT02680756|581345313|FG000|Overall Study|Adverse Event|10|||
160988566|NCT02680756|581345314|FG001|Overall Study|Adverse Event|2|||
161240259|NCT02358538|582260561|FG002|Through Week 26|Lack of Efficacy|3|||
161240260|NCT02358538|582260562|FG003|Through Week 26|Lack of Efficacy|3|||
161240261|NCT02358538|582260559|FG000|Through Week 26|Withdrawal by Subject|1|||
161240262|NCT02358538|582260560|FG001|Through Week 26|Withdrawal by Subject|0|||
161240263|NCT02358538|582260561|FG002|Through Week 26|Withdrawal by Subject|0|||
161240264|NCT02358538|582260562|FG003|Through Week 26|Withdrawal by Subject|0|||
160988567|NCT02680756|581345313|FG000|Overall Study|Lost to Follow-up|7|||
160988568|NCT02680756|581345314|FG001|Overall Study|Lost to Follow-up|6|||
160988569|NCT02680756|581345313|FG000|Overall Study|Withdrawal by Subject|5|||
160988570|NCT02680756|581345314|FG001|Overall Study|Withdrawal by Subject|5|||
160988571|NCT02680756|581345313|FG000|Overall Study|Physician Decision|4|||
161240265|NCT02358538|582260559|FG000|Through Week 26|Non-Compliance|0|||
161240266|NCT02358538|582260560|FG001|Through Week 26|Non-Compliance|0|||
161240267|NCT02358538|582260561|FG002|Through Week 26|Non-Compliance|1|||
161240268|NCT02358538|582260562|FG003|Through Week 26|Non-Compliance|0|||
161240269|NCT02358538|582260559|FG000|Through Week 26|Family did not see benefit from IP|1|||
161240270|NCT02358538|582260560|FG001|Through Week 26|Family did not see benefit from IP|0|||
161240271|NCT02358538|582260561|FG002|Through Week 26|Family did not see benefit from IP|0|||
160821374|NCT02979093|580731295|FG002|Second Scan Session|Scanning data problems|1|||
160821375|NCT02979093|580731296|FG003|Second Scan Session|Scanning data problems|3|||
160821376|NCT00443053|580731297|FG000|Overall Study|Adverse Event|2|||
160821377|NCT00443053|580731298|FG001|Overall Study|Adverse Event|1|||
161240272|NCT02358538|582260562|FG003|Through Week 26|Family did not see benefit from IP|0|||
161240273|NCT02358538|582260559|FG000|52 Week Extension Period|Lack of Efficacy|0|||
161240274|NCT02358538|582260560|FG001|52 Week Extension Period|Lack of Efficacy|0|||
161240275|NCT02358538|582260561|FG002|52 Week Extension Period|Lack of Efficacy|2|||
161240276|NCT02358538|582260562|FG003|52 Week Extension Period|Lack of Efficacy|4|||
161240277|NCT01686477|582260563|FG000|Feeding Intervention|Death|1|||
161240278|NCT01686477|582260564|FG001|Feeding Intervention|Death|0|||
161240279|NCT01686477|582260565|FG002|Feeding Intervention|Death|1|||
161240280|NCT01686477|582260563|FG000|Feeding Intervention|Withdrawal by Subject|0|||
161240281|NCT01686477|582260564|FG001|Feeding Intervention|Withdrawal by Subject|6|||
161240282|NCT01686477|582260565|FG002|Feeding Intervention|Withdrawal by Subject|0|||
161240283|NCT01686477|582260563|FG000|Feeding Intervention|Physician Decision|1|||
161240284|NCT01686477|582260564|FG001|Feeding Intervention|Physician Decision|2|||
161240285|NCT01686477|582260565|FG002|Feeding Intervention|Physician Decision|0|||
161240286|NCT01686477|582260563|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
161240287|NCT01686477|582260564|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
161240288|NCT01686477|582260565|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
161240289|NCT01686477|582260563|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
161240290|NCT01686477|582260564|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
161240291|NCT01686477|582260565|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
161240292|NCT01686477|582260563|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
161240293|NCT01686477|582260564|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
161240294|NCT01686477|582260565|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
161240295|NCT01686477|582260563|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
161240296|NCT01686477|582260564|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
161240297|NCT01686477|582260565|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
161240298|NCT01686477|582260563|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
161240299|NCT01686477|582260564|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
161240300|NCT01686477|582260565|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
161240301|NCT01686477|582260563|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
161240302|NCT01686477|582260564|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
161240303|NCT01686477|582260565|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
161240304|NCT01686477|582260563|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
161240305|NCT01686477|582260564|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
161240306|NCT01686477|582260565|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
161240307|NCT06999265|582260567|FG000|Overall Study|Lost to Follow-up|1|||
161240308|NCT06999265|582260568|FG001|Overall Study|Lost to Follow-up|1|||
161240309|NCT02178787|582260569|FG000|Overall Study|Lost to Follow-up|1|||
161240310|NCT02178787|582260570|FG001|Overall Study|Lost to Follow-up|0|||
161240311|NCT02178787|582260569|FG000|Overall Study|Withdrawal by Subject|0|||
161240312|NCT02178787|582260570|FG001|Overall Study|Withdrawal by Subject|2|||
161240313|NCT02178787|582260569|FG000|Overall Study|No TCD window|3|||
161240314|NCT02178787|582260570|FG001|Overall Study|No TCD window|7|||
161240315|NCT02178787|582260569|FG000|Overall Study|Physician Decision|1|||
161240316|NCT02178787|582260570|FG001|Overall Study|Physician Decision|0|||
161240317|NCT02554890|582260571|FG000|Double-blind|Adverse Event|45|||
161240318|NCT02554890|582260572|FG001|Double-blind|Adverse Event|51|||
161240319|NCT02554890|582260571|FG000|Double-blind|Death|6|||
161240320|NCT02554890|582260572|FG001|Double-blind|Death|4|||
161240321|NCT02554890|582260571|FG000|Double-blind|Protocol Violation|1|||
161240322|NCT02554890|582260572|FG001|Double-blind|Protocol Violation|1|||
161240323|NCT02554890|582260571|FG000|Double-blind|Physician Decision|4|||
161240324|NCT02554890|582260572|FG001|Double-blind|Physician Decision|3|||
161240325|NCT02554890|582260571|FG000|Double-blind|Subject/Guardian decision|21|||
161240326|NCT02554890|582260572|FG001|Double-blind|Subject/Guardian decision|16|||
161240327|NCT02554890|582260571|FG000|Double-blind|Lost to Follow-up|7|||
161240328|NCT02554890|582260572|FG001|Double-blind|Lost to Follow-up|5|||
161240329|NCT02554890|582260571|FG000|Double-blind|Technical problems|1|||
161240330|NCT02554890|582260572|FG001|Double-blind|Technical problems|0|||
161240331|NCT02554890|582260571|FG000|Double-blind|Withdrawal by Subject|5|||
161240332|NCT02554890|582260572|FG001|Double-blind|Withdrawal by Subject|6|||
161240333|NCT02554890|582260571|FG000|Double-blind|Noncompliance with study treatment|6|||
161240334|NCT02554890|582260572|FG001|Double-blind|Noncompliance with study treatment|5|||
161240335|NCT02554890|582260571|FG000|Open-label|Adverse Event|0|||
161240336|NCT02554890|582260572|FG001|Open-label|Adverse Event|30|||
160821378|NCT00443053|580731297|FG000|Overall Study|Withdrawal by Subject|9|||
161240337|NCT02554890|582260571|FG000|Open-label|Death|0|||
161240338|NCT02554890|582260572|FG001|Open-label|Death|1|||
161240339|NCT02554890|582260571|FG000|Open-label|Physician Decision|0|||
160821379|NCT00443053|580731298|FG001|Overall Study|Withdrawal by Subject|18|||
160988572|NCT02680756|581345314|FG001|Overall Study|Physician Decision|1|||
161240340|NCT02554890|582260572|FG001|Open-label|Physician Decision|1|||
161240341|NCT02554890|582260571|FG000|Open-label|Subject/Guardian decision|0|||
161240342|NCT02554890|582260572|FG001|Open-label|Subject/Guardian decision|11|||
161240343|NCT02554890|582260571|FG000|Open-label|Lost to Follow-up|0|||
161240344|NCT02554890|582260572|FG001|Open-label|Lost to Follow-up|7|||
161240345|NCT02554890|582260571|FG000|Open-label|Technical problems|0|||
161240346|NCT02554890|582260572|FG001|Open-label|Technical problems|1|||
161240347|NCT02554890|582260571|FG000|Open-label|Withdrawal by Subject|0|||
161240348|NCT02554890|582260572|FG001|Open-label|Withdrawal by Subject|1|||
161240349|NCT03649477|582260575|FG000|Overall Study|Adverse Event|2|||
160988573|NCT02680756|581345313|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
160988574|NCT02680756|581345314|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
160988575|NCT02680756|581345313|FG000|Overall Study|Blood transfusion for any reason|0|||
161240350|NCT03649477|582260576|FG001|Overall Study|Adverse Event|0|||
161240351|NCT03649477|582260577|FG002|Overall Study|Adverse Event|0|||
161240352|NCT04544410|582260578|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161240353|NCT04544410|582260579|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161240354|NCT04544410|582260578|FG000|Double-blind Treatment Period|Adverse Event|1|||
161240355|NCT04544410|582260579|FG001|Double-blind Treatment Period|Adverse Event|0|||
161240356|NCT04544410|582260578|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161240357|NCT04544410|582260579|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161240358|NCT04544410|582260578|FG000|Double-blind Treatment Period|Protocol Violation|1|||
161240359|NCT04544410|582260579|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161240360|NCT04544410|582260578|FG000|Open-Label Treatment Period|Study Terminated|15|||
160988576|NCT02680756|581345314|FG001|Overall Study|Blood transfusion for any reason|1|||
160988577|NCT02680756|581345313|FG000|Overall Study|Death|1|||
160988578|NCT02680756|581345314|FG001|Overall Study|Death|0|||
160988579|NCT02680756|581345313|FG000|Overall Study|Protocol Violation|1|||
160988580|NCT02680756|581345314|FG001|Overall Study|Protocol Violation|0|||
160988581|NCT02680756|581345313|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
160988582|NCT02680756|581345314|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
160988583|NCT02680756|581345313|FG000|Overall Study|None of above or not recorded|3|||
160988584|NCT02680756|581345314|FG001|Overall Study|None of above or not recorded|2|||
160988585|NCT02374957|581345315|FG000|Overall Study|Patient did not complete forms correctly|1|||
160988586|NCT02374957|581345316|FG001|Overall Study|Patient did not complete forms correctly|0|||
160988587|NCT00748969|581345317|FG000|Overall Study|Withdrawal by Subject|1|||
160988588|NCT00748969|581345318|FG001|Overall Study|Withdrawal by Subject|0|||
160988589|NCT00748969|581345317|FG000|Overall Study|Withdrawal by Subject|0|||
160988590|NCT00748969|581345318|FG001|Overall Study|Withdrawal by Subject|1|||
160821380|NCT00443053|580731297|FG000|Overall Study|Lost to Follow-up|4|||
160821381|NCT00443053|580731298|FG001|Overall Study|Lost to Follow-up|5|||
160821382|NCT00443053|580731297|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
160821383|NCT00443053|580731298|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160821384|NCT00443053|580731297|FG000|Overall Study|Noncompliance|2|||
160821385|NCT00443053|580731298|FG001|Overall Study|Noncompliance|1|||
160821386|NCT00443053|580731297|FG000|Overall Study|Other|3|||
160821387|NCT00443053|580731298|FG001|Overall Study|Other|4|||
160821388|NCT00443053|580731297|FG000|Overall Study|Physician Decision|0|||
160821389|NCT00443053|580731298|FG001|Overall Study|Physician Decision|4|||
160988591|NCT00562965|581345319|FG000|Overall Study|Withdrawal by Subject|0|||
160988592|NCT00562965|581345320|FG001|Overall Study|Withdrawal by Subject|1|||
160988593|NCT00562965|581345319|FG000|Overall Study|Death|2|||
160988594|NCT00562965|581345320|FG001|Overall Study|Death|4|||
160988595|NCT00562965|581345319|FG000|Overall Study|Lost to Follow-up|1|||
160988596|NCT00562965|581345320|FG001|Overall Study|Lost to Follow-up|0|||
160988597|NCT00562965|581345319|FG000|Overall Study|Other|0|||
160988598|NCT00562965|581345320|FG001|Overall Study|Other|1|||
160988599|NCT00761774|581345321|FG000|Overall Study|Adverse Event|17|||
160988600|NCT00761774|581345321|FG000|Overall Study|Lack of Efficacy|37|||
160988601|NCT00761774|581345321|FG000|Overall Study|Lost to Follow-up|2|||
160988602|NCT00761774|581345321|FG000|Overall Study|Withdrawal by Subject|9|||
160988603|NCT00761774|581345321|FG000|Overall Study|Non-compliance|4|||
160988604|NCT00761774|581345321|FG000|Overall Study|End of study|2|||
160988605|NCT00761774|581345321|FG000|Overall Study|Reclassification of seizures|1|||
160988606|NCT00761774|581345321|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
160988607|NCT00761774|581345321|FG000|Overall Study|Sponsor decision|1|||
160988608|NCT00761774|581345321|FG000|Overall Study|Investigator clinical judgement|1|||
160988609|NCT00761774|581345321|FG000|Overall Study|Patient moved out of study area|1|||
160988610|NCT00761774|581345321|FG000|Overall Study|Coordinator leaving site|1|||
160988611|NCT00761774|581345321|FG000|Overall Study|Subject IP non-compliance|1|||
160988612|NCT00761774|581345321|FG000|Overall Study|IP stopped by hospital physician|1|||
160988613|NCT01124617|581345322|FG000|Overall Study|Adverse Event|5|||
161240361|NCT04544410|582260579|FG001|Open-Label Treatment Period|Study Terminated|19|||
161240362|NCT04544410|582260578|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
160821390|NCT02256384|580731303|FG000|Overall Study|Withdrawal by Subject|12|||
161333835|NCT03327324|582610631|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333836|NCT03327324|582610632|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
161333837|NCT03327324|582610633|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
161333838|NCT03327324|582610634|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
161333839|NCT03327324|582610629|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
161333840|NCT03327324|582610630|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161333841|NCT03327324|582610631|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161333842|NCT03327324|582610632|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161333843|NCT03327324|582610633|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
161333844|NCT03327324|582610634|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
160821391|NCT02256384|580731303|FG000|Overall Study|Equipment not capturing data|2|||
160821392|NCT05032690|580731304|FG000|Period 1|Adverse Event|0|||
160821393|NCT05032690|580731305|FG001|Period 1|Adverse Event|1|||
160821394|NCT05032690|580731306|FG002|Period 1|Adverse Event|0|||
160821395|NCT05032690|580731307|FG003|Period 1|Adverse Event|0|||
160821396|NCT05032690|580731304|FG000|Period 1|Withdrawal by Subject|1|||
160821397|NCT05032690|580731305|FG001|Period 1|Withdrawal by Subject|0|||
160988614|NCT01124617|581345323|FG001|Overall Study|Adverse Event|2|||
160988615|NCT01124617|581345322|FG000|Overall Study|Lack of Efficacy|2|||
160988616|NCT01124617|581345323|FG001|Overall Study|Lack of Efficacy|1|||
160988617|NCT01124617|581345322|FG000|Overall Study|Protocol Violation|1|||
160988618|NCT01124617|581345323|FG001|Overall Study|Protocol Violation|1|||
160988619|NCT01124617|581345322|FG000|Overall Study|Withdrawal by Subject|9|||
160988620|NCT01124617|581345323|FG001|Overall Study|Withdrawal by Subject|1|||
160988621|NCT01124617|581345322|FG000|Overall Study|Other|2|||
160988622|NCT01124617|581345323|FG001|Overall Study|Other|1|||
160988623|NCT01163149|581345330|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
160988624|NCT01163149|581345331|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
160988625|NCT01163149|581345332|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
161333845|NCT03327324|582610629|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
161333846|NCT03327324|582610630|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161333847|NCT03327324|582610631|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161333848|NCT03327324|582610632|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161333849|NCT03327324|582610633|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161333850|NCT03327324|582610634|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
161333851|NCT01791985|582610635|FG000|Overall Study|Adverse Event|7|||
161333852|NCT01791985|582610635|FG000|Overall Study|Withdrawal by Subject|1|||
160821398|NCT05032690|580731306|FG002|Period 1|Withdrawal by Subject|0|||
161333853|NCT01103323|582610636|FG000|Without/Before Drug Switch|Adverse Event|50|||
161333854|NCT01103323|582610637|FG001|Without/Before Drug Switch|Adverse Event|7|||
161333855|NCT01103323|582610636|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
161333856|NCT01103323|582610637|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
161333857|NCT01103323|582610636|FG000|Without/Before Drug Switch|Protocol Violation|2|||
161333858|NCT01103323|582610637|FG001|Without/Before Drug Switch|Protocol Violation|0|||
161333859|NCT01103323|582610636|FG000|Without/Before Drug Switch|Physician Decision|2|||
161333860|NCT01103323|582610637|FG001|Without/Before Drug Switch|Physician Decision|0|||
160821399|NCT05032690|580731307|FG003|Period 1|Withdrawal by Subject|0|||
160821400|NCT05032690|580731304|FG000|Period 1|No longer meets eligibility criteria|0|||
160988626|NCT01163149|581345330|FG000|Extension Treatment Period|Adverse Event|0|||
161333861|NCT01103323|582610636|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
161333862|NCT01103323|582610637|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
161333863|NCT01103323|582610636|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
161333864|NCT01103323|582610637|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
161333865|NCT01103323|582610636|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
161333866|NCT01103323|582610637|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
161333867|NCT01946204|582610643|FG000|Overall Study|Death|38|||
161333868|NCT01946204|582610644|FG001|Overall Study|Death|59|||
161333869|NCT01946204|582610643|FG000|Overall Study|Withdrawal by Subject|37|||
161333870|NCT01946204|582610644|FG001|Overall Study|Withdrawal by Subject|50|||
161333871|NCT01946204|582610643|FG000|Overall Study|Lost to Follow-up|3|||
161333872|NCT01946204|582610644|FG001|Overall Study|Lost to Follow-up|7|||
161333873|NCT01946204|582610643|FG000|Overall Study|Ongoing|316|||
161333874|NCT01946204|582610644|FG001|Overall Study|Ongoing|687|||
161333875|NCT01946204|582610643|FG000|Overall Study|Other|7|||
161333876|NCT01946204|582610644|FG001|Overall Study|Other|3|||
161333877|NCT03797898|582610645|FG000|Overall Study|Lost to Follow-up|60|||
160988627|NCT01163149|581345331|FG001|Extension Treatment Period|Adverse Event|1|||
160988628|NCT01163149|581345332|FG002|Extension Treatment Period|Adverse Event|0|||
161333878|NCT03797898|582610646|FG001|Overall Study|Lost to Follow-up|69|||
160988629|NCT01163149|581345330|FG000|Extension Treatment Period|Noncompliance|0|||
160821401|NCT05032690|580731305|FG001|Period 1|No longer meets eligibility criteria|1|||
161240363|NCT04544410|582260579|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
161240364|NCT04544410|582260578|FG000|Open-Label Treatment Period|Adverse Event|0|||
160821402|NCT05032690|580731306|FG002|Period 1|No longer meets eligibility criteria|0|||
160821403|NCT05032690|580731307|FG003|Period 1|No longer meets eligibility criteria|0|||
160821404|NCT05032690|580731304|FG000|Period 2|Adverse Event|1|||
160821405|NCT05032690|580731305|FG001|Period 2|Adverse Event|0|||
160821406|NCT05032690|580731306|FG002|Period 2|Adverse Event|0|||
160821407|NCT05032690|580731307|FG003|Period 2|Adverse Event|0|||
160821408|NCT05032690|580731304|FG000|Period 2|Withdrawal by Subject|0|||
160821409|NCT05032690|580731305|FG001|Period 2|Withdrawal by Subject|1|||
160821410|NCT05032690|580731306|FG002|Period 2|Withdrawal by Subject|0|||
160821411|NCT05032690|580731307|FG003|Period 2|Withdrawal by Subject|0|||
160821412|NCT05032690|580731304|FG000|Period 2|No longer meets eligibility criteria|0|||
160821413|NCT05032690|580731305|FG001|Period 2|No longer meets eligibility criteria|1|||
160821414|NCT05032690|580731306|FG002|Period 2|No longer meets eligibility criteria|0|||
160821415|NCT05032690|580731307|FG003|Period 2|No longer meets eligibility criteria|0|||
160821416|NCT05032690|580731304|FG000|Period 3|Adverse Event|0|||
160821417|NCT05032690|580731305|FG001|Period 3|Adverse Event|1|||
160821418|NCT05032690|580731306|FG002|Period 3|Adverse Event|0|||
160821419|NCT05032690|580731307|FG003|Period 3|Adverse Event|0|||
160821420|NCT00487942|580731308|FG000|Overall Study|Adverse Event|1|||
160821421|NCT00487942|580731309|FG001|Overall Study|Adverse Event|1|||
160821422|NCT00487942|580731310|FG002|Overall Study|Adverse Event|1|||
160901214|NCT00142298|581032003|FG002|Overall Study|Clinical disease progression|0|||
160901215|NCT00142298|581032004|FG003|Overall Study|Clinical disease progression|0|||
160901216|NCT00142298|581032005|FG004|Overall Study|Clinical disease progression|0|||
161240365|NCT04544410|582260579|FG001|Open-Label Treatment Period|Adverse Event|1|||
161240366|NCT04544410|582260578|FG000|Open-Label Treatment Period|Physician Decision|1|||
160821423|NCT00487942|580731311|FG003|Overall Study|Adverse Event|1|||
160821424|NCT00487942|580731308|FG000|Overall Study|Lost to Follow-up|1|||
160821425|NCT00487942|580731309|FG001|Overall Study|Lost to Follow-up|0|||
160821426|NCT00487942|580731310|FG002|Overall Study|Lost to Follow-up|0|||
160901217|NCT00142298|581032006|FG005|Overall Study|Clinical disease progression|0|||
160901218|NCT00142298|581032007|FG006|Overall Study|Clinical disease progression|0|||
160901219|NCT00142298|581032008|FG007|Overall Study|Clinical disease progression|0|||
160901220|NCT00142298|581032009|FG008|Overall Study|Clinical disease progression|0|||
160901221|NCT00142298|581032010|FG009|Overall Study|Clinical disease progression|0|||
160901222|NCT00142298|581032001|FG000|Overall Study|Death|1|||
160901223|NCT00142298|581032002|FG001|Overall Study|Death|1|||
160901224|NCT00142298|581032003|FG002|Overall Study|Death|1|||
160901225|NCT00142298|581032004|FG003|Overall Study|Death|0|||
160901226|NCT00142298|581032005|FG004|Overall Study|Death|0|||
160901227|NCT00142298|581032006|FG005|Overall Study|Death|6|||
160901228|NCT00142298|581032007|FG006|Overall Study|Death|0|||
160901229|NCT00142298|581032008|FG007|Overall Study|Death|0|||
160901230|NCT00142298|581032009|FG008|Overall Study|Death|0|||
160901231|NCT00142298|581032010|FG009|Overall Study|Death|0|||
160901232|NCT00142298|581032001|FG000|Overall Study|Lack of Efficacy|44|||
160901233|NCT00142298|581032002|FG001|Overall Study|Lack of Efficacy|62|||
160901234|NCT00142298|581032003|FG002|Overall Study|Lack of Efficacy|9|||
160901235|NCT00142298|581032004|FG003|Overall Study|Lack of Efficacy|12|||
160901236|NCT00142298|581032005|FG004|Overall Study|Lack of Efficacy|1|||
160901237|NCT00142298|581032006|FG005|Overall Study|Lack of Efficacy|0|||
160901238|NCT00142298|581032007|FG006|Overall Study|Lack of Efficacy|0|||
160901239|NCT00142298|581032008|FG007|Overall Study|Lack of Efficacy|1|||
160901240|NCT00142298|581032009|FG008|Overall Study|Lack of Efficacy|0|||
160901241|NCT00142298|581032010|FG009|Overall Study|Lack of Efficacy|0|||
160901242|NCT00142298|581032001|FG000|Overall Study|Non-compliance|15|||
160901243|NCT00142298|581032002|FG001|Overall Study|Non-compliance|13|||
160901244|NCT00142298|581032003|FG002|Overall Study|Non-compliance|0|||
160901245|NCT00142298|581032004|FG003|Overall Study|Non-compliance|6|||
160901246|NCT00142298|581032005|FG004|Overall Study|Non-compliance|1|||
160901247|NCT00142298|581032006|FG005|Overall Study|Non-compliance|0|||
160901248|NCT00142298|581032007|FG006|Overall Study|Non-compliance|0|||
160901249|NCT00142298|581032008|FG007|Overall Study|Non-compliance|3|||
160901250|NCT00142298|581032009|FG008|Overall Study|Non-compliance|3|||
160901251|NCT00142298|581032010|FG009|Overall Study|Non-compliance|0|||
160901252|NCT00142298|581032001|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
160901253|NCT00142298|581032002|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
160901254|NCT00142298|581032003|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
160901255|NCT00142298|581032004|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
160901256|NCT00142298|581032005|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
160901257|NCT00142298|581032006|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
160901258|NCT00142298|581032007|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
160901259|NCT00142298|581032008|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
160901260|NCT00142298|581032009|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
160988630|NCT01163149|581345331|FG001|Extension Treatment Period|Noncompliance|0|||
160988631|NCT01163149|581345332|FG002|Extension Treatment Period|Noncompliance|1|||
160988632|NCT01700530|581345333|FG000|Overall Study|Withdrawal by Subject|0|||
160988633|NCT01700530|581345334|FG001|Overall Study|Withdrawal by Subject|3|||
160988634|NCT01700530|581345335|FG002|Overall Study|Withdrawal by Subject|1|||
160988635|NCT00916006|581345336|FG000|Overall Study|Adverse Event|1|||
160988636|NCT00916006|581345337|FG001|Overall Study|Adverse Event|1|||
160988637|NCT00916006|581345336|FG000|Overall Study|Withdrawal by Subject|2|||
160988638|NCT00916006|581345337|FG001|Overall Study|Withdrawal by Subject|5|||
160988639|NCT00916006|581345336|FG000|Overall Study|Protocol Violation|0|||
161333879|NCT03797898|582610645|FG000|Overall Study|Withdrawal by Subject|9|||
160988640|NCT00916006|581345337|FG001|Overall Study|Protocol Violation|1|||
160988641|NCT01605136|581345340|FG000|Study Period|Withdrawal by Subject|2|||
160821427|NCT00487942|580731311|FG003|Overall Study|Lost to Follow-up|1|||
160821428|NCT00487942|580731308|FG000|Overall Study|Protocol Violation|1|||
160821429|NCT00487942|580731309|FG001|Overall Study|Protocol Violation|1|||
160821430|NCT00487942|580731310|FG002|Overall Study|Protocol Violation|0|||
160821431|NCT00487942|580731311|FG003|Overall Study|Protocol Violation|0|||
160821432|NCT00487942|580731308|FG000|Overall Study|Withdrawal by Subject|0|||
160821433|NCT00487942|580731309|FG001|Overall Study|Withdrawal by Subject|1|||
160821434|NCT00487942|580731310|FG002|Overall Study|Withdrawal by Subject|2|||
160821435|NCT00487942|580731311|FG003|Overall Study|Withdrawal by Subject|0|||
160988642|NCT01605136|581345341|FG001|Study Period|Withdrawal by Subject|0|||
161333880|NCT03797898|582610646|FG001|Overall Study|Withdrawal by Subject|7|||
160821436|NCT05151445|580731312|FG000|Overall Study|Withdrawal by Subject|3|||
160821437|NCT02298179|580731313|FG000|Overall Study|Lost to Follow-up|0|||
160821438|NCT02298179|580731314|FG001|Overall Study|Lost to Follow-up|0|||
160821439|NCT02298179|580731315|FG002|Overall Study|Lost to Follow-up|1|||
160821440|NCT02298179|580731316|FG003|Overall Study|Lost to Follow-up|0|||
160821441|NCT02298179|580731317|FG004|Overall Study|Lost to Follow-up|0|||
160821442|NCT02298179|580731318|FG005|Overall Study|Lost to Follow-up|0|||
160821443|NCT02298179|580731319|FG006|Overall Study|Lost to Follow-up|0|||
160821444|NCT02298179|580731320|FG007|Overall Study|Lost to Follow-up|1|||
160821445|NCT02298179|580731321|FG008|Overall Study|Lost to Follow-up|0|||
160821446|NCT02298179|580731322|FG009|Overall Study|Lost to Follow-up|0|||
160821447|NCT02298179|580731323|FG010|Overall Study|Lost to Follow-up|0|||
160821448|NCT02298179|580731324|FG011|Overall Study|Lost to Follow-up|0|||
160821449|NCT00082368|580731325|FG000|Overall Study|Not treated-pt had poor IV access|1|||
161132972|NCT01701258|581870787|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
161132973|NCT01701258|581870788|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
161132974|NCT01701258|581870789|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
161132975|NCT01701258|581870790|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
161132976|NCT01701258|581870791|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
161132977|NCT01701258|581870792|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
161132978|NCT01701258|581870780|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
161132979|NCT01701258|581870781|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
161132980|NCT01701258|581870782|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
161132981|NCT01701258|581870783|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
161132982|NCT01701258|581870784|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
161132983|NCT01701258|581870785|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
161132984|NCT01701258|581870786|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
161132985|NCT01701258|581870787|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
161132986|NCT01701258|581870788|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
161132987|NCT01701258|581870789|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
161132988|NCT01701258|581870790|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
161132989|NCT01701258|581870791|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
161132990|NCT01701258|581870792|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
161132991|NCT01701258|581870780|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
161132992|NCT01701258|581870781|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
161132993|NCT01701258|581870782|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
161132994|NCT01701258|581870783|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
161132995|NCT01701258|581870784|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
161132996|NCT01701258|581870785|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
161132997|NCT01701258|581870786|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
161132998|NCT01701258|581870787|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
160988643|NCT01605136|581345340|FG000|Study Period|Physician Decision|1|||
160988644|NCT01605136|581345341|FG001|Study Period|Physician Decision|1|||
160988645|NCT01605136|581345340|FG000|Study Period|Lost to Follow-up|0|||
161132999|NCT01701258|581870788|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
161333881|NCT03797898|582610645|FG000|Overall Study|Became ineligible|5|||
160821450|NCT01739933|580733608|FG000|Overall Study|Death|89|||
160821451|NCT01739933|580733609|FG001|Overall Study|Death|86|||
161133000|NCT01701258|581870789|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
160821452|NCT01739933|580733608|FG000|Overall Study|Withdrawal by Subject|10|||
160821453|NCT01739933|580733609|FG001|Overall Study|Withdrawal by Subject|8|||
160821454|NCT01739933|580733608|FG000|Overall Study|Lost to Follow-up|3|||
160821455|NCT01739933|580733609|FG001|Overall Study|Lost to Follow-up|10|||
160821456|NCT01739933|580733608|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
160821457|NCT01739933|580733609|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
160821458|NCT01007435|580733622|FG000|Overall Study|Adverse Event|16|||
160821459|NCT01007435|580733623|FG001|Overall Study|Adverse Event|25|||
160821460|NCT01007435|580733624|FG002|Overall Study|Adverse Event|47|||
160821461|NCT01007435|580733625|FG003|Overall Study|Adverse Event|31|||
160821462|NCT01007435|580733622|FG000|Overall Study|Death|2|||
160821463|NCT01007435|580733623|FG001|Overall Study|Death|4|||
160821464|NCT01007435|580733624|FG002|Overall Study|Death|2|||
160821465|NCT01007435|580733625|FG003|Overall Study|Death|1|||
160821466|NCT01007435|580733622|FG000|Overall Study|Insufficient Therapeutic Response|21|||
160821467|NCT01007435|580733623|FG001|Overall Study|Insufficient Therapeutic Response|7|||
160821468|NCT01007435|580733624|FG002|Overall Study|Insufficient Therapeutic Response|2|||
160821469|NCT01007435|580733625|FG003|Overall Study|Insufficient Therapeutic Response|9|||
160821470|NCT01007435|580733622|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
160988646|NCT01605136|581345341|FG001|Study Period|Lost to Follow-up|2|||
160988647|NCT01605136|581345340|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
160988648|NCT01605136|581345341|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
160988649|NCT02806336|581345342|FG000|Overall Study|Physician Decision|1|||
160988650|NCT02806336|581345343|FG001|Overall Study|Physician Decision|0|||
160988651|NCT02806336|581345342|FG000|Overall Study|Withdrawal by Subject|2|||
161240367|NCT04544410|582260579|FG001|Open-Label Treatment Period|Physician Decision|0|||
161240368|NCT04544410|582260578|FG000|Open-Label Treatment Period|Other|0|||
161240369|NCT04544410|582260579|FG001|Open-Label Treatment Period|Other|1|||
161240370|NCT02430480|582260580|FG000|Overall Study|Death|1|||
161240371|NCT02430480|582260580|FG000|Overall Study|Anesthesia concerns|1|||
161240372|NCT02430480|582260580|FG000|Overall Study|Progressed on treatment|1|||
161240373|NCT01030133|582260581|FG000|Overall Study|failed to experience pain at level 7/10|2|||
161240374|NCT01030133|582260582|FG001|Overall Study|failed to experience pain at level 7/10|2|||
161240375|NCT01097577|582260590|FG000|Overall Study|Adverse Event|0|||
161240376|NCT01097577|582260591|FG001|Overall Study|Adverse Event|1|||
161240377|NCT04493684|582260592|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161240378|NCT04493684|582260593|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240379|NCT04493684|582260594|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
160988652|NCT02806336|581345343|FG001|Overall Study|Withdrawal by Subject|4|||
160988653|NCT02806336|581345342|FG000|Overall Study|COVID-19 research shut down|3|||
160988654|NCT02806336|581345343|FG001|Overall Study|COVID-19 research shut down|4|||
160988655|NCT02806336|581345342|FG000|Overall Study|Lack of Efficacy|0|||
160988656|NCT02806336|581345343|FG001|Overall Study|Lack of Efficacy|1|||
160988657|NCT03682536|581345344|FG000|Randomization|Withdrawal by Subject|0|||
160988658|NCT03682536|581345345|FG001|Randomization|Withdrawal by Subject|2|||
160988659|NCT03682536|581345344|FG000|Treatment|Other Reasons|8|||
160988660|NCT03682536|581345345|FG001|Treatment|Other Reasons|7|||
160988661|NCT03682536|581345344|FG000|Treatment|Physician Decision|5|||
160988662|NCT03682536|581345345|FG001|Treatment|Physician Decision|5|||
160988663|NCT03682536|581345344|FG000|Treatment|Protocol Violation|1|||
160988664|NCT03682536|581345345|FG001|Treatment|Protocol Violation|0|||
160988665|NCT03682536|581345344|FG000|Treatment|Study Terminated by Sponsor|1|||
160988666|NCT03682536|581345345|FG001|Treatment|Study Terminated by Sponsor|2|||
160821471|NCT01007435|580733623|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
160821472|NCT01007435|580733624|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
160821473|NCT01007435|580733625|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
161133001|NCT01701258|581870790|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
160988667|NCT03682536|581345344|FG000|Treatment|Lost to Follow-up|0|||
160988668|NCT03682536|581345345|FG001|Treatment|Lost to Follow-up|1|||
160988669|NCT03682536|581345344|FG000|Treatment|Withdrawal by Subject|16|||
161133002|NCT01701258|581870791|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
161133003|NCT01701258|581870792|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
161133004|NCT01701258|581870780|FG000|Assessment and Scheduling|Investigator Terminated|2|||
161133005|NCT01701258|581870781|FG001|Assessment and Scheduling|Investigator Terminated|0|||
161133006|NCT01701258|581870782|FG002|Assessment and Scheduling|Investigator Terminated|0|||
161133007|NCT01701258|581870783|FG003|Assessment and Scheduling|Investigator Terminated|0|||
161133008|NCT01701258|581870784|FG004|Assessment and Scheduling|Investigator Terminated|0|||
161133009|NCT01701258|581870785|FG005|Assessment and Scheduling|Investigator Terminated|0|||
161133010|NCT01701258|581870786|FG006|Assessment and Scheduling|Investigator Terminated|0|||
161133011|NCT01701258|581870787|FG007|Assessment and Scheduling|Investigator Terminated|0|||
161133012|NCT01701258|581870788|FG008|Assessment and Scheduling|Investigator Terminated|0|||
161133013|NCT01701258|581870789|FG009|Assessment and Scheduling|Investigator Terminated|0|||
161133014|NCT01701258|581870790|FG010|Assessment and Scheduling|Investigator Terminated|0|||
161133015|NCT01701258|581870791|FG011|Assessment and Scheduling|Investigator Terminated|0|||
161133016|NCT01701258|581870792|FG012|Assessment and Scheduling|Investigator Terminated|0|||
160821474|NCT01007435|580733622|FG000|Overall Study|Other Protocol Violation|2|||
160821475|NCT01007435|580733623|FG001|Overall Study|Other Protocol Violation|0|||
160821476|NCT01007435|580733624|FG002|Overall Study|Other Protocol Violation|1|||
160821477|NCT01007435|580733625|FG003|Overall Study|Other Protocol Violation|0|||
160821478|NCT01007435|580733622|FG000|Overall Study|Refused Treatment|13|||
160821479|NCT01007435|580733623|FG001|Overall Study|Refused Treatment|13|||
160821480|NCT01007435|580733624|FG002|Overall Study|Refused Treatment|5|||
160821481|NCT01007435|580733625|FG003|Overall Study|Refused Treatment|8|||
160821482|NCT01007435|580733622|FG000|Overall Study|Failure to Return|5|||
160821483|NCT01007435|580733623|FG001|Overall Study|Failure to Return|4|||
160821484|NCT01007435|580733624|FG002|Overall Study|Failure to Return|3|||
160988670|NCT03682536|581345345|FG001|Treatment|Withdrawal by Subject|18|||
160988671|NCT03682536|581345344|FG000|Treatment|Lack of Efficacy|41|||
160988672|NCT03682536|581345345|FG001|Treatment|Lack of Efficacy|68|||
160988673|NCT03682536|581345344|FG000|Treatment|Disease Progression|9|||
160988674|NCT03682536|581345345|FG001|Treatment|Disease Progression|7|||
160988675|NCT03682536|581345344|FG000|Treatment|Adverse Event|9|||
160988676|NCT03682536|581345345|FG001|Treatment|Adverse Event|5|||
160988677|NCT03682536|581345344|FG000|Treatment|Death|14|||
160988678|NCT03682536|581345345|FG001|Treatment|Death|13|||
160988679|NCT04824131|581345346|FG000|CAB LA Oral Phase|Adverse Event|1|||
160988680|NCT04824131|581345346|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
160988681|NCT04824131|581345346|FG000|Step 3|Withdrawal by Subject|2|||
160988682|NCT03008122|581345352|FG000|Overall Study|Physician Decision|3|||
160988683|NCT03008122|581345353|FG001|Overall Study|Physician Decision|2|||
160988684|NCT03008122|581345354|FG002|Overall Study|Physician Decision|0|||
160988685|NCT03008122|581345352|FG000|Overall Study|Withdrawal by Subject|1|||
160988686|NCT03008122|581345353|FG001|Overall Study|Withdrawal by Subject|3|||
160988687|NCT03008122|581345354|FG002|Overall Study|Withdrawal by Subject|0|||
160988688|NCT03008122|581345352|FG000|Overall Study|Lost to Follow-up|4|||
161240380|NCT04493684|582260595|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240381|NCT04493684|582260596|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240382|NCT04493684|582260597|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
161240383|NCT04493684|582260598|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240384|NCT04493684|582260599|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240385|NCT04493684|582260600|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240386|NCT04493684|582260601|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240387|NCT04493684|582260602|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240388|NCT04493684|582260603|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240389|NCT04493684|582260604|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240390|NCT04493684|582260605|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240391|NCT04493684|582260606|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240392|NCT04493684|582260607|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240393|NCT04493684|582260608|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
161240394|NCT04493684|582260592|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
161240395|NCT04493684|582260593|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240396|NCT04493684|582260594|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240397|NCT04493684|582260595|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240398|NCT04493684|582260596|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240399|NCT04493684|582260597|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240400|NCT04493684|582260598|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240401|NCT04493684|582260599|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240402|NCT04493684|582260600|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161333882|NCT03797898|582610646|FG001|Overall Study|Became ineligible|2|||
161333883|NCT00485069|582610647|FG000|Overall Study|Adverse Event|10|||
161333884|NCT00485069|582610648|FG001|Overall Study|Adverse Event|4|||
161333885|NCT00485069|582610647|FG000|Overall Study|Lack of Efficacy|2|||
160988689|NCT03008122|581345353|FG001|Overall Study|Lost to Follow-up|8|||
161333886|NCT00485069|582610648|FG001|Overall Study|Lack of Efficacy|1|||
160988690|NCT03008122|581345354|FG002|Overall Study|Lost to Follow-up|3|||
160988691|NCT03008122|581345352|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
160988692|NCT03008122|581345353|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
160988693|NCT03008122|581345354|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
160988694|NCT03008122|581345352|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
160988695|NCT03008122|581345353|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
160988696|NCT03008122|581345354|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
160988697|NCT03008122|581345352|FG000|Overall Study|Death|0|||
160988698|NCT03008122|581345353|FG001|Overall Study|Death|0|||
160988699|NCT03008122|581345354|FG002|Overall Study|Death|1|||
160988700|NCT04159896|581345355|FG000|Overall Study|Lack of Efficacy|7|||
160988701|NCT04159896|581345355|FG000|Overall Study|Withdrawal by Subject|1|||
160988702|NCT04159896|581345355|FG000|Overall Study|Adverse Event|1|||
161333887|NCT00485069|582610647|FG000|Overall Study|Protocol Violation|0|||
161333888|NCT00485069|582610648|FG001|Overall Study|Protocol Violation|1|||
161333889|NCT00485069|582610647|FG000|Overall Study|Withdrawal by Subject|6|||
161333890|NCT00485069|582610648|FG001|Overall Study|Withdrawal by Subject|6|||
161333891|NCT00086190|582610649|FG000|Overall Study|Adverse Event|6|||
161333892|NCT00086190|582610650|FG001|Overall Study|Adverse Event|2|||
160901261|NCT00142298|581032010|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
160901262|NCT00142298|581032001|FG000|Overall Study|Pregnancy|4|||
160901263|NCT00142298|581032002|FG001|Overall Study|Pregnancy|4|||
160901264|NCT00142298|581032003|FG002|Overall Study|Pregnancy|2|||
160901265|NCT00142298|581032004|FG003|Overall Study|Pregnancy|3|||
160901266|NCT00142298|581032005|FG004|Overall Study|Pregnancy|0|||
160901267|NCT00142298|581032006|FG005|Overall Study|Pregnancy|0|||
160901268|NCT00142298|581032007|FG006|Overall Study|Pregnancy|0|||
160901269|NCT00142298|581032008|FG007|Overall Study|Pregnancy|0|||
160901270|NCT00142298|581032009|FG008|Overall Study|Pregnancy|1|||
160901271|NCT00142298|581032010|FG009|Overall Study|Pregnancy|0|||
160901272|NCT00142298|581032001|FG000|Overall Study|Virologic breakthrough|19|||
160901273|NCT00142298|581032002|FG001|Overall Study|Virologic breakthrough|23|||
160901274|NCT00142298|581032003|FG002|Overall Study|Virologic breakthrough|9|||
160901275|NCT00142298|581032004|FG003|Overall Study|Virologic breakthrough|7|||
160901276|NCT00142298|581032005|FG004|Overall Study|Virologic breakthrough|2|||
160901277|NCT00142298|581032006|FG005|Overall Study|Virologic breakthrough|3|||
160901278|NCT00142298|581032007|FG006|Overall Study|Virologic breakthrough|3|||
160901279|NCT00142298|581032008|FG007|Overall Study|Virologic breakthrough|0|||
160901280|NCT00142298|581032009|FG008|Overall Study|Virologic breakthrough|0|||
160901281|NCT00142298|581032010|FG009|Overall Study|Virologic breakthrough|0|||
160901282|NCT00142298|581032001|FG000|Overall Study|Other- not specified|0|||
160901283|NCT00142298|581032002|FG001|Overall Study|Other- not specified|3|||
160901284|NCT00142298|581032003|FG002|Overall Study|Other- not specified|0|||
160901285|NCT00142298|581032004|FG003|Overall Study|Other- not specified|1|||
160901286|NCT00142298|581032005|FG004|Overall Study|Other- not specified|0|||
160901287|NCT00142298|581032006|FG005|Overall Study|Other- not specified|0|||
160901288|NCT00142298|581032007|FG006|Overall Study|Other- not specified|0|||
160901289|NCT00142298|581032008|FG007|Overall Study|Other- not specified|0|||
160901290|NCT00142298|581032009|FG008|Overall Study|Other- not specified|0|||
160901291|NCT00142298|581032010|FG009|Overall Study|Other- not specified|0|||
160901292|NCT00142298|581032001|FG000|Overall Study|Lost to Follow-up|0|||
160901293|NCT00142298|581032002|FG001|Overall Study|Lost to Follow-up|0|||
160901294|NCT00142298|581032003|FG002|Overall Study|Lost to Follow-up|0|||
160901295|NCT00142298|581032004|FG003|Overall Study|Lost to Follow-up|0|||
160901296|NCT00142298|581032005|FG004|Overall Study|Lost to Follow-up|0|||
160901297|NCT00142298|581032006|FG005|Overall Study|Lost to Follow-up|0|||
160901298|NCT00142298|581032007|FG006|Overall Study|Lost to Follow-up|2|||
160901299|NCT00142298|581032008|FG007|Overall Study|Lost to Follow-up|0|||
160901300|NCT00142298|581032009|FG008|Overall Study|Lost to Follow-up|0|||
160901301|NCT00142298|581032010|FG009|Overall Study|Lost to Follow-up|0|||
160901302|NCT00142298|581032001|FG000|Overall Study|Treatment Failure|0|||
160901303|NCT00142298|581032002|FG001|Overall Study|Treatment Failure|0|||
160901304|NCT00142298|581032003|FG002|Overall Study|Treatment Failure|0|||
160901305|NCT00142298|581032004|FG003|Overall Study|Treatment Failure|0|||
160901306|NCT00142298|581032005|FG004|Overall Study|Treatment Failure|0|||
160901307|NCT00142298|581032006|FG005|Overall Study|Treatment Failure|2|||
160901308|NCT00142298|581032007|FG006|Overall Study|Treatment Failure|2|||
160901309|NCT00142298|581032008|FG007|Overall Study|Treatment Failure|0|||
160901310|NCT00142298|581032009|FG008|Overall Study|Treatment Failure|0|||
161133017|NCT01323478|581870793|FG000|Overall Study|Adverse Event|7|||
161133018|NCT01323478|581870793|FG000|Overall Study|Lack of Efficacy|4|||
161133019|NCT01323478|581870793|FG000|Overall Study|Non-compliance With Study Product|3|||
161133020|NCT01323478|581870793|FG000|Overall Study|Protocol Violation|1|||
161133021|NCT01323478|581870793|FG000|Overall Study|Withdrawal of Consent|1|||
161133022|NCT01323478|581870793|FG000|Overall Study|Administrative or Other Reasons|8|||
161133023|NCT01756456|581870797|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161133024|NCT01756456|581870798|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161333893|NCT00086190|582610651|FG002|Overall Study|Adverse Event|2|||
160901311|NCT00142298|581032010|FG009|Overall Study|Treatment Failure|0|||
160901312|NCT02423772|581032013|FG000|Overall Study|Lost to Follow-up|3|||
160901313|NCT02423772|581032014|FG001|Overall Study|Lost to Follow-up|3|||
160901314|NCT02423772|581032013|FG000|Overall Study|Did not begin intervention|2|||
160901315|NCT02423772|581032014|FG001|Overall Study|Did not begin intervention|5|||
160901316|NCT01193842|581032015|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901317|NCT01193842|581032016|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
160901318|NCT01193842|581032017|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901319|NCT01193842|581032018|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901320|NCT01193842|581032019|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
160901321|NCT01193842|581032015|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
160901322|NCT01193842|581032016|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
161333894|NCT00086190|582610649|FG000|Overall Study|Withdrawal by Subject|0|||
160821485|NCT01007435|580733625|FG003|Overall Study|Failure to Return|6|||
160821486|NCT01007435|580733622|FG000|Overall Study|Reason not Specified|1|||
160821487|NCT01007435|580733623|FG001|Overall Study|Reason not Specified|1|||
160821488|NCT01007435|580733624|FG002|Overall Study|Reason not Specified|2|||
160821489|NCT01007435|580733625|FG003|Overall Study|Reason not Specified|1|||
160821490|NCT01032291|580733626|FG000|Safety Lead-in|Adverse Event|1|||
161133025|NCT01756456|581870799|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
161133026|NCT01756456|581870800|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161133027|NCT01756456|581870801|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161133028|NCT01756456|581870802|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
161133029|NCT01756456|581870797|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161133030|NCT01756456|581870798|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161133031|NCT01756456|581870799|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
161133032|NCT01756456|581870800|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
161133033|NCT01756456|581870801|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
161133034|NCT01756456|581870802|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
160821491|NCT01032291|580733627|FG001|Safety Lead-in|Adverse Event|0|||
160821492|NCT01032291|580733628|FG002|Safety Lead-in|Adverse Event|0|||
160821493|NCT01032291|580733626|FG000|Safety Lead-in|Death|1|||
160821494|NCT01032291|580733627|FG001|Safety Lead-in|Death|0|||
160821495|NCT01032291|580733628|FG002|Safety Lead-in|Death|0|||
160821496|NCT01032291|580733626|FG000|Proof of Concept|Adverse Event|0|||
160821497|NCT01032291|580733627|FG001|Proof of Concept|Adverse Event|5|||
160821498|NCT01032291|580733628|FG002|Proof of Concept|Adverse Event|1|||
160821499|NCT01032291|580733626|FG000|Proof of Concept|Death|0|||
160821500|NCT01032291|580733627|FG001|Proof of Concept|Death|1|||
160821501|NCT01032291|580733628|FG002|Proof of Concept|Death|2|||
160821502|NCT01032291|580733626|FG000|Proof of Concept|Lack of Efficacy|0|||
160821503|NCT01032291|580733627|FG001|Proof of Concept|Lack of Efficacy|1|||
160821504|NCT01032291|580733628|FG002|Proof of Concept|Lack of Efficacy|0|||
160901323|NCT01193842|581032017|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160901324|NCT01193842|581032018|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160901325|NCT01193842|581032019|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
160901326|NCT01193842|581032015|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901327|NCT01193842|581032016|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901328|NCT01193842|581032017|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
160901329|NCT01193842|581032018|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901330|NCT01193842|581032019|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
160901331|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Death|0|||
160901332|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Death|0|||
160901333|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Death|0|||
160901334|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Death|1|||
160901335|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Death|1|||
160901336|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Adverse Event|0|||
160901337|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Adverse Event|0|||
160901338|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Adverse Event|0|||
160901339|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Adverse Event|5|||
160901340|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Adverse Event|3|||
160901341|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
160901342|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
160901343|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
160901344|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
160901345|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
160901346|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Ineligible|0|||
160901347|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Ineligible|0|||
160901348|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Ineligible|0|||
160901349|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Ineligible|0|||
160901350|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Ineligible|1|||
160901351|NCT01193842|581032015|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
160901352|NCT01193842|581032016|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
160901353|NCT01193842|581032017|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
160901354|NCT01193842|581032018|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
160901355|NCT01193842|581032019|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
160901356|NCT01313858|581033988|FG000|Overall Study|Premature Treatment Termination|251|||
161133035|NCT01756456|581870797|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161133036|NCT01756456|581870798|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
160821505|NCT01032291|580733626|FG000|Proof of Concept|Never Received Study Drug|0|||
160821506|NCT01032291|580733627|FG001|Proof of Concept|Never Received Study Drug|1|||
160821507|NCT01032291|580733628|FG002|Proof of Concept|Never Received Study Drug|0|||
160821508|NCT02576535|580733629|FG000|Overall Study|Withdrawal by Subject|2|||
160821509|NCT00347438|580733630|FG000|Overall Study|Withdrawal by Subject|1|||
160901357|NCT01313858|581033989|FG001|Overall Study|Premature Treatment Termination|219|||
160988703|NCT04159896|581345355|FG000|Overall Study|A transient ischaemic attack|1|||
160988704|NCT01222247|581345356|FG000|Overall Study|Lost to Follow-up|2|||
160988705|NCT01222247|581345357|FG001|Overall Study|Lost to Follow-up|2|||
160988706|NCT02338609|581345358|FG000|Overall Study|Physician Decision|1|||
160988707|NCT02338609|581345358|FG000|Overall Study|Death|1|||
160988708|NCT02084082|581345359|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
160988709|NCT02084082|581345360|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
161133037|NCT01756456|581870799|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161133038|NCT01756456|581870800|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161133039|NCT01756456|581870801|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161133040|NCT01756456|581870802|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
161133041|NCT01756456|581870797|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
161133042|NCT01756456|581870798|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
161133043|NCT01756456|581870799|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
161133044|NCT01756456|581870800|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
161133045|NCT01756456|581870801|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
161133046|NCT01756456|581870802|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
161133047|NCT01756456|581870797|FG000|Treatment Period: Phase I/II|Other causes|0|||
161133048|NCT01756456|581870798|FG001|Treatment Period: Phase I/II|Other causes|0|||
161133049|NCT01756456|581870799|FG002|Treatment Period: Phase I/II|Other causes|0|||
161133050|NCT01756456|581870800|FG003|Treatment Period: Phase I/II|Other causes|1|||
161133051|NCT01756456|581870801|FG004|Treatment Period: Phase I/II|Other causes|2|||
161133052|NCT01756456|581870802|FG005|Treatment Period: Phase I/II|Other causes|2|||
160988710|NCT02084082|581345361|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
160988711|NCT02084082|581345362|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
160988712|NCT02084082|581345359|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160988713|NCT02084082|581345360|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160988714|NCT02084082|581345361|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
160988715|NCT02084082|581345362|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
160988716|NCT01449721|581345367|FG000|Overall Study|Physician Decision|0|||
160988717|NCT01449721|581345368|FG001|Overall Study|Physician Decision|1|||
160988718|NCT01449721|581345367|FG000|Overall Study|Physician Decision|0|||
160988719|NCT01449721|581345368|FG001|Overall Study|Physician Decision|1|||
160988720|NCT02148718|581345369|FG000|Overall Study|Protocol Violation|26|||
160988721|NCT02148718|581345369|FG000|Overall Study|Discontinued Study Prematurely|5|||
160988722|NCT01822821|581345374|FG000|Overall Study|Eligible surgery cancelled|1|||
160988723|NCT01822821|581345375|FG001|Overall Study|Eligible surgery cancelled|1|||
160988724|NCT01822821|581345374|FG000|Overall Study|Other reasons|1|||
160988725|NCT01822821|581345375|FG001|Overall Study|Other reasons|0|||
160988726|NCT00333788|581345378|FG000|Overall Study|Adverse Event|44|||
160988727|NCT00333788|581345378|FG000|Overall Study|Lack of Efficacy|80|||
160988728|NCT00333788|581345378|FG000|Overall Study|Lost to Follow-up|2|||
160988729|NCT00333788|581345378|FG000|Overall Study|Withdrawal by Subject|24|||
160988730|NCT00333788|581345378|FG000|Overall Study|Other: Non-compliance|2|||
161240403|NCT04493684|582260601|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240404|NCT04493684|582260602|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240405|NCT04493684|582260603|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240406|NCT04493684|582260604|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240407|NCT04493684|582260605|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240408|NCT04493684|582260606|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240409|NCT04493684|582260607|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240410|NCT04493684|582260608|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
161240411|NCT04493684|582260592|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240412|NCT04493684|582260593|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240413|NCT04493684|582260594|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240414|NCT04493684|582260595|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240415|NCT04493684|582260596|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240416|NCT04493684|582260597|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240417|NCT04493684|582260598|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
161240418|NCT04493684|582260599|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161133053|NCT01756456|581870797|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
161133054|NCT01756456|581870798|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
161240419|NCT04493684|582260600|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240420|NCT04493684|582260601|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240421|NCT04493684|582260602|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240422|NCT04493684|582260603|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
160988731|NCT00333788|581345378|FG000|Overall Study|Other: Moved|2|||
160988732|NCT00333788|581345378|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
161133055|NCT01756456|581870799|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
161240423|NCT04493684|582260604|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240424|NCT04493684|582260605|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240425|NCT04493684|582260606|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240426|NCT04493684|582260607|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240427|NCT04493684|582260608|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
161240428|NCT04493684|582260592|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
161240429|NCT04493684|582260593|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240430|NCT04493684|582260594|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240431|NCT04493684|582260595|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240432|NCT04493684|582260596|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161333895|NCT00086190|582610650|FG001|Overall Study|Withdrawal by Subject|2|||
161333896|NCT00086190|582610651|FG002|Overall Study|Withdrawal by Subject|2|||
161333897|NCT00086190|582610649|FG000|Overall Study|Protocol Violation|1|||
161333898|NCT00086190|582610650|FG001|Overall Study|Protocol Violation|0|||
161333899|NCT00086190|582610651|FG002|Overall Study|Protocol Violation|0|||
161333900|NCT00086190|582610649|FG000|Overall Study|Moved|1|||
161333901|NCT00086190|582610650|FG001|Overall Study|Moved|0|||
161333902|NCT00086190|582610651|FG002|Overall Study|Moved|0|||
161333903|NCT00086190|582610649|FG000|Overall Study|Worsening depression|0|||
161333904|NCT00086190|582610650|FG001|Overall Study|Worsening depression|0|||
161333905|NCT00086190|582610651|FG002|Overall Study|Worsening depression|2|||
161333906|NCT03217591|582610652|FG000|Overall Study|Adverse Event|1|||
161333907|NCT03217591|582610653|FG001|Overall Study|Adverse Event|2|||
161333908|NCT03217591|582610654|FG002|Overall Study|Adverse Event|6|||
161333909|NCT03217591|582610652|FG000|Overall Study|Withdrawal by Subject|0|||
161333910|NCT03217591|582610653|FG001|Overall Study|Withdrawal by Subject|1|||
161333911|NCT03217591|582610654|FG002|Overall Study|Withdrawal by Subject|3|||
161333912|NCT03217591|582610652|FG000|Overall Study|Lost to Follow-up|1|||
161333913|NCT03217591|582610653|FG001|Overall Study|Lost to Follow-up|0|||
161333914|NCT03217591|582610654|FG002|Overall Study|Lost to Follow-up|0|||
161333915|NCT03217591|582610652|FG000|Overall Study|Protocol Violation|1|||
161333916|NCT03217591|582610653|FG001|Overall Study|Protocol Violation|0|||
161333917|NCT03217591|582610654|FG002|Overall Study|Protocol Violation|1|||
161333918|NCT03902613|582610656|FG000|Overall Study|Physician Decision|1|||
161333919|NCT02873689|582612420|FG000|Overall Study|Lack of Efficacy|1|||
161333920|NCT02873689|582612421|FG001|Overall Study|Lack of Efficacy|0|||
161333921|NCT02873689|582612420|FG000|Overall Study|Withdrawal by Subject|2|||
161333922|NCT02873689|582612421|FG001|Overall Study|Withdrawal by Subject|2|||
161333923|NCT02873689|582612420|FG000|Overall Study|Protocol Violation|1|||
161333924|NCT02873689|582612421|FG001|Overall Study|Protocol Violation|0|||
161333925|NCT02873689|582612420|FG000|Overall Study|Adverse Event|2|||
161333926|NCT02873689|582612421|FG001|Overall Study|Adverse Event|2|||
161333927|NCT02873689|582612420|FG000|Overall Study|Randomized but not Treated|1|||
161333928|NCT02873689|582612421|FG001|Overall Study|Randomized but not Treated|1|||
161333929|NCT00434252|582612425|FG000|Overall Study|Lack of Efficacy|50|||
160901358|NCT01313858|581033990|FG002|Overall Study|Premature Treatment Termination|191|||
160901359|NCT01313858|581033988|FG000|Overall Study|Lost to Follow-up|35|||
160901360|NCT01313858|581033989|FG001|Overall Study|Lost to Follow-up|51|||
160901361|NCT01313858|581033990|FG002|Overall Study|Lost to Follow-up|47|||
160901362|NCT03689530|581033994|FG000|Overall Study|Withdrawal by Subject|53|||
160901363|NCT03689530|581033995|FG001|Overall Study|Withdrawal by Subject|16|||
160901364|NCT01392443|581033996|FG000|Overall Study|Disease progression|30|||
160901365|NCT01392443|581033996|FG000|Overall Study|Adverse Event|24|||
160901366|NCT01392443|581033996|FG000|Overall Study|Death|7|||
160901367|NCT01392443|581033996|FG000|Overall Study|Withdrawal by Subject|5|||
160901368|NCT01392443|581033996|FG000|Overall Study|Lost to Follow-up|1|||
160901369|NCT01392443|581033996|FG000|Overall Study|Protocol Violation|1|||
160901370|NCT01977794|581033997|FG000|Overall Study|Adverse Event|2|||
160901371|NCT01977794|581033998|FG001|Overall Study|Adverse Event|2|||
160901372|NCT01977794|581033997|FG000|Overall Study|Lost to Follow-up|2|||
160901373|NCT01977794|581033998|FG001|Overall Study|Lost to Follow-up|1|||
160901374|NCT01977794|581033997|FG000|Overall Study|Protocol Violation|1|||
161333930|NCT00434252|582612426|FG001|Overall Study|Lack of Efficacy|100|||
161333931|NCT00434252|582612425|FG000|Overall Study|Adverse Event|6|||
161333932|NCT00434252|582612426|FG001|Overall Study|Adverse Event|13|||
161333933|NCT00434252|582612425|FG000|Overall Study|Death|1|||
161333934|NCT00434252|582612426|FG001|Overall Study|Death|2|||
160901375|NCT01977794|581033998|FG001|Overall Study|Protocol Violation|0|||
160901376|NCT01977794|581033997|FG000|Overall Study|Death|1|||
160901377|NCT01977794|581033998|FG001|Overall Study|Death|1|||
161333935|NCT00434252|582612425|FG000|Overall Study|Lost to Follow-up|0|||
161333936|NCT00434252|582612426|FG001|Overall Study|Lost to Follow-up|1|||
161333937|NCT00434252|582612425|FG000|Overall Study|Physician Decision|4|||
160901378|NCT01977794|581033997|FG000|Overall Study|Withdrew consent|2|||
160901379|NCT01977794|581033998|FG001|Overall Study|Withdrew consent|1|||
161333938|NCT00434252|582612426|FG001|Overall Study|Physician Decision|8|||
160901380|NCT01977794|581033997|FG000|Overall Study|Other|0|||
160901381|NCT01977794|581033998|FG001|Overall Study|Other|1|||
160988733|NCT00333788|581345378|FG000|Overall Study|Other: Investigator decision|1|||
160988734|NCT00333788|581345378|FG000|Overall Study|Other: Quality of life concern|1|||
160988735|NCT00333788|581345378|FG000|Overall Study|Other: Sponsor decision|1|||
160988736|NCT00333788|581345378|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
160988737|NCT00333788|581345378|FG000|Overall Study|Other: Medical monitor decision|1|||
160988738|NCT00333788|581345378|FG000|Overall Study|Other: Physician decision|1|||
160988739|NCT00333788|581345378|FG000|Overall Study|Other: Signed consent for another study|1|||
160988740|NCT00114959|581345379|FG000|Overall Study|Lack of Efficacy|6|||
160988741|NCT00114959|581345379|FG000|Overall Study|Physician Decision|1|||
160988742|NCT00114959|581345379|FG000|Overall Study|Death|1|||
160988743|NCT03253653|581345393|FG000|Overall Study|Withdrawal by Subject|4|||
160988744|NCT03253653|581345394|FG001|Overall Study|Withdrawal by Subject|1|||
160988745|NCT03253653|581345393|FG000|Overall Study|Protocol Violation|0|||
160988746|NCT03253653|581345394|FG001|Overall Study|Protocol Violation|5|||
160988747|NCT04978363|581347257|FG000|Overall Study|Other medical issues unrelated to the study|0|||
160988748|NCT04978363|581347258|FG001|Overall Study|Other medical issues unrelated to the study|0|||
160988749|NCT04978363|581347259|FG002|Overall Study|Other medical issues unrelated to the study|0|||
160988750|NCT04978363|581347260|FG003|Overall Study|Other medical issues unrelated to the study|0|||
160988751|NCT04978363|581347261|FG004|Overall Study|Other medical issues unrelated to the study|1|||
160988752|NCT04978363|581347262|FG005|Overall Study|Other medical issues unrelated to the study|0|||
160988753|NCT04978363|581347263|FG006|Overall Study|Other medical issues unrelated to the study|0|||
160988754|NCT04978363|581347264|FG007|Overall Study|Other medical issues unrelated to the study|0|||
160988755|NCT04978363|581347265|FG008|Overall Study|Other medical issues unrelated to the study|0|||
160988756|NCT04978363|581347266|FG009|Overall Study|Other medical issues unrelated to the study|0|||
160988757|NCT04978363|581347267|FG010|Overall Study|Other medical issues unrelated to the study|0|||
160988758|NCT04978363|581347257|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
160988759|NCT04978363|581347258|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
160988760|NCT04978363|581347259|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
160988761|NCT04978363|581347260|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
160988762|NCT04978363|581347261|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
160988763|NCT04978363|581347262|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
160988764|NCT04978363|581347263|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
160988765|NCT04978363|581347264|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
160988766|NCT04978363|581347265|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
160988767|NCT04978363|581347266|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
160988768|NCT04978363|581347267|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
160988769|NCT04978363|581347257|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988770|NCT04978363|581347258|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
160988771|NCT04978363|581347259|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988772|NCT04978363|581347260|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988773|NCT04978363|581347261|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988774|NCT04978363|581347262|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988775|NCT04978363|581347263|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988776|NCT04978363|581347264|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988777|NCT04978363|581347265|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988778|NCT04978363|581347266|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988779|NCT04978363|581347267|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
160988780|NCT01251614|581347268|FG000|Overall Study|Adverse Event|1|||
160988781|NCT01251614|581347269|FG001|Overall Study|Adverse Event|0|||
160988782|NCT01251614|581347270|FG002|Overall Study|Adverse Event|1|||
160988783|NCT01251614|581347268|FG000|Overall Study|Lack of Efficacy|1|||
160988784|NCT01251614|581347269|FG001|Overall Study|Lack of Efficacy|9|||
160988785|NCT01251614|581347270|FG002|Overall Study|Lack of Efficacy|4|||
160988786|NCT01251614|581347268|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
160988787|NCT01251614|581347269|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
160988788|NCT01251614|581347270|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
160988789|NCT01251614|581347268|FG000|Overall Study|Pregnancy|0|||
160988790|NCT01251614|581347269|FG001|Overall Study|Pregnancy|0|||
160988791|NCT01251614|581347270|FG002|Overall Study|Pregnancy|2|||
161240433|NCT04493684|582260597|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240434|NCT04493684|582260598|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240435|NCT04493684|582260599|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240436|NCT04493684|582260600|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240437|NCT04493684|582260601|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
160821510|NCT00347438|580733630|FG000|Overall Study|Physician Decision|1|||
160988792|NCT01251614|581347268|FG000|Overall Study|Loss of Disease Control|0|||
160821511|NCT02545517|580733631|FG000|Overall Study|Death|2|||
161240438|NCT04493684|582260602|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240439|NCT04493684|582260603|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161333939|NCT00434252|582612425|FG000|Overall Study|Withdrawal by Subject|3|||
161333940|NCT00434252|582612426|FG001|Overall Study|Withdrawal by Subject|7|||
161333941|NCT02337764|582612427|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
161240440|NCT04493684|582260604|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240441|NCT04493684|582260605|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240442|NCT04493684|582260606|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240443|NCT04493684|582260607|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240444|NCT04493684|582260608|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
161240445|NCT04493684|582260592|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240446|NCT04493684|582260593|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240447|NCT04493684|582260594|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240448|NCT04493684|582260595|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240449|NCT04493684|582260596|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240450|NCT04493684|582260597|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
161240451|NCT04493684|582260598|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240452|NCT04493684|582260599|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240453|NCT04493684|582260600|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240454|NCT04493684|582260601|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240455|NCT04493684|582260602|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240456|NCT04493684|582260603|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240457|NCT04493684|582260604|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240458|NCT04493684|582260605|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240459|NCT04493684|582260606|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240460|NCT04493684|582260607|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240461|NCT04493684|582260608|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
161240462|NCT04493684|582260592|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240463|NCT04493684|582260593|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240464|NCT04493684|582260594|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161333942|NCT02337764|582612427|FG000|Overall Study|Voluntary Withdrawal|12|||
161333943|NCT02337764|582612427|FG000|Overall Study|Lack of Efficacy|2|||
161333944|NCT02990000|582612428|FG000|Overall Study|Failed to provide data beyond baseline|36|||
160901382|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
160901383|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
160901384|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
160901385|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
160901386|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
160901387|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
160901388|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
160901389|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
160901390|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
160901391|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901392|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901393|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901394|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901395|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901396|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901397|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
160901398|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
160901399|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901400|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901401|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901402|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901403|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901404|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901405|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
160901406|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
161240465|NCT04493684|582260595|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240466|NCT04493684|582260596|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161333945|NCT02990000|582612429|FG001|Overall Study|Failed to provide data beyond baseline|34|||
160901407|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161333946|NCT02810418|582612436|FG000|Arm A Dose Escalation|Adverse Event|2|||
160901408|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901409|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
161333947|NCT02810418|582612437|FG001|Arm A Dose Escalation|Adverse Event|1|||
161333948|NCT02810418|582612438|FG002|Arm A Dose Escalation|Adverse Event|0|||
161240467|NCT04493684|582260597|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240468|NCT04493684|582260598|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240469|NCT04493684|582260599|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240470|NCT04493684|582260600|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240471|NCT04493684|582260601|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240472|NCT04493684|582260602|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240473|NCT04493684|582260603|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
161240474|NCT04493684|582260604|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240475|NCT04493684|582260605|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240476|NCT04493684|582260606|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240477|NCT04493684|582260607|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240478|NCT04493684|582260608|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
161240479|NCT04493684|582260592|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240480|NCT04493684|582260593|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240481|NCT04493684|582260594|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240482|NCT04493684|582260595|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240483|NCT04493684|582260596|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240484|NCT04493684|582260597|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240485|NCT04493684|582260598|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240486|NCT04493684|582260599|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240487|NCT04493684|582260600|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240488|NCT04493684|582260601|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240489|NCT04493684|582260602|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240490|NCT04493684|582260603|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240491|NCT04493684|582260604|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240492|NCT04493684|582260605|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240493|NCT04493684|582260606|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240494|NCT04493684|582260607|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
161240495|NCT04493684|582260608|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
161240496|NCT04493684|582260592|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240497|NCT04493684|582260593|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240498|NCT04493684|582260594|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240499|NCT04493684|582260595|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240500|NCT04493684|582260596|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240501|NCT04493684|582260597|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240502|NCT04493684|582260598|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240503|NCT04493684|582260599|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240504|NCT04493684|582260600|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240505|NCT04493684|582260601|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240506|NCT04493684|582260602|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240507|NCT04493684|582260603|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240508|NCT04493684|582260604|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240509|NCT04493684|582260605|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240510|NCT04493684|582260606|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240511|NCT04493684|582260607|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
161240512|NCT04493684|582260608|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
161240513|NCT01056484|582262031|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
161240514|NCT01056484|582262032|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
161240515|NCT01056484|582262031|FG000|Randomized Controlled Trial|Physician Decision|1|||
161240516|NCT01056484|582262032|FG001|Randomized Controlled Trial|Physician Decision|0|||
161240517|NCT01056484|582262031|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
161240518|NCT01056484|582262032|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
161240519|NCT00835575|582262035|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
160821512|NCT02545517|580733632|FG001|Overall Study|Death|2|||
160821513|NCT02545517|580733633|FG002|Overall Study|Death|1|||
160821514|NCT02545517|580733631|FG000|Overall Study|Lost to Follow-up|14|||
160821515|NCT02545517|580733632|FG001|Overall Study|Lost to Follow-up|13|||
160821516|NCT02545517|580733633|FG002|Overall Study|Lost to Follow-up|17|||
160821517|NCT02545517|580733631|FG000|Overall Study|Protocol Violation|0|||
160821518|NCT02545517|580733632|FG001|Overall Study|Protocol Violation|1|||
160821519|NCT02545517|580733633|FG002|Overall Study|Protocol Violation|1|||
160821520|NCT02545517|580733631|FG000|Overall Study|Withdrawal by Subject|5|||
160821521|NCT02545517|580733632|FG001|Overall Study|Withdrawal by Subject|8|||
160821522|NCT02545517|580733633|FG002|Overall Study|Withdrawal by Subject|9|||
160821523|NCT02545517|580733631|FG000|Overall Study|Administrative reason|5|||
161333949|NCT02810418|582612439|FG003|Arm A Dose Escalation|Adverse Event|0|||
161333950|NCT02810418|582612440|FG004|Arm A Dose Escalation|Adverse Event|0|||
160821524|NCT02545517|580733632|FG001|Overall Study|Administrative reason|6|||
160821525|NCT02545517|580733633|FG002|Overall Study|Administrative reason|10|||
160821526|NCT02545517|580733631|FG000|Overall Study|Other|2|||
160821527|NCT02545517|580733632|FG001|Overall Study|Other|4|||
160821528|NCT02545517|580733633|FG002|Overall Study|Other|3|||
160821529|NCT01529515|580733634|FG000|TRANSITION PHASE|Adverse Event|16|||
160821530|NCT01529515|580733635|FG001|TRANSITION PHASE|Adverse Event|0|||
160821531|NCT01529515|580733636|FG002|TRANSITION PHASE|Adverse Event|0|||
160821532|NCT01529515|580733637|FG003|TRANSITION PHASE|Adverse Event|0|||
160821533|NCT01529515|580733634|FG000|TRANSITION PHASE|Death|1|||
160821534|NCT01529515|580733635|FG001|TRANSITION PHASE|Death|0|||
160821535|NCT01529515|580733636|FG002|TRANSITION PHASE|Death|0|||
160821536|NCT01529515|580733637|FG003|TRANSITION PHASE|Death|0|||
160821537|NCT01529515|580733634|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
160821538|NCT01529515|580733635|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
160821539|NCT01529515|580733636|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
160821540|NCT01529515|580733637|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
160821541|NCT01529515|580733634|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
160821542|NCT01529515|580733635|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
160821543|NCT01529515|580733636|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
160821544|NCT01529515|580733637|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
160821545|NCT01529515|580733634|FG000|TRANSITION PHASE|Protocol Violation|4|||
160821546|NCT01529515|580733635|FG001|TRANSITION PHASE|Protocol Violation|0|||
160821547|NCT01529515|580733636|FG002|TRANSITION PHASE|Protocol Violation|0|||
160821548|NCT01529515|580733637|FG003|TRANSITION PHASE|Protocol Violation|0|||
160821549|NCT01529515|580733634|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
160821550|NCT01529515|580733635|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
160821551|NCT01529515|580733636|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
160821552|NCT01529515|580733637|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
160901410|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901411|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901412|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901413|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
160901414|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
160901415|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901416|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901417|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901418|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901419|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901420|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901421|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
160901422|NCT00533897|581034001|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
160901423|NCT00533897|581034002|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901424|NCT00533897|581034003|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901425|NCT00533897|581034004|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901426|NCT00533897|581034005|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901427|NCT00533897|581034006|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901428|NCT00533897|581034007|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901429|NCT00533897|581034008|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
160901430|NCT00533897|581034001|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
161133056|NCT01756456|581870800|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
161133057|NCT01756456|581870801|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
161133058|NCT01756456|581870802|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
161133059|NCT01756456|581870797|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161133060|NCT01756456|581870798|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
161133061|NCT01756456|581870799|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161133062|NCT01756456|581870800|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161133063|NCT01756456|581870801|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161133064|NCT01756456|581870802|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
161133065|NCT01756456|581870797|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161133066|NCT01756456|581870798|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161133067|NCT01756456|581870799|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161133068|NCT01756456|581870800|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161133069|NCT01756456|581870801|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
161333951|NCT02810418|582612441|FG005|Arm A Dose Escalation|Adverse Event|0|||
160821553|NCT01529515|580733634|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
160821554|NCT01529515|580733635|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
160821555|NCT01529515|580733636|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
160821556|NCT01529515|580733637|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
160821557|NCT01529515|580733634|FG000|TRANSITION PHASE|Other|9|||
161240520|NCT00835575|582262036|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
161240521|NCT01440803|582262037|FG000|Overall Study|Met study stopping rule|2|||
161240522|NCT01440803|582262038|FG001|Overall Study|Met study stopping rule|1|||
161240523|NCT01440803|582262037|FG000|Overall Study|Lost to Follow-up|0|||
160821558|NCT01529515|580733635|FG001|TRANSITION PHASE|Other|0|||
160821559|NCT01529515|580733636|FG002|TRANSITION PHASE|Other|0|||
160821560|NCT01529515|580733637|FG003|TRANSITION PHASE|Other|0|||
160821561|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Adverse Event|0|||
160821562|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Adverse Event|10|||
160821563|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Adverse Event|0|||
160821564|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Adverse Event|0|||
160821565|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
161240524|NCT01440803|582262038|FG001|Overall Study|Lost to Follow-up|2|||
161240525|NCT01440803|582262037|FG000|Overall Study|Withdrawal by Subject|0|||
161240526|NCT01440803|582262038|FG001|Overall Study|Withdrawal by Subject|1|||
161240527|NCT02241551|582262039|FG000|Overall Study|Adverse Event|1|||
161240528|NCT02241551|582262040|FG001|Overall Study|Adverse Event|0|||
161240529|NCT02751424|582262050|FG000|Part 2|Adverse Event|0|||
161240530|NCT02751424|582262051|FG001|Part 2|Adverse Event|0|||
161240531|NCT02751424|582262052|FG002|Part 2|Adverse Event|0|||
161240532|NCT02751424|582262053|FG003|Part 2|Adverse Event|0|||
161240533|NCT02751424|582262054|FG004|Part 2|Adverse Event|0|||
161240534|NCT02751424|582262055|FG005|Part 2|Adverse Event|0|||
161240535|NCT02751424|582262056|FG006|Part 2|Adverse Event|0|||
161240536|NCT02751424|582262057|FG007|Part 2|Adverse Event|5|||
161240537|NCT02751424|582262058|FG008|Part 2|Adverse Event|0|||
161240538|NCT02197416|582262059|FG000|Overall Study|Other reasons|0|||
161240539|NCT02197416|582262060|FG001|Overall Study|Other reasons|2|||
161240540|NCT02197416|582262061|FG002|Overall Study|Other reasons|5|||
161240541|NCT02197416|582262059|FG000|Overall Study|Withdrawal by Subject|0|||
161240542|NCT02197416|582262060|FG001|Overall Study|Withdrawal by Subject|2|||
161333952|NCT02810418|582612442|FG006|Arm A Dose Escalation|Adverse Event|0|||
160821566|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
160821567|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
160901431|NCT00533897|581034002|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
160901432|NCT00533897|581034003|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
160901433|NCT00533897|581034004|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901434|NCT00533897|581034005|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901435|NCT00533897|581034006|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901436|NCT00533897|581034007|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901437|NCT00533897|581034008|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
160901438|NCT00533897|581034001|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901439|NCT00533897|581034002|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901440|NCT00533897|581034003|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
160901441|NCT00533897|581034004|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901442|NCT00533897|581034005|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901443|NCT00533897|581034006|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901444|NCT00533897|581034007|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901445|NCT00533897|581034008|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
160901446|NCT00533897|581034001|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901447|NCT00533897|581034002|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901448|NCT00533897|581034003|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901449|NCT00533897|581034004|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901450|NCT00533897|581034005|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901451|NCT00533897|581034006|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
160901452|NCT00533897|581034007|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901453|NCT00533897|581034008|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
160901454|NCT00533897|581034001|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901455|NCT00533897|581034002|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901456|NCT00533897|581034003|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901457|NCT00533897|581034004|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901458|NCT00533897|581034005|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901459|NCT00533897|581034006|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
160901460|NCT00533897|581034007|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
161240543|NCT02197416|582262061|FG002|Overall Study|Withdrawal by Subject|1|||
161240544|NCT02197416|582262059|FG000|Overall Study|Protocol Violation|1|||
161240545|NCT02197416|582262060|FG001|Overall Study|Protocol Violation|0|||
161240546|NCT02197416|582262061|FG002|Overall Study|Protocol Violation|1|||
161240547|NCT02197416|582262059|FG000|Overall Study|Adverse Event|0|||
161240548|NCT02197416|582262060|FG001|Overall Study|Adverse Event|0|||
161240549|NCT02197416|582262061|FG002|Overall Study|Adverse Event|1|||
160988793|NCT01251614|581347269|FG001|Overall Study|Loss of Disease Control|1|||
160988794|NCT01251614|581347270|FG002|Overall Study|Loss of Disease Control|0|||
160988795|NCT01251614|581347268|FG000|Overall Study|Withdrawal by Subject|0|||
160988796|NCT01251614|581347269|FG001|Overall Study|Withdrawal by Subject|2|||
160988797|NCT01251614|581347270|FG002|Overall Study|Withdrawal by Subject|1|||
160988798|NCT01251614|581347268|FG000|Overall Study|Lost to Follow-up|0|||
160988799|NCT01251614|581347269|FG001|Overall Study|Lost to Follow-up|1|||
160988800|NCT01251614|581347270|FG002|Overall Study|Lost to Follow-up|0|||
160988801|NCT01876043|581347272|FG000|Overall Study|Death|1|||
160988802|NCT01876043|581347272|FG000|Overall Study|Withdrawal by Subject|1|||
160988803|NCT00079937|581347273|FG000|Overall Study|Adverse Event|2|||
160988804|NCT00079937|581347274|FG001|Overall Study|Adverse Event|1|||
160988805|NCT00079937|581347273|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160988806|NCT00079937|581347274|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160988807|NCT00079937|581347273|FG000|Overall Study|Subject no longer requires study drug|3|||
160988808|NCT00079937|581347274|FG001|Overall Study|Subject no longer requires study drug|0|||
160988809|NCT00079937|581347273|FG000|Overall Study|Protocol Violation|8|||
160988810|NCT00079937|581347274|FG001|Overall Study|Protocol Violation|6|||
160988811|NCT00079937|581347273|FG000|Overall Study|Withdrawal by Subject|21|||
160988812|NCT00079937|581347274|FG001|Overall Study|Withdrawal by Subject|7|||
160988813|NCT00079937|581347273|FG000|Overall Study|Lost to Follow-up|12|||
160988814|NCT00079937|581347274|FG001|Overall Study|Lost to Follow-up|5|||
160988815|NCT00079937|581347273|FG000|Overall Study|Administrative problems|22|||
160988816|NCT00079937|581347274|FG001|Overall Study|Administrative problems|11|||
160988817|NCT02857283|581347275|FG000|First Exposure|Withdrawal by Subject|1|||
160988818|NCT02857283|581347276|FG001|First Exposure|Withdrawal by Subject|0|||
160988819|NCT00093795|581347277|FG000|Overall Study|No follow up data|20|||
160988820|NCT00093795|581347278|FG001|Overall Study|No follow up data|16|||
160988821|NCT00093795|581347279|FG002|Overall Study|No follow up data|17|||
160988822|NCT00613301|581347280|FG000|Overall Study|Adverse Event|49|||
160988823|NCT00613301|581347280|FG000|Overall Study|Lost to Follow-up|88|||
160988824|NCT00613301|581347280|FG000|Overall Study|Withdrawal by Subject|5|||
160988825|NCT00613301|581347280|FG000|Overall Study|Death|6|||
160988826|NCT00613301|581347280|FG000|Overall Study|Lack of Efficacy|13|||
160988827|NCT00613301|581347280|FG000|Overall Study|Physician Decision|2|||
160988828|NCT00613301|581347280|FG000|Overall Study|No data was collected|53|||
160988829|NCT00613301|581347280|FG000|Overall Study|Irregularly enrolled patients|12|||
160988830|NCT01684046|581347283|FG000|Period 1, First 30 Days|Adverse Event|0|||
160988831|NCT01684046|581347284|FG001|Period 1, First 30 Days|Adverse Event|2|||
160988832|NCT00797862|581347285|FG000|Overall Study|Adverse Event|86|||
160988833|NCT00797862|581347286|FG001|Overall Study|Adverse Event|44|||
160988834|NCT00797862|581347287|FG002|Overall Study|Adverse Event|58|||
160988835|NCT00797862|581347285|FG000|Overall Study|Abnormal Test Procedure Result|0|||
160988836|NCT00797862|581347286|FG001|Overall Study|Abnormal Test Procedure Result|1|||
160988837|NCT00797862|581347287|FG002|Overall Study|Abnormal Test Procedure Result|1|||
160988838|NCT00797862|581347285|FG000|Overall Study|Lack of Efficacy|1|||
160988839|NCT00797862|581347286|FG001|Overall Study|Lack of Efficacy|7|||
160988840|NCT00797862|581347287|FG002|Overall Study|Lack of Efficacy|6|||
160988841|NCT00797862|581347285|FG000|Overall Study|No longer required study medication|1|||
160988842|NCT00797862|581347286|FG001|Overall Study|No longer required study medication|0|||
160988843|NCT00797862|581347287|FG002|Overall Study|No longer required study medication|0|||
160988844|NCT00797862|581347285|FG000|Overall Study|Withdrawal by Subject|14|||
160988845|NCT00797862|581347286|FG001|Overall Study|Withdrawal by Subject|7|||
160988846|NCT00797862|581347287|FG002|Overall Study|Withdrawal by Subject|7|||
160988847|NCT00797862|581347285|FG000|Overall Study|Lost to Follow-up|11|||
160988848|NCT00797862|581347286|FG001|Overall Study|Lost to Follow-up|0|||
160988849|NCT00797862|581347287|FG002|Overall Study|Lost to Follow-up|5|||
160988850|NCT00797862|581347285|FG000|Overall Study|Administrative Problem|4|||
160988851|NCT00797862|581347286|FG001|Overall Study|Administrative Problem|0|||
160988852|NCT00797862|581347287|FG002|Overall Study|Administrative Problem|0|||
160988853|NCT00797862|581347285|FG000|Overall Study|Protocol Violation|4|||
160988854|NCT00797862|581347286|FG001|Overall Study|Protocol Violation|6|||
160988855|NCT00797862|581347287|FG002|Overall Study|Protocol Violation|8|||
161133070|NCT01756456|581870802|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
161133071|NCT01756456|581870797|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
161133072|NCT01756456|581870798|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
160988856|NCT00797862|581347285|FG000|Overall Study|Mis-randomized|3|||
160988857|NCT00797862|581347286|FG001|Overall Study|Mis-randomized|3|||
160988858|NCT00797862|581347287|FG002|Overall Study|Mis-randomized|1|||
160988859|NCT01306331|581347291|FG000|Overall Study|Adverse Event|28|||
160988860|NCT01306331|581347292|FG001|Overall Study|Adverse Event|25|||
160988861|NCT01306331|581347291|FG000|Overall Study|Lost to Follow-up|321|||
161333953|NCT02810418|582612436|FG000|Dose Expansion|Adverse Event|0|||
160988862|NCT01306331|581347292|FG001|Overall Study|Lost to Follow-up|323|||
161333954|NCT02810418|582612437|FG001|Dose Expansion|Adverse Event|1|||
160988863|NCT01306331|581347291|FG000|Overall Study|Physician Decision|26|||
160988864|NCT01306331|581347292|FG001|Overall Study|Physician Decision|22|||
161333955|NCT02810418|582612438|FG002|Dose Expansion|Adverse Event|1|||
161333956|NCT02810418|582612439|FG003|Dose Expansion|Adverse Event|0|||
161333957|NCT02810418|582612440|FG004|Dose Expansion|Adverse Event|0|||
161333958|NCT02810418|582612441|FG005|Dose Expansion|Adverse Event|0|||
161333959|NCT02810418|582612442|FG006|Dose Expansion|Adverse Event|0|||
161333960|NCT02810418|582612436|FG000|Dose Expansion|Physician Decision|0|||
161333961|NCT02810418|582612437|FG001|Dose Expansion|Physician Decision|0|||
161333962|NCT02810418|582612438|FG002|Dose Expansion|Physician Decision|2|||
161333963|NCT02810418|582612439|FG003|Dose Expansion|Physician Decision|0|||
161333964|NCT02810418|582612440|FG004|Dose Expansion|Physician Decision|0|||
161333965|NCT02810418|582612441|FG005|Dose Expansion|Physician Decision|0|||
161333966|NCT02810418|582612442|FG006|Dose Expansion|Physician Decision|0|||
161333967|NCT02810418|582612436|FG000|Arm B Dose Escalation|Adverse Event|0|||
161333968|NCT02810418|582612437|FG001|Arm B Dose Escalation|Adverse Event|0|||
161333969|NCT02810418|582612438|FG002|Arm B Dose Escalation|Adverse Event|0|||
161333970|NCT02810418|582612439|FG003|Arm B Dose Escalation|Adverse Event|0|||
161333971|NCT02810418|582612440|FG004|Arm B Dose Escalation|Adverse Event|1|||
161333972|NCT02810418|582612441|FG005|Arm B Dose Escalation|Adverse Event|2|||
161333973|NCT02810418|582612442|FG006|Arm B Dose Escalation|Adverse Event|0|||
161333974|NCT03103503|582612443|FG000|Overall Study|Death|64|||
161333975|NCT03103503|582612443|FG000|Overall Study|Physician Decision|57|||
161333976|NCT03103503|582612443|FG000|Overall Study|Withdrawal by Subject|10|||
161333977|NCT03103503|582612443|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
161333978|NCT03103503|582612443|FG000|Overall Study|Lost to Follow-up|3|||
160988865|NCT01306331|581347291|FG000|Overall Study|Pregnancy|136|||
160988866|NCT01306331|581347292|FG001|Overall Study|Pregnancy|151|||
160988867|NCT01306331|581347291|FG000|Overall Study|Protocol Violation|154|||
160988868|NCT01306331|581347292|FG001|Overall Study|Protocol Violation|124|||
160988869|NCT01306331|581347291|FG000|Overall Study|Withdrawal by Subject|163|||
160988870|NCT01306331|581347292|FG001|Overall Study|Withdrawal by Subject|152|||
160988871|NCT01306331|581347291|FG000|Overall Study|Not sexually active|29|||
160988872|NCT01306331|581347292|FG001|Overall Study|Not sexually active|28|||
160988873|NCT01306331|581347291|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
160988874|NCT01306331|581347292|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
160988875|NCT01306331|581347291|FG000|Overall Study|Other|34|||
160988876|NCT01306331|581347292|FG001|Overall Study|Other|32|||
160988877|NCT00172185|581347297|FG000|Overall Study|Adverse Event|0|||
160988878|NCT00172185|581347298|FG001|Overall Study|Adverse Event|1|||
160988879|NCT00172185|581347299|FG002|Overall Study|Adverse Event|3|||
160988880|NCT00172185|581347300|FG003|Overall Study|Adverse Event|4|||
160988881|NCT00172185|581347297|FG000|Overall Study|Physician Decision|0|||
160988882|NCT00172185|581347298|FG001|Overall Study|Physician Decision|0|||
160988883|NCT00172185|581347299|FG002|Overall Study|Physician Decision|1|||
160988884|NCT00172185|581347300|FG003|Overall Study|Physician Decision|0|||
160988885|NCT00172185|581347297|FG000|Overall Study|SPONSOR Decision|0|||
160988886|NCT00172185|581347298|FG001|Overall Study|SPONSOR Decision|1|||
160988887|NCT00172185|581347299|FG002|Overall Study|SPONSOR Decision|0|||
160988888|NCT00172185|581347300|FG003|Overall Study|SPONSOR Decision|0|||
160988889|NCT00172185|581347297|FG000|Overall Study|Withdrawal by Subject|0|||
160988890|NCT00172185|581347298|FG001|Overall Study|Withdrawal by Subject|0|||
160988891|NCT00172185|581347299|FG002|Overall Study|Withdrawal by Subject|1|||
160988892|NCT00172185|581347300|FG003|Overall Study|Withdrawal by Subject|0|||
160988893|NCT02790606|581347303|FG000|Overall Study|Death|27|||
160988894|NCT02790606|581347303|FG000|Overall Study|Lost to Follow-up|4|||
160988895|NCT02790606|581347303|FG000|Overall Study|Physician Decision|3|||
160988896|NCT02790606|581347303|FG000|Overall Study|Withdrawal by Subject|1|||
160988897|NCT02735915|581347304|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
160988898|NCT02735915|581347304|FG000|Overall Study|Withdrawal following SAE|2|||
161333979|NCT03103503|582612443|FG000|Overall Study|Study Closure|757|||
161333980|NCT04161391|582612448|FG000|Overall Study|Adverse Event|0|||
161333981|NCT04161391|582612449|FG001|Overall Study|Adverse Event|1|||
161333982|NCT04161391|582612450|FG002|Overall Study|Adverse Event|0|||
161333983|NCT04161391|582612451|FG003|Overall Study|Adverse Event|1|||
160988899|NCT02735915|581347304|FG000|Overall Study|Withdrawal by Subject|1|||
160988900|NCT05328973|581347305|FG000|Overall Study|Withdrawal by Subject|0|||
160988901|NCT05328973|581347306|FG001|Overall Study|Withdrawal by Subject|1|||
160988902|NCT00409708|581347312|FG000|Treatment|Abnormal test procedure result(s)|1|||
161333984|NCT04161391|582612452|FG004|Overall Study|Adverse Event|0|||
161333985|NCT04161391|582612453|FG005|Overall Study|Adverse Event|0|||
161333986|NCT04161391|582612454|FG006|Overall Study|Adverse Event|0|||
160988903|NCT00409708|581347313|FG001|Treatment|Abnormal test procedure result(s)|0|||
160988904|NCT00409708|581347312|FG000|Treatment|Lack of Efficacy|0|||
160988905|NCT00409708|581347313|FG001|Treatment|Lack of Efficacy|1|||
160988906|NCT00409708|581347312|FG000|Treatment|Protocol Violation|6|||
161333987|NCT04161391|582612455|FG007|Overall Study|Adverse Event|3|||
161333988|NCT04161391|582612456|FG008|Overall Study|Adverse Event|0|||
161333989|NCT04161391|582612448|FG000|Overall Study|Death|0|||
161333990|NCT04161391|582612449|FG001|Overall Study|Death|0|||
160988907|NCT00409708|581347313|FG001|Treatment|Protocol Violation|2|||
161333991|NCT04161391|582612450|FG002|Overall Study|Death|0|||
161333992|NCT04161391|582612451|FG003|Overall Study|Death|0|||
161333993|NCT04161391|582612452|FG004|Overall Study|Death|0|||
161333994|NCT04161391|582612453|FG005|Overall Study|Death|0|||
161333995|NCT04161391|582612454|FG006|Overall Study|Death|0|||
161333996|NCT04161391|582612455|FG007|Overall Study|Death|1|||
161333997|NCT04161391|582612456|FG008|Overall Study|Death|0|||
161333998|NCT04161391|582612448|FG000|Overall Study|Physician Decision|0|||
161333999|NCT04161391|582612449|FG001|Overall Study|Physician Decision|0|||
161334000|NCT04161391|582612450|FG002|Overall Study|Physician Decision|1|||
161334001|NCT04161391|582612451|FG003|Overall Study|Physician Decision|2|||
161334002|NCT04161391|582612452|FG004|Overall Study|Physician Decision|0|||
161334003|NCT04161391|582612453|FG005|Overall Study|Physician Decision|0|||
161334004|NCT04161391|582612454|FG006|Overall Study|Physician Decision|2|||
161334005|NCT04161391|582612455|FG007|Overall Study|Physician Decision|0|||
161334006|NCT04161391|582612456|FG008|Overall Study|Physician Decision|0|||
161334007|NCT04161391|582612448|FG000|Overall Study|Progressive Disease|4|||
161334008|NCT04161391|582612449|FG001|Overall Study|Progressive Disease|3|||
161334009|NCT04161391|582612450|FG002|Overall Study|Progressive Disease|3|||
161334010|NCT04161391|582612451|FG003|Overall Study|Progressive Disease|5|||
161334011|NCT04161391|582612452|FG004|Overall Study|Progressive Disease|3|||
161334012|NCT04161391|582612453|FG005|Overall Study|Progressive Disease|3|||
161334013|NCT04161391|582612454|FG006|Overall Study|Progressive Disease|5|||
161334014|NCT04161391|582612455|FG007|Overall Study|Progressive Disease|2|||
161334015|NCT04161391|582612456|FG008|Overall Study|Progressive Disease|2|||
161334016|NCT02579629|582612462|FG000|Overall Study|Withdrawal by Subject|0|||
161334017|NCT02579629|582612463|FG001|Overall Study|Withdrawal by Subject|1|||
161334018|NCT02579629|582612464|FG002|Overall Study|Withdrawal by Subject|0|||
161334019|NCT02579629|582612462|FG000|Overall Study|Screen Failure|2|||
161334020|NCT02579629|582612463|FG001|Overall Study|Screen Failure|0|||
161334021|NCT02579629|582612464|FG002|Overall Study|Screen Failure|2|||
161334022|NCT00737048|582612465|FG000|Overall Study|Physician Decision|0|||
161334023|NCT00737048|582612466|FG001|Overall Study|Physician Decision|0|||
161334024|NCT00737048|582612467|FG002|Overall Study|Physician Decision|1|||
161334025|NCT00737048|582612465|FG000|Overall Study|Adverse Event|0|||
161334026|NCT00737048|582612466|FG001|Overall Study|Adverse Event|1|||
161334027|NCT00737048|582612467|FG002|Overall Study|Adverse Event|0|||
161334028|NCT00737048|582612465|FG000|Overall Study|Worsening of the symptoms|3|||
161334029|NCT00737048|582612466|FG001|Overall Study|Worsening of the symptoms|5|||
161334030|NCT00737048|582612467|FG002|Overall Study|Worsening of the symptoms|3|||
161334031|NCT01739335|582612468|FG000|Overall Study|Lost to Follow-up|7|||
161334032|NCT01739335|582612469|FG001|Overall Study|Lost to Follow-up|4|||
161334033|NCT01739335|582612468|FG000|Overall Study|Ineligible patient randomized|0|||
161334034|NCT01739335|582612469|FG001|Overall Study|Ineligible patient randomized|1|||
161334035|NCT01863771|582612471|FG000|Induction Phase|Adverse Event|9|||
161334036|NCT01863771|582612472|FG001|Induction Phase|Adverse Event|0|||
161334037|NCT01863771|582612473|FG002|Induction Phase|Adverse Event|0|||
161334038|NCT01863771|582612474|FG003|Induction Phase|Adverse Event|0|||
161334039|NCT01863771|582612471|FG000|Induction Phase|Lack of Efficacy|10|||
161334040|NCT01863771|582612472|FG001|Induction Phase|Lack of Efficacy|0|||
161334041|NCT01863771|582612473|FG002|Induction Phase|Lack of Efficacy|0|||
161334042|NCT01863771|582612474|FG003|Induction Phase|Lack of Efficacy|0|||
161334043|NCT01863771|582612471|FG000|Induction Phase|Withdrawal by Subject|2|||
161334044|NCT01863771|582612472|FG001|Induction Phase|Withdrawal by Subject|0|||
161334045|NCT01863771|582612473|FG002|Induction Phase|Withdrawal by Subject|0|||
161334046|NCT01863771|582612474|FG003|Induction Phase|Withdrawal by Subject|0|||
161334047|NCT01863771|582612471|FG000|Maintenance Phase|Adverse Event|0|||
161334048|NCT01863771|582612472|FG001|Maintenance Phase|Adverse Event|0|||
160821568|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
160821569|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
160821570|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
161334049|NCT01863771|582612473|FG002|Maintenance Phase|Adverse Event|1|||
161334050|NCT01863771|582612474|FG003|Maintenance Phase|Adverse Event|1|||
161334051|NCT01863771|582612471|FG000|Maintenance Phase|Lack of Efficacy|0|||
161334052|NCT01863771|582612472|FG001|Maintenance Phase|Lack of Efficacy|3|||
161334053|NCT01863771|582612473|FG002|Maintenance Phase|Lack of Efficacy|7|||
161334054|NCT01863771|582612474|FG003|Maintenance Phase|Lack of Efficacy|38|||
161334055|NCT01863771|582612471|FG000|Maintenance Phase|Physician Decision|0|||
161334056|NCT01863771|582612472|FG001|Maintenance Phase|Physician Decision|0|||
160821571|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
160821572|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
160988908|NCT00409708|581347312|FG000|Treatment|Withdrawal by Subject|3|||
160821573|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
161334057|NCT01863771|582612473|FG002|Maintenance Phase|Physician Decision|2|||
161334058|NCT01863771|582612474|FG003|Maintenance Phase|Physician Decision|1|||
161334059|NCT01863771|582612471|FG000|Maintenance Phase|Pregnancy|0|||
161334060|NCT01863771|582612472|FG001|Maintenance Phase|Pregnancy|1|||
161334061|NCT01863771|582612473|FG002|Maintenance Phase|Pregnancy|0|||
161334062|NCT01863771|582612474|FG003|Maintenance Phase|Pregnancy|0|||
160821574|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
160821575|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
160821576|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
160821577|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
160821578|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
160821579|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
160821580|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
160821581|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
160821582|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
160821583|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
160821584|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
160821585|NCT01529515|580733634|FG000|MAINTENANCE PHASE|Other|0|||
160821586|NCT01529515|580733635|FG001|MAINTENANCE PHASE|Other|10|||
160821587|NCT01529515|580733636|FG002|MAINTENANCE PHASE|Other|0|||
160821588|NCT01529515|580733637|FG003|MAINTENANCE PHASE|Other|0|||
160821589|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
160821590|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
160821591|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
160821592|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
160821593|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
160901461|NCT00533897|581034008|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
160901462|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901463|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901464|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901465|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901466|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901467|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
160901468|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
160901469|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
160901470|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Death|0|||
160901471|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Death|0|||
160988909|NCT00409708|581347313|FG001|Treatment|Withdrawal by Subject|8|||
160988910|NCT00409708|581347312|FG000|Treatment|Lost to Follow-up|0|||
160988911|NCT00409708|581347313|FG001|Treatment|Lost to Follow-up|6|||
160988912|NCT00409708|581347312|FG000|Treatment|Administrative problems|5|||
160988913|NCT00409708|581347313|FG001|Treatment|Administrative problems|0|||
160988914|NCT00409708|581347312|FG000|Washout|Lack of Efficacy|9|||
160988915|NCT00409708|581347313|FG001|Washout|Lack of Efficacy|1|||
161240550|NCT00716625|582262062|FG000|Overall Study|Safety was not Assessable|1|||
161240551|NCT01492439|582262063|FG000|Overall Study|Withdrew from RTE|4|||
161240552|NCT01492439|582262064|FG001|Overall Study|Withdrew from RTE|9|||
161240553|NCT04349267|582262065|FG000|Overall Study|Adverse Event|0|||
161240554|NCT04349267|582262066|FG001|Overall Study|Adverse Event|0|||
161240555|NCT04349267|582262067|FG002|Overall Study|Adverse Event|0|||
161240556|NCT04349267|582262068|FG003|Overall Study|Adverse Event|0|||
161240557|NCT04349267|582262069|FG004|Overall Study|Adverse Event|0|||
161240558|NCT04349267|582262070|FG005|Overall Study|Adverse Event|1|||
161240559|NCT04349267|582262071|FG006|Overall Study|Adverse Event|0|||
161240560|NCT04349267|582262065|FG000|Overall Study|Other reason|0|||
161240561|NCT04349267|582262066|FG001|Overall Study|Other reason|1|||
161240562|NCT04349267|582262067|FG002|Overall Study|Other reason|0|||
161240563|NCT04349267|582262068|FG003|Overall Study|Other reason|0|||
161240564|NCT04349267|582262069|FG004|Overall Study|Other reason|1|||
161240565|NCT04349267|582262070|FG005|Overall Study|Other reason|1|||
161240566|NCT04349267|582262071|FG006|Overall Study|Other reason|1|||
161240567|NCT04349267|582262065|FG000|Overall Study|Disease Progression|2|||
161240568|NCT04349267|582262066|FG001|Overall Study|Disease Progression|0|||
161240569|NCT04349267|582262067|FG002|Overall Study|Disease Progression|2|||
161240570|NCT04349267|582262068|FG003|Overall Study|Disease Progression|3|||
161240571|NCT04349267|582262069|FG004|Overall Study|Disease Progression|3|||
161240572|NCT04349267|582262070|FG005|Overall Study|Disease Progression|7|||
161240573|NCT04349267|582262071|FG006|Overall Study|Disease Progression|10|||
161240574|NCT04349267|582262065|FG000|Overall Study|Participant withdrew consent|0|||
161240575|NCT04349267|582262066|FG001|Overall Study|Participant withdrew consent|1|||
161240576|NCT04349267|582262067|FG002|Overall Study|Participant withdrew consent|0|||
161240577|NCT04349267|582262068|FG003|Overall Study|Participant withdrew consent|0|||
161240578|NCT04349267|582262069|FG004|Overall Study|Participant withdrew consent|0|||
161240579|NCT04349267|582262070|FG005|Overall Study|Participant withdrew consent|0|||
161240580|NCT04349267|582262071|FG006|Overall Study|Participant withdrew consent|1|||
161240581|NCT03689400|582262072|FG000|Overall Study|Lost to Follow-up|4|||
160821594|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
160821595|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
161240582|NCT01204294|582262073|FG000|Overall Study|Adverse Event|2|||
161240583|NCT01204294|582262074|FG001|Overall Study|Adverse Event|6|||
161240584|NCT01204294|582262075|FG002|Overall Study|Adverse Event|0|||
161240585|NCT01204294|582262076|FG003|Overall Study|Adverse Event|7|||
161240586|NCT01204294|582262077|FG004|Overall Study|Adverse Event|1|||
160988916|NCT00409708|581347312|FG000|Washout|Protocol Violation|0|||
160988917|NCT00409708|581347313|FG001|Washout|Protocol Violation|1|||
160988918|NCT00409708|581347312|FG000|Washout|Withdrawal by Subject|11|||
160988919|NCT00409708|581347313|FG001|Washout|Withdrawal by Subject|5|||
160988920|NCT00409708|581347312|FG000|Washout|Lost to Follow-up|1|||
160988921|NCT00409708|581347313|FG001|Washout|Lost to Follow-up|3|||
160988922|NCT00946114|581347314|FG000|Overall Study|Death|5|||
160988923|NCT00946114|581347315|FG001|Overall Study|Death|2|||
160988924|NCT00946114|581347314|FG000|Overall Study|Other|1|||
160988925|NCT00946114|581347315|FG001|Overall Study|Other|0|||
160988926|NCT00946114|581347314|FG000|Overall Study|Withdrawal by Subject|2|||
160988927|NCT00946114|581347315|FG001|Overall Study|Withdrawal by Subject|0|||
160988928|NCT00723294|581347316|FG000|Overall Study|Lobular histology|2|||
160988929|NCT00723294|581347316|FG000|Overall Study|>25% intraductal component|1|||
160988930|NCT00723294|581347316|FG000|Overall Study|No MRI tumor enhancement|1|||
160988931|NCT00723294|581347316|FG000|Overall Study|1.0-Tesla MRI|1|||
160988932|NCT00723294|581347316|FG000|Overall Study|No cryoabalation|2|||
160988933|NCT00723294|581347316|FG000|Overall Study|Did not undergo surgery|1|||
160988934|NCT00723294|581347316|FG000|Overall Study|Treated prior to registration|1|||
160988935|NCT00723294|581347316|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
160988936|NCT00723294|581347316|FG000|Overall Study|Benign lesion|1|||
160988937|NCT00723294|581347316|FG000|Overall Study|Withdrawal by Subject|1|||
160988938|NCT00723294|581347316|FG000|Overall Study|No treatment due to probe failure|1|||
160988939|NCT01211665|581347317|FG000|Overall Study|Withdrawal by Subject|1|||
160988940|NCT01211665|581347318|FG001|Overall Study|Withdrawal by Subject|0|||
160988941|NCT01211665|581347317|FG000|Overall Study|Death|1|||
160988942|NCT01211665|581347318|FG001|Overall Study|Death|0|||
160988943|NCT00498186|581347321|FG000|Overall Study|Protocol Violation|10|||
160988944|NCT00498186|581347321|FG000|Overall Study|Lack of Efficacy|31|||
160988945|NCT00498186|581347321|FG000|Overall Study|Adverse Event|89|||
160988946|NCT00498186|581347321|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
160988947|NCT00498186|581347321|FG000|Overall Study|Withdrawal by Subject|18|||
160988948|NCT00498186|581347321|FG000|Overall Study|Lost to Follow-up|3|||
160988949|NCT00498186|581347321|FG000|Overall Study|Other|10|||
160988950|NCT03302156|581347322|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
160988951|NCT03302156|581347323|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
160988952|NCT03302156|581347324|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
160988953|NCT02390557|581347325|FG000|Wave 2|Survey non-respondent|72|||
160988954|NCT02390557|581347326|FG001|Wave 2|Survey non-respondent|41|||
160988955|NCT02390557|581347327|FG002|Wave 2|Survey non-respondent|23|||
160988956|NCT03635112|581347329|FG000|Overall Study|Adverse Event|5|||
160988957|NCT03635112|581347330|FG001|Overall Study|Adverse Event|9|||
160988958|NCT03635112|581347331|FG002|Overall Study|Adverse Event|14|||
160988959|NCT03635112|581347329|FG000|Overall Study|Lost to Follow-up|1|||
160988960|NCT03635112|581347330|FG001|Overall Study|Lost to Follow-up|0|||
160988961|NCT03635112|581347331|FG002|Overall Study|Lost to Follow-up|1|||
160988962|NCT03635112|581347329|FG000|Overall Study|Physician Decision|5|||
160988963|NCT03635112|581347330|FG001|Overall Study|Physician Decision|7|||
160988964|NCT03635112|581347331|FG002|Overall Study|Physician Decision|5|||
160988965|NCT03635112|581347329|FG000|Overall Study|Protocol Violation|0|||
160988966|NCT03635112|581347330|FG001|Overall Study|Protocol Violation|0|||
160988967|NCT03635112|581347331|FG002|Overall Study|Protocol Violation|1|||
160988968|NCT03635112|581347329|FG000|Overall Study|Study Terminated by Sponsor|11|||
160988969|NCT03635112|581347330|FG001|Overall Study|Study Terminated by Sponsor|17|||
160988970|NCT03635112|581347331|FG002|Overall Study|Study Terminated by Sponsor|21|||
160988971|NCT03635112|581347329|FG000|Overall Study|Withdrawal by Subject|4|||
160988972|NCT03635112|581347330|FG001|Overall Study|Withdrawal by Subject|9|||
161334063|NCT01863771|582612471|FG000|Maintenance Phase|Withdrawal by Subject|0|||
160821596|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
160821597|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
160821598|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
160821599|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
160821600|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
160821601|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
160988973|NCT03635112|581347331|FG002|Overall Study|Withdrawal by Subject|7|||
160988974|NCT03635112|581347329|FG000|Overall Study|Miscellaneous|0|||
160988975|NCT03635112|581347330|FG001|Overall Study|Miscellaneous|0|||
160821602|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
160821603|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
160988976|NCT03635112|581347331|FG002|Overall Study|Miscellaneous|1|||
160988977|NCT03283553|581347336|FG000|Patient Participant Flow|Death|5|||
160988978|NCT03283553|581347337|FG001|Patient Participant Flow|Death|10|||
160988979|NCT03283553|581347336|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
160821604|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
160821605|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
160988980|NCT03283553|581347337|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
160988981|NCT03283553|581347336|FG000|Patient Participant Flow|Lost to Follow-up|1|||
160988982|NCT03283553|581347337|FG001|Patient Participant Flow|Lost to Follow-up|1|||
160988983|NCT03283553|581347336|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
160988984|NCT03283553|581347337|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
160988985|NCT03283553|581347336|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
160988986|NCT03283553|581347337|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
160988987|NCT03283553|581347336|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
160988988|NCT03283553|581347337|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
160988989|NCT03686683|581347338|FG000|Overall Study|Withdrawal by Subject|52|||
160988990|NCT03686683|581347339|FG001|Overall Study|Withdrawal by Subject|32|||
160988991|NCT03686683|581347338|FG000|Overall Study|Lost to Follow-up|23|||
160988992|NCT03686683|581347339|FG001|Overall Study|Lost to Follow-up|19|||
160988993|NCT03686683|581347338|FG000|Overall Study|Adverse Event|1|||
160988994|NCT03686683|581347339|FG001|Overall Study|Adverse Event|0|||
160988995|NCT03686683|581347338|FG000|Overall Study|Death|10|||
160988996|NCT03686683|581347339|FG001|Overall Study|Death|5|||
160988997|NCT03686683|581347338|FG000|Overall Study|Progressive Disease|1|||
160988998|NCT03686683|581347339|FG001|Overall Study|Progressive Disease|1|||
160988999|NCT03686683|581347338|FG000|Overall Study|Noncompliance|1|||
160989000|NCT03686683|581347339|FG001|Overall Study|Noncompliance|0|||
160989001|NCT03686683|581347338|FG000|Overall Study|Physician Decision|1|||
160989002|NCT03686683|581347339|FG001|Overall Study|Physician Decision|1|||
160989003|NCT03686683|581347338|FG000|Overall Study|Screen fail post-randomization|1|||
160989004|NCT03686683|581347339|FG001|Overall Study|Screen fail post-randomization|0|||
160989005|NCT03686683|581347338|FG000|Overall Study|Protocol Violation|3|||
160989006|NCT03686683|581347339|FG001|Overall Study|Protocol Violation|0|||
160989007|NCT03686683|581347338|FG000|Overall Study|No data available|1|||
160989008|NCT03686683|581347339|FG001|Overall Study|No data available|0|||
160989009|NCT01770860|581347340|FG000|Overall Study|Withdrawal by Subject|4|||
160989010|NCT01770860|581347340|FG000|Overall Study|Lost to Follow-up|1|||
160989011|NCT01770860|581347340|FG000|Overall Study|Administrative decision made by the PI|1|||
160989012|NCT05124899|581347341|FG000|Overall Study|Lost to Follow-up|3|||
160989013|NCT03432533|581347346|FG000|Overall Study|Lost to Follow-up|1|||
160989014|NCT03432533|581347347|FG001|Overall Study|Lost to Follow-up|2|||
160989015|NCT03432533|581347346|FG000|Overall Study|Withdrawal by Subject|14|||
160989016|NCT03432533|581347347|FG001|Overall Study|Withdrawal by Subject|9|||
161240587|NCT01204294|582262078|FG005|Overall Study|Adverse Event|4|||
161240588|NCT01204294|582262079|FG006|Overall Study|Adverse Event|0|||
161240589|NCT01204294|582262073|FG000|Overall Study|Protocol Violation|1|||
161240590|NCT01204294|582262074|FG001|Overall Study|Protocol Violation|0|||
161240591|NCT01204294|582262075|FG002|Overall Study|Protocol Violation|2|||
161240592|NCT01204294|582262076|FG003|Overall Study|Protocol Violation|1|||
161240593|NCT01204294|582262077|FG004|Overall Study|Protocol Violation|0|||
161240594|NCT01204294|582262078|FG005|Overall Study|Protocol Violation|0|||
161240595|NCT01204294|582262079|FG006|Overall Study|Protocol Violation|0|||
161240596|NCT01204294|582262073|FG000|Overall Study|Withdrawal by Subject|0|||
161240597|NCT01204294|582262074|FG001|Overall Study|Withdrawal by Subject|2|||
161240598|NCT01204294|582262075|FG002|Overall Study|Withdrawal by Subject|2|||
161240599|NCT01204294|582262076|FG003|Overall Study|Withdrawal by Subject|1|||
161240600|NCT01204294|582262077|FG004|Overall Study|Withdrawal by Subject|1|||
161240601|NCT01204294|582262078|FG005|Overall Study|Withdrawal by Subject|1|||
161240602|NCT01204294|582262079|FG006|Overall Study|Withdrawal by Subject|2|||
161240603|NCT01204294|582262073|FG000|Overall Study|Lack of Efficacy|0|||
161240604|NCT01204294|582262074|FG001|Overall Study|Lack of Efficacy|0|||
161240605|NCT01204294|582262075|FG002|Overall Study|Lack of Efficacy|0|||
161240606|NCT01204294|582262076|FG003|Overall Study|Lack of Efficacy|2|||
161240607|NCT01204294|582262077|FG004|Overall Study|Lack of Efficacy|0|||
161240608|NCT01204294|582262078|FG005|Overall Study|Lack of Efficacy|0|||
161240609|NCT01204294|582262079|FG006|Overall Study|Lack of Efficacy|0|||
160821606|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
160821607|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
160821608|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
160821609|NCT01529515|580733634|FG000|DOUBLE BLIND PHASE|Other|0|||
160821610|NCT01529515|580733635|FG001|DOUBLE BLIND PHASE|Other|0|||
160821611|NCT01529515|580733636|FG002|DOUBLE BLIND PHASE|Other|9|||
160821612|NCT01529515|580733637|FG003|DOUBLE BLIND PHASE|Other|2|||
160821613|NCT00322023|580733641|FG000|Overall Study|various|0|||
160821614|NCT00322023|580733642|FG001|Overall Study|various|2|||
160989017|NCT01648283|581347348|FG000|Overall Study|Withdrawal by Subject|14|||
160821615|NCT00322023|580733643|FG002|Overall Study|various|6|||
160821616|NCT03334851|580733644|FG000|Overall Study|Other|0|||
160821617|NCT03334851|580733645|FG001|Overall Study|Other|0|||
160989018|NCT00945477|581347349|FG000|Overall Study|Adverse Event|3|||
160989019|NCT00945477|581347349|FG000|Overall Study|Lack of Efficacy|2|||
160989020|NCT00945477|581347349|FG000|Overall Study|Withdrawal by Subject|1|||
160989021|NCT00797225|581347356|FG000|Weeks 1 to 12|Adverse Event|0|||
161240610|NCT01204294|582262073|FG000|Overall Study|Other (house moving)|0|||
161240611|NCT01204294|582262074|FG001|Overall Study|Other (house moving)|0|||
161240612|NCT01204294|582262075|FG002|Overall Study|Other (house moving)|1|||
161240613|NCT01204294|582262076|FG003|Overall Study|Other (house moving)|0|||
160821618|NCT03334851|580733646|FG002|Overall Study|Other|0|||
160821619|NCT03334851|580733647|FG003|Overall Study|Other|0|||
160821620|NCT03334851|580733648|FG004|Overall Study|Other|0|||
160821621|NCT03334851|580733649|FG005|Overall Study|Other|0|||
160821622|NCT03334851|580733650|FG006|Overall Study|Other|0|||
160821623|NCT03334851|580733651|FG007|Overall Study|Other|1|||
160821624|NCT03334851|580733652|FG008|Overall Study|Other|0|||
160821625|NCT03334851|580733653|FG009|Overall Study|Other|0|||
160821626|NCT03334851|580733654|FG010|Overall Study|Other|0|||
160821627|NCT03334851|580733655|FG011|Overall Study|Other|0|||
160821628|NCT03334851|580733656|FG012|Overall Study|Other|0|||
160821629|NCT03334851|580733644|FG000|Overall Study|Adverse Event|0|||
160821630|NCT03334851|580733645|FG001|Overall Study|Adverse Event|0|||
160821631|NCT03334851|580733646|FG002|Overall Study|Adverse Event|0|||
160821632|NCT03334851|580733647|FG003|Overall Study|Adverse Event|0|||
160821633|NCT03334851|580733648|FG004|Overall Study|Adverse Event|0|||
160821634|NCT03334851|580733649|FG005|Overall Study|Adverse Event|0|||
161334064|NCT01863771|582612472|FG001|Maintenance Phase|Withdrawal by Subject|1|||
161334065|NCT01863771|582612473|FG002|Maintenance Phase|Withdrawal by Subject|2|||
161334066|NCT01863771|582612474|FG003|Maintenance Phase|Withdrawal by Subject|3|||
161334067|NCT02666222|582612482|FG000|Overall Study|Death|2|||
161334068|NCT03504917|582612486|FG000|Blinded Treatment Period|Protocol Violation|1|||
161334069|NCT03504917|582612487|FG001|Blinded Treatment Period|Protocol Violation|0|||
161334070|NCT03504917|582612486|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
161334071|NCT03504917|582612487|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
161334072|NCT03504917|582612486|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
161334073|NCT03504917|582612487|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
161334074|NCT03504917|582612486|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
161334075|NCT03504917|582612487|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
161334076|NCT03504917|582612486|FG000|Blinded Treatment Period|Adverse Event|4|||
161334077|NCT03504917|582612487|FG001|Blinded Treatment Period|Adverse Event|4|||
161334078|NCT03504917|582612486|FG000|Blinded Treatment Period|Physician Decision|1|||
161334079|NCT03504917|582612487|FG001|Blinded Treatment Period|Physician Decision|0|||
161334080|NCT03504917|582612486|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
161334081|NCT03504917|582612487|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
161334082|NCT03504917|582612486|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
161334083|NCT03504917|582612487|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
161334084|NCT03504917|582612486|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
161334085|NCT03504917|582612487|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
161334086|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
161334087|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
161334088|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
161334089|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
161334090|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
161334091|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
161334092|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
161334093|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
161334094|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
161334095|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
161334096|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
161334097|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
161334098|NCT03504917|582612486|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
161334099|NCT03504917|582612487|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
161334100|NCT03863353|582612488|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
161334101|NCT03863353|582612489|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
161334102|NCT04079790|582612493|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
160821635|NCT03334851|580733650|FG006|Overall Study|Adverse Event|0|||
160821636|NCT03334851|580733651|FG007|Overall Study|Adverse Event|1|||
161133073|NCT01756456|581870799|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
161133074|NCT01756456|581870800|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
160821637|NCT03334851|580733652|FG008|Overall Study|Adverse Event|0|||
160821638|NCT03334851|580733653|FG009|Overall Study|Adverse Event|0|||
161133075|NCT01756456|581870801|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
161334103|NCT04079790|582612494|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
161334104|NCT04079790|582612495|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
160821639|NCT03334851|580733654|FG010|Overall Study|Adverse Event|0|||
160821640|NCT03334851|580733655|FG011|Overall Study|Adverse Event|0|||
160821641|NCT03334851|580733656|FG012|Overall Study|Adverse Event|0|||
160821642|NCT03334851|580733644|FG000|Overall Study|Withdrawal by Subject|0|||
160821643|NCT03334851|580733645|FG001|Overall Study|Withdrawal by Subject|0|||
160821644|NCT03334851|580733646|FG002|Overall Study|Withdrawal by Subject|0|||
160821645|NCT03334851|580733647|FG003|Overall Study|Withdrawal by Subject|0|||
160821646|NCT03334851|580733648|FG004|Overall Study|Withdrawal by Subject|0|||
160821647|NCT03334851|580733649|FG005|Overall Study|Withdrawal by Subject|0|||
160821648|NCT03334851|580733650|FG006|Overall Study|Withdrawal by Subject|0|||
160821649|NCT03334851|580733651|FG007|Overall Study|Withdrawal by Subject|0|||
160821650|NCT03334851|580733652|FG008|Overall Study|Withdrawal by Subject|0|||
160821651|NCT03334851|580733653|FG009|Overall Study|Withdrawal by Subject|0|||
160821652|NCT03334851|580733654|FG010|Overall Study|Withdrawal by Subject|1|||
160821653|NCT03334851|580733655|FG011|Overall Study|Withdrawal by Subject|0|||
160821654|NCT03334851|580733656|FG012|Overall Study|Withdrawal by Subject|1|||
160821655|NCT03334851|580733644|FG000|Overall Study|Lost to Follow-up|0|||
160821656|NCT03334851|580733645|FG001|Overall Study|Lost to Follow-up|0|||
160821657|NCT03334851|580733646|FG002|Overall Study|Lost to Follow-up|0|||
160821658|NCT03334851|580733647|FG003|Overall Study|Lost to Follow-up|0|||
160821659|NCT03334851|580733648|FG004|Overall Study|Lost to Follow-up|0|||
160821660|NCT03334851|580733649|FG005|Overall Study|Lost to Follow-up|0|||
161133076|NCT01756456|581870802|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
161133077|NCT01756456|581870797|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161133078|NCT01756456|581870798|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161133079|NCT01756456|581870799|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
161133080|NCT01756456|581870800|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
161133081|NCT01756456|581870801|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
161133082|NCT01756456|581870802|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
161133083|NCT01756456|581870797|FG000|Follow Up Period Phase I/II|Other causes|0|||
161133084|NCT01756456|581870798|FG001|Follow Up Period Phase I/II|Other causes|0|||
161133085|NCT01756456|581870799|FG002|Follow Up Period Phase I/II|Other causes|0|||
161133086|NCT01756456|581870800|FG003|Follow Up Period Phase I/II|Other causes|1|||
161133087|NCT01756456|581870801|FG004|Follow Up Period Phase I/II|Other causes|3|||
161133088|NCT01756456|581870802|FG005|Follow Up Period Phase I/II|Other causes|5|||
161133089|NCT02706938|581870803|FG000|First Period, 6 Weeks|Adverse Event|8|||
161133090|NCT02706938|581870804|FG001|First Period, 6 Weeks|Adverse Event|0|||
161133091|NCT02706938|581870803|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
161133092|NCT02706938|581870804|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
161133093|NCT02706938|581870803|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
161133094|NCT02706938|581870804|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
161133095|NCT02706938|581870803|FG000|Second Period, 6 Weeks|Adverse Event|0|||
161133096|NCT02706938|581870804|FG001|Second Period, 6 Weeks|Adverse Event|7|||
161133097|NCT02706938|581870803|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
161133098|NCT02706938|581870804|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
161133099|NCT00813995|581870807|FG000|Overall Study|Clinical adverse event|9|||
161133100|NCT00813995|581870808|FG001|Overall Study|Clinical adverse event|3|||
161133101|NCT00813995|581870807|FG000|Overall Study|Laboratory adverse event|0|||
161133102|NCT00813995|581870808|FG001|Overall Study|Laboratory adverse event|2|||
161133103|NCT00813995|581870807|FG000|Overall Study|Lack of Efficacy|1|||
160821661|NCT03334851|580733650|FG006|Overall Study|Lost to Follow-up|0|||
160821662|NCT03334851|580733651|FG007|Overall Study|Lost to Follow-up|0|||
160821663|NCT03334851|580733652|FG008|Overall Study|Lost to Follow-up|0|||
160821664|NCT03334851|580733653|FG009|Overall Study|Lost to Follow-up|0|||
160821665|NCT03334851|580733654|FG010|Overall Study|Lost to Follow-up|2|||
160821666|NCT03334851|580733655|FG011|Overall Study|Lost to Follow-up|1|||
160821667|NCT03334851|580733656|FG012|Overall Study|Lost to Follow-up|0|||
160821668|NCT03327220|580733657|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
160821669|NCT03327220|580733658|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
160821670|NCT03327220|580733657|FG000|Overall Study|Investigator Decision|2|||
160821671|NCT03327220|580733658|FG001|Overall Study|Investigator Decision|0|||
160821672|NCT03327220|580733657|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
160821673|NCT03327220|580733658|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
160821674|NCT03327220|580733657|FG000|Overall Study|Fungal infection|1|||
160821675|NCT03327220|580733658|FG001|Overall Study|Fungal infection|0|||
160821676|NCT03327220|580733657|FG000|Overall Study|Discharged to Rehabilitation|0|||
160821677|NCT03327220|580733658|FG001|Overall Study|Discharged to Rehabilitation|1|||
160821678|NCT03327220|580733657|FG000|Overall Study|Missing|1|||
160821679|NCT03327220|580733658|FG001|Overall Study|Missing|0|||
160821680|NCT03920293|580733659|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
160821681|NCT03920293|580733660|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
160821682|NCT03920293|580733659|FG000|Randomized-Controlled Period|Physician Decision|1|||
160821683|NCT03920293|580733660|FG001|Randomized-Controlled Period|Physician Decision|2|||
160821684|NCT03920293|580733659|FG000|Randomized-Controlled Period|Adverse Event|0|||
160821685|NCT03920293|580733660|FG001|Randomized-Controlled Period|Adverse Event|2|||
161133104|NCT00813995|581870808|FG001|Overall Study|Lack of Efficacy|0|||
161133105|NCT00813995|581870807|FG000|Overall Study|Lost to Follow-up|4|||
161133106|NCT00813995|581870808|FG001|Overall Study|Lost to Follow-up|2|||
161133107|NCT00813995|581870807|FG000|Overall Study|Other reason|2|||
161133108|NCT00813995|581870808|FG001|Overall Study|Other reason|2|||
161133109|NCT00813995|581870807|FG000|Overall Study|Protocol Violation|3|||
160821686|NCT03920293|580733659|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
160821687|NCT03920293|580733660|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
160821688|NCT03920293|580733659|FG000|Randomized-Controlled Period|Death|2|||
160821689|NCT03920293|580733660|FG001|Randomized-Controlled Period|Death|0|||
160821690|NCT03920293|580733659|FG000|Randomized-Controlled Period|Protocol Violation|1|||
160821691|NCT03920293|580733660|FG001|Randomized-Controlled Period|Protocol Violation|0|||
160821692|NCT03920293|580733659|FG000|Randomized-Controlled Period|Noncompliance|1|||
160821693|NCT03920293|580733660|FG001|Randomized-Controlled Period|Noncompliance|0|||
161240614|NCT01204294|582262077|FG004|Overall Study|Other (house moving)|0|||
161240615|NCT01204294|582262078|FG005|Overall Study|Other (house moving)|0|||
161240616|NCT01204294|582262079|FG006|Overall Study|Other (house moving)|0|||
161240617|NCT03128723|582262080|FG000|Overall Study|Withdrawal by Subject|2|||
161240618|NCT04618211|582262081|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
161240619|NCT04618211|582262082|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
161240620|NCT04618211|582262083|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
161240621|NCT04618211|582262081|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
161240622|NCT04618211|582262082|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
161240623|NCT04618211|582262083|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
161240624|NCT04618211|582262081|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
161240625|NCT04618211|582262082|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
161240626|NCT04618211|582262083|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
161240627|NCT02075463|582262084|FG000|Overall Study|Adverse Event|3|||
161240628|NCT02075463|582262084|FG000|Overall Study|Par. reached stopping criteria|4|||
161240629|NCT02075463|582262084|FG000|Overall Study|Withdrawal by Subject|1|||
161240630|NCT00673660|582262085|FG000|Overall Study|Lost to Follow-up|107|||
161240631|NCT01527006|582262086|FG000|Core Study|Adverse Event|0|||
161240632|NCT01527006|582262087|FG001|Core Study|Adverse Event|2|||
161240633|NCT01527006|582262086|FG000|Core Study|Lost to Follow-up|0|||
161240634|NCT01527006|582262087|FG001|Core Study|Lost to Follow-up|1|||
161240635|NCT01527006|582262086|FG000|Core Study|Subject Choice|1|||
161240636|NCT01527006|582262087|FG001|Core Study|Subject Choice|0|||
161240637|NCT01527006|582262086|FG000|Core Study|Inadequate Therapeutic Effect|1|||
161240638|NCT01527006|582262087|FG001|Core Study|Inadequate Therapeutic Effect|0|||
161240639|NCT01527006|582262086|FG000|Core Study|Withdrawal by Subject|0|||
161240640|NCT01527006|582262087|FG001|Core Study|Withdrawal by Subject|1|||
161240641|NCT01527006|582262086|FG000|Core Study|Other|0|||
161240642|NCT01527006|582262087|FG001|Core Study|Other|2|||
161240643|NCT01527006|582262086|FG000|Extension Phase|Adverse Event|4|||
161240644|NCT01527006|582262087|FG001|Extension Phase|Adverse Event|2|||
161240645|NCT01527006|582262086|FG000|Extension Phase|Lost to Follow-up|0|||
161240646|NCT01527006|582262087|FG001|Extension Phase|Lost to Follow-up|1|||
161240647|NCT01527006|582262086|FG000|Extension Phase|Subject Choice|1|||
161240648|NCT01527006|582262087|FG001|Extension Phase|Subject Choice|1|||
161240649|NCT01527006|582262086|FG000|Extension Phase|Inadequate therapeutic effect|1|||
161240650|NCT01527006|582262087|FG001|Extension Phase|Inadequate therapeutic effect|1|||
161240651|NCT01527006|582262086|FG000|Extension Phase|Other|0|||
161240652|NCT01527006|582262087|FG001|Extension Phase|Other|3|||
161240653|NCT01383486|582262088|FG000|Overall Study|Lost to Follow-up|10|||
161240654|NCT01383486|582262088|FG000|Overall Study|Incomplete information for analysis|2|||
161240655|NCT01383486|582262088|FG000|Overall Study|Did not take any product|6|||
161334105|NCT04079790|582612496|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
160821694|NCT03920293|580733659|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
160821695|NCT03920293|580733660|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
160901472|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Death|0|||
160901473|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Death|0|||
160901474|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Death|0|||
160901475|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Death|0|||
160901476|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Death|1|||
160901477|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Death|3|||
160901478|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901479|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901480|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901481|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901482|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901483|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
160901484|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
160901485|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
160901486|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161240656|NCT00245063|582262089|FG000|Overall Study|Adverse Event|6|||
161240657|NCT00245063|582262090|FG001|Overall Study|Adverse Event|5|||
160901487|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901488|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
161240658|NCT00245063|582262089|FG000|Overall Study|Death|1|||
160989022|NCT00797225|581347357|FG001|Weeks 1 to 12|Adverse Event|0|||
160989023|NCT00797225|581347358|FG002|Weeks 1 to 12|Adverse Event|1|||
160989024|NCT00797225|581347359|FG003|Weeks 1 to 12|Adverse Event|0|||
160989025|NCT00797225|581347360|FG004|Weeks 1 to 12|Adverse Event|0|||
160989026|NCT00797225|581347361|FG005|Weeks 1 to 12|Adverse Event|0|||
160989027|NCT00797225|581347362|FG006|Weeks 1 to 12|Adverse Event|0|||
160989028|NCT00797225|581347363|FG007|Weeks 1 to 12|Adverse Event|0|||
160989029|NCT00797225|581347356|FG000|Weeks 1 to 12|Non-compliance|0|||
160989030|NCT00797225|581347357|FG001|Weeks 1 to 12|Non-compliance|1|||
160989031|NCT00797225|581347358|FG002|Weeks 1 to 12|Non-compliance|0|||
160989032|NCT00797225|581347359|FG003|Weeks 1 to 12|Non-compliance|0|||
160989033|NCT00797225|581347360|FG004|Weeks 1 to 12|Non-compliance|0|||
160989034|NCT00797225|581347361|FG005|Weeks 1 to 12|Non-compliance|0|||
160989035|NCT00797225|581347362|FG006|Weeks 1 to 12|Non-compliance|0|||
160989036|NCT00797225|581347363|FG007|Weeks 1 to 12|Non-compliance|0|||
160989037|NCT00797225|581347356|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
160989038|NCT00797225|581347357|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
160989039|NCT00797225|581347358|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
160989040|NCT00797225|581347359|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
160989041|NCT00797225|581347360|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
160989042|NCT00797225|581347361|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
160989043|NCT00797225|581347362|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
160989044|NCT00797225|581347363|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
160989045|NCT00797225|581347356|FG000|Weeks 1 to 12|Sponsor Decision|1|||
160989046|NCT00797225|581347357|FG001|Weeks 1 to 12|Sponsor Decision|0|||
160989047|NCT00797225|581347358|FG002|Weeks 1 to 12|Sponsor Decision|0|||
160989048|NCT00797225|581347359|FG003|Weeks 1 to 12|Sponsor Decision|0|||
160989049|NCT00797225|581347360|FG004|Weeks 1 to 12|Sponsor Decision|0|||
160989050|NCT00797225|581347361|FG005|Weeks 1 to 12|Sponsor Decision|0|||
160989051|NCT00797225|581347362|FG006|Weeks 1 to 12|Sponsor Decision|0|||
160989052|NCT00797225|581347363|FG007|Weeks 1 to 12|Sponsor Decision|0|||
160989053|NCT00797225|581347356|FG000|Weeks 13 to 24|Non-compliance|0|||
160989054|NCT00797225|581347357|FG001|Weeks 13 to 24|Non-compliance|2|||
160989055|NCT00797225|581347358|FG002|Weeks 13 to 24|Non-compliance|0|||
160989056|NCT00797225|581347359|FG003|Weeks 13 to 24|Non-compliance|0|||
160989057|NCT00797225|581347360|FG004|Weeks 13 to 24|Non-compliance|0|||
160989058|NCT00797225|581347361|FG005|Weeks 13 to 24|Non-compliance|0|||
160989059|NCT00797225|581347362|FG006|Weeks 13 to 24|Non-compliance|0|||
160989060|NCT00797225|581347363|FG007|Weeks 13 to 24|Non-compliance|0|||
160989061|NCT00797225|581347356|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
160989062|NCT00797225|581347357|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
160989063|NCT00797225|581347358|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
160989064|NCT00797225|581347359|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
160989065|NCT00797225|581347360|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
160989066|NCT00797225|581347361|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
160989067|NCT00797225|581347362|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
160989068|NCT00797225|581347363|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
160989069|NCT00797225|581347356|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
160989070|NCT00797225|581347357|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
160989071|NCT00797225|581347358|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
160989072|NCT00797225|581347359|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
160989073|NCT00797225|581347360|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
160989074|NCT00797225|581347361|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
160989075|NCT00797225|581347362|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
160989076|NCT00797225|581347363|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
160989077|NCT00797225|581347356|FG000|Weeks 13 to 24|Adverse Event|0|||
160989078|NCT00797225|581347357|FG001|Weeks 13 to 24|Adverse Event|1|||
160989079|NCT00797225|581347358|FG002|Weeks 13 to 24|Adverse Event|0|||
160989080|NCT00797225|581347359|FG003|Weeks 13 to 24|Adverse Event|0|||
161133110|NCT00813995|581870808|FG001|Overall Study|Protocol Violation|2|||
160989081|NCT00797225|581347360|FG004|Weeks 13 to 24|Adverse Event|0|||
160989082|NCT00797225|581347361|FG005|Weeks 13 to 24|Adverse Event|0|||
160989083|NCT00797225|581347362|FG006|Weeks 13 to 24|Adverse Event|1|||
160989084|NCT00797225|581347363|FG007|Weeks 13 to 24|Adverse Event|0|||
160989085|NCT00797225|581347356|FG000|Weeks 13 to 24|Sponsor Decision|0|||
160989086|NCT00797225|581347357|FG001|Weeks 13 to 24|Sponsor Decision|0|||
160989087|NCT00797225|581347358|FG002|Weeks 13 to 24|Sponsor Decision|0|||
160989088|NCT00797225|581347359|FG003|Weeks 13 to 24|Sponsor Decision|0|||
160989089|NCT00797225|581347360|FG004|Weeks 13 to 24|Sponsor Decision|0|||
160989090|NCT00797225|581347361|FG005|Weeks 13 to 24|Sponsor Decision|0|||
160989091|NCT00797225|581347362|FG006|Weeks 13 to 24|Sponsor Decision|1|||
160989092|NCT00797225|581347363|FG007|Weeks 13 to 24|Sponsor Decision|0|||
160989093|NCT01072929|581347369|FG000|Overall Study|Adverse Event|8|||
160989094|NCT01072929|581347370|FG001|Overall Study|Adverse Event|11|||
160989095|NCT01072929|581347371|FG002|Overall Study|Adverse Event|2|||
160989096|NCT01072929|581347369|FG000|Overall Study|Lack of Efficacy|7|||
160989097|NCT01072929|581347370|FG001|Overall Study|Lack of Efficacy|4|||
160989098|NCT01072929|581347371|FG002|Overall Study|Lack of Efficacy|0|||
160989099|NCT01072929|581347369|FG000|Overall Study|Withdrawal by Subject|7|||
160989100|NCT01072929|581347370|FG001|Overall Study|Withdrawal by Subject|15|||
160989101|NCT01072929|581347371|FG002|Overall Study|Withdrawal by Subject|3|||
160989102|NCT01072929|581347369|FG000|Overall Study|Protocol Violation|13|||
160989103|NCT01072929|581347370|FG001|Overall Study|Protocol Violation|11|||
160989104|NCT01072929|581347371|FG002|Overall Study|Protocol Violation|2|||
160989105|NCT01072929|581347369|FG000|Overall Study|Lost to Follow-up|8|||
160989106|NCT01072929|581347370|FG001|Overall Study|Lost to Follow-up|4|||
160989107|NCT01072929|581347371|FG002|Overall Study|Lost to Follow-up|1|||
160989108|NCT01072929|581347369|FG000|Overall Study|Noncompliance with study medication|0|||
161334106|NCT04079790|582612493|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
160989109|NCT01072929|581347370|FG001|Overall Study|Noncompliance with study medication|3|||
160989110|NCT01072929|581347371|FG002|Overall Study|Noncompliance with study medication|0|||
160989111|NCT01072929|581347369|FG000|Overall Study|Noncompliance with study procedures|1|||
160989112|NCT01072929|581347370|FG001|Overall Study|Noncompliance with study procedures|0|||
160989113|NCT01072929|581347371|FG002|Overall Study|Noncompliance with study procedures|1|||
160989114|NCT01072929|581347369|FG000|Overall Study|Other|0|||
160989115|NCT01072929|581347370|FG001|Overall Study|Other|3|||
160989116|NCT01072929|581347371|FG002|Overall Study|Other|0|||
160989117|NCT04833855|581347372|FG000|Overall Study|Decision by sponsor|0|||
160989118|NCT04833855|581347373|FG001|Overall Study|Decision by sponsor|1|||
160989119|NCT04833855|581347374|FG002|Overall Study|Decision by sponsor|0|||
160989120|NCT04833855|581347375|FG003|Overall Study|Decision by sponsor|0|||
160989121|NCT04833855|581347372|FG000|Overall Study|Withdrawal by Subject|4|||
160989122|NCT04833855|581347373|FG001|Overall Study|Withdrawal by Subject|1|||
160989123|NCT04833855|581347374|FG002|Overall Study|Withdrawal by Subject|3|||
160989124|NCT04833855|581347375|FG003|Overall Study|Withdrawal by Subject|1|||
160989125|NCT04833855|581347372|FG000|Overall Study|Lost to Follow-up|1|||
160989126|NCT04833855|581347373|FG001|Overall Study|Lost to Follow-up|0|||
160989127|NCT04833855|581347374|FG002|Overall Study|Lost to Follow-up|2|||
160989128|NCT04833855|581347375|FG003|Overall Study|Lost to Follow-up|2|||
160989129|NCT04833855|581347372|FG000|Overall Study|Protocol specified criteria|0|||
160989130|NCT04833855|581347373|FG001|Overall Study|Protocol specified criteria|0|||
160989131|NCT04833855|581347374|FG002|Overall Study|Protocol specified criteria|2|||
160989132|NCT04833855|581347375|FG003|Overall Study|Protocol specified criteria|1|||
160989133|NCT02322775|581347378|FG000|Overall Study|Adverse Event|1|||
160989134|NCT02322775|581347379|FG001|Overall Study|Adverse Event|0|||
160989135|NCT02322775|581347378|FG000|Overall Study|Lost to Follow-up|0|||
160989136|NCT02322775|581347379|FG001|Overall Study|Lost to Follow-up|1|||
160989137|NCT02322775|581347378|FG000|Overall Study|Protocol Violation|1|||
160989138|NCT02322775|581347379|FG001|Overall Study|Protocol Violation|0|||
160989139|NCT02322775|581347378|FG000|Overall Study|Withdrawal by Subject|3|||
160989140|NCT02322775|581347379|FG001|Overall Study|Withdrawal by Subject|4|||
160989141|NCT02322775|581347378|FG000|Overall Study|Not willing to perform all FU visits|0|||
160989142|NCT02322775|581347379|FG001|Overall Study|Not willing to perform all FU visits|1|||
160989143|NCT04739423|581347380|FG000|Overall Study|Protocol Violation|0|||
160989144|NCT04739423|581347381|FG001|Overall Study|Protocol Violation|1|||
160989145|NCT04739423|581347382|FG002|Overall Study|Protocol Violation|0|||
160989146|NCT04739423|581347383|FG003|Overall Study|Protocol Violation|0|||
160989147|NCT04739423|581347384|FG004|Overall Study|Protocol Violation|0|||
160989148|NCT04739423|581347385|FG005|Overall Study|Protocol Violation|0|||
160989149|NCT04739423|581347380|FG000|Overall Study|Adverse Event|0|||
160989150|NCT04739423|581347381|FG001|Overall Study|Adverse Event|0|||
160989151|NCT04739423|581347382|FG002|Overall Study|Adverse Event|1|||
160989152|NCT04739423|581347383|FG003|Overall Study|Adverse Event|0|||
161133111|NCT00813995|581870807|FG000|Overall Study|Subject moved|4|||
161133112|NCT00813995|581870808|FG001|Overall Study|Subject moved|0|||
161133113|NCT00813995|581870807|FG000|Overall Study|Withdrawal by Subject|0|||
161133114|NCT00813995|581870808|FG001|Overall Study|Withdrawal by Subject|5|||
161133115|NCT02507349|581870809|FG000|Overall Study|Death|12|||
161133116|NCT02507349|581870810|FG001|Overall Study|Death|16|||
161133117|NCT02507349|581870809|FG000|Overall Study|Withdrawal by Subject|1|||
161133118|NCT02507349|581870810|FG001|Overall Study|Withdrawal by Subject|1|||
160989153|NCT04739423|581347384|FG004|Overall Study|Adverse Event|1|||
160989154|NCT04739423|581347385|FG005|Overall Study|Adverse Event|0|||
160989155|NCT04739423|581347380|FG000|Overall Study|Withdrawal by Subject|0|||
160989156|NCT04739423|581347381|FG001|Overall Study|Withdrawal by Subject|0|||
160989157|NCT04739423|581347382|FG002|Overall Study|Withdrawal by Subject|0|||
160989158|NCT04739423|581347383|FG003|Overall Study|Withdrawal by Subject|0|||
160989159|NCT04739423|581347384|FG004|Overall Study|Withdrawal by Subject|0|||
160989160|NCT04739423|581347385|FG005|Overall Study|Withdrawal by Subject|1|||
160989161|NCT01007552|581347386|FG000|Overall Study|Withdrawal by Subject|1|||
160989162|NCT03212365|581347396|FG000|Overall Study|Discharged prior to Xa level|12|||
160989163|NCT03212365|581347397|FG001|Overall Study|Discharged prior to Xa level|8|||
160989164|NCT03212365|581347396|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
160989165|NCT03212365|581347397|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
161133119|NCT02507349|581870809|FG000|Overall Study|Lost to Follow-up|174|||
161133120|NCT02507349|581870810|FG001|Overall Study|Lost to Follow-up|144|||
161133121|NCT02700984|581870811|FG000|Overall Study|Death|2|||
160901489|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160989166|NCT03212365|581347396|FG000|Overall Study|Refused study medication|3|||
160989167|NCT03212365|581347397|FG001|Overall Study|Refused study medication|0|||
160989168|NCT03212365|581347396|FG000|Overall Study|Initiated heparin infusion on floor|1|||
160989169|NCT03212365|581347397|FG001|Overall Study|Initiated heparin infusion on floor|1|||
160989170|NCT03212365|581347396|FG000|Overall Study|Unexpected return to OR|1|||
160989171|NCT03212365|581347397|FG001|Overall Study|Unexpected return to OR|1|||
160989172|NCT03212365|581347396|FG000|Overall Study|Medication distribution error|1|||
160989173|NCT03212365|581347397|FG001|Overall Study|Medication distribution error|0|||
160989174|NCT03212365|581347396|FG000|Overall Study|Required epidural placement|1|||
160989175|NCT03212365|581347397|FG001|Overall Study|Required epidural placement|0|||
160989176|NCT03212365|581347396|FG000|Overall Study|Withdrawal by Subject|0|||
160989177|NCT03212365|581347397|FG001|Overall Study|Withdrawal by Subject|1|||
160989178|NCT03212365|581347396|FG000|Overall Study|developed acute renal failure|0|||
160989179|NCT03212365|581347397|FG001|Overall Study|developed acute renal failure|1|||
160989180|NCT00333138|581347398|FG000|Core Study (6 Months)|Adverse Event|4|||
160989181|NCT00333138|581347399|FG001|Core Study (6 Months)|Adverse Event|5|||
160989182|NCT00333138|581347400|FG002|Core Study (6 Months)|Adverse Event|8|||
160989183|NCT00333138|581347398|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
160989184|NCT00333138|581347399|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
160989185|NCT00333138|581347400|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
160989186|NCT00333138|581347398|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
160989187|NCT00333138|581347399|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
160989188|NCT00333138|581347400|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
160989189|NCT00333138|581347398|FG000|Core Study (6 Months)|Protocol Violation|1|||
160901490|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901491|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901492|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
160901493|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
160901494|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Adverse Event|0|||
160989190|NCT00333138|581347399|FG001|Core Study (6 Months)|Protocol Violation|0|||
160989191|NCT00333138|581347400|FG002|Core Study (6 Months)|Protocol Violation|1|||
160989192|NCT00333138|581347398|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
160989193|NCT00333138|581347399|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
160989194|NCT00333138|581347400|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
160989195|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
160989196|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
160989197|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
160901495|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Adverse Event|0|||
160901496|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Adverse Event|0|||
160901497|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Adverse Event|0|||
160901498|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Adverse Event|0|||
160901499|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Adverse Event|0|||
160901500|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Adverse Event|2|||
160901501|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Adverse Event|5|||
160901502|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Pregnancy|0|||
160901503|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Pregnancy|0|||
160901504|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Pregnancy|0|||
160901505|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Pregnancy|0|||
160901506|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Pregnancy|0|||
160901507|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Pregnancy|0|||
160901508|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Pregnancy|0|||
160901509|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Pregnancy|2|||
160901510|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901511|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901512|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
160989198|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
160989199|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
160989200|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
160989201|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
160989202|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
161133122|NCT02700984|581870812|FG001|Overall Study|Death|1|||
161133123|NCT02700984|581870811|FG000|Overall Study|Lost to Follow-up|2|||
161133124|NCT02700984|581870812|FG001|Overall Study|Lost to Follow-up|1|||
161133125|NCT02700984|581870811|FG000|Overall Study|Physician Decision|0|||
161133126|NCT02700984|581870812|FG001|Overall Study|Physician Decision|1|||
161133127|NCT02700984|581870811|FG000|Overall Study|Withdrawal by Subject|8|||
160901513|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901514|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901515|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
160901516|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
161133128|NCT02700984|581870812|FG001|Overall Study|Withdrawal by Subject|9|||
160989203|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
161240659|NCT00245063|582262090|FG001|Overall Study|Death|0|||
161240660|NCT01839279|582262093|FG000|Overall Study|Adverse Event|4|||
161240661|NCT01839279|582262094|FG001|Overall Study|Adverse Event|1|||
161240662|NCT01839279|582262095|FG002|Overall Study|Adverse Event|1|||
161240663|NCT01839279|582262093|FG000|Overall Study|Withdrawal by Subject|4|||
161240664|NCT01839279|582262094|FG001|Overall Study|Withdrawal by Subject|1|||
161240665|NCT01839279|582262095|FG002|Overall Study|Withdrawal by Subject|1|||
161240666|NCT01839279|582262093|FG000|Overall Study|Classified as 'Other'|5|||
161240667|NCT01839279|582262094|FG001|Overall Study|Classified as 'Other'|0|||
161240668|NCT01839279|582262095|FG002|Overall Study|Classified as 'Other'|0|||
161240669|NCT05919823|582262099|FG000|Pre-Treatment Period|Screen failure|1|||
161240670|NCT05919823|582262100|FG001|Pre-Treatment Period|Screen failure|0|||
161240671|NCT05919823|582262101|FG002|Pre-Treatment Period|Screen failure|0|||
161240672|NCT05919823|582262102|FG003|Pre-Treatment Period|Screen failure|0|||
161240673|NCT05919823|582262099|FG000|Pre-Treatment Period|Protocol Violation|0|||
161240674|NCT05919823|582262100|FG001|Pre-Treatment Period|Protocol Violation|1|||
161240675|NCT05919823|582262101|FG002|Pre-Treatment Period|Protocol Violation|0|||
160821696|NCT03920293|580733659|FG000|Open- Label Extension Period|Death|3|||
160821697|NCT03920293|580733660|FG001|Open- Label Extension Period|Death|3|||
160821698|NCT03920293|580733659|FG000|Open- Label Extension Period|Physician Decision|5|||
160821699|NCT03920293|580733660|FG001|Open- Label Extension Period|Physician Decision|3|||
160821700|NCT03920293|580733659|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
160821701|NCT03920293|580733660|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
160821702|NCT00523705|580733661|FG000|Overall Study|No time for study.|0|||
160821703|NCT00523705|580733662|FG001|Overall Study|No time for study.|1|||
160821704|NCT00693017|580733663|FG000|Overall Study|Sponsor Decision|2|||
160821705|NCT00693017|580733664|FG001|Overall Study|Sponsor Decision|1|||
160821706|NCT00693017|580733663|FG000|Overall Study|Death|0|||
160821707|NCT00693017|580733664|FG001|Overall Study|Death|1|||
161240676|NCT05919823|582262102|FG003|Pre-Treatment Period|Protocol Violation|0|||
161240677|NCT05919823|582262099|FG000|Double-Blind Period|Adverse Event|8|||
161240678|NCT05919823|582262100|FG001|Double-Blind Period|Adverse Event|9|||
161240679|NCT05919823|582262101|FG002|Double-Blind Period|Adverse Event|0|||
161240680|NCT05919823|582262102|FG003|Double-Blind Period|Adverse Event|0|||
161240681|NCT05919823|582262099|FG000|Double-Blind Period|Protocol Violation|2|||
161240682|NCT05919823|582262100|FG001|Double-Blind Period|Protocol Violation|1|||
161240683|NCT05919823|582262101|FG002|Double-Blind Period|Protocol Violation|0|||
161240684|NCT05919823|582262102|FG003|Double-Blind Period|Protocol Violation|0|||
161240685|NCT05919823|582262099|FG000|Double-Blind Period|Participant withdrew consent|11|||
161240686|NCT05919823|582262100|FG001|Double-Blind Period|Participant withdrew consent|7|||
161240687|NCT05919823|582262101|FG002|Double-Blind Period|Participant withdrew consent|0|||
161240688|NCT05919823|582262102|FG003|Double-Blind Period|Participant withdrew consent|0|||
161240689|NCT05919823|582262099|FG000|Double-Blind Period|Other reasons|2|||
161240690|NCT05919823|582262100|FG001|Double-Blind Period|Other reasons|3|||
161240691|NCT05919823|582262101|FG002|Double-Blind Period|Other reasons|0|||
161240692|NCT05919823|582262102|FG003|Double-Blind Period|Other reasons|0|||
161240693|NCT05919823|582262099|FG000|Open Label Period|Adverse Event|0|||
161240694|NCT05919823|582262100|FG001|Open Label Period|Adverse Event|0|||
161240695|NCT05919823|582262101|FG002|Open Label Period|Adverse Event|2|||
161240696|NCT05919823|582262102|FG003|Open Label Period|Adverse Event|4|||
160821708|NCT01691885|580733668|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
160901517|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
160901518|NCT00533897|581034001|FG000|Long Term Extension (LTE)|Other|0|||
160901519|NCT00533897|581034002|FG001|Long Term Extension (LTE)|Other|0|||
160901520|NCT00533897|581034003|FG002|Long Term Extension (LTE)|Other|0|||
160901521|NCT00533897|581034004|FG003|Long Term Extension (LTE)|Other|0|||
160901522|NCT00533897|581034005|FG004|Long Term Extension (LTE)|Other|0|||
160901523|NCT00533897|581034006|FG005|Long Term Extension (LTE)|Other|0|||
160901524|NCT00533897|581034007|FG006|Long Term Extension (LTE)|Other|1|||
160901525|NCT00533897|581034008|FG007|Long Term Extension (LTE)|Other|6|||
160901526|NCT01546207|581034011|FG000|Overall Study|Death|1|||
160901527|NCT01626456|581034012|FG000|Overall Study|Withdrawal by Subject|21|||
160901528|NCT01626456|581034013|FG001|Overall Study|Withdrawal by Subject|46|||
160901529|NCT01626456|581034012|FG000|Overall Study|Adverse Event|2|||
160901530|NCT01626456|581034013|FG001|Overall Study|Adverse Event|27|||
160901531|NCT01626456|581034012|FG000|Overall Study|Lost to Follow-up|2|||
160901532|NCT01626456|581034013|FG001|Overall Study|Lost to Follow-up|27|||
160901533|NCT01626456|581034012|FG000|Overall Study|Lack of Efficacy|6|||
160821709|NCT01691885|580733669|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
160821710|NCT01691885|580733668|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
160901534|NCT01626456|581034013|FG001|Overall Study|Lack of Efficacy|7|||
160821711|NCT01691885|580733669|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
161240697|NCT05919823|582262099|FG000|Open Label Period|Lost to Follow-up|0|||
160901535|NCT01626456|581034012|FG000|Overall Study|Physician Decision|1|||
160901536|NCT01626456|581034013|FG001|Overall Study|Physician Decision|4|||
160901537|NCT01626456|581034012|FG000|Overall Study|Protocol Violation|1|||
161240698|NCT05919823|582262100|FG001|Open Label Period|Lost to Follow-up|0|||
161240699|NCT05919823|582262101|FG002|Open Label Period|Lost to Follow-up|1|||
161240700|NCT05919823|582262102|FG003|Open Label Period|Lost to Follow-up|0|||
161240701|NCT05919823|582262099|FG000|Open Label Period|Protocol Violation|0|||
161240702|NCT05919823|582262100|FG001|Open Label Period|Protocol Violation|0|||
161240703|NCT05919823|582262101|FG002|Open Label Period|Protocol Violation|0|||
161240704|NCT05919823|582262102|FG003|Open Label Period|Protocol Violation|1|||
161240705|NCT05919823|582262099|FG000|Open Label Period|Participant withdrew consent|0|||
161240706|NCT05919823|582262100|FG001|Open Label Period|Participant withdrew consent|0|||
161240707|NCT05919823|582262101|FG002|Open Label Period|Participant withdrew consent|8|||
161240708|NCT05919823|582262102|FG003|Open Label Period|Participant withdrew consent|6|||
161240709|NCT05919823|582262099|FG000|Open Label Period|Death|0|||
161240710|NCT05919823|582262100|FG001|Open Label Period|Death|0|||
161240711|NCT05919823|582262101|FG002|Open Label Period|Death|0|||
161240712|NCT05919823|582262102|FG003|Open Label Period|Death|1|||
160821712|NCT03555981|580733670|FG000|Overall Study|Lost to Follow-up|0|||
160821713|NCT03555981|580733671|FG001|Overall Study|Lost to Follow-up|2|||
160821714|NCT00688324|580733673|FG000|Overall Study|Withdrawal by Subject|2|||
160821715|NCT00688324|580733673|FG000|Overall Study|Physician Decision|5|||
160821716|NCT00688324|580733673|FG000|Overall Study|Lost to Follow-up|1|||
160821717|NCT01972308|580733676|FG000|Overall Study|Withdrawal by Subject|0|||
160821718|NCT01972308|580733677|FG001|Overall Study|Withdrawal by Subject|1|||
160821719|NCT01972308|580733676|FG000|Overall Study|Lost to Follow-up|4|||
160821720|NCT01972308|580733677|FG001|Overall Study|Lost to Follow-up|6|||
160821721|NCT01972308|580733676|FG000|Overall Study|Death|4|||
160821722|NCT01972308|580733677|FG001|Overall Study|Death|1|||
160821723|NCT04035564|580733679|FG000|Overall Study|Protocol Violation|1|||
160821724|NCT04035564|580733680|FG001|Overall Study|Protocol Violation|2|||
160821725|NCT04035564|580733679|FG000|Overall Study|No laboratory available|2|||
160821726|NCT04035564|580733680|FG001|Overall Study|No laboratory available|2|||
160821727|NCT04035564|580733679|FG000|Overall Study|Guardian declined consent|1|||
160821728|NCT04035564|580733680|FG001|Overall Study|Guardian declined consent|2|||
160821729|NCT01562314|580733681|FG000|Overall Study|Adverse Event|10|||
160821730|NCT01562314|580733682|FG001|Overall Study|Adverse Event|5|||
160821731|NCT01562314|580733681|FG000|Overall Study|Met Withdrawal Criteria|3|||
160821732|NCT01562314|580733682|FG001|Overall Study|Met Withdrawal Criteria|2|||
160821733|NCT01562314|580733681|FG000|Overall Study|Withdrawal by Subject|0|||
160821734|NCT01562314|580733682|FG001|Overall Study|Withdrawal by Subject|1|||
160821735|NCT01190475|580733689|FG000|Overall Study|Withdrawal by Subject|0|||
160821736|NCT01190475|580733690|FG001|Overall Study|Withdrawal by Subject|0|||
160821737|NCT01190475|580733691|FG002|Overall Study|Withdrawal by Subject|1|||
160821738|NCT00543803|580733692|FG000|Overall Study|Adverse Event|14|||
160821739|NCT00543803|580733692|FG000|Overall Study|Lack of Efficacy|22|||
160821740|NCT00543803|580733692|FG000|Overall Study|Lost to Follow-up|20|||
160821741|NCT00543803|580733692|FG000|Overall Study|Other|86|||
160821742|NCT04154345|580733695|FG000|Overall Study|Covid-19 pandemic|4|||
160821743|NCT03505788|580733696|FG000|Overall Study|Lost to Follow-up|2|||
160821744|NCT03505788|580733697|FG001|Overall Study|Lost to Follow-up|1|||
160821745|NCT03505788|580733696|FG000|Overall Study|Withdrawal by Subject|1|||
160821746|NCT03505788|580733697|FG001|Overall Study|Withdrawal by Subject|3|||
160821747|NCT03505788|580733696|FG000|Overall Study|Physician Decision|0|||
160901538|NCT01626456|581034013|FG001|Overall Study|Protocol Violation|1|||
160821748|NCT03505788|580733697|FG001|Overall Study|Physician Decision|1|||
160821749|NCT03575065|580733698|FG000|Overall Study|Death|31|||
160821750|NCT03575065|580733699|FG001|Overall Study|Death|12|||
160821751|NCT03575065|580733698|FG000|Overall Study|Sponsor's Decision|28|||
160821752|NCT03575065|580733699|FG001|Overall Study|Sponsor's Decision|13|||
160821753|NCT03575065|580733698|FG000|Overall Study|Withdrawal by Subject|2|||
160821754|NCT03575065|580733699|FG001|Overall Study|Withdrawal by Subject|1|||
160901539|NCT01626456|581034012|FG000|Overall Study|Site Closure|2|||
160901540|NCT01626456|581034013|FG001|Overall Study|Site Closure|3|||
160901541|NCT01626456|581034012|FG000|Overall Study|Incarceration|0|||
160901542|NCT01626456|581034013|FG001|Overall Study|Incarceration|2|||
160901543|NCT00506662|581034015|FG000|Overall Study|Adverse Event|0|||
160901544|NCT00506662|581034016|FG001|Overall Study|Adverse Event|2|||
160901545|NCT00506662|581034015|FG000|Overall Study|Lack of Efficacy|1|||
160901546|NCT00506662|581034016|FG001|Overall Study|Lack of Efficacy|0|||
160901547|NCT00506662|581034015|FG000|Overall Study|Protocol Violation|2|||
160901548|NCT00506662|581034016|FG001|Overall Study|Protocol Violation|4|||
160901549|NCT00506662|581034015|FG000|Overall Study|Trial terminated|10|||
160901550|NCT00506662|581034016|FG001|Overall Study|Trial terminated|16|||
160901551|NCT00506662|581034015|FG000|Overall Study|Not recorded|4|||
160901552|NCT00506662|581034016|FG001|Overall Study|Not recorded|6|||
160901553|NCT04015336|581034017|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
160901554|NCT00491075|581034018|FG000|Overall Study|Withdrawal by Subject|1|||
160901555|NCT00491075|581034018|FG000|Overall Study|Physician Decision|1|||
160901556|NCT01603355|581034019|FG000|Overall Study|Lack of Efficacy|2|||
161133129|NCT02700984|581870811|FG000|Overall Study|Reason not specified|3|||
161334107|NCT04079790|582612494|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
160901557|NCT00246753|581034020|FG000|Overall Study|Withdrawal by Subject|2|||
160901558|NCT00246753|581034020|FG000|Overall Study|Physician Decision|2|||
160901559|NCT00246753|581034020|FG000|Overall Study|Adverse Event|2|||
160901560|NCT00246753|581034020|FG000|Overall Study|Unacceptable toxicity|2|||
160901561|NCT01030536|581034023|FG000|Overall Study|Withdrawal by Subject|0|||
160901562|NCT01030536|581034024|FG001|Overall Study|Withdrawal by Subject|0|||
160821755|NCT03575065|580733698|FG000|Overall Study|Lost to Follow-up|1|||
160821756|NCT03575065|580733699|FG001|Overall Study|Lost to Follow-up|0|||
160821757|NCT02323126|580733704|FG000|Overall Study|Patient / guardian decision|0|||
160821758|NCT02323126|580733705|FG001|Overall Study|Patient / guardian decision|1|||
160821759|NCT02323126|580733706|FG002|Overall Study|Patient / guardian decision|2|||
160821760|NCT02323126|580733704|FG000|Overall Study|Progressive disease|14|||
160821761|NCT02323126|580733705|FG001|Overall Study|Progressive disease|8|||
160821762|NCT02323126|580733706|FG002|Overall Study|Progressive disease|14|||
160821763|NCT02323126|580733704|FG000|Overall Study|Physician Decision|0|||
160821764|NCT02323126|580733705|FG001|Overall Study|Physician Decision|1|||
160821765|NCT02323126|580733706|FG002|Overall Study|Physician Decision|3|||
160821766|NCT02323126|580733704|FG000|Overall Study|Death|1|||
160821767|NCT02323126|580733705|FG001|Overall Study|Death|1|||
160821768|NCT02323126|580733706|FG002|Overall Study|Death|4|||
160821769|NCT02323126|580733704|FG000|Overall Study|Adverse Event|3|||
160821770|NCT02323126|580733705|FG001|Overall Study|Adverse Event|5|||
160821771|NCT02323126|580733706|FG002|Overall Study|Adverse Event|7|||
160821772|NCT03333252|580733707|FG000|Overall Study|Adverse Event|10|||
160821773|NCT03333252|580733708|FG001|Overall Study|Adverse Event|6|||
160821774|NCT03333252|580733709|FG002|Overall Study|Adverse Event|5|||
160821775|NCT03333252|580733710|FG003|Overall Study|Adverse Event|2|||
160821776|NCT03333252|580733707|FG000|Overall Study|Death|1|||
160821777|NCT03333252|580733708|FG001|Overall Study|Death|3|||
160821778|NCT03333252|580733709|FG002|Overall Study|Death|0|||
160821779|NCT03333252|580733710|FG003|Overall Study|Death|0|||
160821780|NCT03333252|580733707|FG000|Overall Study|Lack of Efficacy|8|||
160821781|NCT03333252|580733708|FG001|Overall Study|Lack of Efficacy|4|||
160821782|NCT03333252|580733709|FG002|Overall Study|Lack of Efficacy|0|||
160821783|NCT03333252|580733710|FG003|Overall Study|Lack of Efficacy|7|||
160821784|NCT03333252|580733707|FG000|Overall Study|Lost to Follow-up|0|||
160821785|NCT03333252|580733708|FG001|Overall Study|Lost to Follow-up|5|||
160821786|NCT03333252|580733709|FG002|Overall Study|Lost to Follow-up|9|||
160821787|NCT03333252|580733710|FG003|Overall Study|Lost to Follow-up|3|||
160821788|NCT03333252|580733707|FG000|Overall Study|Withdrawal by Subject|14|||
160821789|NCT03333252|580733708|FG001|Overall Study|Withdrawal by Subject|24|||
160821790|NCT03333252|580733709|FG002|Overall Study|Withdrawal by Subject|11|||
160821791|NCT03333252|580733710|FG003|Overall Study|Withdrawal by Subject|17|||
160821792|NCT00939029|580733711|FG000|Overall Study|Withdrawal by Subject|3|||
160821793|NCT00939029|580733712|FG001|Overall Study|Withdrawal by Subject|7|||
160821794|NCT00939029|580733711|FG000|Overall Study|Lost to Follow-up|3|||
160821795|NCT00939029|580733712|FG001|Overall Study|Lost to Follow-up|4|||
160821796|NCT00939029|580733711|FG000|Overall Study|Adverse Event|0|||
160821797|NCT00939029|580733712|FG001|Overall Study|Adverse Event|1|||
160821798|NCT00396136|580733713|FG000|Overall Study|Death|43|||
160821799|NCT00396136|580733713|FG000|Overall Study|Withdrawal by Subject|59|||
160821800|NCT00396136|580733713|FG000|Overall Study|Lost to Follow-up|15|||
160821801|NCT00396136|580733713|FG000|Overall Study|Study device explanted|8|||
160821802|NCT01779856|580733714|FG000|Overall Study|Withdrawal by Subject|15|||
160821803|NCT01779856|580733714|FG000|Overall Study|Death|3|||
160821804|NCT01779856|580733714|FG000|Overall Study|Physician Decision|1|||
160821805|NCT01779856|580733714|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
160821806|NCT01779856|580733714|FG000|Overall Study|Delays in scheduling implant|1|||
160821807|NCT01779856|580733714|FG000|Overall Study|Subject ineligible for Implant|2|||
160821808|NCT01535599|580733716|FG000|Overall Study|Adverse Event|6|||
160821809|NCT01535599|580733717|FG001|Overall Study|Adverse Event|15|||
160821810|NCT01535599|580733716|FG000|Overall Study|Lost to Follow-up|3|||
160821811|NCT01535599|580733717|FG001|Overall Study|Lost to Follow-up|4|||
160901563|NCT01030536|581034025|FG002|Overall Study|Withdrawal by Subject|1|||
160901564|NCT01030536|581034026|FG003|Overall Study|Withdrawal by Subject|0|||
160821812|NCT01535599|580733716|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
160821813|NCT01535599|580733717|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
160821814|NCT01535599|580733716|FG000|Overall Study|Treatment Failure|33|||
160821815|NCT01535599|580733717|FG001|Overall Study|Treatment Failure|66|||
160901565|NCT01030536|581034027|FG004|Overall Study|Withdrawal by Subject|0|||
160821816|NCT01535599|580733716|FG000|Overall Study|BL Culture + for Group A Strep|0|||
160821817|NCT01535599|580733717|FG001|Overall Study|BL Culture + for Group A Strep|1|||
160821818|NCT01535599|580733716|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
160821819|NCT01535599|580733717|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
161133130|NCT02700984|581870812|FG001|Overall Study|Reason not specified|2|||
160821820|NCT01535599|580733716|FG000|Overall Study|Randomized in Error|2|||
160821821|NCT01535599|580733717|FG001|Overall Study|Randomized in Error|4|||
160821822|NCT01535599|580733716|FG000|Overall Study|Did not use product|1|||
161133131|NCT02868892|581870813|FG000|Overall Study|Investigator left site and no follow-up|6|||
161133132|NCT01360996|581870821|FG000|Overall Study|Withdrawal by Subject|4|||
161133133|NCT01360996|581870822|FG001|Overall Study|Withdrawal by Subject|3|||
161133134|NCT01360996|581870823|FG002|Overall Study|Withdrawal by Subject|2|||
161334108|NCT04079790|582612495|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
161334109|NCT04079790|582612496|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
161334110|NCT04079790|582612493|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161334111|NCT04079790|582612494|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161334112|NCT04079790|582612495|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
161334113|NCT04079790|582612496|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
161334114|NCT04275336|582612500|FG000|Overall Study|First venipuncture failed|4|||
161334115|NCT04275336|582612501|FG001|Overall Study|First venipuncture failed|6|||
161334116|NCT04275336|582612502|FG002|Overall Study|First venipuncture failed|5|||
160821823|NCT01535599|580733717|FG001|Overall Study|Did not use product|0|||
160821824|NCT01535599|580733716|FG000|Overall Study|Other|1|||
160821825|NCT01535599|580733717|FG001|Overall Study|Other|0|||
161133135|NCT01360996|581870821|FG000|Overall Study|Noncompliant|2|||
161133136|NCT01360996|581870822|FG001|Overall Study|Noncompliant|0|||
161133137|NCT01360996|581870823|FG002|Overall Study|Noncompliant|0|||
161133138|NCT03377634|581870824|FG000|Study Period|Adverse Event|1|||
161133139|NCT03377634|581870825|FG001|Study Period|Adverse Event|0|||
161133140|NCT03377634|581870824|FG000|Study Period|Withdrawal by Subject|1|||
161133141|NCT03377634|581870825|FG001|Study Period|Withdrawal by Subject|0|||
161133142|NCT01454076|581870826|FG000|Overall Study|Other|2|||
161133143|NCT01454076|581870827|FG001|Overall Study|Other|0|||
160821826|NCT01535599|580733716|FG000|Overall Study|Stopped medication|0|||
160821827|NCT01535599|580733717|FG001|Overall Study|Stopped medication|1|||
160821828|NCT01535599|580733716|FG000|Overall Study|Noncompliance|0|||
160821829|NCT01535599|580733717|FG001|Overall Study|Noncompliance|1|||
160821830|NCT03960580|580733721|FG000|Overall Study|Adverse Event|2|||
160821831|NCT03960580|580733722|FG001|Overall Study|Adverse Event|1|||
160821832|NCT03960580|580733723|FG002|Overall Study|Adverse Event|1|||
160821833|NCT03960580|580733721|FG000|Overall Study|Lost to Follow-up|1|||
160821834|NCT03960580|580733722|FG001|Overall Study|Lost to Follow-up|0|||
160821835|NCT03960580|580733723|FG002|Overall Study|Lost to Follow-up|0|||
160821836|NCT03960580|580733721|FG000|Overall Study|Lack of Efficacy|2|||
160821837|NCT03960580|580733722|FG001|Overall Study|Lack of Efficacy|1|||
160821838|NCT03960580|580733723|FG002|Overall Study|Lack of Efficacy|0|||
160821839|NCT03960580|580733721|FG000|Overall Study|Protocol Violation|0|||
160821840|NCT03960580|580733722|FG001|Overall Study|Protocol Violation|0|||
160821841|NCT03960580|580733723|FG002|Overall Study|Protocol Violation|1|||
160821842|NCT03960580|580733721|FG000|Overall Study|Withdrawal by Subject|1|||
160821843|NCT03960580|580733722|FG001|Overall Study|Withdrawal by Subject|1|||
160821844|NCT03960580|580733723|FG002|Overall Study|Withdrawal by Subject|1|||
160821845|NCT03960580|580733721|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
160821846|NCT03960580|580733722|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
160821847|NCT03960580|580733723|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
160821848|NCT03172325|580733728|FG000|Overall Study|Adverse Event|2|||
161133144|NCT01454076|581870828|FG002|Overall Study|Other|0|||
161133145|NCT01454076|581870829|FG003|Overall Study|Other|1|||
161133146|NCT01454076|581870830|FG004|Overall Study|Other|2|||
161133147|NCT01454076|581870826|FG000|Overall Study|Withdrawal by Subject|3|||
161133148|NCT01454076|581870827|FG001|Overall Study|Withdrawal by Subject|4|||
161334117|NCT04275336|582612500|FG000|Overall Study|Unscheduled venipuncture|9|||
160821849|NCT03172325|580733729|FG001|Overall Study|Adverse Event|3|||
160821850|NCT03172325|580733728|FG000|Overall Study|Positive PPD|1|||
160821851|NCT03172325|580733729|FG001|Overall Study|Positive PPD|0|||
160821852|NCT03172325|580733728|FG000|Overall Study|Poor Compliance|1|||
160821853|NCT03172325|580733729|FG001|Overall Study|Poor Compliance|1|||
160821854|NCT00385944|580733733|FG000|1st Maintenance Dose Period|Physician Decision|1|||
160821855|NCT00385944|580733734|FG001|1st Maintenance Dose Period|Physician Decision|0|||
160821856|NCT00385944|580733735|FG002|1st Maintenance Dose Period|Physician Decision|0|||
160821857|NCT00385944|580733733|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
160821858|NCT00385944|580733734|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
160821859|NCT00385944|580733735|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
160821860|NCT00385944|580733733|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
160821861|NCT00385944|580733734|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
161133149|NCT01454076|581870828|FG002|Overall Study|Withdrawal by Subject|2|||
161133150|NCT01454076|581870829|FG003|Overall Study|Withdrawal by Subject|1|||
161133151|NCT01454076|581870830|FG004|Overall Study|Withdrawal by Subject|2|||
161133152|NCT01454076|581870826|FG000|Overall Study|Adverse Event|8|||
161133153|NCT01454076|581870827|FG001|Overall Study|Adverse Event|2|||
161133154|NCT01454076|581870828|FG002|Overall Study|Adverse Event|7|||
160821862|NCT00385944|580733735|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
160821863|NCT00385944|580733733|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
160821864|NCT00385944|580733734|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
160821865|NCT00385944|580733735|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
160821866|NCT00590824|580733736|FG000|Overall Study|Disease could not be resected|0|||
160821867|NCT00590824|580733737|FG001|Overall Study|Disease could not be resected|2|||
160821868|NCT00590824|580733738|FG002|Overall Study|Disease could not be resected|1|||
160989204|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
160989205|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
160989206|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
160989207|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
160989208|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
160989209|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
160989210|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
160989211|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
160989212|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
160989213|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
160989214|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
160989215|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
160989216|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
160989217|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
160989218|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
160989219|NCT00333138|581347398|FG000|Extension Study (Month6 to End of Study)|Death|0|||
160989220|NCT00333138|581347399|FG001|Extension Study (Month6 to End of Study)|Death|1|||
160989221|NCT00333138|581347400|FG002|Extension Study (Month6 to End of Study)|Death|0|||
160989222|NCT03005288|581347401|FG000|Overall Study|Withdrawal by Subject|7|||
160989223|NCT03005288|581347402|FG001|Overall Study|Withdrawal by Subject|5|||
160989224|NCT03005288|581347401|FG000|Overall Study|Lost to Follow-up|0|||
160989225|NCT03005288|581347402|FG001|Overall Study|Lost to Follow-up|1|||
160989226|NCT03005288|581347401|FG000|Overall Study|Adverse Event|5|||
160989227|NCT03005288|581347402|FG001|Overall Study|Adverse Event|0|||
160989228|NCT03005288|581347401|FG000|Overall Study|Protocol deviation|0|||
160989229|NCT03005288|581347402|FG001|Overall Study|Protocol deviation|1|||
160989230|NCT03005288|581347401|FG000|Overall Study|Physician Decision|0|||
160989231|NCT03005288|581347402|FG001|Overall Study|Physician Decision|1|||
160989232|NCT04011033|581347403|FG000|Overall Study|Physician Decision|2|||
160989233|NCT04011033|581347404|FG001|Overall Study|Physician Decision|3|||
160989234|NCT04011033|581347403|FG000|Overall Study|Withdrawal by Subject|1|||
160989235|NCT04011033|581347404|FG001|Overall Study|Withdrawal by Subject|0|||
160989236|NCT01823341|581347405|FG000|Overall Study|Failed run-in|7|||
160989237|NCT01823341|581347405|FG000|Overall Study|Withdrawal by Subject|7|||
160989238|NCT01823341|581347405|FG000|Overall Study|Adverse Event|1|||
160989239|NCT01342887|581347406|FG000|Overall Study|Death|2|||
160989240|NCT00663962|581347407|FG000|Overall Study|somnolence|1|||
160989241|NCT00663962|581347408|FG001|Overall Study|somnolence|0|||
160989242|NCT02698436|581347420|FG000|Overall Study|Adverse Event|1|||
160989243|NCT02698436|581347421|FG001|Overall Study|Adverse Event|0|||
160989244|NCT02698436|581347420|FG000|Overall Study|Withdrawal by Subject|3|||
160989245|NCT02698436|581347421|FG001|Overall Study|Withdrawal by Subject|3|||
160989246|NCT02698436|581347420|FG000|Overall Study|Lost to Follow-up|2|||
160989247|NCT02698436|581347421|FG001|Overall Study|Lost to Follow-up|4|||
160989248|NCT02698436|581347420|FG000|Overall Study|Non-compliance with study regimen|1|||
160821869|NCT00590824|580733739|FG003|Overall Study|Disease could not be resected|0|||
160821870|NCT00590824|580733736|FG000|Overall Study|Adverse Event|0|||
160821871|NCT00590824|580733737|FG001|Overall Study|Adverse Event|0|||
160821872|NCT00590824|580733738|FG002|Overall Study|Adverse Event|0|||
160821873|NCT00590824|580733739|FG003|Overall Study|Adverse Event|1|||
160821874|NCT03832322|580733741|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
160821875|NCT03832322|580733742|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
160821876|NCT01694121|580733744|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
160821877|NCT01694121|580733745|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
160821878|NCT01778049|580733749|FG000|Open Label Treatment Period|Adverse Event|5|||
160821879|NCT01778049|580733750|FG001|Open Label Treatment Period|Adverse Event|15|||
160821880|NCT01778049|580733751|FG002|Open Label Treatment Period|Adverse Event|0|||
160821881|NCT01778049|580733752|FG003|Open Label Treatment Period|Adverse Event|0|||
160821882|NCT01778049|580733753|FG004|Open Label Treatment Period|Adverse Event|0|||
160821883|NCT01778049|580733754|FG005|Open Label Treatment Period|Adverse Event|0|||
160989249|NCT02698436|581347421|FG001|Overall Study|Non-compliance with study regimen|0|||
161133155|NCT01454076|581870829|FG003|Overall Study|Adverse Event|0|||
160821884|NCT01778049|580733749|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
160821885|NCT01778049|580733750|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
160821886|NCT01778049|580733751|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
160989250|NCT00665561|581347426|FG000|Overall Study|Death recorded on subject summary pages|75|||
160989251|NCT00665561|581347427|FG001|Overall Study|Death recorded on subject summary pages|75|||
160989252|NCT00665561|581347426|FG000|Overall Study|Does not meet entrance criteria|19|||
160989253|NCT00665561|581347427|FG001|Overall Study|Does not meet entrance criteria|21|||
160989254|NCT00665561|581347426|FG000|Overall Study|Lost to Follow-up|203|||
160989255|NCT00665561|581347427|FG001|Overall Study|Lost to Follow-up|264|||
160989256|NCT00665561|581347426|FG000|Overall Study|Withdrawal by Subject|74|||
160989257|NCT00665561|581347427|FG001|Overall Study|Withdrawal by Subject|65|||
160989258|NCT00665561|581347426|FG000|Overall Study|Other|123|||
160989259|NCT00665561|581347427|FG001|Overall Study|Other|108|||
160989260|NCT00665561|581347426|FG000|Overall Study|Site closed|8|||
160989261|NCT00665561|581347427|FG001|Overall Study|Site closed|0|||
160989262|NCT00665561|581347426|FG000|Overall Study|Withdrawn due to pregnancy|0|||
160989263|NCT00665561|581347427|FG001|Overall Study|Withdrawn due to pregnancy|1|||
160989264|NCT00097370|581347428|FG000|Stage 1|Adverse Event|3|||
160989265|NCT00097370|581347428|FG000|Stage 1|Withdrawal by Subject|1|||
160989266|NCT00097370|581347428|FG000|Stage 1|Lack of Efficacy|2|||
160989267|NCT00097370|581347428|FG000|Stage 2|Adverse Event|5|||
160989268|NCT00097370|581347428|FG000|Stage 2|Withdrawal by Subject|1|||
160989269|NCT00097370|581347428|FG000|Stage 2|Lack of Efficacy|3|||
160989270|NCT00097370|581347428|FG000|Stage 2|Pregnancy|1|||
160989271|NCT00097370|581347428|FG000|Stage 2|Sponsor Terminated Study|2|||
160989272|NCT00097370|581347428|FG000|Stage 2|Lost to Follow-up|1|||
160989273|NCT00097370|581347428|FG000|Stage 3|Adverse Event|2|||
160989274|NCT00097370|581347428|FG000|Stage 3|Withdrawal by Subject|3|||
160989275|NCT00097370|581347428|FG000|Stage 3|Lack of Efficacy|1|||
160989276|NCT00097370|581347428|FG000|Stage 3|Sponsor Terminated Study|52|||
160989277|NCT00097370|581347428|FG000|Stage 3|Lost to Follow-up|1|||
160989278|NCT00762463|581349491|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
160989279|NCT00762463|581349492|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
160989280|NCT00762463|581349493|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
160989281|NCT00762463|581349494|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
160989282|NCT00762463|581349491|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
160989283|NCT00762463|581349492|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
160989284|NCT00762463|581349493|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
160989285|NCT00762463|581349494|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
160989286|NCT00762463|581349491|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
160989287|NCT00762463|581349492|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
160989288|NCT00762463|581349493|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
160989289|NCT00762463|581349494|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
160989290|NCT00762463|581349491|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
160989291|NCT00762463|581349492|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
160989292|NCT00762463|581349493|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
160989293|NCT00762463|581349494|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
160989294|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
160989295|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
160989296|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
160989297|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
160989298|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
160989299|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
160989300|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
160989301|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
160989302|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
160989303|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
160989304|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
160989305|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
160989306|NCT00762463|581349491|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
160989307|NCT00762463|581349492|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
160989308|NCT00762463|581349493|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
160821887|NCT01778049|580733752|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
160821888|NCT01778049|580733753|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
160821889|NCT01778049|580733754|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
160989309|NCT00762463|581349494|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
160989310|NCT00531479|581349495|FG000|Overall Study|Death|68|||
160821890|NCT01778049|580733749|FG000|Open Label Treatment Period|Protocol Violation|5|||
160821891|NCT01778049|580733750|FG001|Open Label Treatment Period|Protocol Violation|5|||
160821892|NCT01778049|580733751|FG002|Open Label Treatment Period|Protocol Violation|0|||
160989311|NCT00531479|581349496|FG001|Overall Study|Death|71|||
160821893|NCT01778049|580733752|FG003|Open Label Treatment Period|Protocol Violation|0|||
160821894|NCT01778049|580733753|FG004|Open Label Treatment Period|Protocol Violation|0|||
160821895|NCT01778049|580733754|FG005|Open Label Treatment Period|Protocol Violation|0|||
160821896|NCT01778049|580733749|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
160821897|NCT01778049|580733750|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
160821898|NCT01778049|580733751|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
160821899|NCT01778049|580733752|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
160821900|NCT01778049|580733753|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
160821901|NCT01778049|580733754|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
160821902|NCT01778049|580733749|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
160821903|NCT01778049|580733750|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
160821904|NCT01778049|580733751|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
160821905|NCT01778049|580733752|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
160821906|NCT01778049|580733753|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
160821907|NCT01778049|580733754|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
160821908|NCT01778049|580733749|FG000|Open Label Treatment Period|Not treated|2|||
160821909|NCT01778049|580733750|FG001|Open Label Treatment Period|Not treated|1|||
160821910|NCT01778049|580733751|FG002|Open Label Treatment Period|Not treated|0|||
160821911|NCT01778049|580733752|FG003|Open Label Treatment Period|Not treated|0|||
160821912|NCT01778049|580733753|FG004|Open Label Treatment Period|Not treated|0|||
160821913|NCT01778049|580733754|FG005|Open Label Treatment Period|Not treated|0|||
160821914|NCT01778049|580733749|FG000|Open Label Treatment Period|Other reason not defined above|77|||
160821915|NCT01778049|580733750|FG001|Open Label Treatment Period|Other reason not defined above|94|||
160821916|NCT01778049|580733751|FG002|Open Label Treatment Period|Other reason not defined above|0|||
160821917|NCT01778049|580733752|FG003|Open Label Treatment Period|Other reason not defined above|0|||
160821918|NCT01778049|580733753|FG004|Open Label Treatment Period|Other reason not defined above|0|||
160821919|NCT01778049|580733754|FG005|Open Label Treatment Period|Other reason not defined above|0|||
160821920|NCT01778049|580733749|FG000|Double Blind Treatment Period|Adverse Event|0|||
160821921|NCT01778049|580733750|FG001|Double Blind Treatment Period|Adverse Event|0|||
160821922|NCT01778049|580733751|FG002|Double Blind Treatment Period|Adverse Event|4|||
160821923|NCT01778049|580733752|FG003|Double Blind Treatment Period|Adverse Event|5|||
160821924|NCT01778049|580733753|FG004|Double Blind Treatment Period|Adverse Event|3|||
160821925|NCT01778049|580733754|FG005|Double Blind Treatment Period|Adverse Event|2|||
160821926|NCT01778049|580733749|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
160821927|NCT01778049|580733750|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
160821928|NCT01778049|580733751|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
160821929|NCT01778049|580733752|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
160821930|NCT01778049|580733753|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
160821931|NCT01778049|580733754|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
160821932|NCT01778049|580733749|FG000|Double Blind Treatment Period|Protocol Violation|0|||
160821933|NCT01778049|580733750|FG001|Double Blind Treatment Period|Protocol Violation|0|||
160821934|NCT01778049|580733751|FG002|Double Blind Treatment Period|Protocol Violation|2|||
160821935|NCT01778049|580733752|FG003|Double Blind Treatment Period|Protocol Violation|0|||
160821936|NCT01778049|580733753|FG004|Double Blind Treatment Period|Protocol Violation|0|||
160821937|NCT01778049|580733754|FG005|Double Blind Treatment Period|Protocol Violation|0|||
160821938|NCT01778049|580733749|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
160821939|NCT01778049|580733750|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
160821940|NCT01778049|580733751|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
160821941|NCT01778049|580733752|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
160821942|NCT01778049|580733753|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
160821943|NCT01778049|580733754|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
160821944|NCT01778049|580733749|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
160821945|NCT01778049|580733750|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
160821946|NCT01778049|580733751|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
160821947|NCT01778049|580733752|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
160821948|NCT01778049|580733753|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
160821949|NCT01778049|580733754|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
160821950|NCT01778049|580733749|FG000|Double Blind Treatment Period|Not treated|0|||
160821951|NCT01778049|580733750|FG001|Double Blind Treatment Period|Not treated|0|||
160821952|NCT01778049|580733751|FG002|Double Blind Treatment Period|Not treated|0|||
160821953|NCT01778049|580733752|FG003|Double Blind Treatment Period|Not treated|2|||
160821954|NCT01778049|580733753|FG004|Double Blind Treatment Period|Not treated|2|||
160821955|NCT01778049|580733754|FG005|Double Blind Treatment Period|Not treated|0|||
160821956|NCT01778049|580733749|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
160821957|NCT01778049|580733750|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
160821958|NCT01778049|580733751|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
160821959|NCT01778049|580733752|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
160821960|NCT01778049|580733753|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
160821961|NCT01778049|580733754|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
160821962|NCT02186652|580733755|FG000|Overall Study|Lost to Follow-up|2|||
160821963|NCT02186652|580733756|FG001|Overall Study|Lost to Follow-up|0|||
160821964|NCT03770728|580733761|FG000|Overall Study|Adverse Event|1|||
160821965|NCT03770728|580733762|FG001|Overall Study|Adverse Event|0|||
160821966|NCT03770728|580733763|FG002|Overall Study|Adverse Event|1|||
160821967|NCT03770728|580733764|FG003|Overall Study|Adverse Event|0|||
160821968|NCT03770728|580733761|FG000|Overall Study|Poor compliance to protocol|0|||
160821969|NCT03770728|580733762|FG001|Overall Study|Poor compliance to protocol|0|||
160821970|NCT03770728|580733763|FG002|Overall Study|Poor compliance to protocol|1|||
160821971|NCT03770728|580733764|FG003|Overall Study|Poor compliance to protocol|0|||
160821972|NCT03770728|580733761|FG000|Overall Study|Withdrawal by Subject|13|||
160821973|NCT03770728|580733762|FG001|Overall Study|Withdrawal by Subject|8|||
160821974|NCT03770728|580733763|FG002|Overall Study|Withdrawal by Subject|9|||
160821975|NCT03770728|580733764|FG003|Overall Study|Withdrawal by Subject|13|||
160821976|NCT03770728|580733761|FG000|Overall Study|Other than specified|24|||
160821977|NCT03770728|580733762|FG001|Overall Study|Other than specified|23|||
160821978|NCT03770728|580733763|FG002|Overall Study|Other than specified|21|||
160821979|NCT03770728|580733764|FG003|Overall Study|Other than specified|22|||
160821980|NCT00503776|580733765|FG000|Overall Study|Withdrawal by Subject|1|||
160821981|NCT00503776|580733766|FG001|Overall Study|Withdrawal by Subject|0|||
160821982|NCT00503776|580733767|FG002|Overall Study|Withdrawal by Subject|1|||
160821983|NCT00503776|580733768|FG003|Overall Study|Withdrawal by Subject|1|||
160821984|NCT00503776|580733765|FG000|Overall Study|Physician Decision|0|||
160821985|NCT00503776|580733766|FG001|Overall Study|Physician Decision|0|||
160821986|NCT00503776|580733767|FG002|Overall Study|Physician Decision|1|||
160821987|NCT00503776|580733768|FG003|Overall Study|Physician Decision|1|||
160821988|NCT02379988|580733769|FG000|Overall Study|Not eligible|1|||
160821989|NCT00107315|580733770|FG000|Overall Study|Disease Progression|9|||
160821990|NCT00107315|580733770|FG000|Overall Study|Adverse Event|4|||
160821991|NCT00107315|580733770|FG000|Overall Study|Withdrawal by Subject|2|||
160821992|NCT02509039|580733777|FG000|Overall Study|Adverse Event|0|||
160821993|NCT02509039|580733778|FG001|Overall Study|Adverse Event|1|||
160821994|NCT02509039|580733779|FG002|Overall Study|Adverse Event|1|||
160821995|NCT02509039|580733780|FG003|Overall Study|Adverse Event|1|||
160821996|NCT02509039|580733777|FG000|Overall Study|Withdrawal by Subject|0|||
160821997|NCT02509039|580733778|FG001|Overall Study|Withdrawal by Subject|0|||
160821998|NCT02509039|580733779|FG002|Overall Study|Withdrawal by Subject|1|||
160821999|NCT02509039|580733780|FG003|Overall Study|Withdrawal by Subject|0|||
160822000|NCT02509039|580733777|FG000|Overall Study|Progressive disease|2|||
160822001|NCT02509039|580733778|FG001|Overall Study|Progressive disease|2|||
160822002|NCT02509039|580733779|FG002|Overall Study|Progressive disease|1|||
160822003|NCT02509039|580733780|FG003|Overall Study|Progressive disease|5|||
160822004|NCT02509039|580733777|FG000|Overall Study|Study terminated by Sponsor|1|||
160822005|NCT02509039|580733778|FG001|Overall Study|Study terminated by Sponsor|0|||
160901566|NCT01030536|581034023|FG000|Overall Study|undefined|1|||
160901567|NCT01030536|581034024|FG001|Overall Study|undefined|0|||
160901568|NCT01030536|581034025|FG002|Overall Study|undefined|1|||
160901569|NCT01030536|581034026|FG003|Overall Study|undefined|1|||
160901570|NCT01030536|581034027|FG004|Overall Study|undefined|0|||
160901571|NCT01030536|581034023|FG000|Overall Study|Adverse Event|0|||
160901572|NCT01030536|581034024|FG001|Overall Study|Adverse Event|3|||
160901573|NCT01030536|581034025|FG002|Overall Study|Adverse Event|1|||
160901574|NCT01030536|581034026|FG003|Overall Study|Adverse Event|0|||
160901575|NCT01030536|581034027|FG004|Overall Study|Adverse Event|1|||
160901576|NCT01030536|581034023|FG000|Overall Study|Progressive disease|6|||
160901577|NCT01030536|581034024|FG001|Overall Study|Progressive disease|2|||
160901578|NCT01030536|581034025|FG002|Overall Study|Progressive disease|3|||
160901579|NCT01030536|581034026|FG003|Overall Study|Progressive disease|2|||
160901580|NCT01030536|581034027|FG004|Overall Study|Progressive disease|0|||
160901581|NCT01030536|581034023|FG000|Overall Study|Death|0|||
160901582|NCT01030536|581034024|FG001|Overall Study|Death|1|||
160901583|NCT01030536|581034025|FG002|Overall Study|Death|0|||
160901584|NCT01030536|581034026|FG003|Overall Study|Death|0|||
160901585|NCT01030536|581034027|FG004|Overall Study|Death|0|||
160901586|NCT01065597|581034028|FG000|Overall Study|Adverse Event|1|||
160901587|NCT01781975|581034029|FG000|Overall Study|Death|1|||
160901588|NCT01781975|581034030|FG001|Overall Study|Death|0|||
160901589|NCT01781975|581034029|FG000|Overall Study|Withdrawal by Subject|1|||
160901590|NCT01781975|581034030|FG001|Overall Study|Withdrawal by Subject|1|||
160901591|NCT01622231|581034031|FG000|Overall Study|Physician Decision|1|||
160901592|NCT01622231|581034031|FG000|Overall Study|Withdrawal by Subject|1|||
160901593|NCT04889222|581034033|FG000|Overall Study|Did not meet eligibility criteria|8|||
160901594|NCT04889222|581034033|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
160901595|NCT04889222|581034033|FG000|Overall Study|Did not proceed due to time constraints|5|||
160901596|NCT01180647|581034034|FG000|Overall Study|Lost to Follow-up|5|||
160901597|NCT01180647|581034035|FG001|Overall Study|Lost to Follow-up|6|||
160901598|NCT04545554|581034044|FG000|Overall Study|Withdrawal by Subject|0|||
160901599|NCT04545554|581034045|FG001|Overall Study|Withdrawal by Subject|0|||
160901600|NCT04545554|581034046|FG002|Overall Study|Withdrawal by Subject|0|||
160901601|NCT04545554|581034047|FG003|Overall Study|Withdrawal by Subject|1|||
160822006|NCT02509039|580733779|FG002|Overall Study|Study terminated by Sponsor|0|||
160822007|NCT02509039|580733780|FG003|Overall Study|Study terminated by Sponsor|0|||
160822008|NCT03943550|580733783|FG000|Overall Study|Adverse Event|0|||
160822009|NCT03943550|580733784|FG001|Overall Study|Adverse Event|0|||
160822010|NCT03943550|580733785|FG002|Overall Study|Adverse Event|1|||
160822011|NCT03943550|580733783|FG000|Overall Study|Lost to Follow-up|0|||
160822012|NCT03943550|580733784|FG001|Overall Study|Lost to Follow-up|0|||
160822013|NCT03943550|580733785|FG002|Overall Study|Lost to Follow-up|1|||
160822014|NCT03943550|580733783|FG000|Overall Study|Progressive Disease|0|||
160822015|NCT03943550|580733784|FG001|Overall Study|Progressive Disease|0|||
160822016|NCT03943550|580733785|FG002|Overall Study|Progressive Disease|2|||
160822017|NCT03943550|580733783|FG000|Overall Study|Participant Moved Out of the Country|0|||
160822018|NCT03943550|580733784|FG001|Overall Study|Participant Moved Out of the Country|1|||
160822019|NCT03943550|580733785|FG002|Overall Study|Participant Moved Out of the Country|0|||
160822020|NCT03359785|580733786|FG000|Overall Study|Protocol Violation|0|||
160822021|NCT03359785|580733787|FG001|Overall Study|Protocol Violation|1|||
160822022|NCT03359785|580733788|FG002|Overall Study|Protocol Violation|0|||
160822023|NCT03359785|580733789|FG003|Overall Study|Protocol Violation|0|||
160822024|NCT03359785|580733786|FG000|Overall Study|Early study termination due to study pause|0|||
160822025|NCT03359785|580733787|FG001|Overall Study|Early study termination due to study pause|0|||
160822026|NCT03359785|580733788|FG002|Overall Study|Early study termination due to study pause|2|||
160822027|NCT03359785|580733789|FG003|Overall Study|Early study termination due to study pause|0|||
160822028|NCT03359785|580733786|FG000|Overall Study|Withdrawal by Subject|2|||
160822029|NCT03359785|580733787|FG001|Overall Study|Withdrawal by Subject|2|||
160822030|NCT03359785|580733788|FG002|Overall Study|Withdrawal by Subject|0|||
160822031|NCT03359785|580733789|FG003|Overall Study|Withdrawal by Subject|0|||
160822032|NCT01895543|580733790|FG000|Overall Study|Withdrawal by Subject|43|||
160822033|NCT01895543|580733790|FG000|Overall Study|Lost to Follow-up|25|||
160822034|NCT01895543|580733790|FG000|Overall Study|Adverse Event|28|||
160822035|NCT01895543|580733790|FG000|Overall Study|Subject's substantial non-compliance|6|||
160822036|NCT01895543|580733790|FG000|Overall Study|Protocol Violation|1|||
160822037|NCT01895543|580733790|FG000|Overall Study|Physician Decision|2|||
160822038|NCT01895543|580733790|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
160822039|NCT06107803|580733791|FG000|Overall Study|Adverse Event|1|||
160822040|NCT06107803|580733791|FG000|Overall Study|Withdrawal by Subject|2|||
160822041|NCT06107803|580733791|FG000|Overall Study|Protocol Violation|1|||
160822042|NCT04730635|580733792|FG000|Overall Study|Lost to Follow-up|1|||
160822043|NCT04730635|580733793|FG001|Overall Study|Lost to Follow-up|0|||
160822044|NCT04730635|580733792|FG000|Overall Study|Withdrawal by Subject|0|||
160822045|NCT04730635|580733793|FG001|Overall Study|Withdrawal by Subject|1|||
160822046|NCT03070223|580733794|FG000|Overall Study|Lost to Follow-up|34|||
160822047|NCT03070223|580733795|FG001|Overall Study|Lost to Follow-up|27|||
160822048|NCT03070223|580733794|FG000|Overall Study|Withdrawal by Subject|12|||
160822049|NCT03070223|580733795|FG001|Overall Study|Withdrawal by Subject|22|||
160822050|NCT03070223|580733794|FG000|Overall Study|Protocol Violation|0|||
160822051|NCT03070223|580733795|FG001|Overall Study|Protocol Violation|1|||
160822052|NCT00541866|580733797|FG000|Overall Study|Adverse Event|3|||
160822053|NCT00541866|580733798|FG001|Overall Study|Adverse Event|0|||
160822054|NCT00541866|580733799|FG002|Overall Study|Adverse Event|0|||
160822055|NCT00541866|580733800|FG003|Overall Study|Adverse Event|0|||
160822056|NCT00541866|580733801|FG004|Overall Study|Adverse Event|0|||
160822057|NCT00541866|580733797|FG000|Overall Study|Death|1|||
160822058|NCT00541866|580733798|FG001|Overall Study|Death|0|||
160822059|NCT00541866|580733799|FG002|Overall Study|Death|0|||
160822060|NCT00541866|580733800|FG003|Overall Study|Death|0|||
160822061|NCT00541866|580733801|FG004|Overall Study|Death|0|||
160822062|NCT00541866|580733797|FG000|Overall Study|Lack of Efficacy|19|||
160822063|NCT00541866|580733798|FG001|Overall Study|Lack of Efficacy|15|||
160822064|NCT00541866|580733799|FG002|Overall Study|Lack of Efficacy|10|||
160822065|NCT00541866|580733800|FG003|Overall Study|Lack of Efficacy|12|||
160822066|NCT00541866|580733801|FG004|Overall Study|Lack of Efficacy|14|||
160822067|NCT00541866|580733797|FG000|Overall Study|Not Reported or Other|11|||
160822068|NCT00541866|580733798|FG001|Overall Study|Not Reported or Other|3|||
160822069|NCT00541866|580733799|FG002|Overall Study|Not Reported or Other|3|||
160901602|NCT04545554|581034048|FG004|Overall Study|Withdrawal by Subject|0|||
160822070|NCT00541866|580733800|FG003|Overall Study|Not Reported or Other|3|||
160822071|NCT00541866|580733801|FG004|Overall Study|Not Reported or Other|1|||
160822072|NCT00541866|580733797|FG000|Overall Study|Physician Decision|0|||
161240713|NCT05919823|582262099|FG000|Open Label Period|Other reasons|0|||
160822073|NCT00541866|580733798|FG001|Overall Study|Physician Decision|0|||
160822074|NCT00541866|580733799|FG002|Overall Study|Physician Decision|2|||
160822075|NCT00541866|580733800|FG003|Overall Study|Physician Decision|1|||
160822076|NCT00541866|580733801|FG004|Overall Study|Physician Decision|0|||
160822077|NCT00522418|580733802|FG000|Overall Study|Local IRB Consent Violation|5|||
160822078|NCT00522418|580733803|FG001|Overall Study|Local IRB Consent Violation|5|||
160822079|NCT00522418|580733802|FG000|Overall Study|Early Study Termination|46|||
160822080|NCT00522418|580733803|FG001|Overall Study|Early Study Termination|47|||
160901603|NCT04545554|581034049|FG005|Overall Study|Withdrawal by Subject|0|||
160822081|NCT00522418|580733802|FG000|Overall Study|Noncompliance|2|||
160822082|NCT00522418|580733803|FG001|Overall Study|Noncompliance|2|||
160822083|NCT00522418|580733802|FG000|Overall Study|Reason Not Specified|3|||
160822084|NCT00522418|580733803|FG001|Overall Study|Reason Not Specified|1|||
160822085|NCT00522418|580733802|FG000|Overall Study|Consent Withdraw|1|||
160822086|NCT00522418|580733803|FG001|Overall Study|Consent Withdraw|2|||
161133156|NCT01454076|581870830|FG004|Overall Study|Adverse Event|2|||
161133157|NCT00291551|581870832|FG000|Overall Study|Death|7|||
161133158|NCT00291551|581870832|FG000|Overall Study|Withdrawal by Subject|6|||
161133159|NCT02452762|581870833|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
161133160|NCT02452762|581870834|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
161133161|NCT02452762|581870833|FG000|Overall Study|Withdrawal by Subject|1|||
160822087|NCT00522418|580733802|FG000|Overall Study|Lack of Efficacy|0|||
160822088|NCT00522418|580733803|FG001|Overall Study|Lack of Efficacy|1|||
160822089|NCT00578877|580733804|FG000|Overall Study|Lost to Follow-up|8|||
160822090|NCT00578877|580733805|FG001|Overall Study|Lost to Follow-up|10|||
160822091|NCT00578877|580733804|FG000|Overall Study|early discontinue|61|||
160822092|NCT00578877|580733805|FG001|Overall Study|early discontinue|101|||
160822093|NCT00578877|580733804|FG000|Overall Study|did not provide follow-up data|12|||
160822094|NCT00578877|580733805|FG001|Overall Study|did not provide follow-up data|17|||
160822095|NCT01202188|580733807|FG000|Overall Study|Protocol deviation|14|||
160822096|NCT01202188|580733808|FG001|Overall Study|Protocol deviation|8|||
160822097|NCT01202188|580733809|FG002|Overall Study|Protocol deviation|12|||
160822098|NCT01202188|580733810|FG003|Overall Study|Protocol deviation|10|||
160822099|NCT01202188|580733811|FG004|Overall Study|Protocol deviation|11|||
160822100|NCT01202188|580733807|FG000|Overall Study|Subject withdrew consent|12|||
160822101|NCT01202188|580733808|FG001|Overall Study|Subject withdrew consent|13|||
160822102|NCT01202188|580733809|FG002|Overall Study|Subject withdrew consent|22|||
160822103|NCT01202188|580733810|FG003|Overall Study|Subject withdrew consent|11|||
160822104|NCT01202188|580733811|FG004|Overall Study|Subject withdrew consent|13|||
160822105|NCT01202188|580733807|FG000|Overall Study|Adverse Event|5|||
160822106|NCT01202188|580733808|FG001|Overall Study|Adverse Event|23|||
160822107|NCT01202188|580733809|FG002|Overall Study|Adverse Event|13|||
160822108|NCT01202188|580733810|FG003|Overall Study|Adverse Event|10|||
160822109|NCT01202188|580733811|FG004|Overall Study|Adverse Event|10|||
160822110|NCT01202188|580733807|FG000|Overall Study|Administrative problems|3|||
160822111|NCT01202188|580733808|FG001|Overall Study|Administrative problems|2|||
160822112|NCT01202188|580733809|FG002|Overall Study|Administrative problems|1|||
160822113|NCT01202188|580733810|FG003|Overall Study|Administrative problems|1|||
160822114|NCT01202188|580733811|FG004|Overall Study|Administrative problems|2|||
160822115|NCT01202188|580733807|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160822116|NCT01202188|580733808|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160822117|NCT01202188|580733809|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160822118|NCT01202188|580733810|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
160822119|NCT01202188|580733811|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
160822120|NCT01202188|580733807|FG000|Overall Study|Lost to Follow-up|1|||
160822121|NCT01202188|580733808|FG001|Overall Study|Lost to Follow-up|1|||
160822122|NCT01202188|580733809|FG002|Overall Study|Lost to Follow-up|0|||
160822123|NCT01202188|580733810|FG003|Overall Study|Lost to Follow-up|4|||
160822124|NCT01202188|580733811|FG004|Overall Study|Lost to Follow-up|1|||
160822125|NCT01202188|580733807|FG000|Overall Study|Death|1|||
160822126|NCT01202188|580733808|FG001|Overall Study|Death|1|||
160822127|NCT01202188|580733809|FG002|Overall Study|Death|1|||
160822128|NCT01202188|580733810|FG003|Overall Study|Death|1|||
160822129|NCT01202188|580733811|FG004|Overall Study|Death|0|||
160822130|NCT01202188|580733807|FG000|Overall Study|Abnormal test procedure result (s)|0|||
160822131|NCT01202188|580733808|FG001|Overall Study|Abnormal test procedure result (s)|0|||
160822132|NCT01202188|580733809|FG002|Overall Study|Abnormal test procedure result (s)|2|||
160822133|NCT01202188|580733810|FG003|Overall Study|Abnormal test procedure result (s)|0|||
160822134|NCT01202188|580733811|FG004|Overall Study|Abnormal test procedure result (s)|0|||
160822135|NCT00642174|580735774|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
160822136|NCT00642174|580735775|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
161133162|NCT02452762|581870834|FG001|Overall Study|Withdrawal by Subject|0|||
161133163|NCT00631137|581870835|FG000|Overall Study|Withdrawal by Subject|1|||
161240714|NCT05919823|582262100|FG001|Open Label Period|Other reasons|0|||
160822137|NCT01730339|580735776|FG000|Overall Study|Withdrawal by Subject|3|||
160822138|NCT01730339|580735777|FG001|Overall Study|Withdrawal by Subject|2|||
160822139|NCT01730339|580735776|FG000|Overall Study|Lost to Follow-up|1|||
160822140|NCT01730339|580735777|FG001|Overall Study|Lost to Follow-up|1|||
160822141|NCT01730339|580735776|FG000|Overall Study|Un-specified|1|||
160822142|NCT01730339|580735777|FG001|Overall Study|Un-specified|0|||
160822143|NCT00896363|580735778|FG000|Overall Study|Adverse Event|3|||
160822144|NCT00896363|580735779|FG001|Overall Study|Adverse Event|4|||
160822145|NCT00896363|580735780|FG002|Overall Study|Adverse Event|2|||
160822146|NCT00896363|580735778|FG000|Overall Study|Lack of Efficacy|0|||
160822147|NCT00896363|580735779|FG001|Overall Study|Lack of Efficacy|2|||
160822148|NCT00896363|580735780|FG002|Overall Study|Lack of Efficacy|1|||
160822149|NCT00896363|580735778|FG000|Overall Study|Withdrawal by Subject|3|||
160822150|NCT00896363|580735779|FG001|Overall Study|Withdrawal by Subject|5|||
160822151|NCT00896363|580735780|FG002|Overall Study|Withdrawal by Subject|5|||
160822152|NCT03245736|580735781|FG000|Overall Study|Adverse Event|1|||
160822153|NCT03245736|580735781|FG000|Overall Study|Progressive Disease|4|||
160822154|NCT01942161|580735782|FG000|Overall Study|Adverse Event|1|||
160822155|NCT01942161|580735783|FG001|Overall Study|Adverse Event|2|||
160822156|NCT01942161|580735784|FG002|Overall Study|Adverse Event|5|||
160822157|NCT01942161|580735782|FG000|Overall Study|Physician Decision|3|||
160822158|NCT01942161|580735783|FG001|Overall Study|Physician Decision|1|||
160822159|NCT01942161|580735784|FG002|Overall Study|Physician Decision|0|||
160822160|NCT01942161|580735782|FG000|Overall Study|Protocol Violation|1|||
160822161|NCT01942161|580735783|FG001|Overall Study|Protocol Violation|0|||
160822162|NCT01942161|580735784|FG002|Overall Study|Protocol Violation|0|||
160822163|NCT01942161|580735782|FG000|Overall Study|Withdrawal by Subject|3|||
160822164|NCT01942161|580735783|FG001|Overall Study|Withdrawal by Subject|3|||
160822165|NCT01942161|580735784|FG002|Overall Study|Withdrawal by Subject|1|||
160822166|NCT01257568|580735788|FG000|Overall Study|Lost to Follow-up|2|||
160822167|NCT01257568|580735788|FG000|Overall Study|Withdrawal by Subject|6|||
160822168|NCT01257568|580735788|FG000|Overall Study|Terminated|1|||
160822169|NCT01257568|580735788|FG000|Overall Study|Component Revision|24|||
160822170|NCT00132691|580735790|FG000|Overall Study|Lost to Follow-up|5|||
160822171|NCT00132691|580735791|FG001|Overall Study|Lost to Follow-up|8|||
160901604|NCT02639546|581034050|FG000|Overall Study|Death|2|||
160901605|NCT02639546|581034051|FG001|Overall Study|Death|2|||
160901606|NCT02639546|581034052|FG002|Overall Study|Death|1|||
160901607|NCT02639546|581034053|FG003|Overall Study|Death|2|||
160901608|NCT02639546|581034054|FG004|Overall Study|Death|2|||
160901609|NCT02639546|581034055|FG005|Overall Study|Death|2|||
160901610|NCT02639546|581034056|FG006|Overall Study|Death|0|||
160901611|NCT02639546|581034057|FG007|Overall Study|Death|0|||
160901612|NCT02639546|581034050|FG000|Overall Study|Lost to Follow-up|0|||
160901613|NCT02639546|581034051|FG001|Overall Study|Lost to Follow-up|0|||
160901614|NCT02639546|581034052|FG002|Overall Study|Lost to Follow-up|1|||
160901615|NCT02639546|581034053|FG003|Overall Study|Lost to Follow-up|0|||
160901616|NCT02639546|581034054|FG004|Overall Study|Lost to Follow-up|1|||
160901617|NCT02639546|581034055|FG005|Overall Study|Lost to Follow-up|1|||
160901618|NCT02639546|581034056|FG006|Overall Study|Lost to Follow-up|0|||
160901619|NCT02639546|581034057|FG007|Overall Study|Lost to Follow-up|1|||
160901620|NCT02639546|581034050|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
160901621|NCT02639546|581034051|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
160901622|NCT02639546|581034052|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
160901623|NCT02639546|581034053|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
160901624|NCT02639546|581034054|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
160901625|NCT02639546|581034055|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
160901626|NCT02639546|581034056|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
160901627|NCT02639546|581034057|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
160901628|NCT02639546|581034050|FG000|Overall Study|Study Terminated By Sponsor|0|||
160901629|NCT02639546|581034051|FG001|Overall Study|Study Terminated By Sponsor|2|||
160901630|NCT02639546|581034052|FG002|Overall Study|Study Terminated By Sponsor|3|||
160901631|NCT02639546|581034053|FG003|Overall Study|Study Terminated By Sponsor|4|||
160901632|NCT02639546|581034054|FG004|Overall Study|Study Terminated By Sponsor|4|||
160901633|NCT02639546|581034055|FG005|Overall Study|Study Terminated By Sponsor|3|||
160901634|NCT02639546|581034056|FG006|Overall Study|Study Terminated By Sponsor|3|||
160901635|NCT02639546|581034057|FG007|Overall Study|Study Terminated By Sponsor|9|||
160901636|NCT02639546|581034050|FG000|Overall Study|Withdrawal by Subject|2|||
160901637|NCT02639546|581034051|FG001|Overall Study|Withdrawal by Subject|2|||
160901638|NCT02639546|581034052|FG002|Overall Study|Withdrawal by Subject|1|||
160901639|NCT02639546|581034053|FG003|Overall Study|Withdrawal by Subject|0|||
160989312|NCT00531479|581349495|FG000|Overall Study|Lost to Follow-up|0|||
160989313|NCT00531479|581349496|FG001|Overall Study|Lost to Follow-up|2|||
160822172|NCT00132691|580735790|FG000|Overall Study|Missed 2-year visit|4|||
160822173|NCT00132691|580735791|FG001|Overall Study|Missed 2-year visit|4|||
160822174|NCT00132691|580735790|FG000|Overall Study|Death|2|||
160822175|NCT00132691|580735791|FG001|Overall Study|Death|0|||
160822176|NCT02251717|580735798|FG000|Overall Study|Adverse Event|0|||
160822177|NCT02251717|580735799|FG001|Overall Study|Adverse Event|1|||
160901640|NCT02639546|581034054|FG004|Overall Study|Withdrawal by Subject|0|||
160901641|NCT02639546|581034055|FG005|Overall Study|Withdrawal by Subject|1|||
160901642|NCT02639546|581034056|FG006|Overall Study|Withdrawal by Subject|2|||
160901643|NCT02639546|581034057|FG007|Overall Study|Withdrawal by Subject|1|||
160901644|NCT02478372|581034058|FG000|Overall Study|Protocol Violation|12|||
160901645|NCT02478372|581034059|FG001|Overall Study|Protocol Violation|8|||
160901646|NCT02478372|581034058|FG000|Overall Study|Lost to Follow-up|1|||
160901647|NCT02478372|581034059|FG001|Overall Study|Lost to Follow-up|4|||
160901648|NCT02478372|581034058|FG000|Overall Study|Death|0|||
160901649|NCT02478372|581034059|FG001|Overall Study|Death|2|||
160901650|NCT00116428|581034060|FG000|Overall Study|Withdrawal by Subject|2|||
160822178|NCT02251717|580735798|FG000|Overall Study|Withdrew Consent|1|||
160822179|NCT02251717|580735799|FG001|Overall Study|Withdrew Consent|0|||
160822180|NCT04098367|580735800|FG000|Overall Study|Adverse Event|0|||
160822181|NCT04098367|580735801|FG001|Overall Study|Adverse Event|0|||
160822182|NCT04098367|580735802|FG002|Overall Study|Adverse Event|1|||
160822183|NCT04098367|580735800|FG000|Overall Study|Lost to Follow-up|1|||
160822184|NCT04098367|580735801|FG001|Overall Study|Lost to Follow-up|5|||
160822185|NCT04098367|580735802|FG002|Overall Study|Lost to Follow-up|2|||
160822186|NCT04098367|580735800|FG000|Overall Study|Withdrawal by Subject|0|||
160822187|NCT04098367|580735801|FG001|Overall Study|Withdrawal by Subject|0|||
160822188|NCT04098367|580735802|FG002|Overall Study|Withdrawal by Subject|1|||
160822189|NCT04098367|580735800|FG000|Overall Study|Sick . Could not attend visit|1|||
160822190|NCT04098367|580735801|FG001|Overall Study|Sick . Could not attend visit|0|||
160822191|NCT04098367|580735802|FG002|Overall Study|Sick . Could not attend visit|0|||
160822192|NCT00445939|580735805|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
160901651|NCT00116428|581034061|FG001|Overall Study|Withdrawal by Subject|5|||
160901652|NCT00116428|581034060|FG000|Overall Study|Did not meet inclusion criteria|1|||
160901653|NCT00116428|581034061|FG001|Overall Study|Did not meet inclusion criteria|0|||
160901654|NCT01032174|581034062|FG000|Overall Study|Adverse Event|0|||
160901655|NCT01032174|581034063|FG001|Overall Study|Adverse Event|1|||
160901656|NCT00386607|581034064|FG000|Core|Adverse Event|40|||
160901657|NCT00386607|581034065|FG001|Core|Adverse Event|0|||
160901658|NCT00386607|581034064|FG000|Core|Abnormal laboratory value(s)|3|||
160901659|NCT00386607|581034065|FG001|Core|Abnormal laboratory value(s)|0|||
160901660|NCT00386607|581034064|FG000|Core|Unsatisfactory therapeutic effect|23|||
160901661|NCT00386607|581034065|FG001|Core|Unsatisfactory therapeutic effect|0|||
160901662|NCT00386607|581034064|FG000|Core|Condition no longer requires study drug|4|||
160901663|NCT00386607|581034065|FG001|Core|Condition no longer requires study drug|0|||
160901664|NCT00386607|581034064|FG000|Core|Patient withdrew consent|15|||
160901665|NCT00386607|581034065|FG001|Core|Patient withdrew consent|0|||
160901666|NCT00386607|581034064|FG000|Core|Lost to Follow-up|23|||
160901667|NCT00386607|581034065|FG001|Core|Lost to Follow-up|0|||
160901668|NCT00386607|581034064|FG000|Core|Administrative problems|1|||
160901669|NCT00386607|581034065|FG001|Core|Administrative problems|0|||
160901670|NCT00386607|581034064|FG000|Core|Protocol Deviation|6|||
160901671|NCT00386607|581034065|FG001|Core|Protocol Deviation|0|||
160901672|NCT00386607|581034064|FG000|Extension|Adverse Event|0|||
160901673|NCT00386607|581034065|FG001|Extension|Adverse Event|6|||
160901674|NCT00386607|581034064|FG000|Extension|Abnormal laboratory value(s)|0|||
160901675|NCT00386607|581034065|FG001|Extension|Abnormal laboratory value(s)|1|||
160901676|NCT00386607|581034064|FG000|Extension|Administrative problems|0|||
160901677|NCT00386607|581034065|FG001|Extension|Administrative problems|1|||
160901678|NCT00386607|581034064|FG000|Extension|Lost to Follow-up|0|||
160901679|NCT00386607|581034065|FG001|Extension|Lost to Follow-up|3|||
160901680|NCT00386607|581034064|FG000|Extension|Patient withdrew consent|0|||
160901681|NCT00386607|581034065|FG001|Extension|Patient withdrew consent|5|||
160901682|NCT00386607|581034064|FG000|Extension|Unsatisfactory therapeutic effect|0|||
160901683|NCT00386607|581034065|FG001|Extension|Unsatisfactory therapeutic effect|1|||
160901684|NCT02713204|581034066|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
160901685|NCT02713204|581034067|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901686|NCT02713204|581034068|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
160901687|NCT02713204|581034069|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901688|NCT02713204|581034070|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901689|NCT02713204|581034071|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901690|NCT02713204|581034072|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901691|NCT02713204|581034073|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
160901692|NCT02713204|581034066|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901693|NCT02713204|581034067|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901694|NCT02713204|581034068|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
160901695|NCT02713204|581034069|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901696|NCT02713204|581034070|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901697|NCT02713204|581034071|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901698|NCT02713204|581034072|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901699|NCT02713204|581034073|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
160901700|NCT02713204|581034066|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161240715|NCT05919823|582262101|FG002|Open Label Period|Other reasons|9|||
160822193|NCT00445939|580735806|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
160901701|NCT02713204|581034067|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
160822194|NCT00445939|580735807|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
160822195|NCT00445939|580735808|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
160822196|NCT00445939|580735805|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
160822197|NCT00445939|580735806|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
160901702|NCT02713204|581034068|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901703|NCT02713204|581034069|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901704|NCT02713204|581034070|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160822198|NCT00445939|580735807|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
160822199|NCT00445939|580735808|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
160822200|NCT00416715|580735809|FG000|Overall Study|Not evaluable for joint aches|7|||
160822201|NCT00416715|580735809|FG000|Overall Study|Vitamin D levels not evaluable|8|||
160822202|NCT00521599|580735811|FG000|Overall Study|Adverse Event|5|||
160822203|NCT00521599|580735812|FG001|Overall Study|Adverse Event|7|||
160822204|NCT00521599|580735813|FG002|Overall Study|Adverse Event|6|||
160822205|NCT00521599|580735811|FG000|Overall Study|Treatment Failure|8|||
160822206|NCT00521599|580735812|FG001|Overall Study|Treatment Failure|9|||
160822207|NCT00521599|580735813|FG002|Overall Study|Treatment Failure|22|||
160822208|NCT00521599|580735811|FG000|Overall Study|Lost to Follow-up|2|||
160822209|NCT00521599|580735812|FG001|Overall Study|Lost to Follow-up|1|||
160822210|NCT00521599|580735813|FG002|Overall Study|Lost to Follow-up|2|||
160822211|NCT00521599|580735811|FG000|Overall Study|Withdrawal by Subject|3|||
160822212|NCT00521599|580735812|FG001|Overall Study|Withdrawal by Subject|5|||
160822213|NCT00521599|580735813|FG002|Overall Study|Withdrawal by Subject|1|||
160822214|NCT00521599|580735811|FG000|Overall Study|Withdrawal by subject treatment related|3|||
160822215|NCT00521599|580735812|FG001|Overall Study|Withdrawal by subject treatment related|1|||
160822216|NCT00521599|580735813|FG002|Overall Study|Withdrawal by subject treatment related|2|||
160822217|NCT00521599|580735811|FG000|Overall Study|Protocol Violation|2|||
160822218|NCT00521599|580735812|FG001|Overall Study|Protocol Violation|4|||
160822219|NCT00521599|580735813|FG002|Overall Study|Protocol Violation|2|||
160822220|NCT00521599|580735811|FG000|Overall Study|Did not meet protocol eligibility|2|||
160822221|NCT00521599|580735812|FG001|Overall Study|Did not meet protocol eligibility|2|||
160822222|NCT00521599|580735813|FG002|Overall Study|Did not meet protocol eligibility|1|||
160822223|NCT00791479|580735814|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822224|NCT00791479|580735815|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822225|NCT00791479|580735816|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822226|NCT00791479|580735817|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822227|NCT00791479|580735818|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
160822228|NCT00791479|580735819|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
160822229|NCT00791479|580735814|FG000|Overall Study|Adverse Event|0|||
160822230|NCT00791479|580735815|FG001|Overall Study|Adverse Event|1|||
160822231|NCT00791479|580735816|FG002|Overall Study|Adverse Event|0|||
160822232|NCT00791479|580735817|FG003|Overall Study|Adverse Event|2|||
160822233|NCT00791479|580735818|FG004|Overall Study|Adverse Event|0|||
160822234|NCT00791479|580735819|FG005|Overall Study|Adverse Event|1|||
160822235|NCT00791479|580735814|FG000|Overall Study|Lost to Follow-up|0|||
160822236|NCT00791479|580735815|FG001|Overall Study|Lost to Follow-up|1|||
160822237|NCT00791479|580735816|FG002|Overall Study|Lost to Follow-up|0|||
160822238|NCT00791479|580735817|FG003|Overall Study|Lost to Follow-up|0|||
160822239|NCT00791479|580735818|FG004|Overall Study|Lost to Follow-up|0|||
160822240|NCT00791479|580735819|FG005|Overall Study|Lost to Follow-up|1|||
160822241|NCT00791479|580735814|FG000|Overall Study|Protocol Violation|2|||
160822242|NCT00791479|580735815|FG001|Overall Study|Protocol Violation|1|||
160822243|NCT00791479|580735816|FG002|Overall Study|Protocol Violation|0|||
160822244|NCT00791479|580735817|FG003|Overall Study|Protocol Violation|1|||
160822245|NCT00791479|580735818|FG004|Overall Study|Protocol Violation|0|||
160822246|NCT00791479|580735819|FG005|Overall Study|Protocol Violation|0|||
160822247|NCT00791479|580735814|FG000|Overall Study|Withdrawal by Subject|0|||
160822248|NCT00791479|580735815|FG001|Overall Study|Withdrawal by Subject|0|||
160822249|NCT00791479|580735816|FG002|Overall Study|Withdrawal by Subject|0|||
160822250|NCT00791479|580735817|FG003|Overall Study|Withdrawal by Subject|1|||
160822251|NCT00791479|580735818|FG004|Overall Study|Withdrawal by Subject|0|||
160822252|NCT00791479|580735819|FG005|Overall Study|Withdrawal by Subject|1|||
160822253|NCT00496197|580735820|FG000|Overall Study|Discontinued study due to death|43|||
160822254|NCT00496197|580735820|FG000|Overall Study|Adverse Event|13|||
160822255|NCT00496197|580735820|FG000|Overall Study|Does not meet entrance criteria|5|||
161133164|NCT00631137|581870836|FG001|Overall Study|Withdrawal by Subject|0|||
161133165|NCT01015833|581870837|FG000|Overall Study|Death|1|||
161133166|NCT01015833|581870838|FG001|Overall Study|Death|0|||
161133167|NCT01015833|581870837|FG000|Overall Study|Withdrawal by Subject|3|||
161133168|NCT01015833|581870838|FG001|Overall Study|Withdrawal by Subject|2|||
160822256|NCT00496197|580735820|FG000|Overall Study|Insufficient clinical response|3|||
160822257|NCT00496197|580735820|FG000|Overall Study|Insufficient bacteriological response|10|||
160822258|NCT00496197|580735820|FG000|Overall Study|Lost to Follow-up|11|||
160822259|NCT00496197|580735820|FG000|Overall Study|Withdrawal by Subject|11|||
160822260|NCT00496197|580735820|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
160822261|NCT00496197|580735820|FG000|Overall Study|Other|14|||
160822262|NCT00496197|580735820|FG000|Overall Study|Protocol Violation|8|||
160822263|NCT00149994|580735821|FG000|Overall Study|Administrative problems:|1|||
160822264|NCT00149994|580735822|FG001|Overall Study|Administrative problems:|0|||
160822265|NCT00149994|580735821|FG000|Overall Study|Protocol Violation|0|||
160822266|NCT00149994|580735822|FG001|Overall Study|Protocol Violation|1|||
160822267|NCT01610713|580735823|FG000|Overall Study|Adverse Event|3|||
161133169|NCT01015833|581870837|FG000|Overall Study|Adverse Event|0|||
160822268|NCT01610713|580735824|FG001|Overall Study|Adverse Event|0|||
160822269|NCT01610713|580735823|FG000|Overall Study|Lack of Efficacy|1|||
160822270|NCT01610713|580735824|FG001|Overall Study|Lack of Efficacy|0|||
160822271|NCT01610713|580735823|FG000|Overall Study|low mood and poor motivation|1|||
160822272|NCT01610713|580735824|FG001|Overall Study|low mood and poor motivation|0|||
160822273|NCT01610713|580735823|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
160822274|NCT01610713|580735824|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
160822275|NCT01610713|580735823|FG000|Overall Study|Lost to Follow-up|0|||
160822276|NCT01610713|580735824|FG001|Overall Study|Lost to Follow-up|1|||
160822277|NCT04659174|580735834|FG000|Overall Study|Sponsor decision to discontinue study|0|||
160822278|NCT04659174|580735835|FG001|Overall Study|Sponsor decision to discontinue study|2|||
160822279|NCT04659174|580735834|FG000|Overall Study|Lost to Follow-up|9|||
160989314|NCT00531479|581349495|FG000|Overall Study|Other|0|||
160989315|NCT00531479|581349496|FG001|Overall Study|Other|1|||
160989316|NCT00531479|581349495|FG000|Overall Study|Withdrawal by Subject|6|||
160989317|NCT00531479|581349496|FG001|Overall Study|Withdrawal by Subject|6|||
160822280|NCT04659174|580735835|FG001|Overall Study|Lost to Follow-up|11|||
160822281|NCT04659174|580735834|FG000|Overall Study|Adverse Event|8|||
160822282|NCT04659174|580735835|FG001|Overall Study|Adverse Event|5|||
160822283|NCT04659174|580735834|FG000|Overall Study|Withdrawal by Subject|17|||
160822284|NCT04659174|580735835|FG001|Overall Study|Withdrawal by Subject|33|||
160822285|NCT04659174|580735834|FG000|Overall Study|Progressive disease|0|||
160822286|NCT04659174|580735835|FG001|Overall Study|Progressive disease|2|||
160822287|NCT04659174|580735834|FG000|Overall Study|Other reasons|0|||
160822288|NCT04659174|580735835|FG001|Overall Study|Other reasons|2|||
160822289|NCT04659174|580735834|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
160822290|NCT04659174|580735835|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
160822291|NCT04659174|580735834|FG000|Overall Study|Alcohol or illegal drug use|0|||
160822292|NCT04659174|580735835|FG001|Overall Study|Alcohol or illegal drug use|3|||
160822293|NCT04659174|580735834|FG000|Overall Study|Violation of entry criteria|1|||
160822294|NCT04659174|580735835|FG001|Overall Study|Violation of entry criteria|0|||
160822295|NCT04659174|580735834|FG000|Overall Study|Death|0|||
160822296|NCT04659174|580735835|FG001|Overall Study|Death|1|||
160822297|NCT03650803|580735839|FG000|Overall Study|Lost to Follow-up|6|||
160822298|NCT00096226|580735840|FG000|Overall Study|Ineligible|2|||
160822299|NCT00096226|580735840|FG000|Overall Study|Protocol treatment not started|1|||
160822300|NCT04173260|580735846|FG000|Overall Study|Early termination|4|||
160822301|NCT02308163|580735849|FG000|Overall Study|Not fulfill eligible criteria|1|||
160822302|NCT02308163|580735850|FG001|Overall Study|Not fulfill eligible criteria|2|||
160822303|NCT02308163|580735851|FG002|Overall Study|Not fulfill eligible criteria|0|||
160822304|NCT02308163|580735852|FG003|Overall Study|Not fulfill eligible criteria|1|||
160822305|NCT02308163|580735853|FG004|Overall Study|Not fulfill eligible criteria|1|||
160822306|NCT02308163|580735849|FG000|Overall Study|Adverse Event|9|||
160822307|NCT02308163|580735850|FG001|Overall Study|Adverse Event|5|||
160822308|NCT02308163|580735851|FG002|Overall Study|Adverse Event|2|||
160822309|NCT02308163|580735852|FG003|Overall Study|Adverse Event|2|||
160822310|NCT02308163|580735853|FG004|Overall Study|Adverse Event|11|||
160822311|NCT02308163|580735849|FG000|Overall Study|Lack of Efficacy|11|||
160822312|NCT02308163|580735850|FG001|Overall Study|Lack of Efficacy|3|||
160822313|NCT02308163|580735851|FG002|Overall Study|Lack of Efficacy|8|||
160822314|NCT02308163|580735852|FG003|Overall Study|Lack of Efficacy|4|||
160822315|NCT02308163|580735853|FG004|Overall Study|Lack of Efficacy|6|||
160822316|NCT02308163|580735849|FG000|Overall Study|Withdrawal of consent|2|||
160822317|NCT02308163|580735850|FG001|Overall Study|Withdrawal of consent|3|||
160822318|NCT02308163|580735851|FG002|Overall Study|Withdrawal of consent|0|||
160822319|NCT02308163|580735852|FG003|Overall Study|Withdrawal of consent|2|||
160822320|NCT02308163|580735853|FG004|Overall Study|Withdrawal of consent|6|||
160822321|NCT02308163|580735849|FG000|Overall Study|Protocol Violation|3|||
160822322|NCT02308163|580735850|FG001|Overall Study|Protocol Violation|3|||
160822323|NCT02308163|580735851|FG002|Overall Study|Protocol Violation|3|||
160822324|NCT02308163|580735852|FG003|Overall Study|Protocol Violation|2|||
160822325|NCT02308163|580735853|FG004|Overall Study|Protocol Violation|5|||
160822326|NCT02308163|580735849|FG000|Overall Study|Lab data met discontinuation criteria|3|||
160822327|NCT02308163|580735850|FG001|Overall Study|Lab data met discontinuation criteria|0|||
160822328|NCT02308163|580735851|FG002|Overall Study|Lab data met discontinuation criteria|0|||
160822329|NCT02308163|580735852|FG003|Overall Study|Lab data met discontinuation criteria|2|||
160822330|NCT02308163|580735853|FG004|Overall Study|Lab data met discontinuation criteria|0|||
160822331|NCT02308163|580735849|FG000|Overall Study|Miscellaneous|2|||
160822332|NCT02308163|580735850|FG001|Overall Study|Miscellaneous|2|||
160822333|NCT02308163|580735851|FG002|Overall Study|Miscellaneous|1|||
160822334|NCT02308163|580735852|FG003|Overall Study|Miscellaneous|0|||
160822335|NCT02308163|580735853|FG004|Overall Study|Miscellaneous|5|||
160822336|NCT03006458|580735858|FG000|First Intervention|Unsatisfied Vision|0|||
160822337|NCT03006458|580735859|FG001|First Intervention|Unsatisfied Vision|3|||
160989318|NCT00531479|581349495|FG000|Overall Study|Did not receive treatment|2|||
160822338|NCT00118846|580735861|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
160822339|NCT00118846|580735862|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
160822340|NCT00118846|580735861|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
160822341|NCT00118846|580735862|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
160822342|NCT00118846|580735861|FG000|Overall Study|Physician Decision|1|||
160822343|NCT00118846|580735862|FG001|Overall Study|Physician Decision|0|||
160822344|NCT00118846|580735861|FG000|Overall Study|Medical condition|2|||
160989319|NCT00531479|581349496|FG001|Overall Study|Did not receive treatment|3|||
160989320|NCT05074498|581349499|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989321|NCT05074498|581349500|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989322|NCT05074498|581349501|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989323|NCT05074498|581349502|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
160989324|NCT05074498|581349503|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989325|NCT05074498|581349504|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
160989326|NCT05074498|581349499|FG000|Part 1 (Upto Day 104)|Other|1|||
160989327|NCT05074498|581349500|FG001|Part 1 (Upto Day 104)|Other|0|||
160989328|NCT05074498|581349501|FG002|Part 1 (Upto Day 104)|Other|0|||
160989329|NCT05074498|581349502|FG003|Part 1 (Upto Day 104)|Other|0|||
160989330|NCT05074498|581349503|FG004|Part 1 (Upto Day 104)|Other|0|||
160822345|NCT00118846|580735862|FG001|Overall Study|Medical condition|2|||
160822346|NCT00118846|580735861|FG000|Overall Study|Lost to Follow-up|0|||
160822347|NCT00118846|580735862|FG001|Overall Study|Lost to Follow-up|2|||
160822348|NCT00118846|580735861|FG000|Overall Study|Personal reason|4|||
160822349|NCT00118846|580735862|FG001|Overall Study|Personal reason|5|||
160822350|NCT01468233|580735865|FG000|Treatment Period 1|Adverse Event|5|||
160822351|NCT01468233|580735866|FG001|Treatment Period 1|Adverse Event|3|||
160822352|NCT01468233|580735867|FG002|Treatment Period 1|Adverse Event|0|||
160822353|NCT01468233|580735868|FG003|Treatment Period 1|Adverse Event|0|||
160822354|NCT01468233|580735869|FG004|Treatment Period 1|Adverse Event|0|||
160822355|NCT01468233|580735870|FG005|Treatment Period 1|Adverse Event|0|||
160822356|NCT01468233|580735865|FG000|Treatment Period 1|Withdrawal by Subject|3|||
160822357|NCT01468233|580735866|FG001|Treatment Period 1|Withdrawal by Subject|4|||
160822358|NCT01468233|580735867|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160822359|NCT01468233|580735868|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160822360|NCT01468233|580735869|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160822361|NCT01468233|580735870|FG005|Treatment Period 1|Withdrawal by Subject|0|||
160822362|NCT01468233|580735865|FG000|Treatment Period 1|Lost to Follow-up|3|||
160822363|NCT01468233|580735866|FG001|Treatment Period 1|Lost to Follow-up|0|||
160822364|NCT01468233|580735867|FG002|Treatment Period 1|Lost to Follow-up|0|||
160822365|NCT01468233|580735868|FG003|Treatment Period 1|Lost to Follow-up|0|||
160822366|NCT01468233|580735869|FG004|Treatment Period 1|Lost to Follow-up|0|||
160822367|NCT01468233|580735870|FG005|Treatment Period 1|Lost to Follow-up|0|||
160822368|NCT01468233|580735865|FG000|Treatment Period 1|Other|1|||
160822369|NCT01468233|580735866|FG001|Treatment Period 1|Other|1|||
160822370|NCT01468233|580735867|FG002|Treatment Period 1|Other|0|||
160822371|NCT01468233|580735868|FG003|Treatment Period 1|Other|0|||
160822372|NCT01468233|580735869|FG004|Treatment Period 1|Other|0|||
160822373|NCT01468233|580735870|FG005|Treatment Period 1|Other|0|||
160822374|NCT01468233|580735865|FG000|Treatment Period 2|Adverse Event|0|||
160822375|NCT01468233|580735866|FG001|Treatment Period 2|Adverse Event|0|||
160822376|NCT01468233|580735867|FG002|Treatment Period 2|Adverse Event|3|||
160822377|NCT01468233|580735868|FG003|Treatment Period 2|Adverse Event|0|||
160822378|NCT01468233|580735869|FG004|Treatment Period 2|Adverse Event|2|||
160822379|NCT01468233|580735870|FG005|Treatment Period 2|Adverse Event|1|||
160822380|NCT01468233|580735865|FG000|Treatment Period 2|Lack of Efficacy|0|||
160822381|NCT01468233|580735866|FG001|Treatment Period 2|Lack of Efficacy|0|||
160822382|NCT01468233|580735867|FG002|Treatment Period 2|Lack of Efficacy|9|||
160822383|NCT01468233|580735868|FG003|Treatment Period 2|Lack of Efficacy|2|||
160822384|NCT01468233|580735869|FG004|Treatment Period 2|Lack of Efficacy|0|||
160822385|NCT01468233|580735870|FG005|Treatment Period 2|Lack of Efficacy|1|||
160822386|NCT01468233|580735865|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160822387|NCT01468233|580735866|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160822388|NCT01468233|580735867|FG002|Treatment Period 2|Withdrawal by Subject|9|||
160822389|NCT01468233|580735868|FG003|Treatment Period 2|Withdrawal by Subject|1|||
160822390|NCT01468233|580735869|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160822391|NCT01468233|580735870|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160822392|NCT01468233|580735865|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
160822393|NCT01468233|580735866|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
160822394|NCT01468233|580735867|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
160822395|NCT01468233|580735868|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
160822396|NCT01468233|580735869|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
160989331|NCT05074498|581349504|FG005|Part 1 (Upto Day 104)|Other|0|||
160822397|NCT01468233|580735870|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
160822398|NCT01468233|580735865|FG000|Treatment Period 2|Lost to Follow-up|0|||
160822399|NCT01468233|580735866|FG001|Treatment Period 2|Lost to Follow-up|0|||
160989332|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989333|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160822400|NCT01468233|580735867|FG002|Treatment Period 2|Lost to Follow-up|3|||
160822401|NCT01468233|580735868|FG003|Treatment Period 2|Lost to Follow-up|0|||
160822402|NCT01468233|580735869|FG004|Treatment Period 2|Lost to Follow-up|2|||
160822403|NCT01468233|580735870|FG005|Treatment Period 2|Lost to Follow-up|0|||
160822404|NCT01468233|580735865|FG000|Treatment Period 2|Other|0|||
160822405|NCT01468233|580735866|FG001|Treatment Period 2|Other|0|||
160822406|NCT01468233|580735867|FG002|Treatment Period 2|Other|3|||
160822407|NCT01468233|580735868|FG003|Treatment Period 2|Other|0|||
160822408|NCT01468233|580735869|FG004|Treatment Period 2|Other|1|||
160822409|NCT01468233|580735870|FG005|Treatment Period 2|Other|0|||
160822410|NCT01574157|580735874|FG000|Overall Study|Withdrawal by Subject|4|||
160822411|NCT01574157|580735875|FG001|Overall Study|Withdrawal by Subject|5|||
160822412|NCT01574157|580735874|FG000|Overall Study|Lost to Follow-up|0|||
160822413|NCT01574157|580735875|FG001|Overall Study|Lost to Follow-up|3|||
160822414|NCT01944098|580735876|FG000|Overall Study|Physician Decision|1|||
160822415|NCT01944098|580735877|FG001|Overall Study|Physician Decision|0|||
160822416|NCT02136680|580735878|FG000|Overall Study|No Longer Interested|1|||
160822417|NCT02136680|580735879|FG001|Overall Study|No Longer Interested|1|||
160822418|NCT02136680|580735878|FG000|Overall Study|No longer receiving care at clinic|3|||
160822419|NCT02136680|580735879|FG001|Overall Study|No longer receiving care at clinic|5|||
160822420|NCT02136680|580735878|FG000|Overall Study|Moved away|5|||
160822421|NCT02136680|580735879|FG001|Overall Study|Moved away|4|||
160822422|NCT02136680|580735878|FG000|Overall Study|Unable to schedule|17|||
160822423|NCT02136680|580735879|FG001|Overall Study|Unable to schedule|16|||
160822424|NCT02136680|580735878|FG000|Overall Study|Study ended before interview due|6|||
160822425|NCT02136680|580735879|FG001|Overall Study|Study ended before interview due|3|||
160822426|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
160822427|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
160822428|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
160822429|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
160822430|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
160822431|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
160822432|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
160822433|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
160822434|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
160822435|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
160822436|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
160822437|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
160822438|NCT01632241|580735880|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
160822439|NCT01632241|580735881|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
160822440|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
160822441|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
160822442|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
160822443|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
160822444|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
160822445|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
160822446|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
160822447|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
160822448|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
160822449|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
160822450|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
160822451|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
160822452|NCT01632241|580735880|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
160822453|NCT01632241|580735881|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
160822454|NCT01846299|580735887|FG000|Overall Study|Physician Decision|4|||
160822455|NCT01846299|580735888|FG001|Overall Study|Physician Decision|2|||
160822456|NCT01846299|580735887|FG000|Overall Study|Protocol deviation|1|||
160822457|NCT01846299|580735888|FG001|Overall Study|Protocol deviation|0|||
160822458|NCT01846299|580735887|FG000|Overall Study|Death|1|||
160822459|NCT01846299|580735888|FG001|Overall Study|Death|2|||
160822460|NCT01846299|580735887|FG000|Overall Study|Lost to Follow-up|3|||
160822461|NCT01846299|580735888|FG001|Overall Study|Lost to Follow-up|0|||
160822462|NCT01846299|580735887|FG000|Overall Study|Withdrawal by Subject|1|||
160822463|NCT01846299|580735888|FG001|Overall Study|Withdrawal by Subject|6|||
160901705|NCT02713204|581034071|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901706|NCT02713204|581034072|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160901707|NCT02713204|581034073|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
160822464|NCT01846299|580735887|FG000|Overall Study|Adverse Event|2|||
160822465|NCT01846299|580735888|FG001|Overall Study|Adverse Event|0|||
160822466|NCT03559517|580735889|FG000|Overall Study|Withdrawal by Subject|1|||
160822467|NCT03559517|580735890|FG001|Overall Study|Withdrawal by Subject|0|||
160901708|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Adverse Event|1|||
160822468|NCT03559517|580735891|FG002|Overall Study|Withdrawal by Subject|0|||
160901709|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Adverse Event|0|||
160822469|NCT01330628|580735892|FG000|Overall Study|Death|2|||
161133170|NCT01015833|581870838|FG001|Overall Study|Adverse Event|1|||
160822470|NCT01330628|580735893|FG001|Overall Study|Death|3|||
160822471|NCT01330628|580735892|FG000|Overall Study|Lost to Follow-up|5|||
160822472|NCT01330628|580735893|FG001|Overall Study|Lost to Follow-up|6|||
160822473|NCT01330628|580735892|FG000|Overall Study|Adverse Event|44|||
160822474|NCT01330628|580735893|FG001|Overall Study|Adverse Event|25|||
160822475|NCT01330628|580735892|FG000|Overall Study|Withdrawn|18|||
160822476|NCT01330628|580735893|FG001|Overall Study|Withdrawn|6|||
160822477|NCT01330628|580735892|FG000|Overall Study|Didn't receive study treatment|1|||
160822478|NCT01330628|580735893|FG001|Overall Study|Didn't receive study treatment|0|||
160822479|NCT03761394|580735894|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
160822480|NCT03761394|580735895|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
160822481|NCT03761394|580735896|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
160822482|NCT03761394|580735897|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
160822483|NCT03761394|580735894|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
160822484|NCT03761394|580735895|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
160822485|NCT03761394|580735896|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
160822486|NCT03761394|580735897|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
160822487|NCT03761394|580735894|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
160822488|NCT03761394|580735895|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
160822489|NCT03761394|580735896|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
160822490|NCT03761394|580735897|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
160822491|NCT03761394|580735894|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
160822492|NCT03761394|580735895|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
160822493|NCT03761394|580735896|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
160822494|NCT03761394|580735897|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
160822495|NCT01080768|580735907|FG000|Overall Study|Protocol Deviation|2|||
160822496|NCT01080768|580735908|FG001|Overall Study|Protocol Deviation|1|||
160822497|NCT00580034|580735919|FG000|Overall Study|Toxicity|10|||
160822498|NCT00580034|580735920|FG001|Overall Study|Toxicity|0|||
160822499|NCT01939002|580735921|FG000|Overall Study|Adverse Event|13|||
160822500|NCT01939002|580735922|FG001|Overall Study|Adverse Event|13|||
160822501|NCT01939002|580735921|FG000|Overall Study|Withdrawal by Subject|5|||
160822502|NCT01939002|580735922|FG001|Overall Study|Withdrawal by Subject|3|||
160822503|NCT01939002|580735921|FG000|Overall Study|Other|1|||
160822504|NCT01939002|580735922|FG001|Overall Study|Other|2|||
160822505|NCT00098748|580735926|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
160822506|NCT00098748|580735927|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
160822507|NCT00098748|580735928|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
160822508|NCT00098748|580735926|FG000|Received Study Treatment|Death|2|||
160822509|NCT00098748|580735927|FG001|Received Study Treatment|Death|1|||
160822510|NCT00098748|580735928|FG002|Received Study Treatment|Death|2|||
160822511|NCT00098748|580735926|FG000|Received Study Treatment|Adverse Event|1|||
160822512|NCT00098748|580735927|FG001|Received Study Treatment|Adverse Event|2|||
160822513|NCT00098748|580735928|FG002|Received Study Treatment|Adverse Event|5|||
160822514|NCT00098748|580735926|FG000|Received Study Treatment|Lack of Efficacy|40|||
160822515|NCT00098748|580735927|FG001|Received Study Treatment|Lack of Efficacy|27|||
160822516|NCT00098748|580735928|FG002|Received Study Treatment|Lack of Efficacy|27|||
160822517|NCT00098748|580735926|FG000|Received Study Treatment|Other|2|||
160822518|NCT00098748|580735927|FG001|Received Study Treatment|Other|2|||
160822519|NCT00098748|580735928|FG002|Received Study Treatment|Other|6|||
161133171|NCT01015833|581870837|FG000|Overall Study|Physician Decision|2|||
160822520|NCT00098748|580735926|FG000|Received Study Treatment|Subject defaulted|3|||
160822521|NCT00098748|580735927|FG001|Received Study Treatment|Subject defaulted|4|||
160822522|NCT00098748|580735928|FG002|Received Study Treatment|Subject defaulted|4|||
160822523|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
160822524|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
160822525|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
160822526|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
160822527|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
160822528|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
160822529|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
160822530|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
160822531|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
160822532|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
160822533|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
160822534|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
160822535|NCT00098748|580735926|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
160822536|NCT00098748|580735927|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
161133172|NCT01015833|581870838|FG001|Overall Study|Physician Decision|0|||
160989334|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989335|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989336|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
160989337|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
160989338|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Death|0|||
160989339|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Death|0|||
160989340|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Death|0|||
160989341|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Death|0|||
160989342|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Death|1|||
160989343|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Death|0|||
160989344|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989345|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989346|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989347|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
160989348|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
160989349|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
160989350|NCT05074498|581349499|FG000|Part 2 (Upto Day 104)|Other|0|||
160989351|NCT05074498|581349500|FG001|Part 2 (Upto Day 104)|Other|0|||
160989352|NCT05074498|581349501|FG002|Part 2 (Upto Day 104)|Other|0|||
160989353|NCT05074498|581349502|FG003|Part 2 (Upto Day 104)|Other|0|||
160989354|NCT05074498|581349503|FG004|Part 2 (Upto Day 104)|Other|1|||
160989355|NCT05074498|581349504|FG005|Part 2 (Upto Day 104)|Other|0|||
160989356|NCT01677936|581349507|FG000|Overall Study|Lost to Follow-up|4|||
160989357|NCT01677936|581349508|FG001|Overall Study|Lost to Follow-up|1|||
160822537|NCT00098748|580735928|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
160989358|NCT01677936|581349507|FG000|Overall Study|Protocol Violation|3|||
160989359|NCT01677936|581349508|FG001|Overall Study|Protocol Violation|0|||
160989360|NCT01677936|581349507|FG000|Overall Study|Adverse Event|1|||
160989361|NCT01677936|581349508|FG001|Overall Study|Adverse Event|0|||
160989362|NCT01677936|581349507|FG000|Overall Study|Lost to Follow-up|1|||
160989363|NCT01677936|581349508|FG001|Overall Study|Lost to Follow-up|0|||
160989364|NCT01677936|581349507|FG000|Overall Study|Protocol Violation|0|||
160989365|NCT01677936|581349508|FG001|Overall Study|Protocol Violation|4|||
160989366|NCT01257503|581349512|FG000|Overall Study|Lost to Follow-up|7|||
160989367|NCT01257503|581349513|FG001|Overall Study|Lost to Follow-up|10|||
160989368|NCT01257503|581349512|FG000|Overall Study|Over 5 years old at enrollment|0|||
160989369|NCT01257503|581349513|FG001|Overall Study|Over 5 years old at enrollment|1|||
160989370|NCT01257503|581349512|FG000|Overall Study|strep culture positive at enrollment|1|||
160989371|NCT01257503|581349513|FG001|Overall Study|strep culture positive at enrollment|0|||
160989372|NCT00088465|581349514|FG000|Overall Study|Withdrawal by Subject|290|||
160989373|NCT00088465|581349514|FG000|Overall Study|Adverse Event|77|||
160989374|NCT00088465|581349514|FG000|Overall Study|Lost to Follow-up|57|||
160989375|NCT00088465|581349514|FG000|Overall Study|Physician Decision|45|||
160989376|NCT00088465|581349514|FG000|Overall Study|Sponsor Decision|37|||
160989377|NCT00088465|581349514|FG000|Overall Study|Lack of Efficacy|27|||
160822538|NCT03095027|580737723|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
160822539|NCT03095027|580737724|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
160822540|NCT02982018|580737725|FG000|Overall Study|Incorrect Lens Dispensed|1|||
160822541|NCT02982018|580737726|FG001|Overall Study|Incorrect Lens Dispensed|0|||
160822542|NCT02982018|580737725|FG000|Overall Study|Protocol Violation|1|||
160822543|NCT02982018|580737726|FG001|Overall Study|Protocol Violation|1|||
160822544|NCT02982018|580737725|FG000|Overall Study|Adverse Event|1|||
160822545|NCT02982018|580737726|FG001|Overall Study|Adverse Event|1|||
160989378|NCT00088465|581349514|FG000|Overall Study|Protocol Violation|17|||
160989379|NCT00088465|581349514|FG000|Overall Study|Death|11|||
160989380|NCT04565249|581349515|FG000|Overall Study|Death|0|||
160989381|NCT04565249|581349516|FG001|Overall Study|Death|0|||
160989382|NCT04565249|581349517|FG002|Overall Study|Death|0|||
160989383|NCT04565249|581349518|FG003|Overall Study|Death|1|||
160822546|NCT02982018|580737725|FG000|Overall Study|Lens Discomfort|2|||
160989384|NCT02333630|581349519|FG000|Overall Study|Lost to Follow-up|5|||
160989385|NCT02333630|581349520|FG001|Overall Study|Lost to Follow-up|2|||
160989386|NCT04337489|581349527|FG000|Overall Study|Withdrawal by Subject|1|||
160989387|NCT03255941|581349528|FG000|Overall Study|Not eligible or refused injection|37|||
160989388|NCT03255941|581349529|FG001|Overall Study|Not eligible or refused injection|44|||
160989389|NCT03255941|581349530|FG002|Overall Study|Not eligible or refused injection|5|||
160989390|NCT03255941|581349531|FG003|Overall Study|Not eligible or refused injection|6|||
160822547|NCT02982018|580737726|FG001|Overall Study|Lens Discomfort|0|||
160822548|NCT02982018|580737725|FG000|Overall Study|Withdrawal by Subject|0|||
160989391|NCT03255941|581349528|FG000|Overall Study|Did not complete exit interview|1|||
160822549|NCT02982018|580737726|FG001|Overall Study|Withdrawal by Subject|1|||
160822550|NCT03361189|580737730|FG000|Overall Study|Received heart transplant|1|||
160822551|NCT03361189|580737731|FG001|Overall Study|Received heart transplant|0|||
160989392|NCT03255941|581349529|FG001|Overall Study|Did not complete exit interview|2|||
160989393|NCT03255941|581349530|FG002|Overall Study|Did not complete exit interview|0|||
160989394|NCT03255941|581349531|FG003|Overall Study|Did not complete exit interview|0|||
160989395|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
160822552|NCT03361189|580737730|FG000|Overall Study|Pacemake replacement|0|||
160822553|NCT03361189|580737731|FG001|Overall Study|Pacemake replacement|1|||
160901710|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Adverse Event|0|||
160901711|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Adverse Event|1|||
160901712|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Adverse Event|1|||
160901713|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Adverse Event|0|||
160901714|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Adverse Event|2|||
160901715|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Adverse Event|1|||
160901716|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Death|0|||
160901717|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Death|0|||
160901718|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Death|0|||
160901719|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Death|1|||
160901720|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Death|0|||
160901721|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Death|1|||
160901722|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Death|0|||
160901723|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Death|3|||
160901724|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901725|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
160989396|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
160989397|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
160989398|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
160989399|NCT00335153|581349543|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
160989400|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
160989401|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
160989402|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
160989403|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
160989404|NCT00335153|581349543|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
160989405|NCT01528709|581349544|FG000|Overall Study|Death|2|||
160989406|NCT01528709|581349545|FG001|Overall Study|Death|0|||
160989407|NCT01528709|581349544|FG000|Overall Study|Withdrawal by Subject|10|||
160989408|NCT01528709|581349545|FG001|Overall Study|Withdrawal by Subject|15|||
161240716|NCT05919823|582262102|FG003|Open Label Period|Other reasons|5|||
161240717|NCT01648582|582262103|FG000|Overall Study|Adverse Event|6|||
160989409|NCT01528709|581349544|FG000|Overall Study|allergy|1|||
160989410|NCT01528709|581349545|FG001|Overall Study|allergy|0|||
160989411|NCT03398356|581349548|FG000|Before Treatment|Lost to Follow-up|1|||
160989412|NCT03398356|581349549|FG001|Before Treatment|Lost to Follow-up|2|||
160989413|NCT03398356|581349550|FG002|Before Treatment|Lost to Follow-up|0|||
160989414|NCT03398356|581349548|FG000|Before Treatment|drug intolerance|2|||
160989415|NCT03398356|581349549|FG001|Before Treatment|drug intolerance|1|||
160989416|NCT03398356|581349550|FG002|Before Treatment|drug intolerance|0|||
160822554|NCT03344549|580737732|FG000|Overall Study|Withdrawal by Subject|3|||
160822555|NCT03344549|580737733|FG001|Overall Study|Withdrawal by Subject|2|||
160822556|NCT03344549|580737732|FG000|Overall Study|Dialysis|2|||
160822557|NCT03344549|580737733|FG001|Overall Study|Dialysis|0|||
160822558|NCT03344549|580737732|FG000|Overall Study|Cancer|1|||
160822559|NCT03344549|580737733|FG001|Overall Study|Cancer|0|||
160822560|NCT03344549|580737732|FG000|Overall Study|Lack of electronic device|1|||
160822561|NCT03344549|580737733|FG001|Overall Study|Lack of electronic device|0|||
160822562|NCT03344549|580737732|FG000|Overall Study|Transportation difficulty|0|||
160822563|NCT03344549|580737733|FG001|Overall Study|Transportation difficulty|13|||
160822564|NCT01685801|580737739|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
160822565|NCT01685801|580737740|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
160822566|NCT01685801|580737741|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
160822567|NCT01685801|580737742|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
160822568|NCT01685801|580737739|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
160822569|NCT01685801|580737740|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
160822570|NCT01685801|580737741|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
160822571|NCT01685801|580737742|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
160822572|NCT00113399|580737743|FG000|Overall Study|Death|1|||
160822573|NCT00113399|580737744|FG001|Overall Study|Death|1|||
160822574|NCT00113399|580737743|FG000|Overall Study|Withdrawal by Subject|1|||
160822575|NCT00113399|580737744|FG001|Overall Study|Withdrawal by Subject|2|||
160822576|NCT00113399|580737743|FG000|Overall Study|Complete Response|0|||
160901726|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901727|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
160989417|NCT03398356|581349548|FG000|Before Treatment|Withdrawal by Subject|0|||
161240718|NCT01648582|582262104|FG001|Overall Study|Adverse Event|11|||
161240719|NCT01648582|582262105|FG002|Overall Study|Adverse Event|2|||
161240720|NCT01648582|582262103|FG000|Overall Study|Lost to Follow-up|9|||
160822577|NCT00113399|580737744|FG001|Overall Study|Complete Response|1|||
160822578|NCT00113399|580737743|FG000|Overall Study|Other|0|||
160822579|NCT00113399|580737744|FG001|Overall Study|Other|1|||
160822580|NCT00666588|580737745|FG000|Overall Study|ineligible|2|||
160822581|NCT00666588|580737746|FG001|Overall Study|ineligible|0|||
160822582|NCT00666588|580737747|FG002|Overall Study|ineligible|0|||
160901728|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
160989418|NCT03398356|581349549|FG001|Before Treatment|Withdrawal by Subject|5|||
161240721|NCT01648582|582262104|FG001|Overall Study|Lost to Follow-up|6|||
161240722|NCT01648582|582262105|FG002|Overall Study|Lost to Follow-up|8|||
161240723|NCT01648582|582262103|FG000|Overall Study|Protocol Violation|1|||
161240724|NCT01648582|582262104|FG001|Overall Study|Protocol Violation|2|||
161240725|NCT01648582|582262105|FG002|Overall Study|Protocol Violation|1|||
161240726|NCT01648582|582262103|FG000|Overall Study|Withdrawal by Subject|15|||
160822583|NCT00666588|580737748|FG003|Overall Study|ineligible|2|||
160822584|NCT00666588|580737745|FG000|Overall Study|inevaluable|2|||
160989419|NCT03398356|581349550|FG002|Before Treatment|Withdrawal by Subject|0|||
160989420|NCT03398356|581349548|FG000|Before Treatment|Physician Decision|0|||
160989421|NCT03398356|581349549|FG001|Before Treatment|Physician Decision|0|||
160989422|NCT03398356|581349550|FG002|Before Treatment|Physician Decision|11|||
160989423|NCT03398356|581349548|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
160989424|NCT03398356|581349549|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
160989425|NCT03398356|581349550|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
160989426|NCT04438785|581349553|FG000|Overall Study|change of weight, give up intervention|2|||
160989427|NCT04438785|581349554|FG001|Overall Study|change of weight, give up intervention|10|||
160989428|NCT04831775|581349555|FG000|Overall Study|Lost to Follow-up|11|||
160989429|NCT04831775|581349556|FG001|Overall Study|Lost to Follow-up|13|||
160989430|NCT02027935|581349557|FG000|Overall Study|Death|1|||
160989431|NCT02027935|581349557|FG000|Overall Study|Lack of Efficacy|5|||
160989432|NCT02027935|581349557|FG000|Overall Study|Study Closure|1|||
160989433|NCT00689104|581349558|FG000|Overall Study|Eligibility criterion not met|5|||
160989434|NCT00689104|581349559|FG001|Overall Study|Eligibility criterion not met|8|||
160989435|NCT00689104|581349560|FG002|Overall Study|Eligibility criterion not met|0|||
160989436|NCT00689104|581349561|FG003|Overall Study|Eligibility criterion not met|4|||
160989437|NCT00689104|581349558|FG000|Overall Study|Adverse Event|13|||
160989438|NCT00689104|581349559|FG001|Overall Study|Adverse Event|25|||
160989439|NCT00689104|581349560|FG002|Overall Study|Adverse Event|16|||
160989440|NCT00689104|581349561|FG003|Overall Study|Adverse Event|24|||
160989441|NCT00689104|581349558|FG000|Overall Study|Lack of Efficacy|5|||
160989442|NCT00689104|581349559|FG001|Overall Study|Lack of Efficacy|6|||
160989443|NCT00689104|581349560|FG002|Overall Study|Lack of Efficacy|2|||
160989444|NCT00689104|581349561|FG003|Overall Study|Lack of Efficacy|3|||
160989445|NCT00689104|581349558|FG000|Overall Study|Withdrawal by Subject|12|||
160989446|NCT00689104|581349559|FG001|Overall Study|Withdrawal by Subject|11|||
160989447|NCT00689104|581349560|FG002|Overall Study|Withdrawal by Subject|18|||
160989448|NCT00689104|581349561|FG003|Overall Study|Withdrawal by Subject|11|||
160989449|NCT00689104|581349558|FG000|Overall Study|Lost to Follow-up|4|||
160989450|NCT00689104|581349559|FG001|Overall Study|Lost to Follow-up|3|||
160989451|NCT00689104|581349560|FG002|Overall Study|Lost to Follow-up|2|||
160989452|NCT00689104|581349561|FG003|Overall Study|Lost to Follow-up|5|||
160989453|NCT00689104|581349558|FG000|Overall Study|Protocol Violation|2|||
160989454|NCT00689104|581349559|FG001|Overall Study|Protocol Violation|3|||
160989455|NCT00689104|581349560|FG002|Overall Study|Protocol Violation|5|||
160989456|NCT00689104|581349561|FG003|Overall Study|Protocol Violation|3|||
160989457|NCT00689104|581349558|FG000|Overall Study|Randomized but never received study drug|2|||
160989458|NCT00689104|581349559|FG001|Overall Study|Randomized but never received study drug|1|||
160989459|NCT00689104|581349560|FG002|Overall Study|Randomized but never received study drug|1|||
160989460|NCT00689104|581349561|FG003|Overall Study|Randomized but never received study drug|0|||
160989461|NCT00689104|581349558|FG000|Overall Study|Physician Decision|1|||
160989462|NCT00689104|581349559|FG001|Overall Study|Physician Decision|0|||
160989463|NCT00689104|581349560|FG002|Overall Study|Physician Decision|0|||
160989464|NCT00689104|581349561|FG003|Overall Study|Physician Decision|0|||
160822585|NCT00666588|580737746|FG001|Overall Study|inevaluable|0|||
160822586|NCT00666588|580737747|FG002|Overall Study|inevaluable|0|||
160822587|NCT00666588|580737748|FG003|Overall Study|inevaluable|0|||
160822588|NCT03405935|580737755|FG000|Overall Study|Adverse Event|3|||
160989465|NCT00689104|581349558|FG000|Overall Study|Non-compliance with study procedures|0|||
160989466|NCT00689104|581349559|FG001|Overall Study|Non-compliance with study procedures|0|||
160989467|NCT00689104|581349560|FG002|Overall Study|Non-compliance with study procedures|1|||
160989468|NCT00689104|581349561|FG003|Overall Study|Non-compliance with study procedures|0|||
160989469|NCT01737268|581349562|FG000|Overall Study|Adverse Event|6|||
160989470|NCT01737268|581349562|FG000|Overall Study|Worsening of Target Disease|2|||
161240727|NCT01648582|582262104|FG001|Overall Study|Withdrawal by Subject|17|||
161240728|NCT01648582|582262105|FG002|Overall Study|Withdrawal by Subject|17|||
161240729|NCT01648582|582262103|FG000|Overall Study|Physician Decision|0|||
161240730|NCT01648582|582262104|FG001|Overall Study|Physician Decision|1|||
161240731|NCT01648582|582262105|FG002|Overall Study|Physician Decision|3|||
160822589|NCT03405935|580737755|FG000|Overall Study|Death|2|||
160822590|NCT03405935|580737755|FG000|Overall Study|Withdrawal by Subject|1|||
160822591|NCT03405935|580737755|FG000|Overall Study|Lost to Follow-up|2|||
160822592|NCT04979897|580737761|FG000|Overall Study|Death|1|||
160989471|NCT01737268|581349562|FG000|Overall Study|In consideration of the patient's safety|1|||
160989472|NCT04873817|581349563|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
160989473|NCT04873817|581349563|FG000|Overall Study|Lost to Follow-up|4|||
160989474|NCT04873817|581349563|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
160989475|NCT04873817|581349563|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
160989476|NCT04873817|581349563|FG000|Overall Study|Other Reasons|3|||
160989477|NCT02696226|581349571|FG000|Overall Study|Study terminated - lack of enrollment|1|||
160989478|NCT02696226|581349572|FG001|Overall Study|Study terminated - lack of enrollment|0|||
160989479|NCT02696226|581349573|FG002|Overall Study|Study terminated - lack of enrollment|2|||
160989480|NCT02696226|581349574|FG003|Overall Study|Study terminated - lack of enrollment|0|||
160989481|NCT01394991|581349577|FG000|Overall Study|Adverse Event|0|||
160989482|NCT01394991|581349578|FG001|Overall Study|Adverse Event|4|||
160989483|NCT01394991|581349577|FG000|Overall Study|Lack of Efficacy|5|||
160989484|NCT01394991|581349578|FG001|Overall Study|Lack of Efficacy|7|||
160822593|NCT04979897|580737762|FG001|Overall Study|Death|8|||
160822594|NCT04979897|580737761|FG000|Overall Study|Lost to Follow-up|111|||
160822595|NCT04979897|580737762|FG001|Overall Study|Lost to Follow-up|56|||
160822596|NCT04979897|580737761|FG000|Overall Study|Withdrawal by Subject|7|||
160822597|NCT04979897|580737762|FG001|Overall Study|Withdrawal by Subject|2|||
160822598|NCT01774097|580737763|FG000|Overall Study|Withdrawal by Subject|1|||
160822599|NCT01774097|580737764|FG001|Overall Study|Withdrawal by Subject|1|||
160822600|NCT01774097|580737763|FG000|Overall Study|Adverse Event|1|||
160989485|NCT01394991|581349577|FG000|Overall Study|Lost to Follow-up|6|||
160989486|NCT01394991|581349578|FG001|Overall Study|Lost to Follow-up|8|||
160989487|NCT01394991|581349577|FG000|Overall Study|Physician Decision|1|||
160989488|NCT01394991|581349578|FG001|Overall Study|Physician Decision|3|||
160822601|NCT01774097|580737764|FG001|Overall Study|Adverse Event|1|||
160822602|NCT00543296|580737766|FG000|Overall Study|Physician Decision|7|||
160822603|NCT03136497|580737767|FG000|Overall Study|Screen Failure|1|||
160822604|NCT03136497|580737768|FG001|Overall Study|Screen Failure|0|||
160822605|NCT03136497|580737769|FG002|Overall Study|Screen Failure|0|||
160989489|NCT01394991|581349577|FG000|Overall Study|Protocol Violation|1|||
160989490|NCT01394991|581349578|FG001|Overall Study|Protocol Violation|1|||
160989491|NCT01394991|581349577|FG000|Overall Study|Withdrawal by Subject|20|||
160989492|NCT01394991|581349578|FG001|Overall Study|Withdrawal by Subject|17|||
160989493|NCT01394991|581349577|FG000|Overall Study|Chemotherapy Termination|10|||
161133173|NCT01015833|581870837|FG000|Overall Study|Symptomatic deterioration|0|||
161133174|NCT01015833|581870838|FG001|Overall Study|Symptomatic deterioration|1|||
161133175|NCT01015833|581870837|FG000|Overall Study|Other|5|||
160822606|NCT00934947|580737772|FG000|Overall Study|Adverse Event|0|||
160822607|NCT00934947|580737773|FG001|Overall Study|Adverse Event|2|||
161133176|NCT01015833|581870838|FG001|Overall Study|Other|1|||
161133177|NCT01015833|581870837|FG000|Overall Study|Motor Vehicle Accidents|1|||
160822608|NCT00557310|580737774|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
160822609|NCT00557310|580737774|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
160822610|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
160822611|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
160822612|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
160822613|NCT00557310|580737774|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
160822614|NCT02781792|580737776|FG000|Overall Study|Adverse Event|1|||
160822615|NCT02781792|580737777|FG001|Overall Study|Adverse Event|2|||
160822616|NCT02781792|580737776|FG000|Overall Study|Withdrawal by Subject|3|||
160822617|NCT02781792|580737777|FG001|Overall Study|Withdrawal by Subject|1|||
160822618|NCT02781792|580737776|FG000|Overall Study|Lack of Efficacy|1|||
160822619|NCT02781792|580737777|FG001|Overall Study|Lack of Efficacy|1|||
160989494|NCT01394991|581349578|FG001|Overall Study|Chemotherapy Termination|15|||
160989495|NCT01394991|581349577|FG000|Overall Study|Disease Progression|7|||
161133178|NCT01015833|581870838|FG001|Overall Study|Motor Vehicle Accidents|0|||
161133179|NCT01015833|581870837|FG000|Overall Study|Did not start treatment|1|||
161133180|NCT01015833|581870838|FG001|Overall Study|Did not start treatment|0|||
161133181|NCT02040142|581870839|FG000|Overall Study|Lost to Follow-up|5|||
161133182|NCT02040142|581870839|FG000|Overall Study|Death|17|||
161133183|NCT02040142|581870839|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
161133184|NCT03538743|581870840|FG000|Overall Study|Adverse Event|0|||
161133185|NCT03538743|581870841|FG001|Overall Study|Adverse Event|0|||
161133186|NCT03538743|581870842|FG002|Overall Study|Adverse Event|1|||
161133187|NCT03538743|581870843|FG003|Overall Study|Adverse Event|1|||
161133188|NCT03538743|581870844|FG004|Overall Study|Adverse Event|0|||
161133189|NCT03538743|581870845|FG005|Overall Study|Adverse Event|0|||
161133190|NCT03538743|581870846|FG006|Overall Study|Adverse Event|0|||
161133191|NCT03538743|581870847|FG007|Overall Study|Adverse Event|0|||
161133192|NCT03538743|581870848|FG008|Overall Study|Adverse Event|0|||
160822620|NCT02781792|580737776|FG000|Overall Study|Hospice|0|||
160989496|NCT01394991|581349578|FG001|Overall Study|Disease Progression|7|||
160989497|NCT01394991|581349577|FG000|Overall Study|Prematurely Termination of Trial|9|||
161133193|NCT03538743|581870840|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
161133194|NCT03538743|581870841|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
161133195|NCT03538743|581870842|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
161133196|NCT03538743|581870843|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
161133197|NCT03538743|581870844|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
161133198|NCT03538743|581870845|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
161133199|NCT03538743|581870846|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
160822621|NCT02781792|580737777|FG001|Overall Study|Hospice|1|||
160822622|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
160822623|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
160822624|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
160822625|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
160822626|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
160822627|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
160822628|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
160822629|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822630|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822631|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822632|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
160822633|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
160822634|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160901729|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901730|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901731|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
160901732|NCT02713204|581034066|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
160901733|NCT02713204|581034067|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
160901734|NCT02713204|581034068|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
160901735|NCT02713204|581034069|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
160901736|NCT02713204|581034070|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
160901737|NCT02713204|581034071|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
160901738|NCT02713204|581034072|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
160901739|NCT02713204|581034073|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
160901740|NCT00474760|581034077|FG000|Overall Study|Death|0|||
160901741|NCT00474760|581034078|FG001|Overall Study|Death|0|||
160901742|NCT00474760|581034079|FG002|Overall Study|Death|0|||
160901743|NCT00474760|581034080|FG003|Overall Study|Death|0|||
160901744|NCT00474760|581034081|FG004|Overall Study|Death|2|||
160901745|NCT00474760|581034082|FG005|Overall Study|Death|0|||
160901746|NCT00474760|581034083|FG006|Overall Study|Death|0|||
160901747|NCT00474760|581034077|FG000|Overall Study|Adverse Event|0|||
160901748|NCT00474760|581034078|FG001|Overall Study|Adverse Event|0|||
160901749|NCT00474760|581034079|FG002|Overall Study|Adverse Event|0|||
160901750|NCT00474760|581034080|FG003|Overall Study|Adverse Event|0|||
160901751|NCT00474760|581034081|FG004|Overall Study|Adverse Event|1|||
160901752|NCT00474760|581034082|FG005|Overall Study|Adverse Event|7|||
160901753|NCT00474760|581034083|FG006|Overall Study|Adverse Event|0|||
160901754|NCT00474760|581034077|FG000|Overall Study|Laboratory abnormality|0|||
160901755|NCT00474760|581034078|FG001|Overall Study|Laboratory abnormality|0|||
160901756|NCT00474760|581034079|FG002|Overall Study|Laboratory abnormality|0|||
160901757|NCT00474760|581034080|FG003|Overall Study|Laboratory abnormality|0|||
160901758|NCT00474760|581034081|FG004|Overall Study|Laboratory abnormality|0|||
160901759|NCT00474760|581034082|FG005|Overall Study|Laboratory abnormality|1|||
160901760|NCT00474760|581034083|FG006|Overall Study|Laboratory abnormality|0|||
160901761|NCT00474760|581034077|FG000|Overall Study|Withdrawal by Subject|0|||
160901762|NCT00474760|581034078|FG001|Overall Study|Withdrawal by Subject|0|||
160901763|NCT00474760|581034079|FG002|Overall Study|Withdrawal by Subject|0|||
160901764|NCT00474760|581034080|FG003|Overall Study|Withdrawal by Subject|1|||
160901765|NCT00474760|581034081|FG004|Overall Study|Withdrawal by Subject|0|||
160901766|NCT00474760|581034082|FG005|Overall Study|Withdrawal by Subject|1|||
160901767|NCT00474760|581034083|FG006|Overall Study|Withdrawal by Subject|1|||
160901768|NCT00474760|581034077|FG000|Overall Study|Other|0|||
160901769|NCT00474760|581034078|FG001|Overall Study|Other|1|||
160901770|NCT00474760|581034079|FG002|Overall Study|Other|0|||
160901771|NCT00474760|581034080|FG003|Overall Study|Other|0|||
160901772|NCT00474760|581034081|FG004|Overall Study|Other|1|||
160901773|NCT00474760|581034082|FG005|Overall Study|Other|0|||
160901774|NCT00474760|581034083|FG006|Overall Study|Other|0|||
160901775|NCT00474760|581034077|FG000|Overall Study|Progressive disease|3|||
160901776|NCT00474760|581034078|FG001|Overall Study|Progressive disease|2|||
160901777|NCT00474760|581034079|FG002|Overall Study|Progressive disease|3|||
160901778|NCT00474760|581034080|FG003|Overall Study|Progressive disease|2|||
160901779|NCT00474760|581034081|FG004|Overall Study|Progressive disease|8|||
160901780|NCT00474760|581034082|FG005|Overall Study|Progressive disease|20|||
160901781|NCT00474760|581034083|FG006|Overall Study|Progressive disease|7|||
160901782|NCT00474760|581034077|FG000|Overall Study|Terminated by sponsor|0|||
160901783|NCT00474760|581034078|FG001|Overall Study|Terminated by sponsor|0|||
160901784|NCT00474760|581034079|FG002|Overall Study|Terminated by sponsor|0|||
160989498|NCT01394991|581349578|FG001|Overall Study|Prematurely Termination of Trial|10|||
160901785|NCT00474760|581034080|FG003|Overall Study|Terminated by sponsor|0|||
161133200|NCT03538743|581870847|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
161240732|NCT01648582|582262103|FG000|Overall Study|Death|1|||
160822635|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822636|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822637|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822638|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822639|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
160822640|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822641|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822642|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822643|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822644|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822645|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822646|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
160822647|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822648|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822649|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822650|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822651|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822652|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822653|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822654|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822655|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822656|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822657|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
160822658|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822659|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822660|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
160822661|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822662|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822663|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822664|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822665|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822666|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822667|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822668|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822669|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822670|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822671|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822672|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822673|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822674|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822675|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
160822676|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822677|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822678|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
160822679|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822680|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822681|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822682|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822683|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822684|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822685|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822686|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822687|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822688|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822689|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822690|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822691|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822692|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160822693|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
160901786|NCT00474760|581034081|FG004|Overall Study|Terminated by sponsor|0|||
160901787|NCT00474760|581034082|FG005|Overall Study|Terminated by sponsor|0|||
160901788|NCT00474760|581034083|FG006|Overall Study|Terminated by sponsor|2|||
160901789|NCT01927627|581034085|FG000|Overall Study|Adverse Event|3|||
160901790|NCT01927627|581034085|FG000|Overall Study|Lack of Efficacy|1|||
161240733|NCT01648582|582262104|FG001|Overall Study|Death|0|||
160989499|NCT02337361|581349580|FG000|3-month Follow-up|Lost to Follow-up|19|||
160989500|NCT02337361|581349581|FG001|3-month Follow-up|Lost to Follow-up|14|||
160989501|NCT02337361|581349580|FG000|6-month Follow-up|Lost to Follow-up|2|||
160989502|NCT02337361|581349581|FG001|6-month Follow-up|Lost to Follow-up|4|||
160989503|NCT03073005|581349582|FG000|Overall Study|Death|6|||
160989504|NCT03073005|581349583|FG001|Overall Study|Death|0|||
160989505|NCT03073005|581349584|FG002|Overall Study|Death|7|||
160989506|NCT03073005|581349585|FG003|Overall Study|Death|0|||
160989507|NCT03073005|581349582|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
160989508|NCT03073005|581349583|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
160989509|NCT03073005|581349584|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
160989510|NCT03073005|581349585|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
160989511|NCT03073005|581349582|FG000|Overall Study|Lost to Follow-up|2|||
160989512|NCT03073005|581349583|FG001|Overall Study|Lost to Follow-up|2|||
160989513|NCT03073005|581349584|FG002|Overall Study|Lost to Follow-up|1|||
160989514|NCT03073005|581349585|FG003|Overall Study|Lost to Follow-up|2|||
160989515|NCT03073005|581349582|FG000|Overall Study|Withdrawal by Subject|0|||
160989516|NCT03073005|581349583|FG001|Overall Study|Withdrawal by Subject|4|||
160989517|NCT03073005|581349584|FG002|Overall Study|Withdrawal by Subject|4|||
160989518|NCT03073005|581349585|FG003|Overall Study|Withdrawal by Subject|4|||
160989519|NCT00062868|581349593|FG000|Dose Level 1|Death|2|||
160989520|NCT00062868|581349594|FG001|Dose Level 1|Death|0|||
160989521|NCT00062868|581349595|FG002|Dose Level 1|Death|0|||
160989522|NCT00062868|581349596|FG003|Dose Level 1|Death|2|||
160989523|NCT00062868|581349597|FG004|Dose Level 1|Death|0|||
160989524|NCT00062868|581349598|FG005|Dose Level 1|Death|0|||
160989525|NCT00062868|581349599|FG006|Dose Level 1|Death|3|||
160989526|NCT00062868|581349600|FG007|Dose Level 1|Death|0|||
160989527|NCT00062868|581349601|FG008|Dose Level 1|Death|0|||
160989528|NCT00062868|581349602|FG009|Dose Level 1|Death|0|||
160989529|NCT00062868|581349603|FG010|Dose Level 1|Death|0|||
160989530|NCT00062868|581349604|FG011|Dose Level 1|Death|0|||
160989531|NCT00062868|581349605|FG012|Dose Level 1|Death|0|||
160989532|NCT00062868|581349606|FG013|Dose Level 1|Death|0|||
160989533|NCT00062868|581349607|FG014|Dose Level 1|Death|0|||
160989534|NCT00062868|581349608|FG015|Dose Level 1|Death|0|||
160989535|NCT00062868|581349609|FG016|Dose Level 1|Death|0|||
160989536|NCT00062868|581349610|FG017|Dose Level 1|Death|0|||
160989537|NCT00062868|581349611|FG018|Dose Level 1|Death|7|||
160989538|NCT00062868|581349612|FG019|Dose Level 1|Death|0|||
160989539|NCT00062868|581349613|FG020|Dose Level 1|Death|1|||
160989540|NCT00062868|581349593|FG000|Dose Level 1|Lost to Follow-up|0|||
160822694|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822695|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822696|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822697|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
161133201|NCT03538743|581870848|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
161133202|NCT03538743|581870840|FG000|Overall Study|Withdrawal by Subject|0|||
161133203|NCT03538743|581870841|FG001|Overall Study|Withdrawal by Subject|0|||
161133204|NCT03538743|581870842|FG002|Overall Study|Withdrawal by Subject|0|||
161133205|NCT03538743|581870843|FG003|Overall Study|Withdrawal by Subject|1|||
160822698|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822699|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822700|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822701|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160989541|NCT00062868|581349594|FG001|Dose Level 1|Lost to Follow-up|0|||
160989542|NCT00062868|581349595|FG002|Dose Level 1|Lost to Follow-up|0|||
160989543|NCT00062868|581349596|FG003|Dose Level 1|Lost to Follow-up|0|||
160989544|NCT00062868|581349597|FG004|Dose Level 1|Lost to Follow-up|0|||
161133206|NCT03538743|581870844|FG004|Overall Study|Withdrawal by Subject|0|||
161133207|NCT03538743|581870845|FG005|Overall Study|Withdrawal by Subject|0|||
160989545|NCT00062868|581349598|FG005|Dose Level 1|Lost to Follow-up|0|||
160989546|NCT00062868|581349599|FG006|Dose Level 1|Lost to Follow-up|0|||
160989547|NCT00062868|581349600|FG007|Dose Level 1|Lost to Follow-up|0|||
160989548|NCT00062868|581349601|FG008|Dose Level 1|Lost to Follow-up|0|||
160989549|NCT00062868|581349602|FG009|Dose Level 1|Lost to Follow-up|0|||
160989550|NCT00062868|581349603|FG010|Dose Level 1|Lost to Follow-up|0|||
160989551|NCT00062868|581349604|FG011|Dose Level 1|Lost to Follow-up|0|||
160989552|NCT00062868|581349605|FG012|Dose Level 1|Lost to Follow-up|1|||
160989553|NCT00062868|581349606|FG013|Dose Level 1|Lost to Follow-up|0|||
160989554|NCT00062868|581349607|FG014|Dose Level 1|Lost to Follow-up|0|||
160989555|NCT00062868|581349608|FG015|Dose Level 1|Lost to Follow-up|0|||
160989556|NCT00062868|581349609|FG016|Dose Level 1|Lost to Follow-up|0|||
160989557|NCT00062868|581349610|FG017|Dose Level 1|Lost to Follow-up|0|||
161133208|NCT03538743|581870846|FG006|Overall Study|Withdrawal by Subject|0|||
160989558|NCT00062868|581349611|FG018|Dose Level 1|Lost to Follow-up|2|||
160989559|NCT00062868|581349612|FG019|Dose Level 1|Lost to Follow-up|0|||
160989560|NCT00062868|581349613|FG020|Dose Level 1|Lost to Follow-up|1|||
160822702|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822703|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822704|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
160822705|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822706|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822707|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822708|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822709|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822710|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822711|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
160822712|NCT03447314|580737782|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822713|NCT03447314|580737783|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822714|NCT03447314|580737784|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822715|NCT03447314|580737785|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
160822716|NCT03447314|580737786|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822717|NCT03447314|580737787|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
160822718|NCT03447314|580737788|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822719|NCT03447314|580737789|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822720|NCT03447314|580737790|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822721|NCT03447314|580737791|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160989561|NCT00062868|581349593|FG000|Dose Level 2|Death|0|||
161133209|NCT03538743|581870847|FG007|Overall Study|Withdrawal by Subject|0|||
161133210|NCT03538743|581870848|FG008|Overall Study|Withdrawal by Subject|0|||
161334118|NCT04275336|582612501|FG001|Overall Study|Unscheduled venipuncture|13|||
160822722|NCT03447314|580737792|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822723|NCT03447314|580737793|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822724|NCT03447314|580737794|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822725|NCT03447314|580737795|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822726|NCT03447314|580737796|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822727|NCT03447314|580737797|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822728|NCT03447314|580737798|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822729|NCT03447314|580737799|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
160822730|NCT01920568|580737800|FG000|Overall Study|Adverse Event|27|||
160822731|NCT01920568|580737801|FG001|Overall Study|Adverse Event|8|||
160822732|NCT01920568|580737800|FG000|Overall Study|Protocol Violation|5|||
160822733|NCT01920568|580737801|FG001|Overall Study|Protocol Violation|3|||
160822734|NCT01920568|580737800|FG000|Overall Study|Lost to Follow-up|2|||
160822735|NCT01920568|580737801|FG001|Overall Study|Lost to Follow-up|2|||
160822736|NCT01920568|580737800|FG000|Overall Study|Physician Decision|13|||
160822737|NCT01920568|580737801|FG001|Overall Study|Physician Decision|4|||
160822738|NCT01920568|580737800|FG000|Overall Study|Withdrawal by Subject|79|||
160822739|NCT01920568|580737801|FG001|Overall Study|Withdrawal by Subject|55|||
160822740|NCT01920568|580737800|FG000|Overall Study|Death due to disease progression|25|||
160822741|NCT01920568|580737801|FG001|Overall Study|Death due to disease progression|12|||
160822742|NCT04049266|580737805|FG000|Overall Study|Adverse Event|16|||
160822743|NCT04049266|580737806|FG001|Overall Study|Adverse Event|9|||
160822744|NCT04049266|580737805|FG000|Overall Study|Non-compliance with study drug|0|||
160822745|NCT04049266|580737806|FG001|Overall Study|Non-compliance with study drug|3|||
160822746|NCT04049266|580737805|FG000|Overall Study|Withdrawal by Subject|6|||
160822747|NCT04049266|580737806|FG001|Overall Study|Withdrawal by Subject|10|||
160822748|NCT04049266|580737805|FG000|Overall Study|Lost to Follow-up|2|||
160822749|NCT04049266|580737806|FG001|Overall Study|Lost to Follow-up|2|||
160822750|NCT04049266|580737805|FG000|Overall Study|Progressive disease|11|||
160822751|NCT04049266|580737806|FG001|Overall Study|Progressive disease|2|||
160822752|NCT04049266|580737805|FG000|Overall Study|Physician Decision|1|||
160822753|NCT04049266|580737806|FG001|Overall Study|Physician Decision|0|||
160822754|NCT04049266|580737805|FG000|Overall Study|Patient moved out of state|1|||
160822755|NCT04049266|580737806|FG001|Overall Study|Patient moved out of state|0|||
160822756|NCT01703208|580737807|FG000|Overall Study|Death|61|||
160822757|NCT01703208|580737808|FG001|Overall Study|Death|48|||
160822758|NCT01703208|580737807|FG000|Overall Study|Lack of Efficacy|1|||
160822759|NCT01703208|580737808|FG001|Overall Study|Lack of Efficacy|2|||
160989562|NCT00062868|581349594|FG001|Dose Level 2|Death|3|||
160989563|NCT00062868|581349595|FG002|Dose Level 2|Death|0|||
161240734|NCT01648582|582262105|FG002|Overall Study|Death|0|||
161240735|NCT01648582|582262103|FG000|Overall Study|Sponsor Decision|0|||
161240736|NCT01648582|582262104|FG001|Overall Study|Sponsor Decision|1|||
161240737|NCT01648582|582262105|FG002|Overall Study|Sponsor Decision|1|||
161240738|NCT00466167|582262117|FG000|Overall Study|Adverse Event|8|||
161240739|NCT00466167|582262118|FG001|Overall Study|Adverse Event|8|||
160822760|NCT01703208|580737807|FG000|Overall Study|Lost to Follow-up|68|||
160822761|NCT01703208|580737808|FG001|Overall Study|Lost to Follow-up|62|||
160822762|NCT01703208|580737807|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160822763|NCT01703208|580737808|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160822764|NCT01703208|580737807|FG000|Overall Study|Excluded Medication|1|||
160822765|NCT01703208|580737808|FG001|Overall Study|Excluded Medication|2|||
160822766|NCT01703208|580737807|FG000|Overall Study|Site Discontinued Study Participation|23|||
160822767|NCT01703208|580737808|FG001|Overall Study|Site Discontinued Study Participation|27|||
160822768|NCT01703208|580737807|FG000|Overall Study|Physician Decision|11|||
160822769|NCT01703208|580737808|FG001|Overall Study|Physician Decision|13|||
160822770|NCT01703208|580737807|FG000|Overall Study|Progressive disease|2|||
160822771|NCT01703208|580737808|FG001|Overall Study|Progressive disease|2|||
160822772|NCT01703208|580737807|FG000|Overall Study|Protocol Violation|1|||
160822773|NCT01703208|580737808|FG001|Overall Study|Protocol Violation|1|||
160822774|NCT01703208|580737807|FG000|Overall Study|Study Terminated by Sponsor|1710|||
160822775|NCT01703208|580737808|FG001|Overall Study|Study Terminated by Sponsor|1716|||
160822776|NCT01703208|580737807|FG000|Overall Study|Withdrawal by Subject|205|||
160822777|NCT01703208|580737808|FG001|Overall Study|Withdrawal by Subject|209|||
160822778|NCT01703208|580737807|FG000|Overall Study|Adverse Event|14|||
160822779|NCT01703208|580737808|FG001|Overall Study|Adverse Event|19|||
160822780|NCT01703208|580737807|FG000|Overall Study|Technical Problems|0|||
160822781|NCT01703208|580737808|FG001|Overall Study|Technical Problems|1|||
160822782|NCT01703208|580737807|FG000|Overall Study|Protocol Deviation|2|||
160822783|NCT01703208|580737808|FG001|Overall Study|Protocol Deviation|0|||
160822784|NCT00252694|580737814|FG000|Overall Study|Withdrawal by Subject|83|||
160822785|NCT00252694|580737815|FG001|Overall Study|Withdrawal by Subject|91|||
160822786|NCT00252694|580737814|FG000|Overall Study|Death|36|||
160822787|NCT00252694|580737815|FG001|Overall Study|Death|34|||
160822788|NCT00252694|580737814|FG000|Overall Study|Mostly Lost to Follow Up|8|||
160822789|NCT00252694|580737815|FG001|Overall Study|Mostly Lost to Follow Up|13|||
160822790|NCT00252694|580737814|FG000|Overall Study|Patient Moving|17|||
160822791|NCT00252694|580737815|FG001|Overall Study|Patient Moving|16|||
160822792|NCT02378298|580737819|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
160822793|NCT02378298|580737820|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
160822794|NCT02378298|580737821|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
160822795|NCT02378298|580737819|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
160822796|NCT02378298|580737820|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
160822797|NCT02378298|580737821|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
160822798|NCT02378298|580737819|FG000|Surveillance (19-68 Weeks)|Death|1|||
160822799|NCT02378298|580737820|FG001|Surveillance (19-68 Weeks)|Death|0|||
160822800|NCT02378298|580737821|FG002|Surveillance (19-68 Weeks)|Death|0|||
160822801|NCT04669262|580737823|FG000|Overall Study|Withdrawal by Subject|0|||
160822802|NCT04669262|580737824|FG001|Overall Study|Withdrawal by Subject|0|||
160822803|NCT04669262|580737825|FG002|Overall Study|Withdrawal by Subject|0|||
160822804|NCT04669262|580737826|FG003|Overall Study|Withdrawal by Subject|1|||
160822805|NCT04669262|580737823|FG000|Overall Study|Randomized but Not Treated|0|||
160822806|NCT04669262|580737824|FG001|Overall Study|Randomized but Not Treated|1|||
160822807|NCT04669262|580737825|FG002|Overall Study|Randomized but Not Treated|0|||
160822808|NCT04669262|580737826|FG003|Overall Study|Randomized but Not Treated|0|||
160822809|NCT01638013|580737827|FG000|Overall Study|Adverse Event|36|||
160822810|NCT01638013|580737828|FG001|Overall Study|Adverse Event|29|||
160822811|NCT01638013|580737829|FG002|Overall Study|Adverse Event|48|||
160822812|NCT01638013|580737827|FG000|Overall Study|Lack of Efficacy|39|||
160822813|NCT01638013|580737828|FG001|Overall Study|Lack of Efficacy|11|||
160822814|NCT01638013|580737829|FG002|Overall Study|Lack of Efficacy|14|||
160822815|NCT01638013|580737827|FG000|Overall Study|Protocol Violation|10|||
160822816|NCT01638013|580737828|FG001|Overall Study|Protocol Violation|7|||
160822817|NCT01638013|580737829|FG002|Overall Study|Protocol Violation|11|||
160822818|NCT01638013|580737827|FG000|Overall Study|Met discontinuation criteria|4|||
160822819|NCT01638013|580737828|FG001|Overall Study|Met discontinuation criteria|0|||
160901791|NCT01927627|581034085|FG000|Overall Study|Financial Concerns|1|||
160822820|NCT01638013|580737829|FG002|Overall Study|Met discontinuation criteria|7|||
160901792|NCT02635776|581034086|FG000|Overall Study|Physician Decision|1|||
161240740|NCT00466167|582262119|FG002|Overall Study|Adverse Event|7|||
160822821|NCT01638013|580737827|FG000|Overall Study|Subject Lost to Follow up|1|||
160822822|NCT01638013|580737828|FG001|Overall Study|Subject Lost to Follow up|0|||
160901793|NCT02635776|581034087|FG001|Overall Study|Physician Decision|0|||
160901794|NCT02635776|581034086|FG000|Overall Study|Adverse Event|51|||
160901795|NCT02635776|581034087|FG001|Overall Study|Adverse Event|3|||
160822823|NCT01638013|580737829|FG002|Overall Study|Subject Lost to Follow up|1|||
160822824|NCT01638013|580737827|FG000|Overall Study|Miscellaneous|25|||
160822825|NCT01638013|580737828|FG001|Overall Study|Miscellaneous|19|||
160822826|NCT01638013|580737829|FG002|Overall Study|Miscellaneous|23|||
160822827|NCT01638013|580737827|FG000|Overall Study|Withdrawal of Consent|16|||
160822828|NCT01638013|580737828|FG001|Overall Study|Withdrawal of Consent|12|||
160822829|NCT01638013|580737829|FG002|Overall Study|Withdrawal of Consent|16|||
160822830|NCT01638013|580737827|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
160822831|NCT01638013|580737828|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
160822832|NCT01638013|580737829|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
160822833|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
160822834|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
160822835|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
160822836|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
160822837|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
160822838|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
160822839|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
160822840|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
160822841|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
160822842|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
160822843|NCT03549871|580737834|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
160822844|NCT03549871|580737835|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
160822845|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
160822846|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
160822847|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
160822848|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
160822849|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
160822850|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
160822851|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
160822852|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
160822853|NCT03549871|580737834|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
160822854|NCT03549871|580737835|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
160822855|NCT01133626|580737836|FG000|Overall Study|Adverse Event|0|||
160822856|NCT01133626|580737837|FG001|Overall Study|Adverse Event|1|||
160822857|NCT01133626|580737838|FG002|Overall Study|Adverse Event|0|||
160822858|NCT01133626|580737836|FG000|Overall Study|Withdrawal by Subject|1|||
160822859|NCT01133626|580737837|FG001|Overall Study|Withdrawal by Subject|2|||
160822860|NCT01133626|580737838|FG002|Overall Study|Withdrawal by Subject|2|||
160822861|NCT01133626|580737836|FG000|Overall Study|Other|0|||
160822862|NCT01133626|580737837|FG001|Overall Study|Other|2|||
160822863|NCT01133626|580737838|FG002|Overall Study|Other|0|||
160822864|NCT01960998|580737839|FG000|Overall Study|Lost to Follow-up|3|||
160822865|NCT01960998|580737840|FG001|Overall Study|Lost to Follow-up|7|||
160822866|NCT01960998|580737839|FG000|Overall Study|Death|0|||
160822867|NCT01960998|580737840|FG001|Overall Study|Death|1|||
160822868|NCT01960998|580737839|FG000|Overall Study|Withdrawal by Subject|8|||
160822869|NCT01960998|580737840|FG001|Overall Study|Withdrawal by Subject|2|||
160822870|NCT01960998|580737839|FG000|Overall Study|lost computer access|0|||
160822871|NCT01960998|580737840|FG001|Overall Study|lost computer access|1|||
160822872|NCT01774253|580737844|FG000|Overall Study|Lack of Efficacy|4|||
160822873|NCT01774253|580737844|FG000|Overall Study|Physician Decision|2|||
160822874|NCT01774253|580737844|FG000|Overall Study|Withdrawal by Subject|2|||
160822875|NCT01774253|580737844|FG000|Overall Study|Death|1|||
160822876|NCT00772369|580737845|FG000|Overall Study|Did not return record release form|1|||
160822877|NCT03510468|580737846|FG000|Overall Study|Lost to Follow-up|1|||
160822878|NCT03510468|580737846|FG000|Overall Study|Adverse Event|5|||
160822879|NCT03510468|580737846|FG000|Overall Study|Physician Decision|1|||
160822880|NCT03510468|580737846|FG000|Overall Study|non-compliant with treatment|2|||
160822881|NCT03510468|580737846|FG000|Overall Study|Missed visit|1|||
160822882|NCT00871117|580737848|FG000|Overall Study|Lost to Follow-up|5|||
160822883|NCT00871117|580737849|FG001|Overall Study|Lost to Follow-up|6|||
160822884|NCT00871117|580737848|FG000|Overall Study|Other|0|||
160822885|NCT00871117|580737849|FG001|Overall Study|Other|4|||
160822886|NCT02080481|580737850|FG000|Overall Study|Never received a block.|1|||
160822887|NCT02080481|580737851|FG001|Overall Study|Never received a block.|0|||
160822888|NCT04508751|580737857|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
160822889|NCT04508751|580737858|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
160822890|NCT04508751|580737859|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
160822891|NCT03551665|580737864|FG000|Overall Study|Lost to Follow-up|11|||
160901796|NCT02635776|581034086|FG000|Overall Study|Withdrawal by Subject|41|||
160901797|NCT02635776|581034087|FG001|Overall Study|Withdrawal by Subject|7|||
160989564|NCT00062868|581349596|FG003|Dose Level 2|Death|0|||
160989565|NCT00062868|581349597|FG004|Dose Level 2|Death|2|||
160822892|NCT03551665|580737865|FG001|Overall Study|Lost to Follow-up|2|||
160822893|NCT00840060|580739020|FG000|Overall Study|Withdrawal by Subject|1|||
160989566|NCT00062868|581349598|FG005|Dose Level 2|Death|0|||
160989567|NCT00062868|581349599|FG006|Dose Level 2|Death|0|||
160989568|NCT00062868|581349600|FG007|Dose Level 2|Death|0|||
160989569|NCT00062868|581349601|FG008|Dose Level 2|Death|0|||
160989570|NCT00062868|581349602|FG009|Dose Level 2|Death|0|||
160989571|NCT00062868|581349603|FG010|Dose Level 2|Death|1|||
160989572|NCT00062868|581349604|FG011|Dose Level 2|Death|0|||
160989573|NCT00062868|581349605|FG012|Dose Level 2|Death|0|||
160989574|NCT00062868|581349606|FG013|Dose Level 2|Death|0|||
160822894|NCT00840060|580739021|FG001|Overall Study|Withdrawal by Subject|0|||
160822895|NCT00840060|580739020|FG000|Overall Study|Change in emotional/behavioral status|0|||
160822896|NCT00840060|580739021|FG001|Overall Study|Change in emotional/behavioral status|1|||
160822897|NCT01103063|580739022|FG000|Overall Study|Adverse Event|3|||
160822898|NCT01103063|580739023|FG001|Overall Study|Adverse Event|1|||
160822899|NCT01103063|580739022|FG000|Overall Study|Lost to Follow-up|68|||
160822900|NCT01103063|580739023|FG001|Overall Study|Lost to Follow-up|51|||
160822901|NCT01103063|580739022|FG000|Overall Study|Withdrawal by Subject|60|||
160822902|NCT01103063|580739023|FG001|Overall Study|Withdrawal by Subject|15|||
160822903|NCT01103063|580739022|FG000|Overall Study|Other|16|||
160822904|NCT01103063|580739023|FG001|Overall Study|Other|11|||
160822905|NCT01103063|580739022|FG000|Overall Study|Protocol Violation|1|||
160822906|NCT01103063|580739023|FG001|Overall Study|Protocol Violation|0|||
160822907|NCT01103063|580739022|FG000|Overall Study|Study terminated by Sponsor|326|||
160822908|NCT01103063|580739023|FG001|Overall Study|Study terminated by Sponsor|342|||
160822909|NCT01103063|580739022|FG000|Overall Study|Death|3|||
160822910|NCT01103063|580739023|FG001|Overall Study|Death|1|||
160822911|NCT00798317|580739026|FG000|Overall Study|Physician Decision|0|||
160822912|NCT00798317|580739027|FG001|Overall Study|Physician Decision|1|||
160822913|NCT00798317|580739026|FG000|Overall Study|Withdrawal by Subject|5|||
160822914|NCT00798317|580739027|FG001|Overall Study|Withdrawal by Subject|4|||
160822915|NCT00798317|580739026|FG000|Overall Study|Lost to Follow-up|2|||
160822916|NCT00798317|580739027|FG001|Overall Study|Lost to Follow-up|2|||
160822917|NCT00798317|580739026|FG000|Overall Study|Adverse Event|2|||
160822918|NCT00798317|580739027|FG001|Overall Study|Adverse Event|0|||
160822919|NCT00798317|580739026|FG000|Overall Study|Death|1|||
160822920|NCT00798317|580739027|FG001|Overall Study|Death|0|||
160822921|NCT00919867|580739031|FG000|First Intervention|Withdrawal by Subject|0|||
160822922|NCT00919867|580739032|FG001|First Intervention|Withdrawal by Subject|0|||
160822923|NCT00919867|580739033|FG002|First Intervention|Withdrawal by Subject|1|||
160822924|NCT00919867|580739034|FG003|First Intervention|Withdrawal by Subject|0|||
160989575|NCT00062868|581349607|FG014|Dose Level 2|Death|0|||
160989576|NCT00062868|581349608|FG015|Dose Level 2|Death|0|||
160989577|NCT00062868|581349609|FG016|Dose Level 2|Death|2|||
160989578|NCT00062868|581349610|FG017|Dose Level 2|Death|0|||
160989579|NCT00062868|581349611|FG018|Dose Level 2|Death|0|||
160989580|NCT00062868|581349612|FG019|Dose Level 2|Death|0|||
160989581|NCT00062868|581349613|FG020|Dose Level 2|Death|0|||
160989582|NCT00062868|581349593|FG000|Dose Level 2|Lost to Follow-up|0|||
160989583|NCT00062868|581349594|FG001|Dose Level 2|Lost to Follow-up|0|||
160989584|NCT00062868|581349595|FG002|Dose Level 2|Lost to Follow-up|0|||
160989585|NCT00062868|581349596|FG003|Dose Level 2|Lost to Follow-up|0|||
160989586|NCT00062868|581349597|FG004|Dose Level 2|Lost to Follow-up|0|||
160989587|NCT00062868|581349598|FG005|Dose Level 2|Lost to Follow-up|0|||
160989588|NCT00062868|581349599|FG006|Dose Level 2|Lost to Follow-up|0|||
160989589|NCT00062868|581349600|FG007|Dose Level 2|Lost to Follow-up|0|||
160989590|NCT00062868|581349601|FG008|Dose Level 2|Lost to Follow-up|0|||
160989591|NCT00062868|581349602|FG009|Dose Level 2|Lost to Follow-up|0|||
160989592|NCT00062868|581349603|FG010|Dose Level 2|Lost to Follow-up|0|||
160989593|NCT00062868|581349604|FG011|Dose Level 2|Lost to Follow-up|0|||
160989594|NCT00062868|581349605|FG012|Dose Level 2|Lost to Follow-up|0|||
160989595|NCT00062868|581349606|FG013|Dose Level 2|Lost to Follow-up|1|||
160989596|NCT00062868|581349607|FG014|Dose Level 2|Lost to Follow-up|0|||
160989597|NCT00062868|581349608|FG015|Dose Level 2|Lost to Follow-up|0|||
160989598|NCT00062868|581349609|FG016|Dose Level 2|Lost to Follow-up|1|||
160989599|NCT00062868|581349610|FG017|Dose Level 2|Lost to Follow-up|0|||
160989600|NCT00062868|581349611|FG018|Dose Level 2|Lost to Follow-up|0|||
160989601|NCT00062868|581349612|FG019|Dose Level 2|Lost to Follow-up|0|||
160989602|NCT00062868|581349613|FG020|Dose Level 2|Lost to Follow-up|0|||
160989603|NCT00062868|581349593|FG000|Dose Level 3|Death|0|||
160822925|NCT00919867|580739035|FG004|First Intervention|Withdrawal by Subject|0|||
160822926|NCT00919867|580739036|FG005|First Intervention|Withdrawal by Subject|0|||
160822927|NCT00919867|580739031|FG000|First Intervention|Physician Decision|0|||
160822928|NCT00919867|580739032|FG001|First Intervention|Physician Decision|0|||
160989604|NCT00062868|581349594|FG001|Dose Level 3|Death|0|||
160989605|NCT00062868|581349595|FG002|Dose Level 3|Death|0|||
160989606|NCT00062868|581349596|FG003|Dose Level 3|Death|0|||
160989607|NCT00062868|581349597|FG004|Dose Level 3|Death|0|||
160989608|NCT00062868|581349598|FG005|Dose Level 3|Death|0|||
161133211|NCT01929135|581870857|FG000|Overall Study|Lost to Follow-up|1|||
161133212|NCT01929135|581870858|FG001|Overall Study|Lost to Follow-up|1|||
161133213|NCT03136107|581870861|FG000|Overall Study|Other (Not specified)|1|||
161133214|NCT01817790|581870862|FG000|Overall Study|Adverse Event|0|||
161133215|NCT01817790|581870863|FG001|Overall Study|Adverse Event|2|||
161133216|NCT01817790|581870862|FG000|Overall Study|Lost to Follow-up|0|||
161133217|NCT01817790|581870863|FG001|Overall Study|Lost to Follow-up|1|||
161133218|NCT01817790|581870862|FG000|Overall Study|Protocol Violation|2|||
161133219|NCT01817790|581870863|FG001|Overall Study|Protocol Violation|1|||
161133220|NCT01817790|581870862|FG000|Overall Study|Withdrawal by Subject|1|||
161133221|NCT01817790|581870863|FG001|Overall Study|Withdrawal by Subject|3|||
161133222|NCT01817790|581870862|FG000|Overall Study|Other: Could not attend appointment|1|||
161133223|NCT01817790|581870863|FG001|Overall Study|Other: Could not attend appointment|1|||
161133224|NCT01671345|581870864|FG000|Overall Study|Lost to Follow-up|10|||
161133225|NCT01671345|581870865|FG001|Overall Study|Lost to Follow-up|6|||
161133226|NCT01671345|581870864|FG000|Overall Study|visit with non-participating physician|3|||
161133227|NCT01671345|581870865|FG001|Overall Study|visit with non-participating physician|3|||
161133228|NCT03690869|581870866|FG000|Overall Study|Adverse Event|0|||
161133229|NCT03690869|581870867|FG001|Overall Study|Adverse Event|0|||
161133230|NCT03690869|581870868|FG002|Overall Study|Adverse Event|0|||
161133231|NCT03690869|581870869|FG003|Overall Study|Adverse Event|1|||
161133232|NCT03690869|581870870|FG004|Overall Study|Adverse Event|0|||
161133233|NCT03690869|581870871|FG005|Overall Study|Adverse Event|0|||
160989609|NCT00062868|581349599|FG006|Dose Level 3|Death|0|||
160989610|NCT00062868|581349600|FG007|Dose Level 3|Death|0|||
160989611|NCT00062868|581349601|FG008|Dose Level 3|Death|0|||
160989612|NCT00062868|581349602|FG009|Dose Level 3|Death|0|||
160989613|NCT00062868|581349603|FG010|Dose Level 3|Death|0|||
160989614|NCT00062868|581349604|FG011|Dose Level 3|Death|1|||
160989615|NCT00062868|581349605|FG012|Dose Level 3|Death|0|||
160989616|NCT00062868|581349606|FG013|Dose Level 3|Death|0|||
160989617|NCT00062868|581349607|FG014|Dose Level 3|Death|0|||
160989618|NCT00062868|581349608|FG015|Dose Level 3|Death|0|||
160989619|NCT00062868|581349609|FG016|Dose Level 3|Death|0|||
160989620|NCT00062868|581349610|FG017|Dose Level 3|Death|1|||
160989621|NCT00062868|581349611|FG018|Dose Level 3|Death|0|||
160989622|NCT00062868|581349612|FG019|Dose Level 3|Death|0|||
160989623|NCT00062868|581349613|FG020|Dose Level 3|Death|0|||
160989624|NCT00062868|581349593|FG000|Dose Level 3|Lost to Follow-up|0|||
160989625|NCT00062868|581349594|FG001|Dose Level 3|Lost to Follow-up|0|||
160989626|NCT00062868|581349595|FG002|Dose Level 3|Lost to Follow-up|0|||
160989627|NCT00062868|581349596|FG003|Dose Level 3|Lost to Follow-up|0|||
160989628|NCT00062868|581349597|FG004|Dose Level 3|Lost to Follow-up|0|||
160989629|NCT00062868|581349598|FG005|Dose Level 3|Lost to Follow-up|0|||
160989630|NCT00062868|581349599|FG006|Dose Level 3|Lost to Follow-up|0|||
160989631|NCT00062868|581349600|FG007|Dose Level 3|Lost to Follow-up|0|||
160989632|NCT00062868|581349601|FG008|Dose Level 3|Lost to Follow-up|0|||
160989633|NCT00062868|581349602|FG009|Dose Level 3|Lost to Follow-up|0|||
160989634|NCT00062868|581349603|FG010|Dose Level 3|Lost to Follow-up|0|||
160989635|NCT00062868|581349604|FG011|Dose Level 3|Lost to Follow-up|0|||
160989636|NCT00062868|581349605|FG012|Dose Level 3|Lost to Follow-up|0|||
160989637|NCT00062868|581349606|FG013|Dose Level 3|Lost to Follow-up|0|||
161133234|NCT03690869|581870872|FG006|Overall Study|Adverse Event|0|||
161133235|NCT03690869|581870873|FG007|Overall Study|Adverse Event|1|||
161133236|NCT03690869|581870874|FG008|Overall Study|Adverse Event|0|||
161133237|NCT03690869|581870875|FG009|Overall Study|Adverse Event|1|||
161133238|NCT03690869|581870866|FG000|Overall Study|Death|1|||
161133239|NCT03690869|581870867|FG001|Overall Study|Death|1|||
161133240|NCT03690869|581870868|FG002|Overall Study|Death|1|||
160989638|NCT00062868|581349607|FG014|Dose Level 3|Lost to Follow-up|1|||
160989639|NCT00062868|581349608|FG015|Dose Level 3|Lost to Follow-up|0|||
160989640|NCT00062868|581349609|FG016|Dose Level 3|Lost to Follow-up|0|||
160989641|NCT00062868|581349610|FG017|Dose Level 3|Lost to Follow-up|0|||
160989642|NCT00062868|581349611|FG018|Dose Level 3|Lost to Follow-up|0|||
160989643|NCT00062868|581349612|FG019|Dose Level 3|Lost to Follow-up|0|||
160989644|NCT00062868|581349613|FG020|Dose Level 3|Lost to Follow-up|0|||
160989645|NCT00062868|581349593|FG000|Dose Level 3|Withdrew|0|||
160989646|NCT00062868|581349594|FG001|Dose Level 3|Withdrew|0|||
160989647|NCT00062868|581349595|FG002|Dose Level 3|Withdrew|2|||
160989648|NCT00062868|581349596|FG003|Dose Level 3|Withdrew|0|||
160989649|NCT00062868|581349597|FG004|Dose Level 3|Withdrew|0|||
160989650|NCT00062868|581349598|FG005|Dose Level 3|Withdrew|0|||
160989651|NCT00062868|581349599|FG006|Dose Level 3|Withdrew|0|||
161133241|NCT03690869|581870869|FG003|Overall Study|Death|4|||
161133242|NCT03690869|581870870|FG004|Overall Study|Death|2|||
161133243|NCT03690869|581870871|FG005|Overall Study|Death|5|||
161133244|NCT03690869|581870872|FG006|Overall Study|Death|3|||
161133245|NCT03690869|581870873|FG007|Overall Study|Death|2|||
161133246|NCT03690869|581870874|FG008|Overall Study|Death|0|||
161133247|NCT03690869|581870875|FG009|Overall Study|Death|3|||
161133248|NCT03690869|581870866|FG000|Overall Study|Lost to Follow-up|0|||
161133249|NCT03690869|581870867|FG001|Overall Study|Lost to Follow-up|0|||
161133250|NCT03690869|581870868|FG002|Overall Study|Lost to Follow-up|1|||
161133251|NCT03690869|581870869|FG003|Overall Study|Lost to Follow-up|0|||
161133252|NCT03690869|581870870|FG004|Overall Study|Lost to Follow-up|0|||
160822929|NCT00919867|580739033|FG002|First Intervention|Physician Decision|0|||
160822930|NCT00919867|580739034|FG003|First Intervention|Physician Decision|0|||
160822931|NCT00919867|580739035|FG004|First Intervention|Physician Decision|0|||
160822932|NCT00919867|580739036|FG005|First Intervention|Physician Decision|1|||
161133253|NCT03690869|581870871|FG005|Overall Study|Lost to Follow-up|0|||
160822933|NCT03350256|580739044|FG000|Overall Study|Inclusion/exclusion violation|4|||
160822934|NCT03350256|580739044|FG000|Overall Study|Recommended for other therapies|2|||
160822935|NCT03350256|580739044|FG000|Overall Study|Protocol Violation|3|||
160822936|NCT03350256|580739044|FG000|Overall Study|Non compliance|2|||
160822937|NCT03350256|580739044|FG000|Overall Study|Denial by insurance|1|||
160822938|NCT03350256|580739044|FG000|Overall Study|Adverse Event|2|||
160822939|NCT03350256|580739044|FG000|Overall Study|Trial failure|12|||
160822940|NCT03350256|580739044|FG000|Overall Study|Did not proceed to permanent implant|3|||
160822941|NCT03350256|580739044|FG000|Overall Study|Withdrawal by Subject|3|||
160822942|NCT03350256|580739044|FG000|Overall Study|Subject moving out of state|1|||
160822943|NCT03350256|580739044|FG000|Overall Study|Lost to Follow-up|1|||
160822944|NCT03350256|580739044|FG000|Overall Study|Lack of Efficacy|2|||
160822945|NCT01187446|580739045|FG000|Overall Study|Patient started non-protocol therapy|0|||
160822946|NCT01187446|580739046|FG001|Overall Study|Patient started non-protocol therapy|1|||
160822947|NCT00823212|580739048|FG000|Overall Study|Death|8|||
160822948|NCT00823212|580739049|FG001|Overall Study|Death|10|||
160822949|NCT00823212|580739048|FG000|Overall Study|Withdrawal by Subject|6|||
160822950|NCT00823212|580739049|FG001|Overall Study|Withdrawal by Subject|1|||
160822951|NCT00823212|580739048|FG000|Overall Study|Incarcerated|0|||
160822952|NCT00823212|580739049|FG001|Overall Study|Incarcerated|1|||
160822953|NCT00823212|580739048|FG000|Overall Study|Missed 12-month visit|21|||
160822954|NCT00823212|580739049|FG001|Overall Study|Missed 12-month visit|21|||
160822955|NCT04600076|580739059|FG000|Overall Study|Lost to Follow-up|3|||
160822956|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
160822957|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
160822958|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
160822959|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
160822960|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
160822961|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
160822962|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
160822963|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
160822964|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
160822965|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
160822966|NCT01639339|580739060|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
160822967|NCT01639339|580739061|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
160822968|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
160822969|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
160822970|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
160822971|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
160822972|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
160822973|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
160822974|NCT01639339|580739060|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
160822975|NCT01639339|580739061|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
160822976|NCT02891681|580739062|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
160822977|NCT02891681|580739063|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
160901798|NCT02635776|581034086|FG000|Overall Study|Lost to Follow-up|4|||
160901799|NCT02635776|581034087|FG001|Overall Study|Lost to Follow-up|0|||
161133254|NCT03690869|581870872|FG006|Overall Study|Lost to Follow-up|0|||
160822978|NCT02891681|580739064|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
160822979|NCT02891681|580739062|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
160822980|NCT02891681|580739063|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
161133255|NCT03690869|581870873|FG007|Overall Study|Lost to Follow-up|0|||
161133256|NCT03690869|581870874|FG008|Overall Study|Lost to Follow-up|0|||
161133257|NCT03690869|581870875|FG009|Overall Study|Lost to Follow-up|0|||
161133258|NCT03690869|581870866|FG000|Overall Study|Other Treatment|1|||
161133259|NCT03690869|581870867|FG001|Overall Study|Other Treatment|1|||
161133260|NCT03690869|581870868|FG002|Overall Study|Other Treatment|1|||
161133261|NCT03690869|581870869|FG003|Overall Study|Other Treatment|2|||
161133262|NCT03690869|581870870|FG004|Overall Study|Other Treatment|3|||
160822981|NCT02891681|580739064|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
160822982|NCT02891681|580739062|FG000|Overall Study|Taken off study after first imaging appointment|1|||
160901800|NCT02635776|581034086|FG000|Overall Study|Other reasons|5|||
161133263|NCT03690869|581870871|FG005|Overall Study|Other Treatment|1|||
161133264|NCT03690869|581870872|FG006|Overall Study|Other Treatment|2|||
161133265|NCT03690869|581870873|FG007|Overall Study|Other Treatment|7|||
160822983|NCT02891681|580739063|FG001|Overall Study|Taken off study after first imaging appointment|0|||
160822984|NCT02891681|580739064|FG002|Overall Study|Taken off study after first imaging appointment|0|||
160822985|NCT01170598|580739065|FG000|Overall Study|Withdrawal by Subject|1|||
160822986|NCT01170598|580739065|FG000|Overall Study|Death|3|||
160822987|NCT01170598|580739065|FG000|Overall Study|Lost to Follow-up|1|||
160822988|NCT01170598|580739065|FG000|Overall Study|Refused|1|||
160822989|NCT01271712|580739066|FG000|Double Blind Treatment|Death|2|||
160822990|NCT01271712|580739067|FG001|Double Blind Treatment|Death|0|||
160822991|NCT01271712|580739066|FG000|Double Blind Treatment|Lack of Efficacy|1|||
160822992|NCT01271712|580739067|FG001|Double Blind Treatment|Lack of Efficacy|0|||
160822993|NCT01271712|580739066|FG000|Double Blind Treatment|Adverse Event|9|||
160822994|NCT01271712|580739067|FG001|Double Blind Treatment|Adverse Event|4|||
160822995|NCT01271712|580739066|FG000|Double Blind Treatment|Progressive disease|23|||
160822996|NCT01271712|580739067|FG001|Double Blind Treatment|Progressive disease|3|||
160822997|NCT01271712|580739066|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
160822998|NCT01271712|580739067|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
160822999|NCT01271712|580739066|FG000|Double Blind Treatment|Non compliance with study drug|2|||
160823000|NCT01271712|580739067|FG001|Double Blind Treatment|Non compliance with study drug|0|||
160823001|NCT01271712|580739066|FG000|Double Blind Treatment|receive no study drug|1|||
160823002|NCT01271712|580739067|FG001|Double Blind Treatment|receive no study drug|0|||
160823003|NCT01271712|580739066|FG000|Open Label Treatment|Death|6|||
160823004|NCT01271712|580739067|FG001|Open Label Treatment|Death|5|||
160823005|NCT01271712|580739066|FG000|Open Label Treatment|Withdrawal by Subject|6|||
160823006|NCT01271712|580739067|FG001|Open Label Treatment|Withdrawal by Subject|11|||
160823007|NCT01271712|580739066|FG000|Open Label Treatment|Physician Decision|2|||
160823008|NCT01271712|580739067|FG001|Open Label Treatment|Physician Decision|0|||
160823009|NCT01271712|580739066|FG000|Open Label Treatment|Adverse Event|14|||
160823010|NCT01271712|580739067|FG001|Open Label Treatment|Adverse Event|8|||
160823011|NCT01271712|580739066|FG000|Open Label Treatment|Progressive disease|59|||
160823012|NCT01271712|580739067|FG001|Open Label Treatment|Progressive disease|32|||
160823013|NCT01271712|580739066|FG000|Open Label Treatment|transferred to rollover study|1|||
160823014|NCT01271712|580739067|FG001|Open Label Treatment|transferred to rollover study|0|||
160823015|NCT01271712|580739066|FG000|Open Label Treatment|Non-compliance with study drug|1|||
160823016|NCT01271712|580739067|FG001|Open Label Treatment|Non-compliance with study drug|0|||
160823017|NCT01271712|580739066|FG000|Open Label Treatment|Protocol Violation|0|||
160823018|NCT01271712|580739067|FG001|Open Label Treatment|Protocol Violation|1|||
160823019|NCT01271712|580739066|FG000|Open Label Treatment|Switching to other therapy|2|||
160823020|NCT01271712|580739067|FG001|Open Label Treatment|Switching to other therapy|1|||
160823021|NCT01271712|580739066|FG000|Safety Follow-up|Death|11|||
160823022|NCT01271712|580739067|FG001|Safety Follow-up|Death|7|||
160823023|NCT01271712|580739066|FG000|Safety Follow-up|Withdrawal by Subject|4|||
160823024|NCT01271712|580739067|FG001|Safety Follow-up|Withdrawal by Subject|2|||
160823025|NCT01271712|580739066|FG000|Safety Follow-up|Protocol Violation|1|||
160823026|NCT01271712|580739067|FG001|Safety Follow-up|Protocol Violation|1|||
160823027|NCT01271712|580739066|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
160823028|NCT01271712|580739067|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
160823029|NCT01271712|580739066|FG000|Safety Follow-up|No follow-up|1|||
160823030|NCT01271712|580739067|FG001|Safety Follow-up|No follow-up|1|||
160823031|NCT01271712|580739066|FG000|Safety Follow-up|Progressive disease|1|||
160823032|NCT01271712|580739067|FG001|Safety Follow-up|Progressive disease|0|||
160823033|NCT01271712|580739066|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
160823034|NCT01271712|580739067|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
160823035|NCT02685748|580739070|FG000|Overall Study|Withdrawal by Subject|3|||
160823036|NCT02685748|580739071|FG001|Overall Study|Withdrawal by Subject|2|||
160823037|NCT03941964|580739072|FG000|Overall Study|Adverse Event|1|||
160823038|NCT03941964|580739073|FG001|Overall Study|Adverse Event|8|||
160823039|NCT03941964|580739072|FG000|Overall Study|Progressive disease|7|||
160823040|NCT03941964|580739073|FG001|Overall Study|Progressive disease|3|||
160823041|NCT03941964|580739072|FG000|Overall Study|Lack of Efficacy|0|||
160823042|NCT03941964|580739073|FG001|Overall Study|Lack of Efficacy|1|||
160823043|NCT03941964|580739072|FG000|Overall Study|Death|3|||
160823044|NCT03941964|580739073|FG001|Overall Study|Death|1|||
160823045|NCT03941964|580739072|FG000|Overall Study|Withdrew consent|1|||
160823046|NCT03941964|580739073|FG001|Overall Study|Withdrew consent|3|||
160823047|NCT03941964|580739072|FG000|Overall Study|Physician Decision|9|||
160823048|NCT03941964|580739073|FG001|Overall Study|Physician Decision|2|||
160823049|NCT03941964|580739072|FG000|Overall Study|Other, not specified|2|||
160823050|NCT03941964|580739073|FG001|Overall Study|Other, not specified|1|||
160823051|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
160823052|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
160823053|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
160823054|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
160823055|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
160901801|NCT02635776|581034087|FG001|Overall Study|Other reasons|1|||
160989652|NCT00062868|581349600|FG007|Dose Level 3|Withdrew|0|||
160989653|NCT00062868|581349601|FG008|Dose Level 3|Withdrew|0|||
160989654|NCT00062868|581349602|FG009|Dose Level 3|Withdrew|0|||
160989655|NCT00062868|581349603|FG010|Dose Level 3|Withdrew|0|||
160989656|NCT00062868|581349604|FG011|Dose Level 3|Withdrew|0|||
160989657|NCT00062868|581349605|FG012|Dose Level 3|Withdrew|0|||
160989658|NCT00062868|581349606|FG013|Dose Level 3|Withdrew|0|||
160989659|NCT00062868|581349607|FG014|Dose Level 3|Withdrew|0|||
160989660|NCT00062868|581349608|FG015|Dose Level 3|Withdrew|0|||
160989661|NCT00062868|581349609|FG016|Dose Level 3|Withdrew|0|||
160989662|NCT00062868|581349610|FG017|Dose Level 3|Withdrew|0|||
160989663|NCT00062868|581349611|FG018|Dose Level 3|Withdrew|0|||
160989664|NCT00062868|581349612|FG019|Dose Level 3|Withdrew|0|||
160989665|NCT00062868|581349613|FG020|Dose Level 3|Withdrew|0|||
160989666|NCT01734811|581349614|FG000|Overall Study|Lost to Follow-up|2|||
160989667|NCT01734811|581349615|FG001|Overall Study|Lost to Follow-up|3|||
160989668|NCT01734811|581349614|FG000|Overall Study|Withdrawal by Subject|2|||
160989669|NCT01734811|581349615|FG001|Overall Study|Withdrawal by Subject|0|||
160989670|NCT02427646|581349616|FG000|Overall Study|Lack of Efficacy|2|||
160823056|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
160823057|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
160823058|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
160823059|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
160823060|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
160823061|NCT00737568|580739085|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
160823062|NCT00737568|580739086|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
160823063|NCT00737568|580739085|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
160823064|NCT00737568|580739086|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
160823065|NCT00737568|580739085|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
160823066|NCT00737568|580739086|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
160823067|NCT00737568|580739085|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
160823068|NCT00737568|580739086|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
160823069|NCT00855933|580739087|FG000|Overall Study|Withdrawal by Subject|0|||
160823070|NCT00855933|580739088|FG001|Overall Study|Withdrawal by Subject|1|||
160823071|NCT00951080|580739089|FG000|Overall Study|Adverse Event|3|||
160823072|NCT00951080|580739090|FG001|Overall Study|Adverse Event|3|||
160823073|NCT00951080|580739089|FG000|Overall Study|Lost to Follow-up|0|||
160823074|NCT00951080|580739090|FG001|Overall Study|Lost to Follow-up|1|||
160823075|NCT00951080|580739089|FG000|Overall Study|Physician Decision|4|||
160823076|NCT00951080|580739090|FG001|Overall Study|Physician Decision|1|||
160823077|NCT00951080|580739089|FG000|Overall Study|Other|19|||
160823078|NCT00951080|580739090|FG001|Overall Study|Other|22|||
160823079|NCT05463744|580739091|FG000|Treatment Period|Withdrawal by Subject|19|||
160823080|NCT05463744|580739092|FG001|Treatment Period|Withdrawal by Subject|16|||
160823081|NCT05463744|580739091|FG000|Treatment Period|Adverse Event|4|||
160823082|NCT05463744|580739092|FG001|Treatment Period|Adverse Event|4|||
160823083|NCT05463744|580739091|FG000|Treatment Period|Pregnancy|0|||
160823084|NCT05463744|580739092|FG001|Treatment Period|Pregnancy|3|||
160823085|NCT05463744|580739091|FG000|Treatment Period|Lost to Follow-up|1|||
160823086|NCT05463744|580739092|FG001|Treatment Period|Lost to Follow-up|3|||
160823087|NCT05463744|580739091|FG000|Treatment Period|Inadvertent enrollment|2|||
160823088|NCT05463744|580739092|FG001|Treatment Period|Inadvertent enrollment|1|||
160823089|NCT05463744|580739091|FG000|Treatment Period|Death|0|||
160823090|NCT05463744|580739092|FG001|Treatment Period|Death|1|||
160823091|NCT05463744|580739091|FG000|Treatment Period|Non-compliance with Study Drug|1|||
160823092|NCT05463744|580739092|FG001|Treatment Period|Non-compliance with Study Drug|0|||
160823093|NCT05463744|580739091|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
160989671|NCT02427646|581349617|FG001|Overall Study|Lack of Efficacy|3|||
160989672|NCT02427646|581349616|FG000|Overall Study|Physician Decision|1|||
160989673|NCT02427646|581349617|FG001|Overall Study|Physician Decision|4|||
160989674|NCT02427646|581349616|FG000|Overall Study|Protocol Violation|3|||
160989675|NCT02427646|581349617|FG001|Overall Study|Protocol Violation|3|||
160989676|NCT02427646|581349616|FG000|Overall Study|Bothersome hand weakness|2|||
160823094|NCT05463744|580739092|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
160823095|NCT05463744|580739091|FG000|Treatment Period|Physician Decision|0|||
160989677|NCT02427646|581349617|FG001|Overall Study|Bothersome hand weakness|4|||
160823096|NCT05463744|580739092|FG001|Treatment Period|Physician Decision|1|||
160989678|NCT03824236|581349618|FG000|Overall Study|Lost to Follow-up|0|||
160989679|NCT03824236|581349619|FG001|Overall Study|Lost to Follow-up|0|||
160823097|NCT05463744|580739091|FG000|Follow-Up Period|Withdrawal by Subject|3|||
160823098|NCT05463744|580739092|FG001|Follow-Up Period|Withdrawal by Subject|1|||
160823099|NCT05463744|580739091|FG000|Follow-Up Period|Lost to Follow-up|1|||
160823100|NCT05463744|580739092|FG001|Follow-Up Period|Lost to Follow-up|1|||
160989680|NCT03824236|581349620|FG002|Overall Study|Lost to Follow-up|1|||
160989681|NCT01641861|581349621|FG000|Overall Study|Lost to Follow-up|21|||
160989682|NCT01641861|581349622|FG001|Overall Study|Lost to Follow-up|16|||
160989683|NCT01641861|581349621|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
160989684|NCT01641861|581349622|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
160989685|NCT01641861|581349621|FG000|Overall Study|Died due to drowning|0|||
160989686|NCT01641861|581349622|FG001|Overall Study|Died due to drowning|1|||
160989687|NCT01101542|581349625|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
160989688|NCT01101542|581349625|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
160989689|NCT01101542|581349625|FG000|Year 4 Surveillance Period|Other|287|||
160989690|NCT01101542|581349625|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
160989691|NCT01101542|581349625|FG000|Year 5 Surveillance Period|Pregnancy|1|||
160989692|NCT01101542|581349625|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
160989693|NCT01101542|581349625|FG000|Year 6 Surveillance Period|Pregnancy|1|||
160989694|NCT01101542|581349625|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
160989695|NCT00701311|581349626|FG000|Overall Study|Lack of Efficacy|3|||
160989696|NCT00701311|581349626|FG000|Overall Study|Adverse Event|3|||
160989697|NCT00701311|581349626|FG000|Overall Study|Withdrawal by Subject|2|||
160989698|NCT04580407|581349627|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
160989699|NCT04949399|581349630|FG000|Overall Study|Lost to Follow-up|11|||
160989700|NCT04949399|581349631|FG001|Overall Study|Lost to Follow-up|6|||
160989701|NCT04949399|581349630|FG000|Overall Study|Withdrawal by Subject|2|||
160989702|NCT04949399|581349631|FG001|Overall Study|Withdrawal by Subject|3|||
160823101|NCT02585830|580739098|FG000|Overall Study|Withdrawal by Subject|3|||
160823102|NCT01904149|580739099|FG000|Overall Study|Adverse Event|3|||
160823103|NCT01904149|580739100|FG001|Overall Study|Adverse Event|4|||
160823104|NCT01904149|580739101|FG002|Overall Study|Adverse Event|0|||
160823105|NCT01904149|580739102|FG003|Overall Study|Adverse Event|1|||
160823106|NCT01904149|580739103|FG004|Overall Study|Adverse Event|1|||
160823107|NCT01904149|580739104|FG005|Overall Study|Adverse Event|2|||
160823108|NCT01904149|580739099|FG000|Overall Study|Lack of Efficacy|0|||
160823109|NCT01904149|580739100|FG001|Overall Study|Lack of Efficacy|3|||
160989703|NCT00814489|581349632|FG000|Overall Study|Other|2|||
160989704|NCT00814489|581349633|FG001|Overall Study|Other|0|||
160989705|NCT00814489|581349634|FG002|Overall Study|Other|1|||
160989706|NCT01712685|581349660|FG000|Overall Study|pt declined to participate before trmt|1|||
160989707|NCT01515319|581349661|FG000|Overall Study|Withdrawal by Subject|0|||
160989708|NCT01515319|581349662|FG001|Overall Study|Withdrawal by Subject|0|||
160989709|NCT01515319|581349663|FG002|Overall Study|Withdrawal by Subject|0|||
160989710|NCT01515319|581349664|FG003|Overall Study|Withdrawal by Subject|0|||
160989711|NCT01515319|581349665|FG004|Overall Study|Withdrawal by Subject|0|||
160989712|NCT01515319|581349666|FG005|Overall Study|Withdrawal by Subject|0|||
160989713|NCT01515319|581349667|FG006|Overall Study|Withdrawal by Subject|1|||
160989714|NCT01515319|581349668|FG007|Overall Study|Withdrawal by Subject|0|||
160989715|NCT01515319|581349669|FG008|Overall Study|Withdrawal by Subject|0|||
160989716|NCT01515319|581349670|FG009|Overall Study|Withdrawal by Subject|0|||
160989717|NCT01515319|581349661|FG000|Overall Study|Adverse Event|0|||
160989718|NCT01515319|581349662|FG001|Overall Study|Adverse Event|0|||
160989719|NCT01515319|581349663|FG002|Overall Study|Adverse Event|0|||
160989720|NCT01515319|581349664|FG003|Overall Study|Adverse Event|0|||
160989721|NCT01515319|581349665|FG004|Overall Study|Adverse Event|0|||
160989722|NCT01515319|581349666|FG005|Overall Study|Adverse Event|0|||
160989723|NCT01515319|581349667|FG006|Overall Study|Adverse Event|0|||
160989724|NCT01515319|581349668|FG007|Overall Study|Adverse Event|0|||
160823110|NCT01904149|580739101|FG002|Overall Study|Lack of Efficacy|1|||
160823111|NCT01904149|580739102|FG003|Overall Study|Lack of Efficacy|3|||
160823112|NCT01904149|580739103|FG004|Overall Study|Lack of Efficacy|3|||
160989725|NCT01515319|581349669|FG008|Overall Study|Adverse Event|3|||
160823113|NCT01904149|580739104|FG005|Overall Study|Lack of Efficacy|1|||
160823114|NCT01904149|580739099|FG000|Overall Study|Withdrawal by Subject|1|||
160823115|NCT01904149|580739100|FG001|Overall Study|Withdrawal by Subject|3|||
160823116|NCT01904149|580739101|FG002|Overall Study|Withdrawal by Subject|1|||
160823117|NCT01904149|580739102|FG003|Overall Study|Withdrawal by Subject|0|||
160823118|NCT01904149|580739103|FG004|Overall Study|Withdrawal by Subject|1|||
160823119|NCT01904149|580739104|FG005|Overall Study|Withdrawal by Subject|0|||
160989726|NCT01515319|581349670|FG009|Overall Study|Adverse Event|0|||
160989727|NCT01515319|581349661|FG000|Overall Study|Protocol Violation|0|||
160989728|NCT01515319|581349662|FG001|Overall Study|Protocol Violation|0|||
160989729|NCT01515319|581349663|FG002|Overall Study|Protocol Violation|0|||
160989730|NCT01515319|581349664|FG003|Overall Study|Protocol Violation|0|||
160989731|NCT01515319|581349665|FG004|Overall Study|Protocol Violation|0|||
160989732|NCT01515319|581349666|FG005|Overall Study|Protocol Violation|0|||
160989733|NCT01515319|581349667|FG006|Overall Study|Protocol Violation|0|||
160989734|NCT01515319|581349668|FG007|Overall Study|Protocol Violation|0|||
161133266|NCT03690869|581870874|FG008|Overall Study|Other Treatment|0|||
160823120|NCT01904149|580739099|FG000|Overall Study|Protocol Violation|0|||
160823121|NCT01904149|580739100|FG001|Overall Study|Protocol Violation|1|||
160823122|NCT01904149|580739101|FG002|Overall Study|Protocol Violation|0|||
160823123|NCT01904149|580739102|FG003|Overall Study|Protocol Violation|0|||
161133267|NCT03690869|581870875|FG009|Overall Study|Other Treatment|3|||
160823124|NCT01904149|580739103|FG004|Overall Study|Protocol Violation|0|||
160823125|NCT01904149|580739104|FG005|Overall Study|Protocol Violation|0|||
160989735|NCT01515319|581349669|FG008|Overall Study|Protocol Violation|2|||
160989736|NCT01515319|581349670|FG009|Overall Study|Protocol Violation|0|||
160989737|NCT04880161|581349671|FG000|Overall Study|Withdrawal by Subject|1|||
160989738|NCT04880161|581349672|FG001|Overall Study|Withdrawal by Subject|0|||
160989739|NCT04880161|581349671|FG000|Overall Study|Lack of Compliance|1|||
160989740|NCT04880161|581349672|FG001|Overall Study|Lack of Compliance|1|||
160989741|NCT04880161|581349671|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
160989742|NCT04880161|581349672|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
161133268|NCT03690869|581870866|FG000|Overall Study|Physician Decision|0|||
161133269|NCT03690869|581870867|FG001|Overall Study|Physician Decision|1|||
161133270|NCT03690869|581870868|FG002|Overall Study|Physician Decision|0|||
160823126|NCT01904149|580739099|FG000|Overall Study|non compliance with study drug|1|||
160823127|NCT01904149|580739100|FG001|Overall Study|non compliance with study drug|0|||
160823128|NCT01904149|580739101|FG002|Overall Study|non compliance with study drug|0|||
160823129|NCT01904149|580739102|FG003|Overall Study|non compliance with study drug|0|||
160823130|NCT01904149|580739103|FG004|Overall Study|non compliance with study drug|0|||
160823131|NCT01904149|580739104|FG005|Overall Study|non compliance with study drug|0|||
160823132|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Death|5|||
160823133|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Death|0|||
160823134|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Death|0|||
160823135|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
160823136|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
160823137|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
160901802|NCT00788073|581034088|FG000|STX209 Then Placebo|Adverse Event|1|||
160901803|NCT00788073|581034089|FG001|STX209 Then Placebo|Adverse Event|0|||
160901804|NCT00788073|581034088|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
160901805|NCT00788073|581034089|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
160901806|NCT00788073|581034088|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
160901807|NCT00788073|581034089|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
160901808|NCT00788073|581034088|FG000|STX209 Then Placebo|unable to return due to travel|0|||
160901809|NCT00788073|581034089|FG001|STX209 Then Placebo|unable to return due to travel|1|||
160901810|NCT00788073|581034088|FG000|Placebo Then STX209|Adverse Event|2|||
160901811|NCT00788073|581034089|FG001|Placebo Then STX209|Adverse Event|0|||
160901812|NCT00788073|581034088|FG000|Placebo Then STX209|Protocol Violation|0|||
160901813|NCT00788073|581034089|FG001|Placebo Then STX209|Protocol Violation|1|||
160901814|NCT03608254|581034090|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
160901815|NCT03608254|581034090|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
160901816|NCT00910273|581034091|FG000|Overall Study|Lack of Efficacy|6|||
160901817|NCT00910273|581034092|FG001|Overall Study|Lack of Efficacy|9|||
160901818|NCT00910273|581034091|FG000|Overall Study|Adverse Event|1|||
160901819|NCT00910273|581034092|FG001|Overall Study|Adverse Event|1|||
160901820|NCT00910273|581034091|FG000|Overall Study|Withdrawal by Subject|1|||
160901821|NCT00910273|581034092|FG001|Overall Study|Withdrawal by Subject|0|||
160901822|NCT00910273|581034091|FG000|Overall Study|Discontinuation of study by sponsor|8|||
160901823|NCT00910273|581034092|FG001|Overall Study|Discontinuation of study by sponsor|2|||
160901824|NCT00910273|581034091|FG000|Overall Study|Protocol Violation|1|||
160901825|NCT00910273|581034092|FG001|Overall Study|Protocol Violation|0|||
160901826|NCT00910273|581034091|FG000|Overall Study|Lost to Follow-up|1|||
160901827|NCT00910273|581034092|FG001|Overall Study|Lost to Follow-up|1|||
160901828|NCT00660673|581034093|FG000|Overall Study|Adverse Event|84|||
160901829|NCT00660673|581034093|FG000|Overall Study|Lack of Efficacy|7|||
160901830|NCT00660673|581034093|FG000|Overall Study|Withdrawal by Subject|22|||
160901831|NCT00660673|581034093|FG000|Overall Study|Administrative|2|||
160901832|NCT00660673|581034093|FG000|Overall Study|Protocol Violation|2|||
160901833|NCT00579098|581034094|FG000|Overall Study|Lost to Follow-up|2|||
160901834|NCT00579098|581034095|FG001|Overall Study|Lost to Follow-up|0|||
160901835|NCT00579098|581034094|FG000|Overall Study|Adverse Event|2|||
160901836|NCT00579098|581034095|FG001|Overall Study|Adverse Event|3|||
160901837|NCT00579098|581034094|FG000|Overall Study|Withdrawal by Subject|2|||
160901838|NCT00579098|581034095|FG001|Overall Study|Withdrawal by Subject|3|||
160901839|NCT00579098|581034094|FG000|Overall Study|AF returned after ablation|3|||
160901840|NCT00579098|581034095|FG001|Overall Study|AF returned after ablation|2|||
160901841|NCT03540030|581034103|FG000|Overall Study|Withdrawal by Subject|2|||
160901842|NCT03540030|581034104|FG001|Overall Study|Withdrawal by Subject|1|||
160901843|NCT03540030|581034103|FG000|Overall Study|screen fail|7|||
160901844|NCT03540030|581034104|FG001|Overall Study|screen fail|1|||
160901845|NCT03540030|581034103|FG000|Overall Study|never had surgery after signing consent|9|||
160901846|NCT03540030|581034104|FG001|Overall Study|never had surgery after signing consent|1|||
160901847|NCT00569270|581034105|FG000|Period: First Intervention|Protocol Violation|0|||
160901848|NCT00569270|581034106|FG001|Period: First Intervention|Protocol Violation|1|||
160901849|NCT01788228|581034112|FG000|Overall Study|Migrated/moved from study area|1|||
160901850|NCT01788228|581034113|FG001|Overall Study|Migrated/moved from study area|0|||
160901851|NCT01972568|581034114|FG000|Overall Study|Other events|3|||
160901852|NCT01972568|581034115|FG001|Overall Study|Other events|0|||
160901853|NCT01972568|581034116|FG002|Overall Study|Other events|0|||
160823138|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
160823139|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
160823140|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
160823141|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
160823142|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
160823143|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
160823144|NCT01357161|580739105|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
160823145|NCT01357161|580739106|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
160823146|NCT01357161|580739107|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
160823147|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
160823148|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
160823149|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
160823150|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
160823151|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
160823152|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
160823153|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
160823154|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
160823155|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
160823156|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
160823157|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
160823158|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
160823159|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
160823160|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
160823161|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
160823162|NCT01357161|580739105|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
160823163|NCT01357161|580739106|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
160823164|NCT01357161|580739107|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
160823165|NCT00068250|580739108|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
160823166|NCT00068250|580739109|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
160823167|NCT00068250|580739110|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
160823168|NCT00068250|580739111|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
160823169|NCT01824823|580739112|FG000|Overall Study|Lack of Efficacy|1|||
160823170|NCT01824823|580739113|FG001|Overall Study|Lack of Efficacy|1|||
160823171|NCT01824823|580739112|FG000|Overall Study|Off-treatment reason not submitted|1|||
160823172|NCT01824823|580739113|FG001|Overall Study|Off-treatment reason not submitted|0|||
160823173|NCT03349645|580739116|FG000|Overall Study|Sponsor Terminated Study|75|||
160823174|NCT03349645|580739116|FG000|Overall Study|Withdrawal by Subject|4|||
160823175|NCT03349645|580739116|FG000|Overall Study|Protocol Violation|1|||
160823176|NCT03349645|580739116|FG000|Overall Study|Other|2|||
160823177|NCT02927925|580739117|FG000|Overall Study|Death|16|||
160823178|NCT02927925|580739117|FG000|Overall Study|Physician Decision|1|||
160823179|NCT02927925|580739117|FG000|Overall Study|Withdrawal by Subject|11|||
160823180|NCT02927925|580739117|FG000|Overall Study|Other|3|||
160823181|NCT02927925|580739117|FG000|Overall Study|Disease progression at clinical cutoff|1|||
160823182|NCT02910401|580739119|FG000|Overall Study|Study closure Study closure|0|||
160823183|NCT02910401|580739120|FG001|Overall Study|Study closure Study closure|0|||
160823184|NCT02910401|580739121|FG002|Overall Study|Study closure Study closure|2|||
160823185|NCT02910401|580739119|FG000|Overall Study|Physician Decision|1|||
160823186|NCT02910401|580739120|FG001|Overall Study|Physician Decision|0|||
160823187|NCT02910401|580739121|FG002|Overall Study|Physician Decision|0|||
160823188|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
160823189|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
160823190|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Death|0|||
160989743|NCT04880161|581349671|FG000|Overall Study|Screen Failure|0|||
160989744|NCT04880161|581349672|FG001|Overall Study|Screen Failure|1|||
160989745|NCT01354106|581349673|FG000|Overall Study|Withdrawal by Subject|2|||
160823191|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Death|0|||
160823192|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
160823193|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
160989746|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Adverse Event|5|||
160823194|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
160823195|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
160823196|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
160823197|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
160989747|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Adverse Event|13|||
160823198|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
160823199|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
160823200|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
160823201|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
160823202|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
160823203|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
161133271|NCT03690869|581870869|FG003|Overall Study|Physician Decision|0|||
161133272|NCT03690869|581870870|FG004|Overall Study|Physician Decision|0|||
161133273|NCT03690869|581870871|FG005|Overall Study|Physician Decision|0|||
161133274|NCT03690869|581870872|FG006|Overall Study|Physician Decision|0|||
160823204|NCT00433160|580739124|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
160823205|NCT00433160|580739125|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
160823206|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
160823207|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
160823208|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
160823209|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
160823210|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
160823211|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
160823212|NCT00433160|580739124|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
160823213|NCT00433160|580739125|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
160823214|NCT00433160|580739124|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
160823215|NCT00433160|580739125|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
160823216|NCT00433160|580739124|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
160823217|NCT00433160|580739125|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
160823218|NCT00433160|580739124|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
160823219|NCT00433160|580739125|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
160823220|NCT02240368|580739129|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
160823221|NCT02240368|580739130|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
160823222|NCT02240368|580739131|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
160823223|NCT02240368|580739129|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
160823224|NCT02240368|580739130|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
160823225|NCT02240368|580739131|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
160823226|NCT03372460|580739132|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
160823227|NCT03372460|580739133|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
160823228|NCT00916058|580739140|FG000|Phase 1|Screen Failure|0|||
160823229|NCT00916058|580739141|FG001|Phase 1|Screen Failure|0|||
160823230|NCT00916058|580739142|FG002|Phase 1|Screen Failure|0|||
160823231|NCT00916058|580739143|FG003|Phase 1|Screen Failure|0|||
160823232|NCT00916058|580739144|FG004|Phase 1|Screen Failure|0|||
160823233|NCT00916058|580739145|FG005|Phase 1|Screen Failure|1|||
160823234|NCT00916058|580739146|FG006|Phase 1|Screen Failure|0|||
160823235|NCT00916058|580739140|FG000|Phase 2|Screen Failure|0|||
160823236|NCT00916058|580739141|FG001|Phase 2|Screen Failure|0|||
160823237|NCT00916058|580739142|FG002|Phase 2|Screen Failure|0|||
160823238|NCT00916058|580739143|FG003|Phase 2|Screen Failure|0|||
160823239|NCT00916058|580739144|FG004|Phase 2|Screen Failure|0|||
160823240|NCT00916058|580739145|FG005|Phase 2|Screen Failure|0|||
160823241|NCT00916058|580739146|FG006|Phase 2|Screen Failure|3|||
160823242|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
160823243|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
160823244|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
161133275|NCT03690869|581870873|FG007|Overall Study|Physician Decision|0|||
161133276|NCT03690869|581870874|FG008|Overall Study|Physician Decision|0|||
161133277|NCT03690869|581870875|FG009|Overall Study|Physician Decision|0|||
160823245|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
160823246|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
160823247|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
160823248|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
160823249|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
160823250|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
160823251|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
160823252|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
160823253|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
160901854|NCT01972568|581034114|FG000|Overall Study|Lack of Efficacy|0|||
160901855|NCT01972568|581034115|FG001|Overall Study|Lack of Efficacy|1|||
160901856|NCT01972568|581034116|FG002|Overall Study|Lack of Efficacy|2|||
160901857|NCT01972568|581034114|FG000|Overall Study|Protocol Violation|1|||
160901858|NCT01972568|581034115|FG001|Overall Study|Protocol Violation|2|||
160901859|NCT01972568|581034116|FG002|Overall Study|Protocol Violation|2|||
160901860|NCT01972568|581034114|FG000|Overall Study|Withdrawal by Subject|6|||
160901861|NCT01972568|581034115|FG001|Overall Study|Withdrawal by Subject|3|||
160901862|NCT01972568|581034116|FG002|Overall Study|Withdrawal by Subject|7|||
160901863|NCT01972568|581034114|FG000|Overall Study|Lost to Follow-up|1|||
160901864|NCT01972568|581034115|FG001|Overall Study|Lost to Follow-up|0|||
160823254|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
160823255|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
160901865|NCT01972568|581034116|FG002|Overall Study|Lost to Follow-up|0|||
160901866|NCT01972568|581034114|FG000|Overall Study|Adverse Event|5|||
160901867|NCT01972568|581034115|FG001|Overall Study|Adverse Event|6|||
161133278|NCT03690869|581870866|FG000|Overall Study|Progressive Disease|1|||
161133279|NCT03690869|581870867|FG001|Overall Study|Progressive Disease|2|||
160989748|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Adverse Event|0|||
160823256|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
160823257|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
160823258|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
160823259|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
160823260|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
160823261|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
160823262|NCT03222973|580739147|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
160823263|NCT03222973|580739148|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
160823264|NCT03222973|580739149|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
160823265|NCT03222973|580739150|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
160823266|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
160823267|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
160823268|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
160823269|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
160823270|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
160823271|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
160823272|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
160823273|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
160823274|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
160823275|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
160823276|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
160823277|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
160823278|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
160823279|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
160823280|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
160823281|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
160823282|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
160823283|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
160823284|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
160823285|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
160823286|NCT03222973|580739147|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
160823287|NCT03222973|580739148|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
160823288|NCT03222973|580739149|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
160823289|NCT03222973|580739150|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
160823290|NCT03899064|580740802|FG000|Overall Study|Lost to Follow-up|1|||
160823291|NCT03899064|580740802|FG000|Overall Study|Protocol Violation|2|||
160823292|NCT03899064|580740802|FG000|Overall Study|Withdrawal by Subject|2|||
160823293|NCT03899064|580740802|FG000|Overall Study|Other|2|||
160823294|NCT03283098|580740803|FG000|Overall Study|Withdrawal by Subject|0|||
160823295|NCT03283098|580740804|FG001|Overall Study|Withdrawal by Subject|1|||
160823296|NCT01069861|580740805|FG000|Overall Study|Death|1|||
160823297|NCT01069861|580740805|FG000|Overall Study|Adverse Event|1|||
160823298|NCT01069861|580740805|FG000|Overall Study|Did not meet entrance criteria|1|||
160823299|NCT00354107|580740806|FG000|Overall Study|Adverse Event|2|||
160823300|NCT00354107|580740806|FG000|Overall Study|Physician Decision|2|||
160823301|NCT00354107|580740806|FG000|Overall Study|Withdrawal by Subject|1|||
160823302|NCT02351349|580740807|FG000|Overall Study|Withdrawal by Subject|2|||
160823303|NCT02351349|580740808|FG001|Overall Study|Withdrawal by Subject|3|||
160823304|NCT02649218|580740809|FG000|Overall Study|Adverse Event|8|||
160823305|NCT02649218|580740809|FG000|Overall Study|Lack of Efficacy|8|||
160823306|NCT02649218|580740809|FG000|Overall Study|Pregnancy|3|||
160823307|NCT02649218|580740809|FG000|Overall Study|Protocol Violation|3|||
160823308|NCT02649218|580740809|FG000|Overall Study|Physician Decision|1|||
160823309|NCT02649218|580740809|FG000|Overall Study|Withdrawal by Subject|2|||
160823310|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
160823311|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
160823312|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
160823313|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
160989749|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
160989750|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
160989751|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
160989752|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
160989753|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
160989754|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
160823314|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
160823315|NCT01224821|580740810|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
160823316|NCT01224821|580740810|FG000|Long-Term Follow-Up|Death|2|||
160823317|NCT01224821|580740810|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
160823318|NCT00683917|580740811|FG000|Overall Study|Study prematurely terminated|10|||
160823319|NCT02174523|580740812|FG000|Overall Study|Withdrawal by Subject|1|||
160989755|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
160989756|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
160989757|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
160989758|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
160989759|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
160989760|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
160989761|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
160989762|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
160989763|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
160989764|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Physician Decision|2|||
160989765|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Physician Decision|3|||
160989766|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Physician Decision|0|||
160989767|NCT01449929|581349674|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
160989768|NCT01449929|581349675|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
160989769|NCT01449929|581349676|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
160989770|NCT01449929|581349674|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
160989771|NCT01449929|581349675|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
160989772|NCT01449929|581349676|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
160989773|NCT01449929|581349674|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
160989774|NCT01449929|581349675|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
160989775|NCT01449929|581349676|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
160989776|NCT01449929|581349674|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
160989777|NCT01449929|581349675|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
160989778|NCT01449929|581349676|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
160989779|NCT00901485|581349677|FG000|Overall Study|Lack of Efficacy|0|||
160989780|NCT00901485|581349678|FG001|Overall Study|Lack of Efficacy|2|||
160989781|NCT00901485|581349677|FG000|Overall Study|Withdrawal by Subject|1|||
160989782|NCT00901485|581349678|FG001|Overall Study|Withdrawal by Subject|2|||
160989783|NCT01871285|581349679|FG000|First Intervention (1 Day)|Adverse Event|1|||
160989784|NCT01871285|581349680|FG001|First Intervention (1 Day)|Adverse Event|0|||
160989785|NCT01871285|581349681|FG002|First Intervention (1 Day)|Adverse Event|0|||
160989786|NCT01871285|581349682|FG003|First Intervention (1 Day)|Adverse Event|0|||
160989787|NCT01871285|581349679|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
160823320|NCT02174523|580740813|FG001|Overall Study|Withdrawal by Subject|0|||
160823321|NCT00794365|580740814|FG000|Overall Study|Lost to Follow-up|38|||
160823322|NCT00794365|580740814|FG000|Overall Study|Other|17|||
160823323|NCT00794365|580740814|FG000|Overall Study|Poor Compliance|11|||
160823324|NCT00794365|580740814|FG000|Overall Study|Adverse Event|10|||
160823325|NCT00794365|580740814|FG000|Overall Study|Lack of Efficacy|3|||
160823326|NCT03538444|580740828|FG000|Overall Study|opioid withdrawal|1|||
160823327|NCT03538444|580740829|FG001|Overall Study|opioid withdrawal|0|||
160823328|NCT03022097|580740832|FG000|Overall Study|Adverse Event|3|||
160823329|NCT03022097|580740833|FG001|Overall Study|Adverse Event|4|||
160823330|NCT03022097|580740834|FG002|Overall Study|Adverse Event|1|||
160823331|NCT03022097|580740835|FG003|Overall Study|Adverse Event|3|||
160823332|NCT03022097|580740832|FG000|Overall Study|Progressive Disease|2|||
160823333|NCT03022097|580740833|FG001|Overall Study|Progressive Disease|0|||
160823334|NCT03022097|580740834|FG002|Overall Study|Progressive Disease|5|||
160823335|NCT03022097|580740835|FG003|Overall Study|Progressive Disease|2|||
160823336|NCT03022097|580740832|FG000|Overall Study|Lack of Efficacy|0|||
160823337|NCT03022097|580740833|FG001|Overall Study|Lack of Efficacy|0|||
160823338|NCT03022097|580740834|FG002|Overall Study|Lack of Efficacy|3|||
160823339|NCT03022097|580740835|FG003|Overall Study|Lack of Efficacy|3|||
160823340|NCT03022097|580740832|FG000|Overall Study|Protocol Violation|1|||
160823341|NCT03022097|580740833|FG001|Overall Study|Protocol Violation|0|||
160823342|NCT03022097|580740834|FG002|Overall Study|Protocol Violation|1|||
160823343|NCT03022097|580740835|FG003|Overall Study|Protocol Violation|0|||
160989788|NCT01871285|581349680|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
160989789|NCT01871285|581349681|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
160989790|NCT01871285|581349682|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
160989791|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
160989792|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
161334119|NCT04275336|582612502|FG002|Overall Study|Unscheduled venipuncture|7|||
161334120|NCT04275336|582612500|FG000|Overall Study|Failed specimen of saliva|4|||
160823344|NCT03022097|580740832|FG000|Overall Study|Withdrawal by Subject|11|||
160823345|NCT03022097|580740833|FG001|Overall Study|Withdrawal by Subject|13|||
160823346|NCT03022097|580740834|FG002|Overall Study|Withdrawal by Subject|15|||
160823347|NCT03022097|580740835|FG003|Overall Study|Withdrawal by Subject|21|||
160823348|NCT03022097|580740832|FG000|Overall Study|Lost to Follow-up|0|||
160989793|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
160989794|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
160989795|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
160823349|NCT03022097|580740833|FG001|Overall Study|Lost to Follow-up|0|||
160823350|NCT03022097|580740834|FG002|Overall Study|Lost to Follow-up|1|||
160823351|NCT03022097|580740835|FG003|Overall Study|Lost to Follow-up|1|||
160823352|NCT03022097|580740832|FG000|Overall Study|Other|4|||
160823353|NCT03022097|580740833|FG001|Overall Study|Other|1|||
160823354|NCT03022097|580740834|FG002|Overall Study|Other|6|||
160823355|NCT03022097|580740835|FG003|Overall Study|Other|4|||
160823356|NCT03022097|580740832|FG000|Overall Study|Due to COVID-19 pandemic|0|||
160823357|NCT03022097|580740833|FG001|Overall Study|Due to COVID-19 pandemic|1|||
160823358|NCT03022097|580740834|FG002|Overall Study|Due to COVID-19 pandemic|0|||
160823359|NCT03022097|580740835|FG003|Overall Study|Due to COVID-19 pandemic|0|||
160823360|NCT01451931|580740836|FG000|Overall Study|Lost to Follow-up|17|||
160823361|NCT01451931|580740837|FG001|Overall Study|Lost to Follow-up|36|||
160823362|NCT01451931|580740838|FG002|Overall Study|Lost to Follow-up|21|||
160823363|NCT01451931|580740836|FG000|Overall Study|Withdrawal by Subject|16|||
160823364|NCT01451931|580740837|FG001|Overall Study|Withdrawal by Subject|22|||
160823365|NCT01451931|580740838|FG002|Overall Study|Withdrawal by Subject|22|||
160823366|NCT03640052|580740844|FG000|Overall Study|Lost to Follow-up|0|||
160823367|NCT03640052|580740845|FG001|Overall Study|Lost to Follow-up|1|||
160823368|NCT03640052|580740846|FG002|Overall Study|Lost to Follow-up|0|||
160823369|NCT03640052|580740847|FG003|Overall Study|Lost to Follow-up|0|||
160823370|NCT03640052|580740848|FG004|Overall Study|Lost to Follow-up|0|||
160823371|NCT04422561|580740849|FG000|Overall Study|Lost to Follow-up|25|||
160823372|NCT04422561|580740850|FG001|Overall Study|Lost to Follow-up|11|||
160823373|NCT00623545|580740851|FG000|Overall Study|Adverse Event|6|||
160823374|NCT00623545|580740851|FG000|Overall Study|Withdrawal by Subject|4|||
160823375|NCT04239222|580740852|FG000|Baseline|Withdrawal by Subject|0|||
160823376|NCT04239222|580740853|FG001|Baseline|Withdrawal by Subject|0|||
160823377|NCT04239222|580740854|FG002|Baseline|Withdrawal by Subject|1|||
160823378|NCT04239222|580740855|FG003|Baseline|Withdrawal by Subject|1|||
160823379|NCT04239222|580740852|FG000|First Foot Assignment|Withdrawal by Subject|0|||
160823380|NCT04239222|580740853|FG001|First Foot Assignment|Withdrawal by Subject|0|||
160823381|NCT04239222|580740854|FG002|First Foot Assignment|Withdrawal by Subject|1|||
160823382|NCT04239222|580740855|FG003|First Foot Assignment|Withdrawal by Subject|0|||
160823383|NCT04239222|580740852|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
160823384|NCT04239222|580740853|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
160823385|NCT04239222|580740854|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
160823386|NCT04239222|580740855|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
160823387|NCT05479097|580740861|FG000|Overall Study|Withdrawal by Subject|2|||
160823388|NCT04126564|580740862|FG000|Overall Study|Withdrawal by Subject|0|||
160823389|NCT04126564|580740863|FG001|Overall Study|Withdrawal by Subject|2|||
160823390|NCT04126564|580740862|FG000|Overall Study|Lost to Follow-up|0|||
160823391|NCT04126564|580740863|FG001|Overall Study|Lost to Follow-up|1|||
160823392|NCT00457821|580740871|FG000|Part 2|Withdrawal by Subject|0|||
160823393|NCT00457821|580740872|FG001|Part 2|Withdrawal by Subject|0|||
160823394|NCT00457821|580740873|FG002|Part 2|Withdrawal by Subject|0|||
160823395|NCT00457821|580740874|FG003|Part 2|Withdrawal by Subject|0|||
160823396|NCT00457821|580740875|FG004|Part 2|Withdrawal by Subject|0|||
160823397|NCT00457821|580740876|FG005|Part 2|Withdrawal by Subject|0|||
160823398|NCT00457821|580740877|FG006|Part 2|Withdrawal by Subject|0|||
160823399|NCT00457821|580740878|FG007|Part 2|Withdrawal by Subject|1|||
160823400|NCT00790647|580740881|FG000|Overall Study|Adverse Event|1|||
160823401|NCT02437409|580740886|FG000|Overall Study|Withdrawal by Subject|3|||
160823402|NCT02437409|580740886|FG000|Overall Study|Screening failure|12|||
160823403|NCT00027378|580740887|FG000|Overall Study|Physician Decision|0|||
160823404|NCT00027378|580740888|FG001|Overall Study|Physician Decision|3|||
160823405|NCT02701777|580740890|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
160901868|NCT01972568|581034116|FG002|Overall Study|Adverse Event|5|||
160901869|NCT02059408|581034120|FG000|Overall Study|Did not get tested|0|||
160901870|NCT02059408|581034121|FG001|Overall Study|Did not get tested|330|||
160901871|NCT02059408|581034122|FG002|Overall Study|Did not get tested|358|||
160901872|NCT00508755|581034125|FG000|Overall Study|Withdrawal by Subject|1|||
160901873|NCT00957580|581034126|FG000|Overall Study|Ongoing at data cut-off|0|||
160901874|NCT00957580|581034127|FG001|Overall Study|Ongoing at data cut-off|1|||
160901875|NCT00957580|581034128|FG002|Overall Study|Ongoing at data cut-off|0|||
160901876|NCT00957580|581034126|FG000|Overall Study|Enrolled but not treated|0|||
160901877|NCT00957580|581034127|FG001|Overall Study|Enrolled but not treated|1|||
160901878|NCT00957580|581034128|FG002|Overall Study|Enrolled but not treated|0|||
160901879|NCT01187433|581034132|FG000|Overall Study|Protocol Violation|6|||
160901880|NCT01187433|581034133|FG001|Overall Study|Protocol Violation|2|||
160901881|NCT01187433|581034132|FG000|Overall Study|Withdrawal by Subject|5|||
160901882|NCT01187433|581034133|FG001|Overall Study|Withdrawal by Subject|2|||
160901883|NCT00621959|581034134|FG000|Overall Study|Adverse Event|4|||
160901884|NCT00621959|581034135|FG001|Overall Study|Adverse Event|2|||
160901885|NCT00621959|581034134|FG000|Overall Study|Lack of Efficacy|1|||
160901886|NCT00621959|581034135|FG001|Overall Study|Lack of Efficacy|1|||
160901887|NCT00621959|581034134|FG000|Overall Study|Lost to Follow-up|0|||
160901888|NCT00621959|581034135|FG001|Overall Study|Lost to Follow-up|2|||
160901889|NCT00621959|581034134|FG000|Overall Study|Withdrawal by Subject|1|||
160901890|NCT00621959|581034135|FG001|Overall Study|Withdrawal by Subject|1|||
160989796|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
160989797|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
160823406|NCT02701777|580740891|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
160823407|NCT02701777|580740892|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
160823408|NCT02701777|580740893|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
160823409|NCT02701777|580740890|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
160823410|NCT02701777|580740891|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
160823411|NCT02701777|580740892|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
160823412|NCT02701777|580740893|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
160823413|NCT01369680|580740894|FG000|Overall Study|Lost to Follow-up|0|||
160823414|NCT01369680|580740895|FG001|Overall Study|Lost to Follow-up|0|||
160823415|NCT01369680|580740896|FG002|Overall Study|Lost to Follow-up|1|||
160989798|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
160989799|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
160989800|NCT05397470|581349683|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
160989801|NCT05397470|581349684|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
160989802|NCT05397470|581349685|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
160989803|NCT05397470|581349683|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
160989804|NCT05397470|581349684|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
160989805|NCT05397470|581349685|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
160989806|NCT05397470|581349683|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
160989807|NCT05397470|581349684|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
160823416|NCT01369680|580740897|FG003|Overall Study|Lost to Follow-up|2|||
160823417|NCT02851407|580740898|FG000|Overall Study|Withdrawal by parent/guardian|2|||
160823418|NCT02851407|580740899|FG001|Overall Study|Withdrawal by parent/guardian|7|||
160823419|NCT02851407|580740898|FG000|Overall Study|Protocol deviation|0|||
160823420|NCT02851407|580740899|FG001|Overall Study|Protocol deviation|1|||
160823421|NCT02851407|580740898|FG000|Overall Study|Transferred to another hospital to continue|1|||
160823422|NCT02851407|580740899|FG001|Overall Study|Transferred to another hospital to continue|0|||
160823423|NCT02851407|580740898|FG000|Overall Study|Other Death|30|||
160823424|NCT02851407|580740899|FG001|Overall Study|Other Death|20|||
160823425|NCT02851407|580740898|FG000|Overall Study|Adverse event, serious fatal|6|||
160823426|NCT02851407|580740899|FG001|Overall Study|Adverse event, serious fatal|8|||
160823427|NCT02851407|580740898|FG000|Overall Study|Consent withdrawn by participant|5|||
160823428|NCT02851407|580740899|FG001|Overall Study|Consent withdrawn by participant|3|||
160823429|NCT02851407|580740898|FG000|Overall Study|Screen failure|2|||
160823430|NCT02851407|580740899|FG001|Overall Study|Screen failure|1|||
160823431|NCT02851407|580740898|FG000|Overall Study|Disease relapse|9|||
160823432|NCT02851407|580740899|FG001|Overall Study|Disease relapse|6|||
160823433|NCT02851407|580740898|FG000|Overall Study|Physician Decision|7|||
160823434|NCT02851407|580740899|FG001|Overall Study|Physician Decision|6|||
160823435|NCT02851407|580740898|FG000|Overall Study|Transferred to hospital closer to home|0|||
160823436|NCT02851407|580740899|FG001|Overall Study|Transferred to hospital closer to home|1|||
160823437|NCT02851407|580740898|FG000|Overall Study|Enrolled in an investigational study|0|||
160823438|NCT02851407|580740899|FG001|Overall Study|Enrolled in an investigational study|1|||
160989808|NCT05397470|581349685|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
160989809|NCT05397470|581349683|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
160989810|NCT05397470|581349684|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
160989811|NCT05397470|581349685|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
160989812|NCT01919619|581349686|FG000|Overall Study|Physician Decision|1|||
160989813|NCT01919619|581349687|FG001|Overall Study|Physician Decision|1|||
160989814|NCT02268396|581351652|FG000|Overall Study|Adverse Event|3|||
160989815|NCT02268396|581351652|FG000|Overall Study|Administrative|2|||
160989816|NCT02268396|581351652|FG000|Overall Study|Withdrawal by Subject|1|||
160989817|NCT02268396|581351652|FG000|Overall Study|Lost to Follow-up|2|||
160989818|NCT02268396|581351652|FG000|Overall Study|Protocol-Specified Criteria|2|||
160989819|NCT02268396|581351652|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
160989820|NCT01311648|581351653|FG000|Main Study|Protocol Violation|0|||
160989821|NCT01311648|581351654|FG001|Main Study|Protocol Violation|1|||
160989822|NCT01311648|581351653|FG000|Main Study|Adverse Event|0|||
160989823|NCT01311648|581351654|FG001|Main Study|Adverse Event|1|||
160823439|NCT02851407|580740898|FG000|Overall Study|Early recovery|1|||
160989824|NCT01311648|581351653|FG000|Main Study|Inhibitor management|0|||
160823440|NCT02851407|580740899|FG001|Overall Study|Early recovery|0|||
160823441|NCT02851407|580740898|FG000|Overall Study|Adverse event, non-fatal|7|||
160823442|NCT02851407|580740899|FG001|Overall Study|Adverse event, non-fatal|5|||
160989825|NCT01311648|581351654|FG001|Main Study|Inhibitor management|17|||
160823443|NCT02851407|580740898|FG000|Overall Study|Lost to Follow-up|0|||
160823444|NCT02851407|580740899|FG001|Overall Study|Lost to Follow-up|2|||
160823445|NCT01713283|580740900|FG000|Overall Study|Lack of Efficacy|10|||
160823446|NCT01713283|580740901|FG001|Overall Study|Lack of Efficacy|2|||
160823447|NCT01713283|580740900|FG000|Overall Study|Lost to Follow-up|1|||
160823448|NCT01713283|580740901|FG001|Overall Study|Lost to Follow-up|1|||
160823449|NCT00835640|580740902|FG000|Second Intervention|Protocol Violation|1|||
160823450|NCT00835640|580740903|FG001|Second Intervention|Protocol Violation|0|||
160823451|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
160823452|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
160823453|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Death|1|||
160823454|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Death|0|||
160823455|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
160823456|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
160823457|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
160823458|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
160823459|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
160823460|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
160823461|NCT00350272|580740904|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
160823462|NCT00350272|580740905|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
160823463|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
160823464|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
160823465|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
160823466|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
160823467|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
160823468|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
160823469|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
160823470|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
160823471|NCT00350272|580740904|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
160823472|NCT00350272|580740905|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
160823473|NCT00812006|580740906|FG000|Overall Study|Lost to Follow-up|0|||
160823474|NCT00812006|580740907|FG001|Overall Study|Lost to Follow-up|0|||
160823475|NCT00812006|580740908|FG002|Overall Study|Lost to Follow-up|2|||
160823476|NCT00812006|580740906|FG000|Overall Study|Physician Decision|0|||
160823477|NCT00812006|580740907|FG001|Overall Study|Physician Decision|0|||
160823478|NCT00812006|580740908|FG002|Overall Study|Physician Decision|1|||
160823479|NCT00812006|580740906|FG000|Overall Study|Withdrawal by Subject|2|||
160823480|NCT00812006|580740907|FG001|Overall Study|Withdrawal by Subject|1|||
160823481|NCT00812006|580740908|FG002|Overall Study|Withdrawal by Subject|1|||
160823482|NCT00812006|580740906|FG000|Overall Study|Lack of Qualifying Event|4|||
160823483|NCT00812006|580740907|FG001|Overall Study|Lack of Qualifying Event|2|||
160823484|NCT00812006|580740908|FG002|Overall Study|Lack of Qualifying Event|2|||
160823485|NCT00235391|580740910|FG000|Overall Study|Adverse Event|4|||
160823486|NCT00235391|580740911|FG001|Overall Study|Adverse Event|5|||
160823487|NCT00235391|580740912|FG002|Overall Study|Adverse Event|10|||
160823488|NCT00235391|580740913|FG003|Overall Study|Adverse Event|72|||
160823489|NCT00235391|580740914|FG004|Overall Study|Adverse Event|5|||
160823490|NCT00235391|580740915|FG005|Overall Study|Adverse Event|2|||
160823491|NCT00235391|580740910|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160823492|NCT00235391|580740911|FG001|Overall Study|Abnormal laboratory value(s)|5|||
160823493|NCT00235391|580740912|FG002|Overall Study|Abnormal laboratory value(s)|4|||
160823494|NCT00235391|580740913|FG003|Overall Study|Abnormal laboratory value(s)|27|||
160823495|NCT00235391|580740914|FG004|Overall Study|Abnormal laboratory value(s)|1|||
160823496|NCT00235391|580740915|FG005|Overall Study|Abnormal laboratory value(s)|2|||
160823497|NCT00235391|580740910|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160823498|NCT00235391|580740911|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160823499|NCT00235391|580740912|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160823500|NCT00235391|580740913|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
160823501|NCT00235391|580740914|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
160823502|NCT00235391|580740915|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
160823503|NCT00235391|580740910|FG000|Overall Study|Condition no longer requires treatment|3|||
160823504|NCT00235391|580740911|FG001|Overall Study|Condition no longer requires treatment|0|||
160823505|NCT00235391|580740912|FG002|Overall Study|Condition no longer requires treatment|0|||
160823506|NCT00235391|580740913|FG003|Overall Study|Condition no longer requires treatment|11|||
160823507|NCT00235391|580740914|FG004|Overall Study|Condition no longer requires treatment|1|||
160823508|NCT00235391|580740915|FG005|Overall Study|Condition no longer requires treatment|0|||
160823509|NCT00235391|580740910|FG000|Overall Study|Protocol deviation|0|||
160823510|NCT00235391|580740911|FG001|Overall Study|Protocol deviation|0|||
160823511|NCT00235391|580740912|FG002|Overall Study|Protocol deviation|1|||
160901891|NCT00621959|581034134|FG000|Overall Study|Other|1|||
160901892|NCT00621959|581034135|FG001|Overall Study|Other|3|||
160901893|NCT04223973|581034138|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
160901894|NCT04223973|581034139|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
160901895|NCT04223973|581034138|FG000|Overall Study|Adverse Event|4|||
160901896|NCT04223973|581034139|FG001|Overall Study|Adverse Event|0|||
160901897|NCT04223973|581034138|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
160823512|NCT00235391|580740913|FG003|Overall Study|Protocol deviation|11|||
160823513|NCT00235391|580740914|FG004|Overall Study|Protocol deviation|0|||
160989826|NCT01311648|581351653|FG000|Main Study|Withdrawal by Subject|0|||
160989827|NCT01311648|581351654|FG001|Main Study|Withdrawal by Subject|2|||
160823514|NCT00235391|580740915|FG005|Overall Study|Protocol deviation|0|||
160823515|NCT00235391|580740910|FG000|Overall Study|Withdrawal by Subject|2|||
160823516|NCT00235391|580740911|FG001|Overall Study|Withdrawal by Subject|3|||
160823517|NCT00235391|580740912|FG002|Overall Study|Withdrawal by Subject|3|||
160823518|NCT00235391|580740913|FG003|Overall Study|Withdrawal by Subject|61|||
160823519|NCT00235391|580740914|FG004|Overall Study|Withdrawal by Subject|5|||
160823520|NCT00235391|580740915|FG005|Overall Study|Withdrawal by Subject|0|||
160901898|NCT04223973|581034139|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
160989828|NCT01311648|581351653|FG000|Extension Study|Physician Decision|0|||
160989829|NCT01311648|581351654|FG001|Extension Study|Physician Decision|1|||
160989830|NCT01311648|581351653|FG000|Extension Study|ITI therapy with marketed product|0|||
160989831|NCT01311648|581351654|FG001|Extension Study|ITI therapy with marketed product|1|||
160989832|NCT01311648|581351653|FG000|Extension Study|Incorrect visit planning|0|||
160989833|NCT01311648|581351654|FG001|Extension Study|Incorrect visit planning|1|||
160989834|NCT01311648|581351653|FG000|Extension Study|Family's decision|0|||
160989835|NCT01311648|581351654|FG001|Extension Study|Family's decision|1|||
160989836|NCT01311648|581351653|FG000|Extension Study|Failure of ITI therapy|0|||
160989837|NCT01311648|581351654|FG001|Extension Study|Failure of ITI therapy|3|||
160989838|NCT01311648|581351653|FG000|Extension Study|Long travel|0|||
160989839|NCT01311648|581351654|FG001|Extension Study|Long travel|1|||
160989840|NCT01311648|581351653|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
160989841|NCT01311648|581351654|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
160989842|NCT01311648|581351653|FG000|Extension Study|Withdrawal by Subject|0|||
160989843|NCT01311648|581351654|FG001|Extension Study|Withdrawal by Subject|1|||
160989844|NCT01311648|581351653|FG000|Extension Study|Inhibitor management|0|||
160989845|NCT01311648|581351654|FG001|Extension Study|Inhibitor management|2|||
160989846|NCT01645111|581351655|FG000|Overall Study|Did not require Clevidipine|15|||
160989847|NCT01304706|581351658|FG000|Overall Study|Adverse Event|2|||
160989848|NCT01304706|581351658|FG000|Overall Study|Lack of Efficacy|1|||
160989849|NCT01304706|581351658|FG000|Overall Study|Death|3|||
160989850|NCT01304706|581351658|FG000|Overall Study|Withdrawal by Subject|3|||
160989851|NCT01304706|581351658|FG000|Overall Study|Lost to Follow-up|7|||
160989852|NCT01304706|581351658|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
160989853|NCT05526911|581351659|FG000|Overall Study|Adverse Event|2|||
160989854|NCT05025449|581351660|FG000|Overall Study|Withdrawal by Subject|1|||
160989855|NCT05025449|581351660|FG000|Overall Study|Patient emergently taken to operating room|1|||
160989856|NCT01419717|581351661|FG000|Overall Study|Protocol-specified Criteria|62|||
160989857|NCT01419717|581351661|FG000|Overall Study|Adverse Event|19|||
160989858|NCT01419717|581351661|FG000|Overall Study|Death|17|||
160989859|NCT01419717|581351661|FG000|Overall Study|Withdrawal by Subject|10|||
160989860|NCT01419717|581351661|FG000|Overall Study|Disease Progression|9|||
160989861|NCT01419717|581351661|FG000|Overall Study|Other|4|||
160989862|NCT01419717|581351661|FG000|Overall Study|Lost to Follow-up|2|||
160989863|NCT01419717|581351661|FG000|Overall Study|Administrative Decision|1|||
160989864|NCT01419717|581351661|FG000|Overall Study|Noncompliance|1|||
160989865|NCT00587288|581351663|FG000|Overall Study|Adverse Event|0|||
160989866|NCT00587288|581351664|FG001|Overall Study|Adverse Event|1|||
160989867|NCT00587288|581351663|FG000|Overall Study|Lack of Efficacy|2|||
160989868|NCT00587288|581351664|FG001|Overall Study|Lack of Efficacy|8|||
160989869|NCT00587288|581351663|FG000|Overall Study|Protocol Violation|1|||
160901899|NCT04223973|581034138|FG000|Overall Study|Physician Decision|1|||
160901900|NCT04223973|581034139|FG001|Overall Study|Physician Decision|1|||
160901901|NCT04223973|581034138|FG000|Overall Study|Withdrawal by Subject|0|||
160901902|NCT04223973|581034139|FG001|Overall Study|Withdrawal by Subject|1|||
160901903|NCT03360747|581034140|FG000|Overall Study|Voluntary Withdrawal|1|||
160901904|NCT02569671|581034148|FG000|Overall Study|Lost to Follow-up|2|||
160901905|NCT02569671|581034149|FG001|Overall Study|Lost to Follow-up|1|||
160901906|NCT02569671|581034148|FG000|Overall Study|Withdrawal by Subject|1|||
160901907|NCT02569671|581034149|FG001|Overall Study|Withdrawal by Subject|3|||
160901908|NCT01757535|581034150|FG000|Overall Study|Disease Relapse|151|||
160901909|NCT01757535|581034151|FG001|Overall Study|Disease Relapse|181|||
160901910|NCT01757535|581034150|FG000|Overall Study|Other Reasons|28|||
160901911|NCT01757535|581034151|FG001|Overall Study|Other Reasons|27|||
160989870|NCT00587288|581351664|FG001|Overall Study|Protocol Violation|0|||
160989871|NCT01240356|581351665|FG000|Overall Study|Withdrawal by Subject|2|||
160989872|NCT01240356|581351666|FG001|Overall Study|Withdrawal by Subject|0|||
160989873|NCT01240356|581351665|FG000|Overall Study|MRI contraindication|1|||
160989874|NCT01240356|581351666|FG001|Overall Study|MRI contraindication|0|||
160989875|NCT04048135|581351667|FG000|Overall Study|Withdrawal by Subject|1|||
160989876|NCT04048135|581351668|FG001|Overall Study|Withdrawal by Subject|1|||
160989877|NCT04048135|581351669|FG002|Overall Study|Withdrawal by Subject|1|||
160989878|NCT04048135|581351670|FG003|Overall Study|Withdrawal by Subject|2|||
160823521|NCT00235391|580740910|FG000|Overall Study|Lost to Follow-up|0|||
160823522|NCT00235391|580740911|FG001|Overall Study|Lost to Follow-up|3|||
160901912|NCT01757535|581034150|FG000|Overall Study|Adverse Event|31|||
160823523|NCT00235391|580740912|FG002|Overall Study|Lost to Follow-up|3|||
160823524|NCT00235391|580740913|FG003|Overall Study|Lost to Follow-up|16|||
160823525|NCT00235391|580740914|FG004|Overall Study|Lost to Follow-up|0|||
160823526|NCT00235391|580740915|FG005|Overall Study|Lost to Follow-up|0|||
160823527|NCT00235391|580740910|FG000|Overall Study|Administrative problems|0|||
160823528|NCT00235391|580740911|FG001|Overall Study|Administrative problems|0|||
160823529|NCT00235391|580740912|FG002|Overall Study|Administrative problems|0|||
160823530|NCT00235391|580740913|FG003|Overall Study|Administrative problems|1|||
160823531|NCT00235391|580740914|FG004|Overall Study|Administrative problems|0|||
160823532|NCT00235391|580740915|FG005|Overall Study|Administrative problems|0|||
160823533|NCT00235391|580740910|FG000|Overall Study|Death|0|||
160823534|NCT00235391|580740911|FG001|Overall Study|Death|0|||
160823535|NCT00235391|580740912|FG002|Overall Study|Death|1|||
160823536|NCT00235391|580740913|FG003|Overall Study|Death|4|||
160823537|NCT00235391|580740914|FG004|Overall Study|Death|0|||
160823538|NCT00235391|580740915|FG005|Overall Study|Death|0|||
160823539|NCT00075725|580740916|FG000|Overall Study|Adverse Event|6|||
160823540|NCT00075725|580740917|FG001|Overall Study|Adverse Event|6|||
160823541|NCT00075725|580740918|FG002|Overall Study|Adverse Event|20|||
160823542|NCT00075725|580740919|FG003|Overall Study|Adverse Event|8|||
160823543|NCT00075725|580740920|FG004|Overall Study|Adverse Event|4|||
160823544|NCT00075725|580740921|FG005|Overall Study|Adverse Event|38|||
160823545|NCT00075725|580740922|FG006|Overall Study|Adverse Event|3|||
160823546|NCT00075725|580740923|FG007|Overall Study|Adverse Event|51|||
160823547|NCT00075725|580740924|FG008|Overall Study|Adverse Event|15|||
160823548|NCT00075725|580740925|FG009|Overall Study|Adverse Event|4|||
160823549|NCT00075725|580740926|FG010|Overall Study|Adverse Event|2|||
160823550|NCT00075725|580740927|FG011|Overall Study|Adverse Event|2|||
160823551|NCT00075725|580740916|FG000|Overall Study|Death|3|||
160823552|NCT00075725|580740917|FG001|Overall Study|Death|5|||
160823553|NCT00075725|580740918|FG002|Overall Study|Death|10|||
160823554|NCT00075725|580740919|FG003|Overall Study|Death|2|||
160823555|NCT00075725|580740920|FG004|Overall Study|Death|3|||
160823556|NCT00075725|580740921|FG005|Overall Study|Death|25|||
160823557|NCT00075725|580740922|FG006|Overall Study|Death|4|||
160823558|NCT00075725|580740923|FG007|Overall Study|Death|22|||
160823559|NCT00075725|580740924|FG008|Overall Study|Death|14|||
160823560|NCT00075725|580740925|FG009|Overall Study|Death|4|||
160823561|NCT00075725|580740926|FG010|Overall Study|Death|3|||
160823562|NCT00075725|580740927|FG011|Overall Study|Death|0|||
160823563|NCT00075725|580740916|FG000|Overall Study|Lost to Follow-up|1|||
160823564|NCT00075725|580740917|FG001|Overall Study|Lost to Follow-up|1|||
160823565|NCT00075725|580740918|FG002|Overall Study|Lost to Follow-up|4|||
160823566|NCT00075725|580740919|FG003|Overall Study|Lost to Follow-up|1|||
160823567|NCT00075725|580740920|FG004|Overall Study|Lost to Follow-up|0|||
160823568|NCT00075725|580740921|FG005|Overall Study|Lost to Follow-up|13|||
160823569|NCT00075725|580740922|FG006|Overall Study|Lost to Follow-up|2|||
160823570|NCT00075725|580740923|FG007|Overall Study|Lost to Follow-up|4|||
160823571|NCT00075725|580740924|FG008|Overall Study|Lost to Follow-up|1|||
160823572|NCT00075725|580740925|FG009|Overall Study|Lost to Follow-up|0|||
160823573|NCT00075725|580740926|FG010|Overall Study|Lost to Follow-up|0|||
160823574|NCT00075725|580740927|FG011|Overall Study|Lost to Follow-up|0|||
161240741|NCT00466167|582262117|FG000|Overall Study|Lack of Efficacy|2|||
161240742|NCT00466167|582262118|FG001|Overall Study|Lack of Efficacy|0|||
161240743|NCT00466167|582262119|FG002|Overall Study|Lack of Efficacy|3|||
161240744|NCT00466167|582262117|FG000|Overall Study|Protocol Violation|1|||
161240745|NCT00466167|582262118|FG001|Overall Study|Protocol Violation|1|||
161240746|NCT00466167|582262119|FG002|Overall Study|Protocol Violation|2|||
161240747|NCT00466167|582262117|FG000|Overall Study|Lost to Follow-up|3|||
161240748|NCT00466167|582262118|FG001|Overall Study|Lost to Follow-up|2|||
161240749|NCT00466167|582262119|FG002|Overall Study|Lost to Follow-up|2|||
161240750|NCT00466167|582262117|FG000|Overall Study|Withdrawal by Subject|4|||
161240751|NCT00466167|582262118|FG001|Overall Study|Withdrawal by Subject|1|||
161240752|NCT00466167|582262119|FG002|Overall Study|Withdrawal by Subject|6|||
161240753|NCT00466167|582262117|FG000|Overall Study|patient did not meet inclusion criteria|1|||
161240754|NCT00466167|582262118|FG001|Overall Study|patient did not meet inclusion criteria|0|||
161240755|NCT00466167|582262119|FG002|Overall Study|patient did not meet inclusion criteria|1|||
161240756|NCT00466167|582262117|FG000|Overall Study|Not treated|1|||
161240757|NCT00466167|582262118|FG001|Overall Study|Not treated|0|||
161240758|NCT00466167|582262119|FG002|Overall Study|Not treated|0|||
160989879|NCT04048135|581351671|FG004|Overall Study|Withdrawal by Subject|0|||
160823575|NCT00075725|580740916|FG000|Overall Study|Physician Decision|2|||
160823576|NCT00075725|580740917|FG001|Overall Study|Physician Decision|6|||
160823577|NCT00075725|580740918|FG002|Overall Study|Physician Decision|5|||
160823578|NCT00075725|580740919|FG003|Overall Study|Physician Decision|8|||
160823579|NCT00075725|580740920|FG004|Overall Study|Physician Decision|4|||
161240759|NCT03199963|582262120|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
161240760|NCT03199963|582262121|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
161240761|NCT03199963|582262120|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
161240762|NCT03199963|582262121|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
160823580|NCT00075725|580740921|FG005|Overall Study|Physician Decision|19|||
160823581|NCT00075725|580740922|FG006|Overall Study|Physician Decision|3|||
160823582|NCT00075725|580740923|FG007|Overall Study|Physician Decision|17|||
160823583|NCT00075725|580740924|FG008|Overall Study|Physician Decision|5|||
160823584|NCT00075725|580740925|FG009|Overall Study|Physician Decision|0|||
160823585|NCT00075725|580740926|FG010|Overall Study|Physician Decision|1|||
160823586|NCT00075725|580740927|FG011|Overall Study|Physician Decision|0|||
160823587|NCT00075725|580740916|FG000|Overall Study|Pregnancy|0|||
160823588|NCT00075725|580740917|FG001|Overall Study|Pregnancy|0|||
160823589|NCT00075725|580740918|FG002|Overall Study|Pregnancy|0|||
160823590|NCT00075725|580740919|FG003|Overall Study|Pregnancy|0|||
160823591|NCT00075725|580740920|FG004|Overall Study|Pregnancy|0|||
160823592|NCT00075725|580740921|FG005|Overall Study|Pregnancy|1|||
160823593|NCT00075725|580740922|FG006|Overall Study|Pregnancy|0|||
160823594|NCT00075725|580740923|FG007|Overall Study|Pregnancy|1|||
160823595|NCT00075725|580740924|FG008|Overall Study|Pregnancy|0|||
160823596|NCT00075725|580740925|FG009|Overall Study|Pregnancy|0|||
160823597|NCT00075725|580740926|FG010|Overall Study|Pregnancy|0|||
160823598|NCT00075725|580740927|FG011|Overall Study|Pregnancy|0|||
160823599|NCT00075725|580740916|FG000|Overall Study|Protocol Violation|1|||
160823600|NCT00075725|580740917|FG001|Overall Study|Protocol Violation|1|||
160823601|NCT00075725|580740918|FG002|Overall Study|Protocol Violation|0|||
160823602|NCT00075725|580740919|FG003|Overall Study|Protocol Violation|3|||
160823603|NCT00075725|580740920|FG004|Overall Study|Protocol Violation|3|||
160823604|NCT00075725|580740921|FG005|Overall Study|Protocol Violation|2|||
160823605|NCT00075725|580740922|FG006|Overall Study|Protocol Violation|1|||
160823606|NCT00075725|580740923|FG007|Overall Study|Protocol Violation|2|||
160823607|NCT00075725|580740924|FG008|Overall Study|Protocol Violation|3|||
160823608|NCT00075725|580740925|FG009|Overall Study|Protocol Violation|0|||
160823609|NCT00075725|580740926|FG010|Overall Study|Protocol Violation|0|||
160989880|NCT04048135|581351672|FG005|Overall Study|Withdrawal by Subject|0|||
161133280|NCT03690869|581870868|FG002|Overall Study|Progressive Disease|0|||
160823610|NCT00075725|580740927|FG011|Overall Study|Protocol Violation|1|||
160823611|NCT00075725|580740916|FG000|Overall Study|Withdrawal by Subject|12|||
160823612|NCT00075725|580740917|FG001|Overall Study|Withdrawal by Subject|3|||
160823613|NCT00075725|580740918|FG002|Overall Study|Withdrawal by Subject|6|||
160823614|NCT00075725|580740919|FG003|Overall Study|Withdrawal by Subject|10|||
160823615|NCT00075725|580740920|FG004|Overall Study|Withdrawal by Subject|6|||
160823616|NCT00075725|580740921|FG005|Overall Study|Withdrawal by Subject|27|||
160823617|NCT00075725|580740922|FG006|Overall Study|Withdrawal by Subject|7|||
160823618|NCT00075725|580740923|FG007|Overall Study|Withdrawal by Subject|31|||
160823619|NCT00075725|580740924|FG008|Overall Study|Withdrawal by Subject|10|||
160823620|NCT00075725|580740925|FG009|Overall Study|Withdrawal by Subject|2|||
160823621|NCT00075725|580740926|FG010|Overall Study|Withdrawal by Subject|0|||
161133281|NCT03690869|581870869|FG003|Overall Study|Progressive Disease|1|||
161133282|NCT03690869|581870870|FG004|Overall Study|Progressive Disease|0|||
161133283|NCT03690869|581870871|FG005|Overall Study|Progressive Disease|0|||
161133284|NCT03690869|581870872|FG006|Overall Study|Progressive Disease|0|||
161133285|NCT03690869|581870873|FG007|Overall Study|Progressive Disease|0|||
161133286|NCT03690869|581870874|FG008|Overall Study|Progressive Disease|1|||
161133287|NCT03690869|581870875|FG009|Overall Study|Progressive Disease|1|||
161133288|NCT03690869|581870866|FG000|Overall Study|Subject Decision|0|||
161133289|NCT03690869|581870867|FG001|Overall Study|Subject Decision|0|||
161133290|NCT03690869|581870868|FG002|Overall Study|Subject Decision|0|||
161133291|NCT03690869|581870869|FG003|Overall Study|Subject Decision|1|||
161133292|NCT03690869|581870870|FG004|Overall Study|Subject Decision|0|||
161133293|NCT03690869|581870871|FG005|Overall Study|Subject Decision|0|||
161133294|NCT03690869|581870872|FG006|Overall Study|Subject Decision|0|||
161133295|NCT03690869|581870873|FG007|Overall Study|Subject Decision|1|||
161133296|NCT03690869|581870874|FG008|Overall Study|Subject Decision|0|||
161133297|NCT03690869|581870875|FG009|Overall Study|Subject Decision|0|||
161133298|NCT00934102|581872900|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
161133299|NCT00934102|581872901|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
161133300|NCT00934102|581872902|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
161133301|NCT00792298|581872903|FG000|Treatment Period 1|Adverse Event|0|||
161133302|NCT00792298|581872904|FG001|Treatment Period 1|Adverse Event|1|||
161133303|NCT00792298|581872905|FG002|Treatment Period 1|Adverse Event|0|||
161133304|NCT00792298|581872906|FG003|Treatment Period 1|Adverse Event|1|||
161133305|NCT00792298|581872907|FG004|Treatment Period 1|Adverse Event|0|||
161133306|NCT00792298|581872908|FG005|Treatment Period 1|Adverse Event|1|||
161133307|NCT00792298|581872909|FG006|Treatment Period 1|Adverse Event|1|||
161133308|NCT00792298|581872910|FG007|Treatment Period 1|Adverse Event|0|||
161133309|NCT00792298|581872903|FG000|Treatment Period 1|Lack of Efficacy|0|||
161133310|NCT00792298|581872904|FG001|Treatment Period 1|Lack of Efficacy|0|||
161133311|NCT00792298|581872905|FG002|Treatment Period 1|Lack of Efficacy|1|||
161133312|NCT00792298|581872906|FG003|Treatment Period 1|Lack of Efficacy|0|||
161133313|NCT00792298|581872907|FG004|Treatment Period 1|Lack of Efficacy|0|||
161133314|NCT00792298|581872908|FG005|Treatment Period 1|Lack of Efficacy|0|||
161133315|NCT00792298|581872909|FG006|Treatment Period 1|Lack of Efficacy|0|||
160989881|NCT04048135|581351673|FG006|Overall Study|Withdrawal by Subject|1|||
160989882|NCT04048135|581351674|FG007|Overall Study|Withdrawal by Subject|1|||
160989883|NCT04048135|581351667|FG000|Overall Study|Adverse Event|0|||
160823622|NCT00075725|580740927|FG011|Overall Study|Withdrawal by Subject|0|||
160823623|NCT00075725|580740916|FG000|Overall Study|Disease Progression, all other reasons|17|||
160823624|NCT00075725|580740917|FG001|Overall Study|Disease Progression, all other reasons|5|||
160823625|NCT00075725|580740918|FG002|Overall Study|Disease Progression, all other reasons|33|||
160823626|NCT00075725|580740919|FG003|Overall Study|Disease Progression, all other reasons|6|||
160823627|NCT00075725|580740920|FG004|Overall Study|Disease Progression, all other reasons|21|||
160823628|NCT00075725|580740921|FG005|Overall Study|Disease Progression, all other reasons|59|||
160823629|NCT00075725|580740922|FG006|Overall Study|Disease Progression, all other reasons|20|||
160823630|NCT00075725|580740923|FG007|Overall Study|Disease Progression, all other reasons|46|||
160823631|NCT00075725|580740924|FG008|Overall Study|Disease Progression, all other reasons|21|||
160823632|NCT00075725|580740925|FG009|Overall Study|Disease Progression, all other reasons|4|||
160823633|NCT00075725|580740926|FG010|Overall Study|Disease Progression, all other reasons|0|||
160823634|NCT00075725|580740927|FG011|Overall Study|Disease Progression, all other reasons|5|||
160823635|NCT00075725|580740916|FG000|Overall Study|Patient off treatment|0|||
160823636|NCT00075725|580740917|FG001|Overall Study|Patient off treatment|0|||
160823637|NCT00075725|580740918|FG002|Overall Study|Patient off treatment|1|||
160823638|NCT00075725|580740919|FG003|Overall Study|Patient off treatment|2|||
160823639|NCT00075725|580740920|FG004|Overall Study|Patient off treatment|1|||
160823640|NCT00075725|580740921|FG005|Overall Study|Patient off treatment|0|||
160823641|NCT00075725|580740922|FG006|Overall Study|Patient off treatment|0|||
160823642|NCT00075725|580740923|FG007|Overall Study|Patient off treatment|2|||
160823643|NCT00075725|580740924|FG008|Overall Study|Patient off treatment|1|||
160823644|NCT00075725|580740925|FG009|Overall Study|Patient off treatment|0|||
160823645|NCT00075725|580740926|FG010|Overall Study|Patient off treatment|0|||
160823646|NCT00075725|580740927|FG011|Overall Study|Patient off treatment|0|||
160823647|NCT00075725|580740916|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
160823648|NCT00075725|580740917|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
160823649|NCT00075725|580740918|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
160823650|NCT00075725|580740919|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
160823651|NCT00075725|580740920|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
160823652|NCT00075725|580740921|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
160823653|NCT00075725|580740922|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
160823654|NCT00075725|580740923|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
160823655|NCT00075725|580740924|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
160823656|NCT00075725|580740925|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
160823657|NCT00075725|580740926|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
160823658|NCT00075725|580740927|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
160823659|NCT00075725|580740916|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
160823660|NCT00075725|580740917|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
160989884|NCT04048135|581351668|FG001|Overall Study|Adverse Event|0|||
160989885|NCT04048135|581351669|FG002|Overall Study|Adverse Event|0|||
160989886|NCT04048135|581351670|FG003|Overall Study|Adverse Event|1|||
160989887|NCT04048135|581351671|FG004|Overall Study|Adverse Event|1|||
160989888|NCT04048135|581351672|FG005|Overall Study|Adverse Event|0|||
160989889|NCT04048135|581351673|FG006|Overall Study|Adverse Event|0|||
160989890|NCT04048135|581351674|FG007|Overall Study|Adverse Event|0|||
160989891|NCT04048135|581351667|FG000|Overall Study|Protocol Violation|0|||
160989892|NCT04048135|581351668|FG001|Overall Study|Protocol Violation|0|||
160989893|NCT04048135|581351669|FG002|Overall Study|Protocol Violation|0|||
160989894|NCT04048135|581351670|FG003|Overall Study|Protocol Violation|0|||
160989895|NCT04048135|581351671|FG004|Overall Study|Protocol Violation|0|||
160989896|NCT04048135|581351672|FG005|Overall Study|Protocol Violation|1|||
160989897|NCT04048135|581351673|FG006|Overall Study|Protocol Violation|0|||
160989898|NCT04048135|581351674|FG007|Overall Study|Protocol Violation|0|||
160989899|NCT02359435|581351675|FG000|Overall Study|Lost to Follow-up|4|||
160989900|NCT02359435|581351676|FG001|Overall Study|Lost to Follow-up|4|||
160989901|NCT00315055|581351677|FG000|Overall Study|Protocol Violation|2|||
160989902|NCT00315055|581351678|FG001|Overall Study|Protocol Violation|4|||
160989903|NCT00315055|581351677|FG000|Overall Study|Lost to Follow-up|1|||
160989904|NCT00315055|581351678|FG001|Overall Study|Lost to Follow-up|1|||
160989905|NCT02347943|581351680|FG000|Overall Study|Study was cancelled|140|||
160989906|NCT02347943|581351681|FG001|Overall Study|Study was cancelled|67|||
161240763|NCT03199963|582262120|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
160823661|NCT00075725|580740918|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
160823662|NCT00075725|580740919|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
160823663|NCT00075725|580740920|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
160823664|NCT00075725|580740921|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
160823665|NCT00075725|580740922|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
160823666|NCT00075725|580740923|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
160989907|NCT02347943|581351682|FG002|Overall Study|Study was cancelled|45|||
160989908|NCT01124162|581351687|FG000|First Intervention|Adverse Event|2|||
161240764|NCT03199963|582262121|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
161240765|NCT03199963|582262120|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
161240766|NCT03199963|582262121|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
161240767|NCT03199963|582262120|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
161240768|NCT03199963|582262121|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
161240769|NCT03199963|582262120|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
161240770|NCT03199963|582262121|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
161240771|NCT02105272|582262128|FG000|Overall Study|Adverse Event|1|||
160823667|NCT00075725|580740924|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
160823668|NCT00075725|580740925|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
160823669|NCT00075725|580740926|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
160823670|NCT00075725|580740927|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
160823671|NCT00075725|580740916|FG000|Overall Study|Pt non compliant with therapy|2|||
160823672|NCT00075725|580740917|FG001|Overall Study|Pt non compliant with therapy|1|||
160823673|NCT00075725|580740918|FG002|Overall Study|Pt non compliant with therapy|1|||
160823674|NCT00075725|580740919|FG003|Overall Study|Pt non compliant with therapy|0|||
160823675|NCT00075725|580740920|FG004|Overall Study|Pt non compliant with therapy|2|||
160823676|NCT00075725|580740921|FG005|Overall Study|Pt non compliant with therapy|14|||
160823677|NCT00075725|580740922|FG006|Overall Study|Pt non compliant with therapy|2|||
160823678|NCT00075725|580740923|FG007|Overall Study|Pt non compliant with therapy|5|||
160823679|NCT00075725|580740924|FG008|Overall Study|Pt non compliant with therapy|3|||
160823680|NCT00075725|580740925|FG009|Overall Study|Pt non compliant with therapy|0|||
160823681|NCT00075725|580740926|FG010|Overall Study|Pt non compliant with therapy|0|||
160823682|NCT00075725|580740927|FG011|Overall Study|Pt non compliant with therapy|0|||
160823683|NCT00075725|580740916|FG000|Overall Study|Pt age out of range for treatment|0|||
160823684|NCT00075725|580740917|FG001|Overall Study|Pt age out of range for treatment|1|||
160823685|NCT00075725|580740918|FG002|Overall Study|Pt age out of range for treatment|0|||
160823686|NCT00075725|580740919|FG003|Overall Study|Pt age out of range for treatment|0|||
160823687|NCT00075725|580740920|FG004|Overall Study|Pt age out of range for treatment|0|||
160823688|NCT00075725|580740921|FG005|Overall Study|Pt age out of range for treatment|1|||
160823689|NCT00075725|580740922|FG006|Overall Study|Pt age out of range for treatment|0|||
160823690|NCT00075725|580740923|FG007|Overall Study|Pt age out of range for treatment|1|||
160823691|NCT00075725|580740924|FG008|Overall Study|Pt age out of range for treatment|0|||
160823692|NCT00075725|580740925|FG009|Overall Study|Pt age out of range for treatment|0|||
160823693|NCT00075725|580740926|FG010|Overall Study|Pt age out of range for treatment|0|||
160823694|NCT00075725|580740927|FG011|Overall Study|Pt age out of range for treatment|0|||
161240772|NCT02105272|582262129|FG001|Overall Study|Adverse Event|2|||
161240773|NCT02105272|582262128|FG000|Overall Study|Physician Decision|0|||
161240774|NCT02105272|582262129|FG001|Overall Study|Physician Decision|1|||
161240775|NCT02105272|582262128|FG000|Overall Study|Protocol Violation|2|||
161240776|NCT02105272|582262129|FG001|Overall Study|Protocol Violation|0|||
161240777|NCT02105272|582262128|FG000|Overall Study|Withdrawal by Subject|2|||
161240778|NCT02105272|582262129|FG001|Overall Study|Withdrawal by Subject|0|||
161240779|NCT03930732|582262130|FG000|Overall Study|Adverse Event|9|||
161240780|NCT03930732|582262131|FG001|Overall Study|Adverse Event|7|||
161240781|NCT03930732|582262130|FG000|Overall Study|Poor compliance to protocol|0|||
161240782|NCT03930732|582262131|FG001|Overall Study|Poor compliance to protocol|1|||
161240783|NCT03930732|582262130|FG000|Overall Study|Withdrawal by Subject|23|||
161240784|NCT03930732|582262131|FG001|Overall Study|Withdrawal by Subject|11|||
161240785|NCT03930732|582262130|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
161240786|NCT03930732|582262131|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
161240787|NCT03930732|582262130|FG000|Overall Study|Other reason not related to COVID-19|5|||
161240788|NCT03930732|582262131|FG001|Overall Study|Other reason not related to COVID-19|8|||
161240789|NCT04128761|582262138|FG000|Overall Study|Lost to Follow-up|5|||
161240790|NCT04128761|582262139|FG001|Overall Study|Lost to Follow-up|6|||
161240791|NCT06539676|582262140|FG000|Overall Study|Early study termination|1|||
161240792|NCT06539676|582262141|FG001|Overall Study|Early study termination|0|||
161240793|NCT06539676|582262142|FG002|Overall Study|Early study termination|6|||
161240794|NCT00830024|582262145|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161240795|NCT00830024|582262146|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
161240796|NCT01750294|582263525|FG000|Overall Study|Withdrawal by Subject|1|||
161240797|NCT01750294|582263525|FG000|Overall Study|Safety Endpoint|1|||
161240798|NCT01624233|582263526|FG000|Period 2 - Induction|Adverse Event|1|||
161240799|NCT01624233|582263526|FG000|Period 3 - Maintenance|Adverse Event|2|||
161240800|NCT01624233|582263526|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
161240801|NCT01624233|582263526|FG000|Period 3 - Maintenance|Physician Decision|2|||
161240802|NCT01624233|582263526|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
161240803|NCT01624233|582263526|FG000|Period 4 - Drug Free Period|Relapsed|61|||
161240804|NCT01624233|582263526|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
161240805|NCT01624233|582263526|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
161334121|NCT04275336|582612501|FG001|Overall Study|Failed specimen of saliva|3|||
161334122|NCT04275336|582612502|FG002|Overall Study|Failed specimen of saliva|4|||
161334123|NCT03055936|582612503|FG000|Overall Study|Adverse Event|0|||
161334124|NCT03055936|582612504|FG001|Overall Study|Adverse Event|1|||
161334125|NCT03055936|582612505|FG002|Overall Study|Adverse Event|1|||
161334126|NCT03055936|582612506|FG003|Overall Study|Adverse Event|1|||
161334127|NCT03055936|582612503|FG000|Overall Study|Personal reason|2|||
161334128|NCT03055936|582612504|FG001|Overall Study|Personal reason|0|||
161334129|NCT03055936|582612505|FG002|Overall Study|Personal reason|1|||
161334130|NCT03055936|582612506|FG003|Overall Study|Personal reason|0|||
161334131|NCT01909804|582612513|FG000|Overall Study|Randomized but Never Treated|0|||
161334132|NCT01909804|582612514|FG001|Overall Study|Randomized but Never Treated|0|||
160823695|NCT00075725|580740916|FG000|Overall Study|Insurance issues|0|||
160823696|NCT00075725|580740917|FG001|Overall Study|Insurance issues|1|||
160823697|NCT00075725|580740918|FG002|Overall Study|Insurance issues|0|||
160823698|NCT00075725|580740919|FG003|Overall Study|Insurance issues|1|||
160823699|NCT00075725|580740920|FG004|Overall Study|Insurance issues|1|||
161334133|NCT01909804|582612515|FG002|Overall Study|Randomized but Never Treated|0|||
160823700|NCT00075725|580740921|FG005|Overall Study|Insurance issues|1|||
160823701|NCT00075725|580740922|FG006|Overall Study|Insurance issues|0|||
160823702|NCT00075725|580740923|FG007|Overall Study|Insurance issues|1|||
160823703|NCT00075725|580740924|FG008|Overall Study|Insurance issues|0|||
160823704|NCT00075725|580740925|FG009|Overall Study|Insurance issues|0|||
160823705|NCT00075725|580740926|FG010|Overall Study|Insurance issues|0|||
160823706|NCT00075725|580740927|FG011|Overall Study|Insurance issues|0|||
160823707|NCT00075725|580740916|FG000|Overall Study|MRD positive after extended ind|0|||
160823708|NCT00075725|580740917|FG001|Overall Study|MRD positive after extended ind|1|||
160823709|NCT00075725|580740918|FG002|Overall Study|MRD positive after extended ind|1|||
160823710|NCT00075725|580740919|FG003|Overall Study|MRD positive after extended ind|0|||
160823711|NCT00075725|580740920|FG004|Overall Study|MRD positive after extended ind|1|||
160823712|NCT00075725|580740921|FG005|Overall Study|MRD positive after extended ind|2|||
160823713|NCT00075725|580740922|FG006|Overall Study|MRD positive after extended ind|0|||
160823714|NCT00075725|580740923|FG007|Overall Study|MRD positive after extended ind|1|||
160823715|NCT00075725|580740924|FG008|Overall Study|MRD positive after extended ind|0|||
160823716|NCT00075725|580740925|FG009|Overall Study|MRD positive after extended ind|0|||
160823717|NCT00075725|580740926|FG010|Overall Study|MRD positive after extended ind|0|||
160823718|NCT00075725|580740927|FG011|Overall Study|MRD positive after extended ind|0|||
160823719|NCT00075725|580740916|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
160823720|NCT00075725|580740917|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
160823721|NCT00075725|580740918|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
160823722|NCT00075725|580740919|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
160823723|NCT00075725|580740920|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
160823724|NCT00075725|580740921|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
160823725|NCT00075725|580740922|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
160823726|NCT00075725|580740923|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
160823727|NCT00075725|580740924|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
160823728|NCT00075725|580740925|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
160823729|NCT00075725|580740926|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
160823730|NCT00075725|580740927|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
160823731|NCT00075725|580740916|FG000|Overall Study|Inevaluable|1|||
160823732|NCT00075725|580740917|FG001|Overall Study|Inevaluable|1|||
160823733|NCT00075725|580740918|FG002|Overall Study|Inevaluable|4|||
160823734|NCT00075725|580740919|FG003|Overall Study|Inevaluable|2|||
160901913|NCT01757535|581034151|FG001|Overall Study|Adverse Event|11|||
160901914|NCT01757535|581034150|FG000|Overall Study|Withdrew Consent|19|||
160901915|NCT01757535|581034151|FG001|Overall Study|Withdrew Consent|13|||
160901916|NCT01757535|581034150|FG000|Overall Study|Physician Decision|7|||
161133316|NCT00792298|581872910|FG007|Treatment Period 1|Lack of Efficacy|0|||
161133317|NCT00792298|581872903|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161133318|NCT00792298|581872904|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161133319|NCT00792298|581872905|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161133320|NCT00792298|581872906|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161133321|NCT00792298|581872907|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161133322|NCT00792298|581872908|FG005|Treatment Period 1|Withdrawal by Subject|2|||
161133323|NCT00792298|581872909|FG006|Treatment Period 1|Withdrawal by Subject|1|||
161133324|NCT00792298|581872910|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161133325|NCT00792298|581872903|FG000|Treatment Period 1|Lost to Follow-up|0|||
161133326|NCT00792298|581872904|FG001|Treatment Period 1|Lost to Follow-up|0|||
161133327|NCT00792298|581872905|FG002|Treatment Period 1|Lost to Follow-up|0|||
161133328|NCT00792298|581872906|FG003|Treatment Period 1|Lost to Follow-up|0|||
161334134|NCT01909804|582612516|FG003|Overall Study|Randomized but Never Treated|0|||
161334135|NCT01909804|582612517|FG004|Overall Study|Randomized but Never Treated|0|||
161133329|NCT00792298|581872907|FG004|Treatment Period 1|Lost to Follow-up|0|||
161334136|NCT01909804|582612518|FG005|Overall Study|Randomized but Never Treated|0|||
161334137|NCT01909804|582612519|FG006|Overall Study|Randomized but Never Treated|1|||
161334138|NCT01909804|582612520|FG007|Overall Study|Randomized but Never Treated|0|||
161334139|NCT01909804|582612521|FG008|Overall Study|Randomized but Never Treated|0|||
161334140|NCT01909804|582612522|FG009|Overall Study|Randomized but Never Treated|0|||
160823735|NCT00075725|580740920|FG004|Overall Study|Inevaluable|2|||
160823736|NCT00075725|580740921|FG005|Overall Study|Inevaluable|9|||
160823737|NCT00075725|580740922|FG006|Overall Study|Inevaluable|1|||
160823738|NCT00075725|580740923|FG007|Overall Study|Inevaluable|11|||
160823739|NCT00075725|580740924|FG008|Overall Study|Inevaluable|2|||
160823740|NCT00075725|580740925|FG009|Overall Study|Inevaluable|0|||
160823741|NCT00075725|580740926|FG010|Overall Study|Inevaluable|1|||
160823742|NCT00075725|580740927|FG011|Overall Study|Inevaluable|0|||
160823743|NCT00075725|580740916|FG000|Overall Study|Other|4|||
160823744|NCT00075725|580740917|FG001|Overall Study|Other|2|||
160823745|NCT00075725|580740918|FG002|Overall Study|Other|1|||
160823746|NCT00075725|580740919|FG003|Overall Study|Other|1|||
160823747|NCT00075725|580740920|FG004|Overall Study|Other|1|||
160823748|NCT00075725|580740921|FG005|Overall Study|Other|4|||
160823749|NCT00075725|580740922|FG006|Overall Study|Other|2|||
160823750|NCT00075725|580740923|FG007|Overall Study|Other|9|||
160823751|NCT00075725|580740924|FG008|Overall Study|Other|2|||
160823752|NCT00075725|580740925|FG009|Overall Study|Other|1|||
160823753|NCT00075725|580740926|FG010|Overall Study|Other|0|||
160823754|NCT00075725|580740927|FG011|Overall Study|Other|3|||
160823755|NCT00075725|580740916|FG000|Overall Study|Pt trying to find a BM donor|0|||
160823756|NCT00075725|580740917|FG001|Overall Study|Pt trying to find a BM donor|1|||
160823757|NCT00075725|580740918|FG002|Overall Study|Pt trying to find a BM donor|0|||
160823758|NCT00075725|580740919|FG003|Overall Study|Pt trying to find a BM donor|0|||
160823759|NCT00075725|580740920|FG004|Overall Study|Pt trying to find a BM donor|0|||
160823760|NCT00075725|580740921|FG005|Overall Study|Pt trying to find a BM donor|0|||
160823761|NCT00075725|580740922|FG006|Overall Study|Pt trying to find a BM donor|0|||
160823762|NCT00075725|580740923|FG007|Overall Study|Pt trying to find a BM donor|0|||
160823763|NCT00075725|580740924|FG008|Overall Study|Pt trying to find a BM donor|0|||
160823764|NCT00075725|580740925|FG009|Overall Study|Pt trying to find a BM donor|0|||
160823765|NCT00075725|580740926|FG010|Overall Study|Pt trying to find a BM donor|0|||
160823766|NCT00075725|580740927|FG011|Overall Study|Pt trying to find a BM donor|0|||
160823767|NCT00075725|580740916|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
160823768|NCT00075725|580740917|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
160823769|NCT00075725|580740918|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
160823770|NCT00075725|580740919|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
160823771|NCT00075725|580740920|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
160823772|NCT00075725|580740921|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
160823773|NCT00075725|580740922|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
160823774|NCT00075725|580740923|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
160901917|NCT01757535|581034151|FG001|Overall Study|Physician Decision|0|||
160901918|NCT01757535|581034150|FG000|Overall Study|Death|2|||
160901919|NCT01757535|581034151|FG001|Overall Study|Death|2|||
160901920|NCT00589290|581034152|FG000|Overall Study|Withdrawal by Subject|1|||
160901921|NCT03730012|581034153|FG000|Overall Study|Adverse Event|0|||
160901922|NCT03730012|581034154|FG001|Overall Study|Adverse Event|1|||
160901923|NCT03730012|581034153|FG000|Overall Study|Lack of Efficacy|1|||
160901924|NCT03730012|581034154|FG001|Overall Study|Lack of Efficacy|5|||
160901925|NCT03730012|581034153|FG000|Overall Study|Withdrawal by Subject|0|||
160901926|NCT03730012|581034154|FG001|Overall Study|Withdrawal by Subject|1|||
160901927|NCT03730012|581034153|FG000|Overall Study|Miscellaneous|2|||
160901928|NCT03730012|581034154|FG001|Overall Study|Miscellaneous|1|||
160901929|NCT05350410|581035914|FG000|Overall Study|Withdrawal by Subject|1|||
160901930|NCT03750955|581035921|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
160901931|NCT03750955|581035922|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
160901932|NCT03750955|581035921|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
160901933|NCT03750955|581035922|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
160901934|NCT00142935|581035929|FG000|Overall Study|Other reason|1|||
160901935|NCT00142935|581035930|FG001|Overall Study|Other reason|1|||
160901936|NCT00142935|581035931|FG002|Overall Study|Other reason|1|||
160901937|NCT00142935|581035929|FG000|Overall Study|Lost to Follow-up|2|||
160901938|NCT00142935|581035930|FG001|Overall Study|Lost to Follow-up|5|||
160901939|NCT00142935|581035931|FG002|Overall Study|Lost to Follow-up|5|||
160901940|NCT00142935|581035929|FG000|Overall Study|Death|0|||
160901941|NCT00142935|581035930|FG001|Overall Study|Death|2|||
160901942|NCT00142935|581035931|FG002|Overall Study|Death|1|||
160901943|NCT03345914|581035936|FG000|Overall Study|Transition to another study at week 16|80|||
161334141|NCT01909804|582612523|FG010|Overall Study|Randomized but Never Treated|0|||
160901944|NCT03345914|581035937|FG001|Overall Study|Transition to another study at week 16|86|||
160823775|NCT00075725|580740924|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
160823776|NCT00075725|580740925|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
160823777|NCT00075725|580740926|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
160823778|NCT00075725|580740927|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
160823779|NCT00075725|580740916|FG000|Overall Study|Unsuccessful institutional transfer|0|||
160823780|NCT00075725|580740917|FG001|Overall Study|Unsuccessful institutional transfer|0|||
160823781|NCT00075725|580740918|FG002|Overall Study|Unsuccessful institutional transfer|2|||
160823782|NCT00075725|580740919|FG003|Overall Study|Unsuccessful institutional transfer|0|||
160823783|NCT00075725|580740920|FG004|Overall Study|Unsuccessful institutional transfer|0|||
160823784|NCT00075725|580740921|FG005|Overall Study|Unsuccessful institutional transfer|0|||
161133330|NCT00792298|581872908|FG005|Treatment Period 1|Lost to Follow-up|0|||
161334142|NCT01909804|582612524|FG011|Overall Study|Randomized but Never Treated|1|||
160823785|NCT00075725|580740922|FG006|Overall Study|Unsuccessful institutional transfer|0|||
160823786|NCT00075725|580740923|FG007|Overall Study|Unsuccessful institutional transfer|0|||
160823787|NCT00075725|580740924|FG008|Overall Study|Unsuccessful institutional transfer|0|||
160823788|NCT00075725|580740925|FG009|Overall Study|Unsuccessful institutional transfer|1|||
160823789|NCT00075725|580740926|FG010|Overall Study|Unsuccessful institutional transfer|0|||
160823790|NCT00075725|580740927|FG011|Overall Study|Unsuccessful institutional transfer|0|||
160823791|NCT00075725|580740916|FG000|Overall Study|specimen(s) not submitted|0|||
160823792|NCT00075725|580740917|FG001|Overall Study|specimen(s) not submitted|0|||
160823793|NCT00075725|580740918|FG002|Overall Study|specimen(s) not submitted|2|||
160823794|NCT00075725|580740919|FG003|Overall Study|specimen(s) not submitted|0|||
160823795|NCT00075725|580740920|FG004|Overall Study|specimen(s) not submitted|0|||
160823796|NCT00075725|580740921|FG005|Overall Study|specimen(s) not submitted|0|||
160823797|NCT00075725|580740922|FG006|Overall Study|specimen(s) not submitted|0|||
160823798|NCT00075725|580740923|FG007|Overall Study|specimen(s) not submitted|0|||
160823799|NCT00075725|580740924|FG008|Overall Study|specimen(s) not submitted|0|||
160823800|NCT00075725|580740925|FG009|Overall Study|specimen(s) not submitted|0|||
160823801|NCT00075725|580740926|FG010|Overall Study|specimen(s) not submitted|0|||
160823802|NCT00075725|580740927|FG011|Overall Study|specimen(s) not submitted|0|||
160823803|NCT00075725|580740916|FG000|Overall Study|Pt went to transplant|0|||
160823804|NCT00075725|580740917|FG001|Overall Study|Pt went to transplant|0|||
160823805|NCT00075725|580740918|FG002|Overall Study|Pt went to transplant|0|||
160823806|NCT00075725|580740919|FG003|Overall Study|Pt went to transplant|1|||
160823807|NCT00075725|580740920|FG004|Overall Study|Pt went to transplant|0|||
160823808|NCT00075725|580740921|FG005|Overall Study|Pt went to transplant|1|||
160823809|NCT00075725|580740922|FG006|Overall Study|Pt went to transplant|0|||
160823810|NCT00075725|580740923|FG007|Overall Study|Pt went to transplant|0|||
160823811|NCT00075725|580740924|FG008|Overall Study|Pt went to transplant|0|||
160823812|NCT00075725|580740925|FG009|Overall Study|Pt went to transplant|0|||
160823813|NCT00075725|580740926|FG010|Overall Study|Pt went to transplant|0|||
160823814|NCT00075725|580740927|FG011|Overall Study|Pt went to transplant|0|||
160823815|NCT00075725|580740916|FG000|Overall Study|Pt received additional steroids|0|||
160823816|NCT00075725|580740917|FG001|Overall Study|Pt received additional steroids|0|||
160823817|NCT00075725|580740918|FG002|Overall Study|Pt received additional steroids|0|||
160823818|NCT00075725|580740919|FG003|Overall Study|Pt received additional steroids|1|||
160823819|NCT00075725|580740920|FG004|Overall Study|Pt received additional steroids|0|||
160823820|NCT00075725|580740921|FG005|Overall Study|Pt received additional steroids|0|||
160823821|NCT00075725|580740922|FG006|Overall Study|Pt received additional steroids|0|||
160823822|NCT00075725|580740923|FG007|Overall Study|Pt received additional steroids|0|||
160823823|NCT00075725|580740924|FG008|Overall Study|Pt received additional steroids|0|||
160823824|NCT00075725|580740925|FG009|Overall Study|Pt received additional steroids|0|||
160823825|NCT00075725|580740926|FG010|Overall Study|Pt received additional steroids|0|||
160823826|NCT00075725|580740927|FG011|Overall Study|Pt received additional steroids|0|||
160823827|NCT00075725|580740916|FG000|Overall Study|Pt relocated|0|||
160823828|NCT00075725|580740917|FG001|Overall Study|Pt relocated|0|||
160823829|NCT00075725|580740918|FG002|Overall Study|Pt relocated|0|||
160823830|NCT00075725|580740919|FG003|Overall Study|Pt relocated|2|||
160823831|NCT00075725|580740920|FG004|Overall Study|Pt relocated|0|||
160823832|NCT00075725|580740921|FG005|Overall Study|Pt relocated|1|||
160823833|NCT00075725|580740922|FG006|Overall Study|Pt relocated|1|||
160823834|NCT00075725|580740923|FG007|Overall Study|Pt relocated|2|||
160823835|NCT00075725|580740924|FG008|Overall Study|Pt relocated|1|||
160823836|NCT00075725|580740925|FG009|Overall Study|Pt relocated|0|||
160823837|NCT00075725|580740926|FG010|Overall Study|Pt relocated|0|||
160823838|NCT00075725|580740927|FG011|Overall Study|Pt relocated|0|||
160823839|NCT00075725|580740916|FG000|Overall Study|Institution Terminated|0|||
160823840|NCT00075725|580740917|FG001|Overall Study|Institution Terminated|0|||
160823841|NCT00075725|580740918|FG002|Overall Study|Institution Terminated|0|||
160823842|NCT00075725|580740919|FG003|Overall Study|Institution Terminated|0|||
160823843|NCT00075725|580740920|FG004|Overall Study|Institution Terminated|1|||
160823844|NCT00075725|580740921|FG005|Overall Study|Institution Terminated|0|||
161334143|NCT01909804|582612513|FG000|Overall Study|Death|0|||
161334144|NCT01909804|582612514|FG001|Overall Study|Death|0|||
161334145|NCT01909804|582612515|FG002|Overall Study|Death|0|||
161334146|NCT01909804|582612516|FG003|Overall Study|Death|0|||
160823845|NCT00075725|580740922|FG006|Overall Study|Institution Terminated|0|||
161334147|NCT01909804|582612517|FG004|Overall Study|Death|0|||
160823846|NCT00075725|580740923|FG007|Overall Study|Institution Terminated|3|||
160823847|NCT00075725|580740924|FG008|Overall Study|Institution Terminated|0|||
160823848|NCT00075725|580740925|FG009|Overall Study|Institution Terminated|0|||
160823849|NCT00075725|580740926|FG010|Overall Study|Institution Terminated|0|||
160823850|NCT00075725|580740927|FG011|Overall Study|Institution Terminated|0|||
160823851|NCT00075725|580740916|FG000|Overall Study|Study Closure|1|||
160823852|NCT00075725|580740917|FG001|Overall Study|Study Closure|0|||
160823853|NCT00075725|580740918|FG002|Overall Study|Study Closure|0|||
160823854|NCT00075725|580740919|FG003|Overall Study|Study Closure|0|||
160823855|NCT00075725|580740920|FG004|Overall Study|Study Closure|1|||
160823856|NCT00075725|580740921|FG005|Overall Study|Study Closure|3|||
160823857|NCT00075725|580740922|FG006|Overall Study|Study Closure|0|||
160823858|NCT00075725|580740923|FG007|Overall Study|Study Closure|1|||
160823859|NCT00075725|580740924|FG008|Overall Study|Study Closure|0|||
160823860|NCT00075725|580740925|FG009|Overall Study|Study Closure|0|||
160823861|NCT00075725|580740926|FG010|Overall Study|Study Closure|0|||
160823862|NCT00075725|580740927|FG011|Overall Study|Study Closure|0|||
160823863|NCT00075725|580740916|FG000|Overall Study|Other complications|0|||
160823864|NCT00075725|580740917|FG001|Overall Study|Other complications|0|||
160823865|NCT00075725|580740918|FG002|Overall Study|Other complications|0|||
160823866|NCT00075725|580740919|FG003|Overall Study|Other complications|0|||
160823867|NCT00075725|580740920|FG004|Overall Study|Other complications|0|||
160823868|NCT00075725|580740921|FG005|Overall Study|Other complications|1|||
160823869|NCT00075725|580740922|FG006|Overall Study|Other complications|0|||
160823870|NCT00075725|580740923|FG007|Overall Study|Other complications|0|||
160823871|NCT00075725|580740924|FG008|Overall Study|Other complications|0|||
160823872|NCT00075725|580740925|FG009|Overall Study|Other complications|0|||
160823873|NCT00075725|580740926|FG010|Overall Study|Other complications|0|||
160823874|NCT00075725|580740927|FG011|Overall Study|Other complications|0|||
160823875|NCT00075725|580740916|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
160823876|NCT00075725|580740917|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
160823877|NCT00075725|580740918|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
160823878|NCT00075725|580740919|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
160823879|NCT00075725|580740920|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
160823880|NCT00075725|580740921|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
160823881|NCT00075725|580740922|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
160823882|NCT00075725|580740923|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
160823883|NCT00075725|580740924|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
160823884|NCT00075725|580740925|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
160823885|NCT00075725|580740926|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
160823886|NCT00075725|580740927|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
160823887|NCT00075725|580740916|FG000|Overall Study|Pt incarcerated|0|||
160823888|NCT00075725|580740917|FG001|Overall Study|Pt incarcerated|0|||
160823889|NCT00075725|580740918|FG002|Overall Study|Pt incarcerated|0|||
160823890|NCT00075725|580740919|FG003|Overall Study|Pt incarcerated|0|||
160823891|NCT00075725|580740920|FG004|Overall Study|Pt incarcerated|0|||
160823892|NCT00075725|580740921|FG005|Overall Study|Pt incarcerated|0|||
160823893|NCT00075725|580740922|FG006|Overall Study|Pt incarcerated|0|||
160823894|NCT00075725|580740923|FG007|Overall Study|Pt incarcerated|1|||
160823895|NCT00075725|580740924|FG008|Overall Study|Pt incarcerated|0|||
160823896|NCT00075725|580740925|FG009|Overall Study|Pt incarcerated|0|||
160823897|NCT00075725|580740926|FG010|Overall Study|Pt incarcerated|0|||
160823898|NCT00075725|580740927|FG011|Overall Study|Pt incarcerated|0|||
160823899|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Death|1|||
160823900|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Death|1|||
160823901|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Death|0|||
160823902|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Death|0|||
160823903|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Death|1|||
160823904|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Death|0|||
160823905|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Death|0|||
160823906|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Death|0|||
160823907|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Death|0|||
160823908|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Death|0|||
160823909|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
160823910|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
160823911|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
160823912|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823913|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
160823914|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823915|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823916|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823917|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823918|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
160823919|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823920|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160901945|NCT03345914|581035938|FG002|Overall Study|Transition to another study at week 16|78|||
160989909|NCT01124162|581351688|FG001|First Intervention|Adverse Event|0|||
161240806|NCT01624233|582263526|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
161240807|NCT01624233|582263526|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
161240808|NCT01624233|582263526|FG000|Period 6: Follow-up|Adverse Event|3|||
161240809|NCT01624233|582263526|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
161240810|NCT01624233|582263526|FG000|Period 6: Follow-up|Physician Decision|1|||
161240811|NCT01624233|582263526|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
161240812|NCT03121586|582263529|FG000|Overall Study|Study terminated by sponsor|0|||
161240813|NCT03121586|582263530|FG001|Overall Study|Study terminated by sponsor|0|||
161240814|NCT03121586|582263531|FG002|Overall Study|Study terminated by sponsor|99|||
161240815|NCT03121586|582263529|FG000|Overall Study|Withdrawal by Subject|37|||
161240816|NCT03121586|582263530|FG001|Overall Study|Withdrawal by Subject|14|||
161240817|NCT03121586|582263531|FG002|Overall Study|Withdrawal by Subject|9|||
161240818|NCT03121586|582263529|FG000|Overall Study|Not further specified|6|||
161240819|NCT03121586|582263530|FG001|Overall Study|Not further specified|11|||
161240820|NCT03121586|582263531|FG002|Overall Study|Not further specified|10|||
160823921|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823922|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823923|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
160823924|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823925|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823926|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
161240821|NCT03121586|582263529|FG000|Overall Study|Adverse Event|16|||
161240822|NCT03121586|582263530|FG001|Overall Study|Adverse Event|5|||
160823927|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823928|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
160823929|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
160823930|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823931|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823932|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823933|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823934|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823935|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823936|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823937|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823938|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
160823939|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
160823940|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823941|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823942|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
160823943|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
160823944|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823945|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823946|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823947|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823948|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
160823949|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
160823950|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823951|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823952|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
160823953|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823954|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823955|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823956|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823957|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823958|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
160823959|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
160823960|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
160823961|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
160823962|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
160823963|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
160823964|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160823965|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160823966|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
160823967|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161240823|NCT03121586|582263531|FG002|Overall Study|Adverse Event|6|||
161240824|NCT03121586|582263529|FG000|Overall Study|Protocol Violation|0|||
161240825|NCT03121586|582263530|FG001|Overall Study|Protocol Violation|5|||
161334148|NCT01909804|582612518|FG005|Overall Study|Death|0|||
160823968|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
161240826|NCT03121586|582263531|FG002|Overall Study|Protocol Violation|0|||
161240827|NCT03121586|582263529|FG000|Overall Study|Lack of Efficacy|3|||
160823969|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
160823970|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
160823971|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
160823972|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823973|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
160823974|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823975|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823976|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823977|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823978|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160823979|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
160823980|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823981|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823982|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
160823983|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
160823984|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823985|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823986|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823987|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823988|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
160823989|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823990|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823991|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823992|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823993|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160823994|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823995|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823996|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823997|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823998|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160823999|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824000|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824001|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824002|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824003|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824004|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160901946|NCT03345914|581035936|FG000|Overall Study|Transition to OLE during follow-up|37|||
160901947|NCT03345914|581035937|FG001|Overall Study|Transition to OLE during follow-up|33|||
160901948|NCT03345914|581035938|FG002|Overall Study|Transition to OLE during follow-up|39|||
161240828|NCT03121586|582263530|FG001|Overall Study|Lack of Efficacy|3|||
161240829|NCT03121586|582263531|FG002|Overall Study|Lack of Efficacy|1|||
161240830|NCT03121586|582263529|FG000|Overall Study|Physician Decision|2|||
161240831|NCT03121586|582263530|FG001|Overall Study|Physician Decision|2|||
161240832|NCT03121586|582263531|FG002|Overall Study|Physician Decision|0|||
161240833|NCT03121586|582263529|FG000|Overall Study|Noncompliance with study drug|5|||
161240834|NCT03121586|582263530|FG001|Overall Study|Noncompliance with study drug|3|||
161240835|NCT03121586|582263531|FG002|Overall Study|Noncompliance with study drug|5|||
161240836|NCT03121586|582263529|FG000|Overall Study|Lost to Follow-up|4|||
161240837|NCT03121586|582263530|FG001|Overall Study|Lost to Follow-up|2|||
161240838|NCT03121586|582263531|FG002|Overall Study|Lost to Follow-up|0|||
161240839|NCT03121586|582263529|FG000|Overall Study|Death|2|||
161240840|NCT03121586|582263530|FG001|Overall Study|Death|0|||
161240841|NCT03121586|582263531|FG002|Overall Study|Death|0|||
161240842|NCT06381102|582263532|FG000|Washout 5 Days|Withdrawal by Subject|0|||
161240843|NCT06381102|582263533|FG001|Washout 5 Days|Withdrawal by Subject|2|||
161240844|NCT02832063|582263535|FG000|Overall Study|Adverse Event|2|||
161240845|NCT02832063|582263536|FG001|Overall Study|Adverse Event|1|||
161240846|NCT02832063|582263535|FG000|Overall Study|Physician Decision|5|||
161240847|NCT02832063|582263536|FG001|Overall Study|Physician Decision|7|||
161240848|NCT02832063|582263535|FG000|Overall Study|Lost to Follow-up|15|||
161240849|NCT02832063|582263536|FG001|Overall Study|Lost to Follow-up|8|||
161240850|NCT02832063|582263535|FG000|Overall Study|Withdrawal by Subject|10|||
161240851|NCT02832063|582263536|FG001|Overall Study|Withdrawal by Subject|21|||
161240852|NCT02832063|582263535|FG000|Overall Study|Other|2|||
161240853|NCT02832063|582263536|FG001|Overall Study|Other|1|||
161240854|NCT03733730|582263537|FG000|Overall Study|Lost to Follow-up|1|||
161240855|NCT03733730|582263538|FG001|Overall Study|Lost to Follow-up|32|||
161240856|NCT03733730|582263537|FG000|Overall Study|Other|1|||
161240857|NCT03733730|582263538|FG001|Overall Study|Other|0|||
161240858|NCT03733730|582263537|FG000|Overall Study|Adverse Event|0|||
161240859|NCT03733730|582263538|FG001|Overall Study|Adverse Event|4|||
161240860|NCT03733730|582263537|FG000|Overall Study|Death|0|||
161240861|NCT03733730|582263538|FG001|Overall Study|Death|5|||
161240862|NCT03733730|582263537|FG000|Overall Study|Withdrawal by Subject|0|||
161240863|NCT03733730|582263538|FG001|Overall Study|Withdrawal by Subject|8|||
161240864|NCT00772603|582263539|FG000|Overall Study|Withdrawal by Subject|11|||
161240865|NCT00772603|582263540|FG001|Overall Study|Withdrawal by Subject|10|||
161240866|NCT00772603|582263541|FG002|Overall Study|Withdrawal by Subject|6|||
161240867|NCT00772603|582263539|FG000|Overall Study|Adverse Event|37|||
161240868|NCT00772603|582263540|FG001|Overall Study|Adverse Event|18|||
161240869|NCT00772603|582263541|FG002|Overall Study|Adverse Event|10|||
161240870|NCT00772603|582263539|FG000|Overall Study|Subject Non-compliance|1|||
161240871|NCT00772603|582263540|FG001|Overall Study|Subject Non-compliance|6|||
161240872|NCT00772603|582263541|FG002|Overall Study|Subject Non-compliance|4|||
161240873|NCT00772603|582263539|FG000|Overall Study|Protocol Violation|0|||
161240874|NCT00772603|582263540|FG001|Overall Study|Protocol Violation|1|||
161240875|NCT00772603|582263541|FG002|Overall Study|Protocol Violation|1|||
161240876|NCT00772603|582263539|FG000|Overall Study|Lost to Follow-up|1|||
161240877|NCT00772603|582263540|FG001|Overall Study|Lost to Follow-up|5|||
161240878|NCT00772603|582263541|FG002|Overall Study|Lost to Follow-up|2|||
161240879|NCT00772603|582263539|FG000|Overall Study|Physician Decision|0|||
161240880|NCT00772603|582263540|FG001|Overall Study|Physician Decision|0|||
161240881|NCT00772603|582263541|FG002|Overall Study|Physician Decision|1|||
161240882|NCT00772603|582263539|FG000|Overall Study|Other|2|||
161240883|NCT00772603|582263540|FG001|Overall Study|Other|0|||
161240884|NCT00772603|582263541|FG002|Overall Study|Other|2|||
161240885|NCT01564394|582263544|FG000|Overall Study|Withdrawal by Subject|6|||
161240886|NCT01564394|582263545|FG001|Overall Study|Withdrawal by Subject|10|||
161240887|NCT00859521|582263546|FG000|Washout|Withdrawal by Subject|0|||
161240888|NCT00859521|582263547|FG001|Washout|Withdrawal by Subject|1|||
161240889|NCT01609257|582263548|FG000|Overall Study|Lost to Follow-up|2|||
161240890|NCT01609257|582263549|FG001|Overall Study|Lost to Follow-up|1|||
161240891|NCT01609257|582263548|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
161240892|NCT01609257|582263549|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
161240893|NCT01609257|582263548|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
161240894|NCT01609257|582263549|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
161240895|NCT02125461|582263550|FG000|Overall Study|Withdrawal by Subject|30|||
160824005|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824006|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824007|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824008|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
161240896|NCT02125461|582263551|FG001|Overall Study|Withdrawal by Subject|16|||
160824009|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
160824010|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
160824011|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
160824012|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
160824013|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
160901949|NCT03345914|581035936|FG000|Overall Study|Physician Decision|0|||
161240897|NCT02125461|582263550|FG000|Overall Study|Lost to Follow-up|8|||
161240898|NCT02125461|582263551|FG001|Overall Study|Lost to Follow-up|3|||
161240899|NCT02125461|582263550|FG000|Overall Study|Death|260|||
161240900|NCT02125461|582263551|FG001|Overall Study|Death|149|||
161240901|NCT02125461|582263550|FG000|Overall Study|Missing Termination Reason|0|||
161240902|NCT02125461|582263551|FG001|Overall Study|Missing Termination Reason|1|||
161240903|NCT03552484|582263560|FG000|Overall Study|Death|6|||
161240904|NCT03552484|582263561|FG001|Overall Study|Death|4|||
161240905|NCT03552484|582263560|FG000|Overall Study|Lost to Follow-up|0|||
161240906|NCT03552484|582263561|FG001|Overall Study|Lost to Follow-up|16|||
161240907|NCT03499353|582263562|FG000|Treatment|Adverse Event|3|||
161240908|NCT03499353|582263562|FG000|Treatment|Progressive Disease|10|||
161240909|NCT03499353|582263562|FG000|Treatment|Other|1|||
161240910|NCT03499353|582263562|FG000|Treatment|Withdrawal by Subject|2|||
160824014|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824015|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824016|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824017|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824018|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
160824019|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824020|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824021|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824022|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
160824023|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
160824024|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824025|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824026|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824027|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824028|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824029|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824030|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824031|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824032|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824033|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824034|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824035|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824036|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824037|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824038|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824039|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824040|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824041|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824042|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824043|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
160824044|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824045|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824046|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824047|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824048|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
160824049|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824050|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824051|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824052|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824053|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
160824054|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824055|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824056|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824057|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824058|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824059|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
161240911|NCT03499353|582263562|FG000|Long-Term Follow-up|Death|2|||
161240912|NCT03499353|582263562|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
161240913|NCT03499353|582263562|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
161240914|NCT00469898|582263569|FG000|Overall Study|Adverse Event|7|||
161240915|NCT00469898|582263569|FG000|Overall Study|Withdrawal by Subject|4|||
160989910|NCT01124162|581351687|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161240916|NCT00469898|582263569|FG000|Overall Study|Death|4|||
161240917|NCT00469898|582263569|FG000|Overall Study|Disease progression|9|||
161240918|NCT00469898|582263569|FG000|Overall Study|Decreased performance status|1|||
161334149|NCT01909804|582612519|FG006|Overall Study|Death|0|||
161334150|NCT01909804|582612520|FG007|Overall Study|Death|0|||
160824060|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
160824061|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824062|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824063|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
160824064|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824065|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824066|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824067|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824068|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
160824069|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
160824070|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824071|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824072|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824073|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
160824074|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824075|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824076|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824077|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824078|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
160824079|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
160824080|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824081|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
160824082|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824083|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
160824084|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824085|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824086|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824087|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824088|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
160824089|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Other|5|||
160824090|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Other|1|||
160824091|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Other|0|||
160824092|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Other|3|||
160824093|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Other|0|||
160824094|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Other|0|||
160824095|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Other|0|||
160824096|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Other|0|||
160824097|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Other|0|||
160824098|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Other|0|||
160824099|NCT03352557|580740928|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824100|NCT03352557|580740929|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824101|NCT03352557|580740930|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824102|NCT03352557|580740931|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
161133331|NCT00792298|581872909|FG006|Treatment Period 1|Lost to Follow-up|1|||
160824103|NCT03352557|580740932|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
160824104|NCT03352557|580740933|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824105|NCT03352557|580740934|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824106|NCT03352557|580740935|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824107|NCT03352557|580740936|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824108|NCT03352557|580740937|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
160824109|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Death|0|||
160824110|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Death|0|||
160824111|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Death|0|||
160824112|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Death|0|||
161133332|NCT00792298|581872910|FG007|Treatment Period 1|Lost to Follow-up|0|||
161133333|NCT00792298|581872903|FG000|Treatment Period 1|Physician Decision|0|||
161133334|NCT00792298|581872904|FG001|Treatment Period 1|Physician Decision|0|||
160824113|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Death|0|||
160824114|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Death|1|||
160824115|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Death|0|||
160824116|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Death|1|||
161133335|NCT00792298|581872905|FG002|Treatment Period 1|Physician Decision|0|||
161334151|NCT01909804|582612521|FG008|Overall Study|Death|0|||
160824117|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Death|1|||
160824118|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Death|1|||
160824119|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824120|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824121|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824122|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824123|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824124|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
161133336|NCT00792298|581872906|FG003|Treatment Period 1|Physician Decision|1|||
160824125|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824126|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824127|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824128|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
160824129|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824130|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824131|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824132|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824133|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824134|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824135|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824136|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824137|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
160824138|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
160824139|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824140|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824141|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824142|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824143|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
160824144|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
160824145|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
160824146|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
160824147|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
160824148|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
160824149|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824150|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824151|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824152|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824153|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824154|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
160901950|NCT03345914|581035937|FG001|Overall Study|Physician Decision|1|||
160901951|NCT03345914|581035938|FG002|Overall Study|Physician Decision|1|||
160901952|NCT03345914|581035936|FG000|Overall Study|Withdrawal by Subject|5|||
160901953|NCT03345914|581035937|FG001|Overall Study|Withdrawal by Subject|1|||
160901954|NCT03345914|581035938|FG002|Overall Study|Withdrawal by Subject|2|||
160901955|NCT03345914|581035936|FG000|Overall Study|Other|1|||
160901956|NCT03345914|581035937|FG001|Overall Study|Other|1|||
160901957|NCT03345914|581035938|FG002|Overall Study|Other|1|||
160901958|NCT03345914|581035936|FG000|Overall Study|Ongoing|0|||
160901959|NCT03345914|581035937|FG001|Overall Study|Ongoing|0|||
160901960|NCT03345914|581035938|FG002|Overall Study|Ongoing|1|||
160901961|NCT02601027|581035941|FG000|Registration to Surgery|Withdrawal by Subject|20|||
160901962|NCT02601027|581035942|FG001|Registration to Surgery|Withdrawal by Subject|10|||
160901963|NCT01330030|581035943|FG000|Overall Study|Lost to Follow-up|16|||
160901964|NCT01330030|581035944|FG001|Overall Study|Lost to Follow-up|17|||
161240919|NCT02663349|582263572|FG000|Overall Study|Withdrawal by Subject|6|||
161240920|NCT00848536|582263573|FG000|Overall Study|Adverse Event|2|||
161240921|NCT00848536|582263574|FG001|Overall Study|Adverse Event|2|||
161240922|NCT00848536|582263573|FG000|Overall Study|Withdrawal by Subject|0|||
161240923|NCT00848536|582263574|FG001|Overall Study|Withdrawal by Subject|1|||
161240924|NCT00848536|582263573|FG000|Overall Study|Protocol Violation|0|||
161240925|NCT00848536|582263574|FG001|Overall Study|Protocol Violation|1|||
161240926|NCT00848536|582263573|FG000|Overall Study|Noncompliance|1|||
161240927|NCT00848536|582263574|FG001|Overall Study|Noncompliance|0|||
161240928|NCT00848536|582263573|FG000|Overall Study|Inadequate Control of IOP|1|||
161240929|NCT00848536|582263574|FG001|Overall Study|Inadequate Control of IOP|1|||
161240930|NCT00848536|582263573|FG000|Overall Study|Patient Moved|0|||
161240931|NCT00848536|582263574|FG001|Overall Study|Patient Moved|2|||
161240932|NCT01175135|582263575|FG000|Overall Study|Adverse Event|2|||
161240933|NCT01175135|582263576|FG001|Overall Study|Adverse Event|5|||
161240934|NCT01175135|582263577|FG002|Overall Study|Adverse Event|3|||
161240935|NCT01175135|582263578|FG003|Overall Study|Adverse Event|4|||
161240936|NCT01175135|582263575|FG000|Overall Study|Death|1|||
161240937|NCT01175135|582263576|FG001|Overall Study|Death|0|||
161240938|NCT01175135|582263577|FG002|Overall Study|Death|0|||
161240939|NCT01175135|582263578|FG003|Overall Study|Death|0|||
161240940|NCT01175135|582263575|FG000|Overall Study|Lack of Efficacy|4|||
161240941|NCT01175135|582263576|FG001|Overall Study|Lack of Efficacy|5|||
161240942|NCT01175135|582263577|FG002|Overall Study|Lack of Efficacy|0|||
161240943|NCT01175135|582263578|FG003|Overall Study|Lack of Efficacy|5|||
161240944|NCT01175135|582263575|FG000|Overall Study|Lost to Follow-up|1|||
161240945|NCT01175135|582263576|FG001|Overall Study|Lost to Follow-up|2|||
161240946|NCT01175135|582263577|FG002|Overall Study|Lost to Follow-up|0|||
161240947|NCT01175135|582263578|FG003|Overall Study|Lost to Follow-up|0|||
161240948|NCT01175135|582263575|FG000|Overall Study|Protocol Violation|1|||
161240949|NCT01175135|582263576|FG001|Overall Study|Protocol Violation|1|||
161240950|NCT01175135|582263577|FG002|Overall Study|Protocol Violation|0|||
161240951|NCT01175135|582263578|FG003|Overall Study|Protocol Violation|0|||
161240952|NCT01175135|582263575|FG000|Overall Study|Withdrawal by Subject|4|||
161240953|NCT01175135|582263576|FG001|Overall Study|Withdrawal by Subject|8|||
161240954|NCT01175135|582263577|FG002|Overall Study|Withdrawal by Subject|5|||
161240955|NCT01175135|582263578|FG003|Overall Study|Withdrawal by Subject|5|||
161240956|NCT01175135|582263575|FG000|Overall Study|Other|3|||
161240957|NCT01175135|582263576|FG001|Overall Study|Other|1|||
161240958|NCT01175135|582263577|FG002|Overall Study|Other|3|||
161240959|NCT01175135|582263578|FG003|Overall Study|Other|0|||
161240960|NCT01175135|582263575|FG000|Overall Study|Randomized But Not Treated|0|||
161240961|NCT01175135|582263576|FG001|Overall Study|Randomized But Not Treated|0|||
161240962|NCT01175135|582263577|FG002|Overall Study|Randomized But Not Treated|1|||
161240963|NCT01175135|582263578|FG003|Overall Study|Randomized But Not Treated|0|||
161240964|NCT01590563|582263583|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
161240965|NCT03534193|582263584|FG000|Overall Study|Lost to Follow-up|1|||
161240966|NCT03534193|582263585|FG001|Overall Study|Lost to Follow-up|3|||
161240967|NCT02699463|582263586|FG000|Overall Study|Lost to Follow-up|11|||
161240968|NCT02699463|582263587|FG001|Overall Study|Lost to Follow-up|8|||
161240969|NCT02699463|582263586|FG000|Overall Study|Withdrawal by Subject|4|||
161240970|NCT02699463|582263587|FG001|Overall Study|Withdrawal by Subject|1|||
161240971|NCT02488239|582263588|FG000|Overall Study|Death|3|||
161240972|NCT02488239|582263588|FG000|Overall Study|Withdrawal by Subject|3|||
161240973|NCT02488239|582263588|FG000|Overall Study|Physician Decision|2|||
161240974|NCT02488239|582263588|FG000|Overall Study|Consent ineligible|1|||
161240975|NCT02488239|582263588|FG000|Overall Study|Did not undergo implant procedure|1|||
161240976|NCT04414930|582263590|FG000|Overall Study|Withdrawal by Subject|1|||
161240977|NCT04414930|582263591|FG001|Overall Study|Withdrawal by Subject|3|||
161240978|NCT05470699|582263592|FG000|Overall Study|Did not receive intervention|13|||
161240979|NCT05470699|582263592|FG000|Overall Study|Ineligible|1|||
161240980|NCT03325881|582263593|FG000|Overall Study|Protocol Violation|0|||
161240981|NCT03325881|582263594|FG001|Overall Study|Protocol Violation|1|||
161240982|NCT03325881|582263593|FG000|Overall Study|Withdrawal by Subject|0|||
161240983|NCT03325881|582263594|FG001|Overall Study|Withdrawal by Subject|2|||
161240984|NCT03325881|582263593|FG000|Overall Study|Lack of Efficacy|2|||
161240985|NCT03325881|582263594|FG001|Overall Study|Lack of Efficacy|0|||
160824155|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
160824156|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
160901965|NCT01365052|581035945|FG000|Overall Study|Adverse Event|4|||
161240986|NCT03325881|582263593|FG000|Overall Study|Not treated|1|||
161240987|NCT03325881|582263594|FG001|Overall Study|Not treated|0|||
161240988|NCT01848938|582263614|FG000|Overall Study|Lost to Follow-up|1|||
161240989|NCT01848938|582263615|FG001|Overall Study|Lost to Follow-up|1|||
161240990|NCT00909038|582263616|FG000|Overall Study|Protocol Violation|187|||
161240991|NCT00909038|582263616|FG000|Overall Study|Non-evaluable Subjects|230|||
161240992|NCT00207090|582263617|FG000|Overall Study|Study drug toxicity|3|||
161240993|NCT00207090|582263617|FG000|Overall Study|Chest wall mass larger|1|||
161240994|NCT00207090|582263617|FG000|Overall Study|Disease progression/relapse|2|||
161240995|NCT00207090|582263617|FG000|Overall Study|Physician Decision|1|||
161240996|NCT00909753|582263620|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
161240997|NCT00909753|582263621|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
161240998|NCT00909753|582263620|FG000|Period: Second Intervention|Protocol Violation|1|||
161240999|NCT00909753|582263621|FG001|Period: Second Intervention|Protocol Violation|0|||
161241000|NCT03480763|582263626|FG000|Overall Study|Withdrawal by Subject|18|||
161241001|NCT03480763|582263627|FG001|Overall Study|Withdrawal by Subject|10|||
161241002|NCT03480763|582263626|FG000|Overall Study|Lost to Follow-up|4|||
161241003|NCT03480763|582263627|FG001|Overall Study|Lost to Follow-up|7|||
161241004|NCT03480763|582263626|FG000|Overall Study|non-study pneumococcal vaccine|1|||
161241005|NCT03480763|582263627|FG001|Overall Study|non-study pneumococcal vaccine|0|||
161241006|NCT03480763|582263626|FG000|Overall Study|oncological treatment|0|||
161241007|NCT03480763|582263627|FG001|Overall Study|oncological treatment|2|||
161241008|NCT03480763|582263626|FG000|Overall Study|pain with vaccination|1|||
161241009|NCT03480763|582263627|FG001|Overall Study|pain with vaccination|0|||
161241010|NCT01895335|582263628|FG000|Overall Study|Adverse Event|106|||
161241011|NCT01895335|582263628|FG000|Overall Study|Lack of Efficacy|53|||
161241012|NCT01895335|582263628|FG000|Overall Study|Poor Compliance to Protocol|11|||
161241013|NCT01895335|582263628|FG000|Overall Study|Included But Not treated|1|||
161241014|NCT01895335|582263628|FG000|Overall Study|Other than Specified Above|44|||
161241015|NCT01647828|582263631|FG000|Overall Study|Death|3|||
161241016|NCT01647828|582263632|FG001|Overall Study|Death|4|||
161241017|NCT01647828|582263633|FG002|Overall Study|Death|4|||
161241018|NCT01647828|582263634|FG003|Overall Study|Death|5|||
161241019|NCT01647828|582263635|FG004|Overall Study|Death|6|||
161241020|NCT01647828|582263636|FG005|Overall Study|Death|3|||
161241021|NCT01647828|582263637|FG006|Overall Study|Death|10|||
161241022|NCT01647828|582263638|FG007|Overall Study|Death|60|||
161241023|NCT01647828|582263639|FG008|Overall Study|Death|71|||
161241024|NCT01647828|582263631|FG000|Overall Study|Withdrawal by Subject|2|||
161241025|NCT01647828|582263632|FG001|Overall Study|Withdrawal by Subject|0|||
161241026|NCT01647828|582263633|FG002|Overall Study|Withdrawal by Subject|0|||
161241027|NCT01647828|582263634|FG003|Overall Study|Withdrawal by Subject|1|||
161241028|NCT01647828|582263635|FG004|Overall Study|Withdrawal by Subject|0|||
161241029|NCT01647828|582263636|FG005|Overall Study|Withdrawal by Subject|0|||
161241030|NCT01647828|582263637|FG006|Overall Study|Withdrawal by Subject|1|||
161241031|NCT01647828|582263638|FG007|Overall Study|Withdrawal by Subject|0|||
161241032|NCT01647828|582263639|FG008|Overall Study|Withdrawal by Subject|2|||
161241033|NCT01647828|582263631|FG000|Overall Study|Study terminated by Sponsor|0|||
161241034|NCT01647828|582263632|FG001|Overall Study|Study terminated by Sponsor|0|||
161241035|NCT01647828|582263633|FG002|Overall Study|Study terminated by Sponsor|0|||
161241036|NCT01647828|582263634|FG003|Overall Study|Study terminated by Sponsor|0|||
161241037|NCT01647828|582263635|FG004|Overall Study|Study terminated by Sponsor|0|||
161241038|NCT01647828|582263636|FG005|Overall Study|Study terminated by Sponsor|0|||
161241039|NCT01647828|582263637|FG006|Overall Study|Study terminated by Sponsor|1|||
161241040|NCT01647828|582263638|FG007|Overall Study|Study terminated by Sponsor|26|||
161241041|NCT01647828|582263639|FG008|Overall Study|Study terminated by Sponsor|16|||
161241042|NCT01647828|582263631|FG000|Overall Study|Lost to Follow-up|0|||
161241043|NCT01647828|582263632|FG001|Overall Study|Lost to Follow-up|0|||
161241044|NCT01647828|582263633|FG002|Overall Study|Lost to Follow-up|0|||
161241045|NCT01647828|582263634|FG003|Overall Study|Lost to Follow-up|0|||
161241046|NCT01647828|582263635|FG004|Overall Study|Lost to Follow-up|0|||
161241047|NCT01647828|582263636|FG005|Overall Study|Lost to Follow-up|0|||
161241048|NCT01647828|582263637|FG006|Overall Study|Lost to Follow-up|0|||
161241049|NCT01647828|582263638|FG007|Overall Study|Lost to Follow-up|2|||
161241050|NCT01647828|582263639|FG008|Overall Study|Lost to Follow-up|0|||
161241051|NCT00115063|582263640|FG000|Overall Study|Lost to Follow-up|98|||
161241052|NCT00115063|582263641|FG001|Overall Study|Lost to Follow-up|104|||
161241053|NCT00115063|582263640|FG000|Overall Study|Death|1|||
161241054|NCT00115063|582263641|FG001|Overall Study|Death|0|||
161241055|NCT00185458|582263644|FG000|Contraception Phase|Adverse Event|37|||
161241056|NCT00185458|582263644|FG000|Contraception Phase|Lost to Follow-up|10|||
161241057|NCT00185458|582263644|FG000|Contraception Phase|Protocol Violation|2|||
161241058|NCT00185458|582263644|FG000|Contraception Phase|Physician Decision|2|||
161241059|NCT00185458|582263644|FG000|Contraception Phase|Withdrawal by Subject|7|||
161241060|NCT00185458|582263644|FG000|HRT Phase|Adverse Event|18|||
161241061|NCT00185458|582263644|FG000|HRT Phase|Lost to Follow-up|4|||
161241062|NCT00185458|582263644|FG000|HRT Phase|Protocol Violation|2|||
161241063|NCT00185458|582263644|FG000|HRT Phase|Withdrawal by Subject|3|||
161241064|NCT00835536|582263645|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
160824157|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
160824158|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
160824159|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824160|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
161241065|NCT00835536|582263646|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
161241066|NCT01154231|582263649|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
160824161|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160901966|NCT01365052|581035946|FG001|Overall Study|Adverse Event|4|||
161241067|NCT01154231|582263649|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
161241068|NCT01370733|582264599|FG000|Overall Study|Withdrawal by Subject|8|||
161241069|NCT01370733|582264600|FG001|Overall Study|Withdrawal by Subject|8|||
161241070|NCT01370733|582264599|FG000|Overall Study|Lost to Follow-up|3|||
161241071|NCT01370733|582264600|FG001|Overall Study|Lost to Follow-up|0|||
161241072|NCT01370733|582264599|FG000|Overall Study|Adverse Event|2|||
161241073|NCT01370733|582264600|FG001|Overall Study|Adverse Event|4|||
161241074|NCT01370733|582264599|FG000|Overall Study|Lack of Efficacy|3|||
161241075|NCT01370733|582264600|FG001|Overall Study|Lack of Efficacy|5|||
161241076|NCT01370733|582264599|FG000|Overall Study|Physician Decision|0|||
161241077|NCT01370733|582264600|FG001|Overall Study|Physician Decision|2|||
161241078|NCT01370733|582264599|FG000|Overall Study|Protocol Violation|1|||
161241079|NCT01370733|582264600|FG001|Overall Study|Protocol Violation|3|||
161241080|NCT03676634|582264601|FG000|Overall Study|Red blood cell loss|1|||
161241081|NCT03676634|582264601|FG000|Overall Study|Out-of-limit pulse|2|||
161241082|NCT00829712|582264602|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161241083|NCT00829712|582264603|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161241084|NCT02294981|582264604|FG000|Overall Study|Lost to Follow-up|1|||
161241085|NCT01188681|582264605|FG000|Overall Study|bladder cancer|0|||
161241086|NCT01188681|582264606|FG001|Overall Study|bladder cancer|0|||
161241087|NCT01188681|582264607|FG002|Overall Study|bladder cancer|1|||
160824162|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824163|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824164|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160824165|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824166|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160824167|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
160824168|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
160824169|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824170|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824171|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824172|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824173|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824174|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
160824175|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
160824176|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
160824177|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
160824178|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
160824179|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824180|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824181|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824182|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824183|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824184|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824185|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824186|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
160824187|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
160824188|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
160824189|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824190|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824191|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824192|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824193|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824194|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824195|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824196|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
160824197|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824198|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
160824199|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824200|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824201|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824202|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824203|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824204|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824205|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824206|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
160824207|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824208|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
160824209|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824210|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824211|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160862005|NCT03694353|580887918|FG000|Overall Study|Withdrawal by Subject|1|||
161133337|NCT00792298|581872907|FG004|Treatment Period 1|Physician Decision|0|||
161133338|NCT00792298|581872908|FG005|Treatment Period 1|Physician Decision|0|||
161133339|NCT00792298|581872909|FG006|Treatment Period 1|Physician Decision|1|||
161133340|NCT00792298|581872910|FG007|Treatment Period 1|Physician Decision|0|||
161334152|NCT01909804|582612522|FG009|Overall Study|Death|0|||
160824212|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824213|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824214|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824215|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824216|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
160824217|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
160824218|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
160824219|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824220|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824221|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824222|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824223|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824224|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
160824225|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824226|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824227|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
160824228|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
160824229|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824230|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824231|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824232|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824233|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824234|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824235|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824236|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824237|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
160824238|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
160824239|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824240|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824241|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824242|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824243|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824244|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824245|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824246|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
160824247|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
160824248|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
160824249|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824250|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824251|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824252|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824253|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824254|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824255|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824256|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
160824257|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
160824258|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
160824259|NCT03352557|580740928|FG000|LTE Period: Week 80 to Week 173|Other|0|||
160824260|NCT03352557|580740929|FG001|LTE Period: Week 80 to Week 173|Other|0|||
160824261|NCT03352557|580740930|FG002|LTE Period: Week 80 to Week 173|Other|0|||
160824262|NCT03352557|580740931|FG003|LTE Period: Week 80 to Week 173|Other|0|||
160824263|NCT03352557|580740932|FG004|LTE Period: Week 80 to Week 173|Other|0|||
160824264|NCT03352557|580740933|FG005|LTE Period: Week 80 to Week 173|Other|0|||
160824265|NCT03352557|580740934|FG006|LTE Period: Week 80 to Week 173|Other|0|||
160824266|NCT03352557|580740935|FG007|LTE Period: Week 80 to Week 173|Other|1|||
160824267|NCT03352557|580740936|FG008|LTE Period: Week 80 to Week 173|Other|0|||
160824268|NCT03352557|580740937|FG009|LTE Period: Week 80 to Week 173|Other|0|||
160824269|NCT04677660|580740938|FG000|Overall Study|Lost to Follow-up|0|||
160901967|NCT02248701|581035949|FG000|Overall Study|Withdrawal by Subject|2|||
161241088|NCT01188681|582264608|FG003|Overall Study|bladder cancer|0|||
160901968|NCT02248701|581035950|FG001|Overall Study|Withdrawal by Subject|1|||
161241089|NCT01188681|582264605|FG000|Overall Study|Withdrawal by Subject|0|||
161241090|NCT01188681|582264606|FG001|Overall Study|Withdrawal by Subject|0|||
161241091|NCT01188681|582264607|FG002|Overall Study|Withdrawal by Subject|0|||
161241092|NCT01188681|582264608|FG003|Overall Study|Withdrawal by Subject|1|||
161241093|NCT01004510|582264614|FG000|Overall Study|Adverse Event|1|||
160824270|NCT04677660|580740939|FG001|Overall Study|Lost to Follow-up|2|||
160824271|NCT04677660|580740938|FG000|Overall Study|Withdrawal by Subject|0|||
160824272|NCT04677660|580740939|FG001|Overall Study|Withdrawal by Subject|1|||
160824273|NCT04677660|580740938|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
160824274|NCT04677660|580740939|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
160824275|NCT03242772|580740940|FG000|Overall Study|Lost to Follow-up|2|||
160824276|NCT03242772|580740941|FG001|Overall Study|Lost to Follow-up|0|||
160824277|NCT03242772|580740940|FG000|Overall Study|Physician Decision|0|||
160824278|NCT03242772|580740941|FG001|Overall Study|Physician Decision|1|||
160824279|NCT03242772|580740940|FG000|Overall Study|Withdrawal by Subject|1|||
160824280|NCT03242772|580740941|FG001|Overall Study|Withdrawal by Subject|0|||
160824281|NCT02499900|580740942|FG000|Core Study Period|Other|1|||
160824282|NCT02499900|580740943|FG001|Core Study Period|Other|4|||
160824283|NCT02499900|580740942|FG000|Core Study Period|Lost to Follow-up|1|||
160824284|NCT02499900|580740943|FG001|Core Study Period|Lost to Follow-up|2|||
160824285|NCT02499900|580740942|FG000|Core Study Period|Per sponsor request|0|||
160824286|NCT02499900|580740943|FG001|Core Study Period|Per sponsor request|1|||
160824287|NCT02499900|580740942|FG000|Core Study Period|Pregnancy|1|||
160824288|NCT02499900|580740943|FG001|Core Study Period|Pregnancy|0|||
160824289|NCT02499900|580740942|FG000|Core Study Period|Protocol Violation|3|||
160824290|NCT02499900|580740943|FG001|Core Study Period|Protocol Violation|0|||
160824291|NCT02499900|580740942|FG000|Core Study Period|Withdrawal by Subject|11|||
160824292|NCT02499900|580740943|FG001|Core Study Period|Withdrawal by Subject|10|||
160824293|NCT02499900|580740942|FG000|Core Study Period|Adverse Event|18|||
160824294|NCT02499900|580740943|FG001|Core Study Period|Adverse Event|14|||
160824295|NCT02499900|580740942|FG000|Core Study Period|Death|0|||
160824296|NCT02499900|580740943|FG001|Core Study Period|Death|1|||
160824297|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
160824298|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
160824299|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
160824300|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
160824301|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
160824302|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
160824303|NCT02499900|580740942|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
160824304|NCT02499900|580740943|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
160824305|NCT02499900|580740942|FG000|Extension Study Period|Adverse Event|2|||
160824306|NCT02499900|580740943|FG001|Extension Study Period|Adverse Event|4|||
160824307|NCT02499900|580740942|FG000|Extension Study Period|Withdrawal by Subject|5|||
160824308|NCT02499900|580740943|FG001|Extension Study Period|Withdrawal by Subject|2|||
160824309|NCT02499900|580740942|FG000|Extension Study Period|Physician Decision|2|||
160824310|NCT02499900|580740943|FG001|Extension Study Period|Physician Decision|5|||
160824311|NCT02499900|580740942|FG000|Extension Study Period|Pregnancy|1|||
160824312|NCT02499900|580740943|FG001|Extension Study Period|Pregnancy|2|||
160824313|NCT02499900|580740942|FG000|Extension Study Period|Lost to Follow-up|2|||
160824314|NCT02499900|580740943|FG001|Extension Study Period|Lost to Follow-up|5|||
160824315|NCT02499900|580740942|FG000|Extension Study Period|Other|0|||
160824316|NCT02499900|580740943|FG001|Extension Study Period|Other|2|||
160824317|NCT02439450|580740945|FG000|Overall Study|Adverse Event|4|||
160824318|NCT02439450|580740946|FG001|Overall Study|Adverse Event|1|||
160824319|NCT02439450|580740947|FG002|Overall Study|Adverse Event|0|||
160824320|NCT02439450|580740948|FG003|Overall Study|Adverse Event|0|||
160824321|NCT02439450|580740945|FG000|Overall Study|Withdrawal by Subject|1|||
160824322|NCT02439450|580740946|FG001|Overall Study|Withdrawal by Subject|2|||
160824323|NCT02439450|580740947|FG002|Overall Study|Withdrawal by Subject|0|||
160824324|NCT02439450|580740948|FG003|Overall Study|Withdrawal by Subject|0|||
160824325|NCT02439450|580740945|FG000|Overall Study|Death|3|||
160824326|NCT02439450|580740946|FG001|Overall Study|Death|0|||
160901969|NCT02248701|581035949|FG000|Overall Study|Physician Decision|0|||
160901970|NCT02248701|581035950|FG001|Overall Study|Physician Decision|1|||
161241094|NCT01983969|582264617|FG000|Overall Study|Disease Progression|0|||
161241095|NCT01983969|582264618|FG001|Overall Study|Disease Progression|1|||
161241096|NCT01983969|582264619|FG002|Overall Study|Disease Progression|0|||
161241097|NCT02911025|582264620|FG000|Overall Study|Lost to Follow-up|3|||
161241098|NCT03719040|582264621|FG000|Overall Study|Withdrawal by Subject|177|||
160824327|NCT02439450|580740947|FG002|Overall Study|Death|0|||
160824328|NCT02439450|580740948|FG003|Overall Study|Death|1|||
160824329|NCT02439450|580740945|FG000|Overall Study|Progressive Disease|18|||
160824330|NCT02439450|580740946|FG001|Overall Study|Progressive Disease|41|||
160824331|NCT02439450|580740947|FG002|Overall Study|Progressive Disease|2|||
160824332|NCT02439450|580740948|FG003|Overall Study|Progressive Disease|3|||
160824333|NCT03730961|580740951|FG000|Overall Study|Adverse Event|0|||
160824334|NCT03730961|580740952|FG001|Overall Study|Adverse Event|1|||
160824335|NCT01646645|580740955|FG000|Overall Study|No Treated|1|||
161241099|NCT03719040|582264621|FG000|Overall Study|Lost to Follow-up|26|||
160824336|NCT01646645|580740955|FG000|Overall Study|Inevaluable Donor|29|||
160824337|NCT00717522|580740956|FG000|Overall Study|Disease Progression|5|||
161241100|NCT00268203|582264622|FG000|Overall Study|Lost to Follow-up|92|||
160824338|NCT00717522|580740956|FG000|Overall Study|Adverse Event|1|||
160824339|NCT00717522|580740956|FG000|Overall Study|Death|1|||
160824340|NCT01799239|580740957|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
160824341|NCT01799239|580740958|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
160824342|NCT01799239|580740957|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
160824343|NCT01799239|580740958|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
160824344|NCT01799239|580740957|FG000|Period 1 (7 Days)|Protocol Violation|0|||
160824345|NCT01799239|580740958|FG001|Period 1 (7 Days)|Protocol Violation|1|||
160824346|NCT01799239|580740957|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
160824347|NCT01799239|580740958|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
160824348|NCT01799239|580740957|FG000|Period 2 (7 Days)|Protocol Violation|1|||
160824349|NCT01799239|580740958|FG001|Period 2 (7 Days)|Protocol Violation|0|||
160824350|NCT04209114|580740959|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
160824351|NCT04209114|580740960|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
160824352|NCT04209114|580740961|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
160824353|NCT04209114|580740959|FG000|Pre-Treatment Phase|Other reasons|0|||
160824354|NCT04209114|580740960|FG001|Pre-Treatment Phase|Other reasons|0|||
160824355|NCT04209114|580740961|FG002|Pre-Treatment Phase|Other reasons|1|||
160824356|NCT04209114|580740959|FG000|Pre-Treatment Phase|Death|0|||
160824357|NCT04209114|580740960|FG001|Pre-Treatment Phase|Death|0|||
160824358|NCT04209114|580740961|FG002|Pre-Treatment Phase|Death|1|||
160824359|NCT04209114|580740959|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
160824360|NCT04209114|580740960|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
160824361|NCT04209114|580740961|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
160824362|NCT04209114|580740959|FG000|Treatment Phase|Other reasons|5|||
160824363|NCT04209114|580740960|FG001|Treatment Phase|Other reasons|3|||
160824364|NCT04209114|580740961|FG002|Treatment Phase|Other reasons|0|||
160824365|NCT04209114|580740959|FG000|Treatment Phase|Lost to Follow-up|1|||
160824366|NCT04209114|580740960|FG001|Treatment Phase|Lost to Follow-up|0|||
160824367|NCT04209114|580740961|FG002|Treatment Phase|Lost to Follow-up|0|||
160824368|NCT04209114|580740959|FG000|Treatment Phase|Participant withdrew consent|1|||
160824369|NCT04209114|580740960|FG001|Treatment Phase|Participant withdrew consent|0|||
160824370|NCT04209114|580740961|FG002|Treatment Phase|Participant withdrew consent|0|||
160824371|NCT04209114|580740959|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
160824372|NCT04209114|580740960|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
160824373|NCT04209114|580740961|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
160824374|NCT04209114|580740959|FG000|Treatment Phase|Death|4|||
160824375|NCT04209114|580740960|FG001|Treatment Phase|Death|1|||
160824376|NCT04209114|580740961|FG002|Treatment Phase|Death|0|||
160824377|NCT04209114|580740959|FG000|Treatment Phase|Study drug toxicity|4|||
160824378|NCT04209114|580740960|FG001|Treatment Phase|Study drug toxicity|6|||
160824379|NCT04209114|580740961|FG002|Treatment Phase|Study drug toxicity|0|||
160824380|NCT04209114|580740959|FG000|Treatment Phase|Disease progression|6|||
160824381|NCT04209114|580740960|FG001|Treatment Phase|Disease progression|9|||
160824382|NCT04209114|580740961|FG002|Treatment Phase|Disease progression|0|||
160824383|NCT01444027|580740974|FG000|Overall Study|Withdrawal by Subject|4|||
160824384|NCT01444027|580740975|FG001|Overall Study|Withdrawal by Subject|10|||
160824385|NCT01444027|580740976|FG002|Overall Study|Withdrawal by Subject|24|||
160824386|NCT01444027|580740974|FG000|Overall Study|Lost to Follow-up|26|||
160824387|NCT01444027|580740975|FG001|Overall Study|Lost to Follow-up|20|||
160824388|NCT01444027|580740976|FG002|Overall Study|Lost to Follow-up|14|||
160824389|NCT03966885|580742720|FG000|Overall Study|Death|1|||
160824390|NCT03966885|580742721|FG001|Overall Study|Death|0|||
160824391|NCT03966885|580742720|FG000|Overall Study|Lost to Follow-up|1|||
160824392|NCT03966885|580742721|FG001|Overall Study|Lost to Follow-up|2|||
160824393|NCT03966885|580742720|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
160824394|NCT03966885|580742721|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
160824395|NCT03966885|580742720|FG000|Overall Study|Moved from study area.|0|||
160901971|NCT02248701|581035949|FG000|Overall Study|Adverse Event|1|||
160901972|NCT02248701|581035950|FG001|Overall Study|Adverse Event|0|||
160901973|NCT02248701|581035949|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
160901974|NCT02248701|581035950|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
161133341|NCT00792298|581872903|FG000|Treatment Period 1|Protocol Violation|0|||
160824396|NCT03966885|580742721|FG001|Overall Study|Moved from study area.|2|||
160824397|NCT01514240|580742722|FG000|Overall Study|Adverse Event|4|||
160824398|NCT01514240|580742723|FG001|Overall Study|Adverse Event|4|||
160824399|NCT01514240|580742722|FG000|Overall Study|Subject Decision|2|||
160824400|NCT01514240|580742723|FG001|Overall Study|Subject Decision|7|||
160824401|NCT00428220|580742724|FG000|Overall Study|Participant died|8|||
160824402|NCT00428220|580742724|FG000|Overall Study|Global deterioration of health status|7|||
160824403|NCT00428220|580742724|FG000|Overall Study|Lost to Follow-up|4|||
160824404|NCT00428220|580742724|FG000|Overall Study|Objective progression or relapse|123|||
160824405|NCT00428220|580742724|FG000|Overall Study|Participant refused continued treatment|7|||
160824406|NCT00428220|580742724|FG000|Overall Study|Adverse Event|51|||
161133342|NCT00792298|581872904|FG001|Treatment Period 1|Protocol Violation|0|||
160824407|NCT00428220|580742724|FG000|Overall Study|Other|23|||
160824408|NCT00509093|580742725|FG000|Overall Study|Adverse Event|10|||
161241101|NCT00268203|582264622|FG000|Overall Study|Withdrawal by Subject|9|||
161241102|NCT00268203|582264622|FG000|Overall Study|Received Other NHL Therapy|7|||
161241103|NCT00268203|582264622|FG000|Overall Study|Progressive Disease|359|||
161241104|NCT00268203|582264622|FG000|Overall Study|Death|84|||
161241105|NCT00268203|582264622|FG000|Overall Study|Reason Not Specified|34|||
161241106|NCT00268203|582264622|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
161241107|NCT04589650|582264625|FG000|Overall Study|Subject decision|6|||
161241108|NCT04589650|582264626|FG001|Overall Study|Subject decision|2|||
161241109|NCT04589650|582264627|FG002|Overall Study|Subject decision|2|||
161241110|NCT04589650|582264628|FG003|Overall Study|Subject decision|0|||
161334153|NCT01909804|582612523|FG010|Overall Study|Death|1|||
160824409|NCT00509093|580742725|FG000|Overall Study|Disease Progression|9|||
160824410|NCT00509093|580742725|FG000|Overall Study|Transformed into MDS|1|||
160824411|NCT00509093|580742725|FG000|Overall Study|Withdrawal by Subject|3|||
161133343|NCT00792298|581872905|FG002|Treatment Period 1|Protocol Violation|0|||
161133344|NCT00792298|581872906|FG003|Treatment Period 1|Protocol Violation|0|||
161133345|NCT00792298|581872907|FG004|Treatment Period 1|Protocol Violation|0|||
161133346|NCT00792298|581872908|FG005|Treatment Period 1|Protocol Violation|0|||
161133347|NCT00792298|581872909|FG006|Treatment Period 1|Protocol Violation|0|||
161133348|NCT00792298|581872910|FG007|Treatment Period 1|Protocol Violation|1|||
161133349|NCT00792298|581872903|FG000|Washout|Adverse Event|0|||
161133350|NCT00792298|581872904|FG001|Washout|Adverse Event|0|||
161133351|NCT00792298|581872905|FG002|Washout|Adverse Event|0|||
161133352|NCT00792298|581872906|FG003|Washout|Adverse Event|0|||
161133353|NCT00792298|581872907|FG004|Washout|Adverse Event|0|||
161133354|NCT00792298|581872908|FG005|Washout|Adverse Event|1|||
161133355|NCT00792298|581872909|FG006|Washout|Adverse Event|0|||
161133356|NCT00792298|581872910|FG007|Washout|Adverse Event|0|||
161133357|NCT00792298|581872903|FG000|Washout|Withdrawal by Subject|0|||
161133358|NCT00792298|581872904|FG001|Washout|Withdrawal by Subject|0|||
161133359|NCT00792298|581872905|FG002|Washout|Withdrawal by Subject|1|||
161133360|NCT00792298|581872906|FG003|Washout|Withdrawal by Subject|0|||
161133361|NCT00792298|581872907|FG004|Washout|Withdrawal by Subject|0|||
161133362|NCT00792298|581872908|FG005|Washout|Withdrawal by Subject|1|||
161133363|NCT00792298|581872909|FG006|Washout|Withdrawal by Subject|0|||
161133364|NCT00792298|581872910|FG007|Washout|Withdrawal by Subject|0|||
161133365|NCT00792298|581872903|FG000|Treatment Period 2|Lack of Efficacy|0|||
161133366|NCT00792298|581872904|FG001|Treatment Period 2|Lack of Efficacy|0|||
161133367|NCT00792298|581872905|FG002|Treatment Period 2|Lack of Efficacy|0|||
161133368|NCT00792298|581872906|FG003|Treatment Period 2|Lack of Efficacy|0|||
161133369|NCT00792298|581872907|FG004|Treatment Period 2|Lack of Efficacy|1|||
161133370|NCT00792298|581872908|FG005|Treatment Period 2|Lack of Efficacy|0|||
161133371|NCT00792298|581872909|FG006|Treatment Period 2|Lack of Efficacy|0|||
161133372|NCT00792298|581872910|FG007|Treatment Period 2|Lack of Efficacy|0|||
161133373|NCT00792298|581872903|FG000|Treatment Period 2|Physician Decision|0|||
161133374|NCT00792298|581872904|FG001|Treatment Period 2|Physician Decision|0|||
161133375|NCT00792298|581872905|FG002|Treatment Period 2|Physician Decision|0|||
161133376|NCT00792298|581872906|FG003|Treatment Period 2|Physician Decision|0|||
161133377|NCT00792298|581872907|FG004|Treatment Period 2|Physician Decision|0|||
161133378|NCT00792298|581872908|FG005|Treatment Period 2|Physician Decision|0|||
161133379|NCT00792298|581872909|FG006|Treatment Period 2|Physician Decision|1|||
161133380|NCT00792298|581872910|FG007|Treatment Period 2|Physician Decision|0|||
161133381|NCT00792298|581872903|FG000|Treatment Period 2|Pregnancy|0|||
161133382|NCT00792298|581872904|FG001|Treatment Period 2|Pregnancy|0|||
161133383|NCT00792298|581872905|FG002|Treatment Period 2|Pregnancy|1|||
161133384|NCT00792298|581872906|FG003|Treatment Period 2|Pregnancy|0|||
161133385|NCT00792298|581872907|FG004|Treatment Period 2|Pregnancy|0|||
161133386|NCT00792298|581872908|FG005|Treatment Period 2|Pregnancy|0|||
161133387|NCT00792298|581872909|FG006|Treatment Period 2|Pregnancy|0|||
161133388|NCT00792298|581872910|FG007|Treatment Period 2|Pregnancy|0|||
161133389|NCT00792298|581872903|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161133390|NCT00792298|581872904|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161133391|NCT00792298|581872905|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161133392|NCT00792298|581872906|FG003|Treatment Period 2|Withdrawal by Subject|2|||
161133393|NCT00792298|581872907|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161133394|NCT00792298|581872908|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161133395|NCT00792298|581872909|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161133396|NCT00792298|581872910|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161241111|NCT04589650|582264629|FG004|Overall Study|Subject decision|0|||
160824412|NCT00509093|580742725|FG000|Overall Study|Physician Decision|1|||
161133397|NCT03304522|581872911|FG000|Overall Study|Adverse Event|0|||
161133398|NCT03304522|581872912|FG001|Overall Study|Adverse Event|4|||
161133399|NCT03304522|581872911|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161133400|NCT03304522|581872912|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
161133401|NCT03304522|581872911|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
161133402|NCT03304522|581872912|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
161334154|NCT01909804|582612524|FG011|Overall Study|Death|0|||
161334155|NCT01909804|582612513|FG000|Overall Study|Lack of Efficacy|4|||
161334156|NCT01909804|582612514|FG001|Overall Study|Lack of Efficacy|1|||
161334157|NCT01909804|582612515|FG002|Overall Study|Lack of Efficacy|0|||
161334158|NCT01909804|582612516|FG003|Overall Study|Lack of Efficacy|0|||
161334159|NCT01909804|582612517|FG004|Overall Study|Lack of Efficacy|7|||
161334160|NCT01909804|582612518|FG005|Overall Study|Lack of Efficacy|3|||
161334161|NCT01909804|582612519|FG006|Overall Study|Lack of Efficacy|1|||
161334162|NCT01909804|582612520|FG007|Overall Study|Lack of Efficacy|1|||
161334163|NCT01909804|582612521|FG008|Overall Study|Lack of Efficacy|0|||
161334164|NCT01909804|582612522|FG009|Overall Study|Lack of Efficacy|1|||
160824413|NCT05013424|580742726|FG000|Overall Study|Lost to Follow-up|1|||
160824414|NCT05013424|580742727|FG001|Overall Study|Lost to Follow-up|1|||
160824415|NCT05013424|580742728|FG002|Overall Study|Lost to Follow-up|1|||
160824416|NCT05013424|580742726|FG000|Overall Study|Withdrawal by Subject|0|||
160824417|NCT05013424|580742727|FG001|Overall Study|Withdrawal by Subject|1|||
160824418|NCT05013424|580742728|FG002|Overall Study|Withdrawal by Subject|0|||
160824419|NCT04143217|580742735|FG000|Overall Study|Withdrawal by Subject|42|||
160824420|NCT04143217|580742735|FG000|Overall Study|Adverse Event|29|||
160824421|NCT04143217|580742735|FG000|Overall Study|Lost to Follow-up|29|||
160824422|NCT04143217|580742735|FG000|Overall Study|Lack of Efficacy|15|||
160824423|NCT04143217|580742735|FG000|Overall Study|Physician Decision|1|||
160824424|NCT04143217|580742735|FG000|Overall Study|Non-Compliance With Study Drug|6|||
160824425|NCT04143217|580742735|FG000|Overall Study|Other, Multiple Categories|11|||
160824426|NCT02210832|580742738|FG000|Overall Study|Pregnancy termination .|3|||
160824427|NCT02210832|580742739|FG001|Overall Study|Pregnancy termination .|4|||
160824428|NCT02210832|580742740|FG002|Overall Study|Pregnancy termination .|1|||
160824429|NCT02210832|580742738|FG000|Overall Study|Lost to Follow-up|26|||
160824430|NCT02210832|580742739|FG001|Overall Study|Lost to Follow-up|32|||
160824431|NCT02210832|580742740|FG002|Overall Study|Lost to Follow-up|17|||
160824432|NCT00471887|580742746|FG000|Overall Study|Adverse Event|9|||
161241112|NCT04589650|582264630|FG005|Overall Study|Subject decision|0|||
161241113|NCT04589650|582264625|FG000|Overall Study|Adverse Event|3|||
161241114|NCT04589650|582264626|FG001|Overall Study|Adverse Event|1|||
161241115|NCT04589650|582264627|FG002|Overall Study|Adverse Event|1|||
161241116|NCT04589650|582264628|FG003|Overall Study|Adverse Event|1|||
161241117|NCT04589650|582264629|FG004|Overall Study|Adverse Event|0|||
161241118|NCT04589650|582264630|FG005|Overall Study|Adverse Event|1|||
161241119|NCT04589650|582264625|FG000|Overall Study|Physician Decision|1|||
161241120|NCT04589650|582264626|FG001|Overall Study|Physician Decision|1|||
161241121|NCT04589650|582264627|FG002|Overall Study|Physician Decision|0|||
161241122|NCT04589650|582264628|FG003|Overall Study|Physician Decision|0|||
161241123|NCT04589650|582264629|FG004|Overall Study|Physician Decision|0|||
161241124|NCT04589650|582264630|FG005|Overall Study|Physician Decision|0|||
161241125|NCT04589650|582264625|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161241126|NCT04589650|582264626|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160824433|NCT01278407|580742749|FG000|Confirmatory Phase|Adverse Event|5|||
160824434|NCT01278407|580742750|FG001|Confirmatory Phase|Adverse Event|10|||
160824435|NCT01278407|580742751|FG002|Confirmatory Phase|Adverse Event|1|||
160824436|NCT01278407|580742752|FG003|Confirmatory Phase|Adverse Event|0|||
160824437|NCT01278407|580742753|FG004|Confirmatory Phase|Adverse Event|0|||
160824438|NCT01278407|580742749|FG000|Confirmatory Phase|Participant's Choice|3|||
160824439|NCT01278407|580742750|FG001|Confirmatory Phase|Participant's Choice|5|||
160824440|NCT01278407|580742751|FG002|Confirmatory Phase|Participant's Choice|3|||
160824441|NCT01278407|580742752|FG003|Confirmatory Phase|Participant's Choice|0|||
160824442|NCT01278407|580742753|FG004|Confirmatory Phase|Participant's Choice|0|||
160824443|NCT01278407|580742749|FG000|Confirmatory Phase|Other|1|||
160824444|NCT01278407|580742750|FG001|Confirmatory Phase|Other|1|||
160824445|NCT01278407|580742751|FG002|Confirmatory Phase|Other|2|||
160824446|NCT01278407|580742752|FG003|Confirmatory Phase|Other|0|||
160824447|NCT01278407|580742753|FG004|Confirmatory Phase|Other|0|||
160824448|NCT01278407|580742749|FG000|Extension Phase|Adverse Event|0|||
160824449|NCT01278407|580742750|FG001|Extension Phase|Adverse Event|0|||
160824450|NCT01278407|580742751|FG002|Extension Phase|Adverse Event|0|||
160824451|NCT01278407|580742752|FG003|Extension Phase|Adverse Event|7|||
160824452|NCT01278407|580742753|FG004|Extension Phase|Adverse Event|16|||
160824453|NCT01278407|580742749|FG000|Extension Phase|Participant's Choice|0|||
160824454|NCT01278407|580742750|FG001|Extension Phase|Participant's Choice|0|||
160824455|NCT01278407|580742751|FG002|Extension Phase|Participant's Choice|0|||
160824456|NCT01278407|580742752|FG003|Extension Phase|Participant's Choice|4|||
161241127|NCT04589650|582264627|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161241128|NCT04589650|582264628|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161241129|NCT04589650|582264629|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
161334165|NCT01909804|582612523|FG010|Overall Study|Lack of Efficacy|0|||
161334166|NCT01909804|582612524|FG011|Overall Study|Lack of Efficacy|1|||
161334167|NCT01909804|582612513|FG000|Overall Study|Withdrew Consent|0|||
161334168|NCT01909804|582612514|FG001|Overall Study|Withdrew Consent|0|||
160824457|NCT01278407|580742753|FG004|Extension Phase|Participant's Choice|11|||
160824458|NCT01278407|580742749|FG000|Extension Phase|Other|0|||
160824459|NCT01278407|580742750|FG001|Extension Phase|Other|0|||
160824460|NCT01278407|580742751|FG002|Extension Phase|Other|0|||
160824461|NCT01278407|580742752|FG003|Extension Phase|Other|1|||
160824462|NCT01278407|580742753|FG004|Extension Phase|Other|3|||
160824463|NCT03710876|580742754|FG000|Overall Study|Death|0|||
160824464|NCT03710876|580742755|FG001|Overall Study|Death|2|||
160824465|NCT03710876|580742754|FG000|Overall Study|Withdrawal by Subject|0|||
160824466|NCT03710876|580742755|FG001|Overall Study|Withdrawal by Subject|2|||
160824467|NCT01460719|580742757|FG000|Overall Study|Adverse Event|1|||
160824468|NCT01460719|580742757|FG000|Overall Study|Withdrawal by Subject|1|||
160824469|NCT01655381|580742763|FG000|Overall Study|Investigator Decision|1|||
160824470|NCT01655381|580742763|FG000|Overall Study|Moved to Another City|1|||
160824471|NCT01655381|580742763|FG000|Overall Study|Insufficient Treatment Response|1|||
160824472|NCT02285114|580742764|FG000|Main Phase|Investigator's Discretion|0|||
160824473|NCT02285114|580742765|FG001|Main Phase|Investigator's Discretion|2|||
160824474|NCT02285114|580742766|FG002|Main Phase|Investigator's Discretion|0|||
160824475|NCT02285114|580742767|FG003|Main Phase|Investigator's Discretion|0|||
160824476|NCT02285114|580742768|FG004|Main Phase|Investigator's Discretion|0|||
160824477|NCT02285114|580742769|FG005|Main Phase|Investigator's Discretion|0|||
160824478|NCT02285114|580742764|FG000|Main Phase|Enrolled but Never Treated|1|||
160824479|NCT02285114|580742765|FG001|Main Phase|Enrolled but Never Treated|0|||
160824480|NCT02285114|580742766|FG002|Main Phase|Enrolled but Never Treated|0|||
160824481|NCT02285114|580742767|FG003|Main Phase|Enrolled but Never Treated|0|||
160824482|NCT02285114|580742768|FG004|Main Phase|Enrolled but Never Treated|0|||
160824483|NCT02285114|580742769|FG005|Main Phase|Enrolled but Never Treated|0|||
160824484|NCT02285114|580742764|FG000|Main Phase|Withdrew Consent|0|||
160824485|NCT02285114|580742765|FG001|Main Phase|Withdrew Consent|0|||
160824486|NCT02285114|580742766|FG002|Main Phase|Withdrew Consent|1|||
160824487|NCT02285114|580742767|FG003|Main Phase|Withdrew Consent|0|||
160824488|NCT02285114|580742768|FG004|Main Phase|Withdrew Consent|0|||
160824489|NCT02285114|580742769|FG005|Main Phase|Withdrew Consent|0|||
160824490|NCT02285114|580742764|FG000|Extension Phase|Investigator's Discretion|0|||
160824491|NCT02285114|580742765|FG001|Extension Phase|Investigator's Discretion|0|||
160824492|NCT02285114|580742766|FG002|Extension Phase|Investigator's Discretion|0|||
160901975|NCT00885846|581035953|FG000|Overall Study|Withdrawal by Subject|2|||
160901976|NCT00885846|581035954|FG001|Overall Study|Withdrawal by Subject|5|||
160901977|NCT00885846|581035955|FG002|Overall Study|Withdrawal by Subject|2|||
160901978|NCT00074984|581035956|FG000|Overall Study|Death|1|||
160901979|NCT00074984|581035957|FG001|Overall Study|Death|2|||
160901980|NCT00074984|581035956|FG000|Overall Study|Withdrawal by Subject|2|||
161241130|NCT04589650|582264630|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
161241131|NCT04589650|582264625|FG000|Overall Study|Death|0|||
161241132|NCT04589650|582264626|FG001|Overall Study|Death|0|||
161241133|NCT04589650|582264627|FG002|Overall Study|Death|0|||
161241134|NCT04589650|582264628|FG003|Overall Study|Death|1|||
161241135|NCT04589650|582264629|FG004|Overall Study|Death|0|||
161241136|NCT04589650|582264630|FG005|Overall Study|Death|0|||
161241137|NCT04589650|582264625|FG000|Overall Study|Guardian Decision|0|||
160824493|NCT02285114|580742767|FG003|Extension Phase|Investigator's Discretion|14|||
160824494|NCT02285114|580742768|FG004|Extension Phase|Investigator's Discretion|1|||
160824495|NCT02285114|580742769|FG005|Extension Phase|Investigator's Discretion|0|||
160824496|NCT02285114|580742764|FG000|Extension Phase|Lost to Follow-up|0|||
160901981|NCT00074984|581035957|FG001|Overall Study|Withdrawal by Subject|3|||
160901982|NCT00074984|581035956|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
161133403|NCT03304522|581872911|FG000|Overall Study|Other|0|||
161133404|NCT03304522|581872912|FG001|Overall Study|Other|1|||
161133405|NCT00486603|581872914|FG000|Overall Study|Withdrawal by Subject|1|||
161133406|NCT00486603|581872915|FG001|Overall Study|Withdrawal by Subject|0|||
161133407|NCT00486603|581872916|FG002|Overall Study|Withdrawal by Subject|0|||
161133408|NCT00486603|581872917|FG003|Overall Study|Withdrawal by Subject|0|||
161133409|NCT00486603|581872918|FG004|Overall Study|Withdrawal by Subject|0|||
161133410|NCT00486603|581872914|FG000|Overall Study|Physician Decision|0|||
161133411|NCT00486603|581872915|FG001|Overall Study|Physician Decision|1|||
161133412|NCT00486603|581872916|FG002|Overall Study|Physician Decision|0|||
161133413|NCT00486603|581872917|FG003|Overall Study|Physician Decision|0|||
161133414|NCT00486603|581872918|FG004|Overall Study|Physician Decision|0|||
161334169|NCT01909804|582612515|FG002|Overall Study|Withdrew Consent|0|||
161334170|NCT01909804|582612516|FG003|Overall Study|Withdrew Consent|0|||
160824497|NCT02285114|580742765|FG001|Extension Phase|Lost to Follow-up|0|||
160824498|NCT02285114|580742766|FG002|Extension Phase|Lost to Follow-up|0|||
160901983|NCT00074984|581035957|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
160901984|NCT03758443|581035958|FG000|Induction Period|Adverse Event|2|||
160901985|NCT03758443|581035959|FG001|Induction Period|Adverse Event|4|||
161133415|NCT02649634|581872919|FG000|Overall Study|Withdrawal by Subject|3|||
161241138|NCT04589650|582264626|FG001|Overall Study|Guardian Decision|0|||
161334171|NCT01909804|582612517|FG004|Overall Study|Withdrew Consent|1|||
160824499|NCT02285114|580742767|FG003|Extension Phase|Lost to Follow-up|1|||
161133416|NCT02649634|581872920|FG001|Overall Study|Withdrawal by Subject|5|||
161241139|NCT04589650|582264627|FG002|Overall Study|Guardian Decision|0|||
160824500|NCT02285114|580742768|FG004|Extension Phase|Lost to Follow-up|1|||
160824501|NCT02285114|580742769|FG005|Extension Phase|Lost to Follow-up|0|||
160824502|NCT02285114|580742764|FG000|Extension Phase|Non-compliance with Study Drug|0|||
160824503|NCT02285114|580742765|FG001|Extension Phase|Non-compliance with Study Drug|0|||
160824504|NCT02285114|580742766|FG002|Extension Phase|Non-compliance with Study Drug|0|||
160824505|NCT02285114|580742767|FG003|Extension Phase|Non-compliance with Study Drug|2|||
160824506|NCT02285114|580742768|FG004|Extension Phase|Non-compliance with Study Drug|0|||
160824507|NCT02285114|580742769|FG005|Extension Phase|Non-compliance with Study Drug|0|||
160824508|NCT02285114|580742764|FG000|Extension Phase|Pregnancy|0|||
160824509|NCT02285114|580742765|FG001|Extension Phase|Pregnancy|0|||
160824510|NCT02285114|580742766|FG002|Extension Phase|Pregnancy|0|||
160824511|NCT02285114|580742767|FG003|Extension Phase|Pregnancy|1|||
160824512|NCT02285114|580742768|FG004|Extension Phase|Pregnancy|0|||
160824513|NCT02285114|580742769|FG005|Extension Phase|Pregnancy|0|||
160824514|NCT02324205|580742770|FG000|Overall Study|Withdrawal by Subject|37|||
160824515|NCT00320255|580742771|FG000|Overall Study|Lack of Efficacy|1|||
160824516|NCT00320255|580742772|FG001|Overall Study|Lack of Efficacy|0|||
160824517|NCT00320255|580742773|FG002|Overall Study|Lack of Efficacy|0|||
160824518|NCT00320255|580742774|FG003|Overall Study|Lack of Efficacy|0|||
160824519|NCT00320255|580742775|FG004|Overall Study|Lack of Efficacy|0|||
160824520|NCT00320255|580742776|FG005|Overall Study|Lack of Efficacy|0|||
160824521|NCT00320255|580742771|FG000|Overall Study|Adverse Event|5|||
160824522|NCT00320255|580742772|FG001|Overall Study|Adverse Event|2|||
160824523|NCT00320255|580742773|FG002|Overall Study|Adverse Event|3|||
160824524|NCT00320255|580742774|FG003|Overall Study|Adverse Event|2|||
160824525|NCT00320255|580742775|FG004|Overall Study|Adverse Event|0|||
160824526|NCT00320255|580742776|FG005|Overall Study|Adverse Event|0|||
160824527|NCT00320255|580742771|FG000|Overall Study|Withdrawal by Subject|1|||
160824528|NCT00320255|580742772|FG001|Overall Study|Withdrawal by Subject|2|||
160824529|NCT00320255|580742773|FG002|Overall Study|Withdrawal by Subject|2|||
160824530|NCT00320255|580742774|FG003|Overall Study|Withdrawal by Subject|4|||
160824531|NCT00320255|580742775|FG004|Overall Study|Withdrawal by Subject|0|||
160824532|NCT00320255|580742776|FG005|Overall Study|Withdrawal by Subject|0|||
160824533|NCT00320255|580742771|FG000|Overall Study|Poor compliance/noncompliance|1|||
160824534|NCT00320255|580742772|FG001|Overall Study|Poor compliance/noncompliance|1|||
160824535|NCT00320255|580742773|FG002|Overall Study|Poor compliance/noncompliance|0|||
160824536|NCT00320255|580742774|FG003|Overall Study|Poor compliance/noncompliance|1|||
160824537|NCT00320255|580742775|FG004|Overall Study|Poor compliance/noncompliance|0|||
160824538|NCT00320255|580742776|FG005|Overall Study|Poor compliance/noncompliance|0|||
160824539|NCT00320255|580742771|FG000|Overall Study|No longer meets study criteria|0|||
160824540|NCT00320255|580742772|FG001|Overall Study|No longer meets study criteria|0|||
160824541|NCT00320255|580742773|FG002|Overall Study|No longer meets study criteria|0|||
160824542|NCT00320255|580742774|FG003|Overall Study|No longer meets study criteria|1|||
160824543|NCT00320255|580742775|FG004|Overall Study|No longer meets study criteria|0|||
160824544|NCT00320255|580742776|FG005|Overall Study|No longer meets study criteria|0|||
160824545|NCT00320255|580742771|FG000|Overall Study|Other|3|||
160824546|NCT00320255|580742772|FG001|Overall Study|Other|2|||
160824547|NCT00320255|580742773|FG002|Overall Study|Other|1|||
160824548|NCT00320255|580742774|FG003|Overall Study|Other|0|||
160824549|NCT00320255|580742775|FG004|Overall Study|Other|0|||
160824550|NCT00320255|580742776|FG005|Overall Study|Other|0|||
160824551|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
160824552|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
160824553|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
160824554|NCT00230282|580742782|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
160824555|NCT01560637|580742785|FG000|Overall Study|Adverse Event|63|||
160824556|NCT01560637|580742785|FG000|Overall Study|Death|69|||
160824557|NCT01560637|580742785|FG000|Overall Study|Lost to Follow-up|8|||
160824558|NCT01560637|580742785|FG000|Overall Study|Protocol Violation|8|||
160824559|NCT01560637|580742785|FG000|Overall Study|Withdrawal by Subject|24|||
160824560|NCT01560637|580742785|FG000|Overall Study|Progressive Disease|20|||
160824561|NCT01560637|580742785|FG000|Overall Study|Other Reason Not Specified|6|||
160901986|NCT03758443|581035960|FG002|Induction Period|Adverse Event|2|||
160901987|NCT03758443|581035961|FG003|Induction Period|Adverse Event|3|||
160901988|NCT03758443|581035958|FG000|Induction Period|Physician Decision|1|||
160824562|NCT01089023|580742788|FG000|Overall Study|Lost to Follow-up|3|||
160824563|NCT01089023|580742788|FG000|Overall Study|Adverse Event|1|||
160824564|NCT01089023|580742788|FG000|Overall Study|Withdrawal by Subject|1|||
160824565|NCT01089023|580742788|FG000|Overall Study|Protocol Violation|1|||
160824566|NCT01089023|580742788|FG000|Overall Study|Lack of Efficacy|1|||
160824567|NCT02434354|580742791|FG000|Overall Study|screen fail|3|||
160824568|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
160824569|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
160824570|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
160824571|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
160824572|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
160901989|NCT03758443|581035959|FG001|Induction Period|Physician Decision|1|||
160824573|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
160824574|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
160824575|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
160824576|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
160824577|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
160824578|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
160824579|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
160824580|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Adverse Event|1|||
160824581|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Adverse Event|0|||
160824582|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Adverse Event|2|||
160824583|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Adverse Event|0|||
160824584|NCT01185964|580742793|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
160824585|NCT01185964|580742794|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
160824586|NCT01185964|580742795|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
160824587|NCT01185964|580742796|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
160824588|NCT01185964|580742793|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
160824589|NCT01185964|580742794|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
160824590|NCT01185964|580742795|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
160824591|NCT01185964|580742796|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
160824592|NCT01185964|580742793|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
160824593|NCT01185964|580742794|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
160824594|NCT01185964|580742795|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
160824595|NCT01185964|580742796|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
160824596|NCT01185964|580742793|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
160824597|NCT01185964|580742794|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
160824598|NCT01185964|580742795|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
160824599|NCT01185964|580742796|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
160824600|NCT03576755|580742810|FG000|Overall Study|Withdrawal by Subject|1|||
160824601|NCT03576755|580742811|FG001|Overall Study|Withdrawal by Subject|0|||
160824602|NCT03576755|580742812|FG002|Overall Study|Withdrawal by Subject|0|||
160824603|NCT03576755|580742813|FG003|Overall Study|Withdrawal by Subject|0|||
160824604|NCT04962230|580742814|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
160824605|NCT04962230|580742814|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
160824606|NCT02275117|580742815|FG000|Overall Study|Adverse Event|0|||
160824607|NCT02275117|580742816|FG001|Overall Study|Adverse Event|0|||
160824608|NCT02275117|580742817|FG002|Overall Study|Adverse Event|0|||
160824609|NCT02275117|580742818|FG003|Overall Study|Adverse Event|0|||
160824610|NCT02275117|580742819|FG004|Overall Study|Adverse Event|1|||
160824611|NCT02275117|580742815|FG000|Overall Study|Lack of Efficacy|6|||
160824612|NCT02275117|580742816|FG001|Overall Study|Lack of Efficacy|7|||
160824613|NCT02275117|580742817|FG002|Overall Study|Lack of Efficacy|5|||
160824614|NCT02275117|580742818|FG003|Overall Study|Lack of Efficacy|2|||
160824615|NCT02275117|580742819|FG004|Overall Study|Lack of Efficacy|10|||
160824616|NCT02275117|580742815|FG000|Overall Study|Lost to Follow-up|11|||
160824617|NCT02275117|580742816|FG001|Overall Study|Lost to Follow-up|16|||
160824618|NCT02275117|580742817|FG002|Overall Study|Lost to Follow-up|15|||
160824619|NCT02275117|580742818|FG003|Overall Study|Lost to Follow-up|16|||
160824620|NCT02275117|580742819|FG004|Overall Study|Lost to Follow-up|8|||
160824621|NCT02275117|580742815|FG000|Overall Study|Physician Decision|0|||
160824622|NCT02275117|580742816|FG001|Overall Study|Physician Decision|1|||
160824623|NCT02275117|580742817|FG002|Overall Study|Physician Decision|1|||
160824624|NCT02275117|580742818|FG003|Overall Study|Physician Decision|0|||
160901990|NCT03758443|581035960|FG002|Induction Period|Physician Decision|3|||
160901991|NCT03758443|581035961|FG003|Induction Period|Physician Decision|0|||
160901992|NCT03758443|581035958|FG000|Induction Period|Protocol Violation|0|||
160901993|NCT03758443|581035959|FG001|Induction Period|Protocol Violation|0|||
160901994|NCT03758443|581035960|FG002|Induction Period|Protocol Violation|0|||
160901995|NCT03758443|581035961|FG003|Induction Period|Protocol Violation|1|||
160824625|NCT02275117|580742819|FG004|Overall Study|Physician Decision|1|||
160824626|NCT02275117|580742815|FG000|Overall Study|Protocol Violation|1|||
160824627|NCT02275117|580742816|FG001|Overall Study|Protocol Violation|0|||
160824628|NCT02275117|580742817|FG002|Overall Study|Protocol Violation|1|||
160824629|NCT02275117|580742818|FG003|Overall Study|Protocol Violation|1|||
160901996|NCT03758443|581035958|FG000|Induction Period|Withdrawal by Subject|3|||
160901997|NCT03758443|581035959|FG001|Induction Period|Withdrawal by Subject|2|||
160901998|NCT03758443|581035960|FG002|Induction Period|Withdrawal by Subject|2|||
160901999|NCT03758443|581035961|FG003|Induction Period|Withdrawal by Subject|4|||
160902000|NCT03758443|581035958|FG000|Extended Induction Period|Adverse Event|1|||
160902001|NCT03758443|581035959|FG001|Extended Induction Period|Adverse Event|1|||
160902002|NCT03758443|581035960|FG002|Extended Induction Period|Adverse Event|0|||
160902003|NCT03758443|581035961|FG003|Extended Induction Period|Adverse Event|1|||
160902004|NCT03758443|581035958|FG000|Extended Induction Period|Lost to Follow-up|1|||
160902005|NCT03758443|581035959|FG001|Extended Induction Period|Lost to Follow-up|0|||
161334172|NCT01909804|582612518|FG005|Overall Study|Withdrew Consent|1|||
161334173|NCT01909804|582612519|FG006|Overall Study|Withdrew Consent|0|||
161334174|NCT01909804|582612520|FG007|Overall Study|Withdrew Consent|0|||
161334175|NCT01909804|582612521|FG008|Overall Study|Withdrew Consent|0|||
161334176|NCT01909804|582612522|FG009|Overall Study|Withdrew Consent|0|||
161334177|NCT01909804|582612523|FG010|Overall Study|Withdrew Consent|0|||
161334178|NCT01909804|582612524|FG011|Overall Study|Withdrew Consent|0|||
161334179|NCT01909804|582612513|FG000|Overall Study|Protocol Violation|0|||
161334180|NCT01909804|582612514|FG001|Overall Study|Protocol Violation|0|||
161334181|NCT01909804|582612515|FG002|Overall Study|Protocol Violation|0|||
161334182|NCT01909804|582612516|FG003|Overall Study|Protocol Violation|0|||
161334183|NCT01909804|582612517|FG004|Overall Study|Protocol Violation|0|||
161334184|NCT01909804|582612518|FG005|Overall Study|Protocol Violation|0|||
161334185|NCT01909804|582612519|FG006|Overall Study|Protocol Violation|0|||
161334186|NCT01909804|582612520|FG007|Overall Study|Protocol Violation|0|||
161334187|NCT01909804|582612521|FG008|Overall Study|Protocol Violation|0|||
161334188|NCT01909804|582612522|FG009|Overall Study|Protocol Violation|0|||
161334189|NCT01909804|582612523|FG010|Overall Study|Protocol Violation|0|||
161334190|NCT01909804|582612524|FG011|Overall Study|Protocol Violation|1|||
161334191|NCT01091246|582612526|FG000|Overall Study|Lost to Follow-up|23|||
161334192|NCT01091246|582612527|FG001|Overall Study|Lost to Follow-up|11|||
161334193|NCT01091246|582612528|FG002|Overall Study|Lost to Follow-up|7|||
161334194|NCT01091246|582612526|FG000|Overall Study|Adverse Event|1|||
161334195|NCT01091246|582612527|FG001|Overall Study|Adverse Event|0|||
161334196|NCT01091246|582612528|FG002|Overall Study|Adverse Event|1|||
161334197|NCT01091246|582612526|FG000|Overall Study|Withdrawal by Subject|9|||
161334198|NCT01091246|582612527|FG001|Overall Study|Withdrawal by Subject|5|||
161334199|NCT01091246|582612528|FG002|Overall Study|Withdrawal by Subject|4|||
161334200|NCT01091246|582612526|FG000|Overall Study|Subject not dosed|2|||
161334201|NCT01091246|582612527|FG001|Overall Study|Subject not dosed|0|||
161334202|NCT01091246|582612528|FG002|Overall Study|Subject not dosed|1|||
161334203|NCT01676012|582612529|FG000|Overall Study|Adverse Event|2|||
161334204|NCT01676012|582612529|FG000|Overall Study|incomplete set of videos|1|||
161334205|NCT02155985|582612534|FG000|Overall Study|Withdrawal by Subject|0|||
161334206|NCT02155985|582612535|FG001|Overall Study|Withdrawal by Subject|0|||
161334207|NCT02155985|582612536|FG002|Overall Study|Withdrawal by Subject|1|||
161334208|NCT02155985|582612534|FG000|Overall Study|Lost to Follow-up|1|||
160824630|NCT02275117|580742819|FG004|Overall Study|Protocol Violation|0|||
160824631|NCT02275117|580742815|FG000|Overall Study|Withdrawal by Subject|6|||
160824632|NCT02275117|580742816|FG001|Overall Study|Withdrawal by Subject|4|||
160824633|NCT02275117|580742817|FG002|Overall Study|Withdrawal by Subject|7|||
160824634|NCT02275117|580742818|FG003|Overall Study|Withdrawal by Subject|3|||
160824635|NCT02275117|580742819|FG004|Overall Study|Withdrawal by Subject|3|||
160824636|NCT02275117|580742815|FG000|Overall Study|Terminated by Sponsor|4|||
160824637|NCT02275117|580742816|FG001|Overall Study|Terminated by Sponsor|4|||
160824638|NCT02275117|580742817|FG002|Overall Study|Terminated by Sponsor|4|||
160824639|NCT02275117|580742818|FG003|Overall Study|Terminated by Sponsor|6|||
160824640|NCT02275117|580742819|FG004|Overall Study|Terminated by Sponsor|4|||
160824641|NCT02275117|580742815|FG000|Overall Study|Worsening of Study Indication|0|||
160824642|NCT02275117|580742816|FG001|Overall Study|Worsening of Study Indication|1|||
160824643|NCT02275117|580742817|FG002|Overall Study|Worsening of Study Indication|2|||
160824644|NCT02275117|580742818|FG003|Overall Study|Worsening of Study Indication|0|||
160824645|NCT02275117|580742819|FG004|Overall Study|Worsening of Study Indication|0|||
160824646|NCT02275117|580742815|FG000|Overall Study|Study Burden|5|||
160824647|NCT02275117|580742816|FG001|Overall Study|Study Burden|4|||
160824648|NCT02275117|580742817|FG002|Overall Study|Study Burden|7|||
160824649|NCT02275117|580742818|FG003|Overall Study|Study Burden|5|||
160824650|NCT02275117|580742819|FG004|Overall Study|Study Burden|7|||
160824651|NCT02275117|580742815|FG000|Overall Study|Other|1|||
160824652|NCT02275117|580742816|FG001|Overall Study|Other|0|||
160824653|NCT02275117|580742817|FG002|Overall Study|Other|0|||
160824654|NCT02275117|580742818|FG003|Overall Study|Other|0|||
160824655|NCT02275117|580742819|FG004|Overall Study|Other|2|||
160824656|NCT01081301|580742823|FG000|Overall Study|Bereaved|3|||
160824657|NCT01081301|580742823|FG000|Overall Study|Too busy|5|||
161334209|NCT02155985|582612535|FG001|Overall Study|Lost to Follow-up|0|||
161334210|NCT02155985|582612536|FG002|Overall Study|Lost to Follow-up|0|||
160824658|NCT01081301|580742823|FG000|Overall Study|Patient too ill|2|||
161334211|NCT04460326|582612541|FG000|Completed at Least 4 Meals|Early discharge|5|||
161334212|NCT04460326|582612542|FG001|Completed at Least 4 Meals|Early discharge|5|||
161334213|NCT04460326|582612541|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
161334214|NCT04460326|582612542|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
161334215|NCT04460326|582612541|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
160824659|NCT01081301|580742823|FG000|Overall Study|Lost to Follow-up|4|||
160824660|NCT02014480|580742824|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824661|NCT02014480|580742825|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824662|NCT02014480|580742826|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
161334216|NCT04460326|582612542|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
160989911|NCT01124162|581351688|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160824663|NCT02014480|580742827|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824664|NCT02014480|580742828|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824665|NCT02014480|580742829|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160824666|NCT02014480|580742824|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160824667|NCT02014480|580742825|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160824668|NCT02014480|580742826|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160824669|NCT02014480|580742827|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
160824670|NCT02014480|580742828|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160824671|NCT02014480|580742829|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160824672|NCT02014480|580742824|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824673|NCT02014480|580742825|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824674|NCT02014480|580742826|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
160824675|NCT02014480|580742827|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824676|NCT02014480|580742828|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824677|NCT02014480|580742829|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
160824678|NCT02014480|580742824|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160824679|NCT02014480|580742825|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160824680|NCT02014480|580742826|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
160824681|NCT02014480|580742827|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
160824682|NCT02014480|580742828|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160824683|NCT02014480|580742829|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
160824684|NCT02014480|580742824|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824685|NCT02014480|580742825|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
160824686|NCT02014480|580742826|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824687|NCT02014480|580742827|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824688|NCT02014480|580742828|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824689|NCT02014480|580742829|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
160824690|NCT02014480|580742824|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824691|NCT02014480|580742825|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824692|NCT02014480|580742826|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
160824693|NCT02014480|580742827|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824694|NCT02014480|580742828|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
160824695|NCT02014480|580742829|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
160824696|NCT02014480|580742824|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824697|NCT02014480|580742825|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824698|NCT02014480|580742826|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824699|NCT02014480|580742827|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824700|NCT02014480|580742828|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160824701|NCT02014480|580742829|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
160824702|NCT01865812|580742830|FG000|Primary Treatment Phase|Adverse Event|2|||
160824703|NCT01865812|580742831|FG001|Primary Treatment Phase|Adverse Event|0|||
160824704|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
160824705|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
160824706|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Pruritus|0|||
160824707|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Pruritus|3|||
160824708|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
160824709|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
160824710|NCT01865812|580742830|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
160824711|NCT01865812|580742831|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
160824712|NCT01338610|580742832|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
160824713|NCT01338610|580742833|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
160824714|NCT01338610|580742834|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
161241140|NCT04589650|582264628|FG003|Overall Study|Guardian Decision|1|||
160824715|NCT01338610|580742832|FG000|Overall Study|Protocol Violation|1|||
160824716|NCT01338610|580742833|FG001|Overall Study|Protocol Violation|0|||
161241141|NCT04589650|582264629|FG004|Overall Study|Guardian Decision|0|||
161241142|NCT04589650|582264630|FG005|Overall Study|Guardian Decision|0|||
161241143|NCT00950989|582264631|FG000|Overall Study|Death|0|||
160824717|NCT01338610|580742834|FG002|Overall Study|Protocol Violation|1|||
160824718|NCT01338610|580742832|FG000|Overall Study|Adverse Event|3|||
160824719|NCT01338610|580742833|FG001|Overall Study|Adverse Event|0|||
160824720|NCT01338610|580742834|FG002|Overall Study|Adverse Event|0|||
160824721|NCT00724854|580742835|FG000|Overall Study|Lack of Efficacy|187|||
160824722|NCT00724854|580742836|FG001|Overall Study|Lack of Efficacy|13|||
160989912|NCT03681691|581351689|FG000|Overall Study|COVID|1|||
160989913|NCT03681691|581351690|FG001|Overall Study|COVID|0|||
160989914|NCT03681691|581351689|FG000|Overall Study|prolonged bleeding|1|||
160824723|NCT00724854|580742835|FG000|Overall Study|Lost to Follow-up|87|||
160824724|NCT00724854|580742836|FG001|Overall Study|Lost to Follow-up|10|||
160824725|NCT00724854|580742835|FG000|Overall Study|Adverse Event|62|||
160902006|NCT03758443|581035960|FG002|Extended Induction Period|Lost to Follow-up|0|||
161241144|NCT00950989|582264632|FG001|Overall Study|Death|0|||
161241145|NCT00950989|582264633|FG002|Overall Study|Death|1|||
161241146|NCT00950989|582264634|FG003|Overall Study|Death|0|||
161241147|NCT00950989|582264631|FG000|Overall Study|Administrative Decision|0|||
161241148|NCT00950989|582264632|FG001|Overall Study|Administrative Decision|1|||
161241149|NCT00950989|582264633|FG002|Overall Study|Administrative Decision|0|||
161241150|NCT00950989|582264634|FG003|Overall Study|Administrative Decision|0|||
161241151|NCT00950989|582264631|FG000|Overall Study|Disease Progression|0|||
161241152|NCT00950989|582264632|FG001|Overall Study|Disease Progression|0|||
161241153|NCT00950989|582264633|FG002|Overall Study|Disease Progression|1|||
161241154|NCT00950989|582264634|FG003|Overall Study|Disease Progression|0|||
161241155|NCT00950989|582264631|FG000|Overall Study|Withdrawal by Subject|2|||
161241156|NCT00950989|582264632|FG001|Overall Study|Withdrawal by Subject|1|||
161241157|NCT00950989|582264633|FG002|Overall Study|Withdrawal by Subject|0|||
161241158|NCT00950989|582264634|FG003|Overall Study|Withdrawal by Subject|0|||
161241159|NCT00950989|582264631|FG000|Overall Study|Adverse Event|2|||
161241160|NCT00950989|582264632|FG001|Overall Study|Adverse Event|1|||
161241161|NCT00950989|582264633|FG002|Overall Study|Adverse Event|1|||
161241162|NCT00950989|582264634|FG003|Overall Study|Adverse Event|0|||
161241163|NCT03804983|582264635|FG000|Overall Study|Adverse Event|0|||
161241164|NCT03804983|582264636|FG001|Overall Study|Adverse Event|1|||
161241165|NCT03804983|582264635|FG000|Overall Study|Family Obligation|1|||
161241166|NCT03804983|582264636|FG001|Overall Study|Family Obligation|0|||
161241167|NCT03600376|582264637|FG000|Overall Study|Adverse Event|1|||
161241168|NCT03600376|582264638|FG001|Overall Study|Adverse Event|1|||
161241169|NCT03600376|582264637|FG000|Overall Study|Transferred to other facility|1|||
161241170|NCT03600376|582264638|FG001|Overall Study|Transferred to other facility|0|||
161241171|NCT03600376|582264637|FG000|Overall Study|Investigator Decision|0|||
161241172|NCT03600376|582264638|FG001|Overall Study|Investigator Decision|4|||
161241173|NCT03600376|582264637|FG000|Overall Study|Determined to be ineligible for study|0|||
161241174|NCT03600376|582264638|FG001|Overall Study|Determined to be ineligible for study|1|||
161241175|NCT00796562|582264642|FG000|Overall Study|Death|49|||
161241176|NCT05655520|582264643|FG000|Overall Study|Adverse Event|2|||
161241177|NCT05655520|582264644|FG001|Overall Study|Adverse Event|3|||
161241178|NCT05655520|582264643|FG000|Overall Study|Physician Decision|2|||
161241179|NCT05655520|582264644|FG001|Overall Study|Physician Decision|0|||
161241180|NCT05655520|582264643|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161241181|NCT05655520|582264644|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161241182|NCT05655520|582264643|FG000|Overall Study|Lost to Follow-up|1|||
161241183|NCT05655520|582264644|FG001|Overall Study|Lost to Follow-up|0|||
161241184|NCT05655520|582264643|FG000|Overall Study|Withdrawal by Subject|4|||
161241185|NCT05655520|582264644|FG001|Overall Study|Withdrawal by Subject|4|||
161241186|NCT05655520|582264643|FG000|Overall Study|Study Terminated by Sponsor|61|||
161241187|NCT05655520|582264644|FG001|Overall Study|Study Terminated by Sponsor|68|||
161241188|NCT00424047|582264645|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
161241189|NCT00424047|582264646|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
161241190|NCT00424047|582264645|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
161241191|NCT00424047|582264646|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
161241192|NCT00424047|582264645|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
161241193|NCT00424047|582264646|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
161241194|NCT00424047|582264645|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
161241195|NCT00424047|582264646|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
161241196|NCT00424047|582264645|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
161241197|NCT00424047|582264646|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
161241198|NCT00424047|582264645|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
161241199|NCT00424047|582264646|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
161241200|NCT00424047|582264645|FG000|On Study at Time of Unblinding|Adverse Event|22|||
160902007|NCT03758443|581035961|FG003|Extended Induction Period|Lost to Follow-up|0|||
160902008|NCT03758443|581035958|FG000|Extended Induction Period|Physician Decision|2|||
160902009|NCT03758443|581035959|FG001|Extended Induction Period|Physician Decision|1|||
160902010|NCT03758443|581035960|FG002|Extended Induction Period|Physician Decision|2|||
160902011|NCT03758443|581035961|FG003|Extended Induction Period|Physician Decision|2|||
160902012|NCT03758443|581035958|FG000|Extended Induction Period|Protocol Violation|0|||
161241201|NCT00424047|582264646|FG001|On Study at Time of Unblinding|Adverse Event|12|||
161241202|NCT00424047|582264645|FG000|On Study at Time of Unblinding|Progression of disease|92|||
161241203|NCT00424047|582264646|FG001|On Study at Time of Unblinding|Progression of disease|128|||
160902013|NCT03758443|581035959|FG001|Extended Induction Period|Protocol Violation|0|||
160902014|NCT03758443|581035960|FG002|Extended Induction Period|Protocol Violation|0|||
160989915|NCT03681691|581351690|FG001|Overall Study|prolonged bleeding|0|||
161241204|NCT00424047|582264645|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
161241205|NCT00424047|582264646|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
161241206|NCT00424047|582264645|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
160902015|NCT03758443|581035961|FG003|Extended Induction Period|Protocol Violation|1|||
160902016|NCT03758443|581035958|FG000|Extended Induction Period|Withdrawal by Subject|8|||
160902017|NCT03758443|581035959|FG001|Extended Induction Period|Withdrawal by Subject|1|||
160902018|NCT03758443|581035960|FG002|Extended Induction Period|Withdrawal by Subject|7|||
160902019|NCT03758443|581035961|FG003|Extended Induction Period|Withdrawal by Subject|3|||
160902020|NCT03758443|581035958|FG000|Extended Induction Period|Miscellaneous|1|||
160902021|NCT03758443|581035959|FG001|Extended Induction Period|Miscellaneous|0|||
161241207|NCT00424047|582264646|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
161241208|NCT00424047|582264645|FG000|On Study at Time of Unblinding|Death|11|||
161241209|NCT00424047|582264646|FG001|On Study at Time of Unblinding|Death|11|||
160824726|NCT00724854|580742836|FG001|Overall Study|Adverse Event|4|||
160824727|NCT00724854|580742835|FG000|Overall Study|Other|42|||
160824728|NCT00724854|580742836|FG001|Overall Study|Other|3|||
160824729|NCT00724854|580742835|FG000|Overall Study|Death|11|||
160824730|NCT00724854|580742836|FG001|Overall Study|Death|0|||
160824731|NCT00724854|580742835|FG000|Overall Study|Change of treatment|7|||
160824732|NCT00724854|580742836|FG001|Overall Study|Change of treatment|0|||
160824733|NCT00724854|580742835|FG000|Overall Study|Withdrawal by Subject|5|||
160824734|NCT00724854|580742836|FG001|Overall Study|Withdrawal by Subject|0|||
160824735|NCT00724854|580742835|FG000|Overall Study|Adverse event + lack of efficacy|2|||
160824736|NCT00724854|580742836|FG001|Overall Study|Adverse event + lack of efficacy|1|||
160824737|NCT01095653|580742837|FG000|Overall Study|Lack of Efficacy|3|||
160824738|NCT01095653|580742838|FG001|Overall Study|Lack of Efficacy|0|||
160824739|NCT01095653|580742839|FG002|Overall Study|Lack of Efficacy|0|||
160824740|NCT01095653|580742837|FG000|Overall Study|Adverse Event|1|||
160824741|NCT01095653|580742838|FG001|Overall Study|Adverse Event|4|||
160824742|NCT01095653|580742839|FG002|Overall Study|Adverse Event|4|||
160824743|NCT01095653|580742837|FG000|Overall Study|Lost to Follow-up|1|||
160824744|NCT01095653|580742838|FG001|Overall Study|Lost to Follow-up|0|||
160824745|NCT01095653|580742839|FG002|Overall Study|Lost to Follow-up|4|||
160824746|NCT01095653|580742837|FG000|Overall Study|Withdrawal by Subject|4|||
160824747|NCT01095653|580742838|FG001|Overall Study|Withdrawal by Subject|5|||
160824748|NCT01095653|580742839|FG002|Overall Study|Withdrawal by Subject|3|||
160824749|NCT01095653|580742837|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
160824750|NCT01095653|580742838|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
160824751|NCT01095653|580742839|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
160824752|NCT02046226|580742840|FG000|Overall Study|Lost to Follow-up|7|||
160824753|NCT02692040|580742844|FG000|Overall Study|Protocol Violation|0|||
160824754|NCT02692040|580742845|FG001|Overall Study|Protocol Violation|0|||
160824755|NCT02692040|580742846|FG002|Overall Study|Protocol Violation|0|||
160824756|NCT02692040|580742847|FG003|Overall Study|Protocol Violation|0|||
160824757|NCT02692040|580742848|FG004|Overall Study|Protocol Violation|0|||
160824758|NCT02692040|580742849|FG005|Overall Study|Protocol Violation|0|||
160824759|NCT02692040|580742850|FG006|Overall Study|Protocol Violation|0|||
160824760|NCT02692040|580742851|FG007|Overall Study|Protocol Violation|0|||
160824761|NCT02692040|580742852|FG008|Overall Study|Protocol Violation|0|||
160824762|NCT02692040|580742853|FG009|Overall Study|Protocol Violation|0|||
160824763|NCT02692040|580742854|FG010|Overall Study|Protocol Violation|0|||
160824764|NCT02692040|580742855|FG011|Overall Study|Protocol Violation|0|||
160824765|NCT02692040|580742856|FG012|Overall Study|Protocol Violation|1|||
160902022|NCT03758443|581035960|FG002|Extended Induction Period|Miscellaneous|0|||
160902023|NCT03758443|581035961|FG003|Extended Induction Period|Miscellaneous|0|||
160902024|NCT03758443|581035958|FG000|Maintenance Period|Adverse Event|1|||
161241210|NCT00424047|582264645|FG000|On Study at Time of Unblinding|Other|5|||
161241211|NCT00424047|582264646|FG001|On Study at Time of Unblinding|Other|4|||
161241212|NCT00424047|582264645|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
161241213|NCT00424047|582264646|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
161334217|NCT04460326|582612541|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
160824766|NCT02692040|580742857|FG013|Overall Study|Protocol Violation|0|||
160824767|NCT02692040|580742858|FG014|Overall Study|Protocol Violation|0|||
160824768|NCT02692040|580742859|FG015|Overall Study|Protocol Violation|0|||
160824769|NCT02692040|580742860|FG016|Overall Study|Protocol Violation|0|||
160824770|NCT02692040|580742844|FG000|Overall Study|Adverse Event|0|||
160824771|NCT02692040|580742845|FG001|Overall Study|Adverse Event|0|||
160824772|NCT02692040|580742846|FG002|Overall Study|Adverse Event|0|||
160902025|NCT03758443|581035959|FG001|Maintenance Period|Adverse Event|2|||
160989916|NCT03681691|581351689|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
161241214|NCT00424047|582264645|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
161334218|NCT04460326|582612542|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
161334219|NCT04460326|582612541|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
161334220|NCT04460326|582612542|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
160824773|NCT02692040|580742847|FG003|Overall Study|Adverse Event|0|||
160824774|NCT02692040|580742848|FG004|Overall Study|Adverse Event|0|||
160824775|NCT02692040|580742849|FG005|Overall Study|Adverse Event|0|||
160824776|NCT02692040|580742850|FG006|Overall Study|Adverse Event|0|||
160824777|NCT02692040|580742851|FG007|Overall Study|Adverse Event|0|||
160824778|NCT02692040|580742852|FG008|Overall Study|Adverse Event|0|||
160824779|NCT02692040|580742853|FG009|Overall Study|Adverse Event|0|||
160824780|NCT02692040|580742854|FG010|Overall Study|Adverse Event|0|||
160824781|NCT02692040|580742855|FG011|Overall Study|Adverse Event|0|||
160824782|NCT02692040|580742856|FG012|Overall Study|Adverse Event|0|||
160824783|NCT02692040|580742857|FG013|Overall Study|Adverse Event|3|||
160824784|NCT02692040|580742858|FG014|Overall Study|Adverse Event|1|||
160989917|NCT03681691|581351690|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
160989918|NCT03613129|581351691|FG000|Pre-treatment Assessment|Protocol Violation|2|||
160989919|NCT03613129|581351692|FG001|Pre-treatment Assessment|Protocol Violation|0|||
160989920|NCT03613129|581351693|FG002|Pre-treatment Assessment|Protocol Violation|0|||
160989921|NCT03613129|581351694|FG003|Pre-treatment Assessment|Protocol Violation|0|||
160989922|NCT03613129|581351695|FG004|Pre-treatment Assessment|Protocol Violation|0|||
160989923|NCT03613129|581351691|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
161241215|NCT00424047|582264646|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
161241216|NCT00424047|582264645|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
160824785|NCT02692040|580742859|FG015|Overall Study|Adverse Event|1|||
160824786|NCT02692040|580742860|FG016|Overall Study|Adverse Event|0|||
160824787|NCT00171925|580742861|FG000|Overall Study|Adverse Event|10|||
160824788|NCT00171925|580742862|FG001|Overall Study|Adverse Event|6|||
160824789|NCT00171925|580742861|FG000|Overall Study|Protocol Violation|1|||
160824790|NCT00171925|580742862|FG001|Overall Study|Protocol Violation|1|||
160824791|NCT00171925|580742861|FG000|Overall Study|Withdrawal by Subject|6|||
160824792|NCT00171925|580742862|FG001|Overall Study|Withdrawal by Subject|9|||
160824793|NCT00171925|580742861|FG000|Overall Study|Lost to Follow-up|2|||
160824794|NCT00171925|580742862|FG001|Overall Study|Lost to Follow-up|2|||
160824795|NCT00171925|580742861|FG000|Overall Study|Administrative problems|10|||
160824796|NCT00171925|580742862|FG001|Overall Study|Administrative problems|11|||
160824797|NCT00171925|580742861|FG000|Overall Study|Death|1|||
160824798|NCT00171925|580742862|FG001|Overall Study|Death|2|||
160824799|NCT01819129|580742865|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
160902026|NCT03758443|581035960|FG002|Maintenance Period|Adverse Event|0|||
161241217|NCT00424047|582264646|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
161241218|NCT00424047|582264645|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
160902027|NCT03758443|581035961|FG003|Maintenance Period|Adverse Event|0|||
160902028|NCT03758443|581035958|FG000|Maintenance Period|Lost to Follow-up|0|||
160902029|NCT03758443|581035959|FG001|Maintenance Period|Lost to Follow-up|0|||
160902030|NCT03758443|581035960|FG002|Maintenance Period|Lost to Follow-up|0|||
160902031|NCT03758443|581035961|FG003|Maintenance Period|Lost to Follow-up|1|||
160902032|NCT03758443|581035958|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
160902033|NCT03758443|581035959|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
160902034|NCT03758443|581035960|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
160902035|NCT03758443|581035961|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
160902036|NCT03758443|581035958|FG000|Maintenance Period|Protocol Violation|0|||
160902037|NCT03758443|581035959|FG001|Maintenance Period|Protocol Violation|1|||
160902038|NCT03758443|581035960|FG002|Maintenance Period|Protocol Violation|0|||
160902039|NCT03758443|581035961|FG003|Maintenance Period|Protocol Violation|0|||
160902040|NCT03758443|581035958|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
160902041|NCT03758443|581035959|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
160902042|NCT03758443|581035960|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
160902043|NCT03758443|581035961|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
160902044|NCT03758443|581035958|FG000|Maintenance Period|Withdrawal by Subject|1|||
160989924|NCT03613129|581351692|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
160989925|NCT03613129|581351693|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
161241219|NCT00424047|582264646|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
161241220|NCT00424047|582264645|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
161241221|NCT00424047|582264646|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
161241222|NCT01229150|582264650|FG000|Overall Study|Toxicity|2|||
161241223|NCT01229150|582264651|FG001|Overall Study|Toxicity|2|||
161241224|NCT01229150|582264652|FG002|Overall Study|Toxicity|0|||
161241225|NCT01229150|582264653|FG003|Overall Study|Toxicity|0|||
161241226|NCT05248204|582264654|FG000|Overall Study|Lost to Follow-up|13|||
160902045|NCT03758443|581035959|FG001|Maintenance Period|Withdrawal by Subject|0|||
160902046|NCT03758443|581035960|FG002|Maintenance Period|Withdrawal by Subject|1|||
160902047|NCT03758443|581035961|FG003|Maintenance Period|Withdrawal by Subject|1|||
160902048|NCT03758443|581035958|FG000|Maintenance Period|Miscellaneous|0|||
160902049|NCT03758443|581035959|FG001|Maintenance Period|Miscellaneous|0|||
160902050|NCT03758443|581035960|FG002|Maintenance Period|Miscellaneous|1|||
161339977|NCT00042289|582633406|FG002|Overall Study|Severe debilitation, unable to continue|0|||
160902051|NCT03758443|581035961|FG003|Maintenance Period|Miscellaneous|0|||
160902052|NCT03080454|581035962|FG000|Baseline|Adverse Event|2|||
160824800|NCT01819129|580742866|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
160824801|NCT01819129|580742865|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
160824802|NCT01819129|580742866|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
160824803|NCT01819129|580742865|FG000|Overall Study|Other, Subject moved out of the country|0|||
161241227|NCT05248204|582264655|FG001|Overall Study|Lost to Follow-up|13|||
161241228|NCT05248204|582264654|FG000|Overall Study|Protocol Violation|1|||
161241229|NCT05248204|582264655|FG001|Overall Study|Protocol Violation|0|||
161241230|NCT01473953|582264656|FG000|Overall Study|Other|1|||
161241231|NCT01473953|582264657|FG001|Overall Study|Other|0|||
161241232|NCT01473953|582264658|FG002|Overall Study|Other|0|||
161241233|NCT01473953|582264659|FG003|Overall Study|Other|0|||
160824804|NCT01819129|580742866|FG001|Overall Study|Other, Subject moved out of the country|1|||
160824805|NCT01819129|580742865|FG000|Overall Study|Withdrawal by Subject|15|||
160824806|NCT01819129|580742866|FG001|Overall Study|Withdrawal by Subject|15|||
160824807|NCT01819129|580742865|FG000|Overall Study|Lost to Follow-up|5|||
160824808|NCT01819129|580742866|FG001|Overall Study|Lost to Follow-up|2|||
160824809|NCT01819129|580742865|FG000|Overall Study|Lack of Efficacy|0|||
160824810|NCT01819129|580742866|FG001|Overall Study|Lack of Efficacy|1|||
160824811|NCT01819129|580742865|FG000|Overall Study|Adverse Event|1|||
160824812|NCT01819129|580742866|FG001|Overall Study|Adverse Event|4|||
160824813|NCT01819129|580742865|FG000|Overall Study|Death|1|||
160824814|NCT01819129|580742866|FG001|Overall Study|Death|1|||
160824815|NCT01819129|580742865|FG000|Overall Study|Withdrawal Criteria|20|||
160824816|NCT01819129|580742866|FG001|Overall Study|Withdrawal Criteria|15|||
160824817|NCT02752958|580742868|FG000|Overall Study|Adverse Event|3|||
160824818|NCT02752958|580742868|FG000|Overall Study|Lost to Follow-up|1|||
160824819|NCT02752958|580742868|FG000|Overall Study|Protocol Violation|1|||
160824820|NCT02752958|580742868|FG000|Overall Study|Withdrawal by Subject|2|||
160824821|NCT02752958|580742868|FG000|Overall Study|Other (Reason not specified)|2|||
160824822|NCT00054691|580742871|FG000|Overall Study|Unmeasurable Disease|2|||
160824823|NCT00054691|580742871|FG000|Overall Study|Noncompliant|1|||
160824824|NCT02836873|580742878|FG000|Overall Study|Protocol Violation|0|||
160824825|NCT02836873|580742879|FG001|Overall Study|Protocol Violation|1|||
160824826|NCT02836873|580742878|FG000|Overall Study|Adverse Event|1|||
160824827|NCT02836873|580742879|FG001|Overall Study|Adverse Event|4|||
160824828|NCT02836873|580742878|FG000|Overall Study|Withdrawal by Subject|2|||
160824829|NCT02836873|580742879|FG001|Overall Study|Withdrawal by Subject|2|||
160824830|NCT02836873|580742878|FG000|Overall Study|Lost to Follow-up|1|||
160824831|NCT02836873|580742879|FG001|Overall Study|Lost to Follow-up|3|||
160824832|NCT02836873|580742878|FG000|Overall Study|Physician Decision|0|||
160824833|NCT02836873|580742879|FG001|Overall Study|Physician Decision|1|||
160824834|NCT02836873|580742878|FG000|Overall Study|Other|1|||
160824835|NCT02836873|580742879|FG001|Overall Study|Other|0|||
160824836|NCT00853125|580742882|FG000|Overall Study|Study participant's donor was CMV +|1|||
160824837|NCT02914548|580742887|FG000|Overall Study|Adverse Event|15|||
161241234|NCT01473953|582264660|FG004|Overall Study|Other|0|||
161241235|NCT03100344|582264661|FG000|Overall Study|Adverse Event|0|||
161241236|NCT03100344|582264662|FG001|Overall Study|Adverse Event|3|||
161241237|NCT03100344|582264663|FG002|Overall Study|Adverse Event|2|||
161241238|NCT03100344|582264664|FG003|Overall Study|Adverse Event|3|||
161241239|NCT03100344|582264661|FG000|Overall Study|Lack of Efficacy|2|||
161241240|NCT03100344|582264662|FG001|Overall Study|Lack of Efficacy|0|||
161241241|NCT03100344|582264663|FG002|Overall Study|Lack of Efficacy|0|||
161241242|NCT03100344|582264664|FG003|Overall Study|Lack of Efficacy|0|||
161241243|NCT03100344|582264661|FG000|Overall Study|Protocol Violation|1|||
161241244|NCT03100344|582264662|FG001|Overall Study|Protocol Violation|0|||
161241245|NCT03100344|582264663|FG002|Overall Study|Protocol Violation|0|||
161241246|NCT03100344|582264664|FG003|Overall Study|Protocol Violation|0|||
161241247|NCT03100344|582264661|FG000|Overall Study|Withdrawal by Subject|10|||
161241248|NCT03100344|582264662|FG001|Overall Study|Withdrawal by Subject|7|||
161241249|NCT03100344|582264663|FG002|Overall Study|Withdrawal by Subject|4|||
161241250|NCT03100344|582264664|FG003|Overall Study|Withdrawal by Subject|8|||
161241251|NCT03100344|582264661|FG000|Overall Study|Lost to Follow-up|1|||
161241252|NCT03100344|582264662|FG001|Overall Study|Lost to Follow-up|1|||
161241253|NCT03100344|582264663|FG002|Overall Study|Lost to Follow-up|1|||
161241254|NCT03100344|582264664|FG003|Overall Study|Lost to Follow-up|1|||
161334221|NCT04460326|582612541|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
161334222|NCT04460326|582612542|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
161334223|NCT03372798|582612543|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
160824838|NCT02914548|580742888|FG001|Overall Study|Adverse Event|7|||
160824839|NCT02914548|580742889|FG002|Overall Study|Adverse Event|15|||
160902053|NCT03080454|581035962|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
161241255|NCT01010503|582264665|FG000|Overall Study|Adverse Event|1|||
161241256|NCT01010503|582264665|FG000|Overall Study|Death|1|||
161241257|NCT06336356|582264666|FG000|Overall Study|Withdrawal by Subject|1|||
160824840|NCT02914548|580742887|FG000|Overall Study|Physician Decision|2|||
160824841|NCT02914548|580742888|FG001|Overall Study|Physician Decision|2|||
160824842|NCT02914548|580742889|FG002|Overall Study|Physician Decision|0|||
160824843|NCT02914548|580742887|FG000|Overall Study|Protocol Violation|1|||
160824844|NCT02914548|580742888|FG001|Overall Study|Protocol Violation|0|||
160824845|NCT02914548|580742889|FG002|Overall Study|Protocol Violation|0|||
160902054|NCT03080454|581035962|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
161241258|NCT06336356|582264667|FG001|Overall Study|Withdrawal by Subject|0|||
160824846|NCT02914548|580742887|FG000|Overall Study|Withdrawal by Subject|3|||
160989926|NCT03613129|581351694|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
160989927|NCT03613129|581351695|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
160989928|NCT02334306|581351696|FG000|Double-blind Period|Adverse Event|0|||
160989929|NCT02334306|581351697|FG001|Double-blind Period|Adverse Event|1|||
160989930|NCT02334306|581351696|FG000|Double-blind Period|Withdrawal by Subject|1|||
160989931|NCT02334306|581351697|FG001|Double-blind Period|Withdrawal by Subject|1|||
160989932|NCT01687270|581351698|FG000|Overall Study|Lack of Efficacy|11|||
160989933|NCT01687270|581351698|FG000|Overall Study|Lost to Follow-up|1|||
160989934|NCT00465985|581351699|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
160989935|NCT00465985|581351700|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
160989936|NCT00465985|581351699|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
160824847|NCT02914548|580742888|FG001|Overall Study|Withdrawal by Subject|4|||
160824848|NCT02914548|580742889|FG002|Overall Study|Withdrawal by Subject|4|||
160824849|NCT02914548|580742887|FG000|Overall Study|>40% of body surface area|0|||
160824850|NCT02914548|580742888|FG001|Overall Study|>40% of body surface area|1|||
160824851|NCT02914548|580742889|FG002|Overall Study|>40% of body surface area|1|||
160824852|NCT03746600|580742890|FG000|Overall Study|Withdrawal by Subject|3|||
160824853|NCT03746600|580742891|FG001|Overall Study|Withdrawal by Subject|3|||
160824854|NCT03746600|580742890|FG000|Overall Study|dismissed from study|1|||
160824855|NCT03746600|580742891|FG001|Overall Study|dismissed from study|0|||
160824856|NCT03746600|580742890|FG000|Overall Study|Lost to Follow-up|1|||
160824857|NCT03746600|580742891|FG001|Overall Study|Lost to Follow-up|0|||
160824858|NCT01371643|580742899|FG000|Overall Study|Withdrawal by Subject|3|||
160824859|NCT01371643|580742900|FG001|Overall Study|Withdrawal by Subject|0|||
160824860|NCT02374814|580742901|FG000|Overall Study|Lost to Follow-up|1|||
160824861|NCT02374814|580742902|FG001|Overall Study|Lost to Follow-up|1|||
160824862|NCT02374814|580742903|FG002|Overall Study|Lost to Follow-up|0|||
160824863|NCT02374814|580742904|FG003|Overall Study|Lost to Follow-up|1|||
160824864|NCT02374814|580742905|FG004|Overall Study|Lost to Follow-up|0|||
160824865|NCT02374814|580742906|FG005|Overall Study|Lost to Follow-up|0|||
160824866|NCT02374814|580742901|FG000|Overall Study|Withdrawal by Subject|0|||
160824867|NCT02374814|580742902|FG001|Overall Study|Withdrawal by Subject|0|||
160824868|NCT02374814|580742903|FG002|Overall Study|Withdrawal by Subject|1|||
160824869|NCT02374814|580742904|FG003|Overall Study|Withdrawal by Subject|1|||
160824870|NCT02374814|580742905|FG004|Overall Study|Withdrawal by Subject|0|||
160824871|NCT02374814|580742906|FG005|Overall Study|Withdrawal by Subject|0|||
160824872|NCT00884039|580742907|FG000|Overall Study|Withdrawal by Subject|0|||
160824873|NCT00884039|580742908|FG001|Overall Study|Withdrawal by Subject|1|||
160824874|NCT00884039|580742907|FG000|Overall Study|Lack of Efficacy|2|||
160824875|NCT00884039|580742908|FG001|Overall Study|Lack of Efficacy|0|||
160824876|NCT05291936|580742909|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
160824877|NCT05291936|580742910|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
160824878|NCT05291936|580742909|FG000|Period 1|Withdrew Consent during study|1|||
160824879|NCT05291936|580742910|FG001|Period 1|Withdrew Consent during study|0|||
160824880|NCT05291936|580742909|FG000|Period 2|Adverse Event|0|||
160824881|NCT05291936|580742910|FG001|Period 2|Adverse Event|1|||
160824882|NCT05291936|580742909|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
160824883|NCT05291936|580742910|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160824884|NCT01300819|580742911|FG000|Overall Study|Adverse Event|9|||
160824885|NCT01300819|580742912|FG001|Overall Study|Adverse Event|27|||
160824886|NCT01300819|580742911|FG000|Overall Study|Lack of Efficacy|2|||
160824887|NCT01300819|580742912|FG001|Overall Study|Lack of Efficacy|1|||
160824888|NCT01300819|580742911|FG000|Overall Study|Withdrawal by Subject|10|||
160989937|NCT00465985|581351700|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
160989938|NCT00465985|581351699|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
160989939|NCT00465985|581351700|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
160989940|NCT00465985|581351699|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
160989941|NCT00465985|581351700|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
160989942|NCT02534896|581351701|FG000|Overall Study|Adverse Event|2|||
160989943|NCT02534896|581351702|FG001|Overall Study|Adverse Event|1|||
160989944|NCT02534896|581351703|FG002|Overall Study|Adverse Event|1|||
161133417|NCT02649634|581872919|FG000|Overall Study|Lost to Follow-up|0|||
161133418|NCT02649634|581872920|FG001|Overall Study|Lost to Follow-up|1|||
160824889|NCT01300819|580742912|FG001|Overall Study|Withdrawal by Subject|12|||
160989945|NCT02534896|581351701|FG000|Overall Study|Insufficient therapeutic response|2|||
160824890|NCT01300819|580742911|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
160824891|NCT01300819|580742912|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
160824892|NCT01300819|580742911|FG000|Overall Study|Refusal to down titrate study drug|0|||
160824893|NCT01300819|580742912|FG001|Overall Study|Refusal to down titrate study drug|1|||
160824894|NCT01300819|580742911|FG000|Overall Study|Administrative reason|0|||
160824895|NCT01300819|580742912|FG001|Overall Study|Administrative reason|1|||
160824896|NCT01300819|580742911|FG000|Overall Study|Safety follow up not done by mistake|0|||
161241259|NCT06336356|582264666|FG000|Overall Study|Lost to Follow Up|1|||
161241260|NCT06336356|582264667|FG001|Overall Study|Lost to Follow Up|0|||
161241261|NCT04827394|582264672|FG000|Overall Study|Physician Decision|0|||
161241262|NCT04827394|582264673|FG001|Overall Study|Physician Decision|2|||
161241263|NCT06041256|582264674|FG000|Overall Study|Withdrawal by Subject|1|||
161241264|NCT06041256|582264675|FG001|Overall Study|Withdrawal by Subject|0|||
161241265|NCT06041256|582264676|FG002|Overall Study|Withdrawal by Subject|3|||
161241266|NCT06041256|582264677|FG003|Overall Study|Withdrawal by Subject|1|||
161241267|NCT06041256|582264678|FG004|Overall Study|Withdrawal by Subject|1|||
161241268|NCT06041256|582264674|FG000|Overall Study|Rescue|17|||
161241269|NCT06041256|582264675|FG001|Overall Study|Rescue|6|||
161241270|NCT06041256|582264676|FG002|Overall Study|Rescue|9|||
161241271|NCT06041256|582264677|FG003|Overall Study|Rescue|6|||
161241272|NCT06041256|582264678|FG004|Overall Study|Rescue|2|||
161241273|NCT01963728|582264679|FG000|Overall Study|Study terminated early|0|||
161241274|NCT01963728|582264680|FG001|Overall Study|Study terminated early|1|||
161241275|NCT03114891|582264681|FG000|First Treatment Round|Lost to Follow-up|0|||
161241276|NCT03114891|582264682|FG001|First Treatment Round|Lost to Follow-up|1|||
161241277|NCT03114891|582264683|FG002|First Treatment Round|Lost to Follow-up|1|||
161241278|NCT03114891|582264684|FG003|First Treatment Round|Lost to Follow-up|0|||
161241279|NCT03114891|582264681|FG000|First Treatment Round|Withdrawal by Subject|0|||
161241280|NCT03114891|582264682|FG001|First Treatment Round|Withdrawal by Subject|2|||
161241281|NCT03114891|582264683|FG002|First Treatment Round|Withdrawal by Subject|0|||
161241282|NCT03114891|582264684|FG003|First Treatment Round|Withdrawal by Subject|1|||
161241283|NCT03114891|582264681|FG000|3 Week Break|Lost to Follow-up|1|||
161241284|NCT03114891|582264682|FG001|3 Week Break|Lost to Follow-up|0|||
161241285|NCT03114891|582264683|FG002|3 Week Break|Lost to Follow-up|0|||
161241286|NCT03114891|582264684|FG003|3 Week Break|Lost to Follow-up|1|||
161241287|NCT03114891|582264681|FG000|3 Week Break|Withdrawal by Subject|0|||
161241288|NCT03114891|582264682|FG001|3 Week Break|Withdrawal by Subject|1|||
161241289|NCT03114891|582264683|FG002|3 Week Break|Withdrawal by Subject|0|||
161241290|NCT03114891|582264684|FG003|3 Week Break|Withdrawal by Subject|0|||
161241291|NCT03114891|582264681|FG000|Second Treatment Round|Lost to Follow-up|1|||
161241292|NCT03114891|582264682|FG001|Second Treatment Round|Lost to Follow-up|0|||
161241293|NCT03114891|582264683|FG002|Second Treatment Round|Lost to Follow-up|0|||
161241294|NCT03114891|582264684|FG003|Second Treatment Round|Lost to Follow-up|0|||
161241295|NCT03114891|582264681|FG000|Second Treatment Round|Physician Decision|1|||
161241296|NCT03114891|582264682|FG001|Second Treatment Round|Physician Decision|0|||
161241297|NCT03114891|582264683|FG002|Second Treatment Round|Physician Decision|0|||
161241298|NCT03114891|582264684|FG003|Second Treatment Round|Physician Decision|0|||
161241299|NCT03578809|582265958|FG000|Overall Study|Death|0|||
161241300|NCT03578809|582265959|FG001|Overall Study|Death|2|||
161241301|NCT03578809|582265960|FG002|Overall Study|Death|0|||
161241302|NCT03578809|582265961|FG003|Overall Study|Death|1|||
161241303|NCT03578809|582265958|FG000|Overall Study|Lost to Follow-up|0|||
161241304|NCT03578809|582265959|FG001|Overall Study|Lost to Follow-up|1|||
161241305|NCT03578809|582265960|FG002|Overall Study|Lost to Follow-up|0|||
161241306|NCT03578809|582265961|FG003|Overall Study|Lost to Follow-up|0|||
161241307|NCT03578809|582265958|FG000|Overall Study|Withdrawal by Subject|3|||
161241308|NCT03578809|582265959|FG001|Overall Study|Withdrawal by Subject|5|||
161241309|NCT03578809|582265960|FG002|Overall Study|Withdrawal by Subject|2|||
161241310|NCT03578809|582265961|FG003|Overall Study|Withdrawal by Subject|0|||
161241311|NCT03578809|582265958|FG000|Overall Study|Other|3|||
161241312|NCT03578809|582265959|FG001|Overall Study|Other|6|||
161241313|NCT03578809|582265960|FG002|Overall Study|Other|2|||
161241314|NCT03578809|582265961|FG003|Overall Study|Other|8|||
160824897|NCT01300819|580742912|FG001|Overall Study|Safety follow up not done by mistake|1|||
160824898|NCT01300819|580742911|FG000|Overall Study|Follow up call was not done|1|||
160824899|NCT01300819|580742912|FG001|Overall Study|Follow up call was not done|0|||
160824900|NCT02534935|580744900|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
160824901|NCT02534935|580744901|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
161241315|NCT03599193|582265962|FG000|Overall Study|Adverse Event|0|||
161241316|NCT03599193|582265963|FG001|Overall Study|Adverse Event|2|||
161241317|NCT03599193|582265962|FG000|Overall Study|Withdrawal by Subject|1|||
161241318|NCT03599193|582265963|FG001|Overall Study|Withdrawal by Subject|0|||
161241319|NCT03599193|582265962|FG000|Overall Study|Protocol Violation|1|||
161241320|NCT03599193|582265963|FG001|Overall Study|Protocol Violation|0|||
161241321|NCT03599193|582265962|FG000|Overall Study|Lost to Follow-up|0|||
161241322|NCT03599193|582265963|FG001|Overall Study|Lost to Follow-up|1|||
161241323|NCT00835705|582265964|FG000|First Intervention|Difficulty with vein|1|||
161241324|NCT00835705|582265965|FG001|First Intervention|Difficulty with vein|0|||
161241325|NCT00835705|582265964|FG000|Second Intervention|Difficulty with vein|1|||
161241326|NCT00835705|582265965|FG001|Second Intervention|Difficulty with vein|0|||
161241327|NCT01116739|582265966|FG000|Overall Study|Child had 2 years of HS|110|||
161241328|NCT01116739|582265967|FG001|Overall Study|Child had 2 years of HS|128|||
161241329|NCT01116739|582265966|FG000|Overall Study|Withdrawal by Subject|6|||
161241330|NCT01116739|582265967|FG001|Overall Study|Withdrawal by Subject|0|||
160824902|NCT02534935|580744902|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
160824903|NCT02534935|580744900|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
160824904|NCT02534935|580744901|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
160824905|NCT02534935|580744902|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
160824906|NCT02534935|580744900|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
160824907|NCT02534935|580744901|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
160824908|NCT02534935|580744902|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
160824909|NCT02534935|580744900|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
160824910|NCT02534935|580744901|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
160824911|NCT02534935|580744902|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
160824912|NCT02534935|580744900|FG000|Stage 1: 24 Months|Adverse Event|0|||
160824913|NCT02534935|580744901|FG001|Stage 1: 24 Months|Adverse Event|2|||
160824914|NCT02534935|580744902|FG002|Stage 1: 24 Months|Adverse Event|0|||
160824915|NCT02534935|580744900|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
160824916|NCT02534935|580744901|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
160824917|NCT02534935|580744902|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
160824918|NCT02534935|580744900|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
160824919|NCT02534935|580744901|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
160824920|NCT02534935|580744902|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
160824921|NCT03602885|580744903|FG000|Overall Study|Lost to Follow-up|3|||
160824922|NCT03602885|580744904|FG001|Overall Study|Lost to Follow-up|0|||
160824923|NCT01007123|580744909|FG000|Overall Study|Adverse Event|3|||
160824924|NCT01007123|580744910|FG001|Overall Study|Adverse Event|4|||
160824925|NCT01007123|580744911|FG002|Overall Study|Adverse Event|7|||
160824926|NCT01007123|580744912|FG003|Overall Study|Adverse Event|1|||
160824927|NCT01007123|580744909|FG000|Overall Study|Lack of Efficacy|1|||
160824928|NCT01007123|580744910|FG001|Overall Study|Lack of Efficacy|0|||
160824929|NCT01007123|580744911|FG002|Overall Study|Lack of Efficacy|1|||
160824930|NCT01007123|580744912|FG003|Overall Study|Lack of Efficacy|4|||
160824931|NCT01007123|580744909|FG000|Overall Study|Protocol Violation|1|||
160824932|NCT01007123|580744910|FG001|Overall Study|Protocol Violation|1|||
160824933|NCT01007123|580744911|FG002|Overall Study|Protocol Violation|2|||
160824934|NCT01007123|580744912|FG003|Overall Study|Protocol Violation|1|||
160824935|NCT01007123|580744909|FG000|Overall Study|Withdrawal by Subject|1|||
160824936|NCT01007123|580744910|FG001|Overall Study|Withdrawal by Subject|0|||
160824937|NCT01007123|580744911|FG002|Overall Study|Withdrawal by Subject|1|||
160824938|NCT01007123|580744912|FG003|Overall Study|Withdrawal by Subject|0|||
160824939|NCT01007123|580744909|FG000|Overall Study|Lost to Follow-up|0|||
160824940|NCT01007123|580744910|FG001|Overall Study|Lost to Follow-up|1|||
160824941|NCT01007123|580744911|FG002|Overall Study|Lost to Follow-up|0|||
160824942|NCT01007123|580744912|FG003|Overall Study|Lost to Follow-up|0|||
160824943|NCT02838901|580744913|FG000|Overall Study|Withdrawal by Subject|1|||
160824944|NCT02838901|580744914|FG001|Overall Study|Withdrawal by Subject|1|||
160824945|NCT02838901|580744913|FG000|Overall Study|Lost to Follow-up|1|||
160824946|NCT02838901|580744914|FG001|Overall Study|Lost to Follow-up|1|||
160902055|NCT02747875|581035963|FG000|Overall Study|Physician Decision|1|||
160902056|NCT02747875|581035964|FG001|Overall Study|Physician Decision|0|||
160902057|NCT02747875|581035963|FG000|Overall Study|Adverse Event|0|||
160902058|NCT02747875|581035964|FG001|Overall Study|Adverse Event|1|||
160902059|NCT00762385|581035965|FG000|First Intervention|Lens Issue|1|||
160902060|NCT00762385|581035966|FG001|First Intervention|Lens Issue|1|||
160902061|NCT00762385|581035965|FG000|First Intervention|Lost to Follow-up|0|||
160902062|NCT00762385|581035966|FG001|First Intervention|Lost to Follow-up|2|||
160902063|NCT00762385|581035965|FG000|First Intervention|Ineligible|1|||
160902064|NCT00762385|581035966|FG001|First Intervention|Ineligible|0|||
160902065|NCT00762385|581035965|FG000|First Intervention|Protocol Violation|0|||
160902066|NCT00762385|581035966|FG001|First Intervention|Protocol Violation|1|||
160902067|NCT00762385|581035965|FG000|Second Intervention|Protocol Violation|3|||
160902068|NCT00762385|581035966|FG001|Second Intervention|Protocol Violation|3|||
160902069|NCT03863197|581035970|FG000|Overall Study|Lost to Follow-up|2|||
160902070|NCT03863197|581035971|FG001|Overall Study|Lost to Follow-up|3|||
160902071|NCT03863197|581035970|FG000|Overall Study|Withdrawal by Subject|4|||
160902072|NCT03863197|581035971|FG001|Overall Study|Withdrawal by Subject|0|||
161133419|NCT01670994|581872922|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
160824947|NCT02680041|580744915|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
160824948|NCT02680041|580744915|FG000|Overall Study|Lost to Follow-up|2|||
161133420|NCT01670994|581872923|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
160824949|NCT04431713|580744916|FG000|Overall Study|Withdrawal by Subject|2|||
160902073|NCT03863197|581035970|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
160902074|NCT03863197|581035971|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
160824950|NCT04431713|580744917|FG001|Overall Study|Withdrawal by Subject|0|||
160824951|NCT04431713|580744916|FG000|Overall Study|Death|2|||
160824952|NCT04431713|580744917|FG001|Overall Study|Death|2|||
160902075|NCT01058655|581035975|FG000|Overall Study|Withdrawal by Subject|1|||
160824953|NCT01344538|580744918|FG000|Overall Study|Adverse Event|1|||
160824954|NCT01344538|580744919|FG001|Overall Study|Adverse Event|1|||
160824955|NCT01344538|580744918|FG000|Overall Study|Lost to Follow-up|1|||
160824956|NCT01344538|580744919|FG001|Overall Study|Lost to Follow-up|0|||
160824957|NCT04195438|580744924|FG000|Overall Study|Withdrawal by Subject|1|||
160824958|NCT00613925|580744925|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
160824959|NCT00613925|580744926|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
160824960|NCT01156389|580744927|FG000|Overall Study|Elevated liver enzymes|4|||
160824961|NCT01156389|580744928|FG001|Overall Study|Elevated liver enzymes|0|||
160824962|NCT01156389|580744927|FG000|Overall Study|Vomiting|0|||
160824963|NCT01156389|580744928|FG001|Overall Study|Vomiting|1|||
160824964|NCT00350623|580744931|FG000|Overall Study|Lost to Follow-up|8|||
160824965|NCT00350623|580744932|FG001|Overall Study|Lost to Follow-up|3|||
160824966|NCT00350623|580744933|FG002|Overall Study|Lost to Follow-up|4|||
160824967|NCT00350623|580744931|FG000|Overall Study|Withdrawal by Subject|0|||
160824968|NCT00350623|580744932|FG001|Overall Study|Withdrawal by Subject|1|||
160824969|NCT00350623|580744933|FG002|Overall Study|Withdrawal by Subject|1|||
160824970|NCT00350623|580744931|FG000|Overall Study|patient traveling outside the country|0|||
160824971|NCT00350623|580744932|FG001|Overall Study|patient traveling outside the country|0|||
160824972|NCT00350623|580744933|FG002|Overall Study|patient traveling outside the country|1|||
160824973|NCT00937404|580744936|FG000|Overall Study|Protocol Violation|1|||
160824974|NCT00937404|580744936|FG000|Overall Study|Withdrawal by Subject|1|||
160824975|NCT00090233|580744943|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
160824976|NCT00090233|580744944|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
160824977|NCT00090233|580744943|FG000|Overall Study|Adverse Event|214|||
160824978|NCT00090233|580744944|FG001|Overall Study|Adverse Event|198|||
160824979|NCT00090233|580744943|FG000|Overall Study|Lost to Follow-up|68|||
160824980|NCT00090233|580744944|FG001|Overall Study|Lost to Follow-up|95|||
160824981|NCT00090233|580744943|FG000|Overall Study|Protocol Violation|960|||
160824982|NCT00090233|580744944|FG001|Overall Study|Protocol Violation|1022|||
160824983|NCT00090233|580744943|FG000|Overall Study|Withdrawal by Subject|182|||
160824984|NCT00090233|580744944|FG001|Overall Study|Withdrawal by Subject|211|||
160824985|NCT00090233|580744943|FG000|Overall Study|Moved|203|||
160824986|NCT00090233|580744944|FG001|Overall Study|Moved|189|||
160824987|NCT00090233|580744943|FG000|Overall Study|Other|1211|||
160824988|NCT00090233|580744944|FG001|Overall Study|Other|1160|||
160824989|NCT00090233|580744943|FG000|Overall Study|Data not available at data cut-off point|1552|||
160824990|NCT00090233|580744944|FG001|Overall Study|Data not available at data cut-off point|1563|||
160824991|NCT04863248|580744945|FG000|Overall Study|Sponsor Terminated|4|||
160824992|NCT04863248|580744946|FG001|Overall Study|Sponsor Terminated|1|||
160824993|NCT04863248|580744945|FG000|Overall Study|Death|0|||
160824994|NCT04863248|580744946|FG001|Overall Study|Death|1|||
160824995|NCT04863248|580744945|FG000|Overall Study|Withdrawal by Subject|0|||
160824996|NCT04863248|580744946|FG001|Overall Study|Withdrawal by Subject|1|||
160824997|NCT02536300|580744947|FG000|Overall Study|Investigator's Discretion|17|||
160824998|NCT02536300|580744948|FG001|Overall Study|Investigator's Discretion|11|||
160824999|NCT02536300|580744949|FG002|Overall Study|Investigator's Discretion|2|||
160825000|NCT02536300|580744947|FG000|Overall Study|Progressive Disease|11|||
160825001|NCT02536300|580744948|FG001|Overall Study|Progressive Disease|7|||
160825002|NCT02536300|580744949|FG002|Overall Study|Progressive Disease|6|||
160825003|NCT02536300|580744947|FG000|Overall Study|Study Terminated by Sponsor|6|||
160825004|NCT02536300|580744948|FG001|Overall Study|Study Terminated by Sponsor|4|||
160825005|NCT02536300|580744949|FG002|Overall Study|Study Terminated by Sponsor|7|||
160825006|NCT02536300|580744947|FG000|Overall Study|Death|7|||
160825007|NCT02536300|580744948|FG001|Overall Study|Death|0|||
160825008|NCT02536300|580744949|FG002|Overall Study|Death|5|||
160825009|NCT02536300|580744947|FG000|Overall Study|Withdrew Consent|4|||
160902076|NCT01058655|581035976|FG001|Overall Study|Withdrawal by Subject|0|||
160902077|NCT01058655|581035977|FG002|Overall Study|Withdrawal by Subject|3|||
160902078|NCT01058655|581035978|FG003|Overall Study|Withdrawal by Subject|4|||
160825010|NCT02536300|580744948|FG001|Overall Study|Withdrew Consent|2|||
160825011|NCT02536300|580744949|FG002|Overall Study|Withdrew Consent|0|||
160825012|NCT02536300|580744947|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
160825013|NCT02536300|580744948|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
160825014|NCT02536300|580744949|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
160825015|NCT02536300|580744947|FG000|Overall Study|Enrolled but Never Treated|0|||
160825016|NCT02536300|580744948|FG001|Overall Study|Enrolled but Never Treated|0|||
160825017|NCT02536300|580744949|FG002|Overall Study|Enrolled but Never Treated|1|||
160825018|NCT02536300|580744947|FG000|Overall Study|Non-compliance With Study Drug|1|||
160825019|NCT02536300|580744948|FG001|Overall Study|Non-compliance With Study Drug|0|||
160825020|NCT02536300|580744949|FG002|Overall Study|Non-compliance With Study Drug|0|||
160825021|NCT02536300|580744947|FG000|Overall Study|Protocol Violation|0|||
160825022|NCT02536300|580744948|FG001|Overall Study|Protocol Violation|1|||
160825023|NCT02536300|580744949|FG002|Overall Study|Protocol Violation|0|||
160825024|NCT01779869|580744950|FG000|Overall Study|Physician Decision|2|||
160902079|NCT01058655|581035975|FG000|Overall Study|Prolonged Treatment Delay|0|||
160825025|NCT01691105|580744958|FG000|1 Month Follow-up|Lost to Follow-up|41|||
160825026|NCT01691105|580744959|FG001|1 Month Follow-up|Lost to Follow-up|38|||
160825027|NCT01691105|580744958|FG000|1 Month Follow-up|Death|2|||
160825028|NCT01691105|580744959|FG001|1 Month Follow-up|Death|3|||
160825029|NCT01691105|580744958|FG000|6 Month Follow-up|Lost to Follow-up|39|||
160825030|NCT01691105|580744959|FG001|6 Month Follow-up|Lost to Follow-up|58|||
160825031|NCT01691105|580744958|FG000|6 Month Follow-up|Death|13|||
160825032|NCT01691105|580744959|FG001|6 Month Follow-up|Death|13|||
160825033|NCT01691105|580744958|FG000|12 Month Follow-up|Lost to Follow-up|50|||
160825034|NCT01691105|580744959|FG001|12 Month Follow-up|Lost to Follow-up|71|||
160825035|NCT01691105|580744958|FG000|12 Month Follow-up|Death|22|||
160825036|NCT01691105|580744959|FG001|12 Month Follow-up|Death|30|||
160825037|NCT01691105|580744958|FG000|12 Month Biochemical Verification|Death|22|||
160825038|NCT01691105|580744959|FG001|12 Month Biochemical Verification|Death|30|||
160825039|NCT01691105|580744958|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
160825040|NCT01691105|580744959|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
160825041|NCT01691105|580744958|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
160825042|NCT01691105|580744959|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
160825043|NCT00957944|580744960|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
160825044|NCT00957944|580744961|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
160825045|NCT01482169|580744963|FG000|Overall Study|Physician Decision|2|||
160825046|NCT00445848|580744966|FG000|Overall Study|Adverse Event|14|||
160825047|NCT00445848|580744966|FG000|Overall Study|Withdrawal by Subject|4|||
160825048|NCT00445848|580744966|FG000|Overall Study|Progression|62|||
160825049|NCT00445848|580744966|FG000|Overall Study|Other-Not protocol specified|5|||
160825050|NCT01777542|580744967|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
160825051|NCT01777542|580744968|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
160825052|NCT05605691|580744971|FG000|Overall Study|Lost to Follow-up|1|||
160825053|NCT01030874|580744972|FG000|Overall Study|Withdrawal by Subject|1|||
160825054|NCT01030874|580744973|FG001|Overall Study|Withdrawal by Subject|0|||
160825055|NCT01030874|580744972|FG000|Overall Study|Discharged in first 2 weeks|17|||
160825056|NCT01030874|580744973|FG001|Overall Study|Discharged in first 2 weeks|16|||
160825057|NCT02279719|580744974|FG000|Overall Study|Patients randomized but never treated|0|||
160825058|NCT02279719|580744975|FG001|Overall Study|Patients randomized but never treated|0|||
160825059|NCT02279719|580744976|FG002|Overall Study|Patients randomized but never treated|0|||
160825060|NCT02279719|580744977|FG003|Overall Study|Patients randomized but never treated|0|||
160825061|NCT02279719|580744978|FG004|Overall Study|Patients randomized but never treated|3|||
160825062|NCT02279719|580744979|FG005|Overall Study|Patients randomized but never treated|0|||
160825063|NCT02279719|580744980|FG006|Overall Study|Patients randomized but never treated|3|||
160825064|NCT04706273|580744981|FG000|Overall Study|Withdrawal by Subject|27|||
160825065|NCT04706273|580744981|FG000|Overall Study|Physician Decision|1|||
160825066|NCT04706273|580744981|FG000|Overall Study|Lost to Follow-up|42|||
160825067|NCT04706273|580744981|FG000|Overall Study|Death|85|||
160825068|NCT04706273|580744981|FG000|Overall Study|Amputation that removes study device|2|||
160825069|NCT04706273|580744981|FG000|Overall Study|Surgical bypass|3|||
160825070|NCT04706273|580744981|FG000|Overall Study|Changing hospital|23|||
160825071|NCT04706273|580744981|FG000|Overall Study|Unable to attend hospital|2|||
160825072|NCT03541187|580744984|FG000|Overall Study|Lost to Follow-up|2|||
160825073|NCT03541187|580744985|FG001|Overall Study|Lost to Follow-up|6|||
160825074|NCT03541187|580744984|FG000|Overall Study|Pregnancy|0|||
160825075|NCT03541187|580744985|FG001|Overall Study|Pregnancy|1|||
160825076|NCT03541187|580744984|FG000|Overall Study|Withdrawal by Subject|6|||
160825077|NCT03541187|580744985|FG001|Overall Study|Withdrawal by Subject|2|||
160825078|NCT03541187|580744984|FG000|Overall Study|Moved out of town|1|||
160825079|NCT03541187|580744985|FG001|Overall Study|Moved out of town|0|||
160825080|NCT03541187|580744984|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
160902080|NCT01058655|581035976|FG001|Overall Study|Prolonged Treatment Delay|0|||
160902081|NCT01058655|581035977|FG002|Overall Study|Prolonged Treatment Delay|0|||
160902082|NCT01058655|581035978|FG003|Overall Study|Prolonged Treatment Delay|2|||
160902083|NCT01058655|581035975|FG000|Overall Study|Symptomatic Deterioration|0|||
160902084|NCT01058655|581035976|FG001|Overall Study|Symptomatic Deterioration|0|||
160902085|NCT01058655|581035977|FG002|Overall Study|Symptomatic Deterioration|0|||
160902086|NCT01058655|581035978|FG003|Overall Study|Symptomatic Deterioration|1|||
160902087|NCT01058655|581035975|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
160902088|NCT01058655|581035976|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
160825081|NCT03541187|580744985|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
160825082|NCT03541187|580744984|FG000|Overall Study|Did not meet randomization criteria|1|||
160825083|NCT03541187|580744985|FG001|Overall Study|Did not meet randomization criteria|1|||
160825084|NCT03541187|580744984|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
160825085|NCT03541187|580744985|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
160825086|NCT03541187|580744984|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
160825087|NCT03541187|580744985|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
160825088|NCT00869050|580744989|FG000|Overall Study|Screen Failure|3|||
160825089|NCT03298984|580744996|FG000|Overall Study|Physician Decision|1|||
160825090|NCT03298984|580744997|FG001|Overall Study|Physician Decision|0|||
160825091|NCT03298984|580744998|FG002|Overall Study|Physician Decision|0|||
160825092|NCT03298984|580744999|FG003|Overall Study|Physician Decision|6|||
160825093|NCT03298984|580744996|FG000|Overall Study|Lack of Efficacy|0|||
160825094|NCT03298984|580744997|FG001|Overall Study|Lack of Efficacy|1|||
160825095|NCT03298984|580744998|FG002|Overall Study|Lack of Efficacy|1|||
160825096|NCT03298984|580744999|FG003|Overall Study|Lack of Efficacy|4|||
160825097|NCT03298984|580744996|FG000|Overall Study|Relapsed disease (following remission)|0|||
160825098|NCT03298984|580744997|FG001|Overall Study|Relapsed disease (following remission)|0|||
160825099|NCT03298984|580744998|FG002|Overall Study|Relapsed disease (following remission)|1|||
160825100|NCT03298984|580744999|FG003|Overall Study|Relapsed disease (following remission)|1|||
160825101|NCT03298984|580744996|FG000|Overall Study|Adverse Event|0|||
160825102|NCT03298984|580744997|FG001|Overall Study|Adverse Event|0|||
160825103|NCT03298984|580744998|FG002|Overall Study|Adverse Event|0|||
160825104|NCT03298984|580744999|FG003|Overall Study|Adverse Event|1|||
160825105|NCT03298984|580744996|FG000|Overall Study|Death|0|||
160825106|NCT03298984|580744997|FG001|Overall Study|Death|0|||
160825107|NCT03298984|580744998|FG002|Overall Study|Death|0|||
160825108|NCT03298984|580744999|FG003|Overall Study|Death|2|||
160825109|NCT03298984|580744996|FG000|Overall Study|Insurance Company Decision|0|||
160825110|NCT03298984|580744997|FG001|Overall Study|Insurance Company Decision|0|||
160825111|NCT03298984|580744998|FG002|Overall Study|Insurance Company Decision|0|||
160825112|NCT03298984|580744999|FG003|Overall Study|Insurance Company Decision|1|||
160825113|NCT01571284|580745000|FG000|Overall Study|Participant's decision|84|||
160825114|NCT01571284|580745000|FG000|Overall Study|Lost to Follow-up|3|||
160825115|NCT01571284|580745000|FG000|Overall Study|Enrolled but not treated|2|||
160825116|NCT01571284|580745000|FG000|Overall Study|Other than specified above|80|||
160825117|NCT03385265|580745004|FG000|Overall Study|Withdrawal by Subject|5|||
160825118|NCT03385265|580745005|FG001|Overall Study|Withdrawal by Subject|2|||
160825119|NCT03385265|580745006|FG002|Overall Study|Withdrawal by Subject|5|||
160825120|NCT03385265|580745007|FG003|Overall Study|Withdrawal by Subject|2|||
160825121|NCT04465877|580745010|FG000|Overall Study|Noncompliant with study requirements|0|||
160825122|NCT04465877|580745011|FG001|Overall Study|Noncompliant with study requirements|0|||
160825123|NCT04465877|580745012|FG002|Overall Study|Noncompliant with study requirements|1|||
160825124|NCT04465877|580745013|FG003|Overall Study|Noncompliant with study requirements|0|||
160825125|NCT02323204|580745015|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
160825126|NCT02323204|580745016|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
160825127|NCT02323204|580745017|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
160825128|NCT02323204|580745018|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
160825129|NCT02323204|580745015|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
160825130|NCT02323204|580745016|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
160825131|NCT02323204|580745017|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
160825132|NCT02323204|580745018|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
160825133|NCT02323204|580745015|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
160825134|NCT02323204|580745016|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
160825135|NCT02323204|580745017|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
160825136|NCT02323204|580745018|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
160825137|NCT02323204|580745015|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
160825138|NCT02323204|580745016|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
160825139|NCT02323204|580745017|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
160825140|NCT02323204|580745018|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
160825141|NCT02323204|580745015|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
160825142|NCT02323204|580745016|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
160825143|NCT02323204|580745017|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
160825144|NCT02323204|580745018|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
160825145|NCT02323204|580745015|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
160825146|NCT02323204|580745016|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
161334224|NCT03372798|582612544|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
160825147|NCT02323204|580745017|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
160825148|NCT02323204|580745018|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
160825149|NCT02323204|580745015|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160902089|NCT01058655|581035977|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
160825150|NCT02323204|580745016|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
160825151|NCT02323204|580745017|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160825152|NCT02323204|580745018|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
160825153|NCT02323204|580745015|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
160825154|NCT02323204|580745016|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
160825155|NCT02323204|580745017|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
160825156|NCT02323204|580745018|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
161133421|NCT01670994|581872922|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
161133422|NCT01670994|581872923|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
161334225|NCT03372798|582612543|FG000|Overall Study|Failure of imaging probe|0|||
161334226|NCT03372798|582612544|FG001|Overall Study|Failure of imaging probe|1|||
161334227|NCT04794751|582612545|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
161334228|NCT04794751|582612546|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
161334229|NCT04794751|582612545|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
161334230|NCT04794751|582612546|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
161334231|NCT04794751|582612545|FG000|Period 1|Protocol Violation|0|||
161334232|NCT04794751|582612546|FG001|Period 1|Protocol Violation|2|||
161334233|NCT04794751|582612545|FG000|Period 1|Withdrawal by Subject|0|||
161334234|NCT04794751|582612546|FG001|Period 1|Withdrawal by Subject|1|||
161334235|NCT04794751|582612545|FG000|Period 2|Withdrawal by Subject|0|||
161334236|NCT04794751|582612546|FG001|Period 2|Withdrawal by Subject|1|||
161334237|NCT04794751|582612545|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
161334238|NCT04794751|582612546|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
161334239|NCT04794751|582612545|FG000|Period 2|Protocol Violation|1|||
161334240|NCT04794751|582612546|FG001|Period 2|Protocol Violation|0|||
161334241|NCT01405898|582612547|FG000|Overall Study|Withdrawal by Subject|2|||
161334242|NCT01405898|582612548|FG001|Overall Study|Withdrawal by Subject|2|||
161334243|NCT01687218|582612549|FG000|Overall Study|Withdrawal by Subject|2|||
161334244|NCT01687218|582612550|FG001|Overall Study|Withdrawal by Subject|3|||
161334245|NCT01687218|582612551|FG002|Overall Study|Withdrawal by Subject|0|||
161334246|NCT01687218|582612552|FG003|Overall Study|Withdrawal by Subject|1|||
161334247|NCT01687218|582612553|FG004|Overall Study|Withdrawal by Subject|1|||
161334248|NCT01687218|582612554|FG005|Overall Study|Withdrawal by Subject|0|||
161334249|NCT01687218|582612549|FG000|Overall Study|Relocated, no follow-up planned|1|||
161334250|NCT01687218|582612550|FG001|Overall Study|Relocated, no follow-up planned|0|||
160989946|NCT02534896|581351702|FG001|Overall Study|Insufficient therapeutic response|0|||
160989947|NCT02534896|581351703|FG002|Overall Study|Insufficient therapeutic response|0|||
161334251|NCT01687218|582612551|FG002|Overall Study|Relocated, no follow-up planned|1|||
161334252|NCT01687218|582612552|FG003|Overall Study|Relocated, no follow-up planned|1|||
161334253|NCT01687218|582612553|FG004|Overall Study|Relocated, no follow-up planned|0|||
160989948|NCT00711646|581351704|FG000|Overall Study|Adverse Event|6|||
160989949|NCT00711646|581351705|FG001|Overall Study|Adverse Event|1|||
160989950|NCT00711646|581351704|FG000|Overall Study|Withdrawal by Subject|4|||
160989951|NCT00711646|581351705|FG001|Overall Study|Withdrawal by Subject|0|||
160989952|NCT00711646|581351704|FG000|Overall Study|Protocol Violation|0|||
160989953|NCT00711646|581351705|FG001|Overall Study|Protocol Violation|1|||
160989954|NCT00711646|581351704|FG000|Overall Study|Lost to Follow-up|1|||
160989955|NCT00711646|581351705|FG001|Overall Study|Lost to Follow-up|0|||
161133423|NCT01670994|581872922|FG000|Overall Study|Patient experienced DLT|0|||
161133424|NCT01670994|581872923|FG001|Overall Study|Patient experienced DLT|1|||
161133425|NCT01111604|581872924|FG000|Overall Study|Lost to Follow-up|0|||
161334254|NCT01687218|582612554|FG005|Overall Study|Relocated, no follow-up planned|0|||
161334255|NCT03528551|582612561|FG000|Overall Study|Lost to Follow-up|0|||
161334256|NCT03528551|582612562|FG001|Overall Study|Lost to Follow-up|1|||
160825157|NCT02323204|580745015|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160825158|NCT02323204|580745016|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
160825159|NCT02323204|580745017|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
160825160|NCT02323204|580745018|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
160825161|NCT03440918|580745024|FG000|Overall Study|Protocol Violation|0|||
160825162|NCT03440918|580745025|FG001|Overall Study|Protocol Violation|16|||
160825163|NCT04346108|580745026|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
160825164|NCT04346108|580745027|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
160825165|NCT04346108|580745028|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
160825166|NCT04346108|580745026|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
160825167|NCT04346108|580745027|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
160825168|NCT04346108|580745028|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
160825169|NCT01598753|580745029|FG000|Overall Study|Adverse Event|1|||
160825170|NCT01598753|580745030|FG001|Overall Study|Adverse Event|9|||
160825171|NCT01598753|580745031|FG002|Overall Study|Adverse Event|1|||
160825172|NCT01598753|580745032|FG003|Overall Study|Adverse Event|7|||
160825173|NCT01598753|580745029|FG000|Overall Study|Lost to Follow-up|4|||
161334257|NCT03528551|582612563|FG002|Overall Study|Lost to Follow-up|0|||
161334258|NCT03528551|582612561|FG000|Overall Study|Transferred to other arm/group|2|||
161334259|NCT03528551|582612562|FG001|Overall Study|Transferred to other arm/group|3|||
161334260|NCT03528551|582612563|FG002|Overall Study|Transferred to other arm/group|0|||
160825174|NCT01598753|580745030|FG001|Overall Study|Lost to Follow-up|3|||
160989956|NCT00711646|581351704|FG000|Overall Study|administrative decision|0|||
160989957|NCT00711646|581351705|FG001|Overall Study|administrative decision|1|||
160825175|NCT01598753|580745031|FG002|Overall Study|Lost to Follow-up|7|||
160825176|NCT01598753|580745032|FG003|Overall Study|Lost to Follow-up|5|||
161241331|NCT01116739|582265966|FG000|Overall Study|child too young|2|||
161241332|NCT01116739|582265967|FG001|Overall Study|child too young|6|||
161241333|NCT01116739|582265966|FG000|Overall Study|child not enrolled in head start|10|||
161241334|NCT01116739|582265967|FG001|Overall Study|child not enrolled in head start|2|||
161241335|NCT01116739|582265966|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
161241336|NCT01116739|582265967|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
161241337|NCT05090839|582265968|FG000|Overall Study|Lost to Follow-up|2|||
161241338|NCT05090839|582265969|FG001|Overall Study|Lost to Follow-up|3|||
161241339|NCT05090839|582265970|FG002|Overall Study|Lost to Follow-up|1|||
161241340|NCT05090839|582265971|FG003|Overall Study|Lost to Follow-up|1|||
161241341|NCT01987765|582265974|FG000|Overall Study|Protocol Violation|65|||
161241342|NCT01987765|582265974|FG000|Overall Study|Lost to Follow-up|37|||
161241343|NCT00443651|582265977|FG000|Overall Study|Death|1|||
161241344|NCT00443651|582265978|FG001|Overall Study|Death|5|||
161241345|NCT00443651|582265977|FG000|Overall Study|Adverse Event|5|||
161241346|NCT00443651|582265978|FG001|Overall Study|Adverse Event|6|||
161241347|NCT00443651|582265977|FG000|Overall Study|Lost to Follow-up|18|||
161241348|NCT00443651|582265978|FG001|Overall Study|Lost to Follow-up|12|||
161241349|NCT00443651|582265977|FG000|Overall Study|Patient's/Guardian's Decision|58|||
161241350|NCT00443651|582265978|FG001|Overall Study|Patient's/Guardian's Decision|30|||
161241351|NCT00443651|582265977|FG000|Overall Study|Physician Decision|13|||
161241352|NCT00443651|582265978|FG001|Overall Study|Physician Decision|4|||
161241353|NCT00443651|582265977|FG000|Overall Study|Pregnancy|0|||
161241354|NCT00443651|582265978|FG001|Overall Study|Pregnancy|1|||
161241355|NCT03606174|582265981|FG000|Overall Study|Death|37|||
161241356|NCT03606174|582265982|FG001|Overall Study|Death|15|||
161241357|NCT03606174|582265983|FG002|Overall Study|Death|15|||
161241358|NCT03606174|582265984|FG003|Overall Study|Death|7|||
161241359|NCT03606174|582265985|FG004|Overall Study|Death|35|||
161241360|NCT03606174|582265986|FG005|Overall Study|Death|12|||
161241361|NCT03606174|582265987|FG006|Overall Study|Death|35|||
161241362|NCT03606174|582265988|FG007|Overall Study|Death|8|||
161241363|NCT03606174|582265989|FG008|Overall Study|Death|5|||
161241364|NCT03606174|582265990|FG009|Overall Study|Death|3|||
161241365|NCT03606174|582265991|FG010|Overall Study|Death|0|||
161241366|NCT03606174|582265981|FG000|Overall Study|Lost to Follow-up|0|||
161241367|NCT03606174|582265982|FG001|Overall Study|Lost to Follow-up|0|||
161241368|NCT03606174|582265983|FG002|Overall Study|Lost to Follow-up|0|||
161241369|NCT03606174|582265984|FG003|Overall Study|Lost to Follow-up|0|||
161241370|NCT03606174|582265985|FG004|Overall Study|Lost to Follow-up|1|||
161241371|NCT03606174|582265986|FG005|Overall Study|Lost to Follow-up|1|||
161241372|NCT03606174|582265987|FG006|Overall Study|Lost to Follow-up|0|||
161241373|NCT03606174|582265988|FG007|Overall Study|Lost to Follow-up|0|||
161241374|NCT03606174|582265989|FG008|Overall Study|Lost to Follow-up|0|||
161241375|NCT03606174|582265990|FG009|Overall Study|Lost to Follow-up|0|||
161241376|NCT03606174|582265991|FG010|Overall Study|Lost to Follow-up|0|||
161241377|NCT03606174|582265981|FG000|Overall Study|Withdrawal by Subject|6|||
161241378|NCT03606174|582265982|FG001|Overall Study|Withdrawal by Subject|0|||
161241379|NCT03606174|582265983|FG002|Overall Study|Withdrawal by Subject|0|||
161241380|NCT03606174|582265984|FG003|Overall Study|Withdrawal by Subject|1|||
161241381|NCT03606174|582265985|FG004|Overall Study|Withdrawal by Subject|2|||
161241382|NCT03606174|582265986|FG005|Overall Study|Withdrawal by Subject|1|||
161241383|NCT03606174|582265987|FG006|Overall Study|Withdrawal by Subject|4|||
161241384|NCT03606174|582265988|FG007|Overall Study|Withdrawal by Subject|0|||
161241385|NCT03606174|582265989|FG008|Overall Study|Withdrawal by Subject|0|||
161241386|NCT03606174|582265990|FG009|Overall Study|Withdrawal by Subject|0|||
161241387|NCT03606174|582265991|FG010|Overall Study|Withdrawal by Subject|1|||
161241388|NCT03606174|582265981|FG000|Overall Study|Study Terminated by Sponsor|5|||
161241389|NCT03606174|582265982|FG001|Overall Study|Study Terminated by Sponsor|7|||
161241390|NCT03606174|582265983|FG002|Overall Study|Study Terminated by Sponsor|3|||
161241391|NCT03606174|582265984|FG003|Overall Study|Study Terminated by Sponsor|0|||
161241392|NCT03606174|582265985|FG004|Overall Study|Study Terminated by Sponsor|11|||
161241393|NCT03606174|582265986|FG005|Overall Study|Study Terminated by Sponsor|6|||
161241394|NCT03606174|582265987|FG006|Overall Study|Study Terminated by Sponsor|12|||
161241395|NCT03606174|582265988|FG007|Overall Study|Study Terminated by Sponsor|1|||
161241396|NCT03606174|582265989|FG008|Overall Study|Study Terminated by Sponsor|3|||
161241397|NCT03606174|582265990|FG009|Overall Study|Study Terminated by Sponsor|1|||
161334261|NCT03528551|582612561|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161241398|NCT03606174|582265991|FG010|Overall Study|Study Terminated by Sponsor|2|||
161241399|NCT03606174|582265981|FG000|Overall Study|Miscellaneous|1|||
161241400|NCT03606174|582265982|FG001|Overall Study|Miscellaneous|1|||
161241401|NCT03606174|582265983|FG002|Overall Study|Miscellaneous|0|||
161241402|NCT03606174|582265984|FG003|Overall Study|Miscellaneous|1|||
161241403|NCT03606174|582265985|FG004|Overall Study|Miscellaneous|4|||
161241404|NCT03606174|582265986|FG005|Overall Study|Miscellaneous|7|||
161241405|NCT03606174|582265987|FG006|Overall Study|Miscellaneous|5|||
161241406|NCT03606174|582265988|FG007|Overall Study|Miscellaneous|0|||
161241407|NCT03606174|582265989|FG008|Overall Study|Miscellaneous|0|||
161241408|NCT03606174|582265990|FG009|Overall Study|Miscellaneous|0|||
161334262|NCT03528551|582612562|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161334263|NCT03528551|582612563|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161334264|NCT03528551|582612561|FG000|Overall Study|Protocol Violation|0|||
161334265|NCT03528551|582612562|FG001|Overall Study|Protocol Violation|3|||
161334266|NCT03528551|582612563|FG002|Overall Study|Protocol Violation|0|||
161334267|NCT03528551|582612561|FG000|Overall Study|Withdrawal by Subject|0|||
161334268|NCT03528551|582612562|FG001|Overall Study|Withdrawal by Subject|7|||
161334269|NCT03528551|582612563|FG002|Overall Study|Withdrawal by Subject|0|||
161334270|NCT01789047|582612564|FG000|Overall Study|Adverse Event|3|||
161334271|NCT01789047|582612565|FG001|Overall Study|Adverse Event|2|||
161334272|NCT01789047|582612564|FG000|Overall Study|Withdrawal by Subject|1|||
161334273|NCT01789047|582612565|FG001|Overall Study|Withdrawal by Subject|2|||
161334274|NCT03644017|582612566|FG000|Overall Study|Access Abandonment|5|||
161334275|NCT03644017|582612566|FG000|Overall Study|Kidney Transplant|2|||
161334276|NCT02700048|582612567|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
161334277|NCT02700048|582612568|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
161334278|NCT01204671|582612569|FG000|Overall Study|Adverse Event|4|||
161334279|NCT01204671|582612570|FG001|Overall Study|Adverse Event|3|||
161334280|NCT01204671|582612571|FG002|Overall Study|Adverse Event|3|||
161334281|NCT01204671|582612572|FG003|Overall Study|Adverse Event|3|||
161334282|NCT01204671|582612573|FG004|Overall Study|Adverse Event|1|||
161334283|NCT01204671|582612569|FG000|Overall Study|Withdrawal by Subject|2|||
161334284|NCT01204671|582612570|FG001|Overall Study|Withdrawal by Subject|3|||
161334285|NCT01204671|582612571|FG002|Overall Study|Withdrawal by Subject|4|||
161334286|NCT01204671|582612572|FG003|Overall Study|Withdrawal by Subject|5|||
161133426|NCT01111604|581872925|FG001|Overall Study|Lost to Follow-up|0|||
161133427|NCT01111604|581872926|FG002|Overall Study|Lost to Follow-up|1|||
161133428|NCT01111604|581872924|FG000|Overall Study|Withdrew Consent|3|||
161133429|NCT01111604|581872925|FG001|Overall Study|Withdrew Consent|0|||
161133430|NCT01111604|581872926|FG002|Overall Study|Withdrew Consent|2|||
161133431|NCT01111604|581872924|FG000|Overall Study|Withdrawal by Subject|2|||
161133432|NCT01111604|581872925|FG001|Overall Study|Withdrawal by Subject|0|||
161133433|NCT01111604|581872926|FG002|Overall Study|Withdrawal by Subject|0|||
161133434|NCT01111604|581872924|FG000|Overall Study|Death|1|||
161133435|NCT01111604|581872925|FG001|Overall Study|Death|0|||
161133436|NCT01111604|581872926|FG002|Overall Study|Death|0|||
161133437|NCT01111604|581872924|FG000|Overall Study|Met Exclusion Criteria|2|||
161133438|NCT01111604|581872925|FG001|Overall Study|Met Exclusion Criteria|0|||
161133439|NCT01111604|581872926|FG002|Overall Study|Met Exclusion Criteria|0|||
161133440|NCT00584870|581872929|FG000|Overall Study|Adverse Event|4|||
161133441|NCT00584870|581872930|FG001|Overall Study|Adverse Event|3|||
161133442|NCT00584870|581872931|FG002|Overall Study|Adverse Event|2|||
161133443|NCT00584870|581872929|FG000|Overall Study|Lost to Follow-up|4|||
161133444|NCT00584870|581872930|FG001|Overall Study|Lost to Follow-up|1|||
161133445|NCT00584870|581872931|FG002|Overall Study|Lost to Follow-up|1|||
161133446|NCT00584870|581872929|FG000|Overall Study|Lack of Efficacy|7|||
161133447|NCT00584870|581872930|FG001|Overall Study|Lack of Efficacy|14|||
161133448|NCT00584870|581872931|FG002|Overall Study|Lack of Efficacy|8|||
161133449|NCT00584870|581872929|FG000|Overall Study|Withdrawal by Subject|10|||
161133450|NCT00584870|581872930|FG001|Overall Study|Withdrawal by Subject|5|||
161133451|NCT00584870|581872931|FG002|Overall Study|Withdrawal by Subject|3|||
161133452|NCT00584870|581872929|FG000|Overall Study|Protocol Violation|1|||
161133453|NCT00584870|581872930|FG001|Overall Study|Protocol Violation|1|||
161133454|NCT00584870|581872931|FG002|Overall Study|Protocol Violation|2|||
161133455|NCT00584870|581872929|FG000|Overall Study|Did not met entrance criteria|1|||
161133456|NCT00584870|581872930|FG001|Overall Study|Did not met entrance criteria|0|||
161133457|NCT00584870|581872931|FG002|Overall Study|Did not met entrance criteria|0|||
161133458|NCT00584870|581872929|FG000|Overall Study|Other|2|||
161133459|NCT00584870|581872930|FG001|Overall Study|Other|0|||
161133460|NCT00584870|581872931|FG002|Overall Study|Other|0|||
161133461|NCT00584870|581872929|FG000|Overall Study|Randomized but not treated|0|||
161133462|NCT00584870|581872930|FG001|Overall Study|Randomized but not treated|1|||
161133463|NCT00584870|581872931|FG002|Overall Study|Randomized but not treated|2|||
161133464|NCT03682120|581872932|FG000|Overall Study|Lost to Follow-up|11|||
161133465|NCT03682120|581872933|FG001|Overall Study|Lost to Follow-up|4|||
161133466|NCT03682120|581872934|FG002|Overall Study|Lost to Follow-up|5|||
161133467|NCT03682120|581872935|FG003|Overall Study|Lost to Follow-up|2|||
161133468|NCT03682120|581872932|FG000|Overall Study|Physician Decision|1|||
161133469|NCT03682120|581872933|FG001|Overall Study|Physician Decision|0|||
161133470|NCT03682120|581872934|FG002|Overall Study|Physician Decision|0|||
161133471|NCT03682120|581872935|FG003|Overall Study|Physician Decision|0|||
161133472|NCT03682120|581872932|FG000|Overall Study|Withdrawal by Subject|1|||
161133473|NCT03682120|581872933|FG001|Overall Study|Withdrawal by Subject|2|||
161133474|NCT03682120|581872934|FG002|Overall Study|Withdrawal by Subject|3|||
161133475|NCT03682120|581872935|FG003|Overall Study|Withdrawal by Subject|0|||
161133476|NCT03682120|581872932|FG000|Overall Study|Death|0|||
161133477|NCT03682120|581872933|FG001|Overall Study|Death|1|||
161133478|NCT03682120|581872934|FG002|Overall Study|Death|0|||
161334287|NCT01204671|582612573|FG004|Overall Study|Withdrawal by Subject|3|||
161334288|NCT01204671|582612569|FG000|Overall Study|Lost to Follow-up|7|||
160825177|NCT01598753|580745029|FG000|Overall Study|Physician Decision|0|||
160825178|NCT01598753|580745030|FG001|Overall Study|Physician Decision|1|||
160825179|NCT01598753|580745031|FG002|Overall Study|Physician Decision|0|||
160825180|NCT01598753|580745032|FG003|Overall Study|Physician Decision|2|||
160825181|NCT01598753|580745029|FG000|Overall Study|Withdrawal by Subject|7|||
160825182|NCT01598753|580745030|FG001|Overall Study|Withdrawal by Subject|2|||
160825183|NCT01598753|580745031|FG002|Overall Study|Withdrawal by Subject|0|||
160825184|NCT01598753|580745032|FG003|Overall Study|Withdrawal by Subject|1|||
160825185|NCT02142283|580745033|FG000|Overall Study|Death|20|||
160825186|NCT02142283|580745034|FG001|Overall Study|Death|18|||
160825187|NCT02142283|580745033|FG000|Overall Study|Withdrawal by Subject|1|||
160825188|NCT02142283|580745034|FG001|Overall Study|Withdrawal by Subject|3|||
160825189|NCT01484834|580745035|FG000|Overall Study|Lost to Follow-up|5|||
160825190|NCT01484834|580745036|FG001|Overall Study|Lost to Follow-up|8|||
160825191|NCT01484834|580745037|FG002|Overall Study|Lost to Follow-up|1|||
160825192|NCT01484834|580745038|FG003|Overall Study|Lost to Follow-up|4|||
160825193|NCT00747344|580745039|FG000|Controlled Period|Adverse Event|3|||
160825194|NCT00747344|580745040|FG001|Controlled Period|Adverse Event|0|||
160825195|NCT00747344|580745041|FG002|Controlled Period|Adverse Event|0|||
160825196|NCT00747344|580745042|FG003|Controlled Period|Adverse Event|0|||
160825197|NCT00747344|580745039|FG000|Controlled Period|Lack of Efficacy|2|||
160825198|NCT00747344|580745040|FG001|Controlled Period|Lack of Efficacy|1|||
160825199|NCT00747344|580745041|FG002|Controlled Period|Lack of Efficacy|0|||
160825200|NCT00747344|580745042|FG003|Controlled Period|Lack of Efficacy|0|||
160825201|NCT00747344|580745039|FG000|Controlled Period|Other|0|||
160825202|NCT00747344|580745040|FG001|Controlled Period|Other|3|||
160825203|NCT00747344|580745041|FG002|Controlled Period|Other|0|||
160825204|NCT00747344|580745042|FG003|Controlled Period|Other|0|||
160825205|NCT00747344|580745039|FG000|After Controlled Period|Adverse Event|0|||
160825206|NCT00747344|580745040|FG001|After Controlled Period|Adverse Event|0|||
160825207|NCT00747344|580745041|FG002|After Controlled Period|Adverse Event|0|||
160825208|NCT00747344|580745042|FG003|After Controlled Period|Adverse Event|1|||
160825209|NCT02460783|580745043|FG000|Overall Study|Withdrawal by Subject|1|||
160825210|NCT02460783|580745044|FG001|Overall Study|Withdrawal by Subject|3|||
160825211|NCT02460783|580745043|FG000|Overall Study|Lost to Follow-up|1|||
160825212|NCT02460783|580745044|FG001|Overall Study|Lost to Follow-up|1|||
160825213|NCT03754582|580745047|FG000|Treatment Phase|Adverse Event|0|||
160825214|NCT03754582|580745048|FG001|Treatment Phase|Adverse Event|1|||
160825215|NCT03754582|580745049|FG002|Treatment Phase|Adverse Event|0|||
160825216|NCT03754582|580745047|FG000|Follow-up Phase|Other|0|||
160825217|NCT03754582|580745048|FG001|Follow-up Phase|Other|0|||
161334289|NCT01204671|582612570|FG001|Overall Study|Lost to Follow-up|8|||
161334290|NCT01204671|582612571|FG002|Overall Study|Lost to Follow-up|6|||
161334291|NCT01204671|582612572|FG003|Overall Study|Lost to Follow-up|4|||
161334292|NCT01204671|582612573|FG004|Overall Study|Lost to Follow-up|0|||
160825218|NCT03754582|580745049|FG002|Follow-up Phase|Other|1|||
160825219|NCT01561755|580745050|FG000|Overall Study|Lost to Follow-up|0|||
160825220|NCT01561755|580745051|FG001|Overall Study|Lost to Follow-up|1|||
160825221|NCT00624819|580745052|FG000|Follow-up Period: Year 4|Parents decision|0|||
160825222|NCT00624819|580745053|FG001|Follow-up Period: Year 4|Parents decision|0|||
160825223|NCT00624819|580745054|FG002|Follow-up Period: Year 4|Parents decision|1|||
160825224|NCT00624819|580745055|FG003|Follow-up Period: Year 4|Parents decision|0|||
160825225|NCT00624819|580745052|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
160825226|NCT00624819|580745053|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
160825227|NCT00624819|580745054|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
160825228|NCT00624819|580745055|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
160825229|NCT02847858|580745056|FG000|Overall Study|Lost to Follow-up|401|||
160825230|NCT02847858|580745057|FG001|Overall Study|Lost to Follow-up|269|||
161334293|NCT01204671|582612569|FG000|Overall Study|Unknown Completion Status|1|||
160825231|NCT02826421|580745060|FG000|Overall Study|Adverse Event|1|||
161334294|NCT01204671|582612570|FG001|Overall Study|Unknown Completion Status|1|||
160825232|NCT02826421|580745061|FG001|Overall Study|Adverse Event|0|||
160825233|NCT02826421|580745062|FG002|Overall Study|Adverse Event|0|||
160825234|NCT02826421|580745063|FG003|Overall Study|Adverse Event|1|||
160825235|NCT02826421|580745060|FG000|Overall Study|Withdrawal by Subject|1|||
160825236|NCT02826421|580745061|FG001|Overall Study|Withdrawal by Subject|3|||
160825237|NCT02826421|580745062|FG002|Overall Study|Withdrawal by Subject|1|||
160825238|NCT02826421|580745063|FG003|Overall Study|Withdrawal by Subject|1|||
160825239|NCT02826421|580745060|FG000|Overall Study|Reason not given|1|||
160825240|NCT02826421|580745061|FG001|Overall Study|Reason not given|0|||
160825241|NCT02826421|580745062|FG002|Overall Study|Reason not given|1|||
160825242|NCT02826421|580745063|FG003|Overall Study|Reason not given|0|||
161334295|NCT01204671|582612571|FG002|Overall Study|Unknown Completion Status|0|||
160825243|NCT02210221|580745066|FG000|Overall Study|Lack of Efficacy|7|||
160825244|NCT02210221|580745066|FG000|Overall Study|Withdrawal by Subject|43|||
160825245|NCT04030247|580747084|FG000|Overall Study|Withdrawal by Subject|4|||
160825246|NCT04030247|580747084|FG000|Overall Study|Lost to Follow-up|13|||
161241409|NCT03606174|582265991|FG010|Overall Study|Miscellaneous|1|||
161241410|NCT01205035|582265994|FG000|Overall Study|Withdrawal by Subject|1|||
161241411|NCT01205035|582265995|FG001|Overall Study|Withdrawal by Subject|0|||
161241412|NCT01205035|582265994|FG000|Overall Study|Physician Decision|1|||
161241413|NCT01205035|582265995|FG001|Overall Study|Physician Decision|0|||
161241414|NCT01896934|582265996|FG000|Overall Study|Adverse Event|1|||
161241415|NCT01896934|582265996|FG000|Overall Study|Withdrawal by Subject|1|||
161241416|NCT00316277|582265998|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
161241417|NCT00316277|582265999|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
161241418|NCT00316277|582265998|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
161241419|NCT00316277|582265999|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
161241420|NCT00316277|582265998|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
161241421|NCT00316277|582265999|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
161241422|NCT00316277|582265998|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
161241423|NCT00316277|582265999|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
161241424|NCT00316277|582265998|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
161241425|NCT00316277|582265999|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
161241426|NCT00927069|582266000|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
161241427|NCT00927069|582266001|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
161241428|NCT00927069|582266002|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
161241429|NCT00927069|582266003|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
161241430|NCT00927069|582266000|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
161241431|NCT00927069|582266001|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
161241432|NCT00927069|582266002|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
161241433|NCT00927069|582266003|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
161241434|NCT00927069|582266000|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
161241435|NCT00927069|582266001|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
160902090|NCT01058655|581035978|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
160902091|NCT01058655|581035975|FG000|Overall Study|Death|0|||
160902092|NCT01058655|581035976|FG001|Overall Study|Death|1|||
160902093|NCT01058655|581035977|FG002|Overall Study|Death|1|||
160902094|NCT01058655|581035978|FG003|Overall Study|Death|0|||
160902095|NCT01058655|581035975|FG000|Overall Study|Disease Progression|1|||
160902096|NCT01058655|581035976|FG001|Overall Study|Disease Progression|2|||
160902097|NCT01058655|581035977|FG002|Overall Study|Disease Progression|4|||
160902098|NCT01058655|581035978|FG003|Overall Study|Disease Progression|24|||
160902099|NCT01058655|581035975|FG000|Overall Study|Other|0|||
160902100|NCT01058655|581035976|FG001|Overall Study|Other|0|||
160902101|NCT01058655|581035977|FG002|Overall Study|Other|0|||
160902102|NCT01058655|581035978|FG003|Overall Study|Other|4|||
160902103|NCT04545060|581035981|FG000|Overall Study|Adverse Event|0|||
160902104|NCT04545060|581035982|FG001|Overall Study|Adverse Event|1|||
160902105|NCT04545060|581035981|FG000|Overall Study|Death|0|||
160902106|NCT04545060|581035982|FG001|Overall Study|Death|5|||
160902107|NCT04545060|581035981|FG000|Overall Study|Lost to Follow-up|10|||
160902108|NCT04545060|581035982|FG001|Overall Study|Lost to Follow-up|13|||
160902109|NCT04545060|581035981|FG000|Overall Study|Physician Decision|3|||
160902110|NCT04545060|581035982|FG001|Overall Study|Physician Decision|0|||
160902111|NCT04545060|581035981|FG000|Overall Study|Withdrawal by Subject|17|||
160902112|NCT04545060|581035982|FG001|Overall Study|Withdrawal by Subject|22|||
160902113|NCT00619177|581035983|FG000|Overall Study|Adverse Event|18|||
160902114|NCT00619177|581035983|FG000|Overall Study|Lost to Follow-up|2|||
160902115|NCT00619177|581035983|FG000|Overall Study|Lack of Efficacy|1|||
160902116|NCT00619177|581035983|FG000|Overall Study|Missing termination information|481|||
160902117|NCT00619177|581035983|FG000|Overall Study|Not specified reasons|6|||
160902118|NCT01281137|581035984|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
160902119|NCT01281137|581035985|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
160902120|NCT01281137|581035984|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
161133479|NCT03682120|581872935|FG003|Overall Study|Death|0|||
160902121|NCT01281137|581035985|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
160917934|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
161133480|NCT03682120|581872932|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
161133481|NCT03682120|581872933|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
161133482|NCT03682120|581872934|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
161133483|NCT03682120|581872935|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
161133484|NCT03094195|581872936|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
161133485|NCT03094195|581872937|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
161133486|NCT03094195|581872938|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
161133487|NCT03094195|581872939|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161133488|NCT03094195|581872940|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161133489|NCT03094195|581872941|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161133490|NCT03094195|581872942|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161133491|NCT03094195|581872943|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161133492|NCT03094195|581872936|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
161133493|NCT03094195|581872937|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
161133494|NCT03094195|581872938|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
161133495|NCT03094195|581872939|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161133496|NCT03094195|581872940|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161133497|NCT03094195|581872941|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161133498|NCT03094195|581872942|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161133499|NCT03094195|581872943|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
161133500|NCT03094195|581872936|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133501|NCT03094195|581872937|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133502|NCT03094195|581872938|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161133503|NCT03094195|581872939|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133504|NCT03094195|581872940|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133505|NCT03094195|581872941|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133506|NCT03094195|581872942|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133507|NCT03094195|581872943|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161133508|NCT03094195|581872936|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161133509|NCT03094195|581872937|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
161133510|NCT03094195|581872938|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
161133511|NCT03094195|581872939|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161133512|NCT03094195|581872940|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161133513|NCT03094195|581872941|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161133514|NCT03094195|581872942|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161133515|NCT03094195|581872943|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161133516|NCT01651780|581872944|FG000|Overall Study|Physician decision: No 30-day visit|2|||
161133517|NCT01651780|581872945|FG001|Overall Study|Physician decision: No 30-day visit|1|||
161133518|NCT01651780|581872944|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
161133519|NCT01651780|581872945|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
161133520|NCT01651780|581872944|FG000|Overall Study|Withdrawal by Subject|2|||
161133521|NCT01651780|581872945|FG001|Overall Study|Withdrawal by Subject|0|||
161133522|NCT01651780|581872944|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
161133523|NCT01651780|581872945|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161133524|NCT01651780|581872944|FG000|Overall Study|Lost to Follow-up|1|||
161133525|NCT01651780|581872945|FG001|Overall Study|Lost to Follow-up|2|||
161133526|NCT01651780|581872944|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
161241436|NCT00927069|582266002|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
161241437|NCT00927069|582266003|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
161133527|NCT01651780|581872945|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
161133528|NCT02949830|581872946|FG000|Overall Study|Adverse Event|1|||
161133529|NCT02949830|581872946|FG000|Overall Study|Withdrawal by Subject|1|||
160825247|NCT02032407|580747085|FG000|Overall Study|Lost to Follow-up|2|||
160825248|NCT02032407|580747085|FG000|Overall Study|Pregnancy|1|||
160825249|NCT02032407|580747085|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160825250|NCT05320393|580747086|FG000|Overall Study|Withdrawal by Subject|1|||
160825251|NCT05320393|580747087|FG001|Overall Study|Withdrawal by Subject|0|||
160825252|NCT05320393|580747088|FG002|Overall Study|Withdrawal by Subject|2|||
160825253|NCT05320393|580747086|FG000|Overall Study|Lost to Follow-up|1|||
160825254|NCT05320393|580747087|FG001|Overall Study|Lost to Follow-up|2|||
160825255|NCT05320393|580747088|FG002|Overall Study|Lost to Follow-up|1|||
160825256|NCT05320393|580747086|FG000|Overall Study|Moved; too much driving|0|||
160825257|NCT05320393|580747087|FG001|Overall Study|Moved; too much driving|0|||
160825258|NCT05320393|580747088|FG002|Overall Study|Moved; too much driving|2|||
160825259|NCT05320393|580747086|FG000|Overall Study|Did not receive treatment|0|||
160825260|NCT05320393|580747087|FG001|Overall Study|Did not receive treatment|0|||
161133530|NCT00054132|581872947|FG000|Overall Study|Not Treated|1|||
161133531|NCT01290887|581872948|FG000|Overall Study|Adverse Event|6|||
161241438|NCT00927069|582266000|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
161241439|NCT00927069|582266001|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
161241440|NCT00927069|582266002|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
161241441|NCT00927069|582266003|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
161241442|NCT00927069|582266000|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
161241443|NCT00927069|582266001|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161133532|NCT01290887|581872949|FG001|Overall Study|Adverse Event|11|||
161133533|NCT01290887|581872948|FG000|Overall Study|Lack of Efficacy|4|||
161133534|NCT01290887|581872949|FG001|Overall Study|Lack of Efficacy|5|||
160825261|NCT05320393|580747088|FG002|Overall Study|Did not receive treatment|1|||
160825262|NCT04411420|580747089|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
160917935|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
161133535|NCT01290887|581872948|FG000|Overall Study|Withdrawal by Subject|26|||
160825263|NCT04411420|580747090|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
161241444|NCT00927069|582266002|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
161241445|NCT00927069|582266003|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
160825264|NCT04411420|580747089|FG000|Survey Subset|Lost to Follow-up|134|||
160825265|NCT04411420|580747090|FG001|Survey Subset|Lost to Follow-up|120|||
160825266|NCT00549900|580747091|FG000|Overall Study|Adverse Event|1|||
160825267|NCT03187834|580747095|FG000|Overall Study|Lost to Follow-up|0|||
160825268|NCT03187834|580747096|FG001|Overall Study|Lost to Follow-up|1|||
160825269|NCT03187834|580747097|FG002|Overall Study|Lost to Follow-up|2|||
160825270|NCT03187834|580747098|FG003|Overall Study|Lost to Follow-up|2|||
160825271|NCT03187834|580747095|FG000|Overall Study|Had invalid anthropometric measurements|5|||
160825272|NCT03187834|580747096|FG001|Overall Study|Had invalid anthropometric measurements|3|||
160825273|NCT03187834|580747097|FG002|Overall Study|Had invalid anthropometric measurements|4|||
160825274|NCT03187834|580747098|FG003|Overall Study|Had invalid anthropometric measurements|2|||
160825275|NCT03559699|580747101|FG000|Overall Study|Withdrawal by Subject|6|||
160825276|NCT03559699|580747101|FG000|Overall Study|Lost to Follow-up|1|||
160825277|NCT00031460|580747102|FG000|Overall Study|Lost to Follow-up|0|||
160825278|NCT00031460|580747103|FG001|Overall Study|Lost to Follow-up|1|||
160825279|NCT00031460|580747102|FG000|Overall Study|Withdrawal by Subject|1|||
160825280|NCT00031460|580747103|FG001|Overall Study|Withdrawal by Subject|1|||
160825281|NCT00031460|580747102|FG000|Overall Study|Non-Compliant|1|||
160825282|NCT00031460|580747103|FG001|Overall Study|Non-Compliant|1|||
160825283|NCT00031460|580747102|FG000|Overall Study|Death|0|||
160825284|NCT00031460|580747103|FG001|Overall Study|Death|1|||
160825285|NCT00031460|580747102|FG000|Overall Study|Reactivation of Disease|5|||
160825286|NCT00031460|580747103|FG001|Overall Study|Reactivation of Disease|9|||
160825287|NCT00031460|580747102|FG000|Overall Study|Disruption of blinded drug supply|2|||
160825288|NCT00031460|580747103|FG001|Overall Study|Disruption of blinded drug supply|0|||
160825289|NCT00031460|580747102|FG000|Overall Study|Confirmed unevaluable|0|||
160825290|NCT00031460|580747103|FG001|Overall Study|Confirmed unevaluable|1|||
160825291|NCT01930890|580747104|FG000|Overall Study|Study Termination|14|||
160825292|NCT01930890|580747105|FG001|Overall Study|Study Termination|28|||
160825293|NCT01930890|580747106|FG002|Overall Study|Study Termination|13|||
160825294|NCT01930890|580747107|FG003|Overall Study|Study Termination|25|||
160825295|NCT01930890|580747104|FG000|Overall Study|Death|0|||
161241446|NCT04089553|582266004|FG000|Overall Study|Death|1|||
161241447|NCT04089553|582266005|FG001|Overall Study|Death|1|||
160825296|NCT01930890|580747105|FG001|Overall Study|Death|0|||
160825297|NCT01930890|580747106|FG002|Overall Study|Death|0|||
160825298|NCT01930890|580747107|FG003|Overall Study|Death|1|||
160825299|NCT01930890|580747104|FG000|Overall Study|Investigator Decision|0|||
160825300|NCT01930890|580747105|FG001|Overall Study|Investigator Decision|1|||
160825301|NCT01930890|580747106|FG002|Overall Study|Investigator Decision|0|||
160825302|NCT01930890|580747107|FG003|Overall Study|Investigator Decision|0|||
160825303|NCT01930890|580747104|FG000|Overall Study|Consent Withdrawn|0|||
160825304|NCT01930890|580747105|FG001|Overall Study|Consent Withdrawn|3|||
160825305|NCT01930890|580747106|FG002|Overall Study|Consent Withdrawn|0|||
160825306|NCT01930890|580747107|FG003|Overall Study|Consent Withdrawn|1|||
160825307|NCT01930890|580747104|FG000|Overall Study|Adverse Event|0|||
160825308|NCT01930890|580747105|FG001|Overall Study|Adverse Event|1|||
160825309|NCT01930890|580747106|FG002|Overall Study|Adverse Event|0|||
160825310|NCT01930890|580747107|FG003|Overall Study|Adverse Event|0|||
160825311|NCT01176565|580747110|FG000|Overall Study|Lost to Follow-up|12|||
160825312|NCT01176565|580747111|FG001|Overall Study|Lost to Follow-up|16|||
160825313|NCT01176565|580747110|FG000|Overall Study|Withdrawal by Subject|7|||
160825314|NCT01176565|580747111|FG001|Overall Study|Withdrawal by Subject|1|||
160825315|NCT01176565|580747110|FG000|Overall Study|Not Analyzed (any other reason)|1|||
160825316|NCT01176565|580747111|FG001|Overall Study|Not Analyzed (any other reason)|2|||
160825317|NCT02754141|580747112|FG000|Overall Study|Disease progression|11|||
160825318|NCT02754141|580747113|FG001|Overall Study|Disease progression|7|||
160825319|NCT02754141|580747114|FG002|Overall Study|Disease progression|8|||
160825320|NCT02754141|580747115|FG003|Overall Study|Disease progression|5|||
160825321|NCT02754141|580747116|FG004|Overall Study|Disease progression|7|||
160825322|NCT02754141|580747117|FG005|Overall Study|Disease progression|7|||
160825323|NCT02754141|580747118|FG006|Overall Study|Disease progression|7|||
160825324|NCT02754141|580747119|FG007|Overall Study|Disease progression|6|||
160825325|NCT02754141|580747120|FG008|Overall Study|Disease progression|11|||
160825326|NCT02754141|580747121|FG009|Overall Study|Disease progression|16|||
160825327|NCT02754141|580747122|FG010|Overall Study|Disease progression|18|||
160825328|NCT02754141|580747123|FG011|Overall Study|Disease progression|13|||
160825329|NCT02754141|580747124|FG012|Overall Study|Disease progression|10|||
160825330|NCT02754141|580747125|FG013|Overall Study|Disease progression|12|||
160825331|NCT02754141|580747126|FG014|Overall Study|Disease progression|12|||
160825332|NCT02754141|580747127|FG015|Overall Study|Disease progression|14|||
160825333|NCT02754141|580747128|FG016|Overall Study|Disease progression|0|||
160825334|NCT02754141|580747129|FG017|Overall Study|Disease progression|1|||
160825335|NCT02754141|580747112|FG000|Overall Study|Study drug toxicity|1|||
161241448|NCT04089553|582266004|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
160825336|NCT02754141|580747113|FG001|Overall Study|Study drug toxicity|1|||
160825337|NCT02754141|580747114|FG002|Overall Study|Study drug toxicity|0|||
160825338|NCT02754141|580747115|FG003|Overall Study|Study drug toxicity|0|||
160825339|NCT02754141|580747116|FG004|Overall Study|Study drug toxicity|0|||
160825340|NCT02754141|580747117|FG005|Overall Study|Study drug toxicity|0|||
160825341|NCT02754141|580747118|FG006|Overall Study|Study drug toxicity|0|||
160825342|NCT02754141|580747119|FG007|Overall Study|Study drug toxicity|0|||
160825343|NCT02754141|580747120|FG008|Overall Study|Study drug toxicity|0|||
160825344|NCT02754141|580747121|FG009|Overall Study|Study drug toxicity|0|||
160825345|NCT02754141|580747122|FG010|Overall Study|Study drug toxicity|2|||
161241449|NCT04089553|582266005|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
161241450|NCT04089553|582266004|FG000|Overall Study|Withdrawal by Subject|3|||
161241451|NCT04089553|582266005|FG001|Overall Study|Withdrawal by Subject|3|||
161241452|NCT04089553|582266004|FG000|Overall Study|Physician Decision|1|||
161241453|NCT04089553|582266005|FG001|Overall Study|Physician Decision|0|||
161241454|NCT04089553|582266004|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
161241455|NCT04089553|582266005|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
161241456|NCT04089553|582266004|FG000|Overall Study|Other|1|||
161241457|NCT04089553|582266005|FG001|Overall Study|Other|0|||
161241458|NCT04089553|582266004|FG000|Overall Study|Adverse Event|1|||
161241459|NCT04089553|582266005|FG001|Overall Study|Adverse Event|1|||
161241460|NCT01572662|582266006|FG000|Overall Study|Withdrawal by Subject|1|||
161241461|NCT01572662|582266007|FG001|Overall Study|Withdrawal by Subject|0|||
161241462|NCT01572662|582266006|FG000|Overall Study|Physician Decision|0|||
161241463|NCT01572662|582266007|FG001|Overall Study|Physician Decision|1|||
161241464|NCT03364192|582266008|FG000|Overall Study|Ineligible|10|||
161241465|NCT03364192|582266008|FG000|Overall Study|Withdrawal by Subject|5|||
161241466|NCT03364192|582266008|FG000|Overall Study|Lost to Follow-up|1|||
161241467|NCT04692155|582266009|FG000|Overall Study|Death|1|||
161241468|NCT04547192|582266010|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
161241469|NCT04547192|582266011|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
161241470|NCT04547192|582266012|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
161241471|NCT04547192|582266013|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
161241472|NCT04547192|582266010|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
161241473|NCT04547192|582266011|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
161241474|NCT04547192|582266012|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
161241475|NCT04547192|582266013|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
161241476|NCT04547192|582266010|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
161241477|NCT04547192|582266011|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
161241478|NCT04547192|582266012|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
161241479|NCT04547192|582266013|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
161241480|NCT04547192|582266010|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
161241481|NCT04547192|582266011|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
161241482|NCT04547192|582266012|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
161241483|NCT04547192|582266013|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
161241484|NCT04547192|582266010|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
161241485|NCT04547192|582266011|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
161241486|NCT04547192|582266012|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
161241487|NCT04547192|582266013|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
161241488|NCT01535222|582266014|FG000|Overall Study|Inclusion/exclusion|0|||
161241489|NCT01535222|582266015|FG001|Overall Study|Inclusion/exclusion|0|||
160825346|NCT02754141|580747123|FG011|Overall Study|Study drug toxicity|1|||
160825347|NCT02754141|580747124|FG012|Overall Study|Study drug toxicity|1|||
160825348|NCT02754141|580747125|FG013|Overall Study|Study drug toxicity|0|||
160902122|NCT01281137|581035984|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
160902123|NCT01281137|581035985|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
160902124|NCT01281137|581035984|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
160902125|NCT01281137|581035985|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
160902126|NCT01281137|581035984|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
161241490|NCT01535222|582266016|FG002|Overall Study|Inclusion/exclusion|1|||
161241491|NCT01535222|582266017|FG003|Overall Study|Inclusion/exclusion|0|||
161241492|NCT01535222|582266018|FG004|Overall Study|Inclusion/exclusion|0|||
161241493|NCT01535222|582266019|FG005|Overall Study|Inclusion/exclusion|0|||
161241494|NCT00935012|582266022|FG000|Overall Study|Death|19|||
161241495|NCT00935012|582266022|FG000|Overall Study|Withdrawal by Subject|3|||
161241496|NCT00935012|582266022|FG000|Overall Study|Other|5|||
161241497|NCT00935012|582266022|FG000|Overall Study|Adverse Event|2|||
161241498|NCT01442155|582266023|FG000|Overall Study|Complete remission|35|||
161241499|NCT01442155|582266023|FG000|Overall Study|Recurrence|26|||
161241500|NCT01442155|582266023|FG000|Overall Study|Adverse Event|2|||
161241501|NCT01442155|582266023|FG000|Overall Study|Lost to Follow-up|2|||
161241502|NCT01484912|582266032|FG000|Overall Study|Withdrawal by Subject|1|||
160825349|NCT02754141|580747126|FG014|Overall Study|Study drug toxicity|0|||
160825350|NCT02754141|580747127|FG015|Overall Study|Study drug toxicity|0|||
161241503|NCT01484912|582266033|FG001|Overall Study|Withdrawal by Subject|0|||
161241504|NCT01484912|582266032|FG000|Overall Study|Physician Decision|0|||
160825351|NCT02754141|580747128|FG016|Overall Study|Study drug toxicity|0|||
160825352|NCT02754141|580747129|FG017|Overall Study|Study drug toxicity|0|||
160825353|NCT02754141|580747112|FG000|Overall Study|AE unrelated to study drug|1|||
160825354|NCT02754141|580747113|FG001|Overall Study|AE unrelated to study drug|1|||
160825355|NCT02754141|580747114|FG002|Overall Study|AE unrelated to study drug|0|||
160825356|NCT02754141|580747115|FG003|Overall Study|AE unrelated to study drug|1|||
160825357|NCT02754141|580747116|FG004|Overall Study|AE unrelated to study drug|3|||
160825358|NCT02754141|580747117|FG005|Overall Study|AE unrelated to study drug|2|||
160825359|NCT02754141|580747118|FG006|Overall Study|AE unrelated to study drug|1|||
160825360|NCT02754141|580747119|FG007|Overall Study|AE unrelated to study drug|0|||
160825361|NCT02754141|580747120|FG008|Overall Study|AE unrelated to study drug|0|||
160825362|NCT02754141|580747121|FG009|Overall Study|AE unrelated to study drug|0|||
160825363|NCT02754141|580747122|FG010|Overall Study|AE unrelated to study drug|0|||
160825364|NCT02754141|580747123|FG011|Overall Study|AE unrelated to study drug|0|||
160825365|NCT02754141|580747124|FG012|Overall Study|AE unrelated to study drug|0|||
160825366|NCT02754141|580747125|FG013|Overall Study|AE unrelated to study drug|0|||
160825367|NCT02754141|580747126|FG014|Overall Study|AE unrelated to study drug|0|||
160825368|NCT02754141|580747127|FG015|Overall Study|AE unrelated to study drug|0|||
160825369|NCT02754141|580747128|FG016|Overall Study|AE unrelated to study drug|0|||
160825370|NCT02754141|580747129|FG017|Overall Study|AE unrelated to study drug|0|||
160825371|NCT02754141|580747112|FG000|Overall Study|Request to discontinue|0|||
160825372|NCT02754141|580747113|FG001|Overall Study|Request to discontinue|0|||
160825373|NCT02754141|580747114|FG002|Overall Study|Request to discontinue|0|||
160825374|NCT02754141|580747115|FG003|Overall Study|Request to discontinue|0|||
160825375|NCT02754141|580747116|FG004|Overall Study|Request to discontinue|0|||
160825376|NCT02754141|580747117|FG005|Overall Study|Request to discontinue|0|||
160825377|NCT02754141|580747118|FG006|Overall Study|Request to discontinue|0|||
160825378|NCT02754141|580747119|FG007|Overall Study|Request to discontinue|0|||
160825379|NCT02754141|580747120|FG008|Overall Study|Request to discontinue|1|||
160825380|NCT02754141|580747121|FG009|Overall Study|Request to discontinue|0|||
160825381|NCT02754141|580747122|FG010|Overall Study|Request to discontinue|0|||
160825382|NCT02754141|580747123|FG011|Overall Study|Request to discontinue|0|||
160825383|NCT02754141|580747124|FG012|Overall Study|Request to discontinue|0|||
160825384|NCT02754141|580747125|FG013|Overall Study|Request to discontinue|1|||
160825385|NCT02754141|580747126|FG014|Overall Study|Request to discontinue|1|||
160825386|NCT02754141|580747127|FG015|Overall Study|Request to discontinue|0|||
160825387|NCT02754141|580747128|FG016|Overall Study|Request to discontinue|0|||
160825388|NCT02754141|580747129|FG017|Overall Study|Request to discontinue|0|||
160825389|NCT02754141|580747112|FG000|Overall Study|Withdrew consent|0|||
160825390|NCT02754141|580747113|FG001|Overall Study|Withdrew consent|0|||
160825391|NCT02754141|580747114|FG002|Overall Study|Withdrew consent|0|||
160825392|NCT02754141|580747115|FG003|Overall Study|Withdrew consent|0|||
160825393|NCT02754141|580747116|FG004|Overall Study|Withdrew consent|0|||
160825394|NCT02754141|580747117|FG005|Overall Study|Withdrew consent|0|||
160825395|NCT02754141|580747118|FG006|Overall Study|Withdrew consent|0|||
160825396|NCT02754141|580747119|FG007|Overall Study|Withdrew consent|0|||
160825397|NCT02754141|580747120|FG008|Overall Study|Withdrew consent|0|||
160825398|NCT02754141|580747121|FG009|Overall Study|Withdrew consent|1|||
160825399|NCT02754141|580747122|FG010|Overall Study|Withdrew consent|0|||
160825400|NCT02754141|580747123|FG011|Overall Study|Withdrew consent|0|||
160825401|NCT02754141|580747124|FG012|Overall Study|Withdrew consent|0|||
160825402|NCT02754141|580747125|FG013|Overall Study|Withdrew consent|0|||
160825403|NCT02754141|580747126|FG014|Overall Study|Withdrew consent|0|||
161133536|NCT01290887|581872949|FG001|Overall Study|Withdrawal by Subject|32|||
161133537|NCT01290887|581872948|FG000|Overall Study|Protocol Violation|2|||
161133538|NCT01290887|581872949|FG001|Overall Study|Protocol Violation|1|||
161133539|NCT01290887|581872948|FG000|Overall Study|Lost to Follow-up|4|||
161133540|NCT01290887|581872949|FG001|Overall Study|Lost to Follow-up|4|||
160825404|NCT02754141|580747127|FG015|Overall Study|Withdrew consent|0|||
160825405|NCT02754141|580747128|FG016|Overall Study|Withdrew consent|0|||
161133541|NCT01290887|581872948|FG000|Overall Study|Non-compliance to study procedures|0|||
161133542|NCT01290887|581872949|FG001|Overall Study|Non-compliance to study procedures|1|||
161133543|NCT01290887|581872948|FG000|Overall Study|Non-compliance to study medications|1|||
161133544|NCT01290887|581872949|FG001|Overall Study|Non-compliance to study medications|0|||
161133545|NCT01290887|581872948|FG000|Overall Study|Sponsor closure of study|420|||
161133546|NCT01290887|581872949|FG001|Overall Study|Sponsor closure of study|476|||
160825406|NCT02754141|580747129|FG017|Overall Study|Withdrew consent|0|||
160825407|NCT02754141|580747112|FG000|Overall Study|Maximum clinical benefit|0|||
160825408|NCT02754141|580747113|FG001|Overall Study|Maximum clinical benefit|0|||
160825409|NCT02754141|580747114|FG002|Overall Study|Maximum clinical benefit|0|||
160825410|NCT02754141|580747115|FG003|Overall Study|Maximum clinical benefit|1|||
160825411|NCT02754141|580747116|FG004|Overall Study|Maximum clinical benefit|0|||
160825412|NCT02754141|580747117|FG005|Overall Study|Maximum clinical benefit|0|||
161133547|NCT01290887|581872948|FG000|Overall Study|Other|3|||
161133548|NCT01290887|581872949|FG001|Overall Study|Other|6|||
161133549|NCT03029832|581872950|FG000|Overall Study|Safety Follow-Up Completed|2|||
161133550|NCT03029832|581872951|FG001|Overall Study|Safety Follow-Up Completed|0|||
160825413|NCT02754141|580747118|FG006|Overall Study|Maximum clinical benefit|0|||
161334296|NCT01204671|582612572|FG003|Overall Study|Unknown Completion Status|0|||
160825414|NCT02754141|580747119|FG007|Overall Study|Maximum clinical benefit|0|||
160825415|NCT02754141|580747120|FG008|Overall Study|Maximum clinical benefit|0|||
160825416|NCT02754141|580747121|FG009|Overall Study|Maximum clinical benefit|0|||
160825417|NCT02754141|580747122|FG010|Overall Study|Maximum clinical benefit|0|||
160825418|NCT02754141|580747123|FG011|Overall Study|Maximum clinical benefit|0|||
160825419|NCT02754141|580747124|FG012|Overall Study|Maximum clinical benefit|0|||
160825420|NCT02754141|580747125|FG013|Overall Study|Maximum clinical benefit|0|||
160825421|NCT02754141|580747126|FG014|Overall Study|Maximum clinical benefit|0|||
160825422|NCT02754141|580747127|FG015|Overall Study|Maximum clinical benefit|0|||
160825423|NCT02754141|580747128|FG016|Overall Study|Maximum clinical benefit|0|||
160825424|NCT02754141|580747129|FG017|Overall Study|Maximum clinical benefit|0|||
160825425|NCT02754141|580747112|FG000|Overall Study|No longer meets study criteria|0|||
160825426|NCT02754141|580747113|FG001|Overall Study|No longer meets study criteria|0|||
160825427|NCT02754141|580747114|FG002|Overall Study|No longer meets study criteria|0|||
160825428|NCT02754141|580747115|FG003|Overall Study|No longer meets study criteria|1|||
160825429|NCT02754141|580747116|FG004|Overall Study|No longer meets study criteria|0|||
160825430|NCT02754141|580747117|FG005|Overall Study|No longer meets study criteria|0|||
160825431|NCT02754141|580747118|FG006|Overall Study|No longer meets study criteria|0|||
160825432|NCT02754141|580747119|FG007|Overall Study|No longer meets study criteria|0|||
160825433|NCT02754141|580747120|FG008|Overall Study|No longer meets study criteria|0|||
160825434|NCT02754141|580747121|FG009|Overall Study|No longer meets study criteria|0|||
160825435|NCT02754141|580747122|FG010|Overall Study|No longer meets study criteria|0|||
160825436|NCT02754141|580747123|FG011|Overall Study|No longer meets study criteria|0|||
160825437|NCT02754141|580747124|FG012|Overall Study|No longer meets study criteria|0|||
160825438|NCT02754141|580747125|FG013|Overall Study|No longer meets study criteria|0|||
160825439|NCT02754141|580747126|FG014|Overall Study|No longer meets study criteria|0|||
160825440|NCT02754141|580747127|FG015|Overall Study|No longer meets study criteria|0|||
160825441|NCT02754141|580747128|FG016|Overall Study|No longer meets study criteria|0|||
160825442|NCT02754141|580747129|FG017|Overall Study|No longer meets study criteria|0|||
160825443|NCT02754141|580747112|FG000|Overall Study|Other reasons|0|||
160825444|NCT02754141|580747113|FG001|Overall Study|Other reasons|0|||
160825445|NCT02754141|580747114|FG002|Overall Study|Other reasons|0|||
160825446|NCT02754141|580747115|FG003|Overall Study|Other reasons|0|||
160825447|NCT02754141|580747116|FG004|Overall Study|Other reasons|0|||
160825448|NCT02754141|580747117|FG005|Overall Study|Other reasons|0|||
160825449|NCT02754141|580747118|FG006|Overall Study|Other reasons|0|||
160825450|NCT02754141|580747119|FG007|Overall Study|Other reasons|1|||
160825451|NCT02754141|580747120|FG008|Overall Study|Other reasons|0|||
160825452|NCT02754141|580747121|FG009|Overall Study|Other reasons|0|||
160825453|NCT02754141|580747122|FG010|Overall Study|Other reasons|0|||
160825454|NCT02754141|580747123|FG011|Overall Study|Other reasons|0|||
160825455|NCT02754141|580747124|FG012|Overall Study|Other reasons|2|||
160825456|NCT02754141|580747125|FG013|Overall Study|Other reasons|0|||
160989958|NCT00711646|581351704|FG000|Overall Study|patient non-compliance|1|||
161133551|NCT03029832|581872950|FG000|Overall Study|Death due to Disease Progression|1|||
161133552|NCT03029832|581872951|FG001|Overall Study|Death due to Disease Progression|0|||
161133553|NCT03029832|581872950|FG000|Overall Study|Study Terminated By Sponsor|1|||
161133554|NCT03029832|581872951|FG001|Overall Study|Study Terminated By Sponsor|1|||
161133555|NCT01628926|581872952|FG000|Overall Study|Adverse Event|13|||
161133556|NCT01628926|581872953|FG001|Overall Study|Adverse Event|11|||
161133557|NCT01628926|581872954|FG002|Overall Study|Adverse Event|9|||
161133558|NCT01628926|581872952|FG000|Overall Study|Lack of Efficacy|2|||
161133559|NCT01628926|581872953|FG001|Overall Study|Lack of Efficacy|1|||
161133560|NCT01628926|581872954|FG002|Overall Study|Lack of Efficacy|5|||
161133561|NCT01628926|581872952|FG000|Overall Study|Withdrawal by Subject|6|||
161133562|NCT01628926|581872953|FG001|Overall Study|Withdrawal by Subject|4|||
161133563|NCT01628926|581872954|FG002|Overall Study|Withdrawal by Subject|2|||
161133564|NCT01628926|581872952|FG000|Overall Study|Protocol Violation|0|||
161133565|NCT01628926|581872953|FG001|Overall Study|Protocol Violation|1|||
161133566|NCT01628926|581872954|FG002|Overall Study|Protocol Violation|0|||
160825457|NCT02754141|580747126|FG014|Overall Study|Other reasons|0|||
160825458|NCT02754141|580747127|FG015|Overall Study|Other reasons|0|||
160825459|NCT02754141|580747128|FG016|Overall Study|Other reasons|0|||
160825460|NCT02754141|580747129|FG017|Overall Study|Other reasons|0|||
160825461|NCT02754141|580747112|FG000|Overall Study|Completed treatment as per protocol|0|||
160825462|NCT02754141|580747113|FG001|Overall Study|Completed treatment as per protocol|1|||
160825463|NCT02754141|580747114|FG002|Overall Study|Completed treatment as per protocol|0|||
160825464|NCT02754141|580747115|FG003|Overall Study|Completed treatment as per protocol|0|||
160989959|NCT00711646|581351705|FG001|Overall Study|patient non-compliance|0|||
161133567|NCT01628926|581872952|FG000|Overall Study|Discontinuation criteria|3|||
160825465|NCT02754141|580747116|FG004|Overall Study|Completed treatment as per protocol|0|||
160825466|NCT02754141|580747117|FG005|Overall Study|Completed treatment as per protocol|0|||
161133568|NCT01628926|581872953|FG001|Overall Study|Discontinuation criteria|4|||
161133569|NCT01628926|581872954|FG002|Overall Study|Discontinuation criteria|0|||
160825467|NCT02754141|580747118|FG006|Overall Study|Completed treatment as per protocol|0|||
160989960|NCT03441360|581351706|FG000|Overall Study|Radiological disease progression|5|||
160989961|NCT03441360|581351707|FG001|Overall Study|Radiological disease progression|6|||
160825468|NCT02754141|580747119|FG007|Overall Study|Completed treatment as per protocol|0|||
160825469|NCT02754141|580747120|FG008|Overall Study|Completed treatment as per protocol|0|||
160825470|NCT02754141|580747121|FG009|Overall Study|Completed treatment as per protocol|0|||
160825471|NCT02754141|580747122|FG010|Overall Study|Completed treatment as per protocol|0|||
160825472|NCT02754141|580747123|FG011|Overall Study|Completed treatment as per protocol|0|||
160825473|NCT02754141|580747124|FG012|Overall Study|Completed treatment as per protocol|1|||
160825474|NCT02754141|580747125|FG013|Overall Study|Completed treatment as per protocol|0|||
160825475|NCT02754141|580747126|FG014|Overall Study|Completed treatment as per protocol|0|||
160825476|NCT02754141|580747127|FG015|Overall Study|Completed treatment as per protocol|0|||
160825477|NCT02754141|580747128|FG016|Overall Study|Completed treatment as per protocol|0|||
160825478|NCT02754141|580747129|FG017|Overall Study|Completed treatment as per protocol|0|||
160825479|NCT02754141|580747112|FG000|Overall Study|Not completing monotherapy|0|||
160825480|NCT02754141|580747113|FG001|Overall Study|Not completing monotherapy|0|||
160825481|NCT02754141|580747114|FG002|Overall Study|Not completing monotherapy|0|||
160825482|NCT02754141|580747115|FG003|Overall Study|Not completing monotherapy|0|||
160825483|NCT02754141|580747116|FG004|Overall Study|Not completing monotherapy|0|||
160825484|NCT02754141|580747117|FG005|Overall Study|Not completing monotherapy|0|||
160825485|NCT02754141|580747118|FG006|Overall Study|Not completing monotherapy|0|||
160825486|NCT02754141|580747119|FG007|Overall Study|Not completing monotherapy|0|||
160825487|NCT02754141|580747120|FG008|Overall Study|Not completing monotherapy|0|||
160825488|NCT02754141|580747121|FG009|Overall Study|Not completing monotherapy|0|||
160825489|NCT02754141|580747122|FG010|Overall Study|Not completing monotherapy|0|||
160825490|NCT02754141|580747123|FG011|Overall Study|Not completing monotherapy|0|||
160825491|NCT02754141|580747124|FG012|Overall Study|Not completing monotherapy|0|||
160825492|NCT02754141|580747125|FG013|Overall Study|Not completing monotherapy|1|||
160825493|NCT02754141|580747126|FG014|Overall Study|Not completing monotherapy|0|||
160825494|NCT02754141|580747127|FG015|Overall Study|Not completing monotherapy|0|||
160825495|NCT02754141|580747128|FG016|Overall Study|Not completing monotherapy|0|||
160825496|NCT02754141|580747129|FG017|Overall Study|Not completing monotherapy|0|||
160825497|NCT00759356|580747144|FG000|Overall Study|Adverse Event|0|||
160825498|NCT00759356|580747145|FG001|Overall Study|Adverse Event|1|||
160825499|NCT00759356|580747144|FG000|Overall Study|Withdrawal by Subject|0|||
160825500|NCT00759356|580747145|FG001|Overall Study|Withdrawal by Subject|2|||
160825501|NCT00759356|580747144|FG000|Overall Study|Subject was unable to return|1|||
160825502|NCT00759356|580747145|FG001|Overall Study|Subject was unable to return|0|||
160825503|NCT03199053|580747146|FG000|ST Period|Withdrawal by Subject|2|||
160825504|NCT03199053|580747147|FG001|ST Period|Withdrawal by Subject|4|||
160825505|NCT03199053|580747148|FG002|ST Period|Withdrawal by Subject|6|||
160825506|NCT03199053|580747146|FG000|ST Period|Withdrawal by parent/guardian|1|||
160825507|NCT03199053|580747147|FG001|ST Period|Withdrawal by parent/guardian|1|||
160825508|NCT03199053|580747148|FG002|ST Period|Withdrawal by parent/guardian|1|||
160825509|NCT03199053|580747146|FG000|ST Period|Lost to Follow-up|2|||
160825510|NCT03199053|580747147|FG001|ST Period|Lost to Follow-up|0|||
160825511|NCT03199053|580747148|FG002|ST Period|Lost to Follow-up|1|||
160825512|NCT03199053|580747146|FG000|LT Period|Withdrawal by Subject|1|||
160825513|NCT03199053|580747147|FG001|LT Period|Withdrawal by Subject|3|||
160825514|NCT03199053|580747148|FG002|LT Period|Withdrawal by Subject|3|||
160825515|NCT03199053|580747146|FG000|LT Period|Withdrawal by parent/guardian|0|||
160825516|NCT03199053|580747147|FG001|LT Period|Withdrawal by parent/guardian|0|||
160825517|NCT03199053|580747148|FG002|LT Period|Withdrawal by parent/guardian|1|||
160825518|NCT03199053|580747146|FG000|LT Period|Lost to Follow-up|0|||
160825519|NCT03199053|580747147|FG001|LT Period|Lost to Follow-up|1|||
160825520|NCT03199053|580747148|FG002|LT Period|Lost to Follow-up|1|||
160825521|NCT03199053|580747146|FG000|LT Period|Miscellaneous|0|||
160825522|NCT03199053|580747147|FG001|LT Period|Miscellaneous|0|||
160989962|NCT03441360|581351708|FG002|Overall Study|Radiological disease progression|4|||
161241505|NCT01484912|582266033|FG001|Overall Study|Physician Decision|1|||
160825523|NCT03199053|580747148|FG002|LT Period|Miscellaneous|2|||
160825524|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
160825525|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
160825526|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
160825527|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
160825528|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
160825529|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
160825530|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
160825531|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
160825532|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
160825533|NCT03199053|580747146|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
160825534|NCT03199053|580747147|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
160825535|NCT03199053|580747148|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
160825536|NCT03263923|580747150|FG000|Overall Study|Withdrawal by Subject|10|||
161334297|NCT01204671|582612573|FG004|Overall Study|Unknown Completion Status|0|||
161334298|NCT01204671|582612569|FG000|Overall Study|Physician Decision|0|||
161334299|NCT01204671|582612570|FG001|Overall Study|Physician Decision|0|||
161334300|NCT01204671|582612571|FG002|Overall Study|Physician Decision|0|||
161334301|NCT01204671|582612572|FG003|Overall Study|Physician Decision|1|||
161334302|NCT01204671|582612573|FG004|Overall Study|Physician Decision|0|||
161334303|NCT02175225|582612574|FG000|Overall Study|Withdrawal by Subject|1|||
161334304|NCT02175225|582612575|FG001|Overall Study|Withdrawal by Subject|2|||
161334305|NCT02175225|582612574|FG000|Overall Study|Lost to Follow-up|6|||
161334306|NCT02175225|582612575|FG001|Overall Study|Lost to Follow-up|7|||
161334307|NCT02175225|582612574|FG000|Overall Study|Study drug not administered|1|||
161334308|NCT02175225|582612575|FG001|Overall Study|Study drug not administered|2|||
161334309|NCT02340000|582612576|FG000|Time Period 1|Withdrawal by Subject|6|||
161334310|NCT02340000|582612577|FG001|Time Period 1|Withdrawal by Subject|8|||
161334311|NCT02340000|582612576|FG000|Time Period 1|Lost to Follow-up|6|||
161334312|NCT02340000|582612577|FG001|Time Period 1|Lost to Follow-up|7|||
161334313|NCT02340000|582612576|FG000|Time Period 2|Withdrawal by Subject|9|||
161334314|NCT02340000|582612577|FG001|Time Period 2|Withdrawal by Subject|7|||
161334315|NCT02340000|582612576|FG000|Time Period 2|Lost to Follow-up|10|||
161334316|NCT02340000|582612577|FG001|Time Period 2|Lost to Follow-up|8|||
161334317|NCT02668640|582612578|FG000|Overall Study|Lost to Follow-up|13|||
161334318|NCT02668640|582612578|FG000|Overall Study|Other, not specified|1|||
161334319|NCT00919633|582612588|FG000|Overall Study|Adverse Event|1|||
161334320|NCT00919633|582612589|FG001|Overall Study|Adverse Event|9|||
161334321|NCT00919633|582612590|FG002|Overall Study|Adverse Event|12|||
161334322|NCT00919633|582612591|FG003|Overall Study|Adverse Event|10|||
161334323|NCT00919633|582612588|FG000|Overall Study|Death|0|||
161334324|NCT00919633|582612589|FG001|Overall Study|Death|0|||
161334325|NCT00919633|582612590|FG002|Overall Study|Death|2|||
161334326|NCT00919633|582612591|FG003|Overall Study|Death|0|||
161334327|NCT00919633|582612588|FG000|Overall Study|Lack of Efficacy|17|||
160902127|NCT01281137|581035985|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
160902128|NCT00810355|581035988|FG000|Overall Study|Lost to Follow-up|13|||
160902129|NCT00810355|581035989|FG001|Overall Study|Lost to Follow-up|17|||
161133570|NCT01628926|581872952|FG000|Overall Study|Physician Decision|2|||
160902130|NCT00810355|581035990|FG002|Overall Study|Lost to Follow-up|11|||
160902131|NCT00810355|581035988|FG000|Overall Study|Withdrawal by Subject|1|||
160902132|NCT00810355|581035989|FG001|Overall Study|Withdrawal by Subject|0|||
160902133|NCT00810355|581035990|FG002|Overall Study|Withdrawal by Subject|0|||
160902134|NCT00657358|581035991|FG000|Overall Study|Lack of Efficacy|6|||
160902135|NCT00400764|581035992|FG000|Phase Ib|Adverse Event|1|||
160902136|NCT00400764|581035993|FG001|Phase Ib|Adverse Event|0|||
160902137|NCT00400764|581035994|FG002|Phase Ib|Adverse Event|0|||
160902138|NCT00400764|581035995|FG003|Phase Ib|Adverse Event|0|||
160902139|NCT00400764|581035996|FG004|Phase Ib|Adverse Event|0|||
160902140|NCT00400764|581035992|FG000|Phase Ib|Death|1|||
160902141|NCT00400764|581035993|FG001|Phase Ib|Death|0|||
161133571|NCT01628926|581872953|FG001|Overall Study|Physician Decision|2|||
161133572|NCT01628926|581872954|FG002|Overall Study|Physician Decision|1|||
161133573|NCT01412229|581872955|FG000|Overall Study|Physician Decision|1|||
161133574|NCT04373460|581872956|FG000|Overall Study|Did not receive tranfusion|18|||
161133575|NCT04373460|581872957|FG001|Overall Study|Did not receive tranfusion|26|||
161133576|NCT00454207|581872958|FG000|Overall Study|Adverse Event|3|||
161133577|NCT00454207|581872959|FG001|Overall Study|Adverse Event|1|||
161133578|NCT00454207|581872958|FG000|Overall Study|Lack of Efficacy|1|||
161133579|NCT00454207|581872959|FG001|Overall Study|Lack of Efficacy|0|||
161133580|NCT00454207|581872958|FG000|Overall Study|Protocol Violation|0|||
161133581|NCT00454207|581872959|FG001|Overall Study|Protocol Violation|1|||
161133582|NCT01672957|581872960|FG000|Overall Study|Protocol Violation|48|||
161133583|NCT01672957|581872960|FG000|Overall Study|Death|2|||
161133584|NCT01672957|581872960|FG000|Overall Study|ICF Signed After Transplantation|5|||
161133585|NCT01795547|581872963|FG000|Overall Study|Adverse Event|16|||
161133586|NCT01795547|581872964|FG001|Overall Study|Adverse Event|27|||
161133587|NCT01795547|581872963|FG000|Overall Study|Lack of Efficacy|8|||
161133588|NCT01795547|581872964|FG001|Overall Study|Lack of Efficacy|3|||
161334328|NCT00919633|582612589|FG001|Overall Study|Lack of Efficacy|3|||
161334329|NCT00919633|582612590|FG002|Overall Study|Lack of Efficacy|2|||
161334330|NCT00919633|582612591|FG003|Overall Study|Lack of Efficacy|3|||
161334331|NCT00919633|582612588|FG000|Overall Study|Withdrawal by Subject|1|||
161334332|NCT00919633|582612589|FG001|Overall Study|Withdrawal by Subject|2|||
161334333|NCT00919633|582612590|FG002|Overall Study|Withdrawal by Subject|4|||
160902142|NCT00400764|581035994|FG002|Phase Ib|Death|0|||
160902143|NCT00400764|581035995|FG003|Phase Ib|Death|0|||
161133589|NCT01795547|581872963|FG000|Overall Study|Protocol Violation|6|||
161133590|NCT01795547|581872964|FG001|Overall Study|Protocol Violation|4|||
161133591|NCT01795547|581872963|FG000|Overall Study|Lost to Follow-up|2|||
161133592|NCT01795547|581872964|FG001|Overall Study|Lost to Follow-up|5|||
161133593|NCT01795547|581872963|FG000|Overall Study|Withdrawal of consent|7|||
161133594|NCT01795547|581872964|FG001|Overall Study|Withdrawal of consent|12|||
161133595|NCT01795547|581872963|FG000|Overall Study|Not Treated|4|||
160825537|NCT03263923|580747151|FG001|Overall Study|Withdrawal by Subject|8|||
160825538|NCT03263923|580747150|FG000|Overall Study|Lost to Follow-up|15|||
160825539|NCT03263923|580747151|FG001|Overall Study|Lost to Follow-up|13|||
160825540|NCT01323270|580747152|FG000|Overall Study|Withdrawal by Subject|19|||
160825541|NCT01323270|580747153|FG001|Overall Study|Withdrawal by Subject|10|||
160825542|NCT01323270|580747152|FG000|Overall Study|Protocol Violation|9|||
160825543|NCT01323270|580747153|FG001|Overall Study|Protocol Violation|7|||
160825544|NCT01323270|580747152|FG000|Overall Study|Lost to Follow-up|4|||
160825545|NCT01323270|580747153|FG001|Overall Study|Lost to Follow-up|6|||
160825546|NCT01323270|580747152|FG000|Overall Study|Adverse Event|8|||
160825547|NCT01323270|580747153|FG001|Overall Study|Adverse Event|0|||
160825548|NCT01323270|580747152|FG000|Overall Study|Other|0|||
160825549|NCT01323270|580747153|FG001|Overall Study|Other|3|||
160825550|NCT01323270|580747152|FG000|Overall Study|Physician Decision|0|||
160825551|NCT01323270|580747153|FG001|Overall Study|Physician Decision|2|||
160825552|NCT01323270|580747152|FG000|Overall Study|Not eligible|1|||
160825553|NCT01323270|580747153|FG001|Overall Study|Not eligible|1|||
160825554|NCT01323270|580747152|FG000|Overall Study|Death|1|||
160825555|NCT01323270|580747153|FG001|Overall Study|Death|0|||
160825556|NCT01323270|580747152|FG000|Overall Study|Randomized, but not vaccinated|1|||
160825557|NCT01323270|580747153|FG001|Overall Study|Randomized, but not vaccinated|0|||
160825558|NCT00246025|580747154|FG000|Overall Study|Adverse Event|7|||
160825559|NCT00246025|580747155|FG001|Overall Study|Adverse Event|9|||
160825560|NCT00246025|580747156|FG002|Overall Study|Adverse Event|9|||
160825561|NCT00246025|580747157|FG003|Overall Study|Adverse Event|10|||
160825562|NCT00246025|580747154|FG000|Overall Study|Withdrawal by Subject|3|||
160825563|NCT00246025|580747155|FG001|Overall Study|Withdrawal by Subject|0|||
160825564|NCT00246025|580747156|FG002|Overall Study|Withdrawal by Subject|1|||
160825565|NCT00246025|580747157|FG003|Overall Study|Withdrawal by Subject|2|||
160825566|NCT00246025|580747154|FG000|Overall Study|unsuitable medical history was found|0|||
160825567|NCT00246025|580747155|FG001|Overall Study|unsuitable medical history was found|0|||
160825568|NCT00246025|580747156|FG002|Overall Study|unsuitable medical history was found|0|||
160825569|NCT00246025|580747157|FG003|Overall Study|unsuitable medical history was found|1|||
160825570|NCT01218100|580747160|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
160825571|NCT01218100|580747161|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
160825572|NCT01218100|580747162|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
160825573|NCT01218100|580747163|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
160825574|NCT01218100|580747160|FG000|Overall Study|Adverse Event|4|||
160825575|NCT01218100|580747161|FG001|Overall Study|Adverse Event|6|||
160825576|NCT01218100|580747162|FG002|Overall Study|Adverse Event|6|||
160825577|NCT01218100|580747163|FG003|Overall Study|Adverse Event|7|||
160825578|NCT01218100|580747160|FG000|Overall Study|Lack of Efficacy|9|||
160825579|NCT01218100|580747161|FG001|Overall Study|Lack of Efficacy|6|||
160825580|NCT01218100|580747162|FG002|Overall Study|Lack of Efficacy|5|||
160825581|NCT01218100|580747163|FG003|Overall Study|Lack of Efficacy|12|||
160825582|NCT01218100|580747160|FG000|Overall Study|Protocol Violation|0|||
160825583|NCT01218100|580747161|FG001|Overall Study|Protocol Violation|0|||
160825584|NCT01218100|580747162|FG002|Overall Study|Protocol Violation|1|||
160825585|NCT01218100|580747163|FG003|Overall Study|Protocol Violation|1|||
160825586|NCT01218100|580747160|FG000|Overall Study|Withdrawal by Subject|5|||
160825587|NCT01218100|580747161|FG001|Overall Study|Withdrawal by Subject|2|||
160825588|NCT01218100|580747162|FG002|Overall Study|Withdrawal by Subject|6|||
160825589|NCT01218100|580747163|FG003|Overall Study|Withdrawal by Subject|7|||
160825590|NCT01218100|580747160|FG000|Overall Study|Lost to Follow-up|3|||
160825591|NCT01218100|580747161|FG001|Overall Study|Lost to Follow-up|8|||
160825592|NCT01218100|580747162|FG002|Overall Study|Lost to Follow-up|2|||
160825593|NCT01218100|580747163|FG003|Overall Study|Lost to Follow-up|1|||
160825594|NCT01218100|580747160|FG000|Overall Study|Other Reason|2|||
160825595|NCT01218100|580747161|FG001|Overall Study|Other Reason|2|||
160825596|NCT01218100|580747162|FG002|Overall Study|Other Reason|6|||
160825597|NCT01218100|580747163|FG003|Overall Study|Other Reason|4|||
160825598|NCT01118520|580747164|FG000|Overall Study|AAA repair|9|||
160825599|NCT01118520|580747165|FG001|Overall Study|AAA repair|7|||
160825600|NCT01118520|580747166|FG002|Overall Study|AAA repair|9|||
160825601|NCT01118520|580747164|FG000|Overall Study|Adverse Event|3|||
161133596|NCT01795547|581872964|FG001|Overall Study|Not Treated|10|||
160825602|NCT01118520|580747165|FG001|Overall Study|Adverse Event|3|||
160825603|NCT01118520|580747166|FG002|Overall Study|Adverse Event|3|||
160825604|NCT01118520|580747164|FG000|Overall Study|Withdrawal by Subject|8|||
160825605|NCT01118520|580747165|FG001|Overall Study|Withdrawal by Subject|13|||
160825606|NCT01118520|580747166|FG002|Overall Study|Withdrawal by Subject|8|||
160825607|NCT01170065|580747183|FG000|Overall Study|Adverse Event|17|||
160825608|NCT01170065|580747184|FG001|Overall Study|Adverse Event|50|||
160825609|NCT01170065|580747185|FG002|Overall Study|Adverse Event|10|||
160902144|NCT00400764|581035996|FG004|Phase Ib|Death|0|||
160825610|NCT01170065|580747183|FG000|Overall Study|Lost to Follow-up|1|||
160825611|NCT01170065|580747184|FG001|Overall Study|Lost to Follow-up|4|||
160825612|NCT01170065|580747185|FG002|Overall Study|Lost to Follow-up|1|||
161133597|NCT01795547|581872963|FG000|Overall Study|Non-compliance with IMP|1|||
160825613|NCT01170065|580747183|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
160825614|NCT01170065|580747184|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
160825615|NCT01170065|580747185|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
160825616|NCT01170065|580747183|FG000|Overall Study|Reason other than specified|3|||
160825617|NCT01170065|580747184|FG001|Overall Study|Reason other than specified|8|||
160825618|NCT01170065|580747185|FG002|Overall Study|Reason other than specified|3|||
160825619|NCT01170065|580747183|FG000|Overall Study|Ongoing after planned observation time|5|||
160825620|NCT01170065|580747184|FG001|Overall Study|Ongoing after planned observation time|26|||
160825621|NCT01170065|580747185|FG002|Overall Study|Ongoing after planned observation time|10|||
160825622|NCT03220581|580747186|FG000|Overall Study|Withdrawal by Subject|0|||
160825623|NCT03220581|580747187|FG001|Overall Study|Withdrawal by Subject|1|||
161241506|NCT04345653|582266034|FG000|Overall Study|Withdrawal by Subject|2|||
161241507|NCT00418938|582266035|FG000|Overall Study|Reimbursement|1|||
161241508|NCT00418938|582266036|FG001|Overall Study|Reimbursement|0|||
161241509|NCT00418938|582266035|FG000|Overall Study|Administrative decision|3|||
161241510|NCT00418938|582266036|FG001|Overall Study|Administrative decision|3|||
161241511|NCT00418938|582266035|FG000|Overall Study|Withdrawal by Subject|16|||
161241512|NCT00418938|582266036|FG001|Overall Study|Withdrawal by Subject|15|||
161241513|NCT00418938|582266035|FG000|Overall Study|Lost to Follow-up|1|||
161241514|NCT00418938|582266036|FG001|Overall Study|Lost to Follow-up|3|||
161241515|NCT00418938|582266035|FG000|Overall Study|Adverse Event|1|||
161241516|NCT00418938|582266036|FG001|Overall Study|Adverse Event|1|||
161241517|NCT00418938|582266035|FG000|Overall Study|On-going|1|||
161241518|NCT00418938|582266036|FG001|Overall Study|On-going|1|||
161241519|NCT00418938|582266035|FG000|Overall Study|Ineligibility Determined|1|||
161241520|NCT00418938|582266036|FG001|Overall Study|Ineligibility Determined|0|||
161241521|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
161241522|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
161241523|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
161241524|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
160825624|NCT03220581|580747186|FG000|Overall Study|Lost to Follow-up|3|||
160825625|NCT03220581|580747187|FG001|Overall Study|Lost to Follow-up|6|||
160825626|NCT01071200|580747188|FG000|Overall Study|Lack of ovarian response|1|||
160825627|NCT01071200|580747189|FG001|Overall Study|Lack of ovarian response|1|||
160825628|NCT01071200|580747188|FG000|Overall Study|No fertilization|4|||
160825629|NCT01071200|580747189|FG001|Overall Study|No fertilization|0|||
160825630|NCT01071200|580747188|FG000|Overall Study|No oocytes retrieved|1|||
160825631|NCT01071200|580747189|FG001|Overall Study|No oocytes retrieved|1|||
160825632|NCT01071200|580747188|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
160825633|NCT01071200|580747189|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
160825634|NCT01071200|580747188|FG000|Overall Study|No viable embryos|0|||
160825635|NCT01071200|580747189|FG001|Overall Study|No viable embryos|1|||
160825636|NCT01920893|580747192|FG000|Overall Study|Adverse Event|5|||
160825637|NCT01920893|580747193|FG001|Overall Study|Adverse Event|2|||
160825638|NCT01920893|580747192|FG000|Overall Study|Lack of Efficacy|2|||
160825639|NCT01920893|580747193|FG001|Overall Study|Lack of Efficacy|0|||
160825640|NCT03883113|580747194|FG000|Overall Study|Physician Decision|4|||
160825641|NCT03883113|580747195|FG001|Overall Study|Physician Decision|2|||
160825642|NCT03883113|580747194|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
160825643|NCT03883113|580747195|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
160825644|NCT03883113|580747194|FG000|Overall Study|Pregnancy|1|||
160825645|NCT03883113|580747195|FG001|Overall Study|Pregnancy|0|||
160825646|NCT03883113|580747194|FG000|Overall Study|Adverse Event|0|||
160825647|NCT03883113|580747195|FG001|Overall Study|Adverse Event|1|||
161241525|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
161241526|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
161241527|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Death|9|||
161241528|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Death|7|||
161241529|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Death|14|||
161241530|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Death|7|||
161241531|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Death|0|||
161241532|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Death|0|||
160825648|NCT03883113|580747194|FG000|Overall Study|Withdrawal by Subject|1|||
160825649|NCT03883113|580747195|FG001|Overall Study|Withdrawal by Subject|2|||
160825650|NCT03883113|580747194|FG000|Overall Study|Lost to Follow-up|1|||
160825651|NCT03883113|580747195|FG001|Overall Study|Lost to Follow-up|0|||
160825652|NCT01396265|580747196|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
160825653|NCT01767493|580747197|FG000|Overall Study|screen failures|3|||
160825654|NCT03444766|580747198|FG000|Overall Study|Other Reasons|2|||
160902145|NCT00400764|581035992|FG000|Phase Ib|Disease Progression|4|||
160902146|NCT00400764|581035993|FG001|Phase Ib|Disease Progression|4|||
160902147|NCT00400764|581035994|FG002|Phase Ib|Disease Progression|0|||
161241533|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
161241534|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
161241535|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
161241536|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
160825655|NCT03444766|580747198|FG000|Overall Study|Participant Withdrew Consent|5|||
160825656|NCT03444766|580747198|FG000|Overall Study|Lost to Follow-up|2|||
160825657|NCT03444766|580747198|FG000|Overall Study|Death|2|||
160825658|NCT03444766|580747198|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
160825659|NCT03444766|580747198|FG000|Overall Study|Disease Progression|49|||
160825660|NCT03023826|580747200|FG000|Period 1|Withdrawal by Subject|0|||
160825661|NCT03023826|580747201|FG001|Period 1|Withdrawal by Subject|0|||
160825662|NCT03023826|580747202|FG002|Period 1|Withdrawal by Subject|0|||
160825663|NCT03023826|580747203|FG003|Period 1|Withdrawal by Subject|0|||
160825664|NCT03023826|580747204|FG004|Period 1|Withdrawal by Subject|1|||
160825665|NCT03023826|580747205|FG005|Period 1|Withdrawal by Subject|0|||
160825666|NCT00977938|580747206|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
160825667|NCT00977938|580747207|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
160825668|NCT00977938|580747208|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
160825669|NCT00977938|580747209|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
160825670|NCT00977938|580747206|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
160825671|NCT00977938|580747207|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
160825672|NCT00977938|580747208|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
160902148|NCT00400764|581035995|FG003|Phase Ib|Disease Progression|0|||
161241537|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
161241538|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
161241539|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Other Event|49|||
161241540|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Other Event|52|||
161241541|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Other Event|41|||
161241542|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Other Event|58|||
161241543|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Other Event|0|||
161241544|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Other Event|0|||
161241545|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
161241546|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
161241547|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
161241548|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
161241549|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
161241550|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
161241551|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
161334334|NCT00919633|582612591|FG003|Overall Study|Withdrawal by Subject|3|||
161334335|NCT00919633|582612588|FG000|Overall Study|Lost to Follow-up|3|||
160902149|NCT00400764|581035996|FG004|Phase Ib|Disease Progression|0|||
160902150|NCT00400764|581035992|FG000|Phase II|Death|0|||
160902151|NCT00400764|581035993|FG001|Phase II|Death|0|||
160902152|NCT00400764|581035994|FG002|Phase II|Death|1|||
160902153|NCT00400764|581035995|FG003|Phase II|Death|2|||
160902154|NCT00400764|581035996|FG004|Phase II|Death|0|||
160902155|NCT00400764|581035992|FG000|Phase II|Lost to Follow-up|0|||
160902156|NCT00400764|581035993|FG001|Phase II|Lost to Follow-up|0|||
160902157|NCT00400764|581035994|FG002|Phase II|Lost to Follow-up|1|||
160902158|NCT00400764|581035995|FG003|Phase II|Lost to Follow-up|0|||
160902159|NCT00400764|581035996|FG004|Phase II|Lost to Follow-up|0|||
160902160|NCT00400764|581035992|FG000|Phase II|Physician Decision|0|||
160902161|NCT00400764|581035993|FG001|Phase II|Physician Decision|0|||
160902162|NCT00400764|581035994|FG002|Phase II|Physician Decision|1|||
160902163|NCT00400764|581035995|FG003|Phase II|Physician Decision|1|||
160902164|NCT00400764|581035996|FG004|Phase II|Physician Decision|0|||
160902165|NCT00400764|581035992|FG000|Phase II|Sponsor's decision to terminate|0|||
160902166|NCT00400764|581035993|FG001|Phase II|Sponsor's decision to terminate|0|||
160902167|NCT00400764|581035994|FG002|Phase II|Sponsor's decision to terminate|18|||
160902168|NCT00400764|581035995|FG003|Phase II|Sponsor's decision to terminate|22|||
160902169|NCT00400764|581035996|FG004|Phase II|Sponsor's decision to terminate|11|||
160902170|NCT00400764|581035992|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
160902171|NCT00400764|581035993|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
160902172|NCT00400764|581035994|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
160902173|NCT00400764|581035995|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
160825673|NCT00977938|580747209|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
160825674|NCT00977938|580747206|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
160902174|NCT00400764|581035996|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
160902175|NCT00400764|581035992|FG000|Phase II|Withdrawal by Subject|0|||
160902176|NCT00400764|581035993|FG001|Phase II|Withdrawal by Subject|0|||
160902177|NCT00400764|581035994|FG002|Phase II|Withdrawal by Subject|1|||
160902178|NCT00400764|581035995|FG003|Phase II|Withdrawal by Subject|1|||
160989963|NCT03441360|581351706|FG000|Overall Study|Clinical disease progression|2|||
160825675|NCT00977938|580747207|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
160825676|NCT00977938|580747208|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
160902179|NCT00400764|581035996|FG004|Phase II|Withdrawal by Subject|0|||
160902180|NCT03113916|581036000|FG000|Overall Study|Withdrawal by Subject|9|||
161241552|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
161241553|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
160825677|NCT00977938|580747209|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
160825678|NCT00977938|580747206|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
160825679|NCT00977938|580747207|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
160825680|NCT00977938|580747208|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
160825681|NCT00977938|580747209|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
160825682|NCT00977938|580747206|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
160825683|NCT00977938|580747207|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
160825684|NCT00977938|580747208|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
160825685|NCT00977938|580747209|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
160825686|NCT00977938|580747206|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
160825687|NCT00977938|580747207|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
160825688|NCT00977938|580747208|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
160825689|NCT00977938|580747209|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
160825690|NCT02182440|580747221|FG000|Overall Study|Adverse Event|0|||
160825691|NCT02182440|580747222|FG001|Overall Study|Adverse Event|1|||
160825692|NCT02182440|580747223|FG002|Overall Study|Adverse Event|0|||
160825693|NCT02182440|580747224|FG003|Overall Study|Adverse Event|0|||
160825694|NCT02182440|580747221|FG000|Overall Study|Death|31|||
160825695|NCT02182440|580747222|FG001|Overall Study|Death|8|||
160825696|NCT02182440|580747223|FG002|Overall Study|Death|5|||
160825697|NCT02182440|580747224|FG003|Overall Study|Death|16|||
160825698|NCT02182440|580747221|FG000|Overall Study|Protocol Violation|0|||
160825699|NCT02182440|580747222|FG001|Overall Study|Protocol Violation|1|||
160825700|NCT02182440|580747223|FG002|Overall Study|Protocol Violation|0|||
160825701|NCT02182440|580747224|FG003|Overall Study|Protocol Violation|0|||
160825702|NCT02182440|580747221|FG000|Overall Study|Physician Decision|1|||
160825703|NCT02182440|580747222|FG001|Overall Study|Physician Decision|0|||
160825704|NCT02182440|580747223|FG002|Overall Study|Physician Decision|0|||
160825705|NCT02182440|580747224|FG003|Overall Study|Physician Decision|0|||
160825706|NCT02182440|580747221|FG000|Overall Study|Withdrawal by Subject|1|||
160825707|NCT02182440|580747222|FG001|Overall Study|Withdrawal by Subject|1|||
160825708|NCT02182440|580747223|FG002|Overall Study|Withdrawal by Subject|3|||
160825709|NCT02182440|580747224|FG003|Overall Study|Withdrawal by Subject|4|||
160825710|NCT02182440|580747221|FG000|Overall Study|different, e.g adm other hospital|12|||
160825711|NCT02182440|580747222|FG001|Overall Study|different, e.g adm other hospital|3|||
160825712|NCT02182440|580747223|FG002|Overall Study|different, e.g adm other hospital|3|||
160825713|NCT02182440|580747224|FG003|Overall Study|different, e.g adm other hospital|10|||
160825714|NCT00072293|580747225|FG000|Overall Study|Lost to Follow-up|1|||
160825715|NCT00072293|580747226|FG001|Overall Study|Lost to Follow-up|1|||
160825716|NCT00072293|580747225|FG000|Overall Study|Withdrawal by Subject|0|||
160825717|NCT00072293|580747226|FG001|Overall Study|Withdrawal by Subject|1|||
160825718|NCT02680574|580747227|FG000|Overall Study|Death|137|||
160825719|NCT02680574|580747228|FG001|Overall Study|Death|137|||
160825720|NCT02680574|580747227|FG000|Overall Study|Withdrawal by Subject|17|||
160825721|NCT02680574|580747228|FG001|Overall Study|Withdrawal by Subject|9|||
160825722|NCT02680574|580747227|FG000|Overall Study|Lost to Follow-up|4|||
160825723|NCT02680574|580747228|FG001|Overall Study|Lost to Follow-up|6|||
160825724|NCT01166958|580747229|FG000|Overall Study|Withdrawal by Subject|1|||
160902181|NCT03113916|581036001|FG001|Overall Study|Withdrawal by Subject|7|||
160902182|NCT03113916|581036000|FG000|Overall Study|Pregnancy|1|||
160902183|NCT03113916|581036001|FG001|Overall Study|Pregnancy|3|||
160902184|NCT03113916|581036000|FG000|Overall Study|Lost to Follow-up|1|||
160902185|NCT03113916|581036001|FG001|Overall Study|Lost to Follow-up|2|||
160902186|NCT01893203|581036003|FG000|Overall Study|Withdrawal by Subject|1|||
160902187|NCT01758523|581036004|FG000|Overall Study|Adverse Event|2|||
160902188|NCT01758523|581036005|FG001|Overall Study|Adverse Event|1|||
160902189|NCT01758523|581036004|FG000|Overall Study|Lack of Efficacy|4|||
160902190|NCT01758523|581036005|FG001|Overall Study|Lack of Efficacy|2|||
161133598|NCT01795547|581872964|FG001|Overall Study|Non-compliance with IMP|1|||
161133599|NCT01795547|581872963|FG000|Overall Study|Others|4|||
160825725|NCT01166958|580747230|FG001|Overall Study|Withdrawal by Subject|0|||
160825726|NCT01605227|580747231|FG000|Overall Study|Did not receive study treatment|2|||
160825727|NCT01605227|580747232|FG001|Overall Study|Did not receive study treatment|3|||
160825728|NCT01605227|580747231|FG000|Overall Study|Adverse Event|228|||
160825729|NCT01605227|580747232|FG001|Overall Study|Adverse Event|42|||
160825730|NCT01605227|580747231|FG000|Overall Study|Progressive Disease|132|||
160825731|NCT01605227|580747232|FG001|Overall Study|Progressive Disease|128|||
160902191|NCT01758523|581036004|FG000|Overall Study|Lost to Follow-up|3|||
160902192|NCT01758523|581036005|FG001|Overall Study|Lost to Follow-up|4|||
160902193|NCT01758523|581036004|FG000|Overall Study|Withdrawal by Subject|12|||
160902194|NCT01758523|581036005|FG001|Overall Study|Withdrawal by Subject|7|||
160902195|NCT00722800|581036006|FG000|Overall Study|Withdrawal by Subject|1|||
161133600|NCT01795547|581872964|FG001|Overall Study|Others|1|||
160825732|NCT01605227|580747231|FG000|Overall Study|Clinical Deterioration|227|||
160825733|NCT01605227|580747232|FG001|Overall Study|Clinical Deterioration|133|||
160902196|NCT00722800|581036007|FG001|Overall Study|Withdrawal by Subject|0|||
161133601|NCT01795547|581872963|FG000|Overall Study|Not stated|0|||
161334336|NCT00919633|582612589|FG001|Overall Study|Lost to Follow-up|1|||
160825734|NCT01605227|580747231|FG000|Overall Study|Lost to Follow-up|1|||
160825735|NCT01605227|580747232|FG001|Overall Study|Lost to Follow-up|0|||
160825736|NCT01605227|580747231|FG000|Overall Study|Protocol Violation|1|||
160825737|NCT01605227|580747232|FG001|Overall Study|Protocol Violation|0|||
160825738|NCT01605227|580747231|FG000|Overall Study|Physician Decision|9|||
160825739|NCT01605227|580747232|FG001|Overall Study|Physician Decision|7|||
161334337|NCT00919633|582612590|FG002|Overall Study|Lost to Follow-up|0|||
161334338|NCT00919633|582612591|FG003|Overall Study|Lost to Follow-up|2|||
160825740|NCT01605227|580747231|FG000|Overall Study|Withdrawal by Subject|18|||
160825741|NCT01605227|580747232|FG001|Overall Study|Withdrawal by Subject|14|||
160825742|NCT01605227|580747231|FG000|Overall Study|Sponsor Decision|2|||
160825743|NCT01605227|580747232|FG001|Overall Study|Sponsor Decision|0|||
160825744|NCT01605227|580747231|FG000|Overall Study|Started New Therapy|1|||
160825745|NCT01605227|580747232|FG001|Overall Study|Started New Therapy|0|||
160825746|NCT01605227|580747231|FG000|Overall Study|Subject Decision|0|||
160825747|NCT01605227|580747232|FG001|Overall Study|Subject Decision|1|||
160825748|NCT01605227|580747231|FG000|Overall Study|Dose Held >6 weeks|0|||
160825749|NCT01605227|580747232|FG001|Overall Study|Dose Held >6 weeks|1|||
160825750|NCT01286987|580747233|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
160825751|NCT01286987|580747234|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
160825752|NCT01286987|580747235|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
160825753|NCT01286987|580747236|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
160825754|NCT01286987|580747237|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
160825755|NCT01286987|580747238|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
160825756|NCT01286987|580747239|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
160825757|NCT01286987|580747240|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
160825758|NCT01286987|580747241|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
160825759|NCT01286987|580747242|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
160825760|NCT01286987|580747243|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
160825761|NCT01286987|580747244|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
160825762|NCT01286987|580747245|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
160825763|NCT01286987|580747246|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
160825764|NCT01286987|580747247|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
160825765|NCT01286987|580747233|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
160825766|NCT01286987|580747234|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
160825767|NCT01286987|580747235|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
160825768|NCT01286987|580747236|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
160825769|NCT01286987|580747237|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
160825770|NCT01286987|580747238|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
160825771|NCT01286987|580747239|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
160825772|NCT01286987|580747240|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
160902197|NCT00722800|581036006|FG000|Overall Study|Physician Decision|1|||
160902198|NCT00722800|581036007|FG001|Overall Study|Physician Decision|0|||
160902199|NCT04729621|581036008|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
160902200|NCT04729621|581036009|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
160902201|NCT04729621|581036010|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
160902202|NCT04729621|581036011|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
160902203|NCT04729621|581036012|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
160902204|NCT04729621|581036008|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
160902205|NCT04729621|581036009|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
160902206|NCT04729621|581036010|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
160902207|NCT04729621|581036011|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
160902208|NCT04729621|581036012|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
160902209|NCT04729621|581036008|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
160902210|NCT04729621|581036009|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
161133602|NCT01795547|581872964|FG001|Overall Study|Not stated|1|||
161133603|NCT00642642|581872968|FG000|Treatment & Follow Up|Adverse Event|2|||
161133604|NCT00642642|581872968|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
161133605|NCT00642642|581872968|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
160825773|NCT01286987|580747241|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
160825774|NCT01286987|580747242|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
160825775|NCT01286987|580747243|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
160825776|NCT01286987|580747244|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
161133606|NCT02116621|581872969|FG000|Baseline|Withdrawal by Subject|0|||
161133607|NCT02116621|581872970|FG001|Baseline|Withdrawal by Subject|4|||
161133608|NCT02116621|581872969|FG000|Three Month Follow-up|Death|1|||
161133609|NCT02116621|581872970|FG001|Three Month Follow-up|Death|1|||
161133610|NCT02116621|581872969|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
161133611|NCT02116621|581872970|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
161133612|NCT02116621|581872969|FG000|Three Month Follow-up|Lost to Follow-up|0|||
161133613|NCT02116621|581872970|FG001|Three Month Follow-up|Lost to Follow-up|1|||
160825777|NCT01286987|580747245|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
160825778|NCT01286987|580747246|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
160825779|NCT01286987|580747247|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
160825780|NCT01286987|580747233|FG000|Part 1: Dose Escalation|Physician Decision|0|||
160825781|NCT01286987|580747234|FG001|Part 1: Dose Escalation|Physician Decision|0|||
160825782|NCT01286987|580747235|FG002|Part 1: Dose Escalation|Physician Decision|0|||
160825783|NCT01286987|580747236|FG003|Part 1: Dose Escalation|Physician Decision|0|||
160825784|NCT01286987|580747237|FG004|Part 1: Dose Escalation|Physician Decision|1|||
160825785|NCT01286987|580747238|FG005|Part 1: Dose Escalation|Physician Decision|0|||
160825786|NCT01286987|580747239|FG006|Part 1: Dose Escalation|Physician Decision|0|||
160825787|NCT01286987|580747240|FG007|Part 1: Dose Escalation|Physician Decision|0|||
160825788|NCT01286987|580747241|FG008|Part 1: Dose Escalation|Physician Decision|0|||
160825789|NCT01286987|580747242|FG009|Part 1: Dose Escalation|Physician Decision|0|||
160825790|NCT01286987|580747243|FG010|Part 1: Dose Escalation|Physician Decision|0|||
160825791|NCT01286987|580747244|FG011|Part 1: Dose Escalation|Physician Decision|0|||
160825792|NCT01286987|580747245|FG012|Part 1: Dose Escalation|Physician Decision|0|||
160825793|NCT01286987|580747246|FG013|Part 1: Dose Escalation|Physician Decision|0|||
160825794|NCT01286987|580747247|FG014|Part 1: Dose Escalation|Physician Decision|0|||
160825795|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Death|0|||
160825796|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Death|0|||
160825797|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Death|0|||
160825798|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Death|0|||
160825799|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Death|0|||
160825800|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Death|0|||
160825801|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Death|0|||
160825802|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Death|0|||
160825803|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Death|0|||
160825804|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Death|0|||
160825805|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Death|0|||
160825806|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Death|0|||
160825807|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Death|1|||
160825808|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Death|1|||
160825809|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Death|0|||
160825810|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Physician Decision|0|||
160825811|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Physician Decision|0|||
160825812|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Physician Decision|0|||
160825813|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Physician Decision|0|||
160825814|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Physician Decision|0|||
160825815|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Physician Decision|0|||
160825816|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Physician Decision|0|||
160825817|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Physician Decision|0|||
160825818|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Physician Decision|0|||
160825819|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Physician Decision|0|||
160825820|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Physician Decision|1|||
160825821|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Physician Decision|1|||
160825822|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Physician Decision|0|||
160825823|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Physician Decision|1|||
160825824|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Physician Decision|0|||
160825825|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Other|0|||
160825826|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Other|0|||
160825827|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Other|0|||
160825828|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Other|0|||
160825829|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Other|0|||
160825830|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Other|0|||
160825831|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Other|0|||
160825832|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Other|0|||
160825833|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Other|0|||
160825834|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Other|0|||
160825835|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Other|0|||
160825836|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Other|0|||
160825837|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Other|0|||
160825838|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Other|1|||
160825839|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Other|0|||
160825840|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
160825841|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
160825842|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
160825843|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
160825844|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
160825845|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
160825846|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
160825847|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
160825848|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
160825849|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
160825850|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
160825851|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
160825852|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
160825853|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
160825854|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
160825855|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
160825856|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
160825857|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
160825858|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
160825859|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
160825860|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
160825861|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
160825862|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
160825863|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
160825864|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
160825865|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
160825866|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
160825867|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
160825868|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
160825869|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
160825870|NCT01286987|580747233|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825871|NCT01286987|580747234|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825872|NCT01286987|580747235|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825873|NCT01286987|580747236|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825874|NCT01286987|580747237|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825875|NCT01286987|580747238|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825876|NCT01286987|580747239|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825877|NCT01286987|580747240|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825878|NCT01286987|580747241|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825879|NCT01286987|580747242|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825880|NCT01286987|580747243|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
160825881|NCT01286987|580747244|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825882|NCT01286987|580747245|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825883|NCT01286987|580747246|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825884|NCT01286987|580747247|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
160825885|NCT03093974|580747253|FG000|Overall Study|Withdrawal by Subject|32|||
160825886|NCT03093974|580747254|FG001|Overall Study|Withdrawal by Subject|27|||
160825887|NCT03093974|580747253|FG000|Overall Study|Adverse Event|17|||
160825888|NCT03093974|580747254|FG001|Overall Study|Adverse Event|24|||
160825889|NCT03093974|580747253|FG000|Overall Study|Death|0|||
160825890|NCT03093974|580747254|FG001|Overall Study|Death|1|||
160825891|NCT03093974|580747253|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160825892|NCT03093974|580747254|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160825893|NCT03093974|580747253|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
160825894|NCT03093974|580747254|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
160825895|NCT03093974|580747253|FG000|Overall Study|Lost to Follow-up|0|||
160825896|NCT03093974|580747254|FG001|Overall Study|Lost to Follow-up|1|||
160825897|NCT03093974|580747253|FG000|Overall Study|Other|1|||
160825898|NCT03093974|580747254|FG001|Overall Study|Other|2|||
160825899|NCT01009346|580747258|FG000|Overall Study|Adverse Event|4|||
160825900|NCT00033540|580747261|FG000|Overall Study|Adverse Event|14|||
160825901|NCT00033540|580747261|FG000|Overall Study|Death|1|||
160825902|NCT00033540|580747261|FG000|Overall Study|Progression|26|||
160825903|NCT00033540|580747261|FG000|Overall Study|Withdrawal by Subject|6|||
160825904|NCT00033540|580747261|FG000|Overall Study|Other|5|||
160825905|NCT00033540|580747261|FG000|Overall Study|Ineligible|3|||
160825906|NCT00033540|580747261|FG000|Overall Study|Never received treatment|2|||
160825907|NCT00405964|580747262|FG000|Overall Study|Treatment Failure|17|||
160825908|NCT00405964|580747263|FG001|Overall Study|Treatment Failure|45|||
160825909|NCT00405964|580747262|FG000|Overall Study|Adverse Event|7|||
160825910|NCT00405964|580747263|FG001|Overall Study|Adverse Event|16|||
160825911|NCT00405964|580747262|FG000|Overall Study|Lost to Follow-up|5|||
160825912|NCT00405964|580747263|FG001|Overall Study|Lost to Follow-up|5|||
160825913|NCT00405964|580747262|FG000|Overall Study|Withdrawal by Subject|19|||
160989964|NCT03441360|581351707|FG001|Overall Study|Clinical disease progression|2|||
160989965|NCT03441360|581351708|FG002|Overall Study|Clinical disease progression|0|||
160989966|NCT03441360|581351706|FG000|Overall Study|Adverse Event|1|||
160989967|NCT03441360|581351707|FG001|Overall Study|Adverse Event|0|||
160989968|NCT03441360|581351708|FG002|Overall Study|Adverse Event|1|||
160989969|NCT00269399|581351709|FG000|Overall Study|Lack of Efficacy|27|||
160825914|NCT00405964|580747263|FG001|Overall Study|Withdrawal by Subject|23|||
160989970|NCT00269399|581351710|FG001|Overall Study|Lack of Efficacy|10|||
161334339|NCT00919633|582612588|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
160825915|NCT00405964|580747262|FG000|Overall Study|Protocol Violation|11|||
160825916|NCT00405964|580747263|FG001|Overall Study|Protocol Violation|6|||
160825917|NCT01253265|580747266|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
160825918|NCT01253265|580747267|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825919|NCT01253265|580747268|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825920|NCT01253265|580747269|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825921|NCT01253265|580747270|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
160825922|NCT01253265|580747266|FG000|Overall Study|Withdrawal by Subject|0|||
160825923|NCT01253265|580747267|FG001|Overall Study|Withdrawal by Subject|0|||
160825924|NCT01253265|580747268|FG002|Overall Study|Withdrawal by Subject|0|||
160825925|NCT01253265|580747269|FG003|Overall Study|Withdrawal by Subject|0|||
160825926|NCT01253265|580747270|FG004|Overall Study|Withdrawal by Subject|1|||
160825927|NCT00066469|580747273|FG000|Overall Study|Death|3|||
160825928|NCT00066469|580747273|FG000|Overall Study|Lack of Efficacy|9|||
160825929|NCT00066469|580747273|FG000|Overall Study|Lost to Follow-up|1|||
160825930|NCT00066469|580747273|FG000|Overall Study|Physician Decision|1|||
160825931|NCT00066469|580747273|FG000|Overall Study|Withdrawal by Subject|1|||
160825932|NCT00066469|580747273|FG000|Overall Study|ineligible|1|||
160825933|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Death|8|||
160825934|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Death|8|||
160825935|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Death|0|||
160825936|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Death|0|||
160825937|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
160825938|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
160825939|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
160825940|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
160825941|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
160825942|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
160825943|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
160825944|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
160825945|NCT03271047|580747274|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
160825946|NCT03271047|580747275|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
160825947|NCT03271047|580747276|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
160825948|NCT03271047|580747277|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
160825949|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Other|0|||
160825950|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Other|0|||
160825951|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Other|0|||
160825952|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Other|1|||
160825953|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Death|0|||
160825954|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Death|0|||
160825955|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Death|20|||
160825956|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Death|21|||
160825957|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
160825958|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
160825959|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
160825960|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
160825961|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
160825962|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
160825963|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
160825964|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
160825965|NCT03271047|580747274|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
160825966|NCT03271047|580747275|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
160825967|NCT03271047|580747276|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
160825968|NCT03271047|580747277|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
160825969|NCT00711802|580747278|FG000|Overall Study|Not treated (no further detail)|2|||
160825970|NCT00711802|580747279|FG001|Overall Study|Not treated (no further detail)|1|||
160989971|NCT00269399|581351709|FG000|Overall Study|Adverse Event|10|||
160989972|NCT00269399|581351710|FG001|Overall Study|Adverse Event|4|||
160989973|NCT00269399|581351709|FG000|Overall Study|Withdrawal by Subject|2|||
160989974|NCT00269399|581351710|FG001|Overall Study|Withdrawal by Subject|5|||
160825971|NCT00711802|580747280|FG002|Overall Study|Not treated (no further detail)|2|||
160825972|NCT00711802|580747281|FG003|Overall Study|Not treated (no further detail)|0|||
160825973|NCT00711802|580747282|FG004|Overall Study|Not treated (no further detail)|2|||
160825974|NCT00711802|580747283|FG005|Overall Study|Not treated (no further detail)|0|||
160825975|NCT00711802|580747284|FG006|Overall Study|Not treated (no further detail)|0|||
160825976|NCT00711802|580747285|FG007|Overall Study|Not treated (no further detail)|0|||
160825977|NCT00711802|580747278|FG000|Overall Study|Adverse Event|0|||
160989975|NCT00269399|581351709|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
160989976|NCT00269399|581351710|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
160989977|NCT00269399|581351709|FG000|Overall Study|Other|0|||
161334340|NCT00919633|582612589|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
160825978|NCT00711802|580747279|FG001|Overall Study|Adverse Event|0|||
160825979|NCT00711802|580747280|FG002|Overall Study|Adverse Event|0|||
160825980|NCT00711802|580747281|FG003|Overall Study|Adverse Event|0|||
160825981|NCT00711802|580747282|FG004|Overall Study|Adverse Event|1|||
160825982|NCT00711802|580747283|FG005|Overall Study|Adverse Event|1|||
160825983|NCT00711802|580747284|FG006|Overall Study|Adverse Event|0|||
160825984|NCT00711802|580747285|FG007|Overall Study|Adverse Event|0|||
160825985|NCT00711802|580747278|FG000|Overall Study|Microbiological failure|0|||
160825986|NCT00711802|580747279|FG001|Overall Study|Microbiological failure|1|||
160825987|NCT00711802|580747280|FG002|Overall Study|Microbiological failure|0|||
160825988|NCT00711802|580747281|FG003|Overall Study|Microbiological failure|0|||
160825989|NCT00711802|580747282|FG004|Overall Study|Microbiological failure|0|||
160825990|NCT00711802|580747283|FG005|Overall Study|Microbiological failure|1|||
160825991|NCT00711802|580747284|FG006|Overall Study|Microbiological failure|0|||
160825992|NCT00711802|580747285|FG007|Overall Study|Microbiological failure|0|||
160825993|NCT00711802|580747278|FG000|Overall Study|Protocol Violation|0|||
160825994|NCT00711802|580747279|FG001|Overall Study|Protocol Violation|0|||
160825995|NCT00711802|580747280|FG002|Overall Study|Protocol Violation|0|||
160825996|NCT00711802|580747281|FG003|Overall Study|Protocol Violation|1|||
160825997|NCT00711802|580747282|FG004|Overall Study|Protocol Violation|0|||
160825998|NCT00711802|580747283|FG005|Overall Study|Protocol Violation|0|||
160825999|NCT00711802|580747284|FG006|Overall Study|Protocol Violation|0|||
160826000|NCT00711802|580747285|FG007|Overall Study|Protocol Violation|0|||
160826001|NCT00711802|580747278|FG000|Overall Study|Physician Decision|0|||
160826002|NCT00711802|580747279|FG001|Overall Study|Physician Decision|2|||
160826003|NCT00711802|580747280|FG002|Overall Study|Physician Decision|0|||
160826004|NCT00711802|580747281|FG003|Overall Study|Physician Decision|0|||
160826005|NCT00711802|580747282|FG004|Overall Study|Physician Decision|0|||
160826006|NCT00711802|580747283|FG005|Overall Study|Physician Decision|0|||
160826007|NCT00711802|580747284|FG006|Overall Study|Physician Decision|0|||
160826008|NCT00711802|580747285|FG007|Overall Study|Physician Decision|0|||
160826009|NCT00711802|580747278|FG000|Overall Study|Withdrawal by Subject|0|||
160826010|NCT00711802|580747279|FG001|Overall Study|Withdrawal by Subject|1|||
160826011|NCT00711802|580747280|FG002|Overall Study|Withdrawal by Subject|0|||
160826012|NCT00711802|580747281|FG003|Overall Study|Withdrawal by Subject|1|||
160826013|NCT00711802|580747282|FG004|Overall Study|Withdrawal by Subject|0|||
160826014|NCT00711802|580747283|FG005|Overall Study|Withdrawal by Subject|0|||
160826015|NCT00711802|580747284|FG006|Overall Study|Withdrawal by Subject|0|||
160826016|NCT00711802|580747285|FG007|Overall Study|Withdrawal by Subject|0|||
160826017|NCT00711802|580747278|FG000|Overall Study|Lost to Follow-up|0|||
160826018|NCT00711802|580747279|FG001|Overall Study|Lost to Follow-up|0|||
160826019|NCT00711802|580747280|FG002|Overall Study|Lost to Follow-up|3|||
160826020|NCT00711802|580747281|FG003|Overall Study|Lost to Follow-up|1|||
160826021|NCT00711802|580747282|FG004|Overall Study|Lost to Follow-up|10|||
160826022|NCT00711802|580747283|FG005|Overall Study|Lost to Follow-up|6|||
160826023|NCT00711802|580747284|FG006|Overall Study|Lost to Follow-up|4|||
160826024|NCT00711802|580747285|FG007|Overall Study|Lost to Follow-up|2|||
160826025|NCT00711802|580747278|FG000|Overall Study|Reason not reported|0|||
160826026|NCT00711802|580747279|FG001|Overall Study|Reason not reported|1|||
160826027|NCT00711802|580747280|FG002|Overall Study|Reason not reported|1|||
160826028|NCT00711802|580747281|FG003|Overall Study|Reason not reported|0|||
160826029|NCT00711802|580747282|FG004|Overall Study|Reason not reported|1|||
160826030|NCT00711802|580747283|FG005|Overall Study|Reason not reported|0|||
160826031|NCT00711802|580747284|FG006|Overall Study|Reason not reported|1|||
160826032|NCT00711802|580747285|FG007|Overall Study|Reason not reported|0|||
160826033|NCT03283150|580747287|FG000|Overall Study|Withdrawal by Subject|6|||
160826034|NCT03283150|580747288|FG001|Overall Study|Withdrawal by Subject|0|||
160902211|NCT04729621|581036010|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
160902212|NCT04729621|581036011|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
160902213|NCT04729621|581036012|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
161133614|NCT02116621|581872969|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
161133615|NCT02116621|581872970|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
161133616|NCT02116621|581872969|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
161133617|NCT02116621|581872970|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
161133618|NCT02116621|581872969|FG000|Six Month Follow-up|Lost to Follow-up|2|||
161133619|NCT02116621|581872970|FG001|Six Month Follow-up|Lost to Follow-up|1|||
161133620|NCT02116621|581872969|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
161133621|NCT02116621|581872970|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
161133622|NCT02116621|581872969|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
160826035|NCT03283150|580747289|FG002|Overall Study|Withdrawal by Subject|0|||
160826036|NCT00581828|580747290|FG000|Overall Study|Protocol Violation|1|||
160826037|NCT02981407|580747291|FG000|Overall Study|Withdrawal by Subject|2|||
160826038|NCT02981407|580747292|FG001|Overall Study|Withdrawal by Subject|0|||
160826039|NCT02410824|580747295|FG000|First Intervention (One Week)|Headache|0|||
160826040|NCT02410824|580747296|FG001|First Intervention (One Week)|Headache|1|||
160826041|NCT00391391|580747297|FG000|Overall Study|Adverse Event|0|||
160826042|NCT00391391|580747298|FG001|Overall Study|Adverse Event|0|||
160902214|NCT04729621|581036008|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160989978|NCT00269399|581351710|FG001|Overall Study|Other|4|||
160826043|NCT00391391|580747299|FG002|Overall Study|Adverse Event|0|||
160826044|NCT00391391|580747300|FG003|Overall Study|Adverse Event|1|||
160826045|NCT00391391|580747297|FG000|Overall Study|Lost to Follow-up|1|||
160826046|NCT00391391|580747298|FG001|Overall Study|Lost to Follow-up|3|||
160826047|NCT00391391|580747299|FG002|Overall Study|Lost to Follow-up|7|||
160826048|NCT00391391|580747300|FG003|Overall Study|Lost to Follow-up|4|||
160826049|NCT00391391|580747297|FG000|Overall Study|Protocol Violation|2|||
160826050|NCT00391391|580747298|FG001|Overall Study|Protocol Violation|3|||
160826051|NCT00391391|580747299|FG002|Overall Study|Protocol Violation|6|||
160826052|NCT00391391|580747300|FG003|Overall Study|Protocol Violation|7|||
160826053|NCT00391391|580747297|FG000|Overall Study|Withdrawal by Subject|6|||
160826054|NCT00391391|580747298|FG001|Overall Study|Withdrawal by Subject|4|||
160826055|NCT00391391|580747299|FG002|Overall Study|Withdrawal by Subject|10|||
160826056|NCT00391391|580747300|FG003|Overall Study|Withdrawal by Subject|7|||
160826057|NCT02084238|580747301|FG000|Overall Study|Lost to Follow-up|2|||
160826058|NCT02649855|580747302|FG000|Overall Study|Refused further treatment|2|||
160826059|NCT02649855|580747303|FG001|Overall Study|Refused further treatment|1|||
160826060|NCT02649855|580747304|FG002|Overall Study|Refused further treatment|1|||
160826061|NCT02649855|580747302|FG000|Overall Study|Withdrew consent|0|||
160826062|NCT02649855|580747303|FG001|Overall Study|Withdrew consent|1|||
160826063|NCT02649855|580747304|FG002|Overall Study|Withdrew consent|0|||
160826064|NCT02649855|580747302|FG000|Overall Study|Switched to alternative treatment|0|||
160826065|NCT02649855|580747303|FG001|Overall Study|Switched to alternative treatment|1|||
160826066|NCT02649855|580747304|FG002|Overall Study|Switched to alternative treatment|1|||
160826067|NCT02649855|580747302|FG000|Overall Study|Principal investigator discretion|0|||
160826068|NCT02649855|580747303|FG001|Overall Study|Principal investigator discretion|1|||
160826069|NCT02649855|580747304|FG002|Overall Study|Principal investigator discretion|1|||
160826070|NCT02649855|580747302|FG000|Overall Study|No treatment, per protocol|1|||
160826071|NCT02649855|580747303|FG001|Overall Study|No treatment, per protocol|0|||
160826072|NCT02649855|580747304|FG002|Overall Study|No treatment, per protocol|0|||
160826073|NCT02649855|580747302|FG000|Overall Study|Initiate new treatment|1|||
160826074|NCT02649855|580747303|FG001|Overall Study|Initiate new treatment|0|||
160826075|NCT02649855|580747304|FG002|Overall Study|Initiate new treatment|0|||
160826076|NCT02191605|580749160|FG000|Overall Study|Lost to Follow-up|9|||
160826077|NCT02191605|580749161|FG001|Overall Study|Lost to Follow-up|4|||
160826078|NCT02191605|580749162|FG002|Overall Study|Lost to Follow-up|7|||
160826079|NCT02191605|580749163|FG003|Overall Study|Lost to Follow-up|3|||
160826080|NCT02191605|580749164|FG004|Overall Study|Lost to Follow-up|4|||
160826081|NCT01309269|580749167|FG000|Overall Study|Adverse Event|56|||
160826082|NCT01309269|580749167|FG000|Overall Study|Withdrawal by Subject|25|||
160826083|NCT01309269|580749167|FG000|Overall Study|Lack of Acceptance|15|||
160826084|NCT01309269|580749167|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
160826085|NCT01309269|580749167|FG000|Overall Study|Kidney Transplant|25|||
160826086|NCT01309269|580749167|FG000|Overall Study|Administrative Problems|141|||
160826087|NCT01309269|580749167|FG000|Overall Study|Other|256|||
160826088|NCT01309269|580749167|FG000|Overall Study|Other|1|||
160826089|NCT01309269|580749167|FG000|Overall Study|Study Completion Data Not Recorded|95|||
160826090|NCT01309269|580749167|FG000|Overall Study|Enrolled but not Treated|107|||
160826091|NCT03647267|580749184|FG000|Overall Study|Lost to Follow-up|1|||
160826092|NCT03647267|580749185|FG001|Overall Study|Lost to Follow-up|0|||
160826093|NCT05079477|580749186|FG000|Overall Study|Lost to Follow-up|2|||
160826094|NCT05079477|580749187|FG001|Overall Study|Lost to Follow-up|0|||
160826095|NCT05079477|580749186|FG000|Overall Study|Withdrawal by Subject|1|||
160826096|NCT05079477|580749187|FG001|Overall Study|Withdrawal by Subject|0|||
160826097|NCT05079477|580749186|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
160826098|NCT05079477|580749187|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
160826099|NCT05079477|580749186|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
160826100|NCT05079477|580749187|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
160826101|NCT03131596|580749194|FG000|Overall Study|Protocol Violation|3|||
160826102|NCT03131596|580749195|FG001|Overall Study|Protocol Violation|3|||
160826103|NCT03131596|580749194|FG000|Overall Study|Lost to Follow-up|3|||
160826104|NCT03131596|580749195|FG001|Overall Study|Lost to Follow-up|0|||
160902215|NCT04729621|581036009|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
160902216|NCT04729621|581036010|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
160826105|NCT00734071|580749196|FG000|Overall Study|Adverse Event|4|||
160826106|NCT00734071|580749197|FG001|Overall Study|Adverse Event|3|||
160826107|NCT00734071|580749196|FG000|Overall Study|Lack of Efficacy|3|||
160826108|NCT00734071|580749197|FG001|Overall Study|Lack of Efficacy|1|||
160826109|NCT00734071|580749196|FG000|Overall Study|Noncompliance|2|||
160902217|NCT04729621|581036011|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
160826110|NCT00734071|580749197|FG001|Overall Study|Noncompliance|2|||
160826111|NCT00734071|580749196|FG000|Overall Study|Protocol Deviations|3|||
160826112|NCT00734071|580749197|FG001|Overall Study|Protocol Deviations|4|||
160826113|NCT00734071|580749196|FG000|Overall Study|Voluntary Withdrawal|9|||
160826114|NCT00734071|580749197|FG001|Overall Study|Voluntary Withdrawal|7|||
160826115|NCT00734071|580749196|FG000|Overall Study|Lost to Follow-up|16|||
160826116|NCT00734071|580749197|FG001|Overall Study|Lost to Follow-up|8|||
160826117|NCT00734071|580749196|FG000|Overall Study|Other|1|||
160826118|NCT00734071|580749197|FG001|Overall Study|Other|2|||
160826119|NCT03654885|580749198|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
160826120|NCT03654885|580749199|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
160826121|NCT03654885|580749198|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
160826122|NCT03654885|580749199|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
160826123|NCT03654885|580749198|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
160826124|NCT03654885|580749199|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
160826125|NCT03654885|580749198|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
160826126|NCT03654885|580749199|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
160826127|NCT03654885|580749198|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
160826128|NCT03654885|580749199|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
160826129|NCT03654885|580749198|FG000|Overall Study|Adverse Event in Study Eye|3|||
160826130|NCT03654885|580749199|FG001|Overall Study|Adverse Event in Study Eye|0|||
160826131|NCT03654885|580749198|FG000|Overall Study|Consent Withdrawn|1|||
160826132|NCT03654885|580749199|FG001|Overall Study|Consent Withdrawn|0|||
160826133|NCT03654885|580749198|FG000|Overall Study|Death|3|||
160826134|NCT03654885|580749199|FG001|Overall Study|Death|1|||
160826135|NCT03654885|580749198|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
160826136|NCT03654885|580749199|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
160826137|NCT03654885|580749198|FG000|Overall Study|Lost to Follow-up|3|||
160826138|NCT03654885|580749199|FG001|Overall Study|Lost to Follow-up|3|||
160826139|NCT05275582|580749200|FG000|Overall Study|Lost to Follow-up|1|||
160826140|NCT05275582|580749201|FG001|Overall Study|Lost to Follow-up|0|||
160826141|NCT05275582|580749200|FG000|Overall Study|Withdrawal by Subject|0|||
160826142|NCT05275582|580749201|FG001|Overall Study|Withdrawal by Subject|2|||
160826143|NCT05275582|580749200|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
160826144|NCT05275582|580749201|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
160826145|NCT05275582|580749200|FG000|Overall Study|Death|1|||
160826146|NCT05275582|580749201|FG001|Overall Study|Death|0|||
160826147|NCT05275582|580749200|FG000|Overall Study|Protocol Violation|1|||
160826148|NCT05275582|580749201|FG001|Overall Study|Protocol Violation|0|||
160826149|NCT02091284|580749204|FG000|Overall Study|Withdrawal by Subject|2|||
160826150|NCT02091284|580749205|FG001|Overall Study|Withdrawal by Subject|1|||
160826151|NCT02091284|580749204|FG000|Overall Study|unreliable data|1|||
160826152|NCT02091284|580749205|FG001|Overall Study|unreliable data|0|||
160826153|NCT03383783|580749206|FG000|Overall Study|Withdrawal by Subject|2|||
160826154|NCT01703117|580749212|FG000|Overall Study|Adverse Event|4|||
160826155|NCT01703117|580749213|FG001|Overall Study|Adverse Event|3|||
160826156|NCT01703117|580749212|FG000|Overall Study|Withdrawal by Subject|0|||
160826157|NCT01703117|580749213|FG001|Overall Study|Withdrawal by Subject|1|||
160826158|NCT00440310|580749215|FG000|Overall Study|Lost to Follow-up|4|||
160826159|NCT00440310|580749216|FG001|Overall Study|Lost to Follow-up|5|||
160826160|NCT00440310|580749215|FG000|Overall Study|Protocol Violation|0|||
160826161|NCT00440310|580749216|FG001|Overall Study|Protocol Violation|1|||
160826162|NCT00440310|580749215|FG000|Overall Study|Withdrawal by Subject|15|||
160826163|NCT00440310|580749216|FG001|Overall Study|Withdrawal by Subject|14|||
160826164|NCT00440310|580749215|FG000|Overall Study|No Reply at EOS|7|||
160826165|NCT00440310|580749216|FG001|Overall Study|No Reply at EOS|7|||
160826166|NCT00440310|580749215|FG000|Overall Study|Other|1|||
160826167|NCT00440310|580749216|FG001|Overall Study|Other|0|||
160826168|NCT00440310|580749215|FG000|Overall Study|Status Unknown|1|||
160826169|NCT00440310|580749216|FG001|Overall Study|Status Unknown|3|||
160826170|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
160826171|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
160826172|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
160826173|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
160826174|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
160826175|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
160826176|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
160826177|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
160826178|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
160826179|NCT02119156|580749217|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
160826180|NCT02119156|580749218|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
160826181|NCT02119156|580749219|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
160826182|NCT02119156|580749217|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
160826183|NCT02119156|580749218|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
160826184|NCT02119156|580749219|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
160826185|NCT02469415|580749220|FG000|Overall Study|Withdrawal by Subject|1|||
160826186|NCT02469415|580749220|FG000|Overall Study|Investigational agent placed on hold|2|||
160826187|NCT00330928|580749221|FG000|Overall Study|Lost to Follow-up|6|||
160826188|NCT00330928|580749221|FG000|Overall Study|Physician Decision|9|||
160826189|NCT00330928|580749221|FG000|Overall Study|Death|1|||
160826190|NCT00330928|580749221|FG000|Overall Study|IVUS could not be performed.|1|||
160826191|NCT03028480|580749222|FG000|Overall Study|No revisit after the first prescription date|2|||
160826192|NCT03028480|580749222|FG000|Overall Study|Did not use the drug|1|||
160826193|NCT03028480|580749222|FG000|Overall Study|Violation of the enrollment deadline|10|||
160826194|NCT03028480|580749222|FG000|Overall Study|Case report forms were not collected|21|||
160826195|NCT02403635|580749229|FG000|Overall Study|Not eligible|9|||
160826196|NCT00585221|580749233|FG000|Overall Study|Protocol Violation|8|||
160826197|NCT02229214|580749236|FG000|Overall Study|Adverse Event|2|||
160826198|NCT02229214|580749237|FG001|Overall Study|Adverse Event|0|||
160826199|NCT02229214|580749236|FG000|Overall Study|Withdrawal by Subject|4|||
160826200|NCT02229214|580749237|FG001|Overall Study|Withdrawal by Subject|0|||
160826201|NCT03305081|580749250|FG000|Overall Study|Lost to Follow-up|10|||
160826202|NCT03305081|580749251|FG001|Overall Study|Lost to Follow-up|15|||
160826203|NCT00241631|580749252|FG000|Run in (2 Weeks)|Physician Decision|3|||
160826204|NCT00241631|580749253|FG001|Run in (2 Weeks)|Physician Decision|3|||
160826205|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|sore throat|1|||
160826206|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|sore throat|0|||
160826207|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
160826208|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
160826209|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
160826210|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
160826211|NCT00241631|580749252|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
160826212|NCT00241631|580749253|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
160826213|NCT02437305|580749254|FG000|Overall Study|Lost to Follow-up|18|||
160826214|NCT02437305|580749255|FG001|Overall Study|Lost to Follow-up|12|||
160826215|NCT02446418|580749257|FG000|Overall Study|Adverse Event|4|||
160826216|NCT02446418|580749258|FG001|Overall Study|Adverse Event|8|||
160826217|NCT02446418|580749257|FG000|Overall Study|Physician Decision|5|||
160826218|NCT02446418|580749258|FG001|Overall Study|Physician Decision|1|||
160826219|NCT02446418|580749257|FG000|Overall Study|Withdrawal by Subject|3|||
160826220|NCT02446418|580749258|FG001|Overall Study|Withdrawal by Subject|3|||
160826221|NCT02446418|580749257|FG000|Overall Study|Lost to Follow-up|2|||
160826222|NCT02446418|580749258|FG001|Overall Study|Lost to Follow-up|2|||
160826223|NCT02446418|580749257|FG000|Overall Study|Protocol Violation|1|||
160826224|NCT02446418|580749258|FG001|Overall Study|Protocol Violation|2|||
160826225|NCT02446418|580749257|FG000|Overall Study|Lack of Efficacy|2|||
160826226|NCT02446418|580749258|FG001|Overall Study|Lack of Efficacy|0|||
160826227|NCT02446418|580749257|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
160826228|NCT02446418|580749258|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
160826229|NCT03421743|580749261|FG000|Overall Study|Lack of Efficacy|1|||
160826230|NCT03421743|580749262|FG001|Overall Study|Lack of Efficacy|0|||
160826231|NCT03421743|580749261|FG000|Overall Study|Adverse Event|2|||
160826232|NCT03421743|580749262|FG001|Overall Study|Adverse Event|1|||
160826233|NCT03421743|580749261|FG000|Overall Study|Withdrawal by Subject|0|||
160826234|NCT03421743|580749262|FG001|Overall Study|Withdrawal by Subject|1|||
161241554|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
160826235|NCT00435162|580749263|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
160826236|NCT00435162|580749264|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
160826237|NCT00435162|580749265|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
160826238|NCT00435162|580749266|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
160826239|NCT00435162|580749267|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
160826240|NCT00435162|580749268|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
160826241|NCT00694096|580749269|FG000|Overall Study|Withdrawal by Subject|5|||
160826242|NCT00681564|580749276|FG000|Overall Study|Lost to Follow-up|6|||
160826243|NCT00681564|580749277|FG001|Overall Study|Lost to Follow-up|6|||
160826244|NCT00681564|580749276|FG000|Overall Study|Withdrawal by Subject|0|||
160826245|NCT00681564|580749277|FG001|Overall Study|Withdrawal by Subject|1|||
160826246|NCT00681564|580749276|FG000|Overall Study|Death|0|||
160826247|NCT00681564|580749277|FG001|Overall Study|Death|1|||
160826248|NCT02078102|580749282|FG000|Overall Study|Adverse Event|1|||
160826249|NCT02078102|580749283|FG001|Overall Study|Adverse Event|0|||
160826250|NCT02078102|580749282|FG000|Overall Study|Withdrawal by Subject|1|||
160826251|NCT02078102|580749283|FG001|Overall Study|Withdrawal by Subject|0|||
160826252|NCT02078102|580749282|FG000|Overall Study|Physician Decision|0|||
160826253|NCT02078102|580749283|FG001|Overall Study|Physician Decision|1|||
160826254|NCT02185014|580749286|FG000|Overall Study|Adverse Event|18|||
160826255|NCT02185014|580749286|FG000|Overall Study|Withdrew Consent|8|||
160826256|NCT02185014|580749286|FG000|Overall Study|Lost to Follow-up|4|||
160826257|NCT02185014|580749286|FG000|Overall Study|Lack of Efficacy|14|||
160826258|NCT02185014|580749286|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
160826259|NCT02185014|580749286|FG000|Overall Study|Subject Noncompliance|1|||
160826260|NCT02185014|580749286|FG000|Overall Study|Other|4|||
160826261|NCT02141490|580749287|FG000|Overall Study|Screening failures|4|||
160826262|NCT02141490|580749288|FG001|Overall Study|Screening failures|0|||
160826263|NCT02141490|580749289|FG002|Overall Study|Screening failures|0|||
160826264|NCT01813721|580749290|FG000|Overall Study|Ineligibility determined|63|||
160826265|NCT01813721|580749290|FG000|Overall Study|Withdrawal by Subject|1|||
160826266|NCT02387164|580749291|FG000|Overall Study|Lost to Follow-up|2|||
160826267|NCT02387164|580749292|FG001|Overall Study|Lost to Follow-up|0|||
160826268|NCT02387164|580749291|FG000|Overall Study|Diagnosed|1|||
160826269|NCT02387164|580749292|FG001|Overall Study|Diagnosed|2|||
160826270|NCT02133664|580749295|FG000|Overall Study|Lost to Follow-up|2|||
160826271|NCT02133664|580749296|FG001|Overall Study|Lost to Follow-up|1|||
160826272|NCT02133664|580749295|FG000|Overall Study|Adverse Event|3|||
160826273|NCT02133664|580749296|FG001|Overall Study|Adverse Event|6|||
160826274|NCT00882908|580749298|FG000|Overall Study|Adverse Event|0|||
160826275|NCT00882908|580749299|FG001|Overall Study|Adverse Event|0|||
160826276|NCT00882908|580749300|FG002|Overall Study|Adverse Event|1|||
160826277|NCT00882908|580749301|FG003|Overall Study|Adverse Event|0|||
160826278|NCT00882908|580749302|FG004|Overall Study|Adverse Event|1|||
160826279|NCT00882908|580749298|FG000|Overall Study|Lost to Follow-up|3|||
160826280|NCT00882908|580749299|FG001|Overall Study|Lost to Follow-up|5|||
160826281|NCT00882908|580749300|FG002|Overall Study|Lost to Follow-up|3|||
160826282|NCT00882908|580749301|FG003|Overall Study|Lost to Follow-up|1|||
160826283|NCT00882908|580749302|FG004|Overall Study|Lost to Follow-up|2|||
160826284|NCT00882908|580749298|FG000|Overall Study|Protocol Violation|0|||
160826285|NCT00882908|580749299|FG001|Overall Study|Protocol Violation|1|||
160826286|NCT00882908|580749300|FG002|Overall Study|Protocol Violation|0|||
160826287|NCT00882908|580749301|FG003|Overall Study|Protocol Violation|0|||
160826288|NCT00882908|580749302|FG004|Overall Study|Protocol Violation|0|||
160826289|NCT00882908|580749298|FG000|Overall Study|Withdrawal by Subject|0|||
160826290|NCT00882908|580749299|FG001|Overall Study|Withdrawal by Subject|0|||
160826291|NCT00882908|580749300|FG002|Overall Study|Withdrawal by Subject|3|||
160826292|NCT00882908|580749301|FG003|Overall Study|Withdrawal by Subject|5|||
160826293|NCT00882908|580749302|FG004|Overall Study|Withdrawal by Subject|2|||
160826294|NCT00882908|580749298|FG000|Overall Study|Subject reached a virologic endpoint|0|||
161241555|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
161241556|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
161241557|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
161241558|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
161241559|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
161241560|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
161241561|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
161241562|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
161241563|NCT00205777|582266037|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
161241564|NCT00205777|582266038|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
161241565|NCT00205777|582266039|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
161241566|NCT00205777|582266040|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
161241567|NCT00205777|582266041|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
161241568|NCT00205777|582266042|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
161241569|NCT00205777|582266037|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
161241570|NCT00205777|582266038|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
161241571|NCT00205777|582266039|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
161241572|NCT00205777|582266040|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
161241573|NCT00205777|582266041|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
161241574|NCT00205777|582266042|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
161241575|NCT00205777|582266037|FG000|Completed Core Study, Entered SE I|Other Event|52|||
161241576|NCT00205777|582266038|FG001|Completed Core Study, Entered SE I|Other Event|46|||
161241577|NCT00205777|582266039|FG002|Completed Core Study, Entered SE I|Other Event|47|||
161241578|NCT00205777|582266040|FG003|Completed Core Study, Entered SE I|Other Event|50|||
161241579|NCT00205777|582266041|FG004|Completed Core Study, Entered SE I|Other Event|0|||
161241580|NCT00205777|582266042|FG005|Completed Core Study, Entered SE I|Other Event|0|||
161241581|NCT00205777|582266037|FG000|Study Extension I|Adverse Event|57|||
161334341|NCT00919633|582612590|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
160826295|NCT00882908|580749299|FG001|Overall Study|Subject reached a virologic endpoint|0|||
160826296|NCT00882908|580749300|FG002|Overall Study|Subject reached a virologic endpoint|0|||
160826297|NCT00882908|580749301|FG003|Overall Study|Subject reached a virologic endpoint|0|||
160826298|NCT00882908|580749302|FG004|Overall Study|Subject reached a virologic endpoint|1|||
160826299|NCT00882908|580749298|FG000|Overall Study|Study terminated in error|0|||
160826300|NCT00882908|580749299|FG001|Overall Study|Study terminated in error|0|||
160826301|NCT00882908|580749300|FG002|Overall Study|Study terminated in error|0|||
160826302|NCT00882908|580749301|FG003|Overall Study|Study terminated in error|1|||
160826303|NCT00882908|580749302|FG004|Overall Study|Study terminated in error|0|||
160826304|NCT00392808|580749303|FG000|Overall Study|Lost to Follow-up|3|||
160826305|NCT00392808|580749304|FG001|Overall Study|Lost to Follow-up|2|||
160826306|NCT00392808|580749305|FG002|Overall Study|Lost to Follow-up|1|||
160989979|NCT00269399|581351709|FG000|Overall Study|Development of exclusion criteria|0|||
160989980|NCT00269399|581351710|FG001|Overall Study|Development of exclusion criteria|1|||
160989981|NCT03439124|581351711|FG000|Overall Study|Adverse Event|2|||
160989982|NCT03439124|581351712|FG001|Overall Study|Adverse Event|0|||
160989983|NCT03439124|581351711|FG000|Overall Study|Lost to Follow-up|1|||
160989984|NCT03439124|581351712|FG001|Overall Study|Lost to Follow-up|0|||
160989985|NCT03439124|581351711|FG000|Overall Study|Other reasons|1|||
160989986|NCT03439124|581351712|FG001|Overall Study|Other reasons|0|||
160989987|NCT04353037|581351713|FG000|Overall Study|Lost to Follow-up|0|||
160989988|NCT04353037|581351714|FG001|Overall Study|Lost to Follow-up|1|||
160989989|NCT04353037|581351715|FG002|Overall Study|Lost to Follow-up|2|||
160989990|NCT04353037|581351716|FG003|Overall Study|Lost to Follow-up|3|||
160989991|NCT04353037|581351713|FG000|Overall Study|Withdrawal by Subject|0|||
160989992|NCT04353037|581351714|FG001|Overall Study|Withdrawal by Subject|2|||
160989993|NCT04353037|581351715|FG002|Overall Study|Withdrawal by Subject|3|||
160989994|NCT04353037|581351716|FG003|Overall Study|Withdrawal by Subject|5|||
160989995|NCT04353037|581351713|FG000|Overall Study|Adverse Event|0|||
160989996|NCT04353037|581351714|FG001|Overall Study|Adverse Event|0|||
160989997|NCT04353037|581351715|FG002|Overall Study|Adverse Event|2|||
160989998|NCT04353037|581351716|FG003|Overall Study|Adverse Event|0|||
160989999|NCT04353037|581351713|FG000|Overall Study|Exposure Change|0|||
161241582|NCT00205777|582266038|FG001|Study Extension I|Adverse Event|0|||
161241583|NCT00205777|582266039|FG002|Study Extension I|Adverse Event|0|||
161241584|NCT00205777|582266040|FG003|Study Extension I|Adverse Event|61|||
160990000|NCT04353037|581351714|FG001|Overall Study|Exposure Change|0|||
160990001|NCT04353037|581351715|FG002|Overall Study|Exposure Change|0|||
160990002|NCT04353037|581351716|FG003|Overall Study|Exposure Change|2|||
160990003|NCT01360840|581351718|FG000|Overall Study|Ongoing at data cut-off|10|||
160990004|NCT01360840|581351719|FG001|Overall Study|Ongoing at data cut-off|10|||
160990005|NCT01360840|581351720|FG002|Overall Study|Ongoing at data cut-off|9|||
160990006|NCT00920686|581351722|FG000|Overall Study|Lost to Follow-up|2|||
160990007|NCT00920686|581351723|FG001|Overall Study|Lost to Follow-up|3|||
160990008|NCT00920686|581351724|FG002|Overall Study|Lost to Follow-up|1|||
160990009|NCT00920686|581351722|FG000|Overall Study|Study drug dosing criteria not met|17|||
160990010|NCT00920686|581351723|FG001|Overall Study|Study drug dosing criteria not met|19|||
160990011|NCT00920686|581351724|FG002|Overall Study|Study drug dosing criteria not met|12|||
160990012|NCT03006341|581351725|FG000|Overall Study|Not linked in the EMR|25069|||
160990013|NCT03006341|581351726|FG001|Overall Study|Not linked in the EMR|67505|||
160990014|NCT03006341|581351727|FG002|Overall Study|Not linked in the EMR|30993|||
160990015|NCT03006341|581351728|FG003|Overall Study|Not linked in the EMR|10685|||
160990016|NCT00688688|581351729|FG000|Overall Study|Eligibility criterion not met|7|||
160990017|NCT00688688|581351730|FG001|Overall Study|Eligibility criterion not met|7|||
160990018|NCT00688688|581351731|FG002|Overall Study|Eligibility criterion not met|10|||
160990019|NCT00688688|581351729|FG000|Overall Study|Adverse Event|52|||
160990020|NCT00688688|581351730|FG001|Overall Study|Adverse Event|51|||
160990021|NCT00688688|581351731|FG002|Overall Study|Adverse Event|50|||
160990022|NCT00688688|581351729|FG000|Overall Study|Lack of Efficacy|34|||
160990023|NCT00688688|581351730|FG001|Overall Study|Lack of Efficacy|25|||
160990024|NCT00688688|581351731|FG002|Overall Study|Lack of Efficacy|45|||
160990025|NCT00688688|581351729|FG000|Overall Study|Withdrawal by Subject|66|||
161241585|NCT00205777|582266041|FG004|Study Extension I|Adverse Event|58|||
161241586|NCT00205777|582266042|FG005|Study Extension I|Adverse Event|0|||
161241587|NCT00205777|582266037|FG000|Study Extension I|Death|5|||
161241588|NCT00205777|582266038|FG001|Study Extension I|Death|0|||
161241589|NCT00205777|582266039|FG002|Study Extension I|Death|0|||
161241590|NCT00205777|582266040|FG003|Study Extension I|Death|1|||
161241591|NCT00205777|582266041|FG004|Study Extension I|Death|2|||
161241592|NCT00205777|582266042|FG005|Study Extension I|Death|0|||
161241593|NCT00205777|582266037|FG000|Study Extension I|Withdrawal by Subject|99|||
161241594|NCT00205777|582266038|FG001|Study Extension I|Withdrawal by Subject|0|||
161241595|NCT00205777|582266039|FG002|Study Extension I|Withdrawal by Subject|0|||
161241596|NCT00205777|582266040|FG003|Study Extension I|Withdrawal by Subject|106|||
161241597|NCT00205777|582266041|FG004|Study Extension I|Withdrawal by Subject|89|||
161334342|NCT00919633|582612591|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
161334343|NCT00919633|582612588|FG000|Overall Study|Protocol Violation|0|||
160990026|NCT00688688|581351730|FG001|Overall Study|Withdrawal by Subject|75|||
160990027|NCT00688688|581351731|FG002|Overall Study|Withdrawal by Subject|65|||
160990028|NCT00688688|581351729|FG000|Overall Study|Lost to Follow-up|14|||
161334344|NCT00919633|582612589|FG001|Overall Study|Protocol Violation|0|||
160990029|NCT00688688|581351730|FG001|Overall Study|Lost to Follow-up|7|||
160990030|NCT00688688|581351731|FG002|Overall Study|Lost to Follow-up|7|||
160990031|NCT00688688|581351729|FG000|Overall Study|Protocol Violation|6|||
160990032|NCT00688688|581351730|FG001|Overall Study|Protocol Violation|9|||
160990033|NCT00688688|581351731|FG002|Overall Study|Protocol Violation|11|||
161241598|NCT00205777|582266042|FG005|Study Extension I|Withdrawal by Subject|0|||
161241599|NCT00205777|582266037|FG000|Study Extension I|Protocol Violation|4|||
161241600|NCT00205777|582266038|FG001|Study Extension I|Protocol Violation|0|||
160990034|NCT00688688|581351729|FG000|Overall Study|Randomized but never received study drug|1|||
160990035|NCT00688688|581351730|FG001|Overall Study|Randomized but never received study drug|0|||
160990036|NCT00688688|581351731|FG002|Overall Study|Randomized but never received study drug|0|||
160990037|NCT00688688|581351729|FG000|Overall Study|Non-compliance with study procedures|5|||
160990038|NCT00688688|581351730|FG001|Overall Study|Non-compliance with study procedures|3|||
160990039|NCT00688688|581351731|FG002|Overall Study|Non-compliance with study procedures|4|||
160990040|NCT00688688|581351729|FG000|Overall Study|Taking exclusionary medications|1|||
160990041|NCT00688688|581351730|FG001|Overall Study|Taking exclusionary medications|0|||
161334345|NCT00919633|582612590|FG002|Overall Study|Protocol Violation|0|||
161334346|NCT00919633|582612591|FG003|Overall Study|Protocol Violation|1|||
161334347|NCT00919633|582612588|FG000|Overall Study|Physician Decision|0|||
161334348|NCT00919633|582612589|FG001|Overall Study|Physician Decision|0|||
161334349|NCT00919633|582612590|FG002|Overall Study|Physician Decision|0|||
161334350|NCT00919633|582612591|FG003|Overall Study|Physician Decision|1|||
161334351|NCT00919633|582612588|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
161334352|NCT00919633|582612589|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
161334353|NCT00919633|582612590|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
161334354|NCT00919633|582612591|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
161334355|NCT00919633|582612588|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
161334356|NCT00919633|582612589|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
161334357|NCT00919633|582612590|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
161334358|NCT00919633|582612591|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
161334359|NCT01526785|582612592|FG000|Overall Study|Study Terminated by Sponsor|8|||
161334360|NCT01526785|582612592|FG000|Overall Study|Death|2|||
161334361|NCT01526785|582612592|FG000|Overall Study|Physician Decision|1|||
161334362|NCT01526785|582612592|FG000|Overall Study|Withdrawal by Subject|2|||
161334363|NCT01121263|582612595|FG000|Overall Study|Death|3|||
160990042|NCT00688688|581351731|FG002|Overall Study|Taking exclusionary medications|0|||
160990043|NCT00688688|581351729|FG000|Overall Study|Site closure|0|||
160990044|NCT00688688|581351730|FG001|Overall Study|Site closure|1|||
160990045|NCT00688688|581351731|FG002|Overall Study|Site closure|0|||
160990046|NCT00688688|581351729|FG000|Overall Study|Violation of exclusion criterion|0|||
160990047|NCT00688688|581351730|FG001|Overall Study|Violation of exclusion criterion|1|||
160990048|NCT00688688|581351731|FG002|Overall Study|Violation of exclusion criterion|0|||
160990049|NCT02950545|581351732|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990050|NCT02950545|581351733|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990051|NCT02950545|581351734|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990052|NCT02950545|581351735|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990053|NCT02950545|581351736|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
160990054|NCT02950545|581351737|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
160990055|NCT02950545|581351732|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
160990056|NCT02950545|581351733|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
160990057|NCT02950545|581351734|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
161241601|NCT00205777|582266039|FG002|Study Extension I|Protocol Violation|0|||
161241602|NCT00205777|582266040|FG003|Study Extension I|Protocol Violation|8|||
161241603|NCT00205777|582266041|FG004|Study Extension I|Protocol Violation|8|||
161241604|NCT00205777|582266042|FG005|Study Extension I|Protocol Violation|0|||
161241605|NCT00205777|582266037|FG000|Study Extension I|Lack of Efficacy|0|||
161241606|NCT00205777|582266038|FG001|Study Extension I|Lack of Efficacy|0|||
161241607|NCT00205777|582266039|FG002|Study Extension I|Lack of Efficacy|0|||
161241608|NCT00205777|582266040|FG003|Study Extension I|Lack of Efficacy|1|||
161241609|NCT00205777|582266041|FG004|Study Extension I|Lack of Efficacy|2|||
161241610|NCT00205777|582266042|FG005|Study Extension I|Lack of Efficacy|0|||
161241611|NCT00205777|582266037|FG000|Study Extension I|Failed to return|15|||
161241612|NCT00205777|582266038|FG001|Study Extension I|Failed to return|0|||
161241613|NCT00205777|582266039|FG002|Study Extension I|Failed to return|0|||
161241614|NCT00205777|582266040|FG003|Study Extension I|Failed to return|17|||
161241615|NCT00205777|582266041|FG004|Study Extension I|Failed to return|13|||
161241616|NCT00205777|582266042|FG005|Study Extension I|Failed to return|0|||
161241617|NCT00205777|582266037|FG000|Study Extension I|Other Event|34|||
161241618|NCT00205777|582266038|FG001|Study Extension I|Other Event|0|||
161241619|NCT00205777|582266039|FG002|Study Extension I|Other Event|0|||
161241620|NCT00205777|582266040|FG003|Study Extension I|Other Event|34|||
161241621|NCT00205777|582266041|FG004|Study Extension I|Other Event|29|||
161241622|NCT00205777|582266042|FG005|Study Extension I|Other Event|0|||
161241623|NCT00205777|582266037|FG000|Study Extension I|Withdrawn as per protocol|0|||
161241624|NCT00205777|582266038|FG001|Study Extension I|Withdrawn as per protocol|0|||
161241625|NCT00205777|582266039|FG002|Study Extension I|Withdrawn as per protocol|1070|||
161241626|NCT00205777|582266040|FG003|Study Extension I|Withdrawn as per protocol|0|||
161241627|NCT00205777|582266041|FG004|Study Extension I|Withdrawn as per protocol|0|||
161334364|NCT01121263|582612596|FG001|Overall Study|Death|2|||
161241628|NCT00205777|582266042|FG005|Study Extension I|Withdrawn as per protocol|0|||
161241629|NCT00205777|582266037|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
161241630|NCT00205777|582266038|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161334365|NCT01121263|582612595|FG000|Overall Study|Lost to Follow-up|22|||
161334366|NCT01121263|582612596|FG001|Overall Study|Lost to Follow-up|12|||
161334367|NCT01121263|582612595|FG000|Overall Study|Withdrawal by Subject|0|||
161334368|NCT01121263|582612596|FG001|Overall Study|Withdrawal by Subject|1|||
161334369|NCT00350545|582614092|FG000|Overall Study|Withdrawal by Subject|2|||
161334370|NCT01190891|582614093|FG000|Overall Study|Protocol Violation|1|||
161334371|NCT01190891|582614094|FG001|Overall Study|Protocol Violation|0|||
161334372|NCT01190891|582614093|FG000|Overall Study|Withdrawal by Subject|5|||
161334373|NCT01190891|582614094|FG001|Overall Study|Withdrawal by Subject|0|||
161334374|NCT00301834|582614095|FG000|Overall Study|Death|1|||
161334375|NCT02737358|582614096|FG000|Overall Study|Withdrawal by Subject|7|||
161334376|NCT02737358|582614097|FG001|Overall Study|Withdrawal by Subject|12|||
161334377|NCT02737358|582614096|FG000|Overall Study|Lost to Follow-up|2|||
161334378|NCT02737358|582614097|FG001|Overall Study|Lost to Follow-up|3|||
161334379|NCT00744939|582614098|FG000|Overall Study|Withdrawal by Subject|9|||
161334380|NCT00744939|582614098|FG000|Overall Study|Protocol Violation|13|||
161334381|NCT00744939|582614098|FG000|Overall Study|Death|24|||
161334382|NCT00744939|582614098|FG000|Overall Study|distance|4|||
161334383|NCT00744939|582614098|FG000|Overall Study|Lost to Follow-up|12|||
161334384|NCT00744939|582614098|FG000|Overall Study|Medical history exclusionary|1|||
161334385|NCT00744939|582614098|FG000|Overall Study|Did not receive Magnevist|7|||
161334386|NCT00744939|582614098|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
161334387|NCT00744939|582614098|FG000|Overall Study|coma|1|||
161334388|NCT00744939|582614098|FG000|Overall Study|incorrect race|1|||
161334389|NCT00183430|582614099|FG000|Overall Study|Adverse Event|1|||
161334390|NCT00183430|582614100|FG001|Overall Study|Adverse Event|0|||
161334391|NCT00183430|582614099|FG000|Overall Study|Lost to Follow-up|3|||
161334392|NCT00183430|582614100|FG001|Overall Study|Lost to Follow-up|0|||
161334393|NCT00183430|582614099|FG000|Overall Study|did not meet inclusion criteria|1|||
161334394|NCT00183430|582614100|FG001|Overall Study|did not meet inclusion criteria|0|||
160826307|NCT00392808|580749306|FG003|Overall Study|Lost to Follow-up|2|||
160826308|NCT00392808|580749303|FG000|Overall Study|Unable to withdraw blood|3|||
160826309|NCT00392808|580749304|FG001|Overall Study|Unable to withdraw blood|1|||
160826310|NCT00392808|580749305|FG002|Overall Study|Unable to withdraw blood|1|||
160826311|NCT00392808|580749306|FG003|Overall Study|Unable to withdraw blood|2|||
160826312|NCT02436408|580749307|FG000|Overall Study|Death|1|||
160826313|NCT01038713|580749308|FG000|Overall Study|Patient to hospice|1|||
160826314|NCT01038713|580749309|FG001|Overall Study|Patient to hospice|1|||
160826315|NCT01038713|580749310|FG002|Overall Study|Patient to hospice|1|||
160826316|NCT01038713|580749308|FG000|Overall Study|Lost to Follow-up|3|||
160826317|NCT01038713|580749309|FG001|Overall Study|Lost to Follow-up|0|||
160826318|NCT01038713|580749310|FG002|Overall Study|Lost to Follow-up|0|||
160826319|NCT01038713|580749308|FG000|Overall Study|Neuroendocrine Tumor|0|||
160826320|NCT01038713|580749309|FG001|Overall Study|Neuroendocrine Tumor|1|||
160826321|NCT01038713|580749310|FG002|Overall Study|Neuroendocrine Tumor|0|||
160826322|NCT01038713|580749308|FG000|Overall Study|died from PEP|0|||
160826323|NCT01038713|580749309|FG001|Overall Study|died from PEP|1|||
160826324|NCT01038713|580749310|FG002|Overall Study|died from PEP|0|||
160826325|NCT01038713|580749308|FG000|Overall Study|Autoimmune Pancreatitis|1|||
160826326|NCT01038713|580749309|FG001|Overall Study|Autoimmune Pancreatitis|0|||
160826327|NCT01038713|580749310|FG002|Overall Study|Autoimmune Pancreatitis|0|||
160826328|NCT02818036|580749311|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
160826329|NCT02818036|580749312|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
160826330|NCT02818036|580749311|FG000|Overall Study|Withdrawal by Subject|1|||
160826331|NCT02818036|580749312|FG001|Overall Study|Withdrawal by Subject|0|||
160826332|NCT01154283|580749313|FG000|0-6 Weeks|Withdrawal by Subject|7|||
160826333|NCT01154283|580749314|FG001|0-6 Weeks|Withdrawal by Subject|2|||
160826334|NCT01154283|580749313|FG000|0-6 Weeks|Death|0|||
161334395|NCT00183430|582614099|FG000|Overall Study|Withdrawal by Subject|1|||
161334396|NCT00183430|582614100|FG001|Overall Study|Withdrawal by Subject|0|||
161334397|NCT03636256|582614109|FG000|Overall Study|Lost to Follow-up|3|||
161334398|NCT03636256|582614110|FG001|Overall Study|Lost to Follow-up|0|||
161334399|NCT03636256|582614111|FG002|Overall Study|Lost to Follow-up|2|||
161334400|NCT03636256|582614112|FG003|Overall Study|Lost to Follow-up|1|||
161334401|NCT03636256|582614113|FG004|Overall Study|Lost to Follow-up|0|||
160826335|NCT01154283|580749314|FG001|0-6 Weeks|Death|1|||
160826336|NCT01154283|580749313|FG000|7-12 Weeks|Death|1|||
160826337|NCT01154283|580749314|FG001|7-12 Weeks|Death|0|||
160826338|NCT01154283|580749313|FG000|7-12 Weeks|Withdrawal by Subject|0|||
160826339|NCT01154283|580749314|FG001|7-12 Weeks|Withdrawal by Subject|1|||
160826340|NCT03777917|580749315|FG000|Overall Study|Withdrawal by Subject|1|||
160826341|NCT03777917|580749316|FG001|Overall Study|Withdrawal by Subject|0|||
160826342|NCT03777917|580749315|FG000|Overall Study|Physician Decision|1|||
160826343|NCT03777917|580749316|FG001|Overall Study|Physician Decision|0|||
161334402|NCT03636256|582614114|FG005|Overall Study|Lost to Follow-up|4|||
160826344|NCT03777917|580749315|FG000|Overall Study|Lost to Follow-up|6|||
160826345|NCT03777917|580749316|FG001|Overall Study|Lost to Follow-up|2|||
160826346|NCT03777917|580749315|FG000|Overall Study|Other|1|||
161334403|NCT03636256|582614115|FG006|Overall Study|Lost to Follow-up|2|||
160826347|NCT03777917|580749316|FG001|Overall Study|Other|0|||
160826348|NCT00320372|580749317|FG000|Overall Study|Physician Decision|4|||
160826349|NCT00320372|580749318|FG001|Overall Study|Physician Decision|7|||
160826350|NCT00320372|580749317|FG000|Overall Study|Death|7|||
160826351|NCT00320372|580749318|FG001|Overall Study|Death|8|||
160826352|NCT00320372|580749317|FG000|Overall Study|Withdrawal by Subject|55|||
160826353|NCT00320372|580749318|FG001|Overall Study|Withdrawal by Subject|37|||
160826354|NCT00320372|580749317|FG000|Overall Study|Non-Compliance|40|||
160826355|NCT00320372|580749318|FG001|Overall Study|Non-Compliance|39|||
160826356|NCT00320372|580749317|FG000|Overall Study|Did not Meet (I/E)|3|||
160826357|NCT00320372|580749318|FG001|Overall Study|Did not Meet (I/E)|1|||
160826358|NCT00320372|580749317|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
160826359|NCT00320372|580749318|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
160826360|NCT04063787|580749319|FG000|Overall Study|Inadequate Doppler data|4|||
160826361|NCT04063787|580749319|FG000|Overall Study|Lost to Follow-up|2|||
160826362|NCT04063787|580749319|FG000|Overall Study|Death|3|||
160826363|NCT01416441|580749320|FG000|Overall Study|Lost to Follow-up|5|||
160826364|NCT01416441|580749320|FG000|Overall Study|Adverse Event|6|||
160826365|NCT01416441|580749320|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
160826366|NCT01416441|580749320|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
160826367|NCT01416441|580749320|FG000|Overall Study|Investigator Withdrew Subject|2|||
160826368|NCT01416441|580749320|FG000|Overall Study|Subject Withdrew Consent|12|||
160826369|NCT01416441|580749320|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
160826370|NCT03515941|580749330|FG000|Overall Study|Adverse Event|1|||
160826371|NCT03515941|580749331|FG001|Overall Study|Adverse Event|0|||
160826372|NCT00240110|580751758|FG000|Overall Study|Lost to Follow-up|6|||
160826373|NCT00240110|580751759|FG001|Overall Study|Lost to Follow-up|7|||
160826374|NCT00583791|580751760|FG000|Overall Study|Other|67|||
160826375|NCT00583791|580751760|FG000|Overall Study|Death|6|||
160826376|NCT00203021|580751761|FG000|Overall Study|Death|4|||
160826377|NCT00203021|580751762|FG001|Overall Study|Death|1|||
160826378|NCT00203021|580751761|FG000|Overall Study|Adverse Event|10|||
160826379|NCT00203021|580751762|FG001|Overall Study|Adverse Event|5|||
160826380|NCT00203021|580751761|FG000|Overall Study|Withdrawal by Subject|45|||
160826381|NCT00203021|580751762|FG001|Overall Study|Withdrawal by Subject|48|||
160826382|NCT00203021|580751761|FG000|Overall Study|Lost to Follow-up|9|||
160826383|NCT00203021|580751762|FG001|Overall Study|Lost to Follow-up|7|||
160826384|NCT00203021|580751761|FG000|Overall Study|Other than specified|11|||
160826385|NCT00203021|580751762|FG001|Overall Study|Other than specified|16|||
160826386|NCT02080260|580751764|FG000|Overall Study|Death|18|||
160826387|NCT02080260|580751764|FG000|Overall Study|Withdrawal by Subject|1|||
160826388|NCT05438602|580751769|FG000|Treatment (15 Days)|Adverse Event|2|||
160826389|NCT05438602|580751770|FG001|Treatment (15 Days)|Adverse Event|1|||
160826390|NCT05438602|580751771|FG002|Treatment (15 Days)|Adverse Event|3|||
160826391|NCT05438602|580751769|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
160826392|NCT05438602|580751770|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
160826393|NCT05438602|580751771|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
160826394|NCT05438602|580751769|FG000|Treatment (15 Days)|Other|0|||
160826395|NCT05438602|580751770|FG001|Treatment (15 Days)|Other|0|||
160826396|NCT05438602|580751771|FG002|Treatment (15 Days)|Other|1|||
160826397|NCT05438602|580751769|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
160826398|NCT05438602|580751770|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
160826399|NCT05438602|580751771|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
160826400|NCT05438602|580751769|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
160826401|NCT05438602|580751770|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
160826402|NCT05438602|580751771|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
160826403|NCT05438602|580751769|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
160826404|NCT05438602|580751770|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
160826405|NCT05438602|580751771|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
160902218|NCT04729621|581036012|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
160902219|NCT04729621|581036008|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902220|NCT04729621|581036009|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902221|NCT04729621|581036010|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902222|NCT04729621|581036011|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
160902223|NCT04729621|581036012|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
160902224|NCT04729621|581036008|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
160826406|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
160826407|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
160826408|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
160902225|NCT04729621|581036009|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
160902226|NCT04729621|581036010|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
160826409|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
160826410|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
160826411|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
160826412|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
160826413|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
160826414|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
160826415|NCT05438602|580751769|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
160826416|NCT05438602|580751770|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
160826417|NCT05438602|580751771|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
160826418|NCT02853435|580751772|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826419|NCT02853435|580751773|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826420|NCT02853435|580751774|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826421|NCT02853435|580751775|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826422|NCT02853435|580751776|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
160826423|NCT02853435|580751777|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
160826424|NCT03747120|580751778|FG000|Overall Study|treatment related toxicity|3|||
160826425|NCT03747120|580751779|FG001|Overall Study|treatment related toxicity|0|||
160826426|NCT03747120|580751780|FG002|Overall Study|treatment related toxicity|0|||
160826427|NCT03747120|580751778|FG000|Overall Study|Withdrawal by Subject|0|||
160826428|NCT03747120|580751779|FG001|Overall Study|Withdrawal by Subject|1|||
160826429|NCT03747120|580751780|FG002|Overall Study|Withdrawal by Subject|2|||
160826430|NCT01340937|580751783|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
160826431|NCT01340937|580751784|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
160826432|NCT01340937|580751785|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
160826433|NCT01340937|580751786|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
160826434|NCT01340937|580751783|FG000|Period 1: Infant Series|Adverse Event|0|||
160826435|NCT01340937|580751784|FG001|Period 1: Infant Series|Adverse Event|1|||
160826436|NCT01340937|580751785|FG002|Period 1: Infant Series|Adverse Event|4|||
160826437|NCT01340937|580751786|FG003|Period 1: Infant Series|Adverse Event|0|||
160826438|NCT01340937|580751783|FG000|Period 1: Infant Series|Death|2|||
160826439|NCT01340937|580751784|FG001|Period 1: Infant Series|Death|0|||
160826440|NCT01340937|580751785|FG002|Period 1: Infant Series|Death|2|||
160826441|NCT01340937|580751786|FG003|Period 1: Infant Series|Death|0|||
160826442|NCT01340937|580751783|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
160826443|NCT01340937|580751784|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
160826444|NCT01340937|580751785|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
160826445|NCT01340937|580751786|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
160826446|NCT01340937|580751783|FG000|Period 1: Infant Series|Physician Decision|2|||
160826447|NCT01340937|580751784|FG001|Period 1: Infant Series|Physician Decision|3|||
160826448|NCT01340937|580751785|FG002|Period 1: Infant Series|Physician Decision|1|||
160826449|NCT01340937|580751786|FG003|Period 1: Infant Series|Physician Decision|0|||
160826450|NCT01340937|580751783|FG000|Period 1: Infant Series|Protocol Violation|1|||
160826451|NCT01340937|580751784|FG001|Period 1: Infant Series|Protocol Violation|4|||
160826452|NCT01340937|580751785|FG002|Period 1: Infant Series|Protocol Violation|4|||
160826453|NCT01340937|580751786|FG003|Period 1: Infant Series|Protocol Violation|3|||
160826454|NCT01340937|580751783|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
160902227|NCT04729621|581036011|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
160902228|NCT04729621|581036012|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
160902229|NCT02130297|581036020|FG000|Overall Study|Lost to Follow-up|4|||
160902230|NCT00347360|581036031|FG000|Overall Study|Adverse Event|1|||
160902231|NCT00347360|581036032|FG001|Overall Study|Adverse Event|2|||
160902232|NCT00347360|581036033|FG002|Overall Study|Adverse Event|0|||
160902233|NCT00347360|581036034|FG003|Overall Study|Adverse Event|4|||
160902234|NCT00347360|581036035|FG004|Overall Study|Adverse Event|1|||
160902235|NCT00347360|581036036|FG005|Overall Study|Adverse Event|2|||
160902236|NCT00347360|581036037|FG006|Overall Study|Adverse Event|2|||
160826455|NCT01340937|580751784|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
161133623|NCT02116621|581872970|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
161133624|NCT02116621|581872969|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
161133625|NCT02116621|581872970|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
160826456|NCT01340937|580751785|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
160826457|NCT01340937|580751786|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
160826458|NCT01340937|580751783|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
160826459|NCT01340937|580751784|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
160826460|NCT01340937|580751785|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
160826461|NCT01340937|580751786|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
160826462|NCT01340937|580751783|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
160826463|NCT01340937|580751784|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
160902237|NCT00347360|581036038|FG007|Overall Study|Adverse Event|0|||
160902238|NCT00347360|581036039|FG008|Overall Study|Adverse Event|2|||
160902239|NCT00347360|581036040|FG009|Overall Study|Adverse Event|3|||
160902240|NCT00347360|581036041|FG010|Overall Study|Adverse Event|3|||
161133626|NCT02116621|581872969|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
161133627|NCT02116621|581872970|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
160826464|NCT01340937|580751785|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
160902241|NCT00347360|581036042|FG011|Overall Study|Adverse Event|1|||
160826465|NCT01340937|580751786|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
160826466|NCT01340937|580751783|FG000|Period 2: Interim Period|Adverse Event|1|||
160826467|NCT01340937|580751784|FG001|Period 2: Interim Period|Adverse Event|0|||
160826468|NCT01340937|580751785|FG002|Period 2: Interim Period|Adverse Event|1|||
160826469|NCT01340937|580751786|FG003|Period 2: Interim Period|Adverse Event|0|||
160826470|NCT01340937|580751783|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
160826471|NCT01340937|580751784|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
160826472|NCT01340937|580751785|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
160826473|NCT01340937|580751786|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
160826474|NCT01340937|580751783|FG000|Period 2: Interim Period|Physician Decision|0|||
160826475|NCT01340937|580751784|FG001|Period 2: Interim Period|Physician Decision|1|||
160826476|NCT01340937|580751785|FG002|Period 2: Interim Period|Physician Decision|1|||
160826477|NCT01340937|580751786|FG003|Period 2: Interim Period|Physician Decision|0|||
160826478|NCT01340937|580751783|FG000|Period 2: Interim Period|Protocol Violation|5|||
160826479|NCT01340937|580751784|FG001|Period 2: Interim Period|Protocol Violation|3|||
160826480|NCT01340937|580751785|FG002|Period 2: Interim Period|Protocol Violation|6|||
160826481|NCT01340937|580751786|FG003|Period 2: Interim Period|Protocol Violation|3|||
160826482|NCT01340937|580751783|FG000|Period 2: Interim Period|Technical problems|4|||
160826483|NCT01340937|580751784|FG001|Period 2: Interim Period|Technical problems|4|||
160826484|NCT01340937|580751785|FG002|Period 2: Interim Period|Technical problems|6|||
160826485|NCT01340937|580751786|FG003|Period 2: Interim Period|Technical problems|3|||
160826486|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
160826487|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
160826488|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
160826489|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
160826490|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
160826491|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
160826492|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
160826493|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
160826494|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
160826495|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
160826496|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
160826497|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
160826498|NCT01340937|580751783|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
160826499|NCT01340937|580751784|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
160826500|NCT01340937|580751785|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
160826501|NCT01340937|580751786|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
160826502|NCT01657760|580751787|FG000|Overall Study|Withdrawal by Subject|0|||
160826503|NCT01657760|580751788|FG001|Overall Study|Withdrawal by Subject|0|||
160826504|NCT01657760|580751789|FG002|Overall Study|Withdrawal by Subject|0|||
160826505|NCT01657760|580751790|FG003|Overall Study|Withdrawal by Subject|1|||
160826506|NCT01657760|580751787|FG000|Overall Study|Physician Decision|1|||
160826507|NCT01657760|580751788|FG001|Overall Study|Physician Decision|1|||
160826508|NCT01657760|580751789|FG002|Overall Study|Physician Decision|1|||
160826509|NCT01657760|580751790|FG003|Overall Study|Physician Decision|2|||
160826510|NCT00096174|580751795|FG000|Overall Study|Lack of Efficacy|9|||
160826511|NCT00096174|580751795|FG000|Overall Study|Adverse Event|15|||
160826512|NCT00096174|580751795|FG000|Overall Study|Death|6|||
160826513|NCT00096174|580751795|FG000|Overall Study|Withdrawal by Subject|15|||
160826514|NCT00096174|580751795|FG000|Overall Study|Not started protocol therapy|3|||
160826515|NCT00096174|580751795|FG000|Overall Study|Ineligible|6|||
160826516|NCT00096174|580751795|FG000|Overall Study|other reason|8|||
160826517|NCT02509052|580751803|FG000|Overall Study|Non compliance|0|||
160826518|NCT02509052|580751804|FG001|Overall Study|Non compliance|0|||
161241631|NCT00205777|582266039|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
160826519|NCT02509052|580751805|FG002|Overall Study|Non compliance|1|||
160826520|NCT03554772|580751808|FG000|Overall Study|Lost to Follow-up|0|||
160826521|NCT03554772|580751809|FG001|Overall Study|Lost to Follow-up|0|||
160826522|NCT03554772|580751810|FG002|Overall Study|Lost to Follow-up|0|||
160826523|NCT03554772|580751811|FG003|Overall Study|Lost to Follow-up|2|||
160826524|NCT03362931|580751813|FG000|Overall Study|Adverse Event|1|||
160826525|NCT03362931|580751813|FG000|Overall Study|Death|2|||
160826526|NCT01998893|580751814|FG000|Overall Study|Adverse Event|2|||
160826527|NCT01998893|580751814|FG000|Overall Study|Death|1|||
160826528|NCT01998893|580751814|FG000|Overall Study|Lost to Follow-up|8|||
161241632|NCT00205777|582266040|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
160826529|NCT01998893|580751814|FG000|Overall Study|Physician Decision|2|||
160826530|NCT01998893|580751814|FG000|Overall Study|Protocol Violation|2|||
160826531|NCT01998893|580751814|FG000|Overall Study|Withdrawal by Subject|1|||
160826532|NCT01998893|580751814|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
160826533|NCT03276052|580751815|FG000|Overall Study|Withdrawal by Subject|5|||
160826534|NCT03276052|580751815|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
160826535|NCT05136898|580751820|FG000|Overall Study|Adverse Event|2|||
160826536|NCT01994863|580751821|FG000|Period 1|Adverse Event|4|||
160826537|NCT01994863|580751822|FG001|Period 1|Adverse Event|0|||
160826538|NCT01994863|580751821|FG000|Period 1|Withdrawal by Subject|1|||
160826539|NCT01994863|580751822|FG001|Period 1|Withdrawal by Subject|0|||
160826540|NCT01994863|580751821|FG000|Period 1|Trial stopped by sponsor|1|||
160826541|NCT01994863|580751822|FG001|Period 1|Trial stopped by sponsor|3|||
160826542|NCT01994863|580751821|FG000|Period 1|Lack of Efficacy|1|||
160826543|NCT01994863|580751822|FG001|Period 1|Lack of Efficacy|0|||
160826544|NCT01994863|580751821|FG000|Period 2|Adverse Event|0|||
160826545|NCT01994863|580751822|FG001|Period 2|Adverse Event|1|||
160826546|NCT01994863|580751821|FG000|Period 2|Lack of Efficacy|0|||
160826547|NCT01994863|580751822|FG001|Period 2|Lack of Efficacy|2|||
160826548|NCT01994863|580751821|FG000|Period 2|Withdrawal by Subject|1|||
160826549|NCT01994863|580751822|FG001|Period 2|Withdrawal by Subject|1|||
160826550|NCT03784846|580751825|FG000|Pre-COVID Study|Lost to Follow-up|3|||
160826551|NCT03784846|580751826|FG001|Pre-COVID Study|Lost to Follow-up|3|||
160826552|NCT03784846|580751827|FG002|Pre-COVID Study|Lost to Follow-up|2|||
160826553|NCT03784846|580751825|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
160826554|NCT03784846|580751826|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
160826555|NCT03784846|580751827|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
160826556|NCT03784846|580751825|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
160826557|NCT03784846|580751826|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
160826558|NCT03784846|580751827|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
160826559|NCT03784846|580751825|FG000|Post-COVID Study|Lost to Follow-up|3|||
160826560|NCT03784846|580751826|FG001|Post-COVID Study|Lost to Follow-up|5|||
160826561|NCT03784846|580751827|FG002|Post-COVID Study|Lost to Follow-up|1|||
160826562|NCT03784846|580751825|FG000|Post-COVID Study|Withdrawal by Subject|1|||
160826563|NCT03784846|580751826|FG001|Post-COVID Study|Withdrawal by Subject|2|||
160826564|NCT03784846|580751827|FG002|Post-COVID Study|Withdrawal by Subject|0|||
160826565|NCT00931723|580751828|FG000|Overall Study|Withdrawal by Subject|11|||
160826566|NCT00931723|580751829|FG001|Overall Study|Withdrawal by Subject|13|||
160826567|NCT00931723|580751828|FG000|Overall Study|Adverse Event|6|||
160826568|NCT00931723|580751829|FG001|Overall Study|Adverse Event|13|||
160826569|NCT00931723|580751828|FG000|Overall Study|Lithium found in blood|0|||
160826570|NCT00931723|580751829|FG001|Overall Study|Lithium found in blood|1|||
160826571|NCT00931723|580751828|FG000|Overall Study|Condition under investigation worsened|1|||
160826572|NCT00931723|580751829|FG001|Overall Study|Condition under investigation worsened|2|||
160826573|NCT00931723|580751828|FG000|Overall Study|Lost to Follow-up|1|||
160826574|NCT00931723|580751829|FG001|Overall Study|Lost to Follow-up|2|||
160826575|NCT00931723|580751828|FG000|Overall Study|Study-specific discontinuation criteria|1|||
160826576|NCT00931723|580751829|FG001|Overall Study|Study-specific discontinuation criteria|1|||
160826577|NCT00931723|580751828|FG000|Overall Study|Severe non-compliance to protocol|2|||
160826578|NCT00931723|580751829|FG001|Overall Study|Severe non-compliance to protocol|0|||
160826579|NCT00931723|580751828|FG000|Overall Study|Safety reasons|0|||
160826580|NCT00931723|580751829|FG001|Overall Study|Safety reasons|1|||
160826581|NCT00931723|580751828|FG000|Overall Study|Took prohibited concomitant medication|0|||
160826582|NCT00931723|580751829|FG001|Overall Study|Took prohibited concomitant medication|1|||
160826583|NCT00931723|580751828|FG000|Overall Study|Lack or insufficient theraputic response|2|||
160826584|NCT00931723|580751829|FG001|Overall Study|Lack or insufficient theraputic response|5|||
160826585|NCT00931723|580751828|FG000|Overall Study|Sponsor decision|1|||
160826586|NCT00931723|580751829|FG001|Overall Study|Sponsor decision|0|||
160902242|NCT00347360|581036043|FG012|Overall Study|Adverse Event|3|||
160902243|NCT00347360|581036044|FG013|Overall Study|Adverse Event|2|||
160902244|NCT00347360|581036045|FG014|Overall Study|Adverse Event|2|||
160902245|NCT00347360|581036031|FG000|Overall Study|Lost to Follow-up|0|||
160902246|NCT00347360|581036032|FG001|Overall Study|Lost to Follow-up|0|||
160902247|NCT00347360|581036033|FG002|Overall Study|Lost to Follow-up|0|||
160902248|NCT00347360|581036034|FG003|Overall Study|Lost to Follow-up|2|||
160902249|NCT00347360|581036035|FG004|Overall Study|Lost to Follow-up|1|||
160902250|NCT00347360|581036036|FG005|Overall Study|Lost to Follow-up|1|||
160902251|NCT00347360|581036037|FG006|Overall Study|Lost to Follow-up|0|||
160902252|NCT00347360|581036038|FG007|Overall Study|Lost to Follow-up|1|||
160902253|NCT00347360|581036039|FG008|Overall Study|Lost to Follow-up|1|||
160902254|NCT00347360|581036040|FG009|Overall Study|Lost to Follow-up|2|||
160902255|NCT00347360|581036041|FG010|Overall Study|Lost to Follow-up|0|||
160826587|NCT00931723|580751828|FG000|Overall Study|Late hospital discharge|1|||
160826588|NCT00931723|580751829|FG001|Overall Study|Late hospital discharge|0|||
160826589|NCT03054350|580751830|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
160826590|NCT03054350|580751831|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
160826591|NCT03054350|580751832|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
160826592|NCT03054350|580751833|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
160826593|NCT03054350|580751834|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
160826594|NCT03054350|580751835|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
160826595|NCT03054350|580751830|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160902256|NCT00347360|581036042|FG011|Overall Study|Lost to Follow-up|0|||
160826596|NCT03054350|580751831|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826597|NCT03054350|580751832|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
160826598|NCT03054350|580751833|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826599|NCT03054350|580751834|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826600|NCT03054350|580751835|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
160826601|NCT03054350|580751830|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
160826602|NCT03054350|580751831|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826603|NCT03054350|580751832|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826604|NCT03054350|580751833|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
160826605|NCT03054350|580751834|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826606|NCT03054350|580751835|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
160826607|NCT03054350|580751830|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826608|NCT03054350|580751831|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826609|NCT03054350|580751832|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
160826610|NCT03054350|580751833|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826611|NCT03054350|580751834|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826612|NCT03054350|580751835|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
160826613|NCT01643850|580751836|FG000|Overall Study|Withdrawal by Subject|0|||
160826614|NCT01643850|580751837|FG001|Overall Study|Withdrawal by Subject|0|||
160826615|NCT01643850|580751838|FG002|Overall Study|Withdrawal by Subject|0|||
160826616|NCT01643850|580751839|FG003|Overall Study|Withdrawal by Subject|0|||
160826617|NCT01643850|580751840|FG004|Overall Study|Withdrawal by Subject|1|||
160826618|NCT01643850|580751841|FG005|Overall Study|Withdrawal by Subject|0|||
160826619|NCT01643850|580751842|FG006|Overall Study|Withdrawal by Subject|0|||
160826620|NCT01643850|580751843|FG007|Overall Study|Withdrawal by Subject|0|||
160826621|NCT01643850|580751844|FG008|Overall Study|Withdrawal by Subject|0|||
160826622|NCT01643850|580751836|FG000|Overall Study|Lost to Follow-up|0|||
160826623|NCT01643850|580751837|FG001|Overall Study|Lost to Follow-up|0|||
160826624|NCT01643850|580751838|FG002|Overall Study|Lost to Follow-up|0|||
160826625|NCT01643850|580751839|FG003|Overall Study|Lost to Follow-up|0|||
160826626|NCT01643850|580751840|FG004|Overall Study|Lost to Follow-up|0|||
160826627|NCT01643850|580751841|FG005|Overall Study|Lost to Follow-up|0|||
160826628|NCT01643850|580751842|FG006|Overall Study|Lost to Follow-up|1|||
160826629|NCT01643850|580751843|FG007|Overall Study|Lost to Follow-up|0|||
160826630|NCT01643850|580751844|FG008|Overall Study|Lost to Follow-up|1|||
160826631|NCT01643850|580751836|FG000|Overall Study|Adverse Event|0|||
160826632|NCT01643850|580751837|FG001|Overall Study|Adverse Event|0|||
160826633|NCT01643850|580751838|FG002|Overall Study|Adverse Event|0|||
160826634|NCT01643850|580751839|FG003|Overall Study|Adverse Event|0|||
160826635|NCT01643850|580751840|FG004|Overall Study|Adverse Event|1|||
160826636|NCT01643850|580751841|FG005|Overall Study|Adverse Event|0|||
160826637|NCT01643850|580751842|FG006|Overall Study|Adverse Event|0|||
160826638|NCT01643850|580751843|FG007|Overall Study|Adverse Event|0|||
160826639|NCT01643850|580751844|FG008|Overall Study|Adverse Event|0|||
160826640|NCT01643850|580751836|FG000|Overall Study|Administrative Problems|0|||
160826641|NCT01643850|580751837|FG001|Overall Study|Administrative Problems|0|||
160826642|NCT01643850|580751838|FG002|Overall Study|Administrative Problems|1|||
160826643|NCT01643850|580751839|FG003|Overall Study|Administrative Problems|0|||
160826644|NCT01643850|580751840|FG004|Overall Study|Administrative Problems|1|||
160826645|NCT01643850|580751841|FG005|Overall Study|Administrative Problems|0|||
160826646|NCT01643850|580751842|FG006|Overall Study|Administrative Problems|0|||
160826647|NCT01643850|580751843|FG007|Overall Study|Administrative Problems|0|||
160826648|NCT01643850|580751844|FG008|Overall Study|Administrative Problems|0|||
160826649|NCT01133405|580751845|FG000|Period 1|Withdrawal by Subject|0|||
160826650|NCT01133405|580751846|FG001|Period 1|Withdrawal by Subject|1|||
160826651|NCT01133405|580751847|FG002|Period 1|Withdrawal by Subject|0|||
160826652|NCT01133405|580751848|FG003|Period 1|Withdrawal by Subject|1|||
160826653|NCT01133405|580751849|FG004|Period 1|Withdrawal by Subject|0|||
160826654|NCT01133405|580751850|FG005|Period 1|Withdrawal by Subject|1|||
161133628|NCT02116621|581872969|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
161133629|NCT02116621|581872970|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
161133630|NCT00151892|581872971|FG000|Overall Study|Lack of Efficacy|50|||
160826655|NCT01133405|580751851|FG006|Period 1|Withdrawal by Subject|0|||
160826656|NCT01133405|580751852|FG007|Period 1|Withdrawal by Subject|0|||
160826657|NCT01133405|580751853|FG008|Period 1|Withdrawal by Subject|0|||
160826658|NCT01133405|580751854|FG009|Period 1|Withdrawal by Subject|0|||
160826659|NCT01133405|580751845|FG000|Period 1|Physician Decision|0|||
160826660|NCT01133405|580751846|FG001|Period 1|Physician Decision|0|||
160826661|NCT01133405|580751847|FG002|Period 1|Physician Decision|0|||
160826662|NCT01133405|580751848|FG003|Period 1|Physician Decision|1|||
160826663|NCT01133405|580751849|FG004|Period 1|Physician Decision|0|||
160826664|NCT01133405|580751850|FG005|Period 1|Physician Decision|0|||
161133631|NCT00151892|581872972|FG001|Overall Study|Lack of Efficacy|57|||
160826665|NCT01133405|580751851|FG006|Period 1|Physician Decision|0|||
160826666|NCT01133405|580751852|FG007|Period 1|Physician Decision|0|||
160826667|NCT01133405|580751853|FG008|Period 1|Physician Decision|0|||
160826668|NCT01133405|580751854|FG009|Period 1|Physician Decision|0|||
160826669|NCT01133405|580751845|FG000|Period 1|Discontinued after randomization|1|||
160826670|NCT01133405|580751846|FG001|Period 1|Discontinued after randomization|0|||
160826671|NCT01133405|580751847|FG002|Period 1|Discontinued after randomization|0|||
160826672|NCT01133405|580751848|FG003|Period 1|Discontinued after randomization|0|||
160826673|NCT01133405|580751849|FG004|Period 1|Discontinued after randomization|0|||
160826674|NCT01133405|580751850|FG005|Period 1|Discontinued after randomization|0|||
160826675|NCT01133405|580751851|FG006|Period 1|Discontinued after randomization|1|||
160826676|NCT01133405|580751852|FG007|Period 1|Discontinued after randomization|0|||
160826677|NCT01133405|580751853|FG008|Period 1|Discontinued after randomization|0|||
160826678|NCT01133405|580751854|FG009|Period 1|Discontinued after randomization|0|||
160826679|NCT01133405|580751845|FG000|Period 1|Received drug only in period 2|0|||
160826680|NCT01133405|580751846|FG001|Period 1|Received drug only in period 2|1|||
160826681|NCT01133405|580751847|FG002|Period 1|Received drug only in period 2|0|||
160826682|NCT01133405|580751848|FG003|Period 1|Received drug only in period 2|2|||
160826683|NCT01133405|580751849|FG004|Period 1|Received drug only in period 2|0|||
160826684|NCT01133405|580751850|FG005|Period 1|Received drug only in period 2|1|||
160826685|NCT01133405|580751851|FG006|Period 1|Received drug only in period 2|0|||
160826686|NCT01133405|580751852|FG007|Period 1|Received drug only in period 2|0|||
160826687|NCT01133405|580751853|FG008|Period 1|Received drug only in period 2|0|||
160826688|NCT01133405|580751854|FG009|Period 1|Received drug only in period 2|0|||
160826689|NCT01133405|580751845|FG000|Period 1|Received drug only in period 3|0|||
160826690|NCT01133405|580751846|FG001|Period 1|Received drug only in period 3|1|||
160826691|NCT01133405|580751847|FG002|Period 1|Received drug only in period 3|1|||
160826692|NCT01133405|580751848|FG003|Period 1|Received drug only in period 3|0|||
160826693|NCT01133405|580751849|FG004|Period 1|Received drug only in period 3|0|||
160826694|NCT01133405|580751850|FG005|Period 1|Received drug only in period 3|0|||
160826695|NCT01133405|580751851|FG006|Period 1|Received drug only in period 3|0|||
160826696|NCT01133405|580751852|FG007|Period 1|Received drug only in period 3|0|||
160826697|NCT01133405|580751853|FG008|Period 1|Received drug only in period 3|0|||
160826698|NCT01133405|580751854|FG009|Period 1|Received drug only in period 3|0|||
160826699|NCT01133405|580751845|FG000|Period 2|Adverse Event|0|||
160826700|NCT01133405|580751846|FG001|Period 2|Adverse Event|0|||
160826701|NCT01133405|580751847|FG002|Period 2|Adverse Event|1|||
160826702|NCT01133405|580751848|FG003|Period 2|Adverse Event|0|||
160826703|NCT01133405|580751849|FG004|Period 2|Adverse Event|0|||
160826704|NCT01133405|580751850|FG005|Period 2|Adverse Event|0|||
160826705|NCT01133405|580751851|FG006|Period 2|Adverse Event|0|||
160826706|NCT01133405|580751852|FG007|Period 2|Adverse Event|0|||
160826707|NCT01133405|580751853|FG008|Period 2|Adverse Event|0|||
160826708|NCT01133405|580751854|FG009|Period 2|Adverse Event|0|||
160826709|NCT01133405|580751845|FG000|Period 2|Withdrawal by Subject|0|||
160826710|NCT01133405|580751846|FG001|Period 2|Withdrawal by Subject|0|||
160826711|NCT01133405|580751847|FG002|Period 2|Withdrawal by Subject|0|||
160826712|NCT01133405|580751848|FG003|Period 2|Withdrawal by Subject|1|||
160826713|NCT01133405|580751849|FG004|Period 2|Withdrawal by Subject|0|||
160826714|NCT01133405|580751850|FG005|Period 2|Withdrawal by Subject|1|||
160826715|NCT01133405|580751851|FG006|Period 2|Withdrawal by Subject|0|||
160826716|NCT01133405|580751852|FG007|Period 2|Withdrawal by Subject|0|||
160826717|NCT01133405|580751853|FG008|Period 2|Withdrawal by Subject|0|||
160826718|NCT01133405|580751854|FG009|Period 2|Withdrawal by Subject|0|||
160826719|NCT01133405|580751845|FG000|Period 2|Entry Criteria Not Met|0|||
160902257|NCT00347360|581036043|FG012|Overall Study|Lost to Follow-up|1|||
161241633|NCT00205777|582266041|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
161241634|NCT00205777|582266042|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
161241635|NCT00205777|582266037|FG000|Study Extension II|Adverse Event|0|||
161241636|NCT00205777|582266038|FG001|Study Extension II|Adverse Event|0|||
161241637|NCT00205777|582266039|FG002|Study Extension II|Adverse Event|0|||
161241638|NCT00205777|582266040|FG003|Study Extension II|Adverse Event|14|||
160826720|NCT01133405|580751846|FG001|Period 2|Entry Criteria Not Met|1|||
160826721|NCT01133405|580751847|FG002|Period 2|Entry Criteria Not Met|0|||
160826722|NCT01133405|580751848|FG003|Period 2|Entry Criteria Not Met|0|||
160826723|NCT01133405|580751849|FG004|Period 2|Entry Criteria Not Met|0|||
160826724|NCT01133405|580751850|FG005|Period 2|Entry Criteria Not Met|0|||
160826725|NCT01133405|580751851|FG006|Period 2|Entry Criteria Not Met|0|||
160826726|NCT01133405|580751852|FG007|Period 2|Entry Criteria Not Met|0|||
160826727|NCT01133405|580751853|FG008|Period 2|Entry Criteria Not Met|0|||
160826728|NCT01133405|580751854|FG009|Period 2|Entry Criteria Not Met|0|||
160826729|NCT01133405|580751845|FG000|Period 2|Physician Decision|0|||
160826730|NCT01133405|580751846|FG001|Period 2|Physician Decision|0|||
160826731|NCT01133405|580751847|FG002|Period 2|Physician Decision|0|||
160826732|NCT01133405|580751848|FG003|Period 2|Physician Decision|0|||
160826733|NCT01133405|580751849|FG004|Period 2|Physician Decision|0|||
160826734|NCT01133405|580751850|FG005|Period 2|Physician Decision|1|||
160826735|NCT01133405|580751851|FG006|Period 2|Physician Decision|0|||
160826736|NCT01133405|580751852|FG007|Period 2|Physician Decision|0|||
160826737|NCT01133405|580751853|FG008|Period 2|Physician Decision|0|||
160826738|NCT01133405|580751854|FG009|Period 2|Physician Decision|0|||
160826739|NCT00867087|580751857|FG000|Overall Study|Other|1|||
160826740|NCT00867087|580751857|FG000|Overall Study|Withdrawal by Subject|4|||
160826741|NCT00867087|580751857|FG000|Overall Study|Death|37|||
160826742|NCT03300024|580751858|FG000|Overall Study|Physician Decision|4|||
160826743|NCT03300024|580751859|FG001|Overall Study|Physician Decision|6|||
160826744|NCT02370641|580751860|FG000|Overall Study|dropped study|4|||
160826745|NCT02370641|580751861|FG001|Overall Study|dropped study|2|||
160826746|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
160826747|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
160826748|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
160826749|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
160826750|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
160826751|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
160826752|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
160826753|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
160826754|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
160826755|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
160826756|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
160826757|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
160826758|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
160826759|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
160826760|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
160826761|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
160826762|NCT03906656|580751862|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
160826763|NCT03906656|580751863|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
160826764|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
160826765|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
160826766|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
160826767|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
160826768|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
160826769|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
160826770|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
160826771|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
160826772|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
160826773|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
160826774|NCT03906656|580751862|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
160826775|NCT03906656|580751863|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
160826776|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
160826777|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
160826778|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
160826779|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
160826780|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Death|2|||
160826781|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Death|0|||
160826782|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
160826783|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
160826784|NCT03906656|580751862|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
160826785|NCT03906656|580751863|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
160826786|NCT01036529|580751864|FG000|Overall Study|Adverse Event|0|||
160826787|NCT01036529|580751865|FG001|Overall Study|Adverse Event|1|||
160826788|NCT01036529|580751864|FG000|Overall Study|Lost to Follow-up|0|||
160826789|NCT01036529|580751865|FG001|Overall Study|Lost to Follow-up|1|||
160826790|NCT01036529|580751864|FG000|Overall Study|Physician Decision|1|||
160826791|NCT01036529|580751865|FG001|Overall Study|Physician Decision|0|||
160826792|NCT01036529|580751864|FG000|Overall Study|Withdrawal by Subject|1|||
160826793|NCT01036529|580751865|FG001|Overall Study|Withdrawal by Subject|1|||
160826794|NCT01036529|580751864|FG000|Overall Study|Sponsor study termination|11|||
160826795|NCT01036529|580751865|FG001|Overall Study|Sponsor study termination|12|||
160826796|NCT00541099|580751868|FG000|Overall Study|Ineligible|3|||
160826797|NCT00343915|580751869|FG000|Primary Study|Withdrawal by Subject|1|||
160826798|NCT00343915|580751870|FG001|Primary Study|Withdrawal by Subject|0|||
160826799|NCT00343915|580751869|FG000|Primary Study|Lost to Follow-up|2|||
160826800|NCT00343915|580751870|FG001|Primary Study|Lost to Follow-up|3|||
160826801|NCT00343915|580751869|FG000|Primary Study|Other|1|||
160826802|NCT00343915|580751870|FG001|Primary Study|Other|0|||
160826803|NCT01719003|580751874|FG000|Overall Study|Non compliant with protocol|1|||
160826804|NCT01719003|580751875|FG001|Overall Study|Non compliant with protocol|1|||
160826805|NCT01719003|580751876|FG002|Overall Study|Non compliant with protocol|0|||
160826806|NCT01719003|580751877|FG003|Overall Study|Non compliant with protocol|1|||
160826807|NCT01719003|580751878|FG004|Overall Study|Non compliant with protocol|2|||
160826808|NCT01719003|580751879|FG005|Overall Study|Non compliant with protocol|1|||
160826809|NCT01719003|580751880|FG006|Overall Study|Non compliant with protocol|2|||
160826810|NCT01719003|580751881|FG007|Overall Study|Non compliant with protocol|3|||
160826811|NCT01719003|580751882|FG008|Overall Study|Non compliant with protocol|0|||
160826812|NCT01719003|580751874|FG000|Overall Study|Adverse Event|6|||
160826813|NCT01719003|580751875|FG001|Overall Study|Adverse Event|5|||
160826814|NCT01719003|580751876|FG002|Overall Study|Adverse Event|4|||
160826815|NCT01719003|580751877|FG003|Overall Study|Adverse Event|3|||
160826816|NCT01719003|580751878|FG004|Overall Study|Adverse Event|4|||
160826817|NCT01719003|580751879|FG005|Overall Study|Adverse Event|3|||
160826818|NCT01719003|580751880|FG006|Overall Study|Adverse Event|6|||
160826819|NCT01719003|580751881|FG007|Overall Study|Adverse Event|5|||
160826820|NCT01719003|580751882|FG008|Overall Study|Adverse Event|0|||
160826821|NCT01719003|580751874|FG000|Overall Study|Lost to Follow-up|0|||
160826822|NCT01719003|580751875|FG001|Overall Study|Lost to Follow-up|6|||
160826823|NCT01719003|580751876|FG002|Overall Study|Lost to Follow-up|7|||
160826824|NCT01719003|580751877|FG003|Overall Study|Lost to Follow-up|2|||
160826825|NCT01719003|580751878|FG004|Overall Study|Lost to Follow-up|3|||
160826826|NCT01719003|580751879|FG005|Overall Study|Lost to Follow-up|4|||
160826827|NCT01719003|580751880|FG006|Overall Study|Lost to Follow-up|3|||
160826828|NCT01719003|580751881|FG007|Overall Study|Lost to Follow-up|2|||
160826829|NCT01719003|580751882|FG008|Overall Study|Lost to Follow-up|2|||
160826830|NCT01719003|580751874|FG000|Overall Study|Refusal to continue, not due to AE|2|||
160826831|NCT01719003|580751875|FG001|Overall Study|Refusal to continue, not due to AE|5|||
160826832|NCT01719003|580751876|FG002|Overall Study|Refusal to continue, not due to AE|4|||
160826833|NCT01719003|580751877|FG003|Overall Study|Refusal to continue, not due to AE|4|||
160826834|NCT01719003|580751878|FG004|Overall Study|Refusal to continue, not due to AE|4|||
160826835|NCT01719003|580751879|FG005|Overall Study|Refusal to continue, not due to AE|3|||
160826836|NCT01719003|580751880|FG006|Overall Study|Refusal to continue, not due to AE|8|||
160826837|NCT01719003|580751881|FG007|Overall Study|Refusal to continue, not due to AE|7|||
160826838|NCT01719003|580751882|FG008|Overall Study|Refusal to continue, not due to AE|1|||
160826839|NCT01719003|580751874|FG000|Overall Study|Reason other than those specified|0|||
160826840|NCT01719003|580751875|FG001|Overall Study|Reason other than those specified|0|||
160826841|NCT01719003|580751876|FG002|Overall Study|Reason other than those specified|2|||
160826842|NCT01719003|580751877|FG003|Overall Study|Reason other than those specified|3|||
160826843|NCT01719003|580751878|FG004|Overall Study|Reason other than those specified|4|||
160826844|NCT01719003|580751879|FG005|Overall Study|Reason other than those specified|1|||
160826845|NCT01719003|580751880|FG006|Overall Study|Reason other than those specified|0|||
160826846|NCT01719003|580751881|FG007|Overall Study|Reason other than those specified|3|||
160826847|NCT01719003|580751882|FG008|Overall Study|Reason other than those specified|1|||
160826848|NCT01719003|580751874|FG000|Overall Study|Lack of Efficacy|0|||
160826849|NCT01719003|580751875|FG001|Overall Study|Lack of Efficacy|0|||
160826850|NCT01719003|580751876|FG002|Overall Study|Lack of Efficacy|0|||
160826851|NCT01719003|580751877|FG003|Overall Study|Lack of Efficacy|0|||
160826852|NCT01719003|580751878|FG004|Overall Study|Lack of Efficacy|0|||
160826853|NCT01719003|580751879|FG005|Overall Study|Lack of Efficacy|0|||
160826854|NCT01719003|580751880|FG006|Overall Study|Lack of Efficacy|1|||
160826855|NCT01719003|580751881|FG007|Overall Study|Lack of Efficacy|0|||
160826856|NCT01719003|580751882|FG008|Overall Study|Lack of Efficacy|0|||
160826857|NCT02370095|580751883|FG000|Overall Study|Withdrawal by Subject|0|||
160826858|NCT02370095|580751884|FG001|Overall Study|Withdrawal by Subject|1|||
160826859|NCT00700102|580751885|FG000|Overall Study|Died|394|||
160826860|NCT00700102|580751886|FG001|Overall Study|Died|385|||
160826861|NCT00700102|580751885|FG000|Overall Study|Lost to Follow-up|8|||
160826862|NCT00700102|580751886|FG001|Overall Study|Lost to Follow-up|10|||
160826863|NCT01667562|580751887|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
160826864|NCT01667562|580751888|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
160826865|NCT01667562|580751887|FG000|Erlotinib Phase|Lost to Follow-up|0|||
160826866|NCT01667562|580751888|FG001|Erlotinib Phase|Lost to Follow-up|1|||
160826867|NCT01667562|580751887|FG000|Erlotinib Phase|Adverse Event|0|||
160826868|NCT01667562|580751888|FG001|Erlotinib Phase|Adverse Event|1|||
160826869|NCT01667562|580751887|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
160902258|NCT00347360|581036044|FG013|Overall Study|Lost to Follow-up|0|||
160902259|NCT00347360|581036045|FG014|Overall Study|Lost to Follow-up|0|||
160902260|NCT00347360|581036031|FG000|Overall Study|Protocol Violation|2|||
160902261|NCT00347360|581036032|FG001|Overall Study|Protocol Violation|3|||
160902262|NCT00347360|581036033|FG002|Overall Study|Protocol Violation|1|||
160902263|NCT00347360|581036034|FG003|Overall Study|Protocol Violation|2|||
160902264|NCT00347360|581036035|FG004|Overall Study|Protocol Violation|1|||
160826870|NCT01667562|580751888|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
160826871|NCT02525939|580751889|FG000|Overall Study|Lost to Follow-up|27|||
160826872|NCT02525939|580751890|FG001|Overall Study|Lost to Follow-up|24|||
160826873|NCT02525939|580751889|FG000|Overall Study|Physician Decision|0|||
160826874|NCT02525939|580751890|FG001|Overall Study|Physician Decision|1|||
160826875|NCT02525939|580751889|FG000|Overall Study|Withdrawal by Subject|24|||
160826876|NCT02525939|580751890|FG001|Overall Study|Withdrawal by Subject|39|||
160826877|NCT02525939|580751889|FG000|Overall Study|Death|180|||
160902265|NCT00347360|581036036|FG005|Overall Study|Protocol Violation|2|||
160902266|NCT00347360|581036037|FG006|Overall Study|Protocol Violation|0|||
160826878|NCT02525939|580751890|FG001|Overall Study|Death|179|||
160826879|NCT02130986|580751891|FG000|Overall Study|Withdrawal by Subject|4|||
160826880|NCT02130986|580751892|FG001|Overall Study|Withdrawal by Subject|4|||
160826881|NCT02130986|580751891|FG000|Overall Study|Lost to Follow-up|151|||
160826882|NCT02130986|580751892|FG001|Overall Study|Lost to Follow-up|160|||
160826883|NCT01028716|580751893|FG000|Overall Study|Physician Decision|1|||
160826884|NCT01129882|580751894|FG000|Overall Study|Adverse Event|39|||
160826885|NCT01129882|580751894|FG000|Overall Study|Death|6|||
160826886|NCT01129882|580751894|FG000|Overall Study|Lack of Efficacy|5|||
160826887|NCT01129882|580751894|FG000|Overall Study|Lost to Follow-up|13|||
160826888|NCT01129882|580751894|FG000|Overall Study|Physician Decision|27|||
160826889|NCT01129882|580751894|FG000|Overall Study|Protocol Deviation|3|||
160826890|NCT01129882|580751894|FG000|Overall Study|Withdrawal Criteria Met|19|||
160826891|NCT01129882|580751894|FG000|Overall Study|Trial Termination by Sponsor|6|||
160826892|NCT01129882|580751894|FG000|Overall Study|Withdrawal by Subject|160|||
160826893|NCT00536874|580751895|FG000|Overall Study|Adverse Event|1|||
160826894|NCT00536874|580751895|FG000|Overall Study|Death|2|||
160826895|NCT00536874|580751895|FG000|Overall Study|Withdrawal by Subject|1|||
160826896|NCT00762996|580751896|FG000|Period One|Protocol Violation|0|||
160826897|NCT00762996|580751897|FG001|Period One|Protocol Violation|0|||
160826898|NCT00762996|580751898|FG002|Period One|Protocol Violation|1|||
160826899|NCT00762996|580751899|FG003|Period One|Protocol Violation|0|||
160826900|NCT00762996|580751896|FG000|Period One|ineligible|0|||
160826901|NCT00762996|580751897|FG001|Period One|ineligible|0|||
160826902|NCT00762996|580751898|FG002|Period One|ineligible|1|||
160826903|NCT00762996|580751899|FG003|Period One|ineligible|1|||
160826904|NCT00762996|580751896|FG000|Period One|Adverse Event|0|||
160826905|NCT00762996|580751897|FG001|Period One|Adverse Event|0|||
160826906|NCT00762996|580751898|FG002|Period One|Adverse Event|1|||
160826907|NCT00762996|580751899|FG003|Period One|Adverse Event|0|||
160826908|NCT00762996|580751896|FG000|Period One|Withdrawal by Subject|0|||
160826909|NCT00762996|580751897|FG001|Period One|Withdrawal by Subject|0|||
160826910|NCT00762996|580751898|FG002|Period One|Withdrawal by Subject|1|||
160826911|NCT00762996|580751899|FG003|Period One|Withdrawal by Subject|0|||
160826912|NCT01853072|580751901|FG000|Overall Study|Adverse event prior to treatment|0|||
160826913|NCT01853072|580751902|FG001|Overall Study|Adverse event prior to treatment|1|||
160826914|NCT01853072|580751901|FG000|Overall Study|Adverse Event|0|||
160826915|NCT01853072|580751902|FG001|Overall Study|Adverse Event|3|||
160826916|NCT01853072|580751901|FG000|Overall Study|Death|1|||
160826917|NCT01853072|580751902|FG001|Overall Study|Death|4|||
160826918|NCT01853072|580751901|FG000|Overall Study|Lost to Follow-up|0|||
160826919|NCT01853072|580751902|FG001|Overall Study|Lost to Follow-up|3|||
160826920|NCT01853072|580751901|FG000|Overall Study|Non-compliance with study drug|0|||
160826921|NCT01853072|580751902|FG001|Overall Study|Non-compliance with study drug|1|||
160826922|NCT01853072|580751901|FG000|Overall Study|Physician Decision|1|||
160826923|NCT01853072|580751902|FG001|Overall Study|Physician Decision|1|||
160826924|NCT01853072|580751901|FG000|Overall Study|Withdrawal by Subject|1|||
160826925|NCT01853072|580751902|FG001|Overall Study|Withdrawal by Subject|2|||
160826926|NCT01853072|580751901|FG000|Overall Study|Reason not specified|9|||
160826927|NCT01853072|580751902|FG001|Overall Study|Reason not specified|6|||
160826928|NCT01287221|580751903|FG000|Overall Study|Lack of Perceived Benefit|1|||
160826929|NCT01287221|580751904|FG001|Overall Study|Lack of Perceived Benefit|1|||
160826930|NCT01287221|580751903|FG000|Overall Study|Adverse Event|3|||
160826931|NCT01287221|580751904|FG001|Overall Study|Adverse Event|3|||
160826932|NCT01287221|580751903|FG000|Overall Study|Withdrawal by Subject|0|||
160826933|NCT01287221|580751904|FG001|Overall Study|Withdrawal by Subject|1|||
160826934|NCT00930969|580751905|FG000|Overall Study|Death|5|||
160826935|NCT00930969|580751905|FG000|Overall Study|Lost to Follow-up|1|||
160826936|NCT00930969|580751905|FG000|Overall Study|Physician Decision|13|||
160826937|NCT00930969|580751905|FG000|Overall Study|Withdrawal by Subject|19|||
160826938|NCT00657150|580751906|FG000|Overall Study|Adverse Event|19|||
160826939|NCT00657150|580751907|FG001|Overall Study|Adverse Event|10|||
160826940|NCT00657150|580751906|FG000|Overall Study|Non-compliant with protocol|5|||
160826941|NCT00657150|580751907|FG001|Overall Study|Non-compliant with protocol|9|||
160826942|NCT00657150|580751906|FG000|Overall Study|Lost to Follow-up|2|||
160826943|NCT00657150|580751907|FG001|Overall Study|Lost to Follow-up|0|||
160826944|NCT00657150|580751906|FG000|Overall Study|Withdrawal by Subject|51|||
160902267|NCT00347360|581036038|FG007|Overall Study|Protocol Violation|0|||
161133632|NCT00151892|581872971|FG000|Overall Study|Patient request|10|||
161133633|NCT00151892|581872972|FG001|Overall Study|Patient request|7|||
160826945|NCT00657150|580751907|FG001|Overall Study|Withdrawal by Subject|36|||
160826946|NCT00657150|580751906|FG000|Overall Study|Other|38|||
160826947|NCT00657150|580751907|FG001|Overall Study|Other|38|||
160826948|NCT00657150|580751906|FG000|Treatment|Adverse Event|60|||
160826949|NCT00657150|580751907|FG001|Treatment|Adverse Event|53|||
160826950|NCT00657150|580751906|FG000|Treatment|Non-compliant with protocol|10|||
160826951|NCT00657150|580751907|FG001|Treatment|Non-compliant with protocol|9|||
160826952|NCT00657150|580751906|FG000|Treatment|Lost to Follow-up|1|||
160826953|NCT00657150|580751907|FG001|Treatment|Lost to Follow-up|0|||
160826954|NCT00657150|580751906|FG000|Treatment|Withdrawal by Subject|23|||
160826955|NCT00657150|580751907|FG001|Treatment|Withdrawal by Subject|20|||
160826956|NCT00657150|580751906|FG000|Treatment|Other|13|||
160826957|NCT00657150|580751907|FG001|Treatment|Other|15|||
160826958|NCT02966795|580751908|FG000|Overall Study|Patient Left the Country|0|||
160826959|NCT02966795|580751909|FG001|Overall Study|Patient Left the Country|1|||
160826960|NCT00432744|580751910|FG000|Months 0-6|Withdrawal by Subject|4|||
160826961|NCT00432744|580751911|FG001|Months 0-6|Withdrawal by Subject|4|||
160826962|NCT00432744|580751910|FG000|Months 0-6|Too disabled to score|1|||
160826963|NCT00432744|580751911|FG001|Months 0-6|Too disabled to score|0|||
160826964|NCT00432744|580751910|FG000|Months 7 - 12|Withdrawal by Subject|1|||
160826965|NCT00432744|580751911|FG001|Months 7 - 12|Withdrawal by Subject|0|||
160826966|NCT00432744|580751910|FG000|Months 7 - 12|Too disabled to score|0|||
160826967|NCT00432744|580751911|FG001|Months 7 - 12|Too disabled to score|1|||
160826968|NCT01319721|580751919|FG000|Overall Study|Lost to Follow-up|1|||
160826969|NCT01319721|580751920|FG001|Overall Study|Lost to Follow-up|6|||
160826970|NCT02653495|580751921|FG000|Overall Study|Lost to Follow-up|2|||
160826971|NCT02653495|580751922|FG001|Overall Study|Lost to Follow-up|0|||
160826972|NCT02653495|580751921|FG000|Overall Study|Screening Failure|10|||
160826973|NCT02653495|580751922|FG001|Overall Study|Screening Failure|0|||
160902268|NCT00347360|581036039|FG008|Overall Study|Protocol Violation|1|||
160902269|NCT00347360|581036040|FG009|Overall Study|Protocol Violation|2|||
160902270|NCT00347360|581036041|FG010|Overall Study|Protocol Violation|0|||
160902271|NCT00347360|581036042|FG011|Overall Study|Protocol Violation|0|||
160902272|NCT00347360|581036043|FG012|Overall Study|Protocol Violation|0|||
160902273|NCT00347360|581036044|FG013|Overall Study|Protocol Violation|1|||
160902274|NCT00347360|581036045|FG014|Overall Study|Protocol Violation|0|||
160826974|NCT00468845|580751923|FG000|Overall Study|Adverse Event|9|||
160902275|NCT00347360|581036031|FG000|Overall Study|Withdrawal by Subject|0|||
160902276|NCT00347360|581036032|FG001|Overall Study|Withdrawal by Subject|1|||
160902277|NCT00347360|581036033|FG002|Overall Study|Withdrawal by Subject|2|||
160902278|NCT00347360|581036034|FG003|Overall Study|Withdrawal by Subject|4|||
160902279|NCT00347360|581036035|FG004|Overall Study|Withdrawal by Subject|1|||
161133634|NCT00151892|581872971|FG000|Overall Study|Lost to Follow-up|5|||
161133635|NCT00151892|581872972|FG001|Overall Study|Lost to Follow-up|10|||
161133636|NCT00151892|581872971|FG000|Overall Study|Adverse Event|6|||
161133637|NCT00151892|581872972|FG001|Overall Study|Adverse Event|3|||
161133638|NCT00151892|581872971|FG000|Overall Study|Protocol Violation|3|||
161133639|NCT00151892|581872972|FG001|Overall Study|Protocol Violation|3|||
161133640|NCT00151892|581872971|FG000|Overall Study|Non-compliance|0|||
161133641|NCT00151892|581872972|FG001|Overall Study|Non-compliance|1|||
161133642|NCT00151892|581872971|FG000|Overall Study|Pregnancy|0|||
161133643|NCT00151892|581872972|FG001|Overall Study|Pregnancy|1|||
161133644|NCT00151892|581872971|FG000|Overall Study|Did not return for a visit|1|||
161133645|NCT00151892|581872972|FG001|Overall Study|Did not return for a visit|0|||
161133646|NCT00151892|581872971|FG000|Overall Study|Used prohibited corticosteroids|1|||
161133647|NCT00151892|581872972|FG001|Overall Study|Used prohibited corticosteroids|0|||
161133648|NCT00151892|581872971|FG000|Overall Study|Lack of study medication at center|0|||
161133649|NCT00151892|581872972|FG001|Overall Study|Lack of study medication at center|1|||
161133650|NCT03437447|581872975|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161133651|NCT03437447|581872976|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161133652|NCT03437447|581872977|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161133653|NCT04223609|581872978|FG000|Overall Study|Adverse Event|0|||
161133654|NCT04223609|581872979|FG001|Overall Study|Adverse Event|1|||
161133655|NCT04223609|581872978|FG000|Overall Study|Missed last visit|0|||
161133656|NCT04223609|581872979|FG001|Overall Study|Missed last visit|1|||
161133657|NCT03440944|581872982|FG000|Overall Study|Physician Decision|1|||
161133658|NCT03440944|581872983|FG001|Overall Study|Physician Decision|0|||
161133659|NCT03440944|581872982|FG000|Overall Study|No Acceptable Vasculature|0|||
161133660|NCT03440944|581872983|FG001|Overall Study|No Acceptable Vasculature|1|||
161133661|NCT00591734|581872984|FG000|Overall Study|Lack of Efficacy|35|||
161133662|NCT00591734|581872984|FG000|Overall Study|Adverse Event|5|||
161133663|NCT00591734|581872984|FG000|Overall Study|Physician Decision|5|||
161133664|NCT00591734|581872984|FG000|Overall Study|Intercurrent Illness|8|||
161133665|NCT04672083|581872985|FG000|Overall Study|Lost to Follow-up|1|||
161241639|NCT00205777|582266041|FG004|Study Extension II|Adverse Event|0|||
161241640|NCT00205777|582266042|FG005|Study Extension II|Adverse Event|30|||
161241641|NCT00205777|582266037|FG000|Study Extension II|Death|0|||
161241642|NCT00205777|582266038|FG001|Study Extension II|Death|0|||
160826975|NCT00468845|580751924|FG001|Overall Study|Adverse Event|14|||
161133666|NCT04672083|581872986|FG001|Overall Study|Lost to Follow-up|0|||
161133667|NCT04672083|581872987|FG002|Overall Study|Lost to Follow-up|0|||
161133668|NCT04672083|581872988|FG003|Overall Study|Lost to Follow-up|0|||
161133669|NCT04672083|581872989|FG004|Overall Study|Lost to Follow-up|0|||
161133670|NCT01551745|581872990|FG000|Overall Study|Withdrawal by Subject|1|||
161133671|NCT01551745|581872990|FG000|Overall Study|Disease Progression|2|||
161133672|NCT01661790|581872991|FG000|Overall Study|Lost to Follow-up|0|||
160826976|NCT00468845|580751925|FG002|Overall Study|Adverse Event|11|||
160826977|NCT00468845|580751923|FG000|Overall Study|Lost to Follow-up|2|||
161241643|NCT00205777|582266039|FG002|Study Extension II|Death|0|||
161241644|NCT00205777|582266040|FG003|Study Extension II|Death|2|||
161241645|NCT00205777|582266041|FG004|Study Extension II|Death|0|||
161241646|NCT00205777|582266042|FG005|Study Extension II|Death|5|||
161241647|NCT00205777|582266037|FG000|Study Extension II|Withdrawal by Subject|0|||
161241648|NCT00205777|582266038|FG001|Study Extension II|Withdrawal by Subject|0|||
161241649|NCT00205777|582266039|FG002|Study Extension II|Withdrawal by Subject|0|||
161241650|NCT00205777|582266040|FG003|Study Extension II|Withdrawal by Subject|35|||
161241651|NCT00205777|582266041|FG004|Study Extension II|Withdrawal by Subject|0|||
161241652|NCT00205777|582266042|FG005|Study Extension II|Withdrawal by Subject|59|||
161241653|NCT00205777|582266037|FG000|Study Extension II|Protocol Violation|0|||
161241654|NCT00205777|582266038|FG001|Study Extension II|Protocol Violation|0|||
161241655|NCT00205777|582266039|FG002|Study Extension II|Protocol Violation|0|||
161241656|NCT00205777|582266040|FG003|Study Extension II|Protocol Violation|1|||
161241657|NCT00205777|582266041|FG004|Study Extension II|Protocol Violation|0|||
161241658|NCT00205777|582266042|FG005|Study Extension II|Protocol Violation|10|||
161241659|NCT00205777|582266037|FG000|Study Extension II|Lack of Efficacy|0|||
161241660|NCT00205777|582266038|FG001|Study Extension II|Lack of Efficacy|0|||
161241661|NCT00205777|582266039|FG002|Study Extension II|Lack of Efficacy|0|||
161241662|NCT00205777|582266040|FG003|Study Extension II|Lack of Efficacy|0|||
161241663|NCT00205777|582266041|FG004|Study Extension II|Lack of Efficacy|0|||
161241664|NCT00205777|582266042|FG005|Study Extension II|Lack of Efficacy|1|||
161241665|NCT00205777|582266037|FG000|Study Extension II|Failed to return|0|||
161241666|NCT00205777|582266038|FG001|Study Extension II|Failed to return|0|||
161241667|NCT00205777|582266039|FG002|Study Extension II|Failed to return|0|||
161241668|NCT00205777|582266040|FG003|Study Extension II|Failed to return|14|||
161241669|NCT00205777|582266041|FG004|Study Extension II|Failed to return|0|||
161241670|NCT00205777|582266042|FG005|Study Extension II|Failed to return|26|||
161241671|NCT00205777|582266037|FG000|Study Extension II|Other Event|0|||
161241672|NCT00205777|582266038|FG001|Study Extension II|Other Event|0|||
161241673|NCT00205777|582266039|FG002|Study Extension II|Other Event|0|||
161241674|NCT00205777|582266040|FG003|Study Extension II|Other Event|12|||
161241675|NCT00205777|582266041|FG004|Study Extension II|Other Event|0|||
161241676|NCT00205777|582266042|FG005|Study Extension II|Other Event|20|||
161241677|NCT00205777|582266037|FG000|Study Extension II|Enrolled but not treated|0|||
161241678|NCT00205777|582266038|FG001|Study Extension II|Enrolled but not treated|0|||
161241679|NCT00205777|582266039|FG002|Study Extension II|Enrolled but not treated|0|||
161241680|NCT00205777|582266040|FG003|Study Extension II|Enrolled but not treated|71|||
161241681|NCT00205777|582266041|FG004|Study Extension II|Enrolled but not treated|0|||
161241682|NCT00205777|582266042|FG005|Study Extension II|Enrolled but not treated|131|||
161241683|NCT00700739|582266046|FG000|Overall Study|Lost to Follow-up|4|||
161241684|NCT00700739|582266047|FG001|Overall Study|Lost to Follow-up|4|||
161241685|NCT00003470|582266051|FG000|Overall Study|Not evaluable|6|||
161241686|NCT02923349|582266064|FG000|Overall Study|Other|1|||
161241687|NCT02923349|582266065|FG001|Overall Study|Other|2|||
161241688|NCT02923349|582266066|FG002|Overall Study|Other|4|||
161241689|NCT02923349|582266067|FG003|Overall Study|Other|1|||
161241690|NCT02923349|582266068|FG004|Overall Study|Other|3|||
161241691|NCT02923349|582266069|FG005|Overall Study|Other|0|||
161241692|NCT02923349|582266070|FG006|Overall Study|Other|1|||
161241693|NCT02923349|582266064|FG000|Overall Study|Withdrawal by Subject|2|||
161241694|NCT02923349|582266065|FG001|Overall Study|Withdrawal by Subject|2|||
161241695|NCT02923349|582266066|FG002|Overall Study|Withdrawal by Subject|8|||
161241696|NCT02923349|582266067|FG003|Overall Study|Withdrawal by Subject|10|||
161241697|NCT02923349|582266068|FG004|Overall Study|Withdrawal by Subject|12|||
161241698|NCT02923349|582266069|FG005|Overall Study|Withdrawal by Subject|3|||
161241699|NCT02923349|582266070|FG006|Overall Study|Withdrawal by Subject|0|||
161241700|NCT02923349|582266064|FG000|Overall Study|Physician Decision|0|||
161241701|NCT02923349|582266065|FG001|Overall Study|Physician Decision|0|||
161241702|NCT02923349|582266066|FG002|Overall Study|Physician Decision|0|||
160990058|NCT02950545|581351735|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
160990059|NCT02950545|581351736|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
160990060|NCT02950545|581351737|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
161241703|NCT02923349|582266067|FG003|Overall Study|Physician Decision|1|||
161241704|NCT02923349|582266068|FG004|Overall Study|Physician Decision|1|||
161241705|NCT02923349|582266069|FG005|Overall Study|Physician Decision|0|||
161241706|NCT02923349|582266070|FG006|Overall Study|Physician Decision|2|||
161241707|NCT02923349|582266064|FG000|Overall Study|Lost to Follow-up|0|||
161241708|NCT02923349|582266065|FG001|Overall Study|Lost to Follow-up|0|||
161241709|NCT02923349|582266066|FG002|Overall Study|Lost to Follow-up|3|||
161241710|NCT02923349|582266067|FG003|Overall Study|Lost to Follow-up|0|||
161241711|NCT02923349|582266068|FG004|Overall Study|Lost to Follow-up|1|||
161241712|NCT02923349|582266069|FG005|Overall Study|Lost to Follow-up|1|||
161241713|NCT02923349|582266070|FG006|Overall Study|Lost to Follow-up|0|||
161241714|NCT02923349|582266064|FG000|Overall Study|Death|1|||
161241715|NCT02923349|582266065|FG001|Overall Study|Death|0|||
161241716|NCT02923349|582266066|FG002|Overall Study|Death|2|||
161241717|NCT02923349|582266067|FG003|Overall Study|Death|4|||
161241718|NCT02923349|582266068|FG004|Overall Study|Death|2|||
161241719|NCT02923349|582266069|FG005|Overall Study|Death|3|||
161241720|NCT02923349|582266070|FG006|Overall Study|Death|0|||
161241721|NCT00725322|582266073|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
161241722|NCT00725322|582266074|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
161241723|NCT00725322|582266073|FG000|Washout (28 Days)|Protocol Violation|0|||
161241724|NCT00725322|582266074|FG001|Washout (28 Days)|Protocol Violation|1|||
161241725|NCT05871151|582266075|FG000|Overall Study|Lost to Follow-up|1|||
161241726|NCT05871151|582266076|FG001|Overall Study|Lost to Follow-up|0|||
161241727|NCT05871151|582266075|FG000|Overall Study|Unrelated illness|0|||
161241728|NCT05871151|582266076|FG001|Overall Study|Unrelated illness|1|||
161241729|NCT00830258|582267428|FG000|First Intervention|Adverse Event|1|||
161241730|NCT00830258|582267429|FG001|First Intervention|Adverse Event|0|||
161241731|NCT00830258|582267428|FG000|Washout: 7 Days|Protocol Violation|1|||
161241732|NCT00830258|582267429|FG001|Washout: 7 Days|Protocol Violation|0|||
161241733|NCT00798603|582267430|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
161241734|NCT00798603|582267430|FG000|Overall Study|Withdrawal by Subject|10|||
161241735|NCT00798603|582267430|FG000|Overall Study|Adverse Event|22|||
161241736|NCT00798603|582267430|FG000|Overall Study|Physician Decision|1|||
161241737|NCT00798603|582267430|FG000|Overall Study|Lack of insurance coverage|1|||
161241738|NCT05511935|582267431|FG000|Overall Study|Lost to Follow-up|9|||
161241739|NCT05511935|582267432|FG001|Overall Study|Lost to Follow-up|27|||
161241740|NCT04406194|582267433|FG000|Period 1|Withdrawal by Subject|0|||
161241741|NCT04406194|582267434|FG001|Period 1|Withdrawal by Subject|1|||
161241742|NCT04102345|582267435|FG000|Overall Study|Withdrawal by Subject|1|||
161241743|NCT04102345|582267436|FG001|Overall Study|Withdrawal by Subject|0|||
161241744|NCT02888756|582267437|FG000|Analytical Treatment Interruption|Physician Decision|10|||
161241745|NCT02888756|582267438|FG001|Analytical Treatment Interruption|Physician Decision|6|||
161241746|NCT02888756|582267439|FG002|Analytical Treatment Interruption|Physician Decision|5|||
161241747|NCT01015287|582267442|FG000|Overall Study|Death|21|||
161241748|NCT01015287|582267443|FG001|Overall Study|Death|16|||
161241749|NCT01015287|582267442|FG000|Overall Study|Adverse Event|1|||
161241750|NCT01015287|582267443|FG001|Overall Study|Adverse Event|0|||
161241751|NCT01015287|582267442|FG000|Overall Study|Sponsor Decision|3|||
161241752|NCT01015287|582267443|FG001|Overall Study|Sponsor Decision|7|||
161241753|NCT01015287|582267442|FG000|Overall Study|Physician Decision|19|||
161241754|NCT01015287|582267443|FG001|Overall Study|Physician Decision|21|||
161241755|NCT01015287|582267442|FG000|Overall Study|Withdrawal by Subject|14|||
161241756|NCT01015287|582267443|FG001|Overall Study|Withdrawal by Subject|19|||
161241757|NCT01015287|582267442|FG000|Overall Study|Entry Criteria not Met|11|||
161241758|NCT01015287|582267443|FG001|Overall Study|Entry Criteria not Met|14|||
161241759|NCT01015287|582267442|FG000|Overall Study|Lost to Follow-up|2|||
161241760|NCT01015287|582267443|FG001|Overall Study|Lost to Follow-up|1|||
161241761|NCT01015287|582267442|FG000|Overall Study|Protocol Violation|1|||
161241762|NCT01015287|582267443|FG001|Overall Study|Protocol Violation|1|||
161241763|NCT01592240|582267444|FG000|Overall Study|Adverse Event|1|||
161241764|NCT01592240|582267445|FG001|Overall Study|Adverse Event|0|||
161241765|NCT01592240|582267446|FG002|Overall Study|Adverse Event|0|||
161241766|NCT01592240|582267447|FG003|Overall Study|Adverse Event|1|||
161241767|NCT01592240|582267448|FG004|Overall Study|Adverse Event|1|||
161241768|NCT01592240|582267449|FG005|Overall Study|Adverse Event|0|||
161241769|NCT01592240|582267450|FG006|Overall Study|Adverse Event|0|||
161241770|NCT01592240|582267444|FG000|Overall Study|Death|0|||
161241771|NCT01592240|582267445|FG001|Overall Study|Death|1|||
161241772|NCT01592240|582267446|FG002|Overall Study|Death|0|||
161241773|NCT01592240|582267447|FG003|Overall Study|Death|0|||
160826978|NCT00468845|580751924|FG001|Overall Study|Lost to Follow-up|1|||
160826979|NCT00468845|580751925|FG002|Overall Study|Lost to Follow-up|2|||
160826980|NCT00468845|580751923|FG000|Overall Study|Other|4|||
160826981|NCT00468845|580751924|FG001|Overall Study|Other|9|||
160826982|NCT00468845|580751925|FG002|Overall Study|Other|5|||
160826983|NCT00468845|580751923|FG000|Overall Study|No longer willing to participate|5|||
160826984|NCT00468845|580751924|FG001|Overall Study|No longer willing to participate|6|||
161241774|NCT01592240|582267448|FG004|Overall Study|Death|0|||
161241775|NCT01592240|582267449|FG005|Overall Study|Death|0|||
161241776|NCT01592240|582267450|FG006|Overall Study|Death|0|||
161241777|NCT01592240|582267444|FG000|Overall Study|Lost to Follow-up|1|||
161241778|NCT01592240|582267445|FG001|Overall Study|Lost to Follow-up|3|||
161241779|NCT01592240|582267446|FG002|Overall Study|Lost to Follow-up|1|||
161241780|NCT01592240|582267447|FG003|Overall Study|Lost to Follow-up|0|||
161241781|NCT01592240|582267448|FG004|Overall Study|Lost to Follow-up|3|||
160826985|NCT00468845|580751925|FG002|Overall Study|No longer willing to participate|10|||
160826986|NCT00468845|580751923|FG000|Overall Study|Randomized, not treated|1|||
161241782|NCT01592240|582267449|FG005|Overall Study|Lost to Follow-up|2|||
161241783|NCT01592240|582267450|FG006|Overall Study|Lost to Follow-up|0|||
161241784|NCT01592240|582267444|FG000|Overall Study|Protocol Violation|0|||
161241785|NCT01592240|582267445|FG001|Overall Study|Protocol Violation|0|||
161241786|NCT01592240|582267446|FG002|Overall Study|Protocol Violation|0|||
161241787|NCT01592240|582267447|FG003|Overall Study|Protocol Violation|0|||
161241788|NCT01592240|582267448|FG004|Overall Study|Protocol Violation|0|||
161241789|NCT01592240|582267449|FG005|Overall Study|Protocol Violation|1|||
161241790|NCT01592240|582267450|FG006|Overall Study|Protocol Violation|0|||
161241791|NCT01592240|582267444|FG000|Overall Study|Withdrawal by Subject|0|||
161241792|NCT01592240|582267445|FG001|Overall Study|Withdrawal by Subject|4|||
161241793|NCT01592240|582267446|FG002|Overall Study|Withdrawal by Subject|4|||
161241794|NCT01592240|582267447|FG003|Overall Study|Withdrawal by Subject|1|||
161241795|NCT01592240|582267448|FG004|Overall Study|Withdrawal by Subject|3|||
161241796|NCT01592240|582267449|FG005|Overall Study|Withdrawal by Subject|0|||
161241797|NCT01592240|582267450|FG006|Overall Study|Withdrawal by Subject|2|||
161241798|NCT01592240|582267444|FG000|Overall Study|Other|0|||
161241799|NCT01592240|582267445|FG001|Overall Study|Other|3|||
161241800|NCT01592240|582267446|FG002|Overall Study|Other|1|||
161241801|NCT01592240|582267447|FG003|Overall Study|Other|1|||
161241802|NCT01592240|582267448|FG004|Overall Study|Other|0|||
161241803|NCT01592240|582267449|FG005|Overall Study|Other|0|||
161241804|NCT01592240|582267450|FG006|Overall Study|Other|1|||
161241805|NCT01592240|582267444|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
161241806|NCT01592240|582267445|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
161241807|NCT01592240|582267446|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
161241808|NCT01592240|582267447|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
161241809|NCT01592240|582267448|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
161241810|NCT01592240|582267449|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
161241811|NCT01592240|582267450|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
161241812|NCT01117623|582267451|FG000|Overall Study|Adverse Event|0|||
161241813|NCT01117623|582267452|FG001|Overall Study|Adverse Event|2|||
161241814|NCT01117623|582267453|FG002|Overall Study|Adverse Event|4|||
161241815|NCT01117623|582267454|FG003|Overall Study|Adverse Event|0|||
161241816|NCT01117623|582267455|FG004|Overall Study|Adverse Event|2|||
161241817|NCT01117623|582267456|FG005|Overall Study|Adverse Event|0|||
161241818|NCT01117623|582267457|FG006|Overall Study|Adverse Event|0|||
161241819|NCT01117623|582267458|FG007|Overall Study|Adverse Event|2|||
161241820|NCT01117623|582267451|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
161241821|NCT01117623|582267452|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
161241822|NCT01117623|582267453|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
161241823|NCT01117623|582267454|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
161241824|NCT01117623|582267455|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
161241825|NCT01117623|582267456|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
161241826|NCT01117623|582267457|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
161241827|NCT01117623|582267458|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
161241828|NCT01117623|582267451|FG000|Overall Study|Withdrawal by Subject|0|||
161133673|NCT01661790|581872992|FG001|Overall Study|Lost to Follow-up|2|||
161133674|NCT02764541|581872995|FG000|Overall Study|Withdrawal by Subject|0|||
161133675|NCT02764541|581872996|FG001|Overall Study|Withdrawal by Subject|0|||
161133676|NCT02764541|581872997|FG002|Overall Study|Withdrawal by Subject|0|||
161133677|NCT02764541|581872998|FG003|Overall Study|Withdrawal by Subject|0|||
161133678|NCT02764541|581872999|FG004|Overall Study|Withdrawal by Subject|1|||
161133679|NCT02764541|581873000|FG005|Overall Study|Withdrawal by Subject|1|||
161133680|NCT02764541|581873001|FG006|Overall Study|Withdrawal by Subject|0|||
161133681|NCT02764541|581873002|FG007|Overall Study|Withdrawal by Subject|1|||
161133682|NCT02764541|581872995|FG000|Overall Study|Adverse Event|1|||
161133683|NCT02764541|581872996|FG001|Overall Study|Adverse Event|0|||
161133684|NCT02764541|581872997|FG002|Overall Study|Adverse Event|0|||
161241829|NCT01117623|582267452|FG001|Overall Study|Withdrawal by Subject|0|||
161241830|NCT01117623|582267453|FG002|Overall Study|Withdrawal by Subject|2|||
161241831|NCT01117623|582267454|FG003|Overall Study|Withdrawal by Subject|0|||
161241832|NCT01117623|582267455|FG004|Overall Study|Withdrawal by Subject|0|||
160826987|NCT00468845|580751924|FG001|Overall Study|Randomized, not treated|4|||
160826988|NCT00468845|580751925|FG002|Overall Study|Randomized, not treated|2|||
160826989|NCT02761694|580751929|FG000|Overall Study|Lack of Efficacy|0|||
160826990|NCT02761694|580751930|FG001|Overall Study|Lack of Efficacy|0|||
160826991|NCT02761694|580751931|FG002|Overall Study|Lack of Efficacy|0|||
160826992|NCT02761694|580751932|FG003|Overall Study|Lack of Efficacy|0|||
161241833|NCT01117623|582267456|FG005|Overall Study|Withdrawal by Subject|1|||
161241834|NCT01117623|582267457|FG006|Overall Study|Withdrawal by Subject|1|||
161241835|NCT01117623|582267458|FG007|Overall Study|Withdrawal by Subject|1|||
160826993|NCT02761694|580751933|FG004|Overall Study|Lack of Efficacy|0|||
160826994|NCT02761694|580751934|FG005|Overall Study|Lack of Efficacy|0|||
160826995|NCT02761694|580751935|FG006|Overall Study|Lack of Efficacy|6|||
160826996|NCT02761694|580751936|FG007|Overall Study|Lack of Efficacy|0|||
160826997|NCT02761694|580751937|FG008|Overall Study|Lack of Efficacy|0|||
161133685|NCT02764541|581872998|FG003|Overall Study|Adverse Event|0|||
161133686|NCT02764541|581872999|FG004|Overall Study|Adverse Event|0|||
161133687|NCT02764541|581873000|FG005|Overall Study|Adverse Event|0|||
161133688|NCT02764541|581873001|FG006|Overall Study|Adverse Event|1|||
161241836|NCT01117623|582267451|FG000|Overall Study|Non-compliance with study medication|0|||
161241837|NCT01117623|582267452|FG001|Overall Study|Non-compliance with study medication|0|||
161241838|NCT01117623|582267453|FG002|Overall Study|Non-compliance with study medication|0|||
161241839|NCT01117623|582267454|FG003|Overall Study|Non-compliance with study medication|0|||
161241840|NCT01117623|582267455|FG004|Overall Study|Non-compliance with study medication|0|||
161241841|NCT01117623|582267456|FG005|Overall Study|Non-compliance with study medication|0|||
161241842|NCT01117623|582267457|FG006|Overall Study|Non-compliance with study medication|0|||
161241843|NCT01117623|582267458|FG007|Overall Study|Non-compliance with study medication|1|||
160990061|NCT02950545|581351732|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
161241844|NCT01117623|582267451|FG000|Overall Study|Invest. text: completed all planned txs|0|||
161241845|NCT01117623|582267452|FG001|Overall Study|Invest. text: completed all planned txs|0|||
161241846|NCT01117623|582267453|FG002|Overall Study|Invest. text: completed all planned txs|0|||
161241847|NCT01117623|582267454|FG003|Overall Study|Invest. text: completed all planned txs|0|||
161241848|NCT01117623|582267455|FG004|Overall Study|Invest. text: completed all planned txs|0|||
161241849|NCT01117623|582267456|FG005|Overall Study|Invest. text: completed all planned txs|1|||
161241850|NCT01117623|582267457|FG006|Overall Study|Invest. text: completed all planned txs|0|||
161241851|NCT01117623|582267458|FG007|Overall Study|Invest. text: completed all planned txs|0|||
161241852|NCT02727192|582267468|FG000|Overall Study|Lost to Follow-up|1|||
161241853|NCT02727192|582267469|FG001|Overall Study|Lost to Follow-up|0|||
160826998|NCT02761694|580751938|FG009|Overall Study|Lack of Efficacy|1|||
160826999|NCT02761694|580751939|FG010|Overall Study|Lack of Efficacy|1|||
160827000|NCT02761694|580751940|FG011|Overall Study|Lack of Efficacy|4|||
160827001|NCT02761694|580751929|FG000|Overall Study|Death|0|||
160827002|NCT02761694|580751930|FG001|Overall Study|Death|0|||
160827003|NCT02761694|580751931|FG002|Overall Study|Death|0|||
160827004|NCT02761694|580751932|FG003|Overall Study|Death|0|||
160827005|NCT02761694|580751933|FG004|Overall Study|Death|0|||
160827006|NCT02761694|580751934|FG005|Overall Study|Death|0|||
160827007|NCT02761694|580751935|FG006|Overall Study|Death|2|||
160827008|NCT02761694|580751936|FG007|Overall Study|Death|0|||
160827009|NCT02761694|580751937|FG008|Overall Study|Death|2|||
160827010|NCT02761694|580751938|FG009|Overall Study|Death|2|||
160827011|NCT02761694|580751939|FG010|Overall Study|Death|1|||
160827012|NCT02761694|580751940|FG011|Overall Study|Death|0|||
160827013|NCT02761694|580751929|FG000|Overall Study|Physician Decision|0|||
160827014|NCT02761694|580751930|FG001|Overall Study|Physician Decision|0|||
160827015|NCT02761694|580751931|FG002|Overall Study|Physician Decision|0|||
160827016|NCT02761694|580751932|FG003|Overall Study|Physician Decision|0|||
160902280|NCT00347360|581036036|FG005|Overall Study|Withdrawal by Subject|2|||
160902281|NCT00347360|581036037|FG006|Overall Study|Withdrawal by Subject|1|||
160902282|NCT00347360|581036038|FG007|Overall Study|Withdrawal by Subject|1|||
160902283|NCT00347360|581036039|FG008|Overall Study|Withdrawal by Subject|1|||
160902284|NCT00347360|581036040|FG009|Overall Study|Withdrawal by Subject|1|||
160902285|NCT00347360|581036041|FG010|Overall Study|Withdrawal by Subject|0|||
160902286|NCT00347360|581036042|FG011|Overall Study|Withdrawal by Subject|3|||
160902287|NCT00347360|581036043|FG012|Overall Study|Withdrawal by Subject|4|||
160902288|NCT00347360|581036044|FG013|Overall Study|Withdrawal by Subject|2|||
160902289|NCT00347360|581036045|FG014|Overall Study|Withdrawal by Subject|1|||
160902290|NCT00347360|581036031|FG000|Overall Study|Lack of Efficacy|1|||
160902291|NCT00347360|581036032|FG001|Overall Study|Lack of Efficacy|1|||
160902292|NCT00347360|581036033|FG002|Overall Study|Lack of Efficacy|3|||
160902293|NCT00347360|581036034|FG003|Overall Study|Lack of Efficacy|1|||
160902294|NCT00347360|581036035|FG004|Overall Study|Lack of Efficacy|0|||
160902295|NCT00347360|581036036|FG005|Overall Study|Lack of Efficacy|1|||
160902296|NCT00347360|581036037|FG006|Overall Study|Lack of Efficacy|0|||
160902297|NCT00347360|581036038|FG007|Overall Study|Lack of Efficacy|1|||
160902298|NCT00347360|581036039|FG008|Overall Study|Lack of Efficacy|1|||
160902299|NCT00347360|581036040|FG009|Overall Study|Lack of Efficacy|0|||
160902300|NCT00347360|581036041|FG010|Overall Study|Lack of Efficacy|0|||
160902301|NCT00347360|581036042|FG011|Overall Study|Lack of Efficacy|0|||
160902302|NCT00347360|581036043|FG012|Overall Study|Lack of Efficacy|0|||
160902303|NCT00347360|581036044|FG013|Overall Study|Lack of Efficacy|0|||
160902304|NCT00347360|581036045|FG014|Overall Study|Lack of Efficacy|0|||
160902305|NCT00347360|581036031|FG000|Overall Study|Reason not listed/blank|1|||
160902306|NCT00347360|581036032|FG001|Overall Study|Reason not listed/blank|0|||
160902307|NCT00347360|581036033|FG002|Overall Study|Reason not listed/blank|0|||
160902308|NCT00347360|581036034|FG003|Overall Study|Reason not listed/blank|0|||
160902309|NCT00347360|581036035|FG004|Overall Study|Reason not listed/blank|0|||
160902310|NCT00347360|581036036|FG005|Overall Study|Reason not listed/blank|0|||
160902311|NCT00347360|581036037|FG006|Overall Study|Reason not listed/blank|1|||
160902312|NCT00347360|581036038|FG007|Overall Study|Reason not listed/blank|0|||
160902313|NCT00347360|581036039|FG008|Overall Study|Reason not listed/blank|0|||
160902314|NCT00347360|581036040|FG009|Overall Study|Reason not listed/blank|0|||
160902315|NCT00347360|581036041|FG010|Overall Study|Reason not listed/blank|0|||
160902316|NCT00347360|581036042|FG011|Overall Study|Reason not listed/blank|0|||
161241854|NCT02727192|582267470|FG002|Overall Study|Lost to Follow-up|0|||
160827017|NCT02761694|580751933|FG004|Overall Study|Physician Decision|0|||
160827018|NCT02761694|580751934|FG005|Overall Study|Physician Decision|0|||
160827019|NCT02761694|580751935|FG006|Overall Study|Physician Decision|1|||
160827020|NCT02761694|580751936|FG007|Overall Study|Physician Decision|0|||
160827021|NCT02761694|580751937|FG008|Overall Study|Physician Decision|0|||
161241855|NCT00928057|582267472|FG000|Overall Study|Adverse Event|1|||
161241856|NCT00928057|582267473|FG001|Overall Study|Adverse Event|2|||
161241857|NCT00928057|582267472|FG000|Overall Study|Withdrawal by Subject|1|||
161241858|NCT00928057|582267473|FG001|Overall Study|Withdrawal by Subject|0|||
161241859|NCT00928057|582267472|FG000|Overall Study|Lost to Follow-up|0|||
161241860|NCT00928057|582267473|FG001|Overall Study|Lost to Follow-up|1|||
161241861|NCT00928057|582267472|FG000|Overall Study|Protocol Violation|0|||
161241862|NCT00928057|582267473|FG001|Overall Study|Protocol Violation|1|||
161241863|NCT05497557|582267474|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
161241864|NCT05497557|582267475|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
161241865|NCT05497557|582267476|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
161241866|NCT03206749|582267477|FG000|Overall Study|Withdrawal of consent|5|||
161241867|NCT03206749|582267478|FG001|Overall Study|Withdrawal of consent|3|||
161241868|NCT03206749|582267479|FG002|Overall Study|Withdrawal of consent|6|||
161241869|NCT03206749|582267477|FG000|Overall Study|Lost to Follow-up|0|||
161241870|NCT03206749|582267478|FG001|Overall Study|Lost to Follow-up|0|||
161241871|NCT03206749|582267479|FG002|Overall Study|Lost to Follow-up|1|||
161241872|NCT04590027|582267481|FG000|Overall Study|Lost to Follow-up|17|||
161241873|NCT04590027|582267482|FG001|Overall Study|Lost to Follow-up|14|||
161241874|NCT04590027|582267481|FG000|Overall Study|Protocol Violation|0|||
161241875|NCT04590027|582267482|FG001|Overall Study|Protocol Violation|3|||
161241876|NCT03497130|582267485|FG000|Overall Study|Lost to Follow-up|1|||
161241877|NCT03497130|582267486|FG001|Overall Study|Lost to Follow-up|1|||
161241878|NCT04631562|582267487|FG000|Overall Study|Withdrawal by Subject|0|||
161241879|NCT04631562|582267488|FG001|Overall Study|Withdrawal by Subject|0|||
161241880|NCT04631562|582267489|FG002|Overall Study|Withdrawal by Subject|0|||
161241881|NCT04631562|582267490|FG003|Overall Study|Withdrawal by Subject|0|||
161241882|NCT04631562|582267491|FG004|Overall Study|Withdrawal by Subject|0|||
161241883|NCT04631562|582267492|FG005|Overall Study|Withdrawal by Subject|0|||
161241884|NCT04631562|582267493|FG006|Overall Study|Withdrawal by Subject|0|||
161241885|NCT04631562|582267494|FG007|Overall Study|Withdrawal by Subject|1|||
161241886|NCT04631562|582267495|FG008|Overall Study|Withdrawal by Subject|0|||
160990062|NCT02950545|581351733|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990063|NCT02950545|581351734|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990064|NCT02950545|581351735|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990065|NCT02950545|581351736|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
161241887|NCT04631562|582267487|FG000|Overall Study|Other|0|||
161241888|NCT04631562|582267488|FG001|Overall Study|Other|0|||
161241889|NCT04631562|582267489|FG002|Overall Study|Other|0|||
161241890|NCT04631562|582267490|FG003|Overall Study|Other|0|||
161241891|NCT04631562|582267491|FG004|Overall Study|Other|0|||
161241892|NCT04631562|582267492|FG005|Overall Study|Other|0|||
161241893|NCT04631562|582267493|FG006|Overall Study|Other|0|||
161241894|NCT04631562|582267494|FG007|Overall Study|Other|0|||
161241895|NCT04631562|582267495|FG008|Overall Study|Other|1|||
161241896|NCT04631562|582267487|FG000|Overall Study|Lost to Follow-up|0|||
161241897|NCT04631562|582267488|FG001|Overall Study|Lost to Follow-up|0|||
161241898|NCT04631562|582267489|FG002|Overall Study|Lost to Follow-up|0|||
161241899|NCT04631562|582267490|FG003|Overall Study|Lost to Follow-up|1|||
161241900|NCT04631562|582267491|FG004|Overall Study|Lost to Follow-up|0|||
161241901|NCT04631562|582267492|FG005|Overall Study|Lost to Follow-up|0|||
161241902|NCT04631562|582267493|FG006|Overall Study|Lost to Follow-up|0|||
161241903|NCT04631562|582267494|FG007|Overall Study|Lost to Follow-up|0|||
161241904|NCT04631562|582267495|FG008|Overall Study|Lost to Follow-up|0|||
161241905|NCT04631562|582267487|FG000|Overall Study|Adverse Event|0|||
161241906|NCT04631562|582267488|FG001|Overall Study|Adverse Event|0|||
161241907|NCT04631562|582267489|FG002|Overall Study|Adverse Event|0|||
161241908|NCT04631562|582267490|FG003|Overall Study|Adverse Event|0|||
161241909|NCT04631562|582267491|FG004|Overall Study|Adverse Event|0|||
161241910|NCT04631562|582267492|FG005|Overall Study|Adverse Event|0|||
161241911|NCT04631562|582267493|FG006|Overall Study|Adverse Event|1|||
161241912|NCT04631562|582267494|FG007|Overall Study|Adverse Event|0|||
161241913|NCT04631562|582267495|FG008|Overall Study|Adverse Event|0|||
161241914|NCT03503318|582267496|FG000|Overall Study|Death|1|||
161334404|NCT03636256|582614116|FG007|Overall Study|Lost to Follow-up|0|||
161241915|NCT03503318|582267497|FG001|Overall Study|Death|0|||
161334405|NCT03636256|582614117|FG008|Overall Study|Lost to Follow-up|4|||
161241916|NCT03503318|582267498|FG002|Overall Study|Death|4|||
161241917|NCT03503318|582267496|FG000|Overall Study|Adverse Event|3|||
161241918|NCT03503318|582267497|FG001|Overall Study|Adverse Event|4|||
161241919|NCT03503318|582267498|FG002|Overall Study|Adverse Event|2|||
161241920|NCT03503318|582267496|FG000|Overall Study|Withdrawal by Subject|12|||
161241921|NCT03503318|582267497|FG001|Overall Study|Withdrawal by Subject|17|||
161241922|NCT03503318|582267498|FG002|Overall Study|Withdrawal by Subject|16|||
161241923|NCT03503318|582267496|FG000|Overall Study|Protocol Violation|5|||
161241924|NCT03503318|582267497|FG001|Overall Study|Protocol Violation|0|||
161241925|NCT03503318|582267498|FG002|Overall Study|Protocol Violation|3|||
161241926|NCT03503318|582267496|FG000|Overall Study|Lost to Follow-up|17|||
161241927|NCT03503318|582267497|FG001|Overall Study|Lost to Follow-up|15|||
161241928|NCT03503318|582267498|FG002|Overall Study|Lost to Follow-up|12|||
161241929|NCT03503318|582267496|FG000|Overall Study|Other than specified|1|||
161241930|NCT03503318|582267497|FG001|Overall Study|Other than specified|3|||
161241931|NCT03503318|582267498|FG002|Overall Study|Other than specified|3|||
161241932|NCT01794845|582267501|FG000|Overall Study|Withdrawal by Subject|1|||
161241933|NCT02139826|582267502|FG000|Overall Study|Adverse Event|1|||
161241934|NCT03498560|582267503|FG000|Overall Study|Found Ineligible|2|||
161241935|NCT03498560|582267503|FG000|Overall Study|Withdrawal by Subject|14|||
161241936|NCT03498560|582267503|FG000|Overall Study|Lost to Follow-up|4|||
161241937|NCT03498560|582267503|FG000|Overall Study|Death|1|||
161241938|NCT00867360|582267504|FG000|Overall Study|Withdrawal by Subject|1|||
161241939|NCT00867360|582267505|FG001|Overall Study|Withdrawal by Subject|0|||
161241940|NCT00867360|582267504|FG000|Overall Study|Physician Decision|0|||
161241941|NCT00867360|582267505|FG001|Overall Study|Physician Decision|1|||
161241942|NCT01824576|582267507|FG000|Overall Study|Device deficiency|2|||
161241943|NCT00436163|582267511|FG000|Overall Study|Lost to Follow-up|2|||
161241944|NCT00436163|582267511|FG000|Overall Study|Adverse Event|1|||
161241945|NCT02597049|582267512|FG000|Overall Study|Lost to Follow-up|0|||
160827022|NCT02761694|580751938|FG009|Overall Study|Physician Decision|0|||
160827023|NCT02761694|580751939|FG010|Overall Study|Physician Decision|0|||
160827024|NCT02761694|580751940|FG011|Overall Study|Physician Decision|0|||
160827025|NCT02761694|580751929|FG000|Overall Study|Withdrawal by Subject|0|||
160827026|NCT02761694|580751930|FG001|Overall Study|Withdrawal by Subject|0|||
160827027|NCT02761694|580751931|FG002|Overall Study|Withdrawal by Subject|0|||
160827028|NCT02761694|580751932|FG003|Overall Study|Withdrawal by Subject|1|||
160827029|NCT02761694|580751933|FG004|Overall Study|Withdrawal by Subject|0|||
160827030|NCT02761694|580751934|FG005|Overall Study|Withdrawal by Subject|0|||
160827031|NCT02761694|580751935|FG006|Overall Study|Withdrawal by Subject|4|||
160827032|NCT02761694|580751936|FG007|Overall Study|Withdrawal by Subject|0|||
160827033|NCT02761694|580751937|FG008|Overall Study|Withdrawal by Subject|2|||
160827034|NCT02761694|580751938|FG009|Overall Study|Withdrawal by Subject|1|||
160827035|NCT02761694|580751939|FG010|Overall Study|Withdrawal by Subject|0|||
160827036|NCT02761694|580751940|FG011|Overall Study|Withdrawal by Subject|0|||
160827037|NCT02761694|580751929|FG000|Overall Study|Lost to Follow-up|0|||
160827038|NCT02761694|580751930|FG001|Overall Study|Lost to Follow-up|0|||
160827039|NCT02761694|580751931|FG002|Overall Study|Lost to Follow-up|0|||
160827040|NCT02761694|580751932|FG003|Overall Study|Lost to Follow-up|0|||
160827041|NCT02761694|580751933|FG004|Overall Study|Lost to Follow-up|0|||
160827042|NCT02761694|580751934|FG005|Overall Study|Lost to Follow-up|0|||
160827043|NCT02761694|580751935|FG006|Overall Study|Lost to Follow-up|1|||
160827044|NCT02761694|580751936|FG007|Overall Study|Lost to Follow-up|0|||
160827045|NCT02761694|580751937|FG008|Overall Study|Lost to Follow-up|0|||
160827046|NCT02761694|580751938|FG009|Overall Study|Lost to Follow-up|0|||
160827047|NCT02761694|580751939|FG010|Overall Study|Lost to Follow-up|0|||
160827048|NCT02761694|580751940|FG011|Overall Study|Lost to Follow-up|1|||
160827049|NCT02761694|580751929|FG000|Overall Study|Adverse Event|0|||
160827050|NCT02761694|580751930|FG001|Overall Study|Adverse Event|0|||
160827051|NCT02761694|580751931|FG002|Overall Study|Adverse Event|0|||
160827052|NCT02761694|580751932|FG003|Overall Study|Adverse Event|0|||
160827053|NCT02761694|580751933|FG004|Overall Study|Adverse Event|0|||
160827054|NCT02761694|580751934|FG005|Overall Study|Adverse Event|0|||
160827055|NCT02761694|580751935|FG006|Overall Study|Adverse Event|1|||
160827056|NCT02761694|580751936|FG007|Overall Study|Adverse Event|0|||
160827057|NCT02761694|580751937|FG008|Overall Study|Adverse Event|1|||
161241946|NCT02597049|582267513|FG001|Overall Study|Lost to Follow-up|3|||
161241947|NCT02597049|582267514|FG002|Overall Study|Lost to Follow-up|2|||
161241948|NCT02597049|582267512|FG000|Overall Study|Withdrawal by Subject|2|||
161241949|NCT02597049|582267513|FG001|Overall Study|Withdrawal by Subject|2|||
161241950|NCT02597049|582267514|FG002|Overall Study|Withdrawal by Subject|1|||
161241951|NCT02597049|582267512|FG000|Overall Study|Adverse Event|2|||
161241952|NCT02597049|582267513|FG001|Overall Study|Adverse Event|0|||
161241953|NCT02597049|582267514|FG002|Overall Study|Adverse Event|0|||
161241954|NCT02597049|582267512|FG000|Overall Study|Death|2|||
161241955|NCT02597049|582267513|FG001|Overall Study|Death|0|||
161241956|NCT02597049|582267514|FG002|Overall Study|Death|0|||
161241957|NCT02597049|582267512|FG000|Overall Study|Noncompliant with Study Visits|1|||
161241958|NCT02597049|582267513|FG001|Overall Study|Noncompliant with Study Visits|0|||
161241959|NCT02597049|582267514|FG002|Overall Study|Noncompliant with Study Visits|0|||
161241960|NCT06647173|582267517|FG000|Overall Study|Lost to Follow-up|24|||
161241961|NCT01120028|582267518|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
161241962|NCT01120028|582267519|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
161241963|NCT01120028|582267520|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
160827058|NCT02761694|580751938|FG009|Overall Study|Adverse Event|0|||
160827059|NCT02761694|580751939|FG010|Overall Study|Adverse Event|0|||
161241964|NCT01120028|582267521|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
160827060|NCT02761694|580751940|FG011|Overall Study|Adverse Event|1|||
160827061|NCT02761694|580751929|FG000|Overall Study|Other|4|||
161241965|NCT01120028|582267518|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
160827062|NCT02761694|580751930|FG001|Overall Study|Other|4|||
160990066|NCT02950545|581351737|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
160990067|NCT02950545|581351732|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
160990068|NCT02950545|581351733|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990069|NCT02950545|581351734|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990070|NCT02950545|581351735|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990071|NCT02950545|581351736|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990072|NCT02950545|581351737|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
160990073|NCT02950545|581351732|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990074|NCT02950545|581351733|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990075|NCT02950545|581351734|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990076|NCT02950545|581351735|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
161334406|NCT03636256|582614109|FG000|Overall Study|Withdrawal by Subject|0|||
161334407|NCT03636256|582614110|FG001|Overall Study|Withdrawal by Subject|0|||
161334408|NCT03636256|582614111|FG002|Overall Study|Withdrawal by Subject|0|||
161334409|NCT03636256|582614112|FG003|Overall Study|Withdrawal by Subject|0|||
160990077|NCT02950545|581351736|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
160990078|NCT02950545|581351737|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
160990079|NCT04296942|581351738|FG000|Overall Study|Study closure by sponsor|1|||
160990080|NCT04296942|581351739|FG001|Overall Study|Study closure by sponsor|0|||
160990081|NCT04296942|581351740|FG002|Overall Study|Study closure by sponsor|0|||
161133689|NCT02764541|581873002|FG007|Overall Study|Adverse Event|0|||
161133690|NCT02764541|581872995|FG000|Overall Study|Metastasis|1|||
161133691|NCT02764541|581872996|FG001|Overall Study|Metastasis|0|||
161133692|NCT02764541|581872997|FG002|Overall Study|Metastasis|0|||
161133693|NCT02764541|581872998|FG003|Overall Study|Metastasis|0|||
161133694|NCT02764541|581872999|FG004|Overall Study|Metastasis|0|||
161133695|NCT02764541|581873000|FG005|Overall Study|Metastasis|0|||
161133696|NCT02764541|581873001|FG006|Overall Study|Metastasis|0|||
161133697|NCT02764541|581873002|FG007|Overall Study|Metastasis|0|||
161133698|NCT02764541|581872995|FG000|Overall Study|Disease progression|1|||
161133699|NCT02764541|581872996|FG001|Overall Study|Disease progression|1|||
161133700|NCT02764541|581872997|FG002|Overall Study|Disease progression|0|||
161133701|NCT02764541|581872998|FG003|Overall Study|Disease progression|0|||
161133702|NCT02764541|581872999|FG004|Overall Study|Disease progression|0|||
161133703|NCT02764541|581873000|FG005|Overall Study|Disease progression|0|||
161133704|NCT02764541|581873001|FG006|Overall Study|Disease progression|0|||
161133705|NCT02764541|581873002|FG007|Overall Study|Disease progression|1|||
161133706|NCT02764541|581872995|FG000|Overall Study|Protocol Violation|0|||
161133707|NCT02764541|581872996|FG001|Overall Study|Protocol Violation|0|||
161133708|NCT02764541|581872997|FG002|Overall Study|Protocol Violation|0|||
161133709|NCT02764541|581872998|FG003|Overall Study|Protocol Violation|1|||
161133710|NCT02764541|581872999|FG004|Overall Study|Protocol Violation|0|||
161133711|NCT02764541|581873000|FG005|Overall Study|Protocol Violation|1|||
161133712|NCT02764541|581873001|FG006|Overall Study|Protocol Violation|0|||
161133713|NCT02764541|581873002|FG007|Overall Study|Protocol Violation|0|||
161133714|NCT02764541|581872995|FG000|Overall Study|Physician Decision|0|||
161133715|NCT02764541|581872996|FG001|Overall Study|Physician Decision|0|||
161133716|NCT02764541|581872997|FG002|Overall Study|Physician Decision|0|||
161133717|NCT02764541|581872998|FG003|Overall Study|Physician Decision|1|||
161133718|NCT02764541|581872999|FG004|Overall Study|Physician Decision|0|||
161133719|NCT02764541|581873000|FG005|Overall Study|Physician Decision|0|||
161133720|NCT02764541|581873001|FG006|Overall Study|Physician Decision|0|||
161133721|NCT02764541|581873002|FG007|Overall Study|Physician Decision|1|||
161133722|NCT02764541|581872995|FG000|Overall Study|Three Cycles completed before surgery|0|||
161133723|NCT02764541|581872996|FG001|Overall Study|Three Cycles completed before surgery|0|||
161133724|NCT02764541|581872997|FG002|Overall Study|Three Cycles completed before surgery|0|||
161133725|NCT02764541|581872998|FG003|Overall Study|Three Cycles completed before surgery|1|||
161133726|NCT02764541|581872999|FG004|Overall Study|Three Cycles completed before surgery|0|||
161133727|NCT02764541|581873000|FG005|Overall Study|Three Cycles completed before surgery|0|||
161133728|NCT02764541|581873001|FG006|Overall Study|Three Cycles completed before surgery|0|||
161133729|NCT02764541|581873002|FG007|Overall Study|Three Cycles completed before surgery|0|||
161133730|NCT02764541|581872995|FG000|Overall Study|Patient Compliance|0|||
161133731|NCT02764541|581872996|FG001|Overall Study|Patient Compliance|0|||
161133732|NCT02764541|581872997|FG002|Overall Study|Patient Compliance|1|||
161133733|NCT02764541|581872998|FG003|Overall Study|Patient Compliance|0|||
161133734|NCT02764541|581872999|FG004|Overall Study|Patient Compliance|0|||
161133735|NCT02764541|581873000|FG005|Overall Study|Patient Compliance|0|||
161133736|NCT02764541|581873001|FG006|Overall Study|Patient Compliance|0|||
161133737|NCT02764541|581873002|FG007|Overall Study|Patient Compliance|0|||
161133738|NCT02764541|581872995|FG000|Overall Study|Death|0|||
161133739|NCT02764541|581872996|FG001|Overall Study|Death|0|||
161133740|NCT02764541|581872997|FG002|Overall Study|Death|0|||
161334410|NCT03636256|582614113|FG004|Overall Study|Withdrawal by Subject|0|||
161334411|NCT03636256|582614114|FG005|Overall Study|Withdrawal by Subject|0|||
161133741|NCT02764541|581872998|FG003|Overall Study|Death|0|||
161133742|NCT02764541|581872999|FG004|Overall Study|Death|0|||
161133743|NCT02764541|581873000|FG005|Overall Study|Death|0|||
161133744|NCT02764541|581873001|FG006|Overall Study|Death|1|||
161241966|NCT01120028|582267519|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
161241967|NCT01120028|582267520|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
161241968|NCT01120028|582267521|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
161241969|NCT03250117|582267522|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
161241970|NCT03250117|582267523|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161241971|NCT03250117|582267524|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161241972|NCT03250117|582267525|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
161241973|NCT04063878|582267526|FG000|Overall Study|Withdrawal by Subject|2|||
161241974|NCT04063878|582267526|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
161241975|NCT02751827|582267527|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
161241976|NCT02751827|582267528|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
161241977|NCT02751827|582267529|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
161241978|NCT01248728|582267530|FG000|Overall Study|Adverse Event|1|||
161241979|NCT01248728|582267531|FG001|Overall Study|Adverse Event|1|||
161241980|NCT01248728|582267530|FG000|Overall Study|Withdrawal by Subject|2|||
161241981|NCT01248728|582267531|FG001|Overall Study|Withdrawal by Subject|1|||
161241982|NCT01248728|582267530|FG000|Overall Study|Lack of Efficacy|1|||
161241983|NCT01248728|582267531|FG001|Overall Study|Lack of Efficacy|0|||
161241984|NCT01841554|582267532|FG000|Overall Study|Death|7|||
161241985|NCT01841554|582267532|FG000|Overall Study|No Implantation|1|||
161241986|NCT01841554|582267532|FG000|Overall Study|Discontinued Follow Up|5|||
161241987|NCT01841554|582267532|FG000|Overall Study|Study exit due to secondary intervention|6|||
161241988|NCT00147498|582267533|FG000|Overall Study|Adverse Event|1|||
161241989|NCT00147498|582267534|FG001|Overall Study|Adverse Event|6|||
161241990|NCT00147498|582267535|FG002|Overall Study|Adverse Event|7|||
161241991|NCT00147498|582267536|FG003|Overall Study|Adverse Event|3|||
161241992|NCT00147498|582267533|FG000|Overall Study|Lack of Efficacy|1|||
161241993|NCT00147498|582267534|FG001|Overall Study|Lack of Efficacy|1|||
161241994|NCT00147498|582267535|FG002|Overall Study|Lack of Efficacy|1|||
161241995|NCT00147498|582267536|FG003|Overall Study|Lack of Efficacy|8|||
161241996|NCT00147498|582267533|FG000|Overall Study|Laboratory abnormality|0|||
161241997|NCT00147498|582267534|FG001|Overall Study|Laboratory abnormality|0|||
161241998|NCT00147498|582267535|FG002|Overall Study|Laboratory abnormality|2|||
161241999|NCT00147498|582267536|FG003|Overall Study|Laboratory abnormality|0|||
161242000|NCT00147498|582267533|FG000|Overall Study|Participant defaulted|0|||
161242001|NCT00147498|582267534|FG001|Overall Study|Participant defaulted|1|||
161242002|NCT00147498|582267535|FG002|Overall Study|Participant defaulted|4|||
161242003|NCT00147498|582267536|FG003|Overall Study|Participant defaulted|3|||
161242004|NCT00147498|582267533|FG000|Overall Study|Other|1|||
161242005|NCT00147498|582267534|FG001|Overall Study|Other|1|||
161242006|NCT00147498|582267535|FG002|Overall Study|Other|3|||
161242007|NCT00147498|582267536|FG003|Overall Study|Other|3|||
161242008|NCT01838681|582267537|FG000|Period A|Adverse Event|39|||
161242009|NCT01838681|582267538|FG001|Period A|Adverse Event|0|||
161242010|NCT01838681|582267539|FG002|Period A|Adverse Event|0|||
161242011|NCT01838681|582267540|FG003|Period A|Adverse Event|0|||
161242012|NCT01838681|582267537|FG000|Period A|Lack of Efficacy|21|||
161242013|NCT01838681|582267538|FG001|Period A|Lack of Efficacy|0|||
161242014|NCT01838681|582267539|FG002|Period A|Lack of Efficacy|0|||
161242015|NCT01838681|582267540|FG003|Period A|Lack of Efficacy|0|||
161242016|NCT01838681|582267537|FG000|Period A|Early response|148|||
161242017|NCT01838681|582267538|FG001|Period A|Early response|0|||
161242018|NCT01838681|582267539|FG002|Period A|Early response|0|||
161242019|NCT01838681|582267540|FG003|Period A|Early response|0|||
161242020|NCT01838681|582267537|FG000|Period A|Withdrawal by Subject|70|||
161242021|NCT01838681|582267538|FG001|Period A|Withdrawal by Subject|0|||
160827063|NCT02761694|580751931|FG002|Overall Study|Other|1|||
160827064|NCT02761694|580751932|FG003|Overall Study|Other|2|||
160827065|NCT02761694|580751933|FG004|Overall Study|Other|3|||
160827066|NCT02761694|580751934|FG005|Overall Study|Other|3|||
160827067|NCT02761694|580751935|FG006|Overall Study|Other|18|||
160827068|NCT02761694|580751936|FG007|Overall Study|Other|8|||
161242022|NCT01838681|582267539|FG002|Period A|Withdrawal by Subject|0|||
161242023|NCT01838681|582267540|FG003|Period A|Withdrawal by Subject|0|||
161242024|NCT01838681|582267537|FG000|Period A|Protocol Violation|16|||
161242025|NCT01838681|582267538|FG001|Period A|Protocol Violation|0|||
161242026|NCT01838681|582267539|FG002|Period A|Protocol Violation|0|||
161242027|NCT01838681|582267540|FG003|Period A|Protocol Violation|0|||
160990082|NCT01579578|581351741|FG000|Overall Study|Death|4|||
161242028|NCT01838681|582267537|FG000|Period A|Non-compliance with IMP|6|||
161242029|NCT01838681|582267538|FG001|Period A|Non-compliance with IMP|0|||
161242030|NCT01838681|582267539|FG002|Period A|Non-compliance with IMP|0|||
161242031|NCT01838681|582267540|FG003|Period A|Non-compliance with IMP|0|||
161242032|NCT01838681|582267537|FG000|Period A|Lost to Follow-up|4|||
161242033|NCT01838681|582267538|FG001|Period A|Lost to Follow-up|0|||
160827069|NCT02761694|580751937|FG008|Overall Study|Other|0|||
161242034|NCT01838681|582267539|FG002|Period A|Lost to Follow-up|0|||
161242035|NCT01838681|582267540|FG003|Period A|Lost to Follow-up|0|||
161242036|NCT01838681|582267537|FG000|Period A|Withdrawal before treatment|4|||
161242037|NCT01838681|582267538|FG001|Period A|Withdrawal before treatment|0|||
161242038|NCT01838681|582267539|FG002|Period A|Withdrawal before treatment|0|||
161242039|NCT01838681|582267540|FG003|Period A|Withdrawal before treatment|0|||
161242040|NCT01838681|582267537|FG000|Period A|Administrative or other reasons|17|||
161242041|NCT01838681|582267538|FG001|Period A|Administrative or other reasons|0|||
161242042|NCT01838681|582267539|FG002|Period A|Administrative or other reasons|0|||
161242043|NCT01838681|582267540|FG003|Period A|Administrative or other reasons|0|||
161242044|NCT01838681|582267537|FG000|Period B/A+|Adverse Event|0|||
161242045|NCT01838681|582267538|FG001|Period B/A+|Adverse Event|13|||
161242046|NCT01838681|582267539|FG002|Period B/A+|Adverse Event|27|||
161242047|NCT01838681|582267540|FG003|Period B/A+|Adverse Event|16|||
161242048|NCT01838681|582267537|FG000|Period B/A+|Lack of Efficacy|0|||
161242049|NCT01838681|582267538|FG001|Period B/A+|Lack of Efficacy|9|||
161242050|NCT01838681|582267539|FG002|Period B/A+|Lack of Efficacy|11|||
161242051|NCT01838681|582267540|FG003|Period B/A+|Lack of Efficacy|6|||
161242052|NCT01838681|582267537|FG000|Period B/A+|Withdrawal by Subject|0|||
161242053|NCT01838681|582267538|FG001|Period B/A+|Withdrawal by Subject|28|||
161242054|NCT01838681|582267539|FG002|Period B/A+|Withdrawal by Subject|35|||
161242055|NCT01838681|582267540|FG003|Period B/A+|Withdrawal by Subject|47|||
161242056|NCT01838681|582267537|FG000|Period B/A+|Protocol Violation|0|||
161242057|NCT01838681|582267538|FG001|Period B/A+|Protocol Violation|1|||
161242058|NCT01838681|582267539|FG002|Period B/A+|Protocol Violation|4|||
161242059|NCT01838681|582267540|FG003|Period B/A+|Protocol Violation|6|||
161242060|NCT01838681|582267537|FG000|Period B/A+|Non-compliance with IMP|0|||
161242061|NCT01838681|582267538|FG001|Period B/A+|Non-compliance with IMP|2|||
161242062|NCT01838681|582267539|FG002|Period B/A+|Non-compliance with IMP|3|||
161242063|NCT01838681|582267540|FG003|Period B/A+|Non-compliance with IMP|3|||
161242064|NCT01838681|582267537|FG000|Period B/A+|Lost to Follow-up|0|||
161242065|NCT01838681|582267538|FG001|Period B/A+|Lost to Follow-up|2|||
161242066|NCT01838681|582267539|FG002|Period B/A+|Lost to Follow-up|5|||
161242067|NCT01838681|582267540|FG003|Period B/A+|Lost to Follow-up|11|||
161242068|NCT01838681|582267537|FG000|Period B/A+|Withdrawal before treatment|0|||
161242069|NCT01838681|582267538|FG001|Period B/A+|Withdrawal before treatment|1|||
161242070|NCT01838681|582267539|FG002|Period B/A+|Withdrawal before treatment|0|||
161242071|NCT01838681|582267540|FG003|Period B/A+|Withdrawal before treatment|0|||
161242072|NCT01838681|582267537|FG000|Period B/A+|Administrative or other reasons|0|||
161242073|NCT01838681|582267538|FG001|Period B/A+|Administrative or other reasons|6|||
161242074|NCT01838681|582267539|FG002|Period B/A+|Administrative or other reasons|10|||
161242075|NCT01838681|582267540|FG003|Period B/A+|Administrative or other reasons|28|||
161242076|NCT00312897|582267541|FG000|Overall Study|Adverse Event|1|||
161242077|NCT00312897|582267542|FG001|Overall Study|Adverse Event|0|||
161242078|NCT00312897|582267541|FG000|Overall Study|Lost to Follow-up|2|||
161242079|NCT00312897|582267542|FG001|Overall Study|Lost to Follow-up|0|||
161242080|NCT00312897|582267541|FG000|Overall Study|Physician Decision|1|||
161242081|NCT00312897|582267542|FG001|Overall Study|Physician Decision|0|||
161242082|NCT00312897|582267541|FG000|Overall Study|Withdrawal by Subject|1|||
161242083|NCT00312897|582267542|FG001|Overall Study|Withdrawal by Subject|3|||
161242084|NCT00312897|582267541|FG000|Overall Study|Pregnancy|1|||
161242085|NCT00312897|582267542|FG001|Overall Study|Pregnancy|0|||
161242086|NCT00312897|582267541|FG000|Overall Study|discontinued prior to getting treatment|0|||
161242087|NCT00312897|582267542|FG001|Overall Study|discontinued prior to getting treatment|3|||
161242088|NCT00902538|582267545|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
160902317|NCT00347360|581036043|FG012|Overall Study|Reason not listed/blank|0|||
160902318|NCT00347360|581036044|FG013|Overall Study|Reason not listed/blank|1|||
160902319|NCT00347360|581036045|FG014|Overall Study|Reason not listed/blank|0|||
160902320|NCT00347360|581036031|FG000|Overall Study|Per sponsors instruction|0|||
160902321|NCT00347360|581036032|FG001|Overall Study|Per sponsors instruction|1|||
160902322|NCT00347360|581036033|FG002|Overall Study|Per sponsors instruction|0|||
161242089|NCT00902538|582267546|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161242090|NCT00902538|582267547|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161242091|NCT00902538|582267548|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161242092|NCT00902538|582267549|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
161242093|NCT00902538|582267550|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
160902323|NCT00347360|581036034|FG003|Overall Study|Per sponsors instruction|0|||
160902324|NCT00347360|581036035|FG004|Overall Study|Per sponsors instruction|0|||
160990083|NCT01579578|581351742|FG001|Overall Study|Death|1|||
161242094|NCT00902538|582267545|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
161242095|NCT00902538|582267546|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161242096|NCT00902538|582267547|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
160990084|NCT01579578|581351741|FG000|Overall Study|Lost to Follow-up|1|||
161242097|NCT00902538|582267548|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161242098|NCT00902538|582267549|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161242099|NCT00902538|582267550|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
161242100|NCT00902538|582267545|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
161242101|NCT00902538|582267546|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161242102|NCT00902538|582267547|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161242103|NCT00902538|582267548|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161242104|NCT00902538|582267549|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161242105|NCT00902538|582267550|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
161242106|NCT00902538|582267545|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
161242107|NCT00902538|582267546|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161242108|NCT00902538|582267547|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161242109|NCT00902538|582267548|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161242110|NCT00902538|582267549|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161242111|NCT00902538|582267550|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
161242112|NCT00902538|582267545|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
161242113|NCT00902538|582267546|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161242114|NCT00902538|582267547|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161242115|NCT00902538|582267548|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161242116|NCT00902538|582267549|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161242117|NCT00902538|582267550|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
161242118|NCT00902538|582267545|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
161242119|NCT00902538|582267546|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
161242120|NCT00902538|582267547|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
161242121|NCT00902538|582267548|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161242122|NCT00902538|582267549|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161242123|NCT00902538|582267550|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
161242124|NCT00902538|582267545|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
161242125|NCT00902538|582267546|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
161242126|NCT00902538|582267547|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
161242127|NCT00902538|582267548|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161242128|NCT00902538|582267549|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161242129|NCT00902538|582267550|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
161242130|NCT00902538|582267545|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
161242131|NCT00902538|582267546|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161242132|NCT00902538|582267547|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
161242133|NCT00902538|582267548|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161242134|NCT00902538|582267549|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161242135|NCT00902538|582267550|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
161242136|NCT00902538|582267545|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
161242137|NCT00902538|582267546|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
161242138|NCT00902538|582267547|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
161242139|NCT00902538|582267548|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
161242140|NCT00902538|582267549|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
161242141|NCT00902538|582267550|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
161242142|NCT00902538|582267545|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
161242143|NCT00902538|582267546|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
161242144|NCT00902538|582267547|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
161242145|NCT00902538|582267548|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161242146|NCT00902538|582267549|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161242147|NCT00902538|582267550|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
161242148|NCT00902538|582267545|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
161242149|NCT00902538|582267546|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
161242150|NCT00902538|582267547|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
161242151|NCT00902538|582267548|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
161242152|NCT00902538|582267549|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
161242153|NCT00902538|582267550|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
161334412|NCT03636256|582614115|FG006|Overall Study|Withdrawal by Subject|0|||
161334413|NCT03636256|582614116|FG007|Overall Study|Withdrawal by Subject|0|||
160902325|NCT00347360|581036036|FG005|Overall Study|Per sponsors instruction|0|||
160902326|NCT00347360|581036037|FG006|Overall Study|Per sponsors instruction|0|||
160902327|NCT00347360|581036038|FG007|Overall Study|Per sponsors instruction|0|||
160902328|NCT00347360|581036039|FG008|Overall Study|Per sponsors instruction|0|||
160902329|NCT00347360|581036040|FG009|Overall Study|Per sponsors instruction|0|||
160902330|NCT00347360|581036041|FG010|Overall Study|Per sponsors instruction|0|||
160902331|NCT00347360|581036042|FG011|Overall Study|Per sponsors instruction|0|||
160902332|NCT00347360|581036043|FG012|Overall Study|Per sponsors instruction|0|||
160990085|NCT01579578|581351742|FG001|Overall Study|Lost to Follow-up|1|||
161242154|NCT00902538|582267545|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
161242155|NCT00902538|582267546|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
161242156|NCT00902538|582267547|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
161242157|NCT00902538|582267548|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
161242158|NCT00902538|582267549|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
161242159|NCT00902538|582267550|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
161242160|NCT00902538|582267545|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161242161|NCT00902538|582267546|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
161242162|NCT00902538|582267547|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161242163|NCT00902538|582267548|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161242164|NCT00902538|582267549|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
160902333|NCT00347360|581036044|FG013|Overall Study|Per sponsors instruction|0|||
160902334|NCT00347360|581036045|FG014|Overall Study|Per sponsors instruction|0|||
160902335|NCT00347360|581036031|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
160902336|NCT00347360|581036032|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
160902337|NCT00347360|581036033|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
160902338|NCT00347360|581036034|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
160902339|NCT00347360|581036035|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
161242165|NCT00902538|582267550|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
161242166|NCT00902538|582267545|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161242167|NCT00902538|582267546|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
161242168|NCT00902538|582267547|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161242169|NCT00902538|582267548|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161242170|NCT00902538|582267549|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161242171|NCT00902538|582267550|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
161242172|NCT00902538|582267545|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161242173|NCT00902538|582267546|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161242174|NCT00902538|582267547|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
161242175|NCT00902538|582267548|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
161242176|NCT00902538|582267549|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
161242177|NCT00902538|582267550|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
161133745|NCT02764541|581873002|FG007|Overall Study|Death|0|||
161133746|NCT02764541|581872995|FG000|Overall Study|Insurance reasons|0|||
161133747|NCT02764541|581872996|FG001|Overall Study|Insurance reasons|0|||
161133748|NCT02764541|581872997|FG002|Overall Study|Insurance reasons|0|||
161242178|NCT00902538|582267545|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161242179|NCT00902538|582267546|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161242180|NCT00902538|582267547|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
161242181|NCT00902538|582267548|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
161242182|NCT00902538|582267549|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
161242183|NCT00902538|582267550|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
160902340|NCT00347360|581036036|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
160902341|NCT00347360|581036037|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
160902342|NCT00347360|581036038|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
161133749|NCT02764541|581872998|FG003|Overall Study|Insurance reasons|0|||
161133750|NCT02764541|581872999|FG004|Overall Study|Insurance reasons|0|||
161133751|NCT02764541|581873000|FG005|Overall Study|Insurance reasons|0|||
161133752|NCT02764541|581873001|FG006|Overall Study|Insurance reasons|1|||
161133753|NCT02764541|581873002|FG007|Overall Study|Insurance reasons|0|||
161133754|NCT02048904|581873005|FG000|Overall Study|Withdrawal by Subject|7|||
161133755|NCT02048904|581873005|FG000|Overall Study|Physician Decision|70|||
161133756|NCT00749190|581873006|FG000|Overall Study|Adverse Event|0|||
161133757|NCT00749190|581873007|FG001|Overall Study|Adverse Event|2|||
161133758|NCT00749190|581873008|FG002|Overall Study|Adverse Event|0|||
161133759|NCT00749190|581873009|FG003|Overall Study|Adverse Event|4|||
161133760|NCT00749190|581873010|FG004|Overall Study|Adverse Event|0|||
161133761|NCT00749190|581873011|FG005|Overall Study|Adverse Event|3|||
161133762|NCT00749190|581873012|FG006|Overall Study|Adverse Event|0|||
161133763|NCT00749190|581873006|FG000|Overall Study|Lack of Efficacy|3|||
161133764|NCT00749190|581873007|FG001|Overall Study|Lack of Efficacy|1|||
161133765|NCT00749190|581873008|FG002|Overall Study|Lack of Efficacy|1|||
161133766|NCT00749190|581873009|FG003|Overall Study|Lack of Efficacy|0|||
161242184|NCT00902538|582267545|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
160902343|NCT00347360|581036039|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
160902344|NCT00347360|581036040|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
160902345|NCT00347360|581036041|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
160902346|NCT00347360|581036042|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
161133767|NCT00749190|581873010|FG004|Overall Study|Lack of Efficacy|0|||
161133768|NCT00749190|581873011|FG005|Overall Study|Lack of Efficacy|1|||
161133769|NCT00749190|581873012|FG006|Overall Study|Lack of Efficacy|0|||
161242185|NCT00902538|582267546|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161242186|NCT00902538|582267547|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161242187|NCT00902538|582267548|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
161242188|NCT00902538|582267549|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161242189|NCT00902538|582267550|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
161242190|NCT01279486|582267553|FG000|Overall Study|Lost to Follow-up|1|||
161242191|NCT03215706|582267558|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161242192|NCT03215706|582267559|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161242193|NCT03215706|582267558|FG000|Randomization|participant withdrew consent|1|||
161242194|NCT03215706|582267559|FG001|Randomization|participant withdrew consent|3|||
161242195|NCT03215706|582267558|FG000|Randomization|no longer meets study criteria|1|||
161242196|NCT03215706|582267559|FG001|Randomization|no longer meets study criteria|4|||
160902347|NCT00347360|581036043|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
160902348|NCT00347360|581036044|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
160902349|NCT00347360|581036045|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
160902350|NCT00347360|581036031|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
160902351|NCT00347360|581036032|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
160902352|NCT00347360|581036033|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
160902353|NCT00347360|581036034|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
160902354|NCT00347360|581036035|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
160902355|NCT00347360|581036036|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
160902356|NCT00347360|581036037|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
160902357|NCT00347360|581036038|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
160902358|NCT00347360|581036039|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
160902359|NCT00347360|581036040|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
160902360|NCT00347360|581036041|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
160902361|NCT00347360|581036042|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
160902362|NCT00347360|581036043|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
160902363|NCT00347360|581036044|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
160902364|NCT00347360|581036045|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
160902365|NCT00347360|581036031|FG000|Overall Study|Abnormal lab values|0|||
160902366|NCT00347360|581036032|FG001|Overall Study|Abnormal lab values|0|||
160902367|NCT00347360|581036033|FG002|Overall Study|Abnormal lab values|0|||
160902368|NCT00347360|581036034|FG003|Overall Study|Abnormal lab values|0|||
160902369|NCT00347360|581036035|FG004|Overall Study|Abnormal lab values|0|||
160902370|NCT00347360|581036036|FG005|Overall Study|Abnormal lab values|0|||
160902371|NCT00347360|581036037|FG006|Overall Study|Abnormal lab values|1|||
160902372|NCT00347360|581036038|FG007|Overall Study|Abnormal lab values|0|||
160902373|NCT00347360|581036039|FG008|Overall Study|Abnormal lab values|0|||
160902374|NCT00347360|581036040|FG009|Overall Study|Abnormal lab values|0|||
160902375|NCT00347360|581036041|FG010|Overall Study|Abnormal lab values|0|||
160902376|NCT00347360|581036042|FG011|Overall Study|Abnormal lab values|0|||
160902377|NCT00347360|581036043|FG012|Overall Study|Abnormal lab values|0|||
160902378|NCT00347360|581036044|FG013|Overall Study|Abnormal lab values|0|||
160902379|NCT00347360|581036045|FG014|Overall Study|Abnormal lab values|0|||
160902380|NCT00347360|581036031|FG000|Overall Study|PI recommended early withdrawal|0|||
160902381|NCT00347360|581036032|FG001|Overall Study|PI recommended early withdrawal|0|||
160902382|NCT00347360|581036033|FG002|Overall Study|PI recommended early withdrawal|0|||
160902383|NCT00347360|581036034|FG003|Overall Study|PI recommended early withdrawal|0|||
160902384|NCT00347360|581036035|FG004|Overall Study|PI recommended early withdrawal|0|||
160902385|NCT00347360|581036036|FG005|Overall Study|PI recommended early withdrawal|0|||
160902386|NCT00347360|581036037|FG006|Overall Study|PI recommended early withdrawal|0|||
160902387|NCT00347360|581036038|FG007|Overall Study|PI recommended early withdrawal|0|||
160902388|NCT00347360|581036039|FG008|Overall Study|PI recommended early withdrawal|0|||
160902389|NCT00347360|581036040|FG009|Overall Study|PI recommended early withdrawal|1|||
160902390|NCT00347360|581036041|FG010|Overall Study|PI recommended early withdrawal|0|||
160902391|NCT00347360|581036042|FG011|Overall Study|PI recommended early withdrawal|0|||
160902392|NCT00347360|581036043|FG012|Overall Study|PI recommended early withdrawal|0|||
160902393|NCT00347360|581036044|FG013|Overall Study|PI recommended early withdrawal|0|||
160902394|NCT00347360|581036045|FG014|Overall Study|PI recommended early withdrawal|0|||
160902395|NCT00347360|581036031|FG000|Overall Study|Did not meet criteria before ABPM|0|||
160902396|NCT00347360|581036032|FG001|Overall Study|Did not meet criteria before ABPM|0|||
160902397|NCT00347360|581036033|FG002|Overall Study|Did not meet criteria before ABPM|0|||
160902398|NCT00347360|581036034|FG003|Overall Study|Did not meet criteria before ABPM|0|||
160902399|NCT00347360|581036035|FG004|Overall Study|Did not meet criteria before ABPM|0|||
160902400|NCT00347360|581036036|FG005|Overall Study|Did not meet criteria before ABPM|0|||
160902401|NCT00347360|581036037|FG006|Overall Study|Did not meet criteria before ABPM|0|||
160902402|NCT00347360|581036038|FG007|Overall Study|Did not meet criteria before ABPM|0|||
160902403|NCT00347360|581036039|FG008|Overall Study|Did not meet criteria before ABPM|0|||
160902404|NCT00347360|581036040|FG009|Overall Study|Did not meet criteria before ABPM|0|||
161242197|NCT03215706|582267558|FG000|Randomization|other reasons|0|||
161242198|NCT03215706|582267559|FG001|Randomization|other reasons|2|||
161242199|NCT03215706|582267558|FG000|Treatment Period|Disease Progression|184|||
161242200|NCT03215706|582267559|FG001|Treatment Period|Disease Progression|174|||
161242201|NCT03215706|582267558|FG000|Treatment Period|Study Drug Toxicity|70|||
161242202|NCT03215706|582267559|FG001|Treatment Period|Study Drug Toxicity|24|||
161242203|NCT03215706|582267558|FG000|Treatment Period|Death|7|||
161242204|NCT03215706|582267559|FG001|Treatment Period|Death|1|||
161242205|NCT03215706|582267558|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
161242206|NCT03215706|582267559|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
161242207|NCT03215706|582267558|FG000|Treatment Period|Request to D/C treatment|2|||
161242208|NCT03215706|582267559|FG001|Treatment Period|Request to D/C treatment|10|||
161242209|NCT03215706|582267558|FG000|Treatment Period|Participant withdrew consent|4|||
161242210|NCT03215706|582267559|FG001|Treatment Period|Participant withdrew consent|5|||
161242211|NCT03215706|582267558|FG000|Treatment Period|Lost to Follow-up|0|||
161242212|NCT03215706|582267559|FG001|Treatment Period|Lost to Follow-up|1|||
161242213|NCT03215706|582267558|FG000|Treatment Period|Administrative reason by sponsor|0|||
161242214|NCT03215706|582267559|FG001|Treatment Period|Administrative reason by sponsor|2|||
161242215|NCT03215706|582267558|FG000|Treatment Period|other reasons|10|||
161242216|NCT03215706|582267559|FG001|Treatment Period|other reasons|5|||
161242217|NCT03215706|582267558|FG000|Treatment Period|Not reported|1|||
161242218|NCT03215706|582267559|FG001|Treatment Period|Not reported|0|||
161242219|NCT03506633|582269343|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
161242220|NCT03506633|582269344|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
161242221|NCT00640341|582269347|FG000|Overall Study|Adverse Event|0|||
161242222|NCT00640341|582269348|FG001|Overall Study|Adverse Event|0|||
161242223|NCT00640341|582269349|FG002|Overall Study|Adverse Event|1|||
161242224|NCT00640341|582269347|FG000|Overall Study|Positive Slit Lamp Findings|0|||
161242225|NCT00640341|582269348|FG001|Overall Study|Positive Slit Lamp Findings|0|||
161242226|NCT00640341|582269349|FG002|Overall Study|Positive Slit Lamp Findings|1|||
161242227|NCT00640341|582269347|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
161242228|NCT00640341|582269348|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
161242229|NCT00640341|582269349|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
161242230|NCT00640341|582269347|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
161242231|NCT00640341|582269348|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
161242232|NCT00640341|582269349|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
161242233|NCT00640341|582269347|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
161242234|NCT00640341|582269348|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
161242235|NCT00640341|582269349|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
161242236|NCT00640341|582269347|FG000|Overall Study|Lost to Follow-up|2|||
161242237|NCT00640341|582269348|FG001|Overall Study|Lost to Follow-up|0|||
161242238|NCT00640341|582269349|FG002|Overall Study|Lost to Follow-up|0|||
161242239|NCT00640341|582269347|FG000|Overall Study|Withdrawal by Subject|4|||
161242240|NCT00640341|582269348|FG001|Overall Study|Withdrawal by Subject|0|||
161242241|NCT00640341|582269349|FG002|Overall Study|Withdrawal by Subject|1|||
161242242|NCT00640341|582269347|FG000|Overall Study|Unacceptable Lens Movement|1|||
161242243|NCT00640341|582269348|FG001|Overall Study|Unacceptable Lens Movement|0|||
161242244|NCT00640341|582269349|FG002|Overall Study|Unacceptable Lens Movement|0|||
161242245|NCT00640341|582269347|FG000|Overall Study|Poor fit/Uncomfortable|4|||
161242246|NCT00640341|582269348|FG001|Overall Study|Poor fit/Uncomfortable|0|||
161242247|NCT00640341|582269349|FG002|Overall Study|Poor fit/Uncomfortable|0|||
161242248|NCT00640341|582269347|FG000|Overall Study|Ineligable at Baseline|5|||
161242249|NCT00640341|582269348|FG001|Overall Study|Ineligable at Baseline|3|||
161242250|NCT00640341|582269349|FG002|Overall Study|Ineligable at Baseline|2|||
161242251|NCT00640341|582269347|FG000|Overall Study|Adverse event and positive slit lamp|1|||
161242252|NCT00640341|582269348|FG001|Overall Study|Adverse event and positive slit lamp|0|||
161242253|NCT00640341|582269349|FG002|Overall Study|Adverse event and positive slit lamp|0|||
161242254|NCT03247686|582269352|FG000|Overall Study|Withdrawal by Subject|1|||
161242255|NCT03247686|582269353|FG001|Overall Study|Withdrawal by Subject|2|||
161242256|NCT02302716|582269354|FG000|Overall Study|Adverse Event|1|||
161242257|NCT02302716|582269355|FG001|Overall Study|Adverse Event|1|||
161242258|NCT02302716|582269354|FG000|Overall Study|Death|0|||
161242259|NCT02302716|582269355|FG001|Overall Study|Death|1|||
161242260|NCT02302716|582269354|FG000|Overall Study|Lack of Efficacy|0|||
161242261|NCT02302716|582269355|FG001|Overall Study|Lack of Efficacy|1|||
161242262|NCT02302716|582269354|FG000|Overall Study|Lost to Follow-up|2|||
161242263|NCT02302716|582269355|FG001|Overall Study|Lost to Follow-up|4|||
161242264|NCT02302716|582269354|FG000|Overall Study|Physician Decision|3|||
161242265|NCT02302716|582269355|FG001|Overall Study|Physician Decision|4|||
161242266|NCT02302716|582269354|FG000|Overall Study|Withdrawal by Subject|13|||
161242267|NCT02302716|582269355|FG001|Overall Study|Withdrawal by Subject|7|||
161242268|NCT02302716|582269354|FG000|Overall Study|Protocol Violation|0|||
161242269|NCT02302716|582269355|FG001|Overall Study|Protocol Violation|1|||
161242270|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Subject request|8|||
161242271|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Subject request|11|||
161242272|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
161242273|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
161242274|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
161242275|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
161242276|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
161242277|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
161242278|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
161242279|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
161242280|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
161242281|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
161133770|NCT00749190|581873006|FG000|Overall Study|Withdrawal by Subject|2|||
161242282|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Death|1|||
161242283|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Death|0|||
161242284|NCT00521586|582269360|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
161242285|NCT00521586|582269361|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
161242286|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
161133771|NCT00749190|581873007|FG001|Overall Study|Withdrawal by Subject|1|||
161133772|NCT00749190|581873008|FG002|Overall Study|Withdrawal by Subject|0|||
161133773|NCT00749190|581873009|FG003|Overall Study|Withdrawal by Subject|0|||
161133774|NCT00749190|581873010|FG004|Overall Study|Withdrawal by Subject|0|||
161133775|NCT00749190|581873011|FG005|Overall Study|Withdrawal by Subject|1|||
161133776|NCT00749190|581873012|FG006|Overall Study|Withdrawal by Subject|0|||
161133777|NCT00749190|581873006|FG000|Overall Study|Protocol Violation|0|||
161133778|NCT00749190|581873007|FG001|Overall Study|Protocol Violation|1|||
161133779|NCT00749190|581873008|FG002|Overall Study|Protocol Violation|0|||
161133780|NCT00749190|581873009|FG003|Overall Study|Protocol Violation|0|||
161133781|NCT00749190|581873010|FG004|Overall Study|Protocol Violation|0|||
161133782|NCT00749190|581873011|FG005|Overall Study|Protocol Violation|0|||
161133783|NCT00749190|581873012|FG006|Overall Study|Protocol Violation|1|||
161133784|NCT00749190|581873006|FG000|Overall Study|Other reason not defined above|0|||
161133785|NCT00749190|581873007|FG001|Overall Study|Other reason not defined above|0|||
161133786|NCT00749190|581873008|FG002|Overall Study|Other reason not defined above|0|||
161133787|NCT00749190|581873009|FG003|Overall Study|Other reason not defined above|1|||
161133788|NCT00749190|581873010|FG004|Overall Study|Other reason not defined above|0|||
161133789|NCT00749190|581873011|FG005|Overall Study|Other reason not defined above|0|||
161133790|NCT00749190|581873012|FG006|Overall Study|Other reason not defined above|0|||
161133791|NCT04752384|581873014|FG000|Overall Study|Withdrawal by Subject|1|||
161133792|NCT04752384|581873014|FG000|Overall Study|Death|1|||
161133793|NCT04439331|581873021|FG000|Overall Study|Never Start Protocol Therapy|2|||
161133794|NCT04439331|581873021|FG000|Overall Study|Ineligible|2|||
161133795|NCT04439331|581873021|FG000|Overall Study|Mutation Status Not Confirmed|1|||
161133796|NCT04439331|581873021|FG000|Overall Study|Adverse Event|1|||
161133797|NCT04439331|581873021|FG000|Overall Study|Death|1|||
161133798|NCT04439331|581873021|FG000|Overall Study|Disease Progression|20|||
161133799|NCT04439331|581873021|FG000|Overall Study|Withdrawal by Subject|6|||
161242287|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
161242288|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
161242289|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
161242290|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
161242291|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
161242292|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
161242293|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
161242294|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
161242295|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
161242296|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
161242297|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
161242298|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
161242299|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
161242300|NCT00521586|582269360|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
161242301|NCT00521586|582269361|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
161242302|NCT00521586|582269360|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
161242303|NCT00521586|582269361|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
161242304|NCT00521586|582269360|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
161242305|NCT00521586|582269361|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
161242306|NCT00521586|582269360|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
161133800|NCT04439331|581873021|FG000|Overall Study|Physician Decision|1|||
161133801|NCT04439331|581873021|FG000|Overall Study|Other Complicating Disease|1|||
161133802|NCT03726268|581873023|FG000|Overall Study|Physician Decision|2|||
161133803|NCT03726268|581873024|FG001|Overall Study|Physician Decision|8|||
161133804|NCT03726268|581873025|FG002|Overall Study|Physician Decision|6|||
161242307|NCT00521586|582269361|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
161133805|NCT03726268|581873026|FG003|Overall Study|Physician Decision|3|||
161242308|NCT00529763|582269362|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
161242309|NCT00529763|582269363|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
161242310|NCT00529763|582269364|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
161242311|NCT00529763|582269362|FG000|Overall Study|Death|1|||
161242312|NCT00529763|582269363|FG001|Overall Study|Death|1|||
161242313|NCT00529763|582269364|FG002|Overall Study|Death|1|||
161242314|NCT00529763|582269362|FG000|Overall Study|Disease Progression|10|||
161242315|NCT00529763|582269363|FG001|Overall Study|Disease Progression|16|||
161242316|NCT00529763|582269364|FG002|Overall Study|Disease Progression|11|||
161242317|NCT00529763|582269362|FG000|Overall Study|Lost to Follow-up|1|||
161242318|NCT00529763|582269363|FG001|Overall Study|Lost to Follow-up|2|||
161242319|NCT00529763|582269364|FG002|Overall Study|Lost to Follow-up|3|||
161242320|NCT00529763|582269362|FG000|Overall Study|Stem Cell Transplant|0|||
161242321|NCT00529763|582269363|FG001|Overall Study|Stem Cell Transplant|3|||
161242322|NCT00529763|582269364|FG002|Overall Study|Stem Cell Transplant|1|||
161242323|NCT00529763|582269362|FG000|Overall Study|Study Drug Toxicity|3|||
161242324|NCT00529763|582269363|FG001|Overall Study|Study Drug Toxicity|6|||
161242325|NCT00529763|582269364|FG002|Overall Study|Study Drug Toxicity|4|||
161242326|NCT00529763|582269362|FG000|Overall Study|Participant Withdrew Consent|2|||
161242327|NCT00529763|582269363|FG001|Overall Study|Participant Withdrew Consent|3|||
161242328|NCT00529763|582269364|FG002|Overall Study|Participant Withdrew Consent|4|||
161242329|NCT00529763|582269362|FG000|Overall Study|Other reasons|2|||
161242330|NCT00529763|582269363|FG001|Overall Study|Other reasons|0|||
161242331|NCT00529763|582269364|FG002|Overall Study|Other reasons|2|||
161242332|NCT00529763|582269362|FG000|Overall Study|Participant request to discontinue treatment|1|||
161242333|NCT00529763|582269363|FG001|Overall Study|Participant request to discontinue treatment|1|||
161242334|NCT00529763|582269364|FG002|Overall Study|Participant request to discontinue treatment|3|||
161242335|NCT03669250|582269365|FG000|Overall Study|Adverse Event|0|||
161242336|NCT03669250|582269366|FG001|Overall Study|Adverse Event|0|||
161242337|NCT03669250|582269367|FG002|Overall Study|Adverse Event|0|||
161242338|NCT03669250|582269368|FG003|Overall Study|Adverse Event|0|||
161242339|NCT03669250|582269369|FG004|Overall Study|Adverse Event|1|||
161242340|NCT03669250|582269370|FG005|Overall Study|Adverse Event|0|||
161242341|NCT03669250|582269365|FG000|Overall Study|Withdrawal by Subject|0|||
161242342|NCT03669250|582269366|FG001|Overall Study|Withdrawal by Subject|1|||
161242343|NCT03669250|582269367|FG002|Overall Study|Withdrawal by Subject|0|||
161242344|NCT03669250|582269368|FG003|Overall Study|Withdrawal by Subject|1|||
161242345|NCT03669250|582269369|FG004|Overall Study|Withdrawal by Subject|0|||
161242346|NCT03669250|582269370|FG005|Overall Study|Withdrawal by Subject|0|||
161242347|NCT00828321|582269371|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
161242348|NCT00828321|582269372|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
161242349|NCT00828321|582269371|FG000|Second Intervention|Protocol Violation|0|||
161242350|NCT00828321|582269372|FG001|Second Intervention|Protocol Violation|1|||
161242351|NCT02997176|582269373|FG000|Overall Study|Adverse Event|0|||
161242352|NCT02997176|582269374|FG001|Overall Study|Adverse Event|0|||
161242353|NCT02997176|582269375|FG002|Overall Study|Adverse Event|0|||
161242354|NCT02997176|582269376|FG003|Overall Study|Adverse Event|8|||
161242355|NCT02997176|582269373|FG000|Overall Study|Progressive Disease|1|||
161242356|NCT02997176|582269374|FG001|Overall Study|Progressive Disease|0|||
161242357|NCT02997176|582269375|FG002|Overall Study|Progressive Disease|1|||
161242358|NCT02997176|582269376|FG003|Overall Study|Progressive Disease|1|||
161242359|NCT02997176|582269373|FG000|Overall Study|Death|0|||
161242360|NCT02997176|582269374|FG001|Overall Study|Death|0|||
161242361|NCT02997176|582269375|FG002|Overall Study|Death|1|||
161242362|NCT02997176|582269376|FG003|Overall Study|Death|1|||
161242363|NCT02997176|582269373|FG000|Overall Study|Withdrawal by Subject|0|||
161242364|NCT02997176|582269374|FG001|Overall Study|Withdrawal by Subject|2|||
161242365|NCT02997176|582269375|FG002|Overall Study|Withdrawal by Subject|0|||
161242366|NCT02997176|582269376|FG003|Overall Study|Withdrawal by Subject|1|||
161242367|NCT00691704|582269377|FG000|Induction Therapy|Disease Progression|1|||
161242368|NCT00691704|582269377|FG000|Induction Therapy|Active Hepatitis|1|||
161242369|NCT00691704|582269377|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
161242370|NCT00691704|582269377|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
161242371|NCT00691704|582269377|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
161242372|NCT01993186|582269378|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
161242373|NCT01993186|582269379|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
161242374|NCT01993186|582269378|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
161242375|NCT01993186|582269379|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
161242376|NCT01993186|582269378|FG000|Open-Label Extension Period|Other, Not Specified|0|||
161334414|NCT03636256|582614117|FG008|Overall Study|Withdrawal by Subject|1|||
161242377|NCT01993186|582269379|FG001|Open-Label Extension Period|Other, Not Specified|1|||
161242378|NCT01993186|582269378|FG000|Open-Label Extension Period|Adverse Event|1|||
161242379|NCT01993186|582269379|FG001|Open-Label Extension Period|Adverse Event|0|||
161334415|NCT01218308|582614118|FG000|Overall Study|Adverse Event|1|||
160990086|NCT01579578|581351741|FG000|Overall Study|Withdrawal by Subject|2|||
161334416|NCT01218308|582614119|FG001|Overall Study|Adverse Event|2|||
161242380|NCT01993186|582269378|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
161242381|NCT01993186|582269379|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
161242382|NCT01993186|582269378|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
161242383|NCT01993186|582269379|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
161242384|NCT01993186|582269378|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
161242385|NCT01993186|582269379|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
161242386|NCT04523480|582269380|FG000|Overall Study|Lost to Follow-up|30|||
161242387|NCT04523480|582269381|FG001|Overall Study|Lost to Follow-up|35|||
161242388|NCT04523480|582269382|FG002|Overall Study|Lost to Follow-up|0|||
161242389|NCT02451696|582269383|FG000|Overall Study|Surgery postponed|1|||
161242390|NCT02451696|582269384|FG001|Overall Study|Surgery postponed|0|||
161242391|NCT00198133|582269385|FG000|Overall Study|Disease progression|2|||
161242392|NCT00198133|582269386|FG001|Overall Study|Disease progression|5|||
161242393|NCT00198133|582269385|FG000|Overall Study|Adverse Event|1|||
161242394|NCT00198133|582269386|FG001|Overall Study|Adverse Event|3|||
161242395|NCT00198133|582269385|FG000|Overall Study|Withdrawal by Subject|1|||
161242396|NCT00198133|582269386|FG001|Overall Study|Withdrawal by Subject|0|||
161242397|NCT00198133|582269385|FG000|Overall Study|Physician Decision|1|||
161242398|NCT00198133|582269386|FG001|Overall Study|Physician Decision|0|||
161242399|NCT01557751|582269387|FG000|Overall Study|Physician Decision|3|||
161242400|NCT00488774|582269388|FG000|Overall Study|Withdrawal of consent|2|||
161242401|NCT00488774|582269389|FG001|Overall Study|Withdrawal of consent|2|||
161242402|NCT00488774|582269390|FG002|Overall Study|Withdrawal of consent|2|||
161242403|NCT00488774|582269391|FG003|Overall Study|Withdrawal of consent|0|||
161242404|NCT00488774|582269388|FG000|Overall Study|Other|6|||
161242405|NCT00488774|582269389|FG001|Overall Study|Other|3|||
161242406|NCT00488774|582269390|FG002|Overall Study|Other|2|||
161242407|NCT00488774|582269391|FG003|Overall Study|Other|2|||
161242408|NCT00488774|582269388|FG000|Overall Study|Lost to Follow-up|0|||
161242409|NCT00488774|582269389|FG001|Overall Study|Lost to Follow-up|0|||
161242410|NCT00488774|582269390|FG002|Overall Study|Lost to Follow-up|1|||
161242411|NCT00488774|582269391|FG003|Overall Study|Lost to Follow-up|1|||
161242412|NCT05523895|582269392|FG000|Overall Study|Adverse Event|2|||
161242413|NCT05523895|582269393|FG001|Overall Study|Adverse Event|1|||
161242414|NCT05523895|582269394|FG002|Overall Study|Adverse Event|1|||
161242415|NCT05523895|582269392|FG000|Overall Study|Lost to Follow-up|0|||
161242416|NCT05523895|582269393|FG001|Overall Study|Lost to Follow-up|1|||
161242417|NCT05523895|582269394|FG002|Overall Study|Lost to Follow-up|2|||
161242418|NCT05523895|582269392|FG000|Overall Study|Noncompliance with study drug|1|||
161242419|NCT05523895|582269393|FG001|Overall Study|Noncompliance with study drug|1|||
161242420|NCT05523895|582269394|FG002|Overall Study|Noncompliance with study drug|1|||
161242421|NCT05523895|582269392|FG000|Overall Study|Protocol Violation|0|||
161242422|NCT05523895|582269393|FG001|Overall Study|Protocol Violation|2|||
161242423|NCT05523895|582269394|FG002|Overall Study|Protocol Violation|0|||
161242424|NCT05523895|582269392|FG000|Overall Study|Withdrawal by Subject|1|||
161242425|NCT05523895|582269393|FG001|Overall Study|Withdrawal by Subject|3|||
161242426|NCT05523895|582269394|FG002|Overall Study|Withdrawal by Subject|1|||
161242427|NCT05523895|582269392|FG000|Overall Study|Not further specified|0|||
161242428|NCT05523895|582269393|FG001|Overall Study|Not further specified|3|||
161242429|NCT05523895|582269394|FG002|Overall Study|Not further specified|1|||
161242430|NCT03674892|582269395|FG000|Overall Study|Lack of Efficacy|5|||
161242431|NCT03674892|582269395|FG000|Overall Study|Lost to Follow-up|3|||
161242432|NCT03674892|582269395|FG000|Overall Study|Migraine|2|||
161242433|NCT03674892|582269395|FG000|Overall Study|Excessive Tearing|1|||
161242434|NCT03674892|582269395|FG000|Overall Study|Increased Eye Pain|1|||
161242435|NCT03674892|582269395|FG000|Overall Study|Increased Facial Pain|1|||
161242436|NCT03674892|582269395|FG000|Overall Study|Sinus Irritation|1|||
161242437|NCT03674892|582269395|FG000|Overall Study|Sinus Infection|1|||
161242438|NCT05099380|582269396|FG000|Overall Study|Subject enrolled in error|1|||
161242439|NCT05099380|582269397|FG001|Overall Study|Subject enrolled in error|0|||
161242440|NCT05099380|582269396|FG000|Overall Study|Study Procedure|1|||
161242441|NCT05099380|582269397|FG001|Overall Study|Study Procedure|0|||
161242442|NCT05099380|582269396|FG000|Overall Study|Protocol Violation|1|||
161242443|NCT05099380|582269397|FG001|Overall Study|Protocol Violation|0|||
161242444|NCT05099380|582269396|FG000|Overall Study|Adverse Event|1|||
161242445|NCT05099380|582269397|FG001|Overall Study|Adverse Event|1|||
161242446|NCT05099380|582269396|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
161242447|NCT05099380|582269397|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
161242448|NCT01959672|582269403|FG000|Overall Study|Death|1|||
161242449|NCT02392195|582269404|FG000|Overall Study|Lost to Follow-up|4|||
161242450|NCT02392195|582269404|FG000|Overall Study|Withdrawal by Subject|4|||
161242451|NCT03276754|582269405|FG000|Overall Study|Withdrawal of informed consent|4|||
161242452|NCT03276754|582269405|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
161242453|NCT03276754|582269405|FG000|Overall Study|Lost to Follow-up|27|||
161242454|NCT03276754|582269405|FG000|Overall Study|No data reported at Month 24|31|||
161242455|NCT03276754|582269405|FG000|Overall Study|Death|39|||
161242456|NCT00545792|582269406|FG000|Overall Study|Withdrawal by Subject|1|||
161242457|NCT05041361|582269408|FG000|Overall Study|Lost to Follow-up|1|||
161242458|NCT05041361|582269409|FG001|Overall Study|Lost to Follow-up|3|||
161242459|NCT01642277|582269410|FG000|Overall Study|Adverse Event|10|||
161242460|NCT01642277|582269411|FG001|Overall Study|Adverse Event|0|||
161242461|NCT01642277|582269410|FG000|Overall Study|Physician Decision|2|||
161242462|NCT01642277|582269411|FG001|Overall Study|Physician Decision|0|||
161242463|NCT01642277|582269410|FG000|Overall Study|Protocol Violation|1|||
161242464|NCT01642277|582269411|FG001|Overall Study|Protocol Violation|0|||
161242465|NCT01642277|582269410|FG000|Overall Study|Withdrawal by Subject|11|||
161242466|NCT01642277|582269411|FG001|Overall Study|Withdrawal by Subject|0|||
161242467|NCT03679598|582269412|FG000|Overall Study|Adverse Event|2|||
161242468|NCT03679598|582269413|FG001|Overall Study|Adverse Event|0|||
161242469|NCT03605342|582269414|FG000|Overall Study|Withdrawal by Subject|9|||
161242470|NCT03605342|582269415|FG001|Overall Study|Withdrawal by Subject|7|||
161242471|NCT03605342|582269414|FG000|Overall Study|Lost to Follow-up|1|||
161242472|NCT03605342|582269415|FG001|Overall Study|Lost to Follow-up|1|||
161242473|NCT02842853|582269418|FG000|Overall Study|Non-compliance with the protocol|3|||
161242474|NCT02842853|582269419|FG001|Overall Study|Non-compliance with the protocol|7|||
161242475|NCT02842853|582269420|FG002|Overall Study|Non-compliance with the protocol|2|||
161242476|NCT02842853|582269421|FG003|Overall Study|Non-compliance with the protocol|5|||
161242477|NCT02842853|582269418|FG000|Overall Study|Subject met exclusion criteria|0|||
161242478|NCT02842853|582269419|FG001|Overall Study|Subject met exclusion criteria|1|||
161242479|NCT02842853|582269420|FG002|Overall Study|Subject met exclusion criteria|0|||
161242480|NCT02842853|582269421|FG003|Overall Study|Subject met exclusion criteria|0|||
161242481|NCT02842853|582269418|FG000|Overall Study|Withdrawal by Subject|11|||
161242482|NCT02842853|582269419|FG001|Overall Study|Withdrawal by Subject|13|||
161242483|NCT02842853|582269420|FG002|Overall Study|Withdrawal by Subject|9|||
161242484|NCT02842853|582269421|FG003|Overall Study|Withdrawal by Subject|8|||
161242485|NCT02842853|582269418|FG000|Overall Study|Lost to Follow-up|9|||
161242486|NCT02842853|582269419|FG001|Overall Study|Lost to Follow-up|13|||
161242487|NCT02842853|582269420|FG002|Overall Study|Lost to Follow-up|10|||
161242488|NCT02842853|582269421|FG003|Overall Study|Lost to Follow-up|11|||
161242489|NCT00918645|582269432|FG000|Overall Study|Withdrawal by Subject|1|||
161242490|NCT05133180|582269433|FG000|Overall Study|Withdrawal of consent|1|||
161242491|NCT05133180|582269434|FG001|Overall Study|Withdrawal of consent|1|||
161133806|NCT03726268|581873023|FG000|Overall Study|Withdrawal by Subject|11|||
161133807|NCT03726268|581873024|FG001|Overall Study|Withdrawal by Subject|5|||
161133808|NCT03726268|581873025|FG002|Overall Study|Withdrawal by Subject|9|||
161133809|NCT03726268|581873026|FG003|Overall Study|Withdrawal by Subject|8|||
161133810|NCT04370509|581873028|FG000|Overall Study|Adverse Event|1|||
161133811|NCT04370509|581873029|FG001|Overall Study|Adverse Event|0|||
161133812|NCT04370509|581873028|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
161133813|NCT04370509|581873029|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
161133814|NCT04743856|581873030|FG000|Overall Study|Lost to Follow-up|6|||
161242492|NCT05133180|582269433|FG000|Overall Study|Lost to Follow-up|1|||
161242493|NCT05133180|582269434|FG001|Overall Study|Lost to Follow-up|1|||
161242494|NCT05133180|582269433|FG000|Overall Study|Documented disease progression|0|||
161242495|NCT05133180|582269434|FG001|Overall Study|Documented disease progression|1|||
161242496|NCT04723693|582269435|FG000|Overall Study|Withdrawal by Subject|2|||
161242497|NCT02157974|582269436|FG000|Overall Study|Withdrawal by Subject|0|||
161242498|NCT02157974|582269437|FG001|Overall Study|Withdrawal by Subject|1|||
161242499|NCT02157974|582269438|FG002|Overall Study|Withdrawal by Subject|0|||
161242500|NCT02157974|582269439|FG003|Overall Study|Withdrawal by Subject|0|||
161242501|NCT02157974|582269440|FG004|Overall Study|Withdrawal by Subject|0|||
161242502|NCT02157974|582269436|FG000|Overall Study|Screen Failure|0|||
161242503|NCT02157974|582269437|FG001|Overall Study|Screen Failure|1|||
160827070|NCT02761694|580751938|FG009|Overall Study|Other|1|||
161242504|NCT02157974|582269438|FG002|Overall Study|Screen Failure|0|||
161242505|NCT02157974|582269439|FG003|Overall Study|Screen Failure|0|||
161242506|NCT02157974|582269440|FG004|Overall Study|Screen Failure|0|||
161242507|NCT02157974|582269436|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161242508|NCT02157974|582269437|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
161242509|NCT02157974|582269438|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161242510|NCT02157974|582269439|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161242511|NCT02157974|582269440|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
161242512|NCT01604941|582269443|FG000|Overall Study|Adverse Event|1|||
161242513|NCT01604941|582269444|FG001|Overall Study|Adverse Event|2|||
161242514|NCT01604941|582269445|FG002|Overall Study|Adverse Event|0|||
161242515|NCT01604941|582269446|FG003|Overall Study|Adverse Event|0|||
161242516|NCT01604941|582269447|FG004|Overall Study|Adverse Event|1|||
161242517|NCT01604941|582269448|FG005|Overall Study|Adverse Event|5|||
161242518|NCT01604941|582269443|FG000|Overall Study|Non-compliance|1|||
161242519|NCT01604941|582269444|FG001|Overall Study|Non-compliance|0|||
161242520|NCT01604941|582269445|FG002|Overall Study|Non-compliance|0|||
161242521|NCT01604941|582269446|FG003|Overall Study|Non-compliance|0|||
161242522|NCT01604941|582269447|FG004|Overall Study|Non-compliance|0|||
161242523|NCT01604941|582269448|FG005|Overall Study|Non-compliance|0|||
161242524|NCT01604941|582269443|FG000|Overall Study|Participant Decision|0|||
161242525|NCT01604941|582269444|FG001|Overall Study|Participant Decision|0|||
161242526|NCT01604941|582269445|FG002|Overall Study|Participant Decision|0|||
161242527|NCT01604941|582269446|FG003|Overall Study|Participant Decision|0|||
161242528|NCT01604941|582269447|FG004|Overall Study|Participant Decision|0|||
161242529|NCT01604941|582269448|FG005|Overall Study|Participant Decision|2|||
161242530|NCT01604941|582269443|FG000|Overall Study|Early Study Termination|9|||
161242531|NCT01604941|582269444|FG001|Overall Study|Early Study Termination|2|||
161242532|NCT01604941|582269445|FG002|Overall Study|Early Study Termination|3|||
161242533|NCT01604941|582269446|FG003|Overall Study|Early Study Termination|3|||
161242534|NCT01604941|582269447|FG004|Overall Study|Early Study Termination|0|||
161242535|NCT01604941|582269448|FG005|Overall Study|Early Study Termination|0|||
161242536|NCT03366792|582269449|FG000|Overall Study|Withdrawal by Subject|7|||
161242537|NCT03366792|582269449|FG000|Overall Study|Lost to Follow-up|2|||
161242538|NCT03366792|582269449|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
161242539|NCT03366792|582269449|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
161242540|NCT01808651|582269450|FG000|Study Period 1|Lost to Follow-up|1|||
161242541|NCT01808651|582269451|FG001|Study Period 1|Lost to Follow-up|3|||
161334417|NCT01218308|582614118|FG000|Overall Study|Protocol Violation|0|||
161334418|NCT01218308|582614119|FG001|Overall Study|Protocol Violation|2|||
161334419|NCT01218308|582614118|FG000|Overall Study|Withdrawal by Subject|61|||
161334420|NCT01218308|582614119|FG001|Overall Study|Withdrawal by Subject|64|||
161334421|NCT01218308|582614118|FG000|Overall Study|Lost to Follow-up|27|||
161334422|NCT01218308|582614119|FG001|Overall Study|Lost to Follow-up|31|||
161334423|NCT01218308|582614118|FG000|Overall Study|Other|14|||
161334424|NCT01218308|582614119|FG001|Overall Study|Other|21|||
161334425|NCT05222880|582614122|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161334426|NCT05222880|582614122|FG000|Overall Study|Withdrew Consent during Study|1|||
161334427|NCT05222880|582614122|FG000|Overall Study|COVID-19 Related|1|||
161334428|NCT05401565|582614123|FG000|Overall Study|Lost to Follow-up|1|||
161334429|NCT05401565|582614124|FG001|Overall Study|Lost to Follow-up|0|||
161334430|NCT05401565|582614123|FG000|Overall Study|Adverse Event|2|||
161334431|NCT05401565|582614124|FG001|Overall Study|Adverse Event|0|||
161334432|NCT01077323|582614127|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
161334433|NCT01077323|582614128|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
161334434|NCT01077323|582614129|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
161334435|NCT01077323|582614127|FG000|Overall Study|Dispensing of drug in baseline period|0|||
161334436|NCT01077323|582614128|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
161334437|NCT01077323|582614129|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
161334438|NCT01077323|582614127|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
161334439|NCT01077323|582614128|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
161334440|NCT01077323|582614129|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
161334441|NCT02984982|582614130|FG000|Overall Study|Adverse Event|2|||
161334442|NCT02984982|582614131|FG001|Overall Study|Adverse Event|5|||
161334443|NCT02984982|582614130|FG000|Overall Study|Poor Compliance to Protocol|4|||
161334444|NCT02984982|582614131|FG001|Overall Study|Poor Compliance to Protocol|4|||
161334445|NCT02984982|582614130|FG000|Overall Study|Withdrawal by Subject|2|||
161334446|NCT02984982|582614131|FG001|Overall Study|Withdrawal by Subject|0|||
161334447|NCT02984982|582614130|FG000|Overall Study|Randomized but not treated|0|||
161334448|NCT02984982|582614131|FG001|Overall Study|Randomized but not treated|1|||
161334449|NCT02144701|582614132|FG000|Overall Study|development of relapse, GVHD or death|9|||
161334450|NCT02144701|582614133|FG001|Overall Study|development of relapse, GVHD or death|3|||
161334451|NCT04622969|582614144|FG000|Overall Study|Withdrawal by Subject|2|||
161334452|NCT04622969|582614145|FG001|Overall Study|Withdrawal by Subject|3|||
161334453|NCT04467515|582614146|FG000|Overall Study|Lost to Follow-up|1|||
161334454|NCT04467515|582614147|FG001|Overall Study|Lost to Follow-up|0|||
161334455|NCT04467515|582614148|FG002|Overall Study|Lost to Follow-up|0|||
161334456|NCT04467515|582614146|FG000|Overall Study|Withdrawal by Subject|1|||
161334457|NCT04467515|582614147|FG001|Overall Study|Withdrawal by Subject|0|||
161334458|NCT04467515|582614148|FG002|Overall Study|Withdrawal by Subject|1|||
161334459|NCT04467515|582614146|FG000|Overall Study|Progressive Disease|0|||
161334460|NCT04467515|582614147|FG001|Overall Study|Progressive Disease|1|||
161334461|NCT04467515|582614148|FG002|Overall Study|Progressive Disease|3|||
161334462|NCT04467515|582614146|FG000|Overall Study|Death|0|||
161334463|NCT04467515|582614147|FG001|Overall Study|Death|1|||
161334464|NCT04467515|582614148|FG002|Overall Study|Death|0|||
161334465|NCT04249427|582614151|FG000|Overall Study|Adverse Event|3|||
160827071|NCT02761694|580751939|FG010|Overall Study|Other|1|||
161242542|NCT01808651|582269452|FG002|Study Period 1|Lost to Follow-up|0|||
161242543|NCT01808651|582269450|FG000|Study Period 1|Protocol Violation|1|||
161242544|NCT01808651|582269451|FG001|Study Period 1|Protocol Violation|0|||
161242545|NCT01808651|582269452|FG002|Study Period 1|Protocol Violation|1|||
161242546|NCT01808651|582269450|FG000|Study Period 1|Physician Decision|3|||
161334466|NCT04249427|582614152|FG001|Overall Study|Adverse Event|1|||
161334467|NCT04249427|582614151|FG000|Overall Study|Lack of Efficacy|0|||
161242547|NCT01808651|582269451|FG001|Study Period 1|Physician Decision|2|||
161242548|NCT01808651|582269452|FG002|Study Period 1|Physician Decision|0|||
161242549|NCT01808651|582269450|FG000|Study Period 1|Lack of Efficacy|2|||
161242550|NCT01808651|582269451|FG001|Study Period 1|Lack of Efficacy|1|||
161242551|NCT01808651|582269452|FG002|Study Period 1|Lack of Efficacy|0|||
161242552|NCT01808651|582269450|FG000|Study Period 1|Adverse Event|10|||
161242553|NCT01808651|582269451|FG001|Study Period 1|Adverse Event|4|||
161242554|NCT01808651|582269452|FG002|Study Period 1|Adverse Event|1|||
161242555|NCT01808651|582269450|FG000|Study Period 1|Participant Decision|9|||
161242556|NCT01808651|582269451|FG001|Study Period 1|Participant Decision|7|||
161242557|NCT01808651|582269452|FG002|Study Period 1|Participant Decision|3|||
161242558|NCT00216736|582269457|FG000|Overall Study|Lost to Follow-up|1|||
161242559|NCT00216736|582269458|FG001|Overall Study|Lost to Follow-up|1|||
161242560|NCT00807495|582269459|FG000|Overall Study|Adverse Event|6|||
161242561|NCT00807495|582269460|FG001|Overall Study|Adverse Event|3|||
161242562|NCT00807495|582269461|FG002|Overall Study|Adverse Event|1|||
161242563|NCT00807495|582269462|FG003|Overall Study|Adverse Event|1|||
161242564|NCT00807495|582269463|FG004|Overall Study|Adverse Event|2|||
161242565|NCT00807495|582269459|FG000|Overall Study|Withdrawal by Patient|2|||
161242566|NCT00807495|582269460|FG001|Overall Study|Withdrawal by Patient|0|||
161242567|NCT00807495|582269461|FG002|Overall Study|Withdrawal by Patient|1|||
161242568|NCT00807495|582269462|FG003|Overall Study|Withdrawal by Patient|0|||
161242569|NCT00807495|582269463|FG004|Overall Study|Withdrawal by Patient|0|||
161242570|NCT00807495|582269459|FG000|Overall Study|Reason Not Specified|0|||
161242571|NCT00807495|582269460|FG001|Overall Study|Reason Not Specified|3|||
161242572|NCT00807495|582269461|FG002|Overall Study|Reason Not Specified|2|||
161242573|NCT00807495|582269462|FG003|Overall Study|Reason Not Specified|0|||
161242574|NCT00807495|582269463|FG004|Overall Study|Reason Not Specified|3|||
161242575|NCT00841542|582269465|FG000|Period 1|Adverse Event|1|||
161242576|NCT00841542|582269466|FG001|Period 1|Adverse Event|0|||
161242577|NCT03214588|582269467|FG000|Overall Study|Adverse Event|1|||
161242578|NCT03214588|582269468|FG001|Overall Study|Adverse Event|0|||
161242579|NCT03214588|582269469|FG002|Overall Study|Adverse Event|2|||
161242580|NCT03214588|582269467|FG000|Overall Study|Reason Not Specified|0|||
161242581|NCT03214588|582269468|FG001|Overall Study|Reason Not Specified|1|||
161242582|NCT03214588|582269469|FG002|Overall Study|Reason Not Specified|0|||
161242583|NCT03808376|582269470|FG000|Overall Study|Withdrawal by Subject|10|||
161242584|NCT02679729|582269471|FG000|Overall Study|Lost to Follow-up|0|||
161242585|NCT02679729|582269472|FG001|Overall Study|Lost to Follow-up|1|||
161242586|NCT02679729|582269473|FG002|Overall Study|Lost to Follow-up|0|||
161242587|NCT02679729|582269474|FG003|Overall Study|Lost to Follow-up|0|||
161242588|NCT02679729|582269475|FG004|Overall Study|Lost to Follow-up|1|||
161242589|NCT02679729|582269476|FG005|Overall Study|Lost to Follow-up|0|||
161242590|NCT02679729|582269477|FG006|Overall Study|Lost to Follow-up|0|||
161242591|NCT02679729|582269478|FG007|Overall Study|Lost to Follow-up|0|||
161242592|NCT02679729|582269479|FG008|Overall Study|Lost to Follow-up|0|||
161242593|NCT02679729|582269471|FG000|Overall Study|Participant decision|0|||
161242594|NCT02679729|582269472|FG001|Overall Study|Participant decision|1|||
161242595|NCT02679729|582269473|FG002|Overall Study|Participant decision|0|||
161242596|NCT02679729|582269474|FG003|Overall Study|Participant decision|0|||
161242597|NCT02679729|582269475|FG004|Overall Study|Participant decision|0|||
161242598|NCT02679729|582269476|FG005|Overall Study|Participant decision|0|||
161242599|NCT02679729|582269477|FG006|Overall Study|Participant decision|1|||
161242600|NCT02679729|582269478|FG007|Overall Study|Participant decision|0|||
161242601|NCT02679729|582269479|FG008|Overall Study|Participant decision|0|||
161242602|NCT00748566|582269480|FG000|Overall Study|Adverse Event|49|||
161242603|NCT00748566|582269480|FG000|Overall Study|Death|1|||
161242604|NCT00748566|582269480|FG000|Overall Study|Lack of Efficacy|12|||
161242605|NCT00748566|582269480|FG000|Overall Study|Lost to Follow-up|1|||
161242606|NCT00748566|582269480|FG000|Overall Study|Protocol Violation|13|||
161242607|NCT00748566|582269480|FG000|Overall Study|Withdrawal by Subject|22|||
161242608|NCT00748566|582269480|FG000|Overall Study|Study terminated by sponsor|5|||
161242609|NCT00748566|582269480|FG000|Overall Study|Other|9|||
161242610|NCT00624286|582269483|FG000|Overall Study|Protocol Deviation|7|||
160827072|NCT02761694|580751940|FG011|Overall Study|Other|0|||
161242611|NCT00624286|582269484|FG001|Overall Study|Protocol Deviation|9|||
160827073|NCT02395055|580751946|FG000|Overall Study|Withdrawal by Subject|7|||
161242612|NCT00624286|582269483|FG000|Overall Study|Adverse Event|6|||
161242613|NCT00624286|582269484|FG001|Overall Study|Adverse Event|3|||
161242614|NCT00624286|582269483|FG000|Overall Study|Withdrawal by Subject|5|||
160827074|NCT02395055|580751947|FG001|Overall Study|Withdrawal by Subject|3|||
160827075|NCT01896271|580751948|FG000|Overall Study|Physician Decision|10|||
160827076|NCT01294462|580751949|FG000|Overall Study|Lost to Follow-up|1|||
160827077|NCT01294462|580751950|FG001|Overall Study|Lost to Follow-up|0|||
160827078|NCT01294462|580751949|FG000|Overall Study|Withdrawal by Subject|65|||
160827079|NCT01294462|580751950|FG001|Overall Study|Withdrawal by Subject|63|||
161242615|NCT00624286|582269484|FG001|Overall Study|Withdrawal by Subject|4|||
161242616|NCT00624286|582269483|FG000|Overall Study|Lost to Follow-up|3|||
161242617|NCT00624286|582269484|FG001|Overall Study|Lost to Follow-up|2|||
161242618|NCT00624286|582269483|FG000|Overall Study|Administrative problems|3|||
161242619|NCT00624286|582269484|FG001|Overall Study|Administrative problems|0|||
161242620|NCT00624286|582269483|FG000|Overall Study|Lack of Efficacy|1|||
161242621|NCT00624286|582269484|FG001|Overall Study|Lack of Efficacy|6|||
161242622|NCT00624286|582269483|FG000|Overall Study|Not stated|0|||
161242623|NCT00624286|582269484|FG001|Overall Study|Not stated|1|||
161242624|NCT00624286|582269483|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161242625|NCT00624286|582269484|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161242626|NCT00624286|582269483|FG000|Overall Study|Death|0|||
161242627|NCT00624286|582269484|FG001|Overall Study|Death|1|||
161242628|NCT01442376|582269489|FG000|Overall Study|Adverse Event|0|||
161242629|NCT01442376|582269490|FG001|Overall Study|Adverse Event|3|||
161242630|NCT01442376|582269491|FG002|Overall Study|Adverse Event|2|||
161242631|NCT01442376|582269489|FG000|Overall Study|Death|0|||
161242632|NCT01442376|582269490|FG001|Overall Study|Death|1|||
161242633|NCT01442376|582269491|FG002|Overall Study|Death|1|||
161242634|NCT01442376|582269489|FG000|Overall Study|Withdrawal of consent|0|||
161242635|NCT01442376|582269490|FG001|Overall Study|Withdrawal of consent|0|||
161242636|NCT01442376|582269491|FG002|Overall Study|Withdrawal of consent|1|||
161242637|NCT01442376|582269489|FG000|Overall Study|Patients not treated|2|||
160990087|NCT01579578|581351742|FG001|Overall Study|Withdrawal by Subject|1|||
160990088|NCT01579578|581351741|FG000|Overall Study|Eligibility criteria|3|||
160990089|NCT01579578|581351742|FG001|Overall Study|Eligibility criteria|9|||
160990090|NCT01579578|581351741|FG000|Overall Study|Ongoing|3|||
160990091|NCT01579578|581351742|FG001|Overall Study|Ongoing|0|||
160990092|NCT01004263|581351747|FG000|Overall Study|Adverse Event|15|||
160990093|NCT01004263|581351747|FG000|Overall Study|Withdrawal by Subject|58|||
160990094|NCT01004263|581351747|FG000|Overall Study|Protocol Violation|10|||
160990095|NCT01004263|581351747|FG000|Overall Study|Lost to Follow-up|64|||
160990096|NCT01004263|581351747|FG000|Overall Study|Lack of Efficacy|13|||
160990097|NCT01004263|581351747|FG000|Overall Study|Pregnancy|2|||
160990098|NCT01004263|581351747|FG000|Overall Study|Physician Decision|15|||
160990099|NCT01004263|581351747|FG000|Overall Study|Lack of Qualifying Event|2|||
160990100|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
160990101|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
160990102|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
160990103|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
160990104|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
160990105|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
160990106|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
160990107|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
160990108|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
160990109|NCT01237678|581351749|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
160990110|NCT01237678|581351750|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
161242638|NCT01442376|582269490|FG001|Overall Study|Patients not treated|3|||
161242639|NCT01442376|582269491|FG002|Overall Study|Patients not treated|1|||
161242640|NCT01442376|582269489|FG000|Overall Study|Not eligible for subsequent cycles|1|||
161242641|NCT01442376|582269490|FG001|Overall Study|Not eligible for subsequent cycles|2|||
161242642|NCT01442376|582269491|FG002|Overall Study|Not eligible for subsequent cycles|0|||
161242643|NCT04404725|582269492|FG000|First Intervention|Withdrawal by Subject|0|||
161242644|NCT04404725|582269493|FG001|First Intervention|Withdrawal by Subject|2|||
161242645|NCT04404725|582269492|FG000|Second Intervention|Adverse Event|1|||
161242646|NCT04404725|582269493|FG001|Second Intervention|Adverse Event|1|||
161242647|NCT04404725|582269492|FG000|Second Intervention|Withdrawal by Subject|0|||
161242648|NCT04404725|582269493|FG001|Second Intervention|Withdrawal by Subject|1|||
161242649|NCT01075516|582269494|FG000|Overall Study|Death|5|||
160990111|NCT01237678|581351751|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
161242650|NCT01075516|582269495|FG001|Overall Study|Death|9|||
161242651|NCT01075516|582269494|FG000|Overall Study|Lost to Follow-up|10|||
161242652|NCT01075516|582269495|FG001|Overall Study|Lost to Follow-up|2|||
161242653|NCT01075516|582269494|FG000|Overall Study|Withdrawal by Subject|3|||
161242654|NCT01075516|582269495|FG001|Overall Study|Withdrawal by Subject|5|||
160990112|NCT01237678|581351749|FG000|Phase II|Adverse Event|0|||
160990113|NCT01237678|581351750|FG001|Phase II|Adverse Event|39|||
160990114|NCT01237678|581351751|FG002|Phase II|Adverse Event|9|||
160990115|NCT01237678|581351749|FG000|Phase II|Death|0|||
161133815|NCT04743856|581873031|FG001|Overall Study|Lost to Follow-up|7|||
161133816|NCT04743856|581873030|FG000|Overall Study|Withdrawal by Subject|1|||
161133817|NCT04743856|581873031|FG001|Overall Study|Withdrawal by Subject|0|||
161133818|NCT04696861|581873032|FG000|Overall Study|Death|1|||
161133819|NCT04696861|581873033|FG001|Overall Study|Death|0|||
161133820|NCT04696861|581873032|FG000|Overall Study|Lost to Follow-up|3|||
161133821|NCT04696861|581873033|FG001|Overall Study|Lost to Follow-up|0|||
161133822|NCT04439188|581873034|FG000|Overall Study|Ineligible|3|||
161133823|NCT04439188|581873034|FG000|Overall Study|Adverse Event|4|||
161133824|NCT04439188|581873034|FG000|Overall Study|Death|1|||
161242655|NCT02252016|582269496|FG000|Overall Study|Lost to Follow-up|2|||
161242656|NCT02252016|582269497|FG001|Overall Study|Lost to Follow-up|1|||
161242657|NCT02252016|582269496|FG000|Overall Study|Physician Decision|1|||
161242658|NCT02252016|582269497|FG001|Overall Study|Physician Decision|0|||
161242659|NCT02252016|582269496|FG000|Overall Study|Withdrawal by Subject|0|||
161242660|NCT02252016|582269497|FG001|Overall Study|Withdrawal by Subject|2|||
161242661|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
161242662|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
161242663|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
161242664|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
161242665|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
161242666|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242667|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242668|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242669|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242670|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242671|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242672|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242673|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242674|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242675|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242676|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242677|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242678|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242679|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242680|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242681|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242682|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242683|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242684|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242685|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242686|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
161242687|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242688|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
161242689|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242690|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242691|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242692|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242693|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242694|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242695|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160827080|NCT02743780|580751951|FG000|Part 3 (7 Days)|Adverse Event|0|||
161242696|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242697|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242698|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242699|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160827081|NCT02743780|580751952|FG001|Part 3 (7 Days)|Adverse Event|0|||
160827082|NCT02743780|580751953|FG002|Part 3 (7 Days)|Adverse Event|1|||
160827083|NCT02743780|580751954|FG003|Part 3 (7 Days)|Adverse Event|0|||
160827084|NCT02743780|580751955|FG004|Part 3 (7 Days)|Adverse Event|0|||
160827085|NCT01460407|580751961|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
160827086|NCT01460407|580751962|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
160827087|NCT00526110|580751963|FG000|Overall Study|Adverse Event|2|||
160827088|NCT00526110|580751964|FG001|Overall Study|Adverse Event|9|||
160827089|NCT00526110|580751963|FG000|Overall Study|Disease Progression|0|||
160827090|NCT00526110|580751964|FG001|Overall Study|Disease Progression|19|||
160827091|NCT00526110|580751963|FG000|Overall Study|Maximal Response|0|||
160827092|NCT00526110|580751964|FG001|Overall Study|Maximal Response|6|||
160827093|NCT00526110|580751963|FG000|Overall Study|Withdrawal by Subject|0|||
160827094|NCT00526110|580751964|FG001|Overall Study|Withdrawal by Subject|2|||
160827095|NCT00526110|580751963|FG000|Overall Study|Poor Tolerance|0|||
160827096|NCT00526110|580751964|FG001|Overall Study|Poor Tolerance|5|||
160827097|NCT01400243|580751965|FG000|Overall Study|Protocol Violation|8|||
160827098|NCT01400243|580751966|FG001|Overall Study|Protocol Violation|11|||
160827099|NCT00953680|580751967|FG000|Period 1|Withdrawal by Subject|0|||
160827100|NCT00953680|580751968|FG001|Period 1|Withdrawal by Subject|1|||
160827101|NCT03762616|580751970|FG000|Overall Study|Protocol Violation|2|||
160827102|NCT03959982|580753704|FG000|Overall Study|Withdrawal by Subject|1|||
160827103|NCT03959982|580753705|FG001|Overall Study|Withdrawal by Subject|0|||
160827104|NCT03959982|580753704|FG000|Overall Study|Physician Decision|2|||
160827105|NCT03959982|580753705|FG001|Overall Study|Physician Decision|0|||
160827106|NCT03959982|580753704|FG000|Overall Study|Lost to Follow-up|1|||
160827107|NCT03959982|580753705|FG001|Overall Study|Lost to Follow-up|0|||
160827108|NCT00758589|580753706|FG000|Overall Study|Adverse Event|3|||
160827109|NCT00758589|580753707|FG001|Overall Study|Adverse Event|2|||
160827110|NCT00758589|580753708|FG002|Overall Study|Adverse Event|5|||
160827111|NCT00758589|580753709|FG003|Overall Study|Adverse Event|4|||
161133825|NCT04439188|581873034|FG000|Overall Study|Disease Progression|25|||
161133826|NCT04439188|581873034|FG000|Overall Study|Withdrawal by Subject|2|||
161133827|NCT00413959|581873035|FG000|Overall Study|Pt had only one cycle.|1|||
161133828|NCT01813890|581873038|FG000|Overall Study|Adverse Event|0|||
161133829|NCT01813890|581873039|FG001|Overall Study|Adverse Event|3|||
161133830|NCT01813890|581873040|FG002|Overall Study|Adverse Event|4|||
161133831|NCT01813890|581873038|FG000|Overall Study|Lack of Efficacy|9|||
161133832|NCT01813890|581873039|FG001|Overall Study|Lack of Efficacy|1|||
161133833|NCT01813890|581873040|FG002|Overall Study|Lack of Efficacy|2|||
161133834|NCT04482647|581873041|FG000|Overall Study|Time constraints|2|||
161133835|NCT04482647|581873041|FG000|Overall Study|Health issues|1|||
161133836|NCT04482647|581873041|FG000|Overall Study|Death in the family|1|||
161133837|NCT04482647|581873041|FG000|Overall Study|Disliked the intervention|1|||
161133838|NCT04482647|581873041|FG000|Overall Study|No reasons specified|7|||
161133839|NCT03952559|581873042|FG000|Double Blind Treatment Period|Adverse Event|0|||
161133840|NCT03952559|581873043|FG001|Double Blind Treatment Period|Adverse Event|2|||
161133841|NCT03952559|581873044|FG002|Double Blind Treatment Period|Adverse Event|1|||
161133842|NCT03952559|581873045|FG003|Double Blind Treatment Period|Adverse Event|0|||
161133843|NCT03952559|581873046|FG004|Double Blind Treatment Period|Adverse Event|1|||
161133844|NCT03952559|581873042|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
161133845|NCT03952559|581873043|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
161133846|NCT03952559|581873044|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
161133847|NCT03952559|581873045|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
161133848|NCT03952559|581873046|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
161133849|NCT03952559|581873042|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161133850|NCT03952559|581873043|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
161133851|NCT03952559|581873044|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
161133852|NCT03952559|581873045|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
161133853|NCT03952559|581873046|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161133854|NCT03952559|581873042|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
161133855|NCT03952559|581873043|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
161133856|NCT03952559|581873044|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
161133857|NCT03952559|581873045|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
161133858|NCT03952559|581873046|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
161133859|NCT00630331|581873047|FG000|Overall Study|Death|2|||
161133860|NCT00630331|581873048|FG001|Overall Study|Death|1|||
161133861|NCT00630331|581873049|FG002|Overall Study|Death|1|||
161133862|NCT00630331|581873047|FG000|Overall Study|Adverse Event|1|||
161133863|NCT00630331|581873048|FG001|Overall Study|Adverse Event|0|||
161133864|NCT00630331|581873049|FG002|Overall Study|Adverse Event|0|||
161133865|NCT00630331|581873047|FG000|Overall Study|Withdrawal by Subject|12|||
161133866|NCT00630331|581873048|FG001|Overall Study|Withdrawal by Subject|7|||
161133867|NCT00630331|581873049|FG002|Overall Study|Withdrawal by Subject|5|||
161133868|NCT00630331|581873047|FG000|Overall Study|Lost to Follow-up|175|||
161133869|NCT00630331|581873048|FG001|Overall Study|Lost to Follow-up|143|||
161133870|NCT00630331|581873049|FG002|Overall Study|Lost to Follow-up|170|||
161133871|NCT00630331|581873047|FG000|Overall Study|Inappropriate enrollment|3|||
161133872|NCT00630331|581873048|FG001|Overall Study|Inappropriate enrollment|6|||
161133873|NCT00630331|581873049|FG002|Overall Study|Inappropriate enrollment|3|||
161133874|NCT00630331|581873047|FG000|Overall Study|Unable to classify|9|||
161133875|NCT00630331|581873048|FG001|Overall Study|Unable to classify|4|||
161133876|NCT00630331|581873049|FG002|Overall Study|Unable to classify|3|||
161133877|NCT00630331|581873047|FG000|Overall Study|Protocol Violation|4|||
161133878|NCT00630331|581873048|FG001|Overall Study|Protocol Violation|5|||
161133879|NCT00630331|581873049|FG002|Overall Study|Protocol Violation|6|||
161133880|NCT01955707|581873052|FG000|Overall Study|Adverse Event|1|||
161133881|NCT01955707|581873053|FG001|Overall Study|Adverse Event|2|||
161133882|NCT01955707|581873052|FG000|Overall Study|Lost to Follow-up|2|||
161133883|NCT01955707|581873053|FG001|Overall Study|Lost to Follow-up|1|||
161133884|NCT01955707|581873052|FG000|Overall Study|Withdrawal by Subject|0|||
161133885|NCT01955707|581873053|FG001|Overall Study|Withdrawal by Subject|3|||
161133886|NCT01955707|581873052|FG000|Overall Study|Death|13|||
161133887|NCT01955707|581873053|FG001|Overall Study|Death|14|||
161133888|NCT01955707|581873052|FG000|Overall Study|Other|4|||
161133889|NCT01955707|581873053|FG001|Overall Study|Other|2|||
161133890|NCT02847598|581873060|FG000|Overall Study|Adverse Event|0|||
161133891|NCT02847598|581873061|FG001|Overall Study|Adverse Event|0|||
161133892|NCT02847598|581873062|FG002|Overall Study|Adverse Event|0|||
161133893|NCT02847598|581873063|FG003|Overall Study|Adverse Event|0|||
160827112|NCT00758589|580753706|FG000|Overall Study|Withdrawal by Subject|0|||
161133894|NCT02847598|581873064|FG004|Overall Study|Adverse Event|0|||
161133895|NCT02847598|581873065|FG005|Overall Study|Adverse Event|0|||
161133896|NCT02847598|581873066|FG006|Overall Study|Adverse Event|0|||
161133897|NCT02847598|581873067|FG007|Overall Study|Adverse Event|1|||
161133898|NCT02847598|581873060|FG000|Overall Study|Consent withdrawn|2|||
160990116|NCT01237678|581351750|FG001|Phase II|Death|0|||
160990117|NCT01237678|581351751|FG002|Phase II|Death|2|||
160990118|NCT01237678|581351749|FG000|Phase II|Lack of Efficacy|0|||
160990119|NCT01237678|581351750|FG001|Phase II|Lack of Efficacy|25|||
160990120|NCT01237678|581351751|FG002|Phase II|Lack of Efficacy|3|||
160990121|NCT01237678|581351749|FG000|Phase II|Withdrawal by Subject|0|||
160990122|NCT01237678|581351750|FG001|Phase II|Withdrawal by Subject|1|||
160990123|NCT01237678|581351751|FG002|Phase II|Withdrawal by Subject|5|||
160990124|NCT01237678|581351749|FG000|Phase II|Completed Cycles 4-6|0|||
160990125|NCT01237678|581351750|FG001|Phase II|Completed Cycles 4-6|11|||
160990126|NCT01237678|581351751|FG002|Phase II|Completed Cycles 4-6|21|||
160990127|NCT01237678|581351749|FG000|Phase II|Sponsor Decision/Study Closed|0|||
160990128|NCT01237678|581351750|FG001|Phase II|Sponsor Decision/Study Closed|18|||
160990129|NCT01237678|581351751|FG002|Phase II|Sponsor Decision/Study Closed|7|||
160990130|NCT01237678|581351749|FG000|Phase II|Randomized but were not treated|0|||
160990131|NCT01237678|581351750|FG001|Phase II|Randomized but were not treated|4|||
160990132|NCT01237678|581351751|FG002|Phase II|Randomized but were not treated|3|||
160990133|NCT01982760|581351756|FG000|Overall Study|Physician Decision|1|||
160990134|NCT01982760|581351757|FG001|Overall Study|Physician Decision|0|||
160990135|NCT00821236|581351758|FG000|Overall Study|Lost to Follow-up|3|||
160990136|NCT00530777|581351759|FG000|Overall Study|Lost to Follow-up|0|||
160990137|NCT00530777|581351760|FG001|Overall Study|Lost to Follow-up|1|||
160990138|NCT00530777|581351759|FG000|Overall Study|Death|1|||
160990139|NCT00530777|581351760|FG001|Overall Study|Death|2|||
160990140|NCT00530777|581351759|FG000|Overall Study|Physician Decision|1|||
160990141|NCT00530777|581351760|FG001|Overall Study|Physician Decision|0|||
160990142|NCT00530777|581351759|FG000|Overall Study|Withdrawal by Subject|0|||
160990143|NCT00530777|581351760|FG001|Overall Study|Withdrawal by Subject|1|||
160990144|NCT00530777|581351759|FG000|Overall Study|Unable to adhere to visit schedule|5|||
160990145|NCT00530777|581351760|FG001|Overall Study|Unable to adhere to visit schedule|1|||
160990146|NCT01582243|581351762|FG000|Overall Study|Withdrawal by Subject|1|||
160990147|NCT01582243|581351762|FG000|Overall Study|Adverse Event|1|||
160990148|NCT01582243|581351762|FG000|Overall Study|Lost to Follow-up|1|||
160990149|NCT02954055|581351764|FG000|Overall Study|Did not initiate therapy|6|||
160990150|NCT02954055|581351765|FG001|Overall Study|Did not initiate therapy|1|||
160990151|NCT02096003|581351766|FG000|Overall Study|Protocol Violation|0|||
160990152|NCT02096003|581351767|FG001|Overall Study|Protocol Violation|2|||
160990153|NCT02096003|581351766|FG000|Overall Study|additional surgery|2|||
160990154|NCT02096003|581351767|FG001|Overall Study|additional surgery|1|||
160990155|NCT01763047|581351768|FG000|Period 1|Test Article Not Available|4|||
160990156|NCT01763047|581351769|FG001|Period 1|Test Article Not Available|1|||
160990157|NCT01763047|581351768|FG000|Period 1|Protocol Violation|4|||
160990158|NCT01763047|581351769|FG001|Period 1|Protocol Violation|4|||
160990159|NCT01763047|581351768|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
160990160|NCT01763047|581351769|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
160990161|NCT01763047|581351768|FG000|Period 1|Adverse Event|0|||
160990162|NCT01763047|581351769|FG001|Period 1|Adverse Event|1|||
160990163|NCT01763047|581351768|FG000|Period 1|Unsatisfactory Visual Response|0|||
160990164|NCT01763047|581351769|FG001|Period 1|Unsatisfactory Visual Response|3|||
160827113|NCT00758589|580753707|FG001|Overall Study|Withdrawal by Subject|1|||
160827114|NCT00758589|580753708|FG002|Overall Study|Withdrawal by Subject|1|||
160827115|NCT00758589|580753709|FG003|Overall Study|Withdrawal by Subject|1|||
160827116|NCT00758589|580753706|FG000|Overall Study|Palm stopped to work|0|||
160827117|NCT00758589|580753707|FG001|Overall Study|Palm stopped to work|0|||
160827118|NCT00758589|580753708|FG002|Overall Study|Palm stopped to work|0|||
160827119|NCT00758589|580753709|FG003|Overall Study|Palm stopped to work|1|||
160827120|NCT04524455|580753721|FG000|Overall Study|Death|3|||
160827121|NCT04524455|580753722|FG001|Overall Study|Death|3|||
160827122|NCT04524455|580753721|FG000|Overall Study|Decision by Sponsor|0|||
160827123|NCT04524455|580753722|FG001|Overall Study|Decision by Sponsor|2|||
160990165|NCT01763047|581351768|FG000|Period 1|Lens Power Not Available|0|||
160990166|NCT01763047|581351769|FG001|Period 1|Lens Power Not Available|1|||
160990167|NCT01763047|581351768|FG000|Period 1|Study Site office Closed|0|||
160990168|NCT01763047|581351769|FG001|Period 1|Study Site office Closed|1|||
160990169|NCT01763047|581351768|FG000|Period 2|Lens Discomfort|1|||
160990170|NCT01763047|581351769|FG001|Period 2|Lens Discomfort|0|||
160990171|NCT01763047|581351768|FG000|Period 2|No longer meets Eligibility Criteria|1|||
160990172|NCT01763047|581351769|FG001|Period 2|No longer meets Eligibility Criteria|0|||
160990173|NCT01763047|581351768|FG000|Period 2|Study Site office Closed|1|||
160990174|NCT01763047|581351769|FG001|Period 2|Study Site office Closed|1|||
161133899|NCT02847598|581873061|FG001|Overall Study|Consent withdrawn|0|||
160990175|NCT01763047|581351768|FG000|Period 2|Unsatisfactory Visual Response|1|||
160990176|NCT01763047|581351769|FG001|Period 2|Unsatisfactory Visual Response|1|||
161133900|NCT02847598|581873062|FG002|Overall Study|Consent withdrawn|0|||
160827124|NCT04524455|580753721|FG000|Overall Study|Withdrawal of Consent From Study|1|||
160827125|NCT04524455|580753722|FG001|Overall Study|Withdrawal of Consent From Study|0|||
160990177|NCT01763047|581351768|FG000|Period 2|Protocol Violation|0|||
160990178|NCT01763047|581351769|FG001|Period 2|Protocol Violation|2|||
160990179|NCT01763047|581351768|FG000|Period 2|Unsatisfactory lens Fitting|0|||
160990180|NCT01763047|581351769|FG001|Period 2|Unsatisfactory lens Fitting|1|||
160990181|NCT01008748|581351772|FG000|Overall Study|Lost to Follow-up|80|||
160990182|NCT01008748|581351772|FG000|Overall Study|Other|1|||
160990183|NCT01767909|581351773|FG000|Overall Study|Withdrawal by Subject|4|||
160990184|NCT01767909|581351774|FG001|Overall Study|Withdrawal by Subject|7|||
160990185|NCT01767909|581351773|FG000|Overall Study|Adverse Event|3|||
160990186|NCT01767909|581351774|FG001|Overall Study|Adverse Event|1|||
160990187|NCT01767909|581351773|FG000|Overall Study|Withdrawal by Study Partner|3|||
160990188|NCT01767909|581351774|FG001|Overall Study|Withdrawal by Study Partner|1|||
160990189|NCT01767909|581351773|FG000|Overall Study|Non-Compliance|2|||
160990190|NCT01767909|581351774|FG001|Overall Study|Non-Compliance|0|||
160990191|NCT01767909|581351773|FG000|Overall Study|Perceived Lack of Efficacy|1|||
160990192|NCT01767909|581351774|FG001|Overall Study|Perceived Lack of Efficacy|0|||
160990193|NCT01767909|581351773|FG000|Overall Study|Investigator Recommendation|0|||
160990194|NCT01767909|581351774|FG001|Overall Study|Investigator Recommendation|1|||
160990195|NCT01767909|581351773|FG000|Overall Study|Lost to Follow-up|0|||
160990196|NCT01767909|581351774|FG001|Overall Study|Lost to Follow-up|1|||
160990197|NCT01767909|581351773|FG000|Overall Study|LP uncessessful|0|||
160990198|NCT01767909|581351774|FG001|Overall Study|LP uncessessful|1|||
160990199|NCT02696785|581351776|FG000|Blinded Treatment Period|Adverse Event|0|||
160990200|NCT02696785|581351777|FG001|Blinded Treatment Period|Adverse Event|1|||
160990201|NCT02696785|581351778|FG002|Blinded Treatment Period|Adverse Event|3|||
160990202|NCT02696785|581351779|FG003|Blinded Treatment Period|Adverse Event|0|||
161133901|NCT02847598|581873063|FG003|Overall Study|Consent withdrawn|4|||
161133902|NCT02847598|581873064|FG004|Overall Study|Consent withdrawn|3|||
161133903|NCT02847598|581873065|FG005|Overall Study|Consent withdrawn|2|||
161133904|NCT02847598|581873066|FG006|Overall Study|Consent withdrawn|1|||
161133905|NCT02847598|581873067|FG007|Overall Study|Consent withdrawn|3|||
161133906|NCT02847598|581873060|FG000|Overall Study|Death|3|||
161133907|NCT02847598|581873061|FG001|Overall Study|Death|0|||
161133908|NCT02847598|581873062|FG002|Overall Study|Death|0|||
161133909|NCT02847598|581873063|FG003|Overall Study|Death|0|||
161133910|NCT02847598|581873064|FG004|Overall Study|Death|0|||
161133911|NCT02847598|581873065|FG005|Overall Study|Death|0|||
161133912|NCT02847598|581873066|FG006|Overall Study|Death|0|||
161133913|NCT02847598|581873067|FG007|Overall Study|Death|0|||
161133914|NCT02847598|581873060|FG000|Overall Study|Lost to Follow-up|0|||
161133915|NCT02847598|581873061|FG001|Overall Study|Lost to Follow-up|0|||
161133916|NCT02847598|581873062|FG002|Overall Study|Lost to Follow-up|0|||
161133917|NCT02847598|581873063|FG003|Overall Study|Lost to Follow-up|0|||
161133918|NCT02847598|581873064|FG004|Overall Study|Lost to Follow-up|0|||
161133919|NCT02847598|581873065|FG005|Overall Study|Lost to Follow-up|1|||
161133920|NCT02847598|581873066|FG006|Overall Study|Lost to Follow-up|1|||
161133921|NCT02847598|581873067|FG007|Overall Study|Lost to Follow-up|0|||
161133922|NCT00960076|581874093|FG000|Overall Study|Adverse Event|1|||
161133923|NCT00960076|581874094|FG001|Overall Study|Adverse Event|7|||
161133924|NCT00960076|581874093|FG000|Overall Study|No longer met study criteria|1|||
161133925|NCT00960076|581874094|FG001|Overall Study|No longer met study criteria|5|||
161133926|NCT00960076|581874093|FG000|Overall Study|Withdrawal by Subject|1|||
161133927|NCT00960076|581874094|FG001|Overall Study|Withdrawal by Subject|2|||
161133928|NCT00960076|581874093|FG000|Overall Study|Lost to Follow-up|3|||
161133929|NCT00960076|581874094|FG001|Overall Study|Lost to Follow-up|3|||
161133930|NCT00960076|581874093|FG000|Overall Study|Severe non-compliance to protocol|1|||
161133931|NCT00960076|581874094|FG001|Overall Study|Severe non-compliance to protocol|2|||
161133932|NCT00960076|581874093|FG000|Overall Study|Hyperglycemia|1|||
161133933|NCT00960076|581874094|FG001|Overall Study|Hyperglycemia|5|||
161133934|NCT00960076|581874093|FG000|Overall Study|Did not attend the termination visit|0|||
161133935|NCT00960076|581874094|FG001|Overall Study|Did not attend the termination visit|1|||
161133936|NCT02029976|581874095|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
161133937|NCT02029976|581874096|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
161133938|NCT02029976|581874095|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
161133939|NCT02029976|581874096|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
161133940|NCT02029976|581874095|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
161133941|NCT02029976|581874096|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
161133942|NCT02029976|581874095|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
161133943|NCT02029976|581874096|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
160827126|NCT04524455|580753721|FG000|Overall Study|Lost to Follow-up|0|||
160990203|NCT02696785|581351776|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
160990204|NCT02696785|581351777|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
160990205|NCT02696785|581351778|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
160990206|NCT02696785|581351779|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
161133944|NCT03263806|581874097|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
161133945|NCT03263806|581874098|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
161133946|NCT03263806|581874097|FG000|Overall Study|Withdrawal by Subject|0|||
161133947|NCT03263806|581874098|FG001|Overall Study|Withdrawal by Subject|1|||
161133948|NCT03263806|581874097|FG000|Overall Study|Study Termination|5|||
161133949|NCT03263806|581874098|FG001|Overall Study|Study Termination|6|||
161133950|NCT04840667|581874099|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
161133951|NCT01445171|581874100|FG000|Overall Study|Lost to Follow-up|11|||
161133952|NCT01445171|581874100|FG000|Overall Study|Withdrawal by Subject|16|||
161133953|NCT01445171|581874100|FG000|Overall Study|Death|51|||
161133954|NCT01445171|581874100|FG000|Overall Study|Subjects declined to return for followup|9|||
161133955|NCT01445171|581874100|FG000|Overall Study|Consented but did not receive device|8|||
161133956|NCT00023322|581874101|FG000|Overall Study|Lost to Follow-up|1|||
161133957|NCT05194345|581874104|FG000|Overall Study|Withdrawal by Subject|6|||
161133958|NCT05194345|581874105|FG001|Overall Study|Withdrawal by Subject|4|||
161133959|NCT05194345|581874106|FG002|Overall Study|Withdrawal by Subject|0|||
161133960|NCT05194345|581874104|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
161133961|NCT05194345|581874105|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
161133962|NCT05194345|581874106|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
161133963|NCT02612909|581874107|FG000|Phase 2|Withdrawal by Subject|2|||
161133964|NCT02612909|581874108|FG001|Phase 2|Withdrawal by Subject|5|||
161133965|NCT02612909|581874109|FG002|Phase 2|Withdrawal by Subject|0|||
161133966|NCT02612909|581874110|FG003|Phase 2|Withdrawal by Subject|0|||
161133967|NCT02612909|581874111|FG004|Phase 2|Withdrawal by Subject|0|||
161133968|NCT02612909|581874107|FG000|Phase 2|Pregnancy|0|||
161133969|NCT02612909|581874108|FG001|Phase 2|Pregnancy|0|||
161133970|NCT02612909|581874109|FG002|Phase 2|Pregnancy|1|||
161133971|NCT02612909|581874110|FG003|Phase 2|Pregnancy|0|||
161133972|NCT02612909|581874111|FG004|Phase 2|Pregnancy|0|||
161133973|NCT02612909|581874107|FG000|Phase 3|Withdrawal by Subject|0|||
161133974|NCT02612909|581874108|FG001|Phase 3|Withdrawal by Subject|0|||
161133975|NCT02612909|581874109|FG002|Phase 3|Withdrawal by Subject|0|||
161133976|NCT02612909|581874110|FG003|Phase 3|Withdrawal by Subject|1|||
161133977|NCT02612909|581874111|FG004|Phase 3|Withdrawal by Subject|0|||
161133978|NCT05067127|581874116|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161133979|NCT05067127|581874117|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
161133980|NCT05067127|581874118|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161133981|NCT05067127|581874119|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
161133982|NCT05067127|581874116|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161133983|NCT05067127|581874117|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
161133984|NCT05067127|581874118|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161133985|NCT05067127|581874119|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
161133986|NCT05067127|581874116|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
161133987|NCT05067127|581874117|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161133988|NCT05067127|581874118|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161133989|NCT05067127|581874119|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161133990|NCT05067127|581874116|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161133991|NCT05067127|581874117|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
161133992|NCT05067127|581874118|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161133993|NCT05067127|581874119|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
161133994|NCT05067127|581874116|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
161133995|NCT05067127|581874117|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
161133996|NCT05067127|581874118|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
161133997|NCT05067127|581874119|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
161133998|NCT05067127|581874116|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161133999|NCT05067127|581874117|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161134000|NCT05067127|581874118|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
161134001|NCT05067127|581874119|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
161134002|NCT05067127|581874116|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161134003|NCT05067127|581874117|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
161134004|NCT05067127|581874118|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
161134005|NCT05067127|581874119|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
161134006|NCT03615222|581874121|FG000|Overall Study|Ineligible|26|||
161134007|NCT03615222|581874121|FG000|Overall Study|Withdrawal by Subject|7|||
161134008|NCT03615222|581874121|FG000|Overall Study|Death|1|||
161134009|NCT04572633|581874122|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
161134010|NCT03155997|581874125|FG000|Overall Study|Withdrawal by Subject|119|||
161134011|NCT03155997|581874126|FG001|Overall Study|Withdrawal by Subject|134|||
161134012|NCT03155997|581874125|FG000|Overall Study|Lost to Follow-up|12|||
161134013|NCT03155997|581874126|FG001|Overall Study|Lost to Follow-up|13|||
160827127|NCT04524455|580753722|FG001|Overall Study|Lost to Follow-up|1|||
161134014|NCT03155997|581874125|FG000|Overall Study|Missing disposition data|0|||
161134015|NCT03155997|581874126|FG001|Overall Study|Missing disposition data|1|||
161134016|NCT03155997|581874125|FG000|Overall Study|On study treatment|2027|||
161134017|NCT03155997|581874126|FG001|Overall Study|On study treatment|2074|||
161134018|NCT03367871|581874131|FG000|Overall Study|Lost to Follow-up|1|||
161242700|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242701|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242702|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242703|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242704|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242705|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242706|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242707|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242708|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
160990207|NCT02696785|581351776|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
160990208|NCT02696785|581351777|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
160990209|NCT02696785|581351778|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
160990210|NCT02696785|581351779|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
160990211|NCT02696785|581351776|FG000|Blinded Treatment Period|Screen Failure|1|||
160990212|NCT02696785|581351777|FG001|Blinded Treatment Period|Screen Failure|0|||
160990213|NCT02696785|581351778|FG002|Blinded Treatment Period|Screen Failure|0|||
160990214|NCT02696785|581351779|FG003|Blinded Treatment Period|Screen Failure|0|||
160990215|NCT02696785|581351776|FG000|Washout Period|Withdrawal by Subject|0|||
160990216|NCT02696785|581351777|FG001|Washout Period|Withdrawal by Subject|1|||
160990217|NCT02696785|581351778|FG002|Washout Period|Withdrawal by Subject|0|||
160990218|NCT02696785|581351779|FG003|Washout Period|Withdrawal by Subject|0|||
160990219|NCT02696785|581351776|FG000|Washout Period|Lack of Efficacy|0|||
160990220|NCT02696785|581351777|FG001|Washout Period|Lack of Efficacy|1|||
161134019|NCT00885365|581874135|FG000|4 Weeks ON Treatment|Adverse Event|2|||
161134020|NCT00885365|581874136|FG001|4 Weeks ON Treatment|Adverse Event|4|||
161134021|NCT00885365|581874135|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
161134022|NCT00885365|581874136|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
161134023|NCT00885365|581874135|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
161134024|NCT00885365|581874136|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
161134025|NCT01824979|581874137|FG000|Overall Study|Withdrawal by Subject|5|||
161134026|NCT01824979|581874138|FG001|Overall Study|Withdrawal by Subject|0|||
161134027|NCT01824979|581874137|FG000|Overall Study|Physician Decision|2|||
161134028|NCT01824979|581874138|FG001|Overall Study|Physician Decision|0|||
161134029|NCT01824979|581874137|FG000|Overall Study|Protocol Violation|6|||
161134030|NCT01824979|581874138|FG001|Overall Study|Protocol Violation|13|||
161134031|NCT00490542|581874141|FG000|Overall Study|Lost to Follow-up|3|||
161134032|NCT00490542|581874142|FG001|Overall Study|Lost to Follow-up|0|||
161134033|NCT00490542|581874141|FG000|Overall Study|Adverse Event|3|||
161134034|NCT00490542|581874142|FG001|Overall Study|Adverse Event|3|||
161134035|NCT00490542|581874141|FG000|Overall Study|Lack of Efficacy|1|||
161134036|NCT00490542|581874142|FG001|Overall Study|Lack of Efficacy|1|||
161134037|NCT02875223|581874143|FG000|Overall Study|Other reasons|0|||
161134038|NCT02875223|581874144|FG001|Overall Study|Other reasons|0|||
161134039|NCT02875223|581874145|FG002|Overall Study|Other reasons|1|||
161134040|NCT02875223|581874146|FG003|Overall Study|Other reasons|0|||
161134041|NCT02875223|581874147|FG004|Overall Study|Other reasons|1|||
161134042|NCT02875223|581874148|FG005|Overall Study|Other reasons|2|||
161134043|NCT02875223|581874149|FG006|Overall Study|Other reasons|0|||
161134044|NCT02875223|581874150|FG007|Overall Study|Other reasons|2|||
161134045|NCT02875223|581874151|FG008|Overall Study|Other reasons|0|||
161134046|NCT02875223|581874152|FG009|Overall Study|Other reasons|0|||
161134047|NCT02875223|581874153|FG010|Overall Study|Other reasons|0|||
161134048|NCT02875223|581874154|FG011|Overall Study|Other reasons|0|||
161134049|NCT02875223|581874155|FG012|Overall Study|Other reasons|0|||
161134050|NCT02875223|581874143|FG000|Overall Study|Withdrawal by Subject|0|||
161134051|NCT02875223|581874144|FG001|Overall Study|Withdrawal by Subject|0|||
161134052|NCT02875223|581874145|FG002|Overall Study|Withdrawal by Subject|0|||
161134053|NCT02875223|581874146|FG003|Overall Study|Withdrawal by Subject|0|||
161134054|NCT02875223|581874147|FG004|Overall Study|Withdrawal by Subject|1|||
161134055|NCT02875223|581874148|FG005|Overall Study|Withdrawal by Subject|1|||
161134056|NCT02875223|581874149|FG006|Overall Study|Withdrawal by Subject|0|||
161134057|NCT02875223|581874150|FG007|Overall Study|Withdrawal by Subject|0|||
161134058|NCT02875223|581874151|FG008|Overall Study|Withdrawal by Subject|1|||
161134059|NCT02875223|581874152|FG009|Overall Study|Withdrawal by Subject|0|||
161134060|NCT02875223|581874153|FG010|Overall Study|Withdrawal by Subject|0|||
161134061|NCT02875223|581874154|FG011|Overall Study|Withdrawal by Subject|0|||
161134062|NCT02875223|581874155|FG012|Overall Study|Withdrawal by Subject|0|||
161134063|NCT02875223|581874143|FG000|Overall Study|Progressive disease|0|||
161134064|NCT02875223|581874144|FG001|Overall Study|Progressive disease|0|||
160990221|NCT02696785|581351778|FG002|Washout Period|Lack of Efficacy|0|||
160990222|NCT02696785|581351779|FG003|Washout Period|Lack of Efficacy|0|||
161134065|NCT02875223|581874145|FG002|Overall Study|Progressive disease|1|||
161134066|NCT02875223|581874146|FG003|Overall Study|Progressive disease|0|||
161134067|NCT02875223|581874147|FG004|Overall Study|Progressive disease|0|||
161134068|NCT02875223|581874148|FG005|Overall Study|Progressive disease|0|||
161134069|NCT02875223|581874149|FG006|Overall Study|Progressive disease|0|||
161134070|NCT02875223|581874150|FG007|Overall Study|Progressive disease|0|||
161134071|NCT02875223|581874151|FG008|Overall Study|Progressive disease|0|||
161134072|NCT02875223|581874152|FG009|Overall Study|Progressive disease|12|||
161134073|NCT02875223|581874153|FG010|Overall Study|Progressive disease|2|||
161134074|NCT02875223|581874154|FG011|Overall Study|Progressive disease|3|||
161134075|NCT02875223|581874155|FG012|Overall Study|Progressive disease|6|||
161134076|NCT02875223|581874143|FG000|Overall Study|Death|4|||
161134077|NCT02875223|581874144|FG001|Overall Study|Death|4|||
161134078|NCT02875223|581874145|FG002|Overall Study|Death|3|||
161134079|NCT02875223|581874146|FG003|Overall Study|Death|4|||
161134080|NCT02875223|581874147|FG004|Overall Study|Death|2|||
161134081|NCT02875223|581874148|FG005|Overall Study|Death|3|||
161134082|NCT02875223|581874149|FG006|Overall Study|Death|5|||
161134083|NCT02875223|581874150|FG007|Overall Study|Death|7|||
161134084|NCT02875223|581874151|FG008|Overall Study|Death|3|||
161134085|NCT02875223|581874152|FG009|Overall Study|Death|2|||
161134086|NCT02875223|581874153|FG010|Overall Study|Death|0|||
161134087|NCT02875223|581874154|FG011|Overall Study|Death|0|||
161134088|NCT02875223|581874155|FG012|Overall Study|Death|0|||
161134089|NCT02875223|581874143|FG000|Overall Study|Lost to Follow-up|0|||
161134090|NCT02875223|581874144|FG001|Overall Study|Lost to Follow-up|1|||
161134091|NCT02875223|581874145|FG002|Overall Study|Lost to Follow-up|1|||
161134092|NCT02875223|581874146|FG003|Overall Study|Lost to Follow-up|0|||
161134093|NCT02875223|581874147|FG004|Overall Study|Lost to Follow-up|1|||
161134094|NCT02875223|581874148|FG005|Overall Study|Lost to Follow-up|0|||
161134095|NCT02875223|581874149|FG006|Overall Study|Lost to Follow-up|1|||
161134096|NCT02875223|581874150|FG007|Overall Study|Lost to Follow-up|1|||
161134097|NCT02875223|581874151|FG008|Overall Study|Lost to Follow-up|0|||
161134098|NCT02875223|581874152|FG009|Overall Study|Lost to Follow-up|0|||
161134099|NCT02875223|581874153|FG010|Overall Study|Lost to Follow-up|0|||
161134100|NCT02875223|581874154|FG011|Overall Study|Lost to Follow-up|0|||
161134101|NCT02875223|581874155|FG012|Overall Study|Lost to Follow-up|0|||
161134102|NCT01986062|581874158|FG000|Overall Study|Lost to Follow-up|1|||
161134103|NCT01986062|581874159|FG001|Overall Study|Lost to Follow-up|0|||
161134104|NCT01986062|581874158|FG000|Overall Study|Withdrawal by Subject|0|||
161134105|NCT01986062|581874159|FG001|Overall Study|Withdrawal by Subject|1|||
161134106|NCT01827384|581874160|FG000|Overall Study|Switched to alternative treatment|0|||
161134107|NCT01827384|581874161|FG001|Overall Study|Switched to alternative treatment|0|||
161134108|NCT01827384|581874162|FG002|Overall Study|Switched to alternative treatment|0|||
161134109|NCT01827384|581874163|FG003|Overall Study|Switched to alternative treatment|0|||
161134110|NCT01827384|581874164|FG004|Overall Study|Switched to alternative treatment|0|||
161134111|NCT01827384|581874165|FG005|Overall Study|Switched to alternative treatment|0|||
161134112|NCT01827384|581874166|FG006|Overall Study|Switched to alternative treatment|0|||
161134113|NCT01827384|581874167|FG007|Overall Study|Switched to alternative treatment|0|||
161134114|NCT01827384|581874168|FG008|Overall Study|Switched to alternative treatment|0|||
161134115|NCT01827384|581874169|FG009|Overall Study|Switched to alternative treatment|0|||
161134116|NCT01827384|581874170|FG010|Overall Study|Switched to alternative treatment|0|||
161134117|NCT01827384|581874171|FG011|Overall Study|Switched to alternative treatment|0|||
161134118|NCT01827384|581874172|FG012|Overall Study|Switched to alternative treatment|0|||
161134119|NCT01827384|581874173|FG013|Overall Study|Switched to alternative treatment|2|||
161134120|NCT01827384|581874160|FG000|Overall Study|Disease progression before treatment|0|||
161134121|NCT01827384|581874161|FG001|Overall Study|Disease progression before treatment|0|||
161134122|NCT01827384|581874162|FG002|Overall Study|Disease progression before treatment|0|||
161134123|NCT01827384|581874163|FG003|Overall Study|Disease progression before treatment|0|||
161134124|NCT01827384|581874164|FG004|Overall Study|Disease progression before treatment|0|||
161134125|NCT01827384|581874165|FG005|Overall Study|Disease progression before treatment|0|||
161134126|NCT01827384|581874166|FG006|Overall Study|Disease progression before treatment|0|||
161134127|NCT01827384|581874167|FG007|Overall Study|Disease progression before treatment|0|||
161134128|NCT01827384|581874168|FG008|Overall Study|Disease progression before treatment|0|||
161134129|NCT01827384|581874169|FG009|Overall Study|Disease progression before treatment|0|||
161134130|NCT01827384|581874170|FG010|Overall Study|Disease progression before treatment|0|||
161134131|NCT01827384|581874171|FG011|Overall Study|Disease progression before treatment|0|||
161134132|NCT01827384|581874172|FG012|Overall Study|Disease progression before treatment|0|||
161134133|NCT01827384|581874173|FG013|Overall Study|Disease progression before treatment|4|||
161134134|NCT01827384|581874160|FG000|Overall Study|Ineligible|0|||
161134135|NCT01827384|581874161|FG001|Overall Study|Ineligible|0|||
161134136|NCT01827384|581874162|FG002|Overall Study|Ineligible|0|||
161134137|NCT01827384|581874163|FG003|Overall Study|Ineligible|0|||
161134138|NCT01827384|581874164|FG004|Overall Study|Ineligible|0|||
161134139|NCT01827384|581874165|FG005|Overall Study|Ineligible|0|||
161134140|NCT01827384|581874166|FG006|Overall Study|Ineligible|0|||
161134141|NCT01827384|581874167|FG007|Overall Study|Ineligible|0|||
161134142|NCT01827384|581874168|FG008|Overall Study|Ineligible|0|||
161134143|NCT01827384|581874169|FG009|Overall Study|Ineligible|0|||
160827128|NCT00046930|580753724|FG000|Overall Study|Ineligible|12|||
161134144|NCT01827384|581874170|FG010|Overall Study|Ineligible|0|||
161134145|NCT01827384|581874171|FG011|Overall Study|Ineligible|0|||
161134146|NCT01827384|581874172|FG012|Overall Study|Ineligible|0|||
161134147|NCT01827384|581874173|FG013|Overall Study|Ineligible|19|||
161134148|NCT01827384|581874160|FG000|Overall Study|Participant died before treatment|0|||
161242709|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242710|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242711|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242712|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
161242713|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242714|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
161242715|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242716|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
160990223|NCT02696785|581351776|FG000|Extended Treatment Period|Adverse Event|2|||
160990224|NCT02696785|581351777|FG001|Extended Treatment Period|Adverse Event|3|||
160990225|NCT02696785|581351778|FG002|Extended Treatment Period|Adverse Event|2|||
160990226|NCT02696785|581351779|FG003|Extended Treatment Period|Adverse Event|1|||
160990227|NCT02696785|581351776|FG000|Extended Treatment Period|Lack of Efficacy|0|||
160990228|NCT02696785|581351777|FG001|Extended Treatment Period|Lack of Efficacy|1|||
160990229|NCT02696785|581351778|FG002|Extended Treatment Period|Lack of Efficacy|0|||
160990230|NCT02696785|581351779|FG003|Extended Treatment Period|Lack of Efficacy|0|||
161242717|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242718|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242719|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242720|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242721|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242722|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242723|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242724|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242725|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242726|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242727|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242728|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242729|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242730|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242731|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242732|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242733|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242734|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242735|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242736|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242737|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242738|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
161242739|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161242740|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242741|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
161242742|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
161242743|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
160827129|NCT00046930|580753725|FG001|Overall Study|Ineligible|4|||
160827130|NCT02317809|580753739|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
160827131|NCT02317809|580753740|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
160990231|NCT02696785|581351776|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
160990232|NCT02696785|581351777|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
160990233|NCT02696785|581351778|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
160990234|NCT02696785|581351779|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
160990235|NCT02696785|581351776|FG000|Follow-up Period|Adverse Event|0|||
160990236|NCT02696785|581351777|FG001|Follow-up Period|Adverse Event|0|||
160990237|NCT02696785|581351778|FG002|Follow-up Period|Adverse Event|8|||
160990238|NCT02696785|581351779|FG003|Follow-up Period|Adverse Event|2|||
160990239|NCT02696785|581351776|FG000|Follow-up Period|Lost to Follow-up|0|||
160990240|NCT02696785|581351777|FG001|Follow-up Period|Lost to Follow-up|0|||
160990241|NCT02696785|581351778|FG002|Follow-up Period|Lost to Follow-up|0|||
160990242|NCT02696785|581351779|FG003|Follow-up Period|Lost to Follow-up|1|||
160990243|NCT02696785|581351776|FG000|Follow-up Period|Lack of Efficacy|0|||
160990244|NCT02696785|581351777|FG001|Follow-up Period|Lack of Efficacy|0|||
160990245|NCT02696785|581351778|FG002|Follow-up Period|Lack of Efficacy|0|||
160990246|NCT02696785|581351779|FG003|Follow-up Period|Lack of Efficacy|1|||
160990247|NCT02696785|581351776|FG000|Follow-up Period|Withdrawal by Subject|1|||
160990248|NCT02696785|581351777|FG001|Follow-up Period|Withdrawal by Subject|0|||
160990249|NCT02696785|581351778|FG002|Follow-up Period|Withdrawal by Subject|5|||
160990250|NCT02696785|581351779|FG003|Follow-up Period|Withdrawal by Subject|4|||
160990251|NCT04863898|581351781|FG000|Overall Study|Away from study clinic during intervention training period|2|||
160990252|NCT04863898|581351781|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
161242744|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242745|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160990253|NCT04863898|581351781|FG000|Overall Study|Lost to Follow-up|3|||
160990254|NCT04863898|581351781|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
160990255|NCT04863898|581351781|FG000|Overall Study|No longer employed at clinic|3|||
160990256|NCT02431533|581351782|FG000|Overall Study|Withdrawal by Subject|1|||
160990257|NCT02431533|581351783|FG001|Overall Study|Withdrawal by Subject|3|||
160990258|NCT02431533|581351782|FG000|Overall Study|Developed Exclusionary criteria|1|||
160990259|NCT02431533|581351783|FG001|Overall Study|Developed Exclusionary criteria|0|||
160990260|NCT02320253|581351784|FG000|Overall Study|Withdrawal by Subject|3|||
160990261|NCT02320253|581351785|FG001|Overall Study|Withdrawal by Subject|0|||
160990262|NCT02320253|581351786|FG002|Overall Study|Withdrawal by Subject|0|||
160990263|NCT02320253|581351784|FG000|Overall Study|Lost to Follow-up|2|||
160990264|NCT02320253|581351785|FG001|Overall Study|Lost to Follow-up|2|||
160990265|NCT02320253|581351786|FG002|Overall Study|Lost to Follow-up|1|||
160990266|NCT02320253|581351784|FG000|Overall Study|Death|1|||
160990267|NCT02320253|581351785|FG001|Overall Study|Death|0|||
160990268|NCT02320253|581351786|FG002|Overall Study|Death|1|||
160990269|NCT03251378|581351787|FG000|Overall Study|Death|3|||
160990270|NCT03251378|581351788|FG001|Overall Study|Death|2|||
160990271|NCT03251378|581351789|FG002|Overall Study|Death|3|||
160990272|NCT03251378|581351790|FG003|Overall Study|Death|30|||
160990273|NCT03251378|581351791|FG004|Overall Study|Death|24|||
160990274|NCT03251378|581351792|FG005|Overall Study|Death|12|||
160990275|NCT03251378|581351793|FG006|Overall Study|Death|12|||
160990276|NCT03251378|581351787|FG000|Overall Study|Lost to Follow-up|0|||
160990277|NCT03251378|581351788|FG001|Overall Study|Lost to Follow-up|0|||
160990278|NCT03251378|581351789|FG002|Overall Study|Lost to Follow-up|1|||
160990279|NCT03251378|581351790|FG003|Overall Study|Lost to Follow-up|3|||
160990280|NCT03251378|581351791|FG004|Overall Study|Lost to Follow-up|0|||
160990281|NCT03251378|581351792|FG005|Overall Study|Lost to Follow-up|0|||
160990282|NCT03251378|581351793|FG006|Overall Study|Lost to Follow-up|0|||
160990283|NCT03251378|581351787|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
160990284|NCT03251378|581351788|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
160990285|NCT03251378|581351789|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
160990286|NCT03251378|581351790|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
160990287|NCT03251378|581351791|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
160990288|NCT03251378|581351792|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
160990289|NCT03251378|581351793|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
160990290|NCT03251378|581351787|FG000|Overall Study|Progressive disease|2|||
160990291|NCT03251378|581351788|FG001|Overall Study|Progressive disease|0|||
160990292|NCT03251378|581351789|FG002|Overall Study|Progressive disease|0|||
160990293|NCT03251378|581351790|FG003|Overall Study|Progressive disease|1|||
160990294|NCT03251378|581351791|FG004|Overall Study|Progressive disease|0|||
160990295|NCT03251378|581351792|FG005|Overall Study|Progressive disease|0|||
160990296|NCT03251378|581351793|FG006|Overall Study|Progressive disease|0|||
160990297|NCT03251378|581351787|FG000|Overall Study|Physician Decision|0|||
160990298|NCT03251378|581351788|FG001|Overall Study|Physician Decision|2|||
160990299|NCT03251378|581351789|FG002|Overall Study|Physician Decision|0|||
160990300|NCT03251378|581351790|FG003|Overall Study|Physician Decision|0|||
160990301|NCT03251378|581351791|FG004|Overall Study|Physician Decision|0|||
160990302|NCT03251378|581351792|FG005|Overall Study|Physician Decision|0|||
160990303|NCT03251378|581351793|FG006|Overall Study|Physician Decision|0|||
160990304|NCT03251378|581351787|FG000|Overall Study|Other|2|||
160990305|NCT03251378|581351788|FG001|Overall Study|Other|3|||
160990306|NCT03251378|581351789|FG002|Overall Study|Other|2|||
161242746|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242747|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242748|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242749|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160990307|NCT03251378|581351790|FG003|Overall Study|Other|0|||
161242750|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242751|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242752|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242753|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242754|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242755|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242756|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242757|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242758|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242759|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242760|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
160990308|NCT03251378|581351791|FG004|Overall Study|Other|1|||
160990309|NCT03251378|581351792|FG005|Overall Study|Other|1|||
160990310|NCT03251378|581351793|FG006|Overall Study|Other|1|||
160990311|NCT03251378|581351787|FG000|Overall Study|Other|0|||
160990312|NCT03251378|581351788|FG001|Overall Study|Other|0|||
160990313|NCT03251378|581351789|FG002|Overall Study|Other|0|||
161242761|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242762|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242763|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242764|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
161242765|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
161242766|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
161242767|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
161242768|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
161242769|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
161242770|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242771|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242772|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242773|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242774|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242775|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242776|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242777|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242778|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242779|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242780|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242781|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242782|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242783|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242784|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242785|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242786|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242787|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242788|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242789|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242790|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
161242791|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|moved|0|||
161242792|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|moved|1|||
161242793|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|moved|1|||
161242794|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|moved|0|||
161242795|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|moved|0|||
161242796|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|moved|0|||
161242797|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|moved|0|||
161242798|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|moved|0|||
161242799|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|moved|0|||
161242800|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|moved|0|||
161242801|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|moved|0|||
161242802|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|moved|0|||
161242803|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|moved|0|||
161242804|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|moved|0|||
161242805|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|moved|0|||
160990314|NCT03251378|581351790|FG003|Overall Study|Other|4|||
160990315|NCT03251378|581351791|FG004|Overall Study|Other|13|||
160990316|NCT03251378|581351792|FG005|Overall Study|Other|0|||
160990317|NCT03251378|581351793|FG006|Overall Study|Other|0|||
160990318|NCT01516892|581351794|FG000|Overall Study|Adverse Event|25|||
160990319|NCT01516892|581351794|FG000|Overall Study|Lack of Efficacy|35|||
160990320|NCT01516892|581351794|FG000|Overall Study|Pregnancy|5|||
160990321|NCT01516892|581351794|FG000|Overall Study|Lost to Follow-up|82|||
160990322|NCT01516892|581351794|FG000|Overall Study|Subject Withdrew Consent|92|||
160990323|NCT01516892|581351794|FG000|Overall Study|Protocol Violation|60|||
160990324|NCT01516892|581351794|FG000|Overall Study|Other Miscellaneous Reasons|43|||
160990325|NCT01516892|581351794|FG000|Overall Study|Missing|1|||
160990326|NCT02956967|581351795|FG000|Overall Study|Adverse Event|3|||
160990327|NCT02956967|581351795|FG000|Overall Study|Reason non-related to neutropenia|10|||
160990328|NCT02956967|581351795|FG000|Overall Study|Lost to Follow-up|5|||
160990329|NCT02956967|581351795|FG000|Overall Study|Missing|1|||
160990330|NCT02956967|581351795|FG000|Overall Study|Termination of Nivestim administration|29|||
161242806|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|moved|0|||
161242807|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|moved|0|||
161242808|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|moved|0|||
161242809|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|moved|0|||
161242810|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|moved|0|||
161242811|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|moved|0|||
160990331|NCT05780047|581351796|FG000|Overall Study|Did not submit baseline urine test kit|226|||
160990332|NCT05780047|581351796|FG000|Overall Study|Lost to Follow-up|34|||
161242812|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|moved|0|||
160990333|NCT05780047|581351796|FG000|Overall Study|Did not submit second urine test kit|124|||
161134149|NCT01827384|581874161|FG001|Overall Study|Participant died before treatment|0|||
161134150|NCT01827384|581874162|FG002|Overall Study|Participant died before treatment|0|||
161134151|NCT01827384|581874163|FG003|Overall Study|Participant died before treatment|0|||
161134152|NCT01827384|581874164|FG004|Overall Study|Participant died before treatment|0|||
161134153|NCT01827384|581874165|FG005|Overall Study|Participant died before treatment|0|||
161134154|NCT01827384|581874166|FG006|Overall Study|Participant died before treatment|0|||
161242813|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|moved|0|||
161242814|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|moved|0|||
161242815|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|moved|0|||
161242816|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|moved|0|||
161242817|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242818|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242819|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242820|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
161242821|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242822|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242823|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242824|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242825|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242826|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242827|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242828|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242829|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242830|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242831|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242832|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242833|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242834|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242835|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242836|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242837|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242838|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242839|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242840|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242841|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242842|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
161242843|NCT00112437|582269507|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242844|NCT00112437|582269508|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242845|NCT00112437|582269509|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242846|NCT00112437|582269510|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242847|NCT00112437|582269511|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
161334468|NCT04249427|582614152|FG001|Overall Study|Lack of Efficacy|1|||
161334469|NCT04249427|582614151|FG000|Overall Study|Withdrawal by Subject|1|||
161334470|NCT04249427|582614152|FG001|Overall Study|Withdrawal by Subject|2|||
160902405|NCT00347360|581036041|FG010|Overall Study|Did not meet criteria before ABPM|1|||
161134155|NCT01827384|581874167|FG007|Overall Study|Participant died before treatment|0|||
161134156|NCT01827384|581874168|FG008|Overall Study|Participant died before treatment|0|||
161242848|NCT00112437|582269512|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242849|NCT00112437|582269513|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242850|NCT00112437|582269514|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242851|NCT00112437|582269515|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242852|NCT00112437|582269516|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242853|NCT00112437|582269517|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160902406|NCT00347360|581036042|FG011|Overall Study|Did not meet criteria before ABPM|0|||
160902407|NCT00347360|581036043|FG012|Overall Study|Did not meet criteria before ABPM|0|||
160902408|NCT00347360|581036044|FG013|Overall Study|Did not meet criteria before ABPM|0|||
160902409|NCT00347360|581036045|FG014|Overall Study|Did not meet criteria before ABPM|0|||
160902410|NCT00347360|581036031|FG000|Overall Study|Randomized in error|0|||
160902411|NCT00347360|581036032|FG001|Overall Study|Randomized in error|0|||
160902412|NCT00347360|581036033|FG002|Overall Study|Randomized in error|0|||
160902413|NCT00347360|581036034|FG003|Overall Study|Randomized in error|0|||
160902414|NCT00347360|581036035|FG004|Overall Study|Randomized in error|0|||
161134157|NCT01827384|581874169|FG009|Overall Study|Participant died before treatment|0|||
161134158|NCT01827384|581874170|FG010|Overall Study|Participant died before treatment|0|||
160902415|NCT00347360|581036036|FG005|Overall Study|Randomized in error|0|||
160902416|NCT00347360|581036037|FG006|Overall Study|Randomized in error|0|||
160902417|NCT00347360|581036038|FG007|Overall Study|Randomized in error|0|||
160902418|NCT00347360|581036039|FG008|Overall Study|Randomized in error|0|||
160902419|NCT00347360|581036040|FG009|Overall Study|Randomized in error|0|||
161134159|NCT01827384|581874171|FG011|Overall Study|Participant died before treatment|0|||
161134160|NCT01827384|581874172|FG012|Overall Study|Participant died before treatment|0|||
161134161|NCT01827384|581874173|FG013|Overall Study|Participant died before treatment|5|||
161134162|NCT01827384|581874160|FG000|Overall Study|Insufficient tumor cells|0|||
161134163|NCT01827384|581874161|FG001|Overall Study|Insufficient tumor cells|0|||
161134164|NCT01827384|581874162|FG002|Overall Study|Insufficient tumor cells|0|||
161134165|NCT01827384|581874163|FG003|Overall Study|Insufficient tumor cells|0|||
161134166|NCT01827384|581874164|FG004|Overall Study|Insufficient tumor cells|0|||
161134167|NCT01827384|581874165|FG005|Overall Study|Insufficient tumor cells|0|||
161134168|NCT01827384|581874166|FG006|Overall Study|Insufficient tumor cells|0|||
161134169|NCT01827384|581874167|FG007|Overall Study|Insufficient tumor cells|0|||
161134170|NCT01827384|581874168|FG008|Overall Study|Insufficient tumor cells|0|||
161134171|NCT01827384|581874169|FG009|Overall Study|Insufficient tumor cells|0|||
161134172|NCT01827384|581874170|FG010|Overall Study|Insufficient tumor cells|0|||
161134173|NCT01827384|581874171|FG011|Overall Study|Insufficient tumor cells|0|||
161134174|NCT01827384|581874172|FG012|Overall Study|Insufficient tumor cells|0|||
161134175|NCT01827384|581874173|FG013|Overall Study|Insufficient tumor cells|13|||
161134176|NCT01827384|581874160|FG000|Overall Study|No actionable mutation|0|||
161134177|NCT01827384|581874161|FG001|Overall Study|No actionable mutation|0|||
161134178|NCT01827384|581874162|FG002|Overall Study|No actionable mutation|0|||
161134179|NCT01827384|581874163|FG003|Overall Study|No actionable mutation|0|||
161134180|NCT01827384|581874164|FG004|Overall Study|No actionable mutation|0|||
161134181|NCT01827384|581874165|FG005|Overall Study|No actionable mutation|0|||
161134182|NCT01827384|581874166|FG006|Overall Study|No actionable mutation|0|||
161134183|NCT01827384|581874167|FG007|Overall Study|No actionable mutation|0|||
161134184|NCT01827384|581874168|FG008|Overall Study|No actionable mutation|0|||
161134185|NCT01827384|581874169|FG009|Overall Study|No actionable mutation|0|||
161134186|NCT01827384|581874170|FG010|Overall Study|No actionable mutation|0|||
161134187|NCT01827384|581874171|FG011|Overall Study|No actionable mutation|0|||
161134188|NCT01827384|581874172|FG012|Overall Study|No actionable mutation|0|||
161134189|NCT01827384|581874173|FG013|Overall Study|No actionable mutation|73|||
161134190|NCT01827384|581874160|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161134191|NCT01827384|581874161|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
161134192|NCT01827384|581874162|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
161134193|NCT01827384|581874163|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
161134194|NCT01827384|581874164|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
161134195|NCT01827384|581874165|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
161134196|NCT01827384|581874166|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
161134197|NCT01827384|581874167|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
161134198|NCT01827384|581874168|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
161134199|NCT01827384|581874169|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
161134200|NCT01827384|581874170|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
161134201|NCT01827384|581874171|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
161134202|NCT01827384|581874172|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
161134203|NCT01827384|581874173|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
161134204|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
161134205|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
161134206|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
161134207|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161134208|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161134209|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
161134210|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
161134211|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
161134212|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
161134213|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161134214|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161134215|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
161134216|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
161134217|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
161134218|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
161134219|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161134220|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161134221|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
161134222|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
161134223|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161134224|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161134225|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161134226|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161134227|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
161134228|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
161134229|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
161134230|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
161134231|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161134232|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161134233|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
161134234|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
161134235|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
161134236|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
161134237|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161134238|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161134239|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
161134240|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
161134241|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
161134242|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
161134243|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
161134244|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
161134245|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
161134246|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
161134247|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
161134248|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
161134249|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161134250|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161134251|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
161134252|NCT01707992|581874175|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
161134253|NCT01707992|581874176|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
161134254|NCT01707992|581874177|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
161134255|NCT01707992|581874178|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161242854|NCT00112437|582269518|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160990334|NCT00764868|581351806|FG000|Overall Study|Adverse Event|18|||
160990335|NCT00764868|581351806|FG000|Overall Study|Withdrawal by Subject|31|||
160990336|NCT00764868|581351806|FG000|Overall Study|Non-compliance|16|||
160990337|NCT00764868|581351806|FG000|Overall Study|Lost to Follow-up|25|||
160990338|NCT00764868|581351806|FG000|Overall Study|Lack of Efficacy|5|||
160990339|NCT00764868|581351806|FG000|Overall Study|Subject moved|7|||
160990340|NCT00764868|581351806|FG000|Overall Study|Pregnancy|3|||
160990341|NCT00764868|581351806|FG000|Overall Study|Prohibited medication|1|||
160990342|NCT00764868|581351806|FG000|Overall Study|Out of town|1|||
160990343|NCT00764868|581351806|FG000|Overall Study|Misuse and compliance of study drug|1|||
160990344|NCT00764868|581351806|FG000|Overall Study|Subject sent to boarding school|1|||
160990345|NCT00764868|581351806|FG000|Overall Study|Met an exclusion criteria|1|||
160990346|NCT00764868|581351806|FG000|Overall Study|Positive drug screen|2|||
160990347|NCT00764868|581351806|FG000|Overall Study|Sponsor requested withdrawal|1|||
160990348|NCT00783692|581351807|FG000|Induction Phase|Adverse Event|7|||
160990349|NCT00783692|581351808|FG001|Induction Phase|Adverse Event|9|||
160990350|NCT00783692|581351809|FG002|Induction Phase|Adverse Event|24|||
160990351|NCT00783692|581351810|FG003|Induction Phase|Adverse Event|0|||
160990352|NCT00783692|581351811|FG004|Induction Phase|Adverse Event|0|||
161242855|NCT00112437|582269519|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242856|NCT00112437|582269520|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242857|NCT00112437|582269521|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242858|NCT00112437|582269522|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242859|NCT00112437|582269523|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242860|NCT00112437|582269524|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
160990353|NCT00783692|581351812|FG005|Induction Phase|Adverse Event|0|||
160990354|NCT00783692|581351813|FG006|Induction Phase|Adverse Event|0|||
161134256|NCT01707992|581874179|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161134257|NCT01707992|581874180|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
161334471|NCT03886272|582614153|FG000|Period 1|Withdrawal by Subject|0|||
161334472|NCT03886272|582614154|FG001|Period 1|Withdrawal by Subject|0|||
160990355|NCT00783692|581351807|FG000|Induction Phase|Protocol Violation|0|||
160990356|NCT00783692|581351808|FG001|Induction Phase|Protocol Violation|0|||
161242861|NCT00112437|582269525|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242862|NCT00112437|582269526|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242863|NCT00112437|582269527|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242864|NCT00112437|582269528|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242865|NCT00112437|582269529|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242866|NCT00112437|582269530|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242867|NCT00112437|582269531|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242868|NCT00112437|582269532|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
161242869|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
161242870|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
161242871|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
161242872|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
161242873|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
161242874|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
161242875|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
161242876|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
161242877|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
161242878|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
161242879|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
161242880|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
161242881|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
161242882|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
161242883|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
161242884|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
161242885|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
161242886|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
161242887|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
161242888|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
161242889|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
161242890|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
161242891|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
161242892|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
161242893|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
161242894|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
161242895|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242896|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242897|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242898|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242899|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242900|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
161242901|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
161242902|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242903|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
160827132|NCT02317809|580753739|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
160827133|NCT02317809|580753740|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
160827134|NCT02435680|580753741|FG000|Overall Study|Physician Decision|3|||
160827135|NCT02435680|580753742|FG001|Overall Study|Physician Decision|0|||
160827136|NCT02435680|580753743|FG002|Overall Study|Physician Decision|0|||
160827137|NCT02435680|580753741|FG000|Overall Study|subject / guardian decision|0|||
160827138|NCT02435680|580753742|FG001|Overall Study|subject / guardian decision|3|||
160827139|NCT02435680|580753743|FG002|Overall Study|subject / guardian decision|2|||
160827140|NCT02435680|580753741|FG000|Overall Study|Adverse Event|8|||
160827141|NCT02435680|580753742|FG001|Overall Study|Adverse Event|3|||
160827142|NCT02435680|580753743|FG002|Overall Study|Adverse Event|2|||
160827143|NCT02435680|580753741|FG000|Overall Study|progressive disease|10|||
160827144|NCT02435680|580753742|FG001|Overall Study|progressive disease|7|||
160827145|NCT02435680|580753743|FG002|Overall Study|progressive disease|11|||
160827146|NCT02435680|580753741|FG000|Overall Study|not treated|0|||
160827147|NCT02435680|580753742|FG001|Overall Study|not treated|0|||
160827148|NCT02435680|580753743|FG002|Overall Study|not treated|1|||
160827149|NCT00953524|580753744|FG000|Overall Study|Adverse Event|2|||
160827150|NCT00953524|580753745|FG001|Overall Study|Adverse Event|0|||
160827151|NCT00953524|580753746|FG002|Overall Study|Adverse Event|1|||
160827152|NCT00953524|580753747|FG003|Overall Study|Adverse Event|2|||
160827153|NCT00953524|580753744|FG000|Overall Study|Protocol Violation|18|||
160827154|NCT00953524|580753745|FG001|Overall Study|Protocol Violation|10|||
161242904|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
161242905|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242906|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161334473|NCT03886272|582614155|FG002|Period 1|Withdrawal by Subject|0|||
160827155|NCT00953524|580753746|FG002|Overall Study|Protocol Violation|11|||
160827156|NCT00953524|580753747|FG003|Overall Study|Protocol Violation|6|||
160827157|NCT00953524|580753744|FG000|Overall Study|Lost to Follow-up|0|||
160827158|NCT00953524|580753745|FG001|Overall Study|Lost to Follow-up|1|||
160990357|NCT00783692|581351809|FG002|Induction Phase|Protocol Violation|1|||
160990358|NCT00783692|581351810|FG003|Induction Phase|Protocol Violation|0|||
160990359|NCT00783692|581351811|FG004|Induction Phase|Protocol Violation|0|||
160990360|NCT00783692|581351812|FG005|Induction Phase|Protocol Violation|0|||
160990361|NCT00783692|581351813|FG006|Induction Phase|Protocol Violation|0|||
160990362|NCT00783692|581351807|FG000|Induction Phase|Lack of Efficacy|1|||
160990363|NCT00783692|581351808|FG001|Induction Phase|Lack of Efficacy|3|||
160990364|NCT00783692|581351809|FG002|Induction Phase|Lack of Efficacy|28|||
160990365|NCT00783692|581351810|FG003|Induction Phase|Lack of Efficacy|0|||
160990366|NCT00783692|581351811|FG004|Induction Phase|Lack of Efficacy|0|||
160990367|NCT00783692|581351812|FG005|Induction Phase|Lack of Efficacy|0|||
160990368|NCT00783692|581351813|FG006|Induction Phase|Lack of Efficacy|0|||
160990369|NCT00783692|581351807|FG000|Induction Phase|Withdrawal by Subject|3|||
160990370|NCT00783692|581351808|FG001|Induction Phase|Withdrawal by Subject|9|||
160990371|NCT00783692|581351809|FG002|Induction Phase|Withdrawal by Subject|16|||
160990372|NCT00783692|581351810|FG003|Induction Phase|Withdrawal by Subject|0|||
160990373|NCT00783692|581351811|FG004|Induction Phase|Withdrawal by Subject|0|||
160990374|NCT00783692|581351812|FG005|Induction Phase|Withdrawal by Subject|0|||
160990375|NCT00783692|581351813|FG006|Induction Phase|Withdrawal by Subject|0|||
160990376|NCT00783692|581351807|FG000|Induction Phase|Lost to Follow-up|0|||
160990377|NCT00783692|581351808|FG001|Induction Phase|Lost to Follow-up|0|||
160990378|NCT00783692|581351809|FG002|Induction Phase|Lost to Follow-up|3|||
160990379|NCT00783692|581351810|FG003|Induction Phase|Lost to Follow-up|0|||
160990380|NCT00783692|581351811|FG004|Induction Phase|Lost to Follow-up|0|||
160990381|NCT00783692|581351812|FG005|Induction Phase|Lost to Follow-up|0|||
160990382|NCT00783692|581351813|FG006|Induction Phase|Lost to Follow-up|0|||
160990383|NCT00783692|581351807|FG000|Induction Phase|Other|0|||
160990384|NCT00783692|581351808|FG001|Induction Phase|Other|0|||
160990385|NCT00783692|581351809|FG002|Induction Phase|Other|2|||
160990386|NCT00783692|581351810|FG003|Induction Phase|Other|0|||
160990387|NCT00783692|581351811|FG004|Induction Phase|Other|0|||
160990388|NCT00783692|581351812|FG005|Induction Phase|Other|0|||
160990389|NCT00783692|581351813|FG006|Induction Phase|Other|0|||
160990390|NCT00783692|581351807|FG000|Maintenance Phase|Adverse Event|7|||
160990391|NCT00783692|581351808|FG001|Maintenance Phase|Adverse Event|0|||
160990392|NCT00783692|581351809|FG002|Maintenance Phase|Adverse Event|0|||
160990393|NCT00783692|581351810|FG003|Maintenance Phase|Adverse Event|15|||
160990394|NCT00783692|581351811|FG004|Maintenance Phase|Adverse Event|12|||
160990395|NCT00783692|581351812|FG005|Maintenance Phase|Adverse Event|9|||
160990396|NCT00783692|581351813|FG006|Maintenance Phase|Adverse Event|38|||
160990397|NCT00783692|581351807|FG000|Maintenance Phase|Protocol Violation|0|||
160990398|NCT00783692|581351808|FG001|Maintenance Phase|Protocol Violation|0|||
160990399|NCT00783692|581351809|FG002|Maintenance Phase|Protocol Violation|0|||
160990400|NCT00783692|581351810|FG003|Maintenance Phase|Protocol Violation|1|||
160990401|NCT00783692|581351811|FG004|Maintenance Phase|Protocol Violation|2|||
160990402|NCT00783692|581351812|FG005|Maintenance Phase|Protocol Violation|3|||
160990403|NCT00783692|581351813|FG006|Maintenance Phase|Protocol Violation|4|||
160990404|NCT00783692|581351807|FG000|Maintenance Phase|Lack of Efficacy|79|||
160990405|NCT00783692|581351808|FG001|Maintenance Phase|Lack of Efficacy|0|||
160990406|NCT00783692|581351809|FG002|Maintenance Phase|Lack of Efficacy|0|||
160990407|NCT00783692|581351810|FG003|Maintenance Phase|Lack of Efficacy|64|||
160990408|NCT00783692|581351811|FG004|Maintenance Phase|Lack of Efficacy|58|||
160990409|NCT00783692|581351812|FG005|Maintenance Phase|Lack of Efficacy|48|||
160990410|NCT00783692|581351813|FG006|Maintenance Phase|Lack of Efficacy|177|||
160990411|NCT00783692|581351807|FG000|Maintenance Phase|Withdrawal by Subject|7|||
160990412|NCT00783692|581351808|FG001|Maintenance Phase|Withdrawal by Subject|0|||
160990413|NCT00783692|581351809|FG002|Maintenance Phase|Withdrawal by Subject|0|||
160990414|NCT00783692|581351810|FG003|Maintenance Phase|Withdrawal by Subject|7|||
160990415|NCT00783692|581351811|FG004|Maintenance Phase|Withdrawal by Subject|6|||
160990416|NCT00783692|581351812|FG005|Maintenance Phase|Withdrawal by Subject|9|||
160990417|NCT00783692|581351813|FG006|Maintenance Phase|Withdrawal by Subject|24|||
160990418|NCT00783692|581351807|FG000|Maintenance Phase|Lost to Follow-up|2|||
160990419|NCT00783692|581351808|FG001|Maintenance Phase|Lost to Follow-up|0|||
161134258|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
161134259|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
161134260|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
161134261|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
161134262|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
161334474|NCT03886272|582614156|FG003|Period 1|Withdrawal by Subject|0|||
161334475|NCT03886272|582614157|FG004|Period 1|Withdrawal by Subject|0|||
160990420|NCT00783692|581351809|FG002|Maintenance Phase|Lost to Follow-up|0|||
160990421|NCT00783692|581351810|FG003|Maintenance Phase|Lost to Follow-up|1|||
160990422|NCT00783692|581351811|FG004|Maintenance Phase|Lost to Follow-up|3|||
160990423|NCT00783692|581351812|FG005|Maintenance Phase|Lost to Follow-up|2|||
160990424|NCT00783692|581351813|FG006|Maintenance Phase|Lost to Follow-up|5|||
160990425|NCT00783692|581351807|FG000|Maintenance Phase|Other|0|||
160990426|NCT00783692|581351808|FG001|Maintenance Phase|Other|0|||
160990427|NCT00783692|581351809|FG002|Maintenance Phase|Other|0|||
160827159|NCT00953524|580753746|FG002|Overall Study|Lost to Follow-up|1|||
160990428|NCT00783692|581351810|FG003|Maintenance Phase|Other|1|||
160990429|NCT00783692|581351811|FG004|Maintenance Phase|Other|0|||
160990430|NCT00783692|581351812|FG005|Maintenance Phase|Other|1|||
160990431|NCT00783692|581351813|FG006|Maintenance Phase|Other|1|||
160990432|NCT00819234|581351819|FG000|Overall Study|Withdrawal by Subject|8|||
160990433|NCT00819234|581351820|FG001|Overall Study|Withdrawal by Subject|13|||
160990434|NCT00819234|581351821|FG002|Overall Study|Withdrawal by Subject|6|||
160990435|NCT00819234|581351822|FG003|Overall Study|Withdrawal by Subject|3|||
160990436|NCT00819234|581351823|FG004|Overall Study|Withdrawal by Subject|0|||
160990437|NCT00819234|581351824|FG005|Overall Study|Withdrawal by Subject|4|||
160990438|NCT00819234|581351825|FG006|Overall Study|Withdrawal by Subject|4|||
160990439|NCT00819234|581351826|FG007|Overall Study|Withdrawal by Subject|8|||
160990440|NCT00819234|581351827|FG008|Overall Study|Withdrawal by Subject|5|||
160990441|NCT00819234|581351828|FG009|Overall Study|Withdrawal by Subject|3|||
160990442|NCT00819234|581351819|FG000|Overall Study|Adverse Event|0|||
160990443|NCT00819234|581351820|FG001|Overall Study|Adverse Event|0|||
160990444|NCT00819234|581351821|FG002|Overall Study|Adverse Event|1|||
160990445|NCT00819234|581351822|FG003|Overall Study|Adverse Event|0|||
160990446|NCT00819234|581351823|FG004|Overall Study|Adverse Event|0|||
160990447|NCT00819234|581351824|FG005|Overall Study|Adverse Event|2|||
160990448|NCT00819234|581351825|FG006|Overall Study|Adverse Event|0|||
160990449|NCT00819234|581351826|FG007|Overall Study|Adverse Event|0|||
160990450|NCT00819234|581351827|FG008|Overall Study|Adverse Event|0|||
160990451|NCT00819234|581351828|FG009|Overall Study|Adverse Event|0|||
160990452|NCT00819234|581351819|FG000|Overall Study|Physician Decision|0|||
160990453|NCT00819234|581351820|FG001|Overall Study|Physician Decision|0|||
160990454|NCT00819234|581351821|FG002|Overall Study|Physician Decision|0|||
160990455|NCT00819234|581351822|FG003|Overall Study|Physician Decision|1|||
160990456|NCT00819234|581351823|FG004|Overall Study|Physician Decision|0|||
160990457|NCT00819234|581351824|FG005|Overall Study|Physician Decision|0|||
160990458|NCT00819234|581351825|FG006|Overall Study|Physician Decision|0|||
160990459|NCT00819234|581351826|FG007|Overall Study|Physician Decision|0|||
160990460|NCT00819234|581351827|FG008|Overall Study|Physician Decision|0|||
160990461|NCT00819234|581351828|FG009|Overall Study|Physician Decision|2|||
160990462|NCT00819234|581351819|FG000|Overall Study|Protocol Violation|0|||
160990463|NCT00819234|581351820|FG001|Overall Study|Protocol Violation|0|||
160990464|NCT00819234|581351821|FG002|Overall Study|Protocol Violation|1|||
160990465|NCT00819234|581351822|FG003|Overall Study|Protocol Violation|0|||
160990466|NCT00819234|581351823|FG004|Overall Study|Protocol Violation|0|||
160990467|NCT00819234|581351824|FG005|Overall Study|Protocol Violation|0|||
160990468|NCT00819234|581351825|FG006|Overall Study|Protocol Violation|0|||
160990469|NCT00819234|581351826|FG007|Overall Study|Protocol Violation|0|||
160990470|NCT00819234|581351827|FG008|Overall Study|Protocol Violation|0|||
160990471|NCT00819234|581351828|FG009|Overall Study|Protocol Violation|0|||
160990472|NCT00819234|581351819|FG000|Overall Study|Lost to Follow-up|2|||
160990473|NCT00819234|581351820|FG001|Overall Study|Lost to Follow-up|2|||
160990474|NCT00819234|581351821|FG002|Overall Study|Lost to Follow-up|0|||
160990475|NCT00819234|581351822|FG003|Overall Study|Lost to Follow-up|2|||
160990476|NCT00819234|581351823|FG004|Overall Study|Lost to Follow-up|1|||
160990477|NCT00819234|581351824|FG005|Overall Study|Lost to Follow-up|1|||
160990478|NCT00819234|581351825|FG006|Overall Study|Lost to Follow-up|1|||
160990479|NCT00819234|581351826|FG007|Overall Study|Lost to Follow-up|1|||
160990480|NCT00819234|581351827|FG008|Overall Study|Lost to Follow-up|1|||
160990481|NCT00819234|581351828|FG009|Overall Study|Lost to Follow-up|2|||
160990482|NCT01096056|581351829|FG000|Overall Study|Lost to Follow-up|0|||
160990483|NCT01096056|581351830|FG001|Overall Study|Lost to Follow-up|1|||
160990484|NCT03115346|581351831|FG000|Overall Study|Did not have AAA surgery|28|||
161134263|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
160990485|NCT03115346|581351832|FG001|Overall Study|Did not have AAA surgery|15|||
160990486|NCT03115346|581351831|FG000|Overall Study|Death|3|||
160990487|NCT03115346|581351832|FG001|Overall Study|Death|1|||
161134264|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161134265|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161134266|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
161134267|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
161134268|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
160990488|NCT03115346|581351831|FG000|Overall Study|Withdrawal by Subject|0|||
160990489|NCT03115346|581351832|FG001|Overall Study|Withdrawal by Subject|3|||
161134269|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
160990490|NCT03115346|581351831|FG000|Overall Study|Lost to Follow-up|0|||
160990491|NCT03115346|581351832|FG001|Overall Study|Lost to Follow-up|3|||
160990492|NCT00924560|581351833|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
160990493|NCT00924560|581351834|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
161134270|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
160990494|NCT00924560|581351835|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
160990495|NCT00924560|581351833|FG000|Overall Study|Non Compliance with the Protocol|20|||
160990496|NCT00924560|581351834|FG001|Overall Study|Non Compliance with the Protocol|15|||
161242907|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242908|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242909|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242910|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242911|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242912|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242913|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242914|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242915|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242916|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242917|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242918|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242919|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242920|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
161242921|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242922|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242923|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242924|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242925|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242926|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242927|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242928|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242929|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
161242930|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242931|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242932|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242933|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242934|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242935|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242936|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242937|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242938|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242939|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242940|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242941|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242942|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242943|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242944|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242945|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242946|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
161242947|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242948|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242949|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242950|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242951|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242952|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242953|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242954|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242955|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
161242956|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
161334476|NCT03886272|582614158|FG005|Period 1|Withdrawal by Subject|1|||
160990497|NCT00924560|581351835|FG002|Overall Study|Non Compliance with the Protocol|4|||
161134271|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161134272|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
161134273|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
161134274|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
161134275|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
161134276|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
161134277|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
161134278|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
161134279|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
161134280|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
161134281|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
161134282|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161134283|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161242957|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242958|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242959|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242960|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242961|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
160827160|NCT00953524|580753747|FG003|Overall Study|Lost to Follow-up|0|||
160827161|NCT00953524|580753744|FG000|Overall Study|Withdrawal by Subject|2|||
160827162|NCT00953524|580753745|FG001|Overall Study|Withdrawal by Subject|4|||
160827163|NCT00953524|580753746|FG002|Overall Study|Withdrawal by Subject|1|||
160827164|NCT00953524|580753747|FG003|Overall Study|Withdrawal by Subject|0|||
160827165|NCT00294645|580753748|FG000|Overall Study|Death|10|||
160827166|NCT00294645|580753749|FG001|Overall Study|Death|18|||
160827167|NCT00294645|580753748|FG000|Overall Study|Lost to Follow-up|1|||
160827168|NCT00294645|580753749|FG001|Overall Study|Lost to Follow-up|10|||
160827169|NCT00294645|580753748|FG000|Overall Study|Withdrawal by Subject|18|||
160827170|NCT00294645|580753749|FG001|Overall Study|Withdrawal by Subject|34|||
160827171|NCT00294645|580753748|FG000|Overall Study|Physician Decision|15|||
161134284|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
161134285|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
161134286|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
161134287|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
161134288|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Death|0|||
161134289|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Death|0|||
161134290|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Death|0|||
161134291|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Death|2|||
161134292|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Death|0|||
161134293|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Death|0|||
161134294|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
161134295|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
161134296|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
161134297|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
161134298|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
161134299|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
161134300|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
161134301|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
161134302|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
161134303|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
161134304|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
161134305|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
161134306|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161134307|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161134308|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
161134309|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
161134310|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
161134311|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
161134312|NCT01707992|581874175|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161134313|NCT01707992|581874176|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161134314|NCT01707992|581874177|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161134315|NCT01707992|581874178|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161134316|NCT01707992|581874179|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
161134317|NCT01707992|581874180|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
161134318|NCT00998738|581874181|FG000|Overall Study|Uknown|1|||
161134319|NCT03498521|581874182|FG000|Overall Study|Death|227|||
161134320|NCT03498521|581874183|FG001|Overall Study|Death|79|||
161134321|NCT03498521|581874184|FG002|Overall Study|Death|84|||
161134322|NCT03498521|581874182|FG000|Overall Study|Exclusion criteria|1|||
161134323|NCT03498521|581874183|FG001|Overall Study|Exclusion criteria|0|||
161134324|NCT03498521|581874184|FG002|Overall Study|Exclusion criteria|0|||
161134325|NCT03498521|581874182|FG000|Overall Study|Lost to Follow-up|4|||
161134326|NCT03498521|581874183|FG001|Overall Study|Lost to Follow-up|3|||
161134327|NCT03498521|581874184|FG002|Overall Study|Lost to Follow-up|3|||
161134328|NCT03498521|581874182|FG000|Overall Study|No profile due to technical failure|1|||
161134329|NCT03498521|581874183|FG001|Overall Study|No profile due to technical failure|0|||
161134330|NCT03498521|581874184|FG002|Overall Study|No profile due to technical failure|0|||
161134331|NCT03498521|581874182|FG000|Overall Study|Physician Decision|3|||
161134332|NCT03498521|581874183|FG001|Overall Study|Physician Decision|1|||
161134333|NCT03498521|581874184|FG002|Overall Study|Physician Decision|0|||
161134334|NCT03498521|581874182|FG000|Overall Study|Withdrawal by Subject|11|||
161134335|NCT03498521|581874183|FG001|Overall Study|Withdrawal by Subject|6|||
161134336|NCT03498521|581874184|FG002|Overall Study|Withdrawal by Subject|2|||
160827172|NCT00294645|580753749|FG001|Overall Study|Physician Decision|20|||
161134337|NCT03498521|581874182|FG000|Overall Study|Study terminated by sponsor|79|||
161134338|NCT03498521|581874183|FG001|Overall Study|Study terminated by sponsor|21|||
161134339|NCT03498521|581874184|FG002|Overall Study|Study terminated by sponsor|4|||
161334477|NCT03886272|582614159|FG006|Period 1|Withdrawal by Subject|0|||
160827173|NCT00294645|580753748|FG000|Overall Study|Other|4|||
160827174|NCT00294645|580753749|FG001|Overall Study|Other|10|||
161134340|NCT02848833|581874193|FG000|Overall Study|subject who are duplicated|1|||
161134341|NCT02848833|581874193|FG000|Overall Study|have not taken the study drug|11|||
161134342|NCT02848833|581874193|FG000|Overall Study|follow-up failure|6|||
161134343|NCT02848833|581874193|FG000|Overall Study|Protocol Violation|119|||
161134344|NCT04980391|581874194|FG000|Overall Study|Death|0|||
161134345|NCT04980391|581874195|FG001|Overall Study|Death|0|||
161242962|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242963|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242964|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242965|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242966|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242967|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242968|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242969|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242970|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242971|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242972|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
161242973|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242974|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242975|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242976|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242977|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242978|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161242979|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161242980|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
161242981|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
161242982|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
161242983|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242984|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242985|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242986|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242987|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242988|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242989|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242990|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242991|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242992|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242993|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242994|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242995|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242996|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242997|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242998|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
161242999|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243000|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243001|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243002|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243003|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243004|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243005|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243006|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160827175|NCT01238835|580753752|FG000|Overall Study|Death|124|||
160827176|NCT01238835|580753752|FG000|Overall Study|Withdrawal by Subject|9|||
161134346|NCT04980391|581874196|FG002|Overall Study|Death|1|||
161243007|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243008|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
161243009|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243010|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243011|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243012|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243013|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243014|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243015|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
160827177|NCT01238835|580753752|FG000|Overall Study|Lost to Follow-up|1|||
161134347|NCT04980391|581874197|FG003|Overall Study|Death|1|||
161134348|NCT04980391|581874194|FG000|Overall Study|Lost to Follow-up|3|||
161134349|NCT04980391|581874195|FG001|Overall Study|Lost to Follow-up|3|||
161134350|NCT04980391|581874196|FG002|Overall Study|Lost to Follow-up|2|||
161134351|NCT04980391|581874197|FG003|Overall Study|Lost to Follow-up|3|||
161134352|NCT04980391|581874194|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
161134353|NCT04980391|581874195|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161134354|NCT04980391|581874196|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161134355|NCT04980391|581874197|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
161134356|NCT04980391|581874194|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161134357|NCT04980391|581874195|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161134358|NCT04980391|581874196|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161134359|NCT04980391|581874197|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161134360|NCT04980391|581874194|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161134361|NCT04980391|581874195|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161134362|NCT04980391|581874196|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
161134363|NCT04980391|581874197|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
161134364|NCT04167345|581874198|FG000|Overall Study|Other|1|||
161134365|NCT04167345|581874199|FG001|Overall Study|Other|1|||
161134366|NCT04167345|581874200|FG002|Overall Study|Other|0|||
161134367|NCT04167345|581874201|FG003|Overall Study|Other|0|||
160827178|NCT01238835|580753752|FG000|Overall Study|Site early discontinuation|2|||
160827179|NCT00554619|580753753|FG000|Overall Study|Adverse Event|1|||
161134368|NCT04167345|581874202|FG004|Overall Study|Other|0|||
161134369|NCT01552057|581876567|FG000|Overall Study|Adverse Event|14|||
160827180|NCT00554619|580753753|FG000|Overall Study|Physician Decision|1|||
160827181|NCT00554619|580753753|FG000|Overall Study|Liver Function Test Abnormality|1|||
161134370|NCT01552057|581876568|FG001|Overall Study|Adverse Event|15|||
161134371|NCT01552057|581876567|FG000|Overall Study|Lack of Efficacy|8|||
161134372|NCT01552057|581876568|FG001|Overall Study|Lack of Efficacy|23|||
161134373|NCT01552057|581876567|FG000|Overall Study|Withdrawal by Subject|5|||
161134374|NCT01552057|581876568|FG001|Overall Study|Withdrawal by Subject|8|||
161134375|NCT01552057|581876567|FG000|Overall Study|Entry Criteria Not Met|2|||
161134376|NCT01552057|581876568|FG001|Overall Study|Entry Criteria Not Met|2|||
161134377|NCT01552057|581876567|FG000|Overall Study|Physician Decision|1|||
161134378|NCT01552057|581876568|FG001|Overall Study|Physician Decision|0|||
161134379|NCT00476086|581876569|FG000|Overall Study|Alternative therapy|1|||
161134380|NCT00476086|581876569|FG000|Overall Study|Progressive Disease|4|||
161134381|NCT02900092|581876570|FG000|Overall Study|Adverse Event|1|||
161134382|NCT03895203|581876571|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
161134383|NCT03895203|581876572|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
161134384|NCT03895203|581876573|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
161134385|NCT03895203|581876574|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161134386|NCT03895203|581876575|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161134387|NCT03895203|581876576|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
161134388|NCT03895203|581876571|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
161134389|NCT03895203|581876572|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161134390|NCT03895203|581876573|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161134391|NCT03895203|581876574|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161134392|NCT03895203|581876575|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161134393|NCT03895203|581876576|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
161134394|NCT03895203|581876571|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
161134395|NCT03895203|581876572|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161134396|NCT03895203|581876573|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161134397|NCT03895203|581876574|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161134398|NCT03895203|581876575|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161134399|NCT03895203|581876576|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
161134400|NCT03895203|581876571|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
161134401|NCT03895203|581876572|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
161134402|NCT03895203|581876573|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
161134403|NCT03895203|581876574|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161134404|NCT03895203|581876575|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161134405|NCT03895203|581876576|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
161134406|NCT03895203|581876571|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161134407|NCT03895203|581876572|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
161134408|NCT03895203|581876573|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161134409|NCT03895203|581876574|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161134410|NCT03895203|581876575|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161134411|NCT03895203|581876576|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
161134412|NCT03895203|581876571|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161134413|NCT03895203|581876572|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
161134414|NCT03895203|581876573|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161243016|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243017|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243018|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243019|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243020|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243021|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243022|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243023|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243024|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
161243025|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243026|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243027|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243028|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243029|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243030|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243031|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243032|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243033|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243034|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
161243035|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243036|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243037|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243038|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243039|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243040|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243041|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243042|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243043|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
160827182|NCT02088073|580753755|FG000|Acute Phase|Withdrawal by Subject|5|||
160827183|NCT02088073|580753756|FG001|Acute Phase|Withdrawal by Subject|0|||
160827184|NCT02088073|580753757|FG002|Acute Phase|Withdrawal by Subject|0|||
160827185|NCT02088073|580753758|FG003|Acute Phase|Withdrawal by Subject|0|||
160827186|NCT02088073|580753759|FG004|Acute Phase|Withdrawal by Subject|0|||
160827187|NCT02088073|580753755|FG000|Acute Phase|Hyperkalemia|2|||
160827188|NCT02088073|580753756|FG001|Acute Phase|Hyperkalemia|0|||
160827189|NCT02088073|580753757|FG002|Acute Phase|Hyperkalemia|0|||
160827190|NCT02088073|580753758|FG003|Acute Phase|Hyperkalemia|0|||
160827191|NCT02088073|580753759|FG004|Acute Phase|Hyperkalemia|0|||
160827192|NCT02088073|580753755|FG000|Maintanance Phase|Withdrawal by Subject|0|||
160827193|NCT02088073|580753756|FG001|Maintanance Phase|Withdrawal by Subject|2|||
160827194|NCT02088073|580753757|FG002|Maintanance Phase|Withdrawal by Subject|0|||
160827195|NCT02088073|580753758|FG003|Maintanance Phase|Withdrawal by Subject|0|||
160827196|NCT02088073|580753759|FG004|Maintanance Phase|Withdrawal by Subject|0|||
160827197|NCT02088073|580753755|FG000|Maintanance Phase|Adverse Event|0|||
160827198|NCT02088073|580753756|FG001|Maintanance Phase|Adverse Event|0|||
160827199|NCT02088073|580753757|FG002|Maintanance Phase|Adverse Event|3|||
160827200|NCT02088073|580753758|FG003|Maintanance Phase|Adverse Event|0|||
160902420|NCT00347360|581036041|FG010|Overall Study|Randomized in error|0|||
160827201|NCT02088073|580753759|FG004|Maintanance Phase|Adverse Event|1|||
160827202|NCT02088073|580753755|FG000|Maintanance Phase|Physician Decision|0|||
160827203|NCT02088073|580753756|FG001|Maintanance Phase|Physician Decision|0|||
160902421|NCT00347360|581036042|FG011|Overall Study|Randomized in error|1|||
160902422|NCT00347360|581036043|FG012|Overall Study|Randomized in error|0|||
160902423|NCT00347360|581036044|FG013|Overall Study|Randomized in error|0|||
160902424|NCT00347360|581036045|FG014|Overall Study|Randomized in error|0|||
161243044|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243045|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243046|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243047|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243048|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243049|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243050|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
161243051|NCT00112437|582269507|FG000|Year 2 (12-Month Extension)|Moved|0|||
160902425|NCT00347360|581036031|FG000|Overall Study|Failed inclusion criteria #4|0|||
160827204|NCT02088073|580753757|FG002|Maintanance Phase|Physician Decision|0|||
160827205|NCT02088073|580753758|FG003|Maintanance Phase|Physician Decision|0|||
160902426|NCT00347360|581036032|FG001|Overall Study|Failed inclusion criteria #4|0|||
160827206|NCT02088073|580753759|FG004|Maintanance Phase|Physician Decision|1|||
160827207|NCT02088073|580753755|FG000|Maintanance Phase|Sponsor's decision|0|||
160902427|NCT00347360|581036033|FG002|Overall Study|Failed inclusion criteria #4|0|||
160827208|NCT02088073|580753756|FG001|Maintanance Phase|Sponsor's decision|2|||
160827209|NCT02088073|580753757|FG002|Maintanance Phase|Sponsor's decision|0|||
160990498|NCT00924560|581351833|FG000|Overall Study|Physician Decision|2|||
160990499|NCT00924560|581351834|FG001|Overall Study|Physician Decision|3|||
160990500|NCT00924560|581351835|FG002|Overall Study|Physician Decision|4|||
160990501|NCT00924560|581351833|FG000|Overall Study|Withdrawal by Subject|50|||
161243052|NCT00112437|582269508|FG001|Year 2 (12-Month Extension)|Moved|0|||
161243053|NCT00112437|582269509|FG002|Year 2 (12-Month Extension)|Moved|0|||
161243054|NCT00112437|582269510|FG003|Year 2 (12-Month Extension)|Moved|0|||
161243055|NCT00112437|582269511|FG004|Year 2 (12-Month Extension)|Moved|0|||
161243056|NCT00112437|582269512|FG005|Year 2 (12-Month Extension)|Moved|0|||
161243057|NCT00112437|582269513|FG006|Year 2 (12-Month Extension)|Moved|0|||
161243058|NCT00112437|582269514|FG007|Year 2 (12-Month Extension)|Moved|0|||
161243059|NCT00112437|582269515|FG008|Year 2 (12-Month Extension)|Moved|0|||
161243060|NCT00112437|582269516|FG009|Year 2 (12-Month Extension)|Moved|1|||
161243061|NCT00112437|582269517|FG010|Year 2 (12-Month Extension)|Moved|0|||
161243062|NCT00112437|582269518|FG011|Year 2 (12-Month Extension)|Moved|0|||
161243063|NCT00112437|582269519|FG012|Year 2 (12-Month Extension)|Moved|0|||
161243064|NCT00112437|582269520|FG013|Year 2 (12-Month Extension)|Moved|0|||
161243065|NCT00112437|582269521|FG014|Year 2 (12-Month Extension)|Moved|0|||
161243066|NCT00112437|582269522|FG015|Year 2 (12-Month Extension)|Moved|0|||
161243067|NCT00112437|582269523|FG016|Year 2 (12-Month Extension)|Moved|0|||
161243068|NCT00112437|582269524|FG017|Year 2 (12-Month Extension)|Moved|0|||
161243069|NCT00112437|582269525|FG018|Year 2 (12-Month Extension)|Moved|0|||
161243070|NCT00112437|582269526|FG019|Year 2 (12-Month Extension)|Moved|0|||
161243071|NCT00112437|582269527|FG020|Year 2 (12-Month Extension)|Moved|0|||
161243072|NCT00112437|582269528|FG021|Year 2 (12-Month Extension)|Moved|0|||
161243073|NCT00112437|582269529|FG022|Year 2 (12-Month Extension)|Moved|0|||
161243074|NCT00112437|582269530|FG023|Year 2 (12-Month Extension)|Moved|0|||
161243075|NCT00112437|582269531|FG024|Year 2 (12-Month Extension)|Moved|0|||
161243076|NCT00112437|582269532|FG025|Year 2 (12-Month Extension)|Moved|0|||
161243077|NCT00112437|582269507|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
161243078|NCT00112437|582269508|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
161243079|NCT00112437|582269509|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
161243080|NCT00112437|582269510|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
161243081|NCT00112437|582269511|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
161243082|NCT00112437|582269512|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
161243083|NCT00112437|582269513|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
161243084|NCT00112437|582269514|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
161243085|NCT00112437|582269515|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
161243086|NCT00112437|582269516|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
161243087|NCT00112437|582269517|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
161243088|NCT00112437|582269518|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
161243089|NCT00112437|582269519|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
161243090|NCT00112437|582269520|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
161243091|NCT00112437|582269521|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
161243092|NCT00112437|582269522|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
161243093|NCT00112437|582269523|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
161243094|NCT00112437|582269524|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
161243095|NCT00112437|582269525|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
161243096|NCT00112437|582269526|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
161243097|NCT00112437|582269527|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
161243098|NCT00112437|582269528|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
161243099|NCT00112437|582269529|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
161243100|NCT00112437|582269530|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
161243101|NCT00112437|582269531|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
161334478|NCT02848664|582614165|FG000|Overall Study|Withdrawal by Subject|2|||
161334479|NCT02848664|582614165|FG000|Overall Study|Adverse Event|1|||
160827210|NCT02088073|580753758|FG003|Maintanance Phase|Sponsor's decision|2|||
160827211|NCT02088073|580753759|FG004|Maintanance Phase|Sponsor's decision|1|||
160827212|NCT02088073|580753755|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
160827213|NCT02088073|580753756|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
160990502|NCT00924560|581351834|FG001|Overall Study|Withdrawal by Subject|44|||
160990503|NCT00924560|581351835|FG002|Overall Study|Withdrawal by Subject|18|||
160990504|NCT00924560|581351833|FG000|Overall Study|Adverse Event|39|||
160990505|NCT00924560|581351834|FG001|Overall Study|Adverse Event|33|||
161243102|NCT00112437|582269532|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
161243103|NCT00112437|582269507|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243104|NCT00112437|582269508|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243105|NCT00112437|582269509|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243106|NCT00112437|582269510|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243107|NCT00112437|582269511|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243108|NCT00112437|582269512|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243109|NCT00112437|582269513|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243110|NCT00112437|582269514|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243111|NCT00112437|582269515|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243112|NCT00112437|582269516|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243113|NCT00112437|582269517|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161334480|NCT02848664|582614165|FG000|Overall Study|no assistance for device training|1|||
161334481|NCT02849080|582614168|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
161334482|NCT02849080|582614169|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
161334483|NCT02849080|582614170|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
161334484|NCT02849080|582614171|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
161334485|NCT02849080|582614168|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
161334486|NCT02849080|582614169|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
161334487|NCT02849080|582614170|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
161334488|NCT02849080|582614171|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
161334489|NCT02849080|582614168|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
161334490|NCT02849080|582614169|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
161334491|NCT02849080|582614170|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
161334492|NCT02849080|582614171|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
160827214|NCT02088073|580753757|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
160827215|NCT02088073|580753758|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
160827216|NCT02088073|580753759|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
160827217|NCT02088073|580753755|FG000|Maintanance Phase|Miscellaneous|0|||
160827218|NCT02088073|580753756|FG001|Maintanance Phase|Miscellaneous|2|||
160827219|NCT02088073|580753757|FG002|Maintanance Phase|Miscellaneous|1|||
160827220|NCT02088073|580753758|FG003|Maintanance Phase|Miscellaneous|2|||
160827221|NCT02088073|580753759|FG004|Maintanance Phase|Miscellaneous|1|||
160827222|NCT02088073|580753755|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
160827223|NCT02088073|580753756|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
160827224|NCT02088073|580753757|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
160827225|NCT02088073|580753758|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
160827226|NCT02088073|580753759|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
160827227|NCT02088073|580753755|FG000|Maintanance Phase|Subject compliance|0|||
160827228|NCT02088073|580753756|FG001|Maintanance Phase|Subject compliance|1|||
160827229|NCT02088073|580753757|FG002|Maintanance Phase|Subject compliance|0|||
160827230|NCT02088073|580753758|FG003|Maintanance Phase|Subject compliance|0|||
160827231|NCT02088073|580753759|FG004|Maintanance Phase|Subject compliance|0|||
160827232|NCT00907803|580753760|FG000|Overall Study|Withdrawal of consent - long commute|1|||
160827233|NCT00907803|580753761|FG001|Overall Study|Withdrawal of consent - long commute|0|||
160827234|NCT00907803|580753762|FG002|Overall Study|Withdrawal of consent - long commute|0|||
160827235|NCT00907803|580753760|FG000|Overall Study|Adverse Event|2|||
160827236|NCT00907803|580753761|FG001|Overall Study|Adverse Event|0|||
160827237|NCT00907803|580753762|FG002|Overall Study|Adverse Event|0|||
160827238|NCT00907803|580753760|FG000|Overall Study|Withdrawal by Subject|0|||
160827239|NCT00907803|580753761|FG001|Overall Study|Withdrawal by Subject|1|||
160827240|NCT00907803|580753762|FG002|Overall Study|Withdrawal by Subject|0|||
160827241|NCT00907803|580753760|FG000|Overall Study|Lost to Follow-up|0|||
160827242|NCT00907803|580753761|FG001|Overall Study|Lost to Follow-up|1|||
160827243|NCT00907803|580753762|FG002|Overall Study|Lost to Follow-up|0|||
160827244|NCT00907803|580753760|FG000|Overall Study|Protocol Violation|0|||
160827245|NCT00907803|580753761|FG001|Overall Study|Protocol Violation|1|||
160827246|NCT00907803|580753762|FG002|Overall Study|Protocol Violation|0|||
160827247|NCT04612842|580753767|FG000|Overall Study|Lost to Follow-up|20|||
160827248|NCT04612842|580753768|FG001|Overall Study|Lost to Follow-up|11|||
160827249|NCT04612842|580753767|FG000|Overall Study|Withdrawal by Subject|26|||
160827250|NCT04612842|580753768|FG001|Overall Study|Withdrawal by Subject|15|||
160827251|NCT04612842|580753767|FG000|Overall Study|Death|2|||
160827252|NCT04612842|580753768|FG001|Overall Study|Death|2|||
160827253|NCT02419131|580753769|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
160827254|NCT02419131|580753770|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
160827255|NCT02419131|580753771|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
160827256|NCT02419131|580753769|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
160827257|NCT02419131|580753770|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
160827258|NCT02419131|580753771|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
160827259|NCT05426031|580753772|FG000|Overall Study|Circulatory Arrest|3|||
160990506|NCT00924560|581351835|FG002|Overall Study|Adverse Event|0|||
160990507|NCT00924560|581351833|FG000|Overall Study|Pregnancy|5|||
161134415|NCT03895203|581876574|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161334493|NCT02849080|582614168|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
160827260|NCT05426031|580753773|FG001|Overall Study|Circulatory Arrest|2|||
160827261|NCT03060512|580753774|FG000|Overall Study|Adverse Event|4|||
160827262|NCT03060512|580753775|FG001|Overall Study|Adverse Event|6|||
161334494|NCT02849080|582614169|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
160827263|NCT03060512|580753774|FG000|Overall Study|Lost to Follow-up|1|||
160827264|NCT03060512|580753775|FG001|Overall Study|Lost to Follow-up|1|||
160827265|NCT03060512|580753774|FG000|Overall Study|Withdrawal by Subject|1|||
160827266|NCT03060512|580753775|FG001|Overall Study|Withdrawal by Subject|0|||
160827267|NCT03060512|580753774|FG000|Overall Study|Non-compliance with study medication|1|||
161334495|NCT02849080|582614170|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
160827268|NCT03060512|580753775|FG001|Overall Study|Non-compliance with study medication|2|||
160827269|NCT00089986|580753776|FG000|Overall Study|Adverse Event|6|||
160827270|NCT00089986|580753777|FG001|Overall Study|Adverse Event|9|||
160827271|NCT00089986|580753778|FG002|Overall Study|Adverse Event|6|||
160827272|NCT00089986|580753776|FG000|Overall Study|Lost to Follow-up|3|||
160827273|NCT00089986|580753777|FG001|Overall Study|Lost to Follow-up|1|||
160827274|NCT00089986|580753778|FG002|Overall Study|Lost to Follow-up|1|||
160827275|NCT00089986|580753776|FG000|Overall Study|Protocol Violation|0|||
160827276|NCT00089986|580753777|FG001|Overall Study|Protocol Violation|1|||
160827277|NCT00089986|580753778|FG002|Overall Study|Protocol Violation|0|||
160827278|NCT00089986|580753776|FG000|Overall Study|Patient transferred to another hospital|2|||
160827279|NCT00089986|580753777|FG001|Overall Study|Patient transferred to another hospital|1|||
160827280|NCT00089986|580753778|FG002|Overall Study|Patient transferred to another hospital|0|||
160827281|NCT00089986|580753776|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
160827282|NCT00089986|580753777|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
160827283|NCT00089986|580753778|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
160827284|NCT00089986|580753776|FG000|Overall Study|Hemohlobin stopping rule|0|||
160827285|NCT00089986|580753777|FG001|Overall Study|Hemohlobin stopping rule|1|||
160827286|NCT00089986|580753778|FG002|Overall Study|Hemohlobin stopping rule|0|||
160827287|NCT00089986|580753776|FG000|Overall Study|Investigator decision to withdrew|0|||
160827288|NCT00089986|580753777|FG001|Overall Study|Investigator decision to withdrew|1|||
160827289|NCT00089986|580753778|FG002|Overall Study|Investigator decision to withdrew|0|||
160827290|NCT00089986|580753776|FG000|Overall Study|Enrollment in another study|0|||
160827291|NCT00089986|580753777|FG001|Overall Study|Enrollment in another study|1|||
160827292|NCT00089986|580753778|FG002|Overall Study|Enrollment in another study|0|||
160827293|NCT00089986|580753776|FG000|Overall Study|Family decision|0|||
160827294|NCT00089986|580753777|FG001|Overall Study|Family decision|1|||
160827295|NCT00089986|580753778|FG002|Overall Study|Family decision|0|||
160827296|NCT00089986|580753776|FG000|Overall Study|Do not resuscitate (DNR)|0|||
160827297|NCT00089986|580753777|FG001|Overall Study|Do not resuscitate (DNR)|0|||
160827298|NCT00089986|580753778|FG002|Overall Study|Do not resuscitate (DNR)|1|||
160827299|NCT00089986|580753776|FG000|Overall Study|Withdrawal by Subject|3|||
160827300|NCT00089986|580753777|FG001|Overall Study|Withdrawal by Subject|6|||
160827301|NCT00089986|580753778|FG002|Overall Study|Withdrawal by Subject|2|||
160827302|NCT04065074|580753782|FG000|Overall Study|Adverse Event|1|||
160827303|NCT04065074|580753782|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
160827304|NCT02334683|580753783|FG000|First 12 Week Period|Lost to Follow-up|1|||
160827305|NCT02334683|580753784|FG001|First 12 Week Period|Lost to Follow-up|0|||
160827306|NCT02334683|580753783|FG000|Second 12 Week Period|Adverse Event|0|||
160827307|NCT02334683|580753784|FG001|Second 12 Week Period|Adverse Event|1|||
160827308|NCT01062841|580753785|FG000|Overall Study|Indwelling Device Removed|41|||
160827309|NCT01062841|580753786|FG001|Overall Study|Indwelling Device Removed|48|||
160827310|NCT01062841|580753785|FG000|Overall Study|Death|3|||
160827311|NCT01062841|580753786|FG001|Overall Study|Death|5|||
160827312|NCT01062841|580753785|FG000|Overall Study|Withdrawal by Subject|2|||
160827313|NCT01062841|580753786|FG001|Overall Study|Withdrawal by Subject|0|||
160827314|NCT01062841|580753785|FG000|Overall Study|Withdrawal by Study|3|||
160827315|NCT01062841|580753786|FG001|Overall Study|Withdrawal by Study|0|||
160827316|NCT03958656|580753789|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
160827317|NCT03958656|580753790|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
160827318|NCT03958656|580753791|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
160827319|NCT03958656|580753792|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
160827320|NCT03958656|580753789|FG000|Overall Study|No longer meets eligibility criteria|0|||
160827321|NCT03958656|580753790|FG001|Overall Study|No longer meets eligibility criteria|0|||
160827322|NCT03958656|580753791|FG002|Overall Study|No longer meets eligibility criteria|1|||
160827323|NCT03958656|580753792|FG003|Overall Study|No longer meets eligibility criteria|0|||
160827324|NCT03958656|580753789|FG000|Overall Study|Started anti-cancer treatment|0|||
160827325|NCT03958656|580753790|FG001|Overall Study|Started anti-cancer treatment|0|||
160902428|NCT00347360|581036034|FG003|Overall Study|Failed inclusion criteria #4|0|||
160902429|NCT00347360|581036035|FG004|Overall Study|Failed inclusion criteria #4|0|||
160902430|NCT00347360|581036036|FG005|Overall Study|Failed inclusion criteria #4|0|||
160902431|NCT00347360|581036037|FG006|Overall Study|Failed inclusion criteria #4|0|||
160902432|NCT00347360|581036038|FG007|Overall Study|Failed inclusion criteria #4|0|||
160902433|NCT00347360|581036039|FG008|Overall Study|Failed inclusion criteria #4|0|||
160902434|NCT00347360|581036040|FG009|Overall Study|Failed inclusion criteria #4|0|||
160827326|NCT03958656|580753791|FG002|Overall Study|Started anti-cancer treatment|1|||
160827327|NCT03958656|580753792|FG003|Overall Study|Started anti-cancer treatment|0|||
160827328|NCT03831880|580753793|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
160827329|NCT03831880|580753794|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
160827330|NCT03831880|580753793|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
160827331|NCT03831880|580753794|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
160902435|NCT00347360|581036041|FG010|Overall Study|Failed inclusion criteria #4|0|||
160902436|NCT00347360|581036042|FG011|Overall Study|Failed inclusion criteria #4|1|||
160902437|NCT00347360|581036043|FG012|Overall Study|Failed inclusion criteria #4|0|||
160827332|NCT03158012|580753797|FG000|Overall Study|Withdrawal by Subject|0|||
160827333|NCT03158012|580753798|FG001|Overall Study|Withdrawal by Subject|1|||
160827334|NCT02788201|580753799|FG000|Overall Study|Death|1|||
160827335|NCT02788201|580753800|FG001|Overall Study|Death|1|||
160827336|NCT02788201|580753801|FG002|Overall Study|Death|1|||
160827337|NCT02788201|580753802|FG003|Overall Study|Death|1|||
160827338|NCT02788201|580753803|FG004|Overall Study|Death|0|||
160827339|NCT02788201|580753804|FG005|Overall Study|Death|1|||
160827340|NCT02788201|580753799|FG000|Overall Study|Ineligible|0|||
160827341|NCT02788201|580753800|FG001|Overall Study|Ineligible|0|||
160827342|NCT02788201|580753801|FG002|Overall Study|Ineligible|0|||
160827343|NCT02788201|580753802|FG003|Overall Study|Ineligible|0|||
160827344|NCT02788201|580753803|FG004|Overall Study|Ineligible|0|||
160827345|NCT02788201|580753804|FG005|Overall Study|Ineligible|1|||
160827346|NCT02788201|580753799|FG000|Overall Study|Withdrawal by Subject|0|||
160827347|NCT02788201|580753800|FG001|Overall Study|Withdrawal by Subject|0|||
160827348|NCT02788201|580753801|FG002|Overall Study|Withdrawal by Subject|0|||
160827349|NCT02788201|580753802|FG003|Overall Study|Withdrawal by Subject|0|||
160827350|NCT02788201|580753803|FG004|Overall Study|Withdrawal by Subject|0|||
160827351|NCT02788201|580753804|FG005|Overall Study|Withdrawal by Subject|1|||
160827352|NCT02969590|580753808|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
160827353|NCT02969590|580753809|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
160827354|NCT02969590|580753810|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
160827355|NCT01414205|580753811|FG000|Overall Study|Death|5|||
160827356|NCT01414205|580753812|FG001|Overall Study|Death|1|||
160827357|NCT01414205|580753811|FG000|Overall Study|Lost to Follow-up|1|||
160827358|NCT01414205|580753812|FG001|Overall Study|Lost to Follow-up|4|||
160827359|NCT01414205|580753811|FG000|Overall Study|Physician Decision|0|||
160827360|NCT01414205|580753812|FG001|Overall Study|Physician Decision|1|||
160827361|NCT01414205|580753811|FG000|Overall Study|Randomized but not Treated|1|||
160827362|NCT01414205|580753812|FG001|Overall Study|Randomized but not Treated|1|||
160827363|NCT01166373|580753813|FG000|Overall Study|Lost to Follow-up|3|||
160827364|NCT01166373|580753814|FG001|Overall Study|Lost to Follow-up|2|||
160827365|NCT01166373|580753815|FG002|Overall Study|Lost to Follow-up|2|||
160827366|NCT01166373|580753816|FG003|Overall Study|Lost to Follow-up|2|||
160827367|NCT01166373|580753813|FG000|Overall Study|Withdrawal by Subject|1|||
160827368|NCT01166373|580753814|FG001|Overall Study|Withdrawal by Subject|2|||
160827369|NCT01166373|580753815|FG002|Overall Study|Withdrawal by Subject|2|||
160827370|NCT01166373|580753816|FG003|Overall Study|Withdrawal by Subject|3|||
160827371|NCT01166373|580753813|FG000|Overall Study|Physician Decision|1|||
160827372|NCT01166373|580753814|FG001|Overall Study|Physician Decision|0|||
160827373|NCT01166373|580753815|FG002|Overall Study|Physician Decision|0|||
160827374|NCT01166373|580753816|FG003|Overall Study|Physician Decision|0|||
160827375|NCT02498067|580753817|FG000|Overall Study|Lost to Follow-up|22|||
160827376|NCT02498067|580753817|FG000|Overall Study|Did not meet inclusion criteria|11|||
160827377|NCT01874275|580753818|FG000|Overall Study|Lost to Follow-up|1|||
160827378|NCT01874275|580753819|FG001|Overall Study|Lost to Follow-up|0|||
160827379|NCT02214225|580753824|FG000|Overall Study|Lost to Follow-up|46|||
160827380|NCT02214225|580753825|FG001|Overall Study|Lost to Follow-up|18|||
160827381|NCT02214225|580753826|FG002|Overall Study|Lost to Follow-up|18|||
160827382|NCT02214225|580753824|FG000|Overall Study|Withdrawal by Subject|2|||
160827383|NCT02214225|580753825|FG001|Overall Study|Withdrawal by Subject|0|||
160827384|NCT02214225|580753826|FG002|Overall Study|Withdrawal by Subject|2|||
160827385|NCT02214225|580753824|FG000|Overall Study|Death|5|||
160827386|NCT02214225|580753825|FG001|Overall Study|Death|0|||
160827387|NCT02214225|580753826|FG002|Overall Study|Death|1|||
160827388|NCT02214225|580753824|FG000|Overall Study|randomized in error, not vaccinated|2|||
160827389|NCT02214225|580753825|FG001|Overall Study|randomized in error, not vaccinated|1|||
160827390|NCT02214225|580753826|FG002|Overall Study|randomized in error, not vaccinated|1|||
160827391|NCT03987932|580753827|FG000|Overall Study|Lost to Follow-up|2|||
160827392|NCT03987932|580753828|FG001|Overall Study|Lost to Follow-up|1|||
160827393|NCT03987932|580753829|FG002|Overall Study|Lost to Follow-up|1|||
160827394|NCT03987932|580753827|FG000|Overall Study|Non-study related elective surgery|0|||
160827395|NCT03987932|580753828|FG001|Overall Study|Non-study related elective surgery|0|||
160827396|NCT03987932|580753829|FG002|Overall Study|Non-study related elective surgery|1|||
160827397|NCT01669421|580753830|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
160827398|NCT01669421|580753830|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
160827399|NCT02813668|580753836|FG000|Overall Study|Death|4|||
160827400|NCT02813668|580753836|FG000|Overall Study|Lost to Follow-up|509|||
160827401|NCT02813668|580753836|FG000|Overall Study|Withdrawal by Subject|148|||
160827402|NCT02813668|580753836|FG000|Overall Study|No longer at worksite|85|||
160827403|NCT02813668|580753836|FG000|Overall Study|Medical reasons not related to the study|4|||
160827404|NCT02961790|580753837|FG000|Overall Study|Canceled|4|||
160827405|NCT02961790|580753838|FG001|Overall Study|Canceled|5|||
160827406|NCT02961790|580753839|FG002|Overall Study|Canceled|1|||
160827407|NCT02961790|580753840|FG003|Overall Study|Canceled|4|||
160827408|NCT02961790|580753837|FG000|Overall Study|without baseline data|4|||
160827409|NCT02961790|580753838|FG001|Overall Study|without baseline data|0|||
160827410|NCT02961790|580753839|FG002|Overall Study|without baseline data|1|||
160827411|NCT02961790|580753840|FG003|Overall Study|without baseline data|0|||
160827412|NCT02961790|580753837|FG000|Overall Study|without post baseline data|7|||
160827413|NCT02961790|580753838|FG001|Overall Study|without post baseline data|6|||
160827414|NCT02961790|580753839|FG002|Overall Study|without post baseline data|4|||
160827415|NCT02961790|580753840|FG003|Overall Study|without post baseline data|1|||
160827416|NCT02594098|580753843|FG000|Overall Study|Lack of Efficacy|17|||
160827417|NCT02594098|580753844|FG001|Overall Study|Lack of Efficacy|6|||
160827418|NCT02594098|580753843|FG000|Overall Study|Withdrawal by Subject|1|||
160827419|NCT02594098|580753844|FG001|Overall Study|Withdrawal by Subject|3|||
160827420|NCT02594098|580753843|FG000|Overall Study|Terminated participation|6|||
160827421|NCT02594098|580753844|FG001|Overall Study|Terminated participation|2|||
160827422|NCT02594098|580753843|FG000|Overall Study|Seek alternative treatment|2|||
160827423|NCT02594098|580753844|FG001|Overall Study|Seek alternative treatment|1|||
160827424|NCT02594098|580753843|FG000|Overall Study|Other|0|||
160827425|NCT02594098|580753844|FG001|Overall Study|Other|1|||
160827426|NCT01866423|580753845|FG000|Overall Study|Lack of Efficacy|3|||
160827427|NCT01866423|580753845|FG000|Overall Study|Sponsor Decision|1|||
161334496|NCT02849080|582614171|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
161334497|NCT02849080|582614168|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
161334498|NCT02849080|582614169|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
161334499|NCT02849080|582614170|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
161334500|NCT02849080|582614171|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
161334501|NCT02849080|582614168|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
161334502|NCT02849080|582614169|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161334503|NCT02849080|582614170|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161334504|NCT02849080|582614171|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
161334505|NCT01819727|582614174|FG000|Overall Study|Adverse Event|8|||
161334506|NCT01819727|582614175|FG001|Overall Study|Adverse Event|9|||
161334507|NCT01819727|582614174|FG000|Overall Study|Death|1|||
161334508|NCT01819727|582614175|FG001|Overall Study|Death|0|||
161334509|NCT01819727|582614174|FG000|Overall Study|Lost to Follow-up|1|||
161334510|NCT01819727|582614175|FG001|Overall Study|Lost to Follow-up|1|||
161334511|NCT01819727|582614174|FG000|Overall Study|Physician Decision|3|||
161334512|NCT01819727|582614175|FG001|Overall Study|Physician Decision|2|||
161334513|NCT01819727|582614174|FG000|Overall Study|Pregnancy|1|||
161334514|NCT01819727|582614175|FG001|Overall Study|Pregnancy|0|||
161334515|NCT01819727|582614174|FG000|Overall Study|Protocol Violation|0|||
161334516|NCT01819727|582614175|FG001|Overall Study|Protocol Violation|2|||
161334517|NCT01819727|582614174|FG000|Overall Study|Study Terminated by Sponsor|0|||
161334518|NCT01819727|582614175|FG001|Overall Study|Study Terminated by Sponsor|1|||
161334519|NCT01819727|582614174|FG000|Overall Study|Withdrawal by Subject|6|||
161334520|NCT01819727|582614175|FG001|Overall Study|Withdrawal by Subject|11|||
161334521|NCT01819727|582614174|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
161334522|NCT01819727|582614175|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
161334523|NCT01819727|582614174|FG000|Overall Study|Quit due to lack of health benifits|0|||
161334524|NCT01819727|582614175|FG001|Overall Study|Quit due to lack of health benifits|1|||
161334525|NCT00402727|582614178|FG000|Overall Study|Adverse Event|10|||
161334526|NCT00402727|582614179|FG001|Overall Study|Adverse Event|6|||
161334527|NCT00402727|582614178|FG000|Overall Study|Death|1|||
160827428|NCT00434759|580753856|FG000|Overall Study|Lack of Efficacy|5|||
160827429|NCT00434759|580753857|FG001|Overall Study|Lack of Efficacy|4|||
160827430|NCT00434759|580753856|FG000|Overall Study|Withdrawal by Subject|17|||
160827431|NCT00434759|580753857|FG001|Overall Study|Withdrawal by Subject|1|||
160827432|NCT00434759|580753856|FG000|Overall Study|family affairs|2|||
160827433|NCT00434759|580753857|FG001|Overall Study|family affairs|0|||
160827434|NCT00787930|580753858|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
160827435|NCT02513823|580753859|FG000|Overall Study|Lost to Follow-up|4|||
160827436|NCT02513823|580753859|FG000|Overall Study|Physician Decision|1|||
161334528|NCT00402727|582614179|FG001|Overall Study|Death|0|||
161334529|NCT00402727|582614178|FG000|Overall Study|Lack of Efficacy|1|||
160827437|NCT03002623|580753860|FG000|Overall Study|Lost to Follow-up|1|||
160827438|NCT03002623|580753861|FG001|Overall Study|Lost to Follow-up|0|||
160827439|NCT03002623|580753860|FG000|Overall Study|Physician Decision|1|||
160827440|NCT03002623|580753861|FG001|Overall Study|Physician Decision|1|||
160827441|NCT03204890|580756311|FG000|Overall Study|Withdrawal by Subject|1|||
160827442|NCT01688739|580756319|FG000|Overall Study|Administrative Decision|1|||
160990508|NCT00924560|581351834|FG001|Overall Study|Pregnancy|7|||
160990509|NCT00924560|581351835|FG002|Overall Study|Pregnancy|1|||
160990510|NCT00924560|581351833|FG000|Overall Study|Lost to Follow-up|78|||
160990511|NCT00924560|581351834|FG001|Overall Study|Lost to Follow-up|94|||
160990512|NCT00924560|581351835|FG002|Overall Study|Lost to Follow-up|45|||
161134416|NCT03895203|581876575|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
160827443|NCT01688739|580756320|FG001|Overall Study|Administrative Decision|0|||
161134417|NCT03895203|581876576|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
161334530|NCT00402727|582614179|FG001|Overall Study|Lack of Efficacy|3|||
161334531|NCT00402727|582614178|FG000|Overall Study|Lost to Follow-up|24|||
160827444|NCT01688739|580756321|FG002|Overall Study|Administrative Decision|0|||
160827445|NCT01688739|580756322|FG003|Overall Study|Administrative Decision|0|||
160827446|NCT01688739|580756323|FG004|Overall Study|Administrative Decision|0|||
160827447|NCT01688739|580756324|FG005|Overall Study|Administrative Decision|0|||
160827448|NCT01688739|580756325|FG006|Overall Study|Administrative Decision|0|||
160827449|NCT01688739|580756326|FG007|Overall Study|Administrative Decision|0|||
160827450|NCT01688739|580756327|FG008|Overall Study|Administrative Decision|0|||
160827451|NCT01688739|580756328|FG009|Overall Study|Administrative Decision|0|||
160827452|NCT00490776|580756331|FG000|Overall Study|Withdrawal by Subject|1|||
160827453|NCT00490776|580756331|FG000|Overall Study|Administrative Problems|1|||
160827454|NCT00490776|580756331|FG000|Overall Study|Death|1|||
160827455|NCT00490776|580756331|FG000|Overall Study|New Cancer Therapy|1|||
160827456|NCT00490776|580756331|FG000|Overall Study|Disease Progression|5|||
160827457|NCT00940485|580756336|FG000|Overall Study|HBeAb positive at Baseline|3|||
160827458|NCT00940485|580756337|FG001|Overall Study|HBeAb positive at Baseline|2|||
160827459|NCT00940485|580756336|FG000|Overall Study|Lost to Follow-up|2|||
160827460|NCT00940485|580756337|FG001|Overall Study|Lost to Follow-up|3|||
160827461|NCT00940485|580756336|FG000|Overall Study|Adverse Event|8|||
160827462|NCT00940485|580756337|FG001|Overall Study|Adverse Event|0|||
160827463|NCT00940485|580756336|FG000|Overall Study|Withdrawal by Subject|1|||
160827464|NCT00940485|580756337|FG001|Overall Study|Withdrawal by Subject|1|||
160827465|NCT00940485|580756336|FG000|Overall Study|Others|1|||
160827466|NCT00940485|580756337|FG001|Overall Study|Others|1|||
160827467|NCT01113580|580756338|FG000|Overall Study|Protocol Violation|1|||
160827468|NCT01113580|580756339|FG001|Overall Study|Protocol Violation|0|||
160827469|NCT04599166|580756340|FG000|Overall Study|Technological failure connecting to study app|80|||
160827470|NCT01974752|580756341|FG000|Overall Study|Death|33|||
160827471|NCT01974752|580756342|FG001|Overall Study|Death|11|||
160827472|NCT01974752|580756341|FG000|Overall Study|Lost to Follow-up|2|||
160827473|NCT01974752|580756342|FG001|Overall Study|Lost to Follow-up|0|||
160827474|NCT01974752|580756341|FG000|Overall Study|Withdrawal by Subject|2|||
160827475|NCT01974752|580756342|FG001|Overall Study|Withdrawal by Subject|3|||
160827476|NCT01974752|580756341|FG000|Overall Study|Other Eligibility Criteria|0|||
160827477|NCT01974752|580756342|FG001|Overall Study|Other Eligibility Criteria|1|||
160827478|NCT02233738|580756343|FG000|Overall Study|Lost to Follow-up|5|||
160827479|NCT02233738|580756344|FG001|Overall Study|Lost to Follow-up|12|||
160827480|NCT02233738|580756343|FG000|Overall Study|Death|0|||
160827481|NCT02233738|580756344|FG001|Overall Study|Death|1|||
160827482|NCT02233738|580756343|FG000|Overall Study|Withdrawal by Subject|0|||
160827483|NCT02233738|580756344|FG001|Overall Study|Withdrawal by Subject|1|||
160827484|NCT02233738|580756343|FG000|Overall Study|Did not return after Baseline|3|||
160902438|NCT00347360|581036044|FG013|Overall Study|Failed inclusion criteria #4|0|||
160902439|NCT00347360|581036045|FG014|Overall Study|Failed inclusion criteria #4|0|||
160902440|NCT00347360|581036031|FG000|Overall Study|Prolonged duration between visits|0|||
160902441|NCT00347360|581036032|FG001|Overall Study|Prolonged duration between visits|0|||
160902442|NCT00347360|581036033|FG002|Overall Study|Prolonged duration between visits|0|||
160902443|NCT00347360|581036034|FG003|Overall Study|Prolonged duration between visits|0|||
160902444|NCT00347360|581036035|FG004|Overall Study|Prolonged duration between visits|0|||
160902445|NCT00347360|581036036|FG005|Overall Study|Prolonged duration between visits|0|||
160902446|NCT00347360|581036037|FG006|Overall Study|Prolonged duration between visits|0|||
160902447|NCT00347360|581036038|FG007|Overall Study|Prolonged duration between visits|0|||
160902448|NCT00347360|581036039|FG008|Overall Study|Prolonged duration between visits|0|||
160902449|NCT00347360|581036040|FG009|Overall Study|Prolonged duration between visits|0|||
160902450|NCT00347360|581036041|FG010|Overall Study|Prolonged duration between visits|0|||
160902451|NCT00347360|581036042|FG011|Overall Study|Prolonged duration between visits|0|||
160902452|NCT00347360|581036043|FG012|Overall Study|Prolonged duration between visits|1|||
160902453|NCT00347360|581036044|FG013|Overall Study|Prolonged duration between visits|0|||
160902454|NCT00347360|581036045|FG014|Overall Study|Prolonged duration between visits|0|||
160902455|NCT00347360|581036031|FG000|Overall Study|Subject left town, ran out of study drug|0|||
160902456|NCT00347360|581036032|FG001|Overall Study|Subject left town, ran out of study drug|0|||
160902457|NCT00347360|581036033|FG002|Overall Study|Subject left town, ran out of study drug|0|||
160902458|NCT00347360|581036034|FG003|Overall Study|Subject left town, ran out of study drug|0|||
160990513|NCT00924560|581351833|FG000|Overall Study|Miscellaneous Reasons|13|||
160990514|NCT00924560|581351834|FG001|Overall Study|Miscellaneous Reasons|10|||
161134418|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161134419|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161134420|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
160827485|NCT02233738|580756344|FG001|Overall Study|Did not return after Baseline|2|||
160827486|NCT02098369|580756345|FG000|Overall Study|Withdrawal by Subject|1|||
160827487|NCT02098369|580756346|FG001|Overall Study|Withdrawal by Subject|5|||
160827488|NCT02098369|580756347|FG002|Overall Study|Withdrawal by Subject|0|||
160827489|NCT02098369|580756345|FG000|Overall Study|Lost to Follow-up|5|||
160827490|NCT02098369|580756346|FG001|Overall Study|Lost to Follow-up|1|||
160827491|NCT02098369|580756347|FG002|Overall Study|Lost to Follow-up|3|||
160827492|NCT02098369|580756345|FG000|Overall Study|Death|1|||
160827493|NCT02098369|580756346|FG001|Overall Study|Death|1|||
160902459|NCT00347360|581036035|FG004|Overall Study|Subject left town, ran out of study drug|0|||
160902460|NCT00347360|581036036|FG005|Overall Study|Subject left town, ran out of study drug|0|||
160902461|NCT00347360|581036037|FG006|Overall Study|Subject left town, ran out of study drug|0|||
160902462|NCT00347360|581036038|FG007|Overall Study|Subject left town, ran out of study drug|0|||
160902463|NCT00347360|581036039|FG008|Overall Study|Subject left town, ran out of study drug|0|||
160902464|NCT00347360|581036040|FG009|Overall Study|Subject left town, ran out of study drug|0|||
160902465|NCT00347360|581036041|FG010|Overall Study|Subject left town, ran out of study drug|0|||
160902466|NCT00347360|581036042|FG011|Overall Study|Subject left town, ran out of study drug|0|||
160902467|NCT00347360|581036043|FG012|Overall Study|Subject left town, ran out of study drug|0|||
160902468|NCT00347360|581036044|FG013|Overall Study|Subject left town, ran out of study drug|1|||
160902469|NCT00347360|581036045|FG014|Overall Study|Subject left town, ran out of study drug|0|||
160902470|NCT00347360|581036031|FG000|Overall Study|Subject refuse to sign updated consent|0|||
160902471|NCT00347360|581036032|FG001|Overall Study|Subject refuse to sign updated consent|0|||
160902472|NCT00347360|581036033|FG002|Overall Study|Subject refuse to sign updated consent|0|||
160902473|NCT00347360|581036034|FG003|Overall Study|Subject refuse to sign updated consent|0|||
160902474|NCT00347360|581036035|FG004|Overall Study|Subject refuse to sign updated consent|0|||
160902475|NCT00347360|581036036|FG005|Overall Study|Subject refuse to sign updated consent|0|||
160902476|NCT00347360|581036037|FG006|Overall Study|Subject refuse to sign updated consent|0|||
160902477|NCT00347360|581036038|FG007|Overall Study|Subject refuse to sign updated consent|0|||
160902478|NCT00347360|581036039|FG008|Overall Study|Subject refuse to sign updated consent|0|||
160902479|NCT00347360|581036040|FG009|Overall Study|Subject refuse to sign updated consent|0|||
160902480|NCT00347360|581036041|FG010|Overall Study|Subject refuse to sign updated consent|0|||
160902481|NCT00347360|581036042|FG011|Overall Study|Subject refuse to sign updated consent|0|||
160902482|NCT00347360|581036043|FG012|Overall Study|Subject refuse to sign updated consent|0|||
160902483|NCT00347360|581036044|FG013|Overall Study|Subject refuse to sign updated consent|0|||
160902484|NCT00347360|581036045|FG014|Overall Study|Subject refuse to sign updated consent|1|||
160902485|NCT00347360|581036031|FG000|Overall Study|Visits conflicted with new job|0|||
160902486|NCT00347360|581036032|FG001|Overall Study|Visits conflicted with new job|0|||
160902487|NCT00347360|581036033|FG002|Overall Study|Visits conflicted with new job|0|||
160902488|NCT00347360|581036034|FG003|Overall Study|Visits conflicted with new job|0|||
160902489|NCT00347360|581036035|FG004|Overall Study|Visits conflicted with new job|0|||
160902490|NCT00347360|581036036|FG005|Overall Study|Visits conflicted with new job|0|||
160902491|NCT00347360|581036037|FG006|Overall Study|Visits conflicted with new job|1|||
161243114|NCT00112437|582269518|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161243115|NCT00112437|582269519|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243116|NCT00112437|582269520|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161243117|NCT00112437|582269521|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243118|NCT00112437|582269522|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
161243119|NCT00112437|582269523|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243120|NCT00112437|582269524|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243121|NCT00112437|582269525|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
161243122|NCT00112437|582269526|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243123|NCT00112437|582269527|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243124|NCT00112437|582269528|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243125|NCT00112437|582269529|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243126|NCT00112437|582269530|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243127|NCT00112437|582269531|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243128|NCT00112437|582269532|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
161243129|NCT00112437|582269507|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243130|NCT00112437|582269508|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243131|NCT00112437|582269509|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243132|NCT00112437|582269510|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243133|NCT00112437|582269511|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243134|NCT00112437|582269512|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243135|NCT00112437|582269513|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243136|NCT00112437|582269514|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243137|NCT00112437|582269515|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243138|NCT00112437|582269516|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243139|NCT00112437|582269517|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243140|NCT00112437|582269518|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243141|NCT00112437|582269519|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243142|NCT00112437|582269520|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160902492|NCT00347360|581036038|FG007|Overall Study|Visits conflicted with new job|0|||
160990515|NCT00924560|581351835|FG002|Overall Study|Miscellaneous Reasons|10|||
160990516|NCT03590743|581351838|FG000|Overall Study|Withdrawal by Subject|0|||
161243143|NCT00112437|582269521|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243144|NCT00112437|582269522|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
161243145|NCT00112437|582269523|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
160827494|NCT02098369|580756347|FG002|Overall Study|Death|1|||
160827495|NCT02098369|580756345|FG000|Overall Study|Other|0|||
160827496|NCT02098369|580756346|FG001|Overall Study|Other|2|||
160827497|NCT02098369|580756347|FG002|Overall Study|Other|1|||
160827498|NCT00570037|580756349|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
160827499|NCT00570037|580756350|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
160827500|NCT03946124|580756353|FG000|Overall Study|Withdrawal by Subject|19|||
160827501|NCT02046174|580756359|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
160827502|NCT02046174|580756360|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
160827503|NCT00413920|580756364|FG000|Overall Study|Adverse Event|9|||
160827504|NCT00413920|580756365|FG001|Overall Study|Adverse Event|11|||
160827505|NCT00413920|580756364|FG000|Overall Study|Lack of Efficacy|11|||
160827506|NCT00413920|580756365|FG001|Overall Study|Lack of Efficacy|9|||
160827507|NCT00413920|580756364|FG000|Overall Study|Death|3|||
160827508|NCT00413920|580756365|FG001|Overall Study|Death|5|||
160827509|NCT00413920|580756364|FG000|Overall Study|Graft Loss|5|||
160827510|NCT00413920|580756365|FG001|Overall Study|Graft Loss|3|||
160827511|NCT02118597|580756368|FG000|Overall Study|Sponsor terminated the study|14|||
160827512|NCT02118597|580756368|FG000|Overall Study|Serious Adverse Event|1|||
160827513|NCT02118597|580756368|FG000|Overall Study|Investigator's decision|1|||
160827514|NCT01891344|580756369|FG000|Overall Study|Ongoing|6|||
160827515|NCT01891344|580756370|FG001|Overall Study|Ongoing|2|||
160827516|NCT01891344|580756371|FG002|Overall Study|Ongoing|0|||
160827517|NCT01891344|580756372|FG003|Overall Study|Ongoing|1|||
160827518|NCT01891344|580756373|FG004|Overall Study|Ongoing|4|||
160827519|NCT01891344|580756374|FG005|Overall Study|Ongoing|1|||
160827520|NCT01891344|580756375|FG006|Overall Study|Ongoing|0|||
160827521|NCT01891344|580756376|FG007|Overall Study|Ongoing|0|||
160827522|NCT01852825|580756377|FG000|Overall Study|Withdrawal by Subject|2|||
160827523|NCT01852825|580756378|FG001|Overall Study|Withdrawal by Subject|0|||
160827524|NCT01852825|580756379|FG002|Overall Study|Withdrawal by Subject|0|||
160827525|NCT00186537|580756380|FG000|Overall Study|Withdrawal by Subject|4|||
160827526|NCT00186537|580756381|FG001|Overall Study|Withdrawal by Subject|0|||
160827527|NCT00186537|580756382|FG002|Overall Study|Withdrawal by Subject|3|||
160827528|NCT00186537|580756380|FG000|Overall Study|ALT > 1.5 x ULN|3|||
160827529|NCT00186537|580756381|FG001|Overall Study|ALT > 1.5 x ULN|0|||
160827530|NCT00186537|580756382|FG002|Overall Study|ALT > 1.5 x ULN|0|||
160827531|NCT02120365|580756388|FG000|Overall Study|Withdrawal by Subject|0|||
160827532|NCT02120365|580756389|FG001|Overall Study|Withdrawal by Subject|0|||
160827533|NCT02120365|580756390|FG002|Overall Study|Withdrawal by Subject|2|||
160827534|NCT02120365|580756391|FG003|Overall Study|Withdrawal by Subject|4|||
160827535|NCT02120365|580756392|FG004|Overall Study|Withdrawal by Subject|0|||
160827536|NCT02120365|580756393|FG005|Overall Study|Withdrawal by Subject|2|||
160827537|NCT02305849|580756394|FG000|Overall Study|Adverse Event|10|||
160827538|NCT02305849|580756395|FG001|Overall Study|Adverse Event|12|||
160827539|NCT02305849|580756396|FG002|Overall Study|Adverse Event|7|||
160827540|NCT02305849|580756397|FG003|Overall Study|Adverse Event|3|||
160827541|NCT02305849|580756394|FG000|Overall Study|Lack of Efficacy|10|||
160827542|NCT02305849|580756395|FG001|Overall Study|Lack of Efficacy|6|||
160827543|NCT02305849|580756396|FG002|Overall Study|Lack of Efficacy|3|||
160827544|NCT02305849|580756397|FG003|Overall Study|Lack of Efficacy|9|||
160827545|NCT02305849|580756394|FG000|Overall Study|Withdrawal by Subject|2|||
160827546|NCT02305849|580756395|FG001|Overall Study|Withdrawal by Subject|2|||
160827547|NCT02305849|580756396|FG002|Overall Study|Withdrawal by Subject|1|||
160827548|NCT02305849|580756397|FG003|Overall Study|Withdrawal by Subject|4|||
160827549|NCT02305849|580756394|FG000|Overall Study|Lost to Follow-up|0|||
160827550|NCT02305849|580756395|FG001|Overall Study|Lost to Follow-up|2|||
160827551|NCT02305849|580756396|FG002|Overall Study|Lost to Follow-up|0|||
160827552|NCT02305849|580756397|FG003|Overall Study|Lost to Follow-up|0|||
160827553|NCT02305849|580756394|FG000|Overall Study|Protocol Violation|3|||
160827554|NCT02305849|580756395|FG001|Overall Study|Protocol Violation|2|||
160827555|NCT02305849|580756396|FG002|Overall Study|Protocol Violation|1|||
160827556|NCT02305849|580756397|FG003|Overall Study|Protocol Violation|1|||
160827557|NCT02305849|580756394|FG000|Overall Study|Lab data met discontinuation criteria|0|||
161134421|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
161134422|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161134423|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
161134424|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
160990517|NCT03590743|581351839|FG001|Overall Study|Withdrawal by Subject|1|||
161334532|NCT00402727|582614179|FG001|Overall Study|Lost to Follow-up|11|||
160827558|NCT02305849|580756395|FG001|Overall Study|Lab data met discontinuation criteria|1|||
160827559|NCT02305849|580756396|FG002|Overall Study|Lab data met discontinuation criteria|2|||
160827560|NCT02305849|580756397|FG003|Overall Study|Lab data met discontinuation criteria|1|||
160827561|NCT02305849|580756394|FG000|Overall Study|Miscellaneous|1|||
160827562|NCT02305849|580756395|FG001|Overall Study|Miscellaneous|2|||
160827563|NCT02305849|580756396|FG002|Overall Study|Miscellaneous|4|||
160827564|NCT02305849|580756397|FG003|Overall Study|Miscellaneous|1|||
160827565|NCT02305849|580756394|FG000|Overall Study|Not fulfill eligibility criteria|1|||
160827566|NCT02305849|580756395|FG001|Overall Study|Not fulfill eligibility criteria|1|||
160827567|NCT02305849|580756396|FG002|Overall Study|Not fulfill eligibility criteria|0|||
160827568|NCT02305849|580756397|FG003|Overall Study|Not fulfill eligibility criteria|0|||
160827569|NCT00355342|580756398|FG000|Overall Study|Adverse Event|13|||
160827570|NCT00355342|580756399|FG001|Overall Study|Adverse Event|15|||
160827571|NCT00355342|580756398|FG000|Overall Study|Lost to Follow-up|4|||
160827572|NCT00355342|580756399|FG001|Overall Study|Lost to Follow-up|2|||
160827573|NCT00355342|580756398|FG000|Overall Study|Withdrawal by Subject|14|||
160827574|NCT00355342|580756399|FG001|Overall Study|Withdrawal by Subject|11|||
160827575|NCT00355342|580756398|FG000|Overall Study|Sponsor terminated study|2|||
160827576|NCT00355342|580756399|FG001|Overall Study|Sponsor terminated study|2|||
160827577|NCT00355342|580756398|FG000|Overall Study|Overcompliant-PI discretion|1|||
160827578|NCT00355342|580756399|FG001|Overall Study|Overcompliant-PI discretion|0|||
160827579|NCT00355342|580756398|FG000|Overall Study|Use of prohibited medication|1|||
160827580|NCT00355342|580756399|FG001|Overall Study|Use of prohibited medication|0|||
160827581|NCT00355342|580756398|FG000|Overall Study|COPD exacerbation|1|||
160827582|NCT00355342|580756399|FG001|Overall Study|COPD exacerbation|1|||
160827583|NCT00355342|580756398|FG000|Overall Study|Dispensed wrong study drug kit|1|||
160827584|NCT00355342|580756399|FG001|Overall Study|Dispensed wrong study drug kit|0|||
160827585|NCT00355342|580756398|FG000|Overall Study|Non-compliance with Dexa scans|1|||
160827586|NCT00355342|580756399|FG001|Overall Study|Non-compliance with Dexa scans|0|||
160827587|NCT00355342|580756398|FG000|Overall Study|Withdrawal by participant and physician|1|||
160827588|NCT00355342|580756399|FG001|Overall Study|Withdrawal by participant and physician|0|||
160827589|NCT00355342|580756398|FG000|Overall Study|Participant relocated|0|||
160827590|NCT00355342|580756399|FG001|Overall Study|Participant relocated|1|||
160827591|NCT00355342|580756398|FG000|Overall Study|Participant discontinued study drug|0|||
160827592|NCT00355342|580756399|FG001|Overall Study|Participant discontinued study drug|1|||
160827593|NCT00355342|580756398|FG000|Overall Study|Study management|0|||
160827594|NCT00355342|580756399|FG001|Overall Study|Study management|1|||
160827595|NCT00355342|580756398|FG000|Overall Study|Protocol Violation|0|||
160827596|NCT00355342|580756399|FG001|Overall Study|Protocol Violation|1|||
160827597|NCT00355342|580756398|FG000|Overall Study|Use of protocol excluded medication|0|||
160827598|NCT00355342|580756399|FG001|Overall Study|Use of protocol excluded medication|1|||
160827599|NCT00495521|580756401|FG000|Overall Study|Physician Decision|0|||
160827600|NCT00495521|580756402|FG001|Overall Study|Physician Decision|1|||
160827601|NCT00693472|580756405|FG000|Part 1|Adverse Event|1|||
160827602|NCT00693472|580756406|FG001|Part 1|Adverse Event|1|||
160827603|NCT00693472|580756407|FG002|Part 1|Adverse Event|0|||
160827604|NCT00693472|580756408|FG003|Part 1|Adverse Event|0|||
160827605|NCT00693472|580756405|FG000|Part 1|Lost to Follow-up|0|||
160827606|NCT00693472|580756406|FG001|Part 1|Lost to Follow-up|1|||
160827607|NCT00693472|580756407|FG002|Part 1|Lost to Follow-up|0|||
160990518|NCT01190176|581351840|FG000|Overall Study|Withdrawal by Subject|1|||
160990519|NCT01190176|581351840|FG000|Overall Study|Lost to Follow-up|1|||
160990520|NCT01221181|581351841|FG000|Overall Study|Lost to Follow-up|1|||
160990521|NCT01290094|581351842|FG000|Overall Study|Withdrawal by Subject|1|||
160990522|NCT01290094|581351842|FG000|Overall Study|Lost to Follow-up|5|||
160990523|NCT02738840|581353866|FG000|Overall Study|MRI Scan not Performed|5|||
160990524|NCT02738840|581353866|FG000|Overall Study|Lost to Follow-up|1|||
160990525|NCT02738840|581353866|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
160990526|NCT02738840|581353866|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
160990527|NCT02466516|581353875|FG000|Overall Study|Adverse Event|1|||
160990528|NCT02466516|581353876|FG001|Overall Study|Adverse Event|1|||
160990529|NCT02466516|581353877|FG002|Overall Study|Adverse Event|0|||
160990530|NCT02466516|581353878|FG003|Overall Study|Adverse Event|0|||
160990531|NCT02466516|581353879|FG004|Overall Study|Adverse Event|0|||
160990532|NCT02466516|581353875|FG000|Overall Study|Withdrew Consent|1|||
160827608|NCT00693472|580756408|FG003|Part 1|Lost to Follow-up|0|||
160827609|NCT00693472|580756405|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
160827610|NCT00693472|580756406|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
160827611|NCT00693472|580756407|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
160990533|NCT02466516|581353876|FG001|Overall Study|Withdrew Consent|0|||
160990534|NCT02466516|581353877|FG002|Overall Study|Withdrew Consent|0|||
160990535|NCT02466516|581353878|FG003|Overall Study|Withdrew Consent|0|||
160990536|NCT02466516|581353879|FG004|Overall Study|Withdrew Consent|0|||
160827612|NCT00693472|580756408|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
160827613|NCT00693472|580756405|FG000|Part 2|Adverse Event|0|||
160827614|NCT00693472|580756406|FG001|Part 2|Adverse Event|0|||
160827615|NCT00693472|580756407|FG002|Part 2|Adverse Event|1|||
160827616|NCT00693472|580756408|FG003|Part 2|Adverse Event|0|||
161134425|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161134426|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
161134427|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
161134428|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
161134429|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
161134430|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
160827617|NCT00693472|580756405|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
160827618|NCT00693472|580756406|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
160827619|NCT00693472|580756407|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
160827620|NCT00693472|580756408|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
160827621|NCT02782325|580756409|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
160827622|NCT02782325|580756410|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
160827623|NCT02782325|580756411|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
160827624|NCT02782325|580756409|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
160827625|NCT02782325|580756410|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
160827626|NCT02782325|580756411|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
160827627|NCT00042432|580756414|FG000|Overall Study|Adverse Event|4|||
160827628|NCT00042432|580756415|FG001|Overall Study|Adverse Event|1|||
160827629|NCT00042432|580756414|FG000|Overall Study|Withdrawal by Subject|1|||
160827630|NCT00042432|580756415|FG001|Overall Study|Withdrawal by Subject|3|||
160827631|NCT00042432|580756414|FG000|Overall Study|Death|0|||
160827632|NCT00042432|580756415|FG001|Overall Study|Death|2|||
160827633|NCT00042432|580756414|FG000|Overall Study|Ineligibility determined|1|||
160827634|NCT00042432|580756415|FG001|Overall Study|Ineligibility determined|0|||
160827635|NCT00042432|580756414|FG000|Overall Study|Initiation of maintenance dialysis|1|||
160827636|NCT00042432|580756415|FG001|Overall Study|Initiation of maintenance dialysis|1|||
160827637|NCT00042432|580756414|FG000|Overall Study|Other|2|||
160827638|NCT00042432|580756415|FG001|Overall Study|Other|0|||
160827639|NCT01527383|580756416|FG000|Overall Study|Adverse Event|5|||
160827640|NCT01527383|580756417|FG001|Overall Study|Adverse Event|0|||
160827641|NCT01527383|580756416|FG000|Overall Study|Lost to Follow-up|3|||
160827642|NCT01527383|580756417|FG001|Overall Study|Lost to Follow-up|0|||
160827643|NCT01527383|580756416|FG000|Overall Study|Physician Decision|2|||
160827644|NCT01527383|580756417|FG001|Overall Study|Physician Decision|0|||
160827645|NCT01527383|580756416|FG000|Overall Study|Pregnancy|1|||
160827646|NCT01527383|580756417|FG001|Overall Study|Pregnancy|0|||
160827647|NCT01527383|580756416|FG000|Overall Study|Protocol Violation|1|||
160827648|NCT01527383|580756417|FG001|Overall Study|Protocol Violation|0|||
160827649|NCT01527383|580756416|FG000|Overall Study|Screen failure|1|||
160827650|NCT01527383|580756417|FG001|Overall Study|Screen failure|0|||
160827651|NCT01527383|580756416|FG000|Overall Study|Participant moved|0|||
160827652|NCT01527383|580756417|FG001|Overall Study|Participant moved|1|||
160827653|NCT01527383|580756416|FG000|Overall Study|Withdrawal by Subject|2|||
160827654|NCT01527383|580756417|FG001|Overall Study|Withdrawal by Subject|3|||
160827655|NCT00849875|580756418|FG000|Overall Study|Death|28|||
160827656|NCT00849875|580756418|FG000|Overall Study|Ongoing (unknown completion status)|11|||
160827657|NCT00849875|580756418|FG000|Overall Study|Others|6|||
160827658|NCT00849875|580756418|FG000|Overall Study|Lost to Follow-up|2|||
160827659|NCT00461305|580756419|FG000|Treatment|Adverse Event|26|||
160827660|NCT00461305|580756420|FG001|Treatment|Adverse Event|3|||
160827661|NCT00461305|580756419|FG000|Treatment|Lost to Follow-up|4|||
160827662|NCT00461305|580756420|FG001|Treatment|Lost to Follow-up|2|||
160827663|NCT00461305|580756419|FG000|Treatment|Protocol Violation|13|||
160827664|NCT00461305|580756420|FG001|Treatment|Protocol Violation|2|||
160827665|NCT00461305|580756419|FG000|Treatment|Withdrawal by Subject|48|||
160827666|NCT00461305|580756420|FG001|Treatment|Withdrawal by Subject|2|||
160827667|NCT00461305|580756419|FG000|Treatment|Never dispensed|5|||
160827668|NCT00461305|580756420|FG001|Treatment|Never dispensed|0|||
160827669|NCT00461305|580756419|FG000|Treatment|Study drug not taken|1|||
160827670|NCT00461305|580756420|FG001|Treatment|Study drug not taken|0|||
160827671|NCT00461305|580756419|FG000|Treatment|Partially missing diary|2|||
160827672|NCT00461305|580756420|FG001|Treatment|Partially missing diary|0|||
160902493|NCT00347360|581036039|FG008|Overall Study|Visits conflicted with new job|0|||
160902494|NCT00347360|581036040|FG009|Overall Study|Visits conflicted with new job|0|||
160902495|NCT00347360|581036041|FG010|Overall Study|Visits conflicted with new job|0|||
160902496|NCT00347360|581036042|FG011|Overall Study|Visits conflicted with new job|0|||
160902497|NCT00347360|581036043|FG012|Overall Study|Visits conflicted with new job|0|||
160902498|NCT00347360|581036044|FG013|Overall Study|Visits conflicted with new job|0|||
160902499|NCT00347360|581036045|FG014|Overall Study|Visits conflicted with new job|0|||
160902500|NCT01449539|581036046|FG000|Overall Study|Withdrawal by Subject|3|||
160902501|NCT01449539|581036046|FG000|Overall Study|Toxicity not study related|1|||
161334533|NCT00402727|582614178|FG000|Overall Study|Physician Decision|1|||
160902502|NCT01387789|581036047|FG000|Overall Study|Adverse Event|5|||
160827673|NCT00461305|580756419|FG000|Treatment|Other (missing drug etc)|2|||
160827674|NCT00461305|580756420|FG001|Treatment|Other (missing drug etc)|0|||
160827675|NCT00461305|580756419|FG000|Continued Treatment|Adverse Event|26|||
160827676|NCT00461305|580756420|FG001|Continued Treatment|Adverse Event|0|||
160827677|NCT00461305|580756419|FG000|Continued Treatment|Lost to Follow-up|4|||
160827678|NCT00461305|580756420|FG001|Continued Treatment|Lost to Follow-up|0|||
160827679|NCT00461305|580756419|FG000|Continued Treatment|Protocol Violation|13|||
160827680|NCT00461305|580756420|FG001|Continued Treatment|Protocol Violation|0|||
160902503|NCT01387789|581036047|FG000|Overall Study|Lack of Efficacy|2|||
160902504|NCT01387789|581036047|FG000|Overall Study|Lost to Follow-up|1|||
160827681|NCT00461305|580756419|FG000|Continued Treatment|Withdrawal by Subject|48|||
160827682|NCT00461305|580756420|FG001|Continued Treatment|Withdrawal by Subject|0|||
160827683|NCT00461305|580756419|FG000|Continued Treatment|Partially missing diary|2|||
160827684|NCT00461305|580756420|FG001|Continued Treatment|Partially missing diary|0|||
160827685|NCT00461305|580756419|FG000|Continued Treatment|Other (missing drug etc)|2|||
160827686|NCT00461305|580756420|FG001|Continued Treatment|Other (missing drug etc)|0|||
160827687|NCT04342689|580756424|FG000|Overall Study|Withdrawal by Subject|32|||
160827688|NCT04342689|580756425|FG001|Overall Study|Withdrawal by Subject|33|||
160827689|NCT04342689|580756424|FG000|Overall Study|Lost to Follow-up|10|||
160827690|NCT04342689|580756425|FG001|Overall Study|Lost to Follow-up|12|||
160827691|NCT00844805|580756427|FG000|Treatment Phase|Adverse Event|5|||
160827692|NCT00844805|580756428|FG001|Treatment Phase|Adverse Event|1|||
160827693|NCT00844805|580756429|FG002|Treatment Phase|Adverse Event|0|||
160827694|NCT00844805|580756430|FG003|Treatment Phase|Adverse Event|0|||
160827695|NCT00844805|580756427|FG000|Treatment Phase|Withdrawal by Subject|3|||
160827696|NCT00844805|580756428|FG001|Treatment Phase|Withdrawal by Subject|4|||
160827697|NCT00844805|580756429|FG002|Treatment Phase|Withdrawal by Subject|0|||
160827698|NCT00844805|580756430|FG003|Treatment Phase|Withdrawal by Subject|0|||
160827699|NCT00844805|580756427|FG000|Treatment Phase|Noncompliance With Protocol|1|||
160827700|NCT00844805|580756428|FG001|Treatment Phase|Noncompliance With Protocol|0|||
160827701|NCT00844805|580756429|FG002|Treatment Phase|Noncompliance With Protocol|0|||
160827702|NCT00844805|580756430|FG003|Treatment Phase|Noncompliance With Protocol|0|||
160827703|NCT00844805|580756427|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
160827704|NCT00844805|580756428|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
160827705|NCT00844805|580756429|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
160827706|NCT00844805|580756430|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
160827707|NCT00844805|580756427|FG000|Follow-Up Phase|Adverse Event|0|||
160827708|NCT00844805|580756428|FG001|Follow-Up Phase|Adverse Event|0|||
160827709|NCT00844805|580756429|FG002|Follow-Up Phase|Adverse Event|1|||
160827710|NCT00844805|580756430|FG003|Follow-Up Phase|Adverse Event|0|||
160827711|NCT00844805|580756427|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
160827712|NCT00844805|580756428|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
160827713|NCT00844805|580756429|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
160827714|NCT00844805|580756430|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
160827715|NCT00844805|580756427|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
160827716|NCT00844805|580756428|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
160827717|NCT00844805|580756429|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
160827718|NCT00844805|580756430|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
160827719|NCT00844805|580756427|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
160827720|NCT00844805|580756428|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
160827721|NCT00844805|580756429|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
160827722|NCT00844805|580756430|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
160827723|NCT00844805|580756427|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
160827724|NCT00844805|580756428|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
160827725|NCT00844805|580756429|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
160827726|NCT00844805|580756430|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
160827727|NCT00259298|580756434|FG000|Overall Study|Withdrawal by Subject|1|||
160827728|NCT00259298|580756434|FG000|Overall Study|Physician Decision|2|||
160827729|NCT01367704|580756435|FG000|Overall Study|Lost to Follow-up|47|||
160827730|NCT01367704|580756436|FG001|Overall Study|Lost to Follow-up|161|||
160827731|NCT01011933|580756437|FG000|Overall Study|Wrong cell type|1|||
160827732|NCT01011933|580756437|FG000|Overall Study|Improper pre-protocol Rx|1|||
160827733|NCT01011933|580756437|FG000|Overall Study|Inadequate pathology|1|||
160827734|NCT01011933|580756437|FG000|Overall Study|Never treated|1|||
160827735|NCT00475865|580756439|FG000|Overall Study|Adverse Event|0|||
161134431|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161134432|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
161134433|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
161134434|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
161134435|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
161134436|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161134437|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161134438|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
161134439|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
160827736|NCT00475865|580756440|FG001|Overall Study|Adverse Event|3|||
161134440|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
161134441|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
160827737|NCT00475865|580756441|FG002|Overall Study|Adverse Event|4|||
160827738|NCT00475865|580756439|FG000|Overall Study|Lack of Efficacy|1|||
160827739|NCT00475865|580756440|FG001|Overall Study|Lack of Efficacy|0|||
160827740|NCT00475865|580756441|FG002|Overall Study|Lack of Efficacy|0|||
160827741|NCT00475865|580756439|FG000|Overall Study|Progressive disease|0|||
160827742|NCT00475865|580756440|FG001|Overall Study|Progressive disease|1|||
160827743|NCT00475865|580756441|FG002|Overall Study|Progressive disease|2|||
160827744|NCT00475865|580756439|FG000|Overall Study|Participant did not wish to continue|1|||
160827745|NCT00475865|580756440|FG001|Overall Study|Participant did not wish to continue|0|||
160827746|NCT00475865|580756441|FG002|Overall Study|Participant did not wish to continue|0|||
160827747|NCT00475865|580756439|FG000|Overall Study|Other than above|0|||
160827748|NCT00475865|580756440|FG001|Overall Study|Other than above|1|||
160827749|NCT00475865|580756441|FG002|Overall Study|Other than above|0|||
160827750|NCT04316741|580756442|FG000|Baseline Enrollment|Lost to Follow-up|1|||
160827751|NCT04316741|580756443|FG001|Baseline Enrollment|Lost to Follow-up|1|||
160827752|NCT04316741|580756442|FG000|Immediate Post-Test|Lost to Follow-up|5|||
160827753|NCT04316741|580756443|FG001|Immediate Post-Test|Lost to Follow-up|1|||
160827754|NCT04316741|580756442|FG000|1-month Post-test|Lost to Follow-up|7|||
160827755|NCT04316741|580756443|FG001|1-month Post-test|Lost to Follow-up|2|||
160827756|NCT04316741|580756442|FG000|3-month Follow-up|Lost to Follow-up|10|||
160827757|NCT04316741|580756443|FG001|3-month Follow-up|Lost to Follow-up|2|||
160827758|NCT02726880|580756444|FG000|Overall Study|Withdrawal by Subject|2|||
160827759|NCT02726880|580756445|FG001|Overall Study|Withdrawal by Subject|0|||
160827760|NCT02726880|580756444|FG000|Overall Study|Lost to Follow-up|1|||
160827761|NCT02726880|580756445|FG001|Overall Study|Lost to Follow-up|3|||
160827762|NCT00787202|580756446|FG000|Overall Study|Adverse Event|3|||
160827763|NCT00787202|580756447|FG001|Overall Study|Adverse Event|2|||
160827764|NCT00787202|580756448|FG002|Overall Study|Adverse Event|0|||
160827765|NCT00787202|580756449|FG003|Overall Study|Adverse Event|0|||
160827766|NCT00787202|580756450|FG004|Overall Study|Adverse Event|2|||
160827767|NCT00787202|580756446|FG000|Overall Study|Lack of Efficacy|5|||
160827768|NCT00787202|580756447|FG001|Overall Study|Lack of Efficacy|6|||
160827769|NCT00787202|580756448|FG002|Overall Study|Lack of Efficacy|5|||
160827770|NCT00787202|580756449|FG003|Overall Study|Lack of Efficacy|2|||
160827771|NCT00787202|580756450|FG004|Overall Study|Lack of Efficacy|1|||
160827772|NCT00787202|580756446|FG000|Overall Study|Lost to Follow-up|1|||
160827773|NCT00787202|580756447|FG001|Overall Study|Lost to Follow-up|0|||
160827774|NCT00787202|580756448|FG002|Overall Study|Lost to Follow-up|0|||
160827775|NCT00787202|580756449|FG003|Overall Study|Lost to Follow-up|0|||
160827776|NCT00787202|580756450|FG004|Overall Study|Lost to Follow-up|0|||
160827777|NCT00787202|580756446|FG000|Overall Study|Withdrawal by Subject|2|||
160827778|NCT00787202|580756447|FG001|Overall Study|Withdrawal by Subject|2|||
160827779|NCT00787202|580756448|FG002|Overall Study|Withdrawal by Subject|2|||
160827780|NCT00787202|580756449|FG003|Overall Study|Withdrawal by Subject|0|||
160827781|NCT00787202|580756450|FG004|Overall Study|Withdrawal by Subject|0|||
160827782|NCT00787202|580756446|FG000|Overall Study|Protocol Violation|2|||
160827783|NCT00787202|580756447|FG001|Overall Study|Protocol Violation|1|||
160827784|NCT00787202|580756448|FG002|Overall Study|Protocol Violation|0|||
160827785|NCT00787202|580756449|FG003|Overall Study|Protocol Violation|0|||
160827786|NCT00787202|580756450|FG004|Overall Study|Protocol Violation|1|||
160827787|NCT00787202|580756446|FG000|Overall Study|Randomized, not treated|1|||
160827788|NCT00787202|580756447|FG001|Overall Study|Randomized, not treated|0|||
160827789|NCT00787202|580756448|FG002|Overall Study|Randomized, not treated|0|||
160827790|NCT00787202|580756449|FG003|Overall Study|Randomized, not treated|0|||
160827791|NCT00787202|580756450|FG004|Overall Study|Randomized, not treated|0|||
160827792|NCT01510145|580756451|FG000|Overall Study|Adverse Event|6|||
160827793|NCT01510145|580756451|FG000|Overall Study|Lost to Follow-up|5|||
160827794|NCT01510145|580756451|FG000|Overall Study|Withdrawal by Subject|6|||
161243146|NCT00112437|582269524|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243147|NCT00112437|582269525|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243148|NCT00112437|582269526|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243149|NCT00112437|582269527|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243150|NCT00112437|582269528|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243151|NCT00112437|582269529|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243152|NCT00112437|582269530|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243153|NCT00112437|582269531|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243154|NCT00112437|582269532|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
161243155|NCT00112437|582269507|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243156|NCT00112437|582269508|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243157|NCT00112437|582269509|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243158|NCT00112437|582269510|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243159|NCT00112437|582269511|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
160827795|NCT01510145|580756451|FG000|Overall Study|Relative reported subject withdrew|1|||
160827796|NCT01442064|580756452|FG000|Overall Study|Adverse Event|2|||
160827797|NCT01442064|580756453|FG001|Overall Study|Adverse Event|2|||
160827798|NCT01442064|580756454|FG002|Overall Study|Adverse Event|2|||
160827799|NCT01442064|580756455|FG003|Overall Study|Adverse Event|1|||
160827800|NCT01442064|580756456|FG004|Overall Study|Adverse Event|2|||
160827801|NCT01442064|580756457|FG005|Overall Study|Adverse Event|0|||
160827802|NCT01442064|580756452|FG000|Overall Study|Death|0|||
160827803|NCT01442064|580756453|FG001|Overall Study|Death|1|||
160827804|NCT01442064|580756454|FG002|Overall Study|Death|3|||
160827805|NCT01442064|580756455|FG003|Overall Study|Death|3|||
161243160|NCT00112437|582269512|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
160827806|NCT01442064|580756456|FG004|Overall Study|Death|1|||
160827807|NCT01442064|580756457|FG005|Overall Study|Death|3|||
160827808|NCT01442064|580756452|FG000|Overall Study|Lost to Follow-up|5|||
160827809|NCT01442064|580756453|FG001|Overall Study|Lost to Follow-up|5|||
160827810|NCT01442064|580756454|FG002|Overall Study|Lost to Follow-up|1|||
160827811|NCT01442064|580756455|FG003|Overall Study|Lost to Follow-up|1|||
160827812|NCT01442064|580756456|FG004|Overall Study|Lost to Follow-up|3|||
160827813|NCT01442064|580756457|FG005|Overall Study|Lost to Follow-up|3|||
160827814|NCT01442064|580756452|FG000|Overall Study|Physician Decision|1|||
160827815|NCT01442064|580756453|FG001|Overall Study|Physician Decision|1|||
160827816|NCT01442064|580756454|FG002|Overall Study|Physician Decision|2|||
160827817|NCT01442064|580756455|FG003|Overall Study|Physician Decision|3|||
160827818|NCT01442064|580756456|FG004|Overall Study|Physician Decision|3|||
160827819|NCT01442064|580756457|FG005|Overall Study|Physician Decision|1|||
160827820|NCT01442064|580756452|FG000|Overall Study|Withdrawal by Subject|6|||
160827821|NCT01442064|580756453|FG001|Overall Study|Withdrawal by Subject|3|||
160827822|NCT01442064|580756454|FG002|Overall Study|Withdrawal by Subject|2|||
160827823|NCT01442064|580756455|FG003|Overall Study|Withdrawal by Subject|2|||
160827824|NCT01442064|580756456|FG004|Overall Study|Withdrawal by Subject|2|||
160827825|NCT01442064|580756457|FG005|Overall Study|Withdrawal by Subject|1|||
160827826|NCT01442064|580756452|FG000|Overall Study|Sponsor decision|82|||
160827827|NCT01442064|580756453|FG001|Overall Study|Sponsor decision|88|||
160827828|NCT01442064|580756454|FG002|Overall Study|Sponsor decision|92|||
160827829|NCT01442064|580756455|FG003|Overall Study|Sponsor decision|88|||
160827830|NCT01442064|580756456|FG004|Overall Study|Sponsor decision|95|||
160827831|NCT01442064|580756457|FG005|Overall Study|Sponsor decision|87|||
160827832|NCT01442064|580756452|FG000|Overall Study|Subject non-compliance|0|||
160827833|NCT01442064|580756453|FG001|Overall Study|Subject non-compliance|0|||
160827834|NCT01442064|580756454|FG002|Overall Study|Subject non-compliance|0|||
160827835|NCT01442064|580756455|FG003|Overall Study|Subject non-compliance|0|||
160827836|NCT01442064|580756456|FG004|Overall Study|Subject non-compliance|0|||
160827837|NCT01442064|580756457|FG005|Overall Study|Subject non-compliance|2|||
160827838|NCT01442064|580756452|FG000|Overall Study|Condition mandated other intervention|1|||
160827839|NCT01442064|580756453|FG001|Overall Study|Condition mandated other intervention|1|||
160827840|NCT01442064|580756454|FG002|Overall Study|Condition mandated other intervention|2|||
160827841|NCT01442064|580756455|FG003|Overall Study|Condition mandated other intervention|0|||
160827842|NCT01442064|580756456|FG004|Overall Study|Condition mandated other intervention|0|||
160827843|NCT01442064|580756457|FG005|Overall Study|Condition mandated other intervention|2|||
160827844|NCT01360398|580756460|FG000|Overall Study|Withdrawal by Subject|14|||
160827845|NCT01360398|580756460|FG000|Overall Study|Other|7|||
160827846|NCT01360398|580756460|FG000|Overall Study|Migrated/moved from study area|1|||
160827847|NCT02153346|580756461|FG000|Overall Study|Lost to Follow-up|11|||
160827848|NCT01710527|580756462|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
160827849|NCT01710527|580756463|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
160827850|NCT01822535|580756464|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
160827851|NCT01822535|580756465|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
160827852|NCT01822535|580756464|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
160827853|NCT01822535|580756465|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
160827854|NCT01822535|580756464|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
160827855|NCT01822535|580756465|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
160827856|NCT02278614|580756468|FG000|Overall Study|Withdrawal by Subject|3|||
160827857|NCT02278614|580756469|FG001|Overall Study|Withdrawal by Subject|5|||
160827858|NCT02278614|580756468|FG000|Overall Study|Adverse Event|1|||
160827859|NCT02278614|580756469|FG001|Overall Study|Adverse Event|0|||
160827860|NCT02278614|580756468|FG000|Overall Study|left eye was not eligible|1|||
160827861|NCT02278614|580756469|FG001|Overall Study|left eye was not eligible|0|||
160902505|NCT00913380|581036050|FG000|Clinical Outcomes|Lost to Follow-up|6|||
160902506|NCT00913380|581036051|FG001|Clinical Outcomes|Lost to Follow-up|6|||
160902507|NCT02187744|581036052|FG000|Study|Participant refused further follow-up|1|||
160902508|NCT02187744|581036053|FG001|Study|Participant refused further follow-up|0|||
160902509|NCT02187744|581036052|FG000|Study|Other|2|||
160902510|NCT02187744|581036053|FG001|Study|Other|1|||
160827862|NCT02279498|580756470|FG000|Overall Study|Adverse Event|3|||
160902511|NCT02187744|581036052|FG000|Study|Lost to Follow-up|0|||
160902512|NCT02187744|581036053|FG001|Study|Lost to Follow-up|2|||
160827863|NCT02279498|580756471|FG001|Overall Study|Adverse Event|0|||
160827864|NCT02279498|580756470|FG000|Overall Study|Lack of Efficacy|4|||
160827865|NCT02279498|580756471|FG001|Overall Study|Lack of Efficacy|0|||
160827866|NCT02279498|580756470|FG000|Overall Study|Lost to Follow-up|0|||
160827867|NCT02279498|580756471|FG001|Overall Study|Lost to Follow-up|1|||
160827868|NCT02279498|580756470|FG000|Overall Study|Withdrawal by Subject|9|||
160827869|NCT02279498|580756471|FG001|Overall Study|Withdrawal by Subject|2|||
160827870|NCT02279498|580756470|FG000|Overall Study|Undefined|2|||
160827871|NCT02279498|580756471|FG001|Overall Study|Undefined|1|||
160827872|NCT00737711|580756474|FG000|Overall Study|Adverse Event|2|||
160902513|NCT02187744|581036052|FG000|Study|Related adverse event, not serious|0|||
161334534|NCT00402727|582614179|FG001|Overall Study|Physician Decision|1|||
161334535|NCT00402727|582614178|FG000|Overall Study|Protocol Violation|0|||
161334536|NCT00402727|582614179|FG001|Overall Study|Protocol Violation|4|||
161334537|NCT00402727|582614178|FG000|Overall Study|Withdrawal by Subject|3|||
161334538|NCT00402727|582614179|FG001|Overall Study|Withdrawal by Subject|7|||
161334539|NCT00402727|582614178|FG000|Overall Study|supply problems|2|||
161334540|NCT00402727|582614179|FG001|Overall Study|supply problems|1|||
161334541|NCT00402727|582614178|FG000|Overall Study|non-compliance|0|||
161334542|NCT00402727|582614179|FG001|Overall Study|non-compliance|1|||
161334543|NCT00732069|582614180|FG000|Washout After First Study Drug|Adverse Event|1|||
161334544|NCT00732069|582614181|FG001|Washout After First Study Drug|Adverse Event|0|||
161334545|NCT00732069|582614182|FG002|Washout After First Study Drug|Adverse Event|0|||
161334546|NCT00732069|582614183|FG003|Washout After First Study Drug|Adverse Event|0|||
161334547|NCT00732069|582614184|FG004|Washout After First Study Drug|Adverse Event|0|||
161334548|NCT00732069|582614185|FG005|Washout After First Study Drug|Adverse Event|0|||
161334549|NCT00577317|582614186|FG000|Overall Study|Study Terminated|0|||
161334550|NCT00577317|582614187|FG001|Overall Study|Study Terminated|2|||
161334551|NCT02283658|582614191|FG000|Overall Study|Withdrawal by Subject|1|||
161334552|NCT03608826|582614193|FG000|Overall Study|Death|3|||
161334553|NCT03608826|582614193|FG000|Overall Study|Heart Transplant|3|||
161334554|NCT03608826|582614193|FG000|Overall Study|Physician Decision|4|||
161334555|NCT00875810|582614210|FG000|Overall Study|Withdrawal by Subject|1|||
161334556|NCT00875810|582614210|FG000|Overall Study|Physician Decision|3|||
161334557|NCT00875810|582614210|FG000|Overall Study|Lost to Follow-up|39|||
161334558|NCT00875810|582614210|FG000|Overall Study|Patient enroled but not implanted|2|||
161334559|NCT00875810|582614210|FG000|Overall Study|Device explanted|1|||
161334560|NCT00887484|582614214|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
161334561|NCT00887484|582614214|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
161334562|NCT00887484|582614214|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
161334563|NCT01061606|582614215|FG000|Overall Study|Adverse Event|1|||
161334564|NCT01061606|582614215|FG000|Overall Study|Death|1|||
161334565|NCT01061606|582614215|FG000|Overall Study|Disease Progression|4|||
161334566|NCT01061606|582614215|FG000|Overall Study|alternative therapy|2|||
161334567|NCT01316224|582614216|FG000|Overall Study|Protocol Violation|3|||
161334568|NCT01316224|582614216|FG000|Overall Study|Adverse Event|3|||
161334569|NCT01316224|582614216|FG000|Overall Study|Lack of Efficacy|1|||
161334570|NCT01316224|582614216|FG000|Overall Study|Withdrawal by Subject|1|||
161334571|NCT01316224|582614216|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
161334572|NCT01316224|582614216|FG000|Overall Study|Other|1|||
161334573|NCT03106077|582614219|FG000|Overall Study|Screen Failure|94|||
161334574|NCT03106077|582614220|FG001|Overall Study|Screen Failure|0|||
161334575|NCT01274533|582614223|FG000|Overall Study|Withdrawal by Subject|1|||
161334576|NCT01274533|582614223|FG000|Overall Study|Non-compliance|1|||
161334577|NCT01274533|582614223|FG000|Overall Study|Disease progression|2|||
161334578|NCT02563899|582614224|FG000|Overall Study|Protocol Violation|1|||
160827873|NCT00737711|580756474|FG000|Overall Study|Death|8|||
160827874|NCT00737711|580756474|FG000|Overall Study|Failure to return|4|||
160827875|NCT00737711|580756474|FG000|Overall Study|Protocol Violation|1|||
160827876|NCT00737711|580756474|FG000|Overall Study|Withdrawal by Subject|5|||
160827877|NCT00737711|580756474|FG000|Overall Study|Blood transfusion|6|||
160827878|NCT00737711|580756474|FG000|Overall Study|Other|5|||
160827879|NCT02739321|580756475|FG000|Overall Study|Lack of Efficacy|1|||
160827880|NCT02739321|580756476|FG001|Overall Study|Lack of Efficacy|1|||
160827881|NCT02739321|580756475|FG000|Overall Study|Lost to Follow-up|1|||
160827882|NCT02739321|580756476|FG001|Overall Study|Lost to Follow-up|1|||
160827883|NCT02739321|580756475|FG000|Overall Study|Withdrawal by Subject|1|||
160827884|NCT02739321|580756476|FG001|Overall Study|Withdrawal by Subject|2|||
160827885|NCT02558400|580756477|FG000|Overall Study|Adverse Event|47|||
160827886|NCT02558400|580756478|FG001|Overall Study|Adverse Event|53|||
160902514|NCT02187744|581036053|FG001|Study|Related adverse event, not serious|2|||
160902515|NCT02187744|581036052|FG000|Study|Death|1|||
160902516|NCT02187744|581036053|FG001|Study|Death|0|||
160902517|NCT02187744|581036052|FG000|Study|Related adverse event, serious non-fatal|0|||
160902518|NCT02187744|581036053|FG001|Study|Related adverse event, serious non-fatal|1|||
161334579|NCT02563899|582614225|FG001|Overall Study|Protocol Violation|0|||
161334580|NCT02563899|582614226|FG002|Overall Study|Protocol Violation|0|||
161334581|NCT02563899|582614227|FG003|Overall Study|Protocol Violation|0|||
160902519|NCT02187744|581036052|FG000|Treatment|Death|1|||
161334582|NCT02563899|582614224|FG000|Overall Study|Withdrawal by Subject|0|||
161334583|NCT02563899|582614225|FG001|Overall Study|Withdrawal by Subject|0|||
160827887|NCT02558400|580756479|FG002|Overall Study|Adverse Event|4|||
160827888|NCT02558400|580756477|FG000|Overall Study|Withdrawal by Subject|13|||
161334584|NCT02563899|582614226|FG002|Overall Study|Withdrawal by Subject|1|||
161334585|NCT02563899|582614227|FG003|Overall Study|Withdrawal by Subject|0|||
160827889|NCT02558400|580756478|FG001|Overall Study|Withdrawal by Subject|9|||
160902520|NCT02187744|581036053|FG001|Treatment|Death|0|||
160902521|NCT02187744|581036052|FG000|Treatment|Related adverse event, serious non-fatal|0|||
160902522|NCT02187744|581036053|FG001|Treatment|Related adverse event, serious non-fatal|1|||
161334586|NCT02008526|582614228|FG000|Overall Study|Death|0|||
160827890|NCT02558400|580756479|FG002|Overall Study|Withdrawal by Subject|8|||
160827891|NCT02558400|580756477|FG000|Overall Study|Non-Compliant|0|||
160827892|NCT02558400|580756478|FG001|Overall Study|Non-Compliant|1|||
160827893|NCT02558400|580756479|FG002|Overall Study|Non-Compliant|3|||
160827894|NCT02558400|580756477|FG000|Overall Study|Lost to Follow-up|5|||
160827895|NCT02558400|580756478|FG001|Overall Study|Lost to Follow-up|5|||
160827896|NCT02558400|580756479|FG002|Overall Study|Lost to Follow-up|4|||
160827897|NCT02558400|580756477|FG000|Overall Study|Lack of Efficacy|0|||
160827898|NCT02558400|580756478|FG001|Overall Study|Lack of Efficacy|13|||
160827899|NCT02558400|580756479|FG002|Overall Study|Lack of Efficacy|1|||
160827900|NCT02558400|580756477|FG000|Overall Study|Disallowed Concurrent Medication|6|||
160827901|NCT02558400|580756478|FG001|Overall Study|Disallowed Concurrent Medication|7|||
160827902|NCT02558400|580756479|FG002|Overall Study|Disallowed Concurrent Medication|5|||
160827903|NCT02558400|580756477|FG000|Overall Study|Physician Decision|2|||
160827904|NCT02558400|580756478|FG001|Overall Study|Physician Decision|2|||
160827905|NCT02558400|580756479|FG002|Overall Study|Physician Decision|0|||
160827906|NCT02558400|580756477|FG000|Overall Study|Protocol Violation|6|||
160827907|NCT02558400|580756478|FG001|Overall Study|Protocol Violation|3|||
160827908|NCT02558400|580756479|FG002|Overall Study|Protocol Violation|8|||
160827909|NCT02558400|580756477|FG000|Overall Study|Death|0|||
160827910|NCT02558400|580756478|FG001|Overall Study|Death|1|||
160827911|NCT02558400|580756479|FG002|Overall Study|Death|0|||
160827912|NCT02558400|580756477|FG000|Overall Study|Ineligible for the study|0|||
160827913|NCT02558400|580756478|FG001|Overall Study|Ineligible for the study|2|||
160827914|NCT02558400|580756479|FG002|Overall Study|Ineligible for the study|0|||
160827915|NCT02230683|580756483|FG000|Overall Study|Adverse Event|1|||
160827916|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
160827917|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
160827918|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
160827919|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
160827920|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
160827921|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
160827922|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
160827923|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
160827924|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
160827925|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
161243161|NCT00112437|582269513|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243162|NCT00112437|582269514|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243163|NCT00112437|582269515|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243164|NCT00112437|582269516|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243165|NCT00112437|582269517|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243166|NCT00112437|582269518|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243167|NCT00112437|582269519|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243168|NCT00112437|582269520|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243169|NCT00112437|582269521|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243170|NCT00112437|582269522|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
161243171|NCT00112437|582269523|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243172|NCT00112437|582269524|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243173|NCT00112437|582269525|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243174|NCT00112437|582269526|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243175|NCT00112437|582269527|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243176|NCT00112437|582269528|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243177|NCT00112437|582269529|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243178|NCT00112437|582269530|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243179|NCT00112437|582269531|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243180|NCT00112437|582269532|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
161243181|NCT00112437|582269507|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243182|NCT00112437|582269508|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243183|NCT00112437|582269509|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161334587|NCT02008526|582614229|FG001|Overall Study|Death|2|||
160827926|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
160827927|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
160827928|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
160827929|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
160827930|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
160827931|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
160827932|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
160902523|NCT02187744|581036052|FG000|Treatment|Related adverse event, not serious|0|||
161243184|NCT00112437|582269510|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243185|NCT00112437|582269511|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243186|NCT00112437|582269512|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160990537|NCT02466516|581353875|FG000|Overall Study|Lost to Follow-up|2|||
160990538|NCT02466516|581353876|FG001|Overall Study|Lost to Follow-up|0|||
160827933|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
160827934|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
160827935|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
160827936|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
160827937|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
160827938|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
160827939|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
160827940|NCT00624780|580756484|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
160827941|NCT00624780|580756485|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
160827942|NCT00624780|580756486|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
160827943|NCT00624780|580756487|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
160827944|NCT00624780|580756488|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
160827945|NCT00624780|580756489|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
160827946|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
160827947|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
160827948|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
160827949|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
160827950|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
160827951|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
160827952|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
160827953|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
160827954|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
160827955|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
160827956|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
160827957|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
160827958|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160827959|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
160827960|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160990539|NCT02466516|581353877|FG002|Overall Study|Lost to Follow-up|1|||
160990540|NCT02466516|581353878|FG003|Overall Study|Lost to Follow-up|0|||
160827961|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
160827962|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160827963|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
160827964|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
160827965|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
160827966|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
160827967|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
160827968|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
160827969|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
160827970|NCT00624780|580756484|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
160827971|NCT00624780|580756485|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
160827972|NCT00624780|580756486|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
160827973|NCT00624780|580756487|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
160827974|NCT00624780|580756488|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
160827975|NCT00624780|580756489|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
160827976|NCT00624780|580756484|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
160827977|NCT00624780|580756485|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
160827978|NCT00624780|580756486|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
160827979|NCT00624780|580756487|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
160827980|NCT00624780|580756488|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
160990541|NCT02466516|581353879|FG004|Overall Study|Lost to Follow-up|0|||
160827981|NCT00624780|580756489|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
160990542|NCT04358549|581353880|FG000|Overall Study|Adverse Event|0|||
160990543|NCT04358549|581353881|FG001|Overall Study|Adverse Event|1|||
160990544|NCT04358549|581353880|FG000|Overall Study|Death|1|||
160990545|NCT04358549|581353881|FG001|Overall Study|Death|0|||
160827982|NCT00624780|580756484|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
160827983|NCT00624780|580756485|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827984|NCT00624780|580756486|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827985|NCT00624780|580756487|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827986|NCT00624780|580756488|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827987|NCT00624780|580756489|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
160827988|NCT00624780|580756484|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827989|NCT00624780|580756485|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160990546|NCT04358549|581353880|FG000|Overall Study|Lost to Follow-up|2|||
160990547|NCT04358549|581353881|FG001|Overall Study|Lost to Follow-up|1|||
161334588|NCT02008526|582614230|FG002|Overall Study|Death|1|||
161334589|NCT02008526|582614228|FG000|Overall Study|Withdrawal by Subject|3|||
160990548|NCT04358549|581353880|FG000|Overall Study|Withdrawal by Subject|6|||
160990549|NCT04358549|581353881|FG001|Overall Study|Withdrawal by Subject|6|||
160990550|NCT04358549|581353880|FG000|Overall Study|Start remdesivir|1|||
160990551|NCT04358549|581353881|FG001|Overall Study|Start remdesivir|0|||
160990552|NCT00646451|581353882|FG000|Overall Study|Adverse Event|3|||
160990553|NCT00646451|581353883|FG001|Overall Study|Adverse Event|0|||
160990554|NCT00646451|581353882|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
160990555|NCT00646451|581353883|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
160990556|NCT04867902|581353884|FG000|Overall Study|Lost to Follow-up|1|||
160990557|NCT04867902|581353884|FG000|Overall Study|Withdrawal by Subject|2|||
160990558|NCT04867902|581353884|FG000|Overall Study|Protocol Violation|1|||
160990559|NCT00448864|581353887|FG000|Overall Study|Death|1|||
160990560|NCT00448864|581353888|FG001|Overall Study|Death|0|||
160990561|NCT00448864|581353889|FG002|Overall Study|Death|0|||
160990562|NCT00448864|581353887|FG000|Overall Study|Lost to Follow-up|3|||
160990563|NCT00448864|581353888|FG001|Overall Study|Lost to Follow-up|1|||
160990564|NCT00448864|581353889|FG002|Overall Study|Lost to Follow-up|0|||
160990565|NCT00448864|581353887|FG000|Overall Study|Physician Decision|1|||
160990566|NCT00448864|581353888|FG001|Overall Study|Physician Decision|0|||
160990567|NCT00448864|581353889|FG002|Overall Study|Physician Decision|1|||
160990568|NCT00448864|581353887|FG000|Overall Study|Withdrawal by Subject|0|||
160990569|NCT00448864|581353888|FG001|Overall Study|Withdrawal by Subject|2|||
160990570|NCT00448864|581353889|FG002|Overall Study|Withdrawal by Subject|0|||
160990571|NCT00448864|581353887|FG000|Overall Study|Protocol Violation|0|||
160990572|NCT00448864|581353888|FG001|Overall Study|Protocol Violation|2|||
160990573|NCT00448864|581353889|FG002|Overall Study|Protocol Violation|0|||
160990574|NCT01390857|581353890|FG000|Overall Study|Protocol Violation|2|||
160990575|NCT01390857|581353890|FG000|Overall Study|Lost to Follow-up|1|||
160990576|NCT01390857|581353890|FG000|Overall Study|No Visit after the First Visit|7|||
160827990|NCT00624780|580756486|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
160827991|NCT00624780|580756487|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827992|NCT00624780|580756488|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827993|NCT00624780|580756489|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
160827994|NCT00624780|580756484|FG000|Follow-up (Week 26)|Death|0|||
160827995|NCT00624780|580756485|FG001|Follow-up (Week 26)|Death|0|||
160827996|NCT00624780|580756486|FG002|Follow-up (Week 26)|Death|1|||
160827997|NCT00624780|580756487|FG003|Follow-up (Week 26)|Death|0|||
160827998|NCT00624780|580756488|FG004|Follow-up (Week 26)|Death|0|||
160827999|NCT00624780|580756489|FG005|Follow-up (Week 26)|Death|0|||
160828000|NCT00624780|580756484|FG000|Follow-up (Week 26)|Adverse Event|0|||
160828001|NCT00624780|580756485|FG001|Follow-up (Week 26)|Adverse Event|0|||
160828002|NCT00624780|580756486|FG002|Follow-up (Week 26)|Adverse Event|0|||
160828003|NCT00624780|580756487|FG003|Follow-up (Week 26)|Adverse Event|0|||
160828004|NCT00624780|580756488|FG004|Follow-up (Week 26)|Adverse Event|1|||
160828005|NCT00624780|580756489|FG005|Follow-up (Week 26)|Adverse Event|0|||
160828006|NCT00624780|580756484|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
160828007|NCT00624780|580756485|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
160828008|NCT00624780|580756486|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
160828009|NCT00624780|580756487|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
160828010|NCT00624780|580756488|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
160828011|NCT00624780|580756489|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
160828012|NCT00624780|580756484|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
160828013|NCT00624780|580756485|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
160828014|NCT00624780|580756486|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
160828015|NCT00624780|580756487|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
160990577|NCT01474538|581353892|FG000|Treatment Period 1|Death|1|||
161334590|NCT02008526|582614229|FG001|Overall Study|Withdrawal by Subject|3|||
161334591|NCT02008526|582614230|FG002|Overall Study|Withdrawal by Subject|2|||
161334592|NCT02008526|582614228|FG000|Overall Study|Lost to Follow-up|5|||
161334593|NCT02008526|582614229|FG001|Overall Study|Lost to Follow-up|9|||
161334594|NCT02008526|582614230|FG002|Overall Study|Lost to Follow-up|6|||
161334595|NCT01305564|582614237|FG000|Overall Study|Death|21|||
160828016|NCT00624780|580756488|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
160990578|NCT01474538|581353893|FG001|Treatment Period 1|Death|0|||
160990579|NCT01474538|581353892|FG000|Treatment Period 1|Physician Decision|1|||
160990580|NCT01474538|581353893|FG001|Treatment Period 1|Physician Decision|0|||
161134442|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161334596|NCT01305564|582614237|FG000|Overall Study|Lost to Follow-up|12|||
160828017|NCT00624780|580756489|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
160828018|NCT00624780|580756484|FG000|Follow-up (Week 26)|Other|1|||
160828019|NCT00624780|580756485|FG001|Follow-up (Week 26)|Other|1|||
160828020|NCT00624780|580756486|FG002|Follow-up (Week 26)|Other|0|||
160828021|NCT00624780|580756487|FG003|Follow-up (Week 26)|Other|0|||
160828022|NCT00624780|580756488|FG004|Follow-up (Week 26)|Other|0|||
160990581|NCT01474538|581353892|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160990582|NCT01474538|581353893|FG001|Treatment Period 1|Withdrawal by Subject|3|||
160990583|NCT01474538|581353892|FG000|Treatment Period 1|Protocol Violation|0|||
160990584|NCT01474538|581353893|FG001|Treatment Period 1|Protocol Violation|1|||
160828023|NCT00624780|580756489|FG005|Follow-up (Week 26)|Other|0|||
160990585|NCT01474538|581353892|FG000|Treatment Period 2|Death|1|||
160828024|NCT04068519|580756491|FG000|Dose Verification|Death|15|||
160828025|NCT04068519|580756491|FG000|Dose Verification|Withdrawal by Subject|1|||
160828026|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Death|35|||
160828027|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
160828028|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
160828029|NCT04068519|580756491|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
160828030|NCT04068519|580756491|FG000|Indication Expansion|Death|152|||
160828031|NCT04068519|580756491|FG000|Indication Expansion|Withdrawal by Subject|10|||
160828032|NCT04068519|580756491|FG000|Indication Expansion|Lost to Follow-up|7|||
160828033|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828034|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828035|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828036|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828037|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828038|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828039|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828040|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828041|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828042|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
160828043|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828044|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
160828045|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828046|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828047|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
160828048|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828049|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828050|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828051|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828052|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160990586|NCT01474538|581353893|FG001|Treatment Period 2|Death|0|||
160990587|NCT01474538|581353892|FG000|Treatment Period 2|Adverse Event|1|||
160990588|NCT01474538|581353893|FG001|Treatment Period 2|Adverse Event|1|||
160990589|NCT01474538|581353892|FG000|Treatment Period 2|Withdrawal by Subject|2|||
160990590|NCT01474538|581353893|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160990591|NCT01474538|581353892|FG000|Treatment Period 2|Sponsor decision|1|||
160990592|NCT01474538|581353893|FG001|Treatment Period 2|Sponsor decision|0|||
161243187|NCT00112437|582269513|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243188|NCT00112437|582269514|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243189|NCT00112437|582269515|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243190|NCT00112437|582269516|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
160828053|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828054|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828055|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828056|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
160828057|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828058|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828059|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
160828060|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828061|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828062|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828063|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828064|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828065|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828066|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828067|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828068|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
160828069|NCT00969761|580756492|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160990593|NCT01474538|581353892|FG000|Treatment Period 2|Physician Decision|0|||
160990594|NCT01474538|581353893|FG001|Treatment Period 2|Physician Decision|1|||
160990595|NCT01474538|581353892|FG000|Treatment Period 2|Protocol Violation|1|||
161243191|NCT00112437|582269517|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243192|NCT00112437|582269518|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
160990596|NCT01474538|581353893|FG001|Treatment Period 2|Protocol Violation|0|||
160990597|NCT00367237|581353894|FG000|Overall Study|Adverse Event|7|||
161243193|NCT00112437|582269519|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161334597|NCT01305564|582614237|FG000|Overall Study|Withdrawal by Subject|1|||
161334598|NCT01305564|582614237|FG000|Overall Study|Physician Decision|3|||
161334599|NCT02322749|582614238|FG000|Period 2|Adverse Event|0|||
160828070|NCT00969761|580756493|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828071|NCT00969761|580756494|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828072|NCT00969761|580756495|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160902524|NCT02187744|581036053|FG001|Treatment|Related adverse event, not serious|2|||
160902525|NCT02187744|581036052|FG000|Treatment|Lost to Follow-up|0|||
160902526|NCT02187744|581036053|FG001|Treatment|Lost to Follow-up|1|||
160902527|NCT02187744|581036052|FG000|Treatment|Other|2|||
160902528|NCT02187744|581036053|FG001|Treatment|Other|0|||
160902529|NCT02187744|581036052|FG000|Treatment|Participant refused continued treatment|1|||
160902530|NCT02187744|581036053|FG001|Treatment|Participant refused continued treatment|1|||
160902531|NCT00945893|581036054|FG000|Overall Study|Lost to Follow-up|2|||
160902532|NCT00945893|581036055|FG001|Overall Study|Lost to Follow-up|8|||
160902533|NCT00945893|581036054|FG000|Overall Study|Withdrawal of consent|1|||
160902534|NCT00945893|581036055|FG001|Overall Study|Withdrawal of consent|2|||
160902535|NCT03113071|581036056|FG000|Overall Study|Withdrawal by Subject|1|||
160828073|NCT00969761|580756496|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828074|NCT00969761|580756497|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828075|NCT00969761|580756498|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828076|NCT00969761|580756499|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828077|NCT00969761|580756500|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
160828078|NCT00969761|580756501|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160902536|NCT03113071|581036057|FG001|Overall Study|Withdrawal by Subject|0|||
160902537|NCT01602120|581036058|FG000|Overall Study|Adverse Event|3|||
160902538|NCT01602120|581036059|FG001|Overall Study|Adverse Event|6|||
161134443|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161134444|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
161134445|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
161134446|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
161134447|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
161134448|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161134449|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161134450|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161134451|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
161134452|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161134453|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
161134454|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161134455|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161134456|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161134457|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
161134458|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161134459|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
161134460|NCT03895203|581876571|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161134461|NCT03895203|581876572|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161134462|NCT03895203|581876573|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161134463|NCT03895203|581876574|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161134464|NCT03895203|581876575|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
161134465|NCT03895203|581876576|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
161134466|NCT01389245|581876577|FG000|Overall Study|Protocol Violation|10|||
161134467|NCT01389245|581876577|FG000|Overall Study|Lost to Follow-up|3|||
161134468|NCT01389245|581876577|FG000|Overall Study|Withdrawal by Subject|2|||
161134469|NCT05540652|581876578|FG000|Overall Study|Withdrawal by Subject|1|||
161134470|NCT05424276|581876579|FG000|Overall Study|Adverse Event|1|||
161134471|NCT05424276|581876580|FG001|Overall Study|Adverse Event|0|||
161134472|NCT05424276|581876581|FG002|Overall Study|Adverse Event|0|||
161134473|NCT05424276|581876582|FG003|Overall Study|Adverse Event|2|||
161134474|NCT05424276|581876579|FG000|Overall Study|Withdrawal by Subject|0|||
161134475|NCT05424276|581876580|FG001|Overall Study|Withdrawal by Subject|0|||
161134476|NCT05424276|581876581|FG002|Overall Study|Withdrawal by Subject|2|||
161134477|NCT05424276|581876582|FG003|Overall Study|Withdrawal by Subject|0|||
161134478|NCT05424276|581876579|FG000|Overall Study|Protocol Violation|0|||
161134479|NCT05424276|581876580|FG001|Overall Study|Protocol Violation|1|||
161334600|NCT02322749|582614239|FG001|Period 2|Adverse Event|0|||
160902539|NCT01602120|581036060|FG002|Overall Study|Adverse Event|0|||
160902540|NCT01602120|581036061|FG003|Overall Study|Adverse Event|2|||
161334601|NCT02322749|582614240|FG002|Period 2|Adverse Event|0|||
160828079|NCT00969761|580756502|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828080|NCT00969761|580756503|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
160828081|NCT00969761|580756492|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
160902541|NCT01602120|581036058|FG000|Overall Study|Death|0|||
160828082|NCT00969761|580756493|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828083|NCT00969761|580756494|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
160828084|NCT00969761|580756495|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828085|NCT00969761|580756496|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
160828086|NCT00969761|580756497|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828087|NCT00969761|580756498|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828088|NCT00969761|580756499|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
160828089|NCT00969761|580756500|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
160828090|NCT00969761|580756501|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
160828091|NCT00969761|580756502|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828092|NCT00969761|580756503|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
160828093|NCT00969761|580756492|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828094|NCT00969761|580756493|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828095|NCT00969761|580756494|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828096|NCT00969761|580756495|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
160828097|NCT00969761|580756496|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
160902542|NCT01602120|581036059|FG001|Overall Study|Death|4|||
160902543|NCT01602120|581036060|FG002|Overall Study|Death|0|||
160902544|NCT01602120|581036061|FG003|Overall Study|Death|0|||
160902545|NCT01602120|581036058|FG000|Overall Study|Lost to Follow-up|0|||
160902546|NCT01602120|581036059|FG001|Overall Study|Lost to Follow-up|1|||
160902547|NCT01602120|581036060|FG002|Overall Study|Lost to Follow-up|0|||
160902548|NCT01602120|581036061|FG003|Overall Study|Lost to Follow-up|1|||
160902549|NCT01602120|581036058|FG000|Overall Study|Protocol Violation|1|||
160902550|NCT01602120|581036059|FG001|Overall Study|Protocol Violation|1|||
160902551|NCT01602120|581036060|FG002|Overall Study|Protocol Violation|0|||
160902552|NCT01602120|581036061|FG003|Overall Study|Protocol Violation|0|||
160902553|NCT01602120|581036058|FG000|Overall Study|Non-compliance|0|||
160902554|NCT01602120|581036059|FG001|Overall Study|Non-compliance|3|||
160902555|NCT01602120|581036060|FG002|Overall Study|Non-compliance|0|||
160902556|NCT01602120|581036061|FG003|Overall Study|Non-compliance|1|||
160902557|NCT01602120|581036058|FG000|Overall Study|Withdrawal by Subject|8|||
160902558|NCT01602120|581036059|FG001|Overall Study|Withdrawal by Subject|17|||
160902559|NCT01602120|581036060|FG002|Overall Study|Withdrawal by Subject|0|||
160902560|NCT01602120|581036061|FG003|Overall Study|Withdrawal by Subject|3|||
160902561|NCT01602120|581036058|FG000|Overall Study|Study Terminated by Sponsor|12|||
160902562|NCT01602120|581036059|FG001|Overall Study|Study Terminated by Sponsor|24|||
160902563|NCT01602120|581036060|FG002|Overall Study|Study Terminated by Sponsor|17|||
160902564|NCT01602120|581036061|FG003|Overall Study|Study Terminated by Sponsor|44|||
160902565|NCT01602120|581036058|FG000|Overall Study|Physician Decision|2|||
161243194|NCT00112437|582269520|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243195|NCT00112437|582269521|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
161243196|NCT00112437|582269522|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243197|NCT00112437|582269523|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243198|NCT00112437|582269524|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243199|NCT00112437|582269525|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243200|NCT00112437|582269526|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243201|NCT00112437|582269527|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243202|NCT00112437|582269528|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161334602|NCT02322749|582614241|FG003|Period 2|Adverse Event|1|||
161334603|NCT02322749|582614242|FG004|Period 2|Adverse Event|0|||
161334604|NCT02322749|582614243|FG005|Period 2|Adverse Event|0|||
161334605|NCT02322749|582614238|FG000|Period 2|Withdrawal by Subject|0|||
161334606|NCT02322749|582614239|FG001|Period 2|Withdrawal by Subject|0|||
161334607|NCT02322749|582614240|FG002|Period 2|Withdrawal by Subject|0|||
161334608|NCT02322749|582614241|FG003|Period 2|Withdrawal by Subject|1|||
161334609|NCT02322749|582614242|FG004|Period 2|Withdrawal by Subject|0|||
161334610|NCT02322749|582614243|FG005|Period 2|Withdrawal by Subject|0|||
161334611|NCT02322749|582614238|FG000|Period 3|Withdrawal by Subject|0|||
160828098|NCT00969761|580756497|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160902566|NCT01602120|581036059|FG001|Overall Study|Physician Decision|3|||
160902567|NCT01602120|581036060|FG002|Overall Study|Physician Decision|0|||
161334612|NCT02322749|582614239|FG001|Period 3|Withdrawal by Subject|0|||
160902568|NCT01602120|581036061|FG003|Overall Study|Physician Decision|0|||
160902569|NCT01602120|581036058|FG000|Overall Study|Unspecified Reason|3|||
160902570|NCT01602120|581036059|FG001|Overall Study|Unspecified Reason|1|||
160902571|NCT01602120|581036060|FG002|Overall Study|Unspecified Reason|0|||
160902572|NCT01602120|581036061|FG003|Overall Study|Unspecified Reason|2|||
160902573|NCT04502433|581036062|FG000|Overall Study|Death|2|||
161243203|NCT00112437|582269529|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161334613|NCT02322749|582614240|FG002|Period 3|Withdrawal by Subject|1|||
160828099|NCT00969761|580756498|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828100|NCT00969761|580756499|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828101|NCT00969761|580756500|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
160828102|NCT00969761|580756501|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828103|NCT00969761|580756502|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828104|NCT00969761|580756503|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
160828105|NCT03081858|580758154|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
160828106|NCT03081858|580758155|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
160828107|NCT03081858|580758156|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
160828108|NCT03081858|580758157|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
160828109|NCT02936284|580758160|FG000|Overall Study|Withdrawal by Subject|3|||
160828110|NCT02936284|580758161|FG001|Overall Study|Withdrawal by Subject|1|||
160828111|NCT02936284|580758160|FG000|Overall Study|Lost to Follow-up|7|||
160828112|NCT02936284|580758161|FG001|Overall Study|Lost to Follow-up|8|||
160828113|NCT01610596|580758162|FG000|Overall Study|Lost to Follow-up|0|||
160828114|NCT01610596|580758163|FG001|Overall Study|Lost to Follow-up|1|||
160828115|NCT00799591|580758166|FG000|Overall Study|De-escalation of doses|20|||
160828116|NCT00799591|580758166|FG000|Overall Study|Death|14|||
160828117|NCT00799591|580758166|FG000|Overall Study|Technical failure|12|||
160828118|NCT00799591|580758166|FG000|Overall Study|Resistant germ|11|||
160828119|NCT00799591|580758166|FG000|Overall Study|New infection|4|||
160828120|NCT00799591|580758166|FG000|Overall Study|Resistance germ and technical failure|2|||
160828121|NCT00799591|580758166|FG000|Overall Study|Persistance of fever undetermined origin|1|||
160828122|NCT00799591|580758166|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
160828123|NCT00799591|580758166|FG000|Overall Study|Infectious origin not probable|1|||
160828124|NCT01765426|580758172|FG000|Overall Study|Lost to Follow-up|0|||
160828125|NCT01765426|580758173|FG001|Overall Study|Lost to Follow-up|1|||
160828126|NCT01765426|580758174|FG002|Overall Study|Lost to Follow-up|0|||
160828127|NCT01765426|580758175|FG003|Overall Study|Lost to Follow-up|0|||
160828128|NCT03351114|580758176|FG000|Overall Study|Withdrawal by Subject|1|||
160902574|NCT04502433|581036063|FG001|Overall Study|Death|4|||
160902575|NCT04502433|581036062|FG000|Overall Study|Lost to Follow-up|1|||
160902576|NCT04502433|581036063|FG001|Overall Study|Lost to Follow-up|0|||
161134480|NCT05424276|581876581|FG002|Overall Study|Protocol Violation|0|||
161134481|NCT05424276|581876582|FG003|Overall Study|Protocol Violation|0|||
161134482|NCT05424276|581876579|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161134483|NCT05424276|581876580|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
161134484|NCT05424276|581876581|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161134485|NCT05424276|581876582|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
161134486|NCT05113940|581876583|FG000|Part A (18 Days)|Adverse Event|0|||
161134487|NCT05113940|581876584|FG001|Part A (18 Days)|Adverse Event|0|||
161134488|NCT05113940|581876585|FG002|Part A (18 Days)|Adverse Event|1|||
161134489|NCT05113940|581876586|FG003|Part A (18 Days)|Adverse Event|1|||
161134490|NCT05113940|581876587|FG004|Part A (18 Days)|Adverse Event|1|||
161134491|NCT05113940|581876588|FG005|Part A (18 Days)|Adverse Event|0|||
161134492|NCT05113940|581876589|FG006|Part A (18 Days)|Adverse Event|0|||
161134493|NCT05113940|581876590|FG007|Part A (18 Days)|Adverse Event|0|||
161134494|NCT05113940|581876591|FG008|Part A (18 Days)|Adverse Event|0|||
161134495|NCT05113940|581876592|FG009|Part A (18 Days)|Adverse Event|0|||
161134496|NCT05113940|581876593|FG010|Part A (18 Days)|Adverse Event|0|||
161134497|NCT05113940|581876594|FG011|Part A (18 Days)|Adverse Event|2|||
161134498|NCT05113940|581876595|FG012|Part A (18 Days)|Adverse Event|0|||
161134499|NCT05113940|581876596|FG013|Part A (18 Days)|Adverse Event|0|||
161134500|NCT05113940|581876597|FG014|Part A (18 Days)|Adverse Event|0|||
161134501|NCT05113940|581876583|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134502|NCT05113940|581876584|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134503|NCT05113940|581876585|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134504|NCT05113940|581876586|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134505|NCT05113940|581876587|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134506|NCT05113940|581876588|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134507|NCT05113940|581876589|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134508|NCT05113940|581876590|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134509|NCT05113940|581876591|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134510|NCT05113940|581876592|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134511|NCT05113940|581876593|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134512|NCT05113940|581876594|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134513|NCT05113940|581876595|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134514|NCT05113940|581876596|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
161134515|NCT05113940|581876597|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
161134516|NCT04454489|581876598|FG000|Overall Study|Disease progression|12|||
161134517|NCT04454489|581876598|FG000|Overall Study|Death|4|||
161134518|NCT04454489|581876598|FG000|Overall Study|Adverse Event|1|||
161134519|NCT04454489|581876598|FG000|Overall Study|Physician Decision|1|||
160828129|NCT01665430|580758180|FG000|Overall Study|Adverse Event|1|||
161243204|NCT00112437|582269530|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243205|NCT00112437|582269531|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243206|NCT00112437|582269532|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
161243207|NCT00112437|582269507|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243208|NCT00112437|582269508|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243209|NCT00112437|582269509|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243210|NCT00112437|582269510|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243211|NCT00112437|582269511|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243212|NCT00112437|582269512|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243213|NCT00112437|582269513|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243214|NCT00112437|582269514|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243215|NCT00112437|582269515|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243216|NCT00112437|582269516|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243217|NCT00112437|582269517|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
161243218|NCT00112437|582269518|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
161243219|NCT00112437|582269519|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243220|NCT00112437|582269520|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243221|NCT00112437|582269521|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243222|NCT00112437|582269522|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243223|NCT00112437|582269523|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243224|NCT00112437|582269524|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243225|NCT00112437|582269525|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243226|NCT00112437|582269526|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243227|NCT00112437|582269527|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243228|NCT00112437|582269528|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243229|NCT00112437|582269529|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243230|NCT00112437|582269530|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
160828130|NCT01665430|580758180|FG000|Overall Study|Withdrawal by Subject|6|||
160828131|NCT01665430|580758180|FG000|Overall Study|Other Unspecified|2|||
160828132|NCT02310230|580758181|FG000|Overall Study|Physician Decision|1|||
161134520|NCT01756274|581876604|FG000|Overall Study|Protocol Violation|2|||
161134521|NCT01756274|581876604|FG000|Overall Study|Laboratory error|1|||
161134522|NCT03514914|581876605|FG000|Overall Study|Death|3|||
161134523|NCT03514914|581876606|FG001|Overall Study|Death|3|||
161134524|NCT03514914|581876605|FG000|Overall Study|Lost to Follow-up|117|||
161134525|NCT03514914|581876606|FG001|Overall Study|Lost to Follow-up|89|||
161134526|NCT03926143|581876612|FG000|Overall Study|Physician Decision|3|||
161134527|NCT03926143|581876612|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
161134528|NCT03926143|581876612|FG000|Overall Study|Adverse Event|2|||
161134529|NCT03926143|581876612|FG000|Overall Study|Progressive disease|3|||
161134530|NCT01071070|581876619|FG000|Overall Study|Adverse Event|0|||
161134531|NCT01071070|581876620|FG001|Overall Study|Adverse Event|3|||
161134532|NCT01071070|581876619|FG000|Overall Study|Withdrawal by Subject|1|||
161134533|NCT01071070|581876620|FG001|Overall Study|Withdrawal by Subject|0|||
161134534|NCT01071070|581876619|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
161134535|NCT01071070|581876620|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
161134536|NCT01071070|581876619|FG000|Overall Study|Hypercalcemia|1|||
161134537|NCT01071070|581876620|FG001|Overall Study|Hypercalcemia|0|||
161134538|NCT00473876|581876626|FG000|Overall Study|Lost to Follow-up|3|||
161134539|NCT00473876|581876627|FG001|Overall Study|Lost to Follow-up|1|||
161134540|NCT02393209|581876630|FG000|Overall Study|Study Terminated by Sponsor|1|||
161134541|NCT02393209|581876631|FG001|Overall Study|Study Terminated by Sponsor|1|||
161134542|NCT02393209|581876632|FG002|Overall Study|Study Terminated by Sponsor|0|||
161134543|NCT02393209|581876633|FG003|Overall Study|Study Terminated by Sponsor|0|||
161134544|NCT02393209|581876630|FG000|Overall Study|Withdrawal by Patient|1|||
161134545|NCT02393209|581876631|FG001|Overall Study|Withdrawal by Patient|0|||
161134546|NCT02393209|581876632|FG002|Overall Study|Withdrawal by Patient|0|||
161134547|NCT02393209|581876633|FG003|Overall Study|Withdrawal by Patient|0|||
161134548|NCT02393209|581876630|FG000|Overall Study|Death|2|||
161134549|NCT02393209|581876631|FG001|Overall Study|Death|2|||
161134550|NCT02393209|581876632|FG002|Overall Study|Death|0|||
161134551|NCT02393209|581876633|FG003|Overall Study|Death|0|||
161134552|NCT02393209|581876630|FG000|Overall Study|Death due to Disease Progression|2|||
161134553|NCT02393209|581876631|FG001|Overall Study|Death due to Disease Progression|2|||
161134554|NCT02393209|581876632|FG002|Overall Study|Death due to Disease Progression|0|||
161134555|NCT02393209|581876633|FG003|Overall Study|Death due to Disease Progression|0|||
161134556|NCT02393209|581876630|FG000|Overall Study|Death from Legionella Infection|0|||
161134557|NCT02393209|581876631|FG001|Overall Study|Death from Legionella Infection|1|||
161134558|NCT02393209|581876632|FG002|Overall Study|Death from Legionella Infection|0|||
161134559|NCT02393209|581876633|FG003|Overall Study|Death from Legionella Infection|0|||
161134560|NCT02393209|581876630|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
161134561|NCT02393209|581876631|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
161134562|NCT02393209|581876632|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
161134563|NCT02393209|581876633|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
161134564|NCT02393209|581876630|FG000|Overall Study|Lost to Follow-up|0|||
161134565|NCT02393209|581876631|FG001|Overall Study|Lost to Follow-up|1|||
161134566|NCT02393209|581876632|FG002|Overall Study|Lost to Follow-up|0|||
161134567|NCT02393209|581876633|FG003|Overall Study|Lost to Follow-up|0|||
161134568|NCT00727402|581876634|FG000|Overall Study|Physician Decision|116|||
161134569|NCT03751111|581876635|FG000|Overall Study|Lack of Efficacy|9|||
161134570|NCT03751111|581876636|FG001|Overall Study|Lack of Efficacy|30|||
160828133|NCT02310230|580758182|FG001|Overall Study|Physician Decision|3|||
160828134|NCT02310230|580758181|FG000|Overall Study|monitor baseline taken after induction|2|||
160828135|NCT02310230|580758182|FG001|Overall Study|monitor baseline taken after induction|7|||
160828136|NCT02310230|580758181|FG000|Overall Study|Poor signal quality|5|||
160828137|NCT02310230|580758182|FG001|Overall Study|Poor signal quality|8|||
160828138|NCT02310230|580758181|FG000|Overall Study|Case cancelled|1|||
160828139|NCT02310230|580758182|FG001|Overall Study|Case cancelled|0|||
160828140|NCT00989235|580758183|FG000|Overall Study|Death|0|||
160828141|NCT00989235|580758184|FG001|Overall Study|Death|1|||
160828142|NCT00989235|580758183|FG000|Overall Study|Adverse Event|0|||
160902577|NCT04502433|581036062|FG000|Overall Study|Physician Decision|0|||
160902578|NCT04502433|581036063|FG001|Overall Study|Physician Decision|1|||
160902579|NCT02369016|581036066|FG000|Overall Study|AE associated with clinical disease progression|2|||
160902580|NCT02369016|581036067|FG001|Overall Study|AE associated with clinical disease progression|1|||
161134571|NCT03751111|581876635|FG000|Overall Study|Adverse Event|3|||
161134572|NCT03751111|581876636|FG001|Overall Study|Adverse Event|2|||
161134573|NCT00755079|581876637|FG000|Overall Study|Lost to Follow-up|1|||
160902581|NCT02369016|581036066|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
161134574|NCT00755079|581876638|FG001|Overall Study|Lost to Follow-up|3|||
161134575|NCT00755079|581876637|FG000|Overall Study|Adverse Event|0|||
161134576|NCT00755079|581876638|FG001|Overall Study|Adverse Event|1|||
161134577|NCT00755079|581876637|FG000|Overall Study|Withdrawal by Subject|0|||
161134578|NCT00755079|581876638|FG001|Overall Study|Withdrawal by Subject|2|||
161134579|NCT03545282|581876639|FG000|Overall Study|Lost to Follow-up|15|||
161134580|NCT03545282|581876640|FG001|Overall Study|Lost to Follow-up|10|||
161243231|NCT00112437|582269531|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243232|NCT00112437|582269532|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
161243233|NCT00112437|582269507|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243234|NCT00112437|582269508|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243235|NCT00112437|582269509|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243236|NCT00112437|582269510|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243237|NCT00112437|582269511|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243238|NCT00112437|582269512|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243239|NCT00112437|582269513|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243240|NCT00112437|582269514|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243241|NCT00112437|582269515|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243242|NCT00112437|582269516|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243243|NCT00112437|582269517|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243244|NCT00112437|582269518|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243245|NCT00112437|582269519|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243246|NCT00112437|582269520|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243247|NCT00112437|582269521|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243248|NCT00112437|582269522|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243249|NCT00112437|582269523|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243250|NCT00112437|582269524|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243251|NCT00112437|582269525|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243252|NCT00112437|582269526|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243253|NCT00112437|582269527|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
161243254|NCT00112437|582269528|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
161134581|NCT03545282|581876639|FG000|Overall Study|Withdrawal by Subject|2|||
161243255|NCT00112437|582269529|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243256|NCT00112437|582269530|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243257|NCT00112437|582269531|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243258|NCT00112437|582269532|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
161243259|NCT00112437|582269507|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161334614|NCT02322749|582614241|FG003|Period 3|Withdrawal by Subject|0|||
160990598|NCT00367237|581353895|FG001|Overall Study|Adverse Event|2|||
161134582|NCT03545282|581876640|FG001|Overall Study|Withdrawal by Subject|2|||
161134583|NCT02582671|581876641|FG000|Overall Study|Failure to return|1|||
160828143|NCT00989235|580758184|FG001|Overall Study|Adverse Event|1|||
160828144|NCT00989235|580758183|FG000|Overall Study|Lack of Efficacy|1|||
160828145|NCT00989235|580758184|FG001|Overall Study|Lack of Efficacy|0|||
161134584|NCT02582671|581876641|FG000|Overall Study|Other, not specified|1|||
160828146|NCT00989235|580758183|FG000|Overall Study|Withdrawal of Consent|1|||
160828147|NCT00989235|580758184|FG001|Overall Study|Withdrawal of Consent|1|||
160828148|NCT00989235|580758183|FG000|Overall Study|Desire to Become Pregnant|1|||
160828149|NCT00989235|580758184|FG001|Overall Study|Desire to Become Pregnant|0|||
160828150|NCT00989235|580758183|FG000|Overall Study|Randomized by Mistake|0|||
160828151|NCT00989235|580758184|FG001|Overall Study|Randomized by Mistake|2|||
160828152|NCT00989235|580758183|FG000|Overall Study|Lost to Follow-up|0|||
160828153|NCT00989235|580758184|FG001|Overall Study|Lost to Follow-up|1|||
160828154|NCT03249935|580758185|FG000|Overall Study|Discharged from facility early|36|||
160828155|NCT03249935|580758185|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
160828156|NCT03249935|580758185|FG000|Overall Study|Protocol Violation|5|||
160828157|NCT00545532|580758186|FG000|Overall Study|Withdrawal by Subject|1|||
160828158|NCT00545532|580758187|FG001|Overall Study|Withdrawal by Subject|3|||
160828159|NCT00545532|580758186|FG000|Overall Study|Lost to Follow-up|5|||
160828160|NCT00545532|580758187|FG001|Overall Study|Lost to Follow-up|6|||
160828161|NCT00545532|580758186|FG000|Overall Study|Death|0|||
160828162|NCT00545532|580758187|FG001|Overall Study|Death|1|||
160828163|NCT03593681|580758190|FG000|Overall Study|Inadequate sample collected|12|||
160828164|NCT03593681|580758190|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
160828165|NCT03593681|580758190|FG000|Overall Study|Protocol Violation|3|||
160828166|NCT03593681|580758190|FG000|Overall Study|Withdrawal by Subject|3|||
160828167|NCT03593681|580758190|FG000|Overall Study|Procedure not attempted|3|||
160828168|NCT03593681|580758190|FG000|Overall Study|Adverse Event|2|||
160828169|NCT03593681|580758190|FG000|Overall Study|Physician Decision|1|||
160828170|NCT01149486|580758191|FG000|First Intervention|Adverse Event|0|||
160828171|NCT01149486|580758192|FG001|First Intervention|Adverse Event|1|||
160828172|NCT03630302|580758193|FG000|Surgery|hardware issue prevented LFP recordings|1|||
160828173|NCT03630302|580758193|FG000|3 Month Visit|Adverse Event|2|||
160828174|NCT03630302|580758193|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
160828175|NCT04662073|580758194|FG000|Overall Study|Withdrawal by Subject|1|||
160828176|NCT04662073|580758195|FG001|Overall Study|Withdrawal by Subject|0|||
160828177|NCT01135914|580758196|FG000|Overall Study|Withdrawal by Subject|1|||
160990599|NCT00367237|581353894|FG000|Overall Study|Lost to Follow-up|1|||
160990600|NCT00367237|581353895|FG001|Overall Study|Lost to Follow-up|0|||
160990601|NCT00367237|581353894|FG000|Overall Study|Withdrawal by Subject|0|||
160990602|NCT00367237|581353895|FG001|Overall Study|Withdrawal by Subject|4|||
161134585|NCT01287104|581876642|FG000|Overall Study|Patient developed progressive disease|1|||
161134586|NCT01287104|581876643|FG001|Overall Study|Patient developed progressive disease|1|||
160828178|NCT01135914|580758197|FG001|Overall Study|Withdrawal by Subject|3|||
160828179|NCT01135914|580758198|FG002|Overall Study|Withdrawal by Subject|6|||
160990603|NCT00367237|581353894|FG000|Overall Study|Protocol Violation|2|||
161134587|NCT01287104|581876644|FG002|Overall Study|Patient developed progressive disease|3|||
161134588|NCT01287104|581876645|FG003|Overall Study|Patient developed progressive disease|2|||
161134589|NCT01287104|581876642|FG000|Overall Study|Donor anaphylaxis|0|||
161134590|NCT01287104|581876643|FG001|Overall Study|Donor anaphylaxis|1|||
161134591|NCT01287104|581876644|FG002|Overall Study|Donor anaphylaxis|0|||
161134592|NCT01287104|581876645|FG003|Overall Study|Donor anaphylaxis|1|||
161134593|NCT01287104|581876642|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
161134594|NCT01287104|581876643|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
161134595|NCT01287104|581876644|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
161134596|NCT01287104|581876645|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
161134597|NCT01287104|581876642|FG000|Overall Study|Low donor chimerism|0|||
161134598|NCT01287104|581876643|FG001|Overall Study|Low donor chimerism|1|||
161134599|NCT01287104|581876644|FG002|Overall Study|Low donor chimerism|0|||
161134600|NCT01287104|581876645|FG003|Overall Study|Low donor chimerism|0|||
161134601|NCT01287104|581876642|FG000|Overall Study|NK cells did not meet release criteria|0|||
161134602|NCT01287104|581876643|FG001|Overall Study|NK cells did not meet release criteria|1|||
161134603|NCT01287104|581876644|FG002|Overall Study|NK cells did not meet release criteria|0|||
161134604|NCT01287104|581876645|FG003|Overall Study|NK cells did not meet release criteria|0|||
161134605|NCT01276288|581876654|FG000|Overall Study|Adverse Event|1|||
161134606|NCT01276288|581876655|FG001|Overall Study|Adverse Event|1|||
161134607|NCT01276288|581876656|FG002|Overall Study|Adverse Event|0|||
161134608|NCT01276288|581876657|FG003|Overall Study|Adverse Event|0|||
161134609|NCT01276288|581876654|FG000|Overall Study|not treated|1|||
161134610|NCT01276288|581876655|FG001|Overall Study|not treated|0|||
161134611|NCT01276288|581876656|FG002|Overall Study|not treated|0|||
161134612|NCT01276288|581876657|FG003|Overall Study|not treated|0|||
161134613|NCT01478958|581876664|FG000|Overall Study|Withdrawal by Subject|1|||
161134614|NCT01478958|581876665|FG001|Overall Study|Withdrawal by Subject|1|||
161134615|NCT01478958|581876666|FG002|Overall Study|Withdrawal by Subject|1|||
160828180|NCT01135914|580758196|FG000|Overall Study|Lost to Follow-up|1|||
161134616|NCT01478958|581876664|FG000|Overall Study|Weight loss|1|||
161134617|NCT01478958|581876665|FG001|Overall Study|Weight loss|0|||
161134618|NCT01478958|581876666|FG002|Overall Study|Weight loss|0|||
161134619|NCT01478958|581876664|FG000|Overall Study|Re-located|0|||
160828181|NCT01135914|580758197|FG001|Overall Study|Lost to Follow-up|0|||
160902582|NCT02369016|581036067|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
160902583|NCT02369016|581036066|FG000|Overall Study|Progressive disease - clinical progression|1|||
160902584|NCT02369016|581036067|FG001|Overall Study|Progressive disease - clinical progression|4|||
160902585|NCT02369016|581036066|FG000|Overall Study|withdrawal by patient|4|||
160902586|NCT02369016|581036067|FG001|Overall Study|withdrawal by patient|0|||
160902587|NCT02369016|581036066|FG000|Overall Study|Progressive disease - radiological progression|6|||
160902588|NCT02369016|581036067|FG001|Overall Study|Progressive disease - radiological progression|2|||
161243260|NCT00112437|582269508|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
160902589|NCT04203797|581036068|FG000|Overall Study|Adverse Event|1|||
160902590|NCT04203797|581036069|FG001|Overall Study|Adverse Event|0|||
160902591|NCT04203797|581036068|FG000|Overall Study|Did not complete End of Study follow-up|1|||
160902592|NCT04203797|581036069|FG001|Overall Study|Did not complete End of Study follow-up|0|||
160902593|NCT00300274|581036070|FG000|Overall Study|Withdrawal by Subject|12|||
160902594|NCT00300274|581036071|FG001|Overall Study|Withdrawal by Subject|3|||
160902595|NCT00300274|581036072|FG002|Overall Study|Withdrawal by Subject|14|||
160902596|NCT00300274|581036070|FG000|Overall Study|Lost to Follow-up|3|||
160902597|NCT00300274|581036071|FG001|Overall Study|Lost to Follow-up|4|||
160902598|NCT00300274|581036072|FG002|Overall Study|Lost to Follow-up|5|||
160902599|NCT00300274|581036070|FG000|Overall Study|Death|31|||
160902600|NCT00300274|581036071|FG001|Overall Study|Death|20|||
160902601|NCT00300274|581036072|FG002|Overall Study|Death|25|||
160902602|NCT00300274|581036070|FG000|Overall Study|Re-transplant|0|||
160902603|NCT00300274|581036071|FG001|Overall Study|Re-transplant|0|||
161243261|NCT00112437|582269509|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243262|NCT00112437|582269510|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243263|NCT00112437|582269511|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243264|NCT00112437|582269512|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243265|NCT00112437|582269513|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243266|NCT00112437|582269514|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243267|NCT00112437|582269515|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243268|NCT00112437|582269516|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243269|NCT00112437|582269517|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243270|NCT00112437|582269518|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243271|NCT00112437|582269519|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243272|NCT00112437|582269520|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243273|NCT00112437|582269521|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243274|NCT00112437|582269522|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243275|NCT00112437|582269523|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243276|NCT00112437|582269524|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243277|NCT00112437|582269525|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243278|NCT00112437|582269526|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243279|NCT00112437|582269527|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
161243280|NCT00112437|582269528|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243281|NCT00112437|582269529|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243282|NCT00112437|582269530|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243283|NCT00112437|582269531|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243284|NCT00112437|582269532|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
161243285|NCT00112437|582269507|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243286|NCT00112437|582269508|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243287|NCT00112437|582269509|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243288|NCT00112437|582269510|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243289|NCT00112437|582269511|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243290|NCT00112437|582269512|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243291|NCT00112437|582269513|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243292|NCT00112437|582269514|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243293|NCT00112437|582269515|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243294|NCT00112437|582269516|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243295|NCT00112437|582269517|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243296|NCT00112437|582269518|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243297|NCT00112437|582269519|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243298|NCT00112437|582269520|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243299|NCT00112437|582269521|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243300|NCT00112437|582269522|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243301|NCT00112437|582269523|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243302|NCT00112437|582269524|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243303|NCT00112437|582269525|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243304|NCT00112437|582269526|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243305|NCT00112437|582269527|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
160828182|NCT01135914|580758198|FG002|Overall Study|Lost to Follow-up|1|||
160828183|NCT01135914|580758196|FG000|Overall Study|Protocol Violation|0|||
160828184|NCT01135914|580758197|FG001|Overall Study|Protocol Violation|0|||
160828185|NCT01135914|580758198|FG002|Overall Study|Protocol Violation|3|||
160828186|NCT01135914|580758196|FG000|Overall Study|Lack of Efficacy|2|||
160828187|NCT01135914|580758197|FG001|Overall Study|Lack of Efficacy|1|||
160828188|NCT01135914|580758198|FG002|Overall Study|Lack of Efficacy|10|||
160828189|NCT01135914|580758196|FG000|Overall Study|Adverse Event|0|||
160828190|NCT01135914|580758197|FG001|Overall Study|Adverse Event|1|||
160828191|NCT01135914|580758198|FG002|Overall Study|Adverse Event|2|||
160828192|NCT00598078|580758199|FG000|Period 2 (Day 2)|Adverse Event|1|||
160828193|NCT00598078|580758200|FG001|Period 2 (Day 2)|Adverse Event|0|||
160828194|NCT01479595|580758205|FG000|Overall Study|Protocol deviation|0|||
160828195|NCT01479595|580758206|FG001|Overall Study|Protocol deviation|1|||
160828196|NCT01479595|580758205|FG000|Overall Study|Adverse Event|2|||
160828197|NCT01479595|580758206|FG001|Overall Study|Adverse Event|1|||
160828198|NCT03366103|580758207|FG000|Overall Study|Disease Progression|3|||
160828199|NCT03366103|580758208|FG001|Overall Study|Disease Progression|1|||
160828200|NCT03366103|580758209|FG002|Overall Study|Disease Progression|0|||
160828201|NCT03366103|580758207|FG000|Overall Study|Adverse Event|0|||
160828202|NCT03366103|580758208|FG001|Overall Study|Adverse Event|1|||
160828203|NCT03366103|580758209|FG002|Overall Study|Adverse Event|0|||
160828204|NCT01344629|580758214|FG000|Crossover Period 2|Withdrawal by Subject|0|||
160828205|NCT01344629|580758215|FG001|Crossover Period 2|Withdrawal by Subject|1|||
160828206|NCT00900146|580758216|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
160828207|NCT00900146|580758217|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
160828208|NCT00900146|580758218|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
160828209|NCT00900146|580758219|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
160828210|NCT00900146|580758220|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
160828211|NCT00900146|580758216|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
160828212|NCT00900146|580758217|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
160828213|NCT00900146|580758218|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
160828214|NCT00900146|580758219|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
160828215|NCT00900146|580758220|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
160828216|NCT00900146|580758216|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
160828217|NCT00900146|580758217|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828218|NCT00900146|580758218|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828219|NCT00900146|580758219|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828220|NCT00900146|580758220|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
160828221|NCT00900146|580758216|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
160902604|NCT00300274|581036072|FG002|Overall Study|Re-transplant|1|||
160902605|NCT00242216|581036073|FG000|Overall Study|Lost to Follow-up|12|||
160902606|NCT00242216|581036074|FG001|Overall Study|Lost to Follow-up|17|||
160902607|NCT00242216|581036073|FG000|Overall Study|Death|4|||
160902608|NCT00242216|581036074|FG001|Overall Study|Death|2|||
160902609|NCT00242216|581036073|FG000|Overall Study|Lack of Efficacy|1|||
160902610|NCT00242216|581036074|FG001|Overall Study|Lack of Efficacy|2|||
160902611|NCT00242216|581036073|FG000|Overall Study|no medicaiton dispensed|1|||
160902612|NCT00242216|581036074|FG001|Overall Study|no medicaiton dispensed|1|||
160902613|NCT02484690|581036075|FG000|Overall Study|Adverse Event|1|||
160902614|NCT02484690|581036076|FG001|Overall Study|Adverse Event|3|||
160902615|NCT02484690|581036077|FG002|Overall Study|Adverse Event|0|||
160902616|NCT02484690|581036078|FG003|Overall Study|Adverse Event|0|||
160902617|NCT02484690|581036079|FG004|Overall Study|Adverse Event|5|||
160902618|NCT02484690|581036075|FG000|Overall Study|Death|0|||
160902619|NCT02484690|581036076|FG001|Overall Study|Death|0|||
160902620|NCT02484690|581036077|FG002|Overall Study|Death|0|||
160902621|NCT02484690|581036078|FG003|Overall Study|Death|0|||
160902622|NCT02484690|581036079|FG004|Overall Study|Death|1|||
160902623|NCT02484690|581036075|FG000|Overall Study|Withdrawal by Subject|1|||
160902624|NCT02484690|581036076|FG001|Overall Study|Withdrawal by Subject|3|||
160990604|NCT00367237|581353895|FG001|Overall Study|Protocol Violation|5|||
160990605|NCT02501629|581353896|FG000|Overall Study|Death|0|||
161134620|NCT01478958|581876665|FG001|Overall Study|Re-located|1|||
160828222|NCT00900146|580758217|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
160828223|NCT00900146|580758218|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
160828224|NCT00900146|580758219|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
160828225|NCT00900146|580758220|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
160828226|NCT00900146|580758216|FG000|Intermediate: Period III|Lost to Follow-up|2|||
160902625|NCT02484690|581036077|FG002|Overall Study|Withdrawal by Subject|1|||
160902626|NCT02484690|581036078|FG003|Overall Study|Withdrawal by Subject|2|||
160902627|NCT02484690|581036079|FG004|Overall Study|Withdrawal by Subject|0|||
160902628|NCT02484690|581036075|FG000|Overall Study|Physician Decision|2|||
160902629|NCT02484690|581036076|FG001|Overall Study|Physician Decision|0|||
160902630|NCT02484690|581036077|FG002|Overall Study|Physician Decision|1|||
160902631|NCT02484690|581036078|FG003|Overall Study|Physician Decision|0|||
160828227|NCT00900146|580758217|FG001|Intermediate: Period III|Lost to Follow-up|0|||
160828228|NCT00900146|580758218|FG002|Intermediate: Period III|Lost to Follow-up|0|||
160828229|NCT00900146|580758219|FG003|Intermediate: Period III|Lost to Follow-up|0|||
160828230|NCT00900146|580758220|FG004|Intermediate: Period III|Lost to Follow-up|1|||
160828231|NCT00900146|580758216|FG000|Intermediate: Period III|Administrative problems|85|||
160828232|NCT00900146|580758217|FG001|Intermediate: Period III|Administrative problems|92|||
160828233|NCT00900146|580758218|FG002|Intermediate: Period III|Administrative problems|84|||
160828234|NCT00900146|580758219|FG003|Intermediate: Period III|Administrative problems|90|||
160828235|NCT00900146|580758220|FG004|Intermediate: Period III|Administrative problems|163|||
160828236|NCT05590000|580758224|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
160828237|NCT00933244|580758225|FG000|Overall Study|Withdrawal by Subject|5|||
160828238|NCT00933244|580758226|FG001|Overall Study|Withdrawal by Subject|1|||
160828239|NCT00933244|580758227|FG002|Overall Study|Withdrawal by Subject|3|||
160828240|NCT01174004|580758228|FG000|Overall Study|Adverse Event|2|||
160828241|NCT01174004|580758229|FG001|Overall Study|Adverse Event|10|||
160828242|NCT01174004|580758228|FG000|Overall Study|Withdrawal by Subject|2|||
160828243|NCT01174004|580758229|FG001|Overall Study|Withdrawal by Subject|3|||
160828244|NCT01174004|580758228|FG000|Overall Study|At Discretion of Sponsor|2|||
160828245|NCT01174004|580758229|FG001|Overall Study|At Discretion of Sponsor|2|||
160828246|NCT01174004|580758228|FG000|Overall Study|Protocol Violation|0|||
160828247|NCT01174004|580758229|FG001|Overall Study|Protocol Violation|1|||
161243306|NCT00112437|582269528|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
161243307|NCT00112437|582269529|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243308|NCT00112437|582269530|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243309|NCT00112437|582269531|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243310|NCT00112437|582269532|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
161243311|NCT00112437|582269507|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243312|NCT00112437|582269508|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243313|NCT00112437|582269509|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243314|NCT00112437|582269510|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243315|NCT00112437|582269511|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243316|NCT00112437|582269512|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243317|NCT00112437|582269513|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243318|NCT00112437|582269514|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243319|NCT00112437|582269515|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243320|NCT00112437|582269516|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243321|NCT00112437|582269517|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243322|NCT00112437|582269518|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243323|NCT00112437|582269519|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243324|NCT00112437|582269520|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243325|NCT00112437|582269521|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243326|NCT00112437|582269522|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243327|NCT00112437|582269523|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243328|NCT00112437|582269524|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243329|NCT00112437|582269525|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243330|NCT00112437|582269526|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243331|NCT00112437|582269527|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243332|NCT00112437|582269528|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
161243333|NCT00112437|582269529|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243334|NCT00112437|582269530|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243335|NCT00112437|582269531|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243336|NCT00112437|582269532|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
161243337|NCT00112437|582269507|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243338|NCT00112437|582269508|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243339|NCT00112437|582269509|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243340|NCT00112437|582269510|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243341|NCT00112437|582269511|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243342|NCT00112437|582269512|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
160828248|NCT01174004|580758228|FG000|Overall Study|Physician Decision|1|||
160828249|NCT01174004|580758229|FG001|Overall Study|Physician Decision|0|||
160828250|NCT02689076|580758230|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
160828251|NCT02689076|580758231|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
160828252|NCT02689076|580758232|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
160828253|NCT02689076|580758230|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
160828254|NCT02689076|580758231|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
160828255|NCT02689076|580758232|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
160828256|NCT02689076|580758230|FG000|Overall Study|Did not have an HIE match|2|||
161243343|NCT00112437|582269513|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243344|NCT00112437|582269514|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243345|NCT00112437|582269515|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243346|NCT00112437|582269516|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243347|NCT00112437|582269517|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243348|NCT00112437|582269518|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243349|NCT00112437|582269519|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243350|NCT00112437|582269520|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243351|NCT00112437|582269521|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243352|NCT00112437|582269522|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243353|NCT00112437|582269523|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243354|NCT00112437|582269524|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243355|NCT00112437|582269525|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243356|NCT00112437|582269526|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243357|NCT00112437|582269527|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
161243358|NCT00112437|582269528|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
161243359|NCT00112437|582269529|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243360|NCT00112437|582269530|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243361|NCT00112437|582269531|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243362|NCT00112437|582269532|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
161243363|NCT00112437|582269507|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243364|NCT00112437|582269508|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243365|NCT00112437|582269509|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243366|NCT00112437|582269510|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243367|NCT00112437|582269511|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243368|NCT00112437|582269512|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243369|NCT00112437|582269513|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243370|NCT00112437|582269514|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243371|NCT00112437|582269515|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243372|NCT00112437|582269516|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243373|NCT00112437|582269517|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243374|NCT00112437|582269518|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243375|NCT00112437|582269519|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243376|NCT00112437|582269520|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243377|NCT00112437|582269521|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243378|NCT00112437|582269522|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243379|NCT00112437|582269523|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243380|NCT00112437|582269524|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243381|NCT00112437|582269525|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243382|NCT00112437|582269526|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243383|NCT00112437|582269527|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243384|NCT00112437|582269528|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243385|NCT00112437|582269529|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
161243386|NCT00112437|582269530|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
161243387|NCT00112437|582269531|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
161243388|NCT00112437|582269532|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
161243389|NCT00112437|582269507|FG000|Years 6-10 (60-Month Extension)|Death|0|||
161243390|NCT00112437|582269508|FG001|Years 6-10 (60-Month Extension)|Death|0|||
161243391|NCT00112437|582269509|FG002|Years 6-10 (60-Month Extension)|Death|0|||
161243392|NCT00112437|582269510|FG003|Years 6-10 (60-Month Extension)|Death|0|||
161243393|NCT00112437|582269511|FG004|Years 6-10 (60-Month Extension)|Death|0|||
161243394|NCT00112437|582269512|FG005|Years 6-10 (60-Month Extension)|Death|0|||
161243395|NCT00112437|582269513|FG006|Years 6-10 (60-Month Extension)|Death|0|||
161243396|NCT00112437|582269514|FG007|Years 6-10 (60-Month Extension)|Death|0|||
161243397|NCT00112437|582269515|FG008|Years 6-10 (60-Month Extension)|Death|0|||
161334615|NCT02322749|582614242|FG004|Period 3|Withdrawal by Subject|0|||
160828257|NCT02689076|580758231|FG001|Overall Study|Did not have an HIE match|0|||
160828258|NCT02689076|580758232|FG002|Overall Study|Did not have an HIE match|0|||
160828259|NCT02689076|580758230|FG000|Overall Study|Death during non-VA encounter|2|||
160828260|NCT02689076|580758231|FG001|Overall Study|Death during non-VA encounter|5|||
160828261|NCT02689076|580758232|FG002|Overall Study|Death during non-VA encounter|0|||
160828262|NCT02689076|580758230|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
160828263|NCT02689076|580758231|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
160828264|NCT02689076|580758232|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
160828265|NCT02689076|580758230|FG000|Overall Study|Participant no longer active in VA system|1|||
160828266|NCT02689076|580758231|FG001|Overall Study|Participant no longer active in VA system|0|||
160828267|NCT02689076|580758232|FG002|Overall Study|Participant no longer active in VA system|0|||
160828268|NCT02689076|580758230|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
160902632|NCT02484690|581036079|FG004|Overall Study|Physician Decision|0|||
161334616|NCT02322749|582614243|FG005|Period 3|Withdrawal by Subject|0|||
161243398|NCT00112437|582269516|FG009|Years 6-10 (60-Month Extension)|Death|0|||
161243399|NCT00112437|582269517|FG010|Years 6-10 (60-Month Extension)|Death|0|||
161243400|NCT00112437|582269518|FG011|Years 6-10 (60-Month Extension)|Death|0|||
161243401|NCT00112437|582269519|FG012|Years 6-10 (60-Month Extension)|Death|0|||
161243402|NCT00112437|582269520|FG013|Years 6-10 (60-Month Extension)|Death|0|||
161243403|NCT00112437|582269521|FG014|Years 6-10 (60-Month Extension)|Death|0|||
161243404|NCT00112437|582269522|FG015|Years 6-10 (60-Month Extension)|Death|0|||
161243405|NCT00112437|582269523|FG016|Years 6-10 (60-Month Extension)|Death|0|||
161243406|NCT00112437|582269524|FG017|Years 6-10 (60-Month Extension)|Death|0|||
161243407|NCT00112437|582269525|FG018|Years 6-10 (60-Month Extension)|Death|0|||
161243408|NCT00112437|582269526|FG019|Years 6-10 (60-Month Extension)|Death|0|||
161243409|NCT00112437|582269527|FG020|Years 6-10 (60-Month Extension)|Death|0|||
161243410|NCT00112437|582269528|FG021|Years 6-10 (60-Month Extension)|Death|0|||
161243411|NCT00112437|582269529|FG022|Years 6-10 (60-Month Extension)|Death|0|||
161243412|NCT00112437|582269530|FG023|Years 6-10 (60-Month Extension)|Death|2|||
161243413|NCT00112437|582269531|FG024|Years 6-10 (60-Month Extension)|Death|0|||
161243414|NCT00112437|582269532|FG025|Years 6-10 (60-Month Extension)|Death|0|||
161243415|NCT00112437|582269507|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243416|NCT00112437|582269508|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243417|NCT00112437|582269509|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243418|NCT00112437|582269510|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243419|NCT00112437|582269511|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243420|NCT00112437|582269512|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243421|NCT00112437|582269513|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243422|NCT00112437|582269514|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243423|NCT00112437|582269515|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243424|NCT00112437|582269516|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243425|NCT00112437|582269517|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243426|NCT00112437|582269518|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243427|NCT00112437|582269519|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243428|NCT00112437|582269520|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243429|NCT00112437|582269521|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243430|NCT00112437|582269522|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243431|NCT00112437|582269523|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243432|NCT00112437|582269524|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243433|NCT00112437|582269525|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243434|NCT00112437|582269526|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243435|NCT00112437|582269527|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243436|NCT00112437|582269528|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243437|NCT00112437|582269529|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243438|NCT00112437|582269530|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243439|NCT00112437|582269531|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
161243440|NCT00112437|582269532|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
161243441|NCT00112437|582269507|FG000|Years 6-10 (60-Month Extension)|Other|0|||
161243442|NCT00112437|582269508|FG001|Years 6-10 (60-Month Extension)|Other|0|||
161243443|NCT00112437|582269509|FG002|Years 6-10 (60-Month Extension)|Other|0|||
161243444|NCT00112437|582269510|FG003|Years 6-10 (60-Month Extension)|Other|0|||
161243445|NCT00112437|582269511|FG004|Years 6-10 (60-Month Extension)|Other|0|||
161243446|NCT00112437|582269512|FG005|Years 6-10 (60-Month Extension)|Other|0|||
161243447|NCT00112437|582269513|FG006|Years 6-10 (60-Month Extension)|Other|0|||
161243448|NCT00112437|582269514|FG007|Years 6-10 (60-Month Extension)|Other|0|||
161243449|NCT00112437|582269515|FG008|Years 6-10 (60-Month Extension)|Other|0|||
161243450|NCT00112437|582269516|FG009|Years 6-10 (60-Month Extension)|Other|0|||
161243451|NCT00112437|582269517|FG010|Years 6-10 (60-Month Extension)|Other|0|||
161243452|NCT00112437|582269518|FG011|Years 6-10 (60-Month Extension)|Other|0|||
161243453|NCT00112437|582269519|FG012|Years 6-10 (60-Month Extension)|Other|0|||
161243454|NCT00112437|582269520|FG013|Years 6-10 (60-Month Extension)|Other|0|||
161243455|NCT00112437|582269521|FG014|Years 6-10 (60-Month Extension)|Other|0|||
161243456|NCT00112437|582269522|FG015|Years 6-10 (60-Month Extension)|Other|0|||
161243457|NCT00112437|582269523|FG016|Years 6-10 (60-Month Extension)|Other|0|||
161243458|NCT00112437|582269524|FG017|Years 6-10 (60-Month Extension)|Other|0|||
161243459|NCT00112437|582269525|FG018|Years 6-10 (60-Month Extension)|Other|0|||
161243460|NCT00112437|582269526|FG019|Years 6-10 (60-Month Extension)|Other|0|||
161243461|NCT00112437|582269527|FG020|Years 6-10 (60-Month Extension)|Other|0|||
161243462|NCT00112437|582269528|FG021|Years 6-10 (60-Month Extension)|Other|0|||
161243463|NCT00112437|582269529|FG022|Years 6-10 (60-Month Extension)|Other|0|||
161243464|NCT00112437|582269530|FG023|Years 6-10 (60-Month Extension)|Other|0|||
161243465|NCT00112437|582269531|FG024|Years 6-10 (60-Month Extension)|Other|1|||
161243466|NCT00112437|582269532|FG025|Years 6-10 (60-Month Extension)|Other|0|||
160828269|NCT02689076|580758231|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
161334617|NCT01190813|582614248|FG000|Overall Study|Lost to Follow-up|1|||
160828270|NCT02689076|580758232|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
160828271|NCT01143896|580758237|FG000|Overall Study|Did not complete Baseline Interview|5|||
160828272|NCT01143896|580758238|FG001|Overall Study|Did not complete Baseline Interview|4|||
160828273|NCT01143896|580758237|FG000|Overall Study|Lost to Follow-up|18|||
160828274|NCT01143896|580758238|FG001|Overall Study|Lost to Follow-up|13|||
160828275|NCT01143896|580758237|FG000|Overall Study|Withdrawal by Subject|13|||
160828276|NCT01143896|580758238|FG001|Overall Study|Withdrawal by Subject|5|||
160828277|NCT01143896|580758237|FG000|Overall Study|Death|6|||
160828278|NCT01143896|580758238|FG001|Overall Study|Death|3|||
160828279|NCT01318070|580758239|FG000|Overall Study|Adverse Event|1|||
160828280|NCT01318070|580758240|FG001|Overall Study|Adverse Event|1|||
160828281|NCT01318070|580758241|FG002|Overall Study|Adverse Event|5|||
160828282|NCT01318070|580758239|FG000|Overall Study|Withdrawal by Subject|0|||
160828283|NCT01318070|580758240|FG001|Overall Study|Withdrawal by Subject|1|||
160828284|NCT01318070|580758241|FG002|Overall Study|Withdrawal by Subject|1|||
160828285|NCT01318070|580758239|FG000|Overall Study|Lack of Efficacy|0|||
160828286|NCT01318070|580758240|FG001|Overall Study|Lack of Efficacy|0|||
160828287|NCT01318070|580758241|FG002|Overall Study|Lack of Efficacy|1|||
160828288|NCT01318070|580758239|FG000|Overall Study|Principal Investigator Discretion|1|||
160828289|NCT01318070|580758240|FG001|Overall Study|Principal Investigator Discretion|0|||
160828290|NCT01318070|580758241|FG002|Overall Study|Principal Investigator Discretion|0|||
160828291|NCT00334282|580758247|FG000|Overall Study|Lost to Follow-up|11|||
160828292|NCT00334282|580758248|FG001|Overall Study|Lost to Follow-up|5|||
160828293|NCT00334282|580758247|FG000|Overall Study|Withdrawal by Subject|17|||
160828294|NCT00334282|580758248|FG001|Overall Study|Withdrawal by Subject|3|||
160828295|NCT00334282|580758247|FG000|Overall Study|Death|194|||
160828296|NCT00334282|580758248|FG001|Overall Study|Death|100|||
160828297|NCT00276094|580758253|FG000|Overall Study|Adverse Event|15|||
160828298|NCT00276094|580758254|FG001|Overall Study|Adverse Event|13|||
160828299|NCT00276094|580758255|FG002|Overall Study|Adverse Event|11|||
160828300|NCT00276094|580758253|FG000|Overall Study|Withdrawal by Subject|14|||
160828301|NCT00276094|580758254|FG001|Overall Study|Withdrawal by Subject|14|||
160828302|NCT00276094|580758255|FG002|Overall Study|Withdrawal by Subject|12|||
160828303|NCT00276094|580758253|FG000|Overall Study|Protocol Violation|16|||
160828304|NCT00276094|580758254|FG001|Overall Study|Protocol Violation|7|||
160828305|NCT00276094|580758255|FG002|Overall Study|Protocol Violation|10|||
160828306|NCT00276094|580758253|FG000|Overall Study|Lost to Follow-up|8|||
160828307|NCT00276094|580758254|FG001|Overall Study|Lost to Follow-up|6|||
160828308|NCT00276094|580758255|FG002|Overall Study|Lost to Follow-up|4|||
160828309|NCT00276094|580758253|FG000|Overall Study|Other-Subject moved out of country|1|||
160828310|NCT00276094|580758254|FG001|Overall Study|Other-Subject moved out of country|0|||
160828311|NCT00276094|580758255|FG002|Overall Study|Other-Subject moved out of country|0|||
160828312|NCT00276094|580758253|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
160828313|NCT00276094|580758254|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
160828314|NCT00276094|580758255|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
160828315|NCT00276094|580758253|FG000|Overall Study|Other-Lack of efficacy|1|||
160828316|NCT00276094|580758254|FG001|Overall Study|Other-Lack of efficacy|0|||
160828317|NCT00276094|580758255|FG002|Overall Study|Other-Lack of efficacy|0|||
160828318|NCT00276094|580758253|FG000|Overall Study|Other-Refused follow-up visit|1|||
160828319|NCT00276094|580758254|FG001|Overall Study|Other-Refused follow-up visit|0|||
160828320|NCT00276094|580758255|FG002|Overall Study|Other-Refused follow-up visit|0|||
160828321|NCT00276094|580758253|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
160828322|NCT00276094|580758254|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
160828323|NCT00276094|580758255|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
160828324|NCT00276094|580758253|FG000|Overall Study|Other-Relocation|0|||
160828325|NCT00276094|580758254|FG001|Overall Study|Other-Relocation|1|||
160828326|NCT00276094|580758255|FG002|Overall Study|Other-Relocation|0|||
161243467|NCT00112437|582269507|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243468|NCT00112437|582269508|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243469|NCT00112437|582269509|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243470|NCT00112437|582269510|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243471|NCT00112437|582269511|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160828327|NCT00276094|580758253|FG000|Overall Study|Other-Study medication lost|0|||
160828328|NCT00276094|580758254|FG001|Overall Study|Other-Study medication lost|0|||
160828329|NCT00276094|580758255|FG002|Overall Study|Other-Study medication lost|1|||
160828330|NCT00787137|580758258|FG000|Overall Study|Study Termination|0|||
160828331|NCT00787137|580758259|FG001|Overall Study|Study Termination|0|||
160828332|NCT00787137|580758260|FG002|Overall Study|Study Termination|1|||
160828333|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
160828334|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
160828335|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
160902633|NCT02484690|581036075|FG000|Overall Study|Lost to Follow-up|0|||
160902634|NCT02484690|581036076|FG001|Overall Study|Lost to Follow-up|0|||
160902635|NCT02484690|581036077|FG002|Overall Study|Lost to Follow-up|1|||
160902636|NCT02484690|581036078|FG003|Overall Study|Lost to Follow-up|0|||
161243472|NCT00112437|582269512|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160902637|NCT02484690|581036079|FG004|Overall Study|Lost to Follow-up|0|||
160902638|NCT01759511|581036080|FG000|Overall Study|Adverse Event|4|||
161243473|NCT00112437|582269513|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243474|NCT00112437|582269514|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243475|NCT00112437|582269515|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243476|NCT00112437|582269516|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243477|NCT00112437|582269517|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243478|NCT00112437|582269518|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243479|NCT00112437|582269519|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243480|NCT00112437|582269520|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
160902639|NCT01759511|581036080|FG000|Overall Study|Death|2|||
161243481|NCT00112437|582269521|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243482|NCT00112437|582269522|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243483|NCT00112437|582269523|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243484|NCT00112437|582269524|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243485|NCT00112437|582269525|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243486|NCT00112437|582269526|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243487|NCT00112437|582269527|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243488|NCT00112437|582269528|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243489|NCT00112437|582269529|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243490|NCT00112437|582269530|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
161243491|NCT00112437|582269531|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243492|NCT00112437|582269532|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
161243493|NCT00112437|582269507|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243494|NCT00112437|582269508|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243495|NCT00112437|582269509|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243496|NCT00112437|582269510|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243497|NCT00112437|582269511|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243498|NCT00112437|582269512|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243499|NCT00112437|582269513|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243500|NCT00112437|582269514|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
160902640|NCT01759511|581036080|FG000|Overall Study|Lack of Efficacy|2|||
160902641|NCT01759511|581036080|FG000|Overall Study|Physician Decision|1|||
160902642|NCT01759511|581036080|FG000|Overall Study|Progressive Disease|5|||
160902643|NCT01759511|581036080|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
160902644|NCT01759511|581036080|FG000|Overall Study|Study Terminated by Sponsor|13|||
160902645|NCT01759511|581036080|FG000|Overall Study|Withdrawal by Subject|3|||
160902646|NCT04439201|581036083|FG000|Overall Study|Ineligible|2|||
160902647|NCT04439201|581036083|FG000|Overall Study|Never start protocol therapy|1|||
160902648|NCT04439201|581036083|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
160902649|NCT04439201|581036083|FG000|Overall Study|Mutation status not confirmed|4|||
160902650|NCT04439201|581036083|FG000|Overall Study|Adverse Event|1|||
160902651|NCT04439201|581036083|FG000|Overall Study|Death|7|||
160902652|NCT04439201|581036083|FG000|Overall Study|Withdrawal by Subject|2|||
160902653|NCT04439201|581036083|FG000|Overall Study|Disease progression|20|||
160902654|NCT04439201|581036083|FG000|Overall Study|Alternative therapy|1|||
160902655|NCT04439201|581036083|FG000|Overall Study|Physician Decision|1|||
160902656|NCT01995825|581037769|FG000|Overall Study|Withdrawal by Subject|1|||
160902657|NCT01995825|581037770|FG001|Overall Study|Withdrawal by Subject|0|||
160902658|NCT01367002|581037771|FG000|Overall Study|Withdrawal by Subject|1|||
160902659|NCT01367002|581037772|FG001|Overall Study|Withdrawal by Subject|0|||
160902660|NCT01367002|581037771|FG000|Overall Study|Physician Decision|0|||
160902661|NCT01367002|581037772|FG001|Overall Study|Physician Decision|2|||
160902662|NCT01516437|581037773|FG000|Overall Study|Reason not specified|0|||
160902663|NCT01516437|581037774|FG001|Overall Study|Reason not specified|0|||
160902664|NCT01516437|581037775|FG002|Overall Study|Reason not specified|1|||
160902665|NCT01516437|581037776|FG003|Overall Study|Reason not specified|1|||
160902666|NCT00403234|581037777|FG000|Overall Study|Withdrawal by Subject|0|||
160902667|NCT00403234|581037778|FG001|Overall Study|Withdrawal by Subject|1|||
160902668|NCT00403234|581037779|FG002|Overall Study|Withdrawal by Subject|0|||
160902669|NCT00403234|581037780|FG003|Overall Study|Withdrawal by Subject|0|||
160902670|NCT00403234|581037777|FG000|Overall Study|Adverse Event|1|||
161334618|NCT01190813|582614249|FG001|Overall Study|Lost to Follow-up|2|||
161334619|NCT01190813|582614248|FG000|Overall Study|Withdrawal by Subject|2|||
161334620|NCT01190813|582614249|FG001|Overall Study|Withdrawal by Subject|1|||
161334621|NCT01190813|582614248|FG000|Overall Study|Refused study treatment after randomized|1|||
161334622|NCT01190813|582614249|FG001|Overall Study|Refused study treatment after randomized|0|||
160902671|NCT00403234|581037778|FG001|Overall Study|Adverse Event|0|||
160902672|NCT00403234|581037779|FG002|Overall Study|Adverse Event|1|||
160902673|NCT00403234|581037780|FG003|Overall Study|Adverse Event|0|||
160902674|NCT00560105|581037783|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
160902675|NCT00560105|581037784|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
160902676|NCT01550289|581037785|FG000|Overall Study|Protocol Violation|1|||
160990606|NCT02501629|581353897|FG001|Overall Study|Death|1|||
161334623|NCT01190813|582614248|FG000|Overall Study|Adverse Event|0|||
161334624|NCT01190813|582614249|FG001|Overall Study|Adverse Event|1|||
161334625|NCT03810456|582614251|FG000|Treatment|Urgent Family Matters|3|||
161334626|NCT03810456|582614252|FG001|Treatment|Urgent Family Matters|0|||
161334627|NCT03810456|582614253|FG002|Treatment|Urgent Family Matters|0|||
161334628|NCT03810456|582614251|FG000|Treatment|Scheduling Conflicts|0|||
161334629|NCT03810456|582614252|FG001|Treatment|Scheduling Conflicts|11|||
161334630|NCT03810456|582614253|FG002|Treatment|Scheduling Conflicts|0|||
161334631|NCT03810456|582614251|FG000|Treatment|No Longer Interested|0|||
161334632|NCT03810456|582614252|FG001|Treatment|No Longer Interested|12|||
161334633|NCT03810456|582614253|FG002|Treatment|No Longer Interested|0|||
161334634|NCT03810456|582614251|FG000|Treatment|Transportation Issues|0|||
161334635|NCT03810456|582614252|FG001|Treatment|Transportation Issues|1|||
161334636|NCT03810456|582614253|FG002|Treatment|Transportation Issues|0|||
161334637|NCT03810456|582614251|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
161334638|NCT03810456|582614252|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
161334639|NCT03810456|582614253|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
161334640|NCT03810456|582614251|FG000|1 Month Follow-Up|Relocated to Different State|1|||
161334641|NCT03810456|582614252|FG001|1 Month Follow-Up|Relocated to Different State|0|||
161334642|NCT03810456|582614253|FG002|1 Month Follow-Up|Relocated to Different State|1|||
161334643|NCT03810456|582614251|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
161334644|NCT03810456|582614252|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
161334645|NCT03810456|582614253|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
161334646|NCT03810456|582614251|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
161334647|NCT03810456|582614252|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
161334648|NCT03810456|582614253|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
161334649|NCT03810456|582614251|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
161334650|NCT03810456|582614252|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
161334651|NCT03810456|582614253|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
161334652|NCT03810456|582614251|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
161334653|NCT03810456|582614252|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
161334654|NCT03810456|582614253|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
161334655|NCT03810456|582614251|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
161334656|NCT03810456|582614252|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
161334657|NCT03810456|582614253|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
161334658|NCT04265261|582614258|FG000|Overall Study|Adverse Event|2|||
161334659|NCT04265261|582614259|FG001|Overall Study|Adverse Event|0|||
161334660|NCT04265261|582614260|FG002|Overall Study|Adverse Event|0|||
161334661|NCT04265261|582614258|FG000|Overall Study|Death|1|||
161334662|NCT04265261|582614259|FG001|Overall Study|Death|0|||
161334663|NCT04265261|582614260|FG002|Overall Study|Death|0|||
161334664|NCT04265261|582614258|FG000|Overall Study|Lost to Follow-up|4|||
161334665|NCT04265261|582614259|FG001|Overall Study|Lost to Follow-up|1|||
161334666|NCT04265261|582614260|FG002|Overall Study|Lost to Follow-up|3|||
161334667|NCT04265261|582614258|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161334668|NCT04265261|582614259|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161334669|NCT04265261|582614260|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161334670|NCT04265261|582614258|FG000|Overall Study|Physician Decision|0|||
161334671|NCT04265261|582614259|FG001|Overall Study|Physician Decision|0|||
161334672|NCT04265261|582614260|FG002|Overall Study|Physician Decision|1|||
161334673|NCT04265261|582614258|FG000|Overall Study|Protocol Deviation|0|||
161334674|NCT04265261|582614259|FG001|Overall Study|Protocol Deviation|2|||
161334675|NCT04265261|582614260|FG002|Overall Study|Protocol Deviation|0|||
160828336|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
160828337|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
160828338|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
160828339|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160828340|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160828341|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
160828342|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
161334676|NCT04265261|582614258|FG000|Overall Study|Withdrawal by Subject|2|||
161334677|NCT04265261|582614259|FG001|Overall Study|Withdrawal by Subject|1|||
161334678|NCT04265261|582614260|FG002|Overall Study|Withdrawal by Subject|4|||
160828343|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
160828344|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
161334679|NCT07116759|582614261|FG000|Overall Study|Incompatibility with the RHMC device|2|||
161334680|NCT02337491|582615788|FG000|Overall Study|Death|1|||
161334681|NCT02337491|582615789|FG001|Overall Study|Death|1|||
161334682|NCT02337491|582615788|FG000|Overall Study|Adverse Event|0|||
160902677|NCT01550289|581037786|FG001|Overall Study|Protocol Violation|0|||
160902678|NCT01550289|581037785|FG000|Overall Study|Lost to Follow-up|1|||
160902679|NCT01550289|581037786|FG001|Overall Study|Lost to Follow-up|1|||
160902680|NCT01550289|581037785|FG000|Overall Study|Withdrawal by Subject|11|||
160902681|NCT01550289|581037786|FG001|Overall Study|Withdrawal by Subject|3|||
160902682|NCT03539081|581037787|FG000|Overall Study|Withdrawal by Subject|2|||
160902683|NCT03539081|581037788|FG001|Overall Study|Withdrawal by Subject|3|||
161243501|NCT00112437|582269515|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243502|NCT00112437|582269516|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243503|NCT00112437|582269517|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243504|NCT00112437|582269518|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243505|NCT00112437|582269519|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243506|NCT00112437|582269520|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243507|NCT00112437|582269521|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243508|NCT00112437|582269522|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243509|NCT00112437|582269523|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243510|NCT00112437|582269524|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243511|NCT00112437|582269525|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243512|NCT00112437|582269526|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243513|NCT00112437|582269527|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243514|NCT00112437|582269528|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243515|NCT00112437|582269529|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
161243516|NCT00112437|582269530|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
161243517|NCT00112437|582269531|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
161243518|NCT00112437|582269532|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
161243519|NCT03218787|582269534|FG000|Overall Study|Lost to Follow-up|12|||
161243520|NCT03218787|582269534|FG000|Overall Study|Withdrawal by Subject|72|||
161243521|NCT03218787|582269534|FG000|Overall Study|Physician Decision|11|||
161243522|NCT03218787|582269534|FG000|Overall Study|Death|111|||
161243523|NCT02896296|582269535|FG000|Overall Study|Adverse Event|1|||
161243524|NCT02896296|582269535|FG000|Overall Study|Lost to Follow-up|19|||
161243525|NCT02896296|582269535|FG000|Overall Study|Pregnancy|1|||
160990607|NCT02501629|581353896|FG000|Overall Study|Withdrawn from study by sponsor|1|||
160990608|NCT02501629|581353897|FG001|Overall Study|Withdrawn from study by sponsor|0|||
160990609|NCT02501629|581353896|FG000|Overall Study|Early termination by sponsor|1|||
161134621|NCT01478958|581876666|FG002|Overall Study|Re-located|0|||
161134622|NCT01478958|581876664|FG000|Overall Study|Unable to comply|0|||
161134623|NCT01478958|581876665|FG001|Overall Study|Unable to comply|0|||
161134624|NCT01478958|581876666|FG002|Overall Study|Unable to comply|2|||
161134625|NCT00629083|581876667|FG000|Overall Study|Adverse Event|0|||
161134626|NCT00629083|581876668|FG001|Overall Study|Adverse Event|2|||
161134627|NCT00629083|581876667|FG000|Overall Study|Lack of Efficacy|3|||
161134628|NCT00629083|581876668|FG001|Overall Study|Lack of Efficacy|1|||
161134629|NCT00629083|581876667|FG000|Overall Study|Withdrawal by Subject|10|||
161134630|NCT00629083|581876668|FG001|Overall Study|Withdrawal by Subject|2|||
161134631|NCT00629083|581876667|FG000|Overall Study|Lost to Follow-up|12|||
161134632|NCT00629083|581876668|FG001|Overall Study|Lost to Follow-up|8|||
161134633|NCT00629083|581876667|FG000|Overall Study|Moved out of country/state|2|||
161134634|NCT00629083|581876668|FG001|Overall Study|Moved out of country/state|1|||
161134635|NCT00629083|581876667|FG000|Overall Study|Refused to return for 12 month visit|1|||
161134636|NCT00629083|581876668|FG001|Overall Study|Refused to return for 12 month visit|0|||
161134637|NCT01193686|581876669|FG000|Overall Study|Withdrawal by Subject|4|||
161134638|NCT01193686|581876670|FG001|Overall Study|Withdrawal by Subject|1|||
161134639|NCT01193686|581876669|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
161134640|NCT01193686|581876670|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
161134641|NCT03401749|581876671|FG000|Overall Study|Lost to Follow-up|20|||
161134642|NCT03401749|581876672|FG001|Overall Study|Lost to Follow-up|16|||
161134643|NCT03401749|581876673|FG002|Overall Study|Lost to Follow-up|26|||
161134644|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161134645|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
161134646|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
161134647|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161134648|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161134649|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161134650|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161134651|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161134652|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
161134653|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
161134654|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
161134655|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
161134656|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161134657|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161134658|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161134659|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161134660|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161134661|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161134662|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
160990610|NCT02501629|581353897|FG001|Overall Study|Early termination by sponsor|0|||
160990611|NCT02501629|581353896|FG000|Overall Study|Withdrawal by Subject|3|||
161134663|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
161134664|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
161134665|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161134666|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161134667|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161134668|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161134669|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161134670|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161134671|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134672|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134673|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
161134674|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134675|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134676|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134677|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134678|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134679|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
161134680|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
161134681|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
161134682|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
161134683|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161134684|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161134685|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161134686|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161134687|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161134688|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
161134689|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
161134690|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134691|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134692|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134693|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134694|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134695|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134696|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134697|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
161134698|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
161134699|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
161134700|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134701|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134702|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134703|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134704|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134705|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134706|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
161134707|NCT01307423|581876676|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161134708|NCT01307423|581876677|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
161134709|NCT01307423|581876678|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
161134710|NCT01307423|581876679|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160828345|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
160828346|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
160828347|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
160828348|NCT00554099|580758262|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160828349|NCT00554099|580758263|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160828350|NCT00554099|580758264|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
160828351|NCT00554099|580758262|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
160828352|NCT00554099|580758263|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
160828353|NCT00554099|580758264|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
160828354|NCT00554099|580758262|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
160828355|NCT00554099|580758263|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
160828356|NCT00554099|580758264|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
160828357|NCT00554099|580758262|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
160828358|NCT00554099|580758263|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
160828359|NCT00554099|580758264|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
160990612|NCT02501629|581353897|FG001|Overall Study|Withdrawal by Subject|5|||
161243526|NCT02896296|582269535|FG000|Overall Study|Physician Decision|2|||
161243527|NCT02896296|582269535|FG000|Overall Study|Withdrawal by Subject|10|||
161243528|NCT02896296|582269535|FG000|Overall Study|Site closing|7|||
161243529|NCT02896296|582269535|FG000|Overall Study|Incarceration|1|||
161243530|NCT02896296|582269535|FG000|Overall Study|Relocation|1|||
161243531|NCT04633564|582269536|FG000|Period 1|Adverse Event|28|||
161243532|NCT04633564|582269537|FG001|Period 1|Adverse Event|19|||
160990613|NCT02501629|581353896|FG000|Overall Study|Subject did not return to site|0|||
160990614|NCT02501629|581353897|FG001|Overall Study|Subject did not return to site|1|||
160990615|NCT00868231|581353900|FG000|Treatment Period 1|Adverse Event|0|||
160990616|NCT00868231|581353901|FG001|Treatment Period 1|Adverse Event|0|||
160990617|NCT00868231|581353902|FG002|Treatment Period 1|Adverse Event|0|||
160990618|NCT00868231|581353903|FG003|Treatment Period 1|Adverse Event|0|||
160990619|NCT00868231|581353904|FG004|Treatment Period 1|Adverse Event|1|||
160990620|NCT00868231|581353905|FG005|Treatment Period 1|Adverse Event|0|||
160990621|NCT00868231|581353900|FG000|Treatment Period 2|Adverse Event|1|||
160990622|NCT00868231|581353901|FG001|Treatment Period 2|Adverse Event|0|||
160990623|NCT00868231|581353902|FG002|Treatment Period 2|Adverse Event|0|||
160990624|NCT00868231|581353903|FG003|Treatment Period 2|Adverse Event|0|||
160990625|NCT00868231|581353904|FG004|Treatment Period 2|Adverse Event|0|||
160990626|NCT00868231|581353905|FG005|Treatment Period 2|Adverse Event|0|||
160990627|NCT00868231|581353900|FG000|Treatment Period 3|Adverse Event|0|||
160990628|NCT00868231|581353901|FG001|Treatment Period 3|Adverse Event|0|||
161243533|NCT04633564|582269536|FG000|Period 1|Death|8|||
161243534|NCT04633564|582269537|FG001|Period 1|Death|7|||
161243535|NCT04633564|582269536|FG000|Period 1|Lost to Follow-up|3|||
161243536|NCT04633564|582269537|FG001|Period 1|Lost to Follow-up|5|||
161243537|NCT04633564|582269536|FG000|Period 1|Physician Decision|4|||
161243538|NCT04633564|582269537|FG001|Period 1|Physician Decision|12|||
161243539|NCT04633564|582269536|FG000|Period 1|Protocol Violation|0|||
161243540|NCT04633564|582269537|FG001|Period 1|Protocol Violation|1|||
161243541|NCT04633564|582269536|FG000|Period 1|Withdrawal by Subject|10|||
161243542|NCT04633564|582269537|FG001|Period 1|Withdrawal by Subject|8|||
161243543|NCT04633564|582269536|FG000|Period 1|Progressive disease|47|||
161243544|NCT04633564|582269537|FG001|Period 1|Progressive disease|51|||
161243545|NCT04633564|582269536|FG000|Period 1|Terminated by Sponsor|8|||
161243546|NCT04633564|582269537|FG001|Period 1|Terminated by Sponsor|6|||
161243547|NCT04633564|582269536|FG000|Period 2|Adverse Event|3|||
161243548|NCT04633564|582269537|FG001|Period 2|Adverse Event|4|||
161243549|NCT04633564|582269536|FG000|Period 2|Death|0|||
161243550|NCT04633564|582269537|FG001|Period 2|Death|2|||
161243551|NCT04633564|582269536|FG000|Period 2|Lost to Follow-up|0|||
161243552|NCT04633564|582269537|FG001|Period 2|Lost to Follow-up|1|||
161243553|NCT04633564|582269536|FG000|Period 2|Physician Decision|2|||
161243554|NCT04633564|582269537|FG001|Period 2|Physician Decision|4|||
161243555|NCT04633564|582269536|FG000|Period 2|Withdrawal by Subject|5|||
161243556|NCT04633564|582269537|FG001|Period 2|Withdrawal by Subject|1|||
161243557|NCT04633564|582269536|FG000|Period 2|Progressive Disease|74|||
161243558|NCT04633564|582269537|FG001|Period 2|Progressive Disease|82|||
161243559|NCT04633564|582269536|FG000|Period 2|Terminated by Sponsor|9|||
161243560|NCT04633564|582269537|FG001|Period 2|Terminated by Sponsor|3|||
161243561|NCT04198363|582269538|FG000|Overall Study|Adverse Event|1|||
161243562|NCT04198363|582269539|FG001|Overall Study|Adverse Event|1|||
161243563|NCT04198363|582269538|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
161243564|NCT04198363|582269539|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
161243565|NCT04198363|582269538|FG000|Overall Study|Reason not Specified|1|||
161243566|NCT04198363|582269539|FG001|Overall Study|Reason not Specified|0|||
161243567|NCT03500094|582269543|FG000|Overall Study|Withdrawal by Subject|1|||
160990629|NCT00868231|581353902|FG002|Treatment Period 3|Adverse Event|1|||
160990630|NCT00868231|581353903|FG003|Treatment Period 3|Adverse Event|0|||
160990631|NCT00868231|581353904|FG004|Treatment Period 3|Adverse Event|0|||
161243568|NCT03500094|582269543|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
161243569|NCT03500094|582269543|FG000|Overall Study|Lost to Follow-up|1|||
161243570|NCT01541215|582271576|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
161243571|NCT01541215|582271577|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
161243572|NCT01541215|582271576|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
161243573|NCT01541215|582271577|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
161243574|NCT01541215|582271576|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
161243575|NCT01541215|582271577|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
161243576|NCT01541215|582271576|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
161243577|NCT01541215|582271577|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
161243578|NCT01541215|582271576|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
160990632|NCT00868231|581353905|FG005|Treatment Period 3|Adverse Event|0|||
161243579|NCT01541215|582271577|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
161243580|NCT01541215|582271576|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
161243581|NCT01541215|582271577|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
161243582|NCT02316223|582271581|FG000|Overall Study|Lack of Efficacy|0|||
161243583|NCT02316223|582271582|FG001|Overall Study|Lack of Efficacy|1|||
161243584|NCT02316223|582271583|FG002|Overall Study|Lack of Efficacy|1|||
161243585|NCT02316223|582271581|FG000|Overall Study|Lost to Follow-up|27|||
161243586|NCT02316223|582271582|FG001|Overall Study|Lost to Follow-up|34|||
161243587|NCT02316223|582271583|FG002|Overall Study|Lost to Follow-up|36|||
161243588|NCT02316223|582271581|FG000|Overall Study|COPD Diagnosis|3|||
161243589|NCT02316223|582271582|FG001|Overall Study|COPD Diagnosis|2|||
161243590|NCT02316223|582271583|FG002|Overall Study|COPD Diagnosis|3|||
161243591|NCT02316223|582271581|FG000|Overall Study|Reside outside study area|1|||
161243592|NCT02316223|582271582|FG001|Overall Study|Reside outside study area|1|||
161243593|NCT02316223|582271583|FG002|Overall Study|Reside outside study area|1|||
161243594|NCT02316223|582271581|FG000|Overall Study|No asthma|2|||
161243595|NCT02316223|582271582|FG001|Overall Study|No asthma|0|||
161243596|NCT02316223|582271583|FG002|Overall Study|No asthma|0|||
161243597|NCT02316223|582271581|FG000|Overall Study|Discontinued by PI|11|||
161243598|NCT02316223|582271582|FG001|Overall Study|Discontinued by PI|19|||
161243599|NCT02316223|582271583|FG002|Overall Study|Discontinued by PI|3|||
161243600|NCT03234907|582271585|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
161243601|NCT03234907|582271586|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
161243602|NCT03234907|582271587|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161243603|NCT03234907|582271588|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161243604|NCT03234907|582271589|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161243605|NCT03234907|582271590|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
161243606|NCT03234907|582271585|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
161243607|NCT03234907|582271586|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
161243608|NCT03234907|582271587|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161243609|NCT03234907|582271588|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161243610|NCT03234907|582271589|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161243611|NCT03234907|582271590|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
161243612|NCT03234907|582271585|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
161243613|NCT03234907|582271586|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161243614|NCT03234907|582271587|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161243615|NCT03234907|582271588|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161243616|NCT03234907|582271589|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
161243617|NCT03234907|582271590|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
160902684|NCT03539081|581037789|FG002|Overall Study|Withdrawal by Subject|0|||
160902685|NCT03539081|581037787|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
160902686|NCT03539081|581037788|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
160902687|NCT03539081|581037789|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
160902688|NCT00354744|581037793|FG000|Overall Study|Adverse Event|2|||
160902689|NCT00354744|581037793|FG000|Overall Study|Death|2|||
160902690|NCT00354744|581037793|FG000|Overall Study|Lack of Efficacy|11|||
160902691|NCT00354744|581037793|FG000|Overall Study|Lost to Follow-up|2|||
160902692|NCT00354744|581037793|FG000|Overall Study|Physician Decision|11|||
160902693|NCT00354744|581037793|FG000|Overall Study|Withdrawal by Subject|14|||
160902694|NCT00541931|581037794|FG000|Overall Study|Adverse Event|1|||
160902695|NCT00541931|581037795|FG001|Overall Study|Adverse Event|0|||
160902696|NCT00541931|581037794|FG000|Overall Study|Lost to Follow-up|3|||
160902697|NCT00541931|581037795|FG001|Overall Study|Lost to Follow-up|3|||
160902698|NCT00541931|581037794|FG000|Overall Study|Withdrawal by Subject|1|||
160902699|NCT00541931|581037795|FG001|Overall Study|Withdrawal by Subject|0|||
160902700|NCT00541931|581037794|FG000|Overall Study|Transportation Issue|0|||
160902701|NCT00541931|581037795|FG001|Overall Study|Transportation Issue|1|||
160902702|NCT02555683|581037799|FG000|Overall Study|Physician Decision|1|||
160902703|NCT02555683|581037800|FG001|Overall Study|Physician Decision|0|||
160902704|NCT02555683|581037801|FG002|Overall Study|Physician Decision|2|||
160902705|NCT02555683|581037799|FG000|Overall Study|Lost to Follow-up|2|||
160902706|NCT02555683|581037800|FG001|Overall Study|Lost to Follow-up|1|||
160902707|NCT02555683|581037801|FG002|Overall Study|Lost to Follow-up|2|||
160902708|NCT02555683|581037799|FG000|Overall Study|Technical Problems|1|||
161243618|NCT03234907|582271585|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
161243619|NCT03234907|582271586|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
161243620|NCT03234907|582271587|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
160902709|NCT02555683|581037800|FG001|Overall Study|Technical Problems|1|||
161243621|NCT03234907|582271588|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161243622|NCT03234907|582271589|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
161243623|NCT03234907|582271590|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
160902710|NCT02555683|581037801|FG002|Overall Study|Technical Problems|0|||
160902711|NCT02555683|581037799|FG000|Overall Study|Protocol deviation|0|||
160902712|NCT02555683|581037800|FG001|Overall Study|Protocol deviation|1|||
160902713|NCT02555683|581037801|FG002|Overall Study|Protocol deviation|0|||
160902714|NCT02555683|581037799|FG000|Overall Study|Lack of Efficacy|2|||
160902715|NCT02555683|581037800|FG001|Overall Study|Lack of Efficacy|0|||
161243624|NCT03234907|582271585|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161243625|NCT03234907|582271586|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161243626|NCT03234907|582271587|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
161243627|NCT03234907|582271588|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
161243628|NCT03234907|582271589|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
161243629|NCT03234907|582271590|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
161243630|NCT03234907|582271585|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
161243631|NCT03234907|582271586|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
161243632|NCT03234907|582271587|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
161243633|NCT03234907|582271588|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
161243634|NCT03234907|582271589|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
161243635|NCT03234907|582271590|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
161243636|NCT03234907|582271585|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161243637|NCT03234907|582271586|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161243638|NCT03234907|582271587|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
161243639|NCT03234907|582271588|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
161243640|NCT03234907|582271589|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
161243641|NCT03234907|582271590|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
161243642|NCT02986139|582271593|FG000|Overall Study|Sponsor Decision|1|||
161243643|NCT02986139|582271594|FG001|Overall Study|Sponsor Decision|2|||
161243644|NCT02986139|582271593|FG000|Overall Study|Withdrawal by Subject|0|||
161243645|NCT02986139|582271594|FG001|Overall Study|Withdrawal by Subject|1|||
161243646|NCT02986139|582271593|FG000|Overall Study|Lost to Follow-up|0|||
161243647|NCT02986139|582271594|FG001|Overall Study|Lost to Follow-up|1|||
161243648|NCT02583048|582271595|FG000|Overall Study|Withdrawal by Subject|0|||
161243649|NCT02583048|582271596|FG001|Overall Study|Withdrawal by Subject|1|||
161243650|NCT02583048|582271597|FG002|Overall Study|Withdrawal by Subject|0|||
161243651|NCT02583048|582271595|FG000|Overall Study|Failed to meet eligibility criterion|0|||
161243652|NCT02583048|582271596|FG001|Overall Study|Failed to meet eligibility criterion|0|||
161243653|NCT02583048|582271597|FG002|Overall Study|Failed to meet eligibility criterion|1|||
161243654|NCT00414726|582271601|FG000|Overall Study|Withdrawal by Subject|0|||
161243655|NCT00414726|582271602|FG001|Overall Study|Withdrawal by Subject|1|||
161243656|NCT02107196|582271603|FG000|12-week Treatment Period|Adverse Event|6|||
161243657|NCT02107196|582271604|FG001|12-week Treatment Period|Adverse Event|3|||
161243658|NCT02107196|582271603|FG000|12-week Treatment Period|Lack of Efficacy|2|||
161243659|NCT02107196|582271604|FG001|12-week Treatment Period|Lack of Efficacy|1|||
160828360|NCT02075632|580758265|FG000|Overall Study|Adverse Event|1|||
160828361|NCT02075632|580758266|FG001|Overall Study|Adverse Event|1|||
160828362|NCT02075632|580758265|FG000|Overall Study|Lost to Follow-up|0|||
160828363|NCT02075632|580758266|FG001|Overall Study|Lost to Follow-up|3|||
160828364|NCT02075632|580758265|FG000|Overall Study|Withdrawal by Subject|0|||
160828365|NCT02075632|580758266|FG001|Overall Study|Withdrawal by Subject|1|||
160828366|NCT04957758|580758274|FG000|Overall Study|Adverse Event|1|||
160828367|NCT04957758|580758275|FG001|Overall Study|Adverse Event|0|||
160828368|NCT04957758|580758274|FG000|Overall Study|Lost to Follow-up|0|||
160828369|NCT04957758|580758275|FG001|Overall Study|Lost to Follow-up|2|||
160828370|NCT04957758|580758274|FG000|Overall Study|Withdrawal by Subject|4|||
160828371|NCT04957758|580758275|FG001|Overall Study|Withdrawal by Subject|2|||
160828372|NCT04957758|580758274|FG000|Overall Study|Protocol Violation|0|||
160828373|NCT04957758|580758275|FG001|Overall Study|Protocol Violation|1|||
160828374|NCT03353922|580758276|FG000|Overall Study|Withdrawal by Subject|1|||
160828375|NCT03353922|580758277|FG001|Overall Study|Withdrawal by Subject|0|||
160828376|NCT03353922|580758278|FG002|Overall Study|Withdrawal by Subject|1|||
160828377|NCT03353922|580758279|FG003|Overall Study|Withdrawal by Subject|1|||
160828378|NCT03353922|580758280|FG004|Overall Study|Withdrawal by Subject|0|||
160828379|NCT03353922|580758281|FG005|Overall Study|Withdrawal by Subject|0|||
160828380|NCT03353922|580758276|FG000|Overall Study|Adverse Event|0|||
160828381|NCT03353922|580758277|FG001|Overall Study|Adverse Event|1|||
160828382|NCT03353922|580758278|FG002|Overall Study|Adverse Event|0|||
161243660|NCT02107196|582271603|FG000|12-week Treatment Period|Lost to Follow-up|3|||
161243661|NCT02107196|582271604|FG001|12-week Treatment Period|Lost to Follow-up|6|||
161334683|NCT02337491|582615789|FG001|Overall Study|Adverse Event|1|||
161334684|NCT02337491|582615788|FG000|Overall Study|Withdrawal by Subject|3|||
160828383|NCT03353922|580758279|FG003|Overall Study|Adverse Event|0|||
160828384|NCT03353922|580758280|FG004|Overall Study|Adverse Event|0|||
160828385|NCT03353922|580758281|FG005|Overall Study|Adverse Event|0|||
160828386|NCT00740714|580758282|FG000|Overall Study|Withdrawal by Subject|17|||
160828387|NCT00740714|580758283|FG001|Overall Study|Withdrawal by Subject|19|||
160828388|NCT00740714|580758284|FG002|Overall Study|Withdrawal by Subject|29|||
160828389|NCT03688555|580758285|FG000|Treatment Period|Adverse Event|0|||
160828390|NCT03688555|580758286|FG001|Treatment Period|Adverse Event|0|||
160828391|NCT03688555|580758287|FG002|Treatment Period|Adverse Event|1|||
160828392|NCT00886119|580758291|FG000|Period 1|Did not meet inclusion criteria|1|||
160828393|NCT00886119|580758292|FG001|Period 1|Did not meet inclusion criteria|0|||
161134711|NCT01307423|581876680|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161134712|NCT01307423|581876681|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161134713|NCT01307423|581876682|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161134714|NCT01307423|581876683|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
160828394|NCT00394901|580758293|FG000|Baseline Phase|Protocol Violation|0|||
160828395|NCT00394901|580758294|FG001|Baseline Phase|Protocol Violation|0|||
160828396|NCT00394901|580758295|FG002|Baseline Phase|Protocol Violation|1|||
160828397|NCT00394901|580758296|FG003|Baseline Phase|Protocol Violation|0|||
160828398|NCT00394901|580758293|FG000|Double-blind Phase|Adverse Event|5|||
160828399|NCT00394901|580758294|FG001|Double-blind Phase|Adverse Event|7|||
160828400|NCT00394901|580758295|FG002|Double-blind Phase|Adverse Event|16|||
160828401|NCT00394901|580758296|FG003|Double-blind Phase|Adverse Event|20|||
160828402|NCT00394901|580758293|FG000|Double-blind Phase|Lack of Efficacy|6|||
161134715|NCT01307423|581876684|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
161134716|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161134717|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
161134718|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161134719|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161134720|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
161134721|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161134722|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161134723|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161134724|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
161134725|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161134726|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
161134727|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
161134728|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
161134729|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
161134730|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161134731|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161134732|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161134733|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
161134734|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134735|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134736|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134737|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134738|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134739|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
161134740|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134741|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134742|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
161134743|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161134744|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
161134745|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
161134746|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161134747|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161134748|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
161134749|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
161134750|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161134751|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
161134752|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134753|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134754|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134755|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
161134756|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134757|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134758|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134759|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161243662|NCT02107196|582271603|FG000|12-week Treatment Period|Physician Decision|0|||
160828403|NCT00394901|580758294|FG001|Double-blind Phase|Lack of Efficacy|4|||
160828404|NCT00394901|580758295|FG002|Double-blind Phase|Lack of Efficacy|1|||
160902716|NCT02555683|581037801|FG002|Overall Study|Lack of Efficacy|0|||
160902717|NCT02555683|581037799|FG000|Overall Study|Death|0|||
160902718|NCT02555683|581037800|FG001|Overall Study|Death|1|||
160902719|NCT02555683|581037801|FG002|Overall Study|Death|2|||
160902720|NCT02555683|581037799|FG000|Overall Study|Adverse Event|1|||
161243663|NCT02107196|582271604|FG001|12-week Treatment Period|Physician Decision|1|||
161243664|NCT02107196|582271603|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
161243665|NCT02107196|582271604|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
161243666|NCT02107196|582271603|FG000|12-week Treatment Period|Protocol Violation|7|||
161243667|NCT02107196|582271604|FG001|12-week Treatment Period|Protocol Violation|8|||
161243668|NCT02107196|582271603|FG000|12-week Treatment Period|Reason Missing|11|||
161243669|NCT02107196|582271604|FG001|12-week Treatment Period|Reason Missing|8|||
161243670|NCT02107196|582271603|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
161243671|NCT02107196|582271604|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
161243672|NCT02107196|582271603|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
161243673|NCT02107196|582271604|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161243674|NCT02107196|582271603|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
161243675|NCT02107196|582271604|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
161243676|NCT02107196|582271603|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
161243677|NCT02107196|582271604|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
161243678|NCT02752074|582271607|FG000|Overall Study|Lost to Follow-up|1|||
161243679|NCT02752074|582271608|FG001|Overall Study|Lost to Follow-up|4|||
161243680|NCT02752074|582271607|FG000|Overall Study|Death|146|||
161243681|NCT02752074|582271608|FG001|Overall Study|Death|129|||
161243682|NCT02752074|582271607|FG000|Overall Study|Withdrawal by Subject|9|||
161243683|NCT02752074|582271608|FG001|Overall Study|Withdrawal by Subject|10|||
161243684|NCT00840216|582271609|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
161243685|NCT00840216|582271610|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160828405|NCT00394901|580758296|FG003|Double-blind Phase|Lack of Efficacy|3|||
160828406|NCT00394901|580758293|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161243686|NCT01380782|582271611|FG000|Overall Study|Adverse Event|0|||
161243687|NCT01380782|582271612|FG001|Overall Study|Adverse Event|1|||
161243688|NCT01380782|582271613|FG002|Overall Study|Adverse Event|0|||
161243689|NCT01380782|582271614|FG003|Overall Study|Adverse Event|0|||
161243690|NCT01380782|582271611|FG000|Overall Study|Death|1|||
161243691|NCT01380782|582271612|FG001|Overall Study|Death|0|||
161243692|NCT01380782|582271613|FG002|Overall Study|Death|0|||
161243693|NCT01380782|582271614|FG003|Overall Study|Death|0|||
161243694|NCT01380782|582271611|FG000|Overall Study|Lack of Efficacy|10|||
161243695|NCT01380782|582271612|FG001|Overall Study|Lack of Efficacy|9|||
161243696|NCT01380782|582271613|FG002|Overall Study|Lack of Efficacy|10|||
161243697|NCT01380782|582271614|FG003|Overall Study|Lack of Efficacy|3|||
161243698|NCT01380782|582271611|FG000|Overall Study|Physician Decision|1|||
161243699|NCT01380782|582271612|FG001|Overall Study|Physician Decision|0|||
161243700|NCT01380782|582271613|FG002|Overall Study|Physician Decision|0|||
161243701|NCT01380782|582271614|FG003|Overall Study|Physician Decision|0|||
161243702|NCT01380782|582271611|FG000|Overall Study|Withdrawal by Subject|0|||
161243703|NCT01380782|582271612|FG001|Overall Study|Withdrawal by Subject|0|||
161243704|NCT01380782|582271613|FG002|Overall Study|Withdrawal by Subject|1|||
161243705|NCT01380782|582271614|FG003|Overall Study|Withdrawal by Subject|1|||
161243706|NCT01403194|582271618|FG000|Overall Study|Screen Failure|2|||
161243707|NCT01403194|582271618|FG000|Overall Study|Lost to Follow-up|8|||
161243708|NCT03428750|582271619|FG000|Overall Study|Withdrawal by Subject|11|||
161243709|NCT03428750|582271620|FG001|Overall Study|Withdrawal by Subject|10|||
161243710|NCT03428750|582271619|FG000|Overall Study|Lost to Follow-up|3|||
161243711|NCT03428750|582271620|FG001|Overall Study|Lost to Follow-up|9|||
161243712|NCT03428750|582271619|FG000|Overall Study|Adverse Event|9|||
161243713|NCT03428750|582271620|FG001|Overall Study|Adverse Event|1|||
161243714|NCT03428750|582271619|FG000|Overall Study|Protocol Violation|1|||
161243715|NCT03428750|582271620|FG001|Overall Study|Protocol Violation|0|||
161243716|NCT03428750|582271619|FG000|Overall Study|Administrative|0|||
161243717|NCT03428750|582271620|FG001|Overall Study|Administrative|1|||
161334685|NCT02337491|582615789|FG001|Overall Study|Withdrawal by Subject|0|||
160828407|NCT00394901|580758294|FG001|Double-blind Phase|Withdrawal by Subject|0|||
160828408|NCT00394901|580758295|FG002|Double-blind Phase|Withdrawal by Subject|0|||
160828409|NCT00394901|580758296|FG003|Double-blind Phase|Withdrawal by Subject|0|||
160828410|NCT00394901|580758293|FG000|Double-blind Phase|Lost to Follow-up|0|||
160828411|NCT00394901|580758294|FG001|Double-blind Phase|Lost to Follow-up|0|||
160828412|NCT00394901|580758295|FG002|Double-blind Phase|Lost to Follow-up|0|||
160828413|NCT00394901|580758296|FG003|Double-blind Phase|Lost to Follow-up|1|||
160828414|NCT00394901|580758293|FG000|Double-blind Phase|Protocol Violation|0|||
160828415|NCT00394901|580758294|FG001|Double-blind Phase|Protocol Violation|0|||
160828416|NCT00394901|580758295|FG002|Double-blind Phase|Protocol Violation|0|||
160990633|NCT03120676|581353906|FG000|Overall Study|Not treated|1|||
161243718|NCT04474405|582271623|FG000|Overall Study|Withdrawal by Subject|0|||
160828417|NCT00394901|580758296|FG003|Double-blind Phase|Protocol Violation|1|||
160828418|NCT00394901|580758293|FG000|Double-blind Phase|Death|1|||
160828419|NCT00394901|580758294|FG001|Double-blind Phase|Death|0|||
161243719|NCT04474405|582271624|FG001|Overall Study|Withdrawal by Subject|0|||
161243720|NCT04474405|582271625|FG002|Overall Study|Withdrawal by Subject|1|||
161243721|NCT04474405|582271626|FG003|Overall Study|Withdrawal by Subject|0|||
161243722|NCT04474405|582271627|FG004|Overall Study|Withdrawal by Subject|1|||
161243723|NCT04474405|582271628|FG005|Overall Study|Withdrawal by Subject|0|||
161243724|NCT04474405|582271623|FG000|Overall Study|Other|0|||
161243725|NCT04474405|582271624|FG001|Overall Study|Other|0|||
161243726|NCT04474405|582271625|FG002|Overall Study|Other|0|||
161243727|NCT04474405|582271626|FG003|Overall Study|Other|0|||
161243728|NCT04474405|582271627|FG004|Overall Study|Other|3|||
161243729|NCT04474405|582271628|FG005|Overall Study|Other|0|||
161243730|NCT00274651|582271629|FG000|Overall Study|Adverse Event|6|||
161243731|NCT00274651|582271630|FG001|Overall Study|Adverse Event|3|||
161243732|NCT00274651|582271629|FG000|Overall Study|Lack of Efficacy|13|||
161243733|NCT00274651|582271630|FG001|Overall Study|Lack of Efficacy|6|||
161243734|NCT00274651|582271629|FG000|Overall Study|Death|1|||
161243735|NCT00274651|582271630|FG001|Overall Study|Death|3|||
161243736|NCT00274651|582271629|FG000|Overall Study|Withdrawal by Subject|0|||
161243737|NCT00274651|582271630|FG001|Overall Study|Withdrawal by Subject|1|||
161243738|NCT00274651|582271629|FG000|Overall Study|Physician Decision|8|||
161243739|NCT00274651|582271630|FG001|Overall Study|Physician Decision|7|||
161243740|NCT03446768|582271631|FG000|Overall Study|Withdrawal by Subject|0|||
161243741|NCT03446768|582271632|FG001|Overall Study|Withdrawal by Subject|1|||
161243742|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
161243743|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
161243744|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
161243745|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
161243746|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
161243747|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
161243748|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
161243749|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
161243750|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
161243751|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
161243752|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
161243753|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
161243754|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
161243755|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
161243756|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
161243757|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
161243758|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
161243759|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
161243760|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
161243761|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
161243762|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
161243763|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
161243764|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
161243765|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
161243766|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
161243767|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
161243768|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
161243769|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
161243770|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
161334686|NCT02337491|582615788|FG000|Overall Study|Progressive Disease|44|||
161334687|NCT02337491|582615789|FG001|Overall Study|Progressive Disease|28|||
160828420|NCT00394901|580758295|FG002|Double-blind Phase|Death|0|||
160828421|NCT00394901|580758296|FG003|Double-blind Phase|Death|0|||
160828422|NCT00394901|580758293|FG000|Double-blind Phase|Subject's Personal Reason|1|||
160828423|NCT00394901|580758294|FG001|Double-blind Phase|Subject's Personal Reason|0|||
160828424|NCT00394901|580758295|FG002|Double-blind Phase|Subject's Personal Reason|0|||
160828425|NCT00394901|580758296|FG003|Double-blind Phase|Subject's Personal Reason|1|||
160828426|NCT00394901|580758293|FG000|Double-blind Phase|Lack of Compliance|0|||
160828427|NCT00394901|580758294|FG001|Double-blind Phase|Lack of Compliance|3|||
160828428|NCT00394901|580758295|FG002|Double-blind Phase|Lack of Compliance|0|||
160828429|NCT00394901|580758296|FG003|Double-blind Phase|Lack of Compliance|0|||
160902721|NCT02555683|581037800|FG001|Overall Study|Adverse Event|0|||
160902722|NCT02555683|581037801|FG002|Overall Study|Adverse Event|1|||
160902723|NCT02555683|581037799|FG000|Overall Study|Subject/guardian decision|12|||
161243771|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
161243772|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
161243773|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
161243774|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
161334688|NCT02337491|582615788|FG000|Overall Study|On Treatment|2|||
160828430|NCT00394901|580758293|FG000|Double-blind Phase|Entry into another study was found|0|||
160902724|NCT02555683|581037800|FG001|Overall Study|Subject/guardian decision|12|||
161243775|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
161243776|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
161243777|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
161243778|NCT04194801|582271633|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
161243779|NCT04194801|582271634|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
161243780|NCT04194801|582271635|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
161243781|NCT04194801|582271633|FG000|Part Ib/II End of Study|Death|2|||
161243782|NCT04194801|582271634|FG001|Part Ib/II End of Study|Death|3|||
161243783|NCT04194801|582271635|FG002|Part Ib/II End of Study|Death|3|||
161243784|NCT04194801|582271633|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
161243785|NCT04194801|582271634|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
160828431|NCT00394901|580758294|FG001|Double-blind Phase|Entry into another study was found|0|||
160828432|NCT00394901|580758295|FG002|Double-blind Phase|Entry into another study was found|1|||
160828433|NCT00394901|580758296|FG003|Double-blind Phase|Entry into another study was found|0|||
160828434|NCT00394901|580758293|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
160828435|NCT00394901|580758294|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
160828436|NCT00394901|580758295|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
160828437|NCT00394901|580758296|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
160828438|NCT03158272|580758306|FG000|Overall Study|Disease progression|3|||
160828439|NCT03158272|580758307|FG001|Overall Study|Disease progression|3|||
160828440|NCT03158272|580758308|FG002|Overall Study|Disease progression|4|||
160828441|NCT03158272|580758309|FG003|Overall Study|Disease progression|6|||
160828442|NCT03158272|580758306|FG000|Overall Study|Death|0|||
160828443|NCT03158272|580758307|FG001|Overall Study|Death|0|||
160828444|NCT03158272|580758308|FG002|Overall Study|Death|1|||
160828445|NCT03158272|580758309|FG003|Overall Study|Death|0|||
160828446|NCT03158272|580758306|FG000|Overall Study|Other reasons|0|||
160828447|NCT03158272|580758307|FG001|Overall Study|Other reasons|0|||
160828448|NCT03158272|580758308|FG002|Overall Study|Other reasons|1|||
160828449|NCT03158272|580758309|FG003|Overall Study|Other reasons|0|||
160828450|NCT03158272|580758306|FG000|Overall Study|Adverse event unrelated to the drug|0|||
160828451|NCT03158272|580758307|FG001|Overall Study|Adverse event unrelated to the drug|1|||
160828452|NCT03158272|580758308|FG002|Overall Study|Adverse event unrelated to the drug|0|||
160828453|NCT03158272|580758309|FG003|Overall Study|Adverse event unrelated to the drug|0|||
160828454|NCT01688921|580758310|FG000|Overall Study|Lost to Follow-up|7|||
160828455|NCT01688921|580758311|FG001|Overall Study|Lost to Follow-up|13|||
160990634|NCT00886613|581353911|FG000|Overall Study|Protocol deviation (Part B)|1|||
161243786|NCT04194801|582271635|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
161243787|NCT04194801|582271633|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
161243788|NCT04194801|582271634|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
161243789|NCT04194801|582271635|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
161243790|NCT04194801|582271633|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
161243791|NCT04194801|582271634|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
161243792|NCT04194801|582271635|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
161243793|NCT04194801|582271633|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
161243794|NCT04194801|582271634|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
161243795|NCT04194801|582271635|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
160828456|NCT01688921|580758310|FG000|Overall Study|Physician Decision|6|||
160828457|NCT01688921|580758311|FG001|Overall Study|Physician Decision|1|||
160828458|NCT01688921|580758310|FG000|Overall Study|Protocol Violation|0|||
160828459|NCT01688921|580758311|FG001|Overall Study|Protocol Violation|1|||
160828460|NCT01688921|580758310|FG000|Overall Study|informed consent|3|||
160828461|NCT01688921|580758311|FG001|Overall Study|informed consent|0|||
160828462|NCT00664326|580759803|FG000|Overall Study|Adverse Event|14|||
160828463|NCT00664326|580759803|FG000|Overall Study|Noncompliance with study medication|3|||
160828464|NCT00664326|580759803|FG000|Overall Study|Withdrawal by Subject|1|||
160828465|NCT00664326|580759803|FG000|Overall Study|Physician Decision|1|||
160828466|NCT00664326|580759803|FG000|Overall Study|Other Reasons|3|||
160828467|NCT00664326|580759803|FG000|Overall Study|Death|2|||
160828468|NCT00664326|580759803|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
160828469|NCT00262847|580759804|FG000|Overall Study|Disease Progression|309|||
160828470|NCT00262847|580759805|FG001|Overall Study|Disease Progression|274|||
160828471|NCT00262847|580759806|FG002|Overall Study|Disease Progression|195|||
160828472|NCT00262847|580759804|FG000|Overall Study|Patient Refusal|41|||
160828473|NCT00262847|580759805|FG001|Overall Study|Patient Refusal|52|||
160828474|NCT00262847|580759806|FG002|Overall Study|Patient Refusal|47|||
160828475|NCT00262847|580759804|FG000|Overall Study|Adverse Event|74|||
160828476|NCT00262847|580759805|FG001|Overall Study|Adverse Event|88|||
160828477|NCT00262847|580759806|FG002|Overall Study|Adverse Event|108|||
160828478|NCT00262847|580759804|FG000|Overall Study|Death|8|||
160828479|NCT00262847|580759805|FG001|Overall Study|Death|8|||
160828480|NCT00262847|580759806|FG002|Overall Study|Death|11|||
160828481|NCT00262847|580759804|FG000|Overall Study|Concomitant disease|3|||
160828482|NCT00262847|580759805|FG001|Overall Study|Concomitant disease|2|||
160828483|NCT00262847|580759806|FG002|Overall Study|Concomitant disease|4|||
160828484|NCT00262847|580759804|FG000|Overall Study|Other Reasons|79|||
160990635|NCT00886613|581353912|FG001|Overall Study|Protocol deviation (Part B)|0|||
160990636|NCT00886613|581353913|FG002|Overall Study|Protocol deviation (Part B)|0|||
160990637|NCT00886613|581353911|FG000|Overall Study|Lost to follow-up (Part B)|1|||
160990638|NCT00886613|581353912|FG001|Overall Study|Lost to follow-up (Part B)|0|||
160990639|NCT00886613|581353913|FG002|Overall Study|Lost to follow-up (Part B)|1|||
160990640|NCT00886613|581353911|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
160990641|NCT00886613|581353912|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
160990642|NCT00886613|581353913|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
160990643|NCT00463151|581353914|FG000|Overall Study|Adverse Event|0|||
160990644|NCT00463151|581353915|FG001|Overall Study|Adverse Event|0|||
160990645|NCT00463151|581353916|FG002|Overall Study|Adverse Event|1|||
160990646|NCT00463151|581353917|FG003|Overall Study|Adverse Event|0|||
160990647|NCT00463151|581353914|FG000|Overall Study|Lack of Efficacy|2|||
160990648|NCT00463151|581353915|FG001|Overall Study|Lack of Efficacy|5|||
160990649|NCT00463151|581353916|FG002|Overall Study|Lack of Efficacy|2|||
160990650|NCT00463151|581353917|FG003|Overall Study|Lack of Efficacy|5|||
160990651|NCT00463151|581353914|FG000|Overall Study|Protocol Violation|0|||
160990652|NCT00463151|581353915|FG001|Overall Study|Protocol Violation|0|||
160990653|NCT00463151|581353916|FG002|Overall Study|Protocol Violation|0|||
160990654|NCT00463151|581353917|FG003|Overall Study|Protocol Violation|1|||
160990655|NCT00463151|581353914|FG000|Overall Study|Withdrawal by Subject|0|||
160990656|NCT00463151|581353915|FG001|Overall Study|Withdrawal by Subject|0|||
160990657|NCT00463151|581353916|FG002|Overall Study|Withdrawal by Subject|0|||
161243796|NCT02213263|582271643|FG000|Overall Study|Insufficient clinical response|4|||
161243797|NCT02213263|582271644|FG001|Overall Study|Insufficient clinical response|3|||
161243798|NCT02213263|582271643|FG000|Overall Study|Lost to Follow-up|0|||
161243799|NCT02213263|582271644|FG001|Overall Study|Lost to Follow-up|1|||
161243800|NCT02213263|582271643|FG000|Overall Study|No longer willing to participate|3|||
161243801|NCT02213263|582271644|FG001|Overall Study|No longer willing to participate|4|||
161243802|NCT02213263|582271643|FG000|Overall Study|Progressive disease|20|||
161243803|NCT02213263|582271644|FG001|Overall Study|Progressive disease|14|||
161243804|NCT02213263|582271643|FG000|Overall Study|Protocol Violation|0|||
161243805|NCT02213263|582271644|FG001|Overall Study|Protocol Violation|1|||
161243806|NCT02213263|582271643|FG000|Overall Study|Adverse Event|1|||
161243807|NCT02213263|582271644|FG001|Overall Study|Adverse Event|3|||
161243808|NCT05752721|582271645|FG000|Overall Study|Lost to Follow-up|22|||
161243809|NCT05752721|582271646|FG001|Overall Study|Lost to Follow-up|20|||
161243810|NCT05752721|582271645|FG000|Overall Study|Withdrawal by Subject|15|||
161243811|NCT05752721|582271646|FG001|Overall Study|Withdrawal by Subject|12|||
161243812|NCT00263588|582271647|FG000|Overall Study|Death|54|||
161243813|NCT00263588|582271648|FG001|Overall Study|Death|90|||
161243814|NCT00263588|582271647|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
161243815|NCT00263588|582271648|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
161243816|NCT00263588|582271647|FG000|Overall Study|Lost to Follow-up|7|||
161243817|NCT00263588|582271648|FG001|Overall Study|Lost to Follow-up|10|||
161243818|NCT00263588|582271647|FG000|Overall Study|Withdrawal by Subject|3|||
161243819|NCT00263588|582271648|FG001|Overall Study|Withdrawal by Subject|4|||
161243820|NCT00263588|582271647|FG000|Overall Study|Protocol Violation|0|||
161243821|NCT00263588|582271648|FG001|Overall Study|Protocol Violation|1|||
161243822|NCT00263588|582271647|FG000|Overall Study|Investigator decision|7|||
161243823|NCT00263588|582271648|FG001|Overall Study|Investigator decision|15|||
161243824|NCT00263588|582271647|FG000|Overall Study|Sponsor terminated study|0|||
161243825|NCT00263588|582271648|FG001|Overall Study|Sponsor terminated study|1|||
161243826|NCT00463684|582271660|FG000|Overall Study|Withdrawal by Subject|1|||
161243827|NCT00463684|582271660|FG000|Overall Study|Lost to Follow-up|3|||
161243828|NCT01906372|582271661|FG000|Overall Study|Withdrawal by Subject|2|||
161243829|NCT03629054|582271662|FG000|Period 2 (4 Days)|Not treated|0|||
161243830|NCT03629054|582271663|FG001|Period 2 (4 Days)|Not treated|1|||
161243831|NCT02462837|582271664|FG000|Overall Study|pt developed hives|1|||
161243832|NCT02462837|582271665|FG001|Overall Study|pt developed hives|0|||
161243833|NCT02462837|582271664|FG000|Overall Study|Withdrawal by Subject|1|||
161243834|NCT02462837|582271665|FG001|Overall Study|Withdrawal by Subject|0|||
161243835|NCT00924638|582271669|FG000|Overall Study|Death|3|||
161243836|NCT00924638|582271670|FG001|Overall Study|Death|2|||
161243837|NCT00924638|582271669|FG000|Overall Study|Lost to Follow-up|1|||
161243838|NCT00924638|582271670|FG001|Overall Study|Lost to Follow-up|1|||
161243839|NCT00924638|582271669|FG000|Overall Study|Withdrawal by Subject|5|||
161243840|NCT00924638|582271670|FG001|Overall Study|Withdrawal by Subject|7|||
161243841|NCT00924638|582271669|FG000|Overall Study|Physician Decision|3|||
161243842|NCT00924638|582271670|FG001|Overall Study|Physician Decision|3|||
161243843|NCT01316055|582271671|FG000|Overall Study|Lost to Follow-up|1|||
161243844|NCT01316055|582271672|FG001|Overall Study|Lost to Follow-up|0|||
161243845|NCT01316055|582271673|FG002|Overall Study|Lost to Follow-up|0|||
161243846|NCT00989950|582271675|FG000|Randomized Phase|Protocol Violation|1|||
161243847|NCT00989950|582271676|FG001|Randomized Phase|Protocol Violation|0|||
161243848|NCT00989950|582271677|FG002|Randomized Phase|Protocol Violation|0|||
161243849|NCT00989950|582271678|FG003|Randomized Phase|Protocol Violation|0|||
161243850|NCT00989950|582271675|FG000|Randomized Phase|Adverse Event|0|||
161243851|NCT00989950|582271676|FG001|Randomized Phase|Adverse Event|1|||
161243852|NCT00989950|582271677|FG002|Randomized Phase|Adverse Event|0|||
161243853|NCT00989950|582271678|FG003|Randomized Phase|Adverse Event|0|||
161243854|NCT02845336|582271682|FG000|Overall Study|Lost to Follow-up|3|||
161243855|NCT02845336|582271683|FG001|Overall Study|Lost to Follow-up|1|||
161243856|NCT02845336|582271682|FG000|Overall Study|Inability to get medication|2|||
161243857|NCT02845336|582271683|FG001|Overall Study|Inability to get medication|0|||
161243858|NCT03488108|582271685|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161243859|NCT03488108|582271686|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161243860|NCT03488108|582271685|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
161243861|NCT03488108|582271686|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
161243862|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Refused|1|||
161243863|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Refused|3|||
161243864|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Medical|0|||
161243865|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Medical|1|||
161243866|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
161243867|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
161243868|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
161243869|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
161243870|NCT02054715|582271687|FG000|Baseline/Follow-up 1|No Reason|0|||
161243871|NCT02054715|582271688|FG001|Baseline/Follow-up 1|No Reason|1|||
161243872|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
161243873|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
161243874|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Ineligible|3|||
161243875|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Ineligible|0|||
161243876|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Hospitalization|1|||
161243877|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Hospitalization|0|||
161243878|NCT02054715|582271687|FG000|Baseline/Follow-up 1|Changed Mind|1|||
161243879|NCT02054715|582271688|FG001|Baseline/Follow-up 1|Changed Mind|0|||
161243880|NCT02054715|582271687|FG000|Follow-up 2|Lost to Followup|3|||
161243881|NCT02054715|582271688|FG001|Follow-up 2|Lost to Followup|1|||
161243882|NCT02054715|582271687|FG000|Follow-up 2|Refused|3|||
161243883|NCT02054715|582271688|FG001|Follow-up 2|Refused|2|||
161243884|NCT02054715|582271687|FG000|Follow-up 2|Followup Not Completed|3|||
161243885|NCT02054715|582271688|FG001|Follow-up 2|Followup Not Completed|4|||
161243886|NCT02054715|582271687|FG000|Follow-up 2|Ineligible|4|||
161243887|NCT02054715|582271688|FG001|Follow-up 2|Ineligible|5|||
161243888|NCT02054715|582271687|FG000|Follow-up 2|Death|3|||
161243889|NCT02054715|582271688|FG001|Follow-up 2|Death|3|||
161243890|NCT02054715|582271687|FG000|Follow-up 2|Hospitalization|0|||
161243891|NCT02054715|582271688|FG001|Follow-up 2|Hospitalization|2|||
161243892|NCT02054715|582271687|FG000|Follow-up 2|Changed MD/Facility|0|||
161243893|NCT02054715|582271688|FG001|Follow-up 2|Changed MD/Facility|1|||
161243894|NCT02054715|582271687|FG000|Follow-up 2|Changed Mind|0|||
160828485|NCT00262847|580759805|FG001|Overall Study|Other Reasons|88|||
160990658|NCT00463151|581353917|FG003|Overall Study|Withdrawal by Subject|1|||
161243895|NCT02054715|582271688|FG001|Follow-up 2|Changed Mind|1|||
161243896|NCT02054715|582271687|FG000|Follow-up 2|No Reason|2|||
161243897|NCT02054715|582271688|FG001|Follow-up 2|No Reason|0|||
161243898|NCT02054715|582271687|FG000|Follow-up 2|Treatment Change or Delay|1|||
161243899|NCT02054715|582271688|FG001|Follow-up 2|Treatment Change or Delay|0|||
161243900|NCT00674128|582271691|FG000|Overall Study|Withdrawal by Subject|25|||
161243901|NCT00674128|582271692|FG001|Overall Study|Withdrawal by Subject|23|||
161243902|NCT01825798|582271693|FG000|Overall Study|Adverse Event|1|||
161243903|NCT01825798|582271694|FG001|Overall Study|Adverse Event|5|||
161243904|NCT01825798|582271693|FG000|Overall Study|Lost to Follow-up|1|||
161243905|NCT01825798|582271694|FG001|Overall Study|Lost to Follow-up|0|||
161243906|NCT02471807|582271704|FG000|Overall Study|Death|14|||
161243907|NCT02471807|582271704|FG000|Overall Study|Withdrawal by Subject|2|||
161243908|NCT02471807|582271704|FG000|Overall Study|Explant|5|||
160828486|NCT00262847|580759806|FG002|Overall Study|Other Reasons|27|||
160990659|NCT05349084|581353918|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
161243909|NCT02471807|582271704|FG000|Overall Study|Lost to Follow-up|1|||
161243910|NCT01559363|582271705|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
161243911|NCT01559363|582271706|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
161243912|NCT01559363|582271707|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
161243913|NCT01559363|582271708|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161243914|NCT01559363|582271709|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161243915|NCT01559363|582271710|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
161243916|NCT01559363|582271705|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
160990660|NCT00972543|581353919|FG000|Overall Study|Adverse Event|1|||
161243917|NCT01559363|582271706|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
161243918|NCT01559363|582271707|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
161243919|NCT01559363|582271708|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
161243920|NCT01559363|582271709|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
161243921|NCT01559363|582271710|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
161243922|NCT01559363|582271705|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
160828487|NCT00262847|580759804|FG000|Overall Study|Did not receive study treatment|4|||
160828488|NCT00262847|580759805|FG001|Overall Study|Did not receive study treatment|1|||
161134760|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
161134761|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
161134762|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
161134763|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
160828489|NCT00262847|580759806|FG002|Overall Study|Did not receive study treatment|4|||
160828490|NCT00387647|580759807|FG000|Overall Study|Death|18|||
160828491|NCT05160766|580759808|FG000|Overall Study|Adverse Event|0|||
160828492|NCT05160766|580759809|FG001|Overall Study|Adverse Event|1|||
160828493|NCT05160766|580759810|FG002|Overall Study|Adverse Event|0|||
160828494|NCT05160766|580759811|FG003|Overall Study|Adverse Event|0|||
160828495|NCT05160766|580759808|FG000|Overall Study|COVID-19 infection|0|||
160828496|NCT05160766|580759809|FG001|Overall Study|COVID-19 infection|1|||
160828497|NCT05160766|580759810|FG002|Overall Study|COVID-19 infection|0|||
160828498|NCT05160766|580759811|FG003|Overall Study|COVID-19 infection|0|||
160828499|NCT05160766|580759808|FG000|Overall Study|travel time|1|||
160828500|NCT05160766|580759809|FG001|Overall Study|travel time|0|||
160828501|NCT05160766|580759810|FG002|Overall Study|travel time|0|||
160828502|NCT05160766|580759811|FG003|Overall Study|travel time|1|||
160828503|NCT05160766|580759808|FG000|Overall Study|Withdrawal by Subject|3|||
160828504|NCT05160766|580759809|FG001|Overall Study|Withdrawal by Subject|5|||
160828505|NCT05160766|580759810|FG002|Overall Study|Withdrawal by Subject|4|||
160828506|NCT05160766|580759811|FG003|Overall Study|Withdrawal by Subject|2|||
160828507|NCT05160766|580759808|FG000|Overall Study|Death|0|||
161243923|NCT01559363|582271706|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
161243924|NCT01559363|582271707|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
160828508|NCT05160766|580759809|FG001|Overall Study|Death|0|||
160828509|NCT05160766|580759810|FG002|Overall Study|Death|2|||
160828510|NCT05160766|580759811|FG003|Overall Study|Death|5|||
160828511|NCT05160766|580759808|FG000|Overall Study|Lost to Follow-up|0|||
160828512|NCT05160766|580759809|FG001|Overall Study|Lost to Follow-up|0|||
160828513|NCT05160766|580759810|FG002|Overall Study|Lost to Follow-up|1|||
160828514|NCT05160766|580759811|FG003|Overall Study|Lost to Follow-up|2|||
160828515|NCT05160766|580759808|FG000|Overall Study|No show|0|||
160828516|NCT05160766|580759809|FG001|Overall Study|No show|0|||
160828517|NCT05160766|580759810|FG002|Overall Study|No show|1|||
160828518|NCT05160766|580759811|FG003|Overall Study|No show|1|||
160828519|NCT05160766|580759808|FG000|Overall Study|Physician Decision|0|||
160828520|NCT05160766|580759809|FG001|Overall Study|Physician Decision|0|||
160828521|NCT05160766|580759810|FG002|Overall Study|Physician Decision|0|||
160828522|NCT05160766|580759811|FG003|Overall Study|Physician Decision|1|||
160828523|NCT05160766|580759808|FG000|Overall Study|Protocol Violation|0|||
160828524|NCT05160766|580759809|FG001|Overall Study|Protocol Violation|0|||
160828525|NCT05160766|580759810|FG002|Overall Study|Protocol Violation|1|||
160828526|NCT05160766|580759811|FG003|Overall Study|Protocol Violation|0|||
160828527|NCT02943915|580759812|FG000|Overall Study|Withdrawal by Subject|2|||
161134764|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
161134765|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
161134766|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
161134767|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
161134768|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
161134769|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
161134770|NCT01307423|581876676|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134771|NCT01307423|581876677|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134772|NCT01307423|581876678|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134773|NCT01307423|581876679|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134774|NCT01307423|581876680|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134775|NCT01307423|581876681|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
161134776|NCT01307423|581876682|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134777|NCT01307423|581876683|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134778|NCT01307423|581876684|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
161134779|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161134780|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
161243925|NCT01559363|582271708|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
160828528|NCT02943915|580759813|FG001|Overall Study|Withdrawal by Subject|1|||
160828529|NCT02943915|580759814|FG002|Overall Study|Withdrawal by Subject|0|||
160828530|NCT02943915|580759815|FG003|Overall Study|Withdrawal by Subject|0|||
161134781|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
161134782|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160828531|NCT02943915|580759812|FG000|Overall Study|Lost to Follow-up|3|||
160828532|NCT02943915|580759813|FG001|Overall Study|Lost to Follow-up|1|||
160828533|NCT02943915|580759814|FG002|Overall Study|Lost to Follow-up|0|||
160828534|NCT02943915|580759815|FG003|Overall Study|Lost to Follow-up|0|||
160828535|NCT02943915|580759812|FG000|Overall Study|excluded|0|||
160828536|NCT02943915|580759813|FG001|Overall Study|excluded|1|||
161134783|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161243926|NCT01559363|582271709|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161243927|NCT01559363|582271710|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
161243928|NCT01559363|582271705|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
161243929|NCT01559363|582271706|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161243930|NCT01559363|582271707|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
161243931|NCT01559363|582271708|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161243932|NCT01559363|582271709|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161243933|NCT01559363|582271710|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
161243934|NCT01559363|582271705|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161243935|NCT01559363|582271706|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
161243936|NCT01559363|582271707|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161243937|NCT01559363|582271708|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161243938|NCT01559363|582271709|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161243939|NCT01559363|582271710|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
161243940|NCT01559363|582271705|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161243941|NCT01559363|582271706|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161243942|NCT01559363|582271707|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161243943|NCT01559363|582271708|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
161243944|NCT01559363|582271709|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
161243945|NCT01559363|582271710|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
161243946|NCT01559363|582271705|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
160828537|NCT02943915|580759814|FG002|Overall Study|excluded|0|||
160828538|NCT02943915|580759815|FG003|Overall Study|excluded|0|||
160828539|NCT03769311|580759816|FG000|Overall Study|Withdrawal by Subject|1|||
160828540|NCT03627065|580759817|FG000|Overall Study|Study Terminated by sponsor|1|||
160828541|NCT03627065|580759817|FG000|Overall Study|Withdrawal by Subject|2|||
160828542|NCT00076336|580759818|FG000|Overall Study|Death|13|||
160828543|NCT00076336|580759819|FG001|Overall Study|Death|17|||
160828544|NCT00076336|580759818|FG000|Overall Study|Adverse Event|4|||
160828545|NCT00076336|580759819|FG001|Overall Study|Adverse Event|4|||
160828546|NCT00076336|580759818|FG000|Overall Study|Lost to Follow-up|4|||
160828547|NCT00076336|580759819|FG001|Overall Study|Lost to Follow-up|4|||
160828548|NCT00076336|580759818|FG000|Overall Study|Non-Compliance|2|||
160828549|NCT00076336|580759819|FG001|Overall Study|Non-Compliance|0|||
160828550|NCT00076336|580759818|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
160828551|NCT00076336|580759819|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
160828552|NCT00076336|580759818|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
160828553|NCT00076336|580759819|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
160828554|NCT00076336|580759818|FG000|Overall Study|Liver Transplantation|3|||
161243947|NCT01559363|582271706|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161243948|NCT01559363|582271707|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161243949|NCT01559363|582271708|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
161243950|NCT01559363|582271709|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161243951|NCT01559363|582271710|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
161243952|NCT00834873|582271712|FG000|First Intervention|Adverse Event|0|||
161243953|NCT00834873|582271713|FG001|First Intervention|Adverse Event|1|||
161243954|NCT02055547|582271717|FG000|Overall Study|Protocol Violation|0|||
161243955|NCT02055547|582271718|FG001|Overall Study|Protocol Violation|0|||
161243956|NCT02055547|582271719|FG002|Overall Study|Protocol Violation|1|||
161243957|NCT02055547|582271720|FG003|Overall Study|Protocol Violation|0|||
161243958|NCT02055547|582271721|FG004|Overall Study|Protocol Violation|0|||
161243959|NCT02055547|582271722|FG005|Overall Study|Protocol Violation|0|||
161243960|NCT02055547|582271723|FG006|Overall Study|Protocol Violation|1|||
161243961|NCT02055547|582271724|FG007|Overall Study|Protocol Violation|0|||
161243962|NCT02055547|582271725|FG008|Overall Study|Protocol Violation|0|||
161243963|NCT02055547|582271726|FG009|Overall Study|Protocol Violation|0|||
161243964|NCT02055547|582271727|FG010|Overall Study|Protocol Violation|0|||
161243965|NCT02055547|582271728|FG011|Overall Study|Protocol Violation|0|||
161334689|NCT02337491|582615789|FG001|Overall Study|On Treatment|0|||
161243966|NCT02055547|582271729|FG012|Overall Study|Protocol Violation|0|||
161243967|NCT02055547|582271730|FG013|Overall Study|Protocol Violation|0|||
161334690|NCT00723229|582615790|FG000|First Intervention|Lost to Follow-up|7|||
160828555|NCT00076336|580759819|FG001|Overall Study|Liver Transplantation|3|||
161243968|NCT02055547|582271731|FG014|Overall Study|Protocol Violation|0|||
161243969|NCT02055547|582271732|FG015|Overall Study|Protocol Violation|0|||
161243970|NCT02055547|582271733|FG016|Overall Study|Protocol Violation|0|||
161243971|NCT02055547|582271734|FG017|Overall Study|Protocol Violation|0|||
161243972|NCT02055547|582271735|FG018|Overall Study|Protocol Violation|0|||
161243973|NCT02055547|582271717|FG000|Overall Study|Physician Decision|0|||
161334691|NCT00723229|582615791|FG001|First Intervention|Lost to Follow-up|3|||
160828556|NCT00076336|580759818|FG000|Overall Study|Virologic Breakthrough|14|||
160828557|NCT00076336|580759819|FG001|Overall Study|Virologic Breakthrough|16|||
160828558|NCT00076336|580759818|FG000|Overall Study|Treatment failure|4|||
161334692|NCT01432951|582615792|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
160828559|NCT00076336|580759819|FG001|Overall Study|Treatment failure|5|||
160828560|NCT00524589|580759820|FG000|Overall Study|Withdrawal by Subject|2|||
160828561|NCT00524589|580759820|FG000|Overall Study|Disease Progression|16|||
160828562|NCT01519674|580759826|FG000|Overall Study|Adverse Event|3|||
160828563|NCT01519674|580759827|FG001|Overall Study|Adverse Event|3|||
160828564|NCT01519674|580759828|FG002|Overall Study|Adverse Event|0|||
160828565|NCT01519674|580759826|FG000|Overall Study|Lack of Efficacy|1|||
160828566|NCT01519674|580759827|FG001|Overall Study|Lack of Efficacy|1|||
160828567|NCT01519674|580759828|FG002|Overall Study|Lack of Efficacy|1|||
160828568|NCT01519674|580759826|FG000|Overall Study|Protocol Violation|0|||
160828569|NCT01519674|580759827|FG001|Overall Study|Protocol Violation|3|||
160828570|NCT01519674|580759828|FG002|Overall Study|Protocol Violation|1|||
160828571|NCT01519674|580759826|FG000|Overall Study|Withdrawal Criteria|7|||
160828572|NCT01519674|580759827|FG001|Overall Study|Withdrawal Criteria|2|||
160828573|NCT01519674|580759828|FG002|Overall Study|Withdrawal Criteria|7|||
160828574|NCT01519674|580759826|FG000|Overall Study|Unsclassified|10|||
160828575|NCT01519674|580759827|FG001|Overall Study|Unsclassified|4|||
160828576|NCT01519674|580759828|FG002|Overall Study|Unsclassified|3|||
161134784|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161134785|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
161134786|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
161134787|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
161134788|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161134789|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
161134790|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
161134791|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161134792|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161134793|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161134794|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161134795|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
161134796|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
161134797|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134798|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134799|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
161134800|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134801|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134802|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134803|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134804|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134805|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
161134806|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161134807|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
161134808|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
161134809|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161134810|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161134811|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161134812|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161134813|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
161134814|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
161134815|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161134816|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161134817|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161134818|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161134819|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161134820|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161134821|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
161134822|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161134823|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
161134824|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161134825|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
161134826|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161134827|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161134828|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161134829|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
161134830|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160828577|NCT01510184|580759833|FG000|Overall Study|Sponsor discretion|28|||
160828578|NCT01510184|580759834|FG001|Overall Study|Sponsor discretion|28|||
160828579|NCT01510184|580759833|FG000|Overall Study|Death|1|||
160828580|NCT01510184|580759834|FG001|Overall Study|Death|2|||
160828581|NCT01510184|580759833|FG000|Overall Study|Withdrawal by Subject|1|||
161243974|NCT02055547|582271718|FG001|Overall Study|Physician Decision|1|||
161243975|NCT02055547|582271719|FG002|Overall Study|Physician Decision|1|||
161243976|NCT02055547|582271720|FG003|Overall Study|Physician Decision|0|||
161243977|NCT02055547|582271721|FG004|Overall Study|Physician Decision|1|||
161243978|NCT02055547|582271722|FG005|Overall Study|Physician Decision|0|||
161243979|NCT02055547|582271723|FG006|Overall Study|Physician Decision|0|||
161243980|NCT02055547|582271724|FG007|Overall Study|Physician Decision|0|||
161243981|NCT02055547|582271725|FG008|Overall Study|Physician Decision|0|||
161243982|NCT02055547|582271726|FG009|Overall Study|Physician Decision|1|||
161243983|NCT02055547|582271727|FG010|Overall Study|Physician Decision|1|||
161243984|NCT02055547|582271728|FG011|Overall Study|Physician Decision|0|||
161243985|NCT02055547|582271729|FG012|Overall Study|Physician Decision|0|||
161243986|NCT02055547|582271730|FG013|Overall Study|Physician Decision|0|||
161243987|NCT02055547|582271731|FG014|Overall Study|Physician Decision|0|||
161243988|NCT02055547|582271732|FG015|Overall Study|Physician Decision|0|||
161243989|NCT02055547|582271733|FG016|Overall Study|Physician Decision|0|||
161243990|NCT02055547|582271734|FG017|Overall Study|Physician Decision|0|||
161243991|NCT02055547|582271735|FG018|Overall Study|Physician Decision|0|||
161243992|NCT02055547|582271717|FG000|Overall Study|Adverse Event|0|||
161243993|NCT02055547|582271718|FG001|Overall Study|Adverse Event|0|||
161243994|NCT02055547|582271719|FG002|Overall Study|Adverse Event|0|||
161243995|NCT02055547|582271720|FG003|Overall Study|Adverse Event|0|||
161243996|NCT02055547|582271721|FG004|Overall Study|Adverse Event|0|||
161243997|NCT02055547|582271722|FG005|Overall Study|Adverse Event|0|||
161243998|NCT02055547|582271723|FG006|Overall Study|Adverse Event|1|||
161243999|NCT02055547|582271724|FG007|Overall Study|Adverse Event|0|||
161244000|NCT02055547|582271725|FG008|Overall Study|Adverse Event|1|||
161244001|NCT02055547|582271726|FG009|Overall Study|Adverse Event|0|||
161244002|NCT02055547|582271727|FG010|Overall Study|Adverse Event|0|||
161244003|NCT02055547|582271728|FG011|Overall Study|Adverse Event|0|||
161244004|NCT02055547|582271729|FG012|Overall Study|Adverse Event|0|||
161244005|NCT02055547|582271730|FG013|Overall Study|Adverse Event|0|||
161244006|NCT02055547|582271731|FG014|Overall Study|Adverse Event|0|||
161244007|NCT02055547|582271732|FG015|Overall Study|Adverse Event|0|||
161244008|NCT02055547|582271733|FG016|Overall Study|Adverse Event|0|||
161244009|NCT02055547|582271734|FG017|Overall Study|Adverse Event|0|||
161244010|NCT02055547|582271735|FG018|Overall Study|Adverse Event|0|||
161244011|NCT02055547|582271717|FG000|Overall Study|Withdrawal by Subject|0|||
161244012|NCT02055547|582271718|FG001|Overall Study|Withdrawal by Subject|0|||
161244013|NCT02055547|582271719|FG002|Overall Study|Withdrawal by Subject|0|||
161244014|NCT02055547|582271720|FG003|Overall Study|Withdrawal by Subject|0|||
161244015|NCT02055547|582271721|FG004|Overall Study|Withdrawal by Subject|0|||
161244016|NCT02055547|582271722|FG005|Overall Study|Withdrawal by Subject|1|||
160902725|NCT02555683|581037801|FG002|Overall Study|Subject/guardian decision|22|||
160902726|NCT02555683|581037799|FG000|Overall Study|Death post Treatment/safety period|0|||
160902727|NCT02555683|581037800|FG001|Overall Study|Death post Treatment/safety period|1|||
161244017|NCT02055547|582271723|FG006|Overall Study|Withdrawal by Subject|0|||
161244018|NCT02055547|582271724|FG007|Overall Study|Withdrawal by Subject|0|||
161244019|NCT02055547|582271725|FG008|Overall Study|Withdrawal by Subject|1|||
161244020|NCT02055547|582271726|FG009|Overall Study|Withdrawal by Subject|0|||
161244021|NCT02055547|582271727|FG010|Overall Study|Withdrawal by Subject|0|||
161244022|NCT02055547|582271728|FG011|Overall Study|Withdrawal by Subject|0|||
161244023|NCT02055547|582271729|FG012|Overall Study|Withdrawal by Subject|0|||
161244024|NCT02055547|582271730|FG013|Overall Study|Withdrawal by Subject|1|||
161244025|NCT02055547|582271731|FG014|Overall Study|Withdrawal by Subject|0|||
161244026|NCT02055547|582271732|FG015|Overall Study|Withdrawal by Subject|1|||
161244027|NCT02055547|582271733|FG016|Overall Study|Withdrawal by Subject|0|||
161244028|NCT02055547|582271734|FG017|Overall Study|Withdrawal by Subject|0|||
161244029|NCT02055547|582271735|FG018|Overall Study|Withdrawal by Subject|0|||
161244030|NCT02055547|582271717|FG000|Overall Study|Lost to Follow-up|0|||
161244031|NCT02055547|582271718|FG001|Overall Study|Lost to Follow-up|0|||
161244032|NCT02055547|582271719|FG002|Overall Study|Lost to Follow-up|1|||
161244033|NCT02055547|582271720|FG003|Overall Study|Lost to Follow-up|0|||
161244034|NCT02055547|582271721|FG004|Overall Study|Lost to Follow-up|0|||
161244035|NCT02055547|582271722|FG005|Overall Study|Lost to Follow-up|0|||
161244036|NCT02055547|582271723|FG006|Overall Study|Lost to Follow-up|0|||
161244037|NCT02055547|582271724|FG007|Overall Study|Lost to Follow-up|0|||
160902728|NCT02555683|581037801|FG002|Overall Study|Death post Treatment/safety period|0|||
161244038|NCT02055547|582271725|FG008|Overall Study|Lost to Follow-up|0|||
161244039|NCT02055547|582271726|FG009|Overall Study|Lost to Follow-up|0|||
161244040|NCT02055547|582271727|FG010|Overall Study|Lost to Follow-up|0|||
161244041|NCT02055547|582271728|FG011|Overall Study|Lost to Follow-up|0|||
161244042|NCT02055547|582271729|FG012|Overall Study|Lost to Follow-up|0|||
161244043|NCT02055547|582271730|FG013|Overall Study|Lost to Follow-up|0|||
161244044|NCT02055547|582271731|FG014|Overall Study|Lost to Follow-up|0|||
161244045|NCT02055547|582271732|FG015|Overall Study|Lost to Follow-up|0|||
161244046|NCT02055547|582271733|FG016|Overall Study|Lost to Follow-up|0|||
161244047|NCT02055547|582271734|FG017|Overall Study|Lost to Follow-up|0|||
161244048|NCT02055547|582271735|FG018|Overall Study|Lost to Follow-up|0|||
161244049|NCT01653704|582271736|FG000|Overall Study|Technical failure during recording|1|||
161244050|NCT01653704|582271737|FG001|Overall Study|Technical failure during recording|1|||
161244051|NCT01653704|582271736|FG000|Overall Study|Performance not reflective of training|1|||
161334693|NCT02900352|582615793|FG000|Overall Study|Lost to Follow-up|28|||
161334694|NCT02900352|582615794|FG001|Overall Study|Lost to Follow-up|17|||
161334695|NCT00785356|582615796|FG000|Overall Study|Study prematurely terminated|8|||
161334696|NCT03712280|582615802|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
161334697|NCT03712280|582615803|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
161334698|NCT03712280|582615804|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
161334699|NCT03712280|582615805|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
161334700|NCT03712280|582615802|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
161334701|NCT03712280|582615803|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
161334702|NCT03712280|582615804|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
161334703|NCT03712280|582615805|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
161334704|NCT03712280|582615802|FG000|Overall Study|Adverse Event|0|||
161334705|NCT03712280|582615803|FG001|Overall Study|Adverse Event|0|||
161334706|NCT03712280|582615804|FG002|Overall Study|Adverse Event|1|||
161334707|NCT03712280|582615805|FG003|Overall Study|Adverse Event|0|||
161334708|NCT00106002|582615806|FG000|Overall Study|Did not take any study drug|1|||
161334709|NCT00106002|582615806|FG000|Overall Study|Ineligible after Registration|1|||
161334710|NCT01122173|582615811|FG000|Overall Study|Lost to Follow-up|3|||
161334711|NCT01122173|582615811|FG000|Overall Study|Withdrawal by Subject|3|||
161334712|NCT01122173|582615811|FG000|Overall Study|Left study for other reasons|3|||
161334713|NCT02265510|582615812|FG000|Overall Study|Withdrawal by Subject|1|||
161334714|NCT02265510|582615813|FG001|Overall Study|Withdrawal by Subject|1|||
161334715|NCT02265510|582615814|FG002|Overall Study|Withdrawal by Subject|2|||
161334716|NCT02265510|582615815|FG003|Overall Study|Withdrawal by Subject|1|||
161334717|NCT02265510|582615816|FG004|Overall Study|Withdrawal by Subject|0|||
161334718|NCT02265510|582615817|FG005|Overall Study|Withdrawal by Subject|2|||
161334719|NCT02265510|582615818|FG006|Overall Study|Withdrawal by Subject|0|||
161334720|NCT02265510|582615819|FG007|Overall Study|Withdrawal by Subject|2|||
161334721|NCT02265510|582615820|FG008|Overall Study|Withdrawal by Subject|0|||
161334722|NCT02265510|582615821|FG009|Overall Study|Withdrawal by Subject|0|||
161334723|NCT02265510|582615822|FG010|Overall Study|Withdrawal by Subject|0|||
161334724|NCT02265510|582615823|FG011|Overall Study|Withdrawal by Subject|0|||
161334725|NCT02265510|582615824|FG012|Overall Study|Withdrawal by Subject|1|||
161334726|NCT02265510|582615825|FG013|Overall Study|Withdrawal by Subject|0|||
161334727|NCT02265510|582615812|FG000|Overall Study|Disease Progression|0|||
161334728|NCT02265510|582615813|FG001|Overall Study|Disease Progression|1|||
161334729|NCT02265510|582615814|FG002|Overall Study|Disease Progression|2|||
161334730|NCT02265510|582615815|FG003|Overall Study|Disease Progression|1|||
161334731|NCT02265510|582615816|FG004|Overall Study|Disease Progression|1|||
161334732|NCT02265510|582615817|FG005|Overall Study|Disease Progression|0|||
161334733|NCT02265510|582615818|FG006|Overall Study|Disease Progression|0|||
161334734|NCT02265510|582615819|FG007|Overall Study|Disease Progression|0|||
161334735|NCT02265510|582615820|FG008|Overall Study|Disease Progression|0|||
161334736|NCT02265510|582615821|FG009|Overall Study|Disease Progression|0|||
161334737|NCT02265510|582615822|FG010|Overall Study|Disease Progression|0|||
161334738|NCT02265510|582615823|FG011|Overall Study|Disease Progression|0|||
161334739|NCT02265510|582615824|FG012|Overall Study|Disease Progression|0|||
161244052|NCT01653704|582271737|FG001|Overall Study|Performance not reflective of training|0|||
161244053|NCT01456221|582271738|FG000|Overall Study|Withdrawal by Subject|56|||
161244054|NCT01456221|582271739|FG001|Overall Study|Withdrawal by Subject|49|||
161244055|NCT01456221|582271738|FG000|Overall Study|Lost to Follow-up|1|||
161244056|NCT01456221|582271739|FG001|Overall Study|Lost to Follow-up|4|||
161244057|NCT01456221|582271738|FG000|Overall Study|Received medication|3|||
161244058|NCT01456221|582271739|FG001|Overall Study|Received medication|2|||
161244059|NCT01456221|582271738|FG000|Overall Study|Incomplete data|4|||
161244060|NCT01456221|582271739|FG001|Overall Study|Incomplete data|2|||
161244061|NCT03966911|582271740|FG000|Overall Study|Adverse Event|1|||
161244062|NCT03966911|582271741|FG001|Overall Study|Adverse Event|1|||
161334740|NCT02265510|582615825|FG013|Overall Study|Disease Progression|0|||
161334741|NCT02265510|582615812|FG000|Overall Study|Death|2|||
161334742|NCT02265510|582615813|FG001|Overall Study|Death|0|||
161334743|NCT02265510|582615814|FG002|Overall Study|Death|2|||
161334744|NCT02265510|582615815|FG003|Overall Study|Death|2|||
161334745|NCT02265510|582615816|FG004|Overall Study|Death|1|||
161334746|NCT02265510|582615817|FG005|Overall Study|Death|3|||
161244063|NCT03966911|582271740|FG000|Overall Study|Withdrawal by Subject|8|||
161244064|NCT03966911|582271741|FG001|Overall Study|Withdrawal by Subject|2|||
161334747|NCT02265510|582615818|FG006|Overall Study|Death|2|||
161334748|NCT02265510|582615819|FG007|Overall Study|Death|1|||
161334749|NCT02265510|582615820|FG008|Overall Study|Death|3|||
161334750|NCT02265510|582615821|FG009|Overall Study|Death|3|||
161334751|NCT02265510|582615822|FG010|Overall Study|Death|4|||
161334752|NCT02265510|582615823|FG011|Overall Study|Death|12|||
161334753|NCT02265510|582615824|FG012|Overall Study|Death|7|||
161244065|NCT03966911|582271740|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
161244066|NCT03966911|582271741|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
161244067|NCT00985751|582271742|FG000|Overall Study|Adverse Event|0|||
161244068|NCT00985751|582271743|FG001|Overall Study|Adverse Event|0|||
161244069|NCT00985751|582271744|FG002|Overall Study|Adverse Event|0|||
161244070|NCT00985751|582271745|FG003|Overall Study|Adverse Event|0|||
161244071|NCT00985751|582271746|FG004|Overall Study|Adverse Event|1|||
161244072|NCT01899053|582271747|FG000|Overall Study|Progressive Disease|4|||
161244073|NCT01899053|582271748|FG001|Overall Study|Progressive Disease|0|||
161244074|NCT01899053|582271749|FG002|Overall Study|Progressive Disease|3|||
161244075|NCT01899053|582271750|FG003|Overall Study|Progressive Disease|0|||
161244076|NCT01899053|582271751|FG004|Overall Study|Progressive Disease|3|||
161244077|NCT01899053|582271752|FG005|Overall Study|Progressive Disease|1|||
161244078|NCT01899053|582271753|FG006|Overall Study|Progressive Disease|1|||
161244079|NCT01899053|582271754|FG007|Overall Study|Progressive Disease|1|||
161244080|NCT01899053|582271755|FG008|Overall Study|Progressive Disease|4|||
161244081|NCT01899053|582271756|FG009|Overall Study|Progressive Disease|3|||
161244082|NCT01899053|582271757|FG010|Overall Study|Progressive Disease|12|||
161244083|NCT01899053|582271758|FG011|Overall Study|Progressive Disease|5|||
161244084|NCT01899053|582271759|FG012|Overall Study|Progressive Disease|8|||
161244085|NCT01899053|582271760|FG013|Overall Study|Progressive Disease|17|||
161244086|NCT01899053|582271747|FG000|Overall Study|Adverse Event|1|||
161244087|NCT01899053|582271748|FG001|Overall Study|Adverse Event|1|||
161244088|NCT01899053|582271749|FG002|Overall Study|Adverse Event|1|||
161244089|NCT01899053|582271750|FG003|Overall Study|Adverse Event|3|||
161244090|NCT01899053|582271751|FG004|Overall Study|Adverse Event|1|||
161244091|NCT01899053|582271752|FG005|Overall Study|Adverse Event|1|||
161244092|NCT01899053|582271753|FG006|Overall Study|Adverse Event|1|||
161244093|NCT01899053|582271754|FG007|Overall Study|Adverse Event|0|||
161244094|NCT01899053|582271755|FG008|Overall Study|Adverse Event|2|||
161244095|NCT01899053|582271756|FG009|Overall Study|Adverse Event|0|||
161244096|NCT01899053|582271757|FG010|Overall Study|Adverse Event|3|||
161244097|NCT01899053|582271758|FG011|Overall Study|Adverse Event|1|||
161244098|NCT01899053|582271759|FG012|Overall Study|Adverse Event|2|||
161244099|NCT01899053|582271760|FG013|Overall Study|Adverse Event|2|||
161244100|NCT01899053|582271747|FG000|Overall Study|Reason Not Specified|0|||
161244101|NCT01899053|582271748|FG001|Overall Study|Reason Not Specified|0|||
161244102|NCT01899053|582271749|FG002|Overall Study|Reason Not Specified|0|||
161244103|NCT01899053|582271750|FG003|Overall Study|Reason Not Specified|0|||
161244104|NCT01899053|582271751|FG004|Overall Study|Reason Not Specified|0|||
161244105|NCT01899053|582271752|FG005|Overall Study|Reason Not Specified|0|||
161244106|NCT01899053|582271753|FG006|Overall Study|Reason Not Specified|1|||
161244107|NCT01899053|582271754|FG007|Overall Study|Reason Not Specified|0|||
161244108|NCT01899053|582271755|FG008|Overall Study|Reason Not Specified|0|||
161244109|NCT01899053|582271756|FG009|Overall Study|Reason Not Specified|0|||
161244110|NCT01899053|582271757|FG010|Overall Study|Reason Not Specified|0|||
161244111|NCT01899053|582271758|FG011|Overall Study|Reason Not Specified|0|||
161244112|NCT01899053|582271759|FG012|Overall Study|Reason Not Specified|1|||
160902729|NCT01397890|581037811|FG000|Overall Study|Withdrawal by Subject|7|||
160902730|NCT01397890|581037812|FG001|Overall Study|Withdrawal by Subject|11|||
160902731|NCT01397890|581037811|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
160902732|NCT01397890|581037812|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
160902733|NCT01397890|581037811|FG000|Overall Study|Death|2|||
160902734|NCT01397890|581037812|FG001|Overall Study|Death|3|||
160902735|NCT01397890|581037811|FG000|Overall Study|Lost to Follow-up|1|||
160902736|NCT01397890|581037812|FG001|Overall Study|Lost to Follow-up|4|||
160902737|NCT01397890|581037811|FG000|Overall Study|Condition under Investigation Worsened|1|||
160902738|NCT01397890|581037812|FG001|Overall Study|Condition under Investigation Worsened|3|||
160902739|NCT01397890|581037811|FG000|Overall Study|Adverse Event|1|||
160902740|NCT01397890|581037812|FG001|Overall Study|Adverse Event|2|||
160902741|NCT01397890|581037811|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
160902742|NCT01397890|581037812|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
160902743|NCT01397890|581037811|FG000|Overall Study|Others|2|||
160902744|NCT01397890|581037812|FG001|Overall Study|Others|1|||
161244113|NCT01899053|582271760|FG013|Overall Study|Reason Not Specified|0|||
161244114|NCT01899053|582271747|FG000|Overall Study|Withdrawal by Subject|1|||
161244115|NCT01899053|582271748|FG001|Overall Study|Withdrawal by Subject|1|||
161244116|NCT01899053|582271749|FG002|Overall Study|Withdrawal by Subject|2|||
161244117|NCT01899053|582271750|FG003|Overall Study|Withdrawal by Subject|0|||
161244118|NCT01899053|582271751|FG004|Overall Study|Withdrawal by Subject|2|||
160902745|NCT03094169|581037813|FG000|Overall Study|Lack of Efficacy|0|||
161244119|NCT01899053|582271752|FG005|Overall Study|Withdrawal by Subject|0|||
161244120|NCT01899053|582271753|FG006|Overall Study|Withdrawal by Subject|0|||
161244121|NCT01899053|582271754|FG007|Overall Study|Withdrawal by Subject|1|||
161244122|NCT01899053|582271755|FG008|Overall Study|Withdrawal by Subject|0|||
160902746|NCT03094169|581037814|FG001|Overall Study|Lack of Efficacy|0|||
160902747|NCT03094169|581037815|FG002|Overall Study|Lack of Efficacy|0|||
160902748|NCT03094169|581037816|FG003|Overall Study|Lack of Efficacy|0|||
161244123|NCT01899053|582271756|FG009|Overall Study|Withdrawal by Subject|0|||
161244124|NCT01899053|582271757|FG010|Overall Study|Withdrawal by Subject|0|||
161244125|NCT01899053|582271758|FG011|Overall Study|Withdrawal by Subject|0|||
161244126|NCT01899053|582271759|FG012|Overall Study|Withdrawal by Subject|1|||
161244127|NCT01899053|582271760|FG013|Overall Study|Withdrawal by Subject|1|||
161244128|NCT01899053|582271747|FG000|Overall Study|Protocol Violation|0|||
161244129|NCT01899053|582271748|FG001|Overall Study|Protocol Violation|0|||
161244130|NCT01899053|582271749|FG002|Overall Study|Protocol Violation|1|||
161244131|NCT01899053|582271750|FG003|Overall Study|Protocol Violation|0|||
161244132|NCT01899053|582271751|FG004|Overall Study|Protocol Violation|0|||
161244133|NCT01899053|582271752|FG005|Overall Study|Protocol Violation|0|||
161244134|NCT01899053|582271753|FG006|Overall Study|Protocol Violation|0|||
161244135|NCT01899053|582271754|FG007|Overall Study|Protocol Violation|0|||
161244136|NCT01899053|582271755|FG008|Overall Study|Protocol Violation|0|||
161244137|NCT01899053|582271756|FG009|Overall Study|Protocol Violation|0|||
161244138|NCT01899053|582271757|FG010|Overall Study|Protocol Violation|0|||
161244139|NCT01899053|582271758|FG011|Overall Study|Protocol Violation|0|||
161244140|NCT01899053|582271759|FG012|Overall Study|Protocol Violation|0|||
161244141|NCT01899053|582271760|FG013|Overall Study|Protocol Violation|0|||
161244142|NCT01899053|582271747|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161244143|NCT01899053|582271748|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
161244144|NCT01899053|582271749|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244145|NCT01899053|582271750|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244146|NCT01899053|582271751|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244147|NCT01899053|582271752|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244148|NCT01899053|582271753|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244149|NCT01899053|582271754|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244150|NCT01899053|582271755|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244151|NCT01899053|582271756|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244152|NCT01899053|582271757|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
161244153|NCT01899053|582271758|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244154|NCT01899053|582271759|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244155|NCT01899053|582271760|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
161244156|NCT01899053|582271747|FG000|Overall Study|Symptomatic Deterioration|0|||
161244157|NCT01899053|582271748|FG001|Overall Study|Symptomatic Deterioration|0|||
161244158|NCT01899053|582271749|FG002|Overall Study|Symptomatic Deterioration|0|||
161244159|NCT01899053|582271750|FG003|Overall Study|Symptomatic Deterioration|0|||
161244160|NCT01899053|582271751|FG004|Overall Study|Symptomatic Deterioration|0|||
161244161|NCT01899053|582271752|FG005|Overall Study|Symptomatic Deterioration|1|||
161244162|NCT01899053|582271753|FG006|Overall Study|Symptomatic Deterioration|0|||
161244163|NCT01899053|582271754|FG007|Overall Study|Symptomatic Deterioration|1|||
161244164|NCT01899053|582271755|FG008|Overall Study|Symptomatic Deterioration|0|||
160902749|NCT03094169|581037817|FG004|Overall Study|Lack of Efficacy|0|||
160902750|NCT03094169|581037818|FG005|Overall Study|Lack of Efficacy|0|||
160902751|NCT03094169|581037819|FG006|Overall Study|Lack of Efficacy|0|||
160902752|NCT03094169|581037820|FG007|Overall Study|Lack of Efficacy|21|||
160902753|NCT03094169|581037813|FG000|Overall Study|Adverse Event|0|||
160902754|NCT03094169|581037814|FG001|Overall Study|Adverse Event|0|||
160902755|NCT03094169|581037815|FG002|Overall Study|Adverse Event|0|||
160902756|NCT03094169|581037816|FG003|Overall Study|Adverse Event|0|||
160902757|NCT03094169|581037817|FG004|Overall Study|Adverse Event|0|||
160902758|NCT03094169|581037818|FG005|Overall Study|Adverse Event|0|||
160902759|NCT03094169|581037819|FG006|Overall Study|Adverse Event|0|||
160902760|NCT03094169|581037820|FG007|Overall Study|Adverse Event|2|||
160902761|NCT03094169|581037813|FG000|Overall Study|Withdrawal by Subject|0|||
160902762|NCT03094169|581037814|FG001|Overall Study|Withdrawal by Subject|0|||
160902763|NCT03094169|581037815|FG002|Overall Study|Withdrawal by Subject|0|||
160902764|NCT03094169|581037816|FG003|Overall Study|Withdrawal by Subject|0|||
160902765|NCT03094169|581037817|FG004|Overall Study|Withdrawal by Subject|0|||
160902766|NCT03094169|581037818|FG005|Overall Study|Withdrawal by Subject|0|||
160902767|NCT03094169|581037819|FG006|Overall Study|Withdrawal by Subject|1|||
160902768|NCT03094169|581037820|FG007|Overall Study|Withdrawal by Subject|1|||
160902769|NCT03094169|581037813|FG000|Overall Study|Trial Termination|0|||
160902770|NCT03094169|581037814|FG001|Overall Study|Trial Termination|0|||
160902771|NCT03094169|581037815|FG002|Overall Study|Trial Termination|0|||
160902772|NCT03094169|581037816|FG003|Overall Study|Trial Termination|0|||
160902773|NCT03094169|581037817|FG004|Overall Study|Trial Termination|0|||
160902774|NCT03094169|581037818|FG005|Overall Study|Trial Termination|0|||
160902775|NCT03094169|581037819|FG006|Overall Study|Trial Termination|0|||
160902776|NCT03094169|581037820|FG007|Overall Study|Trial Termination|1|||
160902777|NCT04622306|581037821|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
160902778|NCT04622306|581037822|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
161334754|NCT02265510|582615825|FG013|Overall Study|Death|6|||
160902779|NCT04622306|581037823|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
160902780|NCT04622306|581037824|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
160902781|NCT04622306|581037825|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
160990661|NCT00972543|581353920|FG001|Overall Study|Adverse Event|0|||
160990662|NCT00972543|581353919|FG000|Overall Study|Early study termination by sponsor|4|||
160990663|NCT00972543|581353920|FG001|Overall Study|Early study termination by sponsor|1|||
160990664|NCT00293462|581353921|FG000|Overall Study|Withdrawal by Subject|4|||
160990665|NCT00293462|581353922|FG001|Overall Study|Withdrawal by Subject|3|||
160990666|NCT00293462|581353923|FG002|Overall Study|Withdrawal by Subject|8|||
160990667|NCT00293462|581353921|FG000|Overall Study|Death|1|||
160990668|NCT00293462|581353922|FG001|Overall Study|Death|0|||
160990669|NCT00293462|581353923|FG002|Overall Study|Death|0|||
160990670|NCT00293462|581353921|FG000|Overall Study|Lost to Follow-up|0|||
160990671|NCT00293462|581353922|FG001|Overall Study|Lost to Follow-up|1|||
161244165|NCT01899053|582271756|FG009|Overall Study|Symptomatic Deterioration|0|||
161244166|NCT01899053|582271757|FG010|Overall Study|Symptomatic Deterioration|0|||
161244167|NCT01899053|582271758|FG011|Overall Study|Symptomatic Deterioration|1|||
161244168|NCT01899053|582271759|FG012|Overall Study|Symptomatic Deterioration|2|||
161244169|NCT01899053|582271760|FG013|Overall Study|Symptomatic Deterioration|0|||
161244170|NCT02011945|582271761|FG000|Overall Study|Participant requested to Discontinue|0|||
161244171|NCT02011945|582271762|FG001|Overall Study|Participant requested to Discontinue|1|||
161244172|NCT02011945|582271763|FG002|Overall Study|Participant requested to Discontinue|1|||
161244173|NCT02011945|582271761|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
161244174|NCT02011945|582271762|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
161244175|NCT02011945|582271763|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
161244176|NCT02011945|582271761|FG000|Overall Study|Study Drug Toxicity|0|||
161244177|NCT02011945|582271762|FG001|Overall Study|Study Drug Toxicity|0|||
161244178|NCT02011945|582271763|FG002|Overall Study|Study Drug Toxicity|1|||
161244179|NCT02011945|582271761|FG000|Overall Study|Treatment Failure|0|||
161244180|NCT02011945|582271762|FG001|Overall Study|Treatment Failure|7|||
161244181|NCT02011945|582271763|FG002|Overall Study|Treatment Failure|6|||
161244182|NCT02011945|582271761|FG000|Overall Study|No Longer Meets Study Criteria|1|||
161244183|NCT02011945|582271762|FG001|Overall Study|No Longer Meets Study Criteria|0|||
161244184|NCT02011945|582271763|FG002|Overall Study|No Longer Meets Study Criteria|0|||
161244185|NCT02011945|582271761|FG000|Overall Study|Proceeded to stem cell transplant|0|||
161244186|NCT02011945|582271762|FG001|Overall Study|Proceeded to stem cell transplant|0|||
161244187|NCT02011945|582271763|FG002|Overall Study|Proceeded to stem cell transplant|1|||
161244188|NCT02011945|582271761|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
161244189|NCT02011945|582271762|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
161244190|NCT02011945|582271763|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
161244191|NCT01891357|582271764|FG000|Overall Study|Protocol Violation|3|||
161244192|NCT03733145|582271765|FG000|Overall Study|screenfail|3|||
161244193|NCT03733145|582271766|FG001|Overall Study|screenfail|3|||
161244194|NCT03733145|582271767|FG002|Overall Study|screenfail|2|||
161244195|NCT00829764|582271768|FG000|First Intervention|Adverse Event|1|||
161244196|NCT00829764|582271769|FG001|First Intervention|Adverse Event|0|||
161244197|NCT00829764|582271768|FG000|First Intervention|Withdrawal by Subject|1|||
161244198|NCT00829764|582271769|FG001|First Intervention|Withdrawal by Subject|1|||
161244199|NCT00258856|582273476|FG000|Overall Study|Lost to Follow-up|1|||
161244200|NCT00258856|582273477|FG001|Overall Study|Lost to Follow-up|0|||
161244201|NCT00258856|582273478|FG002|Overall Study|Lost to Follow-up|2|||
161244202|NCT00258856|582273479|FG003|Overall Study|Lost to Follow-up|0|||
161244203|NCT00258856|582273476|FG000|Overall Study|Non-compliance|2|||
161244204|NCT00258856|582273477|FG001|Overall Study|Non-compliance|0|||
161244205|NCT00258856|582273478|FG002|Overall Study|Non-compliance|0|||
161244206|NCT00258856|582273479|FG003|Overall Study|Non-compliance|1|||
161244207|NCT02488109|582273485|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
161244208|NCT02488109|582273486|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
161244209|NCT02488109|582273485|FG000|12-month Follow-Up|Lost to Follow-up|4|||
161244210|NCT02488109|582273486|FG001|12-month Follow-Up|Lost to Follow-up|7|||
161244211|NCT03969641|582273487|FG000|Overall Study|Lost to Follow-up|5|||
161244212|NCT03969641|582273488|FG001|Overall Study|Lost to Follow-up|3|||
161244213|NCT03969641|582273487|FG000|Overall Study|Withdrawal by Subject|1|||
161244214|NCT03969641|582273488|FG001|Overall Study|Withdrawal by Subject|2|||
161244215|NCT03969641|582273487|FG000|Overall Study|Found to be ineligible|1|||
161244216|NCT03969641|582273488|FG001|Overall Study|Found to be ineligible|1|||
161244217|NCT03969641|582273487|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
161244218|NCT03969641|582273488|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
161244219|NCT03969641|582273487|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
161244220|NCT03969641|582273488|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
161244221|NCT03969641|582273487|FG000|Overall Study|Elective termination|0|||
161244222|NCT03969641|582273488|FG001|Overall Study|Elective termination|1|||
161244223|NCT00557245|582273504|FG000|Overall Study|Lost to Follow-up|7|||
161244224|NCT00557245|582273505|FG001|Overall Study|Lost to Follow-up|8|||
160990672|NCT00293462|581353923|FG002|Overall Study|Lost to Follow-up|0|||
160990673|NCT00293462|581353921|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
161244225|NCT00557245|582273506|FG002|Overall Study|Lost to Follow-up|10|||
161244226|NCT00557245|582273504|FG000|Overall Study|Ineligible|5|||
161244227|NCT00557245|582273505|FG001|Overall Study|Ineligible|4|||
161244228|NCT00557245|582273506|FG002|Overall Study|Ineligible|2|||
161244229|NCT02658019|582273507|FG000|Overall Study|Adverse Event|1|||
161244230|NCT00660660|582273508|FG000|Overall Study|Adverse Event|1|||
161244231|NCT00660660|582273509|FG001|Overall Study|Adverse Event|0|||
161244232|NCT00660660|582273508|FG000|Overall Study|Lost to Follow-up|0|||
161244233|NCT00660660|582273509|FG001|Overall Study|Lost to Follow-up|6|||
161244234|NCT00660660|582273508|FG000|Overall Study|Lack of Efficacy|0|||
161244235|NCT00660660|582273509|FG001|Overall Study|Lack of Efficacy|2|||
161244236|NCT00660660|582273508|FG000|Overall Study|Withdrawal by Subject|3|||
161244237|NCT00660660|582273509|FG001|Overall Study|Withdrawal by Subject|0|||
161244238|NCT00660660|582273508|FG000|Overall Study|Incorrect enrollment and other|0|||
161244239|NCT00660660|582273509|FG001|Overall Study|Incorrect enrollment and other|1|||
161244240|NCT00660660|582273508|FG000|Overall Study|New medication after randomization|1|||
161244241|NCT00660660|582273509|FG001|Overall Study|New medication after randomization|0|||
161244242|NCT01630616|582273510|FG000|Overall Study|Adverse Event|0|||
161244243|NCT01630616|582273511|FG001|Overall Study|Adverse Event|0|||
161244244|NCT01630616|582273512|FG002|Overall Study|Adverse Event|0|||
161244245|NCT01630616|582273513|FG003|Overall Study|Adverse Event|1|||
161244246|NCT01630616|582273514|FG004|Overall Study|Adverse Event|0|||
161244247|NCT01630616|582273515|FG005|Overall Study|Adverse Event|0|||
161244248|NCT01630616|582273510|FG000|Overall Study|Withdrawal by Subject|0|||
161244249|NCT01630616|582273511|FG001|Overall Study|Withdrawal by Subject|0|||
161244250|NCT01630616|582273512|FG002|Overall Study|Withdrawal by Subject|0|||
161244251|NCT01630616|582273513|FG003|Overall Study|Withdrawal by Subject|2|||
161244252|NCT01630616|582273514|FG004|Overall Study|Withdrawal by Subject|0|||
161244253|NCT01630616|582273515|FG005|Overall Study|Withdrawal by Subject|0|||
161244254|NCT00640393|582273517|FG000|Part 1|Lost to Follow-up|2|||
161244255|NCT00640393|582273518|FG001|Part 1|Lost to Follow-up|0|||
161244256|NCT00640393|582273519|FG002|Part 1|Lost to Follow-up|0|||
161244257|NCT00640393|582273517|FG000|Part 1|Withdrawal by Subject|3|||
161244258|NCT00640393|582273518|FG001|Part 1|Withdrawal by Subject|0|||
161244259|NCT00640393|582273519|FG002|Part 1|Withdrawal by Subject|0|||
161244260|NCT00640393|582273517|FG000|Randomization|Withdrawn per protocol|17|||
161244261|NCT00640393|582273518|FG001|Randomization|Withdrawn per protocol|0|||
161244262|NCT00640393|582273519|FG002|Randomization|Withdrawn per protocol|0|||
161244263|NCT00640393|582273517|FG000|Randomization|Never randomized by site|2|||
161244264|NCT00640393|582273518|FG001|Randomization|Never randomized by site|0|||
161244265|NCT00640393|582273519|FG002|Randomization|Never randomized by site|0|||
161244266|NCT00640393|582273517|FG000|Part 2|Lost to Follow-up|0|||
161244267|NCT00640393|582273518|FG001|Part 2|Lost to Follow-up|2|||
161244268|NCT00640393|582273519|FG002|Part 2|Lost to Follow-up|2|||
161244269|NCT00640393|582273517|FG000|Part 2|Withdrawal by Subject|0|||
161244270|NCT00640393|582273518|FG001|Part 2|Withdrawal by Subject|6|||
161244271|NCT00640393|582273519|FG002|Part 2|Withdrawal by Subject|1|||
161244272|NCT00640393|582273517|FG000|Part 2|Non-adherence|0|||
161244273|NCT00640393|582273518|FG001|Part 2|Non-adherence|1|||
161244274|NCT00640393|582273519|FG002|Part 2|Non-adherence|0|||
161244275|NCT00640393|582273517|FG000|Part 2|Adverse Event|0|||
161244276|NCT00640393|582273518|FG001|Part 2|Adverse Event|1|||
161244277|NCT00640393|582273519|FG002|Part 2|Adverse Event|0|||
161244278|NCT00294047|582273521|FG000|Month 48|Adverse Event|28|||
161244279|NCT00294047|582273522|FG001|Month 48|Adverse Event|13|||
161244280|NCT00294047|582273521|FG000|Month 48|Protocol Violation|4|||
161244281|NCT00294047|582273522|FG001|Month 48|Protocol Violation|4|||
161244282|NCT00294047|582273521|FG000|Month 48|Withdrawal by Subject|111|||
161244283|NCT00294047|582273522|FG001|Month 48|Withdrawal by Subject|115|||
161244284|NCT00294047|582273521|FG000|Month 48|Lost to Follow-up|272|||
161244285|NCT00294047|582273522|FG001|Month 48|Lost to Follow-up|287|||
161244286|NCT00294047|582273521|FG000|Month 48|Other|10|||
161244287|NCT00294047|582273522|FG001|Month 48|Other|14|||
161244288|NCT00294047|582273521|FG000|Month 84|Adverse Event|4|||
161244289|NCT00294047|582273522|FG001|Month 84|Adverse Event|2|||
160828582|NCT01510184|580759834|FG001|Overall Study|Withdrawal by Subject|4|||
161244290|NCT00294047|582273521|FG000|Month 84|Protocol Violation|1|||
161244291|NCT00294047|582273522|FG001|Month 84|Protocol Violation|1|||
161244292|NCT00294047|582273521|FG000|Month 84|Withdrawal by Subject|33|||
161244293|NCT00294047|582273522|FG001|Month 84|Withdrawal by Subject|31|||
161244294|NCT00294047|582273521|FG000|Month 84|Lost to Follow-up|187|||
161244295|NCT00294047|582273522|FG001|Month 84|Lost to Follow-up|190|||
161244296|NCT00294047|582273521|FG000|Month 84|Absent Cervix|2|||
161244297|NCT00294047|582273522|FG001|Month 84|Absent Cervix|0|||
161244298|NCT00294047|582273521|FG000|Month 84|Work related reasons|4|||
161244299|NCT00294047|582273522|FG001|Month 84|Work related reasons|2|||
161244300|NCT00294047|582273521|FG000|Month 84|Center closed, subject did not transfer|1|||
161244301|NCT00294047|582273522|FG001|Month 84|Center closed, subject did not transfer|0|||
161244302|NCT00294047|582273521|FG000|Month 84|Family problems|2|||
161244303|NCT00294047|582273522|FG001|Month 84|Family problems|2|||
161244304|NCT00294047|582273521|FG000|Month 84|Lack of time|3|||
161244305|NCT00294047|582273522|FG001|Month 84|Lack of time|1|||
161244306|NCT00294047|582273521|FG000|Month 84|Personal reason|2|||
161244307|NCT00294047|582273522|FG001|Month 84|Personal reason|4|||
161244308|NCT00294047|582273521|FG000|Month 84|Subject does not want male physician|1|||
161244309|NCT00294047|582273522|FG001|Month 84|Subject does not want male physician|0|||
161244310|NCT00294047|582273521|FG000|Month 84|Transport reimbursement delayed|0|||
161244311|NCT00294047|582273522|FG001|Month 84|Transport reimbursement delayed|1|||
161244312|NCT00294047|582273521|FG000|Month 84|Unable to reach study site|1|||
161244313|NCT00294047|582273522|FG001|Month 84|Unable to reach study site|0|||
161244314|NCT00294047|582273521|FG000|Month 84|Under investigation locally|1|||
161244315|NCT00294047|582273522|FG001|Month 84|Under investigation locally|0|||
161244316|NCT00294047|582273521|FG000|Month 84|Visit missed|0|||
161244317|NCT00294047|582273522|FG001|Month 84|Visit missed|1|||
161244318|NCT00294047|582273521|FG000|Month 84|No consent for Month 84 Follow-up|731|||
161244319|NCT00294047|582273522|FG001|Month 84|No consent for Month 84 Follow-up|754|||
161244320|NCT00506831|582273523|FG000|Overall Study|Death|1|||
161244321|NCT00506831|582273523|FG000|Overall Study|Withdrawal by Subject|1|||
161244322|NCT01410227|582273527|FG000|Overall Study|Adverse Event|1|||
161244323|NCT01410227|582273528|FG001|Overall Study|Adverse Event|0|||
161244324|NCT01410227|582273529|FG002|Overall Study|Adverse Event|0|||
161244325|NCT01410227|582273530|FG003|Overall Study|Adverse Event|0|||
161244326|NCT01410227|582273527|FG000|Overall Study|Withdrawal by Subject|3|||
161244327|NCT01410227|582273528|FG001|Overall Study|Withdrawal by Subject|0|||
161244328|NCT01410227|582273529|FG002|Overall Study|Withdrawal by Subject|1|||
161244329|NCT01410227|582273530|FG003|Overall Study|Withdrawal by Subject|0|||
161244330|NCT01410227|582273527|FG000|Overall Study|Pregnancy|0|||
161244331|NCT01410227|582273528|FG001|Overall Study|Pregnancy|0|||
161244332|NCT01410227|582273529|FG002|Overall Study|Pregnancy|0|||
161244333|NCT01410227|582273530|FG003|Overall Study|Pregnancy|1|||
161244334|NCT01410227|582273527|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
161244335|NCT01410227|582273528|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
161244336|NCT01410227|582273529|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
161244337|NCT01410227|582273530|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
161244338|NCT00608322|582273533|FG000|Overall Study|Death|2|||
161244339|NCT00608322|582273534|FG001|Overall Study|Death|1|||
161244340|NCT04002648|582273535|FG000|Overall Study|Lost to Follow-up|2|||
161244341|NCT04002648|582273536|FG001|Overall Study|Lost to Follow-up|0|||
161244342|NCT00606281|582273540|FG000|Overall Study|Adverse Event|11|||
161244343|NCT00606281|582273541|FG001|Overall Study|Adverse Event|12|||
161244344|NCT00606281|582273540|FG000|Overall Study|Death|1|||
161244345|NCT00606281|582273541|FG001|Overall Study|Death|0|||
161244346|NCT00606281|582273540|FG000|Overall Study|Lack of Efficacy|28|||
161244347|NCT00606281|582273541|FG001|Overall Study|Lack of Efficacy|35|||
161244348|NCT00606281|582273540|FG000|Overall Study|Physician Decision|0|||
161244349|NCT00606281|582273541|FG001|Overall Study|Physician Decision|1|||
161244350|NCT00606281|582273540|FG000|Overall Study|Protocol Violation|3|||
161244351|NCT00606281|582273541|FG001|Overall Study|Protocol Violation|3|||
161244352|NCT00606281|582273540|FG000|Overall Study|Withdrawal by Subject|11|||
161244353|NCT00606281|582273541|FG001|Overall Study|Withdrawal by Subject|13|||
161244354|NCT00606281|582273540|FG000|Overall Study|Progression to depressive phase|1|||
161244355|NCT00606281|582273541|FG001|Overall Study|Progression to depressive phase|1|||
161244356|NCT00606281|582273540|FG000|Overall Study|Change of residence or other commitments|1|||
161244357|NCT00606281|582273541|FG001|Overall Study|Change of residence or other commitments|1|||
161244358|NCT03131895|582273543|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
161244359|NCT03131895|582273544|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
161244360|NCT03131895|582273545|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
161244361|NCT03131895|582273546|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
161244362|NCT03131895|582273543|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161244363|NCT03131895|582273544|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
161244364|NCT03131895|582273545|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
161244365|NCT03131895|582273546|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
161244366|NCT03131895|582273543|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161244367|NCT03131895|582273544|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
161244368|NCT03131895|582273545|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161244369|NCT03131895|582273546|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161244370|NCT03131895|582273543|FG000|Washout Period (at Least 5 Days)|Other|0|||
161244371|NCT03131895|582273544|FG001|Washout Period (at Least 5 Days)|Other|0|||
161244372|NCT03131895|582273545|FG002|Washout Period (at Least 5 Days)|Other|2|||
160902782|NCT04622306|581037826|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
160902783|NCT04622306|581037821|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
161244373|NCT03131895|582273546|FG003|Washout Period (at Least 5 Days)|Other|0|||
161244374|NCT03131895|582273543|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161244375|NCT03131895|582273544|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
161244376|NCT03131895|582273545|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161244377|NCT03131895|582273546|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
161244378|NCT03131895|582273543|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
161244379|NCT03131895|582273544|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161244380|NCT03131895|582273545|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161244381|NCT03131895|582273546|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
161244382|NCT00540423|582273547|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161244383|NCT00540423|582273548|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161244384|NCT00540423|582273549|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161244385|NCT00540423|582273547|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
161244386|NCT00540423|582273548|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161244387|NCT00540423|582273549|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
161244388|NCT00731939|582273555|FG000|Overall Study|Adverse Event|6|||
161244389|NCT00731939|582273555|FG000|Overall Study|Lost to Follow-up|15|||
161244390|NCT00731939|582273555|FG000|Overall Study|Not implanted with study device|9|||
160902784|NCT04622306|581037822|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
161244391|NCT00731939|582273555|FG000|Overall Study|Withdrawal by Subject|2|||
161244392|NCT00731939|582273555|FG000|Overall Study|Did not meet enrollment criteria|2|||
161244393|NCT02280863|582273556|FG000|Integrated Platform|Met stopping criteria|0|||
161244394|NCT02280863|582273557|FG001|Integrated Platform|Met stopping criteria|1|||
161244395|NCT02622386|582273560|FG000|First Assignment|Withdrawal by Subject|3|||
161244396|NCT02622386|582273561|FG001|First Assignment|Withdrawal by Subject|2|||
161244397|NCT02622386|582273560|FG000|Washout|Withdrawal by Subject|4|||
161244398|NCT02622386|582273561|FG001|Washout|Withdrawal by Subject|4|||
161244399|NCT02622386|582273560|FG000|Second Assignment|Withdrawal by Subject|0|||
161244400|NCT02622386|582273561|FG001|Second Assignment|Withdrawal by Subject|2|||
161244401|NCT00985439|582273562|FG000|Overall Study|Adverse Event|0|||
161244402|NCT00985439|582273563|FG001|Overall Study|Adverse Event|0|||
161244403|NCT00985439|582273564|FG002|Overall Study|Adverse Event|1|||
161244404|NCT00985439|582273565|FG003|Overall Study|Adverse Event|0|||
161244405|NCT01174186|582273566|FG000|Overall Study|Lost to Follow-up|0|||
161244406|NCT01174186|582273567|FG001|Overall Study|Lost to Follow-up|1|||
160902785|NCT04622306|581037823|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
160902786|NCT04622306|581037824|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
160902787|NCT04622306|581037825|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
160902788|NCT04622306|581037826|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
160902789|NCT00617851|581037827|FG000|Overall Study|Death|0|||
160902790|NCT00617851|581037828|FG001|Overall Study|Death|0|||
160902791|NCT00617851|581037829|FG002|Overall Study|Death|0|||
160902792|NCT00617851|581037830|FG003|Overall Study|Death|1|||
160902793|NCT00617851|581037827|FG000|Overall Study|Withdrawal by Subject|14|||
160902794|NCT00617851|581037828|FG001|Overall Study|Withdrawal by Subject|7|||
160902795|NCT00617851|581037829|FG002|Overall Study|Withdrawal by Subject|12|||
160902796|NCT00617851|581037830|FG003|Overall Study|Withdrawal by Subject|4|||
160902797|NCT00617851|581037827|FG000|Overall Study|Lost to Follow-up|27|||
160902798|NCT00617851|581037828|FG001|Overall Study|Lost to Follow-up|29|||
160902799|NCT00617851|581037829|FG002|Overall Study|Lost to Follow-up|31|||
160902800|NCT00617851|581037830|FG003|Overall Study|Lost to Follow-up|19|||
160902801|NCT00617851|581037827|FG000|Overall Study|Inappropriate Enrollment|5|||
160902802|NCT00617851|581037828|FG001|Overall Study|Inappropriate Enrollment|4|||
160902803|NCT00617851|581037829|FG002|Overall Study|Inappropriate Enrollment|1|||
160902804|NCT00617851|581037830|FG003|Overall Study|Inappropriate Enrollment|1|||
160902805|NCT00617851|581037827|FG000|Overall Study|Unable to classify|1|||
160902806|NCT00617851|581037828|FG001|Overall Study|Unable to classify|0|||
160902807|NCT00617851|581037829|FG002|Overall Study|Unable to classify|1|||
160902808|NCT00617851|581037830|FG003|Overall Study|Unable to classify|0|||
160902809|NCT00697788|581037833|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902810|NCT00697788|581037834|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
160902811|NCT00697788|581037835|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902812|NCT00697788|581037836|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902813|NCT00697788|581037837|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902814|NCT00697788|581037838|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902815|NCT00697788|581037839|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902816|NCT00697788|581037840|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
160902817|NCT00697788|581037833|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902818|NCT00697788|581037834|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902819|NCT00697788|581037835|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160990674|NCT00293462|581353922|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
161244407|NCT01174186|582273566|FG000|Overall Study|Withdrawal by Subject|0|||
160902820|NCT00697788|581037836|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902821|NCT00697788|581037837|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
160902822|NCT00697788|581037838|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902823|NCT00697788|581037839|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
160902824|NCT00697788|581037840|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
161244408|NCT01174186|582273567|FG001|Overall Study|Withdrawal by Subject|2|||
161244409|NCT05274763|582273568|FG000|Overall Study|Lost to Follow-up|1|||
161334755|NCT02265510|582615812|FG000|Overall Study|Lost to Follow-up|0|||
161244410|NCT00918684|582273569|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
161244411|NCT00918684|582273569|FG000|Treatment Phase|Lack of Efficacy|6|||
161244412|NCT00918684|582273569|FG000|Treatment Phase|Lost to Follow-up|2|||
161244413|NCT00918684|582273569|FG000|Treatment Phase|Physician Decision|8|||
161244414|NCT00918684|582273569|FG000|Treatment Phase|Protocol Violation|1|||
161244415|NCT00918684|582273569|FG000|Treatment Phase|Withdrawal by Subject|8|||
161244416|NCT00402103|582273570|FG000|Overall Study|Adverse Event|60|||
161244417|NCT00402103|582273571|FG001|Overall Study|Adverse Event|7|||
161244418|NCT00402103|582273570|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161244419|NCT00402103|582273571|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161244420|NCT00402103|582273570|FG000|Overall Study|Condition no longer requires study drug|2|||
161244421|NCT00402103|582273571|FG001|Overall Study|Condition no longer requires study drug|0|||
161244422|NCT00402103|582273570|FG000|Overall Study|Protocol Deviation|8|||
161244423|NCT00402103|582273571|FG001|Overall Study|Protocol Deviation|0|||
161244424|NCT00402103|582273570|FG000|Overall Study|Patient withdrew consent|12|||
161244425|NCT00402103|582273571|FG001|Overall Study|Patient withdrew consent|1|||
161244426|NCT00402103|582273570|FG000|Overall Study|Lost to Follow-up|6|||
161244427|NCT00402103|582273571|FG001|Overall Study|Lost to Follow-up|3|||
161244428|NCT00402103|582273570|FG000|Overall Study|Administrative problems|2|||
161244429|NCT00402103|582273571|FG001|Overall Study|Administrative problems|0|||
161244430|NCT00484679|582273572|FG000|Overall Study|Withdrawal by Subject|3|||
161244431|NCT00418145|582273575|FG000|Overall Study|study terminated|6|||
161244432|NCT00472212|582273576|FG000|Overall Study|Lost to Follow-up|6|||
161244433|NCT00472212|582273577|FG001|Overall Study|Lost to Follow-up|4|||
161244434|NCT00425308|582273578|FG000|Overall Study|Adverse Event|2|||
161244435|NCT00425308|582273579|FG001|Overall Study|Adverse Event|1|||
161244436|NCT00425308|582273578|FG000|Overall Study|Withdrawal by Subject|1|||
161244437|NCT00425308|582273579|FG001|Overall Study|Withdrawal by Subject|0|||
161244438|NCT00425308|582273578|FG000|Overall Study|Death|1|||
161244439|NCT00425308|582273579|FG001|Overall Study|Death|0|||
161244440|NCT01075282|582273580|FG000|Overall Study|Withdrawal by Subject|11|||
161244441|NCT01075282|582273581|FG001|Overall Study|Withdrawal by Subject|7|||
161244442|NCT01075282|582273582|FG002|Overall Study|Withdrawal by Subject|11|||
161244443|NCT01075282|582273580|FG000|Overall Study|Adverse Event|9|||
161244444|NCT01075282|582273581|FG001|Overall Study|Adverse Event|8|||
161244445|NCT01075282|582273582|FG002|Overall Study|Adverse Event|5|||
161244446|NCT01075282|582273580|FG000|Overall Study|Entry Criteria Not Met|3|||
161244447|NCT01075282|582273581|FG001|Overall Study|Entry Criteria Not Met|2|||
161244448|NCT01075282|582273582|FG002|Overall Study|Entry Criteria Not Met|0|||
161244449|NCT01075282|582273580|FG000|Overall Study|Lost to Follow-up|3|||
161244450|NCT01075282|582273581|FG001|Overall Study|Lost to Follow-up|3|||
161244451|NCT01075282|582273582|FG002|Overall Study|Lost to Follow-up|3|||
161244452|NCT01075282|582273580|FG000|Overall Study|Physician Decision|3|||
161244453|NCT01075282|582273581|FG001|Overall Study|Physician Decision|3|||
161244454|NCT01075282|582273582|FG002|Overall Study|Physician Decision|3|||
161244455|NCT01075282|582273580|FG000|Overall Study|Lack of Efficacy|1|||
161244456|NCT01075282|582273581|FG001|Overall Study|Lack of Efficacy|1|||
161244457|NCT01075282|582273582|FG002|Overall Study|Lack of Efficacy|0|||
161244458|NCT01075282|582273580|FG000|Overall Study|Treatment Non-compliance|1|||
161244459|NCT01075282|582273581|FG001|Overall Study|Treatment Non-compliance|2|||
161244460|NCT01075282|582273582|FG002|Overall Study|Treatment Non-compliance|2|||
161244461|NCT01075282|582273580|FG000|Overall Study|Protocol Violation|0|||
161244462|NCT01075282|582273581|FG001|Overall Study|Protocol Violation|2|||
161244463|NCT01075282|582273582|FG002|Overall Study|Protocol Violation|1|||
161244464|NCT01075282|582273580|FG000|Overall Study|Death|0|||
161244465|NCT01075282|582273581|FG001|Overall Study|Death|1|||
161244466|NCT01075282|582273582|FG002|Overall Study|Death|2|||
161244467|NCT00367133|582273583|FG000|2 Years|Death|20|||
161244468|NCT00367133|582273584|FG001|2 Years|Death|12|||
161244469|NCT00367133|582273585|FG002|2 Years|Death|12|||
161244470|NCT00367133|582273583|FG000|2 Years|Dropped|34|||
161244471|NCT00367133|582273584|FG001|2 Years|Dropped|19|||
161244472|NCT00367133|582273585|FG002|2 Years|Dropped|33|||
161244473|NCT00367133|582273583|FG000|2 Years|Missed visit|4|||
161244474|NCT00367133|582273584|FG001|2 Years|Missed visit|5|||
161244475|NCT00367133|582273585|FG002|2 Years|Missed visit|4|||
161244476|NCT00847535|582273586|FG000|Overall Study|Withdrawal by Subject|2|||
161244477|NCT00847535|582273587|FG001|Overall Study|Withdrawal by Subject|1|||
161244478|NCT00847535|582273588|FG002|Overall Study|Withdrawal by Subject|1|||
161244479|NCT00847535|582273586|FG000|Overall Study|Lost to Follow-up|0|||
161244480|NCT00847535|582273587|FG001|Overall Study|Lost to Follow-up|1|||
161244481|NCT00847535|582273588|FG002|Overall Study|Lost to Follow-up|0|||
161244482|NCT01252953|582273589|FG000|Overall Study|Withdrawal by Subject|16|||
161244483|NCT01252953|582273590|FG001|Overall Study|Withdrawal by Subject|17|||
161244484|NCT01252953|582273589|FG000|Overall Study|Lost to Follow-up|22|||
161244485|NCT01252953|582273590|FG001|Overall Study|Lost to Follow-up|21|||
161244486|NCT00906399|582273593|FG000|Year 1|Randomized But Not Treated|0|||
161244487|NCT00906399|582273594|FG001|Year 1|Randomized But Not Treated|1|||
161244488|NCT00906399|582273595|FG002|Year 1|Randomized But Not Treated|3|||
161244489|NCT00906399|582273596|FG003|Year 1|Randomized But Not Treated|0|||
161244490|NCT00906399|582273597|FG004|Year 1|Randomized But Not Treated|0|||
161244491|NCT00906399|582273598|FG005|Year 1|Randomized But Not Treated|0|||
161244492|NCT00906399|582273599|FG006|Year 1|Randomized But Not Treated|0|||
161244493|NCT00906399|582273593|FG000|Year 1|Adverse Event|4|||
161244494|NCT00906399|582273594|FG001|Year 1|Adverse Event|22|||
161134831|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
161134832|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
161244495|NCT00906399|582273595|FG002|Year 1|Adverse Event|24|||
161244496|NCT00906399|582273596|FG003|Year 1|Adverse Event|0|||
161244497|NCT00906399|582273597|FG004|Year 1|Adverse Event|0|||
161244498|NCT00906399|582273598|FG005|Year 1|Adverse Event|0|||
161244499|NCT00906399|582273599|FG006|Year 1|Adverse Event|0|||
161244500|NCT00906399|582273593|FG000|Year 1|Lost to Follow-up|4|||
161244501|NCT00906399|582273594|FG001|Year 1|Lost to Follow-up|4|||
161244502|NCT00906399|582273595|FG002|Year 1|Lost to Follow-up|2|||
161244503|NCT00906399|582273596|FG003|Year 1|Lost to Follow-up|0|||
161244504|NCT00906399|582273597|FG004|Year 1|Lost to Follow-up|0|||
161244505|NCT00906399|582273598|FG005|Year 1|Lost to Follow-up|0|||
161244506|NCT00906399|582273599|FG006|Year 1|Lost to Follow-up|0|||
161244507|NCT00906399|582273593|FG000|Year 1|Withdrawal by Subject|30|||
161244508|NCT00906399|582273594|FG001|Year 1|Withdrawal by Subject|32|||
161244509|NCT00906399|582273595|FG002|Year 1|Withdrawal by Subject|36|||
161134833|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161134834|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161134835|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
161134836|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161134837|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161134838|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161134839|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161134840|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
161134841|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
161134842|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134843|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
161134844|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
161134845|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134846|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134847|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134848|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134849|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134850|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
161134851|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161134852|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
161134853|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
161134854|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161134855|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161134856|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161134857|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
161134858|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
161134859|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
161134860|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161134861|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
161134862|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
161134863|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161134864|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161134865|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161134866|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
161134867|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161244510|NCT00906399|582273596|FG003|Year 1|Withdrawal by Subject|0|||
161244511|NCT00906399|582273597|FG004|Year 1|Withdrawal by Subject|0|||
161244512|NCT00906399|582273598|FG005|Year 1|Withdrawal by Subject|0|||
161244513|NCT00906399|582273599|FG006|Year 1|Withdrawal by Subject|0|||
161244514|NCT00906399|582273593|FG000|Year 1|Physician Decision|0|||
161244515|NCT00906399|582273594|FG001|Year 1|Physician Decision|1|||
161244516|NCT00906399|582273595|FG002|Year 1|Physician Decision|3|||
161244517|NCT00906399|582273596|FG003|Year 1|Physician Decision|0|||
161244518|NCT00906399|582273597|FG004|Year 1|Physician Decision|0|||
161244519|NCT00906399|582273598|FG005|Year 1|Physician Decision|0|||
161244520|NCT00906399|582273599|FG006|Year 1|Physician Decision|0|||
161244521|NCT00906399|582273593|FG000|Year 1|Death|2|||
161244522|NCT00906399|582273594|FG001|Year 1|Death|1|||
161244523|NCT00906399|582273595|FG002|Year 1|Death|1|||
161244524|NCT00906399|582273596|FG003|Year 1|Death|0|||
161244525|NCT00906399|582273597|FG004|Year 1|Death|0|||
161244526|NCT00906399|582273598|FG005|Year 1|Death|0|||
161244527|NCT00906399|582273599|FG006|Year 1|Death|0|||
161244528|NCT00906399|582273593|FG000|Year 1|Other|4|||
160990675|NCT00293462|581353923|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
160990676|NCT00293462|581353921|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
160990677|NCT00293462|581353922|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
160990678|NCT00293462|581353923|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
160990679|NCT00293462|581353921|FG000|Overall Study|Refuse Radiation Treatment|1|||
160990680|NCT00293462|581353922|FG001|Overall Study|Refuse Radiation Treatment|0|||
160990681|NCT00293462|581353923|FG002|Overall Study|Refuse Radiation Treatment|0|||
160990682|NCT00293462|581353921|FG000|Overall Study|No Show|0|||
160990683|NCT00293462|581353922|FG001|Overall Study|No Show|0|||
160990684|NCT00293462|581353923|FG002|Overall Study|No Show|1|||
160990685|NCT00293462|581353921|FG000|Overall Study|Went back to his home country|0|||
160990686|NCT00293462|581353922|FG001|Overall Study|Went back to his home country|0|||
161244529|NCT00906399|582273594|FG001|Year 1|Other|2|||
161244530|NCT00906399|582273595|FG002|Year 1|Other|7|||
161244531|NCT00906399|582273596|FG003|Year 1|Other|0|||
161244532|NCT00906399|582273597|FG004|Year 1|Other|0|||
161244533|NCT00906399|582273598|FG005|Year 1|Other|0|||
161244534|NCT00906399|582273599|FG006|Year 1|Other|0|||
161244535|NCT00906399|582273593|FG000|Year 2|Adverse Event|0|||
161244536|NCT00906399|582273594|FG001|Year 2|Adverse Event|0|||
161244537|NCT00906399|582273595|FG002|Year 2|Adverse Event|0|||
161244538|NCT00906399|582273596|FG003|Year 2|Adverse Event|9|||
161244539|NCT00906399|582273597|FG004|Year 2|Adverse Event|8|||
161244540|NCT00906399|582273598|FG005|Year 2|Adverse Event|11|||
161244541|NCT00906399|582273599|FG006|Year 2|Adverse Event|6|||
161244542|NCT00906399|582273593|FG000|Year 2|Lost to Follow-up|0|||
161244543|NCT00906399|582273594|FG001|Year 2|Lost to Follow-up|0|||
161244544|NCT00906399|582273595|FG002|Year 2|Lost to Follow-up|0|||
161244545|NCT00906399|582273596|FG003|Year 2|Lost to Follow-up|1|||
161244546|NCT00906399|582273597|FG004|Year 2|Lost to Follow-up|4|||
161244547|NCT00906399|582273598|FG005|Year 2|Lost to Follow-up|2|||
161244548|NCT00906399|582273599|FG006|Year 2|Lost to Follow-up|4|||
161244549|NCT00906399|582273593|FG000|Year 2|Withdrawal by Subject|0|||
161244550|NCT00906399|582273594|FG001|Year 2|Withdrawal by Subject|0|||
161244551|NCT00906399|582273595|FG002|Year 2|Withdrawal by Subject|0|||
161244552|NCT00906399|582273596|FG003|Year 2|Withdrawal by Subject|17|||
161244553|NCT00906399|582273597|FG004|Year 2|Withdrawal by Subject|18|||
161244554|NCT00906399|582273598|FG005|Year 2|Withdrawal by Subject|27|||
161244555|NCT00906399|582273599|FG006|Year 2|Withdrawal by Subject|13|||
161244556|NCT00906399|582273593|FG000|Year 2|Physician Decision|0|||
161244557|NCT00906399|582273594|FG001|Year 2|Physician Decision|0|||
161244558|NCT00906399|582273595|FG002|Year 2|Physician Decision|0|||
161244559|NCT00906399|582273596|FG003|Year 2|Physician Decision|0|||
161244560|NCT00906399|582273597|FG004|Year 2|Physician Decision|2|||
161244561|NCT00906399|582273598|FG005|Year 2|Physician Decision|6|||
161244562|NCT00906399|582273599|FG006|Year 2|Physician Decision|3|||
161244563|NCT00906399|582273593|FG000|Year 2|Death|0|||
160990687|NCT00293462|581353923|FG002|Overall Study|Went back to his home country|1|||
160990688|NCT00293462|581353921|FG000|Overall Study|Blood clot after chemotherapy|0|||
160990689|NCT00293462|581353922|FG001|Overall Study|Blood clot after chemotherapy|0|||
160990690|NCT00293462|581353923|FG002|Overall Study|Blood clot after chemotherapy|1|||
160990691|NCT00293462|581353921|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
160990692|NCT00293462|581353922|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
160990693|NCT00293462|581353923|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
160990694|NCT00293462|581353921|FG000|Overall Study|Possible Tracheostomy leakage|0|||
160990695|NCT00293462|581353922|FG001|Overall Study|Possible Tracheostomy leakage|1|||
160990696|NCT00293462|581353923|FG002|Overall Study|Possible Tracheostomy leakage|0|||
160990697|NCT00293462|581353921|FG000|Overall Study|Low radiation dose in oral cavity|0|||
160990698|NCT00293462|581353922|FG001|Overall Study|Low radiation dose in oral cavity|1|||
160990699|NCT00293462|581353923|FG002|Overall Study|Low radiation dose in oral cavity|0|||
160990700|NCT00293462|581353921|FG000|Overall Study|Physician Decision|0|||
160990701|NCT00293462|581353922|FG001|Overall Study|Physician Decision|1|||
160990702|NCT00293462|581353923|FG002|Overall Study|Physician Decision|0|||
160990703|NCT00372060|581353924|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
160990704|NCT00372060|581353925|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
160990705|NCT00372060|581353924|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
160990706|NCT00372060|581353925|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
161244564|NCT00906399|582273594|FG001|Year 2|Death|0|||
161244565|NCT00906399|582273595|FG002|Year 2|Death|0|||
161244566|NCT00906399|582273596|FG003|Year 2|Death|1|||
161244567|NCT00906399|582273597|FG004|Year 2|Death|0|||
161244568|NCT00906399|582273598|FG005|Year 2|Death|0|||
161244569|NCT00906399|582273599|FG006|Year 2|Death|3|||
161244570|NCT00906399|582273593|FG000|Year 2|Other|0|||
161244571|NCT00906399|582273594|FG001|Year 2|Other|0|||
161244572|NCT00906399|582273595|FG002|Year 2|Other|0|||
161244573|NCT00906399|582273596|FG003|Year 2|Other|2|||
161244574|NCT00906399|582273597|FG004|Year 2|Other|3|||
161244575|NCT00906399|582273598|FG005|Year 2|Other|1|||
161244576|NCT00906399|582273599|FG006|Year 2|Other|0|||
161244577|NCT01986647|582273603|FG000|Overall Study|Lost to Follow-up|4|||
161244578|NCT01986647|582273604|FG001|Overall Study|Lost to Follow-up|1|||
161134868|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
161134869|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134870|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161134871|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134872|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134873|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134874|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134875|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134876|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161134877|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161134878|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134879|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
161134880|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134881|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134882|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134883|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134884|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134885|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134886|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
161134887|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134888|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161134889|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134890|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134891|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134892|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134893|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134894|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
161134895|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
161134896|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161134897|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
161134898|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161134899|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161134900|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161134901|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161134902|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
161134903|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
161134904|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
161134905|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134906|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134907|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
161134908|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134909|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134910|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134911|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134912|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134913|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
161134914|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134915|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134916|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134917|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134918|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134919|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134920|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134921|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
161134922|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
161134923|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161134924|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161134925|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161134926|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161134927|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161134928|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160902825|NCT01180985|581037841|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
161134929|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161134930|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
161134931|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
161134932|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161134933|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
161134934|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
161134935|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161244579|NCT01986647|582273605|FG002|Overall Study|Lost to Follow-up|4|||
161134936|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161244580|NCT01986647|582273606|FG003|Overall Study|Lost to Follow-up|4|||
161134937|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161244581|NCT01986647|582273603|FG000|Overall Study|Withdrawal by Subject|1|||
161244582|NCT01986647|582273604|FG001|Overall Study|Withdrawal by Subject|3|||
161244583|NCT01986647|582273605|FG002|Overall Study|Withdrawal by Subject|2|||
161244584|NCT01986647|582273606|FG003|Overall Study|Withdrawal by Subject|3|||
161244585|NCT01986647|582273603|FG000|Overall Study|Health|5|||
161244586|NCT01986647|582273604|FG001|Overall Study|Health|3|||
161244587|NCT01986647|582273605|FG002|Overall Study|Health|6|||
161244588|NCT01986647|582273606|FG003|Overall Study|Health|4|||
161244589|NCT01960296|582273607|FG000|Overall Study|Postponed surgery|1|||
161244590|NCT01960296|582273608|FG001|Overall Study|Postponed surgery|0|||
161244591|NCT01960296|582273607|FG000|Overall Study|Received different procedure|1|||
161244592|NCT01960296|582273608|FG001|Overall Study|Received different procedure|3|||
161244593|NCT02003391|582273609|FG000|Overall Study|Withdrawal by Subject|2|||
161244594|NCT02003391|582273610|FG001|Overall Study|Withdrawal by Subject|1|||
161244595|NCT02003391|582273609|FG000|Overall Study|Protocol Violation|0|||
161244596|NCT02003391|582273610|FG001|Overall Study|Protocol Violation|1|||
161244597|NCT02003391|582273609|FG000|Overall Study|Adverse Event|1|||
161244598|NCT02003391|582273610|FG001|Overall Study|Adverse Event|0|||
161244599|NCT02272803|582273611|FG000|Overall Study|Disease progression|16|||
161244600|NCT02272803|582273612|FG001|Overall Study|Disease progression|8|||
161244601|NCT02272803|582273611|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
161244602|NCT02272803|582273612|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
161244603|NCT02272803|582273611|FG000|Overall Study|Study drug toxicity|4|||
161244604|NCT02272803|582273612|FG001|Overall Study|Study drug toxicity|9|||
161244605|NCT02272803|582273611|FG000|Overall Study|Participant request to discontinue study treatment|3|||
161244606|NCT02272803|582273612|FG001|Overall Study|Participant request to discontinue study treatment|7|||
161244607|NCT02272803|582273611|FG000|Overall Study|Maximum clinical benefit|4|||
161244608|NCT02272803|582273612|FG001|Overall Study|Maximum clinical benefit|2|||
161244609|NCT02272803|582273611|FG000|Overall Study|Poor/non-compliance|2|||
161244610|NCT02272803|582273612|FG001|Overall Study|Poor/non-compliance|2|||
161244611|NCT02272803|582273611|FG000|Overall Study|Withdrawal by Subject|2|||
161244612|NCT02272803|582273612|FG001|Overall Study|Withdrawal by Subject|1|||
161244613|NCT02272803|582273611|FG000|Overall Study|Death|0|||
161244614|NCT02272803|582273612|FG001|Overall Study|Death|1|||
161244615|NCT02272803|582273611|FG000|Overall Study|Other reasons|1|||
161244616|NCT02272803|582273612|FG001|Overall Study|Other reasons|3|||
161244617|NCT02272803|582273611|FG000|Overall Study|Administrative reason by sponsor|5|||
161244618|NCT02272803|582273612|FG001|Overall Study|Administrative reason by sponsor|4|||
161244619|NCT02611323|582273613|FG000|Overall Study|Death|3|||
161244620|NCT02611323|582273614|FG001|Overall Study|Death|1|||
161244621|NCT02611323|582273615|FG002|Overall Study|Death|0|||
161244622|NCT02611323|582273616|FG003|Overall Study|Death|0|||
161244623|NCT02611323|582273617|FG004|Overall Study|Death|1|||
161244624|NCT02611323|582273618|FG005|Overall Study|Death|1|||
161244625|NCT02611323|582273619|FG006|Overall Study|Death|8|||
161244626|NCT02611323|582273620|FG007|Overall Study|Death|0|||
161244627|NCT02611323|582273621|FG008|Overall Study|Death|4|||
161244628|NCT02611323|582273622|FG009|Overall Study|Death|6|||
161244629|NCT02611323|582273623|FG010|Overall Study|Death|26|||
161244630|NCT02611323|582273613|FG000|Overall Study|Lost to Follow-up|1|||
160902826|NCT01180985|581037842|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
161134938|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161134939|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161134940|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
161134941|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161134942|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
161134943|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
161244631|NCT02611323|582273614|FG001|Overall Study|Lost to Follow-up|0|||
161134944|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161134945|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161244632|NCT02611323|582273615|FG002|Overall Study|Lost to Follow-up|0|||
161244633|NCT02611323|582273616|FG003|Overall Study|Lost to Follow-up|0|||
161244634|NCT02611323|582273617|FG004|Overall Study|Lost to Follow-up|0|||
161244635|NCT02611323|582273618|FG005|Overall Study|Lost to Follow-up|0|||
161244636|NCT02611323|582273619|FG006|Overall Study|Lost to Follow-up|3|||
161244637|NCT02611323|582273620|FG007|Overall Study|Lost to Follow-up|0|||
161244638|NCT02611323|582273621|FG008|Overall Study|Lost to Follow-up|0|||
161244639|NCT02611323|582273622|FG009|Overall Study|Lost to Follow-up|0|||
161244640|NCT02611323|582273623|FG010|Overall Study|Lost to Follow-up|2|||
161244641|NCT02611323|582273613|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244642|NCT02611323|582273614|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244643|NCT02611323|582273615|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244644|NCT02611323|582273616|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
161334756|NCT02265510|582615813|FG001|Overall Study|Lost to Follow-up|0|||
161134946|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161134947|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161134948|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161134949|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161134950|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134951|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
161134952|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134953|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134954|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134955|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134956|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134957|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134958|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
161134959|NCT01307423|581876676|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161134960|NCT01307423|581876677|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161134961|NCT01307423|581876678|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
161134962|NCT01307423|581876679|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161134963|NCT01307423|581876680|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161134964|NCT01307423|581876681|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161134965|NCT01307423|581876682|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
161134966|NCT01307423|581876683|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
161134967|NCT01307423|581876684|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
161134968|NCT03406962|581876685|FG000|Overall Study|Death|2|||
161134969|NCT03406962|581876685|FG000|Overall Study|Adverse Event|1|||
161134970|NCT03853694|581876686|FG000|Overall Study|Protocol Violation|3|||
161134971|NCT03853694|581876687|FG001|Overall Study|Protocol Violation|5|||
161134972|NCT03853694|581876688|FG002|Overall Study|Protocol Violation|3|||
161134973|NCT03853694|581876686|FG000|Overall Study|Delivered early|0|||
161134974|NCT03853694|581876687|FG001|Overall Study|Delivered early|1|||
161134975|NCT03853694|581876688|FG002|Overall Study|Delivered early|0|||
161134976|NCT03853694|581876686|FG000|Overall Study|not suitable to proceed|0|||
161134977|NCT03853694|581876687|FG001|Overall Study|not suitable to proceed|1|||
161134978|NCT03853694|581876688|FG002|Overall Study|not suitable to proceed|0|||
161134979|NCT03853694|581876686|FG000|Overall Study|difficult surgery|0|||
161134980|NCT03853694|581876687|FG001|Overall Study|difficult surgery|0|||
161134981|NCT03853694|581876688|FG002|Overall Study|difficult surgery|1|||
161134982|NCT03853694|581876686|FG000|Overall Study|Lost to Follow-up|0|||
161134983|NCT03853694|581876687|FG001|Overall Study|Lost to Follow-up|1|||
161134984|NCT03853694|581876688|FG002|Overall Study|Lost to Follow-up|0|||
161134985|NCT03853694|581876686|FG000|Overall Study|Withdrawal by Subject|0|||
161134986|NCT03853694|581876687|FG001|Overall Study|Withdrawal by Subject|1|||
161134987|NCT03853694|581876688|FG002|Overall Study|Withdrawal by Subject|0|||
161134988|NCT00805207|581876689|FG000|Overall Study|Protocol Violation|0|||
161134989|NCT00805207|581876690|FG001|Overall Study|Protocol Violation|0|||
161134990|NCT00805207|581876691|FG002|Overall Study|Protocol Violation|1|||
161134991|NCT00805207|581876692|FG003|Overall Study|Protocol Violation|0|||
161134992|NCT00805207|581876693|FG004|Overall Study|Protocol Violation|0|||
161134993|NCT00805207|581876694|FG005|Overall Study|Protocol Violation|0|||
161134994|NCT00805207|581876695|FG006|Overall Study|Protocol Violation|0|||
161134995|NCT00805207|581876696|FG007|Overall Study|Protocol Violation|0|||
161134996|NCT00805207|581876697|FG008|Overall Study|Protocol Violation|0|||
161134997|NCT00805207|581876689|FG000|Overall Study|Physician Decision|0|||
161134998|NCT00805207|581876690|FG001|Overall Study|Physician Decision|1|||
161134999|NCT00805207|581876691|FG002|Overall Study|Physician Decision|0|||
161135000|NCT00805207|581876692|FG003|Overall Study|Physician Decision|0|||
161135001|NCT00805207|581876693|FG004|Overall Study|Physician Decision|0|||
161135002|NCT00805207|581876694|FG005|Overall Study|Physician Decision|1|||
161135003|NCT00805207|581876695|FG006|Overall Study|Physician Decision|0|||
161135004|NCT00805207|581876696|FG007|Overall Study|Physician Decision|0|||
161135005|NCT00805207|581876697|FG008|Overall Study|Physician Decision|0|||
161135006|NCT00805207|581876689|FG000|Overall Study|Withdrawal by Subject|0|||
161135007|NCT00805207|581876690|FG001|Overall Study|Withdrawal by Subject|1|||
161135008|NCT00805207|581876691|FG002|Overall Study|Withdrawal by Subject|0|||
161135009|NCT00805207|581876692|FG003|Overall Study|Withdrawal by Subject|0|||
161135010|NCT00805207|581876693|FG004|Overall Study|Withdrawal by Subject|1|||
161135011|NCT00805207|581876694|FG005|Overall Study|Withdrawal by Subject|2|||
161135012|NCT00805207|581876695|FG006|Overall Study|Withdrawal by Subject|0|||
161135013|NCT00805207|581876696|FG007|Overall Study|Withdrawal by Subject|0|||
161135014|NCT00805207|581876697|FG008|Overall Study|Withdrawal by Subject|0|||
161135015|NCT00064701|581876698|FG000|One Year Post-transplant|Did not receive study drug|7|||
161135016|NCT00064701|581876699|FG001|One Year Post-transplant|Did not receive study drug|12|||
161135017|NCT00064701|581876700|FG002|One Year Post-transplant|Did not receive study drug|11|||
161135018|NCT00064701|581876698|FG000|One Year Post-transplant|Adverse Event|23|||
161244645|NCT02611323|582273617|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
161135019|NCT00064701|581876699|FG001|One Year Post-transplant|Adverse Event|19|||
161244646|NCT02611323|582273618|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244647|NCT02611323|582273619|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244648|NCT02611323|582273620|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244649|NCT02611323|582273621|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244650|NCT02611323|582273622|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
161244651|NCT02611323|582273623|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
161244652|NCT02611323|582273613|FG000|Overall Study|Progressive Disease|0|||
161244653|NCT02611323|582273614|FG001|Overall Study|Progressive Disease|0|||
161244654|NCT02611323|582273615|FG002|Overall Study|Progressive Disease|0|||
161244655|NCT02611323|582273616|FG003|Overall Study|Progressive Disease|0|||
161244656|NCT02611323|582273617|FG004|Overall Study|Progressive Disease|0|||
161244657|NCT02611323|582273618|FG005|Overall Study|Progressive Disease|0|||
161244658|NCT02611323|582273619|FG006|Overall Study|Progressive Disease|0|||
161244659|NCT02611323|582273620|FG007|Overall Study|Progressive Disease|0|||
161244660|NCT02611323|582273621|FG008|Overall Study|Progressive Disease|0|||
161135020|NCT00064701|581876700|FG002|One Year Post-transplant|Adverse Event|37|||
161135021|NCT00064701|581876698|FG000|One Year Post-transplant|Rejection|0|||
161135022|NCT00064701|581876699|FG001|One Year Post-transplant|Rejection|1|||
161135023|NCT00064701|581876700|FG002|One Year Post-transplant|Rejection|16|||
161135024|NCT00064701|581876698|FG000|One Year Post-transplant|Non-compliance|4|||
161135025|NCT00064701|581876699|FG001|One Year Post-transplant|Non-compliance|2|||
161135026|NCT00064701|581876700|FG002|One Year Post-transplant|Non-compliance|5|||
161135027|NCT00064701|581876698|FG000|One Year Post-transplant|Graft Failure|3|||
161135028|NCT00064701|581876699|FG001|One Year Post-transplant|Graft Failure|2|||
161135029|NCT00064701|581876700|FG002|One Year Post-transplant|Graft Failure|1|||
161135030|NCT00064701|581876698|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
161135031|NCT00064701|581876699|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
161135032|NCT00064701|581876700|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
161135033|NCT00064701|581876698|FG000|One Year Post-transplant|Lost to Follow-up|1|||
161135034|NCT00064701|581876699|FG001|One Year Post-transplant|Lost to Follow-up|0|||
161135035|NCT00064701|581876700|FG002|One Year Post-transplant|Lost to Follow-up|0|||
161135036|NCT00064701|581876698|FG000|One Year Post-transplant|Converted to rapamycin|1|||
161135037|NCT00064701|581876699|FG001|One Year Post-transplant|Converted to rapamycin|0|||
161135038|NCT00064701|581876700|FG002|One Year Post-transplant|Converted to rapamycin|0|||
161135039|NCT00064701|581876698|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
161135040|NCT00064701|581876699|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
161135041|NCT00064701|581876700|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
161135042|NCT00064701|581876698|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
161135043|NCT00064701|581876699|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
161135044|NCT00064701|581876700|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
161135045|NCT00064701|581876698|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
161135046|NCT00064701|581876699|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
161135047|NCT00064701|581876700|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
161135048|NCT00064701|581876698|FG000|One Year Post-transplant|Poor absorption|0|||
161135049|NCT00064701|581876699|FG001|One Year Post-transplant|Poor absorption|1|||
161135050|NCT00064701|581876700|FG002|One Year Post-transplant|Poor absorption|0|||
161135051|NCT00064701|581876698|FG000|One Year Post-transplant|Pancreas transplant|0|||
161135052|NCT00064701|581876699|FG001|One Year Post-transplant|Pancreas transplant|0|||
161135053|NCT00064701|581876700|FG002|One Year Post-transplant|Pancreas transplant|1|||
161135054|NCT00064701|581876698|FG000|Clinical Continuation Phase|Adverse Event|12|||
161135055|NCT00064701|581876699|FG001|Clinical Continuation Phase|Adverse Event|21|||
161135056|NCT00064701|581876700|FG002|Clinical Continuation Phase|Adverse Event|14|||
161135057|NCT00064701|581876698|FG000|Clinical Continuation Phase|Non-compliance|8|||
161135058|NCT00064701|581876699|FG001|Clinical Continuation Phase|Non-compliance|6|||
161135059|NCT00064701|581876700|FG002|Clinical Continuation Phase|Non-compliance|7|||
161135060|NCT00064701|581876698|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
161244661|NCT02611323|582273622|FG009|Overall Study|Progressive Disease|0|||
161244662|NCT02611323|582273623|FG010|Overall Study|Progressive Disease|1|||
161244663|NCT02611323|582273613|FG000|Overall Study|Withdrawal by Subject|1|||
161244664|NCT02611323|582273614|FG001|Overall Study|Withdrawal by Subject|0|||
161244665|NCT02611323|582273615|FG002|Overall Study|Withdrawal by Subject|0|||
160996829|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
161135061|NCT00064701|581876699|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
161135062|NCT00064701|581876700|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
161135063|NCT00064701|581876698|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
161244666|NCT02611323|582273616|FG003|Overall Study|Withdrawal by Subject|0|||
161244667|NCT02611323|582273617|FG004|Overall Study|Withdrawal by Subject|0|||
161244668|NCT02611323|582273618|FG005|Overall Study|Withdrawal by Subject|0|||
161244669|NCT02611323|582273619|FG006|Overall Study|Withdrawal by Subject|0|||
161244670|NCT02611323|582273620|FG007|Overall Study|Withdrawal by Subject|1|||
161244671|NCT02611323|582273621|FG008|Overall Study|Withdrawal by Subject|0|||
161244672|NCT02611323|582273622|FG009|Overall Study|Withdrawal by Subject|1|||
161244673|NCT02611323|582273623|FG010|Overall Study|Withdrawal by Subject|0|||
161244674|NCT00243347|582273624|FG000|Overall Study|Lack of Efficacy|4|||
161244675|NCT00243347|582273624|FG000|Overall Study|Adverse Event|2|||
161244676|NCT00243347|582273624|FG000|Overall Study|Death|1|||
161244677|NCT00243347|582273624|FG000|Overall Study|Withdrawal by Subject|5|||
161244678|NCT00243347|582273624|FG000|Overall Study|Condition worsened|7|||
161244679|NCT03531827|582273631|FG000|Overall Study|Adverse Event|2|||
161244680|NCT03531827|582273632|FG001|Overall Study|Adverse Event|0|||
161244681|NCT03531827|582273631|FG000|Overall Study|Progressive disease|1|||
161244682|NCT03531827|582273632|FG001|Overall Study|Progressive disease|0|||
161244683|NCT03067987|582273633|FG000|Overall Study|Lost to Follow-up|7|||
161244684|NCT03067987|582273634|FG001|Overall Study|Lost to Follow-up|10|||
161244685|NCT03067987|582273633|FG000|Overall Study|Protocol Violation|1|||
161244686|NCT03067987|582273634|FG001|Overall Study|Protocol Violation|2|||
161244687|NCT03067987|582273633|FG000|Overall Study|Withdrawal by Subject|2|||
161244688|NCT03067987|582273634|FG001|Overall Study|Withdrawal by Subject|1|||
161244689|NCT00754052|582274912|FG000|Overall Study|Study terminated by Sponsor|5|||
161244690|NCT00754052|582274913|FG001|Overall Study|Study terminated by Sponsor|3|||
161244691|NCT00516295|582274917|FG000|Overall Study|Lack of Efficacy|2|||
161244692|NCT00516295|582274918|FG001|Overall Study|Lack of Efficacy|0|||
161244693|NCT00516295|582274919|FG002|Overall Study|Lack of Efficacy|0|||
161244694|NCT00516295|582274917|FG000|Overall Study|Ineligible|1|||
161244695|NCT00516295|582274918|FG001|Overall Study|Ineligible|0|||
161244696|NCT00516295|582274919|FG002|Overall Study|Ineligible|0|||
161244697|NCT02651987|582274922|FG000|Overall Study|Adverse Event|2|||
161244698|NCT02651987|582274923|FG001|Overall Study|Adverse Event|2|||
161244699|NCT02651987|582274922|FG000|Overall Study|Consent Withdrawn|2|||
161244700|NCT02651987|582274923|FG001|Overall Study|Consent Withdrawn|0|||
161244701|NCT02651987|582274922|FG000|Overall Study|Local PD|0|||
161244702|NCT02651987|582274923|FG001|Overall Study|Local PD|2|||
161244703|NCT02651987|582274922|FG000|Overall Study|Investigator Decision|1|||
161244704|NCT02651987|582274923|FG001|Overall Study|Investigator Decision|1|||
161244705|NCT02725515|582274924|FG000|Overall Study|Refused infusion (no study treatment)|1|||
161244706|NCT02725515|582274925|FG001|Overall Study|Refused infusion (no study treatment)|0|||
161244707|NCT02725515|582274924|FG000|Overall Study|Loss of Improvement per Protocol|14|||
161244708|NCT02725515|582274925|FG001|Overall Study|Loss of Improvement per Protocol|25|||
161244709|NCT02725515|582274924|FG000|Overall Study|Withdrawal by Subject|2|||
161244710|NCT02725515|582274925|FG001|Overall Study|Withdrawal by Subject|1|||
161244711|NCT02725515|582274924|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161244712|NCT02725515|582274925|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161244713|NCT02725515|582274924|FG000|Overall Study|Lost to Follow-up|1|||
161244714|NCT02725515|582274925|FG001|Overall Study|Lost to Follow-up|1|||
161244715|NCT02725515|582274924|FG000|Overall Study|Adverse Event|7|||
161244716|NCT02725515|582274925|FG001|Overall Study|Adverse Event|2|||
161244717|NCT02725515|582274924|FG000|Overall Study|No Documented Disease Improvement|0|||
161244718|NCT02725515|582274925|FG001|Overall Study|No Documented Disease Improvement|1|||
161244719|NCT02725515|582274924|FG000|Overall Study|Completed Study Under Original Protocol|0|||
161244720|NCT02725515|582274925|FG001|Overall Study|Completed Study Under Original Protocol|1|||
161244721|NCT02725515|582274924|FG000|Overall Study|Lack of Response|0|||
161244722|NCT02725515|582274925|FG001|Overall Study|Lack of Response|1|||
161244723|NCT00183196|582274931|FG000|Overall Study|Withdrawal by Subject|18|||
161244724|NCT00183196|582274932|FG001|Overall Study|Withdrawal by Subject|11|||
161244725|NCT00183196|582274933|FG002|Overall Study|Withdrawal by Subject|13|||
161244726|NCT00183196|582274931|FG000|Overall Study|Adverse Event|1|||
161244727|NCT00183196|582274932|FG001|Overall Study|Adverse Event|2|||
161244728|NCT00183196|582274933|FG002|Overall Study|Adverse Event|2|||
161244729|NCT00183196|582274931|FG000|Overall Study|Legal event|1|||
161244730|NCT00183196|582274932|FG001|Overall Study|Legal event|1|||
161244731|NCT00183196|582274933|FG002|Overall Study|Legal event|1|||
161244732|NCT00183196|582274931|FG000|Overall Study|Required more intensive care|0|||
161244733|NCT00183196|582274932|FG001|Overall Study|Required more intensive care|1|||
161244734|NCT00183196|582274933|FG002|Overall Study|Required more intensive care|2|||
161244735|NCT00385736|582274934|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
161244736|NCT00385736|582274935|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
161244737|NCT00385736|582274936|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
161244738|NCT00385736|582274934|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
161244739|NCT00385736|582274935|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
161244740|NCT00385736|582274936|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
161244741|NCT00385736|582274934|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
161244742|NCT00385736|582274935|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
161244743|NCT00385736|582274936|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
161244744|NCT00385736|582274934|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
161244745|NCT00385736|582274935|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
161244746|NCT00385736|582274936|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
161244747|NCT00385736|582274934|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
161244748|NCT00385736|582274935|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
161244749|NCT00385736|582274936|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
161244750|NCT00385736|582274934|FG000|Efficacy Analysis Set - Induction|Other|0|||
161244751|NCT00385736|582274935|FG001|Efficacy Analysis Set - Induction|Other|0|||
161244752|NCT00385736|582274936|FG002|Efficacy Analysis Set - Induction|Other|1|||
161244753|NCT00385736|582274934|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
161244754|NCT00385736|582274935|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
161244755|NCT00385736|582274936|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
161244756|NCT00385736|582274934|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
161244757|NCT00385736|582274935|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
161244758|NCT00385736|582274936|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
161244759|NCT00385736|582274934|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
161244760|NCT00385736|582274935|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
161244761|NCT00385736|582274936|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
161244762|NCT00385736|582274934|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
161244763|NCT00385736|582274935|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
161244764|NCT00385736|582274936|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
161244765|NCT00385736|582274934|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
161244766|NCT00385736|582274935|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
161244767|NCT00385736|582274936|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
161244768|NCT00385736|582274934|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
161244769|NCT00385736|582274935|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
161244770|NCT00385736|582274936|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
161244771|NCT00385736|582274934|FG000|Safety Analysis Set|Adverse Event|23|||
161244772|NCT00385736|582274935|FG001|Safety Analysis Set|Adverse Event|15|||
161244773|NCT00385736|582274936|FG002|Safety Analysis Set|Adverse Event|23|||
161244774|NCT00385736|582274934|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
161244775|NCT00385736|582274935|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
161244776|NCT00385736|582274936|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
161244777|NCT00385736|582274934|FG000|Safety Analysis Set|Lost to Follow-up|0|||
161244778|NCT00385736|582274935|FG001|Safety Analysis Set|Lost to Follow-up|2|||
161244779|NCT00385736|582274936|FG002|Safety Analysis Set|Lost to Follow-up|2|||
161244780|NCT00385736|582274934|FG000|Safety Analysis Set|Lack of Efficacy|38|||
161244781|NCT00385736|582274935|FG001|Safety Analysis Set|Lack of Efficacy|16|||
161244782|NCT00385736|582274936|FG002|Safety Analysis Set|Lack of Efficacy|31|||
161244783|NCT00385736|582274934|FG000|Safety Analysis Set|Protocol Violation|2|||
161244784|NCT00385736|582274935|FG001|Safety Analysis Set|Protocol Violation|1|||
161244785|NCT00385736|582274936|FG002|Safety Analysis Set|Protocol Violation|6|||
161244786|NCT00385736|582274934|FG000|Safety Analysis Set|Other|1|||
161244787|NCT00385736|582274935|FG001|Safety Analysis Set|Other|4|||
161244788|NCT00385736|582274936|FG002|Safety Analysis Set|Other|4|||
161244789|NCT01701063|582274943|FG000|Overall Study|Lost to Follow-up|0|||
161244790|NCT01701063|582274944|FG001|Overall Study|Lost to Follow-up|1|||
161244791|NCT01701063|582274945|FG002|Overall Study|Lost to Follow-up|0|||
161244792|NCT01701063|582274943|FG000|Overall Study|Withdrawal by Subject|0|||
160990707|NCT00372060|581353924|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
161244793|NCT01701063|582274944|FG001|Overall Study|Withdrawal by Subject|0|||
161244794|NCT01701063|582274945|FG002|Overall Study|Withdrawal by Subject|1|||
161244795|NCT01701063|582274943|FG000|Overall Study|Other|0|||
161244796|NCT01701063|582274944|FG001|Overall Study|Other|0|||
161244797|NCT01701063|582274945|FG002|Overall Study|Other|1|||
161244798|NCT01919112|582274946|FG000|Secondary Analysis-day 30|Death|1|||
161244799|NCT01919112|582274947|FG001|Secondary Analysis-day 30|Death|1|||
161244800|NCT01919112|582274948|FG002|Secondary Analysis-day 30|Death|1|||
161244801|NCT01919112|582274946|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
161244802|NCT01919112|582274947|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
161244803|NCT01919112|582274948|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
160828583|NCT01510184|580759833|FG000|Overall Study|Other|0|||
160828584|NCT01510184|580759834|FG001|Overall Study|Other|1|||
160828585|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
160828586|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
160828587|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
160990708|NCT00372060|581353925|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
161244804|NCT00835666|582274949|FG000|Washout|Protocol Violation|1|||
161244805|NCT00835666|582274950|FG001|Washout|Protocol Violation|0|||
161244806|NCT00835666|582274949|FG000|Washout|Withdrawal by Subject|1|||
161244807|NCT00835666|582274950|FG001|Washout|Withdrawal by Subject|0|||
161244808|NCT00635648|582274951|FG000|Overall Study|Adverse Event|12|||
161244809|NCT00635648|582274951|FG000|Overall Study|Withdrawal by Subject|9|||
161244810|NCT00635648|582274951|FG000|Overall Study|Physician Decision|4|||
161244811|NCT00635648|582274951|FG000|Overall Study|Rapid progression of baseline disease|4|||
161244812|NCT00635648|582274951|FG000|Overall Study|Use of other antifungal agent needed|1|||
161334757|NCT02265510|582615814|FG002|Overall Study|Lost to Follow-up|0|||
161334758|NCT02265510|582615815|FG003|Overall Study|Lost to Follow-up|0|||
161334759|NCT02265510|582615816|FG004|Overall Study|Lost to Follow-up|1|||
161334760|NCT02265510|582615817|FG005|Overall Study|Lost to Follow-up|0|||
161334761|NCT02265510|582615818|FG006|Overall Study|Lost to Follow-up|0|||
161334762|NCT02265510|582615819|FG007|Overall Study|Lost to Follow-up|0|||
161334763|NCT02265510|582615820|FG008|Overall Study|Lost to Follow-up|0|||
161334764|NCT02265510|582615821|FG009|Overall Study|Lost to Follow-up|2|||
161334765|NCT02265510|582615822|FG010|Overall Study|Lost to Follow-up|0|||
161334766|NCT02265510|582615823|FG011|Overall Study|Lost to Follow-up|0|||
161334767|NCT02265510|582615824|FG012|Overall Study|Lost to Follow-up|0|||
161334768|NCT02265510|582615825|FG013|Overall Study|Lost to Follow-up|2|||
161334769|NCT02265510|582615812|FG000|Overall Study|Other|0|||
161334770|NCT02265510|582615813|FG001|Overall Study|Other|1|||
161334771|NCT02265510|582615814|FG002|Overall Study|Other|0|||
161334772|NCT02265510|582615815|FG003|Overall Study|Other|0|||
161334773|NCT02265510|582615816|FG004|Overall Study|Other|0|||
161334774|NCT02265510|582615817|FG005|Overall Study|Other|0|||
161334775|NCT02265510|582615818|FG006|Overall Study|Other|0|||
161334776|NCT02265510|582615819|FG007|Overall Study|Other|0|||
161334777|NCT02265510|582615820|FG008|Overall Study|Other|0|||
161135064|NCT00064701|581876699|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
161135065|NCT00064701|581876700|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
161135066|NCT00064701|581876698|FG000|Clinical Continuation Phase|Graft Failure|5|||
161334778|NCT02265510|582615821|FG009|Overall Study|Other|0|||
161334779|NCT02265510|582615822|FG010|Overall Study|Other|0|||
161334780|NCT02265510|582615823|FG011|Overall Study|Other|0|||
161334781|NCT02265510|582615824|FG012|Overall Study|Other|0|||
161334782|NCT02265510|582615825|FG013|Overall Study|Other|0|||
161334783|NCT02265510|582615812|FG000|Overall Study|Study Terminated by Sponsor|0|||
161334784|NCT02265510|582615813|FG001|Overall Study|Study Terminated by Sponsor|0|||
161334785|NCT02265510|582615814|FG002|Overall Study|Study Terminated by Sponsor|0|||
161334786|NCT02265510|582615815|FG003|Overall Study|Study Terminated by Sponsor|0|||
161334787|NCT02265510|582615816|FG004|Overall Study|Study Terminated by Sponsor|0|||
161334788|NCT02265510|582615817|FG005|Overall Study|Study Terminated by Sponsor|1|||
161334789|NCT02265510|582615818|FG006|Overall Study|Study Terminated by Sponsor|1|||
161334790|NCT02265510|582615819|FG007|Overall Study|Study Terminated by Sponsor|1|||
161334791|NCT02265510|582615820|FG008|Overall Study|Study Terminated by Sponsor|1|||
161135067|NCT00064701|581876699|FG001|Clinical Continuation Phase|Graft Failure|5|||
161135068|NCT00064701|581876700|FG002|Clinical Continuation Phase|Graft Failure|2|||
161135069|NCT00064701|581876698|FG000|Clinical Continuation Phase|Rejection|1|||
161135070|NCT00064701|581876699|FG001|Clinical Continuation Phase|Rejection|2|||
161135071|NCT00064701|581876700|FG002|Clinical Continuation Phase|Rejection|2|||
161135072|NCT00064701|581876698|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
161135073|NCT00064701|581876699|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
161135074|NCT00064701|581876700|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
161135075|NCT00064701|581876698|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
161135076|NCT00064701|581876699|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
161135077|NCT00064701|581876700|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
161135078|NCT00064701|581876698|FG000|Clinical Continuation Phase|Physician Decision|1|||
161135079|NCT00064701|581876699|FG001|Clinical Continuation Phase|Physician Decision|3|||
161135080|NCT00064701|581876700|FG002|Clinical Continuation Phase|Physician Decision|0|||
161135081|NCT00064701|581876698|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
161135082|NCT00064701|581876699|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
161135083|NCT00064701|581876700|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
161135084|NCT00064701|581876698|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
161135085|NCT00064701|581876699|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
161135086|NCT00064701|581876700|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
161135087|NCT00064701|581876698|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
161135088|NCT00064701|581876699|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
161135089|NCT00064701|581876700|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
161135090|NCT00064701|581876698|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
161135091|NCT00064701|581876699|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
161135092|NCT00064701|581876700|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
161135093|NCT00064701|581876698|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
161135094|NCT00064701|581876699|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
161135095|NCT00064701|581876700|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
161135096|NCT00064701|581876698|FG000|Clinical Continuation Phase|Patient opted out|0|||
161334792|NCT02265510|582615821|FG009|Overall Study|Study Terminated by Sponsor|2|||
161334793|NCT02265510|582615822|FG010|Overall Study|Study Terminated by Sponsor|1|||
161334794|NCT02265510|582615823|FG011|Overall Study|Study Terminated by Sponsor|4|||
161334795|NCT02265510|582615824|FG012|Overall Study|Study Terminated by Sponsor|1|||
161334796|NCT02265510|582615825|FG013|Overall Study|Study Terminated by Sponsor|2|||
161334797|NCT02530385|582615826|FG000|Overall Study|Withdrawal by Subject|0|||
160828588|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
160828589|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
161135097|NCT00064701|581876699|FG001|Clinical Continuation Phase|Patient opted out|0|||
161135098|NCT00064701|581876700|FG002|Clinical Continuation Phase|Patient opted out|1|||
161135099|NCT01818297|581876701|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
161135100|NCT01818297|581876702|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
161135101|NCT01818297|581876701|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
161135102|NCT01818297|581876702|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
161135103|NCT01818297|581876701|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
161135104|NCT01818297|581876702|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
161135105|NCT03308188|581876703|FG000|Overall Study|Withdrawal by Subject|0|||
161135106|NCT03308188|581876704|FG001|Overall Study|Withdrawal by Subject|3|||
161135107|NCT03308188|581876703|FG000|Overall Study|Death|0|||
161135108|NCT03308188|581876704|FG001|Overall Study|Death|1|||
161135109|NCT00481065|581876705|FG000|Overall Study|Adverse event or death|1|||
161135110|NCT00481065|581876706|FG001|Overall Study|Adverse event or death|1|||
161135111|NCT00481065|581876707|FG002|Overall Study|Adverse event or death|3|||
161135112|NCT00481065|581876708|FG003|Overall Study|Adverse event or death|0|||
161135113|NCT00481065|581876709|FG004|Overall Study|Adverse event or death|2|||
161135114|NCT00481065|581876710|FG005|Overall Study|Adverse event or death|0|||
161135115|NCT00481065|581876711|FG006|Overall Study|Adverse event or death|1|||
161135116|NCT00481065|581876712|FG007|Overall Study|Adverse event or death|1|||
161135117|NCT00481065|581876705|FG000|Overall Study|Withdrawal by Subject|11|||
161135118|NCT00481065|581876706|FG001|Overall Study|Withdrawal by Subject|12|||
161135119|NCT00481065|581876707|FG002|Overall Study|Withdrawal by Subject|7|||
161135120|NCT00481065|581876708|FG003|Overall Study|Withdrawal by Subject|11|||
161135121|NCT00481065|581876709|FG004|Overall Study|Withdrawal by Subject|13|||
161135122|NCT00481065|581876710|FG005|Overall Study|Withdrawal by Subject|12|||
161135123|NCT00481065|581876711|FG006|Overall Study|Withdrawal by Subject|9|||
161135124|NCT00481065|581876712|FG007|Overall Study|Withdrawal by Subject|10|||
161135125|NCT00481065|581876705|FG000|Overall Study|Lost to Follow-up|4|||
161135126|NCT00481065|581876706|FG001|Overall Study|Lost to Follow-up|2|||
161135127|NCT00481065|581876707|FG002|Overall Study|Lost to Follow-up|4|||
161135128|NCT00481065|581876708|FG003|Overall Study|Lost to Follow-up|3|||
161135129|NCT00481065|581876709|FG004|Overall Study|Lost to Follow-up|3|||
161135130|NCT00481065|581876710|FG005|Overall Study|Lost to Follow-up|3|||
161135131|NCT00481065|581876711|FG006|Overall Study|Lost to Follow-up|2|||
161135132|NCT00481065|581876712|FG007|Overall Study|Lost to Follow-up|5|||
161135133|NCT00481065|581876705|FG000|Overall Study|Inappropriate enrollment|4|||
161135134|NCT00481065|581876706|FG001|Overall Study|Inappropriate enrollment|0|||
161135135|NCT00481065|581876707|FG002|Overall Study|Inappropriate enrollment|2|||
161135136|NCT00481065|581876708|FG003|Overall Study|Inappropriate enrollment|0|||
161135137|NCT00481065|581876709|FG004|Overall Study|Inappropriate enrollment|2|||
161135138|NCT00481065|581876710|FG005|Overall Study|Inappropriate enrollment|1|||
161135139|NCT00481065|581876711|FG006|Overall Study|Inappropriate enrollment|0|||
161135140|NCT00481065|581876712|FG007|Overall Study|Inappropriate enrollment|1|||
161135141|NCT00481065|581876705|FG000|Overall Study|Administrative reason|0|||
161135142|NCT00481065|581876706|FG001|Overall Study|Administrative reason|0|||
161135143|NCT00481065|581876707|FG002|Overall Study|Administrative reason|0|||
161135144|NCT00481065|581876708|FG003|Overall Study|Administrative reason|0|||
161135145|NCT00481065|581876709|FG004|Overall Study|Administrative reason|0|||
161135146|NCT00481065|581876710|FG005|Overall Study|Administrative reason|2|||
161135147|NCT00481065|581876711|FG006|Overall Study|Administrative reason|1|||
161135148|NCT00481065|581876712|FG007|Overall Study|Administrative reason|0|||
161135149|NCT00481065|581876705|FG000|Overall Study|Protocol Violation|2|||
161135150|NCT00481065|581876706|FG001|Overall Study|Protocol Violation|1|||
161135151|NCT00481065|581876707|FG002|Overall Study|Protocol Violation|1|||
161135152|NCT00481065|581876708|FG003|Overall Study|Protocol Violation|1|||
161135153|NCT00481065|581876709|FG004|Overall Study|Protocol Violation|2|||
161135154|NCT00481065|581876710|FG005|Overall Study|Protocol Violation|6|||
161135155|NCT00481065|581876711|FG006|Overall Study|Protocol Violation|3|||
161135156|NCT00481065|581876712|FG007|Overall Study|Protocol Violation|2|||
161244813|NCT00635648|582274951|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
161244814|NCT00635648|582274951|FG000|Overall Study|Noncompliance with protocol|1|||
161135157|NCT00481065|581876705|FG000|Overall Study|Unable to classify|0|||
161135158|NCT00481065|581876706|FG001|Overall Study|Unable to classify|1|||
161135159|NCT00481065|581876707|FG002|Overall Study|Unable to classify|2|||
161135160|NCT00481065|581876708|FG003|Overall Study|Unable to classify|0|||
161135161|NCT00481065|581876709|FG004|Overall Study|Unable to classify|1|||
161135162|NCT00481065|581876710|FG005|Overall Study|Unable to classify|0|||
161135163|NCT00481065|581876711|FG006|Overall Study|Unable to classify|0|||
161135164|NCT00481065|581876712|FG007|Overall Study|Unable to classify|0|||
161135165|NCT01709331|581876713|FG000|Overall Study|Adverse Event|1|||
161135166|NCT04439344|581876714|FG000|Overall Study|Never started threapy|3|||
161135167|NCT04439344|581876714|FG000|Overall Study|Ineligible|3|||
161135168|NCT04439344|581876714|FG000|Overall Study|Adverse Event|13|||
161244815|NCT00635648|582274951|FG000|Overall Study|Other reason|2|||
161244816|NCT03158727|582274954|FG000|Overall Study|Withdrawal by Subject|2|||
161244817|NCT03158727|582274955|FG001|Overall Study|Withdrawal by Subject|6|||
161244818|NCT03158727|582274954|FG000|Overall Study|Death|11|||
161244819|NCT03158727|582274955|FG001|Overall Study|Death|12|||
161244820|NCT03158727|582274954|FG000|Overall Study|Lost to Follow-up|1|||
161244821|NCT03158727|582274955|FG001|Overall Study|Lost to Follow-up|0|||
161244822|NCT03158727|582274954|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
161244823|NCT03158727|582274955|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
161244824|NCT03158727|582274954|FG000|Overall Study|Visit 11 not done by mistake|0|||
161244825|NCT03158727|582274955|FG001|Overall Study|Visit 11 not done by mistake|1|||
161244826|NCT03158727|582274954|FG000|Overall Study|Enrolled, not treated|1|||
161244827|NCT03158727|582274955|FG001|Overall Study|Enrolled, not treated|0|||
161244828|NCT00101439|582274959|FG000|Period 2|Withdrawal by Subject|0|||
161244829|NCT00101439|582274960|FG001|Period 2|Withdrawal by Subject|2|||
161244830|NCT00863330|582274966|FG000|Overall Study|study terminated early due to administra|6|||
161244831|NCT02615249|582274967|FG000|Overall Study|Withdrawal by Subject|1|||
161244832|NCT05098743|582274968|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
161244833|NCT05098743|582274969|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
161244834|NCT05098743|582274968|FG000|Overall Study|Lost to Follow-up|1|||
161244835|NCT05098743|582274969|FG001|Overall Study|Lost to Follow-up|2|||
161244836|NCT00868998|582274970|FG000|Overall Study|Screen Failure|1|||
161244837|NCT00868998|582274970|FG000|Overall Study|Withdrawal by Subject|1|||
161244838|NCT00868998|582274970|FG000|Overall Study|Progression of disease|2|||
161244839|NCT00868998|582274970|FG000|Overall Study|Death|1|||
161244840|NCT01483820|582274972|FG000|Overall Study|Lack of Efficacy|6|||
161244841|NCT01483820|582274972|FG000|Overall Study|Adverse Event|1|||
161244842|NCT01483820|582274972|FG000|Overall Study|Death|1|||
161244843|NCT00474188|582274976|FG000|Overall Study|Withdrawal by Subject|1|||
161244844|NCT00474188|582274976|FG000|Overall Study|Study discontinued by sponsor|5|||
161334798|NCT02530385|582615827|FG001|Overall Study|Withdrawal by Subject|1|||
161334799|NCT00116142|582615828|FG000|Overall Study|Adverse Event|8|||
161334800|NCT00116142|582615829|FG001|Overall Study|Adverse Event|7|||
161334801|NCT00116142|582615828|FG000|Overall Study|Protocol Violation|2|||
161334802|NCT00116142|582615829|FG001|Overall Study|Protocol Violation|1|||
161334803|NCT00116142|582615828|FG000|Overall Study|Withdrawal by Subject|5|||
161334804|NCT00116142|582615829|FG001|Overall Study|Withdrawal by Subject|5|||
160902827|NCT00705289|581037843|FG000|Overall Study|Subject or treating physician's choice|131|||
160902828|NCT02763462|581037849|FG000|Overall Study|Protocol Violation|6|||
160902829|NCT00129272|581037850|FG000|Overall Study|Lost to Follow-up|12|||
160902830|NCT00129272|581037851|FG001|Overall Study|Lost to Follow-up|11|||
160902831|NCT00129272|581037850|FG000|Overall Study|Withdrawal by Subject|5|||
161334805|NCT00116142|582615828|FG000|Overall Study|Physician Decision|3|||
161334806|NCT00116142|582615829|FG001|Overall Study|Physician Decision|1|||
161334807|NCT00116142|582615828|FG000|Overall Study|Delayed Radiation Therapy|1|||
161334808|NCT00116142|582615829|FG001|Overall Study|Delayed Radiation Therapy|0|||
161334809|NCT00116142|582615828|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
161334810|NCT00116142|582615829|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
161334811|NCT00116142|582615828|FG000|Overall Study|Patient stopped due to depression|0|||
161334812|NCT00116142|582615829|FG001|Overall Study|Patient stopped due to depression|1|||
161334813|NCT00116142|582615828|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
161334814|NCT00116142|582615829|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
161334815|NCT00116142|582615828|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
161334816|NCT00116142|582615829|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
160902832|NCT00129272|581037851|FG001|Overall Study|Withdrawal by Subject|11|||
160902833|NCT00675948|581037853|FG000|Overall Study|Adverse Event|23|||
160902834|NCT00675948|581037854|FG001|Overall Study|Adverse Event|1|||
160990709|NCT00372060|581353924|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
160990710|NCT00372060|581353925|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
160990711|NCT00372060|581353924|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
161135169|NCT04439344|581876714|FG000|Overall Study|Death|2|||
161135170|NCT04439344|581876714|FG000|Overall Study|Disease progression|29|||
161135171|NCT04439344|581876714|FG000|Overall Study|Withdrawal by Subject|2|||
160902835|NCT00675948|581037853|FG000|Overall Study|Lack of Efficacy|3|||
161135172|NCT04439344|581876714|FG000|Overall Study|Alternative therapy|1|||
161135173|NCT00772447|581876715|FG000|Overall Study|Withdrawal by Subject|9|||
161135174|NCT00772447|581876716|FG001|Overall Study|Withdrawal by Subject|5|||
161135175|NCT00772447|581876715|FG000|Overall Study|Physician Decision|4|||
161135176|NCT00772447|581876716|FG001|Overall Study|Physician Decision|8|||
160902836|NCT00675948|581037854|FG001|Overall Study|Lack of Efficacy|0|||
161135177|NCT00772447|581876715|FG000|Overall Study|Lost to Follow-up|2|||
161135178|NCT00772447|581876716|FG001|Overall Study|Lost to Follow-up|4|||
161244845|NCT05412121|582274977|FG000|Overall Study|Withdrawal by Subject|4|||
161244846|NCT05412121|582274977|FG000|Overall Study|Physician Decision|1|||
161244847|NCT05412121|582274977|FG000|Overall Study|Lost to Follow-up|5|||
161244848|NCT03541252|582274978|FG000|Overall Study|Withdrawal by Subject|1|||
161244849|NCT01576705|582274985|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
161244850|NCT01576705|582274986|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
161244851|NCT01576705|582274987|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
161244852|NCT01576705|582274988|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
161244853|NCT01576705|582274985|FG000|Overall Study|invalid ICF|0|||
161334817|NCT00116142|582615828|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
161244854|NCT01576705|582274986|FG001|Overall Study|invalid ICF|1|||
161334818|NCT00116142|582615829|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
161334819|NCT03093181|582615831|FG000|Overall Study|Withdrawal by Subject|2|||
161334820|NCT03093181|582615832|FG001|Overall Study|Withdrawal by Subject|1|||
161334821|NCT03093181|582615833|FG002|Overall Study|Withdrawal by Subject|2|||
161334822|NCT03093181|582615831|FG000|Overall Study|Other (Not specified)|1|||
161334823|NCT03093181|582615832|FG001|Overall Study|Other (Not specified)|0|||
161334824|NCT03093181|582615833|FG002|Overall Study|Other (Not specified)|0|||
161334825|NCT03093181|582615831|FG000|Overall Study|Adverse Event|0|||
161334826|NCT03093181|582615832|FG001|Overall Study|Adverse Event|1|||
161334827|NCT03093181|582615833|FG002|Overall Study|Adverse Event|0|||
161334828|NCT03093181|582615831|FG000|Overall Study|Other (Protocol violation)|0|||
161334829|NCT03093181|582615832|FG001|Overall Study|Other (Protocol violation)|0|||
161334830|NCT03093181|582615833|FG002|Overall Study|Other (Protocol violation)|1|||
161334831|NCT04076917|582615834|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
161334832|NCT04076917|582615834|FG000|Overall Study|Study closure|13|||
161334833|NCT04076917|582615834|FG000|Overall Study|Physician Decision|3|||
161334834|NCT04076917|582615834|FG000|Overall Study|Death|1|||
161244855|NCT01576705|582274987|FG002|Overall Study|invalid ICF|0|||
161244856|NCT01576705|582274988|FG003|Overall Study|invalid ICF|0|||
161244857|NCT03727139|582274989|FG000|Overall Study|Protocol Violation|60|||
161244858|NCT00858403|582274990|FG000|Overall Study|Withdrawal by Subject|1|||
161244859|NCT00858403|582274990|FG000|Overall Study|Death|3|||
161244860|NCT00858403|582274990|FG000|Overall Study|Disease Progression|1|||
161244861|NCT02264977|582274991|FG000|Overall Study|Death|3|||
161244862|NCT02264977|582274991|FG000|Overall Study|Physician Decision|1|||
161244863|NCT02264977|582274991|FG000|Overall Study|Refuse to return|1|||
161244864|NCT00227370|582274995|FG000|Overall Study|Withdrawal by Subject|1|||
161334835|NCT04076917|582615834|FG000|Overall Study|Lost to Follow-up|1|||
161334836|NCT04076917|582615834|FG000|Overall Study|Withdrawal by Subject|1|||
161334837|NCT04076917|582615834|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
161334838|NCT04210986|582615835|FG000|Overall Study|Lost to Follow-up|5|||
161334839|NCT04210986|582615836|FG001|Overall Study|Lost to Follow-up|2|||
161334840|NCT04210986|582615835|FG000|Overall Study|Withdrawal by Subject|3|||
161334841|NCT04210986|582615836|FG001|Overall Study|Withdrawal by Subject|1|||
161334842|NCT04210986|582615835|FG000|Overall Study|Protocol Violation|1|||
161334843|NCT04210986|582615836|FG001|Overall Study|Protocol Violation|1|||
161334844|NCT04210986|582615835|FG000|Overall Study|Physician Decision|0|||
161334845|NCT04210986|582615836|FG001|Overall Study|Physician Decision|1|||
161334846|NCT02378662|582615837|FG000|Overall Study|Early Discontinuation|2|||
161334847|NCT02378662|582615838|FG001|Overall Study|Early Discontinuation|0|||
161334848|NCT01774591|582615839|FG000|Overall Study|Physician Decision|1|||
161334849|NCT01774591|582615840|FG001|Overall Study|Physician Decision|1|||
161334850|NCT01774591|582615839|FG000|Overall Study|Withdrawal by Subject|0|||
161135179|NCT00772447|581876715|FG000|Overall Study|incorrect enrolment|3|||
161135180|NCT00772447|581876716|FG001|Overall Study|incorrect enrolment|4|||
161135181|NCT00772447|581876715|FG000|Overall Study|Protocol Violation|0|||
161135182|NCT00772447|581876716|FG001|Overall Study|Protocol Violation|1|||
161135183|NCT00772447|581876715|FG000|Overall Study|all others|2|||
161135184|NCT00772447|581876716|FG001|Overall Study|all others|2|||
161135185|NCT03770403|581876722|FG000|Overall Study|Adverse Event|8|||
160828590|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
160828591|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
160828592|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
160828593|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
160828594|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
160828595|NCT01352741|580759837|FG000|Open-label Tapentadol Titration Period|Other|4|||
160828596|NCT01352741|580759838|FG001|Open-label Tapentadol Titration Period|Other|0|||
160828597|NCT01352741|580759837|FG000|Double-blind Comparative Period|Protocol Violation|2|||
160902837|NCT00675948|581037853|FG000|Overall Study|Withdrawal by Subject|7|||
161135186|NCT03770403|581876722|FG000|Overall Study|Death|5|||
161135187|NCT03770403|581876722|FG000|Overall Study|Physician Decision|1|||
161135188|NCT03770403|581876722|FG000|Overall Study|Sponsor decision|1|||
161135189|NCT03770403|581876722|FG000|Overall Study|Study terminated by Sponsor|1|||
161244865|NCT00227370|582274996|FG001|Overall Study|Withdrawal by Subject|2|||
161244866|NCT00227370|582274995|FG000|Overall Study|Death|3|||
161244867|NCT00227370|582274996|FG001|Overall Study|Death|4|||
161244868|NCT00227370|582274995|FG000|Overall Study|Adverse Event|6|||
161135190|NCT03770403|581876722|FG000|Overall Study|Withdrawal by Subject|13|||
161135191|NCT03770403|581876722|FG000|Overall Study|Other|88|||
161135192|NCT03896295|581876723|FG000|Overall Study|Adverse Event|0|||
161135193|NCT03896295|581876724|FG001|Overall Study|Adverse Event|1|||
161135194|NCT03896295|581876723|FG000|Overall Study|COVID-19|7|||
161135195|NCT03896295|581876724|FG001|Overall Study|COVID-19|29|||
161135196|NCT01957137|581876725|FG000|Randomized Portion|Adverse Event|1|||
161244869|NCT00227370|582274996|FG001|Overall Study|Adverse Event|11|||
161244870|NCT00227370|582274995|FG000|Overall Study|Physician Decision|9|||
161244871|NCT00227370|582274996|FG001|Overall Study|Physician Decision|6|||
161244872|NCT00227370|582274995|FG000|Overall Study|Other reasons|2|||
161244873|NCT00227370|582274996|FG001|Overall Study|Other reasons|1|||
161244874|NCT03846193|582274997|FG000|Overall Study|Physician Decision|0|||
161244875|NCT03846193|582274998|FG001|Overall Study|Physician Decision|0|||
161244876|NCT03846193|582274999|FG002|Overall Study|Physician Decision|1|||
161244877|NCT03846193|582275000|FG003|Overall Study|Physician Decision|0|||
161244878|NCT03846193|582275001|FG004|Overall Study|Physician Decision|0|||
161244879|NCT03846193|582274997|FG000|Overall Study|Lost to Follow-up|0|||
161244880|NCT03846193|582274998|FG001|Overall Study|Lost to Follow-up|0|||
161244881|NCT03846193|582274999|FG002|Overall Study|Lost to Follow-up|0|||
161244882|NCT03846193|582275000|FG003|Overall Study|Lost to Follow-up|0|||
161244883|NCT03846193|582275001|FG004|Overall Study|Lost to Follow-up|1|||
161244884|NCT03846193|582274997|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161244885|NCT03846193|582274998|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161244886|NCT03846193|582274999|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161244887|NCT03846193|582275000|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
161135197|NCT01957137|581876725|FG000|Randomized Portion|Withdrawal by Subject|1|||
161135198|NCT00700804|581876737|FG000|Overall Study|Withdrawal by Subject|1|||
161135199|NCT00700804|581876738|FG001|Overall Study|Withdrawal by Subject|2|||
161135200|NCT00700804|581876737|FG000|Overall Study|Protocol Violation|1|||
161135201|NCT00700804|581876738|FG001|Overall Study|Protocol Violation|1|||
161135202|NCT00700804|581876737|FG000|Overall Study|Loose Stools|1|||
161135203|NCT00700804|581876738|FG001|Overall Study|Loose Stools|1|||
161135204|NCT02901431|581876739|FG000|PK Part|Adverse Event|0|||
161135205|NCT02901431|581876740|FG001|PK Part|Adverse Event|1|||
161135206|NCT02901431|581876741|FG002|PK Part|Adverse Event|0|||
161135207|NCT02901431|581876742|FG003|PK Part|Adverse Event|0|||
161135208|NCT02901431|581876743|FG004|PK Part|Adverse Event|0|||
161135209|NCT02901431|581876744|FG005|PK Part|Adverse Event|0|||
161135210|NCT02901431|581876745|FG006|PK Part|Adverse Event|0|||
161244888|NCT03846193|582275001|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
161244889|NCT03961204|582275002|FG000|Overall Study|Withdrawal by Subject|2|||
161244890|NCT03961204|582275002|FG000|Overall Study|Lost to Follow-up|3|||
161244891|NCT03961204|582275002|FG000|Overall Study|Other|1|||
161244892|NCT03961204|582275002|FG000|Overall Study|Missing|1|||
161244893|NCT02218216|582275003|FG000|Overall Study|Study terminated before completed|6|||
161244894|NCT02218216|582275004|FG001|Overall Study|Study terminated before completed|0|||
161244895|NCT02218216|582275005|FG002|Overall Study|Study terminated before completed|0|||
161244896|NCT02452463|582275008|FG000|Overall Study|Death|1|||
161244897|NCT02452463|582275009|FG001|Overall Study|Death|0|||
161244898|NCT02452463|582275010|FG002|Overall Study|Death|0|||
161244899|NCT02452463|582275008|FG000|Overall Study|Study Suspended|1|||
161244900|NCT02452463|582275009|FG001|Overall Study|Study Suspended|0|||
161244901|NCT02452463|582275010|FG002|Overall Study|Study Suspended|0|||
161244902|NCT02452463|582275008|FG000|Overall Study|Recommended by DSMB|0|||
161244903|NCT02452463|582275009|FG001|Overall Study|Recommended by DSMB|1|||
161244904|NCT02452463|582275010|FG002|Overall Study|Recommended by DSMB|0|||
161244905|NCT02452463|582275008|FG000|Overall Study|Withdrawal by Subject|0|||
161244906|NCT02452463|582275009|FG001|Overall Study|Withdrawal by Subject|1|||
161135211|NCT02901431|581876746|FG007|PK Part|Adverse Event|0|||
161135212|NCT02901431|581876747|FG008|PK Part|Adverse Event|0|||
161135213|NCT02901431|581876748|FG009|PK Part|Adverse Event|0|||
161135214|NCT02901431|581876749|FG010|PK Part|Adverse Event|0|||
161135215|NCT02901431|581876750|FG011|PK Part|Adverse Event|0|||
161135216|NCT02901431|581876751|FG012|PK Part|Adverse Event|0|||
161135217|NCT02901431|581876739|FG000|PK Part|Lost to Follow-up|0|||
161135218|NCT02901431|581876740|FG001|PK Part|Lost to Follow-up|0|||
161135219|NCT02901431|581876741|FG002|PK Part|Lost to Follow-up|1|||
161135220|NCT02901431|581876742|FG003|PK Part|Lost to Follow-up|0|||
161135221|NCT02901431|581876743|FG004|PK Part|Lost to Follow-up|0|||
161135222|NCT02901431|581876744|FG005|PK Part|Lost to Follow-up|0|||
161135223|NCT02901431|581876745|FG006|PK Part|Lost to Follow-up|0|||
161244907|NCT02452463|582275010|FG002|Overall Study|Withdrawal by Subject|0|||
161244908|NCT01073631|582275011|FG000|Overall Study|Death|82|||
161244909|NCT01073631|582275011|FG000|Overall Study|Adverse Event|24|||
161244910|NCT01073631|582275011|FG000|Overall Study|Other|63|||
161244911|NCT01131260|582275012|FG000|Overall Study|Randomization error|5|||
161244912|NCT01131260|582275013|FG001|Overall Study|Randomization error|1|||
161244913|NCT01131260|582275012|FG000|Overall Study|Declined to continue participation|8|||
161244914|NCT01131260|582275013|FG001|Overall Study|Declined to continue participation|13|||
161135224|NCT02901431|581876746|FG007|PK Part|Lost to Follow-up|0|||
161135225|NCT02901431|581876747|FG008|PK Part|Lost to Follow-up|0|||
161135226|NCT02901431|581876748|FG009|PK Part|Lost to Follow-up|0|||
161135227|NCT02901431|581876749|FG010|PK Part|Lost to Follow-up|0|||
161135228|NCT02901431|581876750|FG011|PK Part|Lost to Follow-up|0|||
161244915|NCT01131260|582275012|FG000|Overall Study|Physician Decision|22|||
161244916|NCT01131260|582275013|FG001|Overall Study|Physician Decision|24|||
161244917|NCT01131260|582275012|FG000|Overall Study|Technical problems|7|||
161244918|NCT01131260|582275013|FG001|Overall Study|Technical problems|6|||
161244919|NCT01131260|582275012|FG000|Overall Study|Staff error|2|||
161244920|NCT01131260|582275013|FG001|Overall Study|Staff error|1|||
161244921|NCT01131260|582275012|FG000|Overall Study|Ineligible|0|||
161244922|NCT01131260|582275013|FG001|Overall Study|Ineligible|2|||
161244923|NCT01494532|582275018|FG000|Overall Study|Adverse Event|4|||
161244924|NCT01494532|582275019|FG001|Overall Study|Adverse Event|1|||
161244925|NCT01494532|582275020|FG002|Overall Study|Adverse Event|8|||
161244926|NCT01494532|582275021|FG003|Overall Study|Adverse Event|6|||
161244927|NCT01494532|582275022|FG004|Overall Study|Adverse Event|5|||
161244928|NCT01494532|582275023|FG005|Overall Study|Adverse Event|0|||
161244929|NCT01494532|582275018|FG000|Overall Study|Lack of Efficacy|0|||
161244930|NCT01494532|582275019|FG001|Overall Study|Lack of Efficacy|0|||
161244931|NCT01494532|582275020|FG002|Overall Study|Lack of Efficacy|0|||
161244932|NCT01494532|582275021|FG003|Overall Study|Lack of Efficacy|0|||
161244933|NCT01494532|582275022|FG004|Overall Study|Lack of Efficacy|2|||
161244934|NCT01494532|582275023|FG005|Overall Study|Lack of Efficacy|0|||
161244935|NCT01494532|582275018|FG000|Overall Study|Protocol deviation|2|||
161244936|NCT01494532|582275019|FG001|Overall Study|Protocol deviation|1|||
161244937|NCT01494532|582275020|FG002|Overall Study|Protocol deviation|3|||
161244938|NCT01494532|582275021|FG003|Overall Study|Protocol deviation|2|||
161244939|NCT01494532|582275022|FG004|Overall Study|Protocol deviation|3|||
161244940|NCT01494532|582275023|FG005|Overall Study|Protocol deviation|0|||
161244941|NCT01494532|582275018|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161244942|NCT01494532|582275019|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161244943|NCT01494532|582275020|FG002|Overall Study|Protocol-defined stopping criteria|1|||
161244944|NCT01494532|582275021|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161244945|NCT01494532|582275022|FG004|Overall Study|Protocol-defined stopping criteria|0|||
161244946|NCT01494532|582275023|FG005|Overall Study|Protocol-defined stopping criteria|0|||
161244947|NCT01494532|582275018|FG000|Overall Study|Lost to Follow-up|1|||
161244948|NCT01494532|582275019|FG001|Overall Study|Lost to Follow-up|0|||
161244949|NCT01494532|582275020|FG002|Overall Study|Lost to Follow-up|0|||
161244950|NCT01494532|582275021|FG003|Overall Study|Lost to Follow-up|2|||
161244951|NCT01494532|582275022|FG004|Overall Study|Lost to Follow-up|0|||
161244952|NCT01494532|582275023|FG005|Overall Study|Lost to Follow-up|0|||
161244953|NCT01494532|582275018|FG000|Overall Study|Physician Decision|0|||
161244954|NCT01494532|582275019|FG001|Overall Study|Physician Decision|1|||
161244955|NCT01494532|582275020|FG002|Overall Study|Physician Decision|1|||
161244956|NCT01494532|582275021|FG003|Overall Study|Physician Decision|2|||
161244957|NCT01494532|582275022|FG004|Overall Study|Physician Decision|0|||
161244958|NCT01494532|582275023|FG005|Overall Study|Physician Decision|0|||
161244959|NCT01494532|582275018|FG000|Overall Study|Withdrawal by Subject|3|||
161244960|NCT01494532|582275019|FG001|Overall Study|Withdrawal by Subject|1|||
161244961|NCT01494532|582275020|FG002|Overall Study|Withdrawal by Subject|4|||
161244962|NCT01494532|582275021|FG003|Overall Study|Withdrawal by Subject|3|||
161244963|NCT01494532|582275022|FG004|Overall Study|Withdrawal by Subject|2|||
161244964|NCT01494532|582275023|FG005|Overall Study|Withdrawal by Subject|0|||
161244965|NCT00679081|582275024|FG000|Overall Study|Lost to Follow-up|1|||
161244966|NCT01404988|582275029|FG000|Overall Study|Death|2|||
161244967|NCT01404988|582275030|FG001|Overall Study|Death|0|||
161244968|NCT01404988|582275031|FG002|Overall Study|Death|2|||
161244969|NCT01404988|582275029|FG000|Overall Study|Adverse Event|1|||
161135229|NCT02901431|581876751|FG012|PK Part|Lost to Follow-up|0|||
161135230|NCT02901431|581876739|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
161135231|NCT02901431|581876740|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135232|NCT02901431|581876741|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
160902838|NCT00675948|581037854|FG001|Overall Study|Withdrawal by Subject|0|||
160902839|NCT00675948|581037853|FG000|Overall Study|Lost to Follow-up|2|||
161244970|NCT01404988|582275030|FG001|Overall Study|Adverse Event|0|||
161244971|NCT01404988|582275031|FG002|Overall Study|Adverse Event|0|||
161244972|NCT01404988|582275029|FG000|Overall Study|Withdrawal by Subject|2|||
161244973|NCT01404988|582275030|FG001|Overall Study|Withdrawal by Subject|2|||
161244974|NCT01404988|582275031|FG002|Overall Study|Withdrawal by Subject|0|||
161244975|NCT01404988|582275029|FG000|Overall Study|Lost to Follow-up|1|||
161244976|NCT01404988|582275030|FG001|Overall Study|Lost to Follow-up|2|||
161244977|NCT01404988|582275031|FG002|Overall Study|Lost to Follow-up|1|||
161244978|NCT04594252|582275032|FG000|Overall Study|Adverse Event|0|||
161244979|NCT04594252|582275033|FG001|Overall Study|Adverse Event|2|||
161244980|NCT01109849|582276631|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
161244981|NCT01109849|582276632|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
161244982|NCT01109849|582276633|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161244983|NCT01109849|582276634|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161244984|NCT01109849|582276635|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
161244985|NCT01109849|582276631|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
161244986|NCT01109849|582276632|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161244987|NCT01109849|582276633|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161244988|NCT01109849|582276634|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161135233|NCT02901431|581876742|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135234|NCT02901431|581876743|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135235|NCT02901431|581876744|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135236|NCT02901431|581876745|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135237|NCT02901431|581876746|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135238|NCT02901431|581876747|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135239|NCT02901431|581876748|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135240|NCT02901431|581876749|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135241|NCT02901431|581876750|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135242|NCT02901431|581876751|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
161135243|NCT02901431|581876739|FG000|PK Part|Pending dose confirmation|0|||
161135244|NCT02901431|581876740|FG001|PK Part|Pending dose confirmation|1|||
161135245|NCT02901431|581876741|FG002|PK Part|Pending dose confirmation|0|||
161135246|NCT02901431|581876742|FG003|PK Part|Pending dose confirmation|0|||
161135247|NCT02901431|581876743|FG004|PK Part|Pending dose confirmation|0|||
161135248|NCT02901431|581876744|FG005|PK Part|Pending dose confirmation|0|||
161135249|NCT02901431|581876745|FG006|PK Part|Pending dose confirmation|0|||
161135250|NCT02901431|581876746|FG007|PK Part|Pending dose confirmation|0|||
161135251|NCT02901431|581876747|FG008|PK Part|Pending dose confirmation|0|||
161135252|NCT02901431|581876748|FG009|PK Part|Pending dose confirmation|0|||
161135253|NCT02901431|581876749|FG010|PK Part|Pending dose confirmation|0|||
161135254|NCT02901431|581876750|FG011|PK Part|Pending dose confirmation|0|||
161135255|NCT02901431|581876751|FG012|PK Part|Pending dose confirmation|0|||
161135256|NCT02901431|581876739|FG000|PK Part|8 weeks of treatment ran out|2|||
161135257|NCT02901431|581876740|FG001|PK Part|8 weeks of treatment ran out|0|||
161135258|NCT02901431|581876741|FG002|PK Part|8 weeks of treatment ran out|0|||
161135259|NCT02901431|581876742|FG003|PK Part|8 weeks of treatment ran out|0|||
161135260|NCT02901431|581876743|FG004|PK Part|8 weeks of treatment ran out|0|||
161135261|NCT02901431|581876744|FG005|PK Part|8 weeks of treatment ran out|0|||
161135262|NCT02901431|581876745|FG006|PK Part|8 weeks of treatment ran out|0|||
161135263|NCT02901431|581876746|FG007|PK Part|8 weeks of treatment ran out|0|||
161135264|NCT02901431|581876747|FG008|PK Part|8 weeks of treatment ran out|0|||
161135265|NCT02901431|581876748|FG009|PK Part|8 weeks of treatment ran out|0|||
161135266|NCT02901431|581876749|FG010|PK Part|8 weeks of treatment ran out|0|||
161135267|NCT02901431|581876750|FG011|PK Part|8 weeks of treatment ran out|0|||
161135268|NCT02901431|581876751|FG012|PK Part|8 weeks of treatment ran out|0|||
161135269|NCT02901431|581876739|FG000|PK Part|Stopped treatment after 8 weeks|1|||
161135270|NCT02901431|581876740|FG001|PK Part|Stopped treatment after 8 weeks|0|||
161135271|NCT02901431|581876741|FG002|PK Part|Stopped treatment after 8 weeks|1|||
161135272|NCT02901431|581876742|FG003|PK Part|Stopped treatment after 8 weeks|0|||
161135273|NCT02901431|581876743|FG004|PK Part|Stopped treatment after 8 weeks|0|||
160828598|NCT01352741|580759838|FG001|Double-blind Comparative Period|Protocol Violation|0|||
160828599|NCT01352741|580759837|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
160828600|NCT01352741|580759838|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
161135274|NCT02901431|581876744|FG005|PK Part|Stopped treatment after 8 weeks|0|||
161135275|NCT02901431|581876745|FG006|PK Part|Stopped treatment after 8 weeks|0|||
161135276|NCT02901431|581876746|FG007|PK Part|Stopped treatment after 8 weeks|0|||
161135277|NCT02901431|581876747|FG008|PK Part|Stopped treatment after 8 weeks|0|||
161135278|NCT02901431|581876748|FG009|PK Part|Stopped treatment after 8 weeks|0|||
161135279|NCT02901431|581876749|FG010|PK Part|Stopped treatment after 8 weeks|0|||
161135280|NCT02901431|581876750|FG011|PK Part|Stopped treatment after 8 weeks|0|||
161135281|NCT02901431|581876751|FG012|PK Part|Stopped treatment after 8 weeks|0|||
161135282|NCT02901431|581876739|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
161135283|NCT02901431|581876740|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135284|NCT02901431|581876741|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
161135285|NCT02901431|581876742|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135286|NCT02901431|581876743|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135287|NCT02901431|581876744|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135288|NCT02901431|581876745|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135289|NCT02901431|581876746|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135290|NCT02901431|581876747|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135291|NCT02901431|581876748|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135292|NCT02901431|581876749|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135293|NCT02901431|581876750|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135294|NCT02901431|581876751|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
161135295|NCT02901431|581876739|FG000|PK Part|Discontinued per Sponsor|0|||
160902840|NCT00675948|581037854|FG001|Overall Study|Lost to Follow-up|0|||
161135296|NCT02901431|581876740|FG001|PK Part|Discontinued per Sponsor|3|||
161135297|NCT02901431|581876741|FG002|PK Part|Discontinued per Sponsor|0|||
161135298|NCT02901431|581876742|FG003|PK Part|Discontinued per Sponsor|0|||
161135299|NCT02901431|581876743|FG004|PK Part|Discontinued per Sponsor|0|||
161135300|NCT02901431|581876744|FG005|PK Part|Discontinued per Sponsor|0|||
161135301|NCT02901431|581876745|FG006|PK Part|Discontinued per Sponsor|0|||
161135302|NCT02901431|581876746|FG007|PK Part|Discontinued per Sponsor|0|||
161135303|NCT02901431|581876747|FG008|PK Part|Discontinued per Sponsor|0|||
161135304|NCT02901431|581876748|FG009|PK Part|Discontinued per Sponsor|0|||
161135305|NCT02901431|581876749|FG010|PK Part|Discontinued per Sponsor|0|||
161135306|NCT02901431|581876750|FG011|PK Part|Discontinued per Sponsor|0|||
161135307|NCT02901431|581876751|FG012|PK Part|Discontinued per Sponsor|0|||
161135308|NCT02901431|581876739|FG000|PK Part|Withdrawal by Subject|1|||
161135309|NCT02901431|581876740|FG001|PK Part|Withdrawal by Subject|1|||
161135310|NCT02901431|581876741|FG002|PK Part|Withdrawal by Subject|3|||
161135311|NCT02901431|581876742|FG003|PK Part|Withdrawal by Subject|0|||
161135312|NCT02901431|581876743|FG004|PK Part|Withdrawal by Subject|0|||
161135313|NCT02901431|581876744|FG005|PK Part|Withdrawal by Subject|0|||
161135314|NCT02901431|581876745|FG006|PK Part|Withdrawal by Subject|0|||
161135315|NCT02901431|581876746|FG007|PK Part|Withdrawal by Subject|0|||
161135316|NCT02901431|581876747|FG008|PK Part|Withdrawal by Subject|0|||
161135317|NCT02901431|581876748|FG009|PK Part|Withdrawal by Subject|0|||
161135318|NCT02901431|581876749|FG010|PK Part|Withdrawal by Subject|0|||
161135319|NCT02901431|581876750|FG011|PK Part|Withdrawal by Subject|0|||
161135320|NCT02901431|581876751|FG012|PK Part|Withdrawal by Subject|0|||
161135321|NCT02901431|581876739|FG000|Main Treatment Part|Adverse Event|0|||
161135322|NCT02901431|581876740|FG001|Main Treatment Part|Adverse Event|0|||
161135323|NCT02901431|581876741|FG002|Main Treatment Part|Adverse Event|0|||
161135324|NCT02901431|581876742|FG003|Main Treatment Part|Adverse Event|3|||
161135325|NCT02901431|581876743|FG004|Main Treatment Part|Adverse Event|3|||
161135326|NCT02901431|581876744|FG005|Main Treatment Part|Adverse Event|4|||
161135327|NCT02901431|581876745|FG006|Main Treatment Part|Adverse Event|1|||
161135328|NCT02901431|581876746|FG007|Main Treatment Part|Adverse Event|0|||
161135329|NCT02901431|581876747|FG008|Main Treatment Part|Adverse Event|0|||
160902841|NCT00675948|581037853|FG000|Overall Study|Protocol Violation|1|||
160902842|NCT00675948|581037854|FG001|Overall Study|Protocol Violation|0|||
160902843|NCT00675948|581037853|FG000|Overall Study|Pain under control|1|||
160902844|NCT00675948|581037854|FG001|Overall Study|Pain under control|0|||
160902845|NCT00675948|581037853|FG000|Overall Study|Sponsor decision|0|||
160902846|NCT00675948|581037854|FG001|Overall Study|Sponsor decision|1|||
160902847|NCT00675948|581037853|FG000|Overall Study|Patient died|1|||
160902848|NCT00675948|581037854|FG001|Overall Study|Patient died|0|||
161135330|NCT02901431|581876748|FG009|Main Treatment Part|Adverse Event|0|||
161135331|NCT02901431|581876749|FG010|Main Treatment Part|Adverse Event|0|||
161135332|NCT02901431|581876750|FG011|Main Treatment Part|Adverse Event|0|||
161135333|NCT02901431|581876751|FG012|Main Treatment Part|Adverse Event|0|||
161135334|NCT02901431|581876739|FG000|Main Treatment Part|Lack of Efficacy|0|||
161135335|NCT02901431|581876740|FG001|Main Treatment Part|Lack of Efficacy|0|||
161135336|NCT02901431|581876741|FG002|Main Treatment Part|Lack of Efficacy|0|||
161135337|NCT02901431|581876742|FG003|Main Treatment Part|Lack of Efficacy|1|||
161135338|NCT02901431|581876743|FG004|Main Treatment Part|Lack of Efficacy|0|||
161135339|NCT02901431|581876744|FG005|Main Treatment Part|Lack of Efficacy|0|||
161135340|NCT02901431|581876745|FG006|Main Treatment Part|Lack of Efficacy|0|||
161135341|NCT02901431|581876746|FG007|Main Treatment Part|Lack of Efficacy|0|||
161135342|NCT02901431|581876747|FG008|Main Treatment Part|Lack of Efficacy|0|||
161135343|NCT02901431|581876748|FG009|Main Treatment Part|Lack of Efficacy|0|||
161135344|NCT02901431|581876749|FG010|Main Treatment Part|Lack of Efficacy|0|||
161135345|NCT02901431|581876750|FG011|Main Treatment Part|Lack of Efficacy|0|||
161135346|NCT02901431|581876751|FG012|Main Treatment Part|Lack of Efficacy|0|||
161135347|NCT02901431|581876739|FG000|Main Treatment Part|Lost to Follow-up|0|||
161135348|NCT02901431|581876740|FG001|Main Treatment Part|Lost to Follow-up|0|||
160902849|NCT00675948|581037853|FG000|Overall Study|Patient unable to comply with diaries|1|||
161135349|NCT02901431|581876741|FG002|Main Treatment Part|Lost to Follow-up|0|||
161135350|NCT02901431|581876742|FG003|Main Treatment Part|Lost to Follow-up|3|||
161135351|NCT02901431|581876743|FG004|Main Treatment Part|Lost to Follow-up|1|||
161135352|NCT02901431|581876744|FG005|Main Treatment Part|Lost to Follow-up|2|||
160902850|NCT00675948|581037854|FG001|Overall Study|Patient unable to comply with diaries|0|||
160902851|NCT00675948|581037853|FG000|Overall Study|Patient feels unable to take medication|0|||
161135353|NCT02901431|581876745|FG006|Main Treatment Part|Lost to Follow-up|3|||
161135354|NCT02901431|581876746|FG007|Main Treatment Part|Lost to Follow-up|0|||
161135355|NCT02901431|581876747|FG008|Main Treatment Part|Lost to Follow-up|0|||
161135356|NCT02901431|581876748|FG009|Main Treatment Part|Lost to Follow-up|0|||
161135357|NCT02901431|581876749|FG010|Main Treatment Part|Lost to Follow-up|0|||
161135358|NCT02901431|581876750|FG011|Main Treatment Part|Lost to Follow-up|0|||
161135359|NCT02901431|581876751|FG012|Main Treatment Part|Lost to Follow-up|0|||
161135360|NCT02901431|581876739|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
161135361|NCT02901431|581876740|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
161244989|NCT01109849|582276635|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
161244990|NCT01109849|582276631|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
161244991|NCT01109849|582276632|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
161135362|NCT02901431|581876741|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
161135363|NCT02901431|581876742|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
161135364|NCT02901431|581876743|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
161135365|NCT02901431|581876744|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
161244992|NCT01109849|582276633|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161244993|NCT01109849|582276634|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161244994|NCT01109849|582276635|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
161244995|NCT01109849|582276631|FG000|Initial Randomization: ADHD Treatment|move away|2|||
161244996|NCT01109849|582276632|FG001|Initial Randomization: ADHD Treatment|move away|7|||
161244997|NCT01109849|582276633|FG002|Initial Randomization: ADHD Treatment|move away|0|||
161244998|NCT01109849|582276634|FG003|Initial Randomization: ADHD Treatment|move away|0|||
161244999|NCT01109849|582276635|FG004|Initial Randomization: ADHD Treatment|move away|0|||
161245000|NCT01109849|582276631|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
161245001|NCT01109849|582276632|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
161245002|NCT01109849|582276633|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161245003|NCT01109849|582276634|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161245004|NCT01109849|582276635|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
161245005|NCT01109849|582276631|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
161245006|NCT01109849|582276632|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
161245007|NCT01109849|582276633|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
161245008|NCT01109849|582276634|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
161245009|NCT01109849|582276635|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
161245010|NCT02485158|582276639|FG000|Overall Study|Withdrawal by Subject|3|||
161245011|NCT02485158|582276639|FG000|Overall Study|expected drug side effect|1|||
161245012|NCT01098851|582276640|FG000|Overall Study|Equipment failure|1|||
161245013|NCT01098851|582276641|FG001|Overall Study|Equipment failure|0|||
161245014|NCT03087786|582276642|FG000|Overall Study|Withdrawal by Subject|2|||
161245015|NCT03087786|582276643|FG001|Overall Study|Withdrawal by Subject|0|||
161245016|NCT04661202|582276644|FG000|Overall Study|Withdrawal by Subject|1|||
161245017|NCT04661202|582276645|FG001|Overall Study|Withdrawal by Subject|1|||
161245018|NCT04661202|582276644|FG000|Overall Study|Lack of Efficacy|2|||
161245019|NCT04661202|582276645|FG001|Overall Study|Lack of Efficacy|0|||
161245020|NCT02313558|582276648|FG000|Overall Study|Withdrawal by Subject|2|||
161245021|NCT02313558|582276649|FG001|Overall Study|Withdrawal by Subject|0|||
161245022|NCT02313558|582276648|FG000|Overall Study|Lost to Follow-up|4|||
161245023|NCT02313558|582276649|FG001|Overall Study|Lost to Follow-up|4|||
161245024|NCT04158687|582276650|FG000|Overall Study|Adverse Event|2|||
161245025|NCT04158687|582276651|FG001|Overall Study|Adverse Event|3|||
161245026|NCT04158687|582276652|FG002|Overall Study|Adverse Event|0|||
161245027|NCT04158687|582276653|FG003|Overall Study|Adverse Event|3|||
161245028|NCT04158687|582276650|FG000|Overall Study|Lost to Follow-up|5|||
161245029|NCT04158687|582276651|FG001|Overall Study|Lost to Follow-up|12|||
161245030|NCT04158687|582276652|FG002|Overall Study|Lost to Follow-up|4|||
161245031|NCT04158687|582276653|FG003|Overall Study|Lost to Follow-up|5|||
161245032|NCT04158687|582276650|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
161245033|NCT04158687|582276651|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
161135366|NCT02901431|581876745|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
161135367|NCT02901431|581876746|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
161135368|NCT02901431|581876747|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
161135369|NCT02901431|581876748|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
161135370|NCT02901431|581876749|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
161135371|NCT02901431|581876750|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
161135372|NCT02901431|581876751|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
161135373|NCT02901431|581876739|FG000|Main Treatment Part|Physician Decision|0|||
161135374|NCT02901431|581876740|FG001|Main Treatment Part|Physician Decision|0|||
161135375|NCT02901431|581876741|FG002|Main Treatment Part|Physician Decision|0|||
161135376|NCT02901431|581876742|FG003|Main Treatment Part|Physician Decision|1|||
161135377|NCT02901431|581876743|FG004|Main Treatment Part|Physician Decision|0|||
161135378|NCT02901431|581876744|FG005|Main Treatment Part|Physician Decision|0|||
161245034|NCT04158687|582276652|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
161245035|NCT04158687|582276653|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
161135379|NCT02901431|581876745|FG006|Main Treatment Part|Physician Decision|1|||
161135380|NCT02901431|581876746|FG007|Main Treatment Part|Physician Decision|0|||
161135381|NCT02901431|581876747|FG008|Main Treatment Part|Physician Decision|0|||
161135382|NCT02901431|581876748|FG009|Main Treatment Part|Physician Decision|0|||
161135383|NCT02901431|581876749|FG010|Main Treatment Part|Physician Decision|0|||
161135384|NCT02901431|581876750|FG011|Main Treatment Part|Physician Decision|0|||
161245036|NCT04158687|582276650|FG000|Overall Study|Non-Compliance with Study Medication|2|||
160902852|NCT00675948|581037854|FG001|Overall Study|Patient feels unable to take medication|1|||
160902853|NCT02100514|581037858|FG000|Treatment Period|Adverse Event|0|||
161135385|NCT02901431|581876751|FG012|Main Treatment Part|Physician Decision|0|||
160902854|NCT02100514|581037859|FG001|Treatment Period|Adverse Event|5|||
160902855|NCT02100514|581037860|FG002|Treatment Period|Adverse Event|0|||
161135386|NCT02901431|581876739|FG000|Main Treatment Part|Withdrawal by Subject|0|||
161135387|NCT02901431|581876740|FG001|Main Treatment Part|Withdrawal by Subject|0|||
161135388|NCT02901431|581876741|FG002|Main Treatment Part|Withdrawal by Subject|0|||
161135389|NCT02901431|581876742|FG003|Main Treatment Part|Withdrawal by Subject|18|||
161135390|NCT02901431|581876743|FG004|Main Treatment Part|Withdrawal by Subject|3|||
161135391|NCT02901431|581876744|FG005|Main Treatment Part|Withdrawal by Subject|5|||
161135392|NCT02901431|581876745|FG006|Main Treatment Part|Withdrawal by Subject|6|||
161135393|NCT02901431|581876746|FG007|Main Treatment Part|Withdrawal by Subject|0|||
161135394|NCT02901431|581876747|FG008|Main Treatment Part|Withdrawal by Subject|0|||
161135395|NCT02901431|581876748|FG009|Main Treatment Part|Withdrawal by Subject|0|||
161135396|NCT02901431|581876749|FG010|Main Treatment Part|Withdrawal by Subject|0|||
161135397|NCT02901431|581876750|FG011|Main Treatment Part|Withdrawal by Subject|0|||
161135398|NCT02901431|581876751|FG012|Main Treatment Part|Withdrawal by Subject|0|||
161135399|NCT02901431|581876739|FG000|Open Label Part|Adverse Event|0|||
161135400|NCT02901431|581876740|FG001|Open Label Part|Adverse Event|0|||
161135401|NCT02901431|581876741|FG002|Open Label Part|Adverse Event|0|||
161135402|NCT02901431|581876742|FG003|Open Label Part|Adverse Event|0|||
161135403|NCT02901431|581876743|FG004|Open Label Part|Adverse Event|0|||
161135404|NCT02901431|581876744|FG005|Open Label Part|Adverse Event|0|||
161135405|NCT02901431|581876745|FG006|Open Label Part|Adverse Event|0|||
161135406|NCT02901431|581876746|FG007|Open Label Part|Adverse Event|0|||
161135407|NCT02901431|581876747|FG008|Open Label Part|Adverse Event|4|||
161135408|NCT02901431|581876748|FG009|Open Label Part|Adverse Event|4|||
161135409|NCT02901431|581876749|FG010|Open Label Part|Adverse Event|0|||
161135410|NCT02901431|581876750|FG011|Open Label Part|Adverse Event|4|||
161135411|NCT02901431|581876751|FG012|Open Label Part|Adverse Event|1|||
161135412|NCT02901431|581876739|FG000|Open Label Part|Lost to Follow-up|0|||
161135413|NCT02901431|581876740|FG001|Open Label Part|Lost to Follow-up|0|||
161135414|NCT02901431|581876741|FG002|Open Label Part|Lost to Follow-up|0|||
161135415|NCT02901431|581876742|FG003|Open Label Part|Lost to Follow-up|0|||
161135416|NCT02901431|581876743|FG004|Open Label Part|Lost to Follow-up|0|||
161135417|NCT02901431|581876744|FG005|Open Label Part|Lost to Follow-up|0|||
161135418|NCT02901431|581876745|FG006|Open Label Part|Lost to Follow-up|0|||
161135419|NCT02901431|581876746|FG007|Open Label Part|Lost to Follow-up|0|||
161135420|NCT02901431|581876747|FG008|Open Label Part|Lost to Follow-up|2|||
161135421|NCT02901431|581876748|FG009|Open Label Part|Lost to Follow-up|2|||
161135422|NCT02901431|581876749|FG010|Open Label Part|Lost to Follow-up|1|||
161135423|NCT02901431|581876750|FG011|Open Label Part|Lost to Follow-up|1|||
161135424|NCT02901431|581876751|FG012|Open Label Part|Lost to Follow-up|1|||
161135425|NCT02901431|581876739|FG000|Open Label Part|Physician Decision|0|||
161135426|NCT02901431|581876740|FG001|Open Label Part|Physician Decision|0|||
161135427|NCT02901431|581876741|FG002|Open Label Part|Physician Decision|0|||
161135428|NCT02901431|581876742|FG003|Open Label Part|Physician Decision|0|||
161135429|NCT02901431|581876743|FG004|Open Label Part|Physician Decision|0|||
161135430|NCT02901431|581876744|FG005|Open Label Part|Physician Decision|0|||
161135431|NCT02901431|581876745|FG006|Open Label Part|Physician Decision|0|||
161135432|NCT02901431|581876746|FG007|Open Label Part|Physician Decision|0|||
161135433|NCT02901431|581876747|FG008|Open Label Part|Physician Decision|1|||
161135434|NCT02901431|581876748|FG009|Open Label Part|Physician Decision|1|||
161135435|NCT02901431|581876749|FG010|Open Label Part|Physician Decision|0|||
161135436|NCT02901431|581876750|FG011|Open Label Part|Physician Decision|0|||
161135437|NCT02901431|581876751|FG012|Open Label Part|Physician Decision|0|||
161135438|NCT02901431|581876739|FG000|Open Label Part|Study Terminated By Sponsor|0|||
161135439|NCT02901431|581876740|FG001|Open Label Part|Study Terminated By Sponsor|0|||
161135440|NCT02901431|581876741|FG002|Open Label Part|Study Terminated By Sponsor|0|||
161135441|NCT02901431|581876742|FG003|Open Label Part|Study Terminated By Sponsor|0|||
161135442|NCT02901431|581876743|FG004|Open Label Part|Study Terminated By Sponsor|0|||
161135443|NCT02901431|581876744|FG005|Open Label Part|Study Terminated By Sponsor|0|||
161135444|NCT02901431|581876745|FG006|Open Label Part|Study Terminated By Sponsor|0|||
161135445|NCT02901431|581876746|FG007|Open Label Part|Study Terminated By Sponsor|0|||
161135446|NCT02901431|581876747|FG008|Open Label Part|Study Terminated By Sponsor|35|||
161135447|NCT02901431|581876748|FG009|Open Label Part|Study Terminated By Sponsor|12|||
161135448|NCT02901431|581876749|FG010|Open Label Part|Study Terminated By Sponsor|21|||
161135449|NCT02901431|581876750|FG011|Open Label Part|Study Terminated By Sponsor|31|||
161135450|NCT02901431|581876751|FG012|Open Label Part|Study Terminated By Sponsor|0|||
161135451|NCT02901431|581876739|FG000|Open Label Part|Withdrawal by Subject|0|||
161135452|NCT02901431|581876740|FG001|Open Label Part|Withdrawal by Subject|0|||
161135453|NCT02901431|581876741|FG002|Open Label Part|Withdrawal by Subject|0|||
161135454|NCT02901431|581876742|FG003|Open Label Part|Withdrawal by Subject|0|||
161245037|NCT04158687|582276651|FG001|Overall Study|Non-Compliance with Study Medication|2|||
161245038|NCT04158687|582276652|FG002|Overall Study|Non-Compliance with Study Medication|3|||
161245039|NCT04158687|582276653|FG003|Overall Study|Non-Compliance with Study Medication|0|||
161245040|NCT04158687|582276650|FG000|Overall Study|Investigator Decision|0|||
161245041|NCT04158687|582276651|FG001|Overall Study|Investigator Decision|0|||
161245042|NCT04158687|582276652|FG002|Overall Study|Investigator Decision|2|||
161135455|NCT02901431|581876743|FG004|Open Label Part|Withdrawal by Subject|0|||
161135456|NCT02901431|581876744|FG005|Open Label Part|Withdrawal by Subject|0|||
161135457|NCT02901431|581876745|FG006|Open Label Part|Withdrawal by Subject|0|||
161135458|NCT02901431|581876746|FG007|Open Label Part|Withdrawal by Subject|0|||
161135459|NCT02901431|581876747|FG008|Open Label Part|Withdrawal by Subject|6|||
161135460|NCT02901431|581876748|FG009|Open Label Part|Withdrawal by Subject|5|||
161135461|NCT02901431|581876749|FG010|Open Label Part|Withdrawal by Subject|7|||
161135462|NCT02901431|581876750|FG011|Open Label Part|Withdrawal by Subject|3|||
161135463|NCT02901431|581876751|FG012|Open Label Part|Withdrawal by Subject|1|||
161135464|NCT03832387|581876754|FG000|Overall Study|Protocol Violation|2|||
161135465|NCT03832387|581876755|FG001|Overall Study|Protocol Violation|6|||
161135466|NCT03832387|581876754|FG000|Overall Study|EXCLUSION CRITERIA|3|||
161135467|NCT03832387|581876755|FG001|Overall Study|EXCLUSION CRITERIA|1|||
161135468|NCT00784758|581876756|FG000|Overall Study|Withdrawal by Subject|3|||
161135469|NCT00784758|581876757|FG001|Overall Study|Withdrawal by Subject|0|||
161245043|NCT04158687|582276653|FG003|Overall Study|Investigator Decision|0|||
161245044|NCT04158687|582276650|FG000|Overall Study|Protocol Violation|0|||
161245045|NCT04158687|582276651|FG001|Overall Study|Protocol Violation|2|||
161135470|NCT00784758|581876756|FG000|Overall Study|Adverse Event|1|||
161135471|NCT00784758|581876757|FG001|Overall Study|Adverse Event|0|||
161135472|NCT05775289|581876758|FG000|Overall Study|Study Ongoing|20|||
161135473|NCT05775289|581876759|FG001|Overall Study|Study Ongoing|53|||
161135474|NCT05775289|581876760|FG002|Overall Study|Study Ongoing|15|||
161135475|NCT05775289|581876761|FG003|Overall Study|Study Ongoing|55|||
161135476|NCT05775289|581876758|FG000|Overall Study|Death|4|||
161135477|NCT05775289|581876759|FG001|Overall Study|Death|11|||
161135478|NCT05775289|581876760|FG002|Overall Study|Death|8|||
161135479|NCT05775289|581876761|FG003|Overall Study|Death|12|||
161135480|NCT05775289|581876758|FG000|Overall Study|Lost to Follow-up|0|||
161135481|NCT05775289|581876759|FG001|Overall Study|Lost to Follow-up|1|||
161135482|NCT05775289|581876760|FG002|Overall Study|Lost to Follow-up|0|||
161135483|NCT05775289|581876761|FG003|Overall Study|Lost to Follow-up|0|||
161135484|NCT05775289|581876758|FG000|Overall Study|Progressive Disease|0|||
161135485|NCT05775289|581876759|FG001|Overall Study|Progressive Disease|0|||
161135486|NCT05775289|581876760|FG002|Overall Study|Progressive Disease|1|||
161135487|NCT05775289|581876761|FG003|Overall Study|Progressive Disease|0|||
161135488|NCT05775289|581876758|FG000|Overall Study|Withdrawal by Subject|1|||
161135489|NCT05775289|581876759|FG001|Overall Study|Withdrawal by Subject|1|||
161135490|NCT05775289|581876760|FG002|Overall Study|Withdrawal by Subject|0|||
161135491|NCT05775289|581876761|FG003|Overall Study|Withdrawal by Subject|0|||
161135492|NCT02330419|581876766|FG000|Overall Study|Lost to Follow-up|3|||
161135493|NCT02330419|581876767|FG001|Overall Study|Lost to Follow-up|7|||
161135494|NCT04375761|581879287|FG000|Overall Study|Death|1|||
161135495|NCT04375761|581879288|FG001|Overall Study|Death|2|||
161135496|NCT04375761|581879287|FG000|Overall Study|Lost to Follow-up|203|||
161135497|NCT04375761|581879288|FG001|Overall Study|Lost to Follow-up|380|||
161135498|NCT04375761|581879287|FG000|Overall Study|Withdrawal by Subject|47|||
161135499|NCT04375761|581879288|FG001|Overall Study|Withdrawal by Subject|98|||
161135500|NCT04375761|581879287|FG000|Overall Study|Noncompliance with study procedure|121|||
161135501|NCT04375761|581879288|FG001|Overall Study|Noncompliance with study procedure|251|||
161135502|NCT04375761|581879287|FG000|Overall Study|Reimbursement not enough|1|||
161135503|NCT04375761|581879288|FG001|Overall Study|Reimbursement not enough|2|||
161135504|NCT04375761|581879287|FG000|Overall Study|Unforeseen family circumstances|1|||
161135505|NCT04375761|581879288|FG001|Overall Study|Unforeseen family circumstances|3|||
161245046|NCT04158687|582276652|FG002|Overall Study|Protocol Violation|1|||
161245047|NCT04158687|582276653|FG003|Overall Study|Protocol Violation|0|||
161245048|NCT04158687|582276650|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
161245049|NCT04158687|582276651|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
161135506|NCT04375761|581879287|FG000|Overall Study|Test too painful|1|||
161135507|NCT04375761|581879288|FG001|Overall Study|Test too painful|1|||
161135508|NCT04375761|581879287|FG000|Overall Study|Moved|0|||
161135509|NCT04375761|581879288|FG001|Overall Study|Moved|2|||
161135510|NCT04375761|581879287|FG000|Overall Study|Nonresponsive|0|||
161135511|NCT04375761|581879288|FG001|Overall Study|Nonresponsive|5|||
161135512|NCT03797001|581879289|FG000|Overall Study|Withdrawn due to COVID19|4|||
161135513|NCT03797001|581879290|FG001|Overall Study|Withdrawn due to COVID19|0|||
161135514|NCT03797001|581879289|FG000|Overall Study|Withdrawal by Subject|7|||
161135515|NCT03797001|581879290|FG001|Overall Study|Withdrawal by Subject|6|||
161245050|NCT04158687|582276652|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
161135516|NCT03797001|581879289|FG000|Overall Study|Adverse Event|0|||
161135517|NCT03797001|581879290|FG001|Overall Study|Adverse Event|1|||
161135518|NCT00500266|581879302|FG000|Overall Study|Death|3|||
160828601|NCT01352741|580759837|FG000|Double-blind Comparative Period|Adverse Event|16|||
160828602|NCT01352741|580759838|FG001|Double-blind Comparative Period|Adverse Event|17|||
160828603|NCT01352741|580759837|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
161245051|NCT04158687|582276653|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
161245052|NCT04158687|582276650|FG000|Overall Study|Reason not Specified|3|||
161245053|NCT04158687|582276651|FG001|Overall Study|Reason not Specified|2|||
161245054|NCT04158687|582276652|FG002|Overall Study|Reason not Specified|4|||
161245055|NCT04158687|582276653|FG003|Overall Study|Reason not Specified|4|||
161245056|NCT02043132|582276661|FG000|Overall Study|Lost to Follow-up|1|||
161245057|NCT02043132|582276662|FG001|Overall Study|Lost to Follow-up|1|||
161245058|NCT02043132|582276661|FG000|Overall Study|screen failures|4|||
161245059|NCT02043132|582276662|FG001|Overall Study|screen failures|8|||
161245060|NCT03827395|582276663|FG000|Overall Study|Lost to Follow-up|1|||
161245061|NCT03827395|582276664|FG001|Overall Study|Lost to Follow-up|0|||
161245062|NCT03827395|582276663|FG000|Overall Study|Protocol Violation|1|||
161245063|NCT03827395|582276664|FG001|Overall Study|Protocol Violation|0|||
161245064|NCT03827395|582276663|FG000|Overall Study|Became ineligible after enrollment|1|||
161245065|NCT03827395|582276664|FG001|Overall Study|Became ineligible after enrollment|2|||
161245066|NCT01370083|582276665|FG000|Overall Study|Lost to Follow-up|2|||
161245067|NCT01370083|582276666|FG001|Overall Study|Lost to Follow-up|0|||
161245068|NCT01370083|582276665|FG000|Overall Study|Adverse Event|0|||
161245069|NCT01370083|582276666|FG001|Overall Study|Adverse Event|1|||
161245070|NCT02450539|582276669|FG000|Overall Study|Withdrawal by Subject|12|||
161245071|NCT02450539|582276670|FG001|Overall Study|Withdrawal by Subject|6|||
161245072|NCT02450539|582276669|FG000|Overall Study|Lost to Follow-up|4|||
161245073|NCT02450539|582276670|FG001|Overall Study|Lost to Follow-up|1|||
161245074|NCT00585286|582276671|FG000|Overall Study|Lost to Follow-up|1|||
161245075|NCT03358147|582276673|FG000|Overall Study|Withdrawal by Subject|13|||
161245076|NCT03358147|582276674|FG001|Overall Study|Withdrawal by Subject|19|||
161245077|NCT03358147|582276675|FG002|Overall Study|Withdrawal by Subject|16|||
161245078|NCT03358147|582276676|FG003|Overall Study|Withdrawal by Subject|10|||
161245079|NCT03358147|582276677|FG004|Overall Study|Withdrawal by Subject|5|||
161245080|NCT03358147|582276673|FG000|Overall Study|Adverse Event|3|||
161245081|NCT03358147|582276674|FG001|Overall Study|Adverse Event|9|||
161245082|NCT03358147|582276675|FG002|Overall Study|Adverse Event|7|||
161245083|NCT03358147|582276676|FG003|Overall Study|Adverse Event|5|||
161245084|NCT03358147|582276677|FG004|Overall Study|Adverse Event|2|||
161245085|NCT03358147|582276673|FG000|Overall Study|Lost to Follow-up|4|||
161245086|NCT03358147|582276674|FG001|Overall Study|Lost to Follow-up|3|||
161245087|NCT03358147|582276675|FG002|Overall Study|Lost to Follow-up|7|||
161245088|NCT03358147|582276676|FG003|Overall Study|Lost to Follow-up|6|||
161245089|NCT03358147|582276677|FG004|Overall Study|Lost to Follow-up|4|||
161245090|NCT03358147|582276673|FG000|Overall Study|Major Protocol Deviation|11|||
161245091|NCT03358147|582276674|FG001|Overall Study|Major Protocol Deviation|3|||
161245092|NCT03358147|582276675|FG002|Overall Study|Major Protocol Deviation|2|||
161245093|NCT03358147|582276676|FG003|Overall Study|Major Protocol Deviation|3|||
161245094|NCT03358147|582276677|FG004|Overall Study|Major Protocol Deviation|1|||
161245095|NCT03358147|582276673|FG000|Overall Study|Protocol specified criteria|2|||
161245096|NCT03358147|582276674|FG001|Overall Study|Protocol specified criteria|3|||
161245097|NCT03358147|582276675|FG002|Overall Study|Protocol specified criteria|0|||
161245098|NCT03358147|582276676|FG003|Overall Study|Protocol specified criteria|3|||
161245099|NCT03358147|582276677|FG004|Overall Study|Protocol specified criteria|1|||
161245100|NCT03358147|582276673|FG000|Overall Study|Physician Decision|1|||
161245101|NCT03358147|582276674|FG001|Overall Study|Physician Decision|0|||
161245102|NCT03358147|582276675|FG002|Overall Study|Physician Decision|1|||
161245103|NCT03358147|582276676|FG003|Overall Study|Physician Decision|6|||
161245104|NCT03358147|582276677|FG004|Overall Study|Physician Decision|1|||
161245105|NCT03358147|582276673|FG000|Overall Study|Administrative reasons|0|||
161245106|NCT03358147|582276674|FG001|Overall Study|Administrative reasons|1|||
161245107|NCT03358147|582276675|FG002|Overall Study|Administrative reasons|0|||
161245108|NCT03358147|582276676|FG003|Overall Study|Administrative reasons|3|||
161245109|NCT03358147|582276677|FG004|Overall Study|Administrative reasons|0|||
161245110|NCT03358147|582276673|FG000|Overall Study|Lack of Efficacy|0|||
161245111|NCT03358147|582276674|FG001|Overall Study|Lack of Efficacy|1|||
161245112|NCT03358147|582276675|FG002|Overall Study|Lack of Efficacy|1|||
161245113|NCT03358147|582276676|FG003|Overall Study|Lack of Efficacy|0|||
161245114|NCT03358147|582276677|FG004|Overall Study|Lack of Efficacy|0|||
161245115|NCT03236311|582276678|FG000|Overall Study|Study terminated by sponsor|0|||
161245116|NCT03236311|582276679|FG001|Overall Study|Study terminated by sponsor|2|||
161245117|NCT03236311|582276678|FG000|Overall Study|Adverse Event|0|||
161245118|NCT03236311|582276679|FG001|Overall Study|Adverse Event|1|||
161245119|NCT00669162|582276680|FG000|Overall Study|Withdrawal by Subject|1|||
161245120|NCT02704091|582276681|FG000|Overall Study|Adverse Event|4|||
161245121|NCT02704091|582276682|FG001|Overall Study|Adverse Event|3|||
161245122|NCT02704091|582276681|FG000|Overall Study|Protocol Violation|5|||
161245123|NCT02704091|582276682|FG001|Overall Study|Protocol Violation|3|||
161245124|NCT02704091|582276681|FG000|Overall Study|Consent withdrawn|4|||
161245125|NCT02704091|582276682|FG001|Overall Study|Consent withdrawn|4|||
161245126|NCT02704091|582276681|FG000|Overall Study|Lost to Follow-up|13|||
161245127|NCT02704091|582276682|FG001|Overall Study|Lost to Follow-up|5|||
161245128|NCT02704091|582276681|FG000|Overall Study|Other|2|||
161245129|NCT02704091|582276682|FG001|Overall Study|Other|8|||
161245130|NCT02412852|582276683|FG000|Overall Study|Withdrawal by Subject|0|||
161245131|NCT02412852|582276684|FG001|Overall Study|Withdrawal by Subject|1|||
161245132|NCT02412852|582276685|FG002|Overall Study|Withdrawal by Subject|0|||
161245133|NCT02412852|582276686|FG003|Overall Study|Withdrawal by Subject|0|||
161245134|NCT02412852|582276683|FG000|Overall Study|Physician Decision|0|||
161245135|NCT02412852|582276684|FG001|Overall Study|Physician Decision|0|||
161245136|NCT02412852|582276685|FG002|Overall Study|Physician Decision|0|||
160828604|NCT01352741|580759838|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
160828605|NCT01352741|580759837|FG000|Double-blind Comparative Period|Death|0|||
160828606|NCT01352741|580759838|FG001|Double-blind Comparative Period|Death|1|||
160902856|NCT02100514|581037861|FG003|Treatment Period|Adverse Event|0|||
160902857|NCT02100514|581037862|FG004|Treatment Period|Adverse Event|0|||
160902858|NCT02100514|581037858|FG000|Treatment Period|Death|2|||
160902859|NCT02100514|581037859|FG001|Treatment Period|Death|2|||
160902860|NCT02100514|581037860|FG002|Treatment Period|Death|0|||
160902861|NCT02100514|581037861|FG003|Treatment Period|Death|0|||
160902862|NCT02100514|581037862|FG004|Treatment Period|Death|0|||
160902863|NCT02100514|581037858|FG000|Treatment Period|Lost to Follow-up|5|||
160902864|NCT02100514|581037859|FG001|Treatment Period|Lost to Follow-up|17|||
160902865|NCT02100514|581037860|FG002|Treatment Period|Lost to Follow-up|0|||
160902866|NCT02100514|581037861|FG003|Treatment Period|Lost to Follow-up|0|||
160902867|NCT02100514|581037862|FG004|Treatment Period|Lost to Follow-up|0|||
160902868|NCT02100514|581037858|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902869|NCT02100514|581037859|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
160902870|NCT02100514|581037860|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902871|NCT02100514|581037861|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902872|NCT02100514|581037862|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
160902873|NCT02100514|581037858|FG000|Treatment Period|Protocol Violation|1|||
160902874|NCT02100514|581037859|FG001|Treatment Period|Protocol Violation|1|||
160902875|NCT02100514|581037860|FG002|Treatment Period|Protocol Violation|0|||
160902876|NCT02100514|581037861|FG003|Treatment Period|Protocol Violation|0|||
160902877|NCT02100514|581037862|FG004|Treatment Period|Protocol Violation|0|||
160902878|NCT02100514|581037858|FG000|Treatment Period|Withdrawal by Subject|12|||
160902879|NCT02100514|581037859|FG001|Treatment Period|Withdrawal by Subject|37|||
160902880|NCT02100514|581037860|FG002|Treatment Period|Withdrawal by Subject|0|||
160902881|NCT02100514|581037861|FG003|Treatment Period|Withdrawal by Subject|0|||
160902882|NCT02100514|581037862|FG004|Treatment Period|Withdrawal by Subject|0|||
160902883|NCT02100514|581037858|FG000|Treatment Period|Other|9|||
160902884|NCT02100514|581037859|FG001|Treatment Period|Other|11|||
160902885|NCT02100514|581037860|FG002|Treatment Period|Other|0|||
160902886|NCT02100514|581037861|FG003|Treatment Period|Other|0|||
160902887|NCT02100514|581037862|FG004|Treatment Period|Other|0|||
160902888|NCT02100514|581037858|FG000|Extension Period|Withdrew consent|0|||
160902889|NCT02100514|581037859|FG001|Extension Period|Withdrew consent|0|||
160902890|NCT02100514|581037860|FG002|Extension Period|Withdrew consent|2|||
160902891|NCT02100514|581037861|FG003|Extension Period|Withdrew consent|0|||
160902892|NCT02100514|581037862|FG004|Extension Period|Withdrew consent|0|||
161245137|NCT02412852|582276686|FG003|Overall Study|Physician Decision|1|||
161245138|NCT01051349|582276687|FG000|Overall Study|Adverse Event|88|||
160828607|NCT01352741|580759837|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
160828608|NCT01352741|580759838|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
160828609|NCT01352741|580759837|FG000|Double-blind Comparative Period|Other|1|||
160828610|NCT01352741|580759838|FG001|Double-blind Comparative Period|Other|2|||
160828611|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
160828612|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
160828613|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
160828614|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
160828615|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
160828616|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
160902893|NCT01896102|581037863|FG000|Overall Study|Death|1|||
160902894|NCT01896102|581037863|FG000|Overall Study|Participant to receive allogenic transplant|2|||
160902895|NCT01145625|581037864|FG000|Overall Study|Lost to Follow-up|8|||
160902896|NCT01145625|581037865|FG001|Overall Study|Lost to Follow-up|9|||
160902897|NCT01145625|581037864|FG000|Overall Study|Adverse Event|6|||
160902898|NCT01145625|581037865|FG001|Overall Study|Adverse Event|4|||
160902899|NCT01145625|581037864|FG000|Overall Study|Protocol Violation|3|||
160902900|NCT01145625|581037865|FG001|Overall Study|Protocol Violation|1|||
160902901|NCT01145625|581037864|FG000|Overall Study|Withdrawal by Subject|7|||
161245139|NCT01051349|582276687|FG000|Overall Study|Consent Withdrawn|54|||
161245140|NCT01051349|582276687|FG000|Overall Study|Investigator Decision|6|||
161245141|NCT01051349|582276687|FG000|Overall Study|Lost to Follow-up|6|||
161245142|NCT01051349|582276687|FG000|Overall Study|Subject non-compliance|7|||
161245143|NCT01051349|582276687|FG000|Overall Study|Reason not Specified|12|||
161245144|NCT00840203|582276690|FG000|First Intervention|Protocol Violation|1|||
161245145|NCT00840203|582276691|FG001|First Intervention|Protocol Violation|1|||
161245146|NCT00840203|582276690|FG000|Washout|Protocol Violation|1|||
161245147|NCT00840203|582276691|FG001|Washout|Protocol Violation|0|||
161245148|NCT01438060|582276699|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
161245149|NCT01438060|582276700|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
161245150|NCT01438060|582276699|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
161245151|NCT01438060|582276700|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
161245152|NCT01438060|582276699|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
161245153|NCT01438060|582276700|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
161245154|NCT01438060|582276699|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
161245155|NCT01438060|582276700|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
161245156|NCT01438060|582276699|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
161245157|NCT01438060|582276700|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
161245158|NCT01438060|582276699|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
161245159|NCT01438060|582276700|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
161245160|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
161245161|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
161245162|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
161245163|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
161245164|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
161245165|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
161245166|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
161245167|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
161245168|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
161245169|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
161245170|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
161245171|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
161245172|NCT01438060|582276699|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
161245173|NCT01438060|582276700|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
161245174|NCT01438060|582276699|FG000|On Study Beyond Week 140|Adverse Event|0|||
161245175|NCT01438060|582276700|FG001|On Study Beyond Week 140|Adverse Event|2|||
161135519|NCT00500266|581879302|FG000|Overall Study|Lost to Follow-up|3|||
161135520|NCT00500266|581879302|FG000|Overall Study|Withdrawal by Subject|3|||
161135521|NCT00500266|581879302|FG000|Overall Study|Assigned, not treated|4|||
161135522|NCT02251743|581879303|FG000|Overall Study|Withdrawal by Subject|1|||
161135523|NCT02251743|581879304|FG001|Overall Study|Withdrawal by Subject|1|||
161135524|NCT00824564|581879305|FG000|Overall Study|Lost to Follow-up|5|||
161135525|NCT00824564|581879306|FG001|Overall Study|Lost to Follow-up|7|||
161135526|NCT00824564|581879305|FG000|Overall Study|Withdrawal by Subject|1|||
161135527|NCT00824564|581879306|FG001|Overall Study|Withdrawal by Subject|1|||
161135528|NCT00824564|581879305|FG000|Overall Study|Other|1|||
161135529|NCT00824564|581879306|FG001|Overall Study|Other|2|||
161245176|NCT01438060|582276699|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
161245177|NCT01438060|582276700|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
161245178|NCT01438060|582276699|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
161245179|NCT01438060|582276700|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
161245180|NCT01438060|582276699|FG000|On Study Beyond Week 140|Death|0|||
161245181|NCT01438060|582276700|FG001|On Study Beyond Week 140|Death|1|||
161245182|NCT01438060|582276699|FG000|On Study Beyond Week 140|Other Reason|0|||
161135530|NCT00824564|581879305|FG000|Overall Study|Randomized, but not treated|1|||
161135531|NCT00824564|581879306|FG001|Overall Study|Randomized, but not treated|0|||
161135532|NCT02292849|581879308|FG000|Overall Study|Lost to Follow-up|0|||
161135533|NCT02292849|581879309|FG001|Overall Study|Lost to Follow-up|2|||
161135534|NCT02292849|581879310|FG002|Overall Study|Lost to Follow-up|2|||
161135535|NCT02292849|581879308|FG000|Overall Study|Physician Decision|4|||
161135536|NCT02292849|581879309|FG001|Overall Study|Physician Decision|0|||
161245183|NCT01438060|582276700|FG001|On Study Beyond Week 140|Other Reason|3|||
160902902|NCT01145625|581037865|FG001|Overall Study|Withdrawal by Subject|16|||
160902903|NCT01145625|581037864|FG000|Overall Study|Pregnancy|0|||
161135537|NCT02292849|581879310|FG002|Overall Study|Physician Decision|0|||
161135538|NCT01562028|581879312|FG000|Overall Study|Withdrawal by Subject|1|||
161135539|NCT01562028|581879313|FG001|Overall Study|Withdrawal by Subject|1|||
161135540|NCT01562028|581879312|FG000|Overall Study|Lost to Follow-up|2|||
161135541|NCT01562028|581879313|FG001|Overall Study|Lost to Follow-up|1|||
161135542|NCT00775021|581879314|FG000|First Intervention|Lost to Follow-up|1|||
161135543|NCT00775021|581879315|FG001|First Intervention|Lost to Follow-up|0|||
161135544|NCT00775021|581879314|FG000|Second Intervention|Adverse Event|0|||
161245184|NCT03602339|582276701|FG000|Overall Study|Withdrawal by Subject|9|||
161245185|NCT03602339|582276701|FG000|Overall Study|Physician Decision|2|||
160902904|NCT01145625|581037865|FG001|Overall Study|Pregnancy|1|||
161245186|NCT03602339|582276701|FG000|Overall Study|Other reason|4|||
161245187|NCT01190865|582276707|FG000|Overall Study|Withdrawal by Subject|1|||
161245188|NCT01190865|582276707|FG000|Overall Study|Non-compliance|2|||
161245189|NCT00875524|582276709|FG000|Overall Study|Serious adverse event|0|||
161245190|NCT00875524|582276710|FG001|Overall Study|Serious adverse event|1|||
161245191|NCT00875524|582276709|FG000|Overall Study|Protocol Violation|4|||
161245192|NCT00875524|582276710|FG001|Overall Study|Protocol Violation|0|||
161245193|NCT00875524|582276709|FG000|Overall Study|Lost to Follow-up|1|||
161245194|NCT00875524|582276710|FG001|Overall Study|Lost to Follow-up|0|||
161245195|NCT00875524|582276709|FG000|Overall Study|Withdrawal by Subject|3|||
161245196|NCT00875524|582276710|FG001|Overall Study|Withdrawal by Subject|5|||
161245197|NCT00829452|582276711|FG000|First Intervention|Withdrawal by Subject|0|||
161245198|NCT00829452|582276712|FG001|First Intervention|Withdrawal by Subject|1|||
161245199|NCT00829452|582276711|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
161245200|NCT00829452|582276712|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
161245201|NCT00829452|582276711|FG000|Second Intervention|Physician Decision|0|||
161245202|NCT00829452|582276712|FG001|Second Intervention|Physician Decision|1|||
161245203|NCT00574847|582276721|FG000|Overall Study|Adverse Event|2|||
161245204|NCT00574847|582276722|FG001|Overall Study|Adverse Event|0|||
161245205|NCT00574847|582276721|FG000|Overall Study|Death|1|||
161245206|NCT00574847|582276722|FG001|Overall Study|Death|0|||
161245207|NCT00574847|582276721|FG000|Overall Study|Withdrawal by Subject|2|||
161245208|NCT00574847|582276722|FG001|Overall Study|Withdrawal by Subject|2|||
161245209|NCT00574847|582276721|FG000|Overall Study|Physician Decision|1|||
161245210|NCT00574847|582276722|FG001|Overall Study|Physician Decision|0|||
161245211|NCT00574847|582276721|FG000|Overall Study|Did not receive medication (declined)|2|||
161245212|NCT00574847|582276722|FG001|Overall Study|Did not receive medication (declined)|5|||
161245213|NCT00957021|582276728|FG000|Overall Study|Death|5|||
161245214|NCT00957021|582276728|FG000|Overall Study|Lost to Follow-up|8|||
161245215|NCT00957021|582276728|FG000|Overall Study|Withdrawal by Subject|34|||
161245216|NCT00957021|582276728|FG000|Overall Study|No 2 yr ROM data|35|||
161245217|NCT00957021|582276728|FG000|Overall Study|Revised study component by 2 yr visit|8|||
161245218|NCT00957021|582276728|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
161245219|NCT00957021|582276728|FG000|Overall Study|Surgery Cancelled|9|||
161245220|NCT00957021|582276728|FG000|Overall Study|Termination due to language issue|2|||
161245221|NCT04060251|582276737|FG000|Overall Study|Study terminated due to low enrollment.|7|||
161245222|NCT04060251|582276738|FG001|Overall Study|Study terminated due to low enrollment.|5|||
161245223|NCT04060251|582276739|FG002|Overall Study|Study terminated due to low enrollment.|7|||
161245224|NCT04060251|582276737|FG000|Overall Study|Adverse Event|1|||
161245225|NCT04060251|582276738|FG001|Overall Study|Adverse Event|1|||
161245226|NCT04060251|582276739|FG002|Overall Study|Adverse Event|0|||
161245227|NCT00487435|582276740|FG000|Overall Study|Adverse Event|146|||
161245228|NCT00487435|582276740|FG000|Overall Study|Death|2|||
161245229|NCT00487435|582276740|FG000|Overall Study|Lack of Efficacy|33|||
161245230|NCT00487435|582276740|FG000|Overall Study|Lost to Follow-up|54|||
161245231|NCT00487435|582276740|FG000|Overall Study|Pregnancy|2|||
161245232|NCT00487435|582276740|FG000|Overall Study|Withdrawal by Subject|132|||
161245233|NCT00487435|582276740|FG000|Overall Study|Resolution Of Pain|1|||
161245234|NCT00487435|582276740|FG000|Overall Study|Study Medication Non-Compliant|32|||
161245235|NCT00487435|582276740|FG000|Overall Study|Other|83|||
161245236|NCT01155531|582276747|FG000|Overall Study|Adverse Event|0|||
161245237|NCT01155531|582276748|FG001|Overall Study|Adverse Event|0|||
161245238|NCT01155531|582276749|FG002|Overall Study|Adverse Event|1|||
161245239|NCT01155531|582276750|FG003|Overall Study|Adverse Event|0|||
161245240|NCT01155531|582276747|FG000|Overall Study|Lost to Follow-up|0|||
161245241|NCT01155531|582276748|FG001|Overall Study|Lost to Follow-up|0|||
161245242|NCT01155531|582276749|FG002|Overall Study|Lost to Follow-up|0|||
161245243|NCT01155531|582276750|FG003|Overall Study|Lost to Follow-up|1|||
161245244|NCT01155531|582276747|FG000|Overall Study|Withdrawal by Subject|1|||
161245245|NCT01155531|582276748|FG001|Overall Study|Withdrawal by Subject|0|||
161245246|NCT01155531|582276749|FG002|Overall Study|Withdrawal by Subject|1|||
161245247|NCT01155531|582276750|FG003|Overall Study|Withdrawal by Subject|0|||
161245248|NCT01087502|582276751|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
160902905|NCT01751178|581037867|FG000|Overall Study|Adverse Event|2|||
160902906|NCT01751178|581037868|FG001|Overall Study|Adverse Event|0|||
161245249|NCT01087502|582276752|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
161245250|NCT01087502|582276751|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
161245251|NCT01087502|582276752|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
161245252|NCT01087502|582276751|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
161245253|NCT01087502|582276752|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
161245254|NCT01087502|582276751|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
161245255|NCT01087502|582276752|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
161245256|NCT01087502|582276751|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
161245257|NCT01087502|582276752|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
161245258|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
161245259|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
161245260|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
161245261|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
161245262|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
161245263|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
161245264|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
161245265|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
161245266|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
161245267|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
161245268|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
161245269|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
161245270|NCT01087502|582276751|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
161245271|NCT01087502|582276752|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
161245272|NCT02705716|582276753|FG000|Overall Study|Adverse Event|0|||
161245273|NCT02705716|582276754|FG001|Overall Study|Adverse Event|1|||
161245274|NCT02705716|582276753|FG000|Overall Study|Protocol Violation|3|||
161245275|NCT02705716|582276754|FG001|Overall Study|Protocol Violation|0|||
161245276|NCT02705716|582276753|FG000|Overall Study|Withdrawal of Consent|1|||
161245277|NCT02705716|582276754|FG001|Overall Study|Withdrawal of Consent|1|||
161245278|NCT01151618|582276755|FG000|Overall Study|Adverse Event|2|||
161245279|NCT01151618|582276755|FG000|Overall Study|Withdrawal by Subject|7|||
161245280|NCT00562718|582276756|FG000|Overall Study|Death|1|||
161245281|NCT00562718|582276756|FG000|Overall Study|Withdrawal by Subject|3|||
161245282|NCT00562718|582276756|FG000|Overall Study|Adverse Event|4|||
161245283|NCT00562718|582276756|FG000|Overall Study|Lack of Efficacy|2|||
161245284|NCT00562718|582276756|FG000|Overall Study|not stated|1|||
161245285|NCT04025021|582276757|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
161245286|NCT04025021|582276758|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
161245287|NCT01663896|582276761|FG000|Overall Study|Various reasons|43|||
161245288|NCT00842309|582276765|FG000|Overall Study|Withdrawal by Subject|3|||
161245289|NCT00842309|582276766|FG001|Overall Study|Withdrawal by Subject|1|||
161245290|NCT02670551|582276767|FG000|Overall Study|Adverse Event|4|||
161245291|NCT02670551|582276768|FG001|Overall Study|Adverse Event|7|||
161245292|NCT02670551|582276769|FG002|Overall Study|Adverse Event|9|||
161245293|NCT02670551|582276767|FG000|Overall Study|Lack of Efficacy|2|||
161245294|NCT02670551|582276768|FG001|Overall Study|Lack of Efficacy|0|||
161245295|NCT02670551|582276769|FG002|Overall Study|Lack of Efficacy|3|||
161245296|NCT02670551|582276767|FG000|Overall Study|Withdrawal of Consent|6|||
161245297|NCT02670551|582276768|FG001|Overall Study|Withdrawal of Consent|3|||
161245298|NCT02670551|582276769|FG002|Overall Study|Withdrawal of Consent|8|||
161245299|NCT02670551|582276767|FG000|Overall Study|Lost to Follow-up|5|||
161245300|NCT02670551|582276768|FG001|Overall Study|Lost to Follow-up|7|||
161245301|NCT02670551|582276769|FG002|Overall Study|Lost to Follow-up|6|||
160828617|NCT01352741|580759837|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
160828618|NCT01352741|580759838|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
160828619|NCT04070326|580759840|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
160828620|NCT04070326|580759841|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
160828621|NCT00645528|580759842|FG000|Overall Study|Did not show up for Visit 2|7|||
160828622|NCT03077698|580759843|FG000|Progestin Monotherapy|Stable Disease|8|||
160828623|NCT03077698|580759844|FG001|Progestin Monotherapy|Stable Disease|0|||
160828624|NCT03077698|580759843|FG000|Progestin Monotherapy|Adverse Event|1|||
160902907|NCT01751178|581037869|FG002|Overall Study|Adverse Event|0|||
160902908|NCT01751178|581037867|FG000|Overall Study|Other Reason (unknown)|1|||
161245302|NCT02670551|582276767|FG000|Overall Study|Protocol Violation|1|||
161245303|NCT02670551|582276768|FG001|Overall Study|Protocol Violation|0|||
161245304|NCT02670551|582276769|FG002|Overall Study|Protocol Violation|0|||
161245305|NCT02670551|582276767|FG000|Overall Study|Noncompliance with study drug|3|||
161245306|NCT02670551|582276768|FG001|Overall Study|Noncompliance with study drug|3|||
161245307|NCT02670551|582276769|FG002|Overall Study|Noncompliance with study drug|2|||
161245308|NCT02670551|582276767|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161245309|NCT02670551|582276768|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161245310|NCT02670551|582276769|FG002|Overall Study|Other Miscellaneous Reasons|3|||
161245311|NCT02670551|582276767|FG000|Overall Study|Did Not Receive Treatment|5|||
161245312|NCT02670551|582276768|FG001|Overall Study|Did Not Receive Treatment|3|||
161245313|NCT02670551|582276769|FG002|Overall Study|Did Not Receive Treatment|0|||
161245314|NCT01962298|582276770|FG000|Overall Study|Protocol Violation|1|||
161245315|NCT01962298|582276771|FG001|Overall Study|Protocol Violation|0|||
161245316|NCT01962298|582276772|FG002|Overall Study|Protocol Violation|1|||
161245317|NCT01962298|582276773|FG003|Overall Study|Protocol Violation|1|||
161245318|NCT01962298|582276774|FG004|Overall Study|Protocol Violation|0|||
161245319|NCT01962298|582276770|FG000|Overall Study|Data quality insufficient|2|||
161245320|NCT01962298|582276771|FG001|Overall Study|Data quality insufficient|0|||
161245321|NCT01962298|582276772|FG002|Overall Study|Data quality insufficient|3|||
161245322|NCT01962298|582276773|FG003|Overall Study|Data quality insufficient|1|||
161245323|NCT01962298|582276774|FG004|Overall Study|Data quality insufficient|4|||
161245324|NCT01962298|582276770|FG000|Overall Study|Insufficient data|0|||
161245325|NCT01962298|582276771|FG001|Overall Study|Insufficient data|2|||
161245326|NCT01962298|582276772|FG002|Overall Study|Insufficient data|1|||
160828625|NCT03077698|580759844|FG001|Progestin Monotherapy|Adverse Event|0|||
160828626|NCT03077698|580759843|FG000|Progestin Monotherapy|Death|1|||
160828627|NCT03077698|580759844|FG001|Progestin Monotherapy|Death|0|||
160828628|NCT03077698|580759843|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
160828629|NCT03077698|580759844|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
160828630|NCT03077698|580759843|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
160828631|NCT03077698|580759844|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
161135545|NCT00775021|581879315|FG001|Second Intervention|Adverse Event|1|||
161135546|NCT01287754|581879316|FG000|Overall Study|Death|2|||
161135547|NCT01287754|581879317|FG001|Overall Study|Death|12|||
161135548|NCT01287754|581879316|FG000|Overall Study|Lost to Follow-up|1|||
161135549|NCT01287754|581879317|FG001|Overall Study|Lost to Follow-up|6|||
161135550|NCT01287754|581879316|FG000|Overall Study|Protocol Violation|0|||
161135551|NCT01287754|581879317|FG001|Overall Study|Protocol Violation|3|||
161135552|NCT04439266|581879328|FG000|Overall Study|Ineligible|1|||
161135553|NCT04439266|581879328|FG000|Overall Study|Adverse Event|1|||
161135554|NCT04439266|581879328|FG000|Overall Study|Death|1|||
161135555|NCT04439266|581879328|FG000|Overall Study|Disease progression|1|||
161135556|NCT04439266|581879328|FG000|Overall Study|Still on treatment|1|||
161135557|NCT05027802|581879330|FG000|Overall Study|Adverse Event|2|||
161135558|NCT05027802|581879330|FG000|Overall Study|Withdrawal by Subject|18|||
161135559|NCT05027802|581879330|FG000|Overall Study|Death|2|||
161135560|NCT05027802|581879330|FG000|Overall Study|Other|1|||
161135561|NCT00001337|581879337|FG000|Overall Study|Switched to alternate treatment|2|||
161135562|NCT00001337|581879338|FG001|Overall Study|Switched to alternate treatment|2|||
161135563|NCT00001337|581879339|FG002|Overall Study|Switched to alternate treatment|0|||
161135564|NCT00001337|581879337|FG000|Overall Study|Refused further treatment|2|||
160828632|NCT03077698|580759843|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
160828633|NCT03077698|580759844|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
160828634|NCT03077698|580759843|FG000|Safety Follow Up|Withdrawal by Subject|2|||
160828635|NCT03077698|580759844|FG001|Safety Follow Up|Withdrawal by Subject|1|||
160828636|NCT03077698|580759843|FG000|Safety Follow Up|Transfer of care to hospice|1|||
160828637|NCT03077698|580759844|FG001|Safety Follow Up|Transfer of care to hospice|0|||
160828638|NCT01886690|580759846|FG000|Overall Study|Protocol Violation|0|||
160828639|NCT01886690|580759847|FG001|Overall Study|Protocol Violation|1|||
160828640|NCT01886690|580759846|FG000|Overall Study|Personal Reasons|0|||
160828641|NCT01886690|580759847|FG001|Overall Study|Personal Reasons|1|||
160828642|NCT01140568|580759848|FG000|Overall Study|disease progression|31|||
160828643|NCT01140568|580759848|FG000|Overall Study|Withdrawal by Subject|1|||
160828644|NCT01140568|580759848|FG000|Overall Study|Screen Fail|4|||
160828645|NCT03618628|580759849|FG000|Overall Study|Death|1|||
160828646|NCT03618628|580759849|FG000|Overall Study|Lost to Follow-up|1|||
160828647|NCT01969500|580759850|FG000|Overall Study|Death|0|||
160828648|NCT01969500|580759851|FG001|Overall Study|Death|1|||
160828649|NCT01969500|580759850|FG000|Overall Study|extended hospitalization|1|||
160828650|NCT01969500|580759851|FG001|Overall Study|extended hospitalization|1|||
160828651|NCT02193087|580759852|FG000|Overall Study|Adverse Event|2|||
160828652|NCT02193087|580759853|FG001|Overall Study|Adverse Event|0|||
160828653|NCT02193087|580759854|FG002|Overall Study|Adverse Event|0|||
160828654|NCT02193087|580759855|FG003|Overall Study|Adverse Event|11|||
160828655|NCT02193087|580759852|FG000|Overall Study|Lost to Follow-up|14|||
160828656|NCT02193087|580759853|FG001|Overall Study|Lost to Follow-up|6|||
160828657|NCT02193087|580759854|FG002|Overall Study|Lost to Follow-up|4|||
160828658|NCT02193087|580759855|FG003|Overall Study|Lost to Follow-up|37|||
160828659|NCT02193087|580759852|FG000|Overall Study|Protocol Violation|2|||
160828660|NCT02193087|580759853|FG001|Overall Study|Protocol Violation|0|||
160828661|NCT02193087|580759854|FG002|Overall Study|Protocol Violation|1|||
160828662|NCT02193087|580759855|FG003|Overall Study|Protocol Violation|2|||
160828663|NCT02193087|580759852|FG000|Overall Study|Withdrawal by Subject|10|||
160828664|NCT02193087|580759853|FG001|Overall Study|Withdrawal by Subject|3|||
160828665|NCT02193087|580759854|FG002|Overall Study|Withdrawal by Subject|1|||
160828666|NCT02193087|580759855|FG003|Overall Study|Withdrawal by Subject|19|||
160828667|NCT02193087|580759852|FG000|Overall Study|Other Reason Not Specified|7|||
160828668|NCT02193087|580759853|FG001|Overall Study|Other Reason Not Specified|2|||
160828669|NCT02193087|580759854|FG002|Overall Study|Other Reason Not Specified|1|||
160828670|NCT02193087|580759855|FG003|Overall Study|Other Reason Not Specified|9|||
160828671|NCT02193087|580759852|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
160828672|NCT02193087|580759853|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
160828673|NCT02193087|580759854|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
160828674|NCT02193087|580759855|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
160828675|NCT04096820|580759856|FG000|Overall Study|Did not return for intervention|2|||
161135565|NCT00001337|581879338|FG001|Overall Study|Refused further treatment|1|||
161135566|NCT00001337|581879339|FG002|Overall Study|Refused further treatment|0|||
160828676|NCT04096820|580759856|FG000|Overall Study|Death|1|||
160828677|NCT02463032|580759857|FG000|Overall Study|Lack of Efficacy|61|||
160828678|NCT02463032|580759858|FG001|Overall Study|Lack of Efficacy|50|||
161135567|NCT00001337|581879337|FG000|Overall Study|Began other Tx|1|||
161135568|NCT00001337|581879338|FG001|Overall Study|Began other Tx|0|||
161135569|NCT00001337|581879339|FG002|Overall Study|Began other Tx|0|||
161135570|NCT00001337|581879337|FG000|Overall Study|Physician Decision|3|||
161135571|NCT00001337|581879338|FG001|Overall Study|Physician Decision|1|||
161135572|NCT00001337|581879339|FG002|Overall Study|Physician Decision|0|||
161135573|NCT00001337|581879337|FG000|Overall Study|Doesn't have NHL|0|||
161135574|NCT00001337|581879338|FG001|Overall Study|Doesn't have NHL|1|||
161135575|NCT00001337|581879339|FG002|Overall Study|Doesn't have NHL|0|||
161135576|NCT00001337|581879337|FG000|Overall Study|Non protocol tx needed|3|||
161135577|NCT00001337|581879338|FG001|Overall Study|Non protocol tx needed|1|||
161135578|NCT00001337|581879339|FG002|Overall Study|Non protocol tx needed|0|||
161135579|NCT00001337|581879337|FG000|Overall Study|Protocol change|1|||
161135580|NCT00001337|581879338|FG001|Overall Study|Protocol change|0|||
161135581|NCT00001337|581879339|FG002|Overall Study|Protocol change|0|||
161135582|NCT00001337|581879337|FG000|Overall Study|2nd primary disease|0|||
161135583|NCT00001337|581879338|FG001|Overall Study|2nd primary disease|0|||
161135584|NCT00001337|581879339|FG002|Overall Study|2nd primary disease|1|||
161135585|NCT00001337|581879337|FG000|Overall Study|Death during follow up period|9|||
161135586|NCT00001337|581879338|FG001|Overall Study|Death during follow up period|4|||
161135587|NCT00001337|581879339|FG002|Overall Study|Death during follow up period|0|||
161135588|NCT00001337|581879337|FG000|Overall Study|Death on study|19|||
161135589|NCT00001337|581879338|FG001|Overall Study|Death on study|9|||
161135590|NCT00001337|581879339|FG002|Overall Study|Death on study|0|||
161135591|NCT00001337|581879337|FG000|Overall Study|Disease progression during follow-up period|3|||
161135592|NCT00001337|581879338|FG001|Overall Study|Disease progression during follow-up period|1|||
161135593|NCT00001337|581879339|FG002|Overall Study|Disease progression during follow-up period|0|||
161135594|NCT00001337|581879337|FG000|Overall Study|Disease progression on study|33|||
161135595|NCT00001337|581879338|FG001|Overall Study|Disease progression on study|41|||
161135596|NCT00001337|581879339|FG002|Overall Study|Disease progression on study|0|||
161135597|NCT00001337|581879337|FG000|Overall Study|Lost to further follow-up|10|||
161135598|NCT00001337|581879338|FG001|Overall Study|Lost to further follow-up|6|||
161135599|NCT00001337|581879339|FG002|Overall Study|Lost to further follow-up|0|||
161135600|NCT00001337|581879337|FG000|Overall Study|2nd malignancy|1|||
161135601|NCT00001337|581879338|FG001|Overall Study|2nd malignancy|0|||
161135602|NCT00001337|581879339|FG002|Overall Study|2nd malignancy|0|||
161135603|NCT00001337|581879337|FG000|Overall Study|Treatment for second lymphoma|0|||
161135604|NCT00001337|581879338|FG001|Overall Study|Treatment for second lymphoma|1|||
161135605|NCT00001337|581879339|FG002|Overall Study|Treatment for second lymphoma|0|||
161135606|NCT00001337|581879337|FG000|Overall Study|Transfer to transplant|0|||
161135607|NCT00001337|581879338|FG001|Overall Study|Transfer to transplant|1|||
161135608|NCT00001337|581879339|FG002|Overall Study|Transfer to transplant|0|||
161135609|NCT06161012|581879340|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
161135610|NCT06161012|581879341|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161135611|NCT00408005|581879346|FG000|Induction|Adverse Event|19|||
161135612|NCT00408005|581879347|FG001|Induction|Adverse Event|3|||
161135613|NCT00408005|581879348|FG002|Induction|Adverse Event|0|||
161135614|NCT00408005|581879349|FG003|Induction|Adverse Event|0|||
161135615|NCT00408005|581879350|FG004|Induction|Adverse Event|0|||
161135616|NCT00408005|581879351|FG005|Induction|Adverse Event|0|||
161135617|NCT00408005|581879352|FG006|Induction|Adverse Event|0|||
161135618|NCT00408005|581879353|FG007|Induction|Adverse Event|0|||
161135619|NCT00408005|581879346|FG000|Induction|Death|6|||
161135620|NCT00408005|581879347|FG001|Induction|Death|0|||
161135621|NCT00408005|581879348|FG002|Induction|Death|0|||
161135622|NCT00408005|581879349|FG003|Induction|Death|0|||
161135623|NCT00408005|581879350|FG004|Induction|Death|0|||
161135624|NCT00408005|581879351|FG005|Induction|Death|0|||
161135625|NCT00408005|581879352|FG006|Induction|Death|0|||
161135626|NCT00408005|581879353|FG007|Induction|Death|0|||
161135627|NCT00408005|581879346|FG000|Induction|Physician Decision|83|||
161135628|NCT00408005|581879347|FG001|Induction|Physician Decision|9|||
161135629|NCT00408005|581879348|FG002|Induction|Physician Decision|0|||
161135630|NCT00408005|581879349|FG003|Induction|Physician Decision|0|||
161135631|NCT00408005|581879350|FG004|Induction|Physician Decision|0|||
161135632|NCT00408005|581879351|FG005|Induction|Physician Decision|0|||
161135633|NCT00408005|581879352|FG006|Induction|Physician Decision|0|||
161135634|NCT00408005|581879353|FG007|Induction|Physician Decision|0|||
161135635|NCT00408005|581879346|FG000|Induction|Withdrawal by Subject|2|||
161135636|NCT00408005|581879347|FG001|Induction|Withdrawal by Subject|4|||
161135637|NCT00408005|581879348|FG002|Induction|Withdrawal by Subject|0|||
161135638|NCT00408005|581879349|FG003|Induction|Withdrawal by Subject|0|||
161135639|NCT00408005|581879350|FG004|Induction|Withdrawal by Subject|0|||
161135640|NCT00408005|581879351|FG005|Induction|Withdrawal by Subject|0|||
161135641|NCT00408005|581879352|FG006|Induction|Withdrawal by Subject|0|||
161135642|NCT00408005|581879353|FG007|Induction|Withdrawal by Subject|0|||
161135643|NCT00408005|581879346|FG000|Induction|Ineligible|33|||
161135644|NCT00408005|581879347|FG001|Induction|Ineligible|14|||
161135645|NCT00408005|581879348|FG002|Induction|Ineligible|0|||
161135646|NCT00408005|581879349|FG003|Induction|Ineligible|0|||
161135647|NCT00408005|581879350|FG004|Induction|Ineligible|0|||
161245327|NCT01962298|582276773|FG003|Overall Study|Insufficient data|0|||
161245328|NCT01962298|582276774|FG004|Overall Study|Insufficient data|1|||
161245329|NCT01962298|582276770|FG000|Overall Study|Incorrect data recorded|0|||
161135648|NCT00408005|581879351|FG005|Induction|Ineligible|0|||
161135649|NCT00408005|581879352|FG006|Induction|Ineligible|0|||
161135650|NCT00408005|581879353|FG007|Induction|Ineligible|0|||
161135651|NCT00408005|581879346|FG000|Induction|Refusal of Further Protocol Therapy|225|||
161135652|NCT00408005|581879347|FG001|Induction|Refusal of Further Protocol Therapy|44|||
161135653|NCT00408005|581879348|FG002|Induction|Refusal of Further Protocol Therapy|0|||
161135654|NCT00408005|581879349|FG003|Induction|Refusal of Further Protocol Therapy|0|||
161135655|NCT00408005|581879350|FG004|Induction|Refusal of Further Protocol Therapy|0|||
161135656|NCT00408005|581879351|FG005|Induction|Refusal of Further Protocol Therapy|0|||
161135657|NCT00408005|581879352|FG006|Induction|Refusal of Further Protocol Therapy|0|||
161135658|NCT00408005|581879353|FG007|Induction|Refusal of Further Protocol Therapy|0|||
161135659|NCT00408005|581879346|FG000|Induction|Entered another COG therapeutic protocol|4|||
161245330|NCT01962298|582276771|FG001|Overall Study|Incorrect data recorded|1|||
161245331|NCT01962298|582276772|FG002|Overall Study|Incorrect data recorded|0|||
161245332|NCT01962298|582276773|FG003|Overall Study|Incorrect data recorded|0|||
161245333|NCT01962298|582276774|FG004|Overall Study|Incorrect data recorded|0|||
161245334|NCT01962298|582276770|FG000|Overall Study|Physician Decision|0|||
161135660|NCT00408005|581879347|FG001|Induction|Entered another COG therapeutic protocol|0|||
161135661|NCT00408005|581879348|FG002|Induction|Entered another COG therapeutic protocol|0|||
161135662|NCT00408005|581879349|FG003|Induction|Entered another COG therapeutic protocol|0|||
161135663|NCT00408005|581879350|FG004|Induction|Entered another COG therapeutic protocol|0|||
161135664|NCT00408005|581879351|FG005|Induction|Entered another COG therapeutic protocol|0|||
161135665|NCT00408005|581879352|FG006|Induction|Entered another COG therapeutic protocol|0|||
161135666|NCT00408005|581879353|FG007|Induction|Entered another COG therapeutic protocol|0|||
161135667|NCT00408005|581879346|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
161135668|NCT00408005|581879347|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
161135669|NCT00408005|581879348|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
161135670|NCT00408005|581879349|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
161135671|NCT00408005|581879350|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
161135672|NCT00408005|581879351|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
161135673|NCT00408005|581879352|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
161135674|NCT00408005|581879353|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
161135675|NCT00408005|581879346|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
161135676|NCT00408005|581879347|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
161135677|NCT00408005|581879348|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
161135678|NCT00408005|581879349|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
161135679|NCT00408005|581879350|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
161135680|NCT00408005|581879351|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
161135681|NCT00408005|581879352|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
161135682|NCT00408005|581879353|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
161135683|NCT00408005|581879346|FG000|Induction|Progressive Disease|0|||
161135684|NCT00408005|581879347|FG001|Induction|Progressive Disease|1|||
161135685|NCT00408005|581879348|FG002|Induction|Progressive Disease|0|||
161135686|NCT00408005|581879349|FG003|Induction|Progressive Disease|0|||
161135687|NCT00408005|581879350|FG004|Induction|Progressive Disease|0|||
161245335|NCT01962298|582276771|FG001|Overall Study|Physician Decision|1|||
161245336|NCT01962298|582276772|FG002|Overall Study|Physician Decision|0|||
161245337|NCT01962298|582276773|FG003|Overall Study|Physician Decision|0|||
161245338|NCT01962298|582276774|FG004|Overall Study|Physician Decision|1|||
161245339|NCT04476277|582276775|FG000|Overall Study|Withdrawal by Subject|0|||
161245340|NCT04476277|582276776|FG001|Overall Study|Withdrawal by Subject|0|||
161245341|NCT04476277|582276777|FG002|Overall Study|Withdrawal by Subject|1|||
161245342|NCT04476277|582276778|FG003|Overall Study|Withdrawal by Subject|0|||
161245343|NCT00566722|582276779|FG000|Overall Study|Adverse Event|0|||
161245344|NCT00566722|582276780|FG001|Overall Study|Adverse Event|1|||
161245345|NCT00566722|582276781|FG002|Overall Study|Adverse Event|0|||
161245346|NCT00566722|582276779|FG000|Overall Study|Withdrawal by Subject|0|||
161245347|NCT00566722|582276780|FG001|Overall Study|Withdrawal by Subject|0|||
161135688|NCT00408005|581879351|FG005|Induction|Progressive Disease|0|||
160990712|NCT00372060|581353925|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
161245348|NCT00566722|582276781|FG002|Overall Study|Withdrawal by Subject|1|||
161245349|NCT00566722|582276779|FG000|Overall Study|Lost to Follow-up|1|||
161245350|NCT00566722|582276780|FG001|Overall Study|Lost to Follow-up|1|||
161135689|NCT00408005|581879352|FG006|Induction|Progressive Disease|0|||
161135690|NCT00408005|581879353|FG007|Induction|Progressive Disease|0|||
161135691|NCT00408005|581879346|FG000|Induction|Inevaluable|18|||
161135692|NCT00408005|581879347|FG001|Induction|Inevaluable|14|||
161135693|NCT00408005|581879348|FG002|Induction|Inevaluable|0|||
161135694|NCT00408005|581879349|FG003|Induction|Inevaluable|0|||
161245351|NCT00566722|582276781|FG002|Overall Study|Lost to Follow-up|1|||
161245352|NCT00566722|582276779|FG000|Overall Study|Lack of Efficacy|1|||
161245353|NCT00566722|582276780|FG001|Overall Study|Lack of Efficacy|2|||
161245354|NCT00566722|582276781|FG002|Overall Study|Lack of Efficacy|4|||
161245355|NCT00566722|582276779|FG000|Overall Study|Did not meet exclusion criteria|0|||
161245356|NCT00566722|582276780|FG001|Overall Study|Did not meet exclusion criteria|0|||
161245357|NCT00566722|582276781|FG002|Overall Study|Did not meet exclusion criteria|2|||
161245358|NCT00566722|582276779|FG000|Overall Study|Serious adverse event|0|||
161245359|NCT00566722|582276780|FG001|Overall Study|Serious adverse event|1|||
161245360|NCT00566722|582276781|FG002|Overall Study|Serious adverse event|0|||
161245361|NCT00566722|582276779|FG000|Overall Study|Noncompliant with drug administration|0|||
161245362|NCT00566722|582276780|FG001|Overall Study|Noncompliant with drug administration|0|||
161245363|NCT00566722|582276781|FG002|Overall Study|Noncompliant with drug administration|1|||
161245364|NCT03573544|582276782|FG000|Overall Study|Adverse Event|0|||
161245365|NCT03573544|582276783|FG001|Overall Study|Adverse Event|0|||
161245366|NCT03573544|582276784|FG002|Overall Study|Adverse Event|0|||
161245367|NCT03573544|582276785|FG003|Overall Study|Adverse Event|3|||
161245368|NCT03573544|582276786|FG004|Overall Study|Adverse Event|1|||
161245369|NCT03573544|582276787|FG005|Overall Study|Adverse Event|0|||
161245370|NCT03573544|582276788|FG006|Overall Study|Adverse Event|2|||
161245371|NCT03573544|582276789|FG007|Overall Study|Adverse Event|0|||
161245372|NCT03573544|582276782|FG000|Overall Study|Physician Decision|0|||
161245373|NCT03573544|582276783|FG001|Overall Study|Physician Decision|0|||
161245374|NCT03573544|582276784|FG002|Overall Study|Physician Decision|0|||
161245375|NCT03573544|582276785|FG003|Overall Study|Physician Decision|0|||
161245376|NCT03573544|582276786|FG004|Overall Study|Physician Decision|0|||
161245377|NCT03573544|582276787|FG005|Overall Study|Physician Decision|0|||
161245378|NCT03573544|582276788|FG006|Overall Study|Physician Decision|1|||
161245379|NCT03573544|582276789|FG007|Overall Study|Physician Decision|0|||
161245380|NCT03573544|582276782|FG000|Overall Study|Withdrawal by Subject|2|||
161245381|NCT03573544|582276783|FG001|Overall Study|Withdrawal by Subject|0|||
161245382|NCT03573544|582276784|FG002|Overall Study|Withdrawal by Subject|0|||
161245383|NCT03573544|582276785|FG003|Overall Study|Withdrawal by Subject|1|||
161245384|NCT03573544|582276786|FG004|Overall Study|Withdrawal by Subject|1|||
161245385|NCT03573544|582276787|FG005|Overall Study|Withdrawal by Subject|1|||
161245386|NCT03573544|582276788|FG006|Overall Study|Withdrawal by Subject|0|||
161245387|NCT03573544|582276789|FG007|Overall Study|Withdrawal by Subject|1|||
161245388|NCT03573544|582276782|FG000|Overall Study|Disease progression|3|||
161245389|NCT03573544|582276783|FG001|Overall Study|Disease progression|3|||
161245390|NCT03573544|582276784|FG002|Overall Study|Disease progression|6|||
161245391|NCT03573544|582276785|FG003|Overall Study|Disease progression|4|||
161245392|NCT03573544|582276786|FG004|Overall Study|Disease progression|5|||
161245393|NCT03573544|582276787|FG005|Overall Study|Disease progression|7|||
161245394|NCT03573544|582276788|FG006|Overall Study|Disease progression|6|||
161245395|NCT03573544|582276789|FG007|Overall Study|Disease progression|7|||
161245396|NCT03105297|582276790|FG000|Baseline Phase (Day 1)|Other|21|||
161245397|NCT03105297|582276790|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
161245398|NCT03105297|582276790|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
161245399|NCT00714051|582276791|FG000|Overall Study|Withdrawal by Subject|1|||
161245400|NCT00714051|582276792|FG001|Overall Study|Withdrawal by Subject|0|||
161245401|NCT00714051|582276791|FG000|Overall Study|Death|0|||
161245402|NCT00714051|582276792|FG001|Overall Study|Death|1|||
161245403|NCT01390948|582276793|FG000|Overall Study|End of Study|1|||
161245404|NCT01390948|582276794|FG001|Overall Study|End of Study|0|||
161245405|NCT01390948|582276795|FG002|Overall Study|End of Study|0|||
161245406|NCT01390948|582276793|FG000|Overall Study|Withdrew consent|2|||
161245407|NCT01390948|582276794|FG001|Overall Study|Withdrew consent|2|||
161245408|NCT01390948|582276795|FG002|Overall Study|Withdrew consent|0|||
161245409|NCT01390948|582276793|FG000|Overall Study|Progressive Disease|2|||
161245410|NCT01390948|582276794|FG001|Overall Study|Progressive Disease|5|||
161245411|NCT01390948|582276795|FG002|Overall Study|Progressive Disease|0|||
161245412|NCT01390948|582276793|FG000|Overall Study|Death during follow-up|10|||
161245413|NCT01390948|582276794|FG001|Overall Study|Death during follow-up|11|||
161245414|NCT01390948|582276795|FG002|Overall Study|Death during follow-up|1|||
161245415|NCT05740098|582276798|FG000|Overall Study|Lost to Follow-up|26|||
161245416|NCT05740098|582276799|FG001|Overall Study|Lost to Follow-up|17|||
161245417|NCT05740098|582276800|FG002|Overall Study|Lost to Follow-up|21|||
161245418|NCT00849797|582276805|FG000|First Intervention|bad veins|1|||
161245419|NCT00849797|582276806|FG001|First Intervention|bad veins|0|||
161245420|NCT00849797|582276805|FG000|First Intervention|Adverse Event|0|||
161245421|NCT00849797|582276806|FG001|First Intervention|Adverse Event|1|||
161245422|NCT00849797|582276805|FG000|Washout: One Week|Withdrawal by Subject|0|||
161245423|NCT00849797|582276806|FG001|Washout: One Week|Withdrawal by Subject|2|||
161245424|NCT01018862|582276814|FG000|Overall Study|Adverse Event|2|||
161245425|NCT01018862|582276815|FG001|Overall Study|Adverse Event|0|||
161245426|NCT01018862|582276816|FG002|Overall Study|Adverse Event|6|||
161245427|NCT01018862|582276814|FG000|Overall Study|Lack of Efficacy|1|||
161245428|NCT01018862|582276815|FG001|Overall Study|Lack of Efficacy|0|||
161245429|NCT01018862|582276816|FG002|Overall Study|Lack of Efficacy|2|||
161245430|NCT01018862|582276814|FG000|Overall Study|Lost to Follow-up|3|||
160902909|NCT01751178|581037868|FG001|Overall Study|Other Reason (unknown)|0|||
160902910|NCT01751178|581037869|FG002|Overall Study|Other Reason (unknown)|2|||
160902911|NCT04289623|581037870|FG000|Wave 1 Emails|Email was not delivered|268|||
160902912|NCT04289623|581037871|FG001|Wave 1 Emails|Email was not delivered|257|||
160902913|NCT04289623|581037872|FG002|Wave 1 Emails|Email was not delivered|0|||
160902914|NCT04289623|581037873|FG003|Wave 1 Emails|Email was not delivered|0|||
160902915|NCT04289623|581037874|FG004|Wave 1 Emails|Email was not delivered|0|||
160902916|NCT04289623|581037875|FG005|Wave 1 Emails|Email was not delivered|0|||
160902917|NCT04138810|581037882|FG000|Overall Study|Withdrawal by Subject|0|||
160902918|NCT04138810|581037883|FG001|Overall Study|Withdrawal by Subject|1|||
160902919|NCT04138810|581037882|FG000|Overall Study|Subject cancelled surgery|1|||
160902920|NCT04138810|581037883|FG001|Overall Study|Subject cancelled surgery|0|||
160902921|NCT00696800|581037884|FG000|Overall Study|Adverse Event|16|||
160902922|NCT00696800|581037885|FG001|Overall Study|Adverse Event|3|||
160902923|NCT00696800|581037884|FG000|Overall Study|Insufficient compliance with medication|2|||
160902924|NCT00696800|581037885|FG001|Overall Study|Insufficient compliance with medication|1|||
160902925|NCT00696800|581037884|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
160902926|NCT00696800|581037885|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
160902927|NCT00696800|581037884|FG000|Overall Study|Insufficient ovarian response|4|||
160902928|NCT00696800|581037885|FG001|Overall Study|Insufficient ovarian response|1|||
160902929|NCT00696800|581037884|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
160902930|NCT00696800|581037885|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
160902931|NCT00696800|581037884|FG000|Overall Study|Too high ovarian response|6|||
160902932|NCT00696800|581037885|FG001|Overall Study|Too high ovarian response|1|||
160902933|NCT00696800|581037884|FG000|Overall Study|No/too few/bad quality oocytes|4|||
160902934|NCT00696800|581037885|FG001|Overall Study|No/too few/bad quality oocytes|3|||
160902935|NCT00696800|581037884|FG000|Overall Study|No/abnormal fertilization|11|||
160902936|NCT00696800|581037885|FG001|Overall Study|No/abnormal fertilization|13|||
160902937|NCT00696800|581037884|FG000|Overall Study|No/too few/bad quality embryos|24|||
160902938|NCT00696800|581037885|FG001|Overall Study|No/too few/bad quality embryos|18|||
160902939|NCT00696800|581037884|FG000|Overall Study|Other Reasons|5|||
160902940|NCT00696800|581037885|FG001|Overall Study|Other Reasons|3|||
160902941|NCT00696800|581037884|FG000|Overall Study|Not treated|1|||
160902942|NCT00696800|581037885|FG001|Overall Study|Not treated|2|||
160902943|NCT00591344|581037886|FG000|Overall Study|Transportation issues|1|||
160902944|NCT00591344|581037887|FG001|Overall Study|Transportation issues|0|||
160902945|NCT00591344|581037886|FG000|Overall Study|Moved out of state|1|||
160902946|NCT00591344|581037887|FG001|Overall Study|Moved out of state|0|||
160902947|NCT00591344|581037886|FG000|Overall Study|Medical complications|1|||
160902948|NCT00591344|581037887|FG001|Overall Study|Medical complications|3|||
160902949|NCT00591344|581037886|FG000|Overall Study|Underwent DBS|2|||
160902950|NCT00591344|581037887|FG001|Overall Study|Underwent DBS|2|||
160902951|NCT00591344|581037886|FG000|Overall Study|Death|0|||
160902952|NCT00591344|581037887|FG001|Overall Study|Death|1|||
160902953|NCT00591344|581037886|FG000|Overall Study|Lost to Follow-up|0|||
160902954|NCT00591344|581037887|FG001|Overall Study|Lost to Follow-up|1|||
160902955|NCT00591344|581037886|FG000|Overall Study|Did not want to come off medication|0|||
160902956|NCT00591344|581037887|FG001|Overall Study|Did not want to come off medication|1|||
160902957|NCT00493025|581037888|FG000|Overall Study|Physician Decision|19|||
160902958|NCT02435147|581037890|FG000|Overall Study|non-evaluable DXA scan|11|||
160902959|NCT02939079|581037891|FG000|Overall Study|Adverse Event|2|||
160902960|NCT02939079|581037892|FG001|Overall Study|Adverse Event|1|||
161135695|NCT00408005|581879350|FG004|Induction|Inevaluable|0|||
161135696|NCT00408005|581879351|FG005|Induction|Inevaluable|0|||
161135697|NCT00408005|581879352|FG006|Induction|Inevaluable|0|||
161135698|NCT00408005|581879353|FG007|Induction|Inevaluable|0|||
161135699|NCT00408005|581879346|FG000|Induction|Failed to Complete Randomization|3|||
161135700|NCT00408005|581879347|FG001|Induction|Failed to Complete Randomization|2|||
161135701|NCT00408005|581879348|FG002|Induction|Failed to Complete Randomization|0|||
161135702|NCT00408005|581879349|FG003|Induction|Failed to Complete Randomization|0|||
161135703|NCT00408005|581879350|FG004|Induction|Failed to Complete Randomization|0|||
161135704|NCT00408005|581879351|FG005|Induction|Failed to Complete Randomization|0|||
161135705|NCT00408005|581879352|FG006|Induction|Failed to Complete Randomization|0|||
161135706|NCT00408005|581879353|FG007|Induction|Failed to Complete Randomization|0|||
161135707|NCT00408005|581879346|FG000|Induction|Protocol Deviation|3|||
161135708|NCT00408005|581879347|FG001|Induction|Protocol Deviation|1|||
161135709|NCT00408005|581879348|FG002|Induction|Protocol Deviation|0|||
161135710|NCT00408005|581879349|FG003|Induction|Protocol Deviation|0|||
161135711|NCT00408005|581879350|FG004|Induction|Protocol Deviation|0|||
161135712|NCT00408005|581879351|FG005|Induction|Protocol Deviation|0|||
160902961|NCT02939079|581037891|FG000|Overall Study|Lost to Follow-up|0|||
160902962|NCT02939079|581037892|FG001|Overall Study|Lost to Follow-up|2|||
160902963|NCT02939079|581037891|FG000|Overall Study|Protocol Violation|1|||
160902964|NCT02939079|581037892|FG001|Overall Study|Protocol Violation|0|||
160902965|NCT02939079|581037891|FG000|Overall Study|Withdrawal by Subject|0|||
160902966|NCT02939079|581037892|FG001|Overall Study|Withdrawal by Subject|1|||
160902967|NCT02939079|581037891|FG000|Overall Study|relapse during the study|1|||
160902968|NCT02939079|581037892|FG001|Overall Study|relapse during the study|1|||
161245431|NCT01018862|582276815|FG001|Overall Study|Lost to Follow-up|1|||
161245432|NCT01018862|582276816|FG002|Overall Study|Lost to Follow-up|0|||
161245433|NCT01018862|582276814|FG000|Overall Study|Protocol Violation|1|||
161245434|NCT01018862|582276815|FG001|Overall Study|Protocol Violation|3|||
161245435|NCT01018862|582276816|FG002|Overall Study|Protocol Violation|3|||
161245436|NCT01018862|582276814|FG000|Overall Study|Withdrawal by Subject|1|||
161245437|NCT01018862|582276815|FG001|Overall Study|Withdrawal by Subject|2|||
161245438|NCT01018862|582276816|FG002|Overall Study|Withdrawal by Subject|1|||
161245439|NCT01018862|582276814|FG000|Overall Study|administrative problems|5|||
161245440|NCT01018862|582276815|FG001|Overall Study|administrative problems|4|||
161245441|NCT01018862|582276816|FG002|Overall Study|administrative problems|4|||
161245442|NCT01968031|582276820|FG000|Overall Study|Adverse Event|13|||
161245443|NCT01968031|582276821|FG001|Overall Study|Adverse Event|10|||
161245444|NCT01968031|582276822|FG002|Overall Study|Adverse Event|22|||
161245445|NCT01968031|582276820|FG000|Overall Study|Withdrawal by Subject|3|||
161245446|NCT01968031|582276821|FG001|Overall Study|Withdrawal by Subject|7|||
161245447|NCT01968031|582276822|FG002|Overall Study|Withdrawal by Subject|3|||
161245448|NCT01968031|582276820|FG000|Overall Study|Did not meet entry criteria|1|||
161245449|NCT01968031|582276821|FG001|Overall Study|Did not meet entry criteria|1|||
161135713|NCT00408005|581879352|FG006|Induction|Protocol Deviation|0|||
161135714|NCT00408005|581879353|FG007|Induction|Protocol Deviation|0|||
161135715|NCT00408005|581879346|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
161135716|NCT00408005|581879347|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
161245450|NCT01968031|582276822|FG002|Overall Study|Did not meet entry criteria|1|||
161245451|NCT01968031|582276820|FG000|Overall Study|Noncompliance|0|||
161245452|NCT01968031|582276821|FG001|Overall Study|Noncompliance|0|||
161245453|NCT01968031|582276822|FG002|Overall Study|Noncompliance|2|||
161245454|NCT01968031|582276820|FG000|Overall Study|Failed inclusion criteria|0|||
161245455|NCT01968031|582276821|FG001|Overall Study|Failed inclusion criteria|2|||
161245456|NCT01968031|582276822|FG002|Overall Study|Failed inclusion criteria|0|||
161245457|NCT01968031|582276820|FG000|Overall Study|Death|0|||
161245458|NCT01968031|582276821|FG001|Overall Study|Death|0|||
161245459|NCT01968031|582276822|FG002|Overall Study|Death|1|||
161245460|NCT01968031|582276820|FG000|Overall Study|Prohibited concomitant medication|1|||
161245461|NCT01968031|582276821|FG001|Overall Study|Prohibited concomitant medication|0|||
161245462|NCT01968031|582276822|FG002|Overall Study|Prohibited concomitant medication|0|||
161245463|NCT00477594|582276823|FG000|Year 1 and Year 2|Adverse Event|4|||
161245464|NCT00477594|582276824|FG001|Year 1 and Year 2|Adverse Event|2|||
161245465|NCT00477594|582276823|FG000|Year 1 and Year 2|Physician Decision|2|||
161245466|NCT00477594|582276824|FG001|Year 1 and Year 2|Physician Decision|1|||
161245467|NCT00477594|582276823|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
161245468|NCT00477594|582276824|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
161245469|NCT00477594|582276823|FG000|Year 1 and Year 2|Other|1|||
161245470|NCT00477594|582276824|FG001|Year 1 and Year 2|Other|0|||
161245471|NCT00477594|582276823|FG000|Year 3|Adverse Event|1|||
161245472|NCT00477594|582276824|FG001|Year 3|Adverse Event|0|||
161245473|NCT00477594|582276823|FG000|Year 3|Withdrawal by Subject|1|||
161245474|NCT00477594|582276824|FG001|Year 3|Withdrawal by Subject|0|||
161245475|NCT00477594|582276823|FG000|Follow-up Period|Withdrawal by Subject|2|||
161245476|NCT00477594|582276824|FG001|Follow-up Period|Withdrawal by Subject|1|||
161245477|NCT00477594|582276823|FG000|Follow-up Period|Other|1|||
161245478|NCT00477594|582276824|FG001|Follow-up Period|Other|0|||
161245479|NCT04573309|582278700|FG000|Overall Study|Protocol Violation|1|||
161245480|NCT04573309|582278701|FG001|Overall Study|Protocol Violation|0|||
161245481|NCT01691430|582278702|FG000|Overall Study|Death|17|||
161245482|NCT01691430|582278703|FG001|Overall Study|Death|16|||
161245483|NCT01691430|582278702|FG000|Overall Study|Withdrawal by Subject|5|||
161245484|NCT01691430|582278703|FG001|Overall Study|Withdrawal by Subject|1|||
161245485|NCT01691430|582278702|FG000|Overall Study|Lost to Follow-up|0|||
161245486|NCT01691430|582278703|FG001|Overall Study|Lost to Follow-up|3|||
161245487|NCT02998541|582278705|FG000|Overall Study|Adverse Event|4|||
161245488|NCT02998541|582278706|FG001|Overall Study|Adverse Event|5|||
161245489|NCT02998541|582278707|FG002|Overall Study|Adverse Event|1|||
161245490|NCT02998541|582278705|FG000|Overall Study|Protocol Violation|1|||
161245491|NCT02998541|582278706|FG001|Overall Study|Protocol Violation|0|||
160902969|NCT01609231|581037893|FG000|Overall Study|Adverse Event|1|||
160902970|NCT01609231|581037894|FG001|Overall Study|Adverse Event|3|||
161135717|NCT00408005|581879348|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
161135718|NCT00408005|581879349|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
161135719|NCT00408005|581879350|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
161135720|NCT00408005|581879351|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
161135721|NCT00408005|581879352|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
161245492|NCT02998541|582278707|FG002|Overall Study|Protocol Violation|0|||
161245493|NCT02998541|582278705|FG000|Overall Study|Withdrawal by Subject|3|||
161245494|NCT02998541|582278706|FG001|Overall Study|Withdrawal by Subject|1|||
161245495|NCT02998541|582278707|FG002|Overall Study|Withdrawal by Subject|0|||
160990713|NCT00372060|581353924|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
160990714|NCT00372060|581353925|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
160990715|NCT00647348|581353926|FG000|Overall Study|Lost to Follow-up|3|||
160990716|NCT00647348|581353927|FG001|Overall Study|Lost to Follow-up|6|||
160990717|NCT03382821|581353931|FG000|Overall Study|Did not receive allocated intervention.|0|||
160990718|NCT03382821|581353932|FG001|Overall Study|Did not receive allocated intervention.|3|||
160990719|NCT00282438|581353933|FG000|Overall Study|Lack of Efficacy|1|||
160990720|NCT00282438|581353934|FG001|Overall Study|Lack of Efficacy|0|||
160990721|NCT00282438|581353933|FG000|Overall Study|Death|0|||
160990722|NCT00282438|581353934|FG001|Overall Study|Death|1|||
160990723|NCT01119703|581353943|FG000|Overall Study|Adverse Event|0|||
160990724|NCT01119703|581353944|FG001|Overall Study|Adverse Event|1|||
160990725|NCT01511250|581353945|FG000|Overall Study|Withdrawal of Consent|1|||
160990726|NCT01511250|581353946|FG001|Overall Study|Withdrawal of Consent|0|||
160990727|NCT01511250|581353947|FG002|Overall Study|Withdrawal of Consent|0|||
160990728|NCT01511250|581353948|FG003|Overall Study|Withdrawal of Consent|0|||
160990729|NCT01511250|581353949|FG004|Overall Study|Withdrawal of Consent|0|||
161245496|NCT02998541|582278705|FG000|Overall Study|Lost to Follow-up|0|||
161245497|NCT02998541|582278706|FG001|Overall Study|Lost to Follow-up|3|||
161245498|NCT02998541|582278707|FG002|Overall Study|Lost to Follow-up|1|||
161245499|NCT02998541|582278705|FG000|Overall Study|Physician Decision|0|||
161245500|NCT02998541|582278706|FG001|Overall Study|Physician Decision|0|||
161245501|NCT02998541|582278707|FG002|Overall Study|Physician Decision|3|||
160990730|NCT01511250|581353950|FG005|Overall Study|Withdrawal of Consent|0|||
160990731|NCT01511250|581353951|FG006|Overall Study|Withdrawal of Consent|0|||
160990732|NCT01511250|581353952|FG007|Overall Study|Withdrawal of Consent|1|||
160990733|NCT01511250|581353953|FG008|Overall Study|Withdrawal of Consent|1|||
160990734|NCT01511250|581353954|FG009|Overall Study|Withdrawal of Consent|0|||
160990735|NCT01511250|581353945|FG000|Overall Study|Sponsor/Investigator Decision|1|||
160990736|NCT01511250|581353946|FG001|Overall Study|Sponsor/Investigator Decision|0|||
160990737|NCT01511250|581353947|FG002|Overall Study|Sponsor/Investigator Decision|0|||
160990738|NCT01511250|581353948|FG003|Overall Study|Sponsor/Investigator Decision|0|||
160990739|NCT01511250|581353949|FG004|Overall Study|Sponsor/Investigator Decision|0|||
161245502|NCT02998541|582278705|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161245503|NCT02998541|582278706|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161245504|NCT02998541|582278707|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
161245505|NCT03540160|582278711|FG000|Overall Study|Protocol Violation|1|||
161245506|NCT03540160|582278711|FG000|Overall Study|Physician Decision|8|||
161245507|NCT03540160|582278711|FG000|Overall Study|Lack of Efficacy|60|||
161245508|NCT03540160|582278711|FG000|Overall Study|Pregnancy|1|||
161245509|NCT03540160|582278711|FG000|Overall Study|Adverse Event|20|||
160990740|NCT01511250|581353950|FG005|Overall Study|Sponsor/Investigator Decision|0|||
160990741|NCT01511250|581353951|FG006|Overall Study|Sponsor/Investigator Decision|0|||
161245510|NCT03540160|582278711|FG000|Overall Study|Withdrawal by Subject|68|||
161245511|NCT03540160|582278711|FG000|Overall Study|COVID-19|2|||
161245512|NCT03540160|582278711|FG000|Overall Study|Study Closure|10|||
161245513|NCT03540160|582278711|FG000|Overall Study|Lost to Follow-up|18|||
161245514|NCT03540160|582278711|FG000|Overall Study|Sponsor decision|191|||
161245515|NCT01944722|582278712|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
161245516|NCT01944722|582278712|FG000|Overall Study|Specimen Shipping Issues|34|||
161245517|NCT01944722|582278712|FG000|Overall Study|Improper Storage/Transport|5|||
161245518|NCT01944722|582278712|FG000|Overall Study|Insufficient Volume for Test|1|||
161245519|NCT01944722|582278712|FG000|Overall Study|Missing Specimens|3|||
161245520|NCT01944722|582278712|FG000|Overall Study|Specimens Mislabeled|2|||
161245521|NCT01944722|582278712|FG000|Overall Study|Withdrawal by Subject|8|||
161245522|NCT01944722|582278712|FG000|Overall Study|NILM Subjects <30 years old|8106|||
161245523|NCT01944722|582278712|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
161245524|NCT01944722|582278712|FG000|Overall Study|>ASCUS Cytology|1122|||
161245525|NCT02906917|582278715|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
161245526|NCT02906917|582278716|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
161245527|NCT02906917|582278715|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
161245528|NCT02906917|582278716|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
161245529|NCT02906917|582278715|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
161245530|NCT02906917|582278716|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
160828679|NCT02463032|580759857|FG000|Overall Study|Death|8|||
160828680|NCT02463032|580759858|FG001|Overall Study|Death|8|||
160828681|NCT02463032|580759857|FG000|Overall Study|Adverse Event|2|||
160828682|NCT02463032|580759858|FG001|Overall Study|Adverse Event|6|||
160828683|NCT00612508|580759859|FG000|Overall Study|Withdrawal by Subject|3|||
160828684|NCT00612508|580759860|FG001|Overall Study|Withdrawal by Subject|4|||
160828685|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
160828686|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
160828687|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
160828688|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
161245531|NCT02906917|582278715|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
161245532|NCT02906917|582278716|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
161245533|NCT02906917|582278715|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
161245534|NCT02906917|582278716|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
161245535|NCT02906917|582278715|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
161245536|NCT02906917|582278716|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
161245537|NCT02906917|582278715|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
161245538|NCT02906917|582278716|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
161245539|NCT02906917|582278715|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
161245540|NCT02906917|582278716|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
161245541|NCT00687739|582278717|FG000|Overall Study|Lost to Follow-up|2|||
161245542|NCT00687739|582278718|FG001|Overall Study|Lost to Follow-up|2|||
161245543|NCT00687739|582278719|FG002|Overall Study|Lost to Follow-up|1|||
161245544|NCT00687739|582278720|FG003|Overall Study|Lost to Follow-up|2|||
161245545|NCT00687739|582278717|FG000|Overall Study|Adverse Event|0|||
161245546|NCT00687739|582278718|FG001|Overall Study|Adverse Event|1|||
161245547|NCT00687739|582278719|FG002|Overall Study|Adverse Event|1|||
161245548|NCT00687739|582278720|FG003|Overall Study|Adverse Event|0|||
161245549|NCT02554877|582278721|FG000|Overall Study|Adverse Event|2|||
161245550|NCT02554877|582278722|FG001|Overall Study|Adverse Event|0|||
161245551|NCT02554877|582278723|FG002|Overall Study|Adverse Event|0|||
161245552|NCT02554877|582278724|FG003|Overall Study|Adverse Event|1|||
161245553|NCT02554877|582278721|FG000|Overall Study|Lost to Follow-up|1|||
161245554|NCT02554877|582278722|FG001|Overall Study|Lost to Follow-up|1|||
161245555|NCT02554877|582278723|FG002|Overall Study|Lost to Follow-up|1|||
161245556|NCT02554877|582278724|FG003|Overall Study|Lost to Follow-up|2|||
161245557|NCT02554877|582278721|FG000|Overall Study|Did not meet entrance criteria|0|||
161245558|NCT02554877|582278722|FG001|Overall Study|Did not meet entrance criteria|0|||
161245559|NCT02554877|582278723|FG002|Overall Study|Did not meet entrance criteria|1|||
161245560|NCT02554877|582278724|FG003|Overall Study|Did not meet entrance criteria|0|||
161245561|NCT02554877|582278721|FG000|Overall Study|No longer met eligibility criteria|1|||
161245562|NCT02554877|582278722|FG001|Overall Study|No longer met eligibility criteria|0|||
161245563|NCT02554877|582278723|FG002|Overall Study|No longer met eligibility criteria|1|||
161245564|NCT02554877|582278724|FG003|Overall Study|No longer met eligibility criteria|1|||
161245565|NCT02554877|582278721|FG000|Overall Study|Protocol Violation|3|||
161245566|NCT02554877|582278722|FG001|Overall Study|Protocol Violation|1|||
161245567|NCT02554877|582278723|FG002|Overall Study|Protocol Violation|1|||
161245568|NCT02554877|582278724|FG003|Overall Study|Protocol Violation|0|||
161245569|NCT02554877|582278721|FG000|Overall Study|Other|1|||
161245570|NCT02554877|582278722|FG001|Overall Study|Other|3|||
161245571|NCT02554877|582278723|FG002|Overall Study|Other|0|||
161245572|NCT02554877|582278724|FG003|Overall Study|Other|3|||
161245573|NCT02554877|582278721|FG000|Overall Study|Insufficient clinical response|4|||
161245574|NCT02554877|582278722|FG001|Overall Study|Insufficient clinical response|0|||
161245575|NCT02554877|582278723|FG002|Overall Study|Insufficient clinical response|0|||
161245576|NCT02554877|582278724|FG003|Overall Study|Insufficient clinical response|0|||
161245577|NCT02554877|582278721|FG000|Overall Study|No longer willing to participate|0|||
161245578|NCT02554877|582278722|FG001|Overall Study|No longer willing to participate|2|||
161245579|NCT02554877|582278723|FG002|Overall Study|No longer willing to participate|2|||
161245580|NCT02554877|582278724|FG003|Overall Study|No longer willing to participate|0|||
161245581|NCT01537887|582278725|FG000|Period 1|Physician Decision|0|||
161245582|NCT01537887|582278726|FG001|Period 1|Physician Decision|0|||
161245583|NCT01537887|582278727|FG002|Period 1|Physician Decision|0|||
161245584|NCT01537887|582278728|FG003|Period 1|Physician Decision|0|||
161245585|NCT01537887|582278729|FG004|Period 1|Physician Decision|1|||
161245586|NCT01537887|582278730|FG005|Period 1|Physician Decision|1|||
161245587|NCT01537887|582278725|FG000|Period 1|Did not receive treatment|0|||
161245588|NCT01537887|582278726|FG001|Period 1|Did not receive treatment|0|||
161245589|NCT01537887|582278727|FG002|Period 1|Did not receive treatment|1|||
161245590|NCT01537887|582278728|FG003|Period 1|Did not receive treatment|0|||
161245591|NCT01537887|582278729|FG004|Period 1|Did not receive treatment|0|||
161245592|NCT01537887|582278730|FG005|Period 1|Did not receive treatment|0|||
161245593|NCT01537887|582278725|FG000|Period 2|Withdrawal by Subject|0|||
161245594|NCT01537887|582278726|FG001|Period 2|Withdrawal by Subject|1|||
161245595|NCT01537887|582278727|FG002|Period 2|Withdrawal by Subject|0|||
161245596|NCT01537887|582278728|FG003|Period 2|Withdrawal by Subject|0|||
161245597|NCT01537887|582278729|FG004|Period 2|Withdrawal by Subject|0|||
161245598|NCT01537887|582278730|FG005|Period 2|Withdrawal by Subject|0|||
161245599|NCT01537887|582278725|FG000|Period 3|Adverse Event|0|||
161245600|NCT01537887|582278726|FG001|Period 3|Adverse Event|0|||
161245601|NCT01537887|582278727|FG002|Period 3|Adverse Event|1|||
161245602|NCT01537887|582278728|FG003|Period 3|Adverse Event|0|||
161245603|NCT01537887|582278729|FG004|Period 3|Adverse Event|0|||
161245604|NCT01537887|582278730|FG005|Period 3|Adverse Event|0|||
161245605|NCT01537887|582278725|FG000|Period 3|Withdrawal by Subject|0|||
161245606|NCT01537887|582278726|FG001|Period 3|Withdrawal by Subject|1|||
161245607|NCT01537887|582278727|FG002|Period 3|Withdrawal by Subject|0|||
160902971|NCT01609231|581037893|FG000|Overall Study|Physician Decision|1|||
160902972|NCT01609231|581037894|FG001|Overall Study|Physician Decision|0|||
160902973|NCT01609231|581037893|FG000|Overall Study|Withdrawal by Subject|1|||
160902974|NCT01609231|581037894|FG001|Overall Study|Withdrawal by Subject|0|||
160902975|NCT00973674|581037895|FG000|Overall Study|Protocol Violation|2|||
160902976|NCT00973674|581037896|FG001|Overall Study|Protocol Violation|0|||
160902977|NCT02846324|581037899|FG000|Overall Study|Other|1|||
160902978|NCT02846324|581037900|FG001|Overall Study|Other|0|||
160902979|NCT02846324|581037901|FG002|Overall Study|Other|0|||
160902980|NCT02846324|581037902|FG003|Overall Study|Other|0|||
160902981|NCT02846324|581037899|FG000|Overall Study|Withdrawal by Subject|1|||
160902982|NCT02846324|581037900|FG001|Overall Study|Withdrawal by Subject|0|||
160902983|NCT02846324|581037901|FG002|Overall Study|Withdrawal by Subject|4|||
160902984|NCT02846324|581037902|FG003|Overall Study|Withdrawal by Subject|0|||
160902985|NCT00516074|581037909|FG000|Overall Study|Adverse Event|0|||
160902986|NCT00516074|581037910|FG001|Overall Study|Adverse Event|1|||
160902987|NCT00516074|581037909|FG000|Overall Study|Subject Decision|4|||
160902988|NCT00516074|581037910|FG001|Overall Study|Subject Decision|2|||
160902989|NCT00516074|581037909|FG000|Overall Study|Loss of Glucose Control|2|||
160902990|NCT00516074|581037910|FG001|Overall Study|Loss of Glucose Control|0|||
160902991|NCT00369824|581037911|FG000|Overall Study|Adverse Event|0|||
160902992|NCT00369824|581037912|FG001|Overall Study|Adverse Event|2|||
160902993|NCT00369824|581037913|FG002|Overall Study|Adverse Event|0|||
160902994|NCT00369824|581037914|FG003|Overall Study|Adverse Event|0|||
160902995|NCT00369824|581037915|FG004|Overall Study|Adverse Event|1|||
160902996|NCT00369824|581037916|FG005|Overall Study|Adverse Event|0|||
160902997|NCT00369824|581037911|FG000|Overall Study|Protocol Violation|0|||
160902998|NCT00369824|581037912|FG001|Overall Study|Protocol Violation|1|||
160902999|NCT00369824|581037913|FG002|Overall Study|Protocol Violation|0|||
160903000|NCT00369824|581037914|FG003|Overall Study|Protocol Violation|1|||
160903001|NCT00369824|581037915|FG004|Overall Study|Protocol Violation|1|||
160903002|NCT00369824|581037916|FG005|Overall Study|Protocol Violation|0|||
160903003|NCT00369824|581037911|FG000|Overall Study|Withdrawal by Subject|9|||
160903004|NCT00369824|581037912|FG001|Overall Study|Withdrawal by Subject|5|||
160903005|NCT00369824|581037913|FG002|Overall Study|Withdrawal by Subject|5|||
160903006|NCT00369824|581037914|FG003|Overall Study|Withdrawal by Subject|4|||
160903007|NCT00369824|581037915|FG004|Overall Study|Withdrawal by Subject|6|||
160903008|NCT00369824|581037916|FG005|Overall Study|Withdrawal by Subject|2|||
160903009|NCT00369824|581037911|FG000|Overall Study|Lost to Follow-up|6|||
160903010|NCT00369824|581037912|FG001|Overall Study|Lost to Follow-up|11|||
160903011|NCT00369824|581037913|FG002|Overall Study|Lost to Follow-up|7|||
160903012|NCT00369824|581037914|FG003|Overall Study|Lost to Follow-up|8|||
160903013|NCT00369824|581037915|FG004|Overall Study|Lost to Follow-up|9|||
160903014|NCT00369824|581037916|FG005|Overall Study|Lost to Follow-up|6|||
160903015|NCT00369824|581037911|FG000|Overall Study|Other|0|||
160903016|NCT00369824|581037912|FG001|Overall Study|Other|0|||
160903017|NCT00369824|581037913|FG002|Overall Study|Other|0|||
160903018|NCT00369824|581037914|FG003|Overall Study|Other|2|||
160903019|NCT00369824|581037915|FG004|Overall Study|Other|1|||
160903020|NCT00369824|581037916|FG005|Overall Study|Other|3|||
160903021|NCT03822182|581037919|FG000|Overall Study|Protocol Violation|0|||
160903022|NCT03822182|581037920|FG001|Overall Study|Protocol Violation|1|||
160903023|NCT03822182|581037921|FG002|Overall Study|Protocol Violation|1|||
160903024|NCT01611155|581037924|FG000|Overall Study|Adverse Event|1|||
160903025|NCT01611155|581037925|FG001|Overall Study|Adverse Event|1|||
160903026|NCT01611155|581037924|FG000|Overall Study|Refused further treatment|6|||
160903027|NCT01611155|581037925|FG001|Overall Study|Refused further treatment|4|||
160903028|NCT01611155|581037924|FG000|Overall Study|Disease progression|1|||
161135722|NCT00408005|581879353|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
160903029|NCT01611155|581037925|FG001|Overall Study|Disease progression|0|||
160903030|NCT01611155|581037924|FG000|Overall Study|Withdrawal by Subject|1|||
160903031|NCT01611155|581037925|FG001|Overall Study|Withdrawal by Subject|0|||
160903032|NCT01611155|581037924|FG000|Overall Study|Alternative treatment|0|||
160903033|NCT01611155|581037925|FG001|Overall Study|Alternative treatment|1|||
160903034|NCT01611155|581037924|FG000|Overall Study|Ineligible patient|0|||
161135723|NCT00408005|581879346|FG000|Induction|Recurrent leukemia|1|||
161135724|NCT00408005|581879347|FG001|Induction|Recurrent leukemia|0|||
161135725|NCT00408005|581879348|FG002|Induction|Recurrent leukemia|0|||
161135726|NCT00408005|581879349|FG003|Induction|Recurrent leukemia|0|||
161135727|NCT00408005|581879350|FG004|Induction|Recurrent leukemia|0|||
161135728|NCT00408005|581879351|FG005|Induction|Recurrent leukemia|0|||
161135729|NCT00408005|581879352|FG006|Induction|Recurrent leukemia|0|||
161135730|NCT00408005|581879353|FG007|Induction|Recurrent leukemia|0|||
161135731|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161135732|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161135733|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
161135734|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
161135735|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
161135736|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
161135737|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
161135738|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
161135739|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
161135740|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
161135741|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
161135742|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
161135743|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
161135744|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
161135745|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
161135746|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
161135747|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161135748|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161135749|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
161135750|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161135751|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
161135752|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161135753|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161135754|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
161135755|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161135756|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
161135757|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
161135758|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
161135759|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
161135760|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
161135761|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
161135762|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
161135763|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161135764|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161135765|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
161135766|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
161135767|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161135768|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
161135769|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161135770|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
161135771|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
161135772|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
161135773|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
161135774|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
161135775|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
161135776|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
161135777|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
161135778|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
161135779|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135780|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135781|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135782|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135783|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
161135784|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135785|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135786|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
161135787|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161135788|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161135789|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
161135790|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161135791|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161135792|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161135793|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
161135794|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
161135795|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161245608|NCT01537887|582278728|FG003|Period 3|Withdrawal by Subject|0|||
161245609|NCT01537887|582278729|FG004|Period 3|Withdrawal by Subject|0|||
161245610|NCT01537887|582278730|FG005|Period 3|Withdrawal by Subject|0|||
161245611|NCT02072096|582278733|FG000|Overall Study|Lack of Efficacy|18|||
161245612|NCT02072096|582278734|FG001|Overall Study|Lack of Efficacy|29|||
161245613|NCT02072096|582278733|FG000|Overall Study|Protocol Violation|7|||
161135796|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161135797|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161135798|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161135799|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
161135800|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
161135801|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
161135802|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
161135803|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135804|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135805|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135806|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135807|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135808|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
161135809|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135810|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
161135811|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161135812|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161135813|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
161135814|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
161135815|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
161135816|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
161135817|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161135818|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
161135819|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161135820|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161135821|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161135822|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161245614|NCT02072096|582278734|FG001|Overall Study|Protocol Violation|7|||
161245615|NCT02072096|582278733|FG000|Overall Study|Withdrawal by Subject|5|||
161245616|NCT02072096|582278734|FG001|Overall Study|Withdrawal by Subject|7|||
161245617|NCT02072096|582278733|FG000|Overall Study|Adverse Event|5|||
161135823|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
161135824|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
161135825|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161135826|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
161135827|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161135828|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161135829|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
161135830|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
161135831|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
161135832|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
161135833|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
161245618|NCT02072096|582278734|FG001|Overall Study|Adverse Event|2|||
161135834|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
161135835|NCT00408005|581879346|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161135836|NCT00408005|581879347|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161135837|NCT00408005|581879348|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
161135838|NCT00408005|581879349|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161135839|NCT00408005|581879350|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161135840|NCT00408005|581879351|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
161245619|NCT02072096|582278733|FG000|Overall Study|No Reason Provided|4|||
161245620|NCT02072096|582278734|FG001|Overall Study|No Reason Provided|2|||
161245621|NCT02072096|582278733|FG000|Overall Study|Death|2|||
161245622|NCT02072096|582278734|FG001|Overall Study|Death|0|||
161245623|NCT02072096|582278733|FG000|Overall Study|Physician Decision|0|||
161245624|NCT02072096|582278734|FG001|Overall Study|Physician Decision|1|||
161245625|NCT02072096|582278733|FG000|Overall Study|Study Terminated by Sponsor|43|||
161245626|NCT02072096|582278734|FG001|Overall Study|Study Terminated by Sponsor|30|||
161245627|NCT02072096|582278733|FG000|Overall Study|Lost to Follow-up|1|||
161245628|NCT02072096|582278734|FG001|Overall Study|Lost to Follow-up|0|||
161245629|NCT02336074|582278741|FG000|Overall Study|Adverse Event|0|||
161245630|NCT02336074|582278742|FG001|Overall Study|Adverse Event|2|||
161245631|NCT00958724|582278745|FG000|Overall Study|Disease Progression|6|||
161245632|NCT05604014|582278746|FG000|Overall Study|Lost to Follow-up|13|||
161245633|NCT01266902|582278765|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
161245634|NCT01266902|582278766|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
161245635|NCT01266902|582278767|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
161245636|NCT01266902|582278765|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
161245637|NCT01266902|582278766|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
161245638|NCT01266902|582278767|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
161245639|NCT01266902|582278765|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
161245640|NCT01266902|582278766|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
161245641|NCT01266902|582278767|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
161245642|NCT01266902|582278765|FG000|Period 1 (Main Study)|Adverse Event|3|||
161245643|NCT01266902|582278766|FG001|Period 1 (Main Study)|Adverse Event|11|||
161245644|NCT01266902|582278767|FG002|Period 1 (Main Study)|Adverse Event|0|||
161245645|NCT01266902|582278765|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
161245646|NCT01266902|582278766|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
161245647|NCT01266902|582278767|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
161245648|NCT01266902|582278765|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
161245649|NCT01266902|582278766|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
161245650|NCT01266902|582278767|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
161245651|NCT01266902|582278765|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
161245652|NCT01266902|582278766|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
161245653|NCT01266902|582278767|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
161245654|NCT01266902|582278765|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
161245655|NCT01266902|582278766|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
161245656|NCT01266902|582278767|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
161245657|NCT01266902|582278765|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
161245658|NCT01266902|582278766|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
161245659|NCT01266902|582278767|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
161245660|NCT01266902|582278765|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
161245661|NCT01266902|582278766|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
161245662|NCT01266902|582278767|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
161245663|NCT02121184|582278768|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
161245664|NCT02121184|582278769|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
161245665|NCT02121184|582278768|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
161245666|NCT02121184|582278769|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
161245667|NCT02121184|582278768|FG000|Overall Study|Emergency cesarean section required|0|||
161245668|NCT02121184|582278769|FG001|Overall Study|Emergency cesarean section required|2|||
161245669|NCT02121184|582278768|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
161245670|NCT02121184|582278769|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
161245671|NCT04567329|582278772|FG000|Overall Study|Withdrawal by Subject|5|||
161245672|NCT04567329|582278773|FG001|Overall Study|Withdrawal by Subject|6|||
161245673|NCT04567329|582278772|FG000|Overall Study|Protocol Violation|2|||
161245674|NCT04567329|582278773|FG001|Overall Study|Protocol Violation|3|||
161245675|NCT04567329|582278772|FG000|Overall Study|Discontinued|2|||
161245676|NCT04567329|582278773|FG001|Overall Study|Discontinued|2|||
161245677|NCT04567329|582278772|FG000|Overall Study|Lost to Follow-up|0|||
161245678|NCT04567329|582278773|FG001|Overall Study|Lost to Follow-up|1|||
161245679|NCT04567329|582278772|FG000|Overall Study|Lack of Efficacy|0|||
161245680|NCT04567329|582278773|FG001|Overall Study|Lack of Efficacy|1|||
161245681|NCT02933060|582278774|FG000|Overall Study|Withdrawal by Subject|0|||
161245682|NCT02933060|582278775|FG001|Overall Study|Withdrawal by Subject|1|||
161245683|NCT01945580|582278776|FG000|Overall Study|Withdrawal by Subject|13|||
161245684|NCT01945580|582278777|FG001|Overall Study|Withdrawal by Subject|35|||
161245685|NCT01945580|582278776|FG000|Overall Study|Physician Decision|3|||
161245686|NCT01945580|582278777|FG001|Overall Study|Physician Decision|2|||
161245687|NCT01945580|582278776|FG000|Overall Study|Lost to Follow-up|26|||
160828689|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
160828690|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
160828691|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
160828692|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
161245688|NCT01945580|582278777|FG001|Overall Study|Lost to Follow-up|39|||
161245689|NCT01945580|582278776|FG000|Overall Study|Death|7|||
161245690|NCT01945580|582278777|FG001|Overall Study|Death|2|||
161245691|NCT01945580|582278776|FG000|Overall Study|Patient moved out of state|0|||
161245692|NCT01945580|582278777|FG001|Overall Study|Patient moved out of state|1|||
161245693|NCT01945580|582278776|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
161245694|NCT01945580|582278777|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
161245695|NCT01945580|582278776|FG000|Overall Study|Family illness - unable to return|0|||
161245696|NCT01945580|582278777|FG001|Overall Study|Family illness - unable to return|1|||
161245697|NCT01945580|582278776|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
161245698|NCT01945580|582278777|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
161245699|NCT01945580|582278776|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
161245700|NCT01945580|582278777|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
161245701|NCT01945580|582278776|FG000|Overall Study|Noncompliance with 36 month visit|1|||
161245702|NCT01945580|582278777|FG001|Overall Study|Noncompliance with 36 month visit|0|||
161245703|NCT01945580|582278776|FG000|Overall Study|The patient moved.|1|||
161245704|NCT01945580|582278777|FG001|Overall Study|The patient moved.|0|||
161245705|NCT01945580|582278776|FG000|Overall Study|No data available|0|||
161245706|NCT01945580|582278777|FG001|Overall Study|No data available|2|||
161245707|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
161245708|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
161245709|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
161245710|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
161245711|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
161245712|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
161245713|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
161245714|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
161245715|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
161245716|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
161245717|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
161245718|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
161245719|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
161245720|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
161245721|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
161245722|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
161245723|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
161245724|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
161245725|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
161245726|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
161245727|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
161245728|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
161245729|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
161245730|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
161245731|NCT00073307|582278785|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
161245732|NCT00073307|582278786|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
161245733|NCT00073307|582278787|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
161245734|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
161245735|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
161245736|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
161245737|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
161245738|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
161245739|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
161245740|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
161245741|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
161245742|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
161245743|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
160990742|NCT01511250|581353952|FG007|Overall Study|Sponsor/Investigator Decision|0|||
160990743|NCT01511250|581353953|FG008|Overall Study|Sponsor/Investigator Decision|0|||
160990744|NCT01511250|581353954|FG009|Overall Study|Sponsor/Investigator Decision|0|||
160990745|NCT01511250|581353945|FG000|Overall Study|Lost to Follow-up|7|||
161135841|NCT00408005|581879352|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161135842|NCT00408005|581879353|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
161135843|NCT05817045|581879354|FG000|Overall Study|Protocol Violation|0|||
161135844|NCT05817045|581879355|FG001|Overall Study|Protocol Violation|3|||
161135845|NCT05817045|581879354|FG000|Overall Study|Withdrawal by Subject|10|||
161135846|NCT05817045|581879355|FG001|Overall Study|Withdrawal by Subject|7|||
161135847|NCT05817045|581879354|FG000|Overall Study|Physician Decision|3|||
160990746|NCT01511250|581353946|FG001|Overall Study|Lost to Follow-up|3|||
161135848|NCT05817045|581879355|FG001|Overall Study|Physician Decision|0|||
161135849|NCT05817045|581879354|FG000|Overall Study|Lost to Follow-up|0|||
161135850|NCT05817045|581879355|FG001|Overall Study|Lost to Follow-up|1|||
161135851|NCT05817045|581879354|FG000|Overall Study|Device Deficiency|1|||
161135852|NCT05817045|581879355|FG001|Overall Study|Device Deficiency|0|||
161135853|NCT05817045|581879354|FG000|Overall Study|System Error|1|||
161135854|NCT05817045|581879355|FG001|Overall Study|System Error|0|||
161135855|NCT01506141|581879356|FG000|Overall Study|Adverse Event|0|||
161135856|NCT01506141|581879357|FG001|Overall Study|Adverse Event|2|||
161135857|NCT01506141|581879356|FG000|Overall Study|Participation Terminated by Investigator|1|||
161135858|NCT01506141|581879357|FG001|Overall Study|Participation Terminated by Investigator|1|||
161135859|NCT01506141|581879356|FG000|Overall Study|Site Terminated by Sponsor|2|||
161135860|NCT01506141|581879357|FG001|Overall Study|Site Terminated by Sponsor|0|||
161135861|NCT01506141|581879356|FG000|Overall Study|Reason Not Specified|4|||
161135862|NCT01506141|581879357|FG001|Overall Study|Reason Not Specified|2|||
161135863|NCT04889209|581879358|FG000|All Cohorts Except 15E|Adverse Event|0|||
161135864|NCT04889209|581879359|FG001|All Cohorts Except 15E|Adverse Event|0|||
161135865|NCT04889209|581879360|FG002|All Cohorts Except 15E|Adverse Event|0|||
161135866|NCT04889209|581879361|FG003|All Cohorts Except 15E|Adverse Event|0|||
161135867|NCT04889209|581879362|FG004|All Cohorts Except 15E|Adverse Event|0|||
161135868|NCT04889209|581879363|FG005|All Cohorts Except 15E|Adverse Event|0|||
161135869|NCT04889209|581879364|FG006|All Cohorts Except 15E|Adverse Event|1|||
161135870|NCT04889209|581879365|FG007|All Cohorts Except 15E|Adverse Event|0|||
161135871|NCT04889209|581879366|FG008|All Cohorts Except 15E|Adverse Event|0|||
161135872|NCT04889209|581879367|FG009|All Cohorts Except 15E|Adverse Event|0|||
161135873|NCT04889209|581879368|FG010|All Cohorts Except 15E|Adverse Event|0|||
161135874|NCT04889209|581879369|FG011|All Cohorts Except 15E|Adverse Event|0|||
161135875|NCT04889209|581879370|FG012|All Cohorts Except 15E|Adverse Event|0|||
161135876|NCT04889209|581879371|FG013|All Cohorts Except 15E|Adverse Event|0|||
161135877|NCT04889209|581879372|FG014|All Cohorts Except 15E|Adverse Event|0|||
161135878|NCT04889209|581879373|FG015|All Cohorts Except 15E|Adverse Event|0|||
161135879|NCT04889209|581879374|FG016|All Cohorts Except 15E|Adverse Event|0|||
161135880|NCT04889209|581879375|FG017|All Cohorts Except 15E|Adverse Event|0|||
161135881|NCT04889209|581879358|FG000|All Cohorts Except 15E|Death|0|||
161135882|NCT04889209|581879359|FG001|All Cohorts Except 15E|Death|1|||
161135883|NCT04889209|581879360|FG002|All Cohorts Except 15E|Death|0|||
161135884|NCT04889209|581879361|FG003|All Cohorts Except 15E|Death|0|||
161135885|NCT04889209|581879362|FG004|All Cohorts Except 15E|Death|0|||
161135886|NCT04889209|581879363|FG005|All Cohorts Except 15E|Death|0|||
161135887|NCT04889209|581879364|FG006|All Cohorts Except 15E|Death|0|||
161135888|NCT04889209|581879365|FG007|All Cohorts Except 15E|Death|0|||
161135889|NCT04889209|581879366|FG008|All Cohorts Except 15E|Death|0|||
161135890|NCT04889209|581879367|FG009|All Cohorts Except 15E|Death|0|||
161135891|NCT04889209|581879368|FG010|All Cohorts Except 15E|Death|0|||
161135892|NCT04889209|581879369|FG011|All Cohorts Except 15E|Death|0|||
161135893|NCT04889209|581879370|FG012|All Cohorts Except 15E|Death|0|||
161135894|NCT04889209|581879371|FG013|All Cohorts Except 15E|Death|0|||
161135895|NCT04889209|581879372|FG014|All Cohorts Except 15E|Death|0|||
161135896|NCT04889209|581879373|FG015|All Cohorts Except 15E|Death|0|||
161135897|NCT04889209|581879374|FG016|All Cohorts Except 15E|Death|0|||
161135898|NCT04889209|581879375|FG017|All Cohorts Except 15E|Death|0|||
161135899|NCT04889209|581879358|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
161135900|NCT04889209|581879359|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
161135901|NCT04889209|581879360|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
161135902|NCT04889209|581879361|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
161135903|NCT04889209|581879362|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
161135904|NCT04889209|581879363|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
161135905|NCT04889209|581879364|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
161135906|NCT04889209|581879365|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
161135907|NCT04889209|581879366|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
161135908|NCT04889209|581879367|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
161135909|NCT04889209|581879368|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
161135910|NCT04889209|581879369|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
161135911|NCT04889209|581879370|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
161135912|NCT04889209|581879371|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
161135913|NCT04889209|581879372|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
161135914|NCT04889209|581879373|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
161135915|NCT04889209|581879374|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
161135916|NCT04889209|581879375|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
161135917|NCT04889209|581879358|FG000|All Cohorts Except 15E|Physician Decision|0|||
161135918|NCT04889209|581879359|FG001|All Cohorts Except 15E|Physician Decision|0|||
161135919|NCT04889209|581879360|FG002|All Cohorts Except 15E|Physician Decision|0|||
161135920|NCT04889209|581879361|FG003|All Cohorts Except 15E|Physician Decision|0|||
161135921|NCT04889209|581879362|FG004|All Cohorts Except 15E|Physician Decision|1|||
161135922|NCT04889209|581879363|FG005|All Cohorts Except 15E|Physician Decision|0|||
161135923|NCT04889209|581879364|FG006|All Cohorts Except 15E|Physician Decision|0|||
161135924|NCT04889209|581879365|FG007|All Cohorts Except 15E|Physician Decision|1|||
161135925|NCT04889209|581879366|FG008|All Cohorts Except 15E|Physician Decision|0|||
161245744|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
161245745|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
161245746|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
161245747|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
161245748|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
161245749|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
161245750|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
161245751|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
161245752|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
161245753|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
161245754|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
161245755|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
161245756|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
161245757|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
161245758|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
161245759|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
161245760|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
161245761|NCT00073307|582278785|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
161245762|NCT00073307|582278786|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
161245763|NCT00073307|582278787|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
161245764|NCT00858780|582278788|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
161245765|NCT00858780|582278789|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161245766|NCT00858780|582278790|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161245767|NCT00858780|582278791|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161245768|NCT00858780|582278792|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
161245769|NCT00858780|582278788|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161245770|NCT00858780|582278789|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161245771|NCT00858780|582278790|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
161245772|NCT00858780|582278791|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161245773|NCT00858780|582278792|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
161245774|NCT00858780|582278788|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
161245775|NCT00858780|582278789|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161245776|NCT00858780|582278790|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161245777|NCT00858780|582278791|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
161245778|NCT00858780|582278792|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
161245779|NCT00858780|582278788|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161245780|NCT00858780|582278789|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
161245781|NCT00858780|582278790|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161245782|NCT00858780|582278791|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161245783|NCT00858780|582278792|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
161245784|NCT00858780|582278788|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161245785|NCT00858780|582278789|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161245786|NCT00858780|582278790|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161245787|NCT00858780|582278791|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
161245788|NCT00858780|582278792|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
161245789|NCT00858780|582278788|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
161245790|NCT00858780|582278789|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
161245791|NCT00858780|582278790|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
161245792|NCT00858780|582278791|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
161245793|NCT00858780|582278792|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
161245794|NCT01964950|582278793|FG000|Overall Study|Protocol Violation|25|||
161245795|NCT00819169|582278801|FG000|Overall Study|Withdrawal by Subject|2|||
161245796|NCT00819169|582278802|FG001|Overall Study|Withdrawal by Subject|0|||
161245797|NCT00819169|582278803|FG002|Overall Study|Withdrawal by Subject|0|||
161245798|NCT00819169|582278804|FG003|Overall Study|Withdrawal by Subject|1|||
161245799|NCT00819169|582278805|FG004|Overall Study|Withdrawal by Subject|1|||
161245800|NCT00819169|582278806|FG005|Overall Study|Withdrawal by Subject|1|||
161245801|NCT00819169|582278807|FG006|Overall Study|Withdrawal by Subject|5|||
161245802|NCT00819169|582278808|FG007|Overall Study|Withdrawal by Subject|1|||
161245803|NCT00819169|582278809|FG008|Overall Study|Withdrawal by Subject|4|||
161245804|NCT00819169|582278801|FG000|Overall Study|Lost to Follow-up|0|||
161245805|NCT00819169|582278802|FG001|Overall Study|Lost to Follow-up|2|||
161245806|NCT00819169|582278803|FG002|Overall Study|Lost to Follow-up|0|||
161245807|NCT00819169|582278804|FG003|Overall Study|Lost to Follow-up|1|||
161245808|NCT00819169|582278805|FG004|Overall Study|Lost to Follow-up|0|||
161245809|NCT00819169|582278806|FG005|Overall Study|Lost to Follow-up|6|||
161245810|NCT00819169|582278807|FG006|Overall Study|Lost to Follow-up|2|||
161245811|NCT00819169|582278808|FG007|Overall Study|Lost to Follow-up|2|||
161245812|NCT00819169|582278809|FG008|Overall Study|Lost to Follow-up|1|||
161245813|NCT00819169|582278801|FG000|Overall Study|Death|1|||
161245814|NCT00819169|582278802|FG001|Overall Study|Death|1|||
161135926|NCT04889209|581879367|FG009|All Cohorts Except 15E|Physician Decision|1|||
161135927|NCT04889209|581879368|FG010|All Cohorts Except 15E|Physician Decision|0|||
161135928|NCT04889209|581879369|FG011|All Cohorts Except 15E|Physician Decision|1|||
161245815|NCT00819169|582278803|FG002|Overall Study|Death|3|||
161245816|NCT00819169|582278804|FG003|Overall Study|Death|8|||
161245817|NCT00819169|582278805|FG004|Overall Study|Death|5|||
161245818|NCT00819169|582278806|FG005|Overall Study|Death|7|||
161245819|NCT00819169|582278807|FG006|Overall Study|Death|9|||
161245820|NCT00819169|582278808|FG007|Overall Study|Death|4|||
161245821|NCT00819169|582278809|FG008|Overall Study|Death|7|||
161245822|NCT00819169|582278801|FG000|Overall Study|Ineligibility determined|0|||
161245823|NCT00819169|582278802|FG001|Overall Study|Ineligibility determined|0|||
161245824|NCT00819169|582278803|FG002|Overall Study|Ineligibility determined|0|||
161245825|NCT00819169|582278804|FG003|Overall Study|Ineligibility determined|2|||
161245826|NCT00819169|582278805|FG004|Overall Study|Ineligibility determined|0|||
161245827|NCT00819169|582278806|FG005|Overall Study|Ineligibility determined|0|||
161245828|NCT00819169|582278807|FG006|Overall Study|Ineligibility determined|0|||
161245829|NCT00819169|582278808|FG007|Overall Study|Ineligibility determined|0|||
161245830|NCT00819169|582278809|FG008|Overall Study|Ineligibility determined|1|||
161245831|NCT00819169|582278801|FG000|Overall Study|Adverse Event|0|||
161245832|NCT00819169|582278802|FG001|Overall Study|Adverse Event|0|||
161245833|NCT00819169|582278803|FG002|Overall Study|Adverse Event|0|||
161245834|NCT00819169|582278804|FG003|Overall Study|Adverse Event|0|||
161245835|NCT00819169|582278805|FG004|Overall Study|Adverse Event|1|||
161245836|NCT00819169|582278806|FG005|Overall Study|Adverse Event|0|||
161245837|NCT00819169|582278807|FG006|Overall Study|Adverse Event|0|||
161245838|NCT00819169|582278808|FG007|Overall Study|Adverse Event|0|||
161245839|NCT00819169|582278809|FG008|Overall Study|Adverse Event|0|||
161245840|NCT00819169|582278801|FG000|Overall Study|Administrative Decision|0|||
161245841|NCT00819169|582278802|FG001|Overall Study|Administrative Decision|0|||
161245842|NCT00819169|582278803|FG002|Overall Study|Administrative Decision|0|||
161245843|NCT00819169|582278804|FG003|Overall Study|Administrative Decision|0|||
161245844|NCT00819169|582278805|FG004|Overall Study|Administrative Decision|1|||
161245845|NCT00819169|582278806|FG005|Overall Study|Administrative Decision|2|||
161245846|NCT00819169|582278807|FG006|Overall Study|Administrative Decision|0|||
161245847|NCT00819169|582278808|FG007|Overall Study|Administrative Decision|2|||
161245848|NCT00819169|582278809|FG008|Overall Study|Administrative Decision|0|||
161245849|NCT02637141|582278813|FG000|Overall Study|Adverse Event|1|||
160828693|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
160828694|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
160828695|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
160828696|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
160828697|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
160828698|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
160828699|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
160828700|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
160828701|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
160828702|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
160828703|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
160903035|NCT01611155|581037925|FG001|Overall Study|Ineligible patient|1|||
160903036|NCT01681472|581037926|FG000|Overall Study|Adverse Event|0|||
161135929|NCT04889209|581879370|FG012|All Cohorts Except 15E|Physician Decision|1|||
161135930|NCT04889209|581879371|FG013|All Cohorts Except 15E|Physician Decision|0|||
161135931|NCT04889209|581879372|FG014|All Cohorts Except 15E|Physician Decision|0|||
161135932|NCT04889209|581879373|FG015|All Cohorts Except 15E|Physician Decision|0|||
161135933|NCT04889209|581879374|FG016|All Cohorts Except 15E|Physician Decision|0|||
161135934|NCT04889209|581879375|FG017|All Cohorts Except 15E|Physician Decision|0|||
161135935|NCT04889209|581879358|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
161135936|NCT04889209|581879359|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
161135937|NCT04889209|581879360|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
161245850|NCT02637141|582278814|FG001|Overall Study|Adverse Event|1|||
161245851|NCT02637141|582278815|FG002|Overall Study|Adverse Event|0|||
161245852|NCT02637141|582278813|FG000|Overall Study|Withdrawal by Subject|1|||
161245853|NCT02637141|582278814|FG001|Overall Study|Withdrawal by Subject|1|||
161245854|NCT02637141|582278815|FG002|Overall Study|Withdrawal by Subject|1|||
161245855|NCT03885934|582278819|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161245856|NCT03885934|582278820|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
161245857|NCT03885934|582278821|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161135938|NCT04889209|581879361|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
161135939|NCT04889209|581879362|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
161135940|NCT04889209|581879363|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135941|NCT04889209|581879364|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135942|NCT04889209|581879365|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
161135943|NCT04889209|581879366|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135944|NCT04889209|581879367|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135945|NCT04889209|581879368|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135946|NCT04889209|581879369|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135947|NCT04889209|581879370|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135948|NCT04889209|581879371|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
161135949|NCT04889209|581879372|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
161135950|NCT04889209|581879373|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
161135951|NCT04889209|581879374|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
161135952|NCT04889209|581879375|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
161135953|NCT04889209|581879358|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
161135954|NCT04889209|581879359|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
161135955|NCT04889209|581879360|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135956|NCT04889209|581879361|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135957|NCT04889209|581879362|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135958|NCT04889209|581879363|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161135959|NCT04889209|581879364|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135960|NCT04889209|581879365|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161135961|NCT04889209|581879366|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135962|NCT04889209|581879367|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161135963|NCT04889209|581879368|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135964|NCT04889209|581879369|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135965|NCT04889209|581879370|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135966|NCT04889209|581879371|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135967|NCT04889209|581879372|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135968|NCT04889209|581879373|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135969|NCT04889209|581879374|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
161135970|NCT04889209|581879375|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
161135971|NCT04889209|581879358|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135972|NCT04889209|581879359|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135973|NCT04889209|581879360|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135974|NCT04889209|581879361|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
161135975|NCT04889209|581879362|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135976|NCT04889209|581879363|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135977|NCT04889209|581879364|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135978|NCT04889209|581879365|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135979|NCT04889209|581879366|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135980|NCT04889209|581879367|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135981|NCT04889209|581879368|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135982|NCT04889209|581879369|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135983|NCT04889209|581879370|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135984|NCT04889209|581879371|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135985|NCT04889209|581879372|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135986|NCT04889209|581879373|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135987|NCT04889209|581879374|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135988|NCT04889209|581879375|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
161135989|NCT04889209|581879358|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161135990|NCT04889209|581879359|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161135991|NCT04889209|581879360|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161135992|NCT04889209|581879361|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161135993|NCT04889209|581879362|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161135994|NCT04889209|581879363|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
160828704|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
161245858|NCT03885934|582278822|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
161245859|NCT03885934|582278823|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
161245860|NCT03885934|582278824|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
161245861|NCT00406393|582278825|FG000|Overall Study|Did not undergo transplantation|2|||
161245862|NCT00406393|582278826|FG001|Overall Study|Did not undergo transplantation|1|||
161245863|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
161245864|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
161245865|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
161245866|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
161245867|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
161245868|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
161245869|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
161245870|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
161245871|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
161245872|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
161245873|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
161245874|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
161135995|NCT04889209|581879364|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161135996|NCT04889209|581879365|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
160828705|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
160828706|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
160828707|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
160903037|NCT01681472|581037927|FG001|Overall Study|Adverse Event|1|||
160828708|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
160828709|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
160828710|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
160828711|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
160828712|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
160828713|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
160828714|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
161135997|NCT04889209|581879366|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161135998|NCT04889209|581879367|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161135999|NCT04889209|581879368|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161136000|NCT04889209|581879369|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161136001|NCT04889209|581879370|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161136002|NCT04889209|581879371|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161136003|NCT04889209|581879372|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161136004|NCT04889209|581879373|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161136005|NCT04889209|581879374|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
161136006|NCT04889209|581879375|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
161136007|NCT04889209|581879358|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136008|NCT04889209|581879359|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136009|NCT04889209|581879360|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136010|NCT04889209|581879361|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136011|NCT04889209|581879362|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136012|NCT04889209|581879363|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136013|NCT04889209|581879364|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136014|NCT04889209|581879365|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136015|NCT04889209|581879366|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136016|NCT04889209|581879367|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136017|NCT04889209|581879368|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136018|NCT04889209|581879369|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136019|NCT04889209|581879370|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136020|NCT04889209|581879371|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136021|NCT04889209|581879372|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136022|NCT04889209|581879373|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136023|NCT04889209|581879374|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
161136024|NCT04889209|581879375|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
161136025|NCT04889209|581879358|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136026|NCT04889209|581879359|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136027|NCT04889209|581879360|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136028|NCT04889209|581879361|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161245875|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
161245876|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
161245877|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
161245878|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161245879|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
161245880|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161245881|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
161245882|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
161245883|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
161245884|NCT02227238|582278827|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
161245885|NCT02227238|582278828|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
161245886|NCT02227238|582278829|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
161245887|NCT02227238|582278827|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
161245888|NCT02227238|582278828|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
161245889|NCT02227238|582278829|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
161245890|NCT02227238|582278827|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
161245891|NCT02227238|582278828|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
161245892|NCT02227238|582278829|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
161245893|NCT02227238|582278827|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
161245894|NCT02227238|582278828|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
161245895|NCT02227238|582278829|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
161245896|NCT02227238|582278827|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
161245897|NCT02227238|582278828|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
161245898|NCT02227238|582278829|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
161245899|NCT02227238|582278827|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
161245900|NCT02227238|582278828|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
161245901|NCT02227238|582278829|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
161245902|NCT02227238|582278827|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
161245903|NCT02227238|582278828|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
161245904|NCT02227238|582278829|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
161245905|NCT00380588|582278830|FG000|Overall Study|Unequivocal Disease Progression|25|||
161245906|NCT00380588|582278831|FG001|Overall Study|Unequivocal Disease Progression|34|||
161245907|NCT00380588|582278830|FG000|Overall Study|Next Cycle Not Started|4|||
161245908|NCT00380588|582278831|FG001|Overall Study|Next Cycle Not Started|0|||
161245909|NCT00380588|582278830|FG000|Overall Study|Adverse Event|7|||
161245910|NCT00380588|582278831|FG001|Overall Study|Adverse Event|3|||
161245911|NCT00380588|582278830|FG000|Overall Study|Withdrawal by Subject|1|||
161245912|NCT00380588|582278831|FG001|Overall Study|Withdrawal by Subject|3|||
161245913|NCT00380588|582278830|FG000|Overall Study|Physician Decision|2|||
161245914|NCT00380588|582278831|FG001|Overall Study|Physician Decision|0|||
161245915|NCT02096705|582278832|FG000|Treatment|Adverse Event|6|||
160828715|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
160828716|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
160828717|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
160828718|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
160828719|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
160828720|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
160828721|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
160990747|NCT01511250|581353947|FG002|Overall Study|Lost to Follow-up|3|||
160990748|NCT01511250|581353948|FG003|Overall Study|Lost to Follow-up|3|||
160990749|NCT01511250|581353949|FG004|Overall Study|Lost to Follow-up|0|||
161136029|NCT04889209|581879362|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136030|NCT04889209|581879363|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136031|NCT04889209|581879364|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136032|NCT04889209|581879365|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136033|NCT04889209|581879366|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136034|NCT04889209|581879367|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136035|NCT04889209|581879368|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136036|NCT04889209|581879369|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136037|NCT04889209|581879370|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136038|NCT04889209|581879371|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136039|NCT04889209|581879372|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136040|NCT04889209|581879373|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136041|NCT04889209|581879374|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
161136042|NCT04889209|581879375|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
161245916|NCT02096705|582278833|FG001|Treatment|Adverse Event|3|||
161245917|NCT02096705|582278832|FG000|Treatment|Subject request to discontinue treatment|1|||
161245918|NCT02096705|582278833|FG001|Treatment|Subject request to discontinue treatment|1|||
161245919|NCT02096705|582278832|FG000|Treatment|Withdrawal by Subject|1|||
161245920|NCT02096705|582278833|FG001|Treatment|Withdrawal by Subject|0|||
161245921|NCT02096705|582278832|FG000|Treatment|Other|1|||
161245922|NCT02096705|582278833|FG001|Treatment|Other|1|||
161245923|NCT02096705|582278832|FG000|Follow-up|Withdrawal by Subject|1|||
161245924|NCT02096705|582278833|FG001|Follow-up|Withdrawal by Subject|0|||
161245925|NCT02096705|582278832|FG000|Follow-up|Adverse Event|2|||
161245926|NCT02096705|582278833|FG001|Follow-up|Adverse Event|2|||
161245927|NCT02096705|582278832|FG000|Follow-up|Subjects not reporting status|1|||
161245928|NCT02096705|582278833|FG001|Follow-up|Subjects not reporting status|2|||
161245929|NCT02905435|582278834|FG000|Overall Study|Death|2|||
161245930|NCT02905435|582278834|FG000|Overall Study|Physician Decision|1|||
161245931|NCT02905435|582278834|FG000|Overall Study|Lost to Follow-up|4|||
161245932|NCT02377349|582278838|FG000|Overall Study|Serious Adverse Event|1|||
161245933|NCT02377349|582278839|FG001|Overall Study|Serious Adverse Event|0|||
161245934|NCT02377349|582278838|FG000|Overall Study|Protocol Violation|3|||
161245935|NCT02377349|582278839|FG001|Overall Study|Protocol Violation|2|||
161245936|NCT02377349|582278838|FG000|Overall Study|Withdrawal by Subject|5|||
161245937|NCT02377349|582278839|FG001|Overall Study|Withdrawal by Subject|3|||
161245938|NCT02377349|582278838|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
161245939|NCT02377349|582278839|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
161245940|NCT02377349|582278838|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
161245941|NCT02377349|582278839|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
161245942|NCT02377349|582278838|FG000|Overall Study|Other|0|||
161245943|NCT02377349|582278839|FG001|Overall Study|Other|1|||
161245944|NCT00999687|582278852|FG000|First Intervention|Withdrawal by Subject|1|||
161245945|NCT00999687|582278852|FG000|Second Intervention|Withdrawal by Subject|2|||
161245946|NCT00999687|582278852|FG000|Second Intervention|Lack of Efficacy|1|||
161245947|NCT03614728|582278855|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
161245948|NCT03614728|582278856|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161245949|NCT03614728|582278857|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161245950|NCT03614728|582278858|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
161245951|NCT03614728|582278855|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161245952|NCT03614728|582278856|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
161245953|NCT03614728|582278857|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
160828722|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
160828723|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
160828724|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
160828725|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
160828726|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
160828727|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
160828728|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
160828729|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
160828730|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
160828731|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
160828732|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
160828733|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
160862006|NCT03694353|580887918|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
161245954|NCT03614728|582278858|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
161245955|NCT01401062|582278861|FG000|Overall Study|Death|9|||
161245956|NCT01401062|582278862|FG001|Overall Study|Death|7|||
161245957|NCT01401062|582278861|FG000|Overall Study|Physician Decision|1|||
161245958|NCT01401062|582278862|FG001|Overall Study|Physician Decision|0|||
161245959|NCT01401062|582278861|FG000|Overall Study|Withdrawal by Subject|1|||
161245960|NCT01401062|582278862|FG001|Overall Study|Withdrawal by Subject|1|||
161245961|NCT03684928|582278865|FG000|First Intervention|Lost to Follow-up|0|||
161245962|NCT03684928|582278866|FG001|First Intervention|Lost to Follow-up|1|||
161245963|NCT03684928|582278865|FG000|First Intervention|Withdrawal by Subject|0|||
161245964|NCT03684928|582278866|FG001|First Intervention|Withdrawal by Subject|2|||
161245965|NCT03684928|582278865|FG000|Second Intervention|Soft Tissue Injury|1|||
161245966|NCT03684928|582278866|FG001|Second Intervention|Soft Tissue Injury|0|||
161245967|NCT03193021|582278867|FG000|Overall Study|Lost to Follow-up|1|||
161245968|NCT03193021|582278868|FG001|Overall Study|Lost to Follow-up|1|||
161245969|NCT02286466|582278869|FG000|Overall Study|Death|1|||
161245970|NCT02286466|582278870|FG001|Overall Study|Death|3|||
161245971|NCT02286466|582278869|FG000|Overall Study|Withdrawal by Subject|5|||
161245972|NCT02286466|582278870|FG001|Overall Study|Withdrawal by Subject|2|||
161245973|NCT02286466|582278869|FG000|Overall Study|Lost to Follow-up|1|||
161245974|NCT02286466|582278870|FG001|Overall Study|Lost to Follow-up|4|||
161245975|NCT02286466|582278869|FG000|Overall Study|Declined Clinician Assessment|0|||
161245976|NCT02286466|582278870|FG001|Overall Study|Declined Clinician Assessment|1|||
161245977|NCT00835081|582278871|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
161245978|NCT00835081|582278872|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161245979|NCT01139762|582278873|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
161245980|NCT01139762|582278874|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
161245981|NCT01139762|582278875|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
161245982|NCT01139762|582278873|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
161245983|NCT01139762|582278874|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
161245984|NCT01139762|582278875|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
161245985|NCT01139762|582278873|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
161245986|NCT01139762|582278874|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
161245987|NCT01139762|582278875|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
161245988|NCT01139762|582278873|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
161245989|NCT01139762|582278874|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
161245990|NCT01139762|582278875|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
161245991|NCT01139762|582278873|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
161245992|NCT01139762|582278874|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
161245993|NCT01139762|582278875|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
161245994|NCT01139762|582278873|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
161245995|NCT01139762|582278874|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
161245996|NCT01139762|582278875|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
161245997|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
161245998|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
161245999|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
161246000|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Death|0|||
161246001|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Death|1|||
161246002|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Death|1|||
161246003|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
161246004|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
161246005|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
161246006|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
161246007|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
161246008|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
161246009|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
161246010|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
161246011|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
161246012|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
161246013|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
161246014|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
161246015|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
161246016|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
161246017|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
161246018|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
161246019|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
161246020|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
161246021|NCT01139762|582278873|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
161246022|NCT01139762|582278874|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
161246023|NCT01139762|582278875|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
161246024|NCT01675596|582278876|FG000|Overall Study|Death|6|||
161246025|NCT01675596|582278876|FG000|Overall Study|Exit with other reason|1|||
161246026|NCT01675596|582278876|FG000|Overall Study|Missed Visit|1|||
161246027|NCT00840879|582278877|FG000|Second Intervention|Withdrawal by Subject|1|||
161246028|NCT00840879|582278878|FG001|Second Intervention|Withdrawal by Subject|0|||
161246029|NCT01894230|582280222|FG000|Overall Study|Lost to Follow-up|2|||
161246030|NCT01894230|582280223|FG001|Overall Study|Lost to Follow-up|2|||
161246031|NCT01894230|582280222|FG000|Overall Study|Withdrawal by Subject|4|||
161246032|NCT01894230|582280223|FG001|Overall Study|Withdrawal by Subject|4|||
161246033|NCT01894230|582280222|FG000|Overall Study|Non-adherent|0|||
161246034|NCT01894230|582280223|FG001|Overall Study|Non-adherent|1|||
161246035|NCT01894230|582280222|FG000|Overall Study|Death|1|||
161246036|NCT01894230|582280223|FG001|Overall Study|Death|0|||
161246037|NCT02300987|582280224|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
161246038|NCT02300987|582280225|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
161246039|NCT02300987|582280224|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
161246040|NCT02300987|582280225|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
161246041|NCT02300987|582280224|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
161246042|NCT02300987|582280225|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
161246043|NCT02300987|582280224|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
161246044|NCT02300987|582280225|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
161246045|NCT02300987|582280224|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
161246046|NCT02300987|582280225|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
161246047|NCT02219009|582280226|FG000|Overall Study|Withdrawal by Subject|5|||
161246048|NCT02219009|582280227|FG001|Overall Study|Withdrawal by Subject|1|||
161246049|NCT02219009|582280226|FG000|Overall Study|Adverse Event|2|||
161246050|NCT02219009|582280227|FG001|Overall Study|Adverse Event|4|||
161246051|NCT02219009|582280226|FG000|Overall Study|Lost to Follow-up|2|||
161246052|NCT02219009|582280227|FG001|Overall Study|Lost to Follow-up|2|||
161246053|NCT02219009|582280226|FG000|Overall Study|Protocol deviation|1|||
161246054|NCT02219009|582280227|FG001|Overall Study|Protocol deviation|0|||
161246055|NCT02219009|582280226|FG000|Overall Study|Physician Decision|0|||
161246056|NCT02219009|582280227|FG001|Overall Study|Physician Decision|1|||
161246057|NCT02259348|582280228|FG000|Overall Study|Donors|6|||
161246058|NCT02259348|582280228|FG000|Overall Study|Death|4|||
161246059|NCT01622660|582280229|FG000|Overall Study|Adverse Event|1|||
161246060|NCT04211766|582280230|FG000|Overall Study|Withdrawal by Subject|5|||
161246061|NCT04211766|582280231|FG001|Overall Study|Withdrawal by Subject|1|||
161246062|NCT00642993|582280232|FG000|Overall Study|Adverse Event|85|||
161246063|NCT00642993|582280233|FG001|Overall Study|Adverse Event|4|||
161246064|NCT00642993|582280232|FG000|Overall Study|Lost to Follow-up|8|||
161246065|NCT00642993|582280233|FG001|Overall Study|Lost to Follow-up|4|||
161246066|NCT00642993|582280232|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
161246067|NCT00642993|582280233|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
161246068|NCT00642993|582280232|FG000|Overall Study|Protocol Violation|1|||
161246069|NCT00642993|582280233|FG001|Overall Study|Protocol Violation|4|||
161246070|NCT00642993|582280232|FG000|Overall Study|Did not meet protocol eligibility|0|||
161246071|NCT00642993|582280233|FG001|Overall Study|Did not meet protocol eligibility|1|||
161246072|NCT00642993|582280232|FG000|Overall Study|Administrative|1|||
161246073|NCT00642993|582280233|FG001|Overall Study|Administrative|0|||
161246074|NCT02664415|582280234|FG000|Overall Study|Adverse Event|1|||
161246075|NCT02664415|582280235|FG001|Overall Study|Adverse Event|0|||
161246076|NCT02034513|582280236|FG000|Overall Study|Adverse Event|11|||
161246077|NCT02034513|582280237|FG001|Overall Study|Adverse Event|10|||
161246078|NCT02034513|582280236|FG000|Overall Study|Lack of Efficacy|0|||
161246079|NCT02034513|582280237|FG001|Overall Study|Lack of Efficacy|1|||
161246080|NCT02034513|582280236|FG000|Overall Study|Lost to Follow-up|6|||
161246081|NCT02034513|582280237|FG001|Overall Study|Lost to Follow-up|7|||
161246082|NCT02034513|582280236|FG000|Overall Study|Pregnancy|0|||
161246083|NCT02034513|582280237|FG001|Overall Study|Pregnancy|3|||
161246084|NCT02034513|582280236|FG000|Overall Study|Protocol Violation|7|||
161246085|NCT02034513|582280237|FG001|Overall Study|Protocol Violation|10|||
161246086|NCT02034513|582280236|FG000|Overall Study|Withdrawal by Subject|25|||
161246087|NCT02034513|582280237|FG001|Overall Study|Withdrawal by Subject|25|||
161246088|NCT02034513|582280236|FG000|Overall Study|Unclassified|0|||
161246089|NCT02034513|582280237|FG001|Overall Study|Unclassified|1|||
161246090|NCT00960154|582280238|FG000|Overall Study|Study termination|25|||
161246091|NCT00960154|582280239|FG001|Overall Study|Study termination|25|||
161246092|NCT00757705|582280240|FG000|Overall Study|Adverse Event|19|||
161246093|NCT00757705|582280240|FG000|Overall Study|Lost to Follow-up|16|||
161246094|NCT00757705|582280240|FG000|Overall Study|Withdrawal by Subject|25|||
161246095|NCT00757705|582280240|FG000|Overall Study|Insufficient Response|26|||
161246096|NCT00757705|582280240|FG000|Overall Study|Ineligible to continue|8|||
161246097|NCT00757705|582280240|FG000|Overall Study|Non-compliant|9|||
161246098|NCT00757705|582280240|FG000|Overall Study|Other|18|||
161246099|NCT04408924|582280244|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
161246100|NCT04408924|582280244|FG000|Overall Study|Lost to Follow-up|3|||
160903038|NCT01681472|581037928|FG002|Overall Study|Adverse Event|0|||
160903039|NCT01681472|581037929|FG003|Overall Study|Adverse Event|0|||
160903040|NCT01696071|581037942|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
160903041|NCT01696071|581037943|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
161246101|NCT04408924|582280244|FG000|Overall Study|Withdrawal by Subject|5|||
161246102|NCT04408924|582280244|FG000|Overall Study|Sponsor Decision|2|||
161246103|NCT00486434|582280245|FG000|Overall Study|Withdrawal by Subject|34|||
161246104|NCT00486434|582280246|FG001|Overall Study|Withdrawal by Subject|39|||
161246105|NCT00486434|582280245|FG000|Overall Study|Adverse Event|118|||
161246106|NCT00486434|582280246|FG001|Overall Study|Adverse Event|44|||
161246107|NCT00486434|582280245|FG000|Overall Study|Protocol Violation|22|||
161246108|NCT00486434|582280246|FG001|Overall Study|Protocol Violation|21|||
161246109|NCT00486434|582280245|FG000|Overall Study|Lack of Efficacy|12|||
161246110|NCT00486434|582280246|FG001|Overall Study|Lack of Efficacy|19|||
161246111|NCT00486434|582280245|FG000|Overall Study|Lost to Follow-up|2|||
161246112|NCT00486434|582280246|FG001|Overall Study|Lost to Follow-up|3|||
160903042|NCT00678080|581037947|FG000|Overall Study|Physician Decision|2|||
160903043|NCT00678080|581037948|FG001|Overall Study|Physician Decision|0|||
161246113|NCT00486434|582280245|FG000|Overall Study|Death|1|||
161246114|NCT00486434|582280246|FG001|Overall Study|Death|2|||
161246115|NCT00486434|582280245|FG000|Overall Study|Personal reasons|5|||
161246116|NCT00486434|582280246|FG001|Overall Study|Personal reasons|6|||
161246117|NCT02218541|582280247|FG000|Overall Study|Lost to Follow-up|2|||
161246118|NCT02218541|582280248|FG001|Overall Study|Lost to Follow-up|1|||
161246119|NCT02218541|582280247|FG000|Overall Study|Implant Failure|4|||
161246120|NCT02218541|582280248|FG001|Overall Study|Implant Failure|1|||
161246121|NCT00856349|582280249|FG000|Overall Study|Death|418|||
161246122|NCT00856349|582280249|FG000|Overall Study|Withdrawal by Subject|116|||
161246123|NCT00856349|582280249|FG000|Overall Study|Lost to Follow-up|91|||
160990750|NCT01511250|581353950|FG005|Overall Study|Lost to Follow-up|0|||
160990751|NCT01511250|581353951|FG006|Overall Study|Lost to Follow-up|2|||
160990752|NCT01511250|581353952|FG007|Overall Study|Lost to Follow-up|3|||
160990753|NCT01511250|581353953|FG008|Overall Study|Lost to Follow-up|13|||
160990754|NCT01511250|581353954|FG009|Overall Study|Lost to Follow-up|5|||
160990755|NCT01511250|581353945|FG000|Overall Study|Protocol Violation|0|||
160990756|NCT01511250|581353946|FG001|Overall Study|Protocol Violation|2|||
160990757|NCT01511250|581353947|FG002|Overall Study|Protocol Violation|1|||
160990758|NCT01511250|581353948|FG003|Overall Study|Protocol Violation|0|||
160990759|NCT01511250|581353949|FG004|Overall Study|Protocol Violation|0|||
160990760|NCT01511250|581353950|FG005|Overall Study|Protocol Violation|0|||
160990761|NCT01511250|581353951|FG006|Overall Study|Protocol Violation|0|||
160990762|NCT01511250|581353952|FG007|Overall Study|Protocol Violation|0|||
160990763|NCT01511250|581353953|FG008|Overall Study|Protocol Violation|0|||
160990764|NCT01511250|581353954|FG009|Overall Study|Protocol Violation|0|||
160990765|NCT02095158|581353960|FG000|Overall Study|Adverse Event|14|||
160990766|NCT02095158|581353960|FG000|Overall Study|Lack of Efficacy|3|||
160990767|NCT02095158|581353960|FG000|Overall Study|Pregnancy|1|||
160990768|NCT02095158|581353960|FG000|Overall Study|Lost to Follow-up|20|||
160990769|NCT02095158|581353960|FG000|Overall Study|Personal Reasons|35|||
160990770|NCT02095158|581353960|FG000|Overall Study|Protocol Violation|1|||
160990771|NCT02095158|581353960|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160990772|NCT01941316|581353961|FG000|Overall Study|Adverse Event|0|||
160990773|NCT01941316|581353962|FG001|Overall Study|Adverse Event|1|||
160990774|NCT01941316|581353963|FG002|Overall Study|Adverse Event|0|||
160990775|NCT01941316|581353964|FG003|Overall Study|Adverse Event|7|||
160990776|NCT01941316|581353961|FG000|Overall Study|Progressive Disease|3|||
160990777|NCT01941316|581353962|FG001|Overall Study|Progressive Disease|6|||
160990778|NCT01941316|581353963|FG002|Overall Study|Progressive Disease|2|||
160990779|NCT01941316|581353964|FG003|Overall Study|Progressive Disease|29|||
160990780|NCT01941316|581353961|FG000|Overall Study|Withdrawal by Subject|0|||
160990781|NCT01941316|581353962|FG001|Overall Study|Withdrawal by Subject|2|||
160990782|NCT01941316|581353963|FG002|Overall Study|Withdrawal by Subject|1|||
160990783|NCT01941316|581353964|FG003|Overall Study|Withdrawal by Subject|8|||
160990784|NCT01941316|581353961|FG000|Overall Study|Death|0|||
160990785|NCT01941316|581353962|FG001|Overall Study|Death|0|||
160990786|NCT01941316|581353963|FG002|Overall Study|Death|0|||
160990787|NCT01941316|581353964|FG003|Overall Study|Death|3|||
160990788|NCT01941316|581353961|FG000|Overall Study|Physician Decision|0|||
160990789|NCT01941316|581353962|FG001|Overall Study|Physician Decision|0|||
161246124|NCT00856349|582280249|FG000|Overall Study|Protocol Violation|38|||
161246125|NCT00856349|582280249|FG000|Overall Study|Physician Decision|13|||
161246126|NCT00856349|582280249|FG000|Overall Study|Subject relocation|104|||
161246127|NCT00856349|582280249|FG000|Overall Study|Device explant|33|||
160828734|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
160828735|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
160828736|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
160828737|NCT02008357|580759861|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
160828738|NCT02008357|580759862|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
160828739|NCT02008357|580759861|FG000|Open-label Extension Period|Adverse Event|8|||
160828740|NCT02008357|580759862|FG001|Open-label Extension Period|Adverse Event|7|||
160828741|NCT02008357|580759861|FG000|Open-label Extension Period|Death|7|||
160828742|NCT02008357|580759862|FG001|Open-label Extension Period|Death|4|||
160828743|NCT02008357|580759861|FG000|Open-label Extension Period|Lack of Efficacy|9|||
160828744|NCT02008357|580759862|FG001|Open-label Extension Period|Lack of Efficacy|5|||
160828745|NCT02008357|580759861|FG000|Open-label Extension Period|Lost to Follow-up|2|||
160828746|NCT02008357|580759862|FG001|Open-label Extension Period|Lost to Follow-up|2|||
160828747|NCT02008357|580759861|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
160828748|NCT02008357|580759862|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
160828749|NCT02008357|580759861|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
160828750|NCT02008357|580759862|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
160828751|NCT02008357|580759861|FG000|Open-label Extension Period|Safety Risk|2|||
160990790|NCT01941316|581353963|FG002|Overall Study|Physician Decision|0|||
160990791|NCT01941316|581353964|FG003|Overall Study|Physician Decision|3|||
160990792|NCT01941316|581353961|FG000|Overall Study|Protocol Violation|0|||
160990793|NCT01941316|581353962|FG001|Overall Study|Protocol Violation|0|||
160990794|NCT01941316|581353963|FG002|Overall Study|Protocol Violation|0|||
161246128|NCT00856349|582280249|FG000|Overall Study|Site closure|78|||
161246129|NCT00856349|582280249|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
161246130|NCT01923740|582280252|FG000|Overall Study|Lost to Follow-up|4|||
161246131|NCT01923740|582280253|FG001|Overall Study|Lost to Follow-up|9|||
161246132|NCT01923740|582280252|FG000|Overall Study|Withdrawal by Subject|2|||
161246133|NCT01923740|582280253|FG001|Overall Study|Withdrawal by Subject|0|||
161246134|NCT03345420|582280256|FG000|Overall Study|Withdrawal by Subject|1|||
161246135|NCT00834444|582280257|FG000|First Intervention|Adverse Event|1|||
161246136|NCT00834444|582280258|FG001|First Intervention|Adverse Event|0|||
161246137|NCT00834444|582280257|FG000|First Intervention|Intolerance to Venopuncture|0|||
161246138|NCT00834444|582280258|FG001|First Intervention|Intolerance to Venopuncture|1|||
161246139|NCT00834444|582280257|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
161246140|NCT00834444|582280258|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
161246141|NCT00834444|582280257|FG000|Second Intervention|Adverse Event|1|||
161246142|NCT00834444|582280258|FG001|Second Intervention|Adverse Event|0|||
161246143|NCT02890992|582280262|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161246144|NCT02890992|582280263|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
161246145|NCT02890992|582280264|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
160990795|NCT01941316|581353964|FG003|Overall Study|Protocol Violation|3|||
160990796|NCT01941316|581353961|FG000|Overall Study|Intercurrent illness|0|||
160990797|NCT01941316|581353962|FG001|Overall Study|Intercurrent illness|0|||
160990798|NCT01941316|581353963|FG002|Overall Study|Intercurrent illness|0|||
160990799|NCT01941316|581353964|FG003|Overall Study|Intercurrent illness|1|||
160990800|NCT01941316|581353961|FG000|Overall Study|Other, not specified|0|||
160990801|NCT01941316|581353962|FG001|Overall Study|Other, not specified|0|||
160990802|NCT01941316|581353963|FG002|Overall Study|Other, not specified|0|||
160990803|NCT01941316|581353964|FG003|Overall Study|Other, not specified|1|||
160990804|NCT02775435|581353965|FG000|Overall Study|Adverse Event|32|||
160990805|NCT02775435|581353966|FG001|Overall Study|Adverse Event|27|||
160990806|NCT02775435|581353965|FG000|Overall Study|Lost to Follow-up|2|||
160990807|NCT02775435|581353966|FG001|Overall Study|Lost to Follow-up|2|||
160990808|NCT02775435|581353965|FG000|Overall Study|Sponsor decision|44|||
160990809|NCT02775435|581353966|FG001|Overall Study|Sponsor decision|19|||
160990810|NCT02775435|581353965|FG000|Overall Study|Withdrawal by Subject|4|||
160990811|NCT02775435|581353966|FG001|Overall Study|Withdrawal by Subject|9|||
161246146|NCT02890992|582280265|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161246147|NCT02890992|582280266|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161246148|NCT02890992|582280267|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161246149|NCT02890992|582280268|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161246150|NCT02890992|582280269|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
161246151|NCT02890992|582280262|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
160990812|NCT02775435|581353965|FG000|Overall Study|Death|196|||
160990813|NCT02775435|581353966|FG001|Overall Study|Death|224|||
161246152|NCT02890992|582280263|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161246153|NCT02890992|582280264|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161246154|NCT02890992|582280265|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161246155|NCT02890992|582280266|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161246156|NCT02890992|582280267|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
161246157|NCT02890992|582280268|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
161246158|NCT02890992|582280269|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
161246159|NCT02890992|582280262|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
161246160|NCT02890992|582280263|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
161246161|NCT02890992|582280264|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
161246162|NCT02890992|582280265|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
161246163|NCT02890992|582280266|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
161246164|NCT02890992|582280267|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
160828752|NCT02008357|580759862|FG001|Open-label Extension Period|Safety Risk|1|||
160828753|NCT02008357|580759861|FG000|Open-label Extension Period|Non-Compliance|0|||
160828754|NCT02008357|580759862|FG001|Open-label Extension Period|Non-Compliance|1|||
160828755|NCT02008357|580759861|FG000|Open-label Extension Period|Investigator Recommendation|0|||
160828756|NCT02008357|580759862|FG001|Open-label Extension Period|Investigator Recommendation|1|||
160828757|NCT02008357|580759861|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
160828758|NCT02008357|580759862|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
160828759|NCT02008357|580759861|FG000|Open-label Extension Period|Coordinating Center Request|2|||
160828760|NCT02008357|580759862|FG001|Open-label Extension Period|Coordinating Center Request|4|||
160828761|NCT02008357|580759861|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
160990814|NCT00320489|581353967|FG000|Overall Study|Adverse Event|26|||
160990815|NCT00320489|581353968|FG001|Overall Study|Adverse Event|25|||
161246165|NCT02890992|582280268|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
161246166|NCT02890992|582280269|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
161246167|NCT01496118|582280272|FG000|Overall Study|Disease progression|3|||
161246168|NCT01496118|582280273|FG001|Overall Study|Disease progression|2|||
161246169|NCT01496118|582280274|FG002|Overall Study|Disease progression|3|||
161246170|NCT01496118|582280275|FG003|Overall Study|Disease progression|1|||
161246171|NCT01496118|582280276|FG004|Overall Study|Disease progression|2|||
161246172|NCT01496118|582280277|FG005|Overall Study|Disease progression|2|||
161246173|NCT01496118|582280278|FG006|Overall Study|Disease progression|14|||
161246174|NCT01496118|582280279|FG007|Overall Study|Disease progression|10|||
161246175|NCT01496118|582280272|FG000|Overall Study|Physician Decision|0|||
161246176|NCT01496118|582280273|FG001|Overall Study|Physician Decision|0|||
161246177|NCT01496118|582280274|FG002|Overall Study|Physician Decision|0|||
161246178|NCT01496118|582280275|FG003|Overall Study|Physician Decision|0|||
161246179|NCT01496118|582280276|FG004|Overall Study|Physician Decision|1|||
161246180|NCT01496118|582280277|FG005|Overall Study|Physician Decision|0|||
161246181|NCT01496118|582280278|FG006|Overall Study|Physician Decision|3|||
161246182|NCT01496118|582280279|FG007|Overall Study|Physician Decision|6|||
161246183|NCT01496118|582280272|FG000|Overall Study|Adverse Event|1|||
161246184|NCT01496118|582280273|FG001|Overall Study|Adverse Event|1|||
161246185|NCT01496118|582280274|FG002|Overall Study|Adverse Event|0|||
161246186|NCT01496118|582280275|FG003|Overall Study|Adverse Event|0|||
161246187|NCT01496118|582280276|FG004|Overall Study|Adverse Event|0|||
161246188|NCT01496118|582280277|FG005|Overall Study|Adverse Event|0|||
161246189|NCT01496118|582280278|FG006|Overall Study|Adverse Event|6|||
161246190|NCT01496118|582280279|FG007|Overall Study|Adverse Event|10|||
161246191|NCT01496118|582280272|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246192|NCT01496118|582280273|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246193|NCT01496118|582280274|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246194|NCT01496118|582280275|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246195|NCT01496118|582280276|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246196|NCT01496118|582280277|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246197|NCT01496118|582280278|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
161246198|NCT01496118|582280279|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
161246199|NCT01496118|582280272|FG000|Overall Study|Death|0|||
161246200|NCT01496118|582280273|FG001|Overall Study|Death|0|||
161246201|NCT01496118|582280274|FG002|Overall Study|Death|0|||
161246202|NCT01496118|582280275|FG003|Overall Study|Death|0|||
161246203|NCT01496118|582280276|FG004|Overall Study|Death|0|||
161246204|NCT01496118|582280277|FG005|Overall Study|Death|0|||
161246205|NCT01496118|582280278|FG006|Overall Study|Death|1|||
161246206|NCT01496118|582280279|FG007|Overall Study|Death|1|||
161246207|NCT01496118|582280272|FG000|Overall Study|Withdrawal by Subject|0|||
161246208|NCT01496118|582280273|FG001|Overall Study|Withdrawal by Subject|0|||
161246209|NCT01496118|582280274|FG002|Overall Study|Withdrawal by Subject|0|||
160828762|NCT02008357|580759862|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
160828763|NCT02008357|580759861|FG000|Open-label Extension Period|Study Ended|20|||
160828764|NCT02008357|580759862|FG001|Open-label Extension Period|Study Ended|25|||
160828765|NCT02008357|580759861|FG000|Open-label Extension Period|Personal Reasons|0|||
160828766|NCT02008357|580759862|FG001|Open-label Extension Period|Personal Reasons|1|||
160828767|NCT02008357|580759861|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
160828768|NCT02008357|580759862|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
160828769|NCT02008357|580759861|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
160828770|NCT02008357|580759862|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
160828771|NCT02008357|580759861|FG000|Open-label Extension Period|Other|2|||
160828772|NCT02008357|580759862|FG001|Open-label Extension Period|Other|0|||
160828773|NCT02312219|580759864|FG000|Overall Study|Withdrawal by Subject|1|||
160828774|NCT02312219|580759865|FG001|Overall Study|Withdrawal by Subject|2|||
160828775|NCT02312219|580759864|FG000|Overall Study|could not schedule imaging in time|0|||
160828776|NCT02312219|580759865|FG001|Overall Study|could not schedule imaging in time|2|||
160828777|NCT02312219|580759864|FG000|Overall Study|Other|0|||
160828778|NCT02312219|580759865|FG001|Overall Study|Other|1|||
160828779|NCT02312219|580759864|FG000|Overall Study|Not randomized. Ineligible|0|||
160828780|NCT02312219|580759865|FG001|Overall Study|Not randomized. Ineligible|1|||
160828781|NCT03553498|580759866|FG000|Overall Study|Missing primary outcome|1|||
160828782|NCT03553498|580759867|FG001|Overall Study|Missing primary outcome|2|||
160828783|NCT04941807|580759868|FG000|Overall Study|Lost to Follow-up|1|||
160828784|NCT04941807|580759869|FG001|Overall Study|Lost to Follow-up|1|||
160828785|NCT02741570|580759870|FG000|Pre-Treatment Period|Other reasons|0|||
160990816|NCT00320489|581353967|FG000|Overall Study|Clinical Relapse|26|||
160828786|NCT02741570|580759871|FG001|Pre-Treatment Period|Other reasons|3|||
161246210|NCT01496118|582280275|FG003|Overall Study|Withdrawal by Subject|2|||
161246211|NCT01496118|582280276|FG004|Overall Study|Withdrawal by Subject|0|||
161246212|NCT01496118|582280277|FG005|Overall Study|Withdrawal by Subject|1|||
161246213|NCT01496118|582280278|FG006|Overall Study|Withdrawal by Subject|6|||
161246214|NCT01496118|582280279|FG007|Overall Study|Withdrawal by Subject|3|||
161246215|NCT00841659|582280280|FG000|Washout: 2 Weeks|Protocol Violation|1|||
161246216|NCT00841659|582280281|FG001|Washout: 2 Weeks|Protocol Violation|0|||
161246217|NCT01149057|582280285|FG000|Overall Study|Lack of Efficacy|16|||
161246218|NCT01149057|582280285|FG000|Overall Study|Adverse Event|13|||
161246219|NCT01149057|582280285|FG000|Overall Study|Withdrawal by Subject|9|||
161246220|NCT01149057|582280285|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
161246221|NCT01149057|582280285|FG000|Overall Study|B Cell Depletion|4|||
161246222|NCT01149057|582280285|FG000|Overall Study|Participant Non-Compliance|2|||
161246223|NCT01149057|582280285|FG000|Overall Study|Lost to Follow-up|1|||
161246224|NCT01149057|582280285|FG000|Overall Study|High Parathyroid Hormone Value|1|||
161246225|NCT01149057|582280285|FG000|Overall Study|Other|6|||
161246226|NCT03499873|582280286|FG000|Overall Study|Withdrawal by Subject|4|||
161246227|NCT03499873|582280287|FG001|Overall Study|Withdrawal by Subject|6|||
161246228|NCT03499873|582280288|FG002|Overall Study|Withdrawal by Subject|1|||
161246229|NCT03499873|582280286|FG000|Overall Study|Subjects condition worsened|0|||
161246230|NCT03499873|582280287|FG001|Overall Study|Subjects condition worsened|3|||
161246231|NCT03499873|582280288|FG002|Overall Study|Subjects condition worsened|11|||
161246232|NCT03499873|582280286|FG000|Overall Study|Adverse Event|8|||
161246233|NCT03499873|582280287|FG001|Overall Study|Adverse Event|3|||
161246234|NCT03499873|582280288|FG002|Overall Study|Adverse Event|6|||
161246235|NCT03499873|582280286|FG000|Overall Study|Physician Decision|1|||
161246236|NCT03499873|582280287|FG001|Overall Study|Physician Decision|0|||
161246237|NCT03499873|582280288|FG002|Overall Study|Physician Decision|0|||
161246238|NCT03499873|582280286|FG000|Overall Study|Administrative reasons|0|||
161246239|NCT03499873|582280287|FG001|Overall Study|Administrative reasons|1|||
161246240|NCT03499873|582280288|FG002|Overall Study|Administrative reasons|0|||
161246241|NCT03499873|582280286|FG000|Overall Study|Concomitant therapy|5|||
161246242|NCT03499873|582280287|FG001|Overall Study|Concomitant therapy|4|||
161246243|NCT03499873|582280288|FG002|Overall Study|Concomitant therapy|7|||
161246244|NCT03499873|582280286|FG000|Overall Study|Miscellaneous|1|||
161246245|NCT03499873|582280287|FG001|Overall Study|Miscellaneous|2|||
161246246|NCT03499873|582280288|FG002|Overall Study|Miscellaneous|2|||
161246247|NCT03499873|582280286|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
161246248|NCT03499873|582280287|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
161246249|NCT03499873|582280288|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
161246250|NCT04608448|582280289|FG000|Overall Study|Withdrawal by Subject|1|||
161246251|NCT04608448|582280289|FG000|Overall Study|Adverse Event|1|||
161246252|NCT01297504|582280290|FG000|Overall Study|Invalid Consent|1|||
161246253|NCT01297504|582280290|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
161246254|NCT01297504|582280290|FG000|Overall Study|No Study Visits|4|||
161246255|NCT01297504|582280290|FG000|Overall Study|Death|3|||
161246256|NCT01297504|582280290|FG000|Overall Study|Lost to Follow-up|43|||
161246257|NCT01297504|582280290|FG000|Overall Study|Withdrawal by Subject|9|||
161246258|NCT01297504|582280290|FG000|Overall Study|Site Closure|3|||
161246259|NCT01297504|582280290|FG000|Overall Study|Protocol Violation|3|||
161246260|NCT00654186|582280291|FG000|Overall Study|Withdrawal by Subject|5|||
161246261|NCT00577655|582280294|FG000|Overall Study|Patient Request|0|||
161246262|NCT00577655|582280295|FG001|Overall Study|Patient Request|2|||
161246263|NCT00577655|582280294|FG000|Overall Study|Protocol Violation|0|||
161246264|NCT00577655|582280295|FG001|Overall Study|Protocol Violation|1|||
161246265|NCT00577655|582280294|FG000|Overall Study|Lost to Follow-up|1|||
161246266|NCT00577655|582280295|FG001|Overall Study|Lost to Follow-up|1|||
161246267|NCT01024855|582280296|FG000|Overall Study|Inclusion/exclusion criteria|1|||
161246268|NCT03306277|582280300|FG000|Overall Study|Death|1|||
161246269|NCT03306277|582280300|FG000|Overall Study|Adverse Event|1|||
161246270|NCT03306277|582280300|FG000|Overall Study|Withdrawal by Subject|1|||
161246271|NCT01370863|582280304|FG000|Overall Study|Adverse Event|1|||
161246272|NCT01370863|582280305|FG001|Overall Study|Adverse Event|1|||
161246273|NCT01370863|582280304|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
161246274|NCT01370863|582280305|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
160903044|NCT00678080|581037947|FG000|Overall Study|Lost to Follow-up|1|||
160903045|NCT00678080|581037948|FG001|Overall Study|Lost to Follow-up|0|||
160903046|NCT00678080|581037947|FG000|Overall Study|Withdrawal by Subject|0|||
161246275|NCT01370863|582280304|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161246276|NCT01370863|582280305|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161246277|NCT00881751|582280306|FG000|Overall Study|Physician Decision|0|||
161246278|NCT00881751|582280307|FG001|Overall Study|Physician Decision|1|||
161246279|NCT00881751|582280306|FG000|Overall Study|Adverse Event|0|||
161246280|NCT00881751|582280307|FG001|Overall Study|Adverse Event|2|||
161246281|NCT00881751|582280306|FG000|Overall Study|Withdrawal by Subject|0|||
161246282|NCT00881751|582280307|FG001|Overall Study|Withdrawal by Subject|2|||
161246283|NCT01926119|582280308|FG000|Overall Study|Withdrawal by Subject|1|||
161246284|NCT01968551|582280309|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
161246285|NCT01968551|582280310|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
161246286|NCT01968551|582280311|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
161246287|NCT01968551|582280309|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
161246288|NCT01968551|582280310|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
161136043|NCT04889209|581879358|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
160903047|NCT00678080|581037948|FG001|Overall Study|Withdrawal by Subject|1|||
160903048|NCT05136690|581037949|FG000|Period 1|Withdrawal by Subject|0|||
160903049|NCT05136690|581037950|FG001|Period 1|Withdrawal by Subject|1|||
160903050|NCT05136690|581037949|FG000|Period 2|Lost to Follow-up|0|||
160903051|NCT05136690|581037950|FG001|Period 2|Lost to Follow-up|3|||
160903052|NCT05136690|581037949|FG000|Period 2|Withdrawal by Subject|0|||
161136044|NCT04889209|581879359|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136045|NCT04889209|581879360|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136046|NCT04889209|581879361|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136047|NCT04889209|581879362|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136048|NCT04889209|581879363|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136049|NCT04889209|581879364|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136050|NCT04889209|581879365|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136051|NCT04889209|581879366|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136052|NCT04889209|581879367|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136053|NCT04889209|581879368|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136054|NCT04889209|581879369|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136055|NCT04889209|581879370|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136056|NCT04889209|581879371|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136057|NCT04889209|581879372|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
161136058|NCT04889209|581879373|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136059|NCT04889209|581879374|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136060|NCT04889209|581879375|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
161136061|NCT04607408|581879376|FG000|Overall Study|Lost to Follow-up|0|||
161136062|NCT04607408|581879377|FG001|Overall Study|Lost to Follow-up|0|||
161136063|NCT04607408|581879378|FG002|Overall Study|Lost to Follow-up|0|||
161136064|NCT04607408|581879379|FG003|Overall Study|Lost to Follow-up|1|||
161136065|NCT04607408|581879380|FG004|Overall Study|Lost to Follow-up|0|||
161136066|NCT04607408|581879376|FG000|Overall Study|Withdrawal by Subject|0|||
161136067|NCT04607408|581879377|FG001|Overall Study|Withdrawal by Subject|1|||
161136068|NCT04607408|581879378|FG002|Overall Study|Withdrawal by Subject|0|||
161136069|NCT04607408|581879379|FG003|Overall Study|Withdrawal by Subject|1|||
161136070|NCT04607408|581879380|FG004|Overall Study|Withdrawal by Subject|0|||
161136071|NCT01725165|581879387|FG000|Overall Study|Death|11|||
161136072|NCT01725165|581879388|FG001|Overall Study|Death|18|||
161136073|NCT00442598|581879392|FG000|Overall Study|Adverse Event|1|||
161136074|NCT00442598|581879393|FG001|Overall Study|Adverse Event|0|||
161136075|NCT00442598|581879394|FG002|Overall Study|Adverse Event|0|||
161136076|NCT00442598|581879392|FG000|Overall Study|Tumor progression|3|||
161136077|NCT00442598|581879393|FG001|Overall Study|Tumor progression|4|||
161136078|NCT00442598|581879394|FG002|Overall Study|Tumor progression|0|||
161136079|NCT00442598|581879392|FG000|Overall Study|Clinical deterioration|1|||
161136080|NCT00442598|581879393|FG001|Overall Study|Clinical deterioration|2|||
161136081|NCT00442598|581879394|FG002|Overall Study|Clinical deterioration|0|||
161136082|NCT00442598|581879392|FG000|Overall Study|CA125 progression|0|||
161136083|NCT00442598|581879393|FG001|Overall Study|CA125 progression|1|||
161136084|NCT00442598|581879394|FG002|Overall Study|CA125 progression|0|||
161136085|NCT00442598|581879392|FG000|Overall Study|Reduced creatinine clearance|1|||
161136086|NCT00442598|581879393|FG001|Overall Study|Reduced creatinine clearance|0|||
161136087|NCT00442598|581879394|FG002|Overall Study|Reduced creatinine clearance|0|||
161136088|NCT00442598|581879392|FG000|Overall Study|Death|0|||
161136089|NCT00442598|581879393|FG001|Overall Study|Death|1|||
161136090|NCT00442598|581879394|FG002|Overall Study|Death|0|||
161136091|NCT02886702|581879395|FG000|Overall Study|Other|4|||
161136092|NCT02886702|581879396|FG001|Overall Study|Other|3|||
161136093|NCT02886702|581879397|FG002|Overall Study|Other|9|||
161136094|NCT02886702|581879395|FG000|Overall Study|Withdrawal by Subject|24|||
161136095|NCT02886702|581879396|FG001|Overall Study|Withdrawal by Subject|18|||
161136096|NCT02886702|581879397|FG002|Overall Study|Withdrawal by Subject|22|||
161136097|NCT02886702|581879395|FG000|Overall Study|Significant Worsening of Condition|0|||
161136098|NCT02886702|581879396|FG001|Overall Study|Significant Worsening of Condition|1|||
161136099|NCT02886702|581879397|FG002|Overall Study|Significant Worsening of Condition|0|||
161136100|NCT02886702|581879395|FG000|Overall Study|Protocol Violation|2|||
161136101|NCT02886702|581879396|FG001|Overall Study|Protocol Violation|2|||
161136102|NCT02886702|581879397|FG002|Overall Study|Protocol Violation|1|||
161136103|NCT02886702|581879395|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160903053|NCT05136690|581037950|FG001|Period 2|Withdrawal by Subject|1|||
160903054|NCT01453361|581037951|FG000|Overall Study|Disease Progression|6|||
161136104|NCT02886702|581879396|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161136105|NCT02886702|581879397|FG002|Overall Study|Non-Compliance With Study Drug|4|||
161136106|NCT02886702|581879395|FG000|Overall Study|Lost to Follow-up|11|||
161136107|NCT02886702|581879396|FG001|Overall Study|Lost to Follow-up|13|||
161136108|NCT02886702|581879397|FG002|Overall Study|Lost to Follow-up|8|||
161246289|NCT01968551|582280311|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
161246290|NCT01968551|582280309|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
161246291|NCT01968551|582280310|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
161246292|NCT01968551|582280311|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
161246293|NCT01968551|582280309|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
161246294|NCT01968551|582280310|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
161246295|NCT01968551|582280311|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
161246296|NCT01968551|582280309|FG000|Extension Phase|Adverse Event|0|||
161246297|NCT01968551|582280310|FG001|Extension Phase|Adverse Event|0|||
161246298|NCT01968551|582280311|FG002|Extension Phase|Adverse Event|2|||
161246299|NCT01968551|582280309|FG000|Extension Phase|Death|0|||
161246300|NCT01968551|582280310|FG001|Extension Phase|Death|1|||
161246301|NCT01968551|582280311|FG002|Extension Phase|Death|0|||
161246302|NCT01968551|582280309|FG000|Extension Phase|Withdrew Consent|0|||
161246303|NCT01968551|582280310|FG001|Extension Phase|Withdrew Consent|0|||
161246304|NCT01968551|582280311|FG002|Extension Phase|Withdrew Consent|1|||
161246305|NCT01968551|582280309|FG000|Extension Phase|Lost to Follow-up|1|||
161246306|NCT01968551|582280310|FG001|Extension Phase|Lost to Follow-up|0|||
161246307|NCT01968551|582280311|FG002|Extension Phase|Lost to Follow-up|1|||
161246308|NCT00645853|582280312|FG000|Overall Study|Adverse Event|18|||
161246309|NCT00645853|582280313|FG001|Overall Study|Adverse Event|7|||
161246310|NCT00645853|582280312|FG000|Overall Study|AZ study closure in Hungary|60|||
161246311|NCT00645853|582280313|FG001|Overall Study|AZ study closure in Hungary|40|||
161246312|NCT00645853|582280312|FG000|Overall Study|Withdrawal by Subject|5|||
161246313|NCT00645853|582280313|FG001|Overall Study|Withdrawal by Subject|2|||
161246314|NCT00645853|582280312|FG000|Overall Study|Protocol Violation|0|||
161246315|NCT00645853|582280313|FG001|Overall Study|Protocol Violation|2|||
161246316|NCT00645853|582280312|FG000|Overall Study|Discontinuation criteria|2|||
161246317|NCT00645853|582280313|FG001|Overall Study|Discontinuation criteria|2|||
161246318|NCT00645853|582280312|FG000|Overall Study|recall of ICF, planned operation, death|7|||
161246319|NCT00645853|582280313|FG001|Overall Study|recall of ICF, planned operation, death|4|||
161246320|NCT01507662|582280314|FG000|Overall Study|Death|26|||
161246321|NCT01507662|582280315|FG001|Overall Study|Death|18|||
161246322|NCT01507662|582280314|FG000|Overall Study|Withdrawal by Subject|290|||
161246323|NCT01507662|582280315|FG001|Overall Study|Withdrawal by Subject|287|||
161246324|NCT01507662|582280314|FG000|Overall Study|Lost to Follow-up|498|||
161246325|NCT01507662|582280315|FG001|Overall Study|Lost to Follow-up|523|||
161246326|NCT01507662|582280314|FG000|Overall Study|Proxy interview done|2|||
161246327|NCT01507662|582280315|FG001|Overall Study|Proxy interview done|3|||
161246328|NCT01395017|582280316|FG000|Overall Study|Lost to Follow-up|1|||
161246329|NCT01395017|582280317|FG001|Overall Study|Lost to Follow-up|0|||
161246330|NCT01395017|582280316|FG000|Overall Study|Adverse Event|26|||
161246331|NCT01395017|582280317|FG001|Overall Study|Adverse Event|12|||
161246332|NCT01395017|582280316|FG000|Overall Study|Physician Decision|11|||
161246333|NCT01395017|582280317|FG001|Overall Study|Physician Decision|15|||
161246334|NCT01395017|582280316|FG000|Overall Study|Withdrawal by Subject|14|||
161246335|NCT01395017|582280317|FG001|Overall Study|Withdrawal by Subject|8|||
161246336|NCT01395017|582280316|FG000|Overall Study|Protocol deviation|1|||
161246337|NCT01395017|582280317|FG001|Overall Study|Protocol deviation|2|||
161246338|NCT01395017|582280316|FG000|Overall Study|Death|4|||
161246339|NCT01395017|582280317|FG001|Overall Study|Death|3|||
161246340|NCT01395017|582280316|FG000|Overall Study|Disease progression|42|||
161246341|NCT01395017|582280317|FG001|Overall Study|Disease progression|58|||
161246342|NCT01395017|582280316|FG000|Overall Study|Sponsor discontinued study|1|||
161246343|NCT01395017|582280317|FG001|Overall Study|Sponsor discontinued study|4|||
161246344|NCT03366428|582280318|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
160990817|NCT00320489|581353968|FG001|Overall Study|Clinical Relapse|20|||
160990818|NCT00320489|581353967|FG000|Overall Study|Death|0|||
161246345|NCT03366428|582280318|FG000|Overall Study|Adverse Event|12|||
161246346|NCT03366428|582280318|FG000|Overall Study|Clinical progression|2|||
161246347|NCT03366428|582280318|FG000|Overall Study|Withdrawal by Subject|4|||
160862007|NCT03804528|580887919|FG000|Overall Study|Time Commitment|18|||
160990819|NCT00320489|581353968|FG001|Overall Study|Death|2|||
161246348|NCT01958476|582280319|FG000|Overall Study|Parent requested exclusion from analysis|1|||
161246349|NCT01958476|582280320|FG001|Overall Study|Parent requested exclusion from analysis|0|||
161246350|NCT01971645|582280321|FG000|Overall Study|Adverse Event|1|||
161246351|NCT01971645|582280322|FG001|Overall Study|Adverse Event|0|||
161246352|NCT01971645|582280323|FG002|Overall Study|Adverse Event|0|||
161246353|NCT01971645|582280321|FG000|Overall Study|Lost to Follow-up|1|||
161246354|NCT01971645|582280322|FG001|Overall Study|Lost to Follow-up|0|||
161246355|NCT01971645|582280323|FG002|Overall Study|Lost to Follow-up|1|||
161246356|NCT01971645|582280321|FG000|Overall Study|Protocol Violation|0|||
161246357|NCT01971645|582280322|FG001|Overall Study|Protocol Violation|0|||
161246358|NCT01971645|582280323|FG002|Overall Study|Protocol Violation|1|||
161246359|NCT02943096|582280326|FG000|Overall Study|Lack of Efficacy|0|||
161246360|NCT02943096|582280327|FG001|Overall Study|Lack of Efficacy|1|||
161246361|NCT03868631|582280329|FG000|Baseline to Week 6|Adverse Event|0|||
161246362|NCT03868631|582280330|FG001|Baseline to Week 6|Adverse Event|3|||
161246363|NCT03868631|582280329|FG000|Baseline to Week 6|Protocol Violation|1|||
161246364|NCT03868631|582280330|FG001|Baseline to Week 6|Protocol Violation|1|||
161246365|NCT03868631|582280329|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
161246366|NCT03868631|582280330|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
161246367|NCT03868631|582280329|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
161246368|NCT03868631|582280330|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
161246369|NCT03868631|582280329|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
161246370|NCT03868631|582280330|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
161246371|NCT03868631|582280329|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
161246372|NCT03868631|582280330|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
161246373|NCT03867760|582280335|FG000|Overall Study|Lost to Follow-up|2|||
161136109|NCT02886702|581879395|FG000|Overall Study|Lack of Efficacy|3|||
161136110|NCT02886702|581879396|FG001|Overall Study|Lack of Efficacy|4|||
161136111|NCT02886702|581879397|FG002|Overall Study|Lack of Efficacy|5|||
161246374|NCT03867760|582280336|FG001|Overall Study|Lost to Follow-up|3|||
161246375|NCT03867760|582280335|FG000|Overall Study|Withdrawal by Subject|1|||
161246376|NCT03867760|582280336|FG001|Overall Study|Withdrawal by Subject|2|||
161246377|NCT03867760|582280335|FG000|Overall Study|subject could not meet study logistics|3|||
161246378|NCT03867760|582280336|FG001|Overall Study|subject could not meet study logistics|3|||
161246379|NCT04203823|582280338|FG000|Overall Study|Withdrawal by Subject|2|||
161246380|NCT04203823|582280339|FG001|Overall Study|Withdrawal by Subject|2|||
161246381|NCT04203823|582280338|FG000|Overall Study|Adverse Event|1|||
161246382|NCT04203823|582280339|FG001|Overall Study|Adverse Event|1|||
161246383|NCT04203823|582280338|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161246384|NCT04203823|582280339|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
161246385|NCT00874276|582280340|FG000|Overall Study|Withdrawal by Subject|1|||
161246386|NCT00874276|582280341|FG001|Overall Study|Withdrawal by Subject|1|||
161246387|NCT04236596|582280342|FG000|Overall Study|Withdrawal by Subject|1|||
161246388|NCT04236596|582280342|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
161246389|NCT04236596|582280342|FG000|Overall Study|Participants did not receive implant at all|4|||
160990820|NCT00320489|581353967|FG000|Overall Study|Entry Criteria Exclusion|2|||
160990821|NCT00320489|581353968|FG001|Overall Study|Entry Criteria Exclusion|4|||
160990822|NCT00320489|581353967|FG000|Overall Study|Lack of Efficacy|16|||
160990823|NCT00320489|581353968|FG001|Overall Study|Lack of Efficacy|7|||
160990824|NCT00320489|581353967|FG000|Overall Study|Lost to Follow-up|21|||
160990825|NCT00320489|581353968|FG001|Overall Study|Lost to Follow-up|22|||
160990826|NCT00320489|581353967|FG000|Overall Study|Physician Decision|8|||
160990827|NCT00320489|581353968|FG001|Overall Study|Physician Decision|8|||
160990828|NCT00320489|581353967|FG000|Overall Study|Protocol Violation|4|||
160990829|NCT00320489|581353968|FG001|Overall Study|Protocol Violation|4|||
160990830|NCT00320489|581353967|FG000|Overall Study|Sponsor Decision|3|||
160990831|NCT00320489|581353968|FG001|Overall Study|Sponsor Decision|3|||
160990832|NCT00320489|581353967|FG000|Overall Study|Withdrawal by Subject|39|||
160990833|NCT00320489|581353968|FG001|Overall Study|Withdrawal by Subject|41|||
160990834|NCT02282527|581353969|FG000|Overall Study|Lost to Follow-up|0|||
160990835|NCT02282527|581353970|FG001|Overall Study|Lost to Follow-up|1|||
160990836|NCT02282527|581353969|FG000|Overall Study|Lack of home health aid|1|||
160990837|NCT02282527|581353970|FG001|Overall Study|Lack of home health aid|0|||
160990838|NCT00941031|581353971|FG000|Induction Period|Lack of Efficacy|2|||
161246390|NCT02588339|582280344|FG000|Overall Study|Withdrawal by Subject|1|||
161246391|NCT02588339|582280344|FG000|Overall Study|GVHD Progression prior to treatment|2|||
161246392|NCT05330975|582281710|FG000|Primary|Lost to Follow-up|12|||
161136112|NCT02886702|581879395|FG000|Overall Study|Adverse Event|4|||
161136113|NCT02886702|581879396|FG001|Overall Study|Adverse Event|9|||
161246393|NCT05330975|582281711|FG001|Primary|Lost to Follow-up|21|||
161246394|NCT05330975|582281712|FG002|Primary|Lost to Follow-up|38|||
161246395|NCT05330975|582281713|FG003|Primary|Lost to Follow-up|30|||
161246396|NCT05330975|582281714|FG004|Primary|Lost to Follow-up|25|||
161246397|NCT05330975|582281715|FG005|Primary|Lost to Follow-up|28|||
161246398|NCT05330975|582281716|FG006|Primary|Lost to Follow-up|0|||
161246399|NCT05330975|582281710|FG000|Primary|Withdrawal by Subject|4|||
161136114|NCT02886702|581879397|FG002|Overall Study|Adverse Event|3|||
161246400|NCT05330975|582281711|FG001|Primary|Withdrawal by Subject|11|||
161246401|NCT05330975|582281712|FG002|Primary|Withdrawal by Subject|8|||
161136115|NCT02886702|581879395|FG000|Overall Study|Administrative Reasons|0|||
161136116|NCT02886702|581879396|FG001|Overall Study|Administrative Reasons|0|||
161246402|NCT05330975|582281713|FG003|Primary|Withdrawal by Subject|23|||
161136117|NCT02886702|581879397|FG002|Overall Study|Administrative Reasons|1|||
160990839|NCT00941031|581353972|FG001|Induction Period|Lack of Efficacy|1|||
161246403|NCT05330975|582281714|FG004|Primary|Withdrawal by Subject|20|||
161246404|NCT05330975|582281715|FG005|Primary|Withdrawal by Subject|19|||
160990840|NCT00941031|581353973|FG002|Induction Period|Lack of Efficacy|0|||
161246405|NCT05330975|582281716|FG006|Primary|Withdrawal by Subject|0|||
161246406|NCT05330975|582281710|FG000|Primary|Protocol Violation|0|||
161246407|NCT05330975|582281711|FG001|Primary|Protocol Violation|2|||
160990841|NCT00941031|581353974|FG003|Induction Period|Lack of Efficacy|5|||
161136118|NCT01147926|581879405|FG000|Overall Study|Subject Withdrew Consent|9|||
160828787|NCT02741570|580759870|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
160828788|NCT02741570|580759871|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
160828789|NCT02741570|580759870|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
160828790|NCT02741570|580759871|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
160828791|NCT02741570|580759870|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
160828792|NCT02741570|580759871|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
160828793|NCT02741570|580759870|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
160828794|NCT02741570|580759871|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
161136119|NCT01147926|581879406|FG001|Overall Study|Subject Withdrew Consent|10|||
161136120|NCT01147926|581879405|FG000|Overall Study|Adverse Event|7|||
161136121|NCT01147926|581879406|FG001|Overall Study|Adverse Event|6|||
161136122|NCT01147926|581879405|FG000|Overall Study|Subject Non-Compliant|5|||
161136123|NCT01147926|581879406|FG001|Overall Study|Subject Non-Compliant|4|||
161136124|NCT01147926|581879405|FG000|Overall Study|Principal investigator left hospital|1|||
161136125|NCT01147926|581879406|FG001|Overall Study|Principal investigator left hospital|3|||
161136126|NCT01147926|581879405|FG000|Overall Study|Selection criteria not met|3|||
161136127|NCT01147926|581879406|FG001|Overall Study|Selection criteria not met|1|||
161136128|NCT01147926|581879405|FG000|Overall Study|Lost to Follow-up|0|||
161136129|NCT01147926|581879406|FG001|Overall Study|Lost to Follow-up|2|||
161136130|NCT01147926|581879405|FG000|Overall Study|Sponsor's Decision|0|||
161136131|NCT01147926|581879406|FG001|Overall Study|Sponsor's Decision|1|||
161136132|NCT01147926|581879405|FG000|Overall Study|Lack of Efficacy|1|||
161136133|NCT01147926|581879406|FG001|Overall Study|Lack of Efficacy|0|||
161136134|NCT01147926|581879405|FG000|Overall Study|Too busy, no time for study|1|||
161136135|NCT01147926|581879406|FG001|Overall Study|Too busy, no time for study|0|||
161136136|NCT01147926|581879405|FG000|Overall Study|Went on holiday|0|||
161136137|NCT01147926|581879406|FG001|Overall Study|Went on holiday|1|||
161136138|NCT01147926|581879405|FG000|Overall Study|Colonoscopy result|0|||
161136139|NCT01147926|581879406|FG001|Overall Study|Colonoscopy result|1|||
161136140|NCT01085682|581879407|FG000|Overall Study|Withdrawal by Subject|25|||
161136141|NCT01085682|581879408|FG001|Overall Study|Withdrawal by Subject|25|||
161136142|NCT02561156|581879411|FG000|Part 2|Adverse Event|0|||
161136143|NCT02561156|581879412|FG001|Part 2|Adverse Event|0|||
161136144|NCT02561156|581879413|FG002|Part 2|Adverse Event|0|||
161136145|NCT02561156|581879414|FG003|Part 2|Adverse Event|0|||
161136146|NCT02561156|581879415|FG004|Part 2|Adverse Event|0|||
161136147|NCT02561156|581879416|FG005|Part 2|Adverse Event|0|||
161136148|NCT02561156|581879417|FG006|Part 2|Adverse Event|0|||
161136149|NCT02561156|581879418|FG007|Part 2|Adverse Event|0|||
161136150|NCT02561156|581879419|FG008|Part 2|Adverse Event|0|||
161136151|NCT02561156|581879420|FG009|Part 2|Adverse Event|0|||
161136152|NCT02561156|581879421|FG010|Part 2|Adverse Event|0|||
161136153|NCT02561156|581879422|FG011|Part 2|Adverse Event|1|||
161136154|NCT02561156|581879423|FG012|Part 2|Adverse Event|0|||
161136155|NCT02207907|581879424|FG000|Overall Study|Lost to Follow-up|3|||
161136156|NCT02207907|581879425|FG001|Overall Study|Lost to Follow-up|1|||
161136157|NCT02207907|581879424|FG000|Overall Study|Withdrawal by Subject|5|||
161136158|NCT02207907|581879425|FG001|Overall Study|Withdrawal by Subject|6|||
161136159|NCT02207907|581879424|FG000|Overall Study|Did not meet study criteria|3|||
161136160|NCT02207907|581879425|FG001|Overall Study|Did not meet study criteria|0|||
161136161|NCT02207907|581879424|FG000|Overall Study|Pregnancy|0|||
161136162|NCT02207907|581879425|FG001|Overall Study|Pregnancy|1|||
161136163|NCT00158184|581879426|FG000|Overall Study|personal issues|3|||
161136164|NCT00158184|581879427|FG001|Overall Study|personal issues|1|||
161136165|NCT00158184|581879426|FG000|Overall Study|failed for follow unit/study rules|2|||
161136166|NCT00158184|581879427|FG001|Overall Study|failed for follow unit/study rules|0|||
161136167|NCT00158184|581879426|FG000|Overall Study|Adverse Event|1|||
161136168|NCT00158184|581879427|FG001|Overall Study|Adverse Event|1|||
161136169|NCT01025635|581879431|FG000|Overall Study|Withdrawal by Subject|6|||
161136170|NCT01025635|581879432|FG001|Overall Study|Withdrawal by Subject|7|||
161136171|NCT01025635|581879431|FG000|Overall Study|Protocol Violation|4|||
161136172|NCT01025635|581879432|FG001|Overall Study|Protocol Violation|2|||
161136173|NCT01025635|581879431|FG000|Overall Study|Lack of Efficacy|0|||
161136174|NCT01025635|581879432|FG001|Overall Study|Lack of Efficacy|1|||
161136175|NCT01025635|581879431|FG000|Overall Study|Lost to Follow-up|9|||
161136176|NCT01025635|581879432|FG001|Overall Study|Lost to Follow-up|13|||
161136177|NCT01025635|581879431|FG000|Overall Study|Reason not known|4|||
161136178|NCT01025635|581879432|FG001|Overall Study|Reason not known|2|||
161136179|NCT00929240|581879433|FG000|Initial Treatment Phase|Adverse Event|31|||
161136180|NCT00929240|581879434|FG001|Initial Treatment Phase|Adverse Event|0|||
161136181|NCT00929240|581879435|FG002|Initial Treatment Phase|Adverse Event|0|||
161136182|NCT00929240|581879433|FG000|Initial Treatment Phase|Disease progression|41|||
161136183|NCT00929240|581879434|FG001|Initial Treatment Phase|Disease progression|0|||
161136184|NCT00929240|581879435|FG002|Initial Treatment Phase|Disease progression|0|||
161136185|NCT00929240|581879433|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
161136186|NCT00929240|581879434|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
161136187|NCT00929240|581879435|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
161136188|NCT00929240|581879433|FG000|Initial Treatment Phase|Protocol Violation|5|||
160903055|NCT01453361|581037951|FG000|Overall Study|Screen-Failures|10|||
160903056|NCT01752985|581037952|FG000|Treatment Period|Subject request to discontinue treatment|1|||
160903057|NCT01752985|581037953|FG001|Treatment Period|Subject request to discontinue treatment|0|||
160903058|NCT01752985|581037954|FG002|Treatment Period|Subject request to discontinue treatment|1|||
160903059|NCT01752985|581037952|FG000|Treatment Period|Subject no longer meets study criteria|0|||
160903060|NCT01752985|581037953|FG001|Treatment Period|Subject no longer meets study criteria|1|||
160903061|NCT01752985|581037954|FG002|Treatment Period|Subject no longer meets study criteria|1|||
160903062|NCT01752985|581037952|FG000|Treatment Period|Adverse Event|2|||
160903063|NCT01752985|581037953|FG001|Treatment Period|Adverse Event|1|||
160903064|NCT01752985|581037954|FG002|Treatment Period|Adverse Event|2|||
160903065|NCT01752985|581037952|FG000|Treatment Period|Withdrawal by Subject|1|||
160903066|NCT01752985|581037953|FG001|Treatment Period|Withdrawal by Subject|1|||
160903067|NCT01752985|581037954|FG002|Treatment Period|Withdrawal by Subject|0|||
160903068|NCT01752985|581037952|FG000|Treatment Period|Lost to Follow-up|0|||
160903069|NCT01752985|581037953|FG001|Treatment Period|Lost to Follow-up|0|||
160903070|NCT01752985|581037954|FG002|Treatment Period|Lost to Follow-up|1|||
160903071|NCT02025621|581038994|FG000|Overall Study|Withdrawal by Subject|1|||
161246408|NCT05330975|582281712|FG002|Primary|Protocol Violation|0|||
161246409|NCT05330975|582281713|FG003|Primary|Protocol Violation|4|||
161246410|NCT05330975|582281714|FG004|Primary|Protocol Violation|0|||
161246411|NCT05330975|582281715|FG005|Primary|Protocol Violation|3|||
161246412|NCT05330975|582281716|FG006|Primary|Protocol Violation|0|||
161246413|NCT05330975|582281710|FG000|Primary|Death|0|||
161246414|NCT05330975|582281711|FG001|Primary|Death|3|||
161246415|NCT05330975|582281712|FG002|Primary|Death|1|||
161246416|NCT05330975|582281713|FG003|Primary|Death|1|||
161246417|NCT05330975|582281714|FG004|Primary|Death|0|||
161246418|NCT05330975|582281715|FG005|Primary|Death|0|||
161246419|NCT05330975|582281716|FG006|Primary|Death|0|||
161246420|NCT05330975|582281710|FG000|Primary|Other Than Specified|0|||
161246421|NCT05330975|582281711|FG001|Primary|Other Than Specified|1|||
161246422|NCT05330975|582281712|FG002|Primary|Other Than Specified|2|||
161246423|NCT05330975|582281713|FG003|Primary|Other Than Specified|1|||
161246424|NCT05330975|582281714|FG004|Primary|Other Than Specified|2|||
161246425|NCT05330975|582281715|FG005|Primary|Other Than Specified|2|||
161246426|NCT05330975|582281716|FG006|Primary|Other Than Specified|0|||
161246427|NCT05330975|582281710|FG000|Primary|Adverse Event|0|||
161246428|NCT05330975|582281711|FG001|Primary|Adverse Event|0|||
161246429|NCT05330975|582281712|FG002|Primary|Adverse Event|0|||
161246430|NCT05330975|582281713|FG003|Primary|Adverse Event|1|||
161246431|NCT05330975|582281714|FG004|Primary|Adverse Event|0|||
161246432|NCT05330975|582281715|FG005|Primary|Adverse Event|0|||
161246433|NCT05330975|582281716|FG006|Primary|Adverse Event|0|||
161246434|NCT05330975|582281710|FG000|Primary|Physician Decision|0|||
161246435|NCT05330975|582281711|FG001|Primary|Physician Decision|0|||
161246436|NCT05330975|582281712|FG002|Primary|Physician Decision|0|||
161246437|NCT05330975|582281713|FG003|Primary|Physician Decision|0|||
161246438|NCT05330975|582281714|FG004|Primary|Physician Decision|1|||
161246439|NCT05330975|582281715|FG005|Primary|Physician Decision|0|||
161246440|NCT05330975|582281716|FG006|Primary|Physician Decision|0|||
161246441|NCT05330975|582281710|FG000|Revaccination|Adverse Event|0|||
161246442|NCT05330975|582281711|FG001|Revaccination|Adverse Event|0|||
161246443|NCT05330975|582281712|FG002|Revaccination|Adverse Event|0|||
161246444|NCT05330975|582281713|FG003|Revaccination|Adverse Event|0|||
161246445|NCT05330975|582281714|FG004|Revaccination|Adverse Event|0|||
161246446|NCT05330975|582281715|FG005|Revaccination|Adverse Event|0|||
161246447|NCT05330975|582281716|FG006|Revaccination|Adverse Event|3|||
161246448|NCT05330975|582281710|FG000|Revaccination|Lost to Follow-up|0|||
161246449|NCT05330975|582281711|FG001|Revaccination|Lost to Follow-up|0|||
160903072|NCT02025621|581038995|FG001|Overall Study|Withdrawal by Subject|0|||
161246450|NCT05330975|582281712|FG002|Revaccination|Lost to Follow-up|0|||
160903073|NCT02025621|581038994|FG000|Overall Study|Death|0|||
160903074|NCT02025621|581038995|FG001|Overall Study|Death|1|||
160903075|NCT02025621|581038994|FG000|Overall Study|No longer eligible|10|||
160903076|NCT02025621|581038995|FG001|Overall Study|No longer eligible|15|||
160903077|NCT02025621|581038994|FG000|Overall Study|Surgery initiated before infusion|3|||
160903078|NCT02025621|581038995|FG001|Overall Study|Surgery initiated before infusion|3|||
160903079|NCT00739674|581038996|FG000|Overall Study|Screening failures|19|||
161246451|NCT05330975|582281713|FG003|Revaccination|Lost to Follow-up|0|||
161246452|NCT05330975|582281714|FG004|Revaccination|Lost to Follow-up|0|||
161246453|NCT05330975|582281715|FG005|Revaccination|Lost to Follow-up|0|||
161246454|NCT05330975|582281716|FG006|Revaccination|Lost to Follow-up|10|||
161246455|NCT05330975|582281710|FG000|Revaccination|Withdrawal by Subject|0|||
161246456|NCT05330975|582281711|FG001|Revaccination|Withdrawal by Subject|0|||
161246457|NCT05330975|582281712|FG002|Revaccination|Withdrawal by Subject|0|||
161246458|NCT05330975|582281713|FG003|Revaccination|Withdrawal by Subject|0|||
161246459|NCT05330975|582281714|FG004|Revaccination|Withdrawal by Subject|0|||
161246460|NCT05330975|582281715|FG005|Revaccination|Withdrawal by Subject|0|||
161246461|NCT05330975|582281716|FG006|Revaccination|Withdrawal by Subject|2|||
161246462|NCT05330975|582281710|FG000|Revaccination|Death|0|||
161246463|NCT05330975|582281711|FG001|Revaccination|Death|0|||
161246464|NCT05330975|582281712|FG002|Revaccination|Death|0|||
161246465|NCT05330975|582281713|FG003|Revaccination|Death|0|||
161246466|NCT05330975|582281714|FG004|Revaccination|Death|0|||
161246467|NCT05330975|582281715|FG005|Revaccination|Death|0|||
161246468|NCT05330975|582281716|FG006|Revaccination|Death|3|||
161246469|NCT05267106|582281717|FG000|Overall Study|Death|50|||
161246470|NCT05267106|582281718|FG001|Overall Study|Death|2|||
161246471|NCT05267106|582281717|FG000|Overall Study|Study terminated by Sponsor|24|||
161246472|NCT05267106|582281718|FG001|Overall Study|Study terminated by Sponsor|6|||
161246473|NCT05267106|582281717|FG000|Overall Study|Withdrawal by Subject|0|||
161246474|NCT05267106|582281718|FG001|Overall Study|Withdrawal by Subject|1|||
161246475|NCT04165824|582281719|FG000|Overall Study|Adverse Event|23|||
161246476|NCT04165824|582281719|FG000|Overall Study|Physician Decision|1|||
161246477|NCT04165824|582281719|FG000|Overall Study|Withdrawal by Subject|17|||
161246478|NCT04165824|582281719|FG000|Overall Study|Other|5|||
161246479|NCT03036930|582281722|FG000|Overall Study|Lost to Follow-up|7|||
161246480|NCT03036930|582281722|FG000|Overall Study|Withdrawal by Subject|3|||
161246481|NCT03036930|582281722|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
161246482|NCT01513239|582281727|FG000|Period 1: Main Phase|Adverse Event|1|||
161246483|NCT01513239|582281728|FG001|Period 1: Main Phase|Adverse Event|1|||
161246484|NCT01513239|582281729|FG002|Period 1: Main Phase|Adverse Event|2|||
161246485|NCT01513239|582281730|FG003|Period 1: Main Phase|Adverse Event|0|||
161246486|NCT01513239|582281731|FG004|Period 1: Main Phase|Adverse Event|0|||
161246487|NCT01513239|582281732|FG005|Period 1: Main Phase|Adverse Event|0|||
161246488|NCT01513239|582281727|FG000|Period 1: Main Phase|Death|29|||
161246489|NCT01513239|582281728|FG001|Period 1: Main Phase|Death|22|||
161246490|NCT01513239|582281729|FG002|Period 1: Main Phase|Death|32|||
161246491|NCT01513239|582281730|FG003|Period 1: Main Phase|Death|0|||
161246492|NCT01513239|582281731|FG004|Period 1: Main Phase|Death|0|||
161246493|NCT01513239|582281732|FG005|Period 1: Main Phase|Death|0|||
161246494|NCT01513239|582281727|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
161246495|NCT01513239|582281728|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
161246496|NCT01513239|582281729|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
161246497|NCT01513239|582281730|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
161246498|NCT01513239|582281731|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
161246499|NCT01513239|582281732|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
161246500|NCT01513239|582281727|FG000|Period 1: Main Phase|Physician Decision|4|||
161246501|NCT01513239|582281728|FG001|Period 1: Main Phase|Physician Decision|4|||
161246502|NCT01513239|582281729|FG002|Period 1: Main Phase|Physician Decision|4|||
161246503|NCT01513239|582281730|FG003|Period 1: Main Phase|Physician Decision|0|||
161246504|NCT01513239|582281731|FG004|Period 1: Main Phase|Physician Decision|0|||
161246505|NCT01513239|582281732|FG005|Period 1: Main Phase|Physician Decision|0|||
161246506|NCT01513239|582281727|FG000|Period 1: Main Phase|Protocol Violation|2|||
161246507|NCT01513239|582281728|FG001|Period 1: Main Phase|Protocol Violation|2|||
161246508|NCT01513239|582281729|FG002|Period 1: Main Phase|Protocol Violation|2|||
161246509|NCT01513239|582281730|FG003|Period 1: Main Phase|Protocol Violation|0|||
161246510|NCT01513239|582281731|FG004|Period 1: Main Phase|Protocol Violation|0|||
161246511|NCT01513239|582281732|FG005|Period 1: Main Phase|Protocol Violation|0|||
161246512|NCT01513239|582281727|FG000|Period 1: Main Phase|Technical Problems|1|||
161246513|NCT01513239|582281728|FG001|Period 1: Main Phase|Technical Problems|2|||
161246514|NCT01513239|582281729|FG002|Period 1: Main Phase|Technical Problems|0|||
161246515|NCT01513239|582281730|FG003|Period 1: Main Phase|Technical Problems|0|||
161246516|NCT01513239|582281731|FG004|Period 1: Main Phase|Technical Problems|0|||
161246517|NCT01513239|582281732|FG005|Period 1: Main Phase|Technical Problems|0|||
161246518|NCT01513239|582281727|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
161246519|NCT01513239|582281728|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
161246520|NCT01513239|582281729|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
161246521|NCT01513239|582281730|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
161246522|NCT01513239|582281731|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
161246523|NCT01513239|582281732|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
160828795|NCT02741570|580759870|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161246524|NCT01513239|582281727|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161246525|NCT01513239|582281728|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
160828796|NCT02741570|580759871|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
161246526|NCT01513239|582281729|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
161246527|NCT01513239|582281730|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
161246528|NCT01513239|582281731|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
161246529|NCT01513239|582281732|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
161246530|NCT01513239|582281727|FG000|Period 2: 9 Month Extension Phase|Death|0|||
161246531|NCT01513239|582281728|FG001|Period 2: 9 Month Extension Phase|Death|0|||
161246532|NCT01513239|582281729|FG002|Period 2: 9 Month Extension Phase|Death|0|||
161246533|NCT01513239|582281730|FG003|Period 2: 9 Month Extension Phase|Death|2|||
161246534|NCT01513239|582281731|FG004|Period 2: 9 Month Extension Phase|Death|5|||
161246535|NCT01513239|582281732|FG005|Period 2: 9 Month Extension Phase|Death|2|||
161246536|NCT01513239|582281727|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161246537|NCT01513239|582281728|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161246538|NCT01513239|582281729|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161246539|NCT01513239|582281730|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
161246540|NCT01513239|582281731|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
161246541|NCT01513239|582281732|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
161246542|NCT01513239|582281727|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161246543|NCT01513239|582281728|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161246544|NCT01513239|582281729|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161246545|NCT01513239|582281730|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
161246546|NCT01513239|582281731|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161246547|NCT01513239|582281732|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
161246548|NCT01513239|582281727|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161246549|NCT01513239|582281728|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161246550|NCT01513239|582281729|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161246551|NCT01513239|582281730|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
161246552|NCT01513239|582281731|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
161246553|NCT01513239|582281732|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
161246554|NCT00396162|582281733|FG000|Overall Study|Withdrawal by Subject|2|||
161246555|NCT00396162|582281734|FG001|Overall Study|Withdrawal by Subject|3|||
161246556|NCT02694536|582281735|FG000|Overall Study|Progressive Disease|40|||
161246557|NCT02694536|582281735|FG000|Overall Study|Lost to Follow-up|1|||
161246558|NCT02694536|582281735|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
161246559|NCT02694536|582281735|FG000|Overall Study|Withdrawal by Subject|8|||
161246560|NCT02694536|582281735|FG000|Overall Study|Death|8|||
161246561|NCT02694536|582281735|FG000|Overall Study|Other|22|||
161246562|NCT01911429|582281736|FG000|Overall Study|Adverse Event|5|||
161246563|NCT01911429|582281737|FG001|Overall Study|Adverse Event|3|||
161246564|NCT01911429|582281738|FG002|Overall Study|Adverse Event|9|||
161246565|NCT01911429|582281736|FG000|Overall Study|Lack of Efficacy|1|||
161246566|NCT01911429|582281737|FG001|Overall Study|Lack of Efficacy|2|||
161246567|NCT01911429|582281738|FG002|Overall Study|Lack of Efficacy|4|||
161246568|NCT01911429|582281736|FG000|Overall Study|Lost to Follow-up|0|||
161246569|NCT01911429|582281737|FG001|Overall Study|Lost to Follow-up|0|||
161246570|NCT01911429|582281738|FG002|Overall Study|Lost to Follow-up|1|||
161246571|NCT01911429|582281736|FG000|Overall Study|Protocol Violation|0|||
161246572|NCT01911429|582281737|FG001|Overall Study|Protocol Violation|0|||
161246573|NCT01911429|582281738|FG002|Overall Study|Protocol Violation|1|||
161246574|NCT01911429|582281736|FG000|Overall Study|Withdrawal by Subject|5|||
161246575|NCT01911429|582281737|FG001|Overall Study|Withdrawal by Subject|5|||
161246576|NCT01911429|582281738|FG002|Overall Study|Withdrawal by Subject|4|||
161246577|NCT01911429|582281736|FG000|Overall Study|Accidental randomization|0|||
161246578|NCT01911429|582281737|FG001|Overall Study|Accidental randomization|0|||
161246579|NCT01911429|582281738|FG002|Overall Study|Accidental randomization|1|||
161246580|NCT01911429|582281736|FG000|Overall Study|subject left study|1|||
161246581|NCT01911429|582281737|FG001|Overall Study|subject left study|0|||
161246582|NCT01911429|582281738|FG002|Overall Study|subject left study|0|||
161246583|NCT04569032|582281740|FG000|Overall Study|Death|10|||
161246584|NCT04569032|582281741|FG001|Overall Study|Death|13|||
161246585|NCT04569032|582281740|FG000|Overall Study|Withdrawal by Subject|2|||
161246586|NCT04569032|582281741|FG001|Overall Study|Withdrawal by Subject|0|||
161246587|NCT04569032|582281740|FG000|Overall Study|Lost to Follow-up|0|||
161246588|NCT04569032|582281741|FG001|Overall Study|Lost to Follow-up|1|||
161246589|NCT04569032|582281740|FG000|Overall Study|In long term follow up|22|||
161246590|NCT04569032|582281741|FG001|Overall Study|In long term follow up|34|||
161246591|NCT03599362|582281747|FG000|Overall Study|Screen Failure|3|||
161246592|NCT03707587|582281748|FG000|Overall Study|Death|0|||
161246593|NCT03707587|582281749|FG001|Overall Study|Death|1|||
161246594|NCT01634139|582281751|FG000|Overall Study|Non compliant with protocol|1|||
161246595|NCT01634139|582281752|FG001|Overall Study|Non compliant with protocol|0|||
161246596|NCT01634139|582281753|FG002|Overall Study|Non compliant with protocol|0|||
161246597|NCT01634139|582281751|FG000|Overall Study|Consent withdrawn not due to AE|4|||
161246598|NCT01634139|582281752|FG001|Overall Study|Consent withdrawn not due to AE|3|||
161246599|NCT01634139|582281753|FG002|Overall Study|Consent withdrawn not due to AE|2|||
161246600|NCT01634139|582281751|FG000|Overall Study|Other|4|||
161246601|NCT01634139|582281752|FG001|Overall Study|Other|0|||
161246602|NCT01634139|582281753|FG002|Overall Study|Other|3|||
161246603|NCT01634139|582281751|FG000|Overall Study|Lost to Follow-up|0|||
161246604|NCT01634139|582281752|FG001|Overall Study|Lost to Follow-up|2|||
161246605|NCT01634139|582281753|FG002|Overall Study|Lost to Follow-up|0|||
161246606|NCT01634139|582281751|FG000|Overall Study|Not treated|1|||
161246607|NCT01634139|582281752|FG001|Overall Study|Not treated|1|||
161246608|NCT01634139|582281753|FG002|Overall Study|Not treated|0|||
161246609|NCT01168856|582281761|FG000|Overall Study|Lost to Follow-up|4|||
161246610|NCT01168856|582281762|FG001|Overall Study|Lost to Follow-up|34|||
161246611|NCT01168856|582281761|FG000|Overall Study|Withdrawal by Subject|6|||
160903080|NCT00739674|581038997|FG001|Overall Study|Screening failures|17|||
160903081|NCT00739674|581038996|FG000|Overall Study|Site 212 removal|19|||
160903082|NCT00739674|581038997|FG001|Overall Study|Site 212 removal|13|||
160903083|NCT00739674|581038996|FG000|Overall Study|No follow-up data|33|||
160903084|NCT00739674|581038997|FG001|Overall Study|No follow-up data|18|||
160903085|NCT00739674|581038996|FG000|Overall Study|Dietician consultation >30 days|1|||
160903086|NCT00739674|581038997|FG001|Overall Study|Dietician consultation >30 days|9|||
160903087|NCT00739674|581038996|FG000|Overall Study|Adverse Event|22|||
160903088|NCT00739674|581038997|FG001|Overall Study|Adverse Event|13|||
160903089|NCT00739674|581038996|FG000|Overall Study|Death|1|||
160903090|NCT00739674|581038997|FG001|Overall Study|Death|0|||
160903091|NCT00739674|581038996|FG000|Overall Study|Lack of Efficacy|1|||
160903092|NCT00739674|581038997|FG001|Overall Study|Lack of Efficacy|0|||
160903093|NCT00739674|581038996|FG000|Overall Study|Lost to Follow-up|52|||
160903094|NCT00739674|581038997|FG001|Overall Study|Lost to Follow-up|30|||
160903095|NCT00739674|581038996|FG000|Overall Study|Protocol Violation|5|||
160903096|NCT00739674|581038997|FG001|Overall Study|Protocol Violation|5|||
160828797|NCT02741570|580759870|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
160828798|NCT02741570|580759871|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
160828799|NCT02741570|580759870|FG000|Pre-Treatment Period|Death|0|||
160828800|NCT02741570|580759871|FG001|Pre-Treatment Period|Death|1|||
160828801|NCT02741570|580759870|FG000|Pre-Treatment Period|Disease progression|0|||
160828802|NCT02741570|580759871|FG001|Pre-Treatment Period|Disease progression|1|||
160828803|NCT02741570|580759870|FG000|Treatment Period|Other reasons|47|||
160828804|NCT02741570|580759871|FG001|Treatment Period|Other reasons|12|||
160828805|NCT02741570|580759870|FG000|Treatment Period|Poor/non-compliance|0|||
160828806|NCT02741570|580759871|FG001|Treatment Period|Poor/non-compliance|2|||
160828807|NCT02741570|580759870|FG000|Treatment Period|Maximum clinical benefit|4|||
160828808|NCT02741570|580759871|FG001|Treatment Period|Maximum clinical benefit|6|||
160828809|NCT02741570|580759870|FG000|Treatment Period|Lost to Follow-up|1|||
160828810|NCT02741570|580759871|FG001|Treatment Period|Lost to Follow-up|3|||
160828811|NCT02741570|580759870|FG000|Treatment Period|Participant withdrew consent|9|||
160828812|NCT02741570|580759871|FG001|Treatment Period|Participant withdrew consent|13|||
160828813|NCT02741570|580759870|FG000|Treatment Period|Participant request to discontinue treatment|8|||
160828814|NCT02741570|580759871|FG001|Treatment Period|Participant request to discontinue treatment|23|||
160828815|NCT02741570|580759870|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
160828816|NCT02741570|580759871|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
160828817|NCT02741570|580759870|FG000|Treatment Period|Death|9|||
160828818|NCT02741570|580759871|FG001|Treatment Period|Death|7|||
160828819|NCT02741570|580759870|FG000|Treatment Period|Study drug toxicity|55|||
160828820|NCT02741570|580759871|FG001|Treatment Period|Study drug toxicity|47|||
160828821|NCT02741570|580759870|FG000|Treatment Period|Disease progression|294|||
160828822|NCT02741570|580759871|FG001|Treatment Period|Disease progression|301|||
160828823|NCT02741570|580759870|FG000|Treatment Period|Administrative reason by sponsor|0|||
160828824|NCT02741570|580759871|FG001|Treatment Period|Administrative reason by sponsor|1|||
160828825|NCT01100567|580759872|FG000|Overall Study|Withdrawal by Subject|5|||
160828826|NCT01100567|580759873|FG001|Overall Study|Withdrawal by Subject|8|||
160828827|NCT01100567|580759872|FG000|Overall Study|Early Hospital Discharge|6|||
160828828|NCT01100567|580759873|FG001|Overall Study|Early Hospital Discharge|4|||
160828829|NCT01100567|580759872|FG000|Overall Study|Lost to Follow-up|1|||
160828830|NCT01100567|580759873|FG001|Overall Study|Lost to Follow-up|2|||
160828831|NCT01100567|580759872|FG000|Overall Study|Physician Decision|0|||
160828832|NCT01100567|580759873|FG001|Overall Study|Physician Decision|1|||
160828833|NCT01100567|580759872|FG000|Overall Study|Deemed ineligible after consent|0|||
160903097|NCT00739674|581038996|FG000|Overall Study|Withdrawal by Subject|9|||
160903098|NCT00739674|581038997|FG001|Overall Study|Withdrawal by Subject|9|||
160903099|NCT00739674|581038996|FG000|Overall Study|Reason missing|2|||
160903100|NCT00739674|581038997|FG001|Overall Study|Reason missing|0|||
161136189|NCT00929240|581879434|FG001|Initial Treatment Phase|Protocol Violation|0|||
161136190|NCT00929240|581879435|FG002|Initial Treatment Phase|Protocol Violation|0|||
160828834|NCT01100567|580759873|FG001|Overall Study|Deemed ineligible after consent|1|||
160828835|NCT01498185|580759874|FG000|Overall Study|Adverse Event|0|||
160828836|NCT01498185|580759875|FG001|Overall Study|Adverse Event|0|||
160903101|NCT00739674|581038996|FG000|Overall Study|Clinic closed|6|||
161136191|NCT00929240|581879433|FG000|Initial Treatment Phase|Death|2|||
160828837|NCT01498185|580759876|FG002|Overall Study|Adverse Event|0|||
160828838|NCT01498185|580759877|FG003|Overall Study|Adverse Event|1|||
160828839|NCT01498185|580759878|FG004|Overall Study|Adverse Event|0|||
160903102|NCT00739674|581038997|FG001|Overall Study|Clinic closed|4|||
160903103|NCT00739674|581038996|FG000|Overall Study|Patient moved|3|||
160903104|NCT00739674|581038997|FG001|Overall Study|Patient moved|2|||
160903105|NCT00739674|581038996|FG000|Overall Study|Non compliant|4|||
160903106|NCT00739674|581038997|FG001|Overall Study|Non compliant|0|||
160903107|NCT00739674|581038996|FG000|Overall Study|Unable to attend visit|3|||
160990842|NCT00941031|581353975|FG004|Induction Period|Lack of Efficacy|0|||
161136192|NCT00929240|581879434|FG001|Initial Treatment Phase|Death|0|||
161136193|NCT00929240|581879435|FG002|Initial Treatment Phase|Death|0|||
160828840|NCT01498185|580759874|FG000|Overall Study|Withdrawal by Subject|1|||
160828841|NCT01498185|580759875|FG001|Overall Study|Withdrawal by Subject|1|||
160828842|NCT01498185|580759876|FG002|Overall Study|Withdrawal by Subject|0|||
160828843|NCT01498185|580759877|FG003|Overall Study|Withdrawal by Subject|2|||
160828844|NCT01498185|580759878|FG004|Overall Study|Withdrawal by Subject|1|||
160828845|NCT01498185|580759874|FG000|Overall Study|No longer met criteria, etc|0|||
160828846|NCT01498185|580759875|FG001|Overall Study|No longer met criteria, etc|0|||
160828847|NCT01498185|580759876|FG002|Overall Study|No longer met criteria, etc|0|||
160828848|NCT01498185|580759877|FG003|Overall Study|No longer met criteria, etc|0|||
160828849|NCT01498185|580759878|FG004|Overall Study|No longer met criteria, etc|2|||
160828850|NCT00946322|580759879|FG000|Pre-treatment|participant failure to follow up|1|||
160828851|NCT00946322|580759879|FG000|Post-treatment|participant failure to follow up|2|||
160828852|NCT01453946|580759880|FG000|Overall Study|Did not receive drug for the taper phase|1|||
160828853|NCT01453946|580759880|FG000|Overall Study|Protocol Violation|2|||
160828854|NCT01453946|580759880|FG000|Overall Study|Lack of Efficacy|3|||
160828855|NCT01453946|580759880|FG000|Overall Study|Adverse Event|3|||
160828856|NCT00846040|580759881|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
160828857|NCT00846040|580759882|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
160828858|NCT00846040|580759883|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
160828859|NCT00846040|580759881|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
160828860|NCT00846040|580759882|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
160828861|NCT00846040|580759883|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
160828862|NCT03352453|580759885|FG000|Overall Study|Miscellaneous Reasons|1|||
160828863|NCT03352453|580759886|FG001|Overall Study|Miscellaneous Reasons|2|||
160828864|NCT03352453|580759885|FG000|Overall Study|Lack of Efficacy|1|||
160828865|NCT03352453|580759886|FG001|Overall Study|Lack of Efficacy|0|||
160828866|NCT03352453|580759885|FG000|Overall Study|Withdrawal by Subject|8|||
160828867|NCT03352453|580759886|FG001|Overall Study|Withdrawal by Subject|14|||
160828868|NCT03352453|580759885|FG000|Overall Study|Study Terminated by Sponsor|2|||
160828869|NCT03352453|580759886|FG001|Overall Study|Study Terminated by Sponsor|1|||
160828870|NCT03352453|580759885|FG000|Overall Study|Protocol Deviation|1|||
160828871|NCT03352453|580759886|FG001|Overall Study|Protocol Deviation|0|||
160828872|NCT03352453|580759885|FG000|Overall Study|Lost to Follow-up|7|||
160828873|NCT03352453|580759886|FG001|Overall Study|Lost to Follow-up|6|||
160828874|NCT03352453|580759885|FG000|Overall Study|Adverse Event|2|||
160828875|NCT03352453|580759886|FG001|Overall Study|Adverse Event|9|||
160828876|NCT02827500|580759889|FG000|Overall Study|Death|7|||
160828877|NCT02827500|580759890|FG001|Overall Study|Death|3|||
160828878|NCT02827500|580759889|FG000|Overall Study|Lost to Follow-up|1|||
160828879|NCT02827500|580759890|FG001|Overall Study|Lost to Follow-up|1|||
160828880|NCT02827500|580759889|FG000|Overall Study|Withdrawal by Subject|3|||
160828881|NCT02827500|580759890|FG001|Overall Study|Withdrawal by Subject|1|||
160828882|NCT02827500|580759889|FG000|Overall Study|Missing primary endpoint data|3|||
160828883|NCT02827500|580759890|FG001|Overall Study|Missing primary endpoint data|1|||
160828884|NCT02827500|580759889|FG000|Overall Study|Other|5|||
160828885|NCT02827500|580759890|FG001|Overall Study|Other|1|||
160828886|NCT01241760|580759893|FG000|Overall Study|Adverse Event|1|||
160828887|NCT01241760|580759894|FG001|Overall Study|Adverse Event|0|||
160828888|NCT01241760|580759893|FG000|Overall Study|Lost to Follow-up|18|||
160903108|NCT00739674|581038997|FG001|Overall Study|Unable to attend visit|1|||
160903109|NCT00739674|581038996|FG000|Overall Study|Home monitoring off meds|1|||
160903110|NCT00739674|581038997|FG001|Overall Study|Home monitoring off meds|0|||
160903111|NCT00739674|581038996|FG000|Overall Study|Erectile dysfunction|0|||
160903112|NCT00739674|581038997|FG001|Overall Study|Erectile dysfunction|1|||
160903113|NCT01897454|581038999|FG000|Overall Study|Withdrawal by Subject|1|||
160903114|NCT02195583|581039003|FG000|Overall Study|Lost to Follow-up|1|||
161246612|NCT01168856|582281762|FG001|Overall Study|Withdrawal by Subject|8|||
161246613|NCT01168856|582281761|FG000|Overall Study|Physician Decision|2|||
161246614|NCT01168856|582281762|FG001|Overall Study|Physician Decision|1|||
161246615|NCT01168856|582281761|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
161246616|NCT01168856|582281762|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
161246617|NCT01168856|582281761|FG000|Overall Study|Participant received anti-HCV treatment|1|||
161246618|NCT01168856|582281762|FG001|Overall Study|Participant received anti-HCV treatment|0|||
161246619|NCT01168856|582281761|FG000|Overall Study|Death|0|||
160828889|NCT01241760|580759894|FG001|Overall Study|Lost to Follow-up|22|||
160828890|NCT01241760|580759893|FG000|Overall Study|Withdrawal by Subject|13|||
160828891|NCT01241760|580759894|FG001|Overall Study|Withdrawal by Subject|13|||
160828892|NCT01241760|580759893|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
160828893|NCT01241760|580759894|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
160828894|NCT01241760|580759893|FG000|Overall Study|Other|1|||
160828895|NCT01241760|580759894|FG001|Overall Study|Other|1|||
160828896|NCT00514020|580759895|FG000|Overall Study|Adverse Event|6|||
160828897|NCT00514020|580759895|FG000|Overall Study|Withdrawal by Subject|3|||
160828898|NCT00514020|580759895|FG000|Overall Study|Physician Decision|1|||
160828899|NCT00514020|580759895|FG000|Overall Study|disease progression|9|||
160903115|NCT02195583|581039003|FG000|Overall Study|Withdrawal by Subject|4|||
160828900|NCT00514020|580759895|FG000|Overall Study|other complicating disease|2|||
160828901|NCT00514020|580759895|FG000|Overall Study|patient went to radiation treatment|1|||
160828902|NCT00514020|580759895|FG000|Overall Study|"patients moved to the no tx group"|6|||
160828903|NCT01636713|580759900|FG000|Overall Study|Adverse Event|16|||
160828904|NCT01636713|580759901|FG001|Overall Study|Adverse Event|16|||
160828905|NCT01636713|580759902|FG002|Overall Study|Adverse Event|7|||
160828906|NCT01636713|580759900|FG000|Overall Study|Lack of Efficacy|6|||
160828907|NCT01636713|580759901|FG001|Overall Study|Lack of Efficacy|6|||
160828908|NCT01636713|580759902|FG002|Overall Study|Lack of Efficacy|2|||
160828909|NCT01636713|580759900|FG000|Overall Study|Protocol Violation|3|||
160828910|NCT01636713|580759901|FG001|Overall Study|Protocol Violation|0|||
160828911|NCT01636713|580759902|FG002|Overall Study|Protocol Violation|1|||
160828912|NCT01636713|580759900|FG000|Overall Study|Lost to Follow-up|0|||
160828913|NCT01636713|580759901|FG001|Overall Study|Lost to Follow-up|0|||
160828914|NCT01636713|580759902|FG002|Overall Study|Lost to Follow-up|1|||
160828915|NCT01636713|580759900|FG000|Overall Study|Withdrawal by Subject|5|||
160828916|NCT01636713|580759901|FG001|Overall Study|Withdrawal by Subject|4|||
160828917|NCT01636713|580759902|FG002|Overall Study|Withdrawal by Subject|8|||
160828918|NCT01636713|580759900|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160828919|NCT01636713|580759901|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
160828920|NCT01636713|580759902|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
160828921|NCT03697993|580759907|FG000|Overall Study|Became Ineligible after Enrollment|1|||
160828922|NCT03697993|580759908|FG001|Overall Study|Became Ineligible after Enrollment|3|||
160828923|NCT03697993|580759907|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
160828924|NCT03697993|580759908|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
160828925|NCT03697993|580759907|FG000|Overall Study|Lost to Follow-up|3|||
160828926|NCT03697993|580759908|FG001|Overall Study|Lost to Follow-up|0|||
160828927|NCT03697993|580759907|FG000|Overall Study|Physician Decision|4|||
160828928|NCT03697993|580759908|FG001|Overall Study|Physician Decision|0|||
160828929|NCT03697993|580759907|FG000|Overall Study|Initial Urine Culture Negative|0|||
160828930|NCT03697993|580759908|FG001|Overall Study|Initial Urine Culture Negative|1|||
160828931|NCT04384107|580759909|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
160828932|NCT04384107|580759910|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
160828933|NCT04384107|580759909|FG000|Overall Study|Lost to Follow-up|1|||
160828934|NCT04384107|580759910|FG001|Overall Study|Lost to Follow-up|0|||
160828935|NCT00276614|580759913|FG000|Overall Study|Progression of disease under study|3|||
160828936|NCT01048866|580759918|FG000|Overall Study|Adverse Event|1|||
160828937|NCT01048866|580759919|FG001|Overall Study|Adverse Event|0|||
160828938|NCT01048866|580759918|FG000|Overall Study|Protocol Violation|1|||
160828939|NCT01048866|580759919|FG001|Overall Study|Protocol Violation|0|||
160828940|NCT01048866|580759918|FG000|Overall Study|Physician Decision|1|||
160828941|NCT01048866|580759919|FG001|Overall Study|Physician Decision|0|||
160828942|NCT01048866|580759918|FG000|Overall Study|Withdrawal by Subject|0|||
160828943|NCT01048866|580759919|FG001|Overall Study|Withdrawal by Subject|2|||
160828944|NCT01048866|580759918|FG000|Overall Study|Lost to Follow-up|0|||
160828945|NCT01048866|580759919|FG001|Overall Study|Lost to Follow-up|2|||
160828946|NCT01048866|580759918|FG000|Overall Study|Other|1|||
160828947|NCT01048866|580759919|FG001|Overall Study|Other|1|||
160828948|NCT03582813|580759920|FG000|Overall Study|Lost to Follow-up|18|||
160828949|NCT03582813|580759921|FG001|Overall Study|Lost to Follow-up|21|||
160828950|NCT03582813|580759920|FG000|Overall Study|Withdrawal by Subject|1|||
160828951|NCT03582813|580759921|FG001|Overall Study|Withdrawal by Subject|0|||
160828952|NCT02525094|580759926|FG000|Overall Study|Lost to Follow-up|2|||
160828953|NCT02525094|580759927|FG001|Overall Study|Lost to Follow-up|1|||
160828954|NCT02525094|580759926|FG000|Overall Study|Withdrawal by Subject|5|||
160828955|NCT02525094|580759927|FG001|Overall Study|Withdrawal by Subject|6|||
160828956|NCT02525094|580759926|FG000|Overall Study|Not Treated|1|||
160828957|NCT02525094|580759927|FG001|Overall Study|Not Treated|1|||
160828958|NCT01591863|580759928|FG000|Overall Study|Adverse Event|3|||
160828959|NCT01591863|580759928|FG000|Overall Study|Withdrawal by Subject|1|||
160828960|NCT01591863|580759928|FG000|Overall Study|recurrence|9|||
160828961|NCT01591863|580759928|FG000|Overall Study|Lack of Efficacy|1|||
160828962|NCT01751776|580759931|FG000|Overall Study|Adverse Event|0|||
160828963|NCT01751776|580759932|FG001|Overall Study|Adverse Event|0|||
160828964|NCT01751776|580759933|FG002|Overall Study|Adverse Event|0|||
160828965|NCT01751776|580759934|FG003|Overall Study|Adverse Event|0|||
160828966|NCT01751776|580759935|FG004|Overall Study|Adverse Event|0|||
160828967|NCT01751776|580759936|FG005|Overall Study|Adverse Event|0|||
160828968|NCT01751776|580759937|FG006|Overall Study|Adverse Event|4|||
160828969|NCT01751776|580759938|FG007|Overall Study|Adverse Event|2|||
160828970|NCT01751776|580759931|FG000|Overall Study|Consent withdrawn|0|||
160828971|NCT01751776|580759932|FG001|Overall Study|Consent withdrawn|0|||
160828972|NCT01751776|580759933|FG002|Overall Study|Consent withdrawn|0|||
160828973|NCT01751776|580759934|FG003|Overall Study|Consent withdrawn|0|||
160828974|NCT01751776|580759935|FG004|Overall Study|Consent withdrawn|0|||
160828975|NCT01751776|580759936|FG005|Overall Study|Consent withdrawn|0|||
160828976|NCT01751776|580759937|FG006|Overall Study|Consent withdrawn|0|||
160828977|NCT01751776|580759938|FG007|Overall Study|Consent withdrawn|1|||
160828978|NCT01751776|580759931|FG000|Overall Study|Other reason not specified above|0|||
160828979|NCT01751776|580759932|FG001|Overall Study|Other reason not specified above|0|||
160828980|NCT01751776|580759933|FG002|Overall Study|Other reason not specified above|0|||
160828981|NCT01751776|580759934|FG003|Overall Study|Other reason not specified above|0|||
160828982|NCT01751776|580759935|FG004|Overall Study|Other reason not specified above|0|||
160828983|NCT01751776|580759936|FG005|Overall Study|Other reason not specified above|0|||
160828984|NCT01751776|580759937|FG006|Overall Study|Other reason not specified above|0|||
160828985|NCT01751776|580759938|FG007|Overall Study|Other reason not specified above|1|||
160828986|NCT00160654|580759939|FG000|Overall Study|Adverse Event|14|||
160828987|NCT00160654|580759939|FG000|Overall Study|Lack of Efficacy|4|||
160828988|NCT00160654|580759939|FG000|Overall Study|Lost to Follow-up|2|||
160828989|NCT00160654|580759939|FG000|Overall Study|Intake of expired drug|7|||
160828990|NCT00160654|580759939|FG000|Overall Study|Psychological trauma|1|||
160828991|NCT00160654|580759939|FG000|Overall Study|Sponsor decision|1|||
160828992|NCT00160654|580759939|FG000|Overall Study|Patient met exclusion criteria|1|||
160828993|NCT00160654|580759939|FG000|Overall Study|Patient decision|1|||
160828994|NCT00160654|580759939|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
160828995|NCT00160654|580759939|FG000|Overall Study|Met exclusion criteria|1|||
160828996|NCT00831701|580759940|FG000|Overall Study|Withdrawal by Subject|2|||
160828997|NCT00831701|580759941|FG001|Overall Study|Withdrawal by Subject|0|||
160828998|NCT00831701|580759940|FG000|Overall Study|Stone expulsion before first medication|2|||
160828999|NCT00831701|580759941|FG001|Overall Study|Stone expulsion before first medication|2|||
160829000|NCT00831701|580759940|FG000|Overall Study|Lost to Follow-up|1|||
160829001|NCT00831701|580759941|FG001|Overall Study|Lost to Follow-up|3|||
160829002|NCT02366767|580759942|FG000|Overall Study|left for home after 1 day at camp|1|||
160829003|NCT02366767|580759943|FG001|Overall Study|left for home after 1 day at camp|0|||
160829004|NCT02117349|580759944|FG000|Overall Study|Withdrawal by Subject|1|||
160829005|NCT02117349|580759945|FG001|Overall Study|Withdrawal by Subject|0|||
160829006|NCT02117349|580759944|FG000|Overall Study|Lost to Follow-up|1|||
160829007|NCT02117349|580759945|FG001|Overall Study|Lost to Follow-up|1|||
160829008|NCT02117349|580759944|FG000|Overall Study|Death|1|||
160829009|NCT02117349|580759945|FG001|Overall Study|Death|0|||
160829010|NCT00546260|580759948|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
160829011|NCT00546260|580759949|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
160829012|NCT03780959|580759950|FG000|Part 1|Adverse Event|1|||
160829013|NCT03780959|580759951|FG001|Part 1|Adverse Event|0|||
160829014|NCT03780959|580759952|FG002|Part 1|Adverse Event|0|||
160829015|NCT03780959|580759950|FG000|Part 1|Withdrawal by Subject|1|||
160829016|NCT03780959|580759951|FG001|Part 1|Withdrawal by Subject|0|||
160829017|NCT03780959|580759952|FG002|Part 1|Withdrawal by Subject|0|||
160829018|NCT03780959|580759950|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
160990843|NCT00941031|581353976|FG005|Induction Period|Lack of Efficacy|0|||
160990844|NCT00941031|581353977|FG006|Induction Period|Lack of Efficacy|0|||
161246620|NCT01168856|582281762|FG001|Overall Study|Death|2|||
161246621|NCT01168856|582281761|FG000|Overall Study|Other|1|||
161246622|NCT01168856|582281762|FG001|Overall Study|Other|291|||
161246623|NCT01168856|582281761|FG000|Overall Study|Protocol Violation|4|||
161246624|NCT01168856|582281762|FG001|Overall Study|Protocol Violation|6|||
161246625|NCT04442503|582281763|FG000|Overall Study|Adverse Event|1|||
161246626|NCT04442503|582281764|FG001|Overall Study|Adverse Event|1|||
161246627|NCT04442503|582281763|FG000|Overall Study|Lost to Follow-up|8|||
161246628|NCT04442503|582281764|FG001|Overall Study|Lost to Follow-up|6|||
161246629|NCT04442503|582281763|FG000|Overall Study|Physician Decision|0|||
161246630|NCT04442503|582281764|FG001|Overall Study|Physician Decision|2|||
161246631|NCT04442503|582281763|FG000|Overall Study|Withdrawal by Subject|3|||
161246632|NCT04442503|582281764|FG001|Overall Study|Withdrawal by Subject|4|||
161246633|NCT04442503|582281763|FG000|Overall Study|Reason not Specified|0|||
161246634|NCT04442503|582281764|FG001|Overall Study|Reason not Specified|1|||
161246635|NCT04442503|582281763|FG000|Overall Study|Randomized but not Treated|3|||
161246636|NCT04442503|582281764|FG001|Overall Study|Randomized but not Treated|1|||
161246637|NCT05562011|582281771|FG000|Overall Study|Withdrawal by Subject|3|||
161246638|NCT05562011|582281771|FG000|Overall Study|Lost to Follow-up|1|||
161246639|NCT05562011|582281771|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
161246640|NCT05562011|582281771|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
161246641|NCT05562011|582281771|FG000|Overall Study|Device malfunction|13|||
161246642|NCT00387153|582281772|FG000|Overall Study|Adverse Event|1|||
161246643|NCT00387153|582281772|FG000|Overall Study|Disease Progression|3|||
161246644|NCT00387153|582281772|FG000|Overall Study|Lack of Response|4|||
161246645|NCT04411680|582281773|FG000|Treatment Period|Adverse Event|3|||
160829019|NCT03780959|580759951|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
160829020|NCT03780959|580759952|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
160829021|NCT03780959|580759950|FG000|Part 1|Response Status|2|||
160829022|NCT03780959|580759951|FG001|Part 1|Response Status|0|||
160829023|NCT03780959|580759952|FG002|Part 1|Response Status|0|||
160829024|NCT03780959|580759950|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
160829025|NCT03780959|580759951|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
160829026|NCT03780959|580759952|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
160829027|NCT03780959|580759950|FG000|Part 2|Response Status|0|||
160829028|NCT03780959|580759951|FG001|Part 2|Response Status|18|||
160829029|NCT03780959|580759952|FG002|Part 2|Response Status|6|||
160829030|NCT03172130|580761549|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
160829031|NCT03172130|580761550|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
160829032|NCT01825941|580761554|FG000|Overall Study|Lost to Follow-up|4|||
160829033|NCT01825941|580761555|FG001|Overall Study|Lost to Follow-up|1|||
160829034|NCT00528996|580761556|FG000|Overall Study|Other reasons than listing|6|||
160829035|NCT00528996|580761557|FG001|Overall Study|Other reasons than listing|7|||
160829036|NCT00528996|580761558|FG002|Overall Study|Other reasons than listing|14|||
160829037|NCT00528996|580761559|FG003|Overall Study|Other reasons than listing|11|||
160829038|NCT00528996|580761560|FG004|Overall Study|Other reasons than listing|5|||
160829039|NCT00528996|580761556|FG000|Overall Study|Refused continue medication|16|||
160829040|NCT00528996|580761557|FG001|Overall Study|Refused continue medication|0|||
160829041|NCT00528996|580761558|FG002|Overall Study|Refused continue medication|3|||
160829042|NCT00528996|580761559|FG003|Overall Study|Refused continue medication|3|||
160829043|NCT00528996|580761560|FG004|Overall Study|Refused continue medication|6|||
160829044|NCT00528996|580761556|FG000|Overall Study|Lost to Follow-up|2|||
160829045|NCT00528996|580761557|FG001|Overall Study|Lost to Follow-up|0|||
160829046|NCT00528996|580761558|FG002|Overall Study|Lost to Follow-up|4|||
160829047|NCT00528996|580761559|FG003|Overall Study|Lost to Follow-up|1|||
160829048|NCT00528996|580761560|FG004|Overall Study|Lost to Follow-up|3|||
160829049|NCT00528996|580761556|FG000|Overall Study|Protocol Violation|1|||
160829050|NCT00528996|580761557|FG001|Overall Study|Protocol Violation|2|||
160829051|NCT00528996|580761558|FG002|Overall Study|Protocol Violation|3|||
160829052|NCT00528996|580761559|FG003|Overall Study|Protocol Violation|3|||
160829053|NCT00528996|580761560|FG004|Overall Study|Protocol Violation|2|||
160829054|NCT00528996|580761556|FG000|Overall Study|Lack of Efficacy|7|||
160829055|NCT00528996|580761557|FG001|Overall Study|Lack of Efficacy|2|||
160829056|NCT00528996|580761558|FG002|Overall Study|Lack of Efficacy|1|||
160829057|NCT00528996|580761559|FG003|Overall Study|Lack of Efficacy|3|||
160829058|NCT00528996|580761560|FG004|Overall Study|Lack of Efficacy|3|||
160829059|NCT00528996|580761556|FG000|Overall Study|Adverse Event|32|||
160829060|NCT00528996|580761557|FG001|Overall Study|Adverse Event|13|||
160829061|NCT00528996|580761558|FG002|Overall Study|Adverse Event|18|||
160829062|NCT00528996|580761559|FG003|Overall Study|Adverse Event|29|||
160829063|NCT00528996|580761560|FG004|Overall Study|Adverse Event|18|||
160829064|NCT02831933|580761562|FG000|Overall Study|Physician Decision|11|||
160829065|NCT03495102|580761563|FG000|Overall Study|Adverse Event|5|||
160829066|NCT03495102|580761564|FG001|Overall Study|Adverse Event|7|||
160829067|NCT03495102|580761565|FG002|Overall Study|Adverse Event|10|||
160829068|NCT03495102|580761563|FG000|Overall Study|Death|3|||
160829069|NCT03495102|580761564|FG001|Overall Study|Death|4|||
160829070|NCT03495102|580761565|FG002|Overall Study|Death|4|||
160829071|NCT03495102|580761563|FG000|Overall Study|Lost to Follow-up|15|||
160829072|NCT03495102|580761564|FG001|Overall Study|Lost to Follow-up|16|||
160829073|NCT03495102|580761565|FG002|Overall Study|Lost to Follow-up|17|||
160829074|NCT03495102|580761563|FG000|Overall Study|Physician Decision|2|||
160829075|NCT03495102|580761564|FG001|Overall Study|Physician Decision|0|||
160829076|NCT03495102|580761565|FG002|Overall Study|Physician Decision|2|||
160829077|NCT03495102|580761563|FG000|Overall Study|Withdrawal by Subject|25|||
160829078|NCT03495102|580761564|FG001|Overall Study|Withdrawal by Subject|36|||
160829079|NCT03495102|580761565|FG002|Overall Study|Withdrawal by Subject|18|||
160829080|NCT03495102|580761563|FG000|Overall Study|Protocol Violation|1|||
160829081|NCT03495102|580761564|FG001|Overall Study|Protocol Violation|1|||
160829082|NCT03495102|580761565|FG002|Overall Study|Protocol Violation|0|||
160829083|NCT03495102|580761563|FG000|Overall Study|Site Closure|3|||
160829084|NCT03495102|580761564|FG001|Overall Study|Site Closure|1|||
160829085|NCT03495102|580761565|FG002|Overall Study|Site Closure|2|||
160829086|NCT03495102|580761563|FG000|Overall Study|Non-compliance|1|||
160829087|NCT03495102|580761564|FG001|Overall Study|Non-compliance|0|||
160829088|NCT03495102|580761565|FG002|Overall Study|Non-compliance|0|||
160829089|NCT03495102|580761563|FG000|Overall Study|Participant Duplicated at Another Site|0|||
160829090|NCT03495102|580761564|FG001|Overall Study|Participant Duplicated at Another Site|0|||
160829091|NCT03495102|580761565|FG002|Overall Study|Participant Duplicated at Another Site|1|||
160829092|NCT03495102|580761563|FG000|Overall Study|Primary Care Physician Recommendation|0|||
160829093|NCT03495102|580761564|FG001|Overall Study|Primary Care Physician Recommendation|1|||
160829094|NCT03495102|580761565|FG002|Overall Study|Primary Care Physician Recommendation|0|||
160829095|NCT03495102|580761563|FG000|Overall Study|Relocated to Another Country|0|||
160829096|NCT03495102|580761564|FG001|Overall Study|Relocated to Another Country|1|||
160829097|NCT03495102|580761565|FG002|Overall Study|Relocated to Another Country|0|||
160829098|NCT03495102|580761563|FG000|Overall Study|Participant was in Rehabilitation|1|||
160829099|NCT03495102|580761564|FG001|Overall Study|Participant was in Rehabilitation|0|||
160829100|NCT03495102|580761565|FG002|Overall Study|Participant was in Rehabilitation|0|||
160829101|NCT01161537|580761568|FG000|Part B|Withdrawal by Subject|2|||
160829102|NCT00358436|580761573|FG000|Overall Study|Adverse Event|29|||
160829103|NCT00358436|580761574|FG001|Overall Study|Adverse Event|13|||
160829104|NCT00358436|580761573|FG000|Overall Study|Lack of Efficacy|34|||
160829105|NCT00358436|580761574|FG001|Overall Study|Lack of Efficacy|36|||
160829106|NCT00358436|580761573|FG000|Overall Study|Lost to Follow-up|11|||
160829107|NCT00358436|580761574|FG001|Overall Study|Lost to Follow-up|6|||
160829108|NCT00358436|580761573|FG000|Overall Study|Protocol Violation|8|||
160829109|NCT00358436|580761574|FG001|Overall Study|Protocol Violation|3|||
160829110|NCT00358436|580761573|FG000|Overall Study|Withdrawal by Subject|40|||
160829111|NCT00358436|580761574|FG001|Overall Study|Withdrawal by Subject|17|||
160829112|NCT00358436|580761573|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
160829113|NCT00358436|580761574|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
160829114|NCT00358436|580761573|FG000|Overall Study|COPD exacerbation|22|||
160829115|NCT00358436|580761574|FG001|Overall Study|COPD exacerbation|10|||
160829116|NCT00358436|580761573|FG000|Overall Study|Other|6|||
160829117|NCT00358436|580761574|FG001|Overall Study|Other|1|||
160829118|NCT05065190|580761576|FG000|Overall Study|Other than listed|2|||
160829119|NCT05065190|580761577|FG001|Overall Study|Other than listed|12|||
160829120|NCT05065190|580761576|FG000|Overall Study|Lack of Efficacy|4|||
160829121|NCT05065190|580761577|FG001|Overall Study|Lack of Efficacy|0|||
161246646|NCT04411680|582281774|FG001|Treatment Period|Adverse Event|0|||
161246647|NCT04411680|582281773|FG000|Treatment Period|Discharged from hospital|18|||
160829122|NCT05065190|580761576|FG000|Overall Study|Adverse Event|1|||
160829123|NCT05065190|580761577|FG001|Overall Study|Adverse Event|10|||
160829124|NCT03938324|580761585|FG000|Overall Study|Lost to Follow-up|42|||
160829125|NCT03938324|580761586|FG001|Overall Study|Lost to Follow-up|21|||
160829126|NCT03938324|580761585|FG000|Overall Study|Withdrawal by Subject|6|||
160829127|NCT03938324|580761586|FG001|Overall Study|Withdrawal by Subject|1|||
160829128|NCT02769962|580761587|FG000|Overall Study|Physician Decision|0|||
160829129|NCT02769962|580761588|FG001|Overall Study|Physician Decision|0|||
160829130|NCT02769962|580761589|FG002|Overall Study|Physician Decision|0|||
160829131|NCT02769962|580761590|FG003|Overall Study|Physician Decision|0|||
160829132|NCT02769962|580761591|FG004|Overall Study|Physician Decision|0|||
160829133|NCT02769962|580761592|FG005|Overall Study|Physician Decision|1|||
160829134|NCT02769962|580761593|FG006|Overall Study|Physician Decision|0|||
160829135|NCT02769962|580761594|FG007|Overall Study|Physician Decision|1|||
160829136|NCT02769962|580761587|FG000|Overall Study|Refused further treatment|0|||
160829137|NCT02769962|580761588|FG001|Overall Study|Refused further treatment|0|||
160829138|NCT02769962|580761589|FG002|Overall Study|Refused further treatment|0|||
160829139|NCT02769962|580761590|FG003|Overall Study|Refused further treatment|0|||
160829140|NCT02769962|580761591|FG004|Overall Study|Refused further treatment|0|||
160829141|NCT02769962|580761592|FG005|Overall Study|Refused further treatment|1|||
160829142|NCT02769962|580761593|FG006|Overall Study|Refused further treatment|1|||
160829143|NCT02769962|580761594|FG007|Overall Study|Refused further treatment|0|||
160829144|NCT02559414|580761601|FG000|Overall Study|Lost to Follow-up|0|||
160829145|NCT02559414|580761602|FG001|Overall Study|Lost to Follow-up|1|||
160829146|NCT02559414|580761603|FG002|Overall Study|Lost to Follow-up|0|||
160829147|NCT02559414|580761601|FG000|Overall Study|Withdrawal by Subject|1|||
160829148|NCT02559414|580761602|FG001|Overall Study|Withdrawal by Subject|0|||
160829149|NCT02559414|580761603|FG002|Overall Study|Withdrawal by Subject|1|||
160829150|NCT02559414|580761601|FG000|Overall Study|Other|0|||
160829151|NCT02559414|580761602|FG001|Overall Study|Other|1|||
160829152|NCT02559414|580761603|FG002|Overall Study|Other|1|||
160829153|NCT00004445|580761604|FG000|Overall Study|Physician Decision|2|||
160829154|NCT00004445|580761604|FG000|Overall Study|Withdrawal by Subject|1|||
160829155|NCT01266317|580761605|FG000|Overall Study|Withdrawal by Subject|2|||
160829156|NCT02753127|580761608|FG000|Overall Study|Lost to Follow-up|13|||
160829157|NCT02753127|580761609|FG001|Overall Study|Lost to Follow-up|11|||
160829158|NCT02753127|580761608|FG000|Overall Study|Withdrawal by Subject|37|||
160829159|NCT02753127|580761609|FG001|Overall Study|Withdrawal by Subject|47|||
160829160|NCT02753127|580761608|FG000|Overall Study|Other|3|||
160829161|NCT02753127|580761609|FG001|Overall Study|Other|8|||
160829162|NCT02753127|580761608|FG000|Overall Study|Hospice|0|||
160829163|NCT02753127|580761609|FG001|Overall Study|Hospice|2|||
160829164|NCT00098722|580761610|FG000|Double Blind Phase|Adverse Event|7|||
160829165|NCT00098722|580761611|FG001|Double Blind Phase|Adverse Event|7|||
160829166|NCT00098722|580761612|FG002|Double Blind Phase|Adverse Event|3|||
160903116|NCT02195583|581039003|FG000|Overall Study|Adverse Event|2|||
160903117|NCT02195583|581039003|FG000|Overall Study|Other Reason|2|||
160903118|NCT01560403|581039004|FG000|Overall Study|Lost to Follow-up|0|||
160903119|NCT01560403|581039005|FG001|Overall Study|Lost to Follow-up|1|||
160903120|NCT00983437|581039007|FG000|Overall Study|Adverse Event|9|||
160829167|NCT00098722|580761613|FG003|Double Blind Phase|Adverse Event|0|||
160829168|NCT00098722|580761614|FG004|Double Blind Phase|Adverse Event|0|||
160829169|NCT00098722|580761615|FG005|Double Blind Phase|Adverse Event|0|||
160829170|NCT00098722|580761616|FG006|Double Blind Phase|Adverse Event|0|||
160829171|NCT00098722|580761610|FG000|Double Blind Phase|Death|2|||
160829172|NCT00098722|580761611|FG001|Double Blind Phase|Death|5|||
160829173|NCT00098722|580761612|FG002|Double Blind Phase|Death|0|||
160829174|NCT00098722|580761613|FG003|Double Blind Phase|Death|0|||
160829175|NCT00098722|580761614|FG004|Double Blind Phase|Death|0|||
161246648|NCT04411680|582281774|FG001|Treatment Period|Discharged from hospital|7|||
160829176|NCT00098722|580761615|FG005|Double Blind Phase|Death|0|||
160829177|NCT00098722|580761616|FG006|Double Blind Phase|Death|0|||
160829178|NCT00098722|580761610|FG000|Double Blind Phase|Lack of Efficacy|21|||
160829179|NCT00098722|580761611|FG001|Double Blind Phase|Lack of Efficacy|23|||
160829180|NCT00098722|580761612|FG002|Double Blind Phase|Lack of Efficacy|15|||
160829181|NCT00098722|580761613|FG003|Double Blind Phase|Lack of Efficacy|0|||
160829182|NCT00098722|580761614|FG004|Double Blind Phase|Lack of Efficacy|0|||
160829183|NCT00098722|580761615|FG005|Double Blind Phase|Lack of Efficacy|0|||
160829184|NCT00098722|580761616|FG006|Double Blind Phase|Lack of Efficacy|0|||
160829185|NCT00098722|580761610|FG000|Double Blind Phase|Participant defaulted|16|||
160829186|NCT00098722|580761611|FG001|Double Blind Phase|Participant defaulted|11|||
160829187|NCT00098722|580761612|FG002|Double Blind Phase|Participant defaulted|9|||
160829188|NCT00098722|580761613|FG003|Double Blind Phase|Participant defaulted|0|||
160829189|NCT00098722|580761614|FG004|Double Blind Phase|Participant defaulted|0|||
160829190|NCT00098722|580761615|FG005|Double Blind Phase|Participant defaulted|0|||
160829191|NCT00098722|580761616|FG006|Double Blind Phase|Participant defaulted|0|||
160829192|NCT00098722|580761610|FG000|Double Blind Phase|Pregnancy|1|||
160829193|NCT00098722|580761611|FG001|Double Blind Phase|Pregnancy|0|||
160829194|NCT00098722|580761612|FG002|Double Blind Phase|Pregnancy|0|||
160829195|NCT00098722|580761613|FG003|Double Blind Phase|Pregnancy|0|||
160829196|NCT00098722|580761614|FG004|Double Blind Phase|Pregnancy|0|||
160829197|NCT00098722|580761615|FG005|Double Blind Phase|Pregnancy|0|||
160829198|NCT00098722|580761616|FG006|Double Blind Phase|Pregnancy|0|||
160829199|NCT00098722|580761610|FG000|Double Blind Phase|Randomized, not treated|4|||
160829200|NCT00098722|580761611|FG001|Double Blind Phase|Randomized, not treated|3|||
160829201|NCT00098722|580761612|FG002|Double Blind Phase|Randomized, not treated|3|||
160829202|NCT00098722|580761613|FG003|Double Blind Phase|Randomized, not treated|0|||
160829203|NCT00098722|580761614|FG004|Double Blind Phase|Randomized, not treated|0|||
160829204|NCT00098722|580761615|FG005|Double Blind Phase|Randomized, not treated|0|||
160829205|NCT00098722|580761616|FG006|Double Blind Phase|Randomized, not treated|0|||
160829206|NCT00098722|580761610|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
160829207|NCT00098722|580761611|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
160829208|NCT00098722|580761612|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
160829209|NCT00098722|580761613|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
160829210|NCT00098722|580761614|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
160829211|NCT00098722|580761615|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
160829212|NCT00098722|580761616|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
160829213|NCT00098722|580761610|FG000|Double Blind Phase|Other|7|||
160829214|NCT00098722|580761611|FG001|Double Blind Phase|Other|8|||
160829215|NCT00098722|580761612|FG002|Double Blind Phase|Other|7|||
160829216|NCT00098722|580761613|FG003|Double Blind Phase|Other|0|||
160829217|NCT00098722|580761614|FG004|Double Blind Phase|Other|0|||
160829218|NCT00098722|580761615|FG005|Double Blind Phase|Other|0|||
160829219|NCT00098722|580761616|FG006|Double Blind Phase|Other|0|||
160829220|NCT00098722|580761610|FG000|Open Label Phase|Adverse Event|0|||
160829221|NCT00098722|580761611|FG001|Open Label Phase|Adverse Event|0|||
160829222|NCT00098722|580761612|FG002|Open Label Phase|Adverse Event|0|||
160829223|NCT00098722|580761613|FG003|Open Label Phase|Adverse Event|5|||
160829224|NCT00098722|580761614|FG004|Open Label Phase|Adverse Event|0|||
160829225|NCT00098722|580761615|FG005|Open Label Phase|Adverse Event|0|||
160829226|NCT00098722|580761616|FG006|Open Label Phase|Adverse Event|0|||
160829227|NCT00098722|580761610|FG000|Open Label Phase|Death|0|||
160829228|NCT00098722|580761611|FG001|Open Label Phase|Death|0|||
160829229|NCT00098722|580761612|FG002|Open Label Phase|Death|0|||
160829230|NCT00098722|580761613|FG003|Open Label Phase|Death|2|||
160829231|NCT00098722|580761614|FG004|Open Label Phase|Death|0|||
160829232|NCT00098722|580761615|FG005|Open Label Phase|Death|0|||
160829233|NCT00098722|580761616|FG006|Open Label Phase|Death|0|||
160903121|NCT00983437|581039007|FG000|Overall Study|Lack of Efficacy|1|||
161136194|NCT00929240|581879433|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
161136195|NCT00929240|581879434|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
161136196|NCT00929240|581879435|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
160829234|NCT00098722|580761610|FG000|Open Label Phase|Lack of Efficacy|0|||
160829235|NCT00098722|580761611|FG001|Open Label Phase|Lack of Efficacy|0|||
160829236|NCT00098722|580761612|FG002|Open Label Phase|Lack of Efficacy|0|||
160829237|NCT00098722|580761613|FG003|Open Label Phase|Lack of Efficacy|8|||
160829238|NCT00098722|580761614|FG004|Open Label Phase|Lack of Efficacy|0|||
160829239|NCT00098722|580761615|FG005|Open Label Phase|Lack of Efficacy|0|||
160829240|NCT00098722|580761616|FG006|Open Label Phase|Lack of Efficacy|0|||
160829241|NCT00098722|580761610|FG000|Open Label Phase|Pregnancy|0|||
160829242|NCT00098722|580761611|FG001|Open Label Phase|Pregnancy|0|||
160829243|NCT00098722|580761612|FG002|Open Label Phase|Pregnancy|0|||
161136197|NCT00929240|581879433|FG000|Initial Treatment Phase|Physician Decision|4|||
160829244|NCT00098722|580761613|FG003|Open Label Phase|Pregnancy|1|||
160829245|NCT00098722|580761614|FG004|Open Label Phase|Pregnancy|0|||
160829246|NCT00098722|580761615|FG005|Open Label Phase|Pregnancy|0|||
160829247|NCT00098722|580761616|FG006|Open Label Phase|Pregnancy|0|||
160829248|NCT00098722|580761610|FG000|Open Label Phase|Participant defaulted|0|||
160829249|NCT00098722|580761611|FG001|Open Label Phase|Participant defaulted|0|||
160829250|NCT00098722|580761612|FG002|Open Label Phase|Participant defaulted|0|||
160829251|NCT00098722|580761613|FG003|Open Label Phase|Participant defaulted|18|||
160829252|NCT00098722|580761614|FG004|Open Label Phase|Participant defaulted|0|||
160829253|NCT00098722|580761615|FG005|Open Label Phase|Participant defaulted|0|||
160829254|NCT00098722|580761616|FG006|Open Label Phase|Participant defaulted|0|||
160829255|NCT00098722|580761610|FG000|Open Label Phase|Ongoing at cut-off date|0|||
160829256|NCT00098722|580761611|FG001|Open Label Phase|Ongoing at cut-off date|0|||
160829257|NCT00098722|580761612|FG002|Open Label Phase|Ongoing at cut-off date|0|||
160829258|NCT00098722|580761613|FG003|Open Label Phase|Ongoing at cut-off date|220|||
160829259|NCT00098722|580761614|FG004|Open Label Phase|Ongoing at cut-off date|50|||
160829260|NCT00098722|580761615|FG005|Open Label Phase|Ongoing at cut-off date|0|||
160829261|NCT00098722|580761616|FG006|Open Label Phase|Ongoing at cut-off date|0|||
160829262|NCT00098722|580761610|FG000|Open Label Phase|Other|0|||
160829263|NCT00098722|580761611|FG001|Open Label Phase|Other|0|||
160829264|NCT00098722|580761612|FG002|Open Label Phase|Other|0|||
160829265|NCT00098722|580761613|FG003|Open Label Phase|Other|18|||
160829266|NCT00098722|580761614|FG004|Open Label Phase|Other|0|||
161136198|NCT00929240|581879434|FG001|Initial Treatment Phase|Physician Decision|0|||
161136199|NCT00929240|581879435|FG002|Initial Treatment Phase|Physician Decision|0|||
160829267|NCT00098722|580761615|FG005|Open Label Phase|Other|0|||
160829268|NCT00098722|580761616|FG006|Open Label Phase|Other|0|||
160829269|NCT00098722|580761610|FG000|Observation Phase|Death|0|||
160829270|NCT00098722|580761611|FG001|Observation Phase|Death|0|||
160829271|NCT00098722|580761612|FG002|Observation Phase|Death|0|||
160829272|NCT00098722|580761613|FG003|Observation Phase|Death|0|||
160829273|NCT00098722|580761614|FG004|Observation Phase|Death|0|||
160829274|NCT00098722|580761615|FG005|Observation Phase|Death|5|||
160829275|NCT00098722|580761616|FG006|Observation Phase|Death|3|||
160829276|NCT00098722|580761610|FG000|Observation Phase|Lack of Efficacy|0|||
160829277|NCT00098722|580761611|FG001|Observation Phase|Lack of Efficacy|0|||
160829278|NCT00098722|580761612|FG002|Observation Phase|Lack of Efficacy|0|||
160829279|NCT00098722|580761613|FG003|Observation Phase|Lack of Efficacy|0|||
160829280|NCT00098722|580761614|FG004|Observation Phase|Lack of Efficacy|0|||
160829281|NCT00098722|580761615|FG005|Observation Phase|Lack of Efficacy|2|||
160829282|NCT00098722|580761616|FG006|Observation Phase|Lack of Efficacy|0|||
160829283|NCT00098722|580761610|FG000|Observation Phase|Participant defaulted|0|||
160829284|NCT00098722|580761611|FG001|Observation Phase|Participant defaulted|0|||
160829285|NCT00098722|580761612|FG002|Observation Phase|Participant defaulted|0|||
160829286|NCT00098722|580761613|FG003|Observation Phase|Participant defaulted|0|||
160829287|NCT00098722|580761614|FG004|Observation Phase|Participant defaulted|0|||
160829288|NCT00098722|580761615|FG005|Observation Phase|Participant defaulted|17|||
160829289|NCT00098722|580761616|FG006|Observation Phase|Participant defaulted|4|||
160829290|NCT00098722|580761610|FG000|Observation Phase|Other|0|||
160829291|NCT00098722|580761611|FG001|Observation Phase|Other|0|||
160829292|NCT00098722|580761612|FG002|Observation Phase|Other|0|||
160829293|NCT00098722|580761613|FG003|Observation Phase|Other|0|||
160829294|NCT00098722|580761614|FG004|Observation Phase|Other|0|||
160829295|NCT00098722|580761615|FG005|Observation Phase|Other|21|||
160829296|NCT00098722|580761616|FG006|Observation Phase|Other|10|||
160829297|NCT01143051|580761621|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
160829298|NCT01143051|580761622|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
160829299|NCT01143051|580761623|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
160829300|NCT01143051|580761624|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
160829301|NCT01143051|580761625|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
160829302|NCT01143051|580761626|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
161136200|NCT00929240|581879433|FG000|Maintenance Phase|Disease progression|0|||
161136201|NCT00929240|581879434|FG001|Maintenance Phase|Disease progression|73|||
161136202|NCT00929240|581879435|FG002|Maintenance Phase|Disease progression|60|||
161136203|NCT00929240|581879433|FG000|Maintenance Phase|Adverse Event|0|||
161136204|NCT00929240|581879434|FG001|Maintenance Phase|Adverse Event|9|||
161136205|NCT00929240|581879435|FG002|Maintenance Phase|Adverse Event|12|||
161136206|NCT00929240|581879433|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161136207|NCT00929240|581879434|FG001|Maintenance Phase|Withdrawal by Subject|2|||
161136208|NCT00929240|581879435|FG002|Maintenance Phase|Withdrawal by Subject|6|||
161136209|NCT00929240|581879433|FG000|Maintenance Phase|Protocol Violation|0|||
161136210|NCT00929240|581879434|FG001|Maintenance Phase|Protocol Violation|1|||
161136211|NCT00929240|581879435|FG002|Maintenance Phase|Protocol Violation|0|||
161136212|NCT00929240|581879433|FG000|Maintenance Phase|Health authority/Study termination|0|||
161136213|NCT00929240|581879434|FG001|Maintenance Phase|Health authority/Study termination|1|||
160829303|NCT01143051|580761621|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
160829304|NCT01143051|580761622|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
160829305|NCT01143051|580761623|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
160829306|NCT01143051|580761624|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
160903122|NCT00983437|581039007|FG000|Overall Study|Withdrawal by Subject|8|||
160829307|NCT01143051|580761625|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
161136214|NCT00929240|581879435|FG002|Maintenance Phase|Health authority/Study termination|2|||
161136215|NCT00929240|581879433|FG000|Maintenance Phase|Physician Decision|0|||
160990845|NCT00941031|581353971|FG000|Induction Period|Withdrawal by Subject|1|||
160990846|NCT00941031|581353972|FG001|Induction Period|Withdrawal by Subject|2|||
160990847|NCT00941031|581353973|FG002|Induction Period|Withdrawal by Subject|2|||
160990848|NCT00941031|581353974|FG003|Induction Period|Withdrawal by Subject|2|||
160990849|NCT00941031|581353975|FG004|Induction Period|Withdrawal by Subject|0|||
160990850|NCT00941031|581353976|FG005|Induction Period|Withdrawal by Subject|0|||
160990851|NCT00941031|581353977|FG006|Induction Period|Withdrawal by Subject|0|||
160990852|NCT00941031|581353971|FG000|Induction Period|Adminstative Problems|1|||
160990853|NCT00941031|581353972|FG001|Induction Period|Adminstative Problems|1|||
160829308|NCT01143051|580761626|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
160829309|NCT01146288|580761627|FG000|First Intervention(1 Day)|Adverse Event|0|||
160829310|NCT01146288|580761628|FG001|First Intervention(1 Day)|Adverse Event|1|||
160829311|NCT02677844|580761629|FG000|Period 3|Withdrawal by Subject|0|||
160829312|NCT02677844|580761630|FG001|Period 3|Withdrawal by Subject|0|||
160829313|NCT02677844|580761631|FG002|Period 3|Withdrawal by Subject|0|||
160829314|NCT02677844|580761632|FG003|Period 3|Withdrawal by Subject|1|||
160829315|NCT02677844|580761633|FG004|Period 3|Withdrawal by Subject|0|||
160829316|NCT02677844|580761634|FG005|Period 3|Withdrawal by Subject|0|||
160829317|NCT02677844|580761635|FG006|Period 3|Withdrawal by Subject|0|||
160829318|NCT00765882|580761636|FG000|Overall Study|Adverse Event|10|||
160829319|NCT00765882|580761637|FG001|Overall Study|Adverse Event|21|||
160829320|NCT00765882|580761638|FG002|Overall Study|Adverse Event|20|||
160829321|NCT00765882|580761636|FG000|Overall Study|Lack of Efficacy|4|||
160829322|NCT00765882|580761637|FG001|Overall Study|Lack of Efficacy|0|||
160829323|NCT00765882|580761638|FG002|Overall Study|Lack of Efficacy|1|||
160829324|NCT00765882|580761636|FG000|Overall Study|Protocol Violation|4|||
160829325|NCT00765882|580761637|FG001|Overall Study|Protocol Violation|3|||
160829326|NCT00765882|580761638|FG002|Overall Study|Protocol Violation|1|||
160829327|NCT00765882|580761636|FG000|Overall Study|Withdrawal by Subject|2|||
160829328|NCT00765882|580761637|FG001|Overall Study|Withdrawal by Subject|6|||
160829329|NCT00765882|580761638|FG002|Overall Study|Withdrawal by Subject|6|||
160903123|NCT00983437|581039007|FG000|Overall Study|Noncompliance to Study Procedures|1|||
160903124|NCT00983437|581039007|FG000|Overall Study|Lost to Follow-up|2|||
160903125|NCT00983437|581039007|FG000|Overall Study|Other Reason|26|||
160903126|NCT04019288|581039008|FG000|Overall Study|Death|1|||
160903127|NCT04019288|581039009|FG001|Overall Study|Death|0|||
160903128|NCT04019288|581039010|FG002|Overall Study|Death|0|||
160903129|NCT00094172|581039012|FG000|Overall Study|Adverse Event|0|||
160903130|NCT00094172|581039013|FG001|Overall Study|Adverse Event|1|||
160903131|NCT00094172|581039012|FG000|Overall Study|Lost to Follow-up|2|||
160903132|NCT00094172|581039013|FG001|Overall Study|Lost to Follow-up|0|||
160990854|NCT00941031|581353973|FG002|Induction Period|Adminstative Problems|1|||
160990855|NCT00941031|581353974|FG003|Induction Period|Adminstative Problems|0|||
160990856|NCT00941031|581353975|FG004|Induction Period|Adminstative Problems|0|||
160990857|NCT00941031|581353976|FG005|Induction Period|Adminstative Problems|0|||
160990858|NCT00941031|581353977|FG006|Induction Period|Adminstative Problems|0|||
160990859|NCT00941031|581353971|FG000|Induction Period|Adverse Event|1|||
160990860|NCT00941031|581353972|FG001|Induction Period|Adverse Event|0|||
160990861|NCT00941031|581353973|FG002|Induction Period|Adverse Event|3|||
160990862|NCT00941031|581353974|FG003|Induction Period|Adverse Event|2|||
160990863|NCT00941031|581353975|FG004|Induction Period|Adverse Event|0|||
160990864|NCT00941031|581353976|FG005|Induction Period|Adverse Event|0|||
161246649|NCT04411680|582281773|FG000|Treatment Period|Missed 1 or more doses|8|||
161246650|NCT04411680|582281774|FG001|Treatment Period|Missed 1 or more doses|0|||
161246651|NCT04411680|582281773|FG000|Treatment Period|Transferred to another hospital|0|||
161246652|NCT04411680|582281774|FG001|Treatment Period|Transferred to another hospital|1|||
161246653|NCT04411680|582281773|FG000|Follow up Period|Withdrawal by Subject|2|||
161246654|NCT04411680|582281774|FG001|Follow up Period|Withdrawal by Subject|0|||
161246655|NCT04411680|582281773|FG000|Follow up Period|Lost to Follow-up|5|||
161246656|NCT04411680|582281774|FG001|Follow up Period|Lost to Follow-up|6|||
160829330|NCT00765882|580761636|FG000|Overall Study|Lost to Follow-up|1|||
160829331|NCT00765882|580761637|FG001|Overall Study|Lost to Follow-up|9|||
160829332|NCT00765882|580761638|FG002|Overall Study|Lost to Follow-up|6|||
160829333|NCT00765882|580761636|FG000|Overall Study|Other Reason|3|||
160829334|NCT00765882|580761637|FG001|Overall Study|Other Reason|1|||
160903133|NCT00094172|581039012|FG000|Overall Study|Protocol Violation|0|||
160903134|NCT00094172|581039013|FG001|Overall Study|Protocol Violation|1|||
160903135|NCT00094172|581039012|FG000|Overall Study|Withdrawal by Subject|10|||
160903136|NCT00094172|581039013|FG001|Overall Study|Withdrawal by Subject|5|||
160903137|NCT00094172|581039012|FG000|Overall Study|Primary endpoint met.|1|||
160990865|NCT00941031|581353977|FG006|Induction Period|Adverse Event|0|||
160990866|NCT00941031|581353971|FG000|Maintenance Period|Withdrawal by Subject|0|||
160829335|NCT00765882|580761638|FG002|Overall Study|Other Reason|2|||
160829336|NCT03532932|580761643|FG000|Overall Study|Protocol Deviation|33|||
160829337|NCT03532932|580761644|FG001|Overall Study|Protocol Deviation|31|||
160829338|NCT03532932|580761643|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
160829339|NCT03532932|580761644|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
160990867|NCT00941031|581353972|FG001|Maintenance Period|Withdrawal by Subject|0|||
160990868|NCT00941031|581353973|FG002|Maintenance Period|Withdrawal by Subject|0|||
160990869|NCT00941031|581353974|FG003|Maintenance Period|Withdrawal by Subject|0|||
160990870|NCT00941031|581353975|FG004|Maintenance Period|Withdrawal by Subject|6|||
160990871|NCT00941031|581353976|FG005|Maintenance Period|Withdrawal by Subject|2|||
160990872|NCT00941031|581353977|FG006|Maintenance Period|Withdrawal by Subject|13|||
160990873|NCT00941031|581353971|FG000|Maintenance Period|Administrative Problems|0|||
160990874|NCT00941031|581353972|FG001|Maintenance Period|Administrative Problems|0|||
160829340|NCT03532932|580761643|FG000|Overall Study|Withdrawal by Subject|2|||
160829341|NCT03532932|580761644|FG001|Overall Study|Withdrawal by Subject|0|||
160829342|NCT03532932|580761643|FG000|Overall Study|Lost to Follow-up|15|||
160829343|NCT03532932|580761644|FG001|Overall Study|Lost to Follow-up|9|||
160829344|NCT03532932|580761643|FG000|Overall Study|Adverse Event|4|||
160829345|NCT03532932|580761644|FG001|Overall Study|Adverse Event|3|||
160829346|NCT03532932|580761643|FG000|Overall Study|Death|0|||
160829347|NCT03532932|580761644|FG001|Overall Study|Death|2|||
160829348|NCT03532932|580761643|FG000|Overall Study|Other|11|||
160829349|NCT03532932|580761644|FG001|Overall Study|Other|16|||
160829350|NCT02255565|580761645|FG000|Overall Study|Withdrawal by Subject|0|||
160829351|NCT02255565|580761646|FG001|Overall Study|Withdrawal by Subject|1|||
160829352|NCT02255565|580761647|FG002|Overall Study|Withdrawal by Subject|0|||
160829353|NCT00810901|580761648|FG000|Overall Study|Lost to Follow-up|88|||
160829354|NCT00810901|580761649|FG001|Overall Study|Lost to Follow-up|58|||
160829355|NCT03689712|580761650|FG000|Overall Study|Adverse Event|1|||
160829356|NCT03689712|580761651|FG001|Overall Study|Adverse Event|0|||
160829357|NCT03689712|580761650|FG000|Overall Study|Death|20|||
160829358|NCT03689712|580761651|FG001|Overall Study|Death|10|||
160829359|NCT03689712|580761650|FG000|Overall Study|Lost to Follow-up|6|||
160829360|NCT03689712|580761651|FG001|Overall Study|Lost to Follow-up|6|||
160829361|NCT03689712|580761650|FG000|Overall Study|Other|1|||
160829362|NCT03689712|580761651|FG001|Overall Study|Other|0|||
160829363|NCT03689712|580761650|FG000|Overall Study|Patient Non-Compliance|0|||
160829364|NCT03689712|580761651|FG001|Overall Study|Patient Non-Compliance|1|||
160829365|NCT03689712|580761650|FG000|Overall Study|Withdrawal by Subject|20|||
160829366|NCT03689712|580761651|FG001|Overall Study|Withdrawal by Subject|4|||
160829367|NCT03689712|580761650|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
160829368|NCT03689712|580761651|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
160829369|NCT03689712|580761650|FG000|Overall Study|Randomized but not Treated|13|||
160829370|NCT03689712|580761651|FG001|Overall Study|Randomized but not Treated|7|||
160829371|NCT03689712|580761650|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
160829372|NCT03689712|580761651|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
160829373|NCT00931801|580761652|FG000|Overall Study|Adverse Event|0|||
160829374|NCT00931801|580761653|FG001|Overall Study|Adverse Event|0|||
160829375|NCT00931801|580761654|FG002|Overall Study|Adverse Event|1|||
160829376|NCT00931801|580761652|FG000|Overall Study|Lost to Follow-up|0|||
160829377|NCT00931801|580761653|FG001|Overall Study|Lost to Follow-up|1|||
160829378|NCT00931801|580761654|FG002|Overall Study|Lost to Follow-up|0|||
160829379|NCT00931801|580761652|FG000|Overall Study|Withdrawal by Subject|1|||
160829380|NCT00931801|580761653|FG001|Overall Study|Withdrawal by Subject|0|||
160829381|NCT00931801|580761654|FG002|Overall Study|Withdrawal by Subject|0|||
160829382|NCT00931801|580761652|FG000|Overall Study|Confirmed Virologic Failure|0|||
160829383|NCT00931801|580761653|FG001|Overall Study|Confirmed Virologic Failure|0|||
160829384|NCT00931801|580761654|FG002|Overall Study|Confirmed Virologic Failure|3|||
160829385|NCT01635764|580761659|FG000|Overall Study|Adverse Event|46|||
160829386|NCT01635764|580761659|FG000|Overall Study|Lack of Efficacy|76|||
160829387|NCT01635764|580761659|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
160829388|NCT01635764|580761659|FG000|Overall Study|Protocol Deviation|1|||
160829389|NCT01635764|580761659|FG000|Overall Study|Withdrew Consent|67|||
160829390|NCT01635764|580761659|FG000|Overall Study|Lost to Follow-up|53|||
160829391|NCT01635764|580761659|FG000|Overall Study|Other|28|||
160829392|NCT01816906|580761663|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
160829393|NCT01816906|580761664|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
160829394|NCT01816906|580761663|FG000|Six Months|Lost to Follow-up|14|||
160990875|NCT00941031|581353973|FG002|Maintenance Period|Administrative Problems|0|||
160990876|NCT00941031|581353974|FG003|Maintenance Period|Administrative Problems|0|||
161136216|NCT00929240|581879434|FG001|Maintenance Phase|Physician Decision|2|||
161136217|NCT00929240|581879435|FG002|Maintenance Phase|Physician Decision|1|||
160829395|NCT01816906|580761664|FG001|Six Months|Lost to Follow-up|16|||
160829396|NCT01816906|580761663|FG000|12 Months|Adverse Event|2|||
160829397|NCT01816906|580761664|FG001|12 Months|Adverse Event|2|||
160829398|NCT01816906|580761663|FG000|12 Months|Death|0|||
160990877|NCT00941031|581353975|FG004|Maintenance Period|Administrative Problems|1|||
160829399|NCT01816906|580761664|FG001|12 Months|Death|2|||
160829400|NCT01816906|580761663|FG000|12 Months|Lost to Follow-up|2|||
160829401|NCT01816906|580761664|FG001|12 Months|Lost to Follow-up|1|||
160829402|NCT04375397|580761665|FG000|Overall Study|Death|1|||
160829403|NCT04375397|580761666|FG001|Overall Study|Death|1|||
160829404|NCT04375397|580761665|FG000|Overall Study|Withdrew consent|2|||
160829405|NCT04375397|580761666|FG001|Overall Study|Withdrew consent|0|||
161246657|NCT04411680|582281773|FG000|Follow up Period|Death|11|||
160829406|NCT04375397|580761665|FG000|Overall Study|Lost to Follow-up|6|||
160829407|NCT04375397|580761666|FG001|Overall Study|Lost to Follow-up|4|||
160829408|NCT04375397|580761665|FG000|Overall Study|Other, not specified|0|||
160829409|NCT04375397|580761666|FG001|Overall Study|Other, not specified|1|||
160829410|NCT00746733|580761667|FG000|Second Intervention|Adverse Event|1|||
160829411|NCT00746733|580761668|FG001|Second Intervention|Adverse Event|0|||
160829412|NCT00746733|580761667|FG000|Third Intervention|Withdrawal by Subject|1|||
160829413|NCT00746733|580761668|FG001|Third Intervention|Withdrawal by Subject|1|||
160829414|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
160829415|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
160829416|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
160829417|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
160829418|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
160829419|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
160829420|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
160829421|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
160829422|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
160829423|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
160829424|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
160829425|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
160829426|NCT00610441|580761672|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
160829427|NCT00610441|580761673|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
160829428|NCT00610441|580761674|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
160829429|NCT00610441|580761675|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
160829430|NCT00610441|580761672|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
160829431|NCT00610441|580761673|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
160829432|NCT00610441|580761674|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
160829433|NCT00610441|580761675|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
160829434|NCT00610441|580761672|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160829435|NCT00610441|580761673|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
160829436|NCT00610441|580761674|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160829437|NCT00610441|580761675|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
160829438|NCT00610441|580761672|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
160829439|NCT00610441|580761673|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
160829440|NCT00610441|580761674|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
160829441|NCT00610441|580761675|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
160829442|NCT00610441|580761672|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
160829443|NCT00610441|580761673|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
160829444|NCT00610441|580761674|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
160829445|NCT00610441|580761675|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
160829446|NCT00610441|580761672|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
160829447|NCT00610441|580761673|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
160829448|NCT00610441|580761674|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
160829449|NCT00610441|580761675|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
160829450|NCT01945775|580761679|FG000|Overall Study|Death|214|||
160829451|NCT01945775|580761680|FG001|Overall Study|Death|98|||
160829452|NCT01945775|580761679|FG000|Overall Study|Lost to Follow-up|12|||
160829453|NCT01945775|580761680|FG001|Overall Study|Lost to Follow-up|7|||
160829454|NCT01945775|580761679|FG000|Overall Study|Withdrawal by Subject|11|||
160829455|NCT01945775|580761680|FG001|Overall Study|Withdrawal by Subject|21|||
160829456|NCT01945775|580761679|FG000|Overall Study|Other|50|||
160829457|NCT01945775|580761680|FG001|Overall Study|Other|18|||
160829458|NCT02876328|580761681|FG000|Overall Study|Death|2|||
160829459|NCT02876328|580761682|FG001|Overall Study|Death|1|||
160829460|NCT02876328|580761683|FG002|Overall Study|Death|3|||
160829461|NCT02876328|580761684|FG003|Overall Study|Death|0|||
160829462|NCT02876328|580761685|FG004|Overall Study|Death|0|||
160829463|NCT02876328|580761686|FG005|Overall Study|Death|0|||
160829464|NCT02876328|580761687|FG006|Overall Study|Death|1|||
160829465|NCT02876328|580761688|FG007|Overall Study|Death|3|||
161136218|NCT00929240|581879433|FG000|Maintenance Phase|Change of treatment|0|||
161136219|NCT00929240|581879434|FG001|Maintenance Phase|Change of treatment|4|||
161136220|NCT00929240|581879435|FG002|Maintenance Phase|Change of treatment|0|||
161136221|NCT00929240|581879433|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
161136222|NCT00929240|581879434|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
160829466|NCT02876328|580761689|FG008|Overall Study|Death|0|||
160829467|NCT02876328|580761690|FG009|Overall Study|Death|1|||
161136223|NCT00929240|581879435|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
161136224|NCT00929240|581879433|FG000|Maintenance Phase|Participant not treated|0|||
160829468|NCT02876328|580761691|FG010|Overall Study|Death|1|||
160829469|NCT02876328|580761692|FG011|Overall Study|Death|0|||
160829470|NCT02876328|580761693|FG012|Overall Study|Death|0|||
160829471|NCT02876328|580761694|FG013|Overall Study|Death|0|||
160829472|NCT02876328|580761695|FG014|Overall Study|Death|0|||
161246658|NCT04411680|582281774|FG001|Follow up Period|Death|8|||
161246659|NCT05034874|582281775|FG000|Overall Study|Withdrawal by Subject|6|||
160829473|NCT02876328|580761696|FG015|Overall Study|Death|0|||
160829474|NCT02876328|580761697|FG016|Overall Study|Death|1|||
160829475|NCT02876328|580761698|FG017|Overall Study|Death|1|||
160829476|NCT02876328|580761699|FG018|Overall Study|Death|0|||
160829477|NCT02876328|580761700|FG019|Overall Study|Death|0|||
160829478|NCT02876328|580761701|FG020|Overall Study|Death|0|||
160829479|NCT02876328|580761702|FG021|Overall Study|Death|1|||
160829480|NCT02876328|580761703|FG022|Overall Study|Death|0|||
160829481|NCT02876328|580761704|FG023|Overall Study|Death|0|||
160829482|NCT02876328|580761681|FG000|Overall Study|Withdrawal by Subject|0|||
160829483|NCT02876328|580761682|FG001|Overall Study|Withdrawal by Subject|2|||
160829484|NCT02876328|580761683|FG002|Overall Study|Withdrawal by Subject|3|||
160829485|NCT02876328|580761684|FG003|Overall Study|Withdrawal by Subject|3|||
160829486|NCT02876328|580761685|FG004|Overall Study|Withdrawal by Subject|0|||
160829487|NCT02876328|580761686|FG005|Overall Study|Withdrawal by Subject|1|||
160829488|NCT02876328|580761687|FG006|Overall Study|Withdrawal by Subject|0|||
160829489|NCT02876328|580761688|FG007|Overall Study|Withdrawal by Subject|1|||
160829490|NCT02876328|580761689|FG008|Overall Study|Withdrawal by Subject|1|||
160829491|NCT02876328|580761690|FG009|Overall Study|Withdrawal by Subject|2|||
160829492|NCT02876328|580761691|FG010|Overall Study|Withdrawal by Subject|0|||
160829493|NCT02876328|580761692|FG011|Overall Study|Withdrawal by Subject|0|||
160829494|NCT02876328|580761693|FG012|Overall Study|Withdrawal by Subject|0|||
160829495|NCT02876328|580761694|FG013|Overall Study|Withdrawal by Subject|0|||
160829496|NCT02876328|580761695|FG014|Overall Study|Withdrawal by Subject|0|||
160829497|NCT02876328|580761696|FG015|Overall Study|Withdrawal by Subject|0|||
160829498|NCT02876328|580761697|FG016|Overall Study|Withdrawal by Subject|1|||
160829499|NCT02876328|580761698|FG017|Overall Study|Withdrawal by Subject|3|||
160829500|NCT02876328|580761699|FG018|Overall Study|Withdrawal by Subject|0|||
161246660|NCT05034874|582281776|FG001|Overall Study|Withdrawal by Subject|6|||
161246661|NCT05034874|582281775|FG000|Overall Study|Lost to Follow-up|18|||
160829501|NCT02876328|580761700|FG019|Overall Study|Withdrawal by Subject|0|||
160829502|NCT02876328|580761701|FG020|Overall Study|Withdrawal by Subject|1|||
160829503|NCT02876328|580761702|FG021|Overall Study|Withdrawal by Subject|0|||
160829504|NCT02876328|580761703|FG022|Overall Study|Withdrawal by Subject|0|||
160829505|NCT02876328|580761704|FG023|Overall Study|Withdrawal by Subject|0|||
160829506|NCT02876328|580761681|FG000|Overall Study|Missed 12 Month Visit|15|||
160829507|NCT02876328|580761682|FG001|Overall Study|Missed 12 Month Visit|10|||
160829508|NCT02876328|580761683|FG002|Overall Study|Missed 12 Month Visit|11|||
160829509|NCT02876328|580761684|FG003|Overall Study|Missed 12 Month Visit|6|||
160829510|NCT02876328|580761685|FG004|Overall Study|Missed 12 Month Visit|10|||
160829511|NCT02876328|580761686|FG005|Overall Study|Missed 12 Month Visit|14|||
160829512|NCT02876328|580761687|FG006|Overall Study|Missed 12 Month Visit|3|||
160829513|NCT02876328|580761688|FG007|Overall Study|Missed 12 Month Visit|8|||
160829514|NCT02876328|580761689|FG008|Overall Study|Missed 12 Month Visit|9|||
160829515|NCT02876328|580761690|FG009|Overall Study|Missed 12 Month Visit|5|||
160829516|NCT02876328|580761691|FG010|Overall Study|Missed 12 Month Visit|4|||
160829517|NCT02876328|580761692|FG011|Overall Study|Missed 12 Month Visit|1|||
160829518|NCT02876328|580761693|FG012|Overall Study|Missed 12 Month Visit|5|||
161246662|NCT05034874|582281776|FG001|Overall Study|Lost to Follow-up|8|||
160829519|NCT02876328|580761694|FG013|Overall Study|Missed 12 Month Visit|4|||
160829520|NCT02876328|580761695|FG014|Overall Study|Missed 12 Month Visit|4|||
160829521|NCT02876328|580761696|FG015|Overall Study|Missed 12 Month Visit|4|||
160829522|NCT02876328|580761697|FG016|Overall Study|Missed 12 Month Visit|3|||
160829523|NCT02876328|580761698|FG017|Overall Study|Missed 12 Month Visit|6|||
160829524|NCT02876328|580761699|FG018|Overall Study|Missed 12 Month Visit|2|||
160829525|NCT02876328|580761700|FG019|Overall Study|Missed 12 Month Visit|2|||
160829526|NCT02876328|580761701|FG020|Overall Study|Missed 12 Month Visit|11|||
160829527|NCT02876328|580761702|FG021|Overall Study|Missed 12 Month Visit|7|||
161246663|NCT05034874|582281775|FG000|Overall Study|Physician Decision|0|||
160829528|NCT02876328|580761703|FG022|Overall Study|Missed 12 Month Visit|1|||
160829529|NCT02876328|580761704|FG023|Overall Study|Missed 12 Month Visit|0|||
160829530|NCT00837876|580761708|FG000|Overall Study|Death|2|||
160903138|NCT00094172|581039013|FG001|Overall Study|Primary endpoint met.|0|||
160903139|NCT00094172|581039012|FG000|Overall Study|Started other MS therapy due to disease|1|||
160903140|NCT00094172|581039013|FG001|Overall Study|Started other MS therapy due to disease|0|||
160903141|NCT01020981|581039016|FG000|Overall Study|Did not return mailed survey|74|||
161246664|NCT05034874|582281776|FG001|Overall Study|Physician Decision|1|||
160903142|NCT01020981|581039017|FG001|Overall Study|Did not return mailed survey|58|||
160903143|NCT01020981|581039016|FG000|Overall Study|Survey returned undeliverable|8|||
160829531|NCT00837876|580761708|FG000|Overall Study|Adverse Event|7|||
160829532|NCT00837876|580761708|FG000|Overall Study|Physician Decision|1|||
160829533|NCT00837876|580761708|FG000|Overall Study|Withdrawal by Subject|3|||
160829534|NCT00837876|580761708|FG000|Overall Study|disease progression|24|||
160829535|NCT03464422|580761712|FG000|Overall Study|Lost to Follow-up|2|||
160829536|NCT03464422|580761712|FG000|Overall Study|Withdrawal by Subject|2|||
160829537|NCT01628367|580761713|FG000|Overall Study|Adverse Event|1|||
160829538|NCT01628367|580761714|FG001|Overall Study|Adverse Event|0|||
160829539|NCT03461406|580761721|FG000|Overall Study|Death|1|||
160829540|NCT03461406|580761722|FG001|Overall Study|Death|2|||
160829541|NCT03461406|580761721|FG000|Overall Study|Consent Withdrawn by Participant|0|||
160829542|NCT03461406|580761722|FG001|Overall Study|Consent Withdrawn by Participant|1|||
160829543|NCT03461406|580761721|FG000|Overall Study|Screen Failure|3|||
160829544|NCT03461406|580761722|FG001|Overall Study|Screen Failure|1|||
160829545|NCT03461406|580761721|FG000|Overall Study|Reason not Specified|1|||
160829546|NCT03461406|580761722|FG001|Overall Study|Reason not Specified|3|||
160829547|NCT03461406|580761721|FG000|Overall Study|Lost to Follow-up|3|||
160829548|NCT03461406|580761722|FG001|Overall Study|Lost to Follow-up|0|||
160829549|NCT01439074|580761723|FG000|Overall Study|Lost to Follow-up|3|||
160829550|NCT01439074|580761724|FG001|Overall Study|Lost to Follow-up|4|||
160829551|NCT01439074|580761723|FG000|Overall Study|Subject shedding|1|||
160829552|NCT01439074|580761724|FG001|Overall Study|Subject shedding|0|||
160829553|NCT01439074|580761723|FG000|Overall Study|Withdrawal by Subject|1|||
160829554|NCT01439074|580761724|FG001|Overall Study|Withdrawal by Subject|5|||
160829555|NCT01439074|580761723|FG000|Overall Study|Other|4|||
160829556|NCT01439074|580761724|FG001|Overall Study|Other|4|||
160829557|NCT02242981|580761729|FG000|Overall Study|Withdrawal by Subject|1|||
160829558|NCT03474081|580761730|FG000|Overall Study|Adverse Event|6|||
160829559|NCT03474081|580761731|FG001|Overall Study|Adverse Event|3|||
160829560|NCT03474081|580761730|FG000|Overall Study|Lost to Follow-up|2|||
160829561|NCT03474081|580761731|FG001|Overall Study|Lost to Follow-up|1|||
160829562|NCT03474081|580761730|FG000|Overall Study|Physician Decision|3|||
160829563|NCT03474081|580761731|FG001|Overall Study|Physician Decision|2|||
160829564|NCT03474081|580761730|FG000|Overall Study|Withdrawal by Subject|5|||
160829565|NCT03474081|580761731|FG001|Overall Study|Withdrawal by Subject|7|||
160829566|NCT03474081|580761730|FG000|Overall Study|Investigator site closed|1|||
160829567|NCT03474081|580761731|FG001|Overall Study|Investigator site closed|0|||
160829568|NCT01977690|580761732|FG000|Overall Study|Withdrawal by Subject|0|||
160829569|NCT01977690|580761733|FG001|Overall Study|Withdrawal by Subject|4|||
160829570|NCT01711866|580761737|FG000|Overall Study|Noncompliant|3|||
160829571|NCT01711866|580761737|FG000|Overall Study|Withdrawal by Subject|3|||
160829572|NCT01711866|580761737|FG000|Overall Study|Adverse Event|2|||
160829573|NCT00459537|580761738|FG000|Overall Study|Adverse Event|1|||
160829574|NCT00459537|580761739|FG001|Overall Study|Adverse Event|6|||
160829575|NCT00459537|580761738|FG000|Overall Study|Lack of Efficacy|10|||
160829576|NCT00459537|580761739|FG001|Overall Study|Lack of Efficacy|11|||
160829577|NCT00459537|580761738|FG000|Overall Study|Withdrawal by Subject|20|||
160829578|NCT00459537|580761739|FG001|Overall Study|Withdrawal by Subject|26|||
160829579|NCT00459537|580761738|FG000|Overall Study|Lost to Follow-up|27|||
160829580|NCT00459537|580761739|FG001|Overall Study|Lost to Follow-up|30|||
160829581|NCT00459537|580761738|FG000|Overall Study|Administrative problems|3|||
160829582|NCT00459537|580761739|FG001|Overall Study|Administrative problems|0|||
160829583|NCT00459537|580761738|FG000|Overall Study|Protocol Violation|4|||
160829584|NCT00459537|580761739|FG001|Overall Study|Protocol Violation|3|||
160829585|NCT00459537|580761738|FG000|Overall Study|Missing|1|||
160829586|NCT00459537|580761739|FG001|Overall Study|Missing|0|||
160829587|NCT00456599|580761741|FG000|Overall Study|Non-compliance|1|||
160829588|NCT00456599|580761741|FG000|Overall Study|Withdrawal by Subject|2|||
160829589|NCT00260065|580761742|FG000|Overall Study|Progressive Disease|22|||
160829590|NCT00260065|580761742|FG000|Overall Study|Adverse Event|17|||
160829591|NCT00260065|580761742|FG000|Overall Study|Death|13|||
160829592|NCT00260065|580761742|FG000|Overall Study|Withdrawal by Subject|13|||
160829593|NCT00260065|580761742|FG000|Overall Study|Physician Decision|19|||
160829594|NCT00260065|580761742|FG000|Overall Study|Not otherwise specified|8|||
160829595|NCT00260065|580761742|FG000|Overall Study|Medication Noncompliance|1|||
160829596|NCT02198235|580761743|FG000|Overall Study|Lost to Follow-up|3|||
160829597|NCT02198235|580761744|FG001|Overall Study|Lost to Follow-up|2|||
161246665|NCT05034874|582281775|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
161246666|NCT05034874|582281776|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
161246667|NCT01867658|582281777|FG000|Overall Study|Withdrawal by Subject|6|||
161246668|NCT01867658|582281777|FG000|Overall Study|Death|2|||
161246669|NCT01867658|582281777|FG000|Overall Study|Subject could not be contacted|1|||
161246670|NCT03101358|582281778|FG000|Overall Study|Non-compliance with study schedule|1|||
160829598|NCT02198235|580761745|FG002|Overall Study|Lost to Follow-up|2|||
160829599|NCT05565937|580763847|FG000|Overall Study|Adverse Event|0|||
160829600|NCT05565937|580763848|FG001|Overall Study|Adverse Event|1|||
161246671|NCT03101358|582281779|FG001|Overall Study|Non-compliance with study schedule|0|||
160829601|NCT05565937|580763847|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
160829602|NCT05565937|580763848|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
160829603|NCT05565937|580763847|FG000|Overall Study|Lost to Follow-up|2|||
160829604|NCT05565937|580763848|FG001|Overall Study|Lost to Follow-up|0|||
160829605|NCT05565937|580763847|FG000|Overall Study|Pregnancy|0|||
160829606|NCT05565937|580763848|FG001|Overall Study|Pregnancy|2|||
160829607|NCT05565937|580763847|FG000|Overall Study|Anisometropia|0|||
160829608|NCT05565937|580763848|FG001|Overall Study|Anisometropia|1|||
160829609|NCT04544683|580763849|FG000|Overall Study|Lost to Follow-up|2|||
160829610|NCT04544683|580763849|FG000|Overall Study|Underwent cervical spine surgery|6|||
160829611|NCT00151372|580763850|FG000|Overall Study|Death|12|||
160829612|NCT00151372|580763851|FG001|Overall Study|Death|11|||
160829613|NCT00151372|580763850|FG000|Overall Study|Lost to Follow-up|5|||
160829614|NCT00151372|580763851|FG001|Overall Study|Lost to Follow-up|5|||
160829615|NCT00151372|580763850|FG000|Overall Study|Too sick medically to continue|5|||
160829616|NCT00151372|580763851|FG001|Overall Study|Too sick medically to continue|6|||
160829617|NCT00151372|580763850|FG000|Overall Study|Withdrawal by Subject|7|||
160829618|NCT00151372|580763851|FG001|Overall Study|Withdrawal by Subject|7|||
160829619|NCT04732949|580763852|FG000|Overall Study|Withdrawal by Subject|23|||
160829620|NCT04732949|580763853|FG001|Overall Study|Withdrawal by Subject|27|||
160829621|NCT04732949|580763852|FG000|Overall Study|Protocol Violation|0|||
160829622|NCT04732949|580763853|FG001|Overall Study|Protocol Violation|1|||
160829623|NCT04732949|580763852|FG000|Overall Study|Non-compliance|0|||
160829624|NCT04732949|580763853|FG001|Overall Study|Non-compliance|2|||
160829625|NCT04732949|580763852|FG000|Overall Study|Physician Decision|2|||
160829626|NCT04732949|580763853|FG001|Overall Study|Physician Decision|1|||
160829627|NCT04732949|580763852|FG000|Overall Study|Serious adverse event (Fatal)|16|||
160829628|NCT04732949|580763853|FG001|Overall Study|Serious adverse event (Fatal)|18|||
160829629|NCT04732949|580763852|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
160829630|NCT04732949|580763853|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
160829631|NCT04732949|580763852|FG000|Overall Study|Non-serious adverse event|1|||
160829632|NCT04732949|580763853|FG001|Overall Study|Non-serious adverse event|3|||
160829633|NCT04732949|580763852|FG000|Overall Study|Lost to Follow-up|26|||
160829634|NCT04732949|580763853|FG001|Overall Study|Lost to Follow-up|27|||
160829635|NCT04732949|580763852|FG000|Overall Study|Other|6|||
160829636|NCT04732949|580763853|FG001|Overall Study|Other|3|||
160829637|NCT01023672|580763854|FG000|Overall Study|Worsening disease|2|||
160829638|NCT01023672|580763854|FG000|Overall Study|Death|1|||
160829639|NCT01286077|580763855|FG000|Overall Study|Adverse Event|2|||
160829640|NCT01286077|580763856|FG001|Overall Study|Adverse Event|0|||
160829641|NCT01286077|580763855|FG000|Overall Study|Death|1|||
160829642|NCT01286077|580763856|FG001|Overall Study|Death|0|||
160829643|NCT01286077|580763855|FG000|Overall Study|Protocol Violation|1|||
160829644|NCT01286077|580763856|FG001|Overall Study|Protocol Violation|1|||
160829645|NCT01286077|580763855|FG000|Overall Study|Withdrawal by Subject|0|||
160829646|NCT01286077|580763856|FG001|Overall Study|Withdrawal by Subject|2|||
160829647|NCT01286077|580763855|FG000|Overall Study|Intercurrent illness|1|||
160829648|NCT01286077|580763856|FG001|Overall Study|Intercurrent illness|0|||
160829649|NCT01286077|580763855|FG000|Overall Study|Non-compliance|1|||
160829650|NCT01286077|580763856|FG001|Overall Study|Non-compliance|0|||
160829651|NCT01286077|580763855|FG000|Overall Study|The subject starts with alternative MMY|0|||
160829652|NCT01286077|580763856|FG001|Overall Study|The subject starts with alternative MMY|3|||
160829653|NCT01286077|580763855|FG000|Overall Study|Patient's decision to stop treatment|3|||
160829654|NCT01286077|580763856|FG001|Overall Study|Patient's decision to stop treatment|0|||
160829655|NCT01286077|580763855|FG000|Overall Study|Progression of disease|0|||
160829656|NCT01286077|580763856|FG001|Overall Study|Progression of disease|1|||
160829657|NCT01286077|580763855|FG000|Overall Study|refill medication not received in time|1|||
160829658|NCT01286077|580763856|FG001|Overall Study|refill medication not received in time|0|||
160829659|NCT01282294|580763857|FG000|Overall Study|Lost to Follow-up|14|||
160829660|NCT01282294|580763857|FG000|Overall Study|Screening failure|1|||
160829661|NCT01282294|580763857|FG000|Overall Study|Adverse Event|1|||
160903144|NCT01020981|581039017|FG001|Overall Study|Survey returned undeliverable|32|||
160903145|NCT01020981|581039016|FG000|Overall Study|Participant declined to complete survey|2|||
160903146|NCT01020981|581039017|FG001|Overall Study|Participant declined to complete survey|0|||
160903147|NCT00289133|581039024|FG000|Overall Study|Non-study device implanted|12|||
160903148|NCT00289133|581039025|FG001|Overall Study|Non-study device implanted|0|||
160903149|NCT00289133|581039024|FG000|Overall Study|Protocol Violation|32|||
160903150|NCT00289133|581039025|FG001|Overall Study|Protocol Violation|38|||
160903151|NCT00289133|581039024|FG000|Overall Study|Withdrawal by Subject|9|||
160903152|NCT00289133|581039025|FG001|Overall Study|Withdrawal by Subject|10|||
160829662|NCT01282294|580763857|FG000|Overall Study|Patient non-compliance|2|||
160829663|NCT01282294|580763857|FG000|Overall Study|Physician Decision|1|||
161246672|NCT03101358|582281780|FG002|Overall Study|Non-compliance with study schedule|0|||
160829664|NCT02408523|580763858|FG000|Overall Study|Adverse Event|4|||
160829665|NCT02408523|580763859|FG001|Overall Study|Adverse Event|10|||
160903153|NCT00289133|581039024|FG000|Overall Study|Death|5|||
160829666|NCT02408523|580763858|FG000|Overall Study|Lack of Efficacy|0|||
160829667|NCT02408523|580763859|FG001|Overall Study|Lack of Efficacy|1|||
160829668|NCT02408523|580763858|FG000|Overall Study|Protocol Violation|1|||
160829669|NCT02408523|580763859|FG001|Overall Study|Protocol Violation|2|||
160829670|NCT02408523|580763858|FG000|Overall Study|Lost to Follow-up|2|||
160829671|NCT02408523|580763859|FG001|Overall Study|Lost to Follow-up|3|||
160903154|NCT00289133|581039025|FG001|Overall Study|Death|10|||
160829672|NCT02408523|580763858|FG000|Overall Study|Withdrawal by Subject|3|||
160829673|NCT02408523|580763859|FG001|Overall Study|Withdrawal by Subject|1|||
160829674|NCT02408523|580763858|FG000|Overall Study|Sponsor request|1|||
160829675|NCT02408523|580763859|FG001|Overall Study|Sponsor request|0|||
160829676|NCT02408523|580763858|FG000|Overall Study|Did not satisfy extension conditions|0|||
160829677|NCT02408523|580763859|FG001|Overall Study|Did not satisfy extension conditions|1|||
160829678|NCT00996801|580763863|FG000|Overall Study|Adverse Event|6|||
160829679|NCT00996801|580763864|FG001|Overall Study|Adverse Event|4|||
160829680|NCT00996801|580763865|FG002|Overall Study|Adverse Event|12|||
160829681|NCT00996801|580763866|FG003|Overall Study|Adverse Event|17|||
160829682|NCT00996801|580763867|FG004|Overall Study|Adverse Event|31|||
160829683|NCT00996801|580763868|FG005|Overall Study|Adverse Event|3|||
160829684|NCT00996801|580763863|FG000|Overall Study|Lack of Efficacy|3|||
160829685|NCT00996801|580763864|FG001|Overall Study|Lack of Efficacy|0|||
160829686|NCT00996801|580763865|FG002|Overall Study|Lack of Efficacy|1|||
160829687|NCT00996801|580763866|FG003|Overall Study|Lack of Efficacy|3|||
160829688|NCT00996801|580763867|FG004|Overall Study|Lack of Efficacy|0|||
160829689|NCT00996801|580763868|FG005|Overall Study|Lack of Efficacy|1|||
160829690|NCT00996801|580763863|FG000|Overall Study|Lost to Follow-up|0|||
160829691|NCT00996801|580763864|FG001|Overall Study|Lost to Follow-up|0|||
160829692|NCT00996801|580763865|FG002|Overall Study|Lost to Follow-up|0|||
160829693|NCT00996801|580763866|FG003|Overall Study|Lost to Follow-up|3|||
160829694|NCT00996801|580763867|FG004|Overall Study|Lost to Follow-up|3|||
160829695|NCT00996801|580763868|FG005|Overall Study|Lost to Follow-up|2|||
160829696|NCT00996801|580763863|FG000|Overall Study|Physician Decision|0|||
160829697|NCT00996801|580763864|FG001|Overall Study|Physician Decision|0|||
160829698|NCT00996801|580763865|FG002|Overall Study|Physician Decision|0|||
160829699|NCT00996801|580763866|FG003|Overall Study|Physician Decision|1|||
160829700|NCT00996801|580763867|FG004|Overall Study|Physician Decision|0|||
160829701|NCT00996801|580763868|FG005|Overall Study|Physician Decision|0|||
160829702|NCT00996801|580763863|FG000|Overall Study|Progressive Disease|0|||
160829703|NCT00996801|580763864|FG001|Overall Study|Progressive Disease|1|||
160829704|NCT00996801|580763865|FG002|Overall Study|Progressive Disease|0|||
160829705|NCT00996801|580763866|FG003|Overall Study|Progressive Disease|0|||
160829706|NCT00996801|580763867|FG004|Overall Study|Progressive Disease|0|||
160829707|NCT00996801|580763868|FG005|Overall Study|Progressive Disease|0|||
160829708|NCT00996801|580763863|FG000|Overall Study|Protocol Violation|3|||
160829709|NCT00996801|580763864|FG001|Overall Study|Protocol Violation|4|||
160829710|NCT00996801|580763865|FG002|Overall Study|Protocol Violation|1|||
160829711|NCT00996801|580763866|FG003|Overall Study|Protocol Violation|2|||
160829712|NCT00996801|580763867|FG004|Overall Study|Protocol Violation|3|||
160829713|NCT00996801|580763868|FG005|Overall Study|Protocol Violation|4|||
160829714|NCT00996801|580763863|FG000|Overall Study|Study Terminated by Sponsor|0|||
160829715|NCT00996801|580763864|FG001|Overall Study|Study Terminated by Sponsor|1|||
160829716|NCT00996801|580763865|FG002|Overall Study|Study Terminated by Sponsor|0|||
160829717|NCT00996801|580763866|FG003|Overall Study|Study Terminated by Sponsor|0|||
160829718|NCT00996801|580763867|FG004|Overall Study|Study Terminated by Sponsor|46|||
160829719|NCT00996801|580763868|FG005|Overall Study|Study Terminated by Sponsor|0|||
160829720|NCT00996801|580763863|FG000|Overall Study|Withdrawal by Subject|8|||
160829721|NCT00996801|580763864|FG001|Overall Study|Withdrawal by Subject|6|||
160829722|NCT00996801|580763865|FG002|Overall Study|Withdrawal by Subject|9|||
160829723|NCT00996801|580763866|FG003|Overall Study|Withdrawal by Subject|5|||
160829724|NCT00996801|580763867|FG004|Overall Study|Withdrawal by Subject|5|||
160829725|NCT00996801|580763868|FG005|Overall Study|Withdrawal by Subject|9|||
160829726|NCT00289198|580763869|FG000|Overall Study|Adverse Event|0|||
160829727|NCT00289198|580763870|FG001|Overall Study|Adverse Event|2|||
160829728|NCT00289198|580763869|FG000|Overall Study|Protocol Violation|2|||
160829729|NCT00289198|580763870|FG001|Overall Study|Protocol Violation|1|||
160829730|NCT00289198|580763869|FG000|Overall Study|Withdrawal by Subject|4|||
160829731|NCT00289198|580763870|FG001|Overall Study|Withdrawal by Subject|1|||
160829732|NCT00289198|580763869|FG000|Overall Study|Lack of Efficacy|2|||
160829733|NCT00289198|580763870|FG001|Overall Study|Lack of Efficacy|0|||
160829734|NCT00289198|580763869|FG000|Overall Study|Other: Low compliance|0|||
160829735|NCT00289198|580763870|FG001|Overall Study|Other: Low compliance|1|||
160829736|NCT00289198|580763869|FG000|Overall Study|Other: Physician's decision|0|||
160829737|NCT00289198|580763870|FG001|Overall Study|Other: Physician's decision|1|||
160829738|NCT00289198|580763869|FG000|Overall Study|Other: Unable to attend on schedule|2|||
160829739|NCT00289198|580763870|FG001|Overall Study|Other: Unable to attend on schedule|1|||
160829740|NCT00289198|580763869|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
160829741|NCT00289198|580763870|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
160829742|NCT00289198|580763869|FG000|Overall Study|Other: Impossible to come on visit|0|||
160829743|NCT00289198|580763870|FG001|Overall Study|Other: Impossible to come on visit|1|||
160829744|NCT03369431|580763872|FG000|Overall Study|Lost to Follow-up|1|||
160829745|NCT03369431|580763873|FG001|Overall Study|Lost to Follow-up|3|||
160829746|NCT03369431|580763872|FG000|Overall Study|Withdrawal by Subject|2|||
160829747|NCT03369431|580763873|FG001|Overall Study|Withdrawal by Subject|3|||
160829748|NCT03369431|580763872|FG000|Overall Study|Protocol Violation|1|||
161246673|NCT03101358|582281781|FG003|Overall Study|Non-compliance with study schedule|1|||
160829749|NCT03369431|580763873|FG001|Overall Study|Protocol Violation|1|||
160829750|NCT01062061|580763874|FG000|Overall Study|Enrolled more than once|2|||
160829751|NCT01062061|580763874|FG000|Overall Study|Investigated before study start|13|||
160829752|NCT01062061|580763874|FG000|Overall Study|Outside chief indications|10|||
160829753|NCT01062061|580763874|FG000|Overall Study|Failed to meet inclusion criteria|2|||
160829754|NCT06250738|580763875|FG000|Overall Study|Lost to Follow-up|1|||
160829755|NCT02046070|580763880|FG000|Overall Study|Progressive Disease|18|||
161136225|NCT00929240|581879434|FG001|Maintenance Phase|Participant not treated|2|||
161136226|NCT00929240|581879435|FG002|Maintenance Phase|Participant not treated|0|||
161136227|NCT01147809|581879436|FG000|Phase I (168 Days)|Adverse Event|0|||
161136228|NCT01147809|581879437|FG001|Phase I (168 Days)|Adverse Event|0|||
161136229|NCT01147809|581879438|FG002|Phase I (168 Days)|Adverse Event|0|||
161136230|NCT01147809|581879439|FG003|Phase I (168 Days)|Adverse Event|1|||
161136231|NCT01147809|581879440|FG004|Phase I (168 Days)|Adverse Event|0|||
161136232|NCT01147809|581879441|FG005|Phase I (168 Days)|Adverse Event|0|||
161136233|NCT01147809|581879436|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
161136234|NCT01147809|581879437|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
161136235|NCT01147809|581879438|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
161136236|NCT01147809|581879439|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
161136237|NCT01147809|581879440|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
161136238|NCT01147809|581879441|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
161136239|NCT01147809|581879436|FG000|Phase I (168 Days)|Physician Decision|0|||
161136240|NCT01147809|581879437|FG001|Phase I (168 Days)|Physician Decision|1|||
161136241|NCT01147809|581879438|FG002|Phase I (168 Days)|Physician Decision|2|||
161136242|NCT01147809|581879439|FG003|Phase I (168 Days)|Physician Decision|0|||
161136243|NCT01147809|581879440|FG004|Phase I (168 Days)|Physician Decision|0|||
161136244|NCT01147809|581879441|FG005|Phase I (168 Days)|Physician Decision|0|||
160829756|NCT02046070|580763881|FG001|Overall Study|Progressive Disease|11|||
160829757|NCT02046070|580763882|FG002|Overall Study|Progressive Disease|40|||
160829758|NCT02046070|580763880|FG000|Overall Study|Adverse Event|8|||
160829759|NCT02046070|580763881|FG001|Overall Study|Adverse Event|10|||
160829760|NCT02046070|580763882|FG002|Overall Study|Adverse Event|17|||
160829761|NCT02046070|580763880|FG000|Overall Study|Withdrawal by Subject|1|||
160829762|NCT02046070|580763881|FG001|Overall Study|Withdrawal by Subject|2|||
160829763|NCT02046070|580763882|FG002|Overall Study|Withdrawal by Subject|6|||
160829764|NCT02046070|580763880|FG000|Overall Study|Study Terminated by Sponsor|1|||
160829765|NCT02046070|580763881|FG001|Overall Study|Study Terminated by Sponsor|1|||
160829766|NCT02046070|580763882|FG002|Overall Study|Study Terminated by Sponsor|1|||
160829767|NCT02046070|580763880|FG000|Overall Study|Reason not Specified|4|||
160829768|NCT02046070|580763881|FG001|Overall Study|Reason not Specified|4|||
160829769|NCT02046070|580763882|FG002|Overall Study|Reason not Specified|6|||
160829770|NCT04619004|580763885|FG000|Overall Study|Death|114|||
160829771|NCT04619004|580763886|FG001|Overall Study|Death|28|||
160829772|NCT04619004|580763885|FG000|Overall Study|Lost to Follow-up|1|||
160829773|NCT04619004|580763886|FG001|Overall Study|Lost to Follow-up|1|||
160829774|NCT04619004|580763885|FG000|Overall Study|Withdrawal by Subject|24|||
160829775|NCT04619004|580763886|FG001|Overall Study|Withdrawal by Subject|7|||
160829776|NCT04619004|580763885|FG000|Overall Study|Other - Not specified|0|||
160829777|NCT04619004|580763886|FG001|Overall Study|Other - Not specified|1|||
160829778|NCT04030962|580763887|FG000|Stage 2|Adverse Event|0|||
160829779|NCT04030962|580763888|FG001|Stage 2|Adverse Event|0|||
160829780|NCT04030962|580763889|FG002|Stage 2|Adverse Event|0|||
160829781|NCT04030962|580763890|FG003|Stage 2|Adverse Event|0|||
160829782|NCT04030962|580763891|FG004|Stage 2|Adverse Event|0|||
160829783|NCT04030962|580763892|FG005|Stage 2|Adverse Event|0|||
160829784|NCT04030962|580763893|FG006|Stage 2|Adverse Event|0|||
160829785|NCT04030962|580763894|FG007|Stage 2|Adverse Event|0|||
160829786|NCT04030962|580763895|FG008|Stage 2|Adverse Event|1|||
160829787|NCT04030962|580763896|FG009|Stage 2|Adverse Event|0|||
160829788|NCT04030962|580763897|FG010|Stage 2|Adverse Event|1|||
160829789|NCT04030962|580763898|FG011|Stage 2|Adverse Event|1|||
160829790|NCT04030962|580763899|FG012|Stage 2|Adverse Event|1|||
160829791|NCT04030962|580763887|FG000|Stage 2|Withdrawal by Subject|0|||
160829792|NCT04030962|580763888|FG001|Stage 2|Withdrawal by Subject|0|||
160829793|NCT04030962|580763889|FG002|Stage 2|Withdrawal by Subject|0|||
160829794|NCT04030962|580763890|FG003|Stage 2|Withdrawal by Subject|0|||
160829795|NCT04030962|580763891|FG004|Stage 2|Withdrawal by Subject|0|||
160829796|NCT04030962|580763892|FG005|Stage 2|Withdrawal by Subject|0|||
160829797|NCT04030962|580763893|FG006|Stage 2|Withdrawal by Subject|0|||
160829798|NCT04030962|580763894|FG007|Stage 2|Withdrawal by Subject|0|||
160829799|NCT04030962|580763895|FG008|Stage 2|Withdrawal by Subject|1|||
160829800|NCT04030962|580763896|FG009|Stage 2|Withdrawal by Subject|0|||
160829801|NCT04030962|580763897|FG010|Stage 2|Withdrawal by Subject|0|||
160829802|NCT04030962|580763898|FG011|Stage 2|Withdrawal by Subject|2|||
160829803|NCT04030962|580763899|FG012|Stage 2|Withdrawal by Subject|1|||
160829804|NCT04030962|580763887|FG000|Stage 2|Lost to Follow-up|0|||
161136245|NCT01147809|581879436|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
161136246|NCT01147809|581879437|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
161136247|NCT01147809|581879438|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
161136248|NCT01147809|581879439|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
161246674|NCT03101358|582281778|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161246675|NCT03101358|582281779|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161246676|NCT03101358|582281780|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
161246677|NCT03101358|582281781|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
161246678|NCT03101358|582281778|FG000|Overall Study|Physician Decision|1|||
161246679|NCT03101358|582281779|FG001|Overall Study|Physician Decision|0|||
161246680|NCT03101358|582281780|FG002|Overall Study|Physician Decision|0|||
161246681|NCT03101358|582281781|FG003|Overall Study|Physician Decision|3|||
161246682|NCT03101358|582281778|FG000|Overall Study|Adverse Event|0|||
160829805|NCT04030962|580763888|FG001|Stage 2|Lost to Follow-up|0|||
160829806|NCT04030962|580763889|FG002|Stage 2|Lost to Follow-up|0|||
160829807|NCT04030962|580763890|FG003|Stage 2|Lost to Follow-up|0|||
160829808|NCT04030962|580763891|FG004|Stage 2|Lost to Follow-up|0|||
160829809|NCT04030962|580763892|FG005|Stage 2|Lost to Follow-up|0|||
160829810|NCT04030962|580763893|FG006|Stage 2|Lost to Follow-up|0|||
161246683|NCT03101358|582281779|FG001|Overall Study|Adverse Event|0|||
160829811|NCT04030962|580763894|FG007|Stage 2|Lost to Follow-up|0|||
160829812|NCT04030962|580763895|FG008|Stage 2|Lost to Follow-up|1|||
160829813|NCT04030962|580763896|FG009|Stage 2|Lost to Follow-up|0|||
160829814|NCT04030962|580763897|FG010|Stage 2|Lost to Follow-up|0|||
160829815|NCT04030962|580763898|FG011|Stage 2|Lost to Follow-up|0|||
160829816|NCT04030962|580763899|FG012|Stage 2|Lost to Follow-up|0|||
160829817|NCT04030962|580763887|FG000|Stage 2|Technical Problems|0|||
160829818|NCT04030962|580763888|FG001|Stage 2|Technical Problems|0|||
160829819|NCT04030962|580763889|FG002|Stage 2|Technical Problems|0|||
160829820|NCT04030962|580763890|FG003|Stage 2|Technical Problems|0|||
160829821|NCT04030962|580763891|FG004|Stage 2|Technical Problems|0|||
160829822|NCT04030962|580763892|FG005|Stage 2|Technical Problems|0|||
160829823|NCT04030962|580763893|FG006|Stage 2|Technical Problems|0|||
160829824|NCT04030962|580763894|FG007|Stage 2|Technical Problems|0|||
160903155|NCT00289133|581039024|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
161246684|NCT03101358|582281780|FG002|Overall Study|Adverse Event|1|||
161246685|NCT03101358|582281781|FG003|Overall Study|Adverse Event|0|||
161246686|NCT03101358|582281778|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161246687|NCT03101358|582281779|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161246688|NCT03101358|582281780|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
161246689|NCT03101358|582281781|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
161246690|NCT03101358|582281778|FG000|Overall Study|Lost to Follow-up|1|||
161246691|NCT03101358|582281779|FG001|Overall Study|Lost to Follow-up|0|||
161246692|NCT03101358|582281780|FG002|Overall Study|Lost to Follow-up|0|||
161246693|NCT03101358|582281781|FG003|Overall Study|Lost to Follow-up|1|||
161246694|NCT00474058|582281782|FG000|Overall Study|Adverse Event|11|||
161246695|NCT00474058|582281783|FG001|Overall Study|Adverse Event|6|||
161246696|NCT00474058|582281782|FG000|Overall Study|Lack of Efficacy|0|||
161246697|NCT00474058|582281783|FG001|Overall Study|Lack of Efficacy|4|||
161246698|NCT00474058|582281782|FG000|Overall Study|Withdrawal by Subject|11|||
161246699|NCT00474058|582281783|FG001|Overall Study|Withdrawal by Subject|7|||
161246700|NCT00474058|582281782|FG000|Overall Study|Other|2|||
161246701|NCT00474058|582281783|FG001|Overall Study|Other|0|||
161246702|NCT02640235|582281784|FG000|Overall Study|Withdrawal by Subject|7|||
161246703|NCT02640235|582281785|FG001|Overall Study|Withdrawal by Subject|6|||
161246704|NCT02640235|582281784|FG000|Overall Study|Lost to Follow-up|4|||
161246705|NCT02640235|582281785|FG001|Overall Study|Lost to Follow-up|3|||
161246706|NCT02640235|582281784|FG000|Overall Study|Death|2|||
161246707|NCT02640235|582281785|FG001|Overall Study|Death|3|||
161246708|NCT02640235|582281784|FG000|Overall Study|Other|1|||
161246709|NCT02640235|582281785|FG001|Overall Study|Other|2|||
161246710|NCT02426918|582281786|FG000|Overall Study|Adverse Event|2|||
161246711|NCT02426918|582281787|FG001|Overall Study|Adverse Event|2|||
160829825|NCT04030962|580763895|FG008|Stage 2|Technical Problems|0|||
160829826|NCT04030962|580763896|FG009|Stage 2|Technical Problems|0|||
160829827|NCT04030962|580763897|FG010|Stage 2|Technical Problems|0|||
160903156|NCT00289133|581039025|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
160903157|NCT00289133|581039024|FG000|Overall Study|Physician Decision|41|||
160903158|NCT00289133|581039025|FG001|Overall Study|Physician Decision|45|||
161246712|NCT02426918|582281788|FG002|Overall Study|Adverse Event|0|||
161246713|NCT02426918|582281786|FG000|Overall Study|Physician Decision|1|||
161246714|NCT02426918|582281787|FG001|Overall Study|Physician Decision|1|||
160829828|NCT04030962|580763898|FG011|Stage 2|Technical Problems|1|||
160829829|NCT04030962|580763899|FG012|Stage 2|Technical Problems|0|||
160829830|NCT05601102|580763903|FG000|Overall Study|Death|1|||
161246715|NCT02426918|582281788|FG002|Overall Study|Physician Decision|1|||
161246716|NCT02426918|582281786|FG000|Overall Study|Withdrawal by Subject|5|||
161246717|NCT02426918|582281787|FG001|Overall Study|Withdrawal by Subject|5|||
160829831|NCT05601102|580763904|FG001|Overall Study|Death|2|||
160829832|NCT05601102|580763903|FG000|Overall Study|Withdrawal by Subject|1|||
160903159|NCT00289133|581039024|FG000|Overall Study|Revision|8|||
160829833|NCT05601102|580763904|FG001|Overall Study|Withdrawal by Subject|1|||
160829834|NCT05601102|580763903|FG000|Overall Study|Lost to Follow-up|0|||
160829835|NCT05601102|580763904|FG001|Overall Study|Lost to Follow-up|2|||
160829836|NCT01114360|580763911|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
160829837|NCT01114360|580763912|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
160829838|NCT03007745|580763913|FG000|Overall Study|Sleep test negative for OSA|53|||
160829839|NCT03007745|580763914|FG001|Overall Study|Sleep test negative for OSA|49|||
160829840|NCT03007745|580763913|FG000|Overall Study|Physician Decision|6|||
160829841|NCT03007745|580763914|FG001|Overall Study|Physician Decision|9|||
160829842|NCT03007745|580763913|FG000|Overall Study|Withdrawal by Subject|38|||
160829843|NCT03007745|580763914|FG001|Overall Study|Withdrawal by Subject|16|||
160829844|NCT03007745|580763913|FG000|Overall Study|Lost to Follow-up|19|||
160829845|NCT03007745|580763914|FG001|Overall Study|Lost to Follow-up|25|||
160829846|NCT03007745|580763913|FG000|Overall Study|Unable to login to website|17|||
160829847|NCT03007745|580763914|FG001|Overall Study|Unable to login to website|4|||
160829848|NCT03344172|580763915|FG000|Overall Study|Received <1 dose of treatment|1|||
160829849|NCT03344172|580763916|FG001|Overall Study|Received <1 dose of treatment|0|||
160829850|NCT04912895|580763917|FG000|Overall Study|Unable to provide specimen|2|||
160829851|NCT04912895|580763918|FG001|Overall Study|Unable to provide specimen|0|||
160829852|NCT04912895|580763919|FG002|Overall Study|Unable to provide specimen|0|||
160829853|NCT04284813|580763920|FG000|Overall Study|Withdrawal by Subject|1|||
160829854|NCT01145053|580763926|FG000|Overall Study|Adverse Event|22|||
160829855|NCT01145053|580763926|FG000|Overall Study|Lost to Follow-up|28|||
160829856|NCT01145053|580763926|FG000|Overall Study|Withdrawal by Subject|25|||
160829857|NCT01145053|580763926|FG000|Overall Study|Other|18|||
161246718|NCT02426918|582281788|FG002|Overall Study|Withdrawal by Subject|4|||
161246719|NCT02426918|582281786|FG000|Overall Study|Other|9|||
161246720|NCT02426918|582281787|FG001|Overall Study|Other|11|||
161246721|NCT02426918|582281788|FG002|Overall Study|Other|9|||
161246722|NCT02420353|582281789|FG000|Overall Study|Withdrawal by Subject|0|||
161246723|NCT02420353|582281790|FG001|Overall Study|Withdrawal by Subject|1|||
161246724|NCT00503867|582281791|FG000|Overall Study|Lost to Follow-up|1|||
161246725|NCT00503867|582281791|FG000|Overall Study|Adverse Event|1|||
161246726|NCT05616728|582281792|FG000|Overall Study|Lost to Follow-up|0|||
161246727|NCT05616728|582281793|FG001|Overall Study|Lost to Follow-up|0|||
161246728|NCT05616728|582281794|FG002|Overall Study|Lost to Follow-up|1|||
161246729|NCT05616728|582281792|FG000|Overall Study|Withdrawal by Subject|1|||
161246730|NCT05616728|582281793|FG001|Overall Study|Withdrawal by Subject|1|||
161246731|NCT05616728|582281794|FG002|Overall Study|Withdrawal by Subject|0|||
161246732|NCT05616728|582281792|FG000|Overall Study|Physician Decision|1|||
161246733|NCT05616728|582281793|FG001|Overall Study|Physician Decision|1|||
161246734|NCT05616728|582281794|FG002|Overall Study|Physician Decision|1|||
161246735|NCT05616728|582281792|FG000|Overall Study|Other|0|||
161246736|NCT05616728|582281793|FG001|Overall Study|Other|2|||
161246737|NCT05616728|582281794|FG002|Overall Study|Other|0|||
161246738|NCT05004649|582281799|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
161246739|NCT05004649|582281799|FG000|Overall Study|Lost to Follow-up|1|||
161246740|NCT05004649|582281799|FG000|Overall Study|Withdrawal by Subject|2|||
161246741|NCT05004649|582281799|FG000|Overall Study|COVID-19|1|||
161246742|NCT00301964|582281802|FG000|Overall Study|Second primary|2|||
161246743|NCT00301964|582281802|FG000|Overall Study|Wrong primary|1|||
161246744|NCT00301964|582281802|FG000|Overall Study|Inadequate pathology|1|||
161246745|NCT02385708|582281804|FG000|Overall Study|Withdrawal by Subject|0|||
161246746|NCT02385708|582281805|FG001|Overall Study|Withdrawal by Subject|2|||
161246747|NCT02385708|582281804|FG000|Overall Study|Withdrawn - surgery canceled|2|||
161246748|NCT02385708|582281805|FG001|Overall Study|Withdrawn - surgery canceled|5|||
161246749|NCT02385708|582281804|FG000|Overall Study|Investigator decision|5|||
161246750|NCT02385708|582281805|FG001|Overall Study|Investigator decision|7|||
161246751|NCT02385708|582281804|FG000|Overall Study|Protocol Violation|1|||
160829858|NCT00293709|580763927|FG000|Overall Study|Other|47|||
160829859|NCT02785458|580763928|FG000|1 Month|Withdrawal by Subject|2|||
160829860|NCT02785458|580763929|FG001|1 Month|Withdrawal by Subject|1|||
160829861|NCT02785458|580763928|FG000|1 Month|Lost to Follow-up|38|||
160829862|NCT02785458|580763929|FG001|1 Month|Lost to Follow-up|31|||
161246752|NCT02385708|582281805|FG001|Overall Study|Protocol Violation|1|||
160829863|NCT02785458|580763928|FG000|1 Month|Deemed Ineligible|1|||
160829864|NCT02785458|580763929|FG001|1 Month|Deemed Ineligible|0|||
160829865|NCT02785458|580763928|FG000|1 Month|Completed Evaluation by Baseline|42|||
161246753|NCT02436200|582281806|FG000|Overall Study|Significant outlier|1|||
161246754|NCT02761915|582281807|FG000|Overall Study|Death|3|||
161246755|NCT02761915|582281808|FG001|Overall Study|Death|1|||
161246756|NCT02761915|582281809|FG002|Overall Study|Death|1|||
161246757|NCT02761915|582281810|FG003|Overall Study|Death|1|||
161246758|NCT02761915|582281811|FG004|Overall Study|Death|0|||
161246759|NCT02761915|582281812|FG005|Overall Study|Death|1|||
161246760|NCT02761915|582281807|FG000|Overall Study|Withdrawal by Subject|1|||
161246761|NCT02761915|582281808|FG001|Overall Study|Withdrawal by Subject|0|||
160829866|NCT02785458|580763929|FG001|1 Month|Completed Evaluation by Baseline|39|||
160829867|NCT02785458|580763928|FG000|1 Month|Partial Interview|0|||
160829868|NCT02785458|580763929|FG001|1 Month|Partial Interview|4|||
160829869|NCT02785458|580763928|FG000|3 Months|Withdrawal by Subject|3|||
160829870|NCT02785458|580763929|FG001|3 Months|Withdrawal by Subject|1|||
160829871|NCT02785458|580763928|FG000|3 Months|Lost to Follow-up|25|||
160829872|NCT02785458|580763929|FG001|3 Months|Lost to Follow-up|21|||
161246762|NCT02761915|582281809|FG002|Overall Study|Withdrawal by Subject|0|||
161246763|NCT02761915|582281810|FG003|Overall Study|Withdrawal by Subject|0|||
161246764|NCT02761915|582281811|FG004|Overall Study|Withdrawal by Subject|1|||
161246765|NCT02761915|582281812|FG005|Overall Study|Withdrawal by Subject|2|||
161246766|NCT02761915|582281807|FG000|Overall Study|Disease Progression|0|||
161246767|NCT02761915|582281808|FG001|Overall Study|Disease Progression|0|||
161246768|NCT02761915|582281809|FG002|Overall Study|Disease Progression|0|||
161246769|NCT02761915|582281810|FG003|Overall Study|Disease Progression|2|||
161246770|NCT02761915|582281811|FG004|Overall Study|Disease Progression|2|||
161246771|NCT02761915|582281812|FG005|Overall Study|Disease Progression|2|||
161246772|NCT02654145|582281819|FG000|Overall Study|Lack of Efficacy|1|||
161246773|NCT02654145|582281819|FG000|Overall Study|Protocol Violation|1|||
161246774|NCT02654145|582281819|FG000|Overall Study|Withdrawal by Subject|5|||
161246775|NCT00354835|582281820|FG000|Overall Study|Death|1|||
161246776|NCT00354835|582281821|FG001|Overall Study|Death|1|||
161246777|NCT00354835|582281820|FG000|Overall Study|Physician Decision|8|||
161246778|NCT00354835|582281821|FG001|Overall Study|Physician Decision|13|||
161246779|NCT00354835|582281820|FG000|Overall Study|Withdrawal by Subject|2|||
161246780|NCT00354835|582281821|FG001|Overall Study|Withdrawal by Subject|1|||
161246781|NCT00354835|582281820|FG000|Overall Study|Ineligible|17|||
161246782|NCT00354835|582281821|FG001|Overall Study|Ineligible|16|||
161246783|NCT00354835|582281820|FG000|Overall Study|Disease progression or relapse|15|||
161246784|NCT00354835|582281821|FG001|Overall Study|Disease progression or relapse|22|||
161246785|NCT00354835|582281820|FG000|Overall Study|Adverse Event|6|||
161246786|NCT00354835|582281821|FG001|Overall Study|Adverse Event|0|||
161246787|NCT00354835|582281820|FG000|Overall Study|Refusal of further therapy|3|||
161246788|NCT00354835|582281821|FG001|Overall Study|Refusal of further therapy|8|||
161246789|NCT06475729|582281822|FG000|Overall Study|Withdrawal by Subject|2|||
161246790|NCT06475729|582281823|FG001|Overall Study|Withdrawal by Subject|1|||
161246791|NCT06475729|582281822|FG000|Overall Study|Randomized but did not receive any dose|3|||
161246792|NCT06475729|582281823|FG001|Overall Study|Randomized but did not receive any dose|2|||
161246793|NCT06475729|582281822|FG000|Overall Study|Lost to Follow-up|1|||
161246794|NCT06475729|582281823|FG001|Overall Study|Lost to Follow-up|2|||
161246795|NCT06475729|582281822|FG000|Overall Study|Physician Decision|5|||
161246796|NCT06475729|582281823|FG001|Overall Study|Physician Decision|2|||
161246797|NCT06475729|582281822|FG000|Overall Study|Adverse Event|1|||
161246798|NCT06475729|582281823|FG001|Overall Study|Adverse Event|1|||
161246799|NCT03922750|582281830|FG000|Overall Study|Unclassified|0|||
161246800|NCT03922750|582281831|FG001|Overall Study|Unclassified|0|||
161246801|NCT03922750|582281832|FG002|Overall Study|Unclassified|1|||
161246802|NCT03922750|582281830|FG000|Overall Study|Adverse Event|0|||
161246803|NCT03922750|582281831|FG001|Overall Study|Adverse Event|1|||
161246804|NCT03922750|582281832|FG002|Overall Study|Adverse Event|0|||
161246805|NCT01046084|582281836|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
161246806|NCT01046084|582281837|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
161246807|NCT02166606|582281838|FG000|Overall Study|Adverse Event|3|||
161246808|NCT02166606|582281838|FG000|Overall Study|Death|31|||
161246809|NCT02166606|582281838|FG000|Overall Study|Protocol Violation|7|||
161246810|NCT02166606|582281838|FG000|Overall Study|Lost to Follow-up|30|||
161246811|NCT02166606|582281838|FG000|Overall Study|Withdrawal by Subject|1|||
161246812|NCT02166606|582281838|FG000|Overall Study|Physician Decision|1|||
161246813|NCT02166606|582281838|FG000|Overall Study|Device upgrade|1|||
161246814|NCT02166606|582281838|FG000|Overall Study|Enrolled after End of Enrollment|4|||
161246815|NCT01717040|582281840|FG000|Overall Study|Lost to Follow-up|2|||
161246816|NCT01717040|582281841|FG001|Overall Study|Lost to Follow-up|3|||
161246817|NCT01717040|582281840|FG000|Overall Study|Lack of Efficacy|1|||
161246818|NCT01717040|582281841|FG001|Overall Study|Lack of Efficacy|1|||
160829873|NCT02785458|580763928|FG000|3 Months|Completed Evaluation at 1 Month|100|||
160829874|NCT02785458|580763929|FG001|3 Months|Completed Evaluation at 1 Month|89|||
160829875|NCT01146652|580763930|FG000|Overall Study|Adverse Event|506|||
161246819|NCT01717040|582281840|FG000|Overall Study|Adverse Event|1|||
161246820|NCT01717040|582281841|FG001|Overall Study|Adverse Event|0|||
161246821|NCT01717040|582281840|FG000|Overall Study|Required Medication Change|0|||
161246822|NCT01717040|582281841|FG001|Overall Study|Required Medication Change|1|||
160829876|NCT01146652|580763931|FG001|Overall Study|Adverse Event|15|||
160829877|NCT01146652|580763930|FG000|Overall Study|Lack of Efficacy|91|||
161246823|NCT01717040|582281840|FG000|Overall Study|New Substance Use Disorder|1|||
161246824|NCT01717040|582281841|FG001|Overall Study|New Substance Use Disorder|0|||
161246825|NCT02957331|582281844|FG000|Overall Study|Protocol Violation|1|||
161246826|NCT02957331|582281845|FG001|Overall Study|Protocol Violation|0|||
161246827|NCT05568615|582283282|FG000|Overall Study|Death|1|||
161246828|NCT05568615|582283282|FG000|Overall Study|Physician Decision|1|||
161246829|NCT00565851|582283283|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
161246830|NCT00565851|582283284|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
160829878|NCT01146652|580763931|FG001|Overall Study|Lack of Efficacy|7|||
160829879|NCT01146652|580763930|FG000|Overall Study|Poor compliance to protocol|38|||
160829880|NCT01146652|580763931|FG001|Overall Study|Poor compliance to protocol|1|||
160829881|NCT01146652|580763930|FG000|Overall Study|Other unspecified reasons|314|||
160829882|NCT01146652|580763931|FG001|Overall Study|Other unspecified reasons|22|||
160829883|NCT01146652|580763930|FG000|Overall Study|Enrolled but not treated|2|||
160829884|NCT01146652|580763931|FG001|Overall Study|Enrolled but not treated|0|||
160829885|NCT02590562|580763937|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
160829886|NCT01457950|580763938|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
160829887|NCT01457950|580763939|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
160829888|NCT01457950|580763940|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
160829889|NCT01457950|580763941|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
160829890|NCT01457950|580763938|FG000|Double-Blind Phase|Protocol Violation|2|||
160829891|NCT01457950|580763939|FG001|Double-Blind Phase|Protocol Violation|1|||
160829892|NCT01457950|580763940|FG002|Double-Blind Phase|Protocol Violation|0|||
160829893|NCT01457950|580763941|FG003|Double-Blind Phase|Protocol Violation|0|||
160829894|NCT01457950|580763938|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
160829895|NCT01457950|580763939|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
160829896|NCT01457950|580763940|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160829897|NCT01457950|580763941|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160829898|NCT01457950|580763938|FG000|Open-Label Phase|Adverse Event|0|||
160829899|NCT01457950|580763939|FG001|Open-Label Phase|Adverse Event|0|||
160829900|NCT01457950|580763940|FG002|Open-Label Phase|Adverse Event|0|||
160829901|NCT01457950|580763941|FG003|Open-Label Phase|Adverse Event|1|||
160829902|NCT01457950|580763938|FG000|Open-Label Phase|Protocol Violation|0|||
160829903|NCT01457950|580763939|FG001|Open-Label Phase|Protocol Violation|0|||
160829904|NCT01457950|580763940|FG002|Open-Label Phase|Protocol Violation|0|||
160829905|NCT01457950|580763941|FG003|Open-Label Phase|Protocol Violation|1|||
160829906|NCT01457950|580763938|FG000|Open-Label Phase|Withdrawal by Subject|0|||
160829907|NCT01457950|580763939|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160829908|NCT01457950|580763940|FG002|Open-Label Phase|Withdrawal by Subject|2|||
160829909|NCT01457950|580763941|FG003|Open-Label Phase|Withdrawal by Subject|0|||
160903160|NCT00289133|581039025|FG001|Overall Study|Revision|6|||
160903161|NCT00289133|581039024|FG000|Overall Study|Lost to Follow-up|92|||
160903162|NCT00289133|581039025|FG001|Overall Study|Lost to Follow-up|115|||
160903163|NCT03372096|581039031|FG000|Overall Study|Study Closed|8|||
160903164|NCT00040365|581039032|FG000|Overall Study|Death|1|||
161136249|NCT01147809|581879440|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
161136250|NCT01147809|581879441|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
160903165|NCT00040365|581039032|FG000|Overall Study|Progressive disease|7|||
160903166|NCT00040365|581039032|FG000|Overall Study|Lost to Follow-up|3|||
160903167|NCT00319553|581039037|FG000|Overall Study|Protocol Violation|1|||
161136251|NCT01147809|581879436|FG000|Phase II (168 Days)|Adverse Event|0|||
160829910|NCT03684304|580763942|FG000|Overall Study|Lost to Follow-up|19|||
160829911|NCT03684304|580763943|FG001|Overall Study|Lost to Follow-up|17|||
160829912|NCT00824005|580763944|FG000|Overall Study|Death|0|||
160829913|NCT00824005|580763945|FG001|Overall Study|Death|1|||
160829914|NCT00824005|580763944|FG000|Overall Study|Lost to Follow-up|0|||
160903168|NCT00319553|581039038|FG001|Overall Study|Protocol Violation|2|||
161136252|NCT01147809|581879437|FG001|Phase II (168 Days)|Adverse Event|0|||
161136253|NCT01147809|581879438|FG002|Phase II (168 Days)|Adverse Event|0|||
161136254|NCT01147809|581879439|FG003|Phase II (168 Days)|Adverse Event|0|||
161136255|NCT01147809|581879440|FG004|Phase II (168 Days)|Adverse Event|3|||
161136256|NCT01147809|581879441|FG005|Phase II (168 Days)|Adverse Event|6|||
161136257|NCT01147809|581879436|FG000|Phase II (168 Days)|Protocol Violation|0|||
161136258|NCT01147809|581879437|FG001|Phase II (168 Days)|Protocol Violation|0|||
161136259|NCT01147809|581879438|FG002|Phase II (168 Days)|Protocol Violation|0|||
161136260|NCT01147809|581879439|FG003|Phase II (168 Days)|Protocol Violation|0|||
161136261|NCT01147809|581879440|FG004|Phase II (168 Days)|Protocol Violation|0|||
161136262|NCT01147809|581879441|FG005|Phase II (168 Days)|Protocol Violation|1|||
161136263|NCT01147809|581879436|FG000|Phase II (168 Days)|Physician Decision|0|||
161136264|NCT01147809|581879437|FG001|Phase II (168 Days)|Physician Decision|0|||
161136265|NCT01147809|581879438|FG002|Phase II (168 Days)|Physician Decision|0|||
161136266|NCT01147809|581879439|FG003|Phase II (168 Days)|Physician Decision|0|||
161136267|NCT01147809|581879440|FG004|Phase II (168 Days)|Physician Decision|5|||
161136268|NCT01147809|581879441|FG005|Phase II (168 Days)|Physician Decision|11|||
161136269|NCT01147809|581879436|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
161136270|NCT01147809|581879437|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
161136271|NCT01147809|581879438|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
161136272|NCT01147809|581879439|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
161136273|NCT01147809|581879440|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
161136274|NCT01147809|581879441|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
161136275|NCT01147809|581879436|FG000|Phase II (168 Days)|Ongoing|0|||
161136276|NCT01147809|581879437|FG001|Phase II (168 Days)|Ongoing|0|||
161136277|NCT01147809|581879438|FG002|Phase II (168 Days)|Ongoing|0|||
161136278|NCT01147809|581879439|FG003|Phase II (168 Days)|Ongoing|0|||
161136279|NCT01147809|581879440|FG004|Phase II (168 Days)|Ongoing|1|||
161136280|NCT01147809|581879441|FG005|Phase II (168 Days)|Ongoing|0|||
161136281|NCT01499290|581879444|FG000|Overall Study|Withdrawal by Subject|22|||
161136282|NCT01499290|581879445|FG001|Overall Study|Withdrawal by Subject|15|||
161136283|NCT01499290|581879444|FG000|Overall Study|Not specified in study report|11|||
161136284|NCT01499290|581879445|FG001|Overall Study|Not specified in study report|5|||
161136285|NCT01499290|581879444|FG000|Overall Study|Condition improved/subject recovered|1|||
161136286|NCT01499290|581879445|FG001|Overall Study|Condition improved/subject recovered|0|||
161136287|NCT01499290|581879444|FG000|Overall Study|Lack of Efficacy|7|||
161136288|NCT01499290|581879445|FG001|Overall Study|Lack of Efficacy|8|||
161136289|NCT01499290|581879444|FG000|Overall Study|Adverse Event|14|||
161136290|NCT01499290|581879445|FG001|Overall Study|Adverse Event|7|||
161136291|NCT02209766|581879446|FG000|Overall Study|Withdrawal by Subject|0|||
161136292|NCT02209766|581879447|FG001|Overall Study|Withdrawal by Subject|0|||
160829915|NCT00824005|580763945|FG001|Overall Study|Lost to Follow-up|1|||
160829916|NCT03458702|580763946|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
160829917|NCT03458702|580763947|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
160829918|NCT03458702|580763946|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
160829919|NCT03458702|580763947|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
160829920|NCT02231762|580763950|FG000|Combination Phase|Adverse Event|10|||
160829921|NCT02231762|580763951|FG001|Combination Phase|Adverse Event|0|||
160829922|NCT02231762|580763952|FG002|Combination Phase|Adverse Event|0|||
160829923|NCT02231762|580763953|FG003|Combination Phase|Adverse Event|0|||
160829924|NCT02231762|580763950|FG000|Combination Phase|Withdrawal by Subject|2|||
160829925|NCT02231762|580763951|FG001|Combination Phase|Withdrawal by Subject|0|||
160903169|NCT00319553|581039037|FG000|Overall Study|Lost to Follow-up|2|||
160903170|NCT00319553|581039038|FG001|Overall Study|Lost to Follow-up|1|||
160903171|NCT00319553|581039037|FG000|Overall Study|Withdrawal by Subject|1|||
160903172|NCT00319553|581039038|FG001|Overall Study|Withdrawal by Subject|1|||
160903173|NCT02329080|581039039|FG000|Overall Study|Adverse Event|1|||
160903174|NCT02329080|581039039|FG000|Overall Study|Death|4|||
160903175|NCT02329080|581039039|FG000|Overall Study|Lack of Efficacy|22|||
160903176|NCT02329080|581039039|FG000|Overall Study|Lost to Follow-up|1|||
160903177|NCT02329080|581039039|FG000|Overall Study|Physician Decision|2|||
160903178|NCT02329080|581039039|FG000|Overall Study|Partial response|4|||
160903179|NCT02329080|581039039|FG000|Overall Study|Complete response|4|||
160903180|NCT00413244|581039041|FG000|Overall Study|Withdrawal by Subject|10|||
160903181|NCT00413244|581039042|FG001|Overall Study|Withdrawal by Subject|1|||
160903182|NCT03082261|581039047|FG000|Overall Study|Death|4|||
160829926|NCT02231762|580763952|FG002|Combination Phase|Withdrawal by Subject|0|||
160829927|NCT02231762|580763953|FG003|Combination Phase|Withdrawal by Subject|0|||
160829928|NCT02231762|580763950|FG000|Combination Phase|Disease Progression|6|||
160829929|NCT02231762|580763951|FG001|Combination Phase|Disease Progression|0|||
160829930|NCT02231762|580763952|FG002|Combination Phase|Disease Progression|0|||
160829931|NCT02231762|580763953|FG003|Combination Phase|Disease Progression|0|||
160829932|NCT02231762|580763950|FG000|Combination Phase|Did not meet inclusion criteria|1|||
160829933|NCT02231762|580763951|FG001|Combination Phase|Did not meet inclusion criteria|0|||
160829934|NCT02231762|580763952|FG002|Combination Phase|Did not meet inclusion criteria|0|||
160829935|NCT02231762|580763953|FG003|Combination Phase|Did not meet inclusion criteria|0|||
160829936|NCT02231762|580763950|FG000|Combination Phase|Protocol Violation|1|||
160829937|NCT02231762|580763951|FG001|Combination Phase|Protocol Violation|0|||
160829938|NCT02231762|580763952|FG002|Combination Phase|Protocol Violation|0|||
160829939|NCT02231762|580763953|FG003|Combination Phase|Protocol Violation|0|||
160829940|NCT02231762|580763950|FG000|Maintenance Phase|Disease progression|0|||
160829941|NCT02231762|580763951|FG001|Maintenance Phase|Disease progression|3|||
160829942|NCT02231762|580763952|FG002|Maintenance Phase|Disease progression|4|||
160829943|NCT02231762|580763953|FG003|Maintenance Phase|Disease progression|3|||
160829944|NCT02231762|580763950|FG000|Maintenance Phase|Adverse Event|0|||
160829945|NCT02231762|580763951|FG001|Maintenance Phase|Adverse Event|0|||
160829946|NCT02231762|580763952|FG002|Maintenance Phase|Adverse Event|1|||
160829947|NCT02231762|580763953|FG003|Maintenance Phase|Adverse Event|2|||
160829948|NCT01697462|580763954|FG000|Overall Study|Disease Progression|1|||
160829949|NCT01697462|580763954|FG000|Overall Study|Adverse Event|6|||
160903183|NCT03082261|581039047|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
160903184|NCT03082261|581039047|FG000|Overall Study|Insurance denial|1|||
160903185|NCT03082261|581039047|FG000|Overall Study|Peripheral lead added|1|||
160903186|NCT03082261|581039047|FG000|Overall Study|Withdrawal by Subject|40|||
160903187|NCT03082261|581039047|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
160903188|NCT03082261|581039047|FG000|Overall Study|Subject implanted with device other than study device|1|||
160829950|NCT01697462|580763954|FG000|Overall Study|Lost to Follow-up|21|||
160829951|NCT01697462|580763954|FG000|Overall Study|Withdrawal by Subject|12|||
160829952|NCT01697462|580763954|FG000|Overall Study|Investigator Decision|21|||
160829953|NCT01697462|580763954|FG000|Overall Study|Death|1|||
161136293|NCT02209766|581879448|FG002|Overall Study|Withdrawal by Subject|0|||
161136294|NCT02209766|581879449|FG003|Overall Study|Withdrawal by Subject|1|||
161246831|NCT00565851|582283285|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
161246832|NCT00565851|582283286|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
161246833|NCT00565851|582283287|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
161246834|NCT00565851|582283288|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
160829954|NCT01697462|580763954|FG000|Overall Study|Other|10|||
160829955|NCT01697462|580763954|FG000|Overall Study|Missing|5|||
160829956|NCT02699450|580763956|FG000|Overall Study|Death|2|||
160829957|NCT02699450|580763957|FG001|Overall Study|Death|1|||
160829958|NCT02699450|580763958|FG002|Overall Study|Death|2|||
160829959|NCT02699450|580763956|FG000|Overall Study|Met Criteria for Study Exit|0|||
160829960|NCT02699450|580763957|FG001|Overall Study|Met Criteria for Study Exit|0|||
160829961|NCT02699450|580763958|FG002|Overall Study|Met Criteria for Study Exit|1|||
160829962|NCT02699450|580763956|FG000|Overall Study|Protocol Violation|4|||
160829963|NCT02699450|580763957|FG001|Overall Study|Protocol Violation|3|||
160829964|NCT02699450|580763958|FG002|Overall Study|Protocol Violation|5|||
160829965|NCT02699450|580763956|FG000|Overall Study|Lost to Follow-up|3|||
160829966|NCT02699450|580763957|FG001|Overall Study|Lost to Follow-up|0|||
160829967|NCT02699450|580763958|FG002|Overall Study|Lost to Follow-up|5|||
160829968|NCT02699450|580763956|FG000|Overall Study|Physician Decision|2|||
160829969|NCT02699450|580763957|FG001|Overall Study|Physician Decision|0|||
160829970|NCT02699450|580763958|FG002|Overall Study|Physician Decision|0|||
160829971|NCT02699450|580763956|FG000|Overall Study|Withdrawal by Subject|3|||
160829972|NCT02699450|580763957|FG001|Overall Study|Withdrawal by Subject|1|||
160829973|NCT02699450|580763958|FG002|Overall Study|Withdrawal by Subject|2|||
160829974|NCT02699450|580763956|FG000|Overall Study|Adverse Event|1|||
160903189|NCT03082261|581039047|FG000|Overall Study|Lost to Follow-up|14|||
160903190|NCT03082261|581039047|FG000|Overall Study|Subject moved to a different state|1|||
160903191|NCT03082261|581039047|FG000|Overall Study|Subject non-compliance|2|||
160903192|NCT03082261|581039047|FG000|Overall Study|Subject participation terminated by investigator|9|||
160903193|NCT03082261|581039047|FG000|Overall Study|Subject participation terminated by sponsor|4|||
160903194|NCT03082261|581039047|FG000|Overall Study|System explant|19|||
160903195|NCT03082261|581039047|FG000|Overall Study|Unable to place lead(s)|2|||
160903196|NCT03082261|581039047|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
160903197|NCT00839852|581039048|FG000|Overall Study|Adverse Event|10|||
160903198|NCT00839852|581039048|FG000|Overall Study|Insufficient Therapeutic Response|3|||
160903199|NCT00839852|581039048|FG000|Overall Study|Protocol Violation|9|||
160903200|NCT00839852|581039048|FG000|Overall Study|Withdrawal of Consent|16|||
160903201|NCT00839852|581039048|FG000|Overall Study|Lost to Follow-up|7|||
160903202|NCT00839852|581039048|FG000|Overall Study|Lack of Compliance While in Jail|1|||
160903203|NCT00839852|581039048|FG000|Overall Study|Pregnancy|1|||
160903204|NCT00494299|581039051|FG000|Overall Study|Adverse Event|93|||
160903205|NCT00494299|581039052|FG001|Overall Study|Adverse Event|13|||
160903206|NCT00494299|581039051|FG000|Overall Study|Lost to Follow-up|1|||
160903207|NCT00494299|581039052|FG001|Overall Study|Lost to Follow-up|0|||
160903208|NCT00494299|581039051|FG000|Overall Study|Physician Decision|0|||
160903209|NCT00494299|581039052|FG001|Overall Study|Physician Decision|2|||
160903210|NCT00494299|581039051|FG000|Overall Study|Protocol Violation|1|||
160903211|NCT00494299|581039052|FG001|Overall Study|Protocol Violation|2|||
160903212|NCT00494299|581039051|FG000|Overall Study|Withdrawal by Subject|8|||
160903213|NCT00494299|581039052|FG001|Overall Study|Withdrawal by Subject|3|||
160903214|NCT00494299|581039051|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
160903215|NCT00494299|581039052|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
160903216|NCT00494299|581039051|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
160903217|NCT00494299|581039052|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
160903218|NCT00494299|581039051|FG000|Overall Study|Site Closed by Sponsor|6|||
160903219|NCT00494299|581039052|FG001|Overall Study|Site Closed by Sponsor|0|||
160903220|NCT00494299|581039051|FG000|Overall Study|Protocol Driven Decision Point|11|||
160903221|NCT00494299|581039052|FG001|Overall Study|Protocol Driven Decision Point|22|||
160903222|NCT00467857|581039054|FG000|Overall Study|Adverse Event|1|||
160903223|NCT00467857|581039055|FG001|Overall Study|Adverse Event|0|||
160903224|NCT00467857|581039054|FG000|Overall Study|Withdrew consent|2|||
161246835|NCT00565851|582283289|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
160829975|NCT02699450|580763957|FG001|Overall Study|Adverse Event|0|||
160829976|NCT02699450|580763958|FG002|Overall Study|Adverse Event|0|||
160829977|NCT01133275|580763959|FG000|Overall Study|Withdrawal by Subject|1|||
160903225|NCT00467857|581039055|FG001|Overall Study|Withdrew consent|0|||
160903226|NCT00467857|581039054|FG000|Overall Study|Death|0|||
161246836|NCT00565851|582283290|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
161246837|NCT00565851|582283283|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
160829978|NCT01133275|580763959|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
160903227|NCT00467857|581039055|FG001|Overall Study|Death|1|||
160903228|NCT00467857|581039054|FG000|Overall Study|Discharged from court service|0|||
160903229|NCT00467857|581039055|FG001|Overall Study|Discharged from court service|1|||
160903230|NCT00467857|581039054|FG000|Overall Study|Emergency care required|0|||
160903231|NCT00467857|581039055|FG001|Overall Study|Emergency care required|1|||
160903232|NCT00467857|581039054|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
161246838|NCT00565851|582283284|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
161246839|NCT00565851|582283285|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
161246840|NCT00565851|582283286|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
161246841|NCT00565851|582283287|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
160829979|NCT02266875|580763961|FG000|Overall Study|Withdrawal by Subject|9|||
160829980|NCT02266875|580763962|FG001|Overall Study|Withdrawal by Subject|0|||
160829981|NCT02266875|580763961|FG000|Overall Study|Lost to Follow-up|2|||
160829982|NCT02266875|580763962|FG001|Overall Study|Lost to Follow-up|0|||
160829983|NCT00086502|580763963|FG000|Overall Study|Adverse Event|11|||
160829984|NCT00086502|580763964|FG001|Overall Study|Adverse Event|2|||
160829985|NCT00086502|580763963|FG000|Overall Study|Lack of Efficacy|0|||
160829986|NCT00086502|580763964|FG001|Overall Study|Lack of Efficacy|2|||
160829987|NCT00086502|580763963|FG000|Overall Study|Lost to Follow-up|3|||
160829988|NCT00086502|580763964|FG001|Overall Study|Lost to Follow-up|1|||
160829989|NCT00086502|580763963|FG000|Overall Study|Physician Decision|1|||
160829990|NCT00086502|580763964|FG001|Overall Study|Physician Decision|1|||
160829991|NCT00086502|580763963|FG000|Overall Study|Pregnancy|0|||
160829992|NCT00086502|580763964|FG001|Overall Study|Pregnancy|1|||
160829993|NCT00086502|580763963|FG000|Overall Study|Protocol Violation|3|||
160829994|NCT00086502|580763964|FG001|Overall Study|Protocol Violation|3|||
160829995|NCT00086502|580763963|FG000|Overall Study|Withdrawal by Subject|5|||
160829996|NCT00086502|580763964|FG001|Overall Study|Withdrawal by Subject|6|||
160829997|NCT00086502|580763963|FG000|Overall Study|Patient Moved|1|||
160829998|NCT00086502|580763964|FG001|Overall Study|Patient Moved|1|||
160829999|NCT00086502|580763963|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
160830000|NCT00086502|580763964|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
160830001|NCT00086502|580763963|FG000|Overall Study|Patient Accidentally Unblinded|1|||
160830002|NCT00086502|580763964|FG001|Overall Study|Patient Accidentally Unblinded|0|||
160830003|NCT01304329|580763965|FG000|Third Intervention (3 Days)|Adverse Event|0|||
160830004|NCT01304329|580763966|FG001|Third Intervention (3 Days)|Adverse Event|1|||
160830005|NCT01304329|580763967|FG002|Third Intervention (3 Days)|Adverse Event|0|||
160830006|NCT01304329|580763968|FG003|Third Intervention (3 Days)|Adverse Event|0|||
160830007|NCT01304329|580763969|FG004|Third Intervention (3 Days)|Adverse Event|0|||
160830008|NCT01304329|580763970|FG005|Third Intervention (3 Days)|Adverse Event|0|||
160830009|NCT05545644|580763972|FG000|Overall Study|Lost to Follow-up|4|||
160830010|NCT05545644|580763973|FG001|Overall Study|Lost to Follow-up|3|||
160830011|NCT01420627|580763974|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
160830012|NCT01490294|580763975|FG000|Overall Study|Prematurely discontinuation|4|||
160830013|NCT01490294|580763976|FG001|Overall Study|Prematurely discontinuation|0|||
160830014|NCT01490294|580763977|FG002|Overall Study|Prematurely discontinuation|1|||
160830015|NCT01490294|580763978|FG003|Overall Study|Prematurely discontinuation|1|||
160830016|NCT01490294|580763975|FG000|Overall Study|Adverse Event|1|||
160830017|NCT01490294|580763976|FG001|Overall Study|Adverse Event|0|||
160830018|NCT01490294|580763977|FG002|Overall Study|Adverse Event|0|||
160830019|NCT01490294|580763978|FG003|Overall Study|Adverse Event|0|||
161136295|NCT02209766|581879450|FG004|Overall Study|Withdrawal by Subject|0|||
161136296|NCT01791855|581879451|FG000|Overall Study|Adverse Event|0|||
161136297|NCT01791855|581879452|FG001|Overall Study|Adverse Event|0|||
161136298|NCT01791855|581879453|FG002|Overall Study|Adverse Event|0|||
161136299|NCT01791855|581879454|FG003|Overall Study|Adverse Event|1|||
161136300|NCT01791855|581879451|FG000|Overall Study|Randomized, not treated|0|||
161136301|NCT01791855|581879452|FG001|Overall Study|Randomized, not treated|1|||
161136302|NCT01791855|581879453|FG002|Overall Study|Randomized, not treated|0|||
161136303|NCT01791855|581879454|FG003|Overall Study|Randomized, not treated|0|||
160830029|NCT02210091|580763993|FG000|Overall Study|Physician Decision|0|||
160830030|NCT02210091|580763994|FG001|Overall Study|Physician Decision|1|||
160830031|NCT02210091|580763993|FG000|Overall Study|Withdrawal by Sponsor|0|||
160830032|NCT02210091|580763994|FG001|Overall Study|Withdrawal by Sponsor|1|||
160830033|NCT01831817|580763995|FG000|Overall Study|Lost to Follow-up|1|||
160830034|NCT01831817|580763996|FG001|Overall Study|Lost to Follow-up|0|||
160830035|NCT01831817|580763997|FG002|Overall Study|Lost to Follow-up|0|||
160903233|NCT00467857|581039055|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
161246842|NCT00565851|582283288|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
160830036|NCT01831817|580763998|FG003|Overall Study|Lost to Follow-up|0|||
160830037|NCT01831817|580763995|FG000|Overall Study|Withdrawl of Consent|3|||
160830038|NCT01831817|580763996|FG001|Overall Study|Withdrawl of Consent|0|||
160830039|NCT01831817|580763997|FG002|Overall Study|Withdrawl of Consent|0|||
160830040|NCT01831817|580763998|FG003|Overall Study|Withdrawl of Consent|0|||
160830041|NCT00958217|580763999|FG000|Overall Study|Death|2|||
160830042|NCT00958217|580764000|FG001|Overall Study|Death|1|||
160830043|NCT00958217|580763999|FG000|Overall Study|Withdrawal by Subject|4|||
160830044|NCT00958217|580764000|FG001|Overall Study|Withdrawal by Subject|3|||
160830045|NCT00958217|580763999|FG000|Overall Study|Lost to Follow-up|17|||
160830046|NCT00958217|580764000|FG001|Overall Study|Lost to Follow-up|19|||
160830047|NCT00958217|580763999|FG000|Overall Study|Moved out of area|1|||
160903234|NCT00467857|581039054|FG000|Overall Study|Discontinuation reason missing|0|||
161246843|NCT00565851|582283289|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
160830048|NCT00958217|580764000|FG001|Overall Study|Moved out of area|1|||
160830049|NCT00958217|580763999|FG000|Overall Study|Inpatient hospitalization|0|||
160830050|NCT00958217|580764000|FG001|Overall Study|Inpatient hospitalization|1|||
160830051|NCT02440789|580764001|FG000|Overall Study|Withdrawal by Subject|3|||
160830052|NCT02440789|580764001|FG000|Overall Study|Not willing to adhere to reqs|1|||
160830053|NCT01999218|580764002|FG000|Overall Study|Hyperglycemia|18|||
160830054|NCT01999218|580764003|FG001|Overall Study|Hyperglycemia|17|||
160830055|NCT01999218|580764004|FG002|Overall Study|Hyperglycemia|17|||
160830056|NCT01999218|580764002|FG000|Overall Study|Lack of Efficacy|1|||
160830057|NCT01999218|580764003|FG001|Overall Study|Lack of Efficacy|0|||
160830058|NCT01999218|580764004|FG002|Overall Study|Lack of Efficacy|1|||
160830059|NCT01999218|580764002|FG000|Overall Study|Lost to Follow-up|22|||
160830060|NCT01999218|580764003|FG001|Overall Study|Lost to Follow-up|17|||
160830061|NCT01999218|580764004|FG002|Overall Study|Lost to Follow-up|18|||
160830062|NCT01999218|580764002|FG000|Overall Study|Non-Compliance With Study Drug|6|||
160830063|NCT01999218|580764003|FG001|Overall Study|Non-Compliance With Study Drug|4|||
160830064|NCT01999218|580764004|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160830065|NCT01999218|580764002|FG000|Overall Study|Physician Decision|1|||
160830066|NCT01999218|580764003|FG001|Overall Study|Physician Decision|4|||
160830067|NCT01999218|580764004|FG002|Overall Study|Physician Decision|6|||
160830068|NCT01999218|580764002|FG000|Overall Study|Protocol Violation|4|||
160830069|NCT01999218|580764003|FG001|Overall Study|Protocol Violation|5|||
160830070|NCT01999218|580764004|FG002|Overall Study|Protocol Violation|4|||
160830071|NCT01999218|580764002|FG000|Overall Study|Screen failure|0|||
160830072|NCT01999218|580764003|FG001|Overall Study|Screen failure|1|||
160830073|NCT01999218|580764004|FG002|Overall Study|Screen failure|0|||
160830074|NCT01999218|580764002|FG000|Overall Study|Study Terminated By Sponsor|7|||
161136304|NCT00552110|581879455|FG000|Overall Study|Serious or Life-Threatening AE|0|||
161136305|NCT00552110|581879456|FG001|Overall Study|Serious or Life-Threatening AE|0|||
161136306|NCT00552110|581879457|FG002|Overall Study|Serious or Life-Threatening AE|1|||
161136307|NCT00552110|581879458|FG003|Overall Study|Serious or Life-Threatening AE|0|||
161136308|NCT00552110|581879459|FG004|Overall Study|Serious or Life-Threatening AE|0|||
161136309|NCT00552110|581879455|FG000|Overall Study|Lack of Efficacy|1|||
161136310|NCT00552110|581879456|FG001|Overall Study|Lack of Efficacy|0|||
161136311|NCT00552110|581879457|FG002|Overall Study|Lack of Efficacy|0|||
161136312|NCT00552110|581879458|FG003|Overall Study|Lack of Efficacy|1|||
161136313|NCT00552110|581879459|FG004|Overall Study|Lack of Efficacy|4|||
161136314|NCT00552110|581879455|FG000|Overall Study|Withdrawal by Subject|0|||
161136315|NCT00552110|581879456|FG001|Overall Study|Withdrawal by Subject|2|||
160830075|NCT01999218|580764003|FG001|Overall Study|Study Terminated By Sponsor|5|||
160830076|NCT01999218|580764004|FG002|Overall Study|Study Terminated By Sponsor|12|||
160830077|NCT01999218|580764002|FG000|Overall Study|Participant moves|2|||
160830078|NCT01999218|580764003|FG001|Overall Study|Participant moves|5|||
160830079|NCT01999218|580764004|FG002|Overall Study|Participant moves|3|||
160830080|NCT01999218|580764002|FG000|Overall Study|Withdrawal by Subject|28|||
160830081|NCT01999218|580764003|FG001|Overall Study|Withdrawal by Subject|29|||
160830082|NCT01999218|580764004|FG002|Overall Study|Withdrawal by Subject|34|||
160830083|NCT01999218|580764002|FG000|Overall Study|Creatinine/eGFR|0|||
160830084|NCT01999218|580764003|FG001|Overall Study|Creatinine/eGFR|0|||
160830085|NCT01999218|580764004|FG002|Overall Study|Creatinine/eGFR|1|||
160830086|NCT01999218|580764002|FG000|Overall Study|Death|7|||
160830087|NCT01999218|580764003|FG001|Overall Study|Death|1|||
160830088|NCT01999218|580764004|FG002|Overall Study|Death|2|||
160830089|NCT01999218|580764002|FG000|Overall Study|Excluded Medication|1|||
160830090|NCT01999218|580764003|FG001|Overall Study|Excluded Medication|1|||
160830091|NCT01999218|580764004|FG002|Overall Study|Excluded Medication|2|||
161136316|NCT00552110|581879457|FG002|Overall Study|Withdrawal by Subject|0|||
161136317|NCT00552110|581879458|FG003|Overall Study|Withdrawal by Subject|3|||
160830092|NCT01999218|580764002|FG000|Overall Study|Adverse Event|9|||
160830093|NCT01999218|580764003|FG001|Overall Study|Adverse Event|7|||
160830094|NCT01999218|580764004|FG002|Overall Study|Adverse Event|7|||
160830095|NCT01999218|580764002|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
160830096|NCT01999218|580764003|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
160830097|NCT01999218|580764004|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
160830098|NCT01266590|580765910|FG000|Overall Study|Adverse Event|3|||
160830099|NCT01266590|580765910|FG000|Overall Study|Lost to Follow-up|1|||
160830100|NCT01266590|580765910|FG000|Overall Study|Withdrawal by Subject|1|||
160830101|NCT01266590|580765910|FG000|Overall Study|Physician Decision|1|||
160830102|NCT02654236|580765913|FG000|Overall Study|Withdrawal by Subject|0|||
160830103|NCT02654236|580765914|FG001|Overall Study|Withdrawal by Subject|0|||
160830104|NCT02654236|580765915|FG002|Overall Study|Withdrawal by Subject|2|||
160830105|NCT01549873|580765916|FG000|Overall Study|Physician Decision|0|||
160830106|NCT01549873|580765917|FG001|Overall Study|Physician Decision|1|||
160830107|NCT02905006|580765918|FG000|Overall Study|Adverse Event|1|||
160830108|NCT02905006|580765919|FG001|Overall Study|Adverse Event|1|||
160830109|NCT02905006|580765920|FG002|Overall Study|Adverse Event|1|||
160830110|NCT02905006|580765921|FG003|Overall Study|Adverse Event|1|||
160830111|NCT02905006|580765922|FG004|Overall Study|Adverse Event|0|||
160830112|NCT02905006|580765923|FG005|Overall Study|Adverse Event|1|||
160830113|NCT02905006|580765918|FG000|Overall Study|Lack of Efficacy|1|||
160830114|NCT02905006|580765919|FG001|Overall Study|Lack of Efficacy|0|||
160830115|NCT02905006|580765920|FG002|Overall Study|Lack of Efficacy|0|||
160830116|NCT02905006|580765921|FG003|Overall Study|Lack of Efficacy|0|||
160830117|NCT02905006|580765922|FG004|Overall Study|Lack of Efficacy|0|||
160830118|NCT02905006|580765923|FG005|Overall Study|Lack of Efficacy|0|||
160830119|NCT02905006|580765918|FG000|Overall Study|Protocol Violation|2|||
160830120|NCT02905006|580765919|FG001|Overall Study|Protocol Violation|0|||
160830121|NCT02905006|580765920|FG002|Overall Study|Protocol Violation|0|||
160830122|NCT02905006|580765921|FG003|Overall Study|Protocol Violation|0|||
160830123|NCT02905006|580765922|FG004|Overall Study|Protocol Violation|0|||
160830124|NCT02905006|580765923|FG005|Overall Study|Protocol Violation|0|||
160830125|NCT02905006|580765918|FG000|Overall Study|Lost to Follow-up|0|||
160830126|NCT02905006|580765919|FG001|Overall Study|Lost to Follow-up|0|||
160830127|NCT02905006|580765920|FG002|Overall Study|Lost to Follow-up|0|||
160830128|NCT02905006|580765921|FG003|Overall Study|Lost to Follow-up|1|||
160830129|NCT02905006|580765922|FG004|Overall Study|Lost to Follow-up|1|||
160830130|NCT02905006|580765923|FG005|Overall Study|Lost to Follow-up|0|||
160830131|NCT02905006|580765918|FG000|Overall Study|Withdrawal by Subject|0|||
160830132|NCT02905006|580765919|FG001|Overall Study|Withdrawal by Subject|0|||
160830133|NCT02905006|580765920|FG002|Overall Study|Withdrawal by Subject|1|||
160830134|NCT02905006|580765921|FG003|Overall Study|Withdrawal by Subject|1|||
161246844|NCT00565851|582283290|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
161246845|NCT03291067|582283291|FG000|Overall Study|Adverse Event|0|||
161246846|NCT03291067|582283292|FG001|Overall Study|Adverse Event|2|||
161246847|NCT03291067|582283293|FG002|Overall Study|Adverse Event|17|||
161246848|NCT03291067|582283294|FG003|Overall Study|Adverse Event|3|||
161246849|NCT03291067|582283291|FG000|Overall Study|Lost to Follow-up|2|||
161246850|NCT03291067|582283292|FG001|Overall Study|Lost to Follow-up|1|||
161246851|NCT03291067|582283293|FG002|Overall Study|Lost to Follow-up|0|||
160830135|NCT02905006|580765922|FG004|Overall Study|Withdrawal by Subject|0|||
160830136|NCT02905006|580765923|FG005|Overall Study|Withdrawal by Subject|1|||
160830137|NCT02905006|580765918|FG000|Overall Study|Screening exclusion criteria met|1|||
160830138|NCT02905006|580765919|FG001|Overall Study|Screening exclusion criteria met|0|||
160830139|NCT02905006|580765920|FG002|Overall Study|Screening exclusion criteria met|0|||
160830140|NCT02905006|580765921|FG003|Overall Study|Screening exclusion criteria met|0|||
160830141|NCT02905006|580765922|FG004|Overall Study|Screening exclusion criteria met|0|||
160830142|NCT02905006|580765923|FG005|Overall Study|Screening exclusion criteria met|0|||
160830143|NCT02905006|580765918|FG000|Overall Study|Lab withdrawal criterion met|0|||
160830144|NCT02905006|580765919|FG001|Overall Study|Lab withdrawal criterion met|1|||
160830145|NCT02905006|580765920|FG002|Overall Study|Lab withdrawal criterion met|2|||
160830146|NCT02905006|580765921|FG003|Overall Study|Lab withdrawal criterion met|2|||
160830147|NCT02905006|580765922|FG004|Overall Study|Lab withdrawal criterion met|2|||
160830148|NCT02905006|580765923|FG005|Overall Study|Lab withdrawal criterion met|1|||
160830149|NCT02905006|580765918|FG000|Overall Study|Positive for Tuberculosis|0|||
160830150|NCT02905006|580765919|FG001|Overall Study|Positive for Tuberculosis|1|||
160830151|NCT02905006|580765920|FG002|Overall Study|Positive for Tuberculosis|0|||
160830152|NCT02905006|580765921|FG003|Overall Study|Positive for Tuberculosis|0|||
160830153|NCT02905006|580765922|FG004|Overall Study|Positive for Tuberculosis|0|||
160830154|NCT02905006|580765923|FG005|Overall Study|Positive for Tuberculosis|0|||
160830155|NCT02905006|580765918|FG000|Overall Study|Subject positive for Hep B|0|||
160830156|NCT02905006|580765919|FG001|Overall Study|Subject positive for Hep B|0|||
160830157|NCT02905006|580765920|FG002|Overall Study|Subject positive for Hep B|1|||
160830158|NCT02905006|580765921|FG003|Overall Study|Subject positive for Hep B|0|||
160830159|NCT02905006|580765922|FG004|Overall Study|Subject positive for Hep B|0|||
160830160|NCT02905006|580765923|FG005|Overall Study|Subject positive for Hep B|0|||
160830161|NCT02905006|580765918|FG000|Overall Study|Patient moved abroad|0|||
160830162|NCT02905006|580765919|FG001|Overall Study|Patient moved abroad|0|||
160830163|NCT02905006|580765920|FG002|Overall Study|Patient moved abroad|0|||
160830164|NCT02905006|580765921|FG003|Overall Study|Patient moved abroad|1|||
160830165|NCT02905006|580765922|FG004|Overall Study|Patient moved abroad|0|||
160830166|NCT02905006|580765923|FG005|Overall Study|Patient moved abroad|0|||
160830167|NCT02905006|580765918|FG000|Overall Study|Patient randomized by mistake|0|||
160830168|NCT02905006|580765919|FG001|Overall Study|Patient randomized by mistake|0|||
160830169|NCT02905006|580765920|FG002|Overall Study|Patient randomized by mistake|0|||
160830170|NCT02905006|580765921|FG003|Overall Study|Patient randomized by mistake|0|||
161246852|NCT03291067|582283294|FG003|Overall Study|Lost to Follow-up|1|||
161246853|NCT03291067|582283291|FG000|Overall Study|Physician Decision|0|||
161246854|NCT03291067|582283292|FG001|Overall Study|Physician Decision|0|||
160830171|NCT02905006|580765922|FG004|Overall Study|Patient randomized by mistake|0|||
160830172|NCT02905006|580765923|FG005|Overall Study|Patient randomized by mistake|1|||
161246855|NCT03291067|582283293|FG002|Overall Study|Physician Decision|1|||
161246856|NCT03291067|582283294|FG003|Overall Study|Physician Decision|0|||
161246857|NCT03291067|582283291|FG000|Overall Study|Protocol Violation|5|||
161246858|NCT03291067|582283292|FG001|Overall Study|Protocol Violation|3|||
160830173|NCT04435600|580765924|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830174|NCT04435600|580765925|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830175|NCT04435600|580765926|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
160830176|NCT04435600|580765927|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830177|NCT04435600|580765928|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830178|NCT04435600|580765929|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830179|NCT04435600|580765930|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830180|NCT04435600|580765931|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830181|NCT04435600|580765932|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830182|NCT04435600|580765933|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
160830183|NCT04435600|580765924|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830184|NCT04435600|580765925|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830185|NCT04435600|580765926|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830186|NCT04435600|580765927|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830187|NCT04435600|580765928|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830188|NCT04435600|580765929|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830189|NCT04435600|580765930|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830190|NCT04435600|580765931|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830191|NCT04435600|580765932|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
160830192|NCT04435600|580765933|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
160830193|NCT04435600|580765924|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830194|NCT04435600|580765925|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830195|NCT04435600|580765926|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830196|NCT04435600|580765927|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830197|NCT04435600|580765928|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830198|NCT04435600|580765929|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830199|NCT04435600|580765930|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830200|NCT04435600|580765931|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830201|NCT04435600|580765932|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
160830202|NCT04435600|580765933|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
160830203|NCT04435600|580765924|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830204|NCT04435600|580765925|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830205|NCT04435600|580765926|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830206|NCT04435600|580765927|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830207|NCT04435600|580765928|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830208|NCT04435600|580765929|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830209|NCT04435600|580765930|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830210|NCT04435600|580765931|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830211|NCT04435600|580765932|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
160830212|NCT04435600|580765933|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
160830213|NCT02797184|580765938|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
160830214|NCT02797184|580765939|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
160830215|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
160830216|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
160830217|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
160830218|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
160830219|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
160830220|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
160830221|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
160830222|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
160830223|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
160830224|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
160830225|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
160830226|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
160830227|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
160830228|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
160830229|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
160830230|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
160830231|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
160830232|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
160830233|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
160830234|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
160830235|NCT05149313|580765940|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
160830236|NCT05149313|580765941|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
160830237|NCT05149313|580765942|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
160830238|NCT05149313|580765943|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
160830239|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
160830240|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
160830241|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
160830242|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
160830243|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160830244|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
160830245|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
160830246|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
160830247|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
160830248|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
160830249|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
160830250|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
160830251|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160830252|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160830253|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
160830254|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
160830255|NCT05149313|580765940|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
160830256|NCT05149313|580765941|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
160830257|NCT05149313|580765942|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
160830258|NCT05149313|580765943|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
160830259|NCT02212678|580765952|FG000|Overall Study|Adverse Event|1|||
160830260|NCT05288166|580765954|FG000|Overall Study|Adverse Event|1|||
160830261|NCT05288166|580765955|FG001|Overall Study|Adverse Event|0|||
160830262|NCT05288166|580765954|FG000|Overall Study|Lost to Follow-up|2|||
160830263|NCT05288166|580765955|FG001|Overall Study|Lost to Follow-up|0|||
160830264|NCT05288166|580765954|FG000|Overall Study|Physician Decision|0|||
160830265|NCT05288166|580765955|FG001|Overall Study|Physician Decision|2|||
160830266|NCT05288166|580765954|FG000|Overall Study|Screen Failure|1|||
161246859|NCT03291067|582283293|FG002|Overall Study|Protocol Violation|4|||
161246860|NCT03291067|582283294|FG003|Overall Study|Protocol Violation|2|||
161246861|NCT03291067|582283291|FG000|Overall Study|Withdrawal by Subject|3|||
161246862|NCT03291067|582283292|FG001|Overall Study|Withdrawal by Subject|4|||
161246863|NCT03291067|582283293|FG002|Overall Study|Withdrawal by Subject|7|||
161246864|NCT03291067|582283294|FG003|Overall Study|Withdrawal by Subject|5|||
161246865|NCT03291067|582283291|FG000|Overall Study|Other|0|||
161246866|NCT03291067|582283292|FG001|Overall Study|Other|4|||
161246867|NCT03291067|582283293|FG002|Overall Study|Other|4|||
161246868|NCT03291067|582283294|FG003|Overall Study|Other|6|||
161246869|NCT01520987|582283302|FG000|Overall Study|Withdrawal by Subject|1|||
161246870|NCT01520987|582283303|FG001|Overall Study|Withdrawal by Subject|0|||
161246871|NCT01520987|582283304|FG002|Overall Study|Withdrawal by Subject|0|||
161246872|NCT01520987|582283305|FG003|Overall Study|Withdrawal by Subject|0|||
161246873|NCT01520987|582283306|FG004|Overall Study|Withdrawal by Subject|0|||
161246874|NCT01520987|582283307|FG005|Overall Study|Withdrawal by Subject|1|||
161246875|NCT01520987|582283308|FG006|Overall Study|Withdrawal by Subject|0|||
161246876|NCT01520987|582283309|FG007|Overall Study|Withdrawal by Subject|0|||
161246877|NCT02005562|582283310|FG000|Overall Study|Death|2|||
161246878|NCT02005562|582283311|FG001|Overall Study|Death|2|||
161246879|NCT02005562|582283310|FG000|Overall Study|Graft loss|7|||
161246880|NCT02005562|582283311|FG001|Overall Study|Graft loss|6|||
161246881|NCT02005562|582283310|FG000|Overall Study|Withdrawal by Subject|2|||
161246882|NCT02005562|582283311|FG001|Overall Study|Withdrawal by Subject|2|||
161246883|NCT02005562|582283310|FG000|Overall Study|No transplant|1|||
161246884|NCT02005562|582283311|FG001|Overall Study|No transplant|4|||
161246885|NCT02005562|582283310|FG000|Overall Study|Physician Decision|0|||
161246886|NCT02005562|582283311|FG001|Overall Study|Physician Decision|1|||
160830267|NCT05288166|580765955|FG001|Overall Study|Screen Failure|1|||
160830268|NCT05288166|580765954|FG000|Overall Study|Withdrawal by Subject|4|||
160830269|NCT05288166|580765955|FG001|Overall Study|Withdrawal by Subject|2|||
161246887|NCT00660387|582283312|FG000|Overall Study|Adverse Event|1|||
161246888|NCT00660387|582283313|FG001|Overall Study|Adverse Event|2|||
161246889|NCT00660387|582283312|FG000|Overall Study|Lack of Efficacy|0|||
161246890|NCT00660387|582283313|FG001|Overall Study|Lack of Efficacy|1|||
161246891|NCT00660387|582283312|FG000|Overall Study|Protocol Violation|1|||
161246892|NCT00660387|582283313|FG001|Overall Study|Protocol Violation|0|||
161246893|NCT03086135|582283314|FG000|Overall Study|Adverse Event|1|||
161246894|NCT03086135|582283314|FG000|Overall Study|Lost to Follow-up|2|||
161246895|NCT01023061|582283315|FG000|Overall Study|Withdrawal prior to treatment|2|||
161246896|NCT02966340|582283316|FG000|Overall Study|Adverse Event|0|||
161246897|NCT02966340|582283317|FG001|Overall Study|Adverse Event|1|||
161246898|NCT02966340|582283316|FG000|Overall Study|Lost to Follow-up|0|||
161246899|NCT02966340|582283317|FG001|Overall Study|Lost to Follow-up|1|||
161246900|NCT02966340|582283316|FG000|Overall Study|Withdrawal by Subject|1|||
161246901|NCT02966340|582283317|FG001|Overall Study|Withdrawal by Subject|0|||
161246902|NCT02966340|582283316|FG000|Overall Study|data acquisition error|1|||
161246903|NCT02966340|582283317|FG001|Overall Study|data acquisition error|0|||
161246904|NCT02966340|582283316|FG000|Overall Study|startle non-responder|1|||
161246905|NCT02966340|582283317|FG001|Overall Study|startle non-responder|1|||
161246906|NCT04768296|582283319|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
161246907|NCT04768296|582283320|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
161246908|NCT00255346|582283327|FG000|Overall Study|Adverse Event|1|||
161246909|NCT00255346|582283328|FG001|Overall Study|Adverse Event|0|||
161246910|NCT00255346|582283329|FG002|Overall Study|Adverse Event|0|||
161246911|NCT00255346|582283330|FG003|Overall Study|Adverse Event|0|||
161246912|NCT00255346|582283331|FG004|Overall Study|Adverse Event|0|||
161246913|NCT04402489|582283337|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
161246914|NCT04402489|582283338|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
160830270|NCT05288166|580765954|FG000|Overall Study|On Study Treatment|408|||
160830271|NCT05288166|580765955|FG001|Overall Study|On Study Treatment|418|||
160830272|NCT03106415|580765958|FG000|Phase 1|Withdrawal by Subject|1|||
160830273|NCT03106415|580765959|FG001|Phase 1|Withdrawal by Subject|0|||
160830274|NCT03106415|580765960|FG002|Phase 1|Withdrawal by Subject|0|||
160830275|NCT03106415|580765958|FG000|Phase 1|Adverse Event|1|||
160830276|NCT03106415|580765959|FG001|Phase 1|Adverse Event|1|||
160830277|NCT03106415|580765960|FG002|Phase 1|Adverse Event|0|||
160830278|NCT03106415|580765958|FG000|Phase 1|Protocol Violation|0|||
160830279|NCT03106415|580765959|FG001|Phase 1|Protocol Violation|1|||
160830280|NCT03106415|580765960|FG002|Phase 1|Protocol Violation|0|||
160830281|NCT00520013|580765961|FG000|Overall Study|Withdrawal by Subject|0|||
160830282|NCT00520013|580765962|FG001|Overall Study|Withdrawal by Subject|0|||
160830283|NCT00520013|580765963|FG002|Overall Study|Withdrawal by Subject|1|||
160830284|NCT00520013|580765961|FG000|Overall Study|Adverse Event|2|||
160830285|NCT00520013|580765962|FG001|Overall Study|Adverse Event|10|||
160830286|NCT00520013|580765963|FG002|Overall Study|Adverse Event|7|||
160830287|NCT00520013|580765961|FG000|Overall Study|Progressive Disease|7|||
160830288|NCT00520013|580765962|FG001|Overall Study|Progressive Disease|3|||
160830289|NCT00520013|580765963|FG002|Overall Study|Progressive Disease|0|||
160830290|NCT00520013|580765961|FG000|Overall Study|Clinical Progression|3|||
160830291|NCT00520013|580765962|FG001|Overall Study|Clinical Progression|1|||
160830292|NCT00520013|580765963|FG002|Overall Study|Clinical Progression|0|||
160830293|NCT00520013|580765961|FG000|Overall Study|Death|0|||
160830294|NCT00520013|580765962|FG001|Overall Study|Death|1|||
160830295|NCT00520013|580765963|FG002|Overall Study|Death|0|||
160830296|NCT00520013|580765961|FG000|Overall Study|Physician Decision|0|||
160830297|NCT00520013|580765962|FG001|Overall Study|Physician Decision|0|||
160830298|NCT00520013|580765963|FG002|Overall Study|Physician Decision|3|||
160830299|NCT02981524|580765964|FG000|Overall Study|Progressive Disease|14|||
160830300|NCT02981524|580765964|FG000|Overall Study|Death (unrelated)|1|||
160830301|NCT02981524|580765964|FG000|Overall Study|Treatment Related Toxicity|1|||
160830302|NCT02981524|580765964|FG000|Overall Study|Withdrawal by Subject|1|||
160830303|NCT00159913|580765965|FG000|Overall Study|Adverse Event|1|||
160830304|NCT00159913|580765966|FG001|Overall Study|Adverse Event|0|||
160830305|NCT00159913|580765967|FG002|Overall Study|Adverse Event|1|||
160830306|NCT00159913|580765968|FG003|Overall Study|Adverse Event|0|||
160830307|NCT00159913|580765965|FG000|Overall Study|Withdrawal by Subject|0|||
160830308|NCT00159913|580765966|FG001|Overall Study|Withdrawal by Subject|0|||
160830309|NCT00159913|580765967|FG002|Overall Study|Withdrawal by Subject|0|||
160830310|NCT00159913|580765968|FG003|Overall Study|Withdrawal by Subject|1|||
160830311|NCT00159913|580765965|FG000|Overall Study|Lost to Follow-up|0|||
160830312|NCT00159913|580765966|FG001|Overall Study|Lost to Follow-up|0|||
160830313|NCT00159913|580765967|FG002|Overall Study|Lost to Follow-up|0|||
160830314|NCT00159913|580765968|FG003|Overall Study|Lost to Follow-up|1|||
160830315|NCT00159913|580765965|FG000|Overall Study|Protocol Violation|1|||
160830316|NCT00159913|580765966|FG001|Overall Study|Protocol Violation|0|||
160830317|NCT00159913|580765967|FG002|Overall Study|Protocol Violation|1|||
160830318|NCT00159913|580765968|FG003|Overall Study|Protocol Violation|0|||
160830319|NCT03294135|580765969|FG000|Overall Study|Serious Adverse Event|1|||
160830320|NCT03294135|580765970|FG001|Overall Study|Serious Adverse Event|0|||
160830321|NCT03294135|580765971|FG002|Overall Study|Serious Adverse Event|0|||
160830322|NCT03294135|580765969|FG000|Overall Study|Lost to Follow-up|1|||
160830323|NCT03294135|580765970|FG001|Overall Study|Lost to Follow-up|0|||
161246915|NCT04402489|582283339|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160830324|NCT03294135|580765971|FG002|Overall Study|Lost to Follow-up|1|||
160830325|NCT03294135|580765969|FG000|Overall Study|Withdrawal by Subject|0|||
161246916|NCT04402489|582283340|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160830326|NCT03294135|580765970|FG001|Overall Study|Withdrawal by Subject|0|||
160830327|NCT03294135|580765971|FG002|Overall Study|Withdrawal by Subject|1|||
160830328|NCT03294135|580765969|FG000|Overall Study|Other|2|||
160830329|NCT03294135|580765970|FG001|Overall Study|Other|0|||
160830330|NCT03294135|580765971|FG002|Overall Study|Other|0|||
160830331|NCT02763254|580765973|FG000|Overall Study|Adverse Event|1|||
161136318|NCT00552110|581879459|FG004|Overall Study|Withdrawal by Subject|2|||
161136319|NCT00552110|581879455|FG000|Overall Study|Lost to Follow-up|0|||
161136320|NCT00552110|581879456|FG001|Overall Study|Lost to Follow-up|0|||
161136321|NCT00552110|581879457|FG002|Overall Study|Lost to Follow-up|0|||
161136322|NCT00552110|581879458|FG003|Overall Study|Lost to Follow-up|1|||
161136323|NCT00552110|581879459|FG004|Overall Study|Lost to Follow-up|1|||
161136324|NCT00552110|581879455|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
161136325|NCT00552110|581879456|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
161136326|NCT00552110|581879457|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
161136327|NCT00552110|581879458|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
161136328|NCT00552110|581879459|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
161136329|NCT00552110|581879455|FG000|Overall Study|Withdrawn per Sponsor|0|||
161136330|NCT00552110|581879456|FG001|Overall Study|Withdrawn per Sponsor|1|||
161136331|NCT00552110|581879457|FG002|Overall Study|Withdrawn per Sponsor|0|||
161136332|NCT00552110|581879458|FG003|Overall Study|Withdrawn per Sponsor|0|||
161136333|NCT00552110|581879459|FG004|Overall Study|Withdrawn per Sponsor|1|||
161136334|NCT00552110|581879455|FG000|Overall Study|Use of Prohibited Medication|1|||
161136335|NCT00552110|581879456|FG001|Overall Study|Use of Prohibited Medication|1|||
161136336|NCT00552110|581879457|FG002|Overall Study|Use of Prohibited Medication|0|||
161136337|NCT00552110|581879458|FG003|Overall Study|Use of Prohibited Medication|0|||
161136338|NCT00552110|581879459|FG004|Overall Study|Use of Prohibited Medication|0|||
161136339|NCT00552110|581879455|FG000|Overall Study|Delay of Study due to Relabeling|0|||
161136340|NCT00552110|581879456|FG001|Overall Study|Delay of Study due to Relabeling|0|||
161136341|NCT00552110|581879457|FG002|Overall Study|Delay of Study due to Relabeling|0|||
161136342|NCT00552110|581879458|FG003|Overall Study|Delay of Study due to Relabeling|1|||
161136343|NCT00552110|581879459|FG004|Overall Study|Delay of Study due to Relabeling|0|||
161136344|NCT00552110|581879455|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
161136345|NCT00552110|581879456|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
161136346|NCT00552110|581879457|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
161136347|NCT00552110|581879458|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
161136348|NCT00552110|581879459|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
161136349|NCT00552110|581879455|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
161136350|NCT00552110|581879456|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
161136351|NCT00552110|581879457|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
161136352|NCT00552110|581879458|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
161136353|NCT00552110|581879459|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
161136354|NCT02500537|581879461|FG000|Overall Study|Death|2|||
161136355|NCT02500537|581879462|FG001|Overall Study|Death|0|||
161136356|NCT02500537|581879461|FG000|Overall Study|Lost to Follow-up|0|||
161136357|NCT02500537|581879462|FG001|Overall Study|Lost to Follow-up|1|||
161136358|NCT02500537|581879461|FG000|Overall Study|Withdrawal by Subject|1|||
161136359|NCT02500537|581879462|FG001|Overall Study|Withdrawal by Subject|0|||
161136360|NCT00355121|581879463|FG000|Overall Study|Did not receive study vaccine|1|||
161136361|NCT00355121|581879464|FG001|Overall Study|Did not receive study vaccine|0|||
161136362|NCT00355121|581879465|FG002|Overall Study|Did not receive study vaccine|1|||
161136363|NCT00355121|581879463|FG000|Overall Study|Adverse Event|0|||
161136364|NCT00355121|581879464|FG001|Overall Study|Adverse Event|1|||
161136365|NCT00355121|581879465|FG002|Overall Study|Adverse Event|0|||
161136366|NCT00355121|581879463|FG000|Overall Study|Protocol Violation|7|||
161136367|NCT00355121|581879464|FG001|Overall Study|Protocol Violation|9|||
161136368|NCT00355121|581879465|FG002|Overall Study|Protocol Violation|1|||
161136369|NCT00355121|581879463|FG000|Overall Study|Lost to Follow-up|4|||
161136370|NCT00355121|581879464|FG001|Overall Study|Lost to Follow-up|7|||
161136371|NCT00355121|581879465|FG002|Overall Study|Lost to Follow-up|1|||
160903235|NCT00467857|581039055|FG001|Overall Study|Discontinuation reason missing|3|||
161136372|NCT00355121|581879463|FG000|Overall Study|Withdrawal by Subject|9|||
161136373|NCT00355121|581879464|FG001|Overall Study|Withdrawal by Subject|10|||
161136374|NCT00355121|581879465|FG002|Overall Study|Withdrawal by Subject|2|||
161136375|NCT00355121|581879463|FG000|Overall Study|Serious adverse events|0|||
161136376|NCT00355121|581879464|FG001|Overall Study|Serious adverse events|2|||
161136377|NCT00355121|581879465|FG002|Overall Study|Serious adverse events|0|||
161136378|NCT01587989|581879469|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
161136379|NCT01587989|581879470|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
161136380|NCT01587989|581879471|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
161136381|NCT01587989|581879469|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
161136382|NCT01587989|581879470|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
161136383|NCT01587989|581879471|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
161136384|NCT01587989|581879469|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
161136385|NCT01587989|581879470|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
161136386|NCT01587989|581879471|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
161136387|NCT01587989|581879469|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
161136388|NCT01587989|581879470|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
161136389|NCT01587989|581879471|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
161136390|NCT01587989|581879469|FG000|Randomized Study Treatment|Screening failure|0|||
161136391|NCT01587989|581879470|FG001|Randomized Study Treatment|Screening failure|1|||
161136392|NCT01587989|581879471|FG002|Randomized Study Treatment|Screening failure|0|||
161136393|NCT01587989|581879469|FG000|Randomized Study Treatment|Physician Decision|0|||
161136394|NCT01587989|581879470|FG001|Randomized Study Treatment|Physician Decision|0|||
161136395|NCT01587989|581879471|FG002|Randomized Study Treatment|Physician Decision|1|||
160830332|NCT00431951|580765974|FG000|Overall Study|Inability to follow study procedures|1|||
160830333|NCT00431951|580765975|FG001|Overall Study|Inability to follow study procedures|0|||
160830334|NCT00431951|580765976|FG002|Overall Study|Inability to follow study procedures|1|||
160830335|NCT00431951|580765977|FG003|Overall Study|Inability to follow study procedures|2|||
160830336|NCT00431951|580765974|FG000|Overall Study|Lost to Follow-up|0|||
160830337|NCT00431951|580765975|FG001|Overall Study|Lost to Follow-up|1|||
160830338|NCT00431951|580765976|FG002|Overall Study|Lost to Follow-up|0|||
160830339|NCT00431951|580765977|FG003|Overall Study|Lost to Follow-up|0|||
160830340|NCT00431951|580765974|FG000|Overall Study|Withdrawal by Subject|0|||
160830341|NCT00431951|580765975|FG001|Overall Study|Withdrawal by Subject|1|||
160830342|NCT00431951|580765976|FG002|Overall Study|Withdrawal by Subject|0|||
160830343|NCT00431951|580765977|FG003|Overall Study|Withdrawal by Subject|0|||
160830344|NCT00431951|580765974|FG000|Overall Study|Adverse Event|0|||
160830345|NCT00431951|580765975|FG001|Overall Study|Adverse Event|0|||
160830346|NCT00431951|580765976|FG002|Overall Study|Adverse Event|1|||
160830347|NCT00431951|580765977|FG003|Overall Study|Adverse Event|0|||
160830348|NCT00385723|580765978|FG000|Overall Study|Lost to Follow-up|1|||
160830349|NCT00385723|580765979|FG001|Overall Study|Lost to Follow-up|1|||
160830350|NCT00385723|580765980|FG002|Overall Study|Lost to Follow-up|0|||
160830351|NCT00385723|580765978|FG000|Overall Study|Withdrawal by Subject|1|||
160830352|NCT00385723|580765979|FG001|Overall Study|Withdrawal by Subject|0|||
161136396|NCT03313050|581879472|FG000|Stage 2: 12 Months|Adverse Event|0|||
161136397|NCT03313050|581879473|FG001|Stage 2: 12 Months|Adverse Event|0|||
161136398|NCT03313050|581879474|FG002|Stage 2: 12 Months|Adverse Event|0|||
161136399|NCT03313050|581879475|FG003|Stage 2: 12 Months|Adverse Event|1|||
161136400|NCT03313050|581879472|FG000|Stage 2: 12 Months|Death|0|||
161136401|NCT03313050|581879473|FG001|Stage 2: 12 Months|Death|0|||
161136402|NCT03313050|581879474|FG002|Stage 2: 12 Months|Death|3|||
161136403|NCT03313050|581879475|FG003|Stage 2: 12 Months|Death|0|||
161136404|NCT03313050|581879472|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
161136405|NCT03313050|581879473|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
161136406|NCT03313050|581879474|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
161136407|NCT03313050|581879475|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
161136408|NCT03313050|581879472|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161136409|NCT03313050|581879473|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161136410|NCT03313050|581879474|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
161136411|NCT03313050|581879475|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
161136412|NCT03313050|581879472|FG000|Stage 2: 12 Months|Protocol deviation|0|||
161136413|NCT03313050|581879473|FG001|Stage 2: 12 Months|Protocol deviation|0|||
161136414|NCT03313050|581879474|FG002|Stage 2: 12 Months|Protocol deviation|7|||
161136415|NCT03313050|581879475|FG003|Stage 2: 12 Months|Protocol deviation|7|||
161136416|NCT03313050|581879472|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
161136417|NCT03313050|581879473|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
161136418|NCT03313050|581879474|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
161136419|NCT03313050|581879475|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
161136420|NCT03313050|581879472|FG000|Stage 2: 12 Months|Other|0|||
161136421|NCT03313050|581879473|FG001|Stage 2: 12 Months|Other|0|||
161136422|NCT03313050|581879474|FG002|Stage 2: 12 Months|Other|0|||
160830353|NCT00385723|580765980|FG002|Overall Study|Withdrawal by Subject|2|||
160830354|NCT01390779|580765981|FG000|Overall Study|Physician Decision|1|||
160830355|NCT00168103|580765982|FG000|Overall Study|Withdrawal by Subject|1|||
160830356|NCT00168103|580765983|FG001|Overall Study|Withdrawal by Subject|2|||
160830357|NCT00168103|580765984|FG002|Overall Study|Withdrawal by Subject|1|||
160830358|NCT00168103|580765985|FG003|Overall Study|Withdrawal by Subject|0|||
160830359|NCT00168103|580765982|FG000|Overall Study|Lost to Follow-up|1|||
160830360|NCT00168103|580765983|FG001|Overall Study|Lost to Follow-up|3|||
161136423|NCT03313050|581879475|FG003|Stage 2: 12 Months|Other|1|||
161136424|NCT04211337|581879476|FG000|Overall Study|On Treatment|175|||
161136425|NCT04211337|581879477|FG001|Overall Study|On Treatment|40|||
161136426|NCT04211337|581879476|FG000|Overall Study|Withdrawal by Subject|0|||
161136427|NCT04211337|581879477|FG001|Overall Study|Withdrawal by Subject|2|||
161136428|NCT01291017|581879478|FG000|Overall Study|Lost to Follow-up|2|||
160830361|NCT00168103|580765984|FG002|Overall Study|Lost to Follow-up|0|||
160830362|NCT00168103|580765985|FG003|Overall Study|Lost to Follow-up|0|||
160830363|NCT00689793|580765992|FG000|Overall Study|Lost to Follow-up|4|||
160830364|NCT00689793|580765993|FG001|Overall Study|Lost to Follow-up|5|||
160830365|NCT02956850|580765999|FG000|Overall Study|Withdrawal by Subject|0|||
160830366|NCT02956850|580766000|FG001|Overall Study|Withdrawal by Subject|0|||
161136429|NCT01291017|581879478|FG000|Overall Study|Withdrawal by Subject|3|||
161136430|NCT00215150|581881603|FG000|Open Label Phase|Lost to Follow-up|7|||
161136431|NCT00215150|581881603|FG000|Open Label Phase|Withdrawal by Subject|1|||
160990878|NCT00941031|581353976|FG005|Maintenance Period|Administrative Problems|0|||
161246917|NCT04402489|582283341|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
160830367|NCT02956850|580766001|FG002|Overall Study|Withdrawal by Subject|0|||
160830368|NCT02956850|580766002|FG003|Overall Study|Withdrawal by Subject|0|||
160830369|NCT02956850|580766003|FG004|Overall Study|Withdrawal by Subject|0|||
160830370|NCT02956850|580766004|FG005|Overall Study|Withdrawal by Subject|0|||
160830371|NCT02956850|580766005|FG006|Overall Study|Withdrawal by Subject|0|||
160830372|NCT02956850|580766006|FG007|Overall Study|Withdrawal by Subject|0|||
160830373|NCT02956850|580766007|FG008|Overall Study|Withdrawal by Subject|0|||
160830374|NCT02956850|580766008|FG009|Overall Study|Withdrawal by Subject|0|||
160830375|NCT02956850|580766009|FG010|Overall Study|Withdrawal by Subject|0|||
160830376|NCT02956850|580766010|FG011|Overall Study|Withdrawal by Subject|0|||
160830377|NCT02956850|580766011|FG012|Overall Study|Withdrawal by Subject|0|||
160830378|NCT02956850|580766012|FG013|Overall Study|Withdrawal by Subject|0|||
160830379|NCT02956850|580766013|FG014|Overall Study|Withdrawal by Subject|0|||
160830380|NCT02956850|580766014|FG015|Overall Study|Withdrawal by Subject|0|||
160830381|NCT02956850|580766015|FG016|Overall Study|Withdrawal by Subject|0|||
160830382|NCT02956850|580766016|FG017|Overall Study|Withdrawal by Subject|1|||
160830383|NCT01920152|580766017|FG000|Overall Study|Withdrawal by Subject|1|||
160830384|NCT01920152|580766018|FG001|Overall Study|Withdrawal by Subject|2|||
160830385|NCT00708734|580766019|FG000|Overall Study|scheduling conflict|2|||
160830386|NCT00708734|580766019|FG000|Overall Study|moved|1|||
160830387|NCT00708734|580766019|FG000|Overall Study|leg injury|1|||
160830388|NCT00708734|580766019|FG000|Overall Study|knee replacement|1|||
160830389|NCT00708734|580766019|FG000|Overall Study|vertigo|1|||
160830390|NCT00708734|580766019|FG000|Overall Study|leg fracture|1|||
160830391|NCT03412604|580766020|FG000|Overall Study|Withdrawal by Subject|1|||
160830392|NCT02634606|580766021|FG000|Overall Study|unable to obtain the drug at start|13|||
160830393|NCT01287195|580766031|FG000|Overall Study|Withdrawal by Subject|2|||
160830394|NCT01995552|580766032|FG000|Overall Study|Protocol Violation|1|||
160830395|NCT01995552|580766032|FG000|Overall Study|Lack of Efficacy|15|||
160830396|NCT01995552|580766032|FG000|Overall Study|Death|1|||
160830397|NCT02068118|580766035|FG000|18-month Comparative Study Period|Death|90|||
160830398|NCT02068118|580766036|FG001|18-month Comparative Study Period|Death|97|||
160830399|NCT02068118|580766035|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
160830400|NCT02068118|580766036|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
160830401|NCT02068118|580766035|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
160830402|NCT02068118|580766036|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
160830403|NCT02068118|580766035|FG000|18-month Comparative Study Period|Heart transplant|9|||
160830404|NCT02068118|580766036|FG001|18-month Comparative Study Period|Heart transplant|15|||
160830405|NCT02068118|580766035|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
160830406|NCT02068118|580766036|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
160830407|NCT02068118|580766035|FG000|18-month Comparative Study Period|Hemiplegia|0|||
160830408|NCT02068118|580766036|FG001|18-month Comparative Study Period|Hemiplegia|1|||
160830409|NCT02068118|580766035|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
160830410|NCT02068118|580766036|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
160830411|NCT02068118|580766035|FG000|18-month Comparative Study Period|Move|0|||
160830412|NCT02068118|580766036|FG001|18-month Comparative Study Period|Move|1|||
160830413|NCT02068118|580766035|FG000|18-month Comparative Study Period|Hearing loss|0|||
160830414|NCT02068118|580766036|FG001|18-month Comparative Study Period|Hearing loss|1|||
160830415|NCT02068118|580766035|FG000|Extension Period|Death|0|||
160830416|NCT02068118|580766036|FG001|Extension Period|Death|2|||
160830417|NCT02068118|580766035|FG000|Extension Period|Withdrawal by Subject|1|||
160830418|NCT02068118|580766036|FG001|Extension Period|Withdrawal by Subject|0|||
160830419|NCT02068118|580766035|FG000|Extension Period|Heart transplant|1|||
160830420|NCT02068118|580766036|FG001|Extension Period|Heart transplant|0|||
160830421|NCT02068118|580766035|FG000|Extension Period|Wrong device use|0|||
160830422|NCT02068118|580766036|FG001|Extension Period|Wrong device use|1|||
160830423|NCT00283868|580766041|FG000|Overall Study|Lost to Follow-up|7|||
160830424|NCT00283868|580766042|FG001|Overall Study|Lost to Follow-up|8|||
160830425|NCT00353873|580766043|FG000|Overall Study|Protocol Violation|1|||
160830426|NCT00353873|580766044|FG001|Overall Study|Protocol Violation|2|||
160830427|NCT00353873|580766043|FG000|Overall Study|Exacerbation|1|||
160830428|NCT00353873|580766044|FG001|Overall Study|Exacerbation|0|||
160830429|NCT00353873|580766043|FG000|Overall Study|Adverse Event|1|||
160830430|NCT00353873|580766044|FG001|Overall Study|Adverse Event|0|||
160830431|NCT00353873|580766043|FG000|Overall Study|Physician Decision|2|||
160830432|NCT00353873|580766044|FG001|Overall Study|Physician Decision|0|||
160830433|NCT00353873|580766043|FG000|Overall Study|Withdrawal by Subject|1|||
160830434|NCT00353873|580766044|FG001|Overall Study|Withdrawal by Subject|1|||
160830435|NCT01515475|580766045|FG000|Overall Study|Lost to Follow-up|20|||
160830436|NCT01515475|580766046|FG001|Overall Study|Lost to Follow-up|15|||
160830437|NCT01515475|580766047|FG002|Overall Study|Lost to Follow-up|12|||
160830438|NCT01515475|580766048|FG003|Overall Study|Lost to Follow-up|12|||
160830439|NCT00453973|580766051|FG000|Overall Study|Adverse Event|4|||
160830440|NCT00453973|580766052|FG001|Overall Study|Adverse Event|9|||
161246918|NCT04402489|582283337|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
160830441|NCT00453973|580766051|FG000|Overall Study|Withdrawal by Subject|7|||
160830442|NCT00453973|580766052|FG001|Overall Study|Withdrawal by Subject|6|||
160830443|NCT00453973|580766051|FG000|Overall Study|PI Decision|0|||
160830444|NCT00453973|580766052|FG001|Overall Study|PI Decision|2|||
161246919|NCT04402489|582283338|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161246920|NCT04402489|582283339|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161246921|NCT04402489|582283340|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161246922|NCT04402489|582283341|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
161246923|NCT04402489|582283337|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
161246924|NCT04402489|582283338|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
161246925|NCT04402489|582283339|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
161246926|NCT04402489|582283340|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
161246927|NCT04402489|582283341|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
161246928|NCT04402489|582283337|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161246929|NCT04402489|582283338|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161246930|NCT04402489|582283339|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
161246931|NCT04402489|582283340|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161246932|NCT04402489|582283341|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
161246933|NCT04402489|582283337|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161246934|NCT04402489|582283338|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161246935|NCT04402489|582283339|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161246936|NCT04402489|582283340|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
161246937|NCT04402489|582283341|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
161246938|NCT04402489|582283337|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161246939|NCT04402489|582283338|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
161246940|NCT04402489|582283339|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
160830445|NCT00453973|580766051|FG000|Overall Study|Relocation|1|||
160830446|NCT00453973|580766052|FG001|Overall Study|Relocation|0|||
161246941|NCT04402489|582283340|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161246942|NCT04402489|582283341|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
161246943|NCT03192891|582283342|FG000|Overall Study|Lost to Follow-up|55|||
161246944|NCT05223868|582283343|FG000|Overall Study|Lost to Follow-up|1|||
161246945|NCT05223868|582283344|FG001|Overall Study|Lost to Follow-up|3|||
161246946|NCT05223868|582283345|FG002|Overall Study|Lost to Follow-up|0|||
161246947|NCT05223868|582283346|FG003|Overall Study|Lost to Follow-up|0|||
161246948|NCT05223868|582283347|FG004|Overall Study|Lost to Follow-up|0|||
161246949|NCT05223868|582283348|FG005|Overall Study|Lost to Follow-up|1|||
161246950|NCT05223868|582283343|FG000|Overall Study|Withdrawal by Subject|6|||
161246951|NCT05223868|582283344|FG001|Overall Study|Withdrawal by Subject|2|||
161246952|NCT05223868|582283345|FG002|Overall Study|Withdrawal by Subject|3|||
161246953|NCT05223868|582283346|FG003|Overall Study|Withdrawal by Subject|1|||
161246954|NCT05223868|582283347|FG004|Overall Study|Withdrawal by Subject|1|||
161246955|NCT05223868|582283348|FG005|Overall Study|Withdrawal by Subject|2|||
161246956|NCT05223868|582283343|FG000|Overall Study|Other|0|||
161246957|NCT05223868|582283344|FG001|Overall Study|Other|2|||
161246958|NCT05223868|582283345|FG002|Overall Study|Other|0|||
161246959|NCT05223868|582283346|FG003|Overall Study|Other|0|||
161246960|NCT05223868|582283347|FG004|Overall Study|Other|1|||
161246961|NCT05223868|582283348|FG005|Overall Study|Other|1|||
161246962|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161246963|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161246964|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161246965|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
161246966|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161246967|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
161246968|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161246969|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161246970|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
161246971|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
161246972|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161246973|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
161246974|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161246975|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160830447|NCT00453973|580766051|FG000|Overall Study|Renal transplant|1|||
160830448|NCT00453973|580766052|FG001|Overall Study|Renal transplant|1|||
160830449|NCT00453973|580766051|FG000|Overall Study|Site closed by sponsor|3|||
161246976|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
161246977|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161246978|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
160903236|NCT03576495|581039056|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
160903237|NCT03576495|581039057|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
160903238|NCT05306977|581039060|FG000|Overall Study|Withdrawal by Subject|1|||
160903239|NCT01484275|581039065|FG000|Overall Study|Study terminated by sponsor|28|||
160903240|NCT01484275|581039066|FG001|Overall Study|Study terminated by sponsor|32|||
160903241|NCT01484275|581039065|FG000|Overall Study|Other|10|||
160903242|NCT01484275|581039066|FG001|Overall Study|Other|0|||
160903243|NCT01484275|581039065|FG000|Overall Study|Death|3|||
160903244|NCT01484275|581039066|FG001|Overall Study|Death|4|||
160903245|NCT01484275|581039065|FG000|Overall Study|Withdrawal by Subject|1|||
160903246|NCT01484275|581039066|FG001|Overall Study|Withdrawal by Subject|5|||
160903247|NCT01484275|581039065|FG000|Overall Study|Lost to Follow-up|1|||
160903248|NCT01484275|581039066|FG001|Overall Study|Lost to Follow-up|1|||
160903249|NCT00003487|581039067|FG000|Overall Study|Not evaluable|2|||
160903250|NCT04154930|581039070|FG000|Overall Study|Withdrawal by Subject|15|||
160903251|NCT04154930|581039071|FG001|Overall Study|Withdrawal by Subject|6|||
160903252|NCT04154930|581039070|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
160903253|NCT04154930|581039071|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
160903254|NCT04154930|581039070|FG000|Overall Study|Lost to Follow-up|14|||
160903255|NCT04154930|581039071|FG001|Overall Study|Lost to Follow-up|6|||
160903256|NCT04154930|581039070|FG000|Overall Study|Other|6|||
160903257|NCT04154930|581039071|FG001|Overall Study|Other|0|||
160903258|NCT02020577|581039075|FG000|Overall Study|Progressive disease|3|||
160903259|NCT02020577|581039076|FG001|Overall Study|Progressive disease|38|||
160903260|NCT02020577|581039075|FG000|Overall Study|Other AE or clinical progression|0|||
160903261|NCT02020577|581039076|FG001|Overall Study|Other AE or clinical progression|15|||
160903262|NCT02020577|581039075|FG000|Overall Study|Withdrawal by Subject|0|||
160903263|NCT02020577|581039076|FG001|Overall Study|Withdrawal by Subject|1|||
160903264|NCT02020577|581039075|FG000|Overall Study|Other than stated above|0|||
160903265|NCT02020577|581039076|FG001|Overall Study|Other than stated above|1|||
160903266|NCT02628938|581039077|FG000|Overall Study|Did not attend the follow up recall|2|||
160903267|NCT02628938|581039078|FG001|Overall Study|Did not attend the follow up recall|2|||
161246979|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
161246980|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161246981|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161246982|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
161246983|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
161246984|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
160903268|NCT02628938|581039079|FG002|Overall Study|Did not attend the follow up recall|1|||
160903269|NCT02628938|581039077|FG000|Overall Study|Failure to comply with the instructions|3|||
160903270|NCT02628938|581039078|FG001|Overall Study|Failure to comply with the instructions|0|||
160903271|NCT02628938|581039079|FG002|Overall Study|Failure to comply with the instructions|3|||
160903272|NCT02058693|581039080|FG000|Phase 1|Withdrawal by Subject|3|||
160903273|NCT02058693|581039081|FG001|Phase 1|Withdrawal by Subject|2|||
160903274|NCT02058693|581039080|FG000|Phase 1|Adverse Event|0|||
160903275|NCT02058693|581039081|FG001|Phase 1|Adverse Event|1|||
160903276|NCT02058693|581039080|FG000|Phase 1|Lack of Efficacy|1|||
160903277|NCT02058693|581039081|FG001|Phase 1|Lack of Efficacy|0|||
160903278|NCT02058693|581039080|FG000|Phase 1|Physician Decision|1|||
160903279|NCT02058693|581039081|FG001|Phase 1|Physician Decision|1|||
160903280|NCT02058693|581039080|FG000|Phase 2|Withdrawal by Subject|0|||
160903281|NCT02058693|581039081|FG001|Phase 2|Withdrawal by Subject|2|||
160903282|NCT03855228|581039082|FG000|Overall Study|Adverse Event|2|||
160903283|NCT03855228|581039083|FG001|Overall Study|Adverse Event|4|||
160903284|NCT03855228|581039084|FG002|Overall Study|Adverse Event|4|||
160903285|NCT03855228|581039085|FG003|Overall Study|Adverse Event|8|||
160903286|NCT03855228|581039082|FG000|Overall Study|Treatment Failure|1|||
160903287|NCT03855228|581039083|FG001|Overall Study|Treatment Failure|2|||
161246985|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
161246986|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161246987|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161246988|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
160903288|NCT03855228|581039084|FG002|Overall Study|Treatment Failure|1|||
160903289|NCT03855228|581039085|FG003|Overall Study|Treatment Failure|8|||
160903290|NCT03855228|581039082|FG000|Overall Study|Lost to Follow-up|0|||
160903291|NCT03855228|581039083|FG001|Overall Study|Lost to Follow-up|0|||
160903292|NCT03855228|581039084|FG002|Overall Study|Lost to Follow-up|0|||
160903293|NCT03855228|581039085|FG003|Overall Study|Lost to Follow-up|1|||
160903294|NCT03855228|581039082|FG000|Overall Study|Protocol Violation|0|||
160903295|NCT03855228|581039083|FG001|Overall Study|Protocol Violation|1|||
160903296|NCT03855228|581039084|FG002|Overall Study|Protocol Violation|2|||
160903297|NCT03855228|581039085|FG003|Overall Study|Protocol Violation|1|||
160903298|NCT03855228|581039082|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
160903299|NCT03855228|581039083|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
160903300|NCT03855228|581039084|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
161136432|NCT00215150|581881603|FG000|Open Label Phase|Did not complete a post base visit|13|||
161136433|NCT00215150|581881603|FG000|Open Label Phase|Did not meet randomization criteria|9|||
161136434|NCT00215150|581881603|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
161136435|NCT00215150|581881603|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
161136436|NCT00215150|581881603|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
161136437|NCT02091440|581881607|FG000|Overall Study|Death|2|||
161136438|NCT00278629|581881614|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
161136439|NCT03323749|581881615|FG000|Double-blind Period|Lost to Follow-up|4|||
161136440|NCT03323749|581881616|FG001|Double-blind Period|Lost to Follow-up|5|||
161136441|NCT03323749|581881615|FG000|Double-blind Period|Adverse Event|3|||
161136442|NCT03323749|581881616|FG001|Double-blind Period|Adverse Event|1|||
161136443|NCT03323749|581881615|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
161136444|NCT03323749|581881616|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
161136445|NCT03323749|581881615|FG000|Open-Label Period|Adverse Event|3|||
161334851|NCT01774591|582615840|FG001|Overall Study|Withdrawal by Subject|1|||
161334852|NCT01774591|582615839|FG000|Overall Study|Adverse Event|0|||
161334853|NCT01774591|582615840|FG001|Overall Study|Adverse Event|2|||
161334854|NCT01159574|582615841|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
161334855|NCT01159574|582615841|FG000|Treatment Phase|Adverse Event|3|||
161334856|NCT01159574|582615841|FG000|Treatment Phase|Death|6|||
161334857|NCT01159574|582615841|FG000|Treatment Phase|Physician Decision|2|||
161334858|NCT01159574|582615841|FG000|Treatment Phase|Withdrawal by Subject|7|||
161334859|NCT01159574|582615841|FG000|Treatment Phase|still on treatment|2|||
161136446|NCT03323749|581881616|FG001|Open-Label Period|Adverse Event|10|||
161136447|NCT03323749|581881615|FG000|Open-Label Period|Withdrawal by Subject|7|||
161136448|NCT03323749|581881616|FG001|Open-Label Period|Withdrawal by Subject|5|||
161136449|NCT01821963|581881617|FG000|Overall Study|Adverse Event|1|||
161136450|NCT00783289|581881618|FG000|Overall Study|Protocol Violation|0|||
161334860|NCT01159574|582615841|FG000|Follow Up Phase|Lost to Follow-up|2|||
161334861|NCT01159574|582615841|FG000|Follow Up Phase|still being followed for overall surviva|18|||
161334862|NCT00630916|582615842|FG000|Overall Study|Death|110|||
161334863|NCT00630916|582615842|FG000|Overall Study|Explant|8|||
161334864|NCT00630916|582615842|FG000|Overall Study|Lost to Follow-up|5|||
161334865|NCT00630916|582615842|FG000|Overall Study|Withdrawal by Subject|30|||
161334866|NCT00630916|582615842|FG000|Overall Study|Protocol Violation|7|||
161334867|NCT00630916|582615842|FG000|Overall Study|Physician Decision|47|||
161136451|NCT00783289|581881619|FG001|Overall Study|Protocol Violation|1|||
161136452|NCT00783289|581881620|FG002|Overall Study|Protocol Violation|0|||
161136453|NCT00783289|581881621|FG003|Overall Study|Protocol Violation|0|||
161136454|NCT00506389|581881622|FG000|In-treatment Period|Other|3|||
161136455|NCT00506389|581881623|FG001|In-treatment Period|Other|3|||
161136456|NCT00506389|581881624|FG002|In-treatment Period|Other|4|||
161136457|NCT00506389|581881622|FG000|In-treatment Period|Lost to Follow-up|0|||
161136458|NCT00506389|581881623|FG001|In-treatment Period|Lost to Follow-up|0|||
161136459|NCT00506389|581881624|FG002|In-treatment Period|Lost to Follow-up|1|||
161136460|NCT00506389|581881622|FG000|In-treatment Period|Lack of compliance|1|||
161334868|NCT00630916|582615842|FG000|Overall Study|Lack of Efficacy|3|||
161334869|NCT03101020|582615844|FG000|Overall Study|Lack of time to participate|1|||
161334870|NCT03101020|582615845|FG001|Overall Study|Lack of time to participate|0|||
161334871|NCT03101020|582615844|FG000|Overall Study|Ran over by a car|0|||
161334872|NCT03101020|582615845|FG001|Overall Study|Ran over by a car|1|||
161334873|NCT03101020|582615844|FG000|Overall Study|Withdrawal by Subject|0|||
160830450|NCT00453973|580766052|FG001|Overall Study|Site closed by sponsor|0|||
160830451|NCT00453973|580766051|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
160830452|NCT00453973|580766052|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
160830453|NCT03743064|580766053|FG000|Overall Study|Adverse Event|7|||
160830454|NCT03743064|580766054|FG001|Overall Study|Adverse Event|9|||
160830455|NCT03743064|580766053|FG000|Overall Study|Death|25|||
160830456|NCT03743064|580766054|FG001|Overall Study|Death|28|||
160830457|NCT03743064|580766053|FG000|Overall Study|Lost to Follow-up|3|||
161334874|NCT03101020|582615845|FG001|Overall Study|Withdrawal by Subject|2|||
161334875|NCT03167242|582615847|FG000|Overall Study|Patient/Guardian Decision|0|||
161334876|NCT03167242|582615848|FG001|Overall Study|Patient/Guardian Decision|1|||
161334877|NCT03167242|582615849|FG002|Overall Study|Patient/Guardian Decision|2|||
161334878|NCT03167242|582615850|FG003|Overall Study|Patient/Guardian Decision|1|||
160903301|NCT03855228|581039085|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
161334879|NCT03167242|582615851|FG004|Overall Study|Patient/Guardian Decision|1|||
161334880|NCT03167242|582615852|FG005|Overall Study|Patient/Guardian Decision|1|||
161334881|NCT03167242|582615853|FG006|Overall Study|Patient/Guardian Decision|0|||
161334882|NCT03167242|582615854|FG007|Overall Study|Patient/Guardian Decision|0|||
161136461|NCT00506389|581881623|FG001|In-treatment Period|Lack of compliance|0|||
161334883|NCT03167242|582615855|FG008|Overall Study|Patient/Guardian Decision|0|||
161334884|NCT03167242|582615856|FG009|Overall Study|Patient/Guardian Decision|0|||
160830458|NCT03743064|580766054|FG001|Overall Study|Lost to Follow-up|6|||
160830459|NCT03743064|580766053|FG000|Overall Study|Withdrawal by Subject|28|||
161334885|NCT03167242|582615857|FG010|Overall Study|Patient/Guardian Decision|1|||
160830460|NCT03743064|580766054|FG001|Overall Study|Withdrawal by Subject|25|||
160830461|NCT03743064|580766053|FG000|Overall Study|Physician Decision|2|||
160830462|NCT03743064|580766054|FG001|Overall Study|Physician Decision|4|||
160830463|NCT03743064|580766053|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
160830464|NCT03743064|580766054|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
160830465|NCT01996592|580766059|FG000|Overall Study|no response to text/no diary entry|32|||
160830466|NCT01996592|580766059|FG000|Overall Study|change in surgical date|4|||
160830467|NCT01996592|580766059|FG000|Overall Study|Withdrawal by Subject|5|||
160830468|NCT01996592|580766059|FG000|Overall Study|change in mode of delivery|4|||
160830469|NCT02759315|580766060|FG000|Overall Study|Adverse Event|0|||
160830470|NCT02759315|580766061|FG001|Overall Study|Adverse Event|0|||
160830471|NCT02759315|580766062|FG002|Overall Study|Adverse Event|0|||
160830472|NCT02759315|580766063|FG003|Overall Study|Adverse Event|1|||
160830473|NCT02759315|580766064|FG004|Overall Study|Adverse Event|0|||
160830474|NCT02759315|580766060|FG000|Overall Study|Death|0|||
160830475|NCT02759315|580766061|FG001|Overall Study|Death|0|||
160830476|NCT02759315|580766062|FG002|Overall Study|Death|1|||
160830477|NCT02759315|580766063|FG003|Overall Study|Death|0|||
160830478|NCT02759315|580766064|FG004|Overall Study|Death|0|||
161136462|NCT00506389|581881624|FG002|In-treatment Period|Lack of compliance|0|||
161136463|NCT00506389|581881622|FG000|In-treatment Period|Reasons not related to trial|4|||
161136464|NCT00506389|581881623|FG001|In-treatment Period|Reasons not related to trial|1|||
161136465|NCT00506389|581881624|FG002|In-treatment Period|Reasons not related to trial|0|||
161136466|NCT00506389|581881622|FG000|In-treatment Period|Withdrawal by Subject|3|||
160903302|NCT00590135|581039086|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
161136467|NCT00506389|581881623|FG001|In-treatment Period|Withdrawal by Subject|3|||
161136468|NCT00506389|581881624|FG002|In-treatment Period|Withdrawal by Subject|4|||
161136469|NCT00506389|581881622|FG000|In-treatment Period|Lack of Efficacy|0|||
161136470|NCT00506389|581881623|FG001|In-treatment Period|Lack of Efficacy|2|||
161136471|NCT00506389|581881624|FG002|In-treatment Period|Lack of Efficacy|0|||
161136472|NCT00506389|581881622|FG000|In-treatment Period|Adverse Event|11|||
161136473|NCT00506389|581881623|FG001|In-treatment Period|Adverse Event|5|||
161136474|NCT00506389|581881624|FG002|In-treatment Period|Adverse Event|2|||
161136475|NCT00506389|581881622|FG000|In-treatment Period|Randomized but not treated|4|||
161136476|NCT00506389|581881623|FG001|In-treatment Period|Randomized but not treated|1|||
161136477|NCT00506389|581881624|FG002|In-treatment Period|Randomized but not treated|1|||
161136478|NCT05224258|581881626|FG000|Overall Study|Withdrawal by Subject|1|||
161136479|NCT05224258|581881627|FG001|Overall Study|Withdrawal by Subject|1|||
161136480|NCT05224258|581881626|FG000|Overall Study|Physician Decision|1|||
161136481|NCT05224258|581881627|FG001|Overall Study|Physician Decision|1|||
161136482|NCT05224258|581881626|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161136483|NCT05224258|581881627|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161136484|NCT05224258|581881626|FG000|Overall Study|Study Product No Longer in Use|1|||
161136485|NCT05224258|581881627|FG001|Overall Study|Study Product No Longer in Use|0|||
161136486|NCT05224258|581881626|FG000|Overall Study|Adverse Event|0|||
161136487|NCT05224258|581881627|FG001|Overall Study|Adverse Event|1|||
161136488|NCT05224258|581881626|FG000|Overall Study|Protocol Deviation|0|||
161136489|NCT05224258|581881627|FG001|Overall Study|Protocol Deviation|1|||
161136490|NCT03095703|581881629|FG000|Overall Study|Withdrawal by Subject|1|||
161136491|NCT03539432|581881630|FG000|Overall Study|Lost to Follow-up|0|||
161136492|NCT03539432|581881631|FG001|Overall Study|Lost to Follow-up|1|||
161136493|NCT01381094|581881632|FG000|Overall Study|Adverse Event|1|||
161136494|NCT01381094|581881633|FG001|Overall Study|Adverse Event|2|||
161136495|NCT01381094|581881634|FG002|Overall Study|Adverse Event|0|||
161136496|NCT01381094|581881635|FG003|Overall Study|Adverse Event|1|||
161136497|NCT01381094|581881636|FG004|Overall Study|Adverse Event|0|||
161136498|NCT01381094|581881632|FG000|Overall Study|Lost to Follow-up|0|||
161136499|NCT01381094|581881633|FG001|Overall Study|Lost to Follow-up|0|||
161136500|NCT01381094|581881634|FG002|Overall Study|Lost to Follow-up|0|||
161136501|NCT01381094|581881635|FG003|Overall Study|Lost to Follow-up|0|||
161136502|NCT01381094|581881636|FG004|Overall Study|Lost to Follow-up|1|||
161136503|NCT01381094|581881632|FG000|Overall Study|Withdrawal of informed consent|0|||
161136504|NCT01381094|581881633|FG001|Overall Study|Withdrawal of informed consent|1|||
161136505|NCT01381094|581881634|FG002|Overall Study|Withdrawal of informed consent|0|||
161136506|NCT01381094|581881635|FG003|Overall Study|Withdrawal of informed consent|0|||
161136507|NCT01381094|581881636|FG004|Overall Study|Withdrawal of informed consent|0|||
161136508|NCT01381094|581881632|FG000|Overall Study|Participant given Aranesp injection|1|||
161136509|NCT01381094|581881633|FG001|Overall Study|Participant given Aranesp injection|0|||
161136510|NCT01381094|581881634|FG002|Overall Study|Participant given Aranesp injection|0|||
160830479|NCT02759315|580766060|FG000|Overall Study|Lost to Follow-up|2|||
160830480|NCT02759315|580766061|FG001|Overall Study|Lost to Follow-up|0|||
160830481|NCT02759315|580766062|FG002|Overall Study|Lost to Follow-up|4|||
161136511|NCT01381094|581881635|FG003|Overall Study|Participant given Aranesp injection|0|||
161136512|NCT01381094|581881636|FG004|Overall Study|Participant given Aranesp injection|0|||
161136513|NCT02443402|581881639|FG000|Overall Study|Withdrawal by Subject|3|||
161136514|NCT02443402|581881640|FG001|Overall Study|Withdrawal by Subject|1|||
160830482|NCT02759315|580766063|FG003|Overall Study|Lost to Follow-up|0|||
160830483|NCT02759315|580766064|FG004|Overall Study|Lost to Follow-up|0|||
160830484|NCT02759315|580766060|FG000|Overall Study|Protocol Violation|0|||
160830485|NCT02759315|580766061|FG001|Overall Study|Protocol Violation|1|||
160830486|NCT02759315|580766062|FG002|Overall Study|Protocol Violation|0|||
160830487|NCT02759315|580766063|FG003|Overall Study|Protocol Violation|0|||
160830488|NCT02759315|580766064|FG004|Overall Study|Protocol Violation|0|||
160830489|NCT02759315|580766060|FG000|Overall Study|Study terminated prior to completion|2|||
160830490|NCT02759315|580766061|FG001|Overall Study|Study terminated prior to completion|0|||
160830491|NCT02759315|580766062|FG002|Overall Study|Study terminated prior to completion|5|||
160830492|NCT02759315|580766063|FG003|Overall Study|Study terminated prior to completion|0|||
160830493|NCT02759315|580766064|FG004|Overall Study|Study terminated prior to completion|1|||
160830494|NCT00870194|580766067|FG000|Overall Study|Adverse Event|10|||
160830495|NCT00870194|580766068|FG001|Overall Study|Adverse Event|5|||
160990879|NCT00941031|581353977|FG006|Maintenance Period|Administrative Problems|1|||
160990880|NCT00941031|581353971|FG000|Maintenance Period|Protocol Violation|0|||
160990881|NCT00941031|581353972|FG001|Maintenance Period|Protocol Violation|0|||
161246989|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
161246990|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161246991|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
161246992|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
161246993|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
161246994|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
161246995|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
161246996|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
161246997|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
161246998|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
161246999|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
161247000|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
161247001|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
161247002|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
161247003|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
161247004|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161247005|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
161247006|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
161247007|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
161247008|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161247009|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
161247010|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
161247011|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161247012|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
161247013|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
161247014|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161247015|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
161247016|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
161247017|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
161247018|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
161247019|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
161247020|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
161247021|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
161247022|NCT03395197|582283349|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
161247023|NCT03395197|582283350|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161247024|NCT03395197|582283351|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
161247025|NCT03395197|582283352|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
160990882|NCT00941031|581353973|FG002|Maintenance Period|Protocol Violation|0|||
160990883|NCT00941031|581353974|FG003|Maintenance Period|Protocol Violation|0|||
160990884|NCT00941031|581353975|FG004|Maintenance Period|Protocol Violation|0|||
160990885|NCT00941031|581353976|FG005|Maintenance Period|Protocol Violation|0|||
160990886|NCT00941031|581353977|FG006|Maintenance Period|Protocol Violation|1|||
160990887|NCT00941031|581353971|FG000|Maintenance Period|Adverse Event|0|||
160990888|NCT00941031|581353972|FG001|Maintenance Period|Adverse Event|0|||
160990889|NCT00941031|581353973|FG002|Maintenance Period|Adverse Event|0|||
160990890|NCT00941031|581353974|FG003|Maintenance Period|Adverse Event|0|||
161247026|NCT03395197|582283353|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
161247027|NCT03395197|582283354|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
160990891|NCT00941031|581353975|FG004|Maintenance Period|Adverse Event|0|||
160990892|NCT00941031|581353976|FG005|Maintenance Period|Adverse Event|2|||
160990893|NCT00941031|581353977|FG006|Maintenance Period|Adverse Event|8|||
160990894|NCT00941031|581353971|FG000|Maintenance Period|Lost to Follow-up|0|||
160990895|NCT00941031|581353972|FG001|Maintenance Period|Lost to Follow-up|0|||
160990896|NCT00941031|581353973|FG002|Maintenance Period|Lost to Follow-up|0|||
160990897|NCT00941031|581353974|FG003|Maintenance Period|Lost to Follow-up|0|||
160990898|NCT00941031|581353975|FG004|Maintenance Period|Lost to Follow-up|2|||
160990899|NCT00941031|581353976|FG005|Maintenance Period|Lost to Follow-up|2|||
160990900|NCT00941031|581353977|FG006|Maintenance Period|Lost to Follow-up|7|||
160990901|NCT00941031|581353971|FG000|Maintenance Period|Lack of Efficacy|0|||
160990902|NCT00941031|581353972|FG001|Maintenance Period|Lack of Efficacy|0|||
160990903|NCT00941031|581353973|FG002|Maintenance Period|Lack of Efficacy|0|||
160990904|NCT00941031|581353974|FG003|Maintenance Period|Lack of Efficacy|0|||
160990905|NCT00941031|581353975|FG004|Maintenance Period|Lack of Efficacy|0|||
160990906|NCT00941031|581353976|FG005|Maintenance Period|Lack of Efficacy|0|||
160990907|NCT00941031|581353977|FG006|Maintenance Period|Lack of Efficacy|13|||
160990908|NCT03441984|581353978|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990909|NCT03441984|581353979|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990910|NCT03441984|581353980|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
160990911|NCT03441984|581353981|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990912|NCT03441984|581353982|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990913|NCT03441984|581353983|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990914|NCT03441984|581353984|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990915|NCT03441984|581353985|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990916|NCT03441984|581353986|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990917|NCT03441984|581353987|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990918|NCT03441984|581353988|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990919|NCT03441984|581353989|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
160990920|NCT01872611|581353990|FG000|Overall Study|Adverse Event|3|||
160990921|NCT01872611|581353991|FG001|Overall Study|Adverse Event|1|||
160990922|NCT01872611|581353990|FG000|Overall Study|Adverse Event, prior to treatment|0|||
160990923|NCT01872611|581353991|FG001|Overall Study|Adverse Event, prior to treatment|1|||
160990924|NCT01872611|581353990|FG000|Overall Study|Death|0|||
160990925|NCT01872611|581353991|FG001|Overall Study|Death|1|||
160990926|NCT01872611|581353990|FG000|Overall Study|Death, prior to treatment|0|||
160990927|NCT01872611|581353991|FG001|Overall Study|Death, prior to treatment|1|||
160990928|NCT01872611|581353990|FG000|Overall Study|Lost to Follow-up|8|||
160990929|NCT01872611|581353991|FG001|Overall Study|Lost to Follow-up|1|||
160990930|NCT01872611|581353990|FG000|Overall Study|Physician Decision|1|||
160990931|NCT01872611|581353991|FG001|Overall Study|Physician Decision|0|||
160990932|NCT01872611|581353990|FG000|Overall Study|Withdrawal by Subject|6|||
160990933|NCT01872611|581353991|FG001|Overall Study|Withdrawal by Subject|1|||
160990934|NCT01872611|581353990|FG000|Overall Study|Reason not provided|6|||
160990935|NCT01872611|581353991|FG001|Overall Study|Reason not provided|6|||
160990936|NCT04555044|581353994|FG000|Overall Study|Adverse Event|0|||
160990937|NCT04555044|581353995|FG001|Overall Study|Adverse Event|1|||
160990938|NCT04088188|581353998|FG000|Overall Study|Withdrawal by Subject|2|||
160990939|NCT04088188|581353999|FG001|Overall Study|Withdrawal by Subject|0|||
160990940|NCT04088188|581353998|FG000|Overall Study|Adverse Event|2|||
160990941|NCT04088188|581353999|FG001|Overall Study|Adverse Event|0|||
160990942|NCT00631917|581354000|FG000|Overall Study|Adverse Event|34|||
160990943|NCT00631917|581354001|FG001|Overall Study|Adverse Event|45|||
160990944|NCT00631917|581354000|FG000|Overall Study|Abnormal laboratory value(s)|2|||
160990945|NCT00631917|581354001|FG001|Overall Study|Abnormal laboratory value(s)|1|||
160990946|NCT00631917|581354000|FG000|Overall Study|Abnormal test procedure result(s)|3|||
160990947|NCT00631917|581354001|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161247028|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Death|0|||
161247029|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Death|0|||
161247030|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Death|0|||
161247031|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Death|0|||
161247032|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Death|1|||
160990948|NCT00631917|581354000|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
160990949|NCT00631917|581354001|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
161247033|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Death|4|||
161247034|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
160830496|NCT00870194|580766067|FG000|Overall Study|Lack of Efficacy|0|||
160990950|NCT00631917|581354000|FG000|Overall Study|No longer required study drug|0|||
160990951|NCT00631917|581354001|FG001|Overall Study|No longer required study drug|1|||
160990952|NCT00631917|581354000|FG000|Overall Study|Protocol deviation|6|||
160990953|NCT00631917|581354001|FG001|Overall Study|Protocol deviation|5|||
160990954|NCT00631917|581354000|FG000|Overall Study|Subject withdrew consent|25|||
160990955|NCT00631917|581354001|FG001|Overall Study|Subject withdrew consent|33|||
160990956|NCT00631917|581354000|FG000|Overall Study|Lost to Follow-up|7|||
160830497|NCT00870194|580766068|FG001|Overall Study|Lack of Efficacy|1|||
160990957|NCT00631917|581354001|FG001|Overall Study|Lost to Follow-up|7|||
160990958|NCT00631917|581354000|FG000|Overall Study|Administrative problems|2|||
160990959|NCT00631917|581354001|FG001|Overall Study|Administrative problems|0|||
160990960|NCT00631917|581354000|FG000|Overall Study|Death|1|||
160990961|NCT00631917|581354001|FG001|Overall Study|Death|0|||
160990962|NCT03686384|581354002|FG000|Overall Study|Lack of Efficacy|4|||
160990963|NCT03686384|581354003|FG001|Overall Study|Lack of Efficacy|13|||
160990964|NCT03686384|581354002|FG000|Overall Study|Lost to Follow-up|3|||
160990965|NCT03686384|581354003|FG001|Overall Study|Lost to Follow-up|0|||
160990966|NCT03686384|581354002|FG000|Overall Study|Physician Decision|0|||
160990967|NCT03686384|581354003|FG001|Overall Study|Physician Decision|1|||
160990968|NCT03686384|581354002|FG000|Overall Study|Took prohibited medication|0|||
160990969|NCT03686384|581354003|FG001|Overall Study|Took prohibited medication|1|||
160990970|NCT00614744|581354014|FG000|Overall Study|Lost to Follow-up|5|||
160990971|NCT00614744|581354015|FG001|Overall Study|Lost to Follow-up|4|||
160990972|NCT00614744|581354014|FG000|Overall Study|Incomplete for Behavior Issues|0|||
160990973|NCT00614744|581354015|FG001|Overall Study|Incomplete for Behavior Issues|2|||
160990974|NCT00877851|581354016|FG000|Overall Study|Lost to Follow-up|5|||
160990975|NCT00877851|581354017|FG001|Overall Study|Lost to Follow-up|5|||
160990976|NCT00877851|581354016|FG000|Overall Study|computer problem|3|||
160990977|NCT00877851|581354017|FG001|Overall Study|computer problem|0|||
160990978|NCT00877851|581354016|FG000|Overall Study|no longer interested in participating|1|||
160990979|NCT00877851|581354017|FG001|Overall Study|no longer interested in participating|0|||
160990980|NCT03285711|581354018|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
160990981|NCT03285711|581354019|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
160990982|NCT03285711|581354020|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
160990983|NCT03285711|581354021|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
160990984|NCT03285711|581354018|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
160990985|NCT03285711|581354019|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
160990986|NCT03285711|581354020|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
160990987|NCT03285711|581354021|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
160990988|NCT03285711|581354018|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
160990989|NCT03285711|581354019|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
160990990|NCT03285711|581354020|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
160990991|NCT03285711|581354021|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
160990992|NCT03285711|581354018|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
160990993|NCT03285711|581354019|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
160990994|NCT03285711|581354020|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
160990995|NCT03285711|581354021|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
160990996|NCT00209274|581354028|FG000|Overall Study|Missed visit|3|||
160990997|NCT00209274|581354029|FG001|Overall Study|Missed visit|2|||
160990998|NCT00209274|581354028|FG000|Overall Study|Death|32|||
160990999|NCT00209274|581354029|FG001|Overall Study|Death|15|||
160991000|NCT00209274|581354028|FG000|Overall Study|Withdrawal by Subject|30|||
160991001|NCT00209274|581354029|FG001|Overall Study|Withdrawal by Subject|15|||
160991002|NCT00209274|581354028|FG000|Overall Study|Randomized not treated (RNT)|6|||
160991003|NCT00209274|581354029|FG001|Overall Study|Randomized not treated (RNT)|15|||
160991004|NCT02753530|581354031|FG000|Overall Study|Adverse Event|7|||
160991005|NCT02753530|581354032|FG001|Overall Study|Adverse Event|1|||
160991006|NCT02753530|581354031|FG000|Overall Study|Death|0|||
160991007|NCT02753530|581354032|FG001|Overall Study|Death|1|||
160991008|NCT02753530|581354031|FG000|Overall Study|Physician Decision|0|||
160991009|NCT02753530|581354032|FG001|Overall Study|Physician Decision|1|||
160991010|NCT02753530|581354031|FG000|Overall Study|Protocol Violation|1|||
160991011|NCT02753530|581354032|FG001|Overall Study|Protocol Violation|0|||
160991012|NCT02753530|581354031|FG000|Overall Study|Withdrawal by Subject|4|||
160991013|NCT02753530|581354032|FG001|Overall Study|Withdrawal by Subject|3|||
160991014|NCT00256308|581355439|FG000|Overall Study|Death|2|||
160991015|NCT03712930|581355440|FG000|Overall Study|Death|7|||
160991016|NCT03712930|581355440|FG000|Overall Study|Physician Decision|1|||
160991017|NCT03712930|581355440|FG000|Overall Study|Study Terminated by Sponsor|3|||
160991018|NCT03712930|581355440|FG000|Overall Study|Progressive Disease|2|||
160991019|NCT01062126|581355444|FG000|Overall Study|Death|209|||
160991020|NCT01062126|581355444|FG000|Overall Study|All Withdrawals|324|||
160991021|NCT03784963|581355445|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
160991022|NCT03784963|581355446|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
160991023|NCT03784963|581355447|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
161136515|NCT02443402|581881639|FG000|Overall Study|Screen Failure|1|||
160991024|NCT03784963|581355448|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
160991025|NCT00349908|581355449|FG000|Overall Study|Withdrawal by Subject|0|||
160991026|NCT00349908|581355450|FG001|Overall Study|Withdrawal by Subject|4|||
160991027|NCT01289119|581355454|FG000|Overall Study|Adverse Event|2|||
161136516|NCT02443402|581881640|FG001|Overall Study|Screen Failure|2|||
161136517|NCT01934504|581881642|FG000|Overall Study|Protocol Deviation|0|||
161247035|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161247036|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161247037|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
161247038|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
161247039|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
161247040|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161247041|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160991028|NCT01289119|581355455|FG001|Overall Study|Adverse Event|1|||
160991029|NCT01289119|581355456|FG002|Overall Study|Adverse Event|0|||
160991030|NCT01289119|581355457|FG003|Overall Study|Adverse Event|2|||
160991031|NCT01289119|581355458|FG004|Overall Study|Adverse Event|1|||
160991032|NCT01289119|581355459|FG005|Overall Study|Adverse Event|0|||
160991033|NCT01289119|581355454|FG000|Overall Study|Major Protocol Deviation|2|||
160991034|NCT01289119|581355455|FG001|Overall Study|Major Protocol Deviation|1|||
160991035|NCT01289119|581355456|FG002|Overall Study|Major Protocol Deviation|3|||
160991036|NCT01289119|581355457|FG003|Overall Study|Major Protocol Deviation|0|||
160991037|NCT01289119|581355458|FG004|Overall Study|Major Protocol Deviation|2|||
160991038|NCT01289119|581355459|FG005|Overall Study|Major Protocol Deviation|1|||
160991039|NCT01289119|581355454|FG000|Overall Study|Lost to Follow-up|0|||
160991040|NCT01289119|581355455|FG001|Overall Study|Lost to Follow-up|3|||
160991041|NCT01289119|581355456|FG002|Overall Study|Lost to Follow-up|0|||
160991042|NCT01289119|581355457|FG003|Overall Study|Lost to Follow-up|0|||
160991043|NCT01289119|581355458|FG004|Overall Study|Lost to Follow-up|0|||
160991044|NCT01289119|581355459|FG005|Overall Study|Lost to Follow-up|1|||
160991045|NCT01289119|581355454|FG000|Overall Study|Withdrawal by Subject|4|||
160991046|NCT01289119|581355455|FG001|Overall Study|Withdrawal by Subject|2|||
160991047|NCT01289119|581355456|FG002|Overall Study|Withdrawal by Subject|4|||
160991048|NCT01289119|581355457|FG003|Overall Study|Withdrawal by Subject|3|||
160991049|NCT01289119|581355458|FG004|Overall Study|Withdrawal by Subject|1|||
160991050|NCT01289119|581355459|FG005|Overall Study|Withdrawal by Subject|1|||
160991051|NCT01289119|581355454|FG000|Overall Study|Pregnancy|0|||
160991052|NCT01289119|581355455|FG001|Overall Study|Pregnancy|1|||
160991053|NCT01289119|581355456|FG002|Overall Study|Pregnancy|0|||
160991054|NCT01289119|581355457|FG003|Overall Study|Pregnancy|0|||
160991055|NCT01289119|581355458|FG004|Overall Study|Pregnancy|0|||
160991056|NCT01289119|581355459|FG005|Overall Study|Pregnancy|0|||
160991057|NCT01289119|581355454|FG000|Overall Study|Lack of Efficacy|0|||
160991058|NCT01289119|581355455|FG001|Overall Study|Lack of Efficacy|1|||
160991059|NCT01289119|581355456|FG002|Overall Study|Lack of Efficacy|1|||
160991060|NCT01289119|581355457|FG003|Overall Study|Lack of Efficacy|1|||
160991061|NCT01289119|581355458|FG004|Overall Study|Lack of Efficacy|1|||
160991062|NCT01289119|581355459|FG005|Overall Study|Lack of Efficacy|1|||
160991063|NCT01289119|581355454|FG000|Overall Study|Other|1|||
160991064|NCT01289119|581355455|FG001|Overall Study|Other|0|||
160991065|NCT01289119|581355456|FG002|Overall Study|Other|1|||
160830498|NCT00870194|580766067|FG000|Overall Study|Lost to Follow-up|2|||
160830499|NCT00870194|580766068|FG001|Overall Study|Lost to Follow-up|0|||
160830500|NCT00870194|580766067|FG000|Overall Study|Physician Decision|3|||
160991066|NCT01289119|581355457|FG003|Overall Study|Other|0|||
160991067|NCT01289119|581355458|FG004|Overall Study|Other|0|||
160991068|NCT01289119|581355459|FG005|Overall Study|Other|0|||
160991069|NCT01704846|581355460|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160991070|NCT01704846|581355461|FG001|Treatment Period 2|Withdrawal by Subject|1|||
160991071|NCT00530335|581355464|FG000|Overall Study|Adverse Event|3|||
160991072|NCT00530335|581355464|FG000|Overall Study|Protocol Violation|1|||
160991073|NCT00530335|581355464|FG000|Overall Study|Withdrawal by Subject|1|||
160991074|NCT00530335|581355464|FG000|Overall Study|Physician Decision|1|||
160830501|NCT00870194|580766068|FG001|Overall Study|Physician Decision|1|||
160830502|NCT00870194|580766067|FG000|Overall Study|Protocol Violation|3|||
160830503|NCT00870194|580766068|FG001|Overall Study|Protocol Violation|3|||
160830504|NCT00870194|580766067|FG000|Overall Study|Entry Criteria Not Met|1|||
160830505|NCT00870194|580766068|FG001|Overall Study|Entry Criteria Not Met|2|||
160830506|NCT00870194|580766067|FG000|Overall Study|Subject Decision|7|||
160830507|NCT00870194|580766068|FG001|Overall Study|Subject Decision|2|||
160830508|NCT01406015|580766069|FG000|Overall Study|Withdrawal by Subject|3|||
160830509|NCT01406015|580766070|FG001|Overall Study|Withdrawal by Subject|3|||
160830510|NCT00707746|580766072|FG000|Treatment Period|Adverse Event|2|||
160830511|NCT00707746|580766073|FG001|Treatment Period|Adverse Event|4|||
160991075|NCT01244984|581355466|FG000|Overall Study|Adverse Event|2|||
160991076|NCT01244984|581355467|FG001|Overall Study|Adverse Event|11|||
160991077|NCT01244984|581355468|FG002|Overall Study|Adverse Event|2|||
160991078|NCT01244984|581355466|FG000|Overall Study|Protocol Violation|1|||
160991079|NCT01244984|581355467|FG001|Overall Study|Protocol Violation|0|||
160991080|NCT01244984|581355468|FG002|Overall Study|Protocol Violation|0|||
160991081|NCT01244984|581355466|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
160991082|NCT01244984|581355467|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
160991083|NCT01244984|581355468|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
160991084|NCT01244984|581355466|FG000|Overall Study|Withdrawal by Subject|1|||
160991085|NCT01244984|581355467|FG001|Overall Study|Withdrawal by Subject|2|||
160991086|NCT01244984|581355468|FG002|Overall Study|Withdrawal by Subject|2|||
160991087|NCT04577183|581355469|FG000|Overall Study|Death|1|||
160991088|NCT04577183|581355469|FG000|Overall Study|Withdrawal by Subject|3|||
160991089|NCT04577183|581355469|FG000|Overall Study|Early termination|2|||
160991090|NCT00672256|581355475|FG000|Overall Study|PI dropped, bad data|44|||
160991091|NCT02072226|581355479|FG000|Overall Study|Lost to Follow-up|11|||
160991092|NCT02072226|581355480|FG001|Overall Study|Lost to Follow-up|7|||
160991093|NCT02072226|581355479|FG000|Overall Study|Patient Non-compliance|2|||
160991094|NCT02072226|581355480|FG001|Overall Study|Patient Non-compliance|3|||
160991095|NCT02072226|581355479|FG000|Overall Study|Death|1|||
160991096|NCT02072226|581355480|FG001|Overall Study|Death|0|||
160991097|NCT02072226|581355479|FG000|Overall Study|Patient Withdrawal of Consent|1|||
160991098|NCT02072226|581355480|FG001|Overall Study|Patient Withdrawal of Consent|0|||
160991099|NCT03255018|581355481|FG000|Overall Study|Death on study|0|||
160991100|NCT03255018|581355482|FG001|Overall Study|Death on study|5|||
160991101|NCT03255018|581355481|FG000|Overall Study|Withdrawal by Subject|0|||
160991102|NCT03255018|581355482|FG001|Overall Study|Withdrawal by Subject|2|||
160991103|NCT01720043|581355484|FG000|Overall Study|Withdrawal by Subject|1|||
160991104|NCT01688973|581355485|FG000|Overall Study|Ineligible|2|||
160991105|NCT01688973|581355486|FG001|Overall Study|Ineligible|3|||
160991106|NCT03467724|581355495|FG000|Overall Study|Lost to Follow-up|5|||
160991107|NCT03467724|581355495|FG000|Overall Study|Withdrawal by Subject|1|||
160991108|NCT03467724|581355495|FG000|Overall Study|Protocol Violation|1|||
160991109|NCT03467724|581355495|FG000|Overall Study|Adverse Event|1|||
160991110|NCT03710564|581355496|FG000|Overall Study|Study Terminated by Sponsor|104|||
160991111|NCT03710564|581355497|FG001|Overall Study|Study Terminated by Sponsor|55|||
160991112|NCT03710564|581355496|FG000|Overall Study|Withdrawal by Subject|57|||
160991113|NCT03710564|581355497|FG001|Overall Study|Withdrawal by Subject|25|||
160991114|NCT03710564|581355496|FG000|Overall Study|Death|10|||
160991115|NCT03710564|581355497|FG001|Overall Study|Death|4|||
160991116|NCT03710564|581355496|FG000|Overall Study|Lost to Follow-up|5|||
160991117|NCT03710564|581355497|FG001|Overall Study|Lost to Follow-up|4|||
160991118|NCT03710564|581355496|FG000|Overall Study|Protocol Violation|3|||
160991119|NCT03710564|581355497|FG001|Overall Study|Protocol Violation|2|||
160991120|NCT03710564|581355496|FG000|Overall Study|Adverse Event|3|||
160991121|NCT03710564|581355497|FG001|Overall Study|Adverse Event|0|||
160991122|NCT03710564|581355496|FG000|Overall Study|Physician Decision|2|||
160991123|NCT03710564|581355497|FG001|Overall Study|Physician Decision|3|||
160991124|NCT02397889|581355498|FG000|Overall Study|Physician Decision|1|||
160991125|NCT02397889|581355499|FG001|Overall Study|Physician Decision|0|||
160991126|NCT01928940|581355503|FG000|Overall Study|Adverse Event|0|||
160991127|NCT01928940|581355504|FG001|Overall Study|Adverse Event|1|||
160991128|NCT04668144|581355507|FG000|Overall Study|Protocol Violation|0|||
160991129|NCT04668144|581355508|FG001|Overall Study|Protocol Violation|1|||
160991130|NCT04668144|581355509|FG002|Overall Study|Protocol Violation|2|||
160991131|NCT00770211|581355510|FG000|Overall Study|Lost to Follow-up|1|||
160991132|NCT00770211|581355511|FG001|Overall Study|Lost to Follow-up|0|||
160991133|NCT00770211|581355510|FG000|Overall Study|Withdrawal by Subject|0|||
160991134|NCT00770211|581355511|FG001|Overall Study|Withdrawal by Subject|2|||
160991135|NCT01446003|581355512|FG000|Period 1|Protocol Violation|2|||
160991136|NCT01446003|581355513|FG001|Period 1|Protocol Violation|0|||
160991137|NCT01446003|581355512|FG000|Period 2|Adverse Event|1|||
160991138|NCT01446003|581355513|FG001|Period 2|Adverse Event|0|||
160991139|NCT00318656|581355515|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
160991140|NCT00318656|581355516|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
160991141|NCT00318656|581355515|FG000|Overall Study|Did not receive any treatment|0|||
160991142|NCT00318656|581355516|FG001|Overall Study|Did not receive any treatment|1|||
160991143|NCT01740557|581355517|FG000|Overall Study|Ineligible|1|||
160991144|NCT01740557|581355517|FG000|Overall Study|Screen failure|1|||
160991145|NCT00490555|581355518|FG000|Overall Study|noncompliant with drug administration|0|||
160991146|NCT00490555|581355519|FG001|Overall Study|noncompliant with drug administration|0|||
160991147|NCT00490555|581355520|FG002|Overall Study|noncompliant with drug administration|2|||
160991148|NCT00490555|581355521|FG003|Overall Study|noncompliant with drug administration|0|||
160991149|NCT01007149|581355522|FG000|Overall Study|Administrative problems|0|||
160991150|NCT01007149|581355523|FG001|Overall Study|Administrative problems|1|||
160991151|NCT03568162|581355524|FG000|Overall Study|Adverse Event|0|||
160991152|NCT03568162|581355525|FG001|Overall Study|Adverse Event|1|||
160991153|NCT03568162|581355526|FG002|Overall Study|Adverse Event|2|||
161247042|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160991154|NCT03568162|581355527|FG003|Overall Study|Adverse Event|0|||
160991155|NCT03568162|581355528|FG004|Overall Study|Adverse Event|0|||
160991156|NCT03568162|581355529|FG005|Overall Study|Adverse Event|1|||
160991157|NCT03568162|581355524|FG000|Overall Study|Death|0|||
161247043|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
160991158|NCT03568162|581355525|FG001|Overall Study|Death|0|||
160991159|NCT03568162|581355526|FG002|Overall Study|Death|0|||
160830512|NCT00707746|580766072|FG000|Treatment Period|Ineligibility|0|||
160830513|NCT00707746|580766073|FG001|Treatment Period|Ineligibility|1|||
160830514|NCT00357656|580766078|FG000|Overall Study|Other, No surgery performed|0|||
160830515|NCT00357656|580766079|FG001|Overall Study|Other, No surgery performed|3|||
160991160|NCT03568162|581355527|FG003|Overall Study|Death|0|||
160991161|NCT03568162|581355528|FG004|Overall Study|Death|1|||
160991162|NCT03568162|581355529|FG005|Overall Study|Death|0|||
160991163|NCT03568162|581355524|FG000|Overall Study|Lost to Follow-up|3|||
160991164|NCT03568162|581355525|FG001|Overall Study|Lost to Follow-up|2|||
160991165|NCT03568162|581355526|FG002|Overall Study|Lost to Follow-up|4|||
160991166|NCT03568162|581355527|FG003|Overall Study|Lost to Follow-up|2|||
160991167|NCT03568162|581355528|FG004|Overall Study|Lost to Follow-up|3|||
160830516|NCT02573246|580766083|FG000|Overall Study|Lost to Follow-up|2|||
160830517|NCT02573246|580766084|FG001|Overall Study|Lost to Follow-up|0|||
160830518|NCT02573246|580766085|FG002|Overall Study|Lost to Follow-up|0|||
160830519|NCT02573246|580766086|FG003|Overall Study|Lost to Follow-up|0|||
160830520|NCT02573246|580766087|FG004|Overall Study|Lost to Follow-up|1|||
160830521|NCT02573246|580766083|FG000|Overall Study|Withdrawal by Subject|0|||
160830522|NCT02573246|580766084|FG001|Overall Study|Withdrawal by Subject|0|||
160830523|NCT02573246|580766085|FG002|Overall Study|Withdrawal by Subject|0|||
160830524|NCT02573246|580766086|FG003|Overall Study|Withdrawal by Subject|0|||
160830525|NCT02573246|580766087|FG004|Overall Study|Withdrawal by Subject|1|||
160830526|NCT02573246|580766083|FG000|Overall Study|Physician Decision|1|||
160830527|NCT02573246|580766084|FG001|Overall Study|Physician Decision|1|||
160830528|NCT02573246|580766085|FG002|Overall Study|Physician Decision|3|||
160830529|NCT02573246|580766086|FG003|Overall Study|Physician Decision|2|||
160830530|NCT02573246|580766087|FG004|Overall Study|Physician Decision|2|||
160830531|NCT01219933|580766088|FG000|Overall Study|Adverse Event|8|||
160830532|NCT01219933|580766088|FG000|Overall Study|No LDA reached|5|||
160830533|NCT01219933|580766088|FG000|Overall Study|No LDA maintained|7|||
160830534|NCT01219933|580766088|FG000|Overall Study|Lost to Follow-up|3|||
160830535|NCT01219933|580766088|FG000|Overall Study|GC free|1|||
160830536|NCT01219933|580766088|FG000|Overall Study|Withdrawal by Subject|5|||
160830537|NCT01219933|580766088|FG000|Overall Study|Protocol Violation|8|||
160830538|NCT01219933|580766088|FG000|Overall Study|Lack of Efficacy|1|||
160830539|NCT02256267|580766089|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
160830540|NCT02256267|580766089|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
160830541|NCT01685983|580766090|FG000|Overall Study|Adverse Event|7|||
160830542|NCT01685983|580766090|FG000|Overall Study|Death|1|||
160830543|NCT01685983|580766090|FG000|Overall Study|Withdrawal by Subject|19|||
160830544|NCT01685983|580766090|FG000|Overall Study|Protocol Violation|2|||
160830545|NCT01685983|580766090|FG000|Overall Study|Physician Decision|13|||
160830546|NCT01685983|580766090|FG000|Overall Study|Other|7|||
160830547|NCT01685983|580766090|FG000|Overall Study|Progressive Disease|32|||
160830548|NCT01685983|580766090|FG000|Overall Study|Noncompliance with Study Drug|1|||
160830549|NCT00582738|580766091|FG000|Overall Study|Administrative Problems|7|||
160830550|NCT00582738|580766092|FG001|Overall Study|Administrative Problems|8|||
160830551|NCT00582738|580766091|FG000|Overall Study|Adverse Event|0|||
160830552|NCT00582738|580766092|FG001|Overall Study|Adverse Event|5|||
160830553|NCT00582738|580766091|FG000|Overall Study|Graft Lost|0|||
160830554|NCT00582738|580766092|FG001|Overall Study|Graft Lost|1|||
160830555|NCT00582738|580766091|FG000|Overall Study|Other|1|||
160830556|NCT00582738|580766092|FG001|Overall Study|Other|0|||
160830557|NCT00582738|580766091|FG000|Overall Study|Protocol Violation|1|||
160830558|NCT00582738|580766092|FG001|Overall Study|Protocol Violation|1|||
160830559|NCT00582738|580766091|FG000|Overall Study|Withdrawal by Subject|0|||
160830560|NCT00582738|580766092|FG001|Overall Study|Withdrawal by Subject|3|||
160830561|NCT01269385|580766093|FG000|Overall Study|Adverse Event|1|||
160991168|NCT03568162|581355529|FG005|Overall Study|Lost to Follow-up|2|||
160991169|NCT03568162|581355524|FG000|Overall Study|Physician Decision|0|||
160991170|NCT03568162|581355525|FG001|Overall Study|Physician Decision|1|||
161136518|NCT01934504|581881643|FG001|Overall Study|Protocol Deviation|0|||
161136519|NCT01934504|581881644|FG002|Overall Study|Protocol Deviation|0|||
161136520|NCT01934504|581881645|FG003|Overall Study|Protocol Deviation|2|||
161136521|NCT01934504|581881642|FG000|Overall Study|Study Terminated by Sponsor|1|||
161136522|NCT01934504|581881643|FG001|Overall Study|Study Terminated by Sponsor|0|||
161136523|NCT01934504|581881644|FG002|Overall Study|Study Terminated by Sponsor|5|||
160830562|NCT01269385|580766094|FG001|Overall Study|Adverse Event|1|||
160830563|NCT01269385|580766095|FG002|Overall Study|Adverse Event|0|||
160830564|NCT01269385|580766096|FG003|Overall Study|Adverse Event|0|||
160830565|NCT01073930|580767461|FG000|Overall Study|Withdrawal by Subject|3|||
160991171|NCT03568162|581355526|FG002|Overall Study|Physician Decision|1|||
160830566|NCT01073930|580767462|FG001|Overall Study|Withdrawal by Subject|2|||
160830567|NCT01073930|580767461|FG000|Overall Study|Lost to Follow-up|0|||
160830568|NCT01073930|580767462|FG001|Overall Study|Lost to Follow-up|1|||
160830569|NCT01073930|580767461|FG000|Overall Study|Adverse Event|0|||
160830570|NCT01073930|580767462|FG001|Overall Study|Adverse Event|1|||
160830571|NCT01073930|580767461|FG000|Overall Study|Noncompliance with study drug|0|||
161136524|NCT01934504|581881645|FG003|Overall Study|Study Terminated by Sponsor|5|||
161136525|NCT02665689|581881646|FG000|Overall Study|Adverse Event|1|||
160830572|NCT01073930|580767462|FG001|Overall Study|Noncompliance with study drug|1|||
160830573|NCT01073930|580767461|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
160830574|NCT01073930|580767462|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
160830575|NCT00541346|580767463|FG000|Follow-up|Adverse Event|1|||
160830576|NCT02008773|580767464|FG000|Overall Study|Adverse Event|3|||
160830577|NCT02008773|580767465|FG001|Overall Study|Adverse Event|3|||
160830578|NCT02008773|580767466|FG002|Overall Study|Adverse Event|1|||
160830579|NCT02008773|580767467|FG003|Overall Study|Adverse Event|2|||
160830580|NCT02008773|580767464|FG000|Overall Study|Medication Non-compliance|2|||
160830581|NCT02008773|580767465|FG001|Overall Study|Medication Non-compliance|1|||
160830582|NCT02008773|580767466|FG002|Overall Study|Medication Non-compliance|3|||
160830583|NCT02008773|580767467|FG003|Overall Study|Medication Non-compliance|2|||
160830584|NCT02008773|580767464|FG000|Overall Study|Withdrawal by Subject|8|||
160830585|NCT02008773|580767465|FG001|Overall Study|Withdrawal by Subject|4|||
160830586|NCT02008773|580767466|FG002|Overall Study|Withdrawal by Subject|7|||
160830587|NCT02008773|580767467|FG003|Overall Study|Withdrawal by Subject|6|||
160830588|NCT02008773|580767464|FG000|Overall Study|Lost to Follow-up|0|||
160830589|NCT02008773|580767465|FG001|Overall Study|Lost to Follow-up|1|||
160830590|NCT02008773|580767466|FG002|Overall Study|Lost to Follow-up|3|||
160830591|NCT02008773|580767467|FG003|Overall Study|Lost to Follow-up|2|||
160830592|NCT03320330|580767470|FG000|Overall Study|Lack of Efficacy|5|||
160830593|NCT03320330|580767471|FG001|Overall Study|Lack of Efficacy|5|||
160830594|NCT03320330|580767472|FG002|Overall Study|Lack of Efficacy|14|||
160830595|NCT03320330|580767470|FG000|Overall Study|Physician Decision|1|||
160830596|NCT03320330|580767471|FG001|Overall Study|Physician Decision|0|||
160830597|NCT03320330|580767472|FG002|Overall Study|Physician Decision|0|||
160830598|NCT03323736|580767473|FG000|Overall Study|Screen Failure|14|||
160830599|NCT03323736|580767474|FG001|Overall Study|Screen Failure|9|||
160830600|NCT03323736|580767475|FG002|Overall Study|Screen Failure|1|||
160830601|NCT03323736|580767473|FG000|Overall Study|Withdrawal Before Treatment|3|||
160830602|NCT03323736|580767474|FG001|Overall Study|Withdrawal Before Treatment|1|||
160830603|NCT03323736|580767475|FG002|Overall Study|Withdrawal Before Treatment|1|||
160830604|NCT03323736|580767473|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
160830605|NCT03323736|580767474|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
160830606|NCT03323736|580767475|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
160830607|NCT00701805|580767478|FG000|Overall Study|Withdrawal by Subject|3|||
160830608|NCT00701805|580767479|FG001|Overall Study|Withdrawal by Subject|1|||
160830609|NCT00701805|580767480|FG002|Overall Study|Withdrawal by Subject|4|||
160830610|NCT00701805|580767481|FG003|Overall Study|Withdrawal by Subject|3|||
160830611|NCT00701805|580767478|FG000|Overall Study|Adverse Event|0|||
160830612|NCT00701805|580767479|FG001|Overall Study|Adverse Event|1|||
160830613|NCT00701805|580767480|FG002|Overall Study|Adverse Event|1|||
160830614|NCT00701805|580767481|FG003|Overall Study|Adverse Event|0|||
160830615|NCT00701805|580767478|FG000|Overall Study|Missed 7 consecutive doses|0|||
160830616|NCT00701805|580767479|FG001|Overall Study|Missed 7 consecutive doses|1|||
160830617|NCT00701805|580767480|FG002|Overall Study|Missed 7 consecutive doses|0|||
160830618|NCT00701805|580767481|FG003|Overall Study|Missed 7 consecutive doses|0|||
160830619|NCT00701805|580767478|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
160830620|NCT00701805|580767479|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
160830621|NCT00701805|580767480|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
160830622|NCT00701805|580767481|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
160830623|NCT00701805|580767478|FG000|Overall Study|Physician decision, change of therapy|0|||
160830624|NCT00701805|580767479|FG001|Overall Study|Physician decision, change of therapy|0|||
160830625|NCT00701805|580767480|FG002|Overall Study|Physician decision, change of therapy|0|||
160830626|NCT00701805|580767481|FG003|Overall Study|Physician decision, change of therapy|1|||
160830627|NCT00701805|580767478|FG000|Overall Study|Difficult to travel to dialysis site|0|||
161247044|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
161247045|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
161247046|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161247047|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161247048|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161247049|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
161247050|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
161247051|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
161247052|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161247053|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
161247054|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
160830628|NCT00701805|580767479|FG001|Overall Study|Difficult to travel to dialysis site|0|||
160830629|NCT00701805|580767480|FG002|Overall Study|Difficult to travel to dialysis site|1|||
160830630|NCT00701805|580767481|FG003|Overall Study|Difficult to travel to dialysis site|0|||
160830631|NCT00701805|580767478|FG000|Overall Study|Resumption criteria were not met|0|||
160830632|NCT00701805|580767479|FG001|Overall Study|Resumption criteria were not met|1|||
161247055|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
160830633|NCT00701805|580767480|FG002|Overall Study|Resumption criteria were not met|0|||
160830634|NCT00701805|580767481|FG003|Overall Study|Resumption criteria were not met|0|||
160830635|NCT03826342|580767488|FG000|Overall Study|Withdrawal by Subject|8|||
160830636|NCT03826342|580767489|FG001|Overall Study|Withdrawal by Subject|1|||
160830637|NCT03826342|580767488|FG000|Overall Study|Lost to Follow-up|7|||
160830638|NCT03826342|580767489|FG001|Overall Study|Lost to Follow-up|7|||
160830639|NCT03826342|580767488|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
160830640|NCT03826342|580767489|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
160830641|NCT01804582|580767490|FG000|Overall Study|Lost to Follow-up|47|||
160830642|NCT01804582|580767491|FG001|Overall Study|Lost to Follow-up|56|||
160830643|NCT01804582|580767490|FG000|Overall Study|Physician Decision|2|||
160830644|NCT01804582|580767491|FG001|Overall Study|Physician Decision|0|||
160830645|NCT03455829|580767492|FG000|Overall Study|Death|2|||
160830646|NCT03455829|580767493|FG001|Overall Study|Death|3|||
160830647|NCT03455829|580767494|FG002|Overall Study|Death|2|||
160830648|NCT03455829|580767495|FG003|Overall Study|Death|4|||
160830649|NCT03455829|580767496|FG004|Overall Study|Death|2|||
160830650|NCT03455829|580767492|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
160830651|NCT03455829|580767493|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
160830652|NCT03455829|580767494|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
160830653|NCT03455829|580767495|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
160830654|NCT03455829|580767496|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
160830655|NCT03455829|580767492|FG000|Overall Study|Disease progression|0|||
160830656|NCT03455829|580767493|FG001|Overall Study|Disease progression|0|||
160830657|NCT03455829|580767494|FG002|Overall Study|Disease progression|0|||
160830658|NCT03455829|580767495|FG003|Overall Study|Disease progression|1|||
160830659|NCT03455829|580767496|FG004|Overall Study|Disease progression|1|||
160830660|NCT02258529|580767506|FG000|Overall Study|Study Terminated by Sponsor|9|||
160830661|NCT02258529|580767506|FG000|Overall Study|Adverse Event|1|||
160830662|NCT00413010|580767507|FG000|Overall Study|Adverse Event|8|||
160830663|NCT00413010|580767508|FG001|Overall Study|Adverse Event|4|||
160830664|NCT00413010|580767507|FG000|Overall Study|Laboratory abnormality|0|||
160830665|NCT00413010|580767508|FG001|Overall Study|Laboratory abnormality|2|||
160830666|NCT00413010|580767507|FG000|Overall Study|Lack of Efficacy|0|||
160830667|NCT00413010|580767508|FG001|Overall Study|Lack of Efficacy|3|||
160830668|NCT00413010|580767507|FG000|Overall Study|Lost to Follow-up|3|||
160830669|NCT00413010|580767508|FG001|Overall Study|Lost to Follow-up|0|||
160830670|NCT00413010|580767507|FG000|Overall Study|Withdrawal by Subject|7|||
160830671|NCT00413010|580767508|FG001|Overall Study|Withdrawal by Subject|2|||
160830672|NCT00413010|580767507|FG000|Overall Study|Due to termination of the study|54|||
160830673|NCT00413010|580767508|FG001|Overall Study|Due to termination of the study|52|||
160830674|NCT00875056|580767509|FG000|Overall Study|Adverse Event|6|||
160830675|NCT00875056|580767510|FG001|Overall Study|Adverse Event|1|||
160830676|NCT00875056|580767511|FG002|Overall Study|Adverse Event|2|||
160830677|NCT00875056|580767509|FG000|Overall Study|Progressive Disease|14|||
160830678|NCT00875056|580767510|FG001|Overall Study|Progressive Disease|8|||
160830679|NCT00875056|580767511|FG002|Overall Study|Progressive Disease|3|||
160830680|NCT00875056|580767509|FG000|Overall Study|Withdrawal by Subject|3|||
160830681|NCT00875056|580767510|FG001|Overall Study|Withdrawal by Subject|0|||
160830682|NCT00875056|580767511|FG002|Overall Study|Withdrawal by Subject|1|||
160830683|NCT01842581|580767519|FG000|Overall Study|Adverse Event|6|||
160830684|NCT01842581|580767520|FG001|Overall Study|Adverse Event|4|||
160830685|NCT01842581|580767519|FG000|Overall Study|HE breakthrough|26|||
160830686|NCT01842581|580767520|FG001|Overall Study|HE breakthrough|13|||
160830687|NCT01842581|580767519|FG000|Overall Study|Liver transplant|2|||
160830688|NCT01842581|580767520|FG001|Overall Study|Liver transplant|0|||
160830689|NCT01842581|580767519|FG000|Overall Study|Lost to Follow-up|2|||
160830690|NCT01842581|580767520|FG001|Overall Study|Lost to Follow-up|5|||
160830691|NCT01842581|580767519|FG000|Overall Study|Withdrawal by Subject|5|||
160830692|NCT01842581|580767520|FG001|Overall Study|Withdrawal by Subject|7|||
160830693|NCT01842581|580767519|FG000|Overall Study|Other than specified|3|||
160830694|NCT01842581|580767520|FG001|Overall Study|Other than specified|1|||
160830695|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Adverse Event|0|||
160830696|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Adverse Event|1|||
160830697|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Adverse Event|0|||
160830698|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Adverse Event|0|||
161247056|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
161247057|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
161247058|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161247059|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
160830699|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Adverse Event|0|||
160830700|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Adverse Event|0|||
160830701|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
160830702|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830703|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830704|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830705|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830706|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
160830707|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
160830708|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
160830709|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
160830710|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
160830711|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
160830712|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
160830713|NCT00993499|580767523|FG000|Run-in Period (8 Days)|Progressive disease|0|||
160830714|NCT00993499|580767524|FG001|Run-in Period (8 Days)|Progressive disease|1|||
160830715|NCT00993499|580767525|FG002|Run-in Period (8 Days)|Progressive disease|1|||
160830716|NCT00993499|580767526|FG003|Run-in Period (8 Days)|Progressive disease|0|||
160830717|NCT00993499|580767527|FG004|Run-in Period (8 Days)|Progressive disease|0|||
160830718|NCT00993499|580767528|FG005|Run-in Period (8 Days)|Progressive disease|0|||
160830719|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
160830720|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
160830721|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830722|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830723|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830724|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
160830725|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
160830726|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
160830727|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830728|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830729|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830730|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
160830731|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830732|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830733|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
160830734|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
160830735|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830736|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
160830737|NCT00993499|580767523|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830738|NCT00993499|580767524|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830739|NCT00993499|580767525|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
160830740|NCT00993499|580767526|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830741|NCT00993499|580767527|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830742|NCT00993499|580767528|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
160830743|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830744|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
160830745|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830746|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830747|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830748|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
160830749|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
160830750|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
160830751|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
160830752|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
160830753|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
160830754|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
160830755|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|DLT|1|||
160830756|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|DLT|0|||
160830757|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|DLT|2|||
160830758|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|DLT|1|||
160830759|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|DLT|0|||
160830760|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|DLT|0|||
160830761|NCT00993499|580767523|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
160830762|NCT00993499|580767524|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
160830763|NCT00993499|580767525|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
160830764|NCT00993499|580767526|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
160830765|NCT00993499|580767527|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
160830766|NCT00993499|580767528|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
161247060|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161247061|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
161247062|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
161247063|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
160830767|NCT05432167|580767529|FG000|Overall Study|Adverse Event|0|||
160830768|NCT05432167|580767530|FG001|Overall Study|Adverse Event|2|||
160830769|NCT05432167|580767531|FG002|Overall Study|Adverse Event|1|||
160830770|NCT05432167|580767529|FG000|Overall Study|Lost to Follow-up|3|||
160830771|NCT05432167|580767530|FG001|Overall Study|Lost to Follow-up|3|||
160830772|NCT05432167|580767531|FG002|Overall Study|Lost to Follow-up|2|||
160830773|NCT05432167|580767529|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
160830774|NCT05432167|580767530|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
160830775|NCT05432167|580767531|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
160830776|NCT05432167|580767529|FG000|Overall Study|Physician Decision|1|||
160830777|NCT05432167|580767530|FG001|Overall Study|Physician Decision|0|||
160830778|NCT05432167|580767531|FG002|Overall Study|Physician Decision|0|||
160830779|NCT05432167|580767529|FG000|Overall Study|Withdrawal by Subject|7|||
160830780|NCT05432167|580767530|FG001|Overall Study|Withdrawal by Subject|4|||
160830781|NCT05432167|580767531|FG002|Overall Study|Withdrawal by Subject|11|||
160830782|NCT05432167|580767529|FG000|Overall Study|Other|0|||
160830783|NCT05432167|580767530|FG001|Overall Study|Other|0|||
160830784|NCT05432167|580767531|FG002|Overall Study|Other|1|||
160830785|NCT01902888|580767532|FG000|Overall Study|Study Terminated|3|||
160830786|NCT03149003|580767533|FG000|Overall Study|Randomized but not treated|0|||
160830787|NCT03149003|580767534|FG001|Overall Study|Randomized but not treated|1|||
160830788|NCT03149003|580767535|FG002|Overall Study|Randomized but not treated|18|||
160830789|NCT01443130|580767536|FG000|Overall Study|Lost to Follow-up|44|||
160830790|NCT01443130|580767537|FG001|Overall Study|Lost to Follow-up|42|||
160830791|NCT01443130|580767538|FG002|Overall Study|Lost to Follow-up|50|||
160830792|NCT01443130|580767539|FG003|Overall Study|Lost to Follow-up|23|||
160830793|NCT01443130|580767540|FG004|Overall Study|Lost to Follow-up|25|||
160830794|NCT01443130|580767541|FG005|Overall Study|Lost to Follow-up|21|||
160830795|NCT01443130|580767536|FG000|Overall Study|Death|0|||
160830796|NCT01443130|580767537|FG001|Overall Study|Death|1|||
160830797|NCT01443130|580767538|FG002|Overall Study|Death|0|||
160830798|NCT01443130|580767539|FG003|Overall Study|Death|7|||
160830799|NCT01443130|580767540|FG004|Overall Study|Death|10|||
160830800|NCT01443130|580767541|FG005|Overall Study|Death|8|||
160830801|NCT01443130|580767536|FG000|Overall Study|Adverse Event|2|||
160830802|NCT01443130|580767537|FG001|Overall Study|Adverse Event|1|||
160830803|NCT01443130|580767538|FG002|Overall Study|Adverse Event|1|||
160830804|NCT01443130|580767539|FG003|Overall Study|Adverse Event|0|||
160830805|NCT01443130|580767540|FG004|Overall Study|Adverse Event|0|||
160830806|NCT01443130|580767541|FG005|Overall Study|Adverse Event|0|||
160830807|NCT01443130|580767536|FG000|Overall Study|Protocol Violation|2|||
160830808|NCT01443130|580767537|FG001|Overall Study|Protocol Violation|1|||
160830809|NCT01443130|580767538|FG002|Overall Study|Protocol Violation|3|||
160830810|NCT01443130|580767539|FG003|Overall Study|Protocol Violation|2|||
160830811|NCT01443130|580767540|FG004|Overall Study|Protocol Violation|2|||
160830812|NCT01443130|580767541|FG005|Overall Study|Protocol Violation|3|||
160830813|NCT01443130|580767536|FG000|Overall Study|Withdrawal by Subject|15|||
160830814|NCT01443130|580767537|FG001|Overall Study|Withdrawal by Subject|14|||
160830815|NCT01443130|580767538|FG002|Overall Study|Withdrawal by Subject|12|||
160830816|NCT01443130|580767539|FG003|Overall Study|Withdrawal by Subject|7|||
160830817|NCT01443130|580767540|FG004|Overall Study|Withdrawal by Subject|7|||
160830818|NCT01443130|580767541|FG005|Overall Study|Withdrawal by Subject|2|||
160830819|NCT01443130|580767536|FG000|Overall Study|Death of Subject's Infant|5|||
160830820|NCT01443130|580767537|FG001|Overall Study|Death of Subject's Infant|10|||
160830821|NCT01443130|580767538|FG002|Overall Study|Death of Subject's Infant|11|||
160830822|NCT01443130|580767539|FG003|Overall Study|Death of Subject's Infant|0|||
160830823|NCT01443130|580767540|FG004|Overall Study|Death of Subject's Infant|0|||
160830824|NCT01443130|580767541|FG005|Overall Study|Death of Subject's Infant|0|||
160830825|NCT00364533|580767545|FG000|Overall Study|Adverse Event|8|||
160830826|NCT00364533|580767546|FG001|Overall Study|Adverse Event|7|||
160830827|NCT00364533|580767547|FG002|Overall Study|Adverse Event|15|||
160830828|NCT00364533|580767548|FG003|Overall Study|Adverse Event|5|||
160830829|NCT00364533|580767549|FG004|Overall Study|Adverse Event|2|||
160830830|NCT00364533|580767545|FG000|Overall Study|Withdrawal by Subject|4|||
160830831|NCT00364533|580767546|FG001|Overall Study|Withdrawal by Subject|8|||
160830832|NCT00364533|580767547|FG002|Overall Study|Withdrawal by Subject|6|||
160830833|NCT00364533|580767548|FG003|Overall Study|Withdrawal by Subject|6|||
160830834|NCT00364533|580767549|FG004|Overall Study|Withdrawal by Subject|6|||
160830835|NCT00364533|580767545|FG000|Overall Study|Lack of Efficacy|22|||
160830836|NCT00364533|580767546|FG001|Overall Study|Lack of Efficacy|22|||
160830837|NCT00364533|580767547|FG002|Overall Study|Lack of Efficacy|21|||
160830838|NCT00364533|580767548|FG003|Overall Study|Lack of Efficacy|17|||
160830839|NCT00364533|580767549|FG004|Overall Study|Lack of Efficacy|42|||
160830840|NCT00364533|580767545|FG000|Overall Study|Subject discharged from hospital|4|||
160830841|NCT00364533|580767546|FG001|Overall Study|Subject discharged from hospital|1|||
160830842|NCT00364533|580767547|FG002|Overall Study|Subject discharged from hospital|2|||
160830843|NCT00364533|580767548|FG003|Overall Study|Subject discharged from hospital|3|||
160830844|NCT00364533|580767549|FG004|Overall Study|Subject discharged from hospital|1|||
160830845|NCT00364533|580767545|FG000|Overall Study|Variations in drug compliance|2|||
160830846|NCT00364533|580767546|FG001|Overall Study|Variations in drug compliance|1|||
160830847|NCT00364533|580767547|FG002|Overall Study|Variations in drug compliance|1|||
160830848|NCT00364533|580767548|FG003|Overall Study|Variations in drug compliance|0|||
160830849|NCT00364533|580767549|FG004|Overall Study|Variations in drug compliance|0|||
160830850|NCT00364533|580767545|FG000|Overall Study|Non-compliance|1|||
160830851|NCT00364533|580767546|FG001|Overall Study|Non-compliance|0|||
160830852|NCT00364533|580767547|FG002|Overall Study|Non-compliance|0|||
160830853|NCT00364533|580767548|FG003|Overall Study|Non-compliance|0|||
160830854|NCT00364533|580767549|FG004|Overall Study|Non-compliance|0|||
160830855|NCT00364533|580767545|FG000|Overall Study|Protocol Violation|1|||
160830856|NCT00364533|580767546|FG001|Overall Study|Protocol Violation|1|||
160830857|NCT00364533|580767547|FG002|Overall Study|Protocol Violation|0|||
160830858|NCT00364533|580767548|FG003|Overall Study|Protocol Violation|0|||
160830859|NCT00364533|580767549|FG004|Overall Study|Protocol Violation|0|||
160830860|NCT02758301|580767550|FG000|Overall Study|Death|12|||
160830861|NCT02758301|580767551|FG001|Overall Study|Death|0|||
160830862|NCT02758301|580767550|FG000|Overall Study|Physician Decision|10|||
160830863|NCT02758301|580767551|FG001|Overall Study|Physician Decision|1|||
160830864|NCT02758301|580767550|FG000|Overall Study|Withdrawal by Subject|5|||
160830865|NCT02758301|580767551|FG001|Overall Study|Withdrawal by Subject|6|||
160830866|NCT02758301|580767550|FG000|Overall Study|Lost to Follow-up|7|||
160830867|NCT02758301|580767551|FG001|Overall Study|Lost to Follow-up|0|||
160830868|NCT02758301|580767550|FG000|Overall Study|Protocol Violation|0|||
160830869|NCT02758301|580767551|FG001|Overall Study|Protocol Violation|1|||
160830870|NCT01167907|580767554|FG000|Overall Study|Protocol Violation|1|||
160830871|NCT01167907|580767555|FG001|Overall Study|Protocol Violation|0|||
160830872|NCT01167907|580767554|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
160830873|NCT01167907|580767555|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
160830874|NCT00815191|580767558|FG000|Overall Study|Protocol Violation|1|||
160830875|NCT00815191|580767559|FG001|Overall Study|Protocol Violation|1|||
160830876|NCT01814670|580767564|FG000|Overall Study|Protocol Violation|12|||
160830877|NCT01873729|580767565|FG000|Overall Study|Withdrawal by Subject|1|||
160830878|NCT01741532|580767566|FG000|Overall Study|Adverse Event|4|||
160830879|NCT01741532|580767567|FG001|Overall Study|Adverse Event|0|||
160830880|NCT01741532|580767566|FG000|Overall Study|Withdrawal by Subject|1|||
160830881|NCT01741532|580767567|FG001|Overall Study|Withdrawal by Subject|1|||
160830882|NCT01741532|580767566|FG000|Overall Study|Protocol Violation|0|||
161136526|NCT02665689|581881647|FG001|Overall Study|Adverse Event|0|||
160830883|NCT01741532|580767567|FG001|Overall Study|Protocol Violation|1|||
160830884|NCT01741532|580767566|FG000|Overall Study|Worsening of the disease|3|||
160830885|NCT01741532|580767567|FG001|Overall Study|Worsening of the disease|1|||
160830886|NCT01741532|580767566|FG000|Overall Study|Sponsor decision|1|||
160830887|NCT01741532|580767567|FG001|Overall Study|Sponsor decision|0|||
160830888|NCT01741532|580767566|FG000|Overall Study|Medical event|1|||
160830889|NCT01741532|580767567|FG001|Overall Study|Medical event|0|||
160830890|NCT00973102|580767568|FG000|Overall Study|Protocol Violation|1|||
160830891|NCT00973102|580767569|FG001|Overall Study|Protocol Violation|0|||
160830892|NCT00973102|580767568|FG000|Overall Study|Prisoner|0|||
160830893|NCT00973102|580767569|FG001|Overall Study|Prisoner|1|||
160830894|NCT01066780|580767570|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
160830895|NCT01066780|580767571|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
160830896|NCT00613080|580767572|FG000|Overall Study|Ineligible / no protocol treatment|11|||
160830897|NCT02360293|580767573|FG000|Overall Study|Lost to Follow-up|73|||
160830898|NCT02360293|580767574|FG001|Overall Study|Lost to Follow-up|95|||
160830899|NCT02360293|580767573|FG000|Overall Study|Withdrawal by Subject|2|||
160830900|NCT02360293|580767574|FG001|Overall Study|Withdrawal by Subject|1|||
160830901|NCT02360293|580767573|FG000|Overall Study|Excluded|1|||
160830902|NCT02360293|580767574|FG001|Overall Study|Excluded|0|||
160830903|NCT02226549|580767575|FG000|Overall Study|Randomized but Never Treated|1|||
160830904|NCT02226549|580767576|FG001|Overall Study|Randomized but Never Treated|0|||
160830905|NCT02226549|580767575|FG000|Overall Study|Lost to Follow-up|0|||
160830906|NCT02226549|580767576|FG001|Overall Study|Lost to Follow-up|1|||
160830907|NCT02012686|580767578|FG000|Overall Study|muscle contraction|0|||
160830908|NCT02012686|580767579|FG001|Overall Study|muscle contraction|1|||
160830909|NCT02012686|580767578|FG000|Overall Study|electrocardiography monitoring noise|0|||
160830910|NCT02012686|580767579|FG001|Overall Study|electrocardiography monitoring noise|1|||
160830911|NCT03099148|580767580|FG000|Wash-out|scheduling conflict|0|||
160830912|NCT03099148|580767581|FG001|Wash-out|scheduling conflict|1|||
160830913|NCT03099148|580767582|FG002|Wash-out|scheduling conflict|0|||
160830914|NCT03099148|580767583|FG003|Wash-out|scheduling conflict|0|||
160830915|NCT03099148|580767580|FG000|Wash-out|Adverse Event|0|||
160830916|NCT03099148|580767581|FG001|Wash-out|Adverse Event|1|||
160830917|NCT03099148|580767582|FG002|Wash-out|Adverse Event|0|||
160830918|NCT03099148|580767583|FG003|Wash-out|Adverse Event|0|||
160830919|NCT01703065|580767586|FG000|Overall Study|Lack of Efficacy|1|||
160830920|NCT01703065|580767587|FG001|Overall Study|Lack of Efficacy|0|||
160830921|NCT00687609|580767590|FG000|Overall Study|Physician Decision|1|||
160830922|NCT00687609|580767590|FG000|Overall Study|Withdrawal by Subject|2|||
160830923|NCT02713529|580767591|FG000|Overall Study|Withdrawal by Subject|3|||
160830924|NCT02713529|580767592|FG001|Overall Study|Withdrawal by Subject|1|||
160830925|NCT02713529|580767593|FG002|Overall Study|Withdrawal by Subject|4|||
160830926|NCT02713529|580767594|FG003|Overall Study|Withdrawal by Subject|2|||
160830927|NCT02713529|580767595|FG004|Overall Study|Withdrawal by Subject|0|||
160830928|NCT02713529|580767596|FG005|Overall Study|Withdrawal by Subject|1|||
160830929|NCT02713529|580767597|FG006|Overall Study|Withdrawal by Subject|1|||
160830930|NCT02713529|580767591|FG000|Overall Study|Lost to Follow-up|1|||
160830931|NCT02713529|580767592|FG001|Overall Study|Lost to Follow-up|0|||
160830932|NCT02713529|580767593|FG002|Overall Study|Lost to Follow-up|1|||
160830933|NCT02713529|580767594|FG003|Overall Study|Lost to Follow-up|0|||
160830934|NCT02713529|580767595|FG004|Overall Study|Lost to Follow-up|0|||
160830935|NCT02713529|580767596|FG005|Overall Study|Lost to Follow-up|0|||
160830936|NCT02713529|580767597|FG006|Overall Study|Lost to Follow-up|0|||
160830937|NCT02713529|580767591|FG000|Overall Study|Death|3|||
160830938|NCT02713529|580767592|FG001|Overall Study|Death|3|||
160830939|NCT02713529|580767593|FG002|Overall Study|Death|26|||
160830940|NCT02713529|580767594|FG003|Overall Study|Death|27|||
160830941|NCT02713529|580767595|FG004|Overall Study|Death|3|||
160830942|NCT02713529|580767596|FG005|Overall Study|Death|13|||
160830943|NCT02713529|580767597|FG006|Overall Study|Death|3|||
160830944|NCT02449018|580767603|FG000|Overall Study|Abnormal laboratory value|0|||
160830945|NCT02449018|580767604|FG001|Overall Study|Abnormal laboratory value|1|||
160830946|NCT02449018|580767603|FG000|Overall Study|Administrative problems|1|||
160830947|NCT02449018|580767604|FG001|Overall Study|Administrative problems|0|||
160830948|NCT02449018|580767603|FG000|Overall Study|Adverse Event|5|||
160830949|NCT02449018|580767604|FG001|Overall Study|Adverse Event|1|||
160830950|NCT02449018|580767603|FG000|Overall Study|Protocol deviation|4|||
160830951|NCT02449018|580767604|FG001|Overall Study|Protocol deviation|0|||
160830952|NCT02449018|580767603|FG000|Overall Study|Patient decision|2|||
160830953|NCT02449018|580767604|FG001|Overall Study|Patient decision|0|||
160830954|NCT02698371|580767612|FG000|All Participants Flow|Lost to Follow-up|3|||
160830955|NCT02698371|580767612|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
160830956|NCT02698371|580767612|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
160830957|NCT02698371|580767612|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
160830958|NCT02698371|580767612|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
160830959|NCT02698371|580767612|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
160830960|NCT02698371|580767612|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
160830961|NCT01192568|580768781|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
160830962|NCT01192568|580768782|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
160830963|NCT01192568|580768783|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
160830964|NCT01192568|580768784|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
160830965|NCT01192568|580768781|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
160830966|NCT01192568|580768782|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
160830967|NCT01192568|580768783|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
160830968|NCT01192568|580768784|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
160830969|NCT02593825|580768785|FG000|Intervention|Lost to Follow-up|10|||
160830970|NCT02593825|580768786|FG001|Intervention|Lost to Follow-up|12|||
160830971|NCT06359080|580768787|FG000|Overall Study|Withdrawal by Subject|3|||
160830972|NCT00511134|580768790|FG000|Overall Study|Withdrawal by Subject|0|||
160830973|NCT00511134|580768791|FG001|Overall Study|Withdrawal by Subject|2|||
160830974|NCT01949090|580768794|FG000|Overall Study|Serious Adverse Event|0|||
160830975|NCT01949090|580768795|FG001|Overall Study|Serious Adverse Event|1|||
160830976|NCT01949090|580768796|FG002|Overall Study|Serious Adverse Event|2|||
160830977|NCT01949090|580768797|FG003|Overall Study|Serious Adverse Event|0|||
160830978|NCT01949090|580768798|FG004|Overall Study|Serious Adverse Event|1|||
160830979|NCT01949090|580768794|FG000|Overall Study|Withdrawal by Subject|2|||
160830980|NCT01949090|580768795|FG001|Overall Study|Withdrawal by Subject|0|||
160830981|NCT01949090|580768796|FG002|Overall Study|Withdrawal by Subject|0|||
160830982|NCT01949090|580768797|FG003|Overall Study|Withdrawal by Subject|0|||
161136527|NCT02665689|581881646|FG000|Overall Study|Trial termination|1|||
161136528|NCT02665689|581881647|FG001|Overall Study|Trial termination|1|||
161136529|NCT02665689|581881646|FG000|Overall Study|Lost to Follow-up|0|||
160830983|NCT01949090|580768798|FG004|Overall Study|Withdrawal by Subject|1|||
160830984|NCT01949090|580768794|FG000|Overall Study|Protocol non-compliance|0|||
160830985|NCT01949090|580768795|FG001|Overall Study|Protocol non-compliance|0|||
160830986|NCT01949090|580768796|FG002|Overall Study|Protocol non-compliance|0|||
160830987|NCT01949090|580768797|FG003|Overall Study|Protocol non-compliance|0|||
160830988|NCT01949090|580768798|FG004|Overall Study|Protocol non-compliance|1|||
160830989|NCT01949090|580768794|FG000|Overall Study|Lost to Follow-up|2|||
160830990|NCT01949090|580768795|FG001|Overall Study|Lost to Follow-up|1|||
160830991|NCT01949090|580768796|FG002|Overall Study|Lost to Follow-up|0|||
161136530|NCT02665689|581881647|FG001|Overall Study|Lost to Follow-up|1|||
160830992|NCT01949090|580768797|FG003|Overall Study|Lost to Follow-up|1|||
160830993|NCT01949090|580768798|FG004|Overall Study|Lost to Follow-up|1|||
160830994|NCT02783170|580768799|FG000|Overall Study|Randomized but not Vaccinated|1|||
160830995|NCT02783170|580768800|FG001|Overall Study|Randomized but not Vaccinated|0|||
160830996|NCT04938037|580768801|FG000|Overall Study|Lost to Follow-up|4|||
160830997|NCT04938037|580768802|FG001|Overall Study|Lost to Follow-up|3|||
160830998|NCT01806064|580768804|FG000|Overall Study|Randomized Not Enrolled|0|||
160830999|NCT01806064|580768805|FG001|Overall Study|Randomized Not Enrolled|0|||
160831000|NCT01806064|580768806|FG002|Overall Study|Randomized Not Enrolled|0|||
160831001|NCT01806064|580768807|FG003|Overall Study|Randomized Not Enrolled|1|||
160831002|NCT01806064|580768808|FG004|Overall Study|Randomized Not Enrolled|2|||
160831003|NCT05063539|580768809|FG000|Overall Study|Adverse Event|1|||
160831004|NCT05063539|580768810|FG001|Overall Study|Adverse Event|2|||
160831005|NCT05063539|580768811|FG002|Overall Study|Adverse Event|1|||
160831006|NCT05063539|580768809|FG000|Overall Study|Death|0|||
160831007|NCT05063539|580768810|FG001|Overall Study|Death|1|||
160831008|NCT05063539|580768811|FG002|Overall Study|Death|1|||
160831009|NCT05063539|580768809|FG000|Overall Study|Lost to Follow-up|0|||
160831010|NCT05063539|580768810|FG001|Overall Study|Lost to Follow-up|1|||
160831011|NCT05063539|580768811|FG002|Overall Study|Lost to Follow-up|0|||
160831012|NCT05063539|580768809|FG000|Overall Study|Physician Decision|4|||
160831013|NCT05063539|580768810|FG001|Overall Study|Physician Decision|3|||
160831014|NCT05063539|580768811|FG002|Overall Study|Physician Decision|1|||
160831015|NCT05063539|580768809|FG000|Overall Study|Progressive Disease|0|||
160831016|NCT05063539|580768810|FG001|Overall Study|Progressive Disease|2|||
160831017|NCT05063539|580768811|FG002|Overall Study|Progressive Disease|0|||
160991172|NCT03568162|581355527|FG003|Overall Study|Physician Decision|0|||
160991173|NCT03568162|581355528|FG004|Overall Study|Physician Decision|1|||
160991174|NCT03568162|581355529|FG005|Overall Study|Physician Decision|0|||
160991175|NCT03568162|581355524|FG000|Overall Study|Pregnancy|0|||
160991176|NCT03568162|581355525|FG001|Overall Study|Pregnancy|0|||
160991177|NCT03568162|581355526|FG002|Overall Study|Pregnancy|0|||
160991178|NCT03568162|581355527|FG003|Overall Study|Pregnancy|1|||
160991179|NCT03568162|581355528|FG004|Overall Study|Pregnancy|0|||
160991180|NCT03568162|581355529|FG005|Overall Study|Pregnancy|0|||
160991181|NCT03568162|581355524|FG000|Overall Study|Protocol Violation|1|||
160991182|NCT03568162|581355525|FG001|Overall Study|Protocol Violation|0|||
160991183|NCT03568162|581355526|FG002|Overall Study|Protocol Violation|1|||
160991184|NCT03568162|581355527|FG003|Overall Study|Protocol Violation|1|||
160991185|NCT03568162|581355528|FG004|Overall Study|Protocol Violation|1|||
160991186|NCT03568162|581355529|FG005|Overall Study|Protocol Violation|1|||
160991187|NCT03568162|581355524|FG000|Overall Study|Withdrawal by Subject|15|||
160991188|NCT03568162|581355525|FG001|Overall Study|Withdrawal by Subject|15|||
160991189|NCT03568162|581355526|FG002|Overall Study|Withdrawal by Subject|26|||
160991190|NCT03568162|581355527|FG003|Overall Study|Withdrawal by Subject|22|||
160991191|NCT03568162|581355528|FG004|Overall Study|Withdrawal by Subject|6|||
160991192|NCT03568162|581355529|FG005|Overall Study|Withdrawal by Subject|9|||
160991193|NCT03568162|581355524|FG000|Overall Study|Others|3|||
160991194|NCT03568162|581355525|FG001|Overall Study|Others|4|||
160991195|NCT03568162|581355526|FG002|Overall Study|Others|1|||
160991196|NCT03568162|581355527|FG003|Overall Study|Others|4|||
160991197|NCT03568162|581355528|FG004|Overall Study|Others|2|||
160991198|NCT03568162|581355529|FG005|Overall Study|Others|1|||
160831018|NCT05063539|580768809|FG000|Overall Study|Withdrawal by Subject|17|||
160831019|NCT05063539|580768810|FG001|Overall Study|Withdrawal by Subject|26|||
160831020|NCT05063539|580768811|FG002|Overall Study|Withdrawal by Subject|14|||
160831021|NCT05063539|580768809|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
160831022|NCT05063539|580768810|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
160831023|NCT05063539|580768811|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
160831024|NCT05063539|580768809|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
160831025|NCT05063539|580768810|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
160831026|NCT05063539|580768811|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
160831027|NCT05063539|580768809|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
160831028|NCT05063539|580768810|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
160831029|NCT05063539|580768811|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
160831030|NCT05063539|580768809|FG000|Overall Study|Discontinued due to Common Close Design|0|||
160831031|NCT05063539|580768810|FG001|Overall Study|Discontinued due to Common Close Design|1|||
160831032|NCT05063539|580768811|FG002|Overall Study|Discontinued due to Common Close Design|0|||
160831033|NCT05063539|580768809|FG000|Overall Study|Participant not co-operative|0|||
160831034|NCT05063539|580768810|FG001|Overall Study|Participant not co-operative|1|||
160991199|NCT00337818|581355530|FG000|Overall Study|Lost to Follow-up|289|||
160991200|NCT00337818|581355531|FG001|Overall Study|Lost to Follow-up|91|||
160991201|NCT00337818|581355532|FG002|Overall Study|Lost to Follow-up|107|||
160831035|NCT05063539|580768811|FG002|Overall Study|Participant not co-operative|0|||
160991202|NCT00938340|581355534|FG000|Overall Study|Withdrawal by Subject|3|||
160831036|NCT05063539|580768809|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
160831037|NCT05063539|580768810|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
160831038|NCT05063539|580768811|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
160831039|NCT05063539|580768809|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
160831040|NCT05063539|580768810|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
160831041|NCT05063539|580768811|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
160831042|NCT04256512|580768812|FG000|Overall Study|Withdrawal by Subject|1|||
160831043|NCT02804750|580768816|FG000|Period 1|Adverse Event|0|||
160831044|NCT02804750|580768817|FG001|Period 1|Adverse Event|2|||
160831045|NCT02804750|580768816|FG000|Period 1|Withdrawal by Subject|0|||
160831046|NCT02804750|580768817|FG001|Period 1|Withdrawal by Subject|1|||
160831047|NCT02804750|580768816|FG000|Period 2|Adverse Event|1|||
160831048|NCT02804750|580768817|FG001|Period 2|Adverse Event|0|||
160831049|NCT02804750|580768816|FG000|Period 3|Adverse Event|0|||
160831050|NCT02804750|580768817|FG001|Period 3|Adverse Event|2|||
160831051|NCT02804750|580768816|FG000|Period 4|Adverse Event|0|||
160831052|NCT02804750|580768817|FG001|Period 4|Adverse Event|5|||
160831053|NCT04692077|580768825|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
160831054|NCT01751139|580768830|FG000|Overall Study|Other|135|||
160831055|NCT01751139|580768830|FG000|Overall Study|Sponsor study termination|1609|||
160831056|NCT01751139|580768830|FG000|Overall Study|Lost to Follow-up|240|||
160831057|NCT01751139|580768830|FG000|Overall Study|Withdrawal by Subject|251|||
160831058|NCT01751139|580768830|FG000|Overall Study|Adverse Event|1|||
160831059|NCT01751139|580768830|FG000|Overall Study|Death|31|||
160831060|NCT03199391|580768831|FG000|Overall Study|Death|1|||
160831061|NCT03199391|580768831|FG000|Overall Study|Lost to Follow-up|3|||
160831062|NCT03199391|580768831|FG000|Overall Study|Adverse Event|2|||
160831063|NCT03199391|580768831|FG000|Overall Study|Withdrawal by Subject|10|||
160831064|NCT01867086|580768832|FG000|Overall Study|Disease Progression|1|||
160831065|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Death|1|||
160831066|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Death|0|||
160831067|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Death|0|||
160831068|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Death|0|||
160831069|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
160831070|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
160831071|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
160831072|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
160831073|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
160831074|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
160831075|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
160831076|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
160831077|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
160831078|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
160831079|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
160831080|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
160831081|NCT04271475|580768837|FG000|DB Period: Day 1 up to EODBT|Other|8|||
160831082|NCT04271475|580768838|FG001|DB Period: Day 1 up to EODBT|Other|5|||
160831083|NCT04271475|580768839|FG002|DB Period: Day 1 up to EODBT|Other|0|||
160831084|NCT04271475|580768840|FG003|DB Period: Day 1 up to EODBT|Other|0|||
160831085|NCT04271475|580768837|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
160831086|NCT04271475|580768838|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
160831087|NCT04271475|580768839|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
160831088|NCT04271475|580768840|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
160831089|NCT04271475|580768837|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
160831090|NCT04271475|580768838|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
160831091|NCT04271475|580768839|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
160831092|NCT04271475|580768840|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
160831093|NCT02337634|580768841|FG000|Overall Study|Protocol Violation|3|||
160831094|NCT02337634|580768842|FG001|Overall Study|Protocol Violation|1|||
160831095|NCT02337634|580768841|FG000|Overall Study|Lost to Follow-up|1|||
160831096|NCT02337634|580768842|FG001|Overall Study|Lost to Follow-up|0|||
160831097|NCT02428205|580768846|FG000|Overall Study|Lack of Efficacy|1|||
160831098|NCT02428205|580768847|FG001|Overall Study|Lack of Efficacy|0|||
160831099|NCT02428205|580768846|FG000|Overall Study|Lost to Follow-up|1|||
160831100|NCT02428205|580768847|FG001|Overall Study|Lost to Follow-up|1|||
160831101|NCT02428205|580768846|FG000|Overall Study|Worse behavior|0|||
160831102|NCT02428205|580768847|FG001|Overall Study|Worse behavior|1|||
160831103|NCT01818284|580768848|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
160831104|NCT01818284|580768849|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
160831105|NCT01818284|580768848|FG000|Overall Study|Death|0|||
160831106|NCT01818284|580768849|FG001|Overall Study|Death|2|||
161334886|NCT03167242|582615858|FG011|Overall Study|Patient/Guardian Decision|0|||
160831107|NCT02888743|580768850|FG000|Overall Study|Withdrawal by Subject|1|||
160831108|NCT02888743|580768851|FG001|Overall Study|Withdrawal by Subject|2|||
160831109|NCT02888743|580768852|FG002|Overall Study|Withdrawal by Subject|2|||
160831110|NCT02888743|580768853|FG003|Overall Study|Withdrawal by Subject|0|||
160831111|NCT02888743|580768854|FG004|Overall Study|Withdrawal by Subject|1|||
160831112|NCT02888743|580768850|FG000|Overall Study|Disease progression before treatment|2|||
160831113|NCT02888743|580768851|FG001|Overall Study|Disease progression before treatment|0|||
160831114|NCT02888743|580768852|FG002|Overall Study|Disease progression before treatment|2|||
160831115|NCT02888743|580768853|FG003|Overall Study|Disease progression before treatment|0|||
160831116|NCT02888743|580768854|FG004|Overall Study|Disease progression before treatment|0|||
160831117|NCT02888743|580768850|FG000|Overall Study|Patient ineligible|1|||
160831118|NCT02888743|580768851|FG001|Overall Study|Patient ineligible|2|||
160831119|NCT02888743|580768852|FG002|Overall Study|Patient ineligible|0|||
160831120|NCT02888743|580768853|FG003|Overall Study|Patient ineligible|0|||
160831121|NCT02888743|580768854|FG004|Overall Study|Patient ineligible|0|||
160831122|NCT00527319|580768855|FG000|Overall Study|Withdrawal by Subject|5|||
160831123|NCT00527319|580768856|FG001|Overall Study|Withdrawal by Subject|0|||
160831124|NCT00527319|580768857|FG002|Overall Study|Withdrawal by Subject|1|||
160831125|NCT00527319|580768855|FG000|Overall Study|Lost to Follow-up|1|||
160831126|NCT00527319|580768856|FG001|Overall Study|Lost to Follow-up|0|||
160831127|NCT00527319|580768857|FG002|Overall Study|Lost to Follow-up|0|||
160831128|NCT00527319|580768855|FG000|Overall Study|Death|0|||
160831129|NCT00527319|580768856|FG001|Overall Study|Death|3|||
160831130|NCT00527319|580768857|FG002|Overall Study|Death|1|||
160831131|NCT00527319|580768855|FG000|Overall Study|Intercurrent Medical Illness|0|||
160831132|NCT00527319|580768856|FG001|Overall Study|Intercurrent Medical Illness|1|||
160831133|NCT00527319|580768857|FG002|Overall Study|Intercurrent Medical Illness|3|||
160831134|NCT00527319|580768855|FG000|Overall Study|Adverse Event|0|||
160831135|NCT00527319|580768856|FG001|Overall Study|Adverse Event|0|||
160831136|NCT00527319|580768857|FG002|Overall Study|Adverse Event|1|||
160831137|NCT01299571|580768863|FG000|Overall Study|Protocol Violation|107|||
160831138|NCT02900170|580768864|FG000|Overall Study|Lost to Follow-up|8|||
160831139|NCT02635347|580768867|FG000|Overall Study|Failed screening|20|||
160831140|NCT02635347|580768868|FG001|Overall Study|Failed screening|7|||
160831141|NCT01739803|580768869|FG000|Overall Study|Lost to Follow-up|9|||
160831142|NCT01739803|580768870|FG001|Overall Study|Lost to Follow-up|6|||
160831143|NCT03759041|580768871|FG000|Overall Study|Withdrawal by Subject|4|||
160831144|NCT03759041|580768872|FG001|Overall Study|Withdrawal by Subject|10|||
160831145|NCT03759041|580768873|FG002|Overall Study|Withdrawal by Subject|10|||
160831146|NCT03759041|580768871|FG000|Overall Study|Adverse Event|1|||
160831147|NCT03759041|580768872|FG001|Overall Study|Adverse Event|3|||
160831148|NCT03759041|580768873|FG002|Overall Study|Adverse Event|4|||
160831149|NCT03759041|580768871|FG000|Overall Study|Lack of Efficacy|0|||
160831150|NCT03759041|580768872|FG001|Overall Study|Lack of Efficacy|0|||
160831151|NCT03759041|580768873|FG002|Overall Study|Lack of Efficacy|1|||
160831152|NCT03759041|580768871|FG000|Overall Study|Study Terminated by Sponsor|15|||
160831153|NCT03759041|580768872|FG001|Overall Study|Study Terminated by Sponsor|16|||
160831154|NCT03759041|580768873|FG002|Overall Study|Study Terminated by Sponsor|10|||
160831155|NCT03759041|580768871|FG000|Overall Study|Other reason for discontinuation|0|||
160831156|NCT03759041|580768872|FG001|Overall Study|Other reason for discontinuation|2|||
160831157|NCT03759041|580768873|FG002|Overall Study|Other reason for discontinuation|1|||
160831158|NCT03759041|580768871|FG000|Overall Study|Lost to Follow-up|7|||
160831159|NCT03759041|580768872|FG001|Overall Study|Lost to Follow-up|2|||
160831160|NCT03759041|580768873|FG002|Overall Study|Lost to Follow-up|2|||
160831161|NCT03759041|580768871|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
160831162|NCT03759041|580768872|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
160831163|NCT03759041|580768873|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
160831164|NCT00525824|580768875|FG000|Overall Study|Adverse Event|7|||
160831165|NCT00525824|580768876|FG001|Overall Study|Adverse Event|11|||
160831166|NCT00525824|580768877|FG002|Overall Study|Adverse Event|6|||
160831167|NCT00525824|580768878|FG003|Overall Study|Adverse Event|7|||
160831168|NCT00525824|580768875|FG000|Overall Study|Withdrawal by Subject|5|||
160831169|NCT00525824|580768876|FG001|Overall Study|Withdrawal by Subject|9|||
160831170|NCT00525824|580768877|FG002|Overall Study|Withdrawal by Subject|3|||
160831171|NCT00525824|580768878|FG003|Overall Study|Withdrawal by Subject|4|||
160831172|NCT00525824|580768875|FG000|Overall Study|Lost to Follow-up|4|||
160831173|NCT00525824|580768876|FG001|Overall Study|Lost to Follow-up|2|||
160831174|NCT00525824|580768877|FG002|Overall Study|Lost to Follow-up|4|||
160831175|NCT00525824|580768878|FG003|Overall Study|Lost to Follow-up|0|||
160831176|NCT00525824|580768875|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
160831177|NCT00525824|580768876|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
160831178|NCT00525824|580768877|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
160831179|NCT00525824|580768878|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
160831180|NCT00525824|580768875|FG000|Overall Study|Severe non-compliance|0|||
160831181|NCT00525824|580768876|FG001|Overall Study|Severe non-compliance|1|||
160831182|NCT00525824|580768877|FG002|Overall Study|Severe non-compliance|1|||
160831183|NCT00525824|580768878|FG003|Overall Study|Severe non-compliance|1|||
160831184|NCT00525824|580768875|FG000|Overall Study|Safety reasons|1|||
160831185|NCT00525824|580768876|FG001|Overall Study|Safety reasons|0|||
160831186|NCT00525824|580768877|FG002|Overall Study|Safety reasons|1|||
160831187|NCT00525824|580768878|FG003|Overall Study|Safety reasons|0|||
160831188|NCT00525824|580768875|FG000|Overall Study|Other|1|||
160831189|NCT00525824|580768876|FG001|Overall Study|Other|3|||
160831190|NCT00525824|580768877|FG002|Overall Study|Other|3|||
160831191|NCT00525824|580768878|FG003|Overall Study|Other|1|||
160831192|NCT01522404|580768879|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
160831193|NCT01522404|580768880|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
160831194|NCT01522404|580768879|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
160831195|NCT01522404|580768880|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
160831196|NCT01522404|580768879|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
160831197|NCT01522404|580768880|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
160831198|NCT00897390|580768888|FG000|Overall Study|Adverse Event|2|||
160831199|NCT00897390|580768888|FG000|Overall Study|No Longer Met Study Criteria|1|||
160831200|NCT00897390|580768888|FG000|Overall Study|Personal Reasons|1|||
160831201|NCT00897390|580768888|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
160831202|NCT03159104|580768889|FG000|Overall Study|Violation of inclusion criteria|1|||
160831203|NCT03159104|580768890|FG001|Overall Study|Violation of inclusion criteria|2|||
160831204|NCT01216683|580770174|FG000|Induction|Never started treatment|0|||
160831205|NCT01216683|580770175|FG001|Induction|Never started treatment|6|||
160831206|NCT01216683|580770176|FG002|Induction|Never started treatment|3|||
160831207|NCT01216683|580770174|FG000|Induction|Lack of Efficacy|4|||
160831208|NCT01216683|580770175|FG001|Induction|Lack of Efficacy|3|||
160831209|NCT01216683|580770176|FG002|Induction|Lack of Efficacy|7|||
160831210|NCT01216683|580770174|FG000|Induction|Adverse Event|0|||
160831211|NCT01216683|580770175|FG001|Induction|Adverse Event|5|||
160831212|NCT01216683|580770176|FG002|Induction|Adverse Event|5|||
160831213|NCT01216683|580770174|FG000|Induction|Death|0|||
160831214|NCT01216683|580770175|FG001|Induction|Death|0|||
160831215|NCT01216683|580770176|FG002|Induction|Death|2|||
160831216|NCT01216683|580770174|FG000|Induction|Withdrawal by Subject|0|||
160831217|NCT01216683|580770175|FG001|Induction|Withdrawal by Subject|4|||
160831218|NCT01216683|580770176|FG002|Induction|Withdrawal by Subject|2|||
160831219|NCT01216683|580770174|FG000|Induction|Other disease|0|||
160831220|NCT01216683|580770175|FG001|Induction|Other disease|1|||
160831221|NCT01216683|580770176|FG002|Induction|Other disease|2|||
160831222|NCT01216683|580770174|FG000|Continuation|Lack of Efficacy|3|||
160831223|NCT01216683|580770175|FG001|Continuation|Lack of Efficacy|2|||
160831224|NCT01216683|580770176|FG002|Continuation|Lack of Efficacy|7|||
160831225|NCT01216683|580770174|FG000|Continuation|Adverse Event|5|||
160831226|NCT01216683|580770175|FG001|Continuation|Adverse Event|3|||
160831227|NCT01216683|580770176|FG002|Continuation|Adverse Event|16|||
160831228|NCT01216683|580770174|FG000|Continuation|Death|1|||
160831229|NCT01216683|580770175|FG001|Continuation|Death|0|||
160831230|NCT01216683|580770176|FG002|Continuation|Death|2|||
160831231|NCT01216683|580770174|FG000|Continuation|Withdrawal by Subject|4|||
160831232|NCT01216683|580770175|FG001|Continuation|Withdrawal by Subject|5|||
160831233|NCT01216683|580770176|FG002|Continuation|Withdrawal by Subject|9|||
160831234|NCT01216683|580770174|FG000|Continuation|Other diseases|0|||
160831235|NCT01216683|580770175|FG001|Continuation|Other diseases|2|||
160831236|NCT01216683|580770176|FG002|Continuation|Other diseases|1|||
160903303|NCT00190671|581039087|FG000|Overall Study|Satisfactory Response|4|||
160903304|NCT00190671|581039088|FG001|Overall Study|Satisfactory Response|7|||
160903305|NCT00190671|581039087|FG000|Overall Study|Lack of Efficacy|19|||
160903306|NCT00190671|581039088|FG001|Overall Study|Lack of Efficacy|24|||
161334887|NCT03167242|582615847|FG000|Overall Study|Lost to Follow-up|0|||
160831237|NCT01216683|580770174|FG000|Continuation|Physician Decision|1|||
160831238|NCT01216683|580770175|FG001|Continuation|Physician Decision|0|||
160831239|NCT01216683|580770176|FG002|Continuation|Physician Decision|1|||
160831240|NCT01216683|580770174|FG000|Continuation|Non-compliance|1|||
160831241|NCT01216683|580770175|FG001|Continuation|Non-compliance|0|||
160831242|NCT01216683|580770176|FG002|Continuation|Non-compliance|1|||
160831243|NCT01216683|580770174|FG000|Continuation|Insurance change|0|||
160831244|NCT01216683|580770175|FG001|Continuation|Insurance change|1|||
160831245|NCT01216683|580770176|FG002|Continuation|Insurance change|0|||
160903307|NCT00190671|581039087|FG000|Overall Study|Death from Study Disease|1|||
160831246|NCT01216683|580770174|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
160903308|NCT00190671|581039088|FG001|Overall Study|Death from Study Disease|1|||
160831247|NCT01216683|580770175|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
160831248|NCT01216683|580770176|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
160831249|NCT01216683|580770174|FG000|Continuation|Not reported|0|||
160831250|NCT01216683|580770175|FG001|Continuation|Not reported|0|||
160831251|NCT01216683|580770176|FG002|Continuation|Not reported|1|||
160831252|NCT01216683|580770174|FG000|Continuation|Never started treatment|0|||
160831253|NCT01216683|580770175|FG001|Continuation|Never started treatment|1|||
161247064|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161247065|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161247066|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161247067|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
161247068|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
161334888|NCT03167242|582615848|FG001|Overall Study|Lost to Follow-up|0|||
160831254|NCT01216683|580770176|FG002|Continuation|Never started treatment|5|||
160831255|NCT05011513|580770177|FG000|Overall Study|Death|0|||
160831256|NCT05011513|580770178|FG001|Overall Study|Death|1|||
160831257|NCT05011513|580770177|FG000|Overall Study|Lost to Follow-up|4|||
160831258|NCT05011513|580770178|FG001|Overall Study|Lost to Follow-up|0|||
160831259|NCT05011513|580770177|FG000|Overall Study|Withdrawal by Subject|18|||
160831260|NCT05011513|580770178|FG001|Overall Study|Withdrawal by Subject|17|||
160831261|NCT05011513|580770177|FG000|Overall Study|Other|4|||
160831262|NCT05011513|580770178|FG001|Overall Study|Other|2|||
160831263|NCT03667690|580770179|FG000|Overall Study|Adverse Event|0|||
160831264|NCT03667690|580770180|FG001|Overall Study|Adverse Event|3|||
160831265|NCT03667690|580770179|FG000|Overall Study|Death|22|||
160831266|NCT03667690|580770180|FG001|Overall Study|Death|21|||
160831267|NCT03667690|580770179|FG000|Overall Study|Lost to Follow-up|4|||
160831268|NCT03667690|580770180|FG001|Overall Study|Lost to Follow-up|5|||
160831269|NCT03667690|580770179|FG000|Overall Study|Withdrawal by Subject|7|||
160831270|NCT03667690|580770180|FG001|Overall Study|Withdrawal by Subject|8|||
160831271|NCT03667690|580770179|FG000|Overall Study|Subject could not return for additional investigational product|1|||
160831272|NCT03667690|580770180|FG001|Overall Study|Subject could not return for additional investigational product|0|||
160831273|NCT03667690|580770179|FG000|Overall Study|Subject discharged to hospice care|2|||
160831274|NCT03667690|580770180|FG001|Overall Study|Subject discharged to hospice care|0|||
160831275|NCT03667690|580770179|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
160831276|NCT03667690|580770180|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
160831277|NCT03667690|580770179|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
160831278|NCT03667690|580770180|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
160831279|NCT03667690|580770179|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
160831280|NCT03667690|580770180|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
160831281|NCT03667690|580770179|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
160831282|NCT03667690|580770180|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
160831283|NCT03667690|580770179|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
160831284|NCT03667690|580770180|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
160831285|NCT01350115|580770189|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
160831286|NCT01350115|580770190|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
160831287|NCT01350115|580770189|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
160831288|NCT01350115|580770190|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
160831289|NCT01350115|580770189|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
160831290|NCT01350115|580770190|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
160831291|NCT04327024|580770191|FG000|Overall Study|Death|1|||
160831292|NCT04327024|580770192|FG001|Overall Study|Death|2|||
160831293|NCT04327024|580770193|FG002|Overall Study|Death|1|||
160831294|NCT04327024|580770191|FG000|Overall Study|Non-compliance with study drug|0|||
160831295|NCT04327024|580770192|FG001|Overall Study|Non-compliance with study drug|1|||
160831296|NCT04327024|580770193|FG002|Overall Study|Non-compliance with study drug|0|||
160831297|NCT04327024|580770191|FG000|Overall Study|Withdrawal by Subject|1|||
160831298|NCT04327024|580770192|FG001|Overall Study|Withdrawal by Subject|1|||
160831299|NCT04327024|580770193|FG002|Overall Study|Withdrawal by Subject|2|||
160831300|NCT00837759|580770197|FG000|Overall Study|Protocol Violation|3|||
160831301|NCT00837759|580770197|FG000|Overall Study|Lost to Follow-up|1|||
160831302|NCT01597635|580770198|FG000|Part A|Adverse Event|3|||
160831303|NCT01597635|580770199|FG001|Part A|Adverse Event|0|||
160831304|NCT01597635|580770200|FG002|Part A|Adverse Event|0|||
160831305|NCT01597635|580770198|FG000|Part B|Adverse Event|0|||
160831306|NCT01597635|580770199|FG001|Part B|Adverse Event|0|||
160831307|NCT01597635|580770200|FG002|Part B|Adverse Event|1|||
160831308|NCT01597635|580770198|FG000|Part B|Protocol Violation|0|||
160831309|NCT01597635|580770199|FG001|Part B|Protocol Violation|1|||
160831310|NCT01597635|580770200|FG002|Part B|Protocol Violation|0|||
160831311|NCT01597635|580770198|FG000|Part B|Protocol-defined stopping criteria|0|||
160831312|NCT01597635|580770199|FG001|Part B|Protocol-defined stopping criteria|4|||
160831313|NCT01597635|580770200|FG002|Part B|Protocol-defined stopping criteria|3|||
160831314|NCT01597635|580770198|FG000|Part B|Withdrawal by Subject|0|||
160831315|NCT01597635|580770199|FG001|Part B|Withdrawal by Subject|1|||
160831316|NCT01597635|580770200|FG002|Part B|Withdrawal by Subject|0|||
160831317|NCT01300351|580770207|FG000|Overall Study|Did not receive treatment|2|||
161136531|NCT00996840|581881654|FG000|Overall Study|Adverse Event|0|||
161334889|NCT03167242|582615849|FG002|Overall Study|Lost to Follow-up|1|||
160831318|NCT01300351|580770208|FG001|Overall Study|Did not receive treatment|0|||
160831319|NCT01300351|580770207|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
160831320|NCT01300351|580770208|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
160831321|NCT01300351|580770207|FG000|Overall Study|Lost to Follow-up|0|||
160831322|NCT01300351|580770208|FG001|Overall Study|Lost to Follow-up|1|||
160831323|NCT01300351|580770207|FG000|Overall Study|Adverse Event|0|||
160831324|NCT01300351|580770208|FG001|Overall Study|Adverse Event|4|||
160831325|NCT01300351|580770207|FG000|Overall Study|Withdrawal by Subject|7|||
160831326|NCT01300351|580770208|FG001|Overall Study|Withdrawal by Subject|10|||
160831327|NCT05824936|580770211|FG000|Overall Study|Lost to Follow-up|1|||
160831328|NCT00673881|580770212|FG000|Overall Study|Withdrawal by Subject|1|||
160831329|NCT00096018|580770213|FG000|Overall Study|Became Ineligible (not treated)|0|||
160831330|NCT00096018|580770214|FG001|Overall Study|Became Ineligible (not treated)|3|||
160831331|NCT00096018|580770213|FG000|Overall Study|Miscellaneous (not treated)|0|||
160831332|NCT00096018|580770214|FG001|Overall Study|Miscellaneous (not treated)|2|||
160831333|NCT00096018|580770213|FG000|Overall Study|Adverse Event|0|||
160831334|NCT00096018|580770214|FG001|Overall Study|Adverse Event|5|||
160831335|NCT00096018|580770213|FG000|Overall Study|Death|0|||
160831336|NCT00096018|580770214|FG001|Overall Study|Death|1|||
160831337|NCT00096018|580770213|FG000|Overall Study|Withdrawal by Subject|0|||
160831338|NCT00096018|580770214|FG001|Overall Study|Withdrawal by Subject|2|||
160831339|NCT00096018|580770213|FG000|Overall Study|Miscellaneous|2|||
160831340|NCT00096018|580770214|FG001|Overall Study|Miscellaneous|1|||
160831341|NCT00483041|580770215|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
160831342|NCT00483041|580770216|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
160831343|NCT03968159|580770217|FG000|Overall Study|Adverse Event|4|||
160831344|NCT03968159|580770218|FG001|Overall Study|Adverse Event|4|||
160831345|NCT03968159|580770217|FG000|Overall Study|Lost to Follow-up|1|||
160831346|NCT03968159|580770218|FG001|Overall Study|Lost to Follow-up|1|||
160831347|NCT03968159|580770217|FG000|Overall Study|Use of prohibited medication|0|||
160831348|NCT03968159|580770218|FG001|Overall Study|Use of prohibited medication|1|||
160831349|NCT03968159|580770217|FG000|Overall Study|Protocol Violation|2|||
160831350|NCT03968159|580770218|FG001|Overall Study|Protocol Violation|2|||
160831351|NCT03968159|580770217|FG000|Overall Study|Withdrawal by Subject|4|||
160831352|NCT03968159|580770218|FG001|Overall Study|Withdrawal by Subject|6|||
160831353|NCT03968159|580770217|FG000|Overall Study|Lack of Efficacy|0|||
160831354|NCT03968159|580770218|FG001|Overall Study|Lack of Efficacy|1|||
160831355|NCT03968159|580770217|FG000|Overall Study|Not further specified|2|||
160831356|NCT03968159|580770218|FG001|Overall Study|Not further specified|0|||
160831357|NCT00864851|580770219|FG000|Overall Study|Withdrawal by Subject|0|||
160831358|NCT00864851|580770220|FG001|Overall Study|Withdrawal by Subject|1|||
160831359|NCT00864851|580770221|FG002|Overall Study|Withdrawal by Subject|0|||
160831360|NCT00864851|580770219|FG000|Overall Study|Physician Decision|1|||
160831361|NCT00864851|580770220|FG001|Overall Study|Physician Decision|0|||
160831362|NCT00864851|580770221|FG002|Overall Study|Physician Decision|0|||
160831363|NCT00864851|580770219|FG000|Overall Study|Death|1|||
160831364|NCT00864851|580770220|FG001|Overall Study|Death|0|||
160831365|NCT00864851|580770221|FG002|Overall Study|Death|0|||
160831366|NCT00864851|580770219|FG000|Overall Study|Patient uncooperative|1|||
160831367|NCT00864851|580770220|FG001|Overall Study|Patient uncooperative|0|||
160831368|NCT00864851|580770221|FG002|Overall Study|Patient uncooperative|0|||
160831369|NCT00443781|580770222|FG000|Overall Study|Lost to Follow-up|10|||
160831370|NCT00443781|580770222|FG000|Overall Study|Physician Decision|2|||
160831371|NCT00443781|580770222|FG000|Overall Study|Protocol Violation|1|||
161334890|NCT03167242|582615850|FG003|Overall Study|Lost to Follow-up|0|||
160831372|NCT00443781|580770222|FG000|Overall Study|Withdrawal by Subject|6|||
160831373|NCT00443781|580770222|FG000|Overall Study|Unable to comply with study follow up|2|||
161334891|NCT03167242|582615851|FG004|Overall Study|Lost to Follow-up|0|||
161334892|NCT03167242|582615852|FG005|Overall Study|Lost to Follow-up|1|||
160831374|NCT00443781|580770222|FG000|Overall Study|Investigator terminated participation|1|||
160831375|NCT00443781|580770222|FG000|Overall Study|Insurance not covered|2|||
160831376|NCT00443781|580770222|FG000|Overall Study|PD/FAD not done|1|||
161334893|NCT03167242|582615853|FG006|Overall Study|Lost to Follow-up|2|||
160831377|NCT00430937|580770223|FG000|Overall Study|Adverse Event|3|||
160831378|NCT00430937|580770224|FG001|Overall Study|Adverse Event|8|||
160831379|NCT00430937|580770223|FG000|Overall Study|Death|0|||
161334894|NCT03167242|582615854|FG007|Overall Study|Lost to Follow-up|1|||
160831380|NCT00430937|580770224|FG001|Overall Study|Death|1|||
160831381|NCT00430937|580770223|FG000|Overall Study|Lost to Follow-up|6|||
160831382|NCT00430937|580770224|FG001|Overall Study|Lost to Follow-up|6|||
160903309|NCT00190671|581039087|FG000|Overall Study|Adverse Event|3|||
160903310|NCT00190671|581039088|FG001|Overall Study|Adverse Event|2|||
161334895|NCT03167242|582615855|FG008|Overall Study|Lost to Follow-up|0|||
160831383|NCT00430937|580770223|FG000|Overall Study|Withdrawal by Subject|5|||
160831384|NCT00430937|580770224|FG001|Overall Study|Withdrawal by Subject|2|||
161334896|NCT03167242|582615856|FG009|Overall Study|Lost to Follow-up|0|||
160831385|NCT00430937|580770223|FG000|Overall Study|Protocol Violation|3|||
160831386|NCT00430937|580770224|FG001|Overall Study|Protocol Violation|2|||
160831387|NCT00430937|580770223|FG000|Overall Study|Lack of Efficacy|6|||
160831388|NCT00430937|580770224|FG001|Overall Study|Lack of Efficacy|5|||
160831389|NCT00430937|580770223|FG000|Overall Study|Inappropriate enrollment|2|||
160831390|NCT00430937|580770224|FG001|Overall Study|Inappropriate enrollment|1|||
160831391|NCT00430937|580770223|FG000|Overall Study|Administrative reasons|1|||
160831392|NCT00430937|580770224|FG001|Overall Study|Administrative reasons|0|||
160831393|NCT00430937|580770223|FG000|Overall Study|Protocol discontinuation criteria met|1|||
160831394|NCT00430937|580770224|FG001|Overall Study|Protocol discontinuation criteria met|2|||
160831395|NCT00430937|580770223|FG000|Overall Study|Unable to classify|0|||
160831396|NCT00430937|580770224|FG001|Overall Study|Unable to classify|1|||
160831397|NCT01533922|580770225|FG000|Overall Study|Adverse Event|5|||
160831398|NCT01533922|580770226|FG001|Overall Study|Adverse Event|8|||
160831399|NCT01533922|580770227|FG002|Overall Study|Adverse Event|6|||
160831400|NCT01533922|580770228|FG003|Overall Study|Adverse Event|3|||
160831401|NCT01533922|580770229|FG004|Overall Study|Adverse Event|4|||
160831402|NCT01533922|580770225|FG000|Overall Study|Lack of Efficacy|0|||
160831403|NCT01533922|580770226|FG001|Overall Study|Lack of Efficacy|0|||
160831404|NCT01533922|580770227|FG002|Overall Study|Lack of Efficacy|1|||
160831405|NCT01533922|580770228|FG003|Overall Study|Lack of Efficacy|0|||
160831406|NCT01533922|580770229|FG004|Overall Study|Lack of Efficacy|0|||
160831407|NCT01533922|580770225|FG000|Overall Study|Protocol Violation|0|||
160831408|NCT01533922|580770226|FG001|Overall Study|Protocol Violation|3|||
160831409|NCT01533922|580770227|FG002|Overall Study|Protocol Violation|0|||
160831410|NCT01533922|580770228|FG003|Overall Study|Protocol Violation|0|||
160831411|NCT01533922|580770229|FG004|Overall Study|Protocol Violation|1|||
160831412|NCT01533922|580770225|FG000|Overall Study|Withdrawal by Subject|3|||
160831413|NCT01533922|580770226|FG001|Overall Study|Withdrawal by Subject|1|||
160831414|NCT01533922|580770227|FG002|Overall Study|Withdrawal by Subject|2|||
160831415|NCT01533922|580770228|FG003|Overall Study|Withdrawal by Subject|2|||
160831416|NCT01533922|580770229|FG004|Overall Study|Withdrawal by Subject|1|||
160831417|NCT01533922|580770225|FG000|Overall Study|Other reason not defined above|2|||
160831418|NCT01533922|580770226|FG001|Overall Study|Other reason not defined above|0|||
160831419|NCT01533922|580770227|FG002|Overall Study|Other reason not defined above|1|||
160831420|NCT01533922|580770228|FG003|Overall Study|Other reason not defined above|0|||
160831421|NCT01533922|580770229|FG004|Overall Study|Other reason not defined above|0|||
160831422|NCT01267175|580770235|FG000|Overall Study|Withdrawal by Subject|1|||
160831423|NCT01267175|580770235|FG000|Overall Study|Lost to Follow-up|1|||
160831424|NCT00895661|580770237|FG000|Overall Study|Death|1|||
160831425|NCT00895661|580770237|FG000|Overall Study|reason unknown|2|||
160831426|NCT02006069|580770238|FG000|Overall Study|MPP other programming|239|||
160831427|NCT02006069|580770239|FG001|Overall Study|MPP other programming|0|||
160831428|NCT02006069|580770238|FG000|Overall Study|RV only pacing|0|||
160831429|NCT02006069|580770239|FG001|Overall Study|RV only pacing|3|||
160831430|NCT02989805|580770242|FG000|Overall Study|invalid consent|6|||
160831431|NCT02989805|580770243|FG001|Overall Study|invalid consent|4|||
160831432|NCT00286221|580770244|FG000|Overall Study|Protocol Violation|2|||
160831433|NCT00286221|580770245|FG001|Overall Study|Protocol Violation|1|||
160831434|NCT00286221|580770246|FG002|Overall Study|Protocol Violation|6|||
160831435|NCT00286221|580770247|FG003|Overall Study|Protocol Violation|4|||
160831436|NCT00286221|580770244|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
160831437|NCT00286221|580770245|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
160831438|NCT00286221|580770246|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
160831439|NCT00286221|580770247|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
160831440|NCT00286221|580770244|FG000|Overall Study|Inability to trigger PCA|2|||
160831441|NCT00286221|580770245|FG001|Overall Study|Inability to trigger PCA|0|||
160831442|NCT00286221|580770246|FG002|Overall Study|Inability to trigger PCA|0|||
160831443|NCT00286221|580770247|FG003|Overall Study|Inability to trigger PCA|0|||
160831444|NCT00286221|580770244|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
160831445|NCT00286221|580770245|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
160831446|NCT00286221|580770246|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
160831447|NCT00286221|580770247|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
160831448|NCT02771626|580770250|FG000|Overall Study|Adverse Event|1|||
160903311|NCT00190671|581039087|FG000|Overall Study|Clinical Relapse|0|||
160831449|NCT02771626|580770251|FG001|Overall Study|Adverse Event|5|||
160831450|NCT02771626|580770252|FG002|Overall Study|Adverse Event|3|||
160831451|NCT02771626|580770253|FG003|Overall Study|Adverse Event|0|||
160831452|NCT02771626|580770254|FG004|Overall Study|Adverse Event|1|||
160831453|NCT02771626|580770255|FG005|Overall Study|Adverse Event|1|||
160831454|NCT02771626|580770250|FG000|Overall Study|Radiologic Disease Progression|6|||
160831455|NCT02771626|580770251|FG001|Overall Study|Radiologic Disease Progression|13|||
160831456|NCT02771626|580770252|FG002|Overall Study|Radiologic Disease Progression|10|||
160831457|NCT02771626|580770253|FG003|Overall Study|Radiologic Disease Progression|7|||
160831458|NCT02771626|580770254|FG004|Overall Study|Radiologic Disease Progression|28|||
160831459|NCT02771626|580770255|FG005|Overall Study|Radiologic Disease Progression|15|||
160831460|NCT02771626|580770250|FG000|Overall Study|Symptomatic Deterioration|0|||
160831461|NCT02771626|580770251|FG001|Overall Study|Symptomatic Deterioration|4|||
160831462|NCT02771626|580770252|FG002|Overall Study|Symptomatic Deterioration|2|||
160831463|NCT02771626|580770253|FG003|Overall Study|Symptomatic Deterioration|0|||
160831464|NCT02771626|580770254|FG004|Overall Study|Symptomatic Deterioration|5|||
160831465|NCT02771626|580770255|FG005|Overall Study|Symptomatic Deterioration|2|||
160831466|NCT02771626|580770250|FG000|Overall Study|Participant Request|0|||
160831467|NCT02771626|580770251|FG001|Overall Study|Participant Request|1|||
160831468|NCT02771626|580770252|FG002|Overall Study|Participant Request|0|||
160831469|NCT02771626|580770253|FG003|Overall Study|Participant Request|2|||
160831470|NCT02771626|580770254|FG004|Overall Study|Participant Request|0|||
160831471|NCT02771626|580770255|FG005|Overall Study|Participant Request|1|||
160831472|NCT02771626|580770250|FG000|Overall Study|Investigator Decision|0|||
160831473|NCT02771626|580770251|FG001|Overall Study|Investigator Decision|1|||
160831474|NCT02771626|580770252|FG002|Overall Study|Investigator Decision|0|||
160831475|NCT02771626|580770253|FG003|Overall Study|Investigator Decision|0|||
160831476|NCT02771626|580770254|FG004|Overall Study|Investigator Decision|1|||
160831477|NCT02771626|580770255|FG005|Overall Study|Investigator Decision|0|||
160831478|NCT02771626|580770250|FG000|Overall Study|Study Termination by Sponsor|0|||
160831479|NCT02771626|580770251|FG001|Overall Study|Study Termination by Sponsor|2|||
160831480|NCT02771626|580770252|FG002|Overall Study|Study Termination by Sponsor|1|||
160831481|NCT02771626|580770253|FG003|Overall Study|Study Termination by Sponsor|0|||
160831482|NCT02771626|580770254|FG004|Overall Study|Study Termination by Sponsor|1|||
160831483|NCT02771626|580770255|FG005|Overall Study|Study Termination by Sponsor|0|||
160831484|NCT02771626|580770250|FG000|Overall Study|Informed Consent Withdrawn|0|||
160831485|NCT02771626|580770251|FG001|Overall Study|Informed Consent Withdrawn|0|||
160831486|NCT02771626|580770252|FG002|Overall Study|Informed Consent Withdrawn|1|||
160831487|NCT02771626|580770253|FG003|Overall Study|Informed Consent Withdrawn|0|||
160831488|NCT02771626|580770254|FG004|Overall Study|Informed Consent Withdrawn|1|||
160831489|NCT02771626|580770255|FG005|Overall Study|Informed Consent Withdrawn|1|||
160831490|NCT02771626|580770250|FG000|Overall Study|Other, Not Specified|1|||
160831491|NCT02771626|580770251|FG001|Overall Study|Other, Not Specified|0|||
160831492|NCT02771626|580770252|FG002|Overall Study|Other, Not Specified|0|||
160831493|NCT02771626|580770253|FG003|Overall Study|Other, Not Specified|0|||
160831494|NCT02771626|580770254|FG004|Overall Study|Other, Not Specified|0|||
160831495|NCT02771626|580770255|FG005|Overall Study|Other, Not Specified|1|||
160831496|NCT02553538|580770258|FG000|Overall Study|Could Not Reach by Telephone|133|||
160831497|NCT02553538|580770259|FG001|Overall Study|Could Not Reach by Telephone|0|||
160831498|NCT02553538|580770258|FG000|Overall Study|Died or Left Network|54|||
160831499|NCT02553538|580770259|FG001|Overall Study|Died or Left Network|56|||
160831500|NCT02648217|580770260|FG000|Overall Study|Adverse Event|0|||
160831501|NCT02648217|580770261|FG001|Overall Study|Adverse Event|1|||
160831502|NCT02648217|580770260|FG000|Overall Study|Lost to Follow-up|1|||
160831503|NCT02648217|580770261|FG001|Overall Study|Lost to Follow-up|1|||
160831504|NCT02648217|580770260|FG000|Overall Study|Withdrawal by Subject|4|||
160831505|NCT02648217|580770261|FG001|Overall Study|Withdrawal by Subject|3|||
160831506|NCT02648217|580770260|FG000|Overall Study|Unclassified|5|||
160831507|NCT02648217|580770261|FG001|Overall Study|Unclassified|0|||
160831508|NCT04094584|580770262|FG000|Overall Study|No interest in study|88|||
160831509|NCT04094584|580770262|FG000|Overall Study|Unwilling to undergo screening tests|36|||
160831510|NCT04094584|580770262|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
160831511|NCT04094584|580770262|FG000|Overall Study|Opioid use|7|||
160831512|NCT04094584|580770262|FG000|Overall Study|Need for major surgery in study period|4|||
160831513|NCT04094584|580770262|FG000|Overall Study|eligible but declined enrollment|4|||
160831514|NCT04094584|580770262|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
160831515|NCT04094584|580770262|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
160831516|NCT04094584|580770262|FG000|Overall Study|Lost to Follow-up|3|||
160831517|NCT04094584|580770262|FG000|Overall Study|Withdrawal by Subject|2|||
160831518|NCT02690649|580770263|FG000|Overall Study|Withdrawal by Subject|1|||
160831519|NCT02690649|580770264|FG001|Overall Study|Withdrawal by Subject|1|||
160831520|NCT02690649|580770263|FG000|Overall Study|Protocol Violation|0|||
160831521|NCT02690649|580770264|FG001|Overall Study|Protocol Violation|3|||
160831522|NCT02276547|580770265|FG000|Overall Study|Death|2|||
160831523|NCT02276547|580770265|FG000|Overall Study|Explant|2|||
160831524|NCT02066129|580770266|FG000|Overall Study|Lost to Follow-up|13|||
160831525|NCT02066129|580770267|FG001|Overall Study|Lost to Follow-up|12|||
160831526|NCT02066129|580770266|FG000|Overall Study|Withdrawal by Subject|7|||
160831527|NCT02066129|580770267|FG001|Overall Study|Withdrawal by Subject|10|||
160831528|NCT02066129|580770266|FG000|Overall Study|Lack of Efficacy|8|||
160831529|NCT02066129|580770267|FG001|Overall Study|Lack of Efficacy|10|||
160831530|NCT02066129|580770266|FG000|Overall Study|Physician Decision|1|||
160831531|NCT02066129|580770267|FG001|Overall Study|Physician Decision|1|||
160831532|NCT02776033|580770269|FG000|Overall Study|Withdrawal by Subject|0|||
160831533|NCT02776033|580770270|FG001|Overall Study|Withdrawal by Subject|0|||
160831534|NCT02776033|580770271|FG002|Overall Study|Withdrawal by Subject|2|||
160831535|NCT02776033|580770269|FG000|Overall Study|Physician Decision|2|||
160831536|NCT02776033|580770270|FG001|Overall Study|Physician Decision|0|||
160831537|NCT02776033|580770271|FG002|Overall Study|Physician Decision|0|||
160831538|NCT02776033|580770269|FG000|Overall Study|Lost to Follow-up|1|||
160831539|NCT02776033|580770270|FG001|Overall Study|Lost to Follow-up|0|||
160831540|NCT02776033|580770271|FG002|Overall Study|Lost to Follow-up|0|||
160831541|NCT02776033|580770269|FG000|Overall Study|Adverse Event|1|||
160831542|NCT02776033|580770270|FG001|Overall Study|Adverse Event|2|||
160831543|NCT02776033|580770271|FG002|Overall Study|Adverse Event|0|||
160831544|NCT00685373|580770275|FG000|Overall Study|Adverse Event|3|||
160831545|NCT00685373|580770275|FG000|Overall Study|Withdrawal by Subject|5|||
160831546|NCT00685373|580770275|FG000|Overall Study|Lack of Efficacy|3|||
160831547|NCT00685373|580770275|FG000|Overall Study|Condition no longer requires study drug|1|||
160831548|NCT00685373|580770275|FG000|Overall Study|Lost to Follow-up|2|||
160831549|NCT00685373|580770275|FG000|Overall Study|Protocol Violation|1|||
160831550|NCT02639338|580770278|FG000|Overall Study|Lost to Follow-up|2|||
160831551|NCT02639338|580770279|FG001|Overall Study|Lost to Follow-up|2|||
160831552|NCT02639338|580770278|FG000|Overall Study|Withdrew Consent|1|||
160831553|NCT02639338|580770279|FG001|Overall Study|Withdrew Consent|2|||
160831554|NCT02639338|580770278|FG000|Overall Study|Death|1|||
160831555|NCT02639338|580770279|FG001|Overall Study|Death|0|||
160831556|NCT02639338|580770278|FG000|Overall Study|Randomized but Not Treated|0|||
160831557|NCT02639338|580770279|FG001|Overall Study|Randomized but Not Treated|1|||
160831558|NCT00160199|580770283|FG000|Overall Study|Adverse Event|5|||
160831559|NCT00160199|580770284|FG001|Overall Study|Adverse Event|14|||
160831560|NCT00160199|580770283|FG000|Overall Study|Lack of Efficacy|0|||
160831561|NCT00160199|580770284|FG001|Overall Study|Lack of Efficacy|1|||
160831562|NCT00160199|580770283|FG000|Overall Study|Lost to Follow-up|7|||
160831563|NCT00160199|580770284|FG001|Overall Study|Lost to Follow-up|7|||
160831564|NCT00160199|580770283|FG000|Overall Study|Withdrawal by Subject|4|||
160831565|NCT00160199|580770284|FG001|Overall Study|Withdrawal by Subject|6|||
160831566|NCT00160199|580770283|FG000|Overall Study|Administrative|0|||
160831567|NCT00160199|580770284|FG001|Overall Study|Administrative|1|||
160831568|NCT00160199|580770283|FG000|Overall Study|Protocol Violation|8|||
160831569|NCT00160199|580770284|FG001|Overall Study|Protocol Violation|8|||
160831570|NCT02124772|580770285|FG000|Overall Study|Lack of Efficacy|2|||
160831571|NCT02124772|580770286|FG001|Overall Study|Lack of Efficacy|0|||
160831572|NCT02124772|580770287|FG002|Overall Study|Lack of Efficacy|0|||
160831573|NCT02124772|580770288|FG003|Overall Study|Lack of Efficacy|1|||
160831574|NCT02124772|580770289|FG004|Overall Study|Lack of Efficacy|2|||
160831575|NCT02124772|580770290|FG005|Overall Study|Lack of Efficacy|3|||
160831576|NCT02124772|580770291|FG006|Overall Study|Lack of Efficacy|0|||
160831577|NCT02124772|580770292|FG007|Overall Study|Lack of Efficacy|2|||
160831578|NCT02124772|580770293|FG008|Overall Study|Lack of Efficacy|0|||
160831579|NCT02124772|580770294|FG009|Overall Study|Lack of Efficacy|1|||
160831580|NCT02124772|580770295|FG010|Overall Study|Lack of Efficacy|0|||
160831581|NCT02124772|580770296|FG011|Overall Study|Lack of Efficacy|0|||
160831582|NCT02124772|580770297|FG012|Overall Study|Lack of Efficacy|1|||
160831583|NCT02124772|580770285|FG000|Overall Study|Adverse Event|1|||
160831584|NCT02124772|580770286|FG001|Overall Study|Adverse Event|4|||
160831585|NCT02124772|580770287|FG002|Overall Study|Adverse Event|1|||
160831586|NCT02124772|580770288|FG003|Overall Study|Adverse Event|5|||
160831587|NCT02124772|580770289|FG004|Overall Study|Adverse Event|2|||
160831588|NCT02124772|580770290|FG005|Overall Study|Adverse Event|1|||
160831589|NCT02124772|580770291|FG006|Overall Study|Adverse Event|1|||
160831590|NCT02124772|580770292|FG007|Overall Study|Adverse Event|5|||
160831591|NCT02124772|580770293|FG008|Overall Study|Adverse Event|0|||
160831592|NCT02124772|580770294|FG009|Overall Study|Adverse Event|3|||
160831593|NCT02124772|580770295|FG010|Overall Study|Adverse Event|1|||
160831594|NCT02124772|580770296|FG011|Overall Study|Adverse Event|3|||
160831595|NCT02124772|580770297|FG012|Overall Study|Adverse Event|1|||
160831596|NCT02124772|580770285|FG000|Overall Study|Withdrawal consent|0|||
160831597|NCT02124772|580770286|FG001|Overall Study|Withdrawal consent|1|||
160831598|NCT02124772|580770287|FG002|Overall Study|Withdrawal consent|1|||
160831599|NCT02124772|580770288|FG003|Overall Study|Withdrawal consent|1|||
160831600|NCT02124772|580770289|FG004|Overall Study|Withdrawal consent|0|||
160831601|NCT02124772|580770290|FG005|Overall Study|Withdrawal consent|1|||
160831602|NCT02124772|580770291|FG006|Overall Study|Withdrawal consent|1|||
160831603|NCT02124772|580770292|FG007|Overall Study|Withdrawal consent|0|||
160831604|NCT02124772|580770293|FG008|Overall Study|Withdrawal consent|0|||
160831605|NCT02124772|580770294|FG009|Overall Study|Withdrawal consent|1|||
160831606|NCT02124772|580770295|FG010|Overall Study|Withdrawal consent|0|||
160831607|NCT02124772|580770296|FG011|Overall Study|Withdrawal consent|1|||
160831608|NCT02124772|580770297|FG012|Overall Study|Withdrawal consent|0|||
160831609|NCT02124772|580770285|FG000|Overall Study|Investigator discretion|0|||
160831610|NCT02124772|580770286|FG001|Overall Study|Investigator discretion|2|||
160831611|NCT02124772|580770287|FG002|Overall Study|Investigator discretion|2|||
160831612|NCT02124772|580770288|FG003|Overall Study|Investigator discretion|1|||
160831613|NCT02124772|580770289|FG004|Overall Study|Investigator discretion|1|||
160831614|NCT02124772|580770290|FG005|Overall Study|Investigator discretion|0|||
160831615|NCT02124772|580770291|FG006|Overall Study|Investigator discretion|1|||
160831616|NCT02124772|580770292|FG007|Overall Study|Investigator discretion|0|||
160831617|NCT02124772|580770293|FG008|Overall Study|Investigator discretion|0|||
160831618|NCT02124772|580770294|FG009|Overall Study|Investigator discretion|1|||
160831619|NCT02124772|580770295|FG010|Overall Study|Investigator discretion|0|||
160831620|NCT02124772|580770296|FG011|Overall Study|Investigator discretion|1|||
160831621|NCT02124772|580770297|FG012|Overall Study|Investigator discretion|0|||
160831622|NCT02124772|580770285|FG000|Overall Study|Progressive disease|0|||
160831623|NCT02124772|580770286|FG001|Overall Study|Progressive disease|0|||
160831624|NCT02124772|580770287|FG002|Overall Study|Progressive disease|0|||
160831625|NCT02124772|580770288|FG003|Overall Study|Progressive disease|0|||
160831626|NCT02124772|580770289|FG004|Overall Study|Progressive disease|0|||
160831627|NCT02124772|580770290|FG005|Overall Study|Progressive disease|0|||
160831628|NCT02124772|580770291|FG006|Overall Study|Progressive disease|1|||
160831629|NCT02124772|580770292|FG007|Overall Study|Progressive disease|1|||
160831630|NCT02124772|580770293|FG008|Overall Study|Progressive disease|0|||
160831631|NCT02124772|580770294|FG009|Overall Study|Progressive disease|0|||
160831632|NCT02124772|580770295|FG010|Overall Study|Progressive disease|0|||
160831633|NCT02124772|580770296|FG011|Overall Study|Progressive disease|0|||
160831634|NCT02124772|580770297|FG012|Overall Study|Progressive disease|0|||
160831635|NCT02124772|580770285|FG000|Overall Study|Other|0|||
160831636|NCT02124772|580770286|FG001|Overall Study|Other|7|||
160831637|NCT02124772|580770287|FG002|Overall Study|Other|2|||
160831638|NCT02124772|580770288|FG003|Overall Study|Other|5|||
160831639|NCT02124772|580770289|FG004|Overall Study|Other|4|||
160831640|NCT02124772|580770290|FG005|Overall Study|Other|3|||
160831641|NCT02124772|580770291|FG006|Overall Study|Other|4|||
160831642|NCT02124772|580770292|FG007|Overall Study|Other|1|||
160831643|NCT02124772|580770293|FG008|Overall Study|Other|1|||
160831644|NCT02124772|580770294|FG009|Overall Study|Other|1|||
160831645|NCT02124772|580770295|FG010|Overall Study|Other|1|||
160831646|NCT02124772|580770296|FG011|Overall Study|Other|1|||
160831647|NCT02124772|580770297|FG012|Overall Study|Other|0|||
160831648|NCT01827332|580770298|FG000|Overall Study|Lost to Follow-up|2|||
160831649|NCT01827332|580770299|FG001|Overall Study|Lost to Follow-up|1|||
160831650|NCT02725593|580770300|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
160831651|NCT02725593|580770301|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
160831652|NCT02725593|580770300|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
160831653|NCT02725593|580770301|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
160831654|NCT02725593|580770300|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
160831655|NCT02725593|580770301|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
160831656|NCT02725593|580770300|FG000|Long Term Extension|Withdrawal by Subject|1|||
160831657|NCT02725593|580770301|FG001|Long Term Extension|Withdrawal by Subject|3|||
160831658|NCT01440881|580770306|FG000|Overall Study|Death|0|||
160831659|NCT01440881|580770307|FG001|Overall Study|Death|1|||
160831660|NCT02644356|580770309|FG000|Overall Study|Withdrawal by Subject|2|||
160831661|NCT02290938|580770310|FG000|Overall Study|Lost to Follow-up|14|||
160831662|NCT02290938|580770311|FG001|Overall Study|Lost to Follow-up|43|||
160831663|NCT03779503|580771930|FG000|First Intervention|Adverse Event|0|||
160831664|NCT03779503|580771931|FG001|First Intervention|Adverse Event|1|||
160831665|NCT03779503|580771930|FG000|First Intervention|Withdrawal by Subject|1|||
160831666|NCT03779503|580771931|FG001|First Intervention|Withdrawal by Subject|0|||
160831667|NCT02616393|580771932|FG000|Overall Study|Death|5|||
160831668|NCT02616393|580771933|FG001|Overall Study|Death|12|||
160831669|NCT02616393|580771934|FG002|Overall Study|Death|1|||
160831670|NCT02616393|580771932|FG000|Overall Study|Termination by Sponsor|4|||
160991203|NCT00938340|581355534|FG000|Overall Study|Protocol Violation|1|||
161247069|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
161247070|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Other|0|||
161247071|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Other|0|||
161247072|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Other|0|||
161247073|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Other|0|||
161247074|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Other|3|||
161247075|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Other|3|||
160831671|NCT02616393|580771933|FG001|Overall Study|Termination by Sponsor|5|||
160831672|NCT02616393|580771934|FG002|Overall Study|Termination by Sponsor|2|||
160831673|NCT02616393|580771932|FG000|Overall Study|Other|3|||
161334897|NCT03167242|582615857|FG010|Overall Study|Lost to Follow-up|1|||
160831674|NCT02616393|580771933|FG001|Overall Study|Other|0|||
160831675|NCT02616393|580771934|FG002|Overall Study|Other|0|||
160831676|NCT02616393|580771932|FG000|Overall Study|Withdrawal by Subject|1|||
160831677|NCT02616393|580771933|FG001|Overall Study|Withdrawal by Subject|1|||
160831678|NCT02616393|580771934|FG002|Overall Study|Withdrawal by Subject|0|||
160831679|NCT02616393|580771932|FG000|Overall Study|Lost to Follow-up|0|||
160831680|NCT02616393|580771933|FG001|Overall Study|Lost to Follow-up|2|||
160831681|NCT02616393|580771934|FG002|Overall Study|Lost to Follow-up|0|||
160831682|NCT02642965|580771935|FG000|Overall Study|Lack of Efficacy|4|||
160831683|NCT02642965|580771935|FG000|Overall Study|Physician Decision|9|||
160831684|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
160831685|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
160831686|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
160831687|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
160831688|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
160831689|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
160831690|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
160831691|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
160831692|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
160831693|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
160831694|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
160831695|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
160831696|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
160831697|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
160831698|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
160831699|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
160831700|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
160831701|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
160831702|NCT01302054|580771942|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
160831703|NCT01302054|580771943|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
160831704|NCT01302054|580771944|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
160831705|NCT01302054|580771942|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
160831706|NCT01302054|580771943|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
160831707|NCT01302054|580771944|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
160831708|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
160831709|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
160831710|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
160831711|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
160831712|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
160831713|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
160831714|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
160831715|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
160831716|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
160831717|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
160831718|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
160831719|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
160831720|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
160831721|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
160831722|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
160831723|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
160831724|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
160831725|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
160831726|NCT01302054|580771942|FG000|Double-Blind Treatment Phase|Other|0|||
160831727|NCT01302054|580771943|FG001|Double-Blind Treatment Phase|Other|4|||
160831728|NCT01302054|580771944|FG002|Double-Blind Treatment Phase|Other|9|||
160831729|NCT02713867|580771945|FG000|Randomization|Other Reason|2|||
160831730|NCT02713867|580771946|FG001|Randomization|Other Reason|1|||
160831731|NCT02713867|580771945|FG000|Randomization|Participant Withdrew consent|0|||
160831732|NCT02713867|580771946|FG001|Randomization|Participant Withdrew consent|2|||
160831733|NCT02713867|580771945|FG000|Treatment Period|Other Reasons|22|||
160831734|NCT02713867|580771946|FG001|Treatment Period|Other Reasons|28|||
160831735|NCT02713867|580771945|FG000|Treatment Period|Administrative reason by sponsor|21|||
160831736|NCT02713867|580771946|FG001|Treatment Period|Administrative reason by sponsor|16|||
160831737|NCT02713867|580771945|FG000|Treatment Period|No longer meets study criteria|2|||
160831738|NCT02713867|580771946|FG001|Treatment Period|No longer meets study criteria|1|||
160831739|NCT02713867|580771945|FG000|Treatment Period|Poor/Non Compliance|1|||
160831740|NCT02713867|580771946|FG001|Treatment Period|Poor/Non Compliance|0|||
160831741|NCT02713867|580771945|FG000|Treatment Period|Maximum Clinical Benefit|5|||
160831742|NCT02713867|580771946|FG001|Treatment Period|Maximum Clinical Benefit|6|||
160831743|NCT02713867|580771945|FG000|Treatment Period|Withdrew consent|3|||
160831744|NCT02713867|580771946|FG001|Treatment Period|Withdrew consent|6|||
160831745|NCT02713867|580771945|FG000|Treatment Period|Requested to Discontinue|8|||
160831746|NCT02713867|580771946|FG001|Treatment Period|Requested to Discontinue|8|||
160831747|NCT02713867|580771945|FG000|Treatment Period|AE unrelated to Study Drug|11|||
160831748|NCT02713867|580771946|FG001|Treatment Period|AE unrelated to Study Drug|10|||
160831749|NCT02713867|580771945|FG000|Treatment Period|Death|7|||
160831750|NCT02713867|580771946|FG001|Treatment Period|Death|3|||
160831751|NCT02713867|580771945|FG000|Treatment Period|Study Drug Toxicity|16|||
160831752|NCT02713867|580771946|FG001|Treatment Period|Study Drug Toxicity|19|||
160991204|NCT00938340|581355534|FG000|Overall Study|Adverse Event|1|||
160991205|NCT05174065|581355536|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161247076|NCT03395197|582283349|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
161247077|NCT03395197|582283350|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
161247078|NCT03395197|582283351|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
161247079|NCT03395197|582283352|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
161247080|NCT03395197|582283353|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
160831753|NCT02713867|580771945|FG000|Treatment Period|Disease Progression|82|||
160831754|NCT02713867|580771946|FG001|Treatment Period|Disease Progression|83|||
160831755|NCT00857948|580771947|FG000|Overall Study|Withdrawal by Subject|2|||
160831756|NCT00857948|580771948|FG001|Overall Study|Withdrawal by Subject|0|||
160831757|NCT00857948|580771949|FG002|Overall Study|Withdrawal by Subject|0|||
160831758|NCT00857948|580771950|FG003|Overall Study|Withdrawal by Subject|0|||
160831759|NCT00857948|580771947|FG000|Overall Study|Protocol Violation|1|||
160831760|NCT00857948|580771948|FG001|Overall Study|Protocol Violation|0|||
160831761|NCT00857948|580771949|FG002|Overall Study|Protocol Violation|1|||
160831762|NCT00857948|580771950|FG003|Overall Study|Protocol Violation|0|||
160831763|NCT00493636|580771954|FG000|Overall Study|Withdrawal by Subject|1|||
160831764|NCT00493636|580771955|FG001|Overall Study|Withdrawal by Subject|0|||
160831765|NCT00493636|580771954|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
160831766|NCT00493636|580771955|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
160831767|NCT00493636|580771954|FG000|Overall Study|Mis-randomization|1|||
160831768|NCT00493636|580771955|FG001|Overall Study|Mis-randomization|1|||
160831769|NCT02715726|580771960|FG000|Overall Study|Adverse Event|2|||
160831770|NCT02715726|580771961|FG001|Overall Study|Adverse Event|6|||
160831771|NCT02715726|580771960|FG000|Overall Study|Protocol Violation|1|||
160831772|NCT02715726|580771961|FG001|Overall Study|Protocol Violation|0|||
160831773|NCT02715726|580771960|FG000|Overall Study|Death|2|||
160831774|NCT02715726|580771961|FG001|Overall Study|Death|1|||
160831775|NCT02715726|580771960|FG000|Overall Study|Participant moved|1|||
160831776|NCT02715726|580771961|FG001|Overall Study|Participant moved|3|||
160831777|NCT02715726|580771960|FG000|Overall Study|Other than specified above|11|||
160831778|NCT02715726|580771961|FG001|Overall Study|Other than specified above|15|||
160831779|NCT02715726|580771960|FG000|Overall Study|Randomized but not treated|1|||
160831780|NCT02715726|580771961|FG001|Overall Study|Randomized but not treated|2|||
160831781|NCT02445573|580771962|FG000|Overall Study|Withdrawal by Subject|1|||
160831782|NCT02445573|580771963|FG001|Overall Study|Withdrawal by Subject|1|||
160831783|NCT02445573|580771962|FG000|Overall Study|Lost to Follow-up|0|||
160831784|NCT02445573|580771963|FG001|Overall Study|Lost to Follow-up|1|||
160831785|NCT04047420|580771964|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
160831786|NCT04047420|580771964|FG000|Washout Period|Refused Participation|2|||
160831787|NCT03757130|580771965|FG000|Overall Study|Lost to Follow-up|0|||
160831788|NCT03757130|580771966|FG001|Overall Study|Lost to Follow-up|0|||
160831789|NCT03757130|580771967|FG002|Overall Study|Lost to Follow-up|0|||
160831790|NCT03757130|580771968|FG003|Overall Study|Lost to Follow-up|1|||
160831791|NCT03757130|580771969|FG004|Overall Study|Lost to Follow-up|0|||
160831792|NCT03757130|580771970|FG005|Overall Study|Lost to Follow-up|0|||
160831793|NCT03757130|580771971|FG006|Overall Study|Lost to Follow-up|0|||
160831794|NCT03757130|580771972|FG007|Overall Study|Lost to Follow-up|1|||
160831795|NCT03757130|580771965|FG000|Overall Study|Withdrawal by Subject|0|||
160831796|NCT03757130|580771966|FG001|Overall Study|Withdrawal by Subject|0|||
160831797|NCT03757130|580771967|FG002|Overall Study|Withdrawal by Subject|0|||
160831798|NCT03757130|580771968|FG003|Overall Study|Withdrawal by Subject|0|||
160831799|NCT03757130|580771969|FG004|Overall Study|Withdrawal by Subject|0|||
160831800|NCT03757130|580771970|FG005|Overall Study|Withdrawal by Subject|0|||
160831801|NCT03757130|580771971|FG006|Overall Study|Withdrawal by Subject|1|||
160831802|NCT03757130|580771972|FG007|Overall Study|Withdrawal by Subject|0|||
160831803|NCT01639755|580771973|FG000|Overall Study|Study Ongoing|15|||
160831804|NCT01639755|580771973|FG000|Overall Study|Patient had device explantation|4|||
160831805|NCT00966719|580771974|FG000|Overall Study|Lost to Follow-up|6|||
160831806|NCT00966719|580771975|FG001|Overall Study|Lost to Follow-up|11|||
160831807|NCT01439126|580771976|FG000|Overall Study|Adverse Event|2|||
160831808|NCT01439126|580771977|FG001|Overall Study|Adverse Event|0|||
160831809|NCT01439126|580771976|FG000|Overall Study|Withdrawal by Subject|5|||
160831810|NCT01439126|580771977|FG001|Overall Study|Withdrawal by Subject|21|||
160831811|NCT01439126|580771976|FG000|Overall Study|Protocol Violation|6|||
160831812|NCT01439126|580771977|FG001|Overall Study|Protocol Violation|4|||
160831813|NCT01439126|580771976|FG000|Overall Study|Lost to Follow-up|6|||
160831814|NCT01439126|580771977|FG001|Overall Study|Lost to Follow-up|3|||
160903312|NCT00190671|581039088|FG001|Overall Study|Clinical Relapse|1|||
160903313|NCT00190671|581039087|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
160903314|NCT00190671|581039088|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
160903315|NCT00190671|581039087|FG000|Overall Study|Death from Other Causes|0|||
160903316|NCT00190671|581039088|FG001|Overall Study|Death from Other Causes|2|||
160903317|NCT00190671|581039087|FG000|Overall Study|Protocol Violation|0|||
160903318|NCT00190671|581039088|FG001|Overall Study|Protocol Violation|1|||
161247081|NCT03395197|582283354|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
160831815|NCT01439126|580771976|FG000|Overall Study|Other-Use of prohibited treatment|0|||
160831816|NCT01439126|580771977|FG001|Overall Study|Other-Use of prohibited treatment|2|||
160831817|NCT01439126|580771976|FG000|Overall Study|Other-Miscellaneous|12|||
160831818|NCT01439126|580771977|FG001|Overall Study|Other-Miscellaneous|12|||
160831819|NCT03242018|580771979|FG000|Overall Study|Adverse Event|7|||
160831820|NCT03242018|580771980|FG001|Overall Study|Adverse Event|7|||
160831821|NCT03242018|580771981|FG002|Overall Study|Adverse Event|6|||
160831822|NCT03242018|580771979|FG000|Overall Study|Lost to Follow-up|2|||
160831823|NCT03242018|580771980|FG001|Overall Study|Lost to Follow-up|2|||
160831824|NCT03242018|580771981|FG002|Overall Study|Lost to Follow-up|2|||
160831825|NCT03242018|580771979|FG000|Overall Study|At the Participant's Own Request|5|||
160831826|NCT03242018|580771980|FG001|Overall Study|At the Participant's Own Request|1|||
160831827|NCT03242018|580771981|FG002|Overall Study|At the Participant's Own Request|4|||
160831828|NCT03242018|580771979|FG000|Overall Study|Reason Not Specified|3|||
160831829|NCT03242018|580771980|FG001|Overall Study|Reason Not Specified|4|||
160831830|NCT03242018|580771981|FG002|Overall Study|Reason Not Specified|1|||
160831831|NCT03242018|580771979|FG000|Overall Study|Study Terminated by Sponsor|1|||
160831832|NCT03242018|580771980|FG001|Overall Study|Study Terminated by Sponsor|0|||
160831833|NCT03242018|580771981|FG002|Overall Study|Study Terminated by Sponsor|1|||
160831834|NCT00477269|580771985|FG000|Core Study|Adverse Event|6|||
160831835|NCT00477269|580771986|FG001|Core Study|Adverse Event|4|||
160831836|NCT00477269|580771987|FG002|Core Study|Adverse Event|0|||
160831837|NCT00477269|580771985|FG000|Core Study|Death|3|||
160831838|NCT00477269|580771986|FG001|Core Study|Death|3|||
160831839|NCT00477269|580771987|FG002|Core Study|Death|0|||
160831840|NCT00477269|580771985|FG000|Core Study|Withdrawn Consent|0|||
160831841|NCT00477269|580771986|FG001|Core Study|Withdrawn Consent|1|||
160831842|NCT00477269|580771987|FG002|Core Study|Withdrawn Consent|0|||
160831843|NCT00477269|580771985|FG000|Open Label Extension|Adverse Event|0|||
160831844|NCT00477269|580771986|FG001|Open Label Extension|Adverse Event|0|||
160831845|NCT00477269|580771987|FG002|Open Label Extension|Adverse Event|4|||
160831846|NCT00477269|580771985|FG000|Open Label Extension|Abnormal laboratory values|0|||
160831847|NCT00477269|580771986|FG001|Open Label Extension|Abnormal laboratory values|0|||
160831848|NCT00477269|580771987|FG002|Open Label Extension|Abnormal laboratory values|1|||
160831849|NCT00477269|580771985|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
160831850|NCT00477269|580771986|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
160831851|NCT00477269|580771987|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
160831852|NCT00477269|580771985|FG000|Open Label Extension|Adminiatrative problems|0|||
160831853|NCT00477269|580771986|FG001|Open Label Extension|Adminiatrative problems|0|||
160831854|NCT00477269|580771987|FG002|Open Label Extension|Adminiatrative problems|2|||
160831855|NCT00477269|580771985|FG000|Open Label Extension|Death|0|||
160831856|NCT00477269|580771986|FG001|Open Label Extension|Death|0|||
160831857|NCT00477269|580771987|FG002|Open Label Extension|Death|4|||
160831858|NCT03089944|580771988|FG000|Overall Study|Lost to Follow-up|8|||
160831859|NCT03089944|580771988|FG000|Overall Study|Withdrew Consent|2|||
160831860|NCT03089944|580771988|FG000|Overall Study|Adverse Event|1|||
160831861|NCT03089944|580771988|FG000|Overall Study|Other|1|||
160831862|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
160831863|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
160831864|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
160831865|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
160831866|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
160831867|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
160831868|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
160831869|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
160831870|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
160831871|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
160831872|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
160831873|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
160831874|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
160831875|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
160831876|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
160831877|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
160831878|NCT03689244|580771989|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
160831879|NCT03689244|580771990|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
160991206|NCT05174065|581355537|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
160991207|NCT05174065|581355538|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
160831880|NCT03689244|580771991|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
160831881|NCT03689244|580771992|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
160831882|NCT03689244|580771989|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
160831883|NCT03689244|580771990|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
160831884|NCT03689244|580771991|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
160831885|NCT03689244|580771992|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
160831886|NCT03689244|580771989|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
160831887|NCT03689244|580771990|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
160831888|NCT03689244|580771991|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
160831889|NCT03689244|580771992|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
160831890|NCT03689244|580771989|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
160831891|NCT03689244|580771990|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
160831892|NCT03689244|580771991|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
160831893|NCT03689244|580771992|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
160831894|NCT00806442|580772017|FG000|Overall Study|Lost to Follow-up|3|||
160831895|NCT00806442|580772018|FG001|Overall Study|Lost to Follow-up|2|||
160831896|NCT00806442|580772017|FG000|Overall Study|Withdrawal by Subject|1|||
160831897|NCT00806442|580772018|FG001|Overall Study|Withdrawal by Subject|5|||
160831898|NCT00654004|580772022|FG000|Overall Study|Lost to Follow-up|1|||
160831899|NCT00654004|580772023|FG001|Overall Study|Lost to Follow-up|0|||
160831900|NCT00444067|580772029|FG000|Overall Study|Lost to Follow-up|0|||
160831901|NCT00444067|580772030|FG001|Overall Study|Lost to Follow-up|1|||
160831902|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831903|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
160831904|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831905|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831906|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831907|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831908|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831909|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831910|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831911|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831912|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831913|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831914|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831915|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831916|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831917|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831918|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831919|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831920|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
160831921|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831922|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831923|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831924|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
160831925|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831926|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
160831927|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831928|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
160831929|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831930|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831931|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831932|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831933|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831934|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831935|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831936|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831937|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831938|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831939|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
160831940|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831941|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831942|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
160831943|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831944|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
160831945|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831946|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
160831947|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
160903319|NCT00190671|581039087|FG000|Overall Study|Withdrawal by Subject|0|||
160903320|NCT00190671|581039088|FG001|Overall Study|Withdrawal by Subject|2|||
161334898|NCT03167242|582615858|FG011|Overall Study|Lost to Follow-up|1|||
160831948|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831949|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831950|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831951|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831952|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831953|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831954|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831955|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831956|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831957|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831958|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
160831959|NCT02528357|580772034|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831960|NCT02528357|580772035|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831961|NCT02528357|580772036|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831962|NCT02528357|580772037|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831963|NCT02528357|580772038|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160831964|NCT02528357|580772039|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831965|NCT02528357|580772040|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831966|NCT02528357|580772041|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831967|NCT02528357|580772042|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831968|NCT02528357|580772043|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831969|NCT02528357|580772044|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831970|NCT02528357|580772045|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831971|NCT02528357|580772046|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831972|NCT02528357|580772047|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831973|NCT02528357|580772048|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831974|NCT02528357|580772049|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831975|NCT02528357|580772050|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831976|NCT02528357|580772051|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831977|NCT02528357|580772052|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160831978|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831979|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831980|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831981|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831982|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831983|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831984|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831985|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831986|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831987|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831988|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831989|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831990|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831991|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
160831992|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
160831993|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831994|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831995|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831996|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
160831997|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
161136532|NCT00996840|581881655|FG001|Overall Study|Adverse Event|1|||
161136533|NCT00996840|581881656|FG002|Overall Study|Adverse Event|0|||
161136534|NCT00996840|581881657|FG003|Overall Study|Adverse Event|0|||
161136535|NCT00996840|581881658|FG004|Overall Study|Adverse Event|0|||
161136536|NCT00996840|581881654|FG000|Overall Study|Physician Decision|0|||
161136537|NCT00996840|581881655|FG001|Overall Study|Physician Decision|0|||
161334899|NCT03167242|582615847|FG000|Overall Study|Reason not provided|0|||
161334900|NCT03167242|582615848|FG001|Overall Study|Reason not provided|0|||
161334901|NCT03167242|582615849|FG002|Overall Study|Reason not provided|0|||
160831998|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160831999|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832000|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832001|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832002|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832003|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832004|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832005|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832006|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832007|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832008|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832009|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832010|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
160832011|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832012|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832013|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832014|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832015|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
160832016|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832017|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832018|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832019|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832020|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832021|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832022|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832023|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832024|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832025|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832026|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
160832027|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832028|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
160832029|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
160832030|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
160832031|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832032|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832033|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832034|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
160832035|NCT02528357|580772034|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832036|NCT02528357|580772035|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832037|NCT02528357|580772036|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832038|NCT02528357|580772037|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832039|NCT02528357|580772038|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832040|NCT02528357|580772039|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832041|NCT02528357|580772040|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832042|NCT02528357|580772041|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832043|NCT02528357|580772042|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832044|NCT02528357|580772043|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832045|NCT02528357|580772044|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832046|NCT02528357|580772045|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
160832047|NCT02528357|580772046|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
160832048|NCT02528357|580772047|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832049|NCT02528357|580772048|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832050|NCT02528357|580772049|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832051|NCT02528357|580772050|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832052|NCT02528357|580772051|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832053|NCT02528357|580772052|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832054|NCT02528357|580772034|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832055|NCT02528357|580772035|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832056|NCT02528357|580772036|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832057|NCT02528357|580772037|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832058|NCT02528357|580772038|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832059|NCT02528357|580772039|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832060|NCT02528357|580772040|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832061|NCT02528357|580772041|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832062|NCT02528357|580772042|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832063|NCT02528357|580772043|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832064|NCT02528357|580772044|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832065|NCT02528357|580772045|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832066|NCT02528357|580772046|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832067|NCT02528357|580772047|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832068|NCT02528357|580772048|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832069|NCT02528357|580772049|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832070|NCT02528357|580772050|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
160832071|NCT02528357|580772051|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832072|NCT02528357|580772052|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
160832073|NCT02528357|580772034|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832074|NCT02528357|580772035|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832075|NCT02528357|580772036|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832076|NCT02528357|580772037|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832077|NCT02528357|580772038|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832078|NCT02528357|580772039|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832079|NCT02528357|580772040|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832080|NCT02528357|580772041|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832081|NCT02528357|580772042|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832082|NCT02528357|580772043|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832083|NCT02528357|580772044|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832084|NCT02528357|580772045|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832085|NCT02528357|580772046|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832086|NCT02528357|580772047|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832087|NCT02528357|580772048|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832088|NCT02528357|580772049|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
160832089|NCT02528357|580772050|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
160832090|NCT02528357|580772051|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
160832091|NCT02528357|580772052|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
160832092|NCT01455220|580772056|FG000|Overall Study|screen fail|30|||
160832093|NCT00267150|580772057|FG000|Overall Study|Adverse Event|1|||
160832094|NCT00969436|580772062|FG000|Overall Study|Protocol Violation|1|||
160832095|NCT00969436|580772063|FG001|Overall Study|Protocol Violation|3|||
160832096|NCT00969436|580772064|FG002|Overall Study|Protocol Violation|0|||
160832097|NCT00969436|580772062|FG000|Overall Study|Migrated/moved from study area|12|||
160832098|NCT00969436|580772063|FG001|Overall Study|Migrated/moved from study area|10|||
160832099|NCT00969436|580772064|FG002|Overall Study|Migrated/moved from study area|2|||
160832100|NCT00969436|580772062|FG000|Overall Study|Father - serious health problem|0|||
160832101|NCT00969436|580772063|FG001|Overall Study|Father - serious health problem|0|||
160832102|NCT00969436|580772064|FG002|Overall Study|Father - serious health problem|1|||
160832103|NCT00969436|580772062|FG000|Overall Study|Parents personal problem|0|||
160832104|NCT00969436|580772063|FG001|Overall Study|Parents personal problem|0|||
160832105|NCT00969436|580772064|FG002|Overall Study|Parents personal problem|1|||
160832106|NCT00969436|580772062|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
160832107|NCT00969436|580772063|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
160832108|NCT00969436|580772064|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
160832109|NCT00969436|580772062|FG000|Overall Study|Withdrawal by Subject|3|||
160832110|NCT00969436|580772063|FG001|Overall Study|Withdrawal by Subject|0|||
160832111|NCT00969436|580772064|FG002|Overall Study|Withdrawal by Subject|2|||
160903321|NCT00967668|581040456|FG000|Overall Study|Withdrawal by Subject|13|||
160903322|NCT00967668|581040457|FG001|Overall Study|Withdrawal by Subject|8|||
160903323|NCT00967668|581040458|FG002|Overall Study|Withdrawal by Subject|8|||
160903324|NCT00967668|581040456|FG000|Overall Study|Death|0|||
160832112|NCT00969436|580772062|FG000|Overall Study|Lost to Follow-up|8|||
160832113|NCT00969436|580772063|FG001|Overall Study|Lost to Follow-up|8|||
160832114|NCT00969436|580772064|FG002|Overall Study|Lost to Follow-up|5|||
160832115|NCT00351273|580772065|FG000|Overall Study|Lost to Follow-up|1|||
160832116|NCT00351273|580772066|FG001|Overall Study|Lost to Follow-up|2|||
160832117|NCT00351273|580772067|FG002|Overall Study|Lost to Follow-up|5|||
160832118|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
160832119|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
160832120|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
160832121|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
160832122|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
160832123|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
160832124|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
160832125|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
160832126|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
160832127|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
160832128|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
160832129|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
160832130|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
160832131|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
160832132|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
160832133|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
160832134|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
160832135|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
160832136|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
160832137|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
160832138|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
160832139|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
160832140|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
160832141|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
160832142|NCT01672866|580772068|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
160832143|NCT01672866|580772069|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
160832144|NCT01672866|580772070|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
160832145|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
160832146|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
160832147|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
160832148|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
160832149|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
160832150|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
160832151|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
160832152|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
160832153|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
160832154|NCT01672866|580772068|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
160832155|NCT01672866|580772069|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
160832156|NCT01672866|580772070|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
160832157|NCT02544373|580772073|FG000|Overall Study|Lost to Follow-up|5|||
160832158|NCT02544373|580772074|FG001|Overall Study|Lost to Follow-up|3|||
160832159|NCT02544373|580772073|FG000|Overall Study|Withdrawal by Subject|8|||
160832160|NCT02544373|580772074|FG001|Overall Study|Withdrawal by Subject|2|||
160832161|NCT04208087|580772075|FG000|Overall Study|Adverse Event|1|||
160832162|NCT04208087|580772076|FG001|Overall Study|Adverse Event|0|||
160832163|NCT04208087|580772077|FG002|Overall Study|Adverse Event|0|||
160832164|NCT04208087|580772078|FG003|Overall Study|Adverse Event|0|||
160832165|NCT04208087|580772079|FG004|Overall Study|Adverse Event|0|||
160832166|NCT04208087|580772075|FG000|Overall Study|Withdrawal by Subject|0|||
160832167|NCT04208087|580772076|FG001|Overall Study|Withdrawal by Subject|0|||
160832168|NCT04208087|580772077|FG002|Overall Study|Withdrawal by Subject|1|||
160832169|NCT04208087|580772078|FG003|Overall Study|Withdrawal by Subject|0|||
160832170|NCT04208087|580772079|FG004|Overall Study|Withdrawal by Subject|0|||
160832171|NCT04208087|580772075|FG000|Overall Study|Other|0|||
160832172|NCT04208087|580772076|FG001|Overall Study|Other|0|||
160903325|NCT00967668|581040457|FG001|Overall Study|Death|2|||
160832173|NCT04208087|580772077|FG002|Overall Study|Other|0|||
160903326|NCT00967668|581040458|FG002|Overall Study|Death|4|||
160832174|NCT04208087|580772078|FG003|Overall Study|Other|0|||
160832175|NCT04208087|580772079|FG004|Overall Study|Other|1|||
160903327|NCT00967668|581040456|FG000|Overall Study|Removed due to behavior|1|||
160832176|NCT01198509|580772080|FG000|Overall Study|Withdrawal by Subject|1|||
160832177|NCT01198509|580772081|FG001|Overall Study|Withdrawal by Subject|0|||
160832178|NCT01198509|580772082|FG002|Overall Study|Withdrawal by Subject|0|||
160903328|NCT00967668|581040457|FG001|Overall Study|Removed due to behavior|1|||
160903329|NCT00967668|581040458|FG002|Overall Study|Removed due to behavior|2|||
160832179|NCT01198509|580772083|FG003|Overall Study|Withdrawal by Subject|0|||
160832180|NCT01198509|580772084|FG004|Overall Study|Withdrawal by Subject|0|||
160832181|NCT01198509|580772085|FG005|Overall Study|Withdrawal by Subject|0|||
160832182|NCT02621073|580772086|FG000|Overall Study|Lost to Follow-up|0|||
160832183|NCT02621073|580772087|FG001|Overall Study|Lost to Follow-up|1|||
160832184|NCT02621073|580772086|FG000|Overall Study|Physician Decision|3|||
160832185|NCT02621073|580772087|FG001|Overall Study|Physician Decision|2|||
160832186|NCT01595581|580772088|FG000|Overall Study|Withdrawal by Subject|1|||
160832187|NCT01595581|580772089|FG001|Overall Study|Withdrawal by Subject|0|||
160832188|NCT01969721|580772100|FG000|Overall Study|Adverse Event|3|||
160832189|NCT01969721|580772101|FG001|Overall Study|Adverse Event|8|||
160832190|NCT01969721|580772102|FG002|Overall Study|Adverse Event|3|||
160832191|NCT01969721|580772103|FG003|Overall Study|Adverse Event|2|||
160832192|NCT01969721|580772100|FG000|Overall Study|Lack of Efficacy|0|||
160832193|NCT01969721|580772101|FG001|Overall Study|Lack of Efficacy|0|||
160832194|NCT01969721|580772102|FG002|Overall Study|Lack of Efficacy|1|||
160832195|NCT01969721|580772103|FG003|Overall Study|Lack of Efficacy|0|||
160832196|NCT01969721|580772100|FG000|Overall Study|Non compliant with protocol|1|||
160832197|NCT01969721|580772101|FG001|Overall Study|Non compliant with protocol|1|||
160832198|NCT01969721|580772102|FG002|Overall Study|Non compliant with protocol|0|||
160832199|NCT01969721|580772103|FG003|Overall Study|Non compliant with protocol|2|||
160832200|NCT01969721|580772100|FG000|Overall Study|Other not defined above|0|||
160832201|NCT01969721|580772101|FG001|Overall Study|Other not defined above|2|||
160832202|NCT01969721|580772102|FG002|Overall Study|Other not defined above|0|||
160832203|NCT01969721|580772103|FG003|Overall Study|Other not defined above|0|||
160832204|NCT01969721|580772100|FG000|Overall Study|Discontinued during washout periods.|0|||
160832205|NCT01969721|580772101|FG001|Overall Study|Discontinued during washout periods.|1|||
160832206|NCT01969721|580772102|FG002|Overall Study|Discontinued during washout periods.|1|||
160832207|NCT01969721|580772103|FG003|Overall Study|Discontinued during washout periods.|2|||
160832208|NCT00495755|580772104|FG000|Overall Study|Adverse Event|3|||
160832209|NCT02920957|580772105|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
160832210|NCT02920957|580772106|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
160832211|NCT02920957|580772105|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
160832212|NCT02920957|580772106|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
160832213|NCT02920957|580772105|FG000|First Intervention : 1 Month|Adverse Event|1|||
160832214|NCT02920957|580772106|FG001|First Intervention : 1 Month|Adverse Event|0|||
160832215|NCT02920957|580772105|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
160832216|NCT02920957|580772106|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
160832217|NCT01789606|580772107|FG000|Overall Study|Participant not Purchased the Product|0|||
160832218|NCT01789606|580772108|FG001|Overall Study|Participant not Purchased the Product|20|||
160832219|NCT01789606|580772107|FG000|Overall Study|Withdrawal by Subject|0|||
160832220|NCT01789606|580772108|FG001|Overall Study|Withdrawal by Subject|1|||
160832221|NCT01789606|580772107|FG000|Overall Study|Ineligible|6|||
160832222|NCT01789606|580772108|FG001|Overall Study|Ineligible|2|||
160832223|NCT01789606|580772107|FG000|Overall Study|Administrative Reasons|17|||
160832224|NCT01789606|580772108|FG001|Overall Study|Administrative Reasons|6|||
160832225|NCT01789606|580772107|FG000|Overall Study|No Study Medication Taken|0|||
160832226|NCT01789606|580772108|FG001|Overall Study|No Study Medication Taken|1|||
160832227|NCT01789606|580772107|FG000|Overall Study|Protocol Violation|0|||
160832228|NCT01789606|580772108|FG001|Overall Study|Protocol Violation|55|||
160832229|NCT01789606|580772107|FG000|Overall Study|Adverse Event|0|||
160832230|NCT01789606|580772108|FG001|Overall Study|Adverse Event|3|||
160832231|NCT01789606|580772107|FG000|Overall Study|Lost to Follow-up|0|||
160832232|NCT01789606|580772108|FG001|Overall Study|Lost to Follow-up|14|||
160832233|NCT01789606|580772107|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
160832234|NCT01789606|580772108|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
160832235|NCT03180307|580772109|FG000|Overall Study|Lost to Follow-up|2|||
160832236|NCT03180307|580772110|FG001|Overall Study|Lost to Follow-up|0|||
160832237|NCT03180307|580772109|FG000|Overall Study|Death|1|||
160832238|NCT03180307|580772110|FG001|Overall Study|Death|0|||
160832239|NCT03180307|580772109|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
160832240|NCT03180307|580772110|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
160832241|NCT01563172|580772116|FG000|Overall Study|Adverse Event|5|||
160832242|NCT01563172|580772116|FG000|Overall Study|Lost to Follow-up|2|||
160832243|NCT01563172|580772116|FG000|Overall Study|Other (Protocol deviation)|5|||
160832244|NCT01563172|580772116|FG000|Overall Study|Other (Not specified)|1|||
160832245|NCT00720343|580773805|FG000|Overall Study|Lost to Follow-up|1|||
160832246|NCT00720343|580773806|FG001|Overall Study|Lost to Follow-up|0|||
160832247|NCT00720343|580773805|FG000|Overall Study|Protocol Violation|0|||
160832248|NCT00720343|580773806|FG001|Overall Study|Protocol Violation|2|||
160832249|NCT03459365|580773809|FG000|Overall Study|Withdrawal by Subject|6|||
160832250|NCT03459365|580773809|FG000|Overall Study|Protocol Violation|8|||
160832251|NCT00344500|580773811|FG000|Overall Study|Adverse Event|6|||
160832252|NCT00344500|580773812|FG001|Overall Study|Adverse Event|2|||
160832253|NCT00344500|580773813|FG002|Overall Study|Adverse Event|0|||
160832254|NCT00344500|580773811|FG000|Overall Study|Lost to Follow-up|5|||
160832255|NCT00344500|580773812|FG001|Overall Study|Lost to Follow-up|13|||
160832256|NCT00344500|580773813|FG002|Overall Study|Lost to Follow-up|1|||
160832257|NCT00344500|580773811|FG000|Overall Study|Withdrawal by Subject|7|||
160832258|NCT00344500|580773812|FG001|Overall Study|Withdrawal by Subject|10|||
160832259|NCT00344500|580773813|FG002|Overall Study|Withdrawal by Subject|0|||
160832260|NCT00344500|580773811|FG000|Overall Study|Protocol Violation|4|||
160832261|NCT00344500|580773812|FG001|Overall Study|Protocol Violation|7|||
160832262|NCT00344500|580773813|FG002|Overall Study|Protocol Violation|1|||
160832263|NCT00344500|580773811|FG000|Overall Study|Not Noted|1|||
160832264|NCT00344500|580773812|FG001|Overall Study|Not Noted|3|||
160832265|NCT00344500|580773813|FG002|Overall Study|Not Noted|0|||
160832266|NCT00599755|580773814|FG000|Overall Study|Adverse Event|11|||
160832267|NCT00599755|580773814|FG000|Overall Study|Withdrawal by Subject|2|||
160832268|NCT00599755|580773814|FG000|Overall Study|Progression of Disease|3|||
160832269|NCT00599755|580773814|FG000|Overall Study|Other Reason|2|||
160832270|NCT00599755|580773814|FG000|Overall Study|No data available|1|||
160832271|NCT04037254|580773815|FG000|Overall Study|Protocol Violation|1|||
160832272|NCT04037254|580773816|FG001|Overall Study|Protocol Violation|0|||
160832273|NCT04037254|580773817|FG002|Overall Study|Protocol Violation|0|||
160832274|NCT04037254|580773818|FG003|Overall Study|Protocol Violation|0|||
160832275|NCT04037254|580773819|FG004|Overall Study|Protocol Violation|0|||
160832276|NCT04037254|580773815|FG000|Overall Study|Withdrawal by Subject|0|||
160832277|NCT04037254|580773816|FG001|Overall Study|Withdrawal by Subject|0|||
160832278|NCT04037254|580773817|FG002|Overall Study|Withdrawal by Subject|1|||
160832279|NCT04037254|580773818|FG003|Overall Study|Withdrawal by Subject|0|||
160832280|NCT04037254|580773819|FG004|Overall Study|Withdrawal by Subject|0|||
160832281|NCT04037254|580773815|FG000|Overall Study|Delayed or incomplete treatment|0|||
160832282|NCT04037254|580773816|FG001|Overall Study|Delayed or incomplete treatment|2|||
160832283|NCT04037254|580773817|FG002|Overall Study|Delayed or incomplete treatment|1|||
160832284|NCT04037254|580773818|FG003|Overall Study|Delayed or incomplete treatment|0|||
160832285|NCT04037254|580773819|FG004|Overall Study|Delayed or incomplete treatment|0|||
160832286|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
160832287|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
160832288|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
160832289|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
160832290|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
160832291|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
160832292|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
160832293|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
160832294|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
160832295|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
160832296|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
160832297|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
160832298|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
160832299|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
160832300|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
160832301|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
160832302|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
160832303|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
160832304|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
160832305|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
160832306|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
160832307|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
160832308|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
160832309|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
160903330|NCT00967668|581040456|FG000|Overall Study|Refused Year 2|11|||
160903331|NCT00967668|581040457|FG001|Overall Study|Refused Year 2|6|||
160903332|NCT00967668|581040458|FG002|Overall Study|Refused Year 2|4|||
160903333|NCT00967668|581040456|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
160903334|NCT00967668|581040457|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
160903335|NCT00967668|581040458|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
160903336|NCT00967668|581040456|FG000|Overall Study|Lost to Follow-up|15|||
160832310|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
160832311|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
160832312|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
160832313|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
160832314|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
160832315|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
160832316|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
160903337|NCT00967668|581040457|FG001|Overall Study|Lost to Follow-up|9|||
160903338|NCT00967668|581040458|FG002|Overall Study|Lost to Follow-up|16|||
160903339|NCT00967668|581040456|FG000|Overall Study|Refused 12-mo assessment|3|||
160903340|NCT00967668|581040457|FG001|Overall Study|Refused 12-mo assessment|1|||
160832317|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
160832318|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
160832319|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
160832320|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
160832321|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
160832322|NCT02198794|580773820|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
160832323|NCT02198794|580773821|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
160832324|NCT02198794|580773822|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
160832325|NCT02198794|580773823|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
160832326|NCT02198794|580773820|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
160832327|NCT02198794|580773821|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
160832328|NCT02198794|580773822|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
160832329|NCT02198794|580773823|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
160832330|NCT02198794|580773820|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
160832331|NCT02198794|580773821|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
160832332|NCT02198794|580773822|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
160832333|NCT02198794|580773823|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
160832334|NCT02198794|580773820|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
160832335|NCT02198794|580773821|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
160832336|NCT02198794|580773822|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
160832337|NCT02198794|580773823|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
160832338|NCT02198794|580773820|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
160832339|NCT02198794|580773821|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
160832340|NCT02198794|580773822|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
160832341|NCT02198794|580773823|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
160832342|NCT02198794|580773820|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
160832343|NCT02198794|580773821|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
160832344|NCT02198794|580773822|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
160832345|NCT02198794|580773823|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
160832346|NCT01306656|580773824|FG000|Overall Study|Lost to Follow-up|1|||
160832347|NCT01306656|580773825|FG001|Overall Study|Lost to Follow-up|0|||
160832348|NCT01918332|580773829|FG000|Overall Study|Adverse Event|0|||
160832349|NCT01918332|580773830|FG001|Overall Study|Adverse Event|0|||
160832350|NCT01918332|580773831|FG002|Overall Study|Adverse Event|0|||
160832351|NCT01918332|580773832|FG003|Overall Study|Adverse Event|1|||
160832352|NCT01918332|580773829|FG000|Overall Study|Withdrawal by Subject|2|||
160832353|NCT01918332|580773830|FG001|Overall Study|Withdrawal by Subject|3|||
160832354|NCT01918332|580773831|FG002|Overall Study|Withdrawal by Subject|2|||
160832355|NCT01918332|580773832|FG003|Overall Study|Withdrawal by Subject|3|||
160832356|NCT01918332|580773829|FG000|Overall Study|Protocol Violation|6|||
160832357|NCT01918332|580773830|FG001|Overall Study|Protocol Violation|2|||
160832358|NCT01918332|580773831|FG002|Overall Study|Protocol Violation|6|||
160832359|NCT01918332|580773832|FG003|Overall Study|Protocol Violation|3|||
160832360|NCT01918332|580773829|FG000|Overall Study|lipid result by central lab did not meet|0|||
160832361|NCT01918332|580773830|FG001|Overall Study|lipid result by central lab did not meet|0|||
160832362|NCT01918332|580773831|FG002|Overall Study|lipid result by central lab did not meet|1|||
160832363|NCT01918332|580773832|FG003|Overall Study|lipid result by central lab did not meet|0|||
160832364|NCT01939366|580773835|FG000|Overall Study|Adverse Event|8|||
160832365|NCT01939366|580773836|FG001|Overall Study|Adverse Event|17|||
160832366|NCT01939366|580773837|FG002|Overall Study|Adverse Event|30|||
160832367|NCT01939366|580773838|FG003|Overall Study|Adverse Event|8|||
160832368|NCT01939366|580773839|FG004|Overall Study|Adverse Event|5|||
160832369|NCT01939366|580773835|FG000|Overall Study|Lack of Efficacy|2|||
160832370|NCT01939366|580773836|FG001|Overall Study|Lack of Efficacy|1|||
160832371|NCT01939366|580773837|FG002|Overall Study|Lack of Efficacy|1|||
160832372|NCT01939366|580773838|FG003|Overall Study|Lack of Efficacy|1|||
160832373|NCT01939366|580773839|FG004|Overall Study|Lack of Efficacy|3|||
160832374|NCT01939366|580773835|FG000|Overall Study|Lost to Follow-up|1|||
160832375|NCT01939366|580773836|FG001|Overall Study|Lost to Follow-up|1|||
160903341|NCT00967668|581040458|FG002|Overall Study|Refused 12-mo assessment|9|||
160903342|NCT00967668|581040456|FG000|Overall Study|Pregnancy|1|||
160903343|NCT00967668|581040457|FG001|Overall Study|Pregnancy|0|||
160903344|NCT00967668|581040458|FG002|Overall Study|Pregnancy|0|||
160832376|NCT01939366|580773837|FG002|Overall Study|Lost to Follow-up|0|||
160832377|NCT01939366|580773838|FG003|Overall Study|Lost to Follow-up|0|||
160832378|NCT01939366|580773839|FG004|Overall Study|Lost to Follow-up|0|||
160832379|NCT01939366|580773835|FG000|Overall Study|Withdrawal by Subject|1|||
160832380|NCT01939366|580773836|FG001|Overall Study|Withdrawal by Subject|0|||
160832381|NCT01939366|580773837|FG002|Overall Study|Withdrawal by Subject|2|||
160832382|NCT01939366|580773838|FG003|Overall Study|Withdrawal by Subject|2|||
160903345|NCT00825682|581040459|FG000|Overall Study|personal reasons/ inconvenience|13|||
160903346|NCT00825682|581040460|FG001|Overall Study|personal reasons/ inconvenience|5|||
160903347|NCT02400333|581040463|FG000|Overall Study|Withdrawal by Subject|0|||
161247082|NCT02308241|582283360|FG000|Overall Study|Withdrawal by Subject|3|||
160832383|NCT01939366|580773839|FG004|Overall Study|Withdrawal by Subject|3|||
160832384|NCT01939366|580773835|FG000|Overall Study|Inclusion criteria not met|0|||
160832385|NCT01939366|580773836|FG001|Overall Study|Inclusion criteria not met|1|||
160832386|NCT01939366|580773837|FG002|Overall Study|Inclusion criteria not met|1|||
160832387|NCT01939366|580773838|FG003|Overall Study|Inclusion criteria not met|0|||
160832388|NCT01939366|580773839|FG004|Overall Study|Inclusion criteria not met|1|||
160832389|NCT01939366|580773835|FG000|Overall Study|Other|0|||
160832390|NCT01939366|580773836|FG001|Overall Study|Other|0|||
160832391|NCT01939366|580773837|FG002|Overall Study|Other|2|||
160832392|NCT01939366|580773838|FG003|Overall Study|Other|2|||
160832393|NCT01939366|580773839|FG004|Overall Study|Other|1|||
160832394|NCT01939366|580773835|FG000|Overall Study|Protocol Violation|0|||
160832395|NCT01939366|580773836|FG001|Overall Study|Protocol Violation|0|||
160832396|NCT01939366|580773837|FG002|Overall Study|Protocol Violation|0|||
160832397|NCT01939366|580773838|FG003|Overall Study|Protocol Violation|1|||
160832398|NCT01939366|580773839|FG004|Overall Study|Protocol Violation|0|||
160832399|NCT01939366|580773835|FG000|Overall Study|Sponsor decision|0|||
160832400|NCT01939366|580773836|FG001|Overall Study|Sponsor decision|0|||
160832401|NCT01939366|580773837|FG002|Overall Study|Sponsor decision|0|||
160832402|NCT01939366|580773838|FG003|Overall Study|Sponsor decision|0|||
160832403|NCT01939366|580773839|FG004|Overall Study|Sponsor decision|2|||
160832404|NCT01939366|580773835|FG000|Overall Study|GCP non-compliance at site|2|||
160832405|NCT01939366|580773836|FG001|Overall Study|GCP non-compliance at site|3|||
160832406|NCT01939366|580773837|FG002|Overall Study|GCP non-compliance at site|2|||
160832407|NCT01939366|580773838|FG003|Overall Study|GCP non-compliance at site|3|||
160832408|NCT01939366|580773839|FG004|Overall Study|GCP non-compliance at site|3|||
160832409|NCT02252965|580773840|FG000|Overall Study|Adverse Event|9|||
160832410|NCT02252965|580773841|FG001|Overall Study|Adverse Event|14|||
160832411|NCT02252965|580773840|FG000|Overall Study|Lost to Follow-up|16|||
160832412|NCT02252965|580773841|FG001|Overall Study|Lost to Follow-up|8|||
160832413|NCT02252965|580773840|FG000|Overall Study|Protocol Violation|4|||
160832414|NCT02252965|580773841|FG001|Overall Study|Protocol Violation|5|||
160832415|NCT02252965|580773840|FG000|Overall Study|Lack of Efficacy|0|||
160832416|NCT02252965|580773841|FG001|Overall Study|Lack of Efficacy|2|||
160832417|NCT02252965|580773840|FG000|Overall Study|Withdrawal by Subject|7|||
160832418|NCT02252965|580773841|FG001|Overall Study|Withdrawal by Subject|9|||
160832419|NCT02252965|580773840|FG000|Overall Study|Other|4|||
160832420|NCT02252965|580773841|FG001|Overall Study|Other|5|||
160903348|NCT02400333|581040464|FG001|Overall Study|Withdrawal by Subject|1|||
160903349|NCT02400333|581040465|FG002|Overall Study|Withdrawal by Subject|0|||
160903350|NCT02400333|581040466|FG003|Overall Study|Withdrawal by Subject|1|||
160903351|NCT02400333|581040463|FG000|Overall Study|Protocol Violation|1|||
160903352|NCT02400333|581040464|FG001|Overall Study|Protocol Violation|0|||
160903353|NCT02400333|581040465|FG002|Overall Study|Protocol Violation|2|||
160903354|NCT02400333|581040466|FG003|Overall Study|Protocol Violation|1|||
160903355|NCT02468674|581040467|FG000|Overall Study|Adverse Event|0|||
160903356|NCT02468674|581040468|FG001|Overall Study|Adverse Event|0|||
160903357|NCT02468674|581040469|FG002|Overall Study|Adverse Event|0|||
160903358|NCT02468674|581040470|FG003|Overall Study|Adverse Event|1|||
160903359|NCT02468674|581040471|FG004|Overall Study|Adverse Event|0|||
160903360|NCT02468674|581040472|FG005|Overall Study|Adverse Event|1|||
160903361|NCT02468674|581040473|FG006|Overall Study|Adverse Event|0|||
160903362|NCT02468674|581040474|FG007|Overall Study|Adverse Event|0|||
160903363|NCT02468674|581040475|FG008|Overall Study|Adverse Event|0|||
160903364|NCT02468674|581040467|FG000|Overall Study|Lost to Follow-up|1|||
160903365|NCT02468674|581040468|FG001|Overall Study|Lost to Follow-up|0|||
160903366|NCT02468674|581040469|FG002|Overall Study|Lost to Follow-up|0|||
160903367|NCT02468674|581040470|FG003|Overall Study|Lost to Follow-up|0|||
161247083|NCT03609944|582283361|FG000|Overall Study|Lost to Follow-up|1|||
161247084|NCT03609944|582283362|FG001|Overall Study|Lost to Follow-up|5|||
161247085|NCT03609944|582283361|FG000|Overall Study|Withdrawal by Subject|1|||
161247086|NCT03609944|582283362|FG001|Overall Study|Withdrawal by Subject|1|||
161247087|NCT00659815|582283363|FG000|Overall Study|Study related symptoms and complaints|2|||
161247088|NCT00659815|582283364|FG001|Overall Study|Study related symptoms and complaints|1|||
161247089|NCT00659815|582283363|FG000|Overall Study|Inability to maintain wearing schedule|1|||
161247090|NCT00659815|582283364|FG001|Overall Study|Inability to maintain wearing schedule|2|||
161247091|NCT00659815|582283363|FG000|Overall Study|Withdrawal by Subject|1|||
161247092|NCT00659815|582283364|FG001|Overall Study|Withdrawal by Subject|1|||
161247093|NCT02578641|582283365|FG000|Overall Study|Adverse Event|5|||
161247094|NCT02578641|582283366|FG001|Overall Study|Adverse Event|15|||
161247095|NCT02578641|582283365|FG000|Overall Study|Death|16|||
160832421|NCT00680368|580773846|FG000|Overall Study|not supervised, not eligible|15|||
160832422|NCT02066415|580773847|FG000|Overall Study|Decision by Sponsor|5|||
160903368|NCT02468674|581040471|FG004|Overall Study|Lost to Follow-up|0|||
160903369|NCT02468674|581040472|FG005|Overall Study|Lost to Follow-up|0|||
160903370|NCT02468674|581040473|FG006|Overall Study|Lost to Follow-up|0|||
160903371|NCT02468674|581040474|FG007|Overall Study|Lost to Follow-up|1|||
160991208|NCT05174065|581355536|FG000|Placebo-controlled Period|Other|0|||
160832423|NCT02066415|580773848|FG001|Overall Study|Decision by Sponsor|4|||
160832424|NCT02066415|580773849|FG002|Overall Study|Decision by Sponsor|2|||
160832425|NCT02066415|580773847|FG000|Overall Study|Withdrawal by Subject|9|||
160832426|NCT02066415|580773848|FG001|Overall Study|Withdrawal by Subject|1|||
160832427|NCT02066415|580773849|FG002|Overall Study|Withdrawal by Subject|4|||
160832428|NCT02066415|580773847|FG000|Overall Study|Lost to Follow-up|7|||
160832429|NCT02066415|580773848|FG001|Overall Study|Lost to Follow-up|2|||
160832430|NCT02066415|580773849|FG002|Overall Study|Lost to Follow-up|2|||
160832431|NCT03242252|580773851|FG000|Overall Study|At the Participant's own Request|18|||
160832432|NCT03242252|580773852|FG001|Overall Study|At the Participant's own Request|10|||
160832433|NCT03242252|580773853|FG002|Overall Study|At the Participant's own Request|15|||
160832434|NCT03242252|580773851|FG000|Overall Study|Adverse Event|8|||
160832435|NCT03242252|580773852|FG001|Overall Study|Adverse Event|6|||
160832436|NCT03242252|580773853|FG002|Overall Study|Adverse Event|9|||
160832437|NCT03242252|580773851|FG000|Overall Study|Poor Compliance to Protocol|0|||
160832438|NCT03242252|580773852|FG001|Overall Study|Poor Compliance to Protocol|2|||
160832439|NCT03242252|580773853|FG002|Overall Study|Poor Compliance to Protocol|3|||
160832440|NCT03242252|580773851|FG000|Overall Study|Study Terminated by Sponsor|1|||
160832441|NCT03242252|580773852|FG001|Overall Study|Study Terminated by Sponsor|0|||
160832442|NCT03242252|580773853|FG002|Overall Study|Study Terminated by Sponsor|0|||
160832443|NCT03242252|580773851|FG000|Overall Study|Reason not Specified|4|||
160832444|NCT03242252|580773852|FG001|Overall Study|Reason not Specified|4|||
160832445|NCT03242252|580773853|FG002|Overall Study|Reason not Specified|1|||
160832446|NCT03242252|580773851|FG000|Overall Study|Lost to Follow-up|5|||
160832447|NCT03242252|580773852|FG001|Overall Study|Lost to Follow-up|1|||
160832448|NCT03242252|580773853|FG002|Overall Study|Lost to Follow-up|4|||
160832449|NCT00106691|580773855|FG000|Overall Study|Adverse Event|60|||
160832450|NCT00106691|580773856|FG001|Overall Study|Adverse Event|64|||
160832451|NCT00106691|580773855|FG000|Overall Study|Lost to Follow-up|23|||
160832452|NCT00106691|580773856|FG001|Overall Study|Lost to Follow-up|18|||
160832453|NCT00106691|580773855|FG000|Overall Study|Physician Decision|18|||
160832454|NCT00106691|580773856|FG001|Overall Study|Physician Decision|21|||
160832455|NCT00106691|580773855|FG000|Overall Study|Protocol Violation|13|||
160832456|NCT00106691|580773856|FG001|Overall Study|Protocol Violation|18|||
160832457|NCT00106691|580773855|FG000|Overall Study|Withdrawal by Subject|75|||
160832458|NCT00106691|580773856|FG001|Overall Study|Withdrawal by Subject|70|||
160832459|NCT00106691|580773855|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
160832460|NCT00106691|580773856|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
160832461|NCT00106691|580773855|FG000|Overall Study|QTc>480|3|||
160832462|NCT00106691|580773856|FG001|Overall Study|QTc>480|1|||
160832463|NCT00106691|580773855|FG000|Overall Study|mililtary deployment|2|||
160832464|NCT00106691|580773856|FG001|Overall Study|mililtary deployment|0|||
160832465|NCT00106691|580773855|FG000|Overall Study|Study Site Closing/PI Moved|1|||
160832466|NCT00106691|580773856|FG001|Overall Study|Study Site Closing/PI Moved|2|||
160832467|NCT00106691|580773855|FG000|Overall Study|Cardiologist recommendation|1|||
160832468|NCT00106691|580773856|FG001|Overall Study|Cardiologist recommendation|0|||
160832469|NCT00106691|580773855|FG000|Overall Study|Pt. moved to another state|1|||
161247096|NCT02578641|582283366|FG001|Overall Study|Death|8|||
161247097|NCT02578641|582283365|FG000|Overall Study|Lost to Follow-up|0|||
161247098|NCT02578641|582283366|FG001|Overall Study|Lost to Follow-up|1|||
161247099|NCT02578641|582283365|FG000|Overall Study|Withdrawal by Subject|14|||
161247100|NCT02578641|582283366|FG001|Overall Study|Withdrawal by Subject|7|||
161247101|NCT02578641|582283365|FG000|Overall Study|Progressive Disease|69|||
161247102|NCT02578641|582283366|FG001|Overall Study|Progressive Disease|21|||
161247103|NCT02578641|582283365|FG000|Overall Study|No Study Drug|2|||
161247104|NCT02578641|582283366|FG001|Overall Study|No Study Drug|0|||
161247105|NCT02578641|582283365|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
161247106|NCT02578641|582283366|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
161247107|NCT02578641|582283365|FG000|Overall Study|Non-compliance with Study Schedule|1|||
161247108|NCT02578641|582283366|FG001|Overall Study|Non-compliance with Study Schedule|0|||
161247109|NCT02578641|582283365|FG000|Overall Study|Other|1|||
161247110|NCT02578641|582283366|FG001|Overall Study|Other|10|||
161247111|NCT02578641|582283365|FG000|Overall Study|Not treated|1|||
160832470|NCT00106691|580773856|FG001|Overall Study|Pt. moved to another state|0|||
160832471|NCT00106691|580773855|FG000|Overall Study|Taking exclusionary avodart|1|||
160832472|NCT00106691|580773856|FG001|Overall Study|Taking exclusionary avodart|0|||
160832473|NCT00106691|580773855|FG000|Overall Study|Not able to discontinue plavix|0|||
160832474|NCT00106691|580773856|FG001|Overall Study|Not able to discontinue plavix|1|||
160832475|NCT01754194|580773857|FG000|Overall Study|Lost to Follow-up|39|||
160832476|NCT01754194|580773858|FG001|Overall Study|Lost to Follow-up|14|||
160832477|NCT01754194|580773857|FG000|Overall Study|Withdrawal by Subject|4|||
160832478|NCT01754194|580773858|FG001|Overall Study|Withdrawal by Subject|5|||
160832479|NCT01754194|580773857|FG000|Overall Study|Other|9|||
160832480|NCT01754194|580773858|FG001|Overall Study|Other|8|||
160832481|NCT00530920|580773859|FG000|Overall Study|Randomized but not treated|0|||
161247112|NCT02578641|582283366|FG001|Overall Study|Not treated|4|||
161247113|NCT02655224|582283369|FG000|Overall Study|Adverse Event|1|||
161247114|NCT02655224|582283370|FG001|Overall Study|Adverse Event|1|||
161247115|NCT04227899|582283377|FG000|Overall Study|Withdrawal by Subject|6|||
161247116|NCT04227899|582283378|FG001|Overall Study|Withdrawal by Subject|3|||
161247117|NCT04227899|582283377|FG000|Overall Study|Death|12|||
160832482|NCT00530920|580773860|FG001|Overall Study|Randomized but not treated|2|||
160832483|NCT00530920|580773861|FG002|Overall Study|Randomized but not treated|0|||
160832484|NCT00530920|580773859|FG000|Overall Study|Adverse Event|0|||
160832485|NCT00530920|580773860|FG001|Overall Study|Adverse Event|0|||
160832486|NCT00530920|580773861|FG002|Overall Study|Adverse Event|3|||
160832487|NCT00530920|580773859|FG000|Overall Study|Withdrawal by Subject|0|||
160832488|NCT00530920|580773860|FG001|Overall Study|Withdrawal by Subject|0|||
160832489|NCT00530920|580773861|FG002|Overall Study|Withdrawal by Subject|1|||
160832490|NCT00907296|580773862|FG000|Overall Study|Ineligibility Determined|1|||
160832491|NCT00907296|580773863|FG001|Overall Study|Ineligibility Determined|0|||
160832492|NCT00907296|580773864|FG002|Overall Study|Ineligibility Determined|0|||
160832493|NCT00907296|580773865|FG003|Overall Study|Ineligibility Determined|1|||
160832494|NCT00907296|580773866|FG004|Overall Study|Ineligibility Determined|0|||
160832495|NCT00907296|580773867|FG005|Overall Study|Ineligibility Determined|0|||
160832496|NCT00907296|580773868|FG006|Overall Study|Ineligibility Determined|0|||
160832497|NCT00907296|580773869|FG007|Overall Study|Ineligibility Determined|1|||
160832498|NCT00907296|580773870|FG008|Overall Study|Ineligibility Determined|0|||
160832499|NCT00907296|580773871|FG009|Overall Study|Ineligibility Determined|0|||
160832500|NCT00907296|580773862|FG000|Overall Study|Protocol Deviation|0|||
160832501|NCT00907296|580773863|FG001|Overall Study|Protocol Deviation|1|||
160832502|NCT00907296|580773864|FG002|Overall Study|Protocol Deviation|0|||
160832503|NCT00907296|580773865|FG003|Overall Study|Protocol Deviation|0|||
160832504|NCT00907296|580773866|FG004|Overall Study|Protocol Deviation|0|||
160832505|NCT00907296|580773867|FG005|Overall Study|Protocol Deviation|0|||
160832506|NCT00907296|580773868|FG006|Overall Study|Protocol Deviation|0|||
160832507|NCT00907296|580773869|FG007|Overall Study|Protocol Deviation|0|||
160832508|NCT00907296|580773870|FG008|Overall Study|Protocol Deviation|0|||
160832509|NCT00907296|580773871|FG009|Overall Study|Protocol Deviation|0|||
160832510|NCT00907296|580773862|FG000|Overall Study|Noncompliance|1|||
160832511|NCT00907296|580773863|FG001|Overall Study|Noncompliance|1|||
160832512|NCT00907296|580773864|FG002|Overall Study|Noncompliance|1|||
160832513|NCT00907296|580773865|FG003|Overall Study|Noncompliance|0|||
160832514|NCT00907296|580773866|FG004|Overall Study|Noncompliance|0|||
160832515|NCT00907296|580773867|FG005|Overall Study|Noncompliance|1|||
160832516|NCT00907296|580773868|FG006|Overall Study|Noncompliance|0|||
160832517|NCT00907296|580773869|FG007|Overall Study|Noncompliance|2|||
160832518|NCT00907296|580773870|FG008|Overall Study|Noncompliance|0|||
160832519|NCT00907296|580773871|FG009|Overall Study|Noncompliance|0|||
160832520|NCT00907296|580773862|FG000|Overall Study|Adverse Event|2|||
160832521|NCT00907296|580773863|FG001|Overall Study|Adverse Event|0|||
160832522|NCT00907296|580773864|FG002|Overall Study|Adverse Event|0|||
160832523|NCT00907296|580773865|FG003|Overall Study|Adverse Event|0|||
160832524|NCT00907296|580773866|FG004|Overall Study|Adverse Event|0|||
160832525|NCT00907296|580773867|FG005|Overall Study|Adverse Event|0|||
160832526|NCT00907296|580773868|FG006|Overall Study|Adverse Event|1|||
160832527|NCT00907296|580773869|FG007|Overall Study|Adverse Event|0|||
160832528|NCT00907296|580773870|FG008|Overall Study|Adverse Event|0|||
160832529|NCT00907296|580773871|FG009|Overall Study|Adverse Event|1|||
160832530|NCT00907296|580773862|FG000|Overall Study|Withdrawal by Subject|7|||
160832531|NCT00907296|580773863|FG001|Overall Study|Withdrawal by Subject|2|||
160832532|NCT00907296|580773864|FG002|Overall Study|Withdrawal by Subject|1|||
161247118|NCT04227899|582283378|FG001|Overall Study|Death|6|||
161247119|NCT04227899|582283377|FG000|Overall Study|Lost to Follow-up|2|||
161247120|NCT04227899|582283378|FG001|Overall Study|Lost to Follow-up|1|||
161247121|NCT05151471|582283379|FG000|Overall Study|Adverse Event|21|||
160832533|NCT00907296|580773865|FG003|Overall Study|Withdrawal by Subject|1|||
160832534|NCT00907296|580773866|FG004|Overall Study|Withdrawal by Subject|1|||
160832535|NCT00907296|580773867|FG005|Overall Study|Withdrawal by Subject|5|||
160832536|NCT00907296|580773868|FG006|Overall Study|Withdrawal by Subject|3|||
160832537|NCT00907296|580773869|FG007|Overall Study|Withdrawal by Subject|2|||
160832538|NCT00907296|580773870|FG008|Overall Study|Withdrawal by Subject|4|||
160832539|NCT00907296|580773871|FG009|Overall Study|Withdrawal by Subject|2|||
160832540|NCT00907296|580773862|FG000|Overall Study|Lost to Follow-up|9|||
160832541|NCT00907296|580773863|FG001|Overall Study|Lost to Follow-up|1|||
160832542|NCT00907296|580773864|FG002|Overall Study|Lost to Follow-up|0|||
160832543|NCT00907296|580773865|FG003|Overall Study|Lost to Follow-up|2|||
160832544|NCT00907296|580773866|FG004|Overall Study|Lost to Follow-up|0|||
160832545|NCT00907296|580773867|FG005|Overall Study|Lost to Follow-up|3|||
160832546|NCT00907296|580773868|FG006|Overall Study|Lost to Follow-up|2|||
160832547|NCT00907296|580773869|FG007|Overall Study|Lost to Follow-up|2|||
160832548|NCT00907296|580773870|FG008|Overall Study|Lost to Follow-up|0|||
160832549|NCT00907296|580773871|FG009|Overall Study|Lost to Follow-up|4|||
160832550|NCT02392403|580773873|FG000|Overall Study|Adverse Event|1|||
160832551|NCT02392403|580773873|FG000|Overall Study|Death|1|||
160832552|NCT02392403|580773873|FG000|Overall Study|Withdrawal by Subject|1|||
161247122|NCT05151471|582283380|FG001|Overall Study|Adverse Event|16|||
160832553|NCT00316888|580773879|FG000|Overall Study|Adverse Event|4|||
160832554|NCT00316888|580773880|FG001|Overall Study|Adverse Event|5|||
160832555|NCT00316888|580773879|FG000|Overall Study|Withdrawal by Subject|2|||
160832556|NCT00316888|580773880|FG001|Overall Study|Withdrawal by Subject|2|||
160832557|NCT00316888|580773879|FG000|Overall Study|Not start protocol therapy|0|||
160832558|NCT00316888|580773880|FG001|Overall Study|Not start protocol therapy|1|||
160832559|NCT00657371|580773884|FG000|Overall Study|Poor bowel preparation|15|||
160832560|NCT00657371|580773884|FG000|Overall Study|Unable to intubate the cecum|5|||
160832561|NCT00657371|580773884|FG000|Overall Study|Protocol Violation|2|||
160832562|NCT00657371|580773884|FG000|Overall Study|Device- related reasons|13|||
160832563|NCT00657371|580773884|FG000|Overall Study|Pre-existing medical condition|4|||
160832564|NCT00652899|580773885|FG000|Overall Study|Death|1|||
160832565|NCT00652899|580773885|FG000|Overall Study|Treating physician decision|1|||
160832566|NCT04135859|580773886|FG000|Overall Study|Withdrawal by Subject|1|||
160832567|NCT04135859|580773887|FG001|Overall Study|Withdrawal by Subject|0|||
160832568|NCT04135859|580773886|FG000|Overall Study|Withdrawal due to screening failure|1|||
160832569|NCT04135859|580773887|FG001|Overall Study|Withdrawal due to screening failure|2|||
160832570|NCT04135859|580773886|FG000|Overall Study|Did not complete stress test|3|||
160832571|NCT04135859|580773887|FG001|Overall Study|Did not complete stress test|3|||
160832572|NCT04135859|580773886|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
160832573|NCT04135859|580773887|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
160832574|NCT01600053|580773888|FG000|Overall Study|Adverse Event|2|||
160832575|NCT01600053|580773888|FG000|Overall Study|trial will not meet the interim endpoint|9|||
160832576|NCT01565941|580773889|FG000|Overall Study|Withdrawn by parent/guardian|3|||
160832577|NCT01565941|580773890|FG001|Overall Study|Withdrawn by parent/guardian|2|||
160832578|NCT01565941|580773889|FG000|Overall Study|Randomized; did not receive intevention|8|||
160832579|NCT01565941|580773890|FG001|Overall Study|Randomized; did not receive intevention|2|||
160832580|NCT03230292|580773893|FG000|Overall Study|Adverse Event|1|||
160832581|NCT03230292|580773893|FG000|Overall Study|Protocol Violation|1|||
160832582|NCT03230292|580773893|FG000|Overall Study|Lost to Follow-up|1|||
160832583|NCT03230292|580773893|FG000|Overall Study|Withdrawal by Subject|3|||
160832584|NCT02855944|580773894|FG000|Period 1: Treatment|Ongoing|14|||
160832585|NCT02855944|580773895|FG001|Period 1: Treatment|Ongoing|0|||
160832586|NCT02855944|580773894|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
160832587|NCT02855944|580773895|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
160832588|NCT02855944|580773894|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
160832589|NCT02855944|580773895|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
160832590|NCT03629912|580773903|FG000|Overall Study|Lost to Follow-up|19|||
160832591|NCT03629912|580773904|FG001|Overall Study|Lost to Follow-up|7|||
160832592|NCT03629912|580773905|FG002|Overall Study|Lost to Follow-up|5|||
160832593|NCT03629912|580773906|FG003|Overall Study|Lost to Follow-up|1|||
160832594|NCT03629912|580773903|FG000|Overall Study|Withdrawal by Subject|6|||
160832595|NCT03629912|580773904|FG001|Overall Study|Withdrawal by Subject|0|||
160832596|NCT03629912|580773905|FG002|Overall Study|Withdrawal by Subject|1|||
160832597|NCT03629912|580773906|FG003|Overall Study|Withdrawal by Subject|2|||
160832598|NCT03629912|580773903|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
160832599|NCT03629912|580773904|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
160832600|NCT03629912|580773905|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
160832601|NCT03629912|580773906|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
160832602|NCT03629912|580773903|FG000|Overall Study|Death|1|||
160832603|NCT03629912|580773904|FG001|Overall Study|Death|0|||
160832604|NCT03629912|580773905|FG002|Overall Study|Death|0|||
160832605|NCT03629912|580773906|FG003|Overall Study|Death|0|||
160832606|NCT02365285|580773909|FG000|Overall Study|Physician Decision|0|||
160832607|NCT02365285|580773910|FG001|Overall Study|Physician Decision|1|||
160832608|NCT02365285|580773911|FG002|Overall Study|Physician Decision|1|||
160832609|NCT02365285|580773912|FG003|Overall Study|Physician Decision|0|||
160832610|NCT02365285|580773909|FG000|Overall Study|Adverse Event|0|||
160832611|NCT02365285|580773910|FG001|Overall Study|Adverse Event|0|||
160832612|NCT02365285|580773911|FG002|Overall Study|Adverse Event|0|||
160832613|NCT02365285|580773912|FG003|Overall Study|Adverse Event|2|||
160832614|NCT03262116|580773913|FG000|Overall Study|Physician Decision|0|||
160832615|NCT03262116|580773914|FG001|Overall Study|Physician Decision|2|||
160832616|NCT03262116|580773915|FG002|Overall Study|Physician Decision|1|||
160832617|NCT03262116|580773916|FG003|Overall Study|Physician Decision|1|||
160832618|NCT03262116|580773917|FG004|Overall Study|Physician Decision|1|||
160832619|NCT03262116|580773918|FG005|Overall Study|Physician Decision|2|||
160832620|NCT02608450|580773921|FG000|Overall Study|Lost to Follow-up|39|||
160832621|NCT02608450|580773922|FG001|Overall Study|Lost to Follow-up|32|||
160832622|NCT02608450|580773921|FG000|Overall Study|Withdrawal by Subject|21|||
160832623|NCT02608450|580773922|FG001|Overall Study|Withdrawal by Subject|15|||
160832624|NCT02608450|580773921|FG000|Overall Study|Adverse Event|3|||
160832625|NCT02608450|580773922|FG001|Overall Study|Adverse Event|6|||
160832626|NCT02608450|580773921|FG000|Overall Study|Withdrawal by parent|2|||
160832627|NCT02608450|580773922|FG001|Overall Study|Withdrawal by parent|3|||
160832628|NCT02608450|580773921|FG000|Overall Study|Lack of Efficacy|0|||
160832629|NCT02608450|580773922|FG001|Overall Study|Lack of Efficacy|3|||
160832630|NCT02608450|580773921|FG000|Overall Study|Noncompliance with study drug|0|||
160832631|NCT02608450|580773922|FG001|Overall Study|Noncompliance with study drug|2|||
160832632|NCT02608450|580773921|FG000|Overall Study|Physician Decision|0|||
160832633|NCT02608450|580773922|FG001|Overall Study|Physician Decision|1|||
160832634|NCT02608450|580773921|FG000|Overall Study|Pregnancy|0|||
160832635|NCT02608450|580773922|FG001|Overall Study|Pregnancy|1|||
160832636|NCT02608450|580773921|FG000|Overall Study|Progressive disease|1|||
160832637|NCT02608450|580773922|FG001|Overall Study|Progressive disease|0|||
160832638|NCT02608450|580773921|FG000|Overall Study|Multiple reasons|0|||
160832639|NCT02608450|580773922|FG001|Overall Study|Multiple reasons|2|||
160832640|NCT00635089|580773924|FG000|Overall Study|Adverse Event|7|||
160832641|NCT00635089|580773924|FG000|Overall Study|Lack of Efficacy|28|||
160832642|NCT00635089|580773924|FG000|Overall Study|Protocol Deviation|4|||
160832643|NCT00635089|580773924|FG000|Overall Study|Lost to Follow-up|8|||
160832644|NCT00635089|580773924|FG000|Overall Study|Other|31|||
160832645|NCT01617447|580773925|FG000|Overall Study|Adverse Event|0|||
160832646|NCT01617447|580773926|FG001|Overall Study|Adverse Event|1|||
160832647|NCT01617447|580773925|FG000|Overall Study|Physician Decision|0|||
160832648|NCT01617447|580773926|FG001|Overall Study|Physician Decision|2|||
160832649|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
160832650|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
160832651|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
160832652|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
160832653|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
160832654|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
160832655|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
160832656|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
160832657|NCT02636946|580773928|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
160832658|NCT02636946|580773929|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
160832659|NCT02636946|580773928|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
160832660|NCT02636946|580773929|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
160832661|NCT01283542|580773930|FG000|Main Phase|Acute or progressive vision loss|1|||
160832662|NCT01283542|580773930|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
160832663|NCT01283542|580773930|FG000|Main Phase|abnormal laboratory values|5|||
160832664|NCT01283542|580773930|FG000|Extension Phase|Physician Decision|1|||
160832665|NCT01283542|580773930|FG000|Extension Phase|Adverse Event|1|||
160832666|NCT01283542|580773930|FG000|Extension Phase|Administrative problems|1|||
160832667|NCT05059977|580773931|FG000|Overall Study|Withdrawal by Subject|0|||
160832668|NCT05059977|580773932|FG001|Overall Study|Withdrawal by Subject|0|||
160832669|NCT05059977|580773933|FG002|Overall Study|Withdrawal by Subject|1|||
160832670|NCT04405245|580773934|FG000|Overall Study|Adverse Event|0|||
160832671|NCT04405245|580773935|FG001|Overall Study|Adverse Event|1|||
160832672|NCT04405245|580773936|FG002|Overall Study|Adverse Event|0|||
160832673|NCT00576472|580773938|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832674|NCT00576472|580773939|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832675|NCT00576472|580773940|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832676|NCT00576472|580773941|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
160832677|NCT00576472|580773942|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832678|NCT00576472|580773943|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832679|NCT00576472|580773944|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832680|NCT00576472|580773945|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832681|NCT00576472|580773946|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832682|NCT00576472|580773947|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
160991209|NCT05174065|581355537|FG001|Placebo-controlled Period|Other|1|||
161136538|NCT00996840|581881656|FG002|Overall Study|Physician Decision|1|||
161136539|NCT00996840|581881657|FG003|Overall Study|Physician Decision|1|||
160832683|NCT00576472|580773948|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832684|NCT00576472|580773949|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832685|NCT00576472|580773950|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832686|NCT00576472|580773951|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832687|NCT00576472|580773952|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
160832688|NCT00576472|580773938|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
160832689|NCT00576472|580773939|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
160832690|NCT00576472|580773940|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
160832691|NCT00576472|580773941|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
160832692|NCT00576472|580773942|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
160832693|NCT00576472|580773943|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
160832694|NCT00576472|580773944|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
160832695|NCT00576472|580773945|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
160832696|NCT00576472|580773946|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
160832697|NCT00576472|580773947|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
160832698|NCT00576472|580773948|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
160832699|NCT00576472|580773949|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
160832700|NCT00576472|580773950|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
160832701|NCT00576472|580773951|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
160832702|NCT00576472|580773952|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
160832703|NCT00576472|580773938|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832704|NCT00576472|580773939|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832705|NCT00576472|580773940|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832706|NCT00576472|580773941|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
160832707|NCT00576472|580773942|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832708|NCT00576472|580773943|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832709|NCT00576472|580773944|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832710|NCT00576472|580773945|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832711|NCT00576472|580773946|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832712|NCT00576472|580773947|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832713|NCT00576472|580773948|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832714|NCT00576472|580773949|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832715|NCT00576472|580773950|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832716|NCT00576472|580773951|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832717|NCT00576472|580773952|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
160832718|NCT00576472|580773938|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
160832719|NCT00576472|580773939|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
160832720|NCT00576472|580773940|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
160832721|NCT00576472|580773941|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
160832722|NCT00576472|580773942|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
160832723|NCT00576472|580773943|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
160832724|NCT00576472|580773944|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
160832725|NCT00576472|580773945|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
160832726|NCT00576472|580773946|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
160832727|NCT00576472|580773947|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
160832728|NCT00576472|580773948|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
160832729|NCT00576472|580773949|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
160832730|NCT00576472|580773950|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
160832731|NCT00576472|580773951|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
160832732|NCT00576472|580773952|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
160832733|NCT00576472|580773938|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832734|NCT00576472|580773939|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832735|NCT00576472|580773940|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832736|NCT00576472|580773941|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
160832737|NCT00576472|580773942|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832738|NCT00576472|580773943|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832739|NCT00576472|580773944|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832740|NCT00576472|580773945|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832741|NCT00576472|580773946|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832742|NCT00576472|580773947|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832743|NCT00576472|580773948|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832744|NCT00576472|580773949|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832745|NCT00576472|580773950|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832746|NCT00576472|580773951|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832747|NCT00576472|580773952|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
160832748|NCT00576472|580773938|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832749|NCT00576472|580773939|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832750|NCT00576472|580773940|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832751|NCT00576472|580773941|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832752|NCT00576472|580773942|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832753|NCT00576472|580773943|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832754|NCT00576472|580773944|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
160903372|NCT02468674|581040475|FG008|Overall Study|Lost to Follow-up|1|||
160903373|NCT02468674|581040467|FG000|Overall Study|Physician Decision|0|||
161247123|NCT05151471|582283379|FG000|Overall Study|Death|1|||
161247124|NCT05151471|582283380|FG001|Overall Study|Death|0|||
160903374|NCT02468674|581040468|FG001|Overall Study|Physician Decision|0|||
160903375|NCT02468674|581040469|FG002|Overall Study|Physician Decision|0|||
160832755|NCT00576472|580773945|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832756|NCT00576472|580773946|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832757|NCT00576472|580773947|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832758|NCT00576472|580773948|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832759|NCT00576472|580773949|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832760|NCT00576472|580773950|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832761|NCT00576472|580773951|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
160832762|NCT00576472|580773952|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
160903376|NCT02468674|581040470|FG003|Overall Study|Physician Decision|0|||
160832763|NCT00576472|580773938|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
160832764|NCT00576472|580773939|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
160832765|NCT00576472|580773940|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
160832766|NCT00576472|580773941|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
160832767|NCT00576472|580773942|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
160832768|NCT00576472|580773943|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
160832769|NCT00576472|580773944|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
160832770|NCT00576472|580773945|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
160832771|NCT00576472|580773946|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
160832772|NCT00576472|580773947|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
160832773|NCT00576472|580773948|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
160832774|NCT00576472|580773949|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
160832775|NCT00576472|580773950|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
160832776|NCT00576472|580773951|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
160832777|NCT00576472|580773952|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
160832778|NCT00576472|580773938|FG000|MPH Cross Over Phase|Physician Decision|0|||
160832779|NCT00576472|580773939|FG001|MPH Cross Over Phase|Physician Decision|0|||
160832780|NCT00576472|580773940|FG002|MPH Cross Over Phase|Physician Decision|0|||
160832781|NCT00576472|580773941|FG003|MPH Cross Over Phase|Physician Decision|0|||
160832782|NCT00576472|580773942|FG004|MPH Cross Over Phase|Physician Decision|0|||
160832783|NCT00576472|580773943|FG005|MPH Cross Over Phase|Physician Decision|0|||
160832784|NCT00576472|580773944|FG006|MPH Cross Over Phase|Physician Decision|4|||
160832785|NCT00576472|580773945|FG007|MPH Cross Over Phase|Physician Decision|0|||
160832786|NCT00576472|580773946|FG008|MPH Cross Over Phase|Physician Decision|0|||
160832787|NCT00576472|580773947|FG009|MPH Cross Over Phase|Physician Decision|0|||
160832788|NCT00576472|580773948|FG010|MPH Cross Over Phase|Physician Decision|0|||
160832789|NCT00576472|580773949|FG011|MPH Cross Over Phase|Physician Decision|0|||
160832790|NCT00576472|580773950|FG012|MPH Cross Over Phase|Physician Decision|0|||
160832791|NCT00576472|580773951|FG013|MPH Cross Over Phase|Physician Decision|0|||
160832792|NCT00576472|580773952|FG014|MPH Cross Over Phase|Physician Decision|0|||
160832793|NCT00576472|580773938|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832794|NCT00576472|580773939|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832795|NCT00576472|580773940|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832796|NCT00576472|580773941|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832797|NCT00576472|580773942|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832798|NCT00576472|580773943|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832799|NCT00576472|580773944|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832800|NCT00576472|580773945|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832801|NCT00576472|580773946|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
160832802|NCT00576472|580773947|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832803|NCT00576472|580773948|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
160832804|NCT00576472|580773949|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
160832805|NCT00576472|580773950|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832806|NCT00576472|580773951|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832807|NCT00576472|580773952|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
160832808|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832809|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832810|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832811|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832812|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832813|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832814|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832815|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
161136540|NCT00996840|581881658|FG004|Overall Study|Physician Decision|2|||
161136541|NCT00996840|581881654|FG000|Overall Study|Withdrawal by Subject|1|||
160832816|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832817|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832818|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832819|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832820|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832821|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
160832822|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
160832823|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
161136542|NCT00996840|581881655|FG001|Overall Study|Withdrawal by Subject|1|||
160832824|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
160832825|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
160832826|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
160832827|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
160832828|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
161247125|NCT05151471|582283379|FG000|Overall Study|Lost to Follow-up|0|||
161247126|NCT05151471|582283380|FG001|Overall Study|Lost to Follow-up|1|||
161247127|NCT05151471|582283379|FG000|Overall Study|Withdrawal by Subject|7|||
161247128|NCT05151471|582283380|FG001|Overall Study|Withdrawal by Subject|9|||
161247129|NCT05151471|582283379|FG000|Overall Study|Study terminated by sponsor|49|||
161247130|NCT05151471|582283380|FG001|Overall Study|Study terminated by sponsor|47|||
161247131|NCT05151471|582283379|FG000|Overall Study|Other|2|||
161247132|NCT05151471|582283380|FG001|Overall Study|Other|1|||
161247133|NCT03292458|582283386|FG000|Period 1|Adverse Event|2|||
161247134|NCT03292458|582283387|FG001|Period 1|Adverse Event|0|||
161247135|NCT01741545|582283388|FG000|Treatment Period|Lack of Efficacy|0|||
161247136|NCT01741545|582283389|FG001|Treatment Period|Lack of Efficacy|1|||
161247137|NCT01741545|582283388|FG000|Treatment Period|Adverse event, non-fatal|1|||
161247138|NCT01741545|582283389|FG001|Treatment Period|Adverse event, non-fatal|3|||
161247139|NCT01741545|582283388|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
161247140|NCT01741545|582283389|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
161247141|NCT01741545|582283388|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161247142|NCT01741545|582283389|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161247143|NCT01664039|582283392|FG000|Overall Study|Adverse Event|3|||
161247144|NCT01664039|582283393|FG001|Overall Study|Adverse Event|4|||
161247145|NCT01664039|582283392|FG000|Overall Study|Lost to Follow-up|1|||
161247146|NCT01664039|582283393|FG001|Overall Study|Lost to Follow-up|1|||
161247147|NCT01664039|582283392|FG000|Overall Study|Withdrawal by Subject|1|||
161247148|NCT01664039|582283393|FG001|Overall Study|Withdrawal by Subject|3|||
160832829|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
160832830|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
160832831|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
160832832|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
160832833|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
160832834|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
160832835|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
160832836|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
160832837|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
160832838|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
160832839|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
160832840|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
160832841|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
160832842|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
160832843|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
160832844|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
160832845|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
160832846|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
160832847|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
160832848|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
160832849|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
160832850|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
160832851|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
160832852|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
160832853|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Side effects|0|||
160832854|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Side effects|0|||
160832855|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Side effects|0|||
160832856|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Side effects|0|||
160832857|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Side effects|0|||
160832858|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Side effects|0|||
161247149|NCT01664039|582283392|FG000|Overall Study|Noncompliance|1|||
161247150|NCT01664039|582283393|FG001|Overall Study|Noncompliance|1|||
161247151|NCT01853176|582283394|FG000|Overall Study|Study terminated|4|||
161247152|NCT01853176|582283395|FG001|Overall Study|Study terminated|0|||
161247153|NCT02276885|582283396|FG000|Overall Study|Withdrawal by Subject|2|||
161247154|NCT02276885|582283397|FG001|Overall Study|Withdrawal by Subject|0|||
161247155|NCT02276885|582283396|FG000|Overall Study|Lost to Follow-up|5|||
160832859|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Side effects|0|||
160832860|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Side effects|0|||
160832861|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Side effects|0|||
160832862|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Side effects|0|||
160832863|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Side effects|0|||
160832864|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Side effects|0|||
160832865|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Side effects|0|||
160832866|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Side effects|0|||
161247156|NCT02276885|582283397|FG001|Overall Study|Lost to Follow-up|2|||
161247157|NCT03837626|582283398|FG000|Overall Study|Adverse Event|3|||
161247158|NCT03837626|582283399|FG001|Overall Study|Adverse Event|3|||
161247159|NCT03837626|582283398|FG000|Overall Study|Withdrawal by Subject|2|||
161247160|NCT03837626|582283399|FG001|Overall Study|Withdrawal by Subject|4|||
160832867|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Side effects|8|||
160832868|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832869|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832870|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832871|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832872|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832873|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832874|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832875|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832876|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832877|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832878|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832879|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832880|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832881|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
160832882|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
160832883|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
160832884|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
160832885|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
160832886|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
160832887|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
160832888|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
160832889|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
160832890|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
160832891|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
160832892|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
160832893|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
160832894|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
160832895|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
160832896|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
160832897|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
160832898|NCT00576472|580773938|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832899|NCT00576472|580773939|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832900|NCT00576472|580773940|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832901|NCT00576472|580773941|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832902|NCT00576472|580773942|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832903|NCT00576472|580773943|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832904|NCT00576472|580773944|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832905|NCT00576472|580773945|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832906|NCT00576472|580773946|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161136543|NCT00996840|581881656|FG002|Overall Study|Withdrawal by Subject|0|||
161136544|NCT00996840|581881657|FG003|Overall Study|Withdrawal by Subject|0|||
161136545|NCT00996840|581881658|FG004|Overall Study|Withdrawal by Subject|0|||
161136546|NCT00603239|581881659|FG000|Overall Study|Adverse Event|4|||
161136547|NCT00603239|581881660|FG001|Overall Study|Adverse Event|1|||
161136548|NCT00603239|581881659|FG000|Overall Study|Entry criteria not met|0|||
161136549|NCT00603239|581881660|FG001|Overall Study|Entry criteria not met|1|||
161136550|NCT00603239|581881659|FG000|Overall Study|Loss of glucose control|3|||
161136551|NCT00603239|581881660|FG001|Overall Study|Loss of glucose control|0|||
161136552|NCT00603239|581881659|FG000|Overall Study|Lost to Follow-up|2|||
161136553|NCT00603239|581881660|FG001|Overall Study|Lost to Follow-up|1|||
161136554|NCT00603239|581881659|FG000|Overall Study|Physician Decision|2|||
161136555|NCT00603239|581881660|FG001|Overall Study|Physician Decision|0|||
161136556|NCT00603239|581881659|FG000|Overall Study|Protocol Violation|2|||
161136557|NCT00603239|581881660|FG001|Overall Study|Protocol Violation|0|||
161136558|NCT00603239|581881659|FG000|Overall Study|Subject decision|2|||
161136559|NCT00603239|581881660|FG001|Overall Study|Subject decision|1|||
161136560|NCT00097539|581881661|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
161136561|NCT00097539|581881662|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
161136562|NCT00097539|581881663|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
161136563|NCT00097539|581881664|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
161136564|NCT00097539|581881665|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
161136565|NCT00097539|581881666|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
161136566|NCT00097539|581881667|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
161136567|NCT00097539|581881661|FG000|Overall Study|Withdrawal by Subject|925|||
161136568|NCT00097539|581881662|FG001|Overall Study|Withdrawal by Subject|323|||
161247161|NCT03837626|582283398|FG000|Overall Study|Physician Decision|2|||
160832907|NCT00576472|580773947|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832908|NCT00576472|580773948|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832909|NCT00576472|580773949|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832910|NCT00576472|580773950|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
160832911|NCT00576472|580773951|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
161247162|NCT03837626|582283399|FG001|Overall Study|Physician Decision|3|||
161247163|NCT03837626|582283398|FG000|Overall Study|Lost to Follow-up|3|||
161247164|NCT03837626|582283399|FG001|Overall Study|Lost to Follow-up|1|||
161247165|NCT05740371|582283400|FG000|Overall Study|Death|1|||
161247166|NCT00874822|582283401|FG000|Overall Study|excluded by criteria|8|||
161247167|NCT02627963|582283402|FG000|Overall Study|Randomized but not treated|2|||
161247168|NCT02627963|582283403|FG001|Overall Study|Randomized but not treated|6|||
161247169|NCT03073798|582283404|FG000|Overall Study|Adverse Event|1|||
161247170|NCT03073798|582283404|FG000|Overall Study|Withdrawal by Subject|1|||
161247171|NCT05278858|582283407|FG000|Overall Study|Withdrawal by Subject|1|||
161247172|NCT00840658|582283408|FG000|Overall Study|Death|2|||
161247173|NCT00840658|582283409|FG001|Overall Study|Death|2|||
161247174|NCT00840658|582283410|FG002|Overall Study|Death|3|||
161247175|NCT00840658|582283411|FG003|Overall Study|Death|3|||
161247176|NCT00840658|582283408|FG000|Overall Study|Lost to Follow-up|3|||
161247177|NCT00840658|582283409|FG001|Overall Study|Lost to Follow-up|1|||
161247178|NCT00840658|582283410|FG002|Overall Study|Lost to Follow-up|2|||
160832912|NCT00576472|580773952|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
160832913|NCT03443427|580773953|FG000|Overall Study|Adverse Event|2|||
160832914|NCT03443427|580773954|FG001|Overall Study|Adverse Event|3|||
160832915|NCT03443427|580773953|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
160832916|NCT03443427|580773954|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
160832917|NCT03443427|580773953|FG000|Overall Study|Other|4|||
160832918|NCT03443427|580773954|FG001|Overall Study|Other|6|||
160832919|NCT00780273|580773957|FG000|Overall Study|Death|1|||
160832920|NCT00780273|580773957|FG000|Overall Study|Lost to Follow-up|1|||
160832921|NCT02576860|580773958|FG000|Overall Study|Adverse Event|6|||
160832922|NCT02576860|580773959|FG001|Overall Study|Adverse Event|6|||
160832923|NCT02576860|580773958|FG000|Overall Study|Lost to Follow-up|5|||
160832924|NCT02576860|580773959|FG001|Overall Study|Lost to Follow-up|7|||
160832925|NCT02576860|580773958|FG000|Overall Study|Physician Decision|0|||
160832926|NCT02576860|580773959|FG001|Overall Study|Physician Decision|1|||
160832927|NCT02576860|580773958|FG000|Overall Study|Protocol Violation|0|||
160832928|NCT02576860|580773959|FG001|Overall Study|Protocol Violation|2|||
160832929|NCT02576860|580773958|FG000|Overall Study|Withdrawal by Subject|13|||
160832930|NCT02576860|580773959|FG001|Overall Study|Withdrawal by Subject|8|||
160832931|NCT02576860|580773958|FG000|Overall Study|Disallowed medication|1|||
160832932|NCT02576860|580773959|FG001|Overall Study|Disallowed medication|0|||
160832933|NCT02391961|580773960|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
160832934|NCT02391961|580773961|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
160832935|NCT02391961|580773960|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
160832936|NCT02391961|580773961|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
160832937|NCT02391961|580773960|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160832938|NCT02391961|580773961|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160832939|NCT02308488|580773964|FG000|Overall Study|Withdrawal by Subject|2|||
160832940|NCT01541917|580773965|FG000|Overall Study|Lost to Follow-up|2|||
160832941|NCT01541917|580773966|FG001|Overall Study|Lost to Follow-up|2|||
160832942|NCT01541917|580773965|FG000|Overall Study|Withdrawal by Subject|13|||
160832943|NCT01541917|580773966|FG001|Overall Study|Withdrawal by Subject|7|||
160832944|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
160832945|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
160832946|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
160832947|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
160832948|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
160832949|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
160832950|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
160832951|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
161334902|NCT03167242|582615850|FG003|Overall Study|Reason not provided|0|||
161334903|NCT03167242|582615851|FG004|Overall Study|Reason not provided|0|||
160832952|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
160832953|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
160832954|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
160832955|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
161247179|NCT00840658|582283411|FG003|Overall Study|Lost to Follow-up|1|||
161334904|NCT03167242|582615852|FG005|Overall Study|Reason not provided|0|||
160832956|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
160832957|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
160832958|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
160832959|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
160832960|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
160832961|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
160832962|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
160862008|NCT03804528|580887919|FG000|Overall Study|Health Reasons|5|||
161247180|NCT00728754|582283416|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
161334905|NCT03167242|582615853|FG006|Overall Study|Reason not provided|0|||
161247181|NCT00728754|582283417|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
161247182|NCT00728754|582283416|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
161247183|NCT00728754|582283417|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
161247184|NCT00728754|582283416|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
161247185|NCT00728754|582283417|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
161247186|NCT00573313|582283422|FG000|Overall Study|Protocol Violation|5|||
161247187|NCT00573313|582283423|FG001|Overall Study|Protocol Violation|0|||
161247188|NCT00573313|582283424|FG002|Overall Study|Protocol Violation|6|||
161247189|NCT00573313|582283425|FG003|Overall Study|Protocol Violation|0|||
161247190|NCT00295490|582283428|FG000|Overall Study|Protocol Violation|0|||
161247191|NCT00295490|582283429|FG001|Overall Study|Protocol Violation|0|||
161247192|NCT00295490|582283430|FG002|Overall Study|Protocol Violation|3|||
161247193|NCT00295490|582283431|FG003|Overall Study|Protocol Violation|3|||
161247194|NCT00295490|582283428|FG000|Overall Study|Withdrawal by Subject|0|||
161247195|NCT00295490|582283429|FG001|Overall Study|Withdrawal by Subject|2|||
161247196|NCT00295490|582283430|FG002|Overall Study|Withdrawal by Subject|0|||
161247197|NCT00295490|582283431|FG003|Overall Study|Withdrawal by Subject|1|||
161247198|NCT00295490|582283428|FG000|Overall Study|Lost to Follow-up|0|||
161247199|NCT00295490|582283429|FG001|Overall Study|Lost to Follow-up|0|||
161247200|NCT00295490|582283430|FG002|Overall Study|Lost to Follow-up|1|||
161247201|NCT00295490|582283431|FG003|Overall Study|Lost to Follow-up|0|||
161247202|NCT00295490|582283428|FG000|Overall Study|Adverse Event|1|||
161247203|NCT00295490|582283429|FG001|Overall Study|Adverse Event|0|||
160832963|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
160832964|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
160832965|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
160832966|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
160832967|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
160832968|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
160832969|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
160832970|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
160832971|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
160832972|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
160832973|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
160832974|NCT00121641|580773967|FG000|24-week Short-term Treatment Period|Other Reason|1|||
160832975|NCT00121641|580773968|FG001|24-week Short-term Treatment Period|Other Reason|0|||
160832976|NCT00121641|580773969|FG002|24-week Short-term Treatment Period|Other Reason|0|||
161136569|NCT00097539|581881663|FG002|Overall Study|Withdrawal by Subject|346|||
161136570|NCT00097539|581881664|FG003|Overall Study|Withdrawal by Subject|217|||
161136571|NCT00097539|581881665|FG004|Overall Study|Withdrawal by Subject|68|||
161136572|NCT00097539|581881666|FG005|Overall Study|Withdrawal by Subject|229|||
161136573|NCT00097539|581881667|FG006|Overall Study|Withdrawal by Subject|3|||
161136574|NCT00097539|581881661|FG000|Overall Study|Participant Non-compliant|2140|||
161136575|NCT00097539|581881662|FG001|Overall Study|Participant Non-compliant|567|||
161136576|NCT00097539|581881663|FG002|Overall Study|Participant Non-compliant|1067|||
161136577|NCT00097539|581881664|FG003|Overall Study|Participant Non-compliant|353|||
161136578|NCT00097539|581881665|FG004|Overall Study|Participant Non-compliant|136|||
161136579|NCT00097539|581881666|FG005|Overall Study|Participant Non-compliant|543|||
161136580|NCT00097539|581881667|FG006|Overall Study|Participant Non-compliant|18|||
161136581|NCT00097539|581881661|FG000|Overall Study|Lack of Efficacy|249|||
161136582|NCT00097539|581881662|FG001|Overall Study|Lack of Efficacy|122|||
161136583|NCT00097539|581881663|FG002|Overall Study|Lack of Efficacy|202|||
161136584|NCT00097539|581881664|FG003|Overall Study|Lack of Efficacy|105|||
161136585|NCT00097539|581881665|FG004|Overall Study|Lack of Efficacy|45|||
161136586|NCT00097539|581881666|FG005|Overall Study|Lack of Efficacy|228|||
161136587|NCT00097539|581881667|FG006|Overall Study|Lack of Efficacy|5|||
161136588|NCT00097539|581881661|FG000|Overall Study|Adverse Event|78|||
161136589|NCT00097539|581881662|FG001|Overall Study|Adverse Event|133|||
161136590|NCT00097539|581881663|FG002|Overall Study|Adverse Event|37|||
161136591|NCT00097539|581881664|FG003|Overall Study|Adverse Event|27|||
161136592|NCT00097539|581881665|FG004|Overall Study|Adverse Event|30|||
161136593|NCT00097539|581881666|FG005|Overall Study|Adverse Event|59|||
161136594|NCT00097539|581881667|FG006|Overall Study|Adverse Event|1|||
161136595|NCT00097539|581881661|FG000|Overall Study|Death|2|||
161136596|NCT00097539|581881662|FG001|Overall Study|Death|7|||
161136597|NCT00097539|581881663|FG002|Overall Study|Death|0|||
161136598|NCT00097539|581881664|FG003|Overall Study|Death|0|||
161136599|NCT00097539|581881665|FG004|Overall Study|Death|1|||
161136600|NCT00097539|581881666|FG005|Overall Study|Death|3|||
161136601|NCT00097539|581881667|FG006|Overall Study|Death|0|||
161136602|NCT00097539|581881661|FG000|Overall Study|Reasons Other Than Above|3602|||
161136603|NCT00097539|581881662|FG001|Overall Study|Reasons Other Than Above|1382|||
161247204|NCT00295490|582283430|FG002|Overall Study|Adverse Event|0|||
161247205|NCT00295490|582283431|FG003|Overall Study|Adverse Event|0|||
161247206|NCT00295490|582283428|FG000|Overall Study|Other|0|||
160832977|NCT00121641|580773970|FG003|24-week Short-term Treatment Period|Other Reason|0|||
160832978|NCT00121641|580773971|FG004|24-week Short-term Treatment Period|Other Reason|0|||
160832979|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
160832980|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
160832981|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
160832982|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
160832983|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
160832984|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
160832985|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
160832986|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
160832987|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
160832988|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
160832989|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
160832990|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
160832991|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
161136604|NCT00097539|581881663|FG002|Overall Study|Reasons Other Than Above|1757|||
161136605|NCT00097539|581881664|FG003|Overall Study|Reasons Other Than Above|692|||
161136606|NCT00097539|581881665|FG004|Overall Study|Reasons Other Than Above|361|||
161136607|NCT00097539|581881666|FG005|Overall Study|Reasons Other Than Above|1244|||
161136608|NCT00097539|581881667|FG006|Overall Study|Reasons Other Than Above|34|||
161136609|NCT00097539|581881661|FG000|Overall Study|Reason not Specified|111|||
161136610|NCT00097539|581881662|FG001|Overall Study|Reason not Specified|49|||
161136611|NCT00097539|581881663|FG002|Overall Study|Reason not Specified|53|||
161136612|NCT00097539|581881664|FG003|Overall Study|Reason not Specified|21|||
161136613|NCT00097539|581881665|FG004|Overall Study|Reason not Specified|11|||
161136614|NCT00097539|581881666|FG005|Overall Study|Reason not Specified|40|||
161136615|NCT00097539|581881667|FG006|Overall Study|Reason not Specified|2|||
161136616|NCT04938648|581881668|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
161136617|NCT04938648|581881669|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
161136618|NCT04938648|581881668|FG000|Overall Study|Patient too ill|0|||
161136619|NCT04938648|581881669|FG001|Overall Study|Patient too ill|1|||
161136620|NCT04938648|581881668|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
161136621|NCT04938648|581881669|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
161136622|NCT04938648|581881668|FG000|Overall Study|Patient did not have memory problems|1|||
161136623|NCT04938648|581881669|FG001|Overall Study|Patient did not have memory problems|1|||
161136624|NCT04938648|581881668|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
161136625|NCT04938648|581881669|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
161136626|NCT04938648|581881668|FG000|Overall Study|Care partner could not be reached|0|||
161136627|NCT04938648|581881669|FG001|Overall Study|Care partner could not be reached|1|||
161136628|NCT04938648|581881668|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
161136629|NCT04938648|581881669|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
161136630|NCT04938648|581881668|FG000|Overall Study|Withdrawal by Subject|2|||
161136631|NCT04938648|581881669|FG001|Overall Study|Withdrawal by Subject|1|||
161136632|NCT05127486|581881670|FG000|Overall Study|Adverse Event|2|||
161136633|NCT05127486|581881671|FG001|Overall Study|Adverse Event|4|||
161136634|NCT05127486|581881670|FG000|Overall Study|Lack of Efficacy|1|||
161136635|NCT05127486|581881671|FG001|Overall Study|Lack of Efficacy|0|||
161136636|NCT05127486|581881670|FG000|Overall Study|Pregnancy|0|||
161136637|NCT05127486|581881671|FG001|Overall Study|Pregnancy|1|||
161136638|NCT05127486|581881670|FG000|Overall Study|Physician Decision|4|||
161136639|NCT05127486|581881671|FG001|Overall Study|Physician Decision|1|||
161136640|NCT05127486|581881670|FG000|Overall Study|Withdrawal by Subject|14|||
161136641|NCT05127486|581881671|FG001|Overall Study|Withdrawal by Subject|13|||
161136642|NCT05127486|581881670|FG000|Overall Study|Lost to Follow-up|5|||
161136643|NCT05127486|581881671|FG001|Overall Study|Lost to Follow-up|8|||
161136644|NCT00363415|581881675|FG000|Overall Study|Progressive Disease|196|||
161136645|NCT00363415|581881676|FG001|Overall Study|Progressive Disease|107|||
161136646|NCT00363415|581881675|FG000|Overall Study|Sponsor Decision|67|||
161136647|NCT00363415|581881676|FG001|Overall Study|Sponsor Decision|31|||
161136648|NCT00363415|581881675|FG000|Overall Study|Death|32|||
161136649|NCT00363415|581881676|FG001|Overall Study|Death|29|||
161136650|NCT00363415|581881675|FG000|Overall Study|Adverse Event|24|||
161136651|NCT00363415|581881676|FG001|Overall Study|Adverse Event|15|||
161136652|NCT00363415|581881675|FG000|Overall Study|Physician Decision|18|||
161136653|NCT00363415|581881676|FG001|Overall Study|Physician Decision|35|||
161136654|NCT00363415|581881675|FG000|Overall Study|Entry Criteria Not Met|11|||
161136655|NCT00363415|581881676|FG001|Overall Study|Entry Criteria Not Met|10|||
161136656|NCT00363415|581881675|FG000|Overall Study|Withdrawal by Subject|9|||
161136657|NCT00363415|581881676|FG001|Overall Study|Withdrawal by Subject|15|||
161136658|NCT00363415|581881675|FG000|Overall Study|Lost to Follow-up|3|||
161136659|NCT00363415|581881676|FG001|Overall Study|Lost to Follow-up|3|||
161136660|NCT00363415|581881675|FG000|Overall Study|Protocol Violation|1|||
161136661|NCT00363415|581881676|FG001|Overall Study|Protocol Violation|4|||
160903377|NCT02468674|581040471|FG004|Overall Study|Physician Decision|0|||
160903378|NCT02468674|581040472|FG005|Overall Study|Physician Decision|0|||
160903379|NCT02468674|581040473|FG006|Overall Study|Physician Decision|1|||
160903380|NCT02468674|581040474|FG007|Overall Study|Physician Decision|0|||
160903381|NCT02468674|581040475|FG008|Overall Study|Physician Decision|0|||
160903382|NCT02468674|581040467|FG000|Overall Study|Patient/Guardian Decision|0|||
160903383|NCT02468674|581040468|FG001|Overall Study|Patient/Guardian Decision|0|||
160903384|NCT02468674|581040469|FG002|Overall Study|Patient/Guardian Decision|0|||
160903385|NCT02468674|581040470|FG003|Overall Study|Patient/Guardian Decision|0|||
160903386|NCT02468674|581040471|FG004|Overall Study|Patient/Guardian Decision|1|||
160903387|NCT02468674|581040472|FG005|Overall Study|Patient/Guardian Decision|0|||
160903388|NCT02468674|581040473|FG006|Overall Study|Patient/Guardian Decision|0|||
161247207|NCT00295490|582283429|FG001|Overall Study|Other|2|||
161247208|NCT00295490|582283430|FG002|Overall Study|Other|0|||
161247209|NCT00295490|582283431|FG003|Overall Study|Other|1|||
161247210|NCT03255980|582283432|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
161247211|NCT03255980|582283433|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
161247212|NCT03255980|582283434|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
161247213|NCT03255980|582283435|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
160832992|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
160832993|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
160832994|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
160832995|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
160832996|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
160832997|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
160832998|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
160832999|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
160833000|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
160833001|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
160833002|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
160833003|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
160833004|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
160833005|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
160833006|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
160833007|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
160833008|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
160833009|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
160833010|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
160833011|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
160833012|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
160833013|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
160833014|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
160833015|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
160833016|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
160833017|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
160833018|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
160833019|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Death|0|||
160833020|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Death|0|||
160833021|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Death|0|||
160833022|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Death|1|||
160833023|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Death|0|||
160833024|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Missing|0|||
160833025|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Missing|0|||
160833026|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Missing|1|||
160833027|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Missing|0|||
160833028|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Missing|0|||
160833029|NCT00121641|580773967|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
160833030|NCT00121641|580773968|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
160833031|NCT00121641|580773969|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
160903389|NCT02468674|581040474|FG007|Overall Study|Patient/Guardian Decision|2|||
161247214|NCT03255980|582283432|FG000|Overall Study|Adverse Event|1|||
161247215|NCT03255980|582283433|FG001|Overall Study|Adverse Event|1|||
160833032|NCT00121641|580773970|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
160833033|NCT00121641|580773971|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
160903390|NCT02468674|581040475|FG008|Overall Study|Patient/Guardian Decision|1|||
160903391|NCT02468674|581040467|FG000|Overall Study|Protocol Deviation|0|||
160903392|NCT02468674|581040468|FG001|Overall Study|Protocol Deviation|0|||
161247216|NCT03255980|582283434|FG002|Overall Study|Adverse Event|0|||
160833034|NCT03263780|580773972|FG000|Overall Study|Withdrawal by Subject|3|||
161247217|NCT03255980|582283435|FG003|Overall Study|Adverse Event|1|||
161247218|NCT03255980|582283432|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
161247219|NCT03255980|582283433|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
161247220|NCT03255980|582283434|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
161247221|NCT03255980|582283435|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
161247222|NCT03255980|582283432|FG000|Overall Study|Lost to Follow-up|1|||
161247223|NCT03255980|582283433|FG001|Overall Study|Lost to Follow-up|1|||
160833035|NCT03263780|580773972|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
160833036|NCT01565564|580773983|FG000|Overall Study|Lost to Follow-up|5|||
160833037|NCT01565564|580773984|FG001|Overall Study|Lost to Follow-up|1|||
160833038|NCT03995355|580773985|FG000|Overall Study|Adverse Event|1|||
161247224|NCT03255980|582283434|FG002|Overall Study|Lost to Follow-up|0|||
161247225|NCT03255980|582283435|FG003|Overall Study|Lost to Follow-up|3|||
161247226|NCT03255980|582283432|FG000|Overall Study|Withdrawal by Subject|0|||
161247227|NCT03255980|582283433|FG001|Overall Study|Withdrawal by Subject|1|||
161247228|NCT03255980|582283434|FG002|Overall Study|Withdrawal by Subject|0|||
161247229|NCT03255980|582283435|FG003|Overall Study|Withdrawal by Subject|3|||
161247230|NCT02611362|582283436|FG000|Overall Study|Withdrawal by Subject|7|||
161247231|NCT02611362|582283437|FG001|Overall Study|Withdrawal by Subject|2|||
161247232|NCT02611362|582283436|FG000|Overall Study|Lost to Follow-up|2|||
161247233|NCT02611362|582283437|FG001|Overall Study|Lost to Follow-up|4|||
161247234|NCT01559116|582283445|FG000|Overall Study|Adverse Event|10|||
161247235|NCT01559116|582283445|FG000|Overall Study|Lack of Efficacy|1|||
161247236|NCT01559116|582283445|FG000|Overall Study|Lost to Follow-up|1|||
161247237|NCT01559116|582283445|FG000|Overall Study|Protocol Violation|1|||
161247238|NCT01559116|582283445|FG000|Overall Study|Withdrawal by Subject|4|||
161247239|NCT01559116|582283445|FG000|Overall Study|other than stated above|9|||
161247240|NCT04577404|582283448|FG000|Overall Study|Adverse Event|31|||
161247241|NCT04577404|582283448|FG000|Overall Study|Death|1|||
161247242|NCT04577404|582283448|FG000|Overall Study|Lack of Efficacy|3|||
161247243|NCT04577404|582283448|FG000|Overall Study|Physician Decision|7|||
161247244|NCT04577404|582283448|FG000|Overall Study|Withdrawal by Subject|21|||
161247245|NCT04577404|582283448|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
161247246|NCT05468320|582283449|FG000|Overall Study|Other|1|||
161247247|NCT05468320|582283449|FG000|Overall Study|Adverse Event|1|||
161247248|NCT03921554|582283450|FG000|Overall Study|Adverse Event|2|||
161247249|NCT03921554|582283450|FG000|Overall Study|Withdrawal by Subject|1|||
161247250|NCT03921554|582283450|FG000|Overall Study|Death|3|||
161247251|NCT04440592|582283451|FG000|Overall Study|Adverse Event|8|||
161247252|NCT04440592|582283452|FG001|Overall Study|Adverse Event|0|||
161247253|NCT04440592|582283451|FG000|Overall Study|Lost to Follow-up|1|||
161247254|NCT04440592|582283452|FG001|Overall Study|Lost to Follow-up|0|||
161247255|NCT04440592|582283451|FG000|Overall Study|Withdrawal by Subject|1|||
161247256|NCT04440592|582283452|FG001|Overall Study|Withdrawal by Subject|1|||
161247257|NCT04440592|582283451|FG000|Overall Study|Other therapy needed|0|||
161247258|NCT04440592|582283452|FG001|Overall Study|Other therapy needed|1|||
161247259|NCT00762411|582285127|FG000|Initial Treatment|Death|7|||
161247260|NCT00762411|582285128|FG001|Initial Treatment|Death|6|||
161247261|NCT00762411|582285127|FG000|Initial Treatment|Adverse Event|132|||
161247262|NCT00762411|582285128|FG001|Initial Treatment|Adverse Event|40|||
161247263|NCT00762411|582285127|FG000|Initial Treatment|Protocol Violation|4|||
161247264|NCT00762411|582285128|FG001|Initial Treatment|Protocol Violation|1|||
161247265|NCT00762411|582285127|FG000|Initial Treatment|Withdrawal by Subject|65|||
161247266|NCT00762411|582285128|FG001|Initial Treatment|Withdrawal by Subject|52|||
161247267|NCT00762411|582285127|FG000|Initial Treatment|Physician Decision|1|||
161247268|NCT00762411|582285128|FG001|Initial Treatment|Physician Decision|0|||
161247269|NCT00762411|582285127|FG000|Initial Treatment|Sponsor Decision|293|||
161247270|NCT00762411|582285128|FG001|Initial Treatment|Sponsor Decision|401|||
161247271|NCT00762411|582285127|FG000|Initial Treatment|Lost to Follow-up|5|||
161247272|NCT00762411|582285128|FG001|Initial Treatment|Lost to Follow-up|0|||
160833039|NCT03995355|580773986|FG001|Overall Study|Adverse Event|0|||
160833040|NCT03995355|580773985|FG000|Overall Study|Withdrawal by Subject|1|||
160833041|NCT03995355|580773986|FG001|Overall Study|Withdrawal by Subject|0|||
160833042|NCT03995355|580773985|FG000|Overall Study|Scheduling Issues|0|||
160833043|NCT03995355|580773986|FG001|Overall Study|Scheduling Issues|1|||
161247273|NCT00762411|582285127|FG000|Initial Treatment|Caregiver Decision|21|||
160833044|NCT00249613|580773987|FG000|12 Month Follow-up|Death|1|||
160833045|NCT00249613|580773988|FG001|12 Month Follow-up|Death|1|||
161247274|NCT00762411|582285128|FG001|Initial Treatment|Caregiver Decision|16|||
161247275|NCT00762411|582285127|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
161247276|NCT00762411|582285128|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
161247277|NCT00762411|582285127|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
161247278|NCT00762411|582285128|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
161247279|NCT00762411|582285127|FG000|Delayed Start|Adverse Event|0|||
161247280|NCT00762411|582285128|FG001|Delayed Start|Adverse Event|4|||
160833046|NCT00249613|580773987|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
160833047|NCT00249613|580773988|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
161247281|NCT00762411|582285127|FG000|Delayed Start|Protocol Violation|0|||
160833048|NCT00249613|580773987|FG000|12 Month Follow-up|Lost to Follow-up|10|||
160833049|NCT00249613|580773988|FG001|12 Month Follow-up|Lost to Follow-up|8|||
160833050|NCT00094107|580773989|FG000|Overall Study|Lack of Efficacy|23|||
160833051|NCT00094107|580773989|FG000|Overall Study|Death|5|||
160833052|NCT00094107|580773989|FG000|Overall Study|Adverse Event|3|||
161247282|NCT00762411|582285128|FG001|Delayed Start|Protocol Violation|1|||
161247283|NCT00762411|582285127|FG000|Delayed Start|Sponsor Decision|16|||
161247284|NCT00762411|582285128|FG001|Delayed Start|Sponsor Decision|20|||
161247285|NCT00762411|582285127|FG000|Delayed Start|Caregiver Decision|1|||
161247286|NCT00762411|582285128|FG001|Delayed Start|Caregiver Decision|1|||
161247287|NCT00762411|582285127|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
161247288|NCT00762411|582285128|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
161247289|NCT00762411|582285127|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161247290|NCT00762411|582285128|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
161247291|NCT00762411|582285127|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
161247292|NCT00762411|582285128|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
161247293|NCT00762411|582285127|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
161247294|NCT00762411|582285128|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
161247295|NCT00762411|582285127|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
161247296|NCT00762411|582285128|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
161247297|NCT00762411|582285127|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
161247298|NCT00762411|582285128|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
161247299|NCT02710214|582285132|FG000|Overall Study|Lost to Follow-up|1|||
161247300|NCT02710214|582285133|FG001|Overall Study|Lost to Follow-up|0|||
161247301|NCT02710214|582285132|FG000|Overall Study|Lack of Efficacy|0|||
161247302|NCT02710214|582285133|FG001|Overall Study|Lack of Efficacy|1|||
161247303|NCT02710214|582285132|FG000|Overall Study|Death|0|||
161247304|NCT02710214|582285133|FG001|Overall Study|Death|1|||
161247305|NCT02832167|582285134|FG000|Treatment Period 1|Disease progression|90|||
161247306|NCT02832167|582285134|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
161247307|NCT02832167|582285134|FG000|Treatment Period 1|Death|2|||
161247308|NCT02832167|582285134|FG000|Treatment Period 1|Study Drug Toxicity|6|||
161247309|NCT02832167|582285134|FG000|Treatment Period 1|Participant request to discontinue|9|||
161247310|NCT02832167|582285134|FG000|Treatment Period 1|No longer meet study criteria|1|||
161247311|NCT02832167|582285134|FG000|Treatment Period 1|Participant withdrew consent|3|||
161247312|NCT02832167|582285134|FG000|Treatment Period 1|Other reasons|6|||
161247313|NCT02832167|582285134|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
161247314|NCT02832167|582285134|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
161247315|NCT02832167|582285134|FG000|Transition From Period 1 to Period 2|Death|2|||
161247316|NCT02832167|582285134|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
161247317|NCT02832167|582285134|FG000|Treatment Period 2|Disease progression|69|||
161247318|NCT02832167|582285134|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
161247319|NCT02832167|582285134|FG000|Treatment Period 2|Maximum clinical benefit|1|||
161247320|NCT02832167|582285134|FG000|Treatment Period 2|Study Drug Toxicity|5|||
161247321|NCT02832167|582285134|FG000|Treatment Period 2|Participant request to discontinue|2|||
161247322|NCT02832167|582285134|FG000|Treatment Period 2|Participant withdrew consent|3|||
161247323|NCT02832167|582285134|FG000|Treatment Period 2|Other reasons|3|||
161247324|NCT01754376|582285135|FG000|Overall Study|Adverse Event|1|||
161247325|NCT01754376|582285135|FG000|Overall Study|Lack of Efficacy|2|||
161247326|NCT04590781|582285136|FG000|Overall Study|Death|0|||
161247327|NCT04590781|582285137|FG001|Overall Study|Death|2|||
161247328|NCT04590781|582285136|FG000|Overall Study|Withdrawal by Subject|2|||
161247329|NCT04590781|582285137|FG001|Overall Study|Withdrawal by Subject|0|||
161247330|NCT00820599|582285139|FG000|Overall Study|Death|129|||
161247331|NCT00820599|582285139|FG000|Overall Study|Withdrawal by Subject|2|||
161247332|NCT03686215|582285140|FG000|Overall Study|Adverse Event|0|||
161247333|NCT03686215|582285141|FG001|Overall Study|Adverse Event|0|||
161247334|NCT03686215|582285142|FG002|Overall Study|Adverse Event|7|||
161247335|NCT03686215|582285140|FG000|Overall Study|Physician Decision|0|||
161247336|NCT03686215|582285141|FG001|Overall Study|Physician Decision|0|||
161247337|NCT03686215|582285142|FG002|Overall Study|Physician Decision|1|||
161247338|NCT03686215|582285140|FG000|Overall Study|Protocol Violation|0|||
161247339|NCT03686215|582285141|FG001|Overall Study|Protocol Violation|0|||
161247340|NCT03686215|582285142|FG002|Overall Study|Protocol Violation|4|||
161247341|NCT03686215|582285140|FG000|Overall Study|Device issue|1|||
161247342|NCT03686215|582285141|FG001|Overall Study|Device issue|0|||
161247343|NCT03686215|582285142|FG002|Overall Study|Device issue|2|||
161247344|NCT00063258|582285145|FG000|Overall Study|Physician Decision|2|||
161247345|NCT00063258|582285146|FG001|Overall Study|Physician Decision|0|||
160833053|NCT00094107|580773989|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
161247346|NCT00063258|582285145|FG000|Overall Study|Lack of Efficacy|2|||
161247347|NCT00063258|582285146|FG001|Overall Study|Lack of Efficacy|0|||
160833054|NCT03268941|580775922|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
161247348|NCT03988608|582285147|FG000|Overall Study|Adverse Event|1|||
161247349|NCT03988608|582285147|FG000|Overall Study|Lost to Follow-up|1|||
161247350|NCT03988608|582285147|FG000|Overall Study|Withdrawal by Subject|3|||
161247351|NCT03988608|582285147|FG000|Overall Study|Death|1|||
161247352|NCT01456962|582285155|FG000|Overall Study|Lost to Follow-up|2|||
161247353|NCT01456962|582285156|FG001|Overall Study|Lost to Follow-up|1|||
161247354|NCT03387462|582285158|FG000|Overall Study|Lost to Follow-up|1|||
161247355|NCT01460628|582285159|FG000|Overall Study|Adverse Event|3|||
161247356|NCT01460628|582285159|FG000|Overall Study|Withdrawal by Subject|2|||
161247357|NCT05029687|582285178|FG000|Overall Study|Withdrawal by Subject|4|||
161247358|NCT05029687|582285179|FG001|Overall Study|Withdrawal by Subject|0|||
161247359|NCT05029687|582285180|FG002|Overall Study|Withdrawal by Subject|2|||
161247360|NCT05029687|582285178|FG000|Overall Study|Lost to Follow-up|4|||
161247361|NCT05029687|582285179|FG001|Overall Study|Lost to Follow-up|0|||
161247362|NCT05029687|582285180|FG002|Overall Study|Lost to Follow-up|2|||
161247363|NCT02854800|582285186|FG000|Overall Study|Protocol Violation|16|||
161247364|NCT02854800|582285187|FG001|Overall Study|Protocol Violation|11|||
161247365|NCT02854800|582285188|FG002|Overall Study|Protocol Violation|3|||
161247366|NCT02854800|582285186|FG000|Overall Study|Withdrawal by Subject|4|||
161247367|NCT02854800|582285187|FG001|Overall Study|Withdrawal by Subject|2|||
161247368|NCT02854800|582285188|FG002|Overall Study|Withdrawal by Subject|3|||
161247369|NCT02372006|582285200|FG000|Overall Study|Progressive disease|8|||
161247370|NCT02372006|582285201|FG001|Overall Study|Progressive disease|7|||
161247371|NCT02372006|582285202|FG002|Overall Study|Progressive disease|34|||
161247372|NCT02372006|582285200|FG000|Overall Study|Dose limiting toxicity|0|||
161247373|NCT02372006|582285201|FG001|Overall Study|Dose limiting toxicity|1|||
161247374|NCT02372006|582285202|FG002|Overall Study|Dose limiting toxicity|0|||
161247375|NCT02372006|582285200|FG000|Overall Study|Adverse Event|0|||
161247376|NCT02372006|582285201|FG001|Overall Study|Adverse Event|0|||
161247377|NCT02372006|582285202|FG002|Overall Study|Adverse Event|3|||
161247378|NCT02372006|582285200|FG000|Overall Study|Withdrawal by Subject|0|||
161247379|NCT02372006|582285201|FG001|Overall Study|Withdrawal by Subject|1|||
161247380|NCT02372006|582285202|FG002|Overall Study|Withdrawal by Subject|1|||
161247381|NCT02372006|582285200|FG000|Overall Study|Other reason for not completing|0|||
161247382|NCT02372006|582285201|FG001|Overall Study|Other reason for not completing|0|||
161247383|NCT02372006|582285202|FG002|Overall Study|Other reason for not completing|1|||
161247384|NCT03504085|582285203|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
161247385|NCT03504085|582285204|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
161247386|NCT03504085|582285203|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
161247387|NCT03504085|582285204|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
161247388|NCT04133311|582285206|FG000|Period 1 Double Masked Treatment Period|Death|1|||
161247389|NCT04133311|582285207|FG001|Period 1 Double Masked Treatment Period|Death|0|||
161247390|NCT04133311|582285208|FG002|Period 1 Double Masked Treatment Period|Death|0|||
161247391|NCT04133311|582285209|FG003|Period 1 Double Masked Treatment Period|Death|0|||
161247392|NCT04133311|582285206|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
161247393|NCT04133311|582285207|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
161247394|NCT04133311|582285208|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
161247395|NCT04133311|582285209|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
161247396|NCT04133311|582285206|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
161247397|NCT04133311|582285207|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
161247398|NCT04133311|582285208|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
161247399|NCT04133311|582285209|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
161247400|NCT04133311|582285206|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161247401|NCT04133311|582285207|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
161247402|NCT04133311|582285208|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161247403|NCT04133311|582285209|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
161247404|NCT04133311|582285206|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
161247405|NCT04133311|582285207|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
161247406|NCT04133311|582285208|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
161247407|NCT04133311|582285209|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
161247408|NCT04133311|582285206|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161247409|NCT04133311|582285207|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161247410|NCT04133311|582285208|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
161247411|NCT04133311|582285209|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
161247412|NCT04133311|582285206|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
161247413|NCT04133311|582285207|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
161247414|NCT04133311|582285208|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
161247415|NCT04133311|582285209|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
161247416|NCT04133311|582285206|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
161247417|NCT04133311|582285207|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
161247418|NCT04133311|582285208|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
161247419|NCT04133311|582285209|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
161247420|NCT01859598|582285216|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
161247421|NCT00009945|582285217|FG000|Overall Study|no follow up data|7|||
161247422|NCT00009945|582285218|FG001|Overall Study|no follow up data|5|||
161247423|NCT00672984|582285219|FG000|First Intervention|Adverse Event|5|||
161247424|NCT00672984|582285220|FG001|First Intervention|Adverse Event|0|||
161247425|NCT00672984|582285221|FG002|First Intervention|Adverse Event|0|||
161247426|NCT00672984|582285219|FG000|First Intervention|Withdrawal by Subject|1|||
161247427|NCT00672984|582285220|FG001|First Intervention|Withdrawal by Subject|2|||
161247428|NCT00672984|582285221|FG002|First Intervention|Withdrawal by Subject|2|||
161247429|NCT00672984|582285219|FG000|First Intervention|Sponsor decision|3|||
161247430|NCT00672984|582285220|FG001|First Intervention|Sponsor decision|0|||
161247431|NCT00672984|582285221|FG002|First Intervention|Sponsor decision|0|||
161247432|NCT00672984|582285219|FG000|Second Intervention|Non-compliance with facility policies|0|||
161247433|NCT00672984|582285220|FG001|Second Intervention|Non-compliance with facility policies|2|||
161247434|NCT00672984|582285221|FG002|Second Intervention|Non-compliance with facility policies|0|||
161247435|NCT00672984|582285219|FG000|Second Intervention|Withdrawal by Subject|0|||
161247436|NCT00672984|582285220|FG001|Second Intervention|Withdrawal by Subject|3|||
161247437|NCT00672984|582285221|FG002|Second Intervention|Withdrawal by Subject|0|||
161247438|NCT00672984|582285219|FG000|Second Intervention|Protocol Violation|0|||
161247439|NCT00672984|582285220|FG001|Second Intervention|Protocol Violation|1|||
161247440|NCT00672984|582285221|FG002|Second Intervention|Protocol Violation|1|||
161247441|NCT00672984|582285219|FG000|Third Intervention|Adverse Event|1|||
161247442|NCT00672984|582285220|FG001|Third Intervention|Adverse Event|0|||
161247443|NCT00672984|582285221|FG002|Third Intervention|Adverse Event|1|||
161247444|NCT01597791|582285222|FG000|Overall Study|Physician Decision|2|||
161247445|NCT01597791|582285223|FG001|Overall Study|Physician Decision|1|||
161247446|NCT01597791|582285222|FG000|Overall Study|Cesarean Section|6|||
161247447|NCT01597791|582285223|FG001|Overall Study|Cesarean Section|7|||
161247448|NCT01597791|582285222|FG000|Overall Study|Subject withdrawal|0|||
161247449|NCT01597791|582285223|FG001|Overall Study|Subject withdrawal|1|||
161247450|NCT01597791|582285222|FG000|Overall Study|Protocol Violation|0|||
161247451|NCT01597791|582285223|FG001|Overall Study|Protocol Violation|1|||
161247452|NCT00354159|582285224|FG000|Randomized Study Period|Withdrawal by Subject|5|||
161247453|NCT00354159|582285225|FG001|Randomized Study Period|Withdrawal by Subject|3|||
161247454|NCT00354159|582285224|FG000|Randomized Study Period|Physician Decision|6|||
161247455|NCT00354159|582285225|FG001|Randomized Study Period|Physician Decision|10|||
161247456|NCT00354159|582285224|FG000|Randomized Study Period|Lost to Follow-up|4|||
161247457|NCT00354159|582285225|FG001|Randomized Study Period|Lost to Follow-up|0|||
161247458|NCT00354159|582285224|FG000|Randomized Study Period|Death|7|||
161247459|NCT00354159|582285225|FG001|Randomized Study Period|Death|9|||
161247460|NCT00354159|582285224|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
161247461|NCT00354159|582285225|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
161247462|NCT00354159|582285224|FG000|Long-term Follow-up|Physician Decision|127|||
161247463|NCT00354159|582285225|FG001|Long-term Follow-up|Physician Decision|122|||
161247464|NCT00354159|582285224|FG000|Long-term Follow-up|Lost to Follow-up|1|||
161247465|NCT00354159|582285225|FG001|Long-term Follow-up|Lost to Follow-up|0|||
161247466|NCT00354159|582285224|FG000|Long-term Follow-up|Death|14|||
161247467|NCT00354159|582285225|FG001|Long-term Follow-up|Death|11|||
161247468|NCT00354159|582285224|FG000|Long-term Follow-up|Study Closed|29|||
161247469|NCT00354159|582285225|FG001|Long-term Follow-up|Study Closed|34|||
161247470|NCT02229084|582285227|FG000|Overall Study|Adverse Event|1|||
161247471|NCT02229084|582285228|FG001|Overall Study|Adverse Event|0|||
161247472|NCT02229084|582285229|FG002|Overall Study|Adverse Event|0|||
161247473|NCT02229084|582285230|FG003|Overall Study|Adverse Event|0|||
161247474|NCT02229084|582285231|FG004|Overall Study|Adverse Event|0|||
161247475|NCT02229084|582285232|FG005|Overall Study|Adverse Event|0|||
161247476|NCT02229084|582285233|FG006|Overall Study|Adverse Event|0|||
161247477|NCT02229084|582285227|FG000|Overall Study|Lost to Follow-up|0|||
161247478|NCT02229084|582285228|FG001|Overall Study|Lost to Follow-up|0|||
161247479|NCT02229084|582285229|FG002|Overall Study|Lost to Follow-up|1|||
161247480|NCT02229084|582285230|FG003|Overall Study|Lost to Follow-up|1|||
161247481|NCT02229084|582285231|FG004|Overall Study|Lost to Follow-up|0|||
161247482|NCT02229084|582285232|FG005|Overall Study|Lost to Follow-up|0|||
161247483|NCT02229084|582285233|FG006|Overall Study|Lost to Follow-up|1|||
161247484|NCT02229084|582285227|FG000|Overall Study|Physician Decision|0|||
161247485|NCT02229084|582285228|FG001|Overall Study|Physician Decision|0|||
161247486|NCT02229084|582285229|FG002|Overall Study|Physician Decision|0|||
161247487|NCT02229084|582285230|FG003|Overall Study|Physician Decision|1|||
161247488|NCT02229084|582285231|FG004|Overall Study|Physician Decision|3|||
161247489|NCT02229084|582285232|FG005|Overall Study|Physician Decision|0|||
161247490|NCT02229084|582285233|FG006|Overall Study|Physician Decision|1|||
161247491|NCT02229084|582285227|FG000|Overall Study|Withdrawal by Subject|0|||
161247492|NCT02229084|582285228|FG001|Overall Study|Withdrawal by Subject|0|||
161247493|NCT02229084|582285229|FG002|Overall Study|Withdrawal by Subject|1|||
161247494|NCT02229084|582285230|FG003|Overall Study|Withdrawal by Subject|0|||
161247495|NCT02229084|582285231|FG004|Overall Study|Withdrawal by Subject|1|||
161247496|NCT02229084|582285232|FG005|Overall Study|Withdrawal by Subject|1|||
161247497|NCT02229084|582285233|FG006|Overall Study|Withdrawal by Subject|1|||
161247498|NCT02229084|582285227|FG000|Overall Study|Death|0|||
161247499|NCT02229084|582285228|FG001|Overall Study|Death|0|||
161247500|NCT02229084|582285229|FG002|Overall Study|Death|0|||
161247501|NCT02229084|582285230|FG003|Overall Study|Death|0|||
161247502|NCT02229084|582285231|FG004|Overall Study|Death|0|||
161247503|NCT02229084|582285232|FG005|Overall Study|Death|0|||
161247504|NCT02229084|582285233|FG006|Overall Study|Death|1|||
161247505|NCT01728116|582285234|FG000|Overall Study|Sponsor Terminated Study|106|||
161247506|NCT01728116|582285235|FG001|Overall Study|Sponsor Terminated Study|35|||
161247507|NCT01728116|582285234|FG000|Overall Study|Withdrawal by Subject|16|||
161247508|NCT01728116|582285235|FG001|Overall Study|Withdrawal by Subject|9|||
161247509|NCT01728116|582285234|FG000|Overall Study|Adverse Event|13|||
161247510|NCT01728116|582285235|FG001|Overall Study|Adverse Event|0|||
161247511|NCT01728116|582285234|FG000|Overall Study|Procedure/device failure|7|||
161247512|NCT01728116|582285235|FG001|Overall Study|Procedure/device failure|0|||
161247513|NCT01728116|582285234|FG000|Overall Study|Lost to Follow-up|9|||
161247514|NCT01728116|582285235|FG001|Overall Study|Lost to Follow-up|2|||
161247515|NCT01728116|582285234|FG000|Overall Study|Physician Decision|2|||
161247516|NCT01728116|582285235|FG001|Overall Study|Physician Decision|0|||
161247517|NCT01728116|582285234|FG000|Overall Study|Subject Non-Compliance|2|||
161247518|NCT01728116|582285235|FG001|Overall Study|Subject Non-Compliance|0|||
161247519|NCT01728116|582285234|FG000|Overall Study|Inter-current finding at procedure|1|||
161247520|NCT01728116|582285235|FG001|Overall Study|Inter-current finding at procedure|0|||
161247521|NCT01728116|582285234|FG000|Overall Study|Incorrectly enrolled in Study|0|||
161247522|NCT01728116|582285235|FG001|Overall Study|Incorrectly enrolled in Study|1|||
161247523|NCT01728116|582285234|FG000|Overall Study|various not noted previously|5|||
161247524|NCT01728116|582285235|FG001|Overall Study|various not noted previously|0|||
161247525|NCT01868243|582285241|FG000|Overall Study|Death|0|||
161247526|NCT01868243|582285242|FG001|Overall Study|Death|1|||
161247527|NCT01745094|582285244|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
161247528|NCT01745094|582285245|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
161247529|NCT01745094|582285246|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
161247530|NCT01745094|582285247|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
161247531|NCT01745094|582285244|FG000|Overall Study|Adverse Event|0|||
161247532|NCT01745094|582285245|FG001|Overall Study|Adverse Event|0|||
161247533|NCT01745094|582285246|FG002|Overall Study|Adverse Event|3|||
161247534|NCT01745094|582285247|FG003|Overall Study|Adverse Event|0|||
161247535|NCT01745094|582285244|FG000|Overall Study|Withdrawal by Subject|2|||
161247536|NCT01745094|582285245|FG001|Overall Study|Withdrawal by Subject|0|||
161247537|NCT01745094|582285246|FG002|Overall Study|Withdrawal by Subject|1|||
161247538|NCT01745094|582285247|FG003|Overall Study|Withdrawal by Subject|2|||
161247539|NCT01745094|582285244|FG000|Overall Study|Protocol Violation|1|||
161247540|NCT01745094|582285245|FG001|Overall Study|Protocol Violation|0|||
161247541|NCT01745094|582285246|FG002|Overall Study|Protocol Violation|3|||
161247542|NCT01745094|582285247|FG003|Overall Study|Protocol Violation|1|||
161247543|NCT01745094|582285244|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
161247544|NCT01745094|582285245|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
161247545|NCT01745094|582285246|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
161247546|NCT01745094|582285247|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
161247547|NCT01745094|582285244|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
161247548|NCT01745094|582285245|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
161247549|NCT01745094|582285246|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
161247550|NCT01745094|582285247|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
161247551|NCT01745094|582285244|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
161247552|NCT01745094|582285245|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161247553|NCT01745094|582285246|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161247554|NCT01745094|582285247|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
161247555|NCT04610580|582285248|FG000|Two-way Crossover Period|Adverse Event|1|||
161247556|NCT04610580|582285249|FG001|Two-way Crossover Period|Adverse Event|0|||
161247557|NCT04610580|582285250|FG002|Two-way Crossover Period|Adverse Event|0|||
161247558|NCT04610580|582285251|FG003|Two-way Crossover Period|Adverse Event|0|||
161247559|NCT04610580|582285252|FG004|Two-way Crossover Period|Adverse Event|0|||
161247560|NCT04610580|582285253|FG005|Two-way Crossover Period|Adverse Event|0|||
161247561|NCT04610580|582285248|FG000|Two-way Crossover Period|Physician Decision|1|||
160903393|NCT02468674|581040469|FG002|Overall Study|Protocol Deviation|0|||
161247562|NCT04610580|582285249|FG001|Two-way Crossover Period|Physician Decision|0|||
161247563|NCT04610580|582285250|FG002|Two-way Crossover Period|Physician Decision|0|||
161247564|NCT04610580|582285251|FG003|Two-way Crossover Period|Physician Decision|0|||
161247565|NCT04610580|582285252|FG004|Two-way Crossover Period|Physician Decision|0|||
161247566|NCT04610580|582285253|FG005|Two-way Crossover Period|Physician Decision|0|||
161247567|NCT04610580|582285248|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
161247568|NCT04610580|582285249|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
161247569|NCT04610580|582285250|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
161247570|NCT04610580|582285251|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
161247571|NCT04610580|582285252|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
161247572|NCT04610580|582285253|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
161247573|NCT04610580|582285248|FG000|Two-way Crossover Period|Other than specified|0|||
161247574|NCT04610580|582285249|FG001|Two-way Crossover Period|Other than specified|1|||
161247575|NCT04610580|582285250|FG002|Two-way Crossover Period|Other than specified|0|||
161247576|NCT04610580|582285251|FG003|Two-way Crossover Period|Other than specified|0|||
161247577|NCT04610580|582285252|FG004|Two-way Crossover Period|Other than specified|0|||
161247578|NCT04610580|582285253|FG005|Two-way Crossover Period|Other than specified|0|||
161247579|NCT04610580|582285248|FG000|Washout Before Extension Period|Other than specified|0|||
161247580|NCT04610580|582285249|FG001|Washout Before Extension Period|Other than specified|1|||
161247581|NCT04610580|582285250|FG002|Washout Before Extension Period|Other than specified|0|||
161247582|NCT04610580|582285251|FG003|Washout Before Extension Period|Other than specified|0|||
161247583|NCT04610580|582285252|FG004|Washout Before Extension Period|Other than specified|0|||
161247584|NCT04610580|582285253|FG005|Washout Before Extension Period|Other than specified|0|||
161247585|NCT04610580|582285248|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
161247586|NCT04610580|582285249|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
161247587|NCT04610580|582285250|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
161247588|NCT04610580|582285251|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
161247589|NCT04610580|582285252|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
161247590|NCT04610580|582285253|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
161247591|NCT04610580|582285248|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161247592|NCT04610580|582285249|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161247593|NCT04610580|582285250|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161334906|NCT03167242|582615854|FG007|Overall Study|Reason not provided|0|||
160833055|NCT03268941|580775923|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160903394|NCT02468674|581040470|FG003|Overall Study|Protocol Deviation|0|||
160903395|NCT02468674|581040471|FG004|Overall Study|Protocol Deviation|0|||
160903396|NCT02468674|581040472|FG005|Overall Study|Protocol Deviation|0|||
160903397|NCT02468674|581040473|FG006|Overall Study|Protocol Deviation|0|||
160903398|NCT02468674|581040474|FG007|Overall Study|Protocol Deviation|1|||
160903399|NCT02468674|581040475|FG008|Overall Study|Protocol Deviation|1|||
160903400|NCT03281577|581040483|FG000|Overall Study|Adverse Event|0|||
160903401|NCT03281577|581040484|FG001|Overall Study|Adverse Event|0|||
160903402|NCT03281577|581040485|FG002|Overall Study|Adverse Event|0|||
160903403|NCT03281577|581040486|FG003|Overall Study|Adverse Event|1|||
160903404|NCT03281577|581040483|FG000|Overall Study|Withdrawal by Subject|1|||
160903405|NCT03281577|581040484|FG001|Overall Study|Withdrawal by Subject|0|||
160903406|NCT03281577|581040485|FG002|Overall Study|Withdrawal by Subject|0|||
160903407|NCT03281577|581040486|FG003|Overall Study|Withdrawal by Subject|0|||
161136662|NCT02688647|581881679|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
161136663|NCT02688647|581881680|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
161136664|NCT02688647|581881679|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
161136665|NCT02688647|581881680|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
161136666|NCT02688647|581881679|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
161136667|NCT02688647|581881680|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
161136668|NCT02688647|581881679|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
161136669|NCT02688647|581881680|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
161136670|NCT02688647|581881679|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
161136671|NCT02688647|581881680|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
161136672|NCT02688647|581881679|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
161136673|NCT02688647|581881680|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
161136674|NCT02688647|581881679|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
161136675|NCT02688647|581881680|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
161136676|NCT03619213|581881681|FG000|Overall Study|Lost to Follow-up|2|||
161136677|NCT03619213|581881682|FG001|Overall Study|Lost to Follow-up|1|||
161136678|NCT03619213|581881681|FG000|Overall Study|Withdrawal by Subject|8|||
161136679|NCT03619213|581881682|FG001|Overall Study|Withdrawal by Subject|10|||
161247594|NCT04610580|582285251|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161334907|NCT03167242|582615855|FG008|Overall Study|Reason not provided|1|||
160833056|NCT03268941|580775924|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833057|NCT03268941|580775925|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
160833058|NCT03268941|580775926|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833059|NCT03268941|580775927|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833060|NCT03268941|580775928|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
160833061|NCT03268941|580775922|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833062|NCT03268941|580775923|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833063|NCT03268941|580775924|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833064|NCT03268941|580775925|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
160833065|NCT03268941|580775926|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833066|NCT03268941|580775927|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
160833067|NCT03268941|580775928|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
160903408|NCT01644565|581040487|FG000|Overall Study|Undisclosed Medical History|1|||
160903409|NCT01644565|581040488|FG001|Overall Study|Undisclosed Medical History|0|||
160903410|NCT01644565|581040489|FG002|Overall Study|Undisclosed Medical History|0|||
160903411|NCT01644565|581040490|FG003|Overall Study|Undisclosed Medical History|0|||
160903412|NCT01644565|581040491|FG004|Overall Study|Undisclosed Medical History|0|||
160903413|NCT01644565|581040492|FG005|Overall Study|Undisclosed Medical History|0|||
160991210|NCT05174065|581355538|FG002|Placebo-controlled Period|Other|0|||
160991211|NCT05174065|581355536|FG000|Placebo-controlled Period|Adverse Event|1|||
160991212|NCT05174065|581355537|FG001|Placebo-controlled Period|Adverse Event|1|||
160991213|NCT05174065|581355538|FG002|Placebo-controlled Period|Adverse Event|0|||
160991214|NCT05174065|581355536|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
160991215|NCT05174065|581355537|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
160991216|NCT05174065|581355538|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
160991217|NCT05174065|581355536|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
160991218|NCT05174065|581355537|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
160991219|NCT05174065|581355538|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
160991220|NCT05174065|581355536|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
160991221|NCT05174065|581355537|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
160991222|NCT05174065|581355538|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
160991223|NCT02909101|581355540|FG000|Overall Study|Lost to Follow-up|1|||
160991224|NCT02909101|581355541|FG001|Overall Study|Lost to Follow-up|1|||
160991225|NCT00604786|581355542|FG000|Overall Study|Lost to Follow-up|2|||
161247595|NCT04610580|582285252|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
161247596|NCT04610580|582285253|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
161247597|NCT01451541|582285255|FG000|Overall Study|Adverse Event|4|||
161247598|NCT01451541|582285256|FG001|Overall Study|Adverse Event|3|||
161247599|NCT01451541|582285257|FG002|Overall Study|Adverse Event|6|||
161247600|NCT01451541|582285255|FG000|Overall Study|Lack of Efficacy|2|||
161247601|NCT01451541|582285256|FG001|Overall Study|Lack of Efficacy|0|||
161247602|NCT01451541|582285257|FG002|Overall Study|Lack of Efficacy|0|||
160903414|NCT01644565|581040493|FG006|Overall Study|Undisclosed Medical History|0|||
160903415|NCT01644565|581040494|FG007|Overall Study|Undisclosed Medical History|0|||
160903416|NCT01644565|581040495|FG008|Overall Study|Undisclosed Medical History|0|||
160903417|NCT01644565|581040487|FG000|Overall Study|Lost to Follow-up|0|||
160903418|NCT01644565|581040488|FG001|Overall Study|Lost to Follow-up|0|||
160903419|NCT01644565|581040489|FG002|Overall Study|Lost to Follow-up|0|||
160903420|NCT01644565|581040490|FG003|Overall Study|Lost to Follow-up|1|||
160903421|NCT01644565|581040491|FG004|Overall Study|Lost to Follow-up|0|||
160903422|NCT01644565|581040492|FG005|Overall Study|Lost to Follow-up|0|||
160903423|NCT01644565|581040493|FG006|Overall Study|Lost to Follow-up|0|||
160903424|NCT01644565|581040494|FG007|Overall Study|Lost to Follow-up|2|||
160903425|NCT01644565|581040495|FG008|Overall Study|Lost to Follow-up|0|||
160903426|NCT01644565|581040487|FG000|Overall Study|Family emergency|0|||
160903427|NCT01644565|581040488|FG001|Overall Study|Family emergency|0|||
160903428|NCT01644565|581040489|FG002|Overall Study|Family emergency|0|||
160903429|NCT01644565|581040490|FG003|Overall Study|Family emergency|0|||
160903430|NCT01644565|581040491|FG004|Overall Study|Family emergency|1|||
160903431|NCT01644565|581040492|FG005|Overall Study|Family emergency|0|||
160903432|NCT01644565|581040493|FG006|Overall Study|Family emergency|0|||
160903433|NCT01644565|581040494|FG007|Overall Study|Family emergency|0|||
160903434|NCT01644565|581040495|FG008|Overall Study|Family emergency|0|||
160903435|NCT01644565|581040487|FG000|Overall Study|Relocation|0|||
160903436|NCT01644565|581040488|FG001|Overall Study|Relocation|0|||
160903437|NCT01644565|581040489|FG002|Overall Study|Relocation|0|||
160903438|NCT01644565|581040490|FG003|Overall Study|Relocation|0|||
160903439|NCT01644565|581040491|FG004|Overall Study|Relocation|0|||
160903440|NCT01644565|581040492|FG005|Overall Study|Relocation|0|||
160903441|NCT01644565|581040493|FG006|Overall Study|Relocation|0|||
160903442|NCT01644565|581040494|FG007|Overall Study|Relocation|0|||
160903443|NCT01644565|581040495|FG008|Overall Study|Relocation|1|||
160903444|NCT01687998|581040496|FG000|Overall Study|Withdrawal by Subject|49|||
160903445|NCT01687998|581040497|FG001|Overall Study|Withdrawal by Subject|51|||
160903446|NCT01687998|581040496|FG000|Overall Study|Known to be Alive at Study End|54|||
160903447|NCT01687998|581040497|FG001|Overall Study|Known to be Alive at Study End|62|||
160903448|NCT01687998|581040496|FG000|Overall Study|Lost to Follow-up|9|||
160991226|NCT00604786|581355543|FG001|Overall Study|Lost to Follow-up|0|||
161247603|NCT01451541|582285255|FG000|Overall Study|Lost to Follow-up|4|||
160991227|NCT03697460|581355544|FG000|Overall Study|Withdrawal by Subject|3|||
161247604|NCT01451541|582285256|FG001|Overall Study|Lost to Follow-up|4|||
161247605|NCT01451541|582285257|FG002|Overall Study|Lost to Follow-up|7|||
161334908|NCT03167242|582615856|FG009|Overall Study|Reason not provided|0|||
160903449|NCT01687998|581040497|FG001|Overall Study|Lost to Follow-up|7|||
160903450|NCT00443261|581040500|FG000|Overall Study|Death|1|||
160903451|NCT01663532|581040501|FG000|Overall Study|Lost to Follow-up|9|||
160903452|NCT01663532|581040502|FG001|Overall Study|Lost to Follow-up|10|||
160903453|NCT01663532|581040501|FG000|Overall Study|Adverse Event|7|||
160903454|NCT01663532|581040502|FG001|Overall Study|Adverse Event|13|||
160903455|NCT01663532|581040501|FG000|Overall Study|Met Withdrawal Criteria|7|||
161247606|NCT01451541|582285255|FG000|Overall Study|Withdrawal by Subject|15|||
161247607|NCT01451541|582285256|FG001|Overall Study|Withdrawal by Subject|8|||
161247608|NCT01451541|582285257|FG002|Overall Study|Withdrawal by Subject|6|||
161247609|NCT01451541|582285255|FG000|Overall Study|randomization error, noncompliance|11|||
161247610|NCT01451541|582285256|FG001|Overall Study|randomization error, noncompliance|10|||
161247611|NCT01451541|582285257|FG002|Overall Study|randomization error, noncompliance|8|||
161247612|NCT05665387|582285258|FG000|Overall Study|Withdrawal by Subject|1|||
161247613|NCT05665387|582285259|FG001|Overall Study|Withdrawal by Subject|0|||
161247614|NCT05665387|582285260|FG002|Overall Study|Withdrawal by Subject|1|||
161247615|NCT01824498|582285261|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
161247616|NCT01824498|582285262|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
161247617|NCT01824498|582285263|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
161247618|NCT01824498|582285264|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
161247619|NCT01824498|582285265|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
161247620|NCT01824498|582285266|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
161247621|NCT00006436|582285267|FG000|Overall Study|Refused further treatment|2|||
161247622|NCT00006436|582285267|FG000|Overall Study|Declined to participate (before treatment started)|1|||
161247623|NCT00939523|582285268|FG000|Overall Study|Lack of Efficacy|1|||
161247624|NCT00939523|582285268|FG000|Overall Study|Physician Decision|2|||
161247625|NCT01528735|582285275|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
161247626|NCT01528735|582285276|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
161247627|NCT01528735|582285275|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
161247628|NCT01528735|582285276|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
161247629|NCT03555695|582285277|FG000|Overall Study|Withdrawal by Subject|1|||
161247630|NCT03555695|582285277|FG000|Overall Study|Lost to Follow-up|1|||
161136680|NCT00382967|581881683|FG000|Overall Study|Protocol Violation|1|||
161136681|NCT00382967|581881684|FG001|Overall Study|Protocol Violation|1|||
161136682|NCT02542267|581881686|FG000|Overall Study|Withdrawal by Subject|10|||
161136683|NCT02542267|581881686|FG000|Overall Study|Physician Decision|6|||
161136684|NCT02542267|581881686|FG000|Overall Study|Lost to Follow-up|4|||
161136685|NCT02542267|581881686|FG000|Overall Study|Death|13|||
161136686|NCT02542267|581881686|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
161136687|NCT02542267|581881686|FG000|Overall Study|Other|9|||
161136688|NCT03093402|581881687|FG000|Overall Study|Lost to Follow-up|1|||
161136689|NCT03093402|581881688|FG001|Overall Study|Lost to Follow-up|0|||
161136690|NCT03093402|581881689|FG002|Overall Study|Lost to Follow-up|0|||
161136691|NCT03093402|581881690|FG003|Overall Study|Lost to Follow-up|0|||
161136692|NCT03093402|581881687|FG000|Overall Study|Withdrawal by Subject|3|||
161136693|NCT03093402|581881688|FG001|Overall Study|Withdrawal by Subject|3|||
161136694|NCT03093402|581881689|FG002|Overall Study|Withdrawal by Subject|0|||
161136695|NCT03093402|581881690|FG003|Overall Study|Withdrawal by Subject|1|||
161136696|NCT03093402|581881687|FG000|Overall Study|Withdrew prior to dosing|2|||
161136697|NCT03093402|581881688|FG001|Overall Study|Withdrew prior to dosing|1|||
161136698|NCT03093402|581881689|FG002|Overall Study|Withdrew prior to dosing|2|||
161136699|NCT03093402|581881690|FG003|Overall Study|Withdrew prior to dosing|3|||
161136700|NCT03093402|581881687|FG000|Overall Study|Ineligible for study|1|||
161136701|NCT03093402|581881688|FG001|Overall Study|Ineligible for study|0|||
161136702|NCT03093402|581881689|FG002|Overall Study|Ineligible for study|0|||
161136703|NCT03093402|581881690|FG003|Overall Study|Ineligible for study|0|||
161136704|NCT03093402|581881687|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
161136705|NCT03093402|581881688|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
161136706|NCT03093402|581881689|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
161136707|NCT03093402|581881690|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
161136708|NCT01147497|581881695|FG000|Overall Study|failed insertion|2|||
161136709|NCT01147497|581881696|FG001|Overall Study|failed insertion|0|||
161136710|NCT00501228|581881697|FG000|Overall Study|Withdrawal by Subject|1|||
161136711|NCT02731742|581881698|FG000|Overall Study|Death|1|||
161136712|NCT02731742|581881699|FG001|Overall Study|Death|2|||
161136713|NCT02731742|581881700|FG002|Overall Study|Death|5|||
161136714|NCT02731742|581881701|FG003|Overall Study|Death|0|||
161136715|NCT02731742|581881698|FG000|Overall Study|Physician Decision|0|||
161136716|NCT02731742|581881699|FG001|Overall Study|Physician Decision|0|||
161136717|NCT02731742|581881700|FG002|Overall Study|Physician Decision|0|||
161136718|NCT02731742|581881701|FG003|Overall Study|Physician Decision|1|||
161136719|NCT02731742|581881698|FG000|Overall Study|Study Terminated by Sponsor|2|||
161136720|NCT02731742|581881699|FG001|Overall Study|Study Terminated by Sponsor|1|||
161247631|NCT03555695|582285277|FG000|Overall Study|appendicitis (unrelated)|1|||
161247632|NCT03555695|582285277|FG000|Overall Study|pre-existing sciatica|1|||
161136721|NCT02731742|581881700|FG002|Overall Study|Study Terminated by Sponsor|1|||
161136722|NCT02731742|581881701|FG003|Overall Study|Study Terminated by Sponsor|1|||
161136723|NCT04026568|581881702|FG000|Overall Study|study terminated|0|||
161136724|NCT04026568|581881703|FG001|Overall Study|study terminated|1|||
161136725|NCT00331760|581881704|FG000|Overall Study|Ineligible / no protocol treatment|15|||
161136726|NCT00331760|581881705|FG001|Overall Study|Ineligible / no protocol treatment|8|||
161136727|NCT00461175|581881706|FG000|Overall Study|Protocol Violation|522|||
160833068|NCT03268941|580775922|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
160833069|NCT03268941|580775923|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833070|NCT03268941|580775924|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833071|NCT03268941|580775925|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833072|NCT03268941|580775926|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833073|NCT03268941|580775927|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833074|NCT03268941|580775928|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
160833075|NCT03268941|580775922|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
160833076|NCT03268941|580775923|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
160833077|NCT03268941|580775924|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
160833078|NCT03268941|580775925|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
160833079|NCT03268941|580775926|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
160833080|NCT03268941|580775927|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
161136728|NCT00461175|581881707|FG001|Overall Study|Protocol Violation|365|||
160833081|NCT03268941|580775928|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
160833082|NCT03268941|580775922|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
161136729|NCT00316264|581881709|FG000|Overall Study|Lost to Follow-up|0|||
161136730|NCT00316264|581881710|FG001|Overall Study|Lost to Follow-up|1|||
161136731|NCT00316264|581881711|FG002|Overall Study|Lost to Follow-up|0|||
161136732|NCT00316264|581881709|FG000|Overall Study|Withdrawal of Consent|3|||
161136733|NCT00316264|581881710|FG001|Overall Study|Withdrawal of Consent|5|||
161136734|NCT00316264|581881711|FG002|Overall Study|Withdrawal of Consent|6|||
161136735|NCT00316264|581881709|FG000|Overall Study|Death|2|||
161136736|NCT00316264|581881710|FG001|Overall Study|Death|0|||
161136737|NCT00316264|581881711|FG002|Overall Study|Death|0|||
161136738|NCT00316264|581881709|FG000|Overall Study|Other|1|||
161136739|NCT00316264|581881710|FG001|Overall Study|Other|1|||
161136740|NCT00316264|581881711|FG002|Overall Study|Other|0|||
161136741|NCT00607048|581881712|FG000|Overall Study|Adverse Event|0|||
161136742|NCT00607048|581881713|FG001|Overall Study|Adverse Event|1|||
161136743|NCT00607048|581881714|FG002|Overall Study|Adverse Event|0|||
161136744|NCT00607048|581881715|FG003|Overall Study|Adverse Event|0|||
161136745|NCT00607048|581881716|FG004|Overall Study|Adverse Event|4|||
161136746|NCT00607048|581881717|FG005|Overall Study|Adverse Event|0|||
161136747|NCT00607048|581881712|FG000|Overall Study|Global deterioration of health|1|||
161136748|NCT00607048|581881713|FG001|Overall Study|Global deterioration of health|0|||
161136749|NCT00607048|581881714|FG002|Overall Study|Global deterioration of health|0|||
161136750|NCT00607048|581881715|FG003|Overall Study|Global deterioration of health|0|||
161136751|NCT00607048|581881716|FG004|Overall Study|Global deterioration of health|0|||
161136752|NCT00607048|581881717|FG005|Overall Study|Global deterioration of health|0|||
161136753|NCT00607048|581881712|FG000|Overall Study|Objective disease progression - relapse|1|||
161136754|NCT00607048|581881713|FG001|Overall Study|Objective disease progression - relapse|2|||
161136755|NCT00607048|581881714|FG002|Overall Study|Objective disease progression - relapse|4|||
161136756|NCT00607048|581881715|FG003|Overall Study|Objective disease progression - relapse|2|||
161136757|NCT00607048|581881716|FG004|Overall Study|Objective disease progression - relapse|2|||
161136758|NCT00607048|581881717|FG005|Overall Study|Objective disease progression - relapse|2|||
161136759|NCT00607048|581881712|FG000|Overall Study|Withdrawal by Subject|0|||
161136760|NCT00607048|581881713|FG001|Overall Study|Withdrawal by Subject|0|||
161136761|NCT00607048|581881714|FG002|Overall Study|Withdrawal by Subject|0|||
161136762|NCT00607048|581881715|FG003|Overall Study|Withdrawal by Subject|1|||
161136763|NCT00607048|581881716|FG004|Overall Study|Withdrawal by Subject|0|||
161136764|NCT00607048|581881717|FG005|Overall Study|Withdrawal by Subject|2|||
161136765|NCT00607048|581881712|FG000|Overall Study|Other|1|||
161136766|NCT00607048|581881713|FG001|Overall Study|Other|1|||
161136767|NCT00607048|581881714|FG002|Overall Study|Other|0|||
161136768|NCT00607048|581881715|FG003|Overall Study|Other|0|||
161136769|NCT00607048|581881716|FG004|Overall Study|Other|0|||
161136770|NCT00607048|581881717|FG005|Overall Study|Other|1|||
161136771|NCT02620020|581881725|FG000|Overall Study|Adverse Event|8|||
161136772|NCT02620020|581881726|FG001|Overall Study|Adverse Event|4|||
161136773|NCT02620020|581881727|FG002|Overall Study|Adverse Event|3|||
161136774|NCT02620020|581881728|FG003|Overall Study|Adverse Event|5|||
161136775|NCT02620020|581881725|FG000|Overall Study|Lost to Follow-up|4|||
161136776|NCT02620020|581881726|FG001|Overall Study|Lost to Follow-up|8|||
161136777|NCT02620020|581881727|FG002|Overall Study|Lost to Follow-up|1|||
161136778|NCT02620020|581881728|FG003|Overall Study|Lost to Follow-up|4|||
161136779|NCT02620020|581881725|FG000|Overall Study|Physician Decision|7|||
161136780|NCT02620020|581881726|FG001|Overall Study|Physician Decision|4|||
161136781|NCT02620020|581881727|FG002|Overall Study|Physician Decision|3|||
161136782|NCT02620020|581881728|FG003|Overall Study|Physician Decision|4|||
161136783|NCT02620020|581881725|FG000|Overall Study|Protocol Violation|5|||
161136784|NCT02620020|581881726|FG001|Overall Study|Protocol Violation|2|||
161136785|NCT02620020|581881727|FG002|Overall Study|Protocol Violation|1|||
161136786|NCT02620020|581881728|FG003|Overall Study|Protocol Violation|1|||
161136787|NCT02620020|581881725|FG000|Overall Study|Withdrawal by Subject|20|||
161334909|NCT03167242|582615857|FG010|Overall Study|Reason not provided|0|||
161334910|NCT03167242|582615858|FG011|Overall Study|Reason not provided|0|||
161334911|NCT03786380|582615860|FG000|Overall Study|Adverse Event|1|||
160833083|NCT03268941|580775923|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833084|NCT03268941|580775924|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833085|NCT03268941|580775925|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833086|NCT03268941|580775926|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833087|NCT03268941|580775927|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
160833088|NCT03268941|580775928|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
160833089|NCT02720692|580775933|FG000|Overall Study|Withdrawal by Subject|3|||
160833090|NCT02720692|580775934|FG001|Overall Study|Withdrawal by Subject|0|||
160833091|NCT02720692|580775933|FG000|Overall Study|Physician Decision|1|||
160833092|NCT02720692|580775934|FG001|Overall Study|Physician Decision|0|||
160833093|NCT02720692|580775933|FG000|Overall Study|Lost to Follow-up|8|||
160833094|NCT02720692|580775934|FG001|Overall Study|Lost to Follow-up|3|||
160833095|NCT02720692|580775933|FG000|Overall Study|Subject unable to return for visit|1|||
160833096|NCT02720692|580775934|FG001|Overall Study|Subject unable to return for visit|0|||
160833097|NCT03878758|580775935|FG000|Overall Study|Withdrawal by Subject|1|||
160833098|NCT03878758|580775935|FG000|Overall Study|Protocol defined|2|||
160833099|NCT03878758|580775935|FG000|Overall Study|Improper consent documentation|1|||
160833100|NCT03614325|580775936|FG000|Overall Study|Withdrawal by Subject|0|||
160833101|NCT03614325|580775937|FG001|Overall Study|Withdrawal by Subject|2|||
160833102|NCT03614325|580775936|FG000|Overall Study|Surgery Cancelled|2|||
160833103|NCT03614325|580775937|FG001|Overall Study|Surgery Cancelled|1|||
160833104|NCT03614325|580775936|FG000|Overall Study|Lost to Follow-up|2|||
160833105|NCT03614325|580775937|FG001|Overall Study|Lost to Follow-up|1|||
160833106|NCT03614325|580775936|FG000|Overall Study|Surgery never scheduled|1|||
160833107|NCT03614325|580775937|FG001|Overall Study|Surgery never scheduled|0|||
160833108|NCT00652951|580775943|FG000|Booster Phase|Adverse event, non-fatal|0|||
160991228|NCT03369951|581355545|FG000|Overall Study|Withdrawal by Subject|3|||
161136788|NCT02620020|581881726|FG001|Overall Study|Withdrawal by Subject|16|||
161136789|NCT02620020|581881727|FG002|Overall Study|Withdrawal by Subject|17|||
161136790|NCT02620020|581881728|FG003|Overall Study|Withdrawal by Subject|12|||
161136791|NCT02620020|581881725|FG000|Overall Study|Death|0|||
161136792|NCT02620020|581881726|FG001|Overall Study|Death|1|||
161136793|NCT02620020|581881727|FG002|Overall Study|Death|0|||
161136794|NCT02620020|581881728|FG003|Overall Study|Death|0|||
161136795|NCT02209506|581881732|FG000|Overall Study|Withdrawal by Subject|0|||
161136796|NCT02209506|581881733|FG001|Overall Study|Withdrawal by Subject|0|||
161136797|NCT02209506|581881734|FG002|Overall Study|Withdrawal by Subject|0|||
161136798|NCT02209506|581881735|FG003|Overall Study|Withdrawal by Subject|0|||
161136799|NCT02209506|581881736|FG004|Overall Study|Withdrawal by Subject|1|||
161136800|NCT00098787|581881737|FG000|Overall Study|Never started treatment|3|||
161136801|NCT00098787|581881738|FG001|Overall Study|Never started treatment|2|||
161136802|NCT00098787|581881739|FG002|Overall Study|Never started treatment|1|||
161136803|NCT00098787|581881737|FG000|Overall Study|Ineligible|9|||
161136804|NCT00098787|581881738|FG001|Overall Study|Ineligible|7|||
161136805|NCT00098787|581881739|FG002|Overall Study|Ineligible|3|||
161136806|NCT00098787|581881737|FG000|Overall Study|Disease progression|28|||
161136807|NCT00098787|581881738|FG001|Overall Study|Disease progression|17|||
161136808|NCT00098787|581881739|FG002|Overall Study|Disease progression|23|||
161136809|NCT00098787|581881737|FG000|Overall Study|Adverse Event|8|||
161136810|NCT00098787|581881738|FG001|Overall Study|Adverse Event|17|||
161136811|NCT00098787|581881739|FG002|Overall Study|Adverse Event|8|||
161136812|NCT00098787|581881737|FG000|Overall Study|Death|6|||
161136813|NCT00098787|581881738|FG001|Overall Study|Death|1|||
161136814|NCT00098787|581881739|FG002|Overall Study|Death|0|||
161136815|NCT00098787|581881737|FG000|Overall Study|Withdrawal by Subject|4|||
161136816|NCT00098787|581881738|FG001|Overall Study|Withdrawal by Subject|12|||
161136817|NCT00098787|581881739|FG002|Overall Study|Withdrawal by Subject|6|||
161136818|NCT00098787|581881737|FG000|Overall Study|Alternative therapy|8|||
161136819|NCT00098787|581881738|FG001|Overall Study|Alternative therapy|13|||
161136820|NCT00098787|581881739|FG002|Overall Study|Alternative therapy|13|||
161136821|NCT00098787|581881737|FG000|Overall Study|Other|7|||
161136822|NCT00098787|581881738|FG001|Overall Study|Other|6|||
161136823|NCT00098787|581881739|FG002|Overall Study|Other|9|||
161136824|NCT02203149|581881740|FG000|Part 1|Adverse Event|0|||
161136825|NCT02203149|581881741|FG001|Part 1|Adverse Event|1|||
161136826|NCT02203149|581881742|FG002|Part 1|Adverse Event|0|||
161136827|NCT02203149|581881743|FG003|Part 1|Adverse Event|0|||
161136828|NCT02203149|581881744|FG004|Part 1|Adverse Event|0|||
161136829|NCT02203149|581881740|FG000|Part 2|Death|0|||
161136830|NCT02203149|581881741|FG001|Part 2|Death|0|||
161136831|NCT02203149|581881742|FG002|Part 2|Death|1|||
161136832|NCT02203149|581881743|FG003|Part 2|Death|1|||
161136833|NCT02203149|581881744|FG004|Part 2|Death|0|||
161136834|NCT02203149|581881740|FG000|Part 2|Withdrawal by Subject|0|||
161136835|NCT02203149|581881741|FG001|Part 2|Withdrawal by Subject|0|||
161136836|NCT02203149|581881742|FG002|Part 2|Withdrawal by Subject|0|||
161136837|NCT02203149|581881743|FG003|Part 2|Withdrawal by Subject|1|||
161334912|NCT03786380|582615861|FG001|Overall Study|Adverse Event|0|||
160833109|NCT00652951|580775944|FG001|Booster Phase|Adverse event, non-fatal|1|||
160833110|NCT00652951|580775945|FG002|Booster Phase|Adverse event, non-fatal|0|||
160833111|NCT00652951|580775943|FG000|Booster Phase|Other|1|||
160833112|NCT00652951|580775944|FG001|Booster Phase|Other|0|||
160833113|NCT00652951|580775945|FG002|Booster Phase|Other|0|||
160833114|NCT01022424|580775946|FG000|Overall Study|Adverse Event|1|||
160833115|NCT01022424|580775946|FG000|Overall Study|Physician Decision|1|||
160833116|NCT01022424|580775946|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
160833117|NCT01206582|580775947|FG000|Overall Study|Withdrew prior to study|1|||
160833118|NCT01206582|580775948|FG001|Overall Study|Withdrew prior to study|0|||
160833119|NCT01206582|580775947|FG000|Overall Study|Discontinued intervention before week 8|1|||
161136838|NCT02203149|581881744|FG004|Part 2|Withdrawal by Subject|0|||
161136839|NCT02203149|581881740|FG000|Part 2|Adverse Event|0|||
161136840|NCT02203149|581881741|FG001|Part 2|Adverse Event|0|||
161136841|NCT02203149|581881742|FG002|Part 2|Adverse Event|0|||
161136842|NCT02203149|581881743|FG003|Part 2|Adverse Event|1|||
161136843|NCT02203149|581881744|FG004|Part 2|Adverse Event|1|||
161136844|NCT00684814|581881745|FG000|Washout Period of 7 Days|Adverse Event|1|||
161136845|NCT00684814|581881746|FG001|Washout Period of 7 Days|Adverse Event|2|||
161136846|NCT00684814|581881745|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161136847|NCT00684814|581881746|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
161136848|NCT00684814|581881745|FG000|Second Intervention|Adverse Event|1|||
161136849|NCT00684814|581881746|FG001|Second Intervention|Adverse Event|0|||
161136850|NCT02537678|581881747|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
161136851|NCT02537678|581881748|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
161136852|NCT02537678|581881747|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
161136853|NCT02537678|581881748|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
161136854|NCT02537678|581881747|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
161136855|NCT02537678|581881748|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
161136856|NCT02537678|581881747|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
161136857|NCT02537678|581881748|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
161136858|NCT02537678|581881747|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
161136859|NCT02537678|581881748|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
161136860|NCT02537678|581881747|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
161136861|NCT02537678|581881748|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
161136862|NCT02537678|581881747|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
161136863|NCT02537678|581881748|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
161136864|NCT04348851|581881749|FG000|Post-Test 1|Withdrawal by Subject|0|||
161136865|NCT04348851|581881750|FG001|Post-Test 1|Withdrawal by Subject|1|||
161136866|NCT04348851|581881751|FG002|Post-Test 1|Withdrawal by Subject|0|||
161136867|NCT04348851|581881752|FG003|Post-Test 1|Withdrawal by Subject|0|||
161136868|NCT04348851|581881749|FG000|Post-Test 1|Lost to Follow-up|0|||
161136869|NCT04348851|581881750|FG001|Post-Test 1|Lost to Follow-up|1|||
161136870|NCT04348851|581881751|FG002|Post-Test 1|Lost to Follow-up|0|||
161136871|NCT04348851|581881752|FG003|Post-Test 1|Lost to Follow-up|0|||
161136872|NCT04348851|581881749|FG000|Post-Test 2|Stroke survivor death|0|||
161136873|NCT04348851|581881750|FG001|Post-Test 2|Stroke survivor death|1|||
161136874|NCT04348851|581881751|FG002|Post-Test 2|Stroke survivor death|0|||
161136875|NCT04348851|581881752|FG003|Post-Test 2|Stroke survivor death|1|||
161136876|NCT00195650|581881753|FG000|Overall Study|Adverse Event|194|||
161136877|NCT00195650|581881753|FG000|Overall Study|Lack of Efficacy|99|||
161136878|NCT00195650|581881753|FG000|Overall Study|Withdrawal by Subject|67|||
161136879|NCT00195650|581881753|FG000|Overall Study|Lost to Follow-up|44|||
161136880|NCT00195650|581881753|FG000|Overall Study|Death|23|||
161136881|NCT00195650|581881753|FG000|Overall Study|Protocol Violation|15|||
161136882|NCT00195650|581881753|FG000|Overall Study|Administrative reasons|83|||
161136883|NCT00432809|581881754|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
161136884|NCT00432809|581881755|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
161136885|NCT00432809|581881756|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
161136886|NCT00432809|581881754|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
161136887|NCT00432809|581881755|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
161136888|NCT00432809|581881756|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
161136889|NCT00655928|581881758|FG000|Overall Study|Withdrawal by Subject|2|||
161136890|NCT00655928|581881759|FG001|Overall Study|Withdrawal by Subject|1|||
161136891|NCT00655928|581881758|FG000|Overall Study|Physician Decision|1|||
161136892|NCT00655928|581881759|FG001|Overall Study|Physician Decision|1|||
161136893|NCT00275561|581881763|FG000|Overall Study|Withdrawal by Subject|0|||
161136894|NCT00275561|581881764|FG001|Overall Study|Withdrawal by Subject|1|||
161136895|NCT00275561|581881763|FG000|Overall Study|Travel|1|||
161136896|NCT00275561|581881764|FG001|Overall Study|Travel|1|||
161136897|NCT00275561|581881763|FG000|Overall Study|Scheduling|1|||
161136898|NCT00275561|581881764|FG001|Overall Study|Scheduling|2|||
161136899|NCT00275561|581881763|FG000|Overall Study|Family Issues|0|||
161136900|NCT00275561|581881764|FG001|Overall Study|Family Issues|2|||
160833120|NCT01206582|580775948|FG001|Overall Study|Discontinued intervention before week 8|2|||
160833121|NCT04736628|580775949|FG000|Overall Study|Not treated|0|||
160833122|NCT04736628|580775950|FG001|Overall Study|Not treated|0|||
160833123|NCT04736628|580775951|FG002|Overall Study|Not treated|0|||
160833124|NCT04736628|580775952|FG003|Overall Study|Not treated|2|||
160833125|NCT04736628|580775949|FG000|Overall Study|Other reason than listed|1|||
160833126|NCT04736628|580775950|FG001|Overall Study|Other reason than listed|2|||
160833127|NCT04736628|580775951|FG002|Overall Study|Other reason than listed|2|||
160991229|NCT03369951|581355545|FG000|Overall Study|Death|1|||
160833128|NCT04736628|580775952|FG003|Overall Study|Other reason than listed|3|||
160833129|NCT04736628|580775949|FG000|Overall Study|Protocol deviation|0|||
160833130|NCT04736628|580775950|FG001|Overall Study|Protocol deviation|0|||
160833131|NCT04736628|580775951|FG002|Overall Study|Protocol deviation|0|||
160833132|NCT04736628|580775952|FG003|Overall Study|Protocol deviation|1|||
160833133|NCT04736628|580775949|FG000|Overall Study|Burden of study procedures|1|||
160833134|NCT04736628|580775950|FG001|Overall Study|Burden of study procedures|0|||
160833135|NCT04736628|580775951|FG002|Overall Study|Burden of study procedures|0|||
160833136|NCT04736628|580775952|FG003|Overall Study|Burden of study procedures|1|||
160833137|NCT04736628|580775949|FG000|Overall Study|Change of residence|0|||
160833138|NCT04736628|580775950|FG001|Overall Study|Change of residence|1|||
160833139|NCT04736628|580775951|FG002|Overall Study|Change of residence|0|||
160903456|NCT01663532|581040502|FG001|Overall Study|Met Withdrawal Criteria|6|||
160903457|NCT01663532|581040501|FG000|Overall Study|Physician Decision|1|||
160903458|NCT01663532|581040502|FG001|Overall Study|Physician Decision|1|||
160903459|NCT01663532|581040501|FG000|Overall Study|Withdrawal by Subject|35|||
160833140|NCT04736628|580775952|FG003|Overall Study|Change of residence|0|||
160833141|NCT04736628|580775949|FG000|Overall Study|Perceived lack of efficacy|1|||
160833142|NCT04736628|580775950|FG001|Overall Study|Perceived lack of efficacy|0|||
160833143|NCT04736628|580775951|FG002|Overall Study|Perceived lack of efficacy|0|||
161136901|NCT01769105|581881769|FG000|First Intervention|Protocol Violation|2|||
161136902|NCT01769105|581881770|FG001|First Intervention|Protocol Violation|2|||
161136903|NCT01769105|581881769|FG000|Cross-over|Lost to Follow-up|5|||
161136904|NCT01769105|581881770|FG001|Cross-over|Lost to Follow-up|0|||
161136905|NCT05630846|581883685|FG000|Overall Study|Death|1|||
161136906|NCT05630846|581883686|FG001|Overall Study|Death|0|||
161136907|NCT05630846|581883687|FG002|Overall Study|Death|0|||
161136908|NCT05630846|581883688|FG003|Overall Study|Death|0|||
161136909|NCT05630846|581883685|FG000|Overall Study|Withdrawal by Subject|3|||
161136910|NCT05630846|581883686|FG001|Overall Study|Withdrawal by Subject|3|||
161136911|NCT05630846|581883687|FG002|Overall Study|Withdrawal by Subject|4|||
161136912|NCT05630846|581883688|FG003|Overall Study|Withdrawal by Subject|1|||
161136913|NCT05630846|581883685|FG000|Overall Study|Lost to Follow-up|6|||
161136914|NCT05630846|581883686|FG001|Overall Study|Lost to Follow-up|5|||
161136915|NCT05630846|581883687|FG002|Overall Study|Lost to Follow-up|2|||
161136916|NCT05630846|581883688|FG003|Overall Study|Lost to Follow-up|5|||
161136917|NCT05630846|581883685|FG000|Overall Study|Other|1|||
161136918|NCT05630846|581883686|FG001|Overall Study|Other|0|||
161136919|NCT05630846|581883687|FG002|Overall Study|Other|0|||
161136920|NCT05630846|581883688|FG003|Overall Study|Other|0|||
161136921|NCT01431287|581883689|FG000|Overall Study|not treated|0|||
160833144|NCT04736628|580775952|FG003|Overall Study|Perceived lack of efficacy|1|||
160833145|NCT04736628|580775949|FG000|Overall Study|Adverse Event|3|||
160833146|NCT04736628|580775950|FG001|Overall Study|Adverse Event|2|||
160833147|NCT04736628|580775951|FG002|Overall Study|Adverse Event|4|||
160833148|NCT04736628|580775952|FG003|Overall Study|Adverse Event|3|||
160903460|NCT01663532|581040502|FG001|Overall Study|Withdrawal by Subject|17|||
160903461|NCT01663532|581040501|FG000|Overall Study|Lack of Efficacy|15|||
160903462|NCT01663532|581040502|FG001|Overall Study|Lack of Efficacy|60|||
160903463|NCT00680017|581040508|FG000|Overall Study|Adverse Event|13|||
160903464|NCT00680017|581040509|FG001|Overall Study|Adverse Event|7|||
160903465|NCT00680017|581040508|FG000|Overall Study|Withdrawal by Subject|2|||
160903466|NCT00680017|581040509|FG001|Overall Study|Withdrawal by Subject|5|||
160903467|NCT00680017|581040508|FG000|Overall Study|Lost to Follow-up|2|||
160903468|NCT00680017|581040509|FG001|Overall Study|Lost to Follow-up|0|||
160903469|NCT01434667|581040510|FG000|Overall Study|Lost to Follow-up|5|||
160903470|NCT01434667|581040511|FG001|Overall Study|Lost to Follow-up|10|||
160903471|NCT02034110|581040514|FG000|Overall Study|Physician Decision|0|||
160903472|NCT02034110|581040515|FG001|Overall Study|Physician Decision|0|||
160903473|NCT02034110|581040516|FG002|Overall Study|Physician Decision|0|||
160903474|NCT02034110|581040517|FG003|Overall Study|Physician Decision|0|||
160903475|NCT02034110|581040518|FG004|Overall Study|Physician Decision|2|||
160903476|NCT02034110|581040519|FG005|Overall Study|Physician Decision|0|||
160903477|NCT02034110|581040520|FG006|Overall Study|Physician Decision|1|||
160903478|NCT02034110|581040521|FG007|Overall Study|Physician Decision|0|||
160903479|NCT02034110|581040514|FG000|Overall Study|Lost to Follow-up|1|||
160903480|NCT02034110|581040515|FG001|Overall Study|Lost to Follow-up|0|||
161136922|NCT01431287|581883690|FG001|Overall Study|not treated|0|||
161136923|NCT01431287|581883691|FG002|Overall Study|not treated|1|||
161136924|NCT01431287|581883692|FG003|Overall Study|not treated|0|||
161136925|NCT01431287|581883693|FG004|Overall Study|not treated|0|||
161136926|NCT01431287|581883689|FG000|Overall Study|Adverse Event|59|||
161247633|NCT00757172|582285278|FG000|Overall Study|Withdrawal by Subject|4|||
161247634|NCT00757172|582285278|FG000|Overall Study|Physician Decision|3|||
160833149|NCT04279613|580775953|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833150|NCT04279613|580775954|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833151|NCT04279613|580775955|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833152|NCT04279613|580775956|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
160833153|NCT04279613|580775957|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
160833154|NCT04279613|580775953|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833155|NCT04279613|580775954|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
160833156|NCT04279613|580775955|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833157|NCT04279613|580775956|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833158|NCT04279613|580775957|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
160833159|NCT04279613|580775953|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833160|NCT04279613|580775954|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833161|NCT04279613|580775955|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
160833162|NCT04279613|580775956|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833163|NCT04279613|580775957|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
160833164|NCT04279613|580775953|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833165|NCT04279613|580775954|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833166|NCT04279613|580775955|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833167|NCT04279613|580775956|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
160833168|NCT04279613|580775957|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
160833169|NCT04279613|580775953|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833170|NCT04279613|580775954|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833171|NCT04279613|580775955|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833172|NCT04279613|580775956|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
160833173|NCT04279613|580775957|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
160833174|NCT02478164|580775958|FG000|Overall Study|Lack of Efficacy|13|||
160833175|NCT02478164|580775958|FG000|Overall Study|Adverse Event|1|||
160833176|NCT02478164|580775958|FG000|Overall Study|Withdrawal by Subject|1|||
160833177|NCT04051827|580775959|FG000|Overall Study|Death|1|||
160833178|NCT04051827|580775959|FG000|Overall Study|Withdrawal by Subject|4|||
160833179|NCT04051827|580775959|FG000|Overall Study|Progressive disease|16|||
160833180|NCT04051827|580775959|FG000|Overall Study|Physician Decision|1|||
160833181|NCT04051827|580775959|FG000|Overall Study|Other|4|||
160833182|NCT05779007|580775960|FG000|Overall Study|not meeting eligibility criteria|3517|||
160833183|NCT05779007|580775961|FG001|Overall Study|not meeting eligibility criteria|2009|||
160833184|NCT01424566|580775962|FG000|Single-blind Treatment|Adverse Event|71|||
160833185|NCT01424566|580775963|FG001|Single-blind Treatment|Adverse Event|0|||
160833186|NCT01424566|580775964|FG002|Single-blind Treatment|Adverse Event|0|||
160833187|NCT01424566|580775962|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
160833188|NCT01424566|580775963|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
160833189|NCT01424566|580775964|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
160833190|NCT01424566|580775962|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
160833191|NCT01424566|580775963|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
160833192|NCT01424566|580775964|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
160833193|NCT01424566|580775962|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
160833194|NCT01424566|580775963|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
160833195|NCT01424566|580775964|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
161247635|NCT00757172|582285278|FG000|Overall Study|Progression|4|||
161247636|NCT01942135|582285281|FG000|Overall Study|Adverse Event|21|||
161247637|NCT01942135|582285282|FG001|Overall Study|Adverse Event|7|||
161247638|NCT01942135|582285281|FG000|Overall Study|Global Deterioration of Health Status|9|||
161247639|NCT01942135|582285282|FG001|Overall Study|Global Deterioration of Health Status|6|||
161247640|NCT01942135|582285281|FG000|Overall Study|Randomized Not Treated|2|||
161247641|NCT01942135|582285282|FG001|Overall Study|Randomized Not Treated|2|||
161247642|NCT01942135|582285281|FG000|Overall Study|Death|2|||
161247643|NCT01942135|582285282|FG001|Overall Study|Death|1|||
161247644|NCT01942135|582285281|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
161247645|NCT01942135|582285282|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
161334913|NCT03786380|582615862|FG002|Overall Study|Adverse Event|0|||
161334914|NCT03786380|582615863|FG003|Overall Study|Adverse Event|3|||
160833196|NCT01424566|580775962|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
160833197|NCT01424566|580775963|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
160833198|NCT01424566|580775964|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
160833199|NCT01424566|580775962|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
160833200|NCT01424566|580775963|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
160833201|NCT01424566|580775964|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
160833202|NCT01424566|580775962|FG000|Double-blind Treatment|Adverse Event|0|||
161247646|NCT01942135|582285281|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
161247647|NCT01942135|582285282|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
161247648|NCT01942135|582285281|FG000|Overall Study|Withdrawal by Subject|4|||
160903481|NCT02034110|581040516|FG002|Overall Study|Lost to Follow-up|0|||
160903482|NCT02034110|581040517|FG003|Overall Study|Lost to Follow-up|0|||
160903483|NCT02034110|581040518|FG004|Overall Study|Lost to Follow-up|1|||
160903484|NCT02034110|581040519|FG005|Overall Study|Lost to Follow-up|0|||
160903485|NCT02034110|581040520|FG006|Overall Study|Lost to Follow-up|1|||
160903486|NCT02034110|581040521|FG007|Overall Study|Lost to Follow-up|0|||
160903487|NCT02034110|581040514|FG000|Overall Study|Withdrawal by Subject|5|||
160903488|NCT02034110|581040515|FG001|Overall Study|Withdrawal by Subject|7|||
160903489|NCT02034110|581040516|FG002|Overall Study|Withdrawal by Subject|0|||
160903490|NCT02034110|581040517|FG003|Overall Study|Withdrawal by Subject|3|||
160903491|NCT02034110|581040518|FG004|Overall Study|Withdrawal by Subject|7|||
160903492|NCT02034110|581040519|FG005|Overall Study|Withdrawal by Subject|0|||
160903493|NCT02034110|581040520|FG006|Overall Study|Withdrawal by Subject|3|||
160903494|NCT02034110|581040521|FG007|Overall Study|Withdrawal by Subject|1|||
160903495|NCT02034110|581040514|FG000|Overall Study|Study closed by sponsor|6|||
160903496|NCT02034110|581040515|FG001|Overall Study|Study closed by sponsor|2|||
160903497|NCT02034110|581040516|FG002|Overall Study|Study closed by sponsor|0|||
160903498|NCT02034110|581040517|FG003|Overall Study|Study closed by sponsor|6|||
160903499|NCT02034110|581040518|FG004|Overall Study|Study closed by sponsor|7|||
160903500|NCT02034110|581040519|FG005|Overall Study|Study closed by sponsor|0|||
160903501|NCT02034110|581040520|FG006|Overall Study|Study closed by sponsor|42|||
160903502|NCT02034110|581040521|FG007|Overall Study|Study closed by sponsor|0|||
160903503|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
160903504|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
160903505|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Progression|3|||
160903506|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
160903507|NCT00064337|581040522|FG000|PBSCC or Induction/PBSCC|Death|2|||
160903508|NCT00064337|581040522|FG000|Transplant|Adverse Event|9|||
160903509|NCT00064337|581040522|FG000|Transplant|Not protocol-specified|5|||
160903510|NCT00064337|581040522|FG000|Transplant|Death|3|||
160903511|NCT00064337|581040522|FG000|Transplant|Patient Refusal|2|||
160903512|NCT00064337|581040522|FG000|Transplant|Progression|2|||
160903513|NCT00064337|581040522|FG000|Maintenance|Adverse Event|3|||
160903514|NCT00064337|581040522|FG000|Maintenance|Progression|2|||
160903515|NCT00064337|581040522|FG000|Maintenance|On treatment at time of analysis|2|||
160903516|NCT00064337|581040522|FG000|Maintenance|Not protocol-specified|2|||
160903517|NCT00064337|581040522|FG000|Maintenance|Death|1|||
160903518|NCT02279420|581040523|FG000|Overall Study|Lost to Follow-up|23|||
160903519|NCT03535844|581040526|FG000|Overall Study|Withdrawal by Subject|0|||
160903520|NCT03535844|581040527|FG001|Overall Study|Withdrawal by Subject|1|||
160903521|NCT00612040|581040528|FG000|Overall Study|Adverse Event|0|||
160903522|NCT00612040|581040529|FG001|Overall Study|Adverse Event|2|||
160903523|NCT00612040|581040530|FG002|Overall Study|Adverse Event|1|||
160903524|NCT00612040|581040528|FG000|Overall Study|Protocol Violation|1|||
160903525|NCT00612040|581040529|FG001|Overall Study|Protocol Violation|2|||
160903526|NCT00612040|581040530|FG002|Overall Study|Protocol Violation|1|||
160903527|NCT00612040|581040528|FG000|Overall Study|Lack of Efficacy|2|||
160903528|NCT00612040|581040529|FG001|Overall Study|Lack of Efficacy|1|||
160903529|NCT00612040|581040530|FG002|Overall Study|Lack of Efficacy|0|||
160903530|NCT00612040|581040528|FG000|Overall Study|Unclassified|2|||
160903531|NCT00612040|581040529|FG001|Overall Study|Unclassified|2|||
160903532|NCT00612040|581040530|FG002|Overall Study|Unclassified|5|||
160903533|NCT00297830|581040531|FG000|6 Month Visit|Death|1|||
161136927|NCT01431287|581883690|FG001|Overall Study|Adverse Event|57|||
161136928|NCT01431287|581883691|FG002|Overall Study|Adverse Event|53|||
161136929|NCT01431287|581883692|FG003|Overall Study|Adverse Event|33|||
161136930|NCT01431287|581883693|FG004|Overall Study|Adverse Event|41|||
161136931|NCT01431287|581883689|FG000|Overall Study|Non compliant with protocol|6|||
160903534|NCT00297830|581040532|FG001|6 Month Visit|Death|0|||
160903535|NCT00297830|581040533|FG002|6 Month Visit|Death|2|||
160903536|NCT00297830|581040531|FG000|6 Month Visit|Withdrawal by Subject|2|||
160903537|NCT00297830|581040532|FG001|6 Month Visit|Withdrawal by Subject|1|||
160903538|NCT00297830|581040533|FG002|6 Month Visit|Withdrawal by Subject|1|||
160903539|NCT00297830|581040531|FG000|6 Month Visit|Adverse Event|0|||
160903540|NCT00297830|581040532|FG001|6 Month Visit|Adverse Event|1|||
160903541|NCT00297830|581040533|FG002|6 Month Visit|Adverse Event|0|||
160903542|NCT00297830|581040531|FG000|12 Month Visit|Lost to Follow-up|1|||
160903543|NCT00297830|581040532|FG001|12 Month Visit|Lost to Follow-up|0|||
160903544|NCT00297830|581040533|FG002|12 Month Visit|Lost to Follow-up|0|||
160903545|NCT00297830|581040531|FG000|12 Month Visit|Adverse Event|0|||
160903546|NCT00297830|581040532|FG001|12 Month Visit|Adverse Event|3|||
160903547|NCT00297830|581040533|FG002|12 Month Visit|Adverse Event|0|||
160903548|NCT00297830|581040531|FG000|12 Month Visit|Withdrawal by Subject|0|||
160903549|NCT00297830|581040532|FG001|12 Month Visit|Withdrawal by Subject|3|||
160903550|NCT00297830|581040533|FG002|12 Month Visit|Withdrawal by Subject|0|||
160903551|NCT02835820|581040534|FG000|Overall Study|Baseline Screen Failure|0|||
160903552|NCT02835820|581040535|FG001|Overall Study|Baseline Screen Failure|3|||
160903553|NCT00827502|581040536|FG000|Overall Study|randomized but not treated|11|||
161136932|NCT01431287|581883690|FG001|Overall Study|Non compliant with protocol|6|||
161247649|NCT01942135|582285282|FG001|Overall Study|Withdrawal by Subject|3|||
161247650|NCT01942135|582285281|FG000|Overall Study|Protocol Violation|1|||
161247651|NCT01942135|582285282|FG001|Overall Study|Protocol Violation|0|||
161247652|NCT01942135|582285281|FG000|Overall Study|Other|19|||
161247653|NCT01942135|582285282|FG001|Overall Study|Other|4|||
161247654|NCT01499043|582285283|FG000|Overall Study|Progressive disease (radiographic)|2|||
161247655|NCT01499043|582285283|FG000|Overall Study|Progressive disease (clinical)|1|||
161247656|NCT01499043|582285283|FG000|Overall Study|Withdrawal by Subject|2|||
161247657|NCT01499043|582285283|FG000|Overall Study|Adverse Event|1|||
161247658|NCT01596127|582285286|FG000|Overall Study|Patient Ineligible|1|||
161247659|NCT00685334|582285292|FG000|Overall Study|Withdrawal by Subject|5|||
161247660|NCT00685334|582285293|FG001|Overall Study|Withdrawal by Subject|6|||
161247661|NCT00685334|582285292|FG000|Overall Study|Lost to Follow-up|4|||
161247662|NCT00685334|582285293|FG001|Overall Study|Lost to Follow-up|0|||
161247663|NCT00685334|582285292|FG000|Overall Study|Chose to enter hospital|1|||
161247664|NCT00685334|582285293|FG001|Overall Study|Chose to enter hospital|1|||
161247665|NCT00202839|582286354|FG000|Overall Study|Adverse Event|1|||
161247666|NCT00202839|582286355|FG001|Overall Study|Adverse Event|5|||
161247667|NCT00202839|582286354|FG000|Overall Study|Physician Decision|12|||
161247668|NCT00202839|582286355|FG001|Overall Study|Physician Decision|0|||
161247669|NCT00202839|582286354|FG000|Overall Study|Withdrawal by Subject|6|||
161247670|NCT00202839|582286355|FG001|Overall Study|Withdrawal by Subject|2|||
161247671|NCT00202839|582286354|FG000|Overall Study|Protocol Violation|2|||
161247672|NCT00202839|582286355|FG001|Overall Study|Protocol Violation|1|||
161247673|NCT00202839|582286354|FG000|Overall Study|Lost to Follow-up|3|||
161247674|NCT00202839|582286355|FG001|Overall Study|Lost to Follow-up|2|||
161247675|NCT01662024|582286356|FG000|Overall Study|Pregnancy|2|||
161247676|NCT01662024|582286356|FG000|Overall Study|Withdrawal by Subject|3|||
161247677|NCT01490190|582286360|FG000|Overall Study|Withdrawal by Subject|9|||
161247678|NCT01490190|582286360|FG000|Overall Study|Adverse Event|17|||
161247679|NCT01490190|582286360|FG000|Overall Study|Protocol Violation|5|||
161247680|NCT01490190|582286360|FG000|Overall Study|Lost to Follow-up|13|||
161247681|NCT01490190|582286360|FG000|Overall Study|Relocation|1|||
161247682|NCT01490190|582286360|FG000|Overall Study|Inconvenience|1|||
161247683|NCT01490190|582286360|FG000|Overall Study|Ring expulsion|2|||
161247684|NCT02483416|582286363|FG000|Overall Study|Other reason|0|||
161247685|NCT02483416|582286364|FG001|Overall Study|Other reason|1|||
160833203|NCT01424566|580775963|FG001|Double-blind Treatment|Adverse Event|21|||
160833204|NCT01424566|580775964|FG002|Double-blind Treatment|Adverse Event|13|||
160833205|NCT01424566|580775962|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
160833206|NCT01424566|580775963|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
160833207|NCT01424566|580775964|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
160833208|NCT01424566|580775962|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
160833209|NCT01424566|580775963|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
160833210|NCT01424566|580775964|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
160833211|NCT01424566|580775962|FG000|Double-blind Treatment|Lack of Efficacy|0|||
160833212|NCT01424566|580775963|FG001|Double-blind Treatment|Lack of Efficacy|1|||
160833213|NCT01424566|580775964|FG002|Double-blind Treatment|Lack of Efficacy|1|||
160833214|NCT02708485|580775969|FG000|Overall Study|Withdrawal by Subject|3|||
160833215|NCT02708485|580775970|FG001|Overall Study|Withdrawal by Subject|2|||
160833216|NCT00231413|580775971|FG000|Overall Study|Non-serious AE|0|||
160833217|NCT00231413|580775972|FG001|Overall Study|Non-serious AE|0|||
160833218|NCT00231413|580775973|FG002|Overall Study|Non-serious AE|1|||
160833219|NCT00231413|580775974|FG003|Overall Study|Non-serious AE|0|||
160833220|NCT00231413|580775975|FG004|Overall Study|Non-serious AE|0|||
160833221|NCT00231413|580775976|FG005|Overall Study|Non-serious AE|0|||
160833222|NCT00231413|580775977|FG006|Overall Study|Non-serious AE|1|||
160833223|NCT00231413|580775971|FG000|Overall Study|Withdrawal by Subject|3|||
160833224|NCT00231413|580775972|FG001|Overall Study|Withdrawal by Subject|1|||
160833225|NCT00231413|580775973|FG002|Overall Study|Withdrawal by Subject|4|||
161247686|NCT02483416|582286363|FG000|Overall Study|Treatment stop|3|||
161247687|NCT02483416|582286364|FG001|Overall Study|Treatment stop|0|||
161247688|NCT00969124|582286367|FG000|Overall Study|Protocol Violation|2|||
160833226|NCT00231413|580775974|FG003|Overall Study|Withdrawal by Subject|2|||
160833227|NCT00231413|580775975|FG004|Overall Study|Withdrawal by Subject|2|||
161334915|NCT03786380|582615864|FG004|Overall Study|Adverse Event|1|||
160833228|NCT00231413|580775976|FG005|Overall Study|Withdrawal by Subject|0|||
160833229|NCT00231413|580775977|FG006|Overall Study|Withdrawal by Subject|3|||
161247689|NCT00969124|582286367|FG000|Overall Study|Inadequate bowel preparation|15|||
161247690|NCT00969124|582286367|FG000|Overall Study|Inability to reach cecum|9|||
161247691|NCT00969124|582286367|FG000|Overall Study|Previously unrecognized disease|3|||
161247692|NCT00969124|582286367|FG000|Overall Study|Technical error|1|||
161247693|NCT00210639|582286368|FG000|Overall Study|Lost to Follow-up|37|||
161247694|NCT00210639|582286369|FG001|Overall Study|Lost to Follow-up|29|||
161247695|NCT00210639|582286368|FG000|Overall Study|Withdrawal by Subject|8|||
161247696|NCT00210639|582286369|FG001|Overall Study|Withdrawal by Subject|1|||
161247697|NCT00210639|582286368|FG000|Overall Study|Other|18|||
161247698|NCT00210639|582286369|FG001|Overall Study|Other|12|||
160833230|NCT00231413|580775971|FG000|Overall Study|Migrated/moved from study area|0|||
160833231|NCT00231413|580775972|FG001|Overall Study|Migrated/moved from study area|0|||
160833232|NCT00231413|580775973|FG002|Overall Study|Migrated/moved from study area|1|||
160833233|NCT00231413|580775974|FG003|Overall Study|Migrated/moved from study area|0|||
160833234|NCT00231413|580775975|FG004|Overall Study|Migrated/moved from study area|0|||
160833235|NCT00231413|580775976|FG005|Overall Study|Migrated/moved from study area|1|||
160833236|NCT00231413|580775977|FG006|Overall Study|Migrated/moved from study area|0|||
160833237|NCT00231413|580775971|FG000|Overall Study|Lost to Follow-up|4|||
160833238|NCT00231413|580775972|FG001|Overall Study|Lost to Follow-up|4|||
160833239|NCT00231413|580775973|FG002|Overall Study|Lost to Follow-up|1|||
160833240|NCT00231413|580775974|FG003|Overall Study|Lost to Follow-up|1|||
160833241|NCT00231413|580775975|FG004|Overall Study|Lost to Follow-up|1|||
160833242|NCT00231413|580775976|FG005|Overall Study|Lost to Follow-up|4|||
160833243|NCT00231413|580775977|FG006|Overall Study|Lost to Follow-up|0|||
160833244|NCT00231413|580775971|FG000|Overall Study|Pregnancy|1|||
160833245|NCT00231413|580775972|FG001|Overall Study|Pregnancy|0|||
160833246|NCT00231413|580775973|FG002|Overall Study|Pregnancy|0|||
160833247|NCT00231413|580775974|FG003|Overall Study|Pregnancy|0|||
160833248|NCT00231413|580775975|FG004|Overall Study|Pregnancy|0|||
160833249|NCT00231413|580775976|FG005|Overall Study|Pregnancy|0|||
160833250|NCT00231413|580775977|FG006|Overall Study|Pregnancy|0|||
160833251|NCT01100528|580775981|FG000|Overall Study|Death|1|||
160833252|NCT01100528|580775981|FG000|Overall Study|Withdrawal by Subject|2|||
160833253|NCT01659255|580775982|FG000|Overall Study|Adverse Event|0|||
160833254|NCT01659255|580775983|FG001|Overall Study|Adverse Event|0|||
160833255|NCT01659255|580775984|FG002|Overall Study|Adverse Event|0|||
160833256|NCT01659255|580775985|FG003|Overall Study|Adverse Event|0|||
160903554|NCT00827502|581040536|FG000|Overall Study|Adverse Event|1|||
160903555|NCT00827502|581040536|FG000|Overall Study|Lost to Follow-up|4|||
160903556|NCT00827502|581040536|FG000|Overall Study|Withdrawal by Subject|5|||
160903557|NCT05096221|581040537|FG000|Part 2|Physician Decision|0|||
160833257|NCT01659255|580775986|FG004|Overall Study|Adverse Event|0|||
160833258|NCT01659255|580775987|FG005|Overall Study|Adverse Event|1|||
160833259|NCT01659255|580775988|FG006|Overall Study|Adverse Event|1|||
160833260|NCT01659255|580775989|FG007|Overall Study|Adverse Event|0|||
160833261|NCT01659255|580775990|FG008|Overall Study|Adverse Event|0|||
160833262|NCT01659255|580775991|FG009|Overall Study|Adverse Event|1|||
160833263|NCT01659255|580775992|FG010|Overall Study|Adverse Event|0|||
160903558|NCT05096221|581040538|FG001|Part 2|Physician Decision|1|||
161136933|NCT01431287|581883691|FG002|Overall Study|Non compliant with protocol|5|||
161136934|NCT01431287|581883692|FG003|Overall Study|Non compliant with protocol|6|||
161136935|NCT01431287|581883693|FG004|Overall Study|Non compliant with protocol|5|||
161136936|NCT01431287|581883689|FG000|Overall Study|Lost to Follow-up|0|||
161136937|NCT01431287|581883690|FG001|Overall Study|Lost to Follow-up|3|||
161136938|NCT01431287|581883691|FG002|Overall Study|Lost to Follow-up|2|||
161136939|NCT01431287|581883692|FG003|Overall Study|Lost to Follow-up|3|||
161136940|NCT01431287|581883693|FG004|Overall Study|Lost to Follow-up|1|||
161136941|NCT01431287|581883689|FG000|Overall Study|Consent withdrawn not due to AE|29|||
161136942|NCT01431287|581883690|FG001|Overall Study|Consent withdrawn not due to AE|30|||
161136943|NCT01431287|581883691|FG002|Overall Study|Consent withdrawn not due to AE|34|||
161136944|NCT01431287|581883692|FG003|Overall Study|Consent withdrawn not due to AE|19|||
161136945|NCT01431287|581883693|FG004|Overall Study|Consent withdrawn not due to AE|29|||
161136946|NCT01431287|581883689|FG000|Overall Study|not stated above|4|||
161136947|NCT01431287|581883690|FG001|Overall Study|not stated above|2|||
161136948|NCT01431287|581883691|FG002|Overall Study|not stated above|2|||
161136949|NCT01431287|581883692|FG003|Overall Study|not stated above|2|||
161136950|NCT01431287|581883693|FG004|Overall Study|not stated above|1|||
161136951|NCT03019549|581883694|FG000|Washout|DId not meet genotype criteria|11|||
161136952|NCT03019549|581883694|FG000|Period 2|Adverse Event|2|||
161136953|NCT03019549|581883694|FG000|Period 2|Physician Decision|2|||
161136954|NCT03019549|581883694|FG000|Period 2|Withdrawal by Subject|1|||
161136955|NCT01412879|581883695|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
161136956|NCT01412879|581883696|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
161136957|NCT01412879|581883697|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
161136958|NCT01412879|581883695|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
161136959|NCT01412879|581883696|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
161136960|NCT01412879|581883697|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
161136961|NCT01412879|581883695|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
161136962|NCT01412879|581883696|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
161136963|NCT01412879|581883697|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
161136964|NCT01412879|581883695|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
161136965|NCT01412879|581883696|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
161136966|NCT01412879|581883697|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
161136967|NCT01412879|581883695|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
161136968|NCT01412879|581883696|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
161247699|NCT04697173|582286378|FG000|Overall Study|Withdrawal by Subject|34|||
161247700|NCT04697173|582286379|FG001|Overall Study|Withdrawal by Subject|38|||
161247701|NCT03277248|582286380|FG000|Overall Study|Adverse Event|3|||
160833264|NCT01659255|580775993|FG011|Overall Study|Adverse Event|1|||
160833265|NCT01659255|580775994|FG012|Overall Study|Adverse Event|0|||
160833266|NCT01659255|580775995|FG013|Overall Study|Adverse Event|2|||
160833267|NCT01659255|580775996|FG014|Overall Study|Adverse Event|0|||
160833268|NCT01659255|580775997|FG015|Overall Study|Adverse Event|1|||
160833269|NCT01659255|580775998|FG016|Overall Study|Adverse Event|0|||
160833270|NCT01659255|580775982|FG000|Overall Study|Death|0|||
160833271|NCT01659255|580775983|FG001|Overall Study|Death|1|||
160833272|NCT01659255|580775984|FG002|Overall Study|Death|0|||
160833273|NCT01659255|580775985|FG003|Overall Study|Death|0|||
160833274|NCT01659255|580775986|FG004|Overall Study|Death|0|||
160833275|NCT01659255|580775987|FG005|Overall Study|Death|0|||
160833276|NCT01659255|580775988|FG006|Overall Study|Death|0|||
160833277|NCT01659255|580775989|FG007|Overall Study|Death|1|||
160833278|NCT01659255|580775990|FG008|Overall Study|Death|1|||
160833279|NCT01659255|580775991|FG009|Overall Study|Death|0|||
160833280|NCT01659255|580775992|FG010|Overall Study|Death|0|||
160833281|NCT01659255|580775993|FG011|Overall Study|Death|0|||
160833282|NCT01659255|580775994|FG012|Overall Study|Death|1|||
160833283|NCT01659255|580775995|FG013|Overall Study|Death|1|||
160833284|NCT01659255|580775996|FG014|Overall Study|Death|2|||
160833285|NCT01659255|580775997|FG015|Overall Study|Death|1|||
160833286|NCT01659255|580775998|FG016|Overall Study|Death|0|||
160833287|NCT01659255|580775982|FG000|Overall Study|Progressive Disease|2|||
160833288|NCT01659255|580775983|FG001|Overall Study|Progressive Disease|0|||
160833289|NCT01659255|580775984|FG002|Overall Study|Progressive Disease|0|||
160833290|NCT01659255|580775985|FG003|Overall Study|Progressive Disease|0|||
160833291|NCT01659255|580775986|FG004|Overall Study|Progressive Disease|0|||
160833292|NCT01659255|580775987|FG005|Overall Study|Progressive Disease|0|||
160833293|NCT01659255|580775988|FG006|Overall Study|Progressive Disease|0|||
160833294|NCT01659255|580775989|FG007|Overall Study|Progressive Disease|1|||
160833295|NCT01659255|580775990|FG008|Overall Study|Progressive Disease|0|||
160833296|NCT01659255|580775991|FG009|Overall Study|Progressive Disease|2|||
160833297|NCT01659255|580775992|FG010|Overall Study|Progressive Disease|2|||
160833298|NCT01659255|580775993|FG011|Overall Study|Progressive Disease|3|||
160833299|NCT01659255|580775994|FG012|Overall Study|Progressive Disease|5|||
160833300|NCT01659255|580775995|FG013|Overall Study|Progressive Disease|13|||
160833301|NCT01659255|580775996|FG014|Overall Study|Progressive Disease|6|||
160833302|NCT01659255|580775997|FG015|Overall Study|Progressive Disease|2|||
160833303|NCT01659255|580775998|FG016|Overall Study|Progressive Disease|3|||
160833304|NCT01659255|580775982|FG000|Overall Study|Withdrew Consent|0|||
160833305|NCT01659255|580775983|FG001|Overall Study|Withdrew Consent|0|||
160833306|NCT01659255|580775984|FG002|Overall Study|Withdrew Consent|0|||
160833307|NCT01659255|580775985|FG003|Overall Study|Withdrew Consent|0|||
160833308|NCT01659255|580775986|FG004|Overall Study|Withdrew Consent|0|||
160833309|NCT01659255|580775987|FG005|Overall Study|Withdrew Consent|0|||
160833310|NCT01659255|580775988|FG006|Overall Study|Withdrew Consent|0|||
160833311|NCT01659255|580775989|FG007|Overall Study|Withdrew Consent|0|||
160833312|NCT01659255|580775990|FG008|Overall Study|Withdrew Consent|0|||
160833313|NCT01659255|580775991|FG009|Overall Study|Withdrew Consent|0|||
160833314|NCT01659255|580775992|FG010|Overall Study|Withdrew Consent|1|||
160833315|NCT01659255|580775993|FG011|Overall Study|Withdrew Consent|0|||
160833316|NCT01659255|580775994|FG012|Overall Study|Withdrew Consent|0|||
160833317|NCT01659255|580775995|FG013|Overall Study|Withdrew Consent|1|||
160833318|NCT01659255|580775996|FG014|Overall Study|Withdrew Consent|0|||
160833319|NCT01659255|580775997|FG015|Overall Study|Withdrew Consent|0|||
160833320|NCT01659255|580775998|FG016|Overall Study|Withdrew Consent|0|||
160833321|NCT01659255|580775982|FG000|Overall Study|Investigator Decision|0|||
160833322|NCT01659255|580775983|FG001|Overall Study|Investigator Decision|0|||
160833323|NCT01659255|580775984|FG002|Overall Study|Investigator Decision|0|||
160833324|NCT01659255|580775985|FG003|Overall Study|Investigator Decision|0|||
160833325|NCT01659255|580775986|FG004|Overall Study|Investigator Decision|0|||
160833326|NCT01659255|580775987|FG005|Overall Study|Investigator Decision|0|||
160833327|NCT01659255|580775988|FG006|Overall Study|Investigator Decision|0|||
160833328|NCT01659255|580775989|FG007|Overall Study|Investigator Decision|0|||
160833329|NCT01659255|580775990|FG008|Overall Study|Investigator Decision|0|||
160833330|NCT01659255|580775991|FG009|Overall Study|Investigator Decision|0|||
160833331|NCT01659255|580775992|FG010|Overall Study|Investigator Decision|0|||
160833332|NCT01659255|580775993|FG011|Overall Study|Investigator Decision|0|||
160833333|NCT01659255|580775994|FG012|Overall Study|Investigator Decision|1|||
160833334|NCT01659255|580775995|FG013|Overall Study|Investigator Decision|1|||
160833335|NCT01659255|580775996|FG014|Overall Study|Investigator Decision|0|||
160833336|NCT01659255|580775997|FG015|Overall Study|Investigator Decision|0|||
160833337|NCT01659255|580775998|FG016|Overall Study|Investigator Decision|0|||
160833338|NCT01659255|580775982|FG000|Overall Study|Sponsor's Decision|0|||
160833339|NCT01659255|580775983|FG001|Overall Study|Sponsor's Decision|0|||
160833340|NCT01659255|580775984|FG002|Overall Study|Sponsor's Decision|0|||
160833341|NCT01659255|580775985|FG003|Overall Study|Sponsor's Decision|0|||
160833342|NCT01659255|580775986|FG004|Overall Study|Sponsor's Decision|0|||
160833343|NCT01659255|580775987|FG005|Overall Study|Sponsor's Decision|0|||
160833344|NCT01659255|580775988|FG006|Overall Study|Sponsor's Decision|1|||
160833345|NCT01659255|580775989|FG007|Overall Study|Sponsor's Decision|0|||
160833346|NCT01659255|580775990|FG008|Overall Study|Sponsor's Decision|0|||
160833347|NCT01659255|580775991|FG009|Overall Study|Sponsor's Decision|0|||
160833348|NCT01659255|580775992|FG010|Overall Study|Sponsor's Decision|0|||
160833349|NCT01659255|580775993|FG011|Overall Study|Sponsor's Decision|0|||
160833350|NCT01659255|580775994|FG012|Overall Study|Sponsor's Decision|0|||
160833351|NCT01659255|580775995|FG013|Overall Study|Sponsor's Decision|0|||
160833352|NCT01659255|580775996|FG014|Overall Study|Sponsor's Decision|0|||
160833353|NCT01659255|580775997|FG015|Overall Study|Sponsor's Decision|0|||
160991230|NCT03369951|581355545|FG000|Overall Study|Lost to Follow-up|1|||
161247702|NCT03277248|582286381|FG001|Overall Study|Adverse Event|1|||
161247703|NCT03277248|582286380|FG000|Overall Study|Subject Withdrawal of Consent|6|||
161247704|NCT03277248|582286381|FG001|Overall Study|Subject Withdrawal of Consent|23|||
161247705|NCT03277248|582286380|FG000|Overall Study|Investigator/Sponsor Decision|2|||
161247706|NCT03277248|582286381|FG001|Overall Study|Investigator/Sponsor Decision|2|||
161247707|NCT03277248|582286380|FG000|Overall Study|Pregnancy|4|||
161247708|NCT03277248|582286381|FG001|Overall Study|Pregnancy|1|||
161247709|NCT03277248|582286380|FG000|Overall Study|Lost to Follow-up|0|||
161247710|NCT03277248|582286381|FG001|Overall Study|Lost to Follow-up|2|||
161247711|NCT03277248|582286380|FG000|Overall Study|Lack of Efficacy|0|||
161247712|NCT03277248|582286381|FG001|Overall Study|Lack of Efficacy|2|||
161247713|NCT03277248|582286380|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
161247714|NCT03277248|582286381|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
161247715|NCT01993940|582286382|FG000|Overall Study|Adverse Event|16|||
161247716|NCT01993940|582286383|FG001|Overall Study|Adverse Event|11|||
161247717|NCT01993940|582286382|FG000|Overall Study|Withdrawal by Subject|15|||
161247718|NCT01993940|582286383|FG001|Overall Study|Withdrawal by Subject|19|||
161247719|NCT01993940|582286382|FG000|Overall Study|Lost to Follow-up|2|||
161247720|NCT01993940|582286383|FG001|Overall Study|Lost to Follow-up|5|||
161247721|NCT01993940|582286382|FG000|Overall Study|Protocol Violation|5|||
161247722|NCT01993940|582286383|FG001|Overall Study|Protocol Violation|8|||
161247723|NCT01993940|582286382|FG000|Overall Study|Death|1|||
161247724|NCT01993940|582286383|FG001|Overall Study|Death|0|||
161247725|NCT01993940|582286382|FG000|Overall Study|Other - Miscellaneous|1|||
161247726|NCT01993940|582286383|FG001|Overall Study|Other - Miscellaneous|1|||
161247727|NCT01949532|582286384|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
161247728|NCT01949532|582286385|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
161247729|NCT00379353|582286386|FG000|Overall Study|Hospitalization|3|||
161247730|NCT00379353|582286387|FG001|Overall Study|Hospitalization|3|||
161247731|NCT00379353|582286386|FG000|Overall Study|Withdrawal by Subject|5|||
161247732|NCT00379353|582286387|FG001|Overall Study|Withdrawal by Subject|2|||
161247733|NCT00379353|582286386|FG000|Overall Study|Death|1|||
161247734|NCT00379353|582286387|FG001|Overall Study|Death|0|||
161247735|NCT00379353|582286386|FG000|Overall Study|Cardiac Tamponade|1|||
161247736|NCT00379353|582286387|FG001|Overall Study|Cardiac Tamponade|0|||
161247737|NCT00379353|582286386|FG000|Overall Study|Non-compliance|1|||
161247738|NCT00379353|582286387|FG001|Overall Study|Non-compliance|0|||
161247739|NCT00379353|582286386|FG000|Overall Study|Conflicting drug treatment|0|||
161247740|NCT00379353|582286387|FG001|Overall Study|Conflicting drug treatment|1|||
161247741|NCT00884390|582286389|FG000|Overall Study|Adverse Event|0|||
161247742|NCT00884390|582286390|FG001|Overall Study|Adverse Event|1|||
161247743|NCT00884390|582286389|FG000|Overall Study|Lost to Follow-up|0|||
161247744|NCT00884390|582286390|FG001|Overall Study|Lost to Follow-up|1|||
161247745|NCT00884390|582286389|FG000|Overall Study|Physician Decision|2|||
161247746|NCT00884390|582286390|FG001|Overall Study|Physician Decision|1|||
161247747|NCT00884390|582286389|FG000|Overall Study|Protocol Violation|4|||
161247748|NCT00884390|582286390|FG001|Overall Study|Protocol Violation|1|||
161247749|NCT00884390|582286389|FG000|Overall Study|Withdrawal by Subject|4|||
161247750|NCT00884390|582286390|FG001|Overall Study|Withdrawal by Subject|1|||
161247751|NCT00884390|582286389|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
160833354|NCT01659255|580775998|FG016|Overall Study|Sponsor's Decision|0|||
160833355|NCT01659255|580775982|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833356|NCT01659255|580775983|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161247752|NCT00884390|582286390|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
161247753|NCT00884390|582286389|FG000|Overall Study|Other|11|||
161247754|NCT00884390|582286390|FG001|Overall Study|Other|1|||
161247755|NCT01211262|582286394|FG000|Overall Study|Progressive Disease|18|||
161247756|NCT01211262|582286395|FG001|Overall Study|Progressive Disease|9|||
161247757|NCT01211262|582286394|FG000|Overall Study|Adverse Event|4|||
161247758|NCT01211262|582286395|FG001|Overall Study|Adverse Event|0|||
161247759|NCT01211262|582286394|FG000|Overall Study|Withdrawal of Consent|1|||
160991231|NCT03369951|581355545|FG000|Overall Study|Protocol Violation|1|||
161247760|NCT01211262|582286395|FG001|Overall Study|Withdrawal of Consent|0|||
161247761|NCT01211262|582286394|FG000|Overall Study|Other|0|||
161247762|NCT01211262|582286395|FG001|Overall Study|Other|1|||
161247763|NCT01277510|582286398|FG000|Double-blind Phase|Non-compliance|0|||
161247764|NCT01277510|582286399|FG001|Double-blind Phase|Non-compliance|1|||
161247765|NCT01277510|582286398|FG000|Double-blind Phase|Adverse Event|1|||
161247766|NCT01277510|582286399|FG001|Double-blind Phase|Adverse Event|0|||
161247767|NCT01277510|582286398|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161247768|NCT01277510|582286399|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161247769|NCT01277510|582286398|FG000|Double-blind Phase|Administrative decision|7|||
161247770|NCT01277510|582286399|FG001|Double-blind Phase|Administrative decision|9|||
161247771|NCT01277510|582286398|FG000|Double-blind Phase|Death|0|||
161247772|NCT01277510|582286399|FG001|Double-blind Phase|Death|1|||
161247773|NCT01277510|582286398|FG000|Double-blind Phase|Protocol-specified criteria|2|||
161247774|NCT01277510|582286399|FG001|Double-blind Phase|Protocol-specified criteria|6|||
161247775|NCT01277510|582286398|FG000|Double-blind Phase|Other|1|||
160833357|NCT01659255|580775984|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833358|NCT01659255|580775985|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
161247776|NCT01277510|582286399|FG001|Double-blind Phase|Other|1|||
161247777|NCT01277510|582286398|FG000|Open-label Phase|Administrative decision|4|||
161247778|NCT01277510|582286399|FG001|Open-label Phase|Administrative decision|3|||
161247779|NCT01277510|582286398|FG000|Open-label Phase|Protocol-specified criteria|1|||
161247780|NCT01277510|582286399|FG001|Open-label Phase|Protocol-specified criteria|0|||
161247781|NCT01277510|582286398|FG000|Open-label Phase|Never received investigational product|2|||
161247782|NCT01277510|582286399|FG001|Open-label Phase|Never received investigational product|0|||
161247783|NCT00533507|582286400|FG000|Overall Study|Withdrawal by Subject|1|||
161247784|NCT02119936|582286409|FG000|Overall Study|Lost to Follow-up|10|||
161247785|NCT00570128|582286410|FG000|Overall Study|Adverse Event|1|||
161247786|NCT00570128|582286411|FG001|Overall Study|Adverse Event|0|||
161247787|NCT00570128|582286410|FG000|Overall Study|Lost to Follow-up|1|||
161247788|NCT00570128|582286411|FG001|Overall Study|Lost to Follow-up|0|||
161247789|NCT00570128|582286410|FG000|Overall Study|Withdrawal by Subject|2|||
161247790|NCT00570128|582286411|FG001|Overall Study|Withdrawal by Subject|0|||
161247791|NCT01426854|582286412|FG000|Overall Study|Adverse Event|1|||
160833359|NCT01659255|580775986|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833360|NCT01659255|580775987|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833361|NCT01659255|580775988|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833362|NCT01659255|580775989|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833363|NCT01659255|580775990|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833364|NCT01659255|580775991|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833365|NCT01659255|580775992|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833366|NCT01659255|580775993|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833367|NCT01659255|580775994|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833368|NCT01659255|580775995|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833369|NCT01659255|580775996|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833370|NCT01659255|580775997|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
160833371|NCT01659255|580775998|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
160833372|NCT01659255|580775982|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
160833373|NCT01659255|580775983|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
160833374|NCT01659255|580775984|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
160833375|NCT01659255|580775985|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
160833376|NCT01659255|580775986|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
161247792|NCT01426854|582286413|FG001|Overall Study|Adverse Event|5|||
161247793|NCT01426854|582286412|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
160833377|NCT01659255|580775987|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
160833378|NCT01659255|580775988|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
160833379|NCT01659255|580775989|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
160833380|NCT01659255|580775990|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
160833381|NCT01659255|580775991|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
160833382|NCT01659255|580775992|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
160833383|NCT01659255|580775993|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
160903559|NCT02478632|581040545|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
160903560|NCT02478632|581040546|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
160903561|NCT02478632|581040545|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
160903562|NCT02478632|581040546|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
160903563|NCT02478632|581040545|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
161247794|NCT01426854|582286413|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
161247795|NCT01426854|582286412|FG000|Overall Study|Lost to Follow-up|3|||
161247796|NCT01426854|582286413|FG001|Overall Study|Lost to Follow-up|0|||
161247797|NCT01426854|582286412|FG000|Overall Study|Noncompliance|0|||
161247798|NCT01426854|582286413|FG001|Overall Study|Noncompliance|1|||
161247799|NCT01426854|582286412|FG000|Overall Study|Treatment Failure|0|||
161247800|NCT01426854|582286413|FG001|Overall Study|Treatment Failure|16|||
160833384|NCT01659255|580775994|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
160833385|NCT01659255|580775995|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
160833386|NCT01659255|580775996|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
160833387|NCT01659255|580775997|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
160833388|NCT01659255|580775998|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
160833389|NCT01116427|580775999|FG000|Core Phase|Adverse Event|0|||
160833390|NCT01116427|580776000|FG001|Core Phase|Adverse Event|1|||
160833391|NCT01116427|580775999|FG000|Core Phase|Lost to Follow-up|1|||
160833392|NCT01116427|580776000|FG001|Core Phase|Lost to Follow-up|0|||
160833393|NCT01116427|580775999|FG000|Core Phase|Withdrawal by Subject|3|||
160833394|NCT01116427|580776000|FG001|Core Phase|Withdrawal by Subject|0|||
160833395|NCT01116427|580775999|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
160833396|NCT01116427|580776000|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
160833397|NCT01116427|580775999|FG000|Extension Phase|Adverse Event|1|||
160833398|NCT01116427|580776000|FG001|Extension Phase|Adverse Event|1|||
160833399|NCT01116427|580775999|FG000|Extension Phase|Lost to Follow-up|2|||
160833400|NCT01116427|580776000|FG001|Extension Phase|Lost to Follow-up|0|||
160833401|NCT01116427|580775999|FG000|Extension Phase|Withdrawal by Subject|5|||
160833402|NCT01116427|580776000|FG001|Extension Phase|Withdrawal by Subject|1|||
160833403|NCT01116427|580775999|FG000|Extension Phase|Not using appropriate birth control|1|||
160833404|NCT01116427|580776000|FG001|Extension Phase|Not using appropriate birth control|0|||
160833405|NCT02211313|580776003|FG000|Overall Study|Treatment Failure|5|||
160833406|NCT02211313|580776004|FG001|Overall Study|Treatment Failure|2|||
160833407|NCT02211313|580776003|FG000|Overall Study|No Follow up Questionnaires|1|||
160833408|NCT02211313|580776004|FG001|Overall Study|No Follow up Questionnaires|1|||
160833409|NCT01423916|580776005|FG000|Overall Study|Adverse Event|5|||
160833410|NCT01423916|580776006|FG001|Overall Study|Adverse Event|9|||
160833411|NCT01423916|580776007|FG002|Overall Study|Adverse Event|2|||
160833412|NCT01423916|580776005|FG000|Overall Study|Met Withdrawal Criteria|1|||
160833413|NCT01423916|580776006|FG001|Overall Study|Met Withdrawal Criteria|1|||
160903564|NCT02478632|581040546|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
160903565|NCT01867424|581040547|FG000|Overall Study|Patient noncompliance|2|||
160903566|NCT01867424|581040548|FG001|Overall Study|Patient noncompliance|1|||
160903567|NCT04645953|581040549|FG000|Overall Study|Lost to Follow-up|2|||
161136969|NCT01412879|581883697|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
161136970|NCT04030195|581883698|FG000|Overall Study|Withdrawal by Subject|2|||
161136971|NCT04030195|581883699|FG001|Overall Study|Withdrawal by Subject|0|||
161136972|NCT04030195|581883700|FG002|Overall Study|Withdrawal by Subject|0|||
161136973|NCT01056107|581883702|FG000|Overall Study|Withdrawal by Subject|0|||
161136974|NCT01056107|581883703|FG001|Overall Study|Withdrawal by Subject|1|||
161136975|NCT01056107|581883704|FG002|Overall Study|Withdrawal by Subject|3|||
161136976|NCT01056107|581883705|FG003|Overall Study|Withdrawal by Subject|0|||
161136977|NCT02210780|581883715|FG000|Overall Study|Adverse Event|0|||
161136978|NCT02210780|581883716|FG001|Overall Study|Adverse Event|5|||
161136979|NCT02210780|581883715|FG000|Overall Study|Lost to Follow-up|2|||
161136980|NCT02210780|581883716|FG001|Overall Study|Lost to Follow-up|1|||
161136981|NCT02210780|581883715|FG000|Overall Study|Withdrawal by Subject|1|||
161136982|NCT02210780|581883716|FG001|Overall Study|Withdrawal by Subject|1|||
161136983|NCT02210780|581883715|FG000|Overall Study|Physician Decision|1|||
161136984|NCT02210780|581883716|FG001|Overall Study|Physician Decision|0|||
161136985|NCT02210780|581883715|FG000|Overall Study|Protocol Violation|1|||
161136986|NCT02210780|581883716|FG001|Overall Study|Protocol Violation|0|||
161136987|NCT02210780|581883715|FG000|Overall Study|Other than specified above|0|||
161136988|NCT02210780|581883716|FG001|Overall Study|Other than specified above|1|||
161136989|NCT00364793|581883717|FG000|Overall Study|Adverse Event|2|||
161136990|NCT00364793|581883718|FG001|Overall Study|Adverse Event|0|||
161136991|NCT00364793|581883719|FG002|Overall Study|Adverse Event|0|||
161136992|NCT00364793|581883720|FG003|Overall Study|Adverse Event|0|||
161136993|NCT00364793|581883717|FG000|Overall Study|Death|1|||
161136994|NCT00364793|581883718|FG001|Overall Study|Death|0|||
160833414|NCT01423916|580776007|FG002|Overall Study|Met Withdrawal Criteria|1|||
160833415|NCT01423916|580776005|FG000|Overall Study|Physician Decision|1|||
160833416|NCT01423916|580776006|FG001|Overall Study|Physician Decision|0|||
160833417|NCT01423916|580776007|FG002|Overall Study|Physician Decision|1|||
160833418|NCT01423916|580776005|FG000|Overall Study|Withdrawal by Subject|3|||
160833419|NCT01423916|580776006|FG001|Overall Study|Withdrawal by Subject|10|||
160833420|NCT01423916|580776007|FG002|Overall Study|Withdrawal by Subject|3|||
160833421|NCT01423916|580776005|FG000|Overall Study|Protocol Deviation|1|||
160903568|NCT04645953|581040550|FG001|Overall Study|Lost to Follow-up|1|||
161136995|NCT00364793|581883719|FG002|Overall Study|Death|1|||
161136996|NCT00364793|581883720|FG003|Overall Study|Death|0|||
161136997|NCT00364793|581883717|FG000|Overall Study|Lack of Efficacy|3|||
161136998|NCT00364793|581883718|FG001|Overall Study|Lack of Efficacy|3|||
160833422|NCT01423916|580776006|FG001|Overall Study|Protocol Deviation|0|||
160833423|NCT01423916|580776007|FG002|Overall Study|Protocol Deviation|0|||
160833424|NCT03316950|580776008|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
160833425|NCT03316950|580776009|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
161136999|NCT00364793|581883719|FG002|Overall Study|Lack of Efficacy|1|||
161137000|NCT00364793|581883720|FG003|Overall Study|Lack of Efficacy|1|||
161137001|NCT00364793|581883717|FG000|Overall Study|Lost to Follow-up|1|||
161137002|NCT00364793|581883718|FG001|Overall Study|Lost to Follow-up|0|||
161137003|NCT00364793|581883719|FG002|Overall Study|Lost to Follow-up|2|||
161137004|NCT00364793|581883720|FG003|Overall Study|Lost to Follow-up|0|||
161137005|NCT00364793|581883717|FG000|Overall Study|Poor or non-compliance|1|||
161137006|NCT00364793|581883718|FG001|Overall Study|Poor or non-compliance|1|||
161137007|NCT00364793|581883719|FG002|Overall Study|Poor or non-compliance|0|||
161137008|NCT00364793|581883720|FG003|Overall Study|Poor or non-compliance|1|||
161137009|NCT00364793|581883717|FG000|Overall Study|No longer meets criteria|0|||
161137010|NCT00364793|581883718|FG001|Overall Study|No longer meets criteria|0|||
161137011|NCT00364793|581883719|FG002|Overall Study|No longer meets criteria|0|||
161137012|NCT00364793|581883720|FG003|Overall Study|No longer meets criteria|1|||
161137013|NCT00364793|581883717|FG000|Overall Study|Withdrawal by Subject|0|||
161137014|NCT00364793|581883718|FG001|Overall Study|Withdrawal by Subject|1|||
161137015|NCT00364793|581883719|FG002|Overall Study|Withdrawal by Subject|0|||
161137016|NCT00364793|581883720|FG003|Overall Study|Withdrawal by Subject|0|||
161137017|NCT01974323|581883727|FG000|Overall Study|Other Reasons|25|||
161137018|NCT01974323|581883728|FG001|Overall Study|Other Reasons|28|||
161137019|NCT01974323|581883727|FG000|Overall Study|Protocol Violation|2|||
161137020|NCT01974323|581883728|FG001|Overall Study|Protocol Violation|2|||
161137021|NCT01974323|581883727|FG000|Overall Study|Personal Reasons|15|||
161137022|NCT01974323|581883728|FG001|Overall Study|Personal Reasons|19|||
161137023|NCT01974323|581883727|FG000|Overall Study|Lost to Follow-up|45|||
161137024|NCT01974323|581883728|FG001|Overall Study|Lost to Follow-up|40|||
161137025|NCT01974323|581883727|FG000|Overall Study|Pregnancy|2|||
161137026|NCT01974323|581883728|FG001|Overall Study|Pregnancy|1|||
161137027|NCT01974323|581883727|FG000|Overall Study|Lack of Efficacy|1|||
161137028|NCT01974323|581883728|FG001|Overall Study|Lack of Efficacy|1|||
161137029|NCT01974323|581883727|FG000|Overall Study|Adverse Event|2|||
161137030|NCT01974323|581883728|FG001|Overall Study|Adverse Event|2|||
161137031|NCT00833092|581883729|FG000|Overall Study|Withdrawal by Subject|2|||
161137032|NCT00833092|581883730|FG001|Overall Study|Withdrawal by Subject|3|||
161137033|NCT00833092|581883729|FG000|Overall Study|Protocol Violation|2|||
161137034|NCT00833092|581883730|FG001|Overall Study|Protocol Violation|1|||
161137035|NCT00833092|581883729|FG000|Overall Study|Diarrhea|0|||
161137036|NCT00833092|581883730|FG001|Overall Study|Diarrhea|2|||
161137037|NCT00833092|581883729|FG000|Overall Study|constipation|0|||
161137038|NCT00833092|581883730|FG001|Overall Study|constipation|1|||
161137039|NCT00619229|581883733|FG000|Overall Study|Withdrawal by Subject|1|||
161137040|NCT00619229|581883734|FG001|Overall Study|Withdrawal by Subject|1|||
161137041|NCT00619229|581883733|FG000|Overall Study|Lost to Follow-up|1|||
161137042|NCT00619229|581883734|FG001|Overall Study|Lost to Follow-up|0|||
161137043|NCT00619229|581883733|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
161137044|NCT00619229|581883734|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
161137045|NCT00619229|581883733|FG000|Overall Study|Investigator planned Cataract Operation|1|||
161137046|NCT00619229|581883734|FG001|Overall Study|Investigator planned Cataract Operation|0|||
161137047|NCT03417440|581883735|FG000|Overall Study|Lost to Follow-up|0|||
161137048|NCT03417440|581883736|FG001|Overall Study|Lost to Follow-up|1|||
161137049|NCT03417440|581883737|FG002|Overall Study|Lost to Follow-up|0|||
161137050|NCT03417440|581883738|FG003|Overall Study|Lost to Follow-up|0|||
161137051|NCT03417440|581883739|FG004|Overall Study|Lost to Follow-up|1|||
161137052|NCT03417440|581883740|FG005|Overall Study|Lost to Follow-up|0|||
161137053|NCT03417440|581883741|FG006|Overall Study|Lost to Follow-up|0|||
161137054|NCT03417440|581883742|FG007|Overall Study|Lost to Follow-up|0|||
160903569|NCT04645953|581040551|FG002|Overall Study|Lost to Follow-up|1|||
160903570|NCT04645953|581040549|FG000|Overall Study|Withdrawal by Subject|0|||
160903571|NCT04645953|581040550|FG001|Overall Study|Withdrawal by Subject|1|||
160903572|NCT04645953|581040551|FG002|Overall Study|Withdrawal by Subject|0|||
160903573|NCT04645953|581040549|FG000|Overall Study|Physician Decision|0|||
160903574|NCT04645953|581040550|FG001|Overall Study|Physician Decision|1|||
160903575|NCT04645953|581040551|FG002|Overall Study|Physician Decision|0|||
161137055|NCT03417440|581883735|FG000|Overall Study|Withdrawal by Subject|2|||
160903576|NCT04645953|581040549|FG000|Overall Study|Discontinued Prior to Dosing|0|||
161137056|NCT03417440|581883736|FG001|Overall Study|Withdrawal by Subject|0|||
161137057|NCT03417440|581883737|FG002|Overall Study|Withdrawal by Subject|2|||
161137058|NCT03417440|581883738|FG003|Overall Study|Withdrawal by Subject|1|||
161137059|NCT03417440|581883739|FG004|Overall Study|Withdrawal by Subject|1|||
161137060|NCT03417440|581883740|FG005|Overall Study|Withdrawal by Subject|0|||
161137061|NCT03417440|581883741|FG006|Overall Study|Withdrawal by Subject|0|||
160903577|NCT04645953|581040550|FG001|Overall Study|Discontinued Prior to Dosing|0|||
160903578|NCT04645953|581040551|FG002|Overall Study|Discontinued Prior to Dosing|2|||
160903579|NCT04613375|581040552|FG000|Overall Study|Death|198|||
161137062|NCT03417440|581883742|FG007|Overall Study|Withdrawal by Subject|1|||
161137063|NCT02786901|581883743|FG000|Overall Study|Adverse Event|1|||
161137064|NCT02786901|581883744|FG001|Overall Study|Adverse Event|1|||
161137065|NCT02786901|581883745|FG002|Overall Study|Adverse Event|2|||
161137066|NCT02786901|581883743|FG000|Overall Study|Physician Decision|1|||
161137067|NCT02786901|581883744|FG001|Overall Study|Physician Decision|0|||
161137068|NCT02786901|581883745|FG002|Overall Study|Physician Decision|0|||
161137069|NCT02786901|581883743|FG000|Overall Study|Rescue Therapy Use|71|||
161137070|NCT02786901|581883744|FG001|Overall Study|Rescue Therapy Use|49|||
161137071|NCT02786901|581883745|FG002|Overall Study|Rescue Therapy Use|33|||
161137072|NCT02786901|581883743|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
161137073|NCT02786901|581883744|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
161137074|NCT02786901|581883745|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
161137075|NCT02786901|581883743|FG000|Overall Study|Disallowed medication|1|||
161137076|NCT02786901|581883744|FG001|Overall Study|Disallowed medication|1|||
161137077|NCT02786901|581883745|FG002|Overall Study|Disallowed medication|0|||
161137078|NCT02786901|581883743|FG000|Overall Study|Randomized in error|2|||
161137079|NCT02786901|581883744|FG001|Overall Study|Randomized in error|0|||
161137080|NCT02786901|581883745|FG002|Overall Study|Randomized in error|1|||
161137081|NCT00466505|581883746|FG000|Overall Study|disease progression|13|||
161137082|NCT00466505|581883746|FG000|Overall Study|Adverse Event|4|||
161137083|NCT00355264|581883747|FG000|Extension (Variable Duration)|Adverse Event|1|||
161137084|NCT00355264|581883747|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
161137085|NCT00699192|581883748|FG000|Overall Study|Missing|1|||
161137086|NCT00699192|581883749|FG001|Overall Study|Missing|1|||
161137087|NCT00699192|581883750|FG002|Overall Study|Missing|1|||
161137088|NCT00699192|581883748|FG000|Overall Study|Adverse Event|9|||
161137089|NCT00699192|581883749|FG001|Overall Study|Adverse Event|4|||
161137090|NCT00699192|581883750|FG002|Overall Study|Adverse Event|3|||
161137091|NCT00699192|581883748|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161137092|NCT00699192|581883749|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161137093|NCT00699192|581883750|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161137094|NCT00699192|581883748|FG000|Overall Study|Lack of Efficacy|0|||
161137095|NCT00699192|581883749|FG001|Overall Study|Lack of Efficacy|0|||
161137096|NCT00699192|581883750|FG002|Overall Study|Lack of Efficacy|1|||
161137097|NCT00699192|581883748|FG000|Overall Study|Withdrawal by Subject|3|||
161137098|NCT00699192|581883749|FG001|Overall Study|Withdrawal by Subject|2|||
161137099|NCT00699192|581883750|FG002|Overall Study|Withdrawal by Subject|4|||
161137100|NCT00699192|581883748|FG000|Overall Study|Administrative problems|1|||
161137101|NCT00699192|581883749|FG001|Overall Study|Administrative problems|3|||
161137102|NCT00699192|581883750|FG002|Overall Study|Administrative problems|1|||
161137103|NCT00699192|581883748|FG000|Overall Study|Protocol Violation|2|||
161137104|NCT00699192|581883749|FG001|Overall Study|Protocol Violation|2|||
161137105|NCT00699192|581883750|FG002|Overall Study|Protocol Violation|0|||
161137106|NCT01773473|581883751|FG000|Overall Study|Adverse Event|3|||
161137107|NCT01773473|581883752|FG001|Overall Study|Adverse Event|2|||
161137108|NCT01773473|581883751|FG000|Overall Study|Protocol Violation|0|||
161137109|NCT01773473|581883752|FG001|Overall Study|Protocol Violation|4|||
161137110|NCT01773473|581883751|FG000|Overall Study|Physician Decision|3|||
161137111|NCT01773473|581883752|FG001|Overall Study|Physician Decision|5|||
161137112|NCT01773473|581883751|FG000|Overall Study|Sponsor Decision|2|||
161137113|NCT01773473|581883752|FG001|Overall Study|Sponsor Decision|0|||
161137114|NCT01773473|581883751|FG000|Overall Study|Lack of Efficacy|0|||
161137115|NCT01773473|581883752|FG001|Overall Study|Lack of Efficacy|1|||
161137116|NCT01773473|581883751|FG000|Overall Study|Non-Compliance with study drug|1|||
161137117|NCT01773473|581883752|FG001|Overall Study|Non-Compliance with study drug|4|||
161137118|NCT01773473|581883751|FG000|Overall Study|Withdrawal by Subject|5|||
161137119|NCT01773473|581883752|FG001|Overall Study|Withdrawal by Subject|3|||
161137120|NCT01773473|581883751|FG000|Overall Study|Lost to Follow-up|2|||
161334916|NCT03786380|582615860|FG000|Overall Study|Lack of Efficacy|0|||
161334917|NCT03786380|582615861|FG001|Overall Study|Lack of Efficacy|0|||
160903580|NCT04613375|581040552|FG000|Overall Study|Withdrawal by Subject|3|||
160903581|NCT00002651|581040553|FG000|Induction|Adverse Event|44|||
160903582|NCT00002651|581040554|FG001|Induction|Adverse Event|0|||
160903583|NCT00002651|581040555|FG002|Induction|Adverse Event|0|||
160903584|NCT00002651|581040553|FG000|Induction|Refusal unrelated to adverse event|50|||
161334918|NCT03786380|582615862|FG002|Overall Study|Lack of Efficacy|0|||
160903585|NCT00002651|581040554|FG001|Induction|Refusal unrelated to adverse event|0|||
160903586|NCT00002651|581040555|FG002|Induction|Refusal unrelated to adverse event|0|||
161137121|NCT01773473|581883752|FG001|Overall Study|Lost to Follow-up|0|||
161137122|NCT00826514|581883753|FG000|Overall Study|Adverse Event|1|||
161137123|NCT00826514|581883754|FG001|Overall Study|Adverse Event|1|||
161137124|NCT00826514|581883753|FG000|Overall Study|Lack of Efficacy|0|||
161137125|NCT00826514|581883754|FG001|Overall Study|Lack of Efficacy|1|||
161137126|NCT00826514|581883753|FG000|Overall Study|Withdrawal by Subject|2|||
161137127|NCT00826514|581883754|FG001|Overall Study|Withdrawal by Subject|3|||
161137128|NCT01451645|581883755|FG000|Overall Study|Protocol Violation|1|||
161334919|NCT03786380|582615863|FG003|Overall Study|Lack of Efficacy|0|||
160903587|NCT00002651|581040553|FG000|Induction|Progression/relapse|274|||
161137129|NCT01451645|581883756|FG001|Overall Study|Protocol Violation|0|||
161137130|NCT01451645|581883755|FG000|Overall Study|Adverse Event|0|||
161137131|NCT01451645|581883756|FG001|Overall Study|Adverse Event|3|||
160833426|NCT03316950|580776010|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
160833427|NCT03316950|580776011|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
160833428|NCT03316950|580776008|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
160833429|NCT03316950|580776009|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
160833430|NCT03316950|580776010|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
160833431|NCT03316950|580776011|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
160833432|NCT03316950|580776008|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
160833433|NCT03316950|580776009|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
160833434|NCT03316950|580776010|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
160833435|NCT03316950|580776011|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
160833436|NCT00791557|580776012|FG000|Overall Study|Adverse Event|1|||
160833437|NCT01079936|580776013|FG000|Phase I: MTD|First Remission Status|2|||
160833438|NCT01079936|580776014|FG001|Phase I: MTD|First Remission Status|0|||
160833439|NCT01079936|580776015|FG002|Phase I: MTD|First Remission Status|0|||
160833440|NCT01079936|580776016|FG003|Phase I: MTD|First Remission Status|0|||
160833441|NCT01079936|580776017|FG004|Phase I: MTD|First Remission Status|0|||
160833442|NCT01079936|580776013|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
160833443|NCT01079936|580776014|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
160833444|NCT01079936|580776015|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
160833445|NCT01079936|580776016|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
160833446|NCT01079936|580776017|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
160833447|NCT01079936|580776013|FG000|Phase II|Adverse Event|0|||
160833448|NCT01079936|580776014|FG001|Phase II|Adverse Event|0|||
160833449|NCT01079936|580776015|FG002|Phase II|Adverse Event|1|||
160833450|NCT01079936|580776016|FG003|Phase II|Adverse Event|0|||
160833451|NCT01079936|580776017|FG004|Phase II|Adverse Event|0|||
160833452|NCT01079936|580776013|FG000|Phase II|Insurance Issue|0|||
160833453|NCT01079936|580776014|FG001|Phase II|Insurance Issue|0|||
160833454|NCT01079936|580776015|FG002|Phase II|Insurance Issue|0|||
160833455|NCT01079936|580776016|FG003|Phase II|Insurance Issue|0|||
160833456|NCT01079936|580776017|FG004|Phase II|Insurance Issue|1|||
160833457|NCT02322190|580776018|FG000|Overall Study|Death on study|1|||
160833458|NCT02322190|580776019|FG001|Overall Study|Death on study|0|||
160833459|NCT03344640|580776020|FG000|Overall Study|Adverse Event|1|||
160833460|NCT03344640|580776021|FG001|Overall Study|Adverse Event|0|||
160833461|NCT03344640|580776020|FG000|Overall Study|Physician Decision|1|||
160833462|NCT03344640|580776021|FG001|Overall Study|Physician Decision|1|||
160833463|NCT03344640|580776020|FG000|Overall Study|Withdrawal by Subject|1|||
160833464|NCT03344640|580776021|FG001|Overall Study|Withdrawal by Subject|2|||
160833465|NCT03344640|580776020|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
160833466|NCT03344640|580776021|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
160833467|NCT01177969|580776027|FG000|Overall Study|Protocol Violation|2|||
160833468|NCT01177969|580776028|FG001|Overall Study|Protocol Violation|1|||
160991232|NCT03677375|581355546|FG000|Overall Study|Incomplete procedure|8|||
160991233|NCT03677375|581355546|FG000|Overall Study|Adverse Event|3|||
160991234|NCT03677375|581355546|FG000|Overall Study|Physician Decision|1|||
160991235|NCT00725010|581355552|FG000|Overall Study|Toxicity|9|||
160991236|NCT00725010|581355552|FG000|Overall Study|Tumor Progression|7|||
160991237|NCT00725010|581355552|FG000|Overall Study|Withdrawal by Subject|2|||
160991238|NCT00725010|581355552|FG000|Overall Study|Death|1|||
160991239|NCT00725010|581355552|FG000|Overall Study|Lost to Follow-up|1|||
160991240|NCT00725010|581355552|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
160991241|NCT00725010|581355552|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
160991242|NCT00725010|581355552|FG000|Overall Study|No further documentation|1|||
160991243|NCT00725010|581355552|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
160991244|NCT02414828|581355553|FG000|Overall Study|Lost to Follow-up|0|||
160991245|NCT02414828|581355554|FG001|Overall Study|Lost to Follow-up|1|||
160991246|NCT02414828|581355555|FG002|Overall Study|Lost to Follow-up|1|||
160991247|NCT02414828|581355556|FG003|Overall Study|Lost to Follow-up|2|||
160991248|NCT00670540|581355560|FG000|Overall Study|ineligible|17|||
160991249|NCT00670540|581355560|FG000|Overall Study|not living in France|348|||
160991250|NCT00670540|581355560|FG000|Overall Study|refused to participate|189|||
160833469|NCT01177969|580776027|FG000|Overall Study|Withdrawal by Subject|1|||
160833470|NCT01177969|580776028|FG001|Overall Study|Withdrawal by Subject|2|||
160833471|NCT02565810|580776029|FG000|Overall Study|Withdrawal by Subject|1|||
160833472|NCT01792518|580776040|FG000|Overall Study|Adverse Event|3|||
160991251|NCT00670540|581355560|FG000|Overall Study|controls randomised for no follow up|2770|||
160991252|NCT00670540|581355560|FG000|Overall Study|missing information inclusion criteria|1|||
160991253|NCT01866917|581355561|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
160833473|NCT01792518|580776041|FG001|Overall Study|Adverse Event|4|||
160991254|NCT01866917|581355562|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
160833474|NCT01792518|580776040|FG000|Overall Study|Protocol Violation|0|||
160833475|NCT01792518|580776041|FG001|Overall Study|Protocol Violation|1|||
160833476|NCT01792518|580776040|FG000|Overall Study|Lost to Follow-up|3|||
160833477|NCT01792518|580776041|FG001|Overall Study|Lost to Follow-up|1|||
160833478|NCT01792518|580776040|FG000|Overall Study|Withdrawal by Subject|2|||
160833479|NCT01792518|580776041|FG001|Overall Study|Withdrawal by Subject|0|||
160833480|NCT01792518|580776040|FG000|Overall Study|Other Reason|0|||
160833481|NCT01792518|580776041|FG001|Overall Study|Other Reason|1|||
160833482|NCT01504204|580776042|FG000|Overall Study|Lost to Follow-up|1|||
160833483|NCT01504204|580776043|FG001|Overall Study|Lost to Follow-up|1|||
160833484|NCT03869333|580776048|FG000|Overall Study|Lost to Follow-up|1|||
160833485|NCT03869333|580776049|FG001|Overall Study|Lost to Follow-up|0|||
160833486|NCT03869333|580776050|FG002|Overall Study|Lost to Follow-up|0|||
160833487|NCT03869333|580776051|FG003|Overall Study|Lost to Follow-up|0|||
160833488|NCT03869333|580776048|FG000|Overall Study|Pregnancy|1|||
160833489|NCT03869333|580776049|FG001|Overall Study|Pregnancy|0|||
160833490|NCT03869333|580776050|FG002|Overall Study|Pregnancy|0|||
160833491|NCT03869333|580776051|FG003|Overall Study|Pregnancy|0|||
160833492|NCT03869333|580776048|FG000|Overall Study|Physician Decision|0|||
160833493|NCT03869333|580776049|FG001|Overall Study|Physician Decision|1|||
160833494|NCT03869333|580776050|FG002|Overall Study|Physician Decision|0|||
160833495|NCT03869333|580776051|FG003|Overall Study|Physician Decision|0|||
160833496|NCT02966015|580776055|FG000|Inclusion Visit|did not answer questionnaire|8|||
160833497|NCT02966015|580776056|FG001|Inclusion Visit|did not answer questionnaire|3|||
160833498|NCT02241187|580776057|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
160833499|NCT02356887|580776058|FG000|Overall Study|poor compliance|2|||
160833500|NCT00199888|580776059|FG000|Overall Study|Lost to Follow-up|1|||
160833501|NCT02177838|580776060|FG000|Overall Study|Withdrawal by Subject|1|||
160833502|NCT02177838|580776060|FG000|Overall Study|Physician Decision|1|||
160833503|NCT02177838|580776060|FG000|Overall Study|Death|1|||
160833504|NCT01839656|580776061|FG000|Overall Study|Withdrawal by Subject|1|||
160833505|NCT01839656|580776062|FG001|Overall Study|Withdrawal by Subject|1|||
160833506|NCT01839656|580776061|FG000|Overall Study|Adverse event, serious fatal|1|||
160833507|NCT01839656|580776062|FG001|Overall Study|Adverse event, serious fatal|4|||
160833508|NCT01839656|580776061|FG000|Overall Study|Early study closure|0|||
160833509|NCT01839656|580776062|FG001|Overall Study|Early study closure|11|||
160833510|NCT01839656|580776061|FG000|Overall Study|Adverse Event|1|||
160833511|NCT01839656|580776062|FG001|Overall Study|Adverse Event|0|||
160833512|NCT02273960|580776065|FG000|Short Term Period|Lost to Follow-up|1|||
160833513|NCT02273960|580776066|FG001|Short Term Period|Lost to Follow-up|0|||
160833514|NCT02273960|580776067|FG002|Short Term Period|Lost to Follow-up|0|||
160903588|NCT00002651|581040554|FG001|Induction|Progression/relapse|0|||
160903589|NCT00002651|581040555|FG002|Induction|Progression/relapse|0|||
160903590|NCT00002651|581040553|FG000|Induction|Death|62|||
160903591|NCT00002651|581040554|FG001|Induction|Death|0|||
161137132|NCT01451645|581883755|FG000|Overall Study|Withdrawal by Subject|4|||
161137133|NCT01451645|581883756|FG001|Overall Study|Withdrawal by Subject|2|||
161137134|NCT01451645|581883755|FG000|Overall Study|Lost to Follow-up|4|||
161137135|NCT01451645|581883756|FG001|Overall Study|Lost to Follow-up|3|||
161137136|NCT03663166|581883757|FG000|Overall Study|Withdrawal by Subject|1|||
161137137|NCT04927312|581883758|FG000|Overall Study|Adverse Event|1|||
161137138|NCT04927312|581883758|FG000|Overall Study|Death|1|||
161137139|NCT04927312|581883758|FG000|Overall Study|Withdrawal by Subject|1|||
161137140|NCT04927312|581883758|FG000|Overall Study|Other|1|||
161137141|NCT04919564|581883764|FG000|Overall Study|Lost to Follow-up|1|||
161137142|NCT04919564|581883765|FG001|Overall Study|Lost to Follow-up|0|||
161137143|NCT04919564|581883764|FG000|Overall Study|Physician Decision|1|||
161137144|NCT04919564|581883765|FG001|Overall Study|Physician Decision|1|||
161137145|NCT05292755|581883769|FG000|Overall Study|Lost to Follow-up|5|||
161137146|NCT05292755|581883770|FG001|Overall Study|Lost to Follow-up|9|||
161137147|NCT04052139|581883771|FG000|Overall Study|Lost to Follow-up|2|||
161137148|NCT04052139|581883772|FG001|Overall Study|Lost to Follow-up|0|||
161137149|NCT04052139|581883773|FG002|Overall Study|Lost to Follow-up|0|||
161137150|NCT04052139|581883771|FG000|Overall Study|Withdrawal by Subject|1|||
161137151|NCT04052139|581883772|FG001|Overall Study|Withdrawal by Subject|0|||
161137152|NCT04052139|581883773|FG002|Overall Study|Withdrawal by Subject|0|||
161137153|NCT00707577|581883774|FG000|Overall Study|Withdrawal by Subject|3|||
161137154|NCT00707577|581883775|FG001|Overall Study|Withdrawal by Subject|2|||
161137155|NCT00707577|581883774|FG000|Overall Study|Lost to Follow-up|34|||
161137156|NCT00707577|581883775|FG001|Overall Study|Lost to Follow-up|25|||
161137157|NCT00707577|581883774|FG000|Overall Study|Left employment|13|||
161137158|NCT00707577|581883775|FG001|Overall Study|Left employment|10|||
161137159|NCT00707577|581883774|FG000|Overall Study|Pregnancy|4|||
161137160|NCT00707577|581883775|FG001|Overall Study|Pregnancy|1|||
161137161|NCT00190775|581883776|FG000|Overall Study|Adverse Event|57|||
161137162|NCT00190775|581883777|FG001|Overall Study|Adverse Event|22|||
161137163|NCT00190775|581883776|FG000|Overall Study|Satisfactory Response|1|||
161137164|NCT00190775|581883777|FG001|Overall Study|Satisfactory Response|0|||
161137165|NCT00190775|581883776|FG000|Overall Study|Lack of Efficacy|28|||
160833515|NCT02273960|580776068|FG003|Short Term Period|Lost to Follow-up|0|||
160833516|NCT02273960|580776065|FG000|Short Term Period|Lack of Efficacy|0|||
160833517|NCT02273960|580776066|FG001|Short Term Period|Lack of Efficacy|0|||
160833518|NCT02273960|580776067|FG002|Short Term Period|Lack of Efficacy|0|||
160903592|NCT00002651|581040555|FG002|Induction|Death|0|||
161137166|NCT00190775|581883777|FG001|Overall Study|Lack of Efficacy|32|||
161247801|NCT01426854|582286412|FG000|Overall Study|Protocol Deviation|0|||
161247802|NCT01426854|582286413|FG001|Overall Study|Protocol Deviation|1|||
161247803|NCT01426854|582286412|FG000|Overall Study|Other|3|||
161247804|NCT01426854|582286413|FG001|Overall Study|Other|2|||
161247805|NCT01566435|582286417|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
161247806|NCT00438633|582286418|FG000|Overall Study|Withdrawal by Subject|1|||
161247807|NCT00438633|582286419|FG001|Overall Study|Withdrawal by Subject|0|||
161247808|NCT00438633|582286418|FG000|Overall Study|Lost to Follow-up|15|||
161247809|NCT00438633|582286419|FG001|Overall Study|Lost to Follow-up|17|||
161247810|NCT04569084|582286420|FG000|Overall Study|Adverse Event|10|||
161247811|NCT04569084|582286421|FG001|Overall Study|Adverse Event|14|||
161247812|NCT04569084|582286420|FG000|Overall Study|Death|2|||
161247813|NCT04569084|582286421|FG001|Overall Study|Death|3|||
161247814|NCT04569084|582286420|FG000|Overall Study|Lost to Follow-up|1|||
161247815|NCT04569084|582286421|FG001|Overall Study|Lost to Follow-up|1|||
161247816|NCT04569084|582286420|FG000|Overall Study|Physician Decision|3|||
161247817|NCT04569084|582286421|FG001|Overall Study|Physician Decision|3|||
161247818|NCT04569084|582286420|FG000|Overall Study|Protocol Violation|2|||
161247819|NCT04569084|582286421|FG001|Overall Study|Protocol Violation|1|||
161247820|NCT04569084|582286420|FG000|Overall Study|Withdrawal by Subject|20|||
161247821|NCT04569084|582286421|FG001|Overall Study|Withdrawal by Subject|21|||
161247822|NCT04569084|582286420|FG000|Overall Study|Study terminated by sponsor|26|||
161247823|NCT04569084|582286421|FG001|Overall Study|Study terminated by sponsor|23|||
161247824|NCT04569084|582286420|FG000|Overall Study|Other|3|||
161247825|NCT04569084|582286421|FG001|Overall Study|Other|5|||
161247826|NCT03196284|582286422|FG000|Main Part|Withdrawal by Subject|0|||
160833519|NCT02273960|580776068|FG003|Short Term Period|Lack of Efficacy|1|||
160833520|NCT02273960|580776065|FG000|Short Term Period|ST complete, not entering LTE|4|||
160833521|NCT02273960|580776066|FG001|Short Term Period|ST complete, not entering LTE|6|||
160833522|NCT02273960|580776067|FG002|Short Term Period|ST complete, not entering LTE|4|||
160833523|NCT02273960|580776068|FG003|Short Term Period|ST complete, not entering LTE|5|||
160833524|NCT02273960|580776065|FG000|Long Term Extension|Death|0|||
160833525|NCT02273960|580776066|FG001|Long Term Extension|Death|0|||
160833526|NCT02273960|580776067|FG002|Long Term Extension|Death|0|||
160833527|NCT02273960|580776068|FG003|Long Term Extension|Death|1|||
160833528|NCT01012323|580776069|FG000|Overall Study|Investigator Judgment|1|||
160833529|NCT00558272|580776072|FG000|Overall Study|Adverse Event|10|||
160833530|NCT00558272|580776073|FG001|Overall Study|Adverse Event|0|||
160833531|NCT00558272|580776072|FG000|Overall Study|Death|1|||
160833532|NCT00558272|580776073|FG001|Overall Study|Death|0|||
160833533|NCT00558272|580776072|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
160833534|NCT00558272|580776073|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
160833535|NCT00558272|580776072|FG000|Overall Study|AZ study team decision|0|||
160833536|NCT00558272|580776073|FG001|Overall Study|AZ study team decision|1|||
160833537|NCT00558272|580776072|FG000|Overall Study|Incorrectly enrolled|1|||
160833538|NCT00558272|580776073|FG001|Overall Study|Incorrectly enrolled|0|||
160833539|NCT00558272|580776072|FG000|Overall Study|Withdrawal by Subject|0|||
160833540|NCT00558272|580776073|FG001|Overall Study|Withdrawal by Subject|1|||
160833541|NCT01105377|580776076|FG000|Overall Study|Withdrawal by Subject|0|||
160833542|NCT01105377|580776077|FG001|Overall Study|Withdrawal by Subject|1|||
160833543|NCT01638559|580776079|FG000|Overall Study|Lost to Follow-up|1|||
160833544|NCT01638559|580776079|FG000|Overall Study|Withdrawal by Subject|1|||
160833545|NCT01638559|580776079|FG000|Overall Study|Subject declined to travel for biopsy|1|||
160833546|NCT03442296|580776083|FG000|3 Month Follow-up|Death|3|||
160833547|NCT03442296|580776084|FG001|3 Month Follow-up|Death|1|||
160903593|NCT00002651|581040553|FG000|Induction|Other|823|||
160903594|NCT00002651|581040554|FG001|Induction|Other|0|||
160903595|NCT00002651|581040555|FG002|Induction|Other|0|||
160903596|NCT00002651|581040553|FG000|Induction|not eligible|90|||
160903597|NCT00002651|581040554|FG001|Induction|not eligible|0|||
160903598|NCT00002651|581040555|FG002|Induction|not eligible|0|||
160903599|NCT00002651|581040553|FG000|Consolidation and Randomization|Adverse Event|0|||
160903600|NCT00002651|581040554|FG001|Consolidation and Randomization|Adverse Event|36|||
160903601|NCT00002651|581040555|FG002|Consolidation and Randomization|Adverse Event|14|||
160833548|NCT03442296|580776083|FG000|3 Month Follow-up|Lost to Follow-up|1|||
160833549|NCT03442296|580776084|FG001|3 Month Follow-up|Lost to Follow-up|1|||
160903602|NCT00002651|581040553|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
161247827|NCT03196284|582286423|FG001|Main Part|Withdrawal by Subject|1|||
161247828|NCT03196284|582286424|FG002|Main Part|Withdrawal by Subject|0|||
161247829|NCT03196284|582286422|FG000|Extension Part|Lack of Efficacy|0|||
161247830|NCT03196284|582286423|FG001|Extension Part|Lack of Efficacy|0|||
161247831|NCT03196284|582286424|FG002|Extension Part|Lack of Efficacy|1|||
160833550|NCT03442296|580776083|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
160833551|NCT03442296|580776084|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
161247832|NCT03196284|582286422|FG000|Extension Part|Withdrawal by Subject|0|||
161247833|NCT03196284|582286423|FG001|Extension Part|Withdrawal by Subject|0|||
161247834|NCT03196284|582286424|FG002|Extension Part|Withdrawal by Subject|1|||
161247835|NCT03196284|582286422|FG000|Extension Part|Physician Decision|0|||
161247836|NCT03196284|582286423|FG001|Extension Part|Physician Decision|0|||
161137167|NCT00190775|581883776|FG000|Overall Study|Lost to Follow-up|31|||
161137168|NCT00190775|581883777|FG001|Overall Study|Lost to Follow-up|23|||
161137169|NCT00190775|581883776|FG000|Overall Study|Participant Moved|0|||
161137170|NCT00190775|581883777|FG001|Overall Study|Participant Moved|1|||
161137171|NCT00190775|581883776|FG000|Overall Study|Withdrawal by Subject|24|||
161137172|NCT00190775|581883777|FG001|Overall Study|Withdrawal by Subject|13|||
161137173|NCT00190775|581883776|FG000|Overall Study|Sponsor Decision|1|||
161137174|NCT00190775|581883777|FG001|Overall Study|Sponsor Decision|0|||
161137175|NCT00190775|581883776|FG000|Overall Study|Physician Decision|3|||
161137176|NCT00190775|581883777|FG001|Overall Study|Physician Decision|0|||
161137177|NCT00190775|581883776|FG000|Overall Study|Noncompliance|3|||
161137178|NCT00190775|581883777|FG001|Overall Study|Noncompliance|5|||
161137179|NCT00190775|581883776|FG000|Overall Study|Protocol Violation|0|||
161137180|NCT00190775|581883777|FG001|Overall Study|Protocol Violation|1|||
161137181|NCT00190775|581883776|FG000|Overall Study|Exclusion Criteria Met|1|||
161137182|NCT00190775|581883777|FG001|Overall Study|Exclusion Criteria Met|3|||
161137183|NCT01794780|581883778|FG000|Overall Study|Adverse Event|0|||
161137184|NCT01794780|581883779|FG001|Overall Study|Adverse Event|1|||
161137185|NCT01794780|581883780|FG002|Overall Study|Adverse Event|2|||
161137186|NCT01794780|581883781|FG003|Overall Study|Adverse Event|0|||
161137187|NCT01794780|581883782|FG004|Overall Study|Adverse Event|0|||
161137188|NCT01794780|581883783|FG005|Overall Study|Adverse Event|0|||
161137189|NCT01794780|581883784|FG006|Overall Study|Adverse Event|0|||
161137190|NCT01794780|581883785|FG007|Overall Study|Adverse Event|0|||
161137191|NCT01794780|581883778|FG000|Overall Study|Death|0|||
161137192|NCT01794780|581883779|FG001|Overall Study|Death|2|||
161137193|NCT01794780|581883780|FG002|Overall Study|Death|14|||
161137194|NCT01794780|581883781|FG003|Overall Study|Death|1|||
161137195|NCT01794780|581883782|FG004|Overall Study|Death|0|||
161137196|NCT01794780|581883783|FG005|Overall Study|Death|9|||
161137197|NCT01794780|581883784|FG006|Overall Study|Death|4|||
161137198|NCT01794780|581883785|FG007|Overall Study|Death|0|||
161137199|NCT01794780|581883778|FG000|Overall Study|Lost to Follow-up|10|||
161137200|NCT01794780|581883779|FG001|Overall Study|Lost to Follow-up|64|||
161137201|NCT01794780|581883780|FG002|Overall Study|Lost to Follow-up|165|||
161137202|NCT01794780|581883781|FG003|Overall Study|Lost to Follow-up|53|||
161137203|NCT01794780|581883782|FG004|Overall Study|Lost to Follow-up|2|||
161137204|NCT01794780|581883783|FG005|Overall Study|Lost to Follow-up|99|||
161137205|NCT01794780|581883784|FG006|Overall Study|Lost to Follow-up|30|||
161137206|NCT01794780|581883785|FG007|Overall Study|Lost to Follow-up|5|||
161137207|NCT01794780|581883778|FG000|Overall Study|Withdrew informed consent|7|||
161137208|NCT01794780|581883779|FG001|Overall Study|Withdrew informed consent|17|||
161137209|NCT01794780|581883780|FG002|Overall Study|Withdrew informed consent|36|||
161137210|NCT01794780|581883781|FG003|Overall Study|Withdrew informed consent|9|||
161137211|NCT01794780|581883782|FG004|Overall Study|Withdrew informed consent|0|||
161137212|NCT01794780|581883783|FG005|Overall Study|Withdrew informed consent|48|||
161137213|NCT01794780|581883784|FG006|Overall Study|Withdrew informed consent|4|||
161137214|NCT01794780|581883785|FG007|Overall Study|Withdrew informed consent|3|||
161137215|NCT01794780|581883778|FG000|Overall Study|Other|0|||
161137216|NCT01794780|581883779|FG001|Overall Study|Other|12|||
161137217|NCT01794780|581883780|FG002|Overall Study|Other|25|||
161137218|NCT01794780|581883781|FG003|Overall Study|Other|20|||
161137219|NCT01794780|581883782|FG004|Overall Study|Other|1|||
161137220|NCT01794780|581883783|FG005|Overall Study|Other|24|||
161137221|NCT01794780|581883784|FG006|Overall Study|Other|4|||
161137222|NCT01794780|581883785|FG007|Overall Study|Other|1|||
161137223|NCT00519077|581883786|FG000|Overall Study|Death|6|||
161137224|NCT00519077|581883786|FG000|Overall Study|Other|2|||
161137225|NCT01967225|581883788|FG000|Overall Study|Adverse Event|3|||
161137226|NCT01967225|581883789|FG001|Overall Study|Adverse Event|1|||
161137227|NCT01967225|581883788|FG000|Overall Study|Withdrawal by Subject|2|||
161137228|NCT01967225|581883789|FG001|Overall Study|Withdrawal by Subject|1|||
161137229|NCT01967225|581883788|FG000|Overall Study|Lack of Efficacy|1|||
161137230|NCT01967225|581883789|FG001|Overall Study|Lack of Efficacy|1|||
161137231|NCT01967225|581883788|FG000|Overall Study|Switching to other therapy|2|||
161137232|NCT01967225|581883789|FG001|Overall Study|Switching to other therapy|0|||
161137233|NCT01967225|581883788|FG000|Overall Study|Protocol driven decision point|1|||
161137234|NCT01967225|581883789|FG001|Overall Study|Protocol driven decision point|0|||
161137235|NCT01967225|581883788|FG000|Overall Study|Logistical difficulties|1|||
161137236|NCT01967225|581883789|FG001|Overall Study|Logistical difficulties|0|||
161137237|NCT01967225|581883788|FG000|Overall Study|Protocol Violation|2|||
161137238|NCT01967225|581883789|FG001|Overall Study|Protocol Violation|0|||
161137239|NCT02286102|581883790|FG000|Overall Study|Screen Failure|1|||
161247837|NCT03196284|582286424|FG002|Extension Part|Physician Decision|1|||
161137240|NCT02286102|581883791|FG001|Overall Study|Screen Failure|1|||
161137241|NCT00327444|581883792|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
161137242|NCT00327444|581883793|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
161137243|NCT00327444|581883792|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
161137244|NCT00327444|581883793|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
161137245|NCT00327444|581883792|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
161247838|NCT03820947|582286425|FG000|Overall Study|Physician Decision|0|||
161247839|NCT03820947|582286426|FG001|Overall Study|Physician Decision|1|||
161247840|NCT03820947|582286427|FG002|Overall Study|Physician Decision|1|||
161247841|NCT03820947|582286428|FG003|Overall Study|Physician Decision|0|||
161247842|NCT03820947|582286429|FG004|Overall Study|Physician Decision|3|||
161247843|NCT03820947|582286425|FG000|Overall Study|Withdrawal by Subject|6|||
161247844|NCT03820947|582286426|FG001|Overall Study|Withdrawal by Subject|10|||
161247845|NCT03820947|582286427|FG002|Overall Study|Withdrawal by Subject|3|||
161247846|NCT03820947|582286428|FG003|Overall Study|Withdrawal by Subject|8|||
161334920|NCT03786380|582615864|FG004|Overall Study|Lack of Efficacy|1|||
161334921|NCT03786380|582615860|FG000|Overall Study|Withdrawal by Subject|1|||
161137246|NCT00327444|581883793|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
161137247|NCT00327444|581883792|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
161137248|NCT00327444|581883793|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
161137249|NCT00327444|581883792|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
161137250|NCT00327444|581883793|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
161137251|NCT00327444|581883792|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
161137252|NCT00327444|581883793|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
161137253|NCT00327444|581883792|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
161137254|NCT00327444|581883793|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
161137255|NCT00327444|581883792|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
161137256|NCT00327444|581883793|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
161137257|NCT01658514|581883795|FG000|Overall Study|Protocol Violation|1|||
161137258|NCT01658514|581883796|FG001|Overall Study|Protocol Violation|0|||
161137259|NCT01658514|581883797|FG002|Overall Study|Protocol Violation|2|||
161137260|NCT00144170|581883799|FG000|Overall Study|Adverse Event|84|||
161137261|NCT00144170|581883800|FG001|Overall Study|Adverse Event|41|||
161137262|NCT00144170|581883799|FG000|Overall Study|Protocol Violation|23|||
161137263|NCT00144170|581883800|FG001|Overall Study|Protocol Violation|16|||
161137264|NCT00144170|581883799|FG000|Overall Study|Lost to Follow-up|5|||
161137265|NCT00144170|581883800|FG001|Overall Study|Lost to Follow-up|10|||
161137266|NCT00144170|581883799|FG000|Overall Study|Withdrawal by Subject|29|||
161137267|NCT00144170|581883800|FG001|Overall Study|Withdrawal by Subject|13|||
161137268|NCT00144170|581883799|FG000|Overall Study|Other reason not defined above|211|||
161137269|NCT00144170|581883800|FG001|Overall Study|Other reason not defined above|316|||
161137270|NCT00981526|581883801|FG000|Overall Study|Withdrawal by Subject|0|||
161137271|NCT00981526|581883802|FG001|Overall Study|Withdrawal by Subject|2|||
161137272|NCT00981526|581883801|FG000|Overall Study|Physician Decision|4|||
161137273|NCT00981526|581883802|FG001|Overall Study|Physician Decision|4|||
161137274|NCT00332202|581883803|FG000|Overall Study|Adverse Event|72|||
161137275|NCT00332202|581883804|FG001|Overall Study|Adverse Event|28|||
161137276|NCT00332202|581883803|FG000|Overall Study|Lost to Follow-up|2|||
161137277|NCT00332202|581883804|FG001|Overall Study|Lost to Follow-up|1|||
161137278|NCT00332202|581883803|FG000|Overall Study|Physician Decision|6|||
161137279|NCT00332202|581883804|FG001|Overall Study|Physician Decision|8|||
161137280|NCT00332202|581883803|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
161137281|NCT00332202|581883804|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
161137282|NCT00332202|581883803|FG000|Overall Study|Protocol Violation|7|||
161137283|NCT00332202|581883804|FG001|Overall Study|Protocol Violation|2|||
161137284|NCT00332202|581883803|FG000|Overall Study|Sponsor Decision|1|||
161137285|NCT00332202|581883804|FG001|Overall Study|Sponsor Decision|2|||
161137286|NCT00332202|581883803|FG000|Overall Study|Withdrawal by Subject|36|||
161137287|NCT00332202|581883804|FG001|Overall Study|Withdrawal by Subject|17|||
161137288|NCT00332202|581883803|FG000|Overall Study|Progressive Disease|106|||
161137289|NCT00332202|581883804|FG001|Overall Study|Progressive Disease|60|||
161137290|NCT00332202|581883803|FG000|Overall Study|Death|5|||
161137291|NCT00332202|581883804|FG001|Overall Study|Death|2|||
161137292|NCT00957853|581883805|FG000|Overall Study|Withdrawal by Subject|1|||
161137293|NCT00957853|581883806|FG001|Overall Study|Withdrawal by Subject|0|||
161137294|NCT00957853|581883807|FG002|Overall Study|Withdrawal by Subject|0|||
161137295|NCT02370121|581883812|FG000|Overall Study|Lost to Follow-up|1|||
161137296|NCT02370121|581883813|FG001|Overall Study|Lost to Follow-up|1|||
161137297|NCT02654002|581883816|FG000|Overall Study|Adverse Event|0|||
161137298|NCT02654002|581883817|FG001|Overall Study|Adverse Event|0|||
161137299|NCT02654002|581883818|FG002|Overall Study|Adverse Event|0|||
161137300|NCT02654002|581883819|FG003|Overall Study|Adverse Event|0|||
161137301|NCT02654002|581883820|FG004|Overall Study|Adverse Event|0|||
161137302|NCT02654002|581883821|FG005|Overall Study|Adverse Event|0|||
161137303|NCT02654002|581883822|FG006|Overall Study|Adverse Event|1|||
161334922|NCT03786380|582615861|FG001|Overall Study|Withdrawal by Subject|2|||
161137304|NCT02654002|581883823|FG007|Overall Study|Adverse Event|0|||
161137305|NCT02654002|581883824|FG008|Overall Study|Adverse Event|0|||
161137306|NCT02654002|581883816|FG000|Overall Study|Withdrew Consent|0|||
161137307|NCT02654002|581883817|FG001|Overall Study|Withdrew Consent|0|||
161247847|NCT03820947|582286429|FG004|Overall Study|Withdrawal by Subject|5|||
161247848|NCT03820947|582286425|FG000|Overall Study|Procedure Not Attempted|0|||
160833552|NCT03442296|580776083|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
160833553|NCT03442296|580776084|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
160833554|NCT03442296|580776083|FG000|12 Month Follow-up|Incomplete measurement|1|||
160833555|NCT03442296|580776084|FG001|12 Month Follow-up|Incomplete measurement|1|||
160833556|NCT02651220|580776085|FG000|Overall Study|Adverse Event|1|||
160833557|NCT02651220|580776086|FG001|Overall Study|Adverse Event|5|||
160833558|NCT02651220|580776087|FG002|Overall Study|Adverse Event|1|||
160833559|NCT02651220|580776085|FG000|Overall Study|Lost to Follow-up|8|||
160833560|NCT02651220|580776086|FG001|Overall Study|Lost to Follow-up|14|||
160833561|NCT02651220|580776087|FG002|Overall Study|Lost to Follow-up|14|||
160833562|NCT02651220|580776085|FG000|Overall Study|Non-Compliance with Study Drug|4|||
160833563|NCT02651220|580776086|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160833564|NCT02651220|580776087|FG002|Overall Study|Non-Compliance with Study Drug|1|||
160833565|NCT02651220|580776085|FG000|Overall Study|Pregnancy|1|||
161137308|NCT02654002|581883818|FG002|Overall Study|Withdrew Consent|0|||
161137309|NCT02654002|581883819|FG003|Overall Study|Withdrew Consent|0|||
161137310|NCT02654002|581883820|FG004|Overall Study|Withdrew Consent|0|||
161137311|NCT02654002|581883821|FG005|Overall Study|Withdrew Consent|1|||
161137312|NCT02654002|581883822|FG006|Overall Study|Withdrew Consent|0|||
161137313|NCT02654002|581883823|FG007|Overall Study|Withdrew Consent|1|||
161137314|NCT02654002|581883824|FG008|Overall Study|Withdrew Consent|0|||
161137315|NCT05262764|581883825|FG000|Overall Study|Case report form not collected|9|||
161137316|NCT05262764|581883825|FG000|Overall Study|No patient visits after entry|23|||
161137317|NCT05262764|581883825|FG000|Overall Study|Registration rule not followed|2|||
161137318|NCT05262764|581883825|FG000|Overall Study|Patient of non-chronic heart failure|1|||
161137319|NCT01392183|581883826|FG000|First Drug Administration|Adverse Event|3|||
161137320|NCT01392183|581883827|FG001|First Drug Administration|Adverse Event|2|||
161137321|NCT01392183|581883826|FG000|First Drug Administration|Death|1|||
161137322|NCT01392183|581883827|FG001|First Drug Administration|Death|0|||
161137323|NCT01392183|581883826|FG000|First Drug Administration|Withdrawal by Subject|10|||
161137324|NCT01392183|581883827|FG001|First Drug Administration|Withdrawal by Subject|17|||
161137325|NCT00963807|581883830|FG000|Overall Study|Physician Decision|2|||
161137326|NCT00963807|581883830|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
161137327|NCT00963807|581883830|FG000|Overall Study|Disease progression|15|||
161137328|NCT00684177|581883833|FG000|Overall Study|Adverse Event|4|||
161137329|NCT00684177|581883834|FG001|Overall Study|Adverse Event|3|||
161137330|NCT00684177|581883833|FG000|Overall Study|Lack of Efficacy|10|||
161137331|NCT00684177|581883834|FG001|Overall Study|Lack of Efficacy|15|||
161137332|NCT00684177|581883833|FG000|Overall Study|Protocol Violation|1|||
161137333|NCT00684177|581883834|FG001|Overall Study|Protocol Violation|0|||
161137334|NCT00684177|581883833|FG000|Overall Study|Lost to Follow-up|2|||
161137335|NCT00684177|581883834|FG001|Overall Study|Lost to Follow-up|1|||
161137336|NCT00684177|581883833|FG000|Overall Study|Physician Decision|2|||
161137337|NCT00684177|581883834|FG001|Overall Study|Physician Decision|0|||
161137338|NCT00684177|581883833|FG000|Overall Study|Withdrawal by Subject|1|||
161137339|NCT00684177|581883834|FG001|Overall Study|Withdrawal by Subject|2|||
161137340|NCT00684177|581883833|FG000|Overall Study|Other|1|||
161137341|NCT00684177|581883834|FG001|Overall Study|Other|2|||
161137342|NCT02109029|581885550|FG000|Part B|Adverse Event|0|||
161137343|NCT02109029|581885551|FG001|Part B|Adverse Event|0|||
161137344|NCT02109029|581885552|FG002|Part B|Adverse Event|0|||
161137345|NCT02109029|581885553|FG003|Part B|Adverse Event|0|||
161137346|NCT02109029|581885554|FG004|Part B|Adverse Event|1|||
161137347|NCT02109029|581885555|FG005|Part B|Adverse Event|1|||
161137348|NCT03195894|581885556|FG000|Overall Study|"An example is Started other treatment."|4|||
161137349|NCT03195894|581885557|FG001|Overall Study|"An example is Started other treatment."|5|||
161137350|NCT03195894|581885556|FG000|Overall Study|Withdrawal by Subject|15|||
161137351|NCT03195894|581885557|FG001|Overall Study|Withdrawal by Subject|4|||
161137352|NCT03195894|581885556|FG000|Overall Study|Lost to Follow-up|14|||
161137353|NCT03195894|581885557|FG001|Overall Study|Lost to Follow-up|19|||
161137354|NCT00377962|581885558|FG000|Core Study: 0-12 Months|Adverse Event|18|||
161137355|NCT00377962|581885559|FG001|Core Study: 0-12 Months|Adverse Event|2|||
161137356|NCT00377962|581885558|FG000|Core Study: 0-12 Months|Death|3|||
161137357|NCT00377962|581885559|FG001|Core Study: 0-12 Months|Death|0|||
161137358|NCT00377962|581885558|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
161137359|NCT00377962|581885559|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
161137360|NCT00377962|581885558|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
161137361|NCT00377962|581885559|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
161137362|NCT00377962|581885558|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
161137363|NCT00377962|581885559|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
161137364|NCT00377962|581885558|FG000|Extension Study: 12-24 Months|Death|1|||
161137365|NCT00377962|581885559|FG001|Extension Study: 12-24 Months|Death|1|||
161137366|NCT00377962|581885558|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
161137367|NCT00377962|581885559|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
161137368|NCT00377962|581885558|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
161247849|NCT03820947|582286426|FG001|Overall Study|Procedure Not Attempted|2|||
161247850|NCT03820947|582286427|FG002|Overall Study|Procedure Not Attempted|1|||
161247851|NCT03820947|582286428|FG003|Overall Study|Procedure Not Attempted|0|||
161247852|NCT03820947|582286429|FG004|Overall Study|Procedure Not Attempted|0|||
161247853|NCT03820947|582286425|FG000|Overall Study|Other Exit|1|||
161247854|NCT03820947|582286426|FG001|Overall Study|Other Exit|3|||
161247855|NCT03820947|582286427|FG002|Overall Study|Other Exit|3|||
161247856|NCT03820947|582286428|FG003|Overall Study|Other Exit|3|||
161247857|NCT03820947|582286429|FG004|Overall Study|Other Exit|0|||
161247858|NCT03820947|582286425|FG000|Overall Study|Follow-up Not Done|10|||
161247859|NCT03820947|582286426|FG001|Overall Study|Follow-up Not Done|13|||
161247860|NCT03820947|582286427|FG002|Overall Study|Follow-up Not Done|2|||
161247861|NCT03820947|582286428|FG003|Overall Study|Follow-up Not Done|3|||
161247862|NCT03820947|582286429|FG004|Overall Study|Follow-up Not Done|12|||
161247863|NCT03820947|582286425|FG000|Overall Study|Death|0|||
161247864|NCT03820947|582286426|FG001|Overall Study|Death|0|||
161247865|NCT03820947|582286427|FG002|Overall Study|Death|0|||
161247866|NCT03820947|582286428|FG003|Overall Study|Death|0|||
161247867|NCT03820947|582286429|FG004|Overall Study|Death|9|||
161247868|NCT03820947|582286425|FG000|Overall Study|Lost to Follow-up|4|||
161247869|NCT03820947|582286426|FG001|Overall Study|Lost to Follow-up|6|||
161247870|NCT03820947|582286427|FG002|Overall Study|Lost to Follow-up|0|||
161247871|NCT03820947|582286428|FG003|Overall Study|Lost to Follow-up|0|||
161247872|NCT03820947|582286429|FG004|Overall Study|Lost to Follow-up|9|||
161247873|NCT04729101|582288197|FG000|Overall Study|Adverse Event|1|||
161247874|NCT04729101|582288198|FG001|Overall Study|Adverse Event|0|||
161247875|NCT04729101|582288197|FG000|Overall Study|Physician Decision|1|||
161247876|NCT04729101|582288198|FG001|Overall Study|Physician Decision|0|||
161247877|NCT04729101|582288197|FG000|Overall Study|Withdrawal by Subject|1|||
161247878|NCT04729101|582288198|FG001|Overall Study|Withdrawal by Subject|0|||
161247879|NCT04556734|582288201|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
161247880|NCT04556734|582288202|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161247881|NCT04556734|582288203|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161247882|NCT04556734|582288204|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161247883|NCT04556734|582288205|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161247884|NCT04556734|582288206|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161247885|NCT04556734|582288207|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161247886|NCT04556734|582288208|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161247887|NCT04556734|582288201|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161247888|NCT04556734|582288202|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247889|NCT04556734|582288203|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247890|NCT04556734|582288204|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247891|NCT04556734|582288205|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247892|NCT04556734|582288206|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247893|NCT04556734|582288207|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247894|NCT04556734|582288208|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161247895|NCT04556734|582288201|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161247896|NCT04556734|582288202|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161247897|NCT04556734|582288203|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161247898|NCT04556734|582288204|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161247899|NCT04556734|582288205|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161247900|NCT04556734|582288206|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161247901|NCT04556734|582288207|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161247902|NCT04556734|582288208|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161247903|NCT04556734|582288201|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
161247904|NCT04556734|582288202|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161247905|NCT04556734|582288203|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161247906|NCT04556734|582288204|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
160991255|NCT01959880|581355567|FG000|Overall Study|Withdrawal by Subject|11|||
160991256|NCT01959880|581355568|FG001|Overall Study|Withdrawal by Subject|13|||
160991257|NCT01959880|581355569|FG002|Overall Study|Withdrawal by Subject|8|||
160991258|NCT01959880|581355570|FG003|Overall Study|Withdrawal by Subject|7|||
160991259|NCT01959880|581355567|FG000|Overall Study|Death|1|||
161247907|NCT04556734|582288205|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161247908|NCT04556734|582288206|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161247909|NCT04556734|582288207|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161247910|NCT04556734|582288208|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161247911|NCT04556734|582288201|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160991260|NCT01959880|581355568|FG001|Overall Study|Death|10|||
160991261|NCT01959880|581355569|FG002|Overall Study|Death|1|||
161247912|NCT04556734|582288202|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161247913|NCT04556734|582288203|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
161247914|NCT04556734|582288204|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161247915|NCT04556734|582288205|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161137369|NCT00377962|581885559|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
161137370|NCT00377962|581885558|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
161137371|NCT00377962|581885559|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
161247916|NCT04556734|582288206|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161247917|NCT04556734|582288207|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
161247918|NCT04556734|582288208|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
160833566|NCT02651220|580776086|FG001|Overall Study|Pregnancy|0|||
160833567|NCT02651220|580776087|FG002|Overall Study|Pregnancy|1|||
160833568|NCT02651220|580776085|FG000|Overall Study|Protocol Violation|0|||
160833569|NCT02651220|580776086|FG001|Overall Study|Protocol Violation|0|||
160833570|NCT02651220|580776087|FG002|Overall Study|Protocol Violation|1|||
160833571|NCT02651220|580776085|FG000|Overall Study|Withdrawal by Subject|5|||
160833572|NCT02651220|580776086|FG001|Overall Study|Withdrawal by Subject|6|||
160833573|NCT02651220|580776087|FG002|Overall Study|Withdrawal by Subject|8|||
160833574|NCT02651220|580776085|FG000|Overall Study|Miscellaneous|4|||
160833575|NCT02651220|580776086|FG001|Overall Study|Miscellaneous|1|||
160833576|NCT02651220|580776087|FG002|Overall Study|Miscellaneous|2|||
160833577|NCT02651220|580776085|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160833578|NCT02651220|580776086|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160833579|NCT02651220|580776087|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
160833580|NCT00447122|580776088|FG000|Overall Study|worsening medical condition -came off|0|||
160833581|NCT00447122|580776089|FG001|Overall Study|worsening medical condition -came off|1|||
160833582|NCT00447122|580776090|FG002|Overall Study|worsening medical condition -came off|0|||
160833583|NCT00447122|580776091|FG003|Overall Study|worsening medical condition -came off|0|||
160833584|NCT02409342|580776092|FG000|Overall Study|Death|211|||
160833585|NCT02409342|580776093|FG001|Overall Study|Death|201|||
160833586|NCT02409342|580776092|FG000|Overall Study|Withdrawal by Subject|24|||
160833587|NCT02409342|580776093|FG001|Overall Study|Withdrawal by Subject|17|||
160833588|NCT02409342|580776092|FG000|Overall Study|Study Terminated By Sponsor|48|||
160833589|NCT02409342|580776093|FG001|Overall Study|Study Terminated By Sponsor|59|||
160833590|NCT02409342|580776092|FG000|Overall Study|Lost to Follow-up|3|||
160833591|NCT02409342|580776093|FG001|Overall Study|Lost to Follow-up|5|||
160833592|NCT02409342|580776092|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
160833593|NCT02409342|580776093|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
160833594|NCT02409342|580776092|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
160833595|NCT02409342|580776093|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
160833596|NCT02409342|580776092|FG000|Overall Study|Sponsor Decision|1|||
161137372|NCT00496366|581885566|FG000|Overall Study|Death|1|||
161137373|NCT00260208|581885567|FG000|Overall Study|Subject withdrew consent|11|||
161137374|NCT00260208|581885568|FG001|Overall Study|Subject withdrew consent|7|||
161137375|NCT00260208|581885567|FG000|Overall Study|Lost to Follow-up|6|||
161137376|NCT00260208|581885568|FG001|Overall Study|Lost to Follow-up|1|||
161137377|NCT00260208|581885567|FG000|Overall Study|Death|12|||
161137378|NCT00260208|581885568|FG001|Overall Study|Death|10|||
161137379|NCT00260208|581885567|FG000|Overall Study|Missing|18|||
161137380|NCT00260208|581885568|FG001|Overall Study|Missing|16|||
161137381|NCT00768222|581885569|FG000|Overall Study|Lost to Follow-up|1|||
161137382|NCT00768222|581885570|FG001|Overall Study|Lost to Follow-up|1|||
161137383|NCT00768222|581885569|FG000|Overall Study|Withdrawal by Subject|3|||
161137384|NCT00768222|581885570|FG001|Overall Study|Withdrawal by Subject|1|||
161137385|NCT00768222|581885569|FG000|Overall Study|Protocol Violation|0|||
161137386|NCT00768222|581885570|FG001|Overall Study|Protocol Violation|2|||
161137387|NCT03263091|581885572|FG000|OL Component|Withdrawal by Subject|1|||
161137388|NCT03263091|581885573|FG001|OL Component|Withdrawal by Subject|1|||
161137389|NCT03263091|581885574|FG002|OL Component|Withdrawal by Subject|0|||
161137390|NCT03263091|581885575|FG003|OL Component|Withdrawal by Subject|0|||
161137391|NCT03263091|581885576|FG004|OL Component|Withdrawal by Subject|0|||
161137392|NCT03263091|581885577|FG005|OL Component|Withdrawal by Subject|0|||
161137393|NCT03263091|581885572|FG000|OL Component|Physician Decision|0|||
161137394|NCT03263091|581885573|FG001|OL Component|Physician Decision|1|||
161137395|NCT03263091|581885574|FG002|OL Component|Physician Decision|2|||
161137396|NCT03263091|581885575|FG003|OL Component|Physician Decision|0|||
161137397|NCT03263091|581885576|FG004|OL Component|Physician Decision|0|||
161137398|NCT03263091|581885577|FG005|OL Component|Physician Decision|0|||
161137399|NCT03263091|581885572|FG000|OL Component|Death|1|||
160833597|NCT02409342|580776093|FG001|Overall Study|Sponsor Decision|0|||
160833598|NCT00279812|580776094|FG000|Overall Study|Protocol Violation|1|||
160833599|NCT00279812|580776095|FG001|Overall Study|Protocol Violation|1|||
160903603|NCT00002651|581040554|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
160991262|NCT01959880|581355570|FG003|Overall Study|Death|2|||
161137400|NCT03263091|581885573|FG001|OL Component|Death|0|||
161137401|NCT03263091|581885574|FG002|OL Component|Death|0|||
161137402|NCT03263091|581885575|FG003|OL Component|Death|0|||
161137403|NCT03263091|581885576|FG004|OL Component|Death|0|||
160833600|NCT00279812|580776096|FG002|Overall Study|Protocol Violation|0|||
161137404|NCT03263091|581885577|FG005|OL Component|Death|0|||
161247919|NCT04556734|582288201|FG000|OLE Period (28 Weeks)|Not reported|0|||
161247920|NCT04556734|582288202|FG001|OLE Period (28 Weeks)|Not reported|0|||
161247921|NCT04556734|582288203|FG002|OLE Period (28 Weeks)|Not reported|0|||
161247922|NCT04556734|582288204|FG003|OLE Period (28 Weeks)|Not reported|0|||
161247923|NCT04556734|582288205|FG004|OLE Period (28 Weeks)|Not reported|0|||
161247924|NCT04556734|582288206|FG005|OLE Period (28 Weeks)|Not reported|1|||
161247925|NCT04556734|582288207|FG006|OLE Period (28 Weeks)|Not reported|0|||
161247926|NCT04556734|582288208|FG007|OLE Period (28 Weeks)|Not reported|0|||
161247927|NCT04556734|582288201|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247928|NCT04556734|582288202|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247929|NCT04556734|582288203|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247930|NCT04556734|582288204|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247931|NCT04556734|582288205|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247932|NCT04556734|582288206|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247933|NCT04556734|582288207|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
161247934|NCT04556734|582288208|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
161247935|NCT04556734|582288201|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
161247936|NCT04556734|582288202|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
161247937|NCT04556734|582288203|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
161247938|NCT04556734|582288204|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
161247939|NCT04556734|582288205|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
161247940|NCT04556734|582288206|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
161247941|NCT04556734|582288207|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
161247942|NCT04556734|582288208|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
161334923|NCT03786380|582615862|FG002|Overall Study|Withdrawal by Subject|2|||
161137405|NCT03263091|581885572|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
161137406|NCT03263091|581885573|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
161137407|NCT03263091|581885574|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
160833601|NCT00279812|580776097|FG003|Overall Study|Protocol Violation|0|||
161247943|NCT04556734|582288201|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161247944|NCT04556734|582288202|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161247945|NCT04556734|582288203|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161137408|NCT03263091|581885575|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
161137409|NCT03263091|581885576|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
161137410|NCT03263091|581885577|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
161137411|NCT03263091|581885572|FG000|OL High-EPO Component|Physician Decision|0|||
160833602|NCT00279812|580776098|FG004|Overall Study|Protocol Violation|1|||
160833603|NCT00279812|580776099|FG005|Overall Study|Protocol Violation|0|||
161247946|NCT04556734|582288204|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161247947|NCT04556734|582288205|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
161247948|NCT04556734|582288206|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
161247949|NCT04556734|582288207|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
161247950|NCT04556734|582288208|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
161247951|NCT01680016|582288210|FG000|Overall Study|Adverse Event|0|||
161247952|NCT01680016|582288211|FG001|Overall Study|Adverse Event|0|||
161247953|NCT01680016|582288212|FG002|Overall Study|Adverse Event|1|||
161247954|NCT01680016|582288213|FG003|Overall Study|Adverse Event|4|||
161247955|NCT01680016|582288210|FG000|Overall Study|The Subject went out of The Trial|1|||
161247956|NCT01680016|582288211|FG001|Overall Study|The Subject went out of The Trial|0|||
161247957|NCT01680016|582288212|FG002|Overall Study|The Subject went out of The Trial|3|||
161247958|NCT01680016|582288213|FG003|Overall Study|The Subject went out of The Trial|0|||
161247959|NCT01680016|582288210|FG000|Overall Study|Protocol Violation|0|||
161247960|NCT01680016|582288211|FG001|Overall Study|Protocol Violation|1|||
161247961|NCT01680016|582288212|FG002|Overall Study|Protocol Violation|0|||
161247962|NCT01680016|582288213|FG003|Overall Study|Protocol Violation|0|||
160833604|NCT00279812|580776094|FG000|Overall Study|Withdrawal by Subject|0|||
160833605|NCT00279812|580776095|FG001|Overall Study|Withdrawal by Subject|4|||
160833606|NCT00279812|580776096|FG002|Overall Study|Withdrawal by Subject|2|||
160833607|NCT00279812|580776097|FG003|Overall Study|Withdrawal by Subject|0|||
160833608|NCT00279812|580776098|FG004|Overall Study|Withdrawal by Subject|0|||
160991263|NCT01959880|581355567|FG000|Overall Study|Lost to Follow-up|95|||
161247963|NCT01680016|582288210|FG000|Overall Study|Withdrawal by Subject|5|||
161247964|NCT01680016|582288211|FG001|Overall Study|Withdrawal by Subject|7|||
161247965|NCT01680016|582288212|FG002|Overall Study|Withdrawal by Subject|1|||
161247966|NCT01680016|582288213|FG003|Overall Study|Withdrawal by Subject|1|||
161247967|NCT01958060|582288215|FG000|Overall Study|Not treated|2|||
161137412|NCT03263091|581885573|FG001|OL High-EPO Component|Physician Decision|0|||
161247968|NCT01958060|582288216|FG001|Overall Study|Not treated|0|||
160991264|NCT01959880|581355568|FG001|Overall Study|Lost to Follow-up|18|||
160991265|NCT01959880|581355569|FG002|Overall Study|Lost to Follow-up|15|||
161247969|NCT01958060|582288217|FG002|Overall Study|Not treated|0|||
161247970|NCT01958060|582288218|FG003|Overall Study|Not treated|0|||
161247971|NCT01958060|582288219|FG004|Overall Study|Not treated|1|||
161247972|NCT01958060|582288220|FG005|Overall Study|Not treated|0|||
161247973|NCT02846883|582288223|FG000|Overall Study|Death|0|||
160833609|NCT00279812|580776099|FG005|Overall Study|Withdrawal by Subject|0|||
161137413|NCT03263091|581885574|FG002|OL High-EPO Component|Physician Decision|0|||
160833610|NCT00279812|580776094|FG000|Overall Study|Adverse Event|0|||
160833611|NCT00279812|580776095|FG001|Overall Study|Adverse Event|1|||
160833612|NCT00279812|580776096|FG002|Overall Study|Adverse Event|1|||
160833613|NCT00279812|580776097|FG003|Overall Study|Adverse Event|0|||
160833614|NCT00279812|580776098|FG004|Overall Study|Adverse Event|2|||
160833615|NCT00279812|580776099|FG005|Overall Study|Adverse Event|1|||
160833616|NCT04046250|580776107|FG000|Overall Study|Death|0|||
160833617|NCT04046250|580776108|FG001|Overall Study|Death|1|||
160833618|NCT04046250|580776107|FG000|Overall Study|Withdrawal by Subject|3|||
160833619|NCT04046250|580776108|FG001|Overall Study|Withdrawal by Subject|3|||
160833620|NCT03834220|580776113|FG000|Overall Study|Adverse Event|1|||
160833621|NCT03834220|580776114|FG001|Overall Study|Adverse Event|0|||
160833622|NCT03834220|580776115|FG002|Overall Study|Adverse Event|0|||
160833623|NCT03834220|580776113|FG000|Overall Study|Death|8|||
160833624|NCT03834220|580776114|FG001|Overall Study|Death|1|||
160833625|NCT03834220|580776115|FG002|Overall Study|Death|17|||
160833626|NCT03834220|580776113|FG000|Overall Study|Reason not Specified|9|||
160833627|NCT03834220|580776114|FG001|Overall Study|Reason not Specified|0|||
160833628|NCT03834220|580776115|FG002|Overall Study|Reason not Specified|6|||
160833629|NCT03834220|580776113|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
160833630|NCT03834220|580776114|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
160833631|NCT03834220|580776115|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
160833632|NCT03834220|580776113|FG000|Overall Study|Withdrawal of Consent|2|||
160833633|NCT03834220|580776114|FG001|Overall Study|Withdrawal of Consent|2|||
160833634|NCT03834220|580776115|FG002|Overall Study|Withdrawal of Consent|2|||
160833635|NCT00527332|580776117|FG000|Overall Study|Protocol Violation|4|||
160833636|NCT00527332|580776118|FG001|Overall Study|Protocol Violation|8|||
160833637|NCT00527332|580776117|FG000|Overall Study|Withdrew consent|5|||
160833638|NCT00527332|580776118|FG001|Overall Study|Withdrew consent|1|||
160833639|NCT03684694|580776121|FG000|Phase 1|Withdrawal by Subject|1|||
160833640|NCT03684694|580776122|FG001|Phase 1|Withdrawal by Subject|0|||
160833641|NCT03684694|580776123|FG002|Phase 1|Withdrawal by Subject|0|||
160833642|NCT03684694|580776124|FG003|Phase 1|Withdrawal by Subject|0|||
160833643|NCT03684694|580776125|FG004|Phase 1|Withdrawal by Subject|0|||
160833644|NCT03684694|580776126|FG005|Phase 1|Withdrawal by Subject|0|||
160833645|NCT03684694|580776121|FG000|Phase 1|Investigator/Sponsor Decision|12|||
160833646|NCT03684694|580776122|FG001|Phase 1|Investigator/Sponsor Decision|2|||
160833647|NCT03684694|580776123|FG002|Phase 1|Investigator/Sponsor Decision|1|||
160833648|NCT03684694|580776124|FG003|Phase 1|Investigator/Sponsor Decision|0|||
160833649|NCT03684694|580776125|FG004|Phase 1|Investigator/Sponsor Decision|0|||
160833650|NCT03684694|580776126|FG005|Phase 1|Investigator/Sponsor Decision|0|||
160833651|NCT03684694|580776121|FG000|Phase 1|Death|24|||
160833652|NCT03684694|580776122|FG001|Phase 1|Death|0|||
160833653|NCT03684694|580776123|FG002|Phase 1|Death|3|||
160833654|NCT03684694|580776124|FG003|Phase 1|Death|0|||
160833655|NCT03684694|580776125|FG004|Phase 1|Death|0|||
160833656|NCT03684694|580776126|FG005|Phase 1|Death|0|||
160833657|NCT03684694|580776121|FG000|Phase 1|Lost to Follow-up|0|||
160833658|NCT03684694|580776122|FG001|Phase 1|Lost to Follow-up|0|||
160833659|NCT03684694|580776123|FG002|Phase 1|Lost to Follow-up|1|||
160833660|NCT03684694|580776124|FG003|Phase 1|Lost to Follow-up|0|||
160833661|NCT03684694|580776125|FG004|Phase 1|Lost to Follow-up|0|||
160833662|NCT03684694|580776126|FG005|Phase 1|Lost to Follow-up|0|||
160833663|NCT03684694|580776121|FG000|Phase 1|Miscellaneous|0|||
160833664|NCT03684694|580776122|FG001|Phase 1|Miscellaneous|1|||
160833665|NCT03684694|580776123|FG002|Phase 1|Miscellaneous|0|||
160833666|NCT03684694|580776124|FG003|Phase 1|Miscellaneous|0|||
160833667|NCT03684694|580776125|FG004|Phase 1|Miscellaneous|0|||
160833668|NCT03684694|580776126|FG005|Phase 1|Miscellaneous|0|||
160833669|NCT03684694|580776121|FG000|Phase 2|Withdrawal by Subject|0|||
160833670|NCT03684694|580776122|FG001|Phase 2|Withdrawal by Subject|0|||
160833671|NCT03684694|580776123|FG002|Phase 2|Withdrawal by Subject|0|||
160833672|NCT03684694|580776124|FG003|Phase 2|Withdrawal by Subject|0|||
160833673|NCT03684694|580776125|FG004|Phase 2|Withdrawal by Subject|0|||
161137414|NCT03263091|581885575|FG003|OL High-EPO Component|Physician Decision|1|||
161137415|NCT03263091|581885576|FG004|OL High-EPO Component|Physician Decision|0|||
161137416|NCT03263091|581885577|FG005|OL High-EPO Component|Physician Decision|0|||
161137417|NCT03263091|581885572|FG000|OL High-EPO Component|Death|0|||
161137418|NCT03263091|581885573|FG001|OL High-EPO Component|Death|0|||
161137419|NCT03263091|581885574|FG002|OL High-EPO Component|Death|0|||
161137420|NCT03263091|581885575|FG003|OL High-EPO Component|Death|3|||
161137421|NCT03263091|581885576|FG004|OL High-EPO Component|Death|0|||
160833674|NCT03684694|580776126|FG005|Phase 2|Withdrawal by Subject|1|||
160833675|NCT03684694|580776121|FG000|Phase 2|Investigator/Sponsor Decision|0|||
160833676|NCT03684694|580776122|FG001|Phase 2|Investigator/Sponsor Decision|0|||
160833677|NCT03684694|580776123|FG002|Phase 2|Investigator/Sponsor Decision|0|||
160833678|NCT03684694|580776124|FG003|Phase 2|Investigator/Sponsor Decision|17|||
160833679|NCT03684694|580776125|FG004|Phase 2|Investigator/Sponsor Decision|16|||
160833680|NCT03684694|580776126|FG005|Phase 2|Investigator/Sponsor Decision|6|||
160833681|NCT03684694|580776121|FG000|Phase 2|Death|0|||
161247974|NCT02846883|582288224|FG001|Overall Study|Death|1|||
160833682|NCT03684694|580776122|FG001|Phase 2|Death|0|||
160833683|NCT03684694|580776123|FG002|Phase 2|Death|0|||
160833684|NCT03684694|580776124|FG003|Phase 2|Death|28|||
160833685|NCT03684694|580776125|FG004|Phase 2|Death|14|||
160833686|NCT03684694|580776126|FG005|Phase 2|Death|3|||
160833687|NCT03684694|580776121|FG000|Phase 2|Lost to Follow-up|0|||
160833688|NCT03684694|580776122|FG001|Phase 2|Lost to Follow-up|0|||
160833689|NCT03684694|580776123|FG002|Phase 2|Lost to Follow-up|0|||
160833690|NCT03684694|580776124|FG003|Phase 2|Lost to Follow-up|1|||
160833691|NCT03684694|580776125|FG004|Phase 2|Lost to Follow-up|0|||
160833692|NCT03684694|580776126|FG005|Phase 2|Lost to Follow-up|0|||
160833693|NCT03684694|580776121|FG000|Phase 2|Miscellaneous|0|||
160833694|NCT03684694|580776122|FG001|Phase 2|Miscellaneous|0|||
160833695|NCT03684694|580776123|FG002|Phase 2|Miscellaneous|0|||
160833696|NCT03684694|580776124|FG003|Phase 2|Miscellaneous|3|||
160833697|NCT03684694|580776125|FG004|Phase 2|Miscellaneous|0|||
160833698|NCT03684694|580776126|FG005|Phase 2|Miscellaneous|0|||
160833699|NCT02100475|580778205|FG000|Overall Study|Unclassified|1|||
160833700|NCT02100475|580778206|FG001|Overall Study|Unclassified|2|||
160833701|NCT02100475|580778205|FG000|Overall Study|Withdrawal criteria|1|||
160833702|NCT02100475|580778206|FG001|Overall Study|Withdrawal criteria|0|||
160833703|NCT02806960|580778207|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833704|NCT02806960|580778208|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833705|NCT02806960|580778209|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833706|NCT02806960|580778210|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
160833707|NCT01769196|580778211|FG000|Overall Study|Adverse Event|24|||
160833708|NCT01769196|580778212|FG001|Overall Study|Adverse Event|20|||
160833709|NCT01769196|580778211|FG000|Overall Study|Death|21|||
160833710|NCT01769196|580778212|FG001|Overall Study|Death|26|||
160833711|NCT01769196|580778211|FG000|Overall Study|Investigator Discretion|7|||
160833712|NCT01769196|580778212|FG001|Overall Study|Investigator Discretion|3|||
160833713|NCT01769196|580778211|FG000|Overall Study|Lack of Efficacy|3|||
160833714|NCT01769196|580778212|FG001|Overall Study|Lack of Efficacy|2|||
160833715|NCT01769196|580778211|FG000|Overall Study|Progressive disease|11|||
160833716|NCT01769196|580778212|FG001|Overall Study|Progressive disease|6|||
160833717|NCT01769196|580778211|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
160833718|NCT01769196|580778212|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
160833719|NCT01769196|580778211|FG000|Overall Study|Protocol Violation|0|||
160833720|NCT01769196|580778212|FG001|Overall Study|Protocol Violation|3|||
160833721|NCT01769196|580778211|FG000|Overall Study|Study terminated by sponsor|160|||
160833722|NCT01769196|580778212|FG001|Overall Study|Study terminated by sponsor|161|||
160833723|NCT01769196|580778211|FG000|Overall Study|Participant never dosed with study drug|1|||
160833724|NCT01769196|580778212|FG001|Overall Study|Participant never dosed with study drug|0|||
160833725|NCT01769196|580778211|FG000|Overall Study|Withdrew consent|36|||
160833726|NCT01769196|580778212|FG001|Overall Study|Withdrew consent|40|||
160833727|NCT00765063|580778213|FG000|Overall Study|Lack of Efficacy|5|||
160833728|NCT00765063|580778213|FG000|Overall Study|Withdrawal by Subject|1|||
160833729|NCT00765063|580778213|FG000|Overall Study|Other|16|||
160833730|NCT00765063|580778213|FG000|Overall Study|Protocol Violation|6|||
160833731|NCT00765063|580778213|FG000|Overall Study|Adverse Event|4|||
160833732|NCT00321464|580778214|FG000|Overall Study|Death|169|||
161137422|NCT03263091|581885577|FG005|OL High-EPO Component|Death|0|||
161137423|NCT03263091|581885572|FG000|DB Component|Withdrawal by Subject|0|||
161137424|NCT03263091|581885573|FG001|DB Component|Withdrawal by Subject|0|||
161137425|NCT03263091|581885574|FG002|DB Component|Withdrawal by Subject|0|||
161137426|NCT03263091|581885575|FG003|DB Component|Withdrawal by Subject|0|||
161137427|NCT03263091|581885576|FG004|DB Component|Withdrawal by Subject|22|||
161137428|NCT03263091|581885577|FG005|DB Component|Withdrawal by Subject|8|||
161137429|NCT03263091|581885572|FG000|DB Component|Physician Decision|0|||
161137430|NCT03263091|581885573|FG001|DB Component|Physician Decision|0|||
161137431|NCT03263091|581885574|FG002|DB Component|Physician Decision|0|||
161137432|NCT03263091|581885575|FG003|DB Component|Physician Decision|0|||
161137433|NCT03263091|581885576|FG004|DB Component|Physician Decision|3|||
161137434|NCT03263091|581885577|FG005|DB Component|Physician Decision|1|||
161137435|NCT03263091|581885572|FG000|DB Component|Adverse Event|0|||
161137436|NCT03263091|581885573|FG001|DB Component|Adverse Event|0|||
161137437|NCT03263091|581885574|FG002|DB Component|Adverse Event|0|||
161137438|NCT03263091|581885575|FG003|DB Component|Adverse Event|0|||
161137439|NCT03263091|581885576|FG004|DB Component|Adverse Event|2|||
161137440|NCT03263091|581885577|FG005|DB Component|Adverse Event|1|||
161137441|NCT03263091|581885572|FG000|DB Component|Lost to Follow-up|0|||
160833733|NCT00321464|580778215|FG001|Overall Study|Death|174|||
160833734|NCT00321464|580778214|FG000|Overall Study|Disease progression|124|||
160833735|NCT00321464|580778215|FG001|Overall Study|Disease progression|124|||
160833736|NCT00321464|580778214|FG000|Overall Study|Withdrawal by Subject|117|||
160833737|NCT00321464|580778215|FG001|Overall Study|Withdrawal by Subject|118|||
160833738|NCT00321464|580778214|FG000|Overall Study|Participant request|57|||
160833739|NCT00321464|580778215|FG001|Overall Study|Participant request|61|||
160833740|NCT00321464|580778214|FG000|Overall Study|Adverse Event|43|||
161137442|NCT03263091|581885573|FG001|DB Component|Lost to Follow-up|0|||
161247975|NCT02846883|582288225|FG002|Overall Study|Death|1|||
161247976|NCT02846883|582288223|FG000|Overall Study|Lost to Follow-up|0|||
161247977|NCT02846883|582288224|FG001|Overall Study|Lost to Follow-up|0|||
161247978|NCT02846883|582288225|FG002|Overall Study|Lost to Follow-up|1|||
161247979|NCT02846883|582288223|FG000|Overall Study|Withdrawal by Subject|1|||
161247980|NCT02846883|582288224|FG001|Overall Study|Withdrawal by Subject|0|||
161247981|NCT02846883|582288225|FG002|Overall Study|Withdrawal by Subject|0|||
161247982|NCT02846883|582288223|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
161247983|NCT02846883|582288224|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
161247984|NCT02846883|582288225|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
161247985|NCT02846883|582288223|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
161247986|NCT02846883|582288224|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
161247987|NCT02846883|582288225|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
161247988|NCT00927251|582288226|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
161247989|NCT01011335|582288228|FG000|Overall Study|Lost to Follow-up|0|||
161247990|NCT01011335|582288229|FG001|Overall Study|Lost to Follow-up|0|||
161247991|NCT01011335|582288230|FG002|Overall Study|Lost to Follow-up|1|||
161247992|NCT01011335|582288231|FG003|Overall Study|Lost to Follow-up|1|||
161247993|NCT01011335|582288232|FG004|Overall Study|Lost to Follow-up|1|||
161247994|NCT01011335|582288233|FG005|Overall Study|Lost to Follow-up|1|||
161247995|NCT01011335|582288234|FG006|Overall Study|Lost to Follow-up|2|||
161247996|NCT01011335|582288235|FG007|Overall Study|Lost to Follow-up|2|||
161247997|NCT01011335|582288236|FG008|Overall Study|Lost to Follow-up|1|||
161247998|NCT01011335|582288237|FG009|Overall Study|Lost to Follow-up|0|||
161247999|NCT01011335|582288238|FG010|Overall Study|Lost to Follow-up|0|||
161248000|NCT01011335|582288239|FG011|Overall Study|Lost to Follow-up|1|||
161248001|NCT01011335|582288240|FG012|Overall Study|Lost to Follow-up|2|||
161248002|NCT01011335|582288228|FG000|Overall Study|Protocol Violation|0|||
161248003|NCT01011335|582288229|FG001|Overall Study|Protocol Violation|1|||
161248004|NCT01011335|582288230|FG002|Overall Study|Protocol Violation|0|||
161248005|NCT01011335|582288231|FG003|Overall Study|Protocol Violation|0|||
161248006|NCT01011335|582288232|FG004|Overall Study|Protocol Violation|0|||
161248007|NCT01011335|582288233|FG005|Overall Study|Protocol Violation|0|||
161248008|NCT01011335|582288234|FG006|Overall Study|Protocol Violation|0|||
161248009|NCT01011335|582288235|FG007|Overall Study|Protocol Violation|0|||
161248010|NCT01011335|582288236|FG008|Overall Study|Protocol Violation|0|||
161248011|NCT01011335|582288237|FG009|Overall Study|Protocol Violation|0|||
161248012|NCT01011335|582288238|FG010|Overall Study|Protocol Violation|0|||
161248013|NCT01011335|582288239|FG011|Overall Study|Protocol Violation|0|||
161248014|NCT01011335|582288240|FG012|Overall Study|Protocol Violation|0|||
161248015|NCT01011335|582288228|FG000|Overall Study|Moved/deployed or no booster|1|||
161248016|NCT01011335|582288229|FG001|Overall Study|Moved/deployed or no booster|0|||
161248017|NCT01011335|582288230|FG002|Overall Study|Moved/deployed or no booster|0|||
161248018|NCT01011335|582288231|FG003|Overall Study|Moved/deployed or no booster|1|||
161248019|NCT01011335|582288232|FG004|Overall Study|Moved/deployed or no booster|0|||
161248020|NCT01011335|582288233|FG005|Overall Study|Moved/deployed or no booster|0|||
161248021|NCT01011335|582288234|FG006|Overall Study|Moved/deployed or no booster|1|||
161248022|NCT01011335|582288235|FG007|Overall Study|Moved/deployed or no booster|0|||
161248023|NCT01011335|582288236|FG008|Overall Study|Moved/deployed or no booster|1|||
161248024|NCT01011335|582288237|FG009|Overall Study|Moved/deployed or no booster|0|||
161248025|NCT01011335|582288238|FG010|Overall Study|Moved/deployed or no booster|2|||
161248026|NCT01011335|582288239|FG011|Overall Study|Moved/deployed or no booster|0|||
161248027|NCT01011335|582288240|FG012|Overall Study|Moved/deployed or no booster|0|||
161248028|NCT01011335|582288228|FG000|Overall Study|Adverse Event|0|||
161248029|NCT01011335|582288229|FG001|Overall Study|Adverse Event|0|||
161248030|NCT01011335|582288230|FG002|Overall Study|Adverse Event|0|||
161248031|NCT01011335|582288231|FG003|Overall Study|Adverse Event|0|||
161248032|NCT01011335|582288232|FG004|Overall Study|Adverse Event|0|||
161248033|NCT01011335|582288233|FG005|Overall Study|Adverse Event|0|||
161248034|NCT01011335|582288234|FG006|Overall Study|Adverse Event|0|||
161248035|NCT01011335|582288235|FG007|Overall Study|Adverse Event|0|||
161248036|NCT01011335|582288236|FG008|Overall Study|Adverse Event|0|||
161248037|NCT01011335|582288237|FG009|Overall Study|Adverse Event|0|||
161248038|NCT01011335|582288238|FG010|Overall Study|Adverse Event|4|||
161248039|NCT01011335|582288239|FG011|Overall Study|Adverse Event|0|||
161248040|NCT01011335|582288240|FG012|Overall Study|Adverse Event|1|||
160833741|NCT00321464|580778215|FG001|Overall Study|Adverse Event|28|||
160833742|NCT00321464|580778214|FG000|Overall Study|Physician Decision|15|||
160833743|NCT00321464|580778215|FG001|Overall Study|Physician Decision|14|||
160833744|NCT00321464|580778214|FG000|Overall Study|Noncompliance|4|||
160833745|NCT00321464|580778215|FG001|Overall Study|Noncompliance|10|||
160833746|NCT00321464|580778214|FG000|Overall Study|Lost to Follow-up|7|||
160833747|NCT00321464|580778215|FG001|Overall Study|Lost to Follow-up|8|||
160833748|NCT00321464|580778214|FG000|Overall Study|Protocol deviation|0|||
160833749|NCT00321464|580778215|FG001|Overall Study|Protocol deviation|2|||
160833750|NCT00321464|580778214|FG000|Overall Study|Ineligibility determined|2|||
160833751|NCT00321464|580778215|FG001|Overall Study|Ineligibility determined|1|||
160833752|NCT00321464|580778214|FG000|Overall Study|Other|21|||
160833753|NCT00321464|580778215|FG001|Overall Study|Other|18|||
160833754|NCT01673620|580778216|FG000|Overall Study|Adverse Event|1|||
160833755|NCT01673620|580778217|FG001|Overall Study|Adverse Event|0|||
160833756|NCT02522325|580778219|FG000|Overall Study|Adverse Event|0|||
160903604|NCT00002651|581040555|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
160903605|NCT00002651|581040553|FG000|Consolidation and Randomization|Progression/relapse|0|||
161137443|NCT03263091|581885574|FG002|DB Component|Lost to Follow-up|0|||
161137444|NCT03263091|581885575|FG003|DB Component|Lost to Follow-up|0|||
161137445|NCT03263091|581885576|FG004|DB Component|Lost to Follow-up|2|||
160833757|NCT02522325|580778220|FG001|Overall Study|Adverse Event|1|||
160833758|NCT02100969|580778221|FG000|Overall Study|Did not pass screening phase|1|||
160903606|NCT00002651|581040554|FG001|Consolidation and Randomization|Progression/relapse|295|||
161137446|NCT03263091|581885577|FG005|DB Component|Lost to Follow-up|1|||
160833759|NCT01629953|580778222|FG000|Overall Study|Death|3|||
161137447|NCT03263091|581885572|FG000|DB Component|Death|0|||
161137448|NCT03263091|581885573|FG001|DB Component|Death|0|||
161137449|NCT03263091|581885574|FG002|DB Component|Death|0|||
161137450|NCT03263091|581885575|FG003|DB Component|Death|0|||
161137451|NCT03263091|581885576|FG004|DB Component|Death|7|||
161137452|NCT03263091|581885577|FG005|DB Component|Death|4|||
161137453|NCT03263091|581885572|FG000|DB Component|Other than specified|0|||
161137454|NCT03263091|581885573|FG001|DB Component|Other than specified|0|||
161137455|NCT03263091|581885574|FG002|DB Component|Other than specified|0|||
161137456|NCT03263091|581885575|FG003|DB Component|Other than specified|0|||
161137457|NCT03263091|581885576|FG004|DB Component|Other than specified|8|||
161137458|NCT03263091|581885577|FG005|DB Component|Other than specified|6|||
161137459|NCT00265941|581885587|FG000|Overall Study|Protocol Violation|22|||
161137460|NCT00265941|581885588|FG001|Overall Study|Protocol Violation|25|||
161137461|NCT00265941|581885587|FG000|Overall Study|Lost to Follow-up|1|||
161137462|NCT00265941|581885588|FG001|Overall Study|Lost to Follow-up|1|||
161137463|NCT01217606|581885595|FG000|Initial Treatment Phase|Other Reasons|0|||
161137464|NCT01217606|581885596|FG001|Initial Treatment Phase|Other Reasons|2|||
161137465|NCT01217606|581885595|FG000|Initial Treatment Phase|Protocol Violation|3|||
161137466|NCT01217606|581885596|FG001|Initial Treatment Phase|Protocol Violation|2|||
161137467|NCT01217606|581885595|FG000|Initial Treatment Phase|Personal Reasons|0|||
161137468|NCT01217606|581885596|FG001|Initial Treatment Phase|Personal Reasons|2|||
161137469|NCT01217606|581885595|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
161137470|NCT01217606|581885596|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
161137471|NCT01217606|581885595|FG000|Initial Treatment Phase|Adverse Event|10|||
161137472|NCT01217606|581885596|FG001|Initial Treatment Phase|Adverse Event|6|||
161137473|NCT01217606|581885595|FG000|9-Month Masked Extension|Adverse Event|3|||
161137474|NCT01217606|581885596|FG001|9-Month Masked Extension|Adverse Event|6|||
161137475|NCT01217606|581885595|FG000|9-Month Masked Extension|Other Reasons|4|||
161137476|NCT01217606|581885596|FG001|9-Month Masked Extension|Other Reasons|4|||
161137477|NCT01217606|581885595|FG000|9-Month Masked Extension|Personal Reasons|2|||
161137478|NCT01217606|581885596|FG001|9-Month Masked Extension|Personal Reasons|1|||
161137479|NCT01217606|581885595|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
161137480|NCT01217606|581885596|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
161137481|NCT01217606|581885595|FG000|9-Month Masked Extension|Pregnancy|1|||
161137482|NCT01217606|581885596|FG001|9-Month Masked Extension|Pregnancy|0|||
161137483|NCT01217606|581885595|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
161137484|NCT01217606|581885596|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
161137485|NCT02432807|581885603|FG000|Overall Study|Adverse Event|0|||
161137486|NCT02432807|581885604|FG001|Overall Study|Adverse Event|2|||
161137487|NCT02432807|581885603|FG000|Overall Study|Lost to Follow-up|1|||
161137488|NCT02432807|581885604|FG001|Overall Study|Lost to Follow-up|0|||
161137489|NCT02432807|581885603|FG000|Overall Study|Withdrawal by Subject|1|||
161137490|NCT02432807|581885604|FG001|Overall Study|Withdrawal by Subject|1|||
161137491|NCT02432807|581885603|FG000|Overall Study|Other|1|||
161137492|NCT02432807|581885604|FG001|Overall Study|Other|1|||
161137493|NCT03976401|581885605|FG000|Overall Study|Adverse Event|2|||
161137494|NCT03976401|581885606|FG001|Overall Study|Adverse Event|0|||
161137495|NCT03976401|581885607|FG002|Overall Study|Adverse Event|4|||
161137496|NCT03976401|581885608|FG003|Overall Study|Adverse Event|1|||
161137497|NCT03976401|581885609|FG004|Overall Study|Adverse Event|1|||
161137498|NCT03976401|581885610|FG005|Overall Study|Adverse Event|0|||
161137499|NCT03976401|581885605|FG000|Overall Study|Withdrawal by Subject|0|||
161137500|NCT03976401|581885606|FG001|Overall Study|Withdrawal by Subject|1|||
161137501|NCT03976401|581885607|FG002|Overall Study|Withdrawal by Subject|0|||
161137502|NCT03976401|581885608|FG003|Overall Study|Withdrawal by Subject|0|||
161137503|NCT03976401|581885609|FG004|Overall Study|Withdrawal by Subject|0|||
161137504|NCT03976401|581885610|FG005|Overall Study|Withdrawal by Subject|1|||
161137505|NCT03976401|581885605|FG000|Overall Study|Physician Decision|0|||
161137506|NCT03976401|581885606|FG001|Overall Study|Physician Decision|0|||
160833760|NCT01629953|580778223|FG001|Overall Study|Death|1|||
160833761|NCT01629953|580778222|FG000|Overall Study|Lost to Follow-up|10|||
160833762|NCT01629953|580778223|FG001|Overall Study|Lost to Follow-up|14|||
160833763|NCT00528801|580778226|FG000|Overall Study|Withdrawal by Subject|1|||
160833764|NCT00528801|580778227|FG001|Overall Study|Withdrawal by Subject|1|||
160833765|NCT00528801|580778226|FG000|Overall Study|Protocol Violation|11|||
160833766|NCT00528801|580778227|FG001|Overall Study|Protocol Violation|5|||
160833767|NCT00528801|580778226|FG000|Overall Study|Lost to Follow-up|15|||
160833768|NCT00528801|580778227|FG001|Overall Study|Lost to Follow-up|4|||
160833769|NCT00528801|580778226|FG000|Overall Study|Administrative Reasons|0|||
160833770|NCT00528801|580778227|FG001|Overall Study|Administrative Reasons|1|||
160833771|NCT02207491|580778228|FG000|Overall Study|Adverse Event|20|||
160833772|NCT02207491|580778229|FG001|Overall Study|Adverse Event|4|||
160833773|NCT02207491|580778228|FG000|Overall Study|Withdrawal by Subject|3|||
160833774|NCT02207491|580778229|FG001|Overall Study|Withdrawal by Subject|2|||
160833775|NCT02207491|580778228|FG000|Overall Study|Non-compliant|0|||
160833776|NCT02207491|580778229|FG001|Overall Study|Non-compliant|1|||
160833777|NCT02207491|580778228|FG000|Overall Study|Lost to Follow-up|0|||
160833778|NCT02207491|580778229|FG001|Overall Study|Lost to Follow-up|1|||
160833779|NCT02207491|580778228|FG000|Overall Study|Lack of Efficacy|3|||
160833780|NCT02207491|580778229|FG001|Overall Study|Lack of Efficacy|0|||
160833781|NCT02207491|580778228|FG000|Overall Study|Physician Decision|2|||
160833782|NCT02207491|580778229|FG001|Overall Study|Physician Decision|0|||
160833783|NCT02207491|580778228|FG000|Overall Study|Protocol Violation|3|||
160833784|NCT02207491|580778229|FG001|Overall Study|Protocol Violation|5|||
160833785|NCT00477152|580778232|FG000|Overall Study|Parent withdrew consent|2|||
160833786|NCT00477152|580778232|FG000|Overall Study|Adverse Event|1|||
160833787|NCT00372697|580778233|FG000|Overall Study|Protocol Violation|1|||
160833788|NCT00372697|580778234|FG001|Overall Study|Protocol Violation|1|||
160833789|NCT03221842|580778235|FG000|Period 1 (Open-label)|Adverse Event|4|||
160833790|NCT03221842|580778236|FG001|Period 1 (Open-label)|Adverse Event|0|||
160833791|NCT03221842|580778235|FG000|Period 1 (Open-label)|Physician Decision|2|||
160833792|NCT03221842|580778236|FG001|Period 1 (Open-label)|Physician Decision|0|||
160833793|NCT03221842|580778235|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
160833794|NCT03221842|580778236|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
160833795|NCT03221842|580778235|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
160833796|NCT03221842|580778236|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
160833797|NCT03221842|580778235|FG000|Period 1 (Open-label)|Other|2|||
160833798|NCT03221842|580778236|FG001|Period 1 (Open-label)|Other|0|||
160833799|NCT03221842|580778235|FG000|Period 2 (Randomized, Blinded)|Death|0|||
160833800|NCT03221842|580778236|FG001|Period 2 (Randomized, Blinded)|Death|1|||
160833801|NCT03221842|580778235|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
160833802|NCT03221842|580778236|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
160903607|NCT00002651|581040555|FG002|Consolidation and Randomization|Progression/relapse|298|||
160903608|NCT00002651|581040553|FG000|Consolidation and Randomization|Death|0|||
160903609|NCT00002651|581040554|FG001|Consolidation and Randomization|Death|38|||
161248041|NCT01813435|582288241|FG000|Overall Study|did not finish experimental regimen|1902|||
161248042|NCT01813435|582288242|FG001|Overall Study|did not finish experimental regimen|770|||
161248043|NCT01813435|582288241|FG000|Overall Study|Lost to Follow-up|268|||
161248044|NCT01813435|582288242|FG001|Overall Study|Lost to Follow-up|237|||
161248045|NCT01765751|582288249|FG000|Overall Study|Lost to Follow-up|0|||
161248046|NCT01765751|582288250|FG001|Overall Study|Lost to Follow-up|2|||
160833803|NCT02504580|580778237|FG000|Overall Study|Other|1|||
160833804|NCT02504580|580778238|FG001|Overall Study|Other|0|||
160833805|NCT02504580|580778239|FG002|Overall Study|Other|0|||
160833806|NCT02504580|580778240|FG003|Overall Study|Other|2|||
160833807|NCT02504580|580778241|FG004|Overall Study|Other|1|||
160833808|NCT02504580|580778242|FG005|Overall Study|Other|1|||
160833809|NCT02504580|580778243|FG006|Overall Study|Other|1|||
160833810|NCT02504580|580778244|FG007|Overall Study|Other|2|||
160833811|NCT02504580|580778245|FG008|Overall Study|Other|0|||
160833812|NCT02504580|580778246|FG009|Overall Study|Other|0|||
160833813|NCT02504580|580778247|FG010|Overall Study|Other|0|||
160833814|NCT02504580|580778248|FG011|Overall Study|Other|2|||
161248047|NCT01765751|582288251|FG002|Overall Study|Lost to Follow-up|1|||
160833815|NCT02504580|580778237|FG000|Overall Study|Subject refusal to continue|0|||
160833816|NCT02504580|580778238|FG001|Overall Study|Subject refusal to continue|1|||
160833817|NCT02504580|580778239|FG002|Overall Study|Subject refusal to continue|0|||
160833818|NCT02504580|580778240|FG003|Overall Study|Subject refusal to continue|0|||
160833819|NCT02504580|580778241|FG004|Overall Study|Subject refusal to continue|0|||
160833820|NCT02504580|580778242|FG005|Overall Study|Subject refusal to continue|0|||
160833821|NCT02504580|580778243|FG006|Overall Study|Subject refusal to continue|0|||
161248048|NCT01120899|582288252|FG000|Overall Study|Withdrawal by Subject|3|||
161248049|NCT00452348|582288253|FG000|Overall Study|Adverse Event|6|||
160833822|NCT02504580|580778244|FG007|Overall Study|Subject refusal to continue|0|||
160833823|NCT02504580|580778245|FG008|Overall Study|Subject refusal to continue|0|||
160833824|NCT02504580|580778246|FG009|Overall Study|Subject refusal to continue|0|||
160833825|NCT02504580|580778247|FG010|Overall Study|Subject refusal to continue|0|||
161248050|NCT00452348|582288254|FG001|Overall Study|Adverse Event|9|||
160833826|NCT02504580|580778248|FG011|Overall Study|Subject refusal to continue|0|||
160833827|NCT01353911|580778251|FG000|Overall Study|Lost to Follow-up|2|||
160833828|NCT01353911|580778252|FG001|Overall Study|Lost to Follow-up|6|||
160833829|NCT01353911|580778253|FG002|Overall Study|Lost to Follow-up|4|||
160833830|NCT01353911|580778254|FG003|Overall Study|Lost to Follow-up|0|||
160833831|NCT01353911|580778255|FG004|Overall Study|Lost to Follow-up|4|||
160833832|NCT01353911|580778256|FG005|Overall Study|Lost to Follow-up|4|||
160833833|NCT01353911|580778257|FG006|Overall Study|Lost to Follow-up|3|||
160833834|NCT01353911|580778258|FG007|Overall Study|Lost to Follow-up|6|||
160833835|NCT01353911|580778251|FG000|Overall Study|Withdrawal by Subject|2|||
160833836|NCT01353911|580778252|FG001|Overall Study|Withdrawal by Subject|3|||
160833837|NCT01353911|580778253|FG002|Overall Study|Withdrawal by Subject|4|||
160833838|NCT01353911|580778254|FG003|Overall Study|Withdrawal by Subject|2|||
160833839|NCT01353911|580778255|FG004|Overall Study|Withdrawal by Subject|2|||
160833840|NCT01353911|580778256|FG005|Overall Study|Withdrawal by Subject|3|||
160833841|NCT01353911|580778257|FG006|Overall Study|Withdrawal by Subject|3|||
160833842|NCT01353911|580778258|FG007|Overall Study|Withdrawal by Subject|9|||
160833843|NCT01353911|580778251|FG000|Overall Study|Status Not Recorded|4|||
160833844|NCT01353911|580778252|FG001|Overall Study|Status Not Recorded|0|||
160833845|NCT01353911|580778253|FG002|Overall Study|Status Not Recorded|1|||
160833846|NCT01353911|580778254|FG003|Overall Study|Status Not Recorded|0|||
160833847|NCT01353911|580778255|FG004|Overall Study|Status Not Recorded|0|||
160833848|NCT01353911|580778256|FG005|Overall Study|Status Not Recorded|0|||
160833849|NCT01353911|580778257|FG006|Overall Study|Status Not Recorded|0|||
160833850|NCT01353911|580778258|FG007|Overall Study|Status Not Recorded|0|||
160833851|NCT02049138|580778261|FG000|Overall Study|Adverse Event|46|||
160833852|NCT02049138|580778262|FG001|Overall Study|Adverse Event|25|||
160833853|NCT02049138|580778263|FG002|Overall Study|Adverse Event|1|||
160833854|NCT02049138|580778261|FG000|Overall Study|Withdrawal by Subject|57|||
160833855|NCT02049138|580778262|FG001|Overall Study|Withdrawal by Subject|21|||
160833856|NCT02049138|580778263|FG002|Overall Study|Withdrawal by Subject|5|||
160833857|NCT02049138|580778261|FG000|Overall Study|Lost to Follow-up|18|||
160833858|NCT02049138|580778262|FG001|Overall Study|Lost to Follow-up|5|||
160833859|NCT02049138|580778263|FG002|Overall Study|Lost to Follow-up|1|||
160833860|NCT02049138|580778261|FG000|Overall Study|Lack of Efficacy|10|||
160833861|NCT02049138|580778262|FG001|Overall Study|Lack of Efficacy|26|||
160833862|NCT02049138|580778263|FG002|Overall Study|Lack of Efficacy|1|||
160833863|NCT02049138|580778261|FG000|Overall Study|Non-Compliance|15|||
160833864|NCT02049138|580778262|FG001|Overall Study|Non-Compliance|6|||
160833865|NCT02049138|580778263|FG002|Overall Study|Non-Compliance|0|||
160833866|NCT02049138|580778261|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
160833867|NCT02049138|580778262|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
160833868|NCT02049138|580778263|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
160833869|NCT02049138|580778261|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
160833870|NCT02049138|580778262|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160833871|NCT02049138|580778263|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
160833872|NCT02049138|580778261|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
160833873|NCT02049138|580778262|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
160833874|NCT02049138|580778263|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
160833875|NCT02049138|580778261|FG000|Overall Study|Other|15|||
160833876|NCT02049138|580778262|FG001|Overall Study|Other|13|||
160833877|NCT02049138|580778263|FG002|Overall Study|Other|0|||
160833878|NCT02049138|580778261|FG000|Overall Study|Missing|0|||
161137507|NCT03976401|581885607|FG002|Overall Study|Physician Decision|1|||
160833879|NCT02049138|580778262|FG001|Overall Study|Missing|1|||
160833880|NCT02049138|580778263|FG002|Overall Study|Missing|0|||
160833881|NCT05086510|580778264|FG000|Overall Study|Lost to Follow-up|0|||
160833882|NCT05086510|580778265|FG001|Overall Study|Lost to Follow-up|2|||
161137508|NCT03976401|581885608|FG003|Overall Study|Physician Decision|0|||
161137509|NCT03976401|581885609|FG004|Overall Study|Physician Decision|0|||
161137510|NCT03976401|581885610|FG005|Overall Study|Physician Decision|0|||
161137511|NCT03976401|581885605|FG000|Overall Study|Lost to Follow-up|1|||
161137512|NCT03976401|581885606|FG001|Overall Study|Lost to Follow-up|2|||
161137513|NCT03976401|581885607|FG002|Overall Study|Lost to Follow-up|0|||
161137514|NCT03976401|581885608|FG003|Overall Study|Lost to Follow-up|0|||
161137515|NCT03976401|581885609|FG004|Overall Study|Lost to Follow-up|0|||
161137516|NCT03976401|581885610|FG005|Overall Study|Lost to Follow-up|0|||
160833883|NCT05086510|580778264|FG000|Overall Study|Death|0|||
160833884|NCT05086510|580778265|FG001|Overall Study|Death|2|||
160833885|NCT00587847|580778266|FG000|Overall Study|Lack of Efficacy|5|||
160833886|NCT00587847|580778266|FG000|Overall Study|Adverse Event|2|||
160833887|NCT00343382|580778267|FG000|Overall Study|Adverse Event|2|||
160833888|NCT00343382|580778268|FG001|Overall Study|Adverse Event|10|||
160833889|NCT00343382|580778269|FG002|Overall Study|Adverse Event|7|||
160833890|NCT00343382|580778267|FG000|Overall Study|Withdrawal by Subject|1|||
160833891|NCT00343382|580778268|FG001|Overall Study|Withdrawal by Subject|2|||
160833892|NCT00343382|580778269|FG002|Overall Study|Withdrawal by Subject|6|||
161137517|NCT03976401|581885605|FG000|Overall Study|Protocol Violation|0|||
161248051|NCT00452348|582288253|FG000|Overall Study|Lack of Efficacy|10|||
161248052|NCT00452348|582288254|FG001|Overall Study|Lack of Efficacy|9|||
161248053|NCT00452348|582288253|FG000|Overall Study|Lost to Follow-up|14|||
161248054|NCT00452348|582288254|FG001|Overall Study|Lost to Follow-up|8|||
161248055|NCT00452348|582288253|FG000|Overall Study|Protocol Violation|22|||
161248056|NCT00452348|582288254|FG001|Overall Study|Protocol Violation|28|||
161248057|NCT00452348|582288253|FG000|Overall Study|Withdrawal by Subject|18|||
161248058|NCT00452348|582288254|FG001|Overall Study|Withdrawal by Subject|21|||
161248059|NCT00452348|582288253|FG000|Overall Study|Other|9|||
161248060|NCT00452348|582288254|FG001|Overall Study|Other|9|||
161248061|NCT02435433|582288257|FG000|Overall Study|Withdrawal by Subject|2|||
161248062|NCT02435433|582288258|FG001|Overall Study|Withdrawal by Subject|3|||
161248063|NCT02435433|582288259|FG002|Overall Study|Withdrawal by Subject|1|||
161248064|NCT02435433|582288260|FG003|Overall Study|Withdrawal by Subject|0|||
161248065|NCT02435433|582288261|FG004|Overall Study|Withdrawal by Subject|0|||
161248066|NCT02435433|582288257|FG000|Overall Study|Lost to Follow-up|2|||
161248067|NCT02435433|582288258|FG001|Overall Study|Lost to Follow-up|2|||
160833893|NCT00343382|580778267|FG000|Overall Study|Other Reason Not Specified|1|||
160833894|NCT00343382|580778268|FG001|Overall Study|Other Reason Not Specified|2|||
160833895|NCT00343382|580778269|FG002|Overall Study|Other Reason Not Specified|4|||
160833896|NCT02337725|580778274|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
160833897|NCT02337725|580778275|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
160833898|NCT02337725|580778274|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
160833899|NCT02337725|580778275|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
160833900|NCT02337725|580778274|FG000|Overall Study|Major Protocol Deviation|0|||
160833901|NCT02337725|580778275|FG001|Overall Study|Major Protocol Deviation|1|||
160833902|NCT02337725|580778274|FG000|Overall Study|Voluntary Withdrawal|14|||
160833903|NCT02337725|580778275|FG001|Overall Study|Voluntary Withdrawal|3|||
161248068|NCT02435433|582288259|FG002|Overall Study|Lost to Follow-up|4|||
161248069|NCT02435433|582288260|FG003|Overall Study|Lost to Follow-up|1|||
161248070|NCT02435433|582288261|FG004|Overall Study|Lost to Follow-up|0|||
161248071|NCT01243151|582288262|FG000|Overall Study|Adverse Event|0|||
161248072|NCT01243151|582288263|FG001|Overall Study|Adverse Event|1|||
161248073|NCT01243151|582288264|FG002|Overall Study|Adverse Event|0|||
161248074|NCT01243151|582288265|FG003|Overall Study|Adverse Event|0|||
161248075|NCT01243151|582288266|FG004|Overall Study|Adverse Event|0|||
161248076|NCT01243151|582288262|FG000|Overall Study|Protocol Violation|0|||
161248077|NCT01243151|582288263|FG001|Overall Study|Protocol Violation|0|||
161248078|NCT01243151|582288264|FG002|Overall Study|Protocol Violation|1|||
161248079|NCT01243151|582288265|FG003|Overall Study|Protocol Violation|0|||
161248080|NCT01243151|582288266|FG004|Overall Study|Protocol Violation|0|||
161248081|NCT01243151|582288262|FG000|Overall Study|Other|0|||
161248082|NCT01243151|582288263|FG001|Overall Study|Other|0|||
161248083|NCT01243151|582288264|FG002|Overall Study|Other|0|||
161248084|NCT01243151|582288265|FG003|Overall Study|Other|1|||
161248085|NCT01243151|582288266|FG004|Overall Study|Other|0|||
161248086|NCT01243151|582288262|FG000|Overall Study|Randomized but not treated|0|||
161248087|NCT01243151|582288263|FG001|Overall Study|Randomized but not treated|0|||
161248088|NCT01243151|582288264|FG002|Overall Study|Randomized but not treated|0|||
161248089|NCT01243151|582288265|FG003|Overall Study|Randomized but not treated|1|||
161248090|NCT01243151|582288266|FG004|Overall Study|Randomized but not treated|0|||
161248091|NCT03119662|582288267|FG000|Overall Study|Withdrawal by Subject|0|||
161248092|NCT03119662|582288268|FG001|Overall Study|Withdrawal by Subject|1|||
161248093|NCT02817828|582288269|FG000|Overall Study|Lost to Follow-up|41|||
161248094|NCT02817828|582288269|FG000|Overall Study|Adverse event not related to bleeding|104|||
161248095|NCT02817828|582288269|FG000|Overall Study|Adverse event related to bleeding|53|||
161248096|NCT02817828|582288269|FG000|Overall Study|Protocol Violation|11|||
161248097|NCT02817828|582288269|FG000|Overall Study|Pregnancy|7|||
161248098|NCT02817828|582288269|FG000|Overall Study|Pregnancy wish|15|||
160833904|NCT02337725|580778274|FG000|Overall Study|Lack of Efficacy|4|||
160833905|NCT02337725|580778275|FG001|Overall Study|Lack of Efficacy|0|||
160833906|NCT01571453|580778276|FG000|Overall Study|Adverse Event|14|||
160833907|NCT01571453|580778277|FG001|Overall Study|Adverse Event|32|||
161248099|NCT02817828|582288269|FG000|Overall Study|Withdrawal by Subject|78|||
161248100|NCT02817828|582288269|FG000|Overall Study|Other|26|||
161248101|NCT00522041|582288271|FG000|Overall Study|Adverse Event|9|||
161248102|NCT00522041|582288272|FG001|Overall Study|Adverse Event|3|||
161248103|NCT00522041|582288271|FG000|Overall Study|Protocol Violation|2|||
161248104|NCT00522041|582288272|FG001|Overall Study|Protocol Violation|0|||
161248105|NCT00522041|582288271|FG000|Overall Study|Lost to Follow-up|1|||
161248106|NCT00522041|582288272|FG001|Overall Study|Lost to Follow-up|4|||
161248107|NCT00522041|582288271|FG000|Overall Study|Voluntary withdrawal|5|||
161248108|NCT00522041|582288272|FG001|Overall Study|Voluntary withdrawal|4|||
160833908|NCT01571453|580778276|FG000|Overall Study|Lack of Efficacy|8|||
160833909|NCT01571453|580778277|FG001|Overall Study|Lack of Efficacy|3|||
161248109|NCT00522041|582288271|FG000|Overall Study|Did not receive treatment|0|||
161248110|NCT00522041|582288272|FG001|Overall Study|Did not receive treatment|1|||
161248111|NCT00544167|582288273|FG000|Overall Study|Adverse Event|21|||
161248112|NCT00544167|582288273|FG000|Overall Study|Physician Decision|8|||
161137518|NCT03976401|581885606|FG001|Overall Study|Protocol Violation|1|||
161137519|NCT03976401|581885607|FG002|Overall Study|Protocol Violation|0|||
161137520|NCT03976401|581885608|FG003|Overall Study|Protocol Violation|0|||
161137521|NCT03976401|581885609|FG004|Overall Study|Protocol Violation|0|||
161137522|NCT03976401|581885610|FG005|Overall Study|Protocol Violation|0|||
161137523|NCT03976401|581885605|FG000|Overall Study|Withdrew Consent|0|||
161137524|NCT03976401|581885606|FG001|Overall Study|Withdrew Consent|0|||
161137525|NCT03976401|581885607|FG002|Overall Study|Withdrew Consent|0|||
161137526|NCT03976401|581885608|FG003|Overall Study|Withdrew Consent|1|||
161137527|NCT03976401|581885609|FG004|Overall Study|Withdrew Consent|0|||
161137528|NCT03976401|581885610|FG005|Overall Study|Withdrew Consent|0|||
161137529|NCT04125680|581885612|FG000|Overall Study|Lost to Follow-up|15|||
161137530|NCT02966314|581885615|FG000|Overall Study|Lost to Follow-up|1|||
161137531|NCT02966314|581885616|FG001|Overall Study|Lost to Follow-up|0|||
161137532|NCT00391976|581885617|FG000|Overall Study|Adverse Event|0|||
161137533|NCT00391976|581885618|FG001|Overall Study|Adverse Event|0|||
161137534|NCT00391976|581885619|FG002|Overall Study|Adverse Event|1|||
161137535|NCT00391976|581885617|FG000|Overall Study|Withdrawal of consent|0|||
161137536|NCT00391976|581885618|FG001|Overall Study|Withdrawal of consent|1|||
161137537|NCT00391976|581885619|FG002|Overall Study|Withdrawal of consent|1|||
161137538|NCT00391976|581885617|FG000|Overall Study|Lost to Follow-up|1|||
161137539|NCT00391976|581885618|FG001|Overall Study|Lost to Follow-up|2|||
161137540|NCT00391976|581885619|FG002|Overall Study|Lost to Follow-up|0|||
161137541|NCT00391976|581885617|FG000|Overall Study|Inappropriate enrollment|1|||
161137542|NCT00391976|581885618|FG001|Overall Study|Inappropriate enrollment|1|||
161137543|NCT00391976|581885619|FG002|Overall Study|Inappropriate enrollment|0|||
161137544|NCT00391976|581885617|FG000|Overall Study|Protocol deviation/violation|4|||
161137545|NCT00391976|581885618|FG001|Overall Study|Protocol deviation/violation|2|||
161137546|NCT00391976|581885619|FG002|Overall Study|Protocol deviation/violation|1|||
161137547|NCT00391976|581885617|FG000|Overall Study|Recurrence/no eradication of infection|21|||
161137548|NCT00391976|581885618|FG001|Overall Study|Recurrence/no eradication of infection|19|||
161137549|NCT00391976|581885619|FG002|Overall Study|Recurrence/no eradication of infection|0|||
161137550|NCT00391976|581885617|FG000|Overall Study|Unable to classify|0|||
161137551|NCT00391976|581885618|FG001|Overall Study|Unable to classify|0|||
161137552|NCT00391976|581885619|FG002|Overall Study|Unable to classify|1|||
161137553|NCT00391976|581885617|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
161137554|NCT00391976|581885618|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
161137555|NCT00391976|581885619|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
161137556|NCT00049127|581885620|FG000|Overall Study|Withdrawal by Subject|0|||
161137557|NCT00049127|581885621|FG001|Overall Study|Withdrawal by Subject|0|||
161137558|NCT00049127|581885622|FG002|Overall Study|Withdrawal by Subject|1|||
161137559|NCT00049127|581885623|FG003|Overall Study|Withdrawal by Subject|0|||
161137560|NCT00049127|581885624|FG004|Overall Study|Withdrawal by Subject|0|||
161137561|NCT02582515|581885627|FG000|Overall Study|Withdrawal by Subject|0|||
161137562|NCT02582515|581885628|FG001|Overall Study|Withdrawal by Subject|1|||
161137563|NCT02725788|581885631|FG000|Overall Study|Lost to Follow-up|1|||
161137564|NCT02725788|581885632|FG001|Overall Study|Lost to Follow-up|1|||
161137565|NCT02725788|581885631|FG000|Overall Study|Protocol Violation|0|||
161137566|NCT02725788|581885632|FG001|Overall Study|Protocol Violation|1|||
161137567|NCT00828464|581885633|FG000|Overall Study|Withdrawal by Subject|1|||
161137568|NCT00474240|581885634|FG000|Overall Study|Withdrawal by Subject|1|||
161137569|NCT00474240|581885635|FG001|Overall Study|Withdrawal by Subject|1|||
161137570|NCT00474240|581885636|FG002|Overall Study|Withdrawal by Subject|0|||
161137571|NCT00474240|581885637|FG003|Overall Study|Withdrawal by Subject|2|||
161137572|NCT00474240|581885638|FG004|Overall Study|Withdrawal by Subject|3|||
161137573|NCT00474240|581885639|FG005|Overall Study|Withdrawal by Subject|1|||
161137574|NCT00474240|581885634|FG000|Overall Study|Adverse Event|0|||
161137575|NCT00474240|581885635|FG001|Overall Study|Adverse Event|0|||
161137576|NCT00474240|581885636|FG002|Overall Study|Adverse Event|9|||
161137577|NCT00474240|581885637|FG003|Overall Study|Adverse Event|14|||
161137578|NCT00474240|581885638|FG004|Overall Study|Adverse Event|5|||
161137579|NCT00474240|581885639|FG005|Overall Study|Adverse Event|16|||
161137580|NCT00474240|581885634|FG000|Overall Study|Removed due to lab value|0|||
161137581|NCT00474240|581885635|FG001|Overall Study|Removed due to lab value|0|||
161137582|NCT00474240|581885636|FG002|Overall Study|Removed due to lab value|0|||
161137583|NCT00474240|581885637|FG003|Overall Study|Removed due to lab value|0|||
161137584|NCT00474240|581885638|FG004|Overall Study|Removed due to lab value|0|||
161137585|NCT00474240|581885639|FG005|Overall Study|Removed due to lab value|1|||
161137586|NCT00502840|581885640|FG000|Overall Study|Adverse Event|5|||
161137587|NCT00502840|581885640|FG000|Overall Study|Additional or changed therapy|48|||
161137588|NCT00502840|581885640|FG000|Overall Study|Lack of Efficacy|11|||
161137589|NCT00502840|581885640|FG000|Overall Study|Protocol Violation|4|||
161137590|NCT00502840|581885640|FG000|Overall Study|Withdrawal by Subject|5|||
161137591|NCT00502840|581885640|FG000|Overall Study|Lost to Follow-up|6|||
161248113|NCT00874549|582288274|FG000|Overall Study|Adverse Event|0|||
161248114|NCT00874549|582288275|FG001|Overall Study|Adverse Event|0|||
161248115|NCT00874549|582288276|FG002|Overall Study|Adverse Event|1|||
161248116|NCT00874549|582288277|FG003|Overall Study|Adverse Event|0|||
161248117|NCT00874549|582288274|FG000|Overall Study|Protocol Violation|1|||
161248118|NCT00874549|582288275|FG001|Overall Study|Protocol Violation|0|||
161248119|NCT00874549|582288276|FG002|Overall Study|Protocol Violation|2|||
161248120|NCT00874549|582288277|FG003|Overall Study|Protocol Violation|1|||
161248121|NCT00874549|582288274|FG000|Overall Study|Lost to Follow-up|0|||
161248122|NCT00874549|582288275|FG001|Overall Study|Lost to Follow-up|0|||
161248123|NCT00874549|582288276|FG002|Overall Study|Lost to Follow-up|1|||
161248124|NCT00874549|582288277|FG003|Overall Study|Lost to Follow-up|0|||
161248125|NCT00874549|582288274|FG000|Overall Study|Withdrawal by Subject|0|||
160833910|NCT01571453|580778276|FG000|Overall Study|Non-compliance|2|||
160833911|NCT01571453|580778277|FG001|Overall Study|Non-compliance|4|||
160833912|NCT01571453|580778276|FG000|Overall Study|Protocol Violation|1|||
160833913|NCT01571453|580778277|FG001|Overall Study|Protocol Violation|5|||
160833914|NCT01571453|580778276|FG000|Overall Study|Withdrawal of consent|5|||
160833915|NCT01571453|580778277|FG001|Overall Study|Withdrawal of consent|13|||
160833916|NCT01571453|580778276|FG000|Overall Study|Lost to Follow-up|4|||
160833917|NCT01571453|580778277|FG001|Overall Study|Lost to Follow-up|2|||
161248126|NCT00874549|582288275|FG001|Overall Study|Withdrawal by Subject|1|||
161248127|NCT00874549|582288276|FG002|Overall Study|Withdrawal by Subject|0|||
161248128|NCT00874549|582288277|FG003|Overall Study|Withdrawal by Subject|1|||
161248129|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
161248130|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
161248131|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
161248132|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
161248133|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
161248134|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
161248135|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
161248136|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
161248137|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
161248138|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
161248139|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
161248140|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
160833918|NCT01571453|580778276|FG000|Overall Study|Administrative or other reason(s)|4|||
160833919|NCT01571453|580778277|FG001|Overall Study|Administrative or other reason(s)|3|||
161248141|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
161248142|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
161248143|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
161248144|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
161248145|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
161248146|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
161248147|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
161248148|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
161248149|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
161248150|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
161248151|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
161248152|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
161248153|NCT01710358|582288280|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
161248154|NCT01710358|582288281|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
160833920|NCT00500760|580778278|FG000|Overall Study|Death|32|||
160833921|NCT00500760|580778279|FG001|Overall Study|Death|15|||
160833922|NCT00500760|580778278|FG000|Overall Study|Withdrawal by Subject|5|||
161248155|NCT01710358|582288282|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
161248156|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
161248157|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
161248158|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
160833923|NCT00500760|580778279|FG001|Overall Study|Withdrawal by Subject|7|||
160833924|NCT00500760|580778278|FG000|Overall Study|Administrative decision|2|||
161248159|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
161248160|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
160833925|NCT00500760|580778279|FG001|Overall Study|Administrative decision|0|||
161248161|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
161248162|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
161248163|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
161248164|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
160833926|NCT00500760|580778278|FG000|Overall Study|Lost to Follow-up|3|||
160833927|NCT00500760|580778279|FG001|Overall Study|Lost to Follow-up|0|||
160833928|NCT00500760|580778278|FG000|Overall Study|Other|1|||
160833929|NCT00500760|580778279|FG001|Overall Study|Other|2|||
160833930|NCT01264770|580778280|FG000|Overall Study|Not reported|0|||
160833931|NCT01264770|580778281|FG001|Overall Study|Not reported|0|||
160833932|NCT01264770|580778282|FG002|Overall Study|Not reported|1|||
160833933|NCT01264770|580778283|FG003|Overall Study|Not reported|0|||
160833934|NCT01264770|580778284|FG004|Overall Study|Not reported|0|||
160833935|NCT01264770|580778285|FG005|Overall Study|Not reported|0|||
160833936|NCT01264770|580778280|FG000|Overall Study|e.g., change in circumstances|8|||
161137592|NCT00502840|581885640|FG000|Overall Study|Administrative problems|1|||
160833937|NCT01264770|580778281|FG001|Overall Study|e.g., change in circumstances|3|||
160833938|NCT01264770|580778282|FG002|Overall Study|e.g., change in circumstances|3|||
161137593|NCT00502840|581885640|FG000|Overall Study|Other|20|||
161137594|NCT02197377|581885641|FG000|Overall Study|Insertion Failure|0|||
161137595|NCT02197377|581885642|FG001|Overall Study|Insertion Failure|3|||
161137596|NCT00809133|581885643|FG000|Overall Study|Progressive disease|2|||
161137597|NCT00809133|581885644|FG001|Overall Study|Progressive disease|5|||
161137598|NCT00809133|581885645|FG002|Overall Study|Progressive disease|5|||
161137599|NCT00809133|581885646|FG003|Overall Study|Progressive disease|3|||
161137600|NCT00809133|581885647|FG004|Overall Study|Progressive disease|4|||
161137601|NCT00809133|581885648|FG005|Overall Study|Progressive disease|1|||
161137602|NCT00809133|581885649|FG006|Overall Study|Progressive disease|3|||
161137603|NCT00809133|581885650|FG007|Overall Study|Progressive disease|3|||
161137604|NCT00809133|581885651|FG008|Overall Study|Progressive disease|3|||
161137605|NCT00809133|581885652|FG009|Overall Study|Progressive disease|9|||
161137606|NCT00809133|581885653|FG010|Overall Study|Progressive disease|5|||
161137607|NCT00809133|581885654|FG011|Overall Study|Progressive disease|7|||
161137608|NCT00809133|581885655|FG012|Overall Study|Progressive disease|5|||
161137609|NCT00809133|581885656|FG013|Overall Study|Progressive disease|4|||
161137610|NCT00809133|581885643|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137611|NCT00809133|581885644|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137612|NCT00809133|581885645|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137613|NCT00809133|581885646|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137614|NCT00809133|581885647|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137615|NCT00809133|581885648|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161137616|NCT00809133|581885649|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161137617|NCT00809133|581885650|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
161137618|NCT00809133|581885651|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137619|NCT00809133|581885652|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137620|NCT00809133|581885653|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137621|NCT00809133|581885654|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137622|NCT00809133|581885655|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161137623|NCT00809133|581885656|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161137624|NCT00809133|581885643|FG000|Overall Study|Other adverse event|1|||
161137625|NCT00809133|581885644|FG001|Overall Study|Other adverse event|1|||
161137626|NCT00809133|581885645|FG002|Overall Study|Other adverse event|1|||
161137627|NCT00809133|581885646|FG003|Overall Study|Other adverse event|0|||
161137628|NCT00809133|581885647|FG004|Overall Study|Other adverse event|0|||
161137629|NCT00809133|581885648|FG005|Overall Study|Other adverse event|3|||
161137630|NCT00809133|581885649|FG006|Overall Study|Other adverse event|2|||
161137631|NCT00809133|581885650|FG007|Overall Study|Other adverse event|4|||
161137632|NCT00809133|581885651|FG008|Overall Study|Other adverse event|0|||
161137633|NCT00809133|581885652|FG009|Overall Study|Other adverse event|0|||
161137634|NCT00809133|581885653|FG010|Overall Study|Other adverse event|1|||
161137635|NCT00809133|581885654|FG011|Overall Study|Other adverse event|1|||
161137636|NCT00809133|581885655|FG012|Overall Study|Other adverse event|0|||
161137637|NCT00809133|581885656|FG013|Overall Study|Other adverse event|1|||
161137638|NCT00809133|581885643|FG000|Overall Study|Lost to Follow-up|0|||
161137639|NCT00809133|581885644|FG001|Overall Study|Lost to Follow-up|0|||
161137640|NCT00809133|581885645|FG002|Overall Study|Lost to Follow-up|0|||
161137641|NCT00809133|581885646|FG003|Overall Study|Lost to Follow-up|0|||
161137642|NCT00809133|581885647|FG004|Overall Study|Lost to Follow-up|0|||
161137643|NCT00809133|581885648|FG005|Overall Study|Lost to Follow-up|1|||
161137644|NCT00809133|581885649|FG006|Overall Study|Lost to Follow-up|0|||
161137645|NCT00809133|581885650|FG007|Overall Study|Lost to Follow-up|0|||
161137646|NCT00809133|581885651|FG008|Overall Study|Lost to Follow-up|0|||
161137647|NCT00809133|581885652|FG009|Overall Study|Lost to Follow-up|0|||
161137648|NCT00809133|581885653|FG010|Overall Study|Lost to Follow-up|0|||
161137649|NCT00809133|581885654|FG011|Overall Study|Lost to Follow-up|0|||
161137650|NCT00809133|581885655|FG012|Overall Study|Lost to Follow-up|0|||
161137651|NCT00809133|581885656|FG013|Overall Study|Lost to Follow-up|0|||
161137652|NCT00809133|581885643|FG000|Overall Study|Consent withdrawn|0|||
161137653|NCT00809133|581885644|FG001|Overall Study|Consent withdrawn|0|||
161137654|NCT00809133|581885645|FG002|Overall Study|Consent withdrawn|0|||
161137655|NCT00809133|581885646|FG003|Overall Study|Consent withdrawn|0|||
161137656|NCT00809133|581885647|FG004|Overall Study|Consent withdrawn|1|||
161137657|NCT00809133|581885648|FG005|Overall Study|Consent withdrawn|0|||
160833939|NCT01264770|580778283|FG003|Overall Study|e.g., change in circumstances|3|||
160833940|NCT01264770|580778284|FG004|Overall Study|e.g., change in circumstances|4|||
160833941|NCT01264770|580778285|FG005|Overall Study|e.g., change in circumstances|4|||
160833942|NCT01264770|580778280|FG000|Overall Study|Severe non-compliance to protocol|0|||
160833943|NCT01264770|580778281|FG001|Overall Study|Severe non-compliance to protocol|0|||
160833944|NCT01264770|580778282|FG002|Overall Study|Severe non-compliance to protocol|1|||
160833945|NCT01264770|580778283|FG003|Overall Study|Severe non-compliance to protocol|1|||
160833946|NCT01264770|580778284|FG004|Overall Study|Severe non-compliance to protocol|0|||
160833947|NCT01264770|580778285|FG005|Overall Study|Severe non-compliance to protocol|0|||
160833948|NCT01264770|580778280|FG000|Overall Study|Lack of therapeutic response|1|||
160833949|NCT01264770|580778281|FG001|Overall Study|Lack of therapeutic response|0|||
160833950|NCT01264770|580778282|FG002|Overall Study|Lack of therapeutic response|2|||
160833951|NCT01264770|580778283|FG003|Overall Study|Lack of therapeutic response|1|||
160833952|NCT01264770|580778284|FG004|Overall Study|Lack of therapeutic response|1|||
160833953|NCT01264770|580778285|FG005|Overall Study|Lack of therapeutic response|0|||
160833954|NCT01264770|580778280|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
160833955|NCT01264770|580778281|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
160833956|NCT01264770|580778282|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
160833957|NCT01264770|580778283|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
160833958|NCT01264770|580778284|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
160903610|NCT00002651|581040555|FG002|Consolidation and Randomization|Death|48|||
160903611|NCT00002651|581040553|FG000|Consolidation and Randomization|Other|0|||
160903612|NCT00002651|581040554|FG001|Consolidation and Randomization|Other|314|||
160903613|NCT00002651|581040555|FG002|Consolidation and Randomization|Other|313|||
160903614|NCT00002651|581040553|FG000|Consolidation and Randomization|not eligible|0|||
160903615|NCT00002651|581040554|FG001|Consolidation and Randomization|not eligible|102|||
160903616|NCT00002651|581040555|FG002|Consolidation and Randomization|not eligible|112|||
160903617|NCT03641339|581040560|FG000|Overall Study|Physician Decision|1|||
160903618|NCT03641339|581040561|FG001|Overall Study|Physician Decision|0|||
160903619|NCT03641339|581040562|FG002|Overall Study|Physician Decision|0|||
160903620|NCT03641339|581040563|FG003|Overall Study|Physician Decision|0|||
160903621|NCT03641339|581040564|FG004|Overall Study|Physician Decision|0|||
160991266|NCT01959880|581355570|FG003|Overall Study|Lost to Follow-up|8|||
161137658|NCT00809133|581885649|FG006|Overall Study|Consent withdrawn|0|||
160833959|NCT01264770|580778285|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
160833960|NCT01264770|580778280|FG000|Overall Study|Lost to Follow-up|0|||
160833961|NCT01264770|580778281|FG001|Overall Study|Lost to Follow-up|0|||
160903622|NCT03641339|581040565|FG005|Overall Study|Physician Decision|0|||
160903623|NCT03641339|581040560|FG000|Overall Study|Withdrawal by Subject|0|||
161137659|NCT00809133|581885650|FG007|Overall Study|Consent withdrawn|0|||
161137660|NCT00809133|581885651|FG008|Overall Study|Consent withdrawn|0|||
161137661|NCT00809133|581885652|FG009|Overall Study|Consent withdrawn|0|||
161137662|NCT00809133|581885653|FG010|Overall Study|Consent withdrawn|0|||
161137663|NCT00809133|581885654|FG011|Overall Study|Consent withdrawn|0|||
161137664|NCT00809133|581885655|FG012|Overall Study|Consent withdrawn|0|||
161137665|NCT00809133|581885656|FG013|Overall Study|Consent withdrawn|0|||
161137666|NCT00809133|581885643|FG000|Overall Study|Other not mentioned above|0|||
161137667|NCT00809133|581885644|FG001|Overall Study|Other not mentioned above|1|||
161137668|NCT00809133|581885645|FG002|Overall Study|Other not mentioned above|0|||
161137669|NCT00809133|581885646|FG003|Overall Study|Other not mentioned above|0|||
161137670|NCT00809133|581885647|FG004|Overall Study|Other not mentioned above|0|||
161137671|NCT00809133|581885648|FG005|Overall Study|Other not mentioned above|1|||
161137672|NCT00809133|581885649|FG006|Overall Study|Other not mentioned above|0|||
161137673|NCT00809133|581885650|FG007|Overall Study|Other not mentioned above|0|||
161137674|NCT00809133|581885651|FG008|Overall Study|Other not mentioned above|0|||
161137675|NCT00809133|581885652|FG009|Overall Study|Other not mentioned above|0|||
161137676|NCT00809133|581885653|FG010|Overall Study|Other not mentioned above|0|||
161137677|NCT00809133|581885654|FG011|Overall Study|Other not mentioned above|0|||
161137678|NCT00809133|581885655|FG012|Overall Study|Other not mentioned above|0|||
161137679|NCT00809133|581885656|FG013|Overall Study|Other not mentioned above|0|||
161137680|NCT03093155|581885658|FG000|Overall Study|Not Eligible|1|||
161137681|NCT03093155|581885659|FG001|Overall Study|Not Eligible|0|||
161137682|NCT03093155|581885658|FG000|Overall Study|Withdrawal by Subject|0|||
161137683|NCT03093155|581885659|FG001|Overall Study|Withdrawal by Subject|1|||
161137684|NCT01700829|581885660|FG000|Overall Study|Withdrawal by Subject|1|||
161137685|NCT01700829|581885661|FG001|Overall Study|Withdrawal by Subject|1|||
161137686|NCT01075178|581885662|FG000|Subject Matching|eligible but not matched|130|||
161137687|NCT01075178|581885663|FG001|Subject Matching|eligible but not matched|403|||
161137688|NCT01075178|581885662|FG000|Subject Chart Review|died before chart review period|0|||
161137689|NCT01075178|581885663|FG001|Subject Chart Review|died before chart review period|2|||
161137690|NCT01075178|581885662|FG000|Subject Chart Review|no data collected due to site closure|3|||
161137691|NCT01075178|581885663|FG001|Subject Chart Review|no data collected due to site closure|4|||
160903624|NCT03641339|581040561|FG001|Overall Study|Withdrawal by Subject|2|||
160903625|NCT03641339|581040562|FG002|Overall Study|Withdrawal by Subject|0|||
160903626|NCT03641339|581040563|FG003|Overall Study|Withdrawal by Subject|2|||
160903627|NCT03641339|581040564|FG004|Overall Study|Withdrawal by Subject|0|||
160903628|NCT03641339|581040565|FG005|Overall Study|Withdrawal by Subject|1|||
160903629|NCT02319837|581040568|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
160903630|NCT02319837|581040569|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
160903631|NCT02319837|581040570|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
160903632|NCT02319837|581040568|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
160903633|NCT02319837|581040569|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
160903634|NCT02319837|581040570|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
160903635|NCT02319837|581040568|FG000|Study Treatment Phase|Adverse Event|73|||
160903636|NCT02319837|581040569|FG001|Study Treatment Phase|Adverse Event|36|||
160903637|NCT02319837|581040570|FG002|Study Treatment Phase|Adverse Event|63|||
160903638|NCT02319837|581040568|FG000|Study Treatment Phase|Development of castration resistance|0|||
160903639|NCT02319837|581040569|FG001|Study Treatment Phase|Development of castration resistance|2|||
160903640|NCT02319837|581040570|FG002|Study Treatment Phase|Development of castration resistance|0|||
160903641|NCT02319837|581040568|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
160903642|NCT02319837|581040569|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
160903643|NCT02319837|581040570|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
160903644|NCT02319837|581040568|FG000|Study Treatment Phase|Protocol Violation|2|||
160903645|NCT02319837|581040569|FG001|Study Treatment Phase|Protocol Violation|2|||
160903646|NCT02319837|581040570|FG002|Study Treatment Phase|Protocol Violation|1|||
160903647|NCT02319837|581040568|FG000|Study Treatment Phase|Lost to Follow-up|0|||
160903648|NCT02319837|581040569|FG001|Study Treatment Phase|Lost to Follow-up|1|||
160903649|NCT02319837|581040570|FG002|Study Treatment Phase|Lost to Follow-up|0|||
160903650|NCT02319837|581040568|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
160903651|NCT02319837|581040569|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
160903652|NCT02319837|581040570|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
160903653|NCT02319837|581040568|FG000|Study Treatment Phase|Other|0|||
160903654|NCT02319837|581040569|FG001|Study Treatment Phase|Other|1|||
160903655|NCT02319837|581040570|FG002|Study Treatment Phase|Other|0|||
160903656|NCT02319837|581040568|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
160903657|NCT02319837|581040569|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
160903658|NCT02319837|581040570|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
160903659|NCT02319837|581040568|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
160903660|NCT02319837|581040569|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
160903661|NCT02319837|581040570|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
160903662|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
160903663|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
160903664|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
160903665|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
160903666|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
160903667|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
160903668|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
160903669|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
160903670|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
160903671|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
160903672|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
160903673|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
160903674|NCT02319837|581040568|FG000|Long-Term Follow-Up Phase|Death|33|||
160903675|NCT02319837|581040569|FG001|Long-Term Follow-Up Phase|Death|54|||
161248165|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
161248166|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
161248167|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
161248168|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
161248169|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
161248170|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
161248171|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
161248172|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
161248173|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
161334924|NCT03786380|582615863|FG003|Overall Study|Withdrawal by Subject|1|||
160903676|NCT02319837|581040570|FG002|Long-Term Follow-Up Phase|Death|42|||
160903677|NCT01313312|581040576|FG000|Overall Study|Adverse Event|5|||
160903678|NCT01313312|581040576|FG000|Overall Study|Withdrawal by Subject|18|||
160903679|NCT01313312|581040576|FG000|Overall Study|Lack of Efficacy|3|||
160903680|NCT01313312|581040576|FG000|Overall Study|Investigator Decision|1|||
160903681|NCT01313312|581040576|FG000|Overall Study|Observational Phase|1|||
160903682|NCT01313312|581040576|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
160903683|NCT01313312|581040576|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
160903684|NCT01206166|581040584|FG000|Overall Study|No evaluable data|2|||
160903685|NCT01206166|581040585|FG001|Overall Study|No evaluable data|3|||
160903686|NCT02716805|581040586|FG000|Overall Study|Progressive disease|2|||
160903687|NCT02716805|581040587|FG001|Overall Study|Progressive disease|0|||
160903688|NCT02716805|581040588|FG002|Overall Study|Progressive disease|0|||
160903689|NCT02716805|581040589|FG003|Overall Study|Progressive disease|0|||
160903690|NCT00066365|581040590|FG000|Overall Study|Adverse Event|1|||
160903691|NCT00066365|581040591|FG001|Overall Study|Adverse Event|0|||
160903692|NCT00066365|581040590|FG000|Overall Study|Lack of Efficacy|15|||
160903693|NCT00066365|581040591|FG001|Overall Study|Lack of Efficacy|12|||
160903694|NCT00066365|581040590|FG000|Overall Study|Physician Decision|1|||
160903695|NCT00066365|581040591|FG001|Overall Study|Physician Decision|0|||
160903696|NCT00066365|581040590|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
160903697|NCT00066365|581040591|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
160903698|NCT00066365|581040590|FG000|Overall Study|Ineligible|4|||
160903699|NCT00066365|581040591|FG001|Overall Study|Ineligible|2|||
160903700|NCT01443078|581040596|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
160903701|NCT01443078|581040596|FG000|Overall Study|Withdrawal by Subject|1|||
160903702|NCT01443078|581040596|FG000|Overall Study|Patient had brain mets|1|||
160903703|NCT01390649|581040597|FG000|Overall Study|Physician Decision|1|||
160903704|NCT00415168|581040598|FG000|Overall Study|Death|26|||
160903705|NCT00415168|581040598|FG000|Overall Study|Lost to Follow-up|3|||
160903706|NCT00415168|581040598|FG000|Overall Study|Physician Decision|13|||
160903707|NCT00415168|581040598|FG000|Overall Study|Sponsor Decision|4|||
160903708|NCT00415168|581040598|FG000|Overall Study|Withdrawal by Subject|6|||
160903709|NCT01612858|581040599|FG000|Overall Study|Withdrawal by Subject|5|||
160833962|NCT01264770|580778282|FG002|Overall Study|Lost to Follow-up|1|||
160833963|NCT01264770|580778283|FG003|Overall Study|Lost to Follow-up|1|||
160833964|NCT01264770|580778284|FG004|Overall Study|Lost to Follow-up|0|||
160833965|NCT01264770|580778285|FG005|Overall Study|Lost to Follow-up|0|||
160833966|NCT01264770|580778280|FG000|Overall Study|Adverse Event|7|||
160833967|NCT01264770|580778281|FG001|Overall Study|Adverse Event|7|||
160833968|NCT01264770|580778282|FG002|Overall Study|Adverse Event|8|||
160833969|NCT01264770|580778283|FG003|Overall Study|Adverse Event|0|||
160833970|NCT01264770|580778284|FG004|Overall Study|Adverse Event|2|||
160833971|NCT01264770|580778285|FG005|Overall Study|Adverse Event|1|||
160833972|NCT00129961|580778286|FG000|Overall Study|Adverse Event|1|||
160833973|NCT00129961|580778287|FG001|Overall Study|Adverse Event|0|||
160833974|NCT00129961|580778286|FG000|Overall Study|Death|1|||
160833975|NCT00129961|580778287|FG001|Overall Study|Death|1|||
160833976|NCT00129961|580778286|FG000|Overall Study|Withdrawal by Sponsor|14|||
160833977|NCT00129961|580778287|FG001|Overall Study|Withdrawal by Sponsor|20|||
160833978|NCT00129961|580778286|FG000|Overall Study|Physician Decision|1|||
160833979|NCT00129961|580778287|FG001|Overall Study|Physician Decision|0|||
160833980|NCT00129961|580778286|FG000|Overall Study|Withdrawal by Subject|2|||
160833981|NCT00129961|580778287|FG001|Overall Study|Withdrawal by Subject|1|||
160833982|NCT00129961|580778286|FG000|Overall Study|Missing Record|0|||
160833983|NCT00129961|580778287|FG001|Overall Study|Missing Record|1|||
160833984|NCT01985360|580778290|FG000|Overall Study|Withdrawal by Subject|4|||
160833985|NCT01985360|580778291|FG001|Overall Study|Withdrawal by Subject|0|||
160833986|NCT01985360|580778290|FG000|Overall Study|Lost to Follow-up|5|||
160903710|NCT01612858|581040600|FG001|Overall Study|Withdrawal by Subject|1|||
160903711|NCT00005044|581040601|FG000|Overall Study|Protocol Violation|37|||
160903712|NCT00005044|581040602|FG001|Overall Study|Protocol Violation|46|||
160903713|NCT00005044|581040601|FG000|Overall Study|Withdrawal by Subject|1|||
160903714|NCT00005044|581040602|FG001|Overall Study|Withdrawal by Subject|5|||
160903715|NCT00005044|581040601|FG000|Overall Study|No protocol treatment|0|||
160903716|NCT00005044|581040602|FG001|Overall Study|No protocol treatment|1|||
160903717|NCT00241358|581040603|FG000|Overall Study|Determined to be not ineligible|0|||
160833987|NCT01985360|580778291|FG001|Overall Study|Lost to Follow-up|3|||
160833988|NCT00084487|580778292|FG000|Overall Study|Death|1|||
160833989|NCT03691779|580778297|FG000|Part B (24 Weeks)|Adverse Event|0|||
160833990|NCT03691779|580778298|FG001|Part B (24 Weeks)|Adverse Event|1|||
160833991|NCT03691779|580778297|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
160903718|NCT00241358|581040604|FG001|Overall Study|Determined to be not ineligible|1|||
160903719|NCT00241358|581040605|FG002|Overall Study|Determined to be not ineligible|1|||
160903720|NCT00843856|581040606|FG000|Overall Study|Lost to Follow-up|1|||
160833992|NCT03691779|580778298|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
160833993|NCT04881747|580778299|FG000|Period 2 Washout|Adverse Event|1|||
160903721|NCT00843856|581040607|FG001|Overall Study|Lost to Follow-up|2|||
160833994|NCT04881747|580778300|FG001|Period 2 Washout|Adverse Event|0|||
160833995|NCT04881747|580778301|FG002|Period 2 Washout|Adverse Event|0|||
160833996|NCT04881747|580778302|FG003|Period 2 Washout|Adverse Event|0|||
160833997|NCT04881747|580778303|FG004|Period 2 Washout|Adverse Event|1|||
160833998|NCT04881747|580778304|FG005|Period 2 Washout|Adverse Event|0|||
160833999|NCT04881747|580778299|FG000|Period 2 Washout|Withdrawal by Subject|1|||
160834000|NCT04881747|580778300|FG001|Period 2 Washout|Withdrawal by Subject|0|||
160834001|NCT04881747|580778301|FG002|Period 2 Washout|Withdrawal by Subject|0|||
160834002|NCT04881747|580778302|FG003|Period 2 Washout|Withdrawal by Subject|1|||
160834003|NCT04881747|580778303|FG004|Period 2 Washout|Withdrawal by Subject|0|||
160834004|NCT04881747|580778304|FG005|Period 2 Washout|Withdrawal by Subject|0|||
160834005|NCT00521222|580778305|FG000|Overall Study|Lost to Follow-up|0|||
160834006|NCT00521222|580778306|FG001|Overall Study|Lost to Follow-up|0|||
160834007|NCT00521222|580778307|FG002|Overall Study|Lost to Follow-up|1|||
160834008|NCT00521222|580778308|FG003|Overall Study|Lost to Follow-up|1|||
160834009|NCT00521222|580778305|FG000|Overall Study|Withdrawal by Subject|0|||
160834010|NCT00521222|580778306|FG001|Overall Study|Withdrawal by Subject|0|||
160834011|NCT00521222|580778307|FG002|Overall Study|Withdrawal by Subject|2|||
160834012|NCT00521222|580778308|FG003|Overall Study|Withdrawal by Subject|0|||
160834013|NCT00521222|580778305|FG000|Overall Study|Physician Decision|0|||
160834014|NCT00521222|580778306|FG001|Overall Study|Physician Decision|1|||
160834015|NCT00521222|580778307|FG002|Overall Study|Physician Decision|0|||
160834016|NCT00521222|580778308|FG003|Overall Study|Physician Decision|1|||
160834017|NCT04598269|580778310|FG000|Overall Study|Adverse Event|0|||
160834018|NCT04598269|580778311|FG001|Overall Study|Adverse Event|3|||
160834019|NCT04598269|580778310|FG000|Overall Study|Withdrawal by Subject|1|||
160834020|NCT04598269|580778311|FG001|Overall Study|Withdrawal by Subject|4|||
160834021|NCT04598269|580778310|FG000|Overall Study|Lost to Follow-up|1|||
160834022|NCT04598269|580778311|FG001|Overall Study|Lost to Follow-up|0|||
160834023|NCT04598269|580778310|FG000|Overall Study|Not Treated|2|||
160834024|NCT04598269|580778311|FG001|Overall Study|Not Treated|0|||
160834025|NCT00424190|580778312|FG000|Overall Study|Withdrew consent|3|||
161334925|NCT03786380|582615864|FG004|Overall Study|Withdrawal by Subject|2|||
161334926|NCT03786380|582615860|FG000|Overall Study|Lost to Follow-up|3|||
160834026|NCT00424190|580778313|FG001|Overall Study|Withdrew consent|4|||
160834027|NCT00424190|580778312|FG000|Overall Study|Death|3|||
160834028|NCT00424190|580778313|FG001|Overall Study|Death|0|||
161248174|NCT01710358|582288280|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
161248175|NCT01710358|582288281|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
161248176|NCT01710358|582288282|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
161248177|NCT01710358|582288280|FG000|Rescue Period|Adverse Event|0|||
161248178|NCT01710358|582288281|FG001|Rescue Period|Adverse Event|15|||
161248179|NCT01710358|582288282|FG002|Rescue Period|Adverse Event|0|||
161248180|NCT01710358|582288280|FG000|Rescue Period|Death|0|||
161248181|NCT01710358|582288281|FG001|Rescue Period|Death|1|||
161248182|NCT01710358|582288282|FG002|Rescue Period|Death|0|||
161248183|NCT01710358|582288280|FG000|Rescue Period|Lack of Efficacy|0|||
161248184|NCT01710358|582288281|FG001|Rescue Period|Lack of Efficacy|7|||
161248185|NCT01710358|582288282|FG002|Rescue Period|Lack of Efficacy|0|||
161248186|NCT01710358|582288280|FG000|Rescue Period|Withdrawal by Subject|0|||
161248187|NCT01710358|582288281|FG001|Rescue Period|Withdrawal by Subject|8|||
161248188|NCT01710358|582288282|FG002|Rescue Period|Withdrawal by Subject|0|||
161248189|NCT00799708|582288285|FG000|Overall Study|non-compliance|1|||
161248190|NCT00799708|582288286|FG001|Overall Study|non-compliance|0|||
161248191|NCT00799708|582288287|FG002|Overall Study|non-compliance|0|||
161248192|NCT00880334|582288288|FG000|Randomized Phase|Physician Decision|1|||
160834029|NCT00424190|580778312|FG000|Overall Study|Noncompliance|1|||
160834030|NCT00424190|580778313|FG001|Overall Study|Noncompliance|2|||
160834031|NCT00424190|580778312|FG000|Overall Study|Request of sponsor or investigator|0|||
160834032|NCT00424190|580778313|FG001|Overall Study|Request of sponsor or investigator|2|||
160834033|NCT00424190|580778312|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
160834034|NCT00424190|580778313|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
160834035|NCT00424190|580778312|FG000|Overall Study|Other|15|||
160834036|NCT00424190|580778313|FG001|Overall Study|Other|21|||
160834037|NCT01927055|580778318|FG000|Open-label|Adverse Event|6|||
160834038|NCT01927055|580778319|FG001|Open-label|Adverse Event|0|||
160834039|NCT01927055|580778320|FG002|Open-label|Adverse Event|0|||
160834040|NCT01927055|580778318|FG000|Open-label|Withdrawal by Subject|1|||
160834041|NCT01927055|580778319|FG001|Open-label|Withdrawal by Subject|0|||
160834042|NCT01927055|580778320|FG002|Open-label|Withdrawal by Subject|0|||
160834043|NCT01927055|580778318|FG000|Open-label|Study Stopped|4|||
160834044|NCT01927055|580778319|FG001|Open-label|Study Stopped|0|||
160834045|NCT01927055|580778320|FG002|Open-label|Study Stopped|0|||
160834046|NCT01927055|580778318|FG000|Open-label|Supine Hypertension|4|||
160834047|NCT01927055|580778319|FG001|Open-label|Supine Hypertension|0|||
160834048|NCT01927055|580778320|FG002|Open-label|Supine Hypertension|0|||
161248193|NCT00880334|582288289|FG001|Randomized Phase|Physician Decision|0|||
161248194|NCT00880334|582288288|FG000|Randomized Phase|Withdrawal by Subject|2|||
161248195|NCT00880334|582288289|FG001|Randomized Phase|Withdrawal by Subject|1|||
160834049|NCT01927055|580778318|FG000|Open-label|Difficulty attending study visits|1|||
160834050|NCT01927055|580778319|FG001|Open-label|Difficulty attending study visits|0|||
160834051|NCT01927055|580778320|FG002|Open-label|Difficulty attending study visits|0|||
160834052|NCT01927055|580778318|FG000|Double-Blind|Adverse Event|0|||
160834053|NCT01927055|580778319|FG001|Double-Blind|Adverse Event|1|||
160834054|NCT01927055|580778320|FG002|Double-Blind|Adverse Event|1|||
160834055|NCT01927055|580778318|FG000|Double-Blind|Protocol Violation|0|||
160834056|NCT01927055|580778319|FG001|Double-Blind|Protocol Violation|0|||
160834057|NCT01927055|580778320|FG002|Double-Blind|Protocol Violation|1|||
160834058|NCT01927055|580778318|FG000|Double-Blind|Withdrawal by Subject|0|||
160834059|NCT01927055|580778319|FG001|Double-Blind|Withdrawal by Subject|2|||
160834060|NCT01927055|580778320|FG002|Double-Blind|Withdrawal by Subject|3|||
161137692|NCT01075178|581885662|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
160834061|NCT01927055|580778318|FG000|Double-Blind|Study Stopped|0|||
160834062|NCT01927055|580778319|FG001|Double-Blind|Study Stopped|7|||
160834063|NCT01927055|580778320|FG002|Double-Blind|Study Stopped|7|||
160834064|NCT01927055|580778318|FG000|Double-Blind|Supine Hypertension|0|||
160834065|NCT01927055|580778319|FG001|Double-Blind|Supine Hypertension|0|||
160834066|NCT01927055|580778320|FG002|Double-Blind|Supine Hypertension|1|||
160834067|NCT01927055|580778318|FG000|Double-Blind|Extended Vacation|0|||
160834068|NCT01927055|580778319|FG001|Double-Blind|Extended Vacation|1|||
160834069|NCT01927055|580778320|FG002|Double-Blind|Extended Vacation|0|||
160834070|NCT02598128|580778321|FG000|Period A: Days -7 to -1|Adverse Event|1|||
160834071|NCT02598128|580778322|FG001|Period A: Days -7 to -1|Adverse Event|0|||
160834072|NCT02598128|580778323|FG002|Period A: Days -7 to -1|Adverse Event|0|||
160834073|NCT02598128|580778324|FG003|Period A: Days -7 to -1|Adverse Event|0|||
161137693|NCT01075178|581885663|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
160834074|NCT01378429|580778325|FG000|Overall Study|Noncompliance with study drug|1|||
160834075|NCT01378429|580778326|FG001|Overall Study|Noncompliance with study drug|0|||
160834076|NCT01064687|580778328|FG000|Overall Study|Adverse Event|9|||
160834077|NCT01064687|580778329|FG001|Overall Study|Adverse Event|4|||
160834078|NCT01064687|580778330|FG002|Overall Study|Adverse Event|10|||
160834079|NCT01064687|580778331|FG003|Overall Study|Adverse Event|3|||
160834080|NCT01064687|580778328|FG000|Overall Study|Death|1|||
160834081|NCT01064687|580778329|FG001|Overall Study|Death|1|||
160834082|NCT01064687|580778330|FG002|Overall Study|Death|0|||
160834083|NCT01064687|580778331|FG003|Overall Study|Death|0|||
160903722|NCT02993757|581040612|FG000|Overall Study|Non compliance with the protocol|155|||
161137694|NCT02983604|581885664|FG000|Overall Study|Enrolled but not Treated|0|||
161137695|NCT02983604|581885665|FG001|Overall Study|Enrolled but not Treated|0|||
161137696|NCT02983604|581885666|FG002|Overall Study|Enrolled but not Treated|1|||
161137697|NCT02983604|581885667|FG003|Overall Study|Enrolled but not Treated|0|||
161137698|NCT04336163|581885669|FG000|Overall Study|Lost to Follow-up|55|||
161137699|NCT04336163|581885670|FG001|Overall Study|Lost to Follow-up|0|||
161137700|NCT01241786|581885671|FG000|Overall Study|Lack of Efficacy|5|||
161137701|NCT00503399|581885680|FG000|Overall Study|Death|2|||
161137702|NCT00503399|581885681|FG001|Overall Study|Death|1|||
161137703|NCT00503399|581885680|FG000|Overall Study|Protocol Violation|1|||
161137704|NCT00503399|581885681|FG001|Overall Study|Protocol Violation|0|||
161137705|NCT00503399|581885680|FG000|Overall Study|Withdrawal by Subject|4|||
161137706|NCT00503399|581885681|FG001|Overall Study|Withdrawal by Subject|2|||
161137707|NCT00503399|581885680|FG000|Overall Study|Adverse Event|0|||
161137708|NCT00503399|581885681|FG001|Overall Study|Adverse Event|3|||
161137709|NCT00503399|581885680|FG000|Overall Study|Lost to Follow-up|0|||
161137710|NCT00503399|581885681|FG001|Overall Study|Lost to Follow-up|2|||
161137711|NCT01676961|581885682|FG000|Overall Study|Death|3|||
161137712|NCT01676961|581885682|FG000|Overall Study|Lost to Follow-up|1|||
161137713|NCT01676961|581885682|FG000|Overall Study|Withdrawal by Subject|1|||
161137714|NCT02499952|581885683|FG000|Overall Study|Lost to Follow-up|1|||
161137715|NCT02499952|581885683|FG000|Overall Study|Death|9|||
161137716|NCT02120417|581885684|FG000|Overall Study|Death|5|||
161137717|NCT02120417|581885685|FG001|Overall Study|Death|1|||
161137718|NCT02120417|581885684|FG000|Overall Study|Adverse Event|3|||
161137719|NCT02120417|581885685|FG001|Overall Study|Adverse Event|9|||
161137720|NCT02120417|581885684|FG000|Overall Study|Participant decision|4|||
161137721|NCT02120417|581885685|FG001|Overall Study|Participant decision|4|||
161137722|NCT02120417|581885684|FG000|Overall Study|Disease progression|41|||
161137723|NCT02120417|581885685|FG001|Overall Study|Disease progression|45|||
161137724|NCT02120417|581885684|FG000|Overall Study|Noncompliance with study treatment|0|||
161137725|NCT02120417|581885685|FG001|Overall Study|Noncompliance with study treatment|2|||
161137726|NCT02120417|581885684|FG000|Overall Study|Physician Decision|2|||
161137727|NCT02120417|581885685|FG001|Overall Study|Physician Decision|3|||
161137728|NCT02120417|581885684|FG000|Overall Study|Other unspecified|5|||
161137729|NCT02120417|581885685|FG001|Overall Study|Other unspecified|4|||
161137730|NCT00927485|581885686|FG000|Overall Study|Adverse Event|4|||
161137731|NCT00927485|581885687|FG001|Overall Study|Adverse Event|2|||
161137732|NCT00927485|581885686|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
161137733|NCT00927485|581885687|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
160834084|NCT01064687|580778328|FG000|Overall Study|Entry Criteria Not Met|3|||
160834085|NCT01064687|580778329|FG001|Overall Study|Entry Criteria Not Met|0|||
160834086|NCT01064687|580778330|FG002|Overall Study|Entry Criteria Not Met|0|||
160834087|NCT01064687|580778331|FG003|Overall Study|Entry Criteria Not Met|0|||
160834088|NCT01064687|580778328|FG000|Overall Study|Lack of Efficacy|1|||
160834089|NCT01064687|580778329|FG001|Overall Study|Lack of Efficacy|0|||
160834090|NCT01064687|580778330|FG002|Overall Study|Lack of Efficacy|2|||
160834091|NCT01064687|580778331|FG003|Overall Study|Lack of Efficacy|3|||
160834092|NCT01064687|580778328|FG000|Overall Study|Lost to Follow-up|7|||
160834093|NCT01064687|580778329|FG001|Overall Study|Lost to Follow-up|10|||
160834094|NCT01064687|580778330|FG002|Overall Study|Lost to Follow-up|13|||
160834095|NCT01064687|580778331|FG003|Overall Study|Lost to Follow-up|5|||
160834096|NCT01064687|580778328|FG000|Overall Study|Physician Decision|2|||
160834097|NCT01064687|580778329|FG001|Overall Study|Physician Decision|2|||
160834098|NCT01064687|580778330|FG002|Overall Study|Physician Decision|0|||
160834099|NCT01064687|580778331|FG003|Overall Study|Physician Decision|0|||
160834100|NCT01064687|580778328|FG000|Overall Study|Protocol Violation|1|||
160834101|NCT01064687|580778329|FG001|Overall Study|Protocol Violation|1|||
160834102|NCT01064687|580778330|FG002|Overall Study|Protocol Violation|0|||
160834103|NCT01064687|580778331|FG003|Overall Study|Protocol Violation|1|||
160834104|NCT01064687|580778328|FG000|Overall Study|Sponsor Decision|0|||
160834105|NCT01064687|580778329|FG001|Overall Study|Sponsor Decision|0|||
160834106|NCT01064687|580778330|FG002|Overall Study|Sponsor Decision|3|||
160834107|NCT01064687|580778331|FG003|Overall Study|Sponsor Decision|0|||
160834108|NCT01064687|580778328|FG000|Overall Study|Withdrawal by Subject|9|||
160834109|NCT01064687|580778329|FG001|Overall Study|Withdrawal by Subject|7|||
160834110|NCT01064687|580778330|FG002|Overall Study|Withdrawal by Subject|12|||
160834111|NCT01064687|580778331|FG003|Overall Study|Withdrawal by Subject|5|||
160834112|NCT01064687|580778328|FG000|Overall Study|Treatment Noncompliance|1|||
160834113|NCT01064687|580778329|FG001|Overall Study|Treatment Noncompliance|1|||
160834114|NCT01064687|580778330|FG002|Overall Study|Treatment Noncompliance|1|||
160834115|NCT01064687|580778331|FG003|Overall Study|Treatment Noncompliance|0|||
160834116|NCT00619489|580778332|FG000|Overall Study|Adverse Event|0|||
160834117|NCT00619489|580778333|FG001|Overall Study|Adverse Event|7|||
160834118|NCT00619489|580778332|FG000|Overall Study|Withdrawal by Subject|1|||
160834119|NCT00619489|580778333|FG001|Overall Study|Withdrawal by Subject|1|||
160834120|NCT00619489|580778332|FG000|Overall Study|Lack of Efficacy|0|||
160834121|NCT00619489|580778333|FG001|Overall Study|Lack of Efficacy|11|||
160834122|NCT00619489|580778332|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
160834123|NCT00619489|580778333|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
160834124|NCT05219669|580778338|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834125|NCT05219669|580778339|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
161248196|NCT00880334|582288288|FG000|Randomized Phase|Inadequate Labs|1|||
161248197|NCT00880334|582288289|FG001|Randomized Phase|Inadequate Labs|1|||
161248198|NCT00880334|582288288|FG000|Randomized Phase|Brain Metastasis|0|||
161248199|NCT00880334|582288289|FG001|Randomized Phase|Brain Metastasis|1|||
161248200|NCT00880334|582288288|FG000|Randomized Phase|Crossover Participants|0|||
161248201|NCT00880334|582288289|FG001|Randomized Phase|Crossover Participants|37|||
161248202|NCT03343639|582288290|FG000|Overall Study|Withdrawal by Subject|10|||
161248203|NCT03343639|582288291|FG001|Overall Study|Withdrawal by Subject|6|||
161248204|NCT03343639|582288290|FG000|Overall Study|Lost to Follow-up|4|||
161248205|NCT03343639|582288291|FG001|Overall Study|Lost to Follow-up|5|||
161248206|NCT03343639|582288290|FG000|Overall Study|Protocol Violation|0|||
161248207|NCT03343639|582288291|FG001|Overall Study|Protocol Violation|1|||
161248208|NCT00735696|582288296|FG000|Overall Study|Withdrawal by Subject|1|||
161248209|NCT00735696|582288296|FG000|Overall Study|Enrolled but never Treated|1|||
161248210|NCT00084864|582288297|FG000|Overall Study|Adverse Event|1|||
161248211|NCT00084864|582288298|FG001|Overall Study|Adverse Event|0|||
161248212|NCT00084864|582288299|FG002|Overall Study|Adverse Event|0|||
161248213|NCT00084864|582288300|FG003|Overall Study|Adverse Event|0|||
161248214|NCT02460835|582288305|FG000|Overall Study|Disease progression prior to treatment|3|||
161248215|NCT02460835|582288305|FG000|Overall Study|Unable to complete planning scans|2|||
160834126|NCT05219669|580778340|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
160834127|NCT05219669|580778341|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834128|NCT05219669|580778342|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834129|NCT05219669|580778343|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
160834130|NCT03134183|580778347|FG000|Overall Study|Withdrawal by Subject|1|||
160834131|NCT03134183|580778348|FG001|Overall Study|Withdrawal by Subject|1|||
160834132|NCT02404649|580778350|FG000|Overall Study|Adverse Event|1|||
160834133|NCT02404649|580778351|FG001|Overall Study|Adverse Event|2|||
160834134|NCT02299076|580778355|FG000|Overall Study|Fraudulent Entries|20|||
160834135|NCT02299076|580778356|FG001|Overall Study|Fraudulent Entries|14|||
160834136|NCT00162266|580778357|FG000|Double-Blind Period|Adverse Event|5|||
160834137|NCT00162266|580778358|FG001|Double-Blind Period|Adverse Event|9|||
160834138|NCT00162266|580778359|FG002|Double-Blind Period|Adverse Event|11|||
160834139|NCT00162266|580778360|FG003|Double-Blind Period|Adverse Event|0|||
161248216|NCT02460835|582288305|FG000|Overall Study|Decrease in performance status|1|||
161248217|NCT02460835|582288305|FG000|Overall Study|Withdrawal by Subject|3|||
161248218|NCT02460835|582288305|FG000|Overall Study|Underwent fractionated RT|10|||
161248219|NCT02460835|582288305|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
161248220|NCT02786953|582288322|FG000|Overall Study|Withdrawal by Subject|3|||
161248221|NCT02786953|582288323|FG001|Overall Study|Withdrawal by Subject|0|||
161248222|NCT02786953|582288322|FG000|Overall Study|Physician Decision|0|||
161248223|NCT02786953|582288323|FG001|Overall Study|Physician Decision|1|||
161248224|NCT01186458|582288327|FG000|Overall Study|Adverse Event|1|||
161248225|NCT04281472|582288328|FG000|Stage A|Lack of Efficacy|8|||
161248226|NCT04281472|582288329|FG001|Stage A|Lack of Efficacy|0|||
161248227|NCT04281472|582288330|FG002|Stage A|Lack of Efficacy|0|||
161248228|NCT04281472|582288328|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
161248229|NCT04281472|582288329|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161248230|NCT04281472|582288330|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161248231|NCT04281472|582288328|FG000|Stage A|Adverse Event|20|||
161248232|NCT04281472|582288329|FG001|Stage A|Adverse Event|0|||
161248233|NCT04281472|582288330|FG002|Stage A|Adverse Event|0|||
161248234|NCT04281472|582288328|FG000|Stage A|Death|1|||
161248235|NCT04281472|582288329|FG001|Stage A|Death|0|||
161248236|NCT04281472|582288330|FG002|Stage A|Death|0|||
161248237|NCT04281472|582288328|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
161248238|NCT04281472|582288329|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
161248239|NCT04281472|582288330|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
161248240|NCT04281472|582288328|FG000|Stage A|Lost to Follow-up|2|||
161248241|NCT04281472|582288329|FG001|Stage A|Lost to Follow-up|0|||
161248242|NCT04281472|582288330|FG002|Stage A|Lost to Follow-up|0|||
161248243|NCT04281472|582288328|FG000|Stage A|Non-compliance with study drug|1|||
161248244|NCT04281472|582288329|FG001|Stage A|Non-compliance with study drug|0|||
161248245|NCT04281472|582288330|FG002|Stage A|Non-compliance with study drug|0|||
161248246|NCT04281472|582288328|FG000|Stage A|Physician Decision|1|||
161248247|NCT04281472|582288329|FG001|Stage A|Physician Decision|0|||
161248248|NCT04281472|582288330|FG002|Stage A|Physician Decision|0|||
161248249|NCT04281472|582288328|FG000|Stage A|Prohibited medications|2|||
161248250|NCT04281472|582288329|FG001|Stage A|Prohibited medications|0|||
161248251|NCT04281472|582288330|FG002|Stage A|Prohibited medications|0|||
161248252|NCT04281472|582288328|FG000|Stage A|Withdrawal by Subject|11|||
161248253|NCT04281472|582288329|FG001|Stage A|Withdrawal by Subject|0|||
161248254|NCT04281472|582288330|FG002|Stage A|Withdrawal by Subject|0|||
161248255|NCT04281472|582288328|FG000|Stage A|Other|5|||
161248256|NCT04281472|582288329|FG001|Stage A|Other|0|||
161248257|NCT04281472|582288330|FG002|Stage A|Other|0|||
161334927|NCT03786380|582615861|FG001|Overall Study|Lost to Follow-up|0|||
161137734|NCT01440101|581885688|FG000|Overall Study|Adverse Event|2|||
161137735|NCT01440101|581885689|FG001|Overall Study|Adverse Event|0|||
161137736|NCT01440101|581885690|FG002|Overall Study|Adverse Event|0|||
161137737|NCT01440101|581885688|FG000|Overall Study|Withdrawal by Subject|0|||
161137738|NCT01440101|581885689|FG001|Overall Study|Withdrawal by Subject|3|||
161137739|NCT01440101|581885690|FG002|Overall Study|Withdrawal by Subject|1|||
161137740|NCT01440101|581885688|FG000|Overall Study|Other|0|||
161137741|NCT01440101|581885689|FG001|Overall Study|Other|1|||
161137742|NCT01440101|581885690|FG002|Overall Study|Other|0|||
161137743|NCT02305563|581885694|FG000|Treatment Period|Disease progression|0|||
161137744|NCT02305563|581885695|FG001|Treatment Period|Disease progression|0|||
161137745|NCT02305563|581885696|FG002|Treatment Period|Disease progression|15|||
161137746|NCT02305563|581885697|FG003|Treatment Period|Disease progression|6|||
161137747|NCT02305563|581885698|FG004|Treatment Period|Disease progression|6|||
161137748|NCT02305563|581885694|FG000|Treatment Period|Study drug toxicity|0|||
161137749|NCT02305563|581885695|FG001|Treatment Period|Study drug toxicity|0|||
161137750|NCT02305563|581885696|FG002|Treatment Period|Study drug toxicity|0|||
161137751|NCT02305563|581885697|FG003|Treatment Period|Study drug toxicity|1|||
161137752|NCT02305563|581885698|FG004|Treatment Period|Study drug toxicity|2|||
161137753|NCT02305563|581885694|FG000|Treatment Period|Death|0|||
161137754|NCT02305563|581885695|FG001|Treatment Period|Death|0|||
161137755|NCT02305563|581885696|FG002|Treatment Period|Death|1|||
161137756|NCT02305563|581885697|FG003|Treatment Period|Death|2|||
161137757|NCT02305563|581885698|FG004|Treatment Period|Death|1|||
161137758|NCT02305563|581885694|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
161137759|NCT02305563|581885695|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
161137760|NCT02305563|581885696|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
161137761|NCT02305563|581885697|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
161137762|NCT02305563|581885698|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
161137763|NCT02305563|581885694|FG000|Treatment Period|Participant request to stop therapy|0|||
161137764|NCT02305563|581885695|FG001|Treatment Period|Participant request to stop therapy|2|||
161137765|NCT02305563|581885696|FG002|Treatment Period|Participant request to stop therapy|0|||
161137766|NCT02305563|581885697|FG003|Treatment Period|Participant request to stop therapy|1|||
161137767|NCT02305563|581885698|FG004|Treatment Period|Participant request to stop therapy|0|||
161137768|NCT02305563|581885694|FG000|Treatment Period|Participant withdrew consent|0|||
161248258|NCT04281472|582288328|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
161248259|NCT04281472|582288329|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
161248260|NCT04281472|582288330|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
161248261|NCT04281472|582288328|FG000|Stage B|Adverse Event|0|||
161248262|NCT04281472|582288329|FG001|Stage B|Adverse Event|3|||
161248263|NCT04281472|582288330|FG002|Stage B|Adverse Event|0|||
161248264|NCT04281472|582288328|FG000|Stage B|Death|0|||
161248265|NCT04281472|582288329|FG001|Stage B|Death|0|||
161248266|NCT04281472|582288330|FG002|Stage B|Death|1|||
161248267|NCT04281472|582288328|FG000|Stage B|Lack of Efficacy|0|||
161248268|NCT04281472|582288329|FG001|Stage B|Lack of Efficacy|0|||
161248269|NCT04281472|582288330|FG002|Stage B|Lack of Efficacy|1|||
161248270|NCT04281472|582288328|FG000|Stage B|Lost to Follow-up|0|||
161248271|NCT04281472|582288329|FG001|Stage B|Lost to Follow-up|0|||
161248272|NCT04281472|582288330|FG002|Stage B|Lost to Follow-up|2|||
161248273|NCT04281472|582288328|FG000|Stage B|Prohibited medications|0|||
161248274|NCT04281472|582288329|FG001|Stage B|Prohibited medications|2|||
161248275|NCT04281472|582288330|FG002|Stage B|Prohibited medications|1|||
161248276|NCT04281472|582288328|FG000|Stage B|Protocol Violation|0|||
161248277|NCT04281472|582288329|FG001|Stage B|Protocol Violation|1|||
161248278|NCT04281472|582288330|FG002|Stage B|Protocol Violation|1|||
161248279|NCT04281472|582288328|FG000|Stage B|Sponsor decision|0|||
161248280|NCT04281472|582288329|FG001|Stage B|Sponsor decision|0|||
161248281|NCT04281472|582288330|FG002|Stage B|Sponsor decision|1|||
161248282|NCT04281472|582288328|FG000|Stage B|Withdrawal by Subject|0|||
161248283|NCT04281472|582288329|FG001|Stage B|Withdrawal by Subject|3|||
161248284|NCT04281472|582288330|FG002|Stage B|Withdrawal by Subject|3|||
161248285|NCT04281472|582288328|FG000|Stage B|Other|0|||
161248286|NCT04281472|582288329|FG001|Stage B|Other|3|||
161248287|NCT04281472|582288330|FG002|Stage B|Other|0|||
161248288|NCT01055834|582288331|FG000|Treatment Period I|Adverse Event|1|||
161248289|NCT01055834|582288332|FG001|Treatment Period I|Adverse Event|0|||
161248290|NCT00467597|582288333|FG000|Overall Study|Withdrawal by Subject|2|||
161248291|NCT00467597|582288334|FG001|Overall Study|Withdrawal by Subject|0|||
161248292|NCT03141151|582288335|FG000|Overall Study|Lost to Follow-up|3|||
161248293|NCT03141151|582288336|FG001|Overall Study|Lost to Follow-up|2|||
161248294|NCT03141151|582288335|FG000|Overall Study|Withdrawal by Subject|3|||
161248295|NCT03141151|582288336|FG001|Overall Study|Withdrawal by Subject|2|||
161248296|NCT04561115|582288343|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
160834140|NCT00162266|580778357|FG000|Double-Blind Period|Death|0|||
160834141|NCT00162266|580778358|FG001|Double-Blind Period|Death|1|||
160834142|NCT00162266|580778359|FG002|Double-Blind Period|Death|0|||
160834143|NCT00162266|580778360|FG003|Double-Blind Period|Death|0|||
160834144|NCT00162266|580778357|FG000|Double-Blind Period|Lost to Follow-up|1|||
160834145|NCT00162266|580778358|FG001|Double-Blind Period|Lost to Follow-up|2|||
160834146|NCT00162266|580778359|FG002|Double-Blind Period|Lost to Follow-up|0|||
160834147|NCT00162266|580778360|FG003|Double-Blind Period|Lost to Follow-up|0|||
160834148|NCT00162266|580778357|FG000|Double-Blind Period|Other Reason|1|||
160834149|NCT00162266|580778358|FG001|Double-Blind Period|Other Reason|0|||
160834150|NCT00162266|580778359|FG002|Double-Blind Period|Other Reason|1|||
160834151|NCT00162266|580778360|FG003|Double-Blind Period|Other Reason|0|||
160834152|NCT00162266|580778357|FG000|Double-Blind Period|Lack of Efficacy|13|||
160834153|NCT00162266|580778358|FG001|Double-Blind Period|Lack of Efficacy|17|||
160834154|NCT00162266|580778359|FG002|Double-Blind Period|Lack of Efficacy|30|||
160834155|NCT00162266|580778360|FG003|Double-Blind Period|Lack of Efficacy|0|||
160834156|NCT00162266|580778357|FG000|Double-Blind Period|Withdrawal by Subject|5|||
160834157|NCT00162266|580778358|FG001|Double-Blind Period|Withdrawal by Subject|2|||
160834158|NCT00162266|580778359|FG002|Double-Blind Period|Withdrawal by Subject|6|||
160834159|NCT00162266|580778360|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160834160|NCT00162266|580778357|FG000|Open-Label Period|Death|0|||
160834161|NCT00162266|580778358|FG001|Open-Label Period|Death|0|||
160834162|NCT00162266|580778359|FG002|Open-Label Period|Death|0|||
160834163|NCT00162266|580778360|FG003|Open-Label Period|Death|7|||
160834164|NCT00162266|580778357|FG000|Open-Label Period|Adverse Event|0|||
160834165|NCT00162266|580778358|FG001|Open-Label Period|Adverse Event|0|||
160834166|NCT00162266|580778359|FG002|Open-Label Period|Adverse Event|0|||
160834167|NCT00162266|580778360|FG003|Open-Label Period|Adverse Event|46|||
160834168|NCT00162266|580778357|FG000|Open-Label Period|Lack of Efficacy|0|||
160834169|NCT00162266|580778358|FG001|Open-Label Period|Lack of Efficacy|0|||
160834170|NCT00162266|580778359|FG002|Open-Label Period|Lack of Efficacy|0|||
160834171|NCT00162266|580778360|FG003|Open-Label Period|Lack of Efficacy|26|||
161248297|NCT04561115|582288344|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
161248298|NCT04561115|582288343|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
161248299|NCT04561115|582288344|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
161248300|NCT04561115|582288343|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
161248301|NCT04561115|582288344|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
161248302|NCT00743145|582288345|FG000|Overall Study|Withdrawal by Subject|1|||
161248303|NCT00743145|582288345|FG000|Overall Study|Adverse Event|2|||
161248304|NCT00743145|582288345|FG000|Overall Study|Pregnancy|1|||
161248305|NCT01670097|582288350|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
161248306|NCT01670097|582288351|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
161248307|NCT01670097|582288350|FG000|Overall Study|Study burden|1|||
161248308|NCT01670097|582288351|FG001|Overall Study|Study burden|0|||
161248309|NCT01670097|582288350|FG000|Overall Study|COPD exacerbation|0|||
161248310|NCT01670097|582288351|FG001|Overall Study|COPD exacerbation|1|||
161248311|NCT01670097|582288350|FG000|Overall Study|Neutropenia|0|||
161248312|NCT01670097|582288351|FG001|Overall Study|Neutropenia|1|||
161248313|NCT01670097|582288350|FG000|Overall Study|Clinical deterioration|0|||
161248314|NCT01670097|582288351|FG001|Overall Study|Clinical deterioration|1|||
161248315|NCT01670097|582288350|FG000|Overall Study|Disease progression|0|||
161248316|NCT01670097|582288351|FG001|Overall Study|Disease progression|1|||
161248317|NCT02311894|582288352|FG000|Overall Study|Discontinued in error|1|||
161248318|NCT02311894|582288352|FG000|Overall Study|Lost to Follow-up|1|||
161248319|NCT02311894|582288352|FG000|Overall Study|Adverse Event|1|||
161248320|NCT02311894|582288352|FG000|Overall Study|Withdrawal by Subject|1|||
161248321|NCT01691612|582288355|FG000|Overall Study|deemed ineligible after 1st visit|6|||
161248322|NCT01691612|582288355|FG000|Overall Study|Adverse Event|1|||
161248323|NCT04049097|582288357|FG000|Overall Study|Adverse Event|18|||
161248324|NCT04049097|582288357|FG000|Overall Study|Death|2|||
161248325|NCT04049097|582288357|FG000|Overall Study|Lost to Follow-up|1|||
161248326|NCT04049097|582288357|FG000|Overall Study|Physician Decision|2|||
161248327|NCT04049097|582288357|FG000|Overall Study|Withdrawal by Subject|9|||
161248328|NCT04049097|582288357|FG000|Overall Study|Protocol Violation|2|||
161248329|NCT04049097|582288357|FG000|Overall Study|Other|1|||
161248330|NCT04049097|582288357|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
161248331|NCT00021541|582288358|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
161248332|NCT00021541|582288359|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
161248333|NCT00021541|582288358|FG000|Period 1-First Treatment|Adverse Event|2|||
161248334|NCT00021541|582288359|FG001|Period 1-First Treatment|Adverse Event|1|||
161248335|NCT00021541|582288358|FG000|Period 1-First Treatment|non-adherence|3|||
161248336|NCT00021541|582288359|FG001|Period 1-First Treatment|non-adherence|0|||
161248337|NCT00021541|582288358|FG000|Period 1-First Treatment|Death|1|||
161248338|NCT00021541|582288359|FG001|Period 1-First Treatment|Death|0|||
161248339|NCT00021541|582288358|FG000|Period 1-First Treatment|Pts that did not progress|2|||
161248340|NCT00021541|582288359|FG001|Period 1-First Treatment|Pts that did not progress|2|||
161248341|NCT00021541|582288358|FG000|Period 1-First Treatment|Ineligible|0|||
161248342|NCT00021541|582288359|FG001|Period 1-First Treatment|Ineligible|2|||
161248343|NCT00021541|582288358|FG000|Period 2-crossover|refused phase B|2|||
160834172|NCT00162266|580778357|FG000|Open-Label Period|Lost to Follow-up|0|||
160834173|NCT00162266|580778358|FG001|Open-Label Period|Lost to Follow-up|0|||
160834174|NCT00162266|580778359|FG002|Open-Label Period|Lost to Follow-up|0|||
160834175|NCT00162266|580778360|FG003|Open-Label Period|Lost to Follow-up|3|||
160834176|NCT00162266|580778357|FG000|Open-Label Period|Withdrawal by Subject|0|||
160834177|NCT00162266|580778358|FG001|Open-Label Period|Withdrawal by Subject|0|||
160834178|NCT00162266|580778359|FG002|Open-Label Period|Withdrawal by Subject|0|||
160834179|NCT00162266|580778360|FG003|Open-Label Period|Withdrawal by Subject|31|||
160834180|NCT00162266|580778357|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
160834181|NCT00162266|580778358|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
160834182|NCT00162266|580778359|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
160834183|NCT00162266|580778360|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
160834184|NCT00162266|580778357|FG000|Open-Label Period|Other Reasons|0|||
160834185|NCT00162266|580778358|FG001|Open-Label Period|Other Reasons|0|||
161248344|NCT00021541|582288359|FG001|Period 2-crossover|refused phase B|2|||
161248345|NCT00021541|582288358|FG000|Period 2-crossover|Withdrawal by Subject|3|||
160834186|NCT00162266|580778359|FG002|Open-Label Period|Other Reasons|0|||
161248346|NCT00021541|582288359|FG001|Period 2-crossover|Withdrawal by Subject|4|||
161248347|NCT00021541|582288358|FG000|Period 2-crossover|Adverse Event|2|||
161248348|NCT00021541|582288359|FG001|Period 2-crossover|Adverse Event|2|||
161248349|NCT00021541|582288358|FG000|Period 2-crossover|non-adherence|1|||
161248350|NCT00021541|582288359|FG001|Period 2-crossover|non-adherence|0|||
161248351|NCT00021541|582288358|FG000|Period 2-crossover|Pts that did not progress|2|||
161248352|NCT00021541|582288359|FG001|Period 2-crossover|Pts that did not progress|3|||
161248353|NCT01874535|582288361|FG000|Overall Study|Lost to Follow-up|10|||
160834187|NCT00162266|580778360|FG003|Open-Label Period|Other Reasons|15|||
161248354|NCT01874535|582288362|FG001|Overall Study|Lost to Follow-up|9|||
161248355|NCT01874535|582288361|FG000|Overall Study|incomplete symptom resolution|45|||
161248356|NCT01874535|582288362|FG001|Overall Study|incomplete symptom resolution|35|||
161248357|NCT05263505|582288366|FG000|Overall Study|Adverse Event|0|||
161248358|NCT05263505|582288367|FG001|Overall Study|Adverse Event|1|||
161248359|NCT02616380|582288368|FG000|Overall Study|Lost to Follow-up|1|||
161248360|NCT02616380|582288368|FG000|Overall Study|Other|2|||
161248361|NCT05065619|582288369|FG000|Up to Day 42|Lost to Follow-up|1|||
161248362|NCT05065619|582288370|FG001|Up to Day 42|Lost to Follow-up|0|||
161248363|NCT05065619|582288369|FG000|Up to Day 42|Withdrawal by Subject|1|||
161248364|NCT05065619|582288370|FG001|Up to Day 42|Withdrawal by Subject|0|||
161248365|NCT05065619|582288369|FG000|After Day 43|Lost to Follow-up|1|||
161248366|NCT05065619|582288370|FG001|After Day 43|Lost to Follow-up|0|||
161248367|NCT05065619|582288369|FG000|After Day 43|Physician Decision|3|||
161248368|NCT05065619|582288370|FG001|After Day 43|Physician Decision|0|||
161248369|NCT05065619|582288369|FG000|After Day 43|Withdrawal by Subject|1|||
161248370|NCT05065619|582288370|FG001|After Day 43|Withdrawal by Subject|2|||
161248371|NCT05065619|582288369|FG000|After Day 43|Public vaccination|6|||
161248372|NCT05065619|582288370|FG001|After Day 43|Public vaccination|8|||
161248373|NCT05065619|582288369|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
161248374|NCT05065619|582288370|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
161248375|NCT05065619|582288369|FG000|After Day 43|Study Terminated by Sponsor|88|||
161248376|NCT05065619|582288370|FG001|After Day 43|Study Terminated by Sponsor|16|||
161248377|NCT01050764|582288371|FG000|Overall Study|Death, before HSCT|1|||
161248378|NCT01050764|582288371|FG000|Overall Study|Donor mobilization failure, death|1|||
161248379|NCT01050764|582288371|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
161248380|NCT01929681|582288376|FG000|Overall Study|Withdrawal by Subject|1|||
161248381|NCT01929681|582288377|FG001|Overall Study|Withdrawal by Subject|0|||
161248382|NCT01929681|582288376|FG000|Overall Study|Physician Decision|1|||
161248383|NCT01929681|582288377|FG001|Overall Study|Physician Decision|1|||
161248384|NCT05315713|582288378|FG000|Overall Study|Death|5|||
161248385|NCT05315713|582288378|FG000|Overall Study|Progressive disease|1|||
161248386|NCT05315713|582288378|FG000|Overall Study|Withdrawal by Subject|1|||
161248387|NCT05315713|582288378|FG000|Overall Study|Study terminated by sponsor|1|||
161248388|NCT04194151|582288380|FG000|Overall Study|Physician Decision|1|||
161248389|NCT04194151|582288381|FG001|Overall Study|Physician Decision|1|||
161248390|NCT04194151|582288382|FG002|Overall Study|Physician Decision|1|||
161248391|NCT04194151|582288383|FG003|Overall Study|Physician Decision|1|||
161248392|NCT04194151|582288384|FG004|Overall Study|Physician Decision|0|||
161248393|NCT04194151|582288385|FG005|Overall Study|Physician Decision|1|||
161248394|NCT04194151|582288380|FG000|Overall Study|Monitorization problem|0|||
161248395|NCT04194151|582288381|FG001|Overall Study|Monitorization problem|1|||
161248396|NCT04194151|582288382|FG002|Overall Study|Monitorization problem|0|||
161248397|NCT04194151|582288383|FG003|Overall Study|Monitorization problem|0|||
161248398|NCT04194151|582288384|FG004|Overall Study|Monitorization problem|0|||
161248399|NCT04194151|582288385|FG005|Overall Study|Monitorization problem|0|||
161248400|NCT00421304|582288386|FG000|Overall Study|Lost to Follow-up|5|||
161248401|NCT00421304|582288387|FG001|Overall Study|Lost to Follow-up|2|||
161248402|NCT00421304|582288388|FG002|Overall Study|Lost to Follow-up|5|||
161248403|NCT00421304|582288386|FG000|Overall Study|Withdrawal by Subject|2|||
161248404|NCT00421304|582288387|FG001|Overall Study|Withdrawal by Subject|2|||
161248405|NCT00421304|582288388|FG002|Overall Study|Withdrawal by Subject|2|||
161248406|NCT00421304|582288386|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
161248407|NCT00421304|582288387|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
161248408|NCT00421304|582288388|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
161248409|NCT00421304|582288386|FG000|Overall Study|Did not attend Day 360 visit|0|||
161248410|NCT00421304|582288387|FG001|Overall Study|Did not attend Day 360 visit|0|||
161248411|NCT00421304|582288388|FG002|Overall Study|Did not attend Day 360 visit|1|||
161248412|NCT00903877|582288389|FG000|Overall Study|Did not meet study criteria|33|||
161248413|NCT00903877|582288389|FG000|Overall Study|Withdrawal by Subject|3|||
161248414|NCT00903877|582288389|FG000|Overall Study|Adverse Event|2|||
161248415|NCT00903877|582288389|FG000|Overall Study|Lost to Follow-up|1|||
161248416|NCT00903877|582288389|FG000|Overall Study|Participation put on hold|4|||
160991267|NCT01959880|581355567|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
160991268|NCT01959880|581355568|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
160991269|NCT01959880|581355569|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
160991270|NCT01959880|581355570|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
160991271|NCT01959880|581355567|FG000|Overall Study|Study completed early-FDA approved|1003|||
160991272|NCT01959880|581355568|FG001|Overall Study|Study completed early-FDA approved|311|||
161248417|NCT00919711|582288390|FG000|Overall Study|Withdrawal by Subject|15|||
161248418|NCT00919711|582288391|FG001|Overall Study|Withdrawal by Subject|7|||
161248419|NCT00919711|582288390|FG000|Overall Study|Adverse Event|13|||
161248420|NCT00919711|582288391|FG001|Overall Study|Adverse Event|3|||
161248421|NCT00919711|582288390|FG000|Overall Study|Other|1|||
161248422|NCT00919711|582288391|FG001|Overall Study|Other|2|||
161248423|NCT00919711|582288390|FG000|Overall Study|Administrative Decision|0|||
161334928|NCT03786380|582615862|FG002|Overall Study|Lost to Follow-up|1|||
161248424|NCT00919711|582288391|FG001|Overall Study|Administrative Decision|1|||
161248425|NCT00919711|582288390|FG000|Overall Study|Lost to Follow-up|2|||
161248426|NCT00919711|582288391|FG001|Overall Study|Lost to Follow-up|0|||
161248427|NCT00919711|582288390|FG000|Overall Study|Death|1|||
161248428|NCT00919711|582288391|FG001|Overall Study|Death|0|||
161248429|NCT00919711|582288390|FG000|Overall Study|Noncompliance|1|||
160991273|NCT01959880|581355569|FG002|Overall Study|Study completed early-FDA approved|179|||
161248430|NCT00919711|582288391|FG001|Overall Study|Noncompliance|0|||
161248431|NCT03694197|582288392|FG000|Overall Study|Adverse Event|9|||
161248432|NCT03694197|582288392|FG000|Overall Study|Protocol became inconvenient to participate|1|||
161248433|NCT03694197|582288392|FG000|Overall Study|Physician Decision|4|||
161248434|NCT03694197|582288392|FG000|Overall Study|Study terminated by sponsor|1350|||
161248435|NCT03694197|582288392|FG000|Overall Study|Participant moved|5|||
161248436|NCT03694197|582288392|FG000|Overall Study|Participant withdrew consent|10|||
161248437|NCT03694197|582288392|FG000|Overall Study|Related to IMP administration|1|||
161248438|NCT03694197|582288392|FG000|Overall Study|Not disclosed|5|||
161248439|NCT00274625|582289726|FG000|Overall Study|Lost to Follow-up|46|||
161248440|NCT00274625|582289727|FG001|Overall Study|Lost to Follow-up|54|||
161248441|NCT00274625|582289726|FG000|Overall Study|Excluded from analysis|14|||
161248442|NCT00274625|582289727|FG001|Overall Study|Excluded from analysis|8|||
161248443|NCT02940522|582289728|FG000|Overall Study|Lost to Follow-up|1|||
161248444|NCT02940522|582289729|FG001|Overall Study|Lost to Follow-up|2|||
161248445|NCT02940522|582289728|FG000|Overall Study|Withdrawal by Subject|1|||
161248446|NCT02940522|582289729|FG001|Overall Study|Withdrawal by Subject|0|||
161248447|NCT05135273|582289730|FG000|Overall Study|Recruited into the army|0|||
161248448|NCT05135273|582289731|FG001|Overall Study|Recruited into the army|0|||
161248449|NCT05135273|582289732|FG002|Overall Study|Recruited into the army|0|||
161248450|NCT05135273|582289733|FG003|Overall Study|Recruited into the army|0|||
161248451|NCT05135273|582289734|FG004|Overall Study|Recruited into the army|1|||
161248452|NCT05135273|582289735|FG005|Overall Study|Recruited into the army|0|||
161248453|NCT05135273|582289736|FG006|Overall Study|Recruited into the army|0|||
160834188|NCT00330668|580778361|FG000|BID Dosing Period|Adverse Event|1|||
160834189|NCT00330668|580778361|FG000|BID Dosing Period|Lost to Follow-up|7|||
161248454|NCT05135273|582289737|FG007|Overall Study|Recruited into the army|0|||
161248455|NCT05135273|582289730|FG000|Overall Study|Moved away from study site|0|||
161248456|NCT05135273|582289731|FG001|Overall Study|Moved away from study site|0|||
161248457|NCT05135273|582289732|FG002|Overall Study|Moved away from study site|0|||
161248458|NCT05135273|582289733|FG003|Overall Study|Moved away from study site|0|||
161248459|NCT05135273|582289734|FG004|Overall Study|Moved away from study site|0|||
161248460|NCT05135273|582289735|FG005|Overall Study|Moved away from study site|1|||
161248461|NCT05135273|582289736|FG006|Overall Study|Moved away from study site|1|||
161248462|NCT05135273|582289737|FG007|Overall Study|Moved away from study site|0|||
161248463|NCT05135273|582289730|FG000|Overall Study|Travel|0|||
160834190|NCT00330668|580778361|FG000|BID Dosing Period|Non-Compliance|5|||
160834191|NCT00330668|580778361|FG000|BID Dosing Period|Withdrawal by Subject|19|||
160834192|NCT00330668|580778361|FG000|BID Dosing Period|Sponsor's decision|1|||
161248464|NCT05135273|582289731|FG001|Overall Study|Travel|0|||
161248465|NCT05135273|582289732|FG002|Overall Study|Travel|0|||
161248466|NCT05135273|582289733|FG003|Overall Study|Travel|0|||
161248467|NCT05135273|582289734|FG004|Overall Study|Travel|0|||
161248468|NCT05135273|582289735|FG005|Overall Study|Travel|0|||
161248469|NCT05135273|582289736|FG006|Overall Study|Travel|0|||
161248470|NCT05135273|582289737|FG007|Overall Study|Travel|1|||
161248471|NCT04264819|582289743|FG000|Overall Study|Physician Decision|19|||
161248472|NCT04264819|582289743|FG000|Overall Study|Adverse Event|12|||
161248473|NCT04264819|582289743|FG000|Overall Study|Withdrawal by Subject|11|||
161248474|NCT04264819|582289743|FG000|Overall Study|Lost to Follow-up|2|||
161248475|NCT04264819|582289743|FG000|Overall Study|Death|2|||
161248476|NCT01188226|582289751|FG000|Overall Study|Withdrawal by Subject|4|||
161248477|NCT04980456|582289752|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
161248478|NCT04980456|582289753|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
161248479|NCT04980456|582289752|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
161248480|NCT04980456|582289753|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
161248481|NCT04980456|582289752|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
161248482|NCT04980456|582289753|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
161248483|NCT04980456|582289752|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
161248484|NCT04980456|582289753|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
161248485|NCT00442351|582289756|FG000|Overall Study|Administrative|6|||
161248486|NCT00442351|582289757|FG001|Overall Study|Administrative|5|||
161334929|NCT03786380|582615863|FG003|Overall Study|Lost to Follow-up|2|||
160834193|NCT00330668|580778361|FG000|BID Dosing Period|Other|3|||
160834194|NCT00330668|580778361|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
160834195|NCT00330668|580778361|FG000|QD Dosing Period|Other|1|||
161248487|NCT00442351|582289756|FG000|Overall Study|Did not meet protocol eligibility|1|||
161248488|NCT00442351|582289757|FG001|Overall Study|Did not meet protocol eligibility|0|||
161248489|NCT00442351|582289756|FG000|Overall Study|Other|0|||
161248490|NCT00442351|582289757|FG001|Overall Study|Other|1|||
161248491|NCT00500318|582289758|FG000|Overall Study|Adverse Event|3|||
161248492|NCT00500318|582289759|FG001|Overall Study|Adverse Event|8|||
160903723|NCT02993757|581040613|FG001|Overall Study|Non compliance with the protocol|170|||
161248493|NCT00500318|582289758|FG000|Overall Study|Protocol Violation|1|||
161248494|NCT00500318|582289759|FG001|Overall Study|Protocol Violation|3|||
161248495|NCT00500318|582289758|FG000|Overall Study|Withdrawal by Subject|1|||
161248496|NCT00500318|582289759|FG001|Overall Study|Withdrawal by Subject|2|||
161334930|NCT03786380|582615864|FG004|Overall Study|Lost to Follow-up|0|||
161334931|NCT03786380|582615860|FG000|Overall Study|Physician Decision|0|||
161334932|NCT03786380|582615861|FG001|Overall Study|Physician Decision|0|||
161248497|NCT00500318|582289758|FG000|Overall Study|Lack of Efficacy|0|||
161248498|NCT00500318|582289759|FG001|Overall Study|Lack of Efficacy|3|||
161248499|NCT00500318|582289758|FG000|Overall Study|Other Reason|0|||
161248500|NCT00500318|582289759|FG001|Overall Study|Other Reason|1|||
161248501|NCT01579006|582289763|FG000|Overall Study|Lack of Efficacy|10|||
161248502|NCT01579006|582289763|FG000|Overall Study|Adverse Event|13|||
161248503|NCT01579006|582289763|FG000|Overall Study|Withdrawal by Subject|5|||
161248504|NCT01579006|582289763|FG000|Overall Study|Non-compliance|3|||
161248505|NCT01579006|582289763|FG000|Overall Study|Due to participant's health fund|1|||
161248506|NCT01579006|582289763|FG000|Overall Study|Scheduled surgery|1|||
161248507|NCT01708954|582289767|FG000|Step 1|Disease progression|26|||
161248508|NCT01708954|582289768|FG001|Step 1|Disease progression|17|||
161248509|NCT01708954|582289769|FG002|Step 1|Disease progression|14|||
161248510|NCT01708954|582289767|FG000|Step 1|Adverse Event|3|||
161248511|NCT01708954|582289768|FG001|Step 1|Adverse Event|11|||
161248512|NCT01708954|582289769|FG002|Step 1|Adverse Event|13|||
161248513|NCT01708954|582289767|FG000|Step 1|Death|3|||
161248514|NCT01708954|582289768|FG001|Step 1|Death|2|||
161248515|NCT01708954|582289769|FG002|Step 1|Death|3|||
161248516|NCT01708954|582289767|FG000|Step 1|Withdrawal by Subject|2|||
161248517|NCT01708954|582289768|FG001|Step 1|Withdrawal by Subject|5|||
161248518|NCT01708954|582289769|FG002|Step 1|Withdrawal by Subject|3|||
161248519|NCT01708954|582289767|FG000|Step 1|Other complicating disease|0|||
161248520|NCT01708954|582289768|FG001|Step 1|Other complicating disease|2|||
161248521|NCT01708954|582289769|FG002|Step 1|Other complicating disease|0|||
161248522|NCT01708954|582289767|FG000|Step 1|Crossed over to Step 2|2|||
161248523|NCT01708954|582289768|FG001|Step 1|Crossed over to Step 2|0|||
161248524|NCT01708954|582289769|FG002|Step 1|Crossed over to Step 2|0|||
161248525|NCT01708954|582289767|FG000|Step 1|Symptomatic deterioration|1|||
161248526|NCT01708954|582289768|FG001|Step 1|Symptomatic deterioration|0|||
161248527|NCT01708954|582289769|FG002|Step 1|Symptomatic deterioration|1|||
161248528|NCT01708954|582289767|FG000|Step 1|Off-treatment reason not submitted|1|||
161248529|NCT01708954|582289768|FG001|Step 1|Off-treatment reason not submitted|1|||
161248530|NCT01708954|582289769|FG002|Step 1|Off-treatment reason not submitted|1|||
161248531|NCT01708954|582289767|FG000|Step 1|Ineligible or never received treatment|4|||
161248532|NCT01708954|582289768|FG001|Step 1|Ineligible or never received treatment|2|||
161248533|NCT01708954|582289769|FG002|Step 1|Ineligible or never received treatment|8|||
161248534|NCT01708954|582289767|FG000|Step 2|Disease progression|9|||
161248535|NCT01708954|582289768|FG001|Step 2|Disease progression|4|||
161248536|NCT01708954|582289769|FG002|Step 2|Disease progression|0|||
161248537|NCT01708954|582289767|FG000|Step 2|Adverse Event|3|||
161248538|NCT01708954|582289768|FG001|Step 2|Adverse Event|2|||
161248539|NCT01708954|582289769|FG002|Step 2|Adverse Event|0|||
161248540|NCT01708954|582289767|FG000|Step 2|Withdrawal by Subject|1|||
161248541|NCT01708954|582289768|FG001|Step 2|Withdrawal by Subject|1|||
161248542|NCT01708954|582289769|FG002|Step 2|Withdrawal by Subject|0|||
161334933|NCT03786380|582615862|FG002|Overall Study|Physician Decision|1|||
161334934|NCT03786380|582615863|FG003|Overall Study|Physician Decision|0|||
161334935|NCT03786380|582615864|FG004|Overall Study|Physician Decision|0|||
161334936|NCT03786380|582615860|FG000|Overall Study|Study Terminated by the Sponsor|30|||
161334937|NCT03786380|582615861|FG001|Overall Study|Study Terminated by the Sponsor|20|||
161334938|NCT03786380|582615862|FG002|Overall Study|Study Terminated by the Sponsor|50|||
161334939|NCT03786380|582615863|FG003|Overall Study|Study Terminated by the Sponsor|57|||
161334940|NCT03786380|582615864|FG004|Overall Study|Study Terminated by the Sponsor|23|||
161334941|NCT03786380|582615860|FG000|Overall Study|Reason Not Specified|0|||
161334942|NCT03786380|582615861|FG001|Overall Study|Reason Not Specified|0|||
161334943|NCT03786380|582615862|FG002|Overall Study|Reason Not Specified|0|||
161248543|NCT01192776|582289770|FG000|Overall Study|Death|8|||
161248544|NCT01192776|582289771|FG001|Overall Study|Death|15|||
161248545|NCT01192776|582289772|FG002|Overall Study|Death|18|||
161248546|NCT01192776|582289773|FG003|Overall Study|Death|15|||
161248547|NCT01192776|582289770|FG000|Overall Study|Lost to Follow-up|3|||
161248548|NCT01192776|582289771|FG001|Overall Study|Lost to Follow-up|6|||
161248549|NCT01192776|582289772|FG002|Overall Study|Lost to Follow-up|3|||
161248550|NCT01192776|582289773|FG003|Overall Study|Lost to Follow-up|5|||
161248551|NCT02587143|582289777|FG000|Overall Study|Adverse Event|1|||
161248552|NCT02587143|582289778|FG001|Overall Study|Adverse Event|0|||
161248553|NCT00611884|582289779|FG000|Overall Study|Adverse Event|1|||
161248554|NCT00611884|582289780|FG001|Overall Study|Adverse Event|0|||
161248555|NCT00611884|582289781|FG002|Overall Study|Adverse Event|0|||
161248556|NCT00611884|582289782|FG003|Overall Study|Adverse Event|1|||
161248557|NCT00611884|582289779|FG000|Overall Study|Non-Compliance|1|||
161248558|NCT00611884|582289780|FG001|Overall Study|Non-Compliance|4|||
161248559|NCT00611884|582289781|FG002|Overall Study|Non-Compliance|2|||
161248560|NCT00611884|582289782|FG003|Overall Study|Non-Compliance|2|||
161248561|NCT00611884|582289779|FG000|Overall Study|Lack of Efficacy|0|||
161248562|NCT00611884|582289780|FG001|Overall Study|Lack of Efficacy|1|||
161248563|NCT00611884|582289781|FG002|Overall Study|Lack of Efficacy|0|||
161248564|NCT00611884|582289782|FG003|Overall Study|Lack of Efficacy|0|||
161248565|NCT00611884|582289779|FG000|Overall Study|Unclassified|7|||
161248566|NCT00611884|582289780|FG001|Overall Study|Unclassified|4|||
161248567|NCT00611884|582289781|FG002|Overall Study|Unclassified|2|||
161248568|NCT00611884|582289782|FG003|Overall Study|Unclassified|3|||
161248569|NCT00981799|582289783|FG000|Overall Study|Adverse Event|1|||
161248570|NCT00981799|582289784|FG001|Overall Study|Adverse Event|1|||
161248571|NCT00981799|582289785|FG002|Overall Study|Adverse Event|0|||
161248572|NCT00981799|582289786|FG003|Overall Study|Adverse Event|0|||
161248573|NCT01717313|582289793|FG000|Phase A (Weeks 0 to 24)|Death|0|||
161248574|NCT01717313|582289794|FG001|Phase A (Weeks 0 to 24)|Death|1|||
161248575|NCT01717313|582289793|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
160834196|NCT00330668|580778361|FG000|QD Dosing Period|Withdrawal by Subject|1|||
160834197|NCT00330668|580778361|FG000|QD Dosing Period|Lost to Follow-up|2|||
160834198|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
160834199|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
160834200|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
160834201|NCT00499746|580778367|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
160834202|NCT04311463|580778368|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
160834203|NCT04311463|580778369|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
161248576|NCT01717313|582289794|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
161248577|NCT01717313|582289793|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
161248578|NCT01717313|582289794|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
161248579|NCT01717313|582289793|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
161248580|NCT01717313|582289794|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
161248581|NCT01717313|582289793|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
161248582|NCT01717313|582289794|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
161248583|NCT01717313|582289793|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
161248584|NCT01717313|582289794|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
161248585|NCT01717313|582289793|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
161248586|NCT01717313|582289794|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
161248587|NCT01717313|582289793|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
161248588|NCT01717313|582289794|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
161248589|NCT01717313|582289793|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
161248590|NCT01717313|582289794|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
161248591|NCT01943435|582289795|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
161248592|NCT01943435|582289796|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
161248593|NCT01943435|582289797|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
161248594|NCT01943435|582289795|FG000|Intervention Period|Withdrawal by Subject|3|||
161248595|NCT01943435|582289796|FG001|Intervention Period|Withdrawal by Subject|3|||
161248596|NCT01943435|582289797|FG002|Intervention Period|Withdrawal by Subject|4|||
161248597|NCT01943435|582289795|FG000|2 Month Follow up|Lost to Follow-up|2|||
161248598|NCT01943435|582289796|FG001|2 Month Follow up|Lost to Follow-up|3|||
161248599|NCT01943435|582289797|FG002|2 Month Follow up|Lost to Follow-up|0|||
161248600|NCT01943435|582289795|FG000|6 Month Follow up|Lost to Follow-up|12|||
161248601|NCT01943435|582289796|FG001|6 Month Follow up|Lost to Follow-up|7|||
161248602|NCT01943435|582289797|FG002|6 Month Follow up|Lost to Follow-up|15|||
161248603|NCT01617096|582289802|FG000|Overall Study|Withdrawal by Subject|96|||
161248604|NCT01617096|582289803|FG001|Overall Study|Withdrawal by Subject|81|||
161248605|NCT01617096|582289802|FG000|Overall Study|Lost to Follow-up|37|||
161248606|NCT01617096|582289803|FG001|Overall Study|Lost to Follow-up|32|||
161248607|NCT01617096|582289802|FG000|Overall Study|Physician Decision|10|||
161248608|NCT01617096|582289803|FG001|Overall Study|Physician Decision|18|||
161248609|NCT01617096|582289802|FG000|Overall Study|Death|4|||
161248610|NCT01617096|582289803|FG001|Overall Study|Death|3|||
161248611|NCT01617096|582289802|FG000|Overall Study|Other|1|||
161248612|NCT01617096|582289803|FG001|Overall Study|Other|3|||
161248613|NCT04535986|582289806|FG000|Overall Study|Death|4|||
161248614|NCT04535986|582289807|FG001|Overall Study|Death|5|||
161248615|NCT04535986|582289806|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
161248616|NCT04535986|582289807|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
161248617|NCT04535986|582289806|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
161248618|NCT04535986|582289807|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
161248619|NCT04535986|582289806|FG000|Overall Study|Adverse Event|10|||
161248620|NCT04535986|582289807|FG001|Overall Study|Adverse Event|1|||
161248621|NCT04535986|582289806|FG000|Overall Study|Lack of Efficacy|3|||
161248622|NCT04535986|582289807|FG001|Overall Study|Lack of Efficacy|2|||
161248623|NCT04535986|582289806|FG000|Overall Study|Investigator discretion|3|||
161248624|NCT04535986|582289807|FG001|Overall Study|Investigator discretion|0|||
161248625|NCT04535986|582289806|FG000|Overall Study|Withdrawal by Subject|32|||
160903724|NCT02993757|581040612|FG000|Overall Study|Lost to Follow-up|1|||
160903725|NCT02993757|581040613|FG001|Overall Study|Lost to Follow-up|0|||
161248626|NCT04535986|582289807|FG001|Overall Study|Withdrawal by Subject|14|||
161248627|NCT04535986|582289806|FG000|Overall Study|Lost to Follow-up|5|||
161248628|NCT04535986|582289807|FG001|Overall Study|Lost to Follow-up|3|||
161248629|NCT04535986|582289806|FG000|Overall Study|Other|7|||
161248630|NCT04535986|582289807|FG001|Overall Study|Other|3|||
161248631|NCT01196390|582289810|FG000|Overall Study|Protocol Violation|4|||
161248632|NCT01196390|582289811|FG001|Overall Study|Protocol Violation|5|||
161248633|NCT01532908|582289812|FG000|Overall Study|Not Transplanted|1|||
161248634|NCT01532908|582289813|FG001|Overall Study|Not Transplanted|0|||
161248635|NCT00252564|582289814|FG000|Overall Study|Adverse Event|17|||
161248636|NCT00252564|582289815|FG001|Overall Study|Adverse Event|13|||
161248637|NCT00252564|582289814|FG000|Overall Study|Unrelated Complication|2|||
161248638|NCT00252564|582289815|FG001|Overall Study|Unrelated Complication|1|||
161248639|NCT00252564|582289814|FG000|Overall Study|Disease Progression|14|||
161248640|NCT00252564|582289815|FG001|Overall Study|Disease Progression|20|||
161248641|NCT00252564|582289814|FG000|Overall Study|Death|0|||
161248642|NCT00252564|582289815|FG001|Overall Study|Death|3|||
161248643|NCT00252564|582289814|FG000|Overall Study|Physician Decision|1|||
161248644|NCT00252564|582289815|FG001|Overall Study|Physician Decision|0|||
161248645|NCT00252564|582289814|FG000|Overall Study|Lost to Follow-up|1|||
161248646|NCT00252564|582289815|FG001|Overall Study|Lost to Follow-up|0|||
161248647|NCT00252564|582289814|FG000|Overall Study|Patient Request|4|||
161248648|NCT00252564|582289815|FG001|Overall Study|Patient Request|5|||
161248649|NCT00252564|582289814|FG000|Overall Study|Withdrawal by Subject|0|||
161248650|NCT00252564|582289815|FG001|Overall Study|Withdrawal by Subject|2|||
161248651|NCT01632306|582289816|FG000|Overall Study|Protocol Violation|1|||
161248652|NCT01632306|582289817|FG001|Overall Study|Protocol Violation|0|||
161248653|NCT01632306|582289818|FG002|Overall Study|Protocol Violation|0|||
161248654|NCT02179190|582289823|FG000|Enrollment|Exit Prior to Device Attempt|11|||
161248655|NCT02179190|582289823|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
161248656|NCT02179190|582289823|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
161248657|NCT02179190|582289823|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
161248658|NCT02179190|582289823|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
161248659|NCT02179190|582289823|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
161248660|NCT00881569|582289824|FG000|Overall Study|Disease progression|1|||
161248661|NCT00881569|582289825|FG001|Overall Study|Disease progression|1|||
161248662|NCT03480022|582289826|FG000|Overall Study|Pregnancy|2|||
161248663|NCT03480022|582289827|FG001|Overall Study|Pregnancy|0|||
161248664|NCT03480022|582289826|FG000|Overall Study|Adverse Event|6|||
161248665|NCT03480022|582289827|FG001|Overall Study|Adverse Event|0|||
161248666|NCT03480022|582289826|FG000|Overall Study|Lack of Efficacy|0|||
161248667|NCT03480022|582289827|FG001|Overall Study|Lack of Efficacy|2|||
161248668|NCT03480022|582289826|FG000|Overall Study|Physician Decision|0|||
160834204|NCT04311463|580778368|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
160834205|NCT04311463|580778369|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
160834206|NCT04311463|580778368|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
160834207|NCT04311463|580778369|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
160834208|NCT00737633|580778376|FG000|Overall Study|Study terminated by sponsor|44|||
160834209|NCT00737633|580778377|FG001|Overall Study|Study terminated by sponsor|55|||
160834210|NCT00737633|580778376|FG000|Overall Study|Lost to Follow-up|0|||
160834211|NCT00737633|580778377|FG001|Overall Study|Lost to Follow-up|1|||
160834212|NCT00737633|580778376|FG000|Overall Study|protocol non-compliance|0|||
160834213|NCT00737633|580778377|FG001|Overall Study|protocol non-compliance|1|||
160834214|NCT03480009|580778381|FG000|Overall Study|Lost to Follow-up|4|||
160834215|NCT03480009|580778382|FG001|Overall Study|Lost to Follow-up|5|||
160834216|NCT03480009|580778383|FG002|Overall Study|Lost to Follow-up|4|||
160834217|NCT03480009|580778384|FG003|Overall Study|Lost to Follow-up|0|||
160834218|NCT02014584|580778385|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834219|NCT02014584|580778386|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
160834220|NCT02014584|580778387|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834221|NCT02014584|580778388|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834222|NCT02014584|580778389|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160903726|NCT02993757|581040612|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
160834223|NCT02014584|580778390|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
160834224|NCT02014584|580778385|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
160834225|NCT02014584|580778386|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
160834226|NCT02014584|580778387|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160834227|NCT02014584|580778388|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161248669|NCT03480022|582289827|FG001|Overall Study|Physician Decision|1|||
161248670|NCT03480022|582289826|FG000|Overall Study|Withdrawal by Subject|2|||
161248671|NCT03480022|582289827|FG001|Overall Study|Withdrawal by Subject|0|||
161248672|NCT03480022|582289826|FG000|Overall Study|Medication concerns|1|||
161248673|NCT03480022|582289827|FG001|Overall Study|Medication concerns|0|||
161248674|NCT03480022|582289826|FG000|Overall Study|Family member COVID exposure|0|||
161248675|NCT03480022|582289827|FG001|Overall Study|Family member COVID exposure|1|||
161248676|NCT02623218|582289828|FG000|Overall Study|Lost to Follow-up|0|||
161248677|NCT02623218|582289829|FG001|Overall Study|Lost to Follow-up|1|||
161248678|NCT02623218|582289830|FG002|Overall Study|Lost to Follow-up|0|||
161248679|NCT02623218|582289831|FG003|Overall Study|Lost to Follow-up|0|||
161248680|NCT02623218|582289832|FG004|Overall Study|Lost to Follow-up|0|||
161248681|NCT00537095|582289837|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
161248682|NCT00537095|582289838|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
161248683|NCT00537095|582289837|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
161248684|NCT00537095|582289838|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
161248685|NCT00537095|582289837|FG000|Randomized Treatment Period (433 Days)|Death|3|||
161248686|NCT00537095|582289838|FG001|Randomized Treatment Period (433 Days)|Death|1|||
161248687|NCT00537095|582289837|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
161248688|NCT00537095|582289838|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
161248689|NCT00537095|582289837|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
161248690|NCT00537095|582289838|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
161248691|NCT00537095|582289837|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
161248692|NCT00537095|582289838|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
161248693|NCT00537095|582289837|FG000|Open-label Period (590 Days)|Adverse Event|2|||
161248694|NCT00537095|582289838|FG001|Open-label Period (590 Days)|Adverse Event|11|||
161248695|NCT00537095|582289837|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
161248696|NCT00537095|582289838|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
161248697|NCT00537095|582289837|FG000|Open-label Period (590 Days)|Death|2|||
161248698|NCT00537095|582289838|FG001|Open-label Period (590 Days)|Death|2|||
161248699|NCT00537095|582289837|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
161248700|NCT00537095|582289838|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
161248701|NCT00537095|582289837|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
161248702|NCT00537095|582289838|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
161248703|NCT01970592|582289839|FG000|Overall Study|Withdrawal by Subject|4|||
161248704|NCT01970592|582289839|FG000|Overall Study|Physician Decision|1|||
161248705|NCT01970592|582289839|FG000|Overall Study|Adverse Event|1|||
161248706|NCT01320722|582289842|FG000|Overall Study|Did not Receive Intervention|3|||
161248707|NCT01320722|582289843|FG001|Overall Study|Did not Receive Intervention|2|||
161248708|NCT01320722|582289844|FG002|Overall Study|Did not Receive Intervention|1|||
161248709|NCT01320722|582289845|FG003|Overall Study|Did not Receive Intervention|1|||
161248710|NCT01320722|582289846|FG004|Overall Study|Did not Receive Intervention|2|||
161248711|NCT01320722|582289842|FG000|Overall Study|Lost to Follow-up|0|||
161248712|NCT01320722|582289843|FG001|Overall Study|Lost to Follow-up|1|||
161248713|NCT01320722|582289844|FG002|Overall Study|Lost to Follow-up|0|||
161248714|NCT01320722|582289845|FG003|Overall Study|Lost to Follow-up|1|||
161248715|NCT01320722|582289846|FG004|Overall Study|Lost to Follow-up|3|||
161248716|NCT01320722|582289842|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
161248717|NCT01320722|582289843|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
161248718|NCT01320722|582289844|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
161248719|NCT01320722|582289845|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
161248720|NCT01320722|582289846|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
161248721|NCT01320722|582289842|FG000|Overall Study|Participant Developed a Rash|0|||
161248722|NCT01320722|582289843|FG001|Overall Study|Participant Developed a Rash|0|||
161248723|NCT01320722|582289844|FG002|Overall Study|Participant Developed a Rash|2|||
161248724|NCT01320722|582289845|FG003|Overall Study|Participant Developed a Rash|1|||
161248725|NCT01320722|582289846|FG004|Overall Study|Participant Developed a Rash|1|||
161248726|NCT01320722|582289842|FG000|Overall Study|Non-compliant with Medication|0|||
161248727|NCT01320722|582289843|FG001|Overall Study|Non-compliant with Medication|0|||
161248728|NCT01320722|582289844|FG002|Overall Study|Non-compliant with Medication|1|||
161248729|NCT01320722|582289845|FG003|Overall Study|Non-compliant with Medication|0|||
161248730|NCT01320722|582289846|FG004|Overall Study|Non-compliant with Medication|0|||
161248731|NCT01320722|582289842|FG000|Overall Study|Adverse Event|0|||
161248732|NCT01320722|582289843|FG001|Overall Study|Adverse Event|0|||
161248733|NCT01320722|582289844|FG002|Overall Study|Adverse Event|3|||
161248734|NCT01320722|582289845|FG003|Overall Study|Adverse Event|6|||
161248735|NCT01320722|582289846|FG004|Overall Study|Adverse Event|0|||
161248736|NCT01320722|582289842|FG000|Overall Study|Not Compliant with Study Procedures|0|||
161248737|NCT01320722|582289843|FG001|Overall Study|Not Compliant with Study Procedures|0|||
161248738|NCT01320722|582289844|FG002|Overall Study|Not Compliant with Study Procedures|0|||
161248739|NCT01320722|582289845|FG003|Overall Study|Not Compliant with Study Procedures|4|||
161248740|NCT01320722|582289846|FG004|Overall Study|Not Compliant with Study Procedures|0|||
161248741|NCT01320722|582289842|FG000|Overall Study|Pregnancy|0|||
161248742|NCT01320722|582289843|FG001|Overall Study|Pregnancy|0|||
161248743|NCT01320722|582289844|FG002|Overall Study|Pregnancy|0|||
161334944|NCT03786380|582615863|FG003|Overall Study|Reason Not Specified|0|||
161334945|NCT03786380|582615864|FG004|Overall Study|Reason Not Specified|1|||
161248744|NCT01320722|582289845|FG003|Overall Study|Pregnancy|1|||
161248745|NCT01320722|582289846|FG004|Overall Study|Pregnancy|0|||
161248746|NCT01320722|582289842|FG000|Overall Study|Started an Exclusionary Medication|0|||
161248747|NCT01320722|582289843|FG001|Overall Study|Started an Exclusionary Medication|0|||
161248748|NCT01320722|582289844|FG002|Overall Study|Started an Exclusionary Medication|0|||
161248749|NCT01320722|582289845|FG003|Overall Study|Started an Exclusionary Medication|0|||
161248750|NCT01320722|582289846|FG004|Overall Study|Started an Exclusionary Medication|1|||
161248751|NCT01320722|582289842|FG000|Overall Study|Withdrew due to Health Condition|0|||
161248752|NCT01320722|582289843|FG001|Overall Study|Withdrew due to Health Condition|0|||
161248753|NCT01320722|582289844|FG002|Overall Study|Withdrew due to Health Condition|0|||
161248754|NCT01320722|582289845|FG003|Overall Study|Withdrew due to Health Condition|0|||
161248755|NCT01320722|582289846|FG004|Overall Study|Withdrew due to Health Condition|1|||
161248756|NCT03980522|582289847|FG000|Treatment Period|Adverse Event|1|||
161248757|NCT03980522|582289848|FG001|Treatment Period|Adverse Event|0|||
161248758|NCT03980522|582289849|FG002|Treatment Period|Adverse Event|0|||
161248759|NCT03980522|582289850|FG003|Treatment Period|Adverse Event|0|||
161248760|NCT03980522|582289851|FG004|Treatment Period|Adverse Event|0|||
161248761|NCT01091363|582289852|FG000|Overall Study|Withdrawal by Subject|11|||
161248762|NCT01091363|582289853|FG001|Overall Study|Withdrawal by Subject|15|||
161248763|NCT01091363|582289852|FG000|Overall Study|Lost to Follow-up|2|||
161248764|NCT01091363|582289853|FG001|Overall Study|Lost to Follow-up|2|||
161248765|NCT00160524|582289854|FG000|Overall Study|Adverse Event|119|||
161248766|NCT00160524|582289854|FG000|Overall Study|Adverse Event and Other|94|||
161248767|NCT00160524|582289854|FG000|Overall Study|Protocol Violation|16|||
161248768|NCT00160524|582289854|FG000|Overall Study|Protocol Violation and Other|2|||
161248769|NCT00160524|582289854|FG000|Overall Study|Withdrawal by Subject|141|||
161248770|NCT00160524|582289854|FG000|Overall Study|Withdrawal by Subject and Other|17|||
161248771|NCT00160524|582289854|FG000|Overall Study|Physician Decision|27|||
161248772|NCT00160524|582289854|FG000|Overall Study|Physician Decision and Other|6|||
161248773|NCT00160524|582289854|FG000|Overall Study|Lost to Follow-up|13|||
161248774|NCT00160524|582289854|FG000|Overall Study|Lost to Follow-up and Other|1|||
161248775|NCT00160524|582289854|FG000|Overall Study|Lack of Efficacy|21|||
161248776|NCT00160524|582289854|FG000|Overall Study|Lack of Efficacy and Other|1|||
161248777|NCT00160524|582289854|FG000|Overall Study|Other|20|||
161248778|NCT04892147|582289855|FG000|Overall Study|Withdrawal by Subject|2|||
161248779|NCT04892147|582289856|FG001|Overall Study|Withdrawal by Subject|0|||
161248780|NCT01215721|582289858|FG000|Overall Study|Adverse Event|2|||
161248781|NCT00045162|582289859|FG000|Overall Study|Ineligible|12|||
161248782|NCT00045162|582289860|FG001|Overall Study|Ineligible|8|||
161248783|NCT00045162|582289859|FG000|Overall Study|Not treated|7|||
161248784|NCT00045162|582289860|FG001|Overall Study|Not treated|2|||
161248785|NCT00045162|582289859|FG000|Overall Study|Adverse Event|55|||
161248786|NCT00045162|582289860|FG001|Overall Study|Adverse Event|50|||
161248787|NCT00045162|582289859|FG000|Overall Study|Lack of Efficacy|32|||
161248788|NCT00045162|582289860|FG001|Overall Study|Lack of Efficacy|29|||
161248789|NCT00045162|582289859|FG000|Overall Study|Death|10|||
161248790|NCT00045162|582289860|FG001|Overall Study|Death|10|||
161248791|NCT00045162|582289859|FG000|Overall Study|Withdrawal by Subject|5|||
161248792|NCT00045162|582289860|FG001|Overall Study|Withdrawal by Subject|3|||
161248793|NCT00045162|582289859|FG000|Overall Study|Other|21|||
161248794|NCT00045162|582289860|FG001|Overall Study|Other|16|||
161248795|NCT01044433|582289861|FG000|Overall Study|Lost to Follow-up|3|||
161248796|NCT01044433|582289861|FG000|Overall Study|Withdrawal by Subject|3|||
161248797|NCT00826241|582289862|FG000|Overall Study|Withdrawal from Follow-up|1|||
161248798|NCT00826241|582289862|FG000|Overall Study|Withdrew consent|2|||
161248799|NCT00826241|582289862|FG000|Overall Study|Death|4|||
161248800|NCT00826241|582289862|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
161248801|NCT00826241|582289862|FG000|Overall Study|Non-compliance|1|||
161248802|NCT00826241|582289862|FG000|Overall Study|Progression of disease|1|||
161248803|NCT00826241|582289862|FG000|Overall Study|Patient refused follow-up|3|||
161248804|NCT00826241|582289862|FG000|Overall Study|Lost to Follow-up|9|||
161248805|NCT00826241|582289862|FG000|Overall Study|Could not obtain records|1|||
161248806|NCT00826241|582289862|FG000|Overall Study|Screen failure|2|||
161248807|NCT00826241|582289862|FG000|Overall Study|Pt unable to proceed to registration|1|||
161248808|NCT00826241|582289862|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
161248809|NCT00556673|582289864|FG000|Overall Study|Protocol deviation|3|||
161248810|NCT00556673|582289865|FG001|Overall Study|Protocol deviation|2|||
161248811|NCT01971554|582289866|FG000|Overall Study|Lost to Follow-up|1|||
161248812|NCT01971554|582289867|FG001|Overall Study|Lost to Follow-up|0|||
161248813|NCT01971554|582289868|FG002|Overall Study|Lost to Follow-up|0|||
161248814|NCT01971554|582289869|FG003|Overall Study|Lost to Follow-up|0|||
161248815|NCT00087529|582289871|FG000|Overall Study|Death|1|||
161248816|NCT00087529|582289872|FG001|Overall Study|Death|0|||
161248817|NCT00087529|582289871|FG000|Overall Study|Adverse Event|0|||
161248818|NCT00087529|582289872|FG001|Overall Study|Adverse Event|8|||
161248819|NCT00087529|582289871|FG000|Overall Study|Pregnancy|0|||
161248820|NCT00087529|582289872|FG001|Overall Study|Pregnancy|1|||
161248821|NCT00087529|582289871|FG000|Overall Study|Lost to Follow-up|2|||
161248822|NCT00087529|582289872|FG001|Overall Study|Lost to Follow-up|3|||
161248823|NCT00087529|582289871|FG000|Overall Study|Participant Decision|14|||
160834228|NCT02014584|580778389|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160834229|NCT02014584|580778390|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
160834230|NCT02014584|580778385|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834231|NCT02014584|580778386|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834232|NCT02014584|580778387|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
160834233|NCT02014584|580778388|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834234|NCT02014584|580778389|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834235|NCT02014584|580778390|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
160834236|NCT02014584|580778385|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834237|NCT02014584|580778386|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834238|NCT02014584|580778387|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
160834239|NCT02014584|580778388|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
160834240|NCT02014584|580778389|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834241|NCT02014584|580778390|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
160834242|NCT02014584|580778385|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834243|NCT02014584|580778386|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834244|NCT02014584|580778387|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834245|NCT02014584|580778388|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834246|NCT02014584|580778389|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
160834247|NCT02014584|580778390|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
160834248|NCT00483002|580778391|FG000|Overall Study|Adverse Event|68|||
160834249|NCT00483002|580778391|FG000|Overall Study|Lack of Efficacy|555|||
160834250|NCT00483002|580778391|FG000|Overall Study|Lost to Follow-up|962|||
160834251|NCT00483002|580778391|FG000|Overall Study|Other|2|||
160834252|NCT00483002|580778391|FG000|Overall Study|Other|967|||
160834253|NCT01274429|580778396|FG000|Overall Study|Study closed do to lack of funding|5|||
160834254|NCT01439373|580778397|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
160834255|NCT01439373|580778398|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
160834256|NCT01439373|580778397|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
160834257|NCT01439373|580778398|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
160991274|NCT01959880|581355570|FG003|Overall Study|Study completed early-FDA approved|152|||
160991275|NCT01537133|581357724|FG000|Overall Study|Withdrawal by Subject|2|||
160991276|NCT01537133|581357725|FG001|Overall Study|Withdrawal by Subject|0|||
160991277|NCT01537133|581357726|FG002|Overall Study|Withdrawal by Subject|0|||
160991278|NCT01537133|581357727|FG003|Overall Study|Withdrawal by Subject|0|||
160991279|NCT01537133|581357724|FG000|Overall Study|Lost to Follow-up|1|||
161137769|NCT02305563|581885695|FG001|Treatment Period|Participant withdrew consent|0|||
161137770|NCT02305563|581885696|FG002|Treatment Period|Participant withdrew consent|1|||
161137771|NCT02305563|581885697|FG003|Treatment Period|Participant withdrew consent|1|||
161137772|NCT02305563|581885698|FG004|Treatment Period|Participant withdrew consent|1|||
161137773|NCT02305563|581885694|FG000|Treatment Period|Maximum clinical benefit|0|||
161137774|NCT02305563|581885695|FG001|Treatment Period|Maximum clinical benefit|0|||
161137775|NCT02305563|581885696|FG002|Treatment Period|Maximum clinical benefit|0|||
161137776|NCT02305563|581885697|FG003|Treatment Period|Maximum clinical benefit|0|||
161137777|NCT02305563|581885698|FG004|Treatment Period|Maximum clinical benefit|1|||
161137778|NCT02305563|581885694|FG000|Treatment Period|Poor/non-compliance|0|||
161137779|NCT02305563|581885695|FG001|Treatment Period|Poor/non-compliance|0|||
161137780|NCT02305563|581885696|FG002|Treatment Period|Poor/non-compliance|0|||
161137781|NCT02305563|581885697|FG003|Treatment Period|Poor/non-compliance|0|||
161137782|NCT02305563|581885698|FG004|Treatment Period|Poor/non-compliance|1|||
161137783|NCT02305563|581885694|FG000|Treatment Period|Administrative reason by Sponsor|0|||
161137784|NCT02305563|581885695|FG001|Treatment Period|Administrative reason by Sponsor|0|||
161137785|NCT02305563|581885696|FG002|Treatment Period|Administrative reason by Sponsor|0|||
161137786|NCT02305563|581885697|FG003|Treatment Period|Administrative reason by Sponsor|0|||
161137787|NCT02305563|581885698|FG004|Treatment Period|Administrative reason by Sponsor|1|||
161137788|NCT02305563|581885694|FG000|Treatment Period|other reason|2|||
161137789|NCT02305563|581885695|FG001|Treatment Period|other reason|0|||
161137790|NCT02305563|581885696|FG002|Treatment Period|other reason|2|||
161137791|NCT02305563|581885697|FG003|Treatment Period|other reason|2|||
161137792|NCT02305563|581885698|FG004|Treatment Period|other reason|1|||
161137793|NCT02305563|581885694|FG000|Treatment Period|Randomized but not treated|0|||
161137794|NCT02305563|581885695|FG001|Treatment Period|Randomized but not treated|0|||
161137795|NCT02305563|581885696|FG002|Treatment Period|Randomized but not treated|0|||
161137796|NCT02305563|581885697|FG003|Treatment Period|Randomized but not treated|0|||
161137797|NCT02305563|581885698|FG004|Treatment Period|Randomized but not treated|2|||
161137798|NCT02305563|581885694|FG000|Treatment Period|added ULO, then disease progression|0|||
161137799|NCT02305563|581885695|FG001|Treatment Period|added ULO, then disease progression|0|||
161137800|NCT02305563|581885696|FG002|Treatment Period|added ULO, then disease progression|0|||
161137801|NCT02305563|581885697|FG003|Treatment Period|added ULO, then disease progression|0|||
161248824|NCT00087529|582289872|FG001|Overall Study|Participant Decision|37|||
161248825|NCT00087529|582289871|FG000|Overall Study|Physician Decision|4|||
160834258|NCT04576897|580778401|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
160834259|NCT02593318|580778404|FG000|Overall Study|Withdrawal by Subject|1|||
160834260|NCT02593318|580778405|FG001|Overall Study|Withdrawal by Subject|1|||
160834261|NCT00448747|580780050|FG000|Overall Study|collapsed veins|1|||
160834262|NCT00448747|580780051|FG001|Overall Study|collapsed veins|0|||
160834263|NCT00387725|580780052|FG000|Overall Study|Adverse Event|0|||
160834264|NCT00387725|580780053|FG001|Overall Study|Adverse Event|0|||
160834265|NCT00387725|580780054|FG002|Overall Study|Adverse Event|0|||
160834266|NCT00387725|580780055|FG003|Overall Study|Adverse Event|1|||
160834267|NCT00387725|580780052|FG000|Overall Study|Protocol Violation|0|||
160834268|NCT00387725|580780053|FG001|Overall Study|Protocol Violation|1|||
160834269|NCT00387725|580780054|FG002|Overall Study|Protocol Violation|0|||
160834270|NCT00387725|580780055|FG003|Overall Study|Protocol Violation|0|||
160834271|NCT00387725|580780052|FG000|Overall Study|Withdrawal by Subject|1|||
160834272|NCT00387725|580780053|FG001|Overall Study|Withdrawal by Subject|0|||
160834273|NCT00387725|580780054|FG002|Overall Study|Withdrawal by Subject|1|||
160834274|NCT00387725|580780055|FG003|Overall Study|Withdrawal by Subject|0|||
160834275|NCT00387725|580780052|FG000|Overall Study|Parent/legal guardian request|0|||
160834276|NCT00387725|580780053|FG001|Overall Study|Parent/legal guardian request|0|||
160834277|NCT00387725|580780054|FG002|Overall Study|Parent/legal guardian request|1|||
160834278|NCT00387725|580780055|FG003|Overall Study|Parent/legal guardian request|1|||
161248826|NCT00087529|582289872|FG001|Overall Study|Physician Decision|8|||
161248827|NCT00087529|582289871|FG000|Overall Study|Initiation of Excluded Therapy|0|||
161248828|NCT00087529|582289872|FG001|Overall Study|Initiation of Excluded Therapy|1|||
161248829|NCT00087529|582289871|FG000|Overall Study|Participant Noncompliance|0|||
160834279|NCT00568126|580780056|FG000|Overall Study|Adverse Event|3|||
160834280|NCT00568126|580780057|FG001|Overall Study|Adverse Event|0|||
160834281|NCT00568126|580780056|FG000|Overall Study|Withdrawal by Subject|2|||
160834282|NCT00568126|580780057|FG001|Overall Study|Withdrawal by Subject|3|||
160834283|NCT00568126|580780056|FG000|Overall Study|Lost to Follow-up|4|||
160834284|NCT00568126|580780057|FG001|Overall Study|Lost to Follow-up|3|||
160834285|NCT00568126|580780056|FG000|Overall Study|Lack of Efficacy|0|||
160834286|NCT00568126|580780057|FG001|Overall Study|Lack of Efficacy|1|||
160834287|NCT00568126|580780056|FG000|Overall Study|Physician Decision|2|||
160834288|NCT00568126|580780057|FG001|Overall Study|Physician Decision|2|||
160834289|NCT00527982|580780059|FG000|Overall Study|Physician Decision|1|||
160834290|NCT00527982|580780060|FG001|Overall Study|Physician Decision|0|||
160834291|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
160834292|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
160834293|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
160834294|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
160834295|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
160834296|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
160834297|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
160834298|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
160834299|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
160834300|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
161248830|NCT00087529|582289872|FG001|Overall Study|Participant Noncompliance|1|||
160834301|NCT02429791|580780066|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
160834302|NCT02429791|580780067|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
160903727|NCT02993757|581040613|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
161248831|NCT00087529|582289871|FG000|Overall Study|Disease Progression|5|||
161248832|NCT00087529|582289872|FG001|Overall Study|Disease Progression|4|||
161248833|NCT00087529|582289871|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
161248834|NCT00087529|582289872|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
161248835|NCT02535923|582289873|FG000|Overall Study|Lost to Follow-up|5|||
161248836|NCT02535923|582289874|FG001|Overall Study|Lost to Follow-up|5|||
161248837|NCT02535923|582289873|FG000|Overall Study|Withdrawal by Subject|4|||
161248838|NCT02535923|582289874|FG001|Overall Study|Withdrawal by Subject|3|||
160903728|NCT00087607|581040623|FG000|Overall Study|Adverse Event|14|||
160903729|NCT00087607|581040624|FG001|Overall Study|Adverse Event|24|||
160903730|NCT00087607|581040623|FG000|Overall Study|Death|0|||
161248839|NCT04388787|582289875|FG000|Blinded Period|Patient could not follow instructions|1|||
161248840|NCT04388787|582289875|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
160834303|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
160834304|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
160834305|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
160834306|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
160903731|NCT00087607|581040624|FG001|Overall Study|Death|1|||
161248841|NCT01350934|582291611|FG000|Base Study|Adverse Event|6|||
160834307|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
160834308|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
160903732|NCT00087607|581040623|FG000|Overall Study|Insufficient Therapeutic Response|53|||
160834309|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
160834310|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
160834311|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
160834312|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
160834313|NCT02429791|580780066|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
160834314|NCT02429791|580780067|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
160834315|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
160991280|NCT01537133|581357725|FG001|Overall Study|Lost to Follow-up|0|||
160991281|NCT01537133|581357726|FG002|Overall Study|Lost to Follow-up|0|||
160991282|NCT01537133|581357727|FG003|Overall Study|Lost to Follow-up|0|||
160991283|NCT03837028|581357728|FG000|Overall Study|Lost to Follow-up|4|||
160991284|NCT03837028|581357729|FG001|Overall Study|Lost to Follow-up|0|||
160991285|NCT03837028|581357730|FG002|Overall Study|Lost to Follow-up|2|||
160991286|NCT03837028|581357731|FG003|Overall Study|Lost to Follow-up|0|||
160991287|NCT03837028|581357728|FG000|Overall Study|Withdrawal by Subject|12|||
160991288|NCT03837028|581357729|FG001|Overall Study|Withdrawal by Subject|11|||
160991289|NCT03837028|581357730|FG002|Overall Study|Withdrawal by Subject|11|||
160991290|NCT03837028|581357731|FG003|Overall Study|Withdrawal by Subject|7|||
160991291|NCT00157014|581357732|FG000|Overall Study|Death|4|||
160991292|NCT00157014|581357733|FG001|Overall Study|Death|2|||
161137802|NCT02305563|581885698|FG004|Treatment Period|added ULO, then disease progression|4|||
161137803|NCT02305563|581885694|FG000|Treatment Period|added ULO; then other reason|0|||
161137804|NCT02305563|581885695|FG001|Treatment Period|added ULO; then other reason|0|||
160834316|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
160834317|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
160834318|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
160834319|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
160991293|NCT00157014|581357734|FG002|Overall Study|Death|1|||
160991294|NCT00157014|581357735|FG003|Overall Study|Death|1|||
160991295|NCT00157014|581357732|FG000|Overall Study|Physician Decision|0|||
161137805|NCT02305563|581885696|FG002|Treatment Period|added ULO; then other reason|0|||
161137806|NCT02305563|581885697|FG003|Treatment Period|added ULO; then other reason|0|||
161137807|NCT02305563|581885698|FG004|Treatment Period|added ULO; then other reason|1|||
161137808|NCT02305563|581885694|FG000|Treatment Period|added ULO, then request to stop|0|||
161137809|NCT02305563|581885695|FG001|Treatment Period|added ULO, then request to stop|0|||
161137810|NCT02305563|581885696|FG002|Treatment Period|added ULO, then request to stop|0|||
161137811|NCT02305563|581885697|FG003|Treatment Period|added ULO, then request to stop|0|||
161137812|NCT02305563|581885698|FG004|Treatment Period|added ULO, then request to stop|1|||
161137813|NCT02305563|581885694|FG000|Follow-up Period|Death|0|||
161137814|NCT02305563|581885695|FG001|Follow-up Period|Death|0|||
161137815|NCT02305563|581885696|FG002|Follow-up Period|Death|5|||
161137816|NCT02305563|581885697|FG003|Follow-up Period|Death|4|||
161137817|NCT02305563|581885698|FG004|Follow-up Period|Death|7|||
161137818|NCT02305563|581885694|FG000|Follow-up Period|Participant withdrew consent|0|||
161137819|NCT02305563|581885695|FG001|Follow-up Period|Participant withdrew consent|0|||
161137820|NCT02305563|581885696|FG002|Follow-up Period|Participant withdrew consent|2|||
161137821|NCT02305563|581885697|FG003|Follow-up Period|Participant withdrew consent|1|||
161137822|NCT02305563|581885698|FG004|Follow-up Period|Participant withdrew consent|0|||
161137823|NCT02305563|581885694|FG000|Follow-up Period|other reason|0|||
161137824|NCT02305563|581885695|FG001|Follow-up Period|other reason|0|||
161137825|NCT02305563|581885696|FG002|Follow-up Period|other reason|0|||
161137826|NCT02305563|581885697|FG003|Follow-up Period|other reason|0|||
161137827|NCT02305563|581885698|FG004|Follow-up Period|other reason|1|||
161137828|NCT02305563|581885694|FG000|Follow-up Period|Followup no longer required per protocol|3|||
161137829|NCT02305563|581885695|FG001|Follow-up Period|Followup no longer required per protocol|3|||
161137830|NCT02305563|581885696|FG002|Follow-up Period|Followup no longer required per protocol|4|||
161137831|NCT02305563|581885697|FG003|Follow-up Period|Followup no longer required per protocol|1|||
161137832|NCT02305563|581885698|FG004|Follow-up Period|Followup no longer required per protocol|4|||
161137833|NCT01275222|581885705|FG000|Phase l by Treatment|Adverse Event|1|||
161137834|NCT01275222|581885706|FG001|Phase l by Treatment|Adverse Event|4|||
161137835|NCT01275222|581885707|FG002|Phase l by Treatment|Adverse Event|2|||
161137836|NCT01275222|581885708|FG003|Phase l by Treatment|Adverse Event|3|||
161137837|NCT01275222|581885709|FG004|Phase l by Treatment|Adverse Event|0|||
161137838|NCT01275222|581885710|FG005|Phase l by Treatment|Adverse Event|0|||
161137839|NCT01275222|581885705|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161137840|NCT01275222|581885706|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161137841|NCT01275222|581885707|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
161137842|NCT01275222|581885708|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161137843|NCT01275222|581885709|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161137844|NCT01275222|581885710|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
161137845|NCT01275222|581885705|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161137846|NCT01275222|581885706|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161137847|NCT01275222|581885707|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160834320|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
160834321|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
160834322|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
160834323|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
160834324|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
160834325|NCT02429791|580780066|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
160834326|NCT02429791|580780067|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
160834327|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
160834328|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
160834329|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
160834330|NCT02615691|580780068|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
160834331|NCT04201093|580780069|FG000|Overall Study|Adverse Event|6|||
160834332|NCT04201093|580780070|FG001|Overall Study|Adverse Event|29|||
160834333|NCT04201093|580780071|FG002|Overall Study|Adverse Event|35|||
160834334|NCT04201093|580780069|FG000|Overall Study|Death|2|||
161248842|NCT01350934|582291612|FG001|Base Study|Adverse Event|0|||
161248843|NCT01350934|582291611|FG000|Base Study|Lost to Follow-up|1|||
161248844|NCT01350934|582291612|FG001|Base Study|Lost to Follow-up|0|||
161248845|NCT01350934|582291611|FG000|Base Study|Protocol Violation|1|||
161248846|NCT01350934|582291612|FG001|Base Study|Protocol Violation|1|||
161248847|NCT01350934|582291611|FG000|Base Study|Withdrawal by Subject|1|||
161248848|NCT01350934|582291612|FG001|Base Study|Withdrawal by Subject|2|||
161248849|NCT01350934|582291611|FG000|Base Study|Non-Compliance With Study Drug|2|||
161248850|NCT01350934|582291612|FG001|Base Study|Non-Compliance With Study Drug|0|||
160834335|NCT04201093|580780070|FG001|Overall Study|Death|1|||
160834336|NCT04201093|580780071|FG002|Overall Study|Death|0|||
160834337|NCT04201093|580780069|FG000|Overall Study|Lack of Efficacy|5|||
160834338|NCT04201093|580780070|FG001|Overall Study|Lack of Efficacy|1|||
160834339|NCT04201093|580780071|FG002|Overall Study|Lack of Efficacy|2|||
160834340|NCT04201093|580780069|FG000|Overall Study|Lost to Follow-up|0|||
160834341|NCT04201093|580780070|FG001|Overall Study|Lost to Follow-up|0|||
160834342|NCT04201093|580780071|FG002|Overall Study|Lost to Follow-up|1|||
160834343|NCT04201093|580780069|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
160834344|NCT04201093|580780070|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
160834345|NCT04201093|580780071|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
160834346|NCT04201093|580780069|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
160834347|NCT04201093|580780070|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
160834348|NCT04201093|580780071|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
160834349|NCT04201093|580780069|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
160834350|NCT04201093|580780070|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
160834351|NCT04201093|580780071|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
160834352|NCT04201093|580780069|FG000|Overall Study|Physician Decision|1|||
160834353|NCT04201093|580780070|FG001|Overall Study|Physician Decision|0|||
160834354|NCT04201093|580780071|FG002|Overall Study|Physician Decision|0|||
160834355|NCT04201093|580780069|FG000|Overall Study|Protocol Deviation|1|||
161248851|NCT01350934|582291611|FG000|Extension Study|Adverse Event|2|||
161248852|NCT01350934|582291612|FG001|Extension Study|Adverse Event|1|||
161248853|NCT01350934|582291611|FG000|Extension Study|Lost to Follow-up|2|||
161248854|NCT01350934|582291612|FG001|Extension Study|Lost to Follow-up|0|||
161248855|NCT01350934|582291611|FG000|Extension Study|Protocol Violation|1|||
161248856|NCT01350934|582291612|FG001|Extension Study|Protocol Violation|1|||
161248857|NCT01350934|582291611|FG000|Extension Study|Lack of Efficacy|0|||
161248858|NCT01350934|582291612|FG001|Extension Study|Lack of Efficacy|1|||
161248859|NCT01350934|582291611|FG000|Extension Study|Withdrawal by Subject|0|||
161248860|NCT01350934|582291612|FG001|Extension Study|Withdrawal by Subject|1|||
161248861|NCT02415387|582291613|FG000|Overall Study|Withdrawal by Subject|6|||
161248862|NCT02415387|582291614|FG001|Overall Study|Withdrawal by Subject|1|||
161248863|NCT02415387|582291613|FG000|Overall Study|blood draw problem|0|||
161248864|NCT02415387|582291614|FG001|Overall Study|blood draw problem|1|||
161248865|NCT02415387|582291613|FG000|Overall Study|Protocol Violation|1|||
161248866|NCT02415387|582291614|FG001|Overall Study|Protocol Violation|0|||
161248867|NCT01151280|582291615|FG000|Overall Study|Adverse Event|1|||
161248868|NCT01151280|582291615|FG000|Overall Study|Lack of Efficacy|3|||
160834356|NCT04201093|580780070|FG001|Overall Study|Protocol Deviation|0|||
160834357|NCT04201093|580780071|FG002|Overall Study|Protocol Deviation|0|||
160834358|NCT04201093|580780069|FG000|Overall Study|Site Terminated by Sponsor|5|||
160834359|NCT04201093|580780070|FG001|Overall Study|Site Terminated by Sponsor|3|||
160834360|NCT04201093|580780071|FG002|Overall Study|Site Terminated by Sponsor|1|||
160834361|NCT04201093|580780069|FG000|Overall Study|Withdrawal by Subject|7|||
160834362|NCT04201093|580780070|FG001|Overall Study|Withdrawal by Subject|8|||
161248869|NCT02473393|582291617|FG000|Overall Study|Adverse Event|0|||
161248870|NCT02473393|582291618|FG001|Overall Study|Adverse Event|0|||
161248871|NCT02473393|582291619|FG002|Overall Study|Adverse Event|1|||
161248872|NCT02473393|582291620|FG003|Overall Study|Adverse Event|0|||
161248873|NCT02473393|582291617|FG000|Overall Study|Withdrawal by Subject|0|||
160834363|NCT04201093|580780071|FG002|Overall Study|Withdrawal by Subject|15|||
160834364|NCT04201093|580780069|FG000|Overall Study|Other|0|||
160834365|NCT04201093|580780070|FG001|Overall Study|Other|1|||
160834366|NCT04201093|580780071|FG002|Overall Study|Other|2|||
160834367|NCT00007020|580780072|FG000|Overall Study|Death|16|||
160834368|NCT00007020|580780072|FG000|Overall Study|Lost to Follow-up|13|||
160834369|NCT00007020|580780072|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
160834370|NCT00007020|580780072|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
160834371|NCT00007020|580780072|FG000|Overall Study|Pt cared for by outside physician|4|||
160834372|NCT00007020|580780072|FG000|Overall Study|No evidence of treatment|6|||
160834373|NCT00881504|580780073|FG000|Overall Study|Withdrawal by Subject|1|||
160834374|NCT01276223|580780074|FG000|Overall Study|Adverse Event|7|||
160834375|NCT01276223|580780075|FG001|Overall Study|Adverse Event|4|||
160834376|NCT01276223|580780076|FG002|Overall Study|Adverse Event|1|||
161248874|NCT02473393|582291618|FG001|Overall Study|Withdrawal by Subject|0|||
161248875|NCT02473393|582291619|FG002|Overall Study|Withdrawal by Subject|1|||
161248876|NCT02473393|582291620|FG003|Overall Study|Withdrawal by Subject|1|||
161248877|NCT02274558|582291623|FG000|Overall Study|Adverse Event|2|||
161248878|NCT02274558|582291624|FG001|Overall Study|Adverse Event|4|||
161248879|NCT02274558|582291625|FG002|Overall Study|Adverse Event|2|||
160834377|NCT01276223|580780074|FG000|Overall Study|Lost to Follow-up|0|||
160834378|NCT01276223|580780075|FG001|Overall Study|Lost to Follow-up|0|||
160834379|NCT01276223|580780076|FG002|Overall Study|Lost to Follow-up|1|||
160834380|NCT01276223|580780074|FG000|Overall Study|Other|0|||
160834381|NCT01276223|580780075|FG001|Overall Study|Other|0|||
161248880|NCT02274558|582291623|FG000|Overall Study|Non-compliance|2|||
161248881|NCT02274558|582291624|FG001|Overall Study|Non-compliance|1|||
161248882|NCT02274558|582291625|FG002|Overall Study|Non-compliance|0|||
161248883|NCT02274558|582291623|FG000|Overall Study|Withdrawal by Subject|1|||
161248884|NCT02274558|582291624|FG001|Overall Study|Withdrawal by Subject|5|||
161248885|NCT02274558|582291625|FG002|Overall Study|Withdrawal by Subject|4|||
161248886|NCT02274558|582291623|FG000|Overall Study|Death|0|||
161248887|NCT02274558|582291624|FG001|Overall Study|Death|0|||
161248888|NCT02274558|582291625|FG002|Overall Study|Death|1|||
161248889|NCT02274558|582291623|FG000|Overall Study|Lost to Follow-up|2|||
161248890|NCT02274558|582291624|FG001|Overall Study|Lost to Follow-up|1|||
161248891|NCT02274558|582291625|FG002|Overall Study|Lost to Follow-up|1|||
161248892|NCT02274558|582291623|FG000|Overall Study|Physician Decision|0|||
161248893|NCT02274558|582291624|FG001|Overall Study|Physician Decision|2|||
161248894|NCT02274558|582291625|FG002|Overall Study|Physician Decision|1|||
161248895|NCT02733627|582291626|FG000|Overall Study|Adverse Event|0|||
161248896|NCT02733627|582291627|FG001|Overall Study|Adverse Event|1|||
161248897|NCT02733627|582291628|FG002|Overall Study|Adverse Event|1|||
161248898|NCT02733627|582291629|FG003|Overall Study|Adverse Event|0|||
161248899|NCT02733627|582291626|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161248900|NCT02733627|582291627|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161248901|NCT02733627|582291628|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
161248902|NCT02733627|582291629|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
161248903|NCT02246764|582291630|FG000|Overall Study|Adverse Event|15|||
161248904|NCT02246764|582291631|FG001|Overall Study|Adverse Event|29|||
161248905|NCT02246764|582291632|FG002|Overall Study|Adverse Event|1|||
161248906|NCT02246764|582291630|FG000|Overall Study|Withdrawal by Subject|0|||
161248907|NCT02246764|582291631|FG001|Overall Study|Withdrawal by Subject|0|||
161248908|NCT02246764|582291632|FG002|Overall Study|Withdrawal by Subject|1|||
161248909|NCT02246764|582291630|FG000|Overall Study|Disallowed Concomitant Medication|1|||
161248910|NCT02246764|582291631|FG001|Overall Study|Disallowed Concomitant Medication|0|||
161248911|NCT02246764|582291632|FG002|Overall Study|Disallowed Concomitant Medication|0|||
161248912|NCT02246764|582291630|FG000|Overall Study|Physician Decision|0|||
161248913|NCT02246764|582291631|FG001|Overall Study|Physician Decision|2|||
161248914|NCT02246764|582291632|FG002|Overall Study|Physician Decision|1|||
161248915|NCT02246764|582291630|FG000|Overall Study|Protocol Violation|2|||
161248916|NCT02246764|582291631|FG001|Overall Study|Protocol Violation|1|||
161248917|NCT02246764|582291632|FG002|Overall Study|Protocol Violation|1|||
161248918|NCT05393271|582291633|FG000|Overall Study|Physician Decision|0|||
160834382|NCT01276223|580780076|FG002|Overall Study|Other|1|||
160834383|NCT01276223|580780074|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
160834384|NCT01276223|580780075|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
160834385|NCT01276223|580780076|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
161248919|NCT05393271|582291634|FG001|Overall Study|Physician Decision|0|||
161248920|NCT05393271|582291635|FG002|Overall Study|Physician Decision|0|||
161248921|NCT05393271|582291636|FG003|Overall Study|Physician Decision|0|||
161248922|NCT05393271|582291637|FG004|Overall Study|Physician Decision|0|||
160834386|NCT01276223|580780074|FG000|Overall Study|Protocol Violation|1|||
160834387|NCT01276223|580780075|FG001|Overall Study|Protocol Violation|0|||
161248923|NCT05393271|582291638|FG005|Overall Study|Physician Decision|0|||
161248924|NCT05393271|582291639|FG006|Overall Study|Physician Decision|1|||
160834388|NCT01276223|580780076|FG002|Overall Study|Protocol Violation|0|||
160834389|NCT02017522|580780077|FG000|Overall Study|Withdrawal by Subject|1|||
160834390|NCT02596230|580780078|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
160834391|NCT02596230|580780079|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
160834392|NCT02596230|580780080|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
160834393|NCT02596230|580780081|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
160834394|NCT02596230|580780082|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
160834395|NCT02596230|580780078|FG000|Objective 2, One Year|Lost to Follow-up|0|||
160834396|NCT02596230|580780079|FG001|Objective 2, One Year|Lost to Follow-up|41|||
160834397|NCT02596230|580780080|FG002|Objective 2, One Year|Lost to Follow-up|41|||
160834398|NCT02596230|580780081|FG003|Objective 2, One Year|Lost to Follow-up|32|||
160834399|NCT02596230|580780082|FG004|Objective 2, One Year|Lost to Follow-up|46|||
160834400|NCT02596230|580780078|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
160834401|NCT02596230|580780079|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
160834402|NCT02596230|580780080|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
160834403|NCT02596230|580780081|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
160834404|NCT02596230|580780082|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
160834405|NCT02596230|580780078|FG000|Objective 2, One Year|Adverse drug reaction|0|||
160834406|NCT02596230|580780079|FG001|Objective 2, One Year|Adverse drug reaction|1|||
160834407|NCT02596230|580780080|FG002|Objective 2, One Year|Adverse drug reaction|0|||
160834408|NCT02596230|580780081|FG003|Objective 2, One Year|Adverse drug reaction|0|||
160834409|NCT02596230|580780082|FG004|Objective 2, One Year|Adverse drug reaction|0|||
160834410|NCT02596230|580780078|FG000|Objective 2, One Year|Death|0|||
160834411|NCT02596230|580780079|FG001|Objective 2, One Year|Death|12|||
160834412|NCT02596230|580780080|FG002|Objective 2, One Year|Death|41|||
160834413|NCT02596230|580780081|FG003|Objective 2, One Year|Death|21|||
160834414|NCT02596230|580780082|FG004|Objective 2, One Year|Death|30|||
160834415|NCT02596230|580780078|FG000|Objective 2, One Year|Other|0|||
160834416|NCT02596230|580780079|FG001|Objective 2, One Year|Other|3|||
160834417|NCT02596230|580780080|FG002|Objective 2, One Year|Other|2|||
160834418|NCT02596230|580780081|FG003|Objective 2, One Year|Other|0|||
160834419|NCT02596230|580780082|FG004|Objective 2, One Year|Other|0|||
160834420|NCT00771615|580780083|FG000|Overall Study|Withdrawal by Subject|0|||
160834421|NCT00771615|580780084|FG001|Overall Study|Withdrawal by Subject|1|||
160834422|NCT00771615|580780085|FG002|Overall Study|Withdrawal by Subject|0|||
160834423|NCT00771615|580780086|FG003|Overall Study|Withdrawal by Subject|0|||
160834424|NCT00771615|580780087|FG004|Overall Study|Withdrawal by Subject|0|||
160834425|NCT00771615|580780088|FG005|Overall Study|Withdrawal by Subject|0|||
160834426|NCT00771615|580780089|FG006|Overall Study|Withdrawal by Subject|0|||
160834427|NCT00771615|580780090|FG007|Overall Study|Withdrawal by Subject|1|||
160834428|NCT00771615|580780091|FG008|Overall Study|Withdrawal by Subject|0|||
160834429|NCT00771615|580780083|FG000|Overall Study|Lost to Follow-up|1|||
160834430|NCT00771615|580780084|FG001|Overall Study|Lost to Follow-up|1|||
160834431|NCT00771615|580780085|FG002|Overall Study|Lost to Follow-up|1|||
160834432|NCT00771615|580780086|FG003|Overall Study|Lost to Follow-up|1|||
160834433|NCT00771615|580780087|FG004|Overall Study|Lost to Follow-up|0|||
160834434|NCT00771615|580780088|FG005|Overall Study|Lost to Follow-up|1|||
160834435|NCT00771615|580780089|FG006|Overall Study|Lost to Follow-up|1|||
160834436|NCT00771615|580780090|FG007|Overall Study|Lost to Follow-up|0|||
160834437|NCT00771615|580780091|FG008|Overall Study|Lost to Follow-up|0|||
160834438|NCT02704689|580780093|FG000|Overall Study|Physician Decision|1|||
160834439|NCT02704689|580780093|FG000|Overall Study|Study device not implanted|2|||
160834440|NCT00802893|580780094|FG000|Overall Study|study terminated|3|||
160991296|NCT00157014|581357733|FG001|Overall Study|Physician Decision|1|||
161248925|NCT05393271|582291640|FG007|Overall Study|Physician Decision|0|||
161248926|NCT05393271|582291641|FG008|Overall Study|Physician Decision|0|||
161248927|NCT05393271|582291642|FG009|Overall Study|Physician Decision|0|||
161248928|NCT05393271|582291643|FG010|Overall Study|Physician Decision|0|||
161248929|NCT02048813|582291644|FG000|Overall Study|Still on treatment|279|||
161248930|NCT02048813|582291645|FG001|Overall Study|Still on treatment|0|||
161248931|NCT02048813|582291644|FG000|Overall Study|Adverse Event|40|||
161248932|NCT02048813|582291645|FG001|Overall Study|Adverse Event|38|||
161248933|NCT02048813|582291644|FG000|Overall Study|Disease progression|13|||
161248934|NCT02048813|582291645|FG001|Overall Study|Disease progression|3|||
161248935|NCT02048813|582291644|FG000|Overall Study|Withdrawal by Subject|7|||
160834441|NCT00320424|580780095|FG000|Overall Study|Adverse Event|3|||
160991297|NCT00157014|581357734|FG002|Overall Study|Physician Decision|0|||
160834442|NCT00320424|580780095|FG000|Overall Study|Other|3|||
160834443|NCT02294734|580780099|FG000|Overall Study|Adverse Event|5|||
160834444|NCT02294734|580780100|FG001|Overall Study|Adverse Event|5|||
160834445|NCT02294734|580780099|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
160834446|NCT02294734|580780100|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
160834447|NCT02294734|580780099|FG000|Overall Study|Lost to Follow-up|2|||
160834448|NCT02294734|580780100|FG001|Overall Study|Lost to Follow-up|0|||
160834449|NCT02294734|580780099|FG000|Overall Study|Physician Decision|2|||
161248936|NCT02048813|582291645|FG001|Overall Study|Withdrawal by Subject|8|||
160834450|NCT02294734|580780100|FG001|Overall Study|Physician Decision|1|||
160834451|NCT02294734|580780099|FG000|Overall Study|Withdrawal by Subject|4|||
160834452|NCT02294734|580780100|FG001|Overall Study|Withdrawal by Subject|2|||
160834453|NCT03157583|580780101|FG000|Overall Study|Other (did not meet study criteria)|1|||
160834454|NCT02809053|580780105|FG000|Overall Study|Death|0|||
160834455|NCT02809053|580780106|FG001|Overall Study|Death|1|||
160834456|NCT02809053|580780105|FG000|Overall Study|Lost to Follow-up|3|||
160834457|NCT02809053|580780106|FG001|Overall Study|Lost to Follow-up|1|||
160834458|NCT02809053|580780105|FG000|Overall Study|Withdrawal by Subject|2|||
160834459|NCT02809053|580780106|FG001|Overall Study|Withdrawal by Subject|3|||
160834460|NCT02809053|580780105|FG000|Overall Study|Disease Progression|2|||
160834461|NCT02809053|580780106|FG001|Overall Study|Disease Progression|1|||
160834462|NCT01943552|580780108|FG000|Overall Study|Adverse Event|3|||
160834463|NCT01943552|580780109|FG001|Overall Study|Adverse Event|2|||
160834464|NCT01943552|580780108|FG000|Overall Study|Withdrawal by Subject|6|||
160834465|NCT01943552|580780109|FG001|Overall Study|Withdrawal by Subject|6|||
160834466|NCT01943552|580780108|FG000|Overall Study|Other Reasons|16|||
160834467|NCT01943552|580780109|FG001|Overall Study|Other Reasons|17|||
160834468|NCT00908037|580780111|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834469|NCT00908037|580780112|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834470|NCT00908037|580780113|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834471|NCT00908037|580780114|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834472|NCT00908037|580780115|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
160834473|NCT00908037|580780116|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834474|NCT00908037|580780117|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
160834475|NCT00908037|580780118|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834476|NCT00908037|580780119|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
160834477|NCT00908037|580780120|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834478|NCT00908037|580780121|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834479|NCT00908037|580780122|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
160834480|NCT00908037|580780111|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834481|NCT00908037|580780112|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834482|NCT00908037|580780113|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834483|NCT00908037|580780114|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834484|NCT00908037|580780115|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
160834485|NCT00908037|580780116|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834486|NCT00908037|580780117|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834487|NCT00908037|580780118|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834488|NCT00908037|580780119|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
160834489|NCT00908037|580780120|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834490|NCT00908037|580780121|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834491|NCT00908037|580780122|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
160834492|NCT00908037|580780111|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834493|NCT00908037|580780112|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834494|NCT00908037|580780113|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834495|NCT00908037|580780114|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
160834496|NCT00908037|580780115|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834497|NCT00908037|580780116|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834498|NCT00908037|580780117|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
160834499|NCT00908037|580780118|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834500|NCT00908037|580780119|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834501|NCT00908037|580780120|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834502|NCT00908037|580780121|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834503|NCT00908037|580780122|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
160834504|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834505|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834506|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834507|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834508|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834509|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834510|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834511|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834512|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160834513|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160903733|NCT00087607|581040624|FG001|Overall Study|Insufficient Therapeutic Response|42|||
160903734|NCT00087607|581040623|FG000|Overall Study|Failure to return|21|||
160834514|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
160903735|NCT00087607|581040624|FG001|Overall Study|Failure to return|17|||
161248937|NCT02048813|582291644|FG000|Overall Study|Death|2|||
161248938|NCT02048813|582291645|FG001|Overall Study|Death|1|||
160834515|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
160834516|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834517|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834518|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834519|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834520|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834521|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834522|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834523|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834524|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834525|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
160834526|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
160834527|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
160834528|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834529|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834530|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834531|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161248939|NCT02048813|582291644|FG000|Overall Study|Complication|2|||
160834532|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
161137848|NCT01275222|581885708|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
161137849|NCT01275222|581885709|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
160834533|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834534|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834535|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834536|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834537|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
160834538|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834539|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
160834540|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834541|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834542|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834543|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834544|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834545|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834546|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834547|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834548|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834549|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834550|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
160834551|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
160834552|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834553|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834554|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834555|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834556|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834557|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834558|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834559|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834560|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
161137850|NCT01275222|581885710|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
161137851|NCT01275222|581885705|FG000|Phase l by Treatment|Disease progression|12|||
161137852|NCT01275222|581885706|FG001|Phase l by Treatment|Disease progression|8|||
161137853|NCT01275222|581885707|FG002|Phase l by Treatment|Disease progression|2|||
161137854|NCT01275222|581885708|FG003|Phase l by Treatment|Disease progression|5|||
161137855|NCT01275222|581885709|FG004|Phase l by Treatment|Disease progression|0|||
161137856|NCT01275222|581885710|FG005|Phase l by Treatment|Disease progression|0|||
161137857|NCT01275222|581885705|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
161137858|NCT01275222|581885706|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
161137859|NCT01275222|581885707|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
161137860|NCT01275222|581885708|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
161137861|NCT01275222|581885709|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
161137862|NCT01275222|581885710|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
161137863|NCT01275222|581885705|FG000|Phase l by Treatment|Death|0|||
161248940|NCT02048813|582291645|FG001|Overall Study|Complication|2|||
160834561|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
160834562|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834563|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
160834564|NCT00908037|580780111|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834565|NCT00908037|580780112|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
161248941|NCT02048813|582291644|FG000|Overall Study|Non-protocol therapy|0|||
161248942|NCT02048813|582291645|FG001|Overall Study|Non-protocol therapy|1|||
161248943|NCT02048813|582291644|FG000|Overall Study|Second primary cancer|2|||
161248944|NCT02048813|582291645|FG001|Overall Study|Second primary cancer|0|||
160834566|NCT00908037|580780113|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834567|NCT00908037|580780114|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834568|NCT00908037|580780115|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834569|NCT00908037|580780116|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834570|NCT00908037|580780117|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834571|NCT00908037|580780118|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834572|NCT00908037|580780119|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834573|NCT00908037|580780120|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834574|NCT00908037|580780121|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
160834575|NCT00908037|580780122|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
160834576|NCT01147900|580780123|FG000|At Year 10|Lost to Follow-up|0|||
160834577|NCT01147900|580780124|FG001|At Year 10|Lost to Follow-up|1|||
160834578|NCT01147900|580780125|FG002|At Year 10|Lost to Follow-up|0|||
160834579|NCT00257660|580780127|FG000|Overall Study|Lack of Efficacy|5|||
160834580|NCT00257660|580780128|FG001|Overall Study|Lack of Efficacy|23|||
160834581|NCT00257660|580780127|FG000|Overall Study|Withdrawal by Subject|2|||
160834582|NCT00257660|580780128|FG001|Overall Study|Withdrawal by Subject|0|||
160834583|NCT00257660|580780127|FG000|Overall Study|Lost to Follow-up|1|||
160834584|NCT00257660|580780128|FG001|Overall Study|Lost to Follow-up|0|||
160903736|NCT00087607|581040623|FG000|Overall Study|Withdrew Consent|12|||
160903737|NCT00087607|581040624|FG001|Overall Study|Withdrew Consent|16|||
160903738|NCT00087607|581040623|FG000|Overall Study|Administrative|12|||
160903739|NCT00087607|581040624|FG001|Overall Study|Administrative|12|||
160903740|NCT00087607|581040623|FG000|Overall Study|Refused Treatment|5|||
160903741|NCT00087607|581040624|FG001|Overall Study|Refused Treatment|7|||
160903742|NCT00087607|581040623|FG000|Overall Study|Other Protocol Violation|5|||
160903743|NCT00087607|581040624|FG001|Overall Study|Other Protocol Violation|2|||
160903744|NCT00087607|581040623|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
160903745|NCT00087607|581040624|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160903746|NCT02699593|581040625|FG000|Period 1|Unsatisfactory Visual Response|0|||
160903747|NCT02699593|581040626|FG001|Period 1|Unsatisfactory Visual Response|1|||
160903748|NCT02699593|581040625|FG000|Period 1|Torn Contact Len|4|||
160903749|NCT02699593|581040626|FG001|Period 1|Torn Contact Len|3|||
160903750|NCT02699593|581040625|FG000|Period 1|Protocol Violation|0|||
160903751|NCT02699593|581040626|FG001|Period 1|Protocol Violation|1|||
160903752|NCT02699593|581040625|FG000|Period 1|Withdrawal by Subject|0|||
160903753|NCT02699593|581040626|FG001|Period 1|Withdrawal by Subject|1|||
160903754|NCT02699593|581040625|FG000|Period 1|Adverse Event|1|||
160903755|NCT02699593|581040626|FG001|Period 1|Adverse Event|1|||
160903756|NCT02699593|581040625|FG000|Period 2|Adverse Event|1|||
160903757|NCT02699593|581040626|FG001|Period 2|Adverse Event|1|||
160903758|NCT02699593|581040625|FG000|Period 2|Lost Contact Lens|0|||
160903759|NCT02699593|581040626|FG001|Period 2|Lost Contact Lens|1|||
160903760|NCT02699593|581040625|FG000|Period 2|Torn Contact Lens|1|||
160903761|NCT02699593|581040626|FG001|Period 2|Torn Contact Lens|0|||
160903762|NCT02015754|581040627|FG000|Overall Study|Disease progression|5|||
161248945|NCT02048813|582291644|FG000|Overall Study|Insurance|2|||
161248946|NCT02048813|582291645|FG001|Overall Study|Insurance|0|||
161248947|NCT02048813|582291644|FG000|Overall Study|Wound infection/healing|2|||
161248948|NCT02048813|582291645|FG001|Overall Study|Wound infection/healing|0|||
161248949|NCT02048813|582291644|FG000|Overall Study|Missed appointment|3|||
161248950|NCT02048813|582291645|FG001|Overall Study|Missed appointment|0|||
161248951|NCT02048813|582291644|FG000|Overall Study|Never started treatment|2|||
161248952|NCT02048813|582291645|FG001|Overall Study|Never started treatment|17|||
160903763|NCT02015754|581040627|FG000|Overall Study|Change in treatment modality|5|||
160903764|NCT02015754|581040627|FG000|Overall Study|Lost to Follow-up|1|||
160903765|NCT02229383|581040628|FG000|Overall Study|Adverse Event|7|||
160903766|NCT02229383|581040629|FG001|Overall Study|Adverse Event|4|||
161248953|NCT03314857|582291646|FG000|Overall Study|Death|4|||
161248954|NCT03314857|582291646|FG000|Overall Study|Physician Decision|1|||
160903767|NCT02229383|581040628|FG000|Overall Study|Death|0|||
160903768|NCT02229383|581040629|FG001|Overall Study|Death|1|||
160903769|NCT02229383|581040628|FG000|Overall Study|Lost to Follow-up|5|||
160903770|NCT02229383|581040629|FG001|Overall Study|Lost to Follow-up|3|||
161248955|NCT01119625|582291647|FG000|Overall Study|Lost to Follow-up|1|||
160834585|NCT00257660|580780127|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
160834586|NCT00257660|580780128|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
160834587|NCT00257660|580780127|FG000|Overall Study|No longer wanted to do blood draws|1|||
160834588|NCT00257660|580780128|FG001|Overall Study|No longer wanted to do blood draws|0|||
160834589|NCT04109976|580780129|FG000|Overall Study|Withdrawal by Subject|1|||
160834590|NCT04109976|580780130|FG001|Overall Study|Withdrawal by Subject|0|||
160834591|NCT00491608|580780131|FG000|Overall Study|Death|2|||
160834592|NCT00491608|580780131|FG000|Overall Study|Withdrawal by Subject|1|||
160834593|NCT00025155|580780134|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
160834594|NCT00025155|580780134|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
160834595|NCT03022981|580780135|FG000|Overall Study|Adverse Event|0|||
160834596|NCT03022981|580780136|FG001|Overall Study|Adverse Event|1|||
160834597|NCT03022981|580780137|FG002|Overall Study|Adverse Event|0|||
160834598|NCT03022981|580780135|FG000|Overall Study|Investigator's Discretion|0|||
160834599|NCT03022981|580780136|FG001|Overall Study|Investigator's Discretion|1|||
160834600|NCT03022981|580780137|FG002|Overall Study|Investigator's Discretion|2|||
160834601|NCT03022981|580780135|FG000|Overall Study|Lost to Follow-up|6|||
160834602|NCT03022981|580780136|FG001|Overall Study|Lost to Follow-up|2|||
160834603|NCT03022981|580780137|FG002|Overall Study|Lost to Follow-up|1|||
160834604|NCT03022981|580780135|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160834605|NCT03022981|580780136|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160834606|NCT03022981|580780137|FG002|Overall Study|Non-Compliance With Study Drug|2|||
160834607|NCT03022981|580780135|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
160834608|NCT03022981|580780136|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
160834609|NCT03022981|580780137|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
160834610|NCT02437084|580780138|FG000|Overall Study|Withdrawal by Subject|2|||
160834611|NCT02437084|580780138|FG000|Overall Study|Physician Decision|1|||
160834612|NCT00884832|580780139|FG000|Overall Study|Withdrawal by Subject|0|||
160834613|NCT00884832|580780140|FG001|Overall Study|Withdrawal by Subject|1|||
160834614|NCT00079677|580780142|FG000|Overall Study|Adverse Event|5|||
160834615|NCT00079677|580780143|FG001|Overall Study|Adverse Event|6|||
160834616|NCT00079677|580780142|FG000|Overall Study|Lack of Efficacy|1|||
160834617|NCT00079677|580780143|FG001|Overall Study|Lack of Efficacy|0|||
160834618|NCT00079677|580780142|FG000|Overall Study|Lost to Follow-up|2|||
160834619|NCT00079677|580780143|FG001|Overall Study|Lost to Follow-up|2|||
160834620|NCT00079677|580780142|FG000|Overall Study|Physician Decision|3|||
160834621|NCT00079677|580780143|FG001|Overall Study|Physician Decision|0|||
160834622|NCT00079677|580780142|FG000|Overall Study|Protocol Violation|2|||
160834623|NCT00079677|580780143|FG001|Overall Study|Protocol Violation|3|||
160834624|NCT00079677|580780142|FG000|Overall Study|Withdrawal by Subject|5|||
160834625|NCT00079677|580780143|FG001|Overall Study|Withdrawal by Subject|3|||
160834626|NCT00079677|580780142|FG000|Overall Study|Miscellaneous|2|||
160834627|NCT00079677|580780143|FG001|Overall Study|Miscellaneous|0|||
160834628|NCT02265796|580780144|FG000|Overall Study|Death|1|||
160834629|NCT02265796|580780145|FG001|Overall Study|Death|0|||
160834630|NCT02265796|580780144|FG000|Overall Study|started on excluded medication|1|||
160834631|NCT02265796|580780145|FG001|Overall Study|started on excluded medication|0|||
160834632|NCT02265796|580780144|FG000|Overall Study|Withdrawal by Subject|1|||
160834633|NCT02265796|580780145|FG001|Overall Study|Withdrawal by Subject|1|||
160834634|NCT02477553|580780146|FG000|Overall Study|Screening up-to-date|12|||
160834635|NCT02477553|580780147|FG001|Overall Study|Screening up-to-date|13|||
160834636|NCT02477553|580780146|FG000|Overall Study|No MD visit|1|||
160834637|NCT02477553|580780147|FG001|Overall Study|No MD visit|1|||
160834638|NCT02477553|580780146|FG000|Overall Study|Workup consistent w/CRC|1|||
160834639|NCT02477553|580780147|FG001|Overall Study|Workup consistent w/CRC|1|||
160834640|NCT02477553|580780146|FG000|Overall Study|Technical issues with intervention|2|||
160834641|NCT02477553|580780147|FG001|Overall Study|Technical issues with intervention|0|||
160834642|NCT02477553|580780146|FG000|Overall Study|Elevated risk for CRC|2|||
161248956|NCT01119625|582291648|FG001|Overall Study|Lost to Follow-up|2|||
161248957|NCT01119625|582291647|FG000|Overall Study|Withdrawal by Subject|2|||
161248958|NCT01119625|582291648|FG001|Overall Study|Withdrawal by Subject|1|||
161248959|NCT01119625|582291647|FG000|Overall Study|Other|0|||
161248960|NCT01119625|582291648|FG001|Overall Study|Other|1|||
161248961|NCT01721772|582291653|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
160834643|NCT02477553|580780147|FG001|Overall Study|Elevated risk for CRC|2|||
160834644|NCT02477553|580780146|FG000|Overall Study|MD advised against screening|1|||
160834645|NCT02477553|580780147|FG001|Overall Study|MD advised against screening|3|||
160834646|NCT02477553|580780146|FG000|Overall Study|patient deceased|1|||
160834647|NCT02477553|580780147|FG001|Overall Study|patient deceased|0|||
160834648|NCT04023682|580780148|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
160834649|NCT00454649|580780149|FG000|Overall Study|Lack of Efficacy|2|||
160834650|NCT00454649|580780150|FG001|Overall Study|Lack of Efficacy|2|||
160834651|NCT00454649|580780151|FG002|Overall Study|Lack of Efficacy|10|||
160834652|NCT00454649|580780152|FG003|Overall Study|Lack of Efficacy|3|||
160834653|NCT00454649|580780153|FG004|Overall Study|Lack of Efficacy|0|||
161248962|NCT01721772|582291654|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
161137864|NCT01275222|581885706|FG001|Phase l by Treatment|Death|1|||
161137865|NCT01275222|581885707|FG002|Phase l by Treatment|Death|0|||
160834654|NCT00454649|580780154|FG005|Overall Study|Lack of Efficacy|4|||
160834655|NCT00454649|580780155|FG006|Overall Study|Lack of Efficacy|5|||
160834656|NCT00454649|580780156|FG007|Overall Study|Lack of Efficacy|13|||
160834657|NCT00454649|580780157|FG008|Overall Study|Lack of Efficacy|10|||
160834658|NCT00454649|580780158|FG009|Overall Study|Lack of Efficacy|2|||
160834659|NCT00454649|580780149|FG000|Overall Study|Adverse Event|0|||
160834660|NCT00454649|580780150|FG001|Overall Study|Adverse Event|1|||
160834661|NCT00454649|580780151|FG002|Overall Study|Adverse Event|3|||
160834662|NCT00454649|580780152|FG003|Overall Study|Adverse Event|0|||
160834663|NCT00454649|580780153|FG004|Overall Study|Adverse Event|1|||
160834664|NCT00454649|580780154|FG005|Overall Study|Adverse Event|2|||
160834665|NCT00454649|580780155|FG006|Overall Study|Adverse Event|3|||
160834666|NCT00454649|580780156|FG007|Overall Study|Adverse Event|4|||
160834667|NCT00454649|580780157|FG008|Overall Study|Adverse Event|6|||
160834668|NCT00454649|580780158|FG009|Overall Study|Adverse Event|2|||
160834669|NCT00454649|580780149|FG000|Overall Study|Lost to Follow-up|0|||
160834670|NCT00454649|580780150|FG001|Overall Study|Lost to Follow-up|0|||
160834671|NCT00454649|580780151|FG002|Overall Study|Lost to Follow-up|1|||
160834672|NCT00454649|580780152|FG003|Overall Study|Lost to Follow-up|0|||
160834673|NCT00454649|580780153|FG004|Overall Study|Lost to Follow-up|0|||
160834674|NCT00454649|580780154|FG005|Overall Study|Lost to Follow-up|0|||
160834675|NCT00454649|580780155|FG006|Overall Study|Lost to Follow-up|1|||
160834676|NCT00454649|580780156|FG007|Overall Study|Lost to Follow-up|0|||
160834677|NCT00454649|580780157|FG008|Overall Study|Lost to Follow-up|0|||
160834678|NCT00454649|580780158|FG009|Overall Study|Lost to Follow-up|0|||
160834679|NCT00454649|580780149|FG000|Overall Study|Other|1|||
160834680|NCT00454649|580780150|FG001|Overall Study|Other|1|||
160834681|NCT00454649|580780151|FG002|Overall Study|Other|5|||
160834682|NCT00454649|580780152|FG003|Overall Study|Other|3|||
160834683|NCT00454649|580780153|FG004|Overall Study|Other|0|||
160834684|NCT00454649|580780154|FG005|Overall Study|Other|0|||
160834685|NCT00454649|580780155|FG006|Overall Study|Other|0|||
160834686|NCT00454649|580780156|FG007|Overall Study|Other|0|||
160834687|NCT00454649|580780157|FG008|Overall Study|Other|3|||
160834688|NCT00454649|580780158|FG009|Overall Study|Other|1|||
160834689|NCT00454649|580780149|FG000|Overall Study|Withdrawal by Subject|0|||
160834690|NCT00454649|580780150|FG001|Overall Study|Withdrawal by Subject|0|||
160834691|NCT00454649|580780151|FG002|Overall Study|Withdrawal by Subject|0|||
160834692|NCT00454649|580780152|FG003|Overall Study|Withdrawal by Subject|0|||
160834693|NCT00454649|580780153|FG004|Overall Study|Withdrawal by Subject|0|||
160834694|NCT00454649|580780154|FG005|Overall Study|Withdrawal by Subject|1|||
160834695|NCT00454649|580780155|FG006|Overall Study|Withdrawal by Subject|0|||
160834696|NCT00454649|580780156|FG007|Overall Study|Withdrawal by Subject|2|||
160834697|NCT00454649|580780157|FG008|Overall Study|Withdrawal by Subject|1|||
160834698|NCT00454649|580780158|FG009|Overall Study|Withdrawal by Subject|0|||
160834699|NCT02745535|580780160|FG000|Overall Study|Death|1|||
160834700|NCT02745535|580780160|FG000|Overall Study|Adverse Event|3|||
160834701|NCT02745535|580780160|FG000|Overall Study|Lost to Follow-up|2|||
160834702|NCT00377364|580780165|FG000|Overall Study|Lost to Follow-up|1|||
160834703|NCT00377364|580780166|FG001|Overall Study|Lost to Follow-up|0|||
160834704|NCT00377364|580780165|FG000|Overall Study|Withdrawal by Subject|1|||
161137866|NCT01275222|581885708|FG003|Phase l by Treatment|Death|1|||
160834705|NCT00377364|580780166|FG001|Overall Study|Withdrawal by Subject|0|||
160834706|NCT01291277|580780167|FG000|Overall Study|Death|2|||
160834707|NCT01291277|580780168|FG001|Overall Study|Death|2|||
160834708|NCT01291277|580780167|FG000|Overall Study|Lost to Follow-up|3|||
160834709|NCT01291277|580780168|FG001|Overall Study|Lost to Follow-up|1|||
161137867|NCT01275222|581885709|FG004|Phase l by Treatment|Death|0|||
161137868|NCT01275222|581885710|FG005|Phase l by Treatment|Death|0|||
161137869|NCT01275222|581885705|FG000|Phase ll by Stratum|Adverse Event|0|||
161137870|NCT01275222|581885706|FG001|Phase ll by Stratum|Adverse Event|0|||
161137871|NCT01275222|581885707|FG002|Phase ll by Stratum|Adverse Event|0|||
161137872|NCT01275222|581885708|FG003|Phase ll by Stratum|Adverse Event|0|||
161137873|NCT01275222|581885709|FG004|Phase ll by Stratum|Adverse Event|2|||
161137874|NCT01275222|581885710|FG005|Phase ll by Stratum|Adverse Event|10|||
161137875|NCT01275222|581885705|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
161137876|NCT01275222|581885706|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
161137877|NCT01275222|581885707|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
160834710|NCT02963701|580780172|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
160834711|NCT02963701|580780173|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
160834712|NCT01345682|580780176|FG000|Overall Study|Progressive disease per RECIST|226|||
160834713|NCT01345682|580780177|FG001|Overall Study|Progressive disease per RECIST|93|||
160834714|NCT01345682|580780176|FG000|Overall Study|Worsening of underlying cancer disease|23|||
160834715|NCT01345682|580780177|FG001|Overall Study|Worsening of underlying cancer disease|12|||
160834716|NCT01345682|580780176|FG000|Overall Study|Adverse Event|51|||
160834717|NCT01345682|580780177|FG001|Overall Study|Adverse Event|41|||
160834718|NCT01345682|580780176|FG000|Overall Study|Non-compliance with protocol|0|||
160834719|NCT01345682|580780177|FG001|Overall Study|Non-compliance with protocol|1|||
160834720|NCT01345682|580780176|FG000|Overall Study|Lost to Follow-up|0|||
160834721|NCT01345682|580780177|FG001|Overall Study|Lost to Follow-up|1|||
160834722|NCT01345682|580780176|FG000|Overall Study|Refused to continue trial medication|16|||
160834723|NCT01345682|580780177|FG001|Overall Study|Refused to continue trial medication|9|||
160834724|NCT01345682|580780176|FG000|Overall Study|Not treated|2|||
160834725|NCT01345682|580780177|FG001|Overall Study|Not treated|1|||
160834726|NCT01345682|580780176|FG000|Overall Study|Reason other than those specified above|4|||
160834727|NCT01345682|580780177|FG001|Overall Study|Reason other than those specified above|3|||
160834728|NCT00637572|580780178|FG000|Overall Study|Adverse Event|1|||
160834729|NCT00637572|580780179|FG001|Overall Study|Adverse Event|2|||
160834730|NCT00637572|580780178|FG000|Overall Study|Death|0|||
160834731|NCT00637572|580780179|FG001|Overall Study|Death|1|||
160834732|NCT00637572|580780178|FG000|Overall Study|Lost to Follow-up|0|||
160834733|NCT00637572|580780179|FG001|Overall Study|Lost to Follow-up|1|||
160834734|NCT00637572|580780178|FG000|Overall Study|Physician Decision|1|||
160834735|NCT00637572|580780179|FG001|Overall Study|Physician Decision|1|||
160834736|NCT00637572|580780178|FG000|Overall Study|Withdrawal by Subject|0|||
160834737|NCT00637572|580780179|FG001|Overall Study|Withdrawal by Subject|2|||
160834738|NCT00637572|580780178|FG000|Overall Study|Illicit Drug Use|1|||
160834739|NCT00637572|580780179|FG001|Overall Study|Illicit Drug Use|0|||
160834740|NCT00896649|580780180|FG000|Overall Study|Physician Decision|1|||
160834741|NCT00896649|580780180|FG000|Overall Study|Pregnancy|1|||
160834742|NCT00896649|580780180|FG000|Overall Study|missing documentation|1|||
160834743|NCT00896649|580780180|FG000|Overall Study|technical difficulties|2|||
160834744|NCT04268745|580780181|FG000|Overall Study|Lost to Follow-up|2|||
160834745|NCT04268745|580780182|FG001|Overall Study|Lost to Follow-up|3|||
160834746|NCT04268745|580780181|FG000|Overall Study|Withdrawal by Subject|4|||
160834747|NCT04268745|580780182|FG001|Overall Study|Withdrawal by Subject|2|||
160834748|NCT04268745|580780181|FG000|Overall Study|Death in the family|1|||
160834749|NCT04268745|580780182|FG001|Overall Study|Death in the family|0|||
160834750|NCT01887353|580780183|FG000|Overall Study|Study stopped early|4|||
160834751|NCT01887353|580780184|FG001|Overall Study|Study stopped early|3|||
160834752|NCT03109184|580781690|FG000|Overall Study|Lost to Follow-up|6|||
160834753|NCT03109184|580781691|FG001|Overall Study|Lost to Follow-up|6|||
160834754|NCT03109184|580781690|FG000|Overall Study|Withdrawal by Subject|1|||
160834755|NCT03109184|580781691|FG001|Overall Study|Withdrawal by Subject|1|||
160834756|NCT00602420|580781692|FG000|Overall Study|Death|1|||
160834757|NCT00602420|580781693|FG001|Overall Study|Death|4|||
160834758|NCT00602420|580781692|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
160834759|NCT00602420|580781693|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
160834760|NCT00602420|580781692|FG000|Overall Study|Withdrawal by Subject|18|||
160991298|NCT00157014|581357735|FG003|Overall Study|Physician Decision|0|||
160991299|NCT00157014|581357732|FG000|Overall Study|Medications withdrawn on family request|0|||
160991300|NCT00157014|581357733|FG001|Overall Study|Medications withdrawn on family request|1|||
160991301|NCT00157014|581357734|FG002|Overall Study|Medications withdrawn on family request|0|||
160991302|NCT00157014|581357735|FG003|Overall Study|Medications withdrawn on family request|0|||
160991303|NCT00157014|581357732|FG000|Overall Study|Patient withdrawn by investigator|1|||
160991304|NCT00157014|581357733|FG001|Overall Study|Patient withdrawn by investigator|0|||
161137878|NCT01275222|581885708|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
161137879|NCT01275222|581885709|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
160834761|NCT00602420|580781693|FG001|Overall Study|Withdrawal by Subject|17|||
160834762|NCT00602420|580781692|FG000|Overall Study|Adverse Event|1|||
160834763|NCT00602420|580781693|FG001|Overall Study|Adverse Event|0|||
160834764|NCT01209078|580781705|FG000|Overall Study|Adverse Event|5|||
160834765|NCT01209078|580781706|FG001|Overall Study|Adverse Event|0|||
160834766|NCT01209078|580781705|FG000|Overall Study|Lost to Follow-up|4|||
160834767|NCT01209078|580781706|FG001|Overall Study|Lost to Follow-up|0|||
160991305|NCT00157014|581357734|FG002|Overall Study|Patient withdrawn by investigator|0|||
161137880|NCT01275222|581885710|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
161137881|NCT01275222|581885705|FG000|Phase ll by Stratum|Disease progression|0|||
161137882|NCT01275222|581885706|FG001|Phase ll by Stratum|Disease progression|0|||
161137883|NCT01275222|581885707|FG002|Phase ll by Stratum|Disease progression|0|||
160834768|NCT01209078|580781705|FG000|Overall Study|Physician Decision|5|||
160834769|NCT01209078|580781706|FG001|Overall Study|Physician Decision|2|||
160834770|NCT01209078|580781705|FG000|Overall Study|Withdrawal by Subject|2|||
160834771|NCT01209078|580781706|FG001|Overall Study|Withdrawal by Subject|1|||
160834772|NCT02540668|580781707|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
160834773|NCT02540668|580781708|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
160834774|NCT03270891|580781709|FG000|Overall Study|Lost to Follow-up|3|||
160834775|NCT03270891|580781710|FG001|Overall Study|Lost to Follow-up|6|||
160834776|NCT03270891|580781711|FG002|Overall Study|Lost to Follow-up|0|||
160834777|NCT03270891|580781709|FG000|Overall Study|Withdrawal by Subject|1|||
160834778|NCT03270891|580781710|FG001|Overall Study|Withdrawal by Subject|0|||
160834779|NCT03270891|580781711|FG002|Overall Study|Withdrawal by Subject|0|||
160862009|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
160834780|NCT03270891|580781709|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
160834781|NCT03270891|580781710|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
160834782|NCT03270891|580781711|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
160834783|NCT00849108|580781712|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
160834784|NCT00849108|580781713|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
160834785|NCT00849108|580781712|FG000|Cohort 2 Efficacy|Adverse Event|0|||
160834786|NCT00849108|580781713|FG001|Cohort 2 Efficacy|Adverse Event|1|||
160834787|NCT00849108|580781712|FG000|Cohort 2 Efficacy|Other|0|||
160834788|NCT00849108|580781713|FG001|Cohort 2 Efficacy|Other|9|||
160834789|NCT01475162|580781716|FG000|Overall Study|Physician Decision|1|||
160834790|NCT01475162|580781716|FG000|Overall Study|Death|10|||
160834791|NCT01475162|580781716|FG000|Overall Study|Study closed for safety|3|||
160834792|NCT00545103|580781717|FG000|Overall Study|Lack of Efficacy|48|||
160834793|NCT00545103|580781718|FG001|Overall Study|Lack of Efficacy|45|||
160834794|NCT00545103|580781719|FG002|Overall Study|Lack of Efficacy|31|||
160834795|NCT00545103|580781720|FG003|Overall Study|Lack of Efficacy|27|||
160834796|NCT00545103|580781717|FG000|Overall Study|Withdrawal by Subject|6|||
160834797|NCT00545103|580781718|FG001|Overall Study|Withdrawal by Subject|10|||
160834798|NCT00545103|580781719|FG002|Overall Study|Withdrawal by Subject|18|||
160834799|NCT00545103|580781720|FG003|Overall Study|Withdrawal by Subject|22|||
160834800|NCT00545103|580781717|FG000|Overall Study|Adverse Event|11|||
160834801|NCT00545103|580781718|FG001|Overall Study|Adverse Event|12|||
160834802|NCT00545103|580781719|FG002|Overall Study|Adverse Event|17|||
160834803|NCT00545103|580781720|FG003|Overall Study|Adverse Event|10|||
160834804|NCT00545103|580781717|FG000|Overall Study|Lost to Follow-up|4|||
160834805|NCT00545103|580781718|FG001|Overall Study|Lost to Follow-up|6|||
160834806|NCT00545103|580781719|FG002|Overall Study|Lost to Follow-up|3|||
160834807|NCT00545103|580781720|FG003|Overall Study|Lost to Follow-up|4|||
160834808|NCT00545103|580781717|FG000|Overall Study|Protocol Violation|1|||
160834809|NCT00545103|580781718|FG001|Overall Study|Protocol Violation|2|||
160834810|NCT00545103|580781719|FG002|Overall Study|Protocol Violation|3|||
160834811|NCT00545103|580781720|FG003|Overall Study|Protocol Violation|0|||
160834812|NCT00545103|580781717|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
160834813|NCT00545103|580781718|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
160834814|NCT00545103|580781719|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
160834815|NCT00545103|580781720|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
160834816|NCT00545103|580781717|FG000|Overall Study|Difficult to open package|0|||
160834817|NCT00545103|580781718|FG001|Overall Study|Difficult to open package|0|||
160834818|NCT00545103|580781719|FG002|Overall Study|Difficult to open package|0|||
160834819|NCT00545103|580781720|FG003|Overall Study|Difficult to open package|1|||
160834820|NCT00545103|580781717|FG000|Overall Study|Investigational product not taken|1|||
160834821|NCT00545103|580781718|FG001|Overall Study|Investigational product not taken|0|||
160834822|NCT00545103|580781719|FG002|Overall Study|Investigational product not taken|0|||
160834823|NCT00545103|580781720|FG003|Overall Study|Investigational product not taken|1|||
160834824|NCT00545103|580781717|FG000|Overall Study|Wish to start a family|0|||
160834825|NCT00545103|580781718|FG001|Overall Study|Wish to start a family|0|||
160834826|NCT00545103|580781719|FG002|Overall Study|Wish to start a family|0|||
160834827|NCT00545103|580781720|FG003|Overall Study|Wish to start a family|1|||
160834828|NCT00545103|580781717|FG000|Overall Study|Diverticulitis crisis|0|||
160834829|NCT00545103|580781718|FG001|Overall Study|Diverticulitis crisis|0|||
160834830|NCT00545103|580781719|FG002|Overall Study|Diverticulitis crisis|0|||
160834831|NCT00545103|580781720|FG003|Overall Study|Diverticulitis crisis|1|||
160834832|NCT00545103|580781717|FG000|Overall Study|Personal reasons|1|||
160834833|NCT00545103|580781718|FG001|Overall Study|Personal reasons|0|||
160834834|NCT00545103|580781719|FG002|Overall Study|Personal reasons|0|||
160834835|NCT00545103|580781720|FG003|Overall Study|Personal reasons|0|||
160834836|NCT00545103|580781717|FG000|Overall Study|Subject's decision|1|||
160834837|NCT00545103|580781718|FG001|Overall Study|Subject's decision|0|||
160834838|NCT00545103|580781719|FG002|Overall Study|Subject's decision|0|||
161137884|NCT01275222|581885708|FG003|Phase ll by Stratum|Disease progression|0|||
161137885|NCT01275222|581885709|FG004|Phase ll by Stratum|Disease progression|23|||
161137886|NCT01275222|581885710|FG005|Phase ll by Stratum|Disease progression|31|||
161137887|NCT01275222|581885705|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
160834839|NCT00545103|580781720|FG003|Overall Study|Subject's decision|0|||
160834840|NCT00545103|580781717|FG000|Overall Study|Noncompliance|0|||
160834841|NCT00545103|580781718|FG001|Overall Study|Noncompliance|1|||
160834842|NCT00545103|580781719|FG002|Overall Study|Noncompliance|0|||
160834843|NCT00545103|580781720|FG003|Overall Study|Noncompliance|0|||
160834844|NCT00545103|580781717|FG000|Overall Study|Investigator decision|0|||
160834845|NCT00545103|580781718|FG001|Overall Study|Investigator decision|0|||
160834846|NCT00545103|580781719|FG002|Overall Study|Investigator decision|1|||
160834847|NCT00545103|580781720|FG003|Overall Study|Investigator decision|0|||
161137888|NCT01275222|581885706|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
160834848|NCT00545103|580781717|FG000|Overall Study|Subject moved|0|||
160834849|NCT00545103|580781718|FG001|Overall Study|Subject moved|1|||
160834850|NCT00545103|580781719|FG002|Overall Study|Subject moved|0|||
160834851|NCT00545103|580781720|FG003|Overall Study|Subject moved|0|||
160834852|NCT00545103|580781717|FG000|Overall Study|Use of prohibited medication|0|||
160834853|NCT00545103|580781718|FG001|Overall Study|Use of prohibited medication|0|||
160834854|NCT00545103|580781719|FG002|Overall Study|Use of prohibited medication|1|||
160834855|NCT00545103|580781720|FG003|Overall Study|Use of prohibited medication|0|||
160834856|NCT00545103|580781717|FG000|Overall Study|Does not want to take study drug anymore|1|||
160834857|NCT00545103|580781718|FG001|Overall Study|Does not want to take study drug anymore|0|||
160834858|NCT00545103|580781719|FG002|Overall Study|Does not want to take study drug anymore|1|||
160834859|NCT00545103|580781720|FG003|Overall Study|Does not want to take study drug anymore|0|||
160834860|NCT00545103|580781717|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
160834861|NCT00545103|580781718|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
160834862|NCT00545103|580781719|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
160834863|NCT00545103|580781720|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
160834864|NCT00545103|580781717|FG000|Overall Study|Death|0|||
160834865|NCT00545103|580781718|FG001|Overall Study|Death|1|||
160834866|NCT00545103|580781719|FG002|Overall Study|Death|0|||
160834867|NCT00545103|580781720|FG003|Overall Study|Death|0|||
160834868|NCT05026853|580781721|FG000|Overall Study|Cancelled appointment|1|||
160834869|NCT05026853|580781722|FG001|Overall Study|Cancelled appointment|0|||
160834870|NCT05026853|580781721|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
160834871|NCT05026853|580781722|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
160834872|NCT05026853|580781721|FG000|Overall Study|Did not complete 12-week survey|16|||
160834873|NCT05026853|580781722|FG001|Overall Study|Did not complete 12-week survey|16|||
160834874|NCT02358044|580781723|FG000|Overall Study|Adverse Event|0|||
160834875|NCT02358044|580781724|FG001|Overall Study|Adverse Event|1|||
160834876|NCT02358044|580781723|FG000|Overall Study|Lost to Follow-up|2|||
160834877|NCT02358044|580781724|FG001|Overall Study|Lost to Follow-up|1|||
160834878|NCT02358044|580781723|FG000|Overall Study|Physician Decision|0|||
160903771|NCT02229383|581040628|FG000|Overall Study|Withdrawal by Subject|4|||
160903772|NCT02229383|581040629|FG001|Overall Study|Withdrawal by Subject|6|||
160903773|NCT02229383|581040628|FG000|Overall Study|Did not receive treatment|1|||
160903774|NCT02229383|581040629|FG001|Overall Study|Did not receive treatment|0|||
160903775|NCT02229383|581040628|FG000|Overall Study|Other|3|||
160903776|NCT02229383|581040629|FG001|Overall Study|Other|8|||
160903777|NCT01218113|581043013|FG000|Overall Study|Withdrawal by Subject|1|||
160903778|NCT01218113|581043014|FG001|Overall Study|Withdrawal by Subject|0|||
160903779|NCT01218113|581043015|FG002|Overall Study|Withdrawal by Subject|1|||
160903780|NCT01218113|581043013|FG000|Overall Study|Lost to Follow-up|4|||
160903781|NCT01218113|581043014|FG001|Overall Study|Lost to Follow-up|1|||
160903782|NCT01218113|581043015|FG002|Overall Study|Lost to Follow-up|4|||
160903783|NCT01218113|581043013|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
160903784|NCT01218113|581043014|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
160903785|NCT01218113|581043015|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
160903786|NCT01385566|581043017|FG000|Overall Study|Lost to Follow-up|1|||
160903787|NCT01385566|581043018|FG001|Overall Study|Lost to Follow-up|0|||
160903788|NCT01385566|581043019|FG002|Overall Study|Lost to Follow-up|0|||
160903789|NCT01385566|581043020|FG003|Overall Study|Lost to Follow-up|0|||
160903790|NCT01385566|581043021|FG004|Overall Study|Lost to Follow-up|0|||
160903791|NCT01385566|581043022|FG005|Overall Study|Lost to Follow-up|0|||
160903792|NCT01385566|581043017|FG000|Overall Study|Withdrawal by Subject|0|||
160903793|NCT01385566|581043018|FG001|Overall Study|Withdrawal by Subject|0|||
160903794|NCT01385566|581043019|FG002|Overall Study|Withdrawal by Subject|0|||
160903795|NCT01385566|581043020|FG003|Overall Study|Withdrawal by Subject|1|||
160903796|NCT01385566|581043021|FG004|Overall Study|Withdrawal by Subject|0|||
160903797|NCT01385566|581043022|FG005|Overall Study|Withdrawal by Subject|0|||
160903798|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
160903799|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
160834879|NCT02358044|580781724|FG001|Overall Study|Physician Decision|1|||
160834880|NCT02358044|580781723|FG000|Overall Study|Withdrawal by Subject|0|||
160834881|NCT02358044|580781724|FG001|Overall Study|Withdrawal by Subject|4|||
160903800|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
160903801|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
161137889|NCT01275222|581885707|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
160834882|NCT01732913|580781725|FG000|Overall Study|Study Terminated by Sponsor|105|||
160903802|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
160903803|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
160903804|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
160903805|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
161137890|NCT01275222|581885708|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
161137891|NCT01275222|581885709|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
161137892|NCT01275222|581885710|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
161137893|NCT01275222|581885705|FG000|Phase ll by Stratum|Death|0|||
161137894|NCT01275222|581885706|FG001|Phase ll by Stratum|Death|0|||
160834883|NCT01732913|580781726|FG001|Overall Study|Study Terminated by Sponsor|55|||
160834884|NCT01732913|580781725|FG000|Overall Study|Withdrawal by Subject|27|||
160834885|NCT01732913|580781726|FG001|Overall Study|Withdrawal by Subject|4|||
160834886|NCT01732913|580781725|FG000|Overall Study|Physician Decision|14|||
160834887|NCT01732913|580781726|FG001|Overall Study|Physician Decision|7|||
160834888|NCT01732913|580781725|FG000|Overall Study|Other|7|||
160834889|NCT01732913|580781726|FG001|Overall Study|Other|1|||
160834890|NCT01732913|580781725|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
160834891|NCT01732913|580781726|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
160834892|NCT00903331|580781727|FG000|Overall Study|Death|4|||
160991306|NCT00157014|581357735|FG003|Overall Study|Patient withdrawn by investigator|0|||
160991307|NCT00157014|581357732|FG000|Overall Study|Patient unable to return in nursing home|1|||
160991308|NCT00157014|581357733|FG001|Overall Study|Patient unable to return in nursing home|0|||
160991309|NCT00157014|581357734|FG002|Overall Study|Patient unable to return in nursing home|0|||
160991310|NCT00157014|581357735|FG003|Overall Study|Patient unable to return in nursing home|0|||
160991311|NCT00157014|581357732|FG000|Overall Study|Patient would not receive transplant|0|||
160991312|NCT00157014|581357733|FG001|Overall Study|Patient would not receive transplant|1|||
160991313|NCT00157014|581357734|FG002|Overall Study|Patient would not receive transplant|0|||
160991314|NCT00157014|581357735|FG003|Overall Study|Patient would not receive transplant|0|||
160991315|NCT00157014|581357732|FG000|Overall Study|Withdrawal by Subject|1|||
160991316|NCT00157014|581357733|FG001|Overall Study|Withdrawal by Subject|0|||
160991317|NCT00157014|581357734|FG002|Overall Study|Withdrawal by Subject|0|||
160991318|NCT00157014|581357735|FG003|Overall Study|Withdrawal by Subject|0|||
160991319|NCT01362491|581357736|FG000|Overall Study|Ineligible|1|||
160991320|NCT01362491|581357737|FG001|Overall Study|Ineligible|0|||
160991321|NCT01362491|581357738|FG002|Overall Study|Ineligible|0|||
160991322|NCT05355116|581357739|FG000|Overall Study|Withdrawal by Subject|2|||
160991323|NCT01168401|581357743|FG000|Overall Study|Lost to Follow-up|1|||
160991324|NCT01168401|581357744|FG001|Overall Study|Lost to Follow-up|1|||
160991325|NCT01168401|581357745|FG002|Overall Study|Lost to Follow-up|2|||
160991326|NCT01168401|581357746|FG003|Overall Study|Lost to Follow-up|1|||
160991327|NCT01168401|581357747|FG004|Overall Study|Lost to Follow-up|0|||
160991328|NCT01168401|581357748|FG005|Overall Study|Lost to Follow-up|0|||
160991329|NCT01168401|581357749|FG006|Overall Study|Lost to Follow-up|0|||
160991330|NCT01168401|581357750|FG007|Overall Study|Lost to Follow-up|0|||
160991331|NCT01168401|581357751|FG008|Overall Study|Lost to Follow-up|0|||
160991332|NCT01168401|581357752|FG009|Overall Study|Lost to Follow-up|0|||
160991333|NCT01168401|581357753|FG010|Overall Study|Lost to Follow-up|0|||
161248963|NCT01721772|582291653|FG000|Pre-Treatment|Poor/non-compliance|0|||
161248964|NCT01721772|582291654|FG001|Pre-Treatment|Poor/non-compliance|1|||
161248965|NCT01721772|582291653|FG000|Pre-Treatment|Participant withdrew consent|0|||
161248966|NCT01721772|582291654|FG001|Pre-Treatment|Participant withdrew consent|1|||
161248967|NCT01721772|582291653|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161248968|NCT01721772|582291654|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
161248969|NCT01721772|582291653|FG000|Treatment|Disease progression|119|||
161248970|NCT01721772|582291654|FG001|Treatment|Disease progression|168|||
161248971|NCT01721772|582291653|FG000|Treatment|Study drug toxicity|19|||
161248972|NCT01721772|582291654|FG001|Treatment|Study drug toxicity|10|||
161248973|NCT01721772|582291653|FG000|Treatment|Adverse event unrelated to study drug|7|||
161248974|NCT01721772|582291654|FG001|Treatment|Adverse event unrelated to study drug|7|||
161248975|NCT01721772|582291653|FG000|Treatment|Maximum clinical benefit|16|||
161248976|NCT01721772|582291654|FG001|Treatment|Maximum clinical benefit|4|||
161248977|NCT01721772|582291653|FG000|Treatment|Other|19|||
161334946|NCT02616783|582615867|FG000|Overall Study|Randomized but Not Treated|1|||
160834893|NCT00903331|580781728|FG001|Overall Study|Death|8|||
160834894|NCT00903331|580781727|FG000|Overall Study|Withdrawal of consent|1|||
160834895|NCT00903331|580781728|FG001|Overall Study|Withdrawal of consent|8|||
160834896|NCT00903331|580781727|FG000|Overall Study|Lung transplant|0|||
160834897|NCT00903331|580781728|FG001|Overall Study|Lung transplant|2|||
160991334|NCT01168401|581357743|FG000|Overall Study|Withdrawal by Subject|0|||
160991335|NCT01168401|581357744|FG001|Overall Study|Withdrawal by Subject|0|||
160991336|NCT01168401|581357745|FG002|Overall Study|Withdrawal by Subject|0|||
161248978|NCT01721772|582291654|FG001|Treatment|Other|2|||
161248979|NCT01721772|582291653|FG000|Treatment|Participant withdrew consent|2|||
160834898|NCT02723175|580781729|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
160834899|NCT02723175|580781730|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
160834900|NCT02723175|580781729|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
160834901|NCT02723175|580781730|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
160991337|NCT01168401|581357746|FG003|Overall Study|Withdrawal by Subject|1|||
160991338|NCT01168401|581357747|FG004|Overall Study|Withdrawal by Subject|0|||
160834902|NCT03233438|580781731|FG000|Overall Study|Lost to Follow-up|4|||
160991339|NCT01168401|581357748|FG005|Overall Study|Withdrawal by Subject|0|||
160991340|NCT01168401|581357749|FG006|Overall Study|Withdrawal by Subject|0|||
160991341|NCT01168401|581357750|FG007|Overall Study|Withdrawal by Subject|0|||
161248980|NCT01721772|582291654|FG001|Treatment|Participant withdrew consent|5|||
161248981|NCT01721772|582291653|FG000|Treatment|Participant request to discontinue study treatment|21|||
160834903|NCT03233438|580781732|FG001|Overall Study|Lost to Follow-up|9|||
160834904|NCT03233438|580781731|FG000|Overall Study|Withdrawal by Subject|2|||
160834905|NCT03233438|580781732|FG001|Overall Study|Withdrawal by Subject|1|||
160834906|NCT03233438|580781731|FG000|Overall Study|No recording of dalbavancin|0|||
160834907|NCT03233438|580781732|FG001|Overall Study|No recording of dalbavancin|1|||
160834908|NCT02925741|580781736|FG000|Overall Study|Withdrawal by Subject|11|||
160834909|NCT02925741|580781737|FG001|Overall Study|Withdrawal by Subject|0|||
160834910|NCT00413374|580781740|FG000|Overall Study|Ineligible due to screening criteria.|3|||
160834911|NCT00413374|580781741|FG001|Overall Study|Ineligible due to screening criteria.|0|||
160834912|NCT00413374|580781740|FG000|Overall Study|Adverse Event|1|||
160834913|NCT00413374|580781741|FG001|Overall Study|Adverse Event|0|||
160834914|NCT00413374|580781740|FG000|Overall Study|Lost to Follow-up|1|||
160834915|NCT00413374|580781741|FG001|Overall Study|Lost to Follow-up|0|||
160834916|NCT00413374|580781740|FG000|Overall Study|Surgery|1|||
160834917|NCT00413374|580781741|FG001|Overall Study|Surgery|0|||
160834918|NCT00552760|580781744|FG000|Overall Study|Adverse Event|3|||
160834919|NCT00552760|580781745|FG001|Overall Study|Adverse Event|5|||
160834920|NCT00552760|580781744|FG000|Overall Study|Relapsed- Depressed Event|10|||
160834921|NCT00552760|580781745|FG001|Overall Study|Relapsed- Depressed Event|16|||
160834922|NCT00552760|580781744|FG000|Overall Study|Relapse- Manic Event|3|||
160834923|NCT00552760|580781745|FG001|Overall Study|Relapse- Manic Event|3|||
160834924|NCT00552760|580781744|FG000|Overall Study|Relapsed- Mixed Event|3|||
160834925|NCT00552760|580781745|FG001|Overall Study|Relapsed- Mixed Event|5|||
160834926|NCT00552760|580781744|FG000|Overall Study|Protocol Violation|0|||
160834927|NCT00552760|580781745|FG001|Overall Study|Protocol Violation|1|||
160834928|NCT00552760|580781744|FG000|Overall Study|Lost to Follow-up|1|||
160834929|NCT00552760|580781745|FG001|Overall Study|Lost to Follow-up|1|||
160834930|NCT00552760|580781744|FG000|Overall Study|Non-compliance|1|||
160834931|NCT00552760|580781745|FG001|Overall Study|Non-compliance|1|||
160834932|NCT00552760|580781744|FG000|Overall Study|Medical Condition|1|||
160834933|NCT00552760|580781745|FG001|Overall Study|Medical Condition|1|||
160834934|NCT00552760|580781744|FG000|Overall Study|Withdrawal by Subject|3|||
160834935|NCT00552760|580781745|FG001|Overall Study|Withdrawal by Subject|0|||
160834936|NCT00552760|580781744|FG000|Overall Study|Medication Change|1|||
160834937|NCT00552760|580781745|FG001|Overall Study|Medication Change|0|||
160834938|NCT00494507|580781747|FG000|Double-Blind Phase|Adverse Event|2|||
160834939|NCT00494507|580781748|FG001|Double-Blind Phase|Adverse Event|0|||
160834940|NCT00494507|580781749|FG002|Double-Blind Phase|Adverse Event|1|||
160834941|NCT00494507|580781750|FG003|Double-Blind Phase|Adverse Event|0|||
160903806|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
160903807|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
160903808|NCT00787891|581043023|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
160903809|NCT00787891|581043024|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
160903810|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
160834942|NCT00494507|580781747|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
160834943|NCT00494507|580781748|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
160903811|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
160903812|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
160903813|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
160903814|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
160903815|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
160903816|NCT00787891|581043023|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
160903817|NCT00787891|581043024|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
160903818|NCT01594281|581043025|FG000|Interventional Core Phase|Protocol Deviation|1|||
160903819|NCT01594281|581043026|FG001|Interventional Core Phase|Protocol Deviation|0|||
160903820|NCT01594281|581043027|FG002|Interventional Core Phase|Protocol Deviation|0|||
160903821|NCT01594281|581043025|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
160903822|NCT01594281|581043026|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
160903823|NCT01594281|581043027|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
160903824|NCT01594281|581043025|FG000|Interventional Core Phase|Death|1|||
160991342|NCT01168401|581357751|FG008|Overall Study|Withdrawal by Subject|0|||
160991343|NCT01168401|581357752|FG009|Overall Study|Withdrawal by Subject|0|||
160834944|NCT00494507|580781749|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160834945|NCT00494507|580781750|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160834946|NCT00494507|580781747|FG000|Double-Blind Phase|Subject Non-compliance|0|||
160834947|NCT00494507|580781748|FG001|Double-Blind Phase|Subject Non-compliance|0|||
160834948|NCT00494507|580781749|FG002|Double-Blind Phase|Subject Non-compliance|1|||
160834949|NCT00494507|580781750|FG003|Double-Blind Phase|Subject Non-compliance|0|||
160834950|NCT00494507|580781747|FG000|Double-Blind Phase|Negative DNA test|0|||
160834951|NCT00494507|580781748|FG001|Double-Blind Phase|Negative DNA test|0|||
160903825|NCT01594281|581043026|FG001|Interventional Core Phase|Death|1|||
160834952|NCT00494507|580781749|FG002|Double-Blind Phase|Negative DNA test|0|||
160834953|NCT00494507|580781750|FG003|Double-Blind Phase|Negative DNA test|1|||
160834954|NCT00494507|580781747|FG000|Open-Label Phase|Adverse Event|0|||
160991344|NCT01168401|581357753|FG010|Overall Study|Withdrawal by Subject|0|||
160991345|NCT01801930|581357755|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
160991346|NCT01801930|581357756|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
160991347|NCT01801930|581357757|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
160991348|NCT01801930|581357758|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
160991349|NCT01801930|581357755|FG000|Overall Study|DLT occurs|0|||
160991350|NCT01801930|581357756|FG001|Overall Study|DLT occurs|1|||
160834955|NCT00494507|580781748|FG001|Open-Label Phase|Adverse Event|1|||
160834956|NCT00494507|580781749|FG002|Open-Label Phase|Adverse Event|5|||
160834957|NCT00494507|580781750|FG003|Open-Label Phase|Adverse Event|3|||
160834958|NCT00494507|580781747|FG000|Open-Label Phase|Worsening Disease|0|||
160834959|NCT00494507|580781748|FG001|Open-Label Phase|Worsening Disease|0|||
160834960|NCT00494507|580781749|FG002|Open-Label Phase|Worsening Disease|0|||
160834961|NCT00494507|580781750|FG003|Open-Label Phase|Worsening Disease|2|||
160834962|NCT03615066|580781753|FG000|Main Study|Withdrew Consent|0|||
160834963|NCT03615066|580781754|FG001|Main Study|Withdrew Consent|1|||
160991351|NCT01801930|581357757|FG002|Overall Study|DLT occurs|0|||
160991352|NCT01801930|581357758|FG003|Overall Study|DLT occurs|0|||
160991353|NCT03396835|581357766|FG000|Overall Study|Withdrawn prior to completion|1|||
160991354|NCT03396835|581357766|FG000|Overall Study|Did not meet criteria for data analysis|1|||
160991355|NCT01451814|581357767|FG000|Overall Study|Withdrawal by Subject|1|||
160991356|NCT01451814|581357768|FG001|Overall Study|Withdrawal by Subject|1|||
160991357|NCT01451814|581357767|FG000|Overall Study|Lost to Follow-up|5|||
160991358|NCT01451814|581357768|FG001|Overall Study|Lost to Follow-up|4|||
160991359|NCT02049866|581357769|FG000|Overall Study|Withdrawal by Subject|1|||
160991360|NCT03101592|581357772|FG000|Overall Study|participant files could not be located|111|||
160991361|NCT03101592|581357773|FG001|Overall Study|participant files could not be located|170|||
160991362|NCT03101592|581357774|FG002|Overall Study|participant files could not be located|118|||
160991363|NCT02219490|581357778|FG000|Overall Study|Adverse Event|24|||
160991364|NCT02219490|581357778|FG000|Overall Study|Withdrew consent|96|||
160991365|NCT02219490|581357778|FG000|Overall Study|Lost to Follow-up|126|||
161137895|NCT01275222|581885707|FG002|Phase ll by Stratum|Death|0|||
161137896|NCT01275222|581885708|FG003|Phase ll by Stratum|Death|0|||
161137897|NCT01275222|581885709|FG004|Phase ll by Stratum|Death|1|||
161137898|NCT01275222|581885710|FG005|Phase ll by Stratum|Death|1|||
161137899|NCT05202808|581885711|FG000|Overall Study|Lost to Follow-up|3|||
161137900|NCT05202808|581885712|FG001|Overall Study|Lost to Follow-up|1|||
161137901|NCT02495948|581885715|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
161137902|NCT02495948|581885716|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
161137903|NCT02495948|581885715|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
161137904|NCT02495948|581885716|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
161137905|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
161137906|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161137907|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161137908|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161137909|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
161137910|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
161137911|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161137912|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
161137913|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
161137914|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161137915|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
161137916|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
161137917|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
161137918|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
161137919|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161137920|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161137921|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
161137922|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
161137923|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
161137924|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
161137925|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
161137926|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
161137927|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
161137928|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
161137929|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
161137930|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
161137931|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
161137932|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
161137933|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
160834964|NCT03615066|580781755|FG002|Main Study|Withdrew Consent|1|||
160834965|NCT03615066|580781753|FG000|Main Study|Lost to Follow-up|0|||
160834966|NCT03615066|580781754|FG001|Main Study|Lost to Follow-up|0|||
160834967|NCT03615066|580781755|FG002|Main Study|Lost to Follow-up|1|||
160834968|NCT03615066|580781753|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
160834969|NCT03615066|580781754|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
160834970|NCT03615066|580781755|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
160834971|NCT03615066|580781753|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
160834972|NCT03615066|580781754|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
160834973|NCT03615066|580781755|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
160834974|NCT03615066|580781753|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
160834975|NCT03615066|580781754|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
160834976|NCT03615066|580781755|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
160834977|NCT00924404|580781756|FG000|Overall Study|Lost to Follow-up|6|||
160834978|NCT00924404|580781757|FG001|Overall Study|Lost to Follow-up|4|||
160834979|NCT03426631|580781760|FG000|Overall Study|Lost to Follow-up|0|||
160834980|NCT03426631|580781761|FG001|Overall Study|Lost to Follow-up|1|||
160834981|NCT03831945|580781762|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
160834982|NCT03831945|580781763|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
160834983|NCT03831945|580781762|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
160834984|NCT03831945|580781763|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
160834985|NCT03831945|580781762|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
160834986|NCT03831945|580781763|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
160834987|NCT00454181|580781764|FG000|Overall Study|Adverse Event|1|||
160834988|NCT00454181|580781765|FG001|Overall Study|Adverse Event|1|||
160834989|NCT00454181|580781764|FG000|Overall Study|Lost to Follow-up|11|||
160834990|NCT00454181|580781765|FG001|Overall Study|Lost to Follow-up|1|||
160834991|NCT00454181|580781764|FG000|Overall Study|Protocol Violation|1|||
160834992|NCT00454181|580781765|FG001|Overall Study|Protocol Violation|1|||
160834993|NCT00454181|580781764|FG000|Overall Study|Withdrawal by Subject|2|||
160834994|NCT00454181|580781765|FG001|Overall Study|Withdrawal by Subject|0|||
160834995|NCT02613169|580781768|FG000|Overall Study|Withdrawal by Subject|4|||
160834996|NCT02613169|580781769|FG001|Overall Study|Withdrawal by Subject|1|||
160834997|NCT02613169|580781768|FG000|Overall Study|Lost to Follow-up|0|||
160834998|NCT02613169|580781769|FG001|Overall Study|Lost to Follow-up|5|||
160834999|NCT02613169|580781768|FG000|Overall Study|HIV|0|||
160835000|NCT02613169|580781769|FG001|Overall Study|HIV|2|||
160835001|NCT02613169|580781768|FG000|Overall Study|No TB infection endpoint|14|||
160835002|NCT02613169|580781769|FG001|Overall Study|No TB infection endpoint|9|||
160835003|NCT04032080|580781770|FG000|Overall Study|Death|6|||
160835004|NCT03729245|580781771|FG000|Overall Study|Lost to Follow-up|5|||
160835005|NCT03729245|580781772|FG001|Overall Study|Lost to Follow-up|6|||
160835006|NCT03729245|580781771|FG000|Overall Study|Withdrawal by Subject|16|||
160835007|NCT03729245|580781772|FG001|Overall Study|Withdrawal by Subject|19|||
160835008|NCT03729245|580781771|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
160835009|NCT03729245|580781772|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
160835010|NCT02096263|580781773|FG000|Overall Study|Adverse Event|1|||
160835011|NCT02096263|580781774|FG001|Overall Study|Adverse Event|0|||
160835012|NCT02096263|580781775|FG002|Overall Study|Adverse Event|1|||
160835013|NCT02096263|580781773|FG000|Overall Study|Lost to Follow-up|14|||
160835014|NCT02096263|580781774|FG001|Overall Study|Lost to Follow-up|18|||
160835015|NCT02096263|580781775|FG002|Overall Study|Lost to Follow-up|15|||
160835016|NCT02096263|580781773|FG000|Overall Study|Other|7|||
160835017|NCT02096263|580781774|FG001|Overall Study|Other|9|||
160835018|NCT02096263|580781775|FG002|Overall Study|Other|6|||
160835019|NCT02096263|580781773|FG000|Overall Study|Sponsor study termination|0|||
160835020|NCT02096263|580781774|FG001|Overall Study|Sponsor study termination|0|||
160835021|NCT02096263|580781775|FG002|Overall Study|Sponsor study termination|1|||
160835022|NCT02096263|580781773|FG000|Overall Study|Protocol Violation|7|||
160835023|NCT02096263|580781774|FG001|Overall Study|Protocol Violation|2|||
160835024|NCT02096263|580781775|FG002|Overall Study|Protocol Violation|8|||
160835025|NCT02096263|580781773|FG000|Overall Study|Withdrawal by Subject|5|||
160835026|NCT02096263|580781774|FG001|Overall Study|Withdrawal by Subject|7|||
160835027|NCT02096263|580781775|FG002|Overall Study|Withdrawal by Subject|8|||
160835028|NCT00845065|580781788|FG000|Overall Study|Adverse Event|3|||
160835029|NCT00845065|580781789|FG001|Overall Study|Adverse Event|23|||
160835030|NCT00845065|580781788|FG000|Overall Study|Lack of Efficacy|43|||
160835031|NCT00845065|580781789|FG001|Overall Study|Lack of Efficacy|21|||
160835032|NCT00845065|580781788|FG000|Overall Study|Non-Medical Reasons|1|||
160835033|NCT00845065|580781789|FG001|Overall Study|Non-Medical Reasons|11|||
160835034|NCT03652675|580781794|FG000|Overall Study|Lost to Follow-up|4|||
160835035|NCT03652675|580781795|FG001|Overall Study|Lost to Follow-up|4|||
160835036|NCT03101085|580781797|FG000|Overall Study|Lost to Follow-up|0|||
160835037|NCT03101085|580781798|FG001|Overall Study|Lost to Follow-up|1|||
160835038|NCT00695864|580781805|FG000|Placebo|Withdrawal by Subject|1|||
160835039|NCT00695864|580781805|FG000|Placebo|Physician Decision|4|||
160835040|NCT01624090|580781806|FG000|Overall Study|DLT, taken off therapy|0|||
160835041|NCT01624090|580781807|FG001|Overall Study|DLT, taken off therapy|1|||
160835042|NCT01624090|580781808|FG002|Overall Study|DLT, taken off therapy|0|||
160835043|NCT01624090|580781809|FG003|Overall Study|DLT, taken off therapy|0|||
160835044|NCT01624090|580781806|FG000|Overall Study|Withdrew prior to treatment|0|||
160835045|NCT01624090|580781807|FG001|Overall Study|Withdrew prior to treatment|1|||
160835046|NCT01624090|580781808|FG002|Overall Study|Withdrew prior to treatment|0|||
160835047|NCT01624090|580781809|FG003|Overall Study|Withdrew prior to treatment|0|||
160835048|NCT01624090|580781806|FG000|Overall Study|Died on study|0|||
160835049|NCT01624090|580781807|FG001|Overall Study|Died on study|0|||
160835050|NCT01624090|580781808|FG002|Overall Study|Died on study|2|||
160835051|NCT01624090|580781809|FG003|Overall Study|Died on study|0|||
160835052|NCT01624090|580781806|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
160835053|NCT01624090|580781807|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
160835054|NCT01624090|580781808|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
160835055|NCT01624090|580781809|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
160835056|NCT01624090|580781806|FG000|Overall Study|Dose escalated|0|||
161137934|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
161137935|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
161137936|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
161137937|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
161137938|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
161137939|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
161137940|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
161137941|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
161137942|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
161137943|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
161137944|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
161137945|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
161137946|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
161137947|NCT00100048|581885718|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161137948|NCT00100048|581885719|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161137949|NCT00100048|581885720|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161137950|NCT00100048|581885721|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
161137951|NCT00100048|581885722|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161137952|NCT00100048|581885723|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
161137953|NCT00818259|581885728|FG000|Part I|Withdrawal by Subject|1|||
161137954|NCT00818259|581885729|FG001|Part I|Withdrawal by Subject|0|||
161137955|NCT00818259|581885730|FG002|Part I|Withdrawal by Subject|0|||
161137956|NCT00818259|581885731|FG003|Part I|Withdrawal by Subject|0|||
161137957|NCT00818259|581885732|FG004|Part I|Withdrawal by Subject|0|||
161137958|NCT00818259|581885733|FG005|Part I|Withdrawal by Subject|0|||
161137959|NCT00818259|581885734|FG006|Part I|Withdrawal by Subject|0|||
161137960|NCT00818259|581885735|FG007|Part I|Withdrawal by Subject|0|||
161137961|NCT00818259|581885736|FG008|Part I|Withdrawal by Subject|0|||
161137962|NCT00818259|581885728|FG000|Part II|Physician Decision|0|||
161137963|NCT00818259|581885729|FG001|Part II|Physician Decision|0|||
161137964|NCT00818259|581885730|FG002|Part II|Physician Decision|1|||
161137965|NCT00818259|581885731|FG003|Part II|Physician Decision|0|||
161137966|NCT00818259|581885732|FG004|Part II|Physician Decision|0|||
161137967|NCT00818259|581885733|FG005|Part II|Physician Decision|0|||
161137968|NCT00818259|581885734|FG006|Part II|Physician Decision|0|||
161137969|NCT00818259|581885735|FG007|Part II|Physician Decision|0|||
161137970|NCT00818259|581885736|FG008|Part II|Physician Decision|0|||
161137971|NCT00818259|581885728|FG000|Part II|Lack of Efficacy|0|||
161137972|NCT00818259|581885729|FG001|Part II|Lack of Efficacy|0|||
161137973|NCT00818259|581885730|FG002|Part II|Lack of Efficacy|0|||
161137974|NCT00818259|581885731|FG003|Part II|Lack of Efficacy|1|||
161137975|NCT00818259|581885732|FG004|Part II|Lack of Efficacy|0|||
161137976|NCT00818259|581885733|FG005|Part II|Lack of Efficacy|0|||
161137977|NCT00818259|581885734|FG006|Part II|Lack of Efficacy|0|||
161137978|NCT00818259|581885735|FG007|Part II|Lack of Efficacy|0|||
161137979|NCT00818259|581885736|FG008|Part II|Lack of Efficacy|0|||
161137980|NCT00818259|581885728|FG000|Part II|Not Treated|0|||
161137981|NCT00818259|581885729|FG001|Part II|Not Treated|0|||
161137982|NCT00818259|581885730|FG002|Part II|Not Treated|0|||
161137983|NCT00818259|581885731|FG003|Part II|Not Treated|1|||
161137984|NCT00818259|581885732|FG004|Part II|Not Treated|0|||
161137985|NCT00818259|581885733|FG005|Part II|Not Treated|0|||
161137986|NCT00818259|581885734|FG006|Part II|Not Treated|0|||
161137987|NCT00818259|581885735|FG007|Part II|Not Treated|0|||
161137988|NCT00818259|581885736|FG008|Part II|Not Treated|0|||
161137989|NCT00818259|581885728|FG000|Part IV|Physician Decision|0|||
160835057|NCT01624090|580781807|FG001|Overall Study|Dose escalated|0|||
160835058|NCT01624090|580781808|FG002|Overall Study|Dose escalated|3|||
160835059|NCT01624090|580781809|FG003|Overall Study|Dose escalated|0|||
160835060|NCT00752726|580781810|FG000|Overall Study|Lost to Follow-up|2|||
160835061|NCT00752726|580781811|FG001|Overall Study|Lost to Follow-up|1|||
160835062|NCT00752726|580781810|FG000|Overall Study|Adverse Event|3|||
160835063|NCT00752726|580781811|FG001|Overall Study|Adverse Event|0|||
160835064|NCT00752726|580781810|FG000|Overall Study|Withdrawal by Subject|5|||
160835065|NCT00752726|580781811|FG001|Overall Study|Withdrawal by Subject|10|||
160835066|NCT00752726|580781810|FG000|Overall Study|Other Reason|1|||
160835067|NCT00752726|580781811|FG001|Overall Study|Other Reason|2|||
160835068|NCT01895309|580781812|FG000|Overall Study|Adverse Event|13|||
160835069|NCT01895309|580781813|FG001|Overall Study|Adverse Event|17|||
160835070|NCT01895309|580781812|FG000|Overall Study|Protocol Violation|1|||
160835071|NCT01895309|580781813|FG001|Overall Study|Protocol Violation|0|||
160835072|NCT01895309|580781812|FG000|Overall Study|Lack of Efficacy|1|||
160835073|NCT01895309|580781813|FG001|Overall Study|Lack of Efficacy|3|||
160835074|NCT01895309|580781812|FG000|Overall Study|Lost to Follow-up|1|||
160835075|NCT01895309|580781813|FG001|Overall Study|Lost to Follow-up|3|||
160835076|NCT01895309|580781812|FG000|Overall Study|Physician Decision|15|||
160835077|NCT01895309|580781813|FG001|Overall Study|Physician Decision|10|||
160835078|NCT01895309|580781812|FG000|Overall Study|Withdrawal by Subject|9|||
160835079|NCT01895309|580781813|FG001|Overall Study|Withdrawal by Subject|18|||
160835080|NCT04232215|580781814|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160835081|NCT04232215|580781815|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160835082|NCT01555125|580781818|FG000|Induction Period|Lost to Follow-up|0|||
160835083|NCT01555125|580781819|FG001|Induction Period|Lost to Follow-up|2|||
160835084|NCT01555125|580781820|FG002|Induction Period|Lost to Follow-up|0|||
160835085|NCT01555125|580781821|FG003|Induction Period|Lost to Follow-up|0|||
160835086|NCT01555125|580781822|FG004|Induction Period|Lost to Follow-up|0|||
160835087|NCT01555125|580781818|FG000|Induction Period|Adverse Event|0|||
160835088|NCT01555125|580781819|FG001|Induction Period|Adverse Event|1|||
160835089|NCT01555125|580781820|FG002|Induction Period|Adverse Event|0|||
160835090|NCT01555125|580781821|FG003|Induction Period|Adverse Event|0|||
160835091|NCT01555125|580781822|FG004|Induction Period|Adverse Event|1|||
160835092|NCT01555125|580781818|FG000|Induction Period|Subject / guardian decision|0|||
160835093|NCT01555125|580781819|FG001|Induction Period|Subject / guardian decision|0|||
160835094|NCT01555125|580781820|FG002|Induction Period|Subject / guardian decision|0|||
160835095|NCT01555125|580781821|FG003|Induction Period|Subject / guardian decision|0|||
160835096|NCT01555125|580781822|FG004|Induction Period|Subject / guardian decision|2|||
160835097|NCT01555125|580781818|FG000|Induction Period|Death|1|||
160835098|NCT01555125|580781819|FG001|Induction Period|Death|0|||
160835099|NCT01555125|580781820|FG002|Induction Period|Death|0|||
160835100|NCT01555125|580781821|FG003|Induction Period|Death|0|||
160835101|NCT01555125|580781822|FG004|Induction Period|Death|0|||
160835102|NCT01555125|580781818|FG000|Maintenance Period|Adverse Event|1|||
160835103|NCT01555125|580781819|FG001|Maintenance Period|Adverse Event|1|||
160835104|NCT01555125|580781820|FG002|Maintenance Period|Adverse Event|0|||
160835105|NCT01555125|580781821|FG003|Maintenance Period|Adverse Event|0|||
160835106|NCT01555125|580781822|FG004|Maintenance Period|Adverse Event|0|||
160835107|NCT01555125|580781818|FG000|Maintenance Period|Subject / guardian decision|1|||
160835108|NCT01555125|580781819|FG001|Maintenance Period|Subject / guardian decision|2|||
160835109|NCT01555125|580781820|FG002|Maintenance Period|Subject / guardian decision|0|||
160835110|NCT01555125|580781821|FG003|Maintenance Period|Subject / guardian decision|0|||
160835111|NCT01555125|580781822|FG004|Maintenance Period|Subject / guardian decision|0|||
160835112|NCT01555125|580781818|FG000|Maintenance Period|Lost to Follow-up|2|||
160835113|NCT01555125|580781819|FG001|Maintenance Period|Lost to Follow-up|0|||
160835114|NCT01555125|580781820|FG002|Maintenance Period|Lost to Follow-up|0|||
160835115|NCT01555125|580781821|FG003|Maintenance Period|Lost to Follow-up|1|||
160835116|NCT01555125|580781822|FG004|Maintenance Period|Lost to Follow-up|0|||
160835117|NCT01555125|580781818|FG000|Maintenance Period|Lack of Efficacy|6|||
160835118|NCT01555125|580781819|FG001|Maintenance Period|Lack of Efficacy|1|||
160835119|NCT01555125|580781820|FG002|Maintenance Period|Lack of Efficacy|3|||
160835120|NCT01555125|580781821|FG003|Maintenance Period|Lack of Efficacy|0|||
160835121|NCT01555125|580781822|FG004|Maintenance Period|Lack of Efficacy|0|||
161137990|NCT00818259|581885729|FG001|Part IV|Physician Decision|0|||
161137991|NCT00818259|581885730|FG002|Part IV|Physician Decision|0|||
160835122|NCT01555125|580781818|FG000|Maintenance Period|Physician Decision|0|||
160835123|NCT01555125|580781819|FG001|Maintenance Period|Physician Decision|0|||
160835124|NCT01555125|580781820|FG002|Maintenance Period|Physician Decision|1|||
161137992|NCT00818259|581885731|FG003|Part IV|Physician Decision|0|||
161137993|NCT00818259|581885732|FG004|Part IV|Physician Decision|0|||
161137994|NCT00818259|581885733|FG005|Part IV|Physician Decision|1|||
161137995|NCT00818259|581885734|FG006|Part IV|Physician Decision|0|||
161137996|NCT00818259|581885735|FG007|Part IV|Physician Decision|0|||
161137997|NCT00818259|581885736|FG008|Part IV|Physician Decision|0|||
161137998|NCT00818259|581885728|FG000|Part V|Adverse Event|0|||
161137999|NCT00818259|581885729|FG001|Part V|Adverse Event|0|||
161138000|NCT00818259|581885730|FG002|Part V|Adverse Event|0|||
161138001|NCT00818259|581885731|FG003|Part V|Adverse Event|0|||
161138002|NCT00818259|581885732|FG004|Part V|Adverse Event|0|||
161138003|NCT00818259|581885733|FG005|Part V|Adverse Event|0|||
161138004|NCT00818259|581885734|FG006|Part V|Adverse Event|0|||
161138005|NCT00818259|581885735|FG007|Part V|Adverse Event|1|||
161138006|NCT00818259|581885736|FG008|Part V|Adverse Event|0|||
161138007|NCT04640766|581885737|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
161138008|NCT01237951|581885738|FG000|Overall Study|Death|1|||
161138009|NCT02970929|581885741|FG000|Overall Study|Adverse Event|18|||
161138010|NCT02970929|581885741|FG000|Overall Study|Lack of Efficacy|8|||
161138011|NCT02970929|581885741|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
161138012|NCT02970929|581885741|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
161138013|NCT02970929|581885741|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
161138014|NCT02970929|581885741|FG000|Overall Study|LOST TO FOLLOWUP|6|||
161138015|NCT02970929|581885741|FG000|Overall Study|MOVED OUT OF STATE|1|||
161138016|NCT02970929|581885741|FG000|Overall Study|Withdrawal by Subject|16|||
161138017|NCT00666562|581885744|FG000|Overall Study|Withdrawal by Subject|0|||
161138018|NCT00666562|581885745|FG001|Overall Study|Withdrawal by Subject|1|||
161138019|NCT00666562|581885746|FG002|Overall Study|Withdrawal by Subject|0|||
161138020|NCT00666562|581885744|FG000|Overall Study|Concomitant Medication|0|||
161138021|NCT00666562|581885745|FG001|Overall Study|Concomitant Medication|1|||
160835125|NCT01555125|580781821|FG003|Maintenance Period|Physician Decision|0|||
160835126|NCT01555125|580781822|FG004|Maintenance Period|Physician Decision|0|||
160835127|NCT01555125|580781818|FG000|Maintenance Period|Death|0|||
160835128|NCT01555125|580781819|FG001|Maintenance Period|Death|0|||
160835129|NCT01555125|580781820|FG002|Maintenance Period|Death|0|||
160835130|NCT01555125|580781821|FG003|Maintenance Period|Death|1|||
160835131|NCT01555125|580781822|FG004|Maintenance Period|Death|0|||
160835132|NCT01555125|580781818|FG000|Extension|Adverse Event|1|||
160835133|NCT01555125|580781819|FG001|Extension|Adverse Event|2|||
160835134|NCT01555125|580781820|FG002|Extension|Adverse Event|1|||
160835135|NCT01555125|580781821|FG003|Extension|Adverse Event|1|||
160835136|NCT01555125|580781822|FG004|Extension|Adverse Event|0|||
160835137|NCT01555125|580781818|FG000|Extension|Protocol deviation|1|||
160835138|NCT01555125|580781819|FG001|Extension|Protocol deviation|0|||
160835139|NCT01555125|580781820|FG002|Extension|Protocol deviation|0|||
160835140|NCT01555125|580781821|FG003|Extension|Protocol deviation|0|||
160835141|NCT01555125|580781822|FG004|Extension|Protocol deviation|0|||
160835142|NCT01555125|580781818|FG000|Extension|Lack of Efficacy|7|||
160835143|NCT01555125|580781819|FG001|Extension|Lack of Efficacy|6|||
160835144|NCT01555125|580781820|FG002|Extension|Lack of Efficacy|3|||
160835145|NCT01555125|580781821|FG003|Extension|Lack of Efficacy|0|||
160835146|NCT01555125|580781822|FG004|Extension|Lack of Efficacy|0|||
160835147|NCT01555125|580781818|FG000|Extension|Lost to Follow-up|2|||
160835148|NCT01555125|580781819|FG001|Extension|Lost to Follow-up|1|||
160835149|NCT01555125|580781820|FG002|Extension|Lost to Follow-up|2|||
160835150|NCT01555125|580781821|FG003|Extension|Lost to Follow-up|0|||
160835151|NCT01555125|580781822|FG004|Extension|Lost to Follow-up|0|||
160835152|NCT01555125|580781818|FG000|Extension|Study terminated by sponsor|32|||
160835153|NCT01555125|580781819|FG001|Extension|Study terminated by sponsor|33|||
160835154|NCT01555125|580781820|FG002|Extension|Study terminated by sponsor|16|||
160835155|NCT01555125|580781821|FG003|Extension|Study terminated by sponsor|20|||
160835156|NCT01555125|580781822|FG004|Extension|Study terminated by sponsor|0|||
160835157|NCT01555125|580781818|FG000|Extension|Subject/guardian decision|1|||
160835158|NCT01555125|580781819|FG001|Extension|Subject/guardian decision|9|||
160835159|NCT01555125|580781820|FG002|Extension|Subject/guardian decision|1|||
160835160|NCT01555125|580781821|FG003|Extension|Subject/guardian decision|0|||
160835161|NCT01555125|580781822|FG004|Extension|Subject/guardian decision|0|||
160835162|NCT01555125|580781818|FG000|Extension|Technical Problems|1|||
161138022|NCT00666562|581885746|FG002|Overall Study|Concomitant Medication|0|||
161138023|NCT00075881|581887020|FG000|Overall Study|Lack of Efficacy|18|||
160835163|NCT01555125|580781819|FG001|Extension|Technical Problems|0|||
160835164|NCT01555125|580781820|FG002|Extension|Technical Problems|0|||
160835165|NCT01555125|580781821|FG003|Extension|Technical Problems|1|||
160835166|NCT01555125|580781822|FG004|Extension|Technical Problems|0|||
161138024|NCT00075881|581887020|FG000|Overall Study|Adverse Event|7|||
160835167|NCT01555125|580781818|FG000|Follow-Up Period|Lost to Follow-up|1|||
160835168|NCT01555125|580781819|FG001|Follow-Up Period|Lost to Follow-up|0|||
161138025|NCT00075881|581887020|FG000|Overall Study|Death|1|||
161138026|NCT00075881|581887020|FG000|Overall Study|Withdrawal by Subject|2|||
161138027|NCT00075881|581887020|FG000|Overall Study|Protocol Violation|4|||
161138028|NCT00075881|581887020|FG000|Overall Study|other complicating disease|3|||
161138029|NCT00075881|581887020|FG000|Overall Study|other|4|||
161138030|NCT00075881|581887020|FG000|Overall Study|missing data|2|||
161138031|NCT00075881|581887020|FG000|Overall Study|Ineligible|1|||
161248982|NCT01721772|582291654|FG001|Treatment|Participant request to discontinue study treatment|8|||
161248983|NCT01721772|582291653|FG000|Treatment|Death|1|||
161248984|NCT01721772|582291654|FG001|Treatment|Death|0|||
161248985|NCT01721772|582291653|FG000|Treatment|Not reported|1|||
161248986|NCT01721772|582291654|FG001|Treatment|Not reported|0|||
161248987|NCT01721772|582291653|FG000|Treatment|Poor/non-compliance|1|||
160835169|NCT01555125|580781820|FG002|Follow-Up Period|Lost to Follow-up|0|||
160835170|NCT01555125|580781821|FG003|Follow-Up Period|Lost to Follow-up|0|||
160835171|NCT01555125|580781822|FG004|Follow-Up Period|Lost to Follow-up|0|||
160835172|NCT01555125|580781818|FG000|Follow-Up Period|Subject / guardian decision|3|||
160835173|NCT01555125|580781819|FG001|Follow-Up Period|Subject / guardian decision|1|||
160835174|NCT01555125|580781820|FG002|Follow-Up Period|Subject / guardian decision|1|||
160835175|NCT01555125|580781821|FG003|Follow-Up Period|Subject / guardian decision|1|||
160835176|NCT01555125|580781822|FG004|Follow-Up Period|Subject / guardian decision|0|||
160835177|NCT02039856|580781824|FG000|Overall Study|Death|5|||
160835178|NCT02039856|580781825|FG001|Overall Study|Death|3|||
160835179|NCT02039856|580781824|FG000|Overall Study|Partial survey completion|61|||
160835180|NCT02039856|580781825|FG001|Overall Study|Partial survey completion|26|||
160835181|NCT02039856|580781824|FG000|Overall Study|Lost to Follow-up|388|||
160835182|NCT02039856|580781825|FG001|Overall Study|Lost to Follow-up|206|||
160835183|NCT02039856|580781824|FG000|Overall Study|Withdrawal by Subject|1573|||
160835184|NCT02039856|580781825|FG001|Overall Study|Withdrawal by Subject|618|||
160835185|NCT05327361|580781839|FG000|Overall Study|Lost to Follow-up|4|||
160835186|NCT00626405|580781840|FG000|Overall Study|Deemed Ineligible|1|||
160835187|NCT00626405|580781841|FG001|Overall Study|Deemed Ineligible|0|||
160835188|NCT00626405|580781840|FG000|Overall Study|Withdrawal by Subject|0|||
160835189|NCT00626405|580781841|FG001|Overall Study|Withdrawal by Subject|1|||
160835190|NCT01174173|580781842|FG000|Overall Study|drug-drug interaction|1|||
160835191|NCT00649428|580784275|FG000|Overall Study|Adverse Event|2|||
160835192|NCT00649428|580784276|FG001|Overall Study|Adverse Event|2|||
160835193|NCT00649428|580784275|FG000|Overall Study|Withdrawal by Subject|6|||
160835194|NCT00649428|580784276|FG001|Overall Study|Withdrawal by Subject|6|||
160835195|NCT00649428|580784275|FG000|Overall Study|Lost to Follow-up|1|||
160835196|NCT00649428|580784276|FG001|Overall Study|Lost to Follow-up|3|||
160835197|NCT00649428|580784275|FG000|Overall Study|Insufficient manufacturing yield|5|||
161248988|NCT01721772|582291654|FG001|Treatment|Poor/non-compliance|0|||
160835198|NCT00649428|580784276|FG001|Overall Study|Insufficient manufacturing yield|1|||
160835199|NCT00649428|580784275|FG000|Overall Study|Protocol Violation|6|||
160835200|NCT00649428|580784276|FG001|Overall Study|Protocol Violation|2|||
160835201|NCT00649428|580784275|FG000|Overall Study|Physician Decision|0|||
160835202|NCT00649428|580784276|FG001|Overall Study|Physician Decision|1|||
160835203|NCT02503501|580784277|FG000|Overall Study|Physician Decision|1|||
160835204|NCT02503501|580784278|FG001|Overall Study|Physician Decision|0|||
160835205|NCT02503501|580784277|FG000|Overall Study|Protocol Violation|0|||
160835206|NCT02503501|580784278|FG001|Overall Study|Protocol Violation|1|||
160835207|NCT02503501|580784277|FG000|Overall Study|Withdrawal by Subject|0|||
160835208|NCT02503501|580784278|FG001|Overall Study|Withdrawal by Subject|2|||
160835209|NCT01740401|580784279|FG000|Overall Study|Progression of disease|6|||
160835210|NCT01740401|580784279|FG000|Overall Study|Adverse Event|2|||
160835211|NCT01740401|580784279|FG000|Overall Study|Did not reach primary endpoint|2|||
160835212|NCT02315560|580784280|FG000|Overall Study|noncompliance by subjects|3|||
160835213|NCT02008227|580784281|FG000|Overall Study|Lost to Follow-up|7|||
160835214|NCT02008227|580784282|FG001|Overall Study|Lost to Follow-up|9|||
160835215|NCT02008227|580784281|FG000|Overall Study|Death|494|||
160835216|NCT02008227|580784282|FG001|Overall Study|Death|485|||
160835217|NCT02008227|580784281|FG000|Overall Study|Withdrawal by Subject|67|||
160835218|NCT02008227|580784282|FG001|Overall Study|Withdrawal by Subject|36|||
160835219|NCT02008227|580784281|FG000|Overall Study|Study Terminated By Sponsor|44|||
160835220|NCT02008227|580784282|FG001|Overall Study|Study Terminated By Sponsor|83|||
160835221|NCT04599465|580784283|FG000|Overall Study|Physician Decision|1|||
160835222|NCT04599465|580784283|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
160835223|NCT04566601|580784284|FG000|Overall Study|Other than listed|13|||
160835224|NCT04566601|580784285|FG001|Overall Study|Other than listed|4|||
160835225|NCT04566601|580784286|FG002|Overall Study|Other than listed|2|||
160835226|NCT04566601|580784287|FG003|Overall Study|Other than listed|1|||
160835227|NCT04566601|580784288|FG004|Overall Study|Other than listed|4|||
160835228|NCT04566601|580784284|FG000|Overall Study|Protocol deviation|3|||
160835229|NCT04566601|580784285|FG001|Overall Study|Protocol deviation|0|||
160835230|NCT04566601|580784286|FG002|Overall Study|Protocol deviation|1|||
160835231|NCT04566601|580784287|FG003|Overall Study|Protocol deviation|1|||
160835232|NCT04566601|580784288|FG004|Overall Study|Protocol deviation|1|||
160835233|NCT04566601|580784284|FG000|Overall Study|Technical problems|0|||
160835234|NCT04566601|580784285|FG001|Overall Study|Technical problems|0|||
160835235|NCT04566601|580784286|FG002|Overall Study|Technical problems|1|||
160835236|NCT04566601|580784287|FG003|Overall Study|Technical problems|0|||
160835237|NCT04566601|580784288|FG004|Overall Study|Technical problems|0|||
161248989|NCT01721772|582291653|FG000|Treatment|Lost to Follow-up|0|||
161248990|NCT01721772|582291654|FG001|Treatment|Lost to Follow-up|1|||
161248991|NCT02754492|582291655|FG000|Overall Study|Protocol Violation|2|||
160835238|NCT04566601|580784284|FG000|Overall Study|No reason available|3|||
160835239|NCT04566601|580784285|FG001|Overall Study|No reason available|2|||
160835240|NCT04566601|580784286|FG002|Overall Study|No reason available|7|||
160835241|NCT04566601|580784287|FG003|Overall Study|No reason available|1|||
160835242|NCT04566601|580784288|FG004|Overall Study|No reason available|5|||
160835243|NCT04566601|580784284|FG000|Overall Study|Burden of study procedures|3|||
161248992|NCT02754492|582291656|FG001|Overall Study|Protocol Violation|2|||
161248993|NCT02754492|582291657|FG002|Overall Study|Protocol Violation|0|||
161248994|NCT02754492|582291658|FG003|Overall Study|Protocol Violation|1|||
161248995|NCT02754492|582291655|FG000|Overall Study|Withdrawal by Subject|2|||
161248996|NCT02754492|582291656|FG001|Overall Study|Withdrawal by Subject|0|||
161248997|NCT02754492|582291657|FG002|Overall Study|Withdrawal by Subject|0|||
161248998|NCT02754492|582291658|FG003|Overall Study|Withdrawal by Subject|0|||
161248999|NCT02754492|582291655|FG000|Overall Study|Equipment malfuntion|0|||
161249000|NCT02754492|582291656|FG001|Overall Study|Equipment malfuntion|0|||
161249001|NCT02754492|582291657|FG002|Overall Study|Equipment malfuntion|2|||
161249002|NCT02754492|582291658|FG003|Overall Study|Equipment malfuntion|5|||
161249003|NCT02754492|582291655|FG000|Overall Study|Adverse Event|0|||
161249004|NCT02754492|582291656|FG001|Overall Study|Adverse Event|0|||
161249005|NCT02754492|582291657|FG002|Overall Study|Adverse Event|0|||
161249006|NCT02754492|582291658|FG003|Overall Study|Adverse Event|13|||
161249007|NCT02754492|582291655|FG000|Overall Study|Venous access issues not resulting in AE|0|||
161249008|NCT02754492|582291656|FG001|Overall Study|Venous access issues not resulting in AE|0|||
161249009|NCT02754492|582291657|FG002|Overall Study|Venous access issues not resulting in AE|0|||
161249010|NCT02754492|582291658|FG003|Overall Study|Venous access issues not resulting in AE|4|||
161249011|NCT01408888|582291659|FG000|First Intervention|Adverse Event|0|||
161334947|NCT02616783|582615868|FG001|Overall Study|Randomized but Not Treated|0|||
161334948|NCT02616783|582615867|FG000|Overall Study|Adverse Event|1|||
160835244|NCT04566601|580784285|FG001|Overall Study|Burden of study procedures|0|||
160835245|NCT04566601|580784286|FG002|Overall Study|Burden of study procedures|0|||
160835246|NCT04566601|580784287|FG003|Overall Study|Burden of study procedures|3|||
160835247|NCT04566601|580784288|FG004|Overall Study|Burden of study procedures|1|||
160835248|NCT04566601|580784284|FG000|Overall Study|Change of residence|2|||
160835249|NCT04566601|580784285|FG001|Overall Study|Change of residence|2|||
160835250|NCT04566601|580784286|FG002|Overall Study|Change of residence|0|||
160835251|NCT04566601|580784287|FG003|Overall Study|Change of residence|1|||
160835252|NCT04566601|580784288|FG004|Overall Study|Change of residence|2|||
160835253|NCT04566601|580784284|FG000|Overall Study|Perceived lack of efficacy|2|||
160835254|NCT04566601|580784285|FG001|Overall Study|Perceived lack of efficacy|0|||
160835255|NCT04566601|580784286|FG002|Overall Study|Perceived lack of efficacy|1|||
160835256|NCT04566601|580784287|FG003|Overall Study|Perceived lack of efficacy|1|||
160835257|NCT04566601|580784288|FG004|Overall Study|Perceived lack of efficacy|2|||
160835258|NCT04566601|580784284|FG000|Overall Study|Adverse Event|7|||
160835259|NCT04566601|580784285|FG001|Overall Study|Adverse Event|4|||
160835260|NCT04566601|580784286|FG002|Overall Study|Adverse Event|6|||
160835261|NCT04566601|580784287|FG003|Overall Study|Adverse Event|5|||
160835262|NCT04566601|580784288|FG004|Overall Study|Adverse Event|12|||
160835263|NCT01272635|580784291|FG000|Overall Study|Lost to Follow-up|31|||
160835264|NCT01272635|580784292|FG001|Overall Study|Lost to Follow-up|20|||
160835265|NCT01272635|580784293|FG002|Overall Study|Lost to Follow-up|31|||
160835266|NCT01272635|580784294|FG003|Overall Study|Lost to Follow-up|23|||
160835267|NCT01543776|580784297|FG000|Overall Study|Withdrawal by Subject|2|||
160835268|NCT01543776|580784298|FG001|Overall Study|Withdrawal by Subject|2|||
160835269|NCT00306527|580784299|FG000|Overall Study|Lost to Follow-up|3|||
160835270|NCT00306527|580784300|FG001|Overall Study|Lost to Follow-up|4|||
160835271|NCT00306527|580784301|FG002|Overall Study|Lost to Follow-up|3|||
160835272|NCT00306527|580784302|FG003|Overall Study|Lost to Follow-up|0|||
160835273|NCT00306527|580784299|FG000|Overall Study|Withdrawal by Subject|2|||
160835274|NCT00306527|580784300|FG001|Overall Study|Withdrawal by Subject|3|||
160835275|NCT00306527|580784301|FG002|Overall Study|Withdrawal by Subject|0|||
160835276|NCT00306527|580784302|FG003|Overall Study|Withdrawal by Subject|3|||
160835277|NCT00306527|580784299|FG000|Overall Study|Adverse Event|0|||
160835278|NCT00306527|580784300|FG001|Overall Study|Adverse Event|0|||
160835279|NCT00306527|580784301|FG002|Overall Study|Adverse Event|1|||
160835280|NCT00306527|580784302|FG003|Overall Study|Adverse Event|1|||
160835281|NCT00306527|580784299|FG000|Overall Study|Death|1|||
160835282|NCT00306527|580784300|FG001|Overall Study|Death|0|||
160835283|NCT00306527|580784301|FG002|Overall Study|Death|1|||
160835284|NCT00306527|580784302|FG003|Overall Study|Death|2|||
160835285|NCT02702180|580784303|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
160903826|NCT01594281|581043027|FG002|Interventional Core Phase|Death|2|||
161249012|NCT01408888|582291660|FG001|First Intervention|Adverse Event|1|||
161249013|NCT01408888|582291659|FG000|First Intervention|Withdrawal by Subject|0|||
161249014|NCT01408888|582291660|FG001|First Intervention|Withdrawal by Subject|2|||
161249015|NCT01408888|582291659|FG000|Second Intervention|Withdrawal by Subject|1|||
161249016|NCT01408888|582291660|FG001|Second Intervention|Withdrawal by Subject|0|||
161249017|NCT01408888|582291659|FG000|Second Intervention|Adverse Event|1|||
161249018|NCT01408888|582291660|FG001|Second Intervention|Adverse Event|0|||
161138032|NCT00075881|581887020|FG000|Overall Study|never start protocol therapy|1|||
161138033|NCT02224664|581887021|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
161138034|NCT02224664|581887022|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161138035|NCT02224664|581887023|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161138036|NCT02224664|581887024|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161138037|NCT02224664|581887025|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
161138038|NCT02224664|581887021|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
161138039|NCT02224664|581887022|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
161138040|NCT02224664|581887023|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
161138041|NCT02224664|581887024|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
161138042|NCT02224664|581887025|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
161138043|NCT02224664|581887021|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161138044|NCT02224664|581887022|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161138045|NCT02224664|581887023|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
161138046|NCT02224664|581887024|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
161138047|NCT02224664|581887025|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
161138048|NCT03182738|581887037|FG000|Overall Study|Lost to Follow-up|9|||
161138049|NCT03182738|581887038|FG001|Overall Study|Lost to Follow-up|3|||
161138050|NCT03182738|581887037|FG000|Overall Study|Pregnancy|0|||
161138051|NCT03182738|581887038|FG001|Overall Study|Pregnancy|1|||
161138052|NCT03182738|581887037|FG000|Overall Study|Withdrawal by Subject|0|||
161138053|NCT03182738|581887038|FG001|Overall Study|Withdrawal by Subject|1|||
161138054|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
161138055|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
161138056|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
161138057|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
161138058|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
160835286|NCT02702180|580784304|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
160835287|NCT02702180|580784305|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
160835288|NCT02702180|580784303|FG000|Double-blind Treatment Period|Adverse Event|0|||
160835289|NCT02702180|580784304|FG001|Double-blind Treatment Period|Adverse Event|0|||
160835290|NCT02702180|580784305|FG002|Double-blind Treatment Period|Adverse Event|1|||
160835291|NCT02702180|580784303|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
160835292|NCT02702180|580784304|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
160835293|NCT02702180|580784305|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
160835294|NCT02702180|580784303|FG000|Double-blind Treatment Period|Protocol Violation|0|||
160835295|NCT02702180|580784304|FG001|Double-blind Treatment Period|Protocol Violation|0|||
160835296|NCT02702180|580784305|FG002|Double-blind Treatment Period|Protocol Violation|2|||
160835297|NCT02702180|580784303|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
160835298|NCT02702180|580784304|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
160835299|NCT02702180|580784305|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
160835300|NCT02702180|580784303|FG000|Open-label Treatment Period|Withdrawn in error|0|||
160835301|NCT02702180|580784304|FG001|Open-label Treatment Period|Withdrawn in error|0|||
160835302|NCT02702180|580784305|FG002|Open-label Treatment Period|Withdrawn in error|1|||
160835303|NCT00567359|580784306|FG000|Overall Study|Withdrawal by Subject|1|||
160835304|NCT00785980|580784307|FG000|7 Day Washout Period|Protocol Violation|3|||
160835305|NCT02397057|580784308|FG000|Overall Study|Withdrawal by Subject|6|||
160835306|NCT02397057|580784309|FG001|Overall Study|Withdrawal by Subject|7|||
160835307|NCT02397057|580784308|FG000|Overall Study|Lost to Follow-up|4|||
160835308|NCT02397057|580784309|FG001|Overall Study|Lost to Follow-up|3|||
160835309|NCT02397057|580784308|FG000|Overall Study|Death|1|||
160835310|NCT02397057|580784309|FG001|Overall Study|Death|0|||
160835311|NCT02397057|580784308|FG000|Overall Study|Adverse Event|0|||
161138059|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
161138060|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
161138061|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
161138062|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
161138063|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
161138064|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
161138065|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
161138066|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
161138067|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
161138068|NCT00446030|581887039|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
161249019|NCT04542694|582291661|FG000|Overall Study|The need for prohibited therapy|2|||
160835312|NCT02397057|580784309|FG001|Overall Study|Adverse Event|1|||
160835313|NCT02397057|580784308|FG000|Overall Study|Physician Decision|0|||
160835314|NCT02397057|580784309|FG001|Overall Study|Physician Decision|1|||
160835315|NCT02397057|580784308|FG000|Overall Study|Subject did not receive study drug|0|||
161138069|NCT00446030|581887040|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
161138070|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
160991366|NCT02219490|581357778|FG000|Overall Study|COVID-19 infection|2|||
161249020|NCT04542694|582291662|FG001|Overall Study|The need for prohibited therapy|0|||
161249021|NCT04542694|582291661|FG000|Overall Study|Adverse Event|1|||
161249022|NCT04542694|582291662|FG001|Overall Study|Adverse Event|0|||
161249023|NCT04542694|582291661|FG000|Overall Study|Protocol Violation|1|||
161249024|NCT04542694|582291662|FG001|Overall Study|Protocol Violation|0|||
161249025|NCT04633642|582291665|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
161249026|NCT04633642|582291666|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
161249027|NCT05387408|582291667|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
160835316|NCT02397057|580784309|FG001|Overall Study|Subject did not receive study drug|1|||
160835317|NCT02352753|580784310|FG000|6-Month Dosing Period|Decision by sponsor|2|||
160835318|NCT02352753|580784310|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
160835319|NCT02352753|580784310|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
160835320|NCT02352753|580784310|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
160835321|NCT02352753|580784310|FG000|3-Month Dosing Period|Decision by sponsor|14|||
160835322|NCT02352753|580784310|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
160835323|NCT00539305|580784311|FG000|Overall Study|Adverse Event|1|||
160835324|NCT00539305|580784312|FG001|Overall Study|Adverse Event|0|||
160835325|NCT00539305|580784311|FG000|Overall Study|Substance Use|0|||
161249028|NCT00397254|582291668|FG000|Overall Study|Lost to Follow-up|2|||
161249029|NCT00397254|582291669|FG001|Overall Study|Lost to Follow-up|2|||
160835326|NCT00539305|580784312|FG001|Overall Study|Substance Use|1|||
160835327|NCT00539305|580784311|FG000|Overall Study|Withdrawal by Subject|0|||
160835328|NCT00539305|580784312|FG001|Overall Study|Withdrawal by Subject|1|||
160835329|NCT00126776|580784314|FG000|Overall Study|follow up complete on all patients|0|||
160835330|NCT00126776|580784315|FG001|Overall Study|follow up complete on all patients|0|||
160835331|NCT00679172|580784319|FG000|Overall Study|Non-compliance|1|||
160835332|NCT00679172|580784320|FG001|Overall Study|Non-compliance|1|||
160835333|NCT00679172|580784321|FG002|Overall Study|Non-compliance|0|||
160835334|NCT00679172|580784322|FG003|Overall Study|Non-compliance|1|||
160835335|NCT00679172|580784323|FG004|Overall Study|Non-compliance|0|||
160835336|NCT00679172|580784319|FG000|Overall Study|Other not specified|0|||
160835337|NCT00679172|580784320|FG001|Overall Study|Other not specified|0|||
160835338|NCT00679172|580784321|FG002|Overall Study|Other not specified|1|||
160835339|NCT00679172|580784322|FG003|Overall Study|Other not specified|0|||
160835340|NCT00679172|580784323|FG004|Overall Study|Other not specified|0|||
160835341|NCT00417963|580784335|FG000|Overall Study|Lost to Follow-up|3|||
160835342|NCT00417963|580784335|FG000|Overall Study|Withdrawal by Subject|18|||
160835343|NCT00417963|580784335|FG000|Overall Study|Death|17|||
160835344|NCT00417963|580784335|FG000|Overall Study|Study device could not be deployed|3|||
160835345|NCT01815840|580784337|FG000|Overall Study|Missing|1|||
160835346|NCT01815840|580784338|FG001|Overall Study|Missing|0|||
160835347|NCT01815840|580784337|FG000|Overall Study|Withdrew Consent|31|||
160835348|NCT01815840|580784338|FG001|Overall Study|Withdrew Consent|30|||
160835349|NCT01815840|580784337|FG000|Overall Study|Administrative/Other|1|||
160835350|NCT01815840|580784338|FG001|Overall Study|Administrative/Other|3|||
160835351|NCT01815840|580784337|FG000|Overall Study|Adverse Event|10|||
161249030|NCT00152451|582291675|FG000|Overall Study|Adverse Event|4|||
161249031|NCT00323258|582291678|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
161249032|NCT00323258|582291679|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
160835352|NCT01815840|580784338|FG001|Overall Study|Adverse Event|16|||
160835353|NCT01815840|580784337|FG000|Overall Study|Death|2|||
160835354|NCT01815840|580784338|FG001|Overall Study|Death|2|||
160835355|NCT01815840|580784337|FG000|Overall Study|Disease progression|3|||
160835356|NCT01815840|580784338|FG001|Overall Study|Disease progression|2|||
160835357|NCT01815840|580784337|FG000|Overall Study|Investigators Decision|2|||
160835358|NCT01815840|580784338|FG001|Overall Study|Investigators Decision|3|||
160835359|NCT01815840|580784337|FG000|Overall Study|Lost to Follow-up|3|||
160903827|NCT01594281|581043025|FG000|Interventional Core Phase|Lost to Follow-up|1|||
160835360|NCT01815840|580784338|FG001|Overall Study|Lost to Follow-up|6|||
160835361|NCT01815840|580784337|FG000|Overall Study|Refused Treatment|5|||
160835362|NCT01815840|580784338|FG001|Overall Study|Refused Treatment|1|||
160835363|NCT01815840|580784337|FG000|Overall Study|Sponsor Termination Treatment|1|||
160835364|NCT01815840|580784338|FG001|Overall Study|Sponsor Termination Treatment|0|||
160835365|NCT00434642|580784339|FG000|Blinded Treatment Phase|Adverse Event|12|||
160835366|NCT00434642|580784340|FG001|Blinded Treatment Phase|Adverse Event|58|||
160835367|NCT00434642|580784339|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
160835368|NCT00434642|580784340|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
160835369|NCT00434642|580784339|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
160835370|NCT00434642|580784340|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
160835371|NCT00434642|580784339|FG000|Blinded Treatment Phase|Physician Decision|19|||
160835372|NCT00434642|580784340|FG001|Blinded Treatment Phase|Physician Decision|27|||
160903828|NCT01594281|581043026|FG001|Interventional Core Phase|Lost to Follow-up|4|||
161249033|NCT00323258|582291678|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
161249034|NCT00323258|582291679|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
161334949|NCT02616783|582615868|FG001|Overall Study|Adverse Event|0|||
160835373|NCT00434642|580784339|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
160835374|NCT00434642|580784340|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
160835375|NCT00434642|580784339|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
160835376|NCT00434642|580784340|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
160835377|NCT00434642|580784339|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
160835378|NCT00434642|580784340|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
160835379|NCT00434642|580784339|FG000|Open-label Treatment Phase|Adverse Event|0|||
160835380|NCT00434642|580784340|FG001|Open-label Treatment Phase|Adverse Event|5|||
160835381|NCT00434642|580784339|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
160835382|NCT00434642|580784340|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
160835383|NCT02241343|580784343|FG000|Overall Study|Adverse Event|1|||
160835384|NCT04680975|580784344|FG000|Overall Study|Adverse Event|3|||
160835385|NCT04680975|580784344|FG000|Overall Study|Death|1|||
160835386|NCT04680975|580784344|FG000|Overall Study|Progressive Disease|1|||
160835387|NCT04680975|580784344|FG000|Overall Study|Withdrawal by Subject|1|||
160835388|NCT00753454|580784345|FG000|Overall Study|Adverse Event|4|||
160835389|NCT00753454|580784345|FG000|Overall Study|Lack of Efficacy|1|||
160835390|NCT00753454|580784345|FG000|Overall Study|Lost to Follow-up|3|||
160835391|NCT00753454|580784345|FG000|Overall Study|Withdrawal by Subject|5|||
160835392|NCT00753454|580784345|FG000|Overall Study|Investigator Decision|1|||
160835393|NCT05856227|580784348|FG000|Overall Study|Adverse Event|0|||
160835394|NCT05856227|580784349|FG001|Overall Study|Adverse Event|1|||
160835395|NCT05856227|580784348|FG000|Overall Study|Due to Investigator absence|1|||
160835396|NCT05856227|580784349|FG001|Overall Study|Due to Investigator absence|0|||
160835397|NCT05856227|580784348|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
160835398|NCT05856227|580784349|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
160835399|NCT05011058|580784350|FG000|Overall Study|Sponsor Decision|2|||
160835400|NCT05011058|580784351|FG001|Overall Study|Sponsor Decision|0|||
160835401|NCT05011058|580784352|FG002|Overall Study|Sponsor Decision|14|||
160835402|NCT05011058|580784353|FG003|Overall Study|Sponsor Decision|0|||
160835403|NCT05011058|580784354|FG004|Overall Study|Sponsor Decision|0|||
161334950|NCT02616783|582615867|FG000|Overall Study|Death|1|||
160835404|NCT05011058|580784355|FG005|Overall Study|Sponsor Decision|1|||
160835405|NCT05011058|580784356|FG006|Overall Study|Sponsor Decision|0|||
160835406|NCT05011058|580784357|FG007|Overall Study|Sponsor Decision|5|||
160835407|NCT01571232|580784358|FG000|Overall Study|Lost to Follow-up|0|||
160835408|NCT01571232|580784359|FG001|Overall Study|Lost to Follow-up|1|||
160835409|NCT01571232|580784358|FG000|Overall Study|Withdrawal by Subject|1|||
160835410|NCT01571232|580784359|FG001|Overall Study|Withdrawal by Subject|0|||
160835411|NCT01272869|580784360|FG000|Period 2 (14 Days)|Adverse Event|1|||
160835412|NCT01272869|580784361|FG001|Period 2 (14 Days)|Adverse Event|0|||
160835413|NCT02271945|580784362|FG000|Overall Study|Death|3|||
160835414|NCT02271945|580784363|FG001|Overall Study|Death|3|||
160835415|NCT02271945|580784362|FG000|Overall Study|Withdrawal by Subject|1|||
160835416|NCT02271945|580784363|FG001|Overall Study|Withdrawal by Subject|1|||
160835417|NCT02271945|580784362|FG000|Overall Study|Other|1|||
160835418|NCT02271945|580784363|FG001|Overall Study|Other|1|||
160835419|NCT02455076|580784364|FG000|Inpatient|Withdrawal by Subject|1|||
160835420|NCT02455076|580784365|FG001|Inpatient|Withdrawal by Subject|0|||
160835421|NCT02455076|580784366|FG002|Inpatient|Withdrawal by Subject|0|||
160835422|NCT02455076|580784367|FG003|Inpatient|Withdrawal by Subject|0|||
160835423|NCT02455076|580784368|FG004|Inpatient|Withdrawal by Subject|0|||
160835424|NCT02455076|580784364|FG000|Inpatient|Discharged <24 h after admission|0|||
160835425|NCT02455076|580784365|FG001|Inpatient|Discharged <24 h after admission|1|||
160835426|NCT02455076|580784366|FG002|Inpatient|Discharged <24 h after admission|0|||
160835427|NCT02455076|580784367|FG003|Inpatient|Discharged <24 h after admission|0|||
160835428|NCT02455076|580784368|FG004|Inpatient|Discharged <24 h after admission|0|||
160835429|NCT02455076|580784364|FG000|Inpatient|Adverse Event|3|||
160835430|NCT02455076|580784365|FG001|Inpatient|Adverse Event|0|||
160835431|NCT02455076|580784366|FG002|Inpatient|Adverse Event|0|||
160835432|NCT02455076|580784367|FG003|Inpatient|Adverse Event|0|||
160835433|NCT02455076|580784368|FG004|Inpatient|Adverse Event|0|||
160835434|NCT02455076|580784364|FG000|Outpatient|Adverse Event|0|||
160835435|NCT02455076|580784365|FG001|Outpatient|Adverse Event|0|||
160835436|NCT02455076|580784366|FG002|Outpatient|Adverse Event|0|||
160835437|NCT02455076|580784367|FG003|Outpatient|Adverse Event|5|||
160835438|NCT02455076|580784368|FG004|Outpatient|Adverse Event|0|||
160835439|NCT02455076|580784364|FG000|Outpatient|Lost to Follow-up|0|||
160835440|NCT02455076|580784365|FG001|Outpatient|Lost to Follow-up|0|||
160835441|NCT02455076|580784366|FG002|Outpatient|Lost to Follow-up|0|||
160835442|NCT02455076|580784367|FG003|Outpatient|Lost to Follow-up|1|||
160835443|NCT02455076|580784368|FG004|Outpatient|Lost to Follow-up|12|||
160835444|NCT03908476|580784370|FG000|Overall Study|Death|3|||
160835445|NCT03908476|580784371|FG001|Overall Study|Death|0|||
160835446|NCT03908476|580784370|FG000|Overall Study|Lost to Follow-up|3|||
160835447|NCT03908476|580784371|FG001|Overall Study|Lost to Follow-up|1|||
160835448|NCT03908476|580784370|FG000|Overall Study|Withdrawal by Subject|7|||
160835449|NCT03908476|580784371|FG001|Overall Study|Withdrawal by Subject|1|||
160835450|NCT03908476|580784370|FG000|Overall Study|Physician Decision|2|||
160835451|NCT03908476|580784371|FG001|Overall Study|Physician Decision|0|||
160835452|NCT03908476|580784370|FG000|Overall Study|System Explanted and not Replaced|4|||
160835453|NCT03908476|580784371|FG001|Overall Study|System Explanted and not Replaced|0|||
160835454|NCT03908476|580784370|FG000|Overall Study|Intrathecal Pump|1|||
160835455|NCT03908476|580784371|FG001|Overall Study|Intrathecal Pump|0|||
160835456|NCT03908476|580784370|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
160835457|NCT03908476|580784371|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
160835458|NCT05194267|580784372|FG000|Overall Study|Withdrawal by Subject|2|||
160835459|NCT02868229|580784373|FG000|Overall Study|Adverse Event|1|||
160835460|NCT02868229|580784374|FG001|Overall Study|Adverse Event|0|||
160835461|NCT02868229|580784375|FG002|Overall Study|Adverse Event|0|||
160835462|NCT02868229|580784376|FG003|Overall Study|Adverse Event|1|||
160835463|NCT02868229|580784373|FG000|Overall Study|Death|0|||
160835464|NCT02868229|580784374|FG001|Overall Study|Death|0|||
160835465|NCT02868229|580784375|FG002|Overall Study|Death|1|||
160835466|NCT02868229|580784376|FG003|Overall Study|Death|1|||
160835467|NCT02868229|580784373|FG000|Overall Study|Missed dose|0|||
160835468|NCT02868229|580784374|FG001|Overall Study|Missed dose|0|||
160835469|NCT02868229|580784375|FG002|Overall Study|Missed dose|0|||
160835470|NCT02868229|580784376|FG003|Overall Study|Missed dose|3|||
160835471|NCT06151288|580784377|FG000|Overall Study|Lost to Follow-up|4|||
160835472|NCT06151288|580784378|FG001|Overall Study|Lost to Follow-up|2|||
160835473|NCT06151288|580784379|FG002|Overall Study|Lost to Follow-up|4|||
160835474|NCT06151288|580784380|FG003|Overall Study|Lost to Follow-up|3|||
160991367|NCT02219490|581357778|FG000|Overall Study|COVID-19 logistical restrictions|33|||
160991368|NCT02219490|581357778|FG000|Overall Study|Other, not specified|57|||
160991369|NCT01352507|581357781|FG000|Treatment Period 1|Adverse Event|3|||
160991370|NCT01352507|581357782|FG001|Treatment Period 1|Adverse Event|0|||
160991371|NCT01352507|581357781|FG000|Treatment Period 1|Lost to Follow-up|3|||
160991372|NCT01352507|581357782|FG001|Treatment Period 1|Lost to Follow-up|4|||
160991373|NCT01352507|581357781|FG000|Treatment Period 1|Withdrawal by Subject|7|||
160991374|NCT01352507|581357782|FG001|Treatment Period 1|Withdrawal by Subject|5|||
160991375|NCT01352507|581357781|FG000|Treatment Period 1|Physician Decision|1|||
160991376|NCT01352507|581357782|FG001|Treatment Period 1|Physician Decision|0|||
160991377|NCT01352507|581357781|FG000|Washout Period|Withdrawal by Subject|0|||
160991378|NCT01352507|581357782|FG001|Washout Period|Withdrawal by Subject|1|||
160991379|NCT01352507|581357781|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
160991380|NCT01352507|581357782|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
160991381|NCT01352507|581357781|FG000|Treatment Period 2|Withdrawal by Subject|4|||
160991382|NCT01352507|581357782|FG001|Treatment Period 2|Withdrawal by Subject|3|||
160991383|NCT01352507|581357781|FG000|Treatment Period 2|Lack of Efficacy|1|||
160991384|NCT01352507|581357782|FG001|Treatment Period 2|Lack of Efficacy|0|||
160991385|NCT03178201|581357783|FG000|Overall Study|Off study|5|||
160991386|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
160991387|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
160991388|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
160991389|NCT03537651|581357788|FG000|Part A (Up to 96 Weeks)|Other|1|||
160991390|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
160991391|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
160991392|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
160991393|NCT03537651|581357788|FG000|Part B (Up to 192 Weeks)|Other|1|||
160991394|NCT00197236|581357789|FG000|Overall Study|Adverse Event|1|||
160991395|NCT00197236|581357790|FG001|Overall Study|Adverse Event|0|||
160991396|NCT00197236|581357791|FG002|Overall Study|Adverse Event|1|||
161138071|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
160991397|NCT00197236|581357789|FG000|Overall Study|Lost to Follow-up|5|||
160991398|NCT00197236|581357790|FG001|Overall Study|Lost to Follow-up|14|||
160991399|NCT00197236|581357791|FG002|Overall Study|Lost to Follow-up|6|||
160991400|NCT00197236|581357789|FG000|Overall Study|Protocol Violation|0|||
160991401|NCT00197236|581357790|FG001|Overall Study|Protocol Violation|0|||
160991402|NCT00197236|581357791|FG002|Overall Study|Protocol Violation|1|||
160991403|NCT00197236|581357789|FG000|Overall Study|Withdrawal by Subject|7|||
160991404|NCT00197236|581357790|FG001|Overall Study|Withdrawal by Subject|3|||
160835475|NCT06151288|580784377|FG000|Overall Study|Withdrawal by Subject|4|||
160835476|NCT06151288|580784378|FG001|Overall Study|Withdrawal by Subject|5|||
160835477|NCT06151288|580784379|FG002|Overall Study|Withdrawal by Subject|1|||
160835478|NCT06151288|580784380|FG003|Overall Study|Withdrawal by Subject|1|||
160835479|NCT01286740|580784385|FG000|Overall Study|Enrolled but not treated|1|||
160835480|NCT01286740|580784385|FG000|Overall Study|Protocol Violation|1|||
160835481|NCT01646203|580784386|FG000|Overall Study|Adverse Event|2|||
160835482|NCT01646203|580784387|FG001|Overall Study|Adverse Event|0|||
160835483|NCT01646203|580784388|FG002|Overall Study|Adverse Event|1|||
160835484|NCT01646203|580784386|FG000|Overall Study|Withdrawal by Subject|0|||
160835485|NCT01646203|580784387|FG001|Overall Study|Withdrawal by Subject|1|||
160835486|NCT01646203|580784388|FG002|Overall Study|Withdrawal by Subject|0|||
160991405|NCT00197236|581357791|FG002|Overall Study|Withdrawal by Subject|11|||
161138072|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
161138073|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
161138074|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
161138075|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
161138076|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
160835487|NCT01646203|580784386|FG000|Overall Study|Physician's Decision|0|||
160835488|NCT01646203|580784387|FG001|Overall Study|Physician's Decision|1|||
160835489|NCT01646203|580784388|FG002|Overall Study|Physician's Decision|0|||
160835490|NCT04676867|580784389|FG000|Overall Study|Screen failure|0|||
160835491|NCT04676867|580784390|FG001|Overall Study|Screen failure|0|||
160835492|NCT04676867|580784391|FG002|Overall Study|Screen failure|6|||
160835493|NCT04676867|580784392|FG003|Overall Study|Screen failure|2|||
160835494|NCT04676867|580784389|FG000|Overall Study|Death|0|||
160835495|NCT04676867|580784390|FG001|Overall Study|Death|0|||
160835496|NCT04676867|580784391|FG002|Overall Study|Death|1|||
160835497|NCT04676867|580784392|FG003|Overall Study|Death|0|||
160835498|NCT04676867|580784389|FG000|Overall Study|Withdrawal by Subject|2|||
160835499|NCT04676867|580784390|FG001|Overall Study|Withdrawal by Subject|2|||
160835500|NCT04676867|580784391|FG002|Overall Study|Withdrawal by Subject|4|||
160835501|NCT04676867|580784392|FG003|Overall Study|Withdrawal by Subject|4|||
160835502|NCT04676867|580784389|FG000|Overall Study|Lost to Follow-up|1|||
160835503|NCT04676867|580784390|FG001|Overall Study|Lost to Follow-up|0|||
160835504|NCT04676867|580784391|FG002|Overall Study|Lost to Follow-up|0|||
160835505|NCT04676867|580784392|FG003|Overall Study|Lost to Follow-up|0|||
160835506|NCT02717130|580784396|FG000|Overall Study|Withdrawal by Subject|1|||
160835507|NCT02717130|580784396|FG000|Overall Study|Adverse Event|1|||
160835508|NCT02717130|580784396|FG000|Overall Study|Physician Decision|1|||
160835509|NCT02717130|580784396|FG000|Overall Study|Study Closure|4|||
160835510|NCT02335424|580784399|FG000|Overall Study|Withdrawal by Subject|19|||
160835511|NCT02335424|580784399|FG000|Overall Study|Adverse Event|25|||
160835512|NCT02335424|580784399|FG000|Overall Study|Death|273|||
160835513|NCT02335424|580784399|FG000|Overall Study|Lost to Follow-up|3|||
160835514|NCT02335424|580784399|FG000|Overall Study|Physician Decision|13|||
160835515|NCT02335424|580784399|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
160835516|NCT02335424|580784399|FG000|Overall Study|Protocol Violation|1|||
160835517|NCT02335424|580784399|FG000|Overall Study|Screen failure|1|||
160835518|NCT00548717|580784400|FG000|Overall Study|Death|5|||
160835519|NCT00548717|580784401|FG001|Overall Study|Death|2|||
160835520|NCT00548717|580784400|FG000|Overall Study|Relapse|3|||
160835521|NCT00548717|580784401|FG001|Overall Study|Relapse|0|||
160835522|NCT00548717|580784400|FG000|Overall Study|Alternative treatment for GVHD|1|||
160835523|NCT00548717|580784401|FG001|Overall Study|Alternative treatment for GVHD|0|||
160835524|NCT00551291|580784405|FG000|Overall Study|Physician Decision|1|||
160835525|NCT04268173|580784406|FG000|Overall Study|Lost to Follow-up|75|||
160835526|NCT04268173|580784407|FG001|Overall Study|Lost to Follow-up|108|||
160835527|NCT01953913|580784408|FG000|Overall Study|Disease Progression|349|||
160835528|NCT01953913|580784408|FG000|Overall Study|Worsening of underlying cancer|22|||
160835529|NCT01953913|580784408|FG000|Overall Study|Adverse Event|20|||
160835530|NCT01953913|580784408|FG000|Overall Study|Protocol Violation|6|||
160835531|NCT01953913|580784408|FG000|Overall Study|Lost to Follow-up|4|||
160835532|NCT01953913|580784408|FG000|Overall Study|Withdrawal by Subject|32|||
160835533|NCT01953913|580784408|FG000|Overall Study|Other than listed|108|||
160835534|NCT01953913|580784408|FG000|Overall Study|Not Treated|1|||
160835535|NCT00710385|580784409|FG000|Overall Study|Did not qualify|1|||
160835536|NCT00710385|580784409|FG000|Overall Study|Withdrawal by Subject|1|||
160835537|NCT00710385|580784409|FG000|Overall Study|Undisclosed back pain|1|||
160835538|NCT00710385|580784409|FG000|Overall Study|Physician Decision|1|||
160835539|NCT00710385|580784409|FG000|Overall Study|Undisclosed excessive methadone use|1|||
160903829|NCT01594281|581043027|FG002|Interventional Core Phase|Lost to Follow-up|1|||
160835540|NCT01600092|580784410|FG000|Overall Study|Adverse Event|2|||
160903830|NCT01594281|581043025|FG000|Interventional Core Phase|Adverse Event|4|||
161138077|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
161138078|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
160835541|NCT01600092|580784411|FG001|Overall Study|Adverse Event|0|||
160835542|NCT01600092|580784410|FG000|Overall Study|Lost to Follow-up|4|||
160835543|NCT01600092|580784411|FG001|Overall Study|Lost to Follow-up|6|||
160835544|NCT01600092|580784410|FG000|Overall Study|Withdrawal by parent/guardian|8|||
160835545|NCT01600092|580784411|FG001|Overall Study|Withdrawal by parent/guardian|6|||
160835546|NCT01600092|580784410|FG000|Overall Study|Physician Decision|1|||
160835547|NCT01600092|580784411|FG001|Overall Study|Physician Decision|1|||
160835548|NCT01600092|580784410|FG000|Overall Study|Randomized but not vaccinated|3|||
161138079|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
161138080|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
161138081|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
161138082|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
161138083|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
160991406|NCT00197236|581357789|FG000|Overall Study|Study drug/medication expiration|1|||
160991407|NCT00197236|581357790|FG001|Overall Study|Study drug/medication expiration|0|||
160835549|NCT01600092|580784411|FG001|Overall Study|Randomized but not vaccinated|3|||
160991408|NCT00197236|581357791|FG002|Overall Study|Study drug/medication expiration|3|||
160991409|NCT00197236|581357789|FG000|Overall Study|Returned out of specified time window|0|||
161249035|NCT00323258|582291678|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
161249036|NCT00323258|582291679|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
161249037|NCT00323258|582291678|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
161249038|NCT00323258|582291679|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
161249039|NCT00323258|582291678|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
161249040|NCT00323258|582291679|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
161249041|NCT00323258|582291678|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
161249042|NCT00323258|582291679|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
161334951|NCT02616783|582615868|FG001|Overall Study|Death|0|||
160835550|NCT02976103|580784412|FG000|Overall Study|Withdrawal by Subject|1|||
160835551|NCT02976103|580784413|FG001|Overall Study|Withdrawal by Subject|0|||
160835552|NCT02976103|580784412|FG000|Overall Study|Lost to Follow-up|12|||
160835553|NCT02976103|580784413|FG001|Overall Study|Lost to Follow-up|8|||
160835554|NCT01561963|580784414|FG000|Overall Study|Adverse Event|1|||
160835555|NCT03040986|580784415|FG000|Overall Study|Hospice|1|||
160835556|NCT03040986|580784416|FG001|Overall Study|Hospice|0|||
160835557|NCT03040986|580784415|FG000|Overall Study|Adverse Event|2|||
160835558|NCT03040986|580784416|FG001|Overall Study|Adverse Event|1|||
160835559|NCT03040986|580784415|FG000|Overall Study|Disease progression on study|3|||
160835560|NCT03040986|580784416|FG001|Overall Study|Disease progression on study|1|||
160835561|NCT02228096|580784420|FG000|Overall Study|Study terminated by Sponsor|24|||
160835562|NCT02228096|580784420|FG000|Overall Study|Lack of Efficacy|18|||
160835563|NCT02228096|580784420|FG000|Overall Study|Death|12|||
160835564|NCT02228096|580784420|FG000|Overall Study|Physician Decision|3|||
160835565|NCT02228096|580784420|FG000|Overall Study|Subject/guardian decision|2|||
160835566|NCT02228096|580784420|FG000|Overall Study|New therapy for study indication|1|||
160835567|NCT02228096|580784420|FG000|Overall Study|Enrolled, not infused|11|||
160835568|NCT02383433|580784421|FG000|Overall Study|Disease progression|2|||
160835569|NCT00952614|580784424|FG000|Overall Study|Death|3|||
160835570|NCT00952614|580784424|FG000|Overall Study|Lost to Follow-up|3|||
160835571|NCT00952614|580784424|FG000|Overall Study|other reason|1|||
160835572|NCT02925728|580784425|FG000|Overall Study|Death|3|||
160835573|NCT02925728|580784426|FG001|Overall Study|Death|5|||
160835574|NCT02925728|580784425|FG000|Overall Study|Physician Decision|1|||
160835575|NCT02925728|580784426|FG001|Overall Study|Physician Decision|0|||
160835576|NCT02925728|580784425|FG000|Overall Study|Withdrawal by Subject|1|||
160835577|NCT02925728|580784426|FG001|Overall Study|Withdrawal by Subject|0|||
160835578|NCT01075984|580784427|FG000|Treatment Phase|Adverse Event|0|||
160835579|NCT01075984|580784428|FG001|Treatment Phase|Adverse Event|1|||
160835580|NCT01075984|580784429|FG002|Treatment Phase|Adverse Event|3|||
160835581|NCT01075984|580784430|FG003|Treatment Phase|Adverse Event|7|||
160835582|NCT01075984|580784431|FG004|Treatment Phase|Adverse Event|35|||
160835583|NCT01075984|580784427|FG000|Treatment Phase|Protocol Violation|0|||
160835584|NCT01075984|580784428|FG001|Treatment Phase|Protocol Violation|0|||
160835585|NCT01075984|580784429|FG002|Treatment Phase|Protocol Violation|1|||
160835586|NCT01075984|580784430|FG003|Treatment Phase|Protocol Violation|0|||
160835587|NCT01075984|580784431|FG004|Treatment Phase|Protocol Violation|3|||
160835588|NCT01075984|580784427|FG000|Treatment Phase|Withdrawal by Subject|0|||
160835589|NCT01075984|580784428|FG001|Treatment Phase|Withdrawal by Subject|0|||
160835590|NCT01075984|580784429|FG002|Treatment Phase|Withdrawal by Subject|2|||
160835591|NCT01075984|580784430|FG003|Treatment Phase|Withdrawal by Subject|0|||
160835592|NCT01075984|580784431|FG004|Treatment Phase|Withdrawal by Subject|15|||
160835593|NCT01075984|580784427|FG000|Treatment Phase|Treatment Failure|0|||
160835594|NCT01075984|580784428|FG001|Treatment Phase|Treatment Failure|0|||
160835595|NCT01075984|580784429|FG002|Treatment Phase|Treatment Failure|1|||
160835596|NCT01075984|580784430|FG003|Treatment Phase|Treatment Failure|0|||
160835597|NCT01075984|580784431|FG004|Treatment Phase|Treatment Failure|5|||
160835598|NCT01075984|580784427|FG000|Treatment Phase|Progression of disease|0|||
160835599|NCT01075984|580784428|FG001|Treatment Phase|Progression of disease|0|||
160835600|NCT01075984|580784429|FG002|Treatment Phase|Progression of disease|0|||
160835601|NCT01075984|580784430|FG003|Treatment Phase|Progression of disease|0|||
160835602|NCT01075984|580784431|FG004|Treatment Phase|Progression of disease|2|||
160835603|NCT01075984|580784427|FG000|Follow-up Phase|Protocol Violation|0|||
160835604|NCT01075984|580784428|FG001|Follow-up Phase|Protocol Violation|0|||
160835605|NCT01075984|580784429|FG002|Follow-up Phase|Protocol Violation|1|||
160835606|NCT01075984|580784430|FG003|Follow-up Phase|Protocol Violation|0|||
160835607|NCT01075984|580784431|FG004|Follow-up Phase|Protocol Violation|3|||
160835608|NCT01075984|580784427|FG000|Follow-up Phase|Adverse Event|0|||
160835609|NCT01075984|580784428|FG001|Follow-up Phase|Adverse Event|0|||
160835610|NCT01075984|580784429|FG002|Follow-up Phase|Adverse Event|0|||
160835611|NCT01075984|580784430|FG003|Follow-up Phase|Adverse Event|2|||
160835612|NCT01075984|580784431|FG004|Follow-up Phase|Adverse Event|27|||
160835613|NCT01075984|580784427|FG000|Follow-up Phase|Administrative|0|||
160835614|NCT01075984|580784428|FG001|Follow-up Phase|Administrative|0|||
160835615|NCT01075984|580784429|FG002|Follow-up Phase|Administrative|0|||
160835616|NCT01075984|580784430|FG003|Follow-up Phase|Administrative|0|||
160835617|NCT01075984|580784431|FG004|Follow-up Phase|Administrative|1|||
160835618|NCT01075984|580784427|FG000|Follow-up Phase|Withdrawal by Subject|0|||
160835619|NCT01075984|580784428|FG001|Follow-up Phase|Withdrawal by Subject|0|||
160835620|NCT01075984|580784429|FG002|Follow-up Phase|Withdrawal by Subject|0|||
160835621|NCT01075984|580784430|FG003|Follow-up Phase|Withdrawal by Subject|0|||
160835622|NCT01075984|580784431|FG004|Follow-up Phase|Withdrawal by Subject|10|||
160835623|NCT01075984|580784427|FG000|Follow-up Phase|Progression of disease|0|||
160835624|NCT01075984|580784428|FG001|Follow-up Phase|Progression of disease|0|||
160835625|NCT01075984|580784429|FG002|Follow-up Phase|Progression of disease|0|||
160903831|NCT01594281|581043026|FG001|Interventional Core Phase|Adverse Event|4|||
160903832|NCT01594281|581043027|FG002|Interventional Core Phase|Adverse Event|4|||
160903833|NCT01594281|581043025|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
160903834|NCT01594281|581043026|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
160903835|NCT01594281|581043027|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
160903836|NCT01594281|581043025|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
160903837|NCT01594281|581043026|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
160903838|NCT01594281|581043027|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
160903839|NCT01594281|581043025|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
160903840|NCT01594281|581043026|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
160903841|NCT01594281|581043027|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
160903842|NCT01871532|581043028|FG000|Overall Study|Withdrawal by Subject|1|||
160903843|NCT01871532|581043029|FG001|Overall Study|Withdrawal by Subject|2|||
160903844|NCT00283400|581043030|FG000|Overall Study|Withdrawal by Subject|1|||
160903845|NCT00283400|581043031|FG001|Overall Study|Withdrawal by Subject|1|||
160903846|NCT00283400|581043032|FG002|Overall Study|Withdrawal by Subject|0|||
160903847|NCT00283400|581043033|FG003|Overall Study|Withdrawal by Subject|0|||
160903848|NCT00283400|581043030|FG000|Overall Study|Death|1|||
160903849|NCT00283400|581043031|FG001|Overall Study|Death|0|||
160903850|NCT00283400|581043032|FG002|Overall Study|Death|1|||
160903851|NCT00283400|581043033|FG003|Overall Study|Death|0|||
160903852|NCT02550106|581043038|FG000|Overall Study|Adverse Event|1|||
160903853|NCT02550106|581043038|FG000|Overall Study|Lack of Efficacy|3|||
160903854|NCT02550106|581043038|FG000|Overall Study|Protocol Violation|6|||
160903855|NCT02550106|581043038|FG000|Overall Study|Withdrawal by Subject|2|||
160903856|NCT01890473|581043039|FG000|Overall Study|Lost to Follow-up|1|||
160903857|NCT01890473|581043040|FG001|Overall Study|Lost to Follow-up|0|||
160903858|NCT01890473|581043039|FG000|Overall Study|Poor/non-compliance|1|||
160903859|NCT01890473|581043040|FG001|Overall Study|Poor/non-compliance|0|||
160903860|NCT00934089|581043041|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
160903861|NCT00934089|581043042|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
160903862|NCT00934089|581043041|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
160903863|NCT00934089|581043042|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
160903864|NCT00926328|581043043|FG000|Overall Study|Lost to Follow-up|12|||
160903865|NCT00926328|581043044|FG001|Overall Study|Lost to Follow-up|14|||
160903866|NCT00726986|581043045|FG000|Induction Phase|Adverse Event|4|||
160903867|NCT00726986|581043045|FG000|Induction Phase|Withdrawal by Subject|2|||
160903868|NCT00726986|581043045|FG000|Induction Phase|Death|2|||
160903869|NCT00726986|581043045|FG000|Induction Phase|Lack of Efficacy|5|||
160903870|NCT00726986|581043045|FG000|Induction Phase|Secondary Disease|2|||
160903871|NCT00726986|581043045|FG000|Maintenance Phase|Adverse Event|1|||
160903872|NCT00726986|581043045|FG000|Maintenance Phase|Lack of Efficacy|2|||
160903873|NCT01819831|581043048|FG000|Overall Study|Withdrawal by Subject|1|||
160903874|NCT05074667|581043049|FG000|Overall Study|Death|1|||
160903875|NCT05074667|581043049|FG000|Overall Study|Withdrawal by Subject|4|||
160903876|NCT05074667|581043049|FG000|Overall Study|Lost to Follow-up|10|||
160903877|NCT01947582|581043050|FG000|Overall Study|Withdrawal by Subject|1|||
160903878|NCT01086033|581043051|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
160835626|NCT01075984|580784430|FG003|Follow-up Phase|Progression of disease|0|||
160903879|NCT01086033|581043051|FG000|Overall Study|Lost to Follow-up|86|||
160835627|NCT01075984|580784431|FG004|Follow-up Phase|Progression of disease|2|||
160835628|NCT01075984|580784427|FG000|Follow-up Phase|Treatment failure|0|||
160835629|NCT01075984|580784428|FG001|Follow-up Phase|Treatment failure|0|||
160835630|NCT01075984|580784429|FG002|Follow-up Phase|Treatment failure|0|||
160835631|NCT01075984|580784430|FG003|Follow-up Phase|Treatment failure|0|||
160835632|NCT01075984|580784431|FG004|Follow-up Phase|Treatment failure|4|||
160903880|NCT01086033|581043051|FG000|Overall Study|Adverse Event|42|||
160903881|NCT01086033|581043051|FG000|Overall Study|Withdrawal by Subject|41|||
160903882|NCT01086033|581043051|FG000|Overall Study|Other|14|||
160903883|NCT01086033|581043051|FG000|Overall Study|Other|13|||
160835633|NCT02986854|580784432|FG000|Overall Study|Withdrawal by Subject|0|||
160835634|NCT02986854|580784433|FG001|Overall Study|Withdrawal by Subject|1|||
160835635|NCT02986854|580784434|FG002|Overall Study|Withdrawal by Subject|1|||
160835636|NCT02986854|580784432|FG000|Overall Study|Lost to Follow-up|3|||
160835637|NCT02986854|580784433|FG001|Overall Study|Lost to Follow-up|11|||
160835638|NCT02986854|580784434|FG002|Overall Study|Lost to Follow-up|2|||
160835639|NCT00086411|580784435|FG000|Overall Study|Lost to Follow-up|11|||
160835640|NCT00086411|580784436|FG001|Overall Study|Lost to Follow-up|11|||
160835641|NCT00086411|580784437|FG002|Overall Study|Lost to Follow-up|13|||
160835642|NCT00086411|580784438|FG003|Overall Study|Lost to Follow-up|12|||
160835643|NCT01403116|580784444|FG000|Overall Study|Adverse Event|7|||
160835644|NCT01403116|580784445|FG001|Overall Study|Adverse Event|4|||
160835645|NCT01403116|580784444|FG000|Overall Study|Lost to Follow-up|7|||
160835646|NCT01403116|580784445|FG001|Overall Study|Lost to Follow-up|5|||
160835647|NCT01403116|580784444|FG000|Overall Study|Withdrawal by Subject|12|||
160835648|NCT01403116|580784445|FG001|Overall Study|Withdrawal by Subject|15|||
160835649|NCT01403116|580784444|FG000|Overall Study|Non-compliance of study drug|3|||
160835650|NCT01403116|580784445|FG001|Overall Study|Non-compliance of study drug|0|||
160835651|NCT01403116|580784444|FG000|Overall Study|Protocol Violation|0|||
160835652|NCT01403116|580784445|FG001|Overall Study|Protocol Violation|1|||
160835653|NCT01403116|580784444|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
160835654|NCT01403116|580784445|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
160835655|NCT01403116|580784444|FG000|Overall Study|Hct >54%|2|||
160835656|NCT01403116|580784445|FG001|Overall Study|Hct >54%|0|||
160835657|NCT01403116|580784444|FG000|Overall Study|unable to keep appointments|0|||
160835658|NCT01403116|580784445|FG001|Overall Study|unable to keep appointments|2|||
160835659|NCT00042666|580784446|FG000|Overall Study|Adverse Event|2|||
160835660|NCT00042666|580784446|FG000|Overall Study|Death|4|||
160835661|NCT00042666|580784446|FG000|Overall Study|Protocol Violation|1|||
160835662|NCT00042666|580784446|FG000|Overall Study|Participant/Physician Perception|1|||
160835663|NCT00042666|580784446|FG000|Overall Study|Progressive Disease|41|||
160835664|NCT00042666|580784446|FG000|Overall Study|Other|1|||
160835665|NCT00042666|580784446|FG000|Overall Study|Other|4|||
160862010|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862011|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862012|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862013|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862014|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862015|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862016|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862017|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862018|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862019|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862020|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862021|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
161138084|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
161249043|NCT00323258|582291678|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
160862022|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862023|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862024|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
160862025|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862026|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
160862027|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862028|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862029|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862030|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862031|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862032|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862033|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
160862034|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862035|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862036|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862037|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862038|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862039|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
161138085|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
161138086|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
161138087|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
161138088|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
161138089|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
161138090|NCT00446030|581887039|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
161138091|NCT00446030|581887040|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
161249044|NCT00323258|582291679|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
161249045|NCT04473326|582291684|FG000|Overall Study|Death|0|||
161249046|NCT04473326|582291685|FG001|Overall Study|Death|1|||
161249047|NCT04473326|582291684|FG000|Overall Study|Withdrawal by Subject|1|||
161249048|NCT04473326|582291685|FG001|Overall Study|Withdrawal by Subject|2|||
161249049|NCT02046122|582291686|FG000|Overall Study|Physician Decision|8|||
161249050|NCT02046122|582291686|FG000|Overall Study|Withdrawal by Subject|1|||
161249051|NCT01097694|582291691|FG000|Overall Study|Adverse Event|5|||
161249052|NCT01097694|582291692|FG001|Overall Study|Adverse Event|0|||
161249053|NCT01097694|582291691|FG000|Overall Study|Lost to Follow-up|0|||
161249054|NCT01097694|582291692|FG001|Overall Study|Lost to Follow-up|3|||
161249055|NCT01097694|582291691|FG000|Overall Study|Withdrawal by Subject|3|||
161249056|NCT01097694|582291692|FG001|Overall Study|Withdrawal by Subject|1|||
161249057|NCT00668395|582291694|FG000|Overall Study|Withdrawal by Subject|4|||
161249058|NCT00668395|582291695|FG001|Overall Study|Withdrawal by Subject|4|||
161249059|NCT00668395|582291696|FG002|Overall Study|Withdrawal by Subject|1|||
161249060|NCT00668395|582291694|FG000|Overall Study|Adverse Event|1|||
160835666|NCT03343626|580786321|FG000|Overall Study|Lost to Follow-up|4|||
160835667|NCT03343626|580786322|FG001|Overall Study|Lost to Follow-up|3|||
160835668|NCT03343626|580786323|FG002|Overall Study|Lost to Follow-up|2|||
160835669|NCT03343626|580786324|FG003|Overall Study|Lost to Follow-up|5|||
160835670|NCT03343626|580786325|FG004|Overall Study|Lost to Follow-up|4|||
160835671|NCT03343626|580786326|FG005|Overall Study|Lost to Follow-up|4|||
160835672|NCT03343626|580786327|FG006|Overall Study|Lost to Follow-up|4|||
160835673|NCT03343626|580786328|FG007|Overall Study|Lost to Follow-up|7|||
160835674|NCT03343626|580786321|FG000|Overall Study|Withdrawal of Consent|2|||
160835675|NCT03343626|580786322|FG001|Overall Study|Withdrawal of Consent|1|||
160835676|NCT03343626|580786323|FG002|Overall Study|Withdrawal of Consent|0|||
160835677|NCT03343626|580786324|FG003|Overall Study|Withdrawal of Consent|3|||
160835678|NCT03343626|580786325|FG004|Overall Study|Withdrawal of Consent|3|||
160835679|NCT03343626|580786326|FG005|Overall Study|Withdrawal of Consent|1|||
160835680|NCT03343626|580786327|FG006|Overall Study|Withdrawal of Consent|1|||
160835681|NCT03343626|580786328|FG007|Overall Study|Withdrawal of Consent|2|||
160835682|NCT03343626|580786321|FG000|Overall Study|Reason not Specified|0|||
160835683|NCT03343626|580786322|FG001|Overall Study|Reason not Specified|1|||
160835684|NCT03343626|580786323|FG002|Overall Study|Reason not Specified|0|||
160835685|NCT03343626|580786324|FG003|Overall Study|Reason not Specified|0|||
160835686|NCT03343626|580786325|FG004|Overall Study|Reason not Specified|0|||
160835687|NCT03343626|580786326|FG005|Overall Study|Reason not Specified|0|||
160835688|NCT03343626|580786327|FG006|Overall Study|Reason not Specified|0|||
160835689|NCT03343626|580786328|FG007|Overall Study|Reason not Specified|1|||
160835690|NCT03343626|580786321|FG000|Overall Study|Data Entry Error|0|||
160835691|NCT03343626|580786322|FG001|Overall Study|Data Entry Error|0|||
160835692|NCT03343626|580786323|FG002|Overall Study|Data Entry Error|0|||
160835693|NCT03343626|580786324|FG003|Overall Study|Data Entry Error|0|||
160835694|NCT03343626|580786325|FG004|Overall Study|Data Entry Error|0|||
160835695|NCT03343626|580786326|FG005|Overall Study|Data Entry Error|0|||
160835696|NCT03343626|580786327|FG006|Overall Study|Data Entry Error|0|||
160835697|NCT03343626|580786328|FG007|Overall Study|Data Entry Error|1|||
160835698|NCT00742417|580786331|FG000|Randomized|Withdrawal by legal representative|0|||
160835699|NCT00742417|580786332|FG001|Randomized|Withdrawal by legal representative|1|||
160835700|NCT00742417|580786331|FG000|Randomized|Withdrawal by Subject|1|||
160835701|NCT00742417|580786332|FG001|Randomized|Withdrawal by Subject|0|||
160835702|NCT00742417|580786331|FG000|Randomized|Physician Decision|1|||
160835703|NCT00742417|580786332|FG001|Randomized|Physician Decision|0|||
160835704|NCT00742417|580786331|FG000|Intensive Period|Withdrawal by Subject|1|||
160835705|NCT00742417|580786332|FG001|Intensive Period|Withdrawal by Subject|1|||
160835706|NCT00742417|580786331|FG000|Intensive Period|Adverse Event|2|||
160835707|NCT00742417|580786332|FG001|Intensive Period|Adverse Event|0|||
160835708|NCT00965575|580786337|FG000|Overall Study|subject unwillingness to swallow study c|1|||
160835709|NCT00965575|580786338|FG001|Overall Study|subject unwillingness to swallow study c|0|||
160835710|NCT01041287|580786341|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
160835711|NCT01041287|580786342|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
160835712|NCT01041287|580786341|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
160835713|NCT01041287|580786342|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
160835714|NCT03775512|580786350|FG000|Overall Study|Death|1|||
160835715|NCT03775512|580786351|FG001|Overall Study|Death|1|||
160835716|NCT03775512|580786350|FG000|Overall Study|Withdrawal by Subject|7|||
160835717|NCT03775512|580786351|FG001|Overall Study|Withdrawal by Subject|4|||
160835718|NCT03775512|580786350|FG000|Overall Study|Lost to Follow-up|5|||
160835719|NCT03775512|580786351|FG001|Overall Study|Lost to Follow-up|5|||
160835720|NCT03775512|580786350|FG000|Overall Study|Excluded before Catheter insertion|14|||
161249061|NCT00668395|582291695|FG001|Overall Study|Adverse Event|1|||
161249062|NCT00668395|582291696|FG002|Overall Study|Adverse Event|0|||
161249063|NCT00668395|582291694|FG000|Overall Study|Physician Decision|1|||
161249064|NCT00668395|582291695|FG001|Overall Study|Physician Decision|1|||
161249065|NCT00668395|582291696|FG002|Overall Study|Physician Decision|0|||
161249066|NCT04164758|582291697|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
161249067|NCT04164758|582291698|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
161249068|NCT04164758|582291699|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
161249069|NCT04164758|582291697|FG000|Overall Study|Adverse Event|0|||
161249070|NCT04164758|582291698|FG001|Overall Study|Adverse Event|1|||
161249071|NCT04164758|582291699|FG002|Overall Study|Adverse Event|0|||
161249072|NCT03259165|582291700|FG000|Overall Study|COVID 19 pandemic|1|||
161249073|NCT03259165|582291701|FG001|Overall Study|COVID 19 pandemic|1|||
161249074|NCT01567527|582291704|FG000|Conversion Phase.|Protocol deviation|3|||
161249075|NCT01567527|582291705|FG001|Conversion Phase.|Protocol deviation|0|||
161249076|NCT01567527|582291706|FG002|Conversion Phase.|Protocol deviation|0|||
161249077|NCT01567527|582291707|FG003|Conversion Phase.|Protocol deviation|0|||
161249078|NCT01567527|582291708|FG004|Conversion Phase.|Protocol deviation|0|||
161249079|NCT01567527|582291704|FG000|Conversion Phase.|Met withdrawal criteria|10|||
161249080|NCT01567527|582291705|FG001|Conversion Phase.|Met withdrawal criteria|0|||
161249081|NCT01567527|582291706|FG002|Conversion Phase.|Met withdrawal criteria|0|||
161249082|NCT01567527|582291707|FG003|Conversion Phase.|Met withdrawal criteria|0|||
161249083|NCT01567527|582291708|FG004|Conversion Phase.|Met withdrawal criteria|0|||
161249084|NCT01567527|582291704|FG000|Conversion Phase.|Withdrawal by Subject|32|||
161249085|NCT01567527|582291705|FG001|Conversion Phase.|Withdrawal by Subject|0|||
161249086|NCT01567527|582291706|FG002|Conversion Phase.|Withdrawal by Subject|0|||
161249087|NCT01567527|582291707|FG003|Conversion Phase.|Withdrawal by Subject|0|||
161249088|NCT01567527|582291708|FG004|Conversion Phase.|Withdrawal by Subject|0|||
161249089|NCT01567527|582291704|FG000|Conversion Phase.|Lost to Follow-up|16|||
161249090|NCT01567527|582291705|FG001|Conversion Phase.|Lost to Follow-up|0|||
161249091|NCT01567527|582291706|FG002|Conversion Phase.|Lost to Follow-up|0|||
161249092|NCT01567527|582291707|FG003|Conversion Phase.|Lost to Follow-up|0|||
161249093|NCT01567527|582291708|FG004|Conversion Phase.|Lost to Follow-up|0|||
161249094|NCT01567527|582291704|FG000|Conversion Phase.|Lack of Efficacy|2|||
161249095|NCT01567527|582291705|FG001|Conversion Phase.|Lack of Efficacy|0|||
161249096|NCT01567527|582291706|FG002|Conversion Phase.|Lack of Efficacy|0|||
161249097|NCT01567527|582291707|FG003|Conversion Phase.|Lack of Efficacy|0|||
161249098|NCT01567527|582291708|FG004|Conversion Phase.|Lack of Efficacy|0|||
161249099|NCT01567527|582291704|FG000|Conversion Phase.|Adverse Event|33|||
161249100|NCT01567527|582291705|FG001|Conversion Phase.|Adverse Event|0|||
161249101|NCT01567527|582291706|FG002|Conversion Phase.|Adverse Event|0|||
161249102|NCT01567527|582291707|FG003|Conversion Phase.|Adverse Event|0|||
161249103|NCT01567527|582291708|FG004|Conversion Phase.|Adverse Event|0|||
161249104|NCT01567527|582291704|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
161249105|NCT01567527|582291705|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
161249106|NCT01567527|582291706|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
161249107|NCT01567527|582291707|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
161249108|NCT01567527|582291708|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
161249109|NCT01567527|582291704|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161249110|NCT01567527|582291705|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
161249111|NCT01567527|582291706|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161249112|NCT01567527|582291707|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161249113|NCT01567527|582291708|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
161249114|NCT01567527|582291704|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161249115|NCT01567527|582291705|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
161249116|NCT01567527|582291706|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161249117|NCT01567527|582291707|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161249118|NCT01567527|582291708|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
161249119|NCT01567527|582291704|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161249120|NCT01567527|582291705|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
161249121|NCT01567527|582291706|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161249122|NCT01567527|582291707|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161249123|NCT01567527|582291708|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
161249124|NCT01567527|582291704|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161249125|NCT01567527|582291705|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
160903884|NCT01086033|581043051|FG000|Overall Study|AE and Withdrew Consent|5|||
160903885|NCT01086033|581043051|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
160903886|NCT01086033|581043051|FG000|Overall Study|Withdrew consent and Other Reason|4|||
160903887|NCT01086033|581043051|FG000|Overall Study|AE and Lack of Efficacy|4|||
161249126|NCT01567527|582291706|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161249127|NCT01567527|582291707|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161249128|NCT01567527|582291708|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
161249129|NCT01567527|582291704|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161249130|NCT01567527|582291705|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
161249131|NCT01567527|582291706|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
160903888|NCT01086033|581043051|FG000|Overall Study|Death|1|||
161249132|NCT01567527|582291707|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161249133|NCT01567527|582291708|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
161249134|NCT01567527|582291704|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161249135|NCT01567527|582291705|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
161249136|NCT01567527|582291706|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161249137|NCT01567527|582291707|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161249138|NCT01567527|582291708|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
161249139|NCT01567527|582291704|FG000|IM Depot Stabilization.|Protocol deviation|0|||
161249140|NCT01567527|582291705|FG001|IM Depot Stabilization.|Protocol deviation|0|||
161249141|NCT01567527|582291706|FG002|IM Depot Stabilization.|Protocol deviation|5|||
161249142|NCT01567527|582291707|FG003|IM Depot Stabilization.|Protocol deviation|0|||
161249143|NCT01567527|582291708|FG004|IM Depot Stabilization.|Protocol deviation|0|||
161249144|NCT01567527|582291704|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
161249145|NCT01567527|582291705|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
161249146|NCT01567527|582291706|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
161249147|NCT01567527|582291707|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
161249148|NCT01567527|582291708|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
161249149|NCT01567527|582291704|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
161249150|NCT01567527|582291705|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
161249151|NCT01567527|582291706|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
161249152|NCT01567527|582291707|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
161249153|NCT01567527|582291708|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
161249154|NCT01567527|582291704|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
161249155|NCT01567527|582291705|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
161249156|NCT01567527|582291706|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
161249157|NCT01567527|582291707|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
161249158|NCT01567527|582291708|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
161249159|NCT01567527|582291704|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
161249160|NCT01567527|582291705|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
161249161|NCT01567527|582291706|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
161249162|NCT01567527|582291707|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
161249163|NCT01567527|582291708|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
161249164|NCT01567527|582291704|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
161249165|NCT01567527|582291705|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
161249166|NCT01567527|582291706|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
161249167|NCT01567527|582291707|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
161249168|NCT01567527|582291708|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
161249169|NCT01567527|582291704|FG000|IM Depot Stabilization.|Adverse Event|0|||
160835721|NCT03775512|580786351|FG001|Overall Study|Excluded before Catheter insertion|5|||
160835722|NCT03775512|580786350|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
160835723|NCT03775512|580786351|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
160835724|NCT03775512|580786350|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
160835725|NCT03775512|580786351|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
160835726|NCT01610336|580786352|FG000|Overall Study|Progressive Disease|4|||
160835727|NCT01610336|580786353|FG001|Overall Study|Progressive Disease|6|||
160835728|NCT01610336|580786354|FG002|Overall Study|Progressive Disease|6|||
160835729|NCT01610336|580786355|FG003|Overall Study|Progressive Disease|5|||
160835730|NCT01610336|580786356|FG004|Overall Study|Progressive Disease|3|||
160835731|NCT01610336|580786357|FG005|Overall Study|Progressive Disease|10|||
160835732|NCT01610336|580786358|FG006|Overall Study|Progressive Disease|1|||
160835733|NCT01610336|580786359|FG007|Overall Study|Progressive Disease|6|||
160835734|NCT01610336|580786360|FG008|Overall Study|Progressive Disease|6|||
160835735|NCT01610336|580786361|FG009|Overall Study|Progressive Disease|40|||
160835736|NCT01610336|580786362|FG010|Overall Study|Progressive Disease|36|||
160835737|NCT01610336|580786352|FG000|Overall Study|Adverse Event|0|||
160835738|NCT01610336|580786353|FG001|Overall Study|Adverse Event|0|||
160835739|NCT01610336|580786354|FG002|Overall Study|Adverse Event|0|||
160835740|NCT01610336|580786355|FG003|Overall Study|Adverse Event|1|||
160835741|NCT01610336|580786356|FG004|Overall Study|Adverse Event|1|||
160835742|NCT01610336|580786357|FG005|Overall Study|Adverse Event|1|||
160835743|NCT01610336|580786358|FG006|Overall Study|Adverse Event|0|||
160835744|NCT01610336|580786359|FG007|Overall Study|Adverse Event|0|||
160835745|NCT01610336|580786360|FG008|Overall Study|Adverse Event|2|||
160835746|NCT01610336|580786361|FG009|Overall Study|Adverse Event|8|||
160835747|NCT01610336|580786362|FG010|Overall Study|Adverse Event|6|||
160835748|NCT01610336|580786352|FG000|Overall Study|Subject/Guardian decision|1|||
160835749|NCT01610336|580786353|FG001|Overall Study|Subject/Guardian decision|1|||
160835750|NCT01610336|580786354|FG002|Overall Study|Subject/Guardian decision|0|||
160835751|NCT01610336|580786355|FG003|Overall Study|Subject/Guardian decision|1|||
160835752|NCT01610336|580786356|FG004|Overall Study|Subject/Guardian decision|0|||
160835753|NCT01610336|580786357|FG005|Overall Study|Subject/Guardian decision|0|||
160835754|NCT01610336|580786358|FG006|Overall Study|Subject/Guardian decision|0|||
161249170|NCT01567527|582291705|FG001|IM Depot Stabilization.|Adverse Event|0|||
161249171|NCT01567527|582291706|FG002|IM Depot Stabilization.|Adverse Event|37|||
161249172|NCT01567527|582291707|FG003|IM Depot Stabilization.|Adverse Event|0|||
161249173|NCT01567527|582291708|FG004|IM Depot Stabilization.|Adverse Event|0|||
161249174|NCT01567527|582291704|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161249175|NCT01567527|582291705|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161249176|NCT01567527|582291706|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
161249177|NCT01567527|582291707|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161249178|NCT01567527|582291708|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
161249179|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161249180|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161249181|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
161249182|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
161249183|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
161249184|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161249185|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161249186|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
161249187|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
161249188|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
161249189|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161249190|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161249191|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
161249192|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
161249193|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
161334952|NCT02616783|582615867|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160835755|NCT01610336|580786359|FG007|Overall Study|Subject/Guardian decision|1|||
160835756|NCT01610336|580786360|FG008|Overall Study|Subject/Guardian decision|0|||
160835757|NCT01610336|580786361|FG009|Overall Study|Subject/Guardian decision|2|||
160835758|NCT01610336|580786362|FG010|Overall Study|Subject/Guardian decision|2|||
160835759|NCT01610336|580786352|FG000|Overall Study|Death|0|||
160835760|NCT01610336|580786353|FG001|Overall Study|Death|0|||
160835761|NCT01610336|580786354|FG002|Overall Study|Death|0|||
160835762|NCT01610336|580786355|FG003|Overall Study|Death|0|||
160835763|NCT01610336|580786356|FG004|Overall Study|Death|0|||
160835764|NCT01610336|580786357|FG005|Overall Study|Death|1|||
160835765|NCT01610336|580786358|FG006|Overall Study|Death|3|||
160835766|NCT01610336|580786359|FG007|Overall Study|Death|0|||
160835767|NCT01610336|580786360|FG008|Overall Study|Death|0|||
160991410|NCT00197236|581357790|FG001|Overall Study|Returned out of specified time window|0|||
160991411|NCT00197236|581357791|FG002|Overall Study|Returned out of specified time window|1|||
160991412|NCT02524288|581357792|FG000|Overall Study|Adverse Event|115|||
160991413|NCT02524288|581357792|FG000|Overall Study|Lost to Follow-up|216|||
160991414|NCT02524288|581357792|FG000|Overall Study|Non-Compliance With Protocol|32|||
160991415|NCT02524288|581357792|FG000|Overall Study|Non-Compliance With Study Drug|14|||
160991416|NCT02524288|581357792|FG000|Overall Study|Pregnancy Wish|6|||
160991417|NCT02524288|581357792|FG000|Overall Study|Protocol Violation|6|||
160991418|NCT02524288|581357792|FG000|Overall Study|Screen Failure|2|||
160991419|NCT02524288|581357792|FG000|Overall Study|Site Discontinued Study Participation|1|||
160991420|NCT02524288|581357792|FG000|Overall Study|Study Terminated By Sponsor|1417|||
160991421|NCT02524288|581357792|FG000|Overall Study|Subject Moved|32|||
160991422|NCT02524288|581357792|FG000|Overall Study|Withdrawal by Subject|76|||
160991423|NCT02524288|581357792|FG000|Overall Study|Pregnancy|22|||
160991424|NCT02524288|581357792|FG000|Overall Study|Physician Decision|2|||
160991425|NCT01835899|581357794|FG000|Overall Study|Adverse Event|0|||
160991426|NCT01835899|581357795|FG001|Overall Study|Adverse Event|0|||
160991427|NCT01835899|581357796|FG002|Overall Study|Adverse Event|1|||
160991428|NCT01835899|581357794|FG000|Overall Study|Other than stated above|0|||
160991429|NCT01835899|581357795|FG001|Overall Study|Other than stated above|1|||
160991430|NCT01835899|581357796|FG002|Overall Study|Other than stated above|0|||
160991431|NCT02616263|581357797|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
161334953|NCT02616783|582615868|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160835768|NCT01610336|580786361|FG009|Overall Study|Death|1|||
160835769|NCT01610336|580786362|FG010|Overall Study|Death|2|||
160991432|NCT02616263|581357798|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
160991433|NCT02616263|581357797|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
160991434|NCT02616263|581357798|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
160991435|NCT02616263|581357797|FG000|6 Month to 1.5 Year|Death|1|||
160991436|NCT02616263|581357798|FG001|6 Month to 1.5 Year|Death|0|||
160991437|NCT02616263|581357797|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
160835770|NCT01610336|580786352|FG000|Overall Study|Non-Compliance with study treatment|0|||
160835771|NCT01610336|580786353|FG001|Overall Study|Non-Compliance with study treatment|0|||
160835772|NCT01610336|580786354|FG002|Overall Study|Non-Compliance with study treatment|0|||
161249194|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161249195|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161249196|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
161249197|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
161249198|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
161249199|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161249200|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161249201|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
161249202|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
161249203|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
161249204|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161249205|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161249206|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
161249207|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
161249208|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
161249209|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161249210|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161249211|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
161249212|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
161249213|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
161249214|NCT01567527|582291704|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161249215|NCT01567527|582291705|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161249216|NCT01567527|582291706|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
161249217|NCT01567527|582291707|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
161249218|NCT01567527|582291708|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
161249219|NCT02004691|582291709|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
161249220|NCT02004691|582291710|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
161249221|NCT02004691|582291709|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
161249222|NCT02004691|582291710|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
161249223|NCT02004691|582291709|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
160835773|NCT01610336|580786355|FG003|Overall Study|Non-Compliance with study treatment|0|||
160835774|NCT01610336|580786356|FG004|Overall Study|Non-Compliance with study treatment|0|||
160835775|NCT01610336|580786357|FG005|Overall Study|Non-Compliance with study treatment|0|||
160835776|NCT01610336|580786358|FG006|Overall Study|Non-Compliance with study treatment|0|||
160835777|NCT01610336|580786359|FG007|Overall Study|Non-Compliance with study treatment|0|||
160835778|NCT01610336|580786360|FG008|Overall Study|Non-Compliance with study treatment|0|||
160835779|NCT01610336|580786361|FG009|Overall Study|Non-Compliance with study treatment|1|||
160835780|NCT01610336|580786362|FG010|Overall Study|Non-Compliance with study treatment|0|||
160835781|NCT01610336|580786352|FG000|Overall Study|Physician Decision|0|||
160835782|NCT01610336|580786353|FG001|Overall Study|Physician Decision|0|||
160835783|NCT01610336|580786354|FG002|Overall Study|Physician Decision|0|||
160835784|NCT01610336|580786355|FG003|Overall Study|Physician Decision|0|||
160835785|NCT01610336|580786356|FG004|Overall Study|Physician Decision|0|||
160835786|NCT01610336|580786357|FG005|Overall Study|Physician Decision|0|||
160835787|NCT01610336|580786358|FG006|Overall Study|Physician Decision|1|||
160835788|NCT01610336|580786359|FG007|Overall Study|Physician Decision|0|||
160835789|NCT01610336|580786360|FG008|Overall Study|Physician Decision|0|||
160835790|NCT01610336|580786361|FG009|Overall Study|Physician Decision|0|||
160835791|NCT01610336|580786362|FG010|Overall Study|Physician Decision|0|||
160835792|NCT01610336|580786352|FG000|Overall Study|Protocol Deviation|0|||
160835793|NCT01610336|580786353|FG001|Overall Study|Protocol Deviation|0|||
160835794|NCT01610336|580786354|FG002|Overall Study|Protocol Deviation|0|||
160835795|NCT01610336|580786355|FG003|Overall Study|Protocol Deviation|0|||
160903889|NCT01086033|581043051|FG000|Overall Study|AE and Lost to Follow-up|1|||
161249224|NCT02004691|582291710|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
161249225|NCT02004691|582291709|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
161249226|NCT02004691|582291710|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
161249227|NCT02004691|582291709|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
161249228|NCT02004691|582291710|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
161249229|NCT02004691|582291709|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
161249230|NCT02004691|582291710|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
160835796|NCT01610336|580786356|FG004|Overall Study|Protocol Deviation|0|||
160835797|NCT01610336|580786357|FG005|Overall Study|Protocol Deviation|0|||
160835798|NCT01610336|580786358|FG006|Overall Study|Protocol Deviation|0|||
160835799|NCT01610336|580786359|FG007|Overall Study|Protocol Deviation|0|||
160835800|NCT01610336|580786360|FG008|Overall Study|Protocol Deviation|0|||
160835801|NCT01610336|580786361|FG009|Overall Study|Protocol Deviation|1|||
160903890|NCT01086033|581043051|FG000|Overall Study|AE and Other Reason|1|||
160903891|NCT01086033|581043051|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
160903892|NCT02193867|581043053|FG000|Overall Study|Death|2|||
160903893|NCT02193867|581043053|FG000|Overall Study|Sponsor Study Termination|2|||
160903894|NCT02924571|581043054|FG000|Overall Study|Lost to Follow-up|1|||
160903895|NCT02924571|581043055|FG001|Overall Study|Lost to Follow-up|1|||
160903896|NCT02924571|581043056|FG002|Overall Study|Lost to Follow-up|0|||
160903897|NCT00434954|581043060|FG000|Overall Study|Adverse Event|17|||
160903898|NCT00434954|581043061|FG001|Overall Study|Adverse Event|2|||
160903899|NCT00434954|581043060|FG000|Overall Study|Entry criteria not met|14|||
160903900|NCT00434954|581043061|FG001|Overall Study|Entry criteria not met|16|||
160903901|NCT00434954|581043060|FG000|Overall Study|Lost to Follow-up|0|||
160903902|NCT00434954|581043061|FG001|Overall Study|Lost to Follow-up|1|||
160903903|NCT00434954|581043060|FG000|Overall Study|Physician Decision|6|||
160835802|NCT01610336|580786362|FG010|Overall Study|Protocol Deviation|0|||
160835803|NCT01610336|580786352|FG000|Overall Study|Transfer to another trial|0|||
160835804|NCT01610336|580786353|FG001|Overall Study|Transfer to another trial|0|||
160835805|NCT01610336|580786354|FG002|Overall Study|Transfer to another trial|0|||
160835806|NCT01610336|580786355|FG003|Overall Study|Transfer to another trial|0|||
160835807|NCT01610336|580786356|FG004|Overall Study|Transfer to another trial|0|||
160835808|NCT01610336|580786357|FG005|Overall Study|Transfer to another trial|0|||
160835809|NCT01610336|580786358|FG006|Overall Study|Transfer to another trial|0|||
160835810|NCT01610336|580786359|FG007|Overall Study|Transfer to another trial|0|||
160835811|NCT01610336|580786360|FG008|Overall Study|Transfer to another trial|0|||
160835812|NCT01610336|580786361|FG009|Overall Study|Transfer to another trial|0|||
160835813|NCT01610336|580786362|FG010|Overall Study|Transfer to another trial|1|||
160835814|NCT02629822|580786363|FG000|Base Study|Lost to Follow-up|2|||
160835815|NCT02629822|580786363|FG000|Base Study|Non-Compliance With Study Drug|1|||
160835816|NCT02629822|580786363|FG000|Extension Study|Adverse Event|1|||
160835817|NCT02629822|580786363|FG000|Extension Study|Lost to Follow-up|1|||
160835818|NCT00082407|580786364|FG000|Overall Study|Adverse Event|20|||
160835819|NCT00082407|580786365|FG001|Overall Study|Adverse Event|0|||
160835820|NCT00082407|580786364|FG000|Overall Study|Protocol Violation|14|||
160835821|NCT00082407|580786365|FG001|Overall Study|Protocol Violation|12|||
160835822|NCT00082407|580786364|FG000|Overall Study|Patient Decision|13|||
160835823|NCT00082407|580786365|FG001|Overall Study|Patient Decision|6|||
160835824|NCT00082407|580786364|FG000|Overall Study|Physician Decision|5|||
160835825|NCT00082407|580786365|FG001|Overall Study|Physician Decision|3|||
160835826|NCT00082407|580786364|FG000|Overall Study|Loss of Glucose Control|2|||
160835827|NCT00082407|580786365|FG001|Overall Study|Loss of Glucose Control|2|||
160835828|NCT00082407|580786364|FG000|Overall Study|Death|2|||
160903904|NCT00434954|581043061|FG001|Overall Study|Physician Decision|3|||
160903905|NCT00434954|581043060|FG000|Overall Study|Protocol Violation|36|||
160903906|NCT00434954|581043061|FG001|Overall Study|Protocol Violation|27|||
160903907|NCT00434954|581043060|FG000|Overall Study|Sponsor decision|1|||
160903908|NCT00434954|581043061|FG001|Overall Study|Sponsor decision|0|||
160903909|NCT00434954|581043060|FG000|Overall Study|Subject decision|8|||
160903910|NCT00434954|581043061|FG001|Overall Study|Subject decision|22|||
160903911|NCT01705730|581043062|FG000|Overall Study|Lack of Efficacy|1|||
160903912|NCT01705730|581043062|FG000|Overall Study|Adverse Event|3|||
160903913|NCT01705730|581043062|FG000|Overall Study|Lost to Follow-up|1|||
160903914|NCT01705730|581043062|FG000|Overall Study|Reason not Specified|4|||
160903915|NCT03417219|581043065|FG000|Overall Study|Lost to Follow-up|0|||
160903916|NCT03417219|581043066|FG001|Overall Study|Lost to Follow-up|3|||
160903917|NCT02589405|581043070|FG000|Overall Study|Adverse Event|3|||
160903918|NCT02589405|581043070|FG000|Overall Study|Withdrawal by Subject|1|||
160903919|NCT00446251|581043073|FG000|Overall Study|On-study Transplants|2|||
160903920|NCT00446251|581043073|FG000|Overall Study|Rituximab Infusion Reaction|2|||
160991438|NCT02616263|581357798|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
160835829|NCT00082407|580786365|FG001|Overall Study|Death|1|||
160835830|NCT00082407|580786364|FG000|Overall Study|Lost to Follow-up|0|||
160991439|NCT02616263|581357797|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
160835831|NCT00082407|580786365|FG001|Overall Study|Lost to Follow-up|3|||
160835832|NCT03464019|580786366|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
160835833|NCT03464019|580786367|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
160835834|NCT03464019|580786368|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
160835835|NCT03464019|580786366|FG000|NODE-301 Part 1|Ablation|0|||
160903921|NCT00446251|581043073|FG000|Overall Study|Lost to Follow-up|1|||
160991440|NCT02616263|581357798|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
160991441|NCT02616263|581357797|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
160991442|NCT02616263|581357798|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
160991443|NCT02939183|581357804|FG000|Overall Study|Death|0|||
160835836|NCT03464019|580786367|FG001|NODE-301 Part 1|Ablation|0|||
160835837|NCT03464019|580786368|FG002|NODE-301 Part 1|Ablation|16|||
160835838|NCT03464019|580786366|FG000|NODE-301 Part 1|Test Dose Failure|0|||
160835839|NCT03464019|580786367|FG001|NODE-301 Part 1|Test Dose Failure|0|||
160903922|NCT02264639|581043078|FG000|Overall Study|Death (after completing single-dose phase)|1|||
160903923|NCT02264639|581043079|FG001|Overall Study|Death (after completing single-dose phase)|0|||
160991444|NCT02939183|581357805|FG001|Overall Study|Death|0|||
160991445|NCT02939183|581357806|FG002|Overall Study|Death|1|||
160991446|NCT02939183|581357807|FG003|Overall Study|Death|0|||
160991447|NCT02939183|581357808|FG004|Overall Study|Death|0|||
160991448|NCT02939183|581357809|FG005|Overall Study|Death|2|||
160991449|NCT02939183|581357810|FG006|Overall Study|Death|1|||
160991450|NCT02939183|581357811|FG007|Overall Study|Death|0|||
160991451|NCT02939183|581357812|FG008|Overall Study|Death|0|||
160991452|NCT02939183|581357804|FG000|Overall Study|Sponsor decision|0|||
160991453|NCT02939183|581357805|FG001|Overall Study|Sponsor decision|1|||
160835840|NCT03464019|580786368|FG002|NODE-301 Part 1|Test Dose Failure|8|||
160835841|NCT03464019|580786366|FG000|NODE-301 Part 1|Adverse Event|0|||
160835842|NCT03464019|580786367|FG001|NODE-301 Part 1|Adverse Event|0|||
160835843|NCT03464019|580786368|FG002|NODE-301 Part 1|Adverse Event|5|||
160835844|NCT03464019|580786366|FG000|NODE-301 Part 1|Physician Decision|0|||
160835845|NCT03464019|580786367|FG001|NODE-301 Part 1|Physician Decision|0|||
160835846|NCT03464019|580786368|FG002|NODE-301 Part 1|Physician Decision|4|||
160835847|NCT03464019|580786366|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
160835848|NCT03464019|580786367|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
160835849|NCT03464019|580786368|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
160835850|NCT03464019|580786366|FG000|NODE-301 Part 1|Protocol Violation|0|||
160835851|NCT03464019|580786367|FG001|NODE-301 Part 1|Protocol Violation|0|||
160835852|NCT03464019|580786368|FG002|NODE-301 Part 1|Protocol Violation|2|||
160835853|NCT03464019|580786366|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
160835854|NCT03464019|580786367|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
160835855|NCT03464019|580786368|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
160835856|NCT03464019|580786366|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
160835857|NCT03464019|580786367|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
160835858|NCT03464019|580786368|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
160835859|NCT03464019|580786366|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
160835860|NCT03464019|580786367|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
160835861|NCT03464019|580786368|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
160835862|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
160835863|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
160835864|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
160835865|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
160835866|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
160835867|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
160835868|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
160835869|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
160835870|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
160835871|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
160835872|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
160835873|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
160835874|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
160835875|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
160835876|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
160835877|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
160835878|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
160835879|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
160835880|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
160835881|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
160835882|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
160835883|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
160835884|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
160835885|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
160835886|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
160835887|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
160835888|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
160991454|NCT02939183|581357806|FG002|Overall Study|Sponsor decision|0|||
160991455|NCT02939183|581357807|FG003|Overall Study|Sponsor decision|1|||
160991456|NCT02939183|581357808|FG004|Overall Study|Sponsor decision|2|||
160991457|NCT02939183|581357809|FG005|Overall Study|Sponsor decision|0|||
160991458|NCT02939183|581357810|FG006|Overall Study|Sponsor decision|3|||
160991459|NCT02939183|581357811|FG007|Overall Study|Sponsor decision|1|||
160991460|NCT02939183|581357812|FG008|Overall Study|Sponsor decision|4|||
160991461|NCT02939183|581357804|FG000|Overall Study|Withdrawal by Subject|0|||
160991462|NCT02939183|581357805|FG001|Overall Study|Withdrawal by Subject|2|||
160991463|NCT02939183|581357806|FG002|Overall Study|Withdrawal by Subject|0|||
160991464|NCT02939183|581357807|FG003|Overall Study|Withdrawal by Subject|1|||
160991465|NCT02939183|581357808|FG004|Overall Study|Withdrawal by Subject|0|||
160991466|NCT02939183|581357809|FG005|Overall Study|Withdrawal by Subject|0|||
160991467|NCT02939183|581357810|FG006|Overall Study|Withdrawal by Subject|2|||
160991468|NCT02939183|581357811|FG007|Overall Study|Withdrawal by Subject|2|||
160835889|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
160835890|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
160835891|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
160835892|NCT03464019|580786366|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
160835893|NCT03464019|580786367|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
160835894|NCT03464019|580786368|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
160835895|NCT00767806|580786369|FG000|Overall Study|Adverse Event|30|||
160835896|NCT00767806|580786370|FG001|Overall Study|Adverse Event|11|||
160835897|NCT00767806|580786369|FG000|Overall Study|Withdrawal by Subject|8|||
160835898|NCT00767806|580786370|FG001|Overall Study|Withdrawal by Subject|13|||
160835899|NCT00767806|580786369|FG000|Overall Study|Protocol Violation|6|||
160835900|NCT00767806|580786370|FG001|Overall Study|Protocol Violation|5|||
160835901|NCT00767806|580786369|FG000|Overall Study|Lack of Efficacy|1|||
160835902|NCT00767806|580786370|FG001|Overall Study|Lack of Efficacy|9|||
160835903|NCT00767806|580786369|FG000|Overall Study|Physician Decision|4|||
160835904|NCT00767806|580786370|FG001|Overall Study|Physician Decision|3|||
160835905|NCT00767806|580786369|FG000|Overall Study|Lost to Follow-up|1|||
160835906|NCT00767806|580786370|FG001|Overall Study|Lost to Follow-up|4|||
160835907|NCT00767806|580786369|FG000|Overall Study|Entry Criteria Not Met|1|||
160835908|NCT00767806|580786370|FG001|Overall Study|Entry Criteria Not Met|1|||
160835909|NCT00767806|580786369|FG000|Overall Study|Sponsor Decision|0|||
160835910|NCT00767806|580786370|FG001|Overall Study|Sponsor Decision|1|||
160835911|NCT02489942|580786371|FG000|Overall Study|Request by patient|602|||
160835912|NCT02489942|580786371|FG000|Overall Study|Improvement/remission|157|||
160835913|NCT02489942|580786371|FG000|Overall Study|No change/Progressive disease|263|||
160835914|NCT02489942|580786371|FG000|Overall Study|Adverse Event|522|||
160835915|NCT02489942|580786371|FG000|Overall Study|Other personal reasons|1218|||
160835916|NCT02489942|580786371|FG000|Overall Study|Lost to Follow-up|456|||
160835917|NCT02489942|580786371|FG000|Overall Study|Not continuously investigated|7|||
160835918|NCT02489942|580786371|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
160835919|NCT02489942|580786371|FG000|Overall Study|Multiple registration|1|||
160835920|NCT02489942|580786371|FG000|Overall Study|No patient visit after entry|100|||
160835921|NCT02489942|580786371|FG000|Overall Study|No treatment with Jardiance|2|||
160835922|NCT02489942|580786371|FG000|Overall Study|Patient received Jardiance before registration|1|||
160835923|NCT02489942|580786371|FG000|Overall Study|No CRF collected|86|||
160835924|NCT00858208|580786372|FG000|Overall Study|Adverse Event|3|||
160835925|NCT00858208|580786372|FG000|Overall Study|Lost to Follow-up|26|||
160835926|NCT00858208|580786372|FG000|Overall Study|Participant refused|40|||
161249231|NCT01726803|582291711|FG000|Overall Study|Lost to Follow-up|6|||
161249232|NCT01726803|582291712|FG001|Overall Study|Lost to Follow-up|1|||
160835927|NCT00858208|580786372|FG000|Overall Study|Other|10|||
160835928|NCT00704288|580786374|FG000|Overall Treatment Period|Adverse Event|11|||
160835929|NCT00704288|580786375|FG001|Overall Treatment Period|Adverse Event|8|||
160835930|NCT00704288|580786376|FG002|Overall Treatment Period|Adverse Event|22|||
160835931|NCT00704288|580786374|FG000|Overall Treatment Period|Death|0|||
160835932|NCT00704288|580786375|FG001|Overall Treatment Period|Death|0|||
160835933|NCT00704288|580786376|FG002|Overall Treatment Period|Death|1|||
160835934|NCT00704288|580786374|FG000|Overall Treatment Period|Physician Decision|0|||
160835935|NCT00704288|580786375|FG001|Overall Treatment Period|Physician Decision|2|||
160835936|NCT00704288|580786376|FG002|Overall Treatment Period|Physician Decision|0|||
160835937|NCT00704288|580786374|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
160835938|NCT00704288|580786375|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
160835939|NCT00704288|580786376|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
160835940|NCT00704288|580786374|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
160835941|NCT00704288|580786375|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
160835942|NCT00704288|580786376|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
160835943|NCT00704288|580786374|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
160835944|NCT00704288|580786375|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
161249233|NCT01726803|582291711|FG000|Overall Study|Withdrawal by Subject|1|||
161249234|NCT01726803|582291712|FG001|Overall Study|Withdrawal by Subject|0|||
161249235|NCT03407729|582291713|FG000|Overall Study|Lost to Follow-up|2|||
161249236|NCT03407729|582291714|FG001|Overall Study|Lost to Follow-up|0|||
161249237|NCT03407729|582291713|FG000|Overall Study|Unable to schedule|0|||
161249238|NCT03407729|582291714|FG001|Overall Study|Unable to schedule|3|||
160835945|NCT00704288|580786376|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
160835946|NCT00704288|580786374|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
160835947|NCT00704288|580786375|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
160835948|NCT00704288|580786376|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
160835949|NCT00704288|580786374|FG000|Overall Treatment Period|Roll-over to another study|1|||
161249239|NCT00024258|582291717|FG000|Overall Study|Withdrawal by Subject|1|||
161249240|NCT00024258|582291717|FG000|Overall Study|Disease Progression|8|||
160835950|NCT00704288|580786375|FG001|Overall Treatment Period|Roll-over to another study|0|||
160835951|NCT00704288|580786376|FG002|Overall Treatment Period|Roll-over to another study|4|||
160835952|NCT00704288|580786374|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
160835953|NCT00704288|580786375|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
160835954|NCT00704288|580786376|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
160835955|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Death|41|||
160835956|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Death|50|||
160835957|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Death|93|||
160835958|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
160835959|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
160835960|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
160835961|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
160835962|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
160835963|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
160835964|NCT00704288|580786374|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
160835965|NCT00704288|580786375|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
160835966|NCT00704288|580786376|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
160835967|NCT01055314|580786377|FG000|Overall Study|Adverse Event|7|||
160835968|NCT01055314|580786378|FG001|Overall Study|Adverse Event|4|||
160835969|NCT01055314|580786377|FG000|Overall Study|Death|2|||
160835970|NCT01055314|580786378|FG001|Overall Study|Death|1|||
160835971|NCT01055314|580786377|FG000|Overall Study|Lack of Efficacy|11|||
160835972|NCT01055314|580786378|FG001|Overall Study|Lack of Efficacy|19|||
160835973|NCT01055314|580786377|FG000|Overall Study|Physician Decision|10|||
160835974|NCT01055314|580786378|FG001|Overall Study|Physician Decision|5|||
160835975|NCT01055314|580786377|FG000|Overall Study|Withdrawal by Subject|1|||
160835976|NCT01055314|580786378|FG001|Overall Study|Withdrawal by Subject|0|||
160835977|NCT01055314|580786377|FG000|Overall Study|Ineligible|3|||
160835978|NCT01055314|580786378|FG001|Overall Study|Ineligible|5|||
160835979|NCT01055314|580786377|FG000|Overall Study|Refusal of further protocol therapy|10|||
160835980|NCT01055314|580786378|FG001|Overall Study|Refusal of further protocol therapy|4|||
160835981|NCT01055314|580786377|FG000|Overall Study|No treatment|1|||
160835982|NCT01055314|580786378|FG001|Overall Study|No treatment|0|||
160835983|NCT04395690|580786379|FG000|Overall Study|Lost to Follow-up|1|||
160835984|NCT04395690|580786380|FG001|Overall Study|Lost to Follow-up|1|||
160835985|NCT03927144|580786381|FG000|Core Phase|Adverse Event|9|||
160835986|NCT03927144|580786382|FG001|Core Phase|Adverse Event|5|||
160835987|NCT03927144|580786381|FG000|Core Phase|Lost to Follow-up|3|||
160835988|NCT03927144|580786382|FG001|Core Phase|Lost to Follow-up|2|||
160835989|NCT03927144|580786381|FG000|Core Phase|New Therapy for Study Indication|0|||
160835990|NCT03927144|580786382|FG001|Core Phase|New Therapy for Study Indication|1|||
160835991|NCT03927144|580786381|FG000|Core Phase|No Longer Clinically Benefiting|4|||
160835992|NCT03927144|580786382|FG001|Core Phase|No Longer Clinically Benefiting|4|||
160835993|NCT03927144|580786381|FG000|Core Phase|Physician Decision|2|||
160835994|NCT03927144|580786382|FG001|Core Phase|Physician Decision|8|||
160835995|NCT03927144|580786381|FG000|Core Phase|Protocol Violation|2|||
160835996|NCT03927144|580786382|FG001|Core Phase|Protocol Violation|2|||
160835997|NCT03927144|580786381|FG000|Core Phase|Withdrawal by Subject|16|||
160835998|NCT03927144|580786382|FG001|Core Phase|Withdrawal by Subject|40|||
160835999|NCT03927144|580786381|FG000|Extension Phase|Adverse Event|2|||
160836000|NCT03927144|580786382|FG001|Extension Phase|Adverse Event|1|||
160836001|NCT03927144|580786381|FG000|Extension Phase|No longer clinically benefiting|4|||
160836002|NCT03927144|580786382|FG001|Extension Phase|No longer clinically benefiting|5|||
160836003|NCT03927144|580786381|FG000|Extension Phase|Pregnancy|1|||
161249241|NCT00830167|582291720|FG000|Overall Study|Lack of Efficacy|26|||
161249242|NCT00830167|582291721|FG001|Overall Study|Lack of Efficacy|10|||
161249243|NCT00830167|582291720|FG000|Overall Study|Adverse Event|8|||
161249244|NCT00830167|582291721|FG001|Overall Study|Adverse Event|24|||
161249245|NCT00830167|582291720|FG000|Overall Study|Not meeting entrance criteria|2|||
161249246|NCT00830167|582291721|FG001|Overall Study|Not meeting entrance criteria|5|||
161249247|NCT00830167|582291720|FG000|Overall Study|Withdrawal by Subject|2|||
161249248|NCT00830167|582291721|FG001|Overall Study|Withdrawal by Subject|0|||
161249249|NCT00830167|582291720|FG000|Overall Study|Lost to Follow-up|0|||
161249250|NCT00830167|582291721|FG001|Overall Study|Lost to Follow-up|1|||
160836004|NCT03927144|580786382|FG001|Extension Phase|Pregnancy|0|||
160836005|NCT03927144|580786381|FG000|Extension Phase|Protocol Violation|0|||
160836006|NCT03927144|580786382|FG001|Extension Phase|Protocol Violation|1|||
160836007|NCT03927144|580786381|FG000|Extension Phase|Withdrawal by Subject|8|||
160836008|NCT03927144|580786382|FG001|Extension Phase|Withdrawal by Subject|3|||
160836009|NCT03909152|580786383|FG000|Overall Study|Adverse Event|14|||
160836010|NCT03909152|580786384|FG001|Overall Study|Adverse Event|5|||
160836011|NCT03909152|580786385|FG002|Overall Study|Adverse Event|1|||
161249251|NCT00830167|582291720|FG000|Overall Study|Protocol Violation|0|||
161249252|NCT00830167|582291721|FG001|Overall Study|Protocol Violation|1|||
161249253|NCT00830167|582291720|FG000|Overall Study|Other|2|||
160836012|NCT03909152|580786386|FG003|Overall Study|Adverse Event|14|||
160836013|NCT00719680|580786391|FG000|Overall Study|Adverse Event|1|||
160836014|NCT00719680|580786391|FG000|Overall Study|Lost to Follow-up|1|||
160836015|NCT00719680|580786391|FG000|Overall Study|Withdrawal by Subject|3|||
160836016|NCT04071158|580786393|FG000|Overall Study|Lost to Follow-up|1|||
160836017|NCT04071158|580786394|FG001|Overall Study|Lost to Follow-up|2|||
160836018|NCT04071158|580786395|FG002|Overall Study|Lost to Follow-up|3|||
160836019|NCT04071158|580786396|FG003|Overall Study|Lost to Follow-up|3|||
160836020|NCT04071158|580786397|FG004|Overall Study|Lost to Follow-up|5|||
161249254|NCT00830167|582291721|FG001|Overall Study|Other|2|||
160836021|NCT04071158|580786393|FG000|Overall Study|Randomized but not treated|2|||
160836022|NCT04071158|580786394|FG001|Overall Study|Randomized but not treated|2|||
160836023|NCT04071158|580786395|FG002|Overall Study|Randomized but not treated|0|||
160836024|NCT04071158|580786396|FG003|Overall Study|Randomized but not treated|0|||
160836025|NCT04071158|580786397|FG004|Overall Study|Randomized but not treated|0|||
160836026|NCT01178099|580786398|FG000|Overall Study|Physician Decision|0|||
160836027|NCT01178099|580786399|FG001|Overall Study|Physician Decision|1|||
160836028|NCT02473367|580786400|FG000|Wait 1|Withdrawal by Subject|1|||
160836029|NCT02473367|580786400|FG000|Period 4|Lost to Follow-up|1|||
160836030|NCT04816721|580786401|FG000|Overall Study|Withdrawal by Subject|0|||
160836031|NCT04816721|580786402|FG001|Overall Study|Withdrawal by Subject|2|||
160903924|NCT02264639|581043080|FG002|Overall Study|Death (after completing single-dose phase)|0|||
160903925|NCT02264639|581043081|FG003|Overall Study|Death (after completing single-dose phase)|0|||
160903926|NCT02264639|581043082|FG004|Overall Study|Death (after completing single-dose phase)|0|||
160903927|NCT02264639|581043078|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
160903928|NCT02264639|581043079|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903929|NCT02264639|581043080|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903930|NCT02264639|581043081|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903931|NCT02264639|581043082|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
160903932|NCT02264639|581043078|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903933|NCT02264639|581043079|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903934|NCT02264639|581043080|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
160903935|NCT02264639|581043081|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903936|NCT02264639|581043082|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
160903937|NCT02264639|581043078|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903938|NCT02264639|581043079|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903939|NCT02264639|581043080|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903940|NCT02264639|581043081|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
160903941|NCT02264639|581043082|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
160903942|NCT01416272|581043084|FG000|Overall Study|Unacceptable distance visual acuity|2|||
160903943|NCT01416272|581043084|FG000|Overall Study|Lost to Follow-up|1|||
160903944|NCT01416272|581043084|FG000|Overall Study|Study related complaints|1|||
160903945|NCT02693119|581043085|FG000|Open-Label Period|Withdrawal by Subject|0|||
160903946|NCT02693119|581043086|FG001|Open-Label Period|Withdrawal by Subject|1|||
160903947|NCT01719783|581043087|FG000|Dose 2|Physician Decision|1|||
160903948|NCT01719783|581043088|FG001|Dose 2|Physician Decision|0|||
160903949|NCT01350492|581043089|FG000|Intervention|Lost to Follow-up|2|||
160903950|NCT01350492|581043090|FG001|Intervention|Lost to Follow-up|5|||
160903951|NCT01350492|581043089|FG000|Intervention|Withdrawal by Subject|3|||
160903952|NCT01350492|581043090|FG001|Intervention|Withdrawal by Subject|1|||
160903953|NCT01350492|581043089|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
160903954|NCT01350492|581043090|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
160903955|NCT01350492|581043089|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
160903956|NCT01350492|581043090|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
160903957|NCT00753766|581043091|FG000|Overall Study|Physician Decision|1|||
160903958|NCT00753766|581043092|FG001|Overall Study|Physician Decision|0|||
160903959|NCT03800173|581043095|FG000|Overall Study|Lost to Follow-up|0|||
160903960|NCT03800173|581043096|FG001|Overall Study|Lost to Follow-up|0|||
160903961|NCT03800173|581043097|FG002|Overall Study|Lost to Follow-up|0|||
160903962|NCT03800173|581043098|FG003|Overall Study|Lost to Follow-up|0|||
160903963|NCT03800173|581043099|FG004|Overall Study|Lost to Follow-up|1|||
161249255|NCT03428945|582291722|FG000|Overall Study|Lost to Follow-up|5|||
161249256|NCT03428945|582291723|FG001|Overall Study|Lost to Follow-up|3|||
161249257|NCT03428945|582291722|FG000|Overall Study|Withdrawal by Subject|10|||
161249258|NCT03428945|582291723|FG001|Overall Study|Withdrawal by Subject|10|||
160903964|NCT00932126|581043102|FG000|Overall Study|Adverse Event|0|||
160903965|NCT00932126|581043103|FG001|Overall Study|Adverse Event|0|||
160836032|NCT04816721|580786403|FG002|Overall Study|Withdrawal by Subject|0|||
160836033|NCT04816721|580786404|FG003|Overall Study|Withdrawal by Subject|1|||
160836034|NCT04816721|580786405|FG004|Overall Study|Withdrawal by Subject|1|||
160836035|NCT04816721|580786406|FG005|Overall Study|Withdrawal by Subject|0|||
160836036|NCT04816721|580786407|FG006|Overall Study|Withdrawal by Subject|0|||
160836037|NCT04816721|580786408|FG007|Overall Study|Withdrawal by Subject|0|||
160836038|NCT04816721|580786401|FG000|Overall Study|Miscellaneous|0|||
160836039|NCT04816721|580786402|FG001|Overall Study|Miscellaneous|0|||
160836040|NCT04816721|580786403|FG002|Overall Study|Miscellaneous|0|||
160836041|NCT04816721|580786404|FG003|Overall Study|Miscellaneous|0|||
160836042|NCT04816721|580786405|FG004|Overall Study|Miscellaneous|0|||
160836043|NCT04816721|580786406|FG005|Overall Study|Miscellaneous|1|||
160836044|NCT04816721|580786407|FG006|Overall Study|Miscellaneous|0|||
160836045|NCT04816721|580786408|FG007|Overall Study|Miscellaneous|0|||
160836046|NCT04816721|580786401|FG000|Overall Study|Lost to Follow-up|0|||
160836047|NCT04816721|580786402|FG001|Overall Study|Lost to Follow-up|0|||
160836048|NCT04816721|580786403|FG002|Overall Study|Lost to Follow-up|0|||
160836049|NCT04816721|580786404|FG003|Overall Study|Lost to Follow-up|1|||
160836050|NCT04816721|580786405|FG004|Overall Study|Lost to Follow-up|0|||
160836051|NCT04816721|580786406|FG005|Overall Study|Lost to Follow-up|0|||
160836052|NCT04816721|580786407|FG006|Overall Study|Lost to Follow-up|0|||
160836053|NCT04816721|580786408|FG007|Overall Study|Lost to Follow-up|0|||
160836054|NCT03194438|580786420|FG000|Overall Study|Withdrawal by Subject|2|||
160836055|NCT00549770|580786423|FG000|Overall Study|Protocol deviation|1|||
160836056|NCT00549770|580786424|FG001|Overall Study|Protocol deviation|1|||
160836057|NCT00549770|580786425|FG002|Overall Study|Protocol deviation|1|||
160836058|NCT00549770|580786426|FG003|Overall Study|Protocol deviation|2|||
160836059|NCT00549770|580786427|FG004|Overall Study|Protocol deviation|2|||
160836060|NCT00549770|580786428|FG005|Overall Study|Protocol deviation|2|||
160836061|NCT00549770|580786429|FG006|Overall Study|Protocol deviation|1|||
160836062|NCT00549770|580786430|FG007|Overall Study|Protocol deviation|2|||
160836063|NCT00549770|580786423|FG000|Overall Study|Administrative problems|0|||
160836064|NCT00549770|580786424|FG001|Overall Study|Administrative problems|1|||
160836065|NCT00549770|580786425|FG002|Overall Study|Administrative problems|0|||
160836066|NCT00549770|580786426|FG003|Overall Study|Administrative problems|0|||
160836067|NCT00549770|580786427|FG004|Overall Study|Administrative problems|0|||
160836068|NCT00549770|580786428|FG005|Overall Study|Administrative problems|0|||
160836069|NCT00549770|580786429|FG006|Overall Study|Administrative problems|0|||
160836070|NCT00549770|580786430|FG007|Overall Study|Administrative problems|1|||
160836071|NCT00549770|580786423|FG000|Overall Study|Lost to Follow-up|0|||
160836072|NCT00549770|580786424|FG001|Overall Study|Lost to Follow-up|0|||
160836073|NCT00549770|580786425|FG002|Overall Study|Lost to Follow-up|2|||
160836074|NCT00549770|580786426|FG003|Overall Study|Lost to Follow-up|2|||
160836075|NCT00549770|580786427|FG004|Overall Study|Lost to Follow-up|3|||
160836076|NCT00549770|580786428|FG005|Overall Study|Lost to Follow-up|2|||
160836077|NCT00549770|580786429|FG006|Overall Study|Lost to Follow-up|0|||
160836078|NCT00549770|580786430|FG007|Overall Study|Lost to Follow-up|0|||
160836079|NCT00549770|580786423|FG000|Overall Study|Withdrawal by Subject|4|||
160836080|NCT00549770|580786424|FG001|Overall Study|Withdrawal by Subject|6|||
160836081|NCT00549770|580786425|FG002|Overall Study|Withdrawal by Subject|4|||
160836082|NCT00549770|580786426|FG003|Overall Study|Withdrawal by Subject|5|||
160836083|NCT00549770|580786427|FG004|Overall Study|Withdrawal by Subject|6|||
160836084|NCT00549770|580786428|FG005|Overall Study|Withdrawal by Subject|6|||
160836085|NCT00549770|580786429|FG006|Overall Study|Withdrawal by Subject|4|||
160836086|NCT00549770|580786430|FG007|Overall Study|Withdrawal by Subject|9|||
160836087|NCT00549770|580786423|FG000|Overall Study|Lack of Efficacy|1|||
160836088|NCT00549770|580786424|FG001|Overall Study|Lack of Efficacy|0|||
160836089|NCT00549770|580786425|FG002|Overall Study|Lack of Efficacy|2|||
160903966|NCT00932126|581043104|FG002|Overall Study|Adverse Event|0|||
160903967|NCT00932126|581043105|FG003|Overall Study|Adverse Event|0|||
160903968|NCT00932126|581043106|FG004|Overall Study|Adverse Event|0|||
160903969|NCT00932126|581043107|FG005|Overall Study|Adverse Event|0|||
160903970|NCT00932126|581043108|FG006|Overall Study|Adverse Event|1|||
160903971|NCT00932126|581043109|FG007|Overall Study|Adverse Event|2|||
160836090|NCT00549770|580786426|FG003|Overall Study|Lack of Efficacy|3|||
160836091|NCT00549770|580786427|FG004|Overall Study|Lack of Efficacy|5|||
160836092|NCT00549770|580786428|FG005|Overall Study|Lack of Efficacy|1|||
160836093|NCT00549770|580786429|FG006|Overall Study|Lack of Efficacy|3|||
160836094|NCT00549770|580786430|FG007|Overall Study|Lack of Efficacy|8|||
160836095|NCT00549770|580786423|FG000|Overall Study|Abnormal test procedure results|0|||
160836096|NCT00549770|580786424|FG001|Overall Study|Abnormal test procedure results|0|||
160836097|NCT00549770|580786425|FG002|Overall Study|Abnormal test procedure results|0|||
160903972|NCT00932126|581043102|FG000|Overall Study|Protocol Violation|0|||
160903973|NCT00932126|581043103|FG001|Overall Study|Protocol Violation|0|||
160903974|NCT00932126|581043104|FG002|Overall Study|Protocol Violation|0|||
161138092|NCT02886715|581887043|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161138093|NCT02886715|581887044|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161138094|NCT02886715|581887045|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161138095|NCT02886715|581887043|FG000|Overall Study|Adverse Event|4|||
161138096|NCT02886715|581887044|FG001|Overall Study|Adverse Event|2|||
161138097|NCT02886715|581887045|FG002|Overall Study|Adverse Event|0|||
161138098|NCT02886715|581887043|FG000|Overall Study|Lack of Efficacy|0|||
161138099|NCT02886715|581887044|FG001|Overall Study|Lack of Efficacy|2|||
161138100|NCT02886715|581887045|FG002|Overall Study|Lack of Efficacy|1|||
161138101|NCT02886715|581887043|FG000|Overall Study|Lost to Follow-up|29|||
161249259|NCT00982228|582291724|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
161249260|NCT00982228|582291725|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
161249261|NCT00982228|582291724|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
160836098|NCT00549770|580786426|FG003|Overall Study|Abnormal test procedure results|2|||
160836099|NCT00549770|580786427|FG004|Overall Study|Abnormal test procedure results|0|||
160836100|NCT00549770|580786428|FG005|Overall Study|Abnormal test procedure results|1|||
160836101|NCT00549770|580786429|FG006|Overall Study|Abnormal test procedure results|1|||
160836102|NCT00549770|580786430|FG007|Overall Study|Abnormal test procedure results|1|||
160836103|NCT00549770|580786423|FG000|Overall Study|Abnormal laboratory values|0|||
160836104|NCT00549770|580786424|FG001|Overall Study|Abnormal laboratory values|0|||
160836105|NCT00549770|580786425|FG002|Overall Study|Abnormal laboratory values|0|||
160836106|NCT00549770|580786426|FG003|Overall Study|Abnormal laboratory values|0|||
160836107|NCT00549770|580786427|FG004|Overall Study|Abnormal laboratory values|0|||
160836108|NCT00549770|580786428|FG005|Overall Study|Abnormal laboratory values|1|||
160836109|NCT00549770|580786429|FG006|Overall Study|Abnormal laboratory values|0|||
160836110|NCT00549770|580786430|FG007|Overall Study|Abnormal laboratory values|0|||
160903975|NCT00932126|581043105|FG003|Overall Study|Protocol Violation|0|||
160903976|NCT00932126|581043106|FG004|Overall Study|Protocol Violation|1|||
160903977|NCT00932126|581043107|FG005|Overall Study|Protocol Violation|0|||
160903978|NCT00932126|581043108|FG006|Overall Study|Protocol Violation|0|||
160903979|NCT00932126|581043109|FG007|Overall Study|Protocol Violation|0|||
160903980|NCT00932126|581043102|FG000|Overall Study|Withdrawal by Subject|0|||
160903981|NCT00932126|581043103|FG001|Overall Study|Withdrawal by Subject|0|||
160903982|NCT00932126|581043104|FG002|Overall Study|Withdrawal by Subject|1|||
160903983|NCT00932126|581043105|FG003|Overall Study|Withdrawal by Subject|0|||
160903984|NCT00932126|581043106|FG004|Overall Study|Withdrawal by Subject|0|||
160903985|NCT00932126|581043107|FG005|Overall Study|Withdrawal by Subject|0|||
160903986|NCT00932126|581043108|FG006|Overall Study|Withdrawal by Subject|0|||
160903987|NCT00932126|581043109|FG007|Overall Study|Withdrawal by Subject|1|||
160903988|NCT00932126|581043102|FG000|Overall Study|Objective progression or relapse|3|||
160903989|NCT00932126|581043103|FG001|Overall Study|Objective progression or relapse|3|||
160903990|NCT00932126|581043104|FG002|Overall Study|Objective progression or relapse|2|||
160903991|NCT00932126|581043105|FG003|Overall Study|Objective progression or relapse|3|||
160903992|NCT00932126|581043106|FG004|Overall Study|Objective progression or relapse|3|||
160903993|NCT00932126|581043107|FG005|Overall Study|Objective progression or relapse|3|||
160903994|NCT00932126|581043108|FG006|Overall Study|Objective progression or relapse|3|||
160903995|NCT00932126|581043109|FG007|Overall Study|Objective progression or relapse|5|||
160903996|NCT00932126|581043102|FG000|Overall Study|Other|0|||
160903997|NCT00932126|581043103|FG001|Overall Study|Other|0|||
160903998|NCT00932126|581043104|FG002|Overall Study|Other|0|||
160903999|NCT00932126|581043105|FG003|Overall Study|Other|0|||
160904000|NCT00932126|581043106|FG004|Overall Study|Other|1|||
160904001|NCT00932126|581043107|FG005|Overall Study|Other|0|||
160904002|NCT00932126|581043108|FG006|Overall Study|Other|1|||
160904003|NCT00932126|581043109|FG007|Overall Study|Other|2|||
160904004|NCT02121522|581043117|FG000|Overall Study|Adverse Event|1|||
160904005|NCT01235689|581043118|FG000|Overall Study|Adverse Event|12|||
160904006|NCT01235689|581043119|FG001|Overall Study|Adverse Event|16|||
160904007|NCT01235689|581043118|FG000|Overall Study|Lack of Efficacy|12|||
160904008|NCT01235689|581043119|FG001|Overall Study|Lack of Efficacy|5|||
160904009|NCT01235689|581043118|FG000|Overall Study|Withdrawal by Subject|3|||
160904010|NCT01235689|581043119|FG001|Overall Study|Withdrawal by Subject|4|||
160904011|NCT01235689|581043118|FG000|Overall Study|Lost to Follow-up|1|||
160904012|NCT01235689|581043119|FG001|Overall Study|Lost to Follow-up|2|||
160904013|NCT01235689|581043118|FG000|Overall Study|Miscellaneous|1|||
160904014|NCT01235689|581043119|FG001|Overall Study|Miscellaneous|5|||
161249262|NCT00982228|582291725|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
160836111|NCT00549770|580786423|FG000|Overall Study|Adverse Event|1|||
160836112|NCT00549770|580786424|FG001|Overall Study|Adverse Event|3|||
160836113|NCT00549770|580786425|FG002|Overall Study|Adverse Event|1|||
160836114|NCT00549770|580786426|FG003|Overall Study|Adverse Event|2|||
160836115|NCT00549770|580786427|FG004|Overall Study|Adverse Event|1|||
160904015|NCT02217878|581043120|FG000|Overall Study|required morphine due to chest pain|1|||
160904016|NCT02217878|581043121|FG001|Overall Study|required morphine due to chest pain|2|||
160904017|NCT02217878|581043120|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
160904018|NCT02217878|581043121|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
160904019|NCT00806351|581043124|FG000|Overall Study|Death|5|||
160904020|NCT00806351|581043125|FG001|Overall Study|Death|4|||
160904021|NCT02151110|581043126|FG000|Overall Study|Withdrawal by Subject|0|||
160904022|NCT02151110|581043127|FG001|Overall Study|Withdrawal by Subject|0|||
160904023|NCT02151110|581043128|FG002|Overall Study|Withdrawal by Subject|0|||
160904024|NCT02151110|581043129|FG003|Overall Study|Withdrawal by Subject|0|||
160904025|NCT02151110|581043130|FG004|Overall Study|Withdrawal by Subject|0|||
160904026|NCT02151110|581043131|FG005|Overall Study|Withdrawal by Subject|0|||
160904027|NCT02151110|581043132|FG006|Overall Study|Withdrawal by Subject|0|||
160904028|NCT02151110|581043133|FG007|Overall Study|Withdrawal by Subject|1|||
161249263|NCT00982228|582291724|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
161249264|NCT00982228|582291725|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
161249265|NCT00982228|582291724|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
161249266|NCT00982228|582291725|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
161249267|NCT00982228|582291724|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
161249268|NCT00982228|582291725|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
161249269|NCT00982228|582291724|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
161249270|NCT00982228|582291725|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
161249271|NCT00982228|582291724|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
161249272|NCT00982228|582291725|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
161249273|NCT00982228|582291724|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
161249274|NCT00982228|582291725|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
161249275|NCT00982228|582291724|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
161249276|NCT00982228|582291725|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
161249277|NCT00982228|582291724|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
161249278|NCT00982228|582291725|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
161249279|NCT00360490|582291729|FG000|Overall Study|Adverse Event|4|||
161249280|NCT00360490|582291730|FG001|Overall Study|Adverse Event|2|||
161249281|NCT00360490|582291729|FG000|Overall Study|Lost to Follow-up|2|||
161249282|NCT00360490|582291730|FG001|Overall Study|Lost to Follow-up|1|||
161249283|NCT00360490|582291729|FG000|Overall Study|Physician Decision|2|||
161249284|NCT00360490|582291730|FG001|Overall Study|Physician Decision|1|||
161249285|NCT00360490|582291729|FG000|Overall Study|Protocol Violation|0|||
160836116|NCT00549770|580786428|FG005|Overall Study|Adverse Event|0|||
160836117|NCT00549770|580786429|FG006|Overall Study|Adverse Event|5|||
160836118|NCT00549770|580786430|FG007|Overall Study|Adverse Event|4|||
160836119|NCT02712424|580786431|FG000|Overall Study|Lost to Follow-up|34|||
160836120|NCT02712424|580786432|FG001|Overall Study|Lost to Follow-up|32|||
160836121|NCT01141478|580786433|FG000|Overall Study|Withdrawal by Subject|1|||
160836122|NCT01141478|580786434|FG001|Overall Study|Withdrawal by Subject|1|||
160836123|NCT02760810|580786439|FG000|Overall Study|Protocol Violation|1|||
160836124|NCT01581619|580786440|FG000|Overall Study|Withdrawal by Subject|1|||
160836125|NCT01581619|580786440|FG000|Overall Study|Lost to Follow-up|1|||
160836126|NCT00290498|580786441|FG000|Overall Study|Death|2|||
160904029|NCT02151110|581043126|FG000|Overall Study|Lost to Follow-up|0|||
160904030|NCT02151110|581043127|FG001|Overall Study|Lost to Follow-up|0|||
160904031|NCT02151110|581043128|FG002|Overall Study|Lost to Follow-up|0|||
160991469|NCT02939183|581357812|FG008|Overall Study|Withdrawal by Subject|2|||
160991470|NCT02939183|581357804|FG000|Overall Study|Not treated due to adverse event|0|||
160991471|NCT02939183|581357805|FG001|Overall Study|Not treated due to adverse event|0|||
160991472|NCT02939183|581357806|FG002|Overall Study|Not treated due to adverse event|0|||
160991473|NCT02939183|581357807|FG003|Overall Study|Not treated due to adverse event|1|||
160991474|NCT02939183|581357808|FG004|Overall Study|Not treated due to adverse event|0|||
160991475|NCT02939183|581357809|FG005|Overall Study|Not treated due to adverse event|0|||
160991476|NCT02939183|581357810|FG006|Overall Study|Not treated due to adverse event|1|||
160991477|NCT02939183|581357811|FG007|Overall Study|Not treated due to adverse event|0|||
160991478|NCT02939183|581357812|FG008|Overall Study|Not treated due to adverse event|0|||
160991479|NCT05015478|581357813|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
160991480|NCT05015478|581357814|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
160991481|NCT05015478|581357815|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
160991482|NCT05015478|581357816|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
160991483|NCT04939428|581357817|FG000|Overall Study|Death|0|||
160991484|NCT04939428|581357818|FG001|Overall Study|Death|1|||
161249286|NCT00360490|582291730|FG001|Overall Study|Protocol Violation|4|||
161249287|NCT00360490|582291729|FG000|Overall Study|Withdrawal by Subject|1|||
161249288|NCT00360490|582291730|FG001|Overall Study|Withdrawal by Subject|3|||
161249289|NCT02289820|582291731|FG000|Overall Study|Withdrawal by Subject|2|||
161249290|NCT02289820|582291732|FG001|Overall Study|Withdrawal by Subject|1|||
161249291|NCT02289820|582291733|FG002|Overall Study|Withdrawal by Subject|2|||
160836127|NCT00290498|580786442|FG001|Overall Study|Death|0|||
160836128|NCT00290498|580786441|FG000|Overall Study|Physician Decision|1|||
160904032|NCT02151110|581043129|FG003|Overall Study|Lost to Follow-up|0|||
160904033|NCT02151110|581043130|FG004|Overall Study|Lost to Follow-up|0|||
160904034|NCT02151110|581043131|FG005|Overall Study|Lost to Follow-up|0|||
160904035|NCT02151110|581043132|FG006|Overall Study|Lost to Follow-up|0|||
160904036|NCT02151110|581043133|FG007|Overall Study|Lost to Follow-up|2|||
161249292|NCT02289820|582291734|FG003|Overall Study|Withdrawal by Subject|1|||
161249293|NCT02289820|582291735|FG004|Overall Study|Withdrawal by Subject|0|||
160904037|NCT00672646|581043137|FG000|Overall Study|Lost to Follow-up|0|||
160904038|NCT00672646|581043138|FG001|Overall Study|Lost to Follow-up|1|||
160904039|NCT00672646|581043139|FG002|Overall Study|Lost to Follow-up|2|||
160904040|NCT00672646|581043137|FG000|Overall Study|Withdrawal by Subject|0|||
160904041|NCT00672646|581043138|FG001|Overall Study|Withdrawal by Subject|0|||
161249294|NCT02289820|582291736|FG005|Overall Study|Withdrawal by Subject|0|||
161138102|NCT02886715|581887044|FG001|Overall Study|Lost to Follow-up|26|||
161138103|NCT02886715|581887045|FG002|Overall Study|Lost to Follow-up|10|||
161138104|NCT02886715|581887043|FG000|Overall Study|Pregnancy|1|||
161138105|NCT02886715|581887044|FG001|Overall Study|Pregnancy|1|||
161138106|NCT02886715|581887045|FG002|Overall Study|Pregnancy|1|||
161138107|NCT02886715|581887043|FG000|Overall Study|Protocol Violation|3|||
161138108|NCT02886715|581887044|FG001|Overall Study|Protocol Violation|2|||
161138109|NCT02886715|581887045|FG002|Overall Study|Protocol Violation|1|||
161138110|NCT02886715|581887043|FG000|Overall Study|Withdrawal by Subject|20|||
161138111|NCT02886715|581887044|FG001|Overall Study|Withdrawal by Subject|18|||
161138112|NCT02886715|581887045|FG002|Overall Study|Withdrawal by Subject|5|||
161138113|NCT02886715|581887043|FG000|Overall Study|missing|7|||
161138114|NCT02886715|581887044|FG001|Overall Study|missing|2|||
161138115|NCT02886715|581887045|FG002|Overall Study|missing|2|||
161138116|NCT03812510|581887046|FG000|Overall Study|Lost to Follow-up|39|||
161138117|NCT03812510|581887046|FG000|Overall Study|Withdrawal by Subject|42|||
161138118|NCT03812510|581887046|FG000|Overall Study|Physician Decision|2|||
161138119|NCT03812510|581887046|FG000|Overall Study|Study Terminated by Sponsor|9|||
161138120|NCT03812510|581887046|FG000|Overall Study|Did Not Start Study Medication|55|||
161138121|NCT03812510|581887046|FG000|Overall Study|Adverse Event|5|||
161138122|NCT03168867|581887047|FG000|Overall Study|Withdrawal by Subject|1|||
161138123|NCT03168867|581887048|FG001|Overall Study|Withdrawal by Subject|5|||
161138124|NCT01128387|581887049|FG000|Overall Study|Physician Decision|0|||
161138125|NCT01128387|581887050|FG001|Overall Study|Physician Decision|1|||
161138126|NCT00858832|581887051|FG000|Overall Study|became ineligible: delivered vaginally|1|||
161138127|NCT00858832|581887052|FG001|Overall Study|became ineligible: delivered vaginally|0|||
161138128|NCT00858832|581887051|FG000|Overall Study|Adverse Event|0|||
161138129|NCT00858832|581887052|FG001|Overall Study|Adverse Event|1|||
161138130|NCT04433117|581887053|FG000|Overall Study|Withdrawal by Subject|1|||
161138131|NCT04433117|581887054|FG001|Overall Study|Withdrawal by Subject|0|||
161138132|NCT00824421|581887055|FG000|Overall Study|Adverse Event|6|||
161138133|NCT00824421|581887056|FG001|Overall Study|Adverse Event|6|||
161138134|NCT00824421|581887057|FG002|Overall Study|Adverse Event|6|||
161138135|NCT00824421|581887055|FG000|Overall Study|Death|0|||
161138136|NCT00824421|581887056|FG001|Overall Study|Death|1|||
161138137|NCT00824421|581887057|FG002|Overall Study|Death|0|||
161138138|NCT00824421|581887055|FG000|Overall Study|Lack of Efficacy|5|||
161138139|NCT00824421|581887056|FG001|Overall Study|Lack of Efficacy|7|||
161138140|NCT00824421|581887057|FG002|Overall Study|Lack of Efficacy|4|||
161138141|NCT00824421|581887055|FG000|Overall Study|Lost to Follow-up|2|||
161138142|NCT00824421|581887056|FG001|Overall Study|Lost to Follow-up|3|||
161138143|NCT00824421|581887057|FG002|Overall Study|Lost to Follow-up|0|||
161138144|NCT00824421|581887055|FG000|Overall Study|Pregnancy|1|||
161138145|NCT00824421|581887056|FG001|Overall Study|Pregnancy|0|||
161138146|NCT00824421|581887057|FG002|Overall Study|Pregnancy|1|||
161138147|NCT00824421|581887055|FG000|Overall Study|Withdrawal by Subject|2|||
161138148|NCT00824421|581887056|FG001|Overall Study|Withdrawal by Subject|3|||
161138149|NCT00824421|581887057|FG002|Overall Study|Withdrawal by Subject|3|||
161249295|NCT02289820|582291737|FG006|Overall Study|Withdrawal by Subject|1|||
161249296|NCT02289820|582291731|FG000|Overall Study|Death|0|||
160904042|NCT00672646|581043139|FG002|Overall Study|Withdrawal by Subject|1|||
160904043|NCT01999179|581043140|FG000|Overall Study|Adverse Event|1|||
160904044|NCT01999179|581043140|FG000|Overall Study|Lost to Follow-up|1|||
160904045|NCT01999179|581043140|FG000|Overall Study|Change in Therapy|3|||
160904046|NCT01999179|581043140|FG000|Overall Study|New catheter|2|||
160904047|NCT00289783|581043143|FG000|Primary Phase|Adverse Event|10|||
160904048|NCT00289783|581043144|FG001|Primary Phase|Adverse Event|1|||
160904049|NCT00289783|581043143|FG000|Primary Phase|Protocol Violation|27|||
160904050|NCT00289783|581043144|FG001|Primary Phase|Protocol Violation|6|||
160904051|NCT00289783|581043143|FG000|Primary Phase|Withdrawal by Subject|93|||
160904052|NCT00289783|581043144|FG001|Primary Phase|Withdrawal by Subject|40|||
161138150|NCT00824421|581887055|FG000|Overall Study|Randomized but not Treated|1|||
161138151|NCT00824421|581887056|FG001|Overall Study|Randomized but not Treated|1|||
161138152|NCT00824421|581887057|FG002|Overall Study|Randomized but not Treated|0|||
161138153|NCT00824421|581887055|FG000|Overall Study|Other|0|||
161138154|NCT00824421|581887056|FG001|Overall Study|Other|1|||
161138155|NCT00824421|581887057|FG002|Overall Study|Other|0|||
161138156|NCT00659438|581887059|FG000|Overall Study|Withdrawal by Subject|2|||
161138157|NCT00659438|581887060|FG001|Overall Study|Withdrawal by Subject|2|||
161138158|NCT00659438|581887059|FG000|Overall Study|Death|11|||
161138159|NCT00659438|581887060|FG001|Overall Study|Death|6|||
161138160|NCT00659438|581887059|FG000|Overall Study|Lost to Follow-up|1|||
161138161|NCT00659438|581887060|FG001|Overall Study|Lost to Follow-up|0|||
161138162|NCT00201851|581887061|FG000|Overall Study|Lost to Follow-up|2|||
160904053|NCT00289783|581043143|FG000|Primary Phase|Lost to Follow-up|60|||
160904054|NCT00289783|581043144|FG001|Primary Phase|Lost to Follow-up|14|||
160991485|NCT04939428|581357819|FG002|Overall Study|Death|0|||
161138163|NCT00201851|581887062|FG001|Overall Study|Lost to Follow-up|1|||
160991486|NCT04939428|581357817|FG000|Overall Study|Lost to Follow-up|0|||
161138164|NCT00201851|581887063|FG002|Overall Study|Lost to Follow-up|0|||
160836129|NCT00290498|580786442|FG001|Overall Study|Physician Decision|0|||
160836130|NCT00290498|580786441|FG000|Overall Study|Withdrawal by Subject|1|||
160836131|NCT00290498|580786442|FG001|Overall Study|Withdrawal by Subject|0|||
160836132|NCT00290498|580786441|FG000|Overall Study|Ineligible|3|||
160836133|NCT00290498|580786442|FG001|Overall Study|Ineligible|0|||
160836134|NCT00290498|580786441|FG000|Overall Study|Non-Compliance|1|||
160836135|NCT00290498|580786442|FG001|Overall Study|Non-Compliance|0|||
160836136|NCT03847909|580786447|FG000|Overall Study|Withdrawal by Subject|1|||
160836137|NCT03847909|580786448|FG001|Overall Study|Withdrawal by Subject|1|||
160836138|NCT00490022|580786449|FG000|Overall Study|Adverse Event|0|||
160836139|NCT00490022|580786450|FG001|Overall Study|Adverse Event|2|||
160836140|NCT00490022|580786449|FG000|Overall Study|Withdrawal by Subject|1|||
160836141|NCT00490022|580786450|FG001|Overall Study|Withdrawal by Subject|0|||
160836142|NCT00490022|580786449|FG000|Overall Study|Subject failed to disclose concommitant|0|||
160836143|NCT00490022|580786450|FG001|Overall Study|Subject failed to disclose concommitant|1|||
160836144|NCT01375608|580786451|FG000|Overall Study|Withdrawal by Subject|2|||
160836145|NCT00694304|580786452|FG000|Overall Study|Adverse Event|42|||
160836146|NCT00694304|580786452|FG000|Overall Study|Lack of Efficacy|35|||
160836147|NCT00694304|580786452|FG000|Overall Study|Non-compliance With Study Product|16|||
160836148|NCT00694304|580786452|FG000|Overall Study|Protocol Violation|6|||
160836149|NCT00694304|580786452|FG000|Overall Study|Withdrawal of Consent|61|||
160836150|NCT00694304|580786452|FG000|Overall Study|Lost to Follow-up|15|||
160836151|NCT00694304|580786452|FG000|Overall Study|Administrative or Other Reasons|32|||
160836152|NCT02102399|580786460|FG000|Overall Study|Withdrawal by Subject|6|||
160991487|NCT04939428|581357818|FG001|Overall Study|Lost to Follow-up|5|||
160991488|NCT04939428|581357819|FG002|Overall Study|Lost to Follow-up|0|||
160991489|NCT04939428|581357817|FG000|Overall Study|Physician Decision|1|||
160991490|NCT04939428|581357818|FG001|Overall Study|Physician Decision|0|||
160991491|NCT04939428|581357819|FG002|Overall Study|Physician Decision|0|||
160991492|NCT04939428|581357817|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160991493|NCT04939428|581357818|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160991494|NCT04939428|581357819|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160991495|NCT04939428|581357817|FG000|Overall Study|Withdrawal by Subject|10|||
160991496|NCT04939428|581357818|FG001|Overall Study|Withdrawal by Subject|11|||
160991497|NCT04939428|581357819|FG002|Overall Study|Withdrawal by Subject|0|||
160991498|NCT04939428|581357817|FG000|Overall Study|Unkown|6|||
160991499|NCT04939428|581357818|FG001|Overall Study|Unkown|3|||
160991500|NCT04939428|581357819|FG002|Overall Study|Unkown|0|||
160991501|NCT04939428|581357817|FG000|Overall Study|Discotinued per protocol|0|||
160991502|NCT04939428|581357818|FG001|Overall Study|Discotinued per protocol|0|||
160991503|NCT04939428|581357819|FG002|Overall Study|Discotinued per protocol|902|||
160991504|NCT04319094|581357822|FG000|Baseline|Lost to Follow-up|4|||
160991505|NCT04319094|581357823|FG001|Baseline|Lost to Follow-up|5|||
160991506|NCT04319094|581357822|FG000|Baseline|Protocol Violation|0|||
160991507|NCT04319094|581357823|FG001|Baseline|Protocol Violation|3|||
160991508|NCT04319094|581357822|FG000|Baseline|Withdrawal by Subject|2|||
160991509|NCT04319094|581357823|FG001|Baseline|Withdrawal by Subject|1|||
160991510|NCT04319094|581357822|FG000|Post-Intervention|Death|0|||
160991511|NCT04319094|581357823|FG001|Post-Intervention|Death|1|||
160991512|NCT04319094|581357822|FG000|Post-Intervention|Lost to Follow-up|4|||
160991513|NCT04319094|581357823|FG001|Post-Intervention|Lost to Follow-up|4|||
160991514|NCT04319094|581357822|FG000|Post-Intervention|Withdrawal by Subject|8|||
160991515|NCT04319094|581357823|FG001|Post-Intervention|Withdrawal by Subject|5|||
160991516|NCT04319094|581357822|FG000|Post-Intervention|Incomplete Data Collection|1|||
160991517|NCT04319094|581357823|FG001|Post-Intervention|Incomplete Data Collection|3|||
161249297|NCT02289820|582291732|FG001|Overall Study|Death|0|||
160836153|NCT02102399|580786461|FG001|Overall Study|Withdrawal by Subject|4|||
160836154|NCT00772109|580786464|FG000|Overall Study|Serious adverse event|1|||
160836155|NCT00772109|580786465|FG001|Overall Study|Serious adverse event|0|||
160836156|NCT00772109|580786466|FG002|Overall Study|Serious adverse event|1|||
160836157|NCT00772109|580786467|FG003|Overall Study|Serious adverse event|0|||
160836158|NCT00772109|580786464|FG000|Overall Study|Protocol Violation|5|||
160836159|NCT00772109|580786465|FG001|Overall Study|Protocol Violation|8|||
160836160|NCT00772109|580786466|FG002|Overall Study|Protocol Violation|7|||
160836161|NCT00772109|580786467|FG003|Overall Study|Protocol Violation|6|||
160836162|NCT00772109|580786464|FG000|Overall Study|Lost to Follow-up|7|||
160836163|NCT00772109|580786465|FG001|Overall Study|Lost to Follow-up|3|||
160836164|NCT00772109|580786466|FG002|Overall Study|Lost to Follow-up|5|||
160836165|NCT00772109|580786467|FG003|Overall Study|Lost to Follow-up|9|||
160836166|NCT00772109|580786464|FG000|Overall Study|Withdrawal by Subject|8|||
160836167|NCT00772109|580786465|FG001|Overall Study|Withdrawal by Subject|8|||
160836168|NCT00772109|580786466|FG002|Overall Study|Withdrawal by Subject|6|||
160836169|NCT00772109|580786467|FG003|Overall Study|Withdrawal by Subject|16|||
160836170|NCT00410605|580786468|FG000|Overall Study|Adverse Event|12|||
160836171|NCT00410605|580786468|FG000|Overall Study|Physician Decision|3|||
160836172|NCT00410605|580786468|FG000|Overall Study|Withdrawal by Subject|5|||
160991518|NCT04319094|581357822|FG000|3-month|Death|1|||
161249298|NCT02289820|582291733|FG002|Overall Study|Death|1|||
161249299|NCT02289820|582291734|FG003|Overall Study|Death|0|||
161249300|NCT02289820|582291735|FG004|Overall Study|Death|0|||
161249301|NCT02289820|582291736|FG005|Overall Study|Death|0|||
161249302|NCT02289820|582291737|FG006|Overall Study|Death|0|||
160836173|NCT00410605|580786468|FG000|Overall Study|Started Non-Protocol Therapy|3|||
160836174|NCT00410605|580786468|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
160836175|NCT00410605|580786468|FG000|Overall Study|Transferred to another Institution|1|||
160836176|NCT04667104|580786472|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
160836177|NCT04667104|580786473|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
161249303|NCT02289820|582291731|FG000|Overall Study|Lost to Follow-up|0|||
161249304|NCT02289820|582291732|FG001|Overall Study|Lost to Follow-up|0|||
161249305|NCT02289820|582291733|FG002|Overall Study|Lost to Follow-up|3|||
161249306|NCT02289820|582291734|FG003|Overall Study|Lost to Follow-up|1|||
161249307|NCT02289820|582291735|FG004|Overall Study|Lost to Follow-up|0|||
161249308|NCT02289820|582291736|FG005|Overall Study|Lost to Follow-up|1|||
161249309|NCT02289820|582291737|FG006|Overall Study|Lost to Follow-up|1|||
161249310|NCT02289820|582291731|FG000|Overall Study|withdrawal of consent|0|||
161249311|NCT02289820|582291732|FG001|Overall Study|withdrawal of consent|1|||
161249312|NCT02289820|582291733|FG002|Overall Study|withdrawal of consent|0|||
161249313|NCT02289820|582291734|FG003|Overall Study|withdrawal of consent|0|||
161249314|NCT02289820|582291735|FG004|Overall Study|withdrawal of consent|0|||
161334954|NCT02616783|582615867|FG000|Overall Study|Protocol Violation|1|||
161334955|NCT02616783|582615868|FG001|Overall Study|Protocol Violation|1|||
160836178|NCT04667104|580786474|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
160836179|NCT01078168|580786475|FG000|Overall Study|Physician Decision|0|||
160836180|NCT01078168|580786476|FG001|Overall Study|Physician Decision|1|||
160836181|NCT05066165|580788345|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
160836182|NCT05066165|580788346|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
160836183|NCT05066165|580788345|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
160836184|NCT05066165|580788346|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
160836185|NCT03210961|580788347|FG000|Overall Study|Adverse Event|0|||
160836186|NCT03210961|580788348|FG001|Overall Study|Adverse Event|0|||
160836187|NCT03210961|580788349|FG002|Overall Study|Adverse Event|0|||
160836188|NCT03210961|580788350|FG003|Overall Study|Adverse Event|0|||
160836189|NCT03210961|580788351|FG004|Overall Study|Adverse Event|0|||
160836190|NCT03210961|580788352|FG005|Overall Study|Adverse Event|0|||
160836191|NCT03210961|580788353|FG006|Overall Study|Adverse Event|0|||
160836192|NCT03210961|580788354|FG007|Overall Study|Adverse Event|0|||
160836193|NCT03210961|580788355|FG008|Overall Study|Adverse Event|0|||
160836194|NCT03210961|580788356|FG009|Overall Study|Adverse Event|0|||
160836195|NCT03210961|580788357|FG010|Overall Study|Adverse Event|0|||
160836196|NCT03210961|580788358|FG011|Overall Study|Adverse Event|0|||
160836197|NCT03210961|580788359|FG012|Overall Study|Adverse Event|0|||
160836198|NCT03210961|580788360|FG013|Overall Study|Adverse Event|1|||
160836199|NCT03210961|580788361|FG014|Overall Study|Adverse Event|0|||
160836200|NCT03210961|580788347|FG000|Overall Study|Lost to Follow-up|0|||
160836201|NCT03210961|580788348|FG001|Overall Study|Lost to Follow-up|0|||
160836202|NCT03210961|580788349|FG002|Overall Study|Lost to Follow-up|0|||
160836203|NCT03210961|580788350|FG003|Overall Study|Lost to Follow-up|0|||
160836204|NCT03210961|580788351|FG004|Overall Study|Lost to Follow-up|0|||
160836205|NCT03210961|580788352|FG005|Overall Study|Lost to Follow-up|0|||
160836206|NCT03210961|580788353|FG006|Overall Study|Lost to Follow-up|0|||
160836207|NCT03210961|580788354|FG007|Overall Study|Lost to Follow-up|0|||
160836208|NCT03210961|580788355|FG008|Overall Study|Lost to Follow-up|0|||
160836209|NCT03210961|580788356|FG009|Overall Study|Lost to Follow-up|0|||
160836210|NCT03210961|580788357|FG010|Overall Study|Lost to Follow-up|0|||
160836211|NCT03210961|580788358|FG011|Overall Study|Lost to Follow-up|0|||
160836212|NCT03210961|580788359|FG012|Overall Study|Lost to Follow-up|0|||
160836213|NCT03210961|580788360|FG013|Overall Study|Lost to Follow-up|0|||
160836214|NCT03210961|580788361|FG014|Overall Study|Lost to Follow-up|1|||
160836215|NCT03210961|580788347|FG000|Overall Study|Withdrawal by Subject|0|||
160836216|NCT03210961|580788348|FG001|Overall Study|Withdrawal by Subject|0|||
160836217|NCT03210961|580788349|FG002|Overall Study|Withdrawal by Subject|0|||
160836218|NCT03210961|580788350|FG003|Overall Study|Withdrawal by Subject|0|||
160904055|NCT00289783|581043143|FG000|Primary Phase|Migration from the study area|26|||
160904056|NCT00289783|581043144|FG001|Primary Phase|Migration from the study area|10|||
160836219|NCT03210961|580788351|FG004|Overall Study|Withdrawal by Subject|0|||
160836220|NCT03210961|580788352|FG005|Overall Study|Withdrawal by Subject|0|||
160836221|NCT03210961|580788353|FG006|Overall Study|Withdrawal by Subject|0|||
160904057|NCT00289783|581043143|FG000|Primary Phase|Other|32|||
160836222|NCT03210961|580788354|FG007|Overall Study|Withdrawal by Subject|0|||
160904058|NCT00289783|581043144|FG001|Primary Phase|Other|12|||
160904059|NCT00289783|581043143|FG000|Fourth Dose Phase|Adverse Event|1|||
161249315|NCT02289820|582291736|FG005|Overall Study|withdrawal of consent|0|||
161249316|NCT02289820|582291737|FG006|Overall Study|withdrawal of consent|0|||
161249317|NCT02005276|582291738|FG000|Overall Study|No longer interested|5|||
161249318|NCT02005276|582291739|FG001|Overall Study|No longer interested|2|||
161334956|NCT02616783|582615867|FG000|Overall Study|Withdrew Consent|1|||
161249319|NCT02005276|582291740|FG002|Overall Study|No longer interested|3|||
161249320|NCT02005276|582291741|FG003|Overall Study|No longer interested|3|||
161249321|NCT01688882|582291748|FG000|Overall Study|Adverse Event|1|||
161249322|NCT01688882|582291749|FG001|Overall Study|Adverse Event|0|||
161249323|NCT01688882|582291748|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161249324|NCT01688882|582291749|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161249325|NCT01688882|582291748|FG000|Overall Study|Administrative problems|1|||
161249326|NCT01688882|582291749|FG001|Overall Study|Administrative problems|0|||
161249327|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
161249328|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
161249329|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
161249330|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
161249331|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
161249332|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
161249333|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
161249334|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
161249335|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
161249336|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
161249337|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
161249338|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
161249339|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
161249340|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
161249341|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
161249342|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
160836223|NCT03210961|580788355|FG008|Overall Study|Withdrawal by Subject|0|||
160836224|NCT03210961|580788356|FG009|Overall Study|Withdrawal by Subject|0|||
160836225|NCT03210961|580788357|FG010|Overall Study|Withdrawal by Subject|0|||
161249343|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
161249344|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
161249345|NCT00950300|582291750|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
161249346|NCT00950300|582291751|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
161249347|NCT00950300|582291750|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
161249348|NCT00950300|582291751|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
161249349|NCT00950300|582291750|FG000|TFFU Period|Death|4|||
161249350|NCT00950300|582291751|FG001|TFFU Period|Death|1|||
161249351|NCT00950300|582291750|FG000|TFFU Period|Refused Treatment|10|||
161249352|NCT00950300|582291751|FG001|TFFU Period|Refused Treatment|11|||
161249353|NCT00950300|582291750|FG000|TFFU Period|Failure to Return|16|||
161249354|NCT00950300|582291751|FG001|TFFU Period|Failure to Return|16|||
161249355|NCT00950300|582291750|FG000|TFFU Period|Recurrence of Disease|63|||
161249356|NCT00950300|582291751|FG001|TFFU Period|Recurrence of Disease|72|||
161249357|NCT00950300|582291750|FG000|TFFU Period|Other|4|||
160836226|NCT03210961|580788358|FG011|Overall Study|Withdrawal by Subject|0|||
160836227|NCT03210961|580788359|FG012|Overall Study|Withdrawal by Subject|0|||
160836228|NCT03210961|580788360|FG013|Overall Study|Withdrawal by Subject|0|||
160836229|NCT03210961|580788361|FG014|Overall Study|Withdrawal by Subject|1|||
160836230|NCT03210961|580788347|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836231|NCT03210961|580788348|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836232|NCT03210961|580788349|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836233|NCT03210961|580788350|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836234|NCT03210961|580788351|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836235|NCT03210961|580788352|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836236|NCT03210961|580788353|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
161249358|NCT00950300|582291751|FG001|TFFU Period|Other|3|||
161249359|NCT00950300|582291750|FG000|SFU Period|Death|44|||
161249360|NCT00950300|582291751|FG001|SFU Period|Death|42|||
161249361|NCT00950300|582291750|FG000|SFU Period|Lost to Follow-up|30|||
160836237|NCT03210961|580788354|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836238|NCT03210961|580788355|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836239|NCT03210961|580788356|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836240|NCT03210961|580788357|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836241|NCT03210961|580788358|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836242|NCT03210961|580788359|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
160836243|NCT03210961|580788360|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
160904060|NCT00289783|581043144|FG001|Fourth Dose Phase|Adverse Event|0|||
160904061|NCT00289783|581043143|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
160904062|NCT00289783|581043144|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
161249362|NCT00950300|582291751|FG001|SFU Period|Lost to Follow-up|28|||
161249363|NCT00950300|582291750|FG000|SFU Period|Withdrawal by Subject|4|||
161249364|NCT00950300|582291751|FG001|SFU Period|Withdrawal by Subject|8|||
161249365|NCT00124618|582291752|FG000|Overall Study|Ineligible|1|||
160836244|NCT03210961|580788361|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
161249366|NCT01912807|582291753|FG000|Overall Study|Did not meet elegibility criteria|6|||
161249367|NCT01912807|582291754|FG001|Overall Study|Did not meet elegibility criteria|4|||
161249368|NCT01912807|582291753|FG000|Overall Study|Lost to Follow-up|36|||
161249369|NCT01912807|582291754|FG001|Overall Study|Lost to Follow-up|37|||
161249370|NCT04750239|582291755|FG000|Overall Study|Withdrawal by Subject|2|||
161249371|NCT04750239|582291755|FG000|Overall Study|Trial terminated by sponsor|1|||
161249372|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Adverse Event|8|||
161249373|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Adverse Event|5|||
161249374|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Adverse Event|9|||
161249375|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Adverse Event|0|||
161249376|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Adverse Event|0|||
160836245|NCT03210961|580788347|FG000|Overall Study|Other|0|||
160836246|NCT03210961|580788348|FG001|Overall Study|Other|0|||
160836247|NCT03210961|580788349|FG002|Overall Study|Other|0|||
160836248|NCT03210961|580788350|FG003|Overall Study|Other|1|||
160836249|NCT03210961|580788351|FG004|Overall Study|Other|0|||
160836250|NCT03210961|580788352|FG005|Overall Study|Other|0|||
160836251|NCT03210961|580788353|FG006|Overall Study|Other|1|||
160836252|NCT03210961|580788354|FG007|Overall Study|Other|0|||
160836253|NCT03210961|580788355|FG008|Overall Study|Other|0|||
160836254|NCT03210961|580788356|FG009|Overall Study|Other|0|||
160836255|NCT03210961|580788357|FG010|Overall Study|Other|1|||
160836256|NCT03210961|580788358|FG011|Overall Study|Other|0|||
160836257|NCT03210961|580788359|FG012|Overall Study|Other|2|||
160836258|NCT03210961|580788360|FG013|Overall Study|Other|2|||
160836259|NCT03210961|580788361|FG014|Overall Study|Other|0|||
160836260|NCT02467582|580788362|FG000|Allocation|Withdrawal by Subject|1|||
160836261|NCT02467582|580788363|FG001|Allocation|Withdrawal by Subject|0|||
160836262|NCT02467582|580788362|FG000|Follow-up|Death|5|||
160836263|NCT02467582|580788363|FG001|Follow-up|Death|4|||
160836264|NCT02467582|580788362|FG000|Follow-up|Lost to Follow-up|6|||
160836265|NCT02467582|580788363|FG001|Follow-up|Lost to Follow-up|5|||
160836266|NCT03047031|580788367|FG000|Overall Study|Other than listed|1|||
160836267|NCT03047031|580788368|FG001|Overall Study|Other than listed|0|||
160836268|NCT03047031|580788369|FG002|Overall Study|Other than listed|0|||
160836269|NCT03047031|580788367|FG000|Overall Study|Lost to Follow-up|4|||
160904063|NCT00289783|581043143|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
160904064|NCT00289783|581043144|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
160904065|NCT00289783|581043143|FG000|Fourth Dose Phase|Migration from the study area|1|||
160904066|NCT00289783|581043144|FG001|Fourth Dose Phase|Migration from the study area|1|||
160904067|NCT00289783|581043143|FG000|Fourth Dose Phase|Other|22|||
160904068|NCT00289783|581043144|FG001|Fourth Dose Phase|Other|10|||
160904069|NCT05248867|581043145|FG000|Double-blind Period|Lost to Follow-up|0|||
160904070|NCT05248867|581043146|FG001|Double-blind Period|Lost to Follow-up|3|||
160904071|NCT05248867|581043147|FG002|Double-blind Period|Lost to Follow-up|0|||
160904072|NCT05248867|581043148|FG003|Double-blind Period|Lost to Follow-up|0|||
160904073|NCT05248867|581043149|FG004|Double-blind Period|Lost to Follow-up|0|||
160904074|NCT05248867|581043150|FG005|Double-blind Period|Lost to Follow-up|0|||
160904075|NCT05248867|581043145|FG000|Double-blind Period|Withdrawal by Subject|5|||
160904076|NCT05248867|581043146|FG001|Double-blind Period|Withdrawal by Subject|14|||
160904077|NCT05248867|581043147|FG002|Double-blind Period|Withdrawal by Subject|0|||
160904078|NCT05248867|581043148|FG003|Double-blind Period|Withdrawal by Subject|0|||
160904079|NCT05248867|581043149|FG004|Double-blind Period|Withdrawal by Subject|0|||
160904080|NCT05248867|581043150|FG005|Double-blind Period|Withdrawal by Subject|0|||
160904081|NCT05248867|581043145|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904082|NCT05248867|581043146|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
160904083|NCT05248867|581043147|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904084|NCT05248867|581043148|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904085|NCT05248867|581043149|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160836270|NCT03047031|580788368|FG001|Overall Study|Lost to Follow-up|0|||
160836271|NCT03047031|580788369|FG002|Overall Study|Lost to Follow-up|0|||
160836272|NCT03047031|580788367|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
160904086|NCT05248867|581043150|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
160904087|NCT05248867|581043145|FG000|Double-blind Period|Other, not specified|3|||
160904088|NCT05248867|581043146|FG001|Double-blind Period|Other, not specified|8|||
160904089|NCT05248867|581043147|FG002|Double-blind Period|Other, not specified|0|||
160991519|NCT04319094|581357823|FG001|3-month|Death|0|||
161249377|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Adverse Event|0|||
161249378|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
160836273|NCT03047031|580788368|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
160836274|NCT03047031|580788369|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
160836275|NCT03047031|580788367|FG000|Overall Study|Adverse Event|1|||
160836276|NCT03047031|580788368|FG001|Overall Study|Adverse Event|0|||
160836277|NCT03047031|580788369|FG002|Overall Study|Adverse Event|0|||
160836278|NCT03047031|580788367|FG000|Overall Study|Withdrawal by Subject|2|||
161334957|NCT02616783|582615868|FG001|Overall Study|Withdrew Consent|1|||
160836279|NCT03047031|580788368|FG001|Overall Study|Withdrawal by Subject|0|||
160836280|NCT03047031|580788369|FG002|Overall Study|Withdrawal by Subject|0|||
160836281|NCT03047031|580788367|FG000|Overall Study|Change to other medication|2|||
160836282|NCT03047031|580788368|FG001|Overall Study|Change to other medication|0|||
160836283|NCT03047031|580788369|FG002|Overall Study|Change to other medication|0|||
160836284|NCT03047031|580788367|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
160836285|NCT03047031|580788368|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
160836286|NCT03047031|580788369|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
160836287|NCT02814175|580788370|FG000|Part 1|Adverse Event|2|||
160836288|NCT02814175|580788371|FG001|Part 1|Adverse Event|3|||
160836289|NCT02814175|580788372|FG002|Part 1|Adverse Event|0|||
160836290|NCT02814175|580788373|FG003|Part 1|Adverse Event|0|||
160836291|NCT02814175|580788374|FG004|Part 1|Adverse Event|0|||
160836292|NCT02814175|580788375|FG005|Part 1|Adverse Event|0|||
160836293|NCT02814175|580788370|FG000|Part 1|Withdrawal Consent|8|||
160836294|NCT02814175|580788371|FG001|Part 1|Withdrawal Consent|1|||
160836295|NCT02814175|580788372|FG002|Part 1|Withdrawal Consent|0|||
160836296|NCT02814175|580788373|FG003|Part 1|Withdrawal Consent|0|||
160836297|NCT02814175|580788374|FG004|Part 1|Withdrawal Consent|0|||
160836298|NCT02814175|580788375|FG005|Part 1|Withdrawal Consent|0|||
160836299|NCT02814175|580788370|FG000|Part 1|Lost to Follow-up|1|||
160836300|NCT02814175|580788371|FG001|Part 1|Lost to Follow-up|0|||
160836301|NCT02814175|580788372|FG002|Part 1|Lost to Follow-up|0|||
160836302|NCT02814175|580788373|FG003|Part 1|Lost to Follow-up|0|||
160836303|NCT02814175|580788374|FG004|Part 1|Lost to Follow-up|0|||
160836304|NCT02814175|580788375|FG005|Part 1|Lost to Follow-up|0|||
160836305|NCT02814175|580788370|FG000|Part 1|Lack of Efficacy|1|||
160836306|NCT02814175|580788371|FG001|Part 1|Lack of Efficacy|2|||
160836307|NCT02814175|580788372|FG002|Part 1|Lack of Efficacy|0|||
160836308|NCT02814175|580788373|FG003|Part 1|Lack of Efficacy|0|||
160836309|NCT02814175|580788374|FG004|Part 1|Lack of Efficacy|0|||
160836310|NCT02814175|580788375|FG005|Part 1|Lack of Efficacy|0|||
160836311|NCT02814175|580788370|FG000|Part 2|Adverse Event|0|||
160836312|NCT02814175|580788371|FG001|Part 2|Adverse Event|0|||
160836313|NCT02814175|580788372|FG002|Part 2|Adverse Event|0|||
161138165|NCT00201851|581887061|FG000|Overall Study|Ineligible post enrollment|6|||
161138166|NCT00201851|581887062|FG001|Overall Study|Ineligible post enrollment|1|||
160836314|NCT02814175|580788373|FG003|Part 2|Adverse Event|1|||
160836315|NCT02814175|580788374|FG004|Part 2|Adverse Event|1|||
160836316|NCT02814175|580788375|FG005|Part 2|Adverse Event|2|||
160836317|NCT02814175|580788370|FG000|Part 2|Withdrawal Consent|0|||
160836318|NCT02814175|580788371|FG001|Part 2|Withdrawal Consent|0|||
160836319|NCT02814175|580788372|FG002|Part 2|Withdrawal Consent|0|||
160836320|NCT02814175|580788373|FG003|Part 2|Withdrawal Consent|2|||
160836321|NCT02814175|580788374|FG004|Part 2|Withdrawal Consent|1|||
160836322|NCT02814175|580788375|FG005|Part 2|Withdrawal Consent|1|||
160836323|NCT02814175|580788370|FG000|Part 2|Lost to Follow-up|0|||
160836324|NCT02814175|580788371|FG001|Part 2|Lost to Follow-up|0|||
160904090|NCT05248867|581043148|FG003|Double-blind Period|Other, not specified|0|||
160904091|NCT05248867|581043149|FG004|Double-blind Period|Other, not specified|0|||
160836325|NCT02814175|580788372|FG002|Part 2|Lost to Follow-up|0|||
160836326|NCT02814175|580788373|FG003|Part 2|Lost to Follow-up|1|||
160836327|NCT02814175|580788374|FG004|Part 2|Lost to Follow-up|0|||
160836328|NCT02814175|580788375|FG005|Part 2|Lost to Follow-up|0|||
160836329|NCT02814175|580788370|FG000|Part 2|Lack of Efficacy|0|||
160836330|NCT02814175|580788371|FG001|Part 2|Lack of Efficacy|0|||
160836331|NCT02814175|580788372|FG002|Part 2|Lack of Efficacy|0|||
160836332|NCT02814175|580788373|FG003|Part 2|Lack of Efficacy|0|||
160836333|NCT02814175|580788374|FG004|Part 2|Lack of Efficacy|0|||
160836334|NCT02814175|580788375|FG005|Part 2|Lack of Efficacy|3|||
160836335|NCT02702414|580788386|FG000|Overall Study|Death|96|||
160836336|NCT02702414|580788387|FG001|Overall Study|Death|42|||
160836337|NCT02702414|580788386|FG000|Overall Study|Lost to Follow-up|0|||
160836338|NCT02702414|580788387|FG001|Overall Study|Lost to Follow-up|1|||
160836339|NCT02702414|580788386|FG000|Overall Study|Withdrawal by Subject|0|||
160836340|NCT02702414|580788387|FG001|Overall Study|Withdrawal by Subject|1|||
160836341|NCT02702414|580788386|FG000|Overall Study|Protocol Violation|1|||
160904092|NCT05248867|581043150|FG005|Double-blind Period|Other, not specified|0|||
160836342|NCT02702414|580788387|FG001|Overall Study|Protocol Violation|0|||
160836343|NCT02702414|580788386|FG000|Overall Study|Sponsor Decision|8|||
160836344|NCT02702414|580788387|FG001|Overall Study|Sponsor Decision|7|||
160836345|NCT04541628|580788388|FG000|Overall Study|Study Terminated|1|||
161138167|NCT00201851|581887063|FG002|Overall Study|Ineligible post enrollment|1|||
161138168|NCT02690701|581887064|FG000|Treatment Period 1|Adverse Event|2|||
161138169|NCT02690701|581887065|FG001|Treatment Period 1|Adverse Event|2|||
161138170|NCT02690701|581887064|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160836346|NCT04541628|580788389|FG001|Overall Study|Study Terminated|1|||
160836347|NCT04541628|580788390|FG002|Overall Study|Study Terminated|1|||
160836348|NCT00859937|580788394|FG000|Overall Study|Protocol Violation|1|||
160836349|NCT00859937|580788395|FG001|Overall Study|Protocol Violation|0|||
160836350|NCT00615030|580788396|FG000|Period I|Administrative problem|0|||
160836351|NCT00615030|580788397|FG001|Period I|Administrative problem|0|||
161138171|NCT02690701|581887065|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160836352|NCT00615030|580788398|FG002|Period I|Administrative problem|0|||
160836353|NCT00615030|580788399|FG003|Period I|Administrative problem|0|||
160836354|NCT00615030|580788400|FG004|Period I|Administrative problem|1|||
160836355|NCT00615030|580788401|FG005|Period I|Administrative problem|0|||
160836356|NCT00615030|580788402|FG006|Period I|Administrative problem|0|||
160836357|NCT00615030|580788403|FG007|Period I|Administrative problem|0|||
160836358|NCT00615030|580788404|FG008|Period I|Administrative problem|0|||
161249379|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
161249380|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
161249381|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
161249382|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
161249383|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
161249384|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
161249385|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
161249386|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
161249387|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
161249388|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
161249389|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
161249390|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Physician Decision|4|||
161249391|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Physician Decision|0|||
161249392|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Physician Decision|2|||
161249393|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Physician Decision|0|||
161249394|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Physician Decision|0|||
161249395|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Physician Decision|0|||
161249396|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Pregnancy|1|||
161249397|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Pregnancy|2|||
161249398|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Pregnancy|0|||
161249399|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Pregnancy|0|||
161249400|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Pregnancy|0|||
161249401|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Pregnancy|0|||
160904093|NCT05248867|581043145|FG000|Open-label Period|Withdrawal by Subject|0|||
160904094|NCT05248867|581043146|FG001|Open-label Period|Withdrawal by Subject|0|||
160904095|NCT05248867|581043147|FG002|Open-label Period|Withdrawal by Subject|3|||
160904096|NCT05248867|581043148|FG003|Open-label Period|Withdrawal by Subject|1|||
160904097|NCT05248867|581043149|FG004|Open-label Period|Withdrawal by Subject|7|||
160904098|NCT05248867|581043150|FG005|Open-label Period|Withdrawal by Subject|9|||
160904099|NCT05248867|581043145|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904100|NCT05248867|581043146|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904101|NCT05248867|581043147|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904102|NCT05248867|581043148|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
160904103|NCT05248867|581043149|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904104|NCT05248867|581043150|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
160904105|NCT05248867|581043145|FG000|Open-label Period|Lost to Follow-up|0|||
160904106|NCT05248867|581043146|FG001|Open-label Period|Lost to Follow-up|0|||
160904107|NCT05248867|581043147|FG002|Open-label Period|Lost to Follow-up|0|||
160904108|NCT05248867|581043148|FG003|Open-label Period|Lost to Follow-up|0|||
160904109|NCT05248867|581043149|FG004|Open-label Period|Lost to Follow-up|5|||
161249402|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
161249403|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
161249404|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
160836359|NCT00615030|580788405|FG009|Period I|Administrative problem|0|||
160836360|NCT00615030|580788406|FG010|Period I|Administrative problem|0|||
160836361|NCT00615030|580788407|FG011|Period I|Administrative problem|0|||
160836362|NCT00615030|580788396|FG000|Period I|Protocol deviation|1|||
160836363|NCT00615030|580788397|FG001|Period I|Protocol deviation|0|||
160836364|NCT00615030|580788398|FG002|Period I|Protocol deviation|0|||
160836365|NCT00615030|580788399|FG003|Period I|Protocol deviation|0|||
160836366|NCT00615030|580788400|FG004|Period I|Protocol deviation|0|||
160836367|NCT00615030|580788401|FG005|Period I|Protocol deviation|0|||
160836368|NCT00615030|580788402|FG006|Period I|Protocol deviation|0|||
160836369|NCT00615030|580788403|FG007|Period I|Protocol deviation|0|||
160836370|NCT00615030|580788404|FG008|Period I|Protocol deviation|0|||
160836371|NCT00615030|580788405|FG009|Period I|Protocol deviation|0|||
160836372|NCT00615030|580788406|FG010|Period I|Protocol deviation|0|||
160836373|NCT00615030|580788407|FG011|Period I|Protocol deviation|0|||
160836374|NCT00615030|580788396|FG000|Period I|Subject withdrew consent|0|||
160836375|NCT00615030|580788397|FG001|Period I|Subject withdrew consent|0|||
160836376|NCT00615030|580788398|FG002|Period I|Subject withdrew consent|0|||
160836377|NCT00615030|580788399|FG003|Period I|Subject withdrew consent|0|||
160836378|NCT00615030|580788400|FG004|Period I|Subject withdrew consent|0|||
160836379|NCT00615030|580788401|FG005|Period I|Subject withdrew consent|0|||
160836380|NCT00615030|580788402|FG006|Period I|Subject withdrew consent|0|||
160836381|NCT00615030|580788403|FG007|Period I|Subject withdrew consent|0|||
160836382|NCT00615030|580788404|FG008|Period I|Subject withdrew consent|1|||
161249405|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
160991520|NCT04319094|581357822|FG000|3-month|Lost to Follow-up|2|||
160991521|NCT04319094|581357823|FG001|3-month|Lost to Follow-up|2|||
161138172|NCT02690701|581887064|FG000|Treatment Period 2|Adverse Event|2|||
161138173|NCT02690701|581887065|FG001|Treatment Period 2|Adverse Event|0|||
161138174|NCT02690701|581887064|FG000|Treatment Period 2|Lack of Efficacy|1|||
160836383|NCT00615030|580788405|FG009|Period I|Subject withdrew consent|0|||
160836384|NCT00615030|580788406|FG010|Period I|Subject withdrew consent|1|||
160836385|NCT00615030|580788407|FG011|Period I|Subject withdrew consent|1|||
160991522|NCT04319094|581357822|FG000|3-month|Withdrawal by Subject|0|||
160991523|NCT04319094|581357823|FG001|3-month|Withdrawal by Subject|3|||
160991524|NCT04319094|581357822|FG000|3-month|Incomplete data collection|9|||
160991525|NCT04319094|581357823|FG001|3-month|Incomplete data collection|7|||
160991526|NCT04319094|581357822|FG000|6-month|Lost to Follow-up|1|||
160991527|NCT04319094|581357823|FG001|6-month|Lost to Follow-up|1|||
160991528|NCT04319094|581357822|FG000|6-month|Withdrawal by Subject|0|||
160991529|NCT04319094|581357823|FG001|6-month|Withdrawal by Subject|3|||
160991530|NCT04319094|581357822|FG000|6-month|Incomplete data collection|14|||
160991531|NCT04319094|581357823|FG001|6-month|Incomplete data collection|9|||
160991532|NCT04319094|581357822|FG000|9-month|Lost to Follow-up|8|||
160991533|NCT04319094|581357823|FG001|9-month|Lost to Follow-up|4|||
160991534|NCT04319094|581357822|FG000|9-month|Withdrawal by Subject|0|||
160991535|NCT04319094|581357823|FG001|9-month|Withdrawal by Subject|1|||
160991536|NCT04319094|581357822|FG000|9-month|Incomplete data collection|8|||
160991537|NCT04319094|581357823|FG001|9-month|Incomplete data collection|5|||
160991538|NCT04319094|581357822|FG000|12-month|Lost to Follow-up|11|||
160991539|NCT04319094|581357823|FG001|12-month|Lost to Follow-up|8|||
160991540|NCT04639947|581357826|FG000|Overall Study|Screen fail|1|||
160991541|NCT01018511|581357828|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
160991542|NCT01018511|581357829|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
160991543|NCT01018511|581357830|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
160991544|NCT01018511|581357831|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
160991545|NCT01018511|581357828|FG000|Overall Study|Adverse Event|5|||
160991546|NCT01018511|581357829|FG001|Overall Study|Adverse Event|9|||
160991547|NCT01018511|581357830|FG002|Overall Study|Adverse Event|13|||
160991548|NCT01018511|581357831|FG003|Overall Study|Adverse Event|10|||
160991549|NCT01018511|581357828|FG000|Overall Study|Lack of Efficacy|4|||
160991550|NCT01018511|581357829|FG001|Overall Study|Lack of Efficacy|1|||
160991551|NCT01018511|581357830|FG002|Overall Study|Lack of Efficacy|1|||
160991552|NCT01018511|581357831|FG003|Overall Study|Lack of Efficacy|2|||
160991553|NCT01018511|581357828|FG000|Overall Study|Withdrawal by Subject|6|||
160991554|NCT01018511|581357829|FG001|Overall Study|Withdrawal by Subject|5|||
160991555|NCT01018511|581357830|FG002|Overall Study|Withdrawal by Subject|11|||
160991556|NCT01018511|581357831|FG003|Overall Study|Withdrawal by Subject|9|||
160991557|NCT01018511|581357828|FG000|Overall Study|Lost to Follow-up|0|||
161138175|NCT02690701|581887065|FG001|Treatment Period 2|Lack of Efficacy|0|||
161138176|NCT02690701|581887064|FG000|Treatment Period 2|Lost to Follow-up|0|||
161138177|NCT02690701|581887065|FG001|Treatment Period 2|Lost to Follow-up|2|||
161138178|NCT02690701|581887064|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161138179|NCT02690701|581887065|FG001|Treatment Period 2|Withdrawal by Subject|2|||
161138180|NCT02690701|581887064|FG000|Treatment Period 2|Protocol Violation|0|||
161138181|NCT02690701|581887065|FG001|Treatment Period 2|Protocol Violation|1|||
161138182|NCT00404092|581887069|FG000|Overall Study|Death|1|||
161138183|NCT00404092|581887070|FG001|Overall Study|Death|0|||
161138184|NCT00404092|581887071|FG002|Overall Study|Death|0|||
161138185|NCT00404092|581887072|FG003|Overall Study|Death|0|||
161138186|NCT00404092|581887069|FG000|Overall Study|Adverse Event|0|||
161138187|NCT00404092|581887070|FG001|Overall Study|Adverse Event|0|||
161138188|NCT00404092|581887071|FG002|Overall Study|Adverse Event|1|||
161138189|NCT00404092|581887072|FG003|Overall Study|Adverse Event|0|||
161138190|NCT02344576|581887076|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
161138191|NCT02344576|581887077|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
161138192|NCT02344576|581887078|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
161138193|NCT02344576|581887079|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
161138194|NCT02344576|581887076|FG000|1-Month Follow-Up|Death|13|||
161138195|NCT02344576|581887077|FG001|1-Month Follow-Up|Death|8|||
161138196|NCT02344576|581887078|FG002|1-Month Follow-Up|Death|0|||
161138197|NCT02344576|581887079|FG003|1-Month Follow-Up|Death|0|||
161138198|NCT02344576|581887076|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
161138199|NCT02344576|581887077|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
161138200|NCT02344576|581887078|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
161138201|NCT02344576|581887079|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
161138202|NCT02344576|581887076|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
161138203|NCT02344576|581887077|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
161138204|NCT02344576|581887078|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
161138205|NCT02344576|581887079|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
161138206|NCT02344576|581887076|FG000|6-Month Follow-Up|Death|14|||
161138207|NCT02344576|581887077|FG001|6-Month Follow-Up|Death|14|||
161138208|NCT02344576|581887078|FG002|6-Month Follow-Up|Death|0|||
161138209|NCT02344576|581887079|FG003|6-Month Follow-Up|Death|0|||
161249406|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
161249407|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
160836386|NCT00615030|580788396|FG000|Period I|Abnormal laboratory value(s)|0|||
160836387|NCT00615030|580788397|FG001|Period I|Abnormal laboratory value(s)|0|||
160836388|NCT00615030|580788398|FG002|Period I|Abnormal laboratory value(s)|0|||
160836389|NCT00615030|580788399|FG003|Period I|Abnormal laboratory value(s)|0|||
160836390|NCT00615030|580788400|FG004|Period I|Abnormal laboratory value(s)|0|||
160836391|NCT00615030|580788401|FG005|Period I|Abnormal laboratory value(s)|1|||
160836392|NCT00615030|580788402|FG006|Period I|Abnormal laboratory value(s)|0|||
160836393|NCT00615030|580788403|FG007|Period I|Abnormal laboratory value(s)|0|||
160836394|NCT00615030|580788404|FG008|Period I|Abnormal laboratory value(s)|0|||
160836395|NCT00615030|580788405|FG009|Period I|Abnormal laboratory value(s)|0|||
160836396|NCT00615030|580788406|FG010|Period I|Abnormal laboratory value(s)|0|||
160836397|NCT00615030|580788407|FG011|Period I|Abnormal laboratory value(s)|0|||
160836398|NCT00615030|580788396|FG000|Period II|Adverse Event|0|||
160836399|NCT00615030|580788397|FG001|Period II|Adverse Event|0|||
160836400|NCT00615030|580788398|FG002|Period II|Adverse Event|1|||
160836401|NCT00615030|580788399|FG003|Period II|Adverse Event|0|||
160836402|NCT00615030|580788400|FG004|Period II|Adverse Event|0|||
160836403|NCT00615030|580788401|FG005|Period II|Adverse Event|0|||
160836404|NCT00615030|580788402|FG006|Period II|Adverse Event|0|||
160836405|NCT00615030|580788403|FG007|Period II|Adverse Event|0|||
160836406|NCT00615030|580788404|FG008|Period II|Adverse Event|1|||
160836407|NCT00615030|580788405|FG009|Period II|Adverse Event|0|||
160836408|NCT00615030|580788406|FG010|Period II|Adverse Event|0|||
160836409|NCT00615030|580788407|FG011|Period II|Adverse Event|0|||
160836410|NCT00615030|580788396|FG000|Period II|Subject withdrew consent|0|||
160836411|NCT00615030|580788397|FG001|Period II|Subject withdrew consent|0|||
160836412|NCT00615030|580788398|FG002|Period II|Subject withdrew consent|0|||
160836413|NCT00615030|580788399|FG003|Period II|Subject withdrew consent|1|||
160836414|NCT00615030|580788400|FG004|Period II|Subject withdrew consent|0|||
160836415|NCT00615030|580788401|FG005|Period II|Subject withdrew consent|0|||
160836416|NCT00615030|580788402|FG006|Period II|Subject withdrew consent|1|||
160836417|NCT00615030|580788403|FG007|Period II|Subject withdrew consent|0|||
160836418|NCT00615030|580788404|FG008|Period II|Subject withdrew consent|0|||
160836419|NCT00615030|580788405|FG009|Period II|Subject withdrew consent|0|||
160836420|NCT00615030|580788406|FG010|Period II|Subject withdrew consent|0|||
160836421|NCT00615030|580788407|FG011|Period II|Subject withdrew consent|0|||
160836422|NCT00615030|580788396|FG000|Period III|Administrative problems|1|||
160836423|NCT00615030|580788397|FG001|Period III|Administrative problems|0|||
160836424|NCT00615030|580788398|FG002|Period III|Administrative problems|0|||
161249408|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
161249409|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
161249410|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
161249411|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
160836425|NCT00615030|580788399|FG003|Period III|Administrative problems|1|||
160836426|NCT00615030|580788400|FG004|Period III|Administrative problems|0|||
160836427|NCT00615030|580788401|FG005|Period III|Administrative problems|0|||
160836428|NCT00615030|580788402|FG006|Period III|Administrative problems|0|||
160836429|NCT00615030|580788403|FG007|Period III|Administrative problems|0|||
160836430|NCT00615030|580788404|FG008|Period III|Administrative problems|0|||
160836431|NCT00615030|580788405|FG009|Period III|Administrative problems|0|||
160836432|NCT00615030|580788406|FG010|Period III|Administrative problems|0|||
160836433|NCT00615030|580788407|FG011|Period III|Administrative problems|0|||
160836434|NCT00151476|580788408|FG000|FAP Identified Subjects|Protocol Violation|0|||
160836435|NCT00151476|580788409|FG001|FAP Identified Subjects|Protocol Violation|1|||
160836436|NCT00151476|580788408|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
160836437|NCT00151476|580788409|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
160836438|NCT00151476|580788408|FG000|FAP Analyzed Subjects|Other study participation|0|||
160836439|NCT00151476|580788409|FG001|FAP Analyzed Subjects|Other study participation|1|||
160836440|NCT03446456|580788410|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
160836441|NCT03446456|580788411|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
160836442|NCT03446456|580788410|FG000|Overall Study|Lost to Follow-up|1|||
160904110|NCT05248867|581043150|FG005|Open-label Period|Lost to Follow-up|2|||
160904111|NCT05248867|581043145|FG000|Open-label Period|COVID-19 Infection|0|||
160904112|NCT05248867|581043146|FG001|Open-label Period|COVID-19 Infection|0|||
160904113|NCT05248867|581043147|FG002|Open-label Period|COVID-19 Infection|0|||
160904114|NCT05248867|581043148|FG003|Open-label Period|COVID-19 Infection|0|||
160904115|NCT05248867|581043149|FG004|Open-label Period|COVID-19 Infection|1|||
160904116|NCT05248867|581043150|FG005|Open-label Period|COVID-19 Infection|0|||
160904117|NCT05248867|581043145|FG000|Open-label Period|Other, not specified|0|||
160904118|NCT05248867|581043146|FG001|Open-label Period|Other, not specified|0|||
161249412|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
160836443|NCT03446456|580788411|FG001|Overall Study|Lost to Follow-up|3|||
160836444|NCT03446456|580788410|FG000|Overall Study|Participant failed the toxicology test|1|||
160836445|NCT03446456|580788411|FG001|Overall Study|Participant failed the toxicology test|0|||
160836446|NCT03446456|580788410|FG000|Overall Study|Break down of the experimental equipment|1|||
160836447|NCT03446456|580788411|FG001|Overall Study|Break down of the experimental equipment|0|||
160836448|NCT03002311|580788426|FG000|Overall Study|Lost to Follow-up|13|||
160836449|NCT03002311|580788427|FG001|Overall Study|Lost to Follow-up|26|||
160836450|NCT03002311|580788426|FG000|Overall Study|Referral provider called to schedule app|3|||
160836451|NCT03002311|580788427|FG001|Overall Study|Referral provider called to schedule app|3|||
160836452|NCT03002311|580788426|FG000|Overall Study|Physician Decision|3|||
160836453|NCT03002311|580788427|FG001|Overall Study|Physician Decision|1|||
160836454|NCT00308074|580788428|FG000|Overall Study|Withdrawal by Subject|1|||
160836455|NCT01329939|580788432|FG000|Overall Study|Lost to Follow-up|3|||
160836456|NCT01329939|580788433|FG001|Overall Study|Lost to Follow-up|0|||
160836457|NCT01329939|580788434|FG002|Overall Study|Lost to Follow-up|1|||
160836458|NCT01329939|580788435|FG003|Overall Study|Lost to Follow-up|2|||
160836459|NCT01329939|580788432|FG000|Overall Study|Withdrawal by Subject|0|||
160836460|NCT01329939|580788433|FG001|Overall Study|Withdrawal by Subject|1|||
160836461|NCT01329939|580788434|FG002|Overall Study|Withdrawal by Subject|0|||
160836462|NCT01329939|580788435|FG003|Overall Study|Withdrawal by Subject|0|||
160836463|NCT01329939|580788432|FG000|Overall Study|Adverse Event|0|||
160836464|NCT01329939|580788433|FG001|Overall Study|Adverse Event|0|||
160836465|NCT01329939|580788434|FG002|Overall Study|Adverse Event|0|||
160836466|NCT01329939|580788435|FG003|Overall Study|Adverse Event|3|||
160836467|NCT03722524|580788436|FG000|Overall Study|Protocol Violation|86|||
160836468|NCT03722524|580788436|FG000|Overall Study|Adverse Event|7|||
160836469|NCT03722524|580788436|FG000|Overall Study|Lost to Follow-up|1|||
160836470|NCT03722524|580788436|FG000|Overall Study|Reason is not stated|1|||
160836471|NCT03722524|580788436|FG000|Overall Study|Physician Decision|1|||
160836472|NCT03722524|580788436|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
160836473|NCT04369950|580788438|FG000|Overall Study|Protocol Violation|2|||
160836474|NCT04369950|580788439|FG001|Overall Study|Protocol Violation|2|||
161138210|NCT02344576|581887076|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
161138211|NCT02344576|581887077|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
160836475|NCT00989963|580788440|FG000|Overall Study|Adverse Event|1|||
160836476|NCT00989963|580788441|FG001|Overall Study|Adverse Event|1|||
160904119|NCT05248867|581043147|FG002|Open-label Period|Other, not specified|0|||
160904120|NCT05248867|581043148|FG003|Open-label Period|Other, not specified|0|||
160904121|NCT05248867|581043149|FG004|Open-label Period|Other, not specified|4|||
160904122|NCT05248867|581043150|FG005|Open-label Period|Other, not specified|0|||
160904123|NCT00873015|581043152|FG000|Overall Study|Withdrawal by Subject|0|||
160904124|NCT00873015|581043153|FG001|Overall Study|Withdrawal by Subject|1|||
160904125|NCT00873015|581043154|FG002|Overall Study|Withdrawal by Subject|0|||
160904126|NCT00873015|581043155|FG003|Overall Study|Withdrawal by Subject|0|||
160904127|NCT03128411|581043156|FG000|Treatment Phase|Adverse Event|21|||
160904128|NCT03128411|581043156|FG000|Treatment Phase|Physician Decision|1|||
160904129|NCT03128411|581043156|FG000|Treatment Phase|Other|2|||
160904130|NCT03128411|581043156|FG000|Long Term Follow-up Phase|Death|2|||
160904131|NCT00345839|581043157|FG000|Overall Study|Withdrawal by Subject|91|||
160904132|NCT00345839|581043158|FG001|Overall Study|Withdrawal by Subject|98|||
160904133|NCT00345839|581043157|FG000|Overall Study|Lost to Follow-up|58|||
160904134|NCT00345839|581043158|FG001|Overall Study|Lost to Follow-up|61|||
160904135|NCT03298867|581043176|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
160904136|NCT03298867|581043177|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
160904137|NCT03298867|581043176|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
160904138|NCT03298867|581043177|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
160904139|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
160904140|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
160904141|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
160904142|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
160904143|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
160904144|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
160904145|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
160904146|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
160904147|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
160904148|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
161138212|NCT02344576|581887078|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
161138213|NCT02344576|581887079|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
161138214|NCT02344576|581887076|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
161138215|NCT02344576|581887077|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
161138216|NCT02344576|581887078|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
161138217|NCT02344576|581887079|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
161138218|NCT04325503|581887081|FG000|Overall Study|Withdrawal by Subject|1|||
161138219|NCT04325503|581887081|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
161138220|NCT02337387|581887082|FG000|Overall Study|Adverse Event|0|||
160991558|NCT01018511|581357829|FG001|Overall Study|Lost to Follow-up|0|||
160991559|NCT01018511|581357830|FG002|Overall Study|Lost to Follow-up|1|||
160991560|NCT01018511|581357831|FG003|Overall Study|Lost to Follow-up|0|||
160991561|NCT01018511|581357828|FG000|Overall Study|Protocol Violation|5|||
160991562|NCT01018511|581357829|FG001|Overall Study|Protocol Violation|8|||
160991563|NCT01018511|581357830|FG002|Overall Study|Protocol Violation|7|||
160991564|NCT01018511|581357831|FG003|Overall Study|Protocol Violation|9|||
160991565|NCT01018511|581357828|FG000|Overall Study|Miscellaneous|0|||
160991566|NCT01018511|581357829|FG001|Overall Study|Miscellaneous|2|||
160991567|NCT01018511|581357830|FG002|Overall Study|Miscellaneous|0|||
160991568|NCT01018511|581357831|FG003|Overall Study|Miscellaneous|0|||
160991569|NCT00654238|581357832|FG000|Overall Study|Screen Failures|4|||
160991570|NCT03424239|581357833|FG000|Overall Study|Withdrawal by Subject|2|||
160991571|NCT04927975|581357843|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
160991572|NCT04927975|581357844|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
160991573|NCT04927975|581357845|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
160991574|NCT04927975|581357846|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
160991575|NCT04927975|581357847|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
160991576|NCT04927975|581357848|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
160991577|NCT04927975|581357843|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160991578|NCT04927975|581357844|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160836477|NCT00989963|580788442|FG002|Overall Study|Adverse Event|1|||
160836478|NCT01240200|580788449|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
160836479|NCT01240200|580788450|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
160836480|NCT00869401|580788453|FG000|Overall Study|Withdrawal by Subject|0|||
160836481|NCT00869401|580788454|FG001|Overall Study|Withdrawal by Subject|0|||
160836482|NCT00869401|580788455|FG002|Overall Study|Withdrawal by Subject|0|||
160836483|NCT00869401|580788456|FG003|Overall Study|Withdrawal by Subject|5|||
160836484|NCT00869401|580788457|FG004|Overall Study|Withdrawal by Subject|3|||
160836485|NCT00975143|580788460|FG000|Overall Study|Adverse Event|19|||
160836486|NCT00975143|580788461|FG001|Overall Study|Adverse Event|15|||
160836487|NCT00975143|580788460|FG000|Overall Study|Withdrawal by Subject|15|||
160836488|NCT00975143|580788461|FG001|Overall Study|Withdrawal by Subject|15|||
160836489|NCT00975143|580788460|FG000|Overall Study|Lost to Follow-up|20|||
160836490|NCT00975143|580788461|FG001|Overall Study|Lost to Follow-up|16|||
160836491|NCT00975143|580788460|FG000|Overall Study|Non-compliance|5|||
160836492|NCT00975143|580788461|FG001|Overall Study|Non-compliance|8|||
160836493|NCT00975143|580788460|FG000|Overall Study|Physician Decision|1|||
160836494|NCT00975143|580788461|FG001|Overall Study|Physician Decision|2|||
160836495|NCT00975143|580788460|FG000|Overall Study|Details not available|10|||
160836496|NCT00975143|580788461|FG001|Overall Study|Details not available|4|||
160836497|NCT01753401|580788462|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
160836498|NCT01753401|580788463|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
160836499|NCT01753401|580788464|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
160836500|NCT01753401|580788465|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
160836501|NCT01753401|580788462|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
160836502|NCT01753401|580788463|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
160836503|NCT01753401|580788464|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
160836504|NCT01753401|580788465|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
160836505|NCT01753401|580788462|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
160836506|NCT01753401|580788463|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
160991579|NCT04927975|581357845|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160991580|NCT04927975|581357846|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
160991581|NCT04927975|581357847|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
161334958|NCT00467519|582615869|FG000|Overall Study|Protocol Violation|8|||
160836507|NCT01753401|580788464|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
160836508|NCT01753401|580788465|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
160836509|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
160836510|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
160836511|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
160836512|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
160836513|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
160836514|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
160991582|NCT04927975|581357848|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
160836515|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
160836516|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
160836517|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
160836518|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
160991583|NCT04927975|581357843|FG000|Period 1 (Baseline-Week 24)|Death|0|||
160991584|NCT04927975|581357844|FG001|Period 1 (Baseline-Week 24)|Death|0|||
160991585|NCT04927975|581357845|FG002|Period 1 (Baseline-Week 24)|Death|0|||
160991586|NCT04927975|581357846|FG003|Period 1 (Baseline-Week 24)|Death|0|||
160991587|NCT04927975|581357847|FG004|Period 1 (Baseline-Week 24)|Death|0|||
160991588|NCT04927975|581357848|FG005|Period 1 (Baseline-Week 24)|Death|1|||
160836519|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
160836520|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
161249413|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
161249414|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
161249415|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
161249416|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
161249417|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
161249418|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161249419|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
161249420|NCT02614196|582291756|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
160836521|NCT01753401|580788462|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
160836522|NCT01753401|580788463|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
160836523|NCT01753401|580788464|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
160836524|NCT01753401|580788465|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
160836525|NCT00581360|580788466|FG000|Overall Study|Withdrawal by Subject|1|||
160836526|NCT03129360|580788467|FG000|Overall Study|Did not meet entry criteria|0|||
160836527|NCT03129360|580788468|FG001|Overall Study|Did not meet entry criteria|2|||
160836528|NCT03129360|580788469|FG002|Overall Study|Did not meet entry criteria|1|||
160836529|NCT03129360|580788467|FG000|Overall Study|Excluded due to motion in scanner|1|||
160836530|NCT03129360|580788468|FG001|Overall Study|Excluded due to motion in scanner|0|||
160836531|NCT03129360|580788469|FG002|Overall Study|Excluded due to motion in scanner|0|||
160836532|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
160836533|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
160836534|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
160836535|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
160836536|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
160836537|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
160836538|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
160836539|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
160836540|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
160836541|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
160836542|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
160836543|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
160836544|NCT00599638|580788470|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
160836545|NCT00599638|580788471|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
160836546|NCT00599638|580788472|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
160836547|NCT00599638|580788473|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
161249421|NCT02614196|582291757|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
161249422|NCT02614196|582291758|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
160836548|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
160836549|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
160836550|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
160836551|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
160836552|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
160836553|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
160836554|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
160836555|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
160836556|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
160836557|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
160836558|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
160836559|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
160836560|NCT00599638|580788470|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
160836561|NCT00599638|580788471|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
160836562|NCT00599638|580788472|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
160836563|NCT00599638|580788473|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
160836564|NCT00599638|580788470|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
161249423|NCT02614196|582291759|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
160836565|NCT00599638|580788471|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
160836566|NCT00599638|580788472|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
160836567|NCT00599638|580788473|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
160836568|NCT03006887|580788477|FG000|Overall Study|Adverse Event|1|||
160836569|NCT03836677|580788478|FG000|Period 1|Adverse Event|0|||
160836570|NCT03836677|580788479|FG001|Period 1|Adverse Event|1|||
160836571|NCT03836677|580788478|FG000|Period 2|Severe non-compliance to protocol|1|||
160836572|NCT03836677|580788479|FG001|Period 2|Severe non-compliance to protocol|0|||
160836573|NCT02895945|580788480|FG000|Overall Study|Physician Decision|2|||
160836574|NCT02895945|580788481|FG001|Overall Study|Physician Decision|1|||
160836575|NCT00462748|580788482|FG000|Overall Study|Adverse Event|7|||
160836576|NCT00462748|580788483|FG001|Overall Study|Adverse Event|5|||
161334959|NCT00467519|582615870|FG001|Overall Study|Protocol Violation|4|||
160836577|NCT00462748|580788484|FG002|Overall Study|Adverse Event|9|||
160836578|NCT00462748|580788482|FG000|Overall Study|Protocol Violation|0|||
160836579|NCT00462748|580788483|FG001|Overall Study|Protocol Violation|2|||
160836580|NCT00462748|580788484|FG002|Overall Study|Protocol Violation|1|||
160836581|NCT00462748|580788482|FG000|Overall Study|Withdrew consent|3|||
160836582|NCT00462748|580788483|FG001|Overall Study|Withdrew consent|3|||
160836583|NCT00462748|580788484|FG002|Overall Study|Withdrew consent|0|||
160836584|NCT00462748|580788482|FG000|Overall Study|Lost to Follow-up|1|||
160836585|NCT00462748|580788483|FG001|Overall Study|Lost to Follow-up|1|||
160836586|NCT00462748|580788484|FG002|Overall Study|Lost to Follow-up|1|||
160836587|NCT00462748|580788482|FG000|Overall Study|Discontinued after 41 days Rx|1|||
160836588|NCT00462748|580788483|FG001|Overall Study|Discontinued after 41 days Rx|0|||
160836589|NCT00462748|580788484|FG002|Overall Study|Discontinued after 41 days Rx|0|||
160836590|NCT03429543|580788485|FG000|Overall Study|Adverse Event|1|||
160836591|NCT03429543|580788486|FG001|Overall Study|Adverse Event|1|||
160836592|NCT03429543|580788487|FG002|Overall Study|Adverse Event|0|||
160836593|NCT03429543|580788488|FG003|Overall Study|Adverse Event|0|||
160836594|NCT03429543|580788489|FG004|Overall Study|Adverse Event|0|||
160836595|NCT03429543|580788490|FG005|Overall Study|Adverse Event|2|||
160836596|NCT03429543|580788491|FG006|Overall Study|Adverse Event|0|||
160836597|NCT03429543|580788485|FG000|Overall Study|Lost to Follow-up|1|||
160836598|NCT03429543|580788486|FG001|Overall Study|Lost to Follow-up|0|||
160836599|NCT03429543|580788487|FG002|Overall Study|Lost to Follow-up|0|||
160836600|NCT03429543|580788488|FG003|Overall Study|Lost to Follow-up|0|||
160836601|NCT03429543|580788489|FG004|Overall Study|Lost to Follow-up|1|||
160836602|NCT03429543|580788490|FG005|Overall Study|Lost to Follow-up|0|||
160836603|NCT03429543|580788491|FG006|Overall Study|Lost to Follow-up|0|||
160836604|NCT03429543|580788485|FG000|Overall Study|Withdrawal by Subject|5|||
160836605|NCT03429543|580788486|FG001|Overall Study|Withdrawal by Subject|0|||
160836606|NCT03429543|580788487|FG002|Overall Study|Withdrawal by Subject|1|||
160836607|NCT03429543|580788488|FG003|Overall Study|Withdrawal by Subject|2|||
160836608|NCT03429543|580788489|FG004|Overall Study|Withdrawal by Subject|6|||
160836609|NCT03429543|580788490|FG005|Overall Study|Withdrawal by Subject|3|||
160836610|NCT03429543|580788491|FG006|Overall Study|Withdrawal by Subject|1|||
160836611|NCT03429543|580788485|FG000|Overall Study|Other reason than listed|0|||
160836612|NCT03429543|580788486|FG001|Overall Study|Other reason than listed|1|||
160836613|NCT03429543|580788487|FG002|Overall Study|Other reason than listed|0|||
160836614|NCT03429543|580788488|FG003|Overall Study|Other reason than listed|0|||
161138221|NCT02337387|581887083|FG001|Overall Study|Adverse Event|1|||
161138222|NCT02337387|581887084|FG002|Overall Study|Adverse Event|0|||
161138223|NCT02337387|581887085|FG003|Overall Study|Adverse Event|0|||
161138224|NCT02337387|581887082|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
161138225|NCT02337387|581887083|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
160836615|NCT03429543|580788489|FG004|Overall Study|Other reason than listed|4|||
160836616|NCT03429543|580788490|FG005|Overall Study|Other reason than listed|4|||
160836617|NCT03429543|580788491|FG006|Overall Study|Other reason than listed|0|||
160836618|NCT03429543|580788485|FG000|Overall Study|Not treated|0|||
160836619|NCT03429543|580788486|FG001|Overall Study|Not treated|0|||
160836620|NCT03429543|580788487|FG002|Overall Study|Not treated|0|||
160836621|NCT03429543|580788488|FG003|Overall Study|Not treated|0|||
160836622|NCT03429543|580788489|FG004|Overall Study|Not treated|1|||
160836623|NCT03429543|580788490|FG005|Overall Study|Not treated|0|||
160836624|NCT03429543|580788491|FG006|Overall Study|Not treated|0|||
160836625|NCT01729208|580788492|FG000|Baseline|Physician Decision|5|||
160836626|NCT01729208|580788493|FG001|Baseline|Physician Decision|4|||
160836627|NCT01729208|580788492|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
160836628|NCT01729208|580788493|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
160836629|NCT01729208|580788492|FG000|12 Months Follow-up|Lost to Follow-up|3|||
160836630|NCT01729208|580788493|FG001|12 Months Follow-up|Lost to Follow-up|3|||
160836631|NCT01729208|580788492|FG000|24 Months Follow-up|Lost to Follow-up|3|||
160836632|NCT01729208|580788493|FG001|24 Months Follow-up|Lost to Follow-up|0|||
160836633|NCT01729208|580788492|FG000|36 Months Follow-up|Physician Decision|1|||
160836634|NCT01729208|580788493|FG001|36 Months Follow-up|Physician Decision|0|||
160836635|NCT01729208|580788492|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
160836636|NCT01729208|580788493|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
160836637|NCT00082381|580788494|FG000|Overall Study|Adverse Event|27|||
160836638|NCT00082381|580788495|FG001|Overall Study|Adverse Event|2|||
160917936|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
161138226|NCT02337387|581887084|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
161138227|NCT02337387|581887085|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
161138228|NCT01243268|581887086|FG000|Overall Study|Lost to Follow-up|4|||
161138229|NCT01243268|581887086|FG000|Overall Study|Protocol Violation|51|||
161138230|NCT01243268|581887086|FG000|Overall Study|Deviation with contract date|7|||
161138231|NCT01243268|581887086|FG000|Overall Study|Duplicate subject|2|||
161138232|NCT00702143|581887087|FG000|Overall Study|Lost to Follow-up|0|||
161138233|NCT00702143|581887088|FG001|Overall Study|Lost to Follow-up|0|||
161138234|NCT00702143|581887089|FG002|Overall Study|Lost to Follow-up|1|||
161138235|NCT03871491|581887092|FG000|Overall Study|Withdrawal by Subject|14|||
160836639|NCT00082381|580788494|FG000|Overall Study|Lost to Follow-up|5|||
160836640|NCT00082381|580788495|FG001|Overall Study|Lost to Follow-up|7|||
160836641|NCT00082381|580788494|FG000|Overall Study|Patient Decision|8|||
160836642|NCT00082381|580788495|FG001|Overall Study|Patient Decision|4|||
160836643|NCT00082381|580788494|FG000|Overall Study|Physician Decision|1|||
160836644|NCT00082381|580788495|FG001|Overall Study|Physician Decision|2|||
160836645|NCT00082381|580788494|FG000|Overall Study|Protocol Violation|10|||
160836646|NCT00082381|580788495|FG001|Overall Study|Protocol Violation|11|||
160836647|NCT00082381|580788494|FG000|Overall Study|Loss of Glucose Control|4|||
160836648|NCT00082381|580788495|FG001|Overall Study|Loss of Glucose Control|0|||
160836649|NCT02428413|580788496|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
160836650|NCT02428413|580788497|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
160836651|NCT02428413|580788496|FG000|Overall Study|Protocol Violation|1|||
160836652|NCT02428413|580788497|FG001|Overall Study|Protocol Violation|2|||
160836653|NCT02428413|580788496|FG000|Overall Study|Case Cancelled|2|||
160836654|NCT02428413|580788497|FG001|Overall Study|Case Cancelled|0|||
160836655|NCT02428413|580788496|FG000|Overall Study|Missed Cases|1|||
160836656|NCT02428413|580788497|FG001|Overall Study|Missed Cases|2|||
160836657|NCT02428413|580788496|FG000|Overall Study|Nurse Refusal|1|||
160836658|NCT02428413|580788497|FG001|Overall Study|Nurse Refusal|0|||
160836659|NCT02345330|580788501|FG000|Overall Study|Death|1|||
160836660|NCT02345330|580788501|FG000|Overall Study|Progressive Disease|2|||
160836661|NCT00295932|580788502|FG000|Overall Study|Not Treated|0|||
160836662|NCT00295932|580788503|FG001|Overall Study|Not Treated|0|||
160836663|NCT00295932|580788504|FG002|Overall Study|Not Treated|0|||
160836664|NCT00295932|580788505|FG003|Overall Study|Not Treated|0|||
160836665|NCT00295932|580788506|FG004|Overall Study|Not Treated|0|||
160836666|NCT00295932|580788507|FG005|Overall Study|Not Treated|0|||
160836667|NCT00295932|580788508|FG006|Overall Study|Not Treated|0|||
160836668|NCT00295932|580788509|FG007|Overall Study|Not Treated|0|||
160836669|NCT00295932|580788510|FG008|Overall Study|Not Treated|0|||
160836670|NCT00295932|580788511|FG009|Overall Study|Not Treated|0|||
160836671|NCT00295932|580788512|FG010|Overall Study|Not Treated|1|||
160836672|NCT00109577|580788513|FG000|Overall Study|Withdrawal by Subject|3|||
160836673|NCT00109577|580788514|FG001|Overall Study|Withdrawal by Subject|3|||
160836674|NCT03322423|580788515|FG000|Period 1|Subject no longer eligible|0|||
160836675|NCT03322423|580788516|FG001|Period 1|Subject no longer eligible|1|||
160836676|NCT03322423|580788515|FG000|Period 1|Withdrawal by Subject|0|||
160836677|NCT03322423|580788516|FG001|Period 1|Withdrawal by Subject|1|||
160836678|NCT03322423|580788515|FG000|Period 1|Incorrect Lens Dispensed|1|||
160836679|NCT03322423|580788516|FG001|Period 1|Incorrect Lens Dispensed|0|||
160836680|NCT03322423|580788515|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
160836681|NCT03322423|580788516|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
160836682|NCT03322423|580788515|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
160836683|NCT03322423|580788516|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
160836684|NCT03322423|580788515|FG000|Period 2|Protocol Violation|1|||
160836685|NCT03322423|580788516|FG001|Period 2|Protocol Violation|0|||
160836686|NCT03322423|580788515|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
160836687|NCT03322423|580788516|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
160836688|NCT04891107|580788517|FG000|Overall Study|Physician Decision|1|||
160836689|NCT04891107|580788517|FG000|Overall Study|Withdrawal by Subject|1|||
160836690|NCT04891107|580788517|FG000|Overall Study|Screen failure after consent|1|||
160836691|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
160836692|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
160836693|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
160836694|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
160836695|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
160836696|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
160836697|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
160836698|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836699|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836700|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836701|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836702|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
160836703|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
160836704|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
160836705|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836706|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836707|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836708|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160836709|NCT02453555|580788518|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
160904149|NCT03298867|581043176|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
160904150|NCT03298867|581043177|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
160904151|NCT03298867|581043176|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
161249424|NCT02614196|582291760|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
161249425|NCT02614196|582291761|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
161249426|NCT02614196|582291756|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
161249427|NCT02614196|582291757|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161249428|NCT02614196|582291758|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161249429|NCT02614196|582291759|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161249430|NCT02614196|582291760|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
161249431|NCT02614196|582291761|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
161249432|NCT02614196|582291756|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
161249433|NCT02614196|582291757|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
160836710|NCT02453555|580788519|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
160836711|NCT02453555|580788520|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
160836712|NCT02453555|580788521|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
160836713|NCT02453555|580788522|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
160836714|NCT02453555|580788523|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
160836715|NCT02453555|580788518|FG000|Extension Period|Adverse Event|0|||
160836716|NCT02453555|580788519|FG001|Extension Period|Adverse Event|0|||
160836717|NCT02453555|580788520|FG002|Extension Period|Adverse Event|1|||
160836718|NCT02453555|580788521|FG003|Extension Period|Adverse Event|2|||
160836719|NCT02453555|580788522|FG004|Extension Period|Adverse Event|1|||
160836720|NCT02453555|580788523|FG005|Extension Period|Adverse Event|1|||
160836721|NCT02453555|580788518|FG000|Extension Period|Protocol Violation|0|||
160836722|NCT02453555|580788519|FG001|Extension Period|Protocol Violation|0|||
160836723|NCT02453555|580788520|FG002|Extension Period|Protocol Violation|1|||
160836724|NCT02453555|580788521|FG003|Extension Period|Protocol Violation|0|||
160836725|NCT02453555|580788522|FG004|Extension Period|Protocol Violation|0|||
160836726|NCT02453555|580788523|FG005|Extension Period|Protocol Violation|0|||
160836727|NCT02453555|580788518|FG000|Extension Period|Withdrawal by Subject|0|||
160836728|NCT02453555|580788519|FG001|Extension Period|Withdrawal by Subject|0|||
160836729|NCT02453555|580788520|FG002|Extension Period|Withdrawal by Subject|1|||
160836730|NCT02453555|580788521|FG003|Extension Period|Withdrawal by Subject|0|||
160836731|NCT02453555|580788522|FG004|Extension Period|Withdrawal by Subject|0|||
160836732|NCT02453555|580788523|FG005|Extension Period|Withdrawal by Subject|0|||
160836733|NCT03689855|580788528|FG000|Overall Study|Adverse Event|3|||
160836734|NCT03689855|580788528|FG000|Overall Study|Withdrawal by Subject|1|||
160836735|NCT03178669|580788529|FG000|Overall Study|Adverse Event|4|||
160836736|NCT03178669|580788530|FG001|Overall Study|Adverse Event|1|||
161249434|NCT02614196|582291758|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
161249435|NCT02614196|582291759|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
161249436|NCT02614196|582291760|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
161249437|NCT02614196|582291761|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
161249438|NCT02614196|582291756|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
161249439|NCT02614196|582291757|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
161249440|NCT02614196|582291758|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
161249441|NCT02614196|582291759|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
161249442|NCT02614196|582291760|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
161249443|NCT02614196|582291761|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
161249444|NCT02614196|582291756|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
161249445|NCT02614196|582291757|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
161249446|NCT02614196|582291758|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
161249447|NCT02614196|582291759|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
160836737|NCT03178669|580788531|FG002|Overall Study|Adverse Event|4|||
160836738|NCT03178669|580788532|FG003|Overall Study|Adverse Event|2|||
160836739|NCT03178669|580788533|FG004|Overall Study|Adverse Event|2|||
160836740|NCT03178669|580788529|FG000|Overall Study|Lack of Efficacy|0|||
160836741|NCT03178669|580788530|FG001|Overall Study|Lack of Efficacy|0|||
160836742|NCT03178669|580788531|FG002|Overall Study|Lack of Efficacy|2|||
161249448|NCT02614196|582291760|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
161249449|NCT02614196|582291761|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
160836743|NCT03178669|580788532|FG003|Overall Study|Lack of Efficacy|0|||
160836744|NCT03178669|580788533|FG004|Overall Study|Lack of Efficacy|1|||
160836745|NCT03178669|580788529|FG000|Overall Study|Physician Decision|0|||
160836746|NCT03178669|580788530|FG001|Overall Study|Physician Decision|0|||
160836747|NCT03178669|580788531|FG002|Overall Study|Physician Decision|0|||
160836748|NCT03178669|580788532|FG003|Overall Study|Physician Decision|0|||
160991589|NCT04927975|581357843|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
160836749|NCT03178669|580788533|FG004|Overall Study|Physician Decision|1|||
160836750|NCT03178669|580788529|FG000|Overall Study|Withdrawal by Subject|1|||
160991590|NCT04927975|581357844|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
160991591|NCT04927975|581357845|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
160836751|NCT03178669|580788530|FG001|Overall Study|Withdrawal by Subject|0|||
160836752|NCT03178669|580788531|FG002|Overall Study|Withdrawal by Subject|1|||
161249450|NCT01539239|582291762|FG000|Overall Study|Death|5|||
161249451|NCT01539239|582291763|FG001|Overall Study|Death|5|||
160836753|NCT03178669|580788532|FG003|Overall Study|Withdrawal by Subject|1|||
160836754|NCT03178669|580788533|FG004|Overall Study|Withdrawal by Subject|0|||
160836755|NCT03178669|580788529|FG000|Overall Study|Lost to Follow-up|0|||
160836756|NCT03178669|580788530|FG001|Overall Study|Lost to Follow-up|0|||
160836757|NCT03178669|580788531|FG002|Overall Study|Lost to Follow-up|0|||
160836758|NCT03178669|580788532|FG003|Overall Study|Lost to Follow-up|1|||
160836759|NCT03178669|580788533|FG004|Overall Study|Lost to Follow-up|0|||
160836760|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
160836761|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
160836762|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
160836763|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
160836764|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
160836765|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
160836766|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836767|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836768|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836769|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836770|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
160836771|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
160836772|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
160836773|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
160836774|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836775|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
160836776|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
160836777|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836778|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836779|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836780|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836781|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
160836782|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836783|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
160836784|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
160836785|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
160836786|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
160836787|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
160836788|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836789|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836790|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836791|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836792|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
160836793|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
160836794|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
160836795|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
160836796|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836797|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
160836798|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
160836799|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836800|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836801|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836802|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836803|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
160836804|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836805|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836806|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
160836807|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836808|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836809|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
160836810|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836811|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836812|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836813|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836814|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
160836815|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
160836816|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836817|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836818|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836819|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836820|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836821|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836822|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836823|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836824|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160904152|NCT03298867|581043177|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
160904153|NCT06934993|581043182|FG000|Overall Study|Withdrawal by Subject|29|||
160904154|NCT06934993|581043182|FG000|Overall Study|elevated postoperative creatinine level|11|||
160904155|NCT06934993|581043182|FG000|Overall Study|Death|3|||
160904156|NCT03749447|581044885|FG000|Overall Study|Adverse Event|11|||
160904157|NCT03749447|581044886|FG001|Overall Study|Adverse Event|3|||
160904158|NCT03749447|581044885|FG000|Overall Study|Death|1|||
160904159|NCT03749447|581044886|FG001|Overall Study|Death|1|||
160904160|NCT03749447|581044885|FG000|Overall Study|Lost to Follow-up|2|||
160904161|NCT03749447|581044886|FG001|Overall Study|Lost to Follow-up|2|||
160904162|NCT03749447|581044885|FG000|Overall Study|Reason Not Specified|0|||
160904163|NCT03749447|581044886|FG001|Overall Study|Reason Not Specified|3|||
160904164|NCT03749447|581044885|FG000|Overall Study|Physician Decision|4|||
160904165|NCT03749447|581044886|FG001|Overall Study|Physician Decision|3|||
160904166|NCT03749447|581044885|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
160904167|NCT03749447|581044886|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
160904168|NCT03749447|581044885|FG000|Overall Study|Study Terminated By Sponsor|112|||
160904169|NCT03749447|581044886|FG001|Overall Study|Study Terminated By Sponsor|105|||
160904170|NCT03749447|581044885|FG000|Overall Study|Withdrawal by Subject|12|||
160904171|NCT03749447|581044886|FG001|Overall Study|Withdrawal by Subject|6|||
160904172|NCT03749447|581044885|FG000|Overall Study|Non-compliance With Study Drug|0|||
160904173|NCT03749447|581044886|FG001|Overall Study|Non-compliance With Study Drug|1|||
160904174|NCT01673867|581044890|FG000|Randomization|Adverse event unrelated to study drug|1|||
160904175|NCT01673867|581044891|FG001|Randomization|Adverse event unrelated to study drug|0|||
160904176|NCT01673867|581044890|FG000|Randomization|Participant request to discontinue study treatment|0|||
160904177|NCT01673867|581044891|FG001|Randomization|Participant request to discontinue study treatment|4|||
160904178|NCT01673867|581044890|FG000|Randomization|Withdrawal by participant|0|||
160904179|NCT01673867|581044891|FG001|Randomization|Withdrawal by participant|12|||
160904180|NCT01673867|581044890|FG000|Randomization|Lost to Follow-up|0|||
160904181|NCT01673867|581044891|FG001|Randomization|Lost to Follow-up|1|||
160904182|NCT01673867|581044890|FG000|Randomization|Participant no longer meets study criteria|4|||
160904183|NCT01673867|581044891|FG001|Randomization|Participant no longer meets study criteria|5|||
160904184|NCT01673867|581044890|FG000|Treatment|Disease Progression|208|||
160904185|NCT01673867|581044891|FG001|Treatment|Disease Progression|178|||
161138236|NCT03871491|581887093|FG001|Overall Study|Withdrawal by Subject|14|||
161138237|NCT03871491|581887094|FG002|Overall Study|Withdrawal by Subject|14|||
161138238|NCT03871491|581887095|FG003|Overall Study|Withdrawal by Subject|14|||
161138239|NCT03871491|581887092|FG000|Overall Study|Physician Decision|0|||
161138240|NCT03871491|581887093|FG001|Overall Study|Physician Decision|0|||
161138241|NCT03871491|581887094|FG002|Overall Study|Physician Decision|1|||
160836825|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
160836826|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836827|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836828|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
160836829|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836830|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836831|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836832|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836833|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836834|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836835|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836836|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
160836837|NCT02914561|580788535|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
160904186|NCT01673867|581044890|FG000|Treatment|Study Drug Toxicity|23|||
160904187|NCT01673867|581044891|FG001|Treatment|Study Drug Toxicity|43|||
160904188|NCT01673867|581044890|FG000|Treatment|Death|2|||
160904189|NCT01673867|581044891|FG001|Treatment|Death|3|||
160904190|NCT01673867|581044890|FG000|Treatment|Adverse event unrelated to study drug|23|||
160904191|NCT01673867|581044891|FG001|Treatment|Adverse event unrelated to study drug|10|||
160904192|NCT01673867|581044890|FG000|Treatment|Participant request to discontinue study treatment|7|||
160904193|NCT01673867|581044891|FG001|Treatment|Participant request to discontinue study treatment|17|||
161138242|NCT03871491|581887095|FG003|Overall Study|Physician Decision|1|||
161138243|NCT03871491|581887092|FG000|Overall Study|Lost to Follow-up|50|||
161138244|NCT03871491|581887093|FG001|Overall Study|Lost to Follow-up|15|||
161138245|NCT03871491|581887094|FG002|Overall Study|Lost to Follow-up|36|||
161138246|NCT03871491|581887095|FG003|Overall Study|Lost to Follow-up|11|||
161138247|NCT04996797|581887096|FG000|Overall Study|Adverse Event|0|||
161138248|NCT04996797|581887097|FG001|Overall Study|Adverse Event|2|||
161249452|NCT01539239|582291762|FG000|Overall Study|Lost to Follow-up|7|||
161249453|NCT01539239|582291763|FG001|Overall Study|Lost to Follow-up|12|||
161249454|NCT01562613|582291764|FG000|Overall Study|Lost to Follow-up|2|||
161249455|NCT01562613|582291764|FG000|Overall Study|Withdrawal by Subject|2|||
161249456|NCT00633022|582291769|FG000|Overall Study|Adverse Event|1|||
161249457|NCT00633022|582291770|FG001|Overall Study|Adverse Event|0|||
161249458|NCT00633022|582291771|FG002|Overall Study|Adverse Event|5|||
161249459|NCT00633022|582291769|FG000|Overall Study|Physician Decision|0|||
160836838|NCT02914561|580788536|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836839|NCT02914561|580788537|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836840|NCT02914561|580788538|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836841|NCT02914561|580788539|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836842|NCT02914561|580788540|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
160836843|NCT02914561|580788541|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836844|NCT02914561|580788542|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836845|NCT02914561|580788543|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836846|NCT02914561|580788544|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836847|NCT02914561|580788545|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
160836848|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836849|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836850|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836851|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836852|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836853|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
160836854|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
160836855|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
160836856|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
160836857|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
160836858|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
160836859|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836860|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836861|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836862|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836863|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836864|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
160836865|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
160836866|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
160836867|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
161249460|NCT00633022|582291770|FG001|Overall Study|Physician Decision|1|||
161249461|NCT00633022|582291771|FG002|Overall Study|Physician Decision|0|||
161249462|NCT00663234|582291773|FG000|Overall Study|Not willing to adhere to requirements|1|||
161249463|NCT01253564|582291776|FG000|Overall Study|Disease Progression|22|||
161249464|NCT01253564|582291776|FG000|Overall Study|Withdrawal by Subject|1|||
160836868|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
160836869|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
160904194|NCT01673867|581044890|FG000|Treatment|Withdrawal by participant|5|||
160904195|NCT01673867|581044891|FG001|Treatment|Withdrawal by participant|5|||
160904196|NCT01673867|581044890|FG000|Treatment|Maximum clinical benefit|1|||
160904197|NCT01673867|581044891|FG001|Treatment|Maximum clinical benefit|10|||
160904198|NCT01673867|581044890|FG000|Treatment|Participant no longer meets study criteria|2|||
160904199|NCT01673867|581044891|FG001|Treatment|Participant no longer meets study criteria|0|||
160904200|NCT01673867|581044890|FG000|Treatment|Administrative reason by sponsor|3|||
160904201|NCT01673867|581044891|FG001|Treatment|Administrative reason by sponsor|0|||
160904202|NCT01673867|581044890|FG000|Treatment|Other reason|11|||
160904203|NCT01673867|581044891|FG001|Treatment|Other reason|2|||
160904204|NCT01709513|581044892|FG000|Overall Study|Randomized but not treated|0|||
160904205|NCT01709513|581044893|FG001|Overall Study|Randomized but not treated|1|||
160904206|NCT01709513|581044894|FG002|Overall Study|Randomized but not treated|0|||
160904207|NCT01709513|581044892|FG000|Overall Study|Adverse Event|16|||
160904208|NCT01709513|581044893|FG001|Overall Study|Adverse Event|31|||
160904209|NCT01709513|581044894|FG002|Overall Study|Adverse Event|23|||
160904210|NCT01709513|581044892|FG000|Overall Study|Poor compliance to protocol|2|||
160904211|NCT01709513|581044893|FG001|Overall Study|Poor compliance to protocol|0|||
160904212|NCT01709513|581044894|FG002|Overall Study|Poor compliance to protocol|0|||
160904213|NCT01709513|581044892|FG000|Overall Study|Other|3|||
160904214|NCT01709513|581044893|FG001|Overall Study|Other|11|||
160904215|NCT01709513|581044894|FG002|Overall Study|Other|7|||
160904216|NCT01193530|581044897|FG000|Overall Study|Withdrawal by Subject|2|||
161249465|NCT01253564|582291776|FG000|Overall Study|Serious Adverse Event|1|||
161249466|NCT02129062|582293037|FG000|Overall Study|Death|1|||
161249467|NCT02129062|582293037|FG000|Overall Study|Disease Progression|2|||
161249468|NCT04662710|582293038|FG000|Overall Study|Death|14|||
161249469|NCT04662710|582293039|FG001|Overall Study|Death|331|||
161249470|NCT04662710|582293040|FG002|Overall Study|Death|367|||
161249471|NCT04662710|582293038|FG000|Overall Study|Ongoing|1|||
161249472|NCT04662710|582293039|FG001|Overall Study|Ongoing|109|||
161249473|NCT04662710|582293040|FG002|Overall Study|Ongoing|56|||
161249474|NCT04662710|582293038|FG000|Overall Study|Withdrawal by Subject|0|||
161249475|NCT04662710|582293039|FG001|Overall Study|Withdrawal by Subject|3|||
161249476|NCT04662710|582293040|FG002|Overall Study|Withdrawal by Subject|14|||
161249477|NCT02722616|582293042|FG000|Overall Study|Sponsor closed study after one month|2|||
161249478|NCT02722616|582293043|FG001|Overall Study|Sponsor closed study after one month|0|||
161249479|NCT02722616|582293044|FG002|Overall Study|Sponsor closed study after one month|0|||
161249480|NCT00224484|582293045|FG000|Overall Study|Serious Adverse Event|1|||
161249481|NCT00224484|582293046|FG001|Overall Study|Serious Adverse Event|1|||
161249482|NCT00224484|582293047|FG002|Overall Study|Serious Adverse Event|0|||
161249483|NCT00224484|582293045|FG000|Overall Study|Non-Serious Adverse Event|5|||
161249484|NCT00224484|582293046|FG001|Overall Study|Non-Serious Adverse Event|7|||
161249485|NCT00224484|582293047|FG002|Overall Study|Non-Serious Adverse Event|3|||
161249486|NCT00224484|582293045|FG000|Overall Study|Protocol Violation|2|||
161249487|NCT00224484|582293046|FG001|Overall Study|Protocol Violation|2|||
161249488|NCT00224484|582293047|FG002|Overall Study|Protocol Violation|0|||
161249489|NCT00224484|582293045|FG000|Overall Study|Withdrawal by Subject|49|||
161249490|NCT00224484|582293046|FG001|Overall Study|Withdrawal by Subject|18|||
161249491|NCT00224484|582293047|FG002|Overall Study|Withdrawal by Subject|16|||
161249492|NCT00224484|582293045|FG000|Overall Study|Migrated/moved from study area|18|||
161249493|NCT00224484|582293046|FG001|Overall Study|Migrated/moved from study area|5|||
161249494|NCT00224484|582293047|FG002|Overall Study|Migrated/moved from study area|5|||
161249495|NCT00224484|582293045|FG000|Overall Study|Lost to Follow-up|66|||
161249496|NCT00224484|582293046|FG001|Overall Study|Lost to Follow-up|28|||
161249497|NCT00224484|582293047|FG002|Overall Study|Lost to Follow-up|36|||
161249498|NCT00224484|582293045|FG000|Overall Study|Reason not specified|5|||
161249499|NCT00224484|582293046|FG001|Overall Study|Reason not specified|4|||
161249500|NCT00224484|582293047|FG002|Overall Study|Reason not specified|2|||
161249501|NCT00108628|582293050|FG000|Overall Study|Withdrawal by Subject|17|||
161249502|NCT00108628|582293051|FG001|Overall Study|Withdrawal by Subject|9|||
161249503|NCT00108628|582293050|FG000|Overall Study|Lack of Efficacy|2|||
161249504|NCT00108628|582293051|FG001|Overall Study|Lack of Efficacy|1|||
161249505|NCT00108628|582293050|FG000|Overall Study|Death|1|||
161249506|NCT00108628|582293051|FG001|Overall Study|Death|0|||
161249507|NCT01453153|582293052|FG000|Overall Study|Physician Decision|0|||
161249508|NCT01453153|582293053|FG001|Overall Study|Physician Decision|0|||
161249509|NCT01453153|582293054|FG002|Overall Study|Physician Decision|1|||
161249510|NCT01453153|582293052|FG000|Overall Study|Progressive Disease|3|||
161249511|NCT01453153|582293053|FG001|Overall Study|Progressive Disease|2|||
161249512|NCT01453153|582293054|FG002|Overall Study|Progressive Disease|16|||
160836870|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836871|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836872|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836873|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836874|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836875|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
160836876|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
160836877|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
160836878|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
160836879|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
160836880|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
160836881|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836882|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161249513|NCT01453153|582293052|FG000|Overall Study|Withdrawal by Subject|0|||
161249514|NCT01453153|582293053|FG001|Overall Study|Withdrawal by Subject|1|||
161249515|NCT01453153|582293054|FG002|Overall Study|Withdrawal by Subject|2|||
161249516|NCT01453153|582293052|FG000|Overall Study|Adverse Event|1|||
161249517|NCT01453153|582293053|FG001|Overall Study|Adverse Event|1|||
161249518|NCT01453153|582293054|FG002|Overall Study|Adverse Event|1|||
161249519|NCT03547635|582293057|FG000|Overall Study|Adverse Event|5|||
161249520|NCT03547635|582293058|FG001|Overall Study|Adverse Event|2|||
161249521|NCT03547635|582293059|FG002|Overall Study|Adverse Event|3|||
161249522|NCT03547635|582293057|FG000|Overall Study|Lost to Follow-up|1|||
161249523|NCT03547635|582293058|FG001|Overall Study|Lost to Follow-up|3|||
161249524|NCT03547635|582293059|FG002|Overall Study|Lost to Follow-up|4|||
161249525|NCT03547635|582293057|FG000|Overall Study|Withdrawal by Subject|1|||
161249526|NCT03547635|582293058|FG001|Overall Study|Withdrawal by Subject|0|||
161249527|NCT03547635|582293059|FG002|Overall Study|Withdrawal by Subject|0|||
161249528|NCT03547635|582293057|FG000|Overall Study|Withdrawal By PI|0|||
161249529|NCT03547635|582293058|FG001|Overall Study|Withdrawal By PI|1|||
161249530|NCT03547635|582293059|FG002|Overall Study|Withdrawal By PI|0|||
161249531|NCT03547635|582293057|FG000|Overall Study|Withdrawal by Sponsor|0|||
160836883|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
161249532|NCT03547635|582293058|FG001|Overall Study|Withdrawal by Sponsor|0|||
161249533|NCT03547635|582293059|FG002|Overall Study|Withdrawal by Sponsor|1|||
161249534|NCT03547635|582293057|FG000|Overall Study|Errant Randomization before Treatment|0|||
161249535|NCT03547635|582293058|FG001|Overall Study|Errant Randomization before Treatment|1|||
161249536|NCT03547635|582293059|FG002|Overall Study|Errant Randomization before Treatment|0|||
161249537|NCT03547635|582293057|FG000|Overall Study|Withdrawal by Subject|1|||
161249538|NCT03547635|582293058|FG001|Overall Study|Withdrawal by Subject|0|||
161249539|NCT03547635|582293059|FG002|Overall Study|Withdrawal by Subject|0|||
161249540|NCT03243396|582293060|FG000|Overall Study|Lost to Follow-up|2|||
161249541|NCT03243396|582293061|FG001|Overall Study|Lost to Follow-up|3|||
161249542|NCT03243396|582293062|FG002|Overall Study|Lost to Follow-up|15|||
161249543|NCT03243396|582293063|FG003|Overall Study|Lost to Follow-up|8|||
161249544|NCT03243396|582293064|FG004|Overall Study|Lost to Follow-up|1|||
161249545|NCT03243396|582293065|FG005|Overall Study|Lost to Follow-up|4|||
161249546|NCT03243396|582293066|FG006|Overall Study|Lost to Follow-up|9|||
161249547|NCT03687242|582293067|FG000|Overall Study|Adverse Event|1|||
161249548|NCT00288704|582293068|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
161249549|NCT00288704|582293069|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
161249550|NCT00288704|582293070|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
161249551|NCT00288704|582293068|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
160836884|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836885|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836886|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836887|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
160836888|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836889|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
160836890|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
160836891|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
160836892|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836893|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836894|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836895|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836896|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836897|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836898|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
160836899|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
160836900|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
160836901|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
160836902|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
160836903|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836904|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836905|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836906|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836907|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836908|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836909|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
160836910|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836911|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
160836912|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836913|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
160836914|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160904217|NCT01193530|581044898|FG001|Overall Study|Withdrawal by Subject|2|||
160904218|NCT01193530|581044897|FG000|Overall Study|Began Contraindicated Therapy|1|||
160904219|NCT01193530|581044898|FG001|Overall Study|Began Contraindicated Therapy|0|||
161249552|NCT00288704|582293069|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
160836915|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836916|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836917|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160904220|NCT01193530|581044897|FG000|Overall Study|Lost Light Box|0|||
160904221|NCT01193530|581044898|FG001|Overall Study|Lost Light Box|1|||
160904222|NCT01193530|581044897|FG000|Overall Study|Returned home - out of state|0|||
160904223|NCT01193530|581044898|FG001|Overall Study|Returned home - out of state|1|||
161249553|NCT00288704|582293070|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
161249554|NCT00288704|582293068|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
161249555|NCT00288704|582293069|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
161334960|NCT00467519|582615869|FG000|Overall Study|Lost to Follow-up|2|||
160836918|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836919|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836920|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836921|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836922|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
160836923|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836924|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
160836925|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836926|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836927|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836928|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836929|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836930|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836931|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
160836932|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836933|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836934|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836935|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
160836936|NCT02914561|580788535|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836937|NCT02914561|580788536|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836938|NCT02914561|580788537|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836939|NCT02914561|580788538|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836940|NCT02914561|580788539|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836941|NCT02914561|580788540|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836942|NCT02914561|580788541|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836943|NCT02914561|580788542|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
160836944|NCT02914561|580788543|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
160836945|NCT02914561|580788544|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
160836946|NCT02914561|580788545|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
160836947|NCT01300455|580788546|FG000|Washout|Withdrawal by Subject|1|||
160836948|NCT01300455|580788547|FG001|Washout|Withdrawal by Subject|0|||
160836949|NCT00565136|580788548|FG000|Overall Study|Lost to Follow-up|1|||
160836950|NCT00565136|580788548|FG000|Overall Study|Withdrawal by Subject|1|||
160836951|NCT00565136|580788548|FG000|Overall Study|Protocol Violation|1|||
160836952|NCT03332160|580788559|FG000|Overall Study|Withdrawal by Subject|1|||
160836953|NCT03332160|580788560|FG001|Overall Study|Withdrawal by Subject|1|||
161249556|NCT00288704|582293070|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
161249557|NCT00288704|582293068|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
161249558|NCT00288704|582293069|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
161249559|NCT00288704|582293070|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
161249560|NCT00288704|582293068|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
161249561|NCT00288704|582293069|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
161249562|NCT00288704|582293070|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
161249563|NCT00288704|582293068|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
161249564|NCT00288704|582293069|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
161249565|NCT00288704|582293070|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
161249566|NCT00288704|582293068|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
161249567|NCT00288704|582293069|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
161249568|NCT00288704|582293070|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
161249569|NCT00676650|582293071|FG000|Overall Study|Death|45|||
160836954|NCT03332160|580788559|FG000|Overall Study|Adverse Event|0|||
160836955|NCT03332160|580788560|FG001|Overall Study|Adverse Event|1|||
160836956|NCT03332160|580788559|FG000|Overall Study|Developed Exclusion Criteria|0|||
160836957|NCT03332160|580788560|FG001|Overall Study|Developed Exclusion Criteria|1|||
160836958|NCT03332160|580788559|FG000|Overall Study|Non-adherence to treatment|0|||
160836959|NCT03332160|580788560|FG001|Overall Study|Non-adherence to treatment|2|||
160836960|NCT01459913|580788564|FG000|Overall Study|Adverse Event|0|||
160836961|NCT01459913|580788565|FG001|Overall Study|Adverse Event|0|||
160836962|NCT01459913|580788566|FG002|Overall Study|Adverse Event|0|||
160836963|NCT01459913|580788567|FG003|Overall Study|Adverse Event|3|||
160836964|NCT01459913|580788564|FG000|Overall Study|Withdrawal by Subject|4|||
160836965|NCT01459913|580788565|FG001|Overall Study|Withdrawal by Subject|0|||
160836966|NCT01459913|580788566|FG002|Overall Study|Withdrawal by Subject|0|||
160836967|NCT01459913|580788567|FG003|Overall Study|Withdrawal by Subject|5|||
160836968|NCT01459913|580788564|FG000|Overall Study|Lost to Follow-up|7|||
160836969|NCT01459913|580788565|FG001|Overall Study|Lost to Follow-up|4|||
161249570|NCT00676650|582293072|FG001|Overall Study|Death|14|||
160836970|NCT01459913|580788566|FG002|Overall Study|Lost to Follow-up|1|||
161249571|NCT00676650|582293071|FG000|Overall Study|Adverse Event|159|||
161249572|NCT00676650|582293072|FG001|Overall Study|Adverse Event|21|||
160836971|NCT01459913|580788567|FG003|Overall Study|Lost to Follow-up|8|||
160836972|NCT01459913|580788564|FG000|Overall Study|Death|0|||
160836973|NCT01459913|580788565|FG001|Overall Study|Death|0|||
160836974|NCT01459913|580788566|FG002|Overall Study|Death|0|||
160836975|NCT01459913|580788567|FG003|Overall Study|Death|1|||
160836976|NCT01459913|580788564|FG000|Overall Study|Non- Compliance|0|||
160836977|NCT01459913|580788565|FG001|Overall Study|Non- Compliance|0|||
160836978|NCT01459913|580788566|FG002|Overall Study|Non- Compliance|0|||
160836979|NCT01459913|580788567|FG003|Overall Study|Non- Compliance|3|||
160836980|NCT01459913|580788564|FG000|Overall Study|Physician Decision|0|||
160836981|NCT01459913|580788565|FG001|Overall Study|Physician Decision|1|||
160836982|NCT01459913|580788566|FG002|Overall Study|Physician Decision|0|||
160836983|NCT01459913|580788567|FG003|Overall Study|Physician Decision|0|||
160836984|NCT01459913|580788564|FG000|Overall Study|Study Terminated by Sponsor|30|||
160836985|NCT01459913|580788565|FG001|Overall Study|Study Terminated by Sponsor|15|||
160836986|NCT01459913|580788566|FG002|Overall Study|Study Terminated by Sponsor|9|||
160836987|NCT01459913|580788567|FG003|Overall Study|Study Terminated by Sponsor|11|||
160836988|NCT01459913|580788564|FG000|Overall Study|Other|0|||
160836989|NCT01459913|580788565|FG001|Overall Study|Other|0|||
160836990|NCT01459913|580788566|FG002|Overall Study|Other|3|||
160836991|NCT01459913|580788567|FG003|Overall Study|Other|1|||
160836992|NCT01459913|580788564|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
160836993|NCT01459913|580788565|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
160836994|NCT01459913|580788566|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
160836995|NCT01459913|580788567|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
160836996|NCT00576576|580788570|FG000|Overall Study|Lost to Follow-up|6|||
160836997|NCT00576576|580788570|FG000|Overall Study|Protocol Violation|1|||
160836998|NCT05096312|580788571|FG000|Overall Study|Lost to Follow-up|2|||
160836999|NCT05096312|580788572|FG001|Overall Study|Lost to Follow-up|4|||
160837000|NCT05096312|580788571|FG000|Overall Study|Adverse Event|1|||
160837001|NCT05096312|580788572|FG001|Overall Study|Adverse Event|0|||
160837002|NCT03135210|580788573|FG000|Overall Study|Death|0|||
161249573|NCT00676650|582293071|FG000|Overall Study|Global deterioration of health status|66|||
161249574|NCT00676650|582293072|FG001|Overall Study|Global deterioration of health status|31|||
161249575|NCT00676650|582293071|FG000|Overall Study|Lost to Follow-up|0|||
161249576|NCT00676650|582293072|FG001|Overall Study|Lost to Follow-up|1|||
160837003|NCT03135210|580788574|FG001|Overall Study|Death|1|||
160837004|NCT02666105|580788577|FG000|Overall Study|Death|1|||
161249577|NCT00676650|582293071|FG000|Overall Study|Objective progression or relapse|189|||
161249578|NCT00676650|582293072|FG001|Overall Study|Objective progression or relapse|140|||
160837005|NCT01264419|580788578|FG000|Overall Study|Lost to Follow-up|3|||
160837006|NCT01370265|580790147|FG000|First Intervention|Adverse Event|1|||
160837007|NCT01370265|580790148|FG001|First Intervention|Adverse Event|1|||
160837008|NCT00703924|580790149|FG000|Overall Study|Withdrawal by Subject|1|||
160837009|NCT00703924|580790150|FG001|Overall Study|Withdrawal by Subject|1|||
160837010|NCT01031979|580790151|FG000|Overall Study|Lost to Follow-up|5|||
160837011|NCT01031979|580790152|FG001|Overall Study|Lost to Follow-up|4|||
160837012|NCT03592368|580790154|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
160837013|NCT03592368|580790155|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
160837014|NCT03592368|580790156|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
160837015|NCT03592368|580790157|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
160837016|NCT03592368|580790154|FG000|Overall Study|Adverse Event|0|||
160837017|NCT03592368|580790155|FG001|Overall Study|Adverse Event|0|||
160837018|NCT03592368|580790156|FG002|Overall Study|Adverse Event|0|||
160837019|NCT03592368|580790157|FG003|Overall Study|Adverse Event|1|||
160837020|NCT03592368|580790154|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
160837021|NCT03592368|580790155|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
161249579|NCT00676650|582293071|FG000|Overall Study|Other|14|||
161249580|NCT00676650|582293072|FG001|Overall Study|Other|10|||
160837022|NCT03592368|580790156|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
160837023|NCT03592368|580790157|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
160837024|NCT03831100|580790158|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
160837025|NCT03831100|580790159|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
160837026|NCT02454478|580790168|FG000|Overall Study|Incomplete DLT Evaluation|1|||
160837027|NCT01732770|580790175|FG000|Overall Study|Lost to Follow-up|2|||
160837028|NCT01732770|580790176|FG001|Overall Study|Lost to Follow-up|3|||
160837029|NCT01732770|580790175|FG000|Overall Study|Withdrawal by Subject|5|||
160837030|NCT01732770|580790176|FG001|Overall Study|Withdrawal by Subject|3|||
160837031|NCT01732770|580790175|FG000|Overall Study|Decision by Sponsor|2|||
160837032|NCT01732770|580790176|FG001|Overall Study|Decision by Sponsor|2|||
160837033|NCT01732770|580790175|FG000|Overall Study|Death|1|||
160837034|NCT01732770|580790176|FG001|Overall Study|Death|0|||
160837035|NCT01959841|580790179|FG000|Overall Study|Adverse Event|1|||
161249581|NCT00676650|582293071|FG000|Overall Study|Protocol Violation|3|||
161249582|NCT00676650|582293072|FG001|Overall Study|Protocol Violation|1|||
161249583|NCT00676650|582293071|FG000|Overall Study|Study terminated by sponsor|57|||
161249584|NCT00676650|582293072|FG001|Overall Study|Study terminated by sponsor|43|||
161249585|NCT00676650|582293071|FG000|Overall Study|Withdrawal by Subject|48|||
161249586|NCT00676650|582293072|FG001|Overall Study|Withdrawal by Subject|24|||
160991592|NCT04927975|581357846|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
160991593|NCT04927975|581357847|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
160991594|NCT04927975|581357848|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
160991595|NCT04927975|581357843|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
160991596|NCT04927975|581357844|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160991597|NCT04927975|581357845|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160991598|NCT04927975|581357846|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
160991599|NCT04927975|581357847|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
160991600|NCT04927975|581357848|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
161249587|NCT00676650|582293071|FG000|Overall Study|Randomized but not treated|3|||
161249588|NCT00676650|582293072|FG001|Overall Study|Randomized but not treated|4|||
161249589|NCT02297841|582293076|FG000|Overall Study|Withdrawal by Subject|1|||
161249590|NCT02297841|582293076|FG000|Overall Study|Protocol Violation|7|||
161249591|NCT05061992|582293077|FG000|Overall Study|Excess bowel movements|1|||
161249592|NCT05061992|582293078|FG001|Overall Study|Excess bowel movements|0|||
161249593|NCT05061992|582293077|FG000|Overall Study|Complications of Medical Care|1|||
161249594|NCT05061992|582293078|FG001|Overall Study|Complications of Medical Care|0|||
160837036|NCT01959841|580790180|FG001|Overall Study|Adverse Event|3|||
160837037|NCT01959841|580790181|FG002|Overall Study|Adverse Event|2|||
160837038|NCT01959841|580790179|FG000|Overall Study|Lack of Efficacy|5|||
160837039|NCT01959841|580790180|FG001|Overall Study|Lack of Efficacy|0|||
160837040|NCT01959841|580790181|FG002|Overall Study|Lack of Efficacy|0|||
160837041|NCT01959841|580790179|FG000|Overall Study|Lost to Follow-up|1|||
160837042|NCT01959841|580790180|FG001|Overall Study|Lost to Follow-up|1|||
160837043|NCT01959841|580790181|FG002|Overall Study|Lost to Follow-up|0|||
160837044|NCT01959841|580790179|FG000|Overall Study|Physician Decision|0|||
160837045|NCT01959841|580790180|FG001|Overall Study|Physician Decision|2|||
160837046|NCT01959841|580790181|FG002|Overall Study|Physician Decision|3|||
160991601|NCT00768066|581357851|FG000|Overall Study|Did not receive study product injection.|3|||
160991602|NCT00768066|581357852|FG001|Overall Study|Did not receive study product injection.|3|||
160991603|NCT00768066|581357853|FG002|Overall Study|Did not receive study product injection.|0|||
160991604|NCT05550337|581357854|FG000|Overall Study|Lack of Efficacy|0|||
160991605|NCT05550337|581357855|FG001|Overall Study|Lack of Efficacy|0|||
161249595|NCT05061992|582293077|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
161249596|NCT05061992|582293078|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
161249597|NCT05061992|582293077|FG000|Overall Study|Withdrawal by Subject|0|||
161249598|NCT05061992|582293078|FG001|Overall Study|Withdrawal by Subject|1|||
161249599|NCT01257581|582293083|FG000|Overall Study|Early Termination|3|||
161249600|NCT01257581|582293084|FG001|Overall Study|Early Termination|1|||
161249601|NCT01257581|582293085|FG002|Overall Study|Early Termination|2|||
161249602|NCT01257581|582293083|FG000|Overall Study|Death|2|||
160991606|NCT05550337|581357856|FG002|Overall Study|Lack of Efficacy|1|||
160991607|NCT05550337|581357854|FG000|Overall Study|Adverse Event|1|||
161249603|NCT01257581|582293084|FG001|Overall Study|Death|2|||
161249604|NCT01257581|582293085|FG002|Overall Study|Death|4|||
161249605|NCT01157234|582293088|FG000|Overall Study|Withdrawal by Subject|1|||
161249606|NCT01157234|582293089|FG001|Overall Study|Withdrawal by Subject|0|||
161249607|NCT05996198|582293100|FG000|Overall Study|Withdrawal by Subject|1|||
161249608|NCT05996198|582293101|FG001|Overall Study|Withdrawal by Subject|0|||
161249609|NCT03167606|582293105|FG000|Overall Study|Lost to Follow-up|73|||
161249610|NCT03167606|582293106|FG001|Overall Study|Lost to Follow-up|64|||
161249611|NCT03167606|582293105|FG000|Overall Study|Withdrawal by Subject|6|||
161249612|NCT03167606|582293106|FG001|Overall Study|Withdrawal by Subject|5|||
160837047|NCT01959841|580790179|FG000|Overall Study|Protocol Violation|16|||
161249613|NCT03167606|582293105|FG000|Overall Study|Withdrawal by Investigator|0|||
161249614|NCT03167606|582293106|FG001|Overall Study|Withdrawal by Investigator|2|||
161249615|NCT00059332|582293107|FG000|Overall Study|Withdrawal by Subject|2|||
161249616|NCT00059332|582293108|FG001|Overall Study|Withdrawal by Subject|1|||
160837048|NCT01959841|580790180|FG001|Overall Study|Protocol Violation|23|||
160837049|NCT01959841|580790181|FG002|Overall Study|Protocol Violation|16|||
160837050|NCT01959841|580790179|FG000|Overall Study|Withdrawal by Subject|7|||
160837051|NCT01959841|580790180|FG001|Overall Study|Withdrawal by Subject|7|||
160837052|NCT01959841|580790181|FG002|Overall Study|Withdrawal by Subject|5|||
160837053|NCT01959841|580790179|FG000|Overall Study|Clinical laboratory value|2|||
160991608|NCT05550337|581357855|FG001|Overall Study|Adverse Event|5|||
160991609|NCT05550337|581357856|FG002|Overall Study|Adverse Event|0|||
160991610|NCT05550337|581357854|FG000|Overall Study|Withdrawal by Subject|8|||
161249617|NCT00059332|582293107|FG000|Overall Study|Lost to Follow-up|1|||
161249618|NCT00059332|582293108|FG001|Overall Study|Lost to Follow-up|1|||
161249619|NCT00487695|582293111|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
161334961|NCT00467519|582615870|FG001|Overall Study|Lost to Follow-up|9|||
160837054|NCT01959841|580790180|FG001|Overall Study|Clinical laboratory value|6|||
160837055|NCT01959841|580790181|FG002|Overall Study|Clinical laboratory value|6|||
160837056|NCT01959841|580790179|FG000|Overall Study|Platelet count below on day1 or 4|11|||
160837057|NCT01959841|580790180|FG001|Overall Study|Platelet count below on day1 or 4|15|||
160837058|NCT01959841|580790181|FG002|Overall Study|Platelet count below on day1 or 4|11|||
160837059|NCT01450098|580790183|FG000|Period 3|Protocol Violation|0|||
160837060|NCT01450098|580790184|FG001|Period 3|Protocol Violation|1|||
160837061|NCT01450098|580790183|FG000|Period 3|Withdrawal by Subject|0|||
160837062|NCT01450098|580790184|FG001|Period 3|Withdrawal by Subject|2|||
160837063|NCT04207749|580790194|FG000|Overall Study|Lost to Follow-up|0|||
160837064|NCT04207749|580790195|FG001|Overall Study|Lost to Follow-up|2|||
160837065|NCT04207749|580790194|FG000|Overall Study|Protocol Violation|0|||
160837066|NCT04207749|580790195|FG001|Overall Study|Protocol Violation|1|||
160837067|NCT04207749|580790194|FG000|Overall Study|Withdrawal by Subject|3|||
160837068|NCT04207749|580790195|FG001|Overall Study|Withdrawal by Subject|0|||
160837069|NCT04207749|580790194|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
160837070|NCT04207749|580790195|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
160837071|NCT00655629|580790196|FG000|Overall Study|Adverse Event|4|||
160837072|NCT00655629|580790197|FG001|Overall Study|Adverse Event|1|||
160837073|NCT00655629|580790196|FG000|Overall Study|Lack of Efficacy|2|||
160837074|NCT00655629|580790197|FG001|Overall Study|Lack of Efficacy|12|||
160837075|NCT00655629|580790196|FG000|Overall Study|Lost to Follow-up|4|||
160837076|NCT00655629|580790197|FG001|Overall Study|Lost to Follow-up|3|||
160837077|NCT00655629|580790196|FG000|Overall Study|Protocol Violation|5|||
160837078|NCT00655629|580790197|FG001|Overall Study|Protocol Violation|3|||
160837079|NCT00655629|580790196|FG000|Overall Study|consent withdrawn|6|||
160837080|NCT00655629|580790197|FG001|Overall Study|consent withdrawn|4|||
160837081|NCT01971008|580790198|FG000|Overall Study|Protocol Violation|2|||
160837082|NCT01971008|580790199|FG001|Overall Study|Protocol Violation|1|||
160837083|NCT03416127|580790200|FG000|Overall Study|Withdrawal by Subject|0|||
160837084|NCT03416127|580790201|FG001|Overall Study|Withdrawal by Subject|1|||
160837085|NCT03416127|580790202|FG002|Overall Study|Withdrawal by Subject|1|||
160837086|NCT00924508|580790203|FG000|Overall Study|Withdrawal by Subject|3|||
160837087|NCT00495625|580790204|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
160837088|NCT03679624|580790205|FG000|Overall Study|Adverse Event|1|||
160837089|NCT03679624|580790206|FG001|Overall Study|Adverse Event|0|||
160837090|NCT01912339|580790207|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
160837091|NCT01912339|580790208|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
160837092|NCT01912339|580790209|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
160837093|NCT01912339|580790207|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
160837094|NCT01912339|580790208|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
160837095|NCT01912339|580790209|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
161138249|NCT04996797|581887098|FG002|Overall Study|Adverse Event|0|||
160837096|NCT01912339|580790207|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
160837097|NCT01912339|580790208|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
160837098|NCT01912339|580790209|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
160837099|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
160837100|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
160837101|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
160837102|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
160837103|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
160837104|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
160837105|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
160837106|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
160837107|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
160837108|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
160837109|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
160837110|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
160837111|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
160837112|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
160837113|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
161138250|NCT04996797|581887099|FG003|Overall Study|Adverse Event|1|||
160837114|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
160837115|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
160837116|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
160837117|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
160837118|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
160904224|NCT01193530|581044897|FG000|Overall Study|Non-Compliance|0|||
161138251|NCT04996797|581887096|FG000|Overall Study|Lack of Efficacy|0|||
161138252|NCT04996797|581887097|FG001|Overall Study|Lack of Efficacy|2|||
161138253|NCT04996797|581887098|FG002|Overall Study|Lack of Efficacy|0|||
161138254|NCT04996797|581887099|FG003|Overall Study|Lack of Efficacy|0|||
161249620|NCT00487695|582293112|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
161249621|NCT00487695|582293111|FG000|First Procedure|active wheezing (did not have procedure)|1|||
161249622|NCT00487695|582293112|FG001|First Procedure|active wheezing (did not have procedure)|0|||
161249623|NCT00487695|582293111|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
161249624|NCT00487695|582293112|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
160837119|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
160837120|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
160837121|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
160837122|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
160837123|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
160837124|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
160837125|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
160837126|NCT01912339|580790207|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
160837127|NCT01912339|580790208|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
160837128|NCT01912339|580790209|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
160837129|NCT00741013|580790210|FG000|Overall Study|Adverse Event|1|||
160837130|NCT00741013|580790211|FG001|Overall Study|Adverse Event|0|||
160837131|NCT00741013|580790212|FG002|Overall Study|Adverse Event|0|||
160837132|NCT00741013|580790210|FG000|Overall Study|Withdrawal by Subject|0|||
160837133|NCT00741013|580790211|FG001|Overall Study|Withdrawal by Subject|0|||
160837134|NCT00741013|580790212|FG002|Overall Study|Withdrawal by Subject|1|||
160837135|NCT00741013|580790210|FG000|Overall Study|Discovered failed screen after enrolled|0|||
160837136|NCT00741013|580790211|FG001|Overall Study|Discovered failed screen after enrolled|2|||
160837137|NCT00741013|580790212|FG002|Overall Study|Discovered failed screen after enrolled|0|||
160837138|NCT01754493|580790214|FG000|Overall Study|Adverse Event|1|||
160837139|NCT01754493|580790214|FG000|Overall Study|Lost to Follow-up|3|||
160837140|NCT01754493|580790214|FG000|Overall Study|Withdrawal by Subject|1|||
160837141|NCT01754493|580790214|FG000|Overall Study|Moved out of town|1|||
160837142|NCT01754493|580790214|FG000|Overall Study|Scheduling conflict|1|||
160837143|NCT04512976|580790215|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837144|NCT04512976|580790216|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837145|NCT04512976|580790217|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837146|NCT04512976|580790218|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837147|NCT04512976|580790219|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
160837148|NCT04512976|580790220|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
160837149|NCT05249569|580790225|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
160837150|NCT01452919|580790227|FG000|Open-Label Treatment|Adverse Event|5|||
160837151|NCT01452919|580790228|FG001|Open-Label Treatment|Adverse Event|0|||
160837152|NCT01452919|580790229|FG002|Open-Label Treatment|Adverse Event|0|||
160837153|NCT01452919|580790227|FG000|Open-Label Treatment|Lost to Follow-up|4|||
160837154|NCT01452919|580790228|FG001|Open-Label Treatment|Lost to Follow-up|0|||
160837155|NCT01452919|580790229|FG002|Open-Label Treatment|Lost to Follow-up|0|||
160837156|NCT01452919|580790227|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
160837157|NCT01452919|580790228|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
160837158|NCT01452919|580790229|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
160837159|NCT01452919|580790227|FG000|Open-Label Treatment|Protocol Violation|4|||
160837160|NCT01452919|580790228|FG001|Open-Label Treatment|Protocol Violation|0|||
160837161|NCT01452919|580790229|FG002|Open-Label Treatment|Protocol Violation|0|||
160837162|NCT01452919|580790227|FG000|Open-Label Treatment|Sponsor Decision|1|||
160837163|NCT01452919|580790228|FG001|Open-Label Treatment|Sponsor Decision|0|||
160837164|NCT01452919|580790229|FG002|Open-Label Treatment|Sponsor Decision|0|||
161249625|NCT00487695|582293111|FG000|Second Procedure|active wheezing|0|||
161249626|NCT00487695|582293112|FG001|Second Procedure|active wheezing|1|||
161249627|NCT00487695|582293111|FG000|Second Procedure|Withdrawal by Subject|1|||
161249628|NCT00487695|582293112|FG001|Second Procedure|Withdrawal by Subject|2|||
161249629|NCT01698554|582293116|FG000|Overall Study|Adverse Event|2|||
161249630|NCT01698554|582293117|FG001|Overall Study|Adverse Event|5|||
161249631|NCT01698554|582293118|FG002|Overall Study|Adverse Event|0|||
160837165|NCT01452919|580790227|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
160837166|NCT01452919|580790228|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
160837167|NCT01452919|580790229|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
160837168|NCT01452919|580790227|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
160837169|NCT01452919|580790228|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
161249632|NCT01698554|582293119|FG003|Overall Study|Adverse Event|1|||
161249633|NCT01698554|582293116|FG000|Overall Study|Lost to Follow-up|1|||
160837170|NCT01452919|580790229|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
160837171|NCT01452919|580790227|FG000|Randomization Treatment|Adverse Event|0|||
160837172|NCT01452919|580790228|FG001|Randomization Treatment|Adverse Event|0|||
160837173|NCT01452919|580790229|FG002|Randomization Treatment|Adverse Event|2|||
160837174|NCT01452919|580790227|FG000|Randomization Treatment|Sponsor Decision|0|||
160837175|NCT01452919|580790228|FG001|Randomization Treatment|Sponsor Decision|1|||
160837176|NCT01452919|580790229|FG002|Randomization Treatment|Sponsor Decision|0|||
160837177|NCT01452919|580790227|FG000|Randomization Treatment|Withdrawal by Subject|0|||
160837178|NCT01452919|580790228|FG001|Randomization Treatment|Withdrawal by Subject|1|||
160837179|NCT01452919|580790229|FG002|Randomization Treatment|Withdrawal by Subject|0|||
160837180|NCT01452919|580790227|FG000|Randomization Treatment|Subject is moving or has moved|0|||
160837181|NCT01452919|580790228|FG001|Randomization Treatment|Subject is moving or has moved|1|||
160837182|NCT01452919|580790229|FG002|Randomization Treatment|Subject is moving or has moved|0|||
160837183|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
160837184|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
160837185|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
160837186|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
160837187|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
160837188|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
160837189|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Death|1|||
160837190|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Death|4|||
160837191|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
160837192|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
160837193|NCT00658814|580790230|FG000|Remission Induction Chemotherapy|Not eligible|1|||
160837194|NCT00658814|580790231|FG001|Remission Induction Chemotherapy|Not eligible|2|||
160837195|NCT00658814|580790230|FG000|Consolidation Therapy|Not protocol specified|0|||
160837196|NCT00658814|580790231|FG001|Consolidation Therapy|Not protocol specified|1|||
160837197|NCT00658814|580790230|FG000|Consolidation Therapy|Not eligible|2|||
160837198|NCT00658814|580790231|FG001|Consolidation Therapy|Not eligible|2|||
160837199|NCT00658814|580790230|FG000|Maintenance Therapy|Adverse Event|1|||
160837200|NCT00658814|580790231|FG001|Maintenance Therapy|Adverse Event|1|||
160837201|NCT00658814|580790230|FG000|Maintenance Therapy|Not protocol specified|1|||
160837202|NCT00658814|580790231|FG001|Maintenance Therapy|Not protocol specified|0|||
160837203|NCT00658814|580790230|FG000|Maintenance Therapy|Not eligible|1|||
160837204|NCT00658814|580790231|FG001|Maintenance Therapy|Not eligible|0|||
160837205|NCT00455143|580790237|FG000|Overall Study|Physician Decision|1|||
160837206|NCT00455143|580790237|FG000|Overall Study|Withdrawal by Subject|1|||
160837207|NCT00455143|580790237|FG000|Overall Study|Staff was not avail to follow patient|2|||
160837208|NCT00455143|580790237|FG000|Overall Study|No longer met Inclusion Criteria|1|||
160837209|NCT00455143|580790237|FG000|Overall Study|Surgical time, staff not available|1|||
160837210|NCT05222555|580790240|FG000|Overall Study|Ongoing|2|||
160837211|NCT05222555|580790241|FG001|Overall Study|Ongoing|18|||
160837212|NCT05222555|580790240|FG000|Overall Study|Adverse Event|1|||
160837213|NCT05222555|580790241|FG001|Overall Study|Adverse Event|1|||
160837214|NCT05222555|580790240|FG000|Overall Study|Death|0|||
160837215|NCT05222555|580790241|FG001|Overall Study|Death|6|||
160837216|NCT05222555|580790240|FG000|Overall Study|Withdrawal by Subject|0|||
160837217|NCT05222555|580790241|FG001|Overall Study|Withdrawal by Subject|11|||
160837218|NCT04856904|580790244|FG000|Overall Study|Physician Decision|1|||
160837219|NCT04856904|580790245|FG001|Overall Study|Physician Decision|1|||
160837220|NCT04856904|580790244|FG000|Overall Study|Withdrawal by Subject|13|||
160837221|NCT04856904|580790245|FG001|Overall Study|Withdrawal by Subject|13|||
161138255|NCT04996797|581887096|FG000|Overall Study|Prohibited Medication|0|||
160837222|NCT04856904|580790244|FG000|Overall Study|Adverse Event|1|||
160837223|NCT04856904|580790245|FG001|Overall Study|Adverse Event|1|||
160837224|NCT04856904|580790244|FG000|Overall Study|Non-compliance with study drug|1|||
160837225|NCT04856904|580790245|FG001|Overall Study|Non-compliance with study drug|1|||
160837226|NCT04856904|580790244|FG000|Overall Study|Lost to Follow-up|4|||
160837227|NCT04856904|580790245|FG001|Overall Study|Lost to Follow-up|4|||
160837228|NCT04856904|580790244|FG000|Overall Study|Withdrawal by Subject|1|||
160837229|NCT04856904|580790245|FG001|Overall Study|Withdrawal by Subject|1|||
160837230|NCT04856904|580790244|FG000|Overall Study|Protocol Violation|1|||
160837231|NCT04856904|580790245|FG001|Overall Study|Protocol Violation|1|||
160837232|NCT00847015|580790246|FG000|Overall Study|Withdrawal by Subject|1|||
160837233|NCT00847015|580790246|FG000|Overall Study|declined any surgery|1|||
160837234|NCT00847015|580790246|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
160837235|NCT01641822|580790247|FG000|Run-in Phase|Noncompliance with study drug|1|||
160837236|NCT01641822|580790248|FG001|Run-in Phase|Noncompliance with study drug|0|||
160837237|NCT01641822|580790249|FG002|Run-in Phase|Noncompliance with study drug|0|||
160837238|NCT01641822|580790247|FG000|Run-in Phase|Adverse Event|3|||
160837239|NCT01641822|580790248|FG001|Run-in Phase|Adverse Event|0|||
160837240|NCT01641822|580790249|FG002|Run-in Phase|Adverse Event|0|||
160837241|NCT01641822|580790247|FG000|Run-in Phase|Withdrew consent|1|||
160837242|NCT01641822|580790248|FG001|Run-in Phase|Withdrew consent|0|||
160837243|NCT01641822|580790249|FG002|Run-in Phase|Withdrew consent|0|||
161138256|NCT04996797|581887097|FG001|Overall Study|Prohibited Medication|1|||
161138257|NCT04996797|581887098|FG002|Overall Study|Prohibited Medication|0|||
161138258|NCT04996797|581887099|FG003|Overall Study|Prohibited Medication|0|||
161138259|NCT04996797|581887096|FG000|Overall Study|Ongoing|68|||
161138260|NCT04996797|581887097|FG001|Overall Study|Ongoing|60|||
160837244|NCT01641822|580790247|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
160837245|NCT01641822|580790248|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
160837246|NCT01641822|580790249|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
160837247|NCT01641822|580790247|FG000|Comparative Phase|Noncompliance with study drug|0|||
160837248|NCT01641822|580790248|FG001|Comparative Phase|Noncompliance with study drug|1|||
160837249|NCT01641822|580790249|FG002|Comparative Phase|Noncompliance with study drug|0|||
160837250|NCT01641822|580790247|FG000|Comparative Phase|Investigator's discretion|0|||
160837251|NCT01641822|580790248|FG001|Comparative Phase|Investigator's discretion|0|||
160837252|NCT01641822|580790249|FG002|Comparative Phase|Investigator's discretion|1|||
160837253|NCT01641822|580790247|FG000|Comparative Phase|Pregnancy|0|||
160837254|NCT01641822|580790248|FG001|Comparative Phase|Pregnancy|0|||
160837255|NCT01641822|580790249|FG002|Comparative Phase|Pregnancy|1|||
160837256|NCT01641822|580790247|FG000|Comparative Phase|Adverse event, serious fatal|0|||
160837257|NCT01641822|580790248|FG001|Comparative Phase|Adverse event, serious fatal|1|||
160837258|NCT01641822|580790249|FG002|Comparative Phase|Adverse event, serious fatal|0|||
160837259|NCT01641822|580790247|FG000|Comparative Phase|Withdrew consent|0|||
160837260|NCT01641822|580790248|FG001|Comparative Phase|Withdrew consent|3|||
160837261|NCT01641822|580790249|FG002|Comparative Phase|Withdrew consent|7|||
160837262|NCT01641822|580790247|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
160837263|NCT01641822|580790248|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
160837264|NCT01641822|580790249|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
160837265|NCT00454584|580790250|FG000|Controlled Period|Adverse Event|5|||
160837266|NCT00454584|580790251|FG001|Controlled Period|Adverse Event|2|||
160837267|NCT00454584|580790252|FG002|Controlled Period|Adverse Event|1|||
160837268|NCT00454584|580790253|FG003|Controlled Period|Adverse Event|0|||
160837269|NCT00454584|580790254|FG004|Controlled Period|Adverse Event|0|||
160837270|NCT00454584|580790255|FG005|Controlled Period|Adverse Event|0|||
160837271|NCT00454584|580790250|FG000|Controlled Period|Lost to Follow-up|1|||
161249634|NCT01698554|582293117|FG001|Overall Study|Lost to Follow-up|0|||
160837272|NCT00454584|580790251|FG001|Controlled Period|Lost to Follow-up|2|||
160837273|NCT00454584|580790252|FG002|Controlled Period|Lost to Follow-up|2|||
160837274|NCT00454584|580790253|FG003|Controlled Period|Lost to Follow-up|0|||
160837275|NCT00454584|580790254|FG004|Controlled Period|Lost to Follow-up|0|||
160837276|NCT00454584|580790255|FG005|Controlled Period|Lost to Follow-up|0|||
160837277|NCT00454584|580790250|FG000|Controlled Period|Other|5|||
160837278|NCT00454584|580790251|FG001|Controlled Period|Other|4|||
160837279|NCT00454584|580790252|FG002|Controlled Period|Other|2|||
160837280|NCT00454584|580790253|FG003|Controlled Period|Other|0|||
160837281|NCT00454584|580790254|FG004|Controlled Period|Other|0|||
160837282|NCT00454584|580790255|FG005|Controlled Period|Other|0|||
160837283|NCT00454584|580790250|FG000|After Controlled Period|Adverse Event|0|||
160837284|NCT00454584|580790251|FG001|After Controlled Period|Adverse Event|0|||
160837285|NCT00454584|580790252|FG002|After Controlled Period|Adverse Event|0|||
160837286|NCT00454584|580790253|FG003|After Controlled Period|Adverse Event|9|||
161249635|NCT01698554|582293118|FG002|Overall Study|Lost to Follow-up|0|||
160837287|NCT00454584|580790254|FG004|After Controlled Period|Adverse Event|3|||
160837288|NCT00454584|580790255|FG005|After Controlled Period|Adverse Event|9|||
160837289|NCT00454584|580790250|FG000|After Controlled Period|Lack of Efficacy|0|||
160837290|NCT00454584|580790251|FG001|After Controlled Period|Lack of Efficacy|0|||
160837291|NCT00454584|580790252|FG002|After Controlled Period|Lack of Efficacy|0|||
160837292|NCT00454584|580790253|FG003|After Controlled Period|Lack of Efficacy|1|||
160837293|NCT00454584|580790254|FG004|After Controlled Period|Lack of Efficacy|0|||
160837294|NCT00454584|580790255|FG005|After Controlled Period|Lack of Efficacy|0|||
160837295|NCT00454584|580790250|FG000|After Controlled Period|Lost to Follow-up|0|||
160837296|NCT00454584|580790251|FG001|After Controlled Period|Lost to Follow-up|0|||
160837297|NCT00454584|580790252|FG002|After Controlled Period|Lost to Follow-up|0|||
160837298|NCT00454584|580790253|FG003|After Controlled Period|Lost to Follow-up|2|||
160837299|NCT00454584|580790254|FG004|After Controlled Period|Lost to Follow-up|4|||
160837300|NCT00454584|580790255|FG005|After Controlled Period|Lost to Follow-up|6|||
160837301|NCT00454584|580790250|FG000|After Controlled Period|Other|0|||
160837302|NCT00454584|580790251|FG001|After Controlled Period|Other|0|||
160837303|NCT00454584|580790252|FG002|After Controlled Period|Other|0|||
160837304|NCT00454584|580790253|FG003|After Controlled Period|Other|1|||
160837305|NCT00454584|580790254|FG004|After Controlled Period|Other|0|||
160837306|NCT00454584|580790255|FG005|After Controlled Period|Other|0|||
160837307|NCT00454584|580790250|FG000|After Controlled Period|Other|0|||
160837308|NCT00454584|580790251|FG001|After Controlled Period|Other|0|||
160837309|NCT00454584|580790252|FG002|After Controlled Period|Other|0|||
160837310|NCT00454584|580790253|FG003|After Controlled Period|Other|13|||
160837311|NCT00454584|580790254|FG004|After Controlled Period|Other|5|||
160837312|NCT00454584|580790255|FG005|After Controlled Period|Other|17|||
160837313|NCT02421601|580790256|FG000|Overall Study|Adverse Event|4|||
160837314|NCT02421601|580790256|FG000|Overall Study|Lack of Efficacy|5|||
160837315|NCT02421601|580790256|FG000|Overall Study|Physician Decision|1|||
160837316|NCT02421601|580790256|FG000|Overall Study|Withdrawal by Subject|31|||
160837317|NCT02421601|580790256|FG000|Overall Study|Others|41|||
160837318|NCT02250664|580790257|FG000|Overall Study|Lost to Follow-up|18|||
160837319|NCT02250664|580790258|FG001|Overall Study|Lost to Follow-up|28|||
160837320|NCT02250664|580790259|FG002|Overall Study|Lost to Follow-up|33|||
160837321|NCT02250664|580790257|FG000|Overall Study|Personal Reasons|7|||
160837322|NCT02250664|580790258|FG001|Overall Study|Personal Reasons|8|||
160837323|NCT02250664|580790259|FG002|Overall Study|Personal Reasons|14|||
160837324|NCT02250664|580790257|FG000|Overall Study|Adverse Event|6|||
160837325|NCT02250664|580790258|FG001|Overall Study|Adverse Event|3|||
160837326|NCT02250664|580790259|FG002|Overall Study|Adverse Event|8|||
160837327|NCT02250664|580790257|FG000|Overall Study|Incarcerated|2|||
160837328|NCT02250664|580790258|FG001|Overall Study|Incarcerated|1|||
160837329|NCT02250664|580790259|FG002|Overall Study|Incarcerated|2|||
160837330|NCT02250664|580790257|FG000|Overall Study|Withdrawal by Subject|0|||
160837331|NCT02250664|580790258|FG001|Overall Study|Withdrawal by Subject|1|||
160837332|NCT02250664|580790259|FG002|Overall Study|Withdrawal by Subject|2|||
160837333|NCT02250664|580790257|FG000|Overall Study|Death|0|||
160837334|NCT02250664|580790258|FG001|Overall Study|Death|1|||
160837335|NCT02250664|580790259|FG002|Overall Study|Death|1|||
160837336|NCT02250664|580790257|FG000|Overall Study|Physician Decision|1|||
160837337|NCT02250664|580790258|FG001|Overall Study|Physician Decision|3|||
160837338|NCT02250664|580790259|FG002|Overall Study|Physician Decision|1|||
160837339|NCT02250664|580790257|FG000|Overall Study|Protocol Violation|1|||
160837340|NCT02250664|580790258|FG001|Overall Study|Protocol Violation|0|||
160837341|NCT02250664|580790259|FG002|Overall Study|Protocol Violation|1|||
160837342|NCT02250664|580790257|FG000|Overall Study|Reason unknown|1|||
160837343|NCT02250664|580790258|FG001|Overall Study|Reason unknown|0|||
160837344|NCT02250664|580790259|FG002|Overall Study|Reason unknown|0|||
160837345|NCT00778895|580790266|FG000|Active Phase|Adverse Event|3|||
160837346|NCT00778895|580790267|FG001|Active Phase|Adverse Event|1|||
160837347|NCT00778895|580790268|FG002|Active Phase|Adverse Event|0|||
160837348|NCT00778895|580790266|FG000|Active Phase|Withdrawal by Subject|1|||
161138261|NCT04996797|581887098|FG002|Overall Study|Ongoing|22|||
160837349|NCT00778895|580790267|FG001|Active Phase|Withdrawal by Subject|4|||
160837350|NCT00778895|580790268|FG002|Active Phase|Withdrawal by Subject|0|||
160837351|NCT00778895|580790266|FG000|Active Phase|Lost to Follow-up|1|||
160837352|NCT00778895|580790267|FG001|Active Phase|Lost to Follow-up|1|||
160837353|NCT00778895|580790268|FG002|Active Phase|Lost to Follow-up|0|||
160837354|NCT00778895|580790266|FG000|Active Phase|Other|2|||
160837355|NCT00778895|580790267|FG001|Active Phase|Other|0|||
160837356|NCT00778895|580790268|FG002|Active Phase|Other|0|||
160837357|NCT00778895|580790266|FG000|ESFU Phase|Adverse Event|2|||
160837358|NCT00778895|580790267|FG001|ESFU Phase|Adverse Event|1|||
160837359|NCT00778895|580790268|FG002|ESFU Phase|Adverse Event|0|||
160837360|NCT00778895|580790266|FG000|ESFU Phase|Withdrawal by Subject|1|||
160837361|NCT00778895|580790267|FG001|ESFU Phase|Withdrawal by Subject|4|||
160837362|NCT00778895|580790268|FG002|ESFU Phase|Withdrawal by Subject|0|||
160837363|NCT00778895|580790266|FG000|ESFU Phase|Lost to Follow-up|6|||
160837364|NCT00778895|580790267|FG001|ESFU Phase|Lost to Follow-up|7|||
160837365|NCT00778895|580790268|FG002|ESFU Phase|Lost to Follow-up|2|||
160837366|NCT00778895|580790266|FG000|ESFU Phase|Other|2|||
160837367|NCT00778895|580790267|FG001|ESFU Phase|Other|0|||
160837368|NCT00778895|580790268|FG002|ESFU Phase|Other|0|||
160837369|NCT03517566|580790271|FG000|Overall Study|Adverse Event|5|||
160837370|NCT03517566|580790272|FG001|Overall Study|Adverse Event|2|||
160837371|NCT03517566|580790273|FG002|Overall Study|Adverse Event|2|||
160837372|NCT03517566|580790274|FG003|Overall Study|Adverse Event|8|||
160837373|NCT03517566|580790275|FG004|Overall Study|Adverse Event|7|||
160837374|NCT03517566|580790271|FG000|Overall Study|Lack of Efficacy|3|||
160837375|NCT03517566|580790272|FG001|Overall Study|Lack of Efficacy|2|||
160837376|NCT03517566|580790273|FG002|Overall Study|Lack of Efficacy|1|||
160837377|NCT03517566|580790274|FG003|Overall Study|Lack of Efficacy|1|||
160837378|NCT03517566|580790275|FG004|Overall Study|Lack of Efficacy|4|||
160837379|NCT03517566|580790271|FG000|Overall Study|Lost to Follow-up|3|||
160837380|NCT03517566|580790272|FG001|Overall Study|Lost to Follow-up|1|||
160837381|NCT03517566|580790273|FG002|Overall Study|Lost to Follow-up|1|||
160837382|NCT03517566|580790274|FG003|Overall Study|Lost to Follow-up|1|||
160837383|NCT03517566|580790275|FG004|Overall Study|Lost to Follow-up|0|||
160837384|NCT03517566|580790271|FG000|Overall Study|Physician Decision|1|||
160837385|NCT03517566|580790272|FG001|Overall Study|Physician Decision|1|||
160837386|NCT03517566|580790273|FG002|Overall Study|Physician Decision|0|||
160837387|NCT03517566|580790274|FG003|Overall Study|Physician Decision|1|||
160837388|NCT03517566|580790275|FG004|Overall Study|Physician Decision|0|||
160837389|NCT03517566|580790271|FG000|Overall Study|Pregnancy|0|||
160837390|NCT03517566|580790272|FG001|Overall Study|Pregnancy|1|||
160837391|NCT03517566|580790273|FG002|Overall Study|Pregnancy|0|||
160837392|NCT03517566|580790274|FG003|Overall Study|Pregnancy|0|||
160837393|NCT03517566|580790275|FG004|Overall Study|Pregnancy|0|||
160837394|NCT03517566|580790271|FG000|Overall Study|Protocol Deviation|0|||
160837395|NCT03517566|580790272|FG001|Overall Study|Protocol Deviation|1|||
160837396|NCT03517566|580790273|FG002|Overall Study|Protocol Deviation|0|||
160837397|NCT03517566|580790274|FG003|Overall Study|Protocol Deviation|1|||
160837398|NCT03517566|580790275|FG004|Overall Study|Protocol Deviation|1|||
160904225|NCT01193530|581044898|FG001|Overall Study|Non-Compliance|1|||
160904226|NCT04218695|581044899|FG000|Overall Study|Adverse Event|1|||
160904227|NCT04218695|581044900|FG001|Overall Study|Adverse Event|0|||
160904228|NCT03166735|581044901|FG000|Overall Study|Not Treated|1|||
160904229|NCT03166735|581044902|FG001|Overall Study|Not Treated|0|||
160904230|NCT03166735|581044903|FG002|Overall Study|Not Treated|0|||
160904231|NCT03166735|581044904|FG003|Overall Study|Not Treated|0|||
160904232|NCT03166735|581044905|FG004|Overall Study|Not Treated|0|||
160904233|NCT03166735|581044901|FG000|Overall Study|follow-up not completed as planned|0|||
160904234|NCT03166735|581044902|FG001|Overall Study|follow-up not completed as planned|1|||
160904235|NCT03166735|581044903|FG002|Overall Study|follow-up not completed as planned|1|||
160904236|NCT03166735|581044904|FG003|Overall Study|follow-up not completed as planned|0|||
160904237|NCT03166735|581044905|FG004|Overall Study|follow-up not completed as planned|1|||
160991611|NCT05550337|581357855|FG001|Overall Study|Withdrawal by Subject|14|||
160991612|NCT05550337|581357856|FG002|Overall Study|Withdrawal by Subject|10|||
160991613|NCT05550337|581357854|FG000|Overall Study|Pregnancy|0|||
160991614|NCT05550337|581357855|FG001|Overall Study|Pregnancy|0|||
160991615|NCT05550337|581357856|FG002|Overall Study|Pregnancy|1|||
160991616|NCT05550337|581357854|FG000|Overall Study|Protocol Violation|1|||
160991617|NCT05550337|581357855|FG001|Overall Study|Protocol Violation|3|||
160991618|NCT05550337|581357856|FG002|Overall Study|Protocol Violation|4|||
160991619|NCT05550337|581357854|FG000|Overall Study|Physician Decision|2|||
160991620|NCT05550337|581357855|FG001|Overall Study|Physician Decision|1|||
160991621|NCT05550337|581357856|FG002|Overall Study|Physician Decision|1|||
160991622|NCT05550337|581357854|FG000|Overall Study|Lost to Follow-up|16|||
160991623|NCT05550337|581357855|FG001|Overall Study|Lost to Follow-up|11|||
160991624|NCT05550337|581357856|FG002|Overall Study|Lost to Follow-up|11|||
160991625|NCT02189863|581357857|FG000|First 2 Weeks|Motion Sickness|4|||
160991626|NCT02189863|581357858|FG001|First 2 Weeks|Motion Sickness|2|||
160991627|NCT02926937|581357865|FG000|Overall Study|Adverse Event|0|||
160991628|NCT02926937|581357866|FG001|Overall Study|Adverse Event|1|||
160991629|NCT02926937|581357867|FG002|Overall Study|Adverse Event|1|||
160991630|NCT02926937|581357865|FG000|Overall Study|Poor Compliance to Protocol|1|||
160991631|NCT02926937|581357866|FG001|Overall Study|Poor Compliance to Protocol|0|||
160991632|NCT02926937|581357867|FG002|Overall Study|Poor Compliance to Protocol|0|||
160991633|NCT02926937|581357865|FG000|Overall Study|Lost to Follow-up|4|||
160991634|NCT02926937|581357866|FG001|Overall Study|Lost to Follow-up|5|||
160991635|NCT02926937|581357867|FG002|Overall Study|Lost to Follow-up|0|||
160991636|NCT02926937|581357865|FG000|Overall Study|At the Participant's own Request|11|||
160991637|NCT02926937|581357866|FG001|Overall Study|At the Participant's own Request|5|||
160991638|NCT02926937|581357867|FG002|Overall Study|At the Participant's own Request|8|||
160991639|NCT02926937|581357865|FG000|Overall Study|Reason not Specified|3|||
160991640|NCT02926937|581357866|FG001|Overall Study|Reason not Specified|4|||
160991641|NCT02926937|581357867|FG002|Overall Study|Reason not Specified|2|||
160991642|NCT01559090|581357868|FG000|Stage I|Withdrawal by Subject|2|||
160991643|NCT01559090|581357869|FG001|Stage I|Withdrawal by Subject|2|||
160991644|NCT01559090|581357870|FG002|Stage I|Withdrawal by Subject|3|||
160991645|NCT01559090|581357868|FG000|Stage II|Withdrawal by Subject|1|||
160991646|NCT01559090|581357869|FG001|Stage II|Withdrawal by Subject|0|||
160991647|NCT01559090|581357870|FG002|Stage II|Withdrawal by Subject|0|||
160991648|NCT03499600|581357874|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
160991649|NCT03499600|581357875|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
160991650|NCT00561574|581357876|FG000|Overall Study|Adverse Event|21|||
160991651|NCT00561574|581357877|FG001|Overall Study|Adverse Event|24|||
160991652|NCT00561574|581357876|FG000|Overall Study|Lack of Efficacy|11|||
160991653|NCT00561574|581357877|FG001|Overall Study|Lack of Efficacy|21|||
160991654|NCT00561574|581357876|FG000|Overall Study|Withdrawal by Subject|4|||
161138262|NCT04996797|581887099|FG003|Overall Study|Ongoing|20|||
161138263|NCT04996797|581887096|FG000|Overall Study|Withdrawal by Subject|0|||
160904238|NCT03166735|581044901|FG000|Overall Study|Withdrawal by Subject|0|||
160904239|NCT03166735|581044902|FG001|Overall Study|Withdrawal by Subject|0|||
160904240|NCT03166735|581044903|FG002|Overall Study|Withdrawal by Subject|1|||
160904241|NCT03166735|581044904|FG003|Overall Study|Withdrawal by Subject|1|||
160904242|NCT03166735|581044905|FG004|Overall Study|Withdrawal by Subject|2|||
160904243|NCT03166735|581044901|FG000|Overall Study|Lost to Follow-up|0|||
160904244|NCT03166735|581044902|FG001|Overall Study|Lost to Follow-up|2|||
160991655|NCT00561574|581357877|FG001|Overall Study|Withdrawal by Subject|4|||
160991656|NCT00561574|581357876|FG000|Overall Study|Reason Unrelated to Trial|6|||
160991657|NCT00561574|581357877|FG001|Overall Study|Reason Unrelated to Trial|2|||
160991658|NCT00561574|581357876|FG000|Overall Study|Lost to Follow-up|1|||
160991659|NCT00561574|581357877|FG001|Overall Study|Lost to Follow-up|0|||
160991660|NCT00561574|581357876|FG000|Overall Study|Other|5|||
160991661|NCT00561574|581357877|FG001|Overall Study|Other|7|||
160991662|NCT00445692|581357878|FG000|Overall Study|Adverse Event|11|||
161138264|NCT04996797|581887097|FG001|Overall Study|Withdrawal by Subject|2|||
160991663|NCT00445692|581357878|FG000|Overall Study|Lack of Efficacy|5|||
160991664|NCT01729871|581357879|FG000|Overall Study|Adverse Event|7|||
160991665|NCT01729871|581357880|FG001|Overall Study|Adverse Event|7|||
160837399|NCT03517566|580790271|FG000|Overall Study|Study terminated by Sponsor|11|||
160837400|NCT03517566|580790272|FG001|Overall Study|Study terminated by Sponsor|5|||
160837401|NCT03517566|580790273|FG002|Overall Study|Study terminated by Sponsor|6|||
160837402|NCT03517566|580790274|FG003|Overall Study|Study terminated by Sponsor|14|||
160837403|NCT03517566|580790275|FG004|Overall Study|Study terminated by Sponsor|12|||
160837404|NCT03517566|580790271|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
160837405|NCT03517566|580790272|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
160837406|NCT03517566|580790273|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
160837407|NCT03517566|580790274|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
160837408|NCT03517566|580790275|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
160837409|NCT00671437|580790276|FG000|Overall Study|Progressive disease before C1 week 8|8|||
160837410|NCT00671437|580790276|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
160837411|NCT00671437|580790276|FG000|Overall Study|Adverse Event|3|||
160837412|NCT00671437|580790276|FG000|Overall Study|Ineligible post-hoc|1|||
160837413|NCT04349033|580790281|FG000|Overall Study|Lost to Follow-up|3|||
160837414|NCT04349033|580790282|FG001|Overall Study|Lost to Follow-up|1|||
160837415|NCT04349033|580790283|FG002|Overall Study|Lost to Follow-up|1|||
160837416|NCT01704456|580790287|FG000|Overall Study|Lost to Follow-up|8|||
160837417|NCT01704456|580790288|FG001|Overall Study|Lost to Follow-up|14|||
160837418|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837419|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837420|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837421|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837422|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837423|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837424|NCT00718770|580790289|FG000|Overall Study|Lack of Efficacy|1|||
160837425|NCT00718770|580790289|FG000|Overall Study|Adverse Event|1|||
160837426|NCT04583956|580790290|FG000|Overall Study|Death|9|||
160837427|NCT04583956|580790291|FG001|Overall Study|Death|11|||
160837428|NCT04583956|580790290|FG000|Overall Study|Lost to Follow-up|7|||
160837429|NCT04583956|580790291|FG001|Overall Study|Lost to Follow-up|9|||
160837430|NCT04583956|580790290|FG000|Overall Study|Protocol Violation|2|||
160837431|NCT04583956|580790291|FG001|Overall Study|Protocol Violation|0|||
160837432|NCT04583956|580790290|FG000|Overall Study|Withdrawal by Subject|0|||
160837433|NCT04583956|580790291|FG001|Overall Study|Withdrawal by Subject|2|||
160837434|NCT04583956|580790290|FG000|Overall Study|Randomized but not dosed|2|||
160837435|NCT04583956|580790291|FG001|Overall Study|Randomized but not dosed|3|||
160837436|NCT04583956|580790290|FG000|Overall Study|Withdrawal of consent before product administration|1|||
160837437|NCT04583956|580790291|FG001|Overall Study|Withdrawal of consent before product administration|0|||
160837438|NCT00915551|580790297|FG000|Overall Study|Withdrawal by Subject|0|||
160837439|NCT00915551|580790298|FG001|Overall Study|Withdrawal by Subject|1|||
160837440|NCT02540291|580790299|FG000|Overall Study|Death|7|||
160837441|NCT02540291|580790300|FG001|Overall Study|Death|7|||
160837442|NCT02540291|580790301|FG002|Overall Study|Death|5|||
160837443|NCT02540291|580790302|FG003|Overall Study|Death|7|||
160837444|NCT02540291|580790299|FG000|Overall Study|Lost to Follow-up|0|||
160837445|NCT02540291|580790300|FG001|Overall Study|Lost to Follow-up|0|||
160837446|NCT02540291|580790301|FG002|Overall Study|Lost to Follow-up|1|||
160837447|NCT02540291|580790302|FG003|Overall Study|Lost to Follow-up|0|||
160837448|NCT02540291|580790299|FG000|Overall Study|Withdrawal Of Consent|0|||
160837449|NCT02540291|580790300|FG001|Overall Study|Withdrawal Of Consent|1|||
160837450|NCT02540291|580790301|FG002|Overall Study|Withdrawal Of Consent|0|||
160904245|NCT03166735|581044903|FG002|Overall Study|Lost to Follow-up|1|||
160904246|NCT03166735|581044904|FG003|Overall Study|Lost to Follow-up|0|||
160904247|NCT03166735|581044905|FG004|Overall Study|Lost to Follow-up|1|||
160904248|NCT01543958|581044906|FG000|Overall Study|Loss to follow-up|3|||
160904249|NCT01543958|581044906|FG000|Overall Study|ART initiation|1|||
160904250|NCT01945281|581044907|FG000|Overall Study|Adverse Event|1|||
160904251|NCT01945281|581044908|FG001|Overall Study|Adverse Event|0|||
160904252|NCT01945281|581044907|FG000|Overall Study|Death|3|||
160904253|NCT01945281|581044908|FG001|Overall Study|Death|3|||
160837451|NCT02540291|580790302|FG003|Overall Study|Withdrawal Of Consent|0|||
160837452|NCT02540291|580790299|FG000|Overall Study|Study Terminated By Sponsor|1|||
160837453|NCT02540291|580790300|FG001|Overall Study|Study Terminated By Sponsor|0|||
160904254|NCT01945281|581044907|FG000|Overall Study|Physician Decision|1|||
160904255|NCT01945281|581044908|FG001|Overall Study|Physician Decision|1|||
160904256|NCT01945281|581044907|FG000|Overall Study|Technical Problems|1|||
160904257|NCT01945281|581044908|FG001|Overall Study|Technical Problems|0|||
160904258|NCT01513343|581044911|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
161249636|NCT01698554|582293119|FG003|Overall Study|Lost to Follow-up|0|||
160837454|NCT02540291|580790301|FG002|Overall Study|Study Terminated By Sponsor|0|||
160837455|NCT02540291|580790302|FG003|Overall Study|Study Terminated By Sponsor|0|||
160837456|NCT02540291|580790299|FG000|Overall Study|Other|0|||
160837457|NCT02540291|580790300|FG001|Overall Study|Other|0|||
160837458|NCT02540291|580790301|FG002|Overall Study|Other|1|||
160837459|NCT02540291|580790302|FG003|Overall Study|Other|0|||
160837460|NCT01879072|580790304|FG000|Overall Study|Withdrawal by Subject|121|||
160837461|NCT01879072|580790304|FG000|Overall Study|Not Transplanted|30|||
161249637|NCT01698554|582293116|FG000|Overall Study|Personal Reasons|0|||
161249638|NCT01698554|582293117|FG001|Overall Study|Personal Reasons|5|||
161249639|NCT01698554|582293118|FG002|Overall Study|Personal Reasons|1|||
161249640|NCT01698554|582293119|FG003|Overall Study|Personal Reasons|1|||
161249641|NCT01698554|582293116|FG000|Overall Study|Protocol Violation|2|||
161249642|NCT01698554|582293117|FG001|Overall Study|Protocol Violation|0|||
161249643|NCT01698554|582293118|FG002|Overall Study|Protocol Violation|1|||
161249644|NCT01698554|582293119|FG003|Overall Study|Protocol Violation|0|||
161249645|NCT01698554|582293116|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161249646|NCT01698554|582293117|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161249647|NCT01698554|582293118|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161249648|NCT01698554|582293119|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161249649|NCT00697827|582293124|FG000|Overall Study|enrolled but not treated|2|||
161249650|NCT00697827|582293125|FG001|Overall Study|enrolled but not treated|1|||
161249651|NCT03732833|582293126|FG000|Overall Study|Adverse Event|0|||
161249652|NCT03732833|582293127|FG001|Overall Study|Adverse Event|3|||
161249653|NCT03732833|582293128|FG002|Overall Study|Adverse Event|1|||
161249654|NCT03732833|582293126|FG000|Overall Study|Withdrawal by Subject|11|||
161249655|NCT03732833|582293127|FG001|Overall Study|Withdrawal by Subject|13|||
161249656|NCT03732833|582293128|FG002|Overall Study|Withdrawal by Subject|8|||
161249657|NCT03732833|582293126|FG000|Overall Study|Lost to Follow-up|3|||
161249658|NCT03732833|582293127|FG001|Overall Study|Lost to Follow-up|5|||
161249659|NCT03732833|582293128|FG002|Overall Study|Lost to Follow-up|4|||
161249660|NCT03732833|582293126|FG000|Overall Study|Pregnancy|0|||
161249661|NCT03732833|582293127|FG001|Overall Study|Pregnancy|2|||
161249662|NCT03732833|582293128|FG002|Overall Study|Pregnancy|0|||
161249663|NCT03732833|582293126|FG000|Overall Study|Physician Decision|2|||
161249664|NCT03732833|582293127|FG001|Overall Study|Physician Decision|3|||
161249665|NCT03732833|582293128|FG002|Overall Study|Physician Decision|1|||
161249666|NCT03732833|582293126|FG000|Overall Study|Covid-19 related and other reasons|2|||
161249667|NCT03732833|582293127|FG001|Overall Study|Covid-19 related and other reasons|7|||
161249668|NCT03732833|582293128|FG002|Overall Study|Covid-19 related and other reasons|3|||
161249669|NCT00766493|582293129|FG000|30 Days Post-Procedure|Discontinued|7|||
160837462|NCT00659230|580790319|FG000|Overall Study|Lost to Follow-up|2|||
160837463|NCT00659230|580790320|FG001|Overall Study|Lost to Follow-up|5|||
160837464|NCT00659230|580790319|FG000|Overall Study|Lost source documentation|5|||
160837465|NCT00659230|580790320|FG001|Overall Study|Lost source documentation|4|||
160837466|NCT00659230|580790319|FG000|Overall Study|Did not return post-randomization|2|||
160837467|NCT00659230|580790320|FG001|Overall Study|Did not return post-randomization|3|||
160837468|NCT01900054|580792075|FG000|Overall Study|Physician Decision|1|||
160837469|NCT01900054|580792075|FG000|Overall Study|Withdrawal by Subject|1|||
160837470|NCT03229109|580792079|FG000|Overall Study|Withdrawal by Subject|0|||
160837471|NCT03229109|580792080|FG001|Overall Study|Withdrawal by Subject|0|||
160837472|NCT03229109|580792081|FG002|Overall Study|Withdrawal by Subject|0|||
160837473|NCT03229109|580792082|FG003|Overall Study|Withdrawal by Subject|1|||
160837474|NCT01835223|580792085|FG000|Overall Study|Adverse Event|1|||
160837475|NCT01835223|580792086|FG001|Overall Study|Adverse Event|0|||
160837476|NCT01835223|580792085|FG000|Overall Study|Withdrawal by Subject|2|||
160837477|NCT01835223|580792086|FG001|Overall Study|Withdrawal by Subject|0|||
160837478|NCT01835223|580792085|FG000|Overall Study|Disease progression|2|||
160837479|NCT01835223|580792086|FG001|Overall Study|Disease progression|1|||
160837480|NCT01835223|580792085|FG000|Overall Study|Became Inelligible|4|||
160837481|NCT01835223|580792086|FG001|Overall Study|Became Inelligible|0|||
160837482|NCT03329196|580792090|FG000|Overall Study|Adverse Event|10|||
160837483|NCT03329196|580792091|FG001|Overall Study|Adverse Event|5|||
160837484|NCT03329196|580792090|FG000|Overall Study|Physician Decision|2|||
160837485|NCT03329196|580792091|FG001|Overall Study|Physician Decision|2|||
160837486|NCT03329196|580792090|FG000|Overall Study|Withdrawal by Subject|11|||
160837487|NCT03329196|580792091|FG001|Overall Study|Withdrawal by Subject|3|||
160837488|NCT03329196|580792090|FG000|Overall Study|Hepatic function abnormalities|0|||
160837489|NCT03329196|580792091|FG001|Overall Study|Hepatic function abnormalities|1|||
160837490|NCT03329196|580792090|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
160837491|NCT03329196|580792091|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
160837492|NCT03329196|580792090|FG000|Overall Study|Difficult to control Hb|2|||
160837493|NCT03329196|580792091|FG001|Overall Study|Difficult to control Hb|3|||
160837494|NCT03329196|580792090|FG000|Overall Study|Dialysis or renal transplant|13|||
160837495|NCT03329196|580792091|FG001|Overall Study|Dialysis or renal transplant|15|||
160837496|NCT04481750|580792095|FG000|Period 1 (Fasted)|Adverse Event|0|||
160837497|NCT04481750|580792096|FG001|Period 1 (Fasted)|Adverse Event|0|||
161249670|NCT00766493|582293129|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
161249671|NCT00766493|582293129|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
161249672|NCT01849458|582293130|FG000|Overall Study|Lost to Follow-up|4|||
161249673|NCT01863433|582293131|FG000|Overall Study|Protocol Violation|1|||
161249674|NCT03950674|582293132|FG000|Overall Study|Death|16|||
161249675|NCT03950674|582293133|FG001|Overall Study|Death|15|||
160837498|NCT04481750|580792097|FG002|Period 1 (Fasted)|Adverse Event|1|||
160837499|NCT04481750|580792098|FG003|Period 1 (Fasted)|Adverse Event|0|||
160837500|NCT04481750|580792099|FG004|Period 1 (Fasted)|Adverse Event|0|||
160837501|NCT04481750|580792100|FG005|Period 1 (Fasted)|Adverse Event|0|||
160837502|NCT04481750|580792101|FG006|Period 1 (Fasted)|Adverse Event|0|||
160837503|NCT04481750|580792102|FG007|Period 1 (Fasted)|Adverse Event|0|||
160837504|NCT04481750|580792103|FG008|Period 1 (Fasted)|Adverse Event|0|||
160837505|NCT04481750|580792104|FG009|Period 1 (Fasted)|Adverse Event|0|||
160837506|NCT04481750|580792105|FG010|Period 1 (Fasted)|Adverse Event|0|||
160837507|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
160837508|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
160837509|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
160837510|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
160837511|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
160837512|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837513|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
160837514|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837515|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837516|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
160837517|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
160837518|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
160837519|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
160837520|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
160837521|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
160837522|NCT03176771|580792106|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837523|NCT03176771|580792107|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837524|NCT03176771|580792108|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
160837525|NCT03176771|580792109|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837526|NCT03176771|580792110|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
160837527|NCT03176771|580792106|FG000|Double-Blind Extension Period|Adverse Event|0|||
160837528|NCT03176771|580792107|FG001|Double-Blind Extension Period|Adverse Event|0|||
160837529|NCT03176771|580792108|FG002|Double-Blind Extension Period|Adverse Event|0|||
160837530|NCT03176771|580792109|FG003|Double-Blind Extension Period|Adverse Event|15|||
160837531|NCT03176771|580792110|FG004|Double-Blind Extension Period|Adverse Event|18|||
160837532|NCT03176771|580792106|FG000|Double-Blind Extension Period|Death|0|||
160837533|NCT03176771|580792107|FG001|Double-Blind Extension Period|Death|0|||
160837534|NCT03176771|580792108|FG002|Double-Blind Extension Period|Death|0|||
160837535|NCT03176771|580792109|FG003|Double-Blind Extension Period|Death|3|||
160837536|NCT03176771|580792110|FG004|Double-Blind Extension Period|Death|4|||
160837537|NCT03176771|580792106|FG000|Double-Blind Extension Period|Physician Decision|0|||
160837538|NCT03176771|580792107|FG001|Double-Blind Extension Period|Physician Decision|0|||
160837539|NCT03176771|580792108|FG002|Double-Blind Extension Period|Physician Decision|0|||
160837540|NCT03176771|580792109|FG003|Double-Blind Extension Period|Physician Decision|3|||
160837541|NCT03176771|580792110|FG004|Double-Blind Extension Period|Physician Decision|1|||
160837542|NCT03176771|580792106|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
160837543|NCT03176771|580792107|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
160837544|NCT03176771|580792108|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
160837545|NCT03176771|580792109|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
160837546|NCT03176771|580792110|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
160837547|NCT03439137|580792111|FG000|Overall Study|Adverse Event|16|||
160837548|NCT03439137|580792112|FG001|Overall Study|Adverse Event|12|||
160837549|NCT03439137|580792111|FG000|Overall Study|Physician Decision|0|||
160837550|NCT03439137|580792112|FG001|Overall Study|Physician Decision|5|||
160837551|NCT03439137|580792111|FG000|Overall Study|Withdrawal by Subject|14|||
160837552|NCT03439137|580792112|FG001|Overall Study|Withdrawal by Subject|4|||
160837553|NCT03439137|580792111|FG000|Overall Study|Conducting rescue therapy|2|||
160837554|NCT03439137|580792112|FG001|Overall Study|Conducting rescue therapy|1|||
160837555|NCT03439137|580792111|FG000|Overall Study|Difficult to control Hb|10|||
160837556|NCT03439137|580792112|FG001|Overall Study|Difficult to control Hb|2|||
160837557|NCT03439137|580792111|FG000|Overall Study|Initiation of a renal transplant|0|||
160837558|NCT03439137|580792112|FG001|Overall Study|Initiation of a renal transplant|2|||
160904259|NCT01513343|581044912|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
160904260|NCT01513343|581044911|FG000|Post Data Collection|Dropped/withdrew from study|7|||
160904261|NCT01513343|581044912|FG001|Post Data Collection|Dropped/withdrew from study|1|||
160837559|NCT04097379|580792113|FG000|Overall Study|Adverse Event|1|||
160837560|NCT04097379|580792114|FG001|Overall Study|Adverse Event|0|||
160837561|NCT04097379|580792115|FG002|Overall Study|Adverse Event|0|||
160837562|NCT04097379|580792116|FG003|Overall Study|Adverse Event|0|||
160837563|NCT04097379|580792113|FG000|Overall Study|Physician Decision|0|||
160904262|NCT01513343|581044911|FG000|Post Data Collection|Lost to Follow-up|10|||
160904263|NCT01513343|581044912|FG001|Post Data Collection|Lost to Follow-up|23|||
161249676|NCT03950674|582293132|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
160837564|NCT04097379|580792114|FG001|Overall Study|Physician Decision|1|||
160837565|NCT04097379|580792115|FG002|Overall Study|Physician Decision|0|||
160837566|NCT04097379|580792116|FG003|Overall Study|Physician Decision|0|||
160837567|NCT03387020|580792117|FG000|Overall Study|Adverse Event|0|||
160837568|NCT03387020|580792118|FG001|Overall Study|Adverse Event|2|||
160837569|NCT03387020|580792119|FG002|Overall Study|Adverse Event|0|||
160837570|NCT03387020|580792117|FG000|Overall Study|Withdrawal by Subject|2|||
160837571|NCT03387020|580792118|FG001|Overall Study|Withdrawal by Subject|0|||
160837572|NCT03387020|580792119|FG002|Overall Study|Withdrawal by Subject|0|||
160837573|NCT01425632|580792120|FG000|Overall Study|Adverse Event|0|||
160837574|NCT01425632|580792121|FG001|Overall Study|Adverse Event|1|||
160837575|NCT01425632|580792122|FG002|Overall Study|Adverse Event|1|||
160837576|NCT01425632|580792120|FG000|Overall Study|Physician Decision|1|||
160837577|NCT01425632|580792121|FG001|Overall Study|Physician Decision|0|||
160837578|NCT01425632|580792122|FG002|Overall Study|Physician Decision|0|||
160837579|NCT01425632|580792120|FG000|Overall Study|Protocol Violation|0|||
160837580|NCT01425632|580792121|FG001|Overall Study|Protocol Violation|0|||
160837581|NCT01425632|580792122|FG002|Overall Study|Protocol Violation|2|||
160837582|NCT01425632|580792120|FG000|Overall Study|Withdrawal by Subject|0|||
160837583|NCT01425632|580792121|FG001|Overall Study|Withdrawal by Subject|0|||
160837584|NCT01425632|580792122|FG002|Overall Study|Withdrawal by Subject|1|||
160837585|NCT03461146|580792126|FG000|Overall Study|Adverse Event|2|||
160837586|NCT03461146|580792126|FG000|Overall Study|Physician Decision|1|||
160837587|NCT02140047|580792127|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160837588|NCT02140047|580792128|FG001|Overall Study|Withdrawal by parent/guardian|1|||
160837589|NCT02140047|580792129|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160837590|NCT04617496|580792130|FG000|Overall Study|Death|2|||
160837591|NCT04617496|580792131|FG001|Overall Study|Death|1|||
160837592|NCT04617496|580792130|FG000|Overall Study|Lost to Follow-up|3|||
160837593|NCT04617496|580792131|FG001|Overall Study|Lost to Follow-up|3|||
160837594|NCT00200356|580792136|FG000|Overall Study|Lack of Efficacy|3|||
160837595|NCT00200356|580792137|FG001|Overall Study|Lack of Efficacy|3|||
160837596|NCT00200356|580792136|FG000|Overall Study|Protocol Violation|4|||
160837597|NCT00200356|580792137|FG001|Overall Study|Protocol Violation|4|||
160837598|NCT00200356|580792136|FG000|Overall Study|Nontreatment|1|||
160837599|NCT00200356|580792137|FG001|Overall Study|Nontreatment|0|||
160837600|NCT04530552|580792140|FG000|Overall Study|Physician Decision|0|||
160837601|NCT04530552|580792141|FG001|Overall Study|Physician Decision|1|||
160991666|NCT01729871|581357879|FG000|Overall Study|Death|0|||
160991667|NCT01729871|581357880|FG001|Overall Study|Death|1|||
160991668|NCT01729871|581357879|FG000|Overall Study|Lack of Efficacy|0|||
160991669|NCT01729871|581357880|FG001|Overall Study|Lack of Efficacy|1|||
160991670|NCT01729871|581357879|FG000|Overall Study|Physician Decision|0|||
160991671|NCT01729871|581357880|FG001|Overall Study|Physician Decision|2|||
160991672|NCT01729871|581357879|FG000|Overall Study|Protocol Violation|1|||
160991673|NCT01729871|581357880|FG001|Overall Study|Protocol Violation|0|||
160991674|NCT01729871|581357879|FG000|Overall Study|Withdrawal by Subject|0|||
161138265|NCT04996797|581887098|FG002|Overall Study|Withdrawal by Subject|0|||
161138266|NCT04996797|581887099|FG003|Overall Study|Withdrawal by Subject|0|||
161138267|NCT02793544|581887100|FG000|Overall Study|Death|10|||
161138268|NCT02793544|581887101|FG001|Overall Study|Death|8|||
161138269|NCT02793544|581887100|FG000|Overall Study|Lost to Follow-up|2|||
161138270|NCT02793544|581887101|FG001|Overall Study|Lost to Follow-up|0|||
161138271|NCT02793544|581887100|FG000|Overall Study|Withdrawal by Subject|1|||
161249677|NCT03950674|582293133|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
161249678|NCT00494013|582293138|FG000|Overall Study|Adverse Event|0|||
161249679|NCT00494013|582293139|FG001|Overall Study|Adverse Event|1|||
161249680|NCT00494013|582293138|FG000|Overall Study|Entry Criteria Not Met|1|||
160837602|NCT04530552|580792140|FG000|Overall Study|Withdrawal by Subject|0|||
160837603|NCT04530552|580792141|FG001|Overall Study|Withdrawal by Subject|1|||
160837604|NCT04530552|580792140|FG000|Overall Study|Adverse Event|0|||
160837605|NCT04530552|580792141|FG001|Overall Study|Adverse Event|1|||
160837606|NCT04530552|580792140|FG000|Overall Study|No surgery|0|||
160837607|NCT04530552|580792141|FG001|Overall Study|No surgery|1|||
160837608|NCT03703856|580792144|FG000|Enrolled in study|Withdrawal by Subject|23|||
160837609|NCT03703856|580792144|FG000|Titrated to full dose|Withdrawal by Subject|5|||
161138272|NCT02793544|581887101|FG001|Overall Study|Withdrawal by Subject|0|||
160837610|NCT03703856|580792144|FG000|16 week assessment|Withdrawal by Subject|1|||
161249681|NCT00494013|582293139|FG001|Overall Study|Entry Criteria Not Met|4|||
160837611|NCT03703856|580792144|FG000|24 week assessment|Withdrawal by Subject|1|||
160837612|NCT01596335|580792145|FG000|Overall Study|exacerbation of primary disease|5|||
160837613|NCT01596335|580792146|FG001|Overall Study|exacerbation of primary disease|9|||
160991675|NCT01729871|581357880|FG001|Overall Study|Withdrawal by Subject|3|||
160991676|NCT01729871|581357879|FG000|Overall Study|Other|4|||
161138273|NCT04091217|581887104|FG000|Overall Study|Lost to Follow-up|2|||
160837614|NCT05138419|580792147|FG000|Overall Study|Study terminated before participant completed.|0|||
160837615|NCT05138419|580792148|FG001|Overall Study|Study terminated before participant completed.|0|||
160991677|NCT01729871|581357880|FG001|Overall Study|Other|9|||
160837616|NCT05138419|580792149|FG002|Overall Study|Study terminated before participant completed.|1|||
160837617|NCT01532570|580792153|FG000|Overall Study|Lack of Efficacy|1|||
160837618|NCT01532570|580792154|FG001|Overall Study|Lack of Efficacy|0|||
160837619|NCT01532570|580792155|FG002|Overall Study|Lack of Efficacy|0|||
160837620|NCT01532570|580792156|FG003|Overall Study|Lack of Efficacy|0|||
160837621|NCT01532570|580792153|FG000|Overall Study|Withdrawal by Subject|0|||
160837622|NCT01532570|580792154|FG001|Overall Study|Withdrawal by Subject|1|||
160837623|NCT01532570|580792155|FG002|Overall Study|Withdrawal by Subject|0|||
160837624|NCT01532570|580792156|FG003|Overall Study|Withdrawal by Subject|0|||
160837625|NCT01585155|580792157|FG000|Overall Study|Adverse Event|1|||
160837626|NCT01585155|580792157|FG000|Overall Study|Lack of Efficacy|2|||
160837627|NCT01585155|580792157|FG000|Overall Study|Worsening ulcerative colitis|2|||
160837628|NCT01192412|580792159|FG000|Overall Study|Lost to Follow-up|2|||
160837629|NCT01192412|580792160|FG001|Overall Study|Lost to Follow-up|1|||
160837630|NCT01192412|580792159|FG000|Overall Study|Withdrawal by Subject|2|||
160837631|NCT01192412|580792160|FG001|Overall Study|Withdrawal by Subject|1|||
160837632|NCT02421588|580792161|FG000|Overall Study|Non-treatment-related AE|8|||
160837633|NCT02421588|580792162|FG001|Overall Study|Non-treatment-related AE|8|||
160837634|NCT02421588|580792161|FG000|Overall Study|Progressive disease|152|||
160837635|NCT02421588|580792162|FG001|Overall Study|Progressive disease|135|||
160837636|NCT02421588|580792161|FG000|Overall Study|Death|11|||
160837637|NCT02421588|580792162|FG001|Overall Study|Death|3|||
160837638|NCT02421588|580792161|FG000|Overall Study|Physician Decision|8|||
160837639|NCT02421588|580792162|FG001|Overall Study|Physician Decision|17|||
160837640|NCT02421588|580792161|FG000|Overall Study|Other reason not specified|3|||
160837641|NCT02421588|580792162|FG001|Overall Study|Other reason not specified|1|||
160837642|NCT02421588|580792161|FG000|Overall Study|Symptomatic deterioration|13|||
160837643|NCT02421588|580792162|FG001|Overall Study|Symptomatic deterioration|19|||
160837644|NCT02421588|580792161|FG000|Overall Study|Treatment-related AE|10|||
160904264|NCT01513343|581044911|FG000|6-month Follow-up|Lost to Follow-up|28|||
160904265|NCT01513343|581044912|FG001|6-month Follow-up|Lost to Follow-up|17|||
160904266|NCT01513343|581044911|FG000|12-month Follow-up|Lost to Follow-up|10|||
160904267|NCT01513343|581044912|FG001|12-month Follow-up|Lost to Follow-up|3|||
160904268|NCT00599924|581044913|FG000|Overall Study|Lack of Efficacy|3|||
160904269|NCT00599924|581044914|FG001|Overall Study|Lack of Efficacy|5|||
160904270|NCT00599924|581044915|FG002|Overall Study|Lack of Efficacy|1|||
160904271|NCT00599924|581044916|FG003|Overall Study|Lack of Efficacy|2|||
160904272|NCT00599924|581044917|FG004|Overall Study|Lack of Efficacy|3|||
160904273|NCT00599924|581044918|FG005|Overall Study|Lack of Efficacy|2|||
160904274|NCT00599924|581044919|FG006|Overall Study|Lack of Efficacy|0|||
160904275|NCT00599924|581044913|FG000|Overall Study|Adverse Event|0|||
160904276|NCT00599924|581044914|FG001|Overall Study|Adverse Event|0|||
160904277|NCT00599924|581044915|FG002|Overall Study|Adverse Event|0|||
160904278|NCT00599924|581044916|FG003|Overall Study|Adverse Event|2|||
160904279|NCT00599924|581044917|FG004|Overall Study|Adverse Event|0|||
160904280|NCT00599924|581044918|FG005|Overall Study|Adverse Event|0|||
160904281|NCT00599924|581044919|FG006|Overall Study|Adverse Event|2|||
160904282|NCT00599924|581044913|FG000|Overall Study|Death|0|||
160904283|NCT00599924|581044914|FG001|Overall Study|Death|0|||
160904284|NCT00599924|581044915|FG002|Overall Study|Death|0|||
160904285|NCT00599924|581044916|FG003|Overall Study|Death|2|||
160904286|NCT00599924|581044917|FG004|Overall Study|Death|0|||
160904287|NCT00599924|581044918|FG005|Overall Study|Death|2|||
160837645|NCT02421588|580792162|FG001|Overall Study|Treatment-related AE|14|||
160837646|NCT02421588|580792161|FG000|Overall Study|Withdrawal by Subject|14|||
160837647|NCT02421588|580792162|FG001|Overall Study|Withdrawal by Subject|16|||
160837648|NCT02421588|580792161|FG000|Overall Study|Not treated|2|||
160837649|NCT02421588|580792162|FG001|Overall Study|Not treated|8|||
160837650|NCT01359943|580792163|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
160837651|NCT01359943|580792164|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
160904288|NCT00599924|581044919|FG006|Overall Study|Death|1|||
160904289|NCT00599924|581044913|FG000|Overall Study|Protocol Violation|0|||
160904290|NCT00599924|581044914|FG001|Overall Study|Protocol Violation|0|||
160904291|NCT00599924|581044915|FG002|Overall Study|Protocol Violation|0|||
160904292|NCT00599924|581044916|FG003|Overall Study|Protocol Violation|1|||
160904293|NCT00599924|581044917|FG004|Overall Study|Protocol Violation|0|||
160904294|NCT00599924|581044918|FG005|Overall Study|Protocol Violation|0|||
160904295|NCT00599924|581044919|FG006|Overall Study|Protocol Violation|0|||
160904296|NCT00599924|581044913|FG000|Overall Study|Withdrawal by Subject|0|||
160837652|NCT01359943|580792165|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
160837653|NCT01359943|580792163|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
160837654|NCT01359943|580792164|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
160837655|NCT01359943|580792165|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
160837656|NCT01359943|580792163|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
160837657|NCT01359943|580792164|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
160837658|NCT01359943|580792165|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
160904297|NCT00599924|581044914|FG001|Overall Study|Withdrawal by Subject|0|||
160904298|NCT00599924|581044915|FG002|Overall Study|Withdrawal by Subject|1|||
161249682|NCT00494013|582293138|FG000|Overall Study|Lost to Follow-up|5|||
161249683|NCT00494013|582293139|FG001|Overall Study|Lost to Follow-up|6|||
161249684|NCT00494013|582293138|FG000|Overall Study|Physician Decision|3|||
161249685|NCT00494013|582293139|FG001|Overall Study|Physician Decision|5|||
161249686|NCT00494013|582293138|FG000|Overall Study|Protocol Violation|8|||
161249687|NCT00494013|582293139|FG001|Overall Study|Protocol Violation|5|||
161249688|NCT00494013|582293138|FG000|Overall Study|Withdrawal by Subject|13|||
161249689|NCT00494013|582293139|FG001|Overall Study|Withdrawal by Subject|14|||
161249690|NCT00494013|582293138|FG000|Overall Study|Sponsor Decision|0|||
161249691|NCT00494013|582293139|FG001|Overall Study|Sponsor Decision|1|||
161249692|NCT00834613|582293141|FG000|First Intervention|Protocol Violation|1|||
161249693|NCT00834613|582293142|FG001|First Intervention|Protocol Violation|0|||
161249694|NCT04584983|582293143|FG000|Overall Study|Parental request for withdraw|2|||
161249695|NCT04584983|582293144|FG001|Overall Study|Parental request for withdraw|0|||
161249696|NCT02293460|582294589|FG000|Overall Study|Protocol Violation|1|||
161249697|NCT02293460|582294589|FG000|Overall Study|Lack of Efficacy|2|||
161249698|NCT02293460|582294589|FG000|Overall Study|Adverse Event|2|||
161249699|NCT02293460|582294589|FG000|Overall Study|Withdrawal by Subject|1|||
161249700|NCT01636934|582294591|FG000|Overall Study|Withdrawal by Subject|3|||
161249701|NCT01636934|582294592|FG001|Overall Study|Withdrawal by Subject|2|||
161249702|NCT01636934|582294591|FG000|Overall Study|Chemo cancel|1|||
161249703|NCT01636934|582294592|FG001|Overall Study|Chemo cancel|0|||
161249704|NCT01636934|582294591|FG000|Overall Study|Too ill to continue|1|||
161249705|NCT01636934|582294592|FG001|Overall Study|Too ill to continue|0|||
161249706|NCT01636934|582294591|FG000|Overall Study|Never started study medication|1|||
161249707|NCT01636934|582294592|FG001|Overall Study|Never started study medication|1|||
161249708|NCT03035890|582294600|FG000|Overall Study|Death|1|||
161249709|NCT02459418|582294606|FG000|Overall Study|Exclusion Criteria|4|||
161249710|NCT02459418|582294607|FG001|Overall Study|Exclusion Criteria|0|||
161249711|NCT02459418|582294606|FG000|Overall Study|Protocol Violation|0|||
161249712|NCT02459418|582294607|FG001|Overall Study|Protocol Violation|2|||
161249713|NCT02459418|582294606|FG000|Overall Study|Physician Decision|0|||
161249714|NCT02459418|582294607|FG001|Overall Study|Physician Decision|2|||
161249715|NCT02459418|582294606|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
161249716|NCT02459418|582294607|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
161249717|NCT02459418|582294606|FG000|Overall Study|Adverse Event|0|||
161249718|NCT02459418|582294607|FG001|Overall Study|Adverse Event|1|||
161249719|NCT02459418|582294606|FG000|Overall Study|Withdrawal by Subject|1|||
161249720|NCT02459418|582294607|FG001|Overall Study|Withdrawal by Subject|1|||
161249721|NCT02459418|582294606|FG000|Overall Study|Elevated Creatine Kinase|1|||
161249722|NCT02459418|582294607|FG001|Overall Study|Elevated Creatine Kinase|0|||
161249723|NCT02459418|582294606|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
161249724|NCT02459418|582294607|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
161249725|NCT00413049|582294608|FG000|Overall Study|Adverse Event|10|||
161249726|NCT00413049|582294609|FG001|Overall Study|Adverse Event|8|||
161249727|NCT00413049|582294608|FG000|Overall Study|Withdrawal by Subject|7|||
161249728|NCT00413049|582294609|FG001|Overall Study|Withdrawal by Subject|5|||
161249729|NCT00413049|582294608|FG000|Overall Study|Lost to Follow-up|2|||
161249730|NCT00413049|582294609|FG001|Overall Study|Lost to Follow-up|3|||
160837659|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
160837660|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
160837661|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
160837662|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
160837663|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
160837664|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
160837665|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
160837666|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
161249731|NCT00413049|582294608|FG000|Overall Study|Protocol Violation|3|||
161249732|NCT00413049|582294609|FG001|Overall Study|Protocol Violation|1|||
161249733|NCT00413049|582294608|FG000|Overall Study|Subject no longer requires study drug|0|||
160837667|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
160837668|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
160837669|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
161249734|NCT00413049|582294609|FG001|Overall Study|Subject no longer requires study drug|1|||
160837670|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
160837671|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
160837672|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
160991678|NCT03971357|581357881|FG000|Overall Study|Lack of Efficacy|0|||
161249735|NCT00413049|582294608|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161249736|NCT00413049|582294609|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161249737|NCT00413049|582294608|FG000|Overall Study|Lack of Efficacy|1|||
161249738|NCT00413049|582294609|FG001|Overall Study|Lack of Efficacy|0|||
161249739|NCT03653026|582294616|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
161249740|NCT03653026|582294617|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
160837673|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
160837674|NCT01359943|580792163|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
160837675|NCT01359943|580792164|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
160837676|NCT01359943|580792165|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
160837677|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
160837678|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
160837679|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
160837680|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
160837681|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
160837682|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
160837683|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
160837684|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
160837685|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
160837686|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
160837687|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
160837688|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
160837689|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
160837690|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
160837691|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
160837692|NCT01359943|580792163|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
160991679|NCT03971357|581357882|FG001|Overall Study|Lack of Efficacy|1|||
161138274|NCT01822561|581887105|FG000|Overall Study|Withdrawal by Subject|2|||
160837693|NCT01359943|580792164|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
160837694|NCT01359943|580792165|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
160837695|NCT01529034|580792166|FG000|Overall Study|Discontinued prior to study treatment|14|||
160837696|NCT01529034|580792166|FG000|Overall Study|Site closure|62|||
160837697|NCT01529034|580792166|FG000|Overall Study|Study termination|29|||
160837698|NCT01529034|580792166|FG000|Overall Study|Withdrawal by Subject|25|||
160837699|NCT01529034|580792166|FG000|Overall Study|No treated SCs within protocol window|13|||
160837700|NCT01529034|580792166|FG000|Overall Study|Noncompliance|8|||
160837701|NCT01529034|580792166|FG000|Overall Study|Caregiver no longer available|7|||
160837702|NCT01529034|580792166|FG000|Overall Study|Adverse Event|4|||
160837703|NCT01529034|580792166|FG000|Overall Study|Protocol Violation|4|||
160837704|NCT01529034|580792166|FG000|Overall Study|Lack of Efficacy|4|||
160837705|NCT01529034|580792166|FG000|Overall Study|Investigator no longer available|2|||
160837706|NCT01529034|580792166|FG000|Overall Study|Study drug not available|2|||
160837707|NCT04588389|580792167|FG000|Overall Study|Issues with anesthesia during surgery|2|||
160837708|NCT04588389|580792168|FG001|Overall Study|Issues with anesthesia during surgery|0|||
160837709|NCT04588389|580792169|FG002|Overall Study|Issues with anesthesia during surgery|0|||
160837710|NCT02911142|580792170|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
160837711|NCT02911142|580792170|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
160837712|NCT02911142|580792170|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
160837713|NCT02911142|580792170|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
160837714|NCT02678923|580792171|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
160837715|NCT02678923|580792172|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
160837716|NCT02678923|580792171|FG000|Overall Study|Withdrawal by Subject|3|||
160837717|NCT02678923|580792172|FG001|Overall Study|Withdrawal by Subject|2|||
160837718|NCT02678923|580792171|FG000|Overall Study|Lost to Follow-up|1|||
160837719|NCT02678923|580792172|FG001|Overall Study|Lost to Follow-up|0|||
160837720|NCT02678923|580792171|FG000|Overall Study|Did Not Return for Study Visits|1|||
160837721|NCT02678923|580792172|FG001|Overall Study|Did Not Return for Study Visits|0|||
160837722|NCT03266172|580792173|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
160837723|NCT03266172|580792174|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
160837724|NCT03266172|580792175|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
160837725|NCT03266172|580792173|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
160837726|NCT03266172|580792174|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
160837727|NCT03266172|580792175|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
160837728|NCT03266172|580792173|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
160837729|NCT03266172|580792174|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
160837730|NCT03266172|580792175|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
161138275|NCT02747004|581887106|FG000|Overall Study|Withdrawal by Subject|8|||
161138276|NCT02747004|581887107|FG001|Overall Study|Withdrawal by Subject|5|||
161138277|NCT02747004|581887108|FG002|Overall Study|Withdrawal by Subject|4|||
161138278|NCT02747004|581887106|FG000|Overall Study|Lost to Follow-up|1|||
161138279|NCT02747004|581887107|FG001|Overall Study|Lost to Follow-up|2|||
161138280|NCT02747004|581887108|FG002|Overall Study|Lost to Follow-up|2|||
161138281|NCT02747004|581887106|FG000|Overall Study|on study treatment/follow-up|48|||
161138282|NCT02747004|581887107|FG001|Overall Study|on study treatment/follow-up|42|||
161138283|NCT02747004|581887108|FG002|Overall Study|on study treatment/follow-up|41|||
161138284|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
160837731|NCT03266172|580792173|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
160837732|NCT03266172|580792174|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
160837733|NCT03266172|580792175|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
160837734|NCT03266172|580792173|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837735|NCT03266172|580792174|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837736|NCT03266172|580792175|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
160991680|NCT01143077|581357886|FG000|Overall Study|Lack of Efficacy|0|||
160991681|NCT01143077|581357887|FG001|Overall Study|Lack of Efficacy|2|||
160991682|NCT01143077|581357888|FG002|Overall Study|Lack of Efficacy|1|||
160991683|NCT01143077|581357886|FG000|Overall Study|Adverse Event|5|||
160991684|NCT01143077|581357887|FG001|Overall Study|Adverse Event|6|||
160991685|NCT01143077|581357888|FG002|Overall Study|Adverse Event|5|||
160991686|NCT01143077|581357886|FG000|Overall Study|Lost to Follow-up|2|||
160991687|NCT01143077|581357887|FG001|Overall Study|Lost to Follow-up|3|||
160991688|NCT01143077|581357888|FG002|Overall Study|Lost to Follow-up|4|||
160991689|NCT01143077|581357886|FG000|Overall Study|Protocol Violation|2|||
160991690|NCT01143077|581357887|FG001|Overall Study|Protocol Violation|0|||
160991691|NCT01143077|581357888|FG002|Overall Study|Protocol Violation|0|||
160991692|NCT01143077|581357886|FG000|Overall Study|Withdrawal by Subject|4|||
160991693|NCT01143077|581357887|FG001|Overall Study|Withdrawal by Subject|3|||
160991694|NCT01143077|581357888|FG002|Overall Study|Withdrawal by Subject|3|||
160991695|NCT01143077|581357886|FG000|Overall Study|Non-compliance with study drug|0|||
160991696|NCT01143077|581357887|FG001|Overall Study|Non-compliance with study drug|1|||
160991697|NCT01143077|581357888|FG002|Overall Study|Non-compliance with study drug|1|||
160991698|NCT01143077|581357886|FG000|Overall Study|Administrative|1|||
160991699|NCT01143077|581357887|FG001|Overall Study|Administrative|0|||
160991700|NCT01143077|581357888|FG002|Overall Study|Administrative|0|||
160991701|NCT01143077|581357886|FG000|Overall Study|Principal Investigator Decision|2|||
160991702|NCT01143077|581357887|FG001|Overall Study|Principal Investigator Decision|0|||
160991703|NCT01143077|581357888|FG002|Overall Study|Principal Investigator Decision|1|||
160991704|NCT00630864|581357892|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
160991705|NCT00630864|581357892|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
160991706|NCT00430677|581357893|FG000|Short-term Period|Death|1|||
160991707|NCT00430677|581357894|FG001|Short-term Period|Death|1|||
160991708|NCT00430677|581357895|FG002|Short-term Period|Death|5|||
160991709|NCT00430677|581357893|FG000|Short-term Period|Adverse Event|15|||
160991710|NCT00430677|581357894|FG001|Short-term Period|Adverse Event|13|||
160991711|NCT00430677|581357895|FG002|Short-term Period|Adverse Event|9|||
160991712|NCT00430677|581357893|FG000|Short-term Period|Lack of Efficacy|5|||
160991713|NCT00430677|581357894|FG001|Short-term Period|Lack of Efficacy|6|||
160991714|NCT00430677|581357895|FG002|Short-term Period|Lack of Efficacy|4|||
160991715|NCT00430677|581357893|FG000|Short-term Period|Withdrawal by Subject|1|||
160837737|NCT03266172|580792173|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837738|NCT03266172|580792174|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
160837739|NCT03266172|580792175|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
160991716|NCT00430677|581357894|FG001|Short-term Period|Withdrawal by Subject|1|||
160991717|NCT00430677|581357895|FG002|Short-term Period|Withdrawal by Subject|2|||
160991718|NCT00430677|581357893|FG000|Short-term Period|Participant no longer met study criteria|1|||
160991719|NCT00430677|581357894|FG001|Short-term Period|Participant no longer met study criteria|1|||
160991720|NCT00430677|581357895|FG002|Short-term Period|Participant no longer met study criteria|2|||
160991721|NCT00430677|581357893|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
160991722|NCT00430677|581357894|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
160991723|NCT00430677|581357895|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
160991724|NCT00430677|581357893|FG000|Short-term Period|Pregnancy|0|||
160991725|NCT00430677|581357894|FG001|Short-term Period|Pregnancy|2|||
160991726|NCT00430677|581357895|FG002|Short-term Period|Pregnancy|0|||
160991727|NCT00430677|581357893|FG000|Long-term Extension Period|Death|1|||
160991728|NCT00430677|581357894|FG001|Long-term Extension Period|Death|0|||
161249741|NCT03653026|582294618|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
161249742|NCT03653026|582294619|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
161249743|NCT03653026|582294616|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
161249744|NCT03653026|582294617|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
160837740|NCT01554514|580792176|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
160837741|NCT01554514|580792176|FG000|Overall Study|Physician Decision|1|||
160991729|NCT00430677|581357895|FG002|Long-term Extension Period|Death|0|||
160991730|NCT00430677|581357893|FG000|Long-term Extension Period|Adverse Event|3|||
160991731|NCT00430677|581357894|FG001|Long-term Extension Period|Adverse Event|2|||
160991732|NCT00430677|581357895|FG002|Long-term Extension Period|Adverse Event|5|||
160991733|NCT00430677|581357893|FG000|Long-term Extension Period|Lack of Efficacy|5|||
160991734|NCT00430677|581357894|FG001|Long-term Extension Period|Lack of Efficacy|3|||
160991735|NCT00430677|581357895|FG002|Long-term Extension Period|Lack of Efficacy|8|||
160991736|NCT00430677|581357893|FG000|Long-term Extension Period|Lost to Follow-up|1|||
160991737|NCT00430677|581357894|FG001|Long-term Extension Period|Lost to Follow-up|1|||
161249745|NCT03653026|582294618|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161138285|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
161138286|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161138287|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161138288|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
161138289|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
161138290|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
161138291|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161138292|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161138293|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
161138294|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
161138295|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161138296|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161138297|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161138298|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
161138299|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
161138300|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161138301|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161138302|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161138303|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
161138304|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Death|0|||
161138305|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Death|1|||
161138306|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Death|0|||
161138307|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Death|0|||
161138308|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Death|0|||
161138309|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161138310|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
161138311|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161138312|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161138313|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
161138314|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
161138315|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161138316|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161138317|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161138318|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
161138319|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
161138320|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161138321|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161138322|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161138323|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
161138324|NCT05087030|581887109|FG000|Main Period (Week 0 to Week 52)|Other|1|||
161138325|NCT05087030|581887110|FG001|Main Period (Week 0 to Week 52)|Other|2|||
161138326|NCT05087030|581887111|FG002|Main Period (Week 0 to Week 52)|Other|0|||
161138327|NCT05087030|581887112|FG003|Main Period (Week 0 to Week 52)|Other|0|||
161138328|NCT05087030|581887113|FG004|Main Period (Week 0 to Week 52)|Other|0|||
161138329|NCT05087030|581887109|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161138330|NCT05087030|581887110|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161138331|NCT05087030|581887111|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161138332|NCT05087030|581887112|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
161138333|NCT05087030|581887113|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
161138334|NCT01444300|581887114|FG000|Overall Study|Adverse Event|4|||
161138335|NCT01444300|581887115|FG001|Overall Study|Adverse Event|0|||
161138336|NCT02722044|581887116|FG000|Overall Study|Adverse Event|2|||
161138337|NCT02722044|581887116|FG000|Overall Study|Physician Decision|1|||
161138338|NCT02722044|581887116|FG000|Overall Study|Withdrawal by Subject|1|||
161138339|NCT02722044|581887116|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
161138340|NCT04885257|581887117|FG000|Overall Study|Withdrawal by Subject|1|||
161138341|NCT04885257|581887118|FG001|Overall Study|Withdrawal by Subject|0|||
160837742|NCT01966445|580792179|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837743|NCT01966445|580792180|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837744|NCT01966445|580792181|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837745|NCT01966445|580792182|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
161138342|NCT00609622|581887119|FG000|Overall Study|Adverse Event|14|||
161138343|NCT00609622|581887120|FG001|Overall Study|Adverse Event|10|||
161138344|NCT00609622|581887119|FG000|Overall Study|Withdrawal by Subject|4|||
161138345|NCT00609622|581887120|FG001|Overall Study|Withdrawal by Subject|20|||
160837746|NCT01966445|580792183|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
161138346|NCT00609622|581887119|FG000|Overall Study|Death|1|||
161138347|NCT00609622|581887120|FG001|Overall Study|Death|4|||
161249746|NCT03653026|582294619|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
161249747|NCT03653026|582294616|FG000|Part 1: Placebo-controlled Period|Other|0|||
161249748|NCT03653026|582294617|FG001|Part 1: Placebo-controlled Period|Other|3|||
161249749|NCT03653026|582294618|FG002|Part 1: Placebo-controlled Period|Other|0|||
161249750|NCT03653026|582294619|FG003|Part 1: Placebo-controlled Period|Other|0|||
161249751|NCT03653026|582294616|FG000|Part 2: Open-label Extension|Adverse Event|0|||
161249752|NCT03653026|582294617|FG001|Part 2: Open-label Extension|Adverse Event|0|||
161249753|NCT03653026|582294618|FG002|Part 2: Open-label Extension|Adverse Event|1|||
161249754|NCT03653026|582294619|FG003|Part 2: Open-label Extension|Adverse Event|1|||
161249755|NCT03653026|582294616|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161249756|NCT03653026|582294617|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
161249757|NCT03653026|582294618|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
161249758|NCT03653026|582294619|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
161249759|NCT03653026|582294616|FG000|Part 2: Open-label Extension|Other|0|||
161249760|NCT03653026|582294617|FG001|Part 2: Open-label Extension|Other|0|||
161249761|NCT03653026|582294618|FG002|Part 2: Open-label Extension|Other|1|||
161249762|NCT03653026|582294619|FG003|Part 2: Open-label Extension|Other|2|||
161249763|NCT02104817|582294620|FG000|Overall Study|Death|363|||
161249764|NCT02104817|582294621|FG001|Overall Study|Death|330|||
161249765|NCT02104817|582294620|FG000|Overall Study|Lost to Follow-up|3|||
161249766|NCT02104817|582294621|FG001|Overall Study|Lost to Follow-up|2|||
161249767|NCT02104817|582294620|FG000|Overall Study|Protocol Violation|0|||
161249768|NCT02104817|582294621|FG001|Overall Study|Protocol Violation|1|||
161249769|NCT02104817|582294620|FG000|Overall Study|Study terminated by sponsor|5854|||
161249770|NCT02104817|582294621|FG001|Overall Study|Study terminated by sponsor|5901|||
161249771|NCT02104817|582294620|FG000|Overall Study|Withdrawal by Subject|111|||
161249772|NCT02104817|582294621|FG001|Overall Study|Withdrawal by Subject|78|||
161249773|NCT02104817|582294620|FG000|Overall Study|Other reasons|128|||
161249774|NCT02104817|582294621|FG001|Overall Study|Other reasons|135|||
161249775|NCT00852917|582294624|FG000|Overall Study|Adverse Event|13|||
161249776|NCT00852917|582294625|FG001|Overall Study|Adverse Event|20|||
161249777|NCT00852917|582294626|FG002|Overall Study|Adverse Event|35|||
161249778|NCT00852917|582294627|FG003|Overall Study|Adverse Event|17|||
161249779|NCT00852917|582294624|FG000|Overall Study|Lack of Efficacy|21|||
161249780|NCT00852917|582294625|FG001|Overall Study|Lack of Efficacy|11|||
161249781|NCT00852917|582294626|FG002|Overall Study|Lack of Efficacy|11|||
161249782|NCT00852917|582294627|FG003|Overall Study|Lack of Efficacy|47|||
161249783|NCT00852917|582294624|FG000|Overall Study|Withdrawal by Subject|4|||
161249784|NCT00852917|582294625|FG001|Overall Study|Withdrawal by Subject|8|||
161249785|NCT00852917|582294626|FG002|Overall Study|Withdrawal by Subject|10|||
161249786|NCT00852917|582294627|FG003|Overall Study|Withdrawal by Subject|9|||
161249787|NCT00852917|582294624|FG000|Overall Study|Physician Decision|6|||
161249788|NCT00852917|582294625|FG001|Overall Study|Physician Decision|7|||
160837747|NCT01966445|580792184|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
161249789|NCT00852917|582294626|FG002|Overall Study|Physician Decision|2|||
161249790|NCT00852917|582294627|FG003|Overall Study|Physician Decision|19|||
161249791|NCT00852917|582294624|FG000|Overall Study|Death|0|||
161249792|NCT00852917|582294625|FG001|Overall Study|Death|0|||
161249793|NCT00852917|582294626|FG002|Overall Study|Death|0|||
160837748|NCT01966445|580792185|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
160837749|NCT01966445|580792179|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837750|NCT01966445|580792180|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
160837751|NCT01966445|580792181|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837752|NCT01966445|580792182|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
160837753|NCT01966445|580792183|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
160837754|NCT01966445|580792184|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837755|NCT01966445|580792185|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
160837756|NCT01966445|580792179|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837757|NCT01966445|580792180|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
160837758|NCT01966445|580792181|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
160837759|NCT01966445|580792182|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837760|NCT01966445|580792183|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
160837761|NCT01966445|580792184|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837762|NCT01966445|580792185|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
160837763|NCT01966445|580792179|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837764|NCT01966445|580792180|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837765|NCT01966445|580792181|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837766|NCT01966445|580792182|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
161249794|NCT00852917|582294627|FG003|Overall Study|Death|1|||
161249795|NCT01358877|582294628|FG000|Overall Study|Withdrawal by Subject|475|||
161249796|NCT01358877|582294629|FG001|Overall Study|Withdrawal by Subject|466|||
161249797|NCT01358877|582294628|FG000|Overall Study|Recurrence of disease|181|||
161249798|NCT01358877|582294629|FG001|Overall Study|Recurrence of disease|269|||
160837767|NCT01966445|580792183|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837768|NCT01966445|580792184|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
160837769|NCT01966445|580792185|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
160837770|NCT01966445|580792179|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837771|NCT01966445|580792180|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837772|NCT01966445|580792181|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837773|NCT01966445|580792182|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837774|NCT01966445|580792183|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837775|NCT01966445|580792184|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
160837776|NCT01966445|580792185|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
160837777|NCT01374178|580792186|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
160837778|NCT01374178|580792187|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
160837779|NCT01374178|580792186|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
160837780|NCT01374178|580792187|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
160837781|NCT01422824|580792188|FG000|Overall Study|Case record form not evaluated|1|||
160837782|NCT01422824|580792188|FG000|Overall Study|Lost to Follow-up|37|||
160837783|NCT01716104|580792189|FG000|Overall Study|Do not meet inclusion criteria|6|||
160837784|NCT01716104|580792190|FG001|Overall Study|Do not meet inclusion criteria|7|||
160904299|NCT00599924|581044916|FG003|Overall Study|Withdrawal by Subject|0|||
160904300|NCT00599924|581044917|FG004|Overall Study|Withdrawal by Subject|1|||
160904301|NCT00599924|581044918|FG005|Overall Study|Withdrawal by Subject|0|||
160904302|NCT00599924|581044919|FG006|Overall Study|Withdrawal by Subject|0|||
160904303|NCT00599924|581044913|FG000|Overall Study|Other|0|||
160904304|NCT00599924|581044914|FG001|Overall Study|Other|0|||
160904305|NCT00599924|581044915|FG002|Overall Study|Other|0|||
160904306|NCT00599924|581044916|FG003|Overall Study|Other|1|||
160904307|NCT00599924|581044917|FG004|Overall Study|Other|2|||
160904308|NCT00599924|581044918|FG005|Overall Study|Other|0|||
160904309|NCT00599924|581044919|FG006|Overall Study|Other|2|||
160904310|NCT02587234|581044920|FG000|Overall Study|Withdrawal by Subject|1|||
160904311|NCT02587234|581044921|FG001|Overall Study|Withdrawal by Subject|1|||
160904312|NCT02587234|581044920|FG000|Overall Study|Lost to Follow-up|0|||
160904313|NCT02587234|581044921|FG001|Overall Study|Lost to Follow-up|2|||
160904314|NCT02165215|581044922|FG000|Induction Phase|Adverse Event|1|||
160904315|NCT02165215|581044923|FG001|Induction Phase|Adverse Event|0|||
160904316|NCT02165215|581044924|FG002|Induction Phase|Adverse Event|0|||
160904317|NCT02165215|581044922|FG000|Induction Phase|Withdrawal by Subject|10|||
160904318|NCT02165215|581044923|FG001|Induction Phase|Withdrawal by Subject|0|||
160904319|NCT02165215|581044924|FG002|Induction Phase|Withdrawal by Subject|0|||
160904320|NCT02165215|581044922|FG000|Induction Phase|Protocol Violation|1|||
160904321|NCT02165215|581044923|FG001|Induction Phase|Protocol Violation|0|||
160904322|NCT02165215|581044924|FG002|Induction Phase|Protocol Violation|0|||
160904323|NCT02165215|581044922|FG000|Induction Phase|Physician Decision|1|||
160904324|NCT02165215|581044923|FG001|Induction Phase|Physician Decision|0|||
160904325|NCT02165215|581044924|FG002|Induction Phase|Physician Decision|0|||
160904326|NCT02165215|581044922|FG000|Induction Phase|Lack of Efficacy|2|||
160904327|NCT02165215|581044923|FG001|Induction Phase|Lack of Efficacy|0|||
160904328|NCT02165215|581044924|FG002|Induction Phase|Lack of Efficacy|0|||
160904329|NCT02165215|581044922|FG000|Induction Phase|Non-Compliance|2|||
160904330|NCT02165215|581044923|FG001|Induction Phase|Non-Compliance|0|||
160904331|NCT02165215|581044924|FG002|Induction Phase|Non-Compliance|0|||
160904332|NCT02165215|581044922|FG000|Induction Phase|Lost to Follow-up|6|||
160904333|NCT02165215|581044923|FG001|Induction Phase|Lost to Follow-up|0|||
160904334|NCT02165215|581044924|FG002|Induction Phase|Lost to Follow-up|0|||
160904335|NCT02165215|581044922|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161138348|NCT00609622|581887119|FG000|Overall Study|Protocol Violation|1|||
160837785|NCT00117793|580792191|FG000|Overall Study|Withdrawal by Subject|12|||
160837786|NCT00470418|580792196|FG000|Overall Study|Withdrawal by Subject|1|||
160837787|NCT00470418|580792197|FG001|Overall Study|Withdrawal by Subject|0|||
160837788|NCT01818492|580792198|FG000|Overall Study|Adverse Event|2|||
160837789|NCT01818492|580792198|FG000|Overall Study|Death|3|||
160837790|NCT01818492|580792198|FG000|Overall Study|Withdrawal by Subject|1|||
160837791|NCT01818492|580792198|FG000|Overall Study|Additional therapy when not allowed PP|4|||
160904336|NCT02165215|581044923|FG001|Maintenance Phase|Withdrawal by Subject|7|||
160904337|NCT02165215|581044924|FG002|Maintenance Phase|Withdrawal by Subject|3|||
160837792|NCT02409719|580792201|FG000|Overall Study|Lost to Follow-up|3|||
160837793|NCT02409719|580792202|FG001|Overall Study|Lost to Follow-up|3|||
160837794|NCT02438813|580792203|FG000|Overall Study|Patient Decision|59|||
160904338|NCT02165215|581044922|FG000|Maintenance Phase|Multiple reasons|0|||
160904339|NCT02165215|581044923|FG001|Maintenance Phase|Multiple reasons|2|||
160904340|NCT02165215|581044924|FG002|Maintenance Phase|Multiple reasons|1|||
160904341|NCT02165215|581044922|FG000|Maintenance Phase|Lost to Follow-up|0|||
160904342|NCT02165215|581044923|FG001|Maintenance Phase|Lost to Follow-up|2|||
161138349|NCT00609622|581887120|FG001|Overall Study|Protocol Violation|1|||
161138350|NCT00609622|581887119|FG000|Overall Study|Objective progression or relapse|47|||
160837795|NCT02438813|580792203|FG000|Overall Study|Patient Lost to Follow-Up|137|||
160837796|NCT02438813|580792203|FG000|Overall Study|Study Ended by Sponsor|80|||
160837797|NCT02438813|580792203|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
160837798|NCT01026220|580792204|FG000|Induction|Death|1|||
160837799|NCT01026220|580792205|FG001|Induction|Death|0|||
160837800|NCT01026220|580792206|FG002|Induction|Death|0|||
160837801|NCT01026220|580792204|FG000|Induction|Lack of Efficacy|2|||
160837802|NCT01026220|580792205|FG001|Induction|Lack of Efficacy|0|||
160837803|NCT01026220|580792206|FG002|Induction|Lack of Efficacy|0|||
160837804|NCT01026220|580792204|FG000|Induction|Physician Decision|12|||
160837805|NCT01026220|580792205|FG001|Induction|Physician Decision|0|||
160837806|NCT01026220|580792206|FG002|Induction|Physician Decision|0|||
160837807|NCT01026220|580792204|FG000|Induction|Withdrawal by Subject|9|||
160837808|NCT01026220|580792205|FG001|Induction|Withdrawal by Subject|0|||
160837809|NCT01026220|580792206|FG002|Induction|Withdrawal by Subject|0|||
160837810|NCT01026220|580792204|FG000|Induction|Ineligible|1|||
160837811|NCT01026220|580792205|FG001|Induction|Ineligible|0|||
160837812|NCT01026220|580792206|FG002|Induction|Ineligible|0|||
160837813|NCT01026220|580792204|FG000|Consolidation Maintenance|Death|0|||
160837814|NCT01026220|580792205|FG001|Consolidation Maintenance|Death|1|||
160837815|NCT01026220|580792206|FG002|Consolidation Maintenance|Death|0|||
160837816|NCT01026220|580792204|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
160837817|NCT01026220|580792205|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
160837818|NCT01026220|580792206|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
160837819|NCT01026220|580792204|FG000|Consolidation Maintenance|Physician Decision|0|||
160837820|NCT01026220|580792205|FG001|Consolidation Maintenance|Physician Decision|2|||
160837821|NCT01026220|580792206|FG002|Consolidation Maintenance|Physician Decision|7|||
160837822|NCT01026220|580792204|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
160837823|NCT01026220|580792205|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
160837824|NCT01026220|580792206|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
160837825|NCT00409344|580792208|FG000|Overall Study|no enrollment|0|||
160837826|NCT00409344|580792209|FG001|Overall Study|no enrollment|0|||
160837827|NCT02879578|580792212|FG000|Overall Study|Adverse Event|1|||
160837828|NCT02879578|580792213|FG001|Overall Study|Adverse Event|2|||
160837829|NCT02879578|580792214|FG002|Overall Study|Adverse Event|14|||
160837830|NCT02879578|580792212|FG000|Overall Study|Protocol Violation|0|||
160837831|NCT02879578|580792213|FG001|Overall Study|Protocol Violation|1|||
160837832|NCT02879578|580792214|FG002|Overall Study|Protocol Violation|1|||
160837833|NCT02879578|580792212|FG000|Overall Study|Withdrawal by Subject|8|||
160837834|NCT02879578|580792213|FG001|Overall Study|Withdrawal by Subject|6|||
160837835|NCT02879578|580792214|FG002|Overall Study|Withdrawal by Subject|9|||
160837836|NCT02879578|580792212|FG000|Overall Study|Lost to Follow-up|1|||
160837837|NCT02879578|580792213|FG001|Overall Study|Lost to Follow-up|0|||
160837838|NCT02879578|580792214|FG002|Overall Study|Lost to Follow-up|4|||
160837839|NCT02879578|580792212|FG000|Overall Study|Physician Decision|0|||
160837840|NCT02879578|580792213|FG001|Overall Study|Physician Decision|0|||
160837841|NCT02879578|580792214|FG002|Overall Study|Physician Decision|4|||
160837842|NCT04390841|580792220|FG000|Overall Study|Withdrawal by Subject|2|||
160837843|NCT00411632|580792221|FG000|Overall Study|Death|1|||
160837844|NCT00691028|580793151|FG000|Open-label Period|Adverse Event|0|||
160837845|NCT00691028|580793152|FG001|Open-label Period|Adverse Event|0|||
160837846|NCT00691028|580793153|FG002|Open-label Period|Adverse Event|0|||
160837847|NCT00691028|580793154|FG003|Open-label Period|Adverse Event|16|||
160837848|NCT00691028|580793151|FG000|Open-label Period|Withdrawal by Subject|0|||
160837849|NCT00691028|580793152|FG001|Open-label Period|Withdrawal by Subject|0|||
160837850|NCT00691028|580793153|FG002|Open-label Period|Withdrawal by Subject|0|||
160837851|NCT00691028|580793154|FG003|Open-label Period|Withdrawal by Subject|3|||
160837852|NCT00691028|580793151|FG000|Open-label Period|not come to a hospital|0|||
160837853|NCT00691028|580793152|FG001|Open-label Period|not come to a hospital|0|||
160837854|NCT00691028|580793153|FG002|Open-label Period|not come to a hospital|0|||
160837855|NCT00691028|580793154|FG003|Open-label Period|not come to a hospital|1|||
160837856|NCT00691028|580793151|FG000|Double-blind Period|Adverse Event|8|||
160837857|NCT00691028|580793152|FG001|Double-blind Period|Adverse Event|9|||
160837858|NCT00691028|580793153|FG002|Double-blind Period|Adverse Event|6|||
160837859|NCT00691028|580793154|FG003|Double-blind Period|Adverse Event|0|||
160837860|NCT00691028|580793151|FG000|Double-blind Period|Lack of Efficacy|4|||
160837861|NCT00691028|580793152|FG001|Double-blind Period|Lack of Efficacy|3|||
160837862|NCT00691028|580793153|FG002|Double-blind Period|Lack of Efficacy|2|||
160837863|NCT00691028|580793154|FG003|Double-blind Period|Lack of Efficacy|0|||
160837864|NCT00691028|580793151|FG000|Double-blind Period|Withdrawal by Subject|1|||
160837865|NCT00691028|580793152|FG001|Double-blind Period|Withdrawal by Subject|0|||
160837866|NCT00691028|580793153|FG002|Double-blind Period|Withdrawal by Subject|1|||
160837867|NCT00691028|580793154|FG003|Double-blind Period|Withdrawal by Subject|0|||
160837868|NCT00691028|580793151|FG000|Double-blind Period|not come to a hospital.|0|||
160837869|NCT00691028|580793152|FG001|Double-blind Period|not come to a hospital.|1|||
160837870|NCT00691028|580793153|FG002|Double-blind Period|not come to a hospital.|0|||
160837871|NCT00691028|580793154|FG003|Double-blind Period|not come to a hospital.|0|||
160837872|NCT03402386|580793157|FG000|Overall Study|Adverse Event|3|||
161138351|NCT00609622|581887120|FG001|Overall Study|Objective progression or relapse|41|||
161138352|NCT00609622|581887119|FG000|Overall Study|Study terminated by sponsor|16|||
161138353|NCT00609622|581887120|FG001|Overall Study|Study terminated by sponsor|3|||
161138354|NCT00609622|581887119|FG000|Overall Study|Other|7|||
161138355|NCT00609622|581887120|FG001|Overall Study|Other|14|||
161138356|NCT00609622|581887119|FG000|Overall Study|Global deterioration of health status|6|||
161138357|NCT00609622|581887120|FG001|Overall Study|Global deterioration of health status|2|||
161138358|NCT01708057|581887123|FG000|Overall Study|Withdrawal due to study termination.|1|||
161138359|NCT01708057|581887124|FG001|Overall Study|Withdrawal due to study termination.|1|||
161138360|NCT01708057|581887125|FG002|Overall Study|Withdrawal due to study termination.|1|||
161138361|NCT01523873|581887133|FG000|Overall Study|Protocol Violation|422|||
161138362|NCT01024244|581888634|FG000|Overall Study|Adverse Event|1|||
161138363|NCT01024244|581888635|FG001|Overall Study|Adverse Event|2|||
161138364|NCT01024244|581888636|FG002|Overall Study|Adverse Event|0|||
161138365|NCT01024244|581888637|FG003|Overall Study|Adverse Event|1|||
161138366|NCT01024244|581888638|FG004|Overall Study|Adverse Event|2|||
161138367|NCT01024244|581888634|FG000|Overall Study|Entry Criteria Not Met|0|||
161138368|NCT01024244|581888635|FG001|Overall Study|Entry Criteria Not Met|1|||
161138369|NCT01024244|581888636|FG002|Overall Study|Entry Criteria Not Met|0|||
161138370|NCT01024244|581888637|FG003|Overall Study|Entry Criteria Not Met|0|||
161138371|NCT01024244|581888638|FG004|Overall Study|Entry Criteria Not Met|0|||
161138372|NCT01024244|581888634|FG000|Overall Study|Lack of Efficacy|1|||
161138373|NCT01024244|581888635|FG001|Overall Study|Lack of Efficacy|0|||
161138374|NCT01024244|581888636|FG002|Overall Study|Lack of Efficacy|0|||
161138375|NCT01024244|581888637|FG003|Overall Study|Lack of Efficacy|0|||
161138376|NCT01024244|581888638|FG004|Overall Study|Lack of Efficacy|0|||
161138377|NCT01024244|581888634|FG000|Overall Study|Protocol Violation|1|||
161138378|NCT01024244|581888635|FG001|Overall Study|Protocol Violation|0|||
161138379|NCT01024244|581888636|FG002|Overall Study|Protocol Violation|0|||
161138380|NCT01024244|581888637|FG003|Overall Study|Protocol Violation|0|||
161138381|NCT01024244|581888638|FG004|Overall Study|Protocol Violation|2|||
161138382|NCT01024244|581888634|FG000|Overall Study|Sponsor Decision|14|||
161138383|NCT01024244|581888635|FG001|Overall Study|Sponsor Decision|7|||
161138384|NCT01024244|581888636|FG002|Overall Study|Sponsor Decision|14|||
161138385|NCT01024244|581888637|FG003|Overall Study|Sponsor Decision|12|||
161138386|NCT01024244|581888638|FG004|Overall Study|Sponsor Decision|10|||
161138387|NCT01024244|581888634|FG000|Overall Study|Withdrawal by Subject|0|||
161138388|NCT01024244|581888635|FG001|Overall Study|Withdrawal by Subject|1|||
161249799|NCT01358877|582294628|FG000|Overall Study|Lost to Follow-up|181|||
161249800|NCT01358877|582294629|FG001|Overall Study|Lost to Follow-up|176|||
161249801|NCT01358877|582294628|FG000|Overall Study|Death|41|||
161249802|NCT01358877|582294629|FG001|Overall Study|Death|46|||
161249803|NCT01358877|582294628|FG000|Overall Study|Adverse Event|39|||
161249804|NCT01358877|582294629|FG001|Overall Study|Adverse Event|42|||
161249805|NCT01358877|582294628|FG000|Overall Study|Physician Decision|43|||
161249806|NCT01358877|582294629|FG001|Overall Study|Physician Decision|32|||
161249807|NCT01358877|582294628|FG000|Overall Study|Contralateral breast cancer|42|||
161249808|NCT01358877|582294629|FG001|Overall Study|Contralateral breast cancer|28|||
161249809|NCT01358877|582294628|FG000|Overall Study|Reason not specified|37|||
160837873|NCT03402386|580793157|FG000|Overall Study|Physician Decision|1|||
160837874|NCT03402386|580793157|FG000|Overall Study|Difficult to control Hb|2|||
160837875|NCT01048853|580793158|FG000|Overall Study|Death|1|||
160837876|NCT01048853|580793159|FG001|Overall Study|Death|0|||
160837877|NCT01048853|580793160|FG002|Overall Study|Death|0|||
160837878|NCT01048853|580793158|FG000|Overall Study|Lost to Follow-up|1|||
160837879|NCT01048853|580793159|FG001|Overall Study|Lost to Follow-up|4|||
160837880|NCT01048853|580793160|FG002|Overall Study|Lost to Follow-up|0|||
160837881|NCT00805766|580793167|FG000|Screening Period|Adverse Event|1|||
160837882|NCT00805766|580793167|FG000|Screening Period|Lack of Efficacy|2|||
160837883|NCT00805766|580793167|FG000|Screening Period|Pregnancy|1|||
160837884|NCT00805766|580793167|FG000|Screening Period|Responder|2|||
160837885|NCT00805766|580793167|FG000|Increased Dose Period|Adverse Event|4|||
160837886|NCT00805766|580793167|FG000|Increased Dose Period|Lack of Efficacy|7|||
160837887|NCT00805766|580793167|FG000|Increased Dose Period|Pregnancy|1|||
160837888|NCT00805766|580793167|FG000|Increased Dose Period|Withdrawal by Subject|1|||
160837889|NCT04254913|580793168|FG000|Overall Study|Adverse Event|1|||
160837890|NCT00971243|580793169|FG000|Double Blind Period|Adverse Event|2|||
160837891|NCT00971243|580793170|FG001|Double Blind Period|Adverse Event|3|||
161138389|NCT01024244|581888636|FG002|Overall Study|Withdrawal by Subject|0|||
161138390|NCT01024244|581888637|FG003|Overall Study|Withdrawal by Subject|0|||
161138391|NCT01024244|581888638|FG004|Overall Study|Withdrawal by Subject|0|||
161138392|NCT03874234|581888643|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161138393|NCT03874234|581888644|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161138394|NCT03874234|581888645|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161138395|NCT03874234|581888646|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
161138396|NCT03874234|581888647|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161249810|NCT01358877|582294629|FG001|Overall Study|Reason not specified|29|||
161249811|NCT02161549|582294633|FG000|Overall Study|Physician Decision|6|||
161249812|NCT02161549|582294634|FG001|Overall Study|Physician Decision|2|||
161249813|NCT03433703|582294635|FG000|Overall Study|Study terminated by Sponsor|2|||
161249814|NCT01583530|582294636|FG000|Overall Study|Adverse Event|0|||
161249815|NCT01583530|582294637|FG001|Overall Study|Adverse Event|0|||
161249816|NCT01583530|582294638|FG002|Overall Study|Adverse Event|0|||
161249817|NCT01583530|582294639|FG003|Overall Study|Adverse Event|0|||
161249818|NCT01583530|582294640|FG004|Overall Study|Adverse Event|0|||
161249819|NCT01583530|582294641|FG005|Overall Study|Adverse Event|1|||
161249820|NCT01583530|582294636|FG000|Overall Study|Withdrawal by Subject|0|||
161249821|NCT01583530|582294637|FG001|Overall Study|Withdrawal by Subject|3|||
161249822|NCT01583530|582294638|FG002|Overall Study|Withdrawal by Subject|0|||
161249823|NCT01583530|582294639|FG003|Overall Study|Withdrawal by Subject|1|||
161249824|NCT01583530|582294640|FG004|Overall Study|Withdrawal by Subject|1|||
161249825|NCT01583530|582294641|FG005|Overall Study|Withdrawal by Subject|2|||
161249826|NCT01583530|582294636|FG000|Overall Study|Lost to Follow-up|0|||
161249827|NCT01583530|582294637|FG001|Overall Study|Lost to Follow-up|0|||
161249828|NCT01583530|582294638|FG002|Overall Study|Lost to Follow-up|0|||
161249829|NCT01583530|582294639|FG003|Overall Study|Lost to Follow-up|0|||
161249830|NCT01583530|582294640|FG004|Overall Study|Lost to Follow-up|3|||
161249831|NCT01583530|582294641|FG005|Overall Study|Lost to Follow-up|0|||
161249832|NCT01583530|582294636|FG000|Overall Study|Lack of compliance|0|||
161249833|NCT01583530|582294637|FG001|Overall Study|Lack of compliance|0|||
161249834|NCT01583530|582294638|FG002|Overall Study|Lack of compliance|0|||
161249835|NCT01583530|582294639|FG003|Overall Study|Lack of compliance|0|||
161249836|NCT01583530|582294640|FG004|Overall Study|Lack of compliance|1|||
161249837|NCT01583530|582294641|FG005|Overall Study|Lack of compliance|0|||
161249838|NCT02416180|582294642|FG000|Overall Study|Withdrawal by Subject|1|||
161249839|NCT00640926|582294643|FG000|Overall Study|Adverse Event|2|||
161249840|NCT00640926|582294644|FG001|Overall Study|Adverse Event|3|||
161249841|NCT00640926|582294645|FG002|Overall Study|Adverse Event|2|||
161249842|NCT00640926|582294643|FG000|Overall Study|Lack of Efficacy|0|||
161249843|NCT00640926|582294644|FG001|Overall Study|Lack of Efficacy|2|||
161249844|NCT00640926|582294645|FG002|Overall Study|Lack of Efficacy|1|||
161249845|NCT00640926|582294643|FG000|Overall Study|Protocol Violation|2|||
161249846|NCT00640926|582294644|FG001|Overall Study|Protocol Violation|0|||
161249847|NCT00640926|582294645|FG002|Overall Study|Protocol Violation|2|||
161249848|NCT00640926|582294643|FG000|Overall Study|Lost to Follow-up|3|||
161249849|NCT00640926|582294644|FG001|Overall Study|Lost to Follow-up|1|||
161249850|NCT00640926|582294645|FG002|Overall Study|Lost to Follow-up|2|||
161249851|NCT00640926|582294643|FG000|Overall Study|Withdrawal by Subject|1|||
161249852|NCT00640926|582294644|FG001|Overall Study|Withdrawal by Subject|0|||
161249853|NCT00640926|582294645|FG002|Overall Study|Withdrawal by Subject|1|||
161249854|NCT02985398|582294646|FG000|Overall Study|Adverse Event|1|||
161249855|NCT02985398|582294646|FG000|Overall Study|Lost to Follow-up|4|||
161249856|NCT02985398|582294646|FG000|Overall Study|Withdrawal by Subject|8|||
161249857|NCT02985398|582294646|FG000|Overall Study|Study Burden|9|||
161249858|NCT01841073|582294647|FG000|Overall Study|Adverse Event|1|||
161249859|NCT01841073|582294648|FG001|Overall Study|Adverse Event|1|||
161249860|NCT01841073|582294647|FG000|Overall Study|Physician Decision|1|||
161249861|NCT01841073|582294648|FG001|Overall Study|Physician Decision|0|||
161249862|NCT01841073|582294647|FG000|Overall Study|Lost to Follow-up|0|||
161249863|NCT01841073|582294648|FG001|Overall Study|Lost to Follow-up|2|||
161249864|NCT00283842|582294653|FG000|Overall Study|Adverse Event|8|||
161249865|NCT00283842|582294654|FG001|Overall Study|Adverse Event|7|||
161249866|NCT00283842|582294655|FG002|Overall Study|Adverse Event|21|||
161249867|NCT00283842|582294656|FG003|Overall Study|Adverse Event|21|||
160837892|NCT00971243|580793171|FG002|Double Blind Period|Adverse Event|2|||
160837893|NCT00971243|580793172|FG003|Double Blind Period|Adverse Event|2|||
160837894|NCT00971243|580793173|FG004|Double Blind Period|Adverse Event|3|||
160837895|NCT00971243|580793169|FG000|Double Blind Period|Lost to Follow-up|0|||
160837896|NCT00971243|580793170|FG001|Double Blind Period|Lost to Follow-up|1|||
160837897|NCT00971243|580793171|FG002|Double Blind Period|Lost to Follow-up|1|||
161249868|NCT00283842|582294657|FG004|Overall Study|Adverse Event|5|||
160837898|NCT00971243|580793172|FG003|Double Blind Period|Lost to Follow-up|0|||
161249869|NCT00283842|582294653|FG000|Overall Study|Protocol Violation|1|||
161249870|NCT00283842|582294654|FG001|Overall Study|Protocol Violation|5|||
161249871|NCT00283842|582294655|FG002|Overall Study|Protocol Violation|4|||
161249872|NCT00283842|582294656|FG003|Overall Study|Protocol Violation|0|||
161249873|NCT00283842|582294657|FG004|Overall Study|Protocol Violation|0|||
161249874|NCT00283842|582294653|FG000|Overall Study|Protocol deviation|0|||
160837899|NCT00971243|580793173|FG004|Double Blind Period|Lost to Follow-up|1|||
160837900|NCT00971243|580793169|FG000|Double Blind Period|Physician Decision|10|||
160837901|NCT00971243|580793170|FG001|Double Blind Period|Physician Decision|6|||
161249875|NCT00283842|582294654|FG001|Overall Study|Protocol deviation|0|||
161249876|NCT00283842|582294655|FG002|Overall Study|Protocol deviation|0|||
161249877|NCT00283842|582294656|FG003|Overall Study|Protocol deviation|0|||
161249878|NCT00283842|582294657|FG004|Overall Study|Protocol deviation|2|||
161249879|NCT00283842|582294653|FG000|Overall Study|Withdrawal by Subject|2|||
161249880|NCT00283842|582294654|FG001|Overall Study|Withdrawal by Subject|1|||
160837902|NCT00971243|580793171|FG002|Double Blind Period|Physician Decision|7|||
160837903|NCT00971243|580793172|FG003|Double Blind Period|Physician Decision|6|||
160837904|NCT00971243|580793173|FG004|Double Blind Period|Physician Decision|7|||
160837905|NCT00971243|580793169|FG000|Double Blind Period|Protocol Violation|2|||
160837906|NCT00971243|580793170|FG001|Double Blind Period|Protocol Violation|0|||
160837907|NCT00971243|580793171|FG002|Double Blind Period|Protocol Violation|3|||
160837908|NCT00971243|580793172|FG003|Double Blind Period|Protocol Violation|2|||
160837909|NCT00971243|580793173|FG004|Double Blind Period|Protocol Violation|2|||
160837910|NCT00971243|580793169|FG000|Double Blind Period|Withdrawal by Subject|4|||
160837911|NCT00971243|580793170|FG001|Double Blind Period|Withdrawal by Subject|1|||
160837912|NCT00971243|580793171|FG002|Double Blind Period|Withdrawal by Subject|4|||
160837913|NCT00971243|580793172|FG003|Double Blind Period|Withdrawal by Subject|4|||
160837914|NCT00971243|580793173|FG004|Double Blind Period|Withdrawal by Subject|4|||
160837915|NCT00971243|580793169|FG000|Double Blind Period|Other reasons|1|||
161138397|NCT03874234|581888648|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160837916|NCT00971243|580793170|FG001|Double Blind Period|Other reasons|0|||
161138398|NCT03874234|581888649|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160837917|NCT00971243|580793171|FG002|Double Blind Period|Other reasons|2|||
160837918|NCT00971243|580793172|FG003|Double Blind Period|Other reasons|0|||
160837919|NCT00971243|580793173|FG004|Double Blind Period|Other reasons|1|||
160837920|NCT00971243|580793169|FG000|Open-label Period|Adverse Event|1|||
160837921|NCT00971243|580793170|FG001|Open-label Period|Adverse Event|0|||
160837922|NCT00971243|580793171|FG002|Open-label Period|Adverse Event|1|||
160837923|NCT00971243|580793172|FG003|Open-label Period|Adverse Event|1|||
160837924|NCT00971243|580793173|FG004|Open-label Period|Adverse Event|0|||
160837925|NCT00971243|580793169|FG000|Open-label Period|Physician Decision|5|||
160837926|NCT00971243|580793170|FG001|Open-label Period|Physician Decision|9|||
160837927|NCT00971243|580793171|FG002|Open-label Period|Physician Decision|3|||
160837928|NCT00971243|580793172|FG003|Open-label Period|Physician Decision|7|||
160837929|NCT00971243|580793173|FG004|Open-label Period|Physician Decision|2|||
160837930|NCT00971243|580793169|FG000|Open-label Period|Protocol Violation|1|||
160837931|NCT00971243|580793170|FG001|Open-label Period|Protocol Violation|1|||
160837932|NCT00971243|580793171|FG002|Open-label Period|Protocol Violation|1|||
160837933|NCT00971243|580793172|FG003|Open-label Period|Protocol Violation|0|||
160837934|NCT00971243|580793173|FG004|Open-label Period|Protocol Violation|1|||
160837935|NCT00971243|580793169|FG000|Open-label Period|Withdrawal by Subject|1|||
160837936|NCT00971243|580793170|FG001|Open-label Period|Withdrawal by Subject|0|||
160837937|NCT00971243|580793171|FG002|Open-label Period|Withdrawal by Subject|0|||
160837938|NCT00971243|580793172|FG003|Open-label Period|Withdrawal by Subject|2|||
160837939|NCT00971243|580793173|FG004|Open-label Period|Withdrawal by Subject|1|||
160837940|NCT00971243|580793169|FG000|Open-label Period|Other reason|0|||
160837941|NCT00971243|580793170|FG001|Open-label Period|Other reason|0|||
160837942|NCT00971243|580793171|FG002|Open-label Period|Other reason|0|||
160837943|NCT00971243|580793172|FG003|Open-label Period|Other reason|0|||
160837944|NCT00971243|580793173|FG004|Open-label Period|Other reason|2|||
160837945|NCT01004952|580793174|FG000|Overall Study|Lost to Follow-up|0|||
160837946|NCT01004952|580793175|FG001|Overall Study|Lost to Follow-up|11|||
160837947|NCT01004952|580793174|FG000|Overall Study|Withdrawal by Subject|0|||
160837948|NCT01004952|580793175|FG001|Overall Study|Withdrawal by Subject|5|||
160837949|NCT02354222|580793179|FG000|Overall Study|Adverse Event|0|||
160837950|NCT02354222|580793180|FG001|Overall Study|Adverse Event|3|||
160837951|NCT02354222|580793179|FG000|Overall Study|Physician Decision|1|||
160837952|NCT02354222|580793180|FG001|Overall Study|Physician Decision|1|||
160837953|NCT02354222|580793179|FG000|Overall Study|Pregnancy|1|||
160837954|NCT02354222|580793180|FG001|Overall Study|Pregnancy|0|||
160837955|NCT02354222|580793179|FG000|Overall Study|Withdrawal by Subject|2|||
160837956|NCT02354222|580793180|FG001|Overall Study|Withdrawal by Subject|3|||
160837957|NCT02354222|580793179|FG000|Overall Study|Conflict with the stopping criteria|0|||
160837958|NCT02354222|580793180|FG001|Overall Study|Conflict with the stopping criteria|4|||
160837959|NCT04300218|580793181|FG000|Overall Study|Lost to Follow-up|6|||
160837960|NCT04300218|580793182|FG001|Overall Study|Lost to Follow-up|8|||
160837961|NCT04099511|580793183|FG000|Overall Study|Lost to Follow-up|2|||
160837962|NCT04099511|580793184|FG001|Overall Study|Lost to Follow-up|2|||
160837963|NCT04099511|580793183|FG000|Overall Study|Withdrawal by Subject|8|||
160837964|NCT04099511|580793184|FG001|Overall Study|Withdrawal by Subject|4|||
160837965|NCT06581094|580793187|FG000|Overall Study|Lost to Follow-up|1|||
160837966|NCT06581094|580793188|FG001|Overall Study|Lost to Follow-up|1|||
160837967|NCT05740618|580793189|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
161138399|NCT03874234|581888650|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160837968|NCT05740618|580793189|FG000|Overall Study|Physician Decision|1|||
160837969|NCT02354235|580793195|FG000|Overall Study|Adverse Event|2|||
160837970|NCT02354235|580793196|FG001|Overall Study|Adverse Event|2|||
160837971|NCT02354235|580793195|FG000|Overall Study|Physician Decision|0|||
161138400|NCT03874234|581888651|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161138401|NCT03874234|581888652|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160837972|NCT02354235|580793196|FG001|Overall Study|Physician Decision|1|||
160837973|NCT02354235|580793195|FG000|Overall Study|Withdrawal by Subject|1|||
160837974|NCT02354235|580793196|FG001|Overall Study|Withdrawal by Subject|3|||
160837975|NCT02354235|580793195|FG000|Overall Study|Conflict with the stopping criteria|0|||
160837976|NCT02354235|580793196|FG001|Overall Study|Conflict with the stopping criteria|1|||
160837977|NCT05451940|580793197|FG000|Treatment Period|Physician Decision|1|||
160837978|NCT03436693|580793198|FG000|Overall Study|Adverse Event|22|||
160837979|NCT03436693|580793199|FG001|Overall Study|Adverse Event|10|||
160837980|NCT03436693|580793198|FG000|Overall Study|Physician Decision|3|||
160837981|NCT03436693|580793199|FG001|Overall Study|Physician Decision|3|||
160837982|NCT03436693|580793198|FG000|Overall Study|Withdrawal by Subject|4|||
160837983|NCT03436693|580793199|FG001|Overall Study|Withdrawal by Subject|13|||
160837984|NCT03436693|580793198|FG000|Overall Study|Progressive Disease|1|||
160837985|NCT03436693|580793199|FG001|Overall Study|Progressive Disease|1|||
160837986|NCT04481789|580793200|FG000|Period 1|Withdrawal by Subject|1|||
160837987|NCT04481789|580793201|FG001|Period 1|Withdrawal by Subject|0|||
160837988|NCT04481789|580793202|FG002|Period 1|Withdrawal by Subject|0|||
160837989|NCT04481789|580793203|FG003|Period 1|Withdrawal by Subject|0|||
160837990|NCT04481789|580793204|FG004|Period 1|Withdrawal by Subject|0|||
160837991|NCT04481789|580793205|FG005|Period 1|Withdrawal by Subject|0|||
160837992|NCT05216224|580793206|FG000|Overall Study|Adverse Event|6|||
160837993|NCT05216224|580793207|FG001|Overall Study|Adverse Event|3|||
160837994|NCT05216224|580793206|FG000|Overall Study|Lack of Efficacy|1|||
160837995|NCT05216224|580793207|FG001|Overall Study|Lack of Efficacy|0|||
160837996|NCT05216224|580793206|FG000|Overall Study|Lost to Follow-up|8|||
160837997|NCT05216224|580793207|FG001|Overall Study|Lost to Follow-up|6|||
160837998|NCT05216224|580793206|FG000|Overall Study|Protocol Violation|1|||
160837999|NCT05216224|580793207|FG001|Overall Study|Protocol Violation|1|||
160838000|NCT05216224|580793206|FG000|Overall Study|Withdrawal by Subject|6|||
160838001|NCT05216224|580793207|FG001|Overall Study|Withdrawal by Subject|5|||
160838002|NCT05216224|580793206|FG000|Overall Study|Other than specified|1|||
160838003|NCT05216224|580793207|FG001|Overall Study|Other than specified|0|||
160838004|NCT03245008|580793208|FG000|Overall Study|Adverse Event|15|||
160838005|NCT03245008|580793209|FG001|Overall Study|Adverse Event|18|||
160838006|NCT03245008|580793210|FG002|Overall Study|Adverse Event|15|||
160838007|NCT03245008|580793211|FG003|Overall Study|Adverse Event|0|||
160838008|NCT03245008|580793212|FG004|Overall Study|Adverse Event|1|||
160838009|NCT03245008|580793208|FG000|Overall Study|Lack of Efficacy|0|||
160838010|NCT03245008|580793209|FG001|Overall Study|Lack of Efficacy|1|||
160838011|NCT03245008|580793210|FG002|Overall Study|Lack of Efficacy|0|||
160838012|NCT03245008|580793211|FG003|Overall Study|Lack of Efficacy|0|||
160838013|NCT03245008|580793212|FG004|Overall Study|Lack of Efficacy|0|||
160838014|NCT03245008|580793208|FG000|Overall Study|Lost to Follow-up|4|||
160838015|NCT03245008|580793209|FG001|Overall Study|Lost to Follow-up|1|||
160838016|NCT03245008|580793210|FG002|Overall Study|Lost to Follow-up|0|||
160838017|NCT03245008|580793211|FG003|Overall Study|Lost to Follow-up|0|||
160838018|NCT03245008|580793212|FG004|Overall Study|Lost to Follow-up|1|||
160838019|NCT03245008|580793208|FG000|Overall Study|Physician Decision|1|||
160838020|NCT03245008|580793209|FG001|Overall Study|Physician Decision|3|||
160838021|NCT03245008|580793210|FG002|Overall Study|Physician Decision|4|||
160838022|NCT03245008|580793211|FG003|Overall Study|Physician Decision|0|||
160838023|NCT03245008|580793212|FG004|Overall Study|Physician Decision|0|||
160838024|NCT03245008|580793208|FG000|Overall Study|Protocol Violation|0|||
160838025|NCT03245008|580793209|FG001|Overall Study|Protocol Violation|1|||
160838026|NCT03245008|580793210|FG002|Overall Study|Protocol Violation|0|||
160838027|NCT03245008|580793211|FG003|Overall Study|Protocol Violation|0|||
160838028|NCT03245008|580793212|FG004|Overall Study|Protocol Violation|0|||
160838029|NCT03245008|580793208|FG000|Overall Study|Withdrawal by Subject|20|||
160838030|NCT03245008|580793209|FG001|Overall Study|Withdrawal by Subject|19|||
160838031|NCT03245008|580793210|FG002|Overall Study|Withdrawal by Subject|11|||
160838032|NCT03245008|580793211|FG003|Overall Study|Withdrawal by Subject|0|||
160838033|NCT03245008|580793212|FG004|Overall Study|Withdrawal by Subject|0|||
160838034|NCT03245008|580793208|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
160838035|NCT03245008|580793209|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
160838036|NCT03245008|580793210|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
160838037|NCT03245008|580793211|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
160838038|NCT03245008|580793212|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
160838039|NCT03245008|580793208|FG000|Overall Study|Failure to meet randomization criteria|0|||
160838040|NCT03245008|580793209|FG001|Overall Study|Failure to meet randomization criteria|1|||
160838041|NCT03245008|580793210|FG002|Overall Study|Failure to meet randomization criteria|0|||
160838042|NCT03245008|580793211|FG003|Overall Study|Failure to meet randomization criteria|1|||
160838043|NCT03245008|580793212|FG004|Overall Study|Failure to meet randomization criteria|0|||
160838044|NCT04655144|580793218|FG000|Overall Study|Consumed THC|1|||
160838045|NCT04655144|580793219|FG001|Overall Study|Consumed THC|0|||
160838046|NCT04655144|580793218|FG000|Overall Study|Unilateral embolization|0|||
160838047|NCT04655144|580793219|FG001|Overall Study|Unilateral embolization|1|||
160838048|NCT04317742|580793220|FG000|Overall Study|Lost to Follow-up|57|||
160838049|NCT04317742|580793221|FG001|Overall Study|Lost to Follow-up|59|||
160838050|NCT04317742|580793220|FG000|Overall Study|Pregnancy|1|||
161138402|NCT03874234|581888653|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
160838051|NCT04317742|580793221|FG001|Overall Study|Pregnancy|1|||
160838052|NCT04317742|580793220|FG000|Overall Study|Withdrawal by Subject|46|||
160838053|NCT04317742|580793221|FG001|Overall Study|Withdrawal by Subject|24|||
160838054|NCT03645863|580793222|FG000|Overall Study|Withdrawal by Subject|1|||
160838055|NCT03645863|580793223|FG001|Overall Study|Withdrawal by Subject|0|||
160838056|NCT03645863|580793224|FG002|Overall Study|Withdrawal by Subject|0|||
160838057|NCT01580670|580793225|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
160838058|NCT01580670|580793225|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
160838059|NCT02220907|580793226|FG000|Overall Study|Adverse Event|7|||
160838060|NCT02220907|580793226|FG000|Overall Study|Physician Decision|1|||
160838061|NCT02220907|580793226|FG000|Overall Study|Withdrawal by Subject|2|||
160838062|NCT02220907|580793226|FG000|Overall Study|Conflict with the stopping criteria|1|||
160838063|NCT00542815|580793227|FG000|Overall Study|Adverse Event|19|||
160838064|NCT00542815|580793228|FG001|Overall Study|Adverse Event|6|||
160838065|NCT00542815|580793229|FG002|Overall Study|Adverse Event|9|||
160838066|NCT00542815|580793227|FG000|Overall Study|Death|10|||
160838067|NCT00542815|580793228|FG001|Overall Study|Death|7|||
160838068|NCT00542815|580793229|FG002|Overall Study|Death|3|||
160838069|NCT00542815|580793227|FG000|Overall Study|Lack of Efficacy|9|||
160838070|NCT00542815|580793228|FG001|Overall Study|Lack of Efficacy|2|||
160838071|NCT00542815|580793229|FG002|Overall Study|Lack of Efficacy|0|||
160838072|NCT00542815|580793227|FG000|Overall Study|Physician Decision|2|||
160838073|NCT00542815|580793228|FG001|Overall Study|Physician Decision|1|||
160838074|NCT00542815|580793229|FG002|Overall Study|Physician Decision|0|||
160838075|NCT00542815|580793227|FG000|Overall Study|Protocol Violation|1|||
160838076|NCT00542815|580793228|FG001|Overall Study|Protocol Violation|1|||
160838077|NCT00542815|580793229|FG002|Overall Study|Protocol Violation|2|||
160838078|NCT00542815|580793227|FG000|Overall Study|Withdrawal by Subject|41|||
160838079|NCT00542815|580793228|FG001|Overall Study|Withdrawal by Subject|5|||
160838080|NCT00542815|580793229|FG002|Overall Study|Withdrawal by Subject|8|||
160838081|NCT00542815|580793227|FG000|Overall Study|Other reasons|24|||
161138403|NCT03874234|581888654|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161138404|NCT03874234|581888655|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
161138405|NCT03874234|581888643|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
161138406|NCT03874234|581888644|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138407|NCT03874234|581888645|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138408|NCT03874234|581888646|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
160838082|NCT00542815|580793228|FG001|Overall Study|Other reasons|10|||
160838083|NCT00542815|580793229|FG002|Overall Study|Other reasons|10|||
160838084|NCT06045507|580793883|FG000|Overall Study|Death|0|||
160838085|NCT06045507|580793884|FG001|Overall Study|Death|0|||
160838086|NCT06045507|580793885|FG002|Overall Study|Death|1|||
161138409|NCT03874234|581888647|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138410|NCT03874234|581888648|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138411|NCT03874234|581888649|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138412|NCT03874234|581888650|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138413|NCT03874234|581888651|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161249881|NCT00283842|582294655|FG002|Overall Study|Withdrawal by Subject|1|||
161249882|NCT00283842|582294656|FG003|Overall Study|Withdrawal by Subject|5|||
161249883|NCT00283842|582294657|FG004|Overall Study|Withdrawal by Subject|4|||
160838087|NCT06045507|580793886|FG003|Overall Study|Death|0|||
160838088|NCT06045507|580793883|FG000|Overall Study|Lost to Follow-up|3|||
160838089|NCT06045507|580793884|FG001|Overall Study|Lost to Follow-up|3|||
160838090|NCT06045507|580793885|FG002|Overall Study|Lost to Follow-up|0|||
160838091|NCT06045507|580793886|FG003|Overall Study|Lost to Follow-up|0|||
161249884|NCT00283842|582294653|FG000|Overall Study|Lack of Efficacy|1|||
161249885|NCT00283842|582294654|FG001|Overall Study|Lack of Efficacy|3|||
161249886|NCT00283842|582294655|FG002|Overall Study|Lack of Efficacy|1|||
160838092|NCT06045507|580793883|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
160838093|NCT06045507|580793884|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
160838094|NCT06045507|580793885|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
160838095|NCT06045507|580793886|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
160838096|NCT06045507|580793883|FG000|Overall Study|Withdrawal by Subject|4|||
161138414|NCT03874234|581888652|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138415|NCT03874234|581888653|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138416|NCT03874234|581888654|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161138417|NCT03874234|581888655|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
161249887|NCT00283842|582294656|FG003|Overall Study|Lack of Efficacy|0|||
161249888|NCT00283842|582294657|FG004|Overall Study|Lack of Efficacy|3|||
160838097|NCT06045507|580793884|FG001|Overall Study|Withdrawal by Subject|1|||
160838098|NCT06045507|580793885|FG002|Overall Study|Withdrawal by Subject|0|||
161138418|NCT03874234|581888643|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
160838099|NCT06045507|580793886|FG003|Overall Study|Withdrawal by Subject|2|||
160838100|NCT06045507|580793883|FG000|Overall Study|Miscellaneous|2|||
161138419|NCT03874234|581888644|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138420|NCT03874234|581888645|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138421|NCT03874234|581888646|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
161138422|NCT03874234|581888647|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138423|NCT03874234|581888648|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138424|NCT03874234|581888649|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138425|NCT03874234|581888650|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138426|NCT03874234|581888651|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138427|NCT03874234|581888652|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138428|NCT03874234|581888653|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138429|NCT03874234|581888654|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138430|NCT03874234|581888655|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
161138431|NCT03874234|581888643|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138432|NCT03874234|581888644|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138433|NCT03874234|581888645|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138434|NCT03874234|581888646|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138435|NCT03874234|581888647|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
161138436|NCT03874234|581888648|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138437|NCT03874234|581888649|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138438|NCT03874234|581888650|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138439|NCT03874234|581888651|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138440|NCT03874234|581888652|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138441|NCT03874234|581888653|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138442|NCT03874234|581888654|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138443|NCT03874234|581888655|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
161138444|NCT03874234|581888643|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138445|NCT03874234|581888644|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138446|NCT03874234|581888645|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138447|NCT03874234|581888646|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138448|NCT03874234|581888647|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138449|NCT03874234|581888648|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138450|NCT03874234|581888649|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138451|NCT03874234|581888650|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
161138452|NCT03874234|581888651|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138453|NCT03874234|581888652|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138454|NCT03874234|581888653|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138455|NCT03874234|581888654|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138456|NCT03874234|581888655|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
161138457|NCT03874234|581888643|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138458|NCT03874234|581888644|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138459|NCT03874234|581888645|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138460|NCT03874234|581888646|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138461|NCT03874234|581888647|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
161138462|NCT03874234|581888648|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
161138463|NCT03874234|581888649|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138464|NCT03874234|581888650|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138465|NCT03874234|581888651|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138466|NCT03874234|581888652|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138467|NCT03874234|581888653|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138468|NCT03874234|581888654|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138469|NCT03874234|581888655|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
161138470|NCT03874234|581888643|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138471|NCT03874234|581888644|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138472|NCT03874234|581888645|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138473|NCT03874234|581888646|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138474|NCT03874234|581888647|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138475|NCT03874234|581888648|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138476|NCT03874234|581888649|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
161138477|NCT03874234|581888650|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138478|NCT03874234|581888651|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138479|NCT03874234|581888652|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138480|NCT03874234|581888653|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138481|NCT03874234|581888654|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138482|NCT03874234|581888655|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
161138483|NCT03874234|581888643|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138484|NCT03874234|581888644|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160838101|NCT06045507|580793884|FG001|Overall Study|Miscellaneous|0|||
160838102|NCT06045507|580793885|FG002|Overall Study|Miscellaneous|0|||
160838103|NCT06045507|580793886|FG003|Overall Study|Miscellaneous|1|||
160838104|NCT03688100|580793891|FG000|Overall Study|Lost to Follow-up|21|||
160838105|NCT03688100|580793892|FG001|Overall Study|Lost to Follow-up|15|||
160838106|NCT03688100|580793893|FG002|Overall Study|Lost to Follow-up|15|||
160838107|NCT03688100|580793894|FG003|Overall Study|Lost to Follow-up|18|||
160838108|NCT03688100|580793891|FG000|Overall Study|Withdrawal by Subject|19|||
160838109|NCT03688100|580793892|FG001|Overall Study|Withdrawal by Subject|16|||
160838110|NCT03688100|580793893|FG002|Overall Study|Withdrawal by Subject|0|||
160904343|NCT02165215|581044924|FG002|Maintenance Phase|Lost to Follow-up|0|||
160904344|NCT02165215|581044922|FG000|Maintenance Phase|Adverse Event|0|||
160904345|NCT02165215|581044923|FG001|Maintenance Phase|Adverse Event|1|||
160904346|NCT02165215|581044924|FG002|Maintenance Phase|Adverse Event|1|||
160904347|NCT00592384|581044925|FG000|Overall Study|Withdrawal by Subject|5|||
160904348|NCT00592384|581044926|FG001|Overall Study|Withdrawal by Subject|6|||
160904349|NCT01153347|581044934|FG000|Overall Study|Withdrawal by Subject|7|||
160904350|NCT01153347|581044935|FG001|Overall Study|Withdrawal by Subject|7|||
160904351|NCT01153347|581044936|FG002|Overall Study|Withdrawal by Subject|7|||
160904352|NCT01153347|581044937|FG003|Overall Study|Withdrawal by Subject|7|||
160904353|NCT01153347|581044934|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160904354|NCT01153347|581044935|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160904355|NCT01153347|581044936|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
160904356|NCT01153347|581044937|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160904357|NCT01153347|581044934|FG000|Overall Study|Adverse Event|3|||
160904358|NCT01153347|581044935|FG001|Overall Study|Adverse Event|9|||
160904359|NCT01153347|581044936|FG002|Overall Study|Adverse Event|21|||
160904360|NCT01153347|581044937|FG003|Overall Study|Adverse Event|7|||
160904361|NCT01153347|581044934|FG000|Overall Study|Severe non-compliance to protocol|6|||
160904362|NCT01153347|581044935|FG001|Overall Study|Severe non-compliance to protocol|7|||
160904363|NCT01153347|581044936|FG002|Overall Study|Severe non-compliance to protocol|4|||
160904364|NCT01153347|581044937|FG003|Overall Study|Severe non-compliance to protocol|3|||
160904365|NCT01153347|581044934|FG000|Overall Study|Condition under investigation worsened|1|||
160904366|NCT01153347|581044935|FG001|Overall Study|Condition under investigation worsened|1|||
160904367|NCT01153347|581044936|FG002|Overall Study|Condition under investigation worsened|0|||
160904368|NCT01153347|581044937|FG003|Overall Study|Condition under investigation worsened|0|||
160904369|NCT01153347|581044934|FG000|Overall Study|Lack of Efficacy|2|||
160904370|NCT01153347|581044935|FG001|Overall Study|Lack of Efficacy|2|||
160904371|NCT01153347|581044936|FG002|Overall Study|Lack of Efficacy|0|||
160904372|NCT01153347|581044937|FG003|Overall Study|Lack of Efficacy|4|||
160904373|NCT01153347|581044934|FG000|Overall Study|Study-specific withdrawal criteria|4|||
160904374|NCT01153347|581044935|FG001|Overall Study|Study-specific withdrawal criteria|3|||
160904375|NCT01153347|581044936|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160904376|NCT01153347|581044937|FG003|Overall Study|Study-specific withdrawal criteria|2|||
160904377|NCT01153347|581044934|FG000|Overall Study|Lost to Follow-up|4|||
160904378|NCT01153347|581044935|FG001|Overall Study|Lost to Follow-up|9|||
160904379|NCT01153347|581044936|FG002|Overall Study|Lost to Follow-up|11|||
160904380|NCT01153347|581044937|FG003|Overall Study|Lost to Follow-up|8|||
160904381|NCT01153347|581044934|FG000|Overall Study|Other|5|||
160904382|NCT01153347|581044935|FG001|Overall Study|Other|5|||
160904383|NCT01153347|581044936|FG002|Overall Study|Other|4|||
160904384|NCT01153347|581044937|FG003|Overall Study|Other|0|||
160904385|NCT01153347|581044934|FG000|Overall Study|Death|1|||
160904386|NCT01153347|581044935|FG001|Overall Study|Death|0|||
160904387|NCT01153347|581044936|FG002|Overall Study|Death|0|||
160904388|NCT01153347|581044937|FG003|Overall Study|Death|0|||
160904389|NCT00003473|581044941|FG000|Overall Study|Three patients were not evaluable.|3|||
160904390|NCT04401423|581044942|FG000|Overall Study|Withdrawal by Subject|3|||
161138485|NCT03874234|581888645|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138486|NCT03874234|581888646|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138487|NCT03874234|581888647|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
160838111|NCT03688100|580793894|FG003|Overall Study|Withdrawal by Subject|0|||
160838112|NCT03688100|580793891|FG000|Overall Study|Death|36|||
160838113|NCT03688100|580793892|FG001|Overall Study|Death|27|||
160904391|NCT04401423|581044943|FG001|Overall Study|Withdrawal by Subject|1|||
160904392|NCT04401423|581044942|FG000|Overall Study|Physician Decision|2|||
160904393|NCT04401423|581044943|FG001|Overall Study|Physician Decision|1|||
160904394|NCT04678661|581044944|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
160904395|NCT04678661|581044945|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
160904396|NCT04678661|581044944|FG000|Overall Study|Protocol Violation|2|||
160904397|NCT04678661|581044945|FG001|Overall Study|Protocol Violation|0|||
160904398|NCT04678661|581044944|FG000|Overall Study|Withdrawal by Subject|1|||
161249889|NCT00283842|582294653|FG000|Overall Study|Lost to Follow-up|0|||
160838114|NCT03688100|580793893|FG002|Overall Study|Death|0|||
160838115|NCT03688100|580793894|FG003|Overall Study|Death|0|||
160838116|NCT02479139|580793900|FG000|Overall Study|Lost to Follow-up|2|||
160838117|NCT02479139|580793901|FG001|Overall Study|Lost to Follow-up|4|||
160838118|NCT02479139|580793902|FG002|Overall Study|Lost to Follow-up|4|||
160838119|NCT02479139|580793903|FG003|Overall Study|Lost to Follow-up|2|||
160838120|NCT02479139|580793904|FG004|Overall Study|Lost to Follow-up|3|||
160838121|NCT02479139|580793905|FG005|Overall Study|Lost to Follow-up|5|||
160838122|NCT02479139|580793900|FG000|Overall Study|Withdrew Consent|5|||
160838123|NCT02479139|580793901|FG001|Overall Study|Withdrew Consent|6|||
160838124|NCT02479139|580793902|FG002|Overall Study|Withdrew Consent|1|||
160838125|NCT02479139|580793903|FG003|Overall Study|Withdrew Consent|4|||
160838126|NCT02479139|580793904|FG004|Overall Study|Withdrew Consent|1|||
160838127|NCT02479139|580793905|FG005|Overall Study|Withdrew Consent|1|||
160838128|NCT02479139|580793900|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838129|NCT02479139|580793901|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838130|NCT02479139|580793902|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
160904399|NCT04678661|581044945|FG001|Overall Study|Withdrawal by Subject|0|||
160904400|NCT04678661|581044944|FG000|Overall Study|Lost to Follow-up|2|||
160904401|NCT04678661|581044945|FG001|Overall Study|Lost to Follow-up|0|||
160904402|NCT04678661|581044944|FG000|Overall Study|Death|2|||
160904403|NCT04678661|581044945|FG001|Overall Study|Death|0|||
160904404|NCT03039283|581044949|FG000|Overall Study|Protocol Violation|2|||
160904405|NCT03639935|581044950|FG000|Overall Study|Death|3|||
160904406|NCT03639935|581044950|FG000|Overall Study|Adverse Event|1|||
160904407|NCT00864721|581044951|FG000|Overall Study|Patient request|11|||
160904408|NCT00864721|581044951|FG000|Overall Study|Hospitalized|1|||
160904409|NCT00864721|581044951|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
160904410|NCT00864721|581044951|FG000|Overall Study|Adverse Event|21|||
160904411|NCT01921387|581044954|FG000|Overall Study|Adverse Event|1|||
160904412|NCT01773733|581044955|FG000|Overall Study|Adverse Event|3286|||
160904413|NCT01773733|581044956|FG001|Overall Study|Adverse Event|540|||
160904414|NCT01773733|581044955|FG000|Overall Study|Pregnancy|28|||
160904415|NCT01773733|581044956|FG001|Overall Study|Pregnancy|0|||
160904416|NCT01773733|581044955|FG000|Overall Study|Other different categories of not compl|55415|||
160904417|NCT01773733|581044956|FG001|Overall Study|Other different categories of not compl|7781|||
160904418|NCT03741062|581044957|FG000|Overall Study|Protocol Violation|1|||
160904419|NCT03741062|581044958|FG001|Overall Study|Protocol Violation|0|||
160904420|NCT00261807|581044959|FG000|Overall Study|Lost to Follow-up|2|||
160904421|NCT00261807|581044959|FG000|Overall Study|Adverse Event|2|||
160904422|NCT00261807|581044959|FG000|Overall Study|Death|1|||
160904423|NCT00261807|581044959|FG000|Overall Study|Protocol Violation|2|||
160904424|NCT02527161|581044961|FG000|Overall Study|Failed MRI|52|||
160904425|NCT02527161|581044961|FG000|Overall Study|Withdrawal by Subject|19|||
160904426|NCT02527161|581044961|FG000|Overall Study|Delay in or unfit for surgery|16|||
160904427|NCT02527161|581044961|FG000|Overall Study|MRI contraindication|6|||
160904428|NCT02527161|581044961|FG000|Overall Study|Consent violation|4|||
160904429|NCT02527161|581044961|FG000|Overall Study|Only Recruited to Part A|27|||
160904430|NCT02527161|581044961|FG000|Overall Study|Physician Decision|1|||
160904431|NCT02527161|581044961|FG000|Overall Study|Adverse Event|1|||
160904432|NCT02527161|581044961|FG000|Overall Study|Lost to Follow-up|6|||
160904433|NCT00762229|581044964|FG000|Overall Study|Lost to Follow-up|1|||
160904434|NCT00762229|581044965|FG001|Overall Study|Lost to Follow-up|1|||
161138488|NCT03874234|581888648|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160838131|NCT02479139|580793903|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838132|NCT02479139|580793904|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838133|NCT02479139|580793905|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
160838134|NCT02479139|580793900|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160838135|NCT02479139|580793901|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160838136|NCT02479139|580793902|FG002|Overall Study|Other Miscellaneous Reasons|1|||
160838137|NCT02479139|580793903|FG003|Overall Study|Other Miscellaneous Reasons|1|||
160838138|NCT02479139|580793904|FG004|Overall Study|Other Miscellaneous Reasons|1|||
160838139|NCT02479139|580793905|FG005|Overall Study|Other Miscellaneous Reasons|0|||
160904435|NCT00762229|581044964|FG000|Overall Study|did not recveive intervention|0|||
160904436|NCT00762229|581044965|FG001|Overall Study|did not recveive intervention|1|||
160904437|NCT02609828|581044966|FG000|Overall Study|Adverse Event|8|||
160904438|NCT02609828|581044967|FG001|Overall Study|Adverse Event|1|||
160904439|NCT02609828|581044968|FG002|Overall Study|Adverse Event|0|||
160904440|NCT02609828|581044969|FG003|Overall Study|Adverse Event|6|||
160904441|NCT02609828|581044966|FG000|Overall Study|Death|15|||
161138489|NCT03874234|581888649|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160904442|NCT02609828|581044967|FG001|Overall Study|Death|1|||
160904443|NCT02609828|581044968|FG002|Overall Study|Death|1|||
160904444|NCT02609828|581044969|FG003|Overall Study|Death|19|||
161138490|NCT03874234|581888650|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138491|NCT03874234|581888651|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138492|NCT03874234|581888652|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138493|NCT03874234|581888653|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138494|NCT03874234|581888654|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
161138495|NCT03874234|581888655|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
160838140|NCT00885482|580793906|FG000|Overall Study|Pregnancy|1|||
160838141|NCT00885482|580793906|FG000|Overall Study|Lack of Efficacy|1|||
160838142|NCT00885482|580793906|FG000|Overall Study|Death|1|||
160838143|NCT00885482|580793906|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
160838144|NCT00084656|580793907|FG000|Overall Study|Other reasons|0|||
160838145|NCT00084656|580793908|FG001|Overall Study|Other reasons|12|||
160838146|NCT00084656|580793909|FG002|Overall Study|Other reasons|11|||
160838147|NCT00084656|580793907|FG000|Overall Study|Withdrawal by Subject|15|||
160838148|NCT00084656|580793908|FG001|Overall Study|Withdrawal by Subject|4|||
160838149|NCT00084656|580793909|FG002|Overall Study|Withdrawal by Subject|4|||
160838150|NCT00084656|580793907|FG000|Overall Study|Disease relapse|0|||
160838151|NCT00084656|580793908|FG001|Overall Study|Disease relapse|9|||
160838152|NCT00084656|580793909|FG002|Overall Study|Disease relapse|10|||
160838153|NCT00084656|580793907|FG000|Overall Study|Disease progression|9|||
160838154|NCT00084656|580793908|FG001|Overall Study|Disease progression|0|||
160838155|NCT00084656|580793909|FG002|Overall Study|Disease progression|0|||
160838156|NCT00084656|580793907|FG000|Overall Study|Lost to Follow-up|1|||
160838157|NCT00084656|580793908|FG001|Overall Study|Lost to Follow-up|0|||
160838158|NCT00084656|580793909|FG002|Overall Study|Lost to Follow-up|1|||
160838159|NCT02772978|580793910|FG000|Overall Study|Withdrawal by Subject|1|||
160838160|NCT02772978|580793911|FG001|Overall Study|Withdrawal by Subject|1|||
160838161|NCT00989781|580793912|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
160838162|NCT00989781|580793913|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
160838163|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
160838164|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
160838165|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
160838166|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
160838167|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
160838168|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
160838169|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
160838170|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
160838171|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
160838172|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
160838173|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
160838174|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
160838175|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
160838176|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
160838177|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
160838178|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
160838179|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
160838180|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
160838181|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
160838182|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
160838183|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
160838184|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
160838185|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
160838186|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
160838187|NCT01532869|580793914|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
160838188|NCT01532869|580793915|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
160838189|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
160838190|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
160838191|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
160838192|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
160838193|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
160838194|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
160838195|NCT01532869|580793914|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
160838196|NCT01532869|580793915|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
160838197|NCT01069705|580793919|FG000|Overall Study|Adverse Event|1|||
160838198|NCT01069705|580793919|FG000|Overall Study|Withdrawal by Subject|2|||
160838199|NCT03624127|580793920|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
160838200|NCT03624127|580793921|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
160838201|NCT03624127|580793922|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
160838202|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
161249890|NCT00283842|582294654|FG001|Overall Study|Lost to Follow-up|2|||
161249891|NCT00283842|582294655|FG002|Overall Study|Lost to Follow-up|4|||
161249892|NCT00283842|582294656|FG003|Overall Study|Lost to Follow-up|1|||
160838203|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
160838204|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
160838205|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Death|0|||
161249893|NCT00283842|582294657|FG004|Overall Study|Lost to Follow-up|1|||
161249894|NCT00550147|582294658|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
160838206|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Death|1|||
160838207|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Death|0|||
160838208|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
160838209|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
160838210|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
160838211|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
160838212|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
160838213|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
160838214|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
160838215|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
160838216|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
161249895|NCT00550147|582294658|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
161249896|NCT00550147|582294658|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
160838217|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
160838218|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
160838219|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
160838220|NCT03624127|580793920|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
161249897|NCT00550147|582294658|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
161249898|NCT00550147|582294658|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
161249899|NCT00046839|582294659|FG000|Overall Study|Ineligible / No protocol treatment|0|||
161249900|NCT00046839|582294660|FG001|Overall Study|Ineligible / No protocol treatment|2|||
161249901|NCT00046839|582294659|FG000|Overall Study|Withdrawal of consent|1|||
161249902|NCT00046839|582294660|FG001|Overall Study|Withdrawal of consent|0|||
161249903|NCT02472639|582294661|FG000|Overall Study|Physician Decision|4|||
161249904|NCT02472639|582294662|FG001|Overall Study|Physician Decision|3|||
161249905|NCT00751023|582294664|FG000|Overall Study|Lost to Follow-up|11|||
161249906|NCT00751023|582294665|FG001|Overall Study|Lost to Follow-up|7|||
161249907|NCT02050321|582294666|FG000|Overall Study|Withdrawal by Subject|1|||
161249908|NCT02050321|582294666|FG000|Overall Study|Adverse Event|1|||
161249909|NCT04768114|582294667|FG000|Overall Study|Lost to Follow-up|5|||
161249910|NCT04768114|582294668|FG001|Overall Study|Lost to Follow-up|10|||
161249911|NCT04768114|582294667|FG000|Overall Study|Withdrawal by Subject|0|||
161249912|NCT04768114|582294668|FG001|Overall Study|Withdrawal by Subject|1|||
161249913|NCT00715676|582294677|FG000|Overall Study|Adverse Event|3|||
161249914|NCT00715676|582294678|FG001|Overall Study|Adverse Event|5|||
161249915|NCT00715676|582294679|FG002|Overall Study|Adverse Event|21|||
160838221|NCT03624127|580793921|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
160838222|NCT03624127|580793922|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
160838223|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
160838224|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
160838225|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
160838226|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
160838227|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
160838228|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
160838229|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
160838230|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
160838231|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
160838232|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
160838233|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
160838234|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
160838235|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
160838236|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
160838237|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
160838238|NCT03624127|580793920|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
160838239|NCT03624127|580793921|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
160838240|NCT03624127|580793922|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
160838241|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
160838242|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
160838243|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
160838244|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
160838245|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
160838246|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
160838247|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
160838248|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
160838249|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
160838250|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
161249916|NCT00715676|582294677|FG000|Overall Study|Withdrawal by Subject|1|||
161249917|NCT00715676|582294678|FG001|Overall Study|Withdrawal by Subject|3|||
160838251|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
160838252|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
161249918|NCT00715676|582294679|FG002|Overall Study|Withdrawal by Subject|8|||
161249919|NCT00715676|582294677|FG000|Overall Study|Lost to Follow-up|1|||
160838253|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
160838254|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
160838255|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
160838256|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
160838257|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
160838258|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161138496|NCT01896232|581888661|FG000|Overall Study|Death|6|||
161138497|NCT01896232|581888662|FG001|Overall Study|Death|10|||
161138498|NCT01896232|581888661|FG000|Overall Study|Withdrawal by Subject|32|||
160838259|NCT03624127|580793920|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
160838260|NCT03624127|580793921|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
160838261|NCT03624127|580793922|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
160838262|NCT01817959|580793923|FG000|Overall Study|Graft loss|1|||
160838263|NCT01817959|580793924|FG001|Overall Study|Graft loss|1|||
160838264|NCT01817959|580793923|FG000|Overall Study|forbidden medication|1|||
160838265|NCT01817959|580793924|FG001|Overall Study|forbidden medication|1|||
160838266|NCT01817959|580793923|FG000|Overall Study|Adverse Event|1|||
160838267|NCT01817959|580793924|FG001|Overall Study|Adverse Event|0|||
160838268|NCT01817959|580793923|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
160838269|NCT01817959|580793924|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
160838270|NCT01123707|580793925|FG000|Overall Study|Lost to Follow-up|3|||
160838271|NCT01123707|580793926|FG001|Overall Study|Lost to Follow-up|1|||
160838272|NCT01123707|580793927|FG002|Overall Study|Lost to Follow-up|3|||
160838273|NCT01123707|580793928|FG003|Overall Study|Lost to Follow-up|2|||
160838274|NCT01123707|580793925|FG000|Overall Study|Adverse Event|5|||
160838275|NCT01123707|580793926|FG001|Overall Study|Adverse Event|7|||
160838276|NCT01123707|580793927|FG002|Overall Study|Adverse Event|5|||
160838277|NCT01123707|580793928|FG003|Overall Study|Adverse Event|3|||
160838278|NCT01123707|580793925|FG000|Overall Study|Sponsor Discontinued Study|30|||
160838279|NCT01123707|580793926|FG001|Overall Study|Sponsor Discontinued Study|24|||
160838280|NCT01123707|580793927|FG002|Overall Study|Sponsor Discontinued Study|25|||
160838281|NCT01123707|580793928|FG003|Overall Study|Sponsor Discontinued Study|40|||
160838282|NCT01123707|580793925|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
160838283|NCT01123707|580793926|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
160838284|NCT01123707|580793927|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
160838285|NCT01123707|580793928|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
160838286|NCT01123707|580793925|FG000|Overall Study|Investigator Withdrew Participant|0|||
160838287|NCT01123707|580793926|FG001|Overall Study|Investigator Withdrew Participant|1|||
160838288|NCT01123707|580793927|FG002|Overall Study|Investigator Withdrew Participant|1|||
160838289|NCT01123707|580793928|FG003|Overall Study|Investigator Withdrew Participant|1|||
160838290|NCT01123707|580793925|FG000|Overall Study|Subject Withdrew Consent|4|||
160838291|NCT01123707|580793926|FG001|Overall Study|Subject Withdrew Consent|5|||
160838292|NCT01123707|580793927|FG002|Overall Study|Subject Withdrew Consent|1|||
160838293|NCT01123707|580793928|FG003|Overall Study|Subject Withdrew Consent|2|||
160838294|NCT01123707|580793925|FG000|Overall Study|Lack of Efficacy|1|||
160838295|NCT01123707|580793926|FG001|Overall Study|Lack of Efficacy|2|||
160838296|NCT01123707|580793927|FG002|Overall Study|Lack of Efficacy|1|||
160904445|NCT02609828|581044966|FG000|Overall Study|Insufficient clinical response|2|||
160904446|NCT02609828|581044967|FG001|Overall Study|Insufficient clinical response|1|||
160904447|NCT02609828|581044968|FG002|Overall Study|Insufficient clinical response|0|||
160904448|NCT02609828|581044969|FG003|Overall Study|Insufficient clinical response|0|||
160904449|NCT02609828|581044966|FG000|Overall Study|Lost to Follow-up|0|||
160904450|NCT02609828|581044967|FG001|Overall Study|Lost to Follow-up|0|||
160904451|NCT02609828|581044968|FG002|Overall Study|Lost to Follow-up|0|||
160904452|NCT02609828|581044969|FG003|Overall Study|Lost to Follow-up|1|||
161138499|NCT01896232|581888662|FG001|Overall Study|Withdrawal by Subject|31|||
161138500|NCT01896232|581888661|FG000|Overall Study|Sponsor Decision|2|||
161138501|NCT01896232|581888662|FG001|Overall Study|Sponsor Decision|0|||
161138502|NCT01896232|581888661|FG000|Overall Study|Lost to Follow-up|9|||
161138503|NCT01896232|581888662|FG001|Overall Study|Lost to Follow-up|12|||
161138504|NCT00686205|581888663|FG000|Overall Study|Protocol Violation|127|||
161138505|NCT00686205|581888664|FG001|Overall Study|Protocol Violation|0|||
161138506|NCT00686205|581888663|FG000|Overall Study|Withdrawal by Subject|2|||
161138507|NCT00686205|581888664|FG001|Overall Study|Withdrawal by Subject|0|||
161138508|NCT00686205|581888663|FG000|Overall Study|Specimen handling procedure altered|5878|||
161138509|NCT00686205|581888664|FG001|Overall Study|Specimen handling procedure altered|0|||
161138510|NCT00686205|581888663|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
161138511|NCT00686205|581888664|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
161138512|NCT01535235|581888678|FG000|Overall Study|Adverse Event|1|||
161138513|NCT01535235|581888679|FG001|Overall Study|Adverse Event|0|||
161138514|NCT03075839|581888686|FG000|Overall Study|Lost to Follow-up|4|||
161138515|NCT05421754|581888691|FG000|Overall Study|Technical issue with sensor|1|||
161138516|NCT01051739|581888692|FG000|Overall Study|Death|3|||
161138517|NCT01051739|581888693|FG001|Overall Study|Death|3|||
161138518|NCT01051739|581888692|FG000|Overall Study|Withdrawal by Subject|25|||
161249920|NCT00715676|582294678|FG001|Overall Study|Lost to Follow-up|2|||
161249921|NCT00715676|582294679|FG002|Overall Study|Lost to Follow-up|1|||
161249922|NCT00715676|582294677|FG000|Overall Study|Terminated by Sponsor|1|||
161249923|NCT00715676|582294678|FG001|Overall Study|Terminated by Sponsor|0|||
161249924|NCT00715676|582294679|FG002|Overall Study|Terminated by Sponsor|0|||
161249925|NCT00715676|582294677|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
161249926|NCT00715676|582294678|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
161249927|NCT00715676|582294679|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
161249928|NCT00715676|582294677|FG000|Overall Study|Use of Exclusionary Medication|0|||
161249929|NCT00715676|582294678|FG001|Overall Study|Use of Exclusionary Medication|0|||
161249930|NCT00715676|582294679|FG002|Overall Study|Use of Exclusionary Medication|1|||
161249931|NCT00715676|582294677|FG000|Overall Study|Elevated Blood Glucose|0|||
161249932|NCT00715676|582294678|FG001|Overall Study|Elevated Blood Glucose|1|||
161249933|NCT00715676|582294679|FG002|Overall Study|Elevated Blood Glucose|0|||
161249934|NCT01547728|582294680|FG000|Overall Study|Change in procedure and equipment|1|||
161249935|NCT01547728|582294680|FG000|Overall Study|Drug not ready for subject|1|||
161249936|NCT01547728|582294680|FG000|Overall Study|Screen failure|39|||
161249937|NCT03828539|582294681|FG000|Overall Study|Adverse Event|3|||
161249938|NCT03828539|582294682|FG001|Overall Study|Adverse Event|12|||
161249939|NCT03828539|582294681|FG000|Overall Study|Patient's/guardian's decision|3|||
161249940|NCT03828539|582294682|FG001|Overall Study|Patient's/guardian's decision|5|||
161249941|NCT03828539|582294681|FG000|Overall Study|Lost to Follow-up|4|||
161249942|NCT03828539|582294682|FG001|Overall Study|Lost to Follow-up|2|||
161249943|NCT03828539|582294681|FG000|Overall Study|Protocol Violation|3|||
161249944|NCT03828539|582294682|FG001|Overall Study|Protocol Violation|2|||
161249945|NCT03828539|582294681|FG000|Overall Study|Withdrawal of informed consent|2|||
161249946|NCT03828539|582294682|FG001|Overall Study|Withdrawal of informed consent|1|||
161249947|NCT03828539|582294681|FG000|Overall Study|New therapy for study indication|1|||
161138519|NCT01051739|581888693|FG001|Overall Study|Withdrawal by Subject|10|||
161138520|NCT05089708|581888694|FG000|Overall Study|Lost to Follow-up|9|||
161138521|NCT05089708|581888695|FG001|Overall Study|Lost to Follow-up|7|||
161138522|NCT05089708|581888694|FG000|Overall Study|Withdrawal by Subject|3|||
161249948|NCT03828539|582294682|FG001|Overall Study|New therapy for study indication|0|||
161249949|NCT01341405|582294683|FG000|Overall Study|Adverse Event|0|||
161138523|NCT05089708|581888695|FG001|Overall Study|Withdrawal by Subject|1|||
161138524|NCT05089708|581888694|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
161138525|NCT05089708|581888695|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
161138526|NCT05089708|581888694|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
161138527|NCT05089708|581888695|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
161138528|NCT02469246|581888696|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
161138529|NCT02469246|581888697|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
161138530|NCT02469246|581888696|FG000|Double-Blind Phase|Adverse Event|12|||
161138531|NCT02469246|581888697|FG001|Double-Blind Phase|Adverse Event|9|||
161138532|NCT02469246|581888696|FG000|Double-Blind Phase|Death|2|||
161138533|NCT02469246|581888697|FG001|Double-Blind Phase|Death|0|||
161138534|NCT02469246|581888696|FG000|Double-Blind Phase|Lack of Efficacy|2|||
161138535|NCT02469246|581888697|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161138536|NCT02469246|581888696|FG000|Double-Blind Phase|Investigator's Discretion|8|||
161138537|NCT02469246|581888697|FG001|Double-Blind Phase|Investigator's Discretion|8|||
161138538|NCT02469246|581888696|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
161138539|NCT02469246|581888697|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161138540|NCT02469246|581888696|FG000|Double-Blind Phase|Protocol Violation|1|||
161138541|NCT02469246|581888697|FG001|Double-Blind Phase|Protocol Violation|1|||
161138542|NCT02469246|581888696|FG000|Double-Blind Phase|Withdrew Consent|25|||
161138543|NCT02469246|581888697|FG001|Double-Blind Phase|Withdrew Consent|25|||
161138544|NCT02469246|581888696|FG000|Double-Blind Phase|Lost to Follow-up|9|||
161138545|NCT02469246|581888697|FG001|Double-Blind Phase|Lost to Follow-up|5|||
161138546|NCT00922935|581888701|FG000|Overall Study|Protocol Violation|0|||
161138547|NCT00922935|581888702|FG001|Overall Study|Protocol Violation|3|||
161138548|NCT00922935|581888703|FG002|Overall Study|Protocol Violation|0|||
161249950|NCT01341405|582294684|FG001|Overall Study|Adverse Event|1|||
161249951|NCT01341405|582294685|FG002|Overall Study|Adverse Event|1|||
161249952|NCT01341405|582294683|FG000|Overall Study|Withdrawal by Subject|3|||
161249953|NCT01341405|582294684|FG001|Overall Study|Withdrawal by Subject|2|||
161249954|NCT01341405|582294685|FG002|Overall Study|Withdrawal by Subject|1|||
161249955|NCT02760433|582294686|FG000|Overall Study|Lost to Follow-up|1|||
161249956|NCT02760433|582294687|FG001|Overall Study|Lost to Follow-up|0|||
161249957|NCT02760433|582294688|FG002|Overall Study|Lost to Follow-up|1|||
161249958|NCT02760433|582294689|FG003|Overall Study|Lost to Follow-up|0|||
161249959|NCT02760433|582294690|FG004|Overall Study|Lost to Follow-up|0|||
161249960|NCT02760433|582294686|FG000|Overall Study|Withdrawal by Subject|23|||
161138549|NCT00922935|581888701|FG000|Overall Study|Physician Decision|1|||
161138550|NCT00922935|581888702|FG001|Overall Study|Physician Decision|1|||
161138551|NCT00922935|581888703|FG002|Overall Study|Physician Decision|0|||
161138552|NCT00922935|581888701|FG000|Overall Study|Lost to Follow-up|0|||
161138553|NCT00922935|581888702|FG001|Overall Study|Lost to Follow-up|1|||
160991738|NCT00430677|581357895|FG002|Long-term Extension Period|Lost to Follow-up|1|||
160991739|NCT00430677|581357893|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
160991740|NCT00430677|581357894|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
160991741|NCT00430677|581357895|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
160991742|NCT00430677|581357893|FG000|Long-term Extension Period|Pregnancy|1|||
160991743|NCT00430677|581357894|FG001|Long-term Extension Period|Pregnancy|1|||
160991744|NCT00430677|581357895|FG002|Long-term Extension Period|Pregnancy|0|||
160991745|NCT00430677|581357893|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
160991746|NCT00430677|581357894|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
160991747|NCT00430677|581357895|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
160991748|NCT00430677|581357893|FG000|Long-term Extension Period|Other|2|||
160991749|NCT00430677|581357894|FG001|Long-term Extension Period|Other|1|||
160991750|NCT00430677|581357895|FG002|Long-term Extension Period|Other|1|||
160991751|NCT00430677|581357893|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
160991752|NCT00430677|581357894|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
160991753|NCT00430677|581357895|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
160991754|NCT01555762|581357896|FG000|Overall Study|No information on Bevacizumab intake|11|||
160991755|NCT01555762|581357896|FG000|Overall Study|Missing start date of infusion|8|||
160991756|NCT01555762|581357896|FG000|Overall Study|75 years old or more ticked No|1|||
160991757|NCT01555762|581357896|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
160991758|NCT01555762|581357896|FG000|Overall Study|Death linked to progression of disease|165|||
160991759|NCT01555762|581357896|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
160991760|NCT01555762|581357896|FG000|Overall Study|Investigator's decision|10|||
160991761|NCT01555762|581357896|FG000|Overall Study|Participant not wishing to continue|5|||
160991762|NCT01555762|581357896|FG000|Overall Study|Missing data|1|||
160991763|NCT01555762|581357896|FG000|Overall Study|Death linked to an adverse event|14|||
160991764|NCT00299702|581357903|FG000|Overall Study|Death|1|||
160991765|NCT00299702|581357904|FG001|Overall Study|Death|0|||
160991766|NCT00299702|581357903|FG000|Overall Study|Adverse Event|0|||
160991767|NCT00299702|581357904|FG001|Overall Study|Adverse Event|4|||
160991768|NCT00299702|581357903|FG000|Overall Study|Lost to Follow-up|18|||
160991769|NCT00299702|581357904|FG001|Overall Study|Lost to Follow-up|10|||
160991770|NCT00299702|581357903|FG000|Overall Study|Withdrawal by Subject|25|||
160991771|NCT00299702|581357904|FG001|Overall Study|Withdrawal by Subject|23|||
160991772|NCT00299702|581357903|FG000|Overall Study|Pregnancy|0|||
160991773|NCT00299702|581357904|FG001|Overall Study|Pregnancy|1|||
160991774|NCT00299702|581357903|FG000|Overall Study|Insufficient Response|4|||
160991775|NCT00299702|581357904|FG001|Overall Study|Insufficient Response|3|||
160991776|NCT00299702|581357903|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
161138554|NCT00922935|581888703|FG002|Overall Study|Lost to Follow-up|0|||
161138555|NCT01491945|581888704|FG000|Overall Study|Death|30|||
161138556|NCT01491945|581888704|FG000|Overall Study|Withdrwan/LTF|16|||
161138557|NCT01491945|581888704|FG000|Overall Study|Conversion|4|||
161138558|NCT01491945|581888704|FG000|Overall Study|Missed Visit|1|||
161138559|NCT02201940|581888705|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
161138560|NCT02201940|581888706|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
161138561|NCT02201940|581888705|FG000|Overall Study|Lack of Efficacy|2|||
161138562|NCT02201940|581888706|FG001|Overall Study|Lack of Efficacy|113|||
161138563|NCT02201940|581888705|FG000|Overall Study|Lost to Follow-up|5|||
161138564|NCT02201940|581888706|FG001|Overall Study|Lost to Follow-up|0|||
161138565|NCT02201940|581888705|FG000|Overall Study|Withdrew Consent|2|||
161138566|NCT02201940|581888706|FG001|Overall Study|Withdrew Consent|1|||
161138567|NCT02201940|581888705|FG000|Overall Study|Investigator's Discretion|1|||
161138568|NCT02201940|581888706|FG001|Overall Study|Investigator's Discretion|1|||
161138569|NCT02201940|581888705|FG000|Overall Study|Death|1|||
161138570|NCT02201940|581888706|FG001|Overall Study|Death|0|||
161138571|NCT02201940|581888705|FG000|Overall Study|Adverse Event|0|||
161138572|NCT02201940|581888706|FG001|Overall Study|Adverse Event|1|||
161138573|NCT00074958|581888708|FG000|Overall Study|Adverse Event|1|||
161138574|NCT02700451|581888712|FG000|Overall Study|Protocol Violation|2|||
161138575|NCT02700451|581888713|FG001|Overall Study|Protocol Violation|2|||
161138576|NCT02700451|581888714|FG002|Overall Study|Protocol Violation|3|||
161138577|NCT02700451|581888712|FG000|Overall Study|Discontinued intervention|14|||
161138578|NCT02700451|581888713|FG001|Overall Study|Discontinued intervention|15|||
161138579|NCT02700451|581888714|FG002|Overall Study|Discontinued intervention|14|||
161138580|NCT01511445|581888715|FG000|Overall Study|Lost to Follow-up|3|||
161138581|NCT01511445|581888716|FG001|Overall Study|Lost to Follow-up|1|||
161138582|NCT01511445|581888715|FG000|Overall Study|Protocol Violation|1|||
161138583|NCT01511445|581888716|FG001|Overall Study|Protocol Violation|3|||
161138584|NCT01511445|581888715|FG000|Overall Study|Protocol Violation|1|||
161138585|NCT01511445|581888716|FG001|Overall Study|Protocol Violation|0|||
161138586|NCT01856114|581888717|FG000|Overall Study|Withdrawal by Subject|1|||
161138587|NCT01856114|581888718|FG001|Overall Study|Withdrawal by Subject|0|||
161138588|NCT01856114|581888717|FG000|Overall Study|Adverse Event|1|||
161138589|NCT01856114|581888718|FG001|Overall Study|Adverse Event|0|||
160838297|NCT01123707|580793928|FG003|Overall Study|Lack of Efficacy|0|||
160838298|NCT01123707|580793925|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
160838299|NCT01123707|580793926|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
160838300|NCT01123707|580793927|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
160838301|NCT01123707|580793928|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
160838302|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
160838303|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
160838304|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
160838305|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
160838306|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
160838307|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
160838308|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
160838309|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
160991777|NCT00299702|581357904|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
161138590|NCT02853760|581888719|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
161138591|NCT02853760|581888720|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
161138592|NCT02853760|581888721|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
160838310|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Death|0|||
160838311|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Death|1|||
160838312|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
160838313|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
160838314|NCT03281304|580793931|FG000|Treatment Phase (up to 42 Months)|Other|0|||
160838315|NCT03281304|580793932|FG001|Treatment Phase (up to 42 Months)|Other|2|||
160838316|NCT03281304|580793931|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
160838317|NCT03281304|580793932|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
160838318|NCT00858637|580793933|FG000|Active Comparison Phase|Adverse Event|14|||
160838319|NCT00858637|580793934|FG001|Active Comparison Phase|Adverse Event|0|||
160838320|NCT00858637|580793935|FG002|Active Comparison Phase|Adverse Event|0|||
160838321|NCT00858637|580793936|FG003|Active Comparison Phase|Adverse Event|9|||
160838322|NCT00858637|580793937|FG004|Active Comparison Phase|Adverse Event|0|||
160838323|NCT00858637|580793938|FG005|Active Comparison Phase|Adverse Event|0|||
160838324|NCT00858637|580793933|FG000|Active Comparison Phase|Death|1|||
160838325|NCT00858637|580793934|FG001|Active Comparison Phase|Death|0|||
160838326|NCT00858637|580793935|FG002|Active Comparison Phase|Death|0|||
160838327|NCT00858637|580793936|FG003|Active Comparison Phase|Death|1|||
160838328|NCT00858637|580793937|FG004|Active Comparison Phase|Death|0|||
160838329|NCT00858637|580793938|FG005|Active Comparison Phase|Death|0|||
160838330|NCT00858637|580793933|FG000|Active Comparison Phase|Physician Decision|1|||
160838331|NCT00858637|580793934|FG001|Active Comparison Phase|Physician Decision|0|||
160838332|NCT00858637|580793935|FG002|Active Comparison Phase|Physician Decision|0|||
160838333|NCT00858637|580793936|FG003|Active Comparison Phase|Physician Decision|1|||
160838334|NCT00858637|580793937|FG004|Active Comparison Phase|Physician Decision|0|||
160838335|NCT00858637|580793938|FG005|Active Comparison Phase|Physician Decision|0|||
160838336|NCT00858637|580793933|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
160991778|NCT03905135|581359889|FG000|Dose Escalation|Adverse Event|1|||
161138593|NCT02853760|581888722|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
161138594|NCT02853760|581888723|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
161138595|NCT02853760|581888724|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
161138596|NCT01642212|581888725|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
161138597|NCT01642212|581888726|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161138598|NCT01642212|581888727|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161138599|NCT01642212|581888728|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161138600|NCT01642212|581888729|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
161138601|NCT01642212|581888725|FG000|Double-blind Treatment|Other|0|||
161138602|NCT01642212|581888726|FG001|Double-blind Treatment|Other|2|||
161138603|NCT01642212|581888727|FG002|Double-blind Treatment|Other|1|||
161138604|NCT01642212|581888728|FG003|Double-blind Treatment|Other|0|||
161138605|NCT01642212|581888729|FG004|Double-blind Treatment|Other|0|||
161138606|NCT01642212|581888725|FG000|Double-blind Treatment|Non-compliance|0|||
161138607|NCT01642212|581888726|FG001|Double-blind Treatment|Non-compliance|1|||
161138608|NCT01642212|581888727|FG002|Double-blind Treatment|Non-compliance|0|||
161138609|NCT01642212|581888728|FG003|Double-blind Treatment|Non-compliance|0|||
161138610|NCT01642212|581888729|FG004|Double-blind Treatment|Non-compliance|0|||
161138611|NCT01642212|581888725|FG000|Double-blind Treatment|Adverse Event|0|||
161138612|NCT01642212|581888726|FG001|Double-blind Treatment|Adverse Event|0|||
161138613|NCT01642212|581888727|FG002|Double-blind Treatment|Adverse Event|1|||
161138614|NCT01642212|581888728|FG003|Double-blind Treatment|Adverse Event|0|||
161138615|NCT01642212|581888729|FG004|Double-blind Treatment|Adverse Event|0|||
161138616|NCT01642212|581888725|FG000|Open-label Extension|Adverse Event|0|||
161138617|NCT01642212|581888726|FG001|Open-label Extension|Adverse Event|0|||
161138618|NCT01642212|581888727|FG002|Open-label Extension|Adverse Event|0|||
161138619|NCT01642212|581888728|FG003|Open-label Extension|Adverse Event|3|||
161249961|NCT02760433|582294687|FG001|Overall Study|Withdrawal by Subject|9|||
161249962|NCT02760433|582294688|FG002|Overall Study|Withdrawal by Subject|0|||
161249963|NCT02760433|582294689|FG003|Overall Study|Withdrawal by Subject|2|||
161249964|NCT02760433|582294690|FG004|Overall Study|Withdrawal by Subject|9|||
161249965|NCT02760433|582294686|FG000|Overall Study|Lack of Response At Week 14|0|||
161249966|NCT02760433|582294687|FG001|Overall Study|Lack of Response At Week 14|0|||
161249967|NCT02760433|582294688|FG002|Overall Study|Lack of Response At Week 14|0|||
161249968|NCT02760433|582294689|FG003|Overall Study|Lack of Response At Week 14|0|||
161249969|NCT02760433|582294690|FG004|Overall Study|Lack of Response At Week 14|1|||
161249970|NCT02760433|582294686|FG000|Overall Study|Subject refused to continue the study|1|||
161249971|NCT02760433|582294687|FG001|Overall Study|Subject refused to continue the study|0|||
161249972|NCT02760433|582294688|FG002|Overall Study|Subject refused to continue the study|0|||
161249973|NCT02760433|582294689|FG003|Overall Study|Subject refused to continue the study|0|||
161249974|NCT02760433|582294690|FG004|Overall Study|Subject refused to continue the study|0|||
161249975|NCT02760433|582294686|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
161249976|NCT02760433|582294687|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161249977|NCT02760433|582294688|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161249978|NCT02760433|582294689|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161249979|NCT02760433|582294690|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
161249980|NCT02760433|582294686|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161249981|NCT02760433|582294687|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
161249982|NCT02760433|582294688|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161249983|NCT02760433|582294689|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161249984|NCT02760433|582294690|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
161249985|NCT03448692|582294695|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
161249986|NCT03448692|582294696|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
161249987|NCT03448692|582294695|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
161249988|NCT03448692|582294696|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
161249989|NCT03448692|582294695|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
160838337|NCT00858637|580793934|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
160838338|NCT00858637|580793935|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
160838339|NCT00858637|580793936|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
160838340|NCT00858637|580793937|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
160838341|NCT00858637|580793938|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
160838342|NCT00858637|580793933|FG000|Active Comparison Phase|Other Reasons|1|||
160838343|NCT00858637|580793934|FG001|Active Comparison Phase|Other Reasons|0|||
160838344|NCT00858637|580793935|FG002|Active Comparison Phase|Other Reasons|0|||
160838345|NCT00858637|580793936|FG003|Active Comparison Phase|Other Reasons|1|||
160838346|NCT00858637|580793937|FG004|Active Comparison Phase|Other Reasons|0|||
160838347|NCT00858637|580793938|FG005|Active Comparison Phase|Other Reasons|0|||
160838348|NCT00858637|580793933|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
160838349|NCT00858637|580793934|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
160838350|NCT00858637|580793935|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
160838351|NCT00858637|580793936|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
160838352|NCT00858637|580793937|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
160838353|NCT00858637|580793938|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
160838354|NCT00858637|580793933|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838355|NCT00858637|580793934|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838356|NCT00858637|580793935|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838357|NCT00858637|580793936|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838358|NCT00858637|580793937|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
160838359|NCT00858637|580793938|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
160838360|NCT00605345|580793941|FG000|Overall Study|Withdrawal by Subject|1|||
160838361|NCT00605345|580793942|FG001|Overall Study|Withdrawal by Subject|0|||
160904453|NCT02609828|581044966|FG000|Overall Study|Protocol Violation|2|||
161249990|NCT03448692|582294696|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
161249991|NCT03448692|582294695|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
160838362|NCT00605345|580793941|FG000|Overall Study|Adverse Event|0|||
160838363|NCT00605345|580793942|FG001|Overall Study|Adverse Event|1|||
160838364|NCT00605345|580793941|FG000|Overall Study|Protocol Violation|0|||
160838365|NCT00605345|580793942|FG001|Overall Study|Protocol Violation|2|||
160838366|NCT02577016|580793943|FG000|Overall Study|Adverse Event|2|||
160838367|NCT02577016|580793944|FG001|Overall Study|Adverse Event|1|||
160904454|NCT02609828|581044967|FG001|Overall Study|Protocol Violation|0|||
160838368|NCT02577016|580793943|FG000|Overall Study|Physician Decision|0|||
160904455|NCT02609828|581044968|FG002|Overall Study|Protocol Violation|0|||
160904456|NCT02609828|581044969|FG003|Overall Study|Protocol Violation|1|||
160838369|NCT02577016|580793944|FG001|Overall Study|Physician Decision|1|||
160838370|NCT02126839|580793945|FG000|Overall Study|Adverse Event|0|||
160838371|NCT02126839|580793946|FG001|Overall Study|Adverse Event|1|||
160838372|NCT02126839|580793945|FG000|Overall Study|Withdrawal by Subject|1|||
160838373|NCT02126839|580793946|FG001|Overall Study|Withdrawal by Subject|0|||
160838374|NCT02126839|580793945|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160838375|NCT02126839|580793946|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160838376|NCT02126839|580793945|FG000|Overall Study|Protocol Violation|2|||
160838377|NCT02126839|580793946|FG001|Overall Study|Protocol Violation|3|||
160838378|NCT02126839|580793945|FG000|Overall Study|Sponsor request|0|||
160838379|NCT02126839|580793946|FG001|Overall Study|Sponsor request|1|||
160838380|NCT02126839|580793945|FG000|Overall Study|Lost to Follow-up|1|||
160838381|NCT02126839|580793946|FG001|Overall Study|Lost to Follow-up|4|||
160838382|NCT02126839|580793945|FG000|Overall Study|Other|5|||
160838383|NCT02126839|580793946|FG001|Overall Study|Other|5|||
160838384|NCT00687531|580793949|FG000|Overall Study|Did not meet protocol eligibility|104|||
160838385|NCT00687531|580793949|FG000|Overall Study|Adverse Event|5|||
160838386|NCT00687531|580793949|FG000|Overall Study|Lost to Follow-up|26|||
160838387|NCT00666224|580795681|FG000|Double-Blind|Adverse Event|15|||
160838388|NCT00666224|580795682|FG001|Double-Blind|Adverse Event|5|||
160838389|NCT00666224|580795681|FG000|Double-Blind|Lost to Follow-up|2|||
160838390|NCT00666224|580795682|FG001|Double-Blind|Lost to Follow-up|2|||
160838391|NCT00666224|580795681|FG000|Double-Blind|Withdrawal by Subject|18|||
160838392|NCT00666224|580795682|FG001|Double-Blind|Withdrawal by Subject|14|||
160838393|NCT00666224|580795681|FG000|Double-Blind|Physician Decision|0|||
160838394|NCT00666224|580795682|FG001|Double-Blind|Physician Decision|3|||
160838395|NCT00666224|580795681|FG000|Double-Blind|Sponsor decision|1|||
160838396|NCT00666224|580795682|FG001|Double-Blind|Sponsor decision|0|||
160838397|NCT00666224|580795681|FG000|Double-Blind|Pregnancy|3|||
160838398|NCT00666224|580795682|FG001|Double-Blind|Pregnancy|2|||
160838399|NCT00666224|580795681|FG000|Double-Blind|Noncompliance|1|||
160838400|NCT00666224|580795682|FG001|Double-Blind|Noncompliance|0|||
160838401|NCT00666224|580795681|FG000|Double-Blind|Death|1|||
160838402|NCT00666224|580795682|FG001|Double-Blind|Death|0|||
160838403|NCT00666224|580795681|FG000|Double-Blind|Undefined/Unknown|4|||
160838404|NCT00666224|580795682|FG001|Double-Blind|Undefined/Unknown|1|||
160838405|NCT00666224|580795681|FG000|Open-Label|Adverse Event|8|||
160838406|NCT00666224|580795682|FG001|Open-Label|Adverse Event|43|||
160838407|NCT00666224|580795681|FG000|Open-Label|Lost to Follow-up|4|||
160838408|NCT00666224|580795682|FG001|Open-Label|Lost to Follow-up|5|||
160838409|NCT00666224|580795681|FG000|Open-Label|Withdrawal by Subject|12|||
160838410|NCT00666224|580795682|FG001|Open-Label|Withdrawal by Subject|25|||
160838411|NCT00666224|580795681|FG000|Open-Label|Physician Decision|7|||
160838412|NCT00666224|580795682|FG001|Open-Label|Physician Decision|5|||
160838413|NCT00666224|580795681|FG000|Open-Label|Pregnancy|1|||
160838414|NCT00666224|580795682|FG001|Open-Label|Pregnancy|5|||
160838415|NCT00666224|580795681|FG000|Open-Label|Noncompliance|2|||
160838416|NCT00666224|580795682|FG001|Open-Label|Noncompliance|1|||
160838417|NCT00666224|580795681|FG000|Open-Label|Undefined/Unknown|1|||
160838418|NCT00666224|580795682|FG001|Open-Label|Undefined/Unknown|1|||
160838419|NCT03521141|580795683|FG000|Overall Study|Death|1|||
160838420|NCT03521141|580795684|FG001|Overall Study|Death|0|||
160838421|NCT03521141|580795685|FG002|Overall Study|Death|1|||
160838422|NCT03828617|580795687|FG000|Overall Study|Lost to Follow-up|22|||
160838423|NCT03828617|580795688|FG001|Overall Study|Lost to Follow-up|12|||
160838424|NCT03828617|580795689|FG002|Overall Study|Lost to Follow-up|23|||
160838425|NCT03828617|580795690|FG003|Overall Study|Lost to Follow-up|7|||
160838426|NCT03828617|580795687|FG000|Overall Study|No longer met eligibility criteria|0|||
160838427|NCT03828617|580795688|FG001|Overall Study|No longer met eligibility criteria|1|||
160838428|NCT03828617|580795689|FG002|Overall Study|No longer met eligibility criteria|1|||
160838429|NCT03828617|580795690|FG003|Overall Study|No longer met eligibility criteria|3|||
160838430|NCT03828617|580795687|FG000|Overall Study|Protocol Violation|0|||
160838431|NCT03828617|580795688|FG001|Overall Study|Protocol Violation|2|||
160838432|NCT03828617|580795689|FG002|Overall Study|Protocol Violation|0|||
160838433|NCT03828617|580795690|FG003|Overall Study|Protocol Violation|0|||
160838434|NCT03828617|580795687|FG000|Overall Study|Withdrawal by Subject|2|||
160838435|NCT03828617|580795688|FG001|Overall Study|Withdrawal by Subject|0|||
160838436|NCT03828617|580795689|FG002|Overall Study|Withdrawal by Subject|2|||
160838437|NCT03828617|580795690|FG003|Overall Study|Withdrawal by Subject|0|||
160838438|NCT03354273|580795691|FG000|Overall Study|Adverse Event|5|||
160838439|NCT03354273|580795691|FG000|Overall Study|Screen Failure|21|||
160838440|NCT03354273|580795691|FG000|Overall Study|Withdrawal by Subject|34|||
160838441|NCT03354273|580795691|FG000|Overall Study|Technical Problems|30|||
160838442|NCT03354273|580795691|FG000|Overall Study|Lost to Follow-up|4|||
160838443|NCT03354273|580795691|FG000|Overall Study|Investigator Decision|3|||
160838444|NCT03354273|580795691|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
160838445|NCT03354273|580795691|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
160838446|NCT03354273|580795691|FG000|Overall Study|COVID-19 Restrictions|9|||
160838447|NCT03354273|580795691|FG000|Overall Study|Other|5|||
160838448|NCT00303485|580795692|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
161249992|NCT03448692|582294696|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
161249993|NCT03448692|582294695|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
161249994|NCT03448692|582294696|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
161249995|NCT02786927|582294699|FG000|Overall Study|Adverse Event|1|||
161249996|NCT02786927|582294699|FG000|Overall Study|Protocol Violation|4|||
161249997|NCT01801917|582294700|FG000|Period 1 - Randomized|Adverse Event|1|||
161249998|NCT01801917|582294701|FG001|Period 1 - Randomized|Adverse Event|0|||
161249999|NCT01801917|582294702|FG002|Period 1 - Randomized|Adverse Event|1|||
161250000|NCT01801917|582294703|FG003|Period 1 - Randomized|Adverse Event|0|||
161250001|NCT01924364|582294704|FG000|Overall Study|Physician Decision|3|||
161250002|NCT00265785|582294705|FG000|Overall Study|Adverse Event|4|||
161250003|NCT00265785|582294705|FG000|Overall Study|Withdrawal by Subject|3|||
161250004|NCT00265785|582294705|FG000|Overall Study|Progression/Relapse|15|||
161250005|NCT00265785|582294705|FG000|Overall Study|Not protocol specified|2|||
161250006|NCT00265785|582294705|FG000|Overall Study|Ineligible|1|||
161250007|NCT00265785|582294705|FG000|Overall Study|Did not receive protocol treatment|2|||
161250008|NCT03919695|582294706|FG000|3-month Follow-up|Death|1|||
161250009|NCT03919695|582294707|FG001|3-month Follow-up|Death|1|||
161250010|NCT03919695|582294706|FG000|3-month Follow-up|unable to contact|0|||
161250011|NCT03919695|582294707|FG001|3-month Follow-up|unable to contact|3|||
161250012|NCT03919695|582294706|FG000|3-month Follow-up|in prison|0|||
161250013|NCT03919695|582294707|FG001|3-month Follow-up|in prison|1|||
161250014|NCT03919695|582294706|FG000|6-month Follow-up|Death|0|||
161250015|NCT03919695|582294707|FG001|6-month Follow-up|Death|1|||
161250016|NCT03919695|582294706|FG000|6-month Follow-up|Lost to Follow-up|1|||
161250017|NCT03919695|582294707|FG001|6-month Follow-up|Lost to Follow-up|2|||
161250018|NCT03919695|582294706|FG000|6-month Follow-up|in prison|0|||
161250019|NCT03919695|582294707|FG001|6-month Follow-up|in prison|2|||
161250020|NCT03919695|582294706|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
161250021|NCT03919695|582294707|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
161250022|NCT03919695|582294706|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
161250023|NCT03919695|582294707|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
161250024|NCT02416934|582294708|FG000|Overall Study|given steroids|1|||
161250025|NCT02416934|582294709|FG001|Overall Study|given steroids|2|||
161250026|NCT02416934|582294708|FG000|Overall Study|Lost to Follow-up|0|||
161250027|NCT02416934|582294709|FG001|Overall Study|Lost to Follow-up|2|||
161250028|NCT02416934|582294708|FG000|Overall Study|Withdrawal by Subject|1|||
161250029|NCT02416934|582294709|FG001|Overall Study|Withdrawal by Subject|0|||
161250030|NCT02416934|582294708|FG000|Overall Study|recruited during continuing renewal proc|0|||
161250031|NCT02416934|582294709|FG001|Overall Study|recruited during continuing renewal proc|1|||
160838449|NCT00303485|580795693|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
160838450|NCT00303485|580795692|FG000|Overall Study|Failure to return|0|||
160838451|NCT00303485|580795693|FG001|Overall Study|Failure to return|1|||
160838452|NCT00303485|580795692|FG000|Overall Study|Withdrawal by Subject|1|||
160838453|NCT00303485|580795693|FG001|Overall Study|Withdrawal by Subject|0|||
160838454|NCT00902174|580795701|FG000|Overall Study|Adverse Event|27|||
160838455|NCT00902174|580795702|FG001|Overall Study|Adverse Event|7|||
160838456|NCT00902174|580795701|FG000|Overall Study|Lack of Efficacy|1|||
160838457|NCT00902174|580795702|FG001|Overall Study|Lack of Efficacy|5|||
160838458|NCT00902174|580795701|FG000|Overall Study|Death|2|||
160838459|NCT00902174|580795702|FG001|Overall Study|Death|2|||
160838460|NCT00902174|580795701|FG000|Overall Study|Withdrawal by Subject|2|||
160838461|NCT00902174|580795702|FG001|Overall Study|Withdrawal by Subject|1|||
160838462|NCT00902174|580795701|FG000|Overall Study|Abnormal labs|1|||
160838463|NCT00902174|580795702|FG001|Overall Study|Abnormal labs|1|||
160838464|NCT00902174|580795701|FG000|Overall Study|Protocol Violation|1|||
160838465|NCT00902174|580795702|FG001|Overall Study|Protocol Violation|1|||
160838466|NCT00902174|580795701|FG000|Overall Study|Administration problem|0|||
160838467|NCT00902174|580795702|FG001|Overall Study|Administration problem|1|||
160838468|NCT00764673|580795703|FG000|Overall Study|Death|1|||
160838469|NCT00764673|580795703|FG000|Overall Study|Lost to Follow-up|3|||
160838470|NCT00764673|580795703|FG000|Overall Study|Withdrawal by Subject|6|||
160838471|NCT00764673|580795703|FG000|Overall Study|Revision of Device|2|||
160838472|NCT01331291|580795704|FG000|Overall Study|Lack of Efficacy|2|||
160838473|NCT01331291|580795705|FG001|Overall Study|Lack of Efficacy|8|||
160838474|NCT01331291|580795704|FG000|Overall Study|Death|0|||
160838475|NCT01331291|580795705|FG001|Overall Study|Death|1|||
161250032|NCT02416934|582294708|FG000|Overall Study|Protocol Violation|0|||
161250033|NCT02416934|582294709|FG001|Overall Study|Protocol Violation|1|||
161250034|NCT02416934|582294708|FG000|Overall Study|surgery started late|0|||
161250035|NCT02416934|582294709|FG001|Overall Study|surgery started late|1|||
161250036|NCT02416934|582294708|FG000|Overall Study|re-operation|1|||
161250037|NCT02416934|582294709|FG001|Overall Study|re-operation|0|||
161250038|NCT05467540|582294712|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
161250039|NCT05467540|582294712|FG000|3-Month Follow-up|Lost to Follow-up|4|||
161250040|NCT05467540|582294712|FG000|3-Month Follow-up|Death|5|||
161250041|NCT05467540|582294712|FG000|12-Month Follow-up|Lost to Follow-up|6|||
161250042|NCT05467540|582294712|FG000|12-Month Follow-up|Death|8|||
161250043|NCT05467540|582294712|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
161250044|NCT03382041|582294736|FG000|Overall Study|Consent Form Lost|2|||
161250045|NCT03382041|582294737|FG001|Overall Study|Consent Form Lost|1|||
161250046|NCT03382041|582294736|FG000|Overall Study|Withdrawal by Subject|1|||
161250047|NCT03382041|582294737|FG001|Overall Study|Withdrawal by Subject|4|||
161250048|NCT03382041|582294736|FG000|Overall Study|Lost to Follow-up|1|||
161250049|NCT03382041|582294737|FG001|Overall Study|Lost to Follow-up|4|||
161250050|NCT01374451|582294740|FG000|Overall Study|Administrative problems|1|||
161250051|NCT01374451|582294741|FG001|Overall Study|Administrative problems|0|||
161250052|NCT01337596|582294742|FG000|Overall Study|Withdrawal by Subject|0|||
161250053|NCT01337596|582294743|FG001|Overall Study|Withdrawal by Subject|0|||
161250054|NCT01337596|582294744|FG002|Overall Study|Withdrawal by Subject|0|||
161250055|NCT01337596|582294745|FG003|Overall Study|Withdrawal by Subject|0|||
161250056|NCT01337596|582294746|FG004|Overall Study|Withdrawal by Subject|2|||
161250057|NCT01337596|582294747|FG005|Overall Study|Withdrawal by Subject|0|||
161250058|NCT01337596|582294748|FG006|Overall Study|Withdrawal by Subject|0|||
161250059|NCT01337596|582294749|FG007|Overall Study|Withdrawal by Subject|0|||
161250060|NCT01337596|582294750|FG008|Overall Study|Withdrawal by Subject|0|||
161250061|NCT04640194|582294751|FG000|Overall Study|Adverse Event|3|||
161250062|NCT04640194|582294752|FG001|Overall Study|Adverse Event|7|||
161250063|NCT04640194|582294753|FG002|Overall Study|Adverse Event|0|||
161250064|NCT04640194|582294754|FG003|Overall Study|Adverse Event|5|||
161250065|NCT04640194|582294755|FG004|Overall Study|Adverse Event|0|||
161250066|NCT04640194|582294756|FG005|Overall Study|Adverse Event|4|||
161250067|NCT04640194|582294757|FG006|Overall Study|Adverse Event|0|||
161250068|NCT04640194|582294751|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
161250069|NCT04640194|582294752|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
161250070|NCT04640194|582294753|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
161250071|NCT04640194|582294754|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
161250072|NCT04640194|582294755|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
161250073|NCT04640194|582294756|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
161250074|NCT04640194|582294757|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
161250075|NCT04640194|582294751|FG000|Overall Study|fibrinogen level too low|0|||
161250076|NCT04640194|582294752|FG001|Overall Study|fibrinogen level too low|0|||
161250077|NCT04640194|582294753|FG002|Overall Study|fibrinogen level too low|0|||
161250078|NCT04640194|582294754|FG003|Overall Study|fibrinogen level too low|1|||
161250079|NCT04640194|582294755|FG004|Overall Study|fibrinogen level too low|0|||
161250080|NCT04640194|582294756|FG005|Overall Study|fibrinogen level too low|0|||
161250081|NCT04640194|582294757|FG006|Overall Study|fibrinogen level too low|0|||
161250082|NCT04640194|582294751|FG000|Overall Study|mild bleeding|0|||
161250083|NCT04640194|582294752|FG001|Overall Study|mild bleeding|0|||
161250084|NCT04640194|582294753|FG002|Overall Study|mild bleeding|0|||
161250085|NCT04640194|582294754|FG003|Overall Study|mild bleeding|1|||
161250086|NCT04640194|582294755|FG004|Overall Study|mild bleeding|0|||
161250087|NCT04640194|582294756|FG005|Overall Study|mild bleeding|0|||
161250088|NCT04640194|582294757|FG006|Overall Study|mild bleeding|0|||
161250089|NCT04640194|582294751|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161250090|NCT04640194|582294752|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
161250091|NCT04640194|582294753|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161250092|NCT04640194|582294754|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161250093|NCT04640194|582294755|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161250094|NCT04640194|582294756|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161250095|NCT04640194|582294757|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
161250096|NCT03201003|582294761|FG000|Overall Study|Adverse Event|14|||
161250097|NCT03201003|582294762|FG001|Overall Study|Adverse Event|1|||
161250098|NCT03201003|582294761|FG000|Overall Study|Other reasons|5|||
161250099|NCT03201003|582294762|FG001|Overall Study|Other reasons|1|||
161250100|NCT03201003|582294761|FG000|Overall Study|Withdrawal by Subject|4|||
160838476|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
160838477|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
160838478|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
160838479|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
160838480|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
160838481|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
160838482|NCT01389323|580795711|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
161250101|NCT03201003|582294762|FG001|Overall Study|Withdrawal by Subject|1|||
161250102|NCT03201003|582294761|FG000|Overall Study|Lost to Follow-up|2|||
161250103|NCT03201003|582294762|FG001|Overall Study|Lost to Follow-up|0|||
161250104|NCT03201003|582294761|FG000|Overall Study|Protocol Violation|1|||
161250105|NCT03201003|582294762|FG001|Overall Study|Protocol Violation|0|||
161250106|NCT01709903|582294768|FG000|Overall Study|administrative problems|2|||
161250107|NCT01709903|582294769|FG001|Overall Study|administrative problems|6|||
161250108|NCT01709903|582294768|FG000|Overall Study|Abnormal test procedure results|1|||
161250109|NCT01709903|582294769|FG001|Overall Study|Abnormal test procedure results|0|||
161250110|NCT01709903|582294768|FG000|Overall Study|In ability to use device|1|||
161250111|NCT01709903|582294769|FG001|Overall Study|In ability to use device|1|||
161250112|NCT01709903|582294768|FG000|Overall Study|no longer needed study drug|0|||
161250113|NCT01709903|582294769|FG001|Overall Study|no longer needed study drug|1|||
161250114|NCT01709903|582294768|FG000|Overall Study|Lost to Follow-up|0|||
161250115|NCT01709903|582294769|FG001|Overall Study|Lost to Follow-up|2|||
161250116|NCT01709903|582294768|FG000|Overall Study|Death|2|||
161250117|NCT01709903|582294769|FG001|Overall Study|Death|0|||
161250118|NCT01709903|582294768|FG000|Overall Study|Protocol Violation|3|||
161250119|NCT01709903|582294769|FG001|Overall Study|Protocol Violation|2|||
161250120|NCT01709903|582294768|FG000|Overall Study|Lack of Efficacy|3|||
161250121|NCT01709903|582294769|FG001|Overall Study|Lack of Efficacy|3|||
161250122|NCT01709903|582294768|FG000|Overall Study|Withdrawal by Subject|6|||
161250123|NCT01709903|582294769|FG001|Overall Study|Withdrawal by Subject|6|||
161250124|NCT01709903|582294768|FG000|Overall Study|Adverse Event|11|||
161250125|NCT01709903|582294769|FG001|Overall Study|Adverse Event|18|||
161250126|NCT01751087|582294774|FG000|Overall Study|Withdrawal by Subject|1|||
161250127|NCT01751087|582294775|FG001|Overall Study|Withdrawal by Subject|0|||
161250128|NCT01751087|582294776|FG002|Overall Study|Withdrawal by Subject|0|||
161250129|NCT01751087|582294774|FG000|Overall Study|Physician Decision|0|||
161250130|NCT01751087|582294775|FG001|Overall Study|Physician Decision|0|||
161250131|NCT01751087|582294776|FG002|Overall Study|Physician Decision|1|||
161250132|NCT05377489|582294777|FG000|Overall Study|Withdrawal by Subject|122|||
161250133|NCT05377489|582294777|FG000|Overall Study|Lost to Follow-up|21|||
161250134|NCT05377489|582294777|FG000|Overall Study|Lack of Efficacy|10|||
161250135|NCT05377489|582294777|FG000|Overall Study|Adverse Event|5|||
161250136|NCT05377489|582294777|FG000|Overall Study|Death|4|||
161250137|NCT05377489|582294777|FG000|Overall Study|Physician Decision|3|||
161250138|NCT05377489|582294777|FG000|Overall Study|Protocol Violation|1|||
161250139|NCT05377489|582294777|FG000|Overall Study|Other|9|||
161250140|NCT00724958|582294778|FG000|Overall Study|Adverse Event|28|||
161250141|NCT00724958|582294778|FG000|Overall Study|Loss of Response|40|||
161250142|NCT00724958|582294778|FG000|Overall Study|No Response|18|||
161250143|NCT00724958|582294778|FG000|Overall Study|Remission|7|||
161250144|NCT00724958|582294778|FG000|Overall Study|Other Reason|76|||
161250145|NCT00724958|582294778|FG000|Overall Study|No documentation for end of therapy|13|||
161250146|NCT00697619|582294779|FG000|Overall Study|Lack of Efficacy|2|||
161250147|NCT00697619|582294780|FG001|Overall Study|Lack of Efficacy|2|||
161250148|NCT00697619|582294779|FG000|Overall Study|Adverse Event|4|||
161250149|NCT00697619|582294780|FG001|Overall Study|Adverse Event|6|||
161250150|NCT00559637|582296744|FG000|Overall Study|Adverse Event|22|||
161250151|NCT00559637|582296744|FG000|Overall Study|Withdrawal by Subject|4|||
161250152|NCT00559637|582296744|FG000|Overall Study|Protocol Violation|6|||
161250153|NCT00559637|582296744|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
161250154|NCT00559637|582296744|FG000|Overall Study|Failure to return|6|||
161250155|NCT00559637|582296744|FG000|Overall Study|Insufficient response|3|||
161250156|NCT00559637|582296744|FG000|Overall Study|Started requiring dialysis after month 7|2|||
160838483|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
160838484|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
160838485|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
160838486|NCT01389323|580795711|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
160838487|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
161250157|NCT00559637|582296744|FG000|Overall Study|Suspected lung cancer|1|||
161250158|NCT00559637|582296744|FG000|Overall Study|Participation in another study|1|||
161250159|NCT00559637|582296744|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
161250160|NCT00559637|582296744|FG000|Overall Study|Change of center|1|||
160838488|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
160838489|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
160838490|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
160838491|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
160838492|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
160838493|NCT01805037|580795713|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
160991779|NCT03905135|581359890|FG001|Dose Escalation|Adverse Event|1|||
161250161|NCT00559637|582296744|FG000|Overall Study|Change of home|1|||
161250162|NCT00559637|582296744|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
161250163|NCT01705717|582296745|FG000|Overall Study|Adverse Event|2|||
161250164|NCT01705717|582296746|FG001|Overall Study|Adverse Event|2|||
161250165|NCT01705717|582296745|FG000|Overall Study|Lack of Efficacy|0|||
161250166|NCT01705717|582296746|FG001|Overall Study|Lack of Efficacy|1|||
161250167|NCT01705717|582296745|FG000|Overall Study|Other|0|||
161250168|NCT01705717|582296746|FG001|Overall Study|Other|2|||
161250169|NCT02031237|582296747|FG000|Overall Study|Death|1|||
161250170|NCT02031237|582296748|FG001|Overall Study|Death|5|||
161250171|NCT02031237|582296749|FG002|Overall Study|Death|0|||
160838494|NCT01805037|580795714|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
161250172|NCT02031237|582296747|FG000|Overall Study|Physician Decision|0|||
161250173|NCT02031237|582296748|FG001|Overall Study|Physician Decision|1|||
161250174|NCT02031237|582296749|FG002|Overall Study|Physician Decision|0|||
161250175|NCT02031237|582296747|FG000|Overall Study|Withdrawal by Subject|2|||
161250176|NCT02031237|582296748|FG001|Overall Study|Withdrawal by Subject|2|||
161250177|NCT02031237|582296749|FG002|Overall Study|Withdrawal by Subject|0|||
161250178|NCT02031237|582296747|FG000|Overall Study|Protocol Violation|2|||
161250179|NCT02031237|582296748|FG001|Overall Study|Protocol Violation|6|||
161250180|NCT02031237|582296749|FG002|Overall Study|Protocol Violation|0|||
161250181|NCT02031237|582296747|FG000|Overall Study|Alternate Treatment Given|0|||
161250182|NCT02031237|582296748|FG001|Overall Study|Alternate Treatment Given|0|||
161250183|NCT02031237|582296749|FG002|Overall Study|Alternate Treatment Given|3|||
160838495|NCT01805037|580795713|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
160838496|NCT01805037|580795714|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
160838497|NCT01805037|580795713|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
160838498|NCT01805037|580795714|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
160838499|NCT01805037|580795713|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
160838500|NCT01805037|580795714|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
160838501|NCT01805037|580795713|FG000|Follow Up (up to 3 Years)|Death|0|||
160838502|NCT01805037|580795714|FG001|Follow Up (up to 3 Years)|Death|2|||
160838503|NCT01805037|580795713|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
160838504|NCT01805037|580795714|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
160838505|NCT01805037|580795713|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
160838506|NCT01805037|580795714|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
160838507|NCT01270256|580795715|FG000|Overall Study|Withdrawal by Subject|1|||
160838508|NCT01270256|580795716|FG001|Overall Study|Withdrawal by Subject|0|||
160904457|NCT02609828|581044966|FG000|Overall Study|Withdrawal by Subject|12|||
160904458|NCT02609828|581044967|FG001|Overall Study|Withdrawal by Subject|1|||
160904459|NCT02609828|581044968|FG002|Overall Study|Withdrawal by Subject|0|||
160904460|NCT02609828|581044969|FG003|Overall Study|Withdrawal by Subject|10|||
160904461|NCT02609828|581044966|FG000|Overall Study|Other|3|||
160904462|NCT02609828|581044967|FG001|Overall Study|Other|0|||
160904463|NCT02609828|581044968|FG002|Overall Study|Other|0|||
160904464|NCT02609828|581044969|FG003|Overall Study|Other|6|||
160904465|NCT02609828|581044966|FG000|Overall Study|Randomized but not treated|1|||
160904466|NCT02609828|581044967|FG001|Overall Study|Randomized but not treated|0|||
160904467|NCT02609828|581044968|FG002|Overall Study|Randomized but not treated|0|||
160904468|NCT02609828|581044969|FG003|Overall Study|Randomized but not treated|0|||
160904469|NCT01081678|581044971|FG000|Overall Study|Ineligibility Determined|0|||
160904470|NCT01081678|581044972|FG001|Overall Study|Ineligibility Determined|0|||
160904471|NCT01081678|581044973|FG002|Overall Study|Ineligibility Determined|1|||
160904472|NCT01081678|581044974|FG003|Overall Study|Ineligibility Determined|1|||
160904473|NCT01081678|581044971|FG000|Overall Study|Noncompliance|3|||
160904474|NCT01081678|581044972|FG001|Overall Study|Noncompliance|4|||
160904475|NCT01081678|581044973|FG002|Overall Study|Noncompliance|5|||
160904476|NCT01081678|581044974|FG003|Overall Study|Noncompliance|2|||
160904477|NCT01081678|581044971|FG000|Overall Study|Adverse Event|2|||
160904478|NCT01081678|581044972|FG001|Overall Study|Adverse Event|1|||
160904479|NCT01081678|581044973|FG002|Overall Study|Adverse Event|2|||
160904480|NCT01081678|581044974|FG003|Overall Study|Adverse Event|2|||
160904481|NCT01081678|581044971|FG000|Overall Study|Withdrawal by Subject|15|||
160904482|NCT01081678|581044972|FG001|Overall Study|Withdrawal by Subject|7|||
160904483|NCT01081678|581044973|FG002|Overall Study|Withdrawal by Subject|17|||
160904484|NCT01081678|581044974|FG003|Overall Study|Withdrawal by Subject|14|||
160904485|NCT01081678|581044971|FG000|Overall Study|Administrative Decision|1|||
160904486|NCT01081678|581044972|FG001|Overall Study|Administrative Decision|0|||
160904487|NCT01081678|581044973|FG002|Overall Study|Administrative Decision|0|||
160904488|NCT01081678|581044974|FG003|Overall Study|Administrative Decision|1|||
160904489|NCT01081678|581044971|FG000|Overall Study|Lost to Follow-up|4|||
160904490|NCT01081678|581044972|FG001|Overall Study|Lost to Follow-up|1|||
160991780|NCT03905135|581359889|FG000|Dose Escalation|Progressive disease|3|||
160838509|NCT04566692|580795720|FG000|Overall Study|Adverse Event|2|||
160991781|NCT03905135|581359890|FG001|Dose Escalation|Progressive disease|1|||
160991782|NCT03905135|581359889|FG000|Dose Escalation|Intercurrent illness|1|||
160838510|NCT04566692|580795721|FG001|Overall Study|Adverse Event|0|||
160838511|NCT04566692|580795720|FG000|Overall Study|Withdrawal by Subject|1|||
160904491|NCT01081678|581044973|FG002|Overall Study|Lost to Follow-up|4|||
160904492|NCT01081678|581044974|FG003|Overall Study|Lost to Follow-up|3|||
160904493|NCT01081678|581044971|FG000|Overall Study|Death|2|||
161250184|NCT01074008|582296755|FG000|Overall Study|Adverse Event|0|||
161250185|NCT01074008|582296756|FG001|Overall Study|Adverse Event|1|||
161250186|NCT01074008|582296757|FG002|Overall Study|Adverse Event|0|||
160838512|NCT04566692|580795721|FG001|Overall Study|Withdrawal by Subject|1|||
160904494|NCT01081678|581044972|FG001|Overall Study|Death|2|||
160904495|NCT01081678|581044973|FG002|Overall Study|Death|2|||
160904496|NCT01081678|581044974|FG003|Overall Study|Death|6|||
160904497|NCT01081678|581044971|FG000|Overall Study|Other|0|||
160904498|NCT01081678|581044972|FG001|Overall Study|Other|1|||
160991783|NCT03905135|581359890|FG001|Dose Escalation|Intercurrent illness|0|||
160904499|NCT01081678|581044973|FG002|Overall Study|Other|0|||
160838513|NCT01183468|580795722|FG000|Overall Study|Lost to Follow-up|2|||
160838514|NCT01183468|580795723|FG001|Overall Study|Lost to Follow-up|1|||
160838515|NCT01183468|580795724|FG002|Overall Study|Lost to Follow-up|0|||
160838516|NCT01183468|580795725|FG003|Overall Study|Lost to Follow-up|0|||
160838517|NCT01183468|580795722|FG000|Overall Study|Physician Decision|1|||
160838518|NCT01183468|580795723|FG001|Overall Study|Physician Decision|0|||
160838519|NCT01183468|580795724|FG002|Overall Study|Physician Decision|0|||
160838520|NCT01183468|580795725|FG003|Overall Study|Physician Decision|0|||
160838521|NCT01183468|580795722|FG000|Overall Study|Withdrawal by Subject|0|||
160838522|NCT01183468|580795723|FG001|Overall Study|Withdrawal by Subject|1|||
160838523|NCT01183468|580795724|FG002|Overall Study|Withdrawal by Subject|0|||
160838524|NCT01183468|580795725|FG003|Overall Study|Withdrawal by Subject|0|||
160838525|NCT00590577|580795726|FG000|Overall Study|Lack of Efficacy|31|||
160838526|NCT00590577|580795727|FG001|Overall Study|Lack of Efficacy|28|||
160838527|NCT00590577|580795728|FG002|Overall Study|Lack of Efficacy|23|||
160838528|NCT00590577|580795729|FG003|Overall Study|Lack of Efficacy|45|||
160904500|NCT01081678|581044974|FG003|Overall Study|Other|0|||
160904501|NCT01619423|581044979|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
160904502|NCT01619423|581044980|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
160904503|NCT01619423|581044981|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
160904504|NCT01619423|581044982|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
160904505|NCT01281865|581044989|FG000|Overall Study|Adverse Event|1|||
160904506|NCT01281865|581044990|FG001|Overall Study|Adverse Event|1|||
160904507|NCT01281865|581044989|FG000|Overall Study|Withdrawal by Subject|1|||
160904508|NCT01281865|581044990|FG001|Overall Study|Withdrawal by Subject|0|||
160904509|NCT01281865|581044989|FG000|Overall Study|Lack of Efficacy|1|||
160904510|NCT01281865|581044990|FG001|Overall Study|Lack of Efficacy|0|||
160904511|NCT03478657|581044992|FG000|Overall Study|Withdrawal by Subject|0|||
160904512|NCT03478657|581044993|FG001|Overall Study|Withdrawal by Subject|1|||
160904513|NCT02590003|581044994|FG000|Overall Study|Death|1|||
160904514|NCT02590003|581044995|FG001|Overall Study|Death|2|||
160904515|NCT03733470|581044998|FG000|Overall Study|PI Decision|1|||
160904516|NCT03733470|581044999|FG001|Overall Study|PI Decision|1|||
160904517|NCT01786668|581045000|FG000|Overall Study|Adverse Event|0|||
160904518|NCT01786668|581045001|FG001|Overall Study|Adverse Event|1|||
160904519|NCT01786668|581045002|FG002|Overall Study|Adverse Event|1|||
160904520|NCT01786668|581045003|FG003|Overall Study|Adverse Event|2|||
160904521|NCT01786668|581045000|FG000|Overall Study|Withdrawal by Subject|0|||
160904522|NCT01786668|581045001|FG001|Overall Study|Withdrawal by Subject|0|||
160904523|NCT01786668|581045002|FG002|Overall Study|Withdrawal by Subject|3|||
160904524|NCT01786668|581045003|FG003|Overall Study|Withdrawal by Subject|1|||
160904525|NCT01786668|581045000|FG000|Overall Study|Pregnancy|0|||
160904526|NCT01786668|581045001|FG001|Overall Study|Pregnancy|0|||
160904527|NCT01786668|581045002|FG002|Overall Study|Pregnancy|0|||
160904528|NCT01786668|581045003|FG003|Overall Study|Pregnancy|1|||
160904529|NCT01786668|581045000|FG000|Overall Study|Lost to Follow-up|1|||
160904530|NCT01786668|581045001|FG001|Overall Study|Lost to Follow-up|0|||
160904531|NCT01786668|581045002|FG002|Overall Study|Lost to Follow-up|1|||
160904532|NCT01786668|581045003|FG003|Overall Study|Lost to Follow-up|0|||
160904533|NCT04891978|581045009|FG000|Baseline|Protocol Violation|2|||
160904534|NCT04891978|581045010|FG001|Baseline|Protocol Violation|1|||
160904535|NCT04891978|581045011|FG002|Baseline|Protocol Violation|0|||
160904536|NCT04891978|581045009|FG000|Baseline|Missing AIRQ|1|||
160904537|NCT04891978|581045010|FG001|Baseline|Missing AIRQ|0|||
160904538|NCT04891978|581045011|FG002|Baseline|Missing AIRQ|0|||
160904539|NCT04891978|581045009|FG000|Baseline|Did not attend a baseline visit|0|||
160904540|NCT04891978|581045010|FG001|Baseline|Did not attend a baseline visit|0|||
160904541|NCT04891978|581045011|FG002|Baseline|Did not attend a baseline visit|9|||
160991784|NCT04523181|581359891|FG000|Overall Study|Withdrawal by Subject|4|||
160904542|NCT01776840|581045012|FG000|Overall Study|Lost to Follow-up|12|||
160904543|NCT01776840|581045013|FG001|Overall Study|Lost to Follow-up|7|||
160904544|NCT01776840|581045012|FG000|Overall Study|Withdrawal by Subject|32|||
160904545|NCT01776840|581045013|FG001|Overall Study|Withdrawal by Subject|48|||
160991785|NCT04523181|581359892|FG001|Overall Study|Withdrawal by Subject|5|||
160904546|NCT01776840|581045012|FG000|Overall Study|Sponsor decision|89|||
160904547|NCT01776840|581045013|FG001|Overall Study|Sponsor decision|87|||
160904548|NCT03068455|581045014|FG000|Pre-treatment Period|Disease progression|0|||
160904549|NCT03068455|581045015|FG001|Pre-treatment Period|Disease progression|1|||
160904550|NCT03068455|581045014|FG000|Pre-treatment Period|Participant withdrew consent|1|||
161138620|NCT01642212|581888729|FG004|Open-label Extension|Adverse Event|0|||
161138621|NCT01642212|581888725|FG000|Open-label Extension|Sponsor Decision|0|||
161138622|NCT01642212|581888726|FG001|Open-label Extension|Sponsor Decision|0|||
161138623|NCT01642212|581888727|FG002|Open-label Extension|Sponsor Decision|0|||
161138624|NCT01642212|581888728|FG003|Open-label Extension|Sponsor Decision|7|||
161138625|NCT01642212|581888729|FG004|Open-label Extension|Sponsor Decision|4|||
161138626|NCT01642212|581888725|FG000|Open-label Extension|Consent Withdrawn|0|||
161138627|NCT01642212|581888726|FG001|Open-label Extension|Consent Withdrawn|0|||
161138628|NCT01642212|581888727|FG002|Open-label Extension|Consent Withdrawn|0|||
161138629|NCT01642212|581888728|FG003|Open-label Extension|Consent Withdrawn|0|||
161138630|NCT01642212|581888729|FG004|Open-label Extension|Consent Withdrawn|2|||
161138631|NCT01642212|581888725|FG000|Open-label Extension|Lost to Follow-up|0|||
161334962|NCT00467519|582615869|FG000|Overall Study|Withdrawal by Subject|4|||
161334963|NCT00467519|582615870|FG001|Overall Study|Withdrawal by Subject|10|||
161334964|NCT00372424|582615871|FG000|Overall Study|Adverse Event|2|||
160838529|NCT00590577|580795726|FG000|Overall Study|Withdrawal by Subject|23|||
160838530|NCT00590577|580795727|FG001|Overall Study|Withdrawal by Subject|28|||
160838531|NCT00590577|580795728|FG002|Overall Study|Withdrawal by Subject|30|||
160838532|NCT00590577|580795729|FG003|Overall Study|Withdrawal by Subject|26|||
160838533|NCT00590577|580795726|FG000|Overall Study|Adverse Event|10|||
160838534|NCT00590577|580795727|FG001|Overall Study|Adverse Event|10|||
160838535|NCT00590577|580795728|FG002|Overall Study|Adverse Event|13|||
160838536|NCT00590577|580795729|FG003|Overall Study|Adverse Event|11|||
160838537|NCT00590577|580795726|FG000|Overall Study|Lost to Follow-up|12|||
160838538|NCT00590577|580795727|FG001|Overall Study|Lost to Follow-up|6|||
160838539|NCT00590577|580795728|FG002|Overall Study|Lost to Follow-up|6|||
160838540|NCT00590577|580795729|FG003|Overall Study|Lost to Follow-up|9|||
160838541|NCT00590577|580795726|FG000|Overall Study|Pregnancy|0|||
160838542|NCT00590577|580795727|FG001|Overall Study|Pregnancy|1|||
160838543|NCT00590577|580795728|FG002|Overall Study|Pregnancy|0|||
160838544|NCT00590577|580795729|FG003|Overall Study|Pregnancy|0|||
160838545|NCT00590577|580795726|FG000|Overall Study|Various reasons|1|||
160838546|NCT00590577|580795727|FG001|Overall Study|Various reasons|3|||
160838547|NCT00590577|580795728|FG002|Overall Study|Various reasons|1|||
160838548|NCT00590577|580795729|FG003|Overall Study|Various reasons|2|||
160838549|NCT03927404|580795731|FG000|Overall Study|Withdrawal by Subject|1|||
160838550|NCT01229449|580795732|FG000|Overall Study|Withdrawal by Subject|0|||
160838551|NCT01229449|580795733|FG001|Overall Study|Withdrawal by Subject|3|||
160838552|NCT01229449|580795734|FG002|Overall Study|Withdrawal by Subject|0|||
160838553|NCT01229449|580795735|FG003|Overall Study|Withdrawal by Subject|1|||
160838554|NCT01229449|580795736|FG004|Overall Study|Withdrawal by Subject|1|||
160838555|NCT01229449|580795732|FG000|Overall Study|Lost to Follow-up|1|||
160838556|NCT01229449|580795733|FG001|Overall Study|Lost to Follow-up|1|||
160838557|NCT01229449|580795734|FG002|Overall Study|Lost to Follow-up|1|||
160838558|NCT01229449|580795735|FG003|Overall Study|Lost to Follow-up|0|||
160838559|NCT01229449|580795736|FG004|Overall Study|Lost to Follow-up|0|||
160838560|NCT01229449|580795732|FG000|Overall Study|Physician Decision|0|||
160838561|NCT01229449|580795733|FG001|Overall Study|Physician Decision|0|||
160838562|NCT01229449|580795734|FG002|Overall Study|Physician Decision|1|||
160838563|NCT01229449|580795735|FG003|Overall Study|Physician Decision|0|||
160838564|NCT01229449|580795736|FG004|Overall Study|Physician Decision|0|||
160838565|NCT03203291|580795740|FG000|Overall Study|Withdrawal by Subject|1|||
160838566|NCT01300260|580795741|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
160838567|NCT01300260|580795742|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
160838568|NCT01300260|580795741|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
160838569|NCT01300260|580795742|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
160838570|NCT01300260|580795741|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
160838571|NCT01300260|580795742|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
160838572|NCT05098509|580795746|FG000|Overall Study|Withdrawal by Subject|0|||
160838573|NCT05098509|580795747|FG001|Overall Study|Withdrawal by Subject|0|||
160838574|NCT05098509|580795748|FG002|Overall Study|Withdrawal by Subject|1|||
160838575|NCT05098509|580795749|FG003|Overall Study|Withdrawal by Subject|0|||
160838576|NCT05098509|580795746|FG000|Overall Study|Early study termination|1|||
160838577|NCT05098509|580795747|FG001|Overall Study|Early study termination|1|||
160838578|NCT05098509|580795748|FG002|Overall Study|Early study termination|1|||
160838579|NCT05098509|580795749|FG003|Overall Study|Early study termination|0|||
160838580|NCT01147848|580795752|FG000|Run-in Period|Screen Failure|623|||
160991786|NCT04523181|581359891|FG000|Overall Study|Lost to Follow-up|2|||
160991787|NCT04523181|581359892|FG001|Overall Study|Lost to Follow-up|3|||
160991788|NCT04523181|581359891|FG000|Overall Study|Physician Decision|1|||
160991789|NCT04523181|581359892|FG001|Overall Study|Physician Decision|0|||
160991790|NCT04523181|581359891|FG000|Overall Study|Transferred to external facility.|1|||
161138632|NCT01642212|581888726|FG001|Open-label Extension|Lost to Follow-up|0|||
161138633|NCT01642212|581888727|FG002|Open-label Extension|Lost to Follow-up|0|||
161138634|NCT01642212|581888728|FG003|Open-label Extension|Lost to Follow-up|0|||
161138635|NCT01642212|581888729|FG004|Open-label Extension|Lost to Follow-up|1|||
161138636|NCT01642212|581888725|FG000|Open-label Extension|Other|0|||
161138637|NCT01642212|581888726|FG001|Open-label Extension|Other|0|||
161138638|NCT01642212|581888727|FG002|Open-label Extension|Other|0|||
161138639|NCT01642212|581888728|FG003|Open-label Extension|Other|0|||
161138640|NCT01642212|581888729|FG004|Open-label Extension|Other|1|||
161138641|NCT01624142|581888730|FG000|Overall Study|Withdrawal by Subject|14|||
161138642|NCT01624142|581888731|FG001|Overall Study|Withdrawal by Subject|4|||
161138643|NCT01624142|581888730|FG000|Overall Study|Death|3|||
161138644|NCT01624142|581888731|FG001|Overall Study|Death|6|||
161138645|NCT01624142|581888730|FG000|Overall Study|Study Closure|12|||
161138646|NCT01624142|581888731|FG001|Overall Study|Study Closure|6|||
161334965|NCT00372424|582615871|FG000|Overall Study|Withdrawal by Subject|1|||
160838581|NCT01147848|580795753|FG001|Run-in Period|Screen Failure|0|||
160838582|NCT01147848|580795754|FG002|Run-in Period|Screen Failure|0|||
160838583|NCT01147848|580795752|FG000|Run-in Period|Run-in Failure|135|||
160838584|NCT01147848|580795753|FG001|Run-in Period|Run-in Failure|0|||
160838585|NCT01147848|580795754|FG002|Run-in Period|Run-in Failure|0|||
160838586|NCT01147848|580795752|FG000|Randomized Phase|Adverse Event|0|||
160838587|NCT01147848|580795753|FG001|Randomized Phase|Adverse Event|6|||
160838588|NCT01147848|580795754|FG002|Randomized Phase|Adverse Event|8|||
160838589|NCT01147848|580795752|FG000|Randomized Phase|Lack of Efficacy|0|||
160838590|NCT01147848|580795753|FG001|Randomized Phase|Lack of Efficacy|20|||
160838591|NCT01147848|580795754|FG002|Randomized Phase|Lack of Efficacy|11|||
160838592|NCT01147848|580795752|FG000|Randomized Phase|Protocol Violation|0|||
160838593|NCT01147848|580795753|FG001|Randomized Phase|Protocol Violation|7|||
161138647|NCT01624142|581888730|FG000|Overall Study|Lost to Follow-up|2|||
161138648|NCT01624142|581888731|FG001|Overall Study|Lost to Follow-up|0|||
161138649|NCT01624142|581888730|FG000|Overall Study|Other|1|||
161138650|NCT01624142|581888731|FG001|Overall Study|Other|0|||
161138651|NCT00667277|581888732|FG000|Overall Study|Withdrawal by Subject|2|||
161138652|NCT02597062|581888733|FG000|Overall Study|Ineligible|1|||
161138653|NCT03372941|581888734|FG000|Overall Study|Lost to Follow-up|2|||
161138654|NCT03372941|581888735|FG001|Overall Study|Lost to Follow-up|4|||
161138655|NCT00741819|581888736|FG000|Overall Study|Adverse Event|3|||
161138656|NCT00741819|581888736|FG000|Overall Study|Withdrawal by Subject|3|||
161138657|NCT00741819|581888736|FG000|Overall Study|Death|1|||
161138658|NCT00741819|581888736|FG000|Overall Study|Disease progression|1|||
161138659|NCT00686543|581888739|FG000|Overall Study|Adverse Event|9|||
161138660|NCT00686543|581888740|FG001|Overall Study|Adverse Event|1|||
161138661|NCT00686543|581888741|FG002|Overall Study|Adverse Event|3|||
161138662|NCT00686543|581888742|FG003|Overall Study|Adverse Event|2|||
161138663|NCT00686543|581888739|FG000|Overall Study|Withdrawal by Subject|2|||
161138664|NCT00686543|581888740|FG001|Overall Study|Withdrawal by Subject|0|||
161138665|NCT00686543|581888741|FG002|Overall Study|Withdrawal by Subject|0|||
161138666|NCT00686543|581888742|FG003|Overall Study|Withdrawal by Subject|0|||
161138667|NCT00686543|581888739|FG000|Overall Study|Protocol Violation|3|||
161138668|NCT00686543|581888740|FG001|Overall Study|Protocol Violation|0|||
161138669|NCT00686543|581888741|FG002|Overall Study|Protocol Violation|2|||
161138670|NCT00686543|581888742|FG003|Overall Study|Protocol Violation|1|||
161138671|NCT01053429|581888743|FG000|Overall Study|Adverse Event|64|||
161138672|NCT01053429|581888743|FG000|Overall Study|Other|309|||
161138673|NCT00752986|581888744|FG000|Overall Study|Withdrawal by Subject|2|||
161138674|NCT00752986|581888745|FG001|Overall Study|Withdrawal by Subject|1|||
161138675|NCT00752986|581888746|FG002|Overall Study|Withdrawal by Subject|2|||
161138676|NCT00752986|581888744|FG000|Overall Study|Protocol Violation|3|||
161138677|NCT00752986|581888745|FG001|Overall Study|Protocol Violation|0|||
161138678|NCT00752986|581888746|FG002|Overall Study|Protocol Violation|0|||
161138679|NCT01697345|581888747|FG000|Overall Study|Withdrawal by Subject|1|||
161138680|NCT00924703|581888748|FG000|Overall Study|Withdrawal by Subject|11|||
161138681|NCT00924703|581888748|FG000|Overall Study|Physician Decision|5|||
161138682|NCT00924703|581888748|FG000|Overall Study|Lost to Follow-up|3|||
161138683|NCT00924703|581888748|FG000|Overall Study|Adverse Event|2|||
161138684|NCT00924703|581888748|FG000|Overall Study|Withdrawal by Sponsor|1|||
161138685|NCT04906707|581888749|FG000|Overall Study|Withdrawal by Subject|2|||
161138686|NCT04906707|581888750|FG001|Overall Study|Withdrawal by Subject|0|||
161138687|NCT04906707|581888749|FG000|Overall Study|Withdrawal due to PI decision|1|||
161138688|NCT04906707|581888750|FG001|Overall Study|Withdrawal due to PI decision|0|||
161138689|NCT04906707|581888749|FG000|Overall Study|Lost to Follow-up|0|||
161138690|NCT04906707|581888750|FG001|Overall Study|Lost to Follow-up|1|||
161138691|NCT01976806|581888751|FG000|Overall Study|Lost to Follow-up|1|||
161138692|NCT01976806|581888752|FG001|Overall Study|Lost to Follow-up|4|||
161138693|NCT01976806|581888751|FG000|Overall Study|Adverse Event|1|||
161138694|NCT01976806|581888752|FG001|Overall Study|Adverse Event|1|||
161138695|NCT01976806|581888751|FG000|Overall Study|Withdrawal by Subject|1|||
161138696|NCT01976806|581888752|FG001|Overall Study|Withdrawal by Subject|1|||
161138697|NCT03929250|581888755|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
161138698|NCT03929250|581888756|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
161138699|NCT04429022|581888759|FG000|Overall Study|Protocol Violation|18|||
161138700|NCT04429022|581888760|FG001|Overall Study|Protocol Violation|1|||
161138701|NCT00045032|581888765|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
161138702|NCT00045032|581888766|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
161138703|NCT00045032|581888767|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
161138704|NCT00045032|581888765|FG000|Overall Study|Death|22|||
161138705|NCT00045032|581888766|FG001|Overall Study|Death|24|||
161138706|NCT00045032|581888767|FG002|Overall Study|Death|17|||
161138707|NCT00045032|581888765|FG000|Overall Study|Insufficient Therapeutic Response|542|||
161138708|NCT00045032|581888766|FG001|Overall Study|Insufficient Therapeutic Response|437|||
161250187|NCT01074008|582296758|FG003|Overall Study|Adverse Event|0|||
161250188|NCT01074008|582296759|FG004|Overall Study|Adverse Event|0|||
161250189|NCT01074008|582296760|FG005|Overall Study|Adverse Event|0|||
161250190|NCT01074008|582296761|FG006|Overall Study|Adverse Event|0|||
161138709|NCT00045032|581888767|FG002|Overall Study|Insufficient Therapeutic Response|445|||
161138710|NCT00045032|581888765|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
161138711|NCT00045032|581888766|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
161138712|NCT00045032|581888767|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
161138713|NCT00045032|581888765|FG000|Overall Study|Other Protocol Violation|2|||
161138714|NCT00045032|581888766|FG001|Overall Study|Other Protocol Violation|0|||
161138715|NCT00045032|581888767|FG002|Overall Study|Other Protocol Violation|1|||
161138716|NCT00045032|581888765|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
161138717|NCT00045032|581888766|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
161138718|NCT00045032|581888767|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
161138719|NCT00045032|581888765|FG000|Overall Study|Failure to Return|57|||
161138720|NCT00045032|581888766|FG001|Overall Study|Failure to Return|62|||
161138721|NCT00045032|581888767|FG002|Overall Study|Failure to Return|61|||
161138722|NCT00045032|581888765|FG000|Overall Study|Other|93|||
161138723|NCT00045032|581888766|FG001|Overall Study|Other|84|||
161138724|NCT00045032|581888767|FG002|Overall Study|Other|105|||
161138725|NCT02582658|581888768|FG000|Overall Study|Failure to Return|10|||
161138726|NCT02582658|581888768|FG000|Overall Study|Insufficient Virological Response|2|||
161138727|NCT02582658|581888768|FG000|Overall Study|Withdrawn Consent|1|||
161138728|NCT02582658|581888768|FG000|Overall Study|Death|1|||
161138729|NCT02582658|581888768|FG000|Overall Study|Not further specified|11|||
161138730|NCT02581995|581888769|FG000|Overall Study|Unspecified other|3|||
161138731|NCT02581995|581888769|FG000|Overall Study|Adverse Event|6|||
161138732|NCT02581995|581888769|FG000|Overall Study|Lost to Follow-up|5|||
161138733|NCT02581995|581888769|FG000|Overall Study|Withdrawal by participant|12|||
161138734|NCT02581995|581888769|FG000|Overall Study|Physician Decision|1|||
161138735|NCT02581995|581888769|FG000|Overall Study|Death|4|||
161138736|NCT04909463|581890074|FG000|Overall Study|Withdrawal by Subject|0|||
161138737|NCT04909463|581890075|FG001|Overall Study|Withdrawal by Subject|1|||
161138738|NCT04909463|581890076|FG002|Overall Study|Withdrawal by Subject|0|||
161138739|NCT04909463|581890077|FG003|Overall Study|Withdrawal by Subject|0|||
161138740|NCT04909463|581890074|FG000|Overall Study|Lost to Follow-up|2|||
161138741|NCT04909463|581890075|FG001|Overall Study|Lost to Follow-up|1|||
161138742|NCT04909463|581890076|FG002|Overall Study|Lost to Follow-up|1|||
161138743|NCT04909463|581890077|FG003|Overall Study|Lost to Follow-up|0|||
161138744|NCT04364854|581890078|FG000|Overall Study|Withdrawal by Subject|1|||
161138745|NCT04364854|581890079|FG001|Overall Study|Withdrawal by Subject|0|||
161138746|NCT04364854|581890080|FG002|Overall Study|Withdrawal by Subject|1|||
161138747|NCT04364854|581890081|FG003|Overall Study|Withdrawal by Subject|3|||
161138748|NCT04364854|581890078|FG000|Overall Study|Death|1|||
161138749|NCT04364854|581890079|FG001|Overall Study|Death|0|||
160904551|NCT03068455|581045015|FG001|Pre-treatment Period|Participant withdrew consent|1|||
161138750|NCT04364854|581890080|FG002|Overall Study|Death|0|||
160904552|NCT03068455|581045014|FG000|Pre-treatment Period|Poor/non-compliance|0|||
160904553|NCT03068455|581045015|FG001|Pre-treatment Period|Poor/non-compliance|1|||
160904554|NCT03068455|581045014|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
160904555|NCT03068455|581045015|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
160904556|NCT03068455|581045014|FG000|Pre-treatment Period|Not reported|2|||
160904557|NCT03068455|581045015|FG001|Pre-treatment Period|Not reported|1|||
160904558|NCT03068455|581045014|FG000|Treatment Period|Disease progression|166|||
160904559|NCT03068455|581045015|FG001|Treatment Period|Disease progression|208|||
160904560|NCT03068455|581045014|FG000|Treatment Period|Study drug toxicity|317|||
160904561|NCT03068455|581045015|FG001|Treatment Period|Study drug toxicity|104|||
160904562|NCT03068455|581045014|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
160904563|NCT03068455|581045015|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
160904564|NCT03068455|581045014|FG000|Treatment Period|Participant request to stop therapy|33|||
160904565|NCT03068455|581045015|FG001|Treatment Period|Participant request to stop therapy|20|||
160904566|NCT03068455|581045014|FG000|Treatment Period|Participant withdrew consent|5|||
161138751|NCT04364854|581890081|FG003|Overall Study|Death|0|||
161138752|NCT04364854|581890078|FG000|Overall Study|Lost to Follow-up|0|||
161138753|NCT04364854|581890079|FG001|Overall Study|Lost to Follow-up|0|||
161138754|NCT04364854|581890080|FG002|Overall Study|Lost to Follow-up|0|||
161138755|NCT04364854|581890081|FG003|Overall Study|Lost to Follow-up|1|||
161138756|NCT03528681|581890084|FG000|Open-Label Phase|Physician Decision|2|||
161138757|NCT03528681|581890085|FG001|Open-Label Phase|Physician Decision|0|||
161138758|NCT03528681|581890086|FG002|Open-Label Phase|Physician Decision|0|||
161138759|NCT03528681|581890087|FG003|Open-Label Phase|Physician Decision|0|||
161138760|NCT03528681|581890084|FG000|Open-Label Phase|Withdrawal by Subject|8|||
161138761|NCT03528681|581890085|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161138762|NCT03528681|581890086|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161138763|NCT03528681|581890087|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161138764|NCT03528681|581890084|FG000|Open-Label Phase|(Not collected)|4|||
161138765|NCT03528681|581890085|FG001|Open-Label Phase|(Not collected)|0|||
161138766|NCT03528681|581890086|FG002|Open-Label Phase|(Not collected)|0|||
161138767|NCT03528681|581890087|FG003|Open-Label Phase|(Not collected)|0|||
161138768|NCT03528681|581890084|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
161250191|NCT01074008|582296762|FG007|Overall Study|Adverse Event|0|||
161250192|NCT01074008|582296763|FG008|Overall Study|Adverse Event|0|||
161250193|NCT01074008|582296755|FG000|Overall Study|Withdrawal by Subject|1|||
161250194|NCT01074008|582296756|FG001|Overall Study|Withdrawal by Subject|1|||
161250195|NCT01074008|582296757|FG002|Overall Study|Withdrawal by Subject|1|||
161250196|NCT01074008|582296758|FG003|Overall Study|Withdrawal by Subject|0|||
161250197|NCT01074008|582296759|FG004|Overall Study|Withdrawal by Subject|1|||
161250198|NCT01074008|582296760|FG005|Overall Study|Withdrawal by Subject|0|||
161250199|NCT01074008|582296761|FG006|Overall Study|Withdrawal by Subject|0|||
161250200|NCT01074008|582296762|FG007|Overall Study|Withdrawal by Subject|0|||
160838594|NCT01147848|580795754|FG002|Randomized Phase|Protocol Violation|10|||
160838595|NCT01147848|580795752|FG000|Randomized Phase|Lost to Follow-up|0|||
160838596|NCT01147848|580795753|FG001|Randomized Phase|Lost to Follow-up|5|||
160838597|NCT01147848|580795754|FG002|Randomized Phase|Lost to Follow-up|7|||
160838598|NCT01147848|580795752|FG000|Randomized Phase|Physician Decision|0|||
160838599|NCT01147848|580795753|FG001|Randomized Phase|Physician Decision|0|||
160838600|NCT01147848|580795754|FG002|Randomized Phase|Physician Decision|1|||
161250201|NCT01074008|582296763|FG008|Overall Study|Withdrawal by Subject|0|||
161250202|NCT01074008|582296755|FG000|Overall Study|Lost to Follow-up|0|||
161250203|NCT01074008|582296756|FG001|Overall Study|Lost to Follow-up|1|||
161250204|NCT01074008|582296757|FG002|Overall Study|Lost to Follow-up|1|||
161250205|NCT01074008|582296758|FG003|Overall Study|Lost to Follow-up|1|||
161250206|NCT01074008|582296759|FG004|Overall Study|Lost to Follow-up|1|||
161250207|NCT01074008|582296760|FG005|Overall Study|Lost to Follow-up|0|||
161250208|NCT01074008|582296761|FG006|Overall Study|Lost to Follow-up|1|||
161250209|NCT01074008|582296762|FG007|Overall Study|Lost to Follow-up|0|||
161250210|NCT01074008|582296763|FG008|Overall Study|Lost to Follow-up|4|||
160838601|NCT01147848|580795752|FG000|Randomized Phase|Withdrawal by Subject|0|||
160838602|NCT01147848|580795753|FG001|Randomized Phase|Withdrawal by Subject|7|||
161250211|NCT02805309|582296764|FG000|Overall Study|Lost to Follow-up|2|||
161250212|NCT02805309|582296765|FG001|Overall Study|Lost to Follow-up|2|||
161250213|NCT02805309|582296766|FG002|Overall Study|Lost to Follow-up|2|||
161250214|NCT02805309|582296764|FG000|Overall Study|Post-Randomization Exclusion|0|||
161250215|NCT02805309|582296765|FG001|Overall Study|Post-Randomization Exclusion|2|||
161250216|NCT02805309|582296766|FG002|Overall Study|Post-Randomization Exclusion|1|||
161250217|NCT05480800|582296775|FG000|Overall Study|Withdrawal by Subject|0|||
161250218|NCT05480800|582296776|FG001|Overall Study|Withdrawal by Subject|0|||
161250219|NCT05480800|582296777|FG002|Overall Study|Withdrawal by Subject|2|||
161250220|NCT05480800|582296778|FG003|Overall Study|Withdrawal by Subject|1|||
161250221|NCT05480800|582296779|FG004|Overall Study|Withdrawal by Subject|0|||
161250222|NCT05480800|582296780|FG005|Overall Study|Withdrawal by Subject|0|||
161250223|NCT05480800|582296781|FG006|Overall Study|Withdrawal by Subject|1|||
161250224|NCT05480800|582296782|FG007|Overall Study|Withdrawal by Subject|0|||
161250225|NCT05480800|582296775|FG000|Overall Study|Other|0|||
161250226|NCT05480800|582296776|FG001|Overall Study|Other|0|||
160838603|NCT01147848|580795754|FG002|Randomized Phase|Withdrawal by Subject|9|||
160838604|NCT04033068|580795755|FG000|Overall Study|Withdrawal by Subject|0|||
160838605|NCT04033068|580795756|FG001|Overall Study|Withdrawal by Subject|0|||
160838606|NCT04033068|580795757|FG002|Overall Study|Withdrawal by Subject|1|||
160838607|NCT04033068|580795758|FG003|Overall Study|Withdrawal by Subject|0|||
160838608|NCT04033068|580795755|FG000|Overall Study|Lost to Follow-up|0|||
160838609|NCT04033068|580795756|FG001|Overall Study|Lost to Follow-up|1|||
160838610|NCT04033068|580795757|FG002|Overall Study|Lost to Follow-up|0|||
160838611|NCT04033068|580795758|FG003|Overall Study|Lost to Follow-up|0|||
160838612|NCT04033068|580795755|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
160838613|NCT04033068|580795756|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
160838614|NCT04033068|580795757|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
161138769|NCT03528681|581890085|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
161138770|NCT03528681|581890086|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
160838615|NCT04033068|580795758|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
160991791|NCT04523181|581359892|FG001|Overall Study|Transferred to external facility.|1|||
161138771|NCT03528681|581890087|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
161138772|NCT03528681|581890084|FG000|Randomized Treatment Phase|Physician Decision|0|||
161138773|NCT03528681|581890085|FG001|Randomized Treatment Phase|Physician Decision|5|||
161138774|NCT03528681|581890086|FG002|Randomized Treatment Phase|Physician Decision|1|||
161138775|NCT03528681|581890087|FG003|Randomized Treatment Phase|Physician Decision|2|||
161250227|NCT05480800|582296777|FG002|Overall Study|Other|0|||
161250228|NCT05480800|582296778|FG003|Overall Study|Other|0|||
161250229|NCT05480800|582296779|FG004|Overall Study|Other|0|||
161250230|NCT05480800|582296780|FG005|Overall Study|Other|0|||
161250231|NCT05480800|582296781|FG006|Overall Study|Other|1|||
160838616|NCT02540265|580795759|FG000|Overall Study|Lost to Follow-up|0|||
161250232|NCT05480800|582296782|FG007|Overall Study|Other|0|||
161250233|NCT00377156|582296785|FG000|Overall Study|Death|23|||
161250234|NCT00377156|582296786|FG001|Overall Study|Death|19|||
161250235|NCT00377156|582296785|FG000|Overall Study|Withdrawal by Subject|16|||
161250236|NCT00377156|582296786|FG001|Overall Study|Withdrawal by Subject|24|||
161250237|NCT00377156|582296785|FG000|Overall Study|Had follow-up <90 d|3|||
161250238|NCT00377156|582296786|FG001|Overall Study|Had follow-up <90 d|6|||
161250239|NCT00377156|582296785|FG000|Overall Study|Cancellation|1|||
161250240|NCT00377156|582296786|FG001|Overall Study|Cancellation|0|||
161250241|NCT00377156|582296785|FG000|Overall Study|Refused testing|0|||
161250242|NCT00377156|582296786|FG001|Overall Study|Refused testing|1|||
161250243|NCT00377156|582296785|FG000|Overall Study|Ineligible|0|||
161250244|NCT00377156|582296786|FG001|Overall Study|Ineligible|1|||
161250245|NCT00377156|582296785|FG000|Overall Study|Disability or language problem|0|||
161250246|NCT00377156|582296786|FG001|Overall Study|Disability or language problem|1|||
161250247|NCT00377156|582296785|FG000|Overall Study|Other|5|||
161250248|NCT00377156|582296786|FG001|Overall Study|Other|2|||
161250249|NCT01802216|582296787|FG000|4 Month Visit|Participant did not show to visit|3|||
161250250|NCT01802216|582296788|FG001|4 Month Visit|Participant did not show to visit|4|||
161250251|NCT01802216|582296787|FG000|8 Month Visit|Participant did not show to visit|3|||
161250252|NCT01802216|582296788|FG001|8 Month Visit|Participant did not show to visit|5|||
161250253|NCT01802216|582296787|FG000|12 Month Visit|Participant did not show to visit|3|||
161250254|NCT01802216|582296788|FG001|12 Month Visit|Participant did not show to visit|4|||
161250255|NCT00683592|582296791|FG000|Overall Study|Adverse Event|12|||
161250256|NCT00683592|582296792|FG001|Overall Study|Adverse Event|4|||
161250257|NCT00683592|582296791|FG000|Overall Study|Withdrawal by Subject|11|||
160838617|NCT02540265|580795760|FG001|Overall Study|Lost to Follow-up|0|||
160838618|NCT02540265|580795761|FG002|Overall Study|Lost to Follow-up|1|||
160838619|NCT03157037|580795764|FG000|Overall Study|Death|1|||
161250258|NCT00683592|582296792|FG001|Overall Study|Withdrawal by Subject|11|||
161250259|NCT00683592|582296791|FG000|Overall Study|Lost to Follow-up|17|||
161250260|NCT00683592|582296792|FG001|Overall Study|Lost to Follow-up|17|||
161250261|NCT00683592|582296791|FG000|Overall Study|Lack of Efficacy|3|||
161250262|NCT00683592|582296792|FG001|Overall Study|Lack of Efficacy|7|||
161250263|NCT00683592|582296791|FG000|Overall Study|Physician Decision|0|||
161250264|NCT00683592|582296792|FG001|Overall Study|Physician Decision|1|||
160838620|NCT00324233|580795765|FG000|First Period|unable to insert catheter|1|||
160838621|NCT00324233|580795766|FG001|First Period|unable to insert catheter|0|||
160838622|NCT00324233|580795765|FG000|Second Period|unable to insert catheter|1|||
160838623|NCT00324233|580795766|FG001|Second Period|unable to insert catheter|1|||
160838624|NCT00324233|580795765|FG000|Second Period|Protocol Violation|4|||
160838625|NCT00324233|580795766|FG001|Second Period|Protocol Violation|6|||
160838626|NCT01972789|580795767|FG000|Overall Study|Adverse Event|11|||
160838627|NCT01972789|580795768|FG001|Overall Study|Adverse Event|4|||
160838628|NCT01972789|580795767|FG000|Overall Study|Subject withdrew consent|14|||
160838629|NCT01972789|580795768|FG001|Overall Study|Subject withdrew consent|12|||
160838630|NCT01972789|580795767|FG000|Overall Study|Lost to Follow-up|4|||
160838631|NCT01972789|580795768|FG001|Overall Study|Lost to Follow-up|7|||
160838632|NCT01972789|580795767|FG000|Overall Study|Death|7|||
160838633|NCT01972789|580795768|FG001|Overall Study|Death|5|||
160838634|NCT01972789|580795767|FG000|Overall Study|Protocol deviation|1|||
160838635|NCT01972789|580795768|FG001|Overall Study|Protocol deviation|0|||
160838636|NCT01972789|580795767|FG000|Overall Study|Physician Decision|3|||
160838637|NCT01972789|580795768|FG001|Overall Study|Physician Decision|2|||
160838638|NCT00498355|580795774|FG000|Overall Study|Lost to Follow-up|1|||
160838639|NCT03596450|580795775|FG000|Overall Study|Death|9|||
160838640|NCT03596450|580795776|FG001|Overall Study|Death|9|||
160838641|NCT03596450|580795775|FG000|Overall Study|Protocol Violation|18|||
160838642|NCT03596450|580795776|FG001|Overall Study|Protocol Violation|26|||
160838643|NCT03596450|580795775|FG000|Overall Study|Lost to Follow-up|50|||
160838644|NCT03596450|580795776|FG001|Overall Study|Lost to Follow-up|56|||
160838645|NCT03596450|580795775|FG000|Overall Study|Adverse Event|14|||
160838646|NCT03596450|580795776|FG001|Overall Study|Adverse Event|7|||
160838647|NCT03596450|580795775|FG000|Overall Study|Withdrawal by Subject|38|||
160838648|NCT03596450|580795776|FG001|Overall Study|Withdrawal by Subject|36|||
160838649|NCT03596450|580795775|FG000|Overall Study|Accidentally Randomized|2|||
160838650|NCT03596450|580795776|FG001|Overall Study|Accidentally Randomized|0|||
160838651|NCT03596450|580795775|FG000|Overall Study|Other reasons|48|||
160838652|NCT03596450|580795776|FG001|Overall Study|Other reasons|53|||
161250265|NCT00683592|582296791|FG000|Overall Study|Non-compliance|3|||
161250266|NCT00683592|582296792|FG001|Overall Study|Non-compliance|5|||
161250267|NCT00683592|582296791|FG000|Overall Study|Other|1|||
160838653|NCT03596450|580795775|FG000|Overall Study|Pregnancy|2|||
160838654|NCT03596450|580795776|FG001|Overall Study|Pregnancy|0|||
160838655|NCT03262441|580795787|FG000|Overall Study|Withdrawal by Subject|1|||
160838656|NCT02607228|580795788|FG000|Overall Study|Progressive Disease|4|||
161250268|NCT00683592|582296792|FG001|Overall Study|Other|1|||
161250269|NCT02697617|582296800|FG000|Overall Study|Withdrawal by Subject|0|||
161250270|NCT02697617|582296801|FG001|Overall Study|Withdrawal by Subject|2|||
160838657|NCT02607228|580795789|FG001|Overall Study|Progressive Disease|3|||
160838658|NCT02607228|580795790|FG002|Overall Study|Progressive Disease|1|||
161250271|NCT02697617|582296800|FG000|Overall Study|Pregnancy|1|||
161250272|NCT02697617|582296801|FG001|Overall Study|Pregnancy|0|||
161250273|NCT03303417|582296802|FG000|Overall Study|Withdrawal by Subject|1|||
161250274|NCT03303417|582296803|FG001|Overall Study|Withdrawal by Subject|1|||
161250275|NCT00329160|582296807|FG000|Overall Study|Adverse Event|27|||
161250276|NCT00329160|582296807|FG000|Overall Study|Withdrawal by Subject|13|||
161250277|NCT00329160|582296807|FG000|Overall Study|Protocol Violation|2|||
161250278|NCT00329160|582296807|FG000|Overall Study|Did not Receive Study Drug|1|||
161250279|NCT00329160|582296807|FG000|Overall Study|Incomplete IVUS|45|||
161250280|NCT05212948|582296812|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
161250281|NCT05212948|582296813|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
161250282|NCT05212948|582296812|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
161250283|NCT05212948|582296813|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
161250284|NCT05212948|582296812|FG000|Initial Vaccination Period|Pregnancy|20|||
161250285|NCT05212948|582296813|FG001|Initial Vaccination Period|Pregnancy|14|||
161250286|NCT05212948|582296812|FG000|Initial Vaccination Period|Physician Decision|686|||
161250287|NCT05212948|582296813|FG001|Initial Vaccination Period|Physician Decision|401|||
161250288|NCT05212948|582296812|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
161250289|NCT05212948|582296813|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
161250290|NCT05212948|582296812|FG000|Initial Vaccination Period|Death|23|||
161250291|NCT05212948|582296813|FG001|Initial Vaccination Period|Death|18|||
160904567|NCT03068455|581045015|FG001|Treatment Period|Participant withdrew consent|10|||
160904568|NCT03068455|581045014|FG000|Treatment Period|Poor/non-compliance|3|||
160904569|NCT03068455|581045015|FG001|Treatment Period|Poor/non-compliance|0|||
160904570|NCT03068455|581045014|FG000|Treatment Period|Participant no longer meets study criteria|1|||
160904571|NCT03068455|581045015|FG001|Treatment Period|Participant no longer meets study criteria|3|||
160904572|NCT03068455|581045014|FG000|Treatment Period|Other reasons|12|||
160904573|NCT03068455|581045015|FG001|Treatment Period|Other reasons|4|||
160904574|NCT05338216|581045017|FG000|Overall Study|Withdrawal by Subject|1|||
160904575|NCT05338216|581045018|FG001|Overall Study|Withdrawal by Subject|1|||
160904576|NCT04457336|581045019|FG000|Period 2: Part A|Withdrawal by Subject|0|||
160904577|NCT04457336|581045020|FG001|Period 2: Part A|Withdrawal by Subject|1|||
160904578|NCT04457336|581045021|FG002|Period 2: Part A|Withdrawal by Subject|1|||
160904579|NCT04457336|581045022|FG003|Period 2: Part A|Withdrawal by Subject|1|||
160904580|NCT04457336|581045023|FG004|Period 2: Part A|Withdrawal by Subject|0|||
160904581|NCT04457336|581045024|FG005|Period 2: Part A|Withdrawal by Subject|0|||
160904582|NCT04457336|581045025|FG006|Period 2: Part A|Withdrawal by Subject|0|||
160904583|NCT04457336|581045026|FG007|Period 2: Part A|Withdrawal by Subject|0|||
160904584|NCT04457336|581045019|FG000|Period 2: Part A|Adverse Event|0|||
160904585|NCT04457336|581045020|FG001|Period 2: Part A|Adverse Event|0|||
160904586|NCT04457336|581045021|FG002|Period 2: Part A|Adverse Event|1|||
160904587|NCT04457336|581045022|FG003|Period 2: Part A|Adverse Event|1|||
160904588|NCT04457336|581045023|FG004|Period 2: Part A|Adverse Event|0|||
160904589|NCT04457336|581045024|FG005|Period 2: Part A|Adverse Event|0|||
160904590|NCT04457336|581045025|FG006|Period 2: Part A|Adverse Event|0|||
160904591|NCT04457336|581045026|FG007|Period 2: Part A|Adverse Event|0|||
160904592|NCT04457336|581045019|FG000|Period 2: Part A|Study Terminated|0|||
160904593|NCT04457336|581045020|FG001|Period 2: Part A|Study Terminated|0|||
160904594|NCT04457336|581045021|FG002|Period 2: Part A|Study Terminated|1|||
160904595|NCT04457336|581045022|FG003|Period 2: Part A|Study Terminated|0|||
160904596|NCT04457336|581045023|FG004|Period 2: Part A|Study Terminated|0|||
160904597|NCT04457336|581045024|FG005|Period 2: Part A|Study Terminated|0|||
160904598|NCT04457336|581045025|FG006|Period 2: Part A|Study Terminated|0|||
160904599|NCT04457336|581045026|FG007|Period 2: Part A|Study Terminated|0|||
160904600|NCT04457336|581045019|FG000|Period 2: Part A|Protocol Violation|0|||
160904601|NCT04457336|581045020|FG001|Period 2: Part A|Protocol Violation|1|||
160904602|NCT04457336|581045021|FG002|Period 2: Part A|Protocol Violation|0|||
160904603|NCT04457336|581045022|FG003|Period 2: Part A|Protocol Violation|0|||
160904604|NCT04457336|581045023|FG004|Period 2: Part A|Protocol Violation|0|||
160904605|NCT04457336|581045024|FG005|Period 2: Part A|Protocol Violation|0|||
160904606|NCT04457336|581045025|FG006|Period 2: Part A|Protocol Violation|0|||
160904607|NCT04457336|581045026|FG007|Period 2: Part A|Protocol Violation|0|||
160904608|NCT04457336|581045019|FG000|Period 2: Part A|Lost to Follow-up|0|||
160904609|NCT04457336|581045020|FG001|Period 2: Part A|Lost to Follow-up|1|||
160904610|NCT04457336|581045021|FG002|Period 2: Part A|Lost to Follow-up|0|||
160904611|NCT04457336|581045022|FG003|Period 2: Part A|Lost to Follow-up|0|||
160904612|NCT04457336|581045023|FG004|Period 2: Part A|Lost to Follow-up|0|||
160904613|NCT04457336|581045024|FG005|Period 2: Part A|Lost to Follow-up|0|||
160904614|NCT04457336|581045025|FG006|Period 2: Part A|Lost to Follow-up|0|||
160904615|NCT04457336|581045026|FG007|Period 2: Part A|Lost to Follow-up|0|||
160904616|NCT04457336|581045019|FG000|Period 2: Part A|Other|0|||
160904617|NCT04457336|581045020|FG001|Period 2: Part A|Other|1|||
160904618|NCT04457336|581045021|FG002|Period 2: Part A|Other|0|||
160904619|NCT04457336|581045022|FG003|Period 2: Part A|Other|0|||
161250292|NCT05212948|582296812|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
161250293|NCT05212948|582296813|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
161250294|NCT05212948|582296812|FG000|Initial Vaccination Period|Adverse Event|36|||
161250295|NCT05212948|582296813|FG001|Initial Vaccination Period|Adverse Event|23|||
161250296|NCT05212948|582296812|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
161250297|NCT05212948|582296813|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
161250298|NCT05212948|582296812|FG000|Crossover Vaccination Period|Pregnancy|6|||
161250299|NCT05212948|582296813|FG001|Crossover Vaccination Period|Pregnancy|1|||
161250300|NCT05212948|582296812|FG000|Crossover Vaccination Period|Physician Decision|49|||
161250301|NCT05212948|582296813|FG001|Crossover Vaccination Period|Physician Decision|24|||
161250302|NCT05212948|582296812|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
161250303|NCT05212948|582296813|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
161250304|NCT05212948|582296812|FG000|Crossover Vaccination Period|Death|10|||
161250305|NCT05212948|582296813|FG001|Crossover Vaccination Period|Death|5|||
161250306|NCT05212948|582296812|FG000|Crossover Vaccination Period|Adverse Event|9|||
161250307|NCT05212948|582296813|FG001|Crossover Vaccination Period|Adverse Event|4|||
161334966|NCT00372424|582615871|FG000|Overall Study|Death|1|||
160838659|NCT02607228|580795791|FG003|Overall Study|Progressive Disease|5|||
160838660|NCT02607228|580795792|FG004|Overall Study|Progressive Disease|4|||
160838661|NCT02607228|580795793|FG005|Overall Study|Progressive Disease|3|||
160838662|NCT02607228|580795794|FG006|Overall Study|Progressive Disease|1|||
160838663|NCT02607228|580795788|FG000|Overall Study|Adverse Event|1|||
160838664|NCT02607228|580795789|FG001|Overall Study|Adverse Event|0|||
160838665|NCT02607228|580795790|FG002|Overall Study|Adverse Event|1|||
160838666|NCT02607228|580795791|FG003|Overall Study|Adverse Event|0|||
160838667|NCT02607228|580795792|FG004|Overall Study|Adverse Event|1|||
160838668|NCT02607228|580795793|FG005|Overall Study|Adverse Event|1|||
160838669|NCT02607228|580795794|FG006|Overall Study|Adverse Event|1|||
160838670|NCT02607228|580795788|FG000|Overall Study|Investigator's Discretion|0|||
160838671|NCT02607228|580795789|FG001|Overall Study|Investigator's Discretion|0|||
160838672|NCT02607228|580795790|FG002|Overall Study|Investigator's Discretion|1|||
160838673|NCT02607228|580795791|FG003|Overall Study|Investigator's Discretion|0|||
160838674|NCT02607228|580795792|FG004|Overall Study|Investigator's Discretion|0|||
160838675|NCT02607228|580795793|FG005|Overall Study|Investigator's Discretion|1|||
160838676|NCT02607228|580795794|FG006|Overall Study|Investigator's Discretion|0|||
160838677|NCT02607228|580795788|FG000|Overall Study|Withdrew Consent|0|||
160838678|NCT02607228|580795789|FG001|Overall Study|Withdrew Consent|1|||
160838679|NCT02607228|580795790|FG002|Overall Study|Withdrew Consent|0|||
160838680|NCT02607228|580795791|FG003|Overall Study|Withdrew Consent|0|||
160838681|NCT02607228|580795792|FG004|Overall Study|Withdrew Consent|0|||
160838682|NCT02607228|580795793|FG005|Overall Study|Withdrew Consent|1|||
160838683|NCT02607228|580795794|FG006|Overall Study|Withdrew Consent|0|||
160838684|NCT02607228|580795788|FG000|Overall Study|Study Terminated by Sponsor|0|||
160838685|NCT02607228|580795789|FG001|Overall Study|Study Terminated by Sponsor|0|||
160838686|NCT02607228|580795790|FG002|Overall Study|Study Terminated by Sponsor|0|||
160838687|NCT02607228|580795791|FG003|Overall Study|Study Terminated by Sponsor|1|||
160838688|NCT02607228|580795792|FG004|Overall Study|Study Terminated by Sponsor|0|||
160838689|NCT02607228|580795793|FG005|Overall Study|Study Terminated by Sponsor|0|||
160838690|NCT02607228|580795794|FG006|Overall Study|Study Terminated by Sponsor|0|||
160838691|NCT03235089|580795795|FG000|Overall Study|Lost to Follow-up|1|||
160838692|NCT03235089|580795796|FG001|Overall Study|Lost to Follow-up|1|||
160838693|NCT03235089|580795795|FG000|Overall Study|Physician Decision|2|||
160838694|NCT03235089|580795796|FG001|Overall Study|Physician Decision|2|||
160838695|NCT03238924|580795806|FG000|Overall Study|Withdrawal by Subject|2|||
160838696|NCT03238924|580795807|FG001|Overall Study|Withdrawal by Subject|2|||
160838697|NCT03576716|580795810|FG000|Overall Study|Withdrawal by Subject|0|||
160838698|NCT03576716|580795811|FG001|Overall Study|Withdrawal by Subject|1|||
160838699|NCT00559988|580795812|FG000|Overall Study|Death|147|||
160838700|NCT00559988|580795813|FG001|Overall Study|Death|140|||
160838701|NCT00559988|580795812|FG000|Overall Study|Withdrawal by Subject|152|||
160838702|NCT00559988|580795813|FG001|Overall Study|Withdrawal by Subject|139|||
160838703|NCT00559988|580795812|FG000|Overall Study|Lost to Follow-up|42|||
160838704|NCT00559988|580795813|FG001|Overall Study|Lost to Follow-up|56|||
160838705|NCT00559988|580795812|FG000|Overall Study|ICD device explanted|10|||
160838706|NCT00559988|580795813|FG001|Overall Study|ICD device explanted|17|||
160838707|NCT02891382|580795814|FG000|Overall Study|Lost to Follow-up|3|||
160838708|NCT02891382|580795815|FG001|Overall Study|Lost to Follow-up|4|||
160838709|NCT02891382|580795816|FG002|Overall Study|Lost to Follow-up|5|||
160838710|NCT02891382|580795817|FG003|Overall Study|Lost to Follow-up|3|||
160838711|NCT02891382|580795818|FG004|Overall Study|Lost to Follow-up|4|||
160838712|NCT02516228|580795819|FG000|Overall Study|Lost to Follow-up|1|||
160838713|NCT02516228|580795819|FG000|Overall Study|Withdrawal by Subject|1|||
160838714|NCT02516228|580795819|FG000|Overall Study|Physician Decision|1|||
160838715|NCT03916484|580795820|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160838716|NCT03916484|580795821|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
160838717|NCT03916484|580795822|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
160838718|NCT03916484|580795823|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
161250308|NCT05347693|582296814|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
161250309|NCT05347693|582296815|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
161250310|NCT05347693|582296816|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
161250311|NCT05347693|582296814|FG000|Inpatient Period|Withdrawal of consent|10|||
161250312|NCT05347693|582296815|FG001|Inpatient Period|Withdrawal of consent|0|||
161250313|NCT05347693|582296816|FG002|Inpatient Period|Withdrawal of consent|0|||
161250314|NCT05347693|582296814|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
161250315|NCT05347693|582296815|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
161250316|NCT05347693|582296816|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
161250317|NCT05347693|582296814|FG000|Inpatient Period|Screening Failure|8|||
161250318|NCT05347693|582296815|FG001|Inpatient Period|Screening Failure|0|||
161250319|NCT05347693|582296816|FG002|Inpatient Period|Screening Failure|0|||
161250320|NCT05347693|582296814|FG000|Inpatient Period|Death|2|||
161250321|NCT05347693|582296815|FG001|Inpatient Period|Death|0|||
161250322|NCT05347693|582296816|FG002|Inpatient Period|Death|0|||
161250323|NCT05347693|582296814|FG000|Inpatient Period|Physician Decision|5|||
161250324|NCT05347693|582296815|FG001|Inpatient Period|Physician Decision|0|||
161250325|NCT05347693|582296816|FG002|Inpatient Period|Physician Decision|0|||
161250326|NCT05347693|582296814|FG000|Inpatient Period|Adverse Event|3|||
161250327|NCT05347693|582296815|FG001|Inpatient Period|Adverse Event|0|||
161250328|NCT05347693|582296816|FG002|Inpatient Period|Adverse Event|0|||
161250329|NCT05347693|582296814|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
161334967|NCT00372424|582615871|FG000|Overall Study|Objective Progression or Relapse|14|||
161334968|NCT00372424|582615871|FG000|Overall Study|Other|7|||
160838719|NCT03916484|580795820|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
160838720|NCT03916484|580795821|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
160838721|NCT03916484|580795822|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
160838722|NCT03916484|580795823|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
160838723|NCT02292706|580795825|FG000|Overall Study|Lost to Follow-up|20|||
160838724|NCT02292706|580795826|FG001|Overall Study|Lost to Follow-up|44|||
160838725|NCT02292706|580795827|FG002|Overall Study|Lost to Follow-up|24|||
160838726|NCT02292706|580795828|FG003|Overall Study|Lost to Follow-up|61|||
161138776|NCT03528681|581890084|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
161138777|NCT03528681|581890085|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
161138778|NCT03528681|581890086|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
161138779|NCT03528681|581890087|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
161138780|NCT03528681|581890084|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
161138781|NCT03528681|581890085|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
161138782|NCT03528681|581890086|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
161138783|NCT03528681|581890087|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
161138784|NCT03528681|581890084|FG000|Randomized Treatment Phase|(Not collected)|0|||
161138785|NCT03528681|581890085|FG001|Randomized Treatment Phase|(Not collected)|4|||
161138786|NCT03528681|581890086|FG002|Randomized Treatment Phase|(Not collected)|6|||
161138787|NCT03528681|581890087|FG003|Randomized Treatment Phase|(Not collected)|5|||
161138788|NCT01614457|581890094|FG000|Overall Study|Non-Compliance|1|||
161138789|NCT01614457|581890095|FG001|Overall Study|Non-Compliance|0|||
161138790|NCT01614457|581890094|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
161138791|NCT01614457|581890095|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
161138792|NCT03518840|581890098|FG000|Overall Study|Lost to Follow-up|6|||
161138793|NCT00374556|581890101|FG000|Overall Study|Lost to Follow-up|1|||
161138794|NCT00374556|581890102|FG001|Overall Study|Lost to Follow-up|0|||
161138795|NCT00374556|581890101|FG000|Overall Study|Removed at baseline due to medical cond|0|||
161138796|NCT00374556|581890102|FG001|Overall Study|Removed at baseline due to medical cond|1|||
161138797|NCT00473694|581890103|FG000|Overall Study|Adverse Event|0|||
161138798|NCT00473694|581890104|FG001|Overall Study|Adverse Event|1|||
161138799|NCT00473694|581890105|FG002|Overall Study|Adverse Event|0|||
161138800|NCT00473694|581890106|FG003|Overall Study|Adverse Event|0|||
161138801|NCT00473694|581890103|FG000|Overall Study|Participants did not receive treatment|11|||
161138802|NCT00473694|581890104|FG001|Overall Study|Participants did not receive treatment|3|||
161138803|NCT00473694|581890105|FG002|Overall Study|Participants did not receive treatment|5|||
161138804|NCT00473694|581890106|FG003|Overall Study|Participants did not receive treatment|6|||
161138805|NCT00473694|581890103|FG000|Overall Study|Lost to Follow-up|0|||
161138806|NCT00473694|581890104|FG001|Overall Study|Lost to Follow-up|0|||
161138807|NCT00473694|581890105|FG002|Overall Study|Lost to Follow-up|0|||
161138808|NCT00473694|581890106|FG003|Overall Study|Lost to Follow-up|1|||
161138809|NCT03816995|581890109|FG000|Overall Study|Withdrawal by Subject|3|||
161138810|NCT03816995|581890110|FG001|Overall Study|Withdrawal by Subject|1|||
161138811|NCT03816995|581890109|FG000|Overall Study|Cancelled Surgery|8|||
161138812|NCT03816995|581890110|FG001|Overall Study|Cancelled Surgery|12|||
161138813|NCT03816995|581890109|FG000|Overall Study|No wound protector used|11|||
161250330|NCT05347693|582296815|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
161250331|NCT05347693|582296816|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
161250332|NCT05347693|582296814|FG000|Outpatient Period|Adverse Event|0|||
161250333|NCT05347693|582296815|FG001|Outpatient Period|Adverse Event|9|||
161250334|NCT05347693|582296816|FG002|Outpatient Period|Adverse Event|0|||
161250335|NCT05347693|582296814|FG000|Outpatient Period|Death|0|||
161138814|NCT03816995|581890110|FG001|Overall Study|No wound protector used|17|||
161138815|NCT03816995|581890109|FG000|Overall Study|Protocol Violation|2|||
161138816|NCT03816995|581890110|FG001|Overall Study|Protocol Violation|3|||
161138817|NCT00486902|581890111|FG000|Overall Study|Withdrawal by Subject|1|||
161138818|NCT00486902|581890112|FG001|Overall Study|Withdrawal by Subject|2|||
160904620|NCT04457336|581045023|FG004|Period 2: Part A|Other|0|||
160904621|NCT04457336|581045024|FG005|Period 2: Part A|Other|0|||
160904622|NCT04457336|581045025|FG006|Period 2: Part A|Other|0|||
160904623|NCT04457336|581045026|FG007|Period 2: Part A|Other|0|||
160904624|NCT04457336|581045019|FG000|Period 2: Part A|Physician Decision|0|||
160904625|NCT04457336|581045020|FG001|Period 2: Part A|Physician Decision|0|||
161138819|NCT00486902|581890111|FG000|Overall Study|decision for postpartum tubal ligation|3|||
161138820|NCT00486902|581890112|FG001|Overall Study|decision for postpartum tubal ligation|1|||
161138821|NCT00486902|581890111|FG000|Overall Study|spinal anesthetic protocal violation|1|||
161138822|NCT00486902|581890112|FG001|Overall Study|spinal anesthetic protocal violation|1|||
161138823|NCT00486902|581890111|FG000|Overall Study|Did not meet inclusion criteria|1|||
161138824|NCT00486902|581890112|FG001|Overall Study|Did not meet inclusion criteria|0|||
161138825|NCT00486902|581890111|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
161138826|NCT00486902|581890112|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
161138827|NCT00541307|581890113|FG000|Overall Study|Death|5|||
161138828|NCT00541307|581890113|FG000|Overall Study|Physician Decision|3|||
161138829|NCT00541307|581890113|FG000|Overall Study|Withdrawal by Subject|6|||
161138830|NCT00541307|581890113|FG000|Overall Study|Lost to Follow-up|4|||
161138831|NCT00541307|581890113|FG000|Overall Study|Subject returned early (outside window)|1|||
161138832|NCT00541307|581890113|FG000|Overall Study|Surgical Bypass|5|||
161138833|NCT00942409|581890114|FG000|Overall Study|Lack of Efficacy|1|||
161138834|NCT00942409|581890114|FG000|Overall Study|study drug unavailable|2|||
161138835|NCT01242111|581890115|FG000|Overall Study|Adverse Event|1|||
161138836|NCT01242111|581890115|FG000|Overall Study|Withdrawal by Subject|1|||
161138837|NCT01242111|581890115|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
161138838|NCT01697215|581890116|FG000|Overall Study|Physician Decision|5|||
161138839|NCT01697215|581890116|FG000|Overall Study|Malfunction|9|||
161138840|NCT01697215|581890116|FG000|Overall Study|CXR not available|9|||
161138841|NCT01929083|581890117|FG000|Intervention 1|Lost to Follow-up|2|||
161138842|NCT01929083|581890118|FG001|Intervention 1|Lost to Follow-up|0|||
161138843|NCT01929083|581890117|FG000|Intervention 1|Nonadherent to study medications|1|||
161138844|NCT01929083|581890118|FG001|Intervention 1|Nonadherent to study medications|0|||
161138845|NCT01929083|581890117|FG000|Intervention 2|Adverse Event|0|||
161138846|NCT01929083|581890118|FG001|Intervention 2|Adverse Event|1|||
161138847|NCT02599402|581890119|FG000|Overall Study|Disease progression|153|||
161138848|NCT02599402|581890119|FG000|Overall Study|Study drug toxicity|201|||
161138849|NCT02599402|581890119|FG000|Overall Study|Death|26|||
161138850|NCT02599402|581890119|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
161138851|NCT02599402|581890119|FG000|Overall Study|Participant request to discontinue study treatment|13|||
161138852|NCT02599402|581890119|FG000|Overall Study|Participant withdrew consent|5|||
161138853|NCT02599402|581890119|FG000|Overall Study|Lost to Follow-up|1|||
161138854|NCT02599402|581890119|FG000|Overall Study|Maximum Clinical Benefit|7|||
161138855|NCT02599402|581890119|FG000|Overall Study|Poor/non-compliance|1|||
161138856|NCT02599402|581890119|FG000|Overall Study|Pregnancy|1|||
161138857|NCT02599402|581890119|FG000|Overall Study|Participant no longer met study criteria|7|||
161138858|NCT02599402|581890119|FG000|Overall Study|Other Reasons|95|||
161138859|NCT02945657|581890120|FG000|Overall Study|Adverse Event|1|||
161138860|NCT02945657|581890120|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161138861|NCT00087438|581890127|FG000|Overall Study|Ineligible / No protocol treatment|4|||
161138862|NCT00283387|581890128|FG000|First Intervention|Subject non-compliant|1|||
161138863|NCT00283387|581890129|FG001|First Intervention|Subject non-compliant|1|||
161138864|NCT00283387|581890128|FG000|First Intervention|Withdrawal by Subject|0|||
161138865|NCT00283387|581890129|FG001|First Intervention|Withdrawal by Subject|1|||
161138866|NCT05340504|581890130|FG000|Overall Study|Withdrawal by Subject|1|||
161138867|NCT05340504|581890131|FG001|Overall Study|Withdrawal by Subject|0|||
161138868|NCT03068715|581890135|FG000|Overall Study|No longer met inclusion criteria|1|||
161138869|NCT03068715|581890136|FG001|Overall Study|No longer met inclusion criteria|0|||
161138870|NCT00728416|581890137|FG000|Overall Study|Adverse Event|1|||
161138871|NCT00728416|581890138|FG001|Overall Study|Adverse Event|1|||
161138872|NCT00728416|581890137|FG000|Overall Study|Treatment Failure|0|||
161138873|NCT00728416|581890138|FG001|Overall Study|Treatment Failure|1|||
161138874|NCT00728416|581890137|FG000|Overall Study|Withdrawal by Subject|1|||
161138875|NCT00728416|581890138|FG001|Overall Study|Withdrawal by Subject|0|||
161138876|NCT00117312|581890139|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
161138877|NCT00117312|581890140|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
161138878|NCT00117312|581890141|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
161138879|NCT00117312|581890142|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
161138880|NCT00117312|581890139|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
161138881|NCT00117312|581890140|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
161138882|NCT00117312|581890141|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
161250336|NCT05347693|582296815|FG001|Outpatient Period|Death|6|||
160904626|NCT04457336|581045021|FG002|Period 2: Part A|Physician Decision|0|||
160904627|NCT04457336|581045022|FG003|Period 2: Part A|Physician Decision|1|||
160904628|NCT04457336|581045023|FG004|Period 2: Part A|Physician Decision|0|||
160904629|NCT04457336|581045024|FG005|Period 2: Part A|Physician Decision|0|||
160904630|NCT04457336|581045025|FG006|Period 2: Part A|Physician Decision|0|||
160904631|NCT04457336|581045026|FG007|Period 2: Part A|Physician Decision|0|||
160904632|NCT04457336|581045019|FG000|Period 3: Part B|Study Terminated|0|||
160904633|NCT04457336|581045020|FG001|Period 3: Part B|Study Terminated|0|||
160904634|NCT04457336|581045021|FG002|Period 3: Part B|Study Terminated|0|||
160904635|NCT04457336|581045022|FG003|Period 3: Part B|Study Terminated|0|||
160904636|NCT04457336|581045023|FG004|Period 3: Part B|Study Terminated|1|||
160904637|NCT04457336|581045024|FG005|Period 3: Part B|Study Terminated|10|||
160904638|NCT04457336|581045025|FG006|Period 3: Part B|Study Terminated|13|||
160904639|NCT04457336|581045026|FG007|Period 3: Part B|Study Terminated|0|||
160904640|NCT04457336|581045019|FG000|Period 3: Part B|Withdrawal by Subject|0|||
160904641|NCT04457336|581045020|FG001|Period 3: Part B|Withdrawal by Subject|0|||
160904642|NCT04457336|581045021|FG002|Period 3: Part B|Withdrawal by Subject|0|||
160904643|NCT04457336|581045022|FG003|Period 3: Part B|Withdrawal by Subject|0|||
160904644|NCT04457336|581045023|FG004|Period 3: Part B|Withdrawal by Subject|0|||
160904645|NCT04457336|581045024|FG005|Period 3: Part B|Withdrawal by Subject|1|||
160904646|NCT04457336|581045025|FG006|Period 3: Part B|Withdrawal by Subject|2|||
160904647|NCT04457336|581045026|FG007|Period 3: Part B|Withdrawal by Subject|0|||
160904648|NCT04457336|581045019|FG000|Period 4: Part C|Study Terminated|0|||
160904649|NCT04457336|581045020|FG001|Period 4: Part C|Study Terminated|0|||
160904650|NCT04457336|581045021|FG002|Period 4: Part C|Study Terminated|0|||
160904651|NCT04457336|581045022|FG003|Period 4: Part C|Study Terminated|0|||
160904652|NCT04457336|581045023|FG004|Period 4: Part C|Study Terminated|0|||
160904653|NCT04457336|581045024|FG005|Period 4: Part C|Study Terminated|0|||
160904654|NCT04457336|581045025|FG006|Period 4: Part C|Study Terminated|0|||
160904655|NCT04457336|581045026|FG007|Period 4: Part C|Study Terminated|30|||
160904656|NCT04457336|581045019|FG000|Period 4: Part C|Adverse Event|0|||
160904657|NCT04457336|581045020|FG001|Period 4: Part C|Adverse Event|0|||
160904658|NCT04457336|581045021|FG002|Period 4: Part C|Adverse Event|0|||
160904659|NCT04457336|581045022|FG003|Period 4: Part C|Adverse Event|0|||
160904660|NCT04457336|581045023|FG004|Period 4: Part C|Adverse Event|0|||
160904661|NCT04457336|581045024|FG005|Period 4: Part C|Adverse Event|0|||
160904662|NCT04457336|581045025|FG006|Period 4: Part C|Adverse Event|0|||
160904663|NCT04457336|581045026|FG007|Period 4: Part C|Adverse Event|2|||
160904664|NCT04457336|581045019|FG000|Period 4: Part C|Site Terminated|0|||
160904665|NCT04457336|581045020|FG001|Period 4: Part C|Site Terminated|0|||
160904666|NCT04457336|581045021|FG002|Period 4: Part C|Site Terminated|0|||
160904667|NCT04457336|581045022|FG003|Period 4: Part C|Site Terminated|0|||
160904668|NCT04457336|581045023|FG004|Period 4: Part C|Site Terminated|0|||
160904669|NCT04457336|581045024|FG005|Period 4: Part C|Site Terminated|0|||
160904670|NCT04457336|581045025|FG006|Period 4: Part C|Site Terminated|0|||
160904671|NCT04457336|581045026|FG007|Period 4: Part C|Site Terminated|1|||
160904672|NCT04457336|581045019|FG000|Period 4: Part C|Other|0|||
160904673|NCT04457336|581045020|FG001|Period 4: Part C|Other|0|||
160904674|NCT04457336|581045021|FG002|Period 4: Part C|Other|0|||
160904675|NCT04457336|581045022|FG003|Period 4: Part C|Other|0|||
160904676|NCT04457336|581045023|FG004|Period 4: Part C|Other|0|||
160904677|NCT04457336|581045024|FG005|Period 4: Part C|Other|0|||
160904678|NCT04457336|581045025|FG006|Period 4: Part C|Other|0|||
160904679|NCT04457336|581045026|FG007|Period 4: Part C|Other|2|||
160904680|NCT04457336|581045019|FG000|Period 4: Part C|Withdrawal by Subject|0|||
160904681|NCT04457336|581045020|FG001|Period 4: Part C|Withdrawal by Subject|0|||
160904682|NCT04457336|581045021|FG002|Period 4: Part C|Withdrawal by Subject|0|||
160904683|NCT04457336|581045022|FG003|Period 4: Part C|Withdrawal by Subject|0|||
160904684|NCT04457336|581045023|FG004|Period 4: Part C|Withdrawal by Subject|0|||
160904685|NCT04457336|581045024|FG005|Period 4: Part C|Withdrawal by Subject|0|||
160904686|NCT04457336|581045025|FG006|Period 4: Part C|Withdrawal by Subject|0|||
160904687|NCT04457336|581045026|FG007|Period 4: Part C|Withdrawal by Subject|3|||
160904688|NCT05379231|581045027|FG000|Home Visit|Withdrawal by Subject|2|||
160904689|NCT05379231|581045027|FG000|In-lab Visit|Withdrawal by Subject|2|||
160904690|NCT01201785|581045039|FG000|Overall Study|Lost to Follow-up|16|||
160904691|NCT01064310|581045040|FG000|Period 1|Adverse Event|7|||
160904692|NCT01064310|581045041|FG001|Period 1|Adverse Event|10|||
161138883|NCT00117312|581890142|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
161138884|NCT00117312|581890139|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
160904693|NCT01064310|581045042|FG002|Period 1|Adverse Event|0|||
160904694|NCT01064310|581045040|FG000|Period 1|Physician Decision|1|||
160904695|NCT01064310|581045041|FG001|Period 1|Physician Decision|0|||
160904696|NCT01064310|581045042|FG002|Period 1|Physician Decision|0|||
160904697|NCT01064310|581045040|FG000|Period 1|Withdrawal by Subject|2|||
160904698|NCT01064310|581045041|FG001|Period 1|Withdrawal by Subject|2|||
160904699|NCT01064310|581045042|FG002|Period 1|Withdrawal by Subject|0|||
160904700|NCT01064310|581045040|FG000|Period 1|Lack of Efficacy|3|||
160904701|NCT01064310|581045041|FG001|Period 1|Lack of Efficacy|5|||
160904702|NCT01064310|581045042|FG002|Period 1|Lack of Efficacy|0|||
160904703|NCT01064310|581045040|FG000|Period 1|Entered Open-label Period|1|||
160991792|NCT02042443|581359895|FG000|Overall Study|Adverse Event|2|||
160991793|NCT02042443|581359896|FG001|Overall Study|Adverse Event|1|||
160991794|NCT02042443|581359895|FG000|Overall Study|Withdrawal by Subject|0|||
160991795|NCT02042443|581359896|FG001|Overall Study|Withdrawal by Subject|1|||
160991796|NCT02042443|581359895|FG000|Overall Study|Progression|21|||
160991797|NCT02042443|581359896|FG001|Overall Study|Progression|17|||
160991798|NCT02042443|581359895|FG000|Overall Study|not protocol specified|1|||
160991799|NCT02042443|581359896|FG001|Overall Study|not protocol specified|1|||
160991800|NCT02042443|581359895|FG000|Overall Study|Not eligible/not analyzable|3|||
160991801|NCT02042443|581359896|FG001|Overall Study|Not eligible/not analyzable|6|||
160991802|NCT01649427|581359897|FG000|Overall Study|Adverse Event|1|||
160991803|NCT01649427|581359898|FG001|Overall Study|Adverse Event|1|||
160991804|NCT01649427|581359897|FG000|Overall Study|Withdrawal by Subject|8|||
160991805|NCT01649427|581359898|FG001|Overall Study|Withdrawal by Subject|7|||
160991806|NCT01649427|581359897|FG000|Overall Study|Lost to Follow-up|0|||
160991807|NCT01649427|581359898|FG001|Overall Study|Lost to Follow-up|1|||
160991808|NCT01649427|581359897|FG000|Overall Study|Graft loss|0|||
160991809|NCT01649427|581359898|FG001|Overall Study|Graft loss|1|||
160991810|NCT01649427|581359897|FG000|Overall Study|Surgical problems during nephrectomy|2|||
160991811|NCT01649427|581359898|FG001|Overall Study|Surgical problems during nephrectomy|2|||
160991812|NCT02138916|581359899|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
160991813|NCT02138916|581359900|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
160991814|NCT02138916|581359901|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
160991815|NCT02138916|581359899|FG000|Overall Study|Death|14|||
160991816|NCT02138916|581359900|FG001|Overall Study|Death|11|||
160991817|NCT02138916|581359901|FG002|Overall Study|Death|12|||
160991818|NCT02138916|581359899|FG000|Overall Study|Withdrawal by Subject|27|||
160991819|NCT02138916|581359900|FG001|Overall Study|Withdrawal by Subject|31|||
160991820|NCT02138916|581359901|FG002|Overall Study|Withdrawal by Subject|32|||
160991821|NCT02138916|581359899|FG000|Overall Study|Study specific withdrawal criteria|0|||
160991822|NCT02138916|581359900|FG001|Overall Study|Study specific withdrawal criteria|0|||
160991823|NCT02138916|581359901|FG002|Overall Study|Study specific withdrawal criteria|1|||
160991824|NCT02138916|581359899|FG000|Overall Study|incorrect enrolment|1|||
160991825|NCT02138916|581359900|FG001|Overall Study|incorrect enrolment|1|||
161250337|NCT05347693|582296816|FG002|Outpatient Period|Death|2|||
161250338|NCT05347693|582296814|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
161250339|NCT05347693|582296815|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
161250340|NCT05347693|582296816|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
160838727|NCT02292706|580795829|FG004|Overall Study|Lost to Follow-up|21|||
160838728|NCT02292706|580795830|FG005|Overall Study|Lost to Follow-up|52|||
160838729|NCT02292706|580795831|FG006|Overall Study|Lost to Follow-up|25|||
160838730|NCT02292706|580795832|FG007|Overall Study|Lost to Follow-up|0|||
160838731|NCT02292706|580795825|FG000|Overall Study|Withdrew consent|15|||
160838732|NCT02292706|580795826|FG001|Overall Study|Withdrew consent|56|||
160838733|NCT02292706|580795827|FG002|Overall Study|Withdrew consent|43|||
160838734|NCT02292706|580795828|FG003|Overall Study|Withdrew consent|36|||
160838735|NCT02292706|580795829|FG004|Overall Study|Withdrew consent|13|||
160838736|NCT02292706|580795830|FG005|Overall Study|Withdrew consent|51|||
160838737|NCT02292706|580795831|FG006|Overall Study|Withdrew consent|20|||
160838738|NCT02292706|580795832|FG007|Overall Study|Withdrew consent|0|||
160838739|NCT02292706|580795825|FG000|Overall Study|Death|3|||
160991826|NCT02138916|581359901|FG002|Overall Study|incorrect enrolment|0|||
160991827|NCT02138916|581359899|FG000|Overall Study|Severe non-compliance|1|||
160991828|NCT02138916|581359900|FG001|Overall Study|Severe non-compliance|2|||
160991829|NCT02138916|581359901|FG002|Overall Study|Severe non-compliance|1|||
160991830|NCT02138916|581359899|FG000|Overall Study|Lost to Follow-up|4|||
160991831|NCT02138916|581359900|FG001|Overall Study|Lost to Follow-up|2|||
160991832|NCT02138916|581359901|FG002|Overall Study|Lost to Follow-up|3|||
160991833|NCT02138916|581359899|FG000|Overall Study|Adverse Event|4|||
160991834|NCT02138916|581359900|FG001|Overall Study|Adverse Event|4|||
160991835|NCT02138916|581359901|FG002|Overall Study|Adverse Event|3|||
160991836|NCT01913340|581359902|FG000|Overall Study|Death|2|||
161250341|NCT05347693|582296814|FG000|Outpatient Period|Lost to Follow-up|0|||
160838740|NCT02292706|580795826|FG001|Overall Study|Death|11|||
160838741|NCT02292706|580795827|FG002|Overall Study|Death|16|||
160838742|NCT02292706|580795828|FG003|Overall Study|Death|22|||
160904704|NCT01064310|581045041|FG001|Period 1|Entered Open-label Period|1|||
160904705|NCT01064310|581045042|FG002|Period 1|Entered Open-label Period|0|||
160904706|NCT01064310|581045040|FG000|Period 2|Adverse Event|2|||
160904707|NCT01064310|581045041|FG001|Period 2|Adverse Event|1|||
160904708|NCT01064310|581045042|FG002|Period 2|Adverse Event|0|||
160904709|NCT01064310|581045040|FG000|Period 2|Physician Decision|0|||
160904710|NCT01064310|581045041|FG001|Period 2|Physician Decision|1|||
160904711|NCT01064310|581045042|FG002|Period 2|Physician Decision|0|||
160904712|NCT01064310|581045040|FG000|Period 2|Entered Open-label Period|1|||
160991837|NCT01913340|581359903|FG001|Overall Study|Death|5|||
160991838|NCT01913340|581359902|FG000|Overall Study|Lost to Follow-up|1|||
161250342|NCT05347693|582296815|FG001|Outpatient Period|Lost to Follow-up|0|||
160904713|NCT01064310|581045041|FG001|Period 2|Entered Open-label Period|0|||
160904714|NCT01064310|581045042|FG002|Period 2|Entered Open-label Period|0|||
160904715|NCT01064310|581045040|FG000|Period 2|Lack of Efficacy|1|||
160904716|NCT01064310|581045041|FG001|Period 2|Lack of Efficacy|4|||
160904717|NCT01064310|581045042|FG002|Period 2|Lack of Efficacy|0|||
160904718|NCT01064310|581045040|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
160904719|NCT01064310|581045041|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
160904720|NCT01064310|581045042|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
160904721|NCT01064310|581045040|FG000|Open Label Pazopinib|Adverse Event|0|||
160904722|NCT01064310|581045041|FG001|Open Label Pazopinib|Adverse Event|0|||
160904723|NCT01064310|581045042|FG002|Open Label Pazopinib|Adverse Event|12|||
160904724|NCT01064310|581045040|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
160904725|NCT01064310|581045041|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
160904726|NCT01064310|581045042|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
160904727|NCT01064310|581045040|FG000|Open Label Pazopinib|Physician Decision|0|||
160904728|NCT01064310|581045041|FG001|Open Label Pazopinib|Physician Decision|0|||
160904729|NCT01064310|581045042|FG002|Open Label Pazopinib|Physician Decision|20|||
160904730|NCT00660699|581045043|FG000|Overall Study|Withdrawal by Subject|2|||
160904731|NCT05147428|581045044|FG000|Overall Study|Removed prior to mailing|289|||
160904732|NCT05147428|581045045|FG001|Overall Study|Removed prior to mailing|306|||
160904733|NCT05147428|581045046|FG002|Overall Study|Removed prior to mailing|270|||
160904734|NCT05147428|581045044|FG000|Overall Study|Died or disenrolled during blackout period|239|||
160904735|NCT05147428|581045045|FG001|Overall Study|Died or disenrolled during blackout period|278|||
160904736|NCT05147428|581045046|FG002|Overall Study|Died or disenrolled during blackout period|273|||
160904737|NCT03128047|581045047|FG000|Overall Study|Withdrawal by Subject|1|||
160904738|NCT00688753|581046292|FG000|Overall Study|Disease progression|55|||
160904739|NCT00688753|581046292|FG000|Overall Study|Missing|1|||
160904740|NCT00688753|581046292|FG000|Overall Study|Death|9|||
160904741|NCT00688753|581046292|FG000|Overall Study|Withdrawal by Subject|3|||
160904742|NCT00688753|581046292|FG000|Overall Study|Adverse Event|20|||
160904743|NCT00688753|581046292|FG000|Overall Study|Protocol Violation|1|||
160904744|NCT00688753|581046292|FG000|Overall Study|Lost to Follow-up|3|||
160904745|NCT05996718|581046294|FG000|Overall Study|Lost to Follow-up|3|||
160904746|NCT01713686|581046295|FG000|Overall Study|Lost to Follow-up|9|||
160904747|NCT01713686|581046295|FG000|Overall Study|Withdrawal by Subject|6|||
160904748|NCT03187197|581046297|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
160904749|NCT03187197|581046298|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
160904750|NCT03187197|581046299|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
160904751|NCT03187197|581046297|FG000|Overall Study|Withdrawal by Subject|8|||
160904752|NCT03187197|581046298|FG001|Overall Study|Withdrawal by Subject|63|||
160904753|NCT03187197|581046299|FG002|Overall Study|Withdrawal by Subject|4|||
160904754|NCT03187197|581046297|FG000|Overall Study|Lost to Follow-up|1|||
160904755|NCT03187197|581046298|FG001|Overall Study|Lost to Follow-up|60|||
160904756|NCT03187197|581046299|FG002|Overall Study|Lost to Follow-up|7|||
160904757|NCT03187197|581046297|FG000|Overall Study|Adverse Event|6|||
160904758|NCT03187197|581046298|FG001|Overall Study|Adverse Event|29|||
160904759|NCT03187197|581046299|FG002|Overall Study|Adverse Event|0|||
160904760|NCT03187197|581046297|FG000|Overall Study|Death|0|||
160904761|NCT03187197|581046298|FG001|Overall Study|Death|11|||
160904762|NCT03187197|581046299|FG002|Overall Study|Death|0|||
160904763|NCT03187197|581046297|FG000|Overall Study|Administrative problem|1|||
160904764|NCT03187197|581046298|FG001|Overall Study|Administrative problem|1|||
160904765|NCT03187197|581046299|FG002|Overall Study|Administrative problem|0|||
160904766|NCT03187197|581046297|FG000|Overall Study|Reason not listed|2|||
160904767|NCT03187197|581046298|FG001|Overall Study|Reason not listed|54|||
160904768|NCT03187197|581046299|FG002|Overall Study|Reason not listed|1|||
160904769|NCT03187197|581046297|FG000|Overall Study|Missing|1|||
160904770|NCT03187197|581046298|FG001|Overall Study|Missing|32|||
160904771|NCT03187197|581046299|FG002|Overall Study|Missing|3|||
160904772|NCT03187197|581046297|FG000|Overall Study|Status missing|2|||
160904773|NCT03187197|581046298|FG001|Overall Study|Status missing|33|||
160904774|NCT03187197|581046299|FG002|Overall Study|Status missing|3|||
160904775|NCT03187197|581046297|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
160904776|NCT03187197|581046298|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
160904777|NCT03187197|581046299|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
160904778|NCT02385045|581046300|FG000|Overall Study|Endoscopy could not be completed|4|||
160904779|NCT00115739|581046301|FG000|Overall Study|Lost to Follow-up|3|||
160904780|NCT00259649|581046304|FG000|Overall Study|Lost to Follow-up|7|||
160904781|NCT00259649|581046304|FG000|Overall Study|irregular menses|3|||
160904782|NCT02200211|581046306|FG000|Overall Study|Lost to Follow-up|7|||
160904783|NCT02200211|581046307|FG001|Overall Study|Lost to Follow-up|7|||
160904784|NCT02200211|581046308|FG002|Overall Study|Lost to Follow-up|1|||
160904785|NCT02200211|581046309|FG003|Overall Study|Lost to Follow-up|2|||
160904786|NCT02200211|581046306|FG000|Overall Study|Withdrawal by Subject|1|||
160904787|NCT02200211|581046307|FG001|Overall Study|Withdrawal by Subject|0|||
160904788|NCT02200211|581046308|FG002|Overall Study|Withdrawal by Subject|0|||
160904789|NCT02200211|581046309|FG003|Overall Study|Withdrawal by Subject|0|||
160991839|NCT01913340|581359903|FG001|Overall Study|Lost to Follow-up|1|||
160838743|NCT02292706|580795829|FG004|Overall Study|Death|8|||
160838744|NCT02292706|580795830|FG005|Overall Study|Death|17|||
160838745|NCT02292706|580795831|FG006|Overall Study|Death|3|||
160838746|NCT02292706|580795832|FG007|Overall Study|Death|0|||
160838747|NCT02292706|580795825|FG000|Overall Study|Study terminated by sponsor|0|||
160838748|NCT02292706|580795826|FG001|Overall Study|Study terminated by sponsor|9|||
160838749|NCT02292706|580795827|FG002|Overall Study|Study terminated by sponsor|4|||
160838750|NCT02292706|580795828|FG003|Overall Study|Study terminated by sponsor|21|||
160838751|NCT02292706|580795829|FG004|Overall Study|Study terminated by sponsor|11|||
160838752|NCT02292706|580795830|FG005|Overall Study|Study terminated by sponsor|13|||
160991840|NCT02784704|581359904|FG000|Overall Study|Adverse Event|4|||
160991841|NCT02784704|581359905|FG001|Overall Study|Adverse Event|2|||
160991842|NCT02784704|581359904|FG000|Overall Study|Lost to Follow-up|6|||
160991843|NCT02784704|581359905|FG001|Overall Study|Lost to Follow-up|4|||
160991844|NCT02784704|581359904|FG000|Overall Study|Withdrawal by Subject|1|||
160991845|NCT02784704|581359905|FG001|Overall Study|Withdrawal by Subject|3|||
160991846|NCT02784704|581359904|FG000|Overall Study|Subject Non Compliance|2|||
160991847|NCT02784704|581359905|FG001|Overall Study|Subject Non Compliance|0|||
160991848|NCT00603538|581359906|FG000|Overall Study|Adverse Event|0|||
160991849|NCT00603538|581359907|FG001|Overall Study|Adverse Event|4|||
160991850|NCT00603538|581359908|FG002|Overall Study|Adverse Event|2|||
160991851|NCT00603538|581359906|FG000|Overall Study|Objective progression or relapse|3|||
160991852|NCT00603538|581359907|FG001|Overall Study|Objective progression or relapse|0|||
160991853|NCT00603538|581359908|FG002|Overall Study|Objective progression or relapse|0|||
160991854|NCT05750745|581359911|FG000|Overall Study|Adverse Event|1|||
160991855|NCT05750745|581359912|FG001|Overall Study|Adverse Event|0|||
160991856|NCT05750745|581359913|FG002|Overall Study|Adverse Event|0|||
160991857|NCT05750745|581359911|FG000|Overall Study|Protocol Violation|1|||
160991858|NCT05750745|581359912|FG001|Overall Study|Protocol Violation|0|||
160991859|NCT05750745|581359913|FG002|Overall Study|Protocol Violation|0|||
160991860|NCT05750745|581359911|FG000|Overall Study|Withdrawal by Subject|0|||
160991861|NCT05750745|581359912|FG001|Overall Study|Withdrawal by Subject|1|||
160991862|NCT05750745|581359913|FG002|Overall Study|Withdrawal by Subject|0|||
160991863|NCT05096884|581359915|FG000|Overall Study|Excluded based on negative tilt table test|4|||
160991864|NCT04794179|581359916|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
160991865|NCT04794179|581359917|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
160991866|NCT02482233|581359924|FG000|Overall Study|Lost to Follow-up|1|||
160991867|NCT02482233|581359925|FG001|Overall Study|Lost to Follow-up|1|||
160991868|NCT04888585|581359926|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
160991869|NCT04888585|581359927|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
160991870|NCT04888585|581359928|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
160991871|NCT04888585|581359929|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
160991872|NCT04888585|581359930|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
160991873|NCT04888585|581359931|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991874|NCT04888585|581359932|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991875|NCT04888585|581359933|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991876|NCT04888585|581359934|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991877|NCT04888585|581359935|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991878|NCT04888585|581359936|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
160991879|NCT04888585|581359926|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991880|NCT04888585|581359927|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
160991881|NCT04888585|581359928|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
160991882|NCT04888585|581359929|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
160991883|NCT04888585|581359930|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
160991884|NCT04888585|581359931|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991885|NCT04888585|581359932|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161138885|NCT00117312|581890140|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
161138886|NCT00117312|581890141|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
161138887|NCT00117312|581890142|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
161138888|NCT00117312|581890139|FG000|Overall Study|Other|0|||
161138889|NCT00117312|581890140|FG001|Overall Study|Other|1|||
160838753|NCT02292706|580795831|FG006|Overall Study|Study terminated by sponsor|3|||
160838754|NCT02292706|580795832|FG007|Overall Study|Study terminated by sponsor|0|||
160838755|NCT02292706|580795825|FG000|Overall Study|Investigator's discretion|4|||
160838756|NCT02292706|580795826|FG001|Overall Study|Investigator's discretion|9|||
160838757|NCT02292706|580795827|FG002|Overall Study|Investigator's discretion|7|||
160838758|NCT02292706|580795828|FG003|Overall Study|Investigator's discretion|11|||
160838759|NCT02292706|580795829|FG004|Overall Study|Investigator's discretion|4|||
160838760|NCT02292706|580795830|FG005|Overall Study|Investigator's discretion|10|||
160838761|NCT02292706|580795831|FG006|Overall Study|Investigator's discretion|1|||
160991886|NCT04888585|581359933|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
161138890|NCT00117312|581890141|FG002|Overall Study|Other|3|||
161138891|NCT00117312|581890142|FG003|Overall Study|Other|1|||
161138892|NCT00117312|581890139|FG000|Overall Study|Patient choice|0|||
161334969|NCT00372424|582615871|FG000|Overall Study|Enrolled, Not Treated|1|||
161334970|NCT00069264|582615879|FG000|Overall Study|Adverse Event|3|||
161334971|NCT00069264|582615879|FG000|Overall Study|Progressive Disease|23|||
160838762|NCT02292706|580795832|FG007|Overall Study|Investigator's discretion|0|||
160838763|NCT02292706|580795825|FG000|Overall Study|Liver transplant|1|||
160838764|NCT02292706|580795826|FG001|Overall Study|Liver transplant|1|||
160838765|NCT02292706|580795827|FG002|Overall Study|Liver transplant|11|||
160838766|NCT02292706|580795828|FG003|Overall Study|Liver transplant|16|||
160838767|NCT02292706|580795829|FG004|Overall Study|Liver transplant|5|||
160838768|NCT02292706|580795830|FG005|Overall Study|Liver transplant|6|||
160838769|NCT02292706|580795831|FG006|Overall Study|Liver transplant|5|||
160838770|NCT02292706|580795832|FG007|Overall Study|Liver transplant|0|||
160838771|NCT02292706|580795825|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
160838772|NCT02292706|580795826|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
160838773|NCT02292706|580795827|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
160838774|NCT02292706|580795828|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
160838775|NCT02292706|580795829|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
160838776|NCT02292706|580795830|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
160838777|NCT02292706|580795831|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
160838778|NCT02292706|580795832|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
160838779|NCT02292706|580795825|FG000|Overall Study|Subject terminated by sponsor|1|||
160838780|NCT02292706|580795826|FG001|Overall Study|Subject terminated by sponsor|0|||
160838781|NCT02292706|580795827|FG002|Overall Study|Subject terminated by sponsor|0|||
160838782|NCT02292706|580795828|FG003|Overall Study|Subject terminated by sponsor|2|||
160838783|NCT02292706|580795829|FG004|Overall Study|Subject terminated by sponsor|1|||
160904790|NCT00381485|581046310|FG000|Open-Label Run-In Period|Adverse Event|9|||
161138893|NCT00117312|581890140|FG001|Overall Study|Patient choice|0|||
161138894|NCT00117312|581890141|FG002|Overall Study|Patient choice|2|||
161138895|NCT00117312|581890142|FG003|Overall Study|Patient choice|1|||
161138896|NCT00117312|581890139|FG000|Overall Study|Adverse Event|0|||
161138897|NCT00117312|581890140|FG001|Overall Study|Adverse Event|2|||
161138898|NCT00117312|581890141|FG002|Overall Study|Adverse Event|0|||
161138899|NCT00117312|581890142|FG003|Overall Study|Adverse Event|0|||
161138900|NCT00117312|581890139|FG000|Overall Study|Protocol Violation|0|||
161138901|NCT00117312|581890140|FG001|Overall Study|Protocol Violation|1|||
161138902|NCT00117312|581890141|FG002|Overall Study|Protocol Violation|3|||
161138903|NCT00117312|581890142|FG003|Overall Study|Protocol Violation|0|||
161138904|NCT00117312|581890139|FG000|Overall Study|PSA decrease <=50%|0|||
161138905|NCT00117312|581890140|FG001|Overall Study|PSA decrease <=50%|2|||
161138906|NCT00117312|581890141|FG002|Overall Study|PSA decrease <=50%|2|||
161138907|NCT00117312|581890142|FG003|Overall Study|PSA decrease <=50%|4|||
161138908|NCT00117312|581890139|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
161138909|NCT00117312|581890140|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
161138910|NCT00117312|581890141|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
161138911|NCT00117312|581890142|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
161138912|NCT00117312|581890139|FG000|Overall Study|Hepatic abnormality|0|||
161138913|NCT00117312|581890140|FG001|Overall Study|Hepatic abnormality|1|||
161138914|NCT00117312|581890141|FG002|Overall Study|Hepatic abnormality|0|||
161138915|NCT00117312|581890142|FG003|Overall Study|Hepatic abnormality|1|||
161138916|NCT00117312|581890139|FG000|Overall Study|Withdrawal by Subject|0|||
161138917|NCT00117312|581890140|FG001|Overall Study|Withdrawal by Subject|2|||
161138918|NCT00117312|581890141|FG002|Overall Study|Withdrawal by Subject|0|||
161138919|NCT00117312|581890142|FG003|Overall Study|Withdrawal by Subject|0|||
161138920|NCT01120626|581890143|FG000|Overall Study|Withdrawal by Subject|1|||
161138921|NCT01120626|581890144|FG001|Overall Study|Withdrawal by Subject|0|||
161138922|NCT00509106|581890146|FG000|Overall Study|Adverse Event|3|||
161138923|NCT00509106|581890147|FG001|Overall Study|Adverse Event|2|||
161138924|NCT00509106|581890146|FG000|Overall Study|Noncompliance|0|||
161138925|NCT00509106|581890147|FG001|Overall Study|Noncompliance|1|||
161138926|NCT00509106|581890146|FG000|Overall Study|At the request of sponsor/investigator|1|||
161138927|NCT00509106|581890147|FG001|Overall Study|At the request of sponsor/investigator|2|||
161138928|NCT00509106|581890146|FG000|Overall Study|Withdrew consent|4|||
161138929|NCT00509106|581890147|FG001|Overall Study|Withdrew consent|8|||
161138930|NCT00509106|581890146|FG000|Overall Study|Lost to Follow-up|16|||
161138931|NCT00509106|581890147|FG001|Overall Study|Lost to Follow-up|10|||
161138932|NCT00509106|581890146|FG000|Overall Study|Other|1|||
161138933|NCT00509106|581890147|FG001|Overall Study|Other|0|||
161138934|NCT00509106|581890146|FG000|Overall Study|Death|6|||
161138935|NCT00509106|581890147|FG001|Overall Study|Death|6|||
161138936|NCT03527043|581890150|FG000|Overall Study|Withdrawal by Subject|1|||
161138937|NCT03527043|581890151|FG001|Overall Study|Withdrawal by Subject|0|||
161138938|NCT03830281|581890153|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
161138939|NCT03830281|581890154|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
161138940|NCT03830281|581890153|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
161138941|NCT03830281|581890154|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
161138942|NCT03830281|581890153|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
161250343|NCT05347693|582296816|FG002|Outpatient Period|Lost to Follow-up|1|||
161250344|NCT05347693|582296814|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
161250345|NCT05347693|582296815|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
161250346|NCT05347693|582296816|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
160838784|NCT02292706|580795830|FG005|Overall Study|Subject terminated by sponsor|0|||
160838785|NCT02292706|580795831|FG006|Overall Study|Subject terminated by sponsor|0|||
160838786|NCT02292706|580795832|FG007|Overall Study|Subject terminated by sponsor|0|||
160838787|NCT02292706|580795825|FG000|Overall Study|Missing|0|||
160838788|NCT02292706|580795826|FG001|Overall Study|Missing|0|||
160838789|NCT02292706|580795827|FG002|Overall Study|Missing|1|||
160838790|NCT02292706|580795828|FG003|Overall Study|Missing|1|||
160838791|NCT02292706|580795829|FG004|Overall Study|Missing|0|||
160838792|NCT02292706|580795830|FG005|Overall Study|Missing|1|||
160838793|NCT02292706|580795831|FG006|Overall Study|Missing|0|||
160838794|NCT02292706|580795832|FG007|Overall Study|Missing|0|||
160838795|NCT02292706|580795825|FG000|Overall Study|Virologic relapse or reinfection|1|||
160838796|NCT02292706|580795826|FG001|Overall Study|Virologic relapse or reinfection|0|||
161250347|NCT05347693|582296814|FG000|Outpatient Period|Scheduled hemodialysis|0|||
161250348|NCT05347693|582296815|FG001|Outpatient Period|Scheduled hemodialysis|1|||
161250349|NCT05347693|582296816|FG002|Outpatient Period|Scheduled hemodialysis|0|||
161250350|NCT05347693|582296814|FG000|Outpatient Period|Severe HK|0|||
161250351|NCT05347693|582296815|FG001|Outpatient Period|Severe HK|0|||
161250352|NCT05347693|582296816|FG002|Outpatient Period|Severe HK|1|||
161250353|NCT05347693|582296814|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
161250354|NCT05347693|582296815|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
161250355|NCT05347693|582296816|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
160838797|NCT02292706|580795827|FG002|Overall Study|Virologic relapse or reinfection|0|||
160838798|NCT02292706|580795828|FG003|Overall Study|Virologic relapse or reinfection|1|||
160838799|NCT02292706|580795829|FG004|Overall Study|Virologic relapse or reinfection|0|||
160838800|NCT02292706|580795830|FG005|Overall Study|Virologic relapse or reinfection|1|||
160838801|NCT02292706|580795831|FG006|Overall Study|Virologic relapse or reinfection|0|||
160838802|NCT02292706|580795832|FG007|Overall Study|Virologic relapse or reinfection|0|||
160838803|NCT01990612|580795837|FG000|Overall Study|Lost to Follow-up|2|||
160838804|NCT01990612|580795838|FG001|Overall Study|Lost to Follow-up|1|||
160838805|NCT01990612|580795837|FG000|Overall Study|Withdrawal by Subject|5|||
160838806|NCT01990612|580795838|FG001|Overall Study|Withdrawal by Subject|2|||
160838807|NCT02725866|580795839|FG000|Overall Study|Failure to return|6|||
160838808|NCT02725866|580795839|FG000|Overall Study|Withdrew consent|3|||
160838809|NCT02725866|580795839|FG000|Overall Study|Insufficient virological response|1|||
160838810|NCT02725866|580795839|FG000|Overall Study|Other, not specified|4|||
160838811|NCT02188849|580795842|FG000|Overall Study|Lost to Follow-up|3|||
160838812|NCT02188849|580795843|FG001|Overall Study|Lost to Follow-up|8|||
160838813|NCT02980133|580795845|FG000|Overall Study|Other than specified|1|||
160838814|NCT02980133|580795846|FG001|Overall Study|Other than specified|1|||
160838815|NCT02980133|580795847|FG002|Overall Study|Other than specified|2|||
160838816|NCT02980133|580795848|FG003|Overall Study|Other than specified|2|||
160838817|NCT02980133|580795845|FG000|Overall Study|Lost to Follow-up|0|||
160838818|NCT02980133|580795846|FG001|Overall Study|Lost to Follow-up|0|||
160838819|NCT02980133|580795847|FG002|Overall Study|Lost to Follow-up|1|||
160838820|NCT02980133|580795848|FG003|Overall Study|Lost to Follow-up|3|||
160838821|NCT02980133|580795845|FG000|Overall Study|Protocol Violation|0|||
160838822|NCT02980133|580795846|FG001|Overall Study|Protocol Violation|1|||
160838823|NCT02980133|580795847|FG002|Overall Study|Protocol Violation|0|||
160838824|NCT02980133|580795848|FG003|Overall Study|Protocol Violation|0|||
160838825|NCT02980133|580795845|FG000|Overall Study|Withdrawal by parent/guardian|6|||
160838826|NCT02980133|580795846|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160838827|NCT02980133|580795847|FG002|Overall Study|Withdrawal by parent/guardian|3|||
160838828|NCT02980133|580795848|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160838829|NCT02980133|580795845|FG000|Overall Study|Withdrawal by Subject|0|||
160838830|NCT02980133|580795846|FG001|Overall Study|Withdrawal by Subject|0|||
160838831|NCT02980133|580795847|FG002|Overall Study|Withdrawal by Subject|1|||
160838832|NCT02980133|580795848|FG003|Overall Study|Withdrawal by Subject|0|||
160904791|NCT00381485|581046311|FG001|Open-Label Run-In Period|Adverse Event|0|||
160904792|NCT00381485|581046312|FG002|Open-Label Run-In Period|Adverse Event|0|||
160838833|NCT03208088|580795856|FG000|Period 2|Withdrawal by Subject|0|||
160838834|NCT03208088|580795857|FG001|Period 2|Withdrawal by Subject|0|||
160838835|NCT03208088|580795858|FG002|Period 2|Withdrawal by Subject|0|||
160838836|NCT03208088|580795859|FG003|Period 2|Withdrawal by Subject|0|||
160838837|NCT03208088|580795860|FG004|Period 2|Withdrawal by Subject|0|||
160838838|NCT03208088|580795861|FG005|Period 2|Withdrawal by Subject|0|||
160838839|NCT03208088|580795862|FG006|Period 2|Withdrawal by Subject|0|||
160838840|NCT03208088|580795863|FG007|Period 2|Withdrawal by Subject|0|||
160838841|NCT03208088|580795864|FG008|Period 2|Withdrawal by Subject|1|||
160838842|NCT03208088|580795865|FG009|Period 2|Withdrawal by Subject|0|||
161250356|NCT05347693|582296814|FG000|Outpatient Period|Start of dialysis|0|||
161250357|NCT05347693|582296815|FG001|Outpatient Period|Start of dialysis|0|||
161250358|NCT05347693|582296816|FG002|Outpatient Period|Start of dialysis|1|||
161250359|NCT05347693|582296814|FG000|Outpatient Period|The participant entered hemodialysis|0|||
161250360|NCT05347693|582296815|FG001|Outpatient Period|The participant entered hemodialysis|0|||
160838843|NCT03208088|580795856|FG000|Period 3|Unsatisfactory Test Article|0|||
160838844|NCT03208088|580795857|FG001|Period 3|Unsatisfactory Test Article|0|||
160838845|NCT03208088|580795858|FG002|Period 3|Unsatisfactory Test Article|0|||
160838846|NCT03208088|580795859|FG003|Period 3|Unsatisfactory Test Article|1|||
160838847|NCT03208088|580795860|FG004|Period 3|Unsatisfactory Test Article|0|||
160838848|NCT03208088|580795861|FG005|Period 3|Unsatisfactory Test Article|0|||
160838849|NCT03208088|580795862|FG006|Period 3|Unsatisfactory Test Article|0|||
160838850|NCT03208088|580795863|FG007|Period 3|Unsatisfactory Test Article|0|||
160838851|NCT03208088|580795864|FG008|Period 3|Unsatisfactory Test Article|0|||
160838852|NCT03208088|580795865|FG009|Period 3|Unsatisfactory Test Article|0|||
160838853|NCT03208088|580795856|FG000|Period 4|Unsatisfactory Test Article|0|||
160838854|NCT03208088|580795857|FG001|Period 4|Unsatisfactory Test Article|0|||
160838855|NCT03208088|580795858|FG002|Period 4|Unsatisfactory Test Article|0|||
160838856|NCT03208088|580795859|FG003|Period 4|Unsatisfactory Test Article|1|||
160838857|NCT03208088|580795860|FG004|Period 4|Unsatisfactory Test Article|0|||
160838858|NCT03208088|580795861|FG005|Period 4|Unsatisfactory Test Article|0|||
160838859|NCT03208088|580795862|FG006|Period 4|Unsatisfactory Test Article|0|||
160838860|NCT03208088|580795863|FG007|Period 4|Unsatisfactory Test Article|0|||
160838861|NCT03208088|580795864|FG008|Period 4|Unsatisfactory Test Article|0|||
160838862|NCT03208088|580795865|FG009|Period 4|Unsatisfactory Test Article|0|||
160838863|NCT01108523|580795870|FG000|Overall Study|Protocol Violation|4|||
160838864|NCT00547521|580795871|FG000|Short Term Study (4 Months)|Adverse Event|1|||
160838865|NCT00547521|580795872|FG001|Short Term Study (4 Months)|Adverse Event|0|||
160838866|NCT00547521|580795871|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
160838867|NCT00547521|580795872|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
160838868|NCT00547521|580795871|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
160838869|NCT00547521|580795872|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
160838870|NCT00547521|580795871|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
160838871|NCT00547521|580795872|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
160838872|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
160838873|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
160838874|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
160838875|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
160838876|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
160838877|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
160838878|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
160838879|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
160838880|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Other|0|||
160838881|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Other|2|||
160838882|NCT00547521|580795871|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
160838883|NCT00547521|580795872|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
160838884|NCT00705367|580797774|FG000|Long-term Extension Period|Adverse Event|2|||
160838885|NCT00705367|580797775|FG001|Long-term Extension Period|Adverse Event|0|||
160838886|NCT00705367|580797774|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
160838887|NCT00705367|580797775|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
160838888|NCT00705367|580797774|FG000|Long-term Extension Period|Lack of Efficacy|1|||
160838889|NCT00705367|580797775|FG001|Long-term Extension Period|Lack of Efficacy|0|||
160838890|NCT00705367|580797774|FG000|Long-term Extension Period|No longer met study criteria|1|||
160838891|NCT00705367|580797775|FG001|Long-term Extension Period|No longer met study criteria|0|||
160838892|NCT00705367|580797774|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
160838893|NCT00705367|580797775|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
160838894|NCT01832155|580797779|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
160838895|NCT01832155|580797780|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
160838896|NCT01832155|580797779|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
160838897|NCT01832155|580797780|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
160838898|NCT01279616|580797781|FG000|Overall Study|donor could not be located|5|||
160838899|NCT01279616|580797781|FG000|Overall Study|no signs of sickle cell disease|2|||
160838900|NCT01369641|580797784|FG000|Overall Study|Withdrawal by Subject|1|||
160838901|NCT00842543|580797785|FG000|Overall Study|Withdrawal by Subject|2|||
160838902|NCT00842543|580797786|FG001|Overall Study|Withdrawal by Subject|0|||
160838903|NCT00842543|580797787|FG002|Overall Study|Withdrawal by Subject|3|||
160838904|NCT00842543|580797788|FG003|Overall Study|Withdrawal by Subject|4|||
160838905|NCT01483183|580797793|FG000|Overall Study|Physician Decision|0|||
160838906|NCT01483183|580797794|FG001|Overall Study|Physician Decision|0|||
160904793|NCT00381485|581046313|FG003|Open-Label Run-In Period|Adverse Event|0|||
161250361|NCT05347693|582296816|FG002|Outpatient Period|The participant entered hemodialysis|1|||
160904794|NCT00381485|581046310|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
160904795|NCT00381485|581046311|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
160904796|NCT00381485|581046312|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
160904797|NCT00381485|581046313|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
160904798|NCT00381485|581046310|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
160904799|NCT00381485|581046311|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
160904800|NCT00381485|581046312|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
160904801|NCT00381485|581046313|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
160904802|NCT00381485|581046310|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
160904803|NCT00381485|581046311|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
160904804|NCT00381485|581046312|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
160904805|NCT00381485|581046313|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
160904806|NCT00381485|581046310|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
160904807|NCT00381485|581046311|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
160904808|NCT00381485|581046312|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
160904809|NCT00381485|581046313|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
160904810|NCT00381485|581046310|FG000|Open-Label Run-In Period|Treatment failure|1|||
160904811|NCT00381485|581046311|FG001|Open-Label Run-In Period|Treatment failure|0|||
160904812|NCT00381485|581046312|FG002|Open-Label Run-In Period|Treatment failure|0|||
160904813|NCT00381485|581046313|FG003|Open-Label Run-In Period|Treatment failure|0|||
160904814|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160904815|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Adverse Event|2|||
160904816|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Adverse Event|2|||
160904817|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Adverse Event|5|||
160904818|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160904819|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
160904820|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
160904821|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
160904822|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160904823|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
160904824|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
160904825|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
160904826|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
160904827|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
160904828|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
160904829|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
160838907|NCT01483183|580797795|FG002|Overall Study|Physician Decision|0|||
160838908|NCT01483183|580797796|FG003|Overall Study|Physician Decision|0|||
160838909|NCT01483183|580797797|FG004|Overall Study|Physician Decision|0|||
160838910|NCT01483183|580797798|FG005|Overall Study|Physician Decision|0|||
160838911|NCT01483183|580797799|FG006|Overall Study|Physician Decision|2|||
160838912|NCT01483183|580797800|FG007|Overall Study|Physician Decision|0|||
161334972|NCT00069264|582615879|FG000|Overall Study|Withdrawal by Subject|3|||
160838913|NCT01483183|580797801|FG008|Overall Study|Physician Decision|0|||
160838914|NCT01483183|580797802|FG009|Overall Study|Physician Decision|0|||
160838915|NCT01483183|580797793|FG000|Overall Study|Withdrawal by Subject|0|||
160838916|NCT01483183|580797794|FG001|Overall Study|Withdrawal by Subject|0|||
160838917|NCT01483183|580797795|FG002|Overall Study|Withdrawal by Subject|0|||
160838918|NCT01483183|580797796|FG003|Overall Study|Withdrawal by Subject|0|||
160838919|NCT01483183|580797797|FG004|Overall Study|Withdrawal by Subject|0|||
160838920|NCT01483183|580797798|FG005|Overall Study|Withdrawal by Subject|0|||
160838921|NCT01483183|580797799|FG006|Overall Study|Withdrawal by Subject|0|||
160838922|NCT01483183|580797800|FG007|Overall Study|Withdrawal by Subject|0|||
160838923|NCT01483183|580797801|FG008|Overall Study|Withdrawal by Subject|0|||
160838924|NCT01483183|580797802|FG009|Overall Study|Withdrawal by Subject|1|||
160838925|NCT00239928|580797803|FG000|Overall Study|Lack of Efficacy|1|||
160838926|NCT00239928|580797803|FG000|Overall Study|Adverse Event|4|||
160838927|NCT00239928|580797803|FG000|Overall Study|Not need to continue study|3|||
160904830|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
161138943|NCT03830281|581890154|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
161138944|NCT03830281|581890153|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
161138945|NCT03830281|581890154|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
161138946|NCT03830281|581890153|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
161138947|NCT03830281|581890154|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
161138948|NCT03830281|581890153|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
161138949|NCT03830281|581890154|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
161138950|NCT03830281|581890153|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
161138951|NCT03830281|581890154|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
161138952|NCT03830281|581890153|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
161138953|NCT03830281|581890154|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
160838928|NCT00239928|580797803|FG000|Overall Study|Withdrawal by Subject|2|||
160838929|NCT02942485|580797805|FG000|Overall Study|Lost to Follow-up|1|||
160838930|NCT02942485|580797806|FG001|Overall Study|Lost to Follow-up|0|||
160838931|NCT04302545|580797813|FG000|Overall Study|Lost to Follow-up|3|||
160838932|NCT04302545|580797814|FG001|Overall Study|Lost to Follow-up|4|||
160838933|NCT02516592|580797815|FG000|Overall Study|Patient withdrew consent|5|||
160838934|NCT02516592|580797816|FG001|Overall Study|Patient withdrew consent|2|||
160838935|NCT02516592|580797815|FG000|Overall Study|Protocol deviation|4|||
160838936|NCT02516592|580797816|FG001|Overall Study|Protocol deviation|4|||
160838937|NCT02516592|580797815|FG000|Overall Study|Lost to Follow-up|2|||
160838938|NCT02516592|580797816|FG001|Overall Study|Lost to Follow-up|3|||
160838939|NCT02516592|580797815|FG000|Overall Study|Patient/guardian decision|2|||
160838940|NCT02516592|580797816|FG001|Overall Study|Patient/guardian decision|1|||
160838941|NCT02516592|580797815|FG000|Overall Study|Adverse Event|1|||
160838942|NCT02516592|580797816|FG001|Overall Study|Adverse Event|2|||
160838943|NCT02516592|580797815|FG000|Overall Study|Abnormal test procedure result|1|||
160838944|NCT02516592|580797816|FG001|Overall Study|Abnormal test procedure result|0|||
160838945|NCT02516592|580797815|FG000|Overall Study|Death|1|||
160838946|NCT02516592|580797816|FG001|Overall Study|Death|1|||
160838947|NCT00300365|580797820|FG000|Overall Study|Lost to Follow-up|1|||
160838948|NCT00300365|580797821|FG001|Overall Study|Lost to Follow-up|0|||
160838949|NCT00300365|580797820|FG000|Overall Study|Physician Decision|2|||
160838950|NCT00300365|580797821|FG001|Overall Study|Physician Decision|0|||
160838951|NCT00300365|580797820|FG000|Overall Study|Withdrawal by Subject|1|||
160838952|NCT00300365|580797821|FG001|Overall Study|Withdrawal by Subject|0|||
160838953|NCT00300365|580797820|FG000|Overall Study|Adverse Event|0|||
160838954|NCT00300365|580797821|FG001|Overall Study|Adverse Event|2|||
160838955|NCT01438177|580797823|FG000|Overall Study|Withdrawal by Subject|1|||
160838956|NCT01438177|580797823|FG000|Overall Study|Initiation of new therapy|1|||
160838957|NCT01727336|580797824|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838958|NCT01727336|580797825|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
160838959|NCT01727336|580797826|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
160838960|NCT01727336|580797827|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838961|NCT01727336|580797828|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838962|NCT01727336|580797829|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
160838963|NCT01727336|580797824|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
160838964|NCT01727336|580797825|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
160838965|NCT01727336|580797826|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
161138954|NCT03830281|581890153|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
160838966|NCT01727336|580797827|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
160838967|NCT01727336|580797828|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
160838968|NCT01727336|580797829|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
160838969|NCT01727336|580797824|FG000|Part 2 Blinded|Death|0|||
160838970|NCT01727336|580797825|FG001|Part 2 Blinded|Death|0|||
160838971|NCT01727336|580797826|FG002|Part 2 Blinded|Death|0|||
160838972|NCT01727336|580797827|FG003|Part 2 Blinded|Death|0|||
160838973|NCT01727336|580797828|FG004|Part 2 Blinded|Death|20|||
160838974|NCT01727336|580797829|FG005|Part 2 Blinded|Death|16|||
160838975|NCT01727336|580797824|FG000|Part 2 Blinded|Lack of Efficacy|0|||
160838976|NCT01727336|580797825|FG001|Part 2 Blinded|Lack of Efficacy|0|||
161138955|NCT03830281|581890154|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
161138956|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
161138957|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
161138958|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
161138959|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
161138960|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
161138961|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
161138962|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Personal issues|2|||
161138963|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Personal issues|0|||
161138964|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Personal issues|0|||
161138965|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Too busy|7|||
161138966|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Too busy|1|||
161138967|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Too busy|0|||
161138968|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Pain|2|||
161138969|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Pain|0|||
161138970|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Pain|0|||
161138971|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Moved|1|||
161138972|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Moved|0|||
161138973|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Moved|0|||
161138974|NCT00594399|581890155|FG000|Initial 3 Month Counseling|Family illness|1|||
161138975|NCT00594399|581890156|FG001|Initial 3 Month Counseling|Family illness|0|||
161138976|NCT00594399|581890157|FG002|Initial 3 Month Counseling|Family illness|0|||
161138977|NCT00594399|581890155|FG000|Rerandomization Arm 1 Only|Death|2|||
161138978|NCT00594399|581890156|FG001|Rerandomization Arm 1 Only|Death|1|||
161138979|NCT00594399|581890157|FG002|Rerandomization Arm 1 Only|Death|0|||
161138980|NCT00594399|581890155|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
161250362|NCT05347693|582296814|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
161250363|NCT05347693|582296815|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
161250364|NCT05347693|582296816|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
161250365|NCT05347693|582296814|FG000|Outpatient Period|Withdrawal by Subject|0|||
161250366|NCT05347693|582296815|FG001|Outpatient Period|Withdrawal by Subject|8|||
161250367|NCT05347693|582296816|FG002|Outpatient Period|Withdrawal by Subject|5|||
161250368|NCT01755975|582296817|FG000|Overall Study|Adverse Event|0|||
160838977|NCT01727336|580797826|FG002|Part 2 Blinded|Lack of Efficacy|0|||
160838978|NCT01727336|580797827|FG003|Part 2 Blinded|Lack of Efficacy|0|||
160838979|NCT01727336|580797828|FG004|Part 2 Blinded|Lack of Efficacy|42|||
160838980|NCT01727336|580797829|FG005|Part 2 Blinded|Lack of Efficacy|44|||
160838981|NCT01727336|580797824|FG000|Part 2 Blinded|Lost to Follow-up|0|||
160838982|NCT01727336|580797825|FG001|Part 2 Blinded|Lost to Follow-up|0|||
160838983|NCT01727336|580797826|FG002|Part 2 Blinded|Lost to Follow-up|0|||
160904831|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
160904832|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
160904833|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161250369|NCT01755975|582296818|FG001|Overall Study|Adverse Event|0|||
161250370|NCT01755975|582296819|FG002|Overall Study|Adverse Event|1|||
161250371|NCT01755975|582296820|FG003|Overall Study|Adverse Event|0|||
161250372|NCT01755975|582296821|FG004|Overall Study|Adverse Event|2|||
161250373|NCT01597479|582296822|FG000|Overall Study|Protocol Violation|1|||
161250374|NCT01597479|582296823|FG001|Overall Study|Protocol Violation|0|||
161250375|NCT01597479|582296822|FG000|Overall Study|Lost to Follow-up|1|||
161250376|NCT01597479|582296823|FG001|Overall Study|Lost to Follow-up|0|||
161250377|NCT02167594|582296824|FG000|Overall Study|Withdrawal by Subject|2|||
161250378|NCT02167594|582296825|FG001|Overall Study|Withdrawal by Subject|0|||
161250379|NCT02167594|582296826|FG002|Overall Study|Withdrawal by Subject|0|||
161250380|NCT02167594|582296824|FG000|Overall Study|Death|0|||
161250381|NCT02167594|582296825|FG001|Overall Study|Death|1|||
161250382|NCT02167594|582296826|FG002|Overall Study|Death|0|||
161250383|NCT02340780|582296827|FG000|Overall Study|Ineligible|1|||
161250384|NCT03422068|582296830|FG000|Overall Study|Adverse Event|0|||
161250385|NCT03422068|582296831|FG001|Overall Study|Adverse Event|1|||
161250386|NCT03422068|582296830|FG000|Overall Study|Inconvenience to frequent study visits|0|||
161250387|NCT03422068|582296831|FG001|Overall Study|Inconvenience to frequent study visits|1|||
161250388|NCT02858037|582296832|FG000|Overall Study|Death|1|||
161250389|NCT02858037|582296832|FG000|Overall Study|Withdrawal by Subject|18|||
161250390|NCT02858037|582296832|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
161250391|NCT02858037|582296832|FG000|Overall Study|Lost to Follow-up|3|||
161250392|NCT02858037|582296832|FG000|Overall Study|Other|4|||
161250393|NCT04320745|582296837|FG000|Overall Study|Adverse Event|26|||
161250394|NCT04320745|582296837|FG000|Overall Study|Withdrawal by Subject|4|||
160838984|NCT01727336|580797827|FG003|Part 2 Blinded|Lost to Follow-up|0|||
160904834|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
160904835|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
160904836|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
160904837|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
160904838|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
160904839|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
160904840|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
160904841|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
160904842|NCT00381485|581046310|FG000|Double-Blind Treatment Period|Administrative|0|||
160904843|NCT00381485|581046311|FG001|Double-Blind Treatment Period|Administrative|1|||
161250395|NCT04320745|582296837|FG000|Overall Study|Lost to Follow-up|12|||
161250396|NCT04320745|582296837|FG000|Overall Study|Protocol Deviation|2|||
161250397|NCT04320745|582296837|FG000|Overall Study|Non-compliance With Study Drug|2|||
161250398|NCT04320745|582296837|FG000|Overall Study|Reason Not Specified|1|||
161250399|NCT01685008|582296840|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
161250400|NCT01685008|582296841|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
160838985|NCT01727336|580797828|FG004|Part 2 Blinded|Lost to Follow-up|0|||
160838986|NCT01727336|580797829|FG005|Part 2 Blinded|Lost to Follow-up|1|||
160904844|NCT00381485|581046312|FG002|Double-Blind Treatment Period|Administrative|0|||
160904845|NCT00381485|581046313|FG003|Double-Blind Treatment Period|Administrative|1|||
160904846|NCT01235351|581046314|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
161250401|NCT01685008|582296842|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
160838987|NCT01727336|580797824|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
161250402|NCT01685008|582296843|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
161250403|NCT01685008|582296840|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161250404|NCT01685008|582296841|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
161250405|NCT01685008|582296842|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161334973|NCT00069264|582615879|FG000|Overall Study|Discon Therapy|3|||
161250406|NCT01685008|582296843|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
161250407|NCT01685008|582296840|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161250408|NCT01685008|582296841|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
161250409|NCT01685008|582296842|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161250410|NCT01685008|582296843|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
161250411|NCT01685008|582296840|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
160838988|NCT01727336|580797825|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
160838989|NCT01727336|580797826|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
160838990|NCT01727336|580797827|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
160838991|NCT01727336|580797828|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
160838992|NCT01727336|580797829|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
160838993|NCT01727336|580797824|FG000|Part 2 Blinded|use of prohibited medications|0|||
160838994|NCT01727336|580797825|FG001|Part 2 Blinded|use of prohibited medications|0|||
160838995|NCT01727336|580797826|FG002|Part 2 Blinded|use of prohibited medications|0|||
160838996|NCT01727336|580797827|FG003|Part 2 Blinded|use of prohibited medications|0|||
160838997|NCT01727336|580797828|FG004|Part 2 Blinded|use of prohibited medications|1|||
160838998|NCT01727336|580797829|FG005|Part 2 Blinded|use of prohibited medications|3|||
160838999|NCT00619099|580797832|FG000|Overall Study|Progressive Disease|7|||
160839000|NCT00619099|580797833|FG001|Overall Study|Progressive Disease|5|||
160839001|NCT00619099|580797832|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
160839002|NCT00619099|580797833|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
160991887|NCT04888585|581359934|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991888|NCT04888585|581359935|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991889|NCT04888585|581359936|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
160991890|NCT04888585|581359926|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991891|NCT04888585|581359927|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991892|NCT04888585|581359928|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
160991893|NCT04888585|581359929|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991894|NCT04888585|581359930|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
160991895|NCT04888585|581359931|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991896|NCT04888585|581359932|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160839003|NCT00619099|580797832|FG000|Overall Study|Adverse Event|4|||
160839004|NCT00619099|580797833|FG001|Overall Study|Adverse Event|3|||
160839005|NCT00619099|580797832|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
160839006|NCT00619099|580797833|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
160839007|NCT00619099|580797832|FG000|Overall Study|Withdrawal by Subject|10|||
160839008|NCT00619099|580797833|FG001|Overall Study|Withdrawal by Subject|2|||
160839009|NCT00619099|580797832|FG000|Overall Study|Physician Decision|9|||
160839010|NCT00619099|580797833|FG001|Overall Study|Physician Decision|6|||
160839011|NCT00666965|580797836|FG000|Overall Study|Adverse Event|0|||
160839012|NCT00666965|580797837|FG001|Overall Study|Adverse Event|2|||
160839013|NCT00666965|580797838|FG002|Overall Study|Adverse Event|1|||
160839014|NCT00666965|580797839|FG003|Overall Study|Adverse Event|9|||
160839015|NCT00666965|580797836|FG000|Overall Study|Lack of Efficacy|1|||
160839016|NCT00666965|580797837|FG001|Overall Study|Lack of Efficacy|1|||
160839017|NCT00666965|580797838|FG002|Overall Study|Lack of Efficacy|0|||
160839018|NCT00666965|580797839|FG003|Overall Study|Lack of Efficacy|0|||
160839019|NCT00666965|580797836|FG000|Overall Study|Protocol Violation|0|||
160839020|NCT00666965|580797837|FG001|Overall Study|Protocol Violation|0|||
160839021|NCT00666965|580797838|FG002|Overall Study|Protocol Violation|0|||
160839022|NCT00666965|580797839|FG003|Overall Study|Protocol Violation|2|||
160839023|NCT00666965|580797836|FG000|Overall Study|Discontinuation criteria|2|||
160839024|NCT00666965|580797837|FG001|Overall Study|Discontinuation criteria|1|||
160839025|NCT00666965|580797838|FG002|Overall Study|Discontinuation criteria|1|||
160839026|NCT00666965|580797839|FG003|Overall Study|Discontinuation criteria|2|||
160839027|NCT00666965|580797836|FG000|Overall Study|Withdrawal by Subject|0|||
160839028|NCT00666965|580797837|FG001|Overall Study|Withdrawal by Subject|0|||
160991897|NCT04888585|581359933|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991898|NCT04888585|581359934|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991899|NCT04888585|581359935|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
160991900|NCT04888585|581359936|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
161250412|NCT01685008|582296841|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
161334974|NCT02895347|582615882|FG000|Overall Study|Withdrawal by Subject|3|||
161250413|NCT01685008|582296842|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
161334975|NCT02895347|582615883|FG001|Overall Study|Withdrawal by Subject|1|||
160839029|NCT00666965|580797838|FG002|Overall Study|Withdrawal by Subject|0|||
160839030|NCT00666965|580797839|FG003|Overall Study|Withdrawal by Subject|2|||
160839031|NCT01455194|580797840|FG000|Overall Study|Screen Failure|20|||
160839032|NCT01455194|580797841|FG001|Overall Study|Screen Failure|0|||
160839033|NCT01455194|580797842|FG002|Overall Study|Screen Failure|0|||
160839034|NCT01455194|580797843|FG003|Overall Study|Screen Failure|0|||
160839035|NCT01455194|580797840|FG000|Overall Study|Randomisation Failure|90|||
160839036|NCT01455194|580797841|FG001|Overall Study|Randomisation Failure|0|||
160839037|NCT01455194|580797842|FG002|Overall Study|Randomisation Failure|0|||
160839038|NCT01455194|580797843|FG003|Overall Study|Randomisation Failure|0|||
160839039|NCT01455194|580797840|FG000|Overall Study|Deterioration in asthma|12|||
160839040|NCT01455194|580797841|FG001|Overall Study|Deterioration in asthma|6|||
160839041|NCT01455194|580797842|FG002|Overall Study|Deterioration in asthma|14|||
161250414|NCT01685008|582296843|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
161250415|NCT01685008|582296840|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
161250416|NCT01685008|582296841|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
161250417|NCT01685008|582296842|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
161250418|NCT01685008|582296843|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
161250419|NCT01963260|582296847|FG000|Overall Study|Withdrawal by Subject|2|||
161250420|NCT01963260|582296848|FG001|Overall Study|Withdrawal by Subject|0|||
161250421|NCT01963260|582296849|FG002|Overall Study|Withdrawal by Subject|0|||
161250422|NCT01963260|582296850|FG003|Overall Study|Withdrawal by Subject|1|||
161250423|NCT01963260|582296851|FG004|Overall Study|Withdrawal by Subject|2|||
161250424|NCT01963260|582296852|FG005|Overall Study|Withdrawal by Subject|0|||
161250425|NCT01963260|582296853|FG006|Overall Study|Withdrawal by Subject|0|||
161250426|NCT01963260|582296854|FG007|Overall Study|Withdrawal by Subject|0|||
161250427|NCT01963260|582296855|FG008|Overall Study|Withdrawal by Subject|0|||
161250428|NCT01963260|582296856|FG009|Overall Study|Withdrawal by Subject|0|||
161250429|NCT02340962|582296857|FG000|Overall Study|Lost to Follow-up|1|||
161250430|NCT02340962|582296858|FG001|Overall Study|Lost to Follow-up|0|||
161250431|NCT04994431|582296859|FG000|Overall Study|Adverse Event|1|||
161250432|NCT04994431|582296860|FG001|Overall Study|Adverse Event|0|||
161250433|NCT02151149|582296864|FG000|Treatment Period|Death|2|||
161250434|NCT02151149|582296865|FG001|Treatment Period|Death|3|||
161250435|NCT02151149|582296864|FG000|Treatment Period|Adverse Event|17|||
161250436|NCT02151149|582296865|FG001|Treatment Period|Adverse Event|14|||
161250437|NCT02151149|582296864|FG000|Treatment Period|Progressive Disease|25|||
161250438|NCT02151149|582296865|FG001|Treatment Period|Progressive Disease|24|||
161250439|NCT02151149|582296864|FG000|Treatment Period|Symptomatic Deterioration|2|||
161250440|NCT02151149|582296865|FG001|Treatment Period|Symptomatic Deterioration|10|||
161250441|NCT02151149|582296864|FG000|Treatment Period|Withdrawal by Subject|13|||
161250442|NCT02151149|582296865|FG001|Treatment Period|Withdrawal by Subject|11|||
161250443|NCT02151149|582296864|FG000|Treatment Period|Miscellaneous|8|||
161250444|NCT02151149|582296865|FG001|Treatment Period|Miscellaneous|7|||
161250445|NCT02151149|582296864|FG000|Treatment Period|Participants randomized but not treated|3|||
161250446|NCT02151149|582296865|FG001|Treatment Period|Participants randomized but not treated|2|||
161250447|NCT02151149|582296864|FG000|Follow-Up Period|Lost to Follow-up|2|||
161250448|NCT02151149|582296865|FG001|Follow-Up Period|Lost to Follow-up|3|||
161250449|NCT02151149|582296864|FG000|Follow-Up Period|Death|37|||
161250450|NCT02151149|582296865|FG001|Follow-Up Period|Death|34|||
161250451|NCT03419962|582296869|FG000|Overall Study|Change to other medication|1|||
161250452|NCT03419962|582296869|FG000|Overall Study|Refusal of continuing with trial drug|1|||
161250453|NCT03419962|582296869|FG000|Overall Study|Lost to Follow-up|3|||
161250454|NCT03419962|582296869|FG000|Overall Study|Difficulty in inhaling the doses|1|||
161250455|NCT03419962|582296869|FG000|Overall Study|Missing completion data|31|||
161250456|NCT03439085|582296870|FG000|Overall Study|Death|2|||
161250457|NCT03439085|582296870|FG000|Overall Study|Screen Failure|20|||
161250458|NCT02224053|582296871|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
161250459|NCT02224053|582296871|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
161250460|NCT02224053|582296871|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
161250461|NCT02224053|582296871|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
161250462|NCT02224053|582296871|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
161250463|NCT01898598|582296875|FG000|Overall Study|Adverse Event|1|||
161250464|NCT01898598|582296876|FG001|Overall Study|Adverse Event|0|||
161250465|NCT01898598|582296875|FG000|Overall Study|Withdrawal by Subject|3|||
161250466|NCT01898598|582296876|FG001|Overall Study|Withdrawal by Subject|0|||
161250467|NCT01898598|582296875|FG000|Overall Study|Lost to Follow-up|0|||
161250468|NCT01898598|582296876|FG001|Overall Study|Lost to Follow-up|1|||
161250469|NCT01898598|582296875|FG000|Overall Study|Other|0|||
161250470|NCT01898598|582296876|FG001|Overall Study|Other|1|||
161250471|NCT03833427|582296877|FG000|Overall Study|Death|4|||
161250472|NCT03833427|582296878|FG001|Overall Study|Death|2|||
161250473|NCT03833427|582296879|FG002|Overall Study|Death|9|||
161250474|NCT03833427|582296880|FG003|Overall Study|Death|11|||
161250475|NCT03833427|582296881|FG004|Overall Study|Death|0|||
161250476|NCT03833427|582296882|FG005|Overall Study|Death|0|||
160839042|NCT01455194|580797843|FG003|Overall Study|Deterioration in asthma|9|||
161250477|NCT03833427|582296883|FG006|Overall Study|Death|0|||
160839043|NCT01455194|580797840|FG000|Overall Study|Adverse Event|1|||
161250478|NCT03833427|582296877|FG000|Overall Study|Withdrawal by Subject|0|||
161250479|NCT03833427|582296878|FG001|Overall Study|Withdrawal by Subject|1|||
161250480|NCT03833427|582296879|FG002|Overall Study|Withdrawal by Subject|1|||
161250481|NCT03833427|582296880|FG003|Overall Study|Withdrawal by Subject|0|||
161250482|NCT03833427|582296881|FG004|Overall Study|Withdrawal by Subject|0|||
161250483|NCT03833427|582296882|FG005|Overall Study|Withdrawal by Subject|0|||
161250484|NCT03833427|582296883|FG006|Overall Study|Withdrawal by Subject|0|||
161250485|NCT03833427|582296877|FG000|Overall Study|Sponsor Decision|0|||
161250486|NCT03833427|582296878|FG001|Overall Study|Sponsor Decision|0|||
161250487|NCT03833427|582296879|FG002|Overall Study|Sponsor Decision|1|||
161250488|NCT03833427|582296880|FG003|Overall Study|Sponsor Decision|3|||
161250489|NCT03833427|582296881|FG004|Overall Study|Sponsor Decision|0|||
161250490|NCT03833427|582296882|FG005|Overall Study|Sponsor Decision|0|||
161250491|NCT03833427|582296883|FG006|Overall Study|Sponsor Decision|0|||
161250492|NCT01499160|582296885|FG000|Overall Study|Adverse Event|1|||
161250493|NCT01499160|582296885|FG000|Overall Study|Withdrawal by Subject|1|||
161250494|NCT01438476|582296886|FG000|Overall Study|Protocol Violation|1|||
161250495|NCT01438476|582296887|FG001|Overall Study|Protocol Violation|0|||
161250496|NCT01438476|582296886|FG000|Overall Study|Withdrawal by Subject|1|||
161250497|NCT01438476|582296887|FG001|Overall Study|Withdrawal by Subject|0|||
161250498|NCT01438476|582296886|FG000|Overall Study|No Surgery- Disease|8|||
160839044|NCT01455194|580797841|FG001|Overall Study|Adverse Event|1|||
160839045|NCT01455194|580797842|FG002|Overall Study|Adverse Event|1|||
160839046|NCT01455194|580797843|FG003|Overall Study|Adverse Event|3|||
160839047|NCT01455194|580797840|FG000|Overall Study|Withdrawal by Subject|21|||
160839048|NCT01455194|580797841|FG001|Overall Study|Withdrawal by Subject|16|||
160839049|NCT01455194|580797842|FG002|Overall Study|Withdrawal by Subject|12|||
160839050|NCT01455194|580797843|FG003|Overall Study|Withdrawal by Subject|9|||
161250499|NCT01438476|582296887|FG001|Overall Study|No Surgery- Disease|10|||
161250500|NCT01438476|582296886|FG000|Overall Study|Communication barrier|0|||
160904847|NCT01235351|581046315|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
160904848|NCT00745823|581046316|FG000|Overall Study|Adverse Event|5|||
161250501|NCT01438476|582296887|FG001|Overall Study|Communication barrier|1|||
160904849|NCT00745823|581046317|FG001|Overall Study|Adverse Event|3|||
160904850|NCT00745823|581046316|FG000|Overall Study|Lack of Efficacy|20|||
161250502|NCT03294317|582296892|FG000|Overall Study|Physician Decision|1|||
161250503|NCT03294317|582296892|FG000|Overall Study|Withdrawal by Subject|6|||
161250504|NCT03294317|582296892|FG000|Overall Study|Lost to Follow-up|1|||
161250505|NCT03294317|582296892|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
161250506|NCT03294317|582296892|FG000|Overall Study|Failed HB lead implant|8|||
161250507|NCT03294317|582296892|FG000|Overall Study|Received CRT instead|1|||
161250508|NCT03294317|582296892|FG000|Overall Study|Exited after lead revision|2|||
161250509|NCT03847974|582296893|FG000|Overall Study|relocated out of region|3|||
161250510|NCT03847974|582296893|FG000|Overall Study|Withdrawal by Subject|2|||
161250511|NCT03847974|582296893|FG000|Overall Study|Adverse Event|1|||
161250512|NCT02911935|582296894|FG000|Overall Study|Lost to Follow-up|5|||
161250513|NCT02911935|582296895|FG001|Overall Study|Lost to Follow-up|7|||
161250514|NCT00603512|582296896|FG000|Overall Study|Adverse Event|0|||
161250515|NCT00603512|582296897|FG001|Overall Study|Adverse Event|2|||
161250516|NCT00603512|582296898|FG002|Overall Study|Adverse Event|4|||
161250517|NCT00603512|582296899|FG003|Overall Study|Adverse Event|4|||
161250518|NCT00603512|582296900|FG004|Overall Study|Adverse Event|2|||
161250519|NCT00603512|582296896|FG000|Overall Study|Lack of Efficacy|0|||
161250520|NCT00603512|582296897|FG001|Overall Study|Lack of Efficacy|1|||
161250521|NCT00603512|582296898|FG002|Overall Study|Lack of Efficacy|0|||
161250522|NCT00603512|582296899|FG003|Overall Study|Lack of Efficacy|0|||
161250523|NCT00603512|582296900|FG004|Overall Study|Lack of Efficacy|1|||
161250524|NCT00603512|582296896|FG000|Overall Study|Other|2|||
161250525|NCT00603512|582296897|FG001|Overall Study|Other|1|||
161250526|NCT00603512|582296898|FG002|Overall Study|Other|0|||
161250527|NCT00603512|582296899|FG003|Overall Study|Other|1|||
161250528|NCT00603512|582296900|FG004|Overall Study|Other|1|||
161250529|NCT00603512|582296896|FG000|Overall Study|Withdrawal by Subject|0|||
161250530|NCT00603512|582296897|FG001|Overall Study|Withdrawal by Subject|0|||
161250531|NCT00603512|582296898|FG002|Overall Study|Withdrawal by Subject|0|||
161250532|NCT00603512|582296899|FG003|Overall Study|Withdrawal by Subject|0|||
161250533|NCT00603512|582296900|FG004|Overall Study|Withdrawal by Subject|1|||
161250534|NCT00603512|582296896|FG000|Overall Study|Randomized but not treated|0|||
161250535|NCT00603512|582296897|FG001|Overall Study|Randomized but not treated|1|||
161250536|NCT00603512|582296898|FG002|Overall Study|Randomized but not treated|1|||
161250537|NCT00603512|582296899|FG003|Overall Study|Randomized but not treated|2|||
161250538|NCT00603512|582296900|FG004|Overall Study|Randomized but not treated|0|||
161250539|NCT04979858|582296901|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
161250540|NCT04979858|582296902|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
161250541|NCT04253236|582296903|FG000|Overall Study|Adverse Event|1|||
161250542|NCT04253236|582296904|FG001|Overall Study|Adverse Event|0|||
161250543|NCT04253236|582296903|FG000|Overall Study|Safety Concerns|1|||
160839051|NCT01455194|580797840|FG000|Overall Study|Lost to Follow-up|2|||
160839052|NCT01455194|580797841|FG001|Overall Study|Lost to Follow-up|0|||
160904851|NCT00745823|581046317|FG001|Overall Study|Lack of Efficacy|6|||
161250544|NCT04253236|582296904|FG001|Overall Study|Safety Concerns|0|||
161334976|NCT01673178|582615884|FG000|Overall Study|Lost to Follow-up|0|||
160839053|NCT01455194|580797842|FG002|Overall Study|Lost to Follow-up|1|||
160839054|NCT01455194|580797843|FG003|Overall Study|Lost to Follow-up|1|||
160839055|NCT01455194|580797840|FG000|Overall Study|Pregnancy|0|||
160839056|NCT01455194|580797841|FG001|Overall Study|Pregnancy|1|||
160839057|NCT01455194|580797842|FG002|Overall Study|Pregnancy|1|||
160839058|NCT01455194|580797843|FG003|Overall Study|Pregnancy|0|||
160839059|NCT01455194|580797840|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
160839060|NCT01455194|580797841|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
160839061|NCT01455194|580797842|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
160839062|NCT01455194|580797843|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
160839063|NCT01455194|580797840|FG000|Overall Study|Miscellaneous|4|||
160839064|NCT01455194|580797841|FG001|Overall Study|Miscellaneous|5|||
160839065|NCT01455194|580797842|FG002|Overall Study|Miscellaneous|1|||
160839066|NCT01455194|580797843|FG003|Overall Study|Miscellaneous|4|||
160839067|NCT00504894|580797844|FG000|Overall Study|fMRI technical problems|1|||
160839068|NCT00504894|580797845|FG001|Overall Study|fMRI technical problems|1|||
160839069|NCT00504894|580797846|FG002|Overall Study|fMRI technical problems|0|||
160839070|NCT00504894|580797844|FG000|Overall Study|Withdrawal by Subject|0|||
160839071|NCT00504894|580797845|FG001|Overall Study|Withdrawal by Subject|1|||
160839072|NCT00504894|580797846|FG002|Overall Study|Withdrawal by Subject|0|||
160839073|NCT00504894|580797844|FG000|Overall Study|Infusion technical problems|0|||
160839074|NCT00504894|580797845|FG001|Overall Study|Infusion technical problems|1|||
160839075|NCT00504894|580797846|FG002|Overall Study|Infusion technical problems|0|||
160839076|NCT00504894|580797844|FG000|Overall Study|poor subject data|2|||
160839077|NCT00504894|580797845|FG001|Overall Study|poor subject data|0|||
160839078|NCT00504894|580797846|FG002|Overall Study|poor subject data|0|||
160839079|NCT01196416|580797847|FG000|Overall Study|Withdrawal by Subject|2|||
160839080|NCT05090852|580797848|FG000|Overall Study|Physician Decision|5|||
160904852|NCT00745823|581046316|FG000|Overall Study|Lost to Follow-up|10|||
160991901|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991902|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991903|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991904|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991905|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991906|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
160904853|NCT00745823|581046317|FG001|Overall Study|Lost to Follow-up|11|||
160904854|NCT00745823|581046316|FG000|Overall Study|Physician Decision|10|||
160904855|NCT00745823|581046317|FG001|Overall Study|Physician Decision|5|||
160904856|NCT00745823|581046316|FG000|Overall Study|Pregnancy|0|||
160904857|NCT00745823|581046317|FG001|Overall Study|Pregnancy|4|||
160904858|NCT00745823|581046316|FG000|Overall Study|Withdrawal by Subject|14|||
160904859|NCT00745823|581046317|FG001|Overall Study|Withdrawal by Subject|8|||
160904860|NCT00745823|581046316|FG000|Overall Study|Study Terminated by Sponsor|326|||
160904861|NCT00745823|581046317|FG001|Overall Study|Study Terminated by Sponsor|349|||
160904862|NCT02980601|581046327|FG000|Overall Study|Lost to Follow-up|2|||
160904863|NCT02980601|581046328|FG001|Overall Study|Lost to Follow-up|2|||
160904864|NCT02980601|581046327|FG000|Overall Study|Death|0|||
160904865|NCT02980601|581046328|FG001|Overall Study|Death|1|||
160904866|NCT02980601|581046327|FG000|Overall Study|Graft loss|1|||
160904867|NCT02980601|581046328|FG001|Overall Study|Graft loss|0|||
160904868|NCT02980601|581046327|FG000|Overall Study|Failed to sign consent|2|||
160904869|NCT02980601|581046328|FG001|Overall Study|Failed to sign consent|0|||
160904870|NCT01575769|581046329|FG000|Overall Study|Adverse Event|1|||
160904871|NCT01575769|581046329|FG000|Overall Study|Study terminated by sponsor|40|||
160904872|NCT00290888|581046330|FG000|Overall Study|Physician Decision|3|||
160904873|NCT00290888|581046331|FG001|Overall Study|Physician Decision|1|||
160904874|NCT01473836|581046332|FG000|Overall Study|Adverse Event|4|||
160904875|NCT01473836|581046332|FG000|Overall Study|Lack of Efficacy|1|||
160904876|NCT01473836|581046332|FG000|Overall Study|Does not meet entrance criteria|1|||
160904877|NCT01034631|581046333|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
160904878|NCT01034631|581046334|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
160904879|NCT01034631|581046335|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
160904880|NCT01034631|581046333|FG000|Phase II|Not Evaluable per protocol|0|||
160904881|NCT01034631|581046334|FG001|Phase II|Not Evaluable per protocol|0|||
160904882|NCT01034631|581046335|FG002|Phase II|Not Evaluable per protocol|2|||
160904883|NCT01034631|581046333|FG000|Phase II|Determined Ineligible per protocol|0|||
160991907|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
161138981|NCT00594399|581890156|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
160839081|NCT00148941|580797849|FG000|Overall Study|Lost to Follow-up|17|||
160839082|NCT00148941|580797850|FG001|Overall Study|Lost to Follow-up|24|||
160839083|NCT00148941|580797851|FG002|Overall Study|Lost to Follow-up|18|||
160839084|NCT00148941|580797852|FG003|Overall Study|Lost to Follow-up|22|||
160839085|NCT00148941|580797849|FG000|Overall Study|Withdrawal by Subject|1|||
160839086|NCT00148941|580797850|FG001|Overall Study|Withdrawal by Subject|0|||
160839087|NCT00148941|580797851|FG002|Overall Study|Withdrawal by Subject|1|||
160839088|NCT00148941|580797852|FG003|Overall Study|Withdrawal by Subject|0|||
160904884|NCT01034631|581046334|FG001|Phase II|Determined Ineligible per protocol|1|||
160839089|NCT00148941|580797849|FG000|Overall Study|Other|0|||
160839090|NCT00148941|580797850|FG001|Overall Study|Other|0|||
160839091|NCT00148941|580797851|FG002|Overall Study|Other|1|||
160839092|NCT00148941|580797852|FG003|Overall Study|Other|2|||
160839093|NCT02673684|580797855|FG000|Overall Study|Study not completed d/t loss of funding|9|||
160839094|NCT02673684|580797856|FG001|Overall Study|Study not completed d/t loss of funding|8|||
160839095|NCT01092663|580797857|FG000|Overall Study|Withdrawal by Subject|3|||
160839096|NCT01092663|580797858|FG001|Overall Study|Withdrawal by Subject|2|||
161334977|NCT01673178|582615885|FG001|Overall Study|Lost to Follow-up|1|||
161138982|NCT00594399|581890157|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
161138983|NCT00709202|581890158|FG000|Overall Study|Withdrawal by Subject|6|||
161138984|NCT00709202|581890159|FG001|Overall Study|Withdrawal by Subject|6|||
161138985|NCT03133767|581890160|FG000|Overall Study|Lost to Follow-up|38|||
161138986|NCT03133767|581890161|FG001|Overall Study|Lost to Follow-up|24|||
161138987|NCT03133767|581890160|FG000|Overall Study|Protocol Violation|0|||
161138988|NCT03133767|581890161|FG001|Overall Study|Protocol Violation|1|||
161138989|NCT03301857|581890162|FG000|Overall Study|Death|0|||
161138990|NCT03301857|581890163|FG001|Overall Study|Death|2|||
161138991|NCT03301857|581890162|FG000|Overall Study|Lost to Follow-up|4|||
161138992|NCT03301857|581890163|FG001|Overall Study|Lost to Follow-up|2|||
161138993|NCT03301857|581890162|FG000|Overall Study|Decision by Sponsor|6|||
161138994|NCT03301857|581890163|FG001|Overall Study|Decision by Sponsor|0|||
161138995|NCT03301857|581890162|FG000|Overall Study|Withdrawal by Subject|12|||
161138996|NCT03301857|581890163|FG001|Overall Study|Withdrawal by Subject|4|||
161138997|NCT04826900|581890178|FG000|Overall Study|Family factor|1|||
161334978|NCT01673178|582615886|FG002|Overall Study|Lost to Follow-up|0|||
161334979|NCT01673178|582615887|FG003|Overall Study|Lost to Follow-up|0|||
161138998|NCT04826900|581890179|FG001|Overall Study|Family factor|1|||
161138999|NCT01126580|581890181|FG000|Overall Study|Adverse Event|14|||
161139000|NCT01126580|581890182|FG001|Overall Study|Adverse Event|8|||
160839097|NCT01092663|580797857|FG000|Overall Study|Glucose >300mg/dL|1|||
161139001|NCT01126580|581890183|FG002|Overall Study|Adverse Event|12|||
160839098|NCT01092663|580797858|FG001|Overall Study|Glucose >300mg/dL|0|||
160839099|NCT01092663|580797857|FG000|Overall Study|High fasting triglyceride|2|||
160839100|NCT01092663|580797858|FG001|Overall Study|High fasting triglyceride|0|||
160839101|NCT01092663|580797857|FG000|Overall Study|Adverse Event|1|||
160839102|NCT01092663|580797858|FG001|Overall Study|Adverse Event|1|||
160839103|NCT01092663|580797857|FG000|Overall Study|Protocol Violation|0|||
160839104|NCT01092663|580797858|FG001|Overall Study|Protocol Violation|1|||
160839105|NCT00788710|580797859|FG000|Overall Study|Adverse Event|1|||
160839106|NCT00788710|580797860|FG001|Overall Study|Adverse Event|3|||
160839107|NCT00788710|580797861|FG002|Overall Study|Adverse Event|4|||
160839108|NCT00788710|580797859|FG000|Overall Study|Lack of Efficacy|0|||
160839109|NCT00788710|580797860|FG001|Overall Study|Lack of Efficacy|0|||
160839110|NCT00788710|580797861|FG002|Overall Study|Lack of Efficacy|1|||
160839111|NCT00788710|580797859|FG000|Overall Study|Lost to Follow-up|0|||
160839112|NCT00788710|580797860|FG001|Overall Study|Lost to Follow-up|1|||
160839113|NCT00788710|580797861|FG002|Overall Study|Lost to Follow-up|0|||
160839114|NCT00788710|580797859|FG000|Overall Study|Physician Decision|2|||
160904885|NCT01034631|581046335|FG002|Phase II|Determined Ineligible per protocol|0|||
161139002|NCT01126580|581890181|FG000|Overall Study|Withdrawal by Subject|11|||
161139003|NCT01126580|581890182|FG001|Overall Study|Withdrawal by Subject|19|||
161139004|NCT01126580|581890183|FG002|Overall Study|Withdrawal by Subject|14|||
161139005|NCT01126580|581890181|FG000|Overall Study|Sponsor Decision|5|||
161139006|NCT01126580|581890182|FG001|Overall Study|Sponsor Decision|4|||
160839115|NCT00788710|580797860|FG001|Overall Study|Physician Decision|1|||
160839116|NCT00788710|580797861|FG002|Overall Study|Physician Decision|0|||
160839117|NCT00788710|580797859|FG000|Overall Study|Protocol Violation|0|||
161139007|NCT01126580|581890183|FG002|Overall Study|Sponsor Decision|7|||
160839118|NCT00788710|580797860|FG001|Overall Study|Protocol Violation|1|||
160839119|NCT00788710|580797861|FG002|Overall Study|Protocol Violation|1|||
160839120|NCT00788710|580797859|FG000|Overall Study|Withdrawal by Subject|2|||
160839121|NCT00788710|580797860|FG001|Overall Study|Withdrawal by Subject|2|||
160839122|NCT00788710|580797861|FG002|Overall Study|Withdrawal by Subject|0|||
160839123|NCT01008904|580797862|FG000|Overall Study|Lost to Follow-up|1|||
160839124|NCT01008904|580797862|FG000|Overall Study|Adverse Event|2|||
160839125|NCT01008904|580797862|FG000|Overall Study|unexpected unrelated surgery|1|||
160904886|NCT00799383|581046336|FG000|Overall Study|Protocol Violation|1|||
161139008|NCT01126580|581890181|FG000|Overall Study|Physician Decision|1|||
161139009|NCT01126580|581890182|FG001|Overall Study|Physician Decision|1|||
161139010|NCT01126580|581890183|FG002|Overall Study|Physician Decision|2|||
161139011|NCT01126580|581890181|FG000|Overall Study|Entry Criteria Not Met|1|||
161139012|NCT01126580|581890182|FG001|Overall Study|Entry Criteria Not Met|1|||
161139013|NCT01126580|581890183|FG002|Overall Study|Entry Criteria Not Met|2|||
161139014|NCT01126580|581890181|FG000|Overall Study|Lack of Efficacy|2|||
161139015|NCT01126580|581890182|FG001|Overall Study|Lack of Efficacy|3|||
161139016|NCT01126580|581890183|FG002|Overall Study|Lack of Efficacy|4|||
161139017|NCT01126580|581890181|FG000|Overall Study|Protocol Violation|0|||
161139018|NCT01126580|581890182|FG001|Overall Study|Protocol Violation|1|||
160904887|NCT00799383|581046337|FG001|Overall Study|Protocol Violation|1|||
160904888|NCT00799383|581046336|FG000|Overall Study|Adverse Event|0|||
160904889|NCT00799383|581046337|FG001|Overall Study|Adverse Event|1|||
160904890|NCT00799383|581046336|FG000|Overall Study|Lost to Follow-up|1|||
160904891|NCT00799383|581046337|FG001|Overall Study|Lost to Follow-up|2|||
160839126|NCT04407234|580797863|FG000|Overall Study|Adverse Event|3|||
160839127|NCT04407234|580797864|FG001|Overall Study|Adverse Event|3|||
160839128|NCT03908970|580797865|FG000|Overall Study|Adverse Event|7|||
160839129|NCT03908970|580797866|FG001|Overall Study|Adverse Event|21|||
160839130|NCT03908970|580797865|FG000|Overall Study|Physician Decision|1|||
160839131|NCT03908970|580797866|FG001|Overall Study|Physician Decision|4|||
160839132|NCT03908970|580797865|FG000|Overall Study|Withdrawal by Subject|9|||
160839133|NCT03908970|580797866|FG001|Overall Study|Withdrawal by Subject|22|||
160839134|NCT00727558|580797872|FG000|Overall Study|Lens issue|0|||
160839135|NCT00727558|580797873|FG001|Overall Study|Lens issue|1|||
160839136|NCT00727558|580797872|FG000|Overall Study|Adverse Event|0|||
160839137|NCT00727558|580797873|FG001|Overall Study|Adverse Event|1|||
160839138|NCT00727558|580797872|FG000|Overall Study|Subject unable to return for follow-up|1|||
160839139|NCT00727558|580797873|FG001|Overall Study|Subject unable to return for follow-up|1|||
160839140|NCT00727558|580797872|FG000|Overall Study|Lost to Follow-up|1|||
160839141|NCT00727558|580797873|FG001|Overall Study|Lost to Follow-up|0|||
160839142|NCT01717326|580797880|FG000|Overall Study|Death|0|||
160839143|NCT01717326|580797881|FG001|Overall Study|Death|0|||
160839144|NCT01717326|580797882|FG002|Overall Study|Death|0|||
160839145|NCT01717326|580797883|FG003|Overall Study|Death|0|||
160839146|NCT01717326|580797884|FG004|Overall Study|Death|0|||
160839147|NCT01717326|580797885|FG005|Overall Study|Death|0|||
160839148|NCT01717326|580797886|FG006|Overall Study|Death|0|||
160839149|NCT01717326|580797887|FG007|Overall Study|Death|0|||
160839150|NCT01717326|580797888|FG008|Overall Study|Death|0|||
160839151|NCT01717326|580797889|FG009|Overall Study|Death|0|||
160839152|NCT01717326|580797890|FG010|Overall Study|Death|1|||
160904892|NCT00799383|581046336|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
160904893|NCT00799383|581046337|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
160839153|NCT01717326|580797891|FG011|Overall Study|Death|0|||
160839154|NCT01717326|580797892|FG012|Overall Study|Death|0|||
160904894|NCT00799383|581046336|FG000|Overall Study|Withdrawal by Subject|0|||
160904895|NCT00799383|581046337|FG001|Overall Study|Withdrawal by Subject|1|||
160904896|NCT03486223|581046347|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
160904897|NCT03486223|581046348|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
160904898|NCT01806298|581046357|FG000|Overall Study|Adverse Event|3|||
160904899|NCT01806298|581046357|FG000|Overall Study|Protocol Non-compliance|1|||
160904900|NCT01806298|581046357|FG000|Overall Study|Withdrawal by Subject|1|||
160904901|NCT01806298|581046357|FG000|Overall Study|Other|5|||
160904902|NCT01877265|581046358|FG000|Treatment Period 1|Sponsor Decision|0|||
160904903|NCT01877265|581046359|FG001|Treatment Period 1|Sponsor Decision|0|||
160991908|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
160991909|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991910|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
160991911|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
160991912|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991913|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991914|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991915|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991916|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
160991917|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
160991918|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
160991919|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
160991920|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
160991921|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
160991922|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
160991923|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160991924|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160904904|NCT01877265|581046360|FG002|Treatment Period 1|Sponsor Decision|1|||
161139019|NCT01126580|581890183|FG002|Overall Study|Protocol Violation|2|||
160839155|NCT01717326|580797893|FG013|Overall Study|Death|0|||
160839156|NCT01717326|580797894|FG014|Overall Study|Death|0|||
160839157|NCT01717326|580797895|FG015|Overall Study|Death|0|||
160839158|NCT01717326|580797896|FG016|Overall Study|Death|0|||
160839159|NCT01717326|580797897|FG017|Overall Study|Death|0|||
160839160|NCT01717326|580797898|FG018|Overall Study|Death|0|||
160839161|NCT01717326|580797899|FG019|Overall Study|Death|0|||
160904905|NCT01877265|581046361|FG003|Treatment Period 1|Sponsor Decision|0|||
160839162|NCT01717326|580797880|FG000|Overall Study|Lost to Follow-up|3|||
160839163|NCT01717326|580797881|FG001|Overall Study|Lost to Follow-up|0|||
161139020|NCT01126580|581890181|FG000|Overall Study|Lost to Follow-up|15|||
160839164|NCT01717326|580797882|FG002|Overall Study|Lost to Follow-up|0|||
160839165|NCT01717326|580797883|FG003|Overall Study|Lost to Follow-up|2|||
160839166|NCT01717326|580797884|FG004|Overall Study|Lost to Follow-up|1|||
160839167|NCT01717326|580797885|FG005|Overall Study|Lost to Follow-up|0|||
160839168|NCT01717326|580797886|FG006|Overall Study|Lost to Follow-up|1|||
160839169|NCT01717326|580797887|FG007|Overall Study|Lost to Follow-up|0|||
160839170|NCT01717326|580797888|FG008|Overall Study|Lost to Follow-up|0|||
160839171|NCT01717326|580797889|FG009|Overall Study|Lost to Follow-up|0|||
160839172|NCT01717326|580797890|FG010|Overall Study|Lost to Follow-up|1|||
160839173|NCT01717326|580797891|FG011|Overall Study|Lost to Follow-up|0|||
160839174|NCT01717326|580797892|FG012|Overall Study|Lost to Follow-up|0|||
160839175|NCT01717326|580797893|FG013|Overall Study|Lost to Follow-up|0|||
160839176|NCT01717326|580797894|FG014|Overall Study|Lost to Follow-up|0|||
160839177|NCT01717326|580797895|FG015|Overall Study|Lost to Follow-up|2|||
160839178|NCT01717326|580797896|FG016|Overall Study|Lost to Follow-up|1|||
160839179|NCT01717326|580797897|FG017|Overall Study|Lost to Follow-up|0|||
160839180|NCT01717326|580797898|FG018|Overall Study|Lost to Follow-up|2|||
160839181|NCT01717326|580797899|FG019|Overall Study|Lost to Follow-up|3|||
160839182|NCT01717326|580797880|FG000|Overall Study|Physician Decision|0|||
160839183|NCT01717326|580797881|FG001|Overall Study|Physician Decision|0|||
160839184|NCT01717326|580797882|FG002|Overall Study|Physician Decision|0|||
160839185|NCT01717326|580797883|FG003|Overall Study|Physician Decision|0|||
160839186|NCT01717326|580797884|FG004|Overall Study|Physician Decision|0|||
160839187|NCT01717326|580797885|FG005|Overall Study|Physician Decision|0|||
160839188|NCT01717326|580797886|FG006|Overall Study|Physician Decision|0|||
160839189|NCT01717326|580797887|FG007|Overall Study|Physician Decision|0|||
160839190|NCT01717326|580797888|FG008|Overall Study|Physician Decision|0|||
160839191|NCT01717326|580797889|FG009|Overall Study|Physician Decision|1|||
160839192|NCT01717326|580797890|FG010|Overall Study|Physician Decision|0|||
160839193|NCT01717326|580797891|FG011|Overall Study|Physician Decision|0|||
160839194|NCT01717326|580797892|FG012|Overall Study|Physician Decision|0|||
160839195|NCT01717326|580797893|FG013|Overall Study|Physician Decision|0|||
160991925|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
160991926|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161139021|NCT01126580|581890182|FG001|Overall Study|Lost to Follow-up|13|||
161139022|NCT01126580|581890183|FG002|Overall Study|Lost to Follow-up|9|||
161139023|NCT01126580|581890181|FG000|Overall Study|Treatment Non-compliance|0|||
161139024|NCT01126580|581890182|FG001|Overall Study|Treatment Non-compliance|2|||
161139025|NCT01126580|581890183|FG002|Overall Study|Treatment Non-compliance|3|||
161139026|NCT01731002|581890193|FG000|Overall Study|Adverse Event|0|||
161139027|NCT01731002|581890194|FG001|Overall Study|Adverse Event|2|||
161139028|NCT01731002|581890195|FG002|Overall Study|Adverse Event|2|||
161139029|NCT01731002|581890193|FG000|Overall Study|Non-Compliant|0|||
161139030|NCT01731002|581890194|FG001|Overall Study|Non-Compliant|1|||
161139031|NCT01731002|581890195|FG002|Overall Study|Non-Compliant|0|||
161139032|NCT01731002|581890193|FG000|Overall Study|Lost to Follow-up|1|||
161139033|NCT01731002|581890194|FG001|Overall Study|Lost to Follow-up|0|||
161139034|NCT01731002|581890195|FG002|Overall Study|Lost to Follow-up|0|||
161139035|NCT01731002|581890193|FG000|Overall Study|Test Agent Discontinuation|0|||
161139036|NCT01731002|581890194|FG001|Overall Study|Test Agent Discontinuation|1|||
161139037|NCT01731002|581890195|FG002|Overall Study|Test Agent Discontinuation|0|||
161139038|NCT01731002|581890193|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
161139039|NCT01731002|581890194|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
161139040|NCT01731002|581890195|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
161139041|NCT01731002|581890193|FG000|Overall Study|Elevated IOP|1|||
161139042|NCT01731002|581890194|FG001|Overall Study|Elevated IOP|0|||
161139043|NCT01731002|581890195|FG002|Overall Study|Elevated IOP|0|||
161139044|NCT01731002|581890193|FG000|Overall Study|Inappropriate use of study medications|0|||
161139045|NCT01731002|581890194|FG001|Overall Study|Inappropriate use of study medications|0|||
161139046|NCT01731002|581890195|FG002|Overall Study|Inappropriate use of study medications|1|||
161139047|NCT04321343|581890197|FG000|Overall Study|Adverse Event|0|||
161139048|NCT04321343|581890198|FG001|Overall Study|Adverse Event|0|||
161139049|NCT04321343|581890199|FG002|Overall Study|Adverse Event|1|||
161139050|NCT04321343|581890200|FG003|Overall Study|Adverse Event|0|||
161139051|NCT04321343|581890197|FG000|Overall Study|Death|0|||
161139052|NCT04321343|581890198|FG001|Overall Study|Death|0|||
161139053|NCT04321343|581890199|FG002|Overall Study|Death|0|||
161139054|NCT04321343|581890200|FG003|Overall Study|Death|1|||
161139055|NCT04321343|581890197|FG000|Overall Study|Pregnancy|1|||
161139056|NCT04321343|581890198|FG001|Overall Study|Pregnancy|0|||
161139057|NCT04321343|581890199|FG002|Overall Study|Pregnancy|0|||
161139058|NCT04321343|581890200|FG003|Overall Study|Pregnancy|0|||
161139059|NCT04321343|581890197|FG000|Overall Study|Protocol Violation|1|||
161139060|NCT04321343|581890198|FG001|Overall Study|Protocol Violation|1|||
161139061|NCT04321343|581890199|FG002|Overall Study|Protocol Violation|1|||
161139062|NCT04321343|581890200|FG003|Overall Study|Protocol Violation|1|||
161139063|NCT04321343|581890197|FG000|Overall Study|Withdrawal by Subject|0|||
161139064|NCT04321343|581890198|FG001|Overall Study|Withdrawal by Subject|6|||
160904906|NCT01877265|581046362|FG004|Treatment Period 1|Sponsor Decision|0|||
160904907|NCT01877265|581046363|FG005|Treatment Period 1|Sponsor Decision|0|||
160904908|NCT01877265|581046358|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904909|NCT01877265|581046359|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904910|NCT01877265|581046360|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904911|NCT01877265|581046361|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904912|NCT01877265|581046362|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
160904913|NCT01877265|581046363|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
160904914|NCT01877265|581046358|FG000|Treatment Period 3|Lost to Follow-up|1|||
160904915|NCT01877265|581046359|FG001|Treatment Period 3|Lost to Follow-up|0|||
160904916|NCT01877265|581046360|FG002|Treatment Period 3|Lost to Follow-up|0|||
160904917|NCT01877265|581046361|FG003|Treatment Period 3|Lost to Follow-up|0|||
160904918|NCT01877265|581046362|FG004|Treatment Period 3|Lost to Follow-up|0|||
160904919|NCT01877265|581046363|FG005|Treatment Period 3|Lost to Follow-up|0|||
160904920|NCT00702689|581046364|FG000|Overall Study|Withdrawal by Subject|4|||
160904921|NCT00702689|581046364|FG000|Overall Study|Recurrent malignancy|1|||
160904922|NCT00702689|581046364|FG000|Overall Study|Adverse Event|1|||
160904923|NCT01986907|581046367|FG000|Overall Study|Adverse Event|11|||
160904924|NCT01986907|581046367|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
160904925|NCT01986907|581046367|FG000|Overall Study|Protocol Violation|4|||
160904926|NCT01986907|581046367|FG000|Overall Study|Withdrawal by Subject|76|||
160904927|NCT01986907|581046367|FG000|Overall Study|Lost to Follow-up|38|||
160904928|NCT01986907|581046367|FG000|Overall Study|Death|9|||
160904929|NCT02805972|581046370|FG000|Washout Period|Lost to Follow-up|3|||
160904930|NCT02805972|581046371|FG001|Washout Period|Lost to Follow-up|0|||
160904931|NCT00939640|581046373|FG000|Overall Study|Physician Decision|1|||
160904932|NCT00239590|581046374|FG000|Randomized|Lost to Follow-up|0|||
160904933|NCT00239590|581046375|FG001|Randomized|Lost to Follow-up|1|||
160904934|NCT00239590|581046374|FG000|Randomized|Withdrawal by Subject|0|||
160904935|NCT00239590|581046375|FG001|Randomized|Withdrawal by Subject|1|||
160904936|NCT00239590|581046374|FG000|Completed Study Protocol|Adverse Event|1|||
160904937|NCT00239590|581046375|FG001|Completed Study Protocol|Adverse Event|1|||
160904938|NCT00239590|581046374|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
160904939|NCT00239590|581046375|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
160904940|NCT00892047|581046380|FG000|Overall Study|Adverse Event|2|||
160904941|NCT00892047|581046381|FG001|Overall Study|Adverse Event|2|||
160904942|NCT00892047|581046380|FG000|Overall Study|subject burden|2|||
160904943|NCT00892047|581046381|FG001|Overall Study|subject burden|3|||
160904944|NCT00892047|581046380|FG000|Overall Study|Lack of Efficacy|0|||
160904945|NCT00892047|581046381|FG001|Overall Study|Lack of Efficacy|2|||
160904946|NCT00389597|581046388|FG000|Overall Study|Lost to Follow-up|8|||
160904947|NCT00389597|581046389|FG001|Overall Study|Lost to Follow-up|6|||
160904948|NCT00389597|581046390|FG002|Overall Study|Lost to Follow-up|4|||
160904949|NCT00389597|581046391|FG003|Overall Study|Lost to Follow-up|6|||
160904950|NCT00306189|581046392|FG000|Overall Study|Physician Decision|0|||
160904951|NCT00306189|581046393|FG001|Overall Study|Physician Decision|0|||
160904952|NCT00306189|581046394|FG002|Overall Study|Physician Decision|0|||
160904953|NCT00306189|581046395|FG003|Overall Study|Physician Decision|1|||
160904954|NCT00306189|581046392|FG000|Overall Study|Adverse Event|3|||
160904955|NCT00306189|581046393|FG001|Overall Study|Adverse Event|3|||
160904956|NCT00306189|581046394|FG002|Overall Study|Adverse Event|2|||
160904957|NCT00306189|581046395|FG003|Overall Study|Adverse Event|2|||
160904958|NCT00306189|581046392|FG000|Overall Study|Withdrawal by Subject|4|||
160904959|NCT00306189|581046393|FG001|Overall Study|Withdrawal by Subject|2|||
160904960|NCT00306189|581046394|FG002|Overall Study|Withdrawal by Subject|8|||
160904961|NCT00306189|581046395|FG003|Overall Study|Withdrawal by Subject|1|||
160904962|NCT00306189|581046392|FG000|Overall Study|Ineligibility determined|1|||
160904963|NCT00306189|581046393|FG001|Overall Study|Ineligibility determined|1|||
160904964|NCT00306189|581046394|FG002|Overall Study|Ineligibility determined|1|||
160904965|NCT00306189|581046395|FG003|Overall Study|Ineligibility determined|1|||
160904966|NCT00306189|581046392|FG000|Overall Study|Other|1|||
160904967|NCT00306189|581046393|FG001|Overall Study|Other|0|||
160904968|NCT00306189|581046394|FG002|Overall Study|Other|0|||
160904969|NCT00306189|581046395|FG003|Overall Study|Other|0|||
160904970|NCT00259610|581046396|FG000|Overall Study|Withdrawal by Subject|33|||
160904971|NCT00259610|581046397|FG001|Overall Study|Withdrawal by Subject|25|||
160904972|NCT00259610|581046398|FG002|Overall Study|Withdrawal by Subject|29|||
160904973|NCT00259610|581046399|FG003|Overall Study|Withdrawal by Subject|19|||
160904974|NCT00259610|581046396|FG000|Overall Study|Lost to Follow-up|19|||
160904975|NCT00259610|581046397|FG001|Overall Study|Lost to Follow-up|8|||
160904976|NCT00259610|581046398|FG002|Overall Study|Lost to Follow-up|18|||
160904977|NCT00259610|581046399|FG003|Overall Study|Lost to Follow-up|15|||
160904978|NCT00259610|581046396|FG000|Overall Study|Physician Decision|6|||
160904979|NCT00259610|581046397|FG001|Overall Study|Physician Decision|4|||
160904980|NCT00259610|581046398|FG002|Overall Study|Physician Decision|7|||
160904981|NCT00259610|581046399|FG003|Overall Study|Physician Decision|2|||
160904982|NCT00259610|581046396|FG000|Overall Study|Death|1|||
160904983|NCT00259610|581046397|FG001|Overall Study|Death|1|||
160839196|NCT01717326|580797894|FG014|Overall Study|Physician Decision|0|||
160839197|NCT01717326|580797895|FG015|Overall Study|Physician Decision|0|||
160839198|NCT01717326|580797896|FG016|Overall Study|Physician Decision|0|||
160839199|NCT01717326|580797897|FG017|Overall Study|Physician Decision|0|||
160839200|NCT01717326|580797898|FG018|Overall Study|Physician Decision|0|||
160839201|NCT01717326|580797899|FG019|Overall Study|Physician Decision|0|||
160839202|NCT01717326|580797880|FG000|Overall Study|Protocol Violation|0|||
160839203|NCT01717326|580797881|FG001|Overall Study|Protocol Violation|0|||
160839204|NCT01717326|580797882|FG002|Overall Study|Protocol Violation|0|||
160839205|NCT01717326|580797883|FG003|Overall Study|Protocol Violation|0|||
160839206|NCT01717326|580797884|FG004|Overall Study|Protocol Violation|1|||
160839207|NCT01717326|580797885|FG005|Overall Study|Protocol Violation|0|||
160839208|NCT01717326|580797886|FG006|Overall Study|Protocol Violation|0|||
160839209|NCT01717326|580797887|FG007|Overall Study|Protocol Violation|0|||
160839210|NCT01717326|580797888|FG008|Overall Study|Protocol Violation|0|||
160839211|NCT01717326|580797889|FG009|Overall Study|Protocol Violation|0|||
160839212|NCT01717326|580797890|FG010|Overall Study|Protocol Violation|0|||
160839213|NCT01717326|580797891|FG011|Overall Study|Protocol Violation|0|||
160839214|NCT01717326|580797892|FG012|Overall Study|Protocol Violation|0|||
160839215|NCT01717326|580797893|FG013|Overall Study|Protocol Violation|0|||
160839216|NCT01717326|580797894|FG014|Overall Study|Protocol Violation|0|||
160839217|NCT01717326|580797895|FG015|Overall Study|Protocol Violation|0|||
160839218|NCT01717326|580797896|FG016|Overall Study|Protocol Violation|0|||
160839219|NCT01717326|580797897|FG017|Overall Study|Protocol Violation|0|||
160839220|NCT01717326|580797898|FG018|Overall Study|Protocol Violation|0|||
160839221|NCT01717326|580797899|FG019|Overall Study|Protocol Violation|0|||
160839222|NCT01717326|580797880|FG000|Overall Study|Withdrawal by Subject|0|||
160839223|NCT01717326|580797881|FG001|Overall Study|Withdrawal by Subject|1|||
160839224|NCT01717326|580797882|FG002|Overall Study|Withdrawal by Subject|0|||
160839225|NCT01717326|580797883|FG003|Overall Study|Withdrawal by Subject|0|||
160839226|NCT01717326|580797884|FG004|Overall Study|Withdrawal by Subject|0|||
160839227|NCT01717326|580797885|FG005|Overall Study|Withdrawal by Subject|0|||
160839228|NCT01717326|580797886|FG006|Overall Study|Withdrawal by Subject|0|||
160839229|NCT01717326|580797887|FG007|Overall Study|Withdrawal by Subject|0|||
160839230|NCT01717326|580797888|FG008|Overall Study|Withdrawal by Subject|0|||
160839231|NCT01717326|580797889|FG009|Overall Study|Withdrawal by Subject|1|||
160839232|NCT01717326|580797890|FG010|Overall Study|Withdrawal by Subject|0|||
160839233|NCT01717326|580797891|FG011|Overall Study|Withdrawal by Subject|0|||
160839234|NCT01717326|580797892|FG012|Overall Study|Withdrawal by Subject|1|||
160839235|NCT01717326|580797893|FG013|Overall Study|Withdrawal by Subject|0|||
160839236|NCT01717326|580797894|FG014|Overall Study|Withdrawal by Subject|0|||
160839237|NCT01717326|580797895|FG015|Overall Study|Withdrawal by Subject|1|||
160839238|NCT01717326|580797896|FG016|Overall Study|Withdrawal by Subject|0|||
160839239|NCT01717326|580797897|FG017|Overall Study|Withdrawal by Subject|0|||
160839240|NCT01717326|580797898|FG018|Overall Study|Withdrawal by Subject|2|||
160839241|NCT01717326|580797899|FG019|Overall Study|Withdrawal by Subject|3|||
160839242|NCT02262754|580797901|FG000|Overall Study|Adverse Event|3|||
160839243|NCT02262754|580797902|FG001|Overall Study|Adverse Event|4|||
160839244|NCT02262754|580797903|FG002|Overall Study|Adverse Event|0|||
160839245|NCT02262754|580797901|FG000|Overall Study|Lack of Efficacy|2|||
160839246|NCT02262754|580797902|FG001|Overall Study|Lack of Efficacy|0|||
160839247|NCT02262754|580797903|FG002|Overall Study|Lack of Efficacy|1|||
160839248|NCT02262754|580797901|FG000|Overall Study|Lost to Follow-up|0|||
160839249|NCT02262754|580797902|FG001|Overall Study|Lost to Follow-up|0|||
160839250|NCT02262754|580797903|FG002|Overall Study|Lost to Follow-up|1|||
161139065|NCT04321343|581890199|FG002|Overall Study|Withdrawal by Subject|0|||
161139066|NCT04321343|581890200|FG003|Overall Study|Withdrawal by Subject|2|||
161139067|NCT04321343|581890197|FG000|Overall Study|Lost to Follow-up|2|||
160839251|NCT02262754|580797901|FG000|Overall Study|No longer meets eligibility criteria|0|||
160839252|NCT02262754|580797902|FG001|Overall Study|No longer meets eligibility criteria|1|||
160839253|NCT02262754|580797903|FG002|Overall Study|No longer meets eligibility criteria|0|||
160839254|NCT02262754|580797901|FG000|Overall Study|Study terminated by sponsor|5|||
161139068|NCT04321343|581890198|FG001|Overall Study|Lost to Follow-up|2|||
161139069|NCT04321343|581890199|FG002|Overall Study|Lost to Follow-up|1|||
161139070|NCT04321343|581890200|FG003|Overall Study|Lost to Follow-up|3|||
161139071|NCT03430310|581890201|FG000|Overall Study|Protocol Violation|2|||
161139072|NCT03430310|581890202|FG001|Overall Study|Protocol Violation|0|||
161139073|NCT03430310|581890201|FG000|Overall Study|Withdrawal by Subject|3|||
161139074|NCT03430310|581890202|FG001|Overall Study|Withdrawal by Subject|2|||
161139075|NCT03430310|581890201|FG000|Overall Study|COVID shutdown March 2020|0|||
161139076|NCT03430310|581890202|FG001|Overall Study|COVID shutdown March 2020|1|||
161139077|NCT03972488|581890203|FG000|Overall Study|Progressive disease|42|||
161139078|NCT03972488|581890204|FG001|Overall Study|Progressive disease|44|||
161139079|NCT03972488|581890203|FG000|Overall Study|Physician Decision|13|||
161139080|NCT03972488|581890204|FG001|Overall Study|Physician Decision|7|||
161139081|NCT03972488|581890203|FG000|Overall Study|Adverse Event|8|||
161139082|NCT03972488|581890204|FG001|Overall Study|Adverse Event|1|||
161139083|NCT03972488|581890203|FG000|Overall Study|Death|4|||
160839255|NCT02262754|580797902|FG001|Overall Study|Study terminated by sponsor|4|||
160839256|NCT02262754|580797903|FG002|Overall Study|Study terminated by sponsor|4|||
160839257|NCT02262754|580797901|FG000|Overall Study|Protocol Violation|1|||
160839258|NCT02262754|580797902|FG001|Overall Study|Protocol Violation|0|||
160839259|NCT02262754|580797903|FG002|Overall Study|Protocol Violation|0|||
160839260|NCT02262754|580797901|FG000|Overall Study|Withdrawal by Subject|1|||
160839261|NCT02262754|580797902|FG001|Overall Study|Withdrawal by Subject|0|||
160839262|NCT02262754|580797903|FG002|Overall Study|Withdrawal by Subject|1|||
160839263|NCT02262754|580797901|FG000|Overall Study|Other|4|||
160839264|NCT02262754|580797902|FG001|Overall Study|Other|0|||
160839265|NCT02262754|580797903|FG002|Overall Study|Other|2|||
160839266|NCT01299116|580797907|FG000|Overall Study|Lost to Follow-up|65|||
160839267|NCT01299116|580797908|FG001|Overall Study|Lost to Follow-up|9|||
160839268|NCT01299116|580797909|FG002|Overall Study|Lost to Follow-up|11|||
160839269|NCT04079114|580797910|FG000|Overall Study|Study prematuely terminated.|166|||
160839270|NCT00629798|580797917|FG000|Overall Study|Not Treated|4|||
160839271|NCT01114438|580797918|FG000|Overall Study|Adverse Event|10|||
160839272|NCT01114438|580797918|FG000|Overall Study|concomitant medication|1|||
160839273|NCT01114438|580797918|FG000|Overall Study|Physician Decision|1|||
160839274|NCT01114438|580797918|FG000|Overall Study|Withdrawal by Subject|2|||
160839275|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Adverse Event|2|||
160839276|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Adverse Event|4|||
160839277|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Adverse Event|4|||
160839278|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
160839279|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
160839280|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
160839281|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
160839282|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
160839283|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
160839284|NCT00428844|580797921|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
160839285|NCT00428844|580797922|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
160839286|NCT00428844|580797923|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
160839287|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
160839288|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
160839289|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
160839290|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
160839291|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
160839292|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
160839293|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
160839294|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
160839295|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
160839296|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
160839297|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
160839298|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
160839299|NCT00428844|580797921|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
160839300|NCT00428844|580797922|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
160839301|NCT00428844|580797923|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
160839302|NCT00488826|580797926|FG000|Overall Study|Withdrawal by Subject|40|||
160839303|NCT00488826|580797927|FG001|Overall Study|Withdrawal by Subject|35|||
160839304|NCT00488826|580797928|FG002|Overall Study|Withdrawal by Subject|19|||
160839305|NCT00488826|580797926|FG000|Overall Study|Protocol Violation|0|||
160839306|NCT00488826|580797927|FG001|Overall Study|Protocol Violation|0|||
160839307|NCT00488826|580797928|FG002|Overall Study|Protocol Violation|2|||
160839308|NCT00488826|580797926|FG000|Overall Study|Adverse Event|9|||
160839309|NCT00488826|580797927|FG001|Overall Study|Adverse Event|15|||
160839310|NCT00488826|580797928|FG002|Overall Study|Adverse Event|4|||
160839311|NCT00488826|580797926|FG000|Overall Study|Lost to Follow-up|5|||
160839312|NCT00488826|580797927|FG001|Overall Study|Lost to Follow-up|1|||
160839313|NCT00488826|580797928|FG002|Overall Study|Lost to Follow-up|0|||
160839314|NCT00488826|580797926|FG000|Overall Study|Protocol Deviations|2|||
160839315|NCT00488826|580797927|FG001|Overall Study|Protocol Deviations|1|||
160839316|NCT00488826|580797928|FG002|Overall Study|Protocol Deviations|1|||
161250545|NCT04253236|582296903|FG000|Overall Study|Study Terminated by Sponsor|1|||
161250546|NCT04253236|582296904|FG001|Overall Study|Study Terminated by Sponsor|0|||
161250547|NCT01896505|582296905|FG000|Overall Study|Adverse Event|1|||
161250548|NCT01896505|582296906|FG001|Overall Study|Adverse Event|0|||
160839317|NCT00812565|580797935|FG000|Overall Study|Did Not Receive Study Medication|1|||
160839318|NCT00812565|580797936|FG001|Overall Study|Did Not Receive Study Medication|1|||
160839319|NCT00812565|580797937|FG002|Overall Study|Did Not Receive Study Medication|0|||
160904984|NCT00259610|581046398|FG002|Overall Study|Death|2|||
161250549|NCT01896505|582296907|FG002|Overall Study|Adverse Event|2|||
161250550|NCT01896505|582296908|FG003|Overall Study|Adverse Event|1|||
160839320|NCT00812565|580797938|FG003|Overall Study|Did Not Receive Study Medication|0|||
161250551|NCT01896505|582296909|FG004|Overall Study|Adverse Event|1|||
160839321|NCT00812565|580797939|FG004|Overall Study|Did Not Receive Study Medication|0|||
160839322|NCT00812565|580797940|FG005|Overall Study|Did Not Receive Study Medication|0|||
160839323|NCT00812565|580797941|FG006|Overall Study|Did Not Receive Study Medication|0|||
160839324|NCT00812565|580797942|FG007|Overall Study|Did Not Receive Study Medication|0|||
160839325|NCT00812565|580797935|FG000|Overall Study|Adverse Event|0|||
160839326|NCT00812565|580797936|FG001|Overall Study|Adverse Event|0|||
160839327|NCT00812565|580797937|FG002|Overall Study|Adverse Event|0|||
160839328|NCT00812565|580797938|FG003|Overall Study|Adverse Event|2|||
160839329|NCT00812565|580797939|FG004|Overall Study|Adverse Event|0|||
160839330|NCT00812565|580797940|FG005|Overall Study|Adverse Event|0|||
160839331|NCT00812565|580797941|FG006|Overall Study|Adverse Event|0|||
160839332|NCT00812565|580797942|FG007|Overall Study|Adverse Event|1|||
160839333|NCT00812565|580797935|FG000|Overall Study|Did Not Come to Study Visit|1|||
160839334|NCT00812565|580797936|FG001|Overall Study|Did Not Come to Study Visit|0|||
160839335|NCT00812565|580797937|FG002|Overall Study|Did Not Come to Study Visit|0|||
160839336|NCT00812565|580797938|FG003|Overall Study|Did Not Come to Study Visit|0|||
160839337|NCT00812565|580797939|FG004|Overall Study|Did Not Come to Study Visit|0|||
160839338|NCT00812565|580797940|FG005|Overall Study|Did Not Come to Study Visit|0|||
160839339|NCT00812565|580797941|FG006|Overall Study|Did Not Come to Study Visit|0|||
160839340|NCT00812565|580797942|FG007|Overall Study|Did Not Come to Study Visit|0|||
161139084|NCT03972488|581890204|FG001|Overall Study|Death|4|||
161139085|NCT03972488|581890203|FG000|Overall Study|Withdrawal by Subject|3|||
161139086|NCT03972488|581890204|FG001|Overall Study|Withdrawal by Subject|4|||
161139087|NCT03972488|581890203|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
160839341|NCT00812565|580797935|FG000|Overall Study|Withdrawal of Consent|1|||
160839342|NCT00812565|580797936|FG001|Overall Study|Withdrawal of Consent|0|||
160839343|NCT00812565|580797937|FG002|Overall Study|Withdrawal of Consent|0|||
160839344|NCT00812565|580797938|FG003|Overall Study|Withdrawal of Consent|0|||
160839345|NCT00812565|580797939|FG004|Overall Study|Withdrawal of Consent|1|||
160839346|NCT00812565|580797940|FG005|Overall Study|Withdrawal of Consent|0|||
160839347|NCT00812565|580797941|FG006|Overall Study|Withdrawal of Consent|0|||
160839348|NCT00812565|580797942|FG007|Overall Study|Withdrawal of Consent|0|||
160839349|NCT00812565|580797935|FG000|Overall Study|Reason Not Specified|0|||
160839350|NCT00812565|580797936|FG001|Overall Study|Reason Not Specified|0|||
160839351|NCT00812565|580797937|FG002|Overall Study|Reason Not Specified|0|||
160839352|NCT00812565|580797938|FG003|Overall Study|Reason Not Specified|0|||
160839353|NCT00812565|580797939|FG004|Overall Study|Reason Not Specified|0|||
160839354|NCT00812565|580797940|FG005|Overall Study|Reason Not Specified|1|||
160839355|NCT00812565|580797941|FG006|Overall Study|Reason Not Specified|0|||
160839356|NCT00812565|580797942|FG007|Overall Study|Reason Not Specified|0|||
160839357|NCT00422383|580797943|FG000|Overall Study|Adverse Event|5|||
160839358|NCT00422383|580797944|FG001|Overall Study|Adverse Event|3|||
160839359|NCT00422383|580797945|FG002|Overall Study|Adverse Event|1|||
160839360|NCT00422383|580797946|FG003|Overall Study|Adverse Event|1|||
160839361|NCT00422383|580797947|FG004|Overall Study|Adverse Event|0|||
160839362|NCT00422383|580797943|FG000|Overall Study|Lack of Efficacy|4|||
160839363|NCT00422383|580797944|FG001|Overall Study|Lack of Efficacy|4|||
160839364|NCT00422383|580797945|FG002|Overall Study|Lack of Efficacy|2|||
160839365|NCT00422383|580797946|FG003|Overall Study|Lack of Efficacy|1|||
160839366|NCT00422383|580797947|FG004|Overall Study|Lack of Efficacy|1|||
160839367|NCT00422383|580797943|FG000|Overall Study|Lost to Follow-up|0|||
160839368|NCT00422383|580797944|FG001|Overall Study|Lost to Follow-up|1|||
160839369|NCT00422383|580797945|FG002|Overall Study|Lost to Follow-up|0|||
160839370|NCT00422383|580797946|FG003|Overall Study|Lost to Follow-up|0|||
160839371|NCT00422383|580797947|FG004|Overall Study|Lost to Follow-up|1|||
160839372|NCT00422383|580797943|FG000|Overall Study|Protocol Violation|1|||
161139088|NCT03972488|581890204|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
161139089|NCT03277196|581890205|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
161139090|NCT03277196|581890205|FG000|Overall Study|Lost to Follow-up|3|||
161139091|NCT03277196|581890205|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161139092|NCT03277196|581890205|FG000|Overall Study|Other|2|||
161139093|NCT06119191|581890206|FG000|Overall Study|Adverse Event|0|||
161139094|NCT06119191|581890207|FG001|Overall Study|Adverse Event|1|||
161139095|NCT06119191|581890206|FG000|Overall Study|Protocol Violation|1|||
161139096|NCT06119191|581890207|FG001|Overall Study|Protocol Violation|0|||
161139097|NCT02468193|581892595|FG000|Overall Study|Adverse Event|4|||
161139098|NCT02468193|581892595|FG000|Overall Study|Subject/ Guardian decision|2|||
161139099|NCT00742781|581892596|FG000|Overall Study|Withdrawal by Subject|3|||
161139100|NCT01416181|581892597|FG000|Part 1|Other|10|||
161139101|NCT01416181|581892598|FG001|Part 1|Other|24|||
161139102|NCT01416181|581892597|FG000|Part 1|Death|0|||
161139103|NCT01416181|581892598|FG001|Part 1|Death|1|||
161139104|NCT01416181|581892597|FG000|Part 1|Investigator Decision|7|||
161139105|NCT01416181|581892598|FG001|Part 1|Investigator Decision|6|||
161139106|NCT01416181|581892597|FG000|Part 1|Withdrawal by Subject|74|||
161139107|NCT01416181|581892598|FG001|Part 1|Withdrawal by Subject|48|||
161139108|NCT01416181|581892597|FG000|Part 1|Lack of Efficacy|16|||
161139109|NCT01416181|581892598|FG001|Part 1|Lack of Efficacy|8|||
161139110|NCT01416181|581892597|FG000|Part 1|Lost to Follow-up|1|||
160839373|NCT00422383|580797944|FG001|Overall Study|Protocol Violation|1|||
160839374|NCT00422383|580797945|FG002|Overall Study|Protocol Violation|1|||
160839375|NCT00422383|580797946|FG003|Overall Study|Protocol Violation|0|||
160839376|NCT00422383|580797947|FG004|Overall Study|Protocol Violation|0|||
160839377|NCT00422383|580797943|FG000|Overall Study|Withdrawal by Subject|5|||
160839378|NCT00422383|580797944|FG001|Overall Study|Withdrawal by Subject|5|||
160839379|NCT00422383|580797945|FG002|Overall Study|Withdrawal by Subject|0|||
160839380|NCT00422383|580797946|FG003|Overall Study|Withdrawal by Subject|0|||
160839381|NCT00422383|580797947|FG004|Overall Study|Withdrawal by Subject|1|||
160839382|NCT00566254|580797948|FG000|Overall Study|Adverse Event|3|||
160839383|NCT00566254|580797949|FG001|Overall Study|Adverse Event|1|||
160839384|NCT00566254|580797948|FG000|Overall Study|Protocol Violation|1|||
160839385|NCT00566254|580797949|FG001|Overall Study|Protocol Violation|3|||
160839386|NCT00566254|580797948|FG000|Overall Study|Withdrawal by Subject|1|||
160839387|NCT00566254|580797949|FG001|Overall Study|Withdrawal by Subject|2|||
160839388|NCT00566254|580797948|FG000|Overall Study|Lack of Efficacy|5|||
160839389|NCT00566254|580797949|FG001|Overall Study|Lack of Efficacy|6|||
160839390|NCT00566254|580797948|FG000|Overall Study|Other|0|||
160839391|NCT00566254|580797949|FG001|Overall Study|Other|2|||
160839392|NCT00238238|580797950|FG000|Overall Study|Withdrawal by Subject|0|||
160839393|NCT00238238|580797951|FG001|Overall Study|Withdrawal by Subject|3|||
160839394|NCT00238238|580797952|FG002|Overall Study|Withdrawal by Subject|0|||
160839395|NCT01007838|580797954|FG000|Overall Study|Withdrawal by Subject|1|||
160839396|NCT01007838|580797955|FG001|Overall Study|Withdrawal by Subject|0|||
160839397|NCT01007838|580797956|FG002|Overall Study|Withdrawal by Subject|0|||
160839398|NCT01007838|580797957|FG003|Overall Study|Withdrawal by Subject|0|||
161139111|NCT01416181|581892598|FG001|Part 1|Lost to Follow-up|1|||
161139112|NCT01416181|581892597|FG000|Part 1|Adverse Event|15|||
161139113|NCT01416181|581892598|FG001|Part 1|Adverse Event|18|||
161139114|NCT01416181|581892597|FG000|Part 1|Ongoing in Follow-Up|14|||
161139115|NCT01416181|581892598|FG001|Part 1|Ongoing in Follow-Up|8|||
161139116|NCT01416181|581892597|FG000|Part 2|Adverse Event|11|||
161139117|NCT01416181|581892598|FG001|Part 2|Adverse Event|4|||
161139118|NCT01416181|581892597|FG000|Part 2|Other|234|||
161139119|NCT01416181|581892598|FG001|Part 2|Other|267|||
161139120|NCT01416181|581892597|FG000|Part 2|Investigator Decision|6|||
161139121|NCT01416181|581892598|FG001|Part 2|Investigator Decision|7|||
161139122|NCT01416181|581892597|FG000|Part 2|Withdrawal by Subject|14|||
161139123|NCT01416181|581892598|FG001|Part 2|Withdrawal by Subject|5|||
161139124|NCT01416181|581892597|FG000|Part 2|Lack of Efficacy|4|||
161139125|NCT01416181|581892598|FG001|Part 2|Lack of Efficacy|1|||
161139126|NCT01416181|581892597|FG000|Part 2|Lost to Follow-up|2|||
161139127|NCT01416181|581892598|FG001|Part 2|Lost to Follow-up|2|||
161139128|NCT04178590|581892599|FG000|Overall Study|Pregnancy|1|||
161139129|NCT04178590|581892599|FG000|Overall Study|Lost to Follow-up|1|||
161139130|NCT04723537|581892600|FG000|Overall Study|Withdrawal by Subject|3|||
161139131|NCT04723537|581892601|FG001|Overall Study|Withdrawal by Subject|0|||
161139132|NCT04723537|581892602|FG002|Overall Study|Withdrawal by Subject|0|||
161139133|NCT04723537|581892600|FG000|Overall Study|Physician Decision|0|||
161139134|NCT04723537|581892601|FG001|Overall Study|Physician Decision|0|||
161139135|NCT04723537|581892602|FG002|Overall Study|Physician Decision|1|||
161139136|NCT04723537|581892600|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161139137|NCT04723537|581892601|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161139138|NCT04723537|581892602|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
161139139|NCT01845025|581892603|FG000|Overall Study|Adverse Event|6|||
161139140|NCT01845025|581892604|FG001|Overall Study|Adverse Event|3|||
161139141|NCT01845025|581892603|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161139142|NCT01845025|581892604|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161139143|NCT01845025|581892603|FG000|Overall Study|Withdrawal by Subject|48|||
161139144|NCT01845025|581892604|FG001|Overall Study|Withdrawal by Subject|44|||
161139145|NCT01845025|581892603|FG000|Overall Study|Lost to Follow-up|13|||
161139146|NCT01845025|581892604|FG001|Overall Study|Lost to Follow-up|13|||
161139147|NCT01845025|581892603|FG000|Overall Study|Administrative problems|8|||
161139148|NCT01845025|581892604|FG001|Overall Study|Administrative problems|8|||
161139149|NCT01845025|581892603|FG000|Overall Study|Death|2|||
161139150|NCT01845025|581892604|FG001|Overall Study|Death|0|||
161139151|NCT01845025|581892603|FG000|Overall Study|Protocol deviation|3|||
161139152|NCT01845025|581892604|FG001|Overall Study|Protocol deviation|6|||
161139153|NCT01845025|581892603|FG000|Overall Study|Missing|1|||
161139154|NCT01845025|581892604|FG001|Overall Study|Missing|1|||
161139155|NCT01485614|581892611|FG000|Randomization|Not Treated|1|||
161139156|NCT01485614|581892612|FG001|Randomization|Not Treated|0|||
161139157|NCT01485614|581892613|FG002|Randomization|Not Treated|0|||
161139158|NCT01485614|581892614|FG003|Randomization|Not Treated|0|||
161139159|NCT01485614|581892611|FG000|Weeks 0-20|Lost to Follow-up|2|||
161139160|NCT01485614|581892612|FG001|Weeks 0-20|Lost to Follow-up|0|||
161139161|NCT01485614|581892613|FG002|Weeks 0-20|Lost to Follow-up|0|||
161139162|NCT01485614|581892614|FG003|Weeks 0-20|Lost to Follow-up|0|||
160839399|NCT01007838|580797954|FG000|Overall Study|Physician Decision|1|||
160839400|NCT01007838|580797955|FG001|Overall Study|Physician Decision|0|||
160839401|NCT01007838|580797956|FG002|Overall Study|Physician Decision|0|||
160839402|NCT01007838|580797957|FG003|Overall Study|Physician Decision|0|||
160839403|NCT01007838|580797954|FG000|Overall Study|Started home haemodialysis|1|||
160839404|NCT01007838|580797955|FG001|Overall Study|Started home haemodialysis|0|||
160839405|NCT01007838|580797956|FG002|Overall Study|Started home haemodialysis|0|||
160839406|NCT01007838|580797957|FG003|Overall Study|Started home haemodialysis|0|||
160839407|NCT02277119|580797960|FG000|Overall Study|Lack of Efficacy|1|||
160839408|NCT02277119|580797961|FG001|Overall Study|Lack of Efficacy|1|||
160839409|NCT02277119|580797962|FG002|Overall Study|Lack of Efficacy|1|||
160839410|NCT02277119|580797960|FG000|Overall Study|Protocol Violation|2|||
160839411|NCT02277119|580797961|FG001|Overall Study|Protocol Violation|3|||
160839412|NCT02277119|580797962|FG002|Overall Study|Protocol Violation|7|||
160839413|NCT01345669|580797963|FG000|Overall Study|Primary tumour recurrence|53|||
160839414|NCT01345669|580797964|FG001|Overall Study|Primary tumour recurrence|32|||
160839415|NCT01345669|580797963|FG000|Overall Study|Second primary tumour|4|||
160839416|NCT01345669|580797964|FG001|Overall Study|Second primary tumour|3|||
160839417|NCT01345669|580797963|FG000|Overall Study|Adverse Event|63|||
160839418|NCT01345669|580797964|FG001|Overall Study|Adverse Event|9|||
160839419|NCT01345669|580797963|FG000|Overall Study|Protocol Violation|3|||
160839420|NCT01345669|580797964|FG001|Overall Study|Protocol Violation|1|||
160839421|NCT01345669|580797963|FG000|Overall Study|Lost to Follow-up|1|||
160839422|NCT01345669|580797964|FG001|Overall Study|Lost to Follow-up|1|||
160839423|NCT01345669|580797963|FG000|Overall Study|Withdrawal by Subject|52|||
160839424|NCT01345669|580797964|FG001|Overall Study|Withdrawal by Subject|13|||
160839425|NCT01345669|580797963|FG000|Overall Study|Other Reasons|111|||
160839426|NCT01345669|580797964|FG001|Overall Study|Other Reasons|60|||
160839427|NCT01793883|580797965|FG000|Overall Study|Withdrawal by Subject|3|||
160839428|NCT01793883|580797966|FG001|Overall Study|Withdrawal by Subject|7|||
160839429|NCT01793883|580797967|FG002|Overall Study|Withdrawal by Subject|3|||
160839430|NCT01793883|580797965|FG000|Overall Study|Subject noncompliance|0|||
160839431|NCT01793883|580797966|FG001|Overall Study|Subject noncompliance|1|||
160839432|NCT01793883|580797967|FG002|Overall Study|Subject noncompliance|1|||
160839433|NCT01793883|580797965|FG000|Overall Study|Lost to Follow-up|5|||
160839434|NCT01793883|580797966|FG001|Overall Study|Lost to Follow-up|1|||
160839435|NCT01793883|580797967|FG002|Overall Study|Lost to Follow-up|3|||
160839436|NCT01793883|580797965|FG000|Overall Study|Randomized in error|1|||
160839437|NCT01793883|580797966|FG001|Overall Study|Randomized in error|0|||
160839438|NCT01793883|580797967|FG002|Overall Study|Randomized in error|0|||
160839439|NCT01793883|580797965|FG000|Overall Study|Unable to complete spriometry|1|||
160839440|NCT01793883|580797966|FG001|Overall Study|Unable to complete spriometry|0|||
160839441|NCT01793883|580797967|FG002|Overall Study|Unable to complete spriometry|0|||
160839442|NCT01793883|580797965|FG000|Overall Study|Unable to complete measurements|1|||
160839443|NCT01793883|580797966|FG001|Overall Study|Unable to complete measurements|0|||
160839444|NCT01793883|580797967|FG002|Overall Study|Unable to complete measurements|0|||
160839445|NCT01793883|580797965|FG000|Overall Study|Met exclusion criteria|1|||
160839446|NCT01793883|580797966|FG001|Overall Study|Met exclusion criteria|0|||
160839447|NCT01793883|580797967|FG002|Overall Study|Met exclusion criteria|0|||
160839448|NCT01793883|580797965|FG000|Overall Study|Dosing error|0|||
160839449|NCT01793883|580797966|FG001|Overall Study|Dosing error|1|||
160839450|NCT01793883|580797967|FG002|Overall Study|Dosing error|0|||
160839451|NCT01793883|580797965|FG000|Overall Study|Respiratory distress during spirometry|0|||
160839452|NCT01793883|580797966|FG001|Overall Study|Respiratory distress during spirometry|0|||
160839453|NCT01793883|580797967|FG002|Overall Study|Respiratory distress during spirometry|1|||
160839454|NCT00761527|580797968|FG000|Overall Study|Adverse Event|3|||
160904985|NCT00259610|581046399|FG003|Overall Study|Death|0|||
160904986|NCT00259610|581046396|FG000|Overall Study|non medical reason|6|||
160904987|NCT00259610|581046397|FG001|Overall Study|non medical reason|2|||
160904988|NCT00259610|581046398|FG002|Overall Study|non medical reason|10|||
160904989|NCT00259610|581046399|FG003|Overall Study|non medical reason|3|||
160904990|NCT00259610|581046396|FG000|Overall Study|Adverse Event|3|||
160904991|NCT00259610|581046397|FG001|Overall Study|Adverse Event|4|||
160839455|NCT00761527|580797968|FG000|Overall Study|Poor Compliance|8|||
160839456|NCT00761527|580797968|FG000|Overall Study|Lost to Follow-up|9|||
161250552|NCT01896505|582296910|FG005|Overall Study|Adverse Event|0|||
160839457|NCT00761527|580797968|FG000|Overall Study|Unknown reason|2|||
160839458|NCT02353728|580797969|FG000|Overall Study|Subject non-compliance|1|||
160839459|NCT02301624|580797970|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
160839460|NCT02301624|580797971|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
160839461|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
160839462|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
160839463|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Adverse Event|2|||
160839464|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Adverse Event|5|||
160839465|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Physician Decision|3|||
160904992|NCT00259610|581046398|FG002|Overall Study|Adverse Event|5|||
160904993|NCT00259610|581046399|FG003|Overall Study|Adverse Event|2|||
160839466|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Physician Decision|3|||
161139163|NCT01485614|581892611|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
161139164|NCT01485614|581892612|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
161139165|NCT01485614|581892613|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
161139166|NCT01485614|581892614|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
161139167|NCT01485614|581892611|FG000|Weeks 0-20|Withdrawal by Subject|3|||
161139168|NCT01485614|581892612|FG001|Weeks 0-20|Withdrawal by Subject|2|||
161139169|NCT01485614|581892613|FG002|Weeks 0-20|Withdrawal by Subject|1|||
161139170|NCT01485614|581892614|FG003|Weeks 0-20|Withdrawal by Subject|0|||
161139171|NCT01485614|581892611|FG000|Weeks 20-54|Lost to Follow-up|4|||
161139172|NCT01485614|581892612|FG001|Weeks 20-54|Lost to Follow-up|3|||
161139173|NCT01485614|581892613|FG002|Weeks 20-54|Lost to Follow-up|1|||
161139174|NCT01485614|581892614|FG003|Weeks 20-54|Lost to Follow-up|0|||
161139175|NCT01485614|581892611|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
161139176|NCT01485614|581892612|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
161139177|NCT01485614|581892613|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
161250553|NCT01896505|582296905|FG000|Overall Study|Physician Decision|1|||
160839467|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Death|2|||
160839468|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Death|1|||
160839469|NCT02301624|580797970|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
160839470|NCT02301624|580797971|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
160839471|NCT00895310|580797972|FG000|Overall Study|Withdrawal by Subject|1|||
160839472|NCT02611817|580799648|FG000|Open-label Induction Phase|Reason not Specified|9|||
160839473|NCT02611817|580799649|FG001|Open-label Induction Phase|Reason not Specified|0|||
160839474|NCT02611817|580799650|FG002|Open-label Induction Phase|Reason not Specified|0|||
160839475|NCT02611817|580799648|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
160839476|NCT02611817|580799649|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
160839477|NCT02611817|580799650|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
160839478|NCT02611817|580799648|FG000|Open-label Induction Phase|Pregnancy|1|||
160839479|NCT02611817|580799649|FG001|Open-label Induction Phase|Pregnancy|0|||
161250554|NCT01896505|582296906|FG001|Overall Study|Physician Decision|3|||
161250555|NCT01896505|582296907|FG002|Overall Study|Physician Decision|2|||
161250556|NCT01896505|582296908|FG003|Overall Study|Physician Decision|0|||
161250557|NCT01896505|582296909|FG004|Overall Study|Physician Decision|0|||
161250558|NCT01896505|582296910|FG005|Overall Study|Physician Decision|1|||
161250559|NCT01896505|582296905|FG000|Overall Study|Withdrawal by Subject|1|||
161250560|NCT01896505|582296906|FG001|Overall Study|Withdrawal by Subject|0|||
161250561|NCT01896505|582296907|FG002|Overall Study|Withdrawal by Subject|3|||
161250562|NCT01896505|582296908|FG003|Overall Study|Withdrawal by Subject|1|||
161250563|NCT01896505|582296909|FG004|Overall Study|Withdrawal by Subject|0|||
161250564|NCT01896505|582296910|FG005|Overall Study|Withdrawal by Subject|0|||
161250565|NCT01896505|582296905|FG000|Overall Study|Disease Progression|7|||
161250566|NCT01896505|582296906|FG001|Overall Study|Disease Progression|5|||
161250567|NCT01896505|582296907|FG002|Overall Study|Disease Progression|8|||
161250568|NCT01896505|582296908|FG003|Overall Study|Disease Progression|4|||
161250569|NCT01896505|582296909|FG004|Overall Study|Disease Progression|4|||
161250570|NCT01896505|582296910|FG005|Overall Study|Disease Progression|4|||
161250571|NCT01896505|582296905|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
161250572|NCT01896505|582296906|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
161250573|NCT01896505|582296907|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
161250574|NCT01896505|582296908|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
161250575|NCT01896505|582296909|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
161250576|NCT01896505|582296910|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
161250577|NCT01896505|582296905|FG000|Overall Study|Intercurrent illness|0|||
161250578|NCT01896505|582296906|FG001|Overall Study|Intercurrent illness|1|||
161250579|NCT01896505|582296907|FG002|Overall Study|Intercurrent illness|0|||
161139178|NCT01485614|581892614|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
160839480|NCT02611817|580799650|FG002|Open-label Induction Phase|Pregnancy|0|||
160839481|NCT02611817|580799648|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
160839482|NCT02611817|580799649|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
160839483|NCT02611817|580799650|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
160839484|NCT02611817|580799648|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
160839485|NCT02611817|580799649|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
161250580|NCT01896505|582296908|FG003|Overall Study|Intercurrent illness|0|||
161250581|NCT01896505|582296909|FG004|Overall Study|Intercurrent illness|0|||
161250582|NCT01896505|582296910|FG005|Overall Study|Intercurrent illness|0|||
161250583|NCT01896505|582296905|FG000|Overall Study|Death|0|||
161250584|NCT01896505|582296906|FG001|Overall Study|Death|0|||
161250585|NCT01896505|582296907|FG002|Overall Study|Death|1|||
161250586|NCT01896505|582296908|FG003|Overall Study|Death|1|||
161250587|NCT01896505|582296909|FG004|Overall Study|Death|0|||
161139179|NCT01485614|581892611|FG000|Weeks 20-54|Withdrawal by Subject|5|||
161139180|NCT01485614|581892612|FG001|Weeks 20-54|Withdrawal by Subject|3|||
161250588|NCT01896505|582296910|FG005|Overall Study|Death|1|||
161250589|NCT02063217|582296911|FG000|Overall Study|Withdrawal by Subject|1|||
161250590|NCT02063217|582296912|FG001|Overall Study|Withdrawal by Subject|0|||
161250591|NCT02063217|582296913|FG002|Overall Study|Withdrawal by Subject|0|||
161250592|NCT04291508|582296914|FG000|Overall Study|Withdrawal by Subject|1|||
161250593|NCT04291508|582296915|FG001|Overall Study|Withdrawal by Subject|0|||
161250594|NCT04291508|582296916|FG002|Overall Study|Withdrawal by Subject|1|||
161250595|NCT04291508|582296917|FG003|Overall Study|Withdrawal by Subject|0|||
161250596|NCT04291508|582296914|FG000|Overall Study|lost to follow up|4|||
161250597|NCT04291508|582296915|FG001|Overall Study|lost to follow up|0|||
161250598|NCT04291508|582296916|FG002|Overall Study|lost to follow up|1|||
161250599|NCT04291508|582296917|FG003|Overall Study|lost to follow up|0|||
161250600|NCT03566238|582296918|FG000|Overall Study|Adverse Event|0|||
161250601|NCT03566238|582296919|FG001|Overall Study|Adverse Event|0|||
161250602|NCT03566238|582296920|FG002|Overall Study|Adverse Event|1|||
161250603|NCT03566238|582296918|FG000|Overall Study|Lack of Efficacy|5|||
161250604|NCT03566238|582296919|FG001|Overall Study|Lack of Efficacy|4|||
161250605|NCT03566238|582296920|FG002|Overall Study|Lack of Efficacy|2|||
161250606|NCT03566238|582296918|FG000|Overall Study|Other|0|||
161250607|NCT03566238|582296919|FG001|Overall Study|Other|1|||
161250608|NCT03566238|582296920|FG002|Overall Study|Other|0|||
161250609|NCT00593827|582296927|FG000|Overall Study|On Active Treatment/Pending|0|||
161250610|NCT00593827|582296928|FG001|Overall Study|On Active Treatment/Pending|2|||
161250611|NCT00089973|582296929|FG000|Overall Study|Adverse Event|3|||
161250612|NCT00089973|582296929|FG000|Overall Study|Withdrawal by Subject|1|||
161250613|NCT00089973|582296929|FG000|Overall Study|Disease progression|45|||
161250614|NCT00089973|582296929|FG000|Overall Study|Death|1|||
161250615|NCT01049581|582296933|FG000|Overall Study|Lost to Follow-up|2|||
161250616|NCT01049581|582296934|FG001|Overall Study|Lost to Follow-up|1|||
161250617|NCT00653159|582298441|FG000|Overall Study|Adverse Event|4|||
161250618|NCT00653159|582298442|FG001|Overall Study|Adverse Event|1|||
161250619|NCT00653159|582298441|FG000|Overall Study|Lost to Follow-up|1|||
161250620|NCT00653159|582298442|FG001|Overall Study|Lost to Follow-up|2|||
161250621|NCT01872715|582298443|FG000|Overall Study|Adverse Event|1|||
161250622|NCT01872715|582298443|FG000|Overall Study|Protocol Violation|1|||
161250623|NCT01872715|582298443|FG000|Overall Study|Withdrawal by Subject|2|||
161250624|NCT01848210|582298444|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
161250625|NCT01848210|582298445|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
161250626|NCT01848210|582298444|FG000|Overall Study|Lost to Follow-up|24|||
161250627|NCT01848210|582298445|FG001|Overall Study|Lost to Follow-up|12|||
161250628|NCT01848210|582298444|FG000|Overall Study|Protocol Violation|3|||
161250629|NCT01848210|582298445|FG001|Overall Study|Protocol Violation|5|||
161250630|NCT01848210|582298444|FG000|Overall Study|Use of Forbidden Drugs|9|||
161250631|NCT01848210|582298445|FG001|Overall Study|Use of Forbidden Drugs|10|||
161250632|NCT01848210|582298444|FG000|Overall Study|Impedition Condition|5|||
161250633|NCT01848210|582298445|FG001|Overall Study|Impedition Condition|9|||
161250634|NCT01848210|582298444|FG000|Overall Study|Adverse Event|7|||
161250635|NCT01848210|582298445|FG001|Overall Study|Adverse Event|9|||
161250636|NCT01848210|582298444|FG000|Overall Study|Discontinuation Criterion|5|||
161250637|NCT01848210|582298445|FG001|Overall Study|Discontinuation Criterion|7|||
161250638|NCT01848210|582298444|FG000|Overall Study|Hypesensitivity|1|||
161250639|NCT01848210|582298445|FG001|Overall Study|Hypesensitivity|0|||
161250640|NCT01848210|582298444|FG000|Overall Study|Hepatic Function Alteration|4|||
161250641|NCT01848210|582298445|FG001|Overall Study|Hepatic Function Alteration|0|||
160839486|NCT02611817|580799650|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
160991927|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
161250642|NCT01848210|582298444|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
161250643|NCT01848210|582298445|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
161250644|NCT01848210|582298444|FG000|Overall Study|Administrative|1|||
161250645|NCT01848210|582298445|FG001|Overall Study|Administrative|0|||
161250646|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
161250647|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
161250648|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
161250649|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
161250650|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
161250651|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
161250652|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
161250653|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
161250654|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
161250655|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
161250656|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
161250657|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
161250658|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
161250659|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
161250660|NCT04592419|582298446|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
161250661|NCT04592419|582298447|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
161334980|NCT01673178|582615888|FG004|Overall Study|Lost to Follow-up|0|||
160839487|NCT02611817|580799648|FG000|Open-label Induction Phase|Protocol Violation|5|||
160839488|NCT02611817|580799649|FG001|Open-label Induction Phase|Protocol Violation|0|||
160839489|NCT02611817|580799650|FG002|Open-label Induction Phase|Protocol Violation|0|||
160839490|NCT02611817|580799648|FG000|Open-label Induction Phase|Adverse Event|16|||
160839491|NCT02611817|580799649|FG001|Open-label Induction Phase|Adverse Event|0|||
160839492|NCT02611817|580799650|FG002|Open-label Induction Phase|Adverse Event|0|||
160839493|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
160839494|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
160839495|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
160839496|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
160839497|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
160839498|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
160839499|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
160839500|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
160839501|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
160839502|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
160839503|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
160839504|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
160839505|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
160839506|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
160839507|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
160839508|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
160839509|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
160839510|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
160839511|NCT02611817|580799648|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
160839512|NCT02611817|580799649|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
160839513|NCT02611817|580799650|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
160904994|NCT00259610|581046396|FG000|Overall Study|Serious Adverse Event|8|||
160904995|NCT00259610|581046397|FG001|Overall Study|Serious Adverse Event|2|||
160904996|NCT00259610|581046398|FG002|Overall Study|Serious Adverse Event|2|||
160904997|NCT00259610|581046399|FG003|Overall Study|Serious Adverse Event|2|||
160904998|NCT00282984|581046403|FG000|Overall Study|Death|2|||
160904999|NCT00282984|581046404|FG001|Overall Study|Death|5|||
160905000|NCT00282984|581046403|FG000|Overall Study|Adverse Event|8|||
160839514|NCT03077919|580799651|FG000|Overall Study|Lost to Follow-up|4|||
160839515|NCT03077919|580799652|FG001|Overall Study|Lost to Follow-up|1|||
160905001|NCT00282984|581046404|FG001|Overall Study|Adverse Event|5|||
160905002|NCT00282984|581046403|FG000|Overall Study|Lack of Efficacy|0|||
160905003|NCT00282984|581046404|FG001|Overall Study|Lack of Efficacy|2|||
160905004|NCT00282984|581046403|FG000|Overall Study|Lost to Follow-up|14|||
160905005|NCT00282984|581046404|FG001|Overall Study|Lost to Follow-up|10|||
160905006|NCT00282984|581046403|FG000|Overall Study|Withdrawal by Participant|22|||
160905007|NCT00282984|581046404|FG001|Overall Study|Withdrawal by Participant|34|||
160905008|NCT00282984|581046403|FG000|Overall Study|Participant stopped study medication|2|||
160905009|NCT00282984|581046404|FG001|Overall Study|Participant stopped study medication|2|||
160905010|NCT00282984|581046403|FG000|Overall Study|Participant only allowed phone follow-up|0|||
160905011|NCT00282984|581046404|FG001|Overall Study|Participant only allowed phone follow-up|1|||
160905012|NCT00282984|581046403|FG000|Overall Study|Participant used antipsychosis meds|0|||
160905013|NCT00282984|581046404|FG001|Overall Study|Participant used antipsychosis meds|1|||
160905014|NCT00282984|581046403|FG000|Overall Study|lack of motivation|1|||
160905015|NCT00282984|581046404|FG001|Overall Study|lack of motivation|0|||
160905016|NCT00282984|581046403|FG000|Overall Study|in prison|0|||
160905017|NCT00282984|581046404|FG001|Overall Study|in prison|1|||
160905018|NCT00282984|581046403|FG000|Overall Study|Protocol Violation|2|||
160905019|NCT00282984|581046404|FG001|Overall Study|Protocol Violation|0|||
160905020|NCT00868608|581046405|FG000|Overall Study|Withdrawal by Subject|3|||
160905021|NCT00868608|581046406|FG001|Overall Study|Withdrawal by Subject|1|||
160905022|NCT00868608|581046407|FG002|Overall Study|Withdrawal by Subject|0|||
160905023|NCT00868608|581046405|FG000|Overall Study|Lost to Follow-up|3|||
160905024|NCT00868608|581046406|FG001|Overall Study|Lost to Follow-up|0|||
160905025|NCT00868608|581046407|FG002|Overall Study|Lost to Follow-up|1|||
160905026|NCT00868608|581046405|FG000|Overall Study|Death|16|||
160905027|NCT00868608|581046406|FG001|Overall Study|Death|2|||
160905028|NCT00868608|581046407|FG002|Overall Study|Death|4|||
160839516|NCT03738618|580799653|FG000|Overall Study|Protocol deviation|23|||
160905029|NCT00868608|581046405|FG000|Overall Study|Other - Unspecified|1|||
160905030|NCT00868608|581046406|FG001|Overall Study|Other - Unspecified|0|||
160905031|NCT00868608|581046407|FG002|Overall Study|Other - Unspecified|0|||
160905032|NCT00457301|581046408|FG000|Overall Study|Withdrawal by Subject|3|||
160905033|NCT00457301|581046409|FG001|Overall Study|Withdrawal by Subject|3|||
160905034|NCT00457301|581046408|FG000|Overall Study|Censored out of the study|15|||
160905035|NCT00457301|581046409|FG001|Overall Study|Censored out of the study|14|||
160905036|NCT00457301|581046408|FG000|Overall Study|Death|5|||
160905037|NCT00457301|581046409|FG001|Overall Study|Death|7|||
160905038|NCT00191269|581046410|FG000|Overall Study|Protocol Violation|0|||
161250662|NCT04592419|582298446|FG000|Open-Label Extension Period|Adverse Event|1|||
161250663|NCT04592419|582298447|FG001|Open-Label Extension Period|Adverse Event|2|||
161250664|NCT04592419|582298446|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
160839517|NCT03738618|580799654|FG001|Overall Study|Protocol deviation|0|||
160839518|NCT03738618|580799653|FG000|Overall Study|Adverse Event|4|||
160839519|NCT03738618|580799654|FG001|Overall Study|Adverse Event|0|||
160839520|NCT03738618|580799653|FG000|Overall Study|Lost to Follow-up|2|||
160839521|NCT03738618|580799654|FG001|Overall Study|Lost to Follow-up|0|||
160839522|NCT03738618|580799653|FG000|Overall Study|Randomization failure|1|||
160839523|NCT03738618|580799654|FG001|Overall Study|Randomization failure|0|||
160839524|NCT03738618|580799653|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
160839525|NCT03738618|580799654|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
160839526|NCT03738618|580799653|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
160839527|NCT03738618|580799654|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
160839528|NCT00826618|580799655|FG000|Overall Study|Withdrawal by Subject|1|||
160839529|NCT01487265|580799660|FG000|Overall Study|Adverse Event|8|||
160839530|NCT01487265|580799660|FG000|Overall Study|Withdrawal by Subject|5|||
160839531|NCT01487265|580799660|FG000|Overall Study|Disease Progression|21|||
160839532|NCT01487265|580799660|FG000|Overall Study|Death|2|||
160839533|NCT01487265|580799660|FG000|Overall Study|Still on Treatment|1|||
160839534|NCT01016600|580799661|FG000|Overall Study|Did not start treatment|1|||
160839535|NCT01016600|580799662|FG001|Overall Study|Did not start treatment|0|||
160839536|NCT01016600|580799663|FG002|Overall Study|Did not start treatment|0|||
160839537|NCT01016600|580799664|FG003|Overall Study|Did not start treatment|0|||
160839538|NCT01271725|580799667|FG000|Part A|Progressive disease according to RECIST|8|||
160839539|NCT01271725|580799668|FG001|Part A|Progressive disease according to RECIST|0|||
160839540|NCT01271725|580799667|FG000|Part A|Clinical signs/symptoms of progression|2|||
160839541|NCT01271725|580799668|FG001|Part A|Clinical signs/symptoms of progression|0|||
160839542|NCT01271725|580799667|FG000|Part A|Other Adverse Event|8|||
160839543|NCT01271725|580799668|FG001|Part A|Other Adverse Event|0|||
160839544|NCT01271725|580799667|FG000|Part A|Lost to Follow-up|1|||
160839545|NCT01271725|580799668|FG001|Part A|Lost to Follow-up|0|||
160839546|NCT01271725|580799667|FG000|Part A|Withdrawal by Subject|12|||
160839547|NCT01271725|580799668|FG001|Part A|Withdrawal by Subject|0|||
160839548|NCT01271725|580799667|FG000|Part A|Other than specified|3|||
160839549|NCT01271725|580799668|FG001|Part A|Other than specified|0|||
160905039|NCT00191269|581046411|FG001|Overall Study|Protocol Violation|2|||
160905040|NCT00191269|581046410|FG000|Overall Study|Adverse Event|1|||
160905041|NCT00191269|581046411|FG001|Overall Study|Adverse Event|4|||
160905042|NCT00191269|581046410|FG000|Overall Study|Progression of Disease|4|||
160905043|NCT00191269|581046411|FG001|Overall Study|Progression of Disease|42|||
160905044|NCT00191269|581046410|FG000|Overall Study|Lack of Efficacy|1|||
160905045|NCT00191269|581046411|FG001|Overall Study|Lack of Efficacy|5|||
160905046|NCT00191269|581046410|FG000|Overall Study|Withdrawal by Subject|0|||
160905047|NCT00191269|581046411|FG001|Overall Study|Withdrawal by Subject|1|||
160905048|NCT00191269|581046410|FG000|Overall Study|Pathologic Aggrevation|0|||
160905049|NCT00191269|581046411|FG001|Overall Study|Pathologic Aggrevation|1|||
160905050|NCT00191269|581046410|FG000|Overall Study|Physician Decision|0|||
160905051|NCT00191269|581046411|FG001|Overall Study|Physician Decision|3|||
160905052|NCT00674362|581046412|FG000|Double Blind|Adverse Event|6|||
160905053|NCT00674362|581046413|FG001|Double Blind|Adverse Event|6|||
160905054|NCT00674362|581046412|FG000|Double Blind|Lack of Efficacy|2|||
160905055|NCT00674362|581046413|FG001|Double Blind|Lack of Efficacy|6|||
160905056|NCT00674362|581046412|FG000|Double Blind|Loss of efficacy|0|||
160905057|NCT00674362|581046413|FG001|Double Blind|Loss of efficacy|1|||
160905058|NCT00674362|581046412|FG000|Double Blind|Withdrawal by Subject|4|||
160905059|NCT00674362|581046413|FG001|Double Blind|Withdrawal by Subject|3|||
160905060|NCT00674362|581046412|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
160905061|NCT00674362|581046413|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
160905062|NCT00674362|581046412|FG000|Double Blind|Other: Surgery|0|||
160905063|NCT00674362|581046413|FG001|Double Blind|Other: Surgery|1|||
160905064|NCT00674362|581046412|FG000|Open Label|Adverse Event|1|||
160905065|NCT00674362|581046413|FG001|Open Label|Adverse Event|0|||
160905066|NCT00674362|581046412|FG000|Open Label|Other: Subject moved to extension study|1|||
160905067|NCT00674362|581046413|FG001|Open Label|Other: Subject moved to extension study|0|||
160905068|NCT00939770|581046416|FG000|Overall Study|Adverse Event|1|||
160905069|NCT00939770|581046417|FG001|Overall Study|Adverse Event|1|||
160905070|NCT00939770|581046418|FG002|Overall Study|Adverse Event|0|||
160905071|NCT00939770|581046419|FG003|Overall Study|Adverse Event|0|||
161250665|NCT04592419|582298447|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
160839550|NCT01271725|580799667|FG000|Part A|Protocol Violation|1|||
160839551|NCT01271725|580799668|FG001|Part A|Protocol Violation|0|||
160839552|NCT01271725|580799667|FG000|Part B|Other than specified|0|||
160905072|NCT00939770|581046420|FG004|Overall Study|Adverse Event|6|||
160996830|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
160839553|NCT01271725|580799668|FG001|Part B|Other than specified|2|||
160839554|NCT01271725|580799667|FG000|Part B|Clinical signs/symptoms of progression|0|||
160839555|NCT01271725|580799668|FG001|Part B|Clinical signs/symptoms of progression|2|||
160839556|NCT01271725|580799667|FG000|Part B|Other Adverse Event|0|||
160839557|NCT01271725|580799668|FG001|Part B|Other Adverse Event|1|||
160839558|NCT01271725|580799667|FG000|Part B|Protocol Violation|0|||
160839559|NCT01271725|580799668|FG001|Part B|Protocol Violation|1|||
160839560|NCT01271725|580799667|FG000|Part B|Withdrawal by Subject|0|||
160839561|NCT01271725|580799668|FG001|Part B|Withdrawal by Subject|6|||
160839562|NCT00801229|580799669|FG000|Signed Consent|Withdrawal by Subject|2|||
160839563|NCT00801229|580799670|FG001|Signed Consent|Withdrawal by Subject|2|||
160839564|NCT00801229|580799669|FG000|Signed Consent|Found Ineligible|1|||
160839565|NCT00801229|580799670|FG001|Signed Consent|Found Ineligible|1|||
160839566|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
160839567|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
160839568|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
161139181|NCT01485614|581892613|FG002|Weeks 20-54|Withdrawal by Subject|0|||
161139182|NCT01485614|581892614|FG003|Weeks 20-54|Withdrawal by Subject|0|||
161139183|NCT00733902|581892615|FG000|Overall Study|Death|0|||
161139184|NCT00733902|581892616|FG001|Overall Study|Death|0|||
161139185|NCT00733902|581892617|FG002|Overall Study|Death|0|||
161139186|NCT00733902|581892618|FG003|Overall Study|Death|1|||
161139187|NCT00733902|581892615|FG000|Overall Study|Adverse Event|3|||
161139188|NCT00733902|581892616|FG001|Overall Study|Adverse Event|4|||
161139189|NCT00733902|581892617|FG002|Overall Study|Adverse Event|7|||
161139190|NCT00733902|581892618|FG003|Overall Study|Adverse Event|11|||
161139191|NCT00733902|581892615|FG000|Overall Study|Lack of Efficacy|56|||
161139192|NCT00733902|581892616|FG001|Overall Study|Lack of Efficacy|21|||
161139193|NCT00733902|581892617|FG002|Overall Study|Lack of Efficacy|34|||
161139194|NCT00733902|581892618|FG003|Overall Study|Lack of Efficacy|23|||
161139195|NCT00733902|581892615|FG000|Overall Study|Protocol Violation|4|||
161139196|NCT00733902|581892616|FG001|Overall Study|Protocol Violation|6|||
161139197|NCT00733902|581892617|FG002|Overall Study|Protocol Violation|3|||
161139198|NCT00733902|581892618|FG003|Overall Study|Protocol Violation|3|||
161139199|NCT00733902|581892615|FG000|Overall Study|Withdrawal by Subject|10|||
161139200|NCT00733902|581892616|FG001|Overall Study|Withdrawal by Subject|5|||
161139201|NCT00733902|581892617|FG002|Overall Study|Withdrawal by Subject|4|||
161139202|NCT00733902|581892618|FG003|Overall Study|Withdrawal by Subject|16|||
161139203|NCT00733902|581892615|FG000|Overall Study|Entered extension study|89|||
161139204|NCT00733902|581892616|FG001|Overall Study|Entered extension study|124|||
161139205|NCT00733902|581892617|FG002|Overall Study|Entered extension study|111|||
161139206|NCT00733902|581892618|FG003|Overall Study|Entered extension study|109|||
161139207|NCT00733902|581892615|FG000|Overall Study|Randomized but not treated|2|||
161139208|NCT00733902|581892616|FG001|Overall Study|Randomized but not treated|2|||
161139209|NCT00733902|581892617|FG002|Overall Study|Randomized but not treated|2|||
161139210|NCT00733902|581892618|FG003|Overall Study|Randomized but not treated|1|||
161139211|NCT01503021|581892623|FG000|Overall Study|Adverse Event|7|||
161139212|NCT01503021|581892624|FG001|Overall Study|Adverse Event|6|||
161139213|NCT01503021|581892623|FG000|Overall Study|Death|0|||
161139214|NCT01503021|581892624|FG001|Overall Study|Death|2|||
161139215|NCT01503021|581892623|FG000|Overall Study|Lost to Follow-up|2|||
161139216|NCT01503021|581892624|FG001|Overall Study|Lost to Follow-up|0|||
161139217|NCT01503021|581892623|FG000|Overall Study|Physician Decision|3|||
161139218|NCT01503021|581892624|FG001|Overall Study|Physician Decision|0|||
161139219|NCT01503021|581892623|FG000|Overall Study|Protocol Violation|1|||
161139220|NCT01503021|581892624|FG001|Overall Study|Protocol Violation|3|||
161139221|NCT01503021|581892623|FG000|Overall Study|Withdrawal by Subject|9|||
161139222|NCT01503021|581892624|FG001|Overall Study|Withdrawal by Subject|8|||
161139223|NCT01503021|581892623|FG000|Overall Study|Moved, received transplant, etc.|5|||
161139224|NCT01503021|581892624|FG001|Overall Study|Moved, received transplant, etc.|7|||
161139225|NCT03941548|581892625|FG000|Overall Study|Adverse Event|0|||
161139226|NCT03941548|581892626|FG001|Overall Study|Adverse Event|1|||
160839569|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
160839570|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
160839571|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
161139227|NCT03941548|581892625|FG000|Overall Study|Lost to Follow-up|0|||
161139228|NCT03941548|581892626|FG001|Overall Study|Lost to Follow-up|1|||
161139229|NCT03941548|581892625|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
161139230|NCT03941548|581892626|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
161139231|NCT00870688|581892628|FG000|Overall Study|Lost to Follow-up|2|||
161139232|NCT00870688|581892628|FG000|Overall Study|Death, Unrelated|1|||
160839572|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
160839573|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
160839574|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
160839575|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
160991928|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
161139233|NCT00870688|581892628|FG000|Overall Study|Granules in the Stools|1|||
161139234|NCT02015819|581892629|FG000|Overall Study|Rickham catheter was misaligned|0|||
161139235|NCT02015819|581892630|FG001|Overall Study|Rickham catheter was misaligned|0|||
160839576|NCT00801229|580799669|FG000|Received Study Drug/Placebo|Adverse Event|1|||
160839577|NCT00801229|580799670|FG001|Received Study Drug/Placebo|Adverse Event|1|||
160839578|NCT03826186|580799671|FG000|Overall Study|Protocol Violation|2|||
160839579|NCT03826186|580799672|FG001|Overall Study|Protocol Violation|0|||
160839580|NCT03826186|580799671|FG000|Overall Study|Withdrawal by Subject|1|||
160839581|NCT03826186|580799672|FG001|Overall Study|Withdrawal by Subject|0|||
160839582|NCT02950480|580799675|FG000|Overall Study|Withdrawal by Subject|1|||
160839583|NCT02950480|580799676|FG001|Overall Study|Withdrawal by Subject|0|||
160839584|NCT01363661|580799677|FG000|Overall Study|Adverse Event|9|||
160839585|NCT01363661|580799678|FG001|Overall Study|Adverse Event|2|||
160839586|NCT01363661|580799677|FG000|Overall Study|Withdrawal by Subject|1|||
160839587|NCT01363661|580799678|FG001|Overall Study|Withdrawal by Subject|1|||
160839588|NCT01363661|580799677|FG000|Overall Study|Protocol Violation|1|||
160839589|NCT01363661|580799678|FG001|Overall Study|Protocol Violation|0|||
160839590|NCT01363661|580799677|FG000|Overall Study|Lost to Follow-up|3|||
160839591|NCT01363661|580799678|FG001|Overall Study|Lost to Follow-up|1|||
160839592|NCT01959139|580799681|FG000|Phase II|Disease progression|0|||
160839593|NCT01959139|580799682|FG001|Phase II|Disease progression|0|||
160839594|NCT01959139|580799683|FG002|Phase II|Disease progression|26|||
160839595|NCT01959139|580799684|FG003|Phase II|Disease progression|34|||
160839596|NCT01959139|580799681|FG000|Phase II|Adverse Event|0|||
160839597|NCT01959139|580799682|FG001|Phase II|Adverse Event|0|||
160839598|NCT01959139|580799683|FG002|Phase II|Adverse Event|10|||
160839599|NCT01959139|580799684|FG003|Phase II|Adverse Event|11|||
160839600|NCT01959139|580799681|FG000|Phase II|Patient Refusal|0|||
160839601|NCT01959139|580799682|FG001|Phase II|Patient Refusal|0|||
160839602|NCT01959139|580799683|FG002|Phase II|Patient Refusal|5|||
160839603|NCT01959139|580799684|FG003|Phase II|Patient Refusal|4|||
160839604|NCT01959139|580799681|FG000|Phase II|Death|0|||
160839605|NCT01959139|580799682|FG001|Phase II|Death|0|||
160839606|NCT01959139|580799683|FG002|Phase II|Death|3|||
160839607|NCT01959139|580799684|FG003|Phase II|Death|1|||
160839608|NCT01959139|580799681|FG000|Phase II|Other/Unknown|0|||
160839609|NCT01959139|580799682|FG001|Phase II|Other/Unknown|0|||
160839610|NCT01959139|580799683|FG002|Phase II|Other/Unknown|8|||
160839611|NCT01959139|580799684|FG003|Phase II|Other/Unknown|5|||
160839612|NCT01959139|580799681|FG000|Phase II|On treatment|0|||
160839613|NCT01959139|580799682|FG001|Phase II|On treatment|0|||
160839614|NCT01959139|580799683|FG002|Phase II|On treatment|4|||
160839615|NCT01959139|580799684|FG003|Phase II|On treatment|0|||
160839616|NCT01378325|580799687|FG000|Overall Study|Protocol Violation|0|||
160839617|NCT01378325|580799688|FG001|Overall Study|Protocol Violation|1|||
160839618|NCT01559675|580799689|FG000|Overall Study|Protocol Violation|1|||
160839619|NCT01559675|580799690|FG001|Overall Study|Protocol Violation|2|||
160905073|NCT00939770|581046421|FG005|Overall Study|Adverse Event|2|||
160905074|NCT00939770|581046422|FG006|Overall Study|Adverse Event|1|||
160905075|NCT00939770|581046423|FG007|Overall Study|Adverse Event|1|||
160905076|NCT00939770|581046416|FG000|Overall Study|Lack of Efficacy|4|||
161139236|NCT02015819|581892631|FG002|Overall Study|Rickham catheter was misaligned|0|||
161139237|NCT02015819|581892632|FG003|Overall Study|Rickham catheter was misaligned|1|||
160839620|NCT01559675|580799689|FG000|Overall Study|2nd operation on same patient excluded|14|||
160839621|NCT01559675|580799690|FG001|Overall Study|2nd operation on same patient excluded|12|||
160839622|NCT01496469|580799691|FG000|Overall Study|Adverse Event|1|||
160839623|NCT01496469|580799692|FG001|Overall Study|Adverse Event|0|||
160839624|NCT01496469|580799691|FG000|Overall Study|Protocol Violation|2|||
160839625|NCT01496469|580799692|FG001|Overall Study|Protocol Violation|0|||
160839626|NCT01496469|580799691|FG000|Overall Study|Lost to Follow-up|1|||
160905077|NCT00939770|581046417|FG001|Overall Study|Lack of Efficacy|6|||
161139238|NCT01486264|581892637|FG000|Overall Study|Death|1|||
160839627|NCT01496469|580799692|FG001|Overall Study|Lost to Follow-up|1|||
160839628|NCT01496469|580799691|FG000|Overall Study|Withdrawal by Subject|4|||
161139239|NCT01486264|581892638|FG001|Overall Study|Death|1|||
161139240|NCT01486264|581892637|FG000|Overall Study|Adverse Event|3|||
161139241|NCT01486264|581892638|FG001|Overall Study|Adverse Event|3|||
161139242|NCT01486264|581892637|FG000|Overall Study|Lack of Efficacy|6|||
161139243|NCT01486264|581892638|FG001|Overall Study|Lack of Efficacy|10|||
161139244|NCT01486264|581892637|FG000|Overall Study|Withdrawal by Subject|7|||
161139245|NCT01486264|581892638|FG001|Overall Study|Withdrawal by Subject|18|||
161139246|NCT01486264|581892637|FG000|Overall Study|Physician Decision|1|||
161139247|NCT01486264|581892638|FG001|Overall Study|Physician Decision|1|||
161139248|NCT01486264|581892637|FG000|Overall Study|Protocol Violation|3|||
161139249|NCT01486264|581892638|FG001|Overall Study|Protocol Violation|0|||
161139250|NCT01486264|581892637|FG000|Overall Study|Lost to Follow-up|3|||
161139251|NCT01486264|581892638|FG001|Overall Study|Lost to Follow-up|2|||
161139252|NCT01486264|581892637|FG000|Overall Study|Other|5|||
161139253|NCT01486264|581892638|FG001|Overall Study|Other|11|||
161139254|NCT01486264|581892637|FG000|Overall Study|Not treated|0|||
161139255|NCT01486264|581892638|FG001|Overall Study|Not treated|1|||
161139256|NCT03584009|581892639|FG000|Overall Study|Death|25|||
161139257|NCT03584009|581892640|FG001|Overall Study|Death|18|||
161139258|NCT03584009|581892639|FG000|Overall Study|Lost to Follow-up|0|||
160839629|NCT01496469|580799692|FG001|Overall Study|Withdrawal by Subject|4|||
160839630|NCT01496469|580799691|FG000|Overall Study|BP exceeds protocol limits|1|||
160839631|NCT01496469|580799692|FG001|Overall Study|BP exceeds protocol limits|2|||
160839632|NCT01496469|580799691|FG000|Overall Study|Other|1|||
160839633|NCT01496469|580799692|FG001|Overall Study|Other|1|||
160839634|NCT00193180|580799696|FG000|Overall Study|Lack of Efficacy|1|||
160839635|NCT00193180|580799696|FG000|Overall Study|Adverse Event|8|||
160839636|NCT00193180|580799696|FG000|Overall Study|Protocol Violation|1|||
160839637|NCT02219334|580799697|FG000|Overall Study|Withdrawal by Subject|1|||
160839638|NCT02219334|580799698|FG001|Overall Study|Withdrawal by Subject|0|||
160839639|NCT02219334|580799697|FG000|Overall Study|Protocol Violation|7|||
160839640|NCT02219334|580799698|FG001|Overall Study|Protocol Violation|3|||
160839641|NCT00891228|580799700|FG000|Overall Study|Adverse Event|0|||
160839642|NCT00891228|580799701|FG001|Overall Study|Adverse Event|2|||
160839643|NCT00891228|580799702|FG002|Overall Study|Adverse Event|3|||
160839644|NCT00891228|580799700|FG000|Overall Study|Withdrawal by Subject|2|||
160839645|NCT00891228|580799701|FG001|Overall Study|Withdrawal by Subject|4|||
160839646|NCT00891228|580799702|FG002|Overall Study|Withdrawal by Subject|5|||
160839647|NCT00891228|580799700|FG000|Overall Study|Protocol Violation|3|||
160839648|NCT00891228|580799701|FG001|Overall Study|Protocol Violation|1|||
160839649|NCT00891228|580799702|FG002|Overall Study|Protocol Violation|2|||
160839650|NCT00891228|580799700|FG000|Overall Study|Physician Decision|2|||
160839651|NCT00891228|580799701|FG001|Overall Study|Physician Decision|1|||
160839652|NCT00891228|580799702|FG002|Overall Study|Physician Decision|0|||
160839653|NCT00891228|580799700|FG000|Overall Study|Lost to Follow-up|4|||
160839654|NCT00891228|580799701|FG001|Overall Study|Lost to Follow-up|4|||
160839655|NCT00891228|580799702|FG002|Overall Study|Lost to Follow-up|5|||
160839656|NCT00891228|580799700|FG000|Overall Study|Pregnancy|0|||
160839657|NCT00891228|580799701|FG001|Overall Study|Pregnancy|1|||
160839658|NCT00891228|580799702|FG002|Overall Study|Pregnancy|0|||
160839659|NCT02688985|580799711|FG000|Overall Study|Adverse Event|1|||
160839660|NCT02688985|580799712|FG001|Overall Study|Adverse Event|2|||
160839661|NCT02688985|580799713|FG002|Overall Study|Adverse Event|2|||
160839662|NCT02688985|580799714|FG003|Overall Study|Adverse Event|0|||
160839663|NCT02688985|580799715|FG004|Overall Study|Adverse Event|0|||
160839664|NCT02688985|580799711|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
160839665|NCT02688985|580799712|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
160839666|NCT02688985|580799713|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
160839667|NCT02688985|580799714|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
160839668|NCT02688985|580799715|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
160839669|NCT02688985|580799711|FG000|Overall Study|Death|0|||
160839670|NCT02688985|580799712|FG001|Overall Study|Death|0|||
160839671|NCT02688985|580799713|FG002|Overall Study|Death|0|||
160839672|NCT02688985|580799714|FG003|Overall Study|Death|0|||
160839673|NCT02688985|580799715|FG004|Overall Study|Death|1|||
160839674|NCT02688985|580799711|FG000|Overall Study|Lack of Efficacy|0|||
160839675|NCT02688985|580799712|FG001|Overall Study|Lack of Efficacy|0|||
160839676|NCT02688985|580799713|FG002|Overall Study|Lack of Efficacy|0|||
160839677|NCT02688985|580799714|FG003|Overall Study|Lack of Efficacy|0|||
160839678|NCT02688985|580799715|FG004|Overall Study|Lack of Efficacy|1|||
160839679|NCT02688985|580799711|FG000|Overall Study|Lost to Follow-up|2|||
160839680|NCT02688985|580799712|FG001|Overall Study|Lost to Follow-up|0|||
160839681|NCT02688985|580799713|FG002|Overall Study|Lost to Follow-up|1|||
160839682|NCT02688985|580799714|FG003|Overall Study|Lost to Follow-up|1|||
160839683|NCT02688985|580799715|FG004|Overall Study|Lost to Follow-up|1|||
160839684|NCT02688985|580799711|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160839685|NCT02688985|580799712|FG001|Overall Study|Non-Compliance With Study Drug|3|||
160839686|NCT02688985|580799713|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160839687|NCT02688985|580799714|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160839688|NCT02688985|580799715|FG004|Overall Study|Non-Compliance With Study Drug|1|||
160839689|NCT02688985|580799711|FG000|Overall Study|Other|3|||
160839690|NCT02688985|580799712|FG001|Overall Study|Other|4|||
161250666|NCT04592419|582298446|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
160839691|NCT02688985|580799713|FG002|Overall Study|Other|1|||
160839692|NCT02688985|580799714|FG003|Overall Study|Other|0|||
160839693|NCT02688985|580799715|FG004|Overall Study|Other|0|||
160839694|NCT02688985|580799711|FG000|Overall Study|Physician Decision|2|||
160839695|NCT02688985|580799712|FG001|Overall Study|Physician Decision|2|||
160839696|NCT02688985|580799713|FG002|Overall Study|Physician Decision|0|||
160839697|NCT02688985|580799714|FG003|Overall Study|Physician Decision|0|||
160839698|NCT02688985|580799715|FG004|Overall Study|Physician Decision|1|||
160839699|NCT02688985|580799711|FG000|Overall Study|Pregnancy|0|||
160839700|NCT02688985|580799712|FG001|Overall Study|Pregnancy|0|||
160839701|NCT02688985|580799713|FG002|Overall Study|Pregnancy|2|||
160839702|NCT02688985|580799714|FG003|Overall Study|Pregnancy|1|||
160839703|NCT02688985|580799715|FG004|Overall Study|Pregnancy|0|||
160839704|NCT02688985|580799711|FG000|Overall Study|Study Terminated By Sponsor|0|||
160839705|NCT02688985|580799712|FG001|Overall Study|Study Terminated By Sponsor|0|||
160839706|NCT02688985|580799713|FG002|Overall Study|Study Terminated By Sponsor|0|||
161139259|NCT03584009|581892640|FG001|Overall Study|Lost to Follow-up|1|||
161139260|NCT03584009|581892639|FG000|Overall Study|Physician Decision|1|||
161139261|NCT03584009|581892640|FG001|Overall Study|Physician Decision|1|||
161139262|NCT03584009|581892639|FG000|Overall Study|Study Terminated by Sponsor|22|||
161139263|NCT03584009|581892640|FG001|Overall Study|Study Terminated by Sponsor|30|||
161139264|NCT03584009|581892639|FG000|Overall Study|Withdrawal by Subject|3|||
161139265|NCT03584009|581892640|FG001|Overall Study|Withdrawal by Subject|2|||
161139266|NCT04112914|581892641|FG000|Overall Study|Lost to Follow-up|13|||
161139267|NCT04112914|581892642|FG001|Overall Study|Lost to Follow-up|9|||
161139268|NCT04112914|581892641|FG000|Overall Study|Withdrawal by Subject|1|||
161139269|NCT04112914|581892642|FG001|Overall Study|Withdrawal by Subject|0|||
161139270|NCT00768560|581892643|FG000|Intervention Set 1|Adverse Event|0|||
161139271|NCT00768560|581892644|FG001|Intervention Set 1|Adverse Event|1|||
161139272|NCT00768560|581892645|FG002|Intervention Set 1|Adverse Event|0|||
161139273|NCT00768560|581892646|FG003|Intervention Set 1|Adverse Event|0|||
161139274|NCT00768560|581892647|FG004|Intervention Set 1|Adverse Event|0|||
161139275|NCT00768560|581892648|FG005|Intervention Set 1|Adverse Event|0|||
160839707|NCT02688985|580799714|FG003|Overall Study|Study Terminated By Sponsor|1|||
160839708|NCT02688985|580799715|FG004|Overall Study|Study Terminated By Sponsor|0|||
160839709|NCT02688985|580799711|FG000|Overall Study|Withdrawal by Subject|2|||
160839710|NCT02688985|580799712|FG001|Overall Study|Withdrawal by Subject|8|||
160839711|NCT02688985|580799713|FG002|Overall Study|Withdrawal by Subject|7|||
160839712|NCT02688985|580799714|FG003|Overall Study|Withdrawal by Subject|1|||
160839713|NCT02688985|580799715|FG004|Overall Study|Withdrawal by Subject|4|||
160839714|NCT01964963|580799718|FG000|Overall Study|Case Report Forms Uncollected|888|||
160839715|NCT01964963|580799718|FG000|Overall Study|Protocol Deviation|50|||
160839716|NCT01964963|580799718|FG000|Overall Study|Data Reliability was not Assured|5|||
160839717|NCT00930553|580799719|FG000|Overall Study|Adverse Event|1|||
160839718|NCT00930553|580799719|FG000|Overall Study|Lack of Efficacy|7|||
160839719|NCT00930553|580799719|FG000|Overall Study|Physician Decision|39|||
160839720|NCT00930553|580799719|FG000|Overall Study|Protocol Violation|1|||
160839721|NCT00930553|580799719|FG000|Overall Study|Pregnancy|1|||
160839722|NCT00930553|580799719|FG000|Overall Study|Withdrawal by Subject|88|||
160839723|NCT00930553|580799719|FG000|Overall Study|Lost to Follow-up|25|||
160839724|NCT00930553|580799719|FG000|Overall Study|Death|9|||
160839725|NCT00930553|580799719|FG000|Overall Study|Study terminated by sponsor|24|||
160839726|NCT00930553|580799719|FG000|Overall Study|Other than specified above|28|||
160839727|NCT01726582|580799720|FG000|Overall Study|Physician Decision|99|||
160839728|NCT01726582|580799720|FG000|Overall Study|Death|85|||
160839729|NCT01235234|580799721|FG000|Overall Study|Adverse Event|2|||
160839730|NCT01235234|580799722|FG001|Overall Study|Adverse Event|2|||
160839731|NCT01235234|580799723|FG002|Overall Study|Adverse Event|1|||
160839732|NCT02630472|580799724|FG000|Overall Study|Physician Decision|10|||
160839733|NCT02630472|580799725|FG001|Overall Study|Physician Decision|0|||
160839734|NCT03704688|580799734|FG000|Overall Study|Adverse Event|0|||
160839735|NCT03704688|580799735|FG001|Overall Study|Adverse Event|0|||
160839736|NCT03704688|580799736|FG002|Overall Study|Adverse Event|0|||
160839737|NCT03704688|580799737|FG003|Overall Study|Adverse Event|4|||
160839738|NCT03704688|580799738|FG004|Overall Study|Adverse Event|1|||
160839739|NCT03704688|580799739|FG005|Overall Study|Adverse Event|0|||
160839740|NCT03704688|580799734|FG000|Overall Study|Disease Progression|0|||
160839741|NCT03704688|580799735|FG001|Overall Study|Disease Progression|0|||
160839742|NCT03704688|580799736|FG002|Overall Study|Disease Progression|0|||
161139276|NCT02635204|581892649|FG000|Overall Study|Adverse Event|1|||
161250667|NCT04592419|582298447|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
161250668|NCT04592419|582298446|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
161250669|NCT04592419|582298447|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
161250670|NCT04592419|582298446|FG000|Open-Label Extension Period|Sponsor Request|73|||
161250671|NCT04592419|582298447|FG001|Open-Label Extension Period|Sponsor Request|84|||
161250672|NCT00381849|582298448|FG000|Wash Out|Withdrawal by Subject|0|||
161250673|NCT00381849|582298449|FG001|Wash Out|Withdrawal by Subject|1|||
161250674|NCT01765270|582298453|FG000|Overall Study|Physician Decision|1|||
161250675|NCT01765270|582298454|FG001|Overall Study|Physician Decision|0|||
161250676|NCT01765270|582298453|FG000|Overall Study|Withdrawal by Subject|0|||
161139277|NCT02635204|581892650|FG001|Overall Study|Adverse Event|0|||
160839743|NCT03704688|580799737|FG003|Overall Study|Disease Progression|3|||
160839744|NCT03704688|580799738|FG004|Overall Study|Disease Progression|1|||
160839745|NCT03704688|580799739|FG005|Overall Study|Disease Progression|0|||
160839746|NCT03704688|580799734|FG000|Overall Study|Death|0|||
160839747|NCT03704688|580799735|FG001|Overall Study|Death|0|||
160839748|NCT03704688|580799736|FG002|Overall Study|Death|0|||
160839749|NCT03704688|580799737|FG003|Overall Study|Death|0|||
161139278|NCT02635204|581892649|FG000|Overall Study|Lost to Follow-up|1|||
161139279|NCT02635204|581892650|FG001|Overall Study|Lost to Follow-up|1|||
160839750|NCT03704688|580799738|FG004|Overall Study|Death|3|||
160839751|NCT03704688|580799739|FG005|Overall Study|Death|0|||
161139280|NCT01772134|581892656|FG000|Overall Study|Adverse Event|6|||
161139281|NCT01772134|581892657|FG001|Overall Study|Adverse Event|5|||
161139282|NCT01772134|581892658|FG002|Overall Study|Adverse Event|10|||
161250677|NCT01765270|582298454|FG001|Overall Study|Withdrawal by Subject|1|||
161250678|NCT00517192|582298455|FG000|Overall Study|Adverse Event|1|||
161250679|NCT00517192|582298456|FG001|Overall Study|Adverse Event|1|||
161250680|NCT00517192|582298455|FG000|Overall Study|Lost to Follow-up|1|||
161250681|NCT00517192|582298456|FG001|Overall Study|Lost to Follow-up|1|||
161250682|NCT00517192|582298455|FG000|Overall Study|Withdrawal by Subject|1|||
161250683|NCT00517192|582298456|FG001|Overall Study|Withdrawal by Subject|0|||
161250684|NCT00517192|582298455|FG000|Overall Study|Early termination of the trial|16|||
161250685|NCT00517192|582298456|FG001|Overall Study|Early termination of the trial|18|||
161250686|NCT04501094|582298460|FG000|Overall Study|Death (unrelated to research)|1|||
161250687|NCT04501094|582298461|FG001|Overall Study|Death (unrelated to research)|0|||
161250688|NCT05693805|582298464|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
161250689|NCT05693805|582298465|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
161250690|NCT02943993|582298468|FG000|Overall Study|Withdrawal by Subject|52|||
161250691|NCT02943993|582298468|FG000|Overall Study|Transfer to another institution|6|||
161250692|NCT02943993|582298468|FG000|Overall Study|Lost to Follow-up|135|||
161250693|NCT02943993|582298468|FG000|Overall Study|Death|98|||
161250694|NCT02943993|582298468|FG000|Overall Study|Other reason for premature termination|32|||
161250695|NCT02943993|582298468|FG000|Overall Study|Missing reason for termination|7|||
161250696|NCT02152982|582298470|FG000|Overall Study|Withdrawal by Subject|17|||
161250697|NCT02152982|582298471|FG001|Overall Study|Withdrawal by Subject|16|||
161250698|NCT02152982|582298470|FG000|Overall Study|Did not start treatment|11|||
161250699|NCT02152982|582298471|FG001|Overall Study|Did not start treatment|5|||
161250700|NCT02152982|582298470|FG000|Overall Study|Disease progression|41|||
161250701|NCT02152982|582298471|FG001|Overall Study|Disease progression|52|||
161250702|NCT02152982|582298470|FG000|Overall Study|Adverse Event|7|||
161250703|NCT02152982|582298471|FG001|Overall Study|Adverse Event|12|||
161250704|NCT02152982|582298470|FG000|Overall Study|Complicating disease|1|||
161250705|NCT02152982|582298471|FG001|Overall Study|Complicating disease|1|||
161250706|NCT02152982|582298470|FG000|Overall Study|Death|0|||
161250707|NCT02152982|582298471|FG001|Overall Study|Death|3|||
161250708|NCT02152982|582298470|FG000|Overall Study|Physician Decision|3|||
161250709|NCT02152982|582298471|FG001|Overall Study|Physician Decision|0|||
161250710|NCT02510261|582298472|FG000|Overall Study|Adverse Event|5|||
160991929|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
160991930|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
160991931|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
160991932|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
160991933|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
160991934|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991935|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991936|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991937|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991938|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
160991939|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
160991940|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
160991941|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
160991942|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
160991943|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
160991944|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
161250711|NCT02510261|582298473|FG001|Overall Study|Adverse Event|8|||
161250712|NCT02510261|582298474|FG002|Overall Study|Adverse Event|0|||
161250713|NCT02510261|582298472|FG000|Overall Study|Physician Decision|1|||
161250714|NCT02510261|582298473|FG001|Overall Study|Physician Decision|5|||
161250715|NCT02510261|582298474|FG002|Overall Study|Physician Decision|0|||
161250716|NCT02510261|582298472|FG000|Overall Study|Death|19|||
161250717|NCT02510261|582298473|FG001|Overall Study|Death|19|||
161250718|NCT02510261|582298474|FG002|Overall Study|Death|0|||
161250719|NCT02510261|582298472|FG000|Overall Study|Withdrawal by Subject|3|||
161250720|NCT02510261|582298473|FG001|Overall Study|Withdrawal by Subject|10|||
160991945|NCT04888585|581359926|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161250721|NCT02510261|582298474|FG002|Overall Study|Withdrawal by Subject|3|||
161250722|NCT02003222|582298476|FG000|Induction|Never started treatment|0|||
161250723|NCT02003222|582298477|FG001|Induction|Never started treatment|0|||
160991946|NCT04888585|581359927|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160991947|NCT04888585|581359928|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
161250724|NCT02003222|582298478|FG002|Induction|Never started treatment|0|||
160839752|NCT00787189|580799741|FG000|Overall Study|Lost to Follow-up|2|||
161250725|NCT02003222|582298479|FG003|Induction|Never started treatment|0|||
161250726|NCT02003222|582298480|FG004|Induction|Never started treatment|8|||
161250727|NCT02003222|582298476|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
161250728|NCT02003222|582298477|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
161250729|NCT02003222|582298478|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
161250730|NCT02003222|582298479|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
161250731|NCT02003222|582298480|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
161250732|NCT02003222|582298476|FG000|Induction|Adverse Event|0|||
161250733|NCT02003222|582298477|FG001|Induction|Adverse Event|0|||
161250734|NCT02003222|582298478|FG002|Induction|Adverse Event|0|||
161250735|NCT02003222|582298479|FG003|Induction|Adverse Event|0|||
161250736|NCT02003222|582298480|FG004|Induction|Adverse Event|13|||
161250737|NCT02003222|582298476|FG000|Induction|Alternative therapy|0|||
161250738|NCT02003222|582298477|FG001|Induction|Alternative therapy|0|||
161250739|NCT02003222|582298478|FG002|Induction|Alternative therapy|0|||
161250740|NCT02003222|582298479|FG003|Induction|Alternative therapy|0|||
161250741|NCT02003222|582298480|FG004|Induction|Alternative therapy|12|||
161250742|NCT02003222|582298476|FG000|Induction|Disease progression|0|||
160839753|NCT00787189|580799742|FG001|Overall Study|Lost to Follow-up|2|||
160839754|NCT00847886|580799743|FG000|Overall Study|Adverse Event|0|||
160839755|NCT00847886|580799744|FG001|Overall Study|Adverse Event|1|||
161250743|NCT02003222|582298477|FG001|Induction|Disease progression|0|||
161250744|NCT02003222|582298478|FG002|Induction|Disease progression|0|||
161250745|NCT02003222|582298479|FG003|Induction|Disease progression|0|||
161250746|NCT02003222|582298480|FG004|Induction|Disease progression|22|||
160839756|NCT00413036|580799745|FG000|Overall Study|Adverse Event|44|||
160839757|NCT00413036|580799745|FG000|Overall Study|Lack of Efficacy|129|||
160839758|NCT00413036|580799745|FG000|Overall Study|Withdrawal by Subject|7|||
161250747|NCT02003222|582298476|FG000|Induction|Death|0|||
161250748|NCT02003222|582298477|FG001|Induction|Death|0|||
161250749|NCT02003222|582298478|FG002|Induction|Death|0|||
161250750|NCT02003222|582298479|FG003|Induction|Death|0|||
161250751|NCT02003222|582298480|FG004|Induction|Death|3|||
161250752|NCT02003222|582298476|FG000|Induction|Withdrawal by Subject|0|||
161250753|NCT02003222|582298477|FG001|Induction|Withdrawal by Subject|0|||
161250754|NCT02003222|582298478|FG002|Induction|Withdrawal by Subject|0|||
161250755|NCT02003222|582298479|FG003|Induction|Withdrawal by Subject|0|||
161250756|NCT02003222|582298480|FG004|Induction|Withdrawal by Subject|8|||
161250757|NCT02003222|582298476|FG000|Induction|Other reasons|0|||
161250758|NCT02003222|582298477|FG001|Induction|Other reasons|0|||
161250759|NCT02003222|582298478|FG002|Induction|Other reasons|0|||
161250760|NCT02003222|582298479|FG003|Induction|Other reasons|0|||
161250761|NCT02003222|582298480|FG004|Induction|Other reasons|22|||
161250762|NCT02003222|582298476|FG000|Intensification|Never started treatment|0|||
161250763|NCT02003222|582298477|FG001|Intensification|Never started treatment|0|||
161250764|NCT02003222|582298478|FG002|Intensification|Never started treatment|0|||
160839759|NCT00413036|580799745|FG000|Overall Study|Death|9|||
160839760|NCT00413036|580799745|FG000|Overall Study|Other|26|||
160839761|NCT00413036|580799745|FG000|Overall Study|Missing|2|||
160839762|NCT00183625|580799746|FG000|Overall Study|Withdrawal by Subject|18|||
160839763|NCT00183625|580799747|FG001|Overall Study|Withdrawal by Subject|18|||
160839764|NCT00183625|580799748|FG002|Overall Study|Withdrawal by Subject|19|||
160839765|NCT00183625|580799749|FG003|Overall Study|Withdrawal by Subject|14|||
160839766|NCT02524158|580799750|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
160839767|NCT02524158|580799751|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
160839768|NCT02524158|580799750|FG000|12-weeks Assessment|Lost to Follow-up|18|||
160839769|NCT02524158|580799751|FG001|12-weeks Assessment|Lost to Follow-up|12|||
160839770|NCT02524158|580799750|FG000|6-month Assessment|Withdrawal by Subject|1|||
160839771|NCT02524158|580799751|FG001|6-month Assessment|Withdrawal by Subject|1|||
160839772|NCT02524158|580799750|FG000|6-month Assessment|Lost to Follow-up|21|||
160839773|NCT02524158|580799751|FG001|6-month Assessment|Lost to Follow-up|20|||
160839774|NCT00887926|580799752|FG000|Overall Study|Withdrawal by Subject|0|||
160839775|NCT00887926|580799753|FG001|Overall Study|Withdrawal by Subject|1|||
160839776|NCT00887926|580799754|FG002|Overall Study|Withdrawal by Subject|0|||
160839777|NCT00887926|580799755|FG003|Overall Study|Withdrawal by Subject|0|||
160839778|NCT01110382|580799756|FG000|Overall Study|Withdrawal by Subject|0|||
160839779|NCT01110382|580799757|FG001|Overall Study|Withdrawal by Subject|1|||
161250765|NCT02003222|582298479|FG003|Intensification|Never started treatment|0|||
160839780|NCT01110382|580799756|FG000|Overall Study|Protocol Violation|0|||
160839781|NCT01110382|580799757|FG001|Overall Study|Protocol Violation|1|||
160839782|NCT00098306|580799758|FG000|Double Blind|Randomized, not treated|9|||
160839783|NCT00098306|580799759|FG001|Double Blind|Randomized, not treated|5|||
160839784|NCT00098306|580799760|FG002|Double Blind|Randomized, not treated|2|||
160839785|NCT00098306|580799761|FG003|Double Blind|Randomized, not treated|0|||
161250766|NCT02003222|582298480|FG004|Intensification|Never started treatment|2|||
161250767|NCT02003222|582298476|FG000|Intensification|Adverse Event|0|||
161250768|NCT02003222|582298477|FG001|Intensification|Adverse Event|0|||
161250769|NCT02003222|582298478|FG002|Intensification|Adverse Event|0|||
161250770|NCT02003222|582298479|FG003|Intensification|Adverse Event|0|||
161250771|NCT02003222|582298480|FG004|Intensification|Adverse Event|6|||
161250772|NCT02003222|582298476|FG000|Intensification|Alternative therapy|0|||
161250773|NCT02003222|582298477|FG001|Intensification|Alternative therapy|0|||
161250774|NCT02003222|582298478|FG002|Intensification|Alternative therapy|0|||
160839786|NCT00098306|580799762|FG004|Double Blind|Randomized, not treated|0|||
160839787|NCT00098306|580799763|FG005|Double Blind|Randomized, not treated|0|||
160839788|NCT00098306|580799764|FG006|Double Blind|Randomized, not treated|0|||
160839789|NCT00098306|580799758|FG000|Double Blind|Ongoing at cut-off date|151|||
160839790|NCT00098306|580799759|FG001|Double Blind|Ongoing at cut-off date|166|||
160839791|NCT00098306|580799760|FG002|Double Blind|Ongoing at cut-off date|72|||
160839792|NCT00098306|580799761|FG003|Double Blind|Ongoing at cut-off date|0|||
160839793|NCT00098306|580799762|FG004|Double Blind|Ongoing at cut-off date|0|||
160839794|NCT00098306|580799763|FG005|Double Blind|Ongoing at cut-off date|0|||
160839795|NCT00098306|580799764|FG006|Double Blind|Ongoing at cut-off date|0|||
160839796|NCT00098306|580799758|FG000|Double Blind|Adverse Event|11|||
160839797|NCT00098306|580799759|FG001|Double Blind|Adverse Event|10|||
160839798|NCT00098306|580799760|FG002|Double Blind|Adverse Event|6|||
160839799|NCT00098306|580799761|FG003|Double Blind|Adverse Event|0|||
160839800|NCT00098306|580799762|FG004|Double Blind|Adverse Event|0|||
160839801|NCT00098306|580799763|FG005|Double Blind|Adverse Event|0|||
161139283|NCT01772134|581892656|FG000|Overall Study|Withdrew Consent|3|||
160905078|NCT00939770|581046418|FG002|Overall Study|Lack of Efficacy|13|||
160905079|NCT00939770|581046419|FG003|Overall Study|Lack of Efficacy|9|||
160905080|NCT00939770|581046420|FG004|Overall Study|Lack of Efficacy|16|||
160905081|NCT00939770|581046421|FG005|Overall Study|Lack of Efficacy|8|||
160905082|NCT00939770|581046422|FG006|Overall Study|Lack of Efficacy|11|||
160905083|NCT00939770|581046423|FG007|Overall Study|Lack of Efficacy|1|||
160905084|NCT00939770|581046416|FG000|Overall Study|Lost to Follow-up|0|||
160905085|NCT00939770|581046417|FG001|Overall Study|Lost to Follow-up|0|||
160905086|NCT00939770|581046418|FG002|Overall Study|Lost to Follow-up|0|||
160905087|NCT00939770|581046419|FG003|Overall Study|Lost to Follow-up|0|||
160905088|NCT00939770|581046420|FG004|Overall Study|Lost to Follow-up|1|||
160905089|NCT00939770|581046421|FG005|Overall Study|Lost to Follow-up|0|||
160905090|NCT00939770|581046422|FG006|Overall Study|Lost to Follow-up|0|||
160905091|NCT00939770|581046423|FG007|Overall Study|Lost to Follow-up|0|||
160905092|NCT00939770|581046416|FG000|Overall Study|Physician Decision|0|||
160905093|NCT00939770|581046417|FG001|Overall Study|Physician Decision|0|||
160905094|NCT00939770|581046418|FG002|Overall Study|Physician Decision|2|||
160905095|NCT00939770|581046419|FG003|Overall Study|Physician Decision|0|||
160905096|NCT00939770|581046420|FG004|Overall Study|Physician Decision|7|||
160905097|NCT00939770|581046421|FG005|Overall Study|Physician Decision|1|||
160905098|NCT00939770|581046422|FG006|Overall Study|Physician Decision|0|||
160905099|NCT00939770|581046423|FG007|Overall Study|Physician Decision|6|||
160905100|NCT00939770|581046416|FG000|Overall Study|Protocol Violation|0|||
160905101|NCT00939770|581046417|FG001|Overall Study|Protocol Violation|0|||
160905102|NCT00939770|581046418|FG002|Overall Study|Protocol Violation|0|||
160905103|NCT00939770|581046419|FG003|Overall Study|Protocol Violation|0|||
160905104|NCT00939770|581046420|FG004|Overall Study|Protocol Violation|1|||
160905105|NCT00939770|581046421|FG005|Overall Study|Protocol Violation|0|||
160905106|NCT00939770|581046422|FG006|Overall Study|Protocol Violation|0|||
160905107|NCT00939770|581046423|FG007|Overall Study|Protocol Violation|0|||
160905108|NCT00939770|581046416|FG000|Overall Study|Withdrawal by Subject|0|||
160905109|NCT00939770|581046417|FG001|Overall Study|Withdrawal by Subject|1|||
160905110|NCT00939770|581046418|FG002|Overall Study|Withdrawal by Subject|5|||
160905111|NCT00939770|581046419|FG003|Overall Study|Withdrawal by Subject|2|||
160905112|NCT00939770|581046420|FG004|Overall Study|Withdrawal by Subject|6|||
160905113|NCT00939770|581046421|FG005|Overall Study|Withdrawal by Subject|0|||
160905114|NCT00939770|581046422|FG006|Overall Study|Withdrawal by Subject|2|||
160905115|NCT00939770|581046423|FG007|Overall Study|Withdrawal by Subject|2|||
160905116|NCT04665856|581046424|FG000|Overall Study|Site Terminated by Sponsor|1|||
160905117|NCT04665856|581046425|FG001|Overall Study|Site Terminated by Sponsor|0|||
160905118|NCT04665856|581046424|FG000|Overall Study|Withdrawal by Subject|2|||
160905119|NCT04665856|581046425|FG001|Overall Study|Withdrawal by Subject|0|||
160905120|NCT04665856|581046424|FG000|Overall Study|Lost to Follow-up|3|||
160905121|NCT04665856|581046425|FG001|Overall Study|Lost to Follow-up|2|||
160905122|NCT04665856|581046424|FG000|Overall Study|Death|39|||
160905123|NCT04665856|581046425|FG001|Overall Study|Death|44|||
160905124|NCT04665856|581046424|FG000|Overall Study|Ongoing in study|17|||
160905125|NCT04665856|581046425|FG001|Overall Study|Ongoing in study|15|||
160905126|NCT03386448|581046426|FG000|Overall Study|Adverse Event|0|||
160905127|NCT03386448|581046427|FG001|Overall Study|Adverse Event|2|||
160905128|NCT01146665|581046428|FG000|Overall Study|Withdrawal by Subject|10|||
160905129|NCT01146665|581046429|FG001|Overall Study|Withdrawal by Subject|16|||
160905130|NCT00001880|581046430|FG000|Overall Study|Death|14|||
160905131|NCT02639065|581046431|FG000|Study Treatment|Disease Progression|13|||
161139284|NCT01772134|581892657|FG001|Overall Study|Withdrew Consent|1|||
161139285|NCT01772134|581892658|FG002|Overall Study|Withdrew Consent|5|||
161139286|NCT01772134|581892656|FG000|Overall Study|Lost to Follow-up|2|||
161139287|NCT01772134|581892657|FG001|Overall Study|Lost to Follow-up|0|||
161139288|NCT01772134|581892658|FG002|Overall Study|Lost to Follow-up|0|||
161139289|NCT01772134|581892656|FG000|Overall Study|Protocol Deviation|4|||
161139290|NCT01772134|581892657|FG001|Overall Study|Protocol Deviation|3|||
161139291|NCT01772134|581892658|FG002|Overall Study|Protocol Deviation|3|||
161250775|NCT02003222|582298479|FG003|Intensification|Alternative therapy|0|||
160839802|NCT00098306|580799764|FG006|Double Blind|Adverse Event|0|||
160839803|NCT00098306|580799758|FG000|Double Blind|Lack of Efficacy|43|||
160839804|NCT00098306|580799759|FG001|Double Blind|Lack of Efficacy|34|||
160839805|NCT00098306|580799760|FG002|Double Blind|Lack of Efficacy|17|||
160839806|NCT00098306|580799761|FG003|Double Blind|Lack of Efficacy|0|||
160839807|NCT00098306|580799762|FG004|Double Blind|Lack of Efficacy|0|||
160839808|NCT00098306|580799763|FG005|Double Blind|Lack of Efficacy|0|||
160839809|NCT00098306|580799764|FG006|Double Blind|Lack of Efficacy|0|||
160839810|NCT00098306|580799758|FG000|Double Blind|Death|1|||
160839811|NCT00098306|580799759|FG001|Double Blind|Death|4|||
161250776|NCT02003222|582298480|FG004|Intensification|Alternative therapy|8|||
161250777|NCT02003222|582298476|FG000|Intensification|Disease progression|0|||
161250778|NCT02003222|582298477|FG001|Intensification|Disease progression|0|||
161250779|NCT02003222|582298478|FG002|Intensification|Disease progression|0|||
161250780|NCT02003222|582298479|FG003|Intensification|Disease progression|0|||
160839812|NCT00098306|580799760|FG002|Double Blind|Death|1|||
160839813|NCT00098306|580799761|FG003|Double Blind|Death|0|||
160839814|NCT00098306|580799762|FG004|Double Blind|Death|0|||
160839815|NCT00098306|580799763|FG005|Double Blind|Death|0|||
160839816|NCT00098306|580799764|FG006|Double Blind|Death|0|||
160839817|NCT00098306|580799758|FG000|Double Blind|Participant defaulted|19|||
160839818|NCT00098306|580799759|FG001|Double Blind|Participant defaulted|18|||
160839819|NCT00098306|580799760|FG002|Double Blind|Participant defaulted|11|||
160839820|NCT00098306|580799761|FG003|Double Blind|Participant defaulted|0|||
160839821|NCT00098306|580799762|FG004|Double Blind|Participant defaulted|0|||
160839822|NCT00098306|580799763|FG005|Double Blind|Participant defaulted|0|||
160839823|NCT00098306|580799764|FG006|Double Blind|Participant defaulted|0|||
160839824|NCT00098306|580799758|FG000|Double Blind|Un-specified|7|||
160839825|NCT00098306|580799759|FG001|Double Blind|Un-specified|3|||
160839826|NCT00098306|580799760|FG002|Double Blind|Un-specified|11|||
160839827|NCT00098306|580799761|FG003|Double Blind|Un-specified|0|||
160839828|NCT00098306|580799762|FG004|Double Blind|Un-specified|0|||
160839829|NCT00098306|580799763|FG005|Double Blind|Un-specified|0|||
160839830|NCT00098306|580799764|FG006|Double Blind|Un-specified|0|||
160839831|NCT00098306|580799758|FG000|Open Label|Lack of Efficacy|0|||
160839832|NCT00098306|580799759|FG001|Open Label|Lack of Efficacy|0|||
160839833|NCT00098306|580799760|FG002|Open Label|Lack of Efficacy|0|||
160839834|NCT00098306|580799761|FG003|Open Label|Lack of Efficacy|13|||
160839835|NCT00098306|580799762|FG004|Open Label|Lack of Efficacy|0|||
160839836|NCT00098306|580799763|FG005|Open Label|Lack of Efficacy|0|||
160839837|NCT00098306|580799764|FG006|Open Label|Lack of Efficacy|0|||
160839838|NCT00098306|580799758|FG000|Open Label|Adverse Event|0|||
160839839|NCT00098306|580799759|FG001|Open Label|Adverse Event|0|||
160839840|NCT00098306|580799760|FG002|Open Label|Adverse Event|0|||
160839841|NCT00098306|580799761|FG003|Open Label|Adverse Event|2|||
160839842|NCT00098306|580799762|FG004|Open Label|Adverse Event|0|||
160839843|NCT00098306|580799763|FG005|Open Label|Adverse Event|0|||
160839844|NCT00098306|580799764|FG006|Open Label|Adverse Event|0|||
160839845|NCT00098306|580799758|FG000|Open Label|Death|0|||
160839846|NCT00098306|580799759|FG001|Open Label|Death|0|||
160839847|NCT00098306|580799760|FG002|Open Label|Death|0|||
160839848|NCT00098306|580799761|FG003|Open Label|Death|4|||
160839849|NCT00098306|580799762|FG004|Open Label|Death|0|||
160839850|NCT00098306|580799763|FG005|Open Label|Death|0|||
160839851|NCT00098306|580799764|FG006|Open Label|Death|0|||
160839852|NCT00098306|580799758|FG000|Open Label|Participant defaulted|0|||
160839853|NCT00098306|580799759|FG001|Open Label|Participant defaulted|0|||
160839854|NCT00098306|580799760|FG002|Open Label|Participant defaulted|0|||
160839855|NCT00098306|580799761|FG003|Open Label|Participant defaulted|24|||
160839856|NCT00098306|580799762|FG004|Open Label|Participant defaulted|0|||
161250781|NCT02003222|582298480|FG004|Intensification|Disease progression|18|||
161250782|NCT02003222|582298476|FG000|Intensification|Withdrawal by Subject|0|||
161250783|NCT02003222|582298477|FG001|Intensification|Withdrawal by Subject|0|||
161250784|NCT02003222|582298478|FG002|Intensification|Withdrawal by Subject|0|||
160839857|NCT00098306|580799763|FG005|Open Label|Participant defaulted|0|||
160839858|NCT00098306|580799764|FG006|Open Label|Participant defaulted|0|||
160839859|NCT00098306|580799758|FG000|Open Label|Un-specified|0|||
160839860|NCT00098306|580799759|FG001|Open Label|Un-specified|0|||
160839861|NCT00098306|580799760|FG002|Open Label|Un-specified|0|||
160839862|NCT00098306|580799761|FG003|Open Label|Un-specified|15|||
160839863|NCT00098306|580799762|FG004|Open Label|Un-specified|0|||
160839864|NCT00098306|580799763|FG005|Open Label|Un-specified|0|||
160839865|NCT00098306|580799764|FG006|Open Label|Un-specified|0|||
160839866|NCT00098306|580799758|FG000|Open Label|Ongoing at cut-off date|0|||
160839867|NCT00098306|580799759|FG001|Open Label|Ongoing at cut-off date|0|||
160839868|NCT00098306|580799760|FG002|Open Label|Ongoing at cut-off date|0|||
160839869|NCT00098306|580799761|FG003|Open Label|Ongoing at cut-off date|269|||
160839870|NCT00098306|580799762|FG004|Open Label|Ongoing at cut-off date|62|||
160839871|NCT00098306|580799763|FG005|Open Label|Ongoing at cut-off date|0|||
160839872|NCT00098306|580799764|FG006|Open Label|Ongoing at cut-off date|0|||
160839873|NCT00098306|580799758|FG000|Observational Phase|Death|0|||
161250785|NCT02003222|582298479|FG003|Intensification|Withdrawal by Subject|0|||
161250786|NCT02003222|582298480|FG004|Intensification|Withdrawal by Subject|5|||
161250787|NCT02003222|582298476|FG000|Intensification|Other reasons|0|||
161250788|NCT02003222|582298477|FG001|Intensification|Other reasons|0|||
161250789|NCT02003222|582298478|FG002|Intensification|Other reasons|0|||
161250790|NCT02003222|582298479|FG003|Intensification|Other reasons|0|||
161250791|NCT02003222|582298480|FG004|Intensification|Other reasons|8|||
161250792|NCT04941768|582298485|FG000|Overall Study|Lost to Follow-up|10|||
161250793|NCT04941768|582298485|FG000|Overall Study|Death|24|||
161250794|NCT04941768|582298485|FG000|Overall Study|Progressive Disease|4|||
161250795|NCT04941768|582298485|FG000|Overall Study|Withdrawal by Subject|4|||
161250796|NCT04941768|582298485|FG000|Overall Study|Other|3|||
161250797|NCT04941768|582298485|FG000|Overall Study|Treatment ongoing|21|||
161250798|NCT04941768|582298485|FG000|Overall Study|Off treatment and in follow-up|21|||
161250799|NCT03302078|582298487|FG000|Washout Period|Adverse Event|0|||
161250800|NCT03302078|582298488|FG001|Washout Period|Adverse Event|1|||
161250801|NCT01886872|582298489|FG000|Overall Study|Ineligible|7|||
161250802|NCT01886872|582298490|FG001|Overall Study|Ineligible|4|||
161250803|NCT01886872|582298491|FG002|Overall Study|Ineligible|12|||
161250804|NCT05148299|582298492|FG000|Treatment Period|Adverse Event|1|||
161250805|NCT05148299|582298492|FG000|Treatment Period|Physician Decision|1|||
161250806|NCT05148299|582298492|FG000|Treatment Period|Death|1|||
161250807|NCT05148299|582298492|FG000|Follow-up Period|Death|3|||
161250808|NCT01957150|582298493|FG000|Overall Study|Adverse Event|23|||
161250809|NCT01957150|582298494|FG001|Overall Study|Adverse Event|20|||
161250810|NCT01957150|582298493|FG000|Overall Study|Withdrawal by Subject|13|||
161250811|NCT01957150|582298494|FG001|Overall Study|Withdrawal by Subject|17|||
161250812|NCT01957150|582298493|FG000|Overall Study|Physician Decision|3|||
161250813|NCT01957150|582298494|FG001|Overall Study|Physician Decision|6|||
161250814|NCT01957150|582298493|FG000|Overall Study|Lost to Follow-up|4|||
161250815|NCT01957150|582298494|FG001|Overall Study|Lost to Follow-up|4|||
161250816|NCT01957150|582298493|FG000|Overall Study|Protocol Violation|1|||
161250817|NCT01957150|582298494|FG001|Overall Study|Protocol Violation|0|||
161250818|NCT01957150|582298493|FG000|Overall Study|Lack of Efficacy|11|||
161250819|NCT01957150|582298494|FG001|Overall Study|Lack of Efficacy|11|||
161250820|NCT01856192|582298495|FG000|Overall Study|Adverse Event|12|||
161250821|NCT01856192|582298496|FG001|Overall Study|Adverse Event|4|||
161250822|NCT01856192|582298495|FG000|Overall Study|Alternative therapy|0|||
161250823|NCT01856192|582298496|FG001|Overall Study|Alternative therapy|3|||
161250824|NCT01856192|582298495|FG000|Overall Study|Death|3|||
161250825|NCT01856192|582298496|FG001|Overall Study|Death|5|||
161250826|NCT01856192|582298495|FG000|Overall Study|Lack of Efficacy|0|||
161250827|NCT01856192|582298496|FG001|Overall Study|Lack of Efficacy|5|||
161250828|NCT01856192|582298495|FG000|Overall Study|Withdrawal by Subject|1|||
161250829|NCT01856192|582298496|FG001|Overall Study|Withdrawal by Subject|1|||
161250830|NCT01856192|582298495|FG000|Overall Study|Other diseases|1|||
161250831|NCT01856192|582298496|FG001|Overall Study|Other diseases|0|||
161250832|NCT01856192|582298495|FG000|Overall Study|Never started treatment|7|||
161250833|NCT01856192|582298496|FG001|Overall Study|Never started treatment|5|||
161250834|NCT01856192|582298495|FG000|Overall Study|Path ineligible|20|||
161250835|NCT01856192|582298496|FG001|Overall Study|Path ineligible|34|||
161250836|NCT01856192|582298495|FG000|Overall Study|Non-path ineligible|2|||
161250837|NCT01856192|582298496|FG001|Overall Study|Non-path ineligible|2|||
161250838|NCT01856192|582298495|FG000|Overall Study|Physician Decision|1|||
161250839|NCT01856192|582298496|FG001|Overall Study|Physician Decision|1|||
161250840|NCT01856192|582298495|FG000|Overall Study|Suspicion of progressive disease|1|||
161250841|NCT01856192|582298496|FG001|Overall Study|Suspicion of progressive disease|0|||
161250842|NCT01856192|582298495|FG000|Overall Study|Non-compliance|1|||
161250843|NCT01856192|582298496|FG001|Overall Study|Non-compliance|0|||
161250844|NCT00098475|582298497|FG000|Step 1|Progressive disease|33|||
161250845|NCT00098475|582298498|FG001|Step 1|Progressive disease|35|||
161334981|NCT01673178|582615884|FG000|Overall Study|Withdrawal by Subject|0|||
161334982|NCT01673178|582615885|FG001|Overall Study|Withdrawal by Subject|0|||
161250846|NCT00098475|582298499|FG002|Step 1|Progressive disease|2|||
161250847|NCT00098475|582298500|FG003|Step 1|Progressive disease|1|||
161250848|NCT00098475|582298497|FG000|Step 1|Adverse Event|56|||
161250849|NCT00098475|582298498|FG001|Step 1|Adverse Event|37|||
161250850|NCT00098475|582298499|FG002|Step 1|Adverse Event|0|||
161250851|NCT00098475|582298500|FG003|Step 1|Adverse Event|1|||
161250852|NCT00098475|582298497|FG000|Step 1|Death|8|||
161250853|NCT00098475|582298498|FG001|Step 1|Death|5|||
161250854|NCT00098475|582298499|FG002|Step 1|Death|0|||
161250855|NCT00098475|582298500|FG003|Step 1|Death|1|||
161250856|NCT00098475|582298497|FG000|Step 1|Withdrawal by Subject|14|||
161250857|NCT00098475|582298498|FG001|Step 1|Withdrawal by Subject|11|||
161250858|NCT00098475|582298499|FG002|Step 1|Withdrawal by Subject|0|||
161250859|NCT00098475|582298500|FG003|Step 1|Withdrawal by Subject|0|||
161250860|NCT00098475|582298497|FG000|Step 1|Physician Decision|5|||
161250861|NCT00098475|582298498|FG001|Step 1|Physician Decision|2|||
161250862|NCT00098475|582298499|FG002|Step 1|Physician Decision|0|||
161250863|NCT00098475|582298500|FG003|Step 1|Physician Decision|0|||
161250864|NCT00098475|582298497|FG000|Step 1|Alternative therapy|31|||
160839874|NCT00098306|580799759|FG001|Observational Phase|Death|0|||
160839875|NCT00098306|580799760|FG002|Observational Phase|Death|0|||
160839876|NCT00098306|580799761|FG003|Observational Phase|Death|0|||
160839877|NCT00098306|580799762|FG004|Observational Phase|Death|0|||
160839878|NCT00098306|580799763|FG005|Observational Phase|Death|5|||
160839879|NCT00098306|580799764|FG006|Observational Phase|Death|4|||
160839880|NCT00098306|580799758|FG000|Observational Phase|Participant defaulted|0|||
160839881|NCT00098306|580799759|FG001|Observational Phase|Participant defaulted|0|||
160839882|NCT00098306|580799760|FG002|Observational Phase|Participant defaulted|0|||
160839883|NCT00098306|580799761|FG003|Observational Phase|Participant defaulted|0|||
160839884|NCT00098306|580799762|FG004|Observational Phase|Participant defaulted|0|||
160839885|NCT00098306|580799763|FG005|Observational Phase|Participant defaulted|34|||
160839886|NCT00098306|580799764|FG006|Observational Phase|Participant defaulted|18|||
160839887|NCT00098306|580799758|FG000|Observational Phase|Un-specified|0|||
160839888|NCT00098306|580799759|FG001|Observational Phase|Un-specified|0|||
160839889|NCT00098306|580799760|FG002|Observational Phase|Un-specified|0|||
160839890|NCT00098306|580799761|FG003|Observational Phase|Un-specified|0|||
160839891|NCT00098306|580799762|FG004|Observational Phase|Un-specified|0|||
160839892|NCT00098306|580799763|FG005|Observational Phase|Un-specified|7|||
160839893|NCT00098306|580799764|FG006|Observational Phase|Un-specified|4|||
160839894|NCT00077649|580799765|FG000|Overall Study|Adverse Event|5|||
160839895|NCT00077649|580799766|FG001|Overall Study|Adverse Event|1|||
160839896|NCT00077649|580799767|FG002|Overall Study|Adverse Event|7|||
160839897|NCT00077649|580799768|FG003|Overall Study|Adverse Event|9|||
160839898|NCT00077649|580799765|FG000|Overall Study|Lack of Efficacy|5|||
160839899|NCT00077649|580799766|FG001|Overall Study|Lack of Efficacy|3|||
160839900|NCT00077649|580799767|FG002|Overall Study|Lack of Efficacy|3|||
160839901|NCT00077649|580799768|FG003|Overall Study|Lack of Efficacy|2|||
160839902|NCT00077649|580799765|FG000|Overall Study|Withdrawal by Subject|0|||
160839903|NCT00077649|580799766|FG001|Overall Study|Withdrawal by Subject|1|||
160839904|NCT00077649|580799767|FG002|Overall Study|Withdrawal by Subject|1|||
160839905|NCT00077649|580799768|FG003|Overall Study|Withdrawal by Subject|2|||
160839906|NCT00077649|580799765|FG000|Overall Study|Lost to Follow-up|2|||
160905132|NCT02639065|581046431|FG000|Study Treatment|Adverse Event|9|||
160905133|NCT02639065|581046431|FG000|Study Treatment|Withdrawal by Subject|1|||
160839907|NCT00077649|580799766|FG001|Overall Study|Lost to Follow-up|2|||
160839908|NCT00077649|580799767|FG002|Overall Study|Lost to Follow-up|3|||
160905134|NCT02639065|581046431|FG000|Follow up|Subject refused to follow up|1|||
160905135|NCT02639065|581046431|FG000|Follow up|Symptomatic Deterioration|2|||
160905136|NCT02639065|581046431|FG000|Follow up|Death|2|||
160905137|NCT02639065|581046431|FG000|Follow up|Study Terminated|1|||
160905138|NCT02639065|581046431|FG000|Follow up|Disease Progression|3|||
160905139|NCT00674700|581048126|FG000|Year 1|Adverse Event|17|||
160905140|NCT00674700|581048127|FG001|Year 1|Adverse Event|20|||
160905141|NCT00674700|581048128|FG002|Year 1|Adverse Event|5|||
160905142|NCT00674700|581048126|FG000|Year 1|Withdrawal by Subject|7|||
160905143|NCT00674700|581048127|FG001|Year 1|Withdrawal by Subject|7|||
160905144|NCT00674700|581048128|FG002|Year 1|Withdrawal by Subject|6|||
160905145|NCT00674700|581048126|FG000|Year 1|Any other reason not above-mentioned|7|||
160905146|NCT00674700|581048127|FG001|Year 1|Any other reason not above-mentioned|7|||
160905147|NCT00674700|581048128|FG002|Year 1|Any other reason not above-mentioned|6|||
160905148|NCT00674700|581048126|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
160905149|NCT00674700|581048127|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
160905150|NCT00674700|581048128|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
160905151|NCT00674700|581048126|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
160905152|NCT00674700|581048127|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
160905153|NCT00674700|581048128|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
160905154|NCT00674700|581048126|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
160905155|NCT00674700|581048127|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
160905156|NCT00674700|581048128|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
160905157|NCT02954237|581048129|FG000|Overall Study|Withdrawal by Subject|25|||
160905158|NCT02954237|581048129|FG000|Overall Study|Missed visit|16|||
160905159|NCT02954237|581048129|FG000|Overall Study|Death|2|||
160905160|NCT00621985|581048140|FG000|Dexamethasone Admission|Adverse Event|1|||
160839909|NCT00077649|580799768|FG003|Overall Study|Lost to Follow-up|2|||
160839910|NCT00077649|580799765|FG000|Overall Study|Abnormality of Laboratory Test|1|||
160905161|NCT03068130|581048143|FG000|Overall Study|Adverse Event|19|||
160905162|NCT03068130|581048143|FG000|Overall Study|Death|14|||
160905163|NCT03068130|581048143|FG000|Overall Study|Lost to Follow-up|4|||
160839911|NCT00077649|580799766|FG001|Overall Study|Abnormality of Laboratory Test|2|||
160839912|NCT00077649|580799767|FG002|Overall Study|Abnormality of Laboratory Test|1|||
160839913|NCT00077649|580799768|FG003|Overall Study|Abnormality of Laboratory Test|2|||
160839914|NCT00077649|580799765|FG000|Overall Study|Randomized but never dosed|1|||
160839915|NCT00077649|580799766|FG001|Overall Study|Randomized but never dosed|0|||
160905164|NCT03068130|581048143|FG000|Overall Study|Withdrawal by Subject|26|||
160905165|NCT03068130|581048143|FG000|Overall Study|Administrative Reasons|3|||
160905166|NCT03068130|581048143|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
161250865|NCT00098475|582298498|FG001|Step 1|Alternative therapy|43|||
160839916|NCT00077649|580799767|FG002|Overall Study|Randomized but never dosed|0|||
160839917|NCT00077649|580799768|FG003|Overall Study|Randomized but never dosed|0|||
160839918|NCT00293020|580799771|FG000|Overall Study|Withdrawal by Subject|34|||
160839919|NCT00293020|580799771|FG000|Overall Study|Adverse Event|30|||
160839920|NCT00293020|580799771|FG000|Overall Study|Death|32|||
160839921|NCT00293020|580799771|FG000|Overall Study|Lack of Efficacy|12|||
160839922|NCT00293020|580799771|FG000|Overall Study|Lost to Follow-up|4|||
160839923|NCT00293020|580799771|FG000|Overall Study|Protocol Violation|6|||
160839924|NCT00293020|580799771|FG000|Overall Study|Physician Decision|21|||
160839925|NCT00293020|580799771|FG000|Overall Study|Other Reason|22|||
160839926|NCT00293020|580799771|FG000|Overall Study|No dose taken|1|||
160839927|NCT01336023|580799772|FG000|Week 0 to Week 26|Adverse Event|8|||
160839928|NCT01336023|580799773|FG001|Week 0 to Week 26|Adverse Event|10|||
160839929|NCT01336023|580799774|FG002|Week 0 to Week 26|Adverse Event|24|||
160839930|NCT01336023|580799772|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
160839931|NCT01336023|580799773|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
160839932|NCT01336023|580799774|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
160839933|NCT01336023|580799772|FG000|Week 0 to Week 26|Protocol Violation|1|||
160839934|NCT01336023|580799773|FG001|Week 0 to Week 26|Protocol Violation|2|||
160839935|NCT01336023|580799774|FG002|Week 0 to Week 26|Protocol Violation|0|||
160839936|NCT01336023|580799772|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
160839937|NCT01336023|580799773|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
160839938|NCT01336023|580799774|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
160839939|NCT01336023|580799772|FG000|Week 0 to Week 26|Unclassified|5|||
160839940|NCT01336023|580799773|FG001|Week 0 to Week 26|Unclassified|16|||
160839941|NCT01336023|580799774|FG002|Week 0 to Week 26|Unclassified|9|||
160839942|NCT01336023|580799772|FG000|Week 27 to 52|Adverse Event|1|||
160839943|NCT01336023|580799773|FG001|Week 27 to 52|Adverse Event|5|||
160839944|NCT01336023|580799774|FG002|Week 27 to 52|Adverse Event|2|||
160839945|NCT01336023|580799772|FG000|Week 27 to 52|Protocol Violation|0|||
160839946|NCT01336023|580799773|FG001|Week 27 to 52|Protocol Violation|2|||
160839947|NCT01336023|580799774|FG002|Week 27 to 52|Protocol Violation|1|||
160839948|NCT01336023|580799772|FG000|Week 27 to 52|Withdrawal Criteria|14|||
160839949|NCT01336023|580799773|FG001|Week 27 to 52|Withdrawal Criteria|19|||
160839950|NCT01336023|580799774|FG002|Week 27 to 52|Withdrawal Criteria|16|||
160839951|NCT01336023|580799772|FG000|Week 27 to 52|Unclassified|13|||
160839952|NCT01336023|580799773|FG001|Week 27 to 52|Unclassified|18|||
160839953|NCT01336023|580799774|FG002|Week 27 to 52|Unclassified|9|||
160839954|NCT04058886|580799779|FG000|Overall Study|Withdrawal by Subject|4|||
160839955|NCT04058886|580799779|FG000|Overall Study|Inadequate deafness interpreter service|1|||
160839956|NCT00699335|580799785|FG000|Overall Study|Combination of multiple reasons|176|||
160839957|NCT00699335|580799785|FG000|Overall Study|Missing data|52|||
160839958|NCT03043651|580799786|FG000|Overall Study|Death|1|||
160839959|NCT03043651|580799786|FG000|Overall Study|Progressive Disease|2|||
160839960|NCT03043651|580799786|FG000|Overall Study|Adverse Event|2|||
160839961|NCT03043651|580799786|FG000|Overall Study|Withdrawal by Subject|4|||
160839962|NCT03043651|580799786|FG000|Overall Study|Study Terminated by Sponsor|39|||
160839963|NCT02974842|580799787|FG000|Overall Study|Withdrawal by Subject|4|||
160839964|NCT02974842|580799787|FG000|Overall Study|Screen failures|4|||
160839965|NCT01959243|580799788|FG000|Overall Study|Investigator Decision|3|||
160839966|NCT01959243|580799789|FG001|Overall Study|Investigator Decision|0|||
160839967|NCT01959243|580799788|FG000|Overall Study|Adverse Event|5|||
160839968|NCT01959243|580799789|FG001|Overall Study|Adverse Event|2|||
160839969|NCT01959243|580799788|FG000|Overall Study|Administrative reasons|2|||
160839970|NCT01959243|580799789|FG001|Overall Study|Administrative reasons|1|||
160839971|NCT01959243|580799788|FG000|Overall Study|Lost to Follow-up|3|||
160839972|NCT01959243|580799789|FG001|Overall Study|Lost to Follow-up|1|||
160839973|NCT02596945|580799790|FG000|Overall Study|No documentation of study drug dosing|3|||
160839974|NCT02596945|580799790|FG000|Overall Study|Other|32|||
160839975|NCT02596945|580799790|FG000|Overall Study|Change to hemodialysis|15|||
160839976|NCT02596945|580799790|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
160839977|NCT02596945|580799790|FG000|Overall Study|Withdrawal by Subject|1|||
160839978|NCT02596945|580799790|FG000|Overall Study|Missing|1|||
160905167|NCT03068130|581048143|FG000|Overall Study|Study terminated by sponsor|194|||
160905168|NCT00590720|581048144|FG000|Overall Study|Lost to Follow-up|1|||
160905169|NCT00590720|581048145|FG001|Overall Study|Lost to Follow-up|0|||
160905170|NCT00590720|581048144|FG000|Overall Study|Withdrawal by Subject|0|||
161250866|NCT00098475|582298499|FG002|Step 1|Alternative therapy|1|||
161250867|NCT00098475|582298500|FG003|Step 1|Alternative therapy|0|||
160839979|NCT04699461|580799791|FG000|Overall Study|Withdrawal by Subject|1|||
161250868|NCT00098475|582298497|FG000|Step 1|Other disease|2|||
160839980|NCT04699461|580799792|FG001|Overall Study|Withdrawal by Subject|0|||
160839981|NCT04699461|580799791|FG000|Overall Study|Study termination by sponsor|2|||
160839982|NCT04699461|580799792|FG001|Overall Study|Study termination by sponsor|1|||
160839983|NCT04699461|580799791|FG000|Overall Study|Death|1|||
160839984|NCT04699461|580799792|FG001|Overall Study|Death|0|||
160905171|NCT00590720|581048145|FG001|Overall Study|Withdrawal by Subject|1|||
161250869|NCT00098475|582298498|FG001|Step 1|Other disease|1|||
161250870|NCT00098475|582298499|FG002|Step 1|Other disease|1|||
161250871|NCT00098475|582298500|FG003|Step 1|Other disease|0|||
161250872|NCT00098475|582298497|FG000|Step 1|Never started treatment|0|||
161250873|NCT00098475|582298498|FG001|Step 1|Never started treatment|2|||
161250874|NCT00098475|582298499|FG002|Step 1|Never started treatment|0|||
161250875|NCT00098475|582298500|FG003|Step 1|Never started treatment|0|||
161250876|NCT00098475|582298497|FG000|Step 1|Still on treatment as of this analysis|14|||
161250877|NCT00098475|582298498|FG001|Step 1|Still on treatment as of this analysis|27|||
161250878|NCT00098475|582298499|FG002|Step 1|Still on treatment as of this analysis|0|||
161250879|NCT00098475|582298500|FG003|Step 1|Still on treatment as of this analysis|0|||
161250880|NCT00098475|582298497|FG000|Step 1|Knee surgery|1|||
161250881|NCT00098475|582298498|FG001|Step 1|Knee surgery|0|||
161250882|NCT00098475|582298499|FG002|Step 1|Knee surgery|0|||
161250883|NCT00098475|582298500|FG003|Step 1|Knee surgery|0|||
161250884|NCT00098475|582298497|FG000|Step 1|Complications|1|||
161250885|NCT00098475|582298498|FG001|Step 1|Complications|0|||
161250886|NCT00098475|582298499|FG002|Step 1|Complications|0|||
161250887|NCT00098475|582298500|FG003|Step 1|Complications|0|||
161250888|NCT00098475|582298497|FG000|Step 1|Cannot comply due to other tx|0|||
161250889|NCT00098475|582298498|FG001|Step 1|Cannot comply due to other tx|1|||
161250890|NCT00098475|582298499|FG002|Step 1|Cannot comply due to other tx|0|||
161250891|NCT00098475|582298500|FG003|Step 1|Cannot comply due to other tx|0|||
161250892|NCT00098475|582298497|FG000|Step 1|Both patient and physician's decision|2|||
161250893|NCT00098475|582298498|FG001|Step 1|Both patient and physician's decision|1|||
161250894|NCT00098475|582298499|FG002|Step 1|Both patient and physician's decision|0|||
161250895|NCT00098475|582298500|FG003|Step 1|Both patient and physician's decision|0|||
161250896|NCT00098475|582298497|FG000|Step 1|Incorrect disease assessment|2|||
161250897|NCT00098475|582298498|FG001|Step 1|Incorrect disease assessment|0|||
161250898|NCT00098475|582298499|FG002|Step 1|Incorrect disease assessment|0|||
161250899|NCT00098475|582298500|FG003|Step 1|Incorrect disease assessment|0|||
161250900|NCT00098475|582298497|FG000|Step 1|Off treatment for > specified timeframe|1|||
161250901|NCT00098475|582298498|FG001|Step 1|Off treatment for > specified timeframe|1|||
161250902|NCT00098475|582298499|FG002|Step 1|Off treatment for > specified timeframe|0|||
161250903|NCT00098475|582298500|FG003|Step 1|Off treatment for > specified timeframe|0|||
161250904|NCT00098475|582298497|FG000|Step 1|Declining performance status|0|||
160839985|NCT04699461|580799791|FG000|Overall Study|Radiographic progression|0|||
160839986|NCT04699461|580799792|FG001|Overall Study|Radiographic progression|1|||
160839987|NCT02478255|580799793|FG000|Overall Study|Physician Decision|6|||
160839988|NCT02478255|580799794|FG001|Overall Study|Physician Decision|0|||
160839989|NCT02478255|580799793|FG000|Overall Study|Withdrawal by Subject|2|||
160839990|NCT02478255|580799794|FG001|Overall Study|Withdrawal by Subject|0|||
160839991|NCT03068767|580799801|FG000|Overall Study|Lost to Follow-up|7|||
160839992|NCT03068767|580799802|FG001|Overall Study|Lost to Follow-up|3|||
160839993|NCT03068767|580799801|FG000|Overall Study|Protocol Violation|3|||
160839994|NCT03068767|580799802|FG001|Overall Study|Protocol Violation|0|||
160839995|NCT00061633|580799805|FG000|Overall Study|Adverse Event|1|||
160839996|NCT00061633|580799806|FG001|Overall Study|Adverse Event|2|||
160839997|NCT00061633|580799805|FG000|Overall Study|Withdrawal by Subject|2|||
160839998|NCT00061633|580799806|FG001|Overall Study|Withdrawal by Subject|2|||
160839999|NCT00061633|580799805|FG000|Overall Study|Lost to Follow-up|1|||
160840000|NCT00061633|580799806|FG001|Overall Study|Lost to Follow-up|4|||
160840001|NCT00061633|580799805|FG000|Overall Study|Other|1|||
160840002|NCT00061633|580799806|FG001|Overall Study|Other|1|||
160840003|NCT00061633|580799805|FG000|Overall Study|Never received study treatment|0|||
160840004|NCT00061633|580799806|FG001|Overall Study|Never received study treatment|2|||
160840005|NCT01431963|580799807|FG000|Overall Study|Adverse Event|18|||
161250905|NCT00098475|582298498|FG001|Step 1|Declining performance status|1|||
161250906|NCT00098475|582298499|FG002|Step 1|Declining performance status|0|||
161250907|NCT00098475|582298500|FG003|Step 1|Declining performance status|0|||
161250908|NCT00098475|582298497|FG000|Step 1|Insurance issue|0|||
161250909|NCT00098475|582298498|FG001|Step 1|Insurance issue|1|||
161250910|NCT00098475|582298499|FG002|Step 1|Insurance issue|0|||
160840006|NCT01431963|580799807|FG000|Overall Study|Lack of Efficacy|7|||
160840007|NCT01431963|580799807|FG000|Overall Study|Protocol Violation|1|||
160840008|NCT01431963|580799807|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
160840009|NCT01431963|580799807|FG000|Overall Study|Physician Decision|4|||
161250911|NCT00098475|582298500|FG003|Step 1|Insurance issue|0|||
160840010|NCT01431963|580799807|FG000|Overall Study|Withdrawal by Subject|3|||
160840011|NCT02737475|580802418|FG000|Overall Study|Other reasons|0|||
160840012|NCT02737475|580802419|FG001|Overall Study|Other reasons|0|||
160840013|NCT02737475|580802420|FG002|Overall Study|Other reasons|0|||
160840014|NCT02737475|580802421|FG003|Overall Study|Other reasons|0|||
160840015|NCT02737475|580802422|FG004|Overall Study|Other reasons|1|||
160840016|NCT02737475|580802423|FG005|Overall Study|Other reasons|1|||
160840017|NCT02737475|580802424|FG006|Overall Study|Other reasons|0|||
160840018|NCT02737475|580802425|FG007|Overall Study|Other reasons|0|||
161250912|NCT00098475|582298497|FG000|Step 1|Rising paraprotein|0|||
161250913|NCT00098475|582298498|FG001|Step 1|Rising paraprotein|1|||
160840019|NCT02737475|580802426|FG008|Overall Study|Other reasons|1|||
160840020|NCT02737475|580802427|FG009|Overall Study|Other reasons|0|||
160840021|NCT02737475|580802428|FG010|Overall Study|Other reasons|1|||
160840022|NCT02737475|580802429|FG011|Overall Study|Other reasons|0|||
160840023|NCT02737475|580802430|FG012|Overall Study|Other reasons|0|||
160840024|NCT02737475|580802431|FG013|Overall Study|Other reasons|0|||
160840025|NCT02737475|580802432|FG014|Overall Study|Other reasons|0|||
160840026|NCT02737475|580802433|FG015|Overall Study|Other reasons|0|||
160840027|NCT02737475|580802434|FG016|Overall Study|Other reasons|0|||
160840028|NCT02737475|580802435|FG017|Overall Study|Other reasons|0|||
160840029|NCT02737475|580802436|FG018|Overall Study|Other reasons|0|||
160840030|NCT02737475|580802437|FG019|Overall Study|Other reasons|0|||
160840031|NCT02737475|580802438|FG020|Overall Study|Other reasons|0|||
160840032|NCT02737475|580802439|FG021|Overall Study|Other reasons|1|||
160840033|NCT02737475|580802440|FG022|Overall Study|Other reasons|0|||
160840034|NCT02737475|580802441|FG023|Overall Study|Other reasons|1|||
160840035|NCT02737475|580802442|FG024|Overall Study|Other reasons|1|||
160840036|NCT02737475|580802443|FG025|Overall Study|Other reasons|1|||
160840037|NCT02737475|580802444|FG026|Overall Study|Other reasons|0|||
160840038|NCT02737475|580802418|FG000|Overall Study|Death|1|||
160840039|NCT02737475|580802419|FG001|Overall Study|Death|0|||
160840040|NCT02737475|580802420|FG002|Overall Study|Death|0|||
160840041|NCT02737475|580802421|FG003|Overall Study|Death|1|||
160840042|NCT02737475|580802422|FG004|Overall Study|Death|0|||
160840043|NCT02737475|580802423|FG005|Overall Study|Death|0|||
160840044|NCT02737475|580802424|FG006|Overall Study|Death|0|||
160840045|NCT02737475|580802425|FG007|Overall Study|Death|2|||
160840046|NCT02737475|580802426|FG008|Overall Study|Death|0|||
160840047|NCT02737475|580802427|FG009|Overall Study|Death|0|||
160840048|NCT02737475|580802428|FG010|Overall Study|Death|0|||
160840049|NCT02737475|580802429|FG011|Overall Study|Death|4|||
160840050|NCT02737475|580802430|FG012|Overall Study|Death|2|||
160840051|NCT02737475|580802431|FG013|Overall Study|Death|2|||
160840052|NCT02737475|580802432|FG014|Overall Study|Death|0|||
160840053|NCT02737475|580802433|FG015|Overall Study|Death|2|||
160840054|NCT02737475|580802434|FG016|Overall Study|Death|2|||
160840055|NCT02737475|580802435|FG017|Overall Study|Death|2|||
160840056|NCT02737475|580802436|FG018|Overall Study|Death|1|||
160840057|NCT02737475|580802437|FG019|Overall Study|Death|0|||
160840058|NCT02737475|580802438|FG020|Overall Study|Death|0|||
160840059|NCT02737475|580802439|FG021|Overall Study|Death|0|||
160840060|NCT02737475|580802440|FG022|Overall Study|Death|0|||
160840061|NCT02737475|580802441|FG023|Overall Study|Death|0|||
160840062|NCT02737475|580802442|FG024|Overall Study|Death|0|||
160840063|NCT02737475|580802443|FG025|Overall Study|Death|0|||
160840064|NCT02737475|580802444|FG026|Overall Study|Death|0|||
160840065|NCT02737475|580802418|FG000|Overall Study|Participant withdrew consent|0|||
160840066|NCT02737475|580802419|FG001|Overall Study|Participant withdrew consent|0|||
160840067|NCT02737475|580802420|FG002|Overall Study|Participant withdrew consent|0|||
160840068|NCT02737475|580802421|FG003|Overall Study|Participant withdrew consent|0|||
160840069|NCT02737475|580802422|FG004|Overall Study|Participant withdrew consent|0|||
160840070|NCT02737475|580802423|FG005|Overall Study|Participant withdrew consent|2|||
160840071|NCT02737475|580802424|FG006|Overall Study|Participant withdrew consent|0|||
160840072|NCT02737475|580802425|FG007|Overall Study|Participant withdrew consent|0|||
160840073|NCT02737475|580802426|FG008|Overall Study|Participant withdrew consent|0|||
160840074|NCT02737475|580802427|FG009|Overall Study|Participant withdrew consent|0|||
160840075|NCT02737475|580802428|FG010|Overall Study|Participant withdrew consent|0|||
160840076|NCT02737475|580802429|FG011|Overall Study|Participant withdrew consent|0|||
160840077|NCT02737475|580802430|FG012|Overall Study|Participant withdrew consent|0|||
160840078|NCT02737475|580802431|FG013|Overall Study|Participant withdrew consent|0|||
160840079|NCT02737475|580802432|FG014|Overall Study|Participant withdrew consent|1|||
160840080|NCT02737475|580802433|FG015|Overall Study|Participant withdrew consent|0|||
160840081|NCT02737475|580802434|FG016|Overall Study|Participant withdrew consent|0|||
160840082|NCT02737475|580802435|FG017|Overall Study|Participant withdrew consent|2|||
160840083|NCT02737475|580802436|FG018|Overall Study|Participant withdrew consent|1|||
160840084|NCT02737475|580802437|FG019|Overall Study|Participant withdrew consent|0|||
160840085|NCT02737475|580802438|FG020|Overall Study|Participant withdrew consent|2|||
160840086|NCT02737475|580802439|FG021|Overall Study|Participant withdrew consent|0|||
160840087|NCT02737475|580802440|FG022|Overall Study|Participant withdrew consent|0|||
160840088|NCT02737475|580802441|FG023|Overall Study|Participant withdrew consent|0|||
160840089|NCT02737475|580802442|FG024|Overall Study|Participant withdrew consent|0|||
160840090|NCT02737475|580802443|FG025|Overall Study|Participant withdrew consent|0|||
160840091|NCT02737475|580802444|FG026|Overall Study|Participant withdrew consent|0|||
160840092|NCT02737475|580802418|FG000|Overall Study|Lost to Follow-up|0|||
160840093|NCT02737475|580802419|FG001|Overall Study|Lost to Follow-up|0|||
160840094|NCT02737475|580802420|FG002|Overall Study|Lost to Follow-up|0|||
160840095|NCT02737475|580802421|FG003|Overall Study|Lost to Follow-up|0|||
160840096|NCT02737475|580802422|FG004|Overall Study|Lost to Follow-up|0|||
160840097|NCT02737475|580802423|FG005|Overall Study|Lost to Follow-up|0|||
160840098|NCT02737475|580802424|FG006|Overall Study|Lost to Follow-up|0|||
160840099|NCT02737475|580802425|FG007|Overall Study|Lost to Follow-up|0|||
160840100|NCT02737475|580802426|FG008|Overall Study|Lost to Follow-up|0|||
160840101|NCT02737475|580802427|FG009|Overall Study|Lost to Follow-up|0|||
160840102|NCT02737475|580802428|FG010|Overall Study|Lost to Follow-up|0|||
160840103|NCT02737475|580802429|FG011|Overall Study|Lost to Follow-up|0|||
160840104|NCT02737475|580802430|FG012|Overall Study|Lost to Follow-up|0|||
160840105|NCT02737475|580802431|FG013|Overall Study|Lost to Follow-up|0|||
160840106|NCT02737475|580802432|FG014|Overall Study|Lost to Follow-up|0|||
160840107|NCT02737475|580802433|FG015|Overall Study|Lost to Follow-up|1|||
160840108|NCT02737475|580802434|FG016|Overall Study|Lost to Follow-up|0|||
160840109|NCT02737475|580802435|FG017|Overall Study|Lost to Follow-up|0|||
160840110|NCT02737475|580802436|FG018|Overall Study|Lost to Follow-up|0|||
160840111|NCT02737475|580802437|FG019|Overall Study|Lost to Follow-up|0|||
160840112|NCT02737475|580802438|FG020|Overall Study|Lost to Follow-up|0|||
160840113|NCT02737475|580802439|FG021|Overall Study|Lost to Follow-up|0|||
160840114|NCT02737475|580802440|FG022|Overall Study|Lost to Follow-up|0|||
160840115|NCT02737475|580802441|FG023|Overall Study|Lost to Follow-up|0|||
160840116|NCT02737475|580802442|FG024|Overall Study|Lost to Follow-up|0|||
160840117|NCT02737475|580802443|FG025|Overall Study|Lost to Follow-up|0|||
160840118|NCT02737475|580802444|FG026|Overall Study|Lost to Follow-up|0|||
160840119|NCT02737475|580802418|FG000|Overall Study|Disease Progression|0|||
160840120|NCT02737475|580802419|FG001|Overall Study|Disease Progression|0|||
160840121|NCT02737475|580802420|FG002|Overall Study|Disease Progression|0|||
160840122|NCT02737475|580802421|FG003|Overall Study|Disease Progression|0|||
160840123|NCT02737475|580802422|FG004|Overall Study|Disease Progression|0|||
160840124|NCT02737475|580802423|FG005|Overall Study|Disease Progression|0|||
160840125|NCT02737475|580802424|FG006|Overall Study|Disease Progression|0|||
160840126|NCT02737475|580802425|FG007|Overall Study|Disease Progression|0|||
160840127|NCT02737475|580802426|FG008|Overall Study|Disease Progression|0|||
160840128|NCT02737475|580802427|FG009|Overall Study|Disease Progression|0|||
160840129|NCT02737475|580802428|FG010|Overall Study|Disease Progression|0|||
160840130|NCT02737475|580802429|FG011|Overall Study|Disease Progression|0|||
160840131|NCT02737475|580802430|FG012|Overall Study|Disease Progression|0|||
160840132|NCT02737475|580802431|FG013|Overall Study|Disease Progression|0|||
160840133|NCT02737475|580802432|FG014|Overall Study|Disease Progression|0|||
160840134|NCT02737475|580802433|FG015|Overall Study|Disease Progression|0|||
160840135|NCT02737475|580802434|FG016|Overall Study|Disease Progression|0|||
160840136|NCT02737475|580802435|FG017|Overall Study|Disease Progression|0|||
160840137|NCT02737475|580802436|FG018|Overall Study|Disease Progression|0|||
160840138|NCT02737475|580802437|FG019|Overall Study|Disease Progression|0|||
160840139|NCT02737475|580802438|FG020|Overall Study|Disease Progression|0|||
160840140|NCT02737475|580802439|FG021|Overall Study|Disease Progression|0|||
160840141|NCT02737475|580802440|FG022|Overall Study|Disease Progression|0|||
160840142|NCT02737475|580802441|FG023|Overall Study|Disease Progression|0|||
160840143|NCT02737475|580802442|FG024|Overall Study|Disease Progression|0|||
160840144|NCT02737475|580802443|FG025|Overall Study|Disease Progression|0|||
160840145|NCT02737475|580802444|FG026|Overall Study|Disease Progression|1|||
160840146|NCT02255461|580802455|FG000|Overall Study|Adverse Event|0|||
160840147|NCT02255461|580802456|FG001|Overall Study|Adverse Event|1|||
160840148|NCT02255461|580802457|FG002|Overall Study|Adverse Event|0|||
160840149|NCT02255461|580802458|FG003|Overall Study|Adverse Event|0|||
160840150|NCT02255461|580802459|FG004|Overall Study|Adverse Event|1|||
160840151|NCT02255461|580802455|FG000|Overall Study|Withdrawal by Subject|0|||
160840152|NCT02255461|580802456|FG001|Overall Study|Withdrawal by Subject|0|||
160840153|NCT02255461|580802457|FG002|Overall Study|Withdrawal by Subject|1|||
160840154|NCT02255461|580802458|FG003|Overall Study|Withdrawal by Subject|0|||
160840155|NCT02255461|580802459|FG004|Overall Study|Withdrawal by Subject|1|||
160840156|NCT02255461|580802455|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
160840157|NCT02255461|580802456|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
160840158|NCT02255461|580802457|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
160840159|NCT02255461|580802458|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
160840160|NCT02255461|580802459|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
161250914|NCT00098475|582298499|FG002|Step 1|Rising paraprotein|0|||
161250915|NCT00098475|582298500|FG003|Step 1|Rising paraprotein|0|||
160840161|NCT01357551|580802462|FG000|Overall Study|Withdrawal by Subject|6|||
160840162|NCT01357551|580802463|FG001|Overall Study|Withdrawal by Subject|4|||
160840163|NCT01357551|580802462|FG000|Overall Study|Death|0|||
161250916|NCT00098475|582298497|FG000|Step 1|Referred to other physicians|0|||
161250917|NCT00098475|582298498|FG001|Step 1|Referred to other physicians|1|||
160840164|NCT01357551|580802463|FG001|Overall Study|Death|1|||
160840165|NCT01357551|580802462|FG000|Overall Study|Lost to Follow-up|16|||
160840166|NCT01357551|580802463|FG001|Overall Study|Lost to Follow-up|6|||
161250918|NCT00098475|582298499|FG002|Step 1|Referred to other physicians|0|||
160840167|NCT00711971|580802475|FG000|Overall Study|Lost to Follow-up|3|||
160840168|NCT00711971|580802476|FG001|Overall Study|Lost to Follow-up|4|||
160840169|NCT00711971|580802477|FG002|Overall Study|Lost to Follow-up|1|||
160840170|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840171|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840172|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
160840173|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
160840174|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
160840175|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840176|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
160840177|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
160840178|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
160840179|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840180|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840181|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840182|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
160840183|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
160840184|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
160840185|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
160840186|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
160840187|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
160840188|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
160840189|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
160840190|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
160840191|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
160840192|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840193|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840194|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840195|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
160840196|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840197|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840198|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840199|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840200|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840201|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840202|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
160840203|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840204|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840205|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840206|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840207|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840208|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
160840209|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840210|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840211|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840212|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840213|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840214|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840215|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840216|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840217|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
160840218|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840219|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840220|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840221|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
160840222|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840223|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840224|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840225|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
160840226|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840227|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840228|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840229|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
160840230|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160905172|NCT01001377|581048146|FG000|Overall Study|Ineligibility determined|2|||
160905173|NCT01001377|581048147|FG001|Overall Study|Ineligibility determined|0|||
160905174|NCT01001377|581048146|FG000|Overall Study|Withdrawal by Subject|19|||
161139292|NCT01772134|581892656|FG000|Overall Study|Lack of Efficacy|11|||
161139293|NCT01772134|581892657|FG001|Overall Study|Lack of Efficacy|5|||
161139294|NCT01772134|581892658|FG002|Overall Study|Lack of Efficacy|3|||
161139295|NCT01772134|581892656|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
161250919|NCT00098475|582298500|FG003|Step 1|Referred to other physicians|0|||
161250920|NCT00098475|582298497|FG000|Step 1|Criteria to continue treatment not met|0|||
161250921|NCT00098475|582298498|FG001|Step 1|Criteria to continue treatment not met|1|||
160840231|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840232|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840233|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840234|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
160840235|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840236|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161250922|NCT00098475|582298499|FG002|Step 1|Criteria to continue treatment not met|0|||
161250923|NCT00098475|582298500|FG003|Step 1|Criteria to continue treatment not met|0|||
161250924|NCT00098475|582298497|FG000|Step 1|Misinterpretation of lab data|0|||
161250925|NCT00098475|582298498|FG001|Step 1|Misinterpretation of lab data|1|||
161250926|NCT00098475|582298499|FG002|Step 1|Misinterpretation of lab data|0|||
161250927|NCT00098475|582298500|FG003|Step 1|Misinterpretation of lab data|0|||
161250928|NCT00098475|582298497|FG000|Step 1|Patient fell with fracture|1|||
161250929|NCT00098475|582298498|FG001|Step 1|Patient fell with fracture|0|||
161250930|NCT00098475|582298499|FG002|Step 1|Patient fell with fracture|0|||
161250931|NCT00098475|582298500|FG003|Step 1|Patient fell with fracture|0|||
161250932|NCT00098475|582298497|FG000|Step 1|Not documented|0|||
161250933|NCT00098475|582298498|FG001|Step 1|Not documented|1|||
161250934|NCT00098475|582298499|FG002|Step 1|Not documented|0|||
161250935|NCT00098475|582298500|FG003|Step 1|Not documented|0|||
161250936|NCT00098475|582298497|FG000|Step 2|Disease progression|1|||
161250937|NCT00098475|582298498|FG001|Step 2|Disease progression|4|||
161250938|NCT00098475|582298499|FG002|Step 2|Disease progression|0|||
161250939|NCT00098475|582298500|FG003|Step 2|Disease progression|0|||
161250940|NCT00098475|582298497|FG000|Step 2|Adverse Event|2|||
161250941|NCT00098475|582298498|FG001|Step 2|Adverse Event|0|||
161250942|NCT00098475|582298499|FG002|Step 2|Adverse Event|0|||
161250943|NCT00098475|582298500|FG003|Step 2|Adverse Event|0|||
161250944|NCT00098475|582298497|FG000|Step 2|Withdrawal by Subject|0|||
161250945|NCT00098475|582298498|FG001|Step 2|Withdrawal by Subject|2|||
161250946|NCT00098475|582298499|FG002|Step 2|Withdrawal by Subject|0|||
161250947|NCT00098475|582298500|FG003|Step 2|Withdrawal by Subject|0|||
161250948|NCT00098475|582298497|FG000|Step 2|Physician Decision|0|||
161250949|NCT00098475|582298498|FG001|Step 2|Physician Decision|1|||
161250950|NCT00098475|582298499|FG002|Step 2|Physician Decision|0|||
161250951|NCT00098475|582298500|FG003|Step 2|Physician Decision|0|||
161250952|NCT00098475|582298497|FG000|Step 2|Alternative therapy|1|||
161250953|NCT00098475|582298498|FG001|Step 2|Alternative therapy|2|||
161250954|NCT00098475|582298499|FG002|Step 2|Alternative therapy|0|||
161250955|NCT00098475|582298500|FG003|Step 2|Alternative therapy|0|||
161250956|NCT00098475|582298497|FG000|Step 2|Never started treatment|1|||
161250957|NCT00098475|582298498|FG001|Step 2|Never started treatment|1|||
161250958|NCT00098475|582298499|FG002|Step 2|Never started treatment|0|||
161250959|NCT00098475|582298500|FG003|Step 2|Never started treatment|0|||
161250960|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
161250961|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
161250962|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
161250963|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
161250964|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
161250965|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
161250966|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
161250967|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
161250968|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
161250969|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
161250970|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
160840237|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840238|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
160840239|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161250971|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
161250972|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
161250973|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
161250974|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
161250975|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
160840240|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840241|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
161250976|NCT01067521|582298503|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
161250977|NCT01067521|582298504|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
161250978|NCT01067521|582298503|FG000|Open-Label Period|Death|3|||
161250979|NCT01067521|582298504|FG001|Open-Label Period|Death|1|||
161250980|NCT01067521|582298503|FG000|Open-Label Period|Adverse Event|30|||
161250981|NCT01067521|582298504|FG001|Open-Label Period|Adverse Event|28|||
160840242|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840243|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840244|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840245|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
161250982|NCT01067521|582298503|FG000|Open-Label Period|Withdrawal by Subject|160|||
161250983|NCT01067521|582298504|FG001|Open-Label Period|Withdrawal by Subject|88|||
161250984|NCT01067521|582298503|FG000|Open-Label Period|Physician Decision|13|||
161250985|NCT01067521|582298504|FG001|Open-Label Period|Physician Decision|11|||
161250986|NCT01067521|582298503|FG000|Open-Label Period|Non-compliance with study drug|5|||
161250987|NCT01067521|582298504|FG001|Open-Label Period|Non-compliance with study drug|0|||
161250988|NCT01067521|582298503|FG000|Open-Label Period|Protocol Violation|3|||
161250989|NCT01067521|582298504|FG001|Open-Label Period|Protocol Violation|0|||
161250990|NCT01067521|582298503|FG000|Open-Label Period|Pregnancy|14|||
161250991|NCT01067521|582298504|FG001|Open-Label Period|Pregnancy|8|||
161250992|NCT01067521|582298503|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
161250993|NCT01067521|582298504|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
161250994|NCT01067521|582298503|FG000|Open-Label Period|Lost to Follow-up|21|||
161250995|NCT01067521|582298504|FG001|Open-Label Period|Lost to Follow-up|20|||
161250996|NCT00057941|582298508|FG000|Overall Study|Death|1|||
161250997|NCT00057941|582298509|FG001|Overall Study|Death|2|||
161250998|NCT00057941|582298508|FG000|Overall Study|Adverse Event|7|||
161250999|NCT00057941|582298509|FG001|Overall Study|Adverse Event|9|||
161251000|NCT00057941|582298508|FG000|Overall Study|Lack of Efficacy|54|||
161251001|NCT00057941|582298509|FG001|Overall Study|Lack of Efficacy|53|||
161251002|NCT00057941|582298508|FG000|Overall Study|Withdrawal by Subject|6|||
161251003|NCT00057941|582298509|FG001|Overall Study|Withdrawal by Subject|1|||
161251004|NCT00057941|582298508|FG000|Overall Study|still on treatment|3|||
161251005|NCT00057941|582298509|FG001|Overall Study|still on treatment|1|||
161251006|NCT00057941|582298508|FG000|Overall Study|insurance, symptomatic deterioration|1|||
161251007|NCT00057941|582298509|FG001|Overall Study|insurance, symptomatic deterioration|3|||
161251008|NCT00057941|582298508|FG000|Overall Study|Ineligible|2|||
161251009|NCT00057941|582298509|FG001|Overall Study|Ineligible|5|||
161251010|NCT04142658|582298510|FG000|Overall Study|Death|2|||
161251011|NCT04142658|582298511|FG001|Overall Study|Death|1|||
161251012|NCT04142658|582298510|FG000|Overall Study|Lost to Follow-up|4|||
161251013|NCT04142658|582298511|FG001|Overall Study|Lost to Follow-up|13|||
161251014|NCT04142658|582298510|FG000|Overall Study|Withdrawal by Subject|9|||
161251015|NCT04142658|582298511|FG001|Overall Study|Withdrawal by Subject|16|||
161251016|NCT01781234|582298512|FG000|Overall Study|Adverse Event|2|||
161251017|NCT01781234|582298513|FG001|Overall Study|Adverse Event|0|||
161251018|NCT01781234|582298512|FG000|Overall Study|Protocol Violation|3|||
161251019|NCT01781234|582298513|FG001|Overall Study|Protocol Violation|0|||
161251020|NCT01781234|582298512|FG000|Overall Study|Withdrawal by Subject|4|||
161251021|NCT01781234|582298513|FG001|Overall Study|Withdrawal by Subject|3|||
161251022|NCT01685216|582298520|FG000|Overall Study|Did not receive study drug|1|||
161251023|NCT01294449|582298521|FG000|Overall Study|Death|11|||
161251024|NCT01294449|582298522|FG001|Overall Study|Death|12|||
161251025|NCT01294449|582298521|FG000|Overall Study|Withdrawal by Subject|1|||
161251026|NCT01294449|582298522|FG001|Overall Study|Withdrawal by Subject|3|||
161251027|NCT02466386|582298523|FG000|Overall Study|Adverse Event|5|||
161251028|NCT02466386|582298523|FG000|Overall Study|Protocol Violation|2|||
161251029|NCT02466386|582298523|FG000|Overall Study|Withdrawal by Subject|14|||
161251030|NCT02466386|582298523|FG000|Overall Study|Lost to Follow-up|5|||
161251031|NCT02466386|582298523|FG000|Overall Study|Lack of Efficacy|8|||
161251032|NCT02466386|582298523|FG000|Overall Study|Other|10|||
160840246|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840247|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
160840248|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840249|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
160840250|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840251|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
161251033|NCT05317195|582298524|FG000|Randomization|Withdrawal by Subject|1|||
161251034|NCT05317195|582298524|FG000|Randomization|Discontinued|6|||
161251035|NCT05317195|582298524|FG000|Admission|Withdrawal by Subject|2|||
161251036|NCT00889252|582298525|FG000|Overall Study|Adverse Event|2|||
161251037|NCT00889252|582298526|FG001|Overall Study|Adverse Event|4|||
161251038|NCT00889252|582298525|FG000|Overall Study|Withdrawal by Subject|3|||
161251039|NCT00889252|582298526|FG001|Overall Study|Withdrawal by Subject|0|||
161251040|NCT00889252|582298525|FG000|Overall Study|Protocol Violation|2|||
161251041|NCT00889252|582298526|FG001|Overall Study|Protocol Violation|0|||
161251042|NCT01833169|582298530|FG000|Overall Study|Disease Progression|99|||
161251043|NCT01833169|582298530|FG000|Overall Study|Adverse Event|33|||
161251044|NCT01833169|582298530|FG000|Overall Study|Withdrawal by Subject|9|||
161251045|NCT01833169|582298530|FG000|Overall Study|Death|3|||
161251046|NCT01833169|582298530|FG000|Overall Study|Physician Decision|2|||
161251047|NCT04718129|582298535|FG000|Overall Study|Lost to Follow-up|6|||
161251048|NCT04718129|582298536|FG001|Overall Study|Lost to Follow-up|7|||
160840252|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840253|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840254|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840255|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840256|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840257|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840258|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840259|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840260|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
160840261|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
160840262|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840263|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840264|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840265|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840266|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840267|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840268|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840269|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840270|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840271|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840272|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
161251049|NCT02212457|582298537|FG000|Overall Study|Adverse Event|1|||
161251050|NCT02212457|582298538|FG001|Overall Study|Adverse Event|2|||
161251051|NCT02212457|582298539|FG002|Overall Study|Adverse Event|2|||
161251052|NCT02212457|582298540|FG003|Overall Study|Adverse Event|2|||
161251053|NCT02212457|582298541|FG004|Overall Study|Adverse Event|0|||
161251054|NCT02212457|582298542|FG005|Overall Study|Adverse Event|1|||
161251055|NCT02212457|582298537|FG000|Overall Study|Withdrawal by Subject|8|||
161251056|NCT02212457|582298538|FG001|Overall Study|Withdrawal by Subject|10|||
161251057|NCT02212457|582298539|FG002|Overall Study|Withdrawal by Subject|8|||
161251058|NCT02212457|582298540|FG003|Overall Study|Withdrawal by Subject|6|||
161251059|NCT02212457|582298541|FG004|Overall Study|Withdrawal by Subject|5|||
161251060|NCT02212457|582298542|FG005|Overall Study|Withdrawal by Subject|4|||
161251061|NCT02212457|582298537|FG000|Overall Study|Lost to Follow-up|6|||
161251062|NCT02212457|582298538|FG001|Overall Study|Lost to Follow-up|7|||
161251063|NCT02212457|582298539|FG002|Overall Study|Lost to Follow-up|4|||
161251064|NCT02212457|582298540|FG003|Overall Study|Lost to Follow-up|1|||
161251065|NCT02212457|582298541|FG004|Overall Study|Lost to Follow-up|8|||
161251066|NCT02212457|582298542|FG005|Overall Study|Lost to Follow-up|4|||
161251067|NCT02212457|582298537|FG000|Overall Study|Protocol Violation|2|||
161251068|NCT02212457|582298538|FG001|Overall Study|Protocol Violation|1|||
161251069|NCT02212457|582298539|FG002|Overall Study|Protocol Violation|0|||
161251070|NCT02212457|582298540|FG003|Overall Study|Protocol Violation|1|||
161251071|NCT02212457|582298541|FG004|Overall Study|Protocol Violation|2|||
161251072|NCT02212457|582298542|FG005|Overall Study|Protocol Violation|3|||
161251073|NCT02212457|582298537|FG000|Overall Study|Other|2|||
161251074|NCT02212457|582298538|FG001|Overall Study|Other|1|||
161251075|NCT02212457|582298539|FG002|Overall Study|Other|2|||
161251076|NCT02212457|582298540|FG003|Overall Study|Other|1|||
161251077|NCT02212457|582298541|FG004|Overall Study|Other|0|||
161251078|NCT02212457|582298542|FG005|Overall Study|Other|1|||
160840273|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
160840274|NCT03100058|580802482|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840275|NCT03100058|580802483|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840276|NCT03100058|580802484|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840277|NCT03100058|580802485|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840278|NCT03100058|580802486|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840279|NCT03100058|580802487|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
161251079|NCT01120691|582298545|FG000|Overall Study|Adverse Event|59|||
161251080|NCT01120691|582298546|FG001|Overall Study|Adverse Event|67|||
161251081|NCT01120691|582298547|FG002|Overall Study|Adverse Event|47|||
161251082|NCT01120691|582298545|FG000|Overall Study|Subject withdrew consent|33|||
161251083|NCT01120691|582298546|FG001|Overall Study|Subject withdrew consent|50|||
160840280|NCT03100058|580802488|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
161251084|NCT01120691|582298547|FG002|Overall Study|Subject withdrew consent|44|||
160840281|NCT03100058|580802489|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840282|NCT03100058|580802490|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840283|NCT03100058|580802491|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840284|NCT03100058|580802492|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840285|NCT03100058|580802493|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840286|NCT03100058|580802494|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
160840287|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840288|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840289|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161251085|NCT01120691|582298545|FG000|Overall Study|Death|21|||
161251086|NCT01120691|582298546|FG001|Overall Study|Death|22|||
160840290|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840291|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840292|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840293|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
161251087|NCT01120691|582298547|FG002|Overall Study|Death|24|||
161251088|NCT01120691|582298545|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
161251089|NCT01120691|582298546|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
161251090|NCT01120691|582298547|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
161251091|NCT01120691|582298545|FG000|Overall Study|Administrative problems|15|||
161251092|NCT01120691|582298546|FG001|Overall Study|Administrative problems|8|||
161251093|NCT01120691|582298547|FG002|Overall Study|Administrative problems|9|||
161251094|NCT01120691|582298545|FG000|Overall Study|Protocol deviation|13|||
161251095|NCT01120691|582298546|FG001|Overall Study|Protocol deviation|12|||
161251096|NCT01120691|582298547|FG002|Overall Study|Protocol deviation|12|||
161251097|NCT01120691|582298545|FG000|Overall Study|Lost to Follow-up|5|||
161251098|NCT01120691|582298546|FG001|Overall Study|Lost to Follow-up|6|||
161251099|NCT01120691|582298547|FG002|Overall Study|Lost to Follow-up|4|||
161251100|NCT01120691|582298545|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161251101|NCT01120691|582298546|FG001|Overall Study|Abnormal test procedure result(s)|2|||
161251102|NCT01120691|582298547|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161251103|NCT01120691|582298545|FG000|Overall Study|Patient's inability to use the device|3|||
161251104|NCT01120691|582298546|FG001|Overall Study|Patient's inability to use the device|1|||
161251105|NCT01120691|582298547|FG002|Overall Study|Patient's inability to use the device|0|||
161251106|NCT01120691|582298545|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161251107|NCT01120691|582298546|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161251108|NCT01120691|582298547|FG002|Overall Study|Abnormal laboratory value(s)|4|||
161251109|NCT00772148|582298549|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
161251110|NCT00772148|582298550|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
161251111|NCT00772148|582298549|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
161251112|NCT00772148|582298550|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
161251113|NCT00772148|582298549|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
161251114|NCT00772148|582298550|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
161251115|NCT00772148|582298549|FG000|Maintenance Phase (Week 52)|Death|2|||
161251116|NCT00772148|582298550|FG001|Maintenance Phase (Week 52)|Death|2|||
161251117|NCT00772148|582298549|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
161251118|NCT00772148|582298550|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
161251119|NCT00772148|582298549|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
161251120|NCT00772148|582298550|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
161251121|NCT00772148|582298549|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
161251122|NCT00772148|582298550|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
161251123|NCT00688844|582298551|FG000|Overall Study|Lost to Follow-up|10|||
161251124|NCT01321697|582298556|FG000|Overall Study|Study Terminated|7|||
161251125|NCT00857818|582298557|FG000|Overall Study|Lack of Efficacy|1|||
161251126|NCT00857818|582298558|FG001|Overall Study|Lack of Efficacy|0|||
161251127|NCT00857818|582298557|FG000|Overall Study|Adverse Event|3|||
161251128|NCT00857818|582298558|FG001|Overall Study|Adverse Event|0|||
161251129|NCT00857818|582298557|FG000|Overall Study|Withdrawal by Subject|0|||
161251130|NCT00857818|582298558|FG001|Overall Study|Withdrawal by Subject|4|||
161251131|NCT00857818|582298557|FG000|Overall Study|Sponsor terminated study|6|||
161251132|NCT00857818|582298558|FG001|Overall Study|Sponsor terminated study|4|||
161251133|NCT00857818|582298557|FG000|Overall Study|Investigator decision|1|||
161251134|NCT00857818|582298558|FG001|Overall Study|Investigator decision|0|||
161251135|NCT02061280|582298562|FG000|Overall Study|Protocol Violation|12|||
161251136|NCT02061280|582298563|FG001|Overall Study|Protocol Violation|8|||
161251137|NCT02061280|582298562|FG000|Overall Study|moved out of state|0|||
161251138|NCT02061280|582298563|FG001|Overall Study|moved out of state|1|||
161251139|NCT02061280|582298562|FG000|Overall Study|Withdrawal by Subject|1|||
161251140|NCT02061280|582298563|FG001|Overall Study|Withdrawal by Subject|2|||
161251141|NCT02061280|582298562|FG000|Overall Study|Lost to Follow-up|5|||
161251142|NCT02061280|582298563|FG001|Overall Study|Lost to Follow-up|1|||
161251143|NCT01977456|582298564|FG000|Overall Study|Death|5|||
161251144|NCT01841060|582300326|FG000|Overall Study|Protocol Violation|10|||
161251145|NCT02419573|582300327|FG000|Overall Study|Lost to Follow-up|3|||
161251146|NCT02419573|582300328|FG001|Overall Study|Lost to Follow-up|0|||
161251147|NCT02419573|582300327|FG000|Overall Study|Withdrawal by Subject|1|||
161251148|NCT02419573|582300328|FG001|Overall Study|Withdrawal by Subject|0|||
161251149|NCT00493792|582300329|FG000|Overall Study|Death|55|||
161251150|NCT00493792|582300330|FG001|Overall Study|Death|50|||
161251151|NCT00493792|582300329|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
161251152|NCT00493792|582300330|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
161251153|NCT00685035|582300335|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
161251154|NCT00685035|582300336|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
161251155|NCT02426541|582300337|FG000|Overall Study|Protocol Violation|1|||
161251156|NCT02426541|582300338|FG001|Overall Study|Protocol Violation|0|||
161251157|NCT00784979|582300341|FG000|Overall Study|incomplete data|6|||
161251158|NCT04241133|582300344|FG000|Overall Study|COVID19 Precautions|14|||
161251159|NCT04241133|582300345|FG001|Overall Study|COVID19 Precautions|34|||
161251160|NCT04968925|582300350|FG000|Phase I- Period 1|COVID-19 related|0|||
161251161|NCT04968925|582300351|FG001|Phase I- Period 1|COVID-19 related|1|||
161251162|NCT04968925|582300352|FG002|Phase I- Period 1|COVID-19 related|0|||
161251163|NCT04968925|582300353|FG003|Phase I- Period 1|COVID-19 related|0|||
161251164|NCT04968925|582300350|FG000|Phase I- Period 1|Subject enrolled in error|1|||
161251165|NCT04968925|582300351|FG001|Phase I- Period 1|Subject enrolled in error|1|||
161251166|NCT04968925|582300352|FG002|Phase I- Period 1|Subject enrolled in error|0|||
161251167|NCT04968925|582300353|FG003|Phase I- Period 1|Subject enrolled in error|0|||
161251168|NCT04968925|582300350|FG000|Phase II- Period 1|COVID-19 Related|0|||
161251169|NCT04968925|582300351|FG001|Phase II- Period 1|COVID-19 Related|0|||
161251170|NCT04968925|582300352|FG002|Phase II- Period 1|COVID-19 Related|6|||
161251171|NCT04968925|582300353|FG003|Phase II- Period 1|COVID-19 Related|6|||
161251172|NCT04968925|582300350|FG000|Phase II- Period 1|Subject enrolled in error|0|||
161251173|NCT04968925|582300351|FG001|Phase II- Period 1|Subject enrolled in error|0|||
161251174|NCT04968925|582300352|FG002|Phase II- Period 1|Subject enrolled in error|1|||
161251175|NCT04968925|582300353|FG003|Phase II- Period 1|Subject enrolled in error|0|||
161251176|NCT04968925|582300350|FG000|Phase II -Period 2|COVID-19 related|0|||
161251177|NCT04968925|582300351|FG001|Phase II -Period 2|COVID-19 related|0|||
161251178|NCT04968925|582300352|FG002|Phase II -Period 2|COVID-19 related|4|||
161251179|NCT04968925|582300353|FG003|Phase II -Period 2|COVID-19 related|3|||
161251180|NCT04968925|582300350|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
161251181|NCT04968925|582300351|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
161251182|NCT04968925|582300352|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
161251183|NCT04968925|582300353|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
161251184|NCT00835796|582300359|FG000|First Intervention|Withdrawal by Subject|0|||
161251185|NCT00835796|582300360|FG001|First Intervention|Withdrawal by Subject|1|||
161251186|NCT00396630|582300361|FG000|Overall Study|Lost to Follow-up|1|||
161251187|NCT00396630|582300362|FG001|Overall Study|Lost to Follow-up|1|||
160840294|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840295|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840296|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
160840297|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
160840298|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
160840299|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
160840300|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840301|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840302|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840303|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840304|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840305|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840306|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840307|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840308|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840309|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840310|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
160840311|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
160840312|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
160840313|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840314|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840315|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840316|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840317|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161251188|NCT00396630|582300361|FG000|Overall Study|Withdrawal by Subject|1|||
161251189|NCT00396630|582300362|FG001|Overall Study|Withdrawal by Subject|1|||
161251190|NCT00396630|582300361|FG000|Overall Study|Not vaccinated at Visit 3|3|||
161251191|NCT00396630|582300362|FG001|Overall Study|Not vaccinated at Visit 3|3|||
161251192|NCT00876265|582300363|FG000|Overall Study|Miscellaneous reasons|4|||
161251193|NCT00876265|582300363|FG000|Overall Study|Lost to Follow-up|6|||
161251194|NCT00876265|582300363|FG000|Overall Study|Withdrawal by Subject|2|||
161251195|NCT02327325|582300364|FG000|Overall Study|Withdrawal by Subject|1|||
160840318|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840319|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
161251196|NCT02327325|582300365|FG001|Overall Study|Withdrawal by Subject|4|||
161251197|NCT02327325|582300366|FG002|Overall Study|Withdrawal by Subject|4|||
161251198|NCT02327325|582300364|FG000|Overall Study|Excluded by Study Team|0|||
161251199|NCT02327325|582300365|FG001|Overall Study|Excluded by Study Team|0|||
161251200|NCT02327325|582300366|FG002|Overall Study|Excluded by Study Team|1|||
161251201|NCT00651183|582300371|FG000|Overall Study|Lack of Efficacy|1|||
160840320|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840321|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840322|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
160840323|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
160840324|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
160840325|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
160840326|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840327|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840328|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840329|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840330|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840331|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840332|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840333|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840334|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840335|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840336|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
160840337|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840338|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
160840339|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840340|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840341|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840342|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840343|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840344|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840345|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840346|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840347|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840348|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840349|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840350|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
160840351|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
160840352|NCT03100058|580802482|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840353|NCT03100058|580802483|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840354|NCT03100058|580802484|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840355|NCT03100058|580802485|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840356|NCT03100058|580802486|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840357|NCT03100058|580802487|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840358|NCT03100058|580802488|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840359|NCT03100058|580802489|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840360|NCT03100058|580802490|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840361|NCT03100058|580802491|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
160840362|NCT03100058|580802492|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840363|NCT03100058|580802493|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160991948|NCT04888585|581359929|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160991949|NCT04888585|581359930|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160840364|NCT03100058|580802494|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
160840365|NCT01067144|580802497|FG000|Treatment|Did not receive allocated intervention|4|||
160840366|NCT01067144|580802498|FG001|Treatment|Did not receive allocated intervention|7|||
160840367|NCT01067144|580802497|FG000|Follow-up|Lost to Follow-up|22|||
160840368|NCT01067144|580802498|FG001|Follow-up|Lost to Follow-up|12|||
160840369|NCT01067144|580802497|FG000|Follow-up|Censored owing to second surgery|19|||
160840370|NCT01067144|580802498|FG001|Follow-up|Censored owing to second surgery|28|||
160840371|NCT01067144|580802497|FG000|Follow-up|Withdrawal by Subject|18|||
160840372|NCT01067144|580802498|FG001|Follow-up|Withdrawal by Subject|14|||
160840373|NCT01067144|580802497|FG000|Follow-up|Surgery cancelled|0|||
160840374|NCT01067144|580802498|FG001|Follow-up|Surgery cancelled|1|||
160840375|NCT01067144|580802497|FG000|Follow-up|Death|0|||
160840376|NCT01067144|580802498|FG001|Follow-up|Death|1|||
160840377|NCT02718716|580802500|FG000|Overall Study|Lack of Efficacy|1|||
160840378|NCT02718716|580802501|FG001|Overall Study|Lack of Efficacy|0|||
160840379|NCT02718716|580802502|FG002|Overall Study|Lack of Efficacy|0|||
160840380|NCT02718716|580802503|FG003|Overall Study|Lack of Efficacy|0|||
160840381|NCT02718716|580802504|FG004|Overall Study|Lack of Efficacy|0|||
160840382|NCT01835158|580802505|FG000|Overall Study|Withdrawal by Subject|1|||
160991950|NCT04888585|581359931|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160840383|NCT01835158|580802506|FG001|Overall Study|Withdrawal by Subject|6|||
160840384|NCT00596830|580802509|FG000|Overall Study|Death|258|||
160840385|NCT00596830|580802510|FG001|Overall Study|Death|247|||
160840386|NCT00596830|580802509|FG000|Overall Study|Lost to Follow-up|7|||
160840387|NCT00596830|580802510|FG001|Overall Study|Lost to Follow-up|11|||
160840388|NCT00596830|580802509|FG000|Overall Study|Withdrawal by Subject|22|||
160840389|NCT00596830|580802510|FG001|Overall Study|Withdrawal by Subject|12|||
160840390|NCT00596830|580802509|FG000|Overall Study|Study terminated by sponsor|51|||
160840391|NCT00596830|580802510|FG001|Overall Study|Study terminated by sponsor|62|||
160840392|NCT00596830|580802509|FG000|Overall Study|Follow-up was discontinued|1|||
160840393|NCT00596830|580802510|FG001|Overall Study|Follow-up was discontinued|0|||
160840394|NCT00596830|580802509|FG000|Overall Study|Randomized but not treated|3|||
160840395|NCT00596830|580802510|FG001|Overall Study|Randomized but not treated|7|||
160840396|NCT01919801|580802513|FG000|Overall Study|Withdrawal by Subject|1|||
160840397|NCT01919801|580802514|FG001|Overall Study|Withdrawal by Subject|0|||
160840398|NCT01919801|580802513|FG000|Overall Study|Physician Decision|0|||
160840399|NCT01919801|580802514|FG001|Overall Study|Physician Decision|1|||
160840400|NCT01919801|580802513|FG000|Overall Study|Lost to Follow-up|0|||
160840401|NCT01919801|580802514|FG001|Overall Study|Lost to Follow-up|1|||
160840402|NCT01919801|580802513|FG000|Overall Study|Other|0|||
160840403|NCT01919801|580802514|FG001|Overall Study|Other|1|||
160840404|NCT01677858|580802519|FG000|Overall Study|Adverse Event|0|||
160840405|NCT01677858|580802520|FG001|Overall Study|Adverse Event|0|||
160840406|NCT01677858|580802521|FG002|Overall Study|Adverse Event|2|||
160840407|NCT01677858|580802522|FG003|Overall Study|Adverse Event|3|||
160840408|NCT01677858|580802523|FG004|Overall Study|Adverse Event|13|||
160840409|NCT01677858|580802519|FG000|Overall Study|Death|0|||
160840410|NCT01677858|580802520|FG001|Overall Study|Death|0|||
160840411|NCT01677858|580802521|FG002|Overall Study|Death|0|||
160840412|NCT01677858|580802522|FG003|Overall Study|Death|0|||
160840413|NCT01677858|580802523|FG004|Overall Study|Death|1|||
160840414|NCT01677858|580802519|FG000|Overall Study|Physician Decision|1|||
160840415|NCT01677858|580802520|FG001|Overall Study|Physician Decision|0|||
160840416|NCT01677858|580802521|FG002|Overall Study|Physician Decision|2|||
160840417|NCT01677858|580802522|FG003|Overall Study|Physician Decision|0|||
160840418|NCT01677858|580802523|FG004|Overall Study|Physician Decision|12|||
160840419|NCT01677858|580802519|FG000|Overall Study|Progressive Disease|2|||
160840420|NCT01677858|580802520|FG001|Overall Study|Progressive Disease|1|||
160840421|NCT01677858|580802521|FG002|Overall Study|Progressive Disease|9|||
160840422|NCT01677858|580802522|FG003|Overall Study|Progressive Disease|3|||
160840423|NCT01677858|580802523|FG004|Overall Study|Progressive Disease|43|||
160840424|NCT01677858|580802519|FG000|Overall Study|Withdrawal by Subject|0|||
160840425|NCT01677858|580802520|FG001|Overall Study|Withdrawal by Subject|1|||
160840426|NCT01677858|580802521|FG002|Overall Study|Withdrawal by Subject|1|||
160840427|NCT01677858|580802522|FG003|Overall Study|Withdrawal by Subject|0|||
160840428|NCT01677858|580802523|FG004|Overall Study|Withdrawal by Subject|15|||
160840429|NCT01677858|580802519|FG000|Overall Study|Lost to Follow-up|0|||
160840430|NCT01677858|580802520|FG001|Overall Study|Lost to Follow-up|0|||
160840431|NCT01677858|580802521|FG002|Overall Study|Lost to Follow-up|0|||
160840432|NCT01677858|580802522|FG003|Overall Study|Lost to Follow-up|0|||
160840433|NCT01677858|580802523|FG004|Overall Study|Lost to Follow-up|1|||
160840434|NCT00988091|580802524|FG000|Double-blind Period|Withdrawal by Subject|15|||
160840435|NCT00988091|580802525|FG001|Double-blind Period|Withdrawal by Subject|13|||
160840436|NCT00988091|580802524|FG000|Double-blind Period|Lost to Follow-up|12|||
160840437|NCT00988091|580802525|FG001|Double-blind Period|Lost to Follow-up|14|||
160840438|NCT00988091|580802524|FG000|Double-blind Period|Other|8|||
160840439|NCT00988091|580802525|FG001|Double-blind Period|Other|8|||
160840440|NCT00988091|580802524|FG000|Double-blind Period|Adverse Event|6|||
160840441|NCT00988091|580802525|FG001|Double-blind Period|Adverse Event|9|||
160840442|NCT00988091|580802524|FG000|Double-blind Period|Use of exclusionary medication|2|||
160840443|NCT00988091|580802525|FG001|Double-blind Period|Use of exclusionary medication|3|||
160840444|NCT00988091|580802524|FG000|Open-label Period|Adverse Event|4|||
161139296|NCT01772134|581892657|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
161139297|NCT01772134|581892658|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
160840445|NCT00988091|580802525|FG001|Open-label Period|Adverse Event|7|||
160840446|NCT00988091|580802524|FG000|Open-label Period|Use of exclusionary medication|1|||
160840447|NCT00988091|580802525|FG001|Open-label Period|Use of exclusionary medication|1|||
160840448|NCT00988091|580802524|FG000|Open-label Period|Protocol Violation|1|||
160840449|NCT00988091|580802525|FG001|Open-label Period|Protocol Violation|1|||
160840450|NCT00988091|580802524|FG000|Open-label Period|Withdrawal by Subject|10|||
160840451|NCT00988091|580802525|FG001|Open-label Period|Withdrawal by Subject|16|||
160840452|NCT00988091|580802524|FG000|Open-label Period|Lost to Follow-up|3|||
161139298|NCT01772134|581892656|FG000|Overall Study|Randomized Study Medication Not Received|2|||
161139299|NCT01772134|581892657|FG001|Overall Study|Randomized Study Medication Not Received|0|||
161139300|NCT01772134|581892658|FG002|Overall Study|Randomized Study Medication Not Received|1|||
161139301|NCT02500550|581892663|FG000|Overall Study|Death|7|||
161139302|NCT03293680|581892664|FG000|Overall Study|Death|1|||
161139303|NCT03293680|581892664|FG000|Overall Study|Did not meet inclusion criteria|8|||
161139304|NCT00636818|581892665|FG000|Overall Study|Adverse Event|1|||
161139305|NCT00636818|581892665|FG000|Overall Study|Lost to Follow-up|2|||
161139306|NCT00636818|581892665|FG000|Overall Study|Entry Criteria Exclusion|3|||
160905175|NCT01001377|581048147|FG001|Overall Study|Withdrawal by Subject|20|||
160905176|NCT01001377|581048146|FG000|Overall Study|Lost to Follow-up|14|||
160905177|NCT01001377|581048147|FG001|Overall Study|Lost to Follow-up|17|||
160905178|NCT01001377|581048146|FG000|Overall Study|Death|391|||
160905179|NCT01001377|581048147|FG001|Overall Study|Death|384|||
160905180|NCT02732119|581048150|FG000|Phase I|Adverse Event|1|||
160905181|NCT02732119|581048151|FG001|Phase I|Adverse Event|3|||
160905182|NCT02732119|581048152|FG002|Phase I|Adverse Event|1|||
160905183|NCT02732119|581048153|FG003|Phase I|Adverse Event|0|||
160905184|NCT02732119|581048154|FG004|Phase I|Adverse Event|0|||
160905185|NCT02732119|581048150|FG000|Phase I|Progressive disease|7|||
160905186|NCT02732119|581048151|FG001|Phase I|Progressive disease|3|||
160905187|NCT02732119|581048152|FG002|Phase I|Progressive disease|2|||
160905188|NCT02732119|581048153|FG003|Phase I|Progressive disease|0|||
160905189|NCT02732119|581048154|FG004|Phase I|Progressive disease|0|||
160905190|NCT02732119|581048150|FG000|Phase I|Protocol deviation|0|||
160905191|NCT02732119|581048151|FG001|Phase I|Protocol deviation|1|||
160905192|NCT02732119|581048152|FG002|Phase I|Protocol deviation|0|||
160905193|NCT02732119|581048153|FG003|Phase I|Protocol deviation|0|||
160905194|NCT02732119|581048154|FG004|Phase I|Protocol deviation|0|||
160905195|NCT02732119|581048150|FG000|Phase I|Physician Decision|0|||
160905196|NCT02732119|581048151|FG001|Phase I|Physician Decision|3|||
160905197|NCT02732119|581048152|FG002|Phase I|Physician Decision|4|||
160905198|NCT02732119|581048153|FG003|Phase I|Physician Decision|0|||
160905199|NCT02732119|581048154|FG004|Phase I|Physician Decision|0|||
160905200|NCT02732119|581048150|FG000|Phase II|Adverse Event|0|||
160905201|NCT02732119|581048151|FG001|Phase II|Adverse Event|0|||
160905202|NCT02732119|581048152|FG002|Phase II|Adverse Event|0|||
160905203|NCT02732119|581048153|FG003|Phase II|Adverse Event|3|||
160905204|NCT02732119|581048154|FG004|Phase II|Adverse Event|3|||
160905205|NCT02732119|581048150|FG000|Phase II|Death|0|||
160905206|NCT02732119|581048151|FG001|Phase II|Death|0|||
160905207|NCT02732119|581048152|FG002|Phase II|Death|0|||
160905208|NCT02732119|581048153|FG003|Phase II|Death|1|||
160905209|NCT02732119|581048154|FG004|Phase II|Death|0|||
160905210|NCT02732119|581048150|FG000|Phase II|Progressive dissease|0|||
160905211|NCT02732119|581048151|FG001|Phase II|Progressive dissease|0|||
160905212|NCT02732119|581048152|FG002|Phase II|Progressive dissease|0|||
160905213|NCT02732119|581048153|FG003|Phase II|Progressive dissease|30|||
160905214|NCT02732119|581048154|FG004|Phase II|Progressive dissease|23|||
160905215|NCT02732119|581048150|FG000|Phase II|Study terminated by sponsor|0|||
160905216|NCT02732119|581048151|FG001|Phase II|Study terminated by sponsor|0|||
160905217|NCT02732119|581048152|FG002|Phase II|Study terminated by sponsor|0|||
160905218|NCT02732119|581048153|FG003|Phase II|Study terminated by sponsor|2|||
160905219|NCT02732119|581048154|FG004|Phase II|Study terminated by sponsor|2|||
160905220|NCT02732119|581048150|FG000|Phase II|Other|0|||
160905221|NCT02732119|581048151|FG001|Phase II|Other|0|||
160905222|NCT02732119|581048152|FG002|Phase II|Other|0|||
160905223|NCT02732119|581048153|FG003|Phase II|Other|2|||
160905224|NCT02732119|581048154|FG004|Phase II|Other|0|||
160905225|NCT02732119|581048150|FG000|Phase II|Physician Decision|0|||
160905226|NCT02732119|581048151|FG001|Phase II|Physician Decision|0|||
160905227|NCT02732119|581048152|FG002|Phase II|Physician Decision|0|||
160905228|NCT02732119|581048153|FG003|Phase II|Physician Decision|8|||
160905229|NCT02732119|581048154|FG004|Phase II|Physician Decision|5|||
160905230|NCT00964860|581048155|FG000|Overall Study|Withdrawal by Subject|0|||
160905231|NCT00964860|581048156|FG001|Overall Study|Withdrawal by Subject|1|||
160905232|NCT00867568|581048157|FG000|Overall Study|Lack of Efficacy|10|||
160905233|NCT00867568|581048157|FG000|Overall Study|Adverse Event|4|||
160905234|NCT00867568|581048157|FG000|Overall Study|Withdrawal by Subject|1|||
160905235|NCT04343261|581048158|FG000|Overall Study|Adverse Event|1|||
160905236|NCT04343261|581048158|FG000|Overall Study|received inadequate amount of antibodies|7|||
160905237|NCT01056653|581048159|FG000|Overall Study|Lost to Follow-up|0|||
160905238|NCT01056653|581048160|FG001|Overall Study|Lost to Follow-up|0|||
160905239|NCT01056653|581048161|FG002|Overall Study|Lost to Follow-up|2|||
160905240|NCT05275400|581048162|FG000|Treatment Period|Adverse Event|7|||
160905241|NCT05275400|581048163|FG001|Treatment Period|Adverse Event|1|||
160905242|NCT05275400|581048162|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
160905243|NCT05275400|581048163|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
160905244|NCT05275400|581048162|FG000|Treatment Period|Death|5|||
160905245|NCT05275400|581048163|FG001|Treatment Period|Death|2|||
160905246|NCT05275400|581048162|FG000|Treatment Period|Protocol Violation|1|||
160905247|NCT05275400|581048163|FG001|Treatment Period|Protocol Violation|0|||
160905248|NCT05275400|581048162|FG000|Treatment Period|Physician Decision|5|||
160905249|NCT05275400|581048163|FG001|Treatment Period|Physician Decision|4|||
160905250|NCT05275400|581048162|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
160905251|NCT05275400|581048163|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
160905252|NCT05275400|581048162|FG000|Treatment Period|Withdrawal by Subject|30|||
160905253|NCT05275400|581048163|FG001|Treatment Period|Withdrawal by Subject|12|||
160905254|NCT05275400|581048162|FG000|Treatment Period|Lost to Follow-up|1|||
160905255|NCT05275400|581048163|FG001|Treatment Period|Lost to Follow-up|5|||
160905256|NCT05275400|581048162|FG000|Treatment Period|Lack of Efficacy|1|||
160840453|NCT00988091|580802525|FG001|Open-label Period|Lost to Follow-up|5|||
161251202|NCT00651183|582300372|FG001|Overall Study|Lack of Efficacy|0|||
161251203|NCT00651183|582300371|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
161251204|NCT00651183|582300372|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
161251205|NCT00651183|582300371|FG000|Overall Study|Tolerability insufficient|5|||
160840454|NCT00988091|580802524|FG000|Open-label Period|Other|2|||
160840455|NCT00988091|580802525|FG001|Open-label Period|Other|3|||
160840456|NCT03078855|580802529|FG000|Overall Study|Lack of Efficacy|62|||
160840457|NCT03078855|580802530|FG001|Overall Study|Lack of Efficacy|31|||
161251206|NCT00651183|582300372|FG001|Overall Study|Tolerability insufficient|2|||
161251207|NCT00651183|582300371|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
161251208|NCT00651183|582300372|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
161251209|NCT00651183|582300371|FG000|Overall Study|Withdrawal by Subject|6|||
161251210|NCT00651183|582300372|FG001|Overall Study|Withdrawal by Subject|3|||
161251211|NCT00651183|582300371|FG000|Overall Study|Lost to Follow-up|3|||
161251212|NCT00651183|582300372|FG001|Overall Study|Lost to Follow-up|1|||
161251213|NCT00651183|582300371|FG000|Overall Study|Other reasons|4|||
161251214|NCT00651183|582300372|FG001|Overall Study|Other reasons|2|||
161251215|NCT00651183|582300371|FG000|Overall Study|missing|1|||
161251216|NCT00651183|582300372|FG001|Overall Study|missing|0|||
161251217|NCT00695110|582300373|FG000|Treatment Period 1|Adverse Event|1|||
161251218|NCT00695110|582300373|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161251219|NCT00695110|582300373|FG000|Treatment Period 3|Withdrawal by Subject|1|||
161251220|NCT00695110|582300373|FG000|Treatment Period 4|Adverse Event|1|||
161251221|NCT01933919|582300385|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
161251222|NCT01933919|582300386|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
161251223|NCT01933919|582300385|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
161251224|NCT01933919|582300386|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
161251225|NCT01933919|582300385|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
161251226|NCT01933919|582300386|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
161251227|NCT01933919|582300385|FG000|Open-label Long-term Phase|Adverse Event|2|||
161251228|NCT01933919|582300386|FG001|Open-label Long-term Phase|Adverse Event|0|||
161251229|NCT01933919|582300385|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
161251230|NCT01933919|582300386|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
161251231|NCT01933919|582300385|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
161251232|NCT01933919|582300386|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
161251233|NCT01933919|582300385|FG000|Open-label Long-term Phase|Other|1|||
161251234|NCT01933919|582300386|FG001|Open-label Long-term Phase|Other|2|||
161251235|NCT02575339|582300387|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161251236|NCT02575339|582300388|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161251237|NCT02575339|582300389|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161251238|NCT02575339|582300387|FG000|Study Treatment|Disease Progression|5|||
160840458|NCT03078855|580802529|FG000|Overall Study|Death|1|||
160840459|NCT03078855|580802530|FG001|Overall Study|Death|0|||
160840460|NCT03078855|580802529|FG000|Overall Study|Withdrawal by Subject|12|||
160840461|NCT03078855|580802530|FG001|Overall Study|Withdrawal by Subject|6|||
160840462|NCT03078855|580802529|FG000|Overall Study|Physician Decision|3|||
160840463|NCT03078855|580802530|FG001|Overall Study|Physician Decision|2|||
160840464|NCT03078855|580802529|FG000|Overall Study|Second Malignancy|4|||
160905257|NCT05275400|581048163|FG001|Treatment Period|Lack of Efficacy|0|||
160840465|NCT03078855|580802530|FG001|Overall Study|Second Malignancy|0|||
160840466|NCT03078855|580802529|FG000|Overall Study|Ineligible|2|||
160840467|NCT03078855|580802530|FG001|Overall Study|Ineligible|0|||
160840468|NCT03078855|580802529|FG000|Overall Study|Withdrew before day 1 treatment|2|||
160840469|NCT03078855|580802530|FG001|Overall Study|Withdrew before day 1 treatment|1|||
160905258|NCT05275400|581048162|FG000|Treatment Period|Sponsor Decision|1|||
160905259|NCT05275400|581048163|FG001|Treatment Period|Sponsor Decision|0|||
160905260|NCT05275400|581048162|FG000|Follow-Up Period|Death|2|||
160905261|NCT05275400|581048163|FG001|Follow-Up Period|Death|0|||
160905262|NCT05275400|581048162|FG000|Follow-Up Period|Protocol Violation|1|||
160905263|NCT05275400|581048163|FG001|Follow-Up Period|Protocol Violation|0|||
161251239|NCT02575339|582300388|FG001|Study Treatment|Disease Progression|2|||
161251240|NCT02575339|582300389|FG002|Study Treatment|Disease Progression|0|||
160840470|NCT03194646|580802531|FG000|Overall Study|Adverse Event|24|||
160840471|NCT03194646|580802532|FG001|Overall Study|Adverse Event|25|||
160840472|NCT03194646|580802533|FG002|Overall Study|Adverse Event|14|||
160840473|NCT03194646|580802534|FG003|Overall Study|Adverse Event|17|||
160840474|NCT03194646|580802531|FG000|Overall Study|Lack of Efficacy|4|||
160840475|NCT03194646|580802532|FG001|Overall Study|Lack of Efficacy|2|||
161251241|NCT02575339|582300387|FG000|Study Treatment|Adverse Event|1|||
161251242|NCT02575339|582300388|FG001|Study Treatment|Adverse Event|2|||
161251243|NCT02575339|582300389|FG002|Study Treatment|Adverse Event|0|||
161251244|NCT02575339|582300387|FG000|Follow up|Death|6|||
160840476|NCT03194646|580802533|FG002|Overall Study|Lack of Efficacy|2|||
160905264|NCT05275400|581048162|FG000|Follow-Up Period|Withdrawal by Subject|3|||
160905265|NCT05275400|581048163|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161251245|NCT02575339|582300388|FG001|Follow up|Death|2|||
161251246|NCT02575339|582300389|FG002|Follow up|Death|0|||
161251247|NCT02575339|582300387|FG000|Follow up|Study Terminated|0|||
161251248|NCT02575339|582300388|FG001|Follow up|Study Terminated|2|||
161251249|NCT02575339|582300389|FG002|Follow up|Study Terminated|0|||
161251250|NCT02575339|582300387|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
161251251|NCT02575339|582300388|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
161251252|NCT02575339|582300389|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
161251253|NCT04675775|582300390|FG000|Overall Study|Withdrawal by Subject|7|||
161251254|NCT00108082|582300393|FG000|Overall Study|Adverse Event|14|||
161251255|NCT00108082|582300394|FG001|Overall Study|Adverse Event|12|||
161251256|NCT00108082|582300395|FG002|Overall Study|Adverse Event|17|||
161251257|NCT00108082|582300393|FG000|Overall Study|Lost to Follow-up|6|||
161251258|NCT00108082|582300394|FG001|Overall Study|Lost to Follow-up|3|||
161251259|NCT00108082|582300395|FG002|Overall Study|Lost to Follow-up|7|||
161251260|NCT00108082|582300393|FG000|Overall Study|Consent Withdrawn|3|||
161251261|NCT00108082|582300394|FG001|Overall Study|Consent Withdrawn|3|||
161251262|NCT00108082|582300395|FG002|Overall Study|Consent Withdrawn|5|||
161251263|NCT00108082|582300393|FG000|Overall Study|Protocol Violation|1|||
161251264|NCT00108082|582300394|FG001|Overall Study|Protocol Violation|2|||
161251265|NCT00108082|582300395|FG002|Overall Study|Protocol Violation|0|||
161251266|NCT00108082|582300393|FG000|Overall Study|Lack of Efficacy|3|||
161251267|NCT00108082|582300394|FG001|Overall Study|Lack of Efficacy|1|||
161251268|NCT00108082|582300395|FG002|Overall Study|Lack of Efficacy|2|||
161251269|NCT00108082|582300393|FG000|Overall Study|Amendment 4: > Month 12|5|||
161251270|NCT00108082|582300394|FG001|Overall Study|Amendment 4: > Month 12|7|||
161251271|NCT00108082|582300395|FG002|Overall Study|Amendment 4: > Month 12|5|||
161251272|NCT00108082|582300393|FG000|Overall Study|Woman of Child-bearing Potential|2|||
161251273|NCT00108082|582300394|FG001|Overall Study|Woman of Child-bearing Potential|0|||
161251274|NCT00108082|582300395|FG002|Overall Study|Woman of Child-bearing Potential|2|||
161251275|NCT00108082|582300393|FG000|Overall Study|Incorrectly Randomized|0|||
161251276|NCT00108082|582300394|FG001|Overall Study|Incorrectly Randomized|0|||
161251277|NCT00108082|582300395|FG002|Overall Study|Incorrectly Randomized|2|||
161251278|NCT00108082|582300393|FG000|Overall Study|Non-compliance|1|||
161251279|NCT00108082|582300394|FG001|Overall Study|Non-compliance|0|||
161251280|NCT00108082|582300395|FG002|Overall Study|Non-compliance|2|||
161251281|NCT00108082|582300393|FG000|Overall Study|Stopped Study Medication|0|||
161251282|NCT00108082|582300394|FG001|Overall Study|Stopped Study Medication|0|||
161251283|NCT00108082|582300395|FG002|Overall Study|Stopped Study Medication|1|||
161251284|NCT00108082|582300393|FG000|Overall Study|Site Closed Study|0|||
161251285|NCT00108082|582300394|FG001|Overall Study|Site Closed Study|2|||
161251286|NCT00108082|582300395|FG002|Overall Study|Site Closed Study|0|||
161251287|NCT00108082|582300393|FG000|Overall Study|Protocol Amendment|0|||
160840477|NCT03194646|580802534|FG003|Overall Study|Lack of Efficacy|12|||
160840478|NCT03194646|580802531|FG000|Overall Study|Lost to Follow-up|30|||
160840479|NCT03194646|580802532|FG001|Overall Study|Lost to Follow-up|22|||
160840480|NCT03194646|580802533|FG002|Overall Study|Lost to Follow-up|12|||
160840481|NCT03194646|580802534|FG003|Overall Study|Lost to Follow-up|35|||
160840482|NCT03194646|580802531|FG000|Overall Study|Non-compliance with study drug|4|||
160840483|NCT03194646|580802532|FG001|Overall Study|Non-compliance with study drug|0|||
160840484|NCT03194646|580802533|FG002|Overall Study|Non-compliance with study drug|1|||
160840485|NCT03194646|580802534|FG003|Overall Study|Non-compliance with study drug|1|||
160840486|NCT03194646|580802531|FG000|Overall Study|Other|89|||
160840487|NCT03194646|580802532|FG001|Overall Study|Other|68|||
160840488|NCT03194646|580802533|FG002|Overall Study|Other|34|||
160840489|NCT03194646|580802534|FG003|Overall Study|Other|31|||
160840490|NCT03194646|580802531|FG000|Overall Study|Physician Decision|7|||
160840491|NCT03194646|580802532|FG001|Overall Study|Physician Decision|9|||
160840492|NCT03194646|580802533|FG002|Overall Study|Physician Decision|5|||
160991951|NCT04888585|581359932|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
161251288|NCT00108082|582300394|FG001|Overall Study|Protocol Amendment|1|||
161251289|NCT00108082|582300395|FG002|Overall Study|Protocol Amendment|0|||
161251290|NCT00108082|582300393|FG000|Overall Study|Study Medication Not Tapered|0|||
161251291|NCT00108082|582300394|FG001|Overall Study|Study Medication Not Tapered|1|||
161251292|NCT00108082|582300395|FG002|Overall Study|Study Medication Not Tapered|0|||
161251293|NCT00108082|582300393|FG000|Overall Study|Subject Left Site Location|1|||
161251294|NCT00108082|582300394|FG001|Overall Study|Subject Left Site Location|0|||
161251295|NCT00108082|582300395|FG002|Overall Study|Subject Left Site Location|0|||
161251296|NCT00108082|582300393|FG000|Overall Study|Investigator Not at Site|1|||
161251297|NCT00108082|582300394|FG001|Overall Study|Investigator Not at Site|0|||
161251298|NCT00108082|582300395|FG002|Overall Study|Investigator Not at Site|0|||
161251299|NCT00108082|582300393|FG000|Overall Study|Blood Pressure Not Controlled|1|||
161251300|NCT00108082|582300394|FG001|Overall Study|Blood Pressure Not Controlled|0|||
160840493|NCT03194646|580802534|FG003|Overall Study|Physician Decision|4|||
160840494|NCT03194646|580802531|FG000|Overall Study|Pregnancy|4|||
160840495|NCT03194646|580802532|FG001|Overall Study|Pregnancy|5|||
160840496|NCT03194646|580802533|FG002|Overall Study|Pregnancy|1|||
160840497|NCT03194646|580802534|FG003|Overall Study|Pregnancy|2|||
160840498|NCT03194646|580802531|FG000|Overall Study|Protocol Violation|4|||
160840499|NCT03194646|580802532|FG001|Overall Study|Protocol Violation|2|||
160840500|NCT03194646|580802533|FG002|Overall Study|Protocol Violation|1|||
160840501|NCT03194646|580802534|FG003|Overall Study|Protocol Violation|1|||
160840502|NCT03194646|580802531|FG000|Overall Study|Site terminated by sponsor|0|||
160840503|NCT03194646|580802532|FG001|Overall Study|Site terminated by sponsor|0|||
160840504|NCT03194646|580802533|FG002|Overall Study|Site terminated by sponsor|2|||
160840505|NCT03194646|580802534|FG003|Overall Study|Site terminated by sponsor|0|||
160840506|NCT03194646|580802531|FG000|Overall Study|Study terminated by sponsor|62|||
160840507|NCT03194646|580802532|FG001|Overall Study|Study terminated by sponsor|61|||
160840508|NCT03194646|580802533|FG002|Overall Study|Study terminated by sponsor|30|||
160840509|NCT03194646|580802534|FG003|Overall Study|Study terminated by sponsor|34|||
160840510|NCT03194646|580802531|FG000|Overall Study|Withdrawal by Subject|75|||
160840511|NCT03194646|580802532|FG001|Overall Study|Withdrawal by Subject|74|||
160840512|NCT03194646|580802533|FG002|Overall Study|Withdrawal by Subject|36|||
160840513|NCT03194646|580802534|FG003|Overall Study|Withdrawal by Subject|131|||
160840514|NCT03194646|580802531|FG000|Overall Study|Missing|1|||
160840515|NCT03194646|580802532|FG001|Overall Study|Missing|0|||
160840516|NCT03194646|580802533|FG002|Overall Study|Missing|1|||
160840517|NCT03194646|580802534|FG003|Overall Study|Missing|12|||
160840518|NCT04869358|580802535|FG000|Overall Study|Wish to have children.|1|||
160840519|NCT04869358|580802536|FG001|Overall Study|Wish to have children.|0|||
160840520|NCT04869358|580802537|FG002|Overall Study|Wish to have children.|0|||
160840521|NCT04869358|580802538|FG003|Overall Study|Wish to have children.|0|||
160840522|NCT04427072|580802539|FG000|Randomized Treatment Phase|Progressive disease|9|||
160840523|NCT04427072|580802540|FG001|Randomized Treatment Phase|Progressive disease|4|||
160840524|NCT04427072|580802539|FG000|Randomized Treatment Phase|Adverse Event|3|||
160840525|NCT04427072|580802540|FG001|Randomized Treatment Phase|Adverse Event|1|||
160840526|NCT04427072|580802539|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
160840527|NCT04427072|580802540|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
160840528|NCT04427072|580802539|FG000|Randomized Treatment Phase|Death|0|||
160840529|NCT04427072|580802540|FG001|Randomized Treatment Phase|Death|1|||
160840530|NCT04427072|580802539|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
160840531|NCT04427072|580802540|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
160840532|NCT04427072|580802539|FG000|Extension Treatment Phase|Progressive disease|0|||
160840533|NCT04427072|580802540|FG001|Extension Treatment Phase|Progressive disease|5|||
160840534|NCT03550404|580802545|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
160840535|NCT03550404|580802546|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
160840536|NCT03550404|580802547|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
160840537|NCT03550404|580802545|FG000|Phase 2|Vacated position|1|||
160840538|NCT03550404|580802546|FG001|Phase 2|Vacated position|0|||
160840539|NCT03550404|580802547|FG002|Phase 2|Vacated position|0|||
160840540|NCT00820222|580802550|FG000|Overall Study|Lost to Follow-up|10|||
160840541|NCT00820222|580802551|FG001|Overall Study|Lost to Follow-up|9|||
160840542|NCT00820222|580802550|FG000|Overall Study|Withdrawal by Subject|19|||
160840543|NCT00820222|580802551|FG001|Overall Study|Withdrawal by Subject|21|||
160840544|NCT00820222|580802550|FG000|Overall Study|Physician Decision|93|||
160840545|NCT00820222|580802551|FG001|Overall Study|Physician Decision|88|||
160840546|NCT00820222|580802550|FG000|Overall Study|Sponsor Terminated Study|43|||
160840547|NCT00820222|580802551|FG001|Overall Study|Sponsor Terminated Study|65|||
160840548|NCT00820222|580802550|FG000|Overall Study|Unkown|11|||
160840549|NCT00820222|580802551|FG001|Overall Study|Unkown|7|||
160840550|NCT02690714|580802552|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
160840551|NCT02690714|580802552|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
160840552|NCT01894022|580802563|FG000|Overall Study|Death|1|||
160840553|NCT01894022|580802564|FG001|Overall Study|Death|0|||
160840554|NCT01894022|580802563|FG000|Overall Study|Adverse Event, non-fatal|1|||
160840555|NCT01894022|580802564|FG001|Overall Study|Adverse Event, non-fatal|0|||
160905266|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Physician Decision|0|||
160840556|NCT01894022|580802563|FG000|Overall Study|Study Closed/terminated|7|||
160840557|NCT01894022|580802564|FG001|Overall Study|Study Closed/terminated|10|||
160840558|NCT02202538|580802566|FG000|Overall Study|Withdrawal by Subject|5|||
160840559|NCT02202538|580802566|FG000|Overall Study|Did not meet all inclusion criteria|2|||
160840560|NCT02202538|580802566|FG000|Overall Study|Investigator Decision|1|||
160840561|NCT04496453|580802567|FG000|Overall Study|Lost to Follow-up|6|||
160840562|NCT00767819|580802568|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
160840563|NCT00767819|580802569|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
160840564|NCT00767819|580802570|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
160840565|NCT00767819|580802568|FG000|Overall Study|Withdrawal by Subject|1|||
160840566|NCT00767819|580802569|FG001|Overall Study|Withdrawal by Subject|1|||
160840567|NCT00767819|580802570|FG002|Overall Study|Withdrawal by Subject|0|||
160840568|NCT00767819|580802568|FG000|Overall Study|Administrative problems|0|||
161251301|NCT00108082|582300395|FG002|Overall Study|Blood Pressure Not Controlled|0|||
160840569|NCT00767819|580802569|FG001|Overall Study|Administrative problems|1|||
160840570|NCT00767819|580802570|FG002|Overall Study|Administrative problems|0|||
160840571|NCT00767819|580802568|FG000|Overall Study|Death|2|||
160840572|NCT00767819|580802569|FG001|Overall Study|Death|3|||
160840573|NCT00767819|580802570|FG002|Overall Study|Death|0|||
160840574|NCT00767819|580802568|FG000|Overall Study|Adverse Event|2|||
160840575|NCT00767819|580802569|FG001|Overall Study|Adverse Event|0|||
160840576|NCT00767819|580802570|FG002|Overall Study|Adverse Event|0|||
160840577|NCT00767819|580802568|FG000|Overall Study|Abnormal lab values|1|||
160840578|NCT00767819|580802569|FG001|Overall Study|Abnormal lab values|0|||
160840579|NCT00767819|580802570|FG002|Overall Study|Abnormal lab values|0|||
160840580|NCT00767819|580802568|FG000|Overall Study|Lost to Follow-up|1|||
160840581|NCT00767819|580802569|FG001|Overall Study|Lost to Follow-up|0|||
160840582|NCT00767819|580802570|FG002|Overall Study|Lost to Follow-up|0|||
160840583|NCT03916081|580802571|FG000|Overall Study|Adverse Event|1|||
160840584|NCT03916081|580802572|FG001|Overall Study|Adverse Event|0|||
160840585|NCT03916081|580802573|FG002|Overall Study|Adverse Event|0|||
160840586|NCT03916081|580802571|FG000|Overall Study|Physician Decision|0|||
160840587|NCT03916081|580802572|FG001|Overall Study|Physician Decision|0|||
160840588|NCT03916081|580802573|FG002|Overall Study|Physician Decision|1|||
160840589|NCT03916081|580802571|FG000|Overall Study|Lost to Follow-up|0|||
160840590|NCT03916081|580802572|FG001|Overall Study|Lost to Follow-up|1|||
160840591|NCT03916081|580802573|FG002|Overall Study|Lost to Follow-up|0|||
160840592|NCT03916081|580802571|FG000|Overall Study|Withdrawal by Subject|3|||
160840593|NCT03916081|580802572|FG001|Overall Study|Withdrawal by Subject|0|||
160840594|NCT03916081|580802573|FG002|Overall Study|Withdrawal by Subject|1|||
160840595|NCT03916081|580802571|FG000|Overall Study|Worsening of AD|0|||
160840596|NCT03916081|580802572|FG001|Overall Study|Worsening of AD|0|||
160840597|NCT03916081|580802573|FG002|Overall Study|Worsening of AD|1|||
160840598|NCT01371305|580802577|FG000|Overall Study|Adverse Event|0|||
160840599|NCT01371305|580802578|FG001|Overall Study|Adverse Event|0|||
160840600|NCT01371305|580802579|FG002|Overall Study|Adverse Event|0|||
160840601|NCT01371305|580802580|FG003|Overall Study|Adverse Event|2|||
160840602|NCT01371305|580802581|FG004|Overall Study|Adverse Event|1|||
160840603|NCT01371305|580802582|FG005|Overall Study|Adverse Event|0|||
160840604|NCT01371305|580802577|FG000|Overall Study|Study terminated by sponsor|0|||
160905267|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Physician Decision|1|||
160905268|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Physician Decision|0|||
160905269|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
160905270|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
160905271|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
160905272|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
160905273|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
161251302|NCT01091103|582300399|FG000|Overall Study|Adverse Event|1|||
161251303|NCT01091103|582300399|FG000|Overall Study|Progressive Disease|3|||
161251304|NCT01270620|582300400|FG000|Overall Study|Withdrawal by Subject|1|||
161251305|NCT01270620|582300401|FG001|Overall Study|Withdrawal by Subject|3|||
161251306|NCT01045707|582300402|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
160905274|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
160905275|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Other|4|||
160905276|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Other|4|||
160905277|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Other|0|||
161251307|NCT01045707|582300403|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
161251308|NCT01045707|582300402|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
161251309|NCT01045707|582300403|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
161251310|NCT01045707|582300402|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
161251311|NCT01045707|582300403|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
161251312|NCT01045707|582300402|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
160905278|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
160905279|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
160905280|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
161251313|NCT01045707|582300403|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
160840605|NCT01371305|580802578|FG001|Overall Study|Study terminated by sponsor|0|||
160840606|NCT01371305|580802579|FG002|Overall Study|Study terminated by sponsor|0|||
160840607|NCT01371305|580802580|FG003|Overall Study|Study terminated by sponsor|0|||
160840608|NCT01371305|580802581|FG004|Overall Study|Study terminated by sponsor|3|||
160840609|NCT01371305|580802582|FG005|Overall Study|Study terminated by sponsor|1|||
160840610|NCT01371305|580802577|FG000|Overall Study|Subject request|0|||
160840611|NCT01371305|580802578|FG001|Overall Study|Subject request|0|||
160840612|NCT01371305|580802579|FG002|Overall Study|Subject request|0|||
160840613|NCT01371305|580802580|FG003|Overall Study|Subject request|0|||
160840614|NCT01371305|580802581|FG004|Overall Study|Subject request|0|||
160840615|NCT01371305|580802582|FG005|Overall Study|Subject request|1|||
160840616|NCT00235716|580802583|FG000|Overall Study|Death|26|||
160840617|NCT00235716|580802584|FG001|Overall Study|Death|39|||
160840618|NCT00235716|580802585|FG002|Overall Study|Death|32|||
160840619|NCT00235716|580802586|FG003|Overall Study|Death|31|||
160905281|NCT02585960|581048164|FG000|PK/Safety Assessment Period|Screen Failure|0|||
161251314|NCT01045707|582300402|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
161251315|NCT01045707|582300403|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
161251316|NCT01045707|582300402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
161251317|NCT01045707|582300403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
161251318|NCT01045707|582300402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
161251319|NCT01045707|582300403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
161251320|NCT01045707|582300402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
161251321|NCT01045707|582300403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
161251322|NCT01045707|582300402|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
161251323|NCT01045707|582300403|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
161251324|NCT00348816|582300404|FG000|Overall Study|Noncompliance with radiation treatment|1|||
161251325|NCT00809965|582300405|FG000|Overall Study|Death|194|||
161251326|NCT00809965|582300406|FG001|Overall Study|Death|147|||
160840620|NCT00235716|580802583|FG000|Overall Study|Withdrawal by Subject|23|||
160840621|NCT00235716|580802584|FG001|Overall Study|Withdrawal by Subject|19|||
161251327|NCT00809965|582300407|FG002|Overall Study|Death|196|||
161251328|NCT00809965|582300405|FG000|Overall Study|Lost to Follow-up|17|||
161251329|NCT00809965|582300406|FG001|Overall Study|Lost to Follow-up|10|||
161251330|NCT00809965|582300407|FG002|Overall Study|Lost to Follow-up|18|||
161251331|NCT00809965|582300405|FG000|Overall Study|Withdrawal by Subject|405|||
161251332|NCT00809965|582300406|FG001|Overall Study|Withdrawal by Subject|448|||
161251333|NCT00809965|582300407|FG002|Overall Study|Withdrawal by Subject|441|||
161251334|NCT00809965|582300405|FG000|Overall Study|Other Reason|167|||
161251335|NCT00809965|582300406|FG001|Overall Study|Other Reason|170|||
161251336|NCT00809965|582300407|FG002|Overall Study|Other Reason|189|||
161251337|NCT02780167|582300408|FG000|Overall Study|Adverse Event|9|||
161251338|NCT02780167|582300409|FG001|Overall Study|Adverse Event|8|||
161251339|NCT02780167|582300410|FG002|Overall Study|Adverse Event|8|||
161251340|NCT02780167|582300411|FG003|Overall Study|Adverse Event|12|||
161251341|NCT02780167|582300412|FG004|Overall Study|Adverse Event|8|||
160840622|NCT00235716|580802585|FG002|Overall Study|Withdrawal by Subject|17|||
160840623|NCT00235716|580802586|FG003|Overall Study|Withdrawal by Subject|18|||
160840624|NCT00235716|580802583|FG000|Overall Study|Lost to Follow-up|12|||
160840625|NCT00235716|580802584|FG001|Overall Study|Lost to Follow-up|7|||
160840626|NCT00235716|580802585|FG002|Overall Study|Lost to Follow-up|14|||
160840627|NCT00235716|580802586|FG003|Overall Study|Lost to Follow-up|10|||
160840628|NCT00235716|580802583|FG000|Overall Study|Adverse Event|1|||
160840629|NCT00235716|580802584|FG001|Overall Study|Adverse Event|1|||
160840630|NCT00235716|580802585|FG002|Overall Study|Adverse Event|1|||
160840631|NCT00235716|580802586|FG003|Overall Study|Adverse Event|0|||
160840632|NCT00235716|580802583|FG000|Overall Study|Physician Decision|0|||
160840633|NCT00235716|580802584|FG001|Overall Study|Physician Decision|1|||
160991952|NCT04888585|581359933|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
160991953|NCT04888585|581359934|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
160991954|NCT04888585|581359935|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
160991955|NCT04888585|581359936|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
160991956|NCT03822351|581359937|FG000|Overall Study|Death|27|||
160991957|NCT03822351|581359938|FG001|Overall Study|Death|23|||
160991958|NCT03822351|581359939|FG002|Overall Study|Death|24|||
160840634|NCT00235716|580802585|FG002|Overall Study|Physician Decision|1|||
160840635|NCT00235716|580802586|FG003|Overall Study|Physician Decision|3|||
160840636|NCT02999633|580802587|FG000|Overall Study|Adverse Event|2|||
160840637|NCT02999633|580802587|FG000|Overall Study|Progressive disease|12|||
160840638|NCT01545050|580802588|FG000|Overall Study|Lack of Efficacy|0|||
160840639|NCT01545050|580802589|FG001|Overall Study|Lack of Efficacy|0|||
160840640|NCT01545050|580802590|FG002|Overall Study|Lack of Efficacy|0|||
160840641|NCT01545050|580802591|FG003|Overall Study|Lack of Efficacy|3|||
160840642|NCT01545050|580802592|FG004|Overall Study|Lack of Efficacy|2|||
160840643|NCT01545050|580802588|FG000|Overall Study|Adverse Event|1|||
160991959|NCT03822351|581359937|FG000|Overall Study|Lost to Follow-up|6|||
160991960|NCT03822351|581359938|FG001|Overall Study|Lost to Follow-up|2|||
160991961|NCT03822351|581359939|FG002|Overall Study|Lost to Follow-up|1|||
160991962|NCT03822351|581359937|FG000|Overall Study|Withdrawal by Subject|10|||
160840644|NCT01545050|580802589|FG001|Overall Study|Adverse Event|1|||
160991963|NCT03822351|581359938|FG001|Overall Study|Withdrawal by Subject|4|||
160991964|NCT03822351|581359939|FG002|Overall Study|Withdrawal by Subject|6|||
160991965|NCT03822351|581359937|FG000|Overall Study|Progressive Disease|2|||
161251342|NCT02780167|582300408|FG000|Overall Study|Lack of Efficacy|6|||
161251343|NCT02780167|582300409|FG001|Overall Study|Lack of Efficacy|5|||
161251344|NCT02780167|582300410|FG002|Overall Study|Lack of Efficacy|6|||
161251345|NCT02780167|582300411|FG003|Overall Study|Lack of Efficacy|1|||
161251346|NCT02780167|582300412|FG004|Overall Study|Lack of Efficacy|0|||
161251347|NCT02780167|582300408|FG000|Overall Study|Lost to Follow-up|2|||
161251348|NCT02780167|582300409|FG001|Overall Study|Lost to Follow-up|0|||
161251349|NCT02780167|582300410|FG002|Overall Study|Lost to Follow-up|1|||
160840645|NCT01545050|580802590|FG002|Overall Study|Adverse Event|2|||
160840646|NCT01545050|580802591|FG003|Overall Study|Adverse Event|2|||
160840647|NCT01545050|580802592|FG004|Overall Study|Adverse Event|0|||
160840648|NCT01545050|580802588|FG000|Overall Study|Discontinued study treatment|1|||
160840649|NCT01545050|580802589|FG001|Overall Study|Discontinued study treatment|0|||
160840650|NCT01545050|580802590|FG002|Overall Study|Discontinued study treatment|0|||
160840651|NCT01545050|580802591|FG003|Overall Study|Discontinued study treatment|0|||
160840652|NCT01545050|580802592|FG004|Overall Study|Discontinued study treatment|0|||
160840653|NCT01545050|580802588|FG000|Overall Study|Withdrawal by Subject|1|||
160840654|NCT01545050|580802589|FG001|Overall Study|Withdrawal by Subject|0|||
160905282|NCT02585960|581048165|FG001|PK/Safety Assessment Period|Screen Failure|0|||
160905283|NCT02585960|581048166|FG002|PK/Safety Assessment Period|Screen Failure|1|||
160905284|NCT02585960|581048164|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
160905285|NCT02585960|581048165|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
160905286|NCT02585960|581048166|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
160840655|NCT01545050|580802590|FG002|Overall Study|Withdrawal by Subject|0|||
160840656|NCT01545050|580802591|FG003|Overall Study|Withdrawal by Subject|2|||
160840657|NCT01545050|580802592|FG004|Overall Study|Withdrawal by Subject|1|||
160840658|NCT01545050|580802588|FG000|Overall Study|Participant no longer meets study criteria|0|||
160840659|NCT01545050|580802589|FG001|Overall Study|Participant no longer meets study criteria|2|||
160840660|NCT01545050|580802590|FG002|Overall Study|Participant no longer meets study criteria|0|||
160840661|NCT01545050|580802591|FG003|Overall Study|Participant no longer meets study criteria|0|||
160840662|NCT01545050|580802592|FG004|Overall Study|Participant no longer meets study criteria|1|||
160840663|NCT01545050|580802588|FG000|Overall Study|Administrative reason by sponsor|4|||
160840664|NCT01545050|580802589|FG001|Overall Study|Administrative reason by sponsor|2|||
160840665|NCT01545050|580802590|FG002|Overall Study|Administrative reason by sponsor|3|||
160840666|NCT01545050|580802591|FG003|Overall Study|Administrative reason by sponsor|5|||
160840667|NCT01545050|580802592|FG004|Overall Study|Administrative reason by sponsor|5|||
160840668|NCT02249182|580802595|FG000|Treatment Phase|Lost to Follow-up|4|||
160840669|NCT02249182|580802596|FG001|Treatment Phase|Lost to Follow-up|0|||
160840670|NCT02249182|580802597|FG002|Treatment Phase|Lost to Follow-up|0|||
160840671|NCT02249182|580802598|FG003|Treatment Phase|Lost to Follow-up|0|||
160840672|NCT02249182|580802599|FG004|Treatment Phase|Lost to Follow-up|0|||
160840673|NCT03244826|580802608|FG000|Overall Study|Withdrawal by Subject|2|||
160840674|NCT03244826|580802609|FG001|Overall Study|Withdrawal by Subject|0|||
160840675|NCT03244826|580802608|FG000|Overall Study|Transplant delayed or withdrawn|12|||
160840676|NCT03244826|580802609|FG001|Overall Study|Transplant delayed or withdrawn|10|||
160840677|NCT04356040|580802610|FG000|Overall Study|Death|2|||
160840678|NCT04356040|580802611|FG001|Overall Study|Death|0|||
160840679|NCT04356040|580802610|FG000|Overall Study|Lost to Follow-up|1|||
160840680|NCT04356040|580802611|FG001|Overall Study|Lost to Follow-up|0|||
160840681|NCT04356040|580802610|FG000|Overall Study|Physician Decision|0|||
160840682|NCT04356040|580802611|FG001|Overall Study|Physician Decision|1|||
160840683|NCT04356040|580802610|FG000|Overall Study|Withdrawal by Subject|13|||
160840684|NCT04356040|580802611|FG001|Overall Study|Withdrawal by Subject|1|||
160840685|NCT04356040|580802610|FG000|Overall Study|Enrollment Pause|10|||
160840686|NCT04356040|580802611|FG001|Overall Study|Enrollment Pause|0|||
160840687|NCT04356040|580802610|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
160840688|NCT04356040|580802611|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
160840689|NCT04356040|580802610|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
160840690|NCT04356040|580802611|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
160840691|NCT04356040|580802610|FG000|Overall Study|PI left institution|3|||
160840692|NCT04356040|580802611|FG001|Overall Study|PI left institution|0|||
160840693|NCT00416455|580802612|FG000|Overall Study|PET / CT not done|3|||
160840694|NCT00416455|580802613|FG001|Overall Study|PET / CT not done|5|||
160840695|NCT00416455|580802612|FG000|Overall Study|PET / CT poor quality|2|||
160840696|NCT00416455|580802613|FG001|Overall Study|PET / CT poor quality|1|||
160840697|NCT00416455|580802612|FG000|Overall Study|Inadequate pathology|11|||
160840698|NCT00416455|580802613|FG001|Overall Study|Inadequate pathology|2|||
160840699|NCT02456857|580802614|FG000|Overall Study|Disease Progression|4|||
160905287|NCT02585960|581048164|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
160905288|NCT02585960|581048165|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
160905289|NCT02585960|581048166|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
160905290|NCT06333613|581048168|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
160905291|NCT03727230|581048169|FG000|Overall Study|Lost to Follow-up|12|||
160905292|NCT00134082|581048171|FG000|Overall Study|Adverse Event|2|||
160905293|NCT00134082|581048171|FG000|Overall Study|Death|1|||
160905294|NCT00724932|581048174|FG000|Overall Study|Lost to Follow-up|1|||
160905295|NCT00724932|581048175|FG001|Overall Study|Lost to Follow-up|0|||
160840700|NCT00781859|580802615|FG000|Overall Study|Adverse Event|2|||
160840701|NCT00781859|580802616|FG001|Overall Study|Adverse Event|2|||
160905296|NCT00724932|581048174|FG000|Overall Study|Not treated|4|||
160840702|NCT00781859|580802615|FG000|Overall Study|Withdrawal by Subject|8|||
160840703|NCT00781859|580802616|FG001|Overall Study|Withdrawal by Subject|4|||
160840704|NCT00781859|580802615|FG000|Overall Study|Lost to Follow-up|6|||
160840705|NCT00781859|580802616|FG001|Overall Study|Lost to Follow-up|3|||
160840706|NCT00781859|580802615|FG000|Overall Study|Death|3|||
160840707|NCT00781859|580802616|FG001|Overall Study|Death|0|||
160840708|NCT01138501|580802617|FG000|Overall Study|Protocol Violation|2|||
160840709|NCT01138501|580802617|FG000|Overall Study|Withdrawal by Subject|3|||
160840710|NCT00360568|580802618|FG000|Overall Study|Adverse Event|1|||
160840711|NCT00360568|580802619|FG001|Overall Study|Adverse Event|2|||
160840712|NCT00360568|580802618|FG000|Overall Study|Lack of Efficacy|1|||
160840713|NCT00360568|580802619|FG001|Overall Study|Lack of Efficacy|0|||
160840714|NCT00360568|580802618|FG000|Overall Study|Withdrawal by Subject|0|||
160991966|NCT03822351|581359938|FG001|Overall Study|Progressive Disease|1|||
160840715|NCT00360568|580802619|FG001|Overall Study|Withdrawal by Subject|3|||
160840716|NCT01008449|580802620|FG000|Overall Study|Lost to Follow-up|29|||
160840717|NCT01008449|580802621|FG001|Overall Study|Lost to Follow-up|19|||
160840718|NCT01220180|580802622|FG000|Overall Study|Lost to Follow-up|76|||
160840719|NCT01220180|580802622|FG000|Overall Study|Other|72|||
160840720|NCT01220180|580802622|FG000|Overall Study|Adverse Event|35|||
160840721|NCT01220180|580802622|FG000|Overall Study|Lack of Efficacy|22|||
160840722|NCT01220180|580802622|FG000|Overall Study|Death|1|||
160840723|NCT01220180|580802622|FG000|Overall Study|Randomized but not treated|1|||
160840724|NCT00348309|580802623|FG000|Overall Study|Adverse Event|56|||
160840725|NCT00348309|580802624|FG001|Overall Study|Adverse Event|28|||
160840726|NCT00348309|580802625|FG002|Overall Study|Adverse Event|63|||
160840727|NCT00348309|580802623|FG000|Overall Study|Lost to Follow-up|6|||
160840728|NCT00348309|580802624|FG001|Overall Study|Lost to Follow-up|7|||
160840729|NCT00348309|580802625|FG002|Overall Study|Lost to Follow-up|4|||
160840730|NCT00348309|580802623|FG000|Overall Study|Protocol Violation|7|||
160840731|NCT00348309|580802624|FG001|Overall Study|Protocol Violation|12|||
160840732|NCT00348309|580802625|FG002|Overall Study|Protocol Violation|7|||
160840733|NCT00348309|580802623|FG000|Overall Study|Withdrawal by Subject|33|||
160840734|NCT00348309|580802624|FG001|Overall Study|Withdrawal by Subject|37|||
160840735|NCT00348309|580802625|FG002|Overall Study|Withdrawal by Subject|40|||
160840736|NCT00348309|580802623|FG000|Overall Study|Non-compliance|8|||
160840737|NCT00348309|580802624|FG001|Overall Study|Non-compliance|6|||
160840738|NCT00348309|580802625|FG002|Overall Study|Non-compliance|8|||
160840739|NCT00348309|580802623|FG000|Overall Study|Death of caregiver|1|||
160840740|NCT00348309|580802624|FG001|Overall Study|Death of caregiver|0|||
160840741|NCT00348309|580802625|FG002|Overall Study|Death of caregiver|1|||
160840742|NCT00348309|580802623|FG000|Overall Study|Lack of insight, dementia|1|||
160840743|NCT00348309|580802624|FG001|Overall Study|Lack of insight, dementia|0|||
160840744|NCT00348309|580802625|FG002|Overall Study|Lack of insight, dementia|0|||
160840745|NCT00348309|580802623|FG000|Overall Study|Wrong bottle allocated|1|||
160840746|NCT00348309|580802624|FG001|Overall Study|Wrong bottle allocated|0|||
160840747|NCT00348309|580802625|FG002|Overall Study|Wrong bottle allocated|0|||
160840748|NCT00348309|580802623|FG000|Overall Study|Caregiver sick|1|||
160840749|NCT00348309|580802624|FG001|Overall Study|Caregiver sick|0|||
160840750|NCT00348309|580802625|FG002|Overall Study|Caregiver sick|0|||
160840751|NCT00348309|580802623|FG000|Overall Study|Use of prohibited medication|5|||
160840752|NCT00348309|580802624|FG001|Overall Study|Use of prohibited medication|2|||
160840753|NCT00348309|580802625|FG002|Overall Study|Use of prohibited medication|2|||
160840754|NCT00348309|580802623|FG000|Overall Study|Caregiver withdrawal|3|||
160840755|NCT00348309|580802624|FG001|Overall Study|Caregiver withdrawal|0|||
160840756|NCT00348309|580802625|FG002|Overall Study|Caregiver withdrawal|7|||
160840757|NCT00348309|580802623|FG000|Overall Study|Unable to complete ET visit|1|||
160840758|NCT00348309|580802624|FG001|Overall Study|Unable to complete ET visit|0|||
160840759|NCT00348309|580802625|FG002|Overall Study|Unable to complete ET visit|0|||
160840760|NCT00348309|580802623|FG000|Overall Study|PI closing medical practice|1|||
160840761|NCT00348309|580802624|FG001|Overall Study|PI closing medical practice|0|||
161251350|NCT02780167|582300411|FG003|Overall Study|Lost to Follow-up|0|||
161251351|NCT02780167|582300412|FG004|Overall Study|Lost to Follow-up|0|||
160840762|NCT00348309|580802625|FG002|Overall Study|PI closing medical practice|0|||
160991967|NCT03822351|581359939|FG002|Overall Study|Progressive Disease|0|||
160991968|NCT03822351|581359937|FG000|Overall Study|Not Treated|1|||
161251352|NCT02780167|582300408|FG000|Overall Study|Does not meet entrance criteria|0|||
161251353|NCT02780167|582300409|FG001|Overall Study|Does not meet entrance criteria|0|||
160840763|NCT00348309|580802623|FG000|Overall Study|Principal investigator's decision|1|||
160840764|NCT00348309|580802624|FG001|Overall Study|Principal investigator's decision|0|||
160840765|NCT00348309|580802625|FG002|Overall Study|Principal investigator's decision|0|||
160840766|NCT00348309|580802623|FG000|Overall Study|No disponibility of medication|1|||
160840767|NCT00348309|580802624|FG001|Overall Study|No disponibility of medication|0|||
160840768|NCT00348309|580802625|FG002|Overall Study|No disponibility of medication|0|||
160840769|NCT00348309|580802623|FG000|Overall Study|Worsened neurodegenerative disease|1|||
160840770|NCT00348309|580802624|FG001|Overall Study|Worsened neurodegenerative disease|0|||
160840771|NCT00348309|580802625|FG002|Overall Study|Worsened neurodegenerative disease|0|||
160840772|NCT00348309|580802623|FG000|Overall Study|Cognitive and behaviour worsening|2|||
161251354|NCT02780167|582300410|FG002|Overall Study|Does not meet entrance criteria|1|||
160840773|NCT00348309|580802624|FG001|Overall Study|Cognitive and behaviour worsening|0|||
160840774|NCT00348309|580802625|FG002|Overall Study|Cognitive and behaviour worsening|0|||
160840775|NCT00348309|580802623|FG000|Overall Study|Worsening of alzheimer|1|||
160840776|NCT00348309|580802624|FG001|Overall Study|Worsening of alzheimer|0|||
160840777|NCT00348309|580802625|FG002|Overall Study|Worsening of alzheimer|1|||
160840778|NCT00348309|580802623|FG000|Overall Study|Did not appear in time for Visit 3|1|||
160840779|NCT00348309|580802624|FG001|Overall Study|Did not appear in time for Visit 3|0|||
160840780|NCT00348309|580802625|FG002|Overall Study|Did not appear in time for Visit 3|0|||
160840781|NCT00348309|580802623|FG000|Overall Study|Participant died|2|||
160840782|NCT00348309|580802624|FG001|Overall Study|Participant died|1|||
160840783|NCT00348309|580802625|FG002|Overall Study|Participant died|1|||
160840784|NCT00348309|580802623|FG000|Overall Study|Decision of sponsor|1|||
160840785|NCT00348309|580802624|FG001|Overall Study|Decision of sponsor|0|||
160840786|NCT00348309|580802625|FG002|Overall Study|Decision of sponsor|0|||
160840787|NCT00348309|580802623|FG000|Overall Study|Ineffectiveness of treatment|0|||
160840788|NCT00348309|580802624|FG001|Overall Study|Ineffectiveness of treatment|1|||
160840789|NCT00348309|580802625|FG002|Overall Study|Ineffectiveness of treatment|0|||
160840790|NCT00348309|580802623|FG000|Overall Study|A foul of exclusion criteria|0|||
160840791|NCT00348309|580802624|FG001|Overall Study|A foul of exclusion criteria|1|||
160840792|NCT00348309|580802625|FG002|Overall Study|A foul of exclusion criteria|0|||
160840793|NCT00348309|580802623|FG000|Overall Study|Participant was hospitalized|0|||
160840794|NCT00348309|580802624|FG001|Overall Study|Participant was hospitalized|1|||
160840795|NCT00348309|580802625|FG002|Overall Study|Participant was hospitalized|0|||
160840796|NCT00348309|580802623|FG000|Overall Study|Sponsor refuseal|0|||
160840797|NCT00348309|580802624|FG001|Overall Study|Sponsor refuseal|1|||
160840798|NCT00348309|580802625|FG002|Overall Study|Sponsor refuseal|1|||
160840799|NCT00348309|580802623|FG000|Overall Study|Forgot often medication|0|||
160840800|NCT00348309|580802624|FG001|Overall Study|Forgot often medication|1|||
160991969|NCT03822351|581359938|FG001|Overall Study|Not Treated|1|||
161251355|NCT02780167|582300411|FG003|Overall Study|Does not meet entrance criteria|0|||
160840801|NCT00348309|580802625|FG002|Overall Study|Forgot often medication|0|||
160840802|NCT00348309|580802623|FG000|Overall Study|Medical Monitor decision|0|||
160840803|NCT00348309|580802624|FG001|Overall Study|Medical Monitor decision|0|||
160840804|NCT00348309|580802625|FG002|Overall Study|Medical Monitor decision|1|||
160840805|NCT00348309|580802623|FG000|Overall Study|Increased dose of Aricept|0|||
160991970|NCT03822351|581359939|FG002|Overall Study|Not Treated|1|||
160991971|NCT03781804|581359945|FG000|Overall Study|Adverse Event|2|||
160991972|NCT03781804|581359946|FG001|Overall Study|Adverse Event|2|||
160991973|NCT03781804|581359947|FG002|Overall Study|Adverse Event|3|||
160991974|NCT03781804|581359945|FG000|Overall Study|Lost to Follow-up|1|||
160991975|NCT03781804|581359946|FG001|Overall Study|Lost to Follow-up|1|||
160991976|NCT03781804|581359947|FG002|Overall Study|Lost to Follow-up|2|||
160991977|NCT03781804|581359945|FG000|Overall Study|Lack of Efficacy|4|||
160991978|NCT03781804|581359946|FG001|Overall Study|Lack of Efficacy|2|||
160991979|NCT03781804|581359947|FG002|Overall Study|Lack of Efficacy|9|||
160991980|NCT03781804|581359945|FG000|Overall Study|Protocol Violation|0|||
160991981|NCT03781804|581359946|FG001|Overall Study|Protocol Violation|0|||
160991982|NCT03781804|581359947|FG002|Overall Study|Protocol Violation|1|||
160991983|NCT03781804|581359945|FG000|Overall Study|Withdrawal by Subject|0|||
160991984|NCT03781804|581359946|FG001|Overall Study|Withdrawal by Subject|1|||
160991985|NCT03781804|581359947|FG002|Overall Study|Withdrawal by Subject|1|||
160991986|NCT03781804|581359945|FG000|Overall Study|Reason not provided|2|||
160991987|NCT03781804|581359946|FG001|Overall Study|Reason not provided|2|||
160991988|NCT03781804|581359947|FG002|Overall Study|Reason not provided|0|||
160991989|NCT03717194|581359948|FG000|Overall Study|Withdrawal by Subject|2|||
160991990|NCT03717194|581359949|FG001|Overall Study|Withdrawal by Subject|4|||
160991991|NCT03717194|581359948|FG000|Overall Study|Adverse Event|1|||
160991992|NCT03717194|581359949|FG001|Overall Study|Adverse Event|1|||
160991993|NCT04678830|581359950|FG000|Overall Study|Lack of Efficacy|2|||
160991994|NCT04678830|581359951|FG001|Overall Study|Lack of Efficacy|0|||
160991995|NCT04678830|581359950|FG000|Overall Study|Withdrawal by Subject|0|||
160991996|NCT04678830|581359951|FG001|Overall Study|Withdrawal by Subject|1|||
160991997|NCT01836458|581359954|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
160991998|NCT01836458|581359955|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
160991999|NCT01836458|581359956|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
160992000|NCT01836458|581359957|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
161251356|NCT02780167|582300412|FG004|Overall Study|Does not meet entrance criteria|0|||
160840806|NCT00348309|580802624|FG001|Overall Study|Increased dose of Aricept|0|||
160840807|NCT00348309|580802625|FG002|Overall Study|Increased dose of Aricept|1|||
160840808|NCT00348309|580802623|FG000|Overall Study|Site closure|0|||
160840809|NCT00348309|580802624|FG001|Overall Study|Site closure|0|||
160992001|NCT00429793|581359958|FG000|Overall Study|Improper pre-protocol treatment|3|||
160992002|NCT00429793|581359958|FG000|Overall Study|Required test not done|1|||
160840810|NCT00348309|580802625|FG002|Overall Study|Site closure|1|||
160992003|NCT00429793|581359958|FG000|Overall Study|Never treated|1|||
160992004|NCT00429793|581359958|FG000|Overall Study|Non-measurable|1|||
160992005|NCT00813488|581359959|FG000|Titration Period 1|Adverse Event|6|||
160992006|NCT00813488|581359960|FG001|Titration Period 1|Adverse Event|1|||
161251357|NCT02780167|582300408|FG000|Overall Study|No longer meets eligibility criteria|0|||
160992007|NCT00813488|581359959|FG000|Titration Period 1|Lack of Efficacy|9|||
160992008|NCT00813488|581359960|FG001|Titration Period 1|Lack of Efficacy|7|||
160992009|NCT00813488|581359959|FG000|Titration Period 1|Withdrawal by Subject|2|||
160992010|NCT00813488|581359960|FG001|Titration Period 1|Withdrawal by Subject|2|||
160992011|NCT00813488|581359959|FG000|Titration Period 1|Protocol Violation|4|||
160992012|NCT00813488|581359960|FG001|Titration Period 1|Protocol Violation|3|||
160992013|NCT00813488|581359959|FG000|Titration Period 1|Non-compliance to study medication|4|||
160992014|NCT00813488|581359960|FG001|Titration Period 1|Non-compliance to study medication|1|||
160992015|NCT00813488|581359959|FG000|Titration Period 1|Non-compliance to study procedures|2|||
160992016|NCT00813488|581359960|FG001|Titration Period 1|Non-compliance to study procedures|2|||
160992017|NCT00813488|581359959|FG000|Titration Period 1|Technical Difficulties|0|||
160992018|NCT00813488|581359960|FG001|Titration Period 1|Technical Difficulties|1|||
160992019|NCT00813488|581359959|FG000|Titration Period 2|Adverse Event|2|||
160992020|NCT00813488|581359960|FG001|Titration Period 2|Adverse Event|3|||
160992021|NCT00813488|581359959|FG000|Titration Period 2|Lack of Efficacy|8|||
160992022|NCT00813488|581359960|FG001|Titration Period 2|Lack of Efficacy|4|||
160992023|NCT00813488|581359959|FG000|Titration Period 2|Protocol Violation|3|||
160992024|NCT00813488|581359960|FG001|Titration Period 2|Protocol Violation|2|||
160992025|NCT00813488|581359959|FG000|Titration Period 2|Lost to Follow-up|1|||
160992026|NCT00813488|581359960|FG001|Titration Period 2|Lost to Follow-up|0|||
160992027|NCT00813488|581359959|FG000|Titration Period 2|Non-compliance with study procedures|2|||
160992028|NCT00813488|581359960|FG001|Titration Period 2|Non-compliance with study procedures|1|||
160992029|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
160992030|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
160992031|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
160992032|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
160992033|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
160992034|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
160992035|NCT00813488|581359959|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
160992036|NCT00813488|581359960|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
160992037|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
160992038|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
160992039|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
160992040|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
160992041|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
160992042|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
160992043|NCT00813488|581359959|FG000|Double-blind Treatment Period 2|Other|1|||
160992044|NCT00813488|581359960|FG001|Double-blind Treatment Period 2|Other|0|||
160992045|NCT00813488|581359959|FG000|Open-label Extension|Adverse Event|1|||
160992046|NCT00813488|581359960|FG001|Open-label Extension|Adverse Event|2|||
160992047|NCT00813488|581359959|FG000|Open-label Extension|Lack of Efficacy|3|||
160992048|NCT00813488|581359960|FG001|Open-label Extension|Lack of Efficacy|0|||
160992049|NCT00813488|581359959|FG000|Open-label Extension|Withdrawal by Subject|0|||
160992050|NCT00813488|581359960|FG001|Open-label Extension|Withdrawal by Subject|2|||
160992051|NCT00813488|581359959|FG000|Open-label Extension|Protocol Violation|1|||
160992052|NCT00813488|581359960|FG001|Open-label Extension|Protocol Violation|2|||
160992053|NCT00813488|581359959|FG000|Open-label Extension|Non-compliance study medication|4|||
160992054|NCT00813488|581359960|FG001|Open-label Extension|Non-compliance study medication|0|||
160992055|NCT00813488|581359959|FG000|Open-label Extension|Non-compliance study procedures|2|||
160992056|NCT00813488|581359960|FG001|Open-label Extension|Non-compliance study procedures|1|||
160992057|NCT00813488|581359959|FG000|Open-label Extension|Other|1|||
160992058|NCT00813488|581359960|FG001|Open-label Extension|Other|0|||
160992059|NCT01333514|581359963|FG000|Overall Study|Withdrawal by Subject|1|||
160992060|NCT01333514|581359964|FG001|Overall Study|Withdrawal by Subject|0|||
160992061|NCT00836810|581359965|FG000|Overall Study|New diagnosis|1|||
160992062|NCT00836810|581359966|FG001|Overall Study|New diagnosis|0|||
160992063|NCT00819910|581359967|FG000|Overall Study|Adverse Event|0|||
160992064|NCT00819910|581359968|FG001|Overall Study|Adverse Event|0|||
160992065|NCT00819910|581359969|FG002|Overall Study|Adverse Event|2|||
160992066|NCT00819910|581359970|FG003|Overall Study|Adverse Event|1|||
160992067|NCT00819910|581359967|FG000|Overall Study|Withdrawal by Subject|1|||
160992068|NCT00819910|581359968|FG001|Overall Study|Withdrawal by Subject|1|||
160992069|NCT00819910|581359969|FG002|Overall Study|Withdrawal by Subject|1|||
160992070|NCT00819910|581359970|FG003|Overall Study|Withdrawal by Subject|0|||
161251358|NCT02780167|582300409|FG001|Overall Study|No longer meets eligibility criteria|0|||
161251359|NCT02780167|582300410|FG002|Overall Study|No longer meets eligibility criteria|0|||
160992071|NCT00819910|581359967|FG000|Overall Study|Lost to Follow-up|1|||
160992072|NCT00819910|581359968|FG001|Overall Study|Lost to Follow-up|0|||
160992073|NCT00819910|581359969|FG002|Overall Study|Lost to Follow-up|0|||
160992074|NCT00819910|581359970|FG003|Overall Study|Lost to Follow-up|0|||
161251360|NCT02780167|582300411|FG003|Overall Study|No longer meets eligibility criteria|1|||
160840811|NCT00348309|580802623|FG000|Overall Study|Adverse event not attended|0|||
160840812|NCT00348309|580802624|FG001|Overall Study|Adverse event not attended|0|||
160840813|NCT00348309|580802625|FG002|Overall Study|Adverse event not attended|1|||
160840814|NCT00348309|580802623|FG000|Overall Study|ECG abnormal|0|||
160840815|NCT00348309|580802624|FG001|Overall Study|ECG abnormal|0|||
160840816|NCT00348309|580802625|FG002|Overall Study|ECG abnormal|2|||
160840817|NCT00348309|580802623|FG000|Overall Study|Cardiologist recommendations|0|||
160840818|NCT00348309|580802624|FG001|Overall Study|Cardiologist recommendations|0|||
160840819|NCT00348309|580802625|FG002|Overall Study|Cardiologist recommendations|1|||
160840820|NCT00348309|580802623|FG000|Overall Study|HCV career|0|||
160840821|NCT00348309|580802624|FG001|Overall Study|HCV career|0|||
160840822|NCT00348309|580802625|FG002|Overall Study|HCV career|1|||
160840823|NCT01364389|580802628|FG000|Overall Study|Withdrawal by Subject|0|||
160840824|NCT01364389|580802629|FG001|Overall Study|Withdrawal by Subject|1|||
160840825|NCT01364389|580802630|FG002|Overall Study|Withdrawal by Subject|0|||
160840826|NCT01364389|580802628|FG000|Overall Study|Protocol deviation|0|||
160840827|NCT01364389|580802629|FG001|Overall Study|Protocol deviation|0|||
161139307|NCT00636818|581892665|FG000|Overall Study|Protocol Violation|1|||
161139308|NCT00636818|581892665|FG000|Overall Study|Withdrawal by Subject|4|||
161139309|NCT02604264|581892667|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
161139310|NCT02604264|581892668|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
161139311|NCT03192904|581892669|FG000|Overall Study|Physician Decision|3|||
160840828|NCT01364389|580802630|FG002|Overall Study|Protocol deviation|1|||
160840829|NCT01364389|580802628|FG000|Overall Study|Administrative problems|1|||
160840830|NCT01364389|580802629|FG001|Overall Study|Administrative problems|0|||
160840831|NCT01364389|580802630|FG002|Overall Study|Administrative problems|0|||
160840832|NCT01364389|580802628|FG000|Overall Study|Adverse Event|1|||
160840833|NCT01364389|580802629|FG001|Overall Study|Adverse Event|0|||
160840834|NCT01364389|580802630|FG002|Overall Study|Adverse Event|0|||
160840835|NCT01534195|580802631|FG000|Overall Study|Withdrawal by Subject|1|||
160840836|NCT01534195|580802632|FG001|Overall Study|Withdrawal by Subject|1|||
160840837|NCT02554981|580802633|FG000|Overall Study|Adverse Event|1|||
160840838|NCT02554981|580802633|FG000|Overall Study|Administrative Reasons|1|||
160840839|NCT02554981|580802633|FG000|Overall Study|Other Miscellaneous Reasons|3|||
160840840|NCT01630889|580802634|FG000|Overall Study|Death|2|||
160840841|NCT01630889|580802634|FG000|Overall Study|Withdrawal by Subject|1|||
160840842|NCT01630889|580802634|FG000|Overall Study|Other than Specified|2|||
160840843|NCT01630889|580802634|FG000|Overall Study|Lost to Follow-up|4|||
160840844|NCT01630889|580802634|FG000|Overall Study|Other|1|||
160840845|NCT02475278|580804967|FG000|Overall Study|Lost to Follow-up|1|||
160840846|NCT02475278|580804967|FG000|Overall Study|Reason Not Specified|1|||
160840847|NCT01946152|580804968|FG000|Overall Study|Adverse Event|1|||
160840848|NCT01946152|580804969|FG001|Overall Study|Adverse Event|0|||
160840849|NCT01946152|580804970|FG002|Overall Study|Adverse Event|0|||
160840850|NCT01946152|580804971|FG003|Overall Study|Adverse Event|0|||
160840851|NCT01946152|580804968|FG000|Overall Study|Withdrawal by Subject|0|||
160840852|NCT01946152|580804969|FG001|Overall Study|Withdrawal by Subject|2|||
160840853|NCT01946152|580804970|FG002|Overall Study|Withdrawal by Subject|0|||
160840854|NCT01946152|580804971|FG003|Overall Study|Withdrawal by Subject|0|||
160840855|NCT01946152|580804968|FG000|Overall Study|Progression|0|||
160840856|NCT01946152|580804969|FG001|Overall Study|Progression|1|||
160840857|NCT01946152|580804970|FG002|Overall Study|Progression|4|||
160840858|NCT01946152|580804971|FG003|Overall Study|Progression|7|||
160840859|NCT01946152|580804968|FG000|Overall Study|Physician Decision|0|||
160840860|NCT01946152|580804969|FG001|Overall Study|Physician Decision|0|||
160840861|NCT01946152|580804970|FG002|Overall Study|Physician Decision|1|||
160840862|NCT01946152|580804971|FG003|Overall Study|Physician Decision|0|||
160840863|NCT01946152|580804968|FG000|Overall Study|Second malignancy|0|||
160840864|NCT01946152|580804969|FG001|Overall Study|Second malignancy|0|||
160840865|NCT01946152|580804970|FG002|Overall Study|Second malignancy|1|||
160840866|NCT01946152|580804971|FG003|Overall Study|Second malignancy|0|||
160840867|NCT01946152|580804968|FG000|Overall Study|Adverse Event|0|||
160840868|NCT01946152|580804969|FG001|Overall Study|Adverse Event|0|||
160840869|NCT01946152|580804970|FG002|Overall Study|Adverse Event|0|||
160840870|NCT01946152|580804971|FG003|Overall Study|Adverse Event|1|||
160840871|NCT03712787|580804972|FG000|Overall Study|Adverse Event|2|||
160840872|NCT03712787|580804973|FG001|Overall Study|Adverse Event|3|||
160840873|NCT03712787|580804974|FG002|Overall Study|Adverse Event|0|||
160840874|NCT03712787|580804975|FG003|Overall Study|Adverse Event|4|||
160840875|NCT03712787|580804972|FG000|Overall Study|Withdrawal by Subject|4|||
160840876|NCT03712787|580804973|FG001|Overall Study|Withdrawal by Subject|14|||
160840877|NCT03712787|580804974|FG002|Overall Study|Withdrawal by Subject|12|||
160840878|NCT03712787|580804975|FG003|Overall Study|Withdrawal by Subject|8|||
161139312|NCT03192904|581892670|FG001|Overall Study|Physician Decision|1|||
161139313|NCT03192904|581892669|FG000|Overall Study|Lost to Follow-up|0|||
161139314|NCT03192904|581892670|FG001|Overall Study|Lost to Follow-up|1|||
161139315|NCT01023789|581892671|FG000|3 - Year Visit|Death|29|||
161139316|NCT01023789|581892671|FG000|3 - Year Visit|Withdrawal of consent|1|||
160840879|NCT03712787|580804972|FG000|Overall Study|Lost to Follow-up|1|||
161251361|NCT02780167|582300412|FG004|Overall Study|No longer meets eligibility criteria|1|||
161251362|NCT02780167|582300408|FG000|Overall Study|Protocol Violation|5|||
161251363|NCT02780167|582300409|FG001|Overall Study|Protocol Violation|5|||
161251364|NCT02780167|582300410|FG002|Overall Study|Protocol Violation|1|||
161251365|NCT02780167|582300411|FG003|Overall Study|Protocol Violation|1|||
161251366|NCT02780167|582300412|FG004|Overall Study|Protocol Violation|2|||
161251367|NCT02780167|582300408|FG000|Overall Study|Withdrawal by Subject|6|||
161251368|NCT02780167|582300409|FG001|Overall Study|Withdrawal by Subject|4|||
161251369|NCT02780167|582300410|FG002|Overall Study|Withdrawal by Subject|4|||
160840880|NCT03712787|580804973|FG001|Overall Study|Lost to Follow-up|1|||
160840881|NCT03712787|580804974|FG002|Overall Study|Lost to Follow-up|2|||
160840882|NCT03712787|580804975|FG003|Overall Study|Lost to Follow-up|1|||
160840883|NCT03712787|580804972|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161251370|NCT02780167|582300411|FG003|Overall Study|Withdrawal by Subject|3|||
161251371|NCT02780167|582300412|FG004|Overall Study|Withdrawal by Subject|4|||
161251372|NCT02780167|582300408|FG000|Overall Study|Other|0|||
161251373|NCT02780167|582300409|FG001|Overall Study|Other|0|||
161251374|NCT02780167|582300410|FG002|Overall Study|Other|3|||
161251375|NCT02780167|582300411|FG003|Overall Study|Other|1|||
161251376|NCT02780167|582300412|FG004|Overall Study|Other|2|||
161251377|NCT05552261|582300414|FG000|Overall Study|Withdrawal by Subject|1|||
161251378|NCT05552261|582300414|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
161251379|NCT02315066|582300415|FG000|Overall Study|Lost to Follow-up|0|||
161251380|NCT02315066|582300416|FG001|Overall Study|Lost to Follow-up|1|||
161251381|NCT02315066|582300417|FG002|Overall Study|Lost to Follow-up|1|||
161251382|NCT02315066|582300418|FG003|Overall Study|Lost to Follow-up|0|||
161251383|NCT02315066|582300419|FG004|Overall Study|Lost to Follow-up|1|||
161251384|NCT02315066|582300420|FG005|Overall Study|Lost to Follow-up|0|||
161251385|NCT02315066|582300421|FG006|Overall Study|Lost to Follow-up|2|||
161251386|NCT02315066|582300422|FG007|Overall Study|Lost to Follow-up|1|||
161251387|NCT02315066|582300423|FG008|Overall Study|Lost to Follow-up|0|||
161251388|NCT02315066|582300424|FG009|Overall Study|Lost to Follow-up|0|||
160840884|NCT03712787|580804973|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
160840885|NCT03712787|580804974|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
160840886|NCT03712787|580804975|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
160840887|NCT03712787|580804972|FG000|Overall Study|COVID-19 Infection|0|||
160840888|NCT03712787|580804973|FG001|Overall Study|COVID-19 Infection|1|||
160840889|NCT03712787|580804974|FG002|Overall Study|COVID-19 Infection|0|||
160840890|NCT03712787|580804975|FG003|Overall Study|COVID-19 Infection|0|||
160840891|NCT03712787|580804972|FG000|Overall Study|Other, Not Specified|79|||
160840892|NCT03712787|580804973|FG001|Overall Study|Other, Not Specified|77|||
160840893|NCT03712787|580804974|FG002|Overall Study|Other, Not Specified|74|||
160840894|NCT03712787|580804975|FG003|Overall Study|Other, Not Specified|78|||
160840895|NCT01865448|580804976|FG000|Overall Study|Adverse Event|1|||
160840896|NCT01865448|580804977|FG001|Overall Study|Adverse Event|1|||
160840897|NCT01865448|580804976|FG000|Overall Study|Pregnancy|0|||
160840898|NCT01865448|580804977|FG001|Overall Study|Pregnancy|1|||
160840899|NCT01865448|580804976|FG000|Overall Study|dropout unrelated to study|1|||
160840900|NCT01865448|580804977|FG001|Overall Study|dropout unrelated to study|1|||
160840901|NCT03499314|580804978|FG000|Overall Study|Time Commitment|1|||
160840902|NCT03499314|580804979|FG001|Overall Study|Time Commitment|2|||
160840903|NCT03499314|580804978|FG000|Overall Study|Medical issue unrelated to research study|1|||
160840904|NCT03499314|580804979|FG001|Overall Study|Medical issue unrelated to research study|1|||
160840905|NCT01618695|580804980|FG000|Core Phase|Adverse Event|4|||
160840906|NCT01618695|580804981|FG001|Core Phase|Adverse Event|5|||
160840907|NCT01618695|580804982|FG002|Core Phase|Adverse Event|15|||
160840908|NCT01618695|580804983|FG003|Core Phase|Adverse Event|20|||
160840909|NCT01618695|580804980|FG000|Core Phase|Lost to Follow-up|0|||
160840910|NCT01618695|580804981|FG001|Core Phase|Lost to Follow-up|0|||
160840911|NCT01618695|580804982|FG002|Core Phase|Lost to Follow-up|1|||
160840912|NCT01618695|580804983|FG003|Core Phase|Lost to Follow-up|0|||
160840913|NCT01618695|580804980|FG000|Core Phase|Withdrawal by Subject|16|||
160905297|NCT00724932|581048175|FG001|Overall Study|Not treated|3|||
161251389|NCT02315066|582300425|FG010|Overall Study|Lost to Follow-up|1|||
161251390|NCT02315066|582300426|FG011|Overall Study|Lost to Follow-up|2|||
161251391|NCT02315066|582300427|FG012|Overall Study|Lost to Follow-up|0|||
160840914|NCT01618695|580804981|FG001|Core Phase|Withdrawal by Subject|11|||
160840915|NCT01618695|580804982|FG002|Core Phase|Withdrawal by Subject|9|||
160840916|NCT01618695|580804983|FG003|Core Phase|Withdrawal by Subject|13|||
160840917|NCT01618695|580804980|FG000|Core Phase|Pregnancy|2|||
160840918|NCT01618695|580804981|FG001|Core Phase|Pregnancy|0|||
160905298|NCT02849678|581048176|FG000|Overall Study|Protocol Violation|3|||
160905299|NCT02849678|581048177|FG001|Overall Study|Protocol Violation|6|||
161251392|NCT02315066|582300428|FG013|Overall Study|Lost to Follow-up|4|||
161251393|NCT02315066|582300415|FG000|Overall Study|Death|2|||
161251394|NCT02315066|582300416|FG001|Overall Study|Death|7|||
160840919|NCT01618695|580804982|FG002|Core Phase|Pregnancy|0|||
160840920|NCT01618695|580804983|FG003|Core Phase|Pregnancy|0|||
160840921|NCT01618695|580804980|FG000|Core Phase|Lack of Efficacy|1|||
161251395|NCT02315066|582300417|FG002|Overall Study|Death|6|||
160840922|NCT01618695|580804981|FG001|Core Phase|Lack of Efficacy|2|||
160840923|NCT01618695|580804982|FG002|Core Phase|Lack of Efficacy|1|||
160840924|NCT01618695|580804983|FG003|Core Phase|Lack of Efficacy|1|||
160840925|NCT01618695|580804980|FG000|Core Phase|Other than specified|1|||
160840926|NCT01618695|580804981|FG001|Core Phase|Other than specified|2|||
160840927|NCT01618695|580804982|FG002|Core Phase|Other than specified|2|||
160840928|NCT01618695|580804983|FG003|Core Phase|Other than specified|2|||
160840929|NCT01618695|580804980|FG000|Core Phase|Not treated|1|||
160840930|NCT01618695|580804981|FG001|Core Phase|Not treated|0|||
160840931|NCT01618695|580804982|FG002|Core Phase|Not treated|2|||
160840932|NCT01618695|580804983|FG003|Core Phase|Not treated|0|||
160840933|NCT01618695|580804980|FG000|Extension Phase|Lack of Efficacy|17|||
160840934|NCT01618695|580804981|FG001|Extension Phase|Lack of Efficacy|33|||
160840935|NCT01618695|580804982|FG002|Extension Phase|Lack of Efficacy|26|||
160840936|NCT01618695|580804983|FG003|Extension Phase|Lack of Efficacy|24|||
160840937|NCT01618695|580804980|FG000|Extension Phase|Pregnancy|2|||
160840938|NCT01618695|580804981|FG001|Extension Phase|Pregnancy|0|||
160840939|NCT01618695|580804982|FG002|Extension Phase|Pregnancy|1|||
160840940|NCT01618695|580804983|FG003|Extension Phase|Pregnancy|1|||
160840941|NCT01618695|580804980|FG000|Extension Phase|Withdrawal by Subject|43|||
160840942|NCT01618695|580804981|FG001|Extension Phase|Withdrawal by Subject|48|||
160840943|NCT01618695|580804982|FG002|Extension Phase|Withdrawal by Subject|42|||
160840944|NCT01618695|580804983|FG003|Extension Phase|Withdrawal by Subject|33|||
160840945|NCT01618695|580804980|FG000|Extension Phase|Adverse Event|18|||
160840946|NCT01618695|580804981|FG001|Extension Phase|Adverse Event|16|||
160840947|NCT01618695|580804982|FG002|Extension Phase|Adverse Event|9|||
160840948|NCT01618695|580804983|FG003|Extension Phase|Adverse Event|20|||
160840949|NCT01618695|580804980|FG000|Extension Phase|Lost to Follow-up|2|||
160840950|NCT01618695|580804981|FG001|Extension Phase|Lost to Follow-up|1|||
160840951|NCT01618695|580804982|FG002|Extension Phase|Lost to Follow-up|1|||
160840952|NCT01618695|580804983|FG003|Extension Phase|Lost to Follow-up|1|||
160840953|NCT01618695|580804980|FG000|Extension Phase|Other than specified|13|||
160840954|NCT01618695|580804981|FG001|Extension Phase|Other than specified|18|||
160840955|NCT01618695|580804982|FG002|Extension Phase|Other than specified|13|||
160840956|NCT01618695|580804983|FG003|Extension Phase|Other than specified|18|||
160840957|NCT02291419|580804987|FG000|Overall Study|Early study termination|1|||
160840958|NCT02291419|580804988|FG001|Overall Study|Early study termination|5|||
160840959|NCT00931606|580804989|FG000|Overall Study|Death|1|||
160840960|NCT00931606|580804990|FG001|Overall Study|Death|3|||
160840961|NCT00931606|580804991|FG002|Overall Study|Death|2|||
160840962|NCT00931606|580804992|FG003|Overall Study|Death|0|||
160840963|NCT00931606|580804989|FG000|Overall Study|Lost to Follow-up|0|||
160840964|NCT00931606|580804990|FG001|Overall Study|Lost to Follow-up|1|||
160840965|NCT00931606|580804991|FG002|Overall Study|Lost to Follow-up|0|||
160840966|NCT00931606|580804992|FG003|Overall Study|Lost to Follow-up|0|||
160840967|NCT00931606|580804989|FG000|Overall Study|Physician Decision|0|||
160840968|NCT00931606|580804990|FG001|Overall Study|Physician Decision|0|||
160840969|NCT00931606|580804991|FG002|Overall Study|Physician Decision|3|||
160840970|NCT00931606|580804992|FG003|Overall Study|Physician Decision|0|||
160840971|NCT00931606|580804989|FG000|Overall Study|Sponsor Decision|1|||
160840972|NCT00931606|580804990|FG001|Overall Study|Sponsor Decision|4|||
160840973|NCT00931606|580804991|FG002|Overall Study|Sponsor Decision|0|||
160840974|NCT00931606|580804992|FG003|Overall Study|Sponsor Decision|2|||
160840975|NCT00931606|580804989|FG000|Overall Study|Withdrawal by Subject|3|||
160840976|NCT00931606|580804990|FG001|Overall Study|Withdrawal by Subject|1|||
160840977|NCT00931606|580804991|FG002|Overall Study|Withdrawal by Subject|1|||
160840978|NCT00931606|580804992|FG003|Overall Study|Withdrawal by Subject|1|||
160840979|NCT00871338|580804993|FG000|Prior to Booster|Withdrawal by Subject|1|||
160840980|NCT00871338|580804994|FG001|Prior to Booster|Withdrawal by Subject|3|||
160840981|NCT00871338|580804993|FG000|Prior to Booster|Lost to Follow-up|1|||
160840982|NCT00871338|580804994|FG001|Prior to Booster|Lost to Follow-up|0|||
160840983|NCT02391363|580804995|FG000|Overall Study|Lost to Follow-up|5|||
160840984|NCT02391363|580804996|FG001|Overall Study|Lost to Follow-up|5|||
160840985|NCT02391363|580804995|FG000|Overall Study|Withdrawal by Subject|6|||
160905300|NCT00288054|581048183|FG000|Overall Study|Protocol Violation|2|||
160905301|NCT00288054|581048183|FG000|Overall Study|Lack of Efficacy|16|||
160905302|NCT00288054|581048183|FG000|Overall Study|Adverse Event|3|||
161251396|NCT02315066|582300418|FG003|Overall Study|Death|11|||
160840986|NCT02391363|580804996|FG001|Overall Study|Withdrawal by Subject|3|||
160840987|NCT00799266|580804997|FG000|Overall Study|Adverse Event|0|||
160840988|NCT00799266|580804998|FG001|Overall Study|Adverse Event|1|||
160840989|NCT00799266|580804997|FG000|Overall Study|Subject withdrew consent|3|||
160840990|NCT00799266|580804998|FG001|Overall Study|Subject withdrew consent|0|||
160840991|NCT00872599|580804999|FG000|Second Washout Period|Adverse Event|1|||
160840992|NCT00872599|580805000|FG001|Second Washout Period|Adverse Event|1|||
160840993|NCT04794270|580805001|FG000|Period 1|Non Compliance|1|||
160840994|NCT04794270|580805002|FG001|Period 1|Non Compliance|0|||
160840995|NCT04794270|580805001|FG000|Period 1|Adverse Event|1|||
160840996|NCT04794270|580805002|FG001|Period 1|Adverse Event|0|||
160840997|NCT04794270|580805001|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
161251397|NCT02315066|582300419|FG004|Overall Study|Death|10|||
161251398|NCT02315066|582300420|FG005|Overall Study|Death|3|||
161251399|NCT02315066|582300421|FG006|Overall Study|Death|9|||
161251400|NCT02315066|582300422|FG007|Overall Study|Death|9|||
161251401|NCT02315066|582300423|FG008|Overall Study|Death|10|||
161251402|NCT02315066|582300424|FG009|Overall Study|Death|8|||
161251403|NCT02315066|582300425|FG010|Overall Study|Death|10|||
161251404|NCT02315066|582300426|FG011|Overall Study|Death|7|||
161251405|NCT02315066|582300427|FG012|Overall Study|Death|8|||
161251406|NCT02315066|582300428|FG013|Overall Study|Death|21|||
161251407|NCT02315066|582300415|FG000|Overall Study|Other|0|||
161251408|NCT02315066|582300416|FG001|Overall Study|Other|0|||
161251409|NCT02315066|582300417|FG002|Overall Study|Other|0|||
161251410|NCT02315066|582300418|FG003|Overall Study|Other|0|||
161251411|NCT02315066|582300419|FG004|Overall Study|Other|0|||
161251412|NCT02315066|582300420|FG005|Overall Study|Other|0|||
161251413|NCT02315066|582300421|FG006|Overall Study|Other|0|||
161251414|NCT02315066|582300422|FG007|Overall Study|Other|1|||
161251415|NCT02315066|582300423|FG008|Overall Study|Other|1|||
161251416|NCT02315066|582300424|FG009|Overall Study|Other|2|||
161251417|NCT02315066|582300425|FG010|Overall Study|Other|0|||
161251418|NCT02315066|582300426|FG011|Overall Study|Other|0|||
161251419|NCT02315066|582300427|FG012|Overall Study|Other|0|||
161251420|NCT02315066|582300428|FG013|Overall Study|Other|0|||
161251421|NCT02315066|582300415|FG000|Overall Study|Subject refused further follow-up|0|||
161251422|NCT02315066|582300416|FG001|Overall Study|Subject refused further follow-up|2|||
161251423|NCT02315066|582300417|FG002|Overall Study|Subject refused further follow-up|2|||
161251424|NCT02315066|582300418|FG003|Overall Study|Subject refused further follow-up|0|||
161251425|NCT02315066|582300419|FG004|Overall Study|Subject refused further follow-up|0|||
161251426|NCT02315066|582300420|FG005|Overall Study|Subject refused further follow-up|0|||
161251427|NCT02315066|582300421|FG006|Overall Study|Subject refused further follow-up|2|||
161251428|NCT02315066|582300422|FG007|Overall Study|Subject refused further follow-up|3|||
161251429|NCT02315066|582300423|FG008|Overall Study|Subject refused further follow-up|0|||
161251430|NCT02315066|582300424|FG009|Overall Study|Subject refused further follow-up|1|||
161251431|NCT02315066|582300425|FG010|Overall Study|Subject refused further follow-up|1|||
161251432|NCT02315066|582300426|FG011|Overall Study|Subject refused further follow-up|2|||
161251433|NCT02315066|582300427|FG012|Overall Study|Subject refused further follow-up|2|||
161251434|NCT02315066|582300428|FG013|Overall Study|Subject refused further follow-up|4|||
161251435|NCT02315066|582300415|FG000|Overall Study|Study ongoing at date of cut-off|0|||
161251436|NCT02315066|582300416|FG001|Overall Study|Study ongoing at date of cut-off|0|||
161251437|NCT02315066|582300417|FG002|Overall Study|Study ongoing at date of cut-off|0|||
161251438|NCT02315066|582300418|FG003|Overall Study|Study ongoing at date of cut-off|0|||
161251439|NCT02315066|582300419|FG004|Overall Study|Study ongoing at date of cut-off|0|||
161251440|NCT02315066|582300420|FG005|Overall Study|Study ongoing at date of cut-off|0|||
161251441|NCT02315066|582300421|FG006|Overall Study|Study ongoing at date of cut-off|0|||
161251442|NCT02315066|582300422|FG007|Overall Study|Study ongoing at date of cut-off|0|||
161251443|NCT02315066|582300423|FG008|Overall Study|Study ongoing at date of cut-off|0|||
160840998|NCT04794270|580805002|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
160840999|NCT00265317|580805006|FG000|Lead-In|Objective progression or relapse|6|||
160841000|NCT00265317|580805007|FG001|Lead-In|Objective progression or relapse|11|||
160841001|NCT00265317|580805008|FG002|Lead-In|Objective progression or relapse|0|||
160841002|NCT00265317|580805009|FG003|Lead-In|Objective progression or relapse|0|||
160841003|NCT00265317|580805006|FG000|Lead-In|Adverse Event|2|||
160841004|NCT00265317|580805007|FG001|Lead-In|Adverse Event|1|||
161251444|NCT02315066|582300424|FG009|Overall Study|Study ongoing at date of cut-off|0|||
161251445|NCT02315066|582300425|FG010|Overall Study|Study ongoing at date of cut-off|0|||
160841005|NCT00265317|580805008|FG002|Lead-In|Adverse Event|0|||
160841006|NCT00265317|580805009|FG003|Lead-In|Adverse Event|0|||
160841007|NCT00265317|580805006|FG000|Lead-In|Death|3|||
160841008|NCT00265317|580805007|FG001|Lead-In|Death|5|||
160841009|NCT00265317|580805008|FG002|Lead-In|Death|0|||
160841010|NCT00265317|580805009|FG003|Lead-In|Death|0|||
160841011|NCT00265317|580805006|FG000|Lead-In|Withdrawal/other than adverse event|1|||
160841012|NCT00265317|580805007|FG001|Lead-In|Withdrawal/other than adverse event|0|||
160841013|NCT00265317|580805008|FG002|Lead-In|Withdrawal/other than adverse event|0|||
160841014|NCT00265317|580805009|FG003|Lead-In|Withdrawal/other than adverse event|0|||
160841015|NCT00265317|580805006|FG000|Phase 2|Objective progression or relapse|0|||
160841016|NCT00265317|580805007|FG001|Phase 2|Objective progression or relapse|0|||
160841017|NCT00265317|580805008|FG002|Phase 2|Objective progression or relapse|37|||
160841018|NCT00265317|580805009|FG003|Phase 2|Objective progression or relapse|38|||
161251446|NCT02315066|582300426|FG011|Overall Study|Study ongoing at date of cut-off|0|||
161251447|NCT02315066|582300427|FG012|Overall Study|Study ongoing at date of cut-off|0|||
160841019|NCT00265317|580805006|FG000|Phase 2|Global deterioration of health status|0|||
160841020|NCT00265317|580805007|FG001|Phase 2|Global deterioration of health status|0|||
160841021|NCT00265317|580805008|FG002|Phase 2|Global deterioration of health status|3|||
161251448|NCT02315066|582300428|FG013|Overall Study|Study ongoing at date of cut-off|1|||
160841022|NCT00265317|580805009|FG003|Phase 2|Global deterioration of health status|0|||
161251449|NCT03259789|582300429|FG000|Overall Study|Adverse Event|3|||
161251450|NCT03259789|582300430|FG001|Overall Study|Adverse Event|2|||
161251451|NCT03259789|582300431|FG002|Overall Study|Adverse Event|1|||
161251452|NCT03259789|582300429|FG000|Overall Study|Withdrawal by Subject|9|||
161251453|NCT03259789|582300430|FG001|Overall Study|Withdrawal by Subject|5|||
161251454|NCT03259789|582300431|FG002|Overall Study|Withdrawal by Subject|1|||
161251455|NCT03259789|582300429|FG000|Overall Study|Lost to Follow-up|5|||
160841023|NCT00265317|580805006|FG000|Phase 2|Adverse Event|0|||
160841024|NCT00265317|580805007|FG001|Phase 2|Adverse Event|0|||
160841025|NCT00265317|580805008|FG002|Phase 2|Adverse Event|7|||
160841026|NCT00265317|580805009|FG003|Phase 2|Adverse Event|5|||
160841027|NCT00265317|580805006|FG000|Phase 2|Death|0|||
160841028|NCT00265317|580805007|FG001|Phase 2|Death|0|||
160841029|NCT00265317|580805008|FG002|Phase 2|Death|12|||
160841030|NCT00265317|580805009|FG003|Phase 2|Death|15|||
160841031|NCT00265317|580805006|FG000|Phase 2|Protocol Violation|0|||
160841032|NCT00265317|580805007|FG001|Phase 2|Protocol Violation|0|||
160841033|NCT00265317|580805008|FG002|Phase 2|Protocol Violation|1|||
160841034|NCT00265317|580805009|FG003|Phase 2|Protocol Violation|4|||
160841035|NCT00265317|580805006|FG000|Phase 2|Lost to Follow-up|0|||
160841036|NCT00265317|580805007|FG001|Phase 2|Lost to Follow-up|0|||
160841037|NCT00265317|580805008|FG002|Phase 2|Lost to Follow-up|0|||
160841038|NCT00265317|580805009|FG003|Phase 2|Lost to Follow-up|1|||
160841039|NCT00265317|580805006|FG000|Phase 2|Withdrawal/other than adverse event|0|||
160841040|NCT00265317|580805007|FG001|Phase 2|Withdrawal/other than adverse event|0|||
160841041|NCT00265317|580805008|FG002|Phase 2|Withdrawal/other than adverse event|2|||
160841042|NCT00265317|580805009|FG003|Phase 2|Withdrawal/other than adverse event|1|||
160905303|NCT00288054|581048183|FG000|Overall Study|Withdrawal by Subject|1|||
160905304|NCT00288054|581048183|FG000|Overall Study|Not protocol specified|2|||
160905305|NCT00289991|581048184|FG000|Overall Study|Death|35|||
160905306|NCT00289991|581048185|FG001|Overall Study|Death|38|||
160905307|NCT00289991|581048184|FG000|Overall Study|Adverse Event|15|||
160992075|NCT00871429|581359972|FG000|Overall Study|Lost to Follow-up|6|||
160992076|NCT00871429|581359972|FG000|Overall Study|Withdrawal by Subject|17|||
160992077|NCT00871429|581359972|FG000|Overall Study|Questionnaire not completed|1|||
160992078|NCT03102242|581359973|FG000|Overall Study|Adverse Event|2|||
160992079|NCT00389519|581359974|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
160992080|NCT00389519|581359975|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
160992081|NCT00389519|581359976|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
160992082|NCT00389519|581359977|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
160992083|NCT00389519|581359974|FG000|Placebo Run-In|Withdrawal by Subject|19|||
160992084|NCT00389519|581359975|FG001|Placebo Run-In|Withdrawal by Subject|0|||
160992085|NCT00389519|581359976|FG002|Placebo Run-In|Withdrawal by Subject|0|||
160992086|NCT00389519|581359977|FG003|Placebo Run-In|Withdrawal by Subject|0|||
160992087|NCT00389519|581359974|FG000|Placebo Run-In|Reason not specified|40|||
160992088|NCT00389519|581359975|FG001|Placebo Run-In|Reason not specified|0|||
160992089|NCT00389519|581359976|FG002|Placebo Run-In|Reason not specified|0|||
160992090|NCT00389519|581359977|FG003|Placebo Run-In|Reason not specified|0|||
160992091|NCT00389519|581359974|FG000|Randomized|Did not receive study drug|2|||
160992092|NCT00389519|581359975|FG001|Randomized|Did not receive study drug|0|||
160992093|NCT00389519|581359976|FG002|Randomized|Did not receive study drug|0|||
160992094|NCT00389519|581359977|FG003|Randomized|Did not receive study drug|0|||
161251456|NCT03259789|582300430|FG001|Overall Study|Lost to Follow-up|9|||
160905308|NCT00289991|581048185|FG001|Overall Study|Adverse Event|13|||
160905309|NCT00289991|581048184|FG000|Overall Study|Failure of prophylaxis|1|||
160905310|NCT00289991|581048185|FG001|Overall Study|Failure of prophylaxis|1|||
160905311|NCT00289991|581048184|FG000|Overall Study|Fungal breakthrough infection|0|||
160905312|NCT00289991|581048185|FG001|Overall Study|Fungal breakthrough infection|1|||
160905313|NCT00289991|581048184|FG000|Overall Study|Lost to Follow-up|0|||
160905314|NCT00289991|581048185|FG001|Overall Study|Lost to Follow-up|1|||
160905315|NCT00289991|581048184|FG000|Overall Study|Withdrawal by Subject|2|||
160905316|NCT00289991|581048185|FG001|Overall Study|Withdrawal by Subject|12|||
160905317|NCT00289991|581048184|FG000|Overall Study|Other|5|||
160905318|NCT00289991|581048185|FG001|Overall Study|Other|14|||
160905319|NCT01091974|581048186|FG000|Overall Study|Did not start intervention|3|||
160992095|NCT00389519|581359974|FG000|Treated|Adverse Event|1|||
160992096|NCT00389519|581359975|FG001|Treated|Adverse Event|0|||
160992097|NCT00389519|581359976|FG002|Treated|Adverse Event|0|||
160841043|NCT00265317|580805006|FG000|Phase 2|Study terminated by sponsor|0|||
160905320|NCT01091974|581048187|FG001|Overall Study|Did not start intervention|1|||
160841044|NCT00265317|580805007|FG001|Phase 2|Study terminated by sponsor|0|||
160905321|NCT01091974|581048188|FG002|Overall Study|Did not start intervention|3|||
160905322|NCT01091974|581048189|FG003|Overall Study|Did not start intervention|1|||
160992098|NCT00389519|581359977|FG003|Treated|Adverse Event|2|||
161251457|NCT03259789|582300431|FG002|Overall Study|Lost to Follow-up|4|||
161251458|NCT03259789|582300429|FG000|Overall Study|Physician Decision|0|||
160841045|NCT00265317|580805008|FG002|Phase 2|Study terminated by sponsor|1|||
160841046|NCT00265317|580805009|FG003|Phase 2|Study terminated by sponsor|0|||
160841047|NCT00265317|580805006|FG000|Phase 2|Other|0|||
160841048|NCT00265317|580805007|FG001|Phase 2|Other|0|||
160841049|NCT00265317|580805008|FG002|Phase 2|Other|1|||
160841050|NCT00265317|580805009|FG003|Phase 2|Other|1|||
160841051|NCT00732875|580805012|FG000|Overall Study|Adverse Event|16|||
160841052|NCT00732875|580805012|FG000|Overall Study|Withdrawal by Subject|6|||
160841053|NCT00732875|580805012|FG000|Overall Study|Lack of Efficacy|13|||
160841054|NCT02300259|580805013|FG000|Period 1|Adverse Event|0|||
160841055|NCT02300259|580805014|FG001|Period 1|Adverse Event|0|||
160905323|NCT01091974|581048186|FG000|Overall Study|resumed sleep medication|0|||
160905324|NCT01091974|581048187|FG001|Overall Study|resumed sleep medication|0|||
160905325|NCT01091974|581048188|FG002|Overall Study|resumed sleep medication|1|||
160905326|NCT01091974|581048189|FG003|Overall Study|resumed sleep medication|2|||
160905327|NCT01091974|581048186|FG000|Overall Study|Withdrawal by Subject|1|||
160905328|NCT01091974|581048187|FG001|Overall Study|Withdrawal by Subject|3|||
160905329|NCT01091974|581048188|FG002|Overall Study|Withdrawal by Subject|2|||
160905330|NCT01091974|581048189|FG003|Overall Study|Withdrawal by Subject|2|||
160905331|NCT01091974|581048186|FG000|Overall Study|side-effects|1|||
160905332|NCT01091974|581048187|FG001|Overall Study|side-effects|1|||
160905333|NCT01091974|581048188|FG002|Overall Study|side-effects|0|||
160905334|NCT01091974|581048189|FG003|Overall Study|side-effects|2|||
160905335|NCT00205881|581048190|FG000|Overall Study|Withdrawal by Subject|16|||
160905336|NCT04203498|581048193|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
160905337|NCT04203498|581048194|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
160905338|NCT04203498|581048193|FG000|Overall Study|Withdrawal of patient consent|7|||
160905339|NCT04203498|581048194|FG001|Overall Study|Withdrawal of patient consent|2|||
160905340|NCT04203498|581048193|FG000|Overall Study|Adverse Event|4|||
160905341|NCT04203498|581048194|FG001|Overall Study|Adverse Event|1|||
160905342|NCT04203498|581048193|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
160905343|NCT04203498|581048194|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
160905344|NCT04203498|581048193|FG000|Overall Study|Did not receive IMP|2|||
160905345|NCT04203498|581048194|FG001|Overall Study|Did not receive IMP|0|||
160905346|NCT00334958|581048196|FG000|Overall Study|Medication Noncompliance|0|||
160905347|NCT00334958|581048197|FG001|Overall Study|Medication Noncompliance|3|||
160905348|NCT00334958|581048196|FG000|Overall Study|Protocol Violation|2|||
160905349|NCT00334958|581048197|FG001|Overall Study|Protocol Violation|2|||
160905350|NCT00334958|581048196|FG000|Overall Study|Request of the investigator or sponsor|0|||
160905351|NCT00334958|581048197|FG001|Overall Study|Request of the investigator or sponsor|1|||
160905352|NCT00334958|581048196|FG000|Overall Study|Withdrawal by Subject|7|||
160905353|NCT00334958|581048197|FG001|Overall Study|Withdrawal by Subject|4|||
160905354|NCT00334958|581048196|FG000|Overall Study|Adverse Event|27|||
160905355|NCT00334958|581048197|FG001|Overall Study|Adverse Event|12|||
160905356|NCT00334958|581048196|FG000|Overall Study|Other|1|||
160905357|NCT00334958|581048197|FG001|Overall Study|Other|2|||
160905358|NCT01548287|581048198|FG000|Screening|No reason provided|0|||
160905359|NCT01548287|581048199|FG001|Screening|No reason provided|0|||
160905360|NCT01548287|581048200|FG002|Screening|No reason provided|0|||
160905361|NCT01548287|581048201|FG003|Screening|No reason provided|0|||
160905362|NCT01548287|581048202|FG004|Screening|No reason provided|9|||
160905363|NCT01548287|581048198|FG000|Screening|Did not meet eligibility criteria|0|||
160905364|NCT01548287|581048199|FG001|Screening|Did not meet eligibility criteria|0|||
160905365|NCT01548287|581048200|FG002|Screening|Did not meet eligibility criteria|0|||
160905366|NCT01548287|581048201|FG003|Screening|Did not meet eligibility criteria|0|||
160905367|NCT01548287|581048202|FG004|Screening|Did not meet eligibility criteria|74|||
160905368|NCT01548287|581048198|FG000|Randomized Period|Did not meet inclusion criteria|0|||
160905369|NCT01548287|581048199|FG001|Randomized Period|Did not meet inclusion criteria|0|||
160905370|NCT01548287|581048200|FG002|Randomized Period|Did not meet inclusion criteria|2|||
160905371|NCT01548287|581048201|FG003|Randomized Period|Did not meet inclusion criteria|0|||
160905372|NCT01548287|581048202|FG004|Randomized Period|Did not meet inclusion criteria|0|||
160905373|NCT01548287|581048198|FG000|Randomized Period|Adverse Event|0|||
160992099|NCT00389519|581359974|FG000|Treated|Reason not specified|1|||
160992100|NCT00389519|581359975|FG001|Treated|Reason not specified|1|||
160905374|NCT01548287|581048199|FG001|Randomized Period|Adverse Event|2|||
160905375|NCT01548287|581048200|FG002|Randomized Period|Adverse Event|5|||
160905376|NCT01548287|581048201|FG003|Randomized Period|Adverse Event|0|||
160905377|NCT01548287|581048202|FG004|Randomized Period|Adverse Event|0|||
160905378|NCT02762578|581048207|FG000|Overall Study|Adverse Event|1|||
160905379|NCT02762578|581048208|FG001|Overall Study|Adverse Event|6|||
160905380|NCT02762578|581048207|FG000|Overall Study|Protocol Violation|4|||
160905381|NCT02762578|581048208|FG001|Overall Study|Protocol Violation|2|||
160905382|NCT02762578|581048207|FG000|Overall Study|Withdrawal by Subject|4|||
160905383|NCT02762578|581048208|FG001|Overall Study|Withdrawal by Subject|2|||
160905384|NCT02762578|581048207|FG000|Overall Study|Unclassified|6|||
160992101|NCT00389519|581359976|FG002|Treated|Reason not specified|0|||
160841056|NCT02300259|580805015|FG002|Period 1|Adverse Event|1|||
160841057|NCT02300259|580805013|FG000|Period 1|Withdrawal by Subject|0|||
160841058|NCT02300259|580805014|FG001|Period 1|Withdrawal by Subject|0|||
160841059|NCT02300259|580805015|FG002|Period 1|Withdrawal by Subject|1|||
161251459|NCT03259789|582300430|FG001|Overall Study|Physician Decision|1|||
161251460|NCT03259789|582300431|FG002|Overall Study|Physician Decision|0|||
161251461|NCT00860262|582300435|FG000|Overall Study|Adverse Event|9|||
161251462|NCT00860262|582300436|FG001|Overall Study|Adverse Event|6|||
160841060|NCT02300259|580805013|FG000|Period 2|Adverse Event|1|||
160841061|NCT02300259|580805014|FG001|Period 2|Adverse Event|0|||
160841062|NCT02300259|580805015|FG002|Period 2|Adverse Event|0|||
160841063|NCT02300259|580805013|FG000|Period 2|Withdrawal by Subject|0|||
161251463|NCT00860262|582300437|FG002|Overall Study|Adverse Event|7|||
161251464|NCT00860262|582300435|FG000|Overall Study|Protocol Violation|0|||
161251465|NCT00860262|582300436|FG001|Overall Study|Protocol Violation|1|||
161251466|NCT00860262|582300437|FG002|Overall Study|Protocol Violation|0|||
161251467|NCT00860262|582300435|FG000|Overall Study|Lost to Follow-up|2|||
161251468|NCT00860262|582300436|FG001|Overall Study|Lost to Follow-up|0|||
161251469|NCT00860262|582300437|FG002|Overall Study|Lost to Follow-up|1|||
161251470|NCT00860262|582300435|FG000|Overall Study|Withdrawal by Subject|4|||
161251471|NCT00860262|582300436|FG001|Overall Study|Withdrawal by Subject|8|||
161251472|NCT00860262|582300437|FG002|Overall Study|Withdrawal by Subject|6|||
161251473|NCT00860262|582300435|FG000|Overall Study|Lack of Efficacy|0|||
161251474|NCT00860262|582300436|FG001|Overall Study|Lack of Efficacy|4|||
161251475|NCT00860262|582300437|FG002|Overall Study|Lack of Efficacy|3|||
161251476|NCT00860262|582300435|FG000|Overall Study|Other|5|||
161251477|NCT00860262|582300436|FG001|Overall Study|Other|3|||
161251478|NCT00860262|582300437|FG002|Overall Study|Other|1|||
161251479|NCT01183884|582300438|FG000|Overall Study|Progressive Disease|26|||
161251480|NCT01183884|582300438|FG000|Overall Study|Adverse Event|3|||
161251481|NCT01183884|582300438|FG000|Overall Study|Withdrawal by Subject|1|||
161251482|NCT01183884|582300438|FG000|Overall Study|Other Complicating Disease|3|||
161251483|NCT01183884|582300438|FG000|Overall Study|Not Treated|1|||
161251484|NCT01183884|582300438|FG000|Overall Study|Other|4|||
161251485|NCT02169336|582300439|FG000|Overall Study|Lack of Efficacy|1|||
161251486|NCT02169336|582300440|FG001|Overall Study|Lack of Efficacy|1|||
161251487|NCT02169336|582300441|FG002|Overall Study|Lack of Efficacy|0|||
161251488|NCT02169336|582300439|FG000|Overall Study|Adverse Event|2|||
161251489|NCT02169336|582300440|FG001|Overall Study|Adverse Event|3|||
161251490|NCT02169336|582300441|FG002|Overall Study|Adverse Event|1|||
161251491|NCT02169336|582300439|FG000|Overall Study|Withdrawal by Subject|1|||
161251492|NCT02169336|582300440|FG001|Overall Study|Withdrawal by Subject|0|||
161251493|NCT02169336|582300441|FG002|Overall Study|Withdrawal by Subject|0|||
161251494|NCT02169336|582300439|FG000|Overall Study|Physician Decision|0|||
161251495|NCT02169336|582300440|FG001|Overall Study|Physician Decision|0|||
161251496|NCT02169336|582300441|FG002|Overall Study|Physician Decision|1|||
161251497|NCT02169336|582300439|FG000|Overall Study|Subject declined to continue dosing|0|||
161251498|NCT02169336|582300440|FG001|Overall Study|Subject declined to continue dosing|0|||
161251499|NCT02169336|582300441|FG002|Overall Study|Subject declined to continue dosing|1|||
161251500|NCT01598896|582300442|FG000|Overall Study|Withdrawal by Subject|0|||
161251501|NCT01598896|582300443|FG001|Overall Study|Withdrawal by Subject|1|||
161251502|NCT01598896|582300442|FG000|Overall Study|Lack of Efficacy|0|||
161251503|NCT01598896|582300443|FG001|Overall Study|Lack of Efficacy|1|||
161251504|NCT00420095|582300444|FG000|Overall Study|Adverse Event|1|||
161251505|NCT00420095|582300445|FG001|Overall Study|Adverse Event|0|||
161251506|NCT00420095|582300444|FG000|Overall Study|Protocol Violation|1|||
161251507|NCT00420095|582300445|FG001|Overall Study|Protocol Violation|1|||
161251508|NCT00420095|582300444|FG000|Overall Study|Lost to Follow-up|1|||
161251509|NCT00420095|582300445|FG001|Overall Study|Lost to Follow-up|0|||
161251510|NCT00393705|582300446|FG000|Overall Study|Adverse Event|0|||
160841064|NCT02300259|580805014|FG001|Period 2|Withdrawal by Subject|0|||
161251511|NCT00393705|582300447|FG001|Overall Study|Adverse Event|2|||
161251512|NCT00393705|582300446|FG000|Overall Study|Death|0|||
161251513|NCT00393705|582300447|FG001|Overall Study|Death|1|||
161251514|NCT00393705|582300446|FG000|Overall Study|Lost to Follow-up|2|||
161251515|NCT00393705|582300447|FG001|Overall Study|Lost to Follow-up|2|||
161251516|NCT00393705|582300446|FG000|Overall Study|Entry Criteria Not Met|10|||
161251517|NCT00393705|582300447|FG001|Overall Study|Entry Criteria Not Met|10|||
161251518|NCT00393705|582300446|FG000|Overall Study|Protocol Violation|4|||
161251519|NCT00393705|582300447|FG001|Overall Study|Protocol Violation|3|||
161251520|NCT00393705|582300446|FG000|Overall Study|Withdrawal by Subject|5|||
160841065|NCT02300259|580805015|FG002|Period 2|Withdrawal by Subject|1|||
160841066|NCT02510001|580805016|FG000|Overall Study|Early disease progression|0|||
161251521|NCT00393705|582300447|FG001|Overall Study|Withdrawal by Subject|3|||
161251522|NCT00393705|582300446|FG000|Overall Study|Physician Decision|2|||
161251523|NCT00393705|582300447|FG001|Overall Study|Physician Decision|2|||
161251524|NCT04553406|582300450|FG000|Overall Study|Study Discontinuation|0|||
161251525|NCT04553406|582300451|FG001|Overall Study|Study Discontinuation|1|||
161251526|NCT03370510|582300452|FG000|Overall Study|COVID-19|2|||
161251527|NCT03370510|582300453|FG001|Overall Study|COVID-19|0|||
161251528|NCT05258630|582302297|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
161251529|NCT05258630|582302298|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
161251530|NCT05258630|582302297|FG000|Overall Study|Lost to Follow-up|0|||
161251531|NCT05258630|582302298|FG001|Overall Study|Lost to Follow-up|2|||
160992102|NCT00389519|581359977|FG003|Treated|Reason not specified|2|||
160992103|NCT03425539|581359980|FG000|Overall Study|Randomized but not treated|0|||
160992104|NCT03425539|581359981|FG001|Overall Study|Randomized but not treated|1|||
160992105|NCT03425539|581359980|FG000|Overall Study|Adverse Event|2|||
160992106|NCT03425539|581359981|FG001|Overall Study|Adverse Event|2|||
161251532|NCT03431337|582302299|FG000|Overall Study|Lost to Follow-up|21|||
161251533|NCT03431337|582302300|FG001|Overall Study|Lost to Follow-up|19|||
161251534|NCT03431337|582302299|FG000|Overall Study|Withdrawal by Subject|8|||
161251535|NCT03431337|582302300|FG001|Overall Study|Withdrawal by Subject|3|||
161251536|NCT00894933|582302307|FG000|Overall Study|Lost to Follow-up|2|||
161251537|NCT00894933|582302307|FG000|Overall Study|Cancelled Procedure|1|||
161251538|NCT00894933|582302307|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
161251539|NCT00631007|582302310|FG000|Overall Study|Adverse Event|0|||
161251540|NCT00631007|582302311|FG001|Overall Study|Adverse Event|2|||
161251541|NCT00631007|582302312|FG002|Overall Study|Adverse Event|0|||
161251542|NCT00631007|582302313|FG003|Overall Study|Adverse Event|2|||
161251543|NCT00631007|582302314|FG004|Overall Study|Adverse Event|3|||
161251544|NCT00631007|582302315|FG005|Overall Study|Adverse Event|2|||
161251545|NCT00631007|582302310|FG000|Overall Study|Lost to Follow-up|2|||
161251546|NCT00631007|582302311|FG001|Overall Study|Lost to Follow-up|1|||
161251547|NCT00631007|582302312|FG002|Overall Study|Lost to Follow-up|2|||
161251548|NCT00631007|582302313|FG003|Overall Study|Lost to Follow-up|4|||
161251549|NCT00631007|582302314|FG004|Overall Study|Lost to Follow-up|5|||
161251550|NCT00631007|582302315|FG005|Overall Study|Lost to Follow-up|3|||
161251551|NCT00631007|582302310|FG000|Overall Study|Physician Decision|1|||
161251552|NCT00631007|582302311|FG001|Overall Study|Physician Decision|0|||
160841067|NCT02510001|580805017|FG001|Overall Study|Early disease progression|0|||
160841068|NCT02510001|580805018|FG002|Overall Study|Early disease progression|0|||
160841069|NCT02510001|580805019|FG003|Overall Study|Early disease progression|1|||
160841070|NCT02510001|580805020|FG004|Overall Study|Early disease progression|1|||
160841071|NCT02510001|580805021|FG005|Overall Study|Early disease progression|1|||
160841072|NCT02510001|580805022|FG006|Overall Study|Early disease progression|0|||
160841073|NCT02510001|580805023|FG007|Overall Study|Early disease progression|0|||
160841074|NCT02510001|580805016|FG000|Overall Study|Adverse Event|0|||
160841075|NCT02510001|580805017|FG001|Overall Study|Adverse Event|0|||
160841076|NCT02510001|580805018|FG002|Overall Study|Adverse Event|0|||
160841077|NCT02510001|580805019|FG003|Overall Study|Adverse Event|1|||
160841078|NCT02510001|580805020|FG004|Overall Study|Adverse Event|2|||
160841079|NCT02510001|580805021|FG005|Overall Study|Adverse Event|1|||
160841080|NCT02510001|580805022|FG006|Overall Study|Adverse Event|2|||
160841081|NCT02510001|580805023|FG007|Overall Study|Adverse Event|5|||
160841082|NCT02510001|580805016|FG000|Overall Study|Physician Decision|0|||
160841083|NCT02510001|580805017|FG001|Overall Study|Physician Decision|0|||
160841084|NCT02510001|580805018|FG002|Overall Study|Physician Decision|0|||
160841085|NCT02510001|580805019|FG003|Overall Study|Physician Decision|0|||
160841086|NCT02510001|580805020|FG004|Overall Study|Physician Decision|1|||
160841087|NCT02510001|580805021|FG005|Overall Study|Physician Decision|0|||
160841088|NCT02510001|580805022|FG006|Overall Study|Physician Decision|0|||
160841089|NCT02510001|580805023|FG007|Overall Study|Physician Decision|0|||
160841090|NCT02510001|580805016|FG000|Overall Study|Withdrawal by Subject|0|||
160841091|NCT02510001|580805017|FG001|Overall Study|Withdrawal by Subject|0|||
160841092|NCT02510001|580805018|FG002|Overall Study|Withdrawal by Subject|0|||
160841093|NCT02510001|580805019|FG003|Overall Study|Withdrawal by Subject|0|||
160841094|NCT02510001|580805020|FG004|Overall Study|Withdrawal by Subject|0|||
160841095|NCT02510001|580805021|FG005|Overall Study|Withdrawal by Subject|0|||
160841096|NCT02510001|580805022|FG006|Overall Study|Withdrawal by Subject|0|||
160841097|NCT02510001|580805023|FG007|Overall Study|Withdrawal by Subject|2|||
160841098|NCT01504841|580805030|FG000|Overall Study|Withdrawal by Subject|1|||
160841099|NCT01504841|580805031|FG001|Overall Study|Withdrawal by Subject|1|||
160841100|NCT01504841|580805032|FG002|Overall Study|Withdrawal by Subject|0|||
160841101|NCT03149055|580805039|FG000|Overall Study|Not treated|4|||
160841102|NCT04440813|580805040|FG000|Overall Study|Lost to Follow-up|5|||
160992107|NCT03425539|581359980|FG000|Overall Study|Withdrawal by Subject|3|||
160992108|NCT03425539|581359981|FG001|Overall Study|Withdrawal by Subject|0|||
160992109|NCT03425539|581359980|FG000|Overall Study|Lost to Follow-up|0|||
160992110|NCT03425539|581359981|FG001|Overall Study|Lost to Follow-up|1|||
160992111|NCT02040844|581359982|FG000|Overall Study|Adverse Event|0|||
160841103|NCT04440813|580805041|FG001|Overall Study|Lost to Follow-up|5|||
161251553|NCT00631007|582302312|FG002|Overall Study|Physician Decision|1|||
161251554|NCT00631007|582302313|FG003|Overall Study|Physician Decision|0|||
161251555|NCT00631007|582302314|FG004|Overall Study|Physician Decision|0|||
161251556|NCT00631007|582302315|FG005|Overall Study|Physician Decision|2|||
160841104|NCT00660179|580805042|FG000|Overall Study|Death|44|||
160841105|NCT00660179|580805043|FG001|Overall Study|Death|47|||
160841106|NCT00660179|580805044|FG002|Overall Study|Death|34|||
160841107|NCT00660179|580805042|FG000|Overall Study|Withdrawal of consent|4|||
161251557|NCT00631007|582302310|FG000|Overall Study|Persistent Hyperglycemia|2|||
161251558|NCT00631007|582302311|FG001|Overall Study|Persistent Hyperglycemia|2|||
161251559|NCT00631007|582302312|FG002|Overall Study|Persistent Hyperglycemia|5|||
160841108|NCT00660179|580805043|FG001|Overall Study|Withdrawal of consent|6|||
160841109|NCT00660179|580805044|FG002|Overall Study|Withdrawal of consent|4|||
160841110|NCT00660179|580805042|FG000|Overall Study|Lost to Follow-up|7|||
160841111|NCT00660179|580805043|FG001|Overall Study|Lost to Follow-up|5|||
160841112|NCT00660179|580805044|FG002|Overall Study|Lost to Follow-up|2|||
160841113|NCT00660179|580805042|FG000|Overall Study|Administrative reason|0|||
160841114|NCT00660179|580805043|FG001|Overall Study|Administrative reason|0|||
160841115|NCT00660179|580805044|FG002|Overall Study|Administrative reason|1|||
160841116|NCT00660179|580805042|FG000|Overall Study|Incorrect randomization|1|||
160841117|NCT00660179|580805043|FG001|Overall Study|Incorrect randomization|0|||
160841118|NCT00660179|580805044|FG002|Overall Study|Incorrect randomization|0|||
160841119|NCT00291018|580805051|FG000|Overall Study|Not Consented or Declined PAS|12|||
160841120|NCT00291018|580805052|FG001|Overall Study|Not Consented or Declined PAS|15|||
160841121|NCT00291018|580805053|FG002|Overall Study|Not Consented or Declined PAS|15|||
160841122|NCT00291018|580805051|FG000|Overall Study|Death|3|||
160841123|NCT00291018|580805052|FG001|Overall Study|Death|3|||
160841124|NCT00291018|580805053|FG002|Overall Study|Death|4|||
160841125|NCT00291018|580805051|FG000|Overall Study|Withdrawal by Subject|2|||
160841126|NCT00291018|580805052|FG001|Overall Study|Withdrawal by Subject|8|||
160841127|NCT00291018|580805053|FG002|Overall Study|Withdrawal by Subject|1|||
160841128|NCT00291018|580805051|FG000|Overall Study|Failures|5|||
160841129|NCT00291018|580805052|FG001|Overall Study|Failures|12|||
160841130|NCT00291018|580805053|FG002|Overall Study|Failures|5|||
160841131|NCT00291018|580805051|FG000|Overall Study|Lost to Follow-up|3|||
160841132|NCT00291018|580805052|FG001|Overall Study|Lost to Follow-up|4|||
160841133|NCT00291018|580805053|FG002|Overall Study|Lost to Follow-up|18|||
160841134|NCT05362058|580805058|FG000|Treatment Period|Adverse Event|3|||
160841135|NCT05362058|580805059|FG001|Treatment Period|Adverse Event|3|||
160841136|NCT05362058|580805058|FG000|Treatment Period|Assigned treatment by mistake|3|||
160841137|NCT05362058|580805059|FG001|Treatment Period|Assigned treatment by mistake|4|||
160841138|NCT05362058|580805058|FG000|Treatment Period|Death|1|||
160841139|NCT05362058|580805059|FG001|Treatment Period|Death|1|||
160841140|NCT05362058|580805058|FG000|Treatment Period|Lost to Follow-up|6|||
160841141|NCT05362058|580805059|FG001|Treatment Period|Lost to Follow-up|3|||
160841142|NCT05362058|580805058|FG000|Treatment Period|Non-compliance with study drug|0|||
160841143|NCT05362058|580805059|FG001|Treatment Period|Non-compliance with study drug|1|||
160841144|NCT05362058|580805058|FG000|Treatment Period|Physician Decision|1|||
160841145|NCT05362058|580805059|FG001|Treatment Period|Physician Decision|0|||
160841146|NCT05362058|580805058|FG000|Treatment Period|Protocol deviation|1|||
160905385|NCT02762578|581048208|FG001|Overall Study|Unclassified|0|||
160905386|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905387|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905388|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905389|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
160905390|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
160905391|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
160905392|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
160905393|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
160905394|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905395|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
160905396|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905397|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905398|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905399|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905400|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
160905401|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
160905402|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905403|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905404|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
160905405|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905406|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905407|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905408|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905409|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905410|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Other|0|||
160841147|NCT05362058|580805059|FG001|Treatment Period|Protocol deviation|0|||
160841148|NCT05362058|580805058|FG000|Treatment Period|Withdrawal by Subject|10|||
160841149|NCT05362058|580805059|FG001|Treatment Period|Withdrawal by Subject|11|||
160841150|NCT05362058|580805058|FG000|Follow-Up Period|Death|1|||
160841151|NCT05362058|580805059|FG001|Follow-Up Period|Death|0|||
160841152|NCT05362058|580805058|FG000|Follow-Up Period|Lost to Follow-up|2|||
160841153|NCT05362058|580805059|FG001|Follow-Up Period|Lost to Follow-up|1|||
160841154|NCT05362058|580805058|FG000|Follow-Up Period|Protocol deviation|1|||
160841155|NCT05362058|580805059|FG001|Follow-Up Period|Protocol deviation|1|||
160841156|NCT05362058|580805058|FG000|Follow-Up Period|Withdrawal by Subject|0|||
160841157|NCT05362058|580805059|FG001|Follow-Up Period|Withdrawal by Subject|3|||
160841158|NCT00887549|580805062|FG000|Induction Therapy|Adverse Event|8|||
160841159|NCT00887549|580805062|FG000|Induction Therapy|Physician Decision|1|||
160841160|NCT00887549|580805062|FG000|Induction Therapy|Progressive Disease|13|||
160841161|NCT00887549|580805062|FG000|Induction Therapy|Death due to Study Disease|4|||
160841162|NCT00887549|580805062|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
160841163|NCT00887549|580805062|FG000|Maintenance Therapy|Adverse Event|16|||
160841164|NCT00887549|580805062|FG000|Maintenance Therapy|Physician Decision|1|||
160841165|NCT00887549|580805062|FG000|Maintenance Therapy|Progressive Disease|25|||
160841166|NCT00887549|580805062|FG000|Maintenance Therapy|Death due to adverse event|1|||
160841167|NCT01858740|580805063|FG000|Overall Study|Death|4|||
160841168|NCT03671304|580805064|FG000|Overall Study|study terminated|7|||
160841169|NCT02097030|580805069|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
160841170|NCT02097030|580805070|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
160841171|NCT02097030|580805069|FG000|First Intervention (3 Days)|Visual Acuity|0|||
160841172|NCT02097030|580805070|FG001|First Intervention (3 Days)|Visual Acuity|1|||
160841173|NCT00391027|580805071|FG000|Overall Study|Adverse Event|8|||
160841174|NCT00391027|580805072|FG001|Overall Study|Adverse Event|8|||
160841175|NCT00391027|580805071|FG000|Overall Study|Lack of Efficacy|3|||
160841176|NCT00391027|580805072|FG001|Overall Study|Lack of Efficacy|0|||
160841177|NCT00391027|580805071|FG000|Overall Study|Withdrawal by Subject|10|||
160841178|NCT00391027|580805072|FG001|Overall Study|Withdrawal by Subject|1|||
160841179|NCT00391027|580805071|FG000|Overall Study|Other|4|||
160841180|NCT00391027|580805072|FG001|Overall Study|Other|3|||
160841181|NCT05232864|580805073|FG000|Overall Study|Adverse Event|0|||
160841182|NCT05232864|580805074|FG001|Overall Study|Adverse Event|1|||
161251560|NCT00631007|582302313|FG003|Overall Study|Persistent Hyperglycemia|1|||
161251561|NCT00631007|582302314|FG004|Overall Study|Persistent Hyperglycemia|2|||
161251562|NCT00631007|582302315|FG005|Overall Study|Persistent Hyperglycemia|5|||
161251563|NCT00631007|582302310|FG000|Overall Study|Withdrawal by Subject|4|||
161251564|NCT00631007|582302311|FG001|Overall Study|Withdrawal by Subject|5|||
161251565|NCT00631007|582302312|FG002|Overall Study|Withdrawal by Subject|2|||
161251566|NCT00631007|582302313|FG003|Overall Study|Withdrawal by Subject|2|||
161251567|NCT00631007|582302314|FG004|Overall Study|Withdrawal by Subject|1|||
161251568|NCT00631007|582302315|FG005|Overall Study|Withdrawal by Subject|3|||
160841183|NCT05232864|580805073|FG000|Overall Study|Study terminated by sponsor|16|||
160841184|NCT05232864|580805074|FG001|Overall Study|Study terminated by sponsor|14|||
160841185|NCT04765202|580805080|FG000|Overall Study|Lost to Follow-up|1|||
160841186|NCT04765202|580805081|FG001|Overall Study|Lost to Follow-up|1|||
160841187|NCT04765202|580805082|FG002|Overall Study|Lost to Follow-up|2|||
160841188|NCT04765202|580805083|FG003|Overall Study|Lost to Follow-up|2|||
160841189|NCT04765202|580805080|FG000|Overall Study|Physician Decision|0|||
160841190|NCT04765202|580805081|FG001|Overall Study|Physician Decision|0|||
160841191|NCT04765202|580805082|FG002|Overall Study|Physician Decision|1|||
160841192|NCT04765202|580805083|FG003|Overall Study|Physician Decision|1|||
160841193|NCT04929249|580805084|FG000|Overall Study|Adverse Event|2|||
160841194|NCT04929249|580805085|FG001|Overall Study|Adverse Event|1|||
160841195|NCT04929249|580805084|FG000|Overall Study|Death|2|||
160841196|NCT04929249|580805085|FG001|Overall Study|Death|1|||
160841197|NCT04929249|580805084|FG000|Overall Study|Lost to Follow-up|3|||
160841198|NCT04929249|580805085|FG001|Overall Study|Lost to Follow-up|11|||
160841199|NCT04929249|580805084|FG000|Overall Study|Technical problems|0|||
160841200|NCT04929249|580805085|FG001|Overall Study|Technical problems|1|||
160841201|NCT04929249|580805084|FG000|Overall Study|Subject decision|6|||
160841202|NCT04929249|580805085|FG001|Overall Study|Subject decision|8|||
160841203|NCT04929249|580805084|FG000|Overall Study|Withdrew consent|0|||
160841204|NCT04929249|580805085|FG001|Overall Study|Withdrew consent|8|||
160841205|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
160841206|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
161251569|NCT00631007|582302310|FG000|Overall Study|Other|2|||
161251570|NCT00631007|582302311|FG001|Overall Study|Other|1|||
161251571|NCT00631007|582302312|FG002|Overall Study|Other|0|||
161251572|NCT00631007|582302313|FG003|Overall Study|Other|0|||
161251573|NCT00631007|582302314|FG004|Overall Study|Other|1|||
160841207|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
160841208|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
160841209|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Death|2|||
160841210|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Death|2|||
160841211|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Death|0|||
160841212|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Death|0|||
160841213|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
160841214|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
160841215|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
161251574|NCT00631007|582302315|FG005|Overall Study|Other|0|||
161251575|NCT02674633|582302316|FG000|Overall Study|Lost to Follow-up|3|||
160841216|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
160841217|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
160841218|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
160841219|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
160841220|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
160841221|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
160841222|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
160841223|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
160841224|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
160841225|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
160841226|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
160841227|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
160841228|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
160841229|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
160841230|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
160841231|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
160841232|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
160841233|NCT03068754|580805086|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
160841234|NCT03068754|580805087|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
160841235|NCT03068754|580805088|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
160841236|NCT03068754|580805089|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
160841237|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
160841238|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
160841239|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
160841240|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
160841241|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Death|0|||
160841242|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Death|0|||
160841243|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Death|0|||
160841244|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Death|1|||
160841245|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
160841246|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
160841247|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
160841248|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
160841249|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
160841250|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
160841251|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
160841252|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
160841253|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
160841254|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
160841255|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
160841256|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
160841257|NCT03068754|580805086|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
160841258|NCT03068754|580805087|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
160841259|NCT03068754|580805088|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
160841260|NCT03068754|580805089|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
160841261|NCT00129467|580805090|FG000|Received Intervention|Death|1|||
160841262|NCT00129467|580805091|FG001|Received Intervention|Death|1|||
160841263|NCT00129467|580805090|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
160841264|NCT00129467|580805091|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
160841265|NCT00129467|580805090|FG000|Received Intervention|Delirium|2|||
160841266|NCT00129467|580805091|FG001|Received Intervention|Delirium|0|||
160841267|NCT00129467|580805090|FG000|Received Intervention|Withdrawal by Subject|1|||
160841268|NCT00129467|580805091|FG001|Received Intervention|Withdrawal by Subject|0|||
160841269|NCT00129467|580805090|FG000|Received Intervention|Nausea|1|||
160841270|NCT00129467|580805091|FG001|Received Intervention|Nausea|0|||
160841271|NCT00129467|580805090|FG000|Received Intervention|Intolerance to citalopram|0|||
160992112|NCT02040844|581359983|FG001|Overall Study|Adverse Event|0|||
160992113|NCT02040844|581359984|FG002|Overall Study|Adverse Event|1|||
160992114|NCT02040844|581359982|FG000|Overall Study|Withdrawal by Subject|16|||
160992115|NCT02040844|581359983|FG001|Overall Study|Withdrawal by Subject|22|||
160992116|NCT02040844|581359984|FG002|Overall Study|Withdrawal by Subject|25|||
160992117|NCT02040844|581359982|FG000|Overall Study|Lost to Follow-up|12|||
160992118|NCT02040844|581359983|FG001|Overall Study|Lost to Follow-up|9|||
160992119|NCT02040844|581359984|FG002|Overall Study|Lost to Follow-up|13|||
160992120|NCT02040844|581359982|FG000|Overall Study|Missing|13|||
160841272|NCT00129467|580805091|FG001|Received Intervention|Intolerance to citalopram|1|||
160841273|NCT00129467|580805090|FG000|Received Intervention|Dizzyness, fatigue|0|||
160992121|NCT02040844|581359983|FG001|Overall Study|Missing|3|||
160841274|NCT00129467|580805091|FG001|Received Intervention|Dizzyness, fatigue|1|||
160841275|NCT00129467|580805090|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
160841276|NCT00129467|580805091|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
160841277|NCT00129467|580805090|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
160841278|NCT00129467|580805091|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
160841279|NCT01009086|580805092|FG000|Overall Study|Lack of Efficacy|16|||
160841280|NCT01009086|580805093|FG001|Overall Study|Lack of Efficacy|15|||
160841281|NCT01009086|580805094|FG002|Overall Study|Lack of Efficacy|9|||
160841282|NCT01009086|580805092|FG000|Overall Study|Lost to Follow-up|4|||
160841283|NCT01009086|580805093|FG001|Overall Study|Lost to Follow-up|5|||
160841284|NCT01009086|580805094|FG002|Overall Study|Lost to Follow-up|3|||
160841285|NCT01009086|580805092|FG000|Overall Study|Adverse Event|12|||
160841286|NCT01009086|580805093|FG001|Overall Study|Adverse Event|11|||
160841287|NCT01009086|580805094|FG002|Overall Study|Adverse Event|8|||
160841288|NCT01009086|580805092|FG000|Overall Study|Withdrawal by Subject|9|||
160841289|NCT01009086|580805093|FG001|Overall Study|Withdrawal by Subject|11|||
160841290|NCT01009086|580805094|FG002|Overall Study|Withdrawal by Subject|13|||
160841291|NCT01009086|580805092|FG000|Overall Study|Other|3|||
160841292|NCT01009086|580805093|FG001|Overall Study|Other|5|||
160841293|NCT01009086|580805094|FG002|Overall Study|Other|1|||
160841294|NCT01853878|580805095|FG000|Overall Study|Recurrence|2|||
160841295|NCT01853878|580805096|FG001|Overall Study|Recurrence|0|||
160841296|NCT01853878|580805095|FG000|Overall Study|Adverse Event|2|||
160841297|NCT01853878|580805096|FG001|Overall Study|Adverse Event|0|||
160841298|NCT01853878|580805095|FG000|Overall Study|Withdrawal by Subject|3|||
160841299|NCT01853878|580805096|FG001|Overall Study|Withdrawal by Subject|1|||
160841300|NCT01853878|580805095|FG000|Overall Study|Migrated/moved from the study area|1|||
160841301|NCT01853878|580805096|FG001|Overall Study|Migrated/moved from the study area|0|||
160841302|NCT01853878|580805095|FG000|Overall Study|Other|55|||
160841303|NCT01853878|580805096|FG001|Overall Study|Other|43|||
160841304|NCT01846741|580805097|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
160841305|NCT01361178|580805098|FG000|Overall Study|Death|13|||
160841306|NCT01361178|580805099|FG001|Overall Study|Death|0|||
160841307|NCT04294147|580805102|FG000|Overall Study|Protocol Violation|2|||
160841308|NCT04294147|580805103|FG001|Overall Study|Protocol Violation|0|||
160841309|NCT04038567|580805108|FG000|Overall Study|Lost to Follow-up|6|||
160841310|NCT04038567|580805109|FG001|Overall Study|Lost to Follow-up|4|||
160841311|NCT04038567|580805110|FG002|Overall Study|Lost to Follow-up|5|||
160841312|NCT04038567|580805111|FG003|Overall Study|Lost to Follow-up|4|||
160841313|NCT04038567|580805112|FG004|Overall Study|Lost to Follow-up|6|||
160841314|NCT04038567|580805113|FG005|Overall Study|Lost to Follow-up|4|||
160841315|NCT04038567|580805114|FG006|Overall Study|Lost to Follow-up|4|||
160841316|NCT04038567|580805115|FG007|Overall Study|Lost to Follow-up|1|||
160841317|NCT04038567|580805108|FG000|Overall Study|Withdrawal by Subject|2|||
160841318|NCT04038567|580805109|FG001|Overall Study|Withdrawal by Subject|1|||
160841319|NCT04038567|580805110|FG002|Overall Study|Withdrawal by Subject|1|||
160841320|NCT04038567|580805111|FG003|Overall Study|Withdrawal by Subject|1|||
160841321|NCT04038567|580805112|FG004|Overall Study|Withdrawal by Subject|4|||
160841322|NCT04038567|580805113|FG005|Overall Study|Withdrawal by Subject|1|||
160841323|NCT04038567|580805114|FG006|Overall Study|Withdrawal by Subject|1|||
160841324|NCT04038567|580805115|FG007|Overall Study|Withdrawal by Subject|1|||
160905411|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Other|0|||
160905412|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Other|1|||
160905413|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Other|1|||
160905414|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Other|2|||
160905415|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Other|0|||
160905416|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Other|0|||
160905417|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Other|0|||
160905418|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905419|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905420|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905421|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905422|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
160905423|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905424|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
160992122|NCT02040844|581359984|FG002|Overall Study|Missing|2|||
160841325|NCT04038567|580805108|FG000|Overall Study|missed survey window|1|||
160841326|NCT04038567|580805109|FG001|Overall Study|missed survey window|2|||
160841327|NCT04038567|580805110|FG002|Overall Study|missed survey window|0|||
160841328|NCT04038567|580805111|FG003|Overall Study|missed survey window|0|||
160841329|NCT04038567|580805112|FG004|Overall Study|missed survey window|1|||
160841330|NCT04038567|580805113|FG005|Overall Study|missed survey window|1|||
160841331|NCT04038567|580805114|FG006|Overall Study|missed survey window|2|||
160841332|NCT04038567|580805115|FG007|Overall Study|missed survey window|2|||
160841333|NCT04038567|580805108|FG000|Overall Study|technical issues|0|||
160841334|NCT04038567|580805109|FG001|Overall Study|technical issues|0|||
160841335|NCT04038567|580805110|FG002|Overall Study|technical issues|0|||
160841336|NCT04038567|580805111|FG003|Overall Study|technical issues|0|||
160841337|NCT04038567|580805112|FG004|Overall Study|technical issues|0|||
160841338|NCT04038567|580805113|FG005|Overall Study|technical issues|0|||
160841339|NCT04038567|580805114|FG006|Overall Study|technical issues|1|||
160841340|NCT04038567|580805115|FG007|Overall Study|technical issues|0|||
160841341|NCT04038567|580805108|FG000|Overall Study|Medical issues (i.e., illness)|0|||
160841342|NCT04038567|580805109|FG001|Overall Study|Medical issues (i.e., illness)|1|||
160841343|NCT04038567|580805110|FG002|Overall Study|Medical issues (i.e., illness)|2|||
160841344|NCT04038567|580805111|FG003|Overall Study|Medical issues (i.e., illness)|1|||
160841345|NCT04038567|580805112|FG004|Overall Study|Medical issues (i.e., illness)|1|||
160841346|NCT04038567|580805113|FG005|Overall Study|Medical issues (i.e., illness)|1|||
160841347|NCT04038567|580805114|FG006|Overall Study|Medical issues (i.e., illness)|0|||
160841348|NCT04038567|580805115|FG007|Overall Study|Medical issues (i.e., illness)|0|||
160841349|NCT04038567|580805108|FG000|Overall Study|Death|0|||
160841350|NCT04038567|580805109|FG001|Overall Study|Death|0|||
160841351|NCT04038567|580805110|FG002|Overall Study|Death|0|||
160841352|NCT04038567|580805111|FG003|Overall Study|Death|1|||
160841353|NCT04038567|580805112|FG004|Overall Study|Death|1|||
160841354|NCT04038567|580805113|FG005|Overall Study|Death|0|||
160841355|NCT04038567|580805114|FG006|Overall Study|Death|0|||
160841356|NCT04038567|580805115|FG007|Overall Study|Death|1|||
160841357|NCT02726022|580805116|FG000|Overall Study|Adverse Event|14|||
160841358|NCT02726022|580805116|FG000|Overall Study|Treatment Failure|8|||
160841359|NCT02726022|580805116|FG000|Overall Study|Poor Compliance|13|||
160841360|NCT02726022|580805116|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
160841361|NCT01990859|580805118|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
160841362|NCT01990859|580805118|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
160841363|NCT00622388|580805119|FG000|Overall Study|Disease Progression|47|||
160841364|NCT00622388|580805119|FG000|Overall Study|Adverse Event|6|||
160841365|NCT00622388|580805119|FG000|Overall Study|Protocol Violation|3|||
160841366|NCT00622388|580805119|FG000|Overall Study|Participant Refusal|1|||
160841367|NCT00622388|580805119|FG000|Overall Study|Death|3|||
160841368|NCT00622388|580805119|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
160841369|NCT00622388|580805119|FG000|Overall Study|Took Prohibited Medication|2|||
160841370|NCT00622388|580805119|FG000|Overall Study|Withdrew Consent|1|||
160841371|NCT00622388|580805119|FG000|Overall Study|Insurance Expired|1|||
160841372|NCT01068158|580805120|FG000|Overall Study|Withdrawal by Subject|1|||
160841373|NCT01068158|580805121|FG001|Overall Study|Withdrawal by Subject|2|||
160841374|NCT01068158|580805120|FG000|Overall Study|Lost to Follow-up|7|||
160841375|NCT01068158|580805121|FG001|Overall Study|Lost to Follow-up|0|||
160841376|NCT01068158|580805120|FG000|Overall Study|Protocol Violation|0|||
160841377|NCT01068158|580805121|FG001|Overall Study|Protocol Violation|2|||
160841378|NCT01300572|580805128|FG000|Overall Study|HAMA + post dosimetry|1|||
160841379|NCT01368081|580805129|FG000|Overall Study|Adverse Event|4|||
160841380|NCT01368081|580805130|FG001|Overall Study|Adverse Event|4|||
160841381|NCT01368081|580805131|FG002|Overall Study|Adverse Event|3|||
160841382|NCT01368081|580805132|FG003|Overall Study|Adverse Event|2|||
160841383|NCT01368081|580805133|FG004|Overall Study|Adverse Event|2|||
160841384|NCT01368081|580805134|FG005|Overall Study|Adverse Event|5|||
160841385|NCT01368081|580805135|FG006|Overall Study|Adverse Event|6|||
160841386|NCT01368081|580805136|FG007|Overall Study|Adverse Event|2|||
160841387|NCT01368081|580805137|FG008|Overall Study|Adverse Event|3|||
160841388|NCT01368081|580805138|FG009|Overall Study|Adverse Event|5|||
160841389|NCT01368081|580805139|FG010|Overall Study|Adverse Event|6|||
160841390|NCT01368081|580805140|FG011|Overall Study|Adverse Event|1|||
160841391|NCT01368081|580805141|FG012|Overall Study|Adverse Event|3|||
160841392|NCT01368081|580805129|FG000|Overall Study|Lack of Efficacy|0|||
160841393|NCT01368081|580805130|FG001|Overall Study|Lack of Efficacy|1|||
160841394|NCT01368081|580805131|FG002|Overall Study|Lack of Efficacy|0|||
160841395|NCT01368081|580805132|FG003|Overall Study|Lack of Efficacy|1|||
160841396|NCT01368081|580805133|FG004|Overall Study|Lack of Efficacy|0|||
160841397|NCT01368081|580805134|FG005|Overall Study|Lack of Efficacy|0|||
160841398|NCT01368081|580805135|FG006|Overall Study|Lack of Efficacy|0|||
160841399|NCT01368081|580805136|FG007|Overall Study|Lack of Efficacy|2|||
160841400|NCT01368081|580805137|FG008|Overall Study|Lack of Efficacy|0|||
160841401|NCT01368081|580805138|FG009|Overall Study|Lack of Efficacy|0|||
160841402|NCT01368081|580805139|FG010|Overall Study|Lack of Efficacy|0|||
160841403|NCT01368081|580805140|FG011|Overall Study|Lack of Efficacy|0|||
160841404|NCT01368081|580805141|FG012|Overall Study|Lack of Efficacy|0|||
160841405|NCT01368081|580805129|FG000|Overall Study|Protocol Violation|0|||
160841406|NCT01368081|580805130|FG001|Overall Study|Protocol Violation|0|||
160992123|NCT02040844|581359982|FG000|Overall Study|Non-specified|8|||
160841407|NCT01368081|580805131|FG002|Overall Study|Protocol Violation|0|||
160841408|NCT01368081|580805132|FG003|Overall Study|Protocol Violation|0|||
160841409|NCT01368081|580805133|FG004|Overall Study|Protocol Violation|0|||
160841410|NCT01368081|580805134|FG005|Overall Study|Protocol Violation|1|||
160841411|NCT01368081|580805135|FG006|Overall Study|Protocol Violation|0|||
160841412|NCT01368081|580805136|FG007|Overall Study|Protocol Violation|1|||
160841413|NCT01368081|580805137|FG008|Overall Study|Protocol Violation|0|||
161251576|NCT02674633|582302317|FG001|Overall Study|Lost to Follow-up|2|||
161251577|NCT02674633|582302316|FG000|Overall Study|Physician Decision|1|||
161251578|NCT02674633|582302317|FG001|Overall Study|Physician Decision|0|||
161251579|NCT02674633|582302316|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160841414|NCT01368081|580805138|FG009|Overall Study|Protocol Violation|0|||
160841415|NCT01368081|580805139|FG010|Overall Study|Protocol Violation|0|||
160841416|NCT01368081|580805140|FG011|Overall Study|Protocol Violation|0|||
160841417|NCT01368081|580805141|FG012|Overall Study|Protocol Violation|0|||
160841418|NCT01368081|580805129|FG000|Overall Study|Lost to Follow-up|0|||
160841419|NCT01368081|580805130|FG001|Overall Study|Lost to Follow-up|0|||
160841420|NCT01368081|580805131|FG002|Overall Study|Lost to Follow-up|0|||
160841421|NCT01368081|580805132|FG003|Overall Study|Lost to Follow-up|0|||
160905425|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
160905426|NCT01090492|581048209|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
161251580|NCT02674633|582302317|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161251581|NCT00683787|582302318|FG000|Overall Study|Progression|3|||
161251582|NCT00683787|582302319|FG001|Overall Study|Progression|3|||
161251583|NCT00683787|582302320|FG002|Overall Study|Progression|0|||
161251584|NCT00683787|582302318|FG000|Overall Study|Adverse Event|0|||
161251585|NCT00683787|582302319|FG001|Overall Study|Adverse Event|0|||
161251586|NCT00683787|582302320|FG002|Overall Study|Adverse Event|2|||
161251587|NCT00460109|582302321|FG000|Overall Study|Death|1|||
161251588|NCT04167618|582302322|FG000|Overall Study|Trial terminated by sponsor|1|||
161251589|NCT04167618|582302323|FG001|Overall Study|Trial terminated by sponsor|1|||
161251590|NCT01235715|582302324|FG000|Overall Study|Physician Decision|0|||
161251591|NCT01235715|582302325|FG001|Overall Study|Physician Decision|2|||
161251592|NCT03619876|582302326|FG000|Overall Study|Withdrawal by Subject|1|||
161251593|NCT03619876|582302327|FG001|Overall Study|Withdrawal by Subject|2|||
161251594|NCT03619876|582302326|FG000|Overall Study|Withdrawal due to incidental finding|0|||
161251595|NCT03619876|582302327|FG001|Overall Study|Withdrawal due to incidental finding|2|||
161251596|NCT02994394|582302328|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
161251597|NCT02994394|582302329|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
161251598|NCT02994394|582302330|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
161251599|NCT02994394|582302331|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
161251600|NCT02994394|582302332|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
161251601|NCT02994394|582302333|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
161251602|NCT02994394|582302328|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
161251603|NCT02994394|582302329|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
161251604|NCT02994394|582302330|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
161251605|NCT02994394|582302331|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
161251606|NCT02994394|582302332|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
161251607|NCT02994394|582302333|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
161251608|NCT02344745|582302334|FG000|Overall Study|Data collection sheets were lost|2|||
161251609|NCT02344745|582302335|FG001|Overall Study|Data collection sheets were lost|0|||
161251610|NCT02788513|582302336|FG000|Overall Study|Withdrawal by Subject|3|||
161251611|NCT02788513|582302337|FG001|Overall Study|Withdrawal by Subject|0|||
161251612|NCT02788513|582302338|FG002|Overall Study|Withdrawal by Subject|2|||
161251613|NCT02788513|582302339|FG003|Overall Study|Withdrawal by Subject|3|||
161251614|NCT02788513|582302340|FG004|Overall Study|Withdrawal by Subject|1|||
161251615|NCT02788513|582302336|FG000|Overall Study|Lost to Follow-up|1|||
161251616|NCT02788513|582302337|FG001|Overall Study|Lost to Follow-up|0|||
161251617|NCT02788513|582302338|FG002|Overall Study|Lost to Follow-up|0|||
161251618|NCT02788513|582302339|FG003|Overall Study|Lost to Follow-up|0|||
161251619|NCT02788513|582302340|FG004|Overall Study|Lost to Follow-up|1|||
161251620|NCT02788513|582302336|FG000|Overall Study|Adverse Event|5|||
161251621|NCT02788513|582302337|FG001|Overall Study|Adverse Event|8|||
161251622|NCT02788513|582302338|FG002|Overall Study|Adverse Event|4|||
161251623|NCT02788513|582302339|FG003|Overall Study|Adverse Event|2|||
161251624|NCT02788513|582302340|FG004|Overall Study|Adverse Event|2|||
161251625|NCT02788513|582302336|FG000|Overall Study|Protocol Violation|0|||
161251626|NCT02788513|582302337|FG001|Overall Study|Protocol Violation|0|||
161251627|NCT02788513|582302338|FG002|Overall Study|Protocol Violation|1|||
161251628|NCT02788513|582302339|FG003|Overall Study|Protocol Violation|1|||
161251629|NCT02788513|582302340|FG004|Overall Study|Protocol Violation|0|||
161251630|NCT02788513|582302336|FG000|Overall Study|Subject decided to stop taking treatment|0|||
161251631|NCT02788513|582302337|FG001|Overall Study|Subject decided to stop taking treatment|0|||
161251632|NCT02788513|582302338|FG002|Overall Study|Subject decided to stop taking treatment|1|||
161251633|NCT02788513|582302339|FG003|Overall Study|Subject decided to stop taking treatment|0|||
161251634|NCT02788513|582302340|FG004|Overall Study|Subject decided to stop taking treatment|0|||
161251635|NCT02788513|582302336|FG000|Overall Study|Decision by the study team|0|||
160841422|NCT01368081|580805133|FG004|Overall Study|Lost to Follow-up|0|||
160841423|NCT01368081|580805134|FG005|Overall Study|Lost to Follow-up|0|||
161251636|NCT02788513|582302337|FG001|Overall Study|Decision by the study team|0|||
160841424|NCT01368081|580805135|FG006|Overall Study|Lost to Follow-up|0|||
160841425|NCT01368081|580805136|FG007|Overall Study|Lost to Follow-up|0|||
161251637|NCT02788513|582302338|FG002|Overall Study|Decision by the study team|0|||
161251638|NCT02788513|582302339|FG003|Overall Study|Decision by the study team|0|||
161251639|NCT02788513|582302340|FG004|Overall Study|Decision by the study team|1|||
161251640|NCT04982445|582302342|FG000|Overall Study|Protocol Violation|1|||
161251641|NCT04982445|582302342|FG000|Overall Study|Withdrawal by Subject|4|||
161251642|NCT04982445|582302342|FG000|Overall Study|Lost to Follow-up|1|||
160841426|NCT01368081|580805137|FG008|Overall Study|Lost to Follow-up|0|||
160841427|NCT01368081|580805138|FG009|Overall Study|Lost to Follow-up|0|||
160841428|NCT01368081|580805139|FG010|Overall Study|Lost to Follow-up|0|||
160841429|NCT01368081|580805140|FG011|Overall Study|Lost to Follow-up|0|||
160841430|NCT01368081|580805141|FG012|Overall Study|Lost to Follow-up|1|||
160841431|NCT01368081|580805129|FG000|Overall Study|Withdrawal by Subject|4|||
160841432|NCT01368081|580805130|FG001|Overall Study|Withdrawal by Subject|4|||
160841433|NCT01368081|580805131|FG002|Overall Study|Withdrawal by Subject|1|||
160841434|NCT01368081|580805132|FG003|Overall Study|Withdrawal by Subject|1|||
160841435|NCT01368081|580805133|FG004|Overall Study|Withdrawal by Subject|0|||
160841436|NCT01368081|580805134|FG005|Overall Study|Withdrawal by Subject|3|||
160841437|NCT01368081|580805135|FG006|Overall Study|Withdrawal by Subject|4|||
160841438|NCT01368081|580805136|FG007|Overall Study|Withdrawal by Subject|2|||
160841439|NCT01368081|580805137|FG008|Overall Study|Withdrawal by Subject|5|||
160841440|NCT01368081|580805138|FG009|Overall Study|Withdrawal by Subject|4|||
160841441|NCT01368081|580805139|FG010|Overall Study|Withdrawal by Subject|3|||
160841442|NCT01368081|580805140|FG011|Overall Study|Withdrawal by Subject|2|||
160841443|NCT01368081|580805141|FG012|Overall Study|Withdrawal by Subject|0|||
160841444|NCT01368081|580805129|FG000|Overall Study|Other reason not defined above|2|||
160841445|NCT01368081|580805130|FG001|Overall Study|Other reason not defined above|0|||
160841446|NCT01368081|580805131|FG002|Overall Study|Other reason not defined above|0|||
160841447|NCT01368081|580805132|FG003|Overall Study|Other reason not defined above|1|||
160841448|NCT01368081|580805133|FG004|Overall Study|Other reason not defined above|0|||
160841449|NCT01368081|580805134|FG005|Overall Study|Other reason not defined above|1|||
160841450|NCT01368081|580805135|FG006|Overall Study|Other reason not defined above|2|||
160841451|NCT01368081|580805136|FG007|Overall Study|Other reason not defined above|0|||
160841452|NCT01368081|580805137|FG008|Overall Study|Other reason not defined above|0|||
160841453|NCT01368081|580805138|FG009|Overall Study|Other reason not defined above|1|||
160841454|NCT01368081|580805139|FG010|Overall Study|Other reason not defined above|0|||
160841455|NCT01368081|580805140|FG011|Overall Study|Other reason not defined above|0|||
160841456|NCT01368081|580805141|FG012|Overall Study|Other reason not defined above|3|||
160841457|NCT01504412|580807448|FG000|Overall Study|Adverse Event|1|||
160841458|NCT01504412|580807449|FG001|Overall Study|Adverse Event|8|||
160841459|NCT01504412|580807450|FG002|Overall Study|Adverse Event|1|||
160841460|NCT01504412|580807451|FG003|Overall Study|Adverse Event|7|||
160841461|NCT01504412|580807452|FG004|Overall Study|Adverse Event|10|||
160841462|NCT01504412|580807448|FG000|Overall Study|Withdrawal by Subject|2|||
160841463|NCT01504412|580807449|FG001|Overall Study|Withdrawal by Subject|1|||
160841464|NCT01504412|580807450|FG002|Overall Study|Withdrawal by Subject|1|||
160841465|NCT01504412|580807451|FG003|Overall Study|Withdrawal by Subject|5|||
160841466|NCT01504412|580807452|FG004|Overall Study|Withdrawal by Subject|1|||
160841467|NCT01504412|580807448|FG000|Overall Study|Other|2|||
160841468|NCT01504412|580807449|FG001|Overall Study|Other|1|||
160841469|NCT01504412|580807450|FG002|Overall Study|Other|1|||
160841470|NCT01504412|580807451|FG003|Overall Study|Other|6|||
160841471|NCT01504412|580807452|FG004|Overall Study|Other|1|||
160841472|NCT01504412|580807448|FG000|Overall Study|Lost to Follow-up|0|||
160841473|NCT01504412|580807449|FG001|Overall Study|Lost to Follow-up|2|||
160841474|NCT01504412|580807450|FG002|Overall Study|Lost to Follow-up|0|||
160841475|NCT01504412|580807451|FG003|Overall Study|Lost to Follow-up|0|||
160841476|NCT01504412|580807452|FG004|Overall Study|Lost to Follow-up|0|||
160841477|NCT01504412|580807448|FG000|Overall Study|Lack of Efficacy|0|||
160841478|NCT01504412|580807449|FG001|Overall Study|Lack of Efficacy|0|||
160841479|NCT01504412|580807450|FG002|Overall Study|Lack of Efficacy|1|||
160841480|NCT01504412|580807451|FG003|Overall Study|Lack of Efficacy|0|||
160841481|NCT01504412|580807452|FG004|Overall Study|Lack of Efficacy|1|||
160841482|NCT01504412|580807448|FG000|Overall Study|Death|0|||
160841483|NCT01504412|580807449|FG001|Overall Study|Death|0|||
160841484|NCT01504412|580807450|FG002|Overall Study|Death|0|||
160841485|NCT01504412|580807451|FG003|Overall Study|Death|1|||
160841486|NCT01504412|580807452|FG004|Overall Study|Death|0|||
160841487|NCT00630344|580807453|FG000|Overall Study|Adverse Event|5|||
160841488|NCT00630344|580807453|FG000|Overall Study|Progressive Disease|19|||
160841489|NCT00630344|580807453|FG000|Overall Study|Physician Decision|9|||
160841490|NCT00630344|580807453|FG000|Overall Study|Withdrawal by Subject|1|||
160841491|NCT00630344|580807453|FG000|Overall Study|Intercurrent Illness|1|||
160841492|NCT00630344|580807453|FG000|Overall Study|Other|1|||
160841493|NCT04774926|580807454|FG000|Overall Study|Adverse Event|15|||
160841494|NCT04774926|580807454|FG000|Overall Study|Lost to Follow-up|3|||
160841495|NCT04774926|580807454|FG000|Overall Study|Physician Decision|6|||
160841496|NCT04774926|580807454|FG000|Overall Study|Withdrawal by Subject|3|||
160841497|NCT04774926|580807454|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
160841498|NCT01393639|580807455|FG000|Overall Study|Protocol Violation|0|||
160841499|NCT01393639|580807456|FG001|Overall Study|Protocol Violation|0|||
160841500|NCT01393639|580807457|FG002|Overall Study|Protocol Violation|0|||
160841501|NCT01393639|580807458|FG003|Overall Study|Protocol Violation|1|||
160841502|NCT01393639|580807459|FG004|Overall Study|Protocol Violation|0|||
160841503|NCT01393639|580807460|FG005|Overall Study|Protocol Violation|0|||
160841504|NCT01393639|580807461|FG006|Overall Study|Protocol Violation|0|||
160841505|NCT01393639|580807455|FG000|Overall Study|Other|0|||
160841506|NCT01393639|580807456|FG001|Overall Study|Other|2|||
160841507|NCT01393639|580807457|FG002|Overall Study|Other|0|||
160841508|NCT01393639|580807458|FG003|Overall Study|Other|2|||
160841509|NCT01393639|580807459|FG004|Overall Study|Other|1|||
160841510|NCT01393639|580807460|FG005|Overall Study|Other|0|||
160841511|NCT01393639|580807461|FG006|Overall Study|Other|1|||
160841512|NCT01393639|580807455|FG000|Overall Study|Withdrawal by Subject|1|||
160841513|NCT01393639|580807456|FG001|Overall Study|Withdrawal by Subject|1|||
160841514|NCT01393639|580807457|FG002|Overall Study|Withdrawal by Subject|0|||
160841515|NCT01393639|580807458|FG003|Overall Study|Withdrawal by Subject|0|||
160841516|NCT01393639|580807459|FG004|Overall Study|Withdrawal by Subject|0|||
160841517|NCT01393639|580807460|FG005|Overall Study|Withdrawal by Subject|0|||
160841518|NCT01393639|580807461|FG006|Overall Study|Withdrawal by Subject|1|||
160841519|NCT01393639|580807455|FG000|Overall Study|Medication error without associated AE|0|||
160841520|NCT01393639|580807456|FG001|Overall Study|Medication error without associated AE|0|||
160841521|NCT01393639|580807457|FG002|Overall Study|Medication error without associated AE|0|||
160841522|NCT01393639|580807458|FG003|Overall Study|Medication error without associated AE|0|||
160841523|NCT01393639|580807459|FG004|Overall Study|Medication error without associated AE|0|||
160841524|NCT01393639|580807460|FG005|Overall Study|Medication error without associated AE|0|||
160841525|NCT01393639|580807461|FG006|Overall Study|Medication error without associated AE|1|||
160841526|NCT01393639|580807455|FG000|Overall Study|Lost to Follow-up|0|||
160841527|NCT01393639|580807456|FG001|Overall Study|Lost to Follow-up|1|||
160841528|NCT01393639|580807457|FG002|Overall Study|Lost to Follow-up|0|||
160841529|NCT01393639|580807458|FG003|Overall Study|Lost to Follow-up|0|||
160841530|NCT01393639|580807459|FG004|Overall Study|Lost to Follow-up|0|||
160841531|NCT01393639|580807460|FG005|Overall Study|Lost to Follow-up|0|||
160841532|NCT01393639|580807461|FG006|Overall Study|Lost to Follow-up|1|||
160841533|NCT01393639|580807455|FG000|Overall Study|Lack of Efficacy|0|||
160841534|NCT01393639|580807456|FG001|Overall Study|Lack of Efficacy|0|||
160841535|NCT01393639|580807457|FG002|Overall Study|Lack of Efficacy|0|||
160841536|NCT01393639|580807458|FG003|Overall Study|Lack of Efficacy|0|||
160841537|NCT01393639|580807459|FG004|Overall Study|Lack of Efficacy|0|||
160841538|NCT01393639|580807460|FG005|Overall Study|Lack of Efficacy|0|||
160841539|NCT01393639|580807461|FG006|Overall Study|Lack of Efficacy|1|||
160841540|NCT01393639|580807455|FG000|Overall Study|Adverse Event|2|||
160841541|NCT01393639|580807456|FG001|Overall Study|Adverse Event|3|||
160841542|NCT01393639|580807457|FG002|Overall Study|Adverse Event|1|||
160905427|NCT01090492|581048210|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
160905428|NCT01090492|581048211|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
160905429|NCT01090492|581048212|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
160905430|NCT01090492|581048213|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
160905431|NCT01090492|581048214|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
160905432|NCT01090492|581048215|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
160905433|NCT01090492|581048216|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
160905434|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905435|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
161139317|NCT01023789|581892671|FG000|3 - Year Visit|Lost to Follow-up|13|||
161139318|NCT02115308|581892682|FG000|Overall Study|Safety Screening|2|||
161139319|NCT02115308|581892683|FG001|Overall Study|Safety Screening|2|||
161139320|NCT01309737|581892684|FG000|Week 0 to 16|Death|1|||
161139321|NCT01309737|581892685|FG001|Week 0 to 16|Death|0|||
161139322|NCT01309737|581892686|FG002|Week 0 to 16|Death|1|||
161139323|NCT01309737|581892687|FG003|Week 0 to 16|Death|0|||
161139324|NCT01309737|581892688|FG004|Week 0 to 16|Death|0|||
161139325|NCT01309737|581892684|FG000|Week 0 to 16|Adverse Event|11|||
161139326|NCT01309737|581892685|FG001|Week 0 to 16|Adverse Event|10|||
161139327|NCT01309737|581892686|FG002|Week 0 to 16|Adverse Event|5|||
161139328|NCT01309737|581892687|FG003|Week 0 to 16|Adverse Event|0|||
161139329|NCT01309737|581892688|FG004|Week 0 to 16|Adverse Event|0|||
161139330|NCT01309737|581892684|FG000|Week 0 to 16|Lack of Efficacy|15|||
161139331|NCT01309737|581892685|FG001|Week 0 to 16|Lack of Efficacy|2|||
161139332|NCT01309737|581892686|FG002|Week 0 to 16|Lack of Efficacy|24|||
161139333|NCT01309737|581892687|FG003|Week 0 to 16|Lack of Efficacy|0|||
161139334|NCT01309737|581892688|FG004|Week 0 to 16|Lack of Efficacy|0|||
161139335|NCT01309737|581892684|FG000|Week 0 to 16|Lost to Follow-up|7|||
161139336|NCT01309737|581892685|FG001|Week 0 to 16|Lost to Follow-up|8|||
161139337|NCT01309737|581892686|FG002|Week 0 to 16|Lost to Follow-up|3|||
161139338|NCT01309737|581892687|FG003|Week 0 to 16|Lost to Follow-up|0|||
161139339|NCT01309737|581892688|FG004|Week 0 to 16|Lost to Follow-up|0|||
161139340|NCT01309737|581892684|FG000|Week 0 to 16|Withdrawal by Subject|7|||
161139341|NCT01309737|581892685|FG001|Week 0 to 16|Withdrawal by Subject|6|||
161139342|NCT01309737|581892686|FG002|Week 0 to 16|Withdrawal by Subject|7|||
160841543|NCT01393639|580807458|FG003|Overall Study|Adverse Event|2|||
160841544|NCT01393639|580807459|FG004|Overall Study|Adverse Event|0|||
160841545|NCT01393639|580807460|FG005|Overall Study|Adverse Event|2|||
160841546|NCT01393639|580807461|FG006|Overall Study|Adverse Event|3|||
160841547|NCT03626545|580807462|FG000|Overall Study|Progressive disease|3|||
160841548|NCT03626545|580807463|FG001|Overall Study|Progressive disease|82|||
160841549|NCT03626545|580807464|FG002|Overall Study|Progressive disease|85|||
160841550|NCT03626545|580807462|FG000|Overall Study|Adverse Event|3|||
160841551|NCT03626545|580807463|FG001|Overall Study|Adverse Event|13|||
160841552|NCT03626545|580807464|FG002|Overall Study|Adverse Event|10|||
160841553|NCT03626545|580807462|FG000|Overall Study|Physician Decision|1|||
160841554|NCT03626545|580807463|FG001|Overall Study|Physician Decision|18|||
160841555|NCT03626545|580807464|FG002|Overall Study|Physician Decision|14|||
160841556|NCT03626545|580807462|FG000|Overall Study|Subject Decision|0|||
161139343|NCT01309737|581892687|FG003|Week 0 to 16|Withdrawal by Subject|0|||
161139344|NCT01309737|581892688|FG004|Week 0 to 16|Withdrawal by Subject|0|||
161139345|NCT01309737|581892684|FG000|Week 0 to 16|Other|10|||
161139346|NCT01309737|581892685|FG001|Week 0 to 16|Other|14|||
161139347|NCT01309737|581892686|FG002|Week 0 to 16|Other|4|||
161139348|NCT01309737|581892687|FG003|Week 0 to 16|Other|0|||
161139349|NCT01309737|581892688|FG004|Week 0 to 16|Other|0|||
161139350|NCT01309737|581892684|FG000|Week 0 to 16|Randomized, but not treated|1|||
161139351|NCT01309737|581892685|FG001|Week 0 to 16|Randomized, but not treated|0|||
161139352|NCT01309737|581892686|FG002|Week 0 to 16|Randomized, but not treated|0|||
161139353|NCT01309737|581892687|FG003|Week 0 to 16|Randomized, but not treated|0|||
161139354|NCT01309737|581892688|FG004|Week 0 to 16|Randomized, but not treated|0|||
160841557|NCT03626545|580807463|FG001|Overall Study|Subject Decision|5|||
160841558|NCT03626545|580807464|FG002|Overall Study|Subject Decision|5|||
160841559|NCT03626545|580807462|FG000|Overall Study|Death|1|||
160841560|NCT03626545|580807463|FG001|Overall Study|Death|1|||
160841561|NCT03626545|580807464|FG002|Overall Study|Death|1|||
160841562|NCT03626545|580807462|FG000|Overall Study|Protocol Deviation|0|||
160841563|NCT03626545|580807463|FG001|Overall Study|Protocol Deviation|1|||
160841564|NCT03626545|580807464|FG002|Overall Study|Protocol Deviation|1|||
160841565|NCT03626545|580807462|FG000|Overall Study|Guardian Decision|0|||
160841566|NCT03626545|580807463|FG001|Overall Study|Guardian Decision|0|||
160841567|NCT03626545|580807464|FG002|Overall Study|Guardian Decision|1|||
160841568|NCT00793325|580807466|FG000|Overall Study|Protocol Violation|18|||
160841569|NCT00793325|580807466|FG000|Overall Study|Lost to Follow-up|1|||
160841570|NCT01440816|580807467|FG000|Overall Study|Disease Progression|0|||
160841571|NCT01440816|580807468|FG001|Overall Study|Disease Progression|9|||
160841572|NCT01440816|580807467|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
160841573|NCT01440816|580807468|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
160841574|NCT02462720|580807472|FG000|Part 2|Withdrawal by Subject|1|||
160841575|NCT02462720|580807473|FG001|Part 2|Withdrawal by Subject|0|||
160841576|NCT02462720|580807472|FG000|Part 2|Protocol Violation|0|||
160841577|NCT02462720|580807473|FG001|Part 2|Protocol Violation|1|||
160841578|NCT03250182|580807478|FG000|Overall Study|Withdrawal by Subject|1|||
160841579|NCT05173012|580807481|FG000|Overall Study|Adverse Event|2|||
160841580|NCT05173012|580807482|FG001|Overall Study|Adverse Event|3|||
160841581|NCT05173012|580807483|FG002|Overall Study|Adverse Event|4|||
160841582|NCT05173012|580807484|FG003|Overall Study|Adverse Event|13|||
160841583|NCT05173012|580807485|FG004|Overall Study|Adverse Event|0|||
160841584|NCT05173012|580807486|FG005|Overall Study|Adverse Event|0|||
160841585|NCT05173012|580807487|FG006|Overall Study|Adverse Event|2|||
160841586|NCT05173012|580807488|FG007|Overall Study|Adverse Event|4|||
160841587|NCT05173012|580807481|FG000|Overall Study|Lost to Follow-up|0|||
160841588|NCT05173012|580807482|FG001|Overall Study|Lost to Follow-up|0|||
160841589|NCT05173012|580807483|FG002|Overall Study|Lost to Follow-up|0|||
160841590|NCT05173012|580807484|FG003|Overall Study|Lost to Follow-up|1|||
160841591|NCT05173012|580807485|FG004|Overall Study|Lost to Follow-up|0|||
160841592|NCT05173012|580807486|FG005|Overall Study|Lost to Follow-up|0|||
160841593|NCT05173012|580807487|FG006|Overall Study|Lost to Follow-up|0|||
160841594|NCT05173012|580807488|FG007|Overall Study|Lost to Follow-up|0|||
160841595|NCT05173012|580807481|FG000|Overall Study|Withdrawal by Subject|1|||
160841596|NCT05173012|580807482|FG001|Overall Study|Withdrawal by Subject|0|||
160841597|NCT05173012|580807483|FG002|Overall Study|Withdrawal by Subject|1|||
160841598|NCT05173012|580807484|FG003|Overall Study|Withdrawal by Subject|3|||
161139355|NCT01309737|581892684|FG000|Week 16 to 52|Death|0|||
161139356|NCT01309737|581892685|FG001|Week 16 to 52|Death|0|||
161139357|NCT01309737|581892686|FG002|Week 16 to 52|Death|0|||
161139358|NCT01309737|581892687|FG003|Week 16 to 52|Death|0|||
160841599|NCT05173012|580807485|FG004|Overall Study|Withdrawal by Subject|1|||
160841600|NCT05173012|580807486|FG005|Overall Study|Withdrawal by Subject|0|||
160841601|NCT05173012|580807487|FG006|Overall Study|Withdrawal by Subject|1|||
160841602|NCT05173012|580807488|FG007|Overall Study|Withdrawal by Subject|0|||
160841603|NCT05173012|580807481|FG000|Overall Study|Protocol Deviation|0|||
160841604|NCT05173012|580807482|FG001|Overall Study|Protocol Deviation|0|||
160841605|NCT05173012|580807483|FG002|Overall Study|Protocol Deviation|0|||
160841606|NCT05173012|580807484|FG003|Overall Study|Protocol Deviation|1|||
160841607|NCT05173012|580807485|FG004|Overall Study|Protocol Deviation|0|||
161139359|NCT01309737|581892688|FG004|Week 16 to 52|Death|1|||
160841608|NCT05173012|580807486|FG005|Overall Study|Protocol Deviation|0|||
160841609|NCT05173012|580807487|FG006|Overall Study|Protocol Deviation|0|||
160841610|NCT05173012|580807488|FG007|Overall Study|Protocol Deviation|0|||
160841611|NCT05173012|580807481|FG000|Overall Study|Other|0|||
160841612|NCT05173012|580807482|FG001|Overall Study|Other|0|||
160841613|NCT05173012|580807483|FG002|Overall Study|Other|0|||
160841614|NCT05173012|580807484|FG003|Overall Study|Other|2|||
160841615|NCT05173012|580807485|FG004|Overall Study|Other|0|||
160841616|NCT05173012|580807486|FG005|Overall Study|Other|0|||
160841617|NCT05173012|580807487|FG006|Overall Study|Other|0|||
160841618|NCT05173012|580807488|FG007|Overall Study|Other|0|||
160841619|NCT03472950|580807489|FG000|Overall Study|Lost to Follow-up|0|||
160841620|NCT03472950|580807490|FG001|Overall Study|Lost to Follow-up|1|||
160841621|NCT03472950|580807489|FG000|Overall Study|Adverse Event|0|||
160841622|NCT03472950|580807490|FG001|Overall Study|Adverse Event|3|||
160841623|NCT03668613|580807491|FG000|Overall Study|Adverse Event|1|||
160841624|NCT03668613|580807492|FG001|Overall Study|Adverse Event|2|||
160841625|NCT03668613|580807491|FG000|Overall Study|Lack of Efficacy|5|||
160841626|NCT03668613|580807492|FG001|Overall Study|Lack of Efficacy|1|||
160841627|NCT03668613|580807491|FG000|Overall Study|Pregnancy|0|||
160841628|NCT03668613|580807492|FG001|Overall Study|Pregnancy|2|||
160841629|NCT03668613|580807491|FG000|Overall Study|Protocol Violation|1|||
160841630|NCT03668613|580807492|FG001|Overall Study|Protocol Violation|0|||
160841631|NCT03668613|580807491|FG000|Overall Study|Physician Decision|1|||
160841632|NCT03668613|580807492|FG001|Overall Study|Physician Decision|0|||
160841633|NCT03668613|580807491|FG000|Overall Study|Withdrawal by Subject|2|||
160841634|NCT03668613|580807492|FG001|Overall Study|Withdrawal by Subject|1|||
160841635|NCT03668613|580807491|FG000|Overall Study|Guardian decision|1|||
160841636|NCT03668613|580807492|FG001|Overall Study|Guardian decision|0|||
160841637|NCT03386487|580807495|FG000|Overall Study|Lost to Follow-up|5|||
160841638|NCT03386487|580807496|FG001|Overall Study|Lost to Follow-up|6|||
160841639|NCT03386487|580807495|FG000|Overall Study|Withdrawal by Subject|11|||
160905436|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160905437|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160905438|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905439|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
160905440|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905441|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
160905442|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905443|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
160905444|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905445|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905446|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905447|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905448|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905449|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
160905450|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Other|0|||
160905451|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Other|1|||
160905452|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Other|1|||
160905453|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Other|0|||
160905454|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Other|0|||
160905455|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Other|0|||
160905456|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Other|0|||
160905457|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Other|0|||
160905458|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
160841640|NCT03386487|580807496|FG001|Overall Study|Withdrawal by Subject|7|||
160841641|NCT03386487|580807495|FG000|Overall Study|Physician Decision|11|||
160841642|NCT03386487|580807496|FG001|Overall Study|Physician Decision|8|||
160841643|NCT01068769|580807497|FG000|Overall Study|Ineligible|1|||
160841644|NCT00894361|580807502|FG000|Overall Study|deaths and less than 2 years followup|24|||
160841645|NCT00894361|580807503|FG001|Overall Study|deaths and less than 2 years followup|64|||
160905459|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
160905460|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
161139360|NCT01309737|581892684|FG000|Week 16 to 52|Adverse Event|7|||
161139361|NCT01309737|581892685|FG001|Week 16 to 52|Adverse Event|7|||
160841646|NCT00286494|580807504|FG000|Overall Study|Hyperglycemic rescue|12|||
160841647|NCT00286494|580807505|FG001|Overall Study|Hyperglycemic rescue|19|||
160841648|NCT00286494|580807506|FG002|Overall Study|Hyperglycemic rescue|18|||
160841649|NCT00286494|580807504|FG000|Overall Study|Withdrawal by Subject|2|||
160841650|NCT00286494|580807505|FG001|Overall Study|Withdrawal by Subject|10|||
160841651|NCT00286494|580807506|FG002|Overall Study|Withdrawal by Subject|9|||
160841652|NCT00286494|580807504|FG000|Overall Study|Adverse Event|3|||
161139362|NCT01309737|581892686|FG002|Week 16 to 52|Adverse Event|0|||
160841653|NCT00286494|580807505|FG001|Overall Study|Adverse Event|8|||
160905461|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
160905462|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160905463|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160905464|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
160905465|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
160905466|NCT01090492|581048209|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905467|NCT01090492|581048210|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905468|NCT01090492|581048211|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905469|NCT01090492|581048212|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905470|NCT01090492|581048213|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905471|NCT01090492|581048214|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905472|NCT01090492|581048215|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
160905473|NCT01090492|581048216|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
160905474|NCT02083965|581048217|FG000|Treatment Period|Other|1|||
160905475|NCT02083965|581048218|FG001|Treatment Period|Other|0|||
160905476|NCT00911547|581048220|FG000|Overall Study|Adverse Event|8|||
160905477|NCT00911547|581048221|FG001|Overall Study|Adverse Event|27|||
160905478|NCT00911547|581048222|FG002|Overall Study|Adverse Event|11|||
160905479|NCT00911547|581048223|FG003|Overall Study|Adverse Event|6|||
160905480|NCT00911547|581048220|FG000|Overall Study|Lost to Follow-up|0|||
160905481|NCT00911547|581048221|FG001|Overall Study|Lost to Follow-up|0|||
160905482|NCT00911547|581048222|FG002|Overall Study|Lost to Follow-up|2|||
160905483|NCT00911547|581048223|FG003|Overall Study|Lost to Follow-up|1|||
160905484|NCT00911547|581048220|FG000|Overall Study|Protocol Violation|0|||
160905485|NCT00911547|581048221|FG001|Overall Study|Protocol Violation|5|||
160905486|NCT00911547|581048222|FG002|Overall Study|Protocol Violation|5|||
160905487|NCT00911547|581048223|FG003|Overall Study|Protocol Violation|1|||
160905488|NCT00911547|581048220|FG000|Overall Study|Withdrawal by Subject|3|||
160905489|NCT00911547|581048221|FG001|Overall Study|Withdrawal by Subject|10|||
160905490|NCT00911547|581048222|FG002|Overall Study|Withdrawal by Subject|4|||
160905491|NCT00911547|581048223|FG003|Overall Study|Withdrawal by Subject|8|||
160905492|NCT02564796|581048226|FG000|Overall Study|Physician Decision|2|||
161251643|NCT03230487|582302346|FG000|Overall Study|Adverse Event|0|||
161251644|NCT03230487|582302347|FG001|Overall Study|Adverse Event|0|||
161251645|NCT03230487|582302348|FG002|Overall Study|Adverse Event|0|||
160905493|NCT02564796|581048227|FG001|Overall Study|Physician Decision|2|||
160905494|NCT03583697|581048228|FG000|Overall Study|Withdrawal by Subject|0|||
160905495|NCT03583697|581048229|FG001|Overall Study|Withdrawal by Subject|0|||
160905496|NCT03583697|581048230|FG002|Overall Study|Withdrawal by Subject|1|||
160905497|NCT03583697|581048228|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
160905498|NCT03583697|581048229|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
160905499|NCT03583697|581048230|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
160905500|NCT00114530|581048232|FG000|Overall Study|Death|3|||
160905501|NCT00114530|581048233|FG001|Overall Study|Death|11|||
160905502|NCT00114530|581048232|FG000|Overall Study|Lost to Follow-up|1|||
160905503|NCT00114530|581048233|FG001|Overall Study|Lost to Follow-up|1|||
160905504|NCT00114530|581048232|FG000|Overall Study|Physician Decision|1|||
161251646|NCT03230487|582302349|FG003|Overall Study|Adverse Event|1|||
161251647|NCT03230487|582302350|FG004|Overall Study|Adverse Event|0|||
160841654|NCT00286494|580807506|FG002|Overall Study|Adverse Event|6|||
160841655|NCT00286494|580807504|FG000|Overall Study|Physician Decision|5|||
160841656|NCT00286494|580807505|FG001|Overall Study|Physician Decision|5|||
160841657|NCT00286494|580807506|FG002|Overall Study|Physician Decision|1|||
160841658|NCT00286494|580807504|FG000|Overall Study|Lost to Follow-up|3|||
160841659|NCT00286494|580807505|FG001|Overall Study|Lost to Follow-up|1|||
160841660|NCT00286494|580807506|FG002|Overall Study|Lost to Follow-up|3|||
160841661|NCT00286494|580807504|FG000|Overall Study|Protocol Violation|1|||
160841662|NCT00286494|580807505|FG001|Overall Study|Protocol Violation|1|||
160841663|NCT00286494|580807506|FG002|Overall Study|Protocol Violation|2|||
160841664|NCT04776317|580807507|FG000|Overall Study|Physician Decision|0|||
160841665|NCT04776317|580807508|FG001|Overall Study|Physician Decision|1|||
160841666|NCT04776317|580807509|FG002|Overall Study|Physician Decision|0|||
160841667|NCT04776317|580807510|FG003|Overall Study|Physician Decision|0|||
160841668|NCT04776317|580807511|FG004|Overall Study|Physician Decision|0|||
160841669|NCT04776317|580807512|FG005|Overall Study|Physician Decision|0|||
160841670|NCT04776317|580807513|FG006|Overall Study|Physician Decision|0|||
160841671|NCT04776317|580807514|FG007|Overall Study|Physician Decision|0|||
160841672|NCT04776317|580807515|FG008|Overall Study|Physician Decision|0|||
160841673|NCT04776317|580807516|FG009|Overall Study|Physician Decision|0|||
160841674|NCT04776317|580807517|FG010|Overall Study|Physician Decision|0|||
160841675|NCT04776317|580807518|FG011|Overall Study|Physician Decision|0|||
160841676|NCT04776317|580807519|FG012|Overall Study|Physician Decision|0|||
160841677|NCT04776317|580807520|FG013|Overall Study|Physician Decision|0|||
160841678|NCT04776317|580807521|FG014|Overall Study|Physician Decision|0|||
160841679|NCT04776317|580807507|FG000|Overall Study|Protocol Violation|0|||
160841680|NCT04776317|580807508|FG001|Overall Study|Protocol Violation|0|||
160841681|NCT04776317|580807509|FG002|Overall Study|Protocol Violation|1|||
160841682|NCT04776317|580807510|FG003|Overall Study|Protocol Violation|0|||
160841683|NCT04776317|580807511|FG004|Overall Study|Protocol Violation|0|||
160841684|NCT04776317|580807512|FG005|Overall Study|Protocol Violation|0|||
160841685|NCT04776317|580807513|FG006|Overall Study|Protocol Violation|0|||
160841686|NCT04776317|580807514|FG007|Overall Study|Protocol Violation|0|||
160841687|NCT04776317|580807515|FG008|Overall Study|Protocol Violation|0|||
160841688|NCT04776317|580807516|FG009|Overall Study|Protocol Violation|0|||
160841689|NCT04776317|580807517|FG010|Overall Study|Protocol Violation|0|||
160841690|NCT04776317|580807518|FG011|Overall Study|Protocol Violation|0|||
160841691|NCT04776317|580807519|FG012|Overall Study|Protocol Violation|0|||
160841692|NCT04776317|580807520|FG013|Overall Study|Protocol Violation|0|||
160841693|NCT04776317|580807521|FG014|Overall Study|Protocol Violation|0|||
160841694|NCT04776317|580807507|FG000|Overall Study|Withdrawal by Subject|0|||
160841695|NCT04776317|580807508|FG001|Overall Study|Withdrawal by Subject|0|||
160841696|NCT04776317|580807509|FG002|Overall Study|Withdrawal by Subject|0|||
160841697|NCT04776317|580807510|FG003|Overall Study|Withdrawal by Subject|0|||
160841698|NCT04776317|580807511|FG004|Overall Study|Withdrawal by Subject|1|||
160841699|NCT04776317|580807512|FG005|Overall Study|Withdrawal by Subject|0|||
160841700|NCT04776317|580807513|FG006|Overall Study|Withdrawal by Subject|0|||
160841701|NCT04776317|580807514|FG007|Overall Study|Withdrawal by Subject|0|||
160841702|NCT04776317|580807515|FG008|Overall Study|Withdrawal by Subject|0|||
160841703|NCT04776317|580807516|FG009|Overall Study|Withdrawal by Subject|0|||
160841704|NCT04776317|580807517|FG010|Overall Study|Withdrawal by Subject|0|||
160841705|NCT04776317|580807518|FG011|Overall Study|Withdrawal by Subject|0|||
160841706|NCT04776317|580807519|FG012|Overall Study|Withdrawal by Subject|0|||
160841707|NCT04776317|580807520|FG013|Overall Study|Withdrawal by Subject|0|||
160841708|NCT04776317|580807521|FG014|Overall Study|Withdrawal by Subject|0|||
160841709|NCT04207060|580807522|FG000|Overall Study|Lost to Follow-up|2|||
160841710|NCT04207060|580807523|FG001|Overall Study|Lost to Follow-up|0|||
160841711|NCT00774800|580807524|FG000|Intervention 4|Withdrawal by Subject|1|||
160841712|NCT00532298|580807525|FG000|Overall Study|Adverse Event|1|||
160841713|NCT00532298|580807526|FG001|Overall Study|Adverse Event|0|||
160841714|NCT00532298|580807527|FG002|Overall Study|Adverse Event|0|||
160841715|NCT00532298|580807528|FG003|Overall Study|Adverse Event|0|||
160841716|NCT00532298|580807529|FG004|Overall Study|Adverse Event|1|||
160841717|NCT00532298|580807530|FG005|Overall Study|Adverse Event|1|||
160841718|NCT00532298|580807525|FG000|Overall Study|Lost to Follow-up|1|||
160841719|NCT00532298|580807526|FG001|Overall Study|Lost to Follow-up|1|||
160841720|NCT00532298|580807527|FG002|Overall Study|Lost to Follow-up|1|||
160841721|NCT00532298|580807528|FG003|Overall Study|Lost to Follow-up|0|||
160841722|NCT00532298|580807529|FG004|Overall Study|Lost to Follow-up|0|||
160841723|NCT00532298|580807530|FG005|Overall Study|Lost to Follow-up|1|||
160841724|NCT00479856|580807531|FG000|Overall Study|Adverse Event|1|||
160841725|NCT00479856|580807531|FG000|Overall Study|Withdrawal by Subject|1|||
161251648|NCT03230487|582302351|FG005|Overall Study|Adverse Event|0|||
161251649|NCT01961882|582302354|FG000|Overall Study|Adverse Event|3|||
160841726|NCT00479856|580807531|FG000|Overall Study|Physician Decision|1|||
160841727|NCT04164732|580807536|FG000|Treatment run-in Period|Adverse Event|4|||
160841728|NCT04164732|580807537|FG001|Treatment run-in Period|Adverse Event|0|||
160841729|NCT04164732|580807538|FG002|Treatment run-in Period|Adverse Event|0|||
160841730|NCT04164732|580807536|FG000|Treatment run-in Period|Physician Decision|1|||
160841731|NCT04164732|580807537|FG001|Treatment run-in Period|Physician Decision|0|||
160841732|NCT04164732|580807538|FG002|Treatment run-in Period|Physician Decision|0|||
160841733|NCT04164732|580807536|FG000|Treatment run-in Period|Screen Failure|1|||
160841734|NCT04164732|580807537|FG001|Treatment run-in Period|Screen Failure|0|||
160841735|NCT04164732|580807538|FG002|Treatment run-in Period|Screen Failure|0|||
160841736|NCT04164732|580807536|FG000|Randomized Treatment Period|Adverse Event|0|||
160841737|NCT04164732|580807537|FG001|Randomized Treatment Period|Adverse Event|1|||
160841738|NCT04164732|580807538|FG002|Randomized Treatment Period|Adverse Event|0|||
160841739|NCT04164732|580807536|FG000|Randomized Treatment Period|Protocol Deviation|0|||
160841740|NCT04164732|580807537|FG001|Randomized Treatment Period|Protocol Deviation|1|||
160841741|NCT04164732|580807538|FG002|Randomized Treatment Period|Protocol Deviation|1|||
161251650|NCT01961882|582302355|FG001|Overall Study|Adverse Event|2|||
160841742|NCT04164732|580807536|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
160841743|NCT04164732|580807537|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
160841744|NCT04164732|580807538|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
160841745|NCT02141360|580807539|FG000|Overall Study|Withdrawal by Subject|6|||
160841746|NCT02141360|580807540|FG001|Overall Study|Withdrawal by Subject|0|||
160841747|NCT02141360|580807541|FG002|Overall Study|Withdrawal by Subject|0|||
160841748|NCT02141360|580807539|FG000|Overall Study|Study Terminated before Visit|1|||
160841749|NCT02141360|580807540|FG001|Overall Study|Study Terminated before Visit|0|||
160841750|NCT02141360|580807541|FG002|Overall Study|Study Terminated before Visit|0|||
160841751|NCT00646399|580807542|FG000|Overall Study|Death|63|||
160841752|NCT00646399|580807543|FG001|Overall Study|Death|53|||
160841753|NCT00646399|580807542|FG000|Overall Study|Withdrawal by Subject|9|||
161251651|NCT01961882|582302354|FG000|Overall Study|Physician Decision|1|||
160841754|NCT00646399|580807543|FG001|Overall Study|Withdrawal by Subject|10|||
160841755|NCT00646399|580807542|FG000|Overall Study|Other Reason|11|||
160841756|NCT00646399|580807543|FG001|Overall Study|Other Reason|11|||
160841757|NCT00661622|580807544|FG000|Overall Study|Protocol Violation|1|||
160841758|NCT00661622|580807545|FG001|Overall Study|Protocol Violation|0|||
160841759|NCT02332291|580807548|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
160841760|NCT02332291|580807549|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
160841761|NCT02332291|580807548|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
160841762|NCT02332291|580807549|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
160841763|NCT02332291|580807548|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
160841764|NCT02332291|580807549|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
160841765|NCT02332291|580807548|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
160841766|NCT02332291|580807549|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
160841767|NCT02332291|580807548|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
160841768|NCT02332291|580807549|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
160841769|NCT02332291|580807548|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
160841770|NCT02332291|580807549|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
160841771|NCT00395850|580807556|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
160841772|NCT00395850|580807557|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
160841773|NCT00395850|580807558|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
160841774|NCT00395850|580807559|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
160841775|NCT00395850|580807556|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
160841776|NCT00395850|580807557|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
160841777|NCT00395850|580807558|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
160841778|NCT00395850|580807559|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
160841779|NCT00395850|580807556|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
160841780|NCT00395850|580807557|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
160841781|NCT00395850|580807558|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
160841782|NCT00395850|580807559|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
160841783|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
160841784|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
160841785|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
160841786|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
160841787|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
160841788|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
160841789|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
160841790|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
160841791|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
160841792|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
160841793|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
160841794|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
160841795|NCT00395850|580807556|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
160841796|NCT00395850|580807557|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
160841797|NCT00395850|580807558|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
160841798|NCT00395850|580807559|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
160841799|NCT01424228|580807563|FG000|Overall Study|Withdrawal by Subject|27|||
160841800|NCT01424228|580807564|FG001|Overall Study|Withdrawal by Subject|11|||
160841801|NCT01424228|580807563|FG000|Overall Study|Adverse Event|10|||
160841802|NCT01424228|580807564|FG001|Overall Study|Adverse Event|14|||
160841803|NCT01424228|580807563|FG000|Overall Study|Sponsor's decision|9|||
160841804|NCT01424228|580807564|FG001|Overall Study|Sponsor's decision|12|||
160841805|NCT01424228|580807563|FG000|Overall Study|Lack of Efficacy|5|||
160841806|NCT01424228|580807564|FG001|Overall Study|Lack of Efficacy|7|||
160841807|NCT01424228|580807563|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
160841808|NCT01424228|580807564|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
160841809|NCT01424228|580807563|FG000|Overall Study|Non-compliance|2|||
160841810|NCT01424228|580807564|FG001|Overall Study|Non-compliance|0|||
160841811|NCT01424228|580807563|FG000|Overall Study|Worsening of symptoms|1|||
160905505|NCT00114530|581048233|FG001|Overall Study|Physician Decision|1|||
160905506|NCT00114530|581048232|FG000|Overall Study|Withdrawal by Subject|2|||
160905507|NCT00114530|581048233|FG001|Overall Study|Withdrawal by Subject|6|||
160905508|NCT00114530|581048232|FG000|Overall Study|Breast Cancer|1|||
160905509|NCT00114530|581048233|FG001|Overall Study|Breast Cancer|0|||
160905510|NCT00114530|581048232|FG000|Overall Study|Subject decision after endpoint failure|0|||
160905511|NCT00114530|581048233|FG001|Overall Study|Subject decision after endpoint failure|1|||
160905512|NCT00114530|581048232|FG000|Overall Study|Ineligible|1|||
160841812|NCT01424228|580807564|FG001|Overall Study|Worsening of symptoms|0|||
160841813|NCT01424228|580807563|FG000|Overall Study|Unplanned journey|0|||
160841814|NCT01424228|580807564|FG001|Overall Study|Unplanned journey|1|||
160841815|NCT00844558|580807565|FG000|Overall Study|Withdrawal by Subject|9|||
160841816|NCT00844558|580807566|FG001|Overall Study|Withdrawal by Subject|2|||
160841817|NCT00844558|580807565|FG000|Overall Study|Death|1|||
160841818|NCT00844558|580807566|FG001|Overall Study|Death|0|||
160841819|NCT00844558|580807565|FG000|Overall Study|Protocol Violation|1|||
160841820|NCT00844558|580807566|FG001|Overall Study|Protocol Violation|1|||
160841821|NCT00844558|580807565|FG000|Overall Study|Lost to Follow-up|0|||
160841822|NCT00844558|580807566|FG001|Overall Study|Lost to Follow-up|1|||
160841823|NCT00844558|580807565|FG000|Overall Study|Physician Decision|1|||
160841824|NCT00844558|580807566|FG001|Overall Study|Physician Decision|0|||
160841825|NCT00588094|580807567|FG000|Overall Study|Adverse Event|3|||
160841826|NCT00588094|580807567|FG000|Overall Study|Progression of Disease|2|||
160841827|NCT02951429|580807574|FG000|Overall Study|Adverse Event|3|||
160841828|NCT02951429|580807575|FG001|Overall Study|Adverse Event|7|||
160841829|NCT02951429|580807574|FG000|Overall Study|Death|28|||
160841830|NCT02951429|580807575|FG001|Overall Study|Death|36|||
160841831|NCT02951429|580807574|FG000|Overall Study|Lack of Efficacy|0|||
160841832|NCT02951429|580807575|FG001|Overall Study|Lack of Efficacy|1|||
160841833|NCT02951429|580807574|FG000|Overall Study|Lost to Follow-up|0|||
160841834|NCT02951429|580807575|FG001|Overall Study|Lost to Follow-up|1|||
160841835|NCT02951429|580807574|FG000|Overall Study|Lung Transplantation|9|||
160841836|NCT02951429|580807575|FG001|Overall Study|Lung Transplantation|6|||
160841837|NCT02951429|580807574|FG000|Overall Study|Other|1|||
160841838|NCT02951429|580807575|FG001|Overall Study|Other|3|||
160841839|NCT02951429|580807574|FG000|Overall Study|Progressive Disease|1|||
160841840|NCT02951429|580807575|FG001|Overall Study|Progressive Disease|1|||
160841841|NCT02951429|580807574|FG000|Overall Study|Withdrawal by Subject|7|||
160841842|NCT02951429|580807575|FG001|Overall Study|Withdrawal by Subject|11|||
160841843|NCT02951429|580807574|FG000|Overall Study|Participant ongoing in the study|23|||
160841844|NCT02951429|580807575|FG001|Overall Study|Participant ongoing in the study|17|||
160841845|NCT03997825|580807584|FG000|Overall Study|Death|3|||
160841846|NCT03997825|580807584|FG000|Overall Study|Lost to Follow-up|10|||
160841847|NCT03997825|580807584|FG000|Overall Study|Withdrawal by Subject|3|||
160841848|NCT03997825|580807584|FG000|Overall Study|Refused participation|1|||
160841849|NCT01153698|580807585|FG000|Overall Study|Adverse Event|12|||
160841850|NCT01153698|580807585|FG000|Overall Study|Lost to Follow-up|4|||
160841851|NCT01153698|580807585|FG000|Overall Study|Withdrawal by Subject|2|||
160841852|NCT01153698|580807585|FG000|Overall Study|Switch to other anticoagulants|4|||
160841853|NCT01153698|580807585|FG000|Overall Study|Other|2|||
160841854|NCT01153698|580807585|FG000|Overall Study|Not treated with Pradaxa|5|||
160841855|NCT00465647|580807587|FG000|Overall Study|Administrative|2|||
160841856|NCT00465647|580807588|FG001|Overall Study|Administrative|2|||
160841857|NCT00465647|580807589|FG002|Overall Study|Administrative|3|||
160841858|NCT00465647|580807590|FG003|Overall Study|Administrative|2|||
160841859|NCT00465647|580807587|FG000|Overall Study|Adverse Event|2|||
160841860|NCT00465647|580807588|FG001|Overall Study|Adverse Event|0|||
160841861|NCT00465647|580807589|FG002|Overall Study|Adverse Event|3|||
160841862|NCT00465647|580807590|FG003|Overall Study|Adverse Event|2|||
160841863|NCT00465647|580807587|FG000|Overall Study|Withdrawal by Subject|1|||
160841864|NCT00465647|580807588|FG001|Overall Study|Withdrawal by Subject|2|||
160841865|NCT00465647|580807589|FG002|Overall Study|Withdrawal by Subject|2|||
160841866|NCT00465647|580807590|FG003|Overall Study|Withdrawal by Subject|7|||
160841867|NCT00465647|580807587|FG000|Overall Study|"The other reasons included loss of IV"|8|||
160841868|NCT00465647|580807588|FG001|Overall Study|"The other reasons included loss of IV"|4|||
160841869|NCT00465647|580807589|FG002|Overall Study|"The other reasons included loss of IV"|3|||
160841870|NCT00465647|580807590|FG003|Overall Study|"The other reasons included loss of IV"|2|||
160905513|NCT00114530|581048233|FG001|Overall Study|Ineligible|0|||
160905514|NCT02538029|581048235|FG000|Overall Study|unable to complete cognitive assessments|1|||
160905515|NCT02538029|581048236|FG001|Overall Study|unable to complete cognitive assessments|0|||
160841871|NCT01240135|580807591|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
160841872|NCT01240135|580807592|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
160841873|NCT01240135|580807591|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
160841874|NCT01240135|580807592|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
160841875|NCT02220712|580807593|FG000|Overall Study|Adverse Event|1|||
160841876|NCT02220712|580807593|FG000|Overall Study|Withdrawal by Subject|2|||
160841877|NCT02220712|580807593|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
160841878|NCT00760838|580807594|FG000|Overall Study|Adverse Event|1|||
160841879|NCT00760838|580807595|FG001|Overall Study|Adverse Event|1|||
160841880|NCT00760838|580807594|FG000|Overall Study|Lack of Efficacy|1|||
160841881|NCT00760838|580807595|FG001|Overall Study|Lack of Efficacy|0|||
160841882|NCT00760838|580807594|FG000|Overall Study|Lost to Follow-up|2|||
160841883|NCT00760838|580807595|FG001|Overall Study|Lost to Follow-up|0|||
160841884|NCT00760838|580807594|FG000|Overall Study|Withdrawal by Subject|1|||
160841885|NCT00760838|580807595|FG001|Overall Study|Withdrawal by Subject|1|||
160841886|NCT01628965|580807596|FG000|Overall Study|Adverse Event|30|||
160841887|NCT01628965|580807596|FG000|Overall Study|Lack of Efficacy|7|||
161251652|NCT01961882|582302355|FG001|Overall Study|Physician Decision|0|||
161251653|NCT01961882|582302354|FG000|Overall Study|Withdrawal by Subject|4|||
161251654|NCT01961882|582302355|FG001|Overall Study|Withdrawal by Subject|1|||
161251655|NCT01961882|582302354|FG000|Overall Study|Relapse of AML|39|||
160841888|NCT01628965|580807596|FG000|Overall Study|Withdrawal by Subject|3|||
160841889|NCT01628965|580807596|FG000|Overall Study|Lost to Follow-up|1|||
160841890|NCT01628965|580807596|FG000|Overall Study|Discontinuation criteria|8|||
160841891|NCT04356352|580807601|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
160841892|NCT04356352|580807602|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
160841893|NCT04356352|580807603|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
160841894|NCT04356352|580807601|FG000|Overall Study|Protocol Violation|0|||
160841895|NCT04356352|580807602|FG001|Overall Study|Protocol Violation|3|||
160841896|NCT04356352|580807603|FG002|Overall Study|Protocol Violation|1|||
160841897|NCT01983774|580807609|FG000|Overall Study|Lung Transplant|0|||
160841898|NCT01983774|580807610|FG001|Overall Study|Lung Transplant|1|||
160841899|NCT01983774|580807609|FG000|Overall Study|Lost to Follow-up|1|||
160841900|NCT01983774|580807610|FG001|Overall Study|Lost to Follow-up|0|||
160841901|NCT01339897|580807611|FG000|Overall Study|Adverse Event|1|||
160841902|NCT01339897|580807612|FG001|Overall Study|Adverse Event|0|||
160841903|NCT01339897|580807613|FG002|Overall Study|Adverse Event|0|||
160841904|NCT01339897|580807614|FG003|Overall Study|Adverse Event|1|||
160841905|NCT03657095|580807615|FG000|Overall Study|Withdrawal by Subject|1|||
160841906|NCT03657095|580807616|FG001|Overall Study|Withdrawal by Subject|1|||
160841907|NCT03657095|580807615|FG000|Overall Study|Adverse Event|0|||
160841908|NCT03657095|580807616|FG001|Overall Study|Adverse Event|3|||
160841909|NCT03657095|580807615|FG000|Overall Study|Study Terminated by Sponsor|58|||
160841910|NCT03657095|580807616|FG001|Overall Study|Study Terminated by Sponsor|49|||
160841911|NCT00847197|580807617|FG000|Overall Study|Adverse Event|21|||
160841912|NCT00847197|580807618|FG001|Overall Study|Adverse Event|3|||
160841913|NCT00847197|580807617|FG000|Overall Study|Protocol Violation|0|||
160841914|NCT00847197|580807618|FG001|Overall Study|Protocol Violation|1|||
160841915|NCT00847197|580807617|FG000|Overall Study|Withdrawal by Subject|3|||
160841916|NCT00847197|580807618|FG001|Overall Study|Withdrawal by Subject|1|||
160841917|NCT01743040|580807621|FG000|Overall Study|Death|1|||
160841918|NCT01743040|580807621|FG000|Overall Study|Lost to Follow-up|66|||
160841919|NCT01743040|580807621|FG000|Overall Study|Physician Decision|40|||
160841920|NCT01743040|580807621|FG000|Overall Study|Protocol Violation|1|||
160841921|NCT01743040|580807621|FG000|Overall Study|Withdrawal by Subject|121|||
160841922|NCT03824587|580807622|FG000|Run-in Period|Screen Failure|0|||
160841923|NCT03824587|580807623|FG001|Run-in Period|Screen Failure|275|||
160841924|NCT03824587|580807622|FG000|Treatment Period|Adverse Event|4|||
160841925|NCT03824587|580807623|FG001|Treatment Period|Adverse Event|1|||
160841926|NCT03824587|580807622|FG000|Treatment Period|Withdrawal by Subject|0|||
160841927|NCT03824587|580807623|FG001|Treatment Period|Withdrawal by Subject|1|||
160841928|NCT03824587|580807622|FG000|Treatment Period|Kidney Transplant|1|||
160841929|NCT03824587|580807623|FG001|Treatment Period|Kidney Transplant|1|||
160841930|NCT02813889|580809683|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
160841931|NCT02813889|580809684|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
160841932|NCT05128578|580809685|FG000|Overall Study|Withdrawal by Subject|9|||
160841933|NCT05128578|580809685|FG000|Overall Study|Lost to Follow-up|5|||
160841934|NCT01128244|580809689|FG000|Overall Study|Adverse Event|1|||
160841935|NCT01128244|580809689|FG000|Overall Study|Scheduling conflict|2|||
160841936|NCT02974257|580809690|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
160841937|NCT02974257|580809691|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
160841938|NCT02974257|580809690|FG000|Overall Study|Clinical indication for thiamine|1|||
160841939|NCT02974257|580809691|FG001|Overall Study|Clinical indication for thiamine|0|||
160841940|NCT02974257|580809690|FG000|Overall Study|Already on thiamine|1|||
160841941|NCT02974257|580809691|FG001|Overall Study|Already on thiamine|0|||
160841942|NCT02974257|580809690|FG000|Overall Study|Extubated prior to study drug|0|||
160841943|NCT02974257|580809691|FG001|Overall Study|Extubated prior to study drug|1|||
160841944|NCT02974257|580809690|FG000|Overall Study|Death|0|||
160841945|NCT02974257|580809691|FG001|Overall Study|Death|1|||
160841946|NCT00398567|580809692|FG000|Overall Study|Disease Progression|3|||
160841947|NCT00398567|580809693|FG001|Overall Study|Disease Progression|4|||
160841948|NCT00398567|580809694|FG002|Overall Study|Disease Progression|27|||
160841949|NCT00398567|580809692|FG000|Overall Study|Withdrawal by Subject|1|||
160841950|NCT00398567|580809693|FG001|Overall Study|Withdrawal by Subject|0|||
161251656|NCT01961882|582302355|FG001|Overall Study|Relapse of AML|37|||
161251657|NCT01961882|582302354|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
160841951|NCT00398567|580809694|FG002|Overall Study|Withdrawal by Subject|4|||
160841952|NCT00398567|580809692|FG000|Overall Study|Adverse Event|0|||
160841953|NCT00398567|580809693|FG001|Overall Study|Adverse Event|0|||
160841954|NCT00398567|580809694|FG002|Overall Study|Adverse Event|2|||
160841955|NCT00398567|580809692|FG000|Overall Study|Protocol Violation|0|||
160841956|NCT00398567|580809693|FG001|Overall Study|Protocol Violation|0|||
160841957|NCT00398567|580809694|FG002|Overall Study|Protocol Violation|1|||
160841958|NCT03437577|580809697|FG000|Pre-Randomization|Withdrawal by Subject|0|||
160841959|NCT03437577|580809698|FG001|Pre-Randomization|Withdrawal by Subject|0|||
160841960|NCT03437577|580809699|FG002|Pre-Randomization|Withdrawal by Subject|10|||
160841961|NCT03437577|580809697|FG000|Post-Randomization|Physician Decision|0|||
160841962|NCT03437577|580809698|FG001|Post-Randomization|Physician Decision|2|||
160841963|NCT03437577|580809699|FG002|Post-Randomization|Physician Decision|0|||
160841964|NCT04273893|580809700|FG000|Overall Study|Withdrawal by Subject|0|||
160841965|NCT04273893|580809701|FG001|Overall Study|Withdrawal by Subject|2|||
160841966|NCT04273893|580809700|FG000|Overall Study|Treatment of Disease Progression|0|||
160841967|NCT04273893|580809701|FG001|Overall Study|Treatment of Disease Progression|2|||
160841968|NCT04273893|580809700|FG000|Overall Study|Death|1|||
160841969|NCT04273893|580809701|FG001|Overall Study|Death|2|||
160841970|NCT04273893|580809700|FG000|Overall Study|Lost to Follow-up|0|||
160841971|NCT04273893|580809701|FG001|Overall Study|Lost to Follow-up|2|||
160841972|NCT04273893|580809700|FG000|Overall Study|Physician Decision|1|||
160841973|NCT04273893|580809701|FG001|Overall Study|Physician Decision|0|||
160841974|NCT00100789|580809709|FG000|Overall Study|Adverse Event|10|||
160841975|NCT00100789|580809709|FG000|Overall Study|Withdrawal by Subject|1|||
160841976|NCT00100789|580809709|FG000|Overall Study|Progression/relapse|42|||
160841977|NCT00100789|580809709|FG000|Overall Study|Death|2|||
160841978|NCT00100789|580809709|FG000|Overall Study|Not protocol specified|5|||
160841979|NCT00100789|580809709|FG000|Overall Study|Ineligible|3|||
160841980|NCT00100789|580809709|FG000|Overall Study|Never received treatment|1|||
160841981|NCT02936843|580809710|FG000|Overall Study|Lost to Follow-up|3|||
160841982|NCT02936843|580809711|FG001|Overall Study|Lost to Follow-up|1|||
160841983|NCT02936843|580809710|FG000|Overall Study|Withdrawal by Subject|1|||
160841984|NCT02936843|580809711|FG001|Overall Study|Withdrawal by Subject|1|||
160841985|NCT01393821|580809712|FG000|Overall Study|Cancel|1|||
160841986|NCT01393821|580809713|FG001|Overall Study|Cancel|1|||
160841987|NCT01393821|580809712|FG000|Overall Study|not evaluable for primary endpoint|4|||
160841988|NCT01393821|580809713|FG001|Overall Study|not evaluable for primary endpoint|2|||
160841989|NCT00517361|580809725|FG000|Overall Study|Death|6|||
160841990|NCT00517361|580809725|FG000|Overall Study|The study was terminated|5|||
160841991|NCT01948063|580809726|FG000|Overall Study|Boston MCI halted research protocol|0|||
160841992|NCT01948063|580809727|FG001|Overall Study|Boston MCI halted research protocol|1|||
160841993|NCT01948063|580809726|FG000|Overall Study|Discovered an enrollment in other study|0|||
160841994|NCT01948063|580809727|FG001|Overall Study|Discovered an enrollment in other study|1|||
160841995|NCT01948063|580809726|FG000|Overall Study|Blood samples were accidentally thawed|1|||
160841996|NCT01948063|580809727|FG001|Overall Study|Blood samples were accidentally thawed|0|||
160841997|NCT01858766|580809728|FG000|Overall Study|Randomized but Never Treated|0|||
160841998|NCT01858766|580809729|FG001|Overall Study|Randomized but Never Treated|0|||
160841999|NCT01858766|580809730|FG002|Overall Study|Randomized but Never Treated|0|||
160842000|NCT01858766|580809731|FG003|Overall Study|Randomized but Never Treated|0|||
160842001|NCT01858766|580809732|FG004|Overall Study|Randomized but Never Treated|0|||
160842002|NCT01858766|580809733|FG005|Overall Study|Randomized but Never Treated|1|||
160842003|NCT01858766|580809734|FG006|Overall Study|Randomized but Never Treated|0|||
160842004|NCT01858766|580809735|FG007|Overall Study|Randomized but Never Treated|0|||
160842005|NCT01858766|580809736|FG008|Overall Study|Randomized but Never Treated|0|||
160842006|NCT01858766|580809737|FG009|Overall Study|Randomized but Never Treated|0|||
160842007|NCT01858766|580809738|FG010|Overall Study|Randomized but Never Treated|0|||
160842008|NCT01858766|580809739|FG011|Overall Study|Randomized but Never Treated|0|||
160842009|NCT01858766|580809740|FG012|Overall Study|Randomized but Never Treated|0|||
160842010|NCT01858766|580809741|FG013|Overall Study|Randomized but Never Treated|0|||
160842011|NCT01858766|580809742|FG014|Overall Study|Randomized but Never Treated|0|||
160842012|NCT01858766|580809743|FG015|Overall Study|Randomized but Never Treated|0|||
161334983|NCT01673178|582615886|FG002|Overall Study|Withdrawal by Subject|1|||
161334984|NCT01673178|582615887|FG003|Overall Study|Withdrawal by Subject|4|||
161334985|NCT01673178|582615888|FG004|Overall Study|Withdrawal by Subject|2|||
161334986|NCT01673178|582615884|FG000|Overall Study|Protocol Violation|1|||
161334987|NCT01673178|582615885|FG001|Overall Study|Protocol Violation|1|||
160842013|NCT01858766|580809744|FG016|Overall Study|Randomized but Never Treated|0|||
160842014|NCT01858766|580809745|FG017|Overall Study|Randomized but Never Treated|1|||
160842015|NCT01858766|580809746|FG018|Overall Study|Randomized but Never Treated|0|||
160842016|NCT01858766|580809728|FG000|Overall Study|Death|0|||
160842017|NCT01858766|580809729|FG001|Overall Study|Death|0|||
160842018|NCT01858766|580809730|FG002|Overall Study|Death|1|||
160842019|NCT01858766|580809731|FG003|Overall Study|Death|0|||
160842020|NCT01858766|580809732|FG004|Overall Study|Death|0|||
160842021|NCT01858766|580809733|FG005|Overall Study|Death|0|||
161334988|NCT01673178|582615886|FG002|Overall Study|Protocol Violation|0|||
160842022|NCT01858766|580809734|FG006|Overall Study|Death|0|||
160842023|NCT01858766|580809735|FG007|Overall Study|Death|0|||
160842024|NCT01858766|580809736|FG008|Overall Study|Death|0|||
160842025|NCT01858766|580809737|FG009|Overall Study|Death|0|||
160842026|NCT01858766|580809738|FG010|Overall Study|Death|0|||
160842027|NCT01858766|580809739|FG011|Overall Study|Death|0|||
160842028|NCT01858766|580809740|FG012|Overall Study|Death|0|||
160842029|NCT01858766|580809741|FG013|Overall Study|Death|0|||
160842030|NCT01858766|580809742|FG014|Overall Study|Death|0|||
160842031|NCT01858766|580809743|FG015|Overall Study|Death|0|||
160842032|NCT01858766|580809744|FG016|Overall Study|Death|0|||
160842033|NCT01858766|580809745|FG017|Overall Study|Death|0|||
160842034|NCT01858766|580809746|FG018|Overall Study|Death|0|||
160842035|NCT01858766|580809728|FG000|Overall Study|Lack of Efficacy|1|||
160842036|NCT01858766|580809729|FG001|Overall Study|Lack of Efficacy|0|||
160842037|NCT01858766|580809730|FG002|Overall Study|Lack of Efficacy|0|||
160842038|NCT01858766|580809731|FG003|Overall Study|Lack of Efficacy|0|||
160842039|NCT01858766|580809732|FG004|Overall Study|Lack of Efficacy|1|||
160842040|NCT01858766|580809733|FG005|Overall Study|Lack of Efficacy|2|||
160842041|NCT01858766|580809734|FG006|Overall Study|Lack of Efficacy|0|||
160842042|NCT01858766|580809735|FG007|Overall Study|Lack of Efficacy|0|||
160842043|NCT01858766|580809736|FG008|Overall Study|Lack of Efficacy|0|||
160842044|NCT01858766|580809737|FG009|Overall Study|Lack of Efficacy|0|||
160842045|NCT01858766|580809738|FG010|Overall Study|Lack of Efficacy|0|||
160842046|NCT01858766|580809739|FG011|Overall Study|Lack of Efficacy|3|||
160842047|NCT01858766|580809740|FG012|Overall Study|Lack of Efficacy|5|||
160842048|NCT01858766|580809741|FG013|Overall Study|Lack of Efficacy|3|||
160842049|NCT01858766|580809742|FG014|Overall Study|Lack of Efficacy|5|||
160842050|NCT01858766|580809743|FG015|Overall Study|Lack of Efficacy|5|||
160842051|NCT01858766|580809744|FG016|Overall Study|Lack of Efficacy|2|||
160842052|NCT01858766|580809745|FG017|Overall Study|Lack of Efficacy|3|||
160842053|NCT01858766|580809746|FG018|Overall Study|Lack of Efficacy|3|||
160842054|NCT01858766|580809728|FG000|Overall Study|Lost to Follow-up|0|||
160842055|NCT01858766|580809729|FG001|Overall Study|Lost to Follow-up|0|||
160842056|NCT01858766|580809730|FG002|Overall Study|Lost to Follow-up|0|||
160842057|NCT01858766|580809731|FG003|Overall Study|Lost to Follow-up|0|||
160842058|NCT01858766|580809732|FG004|Overall Study|Lost to Follow-up|0|||
160842059|NCT01858766|580809733|FG005|Overall Study|Lost to Follow-up|1|||
160842060|NCT01858766|580809734|FG006|Overall Study|Lost to Follow-up|0|||
160842061|NCT01858766|580809735|FG007|Overall Study|Lost to Follow-up|2|||
160842062|NCT01858766|580809736|FG008|Overall Study|Lost to Follow-up|0|||
160842063|NCT01858766|580809737|FG009|Overall Study|Lost to Follow-up|0|||
160842064|NCT01858766|580809738|FG010|Overall Study|Lost to Follow-up|0|||
160842065|NCT01858766|580809739|FG011|Overall Study|Lost to Follow-up|1|||
160842066|NCT01858766|580809740|FG012|Overall Study|Lost to Follow-up|0|||
160842067|NCT01858766|580809741|FG013|Overall Study|Lost to Follow-up|0|||
160842068|NCT01858766|580809742|FG014|Overall Study|Lost to Follow-up|3|||
160842069|NCT01858766|580809743|FG015|Overall Study|Lost to Follow-up|1|||
160842070|NCT01858766|580809744|FG016|Overall Study|Lost to Follow-up|1|||
161334989|NCT01673178|582615887|FG003|Overall Study|Protocol Violation|1|||
160842071|NCT01858766|580809745|FG017|Overall Study|Lost to Follow-up|0|||
160842072|NCT01858766|580809746|FG018|Overall Study|Lost to Follow-up|1|||
160842073|NCT01858766|580809728|FG000|Overall Study|Withdrew Consent|0|||
160842074|NCT01858766|580809729|FG001|Overall Study|Withdrew Consent|0|||
160842075|NCT01858766|580809730|FG002|Overall Study|Withdrew Consent|0|||
160842076|NCT01858766|580809731|FG003|Overall Study|Withdrew Consent|0|||
160842077|NCT01858766|580809732|FG004|Overall Study|Withdrew Consent|0|||
160842078|NCT01858766|580809733|FG005|Overall Study|Withdrew Consent|0|||
160842079|NCT01858766|580809734|FG006|Overall Study|Withdrew Consent|0|||
160842080|NCT01858766|580809735|FG007|Overall Study|Withdrew Consent|0|||
160842081|NCT01858766|580809736|FG008|Overall Study|Withdrew Consent|0|||
160842082|NCT01858766|580809737|FG009|Overall Study|Withdrew Consent|0|||
160842083|NCT01858766|580809738|FG010|Overall Study|Withdrew Consent|0|||
160842084|NCT01858766|580809739|FG011|Overall Study|Withdrew Consent|1|||
160842085|NCT01858766|580809740|FG012|Overall Study|Withdrew Consent|0|||
160842086|NCT01858766|580809741|FG013|Overall Study|Withdrew Consent|0|||
160842087|NCT01858766|580809742|FG014|Overall Study|Withdrew Consent|0|||
160842088|NCT01858766|580809743|FG015|Overall Study|Withdrew Consent|0|||
160842089|NCT01858766|580809744|FG016|Overall Study|Withdrew Consent|0|||
160842090|NCT01858766|580809745|FG017|Overall Study|Withdrew Consent|0|||
160842091|NCT01858766|580809746|FG018|Overall Study|Withdrew Consent|0|||
160842092|NCT05438576|580809761|FG000|Overall Study|Death|1|||
160842093|NCT05438576|580809762|FG001|Overall Study|Death|1|||
160842094|NCT05438576|580809761|FG000|Overall Study|Withdrawal by Subject|4|||
160842095|NCT05438576|580809762|FG001|Overall Study|Withdrawal by Subject|2|||
160842096|NCT05438576|580809761|FG000|Overall Study|Not Eligible|2|||
160842097|NCT05438576|580809762|FG001|Overall Study|Not Eligible|1|||
160842098|NCT05438576|580809761|FG000|Overall Study|Did not complete baseline testing|22|||
160842099|NCT05438576|580809762|FG001|Overall Study|Did not complete baseline testing|4|||
160842100|NCT02881762|580809765|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
160842101|NCT02881762|580809766|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160842102|NCT00245037|580809767|FG000|Overall Study|Death|17|||
160842103|NCT00296140|580809769|FG000|Overall Study|Lost to Follow-up|1|||
160842104|NCT00296140|580809770|FG001|Overall Study|Lost to Follow-up|0|||
160842105|NCT00296140|580809769|FG000|Overall Study|Withdrawal by Subject|1|||
160905516|NCT02538029|581048237|FG002|Overall Study|unable to complete cognitive assessments|1|||
160905517|NCT00404235|581048240|FG000|Overall Study|Withdrawal by Subject|1|||
160905518|NCT00404235|581048241|FG001|Overall Study|Withdrawal by Subject|2|||
160905519|NCT00679432|581048242|FG000|Overall Study|Adverse Event|5|||
160905520|NCT00679432|581048243|FG001|Overall Study|Adverse Event|6|||
160905521|NCT00679432|581048244|FG002|Overall Study|Adverse Event|10|||
160905522|NCT00679432|581048245|FG003|Overall Study|Adverse Event|7|||
160905523|NCT00679432|581048242|FG000|Overall Study|Protocol Violation|1|||
160905524|NCT00679432|581048243|FG001|Overall Study|Protocol Violation|1|||
161139363|NCT01309737|581892687|FG003|Week 16 to 52|Adverse Event|6|||
161139364|NCT01309737|581892688|FG004|Week 16 to 52|Adverse Event|5|||
161139365|NCT01309737|581892684|FG000|Week 16 to 52|Lack of Efficacy|107|||
161139366|NCT01309737|581892685|FG001|Week 16 to 52|Lack of Efficacy|76|||
161251658|NCT01961882|582302355|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
161251659|NCT01961882|582302354|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
161251660|NCT01961882|582302355|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
161251661|NCT01901848|582302356|FG000|Randomized and Treated|Lost to Follow-up|3|||
161251662|NCT01901848|582302357|FG001|Randomized and Treated|Lost to Follow-up|6|||
161251663|NCT01901848|582302356|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
161251664|NCT01901848|582302357|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
161251665|NCT02916693|582302358|FG000|Overall Study|Lost to Follow-up|7|||
161251666|NCT01190930|582302359|FG000|Induction|Adverse Event|17|||
161251667|NCT01190930|582302360|FG001|Induction|Adverse Event|0|||
161251668|NCT01190930|582302361|FG002|Induction|Adverse Event|0|||
161251669|NCT01190930|582302362|FG003|Induction|Adverse Event|0|||
161251670|NCT01190930|582302363|FG004|Induction|Adverse Event|0|||
161251671|NCT01190930|582302364|FG005|Induction|Adverse Event|0|||
161251672|NCT01190930|582302365|FG006|Induction|Adverse Event|0|||
161251673|NCT01190930|582302366|FG007|Induction|Adverse Event|0|||
160842106|NCT00296140|580809770|FG001|Overall Study|Withdrawal by Subject|0|||
160842107|NCT00296140|580809769|FG000|Overall Study|Discharge to Nursing Home|1|||
160842108|NCT00296140|580809770|FG001|Overall Study|Discharge to Nursing Home|0|||
160842109|NCT00880191|580809777|FG000|Overall Study|Refused further treatment|4|||
160842110|NCT00880191|580809778|FG001|Overall Study|Refused further treatment|1|||
160842111|NCT00880191|580809777|FG000|Overall Study|Adverse Event|8|||
160842112|NCT00880191|580809778|FG001|Overall Study|Adverse Event|6|||
160842113|NCT00880191|580809777|FG000|Overall Study|Hospitalization/efficacy|1|||
160842114|NCT00880191|580809778|FG001|Overall Study|Hospitalization/efficacy|1|||
160842115|NCT01843062|580809780|FG000|Overall Study|Protocol Violation|1|||
160842116|NCT01843062|580809781|FG001|Overall Study|Protocol Violation|0|||
160842117|NCT01843062|580809780|FG000|Overall Study|New treatment following progression|2|||
160842118|NCT01843062|580809781|FG001|Overall Study|New treatment following progression|0|||
160842119|NCT01843062|580809780|FG000|Overall Study|Pregnancy|1|||
160842120|NCT01843062|580809781|FG001|Overall Study|Pregnancy|0|||
160842121|NCT01843062|580809780|FG000|Overall Study|Adverse Event|2|||
160842122|NCT01843062|580809781|FG001|Overall Study|Adverse Event|0|||
160842123|NCT01843062|580809780|FG000|Overall Study|Incorrect randomisation|1|||
160842124|NCT01843062|580809781|FG001|Overall Study|Incorrect randomisation|0|||
160842125|NCT01843062|580809780|FG000|Overall Study|Withdrawal by Subject|12|||
160842126|NCT01843062|580809781|FG001|Overall Study|Withdrawal by Subject|3|||
160842127|NCT01843062|580809780|FG000|Overall Study|Death|1|||
160842128|NCT01843062|580809781|FG001|Overall Study|Death|2|||
160842129|NCT01843062|580809780|FG000|Overall Study|Lost to Follow-up|2|||
160842130|NCT01843062|580809781|FG001|Overall Study|Lost to Follow-up|4|||
160842131|NCT00994422|580809785|FG000|Overall Study|Lost to Follow-up|7|||
160842132|NCT00994422|580809786|FG001|Overall Study|Lost to Follow-up|1|||
160905525|NCT00679432|581048244|FG002|Overall Study|Protocol Violation|2|||
160905526|NCT00679432|581048245|FG003|Overall Study|Protocol Violation|1|||
160905527|NCT00679432|581048242|FG000|Overall Study|Withdrawal by Subject|8|||
160905528|NCT00679432|581048243|FG001|Overall Study|Withdrawal by Subject|11|||
161139367|NCT01309737|581892686|FG002|Week 16 to 52|Lack of Efficacy|0|||
161139368|NCT01309737|581892687|FG003|Week 16 to 52|Lack of Efficacy|25|||
161334990|NCT01673178|582615888|FG004|Overall Study|Protocol Violation|0|||
161334991|NCT01673178|582615884|FG000|Overall Study|Adverse Event|1|||
160842133|NCT02669212|580809787|FG000|Overall Study|Lost to Follow-up|1|||
160842134|NCT02669212|580809788|FG001|Overall Study|Lost to Follow-up|0|||
160842135|NCT02669212|580809787|FG000|Overall Study|Medical Condition|3|||
160905529|NCT00679432|581048244|FG002|Overall Study|Withdrawal by Subject|10|||
160842136|NCT02669212|580809788|FG001|Overall Study|Medical Condition|4|||
160842137|NCT02669212|580809787|FG000|Overall Study|Withdrawal by Subject|0|||
160842138|NCT02669212|580809788|FG001|Overall Study|Withdrawal by Subject|2|||
160842139|NCT02669212|580809787|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
160905530|NCT00679432|581048245|FG003|Overall Study|Withdrawal by Subject|9|||
161139369|NCT01309737|581892688|FG004|Week 16 to 52|Lack of Efficacy|21|||
161139370|NCT01309737|581892684|FG000|Week 16 to 52|Lost to Follow-up|4|||
161251674|NCT01190930|582302367|FG008|Induction|Adverse Event|0|||
161251675|NCT01190930|582302368|FG009|Induction|Adverse Event|0|||
161251676|NCT01190930|582302359|FG000|Induction|Death|34|||
160842140|NCT02669212|580809788|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
160842141|NCT03549104|580809791|FG000|Overall Study|Withdrawal by Subject|5|||
160842142|NCT03549104|580809792|FG001|Overall Study|Withdrawal by Subject|2|||
160842143|NCT03549104|580809791|FG000|Overall Study|Covid shelter in place|1|||
160842144|NCT03549104|580809792|FG001|Overall Study|Covid shelter in place|2|||
160842145|NCT04124705|580809793|FG000|Titration Period|Adverse Event|9|||
160842146|NCT04124705|580809794|FG001|Titration Period|Adverse Event|5|||
160842147|NCT04124705|580809793|FG000|Titration Period|Withdrawal by Subject|6|||
160905531|NCT00679432|581048242|FG000|Overall Study|Lost to Follow-up|1|||
160905532|NCT00679432|581048243|FG001|Overall Study|Lost to Follow-up|5|||
160905533|NCT00679432|581048244|FG002|Overall Study|Lost to Follow-up|4|||
160905534|NCT00679432|581048245|FG003|Overall Study|Lost to Follow-up|2|||
160905535|NCT00679432|581048242|FG000|Overall Study|Physician Decision|3|||
160905536|NCT00679432|581048243|FG001|Overall Study|Physician Decision|2|||
160842148|NCT04124705|580809794|FG001|Titration Period|Withdrawal by Subject|3|||
160842149|NCT04124705|580809793|FG000|Titration Period|Lost to Follow-up|0|||
160842150|NCT04124705|580809794|FG001|Titration Period|Lost to Follow-up|1|||
160842151|NCT04124705|580809793|FG000|Titration Period|Death|1|||
160842152|NCT04124705|580809794|FG001|Titration Period|Death|1|||
160842153|NCT04124705|580809793|FG000|Titration Period|Lack of Efficacy|2|||
160842154|NCT04124705|580809794|FG001|Titration Period|Lack of Efficacy|0|||
160905537|NCT00679432|581048244|FG002|Overall Study|Physician Decision|2|||
160905538|NCT00679432|581048245|FG003|Overall Study|Physician Decision|2|||
160905539|NCT00679432|581048242|FG000|Overall Study|Sponsor decision|1|||
160905540|NCT00679432|581048243|FG001|Overall Study|Sponsor decision|0|||
160905541|NCT00679432|581048244|FG002|Overall Study|Sponsor decision|0|||
160905542|NCT00679432|581048245|FG003|Overall Study|Sponsor decision|0|||
160905543|NCT00679432|581048242|FG000|Overall Study|Lack of Efficacy|13|||
160905544|NCT00679432|581048243|FG001|Overall Study|Lack of Efficacy|9|||
160905545|NCT00679432|581048244|FG002|Overall Study|Lack of Efficacy|14|||
160905546|NCT00679432|581048245|FG003|Overall Study|Lack of Efficacy|8|||
160905547|NCT00679432|581048242|FG000|Overall Study|Infectious colitis, normal histology|5|||
160992124|NCT02040844|581359983|FG001|Overall Study|Non-specified|2|||
160992125|NCT02040844|581359984|FG002|Overall Study|Non-specified|5|||
160992126|NCT02040844|581359982|FG000|Overall Study|Concomitant medication|1|||
160992127|NCT02040844|581359983|FG001|Overall Study|Concomitant medication|3|||
160992128|NCT02040844|581359984|FG002|Overall Study|Concomitant medication|1|||
160992129|NCT01772719|581359985|FG000|Overall Study|Withdrawal by Subject|3|||
160992130|NCT01772719|581359985|FG000|Overall Study|Adverse Event|2|||
160992131|NCT01772719|581359985|FG000|Overall Study|Protocol Violation|1|||
160992132|NCT01772719|581359985|FG000|Overall Study|Lost to Follow-up|1|||
160992133|NCT00946192|581359986|FG000|Overall Study|Lost to Follow-up|6|||
160992134|NCT00946192|581359987|FG001|Overall Study|Lost to Follow-up|11|||
160992135|NCT00946192|581359988|FG002|Overall Study|Lost to Follow-up|9|||
160992136|NCT00946192|581359986|FG000|Overall Study|Withdrawal by Subject|10|||
160992137|NCT00946192|581359987|FG001|Overall Study|Withdrawal by Subject|7|||
160992138|NCT00946192|581359988|FG002|Overall Study|Withdrawal by Subject|3|||
160992139|NCT00946192|581359986|FG000|Overall Study|Did not start medication|2|||
160992140|NCT00946192|581359987|FG001|Overall Study|Did not start medication|0|||
160992141|NCT00946192|581359988|FG002|Overall Study|Did not start medication|0|||
160992142|NCT00477412|581359989|FG000|Overall Study|Death|0|||
160992143|NCT00477412|581359990|FG001|Overall Study|Death|0|||
160992144|NCT00477412|581359991|FG002|Overall Study|Death|0|||
160992145|NCT00477412|581359992|FG003|Overall Study|Death|4|||
160992146|NCT00477412|581359989|FG000|Overall Study|Lost to Follow-up|0|||
160992147|NCT00477412|581359990|FG001|Overall Study|Lost to Follow-up|0|||
160842155|NCT04124705|580809793|FG000|Titration Period|Physician Decision|2|||
160842156|NCT04124705|580809794|FG001|Titration Period|Physician Decision|0|||
160842157|NCT04124705|580809793|FG000|Titration Period|Non-compliance with Study Drug|2|||
160905548|NCT00679432|581048243|FG001|Overall Study|Infectious colitis, normal histology|4|||
160905549|NCT00679432|581048244|FG002|Overall Study|Infectious colitis, normal histology|8|||
160905550|NCT00679432|581048245|FG003|Overall Study|Infectious colitis, normal histology|3|||
160905551|NCT00679432|581048242|FG000|Overall Study|Randomization error, return to prior Rx|0|||
160905552|NCT00679432|581048243|FG001|Overall Study|Randomization error, return to prior Rx|0|||
160992148|NCT00477412|581359991|FG002|Overall Study|Lost to Follow-up|0|||
160992149|NCT00477412|581359992|FG003|Overall Study|Lost to Follow-up|1|||
160992150|NCT00477412|581359989|FG000|Overall Study|Withdrawal by Subject|0|||
160842158|NCT04124705|580809794|FG001|Titration Period|Non-compliance with Study Drug|0|||
160842159|NCT04124705|580809793|FG000|Titration Period|Other|4|||
160842160|NCT04124705|580809794|FG001|Titration Period|Other|9|||
160842161|NCT04124705|580809793|FG000|Stabilization Period|Adverse Event|4|||
160905553|NCT00679432|581048244|FG002|Overall Study|Randomization error, return to prior Rx|3|||
160905554|NCT00679432|581048245|FG003|Overall Study|Randomization error, return to prior Rx|0|||
160905555|NCT00824720|581048246|FG000|Overall Study|failed plug insertion|3|||
160905556|NCT00824720|581048247|FG001|Overall Study|failed plug insertion|1|||
160905557|NCT00824720|581048248|FG002|Overall Study|failed plug insertion|0|||
160992151|NCT00477412|581359990|FG001|Overall Study|Withdrawal by Subject|0|||
160842162|NCT04124705|580809794|FG001|Stabilization Period|Adverse Event|2|||
160842163|NCT04124705|580809793|FG000|Stabilization Period|Withdrawal by Subject|1|||
160842164|NCT04124705|580809794|FG001|Stabilization Period|Withdrawal by Subject|1|||
160842165|NCT04124705|580809793|FG000|Stabilization Period|Lost to Follow-up|0|||
160842166|NCT04124705|580809794|FG001|Stabilization Period|Lost to Follow-up|1|||
160842167|NCT04124705|580809793|FG000|Stabilization Period|Lack of Efficacy|4|||
160842168|NCT04124705|580809794|FG001|Stabilization Period|Lack of Efficacy|2|||
160842169|NCT04124705|580809793|FG000|Stabilization Period|Protocol Deviation|0|||
160842170|NCT04124705|580809794|FG001|Stabilization Period|Protocol Deviation|2|||
160842171|NCT04124705|580809793|FG000|Stabilization Period|Other|2|||
160842172|NCT04124705|580809794|FG001|Stabilization Period|Other|2|||
160842173|NCT03422536|580809795|FG000|Randomized|Physician Decision|1|||
160842174|NCT03422536|580809796|FG001|Randomized|Physician Decision|1|||
160842175|NCT03422536|580809795|FG000|Allocation - Received Intervention|Disease progression|19|||
160842176|NCT03422536|580809796|FG001|Allocation - Received Intervention|Disease progression|25|||
160842177|NCT03422536|580809795|FG000|Allocation - Received Intervention|Death|1|||
160842178|NCT03422536|580809796|FG001|Allocation - Received Intervention|Death|3|||
160842179|NCT03422536|580809795|FG000|Allocation - Received Intervention|Adverse Event|1|||
160842180|NCT03422536|580809796|FG001|Allocation - Received Intervention|Adverse Event|0|||
160842181|NCT03422536|580809795|FG000|Allocation - Received Intervention|Physician Decision|1|||
160842182|NCT03422536|580809796|FG001|Allocation - Received Intervention|Physician Decision|1|||
160842183|NCT03422536|580809795|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
160842184|NCT03422536|580809796|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
160842185|NCT03422536|580809795|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
160842186|NCT03422536|580809796|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
160842187|NCT01973998|580809797|FG000|Overall Study|Death|2|||
160842188|NCT01973998|580809798|FG001|Overall Study|Death|2|||
160842189|NCT02540993|580809804|FG000|Overall Study|Lost to Follow-up|5|||
160842190|NCT02540993|580809805|FG001|Overall Study|Lost to Follow-up|3|||
160842191|NCT02540993|580809804|FG000|Overall Study|Withdrawal by Subject|4|||
160842192|NCT02540993|580809805|FG001|Overall Study|Withdrawal by Subject|6|||
160842193|NCT02540993|580809804|FG000|Overall Study|GCP violations|33|||
160842194|NCT02540993|580809805|FG001|Overall Study|GCP violations|27|||
160842195|NCT00932165|580809808|FG000|Overall Study|Lost to Follow-up|1|||
160842196|NCT01620528|580809809|FG000|Treatment Period|Did Not Receive Study Drug|0|||
160842197|NCT01620528|580809810|FG001|Treatment Period|Did Not Receive Study Drug|0|||
160842198|NCT01620528|580809811|FG002|Treatment Period|Did Not Receive Study Drug|1|||
160842199|NCT01620528|580809809|FG000|Treatment Period|Withdrawal by Subject|35|||
160842200|NCT01620528|580809810|FG001|Treatment Period|Withdrawal by Subject|21|||
160842201|NCT01620528|580809811|FG002|Treatment Period|Withdrawal by Subject|16|||
160842202|NCT01620528|580809809|FG000|Treatment Period|Adverse Event|17|||
160842203|NCT01620528|580809810|FG001|Treatment Period|Adverse Event|13|||
160842204|NCT01620528|580809811|FG002|Treatment Period|Adverse Event|21|||
160842205|NCT01620528|580809809|FG000|Treatment Period|Lost to Follow-up|16|||
160842206|NCT01620528|580809810|FG001|Treatment Period|Lost to Follow-up|8|||
160842207|NCT01620528|580809811|FG002|Treatment Period|Lost to Follow-up|14|||
160842208|NCT01620528|580809809|FG000|Treatment Period|Other|9|||
160842209|NCT01620528|580809810|FG001|Treatment Period|Other|5|||
160842210|NCT01620528|580809811|FG002|Treatment Period|Other|7|||
160842211|NCT01620528|580809809|FG000|Treatment Period|Subject Noncompliant|11|||
160842212|NCT01620528|580809810|FG001|Treatment Period|Subject Noncompliant|2|||
160842213|NCT01620528|580809811|FG002|Treatment Period|Subject Noncompliant|2|||
160842214|NCT01620528|580809809|FG000|Treatment Period|Pregnancy|7|||
160842215|NCT01620528|580809810|FG001|Treatment Period|Pregnancy|2|||
160842216|NCT01620528|580809811|FG002|Treatment Period|Pregnancy|2|||
160842217|NCT01620528|580809809|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
160842218|NCT01620528|580809810|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
160842219|NCT01620528|580809811|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
161139371|NCT01309737|581892685|FG001|Week 16 to 52|Lost to Follow-up|2|||
160842220|NCT01620528|580809809|FG000|Treatment Period|Exclusionary Medication Received|0|||
160842221|NCT01620528|580809810|FG001|Treatment Period|Exclusionary Medication Received|1|||
160842222|NCT01620528|580809811|FG002|Treatment Period|Exclusionary Medication Received|0|||
160842223|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
160842224|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
161139372|NCT01309737|581892686|FG002|Week 16 to 52|Lost to Follow-up|0|||
161139373|NCT01309737|581892687|FG003|Week 16 to 52|Lost to Follow-up|1|||
161139374|NCT01309737|581892688|FG004|Week 16 to 52|Lost to Follow-up|4|||
161139375|NCT01309737|581892684|FG000|Week 16 to 52|Withdrawal by Subject|5|||
161139376|NCT01309737|581892685|FG001|Week 16 to 52|Withdrawal by Subject|6|||
161139377|NCT01309737|581892686|FG002|Week 16 to 52|Withdrawal by Subject|0|||
161139378|NCT01309737|581892687|FG003|Week 16 to 52|Withdrawal by Subject|0|||
161139379|NCT01309737|581892688|FG004|Week 16 to 52|Withdrawal by Subject|2|||
161139380|NCT01309737|581892684|FG000|Week 16 to 52|Other|10|||
161139381|NCT01309737|581892685|FG001|Week 16 to 52|Other|12|||
161139382|NCT01309737|581892686|FG002|Week 16 to 52|Other|0|||
161334992|NCT01673178|582615885|FG001|Overall Study|Adverse Event|0|||
161334993|NCT01673178|582615886|FG002|Overall Study|Adverse Event|0|||
160842225|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
160842226|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160842227|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160842228|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
160842229|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
160842230|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
160842231|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
160842232|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
160842233|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
160842234|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
160842235|NCT01620528|580809809|FG000|Post-Treatment Follow-Up Period|Other|6|||
160842236|NCT01620528|580809810|FG001|Post-Treatment Follow-Up Period|Other|4|||
160842237|NCT01620528|580809811|FG002|Post-Treatment Follow-Up Period|Other|2|||
160842238|NCT01457846|580809812|FG000|Overall Study|Death before treatment|1|||
160842239|NCT01457846|580809813|FG001|Overall Study|Death before treatment|2|||
160842240|NCT01457846|580809812|FG000|Overall Study|Did not receive treatment|0|||
160842241|NCT01457846|580809813|FG001|Overall Study|Did not receive treatment|1|||
160842242|NCT01457846|580809812|FG000|Overall Study|Death|27|||
160842243|NCT01457846|580809813|FG001|Overall Study|Death|16|||
160842244|NCT01457846|580809812|FG000|Overall Study|Unclassified reason for not completed|11|||
160842245|NCT01457846|580809813|FG001|Overall Study|Unclassified reason for not completed|10|||
160842246|NCT01457846|580809812|FG000|Overall Study|Withdrawal by Subject|1|||
160842247|NCT01457846|580809813|FG001|Overall Study|Withdrawal by Subject|1|||
160842248|NCT01457846|580809812|FG000|Overall Study|Lost to Follow-up|1|||
160842249|NCT01457846|580809813|FG001|Overall Study|Lost to Follow-up|0|||
160842250|NCT03688620|580809818|FG000|Overall Study|Other|0|||
160842251|NCT03688620|580809819|FG001|Overall Study|Other|0|||
160842252|NCT03688620|580809820|FG002|Overall Study|Other|1|||
160842253|NCT03688620|580809818|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
160842254|NCT03688620|580809819|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
160842255|NCT03688620|580809820|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
160842256|NCT03688620|580809818|FG000|Overall Study|Lost to Follow-up|16|||
160842257|NCT03688620|580809819|FG001|Overall Study|Lost to Follow-up|0|||
160842258|NCT03688620|580809820|FG002|Overall Study|Lost to Follow-up|1|||
160842259|NCT03688620|580809818|FG000|Overall Study|Withdrawal by Subject|0|||
160842260|NCT03688620|580809819|FG001|Overall Study|Withdrawal by Subject|0|||
160842261|NCT03688620|580809820|FG002|Overall Study|Withdrawal by Subject|6|||
160842262|NCT02828020|580809821|FG000|Treatment Period|Adverse Event|3|||
160842263|NCT02828020|580809822|FG001|Treatment Period|Adverse Event|1|||
160842264|NCT02828020|580809823|FG002|Treatment Period|Adverse Event|1|||
160842265|NCT02828020|580809821|FG000|Treatment Period|Withdrawal of Consent|10|||
160842266|NCT02828020|580809822|FG001|Treatment Period|Withdrawal of Consent|14|||
160842267|NCT02828020|580809823|FG002|Treatment Period|Withdrawal of Consent|9|||
160842268|NCT02828020|580809821|FG000|Treatment Period|Lost to Follow-up|21|||
160842269|NCT02828020|580809822|FG001|Treatment Period|Lost to Follow-up|24|||
160842270|NCT02828020|580809823|FG002|Treatment Period|Lost to Follow-up|18|||
160842271|NCT02828020|580809821|FG000|Treatment Period|Lack of Qualifying Event|44|||
160842272|NCT02828020|580809822|FG001|Treatment Period|Lack of Qualifying Event|53|||
160842273|NCT02828020|580809823|FG002|Treatment Period|Lack of Qualifying Event|43|||
160842274|NCT02828020|580809821|FG000|Treatment Period|Pregnancy|0|||
160842275|NCT02828020|580809822|FG001|Treatment Period|Pregnancy|2|||
160842276|NCT02828020|580809823|FG002|Treatment Period|Pregnancy|0|||
160842277|NCT02828020|580809821|FG000|Treatment Period|Protocol Violation|2|||
160842278|NCT02828020|580809822|FG001|Treatment Period|Protocol Violation|4|||
160842279|NCT02828020|580809823|FG002|Treatment Period|Protocol Violation|7|||
160842280|NCT02828020|580809821|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
160842281|NCT02828020|580809822|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
160842282|NCT02828020|580809823|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
160842283|NCT02828020|580809821|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
160842284|NCT02828020|580809822|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
160842285|NCT02828020|580809823|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
160842286|NCT02828020|580809821|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
160842287|NCT02828020|580809822|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
160842288|NCT02828020|580809823|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
160842289|NCT02828020|580809821|FG000|Safety Follow-up Period|Protocol Violation|0|||
160842290|NCT02828020|580809822|FG001|Safety Follow-up Period|Protocol Violation|2|||
160842291|NCT02828020|580809823|FG002|Safety Follow-up Period|Protocol Violation|1|||
160842292|NCT02828020|580809821|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
160842293|NCT02828020|580809822|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
160842294|NCT02828020|580809823|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
160842295|NCT00828750|580809824|FG000|Overall Study|Lack of Efficacy|3|||
160842296|NCT00828750|580809824|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
161251677|NCT01190930|582302360|FG001|Induction|Death|0|||
161251678|NCT01190930|582302361|FG002|Induction|Death|0|||
161251679|NCT01190930|582302362|FG003|Induction|Death|0|||
161251680|NCT01190930|582302363|FG004|Induction|Death|0|||
161251681|NCT01190930|582302364|FG005|Induction|Death|0|||
161251682|NCT01190930|582302365|FG006|Induction|Death|0|||
161251683|NCT01190930|582302366|FG007|Induction|Death|0|||
161251684|NCT01190930|582302367|FG008|Induction|Death|0|||
161251685|NCT01190930|582302368|FG009|Induction|Death|0|||
161251686|NCT01190930|582302359|FG000|Induction|Lost to Follow-up|1|||
161251687|NCT01190930|582302360|FG001|Induction|Lost to Follow-up|0|||
161251688|NCT01190930|582302361|FG002|Induction|Lost to Follow-up|0|||
161251689|NCT01190930|582302362|FG003|Induction|Lost to Follow-up|0|||
161251690|NCT01190930|582302363|FG004|Induction|Lost to Follow-up|0|||
161251691|NCT01190930|582302364|FG005|Induction|Lost to Follow-up|0|||
161251692|NCT01190930|582302365|FG006|Induction|Lost to Follow-up|0|||
161251693|NCT01190930|582302366|FG007|Induction|Lost to Follow-up|0|||
161251694|NCT01190930|582302367|FG008|Induction|Lost to Follow-up|0|||
161251695|NCT01190930|582302368|FG009|Induction|Lost to Follow-up|0|||
161251696|NCT01190930|582302359|FG000|Induction|Physician Decision|125|||
161251697|NCT01190930|582302360|FG001|Induction|Physician Decision|3|||
161251698|NCT01190930|582302361|FG002|Induction|Physician Decision|0|||
161251699|NCT01190930|582302362|FG003|Induction|Physician Decision|0|||
161251700|NCT01190930|582302363|FG004|Induction|Physician Decision|0|||
161251701|NCT01190930|582302364|FG005|Induction|Physician Decision|0|||
161251702|NCT01190930|582302365|FG006|Induction|Physician Decision|0|||
161251703|NCT01190930|582302366|FG007|Induction|Physician Decision|0|||
161251704|NCT01190930|582302367|FG008|Induction|Physician Decision|0|||
161251705|NCT01190930|582302368|FG009|Induction|Physician Decision|0|||
161251706|NCT01190930|582302359|FG000|Induction|Withdrawal by Subject|9|||
160842297|NCT01067469|580809825|FG000|Overall Study|Withdrawal by Subject|0|||
160842298|NCT01067469|580809826|FG001|Overall Study|Withdrawal by Subject|1|||
160842299|NCT01067469|580809825|FG000|Overall Study|Disease Progression|0|||
160842300|NCT01067469|580809826|FG001|Overall Study|Disease Progression|1|||
160842301|NCT04006392|580809827|FG000|Overall Study|Lost to Follow-up|0|||
160842302|NCT04006392|580809828|FG001|Overall Study|Lost to Follow-up|1|||
160842303|NCT04378114|580809829|FG000|Overall Study|Withdrawal by Subject|5|||
160842304|NCT00830180|580809830|FG000|Overall Study|Adverse Event|6|||
160842305|NCT00830180|580809830|FG000|Overall Study|Death|11|||
160842306|NCT00830180|580809830|FG000|Overall Study|Insufficient clinical response|1|||
160842307|NCT00830180|580809830|FG000|Overall Study|Withdrawal by Subject|5|||
160842308|NCT00830180|580809830|FG000|Overall Study|Progressive disease|2|||
160842309|NCT00830180|580809830|FG000|Overall Study|Other - Unspecified|1|||
160842310|NCT01832532|580809832|FG000|Overall Study|Withdrawal by Subject|5|||
160842311|NCT01832532|580809833|FG001|Overall Study|Withdrawal by Subject|2|||
160842312|NCT01736618|580809837|FG000|Overall Study|Death|294|||
160842313|NCT01736618|580809837|FG000|Overall Study|Lost to Follow-up|193|||
160842314|NCT01736618|580809837|FG000|Overall Study|Withdrawal by Subject|54|||
160842315|NCT01736618|580809837|FG000|Overall Study|Subject unable to be followed at study location|223|||
160842316|NCT01736618|580809837|FG000|Overall Study|Physician Decision|33|||
160842317|NCT01736618|580809837|FG000|Overall Study|Transplant or removal of target organ|19|||
160842318|NCT01736618|580809837|FG000|Overall Study|Change in indication or condition|78|||
160842319|NCT01736618|580809837|FG000|Overall Study|Study device explant|103|||
160842320|NCT01736618|580809837|FG000|Overall Study|Unable to complete implant|2|||
160842321|NCT01748825|580809841|FG000|Dose Escalation|Refused further treatment|2|||
160842322|NCT01748825|580809842|FG001|Dose Escalation|Refused further treatment|2|||
160842323|NCT01748825|580809843|FG002|Dose Escalation|Refused further treatment|0|||
160842324|NCT01748825|580809844|FG003|Dose Escalation|Refused further treatment|0|||
160842325|NCT01748825|580809845|FG004|Dose Escalation|Refused further treatment|1|||
160842326|NCT01748825|580809846|FG005|Dose Escalation|Refused further treatment|2|||
160842327|NCT01748825|580809847|FG006|Dose Escalation|Refused further treatment|0|||
160842328|NCT01748825|580809848|FG007|Dose Escalation|Refused further treatment|0|||
160842329|NCT01748825|580809849|FG008|Dose Escalation|Refused further treatment|0|||
160842330|NCT01748825|580809850|FG009|Dose Escalation|Refused further treatment|0|||
160842331|NCT01748825|580809841|FG000|Dose Escalation|Switched to alternative treatment|0|||
160842332|NCT01748825|580809842|FG001|Dose Escalation|Switched to alternative treatment|0|||
160842333|NCT01748825|580809843|FG002|Dose Escalation|Switched to alternative treatment|0|||
160905558|NCT00824720|581048246|FG000|Overall Study|Protocol Violation|0|||
161251707|NCT01190930|582302360|FG001|Induction|Withdrawal by Subject|0|||
161251708|NCT01190930|582302361|FG002|Induction|Withdrawal by Subject|0|||
161251709|NCT01190930|582302362|FG003|Induction|Withdrawal by Subject|0|||
161251710|NCT01190930|582302363|FG004|Induction|Withdrawal by Subject|0|||
161251711|NCT01190930|582302364|FG005|Induction|Withdrawal by Subject|0|||
161251712|NCT01190930|582302365|FG006|Induction|Withdrawal by Subject|0|||
161251713|NCT01190930|582302366|FG007|Induction|Withdrawal by Subject|0|||
161251714|NCT01190930|582302367|FG008|Induction|Withdrawal by Subject|0|||
161251715|NCT01190930|582302368|FG009|Induction|Withdrawal by Subject|0|||
161251716|NCT01190930|582302359|FG000|Induction|Refusal|235|||
161251717|NCT01190930|582302360|FG001|Induction|Refusal|0|||
160842334|NCT01748825|580809844|FG003|Dose Escalation|Switched to alternative treatment|1|||
160842335|NCT01748825|580809845|FG004|Dose Escalation|Switched to alternative treatment|0|||
160842336|NCT01748825|580809846|FG005|Dose Escalation|Switched to alternative treatment|0|||
160842337|NCT01748825|580809847|FG006|Dose Escalation|Switched to alternative treatment|0|||
160842338|NCT01748825|580809848|FG007|Dose Escalation|Switched to alternative treatment|0|||
160842339|NCT01748825|580809849|FG008|Dose Escalation|Switched to alternative treatment|0|||
160842340|NCT01748825|580809850|FG009|Dose Escalation|Switched to alternative treatment|0|||
160842341|NCT01748825|580809841|FG000|Dose Escalation|Adverse Event|0|||
160842342|NCT01748825|580809842|FG001|Dose Escalation|Adverse Event|0|||
160842343|NCT01748825|580809843|FG002|Dose Escalation|Adverse Event|0|||
160842344|NCT01748825|580809844|FG003|Dose Escalation|Adverse Event|0|||
160842345|NCT01748825|580809845|FG004|Dose Escalation|Adverse Event|0|||
160842346|NCT01748825|580809846|FG005|Dose Escalation|Adverse Event|0|||
160842347|NCT01748825|580809847|FG006|Dose Escalation|Adverse Event|1|||
160842348|NCT01748825|580809848|FG007|Dose Escalation|Adverse Event|0|||
160842349|NCT01748825|580809849|FG008|Dose Escalation|Adverse Event|0|||
160842350|NCT01748825|580809850|FG009|Dose Escalation|Adverse Event|0|||
160842351|NCT01748825|580809841|FG000|Dose Expansion|Refused further treatment|0|||
160842352|NCT01748825|580809842|FG001|Dose Expansion|Refused further treatment|0|||
160842353|NCT01748825|580809843|FG002|Dose Expansion|Refused further treatment|0|||
160842354|NCT01748825|580809844|FG003|Dose Expansion|Refused further treatment|0|||
160842355|NCT01748825|580809845|FG004|Dose Expansion|Refused further treatment|0|||
160842356|NCT01748825|580809846|FG005|Dose Expansion|Refused further treatment|0|||
160842357|NCT01748825|580809847|FG006|Dose Expansion|Refused further treatment|0|||
160842358|NCT01748825|580809848|FG007|Dose Expansion|Refused further treatment|0|||
160842359|NCT01748825|580809849|FG008|Dose Expansion|Refused further treatment|1|||
160842360|NCT01748825|580809850|FG009|Dose Expansion|Refused further treatment|1|||
160842361|NCT01748825|580809841|FG000|Dose Expansion|Switched to alternative treatment|0|||
160842362|NCT01748825|580809842|FG001|Dose Expansion|Switched to alternative treatment|0|||
160842363|NCT01748825|580809843|FG002|Dose Expansion|Switched to alternative treatment|0|||
160842364|NCT01748825|580809844|FG003|Dose Expansion|Switched to alternative treatment|0|||
160842365|NCT01748825|580809845|FG004|Dose Expansion|Switched to alternative treatment|0|||
160842366|NCT01748825|580809846|FG005|Dose Expansion|Switched to alternative treatment|0|||
160842367|NCT01748825|580809847|FG006|Dose Expansion|Switched to alternative treatment|0|||
160842368|NCT01748825|580809848|FG007|Dose Expansion|Switched to alternative treatment|0|||
160842369|NCT01748825|580809849|FG008|Dose Expansion|Switched to alternative treatment|0|||
160842370|NCT01748825|580809850|FG009|Dose Expansion|Switched to alternative treatment|1|||
160842371|NCT01748825|580809841|FG000|Dose Expansion|Adverse Event|0|||
160842372|NCT01748825|580809842|FG001|Dose Expansion|Adverse Event|0|||
160842373|NCT01748825|580809843|FG002|Dose Expansion|Adverse Event|0|||
160842374|NCT01748825|580809844|FG003|Dose Expansion|Adverse Event|0|||
160842375|NCT01748825|580809845|FG004|Dose Expansion|Adverse Event|0|||
160842376|NCT01748825|580809846|FG005|Dose Expansion|Adverse Event|0|||
160842377|NCT01748825|580809847|FG006|Dose Expansion|Adverse Event|0|||
160842378|NCT01748825|580809848|FG007|Dose Expansion|Adverse Event|0|||
160842379|NCT01748825|580809849|FG008|Dose Expansion|Adverse Event|0|||
160842380|NCT01748825|580809850|FG009|Dose Expansion|Adverse Event|3|||
160842381|NCT01748825|580809841|FG000|Dose Expansion|Physician Decision|0|||
160842382|NCT01748825|580809842|FG001|Dose Expansion|Physician Decision|0|||
160842383|NCT01748825|580809843|FG002|Dose Expansion|Physician Decision|0|||
160842384|NCT01748825|580809844|FG003|Dose Expansion|Physician Decision|0|||
160842385|NCT01748825|580809845|FG004|Dose Expansion|Physician Decision|0|||
160842386|NCT01748825|580809846|FG005|Dose Expansion|Physician Decision|0|||
160842387|NCT01748825|580809847|FG006|Dose Expansion|Physician Decision|0|||
160842388|NCT01748825|580809848|FG007|Dose Expansion|Physician Decision|0|||
160842389|NCT01748825|580809849|FG008|Dose Expansion|Physician Decision|1|||
160842390|NCT01748825|580809850|FG009|Dose Expansion|Physician Decision|0|||
160842391|NCT01730586|580809854|FG000|Overall Study|Progressive Disease|2|||
160842392|NCT01730586|580809854|FG000|Overall Study|Inadequate Trial|8|||
160842393|NCT01730586|580809854|FG000|Overall Study|Adverse Event|2|||
160842394|NCT01730586|580809854|FG000|Overall Study|Hospice|1|||
160842395|NCT02461745|580809855|FG000|Overall Study|Lack of Efficacy|9|||
160842396|NCT02461745|580809856|FG001|Overall Study|Lack of Efficacy|1|||
161251718|NCT01190930|582302361|FG002|Induction|Refusal|0|||
160842397|NCT02461745|580809855|FG000|Overall Study|Lost to Follow-up|2|||
160842398|NCT02461745|580809856|FG001|Overall Study|Lost to Follow-up|2|||
160842399|NCT02461745|580809855|FG000|Overall Study|Withdrawal by Subject|3|||
160842400|NCT02461745|580809856|FG001|Overall Study|Withdrawal by Subject|1|||
160842401|NCT02921087|580809857|FG000|Overall Study|Withdrawal by Subject|0|||
160842402|NCT02921087|580809858|FG001|Overall Study|Withdrawal by Subject|1|||
160842403|NCT05111249|580811529|FG000|Overall Study|Lost to Follow-up|0|||
160842404|NCT05111249|580811530|FG001|Overall Study|Lost to Follow-up|2|||
160842405|NCT05111249|580811529|FG000|Overall Study|Physician Decision|0|||
160842406|NCT05111249|580811530|FG001|Overall Study|Physician Decision|1|||
160842407|NCT05111249|580811529|FG000|Overall Study|Participant decision|1|||
160842408|NCT05111249|580811530|FG001|Overall Study|Participant decision|5|||
160842409|NCT02610777|580811536|FG000|Overall Study|Lost to Follow-up|1|||
161251719|NCT01190930|582302362|FG003|Induction|Refusal|0|||
160842410|NCT02610777|580811537|FG001|Overall Study|Lost to Follow-up|0|||
160842411|NCT02610777|580811536|FG000|Overall Study|Site Terminated by Sponsor|9|||
160842412|NCT02610777|580811537|FG001|Overall Study|Site Terminated by Sponsor|8|||
160842413|NCT02610777|580811536|FG000|Overall Study|Withdrawal by Subject|2|||
160842414|NCT02610777|580811537|FG001|Overall Study|Withdrawal by Subject|2|||
160842415|NCT02610777|580811536|FG000|Overall Study|Reason not Specified|0|||
160842416|NCT02610777|580811537|FG001|Overall Study|Reason not Specified|1|||
160842417|NCT02610777|580811536|FG000|Overall Study|Death|50|||
160842418|NCT02610777|580811537|FG001|Overall Study|Death|47|||
160842419|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
160842420|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842421|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842422|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842423|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
160842424|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
160842425|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842426|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842427|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842428|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
160842429|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
160842430|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842431|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842432|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842433|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
160842434|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
160842435|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842436|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842437|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842438|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
160842439|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
160842440|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842441|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842442|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842443|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
160842444|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
160842445|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842446|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842447|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842448|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
160842449|NCT01173601|580811540|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
160842450|NCT01173601|580811541|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842451|NCT01173601|580811542|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842452|NCT01173601|580811543|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842453|NCT01173601|580811544|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
160842454|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
160842455|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
160842456|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
160842457|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
160842458|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
160842459|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
160842460|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
160842461|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
161251720|NCT01190930|582302363|FG004|Induction|Refusal|0|||
161251721|NCT01190930|582302364|FG005|Induction|Refusal|0|||
160842462|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
160842463|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
160842464|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
160842465|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
160842466|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
160842467|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
160842468|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
160842469|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
160842470|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
160842471|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161251722|NCT01190930|582302365|FG006|Induction|Refusal|0|||
161251723|NCT01190930|582302366|FG007|Induction|Refusal|0|||
160905559|NCT00824720|581048247|FG001|Overall Study|Protocol Violation|0|||
161251724|NCT01190930|582302367|FG008|Induction|Refusal|0|||
161251725|NCT01190930|582302368|FG009|Induction|Refusal|0|||
161251726|NCT01190930|582302359|FG000|Induction|Inevaluable|23|||
160905560|NCT00824720|581048248|FG002|Overall Study|Protocol Violation|1|||
160905561|NCT01558271|581048251|FG000|Overall Study|Adverse Event|6|||
160842472|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
160842473|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
160842474|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
160842475|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
160905562|NCT01558271|581048252|FG001|Overall Study|Adverse Event|3|||
160905563|NCT01558271|581048253|FG002|Overall Study|Adverse Event|4|||
160905564|NCT01558271|581048251|FG000|Overall Study|Lost to Follow-up|1|||
160905565|NCT01558271|581048252|FG001|Overall Study|Lost to Follow-up|0|||
160905566|NCT01558271|581048253|FG002|Overall Study|Lost to Follow-up|0|||
160905567|NCT01558271|581048251|FG000|Overall Study|Protocol Violation|1|||
160905568|NCT01558271|581048252|FG001|Overall Study|Protocol Violation|0|||
160905569|NCT01558271|581048253|FG002|Overall Study|Protocol Violation|0|||
160905570|NCT01558271|581048251|FG000|Overall Study|Withdrawal by Subject|10|||
160905571|NCT01558271|581048252|FG001|Overall Study|Withdrawal by Subject|6|||
160905572|NCT01558271|581048253|FG002|Overall Study|Withdrawal by Subject|12|||
160905573|NCT01558271|581048251|FG000|Overall Study|Physician Decision|0|||
160905574|NCT01558271|581048252|FG001|Overall Study|Physician Decision|2|||
160905575|NCT01558271|581048253|FG002|Overall Study|Physician Decision|1|||
160905576|NCT02610725|581048254|FG000|Overall Study|Lost to Follow-up|197|||
160905577|NCT02610725|581048254|FG000|Overall Study|self-reported contraindication|9|||
160905578|NCT00743483|581048255|FG000|Baseline Period|Physician Decision|1|||
160905579|NCT00743483|581048255|FG000|Treatment Period|Adverse Event|1|||
160905580|NCT01084083|581048256|FG000|Overall Study|Adverse Event|5|||
160905581|NCT01084083|581048256|FG000|Overall Study|Death|1|||
160842476|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160842477|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
160842478|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
160842479|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
160842480|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
160842481|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
160842482|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
160842483|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
160842484|NCT01173601|580811540|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160842485|NCT01173601|580811541|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160842486|NCT01173601|580811542|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
160842487|NCT01173601|580811543|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
160842488|NCT01173601|580811544|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
160842489|NCT04737278|580811545|FG000|Overall Study|Lost to Follow-up|1|||
160842490|NCT04737278|580811546|FG001|Overall Study|Lost to Follow-up|1|||
160905582|NCT01084083|581048256|FG000|Overall Study|Withdrawal by Subject|2|||
160905583|NCT01084083|581048256|FG000|Overall Study|Complicating disease|1|||
160905584|NCT01084083|581048256|FG000|Overall Study|Other|2|||
160905585|NCT01084083|581048256|FG000|Overall Study|Never started assigned therapy|1|||
160905586|NCT00873912|581048257|FG000|Overall Study|Withdrawal by Subject|1|||
160905587|NCT00873912|581048258|FG001|Overall Study|Withdrawal by Subject|0|||
160905588|NCT00873912|581048257|FG000|Overall Study|Lost to Follow-up|2|||
160905589|NCT00873912|581048258|FG001|Overall Study|Lost to Follow-up|0|||
160905590|NCT01466153|581048261|FG000|Overall Study|Disease Progression|2|||
160905591|NCT01466153|581048262|FG001|Overall Study|Disease Progression|2|||
160905592|NCT01466153|581048263|FG002|Overall Study|Disease Progression|0|||
160905593|NCT01466153|581048261|FG000|Overall Study|Adverse Event|14|||
160905594|NCT01466153|581048262|FG001|Overall Study|Adverse Event|13|||
160905595|NCT01466153|581048263|FG002|Overall Study|Adverse Event|17|||
160905596|NCT01466153|581048261|FG000|Overall Study|Withdrawal of Consent|2|||
160905597|NCT01466153|581048262|FG001|Overall Study|Withdrawal of Consent|0|||
160905598|NCT01466153|581048263|FG002|Overall Study|Withdrawal of Consent|0|||
161251727|NCT01190930|582302360|FG001|Induction|Inevaluable|1|||
161251728|NCT01190930|582302361|FG002|Induction|Inevaluable|0|||
161251729|NCT01190930|582302362|FG003|Induction|Inevaluable|0|||
161251730|NCT01190930|582302363|FG004|Induction|Inevaluable|0|||
161251731|NCT01190930|582302364|FG005|Induction|Inevaluable|0|||
161251732|NCT01190930|582302365|FG006|Induction|Inevaluable|0|||
161251733|NCT01190930|582302366|FG007|Induction|Inevaluable|0|||
161251734|NCT01190930|582302367|FG008|Induction|Inevaluable|0|||
160905599|NCT01466153|581048261|FG000|Overall Study|Investigator Discretion|3|||
160905600|NCT01466153|581048262|FG001|Overall Study|Investigator Discretion|2|||
160905601|NCT01466153|581048263|FG002|Overall Study|Investigator Discretion|2|||
161251735|NCT01190930|582302368|FG009|Induction|Inevaluable|0|||
161251736|NCT01190930|582302359|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
160842491|NCT04737278|580811545|FG000|Overall Study|Withdrawal by Subject|1|||
160842492|NCT04737278|580811546|FG001|Overall Study|Withdrawal by Subject|0|||
160842493|NCT04737278|580811545|FG000|Overall Study|Protocol Violation|1|||
160905602|NCT01466153|581048261|FG000|Overall Study|Randomized-Not Treated|2|||
160842494|NCT04737278|580811546|FG001|Overall Study|Protocol Violation|1|||
160842495|NCT04737278|580811545|FG000|Overall Study|failure to complete questionnaire|1|||
160842496|NCT04737278|580811546|FG001|Overall Study|failure to complete questionnaire|1|||
160842497|NCT02828436|580811555|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
160842498|NCT02828436|580811556|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
160842499|NCT02828436|580811555|FG000|Period 1|Lost to Follow-up|0|||
160842500|NCT02828436|580811556|FG001|Period 1|Lost to Follow-up|1|||
160842501|NCT02828436|580811555|FG000|Period 2|Withdrawal by Subject|4|||
160842502|NCT02828436|580811556|FG001|Period 2|Withdrawal by Subject|0|||
160842503|NCT02828436|580811555|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
160842504|NCT02828436|580811556|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
160842505|NCT02828436|580811555|FG000|Period 2|Lost to Follow-up|1|||
160842506|NCT02828436|580811556|FG001|Period 2|Lost to Follow-up|0|||
160842507|NCT02837029|580811557|FG000|Screening|Failed to meet screening requirements.|7|||
160842508|NCT02837029|580811558|FG001|Screening|Failed to meet screening requirements.|3|||
160842509|NCT02837029|580811559|FG002|Screening|Failed to meet screening requirements.|0|||
160842510|NCT02837029|580811557|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
160842511|NCT02837029|580811558|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
160842512|NCT02837029|580811559|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
160842513|NCT02837029|580811557|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
160842514|NCT02837029|580811558|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
160842515|NCT02837029|580811559|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
160842516|NCT02837029|580811557|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
160842517|NCT02837029|580811558|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
160842518|NCT02837029|580811559|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
160842519|NCT02837029|580811557|FG000|Cycle 2 and Beyond|Adverse Event|1|||
160842520|NCT02837029|580811558|FG001|Cycle 2 and Beyond|Adverse Event|0|||
160842521|NCT02837029|580811559|FG002|Cycle 2 and Beyond|Adverse Event|0|||
160842522|NCT02837029|580811557|FG000|2 Year Follow-up|Death|6|||
160842523|NCT02837029|580811558|FG001|2 Year Follow-up|Death|7|||
160842524|NCT02837029|580811559|FG002|2 Year Follow-up|Death|0|||
160842525|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
160842526|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
160842527|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
160842528|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
160842529|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
160842530|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
160842531|NCT01363908|580811560|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
160842532|NCT01363908|580811561|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
160842533|NCT02644343|580811562|FG000|Overall Study|Withdrawal by Subject|1|||
160842534|NCT05258149|580811563|FG000|Period 1|Protocol Deviation|1|||
160842535|NCT05258149|580811564|FG001|Period 1|Protocol Deviation|0|||
160842536|NCT05258149|580811563|FG000|Period 1|Adverse Event|0|||
160842537|NCT05258149|580811564|FG001|Period 1|Adverse Event|1|||
160842538|NCT05258149|580811563|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
160842539|NCT05258149|580811564|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
160842540|NCT05258149|580811563|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
160842541|NCT05258149|580811564|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
160842542|NCT05258149|580811563|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
160842543|NCT05258149|580811564|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
160842544|NCT00536471|580811567|FG000|Overall Study|Lost to Follow-up|48|||
160842545|NCT00536471|580811568|FG001|Overall Study|Lost to Follow-up|23|||
160842546|NCT00536471|580811569|FG002|Overall Study|Lost to Follow-up|48|||
160842547|NCT00536471|580811570|FG003|Overall Study|Lost to Follow-up|22|||
160842548|NCT00536471|580811567|FG000|Overall Study|Adverse Event|32|||
160842549|NCT00536471|580811568|FG001|Overall Study|Adverse Event|16|||
160842550|NCT00536471|580811569|FG002|Overall Study|Adverse Event|28|||
160842551|NCT00536471|580811570|FG003|Overall Study|Adverse Event|13|||
161251737|NCT01190930|582302360|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161251738|NCT01190930|582302361|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161251739|NCT01190930|582302362|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161251740|NCT01190930|582302363|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160842552|NCT00536471|580811567|FG000|Overall Study|Withdrawal by Subject|40|||
160842553|NCT00536471|580811568|FG001|Overall Study|Withdrawal by Subject|24|||
160842554|NCT00536471|580811569|FG002|Overall Study|Withdrawal by Subject|43|||
160842555|NCT00536471|580811570|FG003|Overall Study|Withdrawal by Subject|21|||
160842556|NCT00536471|580811567|FG000|Overall Study|Lack of Efficacy|17|||
160842557|NCT00536471|580811568|FG001|Overall Study|Lack of Efficacy|18|||
160842558|NCT00536471|580811569|FG002|Overall Study|Lack of Efficacy|11|||
160842559|NCT00536471|580811570|FG003|Overall Study|Lack of Efficacy|9|||
160842560|NCT00536471|580811567|FG000|Overall Study|Protocol Violation|8|||
160842561|NCT00536471|580811568|FG001|Overall Study|Protocol Violation|1|||
160842562|NCT00536471|580811569|FG002|Overall Study|Protocol Violation|2|||
160842563|NCT00536471|580811570|FG003|Overall Study|Protocol Violation|3|||
160842564|NCT00536471|580811567|FG000|Overall Study|Physician Decision|11|||
160842565|NCT00536471|580811568|FG001|Overall Study|Physician Decision|1|||
160842566|NCT00536471|580811569|FG002|Overall Study|Physician Decision|3|||
160842567|NCT00536471|580811570|FG003|Overall Study|Physician Decision|2|||
160842568|NCT00536471|580811567|FG000|Overall Study|Death|0|||
160842569|NCT00536471|580811568|FG001|Overall Study|Death|0|||
160842570|NCT00536471|580811569|FG002|Overall Study|Death|1|||
160842571|NCT00536471|580811570|FG003|Overall Study|Death|2|||
160842572|NCT00536471|580811567|FG000|Overall Study|Sponsor Decision|0|||
160842573|NCT00536471|580811568|FG001|Overall Study|Sponsor Decision|1|||
160842574|NCT00536471|580811569|FG002|Overall Study|Sponsor Decision|3|||
160842575|NCT00536471|580811570|FG003|Overall Study|Sponsor Decision|2|||
160842576|NCT01442714|580811573|FG000|Overall Study|Death|11|||
160842577|NCT01442714|580811573|FG000|Overall Study|Withdrawal by Subject|1|||
160842578|NCT01979952|580811589|FG000|Overall Study|Adverse Event|4|||
160842579|NCT01979952|580811590|FG001|Overall Study|Adverse Event|5|||
160842580|NCT01979952|580811589|FG000|Overall Study|Protocol Violation|1|||
160842581|NCT01979952|580811590|FG001|Overall Study|Protocol Violation|0|||
160842582|NCT01979952|580811589|FG000|Overall Study|Withdrawal by Subject|2|||
160842583|NCT01979952|580811590|FG001|Overall Study|Withdrawal by Subject|1|||
160842584|NCT01979952|580811589|FG000|Overall Study|Other than specified above|1|||
160842585|NCT01979952|580811590|FG001|Overall Study|Other than specified above|0|||
160842586|NCT03781414|580811591|FG000|Overall Study|Study terminated by sponsor|39|||
160842587|NCT03781414|580811592|FG001|Overall Study|Study terminated by sponsor|34|||
160842588|NCT03781414|580811593|FG002|Overall Study|Study terminated by sponsor|25|||
160842589|NCT03781414|580811591|FG000|Overall Study|Adverse Event|3|||
160842590|NCT03781414|580811592|FG001|Overall Study|Adverse Event|6|||
160842591|NCT03781414|580811593|FG002|Overall Study|Adverse Event|3|||
160842592|NCT03781414|580811591|FG000|Overall Study|Physician Decision|2|||
160842593|NCT03781414|580811592|FG001|Overall Study|Physician Decision|0|||
160842594|NCT03781414|580811593|FG002|Overall Study|Physician Decision|1|||
160842595|NCT03781414|580811591|FG000|Overall Study|Withdrawal by Subject|2|||
160842596|NCT03781414|580811592|FG001|Overall Study|Withdrawal by Subject|3|||
160842597|NCT03781414|580811593|FG002|Overall Study|Withdrawal by Subject|3|||
160842598|NCT03781414|580811591|FG000|Overall Study|Death|1|||
160842599|NCT03781414|580811592|FG001|Overall Study|Death|4|||
160842600|NCT03781414|580811593|FG002|Overall Study|Death|0|||
160842601|NCT03781414|580811591|FG000|Overall Study|Lost to Follow-up|1|||
160842602|NCT03781414|580811592|FG001|Overall Study|Lost to Follow-up|1|||
160842603|NCT03781414|580811593|FG002|Overall Study|Lost to Follow-up|0|||
160842604|NCT00203424|580811595|FG000|Treatment Period|Withdrawal by Subject|4|||
160842605|NCT00203424|580811595|FG000|Treatment Period|Adverse Event|5|||
160842606|NCT00203424|580811595|FG000|Treatment Period|progressive disease|2|||
160842607|NCT00203424|580811595|FG000|Follow-up Period|Withdrawal by Subject|1|||
160842608|NCT00203424|580811595|FG000|Follow-up Period|progressive disease|4|||
160842609|NCT00203424|580811595|FG000|Follow-up Period|Lost to Follow-up|1|||
160842610|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
160842611|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842612|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842613|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842614|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842615|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160842616|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
160842617|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842618|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842619|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842620|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842621|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160842622|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
160842623|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160842624|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161251741|NCT01190930|582302364|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160842625|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160842626|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160842627|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
161251742|NCT01190930|582302365|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160842628|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
160842629|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842630|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842631|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
161251743|NCT01190930|582302366|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161251744|NCT01190930|582302367|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
160842632|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842633|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
160842634|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
160842635|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842636|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842637|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842638|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842639|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
160842640|NCT01053988|580811596|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
160842641|NCT01053988|580811597|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842642|NCT01053988|580811598|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842643|NCT01053988|580811599|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842644|NCT01053988|580811600|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842645|NCT01053988|580811601|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160842646|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
160842647|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
160842648|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
160842649|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
160842650|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
160842651|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
160842652|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160842653|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
160842654|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
160842655|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
160842656|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
160842657|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160842658|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
160842659|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
160842660|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
160842661|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
160842662|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
160842663|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
160842664|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160842665|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
160842666|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160842667|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
160842668|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
160842669|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160842670|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
160842671|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
160842672|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
160842673|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
160862040|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
160862041|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862042|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
160862043|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862044|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862045|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
160862046|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862047|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862048|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862049|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862050|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862051|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161139383|NCT01309737|581892687|FG003|Week 16 to 52|Other|2|||
161139384|NCT01309737|581892688|FG004|Week 16 to 52|Other|0|||
161139385|NCT01442181|581892695|FG000|Overall Study|patient refused surgery|1|||
161139386|NCT01442181|581892696|FG001|Overall Study|patient refused surgery|0|||
161139387|NCT01442181|581892695|FG000|Overall Study|no insurance for surgery|1|||
161139388|NCT01442181|581892696|FG001|Overall Study|no insurance for surgery|0|||
161139389|NCT01442181|581892695|FG000|Overall Study|low ejection factor|0|||
161139390|NCT01442181|581892696|FG001|Overall Study|low ejection factor|1|||
161139391|NCT01442181|581892695|FG000|Overall Study|Lost to Follow-up|1|||
161139392|NCT01442181|581892696|FG001|Overall Study|Lost to Follow-up|1|||
161139393|NCT01442181|581892695|FG000|Overall Study|patient in an additional study|1|||
161139394|NCT01442181|581892696|FG001|Overall Study|patient in an additional study|0|||
160842674|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
160842675|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
160842676|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160842677|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
160842678|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160842679|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160842680|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160842681|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
160842682|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
160842683|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
160842684|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
160842685|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
160842686|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
160842687|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
160842688|NCT01053988|580811596|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160842689|NCT01053988|580811597|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
160842690|NCT01053988|580811598|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160842691|NCT01053988|580811599|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
160842692|NCT01053988|580811600|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
160842693|NCT01053988|580811601|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160842694|NCT01922271|580811603|FG000|WASHOUT Period|Withdrawal by Subject|1|||
160842695|NCT01922271|580811604|FG001|WASHOUT Period|Withdrawal by Subject|0|||
160842696|NCT00719355|580811605|FG000|Overall Study|Death|0|||
160842697|NCT00719355|580811606|FG001|Overall Study|Death|1|||
160842698|NCT00719355|580811605|FG000|Overall Study|Medical|14|||
160842699|NCT00719355|580811606|FG001|Overall Study|Medical|5|||
160842700|NCT00719355|580811605|FG000|Overall Study|Compliance|4|||
160842701|NCT00719355|580811606|FG001|Overall Study|Compliance|6|||
160842702|NCT00719355|580811605|FG000|Overall Study|Moved|0|||
160842703|NCT00719355|580811606|FG001|Overall Study|Moved|1|||
160842704|NCT01856582|580811607|FG000|Overall Study|Died prior to Boost infusion|1|||
160842705|NCT01824355|580811608|FG000|Overall Study|Adverse Event|2|||
160842706|NCT01824355|580811608|FG000|Overall Study|unevaluable reference method results per|1|||
160842707|NCT01331109|580811609|FG000|Overall Study|Adverse Event|6|||
160842708|NCT01331109|580811609|FG000|Overall Study|Lack of Efficacy|2|||
160842709|NCT01331109|580811609|FG000|Overall Study|Protocol Violation|3|||
160842710|NCT01331109|580811609|FG000|Overall Study|Withdrawal by Subject|7|||
160842711|NCT01331109|580811609|FG000|Overall Study|Lost to Follow-up|1|||
161139395|NCT01442181|581892695|FG000|Overall Study|atrial fibrillation not noted|0|||
161139396|NCT01442181|581892696|FG001|Overall Study|atrial fibrillation not noted|1|||
160842712|NCT01331109|580811609|FG000|Overall Study|Study Terminated by Sponsor|38|||
160842713|NCT00773747|580811610|FG000|Overall Study|Lack of Efficacy|112|||
160842714|NCT00773747|580811611|FG001|Overall Study|Lack of Efficacy|144|||
160842715|NCT00773747|580811610|FG000|Overall Study|Physician Decision|26|||
160842716|NCT00773747|580811611|FG001|Overall Study|Physician Decision|18|||
160842717|NCT00773747|580811610|FG000|Overall Study|Lost to Follow-up|0|||
160842718|NCT00773747|580811611|FG001|Overall Study|Lost to Follow-up|1|||
160842719|NCT00773747|580811610|FG000|Overall Study|Protocol Violation|2|||
160842720|NCT00773747|580811611|FG001|Overall Study|Protocol Violation|2|||
160842721|NCT00773747|580811610|FG000|Overall Study|Withdrawal by Subject|89|||
160842722|NCT00773747|580811611|FG001|Overall Study|Withdrawal by Subject|61|||
160842723|NCT00773747|580811610|FG000|Overall Study|Adverse Event|61|||
160842724|NCT00773747|580811611|FG001|Overall Study|Adverse Event|62|||
160842725|NCT00773747|580811610|FG000|Overall Study|Death|5|||
160842726|NCT00773747|580811611|FG001|Overall Study|Death|8|||
160842727|NCT00773747|580811610|FG000|Overall Study|Not Treated|2|||
160842728|NCT00773747|580811611|FG001|Overall Study|Not Treated|0|||
160842729|NCT00836186|580811614|FG000|Overall Study|Blood could not be drawn|1|||
160842730|NCT04079816|580811615|FG000|Overall Study|Request of Subject|2|||
160842731|NCT04079816|580811615|FG000|Overall Study|Unable to draw samples|1|||
160842732|NCT01636986|580811616|FG000|Overall Study|Withdrawal by Subject|0|||
160842733|NCT01636986|580811617|FG001|Overall Study|Withdrawal by Subject|1|||
160842734|NCT01636986|580811616|FG000|Overall Study|Corneal Staining|0|||
160842735|NCT01636986|580811617|FG001|Overall Study|Corneal Staining|1|||
160842736|NCT02160145|580811620|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
160842737|NCT02160145|580811621|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
160842738|NCT02160145|580811622|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
160842739|NCT02160145|580811620|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
160842740|NCT02160145|580811621|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
160842741|NCT02160145|580811622|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
160842742|NCT02160145|580811620|FG000|Randomized Double-blind Period|Subject decision|0|||
160842743|NCT02160145|580811621|FG001|Randomized Double-blind Period|Subject decision|21|||
161251745|NCT01190930|582302368|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
161251746|NCT01190930|582302359|FG000|Induction|High Risk Downs|80|||
161251747|NCT01190930|582302360|FG001|Induction|High Risk Downs|0|||
161251748|NCT01190930|582302361|FG002|Induction|High Risk Downs|0|||
161251749|NCT01190930|582302362|FG003|Induction|High Risk Downs|0|||
161251750|NCT01190930|582302363|FG004|Induction|High Risk Downs|0|||
161251751|NCT01190930|582302364|FG005|Induction|High Risk Downs|0|||
160842744|NCT02160145|580811622|FG002|Randomized Double-blind Period|Subject decision|20|||
161251752|NCT01190930|582302365|FG006|Induction|High Risk Downs|0|||
161251753|NCT01190930|582302366|FG007|Induction|High Risk Downs|0|||
160842745|NCT02160145|580811620|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
160842746|NCT02160145|580811621|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
160842747|NCT02160145|580811622|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
160842748|NCT02160145|580811620|FG000|Randomized Double-blind Period|Physician Decision|0|||
160842749|NCT02160145|580811621|FG001|Randomized Double-blind Period|Physician Decision|7|||
160842750|NCT02160145|580811622|FG002|Randomized Double-blind Period|Physician Decision|5|||
160842751|NCT00705146|580811624|FG000|Overall Study|Lost to Follow-up|1|||
160842752|NCT00705146|580811625|FG001|Overall Study|Lost to Follow-up|1|||
160842753|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
160842754|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
160842755|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
160842756|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
160842757|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
160842758|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
160842759|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
160842760|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
160842761|NCT00383162|580811626|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
160842762|NCT00383162|580811627|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
160842763|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
160842764|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
160842765|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
160842766|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
160842767|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
160842768|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
160842769|NCT00383162|580811626|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
160842770|NCT00383162|580811627|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
160842771|NCT05392803|580811630|FG000|Overall Study|Lost to Follow-up|0|||
160842772|NCT05392803|580811631|FG001|Overall Study|Lost to Follow-up|2|||
160842773|NCT00923845|580811635|FG000|Induction Therapy|Poor performance status|0|||
160842774|NCT00923845|580811636|FG001|Induction Therapy|Poor performance status|2|||
160842775|NCT01183065|580811637|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
160842776|NCT02578186|580811639|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
160842777|NCT02578186|580811640|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
160842778|NCT02578186|580811639|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
160842779|NCT02578186|580811640|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
160842780|NCT01894243|580811641|FG000|Overall Study|Adverse Event|0|||
160842781|NCT01894243|580811642|FG001|Overall Study|Adverse Event|1|||
160842782|NCT01894243|580811643|FG002|Overall Study|Adverse Event|2|||
160842783|NCT01894243|580811641|FG000|Overall Study|Death|0|||
160842784|NCT01894243|580811642|FG001|Overall Study|Death|0|||
160842785|NCT01894243|580811643|FG002|Overall Study|Death|3|||
160842786|NCT01894243|580811641|FG000|Overall Study|Lack of Efficacy|3|||
160842787|NCT01894243|580811642|FG001|Overall Study|Lack of Efficacy|3|||
160842788|NCT01894243|580811643|FG002|Overall Study|Lack of Efficacy|1|||
160842789|NCT01894243|580811641|FG000|Overall Study|Condition under investigation worsened|8|||
160842790|NCT01894243|580811642|FG001|Overall Study|Condition under investigation worsened|6|||
161251754|NCT01190930|582302367|FG008|Induction|High Risk Downs|0|||
161334994|NCT01673178|582615887|FG003|Overall Study|Adverse Event|2|||
161334995|NCT01673178|582615888|FG004|Overall Study|Adverse Event|0|||
161334996|NCT01673178|582615884|FG000|Overall Study|Other|1|||
160842791|NCT01894243|580811643|FG002|Overall Study|Condition under investigation worsened|2|||
160842792|NCT01894243|580811641|FG000|Overall Study|Subject decision|1|||
160842793|NCT01894243|580811642|FG001|Overall Study|Subject decision|0|||
160842794|NCT01894243|580811643|FG002|Overall Study|Subject decision|0|||
160842795|NCT01894243|580811641|FG000|Overall Study|Other|1|||
160842796|NCT01894243|580811642|FG001|Overall Study|Other|0|||
160842797|NCT01894243|580811643|FG002|Overall Study|Other|0|||
160842798|NCT01620944|580811646|FG000|Overall Study|Early termination of Study|2|||
160842799|NCT01620944|580811647|FG001|Overall Study|Early termination of Study|1|||
160842800|NCT00392990|580811648|FG000|Treatment on Study|Adverse Event|3|||
160842801|NCT00392990|580811649|FG001|Treatment on Study|Adverse Event|1|||
161251755|NCT01190930|582302368|FG009|Induction|High Risk Downs|0|||
161251756|NCT01190930|582302359|FG000|Induction|Enrollment onto another COG Protocol|1|||
161334997|NCT01673178|582615885|FG001|Overall Study|Other|0|||
161334998|NCT01673178|582615886|FG002|Overall Study|Other|2|||
160842802|NCT00392990|580811648|FG000|Follow up for 2 Years|Death|4|||
160842803|NCT00392990|580811649|FG001|Follow up for 2 Years|Death|0|||
160842804|NCT00825812|580811650|FG000|Overall Study|Never entered follow up|0|||
160842805|NCT00825812|580811651|FG001|Overall Study|Never entered follow up|0|||
160842806|NCT00825812|580811652|FG002|Overall Study|Never entered follow up|0|||
160842807|NCT00825812|580811653|FG003|Overall Study|Never entered follow up|1|||
161251757|NCT01190930|582302360|FG001|Induction|Enrollment onto another COG Protocol|0|||
161251758|NCT01190930|582302361|FG002|Induction|Enrollment onto another COG Protocol|0|||
161251759|NCT01190930|582302362|FG003|Induction|Enrollment onto another COG Protocol|0|||
161251760|NCT01190930|582302363|FG004|Induction|Enrollment onto another COG Protocol|0|||
161251761|NCT01190930|582302364|FG005|Induction|Enrollment onto another COG Protocol|0|||
161251762|NCT01190930|582302365|FG006|Induction|Enrollment onto another COG Protocol|0|||
161251763|NCT01190930|582302366|FG007|Induction|Enrollment onto another COG Protocol|0|||
161251764|NCT01190930|582302367|FG008|Induction|Enrollment onto another COG Protocol|0|||
161251765|NCT01190930|582302368|FG009|Induction|Enrollment onto another COG Protocol|0|||
161251766|NCT01190930|582302359|FG000|Induction|Average Risk|1847|||
161251767|NCT01190930|582302360|FG001|Induction|Average Risk|0|||
161251768|NCT01190930|582302361|FG002|Induction|Average Risk|0|||
161251769|NCT01190930|582302362|FG003|Induction|Average Risk|0|||
161334999|NCT01673178|582615887|FG003|Overall Study|Other|1|||
160842808|NCT00825812|580811650|FG000|Overall Study|Adverse Event|0|||
160842809|NCT00825812|580811651|FG001|Overall Study|Adverse Event|0|||
160842810|NCT00825812|580811652|FG002|Overall Study|Adverse Event|0|||
160842811|NCT00825812|580811653|FG003|Overall Study|Adverse Event|1|||
160842812|NCT00825812|580811650|FG000|Overall Study|Subject withdrew consent|0|||
160842813|NCT00825812|580811651|FG001|Overall Study|Subject withdrew consent|0|||
160842814|NCT00825812|580811652|FG002|Overall Study|Subject withdrew consent|3|||
160842815|NCT00825812|580811653|FG003|Overall Study|Subject withdrew consent|2|||
160842816|NCT00825812|580811650|FG000|Overall Study|Non-compliance with protocol|0|||
160842817|NCT00825812|580811651|FG001|Overall Study|Non-compliance with protocol|0|||
160842818|NCT00825812|580811652|FG002|Overall Study|Non-compliance with protocol|0|||
160842819|NCT00825812|580811653|FG003|Overall Study|Non-compliance with protocol|1|||
161251770|NCT01190930|582302363|FG004|Induction|Average Risk|0|||
161251771|NCT01190930|582302364|FG005|Induction|Average Risk|0|||
161335000|NCT01673178|582615888|FG004|Overall Study|Other|0|||
160842820|NCT00825812|580811650|FG000|Overall Study|Administrative|0|||
160842821|NCT00825812|580811651|FG001|Overall Study|Administrative|1|||
160842822|NCT00825812|580811652|FG002|Overall Study|Administrative|3|||
160842823|NCT00825812|580811653|FG003|Overall Study|Administrative|5|||
160842824|NCT00991406|580811655|FG000|Overall Study|One participant did not respond to FES.|1|||
160842825|NCT00986362|580811656|FG000|Overall Study|Death|2|||
160842826|NCT00986362|580811657|FG001|Overall Study|Death|0|||
160842827|NCT00986362|580811656|FG000|Overall Study|Lost to Follow-up|0|||
160842828|NCT00986362|580811657|FG001|Overall Study|Lost to Follow-up|1|||
160842829|NCT03597061|580811658|FG000|Overall Study|Lost to Follow-up|1|||
160842830|NCT03597061|580811659|FG001|Overall Study|Lost to Follow-up|0|||
160842831|NCT03597061|580811658|FG000|Overall Study|Protocol Violation|0|||
160842832|NCT03597061|580811659|FG001|Overall Study|Protocol Violation|1|||
160842833|NCT03755661|580811664|FG000|Overall Study|Lost to Follow-up|1|||
160842834|NCT03755661|580811665|FG001|Overall Study|Lost to Follow-up|0|||
160842835|NCT02038075|580811666|FG000|Overall Study|Withdrawal by Subject|3|||
160842836|NCT02038075|580811667|FG001|Overall Study|Withdrawal by Subject|0|||
160842837|NCT04000581|580811668|FG000|Overall Study|Withdrawal by Subject|0|||
160842838|NCT04000581|580811669|FG001|Overall Study|Withdrawal by Subject|1|||
160842839|NCT00895453|580811673|FG000|Overall Study|Lost to Follow-up|25|||
160842840|NCT00895453|580811674|FG001|Overall Study|Lost to Follow-up|25|||
160842841|NCT00895453|580811675|FG002|Overall Study|Lost to Follow-up|23|||
160842842|NCT02519595|580811676|FG000|Overall Study|Protocol Violation|8|||
160842843|NCT02519595|580811677|FG001|Overall Study|Protocol Violation|22|||
160842844|NCT02519595|580811678|FG002|Overall Study|Protocol Violation|16|||
160842845|NCT03188510|580811681|FG000|Overall Study|Inappropriate behavior with site staff|0|||
160842846|NCT03188510|580811682|FG001|Overall Study|Inappropriate behavior with site staff|1|||
160842847|NCT03188510|580811683|FG002|Overall Study|Inappropriate behavior with site staff|0|||
160842848|NCT04167137|580811686|FG000|Overall Study|Disease progression|1|||
160842849|NCT04167137|580811687|FG001|Overall Study|Disease progression|1|||
160842850|NCT04167137|580811688|FG002|Overall Study|Disease progression|3|||
160842851|NCT04167137|580811689|FG003|Overall Study|Disease progression|3|||
160842852|NCT04167137|580811690|FG004|Overall Study|Disease progression|2|||
160842853|NCT04167137|580811691|FG005|Overall Study|Disease progression|3|||
160842854|NCT04167137|580811692|FG006|Overall Study|Disease progression|2|||
160842855|NCT04167137|580811693|FG007|Overall Study|Disease progression|2|||
160842856|NCT04167137|580811686|FG000|Overall Study|Withdrawal by Subject|1|||
160842857|NCT04167137|580811687|FG001|Overall Study|Withdrawal by Subject|0|||
160842858|NCT04167137|580811688|FG002|Overall Study|Withdrawal by Subject|0|||
160842859|NCT04167137|580811689|FG003|Overall Study|Withdrawal by Subject|1|||
160842860|NCT04167137|580811690|FG004|Overall Study|Withdrawal by Subject|0|||
161251772|NCT01190930|582302365|FG006|Induction|Average Risk|0|||
161251773|NCT01190930|582302366|FG007|Induction|Average Risk|0|||
160842861|NCT04167137|580811691|FG005|Overall Study|Withdrawal by Subject|2|||
160842862|NCT04167137|580811692|FG006|Overall Study|Withdrawal by Subject|1|||
160842863|NCT04167137|580811693|FG007|Overall Study|Withdrawal by Subject|0|||
160842864|NCT04167137|580811686|FG000|Overall Study|Adverse Event|0|||
160842865|NCT04167137|580811687|FG001|Overall Study|Adverse Event|0|||
160842866|NCT04167137|580811688|FG002|Overall Study|Adverse Event|0|||
160842867|NCT04167137|580811689|FG003|Overall Study|Adverse Event|0|||
160842868|NCT04167137|580811690|FG004|Overall Study|Adverse Event|0|||
160842869|NCT04167137|580811691|FG005|Overall Study|Adverse Event|1|||
160842870|NCT04167137|580811692|FG006|Overall Study|Adverse Event|0|||
160842871|NCT04167137|580811693|FG007|Overall Study|Adverse Event|1|||
160842872|NCT04167137|580811686|FG000|Overall Study|Physician Decision|0|||
160842873|NCT04167137|580811687|FG001|Overall Study|Physician Decision|0|||
160842874|NCT04167137|580811688|FG002|Overall Study|Physician Decision|0|||
160842875|NCT04167137|580811689|FG003|Overall Study|Physician Decision|1|||
160842876|NCT04167137|580811690|FG004|Overall Study|Physician Decision|0|||
160842877|NCT04167137|580811691|FG005|Overall Study|Physician Decision|0|||
160842878|NCT04167137|580811692|FG006|Overall Study|Physician Decision|1|||
160842879|NCT04167137|580811693|FG007|Overall Study|Physician Decision|0|||
160842880|NCT04167137|580811686|FG000|Overall Study|Death|0|||
160842881|NCT04167137|580811687|FG001|Overall Study|Death|1|||
160842882|NCT04167137|580811688|FG002|Overall Study|Death|0|||
160842883|NCT04167137|580811689|FG003|Overall Study|Death|0|||
160842884|NCT04167137|580811690|FG004|Overall Study|Death|0|||
160842885|NCT04167137|580811691|FG005|Overall Study|Death|0|||
160842886|NCT04167137|580811692|FG006|Overall Study|Death|0|||
160842887|NCT04167137|580811693|FG007|Overall Study|Death|0|||
160842888|NCT04167137|580811686|FG000|Overall Study|Study terminated by Sponsor|0|||
160842889|NCT04167137|580811687|FG001|Overall Study|Study terminated by Sponsor|0|||
160842890|NCT04167137|580811688|FG002|Overall Study|Study terminated by Sponsor|0|||
160905603|NCT01466153|581048262|FG001|Overall Study|Randomized-Not Treated|3|||
160905604|NCT01466153|581048263|FG002|Overall Study|Randomized-Not Treated|4|||
160905605|NCT01466153|581048261|FG000|Overall Study|Other-Unspecified|6|||
160905606|NCT01466153|581048262|FG001|Overall Study|Other-Unspecified|4|||
160905607|NCT01466153|581048263|FG002|Overall Study|Other-Unspecified|2|||
160905608|NCT01088997|581048266|FG000|Overall Study|Physician Decision|1|||
160905609|NCT01088997|581048267|FG001|Overall Study|Physician Decision|1|||
161251774|NCT01190930|582302367|FG008|Induction|Average Risk|0|||
160905610|NCT01088997|581048266|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
160905611|NCT01088997|581048267|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
160905612|NCT01088997|581048266|FG000|Overall Study|Excluded prior to receiving drug|1|||
160905613|NCT01088997|581048267|FG001|Overall Study|Excluded prior to receiving drug|1|||
160905614|NCT05570500|581048272|FG000|Overall Study|Lost to Follow-up|7|||
160905615|NCT05570500|581048273|FG001|Overall Study|Lost to Follow-up|5|||
160905616|NCT01095731|581048274|FG000|Overall Study|Protocol Violation|1|||
160905617|NCT01095731|581048275|FG001|Overall Study|Protocol Violation|1|||
160905618|NCT01095731|581048274|FG000|Overall Study|Withdrawal by Subject|0|||
160905619|NCT01095731|581048275|FG001|Overall Study|Withdrawal by Subject|1|||
160905620|NCT02302807|581048278|FG000|Overall Study|Withdrawal by Subject|28|||
160905621|NCT02302807|581048279|FG001|Overall Study|Withdrawal by Subject|11|||
160905622|NCT02302807|581048278|FG000|Overall Study|Lost to Follow-up|4|||
160905623|NCT02302807|581048279|FG001|Overall Study|Lost to Follow-up|6|||
160905624|NCT02302807|581048278|FG000|Overall Study|Death|397|||
160905625|NCT02302807|581048279|FG001|Overall Study|Death|385|||
160905626|NCT02302807|581048278|FG000|Overall Study|Study Terminated By Sponsor|35|||
160905627|NCT02302807|581048279|FG001|Overall Study|Study Terminated By Sponsor|64|||
160905628|NCT02302807|581048278|FG000|Overall Study|Physician Decision|0|||
160905629|NCT02302807|581048279|FG001|Overall Study|Physician Decision|1|||
161251775|NCT01190930|582302368|FG009|Induction|Average Risk|0|||
160842891|NCT04167137|580811689|FG003|Overall Study|Study terminated by Sponsor|0|||
160842892|NCT04167137|580811690|FG004|Overall Study|Study terminated by Sponsor|0|||
160842893|NCT04167137|580811691|FG005|Overall Study|Study terminated by Sponsor|0|||
160842894|NCT04167137|580811692|FG006|Overall Study|Study terminated by Sponsor|0|||
160842895|NCT04167137|580811693|FG007|Overall Study|Study terminated by Sponsor|1|||
160842896|NCT00211887|580811694|FG000|Overall Study|Adverse Event|8|||
160842897|NCT00211887|580811695|FG001|Overall Study|Adverse Event|4|||
160842898|NCT00211887|580811696|FG002|Overall Study|Adverse Event|6|||
160842899|NCT00211887|580811694|FG000|Overall Study|Death|1|||
160842900|NCT00211887|580811695|FG001|Overall Study|Death|1|||
160905630|NCT01980940|581048281|FG000|Overall Study|Protocol Violation|0|||
160905631|NCT01980940|581048282|FG001|Overall Study|Protocol Violation|0|||
160905632|NCT01980940|581048283|FG002|Overall Study|Protocol Violation|0|||
160905633|NCT01980940|581048284|FG003|Overall Study|Protocol Violation|0|||
160992152|NCT00477412|581359991|FG002|Overall Study|Withdrawal by Subject|0|||
160842901|NCT00211887|580811696|FG002|Overall Study|Death|1|||
160842902|NCT00211887|580811694|FG000|Overall Study|Lost to Follow-up|28|||
160842903|NCT00211887|580811695|FG001|Overall Study|Lost to Follow-up|13|||
160842904|NCT00211887|580811696|FG002|Overall Study|Lost to Follow-up|9|||
160842905|NCT00211887|580811694|FG000|Overall Study|Non-medical reason|31|||
160905634|NCT01980940|581048285|FG004|Overall Study|Protocol Violation|0|||
160842906|NCT00211887|580811695|FG001|Overall Study|Non-medical reason|14|||
160842907|NCT00211887|580811696|FG002|Overall Study|Non-medical reason|8|||
160842908|NCT00211887|580811694|FG000|Overall Study|Other medical reason|15|||
160842909|NCT00211887|580811695|FG001|Overall Study|Other medical reason|11|||
160842910|NCT00211887|580811696|FG002|Overall Study|Other medical reason|7|||
160842911|NCT00211887|580811694|FG000|Overall Study|Side effects|19|||
160842912|NCT00211887|580811695|FG001|Overall Study|Side effects|13|||
160842913|NCT00211887|580811696|FG002|Overall Study|Side effects|5|||
160842914|NCT03058692|580813214|FG000|Overall Study|Lost to Follow-up|2|||
160842915|NCT03058692|580813215|FG001|Overall Study|Lost to Follow-up|1|||
160842916|NCT03058692|580813214|FG000|Overall Study|Withdrawal by Subject|1|||
160842917|NCT03058692|580813215|FG001|Overall Study|Withdrawal by Subject|1|||
160842918|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
160842919|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
160842920|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
160842921|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
160842922|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
160842923|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
160842924|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
160842925|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
160842926|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
160842927|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
160842928|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
160842929|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
160842930|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
160842931|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
160842932|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
160842933|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
160842934|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
160842935|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
160842936|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
160842937|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
160842938|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
160842939|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
160842940|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
160842941|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
160842942|NCT03777059|580813216|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
160842943|NCT03777059|580813217|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
160842944|NCT03777059|580813218|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
160842945|NCT03777059|580813219|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
160842946|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
160842947|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
160842948|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
160842949|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
160842950|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
160842951|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
160842952|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
160842953|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
160842954|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
160842955|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
160842956|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
160842957|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
160842958|NCT03777059|580813216|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
160842959|NCT03777059|580813217|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
160842960|NCT03777059|580813218|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
160842961|NCT03777059|580813219|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
161251776|NCT01190930|582302359|FG000|Induction|High Risk|1227|||
161251777|NCT01190930|582302360|FG001|Induction|High Risk|0|||
161251778|NCT01190930|582302361|FG002|Induction|High Risk|0|||
161251779|NCT01190930|582302362|FG003|Induction|High Risk|0|||
161251780|NCT01190930|582302363|FG004|Induction|High Risk|0|||
161251781|NCT01190930|582302364|FG005|Induction|High Risk|0|||
161251782|NCT01190930|582302365|FG006|Induction|High Risk|0|||
161251783|NCT01190930|582302366|FG007|Induction|High Risk|0|||
160842962|NCT01702025|580813222|FG000|Overall Study|Equipment failure|1|||
160842963|NCT01702025|580813223|FG001|Overall Study|Equipment failure|0|||
160842964|NCT01702025|580813224|FG002|Overall Study|Equipment failure|0|||
160842965|NCT01702025|580813225|FG003|Overall Study|Equipment failure|0|||
160842966|NCT01702025|580813222|FG000|Overall Study|Adverse Event|1|||
161251784|NCT01190930|582302367|FG008|Induction|High Risk|0|||
161251785|NCT01190930|582302368|FG009|Induction|High Risk|0|||
161251786|NCT01190930|582302359|FG000|Induction|Low Risk|443|||
160842967|NCT01702025|580813223|FG001|Overall Study|Adverse Event|1|||
160842968|NCT01702025|580813224|FG002|Overall Study|Adverse Event|1|||
160842969|NCT01702025|580813225|FG003|Overall Study|Adverse Event|0|||
160842970|NCT02679755|580813226|FG000|Overall Study|Death|0|||
160842971|NCT02679755|580813227|FG001|Overall Study|Death|3|||
160842972|NCT02679755|580813226|FG000|Overall Study|Global deterioration of health status|1|||
160842973|NCT02679755|580813227|FG001|Overall Study|Global deterioration of health status|8|||
160842974|NCT02679755|580813226|FG000|Overall Study|Lost to Follow-up|1|||
160842975|NCT02679755|580813227|FG001|Overall Study|Lost to Follow-up|0|||
160842976|NCT02679755|580813226|FG000|Overall Study|Objective progression or relapse|24|||
160842977|NCT02679755|580813227|FG001|Overall Study|Objective progression or relapse|83|||
160842978|NCT02679755|580813226|FG000|Overall Study|Not defined|0|||
160842979|NCT02679755|580813227|FG001|Overall Study|Not defined|2|||
160842980|NCT02679755|580813226|FG000|Overall Study|Withdrawal by participant|6|||
160842981|NCT02679755|580813227|FG001|Overall Study|Withdrawal by participant|3|||
160842982|NCT02679755|580813226|FG000|Overall Study|Adverse Event|1|||
160842983|NCT02679755|580813227|FG001|Overall Study|Adverse Event|4|||
160842984|NCT02679755|580813226|FG000|Overall Study|Adverse events not related to study drug|1|||
160842985|NCT02679755|580813227|FG001|Overall Study|Adverse events not related to study drug|2|||
160842986|NCT01061359|580813228|FG000|Overall Study|Death|32|||
160842987|NCT01061359|580813228|FG000|Overall Study|Lost to Follow-up|1072|||
160842988|NCT01061359|580813228|FG000|Overall Study|Relapse|187|||
160842989|NCT01061359|580813228|FG000|Overall Study|Secondary neoplasm|11|||
160842990|NCT03038126|580813230|FG000|Overall Study|Death|1|||
160842991|NCT03038126|580813231|FG001|Overall Study|Death|1|||
160842992|NCT03038126|580813230|FG000|Overall Study|Withdrawal by Subject|5|||
160842993|NCT03038126|580813231|FG001|Overall Study|Withdrawal by Subject|0|||
160842994|NCT03038126|580813230|FG000|Overall Study|Lost to Follow-up|0|||
160842995|NCT03038126|580813231|FG001|Overall Study|Lost to Follow-up|1|||
160842996|NCT03038126|580813230|FG000|Overall Study|Long Term Hospitalization|2|||
160842997|NCT03038126|580813231|FG001|Overall Study|Long Term Hospitalization|0|||
160842998|NCT03038126|580813230|FG000|Overall Study|Too Ill to Participate|1|||
160842999|NCT03038126|580813231|FG001|Overall Study|Too Ill to Participate|2|||
160843000|NCT01724866|580813232|FG000|Overall Study|Adverse Event|0|||
160843001|NCT01724866|580813233|FG001|Overall Study|Adverse Event|0|||
160843002|NCT01724866|580813234|FG002|Overall Study|Adverse Event|1|||
160843003|NCT01724866|580813235|FG003|Overall Study|Adverse Event|1|||
160843004|NCT01724866|580813232|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
160843005|NCT01724866|580813233|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
160843006|NCT01724866|580813234|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
160843007|NCT01724866|580813235|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
160843008|NCT01724866|580813232|FG000|Overall Study|Investigator's Discretion|0|||
160843009|NCT01724866|580813233|FG001|Overall Study|Investigator's Discretion|1|||
160843010|NCT01724866|580813234|FG002|Overall Study|Investigator's Discretion|1|||
160843011|NCT01724866|580813235|FG003|Overall Study|Investigator's Discretion|0|||
160843012|NCT01724866|580813232|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
160843013|NCT01724866|580813233|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
160843014|NCT01724866|580813234|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
160843015|NCT01724866|580813235|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
160843016|NCT01724866|580813232|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
160843017|NCT01724866|580813233|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
160843018|NCT01724866|580813234|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
160843019|NCT01724866|580813235|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
160843020|NCT00411671|580813238|FG000|Overall Study|Adverse Event|15|||
160843021|NCT00411671|580813238|FG000|Overall Study|Death|2|||
160843022|NCT00411671|580813238|FG000|Overall Study|Lost to Follow-up|3|||
160843023|NCT00546000|580813243|FG000|Overall Study|Adverse Event|1|||
160843024|NCT00546000|580813243|FG000|Overall Study|Lost to Follow-up|1|||
160843025|NCT00546000|580813243|FG000|Overall Study|Baseline HPA Axis Supression|2|||
160843026|NCT03688074|580813248|FG000|Overall Study|Adverse Event|0|||
160905635|NCT01980940|581048286|FG005|Overall Study|Protocol Violation|2|||
160905636|NCT01980940|581048287|FG006|Overall Study|Protocol Violation|0|||
160905637|NCT01980940|581048288|FG007|Overall Study|Protocol Violation|0|||
160905638|NCT03192462|581050254|FG000|Overall Study|Death|13|||
160843027|NCT03688074|580813249|FG001|Overall Study|Adverse Event|1|||
160843028|NCT03688074|580813248|FG000|Overall Study|Other|1|||
160843029|NCT03688074|580813249|FG001|Overall Study|Other|0|||
160843030|NCT01362608|580813250|FG000|Overall Study|Protocol Violation|0|||
160905639|NCT03192462|581050255|FG001|Overall Study|Death|11|||
160843031|NCT01362608|580813251|FG001|Overall Study|Protocol Violation|1|||
160905640|NCT03192462|581050256|FG002|Overall Study|Death|10|||
160843032|NCT01362608|580813250|FG000|Overall Study|Lost to Follow-up|3|||
160905641|NCT03192462|581050254|FG000|Overall Study|Lost to Follow-up|0|||
160905642|NCT03192462|581050255|FG001|Overall Study|Lost to Follow-up|1|||
160905643|NCT03192462|581050256|FG002|Overall Study|Lost to Follow-up|0|||
160905644|NCT04840615|581050257|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
160905645|NCT04840615|581050258|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
160905646|NCT04840615|581050259|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
160905647|NCT00982137|581050262|FG000|Overall Study|Lost to Follow-up|0|||
160905648|NCT00982137|581050263|FG001|Overall Study|Lost to Follow-up|0|||
160905649|NCT00982137|581050264|FG002|Overall Study|Lost to Follow-up|0|||
160905650|NCT00982137|581050265|FG003|Overall Study|Lost to Follow-up|1|||
160843033|NCT01362608|580813251|FG001|Overall Study|Lost to Follow-up|1|||
160905651|NCT00982137|581050262|FG000|Overall Study|Withdrawal by Subject|0|||
160905652|NCT00982137|581050263|FG001|Overall Study|Withdrawal by Subject|1|||
160905653|NCT00982137|581050264|FG002|Overall Study|Withdrawal by Subject|0|||
160905654|NCT00982137|581050265|FG003|Overall Study|Withdrawal by Subject|0|||
160905655|NCT00126191|581050266|FG000|Overall Study|Physician Decision|0|||
160905656|NCT00126191|581050267|FG001|Overall Study|Physician Decision|1|||
160905657|NCT00126191|581050266|FG000|Overall Study|Death|0|||
160905658|NCT00126191|581050267|FG001|Overall Study|Death|1|||
160905659|NCT02469298|581050269|FG000|Overall Study|Protocol Violation|0|||
160905660|NCT02469298|581050270|FG001|Overall Study|Protocol Violation|1|||
160905661|NCT02469298|581050271|FG002|Overall Study|Protocol Violation|1|||
160905662|NCT02469298|581050272|FG003|Overall Study|Protocol Violation|0|||
160905663|NCT02469298|581050269|FG000|Overall Study|Lost to Follow-up|1|||
160905664|NCT02469298|581050270|FG001|Overall Study|Lost to Follow-up|0|||
160905665|NCT02469298|581050271|FG002|Overall Study|Lost to Follow-up|1|||
160843034|NCT01362608|580813250|FG000|Overall Study|Withdrawal by Subject|1|||
160843035|NCT01362608|580813251|FG001|Overall Study|Withdrawal by Subject|2|||
160843036|NCT01362608|580813250|FG000|Overall Study|Lack of Efficacy|0|||
160843037|NCT01362608|580813251|FG001|Overall Study|Lack of Efficacy|2|||
160843038|NCT01362608|580813250|FG000|Overall Study|Adverse Event|0|||
160843039|NCT01362608|580813251|FG001|Overall Study|Adverse Event|2|||
160843040|NCT03056339|580813254|FG000|Overall Study|Failed Requirements|0|||
160843041|NCT03056339|580813255|FG001|Overall Study|Failed Requirements|2|||
160843042|NCT03056339|580813256|FG002|Overall Study|Failed Requirements|7|||
160905666|NCT02469298|581050272|FG003|Overall Study|Lost to Follow-up|0|||
160905667|NCT02469298|581050269|FG000|Overall Study|Physician Decision|0|||
160905668|NCT02469298|581050270|FG001|Overall Study|Physician Decision|0|||
160905669|NCT02469298|581050271|FG002|Overall Study|Physician Decision|0|||
160905670|NCT02469298|581050272|FG003|Overall Study|Physician Decision|1|||
160905671|NCT02469298|581050269|FG000|Overall Study|Withdrawal by Subject|0|||
160905672|NCT02469298|581050270|FG001|Overall Study|Withdrawal by Subject|0|||
160905673|NCT02469298|581050271|FG002|Overall Study|Withdrawal by Subject|0|||
160905674|NCT02469298|581050272|FG003|Overall Study|Withdrawal by Subject|1|||
160905675|NCT01433991|581050281|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
160905676|NCT01433991|581050282|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
160905677|NCT01433991|581050283|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
160905678|NCT01433991|581050284|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
160905679|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
160905680|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
160905681|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
160905682|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
160905683|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
160905684|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
160905685|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
160905686|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
160905687|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
160905688|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
160905689|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
160905690|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
160905691|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
160905692|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
160905693|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
160905694|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
160905695|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
160843043|NCT03056339|580813257|FG003|Overall Study|Failed Requirements|1|||
160843044|NCT04171219|580813260|FG000|Overall Study|Adverse Event|1|||
160843045|NCT04171219|580813261|FG001|Overall Study|Adverse Event|0|||
160905696|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
160905697|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
160905698|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
160843046|NCT04171219|580813260|FG000|Overall Study|Death|0|||
160843047|NCT04171219|580813261|FG001|Overall Study|Death|1|||
160843048|NCT04171219|580813260|FG000|Overall Study|Lack of Efficacy|9|||
160843049|NCT04171219|580813261|FG001|Overall Study|Lack of Efficacy|13|||
160843050|NCT04171219|580813260|FG000|Overall Study|Withdrawal by Subject|1|||
160843051|NCT04171219|580813261|FG001|Overall Study|Withdrawal by Subject|2|||
160843052|NCT04171219|580813260|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
160843053|NCT04171219|580813261|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
160843054|NCT04171219|580813260|FG000|Overall Study|Clinical PD/Patient choice|1|||
160843055|NCT04171219|580813261|FG001|Overall Study|Clinical PD/Patient choice|0|||
160843056|NCT04171219|580813260|FG000|Overall Study|Toxicity/ Patient choice|1|||
160843057|NCT04171219|580813261|FG001|Overall Study|Toxicity/ Patient choice|0|||
160843058|NCT04809285|580813262|FG000|Phase 1|Lost to Follow-up|6|||
160843059|NCT04809285|580813262|FG000|Phase 1|Protocol Violation|2|||
160843060|NCT04809285|580813262|FG000|Phase 1|Physician Decision|3|||
160843061|NCT04809285|580813262|FG000|Phase 1|Withdrawal by Subject|29|||
160843062|NCT04809285|580813262|FG000|Phase 2|Protocol Violation|3|||
160843063|NCT04809285|580813262|FG000|Phase 2|Withdrawal by Subject|4|||
160843064|NCT03350815|580813264|FG000|Period 1|Adverse Event|10|||
160843065|NCT03350815|580813265|FG001|Period 1|Adverse Event|0|||
160843066|NCT03350815|580813266|FG002|Period 1|Adverse Event|0|||
160843067|NCT03350815|580813267|FG003|Period 1|Adverse Event|0|||
160843068|NCT03350815|580813264|FG000|Period 1|Technical problems|1|||
160843069|NCT03350815|580813265|FG001|Period 1|Technical problems|0|||
160843070|NCT03350815|580813266|FG002|Period 1|Technical problems|0|||
160843071|NCT03350815|580813267|FG003|Period 1|Technical problems|0|||
160843072|NCT03350815|580813264|FG000|Period 1|Lost to Follow-up|3|||
160843073|NCT03350815|580813265|FG001|Period 1|Lost to Follow-up|0|||
160843074|NCT03350815|580813266|FG002|Period 1|Lost to Follow-up|0|||
160843075|NCT03350815|580813267|FG003|Period 1|Lost to Follow-up|0|||
160843076|NCT03350815|580813264|FG000|Period 1|Physician Decision|1|||
160843077|NCT03350815|580813265|FG001|Period 1|Physician Decision|0|||
160843078|NCT03350815|580813266|FG002|Period 1|Physician Decision|0|||
160843079|NCT03350815|580813267|FG003|Period 1|Physician Decision|0|||
160843080|NCT03350815|580813264|FG000|Period 1|Withdrawal by Subject|8|||
160843081|NCT03350815|580813265|FG001|Period 1|Withdrawal by Subject|0|||
160843082|NCT03350815|580813266|FG002|Period 1|Withdrawal by Subject|0|||
160843083|NCT03350815|580813267|FG003|Period 1|Withdrawal by Subject|0|||
160843084|NCT03350815|580813264|FG000|Period 1|Lack of Efficacy|15|||
160843085|NCT03350815|580813265|FG001|Period 1|Lack of Efficacy|0|||
160843086|NCT03350815|580813266|FG002|Period 1|Lack of Efficacy|0|||
160843087|NCT03350815|580813267|FG003|Period 1|Lack of Efficacy|0|||
160843088|NCT03350815|580813264|FG000|Period 1|Non-compliance with study treatment|2|||
160843089|NCT03350815|580813265|FG001|Period 1|Non-compliance with study treatment|0|||
160843090|NCT03350815|580813266|FG002|Period 1|Non-compliance with study treatment|0|||
160843091|NCT03350815|580813267|FG003|Period 1|Non-compliance with study treatment|0|||
160843092|NCT03350815|580813264|FG000|Period 1|Protocol Violation|3|||
160843093|NCT03350815|580813265|FG001|Period 1|Protocol Violation|0|||
160843094|NCT03350815|580813266|FG002|Period 1|Protocol Violation|0|||
160843095|NCT03350815|580813267|FG003|Period 1|Protocol Violation|0|||
160843096|NCT03350815|580813264|FG000|Period 2|Adverse Event|0|||
160843097|NCT03350815|580813265|FG001|Period 2|Adverse Event|3|||
160843098|NCT03350815|580813266|FG002|Period 2|Adverse Event|5|||
160843099|NCT03350815|580813267|FG003|Period 2|Adverse Event|0|||
160843100|NCT03350815|580813264|FG000|Period 2|Technical problem|0|||
160843101|NCT03350815|580813265|FG001|Period 2|Technical problem|1|||
160843102|NCT03350815|580813266|FG002|Period 2|Technical problem|0|||
160843103|NCT03350815|580813267|FG003|Period 2|Technical problem|0|||
160843104|NCT03350815|580813264|FG000|Period 2|Lost to Follow-up|0|||
160843105|NCT03350815|580813265|FG001|Period 2|Lost to Follow-up|3|||
160843106|NCT03350815|580813266|FG002|Period 2|Lost to Follow-up|3|||
160843107|NCT03350815|580813267|FG003|Period 2|Lost to Follow-up|0|||
160843108|NCT03350815|580813264|FG000|Period 2|Physician Decision|0|||
160843109|NCT03350815|580813265|FG001|Period 2|Physician Decision|0|||
160843110|NCT03350815|580813266|FG002|Period 2|Physician Decision|1|||
160843111|NCT03350815|580813267|FG003|Period 2|Physician Decision|0|||
160843112|NCT03350815|580813264|FG000|Period 2|Withdrawal by Subject|0|||
160843113|NCT03350815|580813265|FG001|Period 2|Withdrawal by Subject|3|||
160843114|NCT03350815|580813266|FG002|Period 2|Withdrawal by Subject|4|||
160843115|NCT03350815|580813267|FG003|Period 2|Withdrawal by Subject|0|||
160843116|NCT03350815|580813264|FG000|Period 2|Lack of Efficacy|0|||
160843117|NCT03350815|580813265|FG001|Period 2|Lack of Efficacy|6|||
160843118|NCT03350815|580813266|FG002|Period 2|Lack of Efficacy|2|||
160843119|NCT03350815|580813267|FG003|Period 2|Lack of Efficacy|0|||
160843120|NCT03350815|580813264|FG000|Period 2|Protocol Violation|0|||
160843121|NCT03350815|580813265|FG001|Period 2|Protocol Violation|0|||
160843122|NCT03350815|580813266|FG002|Period 2|Protocol Violation|1|||
160992153|NCT00477412|581359992|FG003|Overall Study|Withdrawal by Subject|2|||
160843123|NCT03350815|580813267|FG003|Period 2|Protocol Violation|0|||
160843124|NCT03350815|580813264|FG000|Period 2|New therapy for study indication|0|||
160843125|NCT03350815|580813265|FG001|Period 2|New therapy for study indication|0|||
160843126|NCT03350815|580813266|FG002|Period 2|New therapy for study indication|1|||
160843127|NCT03350815|580813267|FG003|Period 2|New therapy for study indication|0|||
160843128|NCT03526146|580813268|FG000|Overall Study|Lost to Follow-up|5|||
160843129|NCT03526146|580813268|FG000|Overall Study|Withdrawal by Subject|6|||
160843130|NCT03526146|580813268|FG000|Overall Study|class canceled due to COVID-19|4|||
160843131|NCT02517541|580813273|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
160843132|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
160843133|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
160843134|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
160843135|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
160843136|NCT02517541|580813273|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
160843137|NCT00699608|580813274|FG000|First Intervention|Withdrawal by Subject|0|||
160843138|NCT00699608|580813275|FG001|First Intervention|Withdrawal by Subject|0|||
160843139|NCT00699608|580813276|FG002|First Intervention|Withdrawal by Subject|1|||
160843140|NCT00699608|580813277|FG003|First Intervention|Withdrawal by Subject|0|||
160843141|NCT00699608|580813278|FG004|First Intervention|Withdrawal by Subject|0|||
160843142|NCT00699608|580813279|FG005|First Intervention|Withdrawal by Subject|0|||
160843143|NCT00699608|580813274|FG000|First Intervention|Protocol Violation|0|||
160843144|NCT00699608|580813275|FG001|First Intervention|Protocol Violation|0|||
160843145|NCT00699608|580813276|FG002|First Intervention|Protocol Violation|0|||
160843146|NCT00699608|580813277|FG003|First Intervention|Protocol Violation|0|||
160843147|NCT00699608|580813278|FG004|First Intervention|Protocol Violation|1|||
160843148|NCT00699608|580813279|FG005|First Intervention|Protocol Violation|0|||
160843149|NCT00699608|580813274|FG000|Second Intervention|Adverse Event|0|||
160843150|NCT00699608|580813275|FG001|Second Intervention|Adverse Event|0|||
160843151|NCT00699608|580813276|FG002|Second Intervention|Adverse Event|1|||
160843152|NCT00699608|580813277|FG003|Second Intervention|Adverse Event|0|||
160843153|NCT00699608|580813278|FG004|Second Intervention|Adverse Event|0|||
160843154|NCT00699608|580813279|FG005|Second Intervention|Adverse Event|0|||
160843155|NCT00699608|580813274|FG000|Second Intervention|Withdrawal by Subject|0|||
160843156|NCT00699608|580813275|FG001|Second Intervention|Withdrawal by Subject|0|||
160843157|NCT00699608|580813276|FG002|Second Intervention|Withdrawal by Subject|0|||
160843158|NCT00699608|580813277|FG003|Second Intervention|Withdrawal by Subject|1|||
160843159|NCT00699608|580813278|FG004|Second Intervention|Withdrawal by Subject|0|||
160843160|NCT00699608|580813279|FG005|Second Intervention|Withdrawal by Subject|0|||
160843161|NCT02034877|580813280|FG000|Overall Study|Lost to Follow-up|0|||
160843162|NCT02034877|580813281|FG001|Overall Study|Lost to Follow-up|3|||
160843163|NCT02034877|580813280|FG000|Overall Study|No Longer Willing to Participate|0|||
160843164|NCT02034877|580813281|FG001|Overall Study|No Longer Willing to Participate|3|||
160843165|NCT01036321|580813285|FG000|Overall Study|Ineligible after randomization|0|||
160843166|NCT01036321|580813286|FG001|Overall Study|Ineligible after randomization|1|||
160843167|NCT01036321|580813285|FG000|Overall Study|Withdrawal by Subject|3|||
160843168|NCT01036321|580813286|FG001|Overall Study|Withdrawal by Subject|2|||
160843169|NCT01036321|580813285|FG000|Overall Study|Adverse Event|2|||
160843170|NCT01036321|580813286|FG001|Overall Study|Adverse Event|1|||
160843171|NCT00381693|580813287|FG000|Overall Study|Death|1|||
160843172|NCT00381693|580813287|FG000|Overall Study|Adverse Event|4|||
160843173|NCT00381693|580813287|FG000|Overall Study|Patient Choice|1|||
160843174|NCT00381693|580813287|FG000|Overall Study|Progression|2|||
160843175|NCT02598297|580813288|FG000|Overall Study|Study terminated by Sponsor|21|||
160843176|NCT02598297|580813289|FG001|Overall Study|Study terminated by Sponsor|23|||
160843177|NCT02598297|580813288|FG000|Overall Study|Adverse Event|1|||
160843178|NCT02598297|580813289|FG001|Overall Study|Adverse Event|1|||
160843179|NCT02598297|580813288|FG000|Overall Study|Physician Decision|1|||
160843180|NCT02598297|580813289|FG001|Overall Study|Physician Decision|0|||
160843181|NCT02598297|580813288|FG000|Overall Study|Subject/guardian decision|1|||
160843182|NCT02598297|580813289|FG001|Overall Study|Subject/guardian decision|0|||
160843183|NCT02598297|580813288|FG000|Overall Study|Followed for survival|1|||
160843184|NCT02598297|580813289|FG001|Overall Study|Followed for survival|0|||
160843185|NCT04112303|580813293|FG000|Overall Study|Death|1|||
160843186|NCT01685697|580813294|FG000|Overall Study|Protocol Violation|3|||
160843187|NCT01685697|580813295|FG001|Overall Study|Protocol Violation|3|||
160843188|NCT02703324|580813296|FG000|Period Two|Withdrawal by Subject|0|||
160843189|NCT02703324|580813297|FG001|Period Two|Withdrawal by Subject|0|||
160843190|NCT02703324|580813298|FG002|Period Two|Withdrawal by Subject|1|||
160843191|NCT02703324|580813299|FG003|Period Two|Withdrawal by Subject|0|||
160843192|NCT02703324|580813300|FG004|Period Two|Withdrawal by Subject|0|||
160843193|NCT02703324|580813301|FG005|Period Two|Withdrawal by Subject|0|||
160843194|NCT04303572|580813304|FG000|Overall Study|Study closed due to poor enrollment|1|||
160843195|NCT06312592|580813305|FG000|Overall Study|Lost to Follow-up|29|||
160843196|NCT06312592|580813306|FG001|Overall Study|Lost to Follow-up|13|||
160843197|NCT03517228|580813309|FG000|Overall Study|Withdrawal by Subject|2|||
160843198|NCT03517228|580813309|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
160843199|NCT03517228|580813309|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
160905699|NCT01433991|581050281|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
160843200|NCT03517228|580813309|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
161251787|NCT01190930|582302360|FG001|Induction|Low Risk|0|||
160843201|NCT03517228|580813309|FG000|Overall Study|Canceled due to device being updated|1|||
160843202|NCT03517228|580813309|FG000|Overall Study|No V Cares in stock|1|||
160843203|NCT03517228|580813309|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
160843204|NCT01620762|580813320|FG000|Overall Study|Protocol Violation|1|||
160843205|NCT01620762|580813321|FG001|Overall Study|Protocol Violation|1|||
160843206|NCT01620762|580813322|FG002|Overall Study|Protocol Violation|1|||
160843207|NCT01620762|580813320|FG000|Overall Study|Adverse Event|9|||
160843208|NCT01620762|580813321|FG001|Overall Study|Adverse Event|5|||
160843209|NCT01620762|580813322|FG002|Overall Study|Adverse Event|2|||
160843210|NCT01620762|580813320|FG000|Overall Study|Withdrawal by Subject|23|||
160843211|NCT01620762|580813321|FG001|Overall Study|Withdrawal by Subject|26|||
160843212|NCT01620762|580813322|FG002|Overall Study|Withdrawal by Subject|27|||
160843213|NCT01620762|580813320|FG000|Overall Study|Lost to Follow-up|11|||
160843214|NCT01620762|580813321|FG001|Overall Study|Lost to Follow-up|17|||
160843215|NCT01620762|580813322|FG002|Overall Study|Lost to Follow-up|10|||
160843216|NCT01620762|580813320|FG000|Overall Study|Protocol deviation|1|||
160843217|NCT01620762|580813321|FG001|Overall Study|Protocol deviation|1|||
160843218|NCT01620762|580813322|FG002|Overall Study|Protocol deviation|6|||
160843219|NCT01620762|580813320|FG000|Overall Study|Subject deterioration|0|||
160843220|NCT01620762|580813321|FG001|Overall Study|Subject deterioration|1|||
160843221|NCT01620762|580813322|FG002|Overall Study|Subject deterioration|1|||
160843222|NCT01620762|580813320|FG000|Overall Study|Non-specified|3|||
160843223|NCT01620762|580813321|FG001|Overall Study|Non-specified|6|||
160843224|NCT01620762|580813322|FG002|Overall Study|Non-specified|5|||
160843225|NCT01620762|580813320|FG000|Overall Study|Use of prohibted therapies|0|||
160843226|NCT01620762|580813321|FG001|Overall Study|Use of prohibted therapies|1|||
160843227|NCT01620762|580813322|FG002|Overall Study|Use of prohibted therapies|1|||
160843228|NCT03664765|580813327|FG000|Overall Study|Withdrawal by Subject|4|||
160843229|NCT03664765|580813328|FG001|Overall Study|Withdrawal by Subject|1|||
160843230|NCT03664765|580813327|FG000|Overall Study|Lost to Follow-up|0|||
160843231|NCT03664765|580813328|FG001|Overall Study|Lost to Follow-up|1|||
160843232|NCT01496846|580813329|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
160843233|NCT01496846|580813330|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
160843234|NCT01496846|580813331|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843235|NCT01496846|580813332|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843236|NCT01496846|580813333|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843237|NCT01496846|580813334|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
160843238|NCT01772576|580813335|FG000|Overall Study|Death|15|||
160843239|NCT01772576|580813335|FG000|Overall Study|Protocol Violation|1|||
160843240|NCT01772576|580813335|FG000|Overall Study|Lost to Follow-up|3|||
160843241|NCT01772576|580813335|FG000|Overall Study|Study device not used|3|||
160843242|NCT01772576|580813335|FG000|Overall Study|Adverse Event|6|||
160843243|NCT01772576|580813335|FG000|Overall Study|Withdrawal by Subject|6|||
160843244|NCT00527904|580813339|FG000|Overall Study|Adverse Event|45|||
160843245|NCT00527904|580813339|FG000|Overall Study|Withdrawal by Subject|21|||
160843246|NCT00527904|580813339|FG000|Overall Study|Lost to Follow-up|8|||
160843247|NCT00527904|580813339|FG000|Overall Study|misc|22|||
160843248|NCT02873338|580813343|FG000|Overall Study|Adverse Event|0|||
160843249|NCT02873338|580813344|FG001|Overall Study|Adverse Event|2|||
160843250|NCT02873338|580813345|FG002|Overall Study|Adverse Event|1|||
160843251|NCT02873338|580813343|FG000|Overall Study|Death|2|||
160843252|NCT02873338|580813344|FG001|Overall Study|Death|1|||
160843253|NCT02873338|580813345|FG002|Overall Study|Death|1|||
160843254|NCT02873338|580813343|FG000|Overall Study|Withdrawal by Subject|2|||
160843255|NCT02873338|580813344|FG001|Overall Study|Withdrawal by Subject|1|||
160843256|NCT02873338|580813345|FG002|Overall Study|Withdrawal by Subject|3|||
160843257|NCT02873338|580813343|FG000|Overall Study|Lack of Efficacy|0|||
161251788|NCT01190930|582302361|FG002|Induction|Low Risk|0|||
160843258|NCT02873338|580813344|FG001|Overall Study|Lack of Efficacy|2|||
160843259|NCT02873338|580813345|FG002|Overall Study|Lack of Efficacy|0|||
160905700|NCT01433991|581050282|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
160905701|NCT01433991|581050283|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
160905702|NCT01433991|581050284|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
161251789|NCT01190930|582302362|FG003|Induction|Low Risk|0|||
161251790|NCT01190930|582302363|FG004|Induction|Low Risk|0|||
160843260|NCT02873338|580813343|FG000|Overall Study|Other or Missing|14|||
160843261|NCT02873338|580813344|FG001|Overall Study|Other or Missing|15|||
160843262|NCT02873338|580813345|FG002|Overall Study|Other or Missing|13|||
160843263|NCT03477838|580813355|FG000|Overall Study|Lost to Follow-up|14|||
160843264|NCT00850538|580813357|FG000|Overall Study|unable/unwilling to complete MRI|13|||
160843265|NCT00850538|580813357|FG000|Overall Study|specimen missed due to scheduling error|14|||
160843266|NCT00850538|580813357|FG000|Overall Study|specimen unusable|7|||
160905703|NCT02955602|581050287|FG000|Overall Study|Adverse Event|0|||
160905704|NCT02955602|581050288|FG001|Overall Study|Adverse Event|3|||
161251791|NCT01190930|582302364|FG005|Induction|Low Risk|0|||
161251792|NCT01190930|582302365|FG006|Induction|Low Risk|0|||
160843267|NCT00850538|580813357|FG000|Overall Study|Withdrawal by Subject|3|||
160843268|NCT00850538|580813357|FG000|Overall Study|radiology error|2|||
160843269|NCT00850538|580813357|FG000|Overall Study|Protocol Violation|2|||
160843270|NCT01088399|580813363|FG000|Overall Study|Adverse Event|211|||
160843271|NCT01088399|580813364|FG001|Overall Study|Adverse Event|16|||
160843272|NCT01088399|580813365|FG002|Overall Study|Adverse Event|0|||
160843273|NCT01088399|580813363|FG000|Overall Study|Death|204|||
160843274|NCT01088399|580813364|FG001|Overall Study|Death|45|||
161251793|NCT01190930|582302366|FG007|Induction|Low Risk|0|||
161251794|NCT01190930|582302367|FG008|Induction|Low Risk|0|||
161251795|NCT01190930|582302368|FG009|Induction|Low Risk|0|||
161251796|NCT01190930|582302359|FG000|Induction|Very High Risk|1012|||
160843275|NCT01088399|580813365|FG002|Overall Study|Death|0|||
160843276|NCT01088399|580813363|FG000|Overall Study|Lack of Efficacy|298|||
160843277|NCT01088399|580813364|FG001|Overall Study|Lack of Efficacy|7|||
160843278|NCT01088399|580813365|FG002|Overall Study|Lack of Efficacy|5|||
160843279|NCT01088399|580813363|FG000|Overall Study|Lost to Follow-up|1070|||
160843280|NCT01088399|580813364|FG001|Overall Study|Lost to Follow-up|278|||
160843281|NCT01088399|580813365|FG002|Overall Study|Lost to Follow-up|58|||
160843282|NCT01088399|580813363|FG000|Overall Study|Physician Decision|531|||
160843283|NCT01088399|580813364|FG001|Overall Study|Physician Decision|88|||
160843284|NCT01088399|580813365|FG002|Overall Study|Physician Decision|16|||
160843285|NCT01088399|580813363|FG000|Overall Study|Withdrawal by Subject|544|||
160843286|NCT01088399|580813364|FG001|Overall Study|Withdrawal by Subject|195|||
160843287|NCT01088399|580813365|FG002|Overall Study|Withdrawal by Subject|33|||
160843288|NCT01088399|580813363|FG000|Overall Study|Change to or start of somatropin therapy|234|||
160843289|NCT01088399|580813364|FG001|Overall Study|Change to or start of somatropin therapy|17|||
160843290|NCT01088399|580813365|FG002|Overall Study|Change to or start of somatropin therapy|12|||
160843291|NCT01088399|580813363|FG000|Overall Study|Sponsor decision|1573|||
160843292|NCT01088399|580813364|FG001|Overall Study|Sponsor decision|298|||
160843293|NCT01088399|580813365|FG002|Overall Study|Sponsor decision|7|||
160843294|NCT01088399|580813363|FG000|Overall Study|Protocol Violation|10|||
160843295|NCT01088399|580813364|FG001|Overall Study|Protocol Violation|1|||
160843296|NCT01088399|580813365|FG002|Overall Study|Protocol Violation|0|||
160843297|NCT01088399|580813363|FG000|Overall Study|Enrollment criteria not met|48|||
160843298|NCT01088399|580813364|FG001|Overall Study|Enrollment criteria not met|119|||
160843299|NCT01088399|580813365|FG002|Overall Study|Enrollment criteria not met|70|||
160843300|NCT01088399|580813363|FG000|Overall Study|Study summary visit not completed|2398|||
160843301|NCT01088399|580813364|FG001|Overall Study|Study summary visit not completed|283|||
160843302|NCT01088399|580813365|FG002|Overall Study|Study summary visit not completed|80|||
160843303|NCT03193736|580813366|FG000|Overall Study|Death|2|||
160843304|NCT03193736|580813366|FG000|Overall Study|Withdrawal by Subject|1|||
160843305|NCT03193736|580813366|FG000|Overall Study|Lost to Follow-up|1|||
160843306|NCT03193736|580813366|FG000|Overall Study|implant not received|1|||
160843307|NCT00852241|580813367|FG000|Overall Study|Physician Decision|18|||
160843308|NCT00534976|580813370|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
160843309|NCT00534976|580813371|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
160843310|NCT00534976|580813370|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
160843311|NCT00534976|580813371|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
160843312|NCT00534976|580813370|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
160843313|NCT00534976|580813371|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
160843314|NCT00269633|580813374|FG000|Overall Study|Withdrawal by Subject|1|||
161251797|NCT01190930|582302360|FG001|Induction|Very High Risk|0|||
161251798|NCT01190930|582302361|FG002|Induction|Very High Risk|0|||
160843315|NCT00269633|580813375|FG001|Overall Study|Withdrawal by Subject|0|||
160843316|NCT04506502|580815437|FG000|Overall Study|Withdrawal by Subject|1|||
160843317|NCT04506502|580815437|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
160843318|NCT01449006|580815438|FG000|Overall Study|Lost to Follow-up|1|||
160843319|NCT01449006|580815439|FG001|Overall Study|Lost to Follow-up|0|||
160843320|NCT01449006|580815438|FG000|Overall Study|Withdrawal by Subject|1|||
160843321|NCT01449006|580815439|FG001|Overall Study|Withdrawal by Subject|0|||
160843322|NCT01449006|580815438|FG000|Overall Study|Protocol Violation|1|||
160843323|NCT01449006|580815439|FG001|Overall Study|Protocol Violation|0|||
160843324|NCT04720417|580815444|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
160843325|NCT03574779|580815445|FG000|Overall Study|Screening failure|13|||
160843326|NCT03574779|580815446|FG001|Overall Study|Screening failure|83|||
160843327|NCT02783599|580815447|FG000|Overall Study|Progressive disease|23|||
160843328|NCT02783599|580815447|FG000|Overall Study|Surgical Resection|10|||
160843329|NCT02783599|580815447|FG000|Overall Study|Adverse Event|4|||
160843330|NCT02783599|580815447|FG000|Overall Study|Physician Decision|2|||
160843331|NCT02783599|580815447|FG000|Overall Study|Death|1|||
160843332|NCT03755882|580815453|FG000|Period 1|Protocol Violation|1|||
160843333|NCT03755882|580815454|FG001|Period 1|Protocol Violation|0|||
160843334|NCT03755882|580815453|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
160843335|NCT03755882|580815454|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
160843336|NCT01687101|580815455|FG000|Overall Study|Lost to Follow-up|7|||
160843337|NCT02003534|580815458|FG000|Overall Study|Lost to Follow-up|47|||
160843338|NCT02206035|580815459|FG000|Overall Study|Physician Decision|10|||
160843339|NCT02206035|580815460|FG001|Overall Study|Physician Decision|0|||
160843340|NCT02206035|580815461|FG002|Overall Study|Physician Decision|175|||
160843341|NCT01934010|580815462|FG000|Overall Study|Adverse Event|1|||
160843342|NCT01934010|580815463|FG001|Overall Study|Adverse Event|1|||
160843343|NCT01934010|580815464|FG002|Overall Study|Adverse Event|0|||
160843344|NCT01934010|580815462|FG000|Overall Study|Withdrawal by Subject|15|||
160843345|NCT01934010|580815463|FG001|Overall Study|Withdrawal by Subject|6|||
160843346|NCT01934010|580815464|FG002|Overall Study|Withdrawal by Subject|2|||
160843347|NCT01934010|580815462|FG000|Overall Study|Lost to Follow-up|7|||
160843348|NCT01934010|580815463|FG001|Overall Study|Lost to Follow-up|4|||
160843349|NCT01934010|580815464|FG002|Overall Study|Lost to Follow-up|0|||
160843350|NCT00377858|580815465|FG000|Overall Study|Withdrawal by Subject|12|||
160843351|NCT00377858|580815466|FG001|Overall Study|Withdrawal by Subject|11|||
160843352|NCT00377858|580815465|FG000|Overall Study|Lost to Follow-up|6|||
160843353|NCT00377858|580815466|FG001|Overall Study|Lost to Follow-up|1|||
160843354|NCT00377858|580815465|FG000|Overall Study|Physician Decision|5|||
160843355|NCT00377858|580815466|FG001|Overall Study|Physician Decision|5|||
160843356|NCT00377858|580815465|FG000|Overall Study|Protocol Violation|3|||
160843357|NCT00377858|580815466|FG001|Overall Study|Protocol Violation|4|||
160843358|NCT00377858|580815465|FG000|Overall Study|Adverse Event|2|||
160843359|NCT00377858|580815466|FG001|Overall Study|Adverse Event|1|||
160843360|NCT00377858|580815465|FG000|Overall Study|Entry Criteria Not Met|2|||
160843361|NCT00377858|580815466|FG001|Overall Study|Entry Criteria Not Met|0|||
160843362|NCT00377858|580815465|FG000|Overall Study|Sponsor Decision|1|||
160843363|NCT00377858|580815466|FG001|Overall Study|Sponsor Decision|2|||
160843364|NCT00377858|580815465|FG000|Overall Study|Death|0|||
160843365|NCT00377858|580815466|FG001|Overall Study|Death|3|||
160843366|NCT03534141|580815467|FG000|Overall Study|Enrolled in other clinical trial|1|||
160843367|NCT03534141|580815468|FG001|Overall Study|Enrolled in other clinical trial|0|||
160843368|NCT03534141|580815467|FG000|Overall Study|Liver transplant aborted after randomization|0|||
160843369|NCT03534141|580815468|FG001|Overall Study|Liver transplant aborted after randomization|2|||
160843370|NCT03534141|580815467|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
160843371|NCT03534141|580815468|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
161139397|NCT04233424|581892697|FG000|Overall Study|Death|15|||
161139398|NCT04233424|581892698|FG001|Overall Study|Death|16|||
160843374|NCT03785405|580815471|FG000|Overall Study|Adverse Event|16|||
160843375|NCT03785405|580815472|FG001|Overall Study|Adverse Event|1|||
160843376|NCT03785405|580815471|FG000|Overall Study|Death|6|||
160843377|NCT03785405|580815472|FG001|Overall Study|Death|4|||
160843378|NCT03785405|580815471|FG000|Overall Study|Guardian decision|4|||
160843379|NCT03785405|580815472|FG001|Overall Study|Guardian decision|1|||
160843380|NCT03785405|580815471|FG000|Overall Study|Lost to Follow-up|1|||
160843381|NCT03785405|580815472|FG001|Overall Study|Lost to Follow-up|0|||
160843382|NCT03785405|580815471|FG000|Overall Study|Physician Decision|8|||
160843383|NCT03785405|580815472|FG001|Overall Study|Physician Decision|5|||
160843384|NCT03785405|580815471|FG000|Overall Study|Participant decision|2|||
160843385|NCT03785405|580815472|FG001|Overall Study|Participant decision|0|||
160843386|NCT03785405|580815471|FG000|Overall Study|Other|1|||
160843387|NCT03785405|580815472|FG001|Overall Study|Other|0|||
160843388|NCT03785405|580815471|FG000|Overall Study|No treatment was received|0|||
160843389|NCT03785405|580815472|FG001|Overall Study|No treatment was received|1|||
160843390|NCT06041919|580815478|FG000|Overall Study|Lost to Follow-up|1|||
160843391|NCT06041919|580815479|FG001|Overall Study|Lost to Follow-up|0|||
160843392|NCT06041919|580815480|FG002|Overall Study|Lost to Follow-up|0|||
160843393|NCT06041919|580815481|FG003|Overall Study|Lost to Follow-up|0|||
160843394|NCT06041919|580815482|FG004|Overall Study|Lost to Follow-up|0|||
160843395|NCT06041919|580815478|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
160843396|NCT06041919|580815479|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
160905705|NCT02955602|581050289|FG002|Overall Study|Adverse Event|0|||
160843397|NCT06041919|580815480|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
160843398|NCT06041919|580815481|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
160843399|NCT06041919|580815482|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
160843400|NCT01147055|580815483|FG000|First Intervention Period|Lost to Follow-up|1|||
160843401|NCT01147055|580815484|FG001|First Intervention Period|Lost to Follow-up|0|||
160843402|NCT03724890|580815485|FG000|Overall Study|Death|2|||
160843403|NCT03724890|580815486|FG001|Overall Study|Death|6|||
160843404|NCT03724890|580815487|FG002|Overall Study|Death|3|||
160843405|NCT03724890|580815488|FG003|Overall Study|Death|5|||
160843406|NCT03724890|580815489|FG004|Overall Study|Death|2|||
160843407|NCT03724890|580815490|FG005|Overall Study|Death|0|||
160843408|NCT03724890|580815491|FG006|Overall Study|Death|2|||
160843409|NCT03724890|580815492|FG007|Overall Study|Death|3|||
160843410|NCT03724890|580815493|FG008|Overall Study|Death|4|||
160843411|NCT03724890|580815494|FG009|Overall Study|Death|2|||
160843412|NCT03724890|580815495|FG010|Overall Study|Death|2|||
160905706|NCT02955602|581050287|FG000|Overall Study|Withdrawal of informed consent|1|||
160843413|NCT03724890|580815485|FG000|Overall Study|Lost to Follow-up|0|||
160843414|NCT03724890|580815486|FG001|Overall Study|Lost to Follow-up|3|||
160843415|NCT03724890|580815487|FG002|Overall Study|Lost to Follow-up|0|||
160843416|NCT03724890|580815488|FG003|Overall Study|Lost to Follow-up|1|||
160843417|NCT03724890|580815489|FG004|Overall Study|Lost to Follow-up|2|||
160843418|NCT03724890|580815490|FG005|Overall Study|Lost to Follow-up|2|||
160843419|NCT03724890|580815491|FG006|Overall Study|Lost to Follow-up|1|||
160843420|NCT03724890|580815492|FG007|Overall Study|Lost to Follow-up|0|||
160843421|NCT03724890|580815493|FG008|Overall Study|Lost to Follow-up|2|||
160843422|NCT03724890|580815494|FG009|Overall Study|Lost to Follow-up|0|||
160843423|NCT03724890|580815495|FG010|Overall Study|Lost to Follow-up|0|||
160843424|NCT03724890|580815485|FG000|Overall Study|Withdrawal by Subject|1|||
160843425|NCT03724890|580815486|FG001|Overall Study|Withdrawal by Subject|2|||
160843426|NCT03724890|580815487|FG002|Overall Study|Withdrawal by Subject|1|||
160992154|NCT00477412|581359989|FG000|Overall Study|Second Malignancy|0|||
160843427|NCT03724890|580815488|FG003|Overall Study|Withdrawal by Subject|0|||
160843428|NCT03724890|580815489|FG004|Overall Study|Withdrawal by Subject|0|||
160843429|NCT03724890|580815490|FG005|Overall Study|Withdrawal by Subject|1|||
160843430|NCT03724890|580815491|FG006|Overall Study|Withdrawal by Subject|0|||
160843431|NCT03724890|580815492|FG007|Overall Study|Withdrawal by Subject|0|||
160843432|NCT03724890|580815493|FG008|Overall Study|Withdrawal by Subject|2|||
160843433|NCT03724890|580815494|FG009|Overall Study|Withdrawal by Subject|2|||
160843434|NCT03724890|580815495|FG010|Overall Study|Withdrawal by Subject|1|||
160843435|NCT03724890|580815485|FG000|Overall Study|Other|1|||
160843436|NCT03724890|580815486|FG001|Overall Study|Other|0|||
160843437|NCT03724890|580815487|FG002|Overall Study|Other|0|||
160843438|NCT03724890|580815488|FG003|Overall Study|Other|0|||
160843439|NCT03724890|580815489|FG004|Overall Study|Other|0|||
160843440|NCT03724890|580815490|FG005|Overall Study|Other|0|||
160843441|NCT03724890|580815491|FG006|Overall Study|Other|0|||
160843442|NCT03724890|580815492|FG007|Overall Study|Other|1|||
160843443|NCT03724890|580815493|FG008|Overall Study|Other|1|||
160843444|NCT03724890|580815494|FG009|Overall Study|Other|0|||
160843445|NCT03724890|580815495|FG010|Overall Study|Other|2|||
160843446|NCT02123823|580815497|FG000|Overall Study|Lack of Efficacy|0|||
160843447|NCT02123823|580815498|FG001|Overall Study|Lack of Efficacy|2|||
160843448|NCT02123823|580815499|FG002|Overall Study|Lack of Efficacy|8|||
160843449|NCT02123823|580815500|FG003|Overall Study|Lack of Efficacy|10|||
160843450|NCT02123823|580815497|FG000|Overall Study|Progressive disease|3|||
160843451|NCT02123823|580815498|FG001|Overall Study|Progressive disease|19|||
160843452|NCT02123823|580815499|FG002|Overall Study|Progressive disease|52|||
160843453|NCT02123823|580815500|FG003|Overall Study|Progressive disease|53|||
160992155|NCT00477412|581359990|FG001|Overall Study|Second Malignancy|0|||
160992156|NCT00477412|581359991|FG002|Overall Study|Second Malignancy|0|||
160992157|NCT00477412|581359992|FG003|Overall Study|Second Malignancy|1|||
160992158|NCT00477412|581359989|FG000|Overall Study|Adverse Event|1|||
160992159|NCT00477412|581359990|FG001|Overall Study|Adverse Event|0|||
160992160|NCT00477412|581359991|FG002|Overall Study|Adverse Event|1|||
160992161|NCT00477412|581359992|FG003|Overall Study|Adverse Event|0|||
160992162|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
160992163|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
160992164|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
160992165|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
160992166|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
160992167|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
160992168|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
160992169|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
160843454|NCT02123823|580815497|FG000|Overall Study|Withdrawal by Subject|0|||
160843455|NCT02123823|580815498|FG001|Overall Study|Withdrawal by Subject|0|||
160992170|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Death|1|||
160992171|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Death|0|||
160992172|NCT01080131|581359993|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
160992173|NCT01080131|581359994|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
160992174|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
161335001|NCT03177148|582615889|FG000|Overall Study|Lost to Follow-up|50|||
160992175|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
160843456|NCT02123823|580815499|FG002|Overall Study|Withdrawal by Subject|7|||
160843457|NCT02123823|580815500|FG003|Overall Study|Withdrawal by Subject|2|||
160843458|NCT02123823|580815497|FG000|Overall Study|Adverse Event|0|||
160843459|NCT02123823|580815498|FG001|Overall Study|Adverse Event|0|||
160843460|NCT02123823|580815499|FG002|Overall Study|Adverse Event|3|||
160843461|NCT02123823|580815500|FG003|Overall Study|Adverse Event|5|||
160843462|NCT01635855|580815535|FG000|Overall Study|Withdrawal by Subject|4|||
160843463|NCT01844778|580815538|FG000|Overall Study|Protocol deviation|0|||
160843464|NCT01844778|580815539|FG001|Overall Study|Protocol deviation|1|||
160843465|NCT01844778|580815540|FG002|Overall Study|Protocol deviation|2|||
160843466|NCT01844778|580815538|FG000|Overall Study|Withdrawal by Subject|2|||
160843467|NCT01844778|580815539|FG001|Overall Study|Withdrawal by Subject|0|||
160843468|NCT01844778|580815540|FG002|Overall Study|Withdrawal by Subject|0|||
160843469|NCT01844778|580815538|FG000|Overall Study|Adverse Event|0|||
160843470|NCT01844778|580815539|FG001|Overall Study|Adverse Event|2|||
160843471|NCT01844778|580815540|FG002|Overall Study|Adverse Event|2|||
160843472|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
160843473|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843474|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843475|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843476|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843477|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
160843478|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
160843479|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843480|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843481|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843482|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843483|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
160843484|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
160843485|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843486|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843487|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843488|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843489|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
160843490|NCT00095173|580815541|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
160843491|NCT00095173|580815542|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
160843492|NCT00095173|580815543|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
160843493|NCT00095173|580815544|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
160843494|NCT00095173|580815545|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
160843495|NCT00095173|580815546|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
160843496|NCT00095173|580815541|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843497|NCT00095173|580815542|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
160843498|NCT00095173|580815543|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
160843499|NCT00095173|580815544|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843500|NCT00095173|580815545|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843501|NCT00095173|580815546|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
160843502|NCT00095173|580815541|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843503|NCT00095173|580815542|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
160843504|NCT00095173|580815543|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843505|NCT00095173|580815544|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843506|NCT00095173|580815545|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843507|NCT00095173|580815546|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
160843508|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Death|0|||
160843509|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Death|0|||
160843510|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Death|0|||
160843511|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Death|0|||
160843512|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Death|0|||
160843513|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Death|1|||
160843514|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
160843515|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
160843516|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
160843517|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
160843518|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
160843519|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
160843520|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
160843521|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
160843522|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
160843523|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
160843524|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
160843525|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
160843526|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
160843527|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
160843528|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
160843529|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
161139399|NCT04233424|581892697|FG000|Overall Study|Withdrawal by Subject|2|||
161139400|NCT04233424|581892698|FG001|Overall Study|Withdrawal by Subject|8|||
161139401|NCT04233424|581892697|FG000|Overall Study|Physician Decision|1|||
161139402|NCT04233424|581892698|FG001|Overall Study|Physician Decision|3|||
161139403|NCT04233424|581892697|FG000|Overall Study|Protocol Violation|3|||
161139404|NCT04233424|581892698|FG001|Overall Study|Protocol Violation|1|||
161139405|NCT04233424|581892697|FG000|Overall Study|Lost to Follow-up|1|||
161251799|NCT01190930|582302362|FG003|Induction|Very High Risk|0|||
161251800|NCT01190930|582302363|FG004|Induction|Very High Risk|0|||
161251801|NCT01190930|582302364|FG005|Induction|Very High Risk|0|||
161251802|NCT01190930|582302365|FG006|Induction|Very High Risk|0|||
161251803|NCT01190930|582302366|FG007|Induction|Very High Risk|0|||
161251804|NCT01190930|582302367|FG008|Induction|Very High Risk|0|||
161251805|NCT01190930|582302368|FG009|Induction|Very High Risk|0|||
161251806|NCT01190930|582302359|FG000|Induction|Philadelphia chromosome-positive|99|||
161251807|NCT01190930|582302360|FG001|Induction|Philadelphia chromosome-positive|0|||
161251808|NCT01190930|582302361|FG002|Induction|Philadelphia chromosome-positive|0|||
161251809|NCT01190930|582302362|FG003|Induction|Philadelphia chromosome-positive|0|||
161251810|NCT01190930|582302363|FG004|Induction|Philadelphia chromosome-positive|0|||
161251811|NCT01190930|582302364|FG005|Induction|Philadelphia chromosome-positive|0|||
161251812|NCT01190930|582302365|FG006|Induction|Philadelphia chromosome-positive|0|||
161251813|NCT01190930|582302366|FG007|Induction|Philadelphia chromosome-positive|0|||
161251814|NCT01190930|582302367|FG008|Induction|Philadelphia chromosome-positive|0|||
161251815|NCT01190930|582302368|FG009|Induction|Philadelphia chromosome-positive|0|||
161251816|NCT01190930|582302359|FG000|Induction|Incomplete Induction data|63|||
161251817|NCT01190930|582302360|FG001|Induction|Incomplete Induction data|0|||
161251818|NCT01190930|582302361|FG002|Induction|Incomplete Induction data|0|||
161251819|NCT01190930|582302362|FG003|Induction|Incomplete Induction data|0|||
161251820|NCT01190930|582302363|FG004|Induction|Incomplete Induction data|0|||
161251821|NCT01190930|582302364|FG005|Induction|Incomplete Induction data|0|||
161251822|NCT01190930|582302365|FG006|Induction|Incomplete Induction data|0|||
161251823|NCT01190930|582302366|FG007|Induction|Incomplete Induction data|0|||
161251824|NCT01190930|582302367|FG008|Induction|Incomplete Induction data|0|||
161251825|NCT01190930|582302368|FG009|Induction|Incomplete Induction data|0|||
161251826|NCT01190930|582302359|FG000|Induction|Progressive disease|0|||
161251827|NCT01190930|582302360|FG001|Induction|Progressive disease|1|||
161251828|NCT01190930|582302361|FG002|Induction|Progressive disease|0|||
161251829|NCT01190930|582302362|FG003|Induction|Progressive disease|0|||
161251830|NCT01190930|582302363|FG004|Induction|Progressive disease|0|||
161251831|NCT01190930|582302364|FG005|Induction|Progressive disease|0|||
161251832|NCT01190930|582302365|FG006|Induction|Progressive disease|0|||
161251833|NCT01190930|582302366|FG007|Induction|Progressive disease|0|||
161251834|NCT01190930|582302367|FG008|Induction|Progressive disease|0|||
161251835|NCT01190930|582302368|FG009|Induction|Progressive disease|0|||
161251836|NCT01190930|582302359|FG000|Induction|No treatment|3|||
161251837|NCT01190930|582302360|FG001|Induction|No treatment|0|||
161251838|NCT01190930|582302361|FG002|Induction|No treatment|0|||
161251839|NCT01190930|582302362|FG003|Induction|No treatment|0|||
161251840|NCT01190930|582302363|FG004|Induction|No treatment|0|||
161251841|NCT01190930|582302364|FG005|Induction|No treatment|0|||
161251842|NCT01190930|582302365|FG006|Induction|No treatment|0|||
161251843|NCT01190930|582302366|FG007|Induction|No treatment|0|||
161251844|NCT01190930|582302367|FG008|Induction|No treatment|0|||
161251845|NCT01190930|582302368|FG009|Induction|No treatment|0|||
161251846|NCT01190930|582302359|FG000|Induction|Ineligible|69|||
161251847|NCT01190930|582302360|FG001|Induction|Ineligible|4|||
161251848|NCT01190930|582302361|FG002|Induction|Ineligible|0|||
161251849|NCT01190930|582302362|FG003|Induction|Ineligible|0|||
160843530|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
160843531|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
160843532|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843533|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843534|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843535|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
160843536|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
160843537|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
160843538|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
160843539|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161251850|NCT01190930|582302363|FG004|Induction|Ineligible|0|||
161251851|NCT01190930|582302364|FG005|Induction|Ineligible|0|||
161251852|NCT01190930|582302365|FG006|Induction|Ineligible|0|||
161251853|NCT01190930|582302366|FG007|Induction|Ineligible|0|||
160843540|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161251854|NCT01190930|582302367|FG008|Induction|Ineligible|0|||
161251855|NCT01190930|582302368|FG009|Induction|Ineligible|0|||
161251856|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
160843541|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
161251857|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
161251858|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
161251859|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
161251860|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
161251861|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
161251862|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
161251863|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
161251864|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
161251865|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
161251866|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Death|0|||
161251867|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Death|0|||
161251868|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Death|8|||
161251869|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Death|4|||
161251870|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Death|0|||
161251871|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Death|0|||
161251872|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Death|0|||
161251873|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Death|0|||
161251874|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Death|0|||
161251875|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Death|0|||
161251876|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
161251877|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
161251878|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
161251879|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
161251880|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
161251881|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
160843542|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
160843543|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
160843544|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843545|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843546|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843547|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
160843548|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
160843549|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
160843550|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
160843551|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
160843552|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
160843553|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
160843554|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
160843555|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
160843556|NCT00095173|580815541|FG000|Open-Label Extension Phase (Period C)|Other|0|||
160843557|NCT00095173|580815542|FG001|Open-Label Extension Phase (Period C)|Other|0|||
160843558|NCT00095173|580815543|FG002|Open-Label Extension Phase (Period C)|Other|0|||
160843559|NCT00095173|580815544|FG003|Open-Label Extension Phase (Period C)|Other|4|||
160843560|NCT00095173|580815545|FG004|Open-Label Extension Phase (Period C)|Other|6|||
160843561|NCT00095173|580815546|FG005|Open-Label Extension Phase (Period C)|Other|8|||
160843562|NCT02161757|580815553|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
160843563|NCT02161757|580815554|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
160843564|NCT02161757|580815555|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
160843565|NCT02161757|580815553|FG000|Treatment Through Study Completion|Adverse Event|1|||
160843566|NCT02161757|580815554|FG001|Treatment Through Study Completion|Adverse Event|1|||
160843567|NCT02161757|580815555|FG002|Treatment Through Study Completion|Adverse Event|0|||
160843568|NCT02161757|580815553|FG000|Treatment Through Study Completion|Protocol Violation|0|||
160843569|NCT02161757|580815554|FG001|Treatment Through Study Completion|Protocol Violation|1|||
160843570|NCT02161757|580815555|FG002|Treatment Through Study Completion|Protocol Violation|2|||
160843571|NCT02161757|580815553|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
160843572|NCT02161757|580815554|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
160843573|NCT02161757|580815555|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
160843574|NCT02161757|580815553|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
160843575|NCT02161757|580815554|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
160843576|NCT02161757|580815555|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
160843577|NCT02161757|580815553|FG000|Treatment Through Study Completion|Other|20|||
160843578|NCT02161757|580815554|FG001|Treatment Through Study Completion|Other|19|||
160843579|NCT02161757|580815555|FG002|Treatment Through Study Completion|Other|12|||
160905707|NCT02955602|581050288|FG001|Overall Study|Withdrawal of informed consent|3|||
161251882|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
161251883|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
160905708|NCT02955602|581050289|FG002|Overall Study|Withdrawal of informed consent|2|||
161251884|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
161251885|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
160843580|NCT02161757|580815553|FG000|Treatment Through Study Completion|Death|2|||
160843581|NCT02161757|580815554|FG001|Treatment Through Study Completion|Death|1|||
161251886|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161251887|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
160843582|NCT02161757|580815555|FG002|Treatment Through Study Completion|Death|1|||
160905709|NCT02955602|581050287|FG000|Overall Study|Lost to Follow-up|0|||
160843583|NCT00391625|580815556|FG000|Month 14|Withdrawal by Subject|1|||
160843584|NCT00391625|580815556|FG000|Month 50|Physician Decision|1|||
160843585|NCT02106403|580815563|FG000|Follow-Up Visit 3|Other Reason|0|||
160843586|NCT02106403|580815564|FG001|Follow-Up Visit 3|Other Reason|0|||
160843587|NCT02106403|580815565|FG002|Follow-Up Visit 3|Other Reason|0|||
160843588|NCT02106403|580815566|FG003|Follow-Up Visit 3|Other Reason|0|||
160843589|NCT02106403|580815567|FG004|Follow-Up Visit 3|Other Reason|0|||
160843590|NCT02106403|580815568|FG005|Follow-Up Visit 3|Other Reason|1|||
160843591|NCT01128946|580815581|FG000|Period I|Protocol Violation|0|||
160843592|NCT01128946|580815582|FG001|Period I|Protocol Violation|1|||
160843593|NCT01128946|580815583|FG002|Period I|Protocol Violation|0|||
160843594|NCT01128946|580815584|FG003|Period I|Protocol Violation|0|||
160843595|NCT01128946|580815581|FG000|Period I|Withdrawal by Subject|0|||
160843596|NCT01128946|580815582|FG001|Period I|Withdrawal by Subject|0|||
160843597|NCT01128946|580815583|FG002|Period I|Withdrawal by Subject|1|||
160843598|NCT01128946|580815584|FG003|Period I|Withdrawal by Subject|1|||
160843599|NCT01128946|580815581|FG000|Period II|Protocol Violation|0|||
160843600|NCT01128946|580815582|FG001|Period II|Protocol Violation|1|||
160843601|NCT01128946|580815583|FG002|Period II|Protocol Violation|0|||
160843602|NCT01128946|580815584|FG003|Period II|Protocol Violation|0|||
160843603|NCT01128946|580815581|FG000|Period II|Withdrawal by Subject|0|||
160843604|NCT01128946|580815582|FG001|Period II|Withdrawal by Subject|0|||
160843605|NCT01128946|580815583|FG002|Period II|Withdrawal by Subject|0|||
160843606|NCT01128946|580815584|FG003|Period II|Withdrawal by Subject|1|||
160843607|NCT01128946|580815581|FG000|Period III|Protocol Violation|1|||
160843608|NCT01128946|580815582|FG001|Period III|Protocol Violation|0|||
160843609|NCT01128946|580815583|FG002|Period III|Protocol Violation|0|||
160843610|NCT01128946|580815584|FG003|Period III|Protocol Violation|0|||
160843611|NCT00379912|580815585|FG000|Overall Study|Lack of Efficacy|1|||
160843612|NCT00379912|580815586|FG001|Overall Study|Lack of Efficacy|0|||
160843613|NCT04698993|580815587|FG000|Overall Study|PCR results not accessible|2|||
160843614|NCT04698993|580815588|FG001|Overall Study|PCR results not accessible|7|||
160843615|NCT04698993|580815587|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
160843616|NCT04698993|580815588|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
160843617|NCT00206440|580815589|FG000|Overall Study|Protocol Violation|1|||
160843618|NCT00206440|580815590|FG001|Overall Study|Protocol Violation|2|||
160843619|NCT00206440|580815589|FG000|Overall Study|Adverse Event|4|||
160843620|NCT00206440|580815590|FG001|Overall Study|Adverse Event|2|||
160843621|NCT01371734|580815591|FG000|Overall Study|Other|2|||
160843622|NCT01371734|580815592|FG001|Overall Study|Other|1|||
160843623|NCT01371734|580815593|FG002|Overall Study|Other|2|||
160843624|NCT01371734|580815591|FG000|Overall Study|Withdrawal by Subject|3|||
160843625|NCT01371734|580815592|FG001|Overall Study|Withdrawal by Subject|4|||
160843626|NCT01371734|580815593|FG002|Overall Study|Withdrawal by Subject|9|||
161251888|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
160843627|NCT01371734|580815591|FG000|Overall Study|Lost to Follow-up|5|||
160843628|NCT01371734|580815592|FG001|Overall Study|Lost to Follow-up|3|||
160843629|NCT01371734|580815593|FG002|Overall Study|Lost to Follow-up|1|||
160843630|NCT01371734|580815591|FG000|Overall Study|Protocol Violation|3|||
160843631|NCT01371734|580815592|FG001|Overall Study|Protocol Violation|1|||
160843632|NCT01371734|580815593|FG002|Overall Study|Protocol Violation|2|||
160843633|NCT01371734|580815591|FG000|Overall Study|Adverse Event|8|||
160843634|NCT01371734|580815592|FG001|Overall Study|Adverse Event|8|||
160843635|NCT01371734|580815593|FG002|Overall Study|Adverse Event|3|||
160843636|NCT01371734|580815591|FG000|Overall Study|Lack of Efficacy|2|||
160843637|NCT01371734|580815592|FG001|Overall Study|Lack of Efficacy|2|||
161251889|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
160843638|NCT01371734|580815593|FG002|Overall Study|Lack of Efficacy|0|||
160843639|NCT01140061|580815596|FG000|Part I|Adverse Event|1|||
160843640|NCT01140061|580815597|FG001|Part I|Adverse Event|0|||
161251890|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161251891|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161251892|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
160843641|NCT01140061|580815598|FG002|Part I|Adverse Event|0|||
160843642|NCT01140061|580815599|FG003|Part I|Adverse Event|0|||
160843643|NCT01140061|580815600|FG004|Part I|Adverse Event|0|||
160843644|NCT01140061|580815601|FG005|Part I|Adverse Event|0|||
160843645|NCT01140061|580815602|FG006|Part I|Adverse Event|0|||
160843646|NCT01140061|580815603|FG007|Part I|Adverse Event|0|||
160843647|NCT01140061|580815604|FG008|Part I|Adverse Event|0|||
160843648|NCT01140061|580815605|FG009|Part I|Adverse Event|0|||
160843649|NCT01140061|580815596|FG000|Extension|Laboratory Adverse Event|0|||
160843650|NCT01140061|580815597|FG001|Extension|Laboratory Adverse Event|0|||
160843651|NCT01140061|580815598|FG002|Extension|Laboratory Adverse Event|0|||
160843652|NCT01140061|580815599|FG003|Extension|Laboratory Adverse Event|0|||
160843653|NCT01140061|580815600|FG004|Extension|Laboratory Adverse Event|0|||
160843654|NCT01140061|580815601|FG005|Extension|Laboratory Adverse Event|0|||
160843655|NCT01140061|580815602|FG006|Extension|Laboratory Adverse Event|0|||
160905710|NCT02955602|581050288|FG001|Overall Study|Lost to Follow-up|0|||
160905711|NCT02955602|581050289|FG002|Overall Study|Lost to Follow-up|1|||
160905712|NCT02955602|581050287|FG000|Overall Study|Other|0|||
160905713|NCT02955602|581050288|FG001|Overall Study|Other|1|||
160905714|NCT02955602|581050289|FG002|Overall Study|Other|3|||
160905715|NCT03000439|581050292|FG000|Open Label Part 1|Adverse Event|6|||
160905716|NCT03000439|581050293|FG001|Open Label Part 1|Adverse Event|0|||
160905717|NCT03000439|581050294|FG002|Open Label Part 1|Adverse Event|0|||
160905718|NCT03000439|581050295|FG003|Open Label Part 1|Adverse Event|0|||
160905719|NCT03000439|581050292|FG000|Open Label Part 1|Other|2|||
160905720|NCT03000439|581050293|FG001|Open Label Part 1|Other|0|||
160905721|NCT03000439|581050294|FG002|Open Label Part 1|Other|0|||
160905722|NCT03000439|581050295|FG003|Open Label Part 1|Other|0|||
160905723|NCT03000439|581050292|FG000|Open Label Part 1|Insufficient clinical response|16|||
160905724|NCT03000439|581050293|FG001|Open Label Part 1|Insufficient clinical response|0|||
160905725|NCT03000439|581050294|FG002|Open Label Part 1|Insufficient clinical response|0|||
160905726|NCT03000439|581050295|FG003|Open Label Part 1|Insufficient clinical response|0|||
160905727|NCT03000439|581050292|FG000|Open Label Part 2|Other|0|||
160905728|NCT03000439|581050293|FG001|Open Label Part 2|Other|5|||
160905729|NCT03000439|581050294|FG002|Open Label Part 2|Other|0|||
160905730|NCT03000439|581050295|FG003|Open Label Part 2|Other|0|||
160905731|NCT03000439|581050292|FG000|Open Label Part 2|Insufficient clinical response|0|||
160905732|NCT03000439|581050293|FG001|Open Label Part 2|Insufficient clinical response|12|||
160905733|NCT03000439|581050294|FG002|Open Label Part 2|Insufficient clinical response|0|||
160905734|NCT03000439|581050295|FG003|Open Label Part 2|Insufficient clinical response|0|||
160905735|NCT03000439|581050292|FG000|Double Blind Phase|Adverse Event|0|||
160905736|NCT03000439|581050293|FG001|Double Blind Phase|Adverse Event|0|||
160905737|NCT03000439|581050294|FG002|Double Blind Phase|Adverse Event|2|||
160905738|NCT03000439|581050295|FG003|Double Blind Phase|Adverse Event|1|||
160905739|NCT03000439|581050292|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
160905740|NCT03000439|581050293|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
160905741|NCT03000439|581050294|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
160905742|NCT03000439|581050295|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
160905743|NCT03000439|581050292|FG000|Double Blind Phase|Other|0|||
160905744|NCT03000439|581050293|FG001|Double Blind Phase|Other|0|||
160905745|NCT03000439|581050294|FG002|Double Blind Phase|Other|10|||
160905746|NCT03000439|581050295|FG003|Double Blind Phase|Other|11|||
160905747|NCT03000439|581050292|FG000|Double Blind Phase|Insufficient clinical response|0|||
160905748|NCT03000439|581050293|FG001|Double Blind Phase|Insufficient clinical response|0|||
160905749|NCT03000439|581050294|FG002|Double Blind Phase|Insufficient clinical response|0|||
160905750|NCT03000439|581050295|FG003|Double Blind Phase|Insufficient clinical response|2|||
160905751|NCT02501473|581050296|FG000|Overall Study|Study Terminated|2|||
160905752|NCT02501473|581050297|FG001|Overall Study|Study Terminated|3|||
160905753|NCT02501473|581050298|FG002|Overall Study|Study Terminated|7|||
160905754|NCT02501473|581050299|FG003|Overall Study|Study Terminated|9|||
160905755|NCT02501473|581050300|FG004|Overall Study|Study Terminated|2|||
160905756|NCT02501473|581050301|FG005|Overall Study|Study Terminated|10|||
160905757|NCT02501473|581050302|FG006|Overall Study|Study Terminated|1|||
160905758|NCT02501473|581050303|FG007|Overall Study|Study Terminated|0|||
160905759|NCT02501473|581050296|FG000|Overall Study|Withdrawal by Subject|0|||
160905760|NCT02501473|581050297|FG001|Overall Study|Withdrawal by Subject|0|||
160905761|NCT02501473|581050298|FG002|Overall Study|Withdrawal by Subject|3|||
160905762|NCT02501473|581050299|FG003|Overall Study|Withdrawal by Subject|3|||
160905763|NCT02501473|581050300|FG004|Overall Study|Withdrawal by Subject|2|||
160905764|NCT02501473|581050301|FG005|Overall Study|Withdrawal by Subject|2|||
160905765|NCT02501473|581050302|FG006|Overall Study|Withdrawal by Subject|0|||
160905766|NCT02501473|581050303|FG007|Overall Study|Withdrawal by Subject|0|||
160905767|NCT02501473|581050296|FG000|Overall Study|Death|0|||
160905768|NCT02501473|581050297|FG001|Overall Study|Death|0|||
160905769|NCT02501473|581050298|FG002|Overall Study|Death|1|||
160905770|NCT02501473|581050299|FG003|Overall Study|Death|1|||
160905771|NCT02501473|581050300|FG004|Overall Study|Death|0|||
160905772|NCT02501473|581050301|FG005|Overall Study|Death|1|||
160905773|NCT02501473|581050302|FG006|Overall Study|Death|0|||
160905774|NCT02501473|581050303|FG007|Overall Study|Death|0|||
160905775|NCT02501473|581050296|FG000|Overall Study|Lost to Follow-up|1|||
160905776|NCT02501473|581050297|FG001|Overall Study|Lost to Follow-up|0|||
160905777|NCT02501473|581050298|FG002|Overall Study|Lost to Follow-up|1|||
160905778|NCT02501473|581050299|FG003|Overall Study|Lost to Follow-up|0|||
160905779|NCT02501473|581050300|FG004|Overall Study|Lost to Follow-up|0|||
160905780|NCT02501473|581050301|FG005|Overall Study|Lost to Follow-up|1|||
160905781|NCT02501473|581050302|FG006|Overall Study|Lost to Follow-up|0|||
160905782|NCT02501473|581050303|FG007|Overall Study|Lost to Follow-up|0|||
161335002|NCT03177148|582615890|FG001|Overall Study|Lost to Follow-up|1|||
160905783|NCT02501473|581050296|FG000|Overall Study|Reason not specified|0|||
160905784|NCT02501473|581050297|FG001|Overall Study|Reason not specified|0|||
160905785|NCT02501473|581050298|FG002|Overall Study|Reason not specified|1|||
160905786|NCT02501473|581050299|FG003|Overall Study|Reason not specified|1|||
160905787|NCT02501473|581050300|FG004|Overall Study|Reason not specified|0|||
160905788|NCT02501473|581050301|FG005|Overall Study|Reason not specified|0|||
160843656|NCT01140061|580815603|FG007|Extension|Laboratory Adverse Event|0|||
160843657|NCT01140061|580815604|FG008|Extension|Laboratory Adverse Event|0|||
160843658|NCT01140061|580815605|FG009|Extension|Laboratory Adverse Event|1|||
160843659|NCT00766051|580815607|FG000|Overall Study|Withdrawal by Subject|2|||
160843660|NCT00766051|580815608|FG001|Overall Study|Withdrawal by Subject|0|||
160843661|NCT02669121|580815609|FG000|Overall Study|Adverse Event|4|||
160843662|NCT02669121|580815610|FG001|Overall Study|Adverse Event|5|||
160843663|NCT02669121|580815609|FG000|Overall Study|Lost to Follow-up|15|||
160843664|NCT02669121|580815610|FG001|Overall Study|Lost to Follow-up|27|||
160843665|NCT02669121|580815609|FG000|Overall Study|Withdrawal by Subject|132|||
160843666|NCT02669121|580815610|FG001|Overall Study|Withdrawal by Subject|140|||
160843667|NCT02669121|580815609|FG000|Overall Study|Pregnancy|0|||
160843668|NCT02669121|580815610|FG001|Overall Study|Pregnancy|1|||
160843669|NCT02669121|580815609|FG000|Overall Study|Discharged from US Military Active Service|117|||
160843670|NCT02669121|580815610|FG001|Overall Study|Discharged from US Military Active Service|91|||
160843671|NCT02669121|580815609|FG000|Overall Study|Reason not Specified|22|||
160843672|NCT02669121|580815610|FG001|Overall Study|Reason not Specified|18|||
160843673|NCT02708355|580815611|FG000|Overall Study|Adverse Event|1|||
160843674|NCT02708355|580815612|FG001|Overall Study|Adverse Event|0|||
160843675|NCT02708355|580815613|FG002|Overall Study|Adverse Event|0|||
160843676|NCT04384523|580815614|FG000|Overall Study|Lost to Follow-up|0|||
160843677|NCT04384523|580815615|FG001|Overall Study|Lost to Follow-up|0|||
160843678|NCT04384523|580815616|FG002|Overall Study|Lost to Follow-up|0|||
160843679|NCT04384523|580815617|FG003|Overall Study|Lost to Follow-up|0|||
160843680|NCT04384523|580815618|FG004|Overall Study|Lost to Follow-up|0|||
160843681|NCT04384523|580815619|FG005|Overall Study|Lost to Follow-up|1|||
160843682|NCT04384523|580815614|FG000|Overall Study|Protocol Violation|0|||
160843683|NCT04384523|580815615|FG001|Overall Study|Protocol Violation|1|||
160843684|NCT04384523|580815616|FG002|Overall Study|Protocol Violation|0|||
160843685|NCT04384523|580815617|FG003|Overall Study|Protocol Violation|0|||
160843686|NCT04384523|580815618|FG004|Overall Study|Protocol Violation|0|||
160843687|NCT04384523|580815619|FG005|Overall Study|Protocol Violation|0|||
160843688|NCT04384523|580815614|FG000|Overall Study|Withdrawal by Subject|1|||
160843689|NCT04384523|580815615|FG001|Overall Study|Withdrawal by Subject|0|||
160843690|NCT04384523|580815616|FG002|Overall Study|Withdrawal by Subject|0|||
160843691|NCT04384523|580815617|FG003|Overall Study|Withdrawal by Subject|0|||
160843692|NCT04384523|580815618|FG004|Overall Study|Withdrawal by Subject|0|||
160843693|NCT04384523|580815619|FG005|Overall Study|Withdrawal by Subject|0|||
160843694|NCT03216746|580815620|FG000|Overall Study|Lost to Follow-up|6|||
160843695|NCT03216746|580815621|FG001|Overall Study|Lost to Follow-up|8|||
160843696|NCT03216746|580815622|FG002|Overall Study|Lost to Follow-up|5|||
160843697|NCT03216746|580815623|FG003|Overall Study|Lost to Follow-up|6|||
160843698|NCT00635882|580815624|FG000|Overall Study|Protocol Violation|1|||
160843699|NCT00635882|580815625|FG001|Overall Study|Protocol Violation|0|||
160843700|NCT00635882|580815626|FG002|Overall Study|Protocol Violation|0|||
160843701|NCT00635882|580815627|FG003|Overall Study|Protocol Violation|0|||
160843702|NCT00635882|580815628|FG004|Overall Study|Protocol Violation|0|||
160905789|NCT02501473|581050302|FG006|Overall Study|Reason not specified|0|||
160843703|NCT00635882|580815629|FG005|Overall Study|Protocol Violation|0|||
160843704|NCT01320202|580815630|FG000|Overall Study|Adverse Event|5|||
160843705|NCT01320202|580815631|FG001|Overall Study|Adverse Event|5|||
160843706|NCT01320202|580815630|FG000|Overall Study|Death|5|||
160843707|NCT01320202|580815631|FG001|Overall Study|Death|3|||
160843708|NCT01320202|580815630|FG000|Overall Study|Lost to Follow-up|1|||
160843709|NCT01320202|580815631|FG001|Overall Study|Lost to Follow-up|0|||
160843710|NCT01320202|580815630|FG000|Overall Study|Physician Decision|3|||
160843711|NCT01320202|580815631|FG001|Overall Study|Physician Decision|1|||
160843712|NCT01320202|580815630|FG000|Overall Study|Protocol Violation|2|||
160843713|NCT01320202|580815631|FG001|Overall Study|Protocol Violation|1|||
160843714|NCT01320202|580815630|FG000|Overall Study|Withdrawal by Subject|10|||
160843715|NCT01320202|580815631|FG001|Overall Study|Withdrawal by Subject|3|||
160843716|NCT01320202|580815630|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
160843717|NCT01320202|580815631|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
160843718|NCT01320202|580815630|FG000|Overall Study|kidney transplant|1|||
160843719|NCT01320202|580815631|FG001|Overall Study|kidney transplant|2|||
161139406|NCT04233424|581892698|FG001|Overall Study|Lost to Follow-up|3|||
160843720|NCT01320202|580815630|FG000|Overall Study|blood transfusion|1|||
160905790|NCT02501473|581050303|FG007|Overall Study|Reason not specified|0|||
161139407|NCT04233424|581892697|FG000|Overall Study|subject refuse to visit site|2|||
161139408|NCT04233424|581892698|FG001|Overall Study|subject refuse to visit site|0|||
161139409|NCT02698189|581892699|FG000|Overall Study|Physician Decision|3|||
161139410|NCT02698189|581892700|FG001|Overall Study|Physician Decision|0|||
161139411|NCT02698189|581892699|FG000|Overall Study|Progressive disease|0|||
161139412|NCT02698189|581892700|FG001|Overall Study|Progressive disease|5|||
161139413|NCT02698189|581892699|FG000|Overall Study|Study terminated by sponsor|0|||
161139414|NCT02698189|581892700|FG001|Overall Study|Study terminated by sponsor|1|||
161139415|NCT02240706|581892701|FG000|Overall Study|Lack of Efficacy|2|||
161139416|NCT02240706|581892702|FG001|Overall Study|Lack of Efficacy|2|||
160843721|NCT01320202|580815631|FG001|Overall Study|blood transfusion|7|||
160843722|NCT01320202|580815630|FG000|Overall Study|moved/changed dialysis|5|||
160843723|NCT01320202|580815631|FG001|Overall Study|moved/changed dialysis|2|||
160843724|NCT01320202|580815630|FG000|Overall Study|sponsor request|2|||
160843725|NCT01320202|580815631|FG001|Overall Study|sponsor request|0|||
160843726|NCT01320202|580815630|FG000|Overall Study|ineligible|3|||
160843727|NCT01320202|580815631|FG001|Overall Study|ineligible|0|||
160843728|NCT01320202|580815630|FG000|Overall Study|regained renal function|1|||
160843729|NCT01320202|580815631|FG001|Overall Study|regained renal function|0|||
160843730|NCT02006979|580815633|FG000|Overall Study|Withdrawal by Subject|1|||
160843731|NCT02006979|580815634|FG001|Overall Study|Withdrawal by Subject|1|||
160843732|NCT02006979|580815633|FG000|Overall Study|Protocol Violation|0|||
160843733|NCT02006979|580815634|FG001|Overall Study|Protocol Violation|1|||
160843734|NCT03848949|580815640|FG000|Overall Study|Lost to Follow-up|5|||
160843735|NCT03848949|580815641|FG001|Overall Study|Lost to Follow-up|7|||
160843736|NCT02697435|580815642|FG000|Overall Study|Withdrawal by Subject|1|||
160843737|NCT02697435|580815643|FG001|Overall Study|Withdrawal by Subject|0|||
160843738|NCT02697435|580815642|FG000|Overall Study|Physician Decision|0|||
160843739|NCT02697435|580815643|FG001|Overall Study|Physician Decision|4|||
160843740|NCT04230213|580815648|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
160843741|NCT04230213|580815649|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
160843742|NCT04230213|580815650|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
160843743|NCT04230213|580815648|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
160843744|NCT04230213|580815649|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
160843745|NCT04230213|580815650|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
160843746|NCT04230213|580815648|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
160843747|NCT04230213|580815649|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
160843748|NCT04230213|580815650|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
160843749|NCT04230213|580815648|FG000|TP2: Week 10 to Week 16|Other|0|||
160843750|NCT04230213|580815649|FG001|TP2: Week 10 to Week 16|Other|2|||
160843751|NCT04230213|580815650|FG002|TP2: Week 10 to Week 16|Other|1|||
160843752|NCT04230213|580815648|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
160843753|NCT04230213|580815649|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
160843754|NCT04230213|580815650|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
160843755|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
160843756|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
160843757|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
160843758|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
160843759|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
160843760|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
160843761|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
160843762|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
160843763|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
160843764|NCT04230213|580815648|FG000|TP3: Week 16 to Week 22|Other|0|||
160843765|NCT04230213|580815649|FG001|TP3: Week 16 to Week 22|Other|1|||
160843766|NCT04230213|580815650|FG002|TP3: Week 16 to Week 22|Other|3|||
160843767|NCT04230213|580815648|FG000|TP4: Week 22 to Week 32|Other|0|||
160843768|NCT04230213|580815649|FG001|TP4: Week 22 to Week 32|Other|5|||
160843769|NCT04230213|580815650|FG002|TP4: Week 22 to Week 32|Other|5|||
160843770|NCT04230213|580815648|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
160992176|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
160992177|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
160992178|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
160992179|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
160992180|NCT01080131|581359993|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
160992181|NCT01080131|581359994|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
160992182|NCT01080131|581359993|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
160992183|NCT01080131|581359994|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
161139417|NCT02240706|581892703|FG002|Overall Study|Lack of Efficacy|2|||
160843771|NCT04230213|580815649|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
160843772|NCT04230213|580815650|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
160843773|NCT04230213|580815648|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
160843774|NCT04230213|580815649|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
160843775|NCT04230213|580815650|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
161139418|NCT02240706|581892704|FG003|Overall Study|Lack of Efficacy|2|||
161139419|NCT02240706|581892705|FG004|Overall Study|Lack of Efficacy|5|||
160843776|NCT04230213|580815648|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
160843777|NCT04230213|580815649|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
160843778|NCT04230213|580815650|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
160843779|NCT04230213|580815648|FG000|Follow up: Week 32 to Week 36|Other|0|||
160843780|NCT04230213|580815649|FG001|Follow up: Week 32 to Week 36|Other|1|||
160843781|NCT04230213|580815650|FG002|Follow up: Week 32 to Week 36|Other|1|||
161139420|NCT02240706|581892706|FG005|Overall Study|Lack of Efficacy|0|||
161139421|NCT02240706|581892707|FG006|Overall Study|Lack of Efficacy|0|||
160843782|NCT00619307|580815660|FG000|Overall Study|Adverse Event|0|||
160843783|NCT00619307|580815661|FG001|Overall Study|Adverse Event|1|||
160843784|NCT00619307|580815660|FG000|Overall Study|Lost to Follow-up|0|||
160843785|NCT00619307|580815661|FG001|Overall Study|Lost to Follow-up|1|||
160843786|NCT00619307|580815660|FG000|Overall Study|Protocol Violation|3|||
160843787|NCT00619307|580815661|FG001|Overall Study|Protocol Violation|0|||
160843788|NCT00619307|580815660|FG000|Overall Study|Withdrew consent|1|||
160843789|NCT00619307|580815661|FG001|Overall Study|Withdrew consent|0|||
160843790|NCT00619307|580815660|FG000|Overall Study|Severe migraine|0|||
160843791|NCT00619307|580815661|FG001|Overall Study|Severe migraine|1|||
160843792|NCT00619307|580815660|FG000|Overall Study|MS attack plus steroids|0|||
160843793|NCT00619307|580815661|FG001|Overall Study|MS attack plus steroids|1|||
160843794|NCT00118430|580815670|FG000|Overall Study|Withdrawal by Subject|6|||
160843795|NCT00118430|580815671|FG001|Overall Study|Withdrawal by Subject|2|||
160843796|NCT00118430|580815672|FG002|Overall Study|Withdrawal by Subject|0|||
160843797|NCT00118430|580815670|FG000|Overall Study|Lost to Follow-up|15|||
160843798|NCT00118430|580815671|FG001|Overall Study|Lost to Follow-up|22|||
160843799|NCT00118430|580815672|FG002|Overall Study|Lost to Follow-up|28|||
160843800|NCT02147288|580815673|FG000|Overall Study|post-operative hematoma|1|||
160843801|NCT02147288|580815674|FG001|Overall Study|post-operative hematoma|1|||
160843802|NCT02147288|580815675|FG002|Overall Study|post-operative hematoma|0|||
160843803|NCT02147288|580815676|FG003|Overall Study|post-operative hematoma|0|||
160843804|NCT02147288|580815677|FG004|Overall Study|post-operative hematoma|0|||
160843805|NCT02147288|580815678|FG005|Overall Study|post-operative hematoma|0|||
160843806|NCT02147288|580815679|FG006|Overall Study|post-operative hematoma|0|||
160843807|NCT02147288|580815680|FG007|Overall Study|post-operative hematoma|0|||
160843808|NCT02147288|580815681|FG008|Overall Study|post-operative hematoma|0|||
160843809|NCT02147288|580815682|FG009|Overall Study|post-operative hematoma|0|||
160843810|NCT02147288|580815673|FG000|Overall Study|complications from concurrent hernia rep|0|||
160843811|NCT02147288|580815674|FG001|Overall Study|complications from concurrent hernia rep|1|||
160843812|NCT02147288|580815675|FG002|Overall Study|complications from concurrent hernia rep|0|||
160843813|NCT02147288|580815676|FG003|Overall Study|complications from concurrent hernia rep|0|||
160843814|NCT02147288|580815677|FG004|Overall Study|complications from concurrent hernia rep|0|||
160843815|NCT02147288|580815678|FG005|Overall Study|complications from concurrent hernia rep|0|||
160843816|NCT02147288|580815679|FG006|Overall Study|complications from concurrent hernia rep|0|||
160843817|NCT02147288|580815680|FG007|Overall Study|complications from concurrent hernia rep|0|||
160843818|NCT02147288|580815681|FG008|Overall Study|complications from concurrent hernia rep|0|||
160843819|NCT02147288|580815682|FG009|Overall Study|complications from concurrent hernia rep|0|||
160843820|NCT00861471|580815683|FG000|Overall Study|Withdrawal by Subject|1|||
160843821|NCT00861471|580815683|FG000|Overall Study|Adverse Event|2|||
160843822|NCT00861471|580815683|FG000|Overall Study|Lack of Efficacy|3|||
160843823|NCT00861471|580815683|FG000|Overall Study|treatment for lumbar laminectomy|1|||
160843824|NCT00861471|580815683|FG000|Overall Study|Physician Decision|2|||
160843825|NCT02069392|580815684|FG000|Overall Study|Withdrawal by Subject|4|||
160843826|NCT02069392|580815685|FG001|Overall Study|Withdrawal by Subject|2|||
160843827|NCT01574651|580815686|FG000|Overall Study|Lost to Follow-up|2|||
160843828|NCT01574651|580815687|FG001|Overall Study|Lost to Follow-up|4|||
160843829|NCT01574651|580815686|FG000|Overall Study|Administrative problems|0|||
161335003|NCT03177148|582615889|FG000|Overall Study|Death|1|||
161335004|NCT03177148|582615890|FG001|Overall Study|Death|0|||
161335005|NCT02557399|582615891|FG000|Overall Study|Adverse Event|6|||
160843830|NCT01574651|580815687|FG001|Overall Study|Administrative problems|1|||
160843831|NCT01574651|580815686|FG000|Overall Study|Death|3|||
160843832|NCT01574651|580815687|FG001|Overall Study|Death|3|||
160843833|NCT01574651|580815686|FG000|Overall Study|Patient's inability to use the device|0|||
160843834|NCT01574651|580815687|FG001|Overall Study|Patient's inability to use the device|1|||
160843835|NCT01574651|580815686|FG000|Overall Study|Adverse Event|36|||
160843836|NCT01574651|580815687|FG001|Overall Study|Adverse Event|27|||
160843837|NCT01574651|580815686|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160843838|NCT01574651|580815687|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160843839|NCT01574651|580815686|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160843840|NCT01574651|580815687|FG001|Overall Study|Abnormal test procedure result(s)|1|||
160843841|NCT01574651|580815686|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160843842|NCT01574651|580815687|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160843843|NCT01574651|580815686|FG000|Overall Study|Protocol Violation|3|||
160843844|NCT01574651|580815687|FG001|Overall Study|Protocol Violation|5|||
160843845|NCT01574651|580815686|FG000|Overall Study|Withdrawal by Subject|9|||
160843846|NCT01574651|580815687|FG001|Overall Study|Withdrawal by Subject|10|||
160843847|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Adverse Event|33|||
160843848|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
160843849|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
160843850|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
160843851|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Physician Decision|6|||
160843852|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
160843853|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
160843854|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
160843855|NCT00965419|580815688|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
160843856|NCT00965419|580815688|FG000|Follow-up Phase|Adverse Event|9|||
160843857|NCT00965419|580815688|FG000|Follow-up Phase|Protocol Violation|4|||
160843858|NCT00965419|580815688|FG000|Follow-up Phase|Withdrawal by Subject|8|||
160843859|NCT00965419|580815688|FG000|Follow-up Phase|Physician Decision|4|||
160843860|NCT00965419|580815688|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
160843861|NCT00965419|580815688|FG000|Follow-up Phase|Lack of Efficacy|28|||
160843862|NCT04412707|580815689|FG000|Cycle 1|Death|0|||
160843863|NCT04412707|580815690|FG001|Cycle 1|Death|3|||
160843864|NCT04412707|580815689|FG000|Cycle 1|Disease progression|1|||
160843865|NCT04412707|580815690|FG001|Cycle 1|Disease progression|2|||
160843866|NCT04412707|580815689|FG000|Cycle 2|Death|0|||
160843867|NCT04412707|580815690|FG001|Cycle 2|Death|1|||
160843868|NCT04412707|580815689|FG000|Cycle 2|Disease progression|3|||
160843869|NCT04412707|580815690|FG001|Cycle 2|Disease progression|0|||
160843870|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
160843871|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
160843872|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
160843873|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
160843874|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
160843875|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
160843876|NCT04412707|580815689|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
160843877|NCT04412707|580815690|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
160843878|NCT00264537|580815691|FG000|Overall Study|Death|0|||
160843879|NCT00264537|580815692|FG001|Overall Study|Death|3|||
160843880|NCT00264537|580815693|FG002|Overall Study|Death|3|||
160843881|NCT00264537|580815694|FG003|Overall Study|Death|2|||
160843882|NCT00264537|580815691|FG000|Overall Study|Lost to Follow-up|3|||
160843883|NCT00264537|580815692|FG001|Overall Study|Lost to Follow-up|4|||
160843884|NCT00264537|580815693|FG002|Overall Study|Lost to Follow-up|7|||
160843885|NCT00264537|580815694|FG003|Overall Study|Lost to Follow-up|6|||
160843886|NCT00264537|580815691|FG000|Overall Study|Adverse Event|21|||
160843887|NCT00264537|580815692|FG001|Overall Study|Adverse Event|32|||
160843888|NCT00264537|580815693|FG002|Overall Study|Adverse Event|24|||
160843889|NCT00264537|580815694|FG003|Overall Study|Adverse Event|34|||
160843890|NCT00264537|580815691|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160843891|NCT00264537|580815692|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
160843892|NCT00264537|580815693|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
160843893|NCT00264537|580815694|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
160843894|NCT00264537|580815691|FG000|Overall Study|Other|21|||
160843895|NCT00264537|580815692|FG001|Overall Study|Other|11|||
160843896|NCT00264537|580815693|FG002|Overall Study|Other|10|||
160843897|NCT00264537|580815694|FG003|Overall Study|Other|11|||
160843898|NCT00264537|580815691|FG000|Overall Study|Not treated|0|||
160843899|NCT00264537|580815692|FG001|Overall Study|Not treated|2|||
160843900|NCT00264537|580815693|FG002|Overall Study|Not treated|1|||
160843901|NCT00264537|580815694|FG003|Overall Study|Not treated|0|||
160843902|NCT00615017|580817877|FG000|Overall Study|Adverse Event|0|||
160843903|NCT00615017|580817878|FG001|Overall Study|Adverse Event|1|||
160843904|NCT00615017|580817879|FG002|Overall Study|Adverse Event|2|||
160843905|NCT00615017|580817880|FG003|Overall Study|Adverse Event|0|||
160843906|NCT00615017|580817881|FG004|Overall Study|Adverse Event|0|||
160843907|NCT00615017|580817882|FG005|Overall Study|Adverse Event|1|||
160843908|NCT00615017|580817877|FG000|Overall Study|Death|0|||
160843909|NCT00615017|580817878|FG001|Overall Study|Death|0|||
160843910|NCT00615017|580817879|FG002|Overall Study|Death|2|||
160843911|NCT00615017|580817880|FG003|Overall Study|Death|0|||
160843912|NCT00615017|580817881|FG004|Overall Study|Death|1|||
160843913|NCT00615017|580817882|FG005|Overall Study|Death|1|||
160905791|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
160843914|NCT00615017|580817877|FG000|Overall Study|Sepsis resolved|0|||
160843915|NCT00615017|580817878|FG001|Overall Study|Sepsis resolved|0|||
160843916|NCT00615017|580817879|FG002|Overall Study|Sepsis resolved|1|||
160843917|NCT00615017|580817880|FG003|Overall Study|Sepsis resolved|0|||
160843918|NCT00615017|580817881|FG004|Overall Study|Sepsis resolved|0|||
160843919|NCT00615017|580817882|FG005|Overall Study|Sepsis resolved|0|||
160905792|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
161139422|NCT02240706|581892701|FG000|Overall Study|Adverse Event|1|||
160843920|NCT00615017|580817877|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
160843921|NCT00615017|580817878|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
160843922|NCT00615017|580817879|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
160843923|NCT00615017|580817880|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
160843924|NCT00615017|580817881|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
160843925|NCT00615017|580817882|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
160843926|NCT00615017|580817877|FG000|Overall Study|Physician discontinued drug|0|||
160843927|NCT00615017|580817878|FG001|Overall Study|Physician discontinued drug|0|||
160843928|NCT00615017|580817879|FG002|Overall Study|Physician discontinued drug|0|||
160843929|NCT00615017|580817880|FG003|Overall Study|Physician discontinued drug|0|||
160843930|NCT00615017|580817881|FG004|Overall Study|Physician discontinued drug|0|||
160843931|NCT00615017|580817882|FG005|Overall Study|Physician discontinued drug|1|||
160843932|NCT00855959|580817883|FG000|Overall Study|Adverse Event|2|||
160843933|NCT00855959|580817883|FG000|Overall Study|Lost to Follow-up|2|||
160843934|NCT00855959|580817883|FG000|Overall Study|Withdrawal by Subject|3|||
160843935|NCT00855959|580817883|FG000|Overall Study|Pregnancy|1|||
160843936|NCT00855959|580817883|FG000|Overall Study|Incorrect enrolment|1|||
160843937|NCT04014062|580817884|FG000|Period I: Dosing|Medical Grounds|4|||
160843938|NCT04014062|580817885|FG001|Period I: Dosing|Medical Grounds|5|||
160843939|NCT04014062|580817884|FG000|Period I: Dosing|Withdrawal by Subject|3|||
160843940|NCT04014062|580817885|FG001|Period I: Dosing|Withdrawal by Subject|1|||
160843941|NCT04306510|580817886|FG000|Overall Study|Voluntarily withdrawal|1|||
160843942|NCT04306510|580817886|FG000|Overall Study|Enrolled but Not Treated|1|||
160843943|NCT03329092|580817887|FG000|Overall Study|Other|2|||
160843944|NCT03329092|580817888|FG001|Overall Study|Other|2|||
160843945|NCT03329092|580817887|FG000|Overall Study|Withdrawal by Subject|16|||
160843946|NCT03329092|580817888|FG001|Overall Study|Withdrawal by Subject|3|||
160843947|NCT03329092|580817887|FG000|Overall Study|Physician Decision|1|||
160843948|NCT03329092|580817888|FG001|Overall Study|Physician Decision|0|||
160843949|NCT03329092|580817887|FG000|Overall Study|Death|17|||
160843950|NCT03329092|580817888|FG001|Overall Study|Death|11|||
160843951|NCT03329092|580817887|FG000|Overall Study|Adverse Event|3|||
160843952|NCT03329092|580817888|FG001|Overall Study|Adverse Event|1|||
160843953|NCT03329092|580817887|FG000|Overall Study|Lost to Follow-up|1|||
160843954|NCT03329092|580817888|FG001|Overall Study|Lost to Follow-up|1|||
160843955|NCT04878211|580817889|FG000|Overall Study|Lost to Follow-up|0|||
160843956|NCT04878211|580817890|FG001|Overall Study|Lost to Follow-up|0|||
160843957|NCT04878211|580817891|FG002|Overall Study|Lost to Follow-up|0|||
160843958|NCT04878211|580817892|FG003|Overall Study|Lost to Follow-up|1|||
160843959|NCT04878211|580817893|FG004|Overall Study|Lost to Follow-up|0|||
160843960|NCT04878211|580817894|FG005|Overall Study|Lost to Follow-up|1|||
160843961|NCT04878211|580817889|FG000|Overall Study|Protocol deviation|1|||
160843962|NCT04878211|580817890|FG001|Overall Study|Protocol deviation|0|||
160843963|NCT04878211|580817891|FG002|Overall Study|Protocol deviation|0|||
160843964|NCT04878211|580817892|FG003|Overall Study|Protocol deviation|0|||
160843965|NCT04878211|580817893|FG004|Overall Study|Protocol deviation|0|||
160843966|NCT04878211|580817894|FG005|Overall Study|Protocol deviation|0|||
160843967|NCT04878211|580817889|FG000|Overall Study|Study terminated by sponsor|0|||
160843968|NCT04878211|580817890|FG001|Overall Study|Study terminated by sponsor|0|||
160843969|NCT04878211|580817891|FG002|Overall Study|Study terminated by sponsor|0|||
160843970|NCT04878211|580817892|FG003|Overall Study|Study terminated by sponsor|0|||
160843971|NCT04878211|580817893|FG004|Overall Study|Study terminated by sponsor|9|||
160843972|NCT04878211|580817894|FG005|Overall Study|Study terminated by sponsor|4|||
160843973|NCT04878211|580817889|FG000|Overall Study|Subject decision|0|||
160843974|NCT04878211|580817890|FG001|Overall Study|Subject decision|0|||
160843975|NCT04878211|580817891|FG002|Overall Study|Subject decision|0|||
160843976|NCT04878211|580817892|FG003|Overall Study|Subject decision|0|||
160843977|NCT04878211|580817893|FG004|Overall Study|Subject decision|1|||
160843978|NCT04878211|580817894|FG005|Overall Study|Subject decision|0|||
160843979|NCT00856544|580817901|FG000|Overall Study|Randomized but not treated|3|||
160843980|NCT00856544|580817902|FG001|Overall Study|Randomized but not treated|0|||
160843981|NCT00856544|580817903|FG002|Overall Study|Randomized but not treated|0|||
160843982|NCT00856544|580817904|FG003|Overall Study|Randomized but not treated|0|||
160843983|NCT00856544|580817901|FG000|Overall Study|Death|0|||
160843984|NCT00856544|580817902|FG001|Overall Study|Death|2|||
160843985|NCT00856544|580817903|FG002|Overall Study|Death|0|||
160843986|NCT00856544|580817904|FG003|Overall Study|Death|0|||
160843987|NCT00856544|580817901|FG000|Overall Study|Adverse Event|20|||
160843988|NCT00856544|580817902|FG001|Overall Study|Adverse Event|29|||
160843989|NCT00856544|580817903|FG002|Overall Study|Adverse Event|2|||
160843990|NCT00856544|580817904|FG003|Overall Study|Adverse Event|3|||
160843991|NCT00856544|580817901|FG000|Overall Study|Lack of Efficacy|16|||
160992184|NCT01080131|581359993|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
160992185|NCT01080131|581359994|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
160843992|NCT00856544|580817902|FG001|Overall Study|Lack of Efficacy|12|||
160843993|NCT00856544|580817903|FG002|Overall Study|Lack of Efficacy|3|||
160843994|NCT00856544|580817904|FG003|Overall Study|Lack of Efficacy|3|||
160843995|NCT00856544|580817901|FG000|Overall Study|Other|9|||
160843996|NCT00856544|580817902|FG001|Overall Study|Other|16|||
160843997|NCT00856544|580817903|FG002|Overall Study|Other|1|||
160843998|NCT00856544|580817904|FG003|Overall Study|Other|6|||
160843999|NCT00856544|580817901|FG000|Overall Study|Lost to Follow-up|1|||
160844000|NCT00856544|580817902|FG001|Overall Study|Lost to Follow-up|2|||
160844001|NCT00856544|580817903|FG002|Overall Study|Lost to Follow-up|2|||
160844002|NCT00856544|580817904|FG003|Overall Study|Lost to Follow-up|0|||
160844003|NCT00856544|580817901|FG000|Overall Study|Withdrawal by Subject|8|||
160844004|NCT00856544|580817902|FG001|Overall Study|Withdrawal by Subject|5|||
160844005|NCT00856544|580817903|FG002|Overall Study|Withdrawal by Subject|0|||
160844006|NCT00856544|580817904|FG003|Overall Study|Withdrawal by Subject|1|||
160844007|NCT01564732|580817905|FG000|Overall Study|Early termination by the study sponsor|6|||
160844008|NCT01564732|580817906|FG001|Overall Study|Early termination by the study sponsor|5|||
160844009|NCT00394706|580817912|FG000|Overall Study|Withdrawal by Subject|2|||
160844010|NCT00394706|580817913|FG001|Overall Study|Withdrawal by Subject|0|||
160844011|NCT00394706|580817914|FG002|Overall Study|Withdrawal by Subject|1|||
160844012|NCT00394706|580817915|FG003|Overall Study|Withdrawal by Subject|0|||
160844013|NCT00394706|580817916|FG004|Overall Study|Withdrawal by Subject|0|||
160844014|NCT00394706|580817917|FG005|Overall Study|Withdrawal by Subject|2|||
160844015|NCT00394706|580817918|FG006|Overall Study|Withdrawal by Subject|1|||
160844016|NCT00394706|580817919|FG007|Overall Study|Withdrawal by Subject|0|||
160844017|NCT00394706|580817912|FG000|Overall Study|Lost to Follow-up|2|||
160844018|NCT00394706|580817913|FG001|Overall Study|Lost to Follow-up|2|||
160844019|NCT00394706|580817914|FG002|Overall Study|Lost to Follow-up|8|||
160844020|NCT00394706|580817915|FG003|Overall Study|Lost to Follow-up|1|||
160844021|NCT00394706|580817916|FG004|Overall Study|Lost to Follow-up|2|||
160844022|NCT00394706|580817917|FG005|Overall Study|Lost to Follow-up|5|||
160844023|NCT00394706|580817918|FG006|Overall Study|Lost to Follow-up|2|||
160844024|NCT00394706|580817919|FG007|Overall Study|Lost to Follow-up|0|||
160844025|NCT03040674|580817921|FG000|Overall Study|Lost to Follow-up|225|||
160844026|NCT03040674|580817921|FG000|Overall Study|Death|23|||
160844027|NCT01746368|580817924|FG000|Overall Study|Lost to Follow-up|2|||
160844028|NCT01746368|580817925|FG001|Overall Study|Lost to Follow-up|0|||
160844029|NCT01746368|580817924|FG000|Overall Study|Withdrawal by Subject|0|||
160844030|NCT01746368|580817925|FG001|Overall Study|Withdrawal by Subject|1|||
160844031|NCT02506192|580817926|FG000|Overall Study|Withdrawal by Subject|1|||
160844032|NCT02506192|580817927|FG001|Overall Study|Withdrawal by Subject|1|||
160844033|NCT04042909|580817928|FG000|Overall Study|Withdrawal by Subject|1|||
160844034|NCT04042909|580817929|FG001|Overall Study|Withdrawal by Subject|0|||
160844035|NCT04042909|580817930|FG002|Overall Study|Withdrawal by Subject|0|||
160844036|NCT04042909|580817928|FG000|Overall Study|duplicate cases|2|||
160844037|NCT04042909|580817929|FG001|Overall Study|duplicate cases|0|||
160844038|NCT04042909|580817930|FG002|Overall Study|duplicate cases|0|||
160844039|NCT04042909|580817928|FG000|Overall Study|technical problem|0|||
160844040|NCT04042909|580817929|FG001|Overall Study|technical problem|1|||
160844041|NCT04042909|580817930|FG002|Overall Study|technical problem|0|||
160844042|NCT03705559|580817931|FG000|Overall Study|COVID Shut down|1|||
160844043|NCT02576795|580817932|FG000|Overall Study|Lost to Follow-up|0|||
160844044|NCT02576795|580817933|FG001|Overall Study|Lost to Follow-up|0|||
160844045|NCT02576795|580817934|FG002|Overall Study|Lost to Follow-up|1|||
160844046|NCT02576795|580817935|FG003|Overall Study|Lost to Follow-up|0|||
160844047|NCT02362464|580817936|FG000|Overall Study|Switched to alternative therapy|1|||
160844048|NCT02362464|580817936|FG000|Overall Study|Refused further treatment|1|||
160844049|NCT02362464|580817936|FG000|Overall Study|Physician Decision|4|||
160844050|NCT02104947|580817937|FG000|Overall Study|Withdrawal by Subject|10|||
160844051|NCT02104947|580817938|FG001|Overall Study|Withdrawal by Subject|3|||
160844052|NCT02104947|580817937|FG000|Overall Study|Lost to Follow-up|4|||
160844053|NCT02104947|580817938|FG001|Overall Study|Lost to Follow-up|4|||
160844054|NCT02104947|580817937|FG000|Overall Study|Protocol Violation|6|||
160844055|NCT02104947|580817938|FG001|Overall Study|Protocol Violation|8|||
160844056|NCT02104947|580817937|FG000|Overall Study|Adverse Event|57|||
160844057|NCT02104947|580817938|FG001|Overall Study|Adverse Event|38|||
160844058|NCT02104947|580817937|FG000|Overall Study|Other than stated above|2|||
160844059|NCT02104947|580817938|FG001|Overall Study|Other than stated above|3|||
160844060|NCT02343406|580817939|FG000|Overall Study|Progressive disease|72|||
160844061|NCT02343406|580817940|FG001|Overall Study|Progressive disease|70|||
160844062|NCT02343406|580817941|FG002|Overall Study|Progressive disease|43|||
160844063|NCT02343406|580817942|FG003|Overall Study|Progressive disease|15|||
161139423|NCT02240706|581892702|FG001|Overall Study|Adverse Event|0|||
161139424|NCT02240706|581892703|FG002|Overall Study|Adverse Event|1|||
161139425|NCT02240706|581892704|FG003|Overall Study|Adverse Event|0|||
160844064|NCT02343406|580817943|FG004|Overall Study|Progressive disease|5|||
160844065|NCT02343406|580817939|FG000|Overall Study|Adverse Event|6|||
160844066|NCT02343406|580817940|FG001|Overall Study|Adverse Event|8|||
160844067|NCT02343406|580817941|FG002|Overall Study|Adverse Event|6|||
160844068|NCT02343406|580817942|FG003|Overall Study|Adverse Event|3|||
160844069|NCT02343406|580817943|FG004|Overall Study|Adverse Event|0|||
160844070|NCT02343406|580817939|FG000|Overall Study|Withdrawal by Subject|6|||
160844071|NCT02343406|580817940|FG001|Overall Study|Withdrawal by Subject|4|||
161139426|NCT02240706|581892705|FG004|Overall Study|Adverse Event|2|||
160844072|NCT02343406|580817941|FG002|Overall Study|Withdrawal by Subject|8|||
160844073|NCT02343406|580817942|FG003|Overall Study|Withdrawal by Subject|3|||
160844074|NCT02343406|580817943|FG004|Overall Study|Withdrawal by Subject|0|||
160844075|NCT02343406|580817939|FG000|Overall Study|Death|2|||
160844076|NCT02343406|580817940|FG001|Overall Study|Death|1|||
160844077|NCT02343406|580817941|FG002|Overall Study|Death|0|||
160844078|NCT02343406|580817942|FG003|Overall Study|Death|0|||
160844079|NCT02343406|580817943|FG004|Overall Study|Death|0|||
160844080|NCT02343406|580817939|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
160905793|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
160905794|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
160905795|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905796|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905797|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905798|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905799|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905800|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905801|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
160905802|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
160905803|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
160905804|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
160905805|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
160905806|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905807|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905808|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905809|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905810|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905811|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905812|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
160905813|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
160905814|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
160905815|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
160905816|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
160905817|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905818|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905819|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905820|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905821|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905822|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905823|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
160905824|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905825|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905826|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905827|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
160905828|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905829|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
161139427|NCT02240706|581892706|FG005|Overall Study|Adverse Event|0|||
161139428|NCT02240706|581892707|FG006|Overall Study|Adverse Event|0|||
161139429|NCT02240706|581892701|FG000|Overall Study|Progressive disease|0|||
161139430|NCT02240706|581892702|FG001|Overall Study|Progressive disease|0|||
161139431|NCT02240706|581892703|FG002|Overall Study|Progressive disease|0|||
161139432|NCT02240706|581892704|FG003|Overall Study|Progressive disease|0|||
161139433|NCT02240706|581892705|FG004|Overall Study|Progressive disease|1|||
161139434|NCT02240706|581892706|FG005|Overall Study|Progressive disease|0|||
161139435|NCT02240706|581892707|FG006|Overall Study|Progressive disease|0|||
161139436|NCT02240706|581892701|FG000|Overall Study|Dose limiting toxicity|0|||
161139437|NCT02240706|581892702|FG001|Overall Study|Dose limiting toxicity|0|||
161139438|NCT02240706|581892703|FG002|Overall Study|Dose limiting toxicity|0|||
161139439|NCT02240706|581892704|FG003|Overall Study|Dose limiting toxicity|0|||
161139440|NCT02240706|581892705|FG004|Overall Study|Dose limiting toxicity|1|||
161139441|NCT02240706|581892706|FG005|Overall Study|Dose limiting toxicity|0|||
161139442|NCT02240706|581892707|FG006|Overall Study|Dose limiting toxicity|0|||
161139443|NCT02240706|581892701|FG000|Overall Study|Refused to continue taking medication|0|||
161139444|NCT02240706|581892702|FG001|Overall Study|Refused to continue taking medication|1|||
161139445|NCT02240706|581892703|FG002|Overall Study|Refused to continue taking medication|3|||
161139446|NCT02240706|581892704|FG003|Overall Study|Refused to continue taking medication|1|||
161139447|NCT02240706|581892705|FG004|Overall Study|Refused to continue taking medication|2|||
161139448|NCT02240706|581892706|FG005|Overall Study|Refused to continue taking medication|0|||
161139449|NCT02240706|581892707|FG006|Overall Study|Refused to continue taking medication|0|||
161139450|NCT02240706|581892701|FG000|Overall Study|Insurance billing concerns|0|||
161139451|NCT02240706|581892702|FG001|Overall Study|Insurance billing concerns|0|||
161139452|NCT02240706|581892703|FG002|Overall Study|Insurance billing concerns|0|||
161139453|NCT02240706|581892704|FG003|Overall Study|Insurance billing concerns|1|||
161139454|NCT02240706|581892705|FG004|Overall Study|Insurance billing concerns|0|||
161139455|NCT02240706|581892706|FG005|Overall Study|Insurance billing concerns|0|||
161139456|NCT02240706|581892707|FG006|Overall Study|Insurance billing concerns|0|||
161139457|NCT00855439|581892712|FG000|Overall Study|Withdrawal by Subject|2|||
161139458|NCT00855439|581892713|FG001|Overall Study|Withdrawal by Subject|0|||
161139459|NCT00855439|581892712|FG000|Overall Study|Pregnancy|1|||
161139460|NCT00855439|581892713|FG001|Overall Study|Pregnancy|0|||
161139461|NCT05502289|581892714|FG000|Period 1|Out Of Window|1|||
161139462|NCT05502289|581892715|FG001|Period 1|Out Of Window|0|||
161139463|NCT02333227|581892725|FG000|Overall Study|Lost to Follow-up|137|||
161139464|NCT02333227|581892726|FG001|Overall Study|Lost to Follow-up|106|||
161139465|NCT02333227|581892725|FG000|Overall Study|Pregnancy Interrupted|42|||
161139466|NCT02333227|581892726|FG001|Overall Study|Pregnancy Interrupted|89|||
161139467|NCT02333227|581892725|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
161139468|NCT02333227|581892726|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
161139469|NCT01564784|581892727|FG000|Overall Study|Other|1|||
161139470|NCT01564784|581892728|FG001|Overall Study|Other|0|||
161139471|NCT01564784|581892727|FG000|Overall Study|Subject refused further follow-up|1|||
161139472|NCT01564784|581892728|FG001|Overall Study|Subject refused further follow-up|6|||
161139473|NCT01564784|581892727|FG000|Overall Study|Lost to Follow-up|1|||
161139474|NCT01564784|581892728|FG001|Overall Study|Lost to Follow-up|1|||
161139475|NCT01564784|581892727|FG000|Overall Study|Death|131|||
161139476|NCT01564784|581892728|FG001|Overall Study|Death|126|||
161251893|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161251894|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161251895|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
161251896|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Refusal|0|||
160844081|NCT02343406|580817940|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
160844082|NCT02343406|580817941|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
160844083|NCT02343406|580817942|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
160844084|NCT02343406|580817943|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
160844085|NCT02343406|580817939|FG000|Overall Study|Other primary malignancy|0|||
160844086|NCT02343406|580817940|FG001|Overall Study|Other primary malignancy|1|||
160844087|NCT02343406|580817941|FG002|Overall Study|Other primary malignancy|0|||
160844088|NCT02343406|580817942|FG003|Overall Study|Other primary malignancy|0|||
160844089|NCT02343406|580817943|FG004|Overall Study|Other primary malignancy|0|||
160844090|NCT02343406|580817939|FG000|Overall Study|Other, not specified|2|||
160844091|NCT02343406|580817940|FG001|Overall Study|Other, not specified|1|||
160844092|NCT02343406|580817941|FG002|Overall Study|Other, not specified|1|||
160844093|NCT02343406|580817942|FG003|Overall Study|Other, not specified|4|||
160844094|NCT02343406|580817943|FG004|Overall Study|Other, not specified|0|||
160844095|NCT00548145|580817944|FG000|Overall Study|Death|0|||
160844096|NCT00548145|580817945|FG001|Overall Study|Death|1|||
160844097|NCT00548145|580817944|FG000|Overall Study|Withdrawal by Subject|0|||
160844098|NCT00548145|580817945|FG001|Overall Study|Withdrawal by Subject|2|||
160844099|NCT00548145|580817944|FG000|Overall Study|Physician Decision|1|||
160844100|NCT00548145|580817945|FG001|Overall Study|Physician Decision|1|||
160844101|NCT00874848|580817946|FG000|Overall Study|Adverse Event|13|||
160844102|NCT00874848|580817947|FG001|Overall Study|Adverse Event|2|||
160844103|NCT00874848|580817946|FG000|Overall Study|Progressive neoplastic disease|38|||
160844104|NCT00874848|580817947|FG001|Overall Study|Progressive neoplastic disease|18|||
160844105|NCT00874848|580817946|FG000|Overall Study|Withdrawal by Subject|7|||
160844106|NCT00874848|580817947|FG001|Overall Study|Withdrawal by Subject|4|||
160844107|NCT00874848|580817946|FG000|Overall Study|Noncompliance|1|||
160844108|NCT00874848|580817947|FG001|Overall Study|Noncompliance|1|||
160844109|NCT00874848|580817946|FG000|Overall Study|Failure to comply with protocol|0|||
160844110|NCT00874848|580817947|FG001|Overall Study|Failure to comply with protocol|1|||
160844111|NCT00874848|580817946|FG000|Overall Study|Physician Decision|0|||
160844112|NCT00874848|580817947|FG001|Overall Study|Physician Decision|2|||
160844113|NCT03301350|580817954|FG000|Overall Study|Withdrawal by Subject|4|||
160844114|NCT03301350|580817954|FG000|Overall Study|Adverse Event|1|||
160844115|NCT03301350|580817954|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
161139477|NCT01076179|581892731|FG000|Overall Study|Withdrawal by Subject|1|||
161139478|NCT03459040|581892732|FG000|Overall Study|Death|8|||
161251897|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Refusal|2|||
161251898|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Refusal|694|||
161251899|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Refusal|4|||
161251900|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Refusal|0|||
161251901|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Refusal|3|||
160844116|NCT03301350|580817954|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
160844117|NCT03301350|580817954|FG000|Overall Study|no detail provided|1|||
160844118|NCT00621140|580817955|FG000|Overall Study|Adverse Event|4|||
161139479|NCT03459040|581892732|FG000|Overall Study|Withdrawal by Subject|1|||
160844119|NCT00621140|580817956|FG001|Overall Study|Adverse Event|5|||
161139480|NCT00488631|581892733|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
161139481|NCT00488631|581892734|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
161139482|NCT00488631|581892735|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
161251902|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Refusal|0|||
161251903|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Refusal|0|||
161251904|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Refusal|0|||
161251905|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Refusal|0|||
161251906|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
161251907|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
161251908|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
161251909|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
161251910|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
161251911|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
161251912|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
161251913|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
161251914|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
161251915|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
161251916|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251917|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
161251918|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251919|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251920|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251921|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251922|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251923|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251924|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251925|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
161251926|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
161335006|NCT02557399|582615892|FG001|Overall Study|Adverse Event|5|||
161335007|NCT02557399|582615891|FG000|Overall Study|Protocol Violation|0|||
161139483|NCT00488631|581892736|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
161139484|NCT00488631|581892737|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
161139485|NCT00488631|581892738|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
160844120|NCT00621140|580817955|FG000|Overall Study|Lost to Follow-up|1|||
160844121|NCT00621140|580817956|FG001|Overall Study|Lost to Follow-up|2|||
160844122|NCT00621140|580817955|FG000|Overall Study|Withdrawal by Subject|4|||
160844123|NCT00621140|580817956|FG001|Overall Study|Withdrawal by Subject|6|||
160844124|NCT00621140|580817955|FG000|Overall Study|Other incl. lack of efficacy|6|||
160844125|NCT00621140|580817956|FG001|Overall Study|Other incl. lack of efficacy|5|||
160844126|NCT00145574|580817957|FG000|Double Blind|Adverse Event|0|||
160844127|NCT00145574|580817958|FG001|Double Blind|Adverse Event|3|||
160844128|NCT00145574|580817959|FG002|Double Blind|Adverse Event|1|||
160844129|NCT00145574|580817957|FG000|Double Blind|Withdrawal by Subject|1|||
160844130|NCT00145574|580817958|FG001|Double Blind|Withdrawal by Subject|1|||
160844131|NCT00145574|580817959|FG002|Double Blind|Withdrawal by Subject|1|||
160844132|NCT00145574|580817957|FG000|Double Blind|required restricted medicine|0|||
160844133|NCT00145574|580817958|FG001|Double Blind|required restricted medicine|1|||
160992186|NCT01080131|581359993|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
160992187|NCT01080131|581359994|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
160844134|NCT00145574|580817959|FG002|Double Blind|required restricted medicine|0|||
161139486|NCT00488631|581892739|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
160844135|NCT00145574|580817957|FG000|Open Label Long-term Extension|Adverse Event|0|||
160844136|NCT00145574|580817958|FG001|Open Label Long-term Extension|Adverse Event|0|||
160844137|NCT00145574|580817959|FG002|Open Label Long-term Extension|Adverse Event|5|||
161139487|NCT00488631|581892740|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
161139488|NCT00488631|581892741|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
161139489|NCT00488631|581892742|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
161139490|NCT00488631|581892733|FG000|Double Blind Period (Week 0-54)|Death|0|||
161139491|NCT00488631|581892734|FG001|Double Blind Period (Week 0-54)|Death|0|||
161139492|NCT00488631|581892735|FG002|Double Blind Period (Week 0-54)|Death|0|||
161139493|NCT00488631|581892736|FG003|Double Blind Period (Week 0-54)|Death|0|||
161139494|NCT00488631|581892737|FG004|Double Blind Period (Week 0-54)|Death|0|||
161139495|NCT00488631|581892738|FG005|Double Blind Period (Week 0-54)|Death|1|||
161139496|NCT00488631|581892739|FG006|Double Blind Period (Week 0-54)|Death|0|||
161139497|NCT00488631|581892740|FG007|Double Blind Period (Week 0-54)|Death|0|||
161139498|NCT00488631|581892741|FG008|Double Blind Period (Week 0-54)|Death|0|||
161139499|NCT00488631|581892742|FG009|Double Blind Period (Week 0-54)|Death|0|||
161139500|NCT00488631|581892733|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
161139501|NCT00488631|581892734|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
161139502|NCT00488631|581892735|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
161139503|NCT00488631|581892736|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
161139504|NCT00488631|581892737|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
160844138|NCT00145574|580817957|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
160844139|NCT00145574|580817958|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
160844140|NCT00145574|580817959|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
160844141|NCT00145574|580817957|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
160844142|NCT00145574|580817958|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
160844143|NCT00145574|580817959|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
160844144|NCT00145574|580817957|FG000|Open Label Long-term Extension|required restricted medicine|0|||
160844145|NCT00145574|580817958|FG001|Open Label Long-term Extension|required restricted medicine|0|||
160844146|NCT00145574|580817959|FG002|Open Label Long-term Extension|required restricted medicine|1|||
160844147|NCT00958165|580817960|FG000|Overall Study|Lost to Follow-up|5|||
160844148|NCT00958165|580817960|FG000|Overall Study|Not eligible|9|||
160844149|NCT01298765|580817962|FG000|Titration Period|Adverse Event|26|||
160844150|NCT01298765|580817962|FG000|Titration Period|Death|1|||
160844151|NCT01298765|580817962|FG000|Titration Period|Lack of Efficacy|21|||
160992188|NCT02014558|581359995|FG000|Overall Study|Never Received Study Drug|0|||
160992189|NCT02014558|581359996|FG001|Overall Study|Never Received Study Drug|0|||
160992190|NCT02014558|581359997|FG002|Overall Study|Never Received Study Drug|0|||
160992191|NCT02014558|581359998|FG003|Overall Study|Never Received Study Drug|0|||
160992192|NCT02014558|581359999|FG004|Overall Study|Never Received Study Drug|1|||
160992193|NCT02014558|581360000|FG005|Overall Study|Never Received Study Drug|0|||
160992194|NCT02014558|581360001|FG006|Overall Study|Never Received Study Drug|1|||
160992195|NCT02014558|581360002|FG007|Overall Study|Never Received Study Drug|0|||
160992196|NCT02014558|581360003|FG008|Overall Study|Never Received Study Drug|2|||
160992197|NCT02014558|581360004|FG009|Overall Study|Never Received Study Drug|0|||
160992198|NCT02014558|581360005|FG010|Overall Study|Never Received Study Drug|2|||
160992199|NCT02014558|581360006|FG011|Overall Study|Never Received Study Drug|2|||
160992200|NCT02014558|581360007|FG012|Overall Study|Never Received Study Drug|0|||
160992201|NCT02014558|581359995|FG000|Overall Study|Adverse Event|0|||
160992202|NCT02014558|581359996|FG001|Overall Study|Adverse Event|0|||
160844152|NCT01298765|580817962|FG000|Titration Period|Lost to Follow-up|9|||
160844153|NCT01298765|580817962|FG000|Titration Period|Physician Decision|1|||
160844154|NCT01298765|580817962|FG000|Titration Period|Withdrawal by Subject|10|||
160844155|NCT01298765|580817962|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
160844156|NCT01298765|580817962|FG000|Long-Term Treatment Period|Adverse Event|19|||
160844157|NCT01298765|580817962|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
160844158|NCT01298765|580817962|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
160844159|NCT01298765|580817962|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
160844160|NCT01298765|580817962|FG000|Long-Term Treatment Period|Physician Decision|1|||
160844161|NCT01298765|580817962|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
160844162|NCT03565237|580817963|FG000|Overall Study|Non-compliance of Investigational Product|1|||
160844163|NCT03565237|580817963|FG000|Overall Study|Physician Decision|1|||
160844164|NCT00428389|580817964|FG000|Core Phase|Adverse Event|6|||
160844165|NCT00428389|580817965|FG001|Core Phase|Adverse Event|4|||
160844166|NCT00428389|580817964|FG000|Core Phase|Lack of Efficacy|2|||
160844167|NCT00428389|580817965|FG001|Core Phase|Lack of Efficacy|0|||
160844168|NCT00428389|580817964|FG000|Core Phase|Abnormal test procedure result(s)|0|||
160844169|NCT00428389|580817965|FG001|Core Phase|Abnormal test procedure result(s)|1|||
160844170|NCT00428389|580817964|FG000|Core Phase|Withdrawal by Subject|3|||
160992203|NCT02014558|581359997|FG002|Overall Study|Adverse Event|0|||
160992204|NCT02014558|581359998|FG003|Overall Study|Adverse Event|0|||
160992205|NCT02014558|581359999|FG004|Overall Study|Adverse Event|1|||
160992206|NCT02014558|581360000|FG005|Overall Study|Adverse Event|0|||
160992207|NCT02014558|581360001|FG006|Overall Study|Adverse Event|0|||
160992208|NCT02014558|581360002|FG007|Overall Study|Adverse Event|0|||
160844171|NCT00428389|580817965|FG001|Core Phase|Withdrawal by Subject|4|||
160844172|NCT00428389|580817964|FG000|Core Phase|Protocol deviation|0|||
160844173|NCT00428389|580817965|FG001|Core Phase|Protocol deviation|2|||
160844174|NCT00428389|580817964|FG000|Extension Phase|Adverse Event|17|||
160844175|NCT00428389|580817965|FG001|Extension Phase|Adverse Event|11|||
160844176|NCT00428389|580817964|FG000|Extension Phase|Lack of Efficacy|4|||
160844177|NCT00428389|580817965|FG001|Extension Phase|Lack of Efficacy|3|||
160844178|NCT00428389|580817964|FG000|Extension Phase|Withdrawal by Subject|6|||
161139505|NCT00488631|581892738|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
161139506|NCT00488631|581892739|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161139507|NCT00488631|581892740|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
161335008|NCT02557399|582615892|FG001|Overall Study|Protocol Violation|1|||
160844179|NCT00428389|580817965|FG001|Extension Phase|Withdrawal by Subject|6|||
160844180|NCT00428389|580817964|FG000|Extension Phase|Lost to Follow-up|0|||
160844181|NCT00428389|580817965|FG001|Extension Phase|Lost to Follow-up|3|||
160844182|NCT00428389|580817964|FG000|Extension Phase|Death|1|||
160992209|NCT02014558|581360003|FG008|Overall Study|Adverse Event|2|||
160992210|NCT02014558|581360004|FG009|Overall Study|Adverse Event|2|||
160992211|NCT02014558|581360005|FG010|Overall Study|Adverse Event|5|||
160992212|NCT02014558|581360006|FG011|Overall Study|Adverse Event|21|||
161139508|NCT00488631|581892741|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
160844183|NCT00428389|580817965|FG001|Extension Phase|Death|0|||
160844184|NCT00428389|580817964|FG000|Extension Phase|Protocol Violation|3|||
160844185|NCT00428389|580817965|FG001|Extension Phase|Protocol Violation|2|||
160844186|NCT00428389|580817964|FG000|Extension Phase|Administrative problems|1|||
160844187|NCT00428389|580817965|FG001|Extension Phase|Administrative problems|1|||
160844188|NCT04090242|580817966|FG000|Overall Study|Withdrawal by Subject|1|||
160844189|NCT04090242|580817967|FG001|Overall Study|Withdrawal by Subject|0|||
160844190|NCT02687581|580817968|FG000|Overall Study|Withdrawal by Subject|1|||
160844191|NCT02687581|580817969|FG001|Overall Study|Withdrawal by Subject|0|||
160844192|NCT02687581|580817970|FG002|Overall Study|Withdrawal by Subject|0|||
160844193|NCT02687581|580817971|FG003|Overall Study|Withdrawal by Subject|1|||
160844194|NCT02687581|580817968|FG000|Overall Study|Lost to Follow-up|2|||
160844195|NCT02687581|580817969|FG001|Overall Study|Lost to Follow-up|2|||
160844196|NCT02687581|580817970|FG002|Overall Study|Lost to Follow-up|0|||
160844197|NCT02687581|580817971|FG003|Overall Study|Lost to Follow-up|0|||
160844198|NCT02687581|580817968|FG000|Overall Study|the device is too small for the patient.|1|||
160844199|NCT02687581|580817969|FG001|Overall Study|the device is too small for the patient.|0|||
160844200|NCT02687581|580817970|FG002|Overall Study|the device is too small for the patient.|0|||
160844201|NCT02687581|580817971|FG003|Overall Study|the device is too small for the patient.|0|||
160844202|NCT00835341|580817972|FG000|Overall Study|Lost to Follow-up|3|||
160844203|NCT00835341|580817973|FG001|Overall Study|Lost to Follow-up|12|||
160844204|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
160844205|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
160844206|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
160844207|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844208|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
160992213|NCT02014558|581360007|FG012|Overall Study|Adverse Event|3|||
160992214|NCT02014558|581359995|FG000|Overall Study|Death|1|||
160992215|NCT02014558|581359996|FG001|Overall Study|Death|0|||
160992216|NCT02014558|581359997|FG002|Overall Study|Death|0|||
160992217|NCT02014558|581359998|FG003|Overall Study|Death|0|||
160992218|NCT02014558|581359999|FG004|Overall Study|Death|0|||
160992219|NCT02014558|581360000|FG005|Overall Study|Death|0|||
160992220|NCT02014558|581360001|FG006|Overall Study|Death|1|||
160844209|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844210|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844211|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844212|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
160844213|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Physician Decision|1|||
160844214|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Physician Decision|2|||
161139509|NCT00488631|581892742|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
160905830|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905831|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905832|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905833|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905834|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
160905835|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
160905836|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
160905837|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
160905838|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
160905839|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905840|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905841|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905842|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905843|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905844|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905845|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
160905846|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
160992221|NCT02014558|581360002|FG007|Overall Study|Death|1|||
161139510|NCT00488631|581892733|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
161139511|NCT00488631|581892734|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
161139512|NCT00488631|581892735|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
161139513|NCT00488631|581892736|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161139514|NCT00488631|581892737|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
161139515|NCT00488631|581892738|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
161139516|NCT00488631|581892739|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161139517|NCT00488631|581892740|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161139518|NCT00488631|581892741|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161139519|NCT00488631|581892742|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
161139520|NCT00488631|581892733|FG000|Double Blind Period (Week 0-54)|Other|6|||
160992222|NCT02014558|581360003|FG008|Overall Study|Death|2|||
160992223|NCT02014558|581360004|FG009|Overall Study|Death|5|||
160992224|NCT02014558|581360005|FG010|Overall Study|Death|5|||
160844215|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Physician Decision|0|||
160844216|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Physician Decision|0|||
160844217|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Physician Decision|0|||
160844218|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Physician Decision|0|||
160844219|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Physician Decision|0|||
160844220|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Physician Decision|0|||
160992225|NCT02014558|581360006|FG011|Overall Study|Death|19|||
160992226|NCT02014558|581360007|FG012|Overall Study|Death|2|||
160992227|NCT02014558|581359995|FG000|Overall Study|Lack of Efficacy|1|||
160844221|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Physician Decision|0|||
160844222|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
160844223|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
160844224|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
160844225|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
160844226|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
160844227|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
160844228|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
160844229|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
160844230|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
160844231|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
160844232|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844233|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844234|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844235|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844236|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844237|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844238|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844239|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
160844240|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
160844241|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
160844242|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844243|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844244|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844245|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844246|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844247|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844248|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
160844249|NCT04405076|580817974|FG000|Part A (Blinded Phase)|Other than Specified|0|||
160844250|NCT04405076|580817975|FG001|Part A (Blinded Phase)|Other than Specified|0|||
160844251|NCT04405076|580817976|FG002|Part A (Blinded Phase)|Other than Specified|3|||
160844252|NCT04405076|580817977|FG003|Part A (Blinded Phase)|Other than Specified|0|||
160844253|NCT04405076|580817978|FG004|Part A (Blinded Phase)|Other than Specified|0|||
160844254|NCT04405076|580817979|FG005|Part A (Blinded Phase)|Other than Specified|0|||
160844255|NCT04405076|580817980|FG006|Part A (Blinded Phase)|Other than Specified|0|||
160844256|NCT04405076|580817981|FG007|Part A (Blinded Phase)|Other than Specified|0|||
160844257|NCT04405076|580817982|FG008|Part A (Blinded Phase)|Other than Specified|0|||
160844258|NCT04405076|580817974|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844259|NCT04405076|580817975|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844260|NCT04405076|580817976|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844261|NCT04405076|580817977|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
160844262|NCT04405076|580817978|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
160844263|NCT04405076|580817979|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
160844264|NCT04405076|580817980|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844265|NCT04405076|580817981|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844266|NCT04405076|580817982|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
160844267|NCT04405076|580817974|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844268|NCT04405076|580817975|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844269|NCT04405076|580817976|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844270|NCT04405076|580817977|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160992228|NCT02014558|581359996|FG001|Overall Study|Lack of Efficacy|2|||
160992229|NCT02014558|581359997|FG002|Overall Study|Lack of Efficacy|1|||
160992230|NCT02014558|581359998|FG003|Overall Study|Lack of Efficacy|1|||
160992231|NCT02014558|581359999|FG004|Overall Study|Lack of Efficacy|0|||
160992232|NCT02014558|581360000|FG005|Overall Study|Lack of Efficacy|0|||
161251927|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
160844271|NCT04405076|580817978|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
160844272|NCT04405076|580817979|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844273|NCT04405076|580817980|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844274|NCT04405076|580817981|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844275|NCT04405076|580817982|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
160844276|NCT04405076|580817974|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844277|NCT04405076|580817975|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844278|NCT04405076|580817976|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844279|NCT04405076|580817977|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
160844280|NCT04405076|580817978|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
160844281|NCT04405076|580817979|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
161139521|NCT00488631|581892734|FG001|Double Blind Period (Week 0-54)|Other|12|||
161139522|NCT00488631|581892735|FG002|Double Blind Period (Week 0-54)|Other|10|||
161139523|NCT00488631|581892736|FG003|Double Blind Period (Week 0-54)|Other|11|||
161139524|NCT00488631|581892737|FG004|Double Blind Period (Week 0-54)|Other|14|||
161139525|NCT00488631|581892738|FG005|Double Blind Period (Week 0-54)|Other|34|||
161139526|NCT00488631|581892739|FG006|Double Blind Period (Week 0-54)|Other|0|||
161139527|NCT00488631|581892740|FG007|Double Blind Period (Week 0-54)|Other|0|||
161139528|NCT00488631|581892741|FG008|Double Blind Period (Week 0-54)|Other|0|||
161139529|NCT00488631|581892742|FG009|Double Blind Period (Week 0-54)|Other|0|||
161139530|NCT00488631|581892733|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139531|NCT00488631|581892734|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139532|NCT00488631|581892735|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139533|NCT00488631|581892736|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139534|NCT00488631|581892737|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139535|NCT00488631|581892738|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139536|NCT00488631|581892739|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
161139537|NCT00488631|581892740|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
161139538|NCT00488631|581892741|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
161139539|NCT00488631|581892742|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
161139540|NCT00488631|581892733|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
160844282|NCT04405076|580817980|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844283|NCT04405076|580817981|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844284|NCT04405076|580817982|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
160844285|NCT04405076|580817974|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844286|NCT04405076|580817975|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844287|NCT04405076|580817976|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844288|NCT04405076|580817977|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844289|NCT04405076|580817978|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844290|NCT04405076|580817979|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844291|NCT04405076|580817980|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
160844292|NCT04405076|580817981|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
160844293|NCT04405076|580817982|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
160844294|NCT04405076|580817974|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844295|NCT04405076|580817975|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844296|NCT04405076|580817976|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
161139541|NCT00488631|581892734|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
161139542|NCT00488631|581892735|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
161139543|NCT00488631|581892736|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
161139544|NCT00488631|581892737|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
161139545|NCT00488631|581892738|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
161139546|NCT00488631|581892739|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
161139547|NCT00488631|581892740|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
161139548|NCT00488631|581892741|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
161139549|NCT00488631|581892742|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
161139550|NCT00488631|581892733|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161139551|NCT00488631|581892734|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161139552|NCT00488631|581892735|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161139553|NCT00488631|581892736|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161139554|NCT00488631|581892737|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161139555|NCT00488631|581892738|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
161139556|NCT00488631|581892739|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
161139557|NCT00488631|581892740|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
161139558|NCT00488631|581892741|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
160844297|NCT04405076|580817977|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844298|NCT04405076|580817978|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844299|NCT04405076|580817979|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844300|NCT04405076|580817980|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
160844301|NCT04405076|580817981|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844302|NCT04405076|580817982|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
160844303|NCT02513472|580817983|FG000|Overall Study|Radiological Disease Progression|45|||
160844304|NCT02513472|580817984|FG001|Overall Study|Radiological Disease Progression|57|||
160844305|NCT02513472|580817983|FG000|Overall Study|Clinical Disease Progression|5|||
160844306|NCT02513472|580817984|FG001|Overall Study|Clinical Disease Progression|13|||
160844307|NCT02513472|580817983|FG000|Overall Study|Adverse Event|8|||
160844308|NCT02513472|580817984|FG001|Overall Study|Adverse Event|11|||
160844309|NCT02513472|580817983|FG000|Overall Study|Withdrawal by Subject|0|||
160844310|NCT02513472|580817984|FG001|Overall Study|Withdrawal by Subject|4|||
160844311|NCT02513472|580817983|FG000|Overall Study|Subject Choice|2|||
160844312|NCT02513472|580817984|FG001|Overall Study|Subject Choice|7|||
160844313|NCT02513472|580817983|FG000|Overall Study|Treatment Completed as per Protocol|3|||
160844314|NCT02513472|580817984|FG001|Overall Study|Treatment Completed as per Protocol|3|||
160844315|NCT02513472|580817983|FG000|Overall Study|Other|3|||
160844316|NCT02513472|580817984|FG001|Overall Study|Other|6|||
160844317|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
160844318|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
160844319|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
160844320|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Death|0|||
160844321|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Death|2|||
160844322|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Death|0|||
160844323|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
160844324|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
160844325|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
160844326|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
160844327|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
160844328|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
160844329|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
160844330|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
160844331|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
160844332|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
160844333|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
160844334|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
160844335|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
160844336|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
160844337|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
160844338|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Recovery|1|||
160844339|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Recovery|0|||
160992233|NCT02014558|581360001|FG006|Overall Study|Lack of Efficacy|1|||
161139559|NCT00488631|581892742|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
161139560|NCT00488631|581892733|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139561|NCT00488631|581892734|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139562|NCT00488631|581892735|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139563|NCT00488631|581892736|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139564|NCT00488631|581892737|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139565|NCT00488631|581892738|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139566|NCT00488631|581892739|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
161139567|NCT00488631|581892740|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139568|NCT00488631|581892741|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
161139569|NCT00488631|581892742|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
161139570|NCT00488631|581892733|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139571|NCT00488631|581892734|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139572|NCT00488631|581892735|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139573|NCT00488631|581892736|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139574|NCT00488631|581892737|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139575|NCT00488631|581892738|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139576|NCT00488631|581892739|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
161139577|NCT00488631|581892740|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
161139578|NCT00488631|581892741|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
161139579|NCT00488631|581892742|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
161139580|NCT05300087|581892743|FG000|Overall Study|Withdrawal by Subject|0|||
161251928|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
161251929|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
161251930|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
161251931|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
161251932|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
161251933|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
161251934|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
161251935|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
161251936|NCT01190930|582302359|FG000|Post Induction Pre-Maintenance|Relapse|0|||
161251937|NCT01190930|582302360|FG001|Post Induction Pre-Maintenance|Relapse|0|||
161251938|NCT01190930|582302361|FG002|Post Induction Pre-Maintenance|Relapse|1|||
161251939|NCT01190930|582302362|FG003|Post Induction Pre-Maintenance|Relapse|0|||
161251940|NCT01190930|582302363|FG004|Post Induction Pre-Maintenance|Relapse|0|||
161251941|NCT01190930|582302364|FG005|Post Induction Pre-Maintenance|Relapse|0|||
161251942|NCT01190930|582302365|FG006|Post Induction Pre-Maintenance|Relapse|0|||
161251943|NCT01190930|582302366|FG007|Post Induction Pre-Maintenance|Relapse|0|||
161251944|NCT01190930|582302367|FG008|Post Induction Pre-Maintenance|Relapse|0|||
161251945|NCT01190930|582302368|FG009|Post Induction Pre-Maintenance|Relapse|0|||
161251946|NCT01190930|582302359|FG000|Maintenance|Adverse Event|0|||
161251947|NCT01190930|582302360|FG001|Maintenance|Adverse Event|0|||
161251948|NCT01190930|582302361|FG002|Maintenance|Adverse Event|0|||
161251949|NCT01190930|582302362|FG003|Maintenance|Adverse Event|0|||
161251950|NCT01190930|582302363|FG004|Maintenance|Adverse Event|0|||
161251951|NCT01190930|582302364|FG005|Maintenance|Adverse Event|1|||
161251952|NCT01190930|582302365|FG006|Maintenance|Adverse Event|1|||
161251953|NCT01190930|582302366|FG007|Maintenance|Adverse Event|3|||
161251954|NCT01190930|582302367|FG008|Maintenance|Adverse Event|3|||
161251955|NCT01190930|582302368|FG009|Maintenance|Adverse Event|0|||
161251956|NCT01190930|582302359|FG000|Maintenance|Death|0|||
161251957|NCT01190930|582302360|FG001|Maintenance|Death|0|||
161251958|NCT01190930|582302361|FG002|Maintenance|Death|0|||
161251959|NCT01190930|582302362|FG003|Maintenance|Death|1|||
161251960|NCT01190930|582302363|FG004|Maintenance|Death|0|||
161251961|NCT01190930|582302364|FG005|Maintenance|Death|0|||
161251962|NCT01190930|582302365|FG006|Maintenance|Death|2|||
161251963|NCT01190930|582302366|FG007|Maintenance|Death|2|||
161251964|NCT01190930|582302367|FG008|Maintenance|Death|2|||
161251965|NCT01190930|582302368|FG009|Maintenance|Death|2|||
161139581|NCT05300087|581892744|FG001|Overall Study|Withdrawal by Subject|1|||
161139582|NCT03248128|581892745|FG000|Overall Study|Lost to Follow-up|1|||
161139583|NCT03248128|581892746|FG001|Overall Study|Lost to Follow-up|0|||
160905847|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
161139584|NCT03248128|581892745|FG000|Overall Study|Withdrawal by Subject|16|||
161139585|NCT03248128|581892746|FG001|Overall Study|Withdrawal by Subject|14|||
161139586|NCT03248128|581892745|FG000|Overall Study|Site Closed|4|||
161139587|NCT03248128|581892746|FG001|Overall Study|Site Closed|3|||
161139588|NCT03248128|581892745|FG000|Overall Study|Randomized, but did not receive treatment|1|||
161139589|NCT03248128|581892746|FG001|Overall Study|Randomized, but did not receive treatment|3|||
161139590|NCT01914679|581892747|FG000|Overall Study|Lack of Efficacy|1|||
161139591|NCT01914679|581892747|FG000|Overall Study|Sponsor terminated study|4|||
161139592|NCT00256295|581892750|FG000|Overall Study|Withdrawal by Subject|3|||
161139593|NCT00256295|581892750|FG000|Overall Study|Death|1|||
161139594|NCT00947349|581892751|FG000|Triple Treatment Combination Period|Adverse Event|0|||
160905848|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
160905849|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
160905850|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905851|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905852|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905853|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905854|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905855|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905856|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
160905857|NCT01847274|581050304|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
160905858|NCT01847274|581050305|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
161251966|NCT01190930|582302359|FG000|Maintenance|Lost to Follow-up|0|||
161251967|NCT01190930|582302360|FG001|Maintenance|Lost to Follow-up|0|||
161139595|NCT00947349|581892752|FG001|Triple Treatment Combination Period|Adverse Event|1|||
161335009|NCT02557399|582615891|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161251968|NCT01190930|582302361|FG002|Maintenance|Lost to Follow-up|0|||
161251969|NCT01190930|582302362|FG003|Maintenance|Lost to Follow-up|0|||
161251970|NCT01190930|582302363|FG004|Maintenance|Lost to Follow-up|0|||
161139596|NCT00947349|581892753|FG002|Triple Treatment Combination Period|Adverse Event|0|||
161139597|NCT00947349|581892754|FG003|Triple Treatment Combination Period|Adverse Event|0|||
161251971|NCT01190930|582302364|FG005|Maintenance|Lost to Follow-up|0|||
161251972|NCT01190930|582302365|FG006|Maintenance|Lost to Follow-up|1|||
160992234|NCT02014558|581360002|FG007|Overall Study|Lack of Efficacy|3|||
161251973|NCT01190930|582302366|FG007|Maintenance|Lost to Follow-up|1|||
161139598|NCT00947349|581892751|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
161139599|NCT00947349|581892752|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
161139600|NCT00947349|581892753|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
161139601|NCT00947349|581892754|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
161139602|NCT00947349|581892751|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
161139603|NCT00947349|581892752|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
161139604|NCT00947349|581892753|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
161139605|NCT00947349|581892754|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
161139606|NCT00947349|581892751|FG000|Overall Study Standard of Care|Other|0|||
161139607|NCT00947349|581892752|FG001|Overall Study Standard of Care|Other|0|||
161139608|NCT00947349|581892753|FG002|Overall Study Standard of Care|Other|0|||
161139609|NCT00947349|581892754|FG003|Overall Study Standard of Care|Other|1|||
161139610|NCT00538681|581892755|FG000|Overall Study|Progressive Disease|7|||
161139611|NCT00538681|581892756|FG001|Overall Study|Progressive Disease|0|||
161139612|NCT00538681|581892757|FG002|Overall Study|Progressive Disease|1|||
160905859|NCT01847274|581050306|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
160905860|NCT01847274|581050307|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
160905861|NCT01847274|581050308|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905862|NCT01847274|581050309|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905863|NCT01847274|581050310|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
161139613|NCT00538681|581892758|FG003|Overall Study|Progressive Disease|0|||
161139614|NCT00538681|581892755|FG000|Overall Study|Sponsor Decision|1|||
161139615|NCT00538681|581892756|FG001|Overall Study|Sponsor Decision|3|||
161139616|NCT00538681|581892757|FG002|Overall Study|Sponsor Decision|8|||
161139617|NCT00538681|581892758|FG003|Overall Study|Sponsor Decision|9|||
161335010|NCT02557399|582615892|FG001|Overall Study|Protocol-defined stopping criteria|1|||
161335011|NCT02557399|582615891|FG000|Overall Study|Withdrawal by Subject|1|||
161335012|NCT02557399|582615892|FG001|Overall Study|Withdrawal by Subject|1|||
161335013|NCT00780975|582615899|FG000|Overall Study|Progressive disease|3|||
161335014|NCT00780975|582615899|FG000|Overall Study|Toxicity|5|||
161335015|NCT03122171|582615900|FG000|Overall Study|Withdrawal by Subject|1|||
161335016|NCT03044314|582615901|FG000|Overall Study|Physician Decision|2|||
161335017|NCT03044314|582615901|FG000|Overall Study|Withdrawal by Subject|1|||
161335018|NCT03044314|582615901|FG000|Overall Study|Connector tubing not available|1|||
161335019|NCT00449163|582615902|FG000|Overall Study|Physician Decision|3|||
161335020|NCT00606307|582615905|FG000|Overall Study|Adverse Event|2|||
161335021|NCT00606307|582615905|FG000|Overall Study|Withdrawal by Subject|2|||
161335022|NCT00606307|582615905|FG000|Overall Study|Disease progression|6|||
161335023|NCT00606307|582615905|FG000|Overall Study|QTc prolongation|1|||
161335024|NCT03368807|582615914|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
161335025|NCT03368807|582615914|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
161335026|NCT03368807|582615914|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
161335027|NCT03368807|582615914|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
161335028|NCT03669588|582615920|FG000|Overall Study|Adverse Event|1|||
161335029|NCT03669588|582615921|FG001|Overall Study|Adverse Event|0|||
161335030|NCT03669588|582615920|FG000|Overall Study|Physician Decision|0|||
161335031|NCT03669588|582615921|FG001|Overall Study|Physician Decision|1|||
160905864|NCT01847274|581050311|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905865|NCT01847274|581050312|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905866|NCT01847274|581050313|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905867|NCT01847274|581050314|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
160905868|NCT01847274|581050304|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905869|NCT01847274|581050305|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905870|NCT01847274|581050306|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905871|NCT01847274|581050307|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905872|NCT01847274|581050308|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905873|NCT01847274|581050309|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
160905874|NCT01847274|581050310|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905875|NCT01847274|581050311|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905876|NCT01847274|581050312|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905877|NCT01847274|581050313|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905878|NCT01847274|581050314|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
160905879|NCT01847274|581050304|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905880|NCT01847274|581050305|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905881|NCT01847274|581050306|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905882|NCT01847274|581050307|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161139618|NCT00538681|581892755|FG000|Overall Study|Adverse Event|1|||
160905883|NCT01847274|581050308|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
160905884|NCT01847274|581050309|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905885|NCT01847274|581050310|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
161139619|NCT00538681|581892756|FG001|Overall Study|Adverse Event|1|||
161335032|NCT03669588|582615920|FG000|Overall Study|Protocol Violation|1|||
160844340|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Recovery|1|||
160844341|NCT00195663|580817985|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
160844342|NCT00195663|580817986|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
160844343|NCT00195663|580817987|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
161251974|NCT01190930|582302367|FG008|Maintenance|Lost to Follow-up|1|||
160844344|NCT00195663|580817985|FG000|Open-Label Extension Period|Adverse Event|21|||
160844345|NCT00195663|580817986|FG001|Open-Label Extension Period|Adverse Event|32|||
160844346|NCT00195663|580817987|FG002|Open-Label Extension Period|Adverse Event|36|||
161251975|NCT01190930|582302368|FG009|Maintenance|Lost to Follow-up|0|||
160844347|NCT00195663|580817985|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
160844348|NCT00195663|580817986|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
160992235|NCT02014558|581360003|FG008|Overall Study|Lack of Efficacy|3|||
161251976|NCT01190930|582302359|FG000|Maintenance|Physician Decision|0|||
161251977|NCT01190930|582302360|FG001|Maintenance|Physician Decision|1|||
161251978|NCT01190930|582302361|FG002|Maintenance|Physician Decision|0|||
161251979|NCT01190930|582302362|FG003|Maintenance|Physician Decision|5|||
161251980|NCT01190930|582302363|FG004|Maintenance|Physician Decision|9|||
161251981|NCT01190930|582302364|FG005|Maintenance|Physician Decision|4|||
161251982|NCT01190930|582302365|FG006|Maintenance|Physician Decision|8|||
161251983|NCT01190930|582302366|FG007|Maintenance|Physician Decision|8|||
161251984|NCT01190930|582302367|FG008|Maintenance|Physician Decision|10|||
161251985|NCT01190930|582302368|FG009|Maintenance|Physician Decision|17|||
161251986|NCT01190930|582302359|FG000|Maintenance|Withdrawal by Subject|0|||
161251987|NCT01190930|582302360|FG001|Maintenance|Withdrawal by Subject|0|||
161251988|NCT01190930|582302361|FG002|Maintenance|Withdrawal by Subject|0|||
161251989|NCT01190930|582302362|FG003|Maintenance|Withdrawal by Subject|0|||
161251990|NCT01190930|582302363|FG004|Maintenance|Withdrawal by Subject|0|||
161251991|NCT01190930|582302364|FG005|Maintenance|Withdrawal by Subject|0|||
161251992|NCT01190930|582302365|FG006|Maintenance|Withdrawal by Subject|2|||
161251993|NCT01190930|582302366|FG007|Maintenance|Withdrawal by Subject|1|||
161251994|NCT01190930|582302367|FG008|Maintenance|Withdrawal by Subject|4|||
161251995|NCT01190930|582302368|FG009|Maintenance|Withdrawal by Subject|1|||
161251996|NCT01190930|582302359|FG000|Maintenance|Refusal|0|||
161251997|NCT01190930|582302360|FG001|Maintenance|Refusal|1|||
161251998|NCT01190930|582302361|FG002|Maintenance|Refusal|0|||
161251999|NCT01190930|582302362|FG003|Maintenance|Refusal|2|||
161252000|NCT01190930|582302363|FG004|Maintenance|Refusal|0|||
161252001|NCT01190930|582302364|FG005|Maintenance|Refusal|4|||
161252002|NCT01190930|582302365|FG006|Maintenance|Refusal|5|||
161252003|NCT01190930|582302366|FG007|Maintenance|Refusal|17|||
161252004|NCT01190930|582302367|FG008|Maintenance|Refusal|13|||
161252005|NCT01190930|582302368|FG009|Maintenance|Refusal|6|||
161252006|NCT01190930|582302359|FG000|Maintenance|second malignant neoplasm|0|||
161252007|NCT01190930|582302360|FG001|Maintenance|second malignant neoplasm|0|||
161252008|NCT01190930|582302361|FG002|Maintenance|second malignant neoplasm|0|||
161252009|NCT01190930|582302362|FG003|Maintenance|second malignant neoplasm|1|||
161252010|NCT01190930|582302363|FG004|Maintenance|second malignant neoplasm|0|||
161252011|NCT01190930|582302364|FG005|Maintenance|second malignant neoplasm|1|||
161252012|NCT01190930|582302365|FG006|Maintenance|second malignant neoplasm|0|||
161252013|NCT01190930|582302366|FG007|Maintenance|second malignant neoplasm|0|||
161252014|NCT01190930|582302367|FG008|Maintenance|second malignant neoplasm|1|||
161252015|NCT01190930|582302368|FG009|Maintenance|second malignant neoplasm|0|||
161252016|NCT01190930|582302359|FG000|Maintenance|Inevaluable|0|||
161252017|NCT01190930|582302360|FG001|Maintenance|Inevaluable|0|||
161252018|NCT01190930|582302361|FG002|Maintenance|Inevaluable|0|||
161252019|NCT01190930|582302362|FG003|Maintenance|Inevaluable|0|||
161252020|NCT01190930|582302363|FG004|Maintenance|Inevaluable|0|||
161252021|NCT01190930|582302364|FG005|Maintenance|Inevaluable|1|||
161252022|NCT01190930|582302365|FG006|Maintenance|Inevaluable|1|||
161252023|NCT01190930|582302366|FG007|Maintenance|Inevaluable|1|||
161252024|NCT01190930|582302367|FG008|Maintenance|Inevaluable|0|||
161252025|NCT01190930|582302368|FG009|Maintenance|Inevaluable|0|||
161252026|NCT01190930|582302359|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
161252027|NCT01190930|582302360|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
161252028|NCT01190930|582302361|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
161252029|NCT01190930|582302362|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
161252030|NCT01190930|582302363|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
161252031|NCT01190930|582302364|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
161252032|NCT01190930|582302365|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
161252033|NCT01190930|582302366|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
161252034|NCT01190930|582302367|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
161252035|NCT01190930|582302368|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
161252036|NCT01190930|582302359|FG000|Maintenance|Relapse|0|||
161252037|NCT01190930|582302360|FG001|Maintenance|Relapse|0|||
161252038|NCT01190930|582302361|FG002|Maintenance|Relapse|0|||
161252039|NCT01190930|582302362|FG003|Maintenance|Relapse|2|||
161252040|NCT01190930|582302363|FG004|Maintenance|Relapse|0|||
161252041|NCT01190930|582302364|FG005|Maintenance|Relapse|1|||
161252042|NCT01190930|582302365|FG006|Maintenance|Relapse|6|||
161335033|NCT03669588|582615921|FG001|Overall Study|Protocol Violation|0|||
161335034|NCT03669588|582615920|FG000|Overall Study|Sponsor Decision|1|||
161335035|NCT03669588|582615921|FG001|Overall Study|Sponsor Decision|1|||
161335036|NCT03669588|582615920|FG000|Overall Study|Withdrawal by Subject|1|||
161335037|NCT03669588|582615921|FG001|Overall Study|Withdrawal by Subject|4|||
161335038|NCT03669588|582615920|FG000|Overall Study|Rescue Therapy Needed|0|||
161335039|NCT03669588|582615921|FG001|Overall Study|Rescue Therapy Needed|1|||
161139620|NCT00538681|581892757|FG002|Overall Study|Adverse Event|1|||
161139621|NCT00538681|581892758|FG003|Overall Study|Adverse Event|0|||
161335040|NCT00369343|582615928|FG000|Double-blind Phase|Adverse Event|19|||
161335041|NCT00369343|582615929|FG001|Double-blind Phase|Adverse Event|4|||
161335042|NCT00369343|582615928|FG000|Double-blind Phase|Failed to return|2|||
161335043|NCT00369343|582615929|FG001|Double-blind Phase|Failed to return|0|||
161335044|NCT00369343|582615928|FG000|Double-blind Phase|Lost to Follow-up|9|||
161335045|NCT00369343|582615929|FG001|Double-blind Phase|Lost to Follow-up|2|||
161335046|NCT00369343|582615928|FG000|Double-blind Phase|Protocol Violation|2|||
161335047|NCT00369343|582615929|FG001|Double-blind Phase|Protocol Violation|0|||
161335048|NCT00369343|582615928|FG000|Double-blind Phase|Withdrawal by Subject|8|||
161335049|NCT00369343|582615929|FG001|Double-blind Phase|Withdrawal by Subject|6|||
161335050|NCT00369343|582615928|FG000|Double-blind Phase|Lack of Efficacy|0|||
161335051|NCT00369343|582615929|FG001|Double-blind Phase|Lack of Efficacy|4|||
161335052|NCT00369343|582615928|FG000|Double-blind Phase|Protocol deviation|4|||
161335053|NCT00369343|582615929|FG001|Double-blind Phase|Protocol deviation|0|||
161335054|NCT00369343|582615928|FG000|Open-label Phase|Adverse Event|19|||
161335055|NCT00369343|582615929|FG001|Open-label Phase|Adverse Event|7|||
161335056|NCT00369343|582615928|FG000|Open-label Phase|Failed to return|4|||
161335057|NCT00369343|582615929|FG001|Open-label Phase|Failed to return|0|||
161335058|NCT00369343|582615928|FG000|Open-label Phase|Physician Decision|2|||
161335059|NCT00369343|582615929|FG001|Open-label Phase|Physician Decision|0|||
161335060|NCT00369343|582615928|FG000|Open-label Phase|Lost to Follow-up|5|||
161335061|NCT00369343|582615929|FG001|Open-label Phase|Lost to Follow-up|3|||
161335062|NCT00369343|582615928|FG000|Open-label Phase|inadvertently reported study completers|3|||
161335063|NCT00369343|582615929|FG001|Open-label Phase|inadvertently reported study completers|2|||
161335064|NCT00369343|582615928|FG000|Open-label Phase|Protocol Violation|1|||
161335065|NCT00369343|582615929|FG001|Open-label Phase|Protocol Violation|3|||
161335066|NCT00369343|582615928|FG000|Open-label Phase|Withdrawal by Subject|15|||
161335067|NCT00369343|582615929|FG001|Open-label Phase|Withdrawal by Subject|6|||
161335068|NCT00369343|582615928|FG000|Open-label Phase|Lack of Efficacy|4|||
161335069|NCT00369343|582615929|FG001|Open-label Phase|Lack of Efficacy|3|||
161335070|NCT00369343|582615928|FG000|Open-label Phase|Lack of continuance tolerability|3|||
161335071|NCT00369343|582615929|FG001|Open-label Phase|Lack of continuance tolerability|4|||
161335072|NCT00369343|582615928|FG000|Open-label Phase|did not take study drug|1|||
161335073|NCT00369343|582615929|FG001|Open-label Phase|did not take study drug|2|||
161335074|NCT00073918|582615930|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
161335075|NCT00073918|582615930|FG000|Overall Study|Rapid disease progression|2|||
161335076|NCT00073918|582615930|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
161335077|NCT02033759|582615933|FG000|Overall Study|Withdrawal by Subject|2|||
161335078|NCT02033759|582615934|FG001|Overall Study|Withdrawal by Subject|1|||
161335079|NCT02033759|582615933|FG000|Overall Study|Protocol Violation|1|||
161335080|NCT02033759|582615934|FG001|Overall Study|Protocol Violation|1|||
161335081|NCT04821830|582615940|FG000|Overall Study|Withdrawal by Subject|1|||
161139622|NCT00538681|581892755|FG000|Overall Study|Death|0|||
161139623|NCT00538681|581892756|FG001|Overall Study|Death|0|||
160844349|NCT00195663|580817987|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
160844350|NCT00195663|580817985|FG000|Open-Label Extension Period|Recovery|0|||
160844351|NCT00195663|580817986|FG001|Open-Label Extension Period|Recovery|2|||
160844352|NCT00195663|580817987|FG002|Open-Label Extension Period|Recovery|2|||
160844353|NCT00195663|580817985|FG000|Open-Label Extension Period|Protocol Violation|3|||
160844354|NCT00195663|580817986|FG001|Open-Label Extension Period|Protocol Violation|4|||
160844355|NCT00195663|580817987|FG002|Open-Label Extension Period|Protocol Violation|4|||
160844356|NCT00195663|580817985|FG000|Open-Label Extension Period|Death|2|||
160844357|NCT00195663|580817986|FG001|Open-Label Extension Period|Death|2|||
160844358|NCT00195663|580817987|FG002|Open-Label Extension Period|Death|2|||
161139624|NCT00538681|581892757|FG002|Overall Study|Death|1|||
161139625|NCT00538681|581892758|FG003|Overall Study|Death|1|||
161139626|NCT00538681|581892755|FG000|Overall Study|Investigator Decision|0|||
161139627|NCT00538681|581892756|FG001|Overall Study|Investigator Decision|0|||
161139628|NCT00538681|581892757|FG002|Overall Study|Investigator Decision|0|||
161139629|NCT00538681|581892758|FG003|Overall Study|Investigator Decision|1|||
161139630|NCT02382133|581892761|FG000|Overall Study|Death|22|||
161139631|NCT02382133|581892761|FG000|Overall Study|transfer out of ICU|4|||
161139632|NCT02382133|581892761|FG000|Overall Study|Physician Decision|2|||
160917937|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
161139633|NCT02382133|581892761|FG000|Overall Study|arterial catheter loss|4|||
161139634|NCT02382133|581892761|FG000|Overall Study|pressure injury both sites|1|||
161139635|NCT05369806|581892762|FG000|Overall Study|Lost to Follow-up|1|||
161139636|NCT00628355|581892763|FG000|Overall Study|Withdrawal by Subject|1|||
161139637|NCT00628355|581892764|FG001|Overall Study|Withdrawal by Subject|1|||
161139638|NCT01446809|581892766|FG000|Overall Study|Adverse Event|0|||
161139639|NCT01446809|581892767|FG001|Overall Study|Adverse Event|0|||
161139640|NCT01446809|581892768|FG002|Overall Study|Adverse Event|1|||
161139641|NCT01446809|581892766|FG000|Overall Study|Failure to complete study procedures|0|||
161139642|NCT01446809|581892767|FG001|Overall Study|Failure to complete study procedures|0|||
161139643|NCT01446809|581892768|FG002|Overall Study|Failure to complete study procedures|1|||
161139644|NCT01331161|581892769|FG000|Overall Study|Physician Decision|1|||
161139645|NCT01331161|581892770|FG001|Overall Study|Physician Decision|0|||
161139646|NCT01331161|581892769|FG000|Overall Study|Lost to Follow-up|0|||
161139647|NCT01331161|581892770|FG001|Overall Study|Lost to Follow-up|1|||
161139648|NCT01331161|581892769|FG000|Overall Study|Pregnancy|0|||
161139649|NCT01331161|581892770|FG001|Overall Study|Pregnancy|1|||
161139650|NCT02770807|581892772|FG000|Overall Study|Adverse Event|3|||
161139651|NCT02770807|581892773|FG001|Overall Study|Adverse Event|3|||
161139652|NCT02770807|581892774|FG002|Overall Study|Adverse Event|1|||
161139653|NCT02770807|581892772|FG000|Overall Study|Withdrawal by Subject|7|||
161139654|NCT02770807|581892773|FG001|Overall Study|Withdrawal by Subject|3|||
161139655|NCT02770807|581892774|FG002|Overall Study|Withdrawal by Subject|4|||
161139656|NCT02770807|581892772|FG000|Overall Study|Other|0|||
161139657|NCT02770807|581892773|FG001|Overall Study|Other|1|||
161139658|NCT02770807|581892774|FG002|Overall Study|Other|0|||
161139659|NCT02770807|581892772|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
161139660|NCT02770807|581892773|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
161139661|NCT02770807|581892774|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
161139662|NCT02770807|581892772|FG000|Overall Study|Physician Decision|0|||
161139663|NCT02770807|581892773|FG001|Overall Study|Physician Decision|0|||
161139664|NCT02770807|581892774|FG002|Overall Study|Physician Decision|1|||
161139665|NCT01084252|581894815|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139666|NCT01084252|581894816|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139667|NCT01084252|581894817|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139668|NCT01084252|581894818|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139669|NCT01084252|581894819|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139670|NCT01084252|581894820|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139671|NCT01084252|581894821|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139672|NCT01084252|581894822|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139673|NCT01084252|581894823|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139674|NCT01084252|581894824|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139675|NCT01084252|581894825|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139676|NCT01084252|581894826|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139677|NCT01084252|581894827|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
161139678|NCT01084252|581894828|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
161139679|NCT00853632|581894829|FG000|Overall Study|Death|88|||
161139680|NCT00853632|581894829|FG000|Overall Study|Withdrawal by Subject|45|||
161139681|NCT00853632|581894829|FG000|Overall Study|Lost to Follow-up|30|||
161139682|NCT00853632|581894829|FG000|Overall Study|Reoperation/Explant|17|||
161139683|NCT00853632|581894829|FG000|Overall Study|Exit with other reason|22|||
161139684|NCT04493619|581894830|FG000|Overall Study|Death|4|||
161139685|NCT04493619|581894831|FG001|Overall Study|Death|3|||
161139686|NCT04493619|581894832|FG002|Overall Study|Death|3|||
161139687|NCT04493619|581894833|FG003|Overall Study|Death|4|||
161139688|NCT04493619|581894830|FG000|Overall Study|Study discontinued early|10|||
161139689|NCT04493619|581894831|FG001|Overall Study|Study discontinued early|0|||
161139690|NCT04493619|581894832|FG002|Overall Study|Study discontinued early|4|||
161139691|NCT04493619|581894833|FG003|Overall Study|Study discontinued early|8|||
161139692|NCT04493619|581894830|FG000|Overall Study|Lost to Follow-up|0|||
161139693|NCT04493619|581894831|FG001|Overall Study|Lost to Follow-up|0|||
161139694|NCT04493619|581894832|FG002|Overall Study|Lost to Follow-up|0|||
161139695|NCT04493619|581894833|FG003|Overall Study|Lost to Follow-up|1|||
161139696|NCT02017444|581894840|FG000|Overall Study|Physician Decision|1|||
161139697|NCT02017444|581894841|FG001|Overall Study|Physician Decision|0|||
161139698|NCT02017444|581894840|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
161139699|NCT02017444|581894841|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
161139700|NCT02342171|581894844|FG000|Overall Study|Death|4|||
161139701|NCT02342171|581894845|FG001|Overall Study|Death|87|||
161139702|NCT02342171|581894844|FG000|Overall Study|Received favipiravir|10|||
161139703|NCT02342171|581894845|FG001|Overall Study|Received favipiravir|0|||
161139704|NCT02342171|581894844|FG000|Overall Study|Missing cycle treshold value|1|||
161139705|NCT02342171|581894845|FG001|Overall Study|Missing cycle treshold value|0|||
161139706|NCT02342171|581894844|FG000|Overall Study|Unknown outcome|0|||
161139707|NCT02342171|581894845|FG001|Overall Study|Unknown outcome|1|||
161139708|NCT02342171|581894844|FG000|Overall Study|Missing age data|0|||
161139709|NCT02342171|581894845|FG001|Overall Study|Missing age data|1|||
161139710|NCT00875420|581894846|FG000|Overall Study|Adverse Event|0|||
161139711|NCT00875420|581894847|FG001|Overall Study|Adverse Event|1|||
161139712|NCT00875420|581894848|FG002|Overall Study|Adverse Event|1|||
161139713|NCT00875420|581894849|FG003|Overall Study|Adverse Event|0|||
161139714|NCT00875420|581894850|FG004|Overall Study|Adverse Event|0|||
161139715|NCT00875420|581894846|FG000|Overall Study|Inability to complete study procedures|1|||
161139716|NCT00875420|581894847|FG001|Overall Study|Inability to complete study procedures|0|||
161139717|NCT00875420|581894848|FG002|Overall Study|Inability to complete study procedures|1|||
161139718|NCT00875420|581894849|FG003|Overall Study|Inability to complete study procedures|1|||
161139719|NCT00875420|581894850|FG004|Overall Study|Inability to complete study procedures|1|||
161139720|NCT00875420|581894846|FG000|Overall Study|Lost to Follow-up|1|||
161139721|NCT00875420|581894847|FG001|Overall Study|Lost to Follow-up|0|||
161139722|NCT00875420|581894848|FG002|Overall Study|Lost to Follow-up|0|||
161139723|NCT00875420|581894849|FG003|Overall Study|Lost to Follow-up|0|||
161139724|NCT00875420|581894850|FG004|Overall Study|Lost to Follow-up|0|||
161139725|NCT00875420|581894846|FG000|Overall Study|Personal reason|0|||
161139726|NCT00875420|581894847|FG001|Overall Study|Personal reason|0|||
161139727|NCT00875420|581894848|FG002|Overall Study|Personal reason|0|||
161139728|NCT00875420|581894849|FG003|Overall Study|Personal reason|0|||
161139729|NCT00875420|581894850|FG004|Overall Study|Personal reason|1|||
161139730|NCT00875420|581894846|FG000|Overall Study|Prohibited medication|0|||
161139731|NCT00875420|581894847|FG001|Overall Study|Prohibited medication|0|||
161139732|NCT00875420|581894848|FG002|Overall Study|Prohibited medication|0|||
161139733|NCT00875420|581894849|FG003|Overall Study|Prohibited medication|1|||
161139734|NCT00875420|581894850|FG004|Overall Study|Prohibited medication|0|||
161139735|NCT00875420|581894846|FG000|Overall Study|Sponsor decision|0|||
161139736|NCT00875420|581894847|FG001|Overall Study|Sponsor decision|1|||
161139737|NCT00875420|581894848|FG002|Overall Study|Sponsor decision|0|||
161139738|NCT00875420|581894849|FG003|Overall Study|Sponsor decision|0|||
161139739|NCT00875420|581894850|FG004|Overall Study|Sponsor decision|0|||
161139740|NCT00875420|581894846|FG000|Overall Study|Withdrawal by Subject|0|||
161139741|NCT00875420|581894847|FG001|Overall Study|Withdrawal by Subject|0|||
161139742|NCT00875420|581894848|FG002|Overall Study|Withdrawal by Subject|1|||
161139743|NCT00875420|581894849|FG003|Overall Study|Withdrawal by Subject|0|||
161139744|NCT00875420|581894850|FG004|Overall Study|Withdrawal by Subject|0|||
161139745|NCT00914628|581894851|FG000|Overall Study|Death|35|||
161139746|NCT00914628|581894852|FG001|Overall Study|Death|17|||
161139747|NCT00914628|581894851|FG000|Overall Study|Medical decision|4|||
161139748|NCT00914628|581894852|FG001|Overall Study|Medical decision|0|||
161139749|NCT00914628|581894851|FG000|Overall Study|Protocol Violation|1|||
161139750|NCT00914628|581894852|FG001|Overall Study|Protocol Violation|0|||
161139751|NCT00914628|581894851|FG000|Overall Study|Lack of Efficacy|1|||
161139752|NCT00914628|581894852|FG001|Overall Study|Lack of Efficacy|0|||
161139753|NCT00914628|581894851|FG000|Overall Study|non-randomized|1|||
161139754|NCT00914628|581894852|FG001|Overall Study|non-randomized|0|||
161139755|NCT00914628|581894851|FG000|Overall Study|Relapse|1|||
161139756|NCT00914628|581894852|FG001|Overall Study|Relapse|2|||
161139757|NCT00914628|581894851|FG000|Overall Study|Study terminated by Sponsor|14|||
161139758|NCT00914628|581894852|FG001|Overall Study|Study terminated by Sponsor|8|||
161139759|NCT00914628|581894851|FG000|Overall Study|Patients who did not receive a single dose|7|||
161139760|NCT00914628|581894852|FG001|Overall Study|Patients who did not receive a single dose|1|||
161139761|NCT01756157|581894853|FG000|First Intervention Period|Withdrawal by Subject|1|||
161139762|NCT01756157|581894854|FG001|First Intervention Period|Withdrawal by Subject|0|||
161139763|NCT01756157|581894853|FG000|First Intervention Period|Lost to Follow-up|0|||
161139764|NCT01756157|581894854|FG001|First Intervention Period|Lost to Follow-up|2|||
161139765|NCT02799381|581894857|FG000|Overall Study|Withdrew consent|3|||
161139766|NCT02799381|581894858|FG001|Overall Study|Withdrew consent|2|||
161139767|NCT02799381|581894857|FG000|Overall Study|Adverse Event|0|||
161139768|NCT02799381|581894858|FG001|Overall Study|Adverse Event|1|||
161139769|NCT02799381|581894857|FG000|Overall Study|Participant did not take any study drug|1|||
161139770|NCT02799381|581894858|FG001|Overall Study|Participant did not take any study drug|0|||
161139771|NCT02698410|581894861|FG000|Overall Study|Adverse Event|2|||
161139772|NCT02698410|581894861|FG000|Overall Study|Withdrawal by Subject|1|||
161139773|NCT02698410|581894861|FG000|Overall Study|Other|1|||
161139774|NCT03952130|581894862|FG000|Overall Study|Adverse Event|0|||
161139775|NCT03952130|581894863|FG001|Overall Study|Adverse Event|1|||
161139776|NCT03952130|581894862|FG000|Overall Study|Lost to Follow-up|1|||
161139777|NCT03952130|581894863|FG001|Overall Study|Lost to Follow-up|0|||
161139778|NCT03952130|581894862|FG000|Overall Study|Withdrawal by Subject|1|||
161139779|NCT03952130|581894863|FG001|Overall Study|Withdrawal by Subject|5|||
161139780|NCT01713348|581894864|FG000|Overall Study|Withdrawal by Subject|3|||
161139781|NCT01713348|581894865|FG001|Overall Study|Withdrawal by Subject|2|||
161139782|NCT01713348|581894866|FG002|Overall Study|Withdrawal by Subject|2|||
161139783|NCT01713348|581894867|FG003|Overall Study|Withdrawal by Subject|0|||
161139784|NCT01713348|581894864|FG000|Overall Study|Lost to Follow-up|1|||
161139785|NCT01713348|581894865|FG001|Overall Study|Lost to Follow-up|0|||
161252043|NCT01190930|582302366|FG007|Maintenance|Relapse|13|||
161252044|NCT01190930|582302367|FG008|Maintenance|Relapse|11|||
161252045|NCT01190930|582302368|FG009|Maintenance|Relapse|11|||
161139786|NCT01713348|581894866|FG002|Overall Study|Lost to Follow-up|0|||
161139787|NCT01713348|581894867|FG003|Overall Study|Lost to Follow-up|0|||
161139788|NCT02638012|581894868|FG000|Overall Study|Lost to Follow-up|1|||
161139789|NCT00621023|581894869|FG000|Overall Study|Death|5|||
161139790|NCT00621023|581894869|FG000|Overall Study|Follow up discontinued|1|||
161139791|NCT03199911|581894876|FG000|Overall Study|Lost to Follow-up|5|||
161139792|NCT03199911|581894877|FG001|Overall Study|Lost to Follow-up|5|||
161139793|NCT03199911|581894876|FG000|Overall Study|Did not proceed with surgery|2|||
161139794|NCT03199911|581894877|FG001|Overall Study|Did not proceed with surgery|1|||
161139795|NCT04331899|581894878|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
161139796|NCT04331899|581894879|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
161139797|NCT01062399|581894882|FG000|Overall Study|Protocol Violation|0|||
161139798|NCT01062399|581894883|FG001|Overall Study|Protocol Violation|1|||
161139799|NCT01062399|581894884|FG002|Overall Study|Protocol Violation|0|||
161139800|NCT01062399|581894885|FG003|Overall Study|Protocol Violation|6|||
161139801|NCT01062399|581894886|FG004|Overall Study|Protocol Violation|4|||
161139802|NCT02424539|581894887|FG000|Overall Study|Adverse Event|0|||
161139803|NCT02424539|581894888|FG001|Overall Study|Adverse Event|0|||
161139804|NCT02424539|581894889|FG002|Overall Study|Adverse Event|1|||
161139805|NCT02424539|581894887|FG000|Overall Study|Physician Decision|0|||
161139806|NCT02424539|581894888|FG001|Overall Study|Physician Decision|0|||
161335082|NCT04821830|582615941|FG001|Overall Study|Withdrawal by Subject|0|||
161335083|NCT00490919|582615942|FG000|Open-label Run-in Period|Adverse Event|239|||
161335084|NCT00490919|582615943|FG001|Open-label Run-in Period|Adverse Event|0|||
161335085|NCT00490919|582615944|FG002|Open-label Run-in Period|Adverse Event|0|||
161139807|NCT02424539|581894889|FG002|Overall Study|Physician Decision|1|||
161139808|NCT02424539|581894887|FG000|Overall Study|Withdrawal by Subject|3|||
161335086|NCT00490919|582615942|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
161335087|NCT00490919|582615943|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161335088|NCT00490919|582615944|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161335089|NCT00490919|582615942|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
161335090|NCT00490919|582615943|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161335091|NCT00490919|582615944|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161335092|NCT00490919|582615942|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
161335093|NCT00490919|582615943|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161335094|NCT00490919|582615944|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161335095|NCT00490919|582615942|FG000|Open-label Run-in Period|Administrative|40|||
161335096|NCT00490919|582615943|FG001|Open-label Run-in Period|Administrative|0|||
161335097|NCT00490919|582615944|FG002|Open-label Run-in Period|Administrative|0|||
161335098|NCT00490919|582615942|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
161335099|NCT00490919|582615943|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
161335100|NCT00490919|582615944|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
161335101|NCT00490919|582615942|FG000|Double-blind Phase|Adverse Event|0|||
161335102|NCT00490919|582615943|FG001|Double-blind Phase|Adverse Event|40|||
161335103|NCT00490919|582615944|FG002|Double-blind Phase|Adverse Event|20|||
161335104|NCT00490919|582615942|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161335105|NCT00490919|582615943|FG001|Double-blind Phase|Withdrawal by Subject|10|||
161335106|NCT00490919|582615944|FG002|Double-blind Phase|Withdrawal by Subject|11|||
161335107|NCT00490919|582615942|FG000|Double-blind Phase|Lost to Follow-up|0|||
161335108|NCT00490919|582615943|FG001|Double-blind Phase|Lost to Follow-up|8|||
161335109|NCT00490919|582615944|FG002|Double-blind Phase|Lost to Follow-up|11|||
161252046|NCT01190930|582302359|FG000|Maintenance|Still on therapy|0|||
161252047|NCT01190930|582302360|FG001|Maintenance|Still on therapy|8|||
161252048|NCT01190930|582302361|FG002|Maintenance|Still on therapy|0|||
161252049|NCT01190930|582302362|FG003|Maintenance|Still on therapy|29|||
161252050|NCT01190930|582302363|FG004|Maintenance|Still on therapy|0|||
161252051|NCT01190930|582302364|FG005|Maintenance|Still on therapy|0|||
161252052|NCT01190930|582302365|FG006|Maintenance|Still on therapy|0|||
161252053|NCT01190930|582302366|FG007|Maintenance|Still on therapy|0|||
161252054|NCT01190930|582302367|FG008|Maintenance|Still on therapy|0|||
161335110|NCT00490919|582615942|FG000|Double-blind Phase|Lack of Efficacy|0|||
161335111|NCT00490919|582615943|FG001|Double-blind Phase|Lack of Efficacy|22|||
161252055|NCT01190930|582302368|FG009|Maintenance|Still on therapy|0|||
161335112|NCT00490919|582615944|FG002|Double-blind Phase|Lack of Efficacy|36|||
161335113|NCT00490919|582615942|FG000|Double-blind Phase|Administrative|0|||
161335114|NCT00490919|582615943|FG001|Double-blind Phase|Administrative|6|||
161335115|NCT00490919|582615944|FG002|Double-blind Phase|Administrative|6|||
161139809|NCT02424539|581894888|FG001|Overall Study|Withdrawal by Subject|1|||
161252056|NCT00979212|582302372|FG000|Overall Study|Protocol Violation|1|||
161252057|NCT00979212|582302373|FG001|Overall Study|Protocol Violation|8|||
161252058|NCT00979212|582302372|FG000|Overall Study|No protocol therapy received|1|||
161139810|NCT02424539|581894889|FG002|Overall Study|Withdrawal by Subject|0|||
161139811|NCT02424539|581894887|FG000|Overall Study|Other: Reached stopping criteria|11|||
161335116|NCT04350827|582615945|FG000|Overall Study|Lost to Follow-up|1|||
161139812|NCT02424539|581894888|FG001|Overall Study|Other: Reached stopping criteria|7|||
161139813|NCT02424539|581894889|FG002|Overall Study|Other: Reached stopping criteria|6|||
161139814|NCT00813748|581894890|FG000|Skin Test Substudy|Physician Decision|0|||
161139815|NCT00813748|581894891|FG001|Skin Test Substudy|Physician Decision|1|||
161139816|NCT01829048|581894892|FG000|Overall Study|Withdrawal by Subject|0|||
161139817|NCT01829048|581894893|FG001|Overall Study|Withdrawal by Subject|0|||
161139818|NCT01829048|581894894|FG002|Overall Study|Withdrawal by Subject|0|||
161139819|NCT01829048|581894895|FG003|Overall Study|Withdrawal by Subject|2|||
161139820|NCT01829048|581894896|FG004|Overall Study|Withdrawal by Subject|0|||
161139821|NCT00500071|581894904|FG000|Screening and Washout Phase|Protocol Violation|1|||
161139822|NCT00500071|581894904|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
161139823|NCT00500071|581894904|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
161139824|NCT00500071|581894904|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
161139825|NCT00500071|581894904|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
161139826|NCT00500071|581894904|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
161139827|NCT00500071|581894904|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
161139828|NCT00389207|581894905|FG000|Overall Study|Adverse Event|26|||
161139829|NCT00389207|581894906|FG001|Overall Study|Adverse Event|32|||
161139830|NCT00389207|581894907|FG002|Overall Study|Adverse Event|10|||
161139831|NCT00389207|581894905|FG000|Overall Study|Protocol Violation|3|||
161139832|NCT00389207|581894906|FG001|Overall Study|Protocol Violation|1|||
161139833|NCT00389207|581894907|FG002|Overall Study|Protocol Violation|4|||
161335117|NCT04350827|582615946|FG001|Overall Study|Lost to Follow-up|2|||
161335118|NCT02034006|582617645|FG000|Overall Study|Withdrawal by Subject|7|||
161335119|NCT02034006|582617645|FG000|Overall Study|Lost to Follow-up|5|||
161335120|NCT02034006|582617645|FG000|Overall Study|Death|1|||
161335121|NCT02034006|582617645|FG000|Overall Study|Pregnancy|1|||
161335122|NCT00161213|582617648|FG000|Overall Study|Withdrawal by Subject|1|||
161335123|NCT00161213|582617648|FG000|Overall Study|Evaluable for toxicity but not response|1|||
161335124|NCT01926028|582617649|FG000|Overall Study|Lost to Follow-up|7|||
161335125|NCT01926028|582617650|FG001|Overall Study|Lost to Follow-up|6|||
161335126|NCT01926028|582617651|FG002|Overall Study|Lost to Follow-up|0|||
161335127|NCT01926028|582617649|FG000|Overall Study|Physician Decision|1|||
161335128|NCT01926028|582617650|FG001|Overall Study|Physician Decision|5|||
161252059|NCT00979212|582302373|FG001|Overall Study|No protocol therapy received|0|||
161335129|NCT01926028|582617651|FG002|Overall Study|Physician Decision|0|||
161335130|NCT01926028|582617649|FG000|Overall Study|Withdrawal by Subject|9|||
161335131|NCT01926028|582617650|FG001|Overall Study|Withdrawal by Subject|9|||
161335132|NCT01926028|582617651|FG002|Overall Study|Withdrawal by Subject|2|||
161139834|NCT00389207|581894905|FG000|Overall Study|Lost to Follow-up|12|||
161139835|NCT00389207|581894906|FG001|Overall Study|Lost to Follow-up|9|||
161139836|NCT00389207|581894907|FG002|Overall Study|Lost to Follow-up|7|||
161139837|NCT00389207|581894905|FG000|Overall Study|Withdrawal by Subject|5|||
161139838|NCT00389207|581894906|FG001|Overall Study|Withdrawal by Subject|7|||
161139839|NCT00389207|581894907|FG002|Overall Study|Withdrawal by Subject|11|||
161139840|NCT00389207|581894905|FG000|Overall Study|Other|17|||
161139841|NCT00389207|581894906|FG001|Overall Study|Other|23|||
161252060|NCT00035555|582302374|FG000|Overall Study|Adverse Event|5|||
161252061|NCT00035555|582302375|FG001|Overall Study|Adverse Event|8|||
161252062|NCT00035555|582302376|FG002|Overall Study|Adverse Event|9|||
161252063|NCT00035555|582302374|FG000|Overall Study|Allograft loss|1|||
161252064|NCT00035555|582302375|FG001|Overall Study|Allograft loss|1|||
161252065|NCT00035555|582302376|FG002|Overall Study|Allograft loss|2|||
161252066|NCT00035555|582302374|FG000|Overall Study|Death|0|||
161252067|NCT00035555|582302375|FG001|Overall Study|Death|0|||
161252068|NCT00035555|582302376|FG002|Overall Study|Death|2|||
161252069|NCT00035555|582302374|FG000|Overall Study|Lost to Follow-up|0|||
161139842|NCT00389207|581894907|FG002|Overall Study|Other|9|||
161139843|NCT00424398|581894911|FG000|Overall Study|Withdrawal by Subject|2|||
161139844|NCT00424398|581894912|FG001|Overall Study|Withdrawal by Subject|1|||
161139845|NCT00424398|581894913|FG002|Overall Study|Withdrawal by Subject|0|||
161335133|NCT01926028|582617649|FG000|Overall Study|Non compliance or other reasons|4|||
161335134|NCT01926028|582617650|FG001|Overall Study|Non compliance or other reasons|2|||
161335135|NCT01926028|582617651|FG002|Overall Study|Non compliance or other reasons|0|||
161335136|NCT02351934|582617652|FG000|Allocation|POD weight<pre-op weight|3|||
161335137|NCT02351934|582617653|FG001|Allocation|POD weight<pre-op weight|0|||
161335138|NCT02351934|582617652|FG000|Allocation|Hypotension preventing administration|2|||
161252070|NCT00035555|582302375|FG001|Overall Study|Lost to Follow-up|0|||
161335139|NCT02351934|582617653|FG001|Allocation|Hypotension preventing administration|0|||
161335140|NCT02351934|582617652|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
161252071|NCT00035555|582302376|FG002|Overall Study|Lost to Follow-up|1|||
161252072|NCT00035555|582302374|FG000|Overall Study|Noncompliance|0|||
161335141|NCT02351934|582617653|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
161335142|NCT02351934|582617652|FG000|Follow-Up|POD weight<pre-op weight|3|||
160992236|NCT02014558|581360004|FG009|Overall Study|Lack of Efficacy|3|||
161139846|NCT00424398|581894911|FG000|Overall Study|Subject met exclusion criteria|1|||
161335143|NCT02351934|582617653|FG001|Follow-Up|POD weight<pre-op weight|0|||
161335144|NCT02351934|582617652|FG000|Follow-Up|Acute Kidney Injury|1|||
161335145|NCT02351934|582617653|FG001|Follow-Up|Acute Kidney Injury|0|||
161335146|NCT02351934|582617652|FG000|Follow-Up|Early dismissal|3|||
161335147|NCT02351934|582617653|FG001|Follow-Up|Early dismissal|0|||
161335148|NCT02351934|582617652|FG000|Follow-Up|Hypotension|3|||
161335149|NCT02351934|582617653|FG001|Follow-Up|Hypotension|0|||
161335150|NCT02351934|582617652|FG000|Follow-Up|No documentation|2|||
161335151|NCT02351934|582617653|FG001|Follow-Up|No documentation|0|||
161335152|NCT02351934|582617652|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
161335153|NCT02351934|582617653|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
161335154|NCT02351934|582617652|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
161335155|NCT02351934|582617653|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
161335156|NCT04635839|582617654|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
161335157|NCT04635839|582617655|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
161335158|NCT02870868|582617656|FG000|Overall Study|Withdrawal by Subject|2|||
161335159|NCT02870868|582617657|FG001|Overall Study|Withdrawal by Subject|1|||
161335160|NCT00288912|582617658|FG000|Overall Study|Developed exclusion criterion|4|||
161335161|NCT00288912|582617659|FG001|Overall Study|Developed exclusion criterion|6|||
161335162|NCT00288912|582617660|FG002|Overall Study|Developed exclusion criterion|7|||
161335163|NCT00288912|582617658|FG000|Overall Study|Lost to Follow-up|9|||
161335164|NCT00288912|582617659|FG001|Overall Study|Lost to Follow-up|6|||
161335165|NCT00288912|582617660|FG002|Overall Study|Lost to Follow-up|9|||
161335166|NCT00288912|582617658|FG000|Overall Study|Withdrawal by Subject|4|||
161335167|NCT00288912|582617659|FG001|Overall Study|Withdrawal by Subject|5|||
160992237|NCT02014558|581360005|FG010|Overall Study|Lack of Efficacy|16|||
160992238|NCT02014558|581360006|FG011|Overall Study|Lack of Efficacy|8|||
160992239|NCT02014558|581360007|FG012|Overall Study|Lack of Efficacy|5|||
160992240|NCT02014558|581359995|FG000|Overall Study|Lost to Follow-up|0|||
160992241|NCT02014558|581359996|FG001|Overall Study|Lost to Follow-up|0|||
160992242|NCT02014558|581359997|FG002|Overall Study|Lost to Follow-up|0|||
160992243|NCT02014558|581359998|FG003|Overall Study|Lost to Follow-up|0|||
160992244|NCT02014558|581359999|FG004|Overall Study|Lost to Follow-up|0|||
160992245|NCT02014558|581360000|FG005|Overall Study|Lost to Follow-up|0|||
160992246|NCT02014558|581360001|FG006|Overall Study|Lost to Follow-up|0|||
160992247|NCT02014558|581360002|FG007|Overall Study|Lost to Follow-up|0|||
160992248|NCT02014558|581360003|FG008|Overall Study|Lost to Follow-up|0|||
161335168|NCT00288912|582617660|FG002|Overall Study|Withdrawal by Subject|12|||
161335169|NCT02466399|582617661|FG000|Overall Study|Adverse Event|1|||
161335170|NCT02466399|582617662|FG001|Overall Study|Adverse Event|0|||
160992249|NCT02014558|581360004|FG009|Overall Study|Lost to Follow-up|0|||
160992250|NCT02014558|581360005|FG010|Overall Study|Lost to Follow-up|1|||
160992251|NCT02014558|581360006|FG011|Overall Study|Lost to Follow-up|0|||
160992252|NCT02014558|581360007|FG012|Overall Study|Lost to Follow-up|0|||
160992253|NCT02014558|581359995|FG000|Overall Study|Progressive Disease|1|||
160992254|NCT02014558|581359996|FG001|Overall Study|Progressive Disease|0|||
160992255|NCT02014558|581359997|FG002|Overall Study|Progressive Disease|1|||
160992256|NCT02014558|581359998|FG003|Overall Study|Progressive Disease|1|||
160992257|NCT02014558|581359999|FG004|Overall Study|Progressive Disease|1|||
160992258|NCT02014558|581360000|FG005|Overall Study|Progressive Disease|2|||
160992259|NCT02014558|581360001|FG006|Overall Study|Progressive Disease|1|||
160992260|NCT02014558|581360002|FG007|Overall Study|Progressive Disease|6|||
160992261|NCT02014558|581360003|FG008|Overall Study|Progressive Disease|5|||
160992262|NCT02014558|581360004|FG009|Overall Study|Progressive Disease|6|||
160992263|NCT02014558|581360005|FG010|Overall Study|Progressive Disease|22|||
160992264|NCT02014558|581360006|FG011|Overall Study|Progressive Disease|31|||
160992265|NCT02014558|581360007|FG012|Overall Study|Progressive Disease|6|||
161139847|NCT00424398|581894912|FG001|Overall Study|Subject met exclusion criteria|0|||
160992266|NCT02014558|581359995|FG000|Overall Study|Withdrawal by Subject|0|||
160992267|NCT02014558|581359996|FG001|Overall Study|Withdrawal by Subject|0|||
160992268|NCT02014558|581359997|FG002|Overall Study|Withdrawal by Subject|0|||
161139848|NCT00424398|581894913|FG002|Overall Study|Subject met exclusion criteria|0|||
161139849|NCT00749203|581894915|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
161139850|NCT00749203|581894916|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
161139851|NCT00749203|581894915|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
161139852|NCT00749203|581894916|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
161139853|NCT00749203|581894915|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
161139854|NCT00749203|581894916|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
161139855|NCT00749203|581894915|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
161139856|NCT00749203|581894916|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
161139857|NCT00749203|581894915|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
161139858|NCT00749203|581894916|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
161139859|NCT00749203|581894915|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
161139860|NCT00749203|581894916|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
161139861|NCT02034123|581894917|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161335171|NCT02466399|582617661|FG000|Overall Study|Early exit due to family emergency|1|||
161252073|NCT00035555|582302375|FG001|Overall Study|Noncompliance|1|||
161252074|NCT00035555|582302376|FG002|Overall Study|Noncompliance|1|||
161252075|NCT00035555|582302374|FG000|Overall Study|Prohibited medication|1|||
161252076|NCT00035555|582302375|FG001|Overall Study|Prohibited medication|1|||
161252077|NCT00035555|582302376|FG002|Overall Study|Prohibited medication|0|||
161252078|NCT00035555|582302374|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
161252079|NCT00035555|582302375|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
161252080|NCT00035555|582302376|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
161252081|NCT00035555|582302374|FG000|Overall Study|Withdrawal by Subject|2|||
161252082|NCT00035555|582302375|FG001|Overall Study|Withdrawal by Subject|0|||
161252083|NCT00035555|582302376|FG002|Overall Study|Withdrawal by Subject|2|||
161252084|NCT00035555|582302374|FG000|Overall Study|Investigator deemed not a good candidate|0|||
161252085|NCT00035555|582302375|FG001|Overall Study|Investigator deemed not a good candidate|0|||
161252086|NCT00035555|582302376|FG002|Overall Study|Investigator deemed not a good candidate|1|||
161252087|NCT00035555|582302374|FG000|Overall Study|Received cyclosporin in error|0|||
161252088|NCT00035555|582302375|FG001|Overall Study|Received cyclosporin in error|0|||
161252089|NCT00035555|582302376|FG002|Overall Study|Received cyclosporin in error|1|||
161252090|NCT00337428|582302377|FG000|Overall Study|Withdrawal by Subject|1|||
161252091|NCT00337428|582302378|FG001|Overall Study|Withdrawal by Subject|2|||
161252092|NCT00337428|582302377|FG000|Overall Study|Lack of Time|1|||
161252093|NCT00337428|582302378|FG001|Overall Study|Lack of Time|1|||
161252094|NCT00337428|582302377|FG000|Overall Study|Unwilling to Continue|1|||
161252095|NCT00337428|582302378|FG001|Overall Study|Unwilling to Continue|0|||
161252096|NCT00337428|582302377|FG000|Overall Study|Anorexia|1|||
161252097|NCT00337428|582302378|FG001|Overall Study|Anorexia|0|||
161252098|NCT02618382|582302379|FG000|Overall Study|Physician Decision|1|||
161252099|NCT02618382|582302379|FG000|Overall Study|Withdrawal by Subject|1|||
161252100|NCT02618382|582302379|FG000|Overall Study|Protocol Violation|1|||
161252101|NCT03223909|582302380|FG000|Overall Study|Protocol Violation|48|||
161252102|NCT03223909|582302381|FG001|Overall Study|Protocol Violation|45|||
161252103|NCT03223909|582302382|FG002|Overall Study|Protocol Violation|16|||
161252104|NCT04886063|582302389|FG000|Overall Study|Adverse Event|50|||
161252105|NCT04886063|582302389|FG000|Overall Study|Lack of Efficacy|31|||
161252106|NCT04886063|582302389|FG000|Overall Study|Withdrawal by Subject|45|||
161252107|NCT04886063|582302389|FG000|Overall Study|Physician Decision|3|||
161252108|NCT04886063|582302389|FG000|Overall Study|Protocol Violation|3|||
161252109|NCT04886063|582302389|FG000|Overall Study|Site closure|4|||
161252110|NCT04886063|582302389|FG000|Overall Study|Nursing home replacement|3|||
161252111|NCT04886063|582302389|FG000|Overall Study|Lost to Follow-up|5|||
161252112|NCT04886063|582302389|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
161252113|NCT04886063|582302389|FG000|Overall Study|>1 reason|20|||
161252114|NCT01628549|582302390|FG000|Overall Study|Adverse Event|1|||
161252115|NCT01628549|582302391|FG001|Overall Study|Adverse Event|1|||
161252116|NCT01628549|582302392|FG002|Overall Study|Adverse Event|0|||
161252117|NCT01628549|582302393|FG003|Overall Study|Adverse Event|4|||
161252118|NCT01628549|582302390|FG000|Overall Study|Lost to Follow-up|3|||
161252119|NCT01628549|582302391|FG001|Overall Study|Lost to Follow-up|4|||
161252120|NCT01628549|582302392|FG002|Overall Study|Lost to Follow-up|3|||
161252121|NCT01628549|582302393|FG003|Overall Study|Lost to Follow-up|3|||
161252122|NCT01628549|582302390|FG000|Overall Study|Withdrawal by Subject|3|||
161252123|NCT01628549|582302391|FG001|Overall Study|Withdrawal by Subject|4|||
161252124|NCT01628549|582302392|FG002|Overall Study|Withdrawal by Subject|4|||
161252125|NCT01628549|582302393|FG003|Overall Study|Withdrawal by Subject|1|||
161252126|NCT01628549|582302390|FG000|Overall Study|Protocol Violation|2|||
161252127|NCT01628549|582302391|FG001|Overall Study|Protocol Violation|1|||
161252128|NCT01628549|582302392|FG002|Overall Study|Protocol Violation|1|||
161252129|NCT01628549|582302393|FG003|Overall Study|Protocol Violation|0|||
161252130|NCT01628549|582302390|FG000|Overall Study|withdrawn for noncompliance|0|||
161252131|NCT01628549|582302391|FG001|Overall Study|withdrawn for noncompliance|2|||
161252132|NCT01628549|582302392|FG002|Overall Study|withdrawn for noncompliance|1|||
161252133|NCT01628549|582302393|FG003|Overall Study|withdrawn for noncompliance|0|||
161252134|NCT01628549|582302390|FG000|Overall Study|abnormal laboratory test results|0|||
161252135|NCT01628549|582302391|FG001|Overall Study|abnormal laboratory test results|0|||
161252136|NCT01628549|582302392|FG002|Overall Study|abnormal laboratory test results|1|||
161252137|NCT01628549|582302393|FG003|Overall Study|abnormal laboratory test results|0|||
161252138|NCT01628549|582302390|FG000|Overall Study|positive pregnancy test|0|||
161252139|NCT01628549|582302391|FG001|Overall Study|positive pregnancy test|0|||
161252140|NCT01628549|582302392|FG002|Overall Study|positive pregnancy test|0|||
161252141|NCT01628549|582302393|FG003|Overall Study|positive pregnancy test|1|||
161252142|NCT00177164|582302401|FG000|Overall Study|Protocol Violation|0|||
161252143|NCT00177164|582302402|FG001|Overall Study|Protocol Violation|7|||
161252144|NCT00177164|582302401|FG000|Overall Study|Lost to Follow-up|4|||
161252145|NCT00177164|582302402|FG001|Overall Study|Lost to Follow-up|5|||
161252146|NCT00177164|582302401|FG000|Overall Study|increase in alcohol and drug use|1|||
161252147|NCT00177164|582302402|FG001|Overall Study|increase in alcohol and drug use|2|||
161252148|NCT00177164|582302401|FG000|Overall Study|Adverse Event|1|||
161335172|NCT02466399|582617662|FG001|Overall Study|Early exit due to family emergency|0|||
161335173|NCT02669849|582617667|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161335174|NCT02669849|582617668|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
161335175|NCT02669849|582617669|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
161335176|NCT02669849|582617667|FG000|Overall Study|Lost to Follow-up|1|||
161335177|NCT02669849|582617668|FG001|Overall Study|Lost to Follow-up|0|||
161335178|NCT02669849|582617669|FG002|Overall Study|Lost to Follow-up|3|||
161335179|NCT02669849|582617667|FG000|Overall Study|Death|1|||
161335180|NCT02669849|582617668|FG001|Overall Study|Death|1|||
161335181|NCT02669849|582617669|FG002|Overall Study|Death|2|||
161335182|NCT02669849|582617667|FG000|Overall Study|Study terminated by sponsor|16|||
161335183|NCT02669849|582617668|FG001|Overall Study|Study terminated by sponsor|1|||
161139862|NCT02034123|581894918|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139863|NCT02034123|581894919|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139864|NCT02034123|581894920|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139865|NCT02034123|581894921|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161139866|NCT02034123|581894922|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139867|NCT02034123|581894923|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139868|NCT02034123|581894924|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161139869|NCT02034123|581894925|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
161139870|NCT02034123|581894926|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139871|NCT02034123|581894927|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139872|NCT02034123|581894928|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139873|NCT02034123|581894929|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139874|NCT02034123|581894930|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139875|NCT02034123|581894931|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139876|NCT02034123|581894932|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139877|NCT02034123|581894933|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139878|NCT02034123|581894934|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
161139879|NCT02034123|581894917|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139880|NCT02034123|581894918|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139881|NCT02034123|581894919|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139882|NCT02034123|581894920|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
161139883|NCT02034123|581894921|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139884|NCT02034123|581894922|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139885|NCT02034123|581894923|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139886|NCT02034123|581894924|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139887|NCT02034123|581894925|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161252149|NCT00177164|582302402|FG001|Overall Study|Adverse Event|0|||
161252150|NCT00177164|582302401|FG000|Overall Study|discharge from hospital|1|||
161252151|NCT00177164|582302402|FG001|Overall Study|discharge from hospital|0|||
161252152|NCT00177164|582302401|FG000|Overall Study|Lack of Efficacy|2|||
161335184|NCT02669849|582617669|FG002|Overall Study|Study terminated by sponsor|14|||
161335185|NCT02669849|582617667|FG000|Overall Study|Other|0|||
161335186|NCT02669849|582617668|FG001|Overall Study|Other|0|||
161335187|NCT02669849|582617669|FG002|Overall Study|Other|2|||
161335188|NCT03408899|582617670|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
161335189|NCT00606008|582617671|FG000|Overall Study|Adverse Event|1|||
161335190|NCT00606008|582617671|FG000|Overall Study|Withdrawal by Subject|4|||
161335191|NCT04745351|582617675|FG000|Overall Study|Death|51|||
161335192|NCT04745351|582617676|FG001|Overall Study|Death|25|||
161335193|NCT04745351|582617675|FG000|Overall Study|Lost to Follow-up|9|||
161335194|NCT04745351|582617676|FG001|Overall Study|Lost to Follow-up|3|||
161335195|NCT04745351|582617675|FG000|Overall Study|Randomized but Never Treated|3|||
161139888|NCT02034123|581894926|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139889|NCT02034123|581894927|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139890|NCT02034123|581894928|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139891|NCT02034123|581894929|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139892|NCT02034123|581894930|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139893|NCT02034123|581894931|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139894|NCT02034123|581894932|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139895|NCT02034123|581894933|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139896|NCT02034123|581894934|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
161139897|NCT02034123|581894917|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161252153|NCT00177164|582302402|FG001|Overall Study|Lack of Efficacy|1|||
161252154|NCT00177164|582302401|FG000|Overall Study|Pregnancy|0|||
161252155|NCT00177164|582302402|FG001|Overall Study|Pregnancy|1|||
161252156|NCT03807440|582302405|FG000|Overall Study|No documentation of index date 2|320|||
161335196|NCT04745351|582617676|FG001|Overall Study|Randomized but Never Treated|3|||
161335197|NCT04745351|582617675|FG000|Overall Study|Adverse Event|4|||
161335198|NCT04745351|582617676|FG001|Overall Study|Adverse Event|0|||
161139898|NCT02034123|581894918|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139899|NCT02034123|581894919|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139900|NCT02034123|581894920|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139901|NCT02034123|581894921|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139902|NCT02034123|581894922|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139903|NCT02034123|581894923|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139904|NCT02034123|581894924|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139905|NCT02034123|581894925|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
161335199|NCT04745351|582617675|FG000|Overall Study|Withdrew Consent|1|||
161335200|NCT04745351|582617676|FG001|Overall Study|Withdrew Consent|2|||
161335201|NCT04745351|582617675|FG000|Overall Study|Investigator's Discretion|2|||
161139906|NCT02034123|581894926|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139907|NCT02034123|581894927|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139908|NCT02034123|581894928|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139909|NCT02034123|581894929|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161335202|NCT04745351|582617676|FG001|Overall Study|Investigator's Discretion|0|||
161335203|NCT04745351|582617675|FG000|Overall Study|Protocol Violation|1|||
161335204|NCT04745351|582617676|FG001|Overall Study|Protocol Violation|0|||
161335205|NCT02014272|582617677|FG000|Intervention Period 1|Withdrawal by Subject|1|||
161335206|NCT02014272|582617678|FG001|Intervention Period 1|Withdrawal by Subject|0|||
161335207|NCT02014272|582617677|FG000|Intervention Period 1|Adverse Event|0|||
161335208|NCT02014272|582617678|FG001|Intervention Period 1|Adverse Event|1|||
161335209|NCT03499795|582617679|FG000|Overall Study|Adverse Event|1|||
161335210|NCT03499795|582617679|FG000|Overall Study|Lost to Follow-up|1|||
161335211|NCT00547339|582617680|FG000|Overall Study|Physician Decision|0|||
161335212|NCT00547339|582617681|FG001|Overall Study|Physician Decision|0|||
161335213|NCT00547339|582617682|FG002|Overall Study|Physician Decision|1|||
161335214|NCT00547339|582617683|FG003|Overall Study|Physician Decision|0|||
161335215|NCT02426684|582617684|FG000|Overall Study|Physician Decision|1|||
161335216|NCT03736967|582617685|FG000|Overall Study|Withdrawal by Subject|26|||
161335217|NCT03736967|582617686|FG001|Overall Study|Withdrawal by Subject|25|||
161335218|NCT03736967|582617687|FG002|Overall Study|Withdrawal by Subject|23|||
161335219|NCT03736967|582617688|FG003|Overall Study|Withdrawal by Subject|26|||
161335220|NCT03736967|582617685|FG000|Overall Study|Lost to Follow-up|3|||
161335221|NCT03736967|582617686|FG001|Overall Study|Lost to Follow-up|2|||
161335222|NCT03736967|582617687|FG002|Overall Study|Lost to Follow-up|1|||
161335223|NCT03736967|582617688|FG003|Overall Study|Lost to Follow-up|1|||
161335224|NCT03736967|582617685|FG000|Overall Study|Physician Decision|1|||
161335225|NCT03736967|582617686|FG001|Overall Study|Physician Decision|0|||
161335226|NCT03736967|582617687|FG002|Overall Study|Physician Decision|0|||
161335227|NCT03736967|582617688|FG003|Overall Study|Physician Decision|1|||
161335228|NCT03736967|582617685|FG000|Overall Study|Adverse Event|0|||
161335229|NCT03736967|582617686|FG001|Overall Study|Adverse Event|1|||
161335230|NCT03736967|582617687|FG002|Overall Study|Adverse Event|0|||
161335231|NCT03736967|582617688|FG003|Overall Study|Adverse Event|1|||
161335232|NCT03736967|582617685|FG000|Overall Study|Death|0|||
161335233|NCT03736967|582617686|FG001|Overall Study|Death|0|||
161335234|NCT03736967|582617687|FG002|Overall Study|Death|0|||
161335235|NCT03736967|582617688|FG003|Overall Study|Death|1|||
161335236|NCT03736967|582617685|FG000|Overall Study|Randomized but never treated|1|||
161335237|NCT03736967|582617686|FG001|Overall Study|Randomized but never treated|0|||
161335238|NCT03736967|582617687|FG002|Overall Study|Randomized but never treated|0|||
161335239|NCT03736967|582617688|FG003|Overall Study|Randomized but never treated|0|||
161335240|NCT01587885|582617689|FG000|Treatment Period 1|Failure to Return|0|||
161335241|NCT01587885|582617690|FG001|Treatment Period 1|Failure to Return|1|||
161335242|NCT01587885|582617689|FG000|Treatment Period 1|Protocol Violation|0|||
161335243|NCT01587885|582617690|FG001|Treatment Period 1|Protocol Violation|2|||
161335244|NCT01935089|582617692|FG000|Overall Study|Adverse Event|2|||
161335245|NCT01935089|582617692|FG000|Overall Study|Withdrawal by Subject|1|||
161335246|NCT00977197|582617693|FG000|Overall Study|Withdrawal by Subject|3|||
161335247|NCT00977197|582617694|FG001|Overall Study|Withdrawal by Subject|4|||
161139910|NCT02034123|581894930|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139911|NCT02034123|581894931|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139912|NCT02034123|581894932|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139913|NCT02034123|581894933|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139914|NCT02034123|581894934|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
161139915|NCT02034123|581894917|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161335248|NCT00977197|582617693|FG000|Overall Study|Adverse Event|3|||
161335249|NCT00977197|582617694|FG001|Overall Study|Adverse Event|1|||
161335250|NCT00977197|582617693|FG000|Overall Study|Lack of Efficacy|1|||
161335251|NCT00977197|582617694|FG001|Overall Study|Lack of Efficacy|0|||
161335252|NCT00977197|582617693|FG000|Overall Study|Lost to Follow-up|1|||
160844359|NCT00195663|580817985|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
160844360|NCT00195663|580817986|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
160844361|NCT00195663|580817987|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
160844362|NCT00195663|580817985|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
160844363|NCT00195663|580817986|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
160844364|NCT00195663|580817987|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
160844365|NCT00195663|580817985|FG000|Open-Label Extension Period|Administrative reasons|11|||
160844366|NCT00195663|580817986|FG001|Open-Label Extension Period|Administrative reasons|11|||
160844367|NCT00195663|580817987|FG002|Open-Label Extension Period|Administrative reasons|13|||
161252157|NCT03807440|582302405|FG000|Overall Study|No informed consent for index date 2|117|||
160844368|NCT01380834|580817988|FG000|Overall Study|Physician Decision|1|||
161252158|NCT02451358|582302406|FG000|Overall Study|Withdrawal by Subject|1|||
161252159|NCT02451358|582302407|FG001|Overall Study|Withdrawal by Subject|1|||
161252160|NCT02451358|582302408|FG002|Overall Study|Withdrawal by Subject|0|||
161252161|NCT02451358|582302409|FG003|Overall Study|Withdrawal by Subject|0|||
161252162|NCT02451358|582302406|FG000|Overall Study|Protocol Violation|0|||
161252163|NCT02451358|582302407|FG001|Overall Study|Protocol Violation|1|||
161252164|NCT02451358|582302408|FG002|Overall Study|Protocol Violation|1|||
161252165|NCT02451358|582302409|FG003|Overall Study|Protocol Violation|0|||
161252166|NCT06128525|582302410|FG000|Overall Study|Patient withdrew consent|1|||
161252167|NCT03414034|582302415|FG000|Overall Study|Adverse Event|6|||
161252168|NCT03414034|582302416|FG001|Overall Study|Adverse Event|1|||
161252169|NCT03414034|582302417|FG002|Overall Study|Adverse Event|1|||
161252170|NCT03414034|582302415|FG000|Overall Study|Death|0|||
161252171|NCT03414034|582302416|FG001|Overall Study|Death|0|||
161252172|NCT03414034|582302417|FG002|Overall Study|Death|1|||
161252173|NCT03414034|582302415|FG000|Overall Study|Non-compliance With Study Drug|0|||
161252174|NCT03414034|582302416|FG001|Overall Study|Non-compliance With Study Drug|0|||
161252175|NCT03414034|582302417|FG002|Overall Study|Non-compliance With Study Drug|1|||
161252176|NCT03414034|582302415|FG000|Overall Study|Physician Decision|1|||
161252177|NCT03414034|582302416|FG001|Overall Study|Physician Decision|3|||
161252178|NCT03414034|582302417|FG002|Overall Study|Physician Decision|2|||
161252179|NCT03414034|582302415|FG000|Overall Study|Withdrawal of Informed Consent|2|||
161252180|NCT03414034|582302416|FG001|Overall Study|Withdrawal of Informed Consent|1|||
161252181|NCT03414034|582302417|FG002|Overall Study|Withdrawal of Informed Consent|4|||
161252182|NCT03414034|582302415|FG000|Overall Study|Progressive Disease|15|||
161252183|NCT03414034|582302416|FG001|Overall Study|Progressive Disease|15|||
161252184|NCT03414034|582302417|FG002|Overall Study|Progressive Disease|17|||
161252185|NCT03414034|582302415|FG000|Overall Study|Miscellaneous|0|||
161252186|NCT03414034|582302416|FG001|Overall Study|Miscellaneous|0|||
161252187|NCT03414034|582302417|FG002|Overall Study|Miscellaneous|2|||
161252188|NCT02351167|582302419|FG000|Overall Study|Withdrawal by Subject|19|||
161252189|NCT02351167|582302420|FG001|Overall Study|Withdrawal by Subject|18|||
161252190|NCT02351167|582302421|FG002|Overall Study|Withdrawal by Subject|21|||
161252191|NCT01332968|582302422|FG000|Induction Period|Adverse Event|23|||
161252192|NCT01332968|582302423|FG001|Induction Period|Adverse Event|26|||
161252193|NCT01332968|582302424|FG002|Induction Period|Adverse Event|0|||
161252194|NCT01332968|582302425|FG003|Induction Period|Adverse Event|0|||
161252195|NCT01332968|582302426|FG004|Induction Period|Adverse Event|0|||
161252196|NCT01332968|582302427|FG005|Induction Period|Adverse Event|0|||
161252197|NCT01332968|582302428|FG006|Induction Period|Adverse Event|0|||
161252198|NCT01332968|582302429|FG007|Induction Period|Adverse Event|0|||
161252199|NCT01332968|582302422|FG000|Induction Period|Death|1|||
161252200|NCT01332968|582302423|FG001|Induction Period|Death|4|||
161252201|NCT01332968|582302424|FG002|Induction Period|Death|0|||
161252202|NCT01332968|582302425|FG003|Induction Period|Death|0|||
161252203|NCT01332968|582302426|FG004|Induction Period|Death|0|||
161252204|NCT01332968|582302427|FG005|Induction Period|Death|0|||
161252205|NCT01332968|582302428|FG006|Induction Period|Death|0|||
161252206|NCT01332968|582302429|FG007|Induction Period|Death|0|||
161252207|NCT01332968|582302422|FG000|Induction Period|Non-compliance|1|||
161252208|NCT01332968|582302423|FG001|Induction Period|Non-compliance|0|||
161252209|NCT01332968|582302424|FG002|Induction Period|Non-compliance|0|||
161252210|NCT01332968|582302425|FG003|Induction Period|Non-compliance|0|||
161252211|NCT01332968|582302426|FG004|Induction Period|Non-compliance|0|||
161252212|NCT01332968|582302427|FG005|Induction Period|Non-compliance|0|||
161252213|NCT01332968|582302428|FG006|Induction Period|Non-compliance|0|||
161252214|NCT01332968|582302429|FG007|Induction Period|Non-compliance|0|||
161252215|NCT01332968|582302422|FG000|Induction Period|Other|2|||
161252216|NCT01332968|582302423|FG001|Induction Period|Other|2|||
161252217|NCT01332968|582302424|FG002|Induction Period|Other|0|||
161252218|NCT01332968|582302425|FG003|Induction Period|Other|0|||
161252219|NCT01332968|582302426|FG004|Induction Period|Other|0|||
161252220|NCT01332968|582302427|FG005|Induction Period|Other|0|||
161252221|NCT01332968|582302428|FG006|Induction Period|Other|0|||
161252222|NCT01332968|582302429|FG007|Induction Period|Other|0|||
161252223|NCT01332968|582302422|FG000|Induction Period|Physician Decision|6|||
161252224|NCT01332968|582302423|FG001|Induction Period|Physician Decision|1|||
161252225|NCT01332968|582302424|FG002|Induction Period|Physician Decision|0|||
161139916|NCT02034123|581894918|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161335253|NCT00977197|582617694|FG001|Overall Study|Lost to Follow-up|3|||
161335254|NCT00977197|582617693|FG000|Overall Study|Nonadherence|1|||
161335255|NCT00977197|582617694|FG001|Overall Study|Nonadherence|1|||
161335256|NCT03482024|582617695|FG000|Overall Study|Physician Decision|1|||
161139917|NCT02034123|581894919|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139918|NCT02034123|581894920|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
161139919|NCT02034123|581894921|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
161139920|NCT02034123|581894922|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139921|NCT02034123|581894923|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139922|NCT02034123|581894924|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139923|NCT02034123|581894925|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139924|NCT02034123|581894926|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139925|NCT02034123|581894927|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139926|NCT02034123|581894928|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139927|NCT02034123|581894929|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139928|NCT02034123|581894930|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139929|NCT02034123|581894931|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139930|NCT02034123|581894932|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139931|NCT02034123|581894933|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139932|NCT02034123|581894934|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
161139933|NCT00246259|581894935|FG000|Overall Study|Other|3|||
161139934|NCT00246259|581894936|FG001|Overall Study|Other|3|||
161139935|NCT00246259|581894935|FG000|Overall Study|Not stable by Week 18|2|||
161335257|NCT03482024|582617696|FG001|Overall Study|Physician Decision|0|||
161335258|NCT03482024|582617697|FG002|Overall Study|Physician Decision|0|||
161139936|NCT00246259|581894936|FG001|Overall Study|Not stable by Week 18|1|||
161139937|NCT00246259|581894935|FG000|Overall Study|Participant non-compliant|4|||
161139938|NCT00246259|581894936|FG001|Overall Study|Participant non-compliant|9|||
161139939|NCT00246259|581894935|FG000|Overall Study|Lack of Efficacy|2|||
161139940|NCT00246259|581894936|FG001|Overall Study|Lack of Efficacy|2|||
161139941|NCT00246259|581894935|FG000|Overall Study|Investigator withdrew participant|2|||
161139942|NCT00246259|581894936|FG001|Overall Study|Investigator withdrew participant|0|||
161139943|NCT00246259|581894935|FG000|Overall Study|Adverse Event|5|||
161139944|NCT00246259|581894936|FG001|Overall Study|Adverse Event|0|||
161139945|NCT00246259|581894935|FG000|Overall Study|Lost to Follow-up|3|||
161139946|NCT00246259|581894936|FG001|Overall Study|Lost to Follow-up|4|||
161139947|NCT00246259|581894935|FG000|Overall Study|Withdrawal by Subject|5|||
161139948|NCT00246259|581894936|FG001|Overall Study|Withdrawal by Subject|1|||
161139949|NCT00246259|581894935|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
161139950|NCT00246259|581894936|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
161139951|NCT02272790|581894937|FG000|Overall Study|Physician Decision|0|||
161139952|NCT02272790|581894938|FG001|Overall Study|Physician Decision|1|||
161139953|NCT02272790|581894939|FG002|Overall Study|Physician Decision|0|||
161139954|NCT02272790|581894940|FG003|Overall Study|Physician Decision|0|||
161335259|NCT03482024|582617698|FG003|Overall Study|Physician Decision|0|||
161335260|NCT03482024|582617699|FG004|Overall Study|Physician Decision|0|||
161335261|NCT02295644|582617700|FG000|Overall Study|Did not meet inclusion criterion|0|||
161335262|NCT02295644|582617701|FG001|Overall Study|Did not meet inclusion criterion|0|||
161335263|NCT02295644|582617702|FG002|Overall Study|Did not meet inclusion criterion|1|||
161335264|NCT02295644|582617703|FG003|Overall Study|Did not meet inclusion criterion|2|||
161335265|NCT02147626|582617704|FG000|Overall Study|Lost to Follow-up|4|||
161139955|NCT02272790|581894941|FG004|Overall Study|Physician Decision|0|||
161139956|NCT02272790|581894942|FG005|Overall Study|Physician Decision|0|||
161139957|NCT04375878|581894943|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
161139958|NCT04375878|581894944|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
161139959|NCT04375878|581894945|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161139960|NCT04375878|581894946|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161139961|NCT04375878|581894947|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161139962|NCT04375878|581894948|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
161139963|NCT04375878|581894943|FG000|Crossover First and Second Interventions|Adverse Event|0|||
161139964|NCT04375878|581894944|FG001|Crossover First and Second Interventions|Adverse Event|0|||
161139965|NCT04375878|581894945|FG002|Crossover First and Second Interventions|Adverse Event|1|||
161139966|NCT04375878|581894946|FG003|Crossover First and Second Interventions|Adverse Event|0|||
161335266|NCT02147626|582617705|FG001|Overall Study|Lost to Follow-up|4|||
161335267|NCT02147626|582617704|FG000|Overall Study|Pregnancy|1|||
161335268|NCT02147626|582617705|FG001|Overall Study|Pregnancy|2|||
161335269|NCT02147626|582617704|FG000|Overall Study|Withdrawal by Subject|0|||
160992269|NCT02014558|581359998|FG003|Overall Study|Withdrawal by Subject|0|||
161335270|NCT02147626|582617705|FG001|Overall Study|Withdrawal by Subject|1|||
161335271|NCT00324155|582617706|FG000|Enrolled and Randomized|No longer met study criteria|3|||
161335272|NCT00324155|582617707|FG001|Enrolled and Randomized|No longer met study criteria|0|||
161335273|NCT00324155|582617706|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
161335274|NCT00324155|582617707|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
161335275|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
161335276|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
161335277|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
161335278|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
161335279|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Death|8|||
161335280|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Death|15|||
161335281|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
161335282|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
161335283|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
161335284|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
161335285|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
161335286|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
161335287|NCT00324155|582617706|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
161335288|NCT00324155|582617707|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
161335289|NCT00324155|582617706|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
161335290|NCT00324155|582617707|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
160844369|NCT01380834|580817989|FG001|Overall Study|Physician Decision|0|||
160844370|NCT03214406|580817990|FG000|Overall Study|did not meet enrollment criteria|9|||
160844371|NCT03214406|580817991|FG001|Overall Study|did not meet enrollment criteria|13|||
160844372|NCT03214406|580817990|FG000|Overall Study|Withdrawal by Subject|1|||
160844373|NCT03214406|580817991|FG001|Overall Study|Withdrawal by Subject|0|||
160844374|NCT03214406|580817990|FG000|Overall Study|Lost to Follow-up|0|||
160844375|NCT03214406|580817991|FG001|Overall Study|Lost to Follow-up|2|||
160844376|NCT01098305|580817992|FG000|Overall Study|Lost to Follow-up|31|||
161335291|NCT00324155|582617706|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
161335292|NCT00324155|582617707|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
161335293|NCT00324155|582617706|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
161335294|NCT00324155|582617707|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
161335295|NCT00324155|582617706|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
161335296|NCT00324155|582617707|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
161335297|NCT00324155|582617706|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
161335298|NCT00324155|582617707|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
161335299|NCT00324155|582617706|FG000|Follow-up Phase|On-going participants still on drug|11|||
161335300|NCT00324155|582617707|FG001|Follow-up Phase|On-going participants still on drug|6|||
161335301|NCT00390689|582617708|FG000|Overall Study|Adverse Event|2|||
161335302|NCT00390689|582617709|FG001|Overall Study|Adverse Event|5|||
161335303|NCT00390689|582617710|FG002|Overall Study|Adverse Event|2|||
161335304|NCT00390689|582617708|FG000|Overall Study|Lack of Efficacy|0|||
161335305|NCT00390689|582617709|FG001|Overall Study|Lack of Efficacy|0|||
161335306|NCT00390689|582617710|FG002|Overall Study|Lack of Efficacy|1|||
161139967|NCT04375878|581894947|FG004|Crossover First and Second Interventions|Adverse Event|0|||
161335307|NCT00390689|582617708|FG000|Overall Study|Protocol Violation|1|||
161335308|NCT00390689|582617709|FG001|Overall Study|Protocol Violation|0|||
161139968|NCT04375878|581894948|FG005|Crossover First and Second Interventions|Adverse Event|0|||
161139969|NCT04375878|581894943|FG000|Extension Phase|Withdrawal by Subject|0|||
161139970|NCT04375878|581894944|FG001|Extension Phase|Withdrawal by Subject|0|||
161139971|NCT04375878|581894945|FG002|Extension Phase|Withdrawal by Subject|0|||
161139972|NCT04375878|581894946|FG003|Extension Phase|Withdrawal by Subject|0|||
161139973|NCT04375878|581894947|FG004|Extension Phase|Withdrawal by Subject|1|||
161139974|NCT04375878|581894948|FG005|Extension Phase|Withdrawal by Subject|0|||
161139975|NCT00986349|581894949|FG000|Overall Study|Unsuccessful implant procedure|3|||
161139976|NCT00986349|581894949|FG000|Overall Study|Adverse Event|2|||
161139977|NCT00986349|581894949|FG000|Overall Study|Physician Decision|1|||
161139978|NCT00986349|581894949|FG000|Overall Study|device migration|1|||
161139979|NCT02299934|581894950|FG000|Overall Study|Termination of study|13|||
161139980|NCT01273818|581894951|FG000|Overall Study|Physician Decision|13|||
161139981|NCT01273818|581894952|FG001|Overall Study|Physician Decision|2|||
161139982|NCT01273818|581894953|FG002|Overall Study|Physician Decision|9|||
161139983|NCT03815175|581894954|FG000|Overall Study|Subject Lost to Follow-up|6|||
161139984|NCT03815175|581894954|FG000|Overall Study|Subject Withdrew Consent|48|||
161139985|NCT03815175|581894954|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
161139986|NCT03815175|581894954|FG000|Overall Study|Death|86|||
161139987|NCT03815175|581894954|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
161139988|NCT03815175|581894954|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
161139989|NCT03815175|581894954|FG000|Overall Study|Other Status Change Reason|1|||
161139990|NCT03815175|581894954|FG000|Overall Study|Missed Visit|12|||
161139991|NCT03577990|581894955|FG000|Overall Study|Lost to Follow-up|4|||
161252226|NCT01332968|582302425|FG003|Induction Period|Physician Decision|0|||
161252227|NCT01332968|582302426|FG004|Induction Period|Physician Decision|0|||
161252228|NCT01332968|582302427|FG005|Induction Period|Physician Decision|0|||
161252229|NCT01332968|582302428|FG006|Induction Period|Physician Decision|0|||
161252230|NCT01332968|582302429|FG007|Induction Period|Physician Decision|0|||
161252231|NCT01332968|582302422|FG000|Induction Period|Progressive Disease|15|||
161252232|NCT01332968|582302423|FG001|Induction Period|Progressive Disease|7|||
161252233|NCT01332968|582302424|FG002|Induction Period|Progressive Disease|0|||
161252234|NCT01332968|582302425|FG003|Induction Period|Progressive Disease|0|||
161252235|NCT01332968|582302426|FG004|Induction Period|Progressive Disease|0|||
161252236|NCT01332968|582302427|FG005|Induction Period|Progressive Disease|0|||
161252237|NCT01332968|582302428|FG006|Induction Period|Progressive Disease|0|||
161252238|NCT01332968|582302429|FG007|Induction Period|Progressive Disease|0|||
161252239|NCT01332968|582302422|FG000|Induction Period|Protocol Violation|3|||
161252240|NCT01332968|582302423|FG001|Induction Period|Protocol Violation|4|||
161252241|NCT01332968|582302424|FG002|Induction Period|Protocol Violation|0|||
161252242|NCT01332968|582302425|FG003|Induction Period|Protocol Violation|0|||
161252243|NCT01332968|582302426|FG004|Induction Period|Protocol Violation|0|||
161252244|NCT01332968|582302427|FG005|Induction Period|Protocol Violation|0|||
161252245|NCT01332968|582302428|FG006|Induction Period|Protocol Violation|0|||
161252246|NCT01332968|582302429|FG007|Induction Period|Protocol Violation|0|||
161252247|NCT01332968|582302422|FG000|Induction Period|Withdrawal by Subject|3|||
160905886|NCT01847274|581050311|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905887|NCT01847274|581050312|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905888|NCT01847274|581050313|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905889|NCT01847274|581050314|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
160905890|NCT01847274|581050304|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905891|NCT01847274|581050305|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905892|NCT01847274|581050306|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905893|NCT01847274|581050307|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905894|NCT01847274|581050308|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905895|NCT01847274|581050309|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905896|NCT01847274|581050310|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
160905897|NCT01847274|581050311|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905898|NCT01847274|581050312|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905899|NCT01847274|581050313|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905900|NCT01847274|581050314|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
160905901|NCT01847274|581050304|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905902|NCT01847274|581050305|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905903|NCT01847274|581050306|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905904|NCT01847274|581050307|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905905|NCT01847274|581050308|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905906|NCT01847274|581050309|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905907|NCT01847274|581050310|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
160905908|NCT01847274|581050311|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905909|NCT01847274|581050312|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905910|NCT01847274|581050313|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905911|NCT01847274|581050314|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
160905912|NCT01847274|581050304|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161252248|NCT01332968|582302423|FG001|Induction Period|Withdrawal by Subject|5|||
161252249|NCT01332968|582302424|FG002|Induction Period|Withdrawal by Subject|0|||
161252250|NCT01332968|582302425|FG003|Induction Period|Withdrawal by Subject|0|||
161252251|NCT01332968|582302426|FG004|Induction Period|Withdrawal by Subject|0|||
161252252|NCT01332968|582302427|FG005|Induction Period|Withdrawal by Subject|0|||
161252253|NCT01332968|582302428|FG006|Induction Period|Withdrawal by Subject|0|||
161252254|NCT01332968|582302429|FG007|Induction Period|Withdrawal by Subject|0|||
161252255|NCT01332968|582302422|FG000|Induction Period|Randomised but not treated|4|||
161252256|NCT01332968|582302423|FG001|Induction Period|Randomised but not treated|7|||
161252257|NCT01332968|582302424|FG002|Induction Period|Randomised but not treated|0|||
161252258|NCT01332968|582302425|FG003|Induction Period|Randomised but not treated|0|||
161252259|NCT01332968|582302426|FG004|Induction Period|Randomised but not treated|0|||
161252260|NCT01332968|582302427|FG005|Induction Period|Randomised but not treated|0|||
161252261|NCT01332968|582302428|FG006|Induction Period|Randomised but not treated|0|||
160905913|NCT01847274|581050305|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161252262|NCT01332968|582302429|FG007|Induction Period|Randomised but not treated|0|||
161252263|NCT01332968|582302422|FG000|Maintenance/Observation Period|Adverse Event|0|||
161252264|NCT01332968|582302423|FG001|Maintenance/Observation Period|Adverse Event|0|||
161252265|NCT01332968|582302424|FG002|Maintenance/Observation Period|Adverse Event|53|||
161252266|NCT01332968|582302425|FG003|Maintenance/Observation Period|Adverse Event|66|||
161335309|NCT00390689|582617710|FG002|Overall Study|Protocol Violation|0|||
161335310|NCT00390689|582617708|FG000|Overall Study|Investigator's judgement|2|||
161335311|NCT00390689|582617709|FG001|Overall Study|Investigator's judgement|0|||
161335312|NCT00390689|582617710|FG002|Overall Study|Investigator's judgement|0|||
161335313|NCT01253161|582617711|FG000|Overall Study|Adverse Event|1|||
161335314|NCT05412134|582617712|FG000|Overall Study|Lost to Follow-up|2|||
161335315|NCT05412134|582617713|FG001|Overall Study|Lost to Follow-up|0|||
161335316|NCT03444584|582617714|FG000|Overall Study|Withdrawal by Subject|0|||
161335317|NCT03444584|582617715|FG001|Overall Study|Withdrawal by Subject|1|||
161335318|NCT03444584|582617714|FG000|Overall Study|Other|0|||
161252267|NCT01332968|582302426|FG004|Maintenance/Observation Period|Adverse Event|0|||
161252268|NCT01332968|582302427|FG005|Maintenance/Observation Period|Adverse Event|0|||
161252269|NCT01332968|582302428|FG006|Maintenance/Observation Period|Adverse Event|0|||
161252270|NCT01332968|582302429|FG007|Maintenance/Observation Period|Adverse Event|0|||
161252271|NCT01332968|582302422|FG000|Maintenance/Observation Period|Death|0|||
161335319|NCT03444584|582617715|FG001|Overall Study|Other|1|||
161335320|NCT00423046|582617716|FG000|Overall Study|Other|340|||
161335321|NCT00423046|582617717|FG001|Overall Study|Other|345|||
161335322|NCT01038687|582617718|FG000|Overall Study|Adverse Event|0|||
161335323|NCT01038687|582617719|FG001|Overall Study|Adverse Event|2|||
161335324|NCT01038687|582617720|FG002|Overall Study|Adverse Event|1|||
161335325|NCT02783911|582617721|FG000|Overall Study|Lost to Follow-up|3|||
160844377|NCT01098305|580817993|FG001|Overall Study|Lost to Follow-up|33|||
160844378|NCT04310566|580818000|FG000|Period 1|Study Termination due to COVID-19|15|||
160844379|NCT04310566|580818001|FG001|Period 1|Study Termination due to COVID-19|17|||
160844380|NCT04310566|580818000|FG000|Period 1|Protocol Violation|0|||
160844381|NCT04310566|580818001|FG001|Period 1|Protocol Violation|1|||
160844382|NCT04310566|580818000|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
160844383|NCT04310566|580818001|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
160844384|NCT04310566|580818000|FG000|Period 1|Lost to Follow-up|1|||
160844385|NCT04310566|580818001|FG001|Period 1|Lost to Follow-up|0|||
160844386|NCT04310566|580818000|FG000|Period 1|Withdrawal by Subject|0|||
160905914|NCT01847274|581050306|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905915|NCT01847274|581050307|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905916|NCT01847274|581050308|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905917|NCT01847274|581050309|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905918|NCT01847274|581050310|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
160905919|NCT01847274|581050311|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161252272|NCT01332968|582302423|FG001|Maintenance/Observation Period|Death|0|||
161252273|NCT01332968|582302424|FG002|Maintenance/Observation Period|Death|5|||
161252274|NCT01332968|582302425|FG003|Maintenance/Observation Period|Death|6|||
161252275|NCT01332968|582302426|FG004|Maintenance/Observation Period|Death|0|||
161252276|NCT01332968|582302427|FG005|Maintenance/Observation Period|Death|0|||
161252277|NCT01332968|582302428|FG006|Maintenance/Observation Period|Death|0|||
161252278|NCT01332968|582302429|FG007|Maintenance/Observation Period|Death|0|||
161335326|NCT02783911|582617722|FG001|Overall Study|Lost to Follow-up|32|||
161335327|NCT05214118|582617726|FG000|Overall Study|Lost to Follow-up|0|||
161335328|NCT05214118|582617727|FG001|Overall Study|Lost to Follow-up|2|||
161335329|NCT05214118|582617726|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
161335330|NCT05214118|582617727|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
161335331|NCT05214118|582617726|FG000|Overall Study|moved|1|||
161335332|NCT05214118|582617727|FG001|Overall Study|moved|0|||
160844387|NCT04310566|580818001|FG001|Period 1|Withdrawal by Subject|1|||
160905920|NCT01847274|581050312|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905921|NCT01847274|581050313|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
160905922|NCT01847274|581050314|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
161139992|NCT03577990|581894956|FG001|Overall Study|Lost to Follow-up|6|||
161139993|NCT03577990|581894955|FG000|Overall Study|Withdrawal by Subject|4|||
161139994|NCT03577990|581894956|FG001|Overall Study|Withdrawal by Subject|7|||
161139995|NCT03934684|581894961|FG000|Overall Study|Participants continuing in study|11|||
161139996|NCT03934684|581894962|FG001|Overall Study|Participants continuing in study|4|||
161139997|NCT03934684|581894961|FG000|Overall Study|Discontinuation of carfilzomib|20|||
161139998|NCT03934684|581894962|FG001|Overall Study|Discontinuation of carfilzomib|30|||
161139999|NCT03934684|581894961|FG000|Overall Study|Death|2|||
161140000|NCT03934684|581894962|FG001|Overall Study|Death|2|||
161140001|NCT03934684|581894961|FG000|Overall Study|Lost to Follow-up|2|||
161140002|NCT03934684|581894962|FG001|Overall Study|Lost to Follow-up|5|||
161140003|NCT03934684|581894961|FG000|Overall Study|Withdrawal by Subject|7|||
161140004|NCT03934684|581894962|FG001|Overall Study|Withdrawal by Subject|8|||
161140005|NCT01073943|581894963|FG000|Overall Study|Withdrawal by Subject|8|||
161140006|NCT01073943|581894964|FG001|Overall Study|Withdrawal by Subject|2|||
161140007|NCT01073943|581894963|FG000|Overall Study|Protocol Violation|2|||
161140008|NCT01073943|581894964|FG001|Overall Study|Protocol Violation|1|||
161140009|NCT01073943|581894963|FG000|Overall Study|Adverse Event|1|||
161140010|NCT01073943|581894964|FG001|Overall Study|Adverse Event|1|||
161140011|NCT01073943|581894963|FG000|Overall Study|Lost to Follow-up|0|||
161252279|NCT01332968|582302422|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
161252280|NCT01332968|582302423|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
161252281|NCT01332968|582302424|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
161252282|NCT01332968|582302425|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
161252283|NCT01332968|582302426|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
161252284|NCT01332968|582302427|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
161252285|NCT01332968|582302428|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
160844388|NCT04310566|580818000|FG000|Period 2|Study Termination|7|||
160844389|NCT04310566|580818001|FG001|Period 2|Study Termination|5|||
161335333|NCT02314728|582617728|FG000|Overall Study|Protocol Violation|1|||
161335334|NCT02314728|582617729|FG001|Overall Study|Protocol Violation|0|||
161335335|NCT02314728|582617728|FG000|Overall Study|Lost to Follow-up|0|||
161335336|NCT02314728|582617729|FG001|Overall Study|Lost to Follow-up|1|||
161252286|NCT01332968|582302429|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
161252287|NCT01332968|582302422|FG000|Maintenance/Observation Period|Non-compliance|0|||
161252288|NCT01332968|582302423|FG001|Maintenance/Observation Period|Non-compliance|0|||
161252289|NCT01332968|582302424|FG002|Maintenance/Observation Period|Non-compliance|4|||
161252290|NCT01332968|582302425|FG003|Maintenance/Observation Period|Non-compliance|3|||
161252291|NCT01332968|582302426|FG004|Maintenance/Observation Period|Non-compliance|0|||
161252292|NCT01332968|582302427|FG005|Maintenance/Observation Period|Non-compliance|0|||
161252293|NCT01332968|582302428|FG006|Maintenance/Observation Period|Non-compliance|0|||
161252294|NCT01332968|582302429|FG007|Maintenance/Observation Period|Non-compliance|0|||
161252295|NCT01332968|582302422|FG000|Maintenance/Observation Period|Other|0|||
161252296|NCT01332968|582302423|FG001|Maintenance/Observation Period|Other|0|||
161252297|NCT01332968|582302424|FG002|Maintenance/Observation Period|Other|4|||
161335337|NCT03080935|582617730|FG000|Overall Study|Death|34|||
161335338|NCT03080935|582617731|FG001|Overall Study|Death|50|||
161335339|NCT03080935|582617730|FG000|Overall Study|Lost to Follow-up|5|||
161335340|NCT03080935|582617731|FG001|Overall Study|Lost to Follow-up|4|||
161335341|NCT03080935|582617730|FG000|Overall Study|Withdrawal by Subject|11|||
161335342|NCT03080935|582617731|FG001|Overall Study|Withdrawal by Subject|15|||
161335343|NCT03118934|582617733|FG000|Overall Study|Adverse Event|0|||
161335344|NCT03118934|582617734|FG001|Overall Study|Adverse Event|0|||
161335345|NCT03118934|582617735|FG002|Overall Study|Adverse Event|0|||
161252298|NCT01332968|582302425|FG003|Maintenance/Observation Period|Other|7|||
161252299|NCT01332968|582302426|FG004|Maintenance/Observation Period|Other|0|||
161252300|NCT01332968|582302427|FG005|Maintenance/Observation Period|Other|0|||
161252301|NCT01332968|582302428|FG006|Maintenance/Observation Period|Other|0|||
161335346|NCT03118934|582617736|FG003|Overall Study|Adverse Event|0|||
161335347|NCT03118934|582617737|FG004|Overall Study|Adverse Event|0|||
161335348|NCT03118934|582617738|FG005|Overall Study|Adverse Event|1|||
161335349|NCT03118934|582617733|FG000|Overall Study|Physician Decision|0|||
161335350|NCT03118934|582617734|FG001|Overall Study|Physician Decision|0|||
161335351|NCT03118934|582617735|FG002|Overall Study|Physician Decision|0|||
161335352|NCT03118934|582617736|FG003|Overall Study|Physician Decision|0|||
161335353|NCT03118934|582617737|FG004|Overall Study|Physician Decision|0|||
161335354|NCT03118934|582617738|FG005|Overall Study|Physician Decision|1|||
161335355|NCT03118934|582617733|FG000|Overall Study|Discontinued prior to exposure|0|||
161335356|NCT03118934|582617734|FG001|Overall Study|Discontinued prior to exposure|1|||
161335357|NCT03118934|582617735|FG002|Overall Study|Discontinued prior to exposure|1|||
161335358|NCT03118934|582617736|FG003|Overall Study|Discontinued prior to exposure|1|||
161335359|NCT03118934|582617737|FG004|Overall Study|Discontinued prior to exposure|2|||
160844390|NCT04677504|580818003|FG000|Overall Study|Death|51|||
161252302|NCT01332968|582302429|FG007|Maintenance/Observation Period|Other|0|||
161252303|NCT01332968|582302422|FG000|Maintenance/Observation Period|Physician Decision|0|||
161252304|NCT01332968|582302423|FG001|Maintenance/Observation Period|Physician Decision|0|||
161252305|NCT01332968|582302424|FG002|Maintenance/Observation Period|Physician Decision|14|||
161335360|NCT03118934|582617738|FG005|Overall Study|Discontinued prior to exposure|0|||
161335361|NCT01614470|582617739|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
161335362|NCT01614470|582617740|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161335363|NCT01614470|582617741|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
160844391|NCT04677504|580818004|FG001|Overall Study|Death|49|||
160844392|NCT04677504|580818003|FG000|Overall Study|Progressive Disease|1|||
160844393|NCT04677504|580818004|FG001|Overall Study|Progressive Disease|0|||
160844394|NCT04677504|580818003|FG000|Overall Study|Symptomatic Deterioration|1|||
160844395|NCT04677504|580818004|FG001|Overall Study|Symptomatic Deterioration|0|||
160844396|NCT04677504|580818003|FG000|Overall Study|Withdrawal by Subject|2|||
160844397|NCT04677504|580818004|FG001|Overall Study|Withdrawal by Subject|5|||
160844398|NCT04677504|580818003|FG000|Overall Study|Study Terminated By Sponsor|28|||
160844399|NCT04677504|580818004|FG001|Overall Study|Study Terminated By Sponsor|24|||
160844400|NCT04677504|580818003|FG000|Overall Study|Adverse Event|0|||
160844401|NCT04677504|580818004|FG001|Overall Study|Adverse Event|1|||
160844402|NCT03182907|580818005|FG000|Overall Study|Death|3|||
160844403|NCT03182907|580818006|FG001|Overall Study|Death|0|||
160844404|NCT03182907|580818005|FG000|Overall Study|Protocol Violation|4|||
161335364|NCT01614470|582617739|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
161335365|NCT01614470|582617740|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
161335366|NCT01614470|582617741|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
161335367|NCT02175121|582617742|FG000|Overall Study|Lack of Efficacy|1|||
161335368|NCT02175121|582617743|FG001|Overall Study|Lack of Efficacy|0|||
161335369|NCT02175121|582617744|FG002|Overall Study|Lack of Efficacy|0|||
161335370|NCT02175121|582617745|FG003|Overall Study|Lack of Efficacy|0|||
161335371|NCT02175121|582617746|FG004|Overall Study|Lack of Efficacy|0|||
161335372|NCT02175121|582617742|FG000|Overall Study|Lost to Follow-up|0|||
161335373|NCT02175121|582617743|FG001|Overall Study|Lost to Follow-up|1|||
161335374|NCT02175121|582617744|FG002|Overall Study|Lost to Follow-up|0|||
161335375|NCT02175121|582617745|FG003|Overall Study|Lost to Follow-up|1|||
161335376|NCT02175121|582617746|FG004|Overall Study|Lost to Follow-up|0|||
161335377|NCT02175121|582617742|FG000|Overall Study|Personal emergency|0|||
161335378|NCT02175121|582617743|FG001|Overall Study|Personal emergency|0|||
161335379|NCT02175121|582617744|FG002|Overall Study|Personal emergency|0|||
161335380|NCT02175121|582617745|FG003|Overall Study|Personal emergency|0|||
161335381|NCT02175121|582617746|FG004|Overall Study|Personal emergency|1|||
161335382|NCT02175121|582617742|FG000|Overall Study|Schedule conflict|0|||
161335383|NCT02175121|582617743|FG001|Overall Study|Schedule conflict|0|||
161335384|NCT02175121|582617744|FG002|Overall Study|Schedule conflict|1|||
161335385|NCT02175121|582617745|FG003|Overall Study|Schedule conflict|0|||
161335386|NCT02175121|582617746|FG004|Overall Study|Schedule conflict|0|||
161335387|NCT02175121|582617742|FG000|Overall Study|Time issues|0|||
161335388|NCT02175121|582617743|FG001|Overall Study|Time issues|0|||
161335389|NCT02175121|582617744|FG002|Overall Study|Time issues|1|||
161335390|NCT02175121|582617745|FG003|Overall Study|Time issues|0|||
161335391|NCT02175121|582617746|FG004|Overall Study|Time issues|0|||
161335392|NCT03014206|582617753|FG000|Overall Study|Registration Violation|12|||
161335393|NCT03139552|582617757|FG000|Overall Study|unable to attend tasting due to schedule|3|||
161140012|NCT01073943|581894964|FG001|Overall Study|Lost to Follow-up|2|||
161140013|NCT01073943|581894963|FG000|Overall Study|Power outage; colonoscopy not done|1|||
161140014|NCT01073943|581894964|FG001|Overall Study|Power outage; colonoscopy not done|0|||
161140015|NCT01073943|581894963|FG000|Overall Study|Subject forgot|0|||
161140016|NCT01073943|581894964|FG001|Overall Study|Subject forgot|1|||
161140017|NCT01073943|581894963|FG000|Overall Study|Unable to return for follow-up|0|||
161140018|NCT01073943|581894964|FG001|Overall Study|Unable to return for follow-up|1|||
161140019|NCT01073943|581894963|FG000|Overall Study|Could not tolerate prep|1|||
161140020|NCT01073943|581894964|FG001|Overall Study|Could not tolerate prep|0|||
161140021|NCT00761215|581894965|FG000|Overall Study|Randomized but didn't receive drug|1|||
161140022|NCT00761215|581894966|FG001|Overall Study|Randomized but didn't receive drug|1|||
161140023|NCT00761215|581894967|FG002|Overall Study|Randomized but didn't receive drug|2|||
161140024|NCT00761215|581894965|FG000|Overall Study|Lost to Follow-up|6|||
161140025|NCT00761215|581894966|FG001|Overall Study|Lost to Follow-up|3|||
161140026|NCT00761215|581894967|FG002|Overall Study|Lost to Follow-up|6|||
161140027|NCT00761215|581894965|FG000|Overall Study|Withdrawal by Subject|1|||
161140028|NCT00761215|581894966|FG001|Overall Study|Withdrawal by Subject|0|||
161140029|NCT00761215|581894967|FG002|Overall Study|Withdrawal by Subject|0|||
161140030|NCT00761215|581894965|FG000|Overall Study|Bacteremia|1|||
161140031|NCT00761215|581894966|FG001|Overall Study|Bacteremia|0|||
161140032|NCT00761215|581894967|FG002|Overall Study|Bacteremia|0|||
161140033|NCT05662332|581894968|FG000|Overall Study|Death|3|||
161140034|NCT05662332|581894969|FG001|Overall Study|Death|3|||
161140035|NCT05662332|581894968|FG000|Overall Study|Lost to Follow-up|3|||
161140036|NCT05662332|581894969|FG001|Overall Study|Lost to Follow-up|8|||
161140037|NCT05662332|581894968|FG000|Overall Study|Physician Decision|1|||
161335394|NCT00264147|582617758|FG000|Treatment I Period|Adverse Event|3|||
161335395|NCT00264147|582617759|FG001|Treatment I Period|Adverse Event|6|||
161140038|NCT05662332|581894969|FG001|Overall Study|Physician Decision|2|||
161140039|NCT05662332|581894968|FG000|Overall Study|Protocol Deviation|2|||
161140040|NCT05662332|581894969|FG001|Overall Study|Protocol Deviation|1|||
161140041|NCT05662332|581894968|FG000|Overall Study|Withdrawal by Subject|14|||
161140042|NCT05662332|581894969|FG001|Overall Study|Withdrawal by Subject|14|||
161140043|NCT05662332|581894968|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161140044|NCT05662332|581894969|FG001|Overall Study|Assigned Treatment by Mistake|7|||
161140045|NCT05662332|581894968|FG000|Overall Study|Non-compliance with study drug|4|||
161140046|NCT05662332|581894969|FG001|Overall Study|Non-compliance with study drug|1|||
161140047|NCT05662332|581894968|FG000|Overall Study|Due to Bariatric surgery|1|||
161140048|NCT05662332|581894969|FG001|Overall Study|Due to Bariatric surgery|0|||
161140049|NCT05662332|581894968|FG000|Overall Study|Subject Moving out of State|0|||
161140050|NCT05662332|581894969|FG001|Overall Study|Subject Moving out of State|1|||
161140051|NCT05662332|581894968|FG000|Overall Study|Subject Missed the Schedule|1|||
161140052|NCT05662332|581894969|FG001|Overall Study|Subject Missed the Schedule|0|||
161140053|NCT05662332|581894968|FG000|Overall Study|The Patient Moved to Another City|1|||
161140054|NCT05662332|581894969|FG001|Overall Study|The Patient Moved to Another City|0|||
161140055|NCT01097044|581894979|FG000|Overall Study|Withdrawal by Subject|4|||
161335396|NCT00264147|582617760|FG002|Treatment I Period|Adverse Event|3|||
161140056|NCT01097044|581894980|FG001|Overall Study|Withdrawal by Subject|4|||
161140057|NCT01097044|581894979|FG000|Overall Study|Lost to Follow-up|1|||
161140058|NCT01097044|581894980|FG001|Overall Study|Lost to Follow-up|0|||
161140059|NCT01097044|581894979|FG000|Overall Study|Withdrawal by Sponsor|0|||
161140060|NCT01097044|581894980|FG001|Overall Study|Withdrawal by Sponsor|1|||
161140061|NCT02452359|581894982|FG000|Overall Study|Adverse Event|1|||
161140062|NCT02452359|581894982|FG000|Overall Study|Lost to Follow-up|15|||
161140063|NCT02452359|581894982|FG000|Overall Study|Pregnancy|1|||
161140064|NCT02452359|581894982|FG000|Overall Study|Withdrawal by Subject|4|||
161140065|NCT03414359|581894983|FG000|Overall Study|Lack of Efficacy|1|||
161140066|NCT03414359|581894984|FG001|Overall Study|Lack of Efficacy|1|||
161140067|NCT03414359|581894983|FG000|Overall Study|Protocol Violation|0|||
161140068|NCT03414359|581894984|FG001|Overall Study|Protocol Violation|1|||
161140069|NCT04865731|581894985|FG000|Overall Study|Physician Decision|2|||
161140070|NCT04865731|581894986|FG001|Overall Study|Physician Decision|1|||
161140071|NCT04865731|581894985|FG000|Overall Study|Adverse Event|1|||
161140072|NCT04865731|581894986|FG001|Overall Study|Adverse Event|0|||
161140073|NCT04865731|581894985|FG000|Overall Study|Withdrawal by Subject|0|||
161140074|NCT04865731|581894986|FG001|Overall Study|Withdrawal by Subject|1|||
161140075|NCT00222105|581894989|FG000|Overall Study|Removed due to wrong diagnosis|1|||
161140076|NCT00222105|581894989|FG000|Overall Study|Withdrawal by Subject|1|||
161140077|NCT00222105|581894989|FG000|Overall Study|Adverse Event|8|||
161335397|NCT00264147|582617761|FG003|Treatment I Period|Adverse Event|5|||
161335398|NCT00264147|582617762|FG004|Treatment I Period|Adverse Event|7|||
161335399|NCT00264147|582617763|FG005|Treatment I Period|Adverse Event|0|||
161335400|NCT00264147|582617758|FG000|Treatment I Period|Laboratory Adverse Event|0|||
161335401|NCT00264147|582617759|FG001|Treatment I Period|Laboratory Adverse Event|0|||
161335402|NCT00264147|582617760|FG002|Treatment I Period|Laboratory Adverse Event|0|||
161335403|NCT00264147|582617761|FG003|Treatment I Period|Laboratory Adverse Event|1|||
161335404|NCT00264147|582617762|FG004|Treatment I Period|Laboratory Adverse Event|0|||
161140078|NCT00222105|581894989|FG000|Overall Study|Treatment delays|2|||
161140079|NCT00222105|581894989|FG000|Overall Study|Death|2|||
161140080|NCT05738486|581897553|FG000|Overall Study|Continuing Study|194|||
161140081|NCT05738486|581897554|FG001|Overall Study|Continuing Study|196|||
161140082|NCT05738486|581897555|FG002|Overall Study|Continuing Study|193|||
161140083|NCT05738486|581897556|FG003|Overall Study|Continuing Study|191|||
161140084|NCT05738486|581897553|FG000|Overall Study|Withdrawal by Subject|8|||
161140085|NCT05738486|581897554|FG001|Overall Study|Withdrawal by Subject|5|||
161140086|NCT05738486|581897555|FG002|Overall Study|Withdrawal by Subject|7|||
161140087|NCT05738486|581897556|FG003|Overall Study|Withdrawal by Subject|13|||
161140088|NCT05738486|581897553|FG000|Overall Study|Adverse Event|4|||
161140089|NCT05738486|581897554|FG001|Overall Study|Adverse Event|6|||
161252306|NCT01332968|582302425|FG003|Maintenance/Observation Period|Physician Decision|19|||
161252307|NCT01332968|582302426|FG004|Maintenance/Observation Period|Physician Decision|0|||
161252308|NCT01332968|582302427|FG005|Maintenance/Observation Period|Physician Decision|1|||
161252309|NCT01332968|582302428|FG006|Maintenance/Observation Period|Physician Decision|0|||
161252310|NCT01332968|582302429|FG007|Maintenance/Observation Period|Physician Decision|0|||
161252311|NCT01332968|582302422|FG000|Maintenance/Observation Period|Progressive Disease|0|||
161252312|NCT01332968|582302423|FG001|Maintenance/Observation Period|Progressive Disease|0|||
161252313|NCT01332968|582302424|FG002|Maintenance/Observation Period|Progressive Disease|72|||
161252314|NCT01332968|582302425|FG003|Maintenance/Observation Period|Progressive Disease|40|||
161252315|NCT01332968|582302426|FG004|Maintenance/Observation Period|Progressive Disease|0|||
161252316|NCT01332968|582302427|FG005|Maintenance/Observation Period|Progressive Disease|0|||
161252317|NCT01332968|582302428|FG006|Maintenance/Observation Period|Progressive Disease|0|||
161252318|NCT01332968|582302429|FG007|Maintenance/Observation Period|Progressive Disease|0|||
161252319|NCT01332968|582302422|FG000|Maintenance/Observation Period|Protocol Violation|0|||
161252320|NCT01332968|582302423|FG001|Maintenance/Observation Period|Protocol Violation|0|||
161252321|NCT01332968|582302424|FG002|Maintenance/Observation Period|Protocol Violation|1|||
161252322|NCT01332968|582302425|FG003|Maintenance/Observation Period|Protocol Violation|1|||
161252323|NCT01332968|582302426|FG004|Maintenance/Observation Period|Protocol Violation|0|||
161252324|NCT01332968|582302427|FG005|Maintenance/Observation Period|Protocol Violation|0|||
161140090|NCT05738486|581897555|FG002|Overall Study|Adverse Event|4|||
161140091|NCT05738486|581897556|FG003|Overall Study|Adverse Event|5|||
161252325|NCT01332968|582302428|FG006|Maintenance/Observation Period|Protocol Violation|0|||
160844405|NCT03182907|580818006|FG001|Overall Study|Protocol Violation|0|||
160844406|NCT03182907|580818005|FG000|Overall Study|Lost to Follow-up|1|||
160844407|NCT03182907|580818006|FG001|Overall Study|Lost to Follow-up|0|||
160844408|NCT03182907|580818005|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160844409|NCT03182907|580818006|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
160844410|NCT01711645|580818009|FG000|Overall Study|Withdrawal by Subject|8|||
160844411|NCT01711645|580818009|FG000|Overall Study|Lost to Follow-up|6|||
160844412|NCT01711645|580818009|FG000|Overall Study|Physician Decision|5|||
160844413|NCT01746173|580818014|FG000|Overall Study|Disease Progression|2|||
160844414|NCT00375518|580818015|FG000|Overall Study|Withdrawal by Subject|2|||
161140092|NCT05738486|581897553|FG000|Overall Study|Physician Decision|0|||
161252326|NCT01332968|582302429|FG007|Maintenance/Observation Period|Protocol Violation|0|||
160844415|NCT00375518|580818016|FG001|Overall Study|Withdrawal by Subject|10|||
160844416|NCT00375518|580818015|FG000|Overall Study|Patient Not Treated|6|||
160844417|NCT00375518|580818016|FG001|Overall Study|Patient Not Treated|6|||
160844418|NCT00375518|580818015|FG000|Overall Study|Death|0|||
160844419|NCT00375518|580818016|FG001|Overall Study|Death|1|||
160844420|NCT03170193|580818017|FG000|Overall Study|Withdrawal by Subject|0|||
160844421|NCT03170193|580818018|FG001|Overall Study|Withdrawal by Subject|0|||
160844422|NCT03170193|580818019|FG002|Overall Study|Withdrawal by Subject|0|||
160844423|NCT03170193|580818020|FG003|Overall Study|Withdrawal by Subject|1|||
161252327|NCT01332968|582302422|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
161252328|NCT01332968|582302423|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
161252329|NCT01332968|582302424|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
161252330|NCT01332968|582302425|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
161252331|NCT01332968|582302426|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
161252332|NCT01332968|582302427|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
161252333|NCT01332968|582302428|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
161252334|NCT01332968|582302429|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
161252335|NCT01332968|582302422|FG000|Follow-Up Period|Adverse Event|0|||
161252336|NCT01332968|582302423|FG001|Follow-Up Period|Adverse Event|0|||
161252337|NCT01332968|582302424|FG002|Follow-Up Period|Adverse Event|0|||
161252338|NCT01332968|582302425|FG003|Follow-Up Period|Adverse Event|0|||
161252339|NCT01332968|582302426|FG004|Follow-Up Period|Adverse Event|0|||
161252340|NCT01332968|582302427|FG005|Follow-Up Period|Adverse Event|0|||
161252341|NCT01332968|582302428|FG006|Follow-Up Period|Adverse Event|0|||
161252342|NCT01332968|582302429|FG007|Follow-Up Period|Adverse Event|4|||
161252343|NCT01332968|582302422|FG000|Follow-Up Period|Death|0|||
161252344|NCT01332968|582302423|FG001|Follow-Up Period|Death|0|||
161252345|NCT01332968|582302424|FG002|Follow-Up Period|Death|0|||
161252346|NCT01332968|582302425|FG003|Follow-Up Period|Death|0|||
161252347|NCT01332968|582302426|FG004|Follow-Up Period|Death|0|||
161252348|NCT01332968|582302427|FG005|Follow-Up Period|Death|0|||
161252349|NCT01332968|582302428|FG006|Follow-Up Period|Death|27|||
161252350|NCT01332968|582302429|FG007|Follow-Up Period|Death|30|||
161252351|NCT01332968|582302422|FG000|Follow-Up Period|Lost to Follow-up|0|||
161252352|NCT01332968|582302423|FG001|Follow-Up Period|Lost to Follow-up|0|||
161252353|NCT01332968|582302424|FG002|Follow-Up Period|Lost to Follow-up|0|||
161252354|NCT01332968|582302425|FG003|Follow-Up Period|Lost to Follow-up|0|||
161252355|NCT01332968|582302426|FG004|Follow-Up Period|Lost to Follow-up|0|||
161252356|NCT01332968|582302427|FG005|Follow-Up Period|Lost to Follow-up|0|||
161252357|NCT01332968|582302428|FG006|Follow-Up Period|Lost to Follow-up|11|||
161252358|NCT01332968|582302429|FG007|Follow-Up Period|Lost to Follow-up|15|||
161252359|NCT01332968|582302422|FG000|Follow-Up Period|Non-compliance|0|||
161252360|NCT01332968|582302423|FG001|Follow-Up Period|Non-compliance|0|||
161252361|NCT01332968|582302424|FG002|Follow-Up Period|Non-compliance|0|||
161252362|NCT01332968|582302425|FG003|Follow-Up Period|Non-compliance|0|||
161252363|NCT01332968|582302426|FG004|Follow-Up Period|Non-compliance|0|||
161252364|NCT01332968|582302427|FG005|Follow-Up Period|Non-compliance|0|||
161252365|NCT01332968|582302428|FG006|Follow-Up Period|Non-compliance|4|||
161252366|NCT01332968|582302429|FG007|Follow-Up Period|Non-compliance|9|||
161252367|NCT01332968|582302422|FG000|Follow-Up Period|Other|0|||
161252368|NCT01332968|582302423|FG001|Follow-Up Period|Other|0|||
161252369|NCT01332968|582302424|FG002|Follow-Up Period|Other|0|||
161252370|NCT01332968|582302425|FG003|Follow-Up Period|Other|0|||
161252371|NCT01332968|582302426|FG004|Follow-Up Period|Other|0|||
161252372|NCT01332968|582302427|FG005|Follow-Up Period|Other|0|||
161252373|NCT01332968|582302428|FG006|Follow-Up Period|Other|18|||
161252374|NCT01332968|582302429|FG007|Follow-Up Period|Other|21|||
161252375|NCT01332968|582302422|FG000|Follow-Up Period|Physician Decision|0|||
161252376|NCT01332968|582302423|FG001|Follow-Up Period|Physician Decision|0|||
161252377|NCT01332968|582302424|FG002|Follow-Up Period|Physician Decision|0|||
161252378|NCT01332968|582302425|FG003|Follow-Up Period|Physician Decision|0|||
161252379|NCT01332968|582302426|FG004|Follow-Up Period|Physician Decision|0|||
161252380|NCT01332968|582302427|FG005|Follow-Up Period|Physician Decision|0|||
161252381|NCT01332968|582302428|FG006|Follow-Up Period|Physician Decision|12|||
161252382|NCT01332968|582302429|FG007|Follow-Up Period|Physician Decision|15|||
161252383|NCT01332968|582302422|FG000|Follow-Up Period|Progressive Disease|0|||
161252384|NCT01332968|582302423|FG001|Follow-Up Period|Progressive Disease|0|||
161252385|NCT01332968|582302424|FG002|Follow-Up Period|Progressive Disease|0|||
161252386|NCT01332968|582302425|FG003|Follow-Up Period|Progressive Disease|0|||
161252387|NCT01332968|582302426|FG004|Follow-Up Period|Progressive Disease|0|||
161252388|NCT01332968|582302427|FG005|Follow-Up Period|Progressive Disease|0|||
161252389|NCT01332968|582302428|FG006|Follow-Up Period|Progressive Disease|126|||
161252390|NCT01332968|582302429|FG007|Follow-Up Period|Progressive Disease|106|||
161252391|NCT01332968|582302422|FG000|Follow-Up Period|Protocol Violation|0|||
161252392|NCT01332968|582302423|FG001|Follow-Up Period|Protocol Violation|0|||
161252393|NCT01332968|582302424|FG002|Follow-Up Period|Protocol Violation|0|||
161252394|NCT01332968|582302425|FG003|Follow-Up Period|Protocol Violation|0|||
161140093|NCT05738486|581897554|FG001|Overall Study|Physician Decision|2|||
161140094|NCT05738486|581897555|FG002|Overall Study|Physician Decision|4|||
161140095|NCT05738486|581897556|FG003|Overall Study|Physician Decision|1|||
161140096|NCT05738486|581897553|FG000|Overall Study|Lost to Follow-up|1|||
161140097|NCT05738486|581897554|FG001|Overall Study|Lost to Follow-up|1|||
161140098|NCT05738486|581897555|FG002|Overall Study|Lost to Follow-up|2|||
161140099|NCT05738486|581897556|FG003|Overall Study|Lost to Follow-up|1|||
161140100|NCT05738486|581897553|FG000|Overall Study|Participant was Non-ambulatory|0|||
161252395|NCT01332968|582302426|FG004|Follow-Up Period|Protocol Violation|0|||
161252396|NCT01332968|582302427|FG005|Follow-Up Period|Protocol Violation|0|||
161140101|NCT05738486|581897554|FG001|Overall Study|Participant was Non-ambulatory|0|||
161140102|NCT05738486|581897555|FG002|Overall Study|Participant was Non-ambulatory|1|||
161252397|NCT01332968|582302428|FG006|Follow-Up Period|Protocol Violation|1|||
161252398|NCT01332968|582302429|FG007|Follow-Up Period|Protocol Violation|0|||
161252399|NCT01332968|582302422|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161252400|NCT01332968|582302423|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161252401|NCT01332968|582302424|FG002|Follow-Up Period|Withdrawal by Subject|0|||
161252402|NCT01332968|582302425|FG003|Follow-Up Period|Withdrawal by Subject|0|||
161252403|NCT01332968|582302426|FG004|Follow-Up Period|Withdrawal by Subject|0|||
161252404|NCT01332968|582302427|FG005|Follow-Up Period|Withdrawal by Subject|0|||
161252405|NCT01332968|582302428|FG006|Follow-Up Period|Withdrawal by Subject|29|||
161252406|NCT01332968|582302429|FG007|Follow-Up Period|Withdrawal by Subject|32|||
161252407|NCT01332968|582302422|FG000|Follow-Up Period|No reason provided|0|||
161252408|NCT01332968|582302423|FG001|Follow-Up Period|No reason provided|0|||
161252409|NCT01332968|582302424|FG002|Follow-Up Period|No reason provided|0|||
161252410|NCT01332968|582302425|FG003|Follow-Up Period|No reason provided|0|||
161252411|NCT01332968|582302426|FG004|Follow-Up Period|No reason provided|0|||
161140103|NCT05738486|581897556|FG003|Overall Study|Participant was Non-ambulatory|0|||
161140104|NCT05738486|581897553|FG000|Overall Study|Participant had Poor Venous Access|0|||
161140105|NCT05738486|581897554|FG001|Overall Study|Participant had Poor Venous Access|0|||
161140106|NCT05738486|581897555|FG002|Overall Study|Participant had Poor Venous Access|0|||
161140107|NCT05738486|581897556|FG003|Overall Study|Participant had Poor Venous Access|1|||
161140108|NCT05738486|581897553|FG000|Overall Study|Assigned Treatment by Mistake|0|||
161140109|NCT05738486|581897554|FG001|Overall Study|Assigned Treatment by Mistake|0|||
161140110|NCT05738486|581897555|FG002|Overall Study|Assigned Treatment by Mistake|0|||
161140111|NCT05738486|581897556|FG003|Overall Study|Assigned Treatment by Mistake|1|||
161140112|NCT05738486|581897553|FG000|Overall Study|Death|0|||
161140113|NCT05738486|581897554|FG001|Overall Study|Death|0|||
161140114|NCT05738486|581897555|FG002|Overall Study|Death|1|||
161140115|NCT05738486|581897556|FG003|Overall Study|Death|0|||
161140116|NCT05738486|581897553|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
161140117|NCT05738486|581897554|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161335405|NCT00264147|582617763|FG005|Treatment I Period|Laboratory Adverse Event|0|||
161335406|NCT00264147|582617758|FG000|Treatment I Period|Lack of Efficacy|6|||
161335407|NCT00264147|582617759|FG001|Treatment I Period|Lack of Efficacy|2|||
161335408|NCT00264147|582617760|FG002|Treatment I Period|Lack of Efficacy|8|||
161140118|NCT05738486|581897555|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161140119|NCT05738486|581897556|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
161140120|NCT00886821|581897557|FG000|Stage 2|Adverse Event|0|||
161140121|NCT00886821|581897558|FG001|Stage 2|Adverse Event|0|||
161140122|NCT00886821|581897559|FG002|Stage 2|Adverse Event|0|||
161140123|NCT00886821|581897560|FG003|Stage 2|Adverse Event|0|||
161140124|NCT00886821|581897561|FG004|Stage 2|Adverse Event|0|||
161140125|NCT00886821|581897562|FG005|Stage 2|Adverse Event|0|||
161140126|NCT00886821|581897563|FG006|Stage 2|Adverse Event|0|||
161140127|NCT00886821|581897564|FG007|Stage 2|Adverse Event|0|||
161140128|NCT00886821|581897565|FG008|Stage 2|Adverse Event|0|||
161140129|NCT00886821|581897566|FG009|Stage 2|Adverse Event|0|||
161252412|NCT01332968|582302427|FG005|Follow-Up Period|No reason provided|0|||
161252413|NCT01332968|582302428|FG006|Follow-Up Period|No reason provided|2|||
161252414|NCT01332968|582302429|FG007|Follow-Up Period|No reason provided|3|||
161252415|NCT00194792|582302430|FG000|Overall Study|Withdrawal by Subject|1|||
161252416|NCT02448563|582302431|FG000|Overall Study|Lost to Follow-up|16|||
161252417|NCT02448563|582302432|FG001|Overall Study|Lost to Follow-up|10|||
161252418|NCT02448563|582302431|FG000|Overall Study|Withdrawal by Subject|0|||
161252419|NCT02448563|582302432|FG001|Overall Study|Withdrawal by Subject|1|||
161252420|NCT00702507|582302434|FG000|Initial Treatment Phase|Adverse Event|2|||
161252421|NCT00702507|582302434|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
161140130|NCT00886821|581897567|FG010|Stage 2|Adverse Event|0|||
161140131|NCT00886821|581897568|FG011|Stage 2|Adverse Event|1|||
161140132|NCT00886821|581897569|FG012|Stage 2|Adverse Event|3|||
161140133|NCT00886821|581897570|FG013|Stage 2|Adverse Event|0|||
161140134|NCT00886821|581897557|FG000|Stage 2|Lost to Follow-up|0|||
161140135|NCT00886821|581897558|FG001|Stage 2|Lost to Follow-up|0|||
161140136|NCT00886821|581897559|FG002|Stage 2|Lost to Follow-up|0|||
161140137|NCT00886821|581897560|FG003|Stage 2|Lost to Follow-up|0|||
161140138|NCT00886821|581897561|FG004|Stage 2|Lost to Follow-up|0|||
161140139|NCT00886821|581897562|FG005|Stage 2|Lost to Follow-up|0|||
161252422|NCT00702507|582302434|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
161252423|NCT00702507|582302434|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
161252424|NCT00702507|582302434|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
161252425|NCT00702507|582302434|FG000|Follow-up Phase|Protocol Violation|2|||
161252426|NCT00702507|582302434|FG000|Follow-up Phase|Lost to Follow-up|23|||
161140140|NCT00886821|581897563|FG006|Stage 2|Lost to Follow-up|0|||
161140141|NCT00886821|581897564|FG007|Stage 2|Lost to Follow-up|0|||
161140142|NCT00886821|581897565|FG008|Stage 2|Lost to Follow-up|0|||
161140143|NCT00886821|581897566|FG009|Stage 2|Lost to Follow-up|0|||
161140144|NCT00886821|581897567|FG010|Stage 2|Lost to Follow-up|0|||
161140145|NCT00886821|581897568|FG011|Stage 2|Lost to Follow-up|0|||
161140146|NCT00886821|581897569|FG012|Stage 2|Lost to Follow-up|2|||
161140147|NCT00886821|581897570|FG013|Stage 2|Lost to Follow-up|1|||
161140148|NCT03716726|581897571|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
161140149|NCT03716726|581897572|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
161140150|NCT03716726|581897571|FG000|12 Months Followup|Lost to Follow-up|10|||
161140151|NCT03716726|581897572|FG001|12 Months Followup|Lost to Follow-up|17|||
161140152|NCT02579603|581897573|FG000|Overall Study|Not treated|1|||
161140153|NCT02579603|581897574|FG001|Overall Study|Not treated|0|||
161140154|NCT02579603|581897573|FG000|Overall Study|Adverse Event|2|||
161140155|NCT02579603|581897574|FG001|Overall Study|Adverse Event|2|||
161140156|NCT02579603|581897573|FG000|Overall Study|Other than stated|1|||
161140157|NCT02579603|581897574|FG001|Overall Study|Other than stated|0|||
161140158|NCT00469079|581897575|FG000|Overall Study|Lack of Efficacy|3|||
161140159|NCT00469079|581897576|FG001|Overall Study|Lack of Efficacy|8|||
161140160|NCT00469079|581897577|FG002|Overall Study|Lack of Efficacy|5|||
161140161|NCT00469079|581897575|FG000|Overall Study|Adverse Event|1|||
161140162|NCT00469079|581897576|FG001|Overall Study|Adverse Event|3|||
161140163|NCT00469079|581897577|FG002|Overall Study|Adverse Event|2|||
161140164|NCT00469079|581897575|FG000|Overall Study|Lost to Follow-up|4|||
161140165|NCT00469079|581897576|FG001|Overall Study|Lost to Follow-up|8|||
161140166|NCT00469079|581897577|FG002|Overall Study|Lost to Follow-up|10|||
161140167|NCT00469079|581897575|FG000|Overall Study|Withdrawal by Subject|1|||
161140168|NCT00469079|581897576|FG001|Overall Study|Withdrawal by Subject|2|||
161140169|NCT00469079|581897577|FG002|Overall Study|Withdrawal by Subject|2|||
161140170|NCT00469079|581897575|FG000|Overall Study|Ineligible|0|||
161140171|NCT00469079|581897576|FG001|Overall Study|Ineligible|1|||
161140172|NCT00469079|581897577|FG002|Overall Study|Ineligible|0|||
161140173|NCT00942162|581897578|FG000|Overall Study|Death|45|||
161140174|NCT00942162|581897579|FG001|Overall Study|Death|35|||
161140175|NCT00942162|581897580|FG002|Overall Study|Death|0|||
161140176|NCT00942162|581897578|FG000|Overall Study|Withdrawal by Subject|7|||
161140177|NCT00942162|581897579|FG001|Overall Study|Withdrawal by Subject|2|||
161140178|NCT00942162|581897580|FG002|Overall Study|Withdrawal by Subject|0|||
161140179|NCT00942162|581897578|FG000|Overall Study|Lost to Follow-up|4|||
161140180|NCT00942162|581897579|FG001|Overall Study|Lost to Follow-up|0|||
161140181|NCT00942162|581897580|FG002|Overall Study|Lost to Follow-up|0|||
161140182|NCT00942162|581897578|FG000|Overall Study|Other|14|||
161140183|NCT00942162|581897579|FG001|Overall Study|Other|13|||
161140184|NCT00942162|581897580|FG002|Overall Study|Other|2|||
161140185|NCT01006356|581897581|FG000|Overall Study|Adverse Event|6|||
161140186|NCT01006356|581897581|FG000|Overall Study|Physician Decision|1|||
161140187|NCT01006356|581897581|FG000|Overall Study|Paticipants did not cooperate|6|||
161140188|NCT01006356|581897581|FG000|Overall Study|Withdrawal by Subject|1|||
161140189|NCT01006356|581897581|FG000|Overall Study|Choice by participants|2|||
161140190|NCT01006356|581897581|FG000|Overall Study|Protocol Violation|3|||
161140191|NCT01006356|581897581|FG000|Overall Study|Other|23|||
161140192|NCT02981472|581897586|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
161140193|NCT02981472|581897587|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
161140194|NCT02981472|581897586|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161140195|NCT02981472|581897587|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161140196|NCT02981472|581897586|FG000|Treatment Period|Adverse Event|6|||
161252427|NCT00702507|582302434|FG000|Follow-up Phase|Late Enrollment|1|||
161252428|NCT00113919|582302435|FG000|Overall Study|Physician Decision|8|||
161252429|NCT00113919|582302435|FG000|Overall Study|Death|6|||
161252430|NCT00721955|582302443|FG000|Overall Study|Adverse Event|0|||
161252431|NCT00721955|582302444|FG001|Overall Study|Adverse Event|0|||
161252432|NCT00721955|582302445|FG002|Overall Study|Adverse Event|2|||
161140197|NCT02981472|581897587|FG001|Treatment Period|Adverse Event|1|||
161140198|NCT02981472|581897586|FG000|Treatment Period|Participant withdrew consent|1|||
161140199|NCT02981472|581897587|FG001|Treatment Period|Participant withdrew consent|0|||
161140200|NCT02981472|581897586|FG000|Treatment Period|Lost to Follow-up|0|||
161140201|NCT02981472|581897587|FG001|Treatment Period|Lost to Follow-up|1|||
161140202|NCT03368859|581897590|FG000|Overall Study|Withdrew Consent|5|||
161140203|NCT03368859|581897591|FG001|Overall Study|Withdrew Consent|4|||
161140204|NCT03368859|581897590|FG000|Overall Study|Death|12|||
161140205|NCT03368859|581897591|FG001|Overall Study|Death|6|||
161140206|NCT03368859|581897590|FG000|Overall Study|Study terminated by Sponsor|18|||
161140207|NCT03368859|581897591|FG001|Overall Study|Study terminated by Sponsor|23|||
161140208|NCT03368859|581897590|FG000|Overall Study|Other|1|||
161140209|NCT03368859|581897591|FG001|Overall Study|Other|1|||
161140210|NCT02559505|581897597|FG000|Overall Study|Lost to Follow-up|23|||
161140211|NCT02559505|581897598|FG001|Overall Study|Lost to Follow-up|20|||
161140212|NCT02559505|581897597|FG000|Overall Study|Withdrawal by Subject|4|||
161252433|NCT04194008|582302450|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
161252434|NCT04194008|582302450|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
161140213|NCT02559505|581897598|FG001|Overall Study|Withdrawal by Subject|2|||
161140214|NCT03523585|581897599|FG000|Overall Study|Progressive Disease|174|||
161140215|NCT03523585|581897600|FG001|Overall Study|Progressive Disease|64|||
161140216|NCT03523585|581897601|FG002|Overall Study|Progressive Disease|77|||
161140217|NCT03523585|581897599|FG000|Overall Study|Adverse Event|74|||
161140218|NCT03523585|581897600|FG001|Overall Study|Adverse Event|5|||
161140219|NCT03523585|581897601|FG002|Overall Study|Adverse Event|9|||
161140220|NCT03523585|581897599|FG000|Overall Study|Withdrawal by Subject|30|||
161140221|NCT03523585|581897600|FG001|Overall Study|Withdrawal by Subject|11|||
161140222|NCT03523585|581897601|FG002|Overall Study|Withdrawal by Subject|6|||
161140223|NCT03523585|581897599|FG000|Overall Study|Clinical Progression|23|||
161140224|NCT03523585|581897600|FG001|Overall Study|Clinical Progression|5|||
161140225|NCT03523585|581897601|FG002|Overall Study|Clinical Progression|10|||
161140226|NCT03523585|581897599|FG000|Overall Study|Death|4|||
161140227|NCT03523585|581897600|FG001|Overall Study|Death|0|||
161140228|NCT03523585|581897601|FG002|Overall Study|Death|1|||
161140229|NCT03523585|581897599|FG000|Overall Study|Physician Decision|2|||
161140230|NCT03523585|581897600|FG001|Overall Study|Physician Decision|1|||
161140231|NCT03523585|581897601|FG002|Overall Study|Physician Decision|0|||
161140232|NCT03523585|581897599|FG000|Overall Study|Lost to Follow-up|1|||
161140233|NCT03523585|581897600|FG001|Overall Study|Lost to Follow-up|0|||
161140234|NCT03523585|581897601|FG002|Overall Study|Lost to Follow-up|0|||
161140235|NCT03523585|581897599|FG000|Overall Study|Miscellaneous|1|||
161140236|NCT03523585|581897600|FG001|Overall Study|Miscellaneous|0|||
161140237|NCT03523585|581897601|FG002|Overall Study|Miscellaneous|0|||
161140238|NCT03523585|581897599|FG000|Overall Study|Protocol Deviation|1|||
161140239|NCT03523585|581897600|FG001|Overall Study|Protocol Deviation|0|||
161140240|NCT03523585|581897601|FG002|Overall Study|Protocol Deviation|1|||
161140241|NCT03523585|581897599|FG000|Overall Study|Randomized But Not Treated|2|||
161140242|NCT03523585|581897600|FG001|Overall Study|Randomized But Not Treated|4|||
161140243|NCT03523585|581897601|FG002|Overall Study|Randomized But Not Treated|3|||
161140244|NCT02874794|581897604|FG000|Overall Study|Physician Decision|3|||
161140245|NCT02874794|581897605|FG001|Overall Study|Physician Decision|2|||
161140246|NCT02874794|581897604|FG000|Overall Study|Withdrawal by Subject|2|||
160992270|NCT02014558|581359999|FG004|Overall Study|Withdrawal by Subject|1|||
160992271|NCT02014558|581360000|FG005|Overall Study|Withdrawal by Subject|0|||
160992272|NCT02014558|581360001|FG006|Overall Study|Withdrawal by Subject|0|||
160992273|NCT02014558|581360002|FG007|Overall Study|Withdrawal by Subject|0|||
160992274|NCT02014558|581360003|FG008|Overall Study|Withdrawal by Subject|0|||
160992275|NCT02014558|581360004|FG009|Overall Study|Withdrawal by Subject|2|||
160992276|NCT02014558|581360005|FG010|Overall Study|Withdrawal by Subject|6|||
160992277|NCT02014558|581360006|FG011|Overall Study|Withdrawal by Subject|10|||
160992278|NCT02014558|581360007|FG012|Overall Study|Withdrawal by Subject|0|||
160992279|NCT02014558|581359995|FG000|Overall Study|Miscellaneous|2|||
160992280|NCT02014558|581359996|FG001|Overall Study|Miscellaneous|1|||
160992281|NCT02014558|581359997|FG002|Overall Study|Miscellaneous|1|||
160992282|NCT02014558|581359998|FG003|Overall Study|Miscellaneous|1|||
160992283|NCT02014558|581359999|FG004|Overall Study|Miscellaneous|0|||
160992284|NCT02014558|581360000|FG005|Overall Study|Miscellaneous|1|||
161252435|NCT04194008|582302450|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
161252436|NCT04194008|582302450|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
161252437|NCT04194008|582302450|FG000|Treatment Phase With Nerivio|Missing data|4|||
161252438|NCT04194008|582302450|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
161140247|NCT02874794|581897605|FG001|Overall Study|Withdrawal by Subject|8|||
161140248|NCT02874794|581897604|FG000|Overall Study|Death|2|||
161140249|NCT02874794|581897605|FG001|Overall Study|Death|1|||
160992285|NCT02014558|581360001|FG006|Overall Study|Miscellaneous|0|||
160992286|NCT02014558|581360002|FG007|Overall Study|Miscellaneous|1|||
160992287|NCT02014558|581360003|FG008|Overall Study|Miscellaneous|1|||
161252439|NCT01785615|582302451|FG000|Dietary Phase|Lost to Follow-up|0|||
161252440|NCT01785615|582302452|FG001|Dietary Phase|Lost to Follow-up|0|||
160992288|NCT02014558|581360004|FG009|Overall Study|Miscellaneous|3|||
160992289|NCT02014558|581360005|FG010|Overall Study|Miscellaneous|12|||
161140250|NCT01473004|581897606|FG000|Overall Study|Incomplete Lobar Treatment|1|||
161140251|NCT01473004|581897607|FG001|Overall Study|Incomplete Lobar Treatment|0|||
161140252|NCT00698516|581897608|FG000|Overall Study|Study Termination|2|||
161140253|NCT00698516|581897608|FG000|Overall Study|Withdrawal by Subject|3|||
161140254|NCT05882890|581897609|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
161140255|NCT01584024|581897618|FG000|Overall Study|Lost to Follow-up|10|||
161140256|NCT01584024|581897618|FG000|Overall Study|Withdrawal by Subject|3|||
161140257|NCT00613314|581897619|FG000|Overall Study|Adverse Event|5|||
161140258|NCT00613314|581897619|FG000|Overall Study|Protocol Violation|14|||
161140259|NCT00613314|581897619|FG000|Overall Study|Lost to Follow-up|46|||
161140260|NCT00613314|581897619|FG000|Overall Study|Other reason not defined above|90|||
161140261|NCT00719810|581897625|FG000|Overall Study|Adverse Event|0|||
161140262|NCT00719810|581897626|FG001|Overall Study|Adverse Event|2|||
161140263|NCT00719810|581897627|FG002|Overall Study|Adverse Event|3|||
161140264|NCT00719810|581897625|FG000|Overall Study|Lost to Follow-up|2|||
161140265|NCT00719810|581897626|FG001|Overall Study|Lost to Follow-up|0|||
161140266|NCT00719810|581897627|FG002|Overall Study|Lost to Follow-up|3|||
161140267|NCT00719810|581897625|FG000|Overall Study|Physician Decision|0|||
161140268|NCT00719810|581897626|FG001|Overall Study|Physician Decision|1|||
161140269|NCT00719810|581897627|FG002|Overall Study|Physician Decision|0|||
161140270|NCT00719810|581897625|FG000|Overall Study|Withdrawal by Subject|1|||
161140271|NCT00719810|581897626|FG001|Overall Study|Withdrawal by Subject|1|||
161140272|NCT00719810|581897627|FG002|Overall Study|Withdrawal by Subject|2|||
161140273|NCT04893265|581897650|FG000|Overall Study|Withdrawal by Subject|2|||
161140274|NCT04893265|581897651|FG001|Overall Study|Withdrawal by Subject|5|||
161140275|NCT04893265|581897650|FG000|Overall Study|Lost to Follow-up|0|||
161140276|NCT04893265|581897651|FG001|Overall Study|Lost to Follow-up|4|||
161140277|NCT02465034|581897652|FG000|Overall Study|Withdrawal by Subject|1|||
161140278|NCT02465034|581897653|FG001|Overall Study|Withdrawal by Subject|1|||
161140279|NCT02465034|581897652|FG000|Overall Study|Screen fail|2|||
161140280|NCT02465034|581897653|FG001|Overall Study|Screen fail|0|||
161140281|NCT02465034|581897652|FG000|Overall Study|Could not be scheduled for study visit|0|||
161140282|NCT02465034|581897653|FG001|Overall Study|Could not be scheduled for study visit|5|||
161140283|NCT03090191|581897654|FG000|Overall Study|Adverse Event|90|||
161140284|NCT03090191|581897655|FG001|Overall Study|Adverse Event|72|||
161140285|NCT03090191|581897654|FG000|Overall Study|Death|365|||
161140286|NCT03090191|581897655|FG001|Overall Study|Death|358|||
161140287|NCT03090191|581897654|FG000|Overall Study|Lost to Follow-up|382|||
161140288|NCT03090191|581897655|FG001|Overall Study|Lost to Follow-up|394|||
161140289|NCT03090191|581897654|FG000|Overall Study|Physician Decision|77|||
161140290|NCT03090191|581897655|FG001|Overall Study|Physician Decision|66|||
161140291|NCT03090191|581897654|FG000|Overall Study|Protocol Violation|43|||
161140292|NCT03090191|581897655|FG001|Overall Study|Protocol Violation|52|||
161140293|NCT03090191|581897654|FG000|Overall Study|Withdrawal by Subject|2160|||
161140294|NCT03090191|581897655|FG001|Overall Study|Withdrawal by Subject|2133|||
161335409|NCT00264147|582617761|FG003|Treatment I Period|Lack of Efficacy|0|||
161140295|NCT03090191|581897654|FG000|Overall Study|Site terminated|7|||
161140296|NCT03090191|581897655|FG001|Overall Study|Site terminated|8|||
161140297|NCT03090191|581897654|FG000|Overall Study|Other|66|||
161140298|NCT03090191|581897655|FG001|Overall Study|Other|60|||
161140299|NCT03090191|581897654|FG000|Overall Study|Withdrawn before any study vaccination|43|||
161140300|NCT03090191|581897655|FG001|Overall Study|Withdrawn before any study vaccination|52|||
161140301|NCT04645797|581897658|FG000|Overall Study|Disease Progression|3|||
161140302|NCT04645797|581897659|FG001|Overall Study|Disease Progression|3|||
161140303|NCT04645797|581897660|FG002|Overall Study|Disease Progression|1|||
161140304|NCT04645797|581897661|FG003|Overall Study|Disease Progression|0|||
161140305|NCT04645797|581897662|FG004|Overall Study|Disease Progression|0|||
161140306|NCT04645797|581897663|FG005|Overall Study|Disease Progression|0|||
161140307|NCT04645797|581897664|FG006|Overall Study|Disease Progression|0|||
161140308|NCT04645797|581897658|FG000|Overall Study|Death|3|||
161140309|NCT04645797|581897659|FG001|Overall Study|Death|1|||
161140310|NCT04645797|581897660|FG002|Overall Study|Death|0|||
161335410|NCT00264147|582617762|FG004|Treatment I Period|Lack of Efficacy|1|||
161335411|NCT00264147|582617763|FG005|Treatment I Period|Lack of Efficacy|0|||
161335412|NCT00264147|582617758|FG000|Treatment I Period|Lost to Follow-up|1|||
161335413|NCT00264147|582617759|FG001|Treatment I Period|Lost to Follow-up|0|||
161335414|NCT00264147|582617760|FG002|Treatment I Period|Lost to Follow-up|0|||
161335415|NCT00264147|582617761|FG003|Treatment I Period|Lost to Follow-up|1|||
161335416|NCT00264147|582617762|FG004|Treatment I Period|Lost to Follow-up|1|||
161335417|NCT00264147|582617763|FG005|Treatment I Period|Lost to Follow-up|0|||
161335418|NCT00264147|582617758|FG000|Treatment I Period|Protocol Violation|2|||
161335419|NCT00264147|582617759|FG001|Treatment I Period|Protocol Violation|2|||
161335420|NCT00264147|582617760|FG002|Treatment I Period|Protocol Violation|0|||
161335421|NCT00264147|582617761|FG003|Treatment I Period|Protocol Violation|0|||
161335422|NCT00264147|582617762|FG004|Treatment I Period|Protocol Violation|0|||
161335423|NCT00264147|582617763|FG005|Treatment I Period|Protocol Violation|0|||
161335424|NCT00264147|582617758|FG000|Treatment I Period|Withdrawal by Subject|2|||
161335425|NCT00264147|582617759|FG001|Treatment I Period|Withdrawal by Subject|0|||
161335426|NCT00264147|582617760|FG002|Treatment I Period|Withdrawal by Subject|0|||
161335427|NCT00264147|582617761|FG003|Treatment I Period|Withdrawal by Subject|2|||
161335428|NCT00264147|582617762|FG004|Treatment I Period|Withdrawal by Subject|2|||
161335429|NCT00264147|582617763|FG005|Treatment I Period|Withdrawal by Subject|0|||
161140311|NCT04645797|581897661|FG003|Overall Study|Death|0|||
161140312|NCT04645797|581897662|FG004|Overall Study|Death|0|||
161140313|NCT04645797|581897663|FG005|Overall Study|Death|0|||
161140314|NCT04645797|581897664|FG006|Overall Study|Death|0|||
161335430|NCT00264147|582617758|FG000|Treatment I Period|Patient out of town for an extended time|0|||
161335431|NCT00264147|582617759|FG001|Treatment I Period|Patient out of town for an extended time|1|||
161335432|NCT00264147|582617760|FG002|Treatment I Period|Patient out of town for an extended time|0|||
161335433|NCT00264147|582617761|FG003|Treatment I Period|Patient out of town for an extended time|0|||
161335434|NCT00264147|582617762|FG004|Treatment I Period|Patient out of town for an extended time|0|||
161140315|NCT01126619|581897667|FG000|Overall Study|Not eligible for the study|2|||
161140316|NCT01126619|581897667|FG000|Overall Study|Investigator decision|4|||
161140317|NCT01126619|581897667|FG000|Overall Study|Serious adverse event|1|||
161140318|NCT01126619|581897667|FG000|Overall Study|Withdrawal by Subject|9|||
161140319|NCT01126619|581897667|FG000|Overall Study|Non-compliance|1|||
161140320|NCT04876391|581897668|FG000|Overall Study|Withdrawal by Subject|1|||
161140321|NCT04876391|581897669|FG001|Overall Study|Withdrawal by Subject|10|||
161140322|NCT04876391|581897668|FG000|Overall Study|Lost to Follow-up|2|||
161140323|NCT04876391|581897669|FG001|Overall Study|Lost to Follow-up|4|||
161140324|NCT04876391|581897668|FG000|Overall Study|Lack of Efficacy|0|||
161140325|NCT04876391|581897669|FG001|Overall Study|Lack of Efficacy|2|||
161140326|NCT04876391|581897668|FG000|Overall Study|Adverse Event|3|||
161140327|NCT04876391|581897669|FG001|Overall Study|Adverse Event|1|||
161140328|NCT04876391|581897668|FG000|Overall Study|Patient non-compliance|0|||
161140329|NCT04876391|581897669|FG001|Overall Study|Patient non-compliance|1|||
161140330|NCT04876391|581897668|FG000|Overall Study|Personal reasons|0|||
161140331|NCT04876391|581897669|FG001|Overall Study|Personal reasons|1|||
161335435|NCT00264147|582617763|FG005|Treatment I Period|Patient out of town for an extended time|0|||
161335436|NCT00264147|582617758|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161335437|NCT00264147|582617759|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161335438|NCT00264147|582617760|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
161335439|NCT00264147|582617761|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161335440|NCT00264147|582617762|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161335441|NCT00264147|582617763|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
161335442|NCT00264147|582617758|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
160844424|NCT03170193|580818021|FG004|Overall Study|Withdrawal by Subject|0|||
160844425|NCT03170193|580818022|FG005|Overall Study|Withdrawal by Subject|0|||
160844426|NCT03170193|580818023|FG006|Overall Study|Withdrawal by Subject|0|||
160844427|NCT03170193|580818017|FG000|Overall Study|Lost to Follow-up|1|||
160844428|NCT03170193|580818018|FG001|Overall Study|Lost to Follow-up|1|||
160844429|NCT03170193|580818019|FG002|Overall Study|Lost to Follow-up|0|||
160844430|NCT03170193|580818020|FG003|Overall Study|Lost to Follow-up|0|||
160844431|NCT03170193|580818021|FG004|Overall Study|Lost to Follow-up|0|||
160844432|NCT03170193|580818022|FG005|Overall Study|Lost to Follow-up|0|||
160844433|NCT03170193|580818023|FG006|Overall Study|Lost to Follow-up|0|||
160844434|NCT02560012|580818024|FG000|Overall Study|Study Terminated|2|||
160844435|NCT03052816|580818025|FG000|Overall Study|Withdrawal by Subject|1|||
160844436|NCT03052816|580818026|FG001|Overall Study|Withdrawal by Subject|0|||
160844437|NCT03052816|580818025|FG000|Overall Study|Desired opioids|2|||
160844438|NCT03052816|580818026|FG001|Overall Study|Desired opioids|0|||
160844439|NCT02218008|580818027|FG000|Stage 1 (S1)|Adverse Event|6|||
160844440|NCT02218008|580818028|FG001|Stage 1 (S1)|Adverse Event|5|||
160844441|NCT02218008|580818029|FG002|Stage 1 (S1)|Adverse Event|11|||
160844442|NCT02218008|580818030|FG003|Stage 1 (S1)|Adverse Event|0|||
161335443|NCT00264147|582617759|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
161335444|NCT00264147|582617760|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
161335445|NCT00264147|582617761|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
161335446|NCT00264147|582617762|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
161335447|NCT00264147|582617763|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
161335448|NCT00264147|582617758|FG000|Treatment II Period|Adverse Event|0|||
161335449|NCT00264147|582617759|FG001|Treatment II Period|Adverse Event|0|||
161335450|NCT00264147|582617760|FG002|Treatment II Period|Adverse Event|0|||
161335451|NCT00264147|582617761|FG003|Treatment II Period|Adverse Event|0|||
161335452|NCT00264147|582617762|FG004|Treatment II Period|Adverse Event|9|||
161140332|NCT04876391|581897668|FG000|Overall Study|Withdrawn as per protocol|2|||
161140333|NCT04876391|581897669|FG001|Overall Study|Withdrawn as per protocol|2|||
161140334|NCT00811252|581897672|FG000|Overall Study|Adverse Event|6|||
161140335|NCT00811252|581897673|FG001|Overall Study|Adverse Event|10|||
161140336|NCT00811252|581897674|FG002|Overall Study|Adverse Event|15|||
161140337|NCT00811252|581897672|FG000|Overall Study|Lack of Efficacy|7|||
161140338|NCT00811252|581897673|FG001|Overall Study|Lack of Efficacy|2|||
161140339|NCT00811252|581897674|FG002|Overall Study|Lack of Efficacy|0|||
161140340|NCT00811252|581897672|FG000|Overall Study|Protocol Violation|3|||
161140341|NCT00811252|581897673|FG001|Overall Study|Protocol Violation|3|||
161140342|NCT00811252|581897674|FG002|Overall Study|Protocol Violation|2|||
160844443|NCT02218008|580818031|FG004|Stage 1 (S1)|Adverse Event|0|||
160844444|NCT02218008|580818032|FG005|Stage 1 (S1)|Adverse Event|0|||
160844445|NCT02218008|580818027|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
160844446|NCT02218008|580818028|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
160844447|NCT02218008|580818029|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
160844448|NCT02218008|580818030|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
160844449|NCT02218008|580818031|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
160844450|NCT02218008|580818032|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
160844451|NCT02218008|580818027|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
160844452|NCT02218008|580818028|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
160844453|NCT02218008|580818029|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
160844454|NCT02218008|580818030|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
160844455|NCT02218008|580818031|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
160844456|NCT02218008|580818032|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
160844457|NCT02218008|580818027|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
160844458|NCT02218008|580818028|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
160844459|NCT02218008|580818029|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
160844460|NCT02218008|580818030|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
160844461|NCT02218008|580818031|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
160844462|NCT02218008|580818032|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
160844463|NCT02218008|580818027|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
161335453|NCT00264147|582617763|FG005|Treatment II Period|Adverse Event|9|||
161335454|NCT00264147|582617758|FG000|Treatment II Period|Laboratory Adverse Event|0|||
161335455|NCT00264147|582617759|FG001|Treatment II Period|Laboratory Adverse Event|0|||
161335456|NCT00264147|582617760|FG002|Treatment II Period|Laboratory Adverse Event|0|||
161335457|NCT00264147|582617761|FG003|Treatment II Period|Laboratory Adverse Event|0|||
161140343|NCT00811252|581897672|FG000|Overall Study|Withdrawal of Consent|1|||
161140344|NCT00811252|581897673|FG001|Overall Study|Withdrawal of Consent|2|||
161140345|NCT00811252|581897674|FG002|Overall Study|Withdrawal of Consent|2|||
160844464|NCT02218008|580818028|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
160844465|NCT02218008|580818029|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844466|NCT02218008|580818030|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844467|NCT02218008|580818031|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844468|NCT02218008|580818032|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
160844469|NCT02218008|580818027|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
160844470|NCT02218008|580818028|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
160844471|NCT02218008|580818029|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
160844472|NCT02218008|580818030|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
160844473|NCT02218008|580818031|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
160844474|NCT02218008|580818032|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
160844475|NCT02218008|580818027|FG000|Stage 1 (S1)|Pregnancy|0|||
160844476|NCT02218008|580818028|FG001|Stage 1 (S1)|Pregnancy|0|||
160844477|NCT02218008|580818029|FG002|Stage 1 (S1)|Pregnancy|1|||
160844478|NCT02218008|580818030|FG003|Stage 1 (S1)|Pregnancy|0|||
160844479|NCT02218008|580818031|FG004|Stage 1 (S1)|Pregnancy|0|||
160844480|NCT02218008|580818032|FG005|Stage 1 (S1)|Pregnancy|0|||
160844481|NCT02218008|580818027|FG000|Stage 1 (S1)|Protocol Violation|0|||
160844482|NCT02218008|580818028|FG001|Stage 1 (S1)|Protocol Violation|0|||
160844483|NCT02218008|580818029|FG002|Stage 1 (S1)|Protocol Violation|1|||
160844484|NCT02218008|580818030|FG003|Stage 1 (S1)|Protocol Violation|0|||
160844485|NCT02218008|580818031|FG004|Stage 1 (S1)|Protocol Violation|0|||
160844486|NCT02218008|580818032|FG005|Stage 1 (S1)|Protocol Violation|0|||
160844487|NCT02218008|580818027|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
160844488|NCT02218008|580818028|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844489|NCT02218008|580818029|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844490|NCT02218008|580818030|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844491|NCT02218008|580818031|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844492|NCT02218008|580818032|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
160844493|NCT02218008|580818027|FG000|Stage 2 (S2)|Adverse Event|0|||
160844494|NCT02218008|580818028|FG001|Stage 2 (S2)|Adverse Event|0|||
161140346|NCT00811252|581897672|FG000|Overall Study|Lost to Follow-up|0|||
160844495|NCT02218008|580818029|FG002|Stage 2 (S2)|Adverse Event|0|||
160844496|NCT02218008|580818030|FG003|Stage 2 (S2)|Adverse Event|2|||
160844497|NCT02218008|580818031|FG004|Stage 2 (S2)|Adverse Event|3|||
160844498|NCT02218008|580818032|FG005|Stage 2 (S2)|Adverse Event|3|||
160844499|NCT02218008|580818027|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
160844500|NCT02218008|580818028|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
160844501|NCT02218008|580818029|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
160844502|NCT02218008|580818030|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
160844503|NCT02218008|580818031|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
161140347|NCT00811252|581897673|FG001|Overall Study|Lost to Follow-up|0|||
161140348|NCT00811252|581897674|FG002|Overall Study|Lost to Follow-up|2|||
161140349|NCT00811252|581897672|FG000|Overall Study|Administrative or Other Reasons|0|||
161140350|NCT00811252|581897673|FG001|Overall Study|Administrative or Other Reasons|3|||
161140351|NCT00811252|581897674|FG002|Overall Study|Administrative or Other Reasons|2|||
161140352|NCT01931865|581897678|FG000|Overall Study|Lost to Follow-up|2|||
161140353|NCT01931865|581897678|FG000|Overall Study|Withdrawal by Subject|2|||
161140354|NCT01121406|581897679|FG000|Overall Study|Progressive disease RECIST|44|||
161335458|NCT00264147|582617762|FG004|Treatment II Period|Laboratory Adverse Event|0|||
160844504|NCT02218008|580818032|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
160844505|NCT02218008|580818027|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
160844506|NCT02218008|580818028|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
161335459|NCT00264147|582617763|FG005|Treatment II Period|Laboratory Adverse Event|1|||
161335460|NCT00264147|582617758|FG000|Treatment II Period|Lack of Efficacy|0|||
161335461|NCT00264147|582617759|FG001|Treatment II Period|Lack of Efficacy|0|||
161335462|NCT00264147|582617760|FG002|Treatment II Period|Lack of Efficacy|0|||
161335463|NCT00264147|582617761|FG003|Treatment II Period|Lack of Efficacy|0|||
161335464|NCT00264147|582617762|FG004|Treatment II Period|Lack of Efficacy|20|||
161140355|NCT01121406|581897680|FG001|Overall Study|Progressive disease RECIST|28|||
161140356|NCT01121406|581897679|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
161140357|NCT01121406|581897680|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
161140358|NCT01121406|581897679|FG000|Overall Study|Other AE|3|||
161140359|NCT01121406|581897680|FG001|Overall Study|Other AE|10|||
161140360|NCT01121406|581897679|FG000|Overall Study|Non-compliant with protocol|0|||
161140361|NCT01121406|581897680|FG001|Overall Study|Non-compliant with protocol|2|||
161140362|NCT01121406|581897679|FG000|Overall Study|Lost to Follow-up|0|||
161140363|NCT01121406|581897680|FG001|Overall Study|Lost to Follow-up|1|||
161140364|NCT01121406|581897679|FG000|Overall Study|Refused continuation of study med.|1|||
160844507|NCT02218008|580818029|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
160844508|NCT02218008|580818030|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
160844509|NCT02218008|580818031|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
160844510|NCT02218008|580818032|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
160844511|NCT02218008|580818027|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844512|NCT02218008|580818028|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844513|NCT02218008|580818029|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844514|NCT02218008|580818030|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
161140365|NCT01121406|581897680|FG001|Overall Study|Refused continuation of study med.|2|||
161140366|NCT01121406|581897679|FG000|Overall Study|Reason other than specified above|2|||
161140367|NCT01121406|581897680|FG001|Overall Study|Reason other than specified above|6|||
161140368|NCT01121406|581897679|FG000|Overall Study|Not treated|1|||
161335465|NCT00264147|582617763|FG005|Treatment II Period|Lack of Efficacy|19|||
161335466|NCT00264147|582617758|FG000|Treatment II Period|Lost to Follow-up|0|||
161335467|NCT00264147|582617759|FG001|Treatment II Period|Lost to Follow-up|0|||
161335468|NCT00264147|582617760|FG002|Treatment II Period|Lost to Follow-up|0|||
161335469|NCT00264147|582617761|FG003|Treatment II Period|Lost to Follow-up|0|||
161335470|NCT00264147|582617762|FG004|Treatment II Period|Lost to Follow-up|1|||
161335471|NCT00264147|582617763|FG005|Treatment II Period|Lost to Follow-up|1|||
161335472|NCT00264147|582617758|FG000|Treatment II Period|Withdrawal by Subject|0|||
161335473|NCT00264147|582617759|FG001|Treatment II Period|Withdrawal by Subject|0|||
161335474|NCT00264147|582617760|FG002|Treatment II Period|Withdrawal by Subject|0|||
161335475|NCT00264147|582617761|FG003|Treatment II Period|Withdrawal by Subject|0|||
161335476|NCT00264147|582617762|FG004|Treatment II Period|Withdrawal by Subject|3|||
161335477|NCT00264147|582617763|FG005|Treatment II Period|Withdrawal by Subject|2|||
161335478|NCT00264147|582617758|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
161335479|NCT00264147|582617759|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
161335480|NCT00264147|582617760|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
161335481|NCT00264147|582617761|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
161335482|NCT00264147|582617762|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
161335483|NCT00264147|582617763|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
161335484|NCT03234465|582617764|FG000|Overall Study|Adverse Event|4|||
161335485|NCT03234465|582617765|FG001|Overall Study|Adverse Event|2|||
161335486|NCT03234465|582617764|FG000|Overall Study|Death|0|||
161335487|NCT03234465|582617765|FG001|Overall Study|Death|1|||
161335488|NCT03234465|582617764|FG000|Overall Study|Lost to Follow-up|1|||
161335489|NCT03234465|582617765|FG001|Overall Study|Lost to Follow-up|1|||
161335490|NCT03234465|582617764|FG000|Overall Study|Withdrawal by Subject|12|||
161335491|NCT03234465|582617765|FG001|Overall Study|Withdrawal by Subject|27|||
161335492|NCT03234465|582617764|FG000|Overall Study|Symptomatic deterioration|0|||
161140369|NCT01121406|581897680|FG001|Overall Study|Not treated|0|||
161140370|NCT00892437|581897681|FG000|Randomized Phase|Randomized but not treated|6|||
161140371|NCT00892437|581897682|FG001|Randomized Phase|Randomized but not treated|0|||
161140372|NCT00892437|581897681|FG000|Randomized Phase|Adverse Event|2|||
161140373|NCT00892437|581897682|FG001|Randomized Phase|Adverse Event|2|||
161140374|NCT00892437|581897681|FG000|Randomized Phase|Lost to Follow-up|1|||
161140375|NCT00892437|581897682|FG001|Randomized Phase|Lost to Follow-up|3|||
161140376|NCT00892437|581897681|FG000|Randomized Phase|Investigator's Discretion|1|||
161140377|NCT00892437|581897682|FG001|Randomized Phase|Investigator's Discretion|0|||
161140378|NCT00892437|581897681|FG000|Randomized Phase|Withdrew Consent|1|||
161140379|NCT00892437|581897682|FG001|Randomized Phase|Withdrew Consent|0|||
161140380|NCT00892437|581897681|FG000|Open-Label Extension Phase|Adverse Event|4|||
161140381|NCT00892437|581897682|FG001|Open-Label Extension Phase|Adverse Event|2|||
161140382|NCT00892437|581897681|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
161140383|NCT00892437|581897682|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
161140384|NCT00892437|581897681|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
161140385|NCT00892437|581897682|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
161140386|NCT00892437|581897681|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
161140387|NCT00892437|581897682|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161140388|NCT00892437|581897681|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
161140389|NCT00892437|581897682|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
161140390|NCT00504257|581897683|FG000|Overall Study|Withdrawal by Subject|2|||
161140391|NCT00504257|581897683|FG000|Overall Study|ineligible histology|2|||
161140392|NCT03185130|581897684|FG000|Overall Study|Withdrawal by Subject|0|||
161140393|NCT03185130|581897685|FG001|Overall Study|Withdrawal by Subject|2|||
161140394|NCT02286960|581897686|FG000|Overall Study|Lost to Follow-up|3|||
161140395|NCT02286960|581897687|FG001|Overall Study|Lost to Follow-up|3|||
161140396|NCT02750410|581897689|FG000|Double-Blind Treatment Period|Adverse Event|2|||
161140397|NCT02750410|581897690|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161140398|NCT02750410|581897689|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161140399|NCT02750410|581897690|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161140400|NCT02750410|581897689|FG000|Open-Label Extension Period|Adverse Event|5|||
161140401|NCT02750410|581897690|FG001|Open-Label Extension Period|Adverse Event|3|||
161140402|NCT02750410|581897689|FG000|Open-Label Extension Period|Protocol Violation|0|||
161140403|NCT02750410|581897690|FG001|Open-Label Extension Period|Protocol Violation|1|||
161140404|NCT02750410|581897689|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
161140405|NCT02750410|581897690|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
161140406|NCT02504541|581897691|FG000|Overall Study|Adverse Event|4|||
161140407|NCT02504541|581897691|FG000|Overall Study|Withdrawal by Subject|4|||
161140408|NCT02504541|581897691|FG000|Overall Study|Lost to Follow-up|1|||
161140409|NCT02504541|581897691|FG000|Overall Study|Met Stopping Criteria|1|||
161140410|NCT02504541|581897691|FG000|Overall Study|Protocol Violation|2|||
161140411|NCT02504541|581897691|FG000|Overall Study|Termination by Sponsor|1|||
161140412|NCT02504541|581897691|FG000|Overall Study|Other|2|||
161140413|NCT02504541|581897691|FG000|Overall Study|Multiple|5|||
161140414|NCT03215277|581897703|FG000|Overall Study|Adverse Event|2|||
161140415|NCT03215277|581897704|FG001|Overall Study|Adverse Event|3|||
161140416|NCT03215277|581897703|FG000|Overall Study|Death|1|||
161140417|NCT03215277|581897704|FG001|Overall Study|Death|0|||
161140418|NCT03215277|581897703|FG000|Overall Study|Lost to Follow-up|0|||
161140419|NCT03215277|581897704|FG001|Overall Study|Lost to Follow-up|1|||
161140420|NCT03215277|581897703|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
161140421|NCT03215277|581897704|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
161140422|NCT03596164|581897705|FG000|Overall Study|Adverse Event|0|||
161140423|NCT03596164|581897706|FG001|Overall Study|Adverse Event|1|||
161140424|NCT03596164|581897705|FG000|Overall Study|Death|1|||
161140425|NCT03596164|581897706|FG001|Overall Study|Death|0|||
161140426|NCT03427073|581897707|FG000|Overall Study|Disease Progression|1|||
161140427|NCT03427073|581897708|FG001|Overall Study|Disease Progression|1|||
161140428|NCT03427073|581897709|FG002|Overall Study|Disease Progression|1|||
161140429|NCT03427073|581897710|FG003|Overall Study|Disease Progression|3|||
161140430|NCT03427073|581897711|FG004|Overall Study|Disease Progression|3|||
161140431|NCT03427073|581897712|FG005|Overall Study|Disease Progression|4|||
161140432|NCT03427073|581897713|FG006|Overall Study|Disease Progression|2|||
161140433|NCT03427073|581897714|FG007|Overall Study|Disease Progression|3|||
161140434|NCT03427073|581897707|FG000|Overall Study|Physician Decision|0|||
161335493|NCT03234465|582617765|FG001|Overall Study|Symptomatic deterioration|1|||
161335494|NCT03234465|582617764|FG000|Overall Study|Non-compliance|2|||
161335495|NCT03234465|582617765|FG001|Overall Study|Non-compliance|0|||
161335496|NCT03234465|582617764|FG000|Overall Study|Other|14|||
161335497|NCT03234465|582617765|FG001|Overall Study|Other|8|||
161335498|NCT02949947|582617770|FG000|Overall Study|Non Compliance|0|||
160992290|NCT02014558|581360006|FG011|Overall Study|Miscellaneous|11|||
160992291|NCT02014558|581360007|FG012|Overall Study|Miscellaneous|1|||
161335499|NCT02949947|582617771|FG001|Overall Study|Non Compliance|1|||
161335500|NCT02949947|582617770|FG000|Overall Study|Insurance change|1|||
161335501|NCT02949947|582617771|FG001|Overall Study|Insurance change|0|||
161335502|NCT00794664|582617772|FG000|Treatment Period|Withdrawal by Subject|0|||
161335503|NCT00794664|582617773|FG001|Treatment Period|Withdrawal by Subject|2|||
160992292|NCT01560949|581360008|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
160992293|NCT01560949|581360008|FG000|Surgery Phase|Physician Decision|3|||
161335504|NCT00794664|582617772|FG000|Treatment Period|Protocol non-compliance|0|||
161335505|NCT00794664|582617773|FG001|Treatment Period|Protocol non-compliance|1|||
161335506|NCT00794664|582617772|FG000|Treatment Period|Other|0|||
161335507|NCT00794664|582617773|FG001|Treatment Period|Other|1|||
161335508|NCT00794664|582617772|FG000|Treatment Period|Adverse Event|1|||
160992294|NCT02931396|581360011|FG000|Overall Study|Lost to Follow-up|3|||
160992295|NCT02931396|581360012|FG001|Overall Study|Lost to Follow-up|0|||
161335509|NCT00794664|582617773|FG001|Treatment Period|Adverse Event|8|||
160992296|NCT02931396|581360011|FG000|Overall Study|Withdrawal by Subject|2|||
160992297|NCT02931396|581360012|FG001|Overall Study|Withdrawal by Subject|0|||
161140435|NCT03427073|581897708|FG001|Overall Study|Physician Decision|0|||
161140436|NCT03427073|581897709|FG002|Overall Study|Physician Decision|0|||
161140437|NCT03427073|581897710|FG003|Overall Study|Physician Decision|0|||
161335510|NCT00794664|582617772|FG000|Follow-up Period|Other|1|||
161335511|NCT00794664|582617773|FG001|Follow-up Period|Other|2|||
161335512|NCT00794664|582617772|FG000|Follow-up Period|Withdrawal by Subject|0|||
161335513|NCT00794664|582617773|FG001|Follow-up Period|Withdrawal by Subject|2|||
161335514|NCT00794664|582617772|FG000|Follow-up Period|Protocol non-compliance|0|||
161335515|NCT00794664|582617773|FG001|Follow-up Period|Protocol non-compliance|1|||
161335516|NCT01973218|582617774|FG000|Overall Study|Adverse Event|1|||
161335517|NCT01973218|582617775|FG001|Overall Study|Adverse Event|0|||
161335518|NCT01973218|582617774|FG000|Overall Study|Withdrawal by Subject|1|||
161335519|NCT01973218|582617775|FG001|Overall Study|Withdrawal by Subject|0|||
161335520|NCT00720499|582617776|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
161335521|NCT00720499|582617777|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
161335522|NCT00720499|582617776|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
161335523|NCT00720499|582617777|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
161335524|NCT00720499|582617776|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
161335525|NCT00720499|582617777|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
161335526|NCT02247466|582617778|FG000|Overall Study|Procedure changed to open surgery|0|||
161335527|NCT02247466|582617779|FG001|Overall Study|Procedure changed to open surgery|3|||
161140438|NCT03427073|581897711|FG004|Overall Study|Physician Decision|0|||
161140439|NCT03427073|581897712|FG005|Overall Study|Physician Decision|0|||
161140440|NCT03427073|581897713|FG006|Overall Study|Physician Decision|1|||
161140441|NCT03427073|581897714|FG007|Overall Study|Physician Decision|1|||
161140442|NCT02835495|581897717|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
161140443|NCT02835495|581897718|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
161140444|NCT02835495|581897717|FG000|Overall Study|Declined in-person follow-up visit|4|||
161140445|NCT02835495|581897718|FG001|Overall Study|Declined in-person follow-up visit|2|||
161140446|NCT02580058|581897720|FG000|Overall Study|Adverse Event|16|||
161140447|NCT02580058|581897721|FG001|Overall Study|Adverse Event|30|||
161140448|NCT02580058|581897722|FG002|Overall Study|Adverse Event|20|||
161140449|NCT02580058|581897720|FG000|Overall Study|Death|4|||
161140450|NCT02580058|581897721|FG001|Overall Study|Death|4|||
161140451|NCT02580058|581897722|FG002|Overall Study|Death|5|||
161140452|NCT02580058|581897720|FG000|Overall Study|Physician Decision|1|||
161140453|NCT02580058|581897721|FG001|Overall Study|Physician Decision|3|||
161140454|NCT02580058|581897722|FG002|Overall Study|Physician Decision|11|||
161140455|NCT02580058|581897720|FG000|Overall Study|Other|5|||
161140456|NCT02580058|581897721|FG001|Overall Study|Other|1|||
161140457|NCT02580058|581897722|FG002|Overall Study|Other|3|||
161140458|NCT02580058|581897720|FG000|Overall Study|Withdrawal by Subject|4|||
161335528|NCT00492726|582617780|FG000|Overall Study|Adverse Event|10|||
161335529|NCT00492726|582617781|FG001|Overall Study|Adverse Event|6|||
161335530|NCT00492726|582617780|FG000|Overall Study|Death|7|||
161335531|NCT00492726|582617781|FG001|Overall Study|Death|2|||
161335532|NCT00492726|582617780|FG000|Overall Study|Lack of Efficacy|0|||
161335533|NCT00492726|582617781|FG001|Overall Study|Lack of Efficacy|2|||
161335534|NCT00492726|582617780|FG000|Overall Study|Lost to Follow-up|27|||
161335535|NCT00492726|582617781|FG001|Overall Study|Lost to Follow-up|19|||
161335536|NCT00492726|582617780|FG000|Overall Study|Physician Decision|0|||
161335537|NCT00492726|582617781|FG001|Overall Study|Physician Decision|1|||
161335538|NCT00492726|582617780|FG000|Overall Study|Withdrawal by Subject|6|||
161335539|NCT00492726|582617781|FG001|Overall Study|Withdrawal by Subject|3|||
161335540|NCT00492726|582617780|FG000|Overall Study|Non compliant with study medication|0|||
161335541|NCT00492726|582617781|FG001|Overall Study|Non compliant with study medication|3|||
161335542|NCT01100502|582617782|FG000|Overall Study|Withdrawal by Subject|18|||
161335543|NCT01100502|582617783|FG001|Overall Study|Withdrawal by Subject|25|||
161335544|NCT01100502|582617782|FG000|Overall Study|Lost to Follow-up|13|||
161335545|NCT01100502|582617783|FG001|Overall Study|Lost to Follow-up|28|||
161335546|NCT01100502|582617782|FG000|Overall Study|Site request to end participation in study|0|||
161335547|NCT01100502|582617783|FG001|Overall Study|Site request to end participation in study|1|||
161335548|NCT01100502|582617782|FG000|Overall Study|Death|45|||
161335549|NCT01100502|582617783|FG001|Overall Study|Death|40|||
161335550|NCT04386902|582617784|FG000|Overall Study|Withdrawal by Subject|5|||
161335551|NCT04386902|582617784|FG000|Overall Study|Technical problems in the recording|5|||
161335552|NCT04356937|582617792|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
161140459|NCT02580058|581897721|FG001|Overall Study|Withdrawal by Subject|7|||
161140460|NCT02580058|581897722|FG002|Overall Study|Withdrawal by Subject|31|||
161140461|NCT02580058|581897720|FG000|Overall Study|Global Deterioration of Health Status|19|||
161140462|NCT02580058|581897721|FG001|Overall Study|Global Deterioration of Health Status|18|||
161140463|NCT02580058|581897722|FG002|Overall Study|Global Deterioration of Health Status|24|||
161140464|NCT02580058|581897720|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
161140465|NCT02580058|581897721|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161140466|NCT02580058|581897722|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
161335553|NCT04356937|582617793|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
161335554|NCT00807365|582617794|FG000|Overall Study|Study Terminated|5|||
161335555|NCT00960804|582617795|FG000|Overall Study|Adverse Event|1|||
161335556|NCT00960804|582617796|FG001|Overall Study|Adverse Event|0|||
161335557|NCT00960804|582617797|FG002|Overall Study|Adverse Event|0|||
161335558|NCT00960804|582617795|FG000|Overall Study|Withdrawal by Subject|1|||
161252441|NCT01785615|582302453|FG002|Dietary Phase|Lost to Follow-up|0|||
161252442|NCT01785615|582302454|FG003|Dietary Phase|Lost to Follow-up|24|||
161252443|NCT02522780|582302455|FG000|Overall Study|Consent withdrawn by subject|5|||
161252444|NCT02522780|582302456|FG001|Overall Study|Consent withdrawn by subject|7|||
161252445|NCT02522780|582302455|FG000|Overall Study|Protocol deviation|1|||
161252446|NCT02522780|582302456|FG001|Overall Study|Protocol deviation|3|||
161252447|NCT02522780|582302455|FG000|Overall Study|Subject refused endoscopic procedure|0|||
161252448|NCT02522780|582302456|FG001|Overall Study|Subject refused endoscopic procedure|1|||
161252449|NCT02522780|582302455|FG000|Overall Study|Adverse event, non-fatal|11|||
161252450|NCT02522780|582302456|FG001|Overall Study|Adverse event, non-fatal|16|||
161252451|NCT00926367|582302457|FG000|Overall Study|Withdrawal by Subject|0|||
161252452|NCT00926367|582302458|FG001|Overall Study|Withdrawal by Subject|1|||
161252453|NCT00926367|582302457|FG000|Overall Study|Lost to Follow-up|1|||
161252454|NCT00926367|582302458|FG001|Overall Study|Lost to Follow-up|0|||
161252455|NCT00926367|582302457|FG000|Overall Study|Skin Irritation|1|||
161252456|NCT00926367|582302458|FG001|Overall Study|Skin Irritation|2|||
161252457|NCT01517867|582302459|FG000|Overall Study|never started treatment|29|||
161252458|NCT01517867|582302460|FG001|Overall Study|never started treatment|32|||
161252459|NCT01517867|582302459|FG000|Overall Study|Withdrawal by Subject|34|||
161252460|NCT01517867|582302460|FG001|Overall Study|Withdrawal by Subject|30|||
161252461|NCT01517867|582302459|FG000|Overall Study|Still in treatment at study end|0|||
161252462|NCT01517867|582302460|FG001|Overall Study|Still in treatment at study end|3|||
161252463|NCT04203667|582302465|FG000|Overall Study|Withdrawal by Subject|1|||
161252464|NCT04203667|582302465|FG000|Overall Study|Lost to Follow-up|1|||
161252465|NCT04203667|582302465|FG000|Overall Study|Death|1|||
161252466|NCT04203667|582302465|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
161252467|NCT01160640|582302466|FG000|Overall Study|Physician Decision|3|||
161252468|NCT01160640|582302467|FG001|Overall Study|Physician Decision|3|||
161252469|NCT01160640|582302466|FG000|Overall Study|Incarceration|1|||
161252470|NCT01160640|582302467|FG001|Overall Study|Incarceration|0|||
161252471|NCT01160640|582302466|FG000|Overall Study|Withdrawal by Subject|0|||
161252472|NCT01160640|582302467|FG001|Overall Study|Withdrawal by Subject|3|||
161252473|NCT01525628|582302468|FG000|Overall Study|Adverse Event|1|||
161252474|NCT01525628|582302469|FG001|Overall Study|Adverse Event|1|||
161252475|NCT01525628|582302470|FG002|Overall Study|Adverse Event|2|||
161252476|NCT01525628|582302471|FG003|Overall Study|Adverse Event|0|||
161252477|NCT01525628|582302472|FG004|Overall Study|Adverse Event|1|||
161252478|NCT01525628|582302468|FG000|Overall Study|Lack of Efficacy|0|||
161252479|NCT01525628|582302469|FG001|Overall Study|Lack of Efficacy|2|||
161252480|NCT01525628|582302470|FG002|Overall Study|Lack of Efficacy|2|||
161252481|NCT01525628|582302471|FG003|Overall Study|Lack of Efficacy|1|||
161252482|NCT01525628|582302472|FG004|Overall Study|Lack of Efficacy|2|||
161252483|NCT01525628|582302468|FG000|Overall Study|Protocol Violation|0|||
161252484|NCT01525628|582302469|FG001|Overall Study|Protocol Violation|0|||
161252485|NCT01525628|582302470|FG002|Overall Study|Protocol Violation|1|||
161252486|NCT01525628|582302471|FG003|Overall Study|Protocol Violation|0|||
161252487|NCT01525628|582302472|FG004|Overall Study|Protocol Violation|0|||
161252488|NCT01525628|582302468|FG000|Overall Study|Lost to Follow-up|1|||
161252489|NCT01525628|582302469|FG001|Overall Study|Lost to Follow-up|1|||
161252490|NCT01525628|582302470|FG002|Overall Study|Lost to Follow-up|0|||
161252491|NCT01525628|582302471|FG003|Overall Study|Lost to Follow-up|0|||
161252492|NCT01525628|582302472|FG004|Overall Study|Lost to Follow-up|0|||
161252493|NCT01525628|582302468|FG000|Overall Study|Withdrawal by Subject|0|||
161252494|NCT01525628|582302469|FG001|Overall Study|Withdrawal by Subject|1|||
161252495|NCT01525628|582302470|FG002|Overall Study|Withdrawal by Subject|0|||
161252496|NCT01525628|582302471|FG003|Overall Study|Withdrawal by Subject|0|||
161252497|NCT01525628|582302472|FG004|Overall Study|Withdrawal by Subject|0|||
161252498|NCT01525628|582302468|FG000|Overall Study|Other reason not defined above|0|||
161252499|NCT01525628|582302469|FG001|Overall Study|Other reason not defined above|0|||
161252500|NCT01525628|582302470|FG002|Overall Study|Other reason not defined above|0|||
161252501|NCT01525628|582302471|FG003|Overall Study|Other reason not defined above|3|||
161252502|NCT01525628|582302472|FG004|Overall Study|Other reason not defined above|0|||
161252503|NCT00787605|582302473|FG000|Overall Study|Administrative Problems|3|||
161252504|NCT00787605|582302474|FG001|Overall Study|Administrative Problems|0|||
161252505|NCT00787605|582302473|FG000|Overall Study|Adverse Event|14|||
161252506|NCT00787605|582302474|FG001|Overall Study|Adverse Event|25|||
161252507|NCT00787605|582302473|FG000|Overall Study|Lost to Follow-up|3|||
161252508|NCT00787605|582302474|FG001|Overall Study|Lost to Follow-up|6|||
161252509|NCT00787605|582302473|FG000|Overall Study|Protocol Violation|7|||
161252510|NCT00787605|582302474|FG001|Overall Study|Protocol Violation|3|||
161252511|NCT00787605|582302473|FG000|Overall Study|Withdrawal by Subject|6|||
161252512|NCT00787605|582302474|FG001|Overall Study|Withdrawal by Subject|13|||
161252513|NCT00787605|582302473|FG000|Overall Study|Lack of Efficacy|13|||
161252514|NCT00787605|582302474|FG001|Overall Study|Lack of Efficacy|9|||
161252515|NCT01223027|582302475|FG000|Overall Study|Adverse Event|20|||
161252516|NCT01223027|582302476|FG001|Overall Study|Adverse Event|10|||
161252517|NCT01223027|582302475|FG000|Overall Study|Death|42|||
161252518|NCT01223027|582302476|FG001|Overall Study|Death|42|||
161335559|NCT00960804|582617796|FG001|Overall Study|Withdrawal by Subject|0|||
161335560|NCT00960804|582617797|FG002|Overall Study|Withdrawal by Subject|0|||
161335561|NCT00960804|582617795|FG000|Overall Study|Study terminated by the sponsor|5|||
161335562|NCT00960804|582617796|FG001|Overall Study|Study terminated by the sponsor|4|||
161335563|NCT00960804|582617797|FG002|Overall Study|Study terminated by the sponsor|10|||
161335564|NCT02007720|582617799|FG000|Overall Study|Withdrawal by Subject|9|||
161335565|NCT02007720|582617800|FG001|Overall Study|Withdrawal by Subject|11|||
161335566|NCT02007720|582617799|FG000|Overall Study|study terminated by sponsor|58|||
161335567|NCT02007720|582617800|FG001|Overall Study|study terminated by sponsor|54|||
161335568|NCT02007720|582617799|FG000|Overall Study|technical problem|4|||
161335569|NCT02007720|582617800|FG001|Overall Study|technical problem|2|||
161335570|NCT02007720|582617799|FG000|Overall Study|patient followd less than 165 days|11|||
161335571|NCT02007720|582617800|FG001|Overall Study|patient followd less than 165 days|5|||
161335572|NCT02100124|582617803|FG000|Overall Study|Lost to Follow-up|5|||
161335573|NCT02100124|582617804|FG001|Overall Study|Lost to Follow-up|11|||
161335574|NCT02100124|582617805|FG002|Overall Study|Lost to Follow-up|3|||
161335575|NCT02100124|582617803|FG000|Overall Study|Withdrawal by Subject|1|||
161335576|NCT02100124|582617804|FG001|Overall Study|Withdrawal by Subject|0|||
161335577|NCT02100124|582617805|FG002|Overall Study|Withdrawal by Subject|0|||
161335578|NCT00499122|582619272|FG000|Overall Study|Withdrawal by Subject|2|||
161335579|NCT03312738|582619273|FG000|Overall Study|Progressive disease|58|||
161335580|NCT03312738|582619274|FG001|Overall Study|Progressive disease|67|||
161335581|NCT03312738|582619273|FG000|Overall Study|Patient/guardian decision|13|||
161335582|NCT03312738|582619274|FG001|Overall Study|Patient/guardian decision|5|||
161335583|NCT03312738|582619273|FG000|Overall Study|Adverse Event|5|||
161335584|NCT03312738|582619274|FG001|Overall Study|Adverse Event|3|||
161335585|NCT03312738|582619273|FG000|Overall Study|Protocol deviation|2|||
161335586|NCT03312738|582619274|FG001|Overall Study|Protocol deviation|0|||
161335587|NCT03312738|582619273|FG000|Overall Study|Technical problems|0|||
161335588|NCT03312738|582619274|FG001|Overall Study|Technical problems|1|||
161335589|NCT03312738|582619273|FG000|Overall Study|Physician Decision|2|||
161335590|NCT03312738|582619274|FG001|Overall Study|Physician Decision|3|||
161335591|NCT04539275|582619283|FG000|Overall Study|Death|2|||
161335592|NCT04539275|582619284|FG001|Overall Study|Death|4|||
161335593|NCT04539275|582619283|FG000|Overall Study|Lost to Follow-up|1|||
161335594|NCT04539275|582619284|FG001|Overall Study|Lost to Follow-up|1|||
161335595|NCT04539275|582619283|FG000|Overall Study|Withdrawal by Subject|3|||
161335596|NCT04539275|582619284|FG001|Overall Study|Withdrawal by Subject|0|||
161335597|NCT00607893|582619285|FG000|Overall Study|Lost to Follow-up|4|||
161335598|NCT00607893|582619286|FG001|Overall Study|Lost to Follow-up|0|||
161335599|NCT00607893|582619285|FG000|Overall Study|withdrew due to loss of interest|0|||
161335600|NCT00607893|582619286|FG001|Overall Study|withdrew due to loss of interest|1|||
161335601|NCT00607893|582619285|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
161335602|NCT00607893|582619286|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
161335603|NCT00607893|582619285|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
161335604|NCT00607893|582619286|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
161335605|NCT00607893|582619285|FG000|Overall Study|Declined to be treated|1|||
161335606|NCT00607893|582619286|FG001|Overall Study|Declined to be treated|0|||
161335607|NCT00607893|582619285|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
161335608|NCT00607893|582619286|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
161335609|NCT01799941|582619287|FG000|Overall Study|Adverse Event|34|||
161335610|NCT01799941|582619287|FG000|Overall Study|Withdrawal by Subject|21|||
161335611|NCT01799941|582619287|FG000|Overall Study|Death|2|||
161335612|NCT01799941|582619287|FG000|Overall Study|Investigator Decision|4|||
161335613|NCT01799941|582619287|FG000|Overall Study|Lack of Efficacy|3|||
160905923|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905924|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161335614|NCT01799941|582619287|FG000|Overall Study|Lost to Follow-up|17|||
161335615|NCT01799941|582619287|FG000|Overall Study|Other|15|||
161335616|NCT02369653|582619288|FG000|Overall Study|Lost to Follow-up|0|||
161335617|NCT02369653|582619289|FG001|Overall Study|Lost to Follow-up|1|||
161335618|NCT02369653|582619288|FG000|Overall Study|Administrative reason by sponsor|0|||
161335619|NCT02369653|582619289|FG001|Overall Study|Administrative reason by sponsor|1|||
161335620|NCT02369653|582619288|FG000|Overall Study|Death|1|||
161335621|NCT02369653|582619289|FG001|Overall Study|Death|2|||
161335622|NCT02369653|582619288|FG000|Overall Study|Participant withdrew consent|13|||
161335623|NCT02369653|582619289|FG001|Overall Study|Participant withdrew consent|3|||
161335624|NCT03587636|582619290|FG000|Overall Study|Lost to Follow-up|2|||
161335625|NCT03587636|582619291|FG001|Overall Study|Lost to Follow-up|5|||
161335626|NCT01458587|582619292|FG000|Overall Study|Withdrawal by Subject|1|||
161335627|NCT01458587|582619293|FG001|Overall Study|Withdrawal by Subject|0|||
161335628|NCT01603602|582619294|FG000|Overall Study|Adverse Event|1|||
161335629|NCT01603602|582619295|FG001|Overall Study|Adverse Event|0|||
161335630|NCT01603602|582619296|FG002|Overall Study|Adverse Event|0|||
161335631|NCT01603602|582619294|FG000|Overall Study|Personal Reasons|1|||
161335632|NCT01603602|582619295|FG001|Overall Study|Personal Reasons|0|||
160992298|NCT00681811|581360015|FG000|Overall Study|Adverse Event|1|||
160992299|NCT00681811|581360016|FG001|Overall Study|Adverse Event|1|||
160992300|NCT00681811|581360015|FG000|Overall Study|Withdrawal by Subject|2|||
160992301|NCT00681811|581360016|FG001|Overall Study|Withdrawal by Subject|2|||
160992302|NCT00681811|581360015|FG000|Overall Study|Non-compliance|0|||
160992303|NCT00681811|581360016|FG001|Overall Study|Non-compliance|1|||
160992304|NCT01140347|581360023|FG000|Overall Study|Lost to Follow-up|5|||
160992305|NCT01140347|581360024|FG001|Overall Study|Lost to Follow-up|6|||
160992306|NCT01140347|581360023|FG000|Overall Study|Withdrawal by Subject|13|||
160992307|NCT01140347|581360024|FG001|Overall Study|Withdrawal by Subject|8|||
160992308|NCT00828919|581360025|FG000|Overall Study|Death|0|||
160992309|NCT00828919|581360026|FG001|Overall Study|Death|1|||
160992310|NCT00828919|581360027|FG002|Overall Study|Death|2|||
160992311|NCT00828919|581360028|FG003|Overall Study|Death|0|||
161252519|NCT01223027|582302475|FG000|Overall Study|Lost to Follow-up|2|||
161252520|NCT01223027|582302476|FG001|Overall Study|Lost to Follow-up|1|||
161252521|NCT01223027|582302475|FG000|Overall Study|Physician Decision|4|||
161252522|NCT01223027|582302476|FG001|Overall Study|Physician Decision|8|||
161252523|NCT01223027|582302475|FG000|Overall Study|Progressive Disease|167|||
161252524|NCT01223027|582302476|FG001|Overall Study|Progressive Disease|183|||
161252525|NCT01223027|582302475|FG000|Overall Study|Protocol Violation|2|||
161252526|NCT01223027|582302476|FG001|Overall Study|Protocol Violation|1|||
161252527|NCT01223027|582302475|FG000|Overall Study|Subject/guardian decicion|18|||
161252528|NCT01223027|582302476|FG001|Overall Study|Subject/guardian decicion|16|||
161252529|NCT01223027|582302475|FG000|Overall Study|New therapy for study indication|17|||
161252530|NCT01223027|582302476|FG001|Overall Study|New therapy for study indication|8|||
161252531|NCT01223027|582302475|FG000|Overall Study|Study terminated by sponsor|2|||
161252532|NCT01223027|582302476|FG001|Overall Study|Study terminated by sponsor|8|||
161252533|NCT03493919|582302477|FG000|Overall Study|Other|2|||
161252534|NCT03493919|582302478|FG001|Overall Study|Other|0|||
161252535|NCT03493919|582302479|FG002|Overall Study|Other|1|||
161252536|NCT03493919|582302480|FG003|Overall Study|Other|0|||
161252537|NCT03493919|582302477|FG000|Overall Study|Withdrawal by Subject|9|||
161252538|NCT03493919|582302478|FG001|Overall Study|Withdrawal by Subject|3|||
161252539|NCT03493919|582302479|FG002|Overall Study|Withdrawal by Subject|1|||
161252540|NCT03493919|582302480|FG003|Overall Study|Withdrawal by Subject|1|||
161252541|NCT03493919|582302477|FG000|Overall Study|Lost to Follow-up|5|||
161252542|NCT03493919|582302478|FG001|Overall Study|Lost to Follow-up|0|||
161252543|NCT03493919|582302479|FG002|Overall Study|Lost to Follow-up|0|||
161252544|NCT03493919|582302480|FG003|Overall Study|Lost to Follow-up|3|||
161252545|NCT03493919|582302477|FG000|Overall Study|Adverse Event|0|||
161252546|NCT03493919|582302478|FG001|Overall Study|Adverse Event|1|||
161252547|NCT03493919|582302479|FG002|Overall Study|Adverse Event|0|||
161252548|NCT03493919|582302480|FG003|Overall Study|Adverse Event|0|||
161252549|NCT01475487|582302481|FG000|Overall Study|had to leave early for personal reasons|2|||
161252550|NCT01475487|582302482|FG001|Overall Study|had to leave early for personal reasons|1|||
161252551|NCT04428645|582302483|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
161252552|NCT00401245|582304372|FG000|Double Blind Titration Phase|Adverse Event|3|||
161252553|NCT00401245|582304373|FG001|Double Blind Titration Phase|Adverse Event|2|||
161252554|NCT00401245|582304374|FG002|Double Blind Titration Phase|Adverse Event|5|||
161252555|NCT00401245|582304375|FG003|Double Blind Titration Phase|Adverse Event|12|||
161252556|NCT00401245|582304376|FG004|Double Blind Titration Phase|Adverse Event|0|||
161252557|NCT00401245|582304377|FG005|Double Blind Titration Phase|Adverse Event|0|||
161252558|NCT00401245|582304378|FG006|Double Blind Titration Phase|Adverse Event|0|||
161252559|NCT00401245|582304379|FG007|Double Blind Titration Phase|Adverse Event|0|||
161252560|NCT00401245|582304372|FG000|Double Blind Titration Phase|Other|0|||
161252561|NCT00401245|582304373|FG001|Double Blind Titration Phase|Other|0|||
161252562|NCT00401245|582304374|FG002|Double Blind Titration Phase|Other|1|||
161252563|NCT00401245|582304375|FG003|Double Blind Titration Phase|Other|0|||
161252564|NCT00401245|582304376|FG004|Double Blind Titration Phase|Other|0|||
161252565|NCT00401245|582304377|FG005|Double Blind Titration Phase|Other|0|||
161252566|NCT00401245|582304378|FG006|Double Blind Titration Phase|Other|0|||
161252567|NCT00401245|582304379|FG007|Double Blind Titration Phase|Other|0|||
161252568|NCT00401245|582304372|FG000|Double Blind Titration Phase|Protocol Violation|0|||
161252569|NCT00401245|582304373|FG001|Double Blind Titration Phase|Protocol Violation|0|||
161252570|NCT00401245|582304374|FG002|Double Blind Titration Phase|Protocol Violation|0|||
161252571|NCT00401245|582304375|FG003|Double Blind Titration Phase|Protocol Violation|1|||
161252572|NCT00401245|582304376|FG004|Double Blind Titration Phase|Protocol Violation|0|||
161252573|NCT00401245|582304377|FG005|Double Blind Titration Phase|Protocol Violation|0|||
161252574|NCT00401245|582304378|FG006|Double Blind Titration Phase|Protocol Violation|0|||
161252575|NCT00401245|582304379|FG007|Double Blind Titration Phase|Protocol Violation|0|||
161252576|NCT00401245|582304372|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
161252577|NCT00401245|582304373|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
161252578|NCT00401245|582304374|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
161252579|NCT00401245|582304375|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
160992312|NCT00828919|581360029|FG004|Overall Study|Death|0|||
161335633|NCT01603602|582619296|FG002|Overall Study|Personal Reasons|1|||
161335634|NCT04748718|582619300|FG000|Overall Study|Lost to Follow-up|50|||
161335635|NCT00316004|582619301|FG000|Overall Study|Subject was not given study fluid.|14|||
161335636|NCT00316004|582619302|FG001|Overall Study|Subject was not given study fluid.|14|||
161335637|NCT00316004|582619303|FG002|Overall Study|Subject was not given study fluid.|21|||
161335638|NCT01118299|582619304|FG000|Overall Study|Death|7|||
161335639|NCT01118299|582619305|FG001|Overall Study|Death|5|||
161335640|NCT01118299|582619304|FG000|Overall Study|Withdrawal by Subject|8|||
161335641|NCT01118299|582619305|FG001|Overall Study|Withdrawal by Subject|8|||
161335642|NCT01118299|582619304|FG000|Overall Study|Lost to Follow-up|2|||
161335643|NCT01118299|582619305|FG001|Overall Study|Lost to Follow-up|1|||
161335644|NCT01118299|582619304|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
161335645|NCT01118299|582619305|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
161335646|NCT02932943|582619306|FG000|Overall Study|Lost to Follow-up|0|||
161335647|NCT02932943|582619307|FG001|Overall Study|Lost to Follow-up|2|||
161335648|NCT02932943|582619306|FG000|Overall Study|Adverse Event|2|||
161335649|NCT02932943|582619307|FG001|Overall Study|Adverse Event|2|||
161335650|NCT02932943|582619306|FG000|Overall Study|Withdrawal by Subject|3|||
161335651|NCT02932943|582619307|FG001|Overall Study|Withdrawal by Subject|3|||
161335652|NCT02665117|582619310|FG000|Overall Study|Physician Decision|1|||
161335653|NCT02665117|582619311|FG001|Overall Study|Physician Decision|0|||
161335654|NCT01483118|582619321|FG000|Overall Study|Lost to Follow-up|12|||
161335655|NCT01483118|582619322|FG001|Overall Study|Lost to Follow-up|16|||
161335656|NCT01079780|582619324|FG000|Overall Study|Disease progression|43|||
161335657|NCT01079780|582619325|FG001|Overall Study|Disease progression|7|||
161335658|NCT01079780|582619326|FG002|Overall Study|Disease progression|31|||
161335659|NCT01079780|582619324|FG000|Overall Study|Adverse Event|13|||
161335660|NCT01079780|582619325|FG001|Overall Study|Adverse Event|5|||
161335661|NCT01079780|582619326|FG002|Overall Study|Adverse Event|7|||
161335662|NCT01079780|582619324|FG000|Overall Study|Death|2|||
161335663|NCT01079780|582619325|FG001|Overall Study|Death|0|||
161335664|NCT01079780|582619326|FG002|Overall Study|Death|2|||
161335665|NCT01079780|582619324|FG000|Overall Study|Withdrawal by Subject|6|||
161335666|NCT01079780|582619325|FG001|Overall Study|Withdrawal by Subject|4|||
161335667|NCT01079780|582619326|FG002|Overall Study|Withdrawal by Subject|4|||
161335668|NCT01079780|582619324|FG000|Overall Study|Alternative therapy|2|||
161335669|NCT01079780|582619325|FG001|Overall Study|Alternative therapy|0|||
161335670|NCT01079780|582619326|FG002|Overall Study|Alternative therapy|2|||
161335671|NCT01079780|582619324|FG000|Overall Study|Physician Decision|1|||
161335672|NCT01079780|582619325|FG001|Overall Study|Physician Decision|0|||
161335673|NCT01079780|582619326|FG002|Overall Study|Physician Decision|1|||
161335674|NCT01079780|582619324|FG000|Overall Study|Error made in lesion measurement|1|||
161335675|NCT01079780|582619325|FG001|Overall Study|Error made in lesion measurement|0|||
161335676|NCT01079780|582619326|FG002|Overall Study|Error made in lesion measurement|0|||
161335677|NCT01079780|582619324|FG000|Overall Study|Patient had surgery|1|||
161335678|NCT01079780|582619325|FG001|Overall Study|Patient had surgery|0|||
161335679|NCT01079780|582619326|FG002|Overall Study|Patient had surgery|0|||
161335680|NCT01079780|582619324|FG000|Overall Study|Treatment cycle delay|0|||
161335681|NCT01079780|582619325|FG001|Overall Study|Treatment cycle delay|0|||
161335682|NCT01079780|582619326|FG002|Overall Study|Treatment cycle delay|1|||
161335683|NCT01079780|582619324|FG000|Overall Study|Never started treatment|1|||
161335684|NCT01079780|582619325|FG001|Overall Study|Never started treatment|0|||
161335685|NCT01079780|582619326|FG002|Overall Study|Never started treatment|2|||
161335686|NCT01178294|582619327|FG000|Overall Study|Adverse Event|4|||
161335687|NCT01178294|582619327|FG000|Overall Study|Lost to Follow-up|2|||
161335688|NCT01178294|582619327|FG000|Overall Study|Lack of Efficacy|1|||
161335689|NCT01178294|582619327|FG000|Overall Study|Death|1|||
161335690|NCT01178294|582619327|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
161335691|NCT01178294|582619327|FG000|Overall Study|Subject status is terminal|1|||
161335692|NCT01178294|582619327|FG000|Overall Study|Completion status could not be verified|1|||
161335693|NCT02783066|582619328|FG000|Overall Study|Withdrawal by Subject|13|||
161335694|NCT00551369|582619329|FG000|Overall Study|Protocol Violation|5|||
161335695|NCT00551369|582619329|FG000|Overall Study|Withdrawal by Subject|1|||
161335696|NCT00551369|582619329|FG000|Overall Study|Not treated per protocol and re|1|||
161335697|NCT05379920|582619332|FG000|Overall Study|Lost to Follow-up|0|||
161335698|NCT05379920|582619333|FG001|Overall Study|Lost to Follow-up|5|||
161335699|NCT05379920|582619334|FG002|Overall Study|Lost to Follow-up|0|||
161335700|NCT05379920|582619335|FG003|Overall Study|Lost to Follow-up|0|||
161335701|NCT03530293|582619338|FG000|Pre-randomization|Adverse Event|12|||
161335702|NCT03530293|582619339|FG001|Pre-randomization|Adverse Event|0|||
161335703|NCT03530293|582619340|FG002|Pre-randomization|Adverse Event|0|||
161335704|NCT03530293|582619338|FG000|Pre-randomization|Protocol Violation|2|||
161335705|NCT03530293|582619339|FG001|Pre-randomization|Protocol Violation|0|||
161335706|NCT03530293|582619340|FG002|Pre-randomization|Protocol Violation|0|||
161335707|NCT03530293|582619338|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
161335708|NCT03530293|582619339|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
161335709|NCT03530293|582619340|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
161335710|NCT03530293|582619338|FG000|Pre-randomization|Withdrawal by Subject|5|||
161140467|NCT02580058|581897720|FG000|Overall Study|Progressive Disease|137|||
161140468|NCT02580058|581897721|FG001|Overall Study|Progressive Disease|125|||
161140469|NCT02580058|581897722|FG002|Overall Study|Progressive Disease|94|||
161140470|NCT02580058|581897720|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161335711|NCT03530293|582619339|FG001|Pre-randomization|Withdrawal by Subject|0|||
161335712|NCT03530293|582619340|FG002|Pre-randomization|Withdrawal by Subject|0|||
161335713|NCT03530293|582619338|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
161335714|NCT03530293|582619339|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
161335715|NCT03530293|582619340|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
160844515|NCT02218008|580818031|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844516|NCT02218008|580818032|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
160844517|NCT02218008|580818027|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
160844518|NCT02218008|580818028|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
160844519|NCT02218008|580818029|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
160844520|NCT02218008|580818030|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
160844521|NCT02218008|580818031|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
160844522|NCT02218008|580818032|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
160844523|NCT00408434|580818033|FG000|Overall Study|Adverse Event|0|||
160844524|NCT00408434|580818034|FG001|Overall Study|Adverse Event|0|||
160844525|NCT00408434|580818035|FG002|Overall Study|Adverse Event|1|||
160844526|NCT00408434|580818036|FG003|Overall Study|Adverse Event|0|||
160844527|NCT00408434|580818037|FG004|Overall Study|Adverse Event|0|||
160905925|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160992313|NCT00828919|581360025|FG000|Overall Study|Adverse Event|2|||
161335716|NCT03530293|582619338|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
161335717|NCT03530293|582619339|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
161335718|NCT03530293|582619340|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
161335719|NCT03530293|582619338|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
161335720|NCT03530293|582619339|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
161335721|NCT03530293|582619340|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
161335722|NCT03530293|582619338|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
161335723|NCT03530293|582619339|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
161335724|NCT03530293|582619340|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
161335725|NCT03530293|582619338|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
161335726|NCT03530293|582619339|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
161335727|NCT03530293|582619340|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
161335728|NCT01663623|582619342|FG000|Overall Study|Adverse Event|3|||
161335729|NCT01663623|582619343|FG001|Overall Study|Adverse Event|7|||
161335730|NCT01663623|582619342|FG000|Overall Study|Lack of Efficacy|5|||
161335731|NCT01663623|582619343|FG001|Overall Study|Lack of Efficacy|6|||
161335732|NCT01663623|582619342|FG000|Overall Study|Protocol Violation|0|||
161335733|NCT01663623|582619343|FG001|Overall Study|Protocol Violation|1|||
161335734|NCT01663623|582619342|FG000|Overall Study|Other-Study closed/terminated|1|||
161335735|NCT01663623|582619343|FG001|Overall Study|Other-Study closed/terminated|1|||
161335736|NCT01663623|582619342|FG000|Overall Study|Physician Decision|1|||
161335737|NCT01663623|582619343|FG001|Overall Study|Physician Decision|4|||
161335738|NCT01663623|582619342|FG000|Overall Study|Withdrawal by Subject|2|||
160844528|NCT00408434|580818038|FG005|Overall Study|Adverse Event|0|||
160844529|NCT00408434|580818039|FG006|Overall Study|Adverse Event|0|||
160844530|NCT00408434|580818033|FG000|Overall Study|Progressive disease|6|||
160844531|NCT00408434|580818034|FG001|Overall Study|Progressive disease|3|||
160844532|NCT00408434|580818035|FG002|Overall Study|Progressive disease|4|||
160844533|NCT00408434|580818036|FG003|Overall Study|Progressive disease|3|||
160844534|NCT00408434|580818037|FG004|Overall Study|Progressive disease|3|||
161140471|NCT02580058|581897721|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161140472|NCT02580058|581897722|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161335739|NCT01663623|582619343|FG001|Overall Study|Withdrawal by Subject|1|||
161335740|NCT01302899|582619344|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
161335741|NCT01302899|582619345|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
161335742|NCT01302899|582619344|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
161335743|NCT01302899|582619345|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
161335744|NCT02834975|582619346|FG000|Overall Study|Physician Decision|2|||
161335745|NCT02834975|582619346|FG000|Overall Study|Adverse Event|1|||
161335746|NCT02834975|582619346|FG000|Overall Study|Withdrawal by Subject|1|||
161335747|NCT02834975|582619346|FG000|Overall Study|Lack of Efficacy|1|||
161335748|NCT02497469|582619348|FG000|Overall Study|Randomized but not Treated|0|||
161335749|NCT02497469|582619349|FG001|Overall Study|Randomized but not Treated|2|||
161335750|NCT02497469|582619348|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
161335751|NCT02497469|582619349|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
161335752|NCT02497469|582619348|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
160844535|NCT00408434|580818038|FG005|Overall Study|Progressive disease|1|||
160844536|NCT00408434|580818039|FG006|Overall Study|Progressive disease|4|||
160844537|NCT00408434|580818033|FG000|Overall Study|Other|0|||
161335753|NCT02497469|582619349|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
161335754|NCT02497469|582619348|FG000|Overall Study|Significant Protocol Deviation|4|||
161335755|NCT02497469|582619349|FG001|Overall Study|Significant Protocol Deviation|5|||
161335756|NCT02497469|582619348|FG000|Overall Study|Lost to Follow-up|14|||
161335757|NCT02497469|582619349|FG001|Overall Study|Lost to Follow-up|4|||
161335758|NCT02497469|582619348|FG000|Overall Study|Voluntary Withdrawal|39|||
161335759|NCT02497469|582619349|FG001|Overall Study|Voluntary Withdrawal|41|||
161335760|NCT02497469|582619348|FG000|Overall Study|Pregnancy|1|||
161335761|NCT02497469|582619349|FG001|Overall Study|Pregnancy|1|||
161335762|NCT02497469|582619348|FG000|Overall Study|Lack of Efficacy|86|||
161335763|NCT02497469|582619349|FG001|Overall Study|Lack of Efficacy|40|||
161335764|NCT02497469|582619348|FG000|Overall Study|Reason not Specified|6|||
161335765|NCT02497469|582619349|FG001|Overall Study|Reason not Specified|6|||
161335766|NCT03558516|582619350|FG000|Overall Study|Protocol Violation|2|||
161335767|NCT03558516|582619351|FG001|Overall Study|Protocol Violation|2|||
160844538|NCT00408434|580818034|FG001|Overall Study|Other|0|||
160844539|NCT00408434|580818035|FG002|Overall Study|Other|1|||
160844540|NCT00408434|580818036|FG003|Overall Study|Other|0|||
160844541|NCT00408434|580818037|FG004|Overall Study|Other|2|||
160844542|NCT00408434|580818038|FG005|Overall Study|Other|1|||
160844543|NCT00408434|580818039|FG006|Overall Study|Other|0|||
160844544|NCT00408434|580818033|FG000|Overall Study|Terminated by Investigator|0|||
160844545|NCT00408434|580818034|FG001|Overall Study|Terminated by Investigator|0|||
160844546|NCT00408434|580818035|FG002|Overall Study|Terminated by Investigator|0|||
160844547|NCT00408434|580818036|FG003|Overall Study|Terminated by Investigator|0|||
160844548|NCT00408434|580818037|FG004|Overall Study|Terminated by Investigator|1|||
160844549|NCT00408434|580818038|FG005|Overall Study|Terminated by Investigator|1|||
160844550|NCT00408434|580818039|FG006|Overall Study|Terminated by Investigator|0|||
160844551|NCT03304873|580818040|FG000|Overall Study|Lost to Follow-up|1|||
160844552|NCT03304873|580818041|FG001|Overall Study|Lost to Follow-up|8|||
160844553|NCT00400569|580818042|FG000|Overall Study|Death|1|||
161140473|NCT04283461|581897723|FG000|Overall Study|Enrolled in separate trial|0|||
160844554|NCT00620113|580818045|FG000|Overall Study|Adverse Event|3|||
161140474|NCT04283461|581897724|FG001|Overall Study|Enrolled in separate trial|0|||
161140475|NCT04283461|581897725|FG002|Overall Study|Enrolled in separate trial|8|||
161140476|NCT04283461|581897726|FG003|Overall Study|Enrolled in separate trial|13|||
161140477|NCT04283461|581897727|FG004|Overall Study|Enrolled in separate trial|12|||
161140478|NCT04283461|581897728|FG005|Overall Study|Enrolled in separate trial|0|||
161140479|NCT04283461|581897729|FG006|Overall Study|Enrolled in separate trial|0|||
161140480|NCT04283461|581897730|FG007|Overall Study|Enrolled in separate trial|8|||
161140481|NCT04283461|581897731|FG008|Overall Study|Enrolled in separate trial|0|||
161140482|NCT04283461|581897732|FG009|Overall Study|Enrolled in separate trial|0|||
161140483|NCT04283461|581897733|FG010|Overall Study|Enrolled in separate trial|0|||
161140484|NCT04283461|581897734|FG011|Overall Study|Enrolled in separate trial|7|||
161140485|NCT04283461|581897735|FG012|Overall Study|Enrolled in separate trial|0|||
161140486|NCT05490771|581897736|FG000|Overall Study|Disease progression|18|||
161140487|NCT05490771|581897736|FG000|Overall Study|Adverse Event|3|||
161140488|NCT05490771|581897736|FG000|Overall Study|Other complicating disease|1|||
161140489|NCT05490771|581897736|FG000|Overall Study|Withdrawal by Subject|3|||
161140490|NCT05490771|581897736|FG000|Overall Study|Physician Decision|1|||
161140491|NCT05490771|581897736|FG000|Overall Study|Still on treatment|2|||
161140492|NCT05490771|581897736|FG000|Overall Study|Never start protocol therapy|5|||
161140493|NCT05490771|581897736|FG000|Overall Study|Ineligible|2|||
161140494|NCT03022461|581897740|FG000|Overall Study|Death|3|||
161140495|NCT01982630|581897741|FG000|Overall Study|Adverse Event|2|||
161140496|NCT01982630|581897742|FG001|Overall Study|Adverse Event|0|||
161140497|NCT01982630|581897743|FG002|Overall Study|Adverse Event|1|||
161140498|NCT01982630|581897744|FG003|Overall Study|Adverse Event|0|||
161140499|NCT01982630|581897745|FG004|Overall Study|Adverse Event|1|||
161140500|NCT01982630|581897746|FG005|Overall Study|Adverse Event|2|||
161140501|NCT01982630|581897747|FG006|Overall Study|Adverse Event|1|||
161140502|NCT01982630|581897748|FG007|Overall Study|Adverse Event|0|||
161140503|NCT01982630|581897741|FG000|Overall Study|Physician Decision|1|||
161140504|NCT01982630|581897742|FG001|Overall Study|Physician Decision|0|||
161140505|NCT01982630|581897743|FG002|Overall Study|Physician Decision|2|||
161140506|NCT01982630|581897744|FG003|Overall Study|Physician Decision|1|||
161140507|NCT01982630|581897745|FG004|Overall Study|Physician Decision|2|||
161140508|NCT01982630|581897746|FG005|Overall Study|Physician Decision|0|||
161140509|NCT01982630|581897747|FG006|Overall Study|Physician Decision|0|||
161140510|NCT01982630|581897748|FG007|Overall Study|Physician Decision|0|||
161140511|NCT01982630|581897741|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161140512|NCT01982630|581897742|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161140513|NCT01982630|581897743|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
161140514|NCT01982630|581897744|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161140515|NCT01982630|581897745|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161140516|NCT01982630|581897746|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161335768|NCT02714153|582619352|FG000|Overall Study|Death|1|||
161335769|NCT02737722|582619353|FG000|Overall Study|Physician Decision|0|||
161335770|NCT02737722|582619354|FG001|Overall Study|Physician Decision|0|||
161335771|NCT02737722|582619355|FG002|Overall Study|Physician Decision|1|||
161335772|NCT02737722|582619356|FG003|Overall Study|Physician Decision|0|||
161335773|NCT01603277|582619359|FG000|Overall Study|Adverse Event|1|||
161335774|NCT01603277|582619360|FG001|Overall Study|Adverse Event|2|||
161335775|NCT01603277|582619359|FG000|Overall Study|Physician Decision|0|||
161335776|NCT01603277|582619360|FG001|Overall Study|Physician Decision|1|||
161335777|NCT01603277|582619359|FG000|Overall Study|Protocol Violation|6|||
161335778|NCT01603277|582619360|FG001|Overall Study|Protocol Violation|10|||
161335779|NCT01603277|582619359|FG000|Overall Study|Withdrawal by Subject|5|||
161335780|NCT01603277|582619360|FG001|Overall Study|Withdrawal by Subject|4|||
161335781|NCT01603277|582619359|FG000|Overall Study|Non-Compliance|2|||
161335782|NCT01603277|582619360|FG001|Overall Study|Non-Compliance|1|||
161335783|NCT02785939|582619366|FG000|Overall Study|Progression|25|||
161335784|NCT02785939|582619367|FG001|Overall Study|Progression|8|||
161335785|NCT02785939|582619366|FG000|Overall Study|Adverse Event|3|||
161335786|NCT02785939|582619367|FG001|Overall Study|Adverse Event|1|||
161335787|NCT02785939|582619366|FG000|Overall Study|Death|1|||
161335788|NCT02785939|582619367|FG001|Overall Study|Death|0|||
161335789|NCT02785939|582619366|FG000|Overall Study|Refusal|1|||
161335790|NCT02785939|582619367|FG001|Overall Study|Refusal|0|||
161335791|NCT02785939|582619366|FG000|Overall Study|Deteriorating health|1|||
161335792|NCT02785939|582619367|FG001|Overall Study|Deteriorating health|0|||
161335793|NCT02785939|582619366|FG000|Overall Study|Not protocol specified|0|||
161335794|NCT02785939|582619367|FG001|Overall Study|Not protocol specified|1|||
161335795|NCT04465422|582619368|FG000|Overall Study|Lost to Follow-up|0|||
161335796|NCT04465422|582619369|FG001|Overall Study|Lost to Follow-up|2|||
161335797|NCT01787552|582619370|FG000|Overall Study|Withdrawal by Subject|2|||
161335798|NCT01787552|582619371|FG001|Overall Study|Withdrawal by Subject|0|||
161335799|NCT01787552|582619372|FG002|Overall Study|Withdrawal by Subject|0|||
161335800|NCT01787552|582619373|FG003|Overall Study|Withdrawal by Subject|4|||
161335801|NCT01787552|582619370|FG000|Overall Study|Physician Decision|2|||
161335802|NCT01787552|582619371|FG001|Overall Study|Physician Decision|2|||
161335803|NCT01787552|582619372|FG002|Overall Study|Physician Decision|1|||
161335804|NCT01787552|582619373|FG003|Overall Study|Physician Decision|2|||
161335805|NCT01787552|582619370|FG000|Overall Study|Death|0|||
161335806|NCT01787552|582619371|FG001|Overall Study|Death|0|||
161335807|NCT01787552|582619372|FG002|Overall Study|Death|0|||
161335808|NCT01787552|582619373|FG003|Overall Study|Death|1|||
161335809|NCT01787552|582619370|FG000|Overall Study|Adverse Event|2|||
161335810|NCT01787552|582619371|FG001|Overall Study|Adverse Event|5|||
161335811|NCT01787552|582619372|FG002|Overall Study|Adverse Event|2|||
161335812|NCT01787552|582619373|FG003|Overall Study|Adverse Event|16|||
161335813|NCT01787552|582619370|FG000|Overall Study|Study terminated by Sponsor|0|||
161335814|NCT01787552|582619371|FG001|Overall Study|Study terminated by Sponsor|0|||
161335815|NCT01787552|582619372|FG002|Overall Study|Study terminated by Sponsor|1|||
160844555|NCT00620113|580818046|FG001|Overall Study|Adverse Event|2|||
160844556|NCT00620113|580818047|FG002|Overall Study|Adverse Event|2|||
161140517|NCT01982630|581897747|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161140518|NCT01982630|581897748|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
161335816|NCT01787552|582619373|FG003|Overall Study|Study terminated by Sponsor|3|||
161335817|NCT01787552|582619370|FG000|Overall Study|Progressive Disease|2|||
161335818|NCT01787552|582619371|FG001|Overall Study|Progressive Disease|2|||
161335819|NCT01787552|582619372|FG002|Overall Study|Progressive Disease|1|||
161335820|NCT01787552|582619373|FG003|Overall Study|Progressive Disease|1|||
161335821|NCT01604785|582619378|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
161335822|NCT01604785|582619379|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
160844557|NCT00620113|580818048|FG003|Overall Study|Adverse Event|1|||
161335823|NCT00931632|582619382|FG000|Overall Study|Withdrawal by Subject|2|||
161335824|NCT00931632|582619383|FG001|Overall Study|Withdrawal by Subject|3|||
161335825|NCT00931632|582619382|FG000|Overall Study|Adverse Event|19|||
161335826|NCT00931632|582619383|FG001|Overall Study|Adverse Event|15|||
161335827|NCT01419314|582619384|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
161335828|NCT01419314|582619385|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
161335829|NCT01419314|582619384|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
161335830|NCT01419314|582619385|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
161335831|NCT01419314|582619384|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
160844558|NCT00620113|580818045|FG000|Overall Study|Lack of Efficacy|2|||
160844559|NCT00620113|580818046|FG001|Overall Study|Lack of Efficacy|3|||
160844560|NCT00620113|580818047|FG002|Overall Study|Lack of Efficacy|0|||
160844561|NCT00620113|580818048|FG003|Overall Study|Lack of Efficacy|2|||
160844562|NCT00620113|580818045|FG000|Overall Study|Physician Decision|1|||
160844563|NCT00620113|580818046|FG001|Overall Study|Physician Decision|0|||
160844564|NCT00620113|580818047|FG002|Overall Study|Physician Decision|0|||
160844565|NCT00620113|580818048|FG003|Overall Study|Physician Decision|2|||
160844566|NCT00620113|580818045|FG000|Overall Study|Protocol Violation|2|||
161140519|NCT01982630|581897741|FG000|Overall Study|Withdrawal by Subject|0|||
161140520|NCT01982630|581897742|FG001|Overall Study|Withdrawal by Subject|0|||
161140521|NCT01982630|581897743|FG002|Overall Study|Withdrawal by Subject|0|||
161140522|NCT01982630|581897744|FG003|Overall Study|Withdrawal by Subject|0|||
161140523|NCT01982630|581897745|FG004|Overall Study|Withdrawal by Subject|0|||
161140524|NCT01982630|581897746|FG005|Overall Study|Withdrawal by Subject|1|||
161140525|NCT01982630|581897747|FG006|Overall Study|Withdrawal by Subject|0|||
161140526|NCT01982630|581897748|FG007|Overall Study|Withdrawal by Subject|0|||
161140527|NCT00561353|581897749|FG000|Overall Study|Subject reached a virologic endpoint|2|||
161140528|NCT00561353|581897750|FG001|Overall Study|Subject reached a virologic endpoint|1|||
161140529|NCT00561353|581897751|FG002|Overall Study|Subject reached a virologic endpoint|1|||
161140530|NCT00561353|581897752|FG003|Overall Study|Subject reached a virologic endpoint|4|||
161140531|NCT00561353|581897753|FG004|Overall Study|Subject reached a virologic endpoint|1|||
161140532|NCT00561353|581897754|FG005|Overall Study|Subject reached a virologic endpoint|3|||
161140533|NCT00561353|581897755|FG006|Overall Study|Subject reached a virologic endpoint|4|||
161140534|NCT00561353|581897756|FG007|Overall Study|Subject reached a virologic endpoint|4|||
161140535|NCT00561353|581897757|FG008|Overall Study|Subject reached a virologic endpoint|5|||
161140536|NCT00561353|581897758|FG009|Overall Study|Subject reached a virologic endpoint|0|||
161140537|NCT00561353|581897749|FG000|Overall Study|Subject ineligible to continue the trial|0|||
161140538|NCT00561353|581897750|FG001|Overall Study|Subject ineligible to continue the trial|0|||
161140539|NCT00561353|581897751|FG002|Overall Study|Subject ineligible to continue the trial|0|||
161140540|NCT00561353|581897752|FG003|Overall Study|Subject ineligible to continue the trial|0|||
161140541|NCT00561353|581897753|FG004|Overall Study|Subject ineligible to continue the trial|0|||
161140542|NCT00561353|581897754|FG005|Overall Study|Subject ineligible to continue the trial|1|||
161335832|NCT01419314|582619385|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
161335833|NCT01118052|582619390|FG000|Overall Study|Never treated|2|||
161335834|NCT00843492|582619391|FG000|Overall Study|Adverse Event|0|||
161140543|NCT00561353|581897755|FG006|Overall Study|Subject ineligible to continue the trial|1|||
161140544|NCT00561353|581897756|FG007|Overall Study|Subject ineligible to continue the trial|0|||
161140545|NCT00561353|581897757|FG008|Overall Study|Subject ineligible to continue the trial|2|||
161140546|NCT00561353|581897758|FG009|Overall Study|Subject ineligible to continue the trial|1|||
161335835|NCT00843492|582619392|FG001|Overall Study|Adverse Event|3|||
161335836|NCT00843492|582619391|FG000|Overall Study|Lost to Follow-up|4|||
161335837|NCT00843492|582619392|FG001|Overall Study|Lost to Follow-up|4|||
161335838|NCT00843492|582619391|FG000|Overall Study|Withdrawal by Subject|0|||
161335839|NCT00843492|582619392|FG001|Overall Study|Withdrawal by Subject|4|||
161335840|NCT00843492|582619391|FG000|Overall Study|Immobilization Stopped|1|||
161335841|NCT00843492|582619392|FG001|Overall Study|Immobilization Stopped|0|||
161335842|NCT00843492|582619391|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
161335843|NCT00843492|582619392|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
161335844|NCT00843492|582619391|FG000|Overall Study|Orthopedic Surgery|0|||
161335845|NCT00843492|582619392|FG001|Overall Study|Orthopedic Surgery|2|||
161335846|NCT00843492|582619391|FG000|Overall Study|Visit Not Performed|1|||
161335847|NCT00843492|582619392|FG001|Overall Study|Visit Not Performed|0|||
161335848|NCT00843492|582619391|FG000|Overall Study|Deep-vein Thrombosis|1|||
161335849|NCT00843492|582619392|FG001|Overall Study|Deep-vein Thrombosis|0|||
161335850|NCT01677741|582619393|FG000|Overall Study|Death|0|||
161335851|NCT01677741|582619394|FG001|Overall Study|Death|0|||
161335852|NCT01677741|582619395|FG002|Overall Study|Death|0|||
161335853|NCT01677741|582619396|FG003|Overall Study|Death|1|||
161335854|NCT01677741|582619397|FG004|Overall Study|Death|0|||
161335855|NCT01677741|582619398|FG005|Overall Study|Death|1|||
161335856|NCT01677741|582619399|FG006|Overall Study|Death|0|||
161335857|NCT01677741|582619400|FG007|Overall Study|Death|0|||
161335858|NCT01677741|582619393|FG000|Overall Study|Withdrawal by Subject|2|||
161335859|NCT01677741|582619394|FG001|Overall Study|Withdrawal by Subject|7|||
160992314|NCT00828919|581360026|FG001|Overall Study|Adverse Event|2|||
161140547|NCT00561353|581897749|FG000|Overall Study|Other|1|||
161140548|NCT00561353|581897750|FG001|Overall Study|Other|0|||
161140549|NCT00561353|581897751|FG002|Overall Study|Other|1|||
161140550|NCT00561353|581897752|FG003|Overall Study|Other|0|||
161335860|NCT01677741|582619395|FG002|Overall Study|Withdrawal by Subject|5|||
161335861|NCT01677741|582619396|FG003|Overall Study|Withdrawal by Subject|4|||
161140551|NCT00561353|581897753|FG004|Overall Study|Other|0|||
161335862|NCT01677741|582619397|FG004|Overall Study|Withdrawal by Subject|11|||
161335863|NCT01677741|582619398|FG005|Overall Study|Withdrawal by Subject|20|||
160992315|NCT00828919|581360027|FG002|Overall Study|Adverse Event|2|||
161335864|NCT01677741|582619399|FG006|Overall Study|Withdrawal by Subject|4|||
161335865|NCT01677741|582619400|FG007|Overall Study|Withdrawal by Subject|2|||
161335866|NCT01677741|582619393|FG000|Overall Study|Enrolled in a rollover study|0|||
161335867|NCT01677741|582619394|FG001|Overall Study|Enrolled in a rollover study|3|||
161335868|NCT01677741|582619395|FG002|Overall Study|Enrolled in a rollover study|2|||
161335869|NCT01677741|582619396|FG003|Overall Study|Enrolled in a rollover study|1|||
161335870|NCT01677741|582619397|FG004|Overall Study|Enrolled in a rollover study|6|||
161140552|NCT00561353|581897754|FG005|Overall Study|Other|2|||
161335871|NCT01677741|582619398|FG005|Overall Study|Enrolled in a rollover study|6|||
161335872|NCT01677741|582619399|FG006|Overall Study|Enrolled in a rollover study|7|||
161335873|NCT01677741|582619400|FG007|Overall Study|Enrolled in a rollover study|0|||
161335874|NCT01677741|582619393|FG000|Overall Study|Progressive disease|1|||
161335875|NCT01677741|582619394|FG001|Overall Study|Progressive disease|0|||
161335876|NCT01677741|582619395|FG002|Overall Study|Progressive disease|1|||
161335877|NCT01677741|582619396|FG003|Overall Study|Progressive disease|0|||
161335878|NCT01677741|582619397|FG004|Overall Study|Progressive disease|0|||
161335879|NCT01677741|582619398|FG005|Overall Study|Progressive disease|1|||
161335880|NCT01677741|582619399|FG006|Overall Study|Progressive disease|0|||
161335881|NCT01677741|582619400|FG007|Overall Study|Progressive disease|0|||
161335882|NCT00721799|582619403|FG000|Overall Study|Withdrawal by Subject|7|||
161335883|NCT00721799|582619403|FG000|Overall Study|withdraw by subject after scan 1|1|||
161335884|NCT01441973|582619404|FG000|Overall Study|Disease progression|8|||
161335885|NCT01441973|582619405|FG001|Overall Study|Disease progression|6|||
161335886|NCT01441973|582619404|FG000|Overall Study|Adverse event unrelated to study drug|3|||
161335887|NCT01441973|582619405|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161335888|NCT01441973|582619404|FG000|Overall Study|Participant request to discontinue|1|||
161335889|NCT01441973|582619405|FG001|Overall Study|Participant request to discontinue|1|||
161335890|NCT01441973|582619404|FG000|Overall Study|Poor compliance/noncompliance|0|||
161335891|NCT01441973|582619405|FG001|Overall Study|Poor compliance/noncompliance|1|||
161335892|NCT01441973|582619404|FG000|Overall Study|Administrative reason by sponsor|3|||
161335893|NCT01441973|582619405|FG001|Overall Study|Administrative reason by sponsor|5|||
161335894|NCT01441973|582619404|FG000|Overall Study|Participant withdrew consent|0|||
161335895|NCT01441973|582619405|FG001|Overall Study|Participant withdrew consent|1|||
161335896|NCT00750269|582621566|FG000|Overall Study|Protocol Violation|0|||
161335897|NCT00750269|582621567|FG001|Overall Study|Protocol Violation|1|||
161335898|NCT00750269|582621568|FG002|Overall Study|Protocol Violation|1|||
161335899|NCT00750269|582621569|FG003|Overall Study|Protocol Violation|2|||
161335900|NCT00750269|582621570|FG004|Overall Study|Protocol Violation|4|||
161335901|NCT00750269|582621566|FG000|Overall Study|Withdrawal by Subject|0|||
161335902|NCT00750269|582621567|FG001|Overall Study|Withdrawal by Subject|0|||
161335903|NCT00750269|582621568|FG002|Overall Study|Withdrawal by Subject|2|||
161335904|NCT00750269|582621569|FG003|Overall Study|Withdrawal by Subject|2|||
161335905|NCT00750269|582621570|FG004|Overall Study|Withdrawal by Subject|2|||
161335906|NCT00750269|582621566|FG000|Overall Study|Physician Decision|0|||
161335907|NCT00750269|582621567|FG001|Overall Study|Physician Decision|0|||
161335908|NCT00750269|582621568|FG002|Overall Study|Physician Decision|0|||
161335909|NCT00750269|582621569|FG003|Overall Study|Physician Decision|0|||
161335910|NCT00750269|582621570|FG004|Overall Study|Physician Decision|2|||
161335911|NCT00750269|582621566|FG000|Overall Study|Patient too large for positioning|0|||
161335912|NCT00750269|582621567|FG001|Overall Study|Patient too large for positioning|0|||
161335913|NCT00750269|582621568|FG002|Overall Study|Patient too large for positioning|1|||
161335914|NCT00750269|582621569|FG003|Overall Study|Patient too large for positioning|0|||
161335915|NCT00750269|582621570|FG004|Overall Study|Patient too large for positioning|0|||
161335916|NCT00750269|582621566|FG000|Overall Study|Site error|0|||
161335917|NCT00750269|582621567|FG001|Overall Study|Site error|0|||
161335918|NCT00750269|582621568|FG002|Overall Study|Site error|0|||
161335919|NCT00750269|582621569|FG003|Overall Study|Site error|1|||
161335920|NCT00750269|582621570|FG004|Overall Study|Site error|0|||
161335921|NCT00750269|582621566|FG000|Overall Study|SBRT plan could not be drawn|0|||
161335922|NCT00750269|582621567|FG001|Overall Study|SBRT plan could not be drawn|0|||
161335923|NCT00750269|582621568|FG002|Overall Study|SBRT plan could not be drawn|0|||
161335924|NCT00750269|582621569|FG003|Overall Study|SBRT plan could not be drawn|0|||
161335925|NCT00750269|582621570|FG004|Overall Study|SBRT plan could not be drawn|1|||
161335926|NCT00750269|582621566|FG000|Overall Study|Fiducials could not be placed|0|||
161335927|NCT00750269|582621567|FG001|Overall Study|Fiducials could not be placed|0|||
161335928|NCT00750269|582621568|FG002|Overall Study|Fiducials could not be placed|0|||
161335929|NCT00750269|582621569|FG003|Overall Study|Fiducials could not be placed|0|||
161335930|NCT00750269|582621570|FG004|Overall Study|Fiducials could not be placed|1|||
160905926|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
161140553|NCT00561353|581897755|FG006|Overall Study|Other|0|||
161140554|NCT00561353|581897756|FG007|Overall Study|Other|0|||
161140555|NCT00561353|581897757|FG008|Overall Study|Other|0|||
161140556|NCT00561353|581897758|FG009|Overall Study|Other|0|||
161140557|NCT00561353|581897749|FG000|Overall Study|Adverse Event|0|||
161140558|NCT00561353|581897750|FG001|Overall Study|Adverse Event|0|||
161140559|NCT00561353|581897751|FG002|Overall Study|Adverse Event|0|||
161140560|NCT00561353|581897752|FG003|Overall Study|Adverse Event|2|||
161140561|NCT00561353|581897753|FG004|Overall Study|Adverse Event|0|||
161140562|NCT00561353|581897754|FG005|Overall Study|Adverse Event|0|||
161140563|NCT00561353|581897755|FG006|Overall Study|Adverse Event|1|||
161140564|NCT00561353|581897756|FG007|Overall Study|Adverse Event|0|||
161140565|NCT00561353|581897757|FG008|Overall Study|Adverse Event|0|||
161140566|NCT00561353|581897758|FG009|Overall Study|Adverse Event|1|||
161335931|NCT01898078|582621571|FG000|Overall Study|Progressive Disease|1|||
161335932|NCT01898078|582621572|FG001|Overall Study|Progressive Disease|5|||
161335933|NCT01898078|582621571|FG000|Overall Study|Adverse Event|2|||
161335934|NCT01898078|582621572|FG001|Overall Study|Adverse Event|1|||
161335935|NCT01898078|582621571|FG000|Overall Study|Withdrawal by Subject|1|||
161335936|NCT01898078|582621572|FG001|Overall Study|Withdrawal by Subject|1|||
161335937|NCT01898078|582621571|FG000|Overall Study|Symptomatic Deterioration|2|||
161335938|NCT01898078|582621572|FG001|Overall Study|Symptomatic Deterioration|0|||
161335939|NCT01898078|582621571|FG000|Overall Study|Reason not Specified|0|||
161335940|NCT01898078|582621572|FG001|Overall Study|Reason not Specified|1|||
161335941|NCT03630393|582621579|FG000|Overall Study|Death|1|||
161335942|NCT03630393|582621580|FG001|Overall Study|Death|0|||
161335943|NCT00900562|582621589|FG000|Overall Study|Progressive disease|9|||
161335944|NCT00900562|582621590|FG001|Overall Study|Progressive disease|5|||
161335945|NCT00900562|582621589|FG000|Overall Study|Toxicity|1|||
161335946|NCT00900562|582621590|FG001|Overall Study|Toxicity|0|||
161335947|NCT00900562|582621589|FG000|Overall Study|Death|1|||
161335948|NCT00900562|582621590|FG001|Overall Study|Death|1|||
161335949|NCT00900562|582621589|FG000|Overall Study|Withdrawal by Subject|0|||
161335950|NCT00900562|582621590|FG001|Overall Study|Withdrawal by Subject|1|||
161335951|NCT00900562|582621589|FG000|Overall Study|Unrelated adverse event|1|||
161335952|NCT00900562|582621590|FG001|Overall Study|Unrelated adverse event|0|||
161335953|NCT02251275|582621593|FG000|Overall Study|Adverse Event|23|||
161335954|NCT02251275|582621594|FG001|Overall Study|Adverse Event|60|||
161335955|NCT02251275|582621595|FG002|Overall Study|Adverse Event|28|||
160844567|NCT00620113|580818046|FG001|Overall Study|Protocol Violation|1|||
160844568|NCT00620113|580818047|FG002|Overall Study|Protocol Violation|0|||
160844569|NCT00620113|580818048|FG003|Overall Study|Protocol Violation|0|||
160844570|NCT00620113|580818045|FG000|Overall Study|Withdrawal by Subject|5|||
160844571|NCT00620113|580818046|FG001|Overall Study|Withdrawal by Subject|1|||
160844572|NCT00620113|580818047|FG002|Overall Study|Withdrawal by Subject|3|||
160844573|NCT00620113|580818048|FG003|Overall Study|Withdrawal by Subject|5|||
160844574|NCT00042991|580818051|FG000|Overall Study|Adverse Event|1|||
160844575|NCT00042991|580818052|FG001|Overall Study|Adverse Event|4|||
160844576|NCT00042991|580818053|FG002|Overall Study|Adverse Event|2|||
160844577|NCT00042991|580818054|FG003|Overall Study|Adverse Event|0|||
160844578|NCT00042991|580818055|FG004|Overall Study|Adverse Event|0|||
160844579|NCT00042991|580818056|FG005|Overall Study|Adverse Event|1|||
160844580|NCT00042991|580818057|FG006|Overall Study|Adverse Event|0|||
160844581|NCT00042991|580818051|FG000|Overall Study|Withdrawal by Subject|0|||
160844582|NCT00042991|580818052|FG001|Overall Study|Withdrawal by Subject|7|||
160844583|NCT00042991|580818053|FG002|Overall Study|Withdrawal by Subject|2|||
160844584|NCT00042991|580818054|FG003|Overall Study|Withdrawal by Subject|0|||
160844585|NCT00042991|580818055|FG004|Overall Study|Withdrawal by Subject|1|||
160844586|NCT00042991|580818056|FG005|Overall Study|Withdrawal by Subject|0|||
160844587|NCT00042991|580818057|FG006|Overall Study|Withdrawal by Subject|0|||
160844588|NCT00042991|580818051|FG000|Overall Study|Disease Progression|5|||
160844589|NCT00042991|580818052|FG001|Overall Study|Disease Progression|29|||
160844590|NCT00042991|580818053|FG002|Overall Study|Disease Progression|2|||
160844591|NCT00042991|580818054|FG003|Overall Study|Disease Progression|2|||
160844592|NCT00042991|580818055|FG004|Overall Study|Disease Progression|1|||
160844593|NCT00042991|580818056|FG005|Overall Study|Disease Progression|4|||
161335956|NCT02251275|582621596|FG003|Overall Study|Adverse Event|0|||
161335957|NCT02251275|582621597|FG004|Overall Study|Adverse Event|0|||
161335958|NCT02251275|582621593|FG000|Overall Study|Lost to Follow-up|5|||
161335959|NCT02251275|582621594|FG001|Overall Study|Lost to Follow-up|6|||
161335960|NCT02251275|582621595|FG002|Overall Study|Lost to Follow-up|4|||
161335961|NCT02251275|582621596|FG003|Overall Study|Lost to Follow-up|0|||
161335962|NCT02251275|582621597|FG004|Overall Study|Lost to Follow-up|0|||
161335963|NCT02251275|582621593|FG000|Overall Study|Physician Decision|19|||
161335964|NCT02251275|582621594|FG001|Overall Study|Physician Decision|30|||
161335965|NCT02251275|582621595|FG002|Overall Study|Physician Decision|26|||
161335966|NCT02251275|582621596|FG003|Overall Study|Physician Decision|0|||
161335967|NCT02251275|582621597|FG004|Overall Study|Physician Decision|1|||
161335968|NCT02251275|582621593|FG000|Overall Study|Protocol Deviation|0|||
161335969|NCT02251275|582621594|FG001|Overall Study|Protocol Deviation|0|||
161335970|NCT02251275|582621595|FG002|Overall Study|Protocol Deviation|1|||
161335971|NCT02251275|582621596|FG003|Overall Study|Protocol Deviation|0|||
161335972|NCT02251275|582621597|FG004|Overall Study|Protocol Deviation|0|||
161335973|NCT02251275|582621593|FG000|Overall Study|Withdrawal by Subject|25|||
161335974|NCT02251275|582621594|FG001|Overall Study|Withdrawal by Subject|51|||
161335975|NCT02251275|582621595|FG002|Overall Study|Withdrawal by Subject|35|||
161335976|NCT02251275|582621596|FG003|Overall Study|Withdrawal by Subject|1|||
161335977|NCT02251275|582621597|FG004|Overall Study|Withdrawal by Subject|0|||
161335978|NCT01004614|582621601|FG000|Washout|Withdrawal by Subject|0|||
161335979|NCT01004614|582621602|FG001|Washout|Withdrawal by Subject|1|||
161335980|NCT01004614|582621603|FG002|Washout|Withdrawal by Subject|0|||
161335981|NCT01004614|582621604|FG003|Washout|Withdrawal by Subject|0|||
161335982|NCT01569022|582621606|FG000|First Intervention|Lost to Follow-up|2|||
161335983|NCT01569022|582621607|FG001|First Intervention|Lost to Follow-up|1|||
161335984|NCT01569022|582621606|FG000|Second Intervention|Lost to Follow-up|2|||
161335985|NCT01569022|582621607|FG001|Second Intervention|Lost to Follow-up|2|||
161335986|NCT02111083|582621612|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
161335987|NCT02111083|582621613|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
161335988|NCT00644059|582621614|FG000|Overall Study|Lost to Follow-up|37|||
161335989|NCT00644059|582621615|FG001|Overall Study|Lost to Follow-up|34|||
161335990|NCT00644059|582621616|FG002|Overall Study|Lost to Follow-up|16|||
161335991|NCT00644059|582621614|FG000|Overall Study|Withdrawal by Subject|52|||
161335992|NCT00644059|582621615|FG001|Overall Study|Withdrawal by Subject|60|||
161335993|NCT00644059|582621616|FG002|Overall Study|Withdrawal by Subject|30|||
161335994|NCT00644059|582621614|FG000|Overall Study|Adverse Event|8|||
161335995|NCT00644059|582621615|FG001|Overall Study|Adverse Event|5|||
161335996|NCT00644059|582621616|FG002|Overall Study|Adverse Event|1|||
161335997|NCT00644059|582621614|FG000|Overall Study|Inappropriate Enrollment|1|||
161335998|NCT00644059|582621615|FG001|Overall Study|Inappropriate Enrollment|3|||
161335999|NCT00644059|582621616|FG002|Overall Study|Inappropriate Enrollment|0|||
161336000|NCT00644059|582621614|FG000|Overall Study|Protocol Deviation/violation|20|||
161336001|NCT00644059|582621615|FG001|Overall Study|Protocol Deviation/violation|19|||
161336002|NCT00644059|582621616|FG002|Overall Study|Protocol Deviation/violation|15|||
161336003|NCT00644059|582621614|FG000|Overall Study|Unable to classify|6|||
161336004|NCT00644059|582621615|FG001|Overall Study|Unable to classify|2|||
161336005|NCT00644059|582621616|FG002|Overall Study|Unable to classify|3|||
161336006|NCT02133508|582621617|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
161336007|NCT02133508|582621617|FG000|Overall Study|Death|12|||
161336008|NCT02133508|582621617|FG000|Overall Study|Lost to Follow-up|2|||
161336009|NCT02152007|582621618|FG000|Overall Study|Withdrawal by Subject|1|||
161336010|NCT03363906|582621627|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
161336011|NCT03363906|582621628|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
161336012|NCT03363906|582621627|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
161336013|NCT03363906|582621628|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
161336014|NCT03363906|582621627|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
161336015|NCT03363906|582621628|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
161336016|NCT03363906|582621627|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
161336017|NCT03363906|582621628|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
161336018|NCT00676143|582621629|FG000|Overall Study|Adverse Event|34|||
161336019|NCT00676143|582621630|FG001|Overall Study|Adverse Event|60|||
161336020|NCT00676143|582621629|FG000|Overall Study|Death|4|||
161336021|NCT00676143|582621630|FG001|Overall Study|Death|4|||
161336022|NCT00676143|582621629|FG000|Overall Study|Lack of Efficacy|0|||
161336023|NCT00676143|582621630|FG001|Overall Study|Lack of Efficacy|6|||
161336024|NCT00676143|582621629|FG000|Overall Study|Lost to Follow-up|0|||
161336025|NCT00676143|582621630|FG001|Overall Study|Lost to Follow-up|13|||
161336026|NCT00676143|582621629|FG000|Overall Study|Physician Decision|5|||
161336027|NCT00676143|582621630|FG001|Overall Study|Physician Decision|8|||
161336028|NCT00676143|582621629|FG000|Overall Study|Protocol Violation|4|||
161336029|NCT00676143|582621630|FG001|Overall Study|Protocol Violation|8|||
161336030|NCT00676143|582621629|FG000|Overall Study|Withdrawal by Subject|24|||
161336031|NCT00676143|582621630|FG001|Overall Study|Withdrawal by Subject|42|||
161336032|NCT00676143|582621629|FG000|Overall Study|Discontinuation of study by sponsor|65|||
161336033|NCT00676143|582621630|FG001|Overall Study|Discontinuation of study by sponsor|88|||
161336034|NCT00676143|582621629|FG000|Overall Study|Failed to return|2|||
161336035|NCT00676143|582621630|FG001|Overall Study|Failed to return|1|||
161336036|NCT00676143|582621629|FG000|Overall Study|Loss of caregiver|5|||
161336037|NCT00676143|582621630|FG001|Overall Study|Loss of caregiver|3|||
161336038|NCT00676143|582621629|FG000|Overall Study|Other|11|||
161336039|NCT00676143|582621630|FG001|Overall Study|Other|20|||
161336040|NCT00676143|582621629|FG000|Overall Study|Participant participation unknown|1|||
161336041|NCT00676143|582621630|FG001|Overall Study|Participant participation unknown|4|||
161336042|NCT00676143|582621629|FG000|Overall Study|Vasogenic edema recurrence|1|||
161336043|NCT00676143|582621630|FG001|Overall Study|Vasogenic edema recurrence|3|||
161336044|NCT00929669|582621631|FG000|Overall Study|elevated glucose levels|1|||
161336045|NCT00472420|582621632|FG000|Induction Treatment Period|Physician Decision|9|||
161336046|NCT00472420|582621632|FG000|Induction Treatment Period|Adverse Event|3|||
161336047|NCT00472420|582621632|FG000|Induction Treatment Period|Non-compliance|1|||
161336048|NCT00472420|582621632|FG000|Induction Treatment Period|Death|3|||
161336049|NCT00472420|582621632|FG000|Follow-up Period|Death|5|||
161336050|NCT00472420|582621632|FG000|Follow-up Period|Physician Decision|9|||
161336051|NCT00472420|582621632|FG000|Follow-up Period|Lost to Follow-up|2|||
161336052|NCT00472420|582621632|FG000|Follow-up Period|Protocol Violation|1|||
161336053|NCT00686972|582621634|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
161336054|NCT01901185|582621635|FG000|Overall Study|Withdrawal by Subject|2|||
161336055|NCT02065557|582621638|FG000|Induction Period|Withdrawal by Subject|2|||
161336056|NCT02065557|582621639|FG001|Induction Period|Withdrawal by Subject|1|||
161336057|NCT02065557|582621640|FG002|Induction Period|Withdrawal by Subject|0|||
161336058|NCT02065557|582621641|FG003|Induction Period|Withdrawal by Subject|0|||
161140567|NCT00561353|581897749|FG000|Overall Study|Lost to Follow-up|2|||
161140568|NCT00561353|581897750|FG001|Overall Study|Lost to Follow-up|0|||
161140569|NCT00561353|581897751|FG002|Overall Study|Lost to Follow-up|1|||
161140570|NCT00561353|581897752|FG003|Overall Study|Lost to Follow-up|0|||
161140571|NCT00561353|581897753|FG004|Overall Study|Lost to Follow-up|0|||
161140572|NCT00561353|581897754|FG005|Overall Study|Lost to Follow-up|0|||
161140573|NCT00561353|581897755|FG006|Overall Study|Lost to Follow-up|0|||
161140574|NCT00561353|581897756|FG007|Overall Study|Lost to Follow-up|0|||
161140575|NCT00561353|581897757|FG008|Overall Study|Lost to Follow-up|0|||
161140576|NCT00561353|581897758|FG009|Overall Study|Lost to Follow-up|0|||
161140577|NCT00561353|581897749|FG000|Overall Study|Withdrawal by Subject|0|||
161140578|NCT00561353|581897750|FG001|Overall Study|Withdrawal by Subject|2|||
161140579|NCT00561353|581897751|FG002|Overall Study|Withdrawal by Subject|0|||
161140580|NCT00561353|581897752|FG003|Overall Study|Withdrawal by Subject|0|||
161252580|NCT00401245|582304376|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
161252581|NCT00401245|582304377|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
161140581|NCT00561353|581897753|FG004|Overall Study|Withdrawal by Subject|0|||
161140582|NCT00561353|581897754|FG005|Overall Study|Withdrawal by Subject|0|||
161252582|NCT00401245|582304378|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
161252583|NCT00401245|582304379|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
161252584|NCT00401245|582304372|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161252585|NCT00401245|582304373|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
161252586|NCT00401245|582304374|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161252587|NCT00401245|582304375|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
161252588|NCT00401245|582304376|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161252589|NCT00401245|582304377|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161252590|NCT00401245|582304378|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161252591|NCT00401245|582304379|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
161252592|NCT00401245|582304372|FG000|Open Label Phase|Adverse Event|5|||
161252593|NCT00401245|582304373|FG001|Open Label Phase|Adverse Event|14|||
161252594|NCT00401245|582304374|FG002|Open Label Phase|Adverse Event|6|||
161252595|NCT00401245|582304375|FG003|Open Label Phase|Adverse Event|7|||
161252596|NCT00401245|582304376|FG004|Open Label Phase|Adverse Event|0|||
161252597|NCT00401245|582304377|FG005|Open Label Phase|Adverse Event|0|||
161252598|NCT00401245|582304378|FG006|Open Label Phase|Adverse Event|0|||
161252599|NCT00401245|582304379|FG007|Open Label Phase|Adverse Event|0|||
161252600|NCT00401245|582304372|FG000|Open Label Phase|Lost to Follow-up|5|||
161252601|NCT00401245|582304373|FG001|Open Label Phase|Lost to Follow-up|7|||
161252602|NCT00401245|582304374|FG002|Open Label Phase|Lost to Follow-up|5|||
161252603|NCT00401245|582304375|FG003|Open Label Phase|Lost to Follow-up|4|||
161252604|NCT00401245|582304376|FG004|Open Label Phase|Lost to Follow-up|0|||
161252605|NCT00401245|582304377|FG005|Open Label Phase|Lost to Follow-up|0|||
161252606|NCT00401245|582304378|FG006|Open Label Phase|Lost to Follow-up|0|||
161252607|NCT00401245|582304379|FG007|Open Label Phase|Lost to Follow-up|0|||
161252608|NCT00401245|582304372|FG000|Open Label Phase|Other|4|||
161252609|NCT00401245|582304373|FG001|Open Label Phase|Other|8|||
161252610|NCT00401245|582304374|FG002|Open Label Phase|Other|7|||
161252611|NCT00401245|582304375|FG003|Open Label Phase|Other|8|||
161252612|NCT00401245|582304376|FG004|Open Label Phase|Other|0|||
161252613|NCT00401245|582304377|FG005|Open Label Phase|Other|0|||
161252614|NCT00401245|582304378|FG006|Open Label Phase|Other|0|||
161252615|NCT00401245|582304379|FG007|Open Label Phase|Other|0|||
161252616|NCT00401245|582304372|FG000|Open Label Phase|Protocol Violation|0|||
161252617|NCT00401245|582304373|FG001|Open Label Phase|Protocol Violation|1|||
161252618|NCT00401245|582304374|FG002|Open Label Phase|Protocol Violation|0|||
161252619|NCT00401245|582304375|FG003|Open Label Phase|Protocol Violation|1|||
161252620|NCT00401245|582304376|FG004|Open Label Phase|Protocol Violation|0|||
161252621|NCT00401245|582304377|FG005|Open Label Phase|Protocol Violation|0|||
161252622|NCT00401245|582304378|FG006|Open Label Phase|Protocol Violation|0|||
161252623|NCT00401245|582304379|FG007|Open Label Phase|Protocol Violation|0|||
161252624|NCT00401245|582304372|FG000|Open Label Phase|Withdrawal by Subject|3|||
161252625|NCT00401245|582304373|FG001|Open Label Phase|Withdrawal by Subject|3|||
161252626|NCT00401245|582304374|FG002|Open Label Phase|Withdrawal by Subject|2|||
161252627|NCT00401245|582304375|FG003|Open Label Phase|Withdrawal by Subject|1|||
161252628|NCT00401245|582304376|FG004|Open Label Phase|Withdrawal by Subject|0|||
161252629|NCT00401245|582304377|FG005|Open Label Phase|Withdrawal by Subject|0|||
161252630|NCT00401245|582304378|FG006|Open Label Phase|Withdrawal by Subject|0|||
161252631|NCT00401245|582304379|FG007|Open Label Phase|Withdrawal by Subject|0|||
161252632|NCT00401245|582304372|FG000|Open Label Phase|Lack of Efficacy|4|||
161252633|NCT00401245|582304373|FG001|Open Label Phase|Lack of Efficacy|2|||
161252634|NCT00401245|582304374|FG002|Open Label Phase|Lack of Efficacy|3|||
161252635|NCT00401245|582304375|FG003|Open Label Phase|Lack of Efficacy|0|||
161252636|NCT00401245|582304376|FG004|Open Label Phase|Lack of Efficacy|0|||
161252637|NCT00401245|582304377|FG005|Open Label Phase|Lack of Efficacy|0|||
161252638|NCT00401245|582304378|FG006|Open Label Phase|Lack of Efficacy|0|||
161336059|NCT02065557|582621642|FG004|Induction Period|Withdrawal by Subject|0|||
161336060|NCT02065557|582621643|FG005|Induction Period|Withdrawal by Subject|0|||
161336061|NCT02065557|582621638|FG000|Induction Period|Lack of Efficacy|2|||
161336062|NCT02065557|582621639|FG001|Induction Period|Lack of Efficacy|1|||
161336063|NCT02065557|582621640|FG002|Induction Period|Lack of Efficacy|1|||
161336064|NCT02065557|582621641|FG003|Induction Period|Lack of Efficacy|0|||
161336065|NCT02065557|582621642|FG004|Induction Period|Lack of Efficacy|0|||
161336066|NCT02065557|582621643|FG005|Induction Period|Lack of Efficacy|0|||
161336067|NCT02065557|582621638|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161336068|NCT02065557|582621639|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161336069|NCT02065557|582621640|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
161336070|NCT02065557|582621641|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161336071|NCT02065557|582621642|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161336072|NCT02065557|582621643|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
161336073|NCT02065557|582621638|FG000|Induction Period|Non-Responder at Week 8|4|||
161336074|NCT02065557|582621639|FG001|Induction Period|Non-Responder at Week 8|4|||
161336075|NCT02065557|582621640|FG002|Induction Period|Non-Responder at Week 8|0|||
161336076|NCT02065557|582621641|FG003|Induction Period|Non-Responder at Week 8|0|||
161336077|NCT02065557|582621642|FG004|Induction Period|Non-Responder at Week 8|0|||
161336078|NCT02065557|582621643|FG005|Induction Period|Non-Responder at Week 8|0|||
161336079|NCT02065557|582621638|FG000|Induction Period|Adverse Event|1|||
161336080|NCT02065557|582621639|FG001|Induction Period|Adverse Event|1|||
161252639|NCT00401245|582304379|FG007|Open Label Phase|Lack of Efficacy|0|||
161252640|NCT00401245|582304372|FG000|Double Blind Tapering Phase|Adverse Event|0|||
161252641|NCT00401245|582304373|FG001|Double Blind Tapering Phase|Adverse Event|0|||
161252642|NCT00401245|582304374|FG002|Double Blind Tapering Phase|Adverse Event|0|||
161252643|NCT00401245|582304375|FG003|Double Blind Tapering Phase|Adverse Event|0|||
161252644|NCT00401245|582304376|FG004|Double Blind Tapering Phase|Adverse Event|1|||
161252645|NCT00401245|582304377|FG005|Double Blind Tapering Phase|Adverse Event|1|||
161252646|NCT00401245|582304378|FG006|Double Blind Tapering Phase|Adverse Event|2|||
161252647|NCT00401245|582304379|FG007|Double Blind Tapering Phase|Adverse Event|4|||
161252648|NCT00401245|582304372|FG000|Double Blind Tapering Phase|Investigator request|0|||
161252649|NCT00401245|582304373|FG001|Double Blind Tapering Phase|Investigator request|0|||
161252650|NCT00401245|582304374|FG002|Double Blind Tapering Phase|Investigator request|0|||
161252651|NCT00401245|582304375|FG003|Double Blind Tapering Phase|Investigator request|0|||
161252652|NCT00401245|582304376|FG004|Double Blind Tapering Phase|Investigator request|0|||
161252653|NCT00401245|582304377|FG005|Double Blind Tapering Phase|Investigator request|0|||
161252654|NCT00401245|582304378|FG006|Double Blind Tapering Phase|Investigator request|0|||
161252655|NCT00401245|582304379|FG007|Double Blind Tapering Phase|Investigator request|1|||
161252656|NCT00401245|582304372|FG000|Double Blind Tapering Phase|Other|0|||
161252657|NCT00401245|582304373|FG001|Double Blind Tapering Phase|Other|0|||
161336081|NCT02065557|582621640|FG002|Induction Period|Adverse Event|0|||
161336082|NCT02065557|582621641|FG003|Induction Period|Adverse Event|0|||
160905927|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905928|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905929|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
160905930|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
160905931|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
160905932|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
160905933|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
160905934|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905935|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905936|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905937|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905938|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905939|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905940|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905941|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
160905942|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905943|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
160905944|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
160905945|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905946|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905947|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905948|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160992316|NCT00828919|581360028|FG003|Overall Study|Adverse Event|1|||
160992317|NCT00828919|581360029|FG004|Overall Study|Adverse Event|3|||
161252658|NCT00401245|582304374|FG002|Double Blind Tapering Phase|Other|0|||
161336083|NCT02065557|582621642|FG004|Induction Period|Adverse Event|0|||
161252659|NCT00401245|582304375|FG003|Double Blind Tapering Phase|Other|0|||
161252660|NCT00401245|582304376|FG004|Double Blind Tapering Phase|Other|1|||
161252661|NCT00401245|582304377|FG005|Double Blind Tapering Phase|Other|0|||
161252662|NCT00401245|582304378|FG006|Double Blind Tapering Phase|Other|2|||
161252663|NCT00401245|582304379|FG007|Double Blind Tapering Phase|Other|2|||
161252664|NCT00401245|582304372|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161252665|NCT00401245|582304373|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161252666|NCT00401245|582304374|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161252667|NCT00401245|582304375|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161336084|NCT02065557|582621643|FG005|Induction Period|Adverse Event|0|||
160905949|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905950|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905951|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905952|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
160905953|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
160905954|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
160905955|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
160905956|NCT01847274|581050304|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905957|NCT01847274|581050305|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161140583|NCT00561353|581897755|FG006|Overall Study|Withdrawal by Subject|0|||
161140584|NCT00561353|581897756|FG007|Overall Study|Withdrawal by Subject|0|||
161140585|NCT00561353|581897757|FG008|Overall Study|Withdrawal by Subject|0|||
161140586|NCT00561353|581897758|FG009|Overall Study|Withdrawal by Subject|0|||
161140587|NCT03395210|581899122|FG000|Overall Study|Other|0|||
161140588|NCT03395210|581899123|FG001|Overall Study|Other|0|||
161140589|NCT03395210|581899124|FG002|Overall Study|Other|0|||
161140590|NCT03395210|581899125|FG003|Overall Study|Other|0|||
161140591|NCT03395210|581899126|FG004|Overall Study|Other|1|||
161140592|NCT03395210|581899122|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
161140593|NCT03395210|581899123|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
161140594|NCT03395210|581899124|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
161140595|NCT03395210|581899125|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
161140596|NCT03395210|581899126|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
161140597|NCT03395210|581899122|FG000|Overall Study|Adverse Event|1|||
161140598|NCT03395210|581899123|FG001|Overall Study|Adverse Event|0|||
161140599|NCT03395210|581899124|FG002|Overall Study|Adverse Event|2|||
161140600|NCT03395210|581899125|FG003|Overall Study|Adverse Event|4|||
161140601|NCT03395210|581899126|FG004|Overall Study|Adverse Event|3|||
161140602|NCT03395210|581899122|FG000|Overall Study|Need of Rescue Medication|1|||
161140603|NCT03395210|581899123|FG001|Overall Study|Need of Rescue Medication|0|||
161140604|NCT03395210|581899124|FG002|Overall Study|Need of Rescue Medication|1|||
161140605|NCT03395210|581899125|FG003|Overall Study|Need of Rescue Medication|4|||
161140606|NCT03395210|581899126|FG004|Overall Study|Need of Rescue Medication|0|||
161140607|NCT03395210|581899122|FG000|Overall Study|Lack of Response|0|||
161140608|NCT03395210|581899123|FG001|Overall Study|Lack of Response|0|||
161140609|NCT03395210|581899124|FG002|Overall Study|Lack of Response|0|||
161140610|NCT03395210|581899125|FG003|Overall Study|Lack of Response|5|||
161140611|NCT03395210|581899126|FG004|Overall Study|Lack of Response|5|||
161140612|NCT03395210|581899122|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
161140613|NCT03395210|581899123|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161140614|NCT03395210|581899124|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161140615|NCT03395210|581899125|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
161140616|NCT03395210|581899126|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
161140617|NCT03395210|581899122|FG000|Overall Study|Participant Decision|1|||
161140618|NCT03395210|581899123|FG001|Overall Study|Participant Decision|1|||
161140619|NCT03395210|581899124|FG002|Overall Study|Participant Decision|0|||
161140620|NCT03395210|581899125|FG003|Overall Study|Participant Decision|4|||
161140621|NCT03395210|581899126|FG004|Overall Study|Participant Decision|0|||
161140622|NCT03395210|581899122|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
161140623|NCT03395210|581899123|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
161140624|NCT03395210|581899124|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
161140625|NCT03395210|581899125|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
161140626|NCT03395210|581899126|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
161140627|NCT01672892|581899127|FG000|Overall Study|Protocol Violation|7|||
161140628|NCT01672892|581899128|FG001|Overall Study|Protocol Violation|3|||
161140629|NCT00573131|581899145|FG000|Overall Study|Withdrawal by Subject|10|||
161140630|NCT00573131|581899146|FG001|Overall Study|Withdrawal by Subject|8|||
161140631|NCT02401256|581899152|FG000|Overall Study|Adverse Event|5|||
161140632|NCT02401256|581899152|FG000|Overall Study|Withdrawal by Subject|12|||
161140633|NCT00893789|581899154|FG000|Overall Study|Withdrawal by Subject|3|||
161140634|NCT00893789|581899155|FG001|Overall Study|Withdrawal by Subject|1|||
161336085|NCT02065557|582621638|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161336086|NCT02065557|582621639|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161336087|NCT02065557|582621640|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161336088|NCT02065557|582621641|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
161336089|NCT02065557|582621642|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
161336090|NCT02065557|582621643|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
161336091|NCT02065557|582621638|FG000|Maintenance Period|Withdrawal by Subject|0|||
161336092|NCT02065557|582621639|FG001|Maintenance Period|Withdrawal by Subject|0|||
161336093|NCT02065557|582621640|FG002|Maintenance Period|Withdrawal by Subject|0|||
161336094|NCT02065557|582621641|FG003|Maintenance Period|Withdrawal by Subject|0|||
161336095|NCT02065557|582621642|FG004|Maintenance Period|Withdrawal by Subject|2|||
161336096|NCT02065557|582621643|FG005|Maintenance Period|Withdrawal by Subject|1|||
161336097|NCT02065557|582621638|FG000|Maintenance Period|Lack of Efficacy|0|||
161336098|NCT02065557|582621639|FG001|Maintenance Period|Lack of Efficacy|0|||
161336099|NCT02065557|582621640|FG002|Maintenance Period|Lack of Efficacy|0|||
161336100|NCT02065557|582621641|FG003|Maintenance Period|Lack of Efficacy|0|||
161336101|NCT02065557|582621642|FG004|Maintenance Period|Lack of Efficacy|5|||
161336102|NCT02065557|582621643|FG005|Maintenance Period|Lack of Efficacy|2|||
161336103|NCT02065557|582621638|FG000|Maintenance Period|Subject Non-Compliance|0|||
161336104|NCT02065557|582621639|FG001|Maintenance Period|Subject Non-Compliance|0|||
161336105|NCT02065557|582621640|FG002|Maintenance Period|Subject Non-Compliance|0|||
161336106|NCT02065557|582621641|FG003|Maintenance Period|Subject Non-Compliance|0|||
161336107|NCT02065557|582621642|FG004|Maintenance Period|Subject Non-Compliance|0|||
161336108|NCT02065557|582621643|FG005|Maintenance Period|Subject Non-Compliance|1|||
161336109|NCT01462942|582621647|FG000|Overall Study|Adverse Event|7|||
161336110|NCT01462942|582621648|FG001|Overall Study|Adverse Event|12|||
161336111|NCT01462942|582621649|FG002|Overall Study|Adverse Event|10|||
161336112|NCT01462942|582621650|FG003|Overall Study|Adverse Event|11|||
161336113|NCT01462942|582621651|FG004|Overall Study|Adverse Event|11|||
161336114|NCT01462942|582621647|FG000|Overall Study|Other, including COPD exacerbation|3|||
161336115|NCT01462942|582621648|FG001|Overall Study|Other, including COPD exacerbation|5|||
161336116|NCT01462942|582621649|FG002|Overall Study|Other, including COPD exacerbation|2|||
161336117|NCT01462942|582621650|FG003|Overall Study|Other, including COPD exacerbation|8|||
161336118|NCT01462942|582621651|FG004|Overall Study|Other, including COPD exacerbation|5|||
161336119|NCT01462942|582621647|FG000|Overall Study|Withdrawal by Subject|14|||
161336120|NCT01462942|582621648|FG001|Overall Study|Withdrawal by Subject|10|||
161336121|NCT01462942|582621649|FG002|Overall Study|Withdrawal by Subject|14|||
161336122|NCT01462942|582621650|FG003|Overall Study|Withdrawal by Subject|16|||
161336123|NCT01462942|582621651|FG004|Overall Study|Withdrawal by Subject|19|||
161336124|NCT01462942|582621647|FG000|Overall Study|Lack of Efficacy|6|||
161336125|NCT01462942|582621648|FG001|Overall Study|Lack of Efficacy|0|||
161336126|NCT01462942|582621649|FG002|Overall Study|Lack of Efficacy|4|||
161336127|NCT01462942|582621650|FG003|Overall Study|Lack of Efficacy|5|||
161336128|NCT01462942|582621651|FG004|Overall Study|Lack of Efficacy|3|||
161336129|NCT01462942|582621647|FG000|Overall Study|Lost to Follow-up|0|||
161336130|NCT01462942|582621648|FG001|Overall Study|Lost to Follow-up|1|||
161336131|NCT01462942|582621649|FG002|Overall Study|Lost to Follow-up|1|||
161336132|NCT01462942|582621650|FG003|Overall Study|Lost to Follow-up|1|||
161336133|NCT01462942|582621651|FG004|Overall Study|Lost to Follow-up|1|||
161336134|NCT01462942|582621647|FG000|Overall Study|Protocol Violation|4|||
161336135|NCT01462942|582621648|FG001|Overall Study|Protocol Violation|6|||
161336136|NCT01462942|582621649|FG002|Overall Study|Protocol Violation|9|||
161336137|NCT01462942|582621650|FG003|Overall Study|Protocol Violation|9|||
161336138|NCT01462942|582621651|FG004|Overall Study|Protocol Violation|6|||
161336139|NCT01026493|582621652|FG000|Overall Study|Protocol Violation|0|||
161336140|NCT01026493|582621653|FG001|Overall Study|Protocol Violation|1|||
161336141|NCT01026493|582621654|FG002|Overall Study|Protocol Violation|0|||
161336142|NCT01026493|582621655|FG003|Overall Study|Protocol Violation|0|||
161336143|NCT01026493|582621656|FG004|Overall Study|Protocol Violation|2|||
161336144|NCT01026493|582621657|FG005|Overall Study|Protocol Violation|3|||
161336145|NCT01026493|582621658|FG006|Overall Study|Protocol Violation|4|||
161336146|NCT01026493|582621659|FG007|Overall Study|Protocol Violation|1|||
161336147|NCT02662569|582621660|FG000|Overall Study|Withdrawal by Subject|6|||
161336148|NCT02662569|582621661|FG001|Overall Study|Withdrawal by Subject|1|||
161336149|NCT02662569|582621662|FG002|Overall Study|Withdrawal by Subject|6|||
161336150|NCT02662569|582621663|FG003|Overall Study|Withdrawal by Subject|4|||
161336151|NCT02662569|582621660|FG000|Overall Study|Lost to Follow-up|1|||
160992318|NCT00828919|581360025|FG000|Overall Study|Objective progression or relapse|4|||
161336152|NCT02662569|582621661|FG001|Overall Study|Lost to Follow-up|0|||
161336153|NCT02662569|582621662|FG002|Overall Study|Lost to Follow-up|0|||
161336154|NCT02662569|582621663|FG003|Overall Study|Lost to Follow-up|0|||
161336155|NCT03154086|582621666|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336156|NCT03154086|582621667|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336157|NCT03154086|582621668|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336158|NCT03154086|582621669|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
161336159|NCT03154086|582621670|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336160|NCT03154086|582621671|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336161|NCT03154086|582621672|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336162|NCT03154086|582621673|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336163|NCT03154086|582621674|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336164|NCT03154086|582621675|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336165|NCT03154086|582621676|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336166|NCT03154086|582621677|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336167|NCT03154086|582621678|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336168|NCT03154086|582621679|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336169|NCT03154086|582621680|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
161336170|NCT03154086|582621666|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336171|NCT03154086|582621667|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
161336172|NCT03154086|582621668|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336173|NCT03154086|582621669|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336174|NCT03154086|582621670|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336175|NCT03154086|582621671|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336176|NCT03154086|582621672|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336177|NCT03154086|582621673|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336178|NCT03154086|582621674|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336179|NCT03154086|582621675|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336180|NCT03154086|582621676|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336181|NCT03154086|582621677|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336182|NCT03154086|582621678|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336183|NCT03154086|582621679|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336184|NCT03154086|582621680|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
161336185|NCT03154086|582621666|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336186|NCT03154086|582621667|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336187|NCT03154086|582621668|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
161336188|NCT03154086|582621669|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336189|NCT03154086|582621670|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336190|NCT03154086|582621671|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336191|NCT03154086|582621672|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336192|NCT03154086|582621673|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336193|NCT03154086|582621674|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336194|NCT03154086|582621675|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336195|NCT03154086|582621676|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336196|NCT03154086|582621677|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336197|NCT03154086|582621678|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336198|NCT03154086|582621679|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336199|NCT03154086|582621680|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
161336200|NCT03154086|582621666|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
161336201|NCT03154086|582621667|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336202|NCT03154086|582621668|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336203|NCT03154086|582621669|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336204|NCT03154086|582621670|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336205|NCT03154086|582621671|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336206|NCT03154086|582621672|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336207|NCT03154086|582621673|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336208|NCT03154086|582621674|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336209|NCT03154086|582621675|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336210|NCT03154086|582621676|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336211|NCT03154086|582621677|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336212|NCT03154086|582621678|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336213|NCT03154086|582621679|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336214|NCT03154086|582621680|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
161336215|NCT03154086|582621666|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336216|NCT03154086|582621667|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336217|NCT03154086|582621668|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336218|NCT03154086|582621669|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336219|NCT03154086|582621670|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336220|NCT03154086|582621671|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336221|NCT03154086|582621672|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336222|NCT03154086|582621673|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336223|NCT03154086|582621674|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
161336224|NCT03154086|582621675|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336225|NCT03154086|582621676|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336226|NCT03154086|582621677|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336227|NCT03154086|582621678|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336228|NCT03154086|582621679|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336229|NCT03154086|582621680|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
161336230|NCT03154086|582621666|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336231|NCT03154086|582621667|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336232|NCT03154086|582621668|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336233|NCT03154086|582621669|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336234|NCT03154086|582621670|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336235|NCT03154086|582621671|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336236|NCT03154086|582621672|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336237|NCT03154086|582621673|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
161336238|NCT03154086|582621674|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336239|NCT03154086|582621675|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336240|NCT03154086|582621676|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336241|NCT03154086|582621677|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336242|NCT03154086|582621678|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336243|NCT03154086|582621679|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336244|NCT03154086|582621680|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
161336245|NCT03154086|582621666|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
161336246|NCT03154086|582621667|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
161336247|NCT03154086|582621668|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
161336248|NCT03154086|582621669|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
161336249|NCT03154086|582621670|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
161336250|NCT03154086|582621671|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
161336251|NCT03154086|582621672|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
161336252|NCT03154086|582621673|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
161336253|NCT03154086|582621674|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
161336254|NCT03154086|582621675|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
161336255|NCT03154086|582621676|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
161336256|NCT03154086|582621677|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
161336257|NCT03154086|582621678|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
161336258|NCT03154086|582621679|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
161336259|NCT03154086|582621680|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
161336260|NCT01701245|582621683|FG000|Overall Study|Protocol Violation|1|||
161336261|NCT01701245|582621684|FG001|Overall Study|Protocol Violation|3|||
161336262|NCT01701245|582621683|FG000|Overall Study|Did not complete the open label period|11|||
161336263|NCT01701245|582621684|FG001|Overall Study|Did not complete the open label period|12|||
161336264|NCT01299584|582621709|FG000|Overall Study|Protocol Violation|9|||
161336265|NCT00572832|582621710|FG000|Overall Study|Lost to Follow-up|0|||
161336266|NCT00572832|582621711|FG001|Overall Study|Lost to Follow-up|11|||
161336267|NCT00572832|582621710|FG000|Overall Study|Pregnancy|0|||
161336268|NCT00572832|582621711|FG001|Overall Study|Pregnancy|1|||
161336269|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
161336270|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161336271|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161336272|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161336273|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161336274|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161336275|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
161336276|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
161336277|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161336278|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161336279|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161336280|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161336281|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161336282|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
161336283|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161336284|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
161336285|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161336286|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161336287|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161336288|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
160905958|NCT01847274|581050306|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905959|NCT01847274|581050307|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161336289|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
161336290|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161336291|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161336292|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
161336293|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161336294|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161336295|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161336296|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
161336297|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161336298|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161336299|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
161336300|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161336301|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161336302|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161336303|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
161336304|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161336305|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161336306|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
161336307|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161336308|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161336309|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161336310|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
161336311|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161336312|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161336313|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161336314|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
161336315|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161336316|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161336317|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
161336318|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161336319|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161336320|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161336321|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
161336322|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161336323|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161336324|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
161336325|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161336326|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161336327|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161336328|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161336329|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
161336330|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161336331|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
161336332|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161336333|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161336334|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161336335|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161336336|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
160905960|NCT01847274|581050308|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905961|NCT01847274|581050309|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905962|NCT01847274|581050310|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905963|NCT01847274|581050311|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905964|NCT01847274|581050312|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
160905965|NCT01847274|581050313|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
160905966|NCT01847274|581050314|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
161336337|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161336338|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
161336339|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161336340|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161336341|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161336342|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
160905967|NCT01706146|581050315|FG000|Overall Study|Withdrawal by Subject|1|||
160905968|NCT01706146|581050315|FG000|Overall Study|Adverse Event|3|||
160905969|NCT01706146|581050315|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
161336343|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
161336344|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161336345|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
161336346|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161336347|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161336348|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161336349|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161336350|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
161336351|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161336352|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
161336353|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161336354|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161336355|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161336356|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161336357|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161336358|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
161336359|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
161336360|NCT01791595|582621723|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161336361|NCT01791595|582621724|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
160844594|NCT00042991|580818057|FG006|Overall Study|Disease Progression|2|||
160844595|NCT00042991|580818051|FG000|Overall Study|Alternative Therapy|0|||
160844596|NCT00042991|580818052|FG001|Overall Study|Alternative Therapy|0|||
161336362|NCT01791595|582621725|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161336363|NCT01791595|582621726|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161336364|NCT01791595|582621727|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161336365|NCT01791595|582621728|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
161336366|NCT01791595|582621729|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
161336367|NCT01791595|582621723|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161336368|NCT01791595|582621724|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161336369|NCT01791595|582621725|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161336370|NCT01791595|582621726|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161336371|NCT01791595|582621727|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161336372|NCT01791595|582621728|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
161336373|NCT01791595|582621729|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
161336374|NCT01791595|582621723|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161336375|NCT01791595|582621724|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161336376|NCT01791595|582621725|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161336377|NCT01791595|582621726|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161336378|NCT01791595|582621727|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161336379|NCT01791595|582621728|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
161336380|NCT01791595|582621729|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
161336381|NCT01791595|582621723|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161336382|NCT01791595|582621724|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161336383|NCT01791595|582621725|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161336384|NCT01791595|582621726|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161336385|NCT01791595|582621727|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
161336386|NCT01791595|582621728|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
160844597|NCT00042991|580818053|FG002|Overall Study|Alternative Therapy|0|||
160844598|NCT00042991|580818054|FG003|Overall Study|Alternative Therapy|0|||
160844599|NCT00042991|580818055|FG004|Overall Study|Alternative Therapy|1|||
160844600|NCT00042991|580818056|FG005|Overall Study|Alternative Therapy|0|||
160844601|NCT00042991|580818057|FG006|Overall Study|Alternative Therapy|0|||
160844602|NCT00856297|580818058|FG000|Overall Study|Unable to classify|2|||
160844603|NCT00856297|580818059|FG001|Overall Study|Unable to classify|0|||
160844604|NCT00856297|580818060|FG002|Overall Study|Unable to classify|0|||
160844605|NCT00856297|580818061|FG003|Overall Study|Unable to classify|0|||
160844606|NCT00856297|580818062|FG004|Overall Study|Unable to classify|0|||
160844607|NCT03369236|580818065|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
160844608|NCT03369236|580818066|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
160844609|NCT03369236|580818065|FG000|Open-label Extension Period|Lack of Efficacy|2|||
160844610|NCT03369236|580818066|FG001|Open-label Extension Period|Lack of Efficacy|1|||
160844611|NCT03369236|580818065|FG000|Open-label Extension Period|Adverse Event|0|||
160844612|NCT03369236|580818066|FG001|Open-label Extension Period|Adverse Event|1|||
160844613|NCT03369236|580818065|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
160844614|NCT03369236|580818066|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
160844615|NCT02508428|580818072|FG000|Overall Study|Death|32|||
160844616|NCT02508428|580818073|FG001|Overall Study|Death|33|||
161252668|NCT00401245|582304376|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
160844617|NCT02508428|580818072|FG000|Overall Study|Liner revised|3|||
160844618|NCT02508428|580818073|FG001|Overall Study|Liner revised|19|||
160844619|NCT02508428|580818072|FG000|Overall Study|Incomplete follow-up|17|||
160844620|NCT02508428|580818073|FG001|Overall Study|Incomplete follow-up|15|||
160844621|NCT00806988|580819613|FG000|Overall Study|Death|15|||
160844622|NCT00806988|580819614|FG001|Overall Study|Death|16|||
160844623|NCT00806988|580819613|FG000|Overall Study|Withdrawal by Subject|8|||
160844624|NCT00806988|580819614|FG001|Overall Study|Withdrawal by Subject|8|||
160844625|NCT00806988|580819613|FG000|Overall Study|Lost to Follow-up|4|||
160844626|NCT00806988|580819614|FG001|Overall Study|Lost to Follow-up|19|||
160844627|NCT04775953|580819616|FG000|Overall Study|Lost to Follow-up|6|||
160844628|NCT04775953|580819617|FG001|Overall Study|Lost to Follow-up|11|||
160844629|NCT04775953|580819616|FG000|Overall Study|Death|5|||
160844630|NCT04775953|580819617|FG001|Overall Study|Death|4|||
160844631|NCT04775953|580819616|FG000|Overall Study|Withdrawal by Subject|3|||
160844632|NCT04775953|580819617|FG001|Overall Study|Withdrawal by Subject|3|||
160844633|NCT04775953|580819616|FG000|Overall Study|Protocol Violation|2|||
160844634|NCT04775953|580819617|FG001|Overall Study|Protocol Violation|0|||
160844635|NCT04775953|580819616|FG000|Overall Study|Participant non-compliance|0|||
160844636|NCT04775953|580819617|FG001|Overall Study|Participant non-compliance|1|||
160844637|NCT01698814|580819618|FG000|Overall Study|Adverse Event|0|||
160844638|NCT01698814|580819619|FG001|Overall Study|Adverse Event|2|||
160844639|NCT01698814|580819618|FG000|Overall Study|Lost to Follow-up|0|||
160844640|NCT01698814|580819619|FG001|Overall Study|Lost to Follow-up|1|||
160844641|NCT01698814|580819618|FG000|Overall Study|Pregnancy|1|||
160844642|NCT01698814|580819619|FG001|Overall Study|Pregnancy|0|||
160844643|NCT01698814|580819618|FG000|Overall Study|Randomized in error|1|||
160844644|NCT01698814|580819619|FG001|Overall Study|Randomized in error|0|||
160844645|NCT00368641|580819622|FG000|Overall Study|Adverse Event|2|||
160844646|NCT00368641|580819623|FG001|Overall Study|Adverse Event|1|||
160844647|NCT00368641|580819622|FG000|Overall Study|Death|1|||
160844648|NCT00368641|580819623|FG001|Overall Study|Death|0|||
160844649|NCT00368641|580819622|FG000|Overall Study|Withdrawal by Subject|1|||
160844650|NCT00368641|580819623|FG001|Overall Study|Withdrawal by Subject|0|||
161252669|NCT00401245|582304377|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
161252670|NCT00401245|582304378|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
161252671|NCT00401245|582304379|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
161252672|NCT00401245|582304372|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252673|NCT00401245|582304373|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252674|NCT00401245|582304374|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252675|NCT00401245|582304375|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252676|NCT00401245|582304376|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252677|NCT00401245|582304377|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
161252678|NCT00401245|582304378|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252679|NCT00401245|582304379|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
161252680|NCT02014441|582304380|FG000|Overall Study|Withdrawal by Subject|12|||
161252681|NCT01363011|582304382|FG000|Main Study|Adverse Event|2|||
161252682|NCT01363011|582304383|FG001|Main Study|Adverse Event|3|||
161252683|NCT01363011|582304382|FG000|Main Study|Investigator's Discretion|1|||
161252684|NCT01363011|582304383|FG001|Main Study|Investigator's Discretion|1|||
161252685|NCT01363011|582304382|FG000|Main Study|Withdrew Consent|1|||
161252686|NCT01363011|582304383|FG001|Main Study|Withdrew Consent|4|||
161252687|NCT01363011|582304382|FG000|Main Study|Protocol Violation|0|||
161252688|NCT01363011|582304383|FG001|Main Study|Protocol Violation|1|||
161252689|NCT01363011|582304382|FG000|Extension Phase|Adverse Event|1|||
161252690|NCT01363011|582304383|FG001|Extension Phase|Adverse Event|1|||
161252691|NCT01363011|582304382|FG000|Extension Phase|Lack of Efficacy|0|||
161252692|NCT01363011|582304383|FG001|Extension Phase|Lack of Efficacy|1|||
161252693|NCT01363011|582304382|FG000|Extension Phase|Investigator's Discretion|2|||
161252694|NCT01363011|582304383|FG001|Extension Phase|Investigator's Discretion|2|||
161252695|NCT01363011|582304382|FG000|Extension Phase|Withdrew Consent|0|||
161252696|NCT01363011|582304383|FG001|Extension Phase|Withdrew Consent|1|||
161252697|NCT01363011|582304382|FG000|Extension Phase|Lost to Follow-up|0|||
161252698|NCT01363011|582304383|FG001|Extension Phase|Lost to Follow-up|2|||
161252699|NCT01363011|582304382|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
161252700|NCT01363011|582304383|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
161252701|NCT04412057|582304384|FG000|Overall Study|Death|3|||
161252702|NCT04412057|582304385|FG001|Overall Study|Death|7|||
161252703|NCT04412057|582304384|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
161252704|NCT04412057|582304385|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
161252705|NCT00114231|582304386|FG000|Overall Study|No consent|2|||
161252706|NCT00114231|582304387|FG001|Overall Study|No consent|0|||
161252707|NCT00114231|582304386|FG000|Overall Study|QARC requirement not met|1|||
161252708|NCT00114231|582304387|FG001|Overall Study|QARC requirement not met|0|||
161252709|NCT00114231|582304386|FG000|Overall Study|Suspected metastatic disease|1|||
160844651|NCT00368641|580819622|FG000|Overall Study|Sponsor decision to terminate study|2|||
160844652|NCT00368641|580819623|FG001|Overall Study|Sponsor decision to terminate study|5|||
161252710|NCT00114231|582304387|FG001|Overall Study|Suspected metastatic disease|0|||
161252711|NCT00114231|582304386|FG000|Overall Study|No adenocarcinoma|1|||
161252712|NCT00114231|582304387|FG001|Overall Study|No adenocarcinoma|0|||
161252713|NCT00114231|582304386|FG000|Overall Study|Low creatinine clearance|0|||
161252714|NCT00114231|582304387|FG001|Overall Study|Low creatinine clearance|1|||
161252715|NCT00114231|582304386|FG000|Overall Study|Tumor size > 4cm|1|||
161252716|NCT00114231|582304387|FG001|Overall Study|Tumor size > 4cm|0|||
161252717|NCT00114231|582304386|FG000|Overall Study|Tumor fixed on digital exam|0|||
161252718|NCT00114231|582304387|FG001|Overall Study|Tumor fixed on digital exam|1|||
161252719|NCT00114231|582304386|FG000|Overall Study|No Absolute Neutrophil Count|2|||
161252720|NCT00114231|582304387|FG001|Overall Study|No Absolute Neutrophil Count|0|||
161252721|NCT00114231|582304386|FG000|Overall Study|Biopsy done after registration|1|||
161252722|NCT00114231|582304387|FG001|Overall Study|Biopsy done after registration|0|||
161252723|NCT02457819|582304388|FG000|Overall Study|reason not given|8|||
160844653|NCT01424501|580819624|FG000|Overall Study|Withdrawal by Subject|1|||
160844654|NCT01424501|580819625|FG001|Overall Study|Withdrawal by Subject|0|||
160844655|NCT01424501|580819626|FG002|Overall Study|Withdrawal by Subject|1|||
160844656|NCT01424501|580819627|FG003|Overall Study|Withdrawal by Subject|0|||
160844657|NCT01424501|580819628|FG004|Overall Study|Withdrawal by Subject|0|||
160844658|NCT01424501|580819629|FG005|Overall Study|Withdrawal by Subject|0|||
160844659|NCT01424501|580819624|FG000|Overall Study|Lost to Follow-up|0|||
160844660|NCT01424501|580819625|FG001|Overall Study|Lost to Follow-up|1|||
160844661|NCT01424501|580819626|FG002|Overall Study|Lost to Follow-up|1|||
160844662|NCT01424501|580819627|FG003|Overall Study|Lost to Follow-up|0|||
161252724|NCT02457819|582304388|FG000|Overall Study|Withdrawal by Subject|24|||
161252725|NCT02457819|582304388|FG000|Overall Study|Protocol Violation|1|||
161252726|NCT02457819|582304388|FG000|Overall Study|non compliance with study drug|4|||
161252727|NCT02457819|582304388|FG000|Overall Study|Lost to Follow-up|10|||
161252728|NCT02457819|582304388|FG000|Overall Study|Lack of Efficacy|19|||
161252729|NCT02457819|582304388|FG000|Overall Study|Adverse Event|33|||
161252730|NCT03330236|582304391|FG000|Overall Study|Death|2|||
161252731|NCT03330236|582304392|FG001|Overall Study|Death|1|||
161252732|NCT03330236|582304391|FG000|Overall Study|Withdrawal by Subject|2|||
161252733|NCT03330236|582304392|FG001|Overall Study|Withdrawal by Subject|4|||
161252734|NCT03330236|582304391|FG000|Overall Study|Lost to Follow-up|0|||
161252735|NCT03330236|582304392|FG001|Overall Study|Lost to Follow-up|2|||
161252736|NCT03330236|582304391|FG000|Overall Study|Physician Decision|2|||
161252737|NCT03330236|582304392|FG001|Overall Study|Physician Decision|0|||
161252738|NCT03330236|582304391|FG000|Overall Study|Protocol Violation|4|||
160844663|NCT01424501|580819628|FG004|Overall Study|Lost to Follow-up|0|||
160844664|NCT01424501|580819629|FG005|Overall Study|Lost to Follow-up|0|||
160844665|NCT01980095|580819630|FG000|Overall Study|Lost to Follow-up|6|||
160844666|NCT01980095|580819631|FG001|Overall Study|Lost to Follow-up|7|||
160844667|NCT01980095|580819630|FG000|Overall Study|Withdrawal by Subject|2|||
160844668|NCT01980095|580819631|FG001|Overall Study|Withdrawal by Subject|3|||
160844669|NCT01980095|580819630|FG000|Overall Study|Poor compliance|5|||
160844670|NCT01980095|580819631|FG001|Overall Study|Poor compliance|0|||
160844671|NCT01980095|580819630|FG000|Overall Study|Safety issue|0|||
160844672|NCT01980095|580819631|FG001|Overall Study|Safety issue|1|||
160844673|NCT01980095|580819630|FG000|Overall Study|Study drug discontinued|1|||
160844674|NCT01980095|580819631|FG001|Overall Study|Study drug discontinued|0|||
160844675|NCT01980095|580819630|FG000|Overall Study|Randomized by mistake|1|||
160844676|NCT01980095|580819631|FG001|Overall Study|Randomized by mistake|0|||
160844677|NCT03920254|580819632|FG000|Overall Study|Adverse Event|1|||
160844678|NCT03920254|580819633|FG001|Overall Study|Adverse Event|0|||
160844679|NCT03920254|580819634|FG002|Overall Study|Adverse Event|0|||
160844680|NCT03920254|580819632|FG000|Overall Study|Physician Decision|0|||
160844681|NCT03920254|580819633|FG001|Overall Study|Physician Decision|1|||
160844682|NCT03920254|580819634|FG002|Overall Study|Physician Decision|2|||
160844683|NCT03920254|580819632|FG000|Overall Study|Study Terminated By Sponsor|12|||
160844684|NCT03920254|580819633|FG001|Overall Study|Study Terminated By Sponsor|17|||
160844685|NCT03920254|580819634|FG002|Overall Study|Study Terminated By Sponsor|12|||
160844686|NCT03920254|580819632|FG000|Overall Study|Withdrawal by Subject|0|||
160844687|NCT03920254|580819633|FG001|Overall Study|Withdrawal by Subject|0|||
160844688|NCT03920254|580819634|FG002|Overall Study|Withdrawal by Subject|1|||
160844689|NCT05274269|580819635|FG000|Overall Study|Adverse Event|0|||
160844690|NCT05274269|580819636|FG001|Overall Study|Adverse Event|3|||
160844691|NCT05274269|580819635|FG000|Overall Study|Death|0|||
160844692|NCT05274269|580819636|FG001|Overall Study|Death|1|||
161252739|NCT03330236|582304392|FG001|Overall Study|Protocol Violation|3|||
161252740|NCT03330236|582304391|FG000|Overall Study|SedLine malfunction/blinding|19|||
160844693|NCT05274269|580819635|FG000|Overall Study|Other|0|||
160844694|NCT05274269|580819636|FG001|Overall Study|Other|2|||
160844695|NCT05274269|580819635|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161252741|NCT03330236|582304392|FG001|Overall Study|SedLine malfunction/blinding|14|||
161252742|NCT03330236|582304391|FG000|Overall Study|Volatile anesthetics used|11|||
160844696|NCT05274269|580819636|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161140635|NCT00893789|581899156|FG002|Overall Study|Withdrawal by Subject|3|||
161140636|NCT00893789|581899157|FG003|Overall Study|Withdrawal by Subject|1|||
161140637|NCT00893789|581899154|FG000|Overall Study|Noncompliance With Study Drug|1|||
161140638|NCT00893789|581899155|FG001|Overall Study|Noncompliance With Study Drug|0|||
161140639|NCT00893789|581899156|FG002|Overall Study|Noncompliance With Study Drug|1|||
161140640|NCT00893789|581899157|FG003|Overall Study|Noncompliance With Study Drug|2|||
161252743|NCT03330236|582304392|FG001|Overall Study|Volatile anesthetics used|8|||
161252744|NCT03330236|582304391|FG000|Overall Study|Surgery aborted/converted to open|60|||
160844697|NCT05636852|580819637|FG000|Overall Study|Withdrawal by Subject|1|||
160844698|NCT05636852|580819637|FG000|Overall Study|Other than specified|1|||
160844699|NCT00709618|580819638|FG000|Overall Study|Withdrawal by Subject|4|||
160844700|NCT00709618|580819638|FG000|Overall Study|Lost to Follow-up|1|||
160844701|NCT00709618|580819638|FG000|Overall Study|Study Closed/Terminated|25|||
160844702|NCT01415401|580819646|FG000|Overall Study|Adverse Event|5|||
160844703|NCT01415401|580819646|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
160844704|NCT01415401|580819646|FG000|Overall Study|Terminated by Sponsor|1|||
160844705|NCT01746225|580819649|FG000|Overall Study|Death|1|||
160844706|NCT01746225|580819650|FG001|Overall Study|Death|0|||
160844707|NCT01746225|580819651|FG002|Overall Study|Death|1|||
160844708|NCT01746225|580819649|FG000|Overall Study|Withdrawal by Subject|5|||
160844709|NCT01746225|580819650|FG001|Overall Study|Withdrawal by Subject|15|||
160844710|NCT01746225|580819651|FG002|Overall Study|Withdrawal by Subject|19|||
160844711|NCT01746225|580819649|FG000|Overall Study|Physician Decision|14|||
160844712|NCT01746225|580819650|FG001|Overall Study|Physician Decision|11|||
160844713|NCT01746225|580819651|FG002|Overall Study|Physician Decision|3|||
160844714|NCT01746225|580819649|FG000|Overall Study|Adverse Event|15|||
160844715|NCT01746225|580819650|FG001|Overall Study|Adverse Event|12|||
160844716|NCT01746225|580819651|FG002|Overall Study|Adverse Event|17|||
160844717|NCT01746225|580819649|FG000|Overall Study|Continuing Treatment|5|||
160844718|NCT01746225|580819650|FG001|Overall Study|Continuing Treatment|8|||
160844719|NCT01746225|580819651|FG002|Overall Study|Continuing Treatment|3|||
160844720|NCT00595478|580819652|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
160844721|NCT00595478|580819653|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
160844722|NCT00595478|580819652|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
160844723|NCT00595478|580819653|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
160844724|NCT02713828|580819656|FG000|Overall Study|Death|2|||
160844725|NCT02713828|580819657|FG001|Overall Study|Death|0|||
160844726|NCT02713828|580819656|FG000|Overall Study|Withdrawal by Subject|1|||
160844727|NCT02713828|580819657|FG001|Overall Study|Withdrawal by Subject|0|||
161140641|NCT00893789|581899154|FG000|Overall Study|Noncompliance With Study Procedures|1|||
161252745|NCT03330236|582304392|FG001|Overall Study|Surgery aborted/converted to open|52|||
161252746|NCT00763555|582304396|FG000|Overall Study|Adverse Event|2|||
161252747|NCT00763555|582304397|FG001|Overall Study|Adverse Event|1|||
161252748|NCT00763555|582304396|FG000|Overall Study|Withdrawal by Subject|2|||
161252749|NCT00763555|582304397|FG001|Overall Study|Withdrawal by Subject|6|||
161252750|NCT00763555|582304396|FG000|Overall Study|Lost to Follow-up|0|||
161252751|NCT00763555|582304397|FG001|Overall Study|Lost to Follow-up|3|||
161252752|NCT01729026|582304398|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
161252753|NCT01729026|582304399|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
160844728|NCT02713828|580819656|FG000|Overall Study|study terminated but patient allowed to|2|||
160844729|NCT02713828|580819657|FG001|Overall Study|study terminated but patient allowed to|0|||
160844730|NCT03302247|580819658|FG000|Overall Study|the study has closed prematurely|2|||
160844731|NCT03302247|580819658|FG000|Overall Study|Death|1|||
160844732|NCT02305238|580819659|FG000|Overall Study|Death|2|||
160844733|NCT02305238|580819660|FG001|Overall Study|Death|1|||
160844734|NCT02305238|580819661|FG002|Overall Study|Death|0|||
160844735|NCT02305238|580819659|FG000|Overall Study|Progressive disease|4|||
161252754|NCT01729026|582304398|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
160844736|NCT02305238|580819660|FG001|Overall Study|Progressive disease|4|||
160844737|NCT02305238|580819661|FG002|Overall Study|Progressive disease|0|||
160844738|NCT02305238|580819659|FG000|Overall Study|Logistical difficulties|1|||
160844739|NCT02305238|580819660|FG001|Overall Study|Logistical difficulties|3|||
161252755|NCT01729026|582304399|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
161252756|NCT00298740|582304401|FG000|Overall Study|Lack of Efficacy|6|||
160844740|NCT02305238|580819661|FG002|Overall Study|Logistical difficulties|0|||
160844741|NCT02305238|580819659|FG000|Overall Study|Protocol Violation|0|||
160844742|NCT02305238|580819660|FG001|Overall Study|Protocol Violation|3|||
160844743|NCT02305238|580819661|FG002|Overall Study|Protocol Violation|0|||
160844744|NCT02305238|580819659|FG000|Overall Study|Physician Decision|2|||
160844745|NCT02305238|580819660|FG001|Overall Study|Physician Decision|1|||
161252757|NCT00298740|582304401|FG000|Overall Study|Withdrawal by Subject|3|||
161252758|NCT00684567|582304403|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
161252759|NCT00684567|582304403|FG000|Monotherapy Period|Adverse Event|2|||
160844746|NCT02305238|580819661|FG002|Overall Study|Physician Decision|0|||
160844747|NCT02305238|580819659|FG000|Overall Study|Adverse Event|4|||
160844748|NCT02305238|580819660|FG001|Overall Study|Adverse Event|2|||
161252760|NCT00684567|582304403|FG000|Monotherapy Period|Death|1|||
160844749|NCT02305238|580819661|FG002|Overall Study|Adverse Event|0|||
160844750|NCT02305238|580819659|FG000|Overall Study|Withdrawal by Subject|3|||
160844751|NCT02305238|580819660|FG001|Overall Study|Withdrawal by Subject|4|||
160844752|NCT02305238|580819661|FG002|Overall Study|Withdrawal by Subject|0|||
161252761|NCT00684567|582304403|FG000|Monotherapy Period|Progression of primary disease|11|||
161252762|NCT02744755|582304404|FG000|Study Period 1|Protocol Violation|2|||
161252763|NCT02744755|582304405|FG001|Study Period 1|Protocol Violation|1|||
161252764|NCT02744755|582304404|FG000|Study Period 1|not defined|0|||
161252765|NCT02744755|582304405|FG001|Study Period 1|not defined|1|||
161252766|NCT02744755|582304404|FG000|Study Period 1|Pregnancy|1|||
161252767|NCT02744755|582304405|FG001|Study Period 1|Pregnancy|0|||
161252768|NCT02744755|582304404|FG000|Study Period 1|Adverse Event|1|||
161252769|NCT02744755|582304405|FG001|Study Period 1|Adverse Event|1|||
161252770|NCT02744755|582304404|FG000|Study Period 1|Lost to Follow-up|1|||
161252771|NCT02744755|582304405|FG001|Study Period 1|Lost to Follow-up|1|||
161252772|NCT02744755|582304404|FG000|Study Period 1|Lack of Efficacy|1|||
161252773|NCT02744755|582304405|FG001|Study Period 1|Lack of Efficacy|0|||
161252774|NCT02744755|582304404|FG000|Study Period 1|Withdrawal by Subject|8|||
161252775|NCT02744755|582304405|FG001|Study Period 1|Withdrawal by Subject|4|||
161252776|NCT02744755|582304404|FG000|Study Period 2|Adverse Event|5|||
161252777|NCT02744755|582304405|FG001|Study Period 2|Adverse Event|0|||
161252778|NCT02744755|582304404|FG000|Study Period 2|Protocol Violation|1|||
161252779|NCT02744755|582304405|FG001|Study Period 2|Protocol Violation|0|||
161252780|NCT02744755|582304404|FG000|Study Period 2|not defined|3|||
161252781|NCT02744755|582304405|FG001|Study Period 2|not defined|2|||
161252782|NCT02744755|582304404|FG000|Study Period 2|Lost to Follow-up|0|||
161252783|NCT02744755|582304405|FG001|Study Period 2|Lost to Follow-up|2|||
161252784|NCT02744755|582304404|FG000|Study Period 2|Withdrawal by Subject|2|||
161252785|NCT02744755|582304405|FG001|Study Period 2|Withdrawal by Subject|2|||
161252786|NCT02744755|582304404|FG000|Study Period 2|Lack of Efficacy|3|||
161252787|NCT02744755|582304405|FG001|Study Period 2|Lack of Efficacy|2|||
161252788|NCT00965757|582304406|FG000|Double-blind Phase|Progression of concomitant disease|1|||
161252789|NCT00965757|582304407|FG001|Double-blind Phase|Progression of concomitant disease|2|||
161252790|NCT00965757|582304408|FG002|Double-blind Phase|Progression of concomitant disease|0|||
161252791|NCT00965757|582304409|FG003|Double-blind Phase|Progression of concomitant disease|0|||
161252792|NCT00965757|582304406|FG000|Double-blind Phase|Adverse drug reaction|2|||
161252793|NCT00965757|582304407|FG001|Double-blind Phase|Adverse drug reaction|1|||
161252794|NCT00965757|582304408|FG002|Double-blind Phase|Adverse drug reaction|0|||
161252795|NCT00965757|582304409|FG003|Double-blind Phase|Adverse drug reaction|0|||
161252796|NCT00965757|582304406|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
161252797|NCT00965757|582304407|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
161252798|NCT00965757|582304408|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
161252799|NCT00965757|582304409|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
161252800|NCT00965757|582304406|FG000|Double-blind Phase|Lack of Efficacy|7|||
161252801|NCT00965757|582304407|FG001|Double-blind Phase|Lack of Efficacy|11|||
161252802|NCT00965757|582304408|FG002|Double-blind Phase|Lack of Efficacy|0|||
161252803|NCT00965757|582304409|FG003|Double-blind Phase|Lack of Efficacy|0|||
161252804|NCT00965757|582304406|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
161252805|NCT00965757|582304407|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161252806|NCT00965757|582304408|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161252807|NCT00965757|582304409|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
161252808|NCT00965757|582304406|FG000|Double-blind Phase|Lost to Follow-up|0|||
161252809|NCT00965757|582304407|FG001|Double-blind Phase|Lost to Follow-up|1|||
161252810|NCT00965757|582304408|FG002|Double-blind Phase|Lost to Follow-up|0|||
161252811|NCT00965757|582304409|FG003|Double-blind Phase|Lost to Follow-up|0|||
161252812|NCT00965757|582304406|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
160844753|NCT02305238|580819659|FG000|Overall Study|Randomized failure|0|||
160844754|NCT02305238|580819660|FG001|Overall Study|Randomized failure|0|||
160844755|NCT02305238|580819661|FG002|Overall Study|Randomized failure|8|||
160844756|NCT02305238|580819659|FG000|Overall Study|Required procedure failed|0|||
160844757|NCT02305238|580819660|FG001|Overall Study|Required procedure failed|1|||
160844758|NCT02305238|580819661|FG002|Overall Study|Required procedure failed|0|||
161252813|NCT00965757|582304407|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
161252814|NCT00965757|582304408|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
161252815|NCT00965757|582304409|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
161252816|NCT00965757|582304406|FG000|Double-blind Phase|Other|1|||
161252817|NCT00965757|582304407|FG001|Double-blind Phase|Other|0|||
161252818|NCT00965757|582304408|FG002|Double-blind Phase|Other|0|||
161252819|NCT00965757|582304409|FG003|Double-blind Phase|Other|0|||
161252820|NCT00965757|582304406|FG000|Extension Phase|Progression of concomitant disease|0|||
161252821|NCT00965757|582304407|FG001|Extension Phase|Progression of concomitant disease|0|||
161252822|NCT00965757|582304408|FG002|Extension Phase|Progression of concomitant disease|4|||
161336387|NCT01791595|582621729|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
160844759|NCT01019369|580819662|FG000|Overall Study|Lost to Follow-up|10|||
160844760|NCT01019369|580819663|FG001|Overall Study|Lost to Follow-up|6|||
160844761|NCT01019369|580819662|FG000|Overall Study|Withdrawal by Subject|0|||
160844762|NCT01019369|580819663|FG001|Overall Study|Withdrawal by Subject|1|||
160844763|NCT00604695|580819664|FG000|Overall Study|Did not receive first bolus.|0|||
160844764|NCT00604695|580819665|FG001|Overall Study|Did not receive first bolus.|4|||
160844765|NCT00172042|580819669|FG000|Overall Study|Adverse Event|27|||
160844766|NCT00172042|580819670|FG001|Overall Study|Adverse Event|13|||
160844767|NCT00172042|580819669|FG000|Overall Study|Abnormal laboratory value(s)|5|||
160844768|NCT00172042|580819670|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161140642|NCT00893789|581899155|FG001|Overall Study|Noncompliance With Study Procedures|0|||
161140643|NCT00893789|581899156|FG002|Overall Study|Noncompliance With Study Procedures|0|||
161140644|NCT00893789|581899157|FG003|Overall Study|Noncompliance With Study Procedures|0|||
161140645|NCT00893789|581899154|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
161140646|NCT00893789|581899155|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
161140647|NCT00893789|581899156|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
161140648|NCT00893789|581899157|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
161140649|NCT00893789|581899154|FG000|Overall Study|Adverse Event|0|||
161140650|NCT00893789|581899155|FG001|Overall Study|Adverse Event|2|||
161140651|NCT00893789|581899156|FG002|Overall Study|Adverse Event|1|||
161140652|NCT00893789|581899157|FG003|Overall Study|Adverse Event|5|||
161140653|NCT00893789|581899154|FG000|Overall Study|Protocol Violation|0|||
161140654|NCT00893789|581899155|FG001|Overall Study|Protocol Violation|1|||
161140655|NCT00893789|581899156|FG002|Overall Study|Protocol Violation|1|||
161140656|NCT00893789|581899157|FG003|Overall Study|Protocol Violation|4|||
161140657|NCT00893789|581899154|FG000|Overall Study|Lost to Follow-up|0|||
161140658|NCT00893789|581899155|FG001|Overall Study|Lost to Follow-up|0|||
161140659|NCT00893789|581899156|FG002|Overall Study|Lost to Follow-up|0|||
161140660|NCT00893789|581899157|FG003|Overall Study|Lost to Follow-up|1|||
161140661|NCT02024464|581899158|FG000|Overall Study|Discontinued|5|||
161140662|NCT02024464|581899159|FG001|Overall Study|Discontinued|4|||
161140663|NCT02024464|581899158|FG000|Overall Study|Missed Visits|1|||
161140664|NCT02024464|581899159|FG001|Overall Study|Missed Visits|0|||
161140665|NCT02024464|581899158|FG000|Overall Study|Lost to Follow-up|4|||
161140666|NCT02024464|581899159|FG001|Overall Study|Lost to Follow-up|7|||
161140667|NCT04419506|581899162|FG000|Overall Study|Adverse Event|0|||
161140668|NCT04419506|581899163|FG001|Overall Study|Adverse Event|10|||
161252823|NCT00965757|582304409|FG003|Extension Phase|Progression of concomitant disease|2|||
161252824|NCT00965757|582304406|FG000|Extension Phase|Adverse drug reaction|0|||
161252825|NCT00965757|582304407|FG001|Extension Phase|Adverse drug reaction|0|||
161252826|NCT00965757|582304408|FG002|Extension Phase|Adverse drug reaction|6|||
161252827|NCT00965757|582304409|FG003|Extension Phase|Adverse drug reaction|3|||
161252828|NCT00965757|582304406|FG000|Extension Phase|Abnormal Laboratory Value|0|||
161252829|NCT00965757|582304407|FG001|Extension Phase|Abnormal Laboratory Value|0|||
161252830|NCT00965757|582304408|FG002|Extension Phase|Abnormal Laboratory Value|6|||
161252831|NCT00965757|582304409|FG003|Extension Phase|Abnormal Laboratory Value|1|||
161252832|NCT00965757|582304406|FG000|Extension Phase|Lack of Efficacy|0|||
161252833|NCT00965757|582304407|FG001|Extension Phase|Lack of Efficacy|0|||
161252834|NCT00965757|582304408|FG002|Extension Phase|Lack of Efficacy|8|||
161252835|NCT00965757|582304409|FG003|Extension Phase|Lack of Efficacy|12|||
161252836|NCT00965757|582304406|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161252837|NCT00965757|582304407|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161252838|NCT00965757|582304408|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
161252839|NCT00965757|582304409|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
161252840|NCT00965757|582304406|FG000|Extension Phase|Lost to Follow-up|0|||
161252841|NCT00965757|582304407|FG001|Extension Phase|Lost to Follow-up|0|||
161252842|NCT00965757|582304408|FG002|Extension Phase|Lost to Follow-up|0|||
161252843|NCT00965757|582304409|FG003|Extension Phase|Lost to Follow-up|1|||
160844769|NCT00172042|580819669|FG000|Overall Study|Abnormal test procedure(s)|0|||
160844770|NCT00172042|580819670|FG001|Overall Study|Abnormal test procedure(s)|3|||
160844771|NCT00172042|580819669|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
160844772|NCT00172042|580819670|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
160844773|NCT00172042|580819669|FG000|Overall Study|Patient no longer requires study drug|10|||
160844774|NCT00172042|580819670|FG001|Overall Study|Patient no longer requires study drug|8|||
160844775|NCT00172042|580819669|FG000|Overall Study|Protocol Violation|8|||
160844776|NCT00172042|580819670|FG001|Overall Study|Protocol Violation|7|||
161140669|NCT04419506|581899164|FG002|Overall Study|Adverse Event|0|||
161140670|NCT04419506|581899165|FG003|Overall Study|Adverse Event|3|||
161140671|NCT04419506|581899162|FG000|Overall Study|Withdrawal by Subject|0|||
161140672|NCT04419506|581899163|FG001|Overall Study|Withdrawal by Subject|0|||
161140673|NCT04419506|581899164|FG002|Overall Study|Withdrawal by Subject|0|||
161140674|NCT04419506|581899165|FG003|Overall Study|Withdrawal by Subject|1|||
161140675|NCT04419506|581899162|FG000|Overall Study|poor-compliance|0|||
161252844|NCT00965757|582304406|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
161252845|NCT00965757|582304407|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
161252846|NCT00965757|582304408|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
160844777|NCT00172042|580819669|FG000|Overall Study|Withdrawal by Subject|37|||
160844778|NCT00172042|580819670|FG001|Overall Study|Withdrawal by Subject|25|||
160844779|NCT00172042|580819669|FG000|Overall Study|Lost to Follow-up|3|||
160844780|NCT00172042|580819670|FG001|Overall Study|Lost to Follow-up|5|||
160844781|NCT00172042|580819669|FG000|Overall Study|Administrative problems|13|||
160844782|NCT00172042|580819670|FG001|Overall Study|Administrative problems|10|||
160844783|NCT00172042|580819669|FG000|Overall Study|Death|42|||
160844784|NCT00172042|580819670|FG001|Overall Study|Death|42|||
160844785|NCT00384332|580819671|FG000|Overall Study|Lost to Follow-up|4|||
160844786|NCT00384332|580819672|FG001|Overall Study|Lost to Follow-up|0|||
160844787|NCT01771250|580819673|FG000|Period 1|Met exclusion criteria|1|||
160844788|NCT01771250|580819674|FG001|Period 1|Met exclusion criteria|0|||
160844789|NCT02058563|580819675|FG000|Overall Study|Lost to Follow-up|26|||
160844790|NCT02058563|580819676|FG001|Overall Study|Lost to Follow-up|22|||
160844791|NCT02058563|580819675|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
160844792|NCT02058563|580819676|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
160844793|NCT02058563|580819675|FG000|Overall Study|Consent Withdrawal|1|||
160844794|NCT02058563|580819676|FG001|Overall Study|Consent Withdrawal|1|||
160844795|NCT02058563|580819675|FG000|Overall Study|Other (patient incarcerated)|0|||
160844796|NCT02058563|580819676|FG001|Overall Study|Other (patient incarcerated)|1|||
160844797|NCT01180296|580819677|FG000|Overall Study|Protocol Violation|1|||
160844798|NCT01180296|580819678|FG001|Overall Study|Protocol Violation|2|||
160844799|NCT00166439|580819679|FG000|Overall Study|Ineligible|5|||
160844800|NCT00483938|580819680|FG000|Overall Study|Protocol Violation|0|||
160844801|NCT00483938|580819681|FG001|Overall Study|Protocol Violation|0|||
160844802|NCT00483938|580819682|FG002|Overall Study|Protocol Violation|0|||
160844803|NCT00483938|580819683|FG003|Overall Study|Protocol Violation|0|||
160844804|NCT00483938|580819684|FG004|Overall Study|Protocol Violation|0|||
160844805|NCT00483938|580819685|FG005|Overall Study|Protocol Violation|0|||
160844806|NCT00483938|580819686|FG006|Overall Study|Protocol Violation|3|||
160844807|NCT00483938|580819680|FG000|Overall Study|Withdrawal by Subject|1|||
160844808|NCT00483938|580819681|FG001|Overall Study|Withdrawal by Subject|6|||
160844809|NCT00483938|580819682|FG002|Overall Study|Withdrawal by Subject|0|||
160844810|NCT00483938|580819683|FG003|Overall Study|Withdrawal by Subject|0|||
160844811|NCT00483938|580819684|FG004|Overall Study|Withdrawal by Subject|1|||
160844812|NCT00483938|580819685|FG005|Overall Study|Withdrawal by Subject|3|||
160844813|NCT00483938|580819686|FG006|Overall Study|Withdrawal by Subject|2|||
160844814|NCT00483938|580819680|FG000|Overall Study|Lost to Follow-up|1|||
160844815|NCT00483938|580819681|FG001|Overall Study|Lost to Follow-up|2|||
160844816|NCT00483938|580819682|FG002|Overall Study|Lost to Follow-up|0|||
160844817|NCT00483938|580819683|FG003|Overall Study|Lost to Follow-up|2|||
160844818|NCT00483938|580819684|FG004|Overall Study|Lost to Follow-up|1|||
160844819|NCT00483938|580819685|FG005|Overall Study|Lost to Follow-up|1|||
160844820|NCT00483938|580819686|FG006|Overall Study|Lost to Follow-up|3|||
160844821|NCT00483938|580819680|FG000|Overall Study|Death|0|||
160844822|NCT00483938|580819681|FG001|Overall Study|Death|2|||
160844823|NCT00483938|580819682|FG002|Overall Study|Death|0|||
160844824|NCT00483938|580819683|FG003|Overall Study|Death|0|||
160844825|NCT00483938|580819684|FG004|Overall Study|Death|0|||
160844826|NCT00483938|580819685|FG005|Overall Study|Death|0|||
160844827|NCT00483938|580819686|FG006|Overall Study|Death|0|||
160844828|NCT00483938|580819680|FG000|Overall Study|Other|3|||
160992319|NCT00828919|581360026|FG001|Overall Study|Objective progression or relapse|4|||
160992320|NCT00828919|581360027|FG002|Overall Study|Objective progression or relapse|11|||
160992321|NCT00828919|581360028|FG003|Overall Study|Objective progression or relapse|0|||
160992322|NCT00828919|581360029|FG004|Overall Study|Objective progression or relapse|5|||
160992323|NCT00828919|581360025|FG000|Overall Study|No longer willing to participate in study|0|||
160992324|NCT00828919|581360026|FG001|Overall Study|No longer willing to participate in study|0|||
160992325|NCT00828919|581360027|FG002|Overall Study|No longer willing to participate in study|2|||
160992326|NCT00828919|581360028|FG003|Overall Study|No longer willing to participate in study|0|||
160992327|NCT00828919|581360029|FG004|Overall Study|No longer willing to participate in study|0|||
160844829|NCT00483938|580819681|FG001|Overall Study|Other|9|||
160844830|NCT00483938|580819682|FG002|Overall Study|Other|0|||
161252847|NCT00965757|582304409|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
160844831|NCT00483938|580819683|FG003|Overall Study|Other|4|||
160844832|NCT00483938|580819684|FG004|Overall Study|Other|0|||
160844833|NCT00483938|580819685|FG005|Overall Study|Other|4|||
160844834|NCT00483938|580819686|FG006|Overall Study|Other|32|||
160844835|NCT00106353|580819693|FG000|Part 1|Disease progression|3|||
160992328|NCT00828919|581360025|FG000|Overall Study|Insufficient Clinical Response|0|||
161252848|NCT00965757|582304406|FG000|Extension Phase|Protocol Violation|0|||
161252849|NCT00965757|582304407|FG001|Extension Phase|Protocol Violation|0|||
160844836|NCT00106353|580819694|FG001|Part 1|Disease progression|4|||
160844837|NCT00106353|580819695|FG002|Part 1|Disease progression|1|||
160844838|NCT00106353|580819696|FG003|Part 1|Disease progression|3|||
160844839|NCT00106353|580819697|FG004|Part 1|Disease progression|0|||
160844840|NCT00106353|580819698|FG005|Part 1|Disease progression|0|||
160844841|NCT00106353|580819699|FG006|Part 1|Disease progression|0|||
160844842|NCT00106353|580819693|FG000|Part 1|Withdrawal by Subject|0|||
160844843|NCT00106353|580819694|FG001|Part 1|Withdrawal by Subject|0|||
160844844|NCT00106353|580819695|FG002|Part 1|Withdrawal by Subject|1|||
160844845|NCT00106353|580819696|FG003|Part 1|Withdrawal by Subject|2|||
160844846|NCT00106353|580819697|FG004|Part 1|Withdrawal by Subject|0|||
160844847|NCT00106353|580819698|FG005|Part 1|Withdrawal by Subject|0|||
160844848|NCT00106353|580819699|FG006|Part 1|Withdrawal by Subject|0|||
160844849|NCT00106353|580819693|FG000|Part 1|Symptomatic deterioration|0|||
160844850|NCT00106353|580819694|FG001|Part 1|Symptomatic deterioration|0|||
160844851|NCT00106353|580819695|FG002|Part 1|Symptomatic deterioration|1|||
160844852|NCT00106353|580819696|FG003|Part 1|Symptomatic deterioration|0|||
160844853|NCT00106353|580819697|FG004|Part 1|Symptomatic deterioration|0|||
160844854|NCT00106353|580819698|FG005|Part 1|Symptomatic deterioration|0|||
160844855|NCT00106353|580819699|FG006|Part 1|Symptomatic deterioration|0|||
160844856|NCT00106353|580819693|FG000|Part 1|Entered follow-up phase|1|||
160844857|NCT00106353|580819694|FG001|Part 1|Entered follow-up phase|1|||
160844858|NCT00106353|580819695|FG002|Part 1|Entered follow-up phase|0|||
160844859|NCT00106353|580819696|FG003|Part 1|Entered follow-up phase|1|||
160844860|NCT00106353|580819697|FG004|Part 1|Entered follow-up phase|0|||
160844861|NCT00106353|580819698|FG005|Part 1|Entered follow-up phase|0|||
160844862|NCT00106353|580819699|FG006|Part 1|Entered follow-up phase|0|||
160844863|NCT00106353|580819693|FG000|Part 1|Adverse Event|0|||
160844864|NCT00106353|580819694|FG001|Part 1|Adverse Event|0|||
160844865|NCT00106353|580819695|FG002|Part 1|Adverse Event|0|||
160844866|NCT00106353|580819696|FG003|Part 1|Adverse Event|1|||
160844867|NCT00106353|580819697|FG004|Part 1|Adverse Event|0|||
160844868|NCT00106353|580819698|FG005|Part 1|Adverse Event|0|||
161252850|NCT00965757|582304408|FG002|Extension Phase|Protocol Violation|0|||
160844869|NCT00106353|580819699|FG006|Part 1|Adverse Event|0|||
160844870|NCT00106353|580819693|FG000|Part 2|Disease progression|0|||
160844871|NCT00106353|580819694|FG001|Part 2|Disease progression|0|||
160844872|NCT00106353|580819695|FG002|Part 2|Disease progression|0|||
160844873|NCT00106353|580819696|FG003|Part 2|Disease progression|0|||
160844874|NCT00106353|580819697|FG004|Part 2|Disease progression|8|||
160844875|NCT00106353|580819698|FG005|Part 2|Disease progression|14|||
160844876|NCT00106353|580819699|FG006|Part 2|Disease progression|13|||
160844877|NCT00106353|580819693|FG000|Part 2|Death|0|||
160844878|NCT00106353|580819694|FG001|Part 2|Death|0|||
160844879|NCT00106353|580819695|FG002|Part 2|Death|0|||
160844880|NCT00106353|580819696|FG003|Part 2|Death|0|||
160844881|NCT00106353|580819697|FG004|Part 2|Death|3|||
160844882|NCT00106353|580819698|FG005|Part 2|Death|0|||
160844883|NCT00106353|580819699|FG006|Part 2|Death|1|||
160844884|NCT00106353|580819693|FG000|Part 2|Symptomatic deterioration|0|||
160844885|NCT00106353|580819694|FG001|Part 2|Symptomatic deterioration|0|||
160844886|NCT00106353|580819695|FG002|Part 2|Symptomatic deterioration|0|||
160844887|NCT00106353|580819696|FG003|Part 2|Symptomatic deterioration|0|||
160844888|NCT00106353|580819697|FG004|Part 2|Symptomatic deterioration|3|||
160844889|NCT00106353|580819698|FG005|Part 2|Symptomatic deterioration|0|||
160844890|NCT00106353|580819699|FG006|Part 2|Symptomatic deterioration|0|||
160844891|NCT00106353|580819693|FG000|Part 2|Adverse Event|0|||
160844892|NCT00106353|580819694|FG001|Part 2|Adverse Event|0|||
160844893|NCT00106353|580819695|FG002|Part 2|Adverse Event|0|||
160844894|NCT00106353|580819696|FG003|Part 2|Adverse Event|0|||
160844895|NCT00106353|580819697|FG004|Part 2|Adverse Event|0|||
160844896|NCT00106353|580819698|FG005|Part 2|Adverse Event|2|||
160844897|NCT00106353|580819699|FG006|Part 2|Adverse Event|1|||
160844898|NCT00106353|580819693|FG000|Part 2|Other|0|||
160844899|NCT00106353|580819694|FG001|Part 2|Other|0|||
160844900|NCT00106353|580819695|FG002|Part 2|Other|0|||
161252851|NCT00965757|582304409|FG003|Extension Phase|Protocol Violation|1|||
160844901|NCT00106353|580819696|FG003|Part 2|Other|0|||
160844902|NCT00106353|580819697|FG004|Part 2|Other|1|||
160844903|NCT00106353|580819698|FG005|Part 2|Other|1|||
160844904|NCT00106353|580819699|FG006|Part 2|Other|1|||
160844905|NCT00106353|580819693|FG000|Part 2|Withdrawal by Subject|0|||
160844906|NCT00106353|580819694|FG001|Part 2|Withdrawal by Subject|0|||
160844907|NCT00106353|580819695|FG002|Part 2|Withdrawal by Subject|0|||
160844908|NCT00106353|580819696|FG003|Part 2|Withdrawal by Subject|0|||
160844909|NCT00106353|580819697|FG004|Part 2|Withdrawal by Subject|1|||
160844910|NCT00106353|580819698|FG005|Part 2|Withdrawal by Subject|0|||
160844911|NCT00106353|580819699|FG006|Part 2|Withdrawal by Subject|0|||
160844912|NCT00106353|580819693|FG000|Part 2|Physician Decision|0|||
160844913|NCT00106353|580819694|FG001|Part 2|Physician Decision|0|||
160844914|NCT00106353|580819695|FG002|Part 2|Physician Decision|0|||
160844915|NCT00106353|580819696|FG003|Part 2|Physician Decision|0|||
160844916|NCT00106353|580819697|FG004|Part 2|Physician Decision|0|||
160844917|NCT00106353|580819698|FG005|Part 2|Physician Decision|1|||
161252852|NCT00965757|582304406|FG000|Extension Phase|Other|0|||
160844918|NCT00106353|580819699|FG006|Part 2|Physician Decision|0|||
160844919|NCT04039217|580819700|FG000|Overall Study|Lost to Follow-up|1|||
160844920|NCT01278797|580819701|FG000|Period 1|Adverse Event|0|||
160844921|NCT01278797|580819702|FG001|Period 1|Adverse Event|1|||
160844922|NCT01278797|580819701|FG000|Period 1|Protocol Violation|1|||
160844923|NCT01278797|580819702|FG001|Period 1|Protocol Violation|0|||
160844924|NCT00588354|580819703|FG000|Baseline to 2 Weeks|Adverse Event|1|||
160844925|NCT00588354|580819704|FG001|Baseline to 2 Weeks|Adverse Event|0|||
160844926|NCT00588354|580819703|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
160844927|NCT00588354|580819704|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
160844928|NCT00588354|580819703|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
160844929|NCT00588354|580819704|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
161252853|NCT00965757|582304407|FG001|Extension Phase|Other|0|||
161252854|NCT00965757|582304408|FG002|Extension Phase|Other|2|||
161252855|NCT00965757|582304409|FG003|Extension Phase|Other|1|||
161252856|NCT01344018|582304413|FG000|Overall Study|Death|22|||
161252857|NCT01344018|582304414|FG001|Overall Study|Death|25|||
160844930|NCT03364309|580819705|FG000|Induction Period|Adverse Event|4|||
160844931|NCT03364309|580819706|FG001|Induction Period|Adverse Event|0|||
160844932|NCT03364309|580819707|FG002|Induction Period|Adverse Event|1|||
160844933|NCT03364309|580819708|FG003|Induction Period|Adverse Event|0|||
160844934|NCT03364309|580819709|FG004|Induction Period|Adverse Event|0|||
160844935|NCT03364309|580819710|FG005|Induction Period|Adverse Event|0|||
160844936|NCT03364309|580819711|FG006|Induction Period|Adverse Event|0|||
160844937|NCT03364309|580819712|FG007|Induction Period|Adverse Event|0|||
160844938|NCT03364309|580819713|FG008|Induction Period|Adverse Event|0|||
160844939|NCT03364309|580819714|FG009|Induction Period|Adverse Event|0|||
160844940|NCT03364309|580819715|FG010|Induction Period|Adverse Event|0|||
160844941|NCT03364309|580819716|FG011|Induction Period|Adverse Event|0|||
160844942|NCT03364309|580819717|FG012|Induction Period|Adverse Event|0|||
160844943|NCT03364309|580819718|FG013|Induction Period|Adverse Event|0|||
160844944|NCT03364309|580819719|FG014|Induction Period|Adverse Event|0|||
160844945|NCT03364309|580819720|FG015|Induction Period|Adverse Event|0|||
160844946|NCT03364309|580819721|FG016|Induction Period|Adverse Event|0|||
160844947|NCT03364309|580819722|FG017|Induction Period|Adverse Event|0|||
160844948|NCT03364309|580819723|FG018|Induction Period|Adverse Event|0|||
160844949|NCT03364309|580819705|FG000|Induction Period|Withdrawal by Subject|1|||
160844950|NCT03364309|580819706|FG001|Induction Period|Withdrawal by Subject|3|||
160844951|NCT03364309|580819707|FG002|Induction Period|Withdrawal by Subject|0|||
160844952|NCT03364309|580819708|FG003|Induction Period|Withdrawal by Subject|0|||
160844953|NCT03364309|580819709|FG004|Induction Period|Withdrawal by Subject|0|||
160844954|NCT03364309|580819710|FG005|Induction Period|Withdrawal by Subject|0|||
160844955|NCT03364309|580819711|FG006|Induction Period|Withdrawal by Subject|0|||
160844956|NCT03364309|580819712|FG007|Induction Period|Withdrawal by Subject|0|||
160844957|NCT03364309|580819713|FG008|Induction Period|Withdrawal by Subject|0|||
160844958|NCT03364309|580819714|FG009|Induction Period|Withdrawal by Subject|0|||
160844959|NCT03364309|580819715|FG010|Induction Period|Withdrawal by Subject|0|||
160844960|NCT03364309|580819716|FG011|Induction Period|Withdrawal by Subject|0|||
160844961|NCT03364309|580819717|FG012|Induction Period|Withdrawal by Subject|0|||
160844962|NCT03364309|580819718|FG013|Induction Period|Withdrawal by Subject|0|||
160844963|NCT03364309|580819719|FG014|Induction Period|Withdrawal by Subject|0|||
160844964|NCT03364309|580819720|FG015|Induction Period|Withdrawal by Subject|0|||
160844965|NCT03364309|580819721|FG016|Induction Period|Withdrawal by Subject|0|||
160844966|NCT03364309|580819722|FG017|Induction Period|Withdrawal by Subject|0|||
160844967|NCT03364309|580819723|FG018|Induction Period|Withdrawal by Subject|0|||
160844968|NCT03364309|580819705|FG000|Induction Period|Lost to Follow-up|1|||
160844969|NCT03364309|580819706|FG001|Induction Period|Lost to Follow-up|0|||
160844970|NCT03364309|580819707|FG002|Induction Period|Lost to Follow-up|0|||
160844971|NCT03364309|580819708|FG003|Induction Period|Lost to Follow-up|0|||
160844972|NCT03364309|580819709|FG004|Induction Period|Lost to Follow-up|0|||
160844973|NCT03364309|580819710|FG005|Induction Period|Lost to Follow-up|0|||
160844974|NCT03364309|580819711|FG006|Induction Period|Lost to Follow-up|0|||
160844975|NCT03364309|580819712|FG007|Induction Period|Lost to Follow-up|0|||
160844976|NCT03364309|580819713|FG008|Induction Period|Lost to Follow-up|0|||
161252858|NCT01344018|582304413|FG000|Overall Study|Lost to Follow-up|4|||
161252859|NCT01344018|582304414|FG001|Overall Study|Lost to Follow-up|7|||
161252860|NCT04010227|582304415|FG000|Overall Study|Death|1|||
161252861|NCT04010227|582304416|FG001|Overall Study|Death|2|||
161252862|NCT04010227|582304415|FG000|Overall Study|Medical Reasons|4|||
161252863|NCT04010227|582304416|FG001|Overall Study|Medical Reasons|3|||
160844977|NCT03364309|580819714|FG009|Induction Period|Lost to Follow-up|0|||
160844978|NCT03364309|580819715|FG010|Induction Period|Lost to Follow-up|0|||
160844979|NCT03364309|580819716|FG011|Induction Period|Lost to Follow-up|0|||
160844980|NCT03364309|580819717|FG012|Induction Period|Lost to Follow-up|0|||
160844981|NCT03364309|580819718|FG013|Induction Period|Lost to Follow-up|0|||
160844982|NCT03364309|580819719|FG014|Induction Period|Lost to Follow-up|0|||
160844983|NCT03364309|580819720|FG015|Induction Period|Lost to Follow-up|0|||
160844984|NCT03364309|580819721|FG016|Induction Period|Lost to Follow-up|0|||
160905970|NCT02582983|581050317|FG000|Overall Study|Death|3|||
161252864|NCT04010227|582304415|FG000|Overall Study|Withdrawal by Subject|2|||
161252865|NCT04010227|582304416|FG001|Overall Study|Withdrawal by Subject|0|||
161252866|NCT04010227|582304415|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
160844985|NCT03364309|580819722|FG017|Induction Period|Lost to Follow-up|0|||
160844986|NCT03364309|580819723|FG018|Induction Period|Lost to Follow-up|0|||
160905971|NCT02582983|581050317|FG000|Overall Study|Withdrawal by Subject|2|||
160905972|NCT02582983|581050317|FG000|Overall Study|Adverse Event|1|||
160905973|NCT02059395|581050318|FG000|Overall Study|Lost to Follow-up|2|||
160905974|NCT02059395|581050319|FG001|Overall Study|Lost to Follow-up|4|||
160905975|NCT05209360|581050320|FG000|Overall Study|Withdrawal by Subject|0|||
160905976|NCT05209360|581050321|FG001|Overall Study|Withdrawal by Subject|0|||
160905977|NCT05209360|581050322|FG002|Overall Study|Withdrawal by Subject|1|||
160905978|NCT05209360|581050323|FG003|Overall Study|Withdrawal by Subject|0|||
160905979|NCT05209360|581050324|FG004|Overall Study|Withdrawal by Subject|0|||
160905980|NCT05209360|581050325|FG005|Overall Study|Withdrawal by Subject|0|||
160905981|NCT02021331|581050326|FG000|Overall Study|Adverse Event|0|||
160905982|NCT02021331|581050327|FG001|Overall Study|Adverse Event|2|||
160905983|NCT02340975|581050338|FG000|Overall Study|Death|6|||
160992329|NCT00828919|581360026|FG001|Overall Study|Insufficient Clinical Response|1|||
160992330|NCT00828919|581360027|FG002|Overall Study|Insufficient Clinical Response|2|||
160992331|NCT00828919|581360028|FG003|Overall Study|Insufficient Clinical Response|0|||
160992332|NCT00828919|581360029|FG004|Overall Study|Insufficient Clinical Response|0|||
160992333|NCT00828919|581360025|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992334|NCT00828919|581360026|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992335|NCT00828919|581360027|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992336|NCT00828919|581360028|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
160992337|NCT00828919|581360029|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
160992338|NCT00828919|581360025|FG000|Overall Study|Other|1|||
160992339|NCT00828919|581360026|FG001|Overall Study|Other|0|||
160992340|NCT00828919|581360027|FG002|Overall Study|Other|1|||
160992341|NCT00828919|581360028|FG003|Overall Study|Other|1|||
160992342|NCT00828919|581360029|FG004|Overall Study|Other|0|||
160992343|NCT00828919|581360025|FG000|Overall Study|Lost to Follow-up|0|||
160992344|NCT00828919|581360026|FG001|Overall Study|Lost to Follow-up|1|||
160992345|NCT00828919|581360027|FG002|Overall Study|Lost to Follow-up|0|||
160992346|NCT00828919|581360028|FG003|Overall Study|Lost to Follow-up|0|||
160992347|NCT00828919|581360029|FG004|Overall Study|Lost to Follow-up|0|||
160992348|NCT01562743|581360030|FG000|Overall Study|Adverse Event|29|||
160992349|NCT01562743|581360030|FG000|Overall Study|Lack of Efficacy|3|||
161252867|NCT04010227|582304416|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
161252868|NCT02308696|582304417|FG000|Overall Study|Lost to Follow-up|28|||
161252869|NCT02308696|582304418|FG001|Overall Study|Lost to Follow-up|21|||
161252870|NCT02308696|582304417|FG000|Overall Study|Death|8|||
161252871|NCT02308696|582304418|FG001|Overall Study|Death|4|||
160844987|NCT03364309|580819705|FG000|Induction Period|Physician Decision|0|||
160844988|NCT03364309|580819706|FG001|Induction Period|Physician Decision|1|||
160844989|NCT03364309|580819707|FG002|Induction Period|Physician Decision|0|||
160844990|NCT03364309|580819708|FG003|Induction Period|Physician Decision|0|||
160844991|NCT03364309|580819709|FG004|Induction Period|Physician Decision|0|||
160844992|NCT03364309|580819710|FG005|Induction Period|Physician Decision|0|||
160905984|NCT02340975|581050339|FG001|Overall Study|Death|23|||
160905985|NCT02340975|581050340|FG002|Overall Study|Death|21|||
160905986|NCT02340975|581050341|FG003|Overall Study|Death|7|||
160992350|NCT01562743|581360030|FG000|Overall Study|Withdrawal by Subject|13|||
160844993|NCT03364309|580819711|FG006|Induction Period|Physician Decision|0|||
160844994|NCT03364309|580819712|FG007|Induction Period|Physician Decision|0|||
160844995|NCT03364309|580819713|FG008|Induction Period|Physician Decision|0|||
160844996|NCT03364309|580819714|FG009|Induction Period|Physician Decision|0|||
160844997|NCT03364309|580819715|FG010|Induction Period|Physician Decision|0|||
160844998|NCT03364309|580819716|FG011|Induction Period|Physician Decision|0|||
160844999|NCT03364309|580819717|FG012|Induction Period|Physician Decision|0|||
160845000|NCT03364309|580819718|FG013|Induction Period|Physician Decision|0|||
160845001|NCT03364309|580819719|FG014|Induction Period|Physician Decision|0|||
160845002|NCT03364309|580819720|FG015|Induction Period|Physician Decision|0|||
160845003|NCT03364309|580819721|FG016|Induction Period|Physician Decision|0|||
160845004|NCT03364309|580819722|FG017|Induction Period|Physician Decision|0|||
160905987|NCT02340975|581050342|FG004|Overall Study|Death|21|||
160905988|NCT02340975|581050343|FG005|Overall Study|Death|13|||
160992351|NCT01562743|581360030|FG000|Overall Study|Protocol Violation|1|||
160992352|NCT01562743|581360030|FG000|Overall Study|Discontinuation criteria|2|||
160992353|NCT01562743|581360030|FG000|Overall Study|Lost to Follow-up|2|||
160992354|NCT01562743|581360030|FG000|Overall Study|Physician Decision|2|||
161252872|NCT02308696|582304417|FG000|Overall Study|Moved to a Higher Level of Care|17|||
160992355|NCT05567159|581360031|FG000|Overall Study|Adverse Event|4|||
161252873|NCT02308696|582304418|FG001|Overall Study|Moved to a Higher Level of Care|6|||
161252874|NCT02914457|582304419|FG000|Overall Study|Withdrawal by Subject|1|||
161252875|NCT02914457|582304419|FG000|Overall Study|Physician Decision|1|||
161252876|NCT02914457|582304419|FG000|Overall Study|No veins available for lead placement|1|||
160905989|NCT02340975|581050338|FG000|Overall Study|Lost to Follow-up|0|||
160905990|NCT02340975|581050339|FG001|Overall Study|Lost to Follow-up|0|||
161252877|NCT02914457|582304419|FG000|Overall Study|Electrical instability of patient|1|||
161252878|NCT02914457|582304419|FG000|Overall Study|ECG acquisition error due to sweating|1|||
161252879|NCT02914457|582304419|FG000|Overall Study|Protocol Violation|1|||
161252880|NCT03843125|582304420|FG000|Overall Study|Adverse Event|17|||
161252881|NCT03843125|582304421|FG001|Overall Study|Adverse Event|13|||
161252882|NCT03843125|582304422|FG002|Overall Study|Adverse Event|5|||
161252883|NCT03843125|582304423|FG003|Overall Study|Adverse Event|9|||
160845005|NCT03364309|580819723|FG018|Induction Period|Physician Decision|0|||
160845006|NCT03364309|580819705|FG000|Maintenance Period|Withdrawal by Subject|0|||
160845007|NCT03364309|580819706|FG001|Maintenance Period|Withdrawal by Subject|0|||
160845008|NCT03364309|580819707|FG002|Maintenance Period|Withdrawal by Subject|0|||
160845009|NCT03364309|580819708|FG003|Maintenance Period|Withdrawal by Subject|1|||
160845010|NCT03364309|580819709|FG004|Maintenance Period|Withdrawal by Subject|3|||
160845011|NCT03364309|580819710|FG005|Maintenance Period|Withdrawal by Subject|1|||
160845012|NCT03364309|580819711|FG006|Maintenance Period|Withdrawal by Subject|3|||
160845013|NCT03364309|580819712|FG007|Maintenance Period|Withdrawal by Subject|0|||
160845014|NCT03364309|580819713|FG008|Maintenance Period|Withdrawal by Subject|1|||
160845015|NCT03364309|580819714|FG009|Maintenance Period|Withdrawal by Subject|1|||
160845016|NCT03364309|580819715|FG010|Maintenance Period|Withdrawal by Subject|2|||
160845017|NCT03364309|580819716|FG011|Maintenance Period|Withdrawal by Subject|0|||
160845018|NCT03364309|580819717|FG012|Maintenance Period|Withdrawal by Subject|0|||
160845019|NCT03364309|580819718|FG013|Maintenance Period|Withdrawal by Subject|0|||
160845020|NCT03364309|580819719|FG014|Maintenance Period|Withdrawal by Subject|0|||
160845021|NCT03364309|580819720|FG015|Maintenance Period|Withdrawal by Subject|0|||
160845022|NCT03364309|580819721|FG016|Maintenance Period|Withdrawal by Subject|0|||
160845023|NCT03364309|580819722|FG017|Maintenance Period|Withdrawal by Subject|0|||
160845024|NCT03364309|580819723|FG018|Maintenance Period|Withdrawal by Subject|0|||
160845025|NCT03364309|580819705|FG000|Maintenance Period|Adverse Event|0|||
160845026|NCT03364309|580819706|FG001|Maintenance Period|Adverse Event|0|||
160845027|NCT03364309|580819707|FG002|Maintenance Period|Adverse Event|0|||
161252884|NCT03843125|582304420|FG000|Overall Study|Death|0|||
161252885|NCT03843125|582304421|FG001|Overall Study|Death|6|||
161252886|NCT03843125|582304422|FG002|Overall Study|Death|2|||
161252887|NCT03843125|582304423|FG003|Overall Study|Death|0|||
161252888|NCT03843125|582304420|FG000|Overall Study|Lack of Efficacy|14|||
161252889|NCT03843125|582304421|FG001|Overall Study|Lack of Efficacy|11|||
161252890|NCT03843125|582304422|FG002|Overall Study|Lack of Efficacy|9|||
161252891|NCT03843125|582304423|FG003|Overall Study|Lack of Efficacy|4|||
161252892|NCT03843125|582304420|FG000|Overall Study|Lost to Follow-up|3|||
161252893|NCT03843125|582304421|FG001|Overall Study|Lost to Follow-up|4|||
161252894|NCT03843125|582304422|FG002|Overall Study|Lost to Follow-up|0|||
161252895|NCT03843125|582304423|FG003|Overall Study|Lost to Follow-up|2|||
161252896|NCT03843125|582304420|FG000|Overall Study|Other|12|||
161252897|NCT03843125|582304421|FG001|Overall Study|Other|14|||
161252898|NCT03843125|582304422|FG002|Overall Study|Other|3|||
161252899|NCT03843125|582304423|FG003|Overall Study|Other|4|||
161252900|NCT03843125|582304420|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
161252901|NCT03843125|582304421|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
161252902|NCT03843125|582304422|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
161252903|NCT03843125|582304423|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
161252904|NCT03843125|582304420|FG000|Overall Study|Study Terminated by Sponsor|318|||
161252905|NCT03843125|582304421|FG001|Overall Study|Study Terminated by Sponsor|318|||
160845028|NCT03364309|580819708|FG003|Maintenance Period|Adverse Event|0|||
160845029|NCT03364309|580819709|FG004|Maintenance Period|Adverse Event|2|||
160845030|NCT03364309|580819710|FG005|Maintenance Period|Adverse Event|0|||
160845031|NCT03364309|580819711|FG006|Maintenance Period|Adverse Event|3|||
160845032|NCT03364309|580819712|FG007|Maintenance Period|Adverse Event|0|||
160845033|NCT03364309|580819713|FG008|Maintenance Period|Adverse Event|1|||
160845034|NCT03364309|580819714|FG009|Maintenance Period|Adverse Event|0|||
160845035|NCT03364309|580819715|FG010|Maintenance Period|Adverse Event|2|||
160845036|NCT03364309|580819716|FG011|Maintenance Period|Adverse Event|0|||
160845037|NCT03364309|580819717|FG012|Maintenance Period|Adverse Event|0|||
161252906|NCT03843125|582304422|FG002|Overall Study|Study Terminated by Sponsor|163|||
160845038|NCT03364309|580819718|FG013|Maintenance Period|Adverse Event|0|||
160845039|NCT03364309|580819719|FG014|Maintenance Period|Adverse Event|0|||
160845040|NCT03364309|580819720|FG015|Maintenance Period|Adverse Event|0|||
160845041|NCT03364309|580819721|FG016|Maintenance Period|Adverse Event|0|||
160845042|NCT03364309|580819722|FG017|Maintenance Period|Adverse Event|0|||
161252907|NCT03843125|582304423|FG003|Overall Study|Study Terminated by Sponsor|163|||
161252908|NCT03843125|582304420|FG000|Overall Study|Withdrawal by Subject|23|||
161252909|NCT03843125|582304421|FG001|Overall Study|Withdrawal by Subject|12|||
161252910|NCT03843125|582304422|FG002|Overall Study|Withdrawal by Subject|6|||
161252911|NCT03843125|582304423|FG003|Overall Study|Withdrawal by Subject|9|||
161252912|NCT03843125|582304420|FG000|Overall Study|Missing data|0|||
161252913|NCT03843125|582304421|FG001|Overall Study|Missing data|1|||
161252914|NCT03843125|582304422|FG002|Overall Study|Missing data|1|||
160845043|NCT03364309|580819723|FG018|Maintenance Period|Adverse Event|0|||
160845044|NCT03364309|580819705|FG000|Maintenance Period|Relapsed|0|||
161252915|NCT03843125|582304423|FG003|Overall Study|Missing data|0|||
160845045|NCT03364309|580819706|FG001|Maintenance Period|Relapsed|0|||
160845046|NCT03364309|580819707|FG002|Maintenance Period|Relapsed|0|||
161252916|NCT01055886|582304424|FG000|Overall Study|Withdrawal by Subject|4|||
161252917|NCT01055886|582304425|FG001|Overall Study|Withdrawal by Subject|9|||
161252918|NCT01055886|582304424|FG000|Overall Study|Lost to Follow-up|1|||
161252919|NCT01055886|582304425|FG001|Overall Study|Lost to Follow-up|1|||
161252920|NCT01055886|582304424|FG000|Overall Study|Withdrawal by PI|0|||
161252921|NCT01055886|582304425|FG001|Overall Study|Withdrawal by PI|1|||
161252922|NCT04254809|582304428|FG000|Overall Study|Lost to Follow-up|5|||
161252923|NCT04254809|582304429|FG001|Overall Study|Lost to Follow-up|10|||
161252924|NCT01928615|582304430|FG000|Overall Study|Study Terminated by Sponsor|2|||
161252925|NCT02972515|582304431|FG000|Overall Study|Lost to Follow-up|78|||
161252926|NCT04531527|582304432|FG000|Overall Study|Found to be Ineligible|3|||
161252927|NCT01077258|582304440|FG000|Overall Study|Lost to Follow-up|1390|||
161252928|NCT01077258|582304440|FG000|Overall Study|Adverse drug reaction|218|||
161252929|NCT01077258|582304440|FG000|Overall Study|Lack of Efficacy|663|||
161252930|NCT01077258|582304440|FG000|Overall Study|Clinical remission|37|||
161252931|NCT01077258|582304440|FG000|Overall Study|Other reasons|260|||
161252932|NCT00726895|582304441|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161252933|NCT00726895|582304442|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161252934|NCT01881737|582304446|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
161252935|NCT01881737|582304446|FG000|Overall Study|Withdrawal by Subject|1|||
161252936|NCT01881737|582304446|FG000|Overall Study|Worsening of baseline behavior|1|||
161252937|NCT03496298|582304447|FG000|Overall Study|Adverse Event|49|||
161252938|NCT03496298|582304448|FG001|Overall Study|Adverse Event|68|||
161252939|NCT03496298|582304449|FG002|Overall Study|Adverse Event|79|||
161252940|NCT03496298|582304447|FG000|Overall Study|Study terminated by Sponsor|1050|||
161252941|NCT03496298|582304448|FG001|Overall Study|Study terminated by Sponsor|1063|||
161252942|NCT03496298|582304449|FG002|Overall Study|Study terminated by Sponsor|1071|||
161252943|NCT03496298|582304447|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
161252944|NCT03496298|582304448|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
161252945|NCT03496298|582304449|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
161252946|NCT03496298|582304447|FG000|Overall Study|Withdrawal by Subject|176|||
161252947|NCT03496298|582304448|FG001|Overall Study|Withdrawal by Subject|154|||
161252948|NCT03496298|582304449|FG002|Overall Study|Withdrawal by Subject|151|||
161252949|NCT03496298|582304447|FG000|Overall Study|Other|29|||
161252950|NCT03496298|582304448|FG001|Overall Study|Other|20|||
161252951|NCT03496298|582304449|FG002|Overall Study|Other|23|||
161252952|NCT03496298|582304447|FG000|Overall Study|Randomized and not treated|1|||
161252953|NCT03496298|582304448|FG001|Overall Study|Randomized and not treated|1|||
161252954|NCT03496298|582304449|FG002|Overall Study|Randomized and not treated|1|||
161252955|NCT02608476|582304452|FG000|Overall Study|Withdrawal by Subject|30|||
161252956|NCT02608476|582304453|FG001|Overall Study|Withdrawal by Subject|37|||
161252957|NCT02608476|582304452|FG000|Overall Study|Lost to Follow-up|24|||
161252958|NCT02608476|582304453|FG001|Overall Study|Lost to Follow-up|24|||
161252959|NCT02608476|582304452|FG000|Overall Study|Adverse Event|2|||
161252960|NCT02608476|582304453|FG001|Overall Study|Adverse Event|8|||
161252961|NCT02608476|582304452|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
161252962|NCT02608476|582304453|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
161252963|NCT02608476|582304452|FG000|Overall Study|Noncompliance with treatment|1|||
161252964|NCT02608476|582304453|FG001|Overall Study|Noncompliance with treatment|5|||
161252965|NCT02608476|582304452|FG000|Overall Study|Lack of Efficacy|3|||
161252966|NCT02608476|582304453|FG001|Overall Study|Lack of Efficacy|1|||
161252967|NCT02608476|582304452|FG000|Overall Study|Other|0|||
161252968|NCT02608476|582304453|FG001|Overall Study|Other|1|||
161252969|NCT02608476|582304452|FG000|Overall Study|Physician Decision|1|||
161336388|NCT01791595|582621723|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160845047|NCT03364309|580819708|FG003|Maintenance Period|Relapsed|43|||
160845048|NCT03364309|580819709|FG004|Maintenance Period|Relapsed|7|||
160845049|NCT03364309|580819710|FG005|Maintenance Period|Relapsed|45|||
160845050|NCT03364309|580819711|FG006|Maintenance Period|Relapsed|10|||
160845051|NCT03364309|580819712|FG007|Maintenance Period|Relapsed|2|||
160845052|NCT03364309|580819713|FG008|Maintenance Period|Relapsed|0|||
160845053|NCT03364309|580819714|FG009|Maintenance Period|Relapsed|0|||
160845054|NCT03364309|580819715|FG010|Maintenance Period|Relapsed|0|||
161252970|NCT02608476|582304453|FG001|Overall Study|Physician Decision|0|||
161252971|NCT02608476|582304452|FG000|Overall Study|Pregnancy|0|||
161252972|NCT02608476|582304453|FG001|Overall Study|Pregnancy|1|||
161252973|NCT02608476|582304452|FG000|Overall Study|Progressive disease|1|||
161252974|NCT02608476|582304453|FG001|Overall Study|Progressive disease|0|||
161252975|NCT00676494|582304454|FG000|Overall Study|Missed Visit|8|||
161252976|NCT00676494|582304454|FG000|Overall Study|Withdrawal by Subject|6|||
161252977|NCT02058160|582304456|FG000|Overall Study|Randomized but not treated|2|||
161252978|NCT02058160|582304457|FG001|Overall Study|Randomized but not treated|4|||
161252979|NCT02058160|582304456|FG000|Overall Study|Poor compliance to protocol|4|||
160845055|NCT03364309|580819716|FG011|Maintenance Period|Relapsed|0|||
161252980|NCT02058160|582304457|FG001|Overall Study|Poor compliance to protocol|1|||
161252981|NCT02058160|582304456|FG000|Overall Study|Adverse Event|12|||
160845056|NCT03364309|580819717|FG012|Maintenance Period|Relapsed|0|||
160845057|NCT03364309|580819718|FG013|Maintenance Period|Relapsed|0|||
160845058|NCT03364309|580819719|FG014|Maintenance Period|Relapsed|0|||
160845059|NCT03364309|580819720|FG015|Maintenance Period|Relapsed|0|||
160845060|NCT03364309|580819721|FG016|Maintenance Period|Relapsed|0|||
160845061|NCT03364309|580819722|FG017|Maintenance Period|Relapsed|0|||
160845062|NCT03364309|580819723|FG018|Maintenance Period|Relapsed|0|||
161252982|NCT02058160|582304457|FG001|Overall Study|Adverse Event|3|||
161252983|NCT02058160|582304456|FG000|Overall Study|Lost to Follow-up|1|||
161252984|NCT02058160|582304457|FG001|Overall Study|Lost to Follow-up|0|||
161252985|NCT02058160|582304456|FG000|Overall Study|Other than specified above|12|||
161252986|NCT02058160|582304457|FG001|Overall Study|Other than specified above|6|||
161252987|NCT04106817|582304458|FG000|Overall Study|Lost to Follow-up|1|||
161252988|NCT04106817|582304459|FG001|Overall Study|Lost to Follow-up|0|||
161252989|NCT04106817|582304460|FG002|Overall Study|Lost to Follow-up|0|||
161252990|NCT01203917|582304461|FG000|Overall Study|Death|29|||
161252991|NCT01203917|582304461|FG000|Overall Study|Lost to Follow-up|2|||
161252992|NCT01203917|582304461|FG000|Overall Study|Withdrawal by Subject|3|||
161252993|NCT01203917|582304461|FG000|Overall Study|Due to objective disease progression|1|||
161252994|NCT01203917|582304461|FG000|Overall Study|Due to EGFR M+I patient|1|||
161252995|NCT02260635|582304462|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
161252996|NCT02260635|582304463|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
161252997|NCT02260635|582304462|FG000|Open-Label Extension|Study Termination|25|||
161252998|NCT02260635|582304463|FG001|Open-Label Extension|Study Termination|25|||
161252999|NCT02260635|582304462|FG000|Open-Label Extension|Withdrawal by Subject|1|||
161253000|NCT02260635|582304463|FG001|Open-Label Extension|Withdrawal by Subject|0|||
161253001|NCT03310619|582304464|FG000|Pre-Treatment Period|Death|1|||
161253002|NCT03310619|582304465|FG001|Pre-Treatment Period|Death|0|||
161253003|NCT03310619|582304466|FG002|Pre-Treatment Period|Death|0|||
161253004|NCT03310619|582304467|FG003|Pre-Treatment Period|Death|0|||
161253005|NCT03310619|582304468|FG004|Pre-Treatment Period|Death|1|||
161253006|NCT03310619|582304469|FG005|Pre-Treatment Period|Death|0|||
161253007|NCT03310619|582304470|FG006|Pre-Treatment Period|Death|0|||
161253008|NCT03310619|582304471|FG007|Pre-Treatment Period|Death|0|||
161253009|NCT03310619|582304464|FG000|Pre-Treatment Period|Other reasons|2|||
161253010|NCT03310619|582304465|FG001|Pre-Treatment Period|Other reasons|1|||
161253011|NCT03310619|582304466|FG002|Pre-Treatment Period|Other reasons|2|||
161253012|NCT03310619|582304467|FG003|Pre-Treatment Period|Other reasons|0|||
161253013|NCT03310619|582304468|FG004|Pre-Treatment Period|Other reasons|0|||
161336389|NCT01791595|582621724|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
160845063|NCT03364309|580819705|FG000|Maintenance Period|Lack of Efficacy|0|||
160845064|NCT03364309|580819706|FG001|Maintenance Period|Lack of Efficacy|0|||
160845065|NCT03364309|580819707|FG002|Maintenance Period|Lack of Efficacy|0|||
160845066|NCT03364309|580819708|FG003|Maintenance Period|Lack of Efficacy|0|||
160845067|NCT03364309|580819709|FG004|Maintenance Period|Lack of Efficacy|0|||
160845068|NCT03364309|580819710|FG005|Maintenance Period|Lack of Efficacy|0|||
160845069|NCT03364309|580819711|FG006|Maintenance Period|Lack of Efficacy|0|||
160845070|NCT03364309|580819712|FG007|Maintenance Period|Lack of Efficacy|0|||
160845071|NCT03364309|580819713|FG008|Maintenance Period|Lack of Efficacy|1|||
161140676|NCT04419506|581899163|FG001|Overall Study|poor-compliance|0|||
160845072|NCT03364309|580819714|FG009|Maintenance Period|Lack of Efficacy|3|||
160845073|NCT03364309|580819715|FG010|Maintenance Period|Lack of Efficacy|2|||
160845074|NCT03364309|580819716|FG011|Maintenance Period|Lack of Efficacy|0|||
160845075|NCT03364309|580819717|FG012|Maintenance Period|Lack of Efficacy|0|||
161140677|NCT04419506|581899164|FG002|Overall Study|poor-compliance|0|||
161140678|NCT04419506|581899165|FG003|Overall Study|poor-compliance|1|||
161140679|NCT04329949|581899166|FG000|Overall Study|Death|36|||
161140680|NCT04329949|581899166|FG000|Overall Study|Withdrawal by Subject|4|||
161140681|NCT04329949|581899166|FG000|Overall Study|Termination of study by sponsor|3|||
161140682|NCT00345605|581899171|FG000|Arm 1|Adverse Event|0|||
161140683|NCT00345605|581899172|FG001|Arm 1|Adverse Event|1|||
161140684|NCT00345605|581899171|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
161140685|NCT00345605|581899172|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
161140686|NCT01324830|581899173|FG000|Overall Study|Progressive Disease|3|||
161140687|NCT01324830|581899174|FG001|Overall Study|Progressive Disease|2|||
161140688|NCT01324830|581899175|FG002|Overall Study|Progressive Disease|3|||
161140689|NCT01324830|581899176|FG003|Overall Study|Progressive Disease|3|||
161140690|NCT01324830|581899177|FG004|Overall Study|Progressive Disease|6|||
161140691|NCT01324830|581899178|FG005|Overall Study|Progressive Disease|6|||
161140692|NCT01324830|581899179|FG006|Overall Study|Progressive Disease|3|||
161140693|NCT01324830|581899180|FG007|Overall Study|Progressive Disease|3|||
161140694|NCT01324830|581899181|FG008|Overall Study|Progressive Disease|3|||
161140695|NCT01324830|581899182|FG009|Overall Study|Progressive Disease|6|||
161140696|NCT01324830|581899183|FG010|Overall Study|Progressive Disease|2|||
161140697|NCT01324830|581899184|FG011|Overall Study|Progressive Disease|1|||
161140698|NCT01324830|581899185|FG012|Overall Study|Progressive Disease|1|||
161336390|NCT01791595|582621725|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161336391|NCT01791595|582621726|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161336392|NCT01791595|582621727|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161336393|NCT01791595|582621728|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
161336394|NCT01791595|582621729|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
161336395|NCT01776554|582621730|FG000|Overall Study|Adverse Event|1|||
161336396|NCT01776554|582621731|FG001|Overall Study|Adverse Event|0|||
161336397|NCT01776554|582621730|FG000|Overall Study|Withdrawal by Subject|3|||
161336398|NCT01776554|582621731|FG001|Overall Study|Withdrawal by Subject|8|||
161336399|NCT01776554|582621730|FG000|Overall Study|Lost to Follow-up|6|||
161336400|NCT01776554|582621731|FG001|Overall Study|Lost to Follow-up|9|||
161336401|NCT01776554|582621730|FG000|Overall Study|Administrative Reason|2|||
161336402|NCT01776554|582621731|FG001|Overall Study|Administrative Reason|5|||
161336403|NCT01776554|582621730|FG000|Overall Study|Protocol Violation|1|||
161336404|NCT01776554|582621731|FG001|Overall Study|Protocol Violation|0|||
161336405|NCT01776554|582621730|FG000|Overall Study|Unclassified|4|||
161336406|NCT01776554|582621731|FG001|Overall Study|Unclassified|1|||
161140699|NCT01324830|581899186|FG013|Overall Study|Progressive Disease|1|||
161140700|NCT01324830|581899187|FG014|Overall Study|Progressive Disease|1|||
161140701|NCT01324830|581899188|FG015|Overall Study|Progressive Disease|3|||
161140702|NCT01324830|581899189|FG016|Overall Study|Progressive Disease|2|||
161253014|NCT03310619|582304469|FG005|Pre-Treatment Period|Other reasons|0|||
161253015|NCT03310619|582304470|FG006|Pre-Treatment Period|Other reasons|2|||
161253016|NCT03310619|582304471|FG007|Pre-Treatment Period|Other reasons|0|||
161253017|NCT03310619|582304464|FG000|Treatment Period|Death|1|||
161253018|NCT03310619|582304465|FG001|Treatment Period|Death|2|||
161253019|NCT03310619|582304466|FG002|Treatment Period|Death|0|||
161253020|NCT03310619|582304467|FG003|Treatment Period|Death|0|||
161253021|NCT03310619|582304468|FG004|Treatment Period|Death|1|||
161253022|NCT03310619|582304469|FG005|Treatment Period|Death|0|||
161253023|NCT03310619|582304470|FG006|Treatment Period|Death|2|||
161253024|NCT03310619|582304471|FG007|Treatment Period|Death|0|||
161253025|NCT03310619|582304464|FG000|Treatment Period|Adverse Event|0|||
161253026|NCT03310619|582304465|FG001|Treatment Period|Adverse Event|1|||
161253027|NCT03310619|582304466|FG002|Treatment Period|Adverse Event|4|||
161253028|NCT03310619|582304467|FG003|Treatment Period|Adverse Event|1|||
161253029|NCT03310619|582304468|FG004|Treatment Period|Adverse Event|0|||
161253030|NCT03310619|582304469|FG005|Treatment Period|Adverse Event|0|||
161253031|NCT03310619|582304470|FG006|Treatment Period|Adverse Event|0|||
161253032|NCT03310619|582304471|FG007|Treatment Period|Adverse Event|0|||
161253033|NCT03310619|582304464|FG000|Treatment Period|Withdrawal by participant|0|||
161253034|NCT03310619|582304465|FG001|Treatment Period|Withdrawal by participant|0|||
161336407|NCT01041859|582621732|FG000|Open-Label Titration|Adverse Event|69|||
161336408|NCT01041859|582621733|FG001|Open-Label Titration|Adverse Event|0|||
161140703|NCT01324830|581899190|FG017|Overall Study|Progressive Disease|3|||
161140704|NCT01324830|581899191|FG018|Overall Study|Progressive Disease|4|||
161140705|NCT01324830|581899173|FG000|Overall Study|Dose limiting toxicity|0|||
161140706|NCT01324830|581899174|FG001|Overall Study|Dose limiting toxicity|0|||
161140707|NCT01324830|581899175|FG002|Overall Study|Dose limiting toxicity|0|||
161140708|NCT01324830|581899176|FG003|Overall Study|Dose limiting toxicity|0|||
161140709|NCT01324830|581899177|FG004|Overall Study|Dose limiting toxicity|1|||
161140710|NCT01324830|581899178|FG005|Overall Study|Dose limiting toxicity|0|||
161140711|NCT01324830|581899179|FG006|Overall Study|Dose limiting toxicity|0|||
161140712|NCT01324830|581899180|FG007|Overall Study|Dose limiting toxicity|0|||
161140713|NCT01324830|581899181|FG008|Overall Study|Dose limiting toxicity|0|||
161140714|NCT01324830|581899182|FG009|Overall Study|Dose limiting toxicity|0|||
161140715|NCT01324830|581899183|FG010|Overall Study|Dose limiting toxicity|0|||
161140716|NCT01324830|581899184|FG011|Overall Study|Dose limiting toxicity|0|||
161140717|NCT01324830|581899185|FG012|Overall Study|Dose limiting toxicity|0|||
161140718|NCT01324830|581899186|FG013|Overall Study|Dose limiting toxicity|0|||
161140719|NCT01324830|581899187|FG014|Overall Study|Dose limiting toxicity|0|||
161140720|NCT01324830|581899188|FG015|Overall Study|Dose limiting toxicity|0|||
161140721|NCT01324830|581899189|FG016|Overall Study|Dose limiting toxicity|1|||
161140722|NCT01324830|581899190|FG017|Overall Study|Dose limiting toxicity|1|||
161140723|NCT01324830|581899191|FG018|Overall Study|Dose limiting toxicity|1|||
161140724|NCT01324830|581899173|FG000|Overall Study|Reason not mentioned above|0|||
161140725|NCT01324830|581899174|FG001|Overall Study|Reason not mentioned above|0|||
161140726|NCT01324830|581899175|FG002|Overall Study|Reason not mentioned above|0|||
161140727|NCT01324830|581899176|FG003|Overall Study|Reason not mentioned above|0|||
161140728|NCT01324830|581899177|FG004|Overall Study|Reason not mentioned above|0|||
161140729|NCT01324830|581899178|FG005|Overall Study|Reason not mentioned above|0|||
161140730|NCT01324830|581899179|FG006|Overall Study|Reason not mentioned above|0|||
161140731|NCT01324830|581899180|FG007|Overall Study|Reason not mentioned above|0|||
161140732|NCT01324830|581899181|FG008|Overall Study|Reason not mentioned above|0|||
161140733|NCT01324830|581899182|FG009|Overall Study|Reason not mentioned above|0|||
161140734|NCT01324830|581899183|FG010|Overall Study|Reason not mentioned above|0|||
161336409|NCT01041859|582621734|FG002|Open-Label Titration|Adverse Event|0|||
161336410|NCT01041859|582621732|FG000|Open-Label Titration|Lack of Efficacy|3|||
161336411|NCT01041859|582621733|FG001|Open-Label Titration|Lack of Efficacy|0|||
161336412|NCT01041859|582621734|FG002|Open-Label Titration|Lack of Efficacy|0|||
161336413|NCT01041859|582621732|FG000|Open-Label Titration|Lost to Follow-up|1|||
161336414|NCT01041859|582621733|FG001|Open-Label Titration|Lost to Follow-up|0|||
161336415|NCT01041859|582621734|FG002|Open-Label Titration|Lost to Follow-up|0|||
161336416|NCT01041859|582621732|FG000|Open-Label Titration|Physician Decision|1|||
161336417|NCT01041859|582621733|FG001|Open-Label Titration|Physician Decision|0|||
161336418|NCT01041859|582621734|FG002|Open-Label Titration|Physician Decision|0|||
161336419|NCT01041859|582621732|FG000|Open-Label Titration|Protocol Violation|1|||
161336420|NCT01041859|582621733|FG001|Open-Label Titration|Protocol Violation|0|||
161336421|NCT01041859|582621734|FG002|Open-Label Titration|Protocol Violation|0|||
161336422|NCT01041859|582621732|FG000|Open-Label Titration|Other|7|||
161253035|NCT03310619|582304466|FG002|Treatment Period|Withdrawal by participant|1|||
161253036|NCT03310619|582304467|FG003|Treatment Period|Withdrawal by participant|0|||
161253037|NCT03310619|582304468|FG004|Treatment Period|Withdrawal by participant|0|||
161253038|NCT03310619|582304469|FG005|Treatment Period|Withdrawal by participant|0|||
161253039|NCT03310619|582304470|FG006|Treatment Period|Withdrawal by participant|0|||
161253040|NCT03310619|582304471|FG007|Treatment Period|Withdrawal by participant|0|||
161253041|NCT03310619|582304464|FG000|Treatment Period|Lost to Follow-up|0|||
161253042|NCT03310619|582304465|FG001|Treatment Period|Lost to Follow-up|0|||
161253043|NCT03310619|582304466|FG002|Treatment Period|Lost to Follow-up|0|||
161253044|NCT03310619|582304467|FG003|Treatment Period|Lost to Follow-up|0|||
161253045|NCT03310619|582304468|FG004|Treatment Period|Lost to Follow-up|0|||
161253046|NCT03310619|582304469|FG005|Treatment Period|Lost to Follow-up|0|||
161336423|NCT01041859|582621733|FG001|Open-Label Titration|Other|0|||
161336424|NCT01041859|582621734|FG002|Open-Label Titration|Other|0|||
161336425|NCT01041859|582621732|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
161336426|NCT01041859|582621733|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
161336427|NCT01041859|582621734|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
161336428|NCT01041859|582621732|FG000|Open-Label Titration|Withdrawal by Subject|11|||
161336429|NCT01041859|582621733|FG001|Open-Label Titration|Withdrawal by Subject|0|||
161336430|NCT01041859|582621734|FG002|Open-Label Titration|Withdrawal by Subject|0|||
161336431|NCT01041859|582621732|FG000|Double-Blind Maintenance|Adverse Event|0|||
161336432|NCT01041859|582621733|FG001|Double-Blind Maintenance|Adverse Event|23|||
161336433|NCT01041859|582621734|FG002|Double-Blind Maintenance|Adverse Event|13|||
161336434|NCT01041859|582621732|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
161336435|NCT01041859|582621733|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
161336436|NCT01041859|582621734|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
161336437|NCT01041859|582621732|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
161336438|NCT01041859|582621733|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
161336439|NCT01041859|582621734|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
161336440|NCT01041859|582621732|FG000|Double-Blind Maintenance|Physician Decision|0|||
161336441|NCT01041859|582621733|FG001|Double-Blind Maintenance|Physician Decision|2|||
161336442|NCT01041859|582621734|FG002|Double-Blind Maintenance|Physician Decision|1|||
161336443|NCT01041859|582621732|FG000|Double-Blind Maintenance|Protocol Violation|0|||
161336444|NCT01041859|582621733|FG001|Double-Blind Maintenance|Protocol Violation|1|||
161336445|NCT01041859|582621734|FG002|Double-Blind Maintenance|Protocol Violation|3|||
161336446|NCT01041859|582621732|FG000|Double-Blind Maintenance|Other|0|||
161336447|NCT01041859|582621733|FG001|Double-Blind Maintenance|Other|6|||
161336448|NCT01041859|582621734|FG002|Double-Blind Maintenance|Other|2|||
161336449|NCT01041859|582621732|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
161336450|NCT01041859|582621733|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
161336451|NCT01041859|582621734|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
161336452|NCT01041859|582621732|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
161336453|NCT01041859|582621733|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
161336454|NCT01041859|582621734|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
161336455|NCT02027025|582621735|FG000|Overall Study|Adverse Event|0|||
161336456|NCT02027025|582621736|FG001|Overall Study|Adverse Event|1|||
161336457|NCT02027025|582621737|FG002|Overall Study|Adverse Event|1|||
161336458|NCT02027025|582621735|FG000|Overall Study|Protocol Violation|1|||
161336459|NCT02027025|582621736|FG001|Overall Study|Protocol Violation|0|||
161336460|NCT02027025|582621737|FG002|Overall Study|Protocol Violation|0|||
161336461|NCT02027025|582621735|FG000|Overall Study|Lost to Follow-up|0|||
161336462|NCT02027025|582621736|FG001|Overall Study|Lost to Follow-up|2|||
161253047|NCT03310619|582304470|FG006|Treatment Period|Lost to Follow-up|0|||
161253048|NCT03310619|582304471|FG007|Treatment Period|Lost to Follow-up|1|||
161336463|NCT02027025|582621737|FG002|Overall Study|Lost to Follow-up|0|||
161336464|NCT02027025|582621735|FG000|Overall Study|Withdrawal by Subject|0|||
161336465|NCT02027025|582621736|FG001|Overall Study|Withdrawal by Subject|1|||
161336466|NCT02027025|582621737|FG002|Overall Study|Withdrawal by Subject|0|||
161253049|NCT03310619|582304464|FG000|Treatment Period|Study terminated by sponsor|0|||
161253050|NCT03310619|582304465|FG001|Treatment Period|Study terminated by sponsor|0|||
160845076|NCT03364309|580819718|FG013|Maintenance Period|Lack of Efficacy|0|||
160845077|NCT03364309|580819719|FG014|Maintenance Period|Lack of Efficacy|0|||
160845078|NCT03364309|580819720|FG015|Maintenance Period|Lack of Efficacy|0|||
160845079|NCT03364309|580819721|FG016|Maintenance Period|Lack of Efficacy|0|||
160845080|NCT03364309|580819722|FG017|Maintenance Period|Lack of Efficacy|0|||
160845081|NCT03364309|580819723|FG018|Maintenance Period|Lack of Efficacy|0|||
160845082|NCT03364309|580819705|FG000|Maintenance Period|Death|0|||
160845083|NCT03364309|580819706|FG001|Maintenance Period|Death|0|||
160845084|NCT03364309|580819707|FG002|Maintenance Period|Death|0|||
160845085|NCT03364309|580819708|FG003|Maintenance Period|Death|0|||
161140735|NCT01324830|581899184|FG011|Overall Study|Reason not mentioned above|0|||
161140736|NCT01324830|581899185|FG012|Overall Study|Reason not mentioned above|0|||
161253051|NCT03310619|582304466|FG002|Treatment Period|Study terminated by sponsor|0|||
161253052|NCT03310619|582304467|FG003|Treatment Period|Study terminated by sponsor|0|||
161253053|NCT03310619|582304468|FG004|Treatment Period|Study terminated by sponsor|0|||
161336467|NCT02027025|582621735|FG000|Overall Study|Sponsor's decision|0|||
160845086|NCT03364309|580819709|FG004|Maintenance Period|Death|0|||
160845087|NCT03364309|580819710|FG005|Maintenance Period|Death|0|||
160845088|NCT03364309|580819711|FG006|Maintenance Period|Death|0|||
161140737|NCT01324830|581899186|FG013|Overall Study|Reason not mentioned above|0|||
160845089|NCT03364309|580819712|FG007|Maintenance Period|Death|0|||
161140738|NCT01324830|581899187|FG014|Overall Study|Reason not mentioned above|0|||
161140739|NCT01324830|581899188|FG015|Overall Study|Reason not mentioned above|0|||
161140740|NCT01324830|581899189|FG016|Overall Study|Reason not mentioned above|0|||
161140741|NCT01324830|581899190|FG017|Overall Study|Reason not mentioned above|1|||
161140742|NCT01324830|581899191|FG018|Overall Study|Reason not mentioned above|0|||
161140743|NCT01324830|581899173|FG000|Overall Study|Adverse Event, serious fatal|0|||
161140744|NCT01324830|581899174|FG001|Overall Study|Adverse Event, serious fatal|1|||
161140745|NCT01324830|581899175|FG002|Overall Study|Adverse Event, serious fatal|0|||
161140746|NCT01324830|581899176|FG003|Overall Study|Adverse Event, serious fatal|0|||
161140747|NCT01324830|581899177|FG004|Overall Study|Adverse Event, serious fatal|0|||
161140748|NCT01324830|581899178|FG005|Overall Study|Adverse Event, serious fatal|0|||
161140749|NCT01324830|581899179|FG006|Overall Study|Adverse Event, serious fatal|0|||
161140750|NCT01324830|581899180|FG007|Overall Study|Adverse Event, serious fatal|0|||
161140751|NCT01324830|581899181|FG008|Overall Study|Adverse Event, serious fatal|0|||
161140752|NCT01324830|581899182|FG009|Overall Study|Adverse Event, serious fatal|0|||
161140753|NCT01324830|581899183|FG010|Overall Study|Adverse Event, serious fatal|0|||
161140754|NCT01324830|581899184|FG011|Overall Study|Adverse Event, serious fatal|0|||
161140755|NCT01324830|581899185|FG012|Overall Study|Adverse Event, serious fatal|0|||
161140756|NCT01324830|581899186|FG013|Overall Study|Adverse Event, serious fatal|0|||
161140757|NCT01324830|581899187|FG014|Overall Study|Adverse Event, serious fatal|0|||
161140758|NCT01324830|581899188|FG015|Overall Study|Adverse Event, serious fatal|0|||
161140759|NCT01324830|581899189|FG016|Overall Study|Adverse Event, serious fatal|0|||
161140760|NCT01324830|581899190|FG017|Overall Study|Adverse Event, serious fatal|0|||
161140761|NCT01324830|581899191|FG018|Overall Study|Adverse Event, serious fatal|0|||
161140762|NCT01324830|581899173|FG000|Overall Study|Adverse Event, non-fatal|0|||
161140763|NCT01324830|581899174|FG001|Overall Study|Adverse Event, non-fatal|0|||
161140764|NCT01324830|581899175|FG002|Overall Study|Adverse Event, non-fatal|0|||
161140765|NCT01324830|581899176|FG003|Overall Study|Adverse Event, non-fatal|0|||
161140766|NCT01324830|581899177|FG004|Overall Study|Adverse Event, non-fatal|0|||
161140767|NCT01324830|581899178|FG005|Overall Study|Adverse Event, non-fatal|0|||
161140768|NCT01324830|581899179|FG006|Overall Study|Adverse Event, non-fatal|0|||
161140769|NCT01324830|581899180|FG007|Overall Study|Adverse Event, non-fatal|0|||
161140770|NCT01324830|581899181|FG008|Overall Study|Adverse Event, non-fatal|2|||
161140771|NCT01324830|581899182|FG009|Overall Study|Adverse Event, non-fatal|0|||
161140772|NCT01324830|581899183|FG010|Overall Study|Adverse Event, non-fatal|1|||
161140773|NCT01324830|581899184|FG011|Overall Study|Adverse Event, non-fatal|0|||
161140774|NCT01324830|581899185|FG012|Overall Study|Adverse Event, non-fatal|0|||
161140775|NCT01324830|581899186|FG013|Overall Study|Adverse Event, non-fatal|0|||
161140776|NCT01324830|581899187|FG014|Overall Study|Adverse Event, non-fatal|0|||
161140777|NCT01324830|581899188|FG015|Overall Study|Adverse Event, non-fatal|0|||
161140778|NCT01324830|581899189|FG016|Overall Study|Adverse Event, non-fatal|0|||
161140779|NCT01324830|581899190|FG017|Overall Study|Adverse Event, non-fatal|1|||
161140780|NCT01324830|581899191|FG018|Overall Study|Adverse Event, non-fatal|0|||
161140781|NCT01324830|581899173|FG000|Overall Study|Withdrawal by Subject|0|||
161140782|NCT01324830|581899174|FG001|Overall Study|Withdrawal by Subject|0|||
161140783|NCT01324830|581899175|FG002|Overall Study|Withdrawal by Subject|0|||
161140784|NCT01324830|581899176|FG003|Overall Study|Withdrawal by Subject|0|||
161140785|NCT01324830|581899177|FG004|Overall Study|Withdrawal by Subject|0|||
161140786|NCT01324830|581899178|FG005|Overall Study|Withdrawal by Subject|1|||
161140787|NCT01324830|581899179|FG006|Overall Study|Withdrawal by Subject|0|||
161140788|NCT01324830|581899180|FG007|Overall Study|Withdrawal by Subject|0|||
161140789|NCT01324830|581899181|FG008|Overall Study|Withdrawal by Subject|0|||
161336468|NCT02027025|582621736|FG001|Overall Study|Sponsor's decision|1|||
161336469|NCT02027025|582621737|FG002|Overall Study|Sponsor's decision|0|||
161336470|NCT04798027|582621738|FG000|Overall Study|Protocol Violation|0|||
160845090|NCT03364309|580819713|FG008|Maintenance Period|Death|1|||
160845091|NCT03364309|580819714|FG009|Maintenance Period|Death|0|||
160845092|NCT03364309|580819715|FG010|Maintenance Period|Death|0|||
160845093|NCT03364309|580819716|FG011|Maintenance Period|Death|0|||
160845094|NCT03364309|580819717|FG012|Maintenance Period|Death|0|||
160845095|NCT03364309|580819718|FG013|Maintenance Period|Death|0|||
160845096|NCT03364309|580819719|FG014|Maintenance Period|Death|0|||
160845097|NCT03364309|580819720|FG015|Maintenance Period|Death|0|||
160845098|NCT03364309|580819721|FG016|Maintenance Period|Death|0|||
160845099|NCT03364309|580819722|FG017|Maintenance Period|Death|0|||
160845100|NCT03364309|580819723|FG018|Maintenance Period|Death|0|||
160845101|NCT03364309|580819705|FG000|Maintenance Period|Lost to Follow-up|0|||
160845102|NCT03364309|580819706|FG001|Maintenance Period|Lost to Follow-up|0|||
160845103|NCT03364309|580819707|FG002|Maintenance Period|Lost to Follow-up|0|||
160845104|NCT03364309|580819708|FG003|Maintenance Period|Lost to Follow-up|0|||
160845105|NCT03364309|580819709|FG004|Maintenance Period|Lost to Follow-up|0|||
160845106|NCT03364309|580819710|FG005|Maintenance Period|Lost to Follow-up|0|||
160845107|NCT03364309|580819711|FG006|Maintenance Period|Lost to Follow-up|0|||
160845108|NCT03364309|580819712|FG007|Maintenance Period|Lost to Follow-up|0|||
160845109|NCT03364309|580819713|FG008|Maintenance Period|Lost to Follow-up|1|||
160845110|NCT03364309|580819714|FG009|Maintenance Period|Lost to Follow-up|0|||
160845111|NCT03364309|580819715|FG010|Maintenance Period|Lost to Follow-up|0|||
160845112|NCT03364309|580819716|FG011|Maintenance Period|Lost to Follow-up|0|||
160845113|NCT03364309|580819717|FG012|Maintenance Period|Lost to Follow-up|0|||
160845114|NCT03364309|580819718|FG013|Maintenance Period|Lost to Follow-up|0|||
160845115|NCT03364309|580819719|FG014|Maintenance Period|Lost to Follow-up|0|||
160845116|NCT03364309|580819720|FG015|Maintenance Period|Lost to Follow-up|0|||
160845117|NCT03364309|580819721|FG016|Maintenance Period|Lost to Follow-up|0|||
160845118|NCT03364309|580819722|FG017|Maintenance Period|Lost to Follow-up|0|||
160845119|NCT03364309|580819723|FG018|Maintenance Period|Lost to Follow-up|0|||
160845120|NCT03364309|580819705|FG000|Maintenance Period|Miscellaneous|0|||
160845121|NCT03364309|580819706|FG001|Maintenance Period|Miscellaneous|0|||
160845122|NCT03364309|580819707|FG002|Maintenance Period|Miscellaneous|0|||
160845123|NCT03364309|580819708|FG003|Maintenance Period|Miscellaneous|0|||
160845124|NCT03364309|580819709|FG004|Maintenance Period|Miscellaneous|0|||
160845125|NCT03364309|580819710|FG005|Maintenance Period|Miscellaneous|0|||
160845126|NCT03364309|580819711|FG006|Maintenance Period|Miscellaneous|0|||
160845127|NCT03364309|580819712|FG007|Maintenance Period|Miscellaneous|0|||
160845128|NCT03364309|580819713|FG008|Maintenance Period|Miscellaneous|1|||
160845129|NCT03364309|580819714|FG009|Maintenance Period|Miscellaneous|0|||
160845130|NCT03364309|580819715|FG010|Maintenance Period|Miscellaneous|0|||
160845131|NCT03364309|580819716|FG011|Maintenance Period|Miscellaneous|0|||
160845132|NCT03364309|580819717|FG012|Maintenance Period|Miscellaneous|0|||
160845133|NCT03364309|580819718|FG013|Maintenance Period|Miscellaneous|0|||
160845134|NCT03364309|580819719|FG014|Maintenance Period|Miscellaneous|0|||
160845135|NCT03364309|580819720|FG015|Maintenance Period|Miscellaneous|0|||
160845136|NCT03364309|580819721|FG016|Maintenance Period|Miscellaneous|0|||
160845137|NCT03364309|580819722|FG017|Maintenance Period|Miscellaneous|0|||
160845138|NCT03364309|580819723|FG018|Maintenance Period|Miscellaneous|0|||
160845139|NCT03364309|580819705|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845140|NCT03364309|580819706|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161140790|NCT01324830|581899182|FG009|Overall Study|Withdrawal by Subject|0|||
160845141|NCT03364309|580819707|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845142|NCT03364309|580819708|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161140791|NCT01324830|581899183|FG010|Overall Study|Withdrawal by Subject|1|||
160845143|NCT03364309|580819709|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161140792|NCT01324830|581899184|FG011|Overall Study|Withdrawal by Subject|0|||
160845144|NCT03364309|580819710|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845145|NCT03364309|580819711|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
161140793|NCT01324830|581899185|FG012|Overall Study|Withdrawal by Subject|0|||
161140794|NCT01324830|581899186|FG013|Overall Study|Withdrawal by Subject|0|||
161140795|NCT01324830|581899187|FG014|Overall Study|Withdrawal by Subject|0|||
161140796|NCT01324830|581899188|FG015|Overall Study|Withdrawal by Subject|0|||
161140797|NCT01324830|581899189|FG016|Overall Study|Withdrawal by Subject|0|||
161140798|NCT01324830|581899190|FG017|Overall Study|Withdrawal by Subject|0|||
161140799|NCT01324830|581899191|FG018|Overall Study|Withdrawal by Subject|1|||
161140800|NCT01973283|581899192|FG000|Overall Study|Lost to Follow-up|4|||
161140801|NCT00817414|581899193|FG000|Overall Study|Adverse Event|1|||
161140802|NCT00817414|581899194|FG001|Overall Study|Adverse Event|1|||
161140803|NCT00817414|581899195|FG002|Overall Study|Adverse Event|1|||
161140804|NCT00817414|581899196|FG003|Overall Study|Adverse Event|0|||
161140805|NCT00817414|581899197|FG004|Overall Study|Adverse Event|0|||
161140806|NCT00817414|581899193|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
161140807|NCT00817414|581899194|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
161253054|NCT03310619|582304469|FG005|Treatment Period|Study terminated by sponsor|0|||
161253055|NCT03310619|582304470|FG006|Treatment Period|Study terminated by sponsor|0|||
161253056|NCT03310619|582304471|FG007|Treatment Period|Study terminated by sponsor|1|||
161253057|NCT03310619|582304464|FG000|Treatment Period|Physician Decision|0|||
161253058|NCT03310619|582304465|FG001|Treatment Period|Physician Decision|0|||
161253059|NCT03310619|582304466|FG002|Treatment Period|Physician Decision|0|||
161253060|NCT03310619|582304467|FG003|Treatment Period|Physician Decision|0|||
161253061|NCT03310619|582304468|FG004|Treatment Period|Physician Decision|3|||
161253062|NCT03310619|582304469|FG005|Treatment Period|Physician Decision|0|||
161253063|NCT03310619|582304470|FG006|Treatment Period|Physician Decision|0|||
161253064|NCT03310619|582304471|FG007|Treatment Period|Physician Decision|0|||
161253065|NCT03310619|582304464|FG000|Treatment Period|Other reasons|1|||
161253066|NCT03310619|582304465|FG001|Treatment Period|Other reasons|0|||
161253067|NCT03310619|582304466|FG002|Treatment Period|Other reasons|2|||
161253068|NCT03310619|582304467|FG003|Treatment Period|Other reasons|0|||
161253069|NCT03310619|582304468|FG004|Treatment Period|Other reasons|0|||
161253070|NCT03310619|582304469|FG005|Treatment Period|Other reasons|0|||
161253071|NCT03310619|582304470|FG006|Treatment Period|Other reasons|0|||
161253072|NCT03310619|582304471|FG007|Treatment Period|Other reasons|0|||
161253073|NCT00152516|582304476|FG000|Overall Study|Adverse Event|18|||
161253074|NCT00152516|582304476|FG000|Overall Study|Lack and Loss of Efficacy|30|||
161253075|NCT00152516|582304476|FG000|Overall Study|Lost to Follow-up|5|||
161253076|NCT00152516|582304476|FG000|Overall Study|Withdrawal by Subject|8|||
161253077|NCT00152516|582304476|FG000|Overall Study|Protocol Violation|3|||
161253078|NCT00152516|582304476|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
161253079|NCT00152516|582304476|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
161253080|NCT00152516|582304476|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
161253081|NCT00152516|582304476|FG000|Overall Study|Other: Non-Compliance|2|||
161253082|NCT00152516|582304476|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
161253083|NCT00152516|582304476|FG000|Overall Study|Other: Moved Out Of State|1|||
161253084|NCT00152516|582304476|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
161253085|NCT00152516|582304476|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
161253086|NCT04660032|582304479|FG000|Overall Study|Protocol Violation|1|||
161253087|NCT04660032|582304480|FG001|Overall Study|Protocol Violation|1|||
161253088|NCT00090753|582304481|FG000|First Treatment Period|Adverse Event|20|||
160992356|NCT05567159|581360031|FG000|Overall Study|Physician Decision|3|||
161253089|NCT00090753|582304482|FG001|First Treatment Period|Adverse Event|8|||
161253090|NCT00090753|582304481|FG000|First Treatment Period|Death|88|||
161253091|NCT00090753|582304482|FG001|First Treatment Period|Death|62|||
161253092|NCT00090753|582304481|FG000|First Treatment Period|Lack of Efficacy|2|||
161253093|NCT00090753|582304482|FG001|First Treatment Period|Lack of Efficacy|1|||
161253094|NCT00090753|582304481|FG000|First Treatment Period|Refused Treatment|32|||
161253095|NCT00090753|582304482|FG001|First Treatment Period|Refused Treatment|25|||
161253096|NCT00090753|582304481|FG000|First Treatment Period|Lost to Follow-up|4|||
161253097|NCT00090753|582304482|FG001|First Treatment Period|Lost to Follow-up|4|||
161253098|NCT00090753|582304481|FG000|First Treatment Period|Renal Transplant|70|||
161253099|NCT00090753|582304482|FG001|First Treatment Period|Renal Transplant|50|||
161253100|NCT00090753|582304481|FG000|First Treatment Period|Mircera Commercialization|1|||
161253101|NCT00090753|582304482|FG001|First Treatment Period|Mircera Commercialization|0|||
161253102|NCT00090753|582304481|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
161253103|NCT00090753|582304482|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
161253104|NCT00090753|582304481|FG000|Extended Treatment Period|Adverse Event|11|||
161253105|NCT00090753|582304482|FG001|Extended Treatment Period|Adverse Event|0|||
161253106|NCT00090753|582304481|FG000|Extended Treatment Period|Death|58|||
161253107|NCT00090753|582304482|FG001|Extended Treatment Period|Death|30|||
161253108|NCT00090753|582304481|FG000|Extended Treatment Period|Lack of Efficacy|1|||
161253109|NCT00090753|582304482|FG001|Extended Treatment Period|Lack of Efficacy|0|||
161253110|NCT00090753|582304481|FG000|Extended Treatment Period|Refused Treatment|18|||
161253111|NCT00090753|582304482|FG001|Extended Treatment Period|Refused Treatment|12|||
161253112|NCT00090753|582304481|FG000|Extended Treatment Period|Lost to Follow-up|3|||
160905991|NCT02340975|581050340|FG002|Overall Study|Lost to Follow-up|0|||
160905992|NCT02340975|581050341|FG003|Overall Study|Lost to Follow-up|0|||
160905993|NCT02340975|581050342|FG004|Overall Study|Lost to Follow-up|2|||
160905994|NCT02340975|581050343|FG005|Overall Study|Lost to Follow-up|0|||
160905995|NCT02340975|581050338|FG000|Overall Study|Withdrawal by Subject|0|||
160905996|NCT02340975|581050339|FG001|Overall Study|Withdrawal by Subject|0|||
161253113|NCT00090753|582304482|FG001|Extended Treatment Period|Lost to Follow-up|1|||
161253114|NCT00090753|582304481|FG000|Extended Treatment Period|Renal Transplant|15|||
161253115|NCT00090753|582304482|FG001|Extended Treatment Period|Renal Transplant|12|||
161253116|NCT00090753|582304481|FG000|Extended Treatment Period|Mircera Commercialization|188|||
161253117|NCT00090753|582304482|FG001|Extended Treatment Period|Mircera Commercialization|93|||
161253118|NCT00090753|582304481|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
161253119|NCT00090753|582304482|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
161253120|NCT01266603|582304491|FG000|Overall Study|Adverse Event|1|||
161253121|NCT01266603|582304491|FG000|Overall Study|Lack of Efficacy|14|||
161253122|NCT01266603|582304491|FG000|Overall Study|Withdrawal by Subject|1|||
161253123|NCT01266603|582304491|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
161253124|NCT02725411|582304494|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
161253125|NCT02725411|582304495|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
161253126|NCT02725411|582304496|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
161253127|NCT02725411|582304494|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
161253128|NCT02725411|582304495|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
161253129|NCT02725411|582304496|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
161253130|NCT02725411|582304494|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
161253131|NCT02725411|582304495|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
161253132|NCT02725411|582304496|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
161253133|NCT02725411|582304494|FG000|Treatment Period (56 Weeks)|Other|1|||
161253134|NCT02725411|582304495|FG001|Treatment Period (56 Weeks)|Other|4|||
161253135|NCT02725411|582304496|FG002|Treatment Period (56 Weeks)|Other|5|||
161253136|NCT02725411|582304494|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
161253137|NCT02725411|582304495|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
161253138|NCT02725411|582304496|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
161253139|NCT02725411|582304494|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
161253140|NCT02725411|582304495|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
161253141|NCT02725411|582304496|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
161253142|NCT02725411|582304494|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
161253143|NCT02725411|582304495|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
161253144|NCT02725411|582304496|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
161253145|NCT02725411|582304494|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
161253146|NCT02725411|582304495|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
161253147|NCT02725411|582304496|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
161253148|NCT02725411|582304494|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
161253149|NCT02725411|582304495|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
161253150|NCT02725411|582304496|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
161253151|NCT02725411|582304494|FG000|Follow-up Period (24 Weeks)|Other|1|||
161253152|NCT02725411|582304495|FG001|Follow-up Period (24 Weeks)|Other|4|||
161253153|NCT02725411|582304496|FG002|Follow-up Period (24 Weeks)|Other|2|||
161253154|NCT02725411|582304494|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
161253155|NCT02725411|582304495|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
161253156|NCT02725411|582304496|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
161253157|NCT04307849|582304497|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
160845146|NCT03364309|580819712|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845147|NCT03364309|580819713|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845148|NCT03364309|580819714|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845149|NCT03364309|580819715|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845150|NCT03364309|580819716|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845151|NCT03364309|580819717|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845152|NCT03364309|580819718|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
160845153|NCT03364309|580819719|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
160845154|NCT03364309|580819720|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
160845155|NCT03364309|580819721|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845156|NCT03364309|580819722|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845157|NCT03364309|580819723|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
160845158|NCT03364309|580819705|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845159|NCT03364309|580819706|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845160|NCT03364309|580819707|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845161|NCT03364309|580819708|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845162|NCT03364309|580819709|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845163|NCT03364309|580819710|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845164|NCT03364309|580819711|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845165|NCT03364309|580819712|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845166|NCT03364309|580819713|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845167|NCT03364309|580819714|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845168|NCT03364309|580819715|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845169|NCT03364309|580819716|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845170|NCT03364309|580819717|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845171|NCT03364309|580819718|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845172|NCT03364309|580819719|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
160845173|NCT03364309|580819720|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
161253158|NCT04307849|582304498|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161336471|NCT04798027|582621739|FG001|Overall Study|Protocol Violation|0|||
161253159|NCT04307849|582304499|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
161253160|NCT04307849|582304500|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
161336472|NCT04798027|582621740|FG002|Overall Study|Protocol Violation|0|||
161336473|NCT04798027|582621741|FG003|Overall Study|Protocol Violation|0|||
161336474|NCT04798027|582621742|FG004|Overall Study|Protocol Violation|1|||
161336475|NCT04798027|582621743|FG005|Overall Study|Protocol Violation|0|||
161336476|NCT04798027|582621744|FG006|Overall Study|Protocol Violation|0|||
161336477|NCT04798027|582621745|FG007|Overall Study|Protocol Violation|1|||
161336478|NCT04798027|582621746|FG008|Overall Study|Protocol Violation|0|||
161336479|NCT04798027|582621738|FG000|Overall Study|Withdrawal by Subject|1|||
161336480|NCT04798027|582621739|FG001|Overall Study|Withdrawal by Subject|0|||
161336481|NCT04798027|582621740|FG002|Overall Study|Withdrawal by Subject|1|||
161336482|NCT04798027|582621741|FG003|Overall Study|Withdrawal by Subject|1|||
161336483|NCT04798027|582621742|FG004|Overall Study|Withdrawal by Subject|1|||
160845174|NCT03364309|580819721|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845175|NCT03364309|580819722|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845176|NCT03364309|580819723|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
160845177|NCT03364309|580819705|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
160845178|NCT03364309|580819706|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
160845179|NCT03364309|580819707|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
160845180|NCT03364309|580819708|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
160845181|NCT03364309|580819709|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
160845182|NCT03364309|580819710|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
160845183|NCT03364309|580819711|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
160845184|NCT03364309|580819712|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
160845185|NCT03364309|580819713|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
160845186|NCT03364309|580819714|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
160845187|NCT03364309|580819715|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
160845188|NCT03364309|580819716|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
160845189|NCT03364309|580819717|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
160845190|NCT03364309|580819718|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
160845191|NCT03364309|580819719|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
160845192|NCT03364309|580819720|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
160845193|NCT03364309|580819721|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
160845194|NCT03364309|580819722|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
160845195|NCT03364309|580819723|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
160845196|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845197|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845198|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845199|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845200|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845201|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845202|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845203|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845204|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845205|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845206|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845207|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845208|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845209|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845210|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845211|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
160845212|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
160845213|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
160845214|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
160845215|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Adverse Event|0|||
160845216|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Adverse Event|0|||
160845217|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Adverse Event|0|||
160845218|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Adverse Event|0|||
160845219|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Adverse Event|0|||
160845220|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Adverse Event|0|||
160845221|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Adverse Event|0|||
160845222|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Adverse Event|0|||
160845223|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Adverse Event|0|||
160992357|NCT05567159|581360031|FG000|Overall Study|Protocol deviation|1|||
160992358|NCT04155424|581360033|FG000|Overall Study|Other than specified|3|||
161336484|NCT04798027|582621743|FG005|Overall Study|Withdrawal by Subject|1|||
161336485|NCT04798027|582621744|FG006|Overall Study|Withdrawal by Subject|3|||
160845224|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Adverse Event|0|||
160845225|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Adverse Event|0|||
160845226|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Adverse Event|0|||
160992359|NCT04155424|581360033|FG000|Overall Study|Withdrawal by Subject|1|||
161336486|NCT04798027|582621745|FG007|Overall Study|Withdrawal by Subject|2|||
161336487|NCT04798027|582621746|FG008|Overall Study|Withdrawal by Subject|2|||
161253161|NCT04307849|582304501|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
161253162|NCT04307849|582304502|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
161253163|NCT04307849|582304497|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161253164|NCT04307849|582304498|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161253165|NCT04307849|582304499|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
161253166|NCT04307849|582304500|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161253167|NCT04307849|582304501|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161253168|NCT04307849|582304502|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
161253169|NCT04307849|582304497|FG000|Overall Study|Family member did not want them to continue|0|||
161253170|NCT04307849|582304498|FG001|Overall Study|Family member did not want them to continue|0|||
161253171|NCT04307849|582304499|FG002|Overall Study|Family member did not want them to continue|1|||
161253172|NCT04307849|582304500|FG003|Overall Study|Family member did not want them to continue|0|||
161253173|NCT04307849|582304501|FG004|Overall Study|Family member did not want them to continue|0|||
161253174|NCT04307849|582304502|FG005|Overall Study|Family member did not want them to continue|0|||
161253175|NCT04307849|582304497|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
161253176|NCT04307849|582304498|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
161253177|NCT04307849|582304499|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
161253178|NCT04307849|582304500|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
161253179|NCT04307849|582304501|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
161253180|NCT04307849|582304502|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
161253181|NCT00756717|582304503|FG000|Overall Study|Withdrawal by Subject|2|||
161253182|NCT02654015|582304504|FG000|Overall Study|Death|12|||
161253183|NCT02654015|582304504|FG000|Overall Study|Lost to Follow-up|3|||
161253184|NCT02418754|582304507|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161253185|NCT02418754|582304508|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
161253186|NCT02418754|582304509|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161253187|NCT02418754|582304510|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161253188|NCT02418754|582304511|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
161253189|NCT02418754|582304507|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
161253190|NCT02418754|582304508|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
161253191|NCT02418754|582304509|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
161253192|NCT02418754|582304510|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
161253193|NCT02418754|582304511|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
161253194|NCT02418754|582304507|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
161253195|NCT02418754|582304508|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161253196|NCT02418754|582304509|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161253197|NCT02418754|582304510|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161253198|NCT02418754|582304511|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
161253199|NCT02418754|582304507|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161253200|NCT02418754|582304508|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
161253201|NCT02418754|582304509|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
161253202|NCT02418754|582304510|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161253203|NCT02418754|582304511|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
161253204|NCT02418754|582304507|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161253205|NCT02418754|582304508|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161253206|NCT02418754|582304509|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
161253207|NCT02418754|582304510|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161253208|NCT02418754|582304511|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
161253209|NCT02418754|582304507|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
161253210|NCT02418754|582304508|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
161253211|NCT02418754|582304509|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
161253212|NCT02418754|582304510|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
161253213|NCT02418754|582304511|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
161253214|NCT02418754|582304507|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
161253215|NCT02418754|582304508|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161253216|NCT02418754|582304509|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161253217|NCT02418754|582304510|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161253218|NCT02418754|582304511|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
161253219|NCT02418754|582304507|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
161253220|NCT02418754|582304508|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
161253221|NCT02418754|582304509|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
161253222|NCT02418754|582304510|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
161253223|NCT02418754|582304511|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
161253224|NCT02418754|582304507|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
160845227|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Adverse Event|0|||
160845228|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Adverse Event|0|||
160845229|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Adverse Event|0|||
161253225|NCT02418754|582304508|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
161336488|NCT04798027|582621738|FG000|Overall Study|Lost to Follow-up|1|||
161336489|NCT04798027|582621739|FG001|Overall Study|Lost to Follow-up|3|||
161336490|NCT04798027|582621740|FG002|Overall Study|Lost to Follow-up|0|||
161336491|NCT04798027|582621741|FG003|Overall Study|Lost to Follow-up|0|||
161336492|NCT04798027|582621742|FG004|Overall Study|Lost to Follow-up|0|||
161336493|NCT04798027|582621743|FG005|Overall Study|Lost to Follow-up|1|||
161336494|NCT04798027|582621744|FG006|Overall Study|Lost to Follow-up|0|||
161336495|NCT04798027|582621745|FG007|Overall Study|Lost to Follow-up|0|||
161336496|NCT04798027|582621746|FG008|Overall Study|Lost to Follow-up|1|||
161336497|NCT04798027|582621738|FG000|Overall Study|Withdrawal by Sponsor|8|||
161336498|NCT04798027|582621739|FG001|Overall Study|Withdrawal by Sponsor|22|||
161336499|NCT04798027|582621740|FG002|Overall Study|Withdrawal by Sponsor|9|||
161336500|NCT04798027|582621741|FG003|Overall Study|Withdrawal by Sponsor|26|||
161336501|NCT04798027|582621742|FG004|Overall Study|Withdrawal by Sponsor|24|||
161336502|NCT04798027|582621743|FG005|Overall Study|Withdrawal by Sponsor|11|||
161336503|NCT04798027|582621744|FG006|Overall Study|Withdrawal by Sponsor|25|||
161336504|NCT04798027|582621745|FG007|Overall Study|Withdrawal by Sponsor|26|||
161336505|NCT04798027|582621746|FG008|Overall Study|Withdrawal by Sponsor|11|||
161336506|NCT00828711|582621749|FG000|Overall Study|Lost to Follow-up|1|||
161336507|NCT00828711|582621750|FG001|Overall Study|Lost to Follow-up|0|||
161336508|NCT00828711|582621751|FG002|Overall Study|Lost to Follow-up|0|||
161253226|NCT02418754|582304509|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
161253227|NCT02418754|582304510|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
161253228|NCT02418754|582304511|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
161253229|NCT02418754|582304507|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
161253230|NCT02418754|582304508|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
161253231|NCT02418754|582304509|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
161253232|NCT02418754|582304510|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
161253233|NCT02418754|582304511|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
161253234|NCT02418754|582304507|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161253235|NCT02418754|582304508|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
161253236|NCT02418754|582304509|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161253237|NCT02418754|582304510|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
161253238|NCT02418754|582304511|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
161253239|NCT00761176|582304514|FG000|Overall Study|Death|1|||
161253240|NCT00761176|582304515|FG001|Overall Study|Death|0|||
161253241|NCT00761176|582304514|FG000|Overall Study|Withdrawal by Subject|1|||
161253242|NCT00761176|582304515|FG001|Overall Study|Withdrawal by Subject|1|||
161253243|NCT02762994|582304518|FG000|Overall Study|Withdrawal by Subject|0|||
161253244|NCT02762994|582304519|FG001|Overall Study|Withdrawal by Subject|1|||
161253245|NCT02762994|582304520|FG002|Overall Study|Withdrawal by Subject|2|||
161253246|NCT02762994|582304521|FG003|Overall Study|Withdrawal by Subject|0|||
161253247|NCT02762994|582304518|FG000|Overall Study|Protocol Violation|1|||
161253248|NCT02762994|582304519|FG001|Overall Study|Protocol Violation|0|||
161253249|NCT02762994|582304520|FG002|Overall Study|Protocol Violation|0|||
161253250|NCT02762994|582304521|FG003|Overall Study|Protocol Violation|2|||
161253251|NCT05103657|582304522|FG000|Overall Study|Other reasons than listed|9|||
161253252|NCT05103657|582304523|FG001|Overall Study|Other reasons than listed|8|||
161253253|NCT05103657|582304522|FG000|Overall Study|Protocol deviation|2|||
161253254|NCT05103657|582304523|FG001|Overall Study|Protocol deviation|2|||
161253255|NCT05103657|582304522|FG000|Overall Study|No reason available|5|||
161253256|NCT05103657|582304523|FG001|Overall Study|No reason available|4|||
161253257|NCT05103657|582304522|FG000|Overall Study|Burden of study procedures|3|||
161253258|NCT05103657|582304523|FG001|Overall Study|Burden of study procedures|1|||
161253259|NCT05103657|582304522|FG000|Overall Study|Perceived lack of efficacy|1|||
161253260|NCT05103657|582304523|FG001|Overall Study|Perceived lack of efficacy|1|||
161253261|NCT05103657|582304522|FG000|Overall Study|Adverse Event|6|||
161253262|NCT05103657|582304523|FG001|Overall Study|Adverse Event|14|||
161253263|NCT05103657|582304522|FG000|Overall Study|Not Treated|1|||
161253264|NCT05103657|582304523|FG001|Overall Study|Not Treated|1|||
161253265|NCT02020967|582304524|FG000|Overall Study|Withdrawal by Subject|51|||
161253266|NCT02387762|582304527|FG000|Overall Study|Withdrawal by Subject|1|||
161253267|NCT02387762|582304528|FG001|Overall Study|Withdrawal by Subject|0|||
161336509|NCT01618968|582621752|FG000|Overall Study|Adverse Event|1|||
161336510|NCT01618968|582621753|FG001|Overall Study|Adverse Event|0|||
161336511|NCT01618968|582621754|FG002|Overall Study|Adverse Event|0|||
161336512|NCT01618968|582621755|FG003|Overall Study|Adverse Event|0|||
161253268|NCT00642811|582304531|FG000|Overall Study|Adverse Event|2|||
161253269|NCT00642811|582304532|FG001|Overall Study|Adverse Event|3|||
161253270|NCT00642811|582304533|FG002|Overall Study|Adverse Event|0|||
161336513|NCT01618968|582621752|FG000|Overall Study|Death|0|||
161336514|NCT01618968|582621753|FG001|Overall Study|Death|0|||
161336515|NCT01618968|582621754|FG002|Overall Study|Death|0|||
161336516|NCT01618968|582621755|FG003|Overall Study|Death|1|||
161253271|NCT00642811|582304534|FG003|Overall Study|Adverse Event|0|||
161336517|NCT05158140|582621758|FG000|Overall Study|Death|0|||
161253272|NCT00642811|582304535|FG004|Overall Study|Adverse Event|0|||
161253273|NCT00642811|582304536|FG005|Overall Study|Adverse Event|1|||
161253274|NCT00642811|582304531|FG000|Overall Study|Developement of discontinuation criteria|0|||
161253275|NCT00642811|582304532|FG001|Overall Study|Developement of discontinuation criteria|0|||
161253276|NCT00642811|582304533|FG002|Overall Study|Developement of discontinuation criteria|0|||
161253277|NCT00642811|582304534|FG003|Overall Study|Developement of discontinuation criteria|0|||
161253278|NCT00642811|582304535|FG004|Overall Study|Developement of discontinuation criteria|1|||
161253279|NCT00642811|582304536|FG005|Overall Study|Developement of discontinuation criteria|0|||
161253280|NCT00642811|582304531|FG000|Overall Study|Severe Non-compliance to protocol|1|||
161253281|NCT00642811|582304532|FG001|Overall Study|Severe Non-compliance to protocol|0|||
161253282|NCT00642811|582304533|FG002|Overall Study|Severe Non-compliance to protocol|0|||
161253283|NCT00642811|582304534|FG003|Overall Study|Severe Non-compliance to protocol|0|||
161253284|NCT00642811|582304535|FG004|Overall Study|Severe Non-compliance to protocol|0|||
161253285|NCT00642811|582304536|FG005|Overall Study|Severe Non-compliance to protocol|0|||
161253286|NCT00642811|582304531|FG000|Overall Study|Other|0|||
161253287|NCT00642811|582304532|FG001|Overall Study|Other|1|||
161253288|NCT00642811|582304533|FG002|Overall Study|Other|0|||
161253289|NCT00642811|582304534|FG003|Overall Study|Other|1|||
161253290|NCT00642811|582304535|FG004|Overall Study|Other|0|||
161253291|NCT00642811|582304536|FG005|Overall Study|Other|0|||
161253292|NCT02614898|582304537|FG000|Overall Study|Participated until study termination|10|||
161253293|NCT02614898|582304538|FG001|Overall Study|Participated until study termination|26|||
161253294|NCT02614898|582304537|FG000|Overall Study|Lost to Follow-up|0|||
161253295|NCT02614898|582304538|FG001|Overall Study|Lost to Follow-up|2|||
161253296|NCT02614898|582304537|FG000|Overall Study|Physician Decision|1|||
161253297|NCT02614898|582304538|FG001|Overall Study|Physician Decision|8|||
161253298|NCT02614898|582304537|FG000|Overall Study|Study Terminated by Sponsor|3|||
161253299|NCT02614898|582304538|FG001|Overall Study|Study Terminated by Sponsor|0|||
161253300|NCT02614898|582304537|FG000|Overall Study|Withdrawal by Subject|0|||
161253301|NCT02614898|582304538|FG001|Overall Study|Withdrawal by Subject|2|||
161253302|NCT02614898|582304537|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161253303|NCT02614898|582304538|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161253304|NCT02614898|582304537|FG000|Overall Study|Other-Additional Information Unavailable|0|||
161253305|NCT02614898|582304538|FG001|Overall Study|Other-Additional Information Unavailable|11|||
161253306|NCT02614898|582304537|FG000|Overall Study|Missing|0|||
161253307|NCT02614898|582304538|FG001|Overall Study|Missing|1|||
161253308|NCT00810602|582304541|FG000|Overall Study|Withdrawal by Subject|8|||
161253309|NCT00810602|582304542|FG001|Overall Study|Withdrawal by Subject|3|||
161253310|NCT00434590|582304543|FG000|Overall Study|Administrative problems|5|||
161253311|NCT00434590|582304544|FG001|Overall Study|Administrative problems|5|||
161253312|NCT00996437|582306573|FG000|Overall Study|Death|1|||
161253313|NCT00996437|582306574|FG001|Overall Study|Death|0|||
161253314|NCT00996437|582306573|FG000|Overall Study|Dropped|2|||
161253315|NCT00996437|582306574|FG001|Overall Study|Dropped|2|||
161253316|NCT00996437|582306573|FG000|Overall Study|Missed|2|||
161253317|NCT00996437|582306574|FG001|Overall Study|Missed|5|||
161253318|NCT02576717|582306575|FG000|Overall Study|Other Reasons|16|||
161253319|NCT02576717|582306576|FG001|Overall Study|Other Reasons|18|||
161253320|NCT02576717|582306577|FG002|Overall Study|Other Reasons|15|||
160845230|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Adverse Event|0|||
160845231|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Adverse Event|2|||
160845232|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Adverse Event|6|||
161253321|NCT02576717|582306575|FG000|Overall Study|Covid-19 Pandemic|0|||
160845233|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Adverse Event|1|||
160845234|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845235|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845236|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845237|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845238|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845239|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845240|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845241|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845242|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845243|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845244|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845245|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845246|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
161253322|NCT02576717|582306576|FG001|Overall Study|Covid-19 Pandemic|1|||
161253323|NCT02576717|582306577|FG002|Overall Study|Covid-19 Pandemic|1|||
161253324|NCT02576717|582306575|FG000|Overall Study|Sponsor Decision|0|||
161253325|NCT02576717|582306576|FG001|Overall Study|Sponsor Decision|0|||
161253326|NCT02576717|582306577|FG002|Overall Study|Sponsor Decision|1|||
161253327|NCT02576717|582306575|FG000|Overall Study|Physician Decision|3|||
161253328|NCT02576717|582306576|FG001|Overall Study|Physician Decision|8|||
161253329|NCT02576717|582306577|FG002|Overall Study|Physician Decision|9|||
161253330|NCT02576717|582306575|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
161253331|NCT02576717|582306576|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
161253332|NCT02576717|582306577|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
161253333|NCT02576717|582306575|FG000|Overall Study|Death|3|||
161253334|NCT02576717|582306576|FG001|Overall Study|Death|5|||
161253335|NCT02576717|582306577|FG002|Overall Study|Death|3|||
161253336|NCT02576717|582306575|FG000|Overall Study|Lost to Follow-up|9|||
161253337|NCT02576717|582306576|FG001|Overall Study|Lost to Follow-up|10|||
161253338|NCT02576717|582306577|FG002|Overall Study|Lost to Follow-up|19|||
161253339|NCT02576717|582306575|FG000|Overall Study|Protocol Violation|4|||
161253340|NCT02576717|582306576|FG001|Overall Study|Protocol Violation|0|||
161253341|NCT02576717|582306577|FG002|Overall Study|Protocol Violation|5|||
161253342|NCT02576717|582306575|FG000|Overall Study|Lack of Efficacy|24|||
161253343|NCT02576717|582306576|FG001|Overall Study|Lack of Efficacy|28|||
161253344|NCT02576717|582306577|FG002|Overall Study|Lack of Efficacy|20|||
161253345|NCT02576717|582306575|FG000|Overall Study|Adverse Event|26|||
161253346|NCT02576717|582306576|FG001|Overall Study|Adverse Event|32|||
161253347|NCT02576717|582306577|FG002|Overall Study|Adverse Event|26|||
161253348|NCT00399893|582306578|FG000|Overall Study|Withdrawal by Subject|1|||
161253349|NCT00399893|582306579|FG001|Overall Study|Withdrawal by Subject|0|||
161253350|NCT00407745|582306591|FG000|Overall Study|Lack of Efficacy|1|||
161253351|NCT00407745|582306592|FG001|Overall Study|Lack of Efficacy|2|||
161253352|NCT00407745|582306591|FG000|Overall Study|Withdrawal by Subject|3|||
161253353|NCT00407745|582306592|FG001|Overall Study|Withdrawal by Subject|3|||
161253354|NCT00407745|582306591|FG000|Overall Study|Protocol Violation|5|||
161253355|NCT00407745|582306592|FG001|Overall Study|Protocol Violation|3|||
161253356|NCT00407745|582306591|FG000|Overall Study|Adverse Event|8|||
161253357|NCT00407745|582306592|FG001|Overall Study|Adverse Event|8|||
161253358|NCT00407745|582306591|FG000|Overall Study|Other|2|||
161253359|NCT00407745|582306592|FG001|Overall Study|Other|0|||
161253360|NCT00407745|582306591|FG000|Overall Study|Randomized, unknown if treated|0|||
161253361|NCT00407745|582306592|FG001|Overall Study|Randomized, unknown if treated|1|||
161253362|NCT02940730|582306595|FG000|Intervention 2|Physician Decision|7|||
161253363|NCT02940730|582306596|FG001|Intervention 2|Physician Decision|0|||
161253364|NCT02960438|582306597|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
161253365|NCT02960438|582306598|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
161253366|NCT02960438|582306599|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
161253367|NCT02960438|582306600|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
161253368|NCT02960438|582306597|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
161253369|NCT02960438|582306598|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
161253370|NCT02960438|582306599|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
161253371|NCT02960438|582306600|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
161253372|NCT02960438|582306597|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
161253373|NCT02960438|582306598|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161253374|NCT02960438|582306599|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161253375|NCT02960438|582306600|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
161253376|NCT02960438|582306597|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
161253377|NCT02960438|582306598|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
161253378|NCT02960438|582306599|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
161253379|NCT02960438|582306600|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
161253380|NCT02960438|582306597|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161253381|NCT02960438|582306598|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161253382|NCT02960438|582306599|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
161253383|NCT02960438|582306600|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
161253384|NCT02960438|582306597|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
161253385|NCT02960438|582306598|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
161253386|NCT02960438|582306599|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
161253387|NCT02960438|582306600|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
161253388|NCT02960438|582306597|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
161253389|NCT02960438|582306598|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
161253390|NCT02960438|582306599|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
160845247|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
161253391|NCT02960438|582306600|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
161253392|NCT02960438|582306597|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161253393|NCT02960438|582306598|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161253394|NCT02960438|582306599|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
161253395|NCT02960438|582306600|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
161253396|NCT02960438|582306597|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161253397|NCT02960438|582306598|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161253398|NCT02960438|582306599|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
161253399|NCT02960438|582306600|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
161253400|NCT02960438|582306597|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
161253401|NCT02960438|582306598|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
161253402|NCT02960438|582306599|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
161253403|NCT02960438|582306600|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
161253404|NCT02960438|582306597|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
161253405|NCT02960438|582306598|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
161253406|NCT02960438|582306599|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
161253407|NCT02960438|582306600|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
161253408|NCT02960438|582306597|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
161253409|NCT02960438|582306598|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
161253410|NCT02960438|582306599|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
161253411|NCT02960438|582306600|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
161253412|NCT01522950|582306601|FG000|Overall Study|Withdrawal by Subject|3|||
161253413|NCT01522950|582306602|FG001|Overall Study|Withdrawal by Subject|2|||
161253414|NCT01522950|582306603|FG002|Overall Study|Withdrawal by Subject|1|||
161253415|NCT01522950|582306601|FG000|Overall Study|Adverse Event|3|||
161253416|NCT01522950|582306602|FG001|Overall Study|Adverse Event|1|||
161253417|NCT01522950|582306603|FG002|Overall Study|Adverse Event|1|||
161253418|NCT01522950|582306601|FG000|Overall Study|Protocol Violation|0|||
161253419|NCT01522950|582306602|FG001|Overall Study|Protocol Violation|0|||
161253420|NCT01522950|582306603|FG002|Overall Study|Protocol Violation|2|||
161253421|NCT01522950|582306601|FG000|Overall Study|Death|0|||
161253422|NCT01522950|582306602|FG001|Overall Study|Death|1|||
160845248|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845249|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845250|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845251|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
161253423|NCT01522950|582306603|FG002|Overall Study|Death|1|||
161253424|NCT01522950|582306601|FG000|Overall Study|Study Medication Sensitivity|0|||
161253425|NCT01522950|582306602|FG001|Overall Study|Study Medication Sensitivity|1|||
161253426|NCT01522950|582306603|FG002|Overall Study|Study Medication Sensitivity|0|||
161253427|NCT01064531|582306608|FG000|Overall Study|Lost to Follow-up|0|||
161253428|NCT01064531|582306609|FG001|Overall Study|Lost to Follow-up|2|||
160845252|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
160845253|NCT03364309|580819705|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
160845254|NCT03364309|580819706|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
160845255|NCT03364309|580819707|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
160845256|NCT03364309|580819708|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
160845257|NCT03364309|580819709|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
160845258|NCT03364309|580819710|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
160845259|NCT03364309|580819711|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
160845260|NCT03364309|580819712|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
160845261|NCT03364309|580819713|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
160845262|NCT03364309|580819714|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
160845263|NCT03364309|580819715|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
160845264|NCT03364309|580819716|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
160845265|NCT03364309|580819717|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
160845266|NCT03364309|580819718|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
160845267|NCT03364309|580819719|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
160845268|NCT03364309|580819720|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
160845269|NCT03364309|580819721|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
160845270|NCT03364309|580819722|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
160845271|NCT03364309|580819723|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
160845272|NCT01371552|580819724|FG000|Part 1, First 3 Days|Inconvenience|0|||
160845273|NCT01371552|580819725|FG001|Part 1, First 3 Days|Inconvenience|0|||
160845274|NCT01371552|580819726|FG002|Part 1, First 3 Days|Inconvenience|1|||
160845275|NCT01371552|580819727|FG003|Part 1, First 3 Days|Inconvenience|0|||
160845276|NCT01371552|580819728|FG004|Part 1, First 3 Days|Inconvenience|0|||
160845277|NCT01371552|580819729|FG005|Part 1, First 3 Days|Inconvenience|0|||
160845278|NCT00167310|580819730|FG000|Overall Study|Protocol Violation|5|||
160845279|NCT00167310|580819731|FG001|Overall Study|Protocol Violation|3|||
160845280|NCT00167310|580819730|FG000|Overall Study|Withdrawal by Subject|3|||
160845281|NCT00167310|580819731|FG001|Overall Study|Withdrawal by Subject|7|||
160845282|NCT00615992|580819732|FG000|Overall Study|Protocol Violation|67|||
161253429|NCT01064531|582306608|FG000|Overall Study|Physician Decision|0|||
161253430|NCT01064531|582306609|FG001|Overall Study|Physician Decision|1|||
160845283|NCT04522141|580819734|FG000|Overall Study|Withdrawal by Subject|1|||
160845284|NCT04522141|580819735|FG001|Overall Study|Withdrawal by Subject|0|||
160845285|NCT03052049|580819736|FG000|Overall Study|Withdrawal by Subject|2|||
160845286|NCT02328027|580819737|FG000|Overall Study|Withdrawal by Subject|0|||
160845287|NCT02328027|580819738|FG001|Overall Study|Withdrawal by Subject|1|||
161336518|NCT05158140|582621759|FG001|Overall Study|Death|0|||
161336519|NCT05158140|582621760|FG002|Overall Study|Death|0|||
161336520|NCT05158140|582621761|FG003|Overall Study|Death|1|||
161336521|NCT05158140|582621758|FG000|Overall Study|Lost to Follow-up|3|||
161336522|NCT05158140|582621759|FG001|Overall Study|Lost to Follow-up|6|||
161336523|NCT05158140|582621760|FG002|Overall Study|Lost to Follow-up|4|||
161336524|NCT05158140|582621761|FG003|Overall Study|Lost to Follow-up|3|||
161336525|NCT05158140|582621758|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160845288|NCT03319212|580819739|FG000|Overall Study|Discontinued as moving out of local area|0|||
160845289|NCT03319212|580819740|FG001|Overall Study|Discontinued as moving out of local area|1|||
160845290|NCT03319212|580819739|FG000|Overall Study|Adverse Event|2|||
160845291|NCT03319212|580819740|FG001|Overall Study|Adverse Event|2|||
160845292|NCT03319212|580819739|FG000|Overall Study|Withdrawal by Subject|0|||
160845293|NCT03319212|580819740|FG001|Overall Study|Withdrawal by Subject|1|||
160845294|NCT03319212|580819739|FG000|Overall Study|Lost to Follow-up|0|||
160845295|NCT03319212|580819740|FG001|Overall Study|Lost to Follow-up|1|||
160845296|NCT03319212|580819739|FG000|Overall Study|Physician Decision|1|||
160845297|NCT03319212|580819740|FG001|Overall Study|Physician Decision|0|||
160845298|NCT01868477|580819741|FG000|Overall Study|Adverse Event|2|||
160845299|NCT01868477|580819742|FG001|Overall Study|Adverse Event|4|||
160845300|NCT01868477|580819741|FG000|Overall Study|Disease progression|1|||
160845301|NCT01868477|580819742|FG001|Overall Study|Disease progression|1|||
160845302|NCT01868477|580819741|FG000|Overall Study|Withdrawal by Subject|1|||
160845303|NCT01868477|580819742|FG001|Overall Study|Withdrawal by Subject|0|||
160845304|NCT02465203|580819743|FG000|Overall Study|Protocol Violation|1|||
160845305|NCT02465203|580819744|FG001|Overall Study|Protocol Violation|1|||
160845306|NCT02465203|580819745|FG002|Overall Study|Protocol Violation|1|||
160845307|NCT02465203|580819743|FG000|Overall Study|Study terminated by sponsor|50|||
160845308|NCT02465203|580819744|FG001|Overall Study|Study terminated by sponsor|34|||
161253431|NCT01064531|582306608|FG000|Overall Study|Withdrawal by Subject|2|||
161253432|NCT01064531|582306609|FG001|Overall Study|Withdrawal by Subject|2|||
161253433|NCT01064531|582306608|FG000|Overall Study|Revision due to femoral stem loosening|1|||
161253434|NCT01064531|582306609|FG001|Overall Study|Revision due to femoral stem loosening|0|||
161253435|NCT01064531|582306608|FG000|Overall Study|Revision due to dislocation|0|||
161253436|NCT01064531|582306609|FG001|Overall Study|Revision due to dislocation|1|||
161253437|NCT01064531|582306608|FG000|Overall Study|Death|0|||
161253438|NCT01064531|582306609|FG001|Overall Study|Death|1|||
161253439|NCT03449199|582306614|FG000|Overall Study|Lost to Follow-up|1|||
161253440|NCT03449199|582306615|FG001|Overall Study|Lost to Follow-up|1|||
161253441|NCT03449199|582306616|FG002|Overall Study|Lost to Follow-up|0|||
161253442|NCT03449199|582306614|FG000|Overall Study|Protocol Deviation|0|||
161253443|NCT03449199|582306615|FG001|Overall Study|Protocol Deviation|0|||
161253444|NCT03449199|582306616|FG002|Overall Study|Protocol Deviation|1|||
161253445|NCT03449199|582306614|FG000|Overall Study|Withdrawal by Subject|0|||
161253446|NCT03449199|582306615|FG001|Overall Study|Withdrawal by Subject|0|||
161253447|NCT03449199|582306616|FG002|Overall Study|Withdrawal by Subject|1|||
161253448|NCT03136406|582306617|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
161253449|NCT01201759|582306618|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
161253450|NCT01201759|582306619|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
161253451|NCT01201759|582306618|FG000|Visit 3 - Washout|Adverse Event|0|||
161253452|NCT01201759|582306619|FG001|Visit 3 - Washout|Adverse Event|3|||
161253453|NCT01201759|582306618|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
161253454|NCT01201759|582306619|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
161253455|NCT01201759|582306618|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
161253456|NCT01201759|582306619|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
161253457|NCT00906373|582306620|FG000|Overall Study|Withdrawal by Subject|0|||
161253458|NCT00906373|582306621|FG001|Overall Study|Withdrawal by Subject|5|||
161253459|NCT00906373|582306620|FG000|Overall Study|Other|0|||
161253460|NCT00906373|582306621|FG001|Overall Study|Other|1|||
161253461|NCT00906373|582306620|FG000|Overall Study|Still on treatment at cutoff date|0|||
161253462|NCT00906373|582306621|FG001|Overall Study|Still on treatment at cutoff date|2|||
160845309|NCT02465203|580819745|FG002|Overall Study|Study terminated by sponsor|11|||
160845310|NCT02465203|580819743|FG000|Overall Study|New therapy for study indication|4|||
160845311|NCT02465203|580819744|FG001|Overall Study|New therapy for study indication|0|||
161253463|NCT00848042|582306622|FG000|Overall Study|Death|1|||
161253464|NCT00848042|582306623|FG001|Overall Study|Death|2|||
161253465|NCT00848042|582306624|FG002|Overall Study|Death|0|||
161253466|NCT00848042|582306622|FG000|Overall Study|Other Therapy|3|||
161253467|NCT00848042|582306623|FG001|Overall Study|Other Therapy|0|||
161253468|NCT00848042|582306624|FG002|Overall Study|Other Therapy|0|||
161253469|NCT01652729|582306625|FG000|Overall Study|Withdrawal by Subject|14|||
161253470|NCT01652729|582306626|FG001|Overall Study|Withdrawal by Subject|7|||
161336526|NCT05158140|582621759|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161336527|NCT05158140|582621760|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
160845312|NCT02465203|580819745|FG002|Overall Study|New therapy for study indication|0|||
160845313|NCT02465203|580819743|FG000|Overall Study|Patient/guardian decision|1|||
160992360|NCT04155424|581360033|FG000|Overall Study|Adverse Event|1|||
161336528|NCT05158140|582621761|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161336529|NCT05158140|582621758|FG000|Overall Study|Withdrawal by Subject|3|||
161336530|NCT05158140|582621759|FG001|Overall Study|Withdrawal by Subject|7|||
161336531|NCT05158140|582621760|FG002|Overall Study|Withdrawal by Subject|3|||
161336532|NCT05158140|582621761|FG003|Overall Study|Withdrawal by Subject|7|||
161336533|NCT03861039|582623521|FG000|Overall Study|Adverse Event|2|||
161336534|NCT03861039|582623522|FG001|Overall Study|Adverse Event|5|||
161336535|NCT03861039|582623523|FG002|Overall Study|Adverse Event|11|||
161336536|NCT03861039|582623521|FG000|Overall Study|Withdrawal by Subject|1|||
161336537|NCT03861039|582623522|FG001|Overall Study|Withdrawal by Subject|3|||
161336538|NCT03861039|582623523|FG002|Overall Study|Withdrawal by Subject|4|||
160845314|NCT02465203|580819744|FG001|Overall Study|Patient/guardian decision|1|||
160845315|NCT02465203|580819745|FG002|Overall Study|Patient/guardian decision|1|||
160845316|NCT04072887|580819750|FG000|Overall Study|Withdrawal by Subject|3|||
160845317|NCT04072887|580819751|FG001|Overall Study|Withdrawal by Subject|8|||
160845318|NCT04072887|580819752|FG002|Overall Study|Withdrawal by Subject|1|||
160845319|NCT04072887|580819753|FG003|Overall Study|Withdrawal by Subject|3|||
160845320|NCT04072887|580819754|FG004|Overall Study|Withdrawal by Subject|3|||
160845321|NCT04072887|580819755|FG005|Overall Study|Withdrawal by Subject|13|||
160845322|NCT04072887|580819750|FG000|Overall Study|Adverse Event|2|||
160845323|NCT04072887|580819751|FG001|Overall Study|Adverse Event|4|||
160845324|NCT04072887|580819752|FG002|Overall Study|Adverse Event|1|||
160845325|NCT04072887|580819753|FG003|Overall Study|Adverse Event|4|||
160845326|NCT04072887|580819754|FG004|Overall Study|Adverse Event|0|||
160845327|NCT04072887|580819755|FG005|Overall Study|Adverse Event|1|||
160845328|NCT04072887|580819750|FG000|Overall Study|Physician Decision|2|||
160845329|NCT04072887|580819751|FG001|Overall Study|Physician Decision|0|||
160845330|NCT04072887|580819752|FG002|Overall Study|Physician Decision|0|||
160845331|NCT04072887|580819753|FG003|Overall Study|Physician Decision|0|||
160845332|NCT04072887|580819754|FG004|Overall Study|Physician Decision|0|||
160845333|NCT04072887|580819755|FG005|Overall Study|Physician Decision|1|||
160845334|NCT04072887|580819750|FG000|Overall Study|Lost to Follow-up|1|||
160845335|NCT04072887|580819751|FG001|Overall Study|Lost to Follow-up|3|||
160845336|NCT04072887|580819752|FG002|Overall Study|Lost to Follow-up|0|||
160845337|NCT04072887|580819753|FG003|Overall Study|Lost to Follow-up|0|||
160845338|NCT04072887|580819754|FG004|Overall Study|Lost to Follow-up|0|||
160845339|NCT04072887|580819755|FG005|Overall Study|Lost to Follow-up|0|||
160845340|NCT04072887|580819750|FG000|Overall Study|Death|0|||
160845341|NCT04072887|580819751|FG001|Overall Study|Death|2|||
160845342|NCT04072887|580819752|FG002|Overall Study|Death|0|||
160845343|NCT04072887|580819753|FG003|Overall Study|Death|2|||
160845344|NCT04072887|580819754|FG004|Overall Study|Death|3|||
160845345|NCT04072887|580819755|FG005|Overall Study|Death|0|||
160845346|NCT01153724|580819758|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161336539|NCT01113749|582623524|FG000|Overall Study|Lost to Follow-up|1|||
161336540|NCT01113749|582623525|FG001|Overall Study|Lost to Follow-up|2|||
161336541|NCT03427892|582623526|FG000|Overall Study|Lost to Follow-up|2|||
161336542|NCT03255187|582623527|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
161336543|NCT03255187|582623528|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
161336544|NCT03255187|582623527|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
161336545|NCT03255187|582623528|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
161336546|NCT02934178|582623529|FG000|Received Vaccination 2|Death|0|||
161336547|NCT02934178|582623530|FG001|Received Vaccination 2|Death|1|||
161336548|NCT02934178|582623529|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
161336549|NCT02934178|582623530|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
161336550|NCT00720278|582623534|FG000|Overall Study|Adverse Event|5|||
161336551|NCT00720278|582623535|FG001|Overall Study|Adverse Event|3|||
160845347|NCT01153724|580819758|FG000|Treatment Period 2|Adverse Event|1|||
160845348|NCT01153724|580819758|FG000|Treatment Period 2|Other reason not defined above|1|||
160845349|NCT04371666|580819763|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
160845350|NCT04371666|580819764|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
161140808|NCT00817414|581899195|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
160905997|NCT02340975|581050340|FG002|Overall Study|Withdrawal by Subject|3|||
160905998|NCT02340975|581050341|FG003|Overall Study|Withdrawal by Subject|3|||
161336552|NCT00720278|582623536|FG002|Overall Study|Adverse Event|4|||
160845351|NCT04371666|580819763|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
160845352|NCT04371666|580819764|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
160905999|NCT02340975|581050342|FG004|Overall Study|Withdrawal by Subject|2|||
161336553|NCT00720278|582623534|FG000|Overall Study|Withdrawal by Subject|0|||
161336554|NCT00720278|582623535|FG001|Overall Study|Withdrawal by Subject|1|||
161336555|NCT00720278|582623536|FG002|Overall Study|Withdrawal by Subject|0|||
161336556|NCT00720278|582623534|FG000|Overall Study|Lost to Follow-up|0|||
160845353|NCT04371666|580819763|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
160845354|NCT04371666|580819764|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
160845355|NCT04371666|580819763|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
160845356|NCT04371666|580819764|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
160845357|NCT04371666|580819763|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
160845358|NCT04371666|580819764|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
160845359|NCT04371666|580819763|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
160845360|NCT04371666|580819764|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
160845361|NCT00445770|580819765|FG000|Overall Study|Adverse Event|9|||
160992361|NCT00662909|581360034|FG000|Overall Study|Adverse Event|17|||
160992362|NCT00662909|581360035|FG001|Overall Study|Adverse Event|18|||
160992363|NCT00662909|581360036|FG002|Overall Study|Adverse Event|19|||
160992364|NCT00662909|581360034|FG000|Overall Study|Lack of Efficacy|9|||
160992365|NCT00662909|581360035|FG001|Overall Study|Lack of Efficacy|1|||
160992366|NCT00662909|581360036|FG002|Overall Study|Lack of Efficacy|5|||
160992367|NCT00662909|581360034|FG000|Overall Study|Withdrawal by Subject|29|||
160992368|NCT00662909|581360035|FG001|Overall Study|Withdrawal by Subject|22|||
160992369|NCT00662909|581360036|FG002|Overall Study|Withdrawal by Subject|16|||
160992370|NCT00662909|581360034|FG000|Overall Study|Lost to Follow-up|2|||
160992371|NCT00662909|581360035|FG001|Overall Study|Lost to Follow-up|9|||
160992372|NCT00662909|581360036|FG002|Overall Study|Lost to Follow-up|3|||
161253471|NCT01652729|582306627|FG002|Overall Study|Withdrawal by Subject|7|||
161253472|NCT01652729|582306625|FG000|Overall Study|Adverse Event|4|||
161253473|NCT01652729|582306626|FG001|Overall Study|Adverse Event|0|||
161253474|NCT01652729|582306627|FG002|Overall Study|Adverse Event|3|||
161253475|NCT01652729|582306625|FG000|Overall Study|Physician Decision|1|||
161253476|NCT01652729|582306626|FG001|Overall Study|Physician Decision|0|||
161253477|NCT01652729|582306627|FG002|Overall Study|Physician Decision|1|||
161253478|NCT01652729|582306625|FG000|Overall Study|Protocol Violation|1|||
161253479|NCT01652729|582306626|FG001|Overall Study|Protocol Violation|0|||
161253480|NCT01652729|582306627|FG002|Overall Study|Protocol Violation|0|||
161253481|NCT01652729|582306625|FG000|Overall Study|Lost to Follow-up|6|||
161253482|NCT01652729|582306626|FG001|Overall Study|Lost to Follow-up|6|||
161253483|NCT01652729|582306627|FG002|Overall Study|Lost to Follow-up|3|||
161253484|NCT01652729|582306625|FG000|Overall Study|Administrative|1|||
161253485|NCT01652729|582306626|FG001|Overall Study|Administrative|0|||
161253486|NCT01652729|582306627|FG002|Overall Study|Administrative|0|||
161253487|NCT00483548|582306628|FG000|Overall Study|Randomized; not treated with study drug|1|||
161253488|NCT00483548|582306629|FG001|Overall Study|Randomized; not treated with study drug|3|||
161253489|NCT00483548|582306628|FG000|Overall Study|Adverse Event|25|||
161253490|NCT00483548|582306629|FG001|Overall Study|Adverse Event|14|||
161253491|NCT00483548|582306628|FG000|Overall Study|Laboratory abnormality|1|||
161253492|NCT00483548|582306629|FG001|Overall Study|Laboratory abnormality|2|||
161253493|NCT00483548|582306628|FG000|Overall Study|Lack of Efficacy|4|||
161253494|NCT00483548|582306629|FG001|Overall Study|Lack of Efficacy|8|||
161253495|NCT00483548|582306628|FG000|Overall Study|Protocol Violation|11|||
161253496|NCT00483548|582306629|FG001|Overall Study|Protocol Violation|7|||
161253497|NCT00483548|582306628|FG000|Overall Study|Pregnancy|1|||
161253498|NCT00483548|582306629|FG001|Overall Study|Pregnancy|0|||
161253499|NCT00483548|582306628|FG000|Overall Study|Protocol required discontinuation|6|||
161253500|NCT00483548|582306629|FG001|Overall Study|Protocol required discontinuation|6|||
161253501|NCT00483548|582306628|FG000|Overall Study|Unable to comply with protocol schedule|1|||
161253502|NCT00483548|582306629|FG001|Overall Study|Unable to comply with protocol schedule|0|||
161253503|NCT00483548|582306628|FG000|Overall Study|Non-compliance with medication|2|||
161253504|NCT00483548|582306629|FG001|Overall Study|Non-compliance with medication|0|||
161253505|NCT00483548|582306628|FG000|Overall Study|Lost to Follow-up|3|||
161253506|NCT00483548|582306629|FG001|Overall Study|Lost to Follow-up|4|||
161253507|NCT00483548|582306628|FG000|Overall Study|Withdrawal by Subject|5|||
160992373|NCT00662909|581360034|FG000|Overall Study|Protocol Violation|7|||
160992374|NCT00662909|581360035|FG001|Overall Study|Protocol Violation|4|||
161140809|NCT00817414|581899196|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
161140810|NCT00817414|581899197|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
160992375|NCT00662909|581360036|FG002|Overall Study|Protocol Violation|5|||
161140811|NCT00817414|581899193|FG000|Overall Study|Withdrawal by Subject|1|||
161140812|NCT00817414|581899194|FG001|Overall Study|Withdrawal by Subject|1|||
161140813|NCT00817414|581899195|FG002|Overall Study|Withdrawal by Subject|0|||
161140814|NCT00817414|581899196|FG003|Overall Study|Withdrawal by Subject|0|||
161140815|NCT00817414|581899197|FG004|Overall Study|Withdrawal by Subject|0|||
161140816|NCT00817414|581899193|FG000|Overall Study|Lost to Follow-up|0|||
161140817|NCT00817414|581899194|FG001|Overall Study|Lost to Follow-up|0|||
161140818|NCT00817414|581899195|FG002|Overall Study|Lost to Follow-up|1|||
161140819|NCT00817414|581899196|FG003|Overall Study|Lost to Follow-up|1|||
161140820|NCT00817414|581899197|FG004|Overall Study|Lost to Follow-up|1|||
161140821|NCT00817414|581899193|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161140822|NCT00817414|581899194|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161140823|NCT00817414|581899195|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161140824|NCT00817414|581899196|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
161253508|NCT00483548|582306629|FG001|Overall Study|Withdrawal by Subject|2|||
161253509|NCT04364737|582306633|FG000|Overall Study|Withdrawal by Subject|4|||
160845362|NCT00445770|580819766|FG001|Overall Study|Adverse Event|15|||
160845363|NCT00445770|580819767|FG002|Overall Study|Adverse Event|19|||
160845364|NCT00445770|580819765|FG000|Overall Study|Lack of Efficacy|38|||
160845365|NCT00445770|580819766|FG001|Overall Study|Lack of Efficacy|13|||
160845366|NCT00445770|580819767|FG002|Overall Study|Lack of Efficacy|6|||
160845367|NCT00445770|580819765|FG000|Overall Study|Lost to Follow-up|0|||
160845368|NCT00445770|580819766|FG001|Overall Study|Lost to Follow-up|2|||
160845369|NCT00445770|580819767|FG002|Overall Study|Lost to Follow-up|0|||
160845370|NCT00445770|580819765|FG000|Overall Study|Other|6|||
160845371|NCT00445770|580819766|FG001|Overall Study|Other|5|||
160845372|NCT00445770|580819767|FG002|Overall Study|Other|6|||
161253510|NCT04364737|582306634|FG001|Overall Study|Withdrawal by Subject|9|||
161253511|NCT04364737|582306633|FG000|Overall Study|Lost to Follow-up|1|||
161253512|NCT04364737|582306634|FG001|Overall Study|Lost to Follow-up|1|||
161253513|NCT01220609|582306635|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
161253514|NCT01220609|582306635|FG000|Overall Study|Ineligible- Wrong cell type|1|||
161253515|NCT01220609|582306635|FG000|Overall Study|Ineligible-Never treated|1|||
161253516|NCT00112294|582306636|FG000|Overall Study|Still on study|5|||
161253517|NCT00112294|582306637|FG001|Overall Study|Still on study|0|||
161253518|NCT05070754|582306647|FG000|Overall Study|Withdrawal by Subject|0|||
161253519|NCT05070754|582306648|FG001|Overall Study|Withdrawal by Subject|0|||
161253520|NCT05070754|582306649|FG002|Overall Study|Withdrawal by Subject|0|||
161253521|NCT05070754|582306650|FG003|Overall Study|Withdrawal by Subject|1|||
161253522|NCT05070754|582306647|FG000|Overall Study|Protocol Violation|0|||
161253523|NCT05070754|582306648|FG001|Overall Study|Protocol Violation|0|||
161253524|NCT05070754|582306649|FG002|Overall Study|Protocol Violation|0|||
161253525|NCT05070754|582306650|FG003|Overall Study|Protocol Violation|1|||
161253526|NCT01398787|582306651|FG000|Overall Study|Adverse Event|1|||
161253527|NCT00529217|582306654|FG000|Overall Study|Lack of Efficacy|2|||
161253528|NCT00529217|582306654|FG000|Overall Study|Unable to adhere to study schedule|2|||
161253529|NCT00372996|582306657|FG000|Overall Study|Death|11|||
161253530|NCT00372996|582306658|FG001|Overall Study|Death|4|||
161253531|NCT00372996|582306659|FG002|Overall Study|Death|8|||
161253532|NCT00372996|582306660|FG003|Overall Study|Death|7|||
160845373|NCT02092025|580819768|FG000|Overall Study|Case Report Forms Uncollected|44|||
160845374|NCT02092025|580819768|FG000|Overall Study|Protocol Deviation|24|||
160845375|NCT02927938|580819769|FG000|Overall Study|Death|0|||
160845376|NCT02927938|580819770|FG001|Overall Study|Death|1|||
160845377|NCT02927938|580819771|FG002|Overall Study|Death|0|||
160845378|NCT02927938|580819772|FG003|Overall Study|Death|4|||
160845379|NCT02927938|580819769|FG000|Overall Study|Early Study Termination|1|||
160845380|NCT02927938|580819770|FG001|Overall Study|Early Study Termination|5|||
160845381|NCT02927938|580819771|FG002|Overall Study|Early Study Termination|4|||
160845382|NCT02927938|580819772|FG003|Overall Study|Early Study Termination|3|||
160845383|NCT00934128|580819773|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
160845384|NCT00934128|580819774|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
160845385|NCT00934128|580819773|FG000|First Intervention (2 Hours)|Adverse Event|4|||
160845386|NCT00934128|580819774|FG001|First Intervention (2 Hours)|Adverse Event|1|||
160845387|NCT00934128|580819773|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
160845388|NCT00934128|580819774|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
160845389|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Patient preference|1|||
160845390|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Patient preference|3|||
160845391|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Pain|1|||
160845392|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Pain|0|||
160845393|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Too tired|1|||
160845394|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Too tired|0|||
160845395|NCT00934128|580819773|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
160845396|NCT00934128|580819774|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
160845397|NCT00934128|580819773|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
160845398|NCT00934128|580819774|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
160906000|NCT02340975|581050343|FG005|Overall Study|Withdrawal by Subject|0|||
161253533|NCT00372996|582306657|FG000|Overall Study|Lost to Follow-up|0|||
161253534|NCT00372996|582306658|FG001|Overall Study|Lost to Follow-up|2|||
161253535|NCT00372996|582306659|FG002|Overall Study|Lost to Follow-up|0|||
160845399|NCT02834247|580819775|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
160845400|NCT02834247|580819776|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
160845401|NCT02834247|580819777|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
160845402|NCT02834247|580819778|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
160845403|NCT02834247|580819775|FG000|Dose Escalation Phase|Death|5|||
160845404|NCT02834247|580819776|FG001|Dose Escalation Phase|Death|6|||
160845405|NCT02834247|580819777|FG002|Dose Escalation Phase|Death|5|||
160845406|NCT02834247|580819778|FG003|Dose Escalation Phase|Death|0|||
160845407|NCT02834247|580819775|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
161253536|NCT00372996|582306660|FG003|Overall Study|Lost to Follow-up|1|||
161253537|NCT00372996|582306657|FG000|Overall Study|Withdrawal by Subject|12|||
160845408|NCT02834247|580819776|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
160845409|NCT02834247|580819777|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
160845410|NCT02834247|580819778|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
160845411|NCT02834247|580819775|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
160845412|NCT02834247|580819776|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
160845413|NCT02834247|580819777|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160845414|NCT02834247|580819778|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160845415|NCT02834247|580819775|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
160845416|NCT02834247|580819776|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
160845417|NCT02834247|580819777|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
160845418|NCT02834247|580819778|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
160845419|NCT02834247|580819775|FG000|Dose Expansion Phase|Death|0|||
160845420|NCT02834247|580819776|FG001|Dose Expansion Phase|Death|0|||
160845421|NCT02834247|580819777|FG002|Dose Expansion Phase|Death|0|||
160845422|NCT02834247|580819778|FG003|Dose Expansion Phase|Death|8|||
160845423|NCT02834247|580819775|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
160845424|NCT02834247|580819776|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
160845425|NCT02834247|580819777|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
160845426|NCT02834247|580819778|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
160845427|NCT02834247|580819775|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
161253538|NCT00372996|582306658|FG001|Overall Study|Withdrawal by Subject|6|||
161253539|NCT00372996|582306659|FG002|Overall Study|Withdrawal by Subject|9|||
161253540|NCT00372996|582306660|FG003|Overall Study|Withdrawal by Subject|5|||
161253541|NCT00372996|582306657|FG000|Overall Study|Study Terminated by Sponsor|4|||
161253542|NCT00372996|582306658|FG001|Overall Study|Study Terminated by Sponsor|0|||
161253543|NCT00372996|582306659|FG002|Overall Study|Study Terminated by Sponsor|4|||
161253544|NCT00372996|582306660|FG003|Overall Study|Study Terminated by Sponsor|0|||
160845428|NCT02834247|580819776|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
160845429|NCT02834247|580819777|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
160845430|NCT02834247|580819778|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
160845431|NCT01807299|580819785|FG000|Overall Study|Protocol Violation|3|||
160845432|NCT01807299|580819786|FG001|Overall Study|Protocol Violation|1|||
160845433|NCT01807299|580819787|FG002|Overall Study|Protocol Violation|0|||
160845434|NCT01807299|580819788|FG003|Overall Study|Protocol Violation|2|||
160845435|NCT02476006|580819789|FG000|Overall Study|Death|4|||
160845436|NCT02476006|580819789|FG000|Overall Study|Lack of treatment efficacy|2|||
160845437|NCT02476006|580819789|FG000|Overall Study|Pregnancy|1|||
160845438|NCT02476006|580819789|FG000|Overall Study|Participant did not wish to continue|39|||
160845439|NCT02476006|580819789|FG000|Overall Study|Adverse Event|41|||
160845440|NCT02476006|580819789|FG000|Overall Study|Poor compliance to study protocol|3|||
160845441|NCT02476006|580819789|FG000|Overall Study|Sponsor decision|6|||
160845442|NCT02476006|580819789|FG000|Overall Study|Lost to Follow-up|5|||
160845443|NCT02476006|580819789|FG000|Overall Study|Physician Decision|5|||
160845444|NCT02476006|580819789|FG000|Overall Study|Study ended treatment not available|4|||
160845445|NCT02476006|580819789|FG000|Overall Study|Switched to commercial drug|4|||
160845446|NCT02476006|580819789|FG000|Overall Study|Excluded from study|1|||
160845447|NCT02476006|580819789|FG000|Overall Study|Protocol Violation|1|||
160845448|NCT02476006|580819789|FG000|Overall Study|Enrolled but not treated|4|||
160845449|NCT00811174|580819790|FG000|Overall Study|Protocol Violation|2|||
160845450|NCT00811174|580819790|FG000|Overall Study|Sponsors Decision|1|||
160845451|NCT01410890|580821119|FG000|Overall Study|Withdrawal by Subject|0|||
160845452|NCT01410890|580821120|FG001|Overall Study|Withdrawal by Subject|1|||
160845453|NCT00412893|580821121|FG000|Overall Study|Adverse Event|31|||
160845454|NCT00412893|580821122|FG001|Overall Study|Adverse Event|53|||
160845455|NCT00412893|580821121|FG000|Overall Study|Death|17|||
160845456|NCT00412893|580821122|FG001|Overall Study|Death|21|||
161253545|NCT00372996|582306657|FG000|Overall Study|Other|10|||
161253546|NCT00372996|582306658|FG001|Overall Study|Other|2|||
161253547|NCT00372996|582306659|FG002|Overall Study|Other|7|||
161253548|NCT00372996|582306660|FG003|Overall Study|Other|7|||
161253549|NCT01098539|582306661|FG000|Overall Study|Adverse Event|26|||
161253550|NCT01098539|582306662|FG001|Overall Study|Adverse Event|26|||
160845457|NCT00412893|580821121|FG000|Overall Study|Insufficient Therapeutic Response|39|||
160845458|NCT00412893|580821122|FG001|Overall Study|Insufficient Therapeutic Response|23|||
160845459|NCT00412893|580821121|FG000|Overall Study|Lost to Follow-up|2|||
160845460|NCT00412893|580821122|FG001|Overall Study|Lost to Follow-up|1|||
160845461|NCT00412893|580821121|FG000|Overall Study|Violation of Selection at Entry|17|||
160845462|NCT00412893|580821122|FG001|Overall Study|Violation of Selection at Entry|10|||
160845463|NCT00412893|580821121|FG000|Overall Study|Other Protocol Violation|10|||
160845464|NCT00412893|580821122|FG001|Overall Study|Other Protocol Violation|6|||
160845465|NCT00412893|580821121|FG000|Overall Study|Did Not Cooperate|12|||
160845466|NCT00412893|580821122|FG001|Overall Study|Did Not Cooperate|9|||
160845467|NCT00412893|580821121|FG000|Overall Study|Administrative Reason|12|||
161253551|NCT01098539|582306661|FG000|Overall Study|Protocol Violation|1|||
160845468|NCT00412893|580821122|FG001|Overall Study|Administrative Reason|15|||
161253552|NCT01098539|582306662|FG001|Overall Study|Protocol Violation|4|||
161253553|NCT01098539|582306661|FG000|Overall Study|Noncompliance|3|||
161336557|NCT00720278|582623535|FG001|Overall Study|Lost to Follow-up|0|||
161336558|NCT00720278|582623536|FG002|Overall Study|Lost to Follow-up|1|||
161336559|NCT00720278|582623534|FG000|Overall Study|Non-compliance|1|||
161336560|NCT00720278|582623535|FG001|Overall Study|Non-compliance|0|||
161336561|NCT00720278|582623536|FG002|Overall Study|Non-compliance|0|||
161336562|NCT00720278|582623534|FG000|Overall Study|eligibility criteria violation|1|||
161336563|NCT00720278|582623535|FG001|Overall Study|eligibility criteria violation|0|||
161336564|NCT00720278|582623536|FG002|Overall Study|eligibility criteria violation|1|||
161336565|NCT01075048|582623538|FG000|Overall Study|Death|4|||
161336566|NCT01075048|582623539|FG001|Overall Study|Death|17|||
161336567|NCT01075048|582623540|FG002|Overall Study|Death|12|||
161336568|NCT01075048|582623538|FG000|Overall Study|Start of other or new therapy|4|||
160845469|NCT00412893|580821121|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
160845470|NCT00412893|580821122|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
160845471|NCT03951077|580821123|FG000|Overall Study|Adverse Event|1|||
160845472|NCT03951077|580821124|FG001|Overall Study|Adverse Event|0|||
160845473|NCT03951077|580821125|FG002|Overall Study|Adverse Event|0|||
160845474|NCT03951077|580821126|FG003|Overall Study|Adverse Event|0|||
160845475|NCT03951077|580821127|FG004|Overall Study|Adverse Event|0|||
160845476|NCT03951077|580821128|FG005|Overall Study|Adverse Event|0|||
160845477|NCT03951077|580821123|FG000|Overall Study|Withdrawal by Subject|3|||
160845478|NCT03951077|580821124|FG001|Overall Study|Withdrawal by Subject|3|||
160845479|NCT03951077|580821125|FG002|Overall Study|Withdrawal by Subject|0|||
160845480|NCT03951077|580821126|FG003|Overall Study|Withdrawal by Subject|3|||
160845481|NCT03951077|580821127|FG004|Overall Study|Withdrawal by Subject|3|||
160845482|NCT03951077|580821128|FG005|Overall Study|Withdrawal by Subject|2|||
160845483|NCT03951077|580821123|FG000|Overall Study|Lost to Follow-up|1|||
160845484|NCT03951077|580821124|FG001|Overall Study|Lost to Follow-up|1|||
160845485|NCT03951077|580821125|FG002|Overall Study|Lost to Follow-up|2|||
160845486|NCT03951077|580821126|FG003|Overall Study|Lost to Follow-up|3|||
160845487|NCT03951077|580821127|FG004|Overall Study|Lost to Follow-up|2|||
160845488|NCT03951077|580821128|FG005|Overall Study|Lost to Follow-up|3|||
160845489|NCT03951077|580821123|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
160845490|NCT03951077|580821124|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
160845491|NCT03951077|580821125|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
160845492|NCT03951077|580821126|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
161140825|NCT00817414|581899197|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
161140826|NCT00817414|581899193|FG000|Overall Study|Protocol Violation|0|||
161140827|NCT00817414|581899194|FG001|Overall Study|Protocol Violation|0|||
161253554|NCT01098539|582306662|FG001|Overall Study|Noncompliance|5|||
161253555|NCT01098539|582306661|FG000|Overall Study|Lost to Follow-up|4|||
161253556|NCT01098539|582306662|FG001|Overall Study|Lost to Follow-up|4|||
161253557|NCT01098539|582306661|FG000|Overall Study|Withdrawal by Subject|12|||
161253558|NCT01098539|582306662|FG001|Overall Study|Withdrawal by Subject|26|||
161253559|NCT01098539|582306661|FG000|Overall Study|Physician Decision|5|||
161253560|NCT01098539|582306662|FG001|Overall Study|Physician Decision|3|||
161253561|NCT03173560|582306663|FG000|Overall Study|Death|70|||
161253562|NCT03173560|582306664|FG001|Overall Study|Death|60|||
161253563|NCT03173560|582306663|FG000|Overall Study|Lost to Follow-up|1|||
161253564|NCT03173560|582306664|FG001|Overall Study|Lost to Follow-up|4|||
161253565|NCT03173560|582306663|FG000|Overall Study|Withdrawal by Subject|10|||
161253566|NCT03173560|582306664|FG001|Overall Study|Withdrawal by Subject|5|||
161253567|NCT03173560|582306663|FG000|Overall Study|Other|0|||
161336569|NCT01075048|582623539|FG001|Overall Study|Start of other or new therapy|36|||
161336570|NCT01075048|582623540|FG002|Overall Study|Start of other or new therapy|46|||
161336571|NCT01075048|582623538|FG000|Overall Study|Withdrawal by Subject|1|||
161336572|NCT01075048|582623539|FG001|Overall Study|Withdrawal by Subject|6|||
160845493|NCT03951077|580821127|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
160845494|NCT03951077|580821128|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
160845495|NCT03951077|580821123|FG000|Overall Study|Other, Not Specified|12|||
161140828|NCT00817414|581899195|FG002|Overall Study|Protocol Violation|0|||
161140829|NCT00817414|581899196|FG003|Overall Study|Protocol Violation|0|||
161140830|NCT00817414|581899197|FG004|Overall Study|Protocol Violation|1|||
161140831|NCT03717922|581899204|FG000|Overall Study|Lost to Follow-up|2|||
161140832|NCT03717922|581899205|FG001|Overall Study|Lost to Follow-up|2|||
161140833|NCT03126227|581899208|FG000|Overall Study|Adverse Event|43|||
161140834|NCT03126227|581899209|FG001|Overall Study|Adverse Event|4|||
161140835|NCT03126227|581899208|FG000|Overall Study|Death|0|||
161140836|NCT03126227|581899209|FG001|Overall Study|Death|1|||
161140837|NCT03126227|581899208|FG000|Overall Study|Lost to Follow-up|0|||
161140838|NCT03126227|581899209|FG001|Overall Study|Lost to Follow-up|1|||
161140839|NCT03126227|581899208|FG000|Overall Study|Physician Decision|2|||
161140840|NCT03126227|581899209|FG001|Overall Study|Physician Decision|0|||
161140841|NCT03126227|581899208|FG000|Overall Study|Protocol Violation|1|||
161140842|NCT03126227|581899209|FG001|Overall Study|Protocol Violation|0|||
161140843|NCT03126227|581899208|FG000|Overall Study|Withdrawal by Subject|19|||
161140844|NCT03126227|581899209|FG001|Overall Study|Withdrawal by Subject|3|||
161140845|NCT03126227|581899208|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
161140846|NCT03126227|581899209|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
161140847|NCT03126227|581899208|FG000|Overall Study|Lack of dosing compliance|2|||
161140848|NCT03126227|581899209|FG001|Overall Study|Lack of dosing compliance|0|||
161140849|NCT03126227|581899208|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
161140850|NCT03126227|581899209|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
161140851|NCT03126227|581899208|FG000|Overall Study|Scheduling conflict|1|||
161140852|NCT03126227|581899209|FG001|Overall Study|Scheduling conflict|0|||
161140853|NCT02586805|581899213|FG000|Overall Study|Withdrawal by Subject|3|||
161140854|NCT02586805|581899214|FG001|Overall Study|Withdrawal by Subject|1|||
161140855|NCT02586805|581899215|FG002|Overall Study|Withdrawal by Subject|1|||
161140856|NCT02586805|581899216|FG003|Overall Study|Withdrawal by Subject|2|||
161140857|NCT02586805|581899213|FG000|Overall Study|Adverse Event|2|||
161140858|NCT02586805|581899214|FG001|Overall Study|Adverse Event|0|||
161140859|NCT02586805|581899215|FG002|Overall Study|Adverse Event|1|||
161140860|NCT02586805|581899216|FG003|Overall Study|Adverse Event|0|||
161140861|NCT02586805|581899213|FG000|Overall Study|Lost to Follow-up|0|||
161140862|NCT02586805|581899214|FG001|Overall Study|Lost to Follow-up|0|||
161140863|NCT02586805|581899215|FG002|Overall Study|Lost to Follow-up|1|||
161140864|NCT02586805|581899216|FG003|Overall Study|Lost to Follow-up|0|||
161140865|NCT02586805|581899213|FG000|Overall Study|Physician Decision|1|||
161140866|NCT02586805|581899214|FG001|Overall Study|Physician Decision|0|||
161140867|NCT02586805|581899215|FG002|Overall Study|Physician Decision|0|||
161140868|NCT02586805|581899216|FG003|Overall Study|Physician Decision|0|||
161140869|NCT01859403|581899217|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
161140870|NCT01859403|581899218|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
161140871|NCT01859403|581899217|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
161140872|NCT01859403|581899218|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
161140873|NCT01859403|581899217|FG000|Primary Endpoint Measure|Physician Decision|0|||
161140874|NCT01859403|581899218|FG001|Primary Endpoint Measure|Physician Decision|1|||
161140875|NCT01859403|581899217|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
161140876|NCT01859403|581899218|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
161140877|NCT01157117|581899219|FG000|Overall Study|Dosing Symptoms|0|||
161140878|NCT01157117|581899220|FG001|Overall Study|Dosing Symptoms|4|||
161140879|NCT01157117|581899221|FG002|Overall Study|Dosing Symptoms|0|||
161140880|NCT01157117|581899219|FG000|Overall Study|Withdrawal by Subject|4|||
161140881|NCT01157117|581899220|FG001|Overall Study|Withdrawal by Subject|1|||
161253568|NCT03173560|582306664|FG001|Overall Study|Other|1|||
161253569|NCT02174276|582306665|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
161253570|NCT02174276|582306666|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161253571|NCT02174276|582306667|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161253572|NCT02174276|582306668|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
161253573|NCT02174276|582306665|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161253574|NCT02174276|582306666|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161253575|NCT02174276|582306667|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
161253576|NCT02174276|582306668|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
161253577|NCT02174276|582306665|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
161253578|NCT02174276|582306666|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
161253579|NCT02174276|582306667|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
161253580|NCT02174276|582306668|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
161253581|NCT02174276|582306665|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161253582|NCT02174276|582306666|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161253583|NCT02174276|582306667|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
161253584|NCT02174276|582306668|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
161253585|NCT02174276|582306665|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161253586|NCT02174276|582306666|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161253587|NCT02174276|582306667|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
161253588|NCT02174276|582306668|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
161253589|NCT02174276|582306665|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
161253590|NCT02174276|582306666|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
161253591|NCT02174276|582306667|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
161253592|NCT02174276|582306668|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
161253593|NCT00725764|582306670|FG000|Overall Study|Withdrawal by Subject|2|||
161140882|NCT01157117|581899221|FG002|Overall Study|Withdrawal by Subject|1|||
161140883|NCT01157117|581899219|FG000|Overall Study|Lack of Efficacy|1|||
161140884|NCT01157117|581899220|FG001|Overall Study|Lack of Efficacy|1|||
161140885|NCT01157117|581899221|FG002|Overall Study|Lack of Efficacy|0|||
161140886|NCT01157117|581899219|FG000|Overall Study|Lost to Follow-up|0|||
161140887|NCT01157117|581899220|FG001|Overall Study|Lost to Follow-up|0|||
161253594|NCT00725764|582306670|FG000|Overall Study|Physician Decision|1|||
161253595|NCT00725764|582306670|FG000|Overall Study|Progressive Disease|7|||
161253596|NCT00725764|582306670|FG000|Overall Study|Lost to Follow-up|1|||
161253597|NCT00725764|582306670|FG000|Overall Study|Death|1|||
161253598|NCT00725764|582306670|FG000|Overall Study|Participant non compliant with protocol|1|||
161336573|NCT01075048|582623540|FG002|Overall Study|Withdrawal by Subject|3|||
161336574|NCT01075048|582623538|FG000|Overall Study|Lost to Follow-up|0|||
161336575|NCT01075048|582623539|FG001|Overall Study|Lost to Follow-up|1|||
161336576|NCT01075048|582623540|FG002|Overall Study|Lost to Follow-up|1|||
161336577|NCT03944616|582623541|FG000|Overall Study|Lost to Follow-up|0|||
161336578|NCT03944616|582623542|FG001|Overall Study|Lost to Follow-up|2|||
161336579|NCT00408499|582623544|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161336580|NCT00408499|582623545|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161336581|NCT00408499|582623546|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
161336582|NCT00408499|582623547|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161336583|NCT00408499|582623548|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
161336584|NCT00408499|582623544|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
160845496|NCT03951077|580821124|FG001|Overall Study|Other, Not Specified|10|||
160845497|NCT03951077|580821125|FG002|Overall Study|Other, Not Specified|10|||
160845498|NCT03951077|580821126|FG003|Overall Study|Other, Not Specified|5|||
160845499|NCT03951077|580821127|FG004|Overall Study|Other, Not Specified|9|||
160845500|NCT03951077|580821128|FG005|Overall Study|Other, Not Specified|6|||
160845501|NCT03951077|580821123|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
161140888|NCT01157117|581899221|FG002|Overall Study|Lost to Follow-up|1|||
161253599|NCT00725764|582306670|FG000|Overall Study|Decline in performance status|1|||
161253600|NCT00434837|582306673|FG000|Overall Study|Lost to Follow-up|20|||
161253601|NCT00434837|582306674|FG001|Overall Study|Lost to Follow-up|23|||
161253602|NCT00434837|582306675|FG002|Overall Study|Lost to Follow-up|30|||
161253603|NCT00250705|582306676|FG000|Overall Study|Lack of Efficacy|2|||
161253604|NCT00587431|582306677|FG000|Overall Study|Adverse Event|1|||
161253605|NCT00587431|582306678|FG001|Overall Study|Adverse Event|0|||
161253606|NCT00587431|582306677|FG000|Overall Study|Withdrawal by Subject|0|||
161253607|NCT00587431|582306678|FG001|Overall Study|Withdrawal by Subject|1|||
161253608|NCT05467982|582306679|FG000|Overall Study|Death|0|||
161253609|NCT05467982|582306680|FG001|Overall Study|Death|1|||
161253610|NCT05467982|582306679|FG000|Overall Study|Lost to Follow-up|3|||
161253611|NCT05467982|582306680|FG001|Overall Study|Lost to Follow-up|1|||
161253612|NCT03507686|582306689|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
161253613|NCT03507686|582306690|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
161253614|NCT03507686|582306689|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
161253615|NCT03507686|582306690|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
161253616|NCT03507686|582306689|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
161253617|NCT03507686|582306690|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
161253618|NCT03507686|582306689|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
161253619|NCT03507686|582306690|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
161253620|NCT03507686|582306689|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
161253621|NCT03507686|582306690|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
161253622|NCT03507686|582306689|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
161253623|NCT03507686|582306690|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
161253624|NCT00585312|582306691|FG000|Overall Study|Adverse Event|3|||
161253625|NCT00585312|582306692|FG001|Overall Study|Adverse Event|0|||
161253626|NCT00585312|582306691|FG000|Overall Study|Lack of Efficacy|6|||
161253627|NCT00585312|582306692|FG001|Overall Study|Lack of Efficacy|11|||
161253628|NCT00585312|582306691|FG000|Overall Study|Lost to Follow-up|1|||
161253629|NCT00585312|582306692|FG001|Overall Study|Lost to Follow-up|1|||
161253630|NCT00585312|582306691|FG000|Overall Study|Reason not specified|2|||
161253631|NCT00585312|582306692|FG001|Overall Study|Reason not specified|0|||
161253632|NCT00585312|582306691|FG000|Overall Study|Withdrawal by Subject|5|||
161253633|NCT00585312|582306692|FG001|Overall Study|Withdrawal by Subject|1|||
161253634|NCT00585312|582306691|FG000|Overall Study|Study terminated by the sponsor|34|||
161253635|NCT00585312|582306692|FG001|Overall Study|Study terminated by the sponsor|31|||
161336585|NCT00408499|582623545|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
161336586|NCT00408499|582623546|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161336587|NCT00408499|582623547|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161336588|NCT00408499|582623548|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
161336589|NCT00408499|582623544|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
160845502|NCT03951077|580821124|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
160845503|NCT03951077|580821125|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
161140889|NCT01157117|581899219|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
161140890|NCT01157117|581899220|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
161140891|NCT01157117|581899221|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
161140892|NCT01531725|581899223|FG000|Overall Study|Protocol Violation|5|||
161140893|NCT02317510|581899224|FG000|Overall Study|Adverse Event|0|||
161140894|NCT02317510|581899225|FG001|Overall Study|Adverse Event|1|||
161140895|NCT00472303|581899226|FG000|Titration Phase|Adverse Event|22|||
161140896|NCT00472303|581899227|FG001|Titration Phase|Adverse Event|12|||
161140897|NCT00472303|581899228|FG002|Titration Phase|Adverse Event|0|||
161336590|NCT00408499|582623545|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
161336591|NCT00408499|582623546|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161336592|NCT00408499|582623547|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
160845504|NCT03951077|580821126|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
160845505|NCT03951077|580821127|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
161336593|NCT00408499|582623548|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
161336594|NCT00408499|582623544|FG000|Phase II- MTD Expansion|Adverse Event|0|||
160845506|NCT03951077|580821128|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
160845507|NCT03579940|580821131|FG000|Period 2|Withdrawal by Subject|0|||
160845508|NCT03579940|580821132|FG001|Period 2|Withdrawal by Subject|0|||
160845509|NCT03579940|580821133|FG002|Period 2|Withdrawal by Subject|1|||
160845510|NCT03579940|580821134|FG003|Period 2|Withdrawal by Subject|0|||
160845511|NCT03579940|580821135|FG004|Period 2|Withdrawal by Subject|0|||
161336595|NCT00408499|582623545|FG001|Phase II- MTD Expansion|Adverse Event|0|||
161336596|NCT00408499|582623546|FG002|Phase II- MTD Expansion|Adverse Event|0|||
161336597|NCT00408499|582623547|FG003|Phase II- MTD Expansion|Adverse Event|0|||
161336598|NCT00408499|582623548|FG004|Phase II- MTD Expansion|Adverse Event|9|||
161336599|NCT00408499|582623544|FG000|Phase II- MTD Expansion|Death|0|||
161336600|NCT00408499|582623545|FG001|Phase II- MTD Expansion|Death|0|||
161336601|NCT00408499|582623546|FG002|Phase II- MTD Expansion|Death|0|||
161336602|NCT00408499|582623547|FG003|Phase II- MTD Expansion|Death|0|||
161336603|NCT00408499|582623548|FG004|Phase II- MTD Expansion|Death|2|||
161336604|NCT00408499|582623544|FG000|Phase II- MTD Expansion|Physician Decision|0|||
161336605|NCT00408499|582623545|FG001|Phase II- MTD Expansion|Physician Decision|0|||
160845512|NCT03579940|580821136|FG005|Period 2|Withdrawal by Subject|0|||
160845513|NCT03579940|580821137|FG006|Period 2|Withdrawal by Subject|0|||
161336606|NCT00408499|582623546|FG002|Phase II- MTD Expansion|Physician Decision|0|||
161336607|NCT00408499|582623547|FG003|Phase II- MTD Expansion|Physician Decision|0|||
161336608|NCT00408499|582623548|FG004|Phase II- MTD Expansion|Physician Decision|1|||
161336609|NCT00408499|582623544|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161336610|NCT00408499|582623545|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161336611|NCT00408499|582623546|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161336612|NCT00408499|582623547|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
161336613|NCT00408499|582623548|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
161336614|NCT00408499|582623544|FG000|Phase II- MTD Expansion|treatment delay|0|||
161336615|NCT00408499|582623545|FG001|Phase II- MTD Expansion|treatment delay|0|||
161336616|NCT00408499|582623546|FG002|Phase II- MTD Expansion|treatment delay|0|||
161336617|NCT00408499|582623547|FG003|Phase II- MTD Expansion|treatment delay|0|||
160845514|NCT03579940|580821138|FG007|Period 2|Withdrawal by Subject|0|||
160845515|NCT03579940|580821139|FG008|Period 2|Withdrawal by Subject|0|||
160845516|NCT03579940|580821140|FG009|Period 2|Withdrawal by Subject|0|||
160845517|NCT03579940|580821141|FG010|Period 2|Withdrawal by Subject|0|||
160845518|NCT01217944|580821142|FG000|Overall Study|Protocol Violation|1|||
160845519|NCT01217944|580821143|FG001|Overall Study|Protocol Violation|1|||
160845520|NCT01217944|580821144|FG002|Overall Study|Protocol Violation|0|||
160845521|NCT01217944|580821142|FG000|Overall Study|Lost to Follow-up|3|||
160845522|NCT01217944|580821143|FG001|Overall Study|Lost to Follow-up|1|||
160845523|NCT01217944|580821144|FG002|Overall Study|Lost to Follow-up|0|||
160845524|NCT01217944|580821142|FG000|Overall Study|Withdrawal by Subject|1|||
160845525|NCT01217944|580821143|FG001|Overall Study|Withdrawal by Subject|2|||
160845526|NCT01217944|580821144|FG002|Overall Study|Withdrawal by Subject|0|||
160845527|NCT01217944|580821142|FG000|Overall Study|Lack of Efficacy|1|||
160845528|NCT01217944|580821143|FG001|Overall Study|Lack of Efficacy|0|||
160845529|NCT01217944|580821144|FG002|Overall Study|Lack of Efficacy|0|||
160845530|NCT02274792|580821145|FG000|Overall Study|Withdrawal by Subject|13|||
160845531|NCT02274792|580821145|FG000|Overall Study|Lost to Follow-up|8|||
160845532|NCT02274792|580821145|FG000|Overall Study|Protocol Specified Criteria|2|||
160845533|NCT02274792|580821145|FG000|Overall Study|Sponsor Decision|2|||
160845534|NCT02751580|580821146|FG000|Overall Study|Lost to Follow-up|4|||
160845535|NCT02751580|580821146|FG000|Overall Study|Death|2|||
161336618|NCT00408499|582623548|FG004|Phase II- MTD Expansion|treatment delay|3|||
160845536|NCT04343755|580821153|FG000|Overall Study|Death|11|||
160845537|NCT04343755|580821153|FG000|Overall Study|Screen Failure|1|||
160845538|NCT00108862|580821158|FG000|Overall Study|Death|31|||
160845539|NCT00108862|580821159|FG001|Overall Study|Death|37|||
160845540|NCT00108862|580821158|FG000|Overall Study|Withdrawal by Subject|10|||
160845541|NCT00108862|580821159|FG001|Overall Study|Withdrawal by Subject|6|||
160845542|NCT00108862|580821158|FG000|Overall Study|Lost to Follow-up|27|||
161336619|NCT00997334|582623550|FG000|Overall Study|still on therapy|12|||
161336620|NCT00997334|582623550|FG000|Overall Study|Adverse Event|3|||
161336621|NCT00997334|582623550|FG000|Overall Study|Patient non-compliance|1|||
161336622|NCT00997334|582623550|FG000|Overall Study|Withdrawal by Subject|3|||
161336623|NCT00997334|582623550|FG000|Overall Study|Death|2|||
160845543|NCT00108862|580821159|FG001|Overall Study|Lost to Follow-up|19|||
160845544|NCT04854551|580821164|FG000|Overall Study|Withdrawal by Subject|1|||
160845545|NCT04854551|580821165|FG001|Overall Study|Withdrawal by Subject|1|||
160906001|NCT02340975|581050338|FG000|Overall Study|Other|0|||
161253636|NCT01263561|582306693|FG000|Overall Study|Death|1|||
161253637|NCT01263561|582306694|FG001|Overall Study|Death|2|||
161253638|NCT00879684|582306695|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
160845546|NCT01076036|580821168|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
160845547|NCT00687804|580821169|FG000|Core Study|Adverse Event|5|||
160845548|NCT00687804|580821170|FG001|Core Study|Adverse Event|3|||
160845549|NCT00687804|580821171|FG002|Core Study|Adverse Event|3|||
160845550|NCT00687804|580821169|FG000|Core Study|Abnormal laboratory value(s)|1|||
160845551|NCT00687804|580821170|FG001|Core Study|Abnormal laboratory value(s)|0|||
160845552|NCT00687804|580821171|FG002|Core Study|Abnormal laboratory value(s)|0|||
160845553|NCT00687804|580821169|FG000|Core Study|Lack of Efficacy|1|||
160845554|NCT00687804|580821170|FG001|Core Study|Lack of Efficacy|1|||
160845555|NCT00687804|580821171|FG002|Core Study|Lack of Efficacy|1|||
160845556|NCT00687804|580821169|FG000|Core Study|Withdrawal by Subject|4|||
160845557|NCT00687804|580821170|FG001|Core Study|Withdrawal by Subject|7|||
160845558|NCT00687804|580821171|FG002|Core Study|Withdrawal by Subject|7|||
160845559|NCT00687804|580821169|FG000|Core Study|Lost to Follow-up|0|||
160845560|NCT00687804|580821170|FG001|Core Study|Lost to Follow-up|1|||
160845561|NCT00687804|580821171|FG002|Core Study|Lost to Follow-up|0|||
160845562|NCT00687804|580821169|FG000|Core Study|Death|2|||
160845563|NCT00687804|580821170|FG001|Core Study|Death|2|||
160845564|NCT00687804|580821171|FG002|Core Study|Death|2|||
160845565|NCT00687804|580821169|FG000|Core Study|Protocol Violation|1|||
160845566|NCT00687804|580821170|FG001|Core Study|Protocol Violation|1|||
160845567|NCT00687804|580821171|FG002|Core Study|Protocol Violation|0|||
160845568|NCT00687804|580821169|FG000|Open-Label Extension Study|Adverse Event|2|||
160845569|NCT00687804|580821170|FG001|Open-Label Extension Study|Adverse Event|2|||
160845570|NCT00687804|580821171|FG002|Open-Label Extension Study|Adverse Event|2|||
160845571|NCT00687804|580821169|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
160845572|NCT00687804|580821170|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
160845573|NCT00687804|580821171|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
160845574|NCT00687804|580821169|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
160845575|NCT00687804|580821170|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
160845576|NCT00687804|580821171|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
160845577|NCT00687804|580821169|FG000|Open-Label Extension Study|Administrative problems|1|||
160845578|NCT00687804|580821170|FG001|Open-Label Extension Study|Administrative problems|1|||
160845579|NCT00687804|580821171|FG002|Open-Label Extension Study|Administrative problems|0|||
161253639|NCT00879684|582306696|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
161253640|NCT00879684|582306697|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
160845580|NCT00687804|580821169|FG000|Open-Label Extension Study|Death|2|||
160845581|NCT00687804|580821170|FG001|Open-Label Extension Study|Death|3|||
160845582|NCT00687804|580821171|FG002|Open-Label Extension Study|Death|3|||
160845583|NCT02221674|580821172|FG000|Overall Study|Lost to Follow-up|1|||
160845584|NCT02221674|580821173|FG001|Overall Study|Lost to Follow-up|0|||
160845585|NCT02221674|580821174|FG002|Overall Study|Lost to Follow-up|0|||
160845586|NCT05292131|580821175|FG000|Overall Study|Lost to Follow-up|1|||
160845587|NCT05292131|580821176|FG001|Overall Study|Lost to Follow-up|1|||
160845588|NCT05292131|580821175|FG000|Overall Study|Withdrawal by Subject|0|||
160845589|NCT05292131|580821176|FG001|Overall Study|Withdrawal by Subject|1|||
160845590|NCT02557542|580821177|FG000|Overall Study|Poor recruitment|3|||
160845591|NCT02557542|580821178|FG001|Overall Study|Poor recruitment|0|||
160845592|NCT04390880|580821179|FG000|Overall Study|Withdrawal by Subject|1|||
160845593|NCT00195091|580821180|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
160845594|NCT01345188|580821181|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
160845595|NCT01345188|580821181|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
160845596|NCT00475709|580821185|FG000|Overall Study|Did not meet eligibility criteria|8|||
160845597|NCT00475709|580821185|FG000|Overall Study|Death|41|||
160845598|NCT00475709|580821185|FG000|Overall Study|Device Explant|6|||
160845599|NCT00475709|580821185|FG000|Overall Study|Lost to Follow-up|21|||
160845600|NCT04752358|580821186|FG000|Overall Study|Death|2|||
160845601|NCT04752358|580821187|FG001|Overall Study|Death|1|||
160845602|NCT00555672|580821190|FG000|Overall Study|Death|0|||
160845603|NCT00555672|580821191|FG001|Overall Study|Death|2|||
160845604|NCT00555672|580821190|FG000|Overall Study|Adverse Event|8|||
160845605|NCT00555672|580821191|FG001|Overall Study|Adverse Event|2|||
160845606|NCT00555672|580821190|FG000|Overall Study|Objective progression or relapse|11|||
160845607|NCT00555672|580821191|FG001|Overall Study|Objective progression or relapse|5|||
160845608|NCT00555672|580821190|FG000|Overall Study|Other|3|||
160845609|NCT00555672|580821191|FG001|Overall Study|Other|1|||
160906002|NCT02340975|581050339|FG001|Overall Study|Other|4|||
160906003|NCT02340975|581050340|FG002|Overall Study|Other|0|||
160906004|NCT02340975|581050341|FG003|Overall Study|Other|2|||
160845610|NCT00555672|580821190|FG000|Overall Study|Participant refused|2|||
160845611|NCT00555672|580821191|FG001|Overall Study|Participant refused|0|||
160845612|NCT04526145|580821192|FG000|Overall Study|Withdrawal by Subject|5|||
160845613|NCT05236257|580821195|FG000|Overall Study|Ongoing with study treatment|29|||
160906005|NCT02340975|581050342|FG004|Overall Study|Other|0|||
160906006|NCT02340975|581050343|FG005|Overall Study|Other|6|||
160845614|NCT05236257|580821196|FG001|Overall Study|Ongoing with study treatment|1|||
160845615|NCT05236257|580821195|FG000|Overall Study|Discontinued study treatment|22|||
160845616|NCT05236257|580821196|FG001|Overall Study|Discontinued study treatment|41|||
160845617|NCT05870865|580821197|FG000|Randomized|Did not receive study treatment|2|||
160845618|NCT05870865|580821198|FG001|Randomized|Did not receive study treatment|4|||
160845619|NCT05870865|580821199|FG002|Randomized|Did not receive study treatment|4|||
160845620|NCT05870865|580821200|FG003|Randomized|Did not receive study treatment|3|||
160845621|NCT05870865|580821197|FG000|Treatment Period|Adverse Event|1|||
160845622|NCT05870865|580821198|FG001|Treatment Period|Adverse Event|1|||
160845623|NCT05870865|580821199|FG002|Treatment Period|Adverse Event|1|||
160845624|NCT05870865|580821200|FG003|Treatment Period|Adverse Event|1|||
160845625|NCT05870865|580821197|FG000|Treatment Period|Lost to Follow-up|0|||
160845626|NCT05870865|580821198|FG001|Treatment Period|Lost to Follow-up|1|||
160845627|NCT05870865|580821199|FG002|Treatment Period|Lost to Follow-up|2|||
160845628|NCT05870865|580821200|FG003|Treatment Period|Lost to Follow-up|0|||
160845629|NCT05870865|580821197|FG000|Treatment Period|Protocol Violation|0|||
160845630|NCT05870865|580821198|FG001|Treatment Period|Protocol Violation|0|||
160845631|NCT05870865|580821199|FG002|Treatment Period|Protocol Violation|0|||
160845632|NCT05870865|580821200|FG003|Treatment Period|Protocol Violation|1|||
160845633|NCT05870865|580821197|FG000|Treatment Period|Withdrawal by Subject|0|||
160845634|NCT05870865|580821198|FG001|Treatment Period|Withdrawal by Subject|1|||
160845635|NCT05870865|580821199|FG002|Treatment Period|Withdrawal by Subject|1|||
160845636|NCT05870865|580821200|FG003|Treatment Period|Withdrawal by Subject|1|||
160845637|NCT03828019|580821203|FG000|Overall Study|Withdrawal by Subject|3|||
160845638|NCT03828019|580821204|FG001|Overall Study|Withdrawal by Subject|8|||
160845639|NCT03828019|580821203|FG000|Overall Study|Lost to Follow-up|1|||
160845640|NCT03828019|580821204|FG001|Overall Study|Lost to Follow-up|6|||
160845641|NCT03828019|580821203|FG000|Overall Study|Incarcerated|1|||
160845642|NCT03828019|580821204|FG001|Overall Study|Incarcerated|0|||
160845643|NCT03828019|580821203|FG000|Overall Study|Adverse Event|0|||
160845644|NCT03828019|580821204|FG001|Overall Study|Adverse Event|1|||
160845645|NCT05715242|580821205|FG000|Overall Study|Lost to Follow-up|0|||
160845646|NCT05715242|580821206|FG001|Overall Study|Lost to Follow-up|0|||
160845647|NCT05715242|580821207|FG002|Overall Study|Lost to Follow-up|1|||
160845648|NCT05715242|580821208|FG003|Overall Study|Lost to Follow-up|0|||
160845649|NCT05715242|580821209|FG004|Overall Study|Lost to Follow-up|0|||
160845650|NCT05715242|580821210|FG005|Overall Study|Lost to Follow-up|1|||
160845651|NCT05715242|580821211|FG006|Overall Study|Lost to Follow-up|0|||
160845652|NCT05715242|580821212|FG007|Overall Study|Lost to Follow-up|0|||
160845653|NCT05715242|580821213|FG008|Overall Study|Lost to Follow-up|0|||
160845654|NCT05715242|580821214|FG009|Overall Study|Lost to Follow-up|0|||
160845655|NCT05715242|580821215|FG010|Overall Study|Lost to Follow-up|0|||
160845656|NCT05715242|580821216|FG011|Overall Study|Lost to Follow-up|0|||
160845657|NCT05715242|580821217|FG012|Overall Study|Lost to Follow-up|0|||
160845658|NCT05715242|580821218|FG013|Overall Study|Lost to Follow-up|0|||
160845659|NCT05715242|580821219|FG014|Overall Study|Lost to Follow-up|0|||
160845660|NCT05715242|580821220|FG015|Overall Study|Lost to Follow-up|0|||
160845661|NCT03400176|580821221|FG000|Dose Escalation|Progressive disease|1|||
160845662|NCT03400176|580821222|FG001|Dose Escalation|Progressive disease|1|||
160845663|NCT03400176|580821223|FG002|Dose Escalation|Progressive disease|0|||
160845664|NCT03400176|580821224|FG003|Dose Escalation|Progressive disease|0|||
160845665|NCT03400176|580821225|FG004|Dose Escalation|Progressive disease|1|||
160845666|NCT03400176|580821221|FG000|Dose Escalation|Patient decision|0|||
160845667|NCT03400176|580821222|FG001|Dose Escalation|Patient decision|0|||
160845668|NCT03400176|580821223|FG002|Dose Escalation|Patient decision|0|||
160845669|NCT03400176|580821224|FG003|Dose Escalation|Patient decision|0|||
160845670|NCT03400176|580821225|FG004|Dose Escalation|Patient decision|1|||
160845671|NCT03400176|580821221|FG000|Dose Expansion|Patient decision|0|||
160845672|NCT03400176|580821222|FG001|Dose Expansion|Patient decision|0|||
160845673|NCT03400176|580821223|FG002|Dose Expansion|Patient decision|0|||
160845674|NCT03400176|580821224|FG003|Dose Expansion|Patient decision|1|||
160845675|NCT03400176|580821225|FG004|Dose Expansion|Patient decision|0|||
160845676|NCT03400176|580821221|FG000|Dose Expansion|Adverse Event|0|||
160845677|NCT03400176|580821222|FG001|Dose Expansion|Adverse Event|0|||
160845678|NCT03400176|580821223|FG002|Dose Expansion|Adverse Event|0|||
160845679|NCT03400176|580821224|FG003|Dose Expansion|Adverse Event|1|||
160845680|NCT03400176|580821225|FG004|Dose Expansion|Adverse Event|0|||
160845681|NCT03400176|580821221|FG000|Dose Expansion|Physician Decision|0|||
160845682|NCT03400176|580821222|FG001|Dose Expansion|Physician Decision|0|||
160845683|NCT03400176|580821223|FG002|Dose Expansion|Physician Decision|0|||
160845684|NCT03400176|580821224|FG003|Dose Expansion|Physician Decision|1|||
160845685|NCT03400176|580821225|FG004|Dose Expansion|Physician Decision|0|||
160845686|NCT03400176|580821221|FG000|Dose Expansion|Progressive disease|0|||
160845687|NCT03400176|580821222|FG001|Dose Expansion|Progressive disease|0|||
160845688|NCT03400176|580821223|FG002|Dose Expansion|Progressive disease|1|||
160845689|NCT03400176|580821224|FG003|Dose Expansion|Progressive disease|1|||
160845690|NCT03400176|580821225|FG004|Dose Expansion|Progressive disease|0|||
160845691|NCT01090063|580821233|FG000|Screen|Screen Failed|4|||
160845692|NCT01090063|580821233|FG000|Treatment|Withdrawal by Subject|4|||
160845693|NCT00048347|580821234|FG000|Overall Study|Screen failure|2|||
160845694|NCT02863328|580821235|FG000|Overall Study|Lost to Follow-up|4|||
160845695|NCT02863328|580821236|FG001|Overall Study|Lost to Follow-up|10|||
161336624|NCT00997334|582623550|FG000|Overall Study|Urgent Palliative Care|2|||
161336625|NCT00997334|582623550|FG000|Overall Study|No lesion amenable|1|||
161336626|NCT00997334|582623550|FG000|Overall Study|Ineligible|1|||
161336627|NCT01586195|582623555|FG000|Overall Study|Death|11|||
161336628|NCT01586195|582623555|FG000|Overall Study|Withdrawal of Consent|5|||
161336629|NCT01586195|582623555|FG000|Overall Study|Started new anti-melanoma therapy|1|||
161336630|NCT01586195|582623555|FG000|Overall Study|Reason not specified|9|||
161336631|NCT01855958|582623556|FG000|Overall Study|Withdrawal by Subject|1|||
161336632|NCT01855958|582623557|FG001|Overall Study|Withdrawal by Subject|0|||
161336633|NCT01287936|582623558|FG000|Overall Study|Lost to Follow-up|0|||
161336634|NCT01287936|582623559|FG001|Overall Study|Lost to Follow-up|1|||
161336635|NCT01287936|582623560|FG002|Overall Study|Lost to Follow-up|1|||
161336636|NCT00296244|582623561|FG000|Overall Study|Underwent retransplant|0|||
161336637|NCT00296244|582623562|FG001|Overall Study|Underwent retransplant|1|||
161336638|NCT00266708|582623568|FG000|Overall Study|No renal function|1|||
161336639|NCT00266708|582623569|FG001|Overall Study|No renal function|1|||
161336640|NCT00266708|582623568|FG000|Overall Study|Refused biopsy|3|||
161336641|NCT00266708|582623569|FG001|Overall Study|Refused biopsy|6|||
161336642|NCT00266708|582623568|FG000|Overall Study|Asthma|0|||
161336643|NCT00266708|582623569|FG001|Overall Study|Asthma|2|||
161336644|NCT00703534|582623570|FG000|Overall Study|Adverse Event|14|||
161336645|NCT00703534|582623571|FG001|Overall Study|Adverse Event|3|||
161336646|NCT00703534|582623570|FG000|Overall Study|Withdrawal by Subject|8|||
161336647|NCT00703534|582623571|FG001|Overall Study|Withdrawal by Subject|7|||
161336648|NCT00703534|582623570|FG000|Overall Study|Incorrect Enrollment|6|||
161336649|NCT00703534|582623571|FG001|Overall Study|Incorrect Enrollment|6|||
161336650|NCT00703534|582623570|FG000|Overall Study|Lost to Follow-up|1|||
161336651|NCT00703534|582623571|FG001|Overall Study|Lost to Follow-up|4|||
161336652|NCT00703534|582623570|FG000|Overall Study|Severe Non Compliance|1|||
161336653|NCT00703534|582623571|FG001|Overall Study|Severe Non Compliance|5|||
161336654|NCT00427934|582623572|FG000|Overall Study|Adverse Event|1|||
161336655|NCT00427934|582623573|FG001|Overall Study|Adverse Event|0|||
161336656|NCT00427934|582623574|FG002|Overall Study|Adverse Event|5|||
161336657|NCT00427934|582623575|FG003|Overall Study|Adverse Event|4|||
161336658|NCT00427934|582623572|FG000|Overall Study|Lack of Efficacy|0|||
161336659|NCT00427934|582623573|FG001|Overall Study|Lack of Efficacy|0|||
161336660|NCT00427934|582623574|FG002|Overall Study|Lack of Efficacy|5|||
161336661|NCT00427934|582623575|FG003|Overall Study|Lack of Efficacy|2|||
161336662|NCT00427934|582623572|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
161336663|NCT00427934|582623573|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
161336664|NCT00427934|582623574|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
161336665|NCT00427934|582623575|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
161336666|NCT00427934|582623572|FG000|Overall Study|Other|0|||
161336667|NCT00427934|582623573|FG001|Overall Study|Other|0|||
160845696|NCT02863328|580821235|FG000|Overall Study|Withdrawal by Subject|7|||
160845697|NCT02863328|580821236|FG001|Overall Study|Withdrawal by Subject|12|||
160845698|NCT02863328|580821235|FG000|Overall Study|Died|0|||
160845699|NCT02863328|580821236|FG001|Overall Study|Died|1|||
160845700|NCT04565951|580821239|FG000|Overall Study|Lost to Follow-up|66|||
160845701|NCT04565951|580821240|FG001|Overall Study|Lost to Follow-up|38|||
160845702|NCT04565951|580821239|FG000|Overall Study|Withdrawal by Subject|14|||
160845703|NCT04565951|580821240|FG001|Overall Study|Withdrawal by Subject|7|||
160845704|NCT04565951|580821239|FG000|Overall Study|Death|0|||
160845705|NCT04565951|580821240|FG001|Overall Study|Death|1|||
160845706|NCT00429169|580821241|FG000|Overall Study|Lost to Follow-up|0|||
160845707|NCT00429169|580821242|FG001|Overall Study|Lost to Follow-up|1|||
160845708|NCT00429169|580821241|FG000|Overall Study|Ineligibility discovered after entry|2|||
160845709|NCT00429169|580821242|FG001|Overall Study|Ineligibility discovered after entry|1|||
160845710|NCT03508609|580821246|FG000|Overall Study|Withdrawal by Subject|1|||
160845711|NCT00423449|580821247|FG000|Overall Study|Clinical Adverse Event|1|||
160845712|NCT00423449|580821248|FG001|Overall Study|Clinical Adverse Event|0|||
160845713|NCT00423449|580821249|FG002|Overall Study|Clinical Adverse Event|1|||
161140898|NCT00472303|581899226|FG000|Titration Phase|Death|4|||
161336668|NCT00427934|582623574|FG002|Overall Study|Other|11|||
161336669|NCT00427934|582623575|FG003|Overall Study|Other|5|||
161336670|NCT00427934|582623572|FG000|Overall Study|Withdrawal by Subject|0|||
161336671|NCT00427934|582623573|FG001|Overall Study|Withdrawal by Subject|0|||
161336672|NCT00427934|582623574|FG002|Overall Study|Withdrawal by Subject|1|||
161336673|NCT00427934|582623575|FG003|Overall Study|Withdrawal by Subject|3|||
161336674|NCT02791269|582623576|FG000|Overall Study|Lost to Follow-up|0|||
161336675|NCT02791269|582623577|FG001|Overall Study|Lost to Follow-up|1|||
161336676|NCT02683109|582623578|FG000|Overall Study|Adverse Event|1|||
161336677|NCT02683109|582623579|FG001|Overall Study|Adverse Event|0|||
161336678|NCT00368251|582623580|FG000|Overall Study|SAE, non-fatal|1|||
161336679|NCT00368251|582623581|FG001|Overall Study|SAE, non-fatal|0|||
161253641|NCT00879684|582306698|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
161253642|NCT00879684|582306699|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
161253643|NCT00879684|582306700|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
161253644|NCT00879684|582306701|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
161253645|NCT00879684|582306695|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
161253646|NCT00879684|582306696|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
161253647|NCT00879684|582306697|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
161253648|NCT00879684|582306698|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
161253649|NCT00879684|582306699|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
161253650|NCT00879684|582306700|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
161253651|NCT00879684|582306701|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
161253652|NCT00879684|582306695|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
161253653|NCT00879684|582306696|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
161253654|NCT00879684|582306697|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
161253655|NCT00879684|582306698|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
161253656|NCT00879684|582306699|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
161253657|NCT00879684|582306700|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
161253658|NCT00879684|582306701|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
161253659|NCT00879684|582306695|FG000|Stage 1: Dose Escalation|Death|0|||
161253660|NCT00879684|582306696|FG001|Stage 1: Dose Escalation|Death|0|||
160906007|NCT01007812|581050344|FG000|Period 1, One Week|Lost to Follow-up|0|||
160906008|NCT01007812|581050345|FG001|Period 1, One Week|Lost to Follow-up|1|||
160906009|NCT01007812|581050344|FG000|Period 1, One Week|Discomfort|1|||
160906010|NCT01007812|581050345|FG001|Period 1, One Week|Discomfort|0|||
160906011|NCT03948581|581050346|FG000|Overall Study|Lost to Follow-up|0|||
160906012|NCT03948581|581050347|FG001|Overall Study|Lost to Follow-up|1|||
160906013|NCT01876420|581050348|FG000|Overall Study|Missed 30 day visit|1|||
160906014|NCT03173313|581050349|FG000|Overall Study|Lost to Follow-up|2|||
160906015|NCT03173313|581050350|FG001|Overall Study|Lost to Follow-up|3|||
160906016|NCT03173313|581050349|FG000|Overall Study|Withdrawal by Subject|0|||
160906017|NCT03173313|581050350|FG001|Overall Study|Withdrawal by Subject|1|||
160906018|NCT03173313|581050349|FG000|Overall Study|Death|5|||
160906019|NCT03173313|581050350|FG001|Overall Study|Death|0|||
160906020|NCT03173313|581050349|FG000|Overall Study|Physician Decision|1|||
160906021|NCT03173313|581050350|FG001|Overall Study|Physician Decision|0|||
160906022|NCT03173313|581050349|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
160906023|NCT03173313|581050350|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
160906024|NCT03173313|581050349|FG000|Overall Study|Bone Fracture|1|||
160906025|NCT03173313|581050350|FG001|Overall Study|Bone Fracture|0|||
160906026|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
160906027|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
160906028|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
160906029|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
160906030|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
160906031|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
160906032|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
160906033|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
161140899|NCT00472303|581899227|FG001|Titration Phase|Death|2|||
161140900|NCT00472303|581899228|FG002|Titration Phase|Death|0|||
161140901|NCT00472303|581899226|FG000|Titration Phase|Lack of Efficacy|10|||
161140902|NCT00472303|581899227|FG001|Titration Phase|Lack of Efficacy|0|||
161140903|NCT00472303|581899228|FG002|Titration Phase|Lack of Efficacy|0|||
161140904|NCT00472303|581899226|FG000|Titration Phase|Withdrawal by Subject|16|||
161140905|NCT00472303|581899227|FG001|Titration Phase|Withdrawal by Subject|13|||
161140906|NCT00472303|581899228|FG002|Titration Phase|Withdrawal by Subject|0|||
161140907|NCT00472303|581899226|FG000|Titration Phase|Trial Medication non-compliant|4|||
161140908|NCT00472303|581899227|FG001|Titration Phase|Trial Medication non-compliant|1|||
161140909|NCT00472303|581899228|FG002|Titration Phase|Trial Medication non-compliant|0|||
161140910|NCT00472303|581899226|FG000|Titration Phase|Other|3|||
161140911|NCT00472303|581899227|FG001|Titration Phase|Other|1|||
161140912|NCT00472303|581899228|FG002|Titration Phase|Other|0|||
161140913|NCT00472303|581899226|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
161140914|NCT00472303|581899227|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
161140915|NCT00472303|581899228|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
161140916|NCT00472303|581899226|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
161140917|NCT00472303|581899227|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
161140918|NCT00472303|581899228|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
161140919|NCT00472303|581899226|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
161140920|NCT00472303|581899227|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
161140921|NCT00472303|581899228|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
161140922|NCT00472303|581899226|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
161253661|NCT00879684|582306697|FG002|Stage 1: Dose Escalation|Death|1|||
161253662|NCT00879684|582306698|FG003|Stage 1: Dose Escalation|Death|0|||
161253663|NCT00879684|582306699|FG004|Stage 1: Dose Escalation|Death|0|||
161253664|NCT00879684|582306700|FG005|Stage 1: Dose Escalation|Death|0|||
161253665|NCT00879684|582306701|FG006|Stage 1: Dose Escalation|Death|0|||
161253666|NCT00879684|582306695|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161253667|NCT00879684|582306696|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
160845714|NCT00423449|580821250|FG003|Overall Study|Clinical Adverse Event|8|||
160845715|NCT00423449|580821251|FG004|Overall Study|Clinical Adverse Event|2|||
160845716|NCT00423449|580821247|FG000|Overall Study|Death|1|||
160845717|NCT00423449|580821248|FG001|Overall Study|Death|0|||
160845718|NCT00423449|580821249|FG002|Overall Study|Death|2|||
160845719|NCT00423449|580821250|FG003|Overall Study|Death|1|||
161253668|NCT00879684|582306697|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161253669|NCT00879684|582306698|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161253670|NCT00879684|582306699|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161253671|NCT00879684|582306700|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
161253672|NCT00879684|582306701|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
161253673|NCT00879684|582306695|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
161253674|NCT00879684|582306696|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
161253675|NCT00879684|582306697|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
161253676|NCT00879684|582306698|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
161253677|NCT00879684|582306699|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
161253678|NCT00879684|582306700|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
161253679|NCT00879684|582306701|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
161253680|NCT00879684|582306695|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161253681|NCT00879684|582306696|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161253682|NCT00879684|582306697|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161253683|NCT00879684|582306698|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161253684|NCT00879684|582306699|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161253685|NCT00879684|582306700|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
161253686|NCT00879684|582306701|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
161253687|NCT03185741|582306706|FG000|Baseline|Withdrawal by Subject|1|||
161253688|NCT03185741|582306707|FG001|Baseline|Withdrawal by Subject|3|||
161253689|NCT03185741|582306708|FG002|Baseline|Withdrawal by Subject|2|||
161253690|NCT03185741|582306706|FG000|Baseline|Lost to Follow-up|1|||
161253691|NCT03185741|582306707|FG001|Baseline|Lost to Follow-up|2|||
161253692|NCT03185741|582306708|FG002|Baseline|Lost to Follow-up|3|||
161253693|NCT03185741|582306706|FG000|3Month|Death|1|||
161253694|NCT03185741|582306707|FG001|3Month|Death|1|||
161253695|NCT03185741|582306708|FG002|3Month|Death|2|||
161253696|NCT03185741|582306706|FG000|3Month|Withdrawal by Subject|1|||
161253697|NCT03185741|582306707|FG001|3Month|Withdrawal by Subject|5|||
161253698|NCT03185741|582306708|FG002|3Month|Withdrawal by Subject|1|||
161253699|NCT03185741|582306706|FG000|3Month|Lost to Follow-up|7|||
161253700|NCT03185741|582306707|FG001|3Month|Lost to Follow-up|9|||
161253701|NCT03185741|582306708|FG002|3Month|Lost to Follow-up|8|||
161253702|NCT03185741|582306706|FG000|3Month|Unavailable for 3Month|11|||
161253703|NCT03185741|582306707|FG001|3Month|Unavailable for 3Month|10|||
161253704|NCT03185741|582306708|FG002|3Month|Unavailable for 3Month|11|||
161253705|NCT03185741|582306706|FG000|3Month|Protocol Violation|0|||
161253706|NCT03185741|582306707|FG001|3Month|Protocol Violation|0|||
161253707|NCT03185741|582306708|FG002|3Month|Protocol Violation|3|||
161253708|NCT03185741|582306706|FG000|6Month|Death|1|||
161253709|NCT03185741|582306707|FG001|6Month|Death|1|||
161253710|NCT03185741|582306708|FG002|6Month|Death|2|||
161253711|NCT03185741|582306706|FG000|6Month|Withdrawal by Subject|2|||
161253712|NCT03185741|582306707|FG001|6Month|Withdrawal by Subject|3|||
161253713|NCT03185741|582306708|FG002|6Month|Withdrawal by Subject|1|||
161253714|NCT03185741|582306706|FG000|6Month|Lost to Follow-up|16|||
161253715|NCT03185741|582306707|FG001|6Month|Lost to Follow-up|15|||
161253716|NCT03185741|582306708|FG002|6Month|Lost to Follow-up|16|||
161253717|NCT03573336|582306711|FG000|Overall Study|Study terminated|2|||
160845720|NCT00423449|580821251|FG004|Overall Study|Death|1|||
160845721|NCT00423449|580821247|FG000|Overall Study|Progressive Disease|1|||
160845722|NCT00423449|580821248|FG001|Overall Study|Progressive Disease|3|||
160845723|NCT00423449|580821249|FG002|Overall Study|Progressive Disease|8|||
161253718|NCT03573336|582306712|FG001|Overall Study|Study terminated|4|||
161253719|NCT03573336|582306713|FG002|Overall Study|Study terminated|2|||
160845724|NCT00423449|580821250|FG003|Overall Study|Progressive Disease|11|||
160845725|NCT00423449|580821251|FG004|Overall Study|Progressive Disease|4|||
161253720|NCT03108820|582306714|FG000|Overall Study|Lost to Follow-up|30|||
161253721|NCT03108820|582306715|FG001|Overall Study|Lost to Follow-up|28|||
161253722|NCT03108820|582306714|FG000|Overall Study|Withdrawal by Subject|32|||
160845726|NCT00423449|580821247|FG000|Overall Study|Laboratory Adverse Event|0|||
161253723|NCT03108820|582306715|FG001|Overall Study|Withdrawal by Subject|24|||
161253724|NCT03108820|582306714|FG000|Overall Study|Death|6|||
161253725|NCT03108820|582306715|FG001|Overall Study|Death|11|||
161336680|NCT00368251|582623582|FG002|Overall Study|SAE, non-fatal|0|||
161253726|NCT01488448|582306721|FG000|Overall Study|Withdrawal by Subject|3|||
160845727|NCT00423449|580821248|FG001|Overall Study|Laboratory Adverse Event|1|||
160845728|NCT00423449|580821249|FG002|Overall Study|Laboratory Adverse Event|2|||
160845729|NCT00423449|580821250|FG003|Overall Study|Laboratory Adverse Event|0|||
160845730|NCT00423449|580821251|FG004|Overall Study|Laboratory Adverse Event|0|||
160845731|NCT00423449|580821247|FG000|Overall Study|Other|0|||
160845732|NCT00423449|580821248|FG001|Overall Study|Other|0|||
160845733|NCT00423449|580821249|FG002|Overall Study|Other|0|||
160845734|NCT00423449|580821250|FG003|Overall Study|Other|1|||
160845735|NCT00423449|580821251|FG004|Overall Study|Other|0|||
160845736|NCT00423449|580821247|FG000|Overall Study|Protocol Violation|0|||
160845737|NCT00423449|580821248|FG001|Overall Study|Protocol Violation|0|||
160845738|NCT00423449|580821249|FG002|Overall Study|Protocol Violation|2|||
160845739|NCT00423449|580821250|FG003|Overall Study|Protocol Violation|1|||
160845740|NCT00423449|580821251|FG004|Overall Study|Protocol Violation|0|||
160845741|NCT00947115|580821252|FG000|Overall Study|Missed reporting interval|3|||
160845742|NCT00947115|580821253|FG001|Overall Study|Missed reporting interval|4|||
160845743|NCT00947115|580821254|FG002|Overall Study|Missed reporting interval|2|||
160845744|NCT00947115|580821252|FG000|Overall Study|Physician Decision|0|||
160845745|NCT00947115|580821253|FG001|Overall Study|Physician Decision|2|||
160845746|NCT00947115|580821254|FG002|Overall Study|Physician Decision|0|||
160845747|NCT00947115|580821252|FG000|Overall Study|Death|0|||
160845748|NCT00947115|580821253|FG001|Overall Study|Death|1|||
160845749|NCT00947115|580821254|FG002|Overall Study|Death|1|||
160845750|NCT00947115|580821252|FG000|Overall Study|Migrated from study area|2|||
160845751|NCT00947115|580821253|FG001|Overall Study|Migrated from study area|0|||
160845752|NCT00947115|580821254|FG002|Overall Study|Migrated from study area|0|||
160845753|NCT00947115|580821252|FG000|Overall Study|Withdrawal by Subject|1|||
160845754|NCT00947115|580821253|FG001|Overall Study|Withdrawal by Subject|3|||
161253727|NCT01488448|582306722|FG001|Overall Study|Withdrawal by Subject|1|||
161253728|NCT01488448|582306721|FG000|Overall Study|Adverse Event|9|||
161253729|NCT01488448|582306722|FG001|Overall Study|Adverse Event|4|||
161253730|NCT01488448|582306721|FG000|Overall Study|Physician Decision|4|||
161253731|NCT01488448|582306722|FG001|Overall Study|Physician Decision|9|||
161253732|NCT01488448|582306721|FG000|Overall Study|Protocol Violation|4|||
161253733|NCT01488448|582306722|FG001|Overall Study|Protocol Violation|3|||
161253734|NCT00654641|582306723|FG000|Overall Study|Lost to Follow-up|2|||
161253735|NCT00654641|582306724|FG001|Overall Study|Lost to Follow-up|3|||
161253736|NCT01992094|582306725|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
161253737|NCT01992094|582306726|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
161253738|NCT01992094|582306727|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
161253739|NCT01992094|582306725|FG000|Overall Study|Adverse Event|1|||
161253740|NCT01992094|582306726|FG001|Overall Study|Adverse Event|0|||
161253741|NCT01992094|582306727|FG002|Overall Study|Adverse Event|0|||
161253742|NCT01992094|582306725|FG000|Overall Study|Death|5|||
161253743|NCT01992094|582306726|FG001|Overall Study|Death|5|||
161253744|NCT01992094|582306727|FG002|Overall Study|Death|2|||
161253745|NCT01992094|582306725|FG000|Overall Study|Lost to Follow-up|26|||
161253746|NCT01992094|582306726|FG001|Overall Study|Lost to Follow-up|9|||
161253747|NCT01992094|582306727|FG002|Overall Study|Lost to Follow-up|13|||
161253748|NCT01992094|582306725|FG000|Overall Study|OTHER|4|||
161253749|NCT01992094|582306726|FG001|Overall Study|OTHER|0|||
161253750|NCT01992094|582306727|FG002|Overall Study|OTHER|0|||
160845755|NCT00947115|580821254|FG002|Overall Study|Withdrawal by Subject|4|||
160845756|NCT00947115|580821252|FG000|Overall Study|Lost to Follow-up|11|||
160845757|NCT00947115|580821253|FG001|Overall Study|Lost to Follow-up|12|||
160845758|NCT00947115|580821254|FG002|Overall Study|Lost to Follow-up|8|||
160845759|NCT03228212|580821257|FG000|Period 1|Adverse Event|1|||
160845760|NCT03228212|580821258|FG001|Period 1|Adverse Event|0|||
160845761|NCT03228212|580821257|FG000|Period 1|no longer meets eligibility criteria|0|||
160845762|NCT03228212|580821258|FG001|Period 1|no longer meets eligibility criteria|1|||
160845763|NCT03228212|580821257|FG000|Period 2|Lost to Follow-up|1|||
160845764|NCT03228212|580821258|FG001|Period 2|Lost to Follow-up|0|||
160845765|NCT00447226|580822885|FG000|12-Week Open-label Phase|Adverse Event|0|||
160845766|NCT00447226|580822886|FG001|12-Week Open-label Phase|Adverse Event|3|||
160845767|NCT00447226|580822885|FG000|12-Week Open-label Phase|Protocol Violation|0|||
160845768|NCT00447226|580822886|FG001|12-Week Open-label Phase|Protocol Violation|1|||
160845769|NCT00447226|580822885|FG000|12-Week Open-label Phase|Disease Progression|0|||
160845770|NCT00447226|580822886|FG001|12-Week Open-label Phase|Disease Progression|20|||
160845771|NCT00447226|580822885|FG000|12-Week Open-label Phase|Physician Decision|0|||
161253751|NCT01992094|582306725|FG000|Overall Study|Protocol Violation|1|||
161253752|NCT01992094|582306726|FG001|Overall Study|Protocol Violation|0|||
161253753|NCT01992094|582306727|FG002|Overall Study|Protocol Violation|1|||
161253754|NCT01992094|582306725|FG000|Overall Study|Withdrawal by Subject|7|||
161253755|NCT01992094|582306726|FG001|Overall Study|Withdrawal by Subject|3|||
161253756|NCT01992094|582306727|FG002|Overall Study|Withdrawal by Subject|4|||
161253757|NCT03168906|582306728|FG000|Overall Study|Lack of Efficacy|6|||
160845772|NCT00447226|580822886|FG001|12-Week Open-label Phase|Physician Decision|1|||
161253758|NCT03168906|582306729|FG001|Overall Study|Lack of Efficacy|6|||
161336681|NCT00368251|582623580|FG000|Overall Study|AE, non-serious non-fatal|0|||
161336682|NCT00368251|582623581|FG001|Overall Study|AE, non-serious non-fatal|0|||
161336683|NCT00368251|582623582|FG002|Overall Study|AE, non-serious non-fatal|1|||
161336684|NCT03617588|582623583|FG000|Overall Study|Withdrawal by Subject|1|||
161336685|NCT03617588|582623584|FG001|Overall Study|Withdrawal by Subject|0|||
161336686|NCT03098979|582623589|FG000|Overall Study|Adverse Event|1|||
161336687|NCT03098979|582623590|FG001|Overall Study|Adverse Event|0|||
161336688|NCT03098979|582623591|FG002|Overall Study|Adverse Event|1|||
161336689|NCT03098979|582623592|FG003|Overall Study|Adverse Event|4|||
161336690|NCT03098979|582623593|FG004|Overall Study|Adverse Event|6|||
161336691|NCT03098979|582623594|FG005|Overall Study|Adverse Event|1|||
161336692|NCT03098979|582623589|FG000|Overall Study|Withdrawal by Subject|2|||
161336693|NCT03098979|582623590|FG001|Overall Study|Withdrawal by Subject|1|||
161336694|NCT03098979|582623591|FG002|Overall Study|Withdrawal by Subject|1|||
161336695|NCT03098979|582623592|FG003|Overall Study|Withdrawal by Subject|1|||
161336696|NCT03098979|582623593|FG004|Overall Study|Withdrawal by Subject|2|||
161336697|NCT03098979|582623594|FG005|Overall Study|Withdrawal by Subject|1|||
161336698|NCT03098979|582623589|FG000|Overall Study|Death|1|||
161336699|NCT03098979|582623590|FG001|Overall Study|Death|0|||
161336700|NCT03098979|582623591|FG002|Overall Study|Death|2|||
161336701|NCT03098979|582623592|FG003|Overall Study|Death|0|||
161336702|NCT03098979|582623593|FG004|Overall Study|Death|1|||
161336703|NCT03098979|582623594|FG005|Overall Study|Death|0|||
161336704|NCT03098979|582623589|FG000|Overall Study|Physician Decision|2|||
160845773|NCT00447226|580822885|FG000|Double-blind Phase|Disease Progression|4|||
160845774|NCT00447226|580822886|FG001|Double-blind Phase|Disease Progression|3|||
160845775|NCT03449758|580822894|FG000|Overall Study|Major protocol deviation|1|||
160845776|NCT03449758|580822894|FG000|Overall Study|Treatment inefficacy|5|||
160845777|NCT03449758|580822894|FG000|Overall Study|Adverse Event|9|||
160845778|NCT03449758|580822894|FG000|Overall Study|Consent withdrawal|1|||
160845779|NCT03449758|580822894|FG000|Overall Study|Other unspecified reason|3|||
160845780|NCT01478971|580822903|FG000|Standard of Care Period|Adverse Event|1|||
160845781|NCT01478971|580822903|FG000|Standard of Care Period|Withdrawal by Subject|3|||
160845782|NCT01478971|580822903|FG000|Standard of Care Period|Death|8|||
160845783|NCT01478971|580822903|FG000|Standard of Care Period|Lost to Follow-up|9|||
160845784|NCT01478971|580822903|FG000|Standard of Care Period|Other|4|||
160845785|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Adverse Event|1|||
160845786|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
161336705|NCT03098979|582623590|FG001|Overall Study|Physician Decision|1|||
161336706|NCT03098979|582623591|FG002|Overall Study|Physician Decision|0|||
161336707|NCT03098979|582623592|FG003|Overall Study|Physician Decision|0|||
161336708|NCT03098979|582623593|FG004|Overall Study|Physician Decision|0|||
161336709|NCT03098979|582623594|FG005|Overall Study|Physician Decision|0|||
161336710|NCT03098979|582623589|FG000|Overall Study|Non-compliance|0|||
161336711|NCT03098979|582623590|FG001|Overall Study|Non-compliance|0|||
161336712|NCT03098979|582623591|FG002|Overall Study|Non-compliance|0|||
161336713|NCT03098979|582623592|FG003|Overall Study|Non-compliance|0|||
161336714|NCT03098979|582623593|FG004|Overall Study|Non-compliance|0|||
161336715|NCT03098979|582623594|FG005|Overall Study|Non-compliance|1|||
161336716|NCT03098979|582623589|FG000|Overall Study|Protocol Violation|0|||
161336717|NCT03098979|582623590|FG001|Overall Study|Protocol Violation|0|||
161336718|NCT03098979|582623591|FG002|Overall Study|Protocol Violation|0|||
160845787|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Death|4|||
160845788|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
160845789|NCT01478971|580822903|FG000|Peginesatide Treatment Period|Other|4|||
160845790|NCT00584012|580822904|FG000|Overall Study|Withdrawal by Subject|1|||
160845791|NCT04404556|580822905|FG000|Intervention|Withdrawal by Subject|15|||
160906034|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
161336719|NCT03098979|582623592|FG003|Overall Study|Protocol Violation|0|||
160906035|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
160906036|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
160906037|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
160906038|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
160906039|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
160906040|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
160906041|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
160906042|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
160906043|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
160906044|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
160906045|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
161336720|NCT03098979|582623593|FG004|Overall Study|Protocol Violation|0|||
161336721|NCT03098979|582623594|FG005|Overall Study|Protocol Violation|1|||
161336722|NCT04459338|582623597|FG000|Overall Study|Loss of IV during study|1|||
161336723|NCT04459338|582623598|FG001|Overall Study|Loss of IV during study|0|||
161336724|NCT03157089|582623599|FG000|Overall Study|Treated only with pembrolizumab|1|||
161336725|NCT03157089|582623600|FG001|Overall Study|Treated only with pembrolizumab|0|||
160845792|NCT04404556|580822906|FG001|Intervention|Withdrawal by Subject|3|||
160845793|NCT04404556|580822905|FG000|Intervention|Did not complete all intervention sessions|2|||
160845794|NCT04404556|580822906|FG001|Intervention|Did not complete all intervention sessions|1|||
160845795|NCT04404556|580822905|FG000|Post-Intervention|Missing Data|1|||
160845796|NCT04404556|580822906|FG001|Post-Intervention|Missing Data|2|||
161253759|NCT01214239|582306730|FG000|Overall Study|Adverse Event|3|||
161253760|NCT01214239|582306731|FG001|Overall Study|Adverse Event|4|||
161253761|NCT01214239|582306730|FG000|Overall Study|Protocol Violation|2|||
161253762|NCT01214239|582306731|FG001|Overall Study|Protocol Violation|1|||
161253763|NCT01214239|582306730|FG000|Overall Study|Lost to Follow-up|1|||
161253764|NCT01214239|582306731|FG001|Overall Study|Lost to Follow-up|1|||
161253765|NCT01214239|582306730|FG000|Overall Study|Withdrawal by Subject|4|||
160845797|NCT04404556|580822905|FG000|Follow-up 1|Withdrawal by Subject|5|||
160845798|NCT04404556|580822906|FG001|Follow-up 1|Withdrawal by Subject|1|||
160845799|NCT04404556|580822905|FG000|Follow-up 1|Missing Data|4|||
160845800|NCT04404556|580822906|FG001|Follow-up 1|Missing Data|7|||
160845801|NCT04404556|580822905|FG000|Follow-up 2|Withdrawal by Subject|1|||
160845802|NCT04404556|580822906|FG001|Follow-up 2|Withdrawal by Subject|1|||
160845803|NCT04404556|580822905|FG000|Follow-up 2|Missing Data|6|||
160845804|NCT04404556|580822906|FG001|Follow-up 2|Missing Data|5|||
160845805|NCT02451943|580822907|FG000|Overall Study|Withdrawal by Subject|13|||
160845806|NCT02451943|580822908|FG001|Overall Study|Withdrawal by Subject|16|||
160845807|NCT02451943|580822907|FG000|Overall Study|Lost to Follow-up|3|||
160845808|NCT02451943|580822908|FG001|Overall Study|Lost to Follow-up|4|||
160845809|NCT02451943|580822907|FG000|Overall Study|Sponsor Decision|0|||
160845810|NCT02451943|580822908|FG001|Overall Study|Sponsor Decision|4|||
160845811|NCT03937713|580822909|FG000|Overall Study|Withdrawal by Subject|3|||
160845812|NCT03937713|580822910|FG001|Overall Study|Withdrawal by Subject|6|||
160845813|NCT03937713|580822909|FG000|Overall Study|Lost to Follow-up|1|||
160845814|NCT03937713|580822910|FG001|Overall Study|Lost to Follow-up|0|||
160845815|NCT00763386|580822916|FG000|Overall Study|Adverse Event|43|||
160845816|NCT00763386|580822917|FG001|Overall Study|Adverse Event|33|||
160845817|NCT00763386|580822916|FG000|Overall Study|Death|1|||
160845818|NCT00763386|580822917|FG001|Overall Study|Death|2|||
160845819|NCT00763386|580822916|FG000|Overall Study|Lost to Follow-up|3|||
160845820|NCT00763386|580822917|FG001|Overall Study|Lost to Follow-up|3|||
160845821|NCT00763386|580822916|FG000|Overall Study|Withdrawal by Subject|0|||
160845822|NCT00763386|580822917|FG001|Overall Study|Withdrawal by Subject|1|||
160845823|NCT00763386|580822916|FG000|Overall Study|CRF missing|0|||
161253766|NCT01214239|582306731|FG001|Overall Study|Withdrawal by Subject|9|||
161253767|NCT01214239|582306730|FG000|Overall Study|Lack of Efficacy|1|||
161253768|NCT01214239|582306731|FG001|Overall Study|Lack of Efficacy|2|||
161253769|NCT01214239|582306730|FG000|Overall Study|patient's private reason|1|||
161253770|NCT01214239|582306731|FG001|Overall Study|patient's private reason|1|||
161253771|NCT03840382|582306732|FG000|Overall Study|Lost to Follow-up|11|||
161253772|NCT01142661|582306733|FG000|Overall Study|Adverse Event|2|||
161253773|NCT01142661|582306733|FG000|Overall Study|Withdrawal by Subject|1|||
161253774|NCT01142661|582306733|FG000|Overall Study|Physician Decision|1|||
161253775|NCT00965731|582306736|FG000|Overall Study|Death|0|||
161253776|NCT00965731|582306737|FG001|Overall Study|Death|4|||
161253777|NCT00965731|582306736|FG000|Overall Study|Withdrawal by Subject|0|||
161253778|NCT00965731|582306737|FG001|Overall Study|Withdrawal by Subject|1|||
161253779|NCT00965731|582306736|FG000|Overall Study|Other|7|||
161253780|NCT00965731|582306737|FG001|Overall Study|Other|15|||
161253781|NCT04773600|582306738|FG000|Overall Study|Withdrawal by Subject|15|||
161253782|NCT04773600|582306739|FG001|Overall Study|Withdrawal by Subject|9|||
161253783|NCT04773600|582306738|FG000|Overall Study|Lost to Follow-up|10|||
160845824|NCT00763386|580822917|FG001|Overall Study|CRF missing|1|||
160845825|NCT00763386|580822916|FG000|Overall Study|Study Prosthesis Removed|1|||
160845826|NCT00763386|580822917|FG001|Overall Study|Study Prosthesis Removed|0|||
160845827|NCT00922623|580822918|FG000|Overall Study|Other|4|||
160845828|NCT00922623|580822918|FG000|Overall Study|Lost to Follow-up|1|||
160845829|NCT02451917|580822919|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
160845830|NCT02451917|580822920|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
160845831|NCT02451917|580822919|FG000|First Intervention (24 Weeks)|Death|0|||
160845832|NCT02451917|580822920|FG001|First Intervention (24 Weeks)|Death|1|||
160906046|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
161253784|NCT04773600|582306739|FG001|Overall Study|Lost to Follow-up|6|||
161253785|NCT04773600|582306738|FG000|Overall Study|Adverse Event|8|||
161253786|NCT04773600|582306739|FG001|Overall Study|Adverse Event|2|||
161253787|NCT04773600|582306738|FG000|Overall Study|Lack of Efficacy|2|||
161253788|NCT04773600|582306739|FG001|Overall Study|Lack of Efficacy|3|||
161253789|NCT04773600|582306738|FG000|Overall Study|Noncompliance|2|||
161336726|NCT03157089|582623599|FG000|Overall Study|Adverse Event|5|||
160845833|NCT02451917|580822919|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
160845834|NCT02451917|580822920|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
160845835|NCT02871635|580822921|FG000|Overall Study|Primary lack of efficacy|4|||
160845836|NCT02871635|580822922|FG001|Overall Study|Primary lack of efficacy|4|||
161253790|NCT04773600|582306739|FG001|Overall Study|Noncompliance|0|||
160992376|NCT00662909|581360034|FG000|Overall Study|Randomized- never received study drug|1|||
160992377|NCT00662909|581360035|FG001|Overall Study|Randomized- never received study drug|0|||
160992378|NCT00662909|581360036|FG002|Overall Study|Randomized- never received study drug|0|||
161140923|NCT00472303|581899227|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
161140924|NCT00472303|581899228|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
161140925|NCT00472303|581899226|FG000|Discontinuations After Titration Phase|Other|5|||
160845837|NCT02871635|580822921|FG000|Overall Study|Protocol Violation|3|||
160845838|NCT02871635|580822922|FG001|Overall Study|Protocol Violation|1|||
161140926|NCT00472303|581899227|FG001|Discontinuations After Titration Phase|Other|0|||
161140927|NCT00472303|581899228|FG002|Discontinuations After Titration Phase|Other|0|||
161253791|NCT04773600|582306738|FG000|Overall Study|Protocol Violation|2|||
161253792|NCT04773600|582306739|FG001|Overall Study|Protocol Violation|0|||
161253793|NCT04773600|582306738|FG000|Overall Study|Physician Decision|0|||
161253794|NCT04773600|582306739|FG001|Overall Study|Physician Decision|1|||
160845839|NCT02871635|580822921|FG000|Overall Study|Lost to Follow-up|1|||
160845840|NCT02871635|580822922|FG001|Overall Study|Lost to Follow-up|2|||
160845841|NCT02871635|580822921|FG000|Overall Study|Pregnancy|0|||
160845842|NCT02871635|580822922|FG001|Overall Study|Pregnancy|2|||
160845843|NCT02871635|580822921|FG000|Overall Study|Physician Decision|1|||
160845844|NCT02871635|580822922|FG001|Overall Study|Physician Decision|1|||
160845845|NCT02871635|580822921|FG000|Overall Study|Withdrawal by Subject|3|||
160845846|NCT02871635|580822922|FG001|Overall Study|Withdrawal by Subject|4|||
160845847|NCT02871635|580822921|FG000|Overall Study|Adverse Event|4|||
160845848|NCT02871635|580822922|FG001|Overall Study|Adverse Event|4|||
161253795|NCT04773600|582306738|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
161253796|NCT04773600|582306739|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
161253797|NCT04773600|582306738|FG000|Overall Study|Emergency Travel Out of Country|1|||
160845849|NCT02871635|580822921|FG000|Overall Study|Secondary lack of efficacy|2|||
160845850|NCT02871635|580822922|FG001|Overall Study|Secondary lack of efficacy|1|||
160845851|NCT02420379|580822923|FG000|Overall Study|Withdrawal by Subject|0|||
160845852|NCT02420379|580822924|FG001|Overall Study|Withdrawal by Subject|3|||
160845853|NCT02420379|580822923|FG000|Overall Study|Unable to complete due to schooling|0|||
160845854|NCT02420379|580822924|FG001|Overall Study|Unable to complete due to schooling|1|||
160845855|NCT02420379|580822923|FG000|Overall Study|Transitioned to commercial drug|1|||
160845856|NCT02420379|580822924|FG001|Overall Study|Transitioned to commercial drug|0|||
160845857|NCT01402817|580822925|FG000|Overall Study|Withdrawal by Subject|3|||
160845858|NCT01402817|580822925|FG000|Overall Study|Study Suspended by FDA|8|||
160845859|NCT00502671|580822926|FG000|Overall Study|Disease Progression|13|||
160845860|NCT00502671|580822926|FG000|Overall Study|Personal Reasons|22|||
160845861|NCT00502671|580822926|FG000|Overall Study|Lost to Follow-up|7|||
160845862|NCT00502671|580822926|FG000|Overall Study|Protocol Violation|16|||
160845863|NCT00502671|580822926|FG000|Overall Study|Adverse Event|19|||
160845864|NCT00681629|580822933|FG000|Overall Study|Study termination|4|||
160845865|NCT00681629|580822934|FG001|Overall Study|Study termination|2|||
160845866|NCT00681629|580822933|FG000|Overall Study|Adverse Event|1|||
160845867|NCT00681629|580822934|FG001|Overall Study|Adverse Event|0|||
160845868|NCT00086047|580822935|FG000|Overall Study|Lost to Follow-up|7|||
160845869|NCT00086047|580822936|FG001|Overall Study|Lost to Follow-up|6|||
161140928|NCT00472303|581899226|FG000|Maintenance Phase|Adverse Event|5|||
161253798|NCT04773600|582306739|FG001|Overall Study|Emergency Travel Out of Country|0|||
161253799|NCT03180528|582308518|FG000|Overall Study|Adverse Event|1|||
161253800|NCT03180528|582308518|FG000|Overall Study|Withdrawal by Subject|1|||
161253801|NCT03180528|582308518|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
161253802|NCT02839798|582308519|FG000|Overall Study|Withdrawal by Subject|2|||
161253803|NCT02447887|582308520|FG000|Overall Study|Study was terminated|3|||
161253804|NCT03429049|582308521|FG000|Overall Study|Adverse Event|2|||
160845870|NCT00086047|580822935|FG000|Overall Study|Physician Decision|0|||
160845871|NCT00086047|580822936|FG001|Overall Study|Physician Decision|1|||
160845872|NCT01395901|580822937|FG000|Overall Study|Lost to Follow-up|4|||
160845873|NCT01395901|580822938|FG001|Overall Study|Lost to Follow-up|0|||
160845874|NCT01395901|580822937|FG000|Overall Study|Randomized but not received study drug|5|||
160845875|NCT01395901|580822938|FG001|Overall Study|Randomized but not received study drug|4|||
160845876|NCT01395901|580822937|FG000|Overall Study|Adverse Event|0|||
160845877|NCT01395901|580822938|FG001|Overall Study|Adverse Event|1|||
160845878|NCT01395901|580822937|FG000|Overall Study|Withdrawal of consent|1|||
161140929|NCT00472303|581899227|FG001|Maintenance Phase|Adverse Event|6|||
161253805|NCT03429049|582308522|FG001|Overall Study|Adverse Event|3|||
160845879|NCT01395901|580822938|FG001|Overall Study|Withdrawal of consent|0|||
160845880|NCT00853151|580822943|FG000|Overall Study|Adverse Event|1|||
160845881|NCT00853151|580822944|FG001|Overall Study|Adverse Event|4|||
160845882|NCT00853151|580822945|FG002|Overall Study|Adverse Event|2|||
160845883|NCT00853151|580822946|FG003|Overall Study|Adverse Event|0|||
160845884|NCT00853151|580822943|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
160845885|NCT00853151|580822944|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160845886|NCT00853151|580822945|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161253806|NCT03429049|582308521|FG000|Overall Study|Death|0|||
161253807|NCT03429049|582308522|FG001|Overall Study|Death|1|||
161253808|NCT03429049|582308521|FG000|Overall Study|Lack of Efficacy|4|||
161253809|NCT03429049|582308522|FG001|Overall Study|Lack of Efficacy|2|||
161253810|NCT03429049|582308521|FG000|Overall Study|Lost to Follow-up|9|||
161253811|NCT03429049|582308522|FG001|Overall Study|Lost to Follow-up|8|||
161253812|NCT03429049|582308521|FG000|Overall Study|Physician Decision|1|||
161336727|NCT03157089|582623600|FG001|Overall Study|Adverse Event|4|||
161336728|NCT03157089|582623599|FG000|Overall Study|Progressive disease|6|||
161336729|NCT03157089|582623600|FG001|Overall Study|Progressive disease|8|||
161336730|NCT00784875|582623601|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
161336731|NCT00784875|582623602|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
161336732|NCT00784875|582623603|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
161336733|NCT00784875|582623604|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
161336734|NCT00784875|582623601|FG000|Period A - Baseline|Adverse Event|0|||
161336735|NCT00784875|582623602|FG001|Period A - Baseline|Adverse Event|0|||
160845887|NCT00853151|580822946|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160845888|NCT00853151|580822943|FG000|Overall Study|Lost to Follow-up|2|||
160845889|NCT00853151|580822944|FG001|Overall Study|Lost to Follow-up|0|||
160845890|NCT00853151|580822945|FG002|Overall Study|Lost to Follow-up|3|||
160845891|NCT00853151|580822946|FG003|Overall Study|Lost to Follow-up|0|||
160845892|NCT00853151|580822943|FG000|Overall Study|Death|1|||
160845893|NCT00853151|580822944|FG001|Overall Study|Death|0|||
160845894|NCT00853151|580822945|FG002|Overall Study|Death|0|||
160845895|NCT00853151|580822946|FG003|Overall Study|Death|1|||
160845896|NCT00853151|580822943|FG000|Overall Study|Protocol Violation|0|||
160845897|NCT00853151|580822944|FG001|Overall Study|Protocol Violation|0|||
160845898|NCT00853151|580822945|FG002|Overall Study|Protocol Violation|0|||
161253813|NCT03429049|582308522|FG001|Overall Study|Physician Decision|0|||
161253814|NCT03429049|582308521|FG000|Overall Study|Protocol Violation|3|||
161253815|NCT03429049|582308522|FG001|Overall Study|Protocol Violation|0|||
161253816|NCT03429049|582308521|FG000|Overall Study|Sponsor Decision|2|||
161253817|NCT03429049|582308522|FG001|Overall Study|Sponsor Decision|0|||
161253818|NCT03429049|582308521|FG000|Overall Study|Withdrawal by Subject|4|||
161253819|NCT03429049|582308522|FG001|Overall Study|Withdrawal by Subject|20|||
161253820|NCT03429049|582308521|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
161253821|NCT03429049|582308522|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
161253822|NCT04703855|582308523|FG000|Overall Study|Heart Transplant|1|||
161336736|NCT00784875|582623603|FG002|Period A - Baseline|Adverse Event|0|||
161336737|NCT00784875|582623604|FG003|Period A - Baseline|Adverse Event|8|||
160845899|NCT00853151|580822946|FG003|Overall Study|Protocol Violation|1|||
160845900|NCT00853151|580822943|FG000|Overall Study|Withdrawal by Subject|5|||
160845901|NCT00853151|580822944|FG001|Overall Study|Withdrawal by Subject|4|||
160845902|NCT00853151|580822945|FG002|Overall Study|Withdrawal by Subject|2|||
160845903|NCT00853151|580822946|FG003|Overall Study|Withdrawal by Subject|1|||
160845904|NCT00853151|580822943|FG000|Overall Study|Physician Decision|0|||
160845905|NCT00853151|580822944|FG001|Overall Study|Physician Decision|2|||
160845906|NCT00853151|580822945|FG002|Overall Study|Physician Decision|1|||
160845907|NCT00853151|580822946|FG003|Overall Study|Physician Decision|0|||
160845908|NCT00853151|580822943|FG000|Overall Study|Sponsor Decision|0|||
160845909|NCT00853151|580822944|FG001|Overall Study|Sponsor Decision|3|||
160845910|NCT00853151|580822945|FG002|Overall Study|Sponsor Decision|0|||
160845911|NCT00853151|580822946|FG003|Overall Study|Sponsor Decision|0|||
160845912|NCT01751984|580822947|FG000|Overall Study|Adverse Event|5|||
160845913|NCT01751984|580822948|FG001|Overall Study|Adverse Event|3|||
160845914|NCT01751984|580822947|FG000|Overall Study|Withdrawal by Subject|0|||
160845915|NCT01751984|580822948|FG001|Overall Study|Withdrawal by Subject|1|||
160845916|NCT01751984|580822947|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
160845917|NCT01751984|580822948|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
160845918|NCT00587158|580822949|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
160845919|NCT00587158|580822950|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
160906047|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
160906048|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
160906049|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
160906050|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
160906051|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906052|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906053|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
160906054|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906055|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
160906056|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
160906057|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906058|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906059|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906060|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
160906061|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906062|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
160906063|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906064|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906065|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
160906066|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
160906067|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
160906068|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
160906069|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
160906070|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
160906071|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906072|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906073|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
160906074|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906075|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
160906076|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
160906077|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
160906078|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
160906079|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
160906080|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
161253823|NCT02418455|582308527|FG000|48-Week Treatment Period|Other- Not Specified|1|||
161253824|NCT02418455|582308527|FG000|Continuation Period|Sponsor Decision|7|||
161253825|NCT02001051|582308530|FG000|Overall Study|Deemed not eligible following enrollment|0|||
161253826|NCT02001051|582308531|FG001|Overall Study|Deemed not eligible following enrollment|1|||
161253827|NCT04205162|582308541|FG000|Overall Study|Lost to Follow-up|1|||
161253828|NCT04205162|582308542|FG001|Overall Study|Lost to Follow-up|0|||
161253829|NCT04205162|582308541|FG000|Overall Study|Withdrawal by Subject|2|||
161253830|NCT04205162|582308542|FG001|Overall Study|Withdrawal by Subject|0|||
161253831|NCT04205162|582308541|FG000|Overall Study|University closure due to COVID-19|1|||
161253832|NCT04205162|582308542|FG001|Overall Study|University closure due to COVID-19|0|||
161253833|NCT01999894|582308543|FG000|Overall Study|Adverse Event|9|||
161253834|NCT01999894|582308543|FG000|Overall Study|Lack of Efficacy|5|||
161253835|NCT01999894|582308543|FG000|Overall Study|Protocol Violation|1|||
161253836|NCT01999894|582308543|FG000|Overall Study|Withdrawal by Subject|7|||
161253837|NCT01999894|582308543|FG000|Overall Study|Lost to Follow-up|10|||
161253838|NCT01999894|582308543|FG000|Overall Study|Other Reason|3|||
161253839|NCT01999894|582308543|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
161253840|NCT01546519|582308545|FG000|Overall Study|Adverse Event|0|||
161253841|NCT01546519|582308546|FG001|Overall Study|Adverse Event|0|||
161253842|NCT01546519|582308547|FG002|Overall Study|Adverse Event|1|||
161253843|NCT01546519|582308548|FG003|Overall Study|Adverse Event|1|||
161253844|NCT01546519|582308545|FG000|Overall Study|Death|0|||
161253845|NCT01546519|582308546|FG001|Overall Study|Death|1|||
161253846|NCT01546519|582308547|FG002|Overall Study|Death|3|||
161253847|NCT01546519|582308548|FG003|Overall Study|Death|1|||
161253848|NCT01546519|582308545|FG000|Overall Study|related to disease progression|2|||
161253849|NCT01546519|582308546|FG001|Overall Study|related to disease progression|2|||
161253850|NCT01546519|582308547|FG002|Overall Study|related to disease progression|2|||
161253851|NCT01546519|582308548|FG003|Overall Study|related to disease progression|1|||
161253852|NCT01546519|582308545|FG000|Overall Study|Physician Decision|6|||
161253853|NCT01546519|582308546|FG001|Overall Study|Physician Decision|5|||
161253854|NCT01546519|582308547|FG002|Overall Study|Physician Decision|2|||
161253855|NCT01546519|582308548|FG003|Overall Study|Physician Decision|3|||
161253856|NCT01546519|582308545|FG000|Overall Study|Withdrawal by Subject|1|||
161253857|NCT01546519|582308546|FG001|Overall Study|Withdrawal by Subject|0|||
161253858|NCT01546519|582308547|FG002|Overall Study|Withdrawal by Subject|0|||
161253859|NCT01546519|582308548|FG003|Overall Study|Withdrawal by Subject|0|||
161336738|NCT00784875|582623601|FG000|Period A - Baseline|Protocol Violation|0|||
161253860|NCT00779402|582308549|FG000|Treatment Phase 1|Disease Progression|1|||
161253861|NCT00779402|582308550|FG001|Treatment Phase 1|Disease Progression|0|||
161253862|NCT00779402|582308549|FG000|Treatment Phase 1|Adverse Event|2|||
161253863|NCT00779402|582308550|FG001|Treatment Phase 1|Adverse Event|0|||
161253864|NCT00779402|582308549|FG000|Treatment Phase 1|Protocol Violation|1|||
161253865|NCT00779402|582308550|FG001|Treatment Phase 1|Protocol Violation|0|||
161253866|NCT00779402|582308549|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
161253867|NCT00779402|582308550|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
161253868|NCT00779402|582308549|FG000|Treatment Phase 1|Lost to Follow-up|0|||
161253869|NCT00779402|582308550|FG001|Treatment Phase 1|Lost to Follow-up|1|||
161253870|NCT00779402|582308549|FG000|Treatment Phase 1|Death|0|||
161253871|NCT00779402|582308550|FG001|Treatment Phase 1|Death|1|||
161253872|NCT00779402|582308549|FG000|Treatment Phase 1|Intercurrent Illness|1|||
161336739|NCT00784875|582623602|FG001|Period A - Baseline|Protocol Violation|0|||
161253873|NCT00779402|582308550|FG001|Treatment Phase 1|Intercurrent Illness|1|||
161253874|NCT00779402|582308549|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
161253875|NCT00779402|582308550|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
161253876|NCT00779402|582308549|FG000|Treatment Phase 1|Other|4|||
161253877|NCT00779402|582308550|FG001|Treatment Phase 1|Other|2|||
161253878|NCT00779402|582308549|FG000|Treatment Phase 1|Closure of Study|3|||
161253879|NCT00779402|582308550|FG001|Treatment Phase 1|Closure of Study|2|||
161253880|NCT00779402|582308549|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
161253881|NCT00779402|582308550|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
161253882|NCT00779402|582308549|FG000|Surveillance Phase|Protocol Violation|0|||
161253883|NCT00779402|582308550|FG001|Surveillance Phase|Protocol Violation|1|||
161253884|NCT00779402|582308549|FG000|Surveillance Phase|Patient refused to continue|22|||
161253885|NCT00779402|582308550|FG001|Surveillance Phase|Patient refused to continue|14|||
161253886|NCT00779402|582308549|FG000|Surveillance Phase|Lost to Follow-up|2|||
161253887|NCT00779402|582308550|FG001|Surveillance Phase|Lost to Follow-up|1|||
160992379|NCT00662909|581360034|FG000|Overall Study|Non-compliance with study procedures|3|||
160992380|NCT00662909|581360035|FG001|Overall Study|Non-compliance with study procedures|3|||
160992381|NCT00662909|581360036|FG002|Overall Study|Non-compliance with study procedures|2|||
160992382|NCT00662909|581360034|FG000|Overall Study|Physician Decision|1|||
160992383|NCT00662909|581360035|FG001|Overall Study|Physician Decision|1|||
160992384|NCT00662909|581360036|FG002|Overall Study|Physician Decision|2|||
160992385|NCT00662909|581360034|FG000|Overall Study|Eligibility criterion not met|0|||
160992386|NCT00662909|581360035|FG001|Overall Study|Eligibility criterion not met|1|||
160992387|NCT00662909|581360036|FG002|Overall Study|Eligibility criterion not met|1|||
160992388|NCT01510912|581361340|FG000|Overall Study|Adverse Event|99|||
160992389|NCT01510912|581361340|FG000|Overall Study|Lack of Efficacy|12|||
160992390|NCT01510912|581361340|FG000|Overall Study|Non-compliance with trial drug|23|||
160992391|NCT01510912|581361340|FG000|Overall Study|Withdrawal by Subject|49|||
160992392|NCT01510912|581361340|FG000|Overall Study|Physician Decision|1|||
160992393|NCT01510912|581361340|FG000|Overall Study|Protocol Violation|27|||
160992394|NCT01510912|581361340|FG000|Overall Study|Lost to Follow-up|26|||
160992395|NCT01510912|581361340|FG000|Overall Study|Other, including joint replacement|5|||
160992396|NCT03179787|581361341|FG000|Overall Study|Lost to Follow-up|15|||
160992397|NCT03179787|581361341|FG000|Overall Study|Case report failures|2|||
160992398|NCT03179787|581361341|FG000|Overall Study|Treatment not administered|1|||
160992399|NCT03181958|581361342|FG000|Overall Study|Lost to Follow-up|17|||
161253888|NCT00779402|582308549|FG000|Surveillance Phase|Death|0|||
161253889|NCT00779402|582308550|FG001|Surveillance Phase|Death|1|||
161253890|NCT00779402|582308549|FG000|Surveillance Phase|Intercurrent Illness|2|||
161253891|NCT00779402|582308550|FG001|Surveillance Phase|Intercurrent Illness|0|||
161253892|NCT00779402|582308549|FG000|Surveillance Phase|Other|5|||
161253893|NCT00779402|582308550|FG001|Surveillance Phase|Other|5|||
161253894|NCT00779402|582308549|FG000|Surveillance Phase|Withdrawal by Subject|4|||
161253895|NCT00779402|582308550|FG001|Surveillance Phase|Withdrawal by Subject|1|||
161253896|NCT00779402|582308549|FG000|Surveillance Phase|Closure of study|5|||
161253897|NCT00779402|582308550|FG001|Surveillance Phase|Closure of study|6|||
161253898|NCT00779402|582308549|FG000|Surveillance Phase|Completed Protocol Visits|3|||
161253899|NCT00779402|582308550|FG001|Surveillance Phase|Completed Protocol Visits|2|||
161253900|NCT00779402|582308549|FG000|Long-term Follow-up|Patient refused to continue|2|||
161253901|NCT00779402|582308550|FG001|Long-term Follow-up|Patient refused to continue|0|||
161253902|NCT00779402|582308549|FG000|Long-term Follow-up|Other|5|||
161253903|NCT00779402|582308550|FG001|Long-term Follow-up|Other|0|||
161253904|NCT00779402|582308549|FG000|Long-term Follow-up|Closure of Study|8|||
161253905|NCT00779402|582308550|FG001|Long-term Follow-up|Closure of Study|4|||
161253906|NCT00779402|582308549|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
161253907|NCT00779402|582308550|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
161253908|NCT01519947|582308551|FG000|Overall Study|Death|0|||
161253909|NCT01519947|582308552|FG001|Overall Study|Death|0|||
160845920|NCT00587158|580822949|FG000|Overall Study|Physician Decision|0|||
160845921|NCT00587158|580822950|FG001|Overall Study|Physician Decision|1|||
160845922|NCT00587158|580822949|FG000|Overall Study|Lost to Follow-up|1|||
160845923|NCT00587158|580822950|FG001|Overall Study|Lost to Follow-up|2|||
160845924|NCT00587158|580822949|FG000|Overall Study|Death|0|||
160992400|NCT03181958|581361343|FG001|Overall Study|Lost to Follow-up|21|||
160992401|NCT03181958|581361344|FG002|Overall Study|Lost to Follow-up|15|||
160992402|NCT02030028|581361345|FG000|Overall Study|Withdrawal by Subject|4|||
161253910|NCT01519947|582308553|FG002|Overall Study|Death|0|||
161253911|NCT01519947|582308554|FG003|Overall Study|Death|1|||
161253912|NCT01519947|582308551|FG000|Overall Study|Protocol Violation|0|||
161253913|NCT01519947|582308552|FG001|Overall Study|Protocol Violation|0|||
161253914|NCT01519947|582308553|FG002|Overall Study|Protocol Violation|2|||
161253915|NCT01519947|582308554|FG003|Overall Study|Protocol Violation|1|||
161253916|NCT01519947|582308551|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
161253917|NCT01519947|582308552|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
161253918|NCT01519947|582308553|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
160845925|NCT00587158|580822950|FG001|Overall Study|Death|1|||
161253919|NCT01519947|582308554|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
161253920|NCT01519947|582308551|FG000|Overall Study|Development of Anemia|0|||
161253921|NCT01519947|582308552|FG001|Overall Study|Development of Anemia|1|||
161253922|NCT01519947|582308553|FG002|Overall Study|Development of Anemia|0|||
161253923|NCT01519947|582308554|FG003|Overall Study|Development of Anemia|1|||
161253924|NCT01519947|582308551|FG000|Overall Study|Blood Transfusion|0|||
161253925|NCT01519947|582308552|FG001|Overall Study|Blood Transfusion|1|||
161253926|NCT01519947|582308553|FG002|Overall Study|Blood Transfusion|1|||
161253927|NCT01519947|582308554|FG003|Overall Study|Blood Transfusion|0|||
161253928|NCT01519947|582308551|FG000|Overall Study|Withdrawal by Subject|0|||
161253929|NCT01519947|582308552|FG001|Overall Study|Withdrawal by Subject|1|||
161253930|NCT01519947|582308553|FG002|Overall Study|Withdrawal by Subject|0|||
161253931|NCT01519947|582308554|FG003|Overall Study|Withdrawal by Subject|1|||
161253932|NCT01519947|582308551|FG000|Overall Study|Lost to Follow-up|0|||
161253933|NCT01519947|582308552|FG001|Overall Study|Lost to Follow-up|0|||
160845926|NCT00587158|580822949|FG000|Overall Study|Subject did not want to take study med|0|||
160845927|NCT00587158|580822950|FG001|Overall Study|Subject did not want to take study med|1|||
160845928|NCT01136408|580822951|FG000|Overall Study|Adverse Event|4|||
160845929|NCT01136408|580822952|FG001|Overall Study|Adverse Event|8|||
160845930|NCT01136408|580822953|FG002|Overall Study|Adverse Event|4|||
160845931|NCT01136408|580822951|FG000|Overall Study|Protocol Violation|1|||
160845932|NCT01136408|580822952|FG001|Overall Study|Protocol Violation|1|||
160845933|NCT01136408|580822953|FG002|Overall Study|Protocol Violation|1|||
160845934|NCT01510158|580822954|FG000|Overall Study|Adverse Event|7|||
160845935|NCT01510158|580822955|FG001|Overall Study|Adverse Event|8|||
160845936|NCT01510158|580822956|FG002|Overall Study|Adverse Event|5|||
160845937|NCT01510158|580822954|FG000|Overall Study|Gout flare|1|||
160845938|NCT01510158|580822955|FG001|Overall Study|Gout flare|0|||
160845939|NCT01510158|580822956|FG002|Overall Study|Gout flare|0|||
161140930|NCT00472303|581899228|FG002|Maintenance Phase|Adverse Event|6|||
161253934|NCT01519947|582308553|FG002|Overall Study|Lost to Follow-up|3|||
161253935|NCT01519947|582308554|FG003|Overall Study|Lost to Follow-up|2|||
161253936|NCT01519947|582308551|FG000|Overall Study|Poor Response|1|||
161253937|NCT01519947|582308552|FG001|Overall Study|Poor Response|0|||
161253938|NCT01519947|582308553|FG002|Overall Study|Poor Response|0|||
161253939|NCT01519947|582308554|FG003|Overall Study|Poor Response|1|||
161253940|NCT01519947|582308551|FG000|Overall Study|Adverse Event|1|||
161253941|NCT01519947|582308552|FG001|Overall Study|Adverse Event|0|||
161253942|NCT01519947|582308553|FG002|Overall Study|Adverse Event|1|||
161253943|NCT01519947|582308554|FG003|Overall Study|Adverse Event|1|||
161253944|NCT00693225|582308555|FG000|Overall Study|Lost to Follow-up|1|||
161253945|NCT00693225|582308556|FG001|Overall Study|Lost to Follow-up|2|||
161253946|NCT00693225|582308555|FG000|Overall Study|Adverse Event|1|||
161253947|NCT00693225|582308556|FG001|Overall Study|Adverse Event|3|||
161253948|NCT03585959|582308561|FG000|Overall Study|Physician Decision|1|||
161253949|NCT03585959|582308561|FG000|Overall Study|Unsuccessful Procedure|2|||
161253950|NCT01186016|582308563|FG000|Overall Study|Withdrawal by Subject|46|||
161253951|NCT01186016|582308564|FG001|Overall Study|Withdrawal by Subject|29|||
161253952|NCT03750695|582308566|FG000|Overall Study|Lost to Follow-up|0|||
161253953|NCT03750695|582308567|FG001|Overall Study|Lost to Follow-up|1|||
161253954|NCT01386125|582308568|FG000|Overall Study|Lost to Follow-up|3|||
161253955|NCT01386125|582308569|FG001|Overall Study|Lost to Follow-up|9|||
161253956|NCT01386125|582308568|FG000|Overall Study|Physician Decision|0|||
161253957|NCT01386125|582308569|FG001|Overall Study|Physician Decision|1|||
161253958|NCT01386125|582308568|FG000|Overall Study|Protocol Violation|5|||
161253959|NCT01386125|582308569|FG001|Overall Study|Protocol Violation|7|||
161253960|NCT01386125|582308568|FG000|Overall Study|Disease Progress|1|||
161253961|NCT01386125|582308569|FG001|Overall Study|Disease Progress|2|||
161253962|NCT01386125|582308568|FG000|Overall Study|Withdrawal by Subject|13|||
160845940|NCT01510158|580822954|FG000|Overall Study|Protocol Violation|17|||
160845941|NCT01510158|580822955|FG001|Overall Study|Protocol Violation|16|||
160992403|NCT02030028|581361345|FG000|Overall Study|lack of transportation|1|||
161140931|NCT00472303|581899226|FG000|Maintenance Phase|Death|3|||
161140932|NCT00472303|581899227|FG001|Maintenance Phase|Death|0|||
160845942|NCT01510158|580822956|FG002|Overall Study|Protocol Violation|24|||
161140933|NCT00472303|581899228|FG002|Maintenance Phase|Death|2|||
161140934|NCT00472303|581899226|FG000|Maintenance Phase|Lack of Efficacy|2|||
161140935|NCT00472303|581899227|FG001|Maintenance Phase|Lack of Efficacy|2|||
161140936|NCT00472303|581899228|FG002|Maintenance Phase|Lack of Efficacy|4|||
161140937|NCT00472303|581899226|FG000|Maintenance Phase|Withdrawal by Subject|6|||
161140938|NCT00472303|581899227|FG001|Maintenance Phase|Withdrawal by Subject|7|||
161140939|NCT00472303|581899228|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161140940|NCT00472303|581899226|FG000|Maintenance Phase|Trial medication non-compliant|0|||
161140941|NCT00472303|581899227|FG001|Maintenance Phase|Trial medication non-compliant|0|||
161140942|NCT00472303|581899228|FG002|Maintenance Phase|Trial medication non-compliant|1|||
161140943|NCT00472303|581899226|FG000|Maintenance Phase|Resolution of pain|0|||
161140944|NCT00472303|581899227|FG001|Maintenance Phase|Resolution of pain|0|||
161140945|NCT00472303|581899228|FG002|Maintenance Phase|Resolution of pain|1|||
161140946|NCT00472303|581899226|FG000|Maintenance Phase|Other|1|||
161140947|NCT00472303|581899227|FG001|Maintenance Phase|Other|1|||
161140948|NCT00472303|581899228|FG002|Maintenance Phase|Other|0|||
161140949|NCT01122927|581899229|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
161253963|NCT01386125|582308569|FG001|Overall Study|Withdrawal by Subject|12|||
161253964|NCT01386125|582308568|FG000|Overall Study|Adverse Event|2|||
161253965|NCT01386125|582308569|FG001|Overall Study|Adverse Event|5|||
161253966|NCT01386125|582308568|FG000|Overall Study|Lack of Efficacy|0|||
161253967|NCT01386125|582308569|FG001|Overall Study|Lack of Efficacy|1|||
161253968|NCT01386125|582308568|FG000|Overall Study|Participant Leaving Country|1|||
161253969|NCT01386125|582308569|FG001|Overall Study|Participant Leaving Country|0|||
161253970|NCT01292837|582308570|FG000|Overall Study|Adverse Event|1|||
161253971|NCT01292837|582308570|FG000|Overall Study|Further treatment determined|1|||
161253972|NCT02661022|582308573|FG000|Overall Study|Withdrawal by Subject|3|||
160845943|NCT01510158|580822954|FG000|Overall Study|Sponsor terminated study.|2|||
160845944|NCT01510158|580822955|FG001|Overall Study|Sponsor terminated study.|0|||
160845945|NCT01510158|580822956|FG002|Overall Study|Sponsor terminated study.|2|||
160845946|NCT01510158|580822954|FG000|Overall Study|Lost to Follow-up|13|||
160845947|NCT01510158|580822955|FG001|Overall Study|Lost to Follow-up|16|||
161253973|NCT02661022|582308574|FG001|Overall Study|Withdrawal by Subject|0|||
161253974|NCT02661022|582308573|FG000|Overall Study|Adverse Event|1|||
161253975|NCT02661022|582308574|FG001|Overall Study|Adverse Event|1|||
161253976|NCT02661022|582308573|FG000|Overall Study|Physician Decision|1|||
161253977|NCT02661022|582308574|FG001|Overall Study|Physician Decision|0|||
161253978|NCT02661022|582308573|FG000|Overall Study|Progressive Disease|2|||
161253979|NCT02661022|582308574|FG001|Overall Study|Progressive Disease|1|||
161253980|NCT02359864|582308575|FG000|Overall Study|Withdrawal by Subject|1|||
161253981|NCT02359864|582308576|FG001|Overall Study|Withdrawal by Subject|0|||
161253982|NCT04480307|582308578|FG000|Overall Study|Withdrawal by Subject|0|||
161253983|NCT04480307|582308579|FG001|Overall Study|Withdrawal by Subject|1|||
161253984|NCT04480307|582308580|FG002|Overall Study|Withdrawal by Subject|0|||
161253985|NCT04480307|582308581|FG003|Overall Study|Withdrawal by Subject|0|||
161253986|NCT04480307|582308578|FG000|Overall Study|Adverse Event|0|||
161253987|NCT04480307|582308579|FG001|Overall Study|Adverse Event|0|||
161253988|NCT04480307|582308580|FG002|Overall Study|Adverse Event|0|||
161253989|NCT04480307|582308581|FG003|Overall Study|Adverse Event|1|||
161253990|NCT00609154|582308582|FG000|Overall Study|Protocol Violation|1|||
161253991|NCT00609154|582308583|FG001|Overall Study|Protocol Violation|2|||
161253992|NCT00609154|582308582|FG000|Overall Study|Unable to establish IV access|0|||
161253993|NCT00609154|582308583|FG001|Overall Study|Unable to establish IV access|4|||
161336740|NCT00784875|582623603|FG002|Period A - Baseline|Protocol Violation|0|||
160845948|NCT01510158|580822956|FG002|Overall Study|Lost to Follow-up|9|||
160845949|NCT01510158|580822954|FG000|Overall Study|Withdrawal by Subject|10|||
160845950|NCT01510158|580822955|FG001|Overall Study|Withdrawal by Subject|13|||
160845951|NCT01510158|580822956|FG002|Overall Study|Withdrawal by Subject|10|||
160845952|NCT01510158|580822954|FG000|Overall Study|Death|1|||
160845953|NCT01510158|580822955|FG001|Overall Study|Death|0|||
160845954|NCT01510158|580822956|FG002|Overall Study|Death|0|||
160845955|NCT03078556|580822957|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
160845956|NCT03078556|580822958|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
160906081|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906082|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
160906083|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906084|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906085|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
160906086|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906087|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906088|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906089|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
160906090|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
160906091|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160906092|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160906093|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
160906094|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
160906095|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
161253994|NCT00609154|582308582|FG000|Overall Study|Adverse Event|0|||
161253995|NCT00609154|582308583|FG001|Overall Study|Adverse Event|2|||
161253996|NCT00515216|582308584|FG000|Overall Study|Withdrawal by Subject|1|||
160845957|NCT03078556|580822959|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
161253997|NCT01450800|582308596|FG000|Overall Study|Protocol Violation|1|||
160845958|NCT03078556|580822960|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
160845959|NCT03078556|580822957|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
161253998|NCT01450800|582308597|FG001|Overall Study|Protocol Violation|3|||
161253999|NCT03023137|582308598|FG000|Overall Study|Multiple pregnancy|2|||
161254000|NCT03023137|582308599|FG001|Overall Study|Multiple pregnancy|4|||
160845960|NCT03078556|580822958|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
161254001|NCT03023137|582308598|FG000|Overall Study|Lost to Follow-up|1|||
161254002|NCT03023137|582308599|FG001|Overall Study|Lost to Follow-up|1|||
161254003|NCT03023137|582308598|FG000|Overall Study|Protocol Violation|0|||
161254004|NCT03023137|582308599|FG001|Overall Study|Protocol Violation|4|||
161254005|NCT03023137|582308598|FG000|Overall Study|Lost the baby in a car accident|1|||
161254006|NCT03023137|582308599|FG001|Overall Study|Lost the baby in a car accident|0|||
161254007|NCT00732160|582308605|FG000|Overall Study|Adverse Event|1|||
161254008|NCT00732160|582308606|FG001|Overall Study|Adverse Event|0|||
161254009|NCT00732160|582308607|FG002|Overall Study|Adverse Event|1|||
161254010|NCT00732160|582308608|FG003|Overall Study|Adverse Event|1|||
161254011|NCT00732160|582308605|FG000|Overall Study|scheduling|4|||
161254012|NCT00732160|582308606|FG001|Overall Study|scheduling|4|||
161254013|NCT00732160|582308607|FG002|Overall Study|scheduling|2|||
161254014|NCT00732160|582308608|FG003|Overall Study|scheduling|1|||
161254015|NCT02795676|582308611|FG000|Overall Study|Adverse Event|2|||
161254016|NCT02795676|582308612|FG001|Overall Study|Adverse Event|0|||
161254017|NCT02795676|582308611|FG000|Overall Study|Withdrawal by Subject|3|||
161254018|NCT02795676|582308612|FG001|Overall Study|Withdrawal by Subject|1|||
161254019|NCT01115933|582308615|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
161254020|NCT02427399|582308616|FG000|Overall Study|Protocol Violation|14|||
161254021|NCT02427399|582308617|FG001|Overall Study|Protocol Violation|16|||
161254022|NCT02427399|582308618|FG002|Overall Study|Protocol Violation|12|||
161254023|NCT02427399|582308619|FG003|Overall Study|Protocol Violation|18|||
161254024|NCT02427399|582308620|FG004|Overall Study|Protocol Violation|15|||
161254025|NCT00605176|582308623|FG000|Overall Study|Adverse Event|2|||
161254026|NCT00605176|582308624|FG001|Overall Study|Adverse Event|1|||
161254027|NCT00605176|582308625|FG002|Overall Study|Adverse Event|3|||
161254028|NCT00605176|582308623|FG000|Overall Study|Withdrawal by Subject|4|||
161254029|NCT00605176|582308624|FG001|Overall Study|Withdrawal by Subject|2|||
161254030|NCT00605176|582308625|FG002|Overall Study|Withdrawal by Subject|4|||
161254031|NCT00605176|582308623|FG000|Overall Study|Lost to Follow-up|2|||
161254032|NCT00605176|582308624|FG001|Overall Study|Lost to Follow-up|2|||
161254033|NCT00605176|582308625|FG002|Overall Study|Lost to Follow-up|1|||
161254034|NCT00605176|582308623|FG000|Overall Study|Non-complicance with study procedures|1|||
161254035|NCT00605176|582308624|FG001|Overall Study|Non-complicance with study procedures|0|||
161254036|NCT00605176|582308625|FG002|Overall Study|Non-complicance with study procedures|0|||
161254037|NCT00605176|582308623|FG000|Overall Study|Use of concomitant therapy|1|||
161254038|NCT00605176|582308624|FG001|Overall Study|Use of concomitant therapy|0|||
161254039|NCT00605176|582308625|FG002|Overall Study|Use of concomitant therapy|1|||
161254040|NCT00605176|582308623|FG000|Overall Study|Other (not due to AE)|1|||
161254041|NCT00605176|582308624|FG001|Overall Study|Other (not due to AE)|1|||
161254042|NCT00605176|582308625|FG002|Overall Study|Other (not due to AE)|0|||
161254043|NCT01086969|582308626|FG000|Overall Study|Withdrawal by Subject|1|||
161254044|NCT01086969|582308627|FG001|Overall Study|Withdrawal by Subject|2|||
161254045|NCT01086969|582308628|FG002|Overall Study|Withdrawal by Subject|0|||
161254046|NCT01609582|582308633|FG000|Overall Study|Adverse Event|20|||
161254047|NCT01609582|582308634|FG001|Overall Study|Adverse Event|18|||
161254048|NCT01609582|582308633|FG000|Overall Study|Lost to Follow-up|10|||
161254049|NCT01609582|582308634|FG001|Overall Study|Lost to Follow-up|10|||
161254050|NCT01609582|582308633|FG000|Overall Study|Withdrawal by Subject|21|||
161254051|NCT01609582|582308634|FG001|Overall Study|Withdrawal by Subject|15|||
161254052|NCT01609582|582308633|FG000|Overall Study|Study Terminated by Sponsor|1543|||
161254053|NCT01609582|582308634|FG001|Overall Study|Study Terminated by Sponsor|1548|||
160845961|NCT03078556|580822959|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
160845962|NCT03078556|580822960|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
160845963|NCT03078556|580822957|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
160845964|NCT03078556|580822958|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
160845965|NCT03078556|580822959|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
160845966|NCT03078556|580822960|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
160845967|NCT03078556|580822957|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
160845968|NCT03078556|580822958|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
161140950|NCT01122927|581899230|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
161140951|NCT01122927|581899229|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
161254054|NCT01609582|582308633|FG000|Overall Study|Other|9|||
161254055|NCT01609582|582308634|FG001|Overall Study|Other|10|||
161254056|NCT01609582|582308633|FG000|Overall Study|Randomized, but not treated|0|||
161254057|NCT01609582|582308634|FG001|Overall Study|Randomized, but not treated|3|||
161254058|NCT00819767|582308635|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161254059|NCT00819767|582308636|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161254060|NCT00685750|582308637|FG000|Overall Study|Tumor sampling failure|0|||
161254061|NCT00685750|582308638|FG001|Overall Study|Tumor sampling failure|0|||
161254062|NCT00685750|582308639|FG002|Overall Study|Tumor sampling failure|1|||
161254063|NCT00685750|582308640|FG003|Overall Study|Tumor sampling failure|0|||
161254064|NCT00685750|582308641|FG004|Overall Study|Tumor sampling failure|0|||
161254065|NCT00685750|582308642|FG005|Overall Study|Tumor sampling failure|0|||
161254066|NCT00685750|582308643|FG006|Overall Study|Tumor sampling failure|0|||
160845969|NCT03078556|580822959|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
160845970|NCT03078556|580822960|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
160845971|NCT00832416|580822967|FG000|Overall Study|Lack of Efficacy|17|||
160845972|NCT00832416|580822968|FG001|Overall Study|Lack of Efficacy|15|||
160845973|NCT00832416|580822969|FG002|Overall Study|Lack of Efficacy|13|||
160845974|NCT00832416|580822970|FG003|Overall Study|Lack of Efficacy|52|||
160845975|NCT00832416|580822967|FG000|Overall Study|Withdrawal by Subject|5|||
160845976|NCT00832416|580822968|FG001|Overall Study|Withdrawal by Subject|7|||
160845977|NCT00832416|580822969|FG002|Overall Study|Withdrawal by Subject|2|||
160845978|NCT00832416|580822970|FG003|Overall Study|Withdrawal by Subject|10|||
160845979|NCT00832416|580822967|FG000|Overall Study|Physician Decision|2|||
160845980|NCT00832416|580822968|FG001|Overall Study|Physician Decision|12|||
160845981|NCT00832416|580822969|FG002|Overall Study|Physician Decision|5|||
160845982|NCT00832416|580822970|FG003|Overall Study|Physician Decision|10|||
160845983|NCT00832416|580822967|FG000|Overall Study|Administrative|0|||
160845984|NCT00832416|580822968|FG001|Overall Study|Administrative|0|||
160845985|NCT00832416|580822969|FG002|Overall Study|Administrative|0|||
160845986|NCT00832416|580822970|FG003|Overall Study|Administrative|1|||
160845987|NCT00832416|580822967|FG000|Overall Study|Adverse Event|21|||
160845988|NCT00832416|580822968|FG001|Overall Study|Adverse Event|19|||
160845989|NCT00832416|580822969|FG002|Overall Study|Adverse Event|41|||
160845990|NCT00832416|580822970|FG003|Overall Study|Adverse Event|10|||
160845991|NCT00832416|580822967|FG000|Overall Study|Death|1|||
160845992|NCT00832416|580822968|FG001|Overall Study|Death|0|||
160845993|NCT00832416|580822969|FG002|Overall Study|Death|0|||
160845994|NCT00832416|580822970|FG003|Overall Study|Death|0|||
160845995|NCT04421482|580822977|FG000|Overall Study|Physician Decision|1|||
160845996|NCT00571038|580822980|FG000|Overall Study|Lost to Follow-up|1|||
160845997|NCT00571038|580822981|FG001|Overall Study|Lost to Follow-up|4|||
160845998|NCT00571038|580822980|FG000|Overall Study|Death|7|||
160845999|NCT00571038|580822981|FG001|Overall Study|Death|5|||
160846000|NCT00571038|580822980|FG000|Overall Study|Withdrawal by Subject|1|||
160846001|NCT00571038|580822981|FG001|Overall Study|Withdrawal by Subject|3|||
160906096|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Change of location|0|||
160906097|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Change of location|0|||
161254067|NCT00685750|582308637|FG000|Overall Study|Patient didn't receive the treatment|0|||
161254068|NCT00685750|582308638|FG001|Overall Study|Patient didn't receive the treatment|0|||
161254069|NCT00685750|582308639|FG002|Overall Study|Patient didn't receive the treatment|0|||
161254070|NCT00685750|582308640|FG003|Overall Study|Patient didn't receive the treatment|0|||
161254071|NCT00685750|582308641|FG004|Overall Study|Patient didn't receive the treatment|0|||
161254072|NCT00685750|582308642|FG005|Overall Study|Patient didn't receive the treatment|0|||
161254073|NCT00685750|582308643|FG006|Overall Study|Patient didn't receive the treatment|1|||
161254074|NCT00685750|582308637|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161254075|NCT00685750|582308638|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161254076|NCT00685750|582308639|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161254077|NCT00685750|582308640|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
161254078|NCT00685750|582308641|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
161254079|NCT00685750|582308642|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
161254080|NCT00685750|582308643|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
160906098|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Change of location|0|||
161254081|NCT00129116|582308646|FG000|Primary Phase|Lost to Follow-up|1|||
161254082|NCT00129116|582308647|FG001|Primary Phase|Lost to Follow-up|1|||
161254083|NCT00129116|582308648|FG002|Primary Phase|Lost to Follow-up|0|||
161254084|NCT00129116|582308649|FG003|Primary Phase|Lost to Follow-up|1|||
161254085|NCT00129116|582308650|FG004|Primary Phase|Lost to Follow-up|1|||
161254086|NCT00129116|582308646|FG000|Primary Phase|Protocol Violation|0|||
161254087|NCT00129116|582308647|FG001|Primary Phase|Protocol Violation|1|||
161254088|NCT00129116|582308648|FG002|Primary Phase|Protocol Violation|0|||
161254089|NCT00129116|582308649|FG003|Primary Phase|Protocol Violation|0|||
161254090|NCT00129116|582308650|FG004|Primary Phase|Protocol Violation|0|||
161254091|NCT00129116|582308646|FG000|Primary Phase|Adverse Event|1|||
161254092|NCT00129116|582308647|FG001|Primary Phase|Adverse Event|1|||
161254093|NCT00129116|582308648|FG002|Primary Phase|Adverse Event|0|||
161254094|NCT00129116|582308649|FG003|Primary Phase|Adverse Event|0|||
161254095|NCT00129116|582308650|FG004|Primary Phase|Adverse Event|0|||
161254096|NCT00129116|582308646|FG000|Primary Phase|Withdrawal by Subject|0|||
161254097|NCT00129116|582308647|FG001|Primary Phase|Withdrawal by Subject|1|||
161254098|NCT00129116|582308648|FG002|Primary Phase|Withdrawal by Subject|0|||
161254099|NCT00129116|582308649|FG003|Primary Phase|Withdrawal by Subject|0|||
161254100|NCT00129116|582308650|FG004|Primary Phase|Withdrawal by Subject|0|||
161254101|NCT00129116|582308646|FG000|Primary Phase|Other|0|||
161254102|NCT00129116|582308647|FG001|Primary Phase|Other|0|||
161254103|NCT00129116|582308648|FG002|Primary Phase|Other|1|||
161254104|NCT00129116|582308649|FG003|Primary Phase|Other|0|||
161254105|NCT00129116|582308650|FG004|Primary Phase|Other|0|||
161254106|NCT00129116|582308646|FG000|Booster Phase|Lost to Follow-up|2|||
161254107|NCT00129116|582308647|FG001|Booster Phase|Lost to Follow-up|0|||
161254108|NCT00129116|582308648|FG002|Booster Phase|Lost to Follow-up|0|||
160846002|NCT00571038|580822980|FG000|Overall Study|Moved out of state|2|||
160846003|NCT00571038|580822981|FG001|Overall Study|Moved out of state|2|||
160846004|NCT05786508|580822982|FG000|Overall Study|Withdrawal by Subject|2|||
160846005|NCT05786508|580822983|FG001|Overall Study|Withdrawal by Subject|0|||
160846006|NCT02588261|580822986|FG000|Overall Study|Study Terminated by Sponsor|157|||
160846007|NCT02588261|580822987|FG001|Overall Study|Study Terminated by Sponsor|142|||
160846008|NCT02588261|580822986|FG000|Overall Study|Protocol Deviation|1|||
160846009|NCT02588261|580822987|FG001|Overall Study|Protocol Deviation|0|||
160846010|NCT02588261|580822986|FG000|Overall Study|Death|1|||
160846011|NCT02588261|580822987|FG001|Overall Study|Death|2|||
160846012|NCT02588261|580822986|FG000|Overall Study|Withdrawal by Subject|12|||
160846013|NCT02588261|580822987|FG001|Overall Study|Withdrawal by Subject|8|||
160846014|NCT02588261|580822986|FG000|Overall Study|Noncompliance with Study Drug|0|||
160846015|NCT02588261|580822987|FG001|Overall Study|Noncompliance with Study Drug|1|||
160846016|NCT02588261|580822986|FG000|Overall Study|Miscellaneous|5|||
160846017|NCT02588261|580822987|FG001|Overall Study|Miscellaneous|4|||
160846018|NCT02588261|580822986|FG000|Overall Study|Progressive Disease|61|||
160846019|NCT02588261|580822987|FG001|Overall Study|Progressive Disease|82|||
160846020|NCT02588261|580822986|FG000|Overall Study|Adverse Event|29|||
160846021|NCT02588261|580822987|FG001|Overall Study|Adverse Event|24|||
160846022|NCT02588261|580822986|FG000|Overall Study|Lost to Follow-up|1|||
160846023|NCT02588261|580822987|FG001|Overall Study|Lost to Follow-up|0|||
160846024|NCT02652156|580822988|FG000|Overall Study|Physician Decision|1|||
160846025|NCT02652156|580822989|FG001|Overall Study|Physician Decision|0|||
160846026|NCT02652156|580822990|FG002|Overall Study|Physician Decision|0|||
160846027|NCT03329846|580822991|FG000|Overall Study|Disease progression|4|||
160846028|NCT03329846|580822992|FG001|Overall Study|Disease progression|6|||
160846029|NCT03329846|580822991|FG000|Overall Study|Study drug toxicity|1|||
160846030|NCT03329846|580822992|FG001|Overall Study|Study drug toxicity|0|||
160846031|NCT03329846|580822991|FG000|Overall Study|Participant request to discontinue treatment|0|||
160846032|NCT03329846|580822992|FG001|Overall Study|Participant request to discontinue treatment|1|||
161254109|NCT00129116|582308649|FG003|Booster Phase|Lost to Follow-up|0|||
161254110|NCT00129116|582308650|FG004|Booster Phase|Lost to Follow-up|1|||
161254111|NCT02539368|582308651|FG000|Overall Study|Death|4|||
161254112|NCT02539368|582308652|FG001|Overall Study|Death|2|||
161254113|NCT02539368|582308653|FG002|Overall Study|Death|1|||
161254114|NCT02539368|582308654|FG003|Overall Study|Death|0|||
161254115|NCT02539368|582308655|FG004|Overall Study|Death|0|||
161254116|NCT02539368|582308651|FG000|Overall Study|Withdrawal by Subject|44|||
161254117|NCT02539368|582308652|FG001|Overall Study|Withdrawal by Subject|35|||
161254118|NCT02539368|582308653|FG002|Overall Study|Withdrawal by Subject|9|||
161254119|NCT02539368|582308654|FG003|Overall Study|Withdrawal by Subject|1|||
161254120|NCT02539368|582308655|FG004|Overall Study|Withdrawal by Subject|3|||
161254121|NCT02539368|582308651|FG000|Overall Study|Physician Decision|49|||
161254122|NCT02539368|582308652|FG001|Overall Study|Physician Decision|15|||
161254123|NCT02539368|582308653|FG002|Overall Study|Physician Decision|7|||
161254124|NCT02539368|582308654|FG003|Overall Study|Physician Decision|0|||
161254125|NCT02539368|582308655|FG004|Overall Study|Physician Decision|2|||
161254126|NCT02539368|582308651|FG000|Overall Study|Lost to Follow-up|96|||
161254127|NCT02539368|582308652|FG001|Overall Study|Lost to Follow-up|21|||
161254128|NCT02539368|582308653|FG002|Overall Study|Lost to Follow-up|16|||
161254129|NCT02539368|582308654|FG003|Overall Study|Lost to Follow-up|4|||
161336741|NCT00784875|582623604|FG003|Period A - Baseline|Protocol Violation|25|||
160846033|NCT03329846|580822991|FG000|Overall Study|Participant withdrew consent|1|||
161254130|NCT02539368|582308655|FG004|Overall Study|Lost to Follow-up|3|||
161254131|NCT02539368|582308651|FG000|Overall Study|Adverse Event|44|||
161254132|NCT02539368|582308652|FG001|Overall Study|Adverse Event|5|||
161254133|NCT02539368|582308653|FG002|Overall Study|Adverse Event|9|||
161254134|NCT02539368|582308654|FG003|Overall Study|Adverse Event|0|||
160846034|NCT03329846|580822992|FG001|Overall Study|Participant withdrew consent|0|||
160846035|NCT03329846|580822991|FG000|Overall Study|Other reasons|2|||
161254135|NCT02539368|582308655|FG004|Overall Study|Adverse Event|3|||
160846036|NCT03329846|580822992|FG001|Overall Study|Other reasons|2|||
160846037|NCT03066193|580822993|FG000|Overall Study|Withdrawal by Subject|1|||
160846038|NCT04034004|580822997|FG000|Overall Study|Withdrawal by Subject|1|||
160846039|NCT04034004|580822998|FG001|Overall Study|Withdrawal by Subject|2|||
160846040|NCT04034004|580822999|FG002|Overall Study|Withdrawal by Subject|2|||
160846041|NCT04034004|580823000|FG003|Overall Study|Withdrawal by Subject|3|||
161254136|NCT02539368|582308651|FG000|Overall Study|Participant Non-compliant|13|||
160846042|NCT04034004|580822997|FG000|Overall Study|could not find vein to administer IV|2|||
160846043|NCT04034004|580822998|FG001|Overall Study|could not find vein to administer IV|1|||
160846044|NCT04034004|580822999|FG002|Overall Study|could not find vein to administer IV|0|||
161254137|NCT02539368|582308652|FG001|Overall Study|Participant Non-compliant|2|||
161254138|NCT02539368|582308653|FG002|Overall Study|Participant Non-compliant|1|||
161254139|NCT02539368|582308654|FG003|Overall Study|Participant Non-compliant|1|||
161254140|NCT02539368|582308655|FG004|Overall Study|Participant Non-compliant|0|||
161254141|NCT02539368|582308651|FG000|Overall Study|Other|145|||
161254142|NCT02539368|582308652|FG001|Overall Study|Other|18|||
160846045|NCT04034004|580823000|FG003|Overall Study|could not find vein to administer IV|0|||
160846046|NCT04034004|580822997|FG000|Overall Study|nurse accidentally unblinded subject|0|||
160846047|NCT04034004|580822998|FG001|Overall Study|nurse accidentally unblinded subject|0|||
160846048|NCT04034004|580822999|FG002|Overall Study|nurse accidentally unblinded subject|0|||
160846049|NCT04034004|580823000|FG003|Overall Study|nurse accidentally unblinded subject|1|||
160846050|NCT01397461|580823001|FG000|Overall Study|Withdrawal by Subject|2|||
160846051|NCT01397461|580823002|FG001|Overall Study|Withdrawal by Subject|1|||
160846052|NCT01397461|580823003|FG002|Overall Study|Withdrawal by Subject|0|||
160846053|NCT01397461|580823001|FG000|Overall Study|Lost to Follow-up|0|||
160846054|NCT01397461|580823002|FG001|Overall Study|Lost to Follow-up|2|||
160846055|NCT01397461|580823003|FG002|Overall Study|Lost to Follow-up|1|||
160846056|NCT01397461|580823001|FG000|Overall Study|Lack of Efficacy|0|||
160846057|NCT01397461|580823002|FG001|Overall Study|Lack of Efficacy|3|||
160846058|NCT01397461|580823003|FG002|Overall Study|Lack of Efficacy|0|||
160846059|NCT01397461|580823001|FG000|Overall Study|Not treated|0|||
160846060|NCT01397461|580823002|FG001|Overall Study|Not treated|0|||
160846061|NCT01397461|580823003|FG002|Overall Study|Not treated|1|||
160846062|NCT03364738|580823024|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
160846063|NCT03364738|580823024|FG000|Overall Study|Withdrawal by Subject|1|||
160846064|NCT03364738|580823024|FG000|Overall Study|Adverse Event|1|||
161254143|NCT02539368|582308653|FG002|Overall Study|Other|24|||
161254144|NCT02539368|582308654|FG003|Overall Study|Other|1|||
161254145|NCT02539368|582308655|FG004|Overall Study|Other|3|||
161254146|NCT02539368|582308651|FG000|Overall Study|Missing|10|||
161254147|NCT02539368|582308652|FG001|Overall Study|Missing|3|||
161254148|NCT02539368|582308653|FG002|Overall Study|Missing|0|||
161254149|NCT02539368|582308654|FG003|Overall Study|Missing|0|||
161254150|NCT02539368|582308655|FG004|Overall Study|Missing|0|||
161254151|NCT00251316|582308658|FG000|Overall Study|Physician Decision|2|||
160846065|NCT03245398|580823025|FG000|Overall Study|Travelled to another island|1|||
161254152|NCT00251316|582308659|FG001|Overall Study|Physician Decision|3|||
161254153|NCT00398073|582308660|FG000|Overall Study|Withdrawal by Subject|1|||
161254154|NCT00398073|582308661|FG001|Overall Study|Withdrawal by Subject|0|||
161254155|NCT00708682|582308662|FG000|Infant Series|Adverse Event|1|||
161254156|NCT00708682|582308662|FG000|Infant Series|Lost to Follow-up|4|||
161254157|NCT00708682|582308662|FG000|Infant Series|Protocol Violation|1|||
161254158|NCT00708682|582308662|FG000|Infant Series|Parent/legal guardian request|6|||
161254159|NCT00708682|582308662|FG000|Infant Series|Failed to return|2|||
161254160|NCT00708682|582308662|FG000|Infant Series|Other|19|||
161254161|NCT00708682|582308662|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
161254162|NCT00708682|582308662|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
161254163|NCT00708682|582308662|FG000|Toddler Dose|Lost to Follow-up|3|||
161254164|NCT00708682|582308662|FG000|Toddler Dose|Failed to Return|4|||
161254165|NCT00569777|582308665|FG000|Overall Study|Withdrawal by Subject|4|||
161254166|NCT00569777|582308666|FG001|Overall Study|Withdrawal by Subject|0|||
161254167|NCT00569777|582308665|FG000|Overall Study|Adverse Event|3|||
161254168|NCT00569777|582308666|FG001|Overall Study|Adverse Event|0|||
161254169|NCT00569777|582308665|FG000|Overall Study|Lost to Follow-up|1|||
161254170|NCT00569777|582308666|FG001|Overall Study|Lost to Follow-up|0|||
161254171|NCT00569777|582308665|FG000|Overall Study|scheduled eye surgery|0|||
161254172|NCT00569777|582308666|FG001|Overall Study|scheduled eye surgery|1|||
161336742|NCT00784875|582623601|FG000|Period A - Baseline|Withdrawal by Subject|0|||
161336743|NCT00784875|582623602|FG001|Period A - Baseline|Withdrawal by Subject|0|||
161336744|NCT00784875|582623603|FG002|Period A - Baseline|Withdrawal by Subject|0|||
161336745|NCT00784875|582623604|FG003|Period A - Baseline|Withdrawal by Subject|27|||
161336746|NCT00784875|582623601|FG000|Period A - Baseline|Physician Decision|0|||
161254173|NCT00569777|582308665|FG000|Overall Study|did not meet exclusion criteria|1|||
160846066|NCT03245398|580823026|FG001|Overall Study|Travelled to another island|0|||
160846067|NCT02735343|580823028|FG000|Overall Study|screen fail|0|||
160846068|NCT02735343|580823029|FG001|Overall Study|screen fail|2|||
160846069|NCT04531241|580823039|FG000|Period 1|Withdrawal by Subject|2|||
160846070|NCT04531241|580823040|FG001|Period 1|Withdrawal by Subject|0|||
160906099|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Change of location|1|||
160906100|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Change of location|0|||
160906101|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
160906102|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
160906103|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
160906104|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
160906105|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
160906106|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
161254174|NCT00569777|582308666|FG001|Overall Study|did not meet exclusion criteria|2|||
161254175|NCT00569777|582308665|FG000|Overall Study|pregnant|1|||
161254176|NCT00569777|582308666|FG001|Overall Study|pregnant|0|||
161254177|NCT02056652|582308667|FG000|Overall Study|Withdrawal by Subject|1|||
161254178|NCT02056652|582308668|FG001|Overall Study|Withdrawal by Subject|0|||
161254179|NCT02056652|582308667|FG000|Overall Study|Lost to Follow-up|0|||
161254180|NCT02056652|582308668|FG001|Overall Study|Lost to Follow-up|3|||
161254181|NCT00239005|582308673|FG000|Overall Study|Adverse Event|6|||
161254182|NCT00239005|582308674|FG001|Overall Study|Adverse Event|6|||
160846071|NCT04531241|580823039|FG000|Period 1|Dispesed incorrect lens power|1|||
160846072|NCT04531241|580823040|FG001|Period 1|Dispesed incorrect lens power|0|||
160846073|NCT04531241|580823039|FG000|Period 1|Protocol Violation|1|||
160846074|NCT04531241|580823040|FG001|Period 1|Protocol Violation|0|||
160846075|NCT04531241|580823039|FG000|Period 1|No longer eligible|0|||
160846076|NCT04531241|580823040|FG001|Period 1|No longer eligible|1|||
160846077|NCT04531241|580823039|FG000|Period 1|Lens Discomfort|0|||
161254183|NCT00239005|582308673|FG000|Overall Study|Withdrawal by Subject|3|||
161254184|NCT00239005|582308674|FG001|Overall Study|Withdrawal by Subject|4|||
161254185|NCT00239005|582308673|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
161254186|NCT00239005|582308674|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
161254187|NCT00239005|582308673|FG000|Overall Study|Protocol Violation|1|||
161254188|NCT00239005|582308674|FG001|Overall Study|Protocol Violation|0|||
161254189|NCT00239005|582308673|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
161254190|NCT00239005|582308674|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
161254191|NCT00239005|582308673|FG000|Overall Study|Lost to Follow-up|0|||
161254192|NCT00239005|582308674|FG001|Overall Study|Lost to Follow-up|1|||
161254193|NCT00987831|582308676|FG000|Overall Study|Never flared in 12 months|1|||
161254194|NCT00987831|582308677|FG001|Overall Study|Never flared in 12 months|0|||
161254195|NCT00987831|582308678|FG002|Overall Study|Never flared in 12 months|0|||
161254196|NCT00987831|582308676|FG000|Overall Study|Lost to Follow-up|0|||
161254197|NCT00987831|582308677|FG001|Overall Study|Lost to Follow-up|3|||
161254198|NCT00987831|582308678|FG002|Overall Study|Lost to Follow-up|0|||
161254199|NCT03253094|582308679|FG000|Overall Study|Adverse Event|2|||
161254200|NCT03253094|582308680|FG001|Overall Study|Adverse Event|0|||
161254201|NCT03253094|582308681|FG002|Overall Study|Adverse Event|0|||
161254202|NCT03253094|582308682|FG003|Overall Study|Adverse Event|0|||
161254203|NCT03253094|582308683|FG004|Overall Study|Adverse Event|0|||
161254204|NCT03253094|582308684|FG005|Overall Study|Adverse Event|0|||
161254205|NCT03253094|582308679|FG000|Overall Study|Lack of Efficacy|0|||
161254206|NCT03253094|582308680|FG001|Overall Study|Lack of Efficacy|0|||
161254207|NCT03253094|582308681|FG002|Overall Study|Lack of Efficacy|2|||
161254208|NCT03253094|582308682|FG003|Overall Study|Lack of Efficacy|1|||
161254209|NCT03253094|582308683|FG004|Overall Study|Lack of Efficacy|2|||
161254210|NCT03253094|582308684|FG005|Overall Study|Lack of Efficacy|1|||
161254211|NCT03253094|582308679|FG000|Overall Study|Lost to Follow-up|0|||
161254212|NCT03253094|582308680|FG001|Overall Study|Lost to Follow-up|0|||
161254213|NCT03253094|582308681|FG002|Overall Study|Lost to Follow-up|1|||
161254214|NCT03253094|582308682|FG003|Overall Study|Lost to Follow-up|1|||
161254215|NCT03253094|582308683|FG004|Overall Study|Lost to Follow-up|0|||
161254216|NCT03253094|582308684|FG005|Overall Study|Lost to Follow-up|1|||
161254217|NCT03253094|582308679|FG000|Overall Study|Physician Decision|1|||
161254218|NCT03253094|582308680|FG001|Overall Study|Physician Decision|0|||
161254219|NCT03253094|582308681|FG002|Overall Study|Physician Decision|0|||
160846078|NCT04531241|580823040|FG001|Period 1|Lens Discomfort|1|||
160846079|NCT04531241|580823039|FG000|Period 2|Covid-19 Related|1|||
160846080|NCT04531241|580823040|FG001|Period 2|Covid-19 Related|1|||
160846081|NCT03983304|580823041|FG000|Overall Study|Withdrawal by Subject|5|||
160846082|NCT03983304|580823041|FG000|Overall Study|Lost to Follow-up|2|||
160846083|NCT01702246|580823042|FG000|Overall Study|Lost to Follow-up|2|||
160846084|NCT01702246|580823042|FG000|Overall Study|Withdrawal by Subject|2|||
160846085|NCT01702246|580823042|FG000|Overall Study|Physician Decision|1|||
160846086|NCT01518374|580823045|FG000|Overall Study|Withdrawal by Subject|2|||
160846087|NCT01518374|580823045|FG000|Overall Study|Protocol Violation|3|||
160846088|NCT01518374|580823045|FG000|Overall Study|Lost to Follow-up|2|||
160846089|NCT04607837|580823046|FG000|Overall Study|Adverse Event|8|||
160846090|NCT04607837|580823047|FG001|Overall Study|Adverse Event|2|||
160846091|NCT04607837|580823046|FG000|Overall Study|Withdrawal by Subject|8|||
160846092|NCT04607837|580823047|FG001|Overall Study|Withdrawal by Subject|7|||
160846093|NCT04607837|580823046|FG000|Overall Study|Physician Decision|2|||
160846094|NCT04607837|580823047|FG001|Overall Study|Physician Decision|0|||
161254220|NCT03253094|582308682|FG003|Overall Study|Physician Decision|1|||
161254221|NCT03253094|582308683|FG004|Overall Study|Physician Decision|0|||
161254222|NCT03253094|582308684|FG005|Overall Study|Physician Decision|2|||
161254223|NCT03253094|582308679|FG000|Overall Study|Withdrawal by Subject|1|||
160846095|NCT04607837|580823046|FG000|Overall Study|Lack of Efficacy|2|||
160846096|NCT04607837|580823047|FG001|Overall Study|Lack of Efficacy|0|||
160992404|NCT00661778|581361346|FG000|Overall Study|Disease Progression|23|||
161254224|NCT03253094|582308680|FG001|Overall Study|Withdrawal by Subject|2|||
161254225|NCT03253094|582308681|FG002|Overall Study|Withdrawal by Subject|1|||
161254226|NCT03253094|582308682|FG003|Overall Study|Withdrawal by Subject|0|||
161254227|NCT03253094|582308683|FG004|Overall Study|Withdrawal by Subject|3|||
161254228|NCT03253094|582308684|FG005|Overall Study|Withdrawal by Subject|0|||
160846097|NCT04607837|580823046|FG000|Overall Study|Participant terminated by sponsor|1|||
161254229|NCT03253094|582308679|FG000|Overall Study|Other|0|||
161254230|NCT03253094|582308680|FG001|Overall Study|Other|1|||
161254231|NCT03253094|582308681|FG002|Overall Study|Other|2|||
160846098|NCT04607837|580823047|FG001|Overall Study|Participant terminated by sponsor|0|||
160846099|NCT04607837|580823046|FG000|Overall Study|Disease worsening|36|||
160846100|NCT04607837|580823047|FG001|Overall Study|Disease worsening|36|||
160846101|NCT04607837|580823046|FG000|Overall Study|Other|1|||
160846102|NCT04607837|580823047|FG001|Overall Study|Other|0|||
160846103|NCT02023996|580823057|FG000|Overall Study|Protocol Violation|6|||
160846104|NCT00465452|580823058|FG000|Overall Study|Adverse Event|1|||
160846105|NCT04209205|580823062|FG000|Overall Study|Adverse Event|2|||
161254232|NCT03253094|582308682|FG003|Overall Study|Other|1|||
161254233|NCT03253094|582308683|FG004|Overall Study|Other|0|||
161254234|NCT03253094|582308684|FG005|Overall Study|Other|0|||
161254235|NCT00824369|582308685|FG000|Overall Study|Nolonger willing to participate in study|1|||
161254236|NCT00824369|582308686|FG001|Overall Study|Nolonger willing to participate in study|0|||
161254237|NCT00824369|582308687|FG002|Overall Study|Nolonger willing to participate in study|1|||
161254238|NCT00824369|582308688|FG003|Overall Study|Nolonger willing to participate in study|2|||
161254239|NCT00824369|582308689|FG004|Overall Study|Nolonger willing to participate in study|0|||
161254240|NCT00824369|582308690|FG005|Overall Study|Nolonger willing to participate in study|1|||
161254241|NCT00824369|582308685|FG000|Overall Study|Lost to Follow-up|0|||
161254242|NCT00824369|582308686|FG001|Overall Study|Lost to Follow-up|0|||
161254243|NCT00824369|582308687|FG002|Overall Study|Lost to Follow-up|0|||
161254244|NCT00824369|582308688|FG003|Overall Study|Lost to Follow-up|0|||
161254245|NCT00824369|582308689|FG004|Overall Study|Lost to Follow-up|1|||
161254246|NCT00824369|582308690|FG005|Overall Study|Lost to Follow-up|0|||
161254247|NCT02413294|582308691|FG000|Overall Study|Withdrawal by Subject|1|||
161254248|NCT02625974|582308692|FG000|Part 1|Lost to Follow-up|9|||
161254249|NCT02625974|582308693|FG001|Part 1|Lost to Follow-up|3|||
161254250|NCT02625974|582308692|FG000|Part 2|Lost to Follow-up|4|||
161254251|NCT02625974|582308693|FG001|Part 2|Lost to Follow-up|6|||
161254252|NCT02625974|582308692|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
161254253|NCT02625974|582308693|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
161254254|NCT01923311|582309916|FG000|Overall Study|Pregnancy|1|||
161254255|NCT01923311|582309917|FG001|Overall Study|Pregnancy|0|||
161254256|NCT01923311|582309916|FG000|Overall Study|Investigator's Discretion|1|||
161254257|NCT01923311|582309917|FG001|Overall Study|Investigator's Discretion|0|||
161254258|NCT01923311|582309916|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161254259|NCT01923311|582309917|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161254260|NCT01923311|582309916|FG000|Overall Study|Withdrew Consent|1|||
161254261|NCT01923311|582309917|FG001|Overall Study|Withdrew Consent|0|||
161254262|NCT01923311|582309916|FG000|Overall Study|Study Terminated by Sponsor|12|||
161254263|NCT01923311|582309917|FG001|Overall Study|Study Terminated by Sponsor|0|||
161254264|NCT04129944|582309920|FG000|Overall Study|Death|0|||
161254265|NCT04129944|582309921|FG001|Overall Study|Death|0|||
161254266|NCT04129944|582309922|FG002|Overall Study|Death|0|||
161336747|NCT00784875|582623602|FG001|Period A - Baseline|Physician Decision|0|||
161336748|NCT00784875|582623603|FG002|Period A - Baseline|Physician Decision|0|||
161336749|NCT00784875|582623604|FG003|Period A - Baseline|Physician Decision|2|||
160846106|NCT04209205|580823063|FG001|Overall Study|Adverse Event|3|||
160846107|NCT04209205|580823062|FG000|Overall Study|Lost to Follow-up|3|||
160846108|NCT04209205|580823063|FG001|Overall Study|Lost to Follow-up|1|||
160846109|NCT04209205|580823062|FG000|Overall Study|Physician Decision|1|||
160846110|NCT04209205|580823063|FG001|Overall Study|Physician Decision|1|||
160846111|NCT04209205|580823062|FG000|Overall Study|Subject decision|10|||
160846112|NCT04209205|580823063|FG001|Overall Study|Subject decision|10|||
160846113|NCT04209205|580823062|FG000|Overall Study|Progressive disease|1|||
160846114|NCT04209205|580823063|FG001|Overall Study|Progressive disease|0|||
160846115|NCT04209205|580823062|FG000|Overall Study|Protocol deviation|0|||
160846116|NCT04209205|580823063|FG001|Overall Study|Protocol deviation|1|||
160846117|NCT04209205|580823062|FG000|Overall Study|New therapy for study indication|1|||
160846118|NCT04209205|580823063|FG001|Overall Study|New therapy for study indication|0|||
160846119|NCT04209205|580823062|FG000|Overall Study|Adverse event - placebo not switched|0|||
160846120|NCT04209205|580823063|FG001|Overall Study|Adverse event - placebo not switched|1|||
160846121|NCT04209205|580823062|FG000|Overall Study|Subject decision - placebo not switched|0|||
160846122|NCT04209205|580823063|FG001|Overall Study|Subject decision - placebo not switched|5|||
160846123|NCT04209205|580823062|FG000|Overall Study|Death - placebo not switched|0|||
160846124|NCT04209205|580823063|FG001|Overall Study|Death - placebo not switched|1|||
160846125|NCT00999544|580824983|FG000|Overall Study|Withdrawal by Subject|1|||
161254267|NCT04129944|582309923|FG003|Overall Study|Death|1|||
161254268|NCT04129944|582309920|FG000|Overall Study|Lost to Follow-up|1|||
161254269|NCT04129944|582309921|FG001|Overall Study|Lost to Follow-up|0|||
161254270|NCT04129944|582309922|FG002|Overall Study|Lost to Follow-up|0|||
161254271|NCT04129944|582309923|FG003|Overall Study|Lost to Follow-up|0|||
161254272|NCT04129944|582309920|FG000|Overall Study|Withdrawal by Subject|1|||
161254273|NCT04129944|582309921|FG001|Overall Study|Withdrawal by Subject|0|||
161254274|NCT04129944|582309922|FG002|Overall Study|Withdrawal by Subject|1|||
160846126|NCT01392547|580824984|FG000|Overall Study|Adverse Event|2|||
160846127|NCT01392547|580824984|FG000|Overall Study|Non-compliance|2|||
160846128|NCT01392547|580824984|FG000|Overall Study|Withdrawal criteria|3|||
160846129|NCT01392547|580824984|FG000|Overall Study|Unclassified|1|||
160846130|NCT02936635|580824986|FG000|Overall Study|Adverse Event|43|||
160846131|NCT02936635|580824987|FG001|Overall Study|Adverse Event|25|||
160846132|NCT02936635|580824986|FG000|Overall Study|Progressive Disease|10|||
160846133|NCT02936635|580824987|FG001|Overall Study|Progressive Disease|18|||
160846134|NCT02936635|580824986|FG000|Overall Study|Sponsor Discretion|10|||
160846135|NCT02936635|580824987|FG001|Overall Study|Sponsor Discretion|16|||
160846136|NCT02936635|580824986|FG000|Overall Study|Death|9|||
160846137|NCT02936635|580824987|FG001|Overall Study|Death|15|||
160846138|NCT02936635|580824986|FG000|Overall Study|Withdrawal by Subject|8|||
160846139|NCT02936635|580824987|FG001|Overall Study|Withdrawal by Subject|15|||
160846140|NCT02936635|580824986|FG000|Overall Study|Physician Decision|2|||
160846141|NCT02936635|580824987|FG001|Overall Study|Physician Decision|9|||
160846142|NCT02936635|580824986|FG000|Overall Study|Lost to Follow-up|1|||
160846143|NCT02936635|580824987|FG001|Overall Study|Lost to Follow-up|2|||
160846144|NCT02936635|580824986|FG000|Overall Study|Protocol Violation|1|||
160846145|NCT02936635|580824987|FG001|Overall Study|Protocol Violation|0|||
160846146|NCT02936635|580824986|FG000|Overall Study|Lack of effect/Entry into other study|31|||
160846147|NCT02936635|580824987|FG001|Overall Study|Lack of effect/Entry into other study|65|||
160846148|NCT02407223|580824988|FG000|Overall Study|Adverse Event|1|||
160846149|NCT02407223|580824989|FG001|Overall Study|Adverse Event|0|||
160846150|NCT02407223|580824990|FG002|Overall Study|Adverse Event|1|||
160846151|NCT02407223|580824988|FG000|Overall Study|Lack of Efficacy|6|||
160846152|NCT02407223|580824989|FG001|Overall Study|Lack of Efficacy|6|||
160846153|NCT02407223|580824990|FG002|Overall Study|Lack of Efficacy|4|||
160846154|NCT02407223|580824988|FG000|Overall Study|Lost to Follow-up|1|||
160846155|NCT02407223|580824989|FG001|Overall Study|Lost to Follow-up|0|||
160846156|NCT02407223|580824990|FG002|Overall Study|Lost to Follow-up|2|||
160846157|NCT02407223|580824988|FG000|Overall Study|Withdrawal by Subject|2|||
160846158|NCT02407223|580824989|FG001|Overall Study|Withdrawal by Subject|4|||
160846159|NCT02407223|580824990|FG002|Overall Study|Withdrawal by Subject|4|||
160846160|NCT02407223|580824988|FG000|Overall Study|Study Terminated by Sponsor|77|||
160846161|NCT02407223|580824989|FG001|Overall Study|Study Terminated by Sponsor|80|||
160846162|NCT02407223|580824990|FG002|Overall Study|Study Terminated by Sponsor|86|||
160846163|NCT02407223|580824988|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
160846164|NCT02407223|580824989|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
160846165|NCT02407223|580824990|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
160846166|NCT02407223|580824988|FG000|Overall Study|Other|29|||
160846167|NCT02407223|580824989|FG001|Overall Study|Other|27|||
160846168|NCT02407223|580824990|FG002|Overall Study|Other|25|||
160846169|NCT00950846|580824992|FG000|Overall Study|Death|6|||
160846170|NCT00950846|580824992|FG000|Overall Study|Lost to Follow-up|3|||
160846171|NCT00950846|580824992|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
160846172|NCT04426318|580824993|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
160846173|NCT04426318|580824994|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
160846174|NCT04829916|580824995|FG000|Overall Study|Withdrawal by Subject|1|||
160846175|NCT04829916|580824996|FG001|Overall Study|Withdrawal by Subject|0|||
160846176|NCT03781778|580824998|FG000|Overall Study|Withdrawal by Subject|2|||
160846177|NCT03781778|580824999|FG001|Overall Study|Withdrawal by Subject|2|||
160846178|NCT02287467|580825000|FG000|Overall Study|Protocol Violation|12|||
160846179|NCT02287467|580825001|FG001|Overall Study|Protocol Violation|9|||
160846180|NCT01456169|580825003|FG000|Overall Study|Adverse Event|1|||
160846181|NCT01456169|580825004|FG001|Overall Study|Adverse Event|2|||
160846182|NCT01456169|580825005|FG002|Overall Study|Adverse Event|7|||
160846183|NCT01456169|580825003|FG000|Overall Study|Major Protocol Deviation|3|||
160846184|NCT01456169|580825004|FG001|Overall Study|Major Protocol Deviation|2|||
160846185|NCT01456169|580825005|FG002|Overall Study|Major Protocol Deviation|3|||
161140952|NCT01122927|581899230|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161140953|NCT01122927|581899229|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
160846186|NCT01456169|580825003|FG000|Overall Study|Voluntary Withdrawal|3|||
160846187|NCT01456169|580825004|FG001|Overall Study|Voluntary Withdrawal|0|||
160846188|NCT01456169|580825005|FG002|Overall Study|Voluntary Withdrawal|2|||
160846189|NCT01456169|580825003|FG000|Overall Study|Lack of Efficacy|2|||
160846190|NCT01456169|580825004|FG001|Overall Study|Lack of Efficacy|0|||
160846191|NCT01456169|580825005|FG002|Overall Study|Lack of Efficacy|0|||
161336750|NCT00784875|582623601|FG000|Period A - Baseline|Sponsor Decision|0|||
160846192|NCT01456169|580825003|FG000|Overall Study|Other|1|||
161140954|NCT01122927|581899230|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
160846193|NCT01456169|580825004|FG001|Overall Study|Other|1|||
160846194|NCT01456169|580825005|FG002|Overall Study|Other|0|||
160846195|NCT02292446|580825006|FG000|Overall Study|Adverse Event|12|||
160846196|NCT02292446|580825006|FG000|Overall Study|Death|1|||
160846197|NCT02292446|580825006|FG000|Overall Study|Disease progression|2|||
160846198|NCT02292446|580825006|FG000|Overall Study|Subject/guardian decision|2|||
160846199|NCT02292446|580825006|FG000|Overall Study|Withdrawal by Subject|3|||
160846200|NCT00496080|580825011|FG000|Overall Study|Lost to Follow-up|9|||
160846201|NCT00496080|580825011|FG000|Overall Study|Surgical re-intervention|7|||
160846202|NCT00496080|580825011|FG000|Overall Study|Withdrawal by Subject|5|||
160846203|NCT00496080|580825011|FG000|Overall Study|Physician Decision|6|||
160846204|NCT04098809|580825012|FG000|Overall Study|Withdrawal by Subject|1|||
160846205|NCT04098809|580825013|FG001|Overall Study|Withdrawal by Subject|3|||
160846206|NCT04098809|580825012|FG000|Overall Study|Physician Decision|2|||
160846207|NCT04098809|580825013|FG001|Overall Study|Physician Decision|1|||
160846208|NCT00570310|580825018|FG000|Overall Study|Adverse Event|1|||
160846209|NCT00570310|580825019|FG001|Overall Study|Adverse Event|2|||
160846210|NCT00570310|580825018|FG000|Overall Study|Lack of Efficacy|1|||
160846211|NCT00570310|580825019|FG001|Overall Study|Lack of Efficacy|4|||
160846212|NCT02741596|580825022|FG000|Overall Study|Adverse Event|1|||
160846213|NCT02741596|580825023|FG001|Overall Study|Adverse Event|5|||
160846214|NCT02741596|580825022|FG000|Overall Study|Lost to Follow-up|1|||
160846215|NCT02741596|580825023|FG001|Overall Study|Lost to Follow-up|1|||
160846216|NCT02741596|580825022|FG000|Overall Study|Physician Decision|2|||
160846217|NCT02741596|580825023|FG001|Overall Study|Physician Decision|1|||
160846218|NCT02741596|580825022|FG000|Overall Study|Pregnancy|3|||
160846219|NCT02741596|580825023|FG001|Overall Study|Pregnancy|1|||
160846220|NCT02741596|580825022|FG000|Overall Study|Other (Unspecified)|0|||
160846221|NCT02741596|580825023|FG001|Overall Study|Other (Unspecified)|3|||
160846222|NCT02741596|580825022|FG000|Overall Study|Subject withdrawn-Other|17|||
160846223|NCT02741596|580825023|FG001|Overall Study|Subject withdrawn-Other|4|||
160846224|NCT02741596|580825022|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
160846225|NCT02741596|580825023|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
160846226|NCT00479336|580825024|FG000|Overall Study|Adverse Event|1|||
160846227|NCT00479336|580825025|FG001|Overall Study|Adverse Event|1|||
160846228|NCT00479336|580825026|FG002|Overall Study|Adverse Event|1|||
160846229|NCT00479336|580825027|FG003|Overall Study|Adverse Event|3|||
160846230|NCT00479336|580825024|FG000|Overall Study|Lack of Efficacy|1|||
160846231|NCT00479336|580825025|FG001|Overall Study|Lack of Efficacy|0|||
160846232|NCT00479336|580825026|FG002|Overall Study|Lack of Efficacy|0|||
160846233|NCT00479336|580825027|FG003|Overall Study|Lack of Efficacy|0|||
160846234|NCT00479336|580825024|FG000|Overall Study|Protocol Violation|0|||
160846235|NCT00479336|580825025|FG001|Overall Study|Protocol Violation|1|||
160846236|NCT00479336|580825026|FG002|Overall Study|Protocol Violation|0|||
160846237|NCT00479336|580825027|FG003|Overall Study|Protocol Violation|0|||
160846238|NCT00479336|580825024|FG000|Overall Study|Withdrawal by Subject|1|||
160846239|NCT00479336|580825025|FG001|Overall Study|Withdrawal by Subject|2|||
160846240|NCT00479336|580825026|FG002|Overall Study|Withdrawal by Subject|0|||
160846241|NCT00479336|580825027|FG003|Overall Study|Withdrawal by Subject|0|||
160846242|NCT00479336|580825024|FG000|Overall Study|Physician Decision|0|||
160846243|NCT00479336|580825025|FG001|Overall Study|Physician Decision|1|||
160846244|NCT00479336|580825026|FG002|Overall Study|Physician Decision|0|||
160846245|NCT00479336|580825027|FG003|Overall Study|Physician Decision|2|||
160846246|NCT00479336|580825024|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
160846247|NCT00479336|580825025|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
160846248|NCT00479336|580825026|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
160846249|NCT00479336|580825027|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
160846250|NCT02021643|580825028|FG000|Overall Study|Enrolled but Never Treated|1|||
160846251|NCT02021643|580825029|FG001|Overall Study|Enrolled but Never Treated|0|||
160846252|NCT02021643|580825030|FG002|Overall Study|Enrolled but Never Treated|0|||
160846253|NCT02021643|580825031|FG003|Overall Study|Enrolled but Never Treated|0|||
160846254|NCT02021643|580825028|FG000|Overall Study|Adverse Event|0|||
160846255|NCT02021643|580825029|FG001|Overall Study|Adverse Event|1|||
160846256|NCT02021643|580825030|FG002|Overall Study|Adverse Event|0|||
160846257|NCT02021643|580825031|FG003|Overall Study|Adverse Event|0|||
160846258|NCT02021643|580825028|FG000|Overall Study|Death|0|||
160846259|NCT02021643|580825029|FG001|Overall Study|Death|1|||
160846260|NCT02021643|580825030|FG002|Overall Study|Death|0|||
160846261|NCT02021643|580825031|FG003|Overall Study|Death|0|||
160846262|NCT02021643|580825028|FG000|Overall Study|Investigator's Discretion|1|||
160846263|NCT02021643|580825029|FG001|Overall Study|Investigator's Discretion|0|||
160846264|NCT02021643|580825030|FG002|Overall Study|Investigator's Discretion|0|||
160846265|NCT02021643|580825031|FG003|Overall Study|Investigator's Discretion|0|||
160846266|NCT02021643|580825028|FG000|Overall Study|Lack of Efficacy|7|||
160846267|NCT02021643|580825029|FG001|Overall Study|Lack of Efficacy|6|||
160846268|NCT02021643|580825030|FG002|Overall Study|Lack of Efficacy|0|||
160846269|NCT02021643|580825031|FG003|Overall Study|Lack of Efficacy|12|||
160846270|NCT02021643|580825028|FG000|Overall Study|Lost to Follow-up|0|||
160846271|NCT02021643|580825029|FG001|Overall Study|Lost to Follow-up|1|||
160846272|NCT02021643|580825030|FG002|Overall Study|Lost to Follow-up|0|||
160846273|NCT02021643|580825031|FG003|Overall Study|Lost to Follow-up|0|||
160846274|NCT02021643|580825028|FG000|Overall Study|Withdrew Consent|0|||
161140955|NCT01122927|581899229|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
160846275|NCT02021643|580825029|FG001|Overall Study|Withdrew Consent|1|||
160846276|NCT02021643|580825030|FG002|Overall Study|Withdrew Consent|0|||
160846277|NCT02021643|580825031|FG003|Overall Study|Withdrew Consent|0|||
160846278|NCT02631551|580825032|FG000|Overall Study|Adverse Event|1|||
160846279|NCT02631551|580825033|FG001|Overall Study|Adverse Event|2|||
160846280|NCT02631551|580825034|FG002|Overall Study|Adverse Event|4|||
160846281|NCT02631551|580825035|FG003|Overall Study|Adverse Event|0|||
160846282|NCT02631551|580825032|FG000|Overall Study|Lack of Efficacy|0|||
160846283|NCT02631551|580825033|FG001|Overall Study|Lack of Efficacy|0|||
160846284|NCT02631551|580825034|FG002|Overall Study|Lack of Efficacy|1|||
160846285|NCT02631551|580825035|FG003|Overall Study|Lack of Efficacy|0|||
160846286|NCT02631551|580825032|FG000|Overall Study|Lost to Follow-up|1|||
160846287|NCT02631551|580825033|FG001|Overall Study|Lost to Follow-up|2|||
160846288|NCT02631551|580825034|FG002|Overall Study|Lost to Follow-up|0|||
160846289|NCT02631551|580825035|FG003|Overall Study|Lost to Follow-up|3|||
160846290|NCT02631551|580825032|FG000|Overall Study|Withdrawal by Subject|2|||
160846291|NCT02631551|580825033|FG001|Overall Study|Withdrawal by Subject|2|||
160846292|NCT02631551|580825034|FG002|Overall Study|Withdrawal by Subject|0|||
160846293|NCT02631551|580825035|FG003|Overall Study|Withdrawal by Subject|5|||
160846294|NCT02631551|580825032|FG000|Overall Study|Protocol deviation|3|||
160846295|NCT02631551|580825033|FG001|Overall Study|Protocol deviation|6|||
160846296|NCT02631551|580825034|FG002|Overall Study|Protocol deviation|3|||
160846297|NCT02631551|580825035|FG003|Overall Study|Protocol deviation|0|||
160846298|NCT02631551|580825032|FG000|Overall Study|Non-compliance with study procedures|0|||
160846299|NCT02631551|580825033|FG001|Overall Study|Non-compliance with study procedures|0|||
160846300|NCT02631551|580825034|FG002|Overall Study|Non-compliance with study procedures|1|||
160846301|NCT02631551|580825035|FG003|Overall Study|Non-compliance with study procedures|1|||
160846302|NCT02631551|580825032|FG000|Overall Study|Non-compliance with study drug|1|||
160846303|NCT02631551|580825033|FG001|Overall Study|Non-compliance with study drug|0|||
160846304|NCT02631551|580825034|FG002|Overall Study|Non-compliance with study drug|0|||
160846305|NCT02631551|580825035|FG003|Overall Study|Non-compliance with study drug|0|||
160846306|NCT02631551|580825032|FG000|Overall Study|Other, specific reasons not collected|5|||
160846307|NCT02631551|580825033|FG001|Overall Study|Other, specific reasons not collected|7|||
160846308|NCT02631551|580825034|FG002|Overall Study|Other, specific reasons not collected|2|||
160846309|NCT02631551|580825035|FG003|Overall Study|Other, specific reasons not collected|2|||
160846310|NCT04390243|580825038|FG000|Overall Study|Death|1|||
160846311|NCT04390243|580825038|FG000|Overall Study|Disease Progression|4|||
160846312|NCT04390243|580825038|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
160846313|NCT01521507|580825045|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
160846314|NCT01521507|580825046|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
160846315|NCT01521507|580825045|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
160846316|NCT01521507|580825046|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
160846317|NCT01521507|580825045|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
160846318|NCT01521507|580825046|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
160846319|NCT01521507|580825045|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
160846320|NCT01521507|580825046|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
160846321|NCT01521507|580825045|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
160846322|NCT01521507|580825046|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
160846323|NCT01521507|580825045|FG000|Stage 2: Observational Design|Physician Decision|1|||
160846324|NCT01521507|580825046|FG001|Stage 2: Observational Design|Physician Decision|0|||
160846325|NCT04317040|580825047|FG000|Overall Study|Lost to Follow-up|2|||
160846326|NCT04317040|580825048|FG001|Overall Study|Lost to Follow-up|0|||
160846327|NCT04317040|580825047|FG000|Overall Study|Death|16|||
160846328|NCT04317040|580825048|FG001|Overall Study|Death|18|||
160846329|NCT04317040|580825047|FG000|Overall Study|Withdrawal by Subject|0|||
160846330|NCT04317040|580825048|FG001|Overall Study|Withdrawal by Subject|1|||
160846331|NCT04317040|580825047|FG000|Overall Study|Incomplete assessments|0|||
160846332|NCT04317040|580825048|FG001|Overall Study|Incomplete assessments|1|||
160846333|NCT03672292|580825049|FG000|Overall Study|Adverse Event|3|||
160846334|NCT03672292|580825050|FG001|Overall Study|Adverse Event|1|||
160846335|NCT03672292|580825049|FG000|Overall Study|Physician Decision|0|||
160846336|NCT03672292|580825050|FG001|Overall Study|Physician Decision|1|||
160846337|NCT03672292|580825049|FG000|Overall Study|Withdrawal by Subject|1|||
160846338|NCT03672292|580825050|FG001|Overall Study|Withdrawal by Subject|2|||
160846339|NCT00799903|580825051|FG000|Overall Study|Investigator Site Closed|25|||
160846340|NCT00799903|580825052|FG001|Overall Study|Investigator Site Closed|23|||
160846341|NCT00799903|580825051|FG000|Overall Study|Withdrawal by Subject|179|||
160846342|NCT00799903|580825052|FG001|Overall Study|Withdrawal by Subject|175|||
161254275|NCT04129944|582309923|FG003|Overall Study|Withdrawal by Subject|2|||
161254276|NCT03941834|582309924|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
161254277|NCT03941834|582309925|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
161254278|NCT03941834|582309926|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
160846343|NCT00799903|580825051|FG000|Overall Study|Lost to Follow-up|69|||
160846344|NCT00799903|580825052|FG001|Overall Study|Lost to Follow-up|80|||
161254279|NCT03941834|582309924|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
161254280|NCT03941834|582309925|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
161254281|NCT03941834|582309926|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
160846345|NCT02518971|580825053|FG000|Overall Study|Lost to Follow-up|0|||
160846346|NCT02518971|580825054|FG001|Overall Study|Lost to Follow-up|1|||
160846347|NCT02518971|580825053|FG000|Overall Study|Physician Decision|6|||
160846348|NCT02518971|580825054|FG001|Overall Study|Physician Decision|6|||
161140956|NCT01122927|581899230|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161140957|NCT01122927|581899229|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
161140958|NCT01122927|581899230|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
160846349|NCT02518971|580825053|FG000|Overall Study|Protocol Violation|6|||
160846350|NCT02518971|580825054|FG001|Overall Study|Protocol Violation|4|||
160846351|NCT02518971|580825053|FG000|Overall Study|Withdrawal by Subject|4|||
160846352|NCT02518971|580825054|FG001|Overall Study|Withdrawal by Subject|5|||
160846353|NCT02518971|580825053|FG000|Overall Study|Side effects|1|||
160846354|NCT02518971|580825054|FG001|Overall Study|Side effects|0|||
160846355|NCT02518971|580825053|FG000|Overall Study|medication lost in mail|0|||
160846356|NCT02518971|580825054|FG001|Overall Study|medication lost in mail|1|||
160846357|NCT02518971|580825053|FG000|Overall Study|eligibility criteria no longer met|6|||
160846358|NCT02518971|580825054|FG001|Overall Study|eligibility criteria no longer met|3|||
160846359|NCT03088917|580825055|FG000|Overall Study|In care/cured elsewhere|15|||
160846360|NCT03088917|580825055|FG000|Overall Study|Refuse re-evaluation|13|||
160846361|NCT03088917|580825055|FG000|Overall Study|Contact not established|13|||
160846362|NCT03088917|580825055|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
160846363|NCT03088917|580825055|FG000|Overall Study|Moved outside study region|50|||
160846364|NCT00757237|580825056|FG000|Overall Study|Lost to Follow-up|0|||
160846365|NCT00757237|580825057|FG001|Overall Study|Lost to Follow-up|1|||
160846366|NCT00757237|580825056|FG000|Overall Study|Protocol Violation|0|||
160846367|NCT00757237|580825057|FG001|Overall Study|Protocol Violation|2|||
160846368|NCT00757237|580825056|FG000|Overall Study|Physician Decision|2|||
160846369|NCT00757237|580825057|FG001|Overall Study|Physician Decision|3|||
160846370|NCT00757237|580825056|FG000|Overall Study|Withdrawal by Subject|8|||
160846371|NCT00757237|580825057|FG001|Overall Study|Withdrawal by Subject|12|||
160846372|NCT00757237|580825056|FG000|Overall Study|Safety or Tolerability|3|||
160846373|NCT00757237|580825057|FG001|Overall Study|Safety or Tolerability|5|||
160846374|NCT00757237|580825056|FG000|Overall Study|Other|0|||
160846375|NCT00757237|580825057|FG001|Overall Study|Other|2|||
160846376|NCT05150990|580825062|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
160846377|NCT05150990|580825063|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
160846378|NCT05150990|580825062|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
160846379|NCT05150990|580825063|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
160846380|NCT05150990|580825062|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
160846381|NCT05150990|580825063|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
160846382|NCT05150990|580825062|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
160846383|NCT05150990|580825063|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
160846384|NCT05150990|580825062|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
160846385|NCT05150990|580825063|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
160846386|NCT05150990|580825062|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
160846387|NCT05150990|580825063|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
160846388|NCT05150990|580825062|FG000|Overall Study|Death (unrelated to the intervention)|1|||
160846389|NCT05150990|580825063|FG001|Overall Study|Death (unrelated to the intervention)|2|||
160846390|NCT01843023|580825064|FG000|Overall Study|Death|1|||
161140959|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
161140960|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
161140961|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
161140962|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
161140963|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
161140964|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
161140965|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
161140966|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
161140967|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
160846391|NCT01843023|580825065|FG001|Overall Study|Death|0|||
160846392|NCT01843023|580825064|FG000|Overall Study|Lost to Follow-up|24|||
160846393|NCT01843023|580825065|FG001|Overall Study|Lost to Follow-up|29|||
160846394|NCT01843023|580825064|FG000|Overall Study|Withdrawal by Subject|8|||
160846395|NCT01843023|580825065|FG001|Overall Study|Withdrawal by Subject|6|||
160846396|NCT04980612|580825067|FG000|Overall Study|Withdrawal by Subject|7|||
160846397|NCT04980612|580825068|FG001|Overall Study|Withdrawal by Subject|5|||
160846398|NCT01514201|580825071|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
160846399|NCT01514201|580825072|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846400|NCT01514201|580825073|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
161140968|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
160846401|NCT01514201|580825074|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846402|NCT01514201|580825071|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846403|NCT01514201|580825072|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
160846404|NCT01514201|580825073|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
160846405|NCT01514201|580825074|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846406|NCT01514201|580825071|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
160846407|NCT01514201|580825072|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
160846408|NCT01514201|580825073|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
160846409|NCT01514201|580825074|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846410|NCT01514201|580825071|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
160846411|NCT01514201|580825072|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
160846412|NCT01514201|580825073|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846413|NCT01514201|580825074|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846414|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
160846415|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
160846416|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
160846417|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
160846418|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
160846419|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
160846420|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
160846421|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
160846422|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
160846423|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
160846424|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
160846425|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
160846426|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846427|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846428|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
160846429|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
160846430|NCT01514201|580825071|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
160846431|NCT01514201|580825072|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
160846432|NCT01514201|580825073|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
160846433|NCT01514201|580825074|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
160846434|NCT01514201|580825071|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846435|NCT01514201|580825072|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846436|NCT01514201|580825073|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
160846437|NCT01514201|580825074|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
160846438|NCT01514201|580825071|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846439|NCT01514201|580825072|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846440|NCT01514201|580825073|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
160846441|NCT01514201|580825074|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
160846442|NCT01514201|580825071|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846443|NCT01514201|580825072|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846444|NCT01514201|580825073|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
160846445|NCT01514201|580825074|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
160846446|NCT00566852|580825079|FG000|Overall Study|Protocol Violation|22|||
160846447|NCT00566852|580825080|FG001|Overall Study|Protocol Violation|24|||
160846448|NCT00566852|580825079|FG000|Overall Study|Death|95|||
160846449|NCT00566852|580825080|FG001|Overall Study|Death|78|||
160846450|NCT00566852|580825079|FG000|Overall Study|Withdrawal by Subject|30|||
160846451|NCT00566852|580825080|FG001|Overall Study|Withdrawal by Subject|25|||
160846452|NCT00566852|580825079|FG000|Overall Study|Patient refusal|37|||
160846453|NCT00566852|580825080|FG001|Overall Study|Patient refusal|37|||
160846454|NCT00566852|580825079|FG000|Overall Study|Not tested due to disability|6|||
160846455|NCT00566852|580825080|FG001|Overall Study|Not tested due to disability|12|||
160846456|NCT00566852|580825079|FG000|Overall Study|Missing reason not specified|1|||
160846457|NCT00566852|580825080|FG001|Overall Study|Missing reason not specified|2|||
160846458|NCT00566852|580825079|FG000|Overall Study|Missing reason not reported|16|||
160846459|NCT00566852|580825080|FG001|Overall Study|Missing reason not reported|20|||
160846460|NCT02715609|580825084|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
160846461|NCT02715609|580825085|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
160846462|NCT02715609|580825086|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
160846463|NCT02715609|580825084|FG000|Overall Study|Withdrawal by Subject|0|||
160846464|NCT02715609|580825085|FG001|Overall Study|Withdrawal by Subject|0|||
160846465|NCT02715609|580825086|FG002|Overall Study|Withdrawal by Subject|1|||
160846466|NCT00286429|580825089|FG000|Overall Study|Adverse Event|4|||
160846467|NCT00286429|580825090|FG001|Overall Study|Adverse Event|1|||
160846468|NCT00286429|580825091|FG002|Overall Study|Adverse Event|6|||
160846469|NCT00286429|580825089|FG000|Overall Study|Lack of Efficacy|52|||
160846470|NCT00286429|580825090|FG001|Overall Study|Lack of Efficacy|27|||
160846471|NCT00286429|580825091|FG002|Overall Study|Lack of Efficacy|25|||
160846472|NCT00286429|580825089|FG000|Overall Study|Lost to Follow-up|2|||
160846473|NCT00286429|580825090|FG001|Overall Study|Lost to Follow-up|4|||
160846474|NCT00286429|580825091|FG002|Overall Study|Lost to Follow-up|3|||
160846475|NCT00286429|580825089|FG000|Overall Study|Physician Decision|10|||
160846476|NCT00286429|580825090|FG001|Overall Study|Physician Decision|7|||
160846477|NCT00286429|580825091|FG002|Overall Study|Physician Decision|7|||
160846478|NCT00286429|580825089|FG000|Overall Study|Protocol Violation|3|||
160846479|NCT00286429|580825090|FG001|Overall Study|Protocol Violation|5|||
160846480|NCT00286429|580825091|FG002|Overall Study|Protocol Violation|4|||
160846481|NCT00286429|580825089|FG000|Overall Study|Withdrawal by Subject|3|||
160846482|NCT00286429|580825090|FG001|Overall Study|Withdrawal by Subject|2|||
160846483|NCT00286429|580825091|FG002|Overall Study|Withdrawal by Subject|6|||
160846484|NCT00286429|580825089|FG000|Overall Study|Administrative Error|1|||
160846485|NCT00286429|580825090|FG001|Overall Study|Administrative Error|1|||
160846486|NCT00286429|580825091|FG002|Overall Study|Administrative Error|1|||
160846487|NCT00286429|580825089|FG000|Overall Study|Administrative Decision|0|||
160846488|NCT00286429|580825090|FG001|Overall Study|Administrative Decision|1|||
161336751|NCT00784875|582623602|FG001|Period A - Baseline|Sponsor Decision|0|||
161336752|NCT00784875|582623603|FG002|Period A - Baseline|Sponsor Decision|0|||
161336753|NCT00784875|582623604|FG003|Period A - Baseline|Sponsor Decision|113|||
161336754|NCT00784875|582623601|FG000|Period A - Baseline|Lost to Follow-up|0|||
161336755|NCT00784875|582623602|FG001|Period A - Baseline|Lost to Follow-up|0|||
161336756|NCT00784875|582623603|FG002|Period A - Baseline|Lost to Follow-up|0|||
160846489|NCT00286429|580825091|FG002|Overall Study|Administrative Decision|0|||
160846490|NCT03197376|580825095|FG000|Primary and Booster Phase|Adverse Event|0|||
160846491|NCT03197376|580825096|FG001|Primary and Booster Phase|Adverse Event|0|||
160846492|NCT03197376|580825097|FG002|Primary and Booster Phase|Adverse Event|0|||
160846493|NCT03197376|580825098|FG003|Primary and Booster Phase|Adverse Event|1|||
160846494|NCT03197376|580825095|FG000|Primary and Booster Phase|Death|1|||
160846495|NCT03197376|580825096|FG001|Primary and Booster Phase|Death|0|||
160846496|NCT03197376|580825097|FG002|Primary and Booster Phase|Death|0|||
160846497|NCT03197376|580825098|FG003|Primary and Booster Phase|Death|2|||
160846498|NCT03197376|580825095|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
160846499|NCT03197376|580825096|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
160846500|NCT03197376|580825097|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
160846501|NCT03197376|580825098|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
160846502|NCT03197376|580825095|FG000|Primary and Booster Phase|Physician Decision|1|||
160846503|NCT03197376|580825096|FG001|Primary and Booster Phase|Physician Decision|0|||
160846504|NCT03197376|580825097|FG002|Primary and Booster Phase|Physician Decision|1|||
160846505|NCT03197376|580825098|FG003|Primary and Booster Phase|Physician Decision|3|||
160846506|NCT03197376|580825095|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
160846507|NCT03197376|580825096|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
160846508|NCT03197376|580825097|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
160846509|NCT03197376|580825098|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
160846510|NCT03197376|580825095|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
160846511|NCT03197376|580825096|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
160846512|NCT03197376|580825097|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
160846513|NCT03197376|580825098|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
160846514|NCT03197376|580825095|FG000|Primary and Booster Phase|Not vaccine related|1|||
160846515|NCT03197376|580825096|FG001|Primary and Booster Phase|Not vaccine related|2|||
160846516|NCT03197376|580825097|FG002|Primary and Booster Phase|Not vaccine related|0|||
160846517|NCT03197376|580825098|FG003|Primary and Booster Phase|Not vaccine related|6|||
160846518|NCT03197376|580825095|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
160846519|NCT03197376|580825096|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
160846520|NCT03197376|580825097|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
160846521|NCT03197376|580825098|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
160846522|NCT03197376|580825095|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
161140969|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
161140970|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
161336757|NCT00784875|582623604|FG003|Period A - Baseline|Lost to Follow-up|2|||
161336758|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
161336759|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
160846523|NCT03197376|580825096|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
160846524|NCT03197376|580825097|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
160846525|NCT03197376|580825098|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
160846526|NCT03197376|580825095|FG000|Immune Persistence Phase|Not vaccine related|1|||
160846527|NCT03197376|580825096|FG001|Immune Persistence Phase|Not vaccine related|0|||
160846528|NCT03197376|580825097|FG002|Immune Persistence Phase|Not vaccine related|1|||
160846529|NCT03197376|580825098|FG003|Immune Persistence Phase|Not vaccine related|1|||
160846530|NCT00999518|580825100|FG000|Overall Study|Adverse Event|1|||
160846531|NCT00999518|580825101|FG001|Overall Study|Adverse Event|6|||
160846532|NCT00999518|580825102|FG002|Overall Study|Adverse Event|3|||
160846533|NCT00999518|580825103|FG003|Overall Study|Adverse Event|1|||
160846534|NCT00999518|580825104|FG004|Overall Study|Adverse Event|2|||
160846535|NCT00999518|580825100|FG000|Overall Study|Lack of Efficacy|2|||
160846536|NCT00999518|580825101|FG001|Overall Study|Lack of Efficacy|0|||
160846537|NCT00999518|580825102|FG002|Overall Study|Lack of Efficacy|0|||
160846538|NCT00999518|580825103|FG003|Overall Study|Lack of Efficacy|2|||
160846539|NCT00999518|580825104|FG004|Overall Study|Lack of Efficacy|2|||
160846540|NCT00999518|580825100|FG000|Overall Study|Lost to Follow-up|0|||
160846541|NCT00999518|580825101|FG001|Overall Study|Lost to Follow-up|0|||
160846542|NCT00999518|580825102|FG002|Overall Study|Lost to Follow-up|0|||
160846543|NCT00999518|580825103|FG003|Overall Study|Lost to Follow-up|4|||
160846544|NCT00999518|580825104|FG004|Overall Study|Lost to Follow-up|1|||
160846545|NCT00999518|580825100|FG000|Overall Study|Did not meet entrance criteria|0|||
160846546|NCT00999518|580825101|FG001|Overall Study|Did not meet entrance criteria|0|||
160846547|NCT00999518|580825102|FG002|Overall Study|Did not meet entrance criteria|0|||
160846548|NCT00999518|580825103|FG003|Overall Study|Did not meet entrance criteria|0|||
160846549|NCT00999518|580825104|FG004|Overall Study|Did not meet entrance criteria|1|||
160846550|NCT00999518|580825100|FG000|Overall Study|Study terminated by sponsor|10|||
160846551|NCT00999518|580825101|FG001|Overall Study|Study terminated by sponsor|6|||
160846552|NCT00999518|580825102|FG002|Overall Study|Study terminated by sponsor|5|||
160846553|NCT00999518|580825103|FG003|Overall Study|Study terminated by sponsor|5|||
160846554|NCT00999518|580825104|FG004|Overall Study|Study terminated by sponsor|9|||
160846555|NCT00999518|580825100|FG000|Overall Study|Pregnancy|0|||
160846556|NCT00999518|580825101|FG001|Overall Study|Pregnancy|0|||
160846557|NCT00999518|580825102|FG002|Overall Study|Pregnancy|1|||
160846558|NCT00999518|580825103|FG003|Overall Study|Pregnancy|0|||
160846559|NCT00999518|580825104|FG004|Overall Study|Pregnancy|0|||
160846560|NCT00999518|580825100|FG000|Overall Study|Protocol Violation|0|||
160846561|NCT00999518|580825101|FG001|Overall Study|Protocol Violation|1|||
160846562|NCT00999518|580825102|FG002|Overall Study|Protocol Violation|0|||
160846563|NCT00999518|580825103|FG003|Overall Study|Protocol Violation|0|||
160846564|NCT00999518|580825104|FG004|Overall Study|Protocol Violation|2|||
160846565|NCT00999518|580825100|FG000|Overall Study|Withdrawal by Subject|5|||
160846566|NCT00999518|580825101|FG001|Overall Study|Withdrawal by Subject|4|||
160846567|NCT00999518|580825102|FG002|Overall Study|Withdrawal by Subject|10|||
160846568|NCT00999518|580825103|FG003|Overall Study|Withdrawal by Subject|6|||
160846569|NCT00999518|580825104|FG004|Overall Study|Withdrawal by Subject|1|||
160846570|NCT00999518|580825100|FG000|Overall Study|Other|5|||
160846571|NCT00999518|580825101|FG001|Overall Study|Other|7|||
160846572|NCT00999518|580825102|FG002|Overall Study|Other|1|||
160846573|NCT00999518|580825103|FG003|Overall Study|Other|4|||
160846574|NCT00999518|580825104|FG004|Overall Study|Other|5|||
160846575|NCT00999518|580825100|FG000|Overall Study|Randomized but not Treated|1|||
160846576|NCT00999518|580825101|FG001|Overall Study|Randomized but not Treated|1|||
160846577|NCT00999518|580825102|FG002|Overall Study|Randomized but not Treated|2|||
160846578|NCT00999518|580825103|FG003|Overall Study|Randomized but not Treated|0|||
160846579|NCT00999518|580825104|FG004|Overall Study|Randomized but not Treated|1|||
160846580|NCT01811186|580825108|FG000|Overall Study|Adverse Event|54|||
160846581|NCT01811186|580825109|FG001|Overall Study|Adverse Event|38|||
160846582|NCT01811186|580825108|FG000|Overall Study|Protocol Violation|5|||
160846583|NCT01811186|580825109|FG001|Overall Study|Protocol Violation|6|||
160846584|NCT01811186|580825108|FG000|Overall Study|Withdrawal by Subject|5|||
160846585|NCT01811186|580825109|FG001|Overall Study|Withdrawal by Subject|10|||
160846586|NCT01811186|580825108|FG000|Overall Study|Lack of Efficacy|3|||
160846587|NCT01811186|580825109|FG001|Overall Study|Lack of Efficacy|6|||
160846588|NCT01811186|580825108|FG000|Overall Study|Lost to Follow-up|4|||
160846589|NCT01811186|580825109|FG001|Overall Study|Lost to Follow-up|2|||
160846590|NCT01445080|580825117|FG000|Overall Study|Adverse Event|5|||
160846591|NCT01445080|580825118|FG001|Overall Study|Adverse Event|3|||
160846592|NCT01445080|580825119|FG002|Overall Study|Adverse Event|11|||
160846593|NCT01445080|580825120|FG003|Overall Study|Adverse Event|6|||
160846594|NCT01445080|580825121|FG004|Overall Study|Adverse Event|2|||
160846595|NCT01445080|580825122|FG005|Overall Study|Adverse Event|3|||
160846596|NCT01445080|580825123|FG006|Overall Study|Adverse Event|0|||
160846597|NCT01445080|580825124|FG007|Overall Study|Adverse Event|3|||
160846598|NCT01445080|580825125|FG008|Overall Study|Adverse Event|10|||
160846599|NCT01445080|580825117|FG000|Overall Study|Physician Decision|0|||
160846600|NCT01445080|580825118|FG001|Overall Study|Physician Decision|0|||
160846601|NCT01445080|580825119|FG002|Overall Study|Physician Decision|1|||
160846602|NCT01445080|580825120|FG003|Overall Study|Physician Decision|0|||
160846603|NCT01445080|580825121|FG004|Overall Study|Physician Decision|0|||
160846604|NCT01445080|580825122|FG005|Overall Study|Physician Decision|3|||
160846605|NCT01445080|580825123|FG006|Overall Study|Physician Decision|2|||
160992405|NCT00661778|581361346|FG000|Overall Study|Adverse Event|18|||
160846606|NCT01445080|580825124|FG007|Overall Study|Physician Decision|2|||
160846607|NCT01445080|580825125|FG008|Overall Study|Physician Decision|0|||
160846608|NCT01445080|580825117|FG000|Overall Study|Withdrawal by Subject|1|||
160846609|NCT01445080|580825118|FG001|Overall Study|Withdrawal by Subject|0|||
160846610|NCT01445080|580825119|FG002|Overall Study|Withdrawal by Subject|0|||
160846611|NCT01445080|580825120|FG003|Overall Study|Withdrawal by Subject|1|||
160846612|NCT01445080|580825121|FG004|Overall Study|Withdrawal by Subject|0|||
160846613|NCT01445080|580825122|FG005|Overall Study|Withdrawal by Subject|0|||
160846614|NCT01445080|580825123|FG006|Overall Study|Withdrawal by Subject|0|||
160846615|NCT01445080|580825124|FG007|Overall Study|Withdrawal by Subject|0|||
160846616|NCT01445080|580825125|FG008|Overall Study|Withdrawal by Subject|2|||
160846617|NCT01445080|580825117|FG000|Overall Study|Ineligible/Inevaluable|1|||
160846618|NCT01445080|580825118|FG001|Overall Study|Ineligible/Inevaluable|2|||
160846619|NCT01445080|580825119|FG002|Overall Study|Ineligible/Inevaluable|0|||
160846620|NCT01445080|580825120|FG003|Overall Study|Ineligible/Inevaluable|1|||
160846621|NCT01445080|580825121|FG004|Overall Study|Ineligible/Inevaluable|2|||
160846622|NCT01445080|580825122|FG005|Overall Study|Ineligible/Inevaluable|3|||
160846623|NCT01445080|580825123|FG006|Overall Study|Ineligible/Inevaluable|0|||
160846624|NCT01445080|580825124|FG007|Overall Study|Ineligible/Inevaluable|0|||
160846625|NCT01445080|580825125|FG008|Overall Study|Ineligible/Inevaluable|6|||
160846626|NCT03887221|580825126|FG000|Overall Study|Protocol Violation|1|||
160846627|NCT03887221|580825127|FG001|Overall Study|Protocol Violation|0|||
160846628|NCT02487030|580825128|FG000|Overall Study|Lack of Efficacy|2|||
160846629|NCT02487030|580825129|FG001|Overall Study|Lack of Efficacy|4|||
160846630|NCT02487030|580825130|FG002|Overall Study|Lack of Efficacy|1|||
160846631|NCT02487030|580825131|FG003|Overall Study|Lack of Efficacy|0|||
160846632|NCT02487030|580825132|FG004|Overall Study|Lack of Efficacy|1|||
160846633|NCT02487030|580825133|FG005|Overall Study|Lack of Efficacy|0|||
160846634|NCT02487030|580825134|FG006|Overall Study|Lack of Efficacy|0|||
160846635|NCT02487030|580825128|FG000|Overall Study|Lost to Follow-up|0|||
160846636|NCT02487030|580825129|FG001|Overall Study|Lost to Follow-up|0|||
160846637|NCT02487030|580825130|FG002|Overall Study|Lost to Follow-up|1|||
160846638|NCT02487030|580825131|FG003|Overall Study|Lost to Follow-up|1|||
160846639|NCT02487030|580825132|FG004|Overall Study|Lost to Follow-up|0|||
160846640|NCT02487030|580825133|FG005|Overall Study|Lost to Follow-up|1|||
160846641|NCT02487030|580825134|FG006|Overall Study|Lost to Follow-up|0|||
160846642|NCT02487030|580825128|FG000|Overall Study|Adverse Event|0|||
160846643|NCT02487030|580825129|FG001|Overall Study|Adverse Event|0|||
160846644|NCT02487030|580825130|FG002|Overall Study|Adverse Event|0|||
160846645|NCT02487030|580825131|FG003|Overall Study|Adverse Event|1|||
160846646|NCT02487030|580825132|FG004|Overall Study|Adverse Event|0|||
160846647|NCT02487030|580825133|FG005|Overall Study|Adverse Event|0|||
160846648|NCT02487030|580825134|FG006|Overall Study|Adverse Event|0|||
160846649|NCT02487030|580825128|FG000|Overall Study|Death|0|||
160846650|NCT02487030|580825129|FG001|Overall Study|Death|0|||
160846651|NCT02487030|580825130|FG002|Overall Study|Death|0|||
160992406|NCT00661778|581361346|FG000|Overall Study|Reason not Specified|6|||
160992407|NCT00661778|581361346|FG000|Overall Study|Protocol Violation|2|||
160992408|NCT00661778|581361346|FG000|Overall Study|Withdrawal of Consent|1|||
160992409|NCT01149681|581361353|FG000|Overall Study|Withdrawal by Subject|7|||
160846652|NCT02487030|580825131|FG003|Overall Study|Death|0|||
160846653|NCT02487030|580825132|FG004|Overall Study|Death|1|||
160846654|NCT02487030|580825133|FG005|Overall Study|Death|0|||
160846655|NCT02487030|580825134|FG006|Overall Study|Death|0|||
160846656|NCT03857542|580825135|FG000|Overall Study|Adverse Event|1|||
160846657|NCT03857542|580825136|FG001|Overall Study|Adverse Event|3|||
160846658|NCT03857542|580825135|FG000|Overall Study|Withdrawal by Subject|2|||
160846659|NCT03857542|580825136|FG001|Overall Study|Withdrawal by Subject|1|||
160846660|NCT03857542|580825135|FG000|Overall Study|Lost to Follow-up|2|||
160846661|NCT03857542|580825136|FG001|Overall Study|Lost to Follow-up|1|||
160846662|NCT03857542|580825135|FG000|Overall Study|Reason not Specified|1|||
160846663|NCT03857542|580825136|FG001|Overall Study|Reason not Specified|0|||
161254282|NCT03941834|582309924|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
161254283|NCT03941834|582309925|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
161254284|NCT03941834|582309926|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
160846664|NCT02123576|580825137|FG000|Overall Study|Adverse Event|1|||
160846665|NCT02123576|580825138|FG001|Overall Study|Adverse Event|0|||
160846666|NCT04864639|580826619|FG000|Overall Study|Death|1|||
160846667|NCT04864639|580826619|FG000|Overall Study|Lost to Follow-up|1|||
160846668|NCT00713544|580826635|FG000|Overall Study|Adverse Event|5|||
160846669|NCT00713544|580826636|FG001|Overall Study|Adverse Event|3|||
160846670|NCT00713544|580826637|FG002|Overall Study|Adverse Event|7|||
160846671|NCT00713544|580826638|FG003|Overall Study|Adverse Event|7|||
160846672|NCT00713544|580826639|FG004|Overall Study|Adverse Event|3|||
160846673|NCT00713544|580826640|FG005|Overall Study|Adverse Event|5|||
160846674|NCT00713544|580826635|FG000|Overall Study|Withdrawal by Subject|2|||
160846675|NCT00713544|580826636|FG001|Overall Study|Withdrawal by Subject|0|||
160846676|NCT00713544|580826637|FG002|Overall Study|Withdrawal by Subject|3|||
160846677|NCT00713544|580826638|FG003|Overall Study|Withdrawal by Subject|2|||
160846678|NCT00713544|580826639|FG004|Overall Study|Withdrawal by Subject|3|||
160846679|NCT00713544|580826640|FG005|Overall Study|Withdrawal by Subject|1|||
160846680|NCT00713544|580826635|FG000|Overall Study|Protocol Violation|0|||
160846681|NCT00713544|580826636|FG001|Overall Study|Protocol Violation|0|||
160846682|NCT00713544|580826637|FG002|Overall Study|Protocol Violation|0|||
160846683|NCT00713544|580826638|FG003|Overall Study|Protocol Violation|0|||
160846684|NCT00713544|580826639|FG004|Overall Study|Protocol Violation|0|||
160846685|NCT00713544|580826640|FG005|Overall Study|Protocol Violation|1|||
160846686|NCT00713544|580826635|FG000|Overall Study|Physician Decision|0|||
160846687|NCT00713544|580826636|FG001|Overall Study|Physician Decision|0|||
160846688|NCT00713544|580826637|FG002|Overall Study|Physician Decision|0|||
160846689|NCT00713544|580826638|FG003|Overall Study|Physician Decision|0|||
160846690|NCT00713544|580826639|FG004|Overall Study|Physician Decision|0|||
160846691|NCT00713544|580826640|FG005|Overall Study|Physician Decision|2|||
160846692|NCT00713544|580826635|FG000|Overall Study|Lack of Efficacy|0|||
160846693|NCT00713544|580826636|FG001|Overall Study|Lack of Efficacy|1|||
160846694|NCT00713544|580826637|FG002|Overall Study|Lack of Efficacy|0|||
160846695|NCT00713544|580826638|FG003|Overall Study|Lack of Efficacy|1|||
160846696|NCT00713544|580826639|FG004|Overall Study|Lack of Efficacy|1|||
160846697|NCT00713544|580826640|FG005|Overall Study|Lack of Efficacy|0|||
160846698|NCT00713544|580826635|FG000|Overall Study|Lost to Follow-up|0|||
160846699|NCT00713544|580826636|FG001|Overall Study|Lost to Follow-up|0|||
160846700|NCT00713544|580826637|FG002|Overall Study|Lost to Follow-up|1|||
160846701|NCT00713544|580826638|FG003|Overall Study|Lost to Follow-up|0|||
160846702|NCT00713544|580826639|FG004|Overall Study|Lost to Follow-up|0|||
160846703|NCT00713544|580826640|FG005|Overall Study|Lost to Follow-up|0|||
160846704|NCT00713544|580826635|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846705|NCT00713544|580826636|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
160846706|NCT00713544|580826637|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846707|NCT00713544|580826638|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846708|NCT00713544|580826639|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846709|NCT00713544|580826640|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
160846710|NCT00713544|580826635|FG000|Overall Study|Incorrect enrollment|0|||
160846711|NCT00713544|580826636|FG001|Overall Study|Incorrect enrollment|1|||
160846712|NCT00713544|580826637|FG002|Overall Study|Incorrect enrollment|0|||
160846713|NCT00713544|580826638|FG003|Overall Study|Incorrect enrollment|0|||
160846714|NCT00713544|580826639|FG004|Overall Study|Incorrect enrollment|0|||
160846715|NCT00713544|580826640|FG005|Overall Study|Incorrect enrollment|0|||
160846716|NCT00713544|580826635|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
160846717|NCT00713544|580826636|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
160846718|NCT00713544|580826637|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
160906107|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160906108|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160906109|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
160906110|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
161254285|NCT03941834|582309924|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
161254286|NCT03941834|582309925|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
160906111|NCT00730405|581050356|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
160906112|NCT00730405|581050357|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906113|NCT00730405|581050358|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906114|NCT00730405|581050359|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906115|NCT00730405|581050360|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
160906116|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
160906117|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
160906118|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
160906119|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
160906120|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
160906121|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
160906122|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
160906123|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
160906124|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
160906125|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
160906126|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
160906127|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
160906128|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
160906129|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
160906130|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
160846719|NCT00713544|580826638|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
160846720|NCT00713544|580826639|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
160846721|NCT00713544|580826640|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
160846722|NCT00269919|580826641|FG000|Overall Study|Other|26|||
160846723|NCT00269919|580826641|FG000|Overall Study|Started but not treated|1|||
160846724|NCT00786799|580826644|FG000|Overall Study|Lost to Follow-up|1|||
160846725|NCT00786799|580826645|FG001|Overall Study|Lost to Follow-up|1|||
160846726|NCT02544503|580826646|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
160846727|NCT02544503|580826647|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
160846728|NCT02544503|580826646|FG000|Overall Study|Lost to Follow-up|9|||
160846729|NCT02544503|580826647|FG001|Overall Study|Lost to Follow-up|0|||
160846730|NCT02544503|580826646|FG000|Overall Study|Withdrawal by Subject|1|||
160846731|NCT02544503|580826647|FG001|Overall Study|Withdrawal by Subject|0|||
160846732|NCT04640311|580826648|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
160846733|NCT04640311|580826649|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846734|NCT04640311|580826650|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846735|NCT04640311|580826651|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846736|NCT04640311|580826652|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846737|NCT04640311|580826653|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846738|NCT04640311|580826654|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846739|NCT04640311|580826655|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846740|NCT04640311|580826656|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846741|NCT04640311|580826657|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846742|NCT04640311|580826658|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846743|NCT04640311|580826659|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846744|NCT04640311|580826660|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846745|NCT04640311|580826648|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846746|NCT04640311|580826649|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
160846747|NCT04640311|580826650|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846748|NCT04640311|580826651|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846749|NCT04640311|580826652|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846750|NCT04640311|580826653|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846751|NCT04640311|580826654|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846752|NCT04640311|580826655|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846753|NCT04640311|580826656|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846754|NCT04640311|580826657|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846755|NCT04640311|580826658|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846756|NCT04640311|580826659|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846757|NCT04640311|580826660|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
160846758|NCT04640311|580826648|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846759|NCT04640311|580826649|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
160846760|NCT04640311|580826650|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846761|NCT04640311|580826651|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846762|NCT04640311|580826652|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846763|NCT04640311|580826653|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846764|NCT04640311|580826654|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846765|NCT04640311|580826655|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846766|NCT04640311|580826656|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846767|NCT04640311|580826657|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846768|NCT04640311|580826658|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846769|NCT04640311|580826659|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846770|NCT04640311|580826660|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846771|NCT04640311|580826648|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
160846772|NCT04640311|580826649|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
160846773|NCT04640311|580826650|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
160846774|NCT04640311|580826651|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846775|NCT04640311|580826652|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846776|NCT04640311|580826653|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846777|NCT04640311|580826654|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846778|NCT04640311|580826655|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846779|NCT04640311|580826656|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846780|NCT04640311|580826657|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160906131|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Death|0|||
160992410|NCT01149681|581361353|FG000|Overall Study|Progressive disease|1|||
161254287|NCT03941834|582309926|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
161254288|NCT03941834|582309924|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
161254289|NCT03941834|582309925|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
161254290|NCT03941834|582309926|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
161254291|NCT03941834|582309924|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
160846781|NCT04640311|580826658|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846782|NCT04640311|580826659|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846783|NCT04640311|580826660|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
160846784|NCT04640311|580826648|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846785|NCT04640311|580826649|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846786|NCT04640311|580826650|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
160846787|NCT04640311|580826651|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846788|NCT04640311|580826652|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846789|NCT04640311|580826653|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846790|NCT04640311|580826654|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846791|NCT04640311|580826655|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846792|NCT04640311|580826656|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846793|NCT04640311|580826657|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846794|NCT04640311|580826658|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846795|NCT04640311|580826659|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846796|NCT04640311|580826660|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
160846797|NCT04640311|580826648|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846798|NCT04640311|580826649|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846799|NCT04640311|580826650|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846800|NCT04640311|580826651|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
160846801|NCT04640311|580826652|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
161254292|NCT03941834|582309925|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
161254293|NCT03941834|582309926|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
160906132|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Death|1|||
160906133|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Death|0|||
160906134|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Death|1|||
160906135|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Death|0|||
160906136|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Change of location|1|||
160906137|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Change of location|1|||
160906138|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Change of location|0|||
160906139|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Change of location|1|||
160906140|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Change of location|0|||
160906141|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906142|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906143|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
160906144|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906145|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
160906146|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906147|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906148|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
160906149|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906150|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
160906151|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906152|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906153|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
160906154|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906155|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
160906156|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906157|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906158|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906159|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
160906160|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
160906161|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
160906162|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906163|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906164|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906165|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
160906166|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
161254294|NCT01560819|582309927|FG000|Overall Study|Physician Decision|1|||
160846802|NCT04640311|580826653|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846803|NCT04640311|580826654|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
160846804|NCT04640311|580826655|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846805|NCT04640311|580826656|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846806|NCT04640311|580826657|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846807|NCT04640311|580826658|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846808|NCT04640311|580826659|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846809|NCT04640311|580826660|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
160846810|NCT04640311|580826648|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846811|NCT04640311|580826649|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846812|NCT04640311|580826650|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846813|NCT04640311|580826651|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846814|NCT04640311|580826652|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846815|NCT04640311|580826653|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
160846816|NCT04640311|580826654|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846817|NCT04640311|580826655|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846818|NCT04640311|580826656|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
160846819|NCT04640311|580826657|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846820|NCT04640311|580826658|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846821|NCT04640311|580826659|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846822|NCT04640311|580826660|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
160846823|NCT04640311|580826648|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846824|NCT04640311|580826649|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846825|NCT04640311|580826650|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846826|NCT04640311|580826651|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846827|NCT04640311|580826652|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846828|NCT04640311|580826653|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846829|NCT04640311|580826654|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
160846830|NCT04640311|580826655|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846831|NCT04640311|580826656|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846832|NCT04640311|580826657|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846833|NCT04640311|580826658|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
160846834|NCT04640311|580826659|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846835|NCT04640311|580826660|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
160846836|NCT04640311|580826648|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846837|NCT04640311|580826649|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846838|NCT04640311|580826650|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846839|NCT04640311|580826651|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846840|NCT04640311|580826652|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846841|NCT04640311|580826653|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846842|NCT04640311|580826654|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846843|NCT04640311|580826655|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846844|NCT04640311|580826656|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846845|NCT04640311|580826657|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846846|NCT04640311|580826658|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846847|NCT04640311|580826659|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
160846848|NCT04640311|580826660|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
160846849|NCT01641601|580826661|FG000|Overall Study|Study discontinued.|3|||
160846850|NCT01641601|580826662|FG001|Overall Study|Study discontinued.|5|||
160846851|NCT01799226|580826666|FG000|Overall Study|Withdrawal by Subject|1|||
160846852|NCT01799226|580826667|FG001|Overall Study|Withdrawal by Subject|0|||
160846853|NCT01799226|580826666|FG000|Overall Study|Disqualified at Day 14|1|||
160846854|NCT01799226|580826667|FG001|Overall Study|Disqualified at Day 14|0|||
160846855|NCT02178995|580826668|FG000|Double Blind|Adverse Event|0|||
160846856|NCT02178995|580826669|FG001|Double Blind|Adverse Event|0|||
160846857|NCT02178995|580826670|FG002|Double Blind|Adverse Event|0|||
160846858|NCT02178995|580826671|FG003|Double Blind|Adverse Event|0|||
160846859|NCT02178995|580826672|FG004|Double Blind|Adverse Event|0|||
160846860|NCT02178995|580826673|FG005|Double Blind|Adverse Event|1|||
160846861|NCT02178995|580826674|FG006|Double Blind|Adverse Event|0|||
160846862|NCT02178995|580826675|FG007|Double Blind|Adverse Event|1|||
160846863|NCT02178995|580826676|FG008|Double Blind|Adverse Event|1|||
161254295|NCT01560819|582309928|FG001|Overall Study|Physician Decision|0|||
160846864|NCT02178995|580826668|FG000|Double Blind|Lost to Follow-up|0|||
160846865|NCT02178995|580826669|FG001|Double Blind|Lost to Follow-up|1|||
160846866|NCT02178995|580826670|FG002|Double Blind|Lost to Follow-up|0|||
160846867|NCT02178995|580826671|FG003|Double Blind|Lost to Follow-up|0|||
160992411|NCT01149681|581361353|FG000|Overall Study|Physician Decision|2|||
160992412|NCT01149681|581361353|FG000|Overall Study|adverse events nonrelated study drug|2|||
160992413|NCT01259102|581361354|FG000|Overall Study|Adverse Event|1|||
160992414|NCT01259102|581361355|FG001|Overall Study|Adverse Event|0|||
161254296|NCT02012452|582309931|FG000|Overall Study|Lost to Follow-up|2|||
160846868|NCT02178995|580826672|FG004|Double Blind|Lost to Follow-up|0|||
161254297|NCT02012452|582309932|FG001|Overall Study|Lost to Follow-up|1|||
161254298|NCT02012452|582309931|FG000|Overall Study|Withdrawal by Subject|4|||
161254299|NCT02012452|582309932|FG001|Overall Study|Withdrawal by Subject|0|||
161254300|NCT04403399|582309935|FG000|Period 2|Physician Decision|0|||
161254301|NCT04403399|582309936|FG001|Period 2|Physician Decision|1|||
161254302|NCT00831233|582309939|FG000|Overall Study|Adverse Event|0|||
161254303|NCT00831233|582309940|FG001|Overall Study|Adverse Event|1|||
160846869|NCT02178995|580826673|FG005|Double Blind|Lost to Follow-up|0|||
160846870|NCT02178995|580826674|FG006|Double Blind|Lost to Follow-up|0|||
160846871|NCT02178995|580826675|FG007|Double Blind|Lost to Follow-up|1|||
160846872|NCT02178995|580826676|FG008|Double Blind|Lost to Follow-up|0|||
160846873|NCT02178995|580826668|FG000|Open Label|Adverse Event|2|||
160846874|NCT02178995|580826669|FG001|Open Label|Adverse Event|0|||
160846875|NCT02178995|580826670|FG002|Open Label|Adverse Event|0|||
160846876|NCT02178995|580826671|FG003|Open Label|Adverse Event|0|||
160846877|NCT02178995|580826672|FG004|Open Label|Adverse Event|0|||
160846878|NCT02178995|580826673|FG005|Open Label|Adverse Event|0|||
160846879|NCT02178995|580826674|FG006|Open Label|Adverse Event|0|||
161254304|NCT00831233|582309939|FG000|Overall Study|Protocol Violation|1|||
161254305|NCT00831233|582309940|FG001|Overall Study|Protocol Violation|0|||
161254306|NCT00831233|582309939|FG000|Overall Study|Selection Criteria Not Met|2|||
161254307|NCT00831233|582309940|FG001|Overall Study|Selection Criteria Not Met|0|||
161254308|NCT00991510|582309941|FG000|Period I (Days 1-14)|Adverse Event|1|||
161254309|NCT00991510|582309942|FG001|Period I (Days 1-14)|Adverse Event|0|||
161254310|NCT00991510|582309941|FG000|Period III (Days 29-112)|Adverse Event|1|||
161254311|NCT00991510|582309942|FG001|Period III (Days 29-112)|Adverse Event|1|||
161254312|NCT03710590|582309943|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
161254313|NCT03710590|582309944|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
161254314|NCT02488824|582309945|FG000|Overall Study|Adverse Event|1|||
161254315|NCT02488824|582309946|FG001|Overall Study|Adverse Event|1|||
161254316|NCT01976728|582309947|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
161254317|NCT01976728|582309948|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
161254318|NCT01976728|582309949|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
161254319|NCT01976728|582309950|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
161254320|NCT02356211|582309951|FG000|Overall Study|Withdrawal by Subject|2|||
161254321|NCT02356211|582309952|FG001|Overall Study|Withdrawal by Subject|2|||
161254322|NCT02356211|582309951|FG000|Overall Study|ineligible|1|||
161254323|NCT02356211|582309952|FG001|Overall Study|ineligible|8|||
161254324|NCT01563237|582309954|FG000|Overall Study|Lost to Follow-up|6|||
161254325|NCT01563237|582309955|FG001|Overall Study|Lost to Follow-up|0|||
161254326|NCT01563237|582309954|FG000|Overall Study|Withdrawal by Subject|1|||
161254327|NCT01563237|582309955|FG001|Overall Study|Withdrawal by Subject|0|||
161254328|NCT01563237|582309954|FG000|Overall Study|Adverse Event|1|||
161254329|NCT01563237|582309955|FG001|Overall Study|Adverse Event|0|||
161254330|NCT01563237|582309954|FG000|Overall Study|Medical Reasons|1|||
161254331|NCT01563237|582309955|FG001|Overall Study|Medical Reasons|0|||
161254332|NCT01563237|582309954|FG000|Overall Study|Death|1|||
161254333|NCT01563237|582309955|FG001|Overall Study|Death|0|||
161254334|NCT02211014|582309956|FG000|Overall Study|Adverse Event|0|||
161254335|NCT02211014|582309957|FG001|Overall Study|Adverse Event|2|||
161254336|NCT02211014|582309956|FG000|Overall Study|Physician Decision|1|||
161336760|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
160846880|NCT02178995|580826675|FG007|Open Label|Adverse Event|0|||
160846881|NCT02178995|580826676|FG008|Open Label|Adverse Event|0|||
160846882|NCT02114606|580826678|FG000|Overall Study|Unable to swallow Cytosponge|6|||
160846883|NCT00981461|580826679|FG000|Overall Study|Lost to Follow-up|5|||
160846884|NCT00981461|580826680|FG001|Overall Study|Lost to Follow-up|2|||
160846885|NCT01388907|580826681|FG000|Overall Study|Adverse Event|2|||
160846886|NCT01388907|580826682|FG001|Overall Study|Adverse Event|0|||
160846887|NCT03361293|580826683|FG000|Overall Study|Lost to Follow-up|0|||
160992415|NCT01259102|581361356|FG002|Overall Study|Adverse Event|1|||
160846888|NCT03361293|580826684|FG001|Overall Study|Lost to Follow-up|2|||
160846889|NCT03361293|580826683|FG000|Overall Study|Withdrawal by Subject|1|||
160846890|NCT03361293|580826684|FG001|Overall Study|Withdrawal by Subject|3|||
160846891|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
160846892|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
160992416|NCT01259102|581361357|FG003|Overall Study|Adverse Event|1|||
160846893|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
161254337|NCT02211014|582309957|FG001|Overall Study|Physician Decision|2|||
161254338|NCT02211014|582309956|FG000|Overall Study|Started another cancer therapy|1|||
161254339|NCT02211014|582309957|FG001|Overall Study|Started another cancer therapy|0|||
161254340|NCT02211014|582309956|FG000|Overall Study|Withdrawal by Subject|0|||
161140971|NCT01122927|581899229|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
161140972|NCT01122927|581899230|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
161140973|NCT00140855|581899245|FG000|Overall Study|Progressive disease|2|||
161140974|NCT03542682|581899246|FG000|Overall Study|COVID-19 Protocol|0|||
161140975|NCT03542682|581899247|FG001|Overall Study|COVID-19 Protocol|1|||
161140976|NCT01682044|581899257|FG000|Overall Study|Death|1|||
161140977|NCT01682044|581899257|FG000|Overall Study|Progression|3|||
161140978|NCT04090164|581899258|FG000|Overall Study|incomplete data on file|245|||
161140979|NCT04090164|581899259|FG001|Overall Study|incomplete data on file|0|||
161140980|NCT00840463|581899262|FG000|Overall Study|Adverse Event|1|||
161140981|NCT00840463|581899263|FG001|Overall Study|Adverse Event|0|||
161140982|NCT03439345|581900927|FG000|Overall Study|Lost to Follow-up|0|||
161140983|NCT03439345|581900928|FG001|Overall Study|Lost to Follow-up|1|||
161140984|NCT03439345|581900927|FG000|Overall Study|Consent withdrawn|0|||
161140985|NCT03439345|581900928|FG001|Overall Study|Consent withdrawn|1|||
161140986|NCT01386385|581900929|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
161140987|NCT01386385|581900930|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140988|NCT01386385|581900931|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140989|NCT01386385|581900932|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140990|NCT01386385|581900933|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140991|NCT01386385|581900934|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140992|NCT01386385|581900935|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140993|NCT01386385|581900936|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
161140994|NCT01386385|581900929|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
161140995|NCT01386385|581900930|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161254341|NCT02211014|582309957|FG001|Overall Study|Withdrawal by Subject|1|||
161254342|NCT02211014|582309956|FG000|Overall Study|In agreement with patient, no benefit|0|||
161254343|NCT02211014|582309957|FG001|Overall Study|In agreement with patient, no benefit|1|||
161254344|NCT01124695|582309961|FG000|Overall Study|Disease progression|77|||
160846894|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
160846895|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
160846896|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
160846897|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
160846898|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
160846899|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
160846900|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
160846901|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
160846902|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
160846903|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
160846904|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
160846905|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
160846906|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
160846907|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
160846908|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
160846909|NCT01910402|580826685|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
160846910|NCT01910402|580826686|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
160846911|NCT01910402|580826687|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
160846912|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
160846913|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
160846914|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
160846915|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
160846916|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
160846917|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
160846918|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
160846919|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
160846920|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
161254345|NCT01124695|582309961|FG000|Overall Study|Adverse Event|11|||
160846921|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
161254346|NCT01124695|582309961|FG000|Overall Study|Death|1|||
161254347|NCT01124695|582309961|FG000|Overall Study|Withdrawal by Subject|7|||
161254348|NCT01124695|582309961|FG000|Overall Study|Physician Decision|3|||
161254349|NCT01124695|582309961|FG000|Overall Study|Alternative therapy|9|||
161254350|NCT01124695|582309961|FG000|Overall Study|No documentation that patient went off treatment|4|||
161140996|NCT01386385|581900931|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161140997|NCT01386385|581900932|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161140998|NCT01386385|581900933|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161254351|NCT01124695|582309961|FG000|Overall Study|Ineligible|9|||
161336761|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
161336762|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
161254352|NCT01124695|582309961|FG000|Overall Study|Ineligible and never start treatment|2|||
161254353|NCT00097786|582309962|FG000|Overall Study|lost to follow-up for all-cause death|296|||
161254354|NCT00097786|582309963|FG001|Overall Study|lost to follow-up for all-cause death|292|||
161254355|NCT00097786|582309964|FG002|Overall Study|lost to follow-up for all-cause death|313|||
161254356|NCT00097786|582309965|FG003|Overall Study|lost to follow-up for all-cause death|310|||
161254357|NCT02668822|582309966|FG000|Overall Study|Protocol Violation|2|||
161254358|NCT02668822|582309967|FG001|Overall Study|Protocol Violation|0|||
161254359|NCT02668822|582309966|FG000|Overall Study|Study Terminated by Sponsor|7|||
160846922|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
160846923|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
160846924|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
160846925|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
160846926|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
160846927|NCT01910402|580826685|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
160846928|NCT01910402|580826686|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
160846929|NCT01910402|580826687|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
160846930|NCT00483405|580826688|FG000|Overall Study|Adverse Event|8|||
160846931|NCT00483405|580826688|FG000|Overall Study|Lack of Efficacy|14|||
160846932|NCT00483405|580826688|FG000|Overall Study|Death|3|||
160846933|NCT00483405|580826688|FG000|Overall Study|Withdrawal by Subject|2|||
160846934|NCT00483405|580826688|FG000|Overall Study|Other complicating disease|1|||
160846935|NCT03010319|580826689|FG000|Overall Study|Adverse Event|15|||
160846936|NCT03010319|580826690|FG001|Overall Study|Adverse Event|9|||
160846937|NCT03010319|580826689|FG000|Overall Study|Withdrawal by Subject|1|||
160846938|NCT03010319|580826690|FG001|Overall Study|Withdrawal by Subject|6|||
160846939|NCT03010319|580826689|FG000|Overall Study|Physician Decision|2|||
160846940|NCT03010319|580826690|FG001|Overall Study|Physician Decision|4|||
160846941|NCT03010319|580826689|FG000|Overall Study|Sponsor requested withdrawal|2|||
160846942|NCT03010319|580826690|FG001|Overall Study|Sponsor requested withdrawal|2|||
160846943|NCT03010319|580826689|FG000|Overall Study|Death|1|||
160846944|NCT03010319|580826690|FG001|Overall Study|Death|0|||
160846945|NCT03010319|580826689|FG000|Overall Study|Lost to Follow-up|0|||
160846946|NCT03010319|580826690|FG001|Overall Study|Lost to Follow-up|1|||
160846947|NCT03010319|580826689|FG000|Overall Study|Other Reason|5|||
160846948|NCT03010319|580826690|FG001|Overall Study|Other Reason|7|||
160846949|NCT02128724|580826691|FG000|Overall Study|Death|1|||
160846950|NCT02128724|580826692|FG001|Overall Study|Death|0|||
160846951|NCT02128724|580826693|FG002|Overall Study|Death|0|||
160846952|NCT02128724|580826694|FG003|Overall Study|Death|0|||
161254360|NCT02668822|582309967|FG001|Overall Study|Study Terminated by Sponsor|9|||
161254361|NCT01647711|582309970|FG000|Overall Study|Progressive disease|6|||
161254362|NCT01647711|582309971|FG001|Overall Study|Progressive disease|2|||
161254363|NCT01647711|582309972|FG002|Overall Study|Progressive disease|6|||
160846953|NCT02128724|580826691|FG000|Overall Study|Adverse Event|0|||
160846954|NCT02128724|580826692|FG001|Overall Study|Adverse Event|1|||
160846955|NCT02128724|580826693|FG002|Overall Study|Adverse Event|0|||
160846956|NCT02128724|580826694|FG003|Overall Study|Adverse Event|0|||
160846957|NCT02128724|580826691|FG000|Overall Study|Physician Decision|0|||
160846958|NCT02128724|580826692|FG001|Overall Study|Physician Decision|0|||
160846959|NCT02128724|580826693|FG002|Overall Study|Physician Decision|0|||
160846960|NCT02128724|580826694|FG003|Overall Study|Physician Decision|2|||
160846961|NCT02128724|580826691|FG000|Overall Study|Withdrawal by Subject|0|||
160846962|NCT02128724|580826692|FG001|Overall Study|Withdrawal by Subject|0|||
160992417|NCT01259102|581361358|FG004|Overall Study|Adverse Event|0|||
160992418|NCT01259102|581361354|FG000|Overall Study|Other|0|||
160992419|NCT01259102|581361355|FG001|Overall Study|Other|0|||
160992420|NCT01259102|581361356|FG002|Overall Study|Other|1|||
160992421|NCT01259102|581361357|FG003|Overall Study|Other|1|||
160992422|NCT01259102|581361358|FG004|Overall Study|Other|1|||
160992423|NCT00817635|581361359|FG000|Overall Study|Adverse Event|1|||
160992424|NCT00817635|581361360|FG001|Overall Study|Adverse Event|0|||
161254364|NCT01647711|582309973|FG003|Overall Study|Progressive disease|8|||
161254365|NCT01647711|582309974|FG004|Overall Study|Progressive disease|2|||
161254366|NCT01647711|582309970|FG000|Overall Study|Other adverse event|0|||
161254367|NCT01647711|582309971|FG001|Overall Study|Other adverse event|0|||
160846963|NCT02128724|580826693|FG002|Overall Study|Withdrawal by Subject|0|||
161140999|NCT01386385|581900934|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161141000|NCT01386385|581900935|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
160846964|NCT02128724|580826694|FG003|Overall Study|Withdrawal by Subject|1|||
160992425|NCT00817635|581361361|FG002|Overall Study|Adverse Event|0|||
161254368|NCT01647711|582309972|FG002|Overall Study|Other adverse event|2|||
160846965|NCT01957202|580826696|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846966|NCT01957202|580826697|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
160846967|NCT01957202|580826698|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160992426|NCT00817635|581361362|FG003|Overall Study|Adverse Event|1|||
161254369|NCT01647711|582309973|FG003|Overall Study|Other adverse event|0|||
160846968|NCT01957202|580826699|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846969|NCT01957202|580826700|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846970|NCT01957202|580826701|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846971|NCT01957202|580826702|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846972|NCT01957202|580826703|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846973|NCT01957202|580826704|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846974|NCT01957202|580826705|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846975|NCT01957202|580826706|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846976|NCT01957202|580826707|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
161336763|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
161336764|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
161336765|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
161336766|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
161336767|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
161336768|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
161336769|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
161336770|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161336771|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
161336772|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161336773|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
161336774|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
161336775|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
161336776|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
161336777|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
161336778|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
161336779|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
161336780|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
160846977|NCT01957202|580826708|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846978|NCT01957202|580826709|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846979|NCT01957202|580826710|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846980|NCT01957202|580826711|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846981|NCT01957202|580826712|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
160846982|NCT01957202|580826713|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
160846983|NCT01957202|580826696|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846984|NCT01957202|580826697|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846985|NCT01957202|580826698|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846986|NCT01957202|580826699|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846987|NCT01957202|580826700|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846988|NCT01957202|580826701|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846989|NCT01957202|580826702|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846990|NCT01957202|580826703|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846991|NCT01957202|580826704|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846992|NCT01957202|580826705|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846993|NCT01957202|580826706|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846994|NCT01957202|580826707|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846995|NCT01957202|580826708|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846996|NCT01957202|580826709|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846997|NCT01957202|580826710|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846998|NCT01957202|580826711|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
160846999|NCT01957202|580826712|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
160847000|NCT01957202|580826713|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
160847001|NCT03594773|580826715|FG000|Overall Study|Withdrawal by Subject|3|||
160847002|NCT03594773|580826716|FG001|Overall Study|Withdrawal by Subject|2|||
160847003|NCT03594773|580826715|FG000|Overall Study|Lost to Follow-up|3|||
160847004|NCT03594773|580826716|FG001|Overall Study|Lost to Follow-up|4|||
160847005|NCT02640547|580826717|FG000|Overall Study|Failure to Return|1|||
160847006|NCT02640547|580826717|FG000|Overall Study|Withdrawal by Subject|1|||
160847007|NCT02640547|580826717|FG000|Overall Study|Death|6|||
160847008|NCT02640547|580826717|FG000|Overall Study|Miscellaneous|3|||
160847009|NCT00193206|580826718|FG000|Preoperative Therapy|Lack of Efficacy|2|||
160847010|NCT00193206|580826718|FG000|Preoperative Therapy|Adverse Event|2|||
160847011|NCT00193206|580826718|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
160847012|NCT00193206|580826718|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
160847013|NCT00193206|580826718|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
160847014|NCT00193206|580826718|FG000|Postoperative Therapy|Physician Decision|3|||
160847015|NCT00193206|580826718|FG000|Postoperative Therapy|Intercurrent Illness|2|||
160847016|NCT00193206|580826718|FG000|Postoperative Therapy|Lack of Efficacy|1|||
160847017|NCT00193206|580826718|FG000|Postoperative Therapy|Protocol Violation|1|||
160847018|NCT01200368|580826719|FG000|Infant Series|Adverse Event|2|||
160906167|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
160906168|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
161336781|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
160847019|NCT01200368|580826720|FG001|Infant Series|Adverse Event|2|||
160847020|NCT01200368|580826721|FG002|Infant Series|Adverse Event|3|||
160847021|NCT01200368|580826719|FG000|Infant Series|Withdrawal by Subject|0|||
160847022|NCT01200368|580826720|FG001|Infant Series|Withdrawal by Subject|2|||
160847023|NCT01200368|580826721|FG002|Infant Series|Withdrawal by Subject|2|||
160847024|NCT01200368|580826719|FG000|Infant Series|Did not meet entrance criteria|0|||
160847025|NCT01200368|580826720|FG001|Infant Series|Did not meet entrance criteria|1|||
160847026|NCT01200368|580826721|FG002|Infant Series|Did not meet entrance criteria|0|||
160847027|NCT01200368|580826719|FG000|Infant Series|Randomized, not vaccinated|0|||
160847028|NCT01200368|580826720|FG001|Infant Series|Randomized, not vaccinated|1|||
160847029|NCT01200368|580826721|FG002|Infant Series|Randomized, not vaccinated|1|||
160847030|NCT01200368|580826719|FG000|Infant Series|Other|1|||
160847031|NCT01200368|580826720|FG001|Infant Series|Other|0|||
160847032|NCT01200368|580826721|FG002|Infant Series|Other|0|||
160847033|NCT01200368|580826719|FG000|After Infant Series|Adverse Event|6|||
160847034|NCT01200368|580826720|FG001|After Infant Series|Adverse Event|6|||
160847035|NCT01200368|580826721|FG002|After Infant Series|Adverse Event|3|||
160847036|NCT01200368|580826719|FG000|After Infant Series|Withdrawal by Subject|10|||
160847037|NCT01200368|580826720|FG001|After Infant Series|Withdrawal by Subject|8|||
160847038|NCT01200368|580826721|FG002|After Infant Series|Withdrawal by Subject|4|||
160847039|NCT01200368|580826719|FG000|After Infant Series|Lost to Follow-up|1|||
160847040|NCT01200368|580826720|FG001|After Infant Series|Lost to Follow-up|0|||
160847041|NCT01200368|580826721|FG002|After Infant Series|Lost to Follow-up|0|||
160847042|NCT01200368|580826719|FG000|After Infant Series|Other|1|||
160847043|NCT01200368|580826720|FG001|After Infant Series|Other|2|||
160847044|NCT01200368|580826721|FG002|After Infant Series|Other|2|||
160847045|NCT01200368|580826719|FG000|Toddler Dose|Adverse Event|0|||
160847046|NCT01200368|580826720|FG001|Toddler Dose|Adverse Event|3|||
160847047|NCT01200368|580826721|FG002|Toddler Dose|Adverse Event|1|||
160847048|NCT01290757|580826723|FG000|Overall Study|Adverse Event|1|||
160847049|NCT01290757|580826724|FG001|Overall Study|Adverse Event|0|||
160847050|NCT01290757|580826723|FG000|Overall Study|Protocol Violation|1|||
160847051|NCT01290757|580826724|FG001|Overall Study|Protocol Violation|1|||
160847052|NCT01290757|580826723|FG000|Overall Study|Other|0|||
160847053|NCT01290757|580826724|FG001|Overall Study|Other|1|||
160847054|NCT00080301|580826726|FG000|Overall Study|Randomized but Never Treated|5|||
160847055|NCT00080301|580826727|FG001|Overall Study|Randomized but Never Treated|10|||
160847056|NCT00080301|580826726|FG000|Overall Study|Still on Treatment as of CSR date|0|||
160847057|NCT00080301|580826727|FG001|Overall Study|Still on Treatment as of CSR date|1|||
160847058|NCT00991939|580826728|FG000|Overall Study|Lost to Follow-up|0|||
160906169|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
160906170|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
160906171|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
160906172|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
160906173|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
160906174|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
160906175|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
161254370|NCT01647711|582309974|FG004|Overall Study|Other adverse event|2|||
161254371|NCT01647711|582309970|FG000|Overall Study|Protocol Violation|0|||
161254372|NCT01647711|582309971|FG001|Overall Study|Protocol Violation|0|||
161254373|NCT01647711|582309972|FG002|Overall Study|Protocol Violation|0|||
161254374|NCT01647711|582309973|FG003|Overall Study|Protocol Violation|0|||
161254375|NCT01647711|582309974|FG004|Overall Study|Protocol Violation|1|||
160847059|NCT00991939|580826729|FG001|Overall Study|Lost to Follow-up|1|||
160847060|NCT00991939|580826728|FG000|Overall Study|Withdrawal by Subject|1|||
160847061|NCT00991939|580826729|FG001|Overall Study|Withdrawal by Subject|0|||
160847062|NCT00991939|580826728|FG000|Overall Study|Entire study terminated|4|||
160847063|NCT00991939|580826729|FG001|Overall Study|Entire study terminated|1|||
160847064|NCT00181766|580826739|FG000|Overall Study|Lost to Follow-up|6|||
160847065|NCT00181766|580826739|FG000|Overall Study|Adverse Event|4|||
160847066|NCT00181766|580826739|FG000|Overall Study|non-compliance|2|||
160847067|NCT01965704|580826742|FG000|Overall Study|Withdrawal by Subject|2|||
160847068|NCT01965704|580826743|FG001|Overall Study|Withdrawal by Subject|2|||
160847069|NCT01965704|580826744|FG002|Overall Study|Withdrawal by Subject|1|||
160847070|NCT01965704|580826745|FG003|Overall Study|Withdrawal by Subject|1|||
160847071|NCT01965704|580826742|FG000|Overall Study|Delivered at home|1|||
160847072|NCT01965704|580826743|FG001|Overall Study|Delivered at home|1|||
160847073|NCT01965704|580826744|FG002|Overall Study|Delivered at home|0|||
160847074|NCT01965704|580826745|FG003|Overall Study|Delivered at home|0|||
160847075|NCT01965704|580826742|FG000|Overall Study|Experienced complications|0|||
160847076|NCT01965704|580826743|FG001|Overall Study|Experienced complications|0|||
160847077|NCT01965704|580826744|FG002|Overall Study|Experienced complications|2|||
160847078|NCT01965704|580826745|FG003|Overall Study|Experienced complications|2|||
160847079|NCT01965704|580826742|FG000|Overall Study|Adverse Event|0|||
160906176|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
161254376|NCT01647711|582309970|FG000|Overall Study|Refused to continue taking medication|0|||
160847080|NCT01965704|580826743|FG001|Overall Study|Adverse Event|0|||
160847081|NCT01965704|580826744|FG002|Overall Study|Adverse Event|1|||
160847082|NCT01965704|580826745|FG003|Overall Study|Adverse Event|1|||
160847083|NCT01965704|580826742|FG000|Overall Study|Did not meet inclusion criteria|0|||
160847084|NCT01965704|580826743|FG001|Overall Study|Did not meet inclusion criteria|0|||
160847085|NCT01965704|580826744|FG002|Overall Study|Did not meet inclusion criteria|1|||
160847086|NCT01965704|580826745|FG003|Overall Study|Did not meet inclusion criteria|1|||
160847087|NCT02524171|580826749|FG000|6-month Follow-up|Lost to Follow-up|53|||
160847088|NCT02524171|580826750|FG001|6-month Follow-up|Lost to Follow-up|45|||
160847089|NCT02524171|580826749|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
160847090|NCT02524171|580826750|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
161254377|NCT01647711|582309971|FG001|Overall Study|Refused to continue taking medication|0|||
161254378|NCT01647711|582309972|FG002|Overall Study|Refused to continue taking medication|0|||
160847091|NCT01502228|580826751|FG000|Overall Study|Death|1|||
160847092|NCT05730387|580826752|FG000|Overall Study|Stillbirth|0|||
160847093|NCT05730387|580826753|FG001|Overall Study|Stillbirth|262|||
160847094|NCT05730387|580826752|FG000|Overall Study|Died during or after delivery|2|||
160847095|NCT05730387|580826753|FG001|Overall Study|Died during or after delivery|85|||
160847096|NCT05730387|580826752|FG000|Overall Study|Died after being admitted|0|||
160847097|NCT05730387|580826753|FG001|Overall Study|Died after being admitted|44|||
160847098|NCT05730387|580826752|FG000|Overall Study|Lost to Follow-up|69|||
160847099|NCT05730387|580826753|FG001|Overall Study|Lost to Follow-up|77|||
160847100|NCT00637416|580826759|FG000|Overall Study|Lost to Follow-up|1|||
160847101|NCT00637416|580826760|FG001|Overall Study|Lost to Follow-up|1|||
160847102|NCT00637416|580826759|FG000|Overall Study|Unable to take study drug|0|||
160847103|NCT00637416|580826760|FG001|Overall Study|Unable to take study drug|1|||
160847104|NCT04137731|580826763|FG000|Overall Study|Surgery Cancellation|1|||
160847105|NCT04137731|580826764|FG001|Overall Study|Surgery Cancellation|2|||
160847106|NCT04137731|580826763|FG000|Overall Study|Withdrawal by Subject|2|||
160847107|NCT04137731|580826764|FG001|Overall Study|Withdrawal by Subject|0|||
160847108|NCT04137731|580826763|FG000|Overall Study|Protocol Violation|0|||
160847109|NCT04137731|580826764|FG001|Overall Study|Protocol Violation|1|||
160847110|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
160847111|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
160847112|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
160847113|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
160847114|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
160847115|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
160847116|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
160847117|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
160847118|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
160847119|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
160847120|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
160847121|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
161254379|NCT01647711|582309973|FG003|Overall Study|Refused to continue taking medication|2|||
161254380|NCT01647711|582309974|FG004|Overall Study|Refused to continue taking medication|1|||
161254381|NCT01647711|582309970|FG000|Overall Study|Other reason not defined|0|||
161254382|NCT01647711|582309971|FG001|Overall Study|Other reason not defined|1|||
161254383|NCT01647711|582309972|FG002|Overall Study|Other reason not defined|1|||
161254384|NCT01647711|582309973|FG003|Overall Study|Other reason not defined|1|||
161254385|NCT01647711|582309974|FG004|Overall Study|Other reason not defined|0|||
161254386|NCT03036839|582309975|FG000|Overall Study|Adverse Event|0|||
160847122|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
160847123|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
160847124|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
160847125|NCT02204072|580826766|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847126|NCT02204072|580826767|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847127|NCT02204072|580826768|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
160847128|NCT02204072|580826769|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847129|NCT02204072|580826770|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
160847130|NCT00310817|580826771|FG000|Overall Study|AE or Death|3|||
160847131|NCT00310817|580826772|FG001|Overall Study|AE or Death|1|||
160847132|NCT00310817|580826773|FG002|Overall Study|AE or Death|0|||
160847133|NCT00310817|580826774|FG003|Overall Study|AE or Death|0|||
160847134|NCT00310817|580826771|FG000|Overall Study|Withdrawal by Subject|1|||
160847135|NCT00310817|580826772|FG001|Overall Study|Withdrawal by Subject|4|||
160847136|NCT00310817|580826773|FG002|Overall Study|Withdrawal by Subject|6|||
160847137|NCT00310817|580826774|FG003|Overall Study|Withdrawal by Subject|7|||
160847138|NCT00310817|580826771|FG000|Overall Study|Lost to Follow-up|2|||
161254387|NCT03036839|582309976|FG001|Overall Study|Adverse Event|0|||
161254388|NCT03036839|582309977|FG002|Overall Study|Adverse Event|1|||
160847139|NCT00310817|580826772|FG001|Overall Study|Lost to Follow-up|1|||
160847140|NCT00310817|580826773|FG002|Overall Study|Lost to Follow-up|0|||
160847141|NCT00310817|580826774|FG003|Overall Study|Lost to Follow-up|0|||
160847142|NCT00310817|580826771|FG000|Overall Study|Inappropriate Enrollment|1|||
160847143|NCT00310817|580826772|FG001|Overall Study|Inappropriate Enrollment|0|||
160847144|NCT00310817|580826773|FG002|Overall Study|Inappropriate Enrollment|1|||
160847145|NCT00310817|580826774|FG003|Overall Study|Inappropriate Enrollment|0|||
160847146|NCT00310817|580826771|FG000|Overall Study|Protocol Violation|1|||
160847147|NCT00310817|580826772|FG001|Overall Study|Protocol Violation|1|||
160847148|NCT00310817|580826773|FG002|Overall Study|Protocol Violation|1|||
160847149|NCT00310817|580826774|FG003|Overall Study|Protocol Violation|1|||
160847150|NCT00310817|580826771|FG000|Overall Study|Unable to classify|3|||
160847151|NCT00310817|580826772|FG001|Overall Study|Unable to classify|1|||
160847152|NCT00310817|580826773|FG002|Overall Study|Unable to classify|0|||
160847153|NCT00310817|580826774|FG003|Overall Study|Unable to classify|0|||
160847154|NCT01587040|580826780|FG000|Overall Study|Protocol Violation|0|||
160847155|NCT01587040|580826781|FG001|Overall Study|Protocol Violation|0|||
160847156|NCT01587040|580826782|FG002|Overall Study|Protocol Violation|1|||
160847157|NCT01587040|580826783|FG003|Overall Study|Protocol Violation|0|||
160847158|NCT01587040|580826780|FG000|Overall Study|Adverse Event|0|||
160847159|NCT01587040|580826781|FG001|Overall Study|Adverse Event|1|||
160847160|NCT01587040|580826782|FG002|Overall Study|Adverse Event|10|||
160847161|NCT01587040|580826783|FG003|Overall Study|Adverse Event|0|||
160847162|NCT01587040|580826780|FG000|Overall Study|Disease progression|12|||
160847163|NCT01587040|580826781|FG001|Overall Study|Disease progression|1|||
160847164|NCT01587040|580826782|FG002|Overall Study|Disease progression|15|||
160847165|NCT01587040|580826783|FG003|Overall Study|Disease progression|3|||
160847166|NCT01587040|580826780|FG000|Overall Study|Other than specified|5|||
160847167|NCT01587040|580826781|FG001|Overall Study|Other than specified|1|||
160847168|NCT01587040|580826782|FG002|Overall Study|Other than specified|11|||
160847169|NCT01587040|580826783|FG003|Overall Study|Other than specified|1|||
161141001|NCT01386385|581900936|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
161141002|NCT01386385|581900929|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160847172|NCT00367835|580826789|FG000|Overall Study|Adverse Event|14|||
160847173|NCT00367835|580826790|FG001|Overall Study|Adverse Event|1|||
160847174|NCT00367835|580826789|FG000|Overall Study|Protocol Violation|1|||
160847175|NCT00367835|580826790|FG001|Overall Study|Protocol Violation|7|||
160847176|NCT00367835|580826789|FG000|Overall Study|Withdrawal by Subject|7|||
160847177|NCT00367835|580826790|FG001|Overall Study|Withdrawal by Subject|6|||
160847178|NCT00367835|580826789|FG000|Overall Study|Lost to Follow-up|1|||
160847179|NCT00367835|580826790|FG001|Overall Study|Lost to Follow-up|4|||
160847180|NCT00367835|580826789|FG000|Overall Study|Lack of Efficacy|3|||
160847181|NCT00367835|580826790|FG001|Overall Study|Lack of Efficacy|12|||
160847182|NCT00367835|580826789|FG000|Overall Study|Subject in juvenile detention center|1|||
160847183|NCT00367835|580826790|FG001|Overall Study|Subject in juvenile detention center|0|||
160847184|NCT00367835|580826789|FG000|Overall Study|refused blood collection|1|||
160847185|NCT00367835|580826790|FG001|Overall Study|refused blood collection|0|||
160847186|NCT00367835|580826789|FG000|Overall Study|Did not respond to calls|1|||
160847187|NCT00367835|580826790|FG001|Overall Study|Did not respond to calls|0|||
160847188|NCT00367835|580826789|FG000|Overall Study|History of lead poisoning|0|||
160847189|NCT00367835|580826790|FG001|Overall Study|History of lead poisoning|1|||
160847190|NCT04346654|580826792|FG000|Overall Study|Adverse Event|2|||
160847191|NCT04346654|580826793|FG001|Overall Study|Adverse Event|0|||
160847192|NCT04346654|580826792|FG000|Overall Study|Non-response|1|||
160847193|NCT04346654|580826793|FG001|Overall Study|Non-response|1|||
160847194|NCT04346654|580826792|FG000|Overall Study|Withdrawal by Subject|2|||
160847195|NCT04346654|580826793|FG001|Overall Study|Withdrawal by Subject|0|||
160847196|NCT04346654|580826792|FG000|Overall Study|Lost to Follow-up|0|||
160847197|NCT04346654|580826793|FG001|Overall Study|Lost to Follow-up|1|||
160847198|NCT04346654|580826792|FG000|Overall Study|Pregnancy|0|||
160847199|NCT04346654|580826793|FG001|Overall Study|Pregnancy|1|||
160847200|NCT01525615|580828623|FG000|Overall Study|Adverse Event|11|||
160847201|NCT01525615|580828624|FG001|Overall Study|Adverse Event|7|||
160847202|NCT01525615|580828625|FG002|Overall Study|Adverse Event|5|||
160847203|NCT01525615|580828623|FG000|Overall Study|Lost to Follow-up|1|||
160847204|NCT01525615|580828624|FG001|Overall Study|Lost to Follow-up|0|||
160847205|NCT01525615|580828625|FG002|Overall Study|Lost to Follow-up|0|||
160847206|NCT01525615|580828623|FG000|Overall Study|Withdrawal by Subject|1|||
160847207|NCT01525615|580828624|FG001|Overall Study|Withdrawal by Subject|0|||
160847208|NCT01525615|580828625|FG002|Overall Study|Withdrawal by Subject|0|||
160847209|NCT01525615|580828623|FG000|Overall Study|Other reason not described above|1|||
160847210|NCT01525615|580828624|FG001|Overall Study|Other reason not described above|0|||
160847211|NCT01525615|580828625|FG002|Overall Study|Other reason not described above|1|||
160847212|NCT04050618|580828626|FG000|First Intervention|Withdrawal by Subject|2|||
160847213|NCT04050618|580828627|FG001|First Intervention|Withdrawal by Subject|0|||
160847214|NCT04050618|580828626|FG000|Second Intervention|Withdrawal by Subject|1|||
160847215|NCT04050618|580828627|FG001|Second Intervention|Withdrawal by Subject|0|||
161254389|NCT03036839|582309975|FG000|Overall Study|Death|3|||
161254390|NCT03036839|582309976|FG001|Overall Study|Death|0|||
161254391|NCT03036839|582309977|FG002|Overall Study|Death|3|||
161254392|NCT03036839|582309975|FG000|Overall Study|Withdrew Consent|0|||
160847216|NCT01101035|580828628|FG000|Overall Study|Adverse Event|191|||
160847217|NCT01101035|580828629|FG001|Overall Study|Adverse Event|172|||
160847218|NCT01101035|580828628|FG000|Overall Study|Major Protocol Deviation|52|||
160847219|NCT01101035|580828629|FG001|Overall Study|Major Protocol Deviation|46|||
160847220|NCT01101035|580828628|FG000|Overall Study|Lost to Follow-up|226|||
160847221|NCT01101035|580828629|FG001|Overall Study|Lost to Follow-up|223|||
160847222|NCT01101035|580828628|FG000|Overall Study|Voluntary Withdrawal|595|||
160847223|NCT01101035|580828629|FG001|Overall Study|Voluntary Withdrawal|587|||
160847224|NCT01101035|580828628|FG000|Overall Study|Reason not Specified|333|||
160847225|NCT01101035|580828629|FG001|Overall Study|Reason not Specified|363|||
161336782|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
161254393|NCT03036839|582309976|FG001|Overall Study|Withdrew Consent|0|||
161254394|NCT03036839|582309977|FG002|Overall Study|Withdrew Consent|1|||
161336783|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
160847226|NCT00217425|580828630|FG000|Overall Study|Never started treatment|2|||
161254395|NCT01316419|582309978|FG000|Overall Study|Not treated|103|||
161336784|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
161336785|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
161336786|NCT00784875|582623601|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161336787|NCT00784875|582623602|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161336788|NCT00784875|582623603|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
161336789|NCT00784875|582623604|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
161336790|NCT00784875|582623601|FG000|Period C|Adverse Event|1|||
161336791|NCT00784875|582623602|FG001|Period C|Adverse Event|0|||
161336792|NCT00784875|582623603|FG002|Period C|Adverse Event|4|||
161336793|NCT00784875|582623604|FG003|Period C|Adverse Event|2|||
161336794|NCT00784875|582623601|FG000|Period C|Protocol Violation|0|||
161336795|NCT00784875|582623602|FG001|Period C|Protocol Violation|0|||
161336796|NCT00784875|582623603|FG002|Period C|Protocol Violation|1|||
161336797|NCT00784875|582623604|FG003|Period C|Protocol Violation|2|||
161336798|NCT00784875|582623601|FG000|Period C|Lack of Efficacy|0|||
161336799|NCT00784875|582623602|FG001|Period C|Lack of Efficacy|0|||
161336800|NCT00784875|582623603|FG002|Period C|Lack of Efficacy|1|||
161336801|NCT00784875|582623604|FG003|Period C|Lack of Efficacy|0|||
161336802|NCT00784875|582623601|FG000|Period C|Withdrawal by Subject|1|||
161336803|NCT00784875|582623602|FG001|Period C|Withdrawal by Subject|1|||
161336804|NCT00784875|582623603|FG002|Period C|Withdrawal by Subject|2|||
161336805|NCT00784875|582623604|FG003|Period C|Withdrawal by Subject|0|||
161336806|NCT00784875|582623601|FG000|Period C|Physician Decision|0|||
161336807|NCT00784875|582623602|FG001|Period C|Physician Decision|0|||
161336808|NCT00784875|582623603|FG002|Period C|Physician Decision|1|||
161336809|NCT00784875|582623604|FG003|Period C|Physician Decision|1|||
161336810|NCT00784875|582623601|FG000|Period C|Sponsor Decision|5|||
161336811|NCT00784875|582623602|FG001|Period C|Sponsor Decision|5|||
161336812|NCT00784875|582623603|FG002|Period C|Sponsor Decision|4|||
161336813|NCT00784875|582623604|FG003|Period C|Sponsor Decision|2|||
161336814|NCT00784875|582623601|FG000|Period D|Adverse Event|0|||
161336815|NCT00784875|582623602|FG001|Period D|Adverse Event|2|||
161336816|NCT00784875|582623603|FG002|Period D|Adverse Event|2|||
161336817|NCT00784875|582623604|FG003|Period D|Adverse Event|0|||
161336818|NCT00784875|582623601|FG000|Period D|Protocol Violation|1|||
161336819|NCT00784875|582623602|FG001|Period D|Protocol Violation|0|||
161336820|NCT00784875|582623603|FG002|Period D|Protocol Violation|0|||
161336821|NCT00784875|582623604|FG003|Period D|Protocol Violation|0|||
161254396|NCT01316419|582309978|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
161254397|NCT01316419|582309978|FG000|Overall Study|Lost to Follow-up|19|||
161254398|NCT00412737|582309980|FG000|Overall Study|Death|1|||
161254399|NCT00412737|582309981|FG001|Overall Study|Death|0|||
161254400|NCT00412737|582309980|FG000|Overall Study|Adverse Event|3|||
161254401|NCT00412737|582309981|FG001|Overall Study|Adverse Event|2|||
161336822|NCT00784875|582623601|FG000|Period D|Withdrawal by Subject|2|||
161336823|NCT00784875|582623602|FG001|Period D|Withdrawal by Subject|0|||
161336824|NCT00784875|582623603|FG002|Period D|Withdrawal by Subject|2|||
161336825|NCT00784875|582623604|FG003|Period D|Withdrawal by Subject|0|||
161336826|NCT00784875|582623601|FG000|Period D|Physician Decision|0|||
161336827|NCT00784875|582623602|FG001|Period D|Physician Decision|1|||
160847227|NCT00217425|580828630|FG000|Overall Study|Patient ineligible|5|||
161254402|NCT00412737|582309980|FG000|Overall Study|Refused Treatment|6|||
160847228|NCT00217425|580828630|FG000|Overall Study|Lack of Efficacy|13|||
160847229|NCT00217425|580828630|FG000|Overall Study|Adverse Event|8|||
161254403|NCT00412737|582309981|FG001|Overall Study|Refused Treatment|2|||
161336828|NCT00784875|582623603|FG002|Period D|Physician Decision|0|||
161336829|NCT00784875|582623604|FG003|Period D|Physician Decision|0|||
161254404|NCT00412737|582309980|FG000|Overall Study|Failure to Return|6|||
161336830|NCT00784875|582623601|FG000|Period D|Sponsor Decision|1|||
161336831|NCT00784875|582623602|FG001|Period D|Sponsor Decision|1|||
161336832|NCT00784875|582623603|FG002|Period D|Sponsor Decision|1|||
160847230|NCT00217425|580828630|FG000|Overall Study|Withdrawal by Subject|4|||
160847231|NCT00217425|580828630|FG000|Overall Study|Other complicating disease|1|||
160847232|NCT00217425|580828630|FG000|Overall Study|Other|4|||
160847233|NCT00330759|580828632|FG000|Overall Study|Death|316|||
160847234|NCT00330759|580828633|FG001|Overall Study|Death|310|||
160847235|NCT00330759|580828632|FG000|Overall Study|Disease progression|104|||
160847236|NCT00330759|580828633|FG001|Overall Study|Disease progression|126|||
160847237|NCT00330759|580828632|FG000|Overall Study|Withdrawal by Subject|143|||
160847238|NCT00330759|580828633|FG001|Overall Study|Withdrawal by Subject|124|||
160847239|NCT00330759|580828632|FG000|Overall Study|Adverse Event|48|||
160847240|NCT00330759|580828633|FG001|Overall Study|Adverse Event|36|||
160847241|NCT00330759|580828632|FG000|Overall Study|Participant request|31|||
160847242|NCT00330759|580828633|FG001|Overall Study|Participant request|22|||
160847243|NCT00330759|580828632|FG000|Overall Study|Lost to Follow-up|16|||
160847244|NCT00330759|580828633|FG001|Overall Study|Lost to Follow-up|22|||
160847245|NCT00330759|580828632|FG000|Overall Study|Noncompliance|15|||
160847246|NCT00330759|580828633|FG001|Overall Study|Noncompliance|17|||
160847247|NCT00330759|580828632|FG000|Overall Study|Physician Decision|1|||
160847248|NCT00330759|580828633|FG001|Overall Study|Physician Decision|2|||
160847249|NCT00330759|580828632|FG000|Overall Study|Protocol deviation|0|||
160847250|NCT00330759|580828633|FG001|Overall Study|Protocol deviation|2|||
160847251|NCT00330759|580828632|FG000|Overall Study|Ineligibility determined|2|||
160847252|NCT00330759|580828633|FG001|Overall Study|Ineligibility determined|1|||
160847253|NCT00330759|580828632|FG000|Overall Study|Other|36|||
160847254|NCT00330759|580828633|FG001|Overall Study|Other|44|||
161336833|NCT00784875|582623604|FG003|Period D|Sponsor Decision|0|||
161336834|NCT00784875|582623601|FG000|Period D|Lost to Follow-up|1|||
161336835|NCT00784875|582623602|FG001|Period D|Lost to Follow-up|0|||
161336836|NCT00784875|582623603|FG002|Period D|Lost to Follow-up|1|||
161336837|NCT00784875|582623604|FG003|Period D|Lost to Follow-up|1|||
161336838|NCT00958074|582623605|FG000|Overall Study|Withdrawal by Subject|0|||
161336839|NCT00958074|582623606|FG001|Overall Study|Withdrawal by Subject|1|||
161336840|NCT00941928|582623611|FG000|Overall Study|Withdrawal by Subject|1|||
161336841|NCT00941928|582623611|FG000|Overall Study|Disease Progression|1|||
161336842|NCT02300610|582623612|FG000|Overall Study|Withdrawal by Subject|1|||
161336843|NCT02300610|582623613|FG001|Overall Study|Withdrawal by Subject|0|||
161336844|NCT02300610|582623614|FG002|Overall Study|Withdrawal by Subject|1|||
161336845|NCT00095979|582623615|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
161336846|NCT01829347|582623616|FG000|VTI-210|Death|5|||
161336847|NCT01829347|582623617|FG001|VTI-210|Death|3|||
161336848|NCT01829347|582623616|FG000|VTI-210|Withdrawal by Subject|1|||
161336849|NCT01829347|582623617|FG001|VTI-210|Withdrawal by Subject|0|||
160847255|NCT00671034|580828634|FG000|Overall Study|Adverse Event|5|||
160847256|NCT00671034|580828635|FG001|Overall Study|Adverse Event|7|||
160847257|NCT00671034|580828636|FG002|Overall Study|Adverse Event|1|||
160906177|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
160906178|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
160906179|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
160906180|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
160906181|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906182|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
160906183|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906184|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906185|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
160906186|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
160906187|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
160906188|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
160906189|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
160906190|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
160906191|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Missing|0|||
160906192|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Missing|0|||
160906193|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Missing|2|||
160906194|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Missing|0|||
160906195|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Missing|0|||
160906196|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160906197|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160906198|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
161336850|NCT01829347|582623616|FG000|VTI-210E|Death|2|||
161336851|NCT01829347|582623617|FG001|VTI-210E|Death|1|||
161336852|NCT01829347|582623616|FG000|VTI-210E|Study terminated prematurely|1|||
161336853|NCT01829347|582623617|FG001|VTI-210E|Study terminated prematurely|5|||
161336854|NCT02051296|582623624|FG000|Overall Study|Lost to Follow-up|1|||
161336855|NCT02051296|582623625|FG001|Overall Study|Lost to Follow-up|2|||
160847258|NCT00671034|580828634|FG000|Overall Study|Death|3|||
160847259|NCT00671034|580828635|FG001|Overall Study|Death|2|||
160847260|NCT00671034|580828636|FG002|Overall Study|Death|1|||
160847261|NCT00671034|580828634|FG000|Overall Study|Physician Decision|12|||
160847262|NCT00671034|580828635|FG001|Overall Study|Physician Decision|4|||
160847263|NCT00671034|580828636|FG002|Overall Study|Physician Decision|5|||
160847264|NCT00671034|580828634|FG000|Overall Study|VHR ALL feature|8|||
160847265|NCT00671034|580828635|FG001|Overall Study|VHR ALL feature|3|||
160847266|NCT00671034|580828636|FG002|Overall Study|VHR ALL feature|5|||
160847267|NCT00671034|580828634|FG000|Overall Study|Refusal|5|||
160847268|NCT00671034|580828635|FG001|Overall Study|Refusal|3|||
160847269|NCT00671034|580828636|FG002|Overall Study|Refusal|5|||
160847270|NCT00671034|580828634|FG000|Overall Study|includes Alternative therapy, etc.|6|||
160847271|NCT00671034|580828635|FG001|Overall Study|includes Alternative therapy, etc.|1|||
160847272|NCT00671034|580828636|FG002|Overall Study|includes Alternative therapy, etc.|7|||
161336856|NCT02051296|582623624|FG000|Overall Study|withdraw prior to treatment|7|||
161336857|NCT02051296|582623625|FG001|Overall Study|withdraw prior to treatment|7|||
161336858|NCT02515227|582623626|FG000|Overall Study|Adverse Event|0|||
161336859|NCT02515227|582623627|FG001|Overall Study|Adverse Event|2|||
161336860|NCT02515227|582623626|FG000|Overall Study|Progressive disease|2|||
161336861|NCT02515227|582623627|FG001|Overall Study|Progressive disease|9|||
161336862|NCT03451071|582623634|FG000|First Vaccine|Withdrawal by Subject|1|||
161336863|NCT03451071|582623634|FG000|Second Vaccine|Lost to Follow-up|19|||
161336864|NCT03451071|582623634|FG000|Third Vaccine|Lost to Follow-up|22|||
161336865|NCT03451071|582623634|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
161336866|NCT00250588|582623635|FG000|Overall Study|Withdrawal by Subject|3|||
161336867|NCT00250588|582623636|FG001|Overall Study|Withdrawal by Subject|6|||
161336868|NCT00250588|582623637|FG002|Overall Study|Withdrawal by Subject|0|||
161336869|NCT00250588|582623635|FG000|Overall Study|Lost to Follow-up|6|||
161336870|NCT00250588|582623636|FG001|Overall Study|Lost to Follow-up|13|||
161336871|NCT00250588|582623637|FG002|Overall Study|Lost to Follow-up|13|||
161336872|NCT00706797|582623640|FG000|Overall Study|Lack of Efficacy|3|||
161336873|NCT00706797|582623641|FG001|Overall Study|Lack of Efficacy|0|||
161336874|NCT00706797|582623640|FG000|Overall Study|Adverse Event|0|||
161336875|NCT00706797|582623641|FG001|Overall Study|Adverse Event|3|||
161336876|NCT00706797|582623640|FG000|Overall Study|Withdrawal by Subject|8|||
161336877|NCT00706797|582623641|FG001|Overall Study|Withdrawal by Subject|1|||
161336878|NCT00706797|582623640|FG000|Overall Study|Death|1|||
161336879|NCT00706797|582623641|FG001|Overall Study|Death|0|||
161336880|NCT00706797|582623640|FG000|Overall Study|Discontinuation of study by sponsor|52|||
161336881|NCT00706797|582623641|FG001|Overall Study|Discontinuation of study by sponsor|63|||
161336882|NCT00706797|582623640|FG000|Overall Study|Protocol Violation|3|||
161336883|NCT00706797|582623641|FG001|Overall Study|Protocol Violation|2|||
161336884|NCT00706797|582623640|FG000|Overall Study|Lost to Follow-up|1|||
161336885|NCT00706797|582623641|FG001|Overall Study|Lost to Follow-up|2|||
161336886|NCT00706797|582623640|FG000|Overall Study|Other|1|||
161336887|NCT00706797|582623641|FG001|Overall Study|Other|0|||
161336888|NCT03555149|582623642|FG000|Overall Study|Death|18|||
161336889|NCT03555149|582623643|FG001|Overall Study|Death|15|||
161336890|NCT03555149|582623644|FG002|Overall Study|Death|15|||
161336891|NCT03555149|582623645|FG003|Overall Study|Death|4|||
161336892|NCT03555149|582623646|FG004|Overall Study|Death|4|||
161336893|NCT03555149|582623647|FG005|Overall Study|Death|11|||
161336894|NCT03555149|582623648|FG006|Overall Study|Death|12|||
161336895|NCT03555149|582623649|FG007|Overall Study|Death|1|||
161336896|NCT03555149|582623642|FG000|Overall Study|Lost to Follow-up|1|||
161336897|NCT03555149|582623643|FG001|Overall Study|Lost to Follow-up|0|||
161336898|NCT03555149|582623644|FG002|Overall Study|Lost to Follow-up|0|||
161336899|NCT03555149|582623645|FG003|Overall Study|Lost to Follow-up|0|||
161336900|NCT03555149|582623646|FG004|Overall Study|Lost to Follow-up|0|||
161336901|NCT03555149|582623647|FG005|Overall Study|Lost to Follow-up|1|||
161336902|NCT03555149|582623648|FG006|Overall Study|Lost to Follow-up|0|||
161336903|NCT03555149|582623649|FG007|Overall Study|Lost to Follow-up|0|||
161336904|NCT03555149|582623642|FG000|Overall Study|Physician Decision|1|||
161336905|NCT03555149|582623643|FG001|Overall Study|Physician Decision|0|||
161336906|NCT03555149|582623644|FG002|Overall Study|Physician Decision|0|||
161336907|NCT03555149|582623645|FG003|Overall Study|Physician Decision|0|||
161336908|NCT03555149|582623646|FG004|Overall Study|Physician Decision|0|||
160847273|NCT02380287|580828637|FG000|Overall Study|Adverse Event|0|||
161336909|NCT03555149|582623647|FG005|Overall Study|Physician Decision|0|||
160847274|NCT02380287|580828638|FG001|Overall Study|Adverse Event|0|||
160847275|NCT02380287|580828639|FG002|Overall Study|Adverse Event|1|||
161336910|NCT03555149|582623648|FG006|Overall Study|Physician Decision|0|||
161336911|NCT03555149|582623649|FG007|Overall Study|Physician Decision|0|||
161336912|NCT03555149|582623642|FG000|Overall Study|Study Terminated By Sponsor|1|||
161336913|NCT03555149|582623643|FG001|Overall Study|Study Terminated By Sponsor|0|||
161336914|NCT03555149|582623644|FG002|Overall Study|Study Terminated By Sponsor|0|||
161336915|NCT03555149|582623645|FG003|Overall Study|Study Terminated By Sponsor|0|||
161336916|NCT03555149|582623646|FG004|Overall Study|Study Terminated By Sponsor|0|||
161336917|NCT03555149|582623647|FG005|Overall Study|Study Terminated By Sponsor|2|||
160847276|NCT02380287|580828640|FG003|Overall Study|Adverse Event|0|||
160847277|NCT02380287|580828641|FG004|Overall Study|Adverse Event|0|||
161336918|NCT03555149|582623648|FG006|Overall Study|Study Terminated By Sponsor|3|||
160847278|NCT02380287|580828642|FG005|Overall Study|Adverse Event|0|||
160847279|NCT02380287|580828643|FG006|Overall Study|Adverse Event|0|||
160847280|NCT02380287|580828644|FG007|Overall Study|Adverse Event|0|||
160847281|NCT04473963|580828645|FG000|Overall Study|Withdrawal by Subject|1|||
160847282|NCT04473963|580828646|FG001|Overall Study|Withdrawal by Subject|1|||
160847283|NCT04473963|580828647|FG002|Overall Study|Withdrawal by Subject|0|||
160847284|NCT04473963|580828645|FG000|Overall Study|Not inducible in AF|0|||
160847285|NCT04473963|580828646|FG001|Overall Study|Not inducible in AF|0|||
160847286|NCT04473963|580828647|FG002|Overall Study|Not inducible in AF|2|||
160847287|NCT04685798|580828648|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
160847288|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Technical problems|0|||
160847289|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Technical problems|0|||
160847290|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Technical problems|0|||
160847291|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Technical problems|1|||
160847292|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
160847293|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
160847294|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
160847295|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
160847296|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
160847297|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
160847298|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
160847299|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
160847300|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
160847301|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
160847302|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
160847303|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
160847304|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Death|0|||
160847305|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Death|3|||
160847306|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Death|1|||
160847307|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Death|0|||
160847308|NCT02152761|580828653|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
161254405|NCT00412737|582309981|FG001|Overall Study|Failure to Return|2|||
161254406|NCT03180801|582309983|FG000|Overall Study|Physician Decision|3|||
161254407|NCT03180801|582309984|FG001|Overall Study|Physician Decision|3|||
161254408|NCT03180801|582309985|FG002|Overall Study|Physician Decision|1|||
161254409|NCT03180801|582309983|FG000|Overall Study|Non-compliance|1|||
161254410|NCT03180801|582309984|FG001|Overall Study|Non-compliance|4|||
161254411|NCT03180801|582309985|FG002|Overall Study|Non-compliance|0|||
161254412|NCT03180801|582309983|FG000|Overall Study|Inoculation Target Reached|1|||
161254413|NCT03180801|582309984|FG001|Overall Study|Inoculation Target Reached|1|||
161254414|NCT03180801|582309985|FG002|Overall Study|Inoculation Target Reached|3|||
161254415|NCT03180801|582309983|FG000|Overall Study|Adverse Event|1|||
161254416|NCT03180801|582309984|FG001|Overall Study|Adverse Event|0|||
161254417|NCT03180801|582309985|FG002|Overall Study|Adverse Event|2|||
161254418|NCT03180801|582309983|FG000|Overall Study|Withdrawal by Subject|2|||
161254419|NCT03180801|582309984|FG001|Overall Study|Withdrawal by Subject|2|||
161254420|NCT03180801|582309985|FG002|Overall Study|Withdrawal by Subject|1|||
161254421|NCT03180801|582309983|FG000|Overall Study|Lost to Follow-up|0|||
161254422|NCT03180801|582309984|FG001|Overall Study|Lost to Follow-up|2|||
161254423|NCT03180801|582309985|FG002|Overall Study|Lost to Follow-up|3|||
161254424|NCT01049412|582309986|FG000|Period I|Withdrawal by Subject|4|||
161254425|NCT01049412|582309987|FG001|Period I|Withdrawal by Subject|6|||
161254426|NCT01049412|582309986|FG000|Period I|Lost to Follow-up|2|||
161254427|NCT01049412|582309987|FG001|Period I|Lost to Follow-up|2|||
161254428|NCT01049412|582309986|FG000|Period I|Physician Decision|0|||
160847309|NCT02152761|580828654|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
160847310|NCT02152761|580828655|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
160847311|NCT02152761|580828656|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
160847312|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
160906199|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
160906200|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
160906201|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906202|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906203|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
160906204|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906205|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
160906206|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
160906207|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
160992427|NCT00817635|581361363|FG004|Overall Study|Adverse Event|1|||
161254429|NCT01049412|582309987|FG001|Period I|Physician Decision|3|||
161254430|NCT01049412|582309986|FG000|Period I|Protocol Violation|1|||
161254431|NCT01049412|582309987|FG001|Period I|Protocol Violation|2|||
161254432|NCT01049412|582309986|FG000|Period I|Adverse Event|1|||
161254433|NCT01049412|582309987|FG001|Period I|Adverse Event|0|||
161254434|NCT01049412|582309986|FG000|Period II|Withdrawal by Subject|2|||
160847313|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
160847314|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
160847315|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
160847316|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
160847317|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
160847318|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
160847319|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
160847320|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
160847321|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
161254435|NCT01049412|582309987|FG001|Period II|Withdrawal by Subject|3|||
161254436|NCT01049412|582309986|FG000|Period II|Adverse Event|1|||
161254437|NCT01049412|582309987|FG001|Period II|Adverse Event|0|||
161254438|NCT01049412|582309986|FG000|Period II|Lost to Follow-up|1|||
161254439|NCT01049412|582309987|FG001|Period II|Lost to Follow-up|0|||
161254440|NCT00868296|582309990|FG000|Overall Study|Adverse Event|0|||
161254441|NCT00868296|582309991|FG001|Overall Study|Adverse Event|2|||
161254442|NCT00868296|582309990|FG000|Overall Study|Withdrawal by Subject|0|||
161254443|NCT00868296|582309991|FG001|Overall Study|Withdrawal by Subject|1|||
161254444|NCT00573170|582309992|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
161254445|NCT00573170|582309993|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
161254446|NCT00573170|582309994|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
161254447|NCT00573170|582309995|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
161254448|NCT00573170|582309996|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
161254449|NCT00573170|582309997|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
161254450|NCT00573170|582309992|FG000|First Washout Period|Adverse Event|1|||
161254451|NCT00573170|582309993|FG001|First Washout Period|Adverse Event|1|||
161254452|NCT00573170|582309994|FG002|First Washout Period|Adverse Event|0|||
161254453|NCT00573170|582309995|FG003|First Washout Period|Adverse Event|0|||
161254454|NCT00573170|582309996|FG004|First Washout Period|Adverse Event|0|||
161254455|NCT00573170|582309997|FG005|First Washout Period|Adverse Event|1|||
161254456|NCT00573170|582309992|FG000|First Washout Period|Lack of Efficacy|0|||
161254457|NCT00573170|582309993|FG001|First Washout Period|Lack of Efficacy|0|||
161254458|NCT00573170|582309994|FG002|First Washout Period|Lack of Efficacy|0|||
161254459|NCT00573170|582309995|FG003|First Washout Period|Lack of Efficacy|0|||
161254460|NCT00573170|582309996|FG004|First Washout Period|Lack of Efficacy|0|||
161254461|NCT00573170|582309997|FG005|First Washout Period|Lack of Efficacy|1|||
161254462|NCT00573170|582309992|FG000|First Washout Period|Lost to Follow-up|1|||
161254463|NCT00573170|582309993|FG001|First Washout Period|Lost to Follow-up|1|||
161254464|NCT00573170|582309994|FG002|First Washout Period|Lost to Follow-up|0|||
161254465|NCT00573170|582309995|FG003|First Washout Period|Lost to Follow-up|2|||
161254466|NCT00573170|582309996|FG004|First Washout Period|Lost to Follow-up|0|||
161254467|NCT00573170|582309997|FG005|First Washout Period|Lost to Follow-up|2|||
161254468|NCT00573170|582309992|FG000|First Washout Period|Withdrawal by Subject|2|||
161254469|NCT00573170|582309993|FG001|First Washout Period|Withdrawal by Subject|0|||
161254470|NCT00573170|582309994|FG002|First Washout Period|Withdrawal by Subject|0|||
161254471|NCT00573170|582309995|FG003|First Washout Period|Withdrawal by Subject|2|||
161254472|NCT00573170|582309996|FG004|First Washout Period|Withdrawal by Subject|3|||
161254473|NCT00573170|582309997|FG005|First Washout Period|Withdrawal by Subject|3|||
161254474|NCT00573170|582309992|FG000|First Washout Period|Other|4|||
161254475|NCT00573170|582309993|FG001|First Washout Period|Other|0|||
161254476|NCT00573170|582309994|FG002|First Washout Period|Other|1|||
161254477|NCT00573170|582309995|FG003|First Washout Period|Other|1|||
161254478|NCT00573170|582309996|FG004|First Washout Period|Other|0|||
161254479|NCT00573170|582309997|FG005|First Washout Period|Other|0|||
161254480|NCT00573170|582309992|FG000|Second Washout Period|Adverse Event|1|||
161254481|NCT00573170|582309993|FG001|Second Washout Period|Adverse Event|0|||
161254482|NCT00573170|582309994|FG002|Second Washout Period|Adverse Event|0|||
161254483|NCT00573170|582309995|FG003|Second Washout Period|Adverse Event|0|||
161254484|NCT00573170|582309996|FG004|Second Washout Period|Adverse Event|1|||
161254485|NCT00573170|582309997|FG005|Second Washout Period|Adverse Event|0|||
161254486|NCT00573170|582309992|FG000|Second Washout Period|Protocol Violation|2|||
161254487|NCT00573170|582309993|FG001|Second Washout Period|Protocol Violation|1|||
161254488|NCT00573170|582309994|FG002|Second Washout Period|Protocol Violation|1|||
161254489|NCT00573170|582309995|FG003|Second Washout Period|Protocol Violation|0|||
161254490|NCT00573170|582309996|FG004|Second Washout Period|Protocol Violation|0|||
161254491|NCT00573170|582309997|FG005|Second Washout Period|Protocol Violation|0|||
161254492|NCT00573170|582309992|FG000|Second Washout Period|Withdrawal by Subject|1|||
161254493|NCT00573170|582309993|FG001|Second Washout Period|Withdrawal by Subject|1|||
161254494|NCT00573170|582309994|FG002|Second Washout Period|Withdrawal by Subject|2|||
161254495|NCT00573170|582309995|FG003|Second Washout Period|Withdrawal by Subject|0|||
161254496|NCT00573170|582309996|FG004|Second Washout Period|Withdrawal by Subject|1|||
161254497|NCT00573170|582309997|FG005|Second Washout Period|Withdrawal by Subject|0|||
161254498|NCT00573170|582309992|FG000|Second Washout Period|Lost to Follow-up|0|||
160847322|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
160847323|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
160847324|NCT02152761|580828653|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
160847325|NCT02152761|580828654|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
160847326|NCT02152761|580828655|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
160847327|NCT02152761|580828656|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
160847328|NCT01797263|580828657|FG000|Overall Study|Withdrawal by Subject|21|||
160847329|NCT01797263|580828658|FG001|Overall Study|Withdrawal by Subject|25|||
160847330|NCT01797263|580828657|FG000|Overall Study|Death|1|||
160847331|NCT01797263|580828658|FG001|Overall Study|Death|0|||
160847332|NCT01797263|580828657|FG000|Overall Study|Lost to Follow-up|15|||
160847333|NCT01797263|580828658|FG001|Overall Study|Lost to Follow-up|15|||
160847334|NCT01550757|580828659|FG000|Overall Study|Lost to Follow-up|21|||
160847335|NCT01550757|580828660|FG001|Overall Study|Lost to Follow-up|14|||
160847336|NCT01550757|580828661|FG002|Overall Study|Lost to Follow-up|42|||
160847337|NCT01550757|580828662|FG003|Overall Study|Lost to Follow-up|53|||
160847338|NCT01550757|580828659|FG000|Overall Study|Withdrawal by Subject|2|||
160847339|NCT01550757|580828660|FG001|Overall Study|Withdrawal by Subject|0|||
160847340|NCT01550757|580828661|FG002|Overall Study|Withdrawal by Subject|3|||
160847341|NCT01550757|580828662|FG003|Overall Study|Withdrawal by Subject|1|||
160847342|NCT02342223|580828663|FG000|Overall Study|Lost to Follow-up|1|||
160847343|NCT03018691|580828664|FG000|Overall Study|Adverse Event|1|||
160847344|NCT03018691|580828665|FG001|Overall Study|Adverse Event|1|||
160847345|NCT03018691|580828666|FG002|Overall Study|Adverse Event|4|||
160847346|NCT03018691|580828664|FG000|Overall Study|Lack of Efficacy|0|||
160847347|NCT03018691|580828665|FG001|Overall Study|Lack of Efficacy|0|||
160847348|NCT03018691|580828666|FG002|Overall Study|Lack of Efficacy|1|||
160847349|NCT03018691|580828664|FG000|Overall Study|Withdrawal by Subject|0|||
160847350|NCT03018691|580828665|FG001|Overall Study|Withdrawal by Subject|0|||
160847351|NCT03018691|580828666|FG002|Overall Study|Withdrawal by Subject|1|||
160847352|NCT03018691|580828664|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160847353|NCT03018691|580828665|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160847354|NCT03018691|580828666|FG002|Overall Study|Withdrawal by parent/guardian|1|||
160847355|NCT03369418|580828667|FG000|Overall Study|Withdrawal by Subject|3|||
160847356|NCT03369418|580828668|FG001|Overall Study|Withdrawal by Subject|3|||
160847357|NCT01485094|580828669|FG000|Overall Study|Adverse Event|1|||
160847358|NCT01485094|580828670|FG001|Overall Study|Adverse Event|1|||
160847359|NCT01485094|580828671|FG002|Overall Study|Adverse Event|1|||
160847360|NCT01485094|580828669|FG000|Overall Study|Lost to Follow-up|1|||
160847361|NCT01485094|580828670|FG001|Overall Study|Lost to Follow-up|0|||
160847362|NCT01485094|580828671|FG002|Overall Study|Lost to Follow-up|0|||
160847363|NCT01485094|580828669|FG000|Overall Study|Withdrawal by Subject|1|||
160847364|NCT01485094|580828670|FG001|Overall Study|Withdrawal by Subject|1|||
160847365|NCT01485094|580828671|FG002|Overall Study|Withdrawal by Subject|0|||
160847366|NCT01426958|580828672|FG000|Overall Study|Adverse Event|2|||
160847367|NCT02859246|580828678|FG000|Overall Study|Screen fails|3|||
160847368|NCT02859246|580828678|FG000|Overall Study|Adverse Event|1|||
160847369|NCT02859246|580828678|FG000|Overall Study|Withdrawal by Subject|1|||
160847370|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
160847371|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
160847372|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
160847373|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847374|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847375|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847376|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
160847377|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
160847378|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847379|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847380|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
161141003|NCT01386385|581900930|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161141004|NCT01386385|581900931|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
160847381|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847382|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847383|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
160847384|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847385|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
161141005|NCT01386385|581900932|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160862052|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862053|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161141006|NCT01386385|581900933|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161141007|NCT01386385|581900934|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161141008|NCT01386385|581900935|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
160847386|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847387|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847388|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847389|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847390|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
160847391|NCT05280717|580828679|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847392|NCT05280717|580828680|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847393|NCT05280717|580828681|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
161254499|NCT00573170|582309993|FG001|Second Washout Period|Lost to Follow-up|0|||
161254500|NCT00573170|582309994|FG002|Second Washout Period|Lost to Follow-up|0|||
161254501|NCT00573170|582309995|FG003|Second Washout Period|Lost to Follow-up|1|||
161254502|NCT00573170|582309996|FG004|Second Washout Period|Lost to Follow-up|0|||
161254503|NCT00573170|582309997|FG005|Second Washout Period|Lost to Follow-up|0|||
161254504|NCT00573170|582309992|FG000|Second Washout Period|Other|1|||
161254505|NCT00573170|582309993|FG001|Second Washout Period|Other|2|||
161254506|NCT00573170|582309994|FG002|Second Washout Period|Other|1|||
161254507|NCT00573170|582309995|FG003|Second Washout Period|Other|4|||
161254508|NCT00573170|582309996|FG004|Second Washout Period|Other|6|||
161254509|NCT00573170|582309997|FG005|Second Washout Period|Other|2|||
161254510|NCT00573170|582309992|FG000|Third Treatment Period|Withdrawal by Subject|1|||
161254511|NCT00573170|582309993|FG001|Third Treatment Period|Withdrawal by Subject|0|||
161254512|NCT00573170|582309994|FG002|Third Treatment Period|Withdrawal by Subject|0|||
161254513|NCT00573170|582309995|FG003|Third Treatment Period|Withdrawal by Subject|0|||
161254514|NCT00573170|582309996|FG004|Third Treatment Period|Withdrawal by Subject|0|||
161254515|NCT00573170|582309997|FG005|Third Treatment Period|Withdrawal by Subject|0|||
161254516|NCT00573170|582309992|FG000|Third Treatment Period|Lost to Follow-up|0|||
161254517|NCT00573170|582309993|FG001|Third Treatment Period|Lost to Follow-up|0|||
161254518|NCT00573170|582309994|FG002|Third Treatment Period|Lost to Follow-up|0|||
161254519|NCT00573170|582309995|FG003|Third Treatment Period|Lost to Follow-up|0|||
161254520|NCT00573170|582309996|FG004|Third Treatment Period|Lost to Follow-up|0|||
161254521|NCT00573170|582309997|FG005|Third Treatment Period|Lost to Follow-up|2|||
161254522|NCT05966090|582309998|FG000|Overall Study|Lost to Follow-up|6|||
161254523|NCT05966090|582309999|FG001|Overall Study|Lost to Follow-up|6|||
160847394|NCT05280717|580828682|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847395|NCT05280717|580828683|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847396|NCT05280717|580828684|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847397|NCT05280717|580828685|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
160847398|NCT05280717|580828679|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847399|NCT05280717|580828680|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847400|NCT05280717|580828681|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847401|NCT05280717|580828682|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847402|NCT05280717|580828683|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847403|NCT05280717|580828684|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
160847404|NCT05280717|580828685|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
160847405|NCT05280717|580828679|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847406|NCT05280717|580828680|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847407|NCT05280717|580828681|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847408|NCT05280717|580828682|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847409|NCT05280717|580828683|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847410|NCT05280717|580828684|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
160847411|NCT05280717|580828685|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
160847412|NCT00740584|580828688|FG000|Overall Study|Withdrawal by Subject|1|||
160847413|NCT00855816|580828689|FG000|Overall Study|Withdrawal by Subject|22|||
160847414|NCT00855816|580828690|FG001|Overall Study|Withdrawal by Subject|15|||
160847415|NCT00855816|580828689|FG000|Overall Study|Lost to Follow-up|3|||
160847416|NCT00855816|580828690|FG001|Overall Study|Lost to Follow-up|5|||
160847417|NCT00855816|580828689|FG000|Overall Study|Death|1|||
160847418|NCT00855816|580828690|FG001|Overall Study|Death|0|||
160847419|NCT00855816|580828689|FG000|Overall Study|Became ineligible|0|||
160847420|NCT00855816|580828690|FG001|Overall Study|Became ineligible|1|||
161254524|NCT05966090|582309998|FG000|Overall Study|Adverse Event|1|||
161254525|NCT05966090|582309999|FG001|Overall Study|Adverse Event|1|||
161254526|NCT05966090|582309998|FG000|Overall Study|Withdrawal by Subject|1|||
161254527|NCT05966090|582309999|FG001|Overall Study|Withdrawal by Subject|1|||
161254528|NCT05966090|582309998|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161254529|NCT05966090|582309999|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161254530|NCT05966090|582309998|FG000|Overall Study|Other|1|||
160847421|NCT03188432|580828697|FG000|Overall Study|Death|3|||
160847422|NCT03188432|580828697|FG000|Overall Study|Withdrawal by Subject|15|||
160847423|NCT03188432|580828697|FG000|Overall Study|Did not complete protocol treatment|9|||
160847424|NCT01196026|580828700|FG000|Overall Study|Withdrawal by Subject|1|||
160847425|NCT01196026|580828701|FG001|Overall Study|Withdrawal by Subject|4|||
160847426|NCT01196026|580828702|FG002|Overall Study|Withdrawal by Subject|0|||
160847427|NCT01196026|580828703|FG003|Overall Study|Withdrawal by Subject|0|||
160847428|NCT01196026|580828704|FG004|Overall Study|Withdrawal by Subject|0|||
160847429|NCT01196026|580828705|FG005|Overall Study|Withdrawal by Subject|0|||
160847430|NCT01196026|580828700|FG000|Overall Study|Lost to Follow-up|0|||
160847431|NCT01196026|580828701|FG001|Overall Study|Lost to Follow-up|3|||
160847432|NCT01196026|580828702|FG002|Overall Study|Lost to Follow-up|0|||
160847433|NCT01196026|580828703|FG003|Overall Study|Lost to Follow-up|0|||
160847434|NCT01196026|580828704|FG004|Overall Study|Lost to Follow-up|1|||
160847435|NCT01196026|580828705|FG005|Overall Study|Lost to Follow-up|0|||
160847436|NCT01196026|580828700|FG000|Overall Study|Other|0|||
160847437|NCT01196026|580828701|FG001|Overall Study|Other|1|||
160847438|NCT01196026|580828702|FG002|Overall Study|Other|0|||
160847439|NCT01196026|580828703|FG003|Overall Study|Other|0|||
160847440|NCT01196026|580828704|FG004|Overall Study|Other|0|||
160847441|NCT01196026|580828705|FG005|Overall Study|Other|0|||
160847442|NCT02868554|580828706|FG000|Overall Study|Lost to Follow-up|3|||
160847443|NCT02868554|580828707|FG001|Overall Study|Lost to Follow-up|0|||
160847444|NCT02868554|580828708|FG002|Overall Study|Lost to Follow-up|1|||
160847445|NCT05447663|580828713|FG000|Overall Study|Study terminated by Sponsor|5|||
160847446|NCT05447663|580828713|FG000|Overall Study|Death|2|||
160847447|NCT05447663|580828713|FG000|Overall Study|Withdrawal by Subject|1|||
160847448|NCT01100320|580828714|FG000|Period 1|Withdrawal by Subject|2|||
160847449|NCT01100320|580828715|FG001|Period 1|Withdrawal by Subject|4|||
160847450|NCT01100320|580828714|FG000|Period 1|Positive Drug Screen|1|||
160847451|NCT01100320|580828715|FG001|Period 1|Positive Drug Screen|1|||
160847452|NCT01100320|580828714|FG000|Period 1|Adverse Event|2|||
160847453|NCT01100320|580828715|FG001|Period 1|Adverse Event|2|||
160847454|NCT01100320|580828714|FG000|Period 2|Withdrawal by Subject|1|||
160847455|NCT01100320|580828715|FG001|Period 2|Withdrawal by Subject|1|||
160847456|NCT04181762|580828716|FG000|Overall Study|Adverse Event|1|||
160847457|NCT04181762|580828717|FG001|Overall Study|Adverse Event|3|||
160847458|NCT04181762|580828716|FG000|Overall Study|Lost to Follow-up|1|||
160847459|NCT04181762|580828717|FG001|Overall Study|Lost to Follow-up|1|||
160847460|NCT04181762|580828716|FG000|Overall Study|Physician Decision|1|||
160847461|NCT04181762|580828717|FG001|Overall Study|Physician Decision|3|||
160847462|NCT04181762|580828716|FG000|Overall Study|Pregnancy|0|||
160847463|NCT04181762|580828717|FG001|Overall Study|Pregnancy|1|||
160847464|NCT04181762|580828716|FG000|Overall Study|Lack of Efficacy|2|||
160847465|NCT04181762|580828717|FG001|Overall Study|Lack of Efficacy|2|||
160847466|NCT04181762|580828716|FG000|Overall Study|Study terminated by sponsor|95|||
160847467|NCT04181762|580828717|FG001|Overall Study|Study terminated by sponsor|97|||
160847468|NCT04181762|580828716|FG000|Overall Study|Subject decision|11|||
160847469|NCT04181762|580828717|FG001|Overall Study|Subject decision|4|||
160847470|NCT04181762|580828716|FG000|Overall Study|Death|1|||
160847471|NCT04181762|580828717|FG001|Overall Study|Death|1|||
160847472|NCT04181762|580828716|FG000|Overall Study|Protocol deviation|1|||
160847473|NCT04181762|580828717|FG001|Overall Study|Protocol deviation|0|||
160847474|NCT04181762|580828716|FG000|Overall Study|Withdrawal of informed consent|1|||
160847475|NCT04181762|580828717|FG001|Overall Study|Withdrawal of informed consent|3|||
160847476|NCT04669301|580828718|FG000|Overall Study|Lost to Follow-up|0|||
161254531|NCT05966090|582309999|FG001|Overall Study|Other|1|||
161254532|NCT00804141|582310000|FG000|Overall Study|Adverse Event|157|||
161254533|NCT00804141|582310000|FG000|Overall Study|Death|4|||
161254534|NCT00804141|582310000|FG000|Overall Study|Failed to return|96|||
161254535|NCT00804141|582310000|FG000|Overall Study|Investigator request|8|||
161254536|NCT00804141|582310000|FG000|Overall Study|Protocol Violation|85|||
161254537|NCT00804141|582310000|FG000|Overall Study|Withdrawal by Subject|131|||
160847477|NCT04669301|580828719|FG001|Overall Study|Lost to Follow-up|1|||
160847478|NCT04669301|580828720|FG002|Overall Study|Lost to Follow-up|0|||
160847479|NCT04669301|580828718|FG000|Overall Study|Withdrawal by Subject|3|||
160847480|NCT04669301|580828719|FG001|Overall Study|Withdrawal by Subject|2|||
160847481|NCT04669301|580828720|FG002|Overall Study|Withdrawal by Subject|0|||
160847482|NCT02586727|580828721|FG000|Overall Study|Lost to Follow-up|1|||
160847483|NCT02586727|580828722|FG001|Overall Study|Lost to Follow-up|0|||
160847484|NCT05888181|580828723|FG000|Overall Study|Lost to Follow-up|1|||
160847485|NCT05888181|580828724|FG001|Overall Study|Lost to Follow-up|1|||
160847486|NCT05888181|580828725|FG002|Overall Study|Lost to Follow-up|0|||
160847487|NCT02534909|580828728|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
160847488|NCT02326597|580828731|FG000|Overall Study|Lost to Follow-up|42|||
160847489|NCT02326597|580828732|FG001|Overall Study|Lost to Follow-up|32|||
160847490|NCT00132808|580828733|FG000|Stratum I|Adverse Event|2|||
160847491|NCT00132808|580828734|FG001|Stratum I|Adverse Event|1|||
160847492|NCT00132808|580828735|FG002|Stratum I|Adverse Event|0|||
160847493|NCT00132808|580828733|FG000|Stratum I|Lost to Follow-up|3|||
161254538|NCT00804141|582310000|FG000|Overall Study|Lack of Efficacy|46|||
160847494|NCT00132808|580828734|FG001|Stratum I|Lost to Follow-up|4|||
160847495|NCT00132808|580828735|FG002|Stratum I|Lost to Follow-up|1|||
160847496|NCT00132808|580828733|FG000|Stratum I|Withdrawal by Subject|4|||
160847497|NCT00132808|580828734|FG001|Stratum I|Withdrawal by Subject|7|||
160847498|NCT00132808|580828735|FG002|Stratum I|Withdrawal by Subject|3|||
160847499|NCT00132808|580828733|FG000|Stratum I|Abnormal test procedure result (s)|0|||
160847500|NCT00132808|580828734|FG001|Stratum I|Abnormal test procedure result (s)|0|||
160847501|NCT00132808|580828735|FG002|Stratum I|Abnormal test procedure result (s)|1|||
160847502|NCT00132808|580828733|FG000|Stratum II|Adverse Event|1|||
160847503|NCT00132808|580828734|FG001|Stratum II|Adverse Event|2|||
160847504|NCT00132808|580828735|FG002|Stratum II|Adverse Event|1|||
160847505|NCT00132808|580828733|FG000|Stratum II|Death|1|||
160847506|NCT00132808|580828734|FG001|Stratum II|Death|0|||
160847507|NCT00132808|580828735|FG002|Stratum II|Death|0|||
160847508|NCT00132808|580828733|FG000|Stratum II|Lost to Follow-up|2|||
160847509|NCT00132808|580828734|FG001|Stratum II|Lost to Follow-up|2|||
160847510|NCT00132808|580828735|FG002|Stratum II|Lost to Follow-up|1|||
160847511|NCT00132808|580828733|FG000|Stratum II|Protocol Violation|0|||
160847512|NCT00132808|580828734|FG001|Stratum II|Protocol Violation|2|||
160847513|NCT00132808|580828735|FG002|Stratum II|Protocol Violation|1|||
160847514|NCT00132808|580828733|FG000|Stratum II|Withdrawal by Subject|4|||
160847515|NCT00132808|580828734|FG001|Stratum II|Withdrawal by Subject|9|||
160847516|NCT00132808|580828735|FG002|Stratum II|Withdrawal by Subject|6|||
160847517|NCT00428948|580828739|FG000|Overall Study|Lost to Follow-up|15|||
160847518|NCT00428948|580828740|FG001|Overall Study|Lost to Follow-up|8|||
160847519|NCT00428948|580828739|FG000|Overall Study|Adverse Event|148|||
160847520|NCT00428948|580828740|FG001|Overall Study|Adverse Event|24|||
160847521|NCT00428948|580828739|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
160847522|NCT00428948|580828740|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
160847523|NCT00428948|580828739|FG000|Overall Study|Investigator Withdrew Subject|3|||
160847524|NCT00428948|580828740|FG001|Overall Study|Investigator Withdrew Subject|4|||
160847525|NCT00428948|580828739|FG000|Overall Study|Subject Withdrew Consent|50|||
160847526|NCT00428948|580828740|FG001|Overall Study|Subject Withdrew Consent|30|||
160847527|NCT00428948|580828739|FG000|Overall Study|Protocol Deviation|1|||
160847528|NCT00428948|580828740|FG001|Overall Study|Protocol Deviation|1|||
160847529|NCT00577824|580828741|FG000|Overall Study|Adverse Event|6|||
160847530|NCT00577824|580828742|FG001|Overall Study|Adverse Event|18|||
160847531|NCT00577824|580828743|FG002|Overall Study|Adverse Event|1|||
160847532|NCT00577824|580828741|FG000|Overall Study|Patient decision|0|||
160847533|NCT00577824|580828742|FG001|Overall Study|Patient decision|1|||
160847534|NCT00577824|580828743|FG002|Overall Study|Patient decision|1|||
160847535|NCT00577824|580828741|FG000|Overall Study|Protocol Violation|1|||
160847536|NCT00577824|580828742|FG001|Overall Study|Protocol Violation|1|||
160847537|NCT00577824|580828743|FG002|Overall Study|Protocol Violation|0|||
160847538|NCT00362648|580828744|FG000|Overall Study|Adverse Event|12|||
160847539|NCT00362648|580828745|FG001|Overall Study|Adverse Event|21|||
160847540|NCT00362648|580828746|FG002|Overall Study|Adverse Event|1|||
160847541|NCT00362648|580828747|FG003|Overall Study|Adverse Event|0|||
160847542|NCT00362648|580828744|FG000|Overall Study|Lost to Follow-up|62|||
160847543|NCT00362648|580828745|FG001|Overall Study|Lost to Follow-up|69|||
160847544|NCT00362648|580828746|FG002|Overall Study|Lost to Follow-up|4|||
160847545|NCT00362648|580828747|FG003|Overall Study|Lost to Follow-up|3|||
160847546|NCT00362648|580828744|FG000|Overall Study|Protocol Violation|4|||
160847547|NCT00362648|580828745|FG001|Overall Study|Protocol Violation|2|||
160847548|NCT00362648|580828746|FG002|Overall Study|Protocol Violation|2|||
160847549|NCT00362648|580828747|FG003|Overall Study|Protocol Violation|2|||
160847550|NCT00362648|580828744|FG000|Overall Study|Withdrawal by Subject|48|||
160847551|NCT00362648|580828745|FG001|Overall Study|Withdrawal by Subject|42|||
160906208|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
160906209|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
160906210|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
160906211|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906212|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906213|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
160906214|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906215|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
160906216|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160906217|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
161336919|NCT03555149|582623649|FG007|Overall Study|Study Terminated By Sponsor|1|||
160847552|NCT00362648|580828746|FG002|Overall Study|Withdrawal by Subject|2|||
160847553|NCT00362648|580828747|FG003|Overall Study|Withdrawal by Subject|6|||
160847554|NCT04752332|580828748|FG000|Overall Study|Adverse Event|3|||
160847555|NCT04752332|580828749|FG001|Overall Study|Adverse Event|1|||
160847556|NCT04752332|580828748|FG000|Overall Study|Disease Relapse|1|||
160847557|NCT04752332|580828749|FG001|Overall Study|Disease Relapse|0|||
160847558|NCT04752332|580828748|FG000|Overall Study|Non-compliance With Study Drug|2|||
160847559|NCT04752332|580828749|FG001|Overall Study|Non-compliance With Study Drug|0|||
160847560|NCT04752332|580828748|FG000|Overall Study|Physician Decision|2|||
160847561|NCT04752332|580828749|FG001|Overall Study|Physician Decision|1|||
160847562|NCT04752332|580828748|FG000|Overall Study|Protocol Violation|1|||
160847563|NCT04752332|580828749|FG001|Overall Study|Protocol Violation|1|||
160847564|NCT04752332|580828748|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
160847565|NCT04752332|580828749|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
160847566|NCT04752332|580828748|FG000|Overall Study|Study Terminated by Sponsor|10|||
160847567|NCT04752332|580828749|FG001|Overall Study|Study Terminated by Sponsor|48|||
160847568|NCT04752332|580828748|FG000|Overall Study|Withdrawal by Subject|11|||
160847569|NCT04752332|580828749|FG001|Overall Study|Withdrawal by Subject|3|||
160847570|NCT00924443|580828750|FG000|Overall Study|Physician Decision|2|||
160847571|NCT00924443|580828750|FG000|Overall Study|Protocol Violation|1|||
160847572|NCT02978833|580828753|FG000|Overall Study|Study terminated|1|||
160847573|NCT02978833|580828754|FG001|Overall Study|Study terminated|1|||
160847574|NCT01123395|580828757|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
160847575|NCT01123395|580828758|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
160847576|NCT00186901|580828759|FG000|Overall Study|Pregnancy|6|||
160847577|NCT00186901|580828760|FG001|Overall Study|Pregnancy|3|||
160847578|NCT00186901|580828761|FG002|Overall Study|Pregnancy|0|||
160847579|NCT00186901|580828759|FG000|Overall Study|Lost to Follow-up|6|||
160847580|NCT00186901|580828760|FG001|Overall Study|Lost to Follow-up|3|||
160847581|NCT00186901|580828761|FG002|Overall Study|Lost to Follow-up|0|||
160847582|NCT00186901|580828759|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
160847583|NCT00186901|580828760|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
160847584|NCT00186901|580828761|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
160847585|NCT00186901|580828759|FG000|Overall Study|ALL relapse or second malignancy|1|||
160847586|NCT00186901|580828760|FG001|Overall Study|ALL relapse or second malignancy|2|||
160847587|NCT00186901|580828761|FG002|Overall Study|ALL relapse or second malignancy|0|||
160847588|NCT00186901|580828759|FG000|Overall Study|Withdrawal by Subject|4|||
160847589|NCT00186901|580828760|FG001|Overall Study|Withdrawal by Subject|5|||
160847590|NCT00186901|580828761|FG002|Overall Study|Withdrawal by Subject|0|||
160847591|NCT00186901|580828759|FG000|Overall Study|Open label|3|||
160847592|NCT00186901|580828760|FG001|Overall Study|Open label|2|||
160847593|NCT00186901|580828761|FG002|Overall Study|Open label|0|||
160847594|NCT00186901|580828759|FG000|Overall Study|Limited adherence to study requirements|20|||
160847595|NCT00186901|580828760|FG001|Overall Study|Limited adherence to study requirements|23|||
160847596|NCT00186901|580828761|FG002|Overall Study|Limited adherence to study requirements|0|||
160847597|NCT00186901|580828759|FG000|Overall Study|Bone Mineral Density > 0|0|||
160847598|NCT00186901|580828760|FG001|Overall Study|Bone Mineral Density > 0|0|||
160847599|NCT00186901|580828761|FG002|Overall Study|Bone Mineral Density > 0|149|||
160847600|NCT00782483|580828764|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
160847601|NCT01052077|580828765|FG000|Phase A|Lost to Follow-up|22|||
160847602|NCT01052077|580828766|FG001|Phase A|Lost to Follow-up|0|||
160847603|NCT01052077|580828767|FG002|Phase A|Lost to Follow-up|0|||
160847604|NCT01052077|580828768|FG003|Phase A|Lost to Follow-up|0|||
160847605|NCT01052077|580828765|FG000|Phase A|Adverse Event|32|||
160847606|NCT01052077|580828766|FG001|Phase A|Adverse Event|0|||
160847607|NCT01052077|580828767|FG002|Phase A|Adverse Event|0|||
160847608|NCT01052077|580828768|FG003|Phase A|Adverse Event|0|||
160847609|NCT01052077|580828765|FG000|Phase A|Met Withdrawal Criteria|26|||
160847610|NCT01052077|580828766|FG001|Phase A|Met Withdrawal Criteria|0|||
160847611|NCT01052077|580828767|FG002|Phase A|Met Withdrawal Criteria|0|||
160847612|NCT01052077|580828768|FG003|Phase A|Met Withdrawal Criteria|0|||
160847613|NCT01052077|580828765|FG000|Phase A|Physician Decision|10|||
160847614|NCT01052077|580828766|FG001|Phase A|Physician Decision|0|||
160847615|NCT01052077|580828767|FG002|Phase A|Physician Decision|0|||
160847616|NCT01052077|580828768|FG003|Phase A|Physician Decision|0|||
160847617|NCT01052077|580828765|FG000|Phase A|Withdrawal by Subject|29|||
160847618|NCT01052077|580828766|FG001|Phase A|Withdrawal by Subject|0|||
161336920|NCT03555149|582623642|FG000|Overall Study|Withdrawal by Subject|3|||
161336921|NCT03555149|582623643|FG001|Overall Study|Withdrawal by Subject|0|||
161336922|NCT03555149|582623644|FG002|Overall Study|Withdrawal by Subject|0|||
161336923|NCT03555149|582623645|FG003|Overall Study|Withdrawal by Subject|2|||
161141009|NCT01386385|581900936|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
161336924|NCT03555149|582623646|FG004|Overall Study|Withdrawal by Subject|0|||
161336925|NCT03555149|582623647|FG005|Overall Study|Withdrawal by Subject|1|||
160847619|NCT01052077|580828767|FG002|Phase A|Withdrawal by Subject|0|||
160847620|NCT01052077|580828768|FG003|Phase A|Withdrawal by Subject|0|||
160847621|NCT01052077|580828765|FG000|Phase A|Protocol Deviation|27|||
160847622|NCT01052077|580828766|FG001|Phase A|Protocol Deviation|0|||
160847623|NCT01052077|580828767|FG002|Phase A|Protocol Deviation|0|||
160847624|NCT01052077|580828768|FG003|Phase A|Protocol Deviation|0|||
160847625|NCT01052077|580828765|FG000|Phase B|Lost to Follow-up|0|||
161336926|NCT03555149|582623648|FG006|Overall Study|Withdrawal by Subject|0|||
160847626|NCT01052077|580828766|FG001|Phase B|Lost to Follow-up|2|||
160847627|NCT01052077|580828767|FG002|Phase B|Lost to Follow-up|3|||
160847628|NCT01052077|580828768|FG003|Phase B|Lost to Follow-up|0|||
160847629|NCT01052077|580828765|FG000|Phase B|Adverse Event|0|||
160847630|NCT01052077|580828766|FG001|Phase B|Adverse Event|9|||
161336927|NCT03555149|582623649|FG007|Overall Study|Withdrawal by Subject|0|||
161336928|NCT01387269|582623653|FG000|Overall Study|Death|38|||
161336929|NCT01387269|582623654|FG001|Overall Study|Death|20|||
161336930|NCT01387269|582623653|FG000|Overall Study|Other|8|||
161336931|NCT01387269|582623654|FG001|Overall Study|Other|7|||
161336932|NCT01387269|582623653|FG000|Overall Study|Unrelated AE|12|||
161336933|NCT01387269|582623654|FG001|Overall Study|Unrelated AE|3|||
161336934|NCT01387269|582623653|FG000|Overall Study|Withdrawal by patient|32|||
161336935|NCT01387269|582623654|FG001|Overall Study|Withdrawal by patient|10|||
161336936|NCT01387269|582623653|FG000|Overall Study|Study drug-related AE|1|||
161336937|NCT01387269|582623654|FG001|Overall Study|Study drug-related AE|0|||
161336938|NCT01387269|582623653|FG000|Overall Study|Lost to Follow-up|1|||
161336939|NCT01387269|582623654|FG001|Overall Study|Lost to Follow-up|0|||
161336940|NCT01200329|582623655|FG000|Overall Study|Lack of financial coverage|2|||
161336941|NCT01200329|582623655|FG000|Overall Study|Progressive disease|1|||
161336942|NCT02230891|582623660|FG000|Baseline|Did not meet inclusion|0|||
161336943|NCT02230891|582623661|FG001|Baseline|Did not meet inclusion|1|||
161336944|NCT02230891|582623662|FG002|Baseline|Did not meet inclusion|1|||
160847631|NCT01052077|580828767|FG002|Phase B|Adverse Event|2|||
160847632|NCT01052077|580828768|FG003|Phase B|Adverse Event|0|||
160847633|NCT01052077|580828765|FG000|Phase B|Met Withdrawal Criteria|0|||
160847634|NCT01052077|580828766|FG001|Phase B|Met Withdrawal Criteria|2|||
160847635|NCT01052077|580828767|FG002|Phase B|Met Withdrawal Criteria|1|||
160847636|NCT01052077|580828768|FG003|Phase B|Met Withdrawal Criteria|0|||
160847637|NCT01052077|580828765|FG000|Phase B|Physician Decision|0|||
160847638|NCT01052077|580828766|FG001|Phase B|Physician Decision|1|||
160847639|NCT01052077|580828767|FG002|Phase B|Physician Decision|1|||
160847640|NCT01052077|580828768|FG003|Phase B|Physician Decision|0|||
160847641|NCT01052077|580828765|FG000|Phase B|Withdrawal by Subject|0|||
160847642|NCT01052077|580828766|FG001|Phase B|Withdrawal by Subject|0|||
160847643|NCT01052077|580828767|FG002|Phase B|Withdrawal by Subject|5|||
160847644|NCT01052077|580828768|FG003|Phase B|Withdrawal by Subject|0|||
160847645|NCT01052077|580828765|FG000|Phase B|Protocol Deviation|0|||
160847646|NCT01052077|580828766|FG001|Phase B|Protocol Deviation|3|||
160847647|NCT01052077|580828767|FG002|Phase B|Protocol Deviation|4|||
160847648|NCT01052077|580828768|FG003|Phase B|Protocol Deviation|0|||
160847649|NCT01052077|580828765|FG000|Phase B|Lack of Efficacy|0|||
160847650|NCT01052077|580828766|FG001|Phase B|Lack of Efficacy|1|||
160847651|NCT01052077|580828767|FG002|Phase B|Lack of Efficacy|0|||
160847652|NCT01052077|580828768|FG003|Phase B|Lack of Efficacy|0|||
160847653|NCT01052077|580828765|FG000|Phase A+|Lost to Follow-up|0|||
160847654|NCT01052077|580828766|FG001|Phase A+|Lost to Follow-up|0|||
160847655|NCT01052077|580828767|FG002|Phase A+|Lost to Follow-up|0|||
160847656|NCT01052077|580828768|FG003|Phase A+|Lost to Follow-up|8|||
160847657|NCT01052077|580828765|FG000|Phase A+|Adverse Event|0|||
160847658|NCT01052077|580828766|FG001|Phase A+|Adverse Event|0|||
160847659|NCT01052077|580828767|FG002|Phase A+|Adverse Event|0|||
160847660|NCT01052077|580828768|FG003|Phase A+|Adverse Event|4|||
160847661|NCT01052077|580828765|FG000|Phase A+|Met Withdrawal Criteria|0|||
160847662|NCT01052077|580828766|FG001|Phase A+|Met Withdrawal Criteria|0|||
160847663|NCT01052077|580828767|FG002|Phase A+|Met Withdrawal Criteria|0|||
160847664|NCT01052077|580828768|FG003|Phase A+|Met Withdrawal Criteria|2|||
160847665|NCT01052077|580828765|FG000|Phase A+|Withdrawal by Subject|0|||
160847666|NCT01052077|580828766|FG001|Phase A+|Withdrawal by Subject|0|||
160847667|NCT01052077|580828767|FG002|Phase A+|Withdrawal by Subject|0|||
160847668|NCT01052077|580828768|FG003|Phase A+|Withdrawal by Subject|7|||
160847669|NCT00003199|580828773|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
160906218|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160906219|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
160906220|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
160906221|NCT00730405|581050356|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
161336945|NCT02230891|582623660|FG000|2 Week|Withdrawal by Subject|2|||
160847670|NCT00003199|580828773|FG000|Overall Study|Lack of insurance clearance|2|||
160906222|NCT00730405|581050357|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160906223|NCT00730405|581050358|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160847671|NCT00003199|580828773|FG000|Overall Study|Screen fail|15|||
160847672|NCT00940498|580828774|FG000|Overall Study|Death|2|||
160906224|NCT00730405|581050359|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
161336946|NCT02230891|582623661|FG001|2 Week|Withdrawal by Subject|2|||
161336947|NCT02230891|582623662|FG002|2 Week|Withdrawal by Subject|0|||
161336948|NCT02230891|582623660|FG000|2 Week|Consent withdrawn|1|||
161336949|NCT02230891|582623661|FG001|2 Week|Consent withdrawn|0|||
161336950|NCT02230891|582623662|FG002|2 Week|Consent withdrawn|0|||
161336951|NCT02230891|582623660|FG000|6 Month|Withdrawal by Subject|1|||
161336952|NCT02230891|582623661|FG001|6 Month|Withdrawal by Subject|1|||
160847673|NCT00940498|580828775|FG001|Overall Study|Death|0|||
160847674|NCT00940498|580828776|FG002|Overall Study|Death|0|||
160847675|NCT00940498|580828777|FG003|Overall Study|Death|1|||
160847676|NCT00940498|580828778|FG004|Overall Study|Death|5|||
160847677|NCT00940498|580828779|FG005|Overall Study|Death|0|||
160847678|NCT00940498|580828780|FG006|Overall Study|Death|1|||
160847679|NCT00940498|580828781|FG007|Overall Study|Death|0|||
160847680|NCT00940498|580828774|FG000|Overall Study|Lost to Follow-up|1|||
160847681|NCT00940498|580828775|FG001|Overall Study|Lost to Follow-up|1|||
160847682|NCT00940498|580828776|FG002|Overall Study|Lost to Follow-up|2|||
160847683|NCT00940498|580828777|FG003|Overall Study|Lost to Follow-up|0|||
160847684|NCT00940498|580828778|FG004|Overall Study|Lost to Follow-up|1|||
160847685|NCT00940498|580828779|FG005|Overall Study|Lost to Follow-up|0|||
160847686|NCT00940498|580828780|FG006|Overall Study|Lost to Follow-up|0|||
160847687|NCT00940498|580828781|FG007|Overall Study|Lost to Follow-up|1|||
160847688|NCT00940498|580828774|FG000|Overall Study|Disease Progression|0|||
160847689|NCT00940498|580828775|FG001|Overall Study|Disease Progression|0|||
160847690|NCT00940498|580828776|FG002|Overall Study|Disease Progression|1|||
160847691|NCT00940498|580828777|FG003|Overall Study|Disease Progression|1|||
160847692|NCT00940498|580828778|FG004|Overall Study|Disease Progression|0|||
160847693|NCT00940498|580828779|FG005|Overall Study|Disease Progression|1|||
160847694|NCT00940498|580828780|FG006|Overall Study|Disease Progression|0|||
160847695|NCT00940498|580828781|FG007|Overall Study|Disease Progression|0|||
160847696|NCT00940498|580828774|FG000|Overall Study|Physician Decision|0|||
160847697|NCT00940498|580828775|FG001|Overall Study|Physician Decision|0|||
160847698|NCT00940498|580828776|FG002|Overall Study|Physician Decision|0|||
160847699|NCT00940498|580828777|FG003|Overall Study|Physician Decision|0|||
160847700|NCT00940498|580828778|FG004|Overall Study|Physician Decision|2|||
160847701|NCT00940498|580828779|FG005|Overall Study|Physician Decision|0|||
160847702|NCT00940498|580828780|FG006|Overall Study|Physician Decision|0|||
160847703|NCT00940498|580828781|FG007|Overall Study|Physician Decision|0|||
160847704|NCT00940498|580828774|FG000|Overall Study|Not treated due to disease related pain|0|||
160847705|NCT00940498|580828775|FG001|Overall Study|Not treated due to disease related pain|0|||
160847706|NCT00940498|580828776|FG002|Overall Study|Not treated due to disease related pain|0|||
160847707|NCT00940498|580828777|FG003|Overall Study|Not treated due to disease related pain|0|||
160847708|NCT00940498|580828778|FG004|Overall Study|Not treated due to disease related pain|1|||
160847709|NCT00940498|580828779|FG005|Overall Study|Not treated due to disease related pain|0|||
160847710|NCT00940498|580828780|FG006|Overall Study|Not treated due to disease related pain|0|||
160847711|NCT00940498|580828781|FG007|Overall Study|Not treated due to disease related pain|0|||
160847712|NCT00900029|580828782|FG000|Overall Study|Lost to Follow-up|0|||
160847713|NCT00900029|580828783|FG001|Overall Study|Lost to Follow-up|2|||
160847714|NCT00900029|580828784|FG002|Overall Study|Lost to Follow-up|1|||
160847715|NCT00900029|580828785|FG003|Overall Study|Lost to Follow-up|4|||
160847716|NCT00900029|580828786|FG004|Overall Study|Lost to Follow-up|4|||
160847717|NCT00900029|580828782|FG000|Overall Study|Withdrawal by Subject|2|||
160847718|NCT00900029|580828783|FG001|Overall Study|Withdrawal by Subject|2|||
160847719|NCT00900029|580828784|FG002|Overall Study|Withdrawal by Subject|1|||
160847720|NCT00900029|580828785|FG003|Overall Study|Withdrawal by Subject|1|||
160847721|NCT00900029|580828786|FG004|Overall Study|Withdrawal by Subject|1|||
160847722|NCT00900029|580828782|FG000|Overall Study|Adverse Event|0|||
160847723|NCT00900029|580828783|FG001|Overall Study|Adverse Event|0|||
160847724|NCT00900029|580828784|FG002|Overall Study|Adverse Event|1|||
160847725|NCT00900029|580828785|FG003|Overall Study|Adverse Event|1|||
160847726|NCT00900029|580828786|FG004|Overall Study|Adverse Event|1|||
160847727|NCT00900029|580828782|FG000|Overall Study|Death|1|||
160847728|NCT00900029|580828783|FG001|Overall Study|Death|0|||
160847729|NCT00900029|580828784|FG002|Overall Study|Death|0|||
160847730|NCT00900029|580828785|FG003|Overall Study|Death|1|||
160847731|NCT00900029|580828786|FG004|Overall Study|Death|0|||
160847732|NCT02709330|580828787|FG000|Overall Study|Death|5|||
160847733|NCT02709330|580828788|FG001|Overall Study|Death|0|||
160847734|NCT02709330|580828787|FG000|Overall Study|Lost to Follow-up|2|||
160847735|NCT02709330|580828788|FG001|Overall Study|Lost to Follow-up|0|||
160847736|NCT02709330|580828787|FG000|Overall Study|Physician Decision|2|||
160847737|NCT02709330|580828788|FG001|Overall Study|Physician Decision|0|||
160847738|NCT02709330|580828787|FG000|Overall Study|Withdrawal by Subject|4|||
160847739|NCT02709330|580828788|FG001|Overall Study|Withdrawal by Subject|0|||
160847740|NCT02587819|580828791|FG000|Overall Study|Adverse Event|1|||
160847741|NCT02587819|580828791|FG000|Overall Study|Lost to Follow-up|1|||
160847742|NCT01594931|580831700|FG000|Overall Study|Adverse Event|3|||
160847743|NCT01594931|580831701|FG001|Overall Study|Adverse Event|1|||
160847744|NCT01594931|580831702|FG002|Overall Study|Adverse Event|1|||
160847745|NCT01594931|580831700|FG000|Overall Study|Withdrawal by Subject|2|||
160847746|NCT01594931|580831701|FG001|Overall Study|Withdrawal by Subject|1|||
161141010|NCT01386385|581900929|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161141011|NCT01386385|581900930|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161141012|NCT01386385|581900931|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
160847747|NCT01594931|580831702|FG002|Overall Study|Withdrawal by Subject|1|||
160847748|NCT01594931|580831700|FG000|Overall Study|Lack of Efficacy|7|||
160847749|NCT01594931|580831701|FG001|Overall Study|Lack of Efficacy|2|||
160847750|NCT01594931|580831702|FG002|Overall Study|Lack of Efficacy|2|||
160847751|NCT01594931|580831700|FG000|Overall Study|Lost to Follow-up|4|||
160847752|NCT01594931|580831701|FG001|Overall Study|Lost to Follow-up|3|||
160847753|NCT01594931|580831702|FG002|Overall Study|Lost to Follow-up|3|||
160847754|NCT01594931|580831700|FG000|Overall Study|Protocol Violation|2|||
160847755|NCT01594931|580831701|FG001|Overall Study|Protocol Violation|1|||
160847756|NCT01594931|580831702|FG002|Overall Study|Protocol Violation|0|||
160847757|NCT01594931|580831700|FG000|Overall Study|No defiined|11|||
161141013|NCT01386385|581900932|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161141014|NCT01386385|581900933|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
161141015|NCT01386385|581900934|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161141016|NCT01386385|581900935|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161141017|NCT01386385|581900936|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
161141018|NCT01386385|581900929|FG000|Phase II Concurrent CRT|Adverse Event|0|||
161141019|NCT01386385|581900930|FG001|Phase II Concurrent CRT|Adverse Event|0|||
161254539|NCT00804141|582310000|FG000|Overall Study|Other than specified|30|||
161254540|NCT00804141|582310000|FG000|Overall Study|Enrolled but not treated|6|||
161254541|NCT01142908|582310001|FG000|Overall Study|Lost to Follow-up|19|||
161254542|NCT01142908|582310002|FG001|Overall Study|Lost to Follow-up|13|||
160847758|NCT01594931|580831701|FG001|Overall Study|No defiined|4|||
160847759|NCT01594931|580831702|FG002|Overall Study|No defiined|7|||
160847760|NCT01929226|580831707|FG000|Overall Study|Lost to Follow-up|4|||
160847761|NCT01929226|580831708|FG001|Overall Study|Lost to Follow-up|0|||
160847762|NCT01929226|580831707|FG000|Overall Study|Withdrawal by Subject|1|||
160847763|NCT01929226|580831708|FG001|Overall Study|Withdrawal by Subject|1|||
160847764|NCT00859547|580831709|FG000|Overall Study|Lost to Follow-up|1|||
160847765|NCT00859547|580831709|FG000|Overall Study|Parent withdrew consent|1|||
160847766|NCT01473732|580831712|FG000|Overall Study|Adverse Event|1|||
160847767|NCT01473732|580831713|FG001|Overall Study|Adverse Event|0|||
160847768|NCT01473732|580831712|FG000|Overall Study|Death|1|||
160847769|NCT01473732|580831713|FG001|Overall Study|Death|0|||
160847770|NCT00592904|580831734|FG000|Overall Study|Adverse Event|15|||
160847771|NCT00592904|580831735|FG001|Overall Study|Adverse Event|25|||
160847772|NCT00592904|580831736|FG002|Overall Study|Adverse Event|13|||
160847773|NCT00592904|580831737|FG003|Overall Study|Adverse Event|5|||
160847774|NCT00592904|580831734|FG000|Overall Study|Protocol Violation|1|||
160847775|NCT00592904|580831735|FG001|Overall Study|Protocol Violation|1|||
160847776|NCT00592904|580831736|FG002|Overall Study|Protocol Violation|0|||
160847777|NCT00592904|580831737|FG003|Overall Study|Protocol Violation|1|||
160847778|NCT00592904|580831734|FG000|Overall Study|Withdrawal by Subject|4|||
160847779|NCT00592904|580831735|FG001|Overall Study|Withdrawal by Subject|16|||
160847780|NCT00592904|580831736|FG002|Overall Study|Withdrawal by Subject|1|||
160847781|NCT00592904|580831737|FG003|Overall Study|Withdrawal by Subject|2|||
160847782|NCT00592904|580831734|FG000|Overall Study|Lack of Efficacy|2|||
160847783|NCT00592904|580831735|FG001|Overall Study|Lack of Efficacy|7|||
160992428|NCT00817635|581361359|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161254543|NCT01142908|582310001|FG000|Overall Study|Death|1|||
161254544|NCT01142908|582310002|FG001|Overall Study|Death|4|||
161254545|NCT01142908|582310001|FG000|Overall Study|Excluded - did not meet criteria|9|||
161254546|NCT01142908|582310002|FG001|Overall Study|Excluded - did not meet criteria|5|||
160847784|NCT00592904|580831736|FG002|Overall Study|Lack of Efficacy|2|||
160847785|NCT00592904|580831737|FG003|Overall Study|Lack of Efficacy|3|||
160847786|NCT00592904|580831734|FG000|Overall Study|Physician Decision|0|||
160847787|NCT00592904|580831735|FG001|Overall Study|Physician Decision|3|||
160847788|NCT00592904|580831736|FG002|Overall Study|Physician Decision|1|||
160992429|NCT00817635|581361360|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
160992430|NCT00817635|581361361|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
160992431|NCT00817635|581361362|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
160992432|NCT00817635|581361363|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
160992433|NCT00817635|581361359|FG000|Overall Study|Withdrawal by Subject|2|||
160992434|NCT00817635|581361360|FG001|Overall Study|Withdrawal by Subject|1|||
160992435|NCT00817635|581361361|FG002|Overall Study|Withdrawal by Subject|0|||
161141020|NCT01386385|581900931|FG002|Phase II Concurrent CRT|Adverse Event|0|||
161254547|NCT01142908|582310001|FG000|Overall Study|Withdrawal by Subject|3|||
161254548|NCT01142908|582310002|FG001|Overall Study|Withdrawal by Subject|0|||
161254549|NCT03235479|582310004|FG000|Overall Study|Lost to Follow-up|8|||
161254550|NCT03235479|582310005|FG001|Overall Study|Lost to Follow-up|11|||
161254551|NCT03235479|582310004|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
161254552|NCT03235479|582310005|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
160847789|NCT00592904|580831737|FG003|Overall Study|Physician Decision|0|||
161254553|NCT03235479|582310004|FG000|Overall Study|Pregnancy|1|||
160847790|NCT00592904|580831734|FG000|Overall Study|Other|3|||
161254554|NCT03235479|582310005|FG001|Overall Study|Pregnancy|0|||
161254555|NCT03235479|582310004|FG000|Overall Study|Protocol Deviation|1|||
160847791|NCT00592904|580831735|FG001|Overall Study|Other|3|||
160847792|NCT00592904|580831736|FG002|Overall Study|Other|0|||
160847793|NCT00592904|580831737|FG003|Overall Study|Other|0|||
160847794|NCT00824473|580831740|FG000|Overall Study|Adverse Event|4|||
160847795|NCT00824473|580831741|FG001|Overall Study|Adverse Event|5|||
160847796|NCT00824473|580831740|FG000|Overall Study|Lack of Efficacy|2|||
160847797|NCT00824473|580831741|FG001|Overall Study|Lack of Efficacy|2|||
160847798|NCT00824473|580831740|FG000|Overall Study|Protocol Violation|2|||
160847799|NCT00824473|580831741|FG001|Overall Study|Protocol Violation|0|||
160847800|NCT00824473|580831740|FG000|Overall Study|Non-Compliance|4|||
160847801|NCT00824473|580831741|FG001|Overall Study|Non-Compliance|2|||
160847802|NCT00824473|580831740|FG000|Overall Study|Withdrawal by Subject|2|||
160847803|NCT00824473|580831741|FG001|Overall Study|Withdrawal by Subject|3|||
160847804|NCT00824473|580831740|FG000|Overall Study|Other|1|||
160847805|NCT00824473|580831741|FG001|Overall Study|Other|1|||
160847806|NCT03906071|580831742|FG000|Overall Study|Death|180|||
160847807|NCT03906071|580831743|FG001|Overall Study|Death|185|||
160847808|NCT03906071|580831742|FG000|Overall Study|Lost to Follow-up|3|||
160847809|NCT03906071|580831743|FG001|Overall Study|Lost to Follow-up|3|||
160847810|NCT03906071|580831742|FG000|Overall Study|Withdrawal by Subject|15|||
160847811|NCT03906071|580831743|FG001|Overall Study|Withdrawal by Subject|27|||
160847812|NCT03906071|580831742|FG000|Overall Study|Other|2|||
160847813|NCT03906071|580831743|FG001|Overall Study|Other|1|||
160847814|NCT01359904|580831744|FG000|Overall Study|Withdrawal by Subject|1|||
160847815|NCT01359904|580831745|FG001|Overall Study|Withdrawal by Subject|0|||
160847816|NCT01172535|580831748|FG000|Overall Study|Death|3|||
160847817|NCT01172535|580831748|FG000|Overall Study|Withdrawal by Subject|2|||
161336953|NCT02230891|582623662|FG002|6 Month|Withdrawal by Subject|1|||
160847818|NCT01172535|580831748|FG000|Overall Study|Lost to Follow-up|1|||
160847819|NCT01172535|580831748|FG000|Overall Study|Ineligible at study entry|1|||
160847820|NCT01172535|580831748|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
160847821|NCT01461707|580831749|FG000|Overall Study|Withdrawal by Subject|1|||
160847822|NCT01461707|580831750|FG001|Overall Study|Withdrawal by Subject|0|||
160847823|NCT00337207|580831751|FG000|Overall Study|Withdrawal by Subject|3|||
160847824|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
160847825|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
160847826|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
160847827|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
160847828|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
160906225|NCT00730405|581050360|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
160906226|NCT01496807|581050361|FG000|Overall Study|Progressive Disease|21|||
160906227|NCT01496807|581050361|FG000|Overall Study|Participant preference/toxicity|8|||
160906228|NCT01496807|581050361|FG000|Overall Study|Change in diagnosis|1|||
160906229|NCT03330288|581050364|FG000|Overall Study|Other reason|1|||
160906230|NCT03330288|581050365|FG001|Overall Study|Other reason|1|||
160906231|NCT03330288|581050364|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
160906232|NCT03330288|581050365|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
160906233|NCT03330288|581050364|FG000|Overall Study|Adverse Event|1|||
160906234|NCT03330288|581050365|FG001|Overall Study|Adverse Event|0|||
160906235|NCT03330288|581050364|FG000|Overall Study|Withdrawal by Subject|1|||
160906236|NCT03330288|581050365|FG001|Overall Study|Withdrawal by Subject|0|||
160906237|NCT03330288|581050364|FG000|Overall Study|Lost to Follow-up|26|||
160906238|NCT03330288|581050365|FG001|Overall Study|Lost to Follow-up|7|||
160906239|NCT04447794|581050366|FG000|Overall Study|Lost to Follow-up|2|||
160906240|NCT04447794|581050367|FG001|Overall Study|Lost to Follow-up|3|||
160906241|NCT04447794|581050368|FG002|Overall Study|Lost to Follow-up|8|||
160906242|NCT04447794|581050366|FG000|Overall Study|Withdrawal by Subject|1|||
160906243|NCT04447794|581050367|FG001|Overall Study|Withdrawal by Subject|1|||
160906244|NCT04447794|581050368|FG002|Overall Study|Withdrawal by Subject|0|||
160906245|NCT00963937|581050373|FG000|Overall Study|Protocol Violation|1|||
160906246|NCT00963937|581050374|FG001|Overall Study|Protocol Violation|1|||
160906247|NCT00963937|581050375|FG002|Overall Study|Protocol Violation|0|||
160906248|NCT00963937|581050373|FG000|Overall Study|Physician Decision|18|||
160906249|NCT00963937|581050374|FG001|Overall Study|Physician Decision|10|||
160906250|NCT00963937|581050375|FG002|Overall Study|Physician Decision|4|||
160906251|NCT02106975|581050376|FG000|Overall Study|Death|25|||
160906252|NCT02106975|581050377|FG001|Overall Study|Death|39|||
160906253|NCT03546062|581050378|FG000|Overall Study|Adverse Event|6|||
160906254|NCT03546062|581050379|FG001|Overall Study|Adverse Event|5|||
160906255|NCT03546062|581050380|FG002|Overall Study|Adverse Event|8|||
160906256|NCT00181155|581050381|FG000|Overall Study|Physician Decision|1|||
160906257|NCT00181155|581050382|FG001|Overall Study|Physician Decision|0|||
160906258|NCT00181155|581050381|FG000|Overall Study|Withdrawal by Subject|1|||
160906259|NCT00181155|581050382|FG001|Overall Study|Withdrawal by Subject|0|||
160906260|NCT02572401|581050383|FG000|Overall Study|Lost to Follow-up|5|||
160906261|NCT02572401|581050384|FG001|Overall Study|Lost to Follow-up|8|||
160906262|NCT02572401|581050385|FG002|Overall Study|Lost to Follow-up|9|||
160906263|NCT02572401|581050386|FG003|Overall Study|Lost to Follow-up|9|||
160906264|NCT02572401|581050383|FG000|Overall Study|Death|0|||
160906265|NCT02572401|581050384|FG001|Overall Study|Death|0|||
160906266|NCT02572401|581050385|FG002|Overall Study|Death|0|||
160906267|NCT02572401|581050386|FG003|Overall Study|Death|1|||
160906268|NCT01768286|581050389|FG000|Overall Study|Randomized But Not Treated|0|||
160906269|NCT01768286|581050390|FG001|Overall Study|Randomized But Not Treated|0|||
161336954|NCT02230891|582623660|FG000|6 Month|Physician Decision|0|||
161141021|NCT01386385|581900932|FG003|Phase II Concurrent CRT|Adverse Event|0|||
161141022|NCT01386385|581900933|FG004|Phase II Concurrent CRT|Adverse Event|0|||
161141023|NCT01386385|581900934|FG005|Phase II Concurrent CRT|Adverse Event|0|||
161141024|NCT01386385|581900935|FG006|Phase II Concurrent CRT|Adverse Event|3|||
161141025|NCT01386385|581900936|FG007|Phase II Concurrent CRT|Adverse Event|3|||
161141026|NCT01386385|581900929|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161141027|NCT01386385|581900930|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161141028|NCT01386385|581900931|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161141029|NCT01386385|581900932|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161141030|NCT01386385|581900933|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
160847829|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
160847830|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
161141031|NCT01386385|581900934|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161141032|NCT01386385|581900935|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
161141033|NCT01386385|581900936|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
161141034|NCT01386385|581900929|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
161141035|NCT01386385|581900930|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
160847831|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
160847832|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
160847833|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
160847834|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
160847835|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
160847836|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
160847837|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
160847838|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
160847839|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
160847840|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
160847841|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
160847842|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
160847843|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
160847844|NCT03573323|580831752|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
160847845|NCT03573323|580831753|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
160847846|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
160847847|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
160847848|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
160847849|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
160847850|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
160847851|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
160847852|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
160847853|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
160847854|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
160847855|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
160847856|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
160847857|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
160847858|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
160847859|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
160847860|NCT03573323|580831752|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
160847861|NCT03573323|580831753|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
160847862|NCT00413218|580831755|FG000|Overall Study|Randomized but didn't receive study drug|2|||
160847863|NCT00413218|580831756|FG001|Overall Study|Randomized but didn't receive study drug|8|||
160847864|NCT00413218|580831755|FG000|Overall Study|Death|57|||
160847865|NCT00413218|580831756|FG001|Overall Study|Death|56|||
160847866|NCT00413218|580831755|FG000|Overall Study|Lost to Follow-up|14|||
160847867|NCT00413218|580831756|FG001|Overall Study|Lost to Follow-up|17|||
160847868|NCT00413218|580831755|FG000|Overall Study|Admin|20|||
160992436|NCT00817635|581361362|FG003|Overall Study|Withdrawal by Subject|1|||
161141036|NCT01386385|581900931|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
161141037|NCT01386385|581900932|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
161141038|NCT01386385|581900933|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
161254556|NCT03235479|582310005|FG001|Overall Study|Protocol Deviation|3|||
161254557|NCT03235479|582310004|FG000|Overall Study|Technical Problems|3|||
161254558|NCT03235479|582310005|FG001|Overall Study|Technical Problems|2|||
161254559|NCT03235479|582310004|FG000|Overall Study|Withdrawal by Subject|2|||
161254560|NCT03235479|582310005|FG001|Overall Study|Withdrawal by Subject|2|||
161254561|NCT03235479|582310004|FG000|Overall Study|Other Reasons|3|||
161254562|NCT03235479|582310005|FG001|Overall Study|Other Reasons|5|||
161254563|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
161254564|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
161141039|NCT01386385|581900934|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
161141040|NCT01386385|581900935|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
161141041|NCT01386385|581900936|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
161141042|NCT01386385|581900929|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141043|NCT01386385|581900930|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141044|NCT01386385|581900931|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141045|NCT01386385|581900932|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141046|NCT01386385|581900933|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141047|NCT01386385|581900934|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141048|NCT01386385|581900935|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
161141049|NCT01386385|581900936|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
161141050|NCT01386385|581900929|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
161141051|NCT01386385|581900930|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
161141052|NCT01386385|581900931|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
161141053|NCT01386385|581900932|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
161141054|NCT01386385|581900933|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
161141055|NCT01386385|581900934|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
161141056|NCT01386385|581900935|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
161141057|NCT01386385|581900936|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
161141058|NCT03746080|581900938|FG000|Overall Study|In follow up|2|||
161141059|NCT03746080|581900938|FG000|Overall Study|Death|15|||
161141060|NCT02128490|581900942|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161141061|NCT02128490|581900943|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161141062|NCT02128490|581900944|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161141063|NCT02128490|581900945|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161141064|NCT02128490|581900946|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161141065|NCT02128490|581900942|FG000|Overall Study|Major Protocol Deviation|1|||
160847869|NCT00413218|580831756|FG001|Overall Study|Admin|14|||
160847870|NCT00413218|580831755|FG000|Overall Study|Missing|1|||
160847871|NCT00413218|580831756|FG001|Overall Study|Missing|0|||
160847872|NCT00413218|580831755|FG000|Overall Study|Withdrawal by Subject|9|||
160847873|NCT00413218|580831756|FG001|Overall Study|Withdrawal by Subject|1|||
160847874|NCT00837213|580831759|FG000|Overall Study|Lost to Follow-up|3|||
160847875|NCT00837213|580831760|FG001|Overall Study|Lost to Follow-up|2|||
160847876|NCT00837213|580831759|FG000|Overall Study|Withdrawal by Subject|2|||
160847877|NCT00837213|580831760|FG001|Overall Study|Withdrawal by Subject|2|||
160847878|NCT00837213|580831759|FG000|Overall Study|not stated|1|||
160847879|NCT00837213|580831760|FG001|Overall Study|not stated|1|||
160847880|NCT02562716|580831768|FG000|Overall Study|Adverse Event|7|||
160847881|NCT02562716|580831769|FG001|Overall Study|Adverse Event|14|||
160847882|NCT02562716|580831768|FG000|Overall Study|Withdrawal unrelated to AE|7|||
160847883|NCT02562716|580831769|FG001|Overall Study|Withdrawal unrelated to AE|1|||
160847884|NCT02562716|580831768|FG000|Overall Study|Progression|8|||
160847885|NCT02562716|580831769|FG001|Overall Study|Progression|10|||
160847886|NCT02562716|580831768|FG000|Overall Study|Death|2|||
160847887|NCT02562716|580831769|FG001|Overall Study|Death|1|||
160847888|NCT02562716|580831768|FG000|Overall Study|Not protocol specified|4|||
160847889|NCT02562716|580831769|FG001|Overall Study|Not protocol specified|2|||
160847890|NCT02753946|580831770|FG000|Overall Study|Adverse Event|7|||
160847891|NCT02753946|580831771|FG001|Overall Study|Adverse Event|6|||
160847892|NCT02753946|580831770|FG000|Overall Study|Withdrawal by Subject|6|||
160847893|NCT02753946|580831771|FG001|Overall Study|Withdrawal by Subject|1|||
160847894|NCT02753946|580831770|FG000|Overall Study|Lack of Efficacy|1|||
160847895|NCT02753946|580831771|FG001|Overall Study|Lack of Efficacy|0|||
160847896|NCT02753946|580831770|FG000|Overall Study|Physician Decision|0|||
160847897|NCT02753946|580831771|FG001|Overall Study|Physician Decision|2|||
160847898|NCT02175017|580831772|FG000|Overall Study|Did not receive the investigational product|1|||
160847899|NCT02175017|580831773|FG001|Overall Study|Did not receive the investigational product|2|||
160847900|NCT02175017|580831772|FG000|Overall Study|Withdrawal by Subject|6|||
160847901|NCT02175017|580831773|FG001|Overall Study|Withdrawal by Subject|3|||
160847902|NCT02175017|580831772|FG000|Overall Study|Met an exclusion criteria|0|||
160847903|NCT02175017|580831773|FG001|Overall Study|Met an exclusion criteria|1|||
161141066|NCT02128490|581900943|FG001|Overall Study|Major Protocol Deviation|2|||
161141067|NCT02128490|581900944|FG002|Overall Study|Major Protocol Deviation|0|||
160847904|NCT02175017|580831772|FG000|Overall Study|Adverse Event|3|||
161141068|NCT02128490|581900945|FG003|Overall Study|Major Protocol Deviation|2|||
161141069|NCT02128490|581900946|FG004|Overall Study|Major Protocol Deviation|2|||
160847905|NCT02175017|580831773|FG001|Overall Study|Adverse Event|10|||
160847906|NCT02175017|580831772|FG000|Overall Study|Disease progression|20|||
160847907|NCT02175017|580831773|FG001|Overall Study|Disease progression|27|||
160847908|NCT02175017|580831772|FG000|Overall Study|Other than above reasons|3|||
160847909|NCT02175017|580831773|FG001|Overall Study|Other than above reasons|0|||
160847910|NCT00216671|580831774|FG000|Overall Study|Adverse Event|4|||
160847911|NCT00216671|580831775|FG001|Overall Study|Adverse Event|9|||
160847912|NCT00216671|580831774|FG000|Overall Study|Pregnancy|0|||
160847913|NCT00216671|580831775|FG001|Overall Study|Pregnancy|1|||
160847914|NCT00216671|580831774|FG000|Overall Study|Withdrawal by Subject|4|||
160847915|NCT00216671|580831775|FG001|Overall Study|Withdrawal by Subject|2|||
160847916|NCT00216671|580831774|FG000|Overall Study|Refused Injections|3|||
160847917|NCT00216671|580831775|FG001|Overall Study|Refused Injections|13|||
160847918|NCT00216671|580831774|FG000|Overall Study|No Need to Continue Medication|1|||
160847919|NCT00216671|580831775|FG001|Overall Study|No Need to Continue Medication|1|||
160847920|NCT00216671|580831774|FG000|Overall Study|Insufficient Response|9|||
160847921|NCT00216671|580831775|FG001|Overall Study|Insufficient Response|4|||
160847922|NCT00216671|580831774|FG000|Overall Study|Lost to Follow-up|3|||
160847923|NCT00216671|580831775|FG001|Overall Study|Lost to Follow-up|5|||
160847924|NCT00216671|580831774|FG000|Overall Study|Non compliant|2|||
160847925|NCT00216671|580831775|FG001|Overall Study|Non compliant|2|||
160847926|NCT00216671|580831774|FG000|Overall Study|Ineligible|0|||
160847927|NCT00216671|580831775|FG001|Overall Study|Ineligible|2|||
160847928|NCT00216671|580831774|FG000|Overall Study|Physician Decision|1|||
160847929|NCT00216671|580831775|FG001|Overall Study|Physician Decision|1|||
161336955|NCT02230891|582623661|FG001|6 Month|Physician Decision|2|||
161336956|NCT02230891|582623662|FG002|6 Month|Physician Decision|0|||
161336957|NCT02230891|582623660|FG000|12 Month|Death|1|||
161336958|NCT02230891|582623661|FG001|12 Month|Death|0|||
161336959|NCT02230891|582623662|FG002|12 Month|Death|0|||
161336960|NCT02230891|582623660|FG000|12 Month|Lost to Follow-up|0|||
161336961|NCT02230891|582623661|FG001|12 Month|Lost to Follow-up|1|||
161336962|NCT02230891|582623662|FG002|12 Month|Lost to Follow-up|0|||
161336963|NCT02230891|582623660|FG000|12 Month|Withdrawal by Subject|0|||
161336964|NCT02230891|582623661|FG001|12 Month|Withdrawal by Subject|2|||
161336965|NCT02230891|582623662|FG002|12 Month|Withdrawal by Subject|0|||
161336966|NCT02230891|582623660|FG000|18 Month End of Study|Death|0|||
160992437|NCT00817635|581361363|FG004|Overall Study|Withdrawal by Subject|2|||
160992438|NCT00817635|581361359|FG000|Overall Study|Lost to Follow-up|0|||
161336967|NCT02230891|582623661|FG001|18 Month End of Study|Death|0|||
160847930|NCT00216671|580831774|FG000|Overall Study|Protocol Violation|3|||
160847931|NCT00216671|580831775|FG001|Overall Study|Protocol Violation|5|||
160847932|NCT00216671|580831774|FG000|Overall Study|Relapse|1|||
160847933|NCT00216671|580831775|FG001|Overall Study|Relapse|0|||
160847934|NCT00216671|580831774|FG000|Overall Study|Investigator Illness|0|||
160847935|NCT00216671|580831775|FG001|Overall Study|Investigator Illness|1|||
160847936|NCT00216671|580831774|FG000|Overall Study|Patient Moved|0|||
160847937|NCT00216671|580831775|FG001|Overall Study|Patient Moved|1|||
160847938|NCT00216671|580831774|FG000|Overall Study|Ineligible, no efficacy data|2|||
160847939|NCT00216671|580831775|FG001|Overall Study|Ineligible, no efficacy data|2|||
160847940|NCT00216671|580831774|FG000|Overall Study|Insufficient Response Adverse Event|2|||
160847941|NCT00216671|580831775|FG001|Overall Study|Insufficient Response Adverse Event|1|||
160847942|NCT02714569|580831776|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
160847943|NCT02714569|580831777|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
160847944|NCT02714569|580831778|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
160847945|NCT02714569|580831779|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
160847946|NCT02714569|580831780|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
160847947|NCT02714569|580831781|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
160847948|NCT02714569|580831782|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
160847949|NCT02714569|580831783|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
160847950|NCT02714569|580831784|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
160847951|NCT02714569|580831785|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
160847952|NCT02714569|580831786|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
160847953|NCT02714569|580831776|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847954|NCT02714569|580831777|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847955|NCT02714569|580831778|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847956|NCT02714569|580831779|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
160847957|NCT02714569|580831780|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160992439|NCT00817635|581361360|FG001|Overall Study|Lost to Follow-up|1|||
161336968|NCT02230891|582623662|FG002|18 Month End of Study|Death|1|||
161336969|NCT02230891|582623660|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
160847958|NCT02714569|580831781|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847959|NCT02714569|580831782|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847960|NCT02714569|580831783|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847961|NCT02714569|580831784|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847962|NCT02714569|580831785|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160992440|NCT00817635|581361361|FG002|Overall Study|Lost to Follow-up|0|||
160992441|NCT00817635|581361362|FG003|Overall Study|Lost to Follow-up|1|||
161336970|NCT02230891|582623661|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
161336971|NCT02230891|582623662|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
161336972|NCT03087058|582623664|FG000|Overall Study|Withdrawal by Subject|2|||
161336973|NCT03087058|582623665|FG001|Overall Study|Withdrawal by Subject|0|||
161336974|NCT03087058|582623666|FG002|Overall Study|Withdrawal by Subject|0|||
160847963|NCT02714569|580831786|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
160847964|NCT02714569|580831776|FG000|Part A Third Intervention|Adverse Event|0|||
160847965|NCT02714569|580831777|FG001|Part A Third Intervention|Adverse Event|0|||
160847966|NCT02714569|580831778|FG002|Part A Third Intervention|Adverse Event|1|||
160847967|NCT02714569|580831779|FG003|Part A Third Intervention|Adverse Event|0|||
160847968|NCT02714569|580831780|FG004|Part A Third Intervention|Adverse Event|0|||
160847969|NCT02714569|580831781|FG005|Part A Third Intervention|Adverse Event|0|||
160847970|NCT02714569|580831782|FG006|Part A Third Intervention|Adverse Event|0|||
160847971|NCT02714569|580831783|FG007|Part A Third Intervention|Adverse Event|0|||
160847972|NCT02714569|580831784|FG008|Part A Third Intervention|Adverse Event|0|||
160847973|NCT02714569|580831785|FG009|Part A Third Intervention|Adverse Event|0|||
160847974|NCT02714569|580831786|FG010|Part A Third Intervention|Adverse Event|0|||
160847975|NCT02714569|580831776|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
160847976|NCT02714569|580831777|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847977|NCT02714569|580831778|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847978|NCT02714569|580831779|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847979|NCT02714569|580831780|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847980|NCT02714569|580831781|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
160847981|NCT02714569|580831782|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847982|NCT02714569|580831783|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847983|NCT02714569|580831784|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847984|NCT02714569|580831785|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847985|NCT02714569|580831786|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
160847986|NCT02714569|580831776|FG000|Part B (Overall)|Lost to Follow-up|0|||
160847987|NCT02714569|580831777|FG001|Part B (Overall)|Lost to Follow-up|0|||
160847988|NCT02714569|580831778|FG002|Part B (Overall)|Lost to Follow-up|0|||
160847989|NCT02714569|580831779|FG003|Part B (Overall)|Lost to Follow-up|0|||
160847990|NCT02714569|580831780|FG004|Part B (Overall)|Lost to Follow-up|0|||
160847991|NCT02714569|580831781|FG005|Part B (Overall)|Lost to Follow-up|0|||
160847992|NCT02714569|580831782|FG006|Part B (Overall)|Lost to Follow-up|1|||
160847993|NCT02714569|580831783|FG007|Part B (Overall)|Lost to Follow-up|0|||
160847994|NCT02714569|580831784|FG008|Part B (Overall)|Lost to Follow-up|0|||
160992442|NCT00817635|581361363|FG004|Overall Study|Lost to Follow-up|0|||
160992443|NCT00817635|581361359|FG000|Overall Study|Administrative Problems|0|||
160992444|NCT00817635|581361360|FG001|Overall Study|Administrative Problems|0|||
160992445|NCT00817635|581361361|FG002|Overall Study|Administrative Problems|0|||
160992446|NCT00817635|581361362|FG003|Overall Study|Administrative Problems|0|||
160992447|NCT00817635|581361363|FG004|Overall Study|Administrative Problems|1|||
160992448|NCT00817635|581361359|FG000|Overall Study|Protocol Violation|5|||
160992449|NCT00817635|581361360|FG001|Overall Study|Protocol Violation|1|||
160992450|NCT00817635|581361361|FG002|Overall Study|Protocol Violation|3|||
160992451|NCT00817635|581361362|FG003|Overall Study|Protocol Violation|2|||
160992452|NCT00817635|581361363|FG004|Overall Study|Protocol Violation|3|||
160992453|NCT00918957|581361365|FG000|Overall Study|Adverse Event|2|||
160992454|NCT00918957|581361366|FG001|Overall Study|Adverse Event|0|||
160992455|NCT00918957|581361365|FG000|Overall Study|Withdrawal by Subject|1|||
160992456|NCT00918957|581361366|FG001|Overall Study|Withdrawal by Subject|0|||
160992457|NCT03107611|581361367|FG000|Overall Study|Adverse Event|1|||
160992458|NCT03107611|581361368|FG001|Overall Study|Adverse Event|0|||
160992459|NCT03107611|581361369|FG002|Overall Study|Adverse Event|2|||
160992460|NCT03107611|581361367|FG000|Overall Study|Lost to Follow-up|3|||
160992461|NCT03107611|581361368|FG001|Overall Study|Lost to Follow-up|3|||
160992462|NCT03107611|581361369|FG002|Overall Study|Lost to Follow-up|3|||
160992463|NCT03107611|581361367|FG000|Overall Study|Protocol Violation|0|||
160992464|NCT03107611|581361368|FG001|Overall Study|Protocol Violation|0|||
160992465|NCT03107611|581361369|FG002|Overall Study|Protocol Violation|1|||
160992466|NCT03107611|581361367|FG000|Overall Study|Withdrawal by Subject|1|||
160992467|NCT03107611|581361368|FG001|Overall Study|Withdrawal by Subject|0|||
160992468|NCT03107611|581361369|FG002|Overall Study|Withdrawal by Subject|1|||
160992469|NCT03107611|581361367|FG000|Overall Study|Worsening signs/symptoms|2|||
160992470|NCT03107611|581361368|FG001|Overall Study|Worsening signs/symptoms|1|||
160992471|NCT03107611|581361369|FG002|Overall Study|Worsening signs/symptoms|2|||
160992472|NCT01720446|581361370|FG000|Overall Study|Lost to Follow-up|12|||
160992473|NCT01720446|581361371|FG001|Overall Study|Lost to Follow-up|6|||
160992474|NCT01720446|581361372|FG002|Overall Study|Lost to Follow-up|16|||
160847995|NCT02714569|580831785|FG009|Part B (Overall)|Lost to Follow-up|0|||
160847996|NCT02714569|580831786|FG010|Part B (Overall)|Lost to Follow-up|0|||
160992475|NCT01720446|581361373|FG003|Overall Study|Lost to Follow-up|16|||
160992476|NCT01720446|581361370|FG000|Overall Study|Withdrawal by Subject|2|||
160992477|NCT01720446|581361371|FG001|Overall Study|Withdrawal by Subject|5|||
160992478|NCT01720446|581361372|FG002|Overall Study|Withdrawal by Subject|4|||
160992479|NCT01720446|581361373|FG003|Overall Study|Withdrawal by Subject|4|||
160992480|NCT01020838|581361376|FG000|Overall Study|Death|90|||
160992481|NCT01020838|581361376|FG000|Overall Study|Adverse Event|1|||
161336975|NCT00617279|582623670|FG000|Overall Study|Study terminated by Sponsor|10|||
161336976|NCT00617279|582623671|FG001|Overall Study|Study terminated by Sponsor|15|||
161336977|NCT00617279|582623670|FG000|Overall Study|Graft abandonment|2|||
161336978|NCT00617279|582623671|FG001|Overall Study|Graft abandonment|0|||
161336979|NCT00617279|582623670|FG000|Overall Study|Lost to Follow-up|1|||
161336980|NCT00617279|582623671|FG001|Overall Study|Lost to Follow-up|0|||
161336981|NCT00617279|582623670|FG000|Overall Study|Death|1|||
161336982|NCT00617279|582623671|FG001|Overall Study|Death|2|||
161336983|NCT04158219|582623677|FG000|Overall Study|Lost to Follow-up|1|||
161336984|NCT01814007|582623679|FG000|Overall Study|Withdrawal by Subject|1|||
161336985|NCT01324947|582623680|FG000|Overall Study|Adverse Event|7|||
161336986|NCT01324947|582623680|FG000|Overall Study|Death|10|||
161336987|NCT01324947|582623680|FG000|Overall Study|Other|3|||
161336988|NCT01324947|582623680|FG000|Overall Study|Progressive Disease|50|||
161336989|NCT01324947|582623680|FG000|Overall Study|Withdrawal by Subject|3|||
161336990|NCT01324947|582623680|FG000|Overall Study|1 discontinued before starting drug|1|||
161336991|NCT01274351|582623681|FG000|Overall Study|Lost to Follow-up|1|||
161336992|NCT01274351|582623681|FG000|Overall Study|patient not compliant with the protocol|1|||
161336993|NCT01274351|582623681|FG000|Overall Study|Pregnancy|1|||
161336994|NCT01274351|582623681|FG000|Overall Study|Death|2|||
161336995|NCT01274351|582623681|FG000|Overall Study|Withdrawal by Subject|3|||
161336996|NCT01274351|582623681|FG000|Overall Study|Adverse Event|8|||
161336997|NCT01274351|582623681|FG000|Overall Study|progression of disease|3|||
161336998|NCT01274351|582623681|FG000|Overall Study|hospitalization|1|||
161336999|NCT01296412|582623684|FG000|Overall Study|Adverse Event|8|||
161337000|NCT01296412|582623685|FG001|Overall Study|Adverse Event|29|||
161337001|NCT01296412|582623684|FG000|Overall Study|Lack of Efficacy|1|||
161337002|NCT01296412|582623685|FG001|Overall Study|Lack of Efficacy|0|||
161337003|NCT01296412|582623684|FG000|Overall Study|Lost to Follow-up|10|||
161337004|NCT01296412|582623685|FG001|Overall Study|Lost to Follow-up|7|||
161337005|NCT01296412|582623684|FG000|Overall Study|Non-compliance with study drug|1|||
161337006|NCT01296412|582623685|FG001|Overall Study|Non-compliance with study drug|2|||
161337007|NCT01296412|582623684|FG000|Overall Study|Other reason not specified|20|||
161337008|NCT01296412|582623685|FG001|Overall Study|Other reason not specified|15|||
161337009|NCT01296412|582623684|FG000|Overall Study|Physician Decision|1|||
161337010|NCT01296412|582623685|FG001|Overall Study|Physician Decision|3|||
161337011|NCT01296412|582623684|FG000|Overall Study|Pregnancy|0|||
161337012|NCT01296412|582623685|FG001|Overall Study|Pregnancy|1|||
161337013|NCT01296412|582623684|FG000|Overall Study|Withdrawal by Subject|10|||
161337014|NCT01296412|582623685|FG001|Overall Study|Withdrawal by Subject|13|||
161337015|NCT02160626|582623686|FG000|Overall Study|Adverse Event|1|||
161337016|NCT02160626|582623687|FG001|Overall Study|Adverse Event|0|||
161337017|NCT02160626|582623688|FG002|Overall Study|Adverse Event|0|||
161337018|NCT02160626|582623686|FG000|Overall Study|Schedule not conducive to study visits|0|||
161337019|NCT02160626|582623687|FG001|Overall Study|Schedule not conducive to study visits|0|||
161337020|NCT02160626|582623688|FG002|Overall Study|Schedule not conducive to study visits|1|||
161337021|NCT02160626|582623686|FG000|Overall Study|Withdrawal by Subject|0|||
161337022|NCT02160626|582623687|FG001|Overall Study|Withdrawal by Subject|1|||
161337023|NCT02160626|582623688|FG002|Overall Study|Withdrawal by Subject|0|||
161337024|NCT04194814|582623692|FG000|Overall Study|Physician Decision|3|||
161337025|NCT04194814|582623693|FG001|Overall Study|Physician Decision|0|||
161337026|NCT04194814|582623692|FG000|Overall Study|Withdrawal by Subject|0|||
161337027|NCT04194814|582623693|FG001|Overall Study|Withdrawal by Subject|2|||
161337028|NCT00959751|582625790|FG000|Overall Study|Lost to Follow-up|2|||
161337029|NCT00959751|582625791|FG001|Overall Study|Lost to Follow-up|3|||
161337030|NCT00959751|582625790|FG000|Overall Study|Consent Withdrawn|0|||
161337031|NCT00959751|582625791|FG001|Overall Study|Consent Withdrawn|1|||
161337032|NCT00959751|582625790|FG000|Overall Study|Non-compliance to Study Procedures|0|||
161337033|NCT00959751|582625791|FG001|Overall Study|Non-compliance to Study Procedures|1|||
161337034|NCT00959751|582625790|FG000|Overall Study|No migraine headache without aura|7|||
161337035|NCT00959751|582625791|FG001|Overall Study|No migraine headache without aura|7|||
161337036|NCT03737994|582625792|FG000|Overall Study|Withdrawal by Subject|0|||
161337037|NCT03737994|582625793|FG001|Overall Study|Withdrawal by Subject|0|||
161337038|NCT03737994|582625794|FG002|Overall Study|Withdrawal by Subject|0|||
161141070|NCT02128490|581900942|FG000|Overall Study|Lost to Follow-up|0|||
161337039|NCT03737994|582625795|FG003|Overall Study|Withdrawal by Subject|0|||
161337040|NCT03737994|582625796|FG004|Overall Study|Withdrawal by Subject|0|||
161337041|NCT03737994|582625797|FG005|Overall Study|Withdrawal by Subject|0|||
161337042|NCT03737994|582625798|FG006|Overall Study|Withdrawal by Subject|1|||
161141071|NCT02128490|581900943|FG001|Overall Study|Lost to Follow-up|0|||
161141072|NCT02128490|581900944|FG002|Overall Study|Lost to Follow-up|1|||
161141073|NCT02128490|581900945|FG003|Overall Study|Lost to Follow-up|1|||
161141074|NCT02128490|581900946|FG004|Overall Study|Lost to Follow-up|1|||
161141075|NCT02128490|581900942|FG000|Overall Study|Voluntary Withdrawal|3|||
161141076|NCT02128490|581900943|FG001|Overall Study|Voluntary Withdrawal|3|||
161141077|NCT02128490|581900944|FG002|Overall Study|Voluntary Withdrawal|1|||
161141078|NCT02128490|581900945|FG003|Overall Study|Voluntary Withdrawal|1|||
161141079|NCT02128490|581900946|FG004|Overall Study|Voluntary Withdrawal|2|||
161141080|NCT02128490|581900942|FG000|Overall Study|Lack of Efficacy|0|||
161141081|NCT02128490|581900943|FG001|Overall Study|Lack of Efficacy|1|||
161141082|NCT02128490|581900944|FG002|Overall Study|Lack of Efficacy|0|||
161141083|NCT02128490|581900945|FG003|Overall Study|Lack of Efficacy|0|||
161141084|NCT02128490|581900946|FG004|Overall Study|Lack of Efficacy|0|||
160847997|NCT02714569|580831776|FG000|Part B (Overall)|Withdrawal by Subject|0|||
161254565|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161254566|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
160847998|NCT02714569|580831777|FG001|Part B (Overall)|Withdrawal by Subject|0|||
160847999|NCT02714569|580831778|FG002|Part B (Overall)|Withdrawal by Subject|0|||
160848000|NCT02714569|580831779|FG003|Part B (Overall)|Withdrawal by Subject|0|||
160848001|NCT02714569|580831780|FG004|Part B (Overall)|Withdrawal by Subject|0|||
160848002|NCT02714569|580831781|FG005|Part B (Overall)|Withdrawal by Subject|0|||
160848003|NCT02714569|580831782|FG006|Part B (Overall)|Withdrawal by Subject|0|||
160848004|NCT02714569|580831783|FG007|Part B (Overall)|Withdrawal by Subject|1|||
160848005|NCT02714569|580831784|FG008|Part B (Overall)|Withdrawal by Subject|0|||
160848006|NCT02714569|580831785|FG009|Part B (Overall)|Withdrawal by Subject|1|||
160848007|NCT02714569|580831786|FG010|Part B (Overall)|Withdrawal by Subject|0|||
160848008|NCT02714569|580831776|FG000|Part B (Overall)|Adverse Event|0|||
160848009|NCT02714569|580831777|FG001|Part B (Overall)|Adverse Event|0|||
160848010|NCT02714569|580831778|FG002|Part B (Overall)|Adverse Event|0|||
160848011|NCT02714569|580831779|FG003|Part B (Overall)|Adverse Event|0|||
160848012|NCT02714569|580831780|FG004|Part B (Overall)|Adverse Event|0|||
160848013|NCT02714569|580831781|FG005|Part B (Overall)|Adverse Event|0|||
160848014|NCT02714569|580831782|FG006|Part B (Overall)|Adverse Event|0|||
160848015|NCT02714569|580831783|FG007|Part B (Overall)|Adverse Event|0|||
160848016|NCT02714569|580831784|FG008|Part B (Overall)|Adverse Event|0|||
160848017|NCT02714569|580831785|FG009|Part B (Overall)|Adverse Event|1|||
160848018|NCT02714569|580831786|FG010|Part B (Overall)|Adverse Event|0|||
161254567|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161254568|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
161254569|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161254570|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161254571|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
161254572|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161254573|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161254574|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161254575|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
161254576|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
161254577|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161254578|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161254579|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Death|2|||
161254580|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Death|1|||
161254581|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Death|0|||
161254582|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Death|0|||
161254583|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
161254584|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
161254585|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
161254586|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
161254587|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
160848019|NCT04915729|580831787|FG000|Overall Study|Lost to Follow-up|20|||
160848020|NCT04915729|580831788|FG001|Overall Study|Lost to Follow-up|10|||
160848021|NCT04915729|580831787|FG000|Overall Study|Withdrawal by Subject|12|||
160848022|NCT04915729|580831788|FG001|Overall Study|Withdrawal by Subject|5|||
160848023|NCT04915729|580831787|FG000|Overall Study|Death|34|||
160848024|NCT04915729|580831788|FG001|Overall Study|Death|44|||
160848025|NCT04915729|580831787|FG000|Overall Study|not treated|3|||
160848026|NCT04915729|580831788|FG001|Overall Study|not treated|6|||
160906270|NCT01768286|581050391|FG002|Overall Study|Randomized But Not Treated|1|||
160906271|NCT01768286|581050392|FG003|Overall Study|Randomized But Not Treated|0|||
160906272|NCT01768286|581050389|FG000|Overall Study|Lack of Efficacy|7|||
160906273|NCT01768286|581050390|FG001|Overall Study|Lack of Efficacy|4|||
160906274|NCT01768286|581050391|FG002|Overall Study|Lack of Efficacy|0|||
161141085|NCT02128490|581900942|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161141086|NCT02128490|581900943|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161141087|NCT02128490|581900944|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161141088|NCT02128490|581900945|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
161141089|NCT02128490|581900946|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
161141090|NCT02128490|581900942|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161141091|NCT02128490|581900943|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161141092|NCT02128490|581900944|FG002|Overall Study|Other Miscellaneous Reasons|2|||
161141093|NCT02128490|581900945|FG003|Overall Study|Other Miscellaneous Reasons|1|||
161141094|NCT02128490|581900946|FG004|Overall Study|Other Miscellaneous Reasons|1|||
160848027|NCT04915729|580831787|FG000|Overall Study|Investigator removed subject|1|||
160848028|NCT04915729|580831788|FG001|Overall Study|Investigator removed subject|2|||
160848029|NCT04915729|580831787|FG000|Overall Study|questionnaire result not evaluated|1|||
160848030|NCT04915729|580831788|FG001|Overall Study|questionnaire result not evaluated|0|||
160848031|NCT04915729|580831787|FG000|Overall Study|refuse of hospital visit|1|||
160848032|NCT04915729|580831788|FG001|Overall Study|refuse of hospital visit|3|||
160848033|NCT04915729|580831787|FG000|Overall Study|Subject withdrew|1|||
160848034|NCT04915729|580831788|FG001|Overall Study|Subject withdrew|0|||
160848035|NCT04961541|580831789|FG000|Overall Study|Adverse Event|0|||
160848036|NCT04961541|580831790|FG001|Overall Study|Adverse Event|0|||
160848037|NCT04961541|580831791|FG002|Overall Study|Adverse Event|0|||
160848038|NCT04961541|580831792|FG003|Overall Study|Adverse Event|0|||
160848039|NCT04961541|580831793|FG004|Overall Study|Adverse Event|0|||
160848040|NCT04961541|580831794|FG005|Overall Study|Adverse Event|1|||
160848041|NCT04961541|580831795|FG006|Overall Study|Adverse Event|0|||
160848042|NCT04961541|580831796|FG007|Overall Study|Adverse Event|0|||
160848043|NCT04961541|580831797|FG008|Overall Study|Adverse Event|0|||
160848044|NCT04961541|580831798|FG009|Overall Study|Adverse Event|0|||
160848045|NCT04961541|580831799|FG010|Overall Study|Adverse Event|0|||
160848046|NCT04961541|580831800|FG011|Overall Study|Adverse Event|0|||
160848047|NCT04961541|580831801|FG012|Overall Study|Adverse Event|0|||
160848048|NCT04961541|580831802|FG013|Overall Study|Adverse Event|0|||
160848049|NCT04961541|580831789|FG000|Overall Study|Lost to Follow-up|0|||
160848050|NCT04961541|580831790|FG001|Overall Study|Lost to Follow-up|0|||
160848051|NCT04961541|580831791|FG002|Overall Study|Lost to Follow-up|3|||
160848052|NCT04961541|580831792|FG003|Overall Study|Lost to Follow-up|0|||
160848053|NCT04961541|580831793|FG004|Overall Study|Lost to Follow-up|0|||
160848054|NCT04961541|580831794|FG005|Overall Study|Lost to Follow-up|0|||
160848055|NCT04961541|580831795|FG006|Overall Study|Lost to Follow-up|1|||
160848056|NCT04961541|580831796|FG007|Overall Study|Lost to Follow-up|1|||
160848057|NCT04961541|580831797|FG008|Overall Study|Lost to Follow-up|0|||
160848058|NCT04961541|580831798|FG009|Overall Study|Lost to Follow-up|1|||
160848059|NCT04961541|580831799|FG010|Overall Study|Lost to Follow-up|0|||
160848060|NCT04961541|580831800|FG011|Overall Study|Lost to Follow-up|0|||
160848061|NCT04961541|580831801|FG012|Overall Study|Lost to Follow-up|1|||
160848062|NCT04961541|580831802|FG013|Overall Study|Lost to Follow-up|0|||
160848063|NCT04961541|580831789|FG000|Overall Study|Withdrawal by Subject|0|||
160848064|NCT04961541|580831790|FG001|Overall Study|Withdrawal by Subject|0|||
160848065|NCT04961541|580831791|FG002|Overall Study|Withdrawal by Subject|1|||
160848066|NCT04961541|580831792|FG003|Overall Study|Withdrawal by Subject|1|||
160848067|NCT04961541|580831793|FG004|Overall Study|Withdrawal by Subject|0|||
160848068|NCT04961541|580831794|FG005|Overall Study|Withdrawal by Subject|0|||
160848069|NCT04961541|580831795|FG006|Overall Study|Withdrawal by Subject|0|||
160848070|NCT04961541|580831796|FG007|Overall Study|Withdrawal by Subject|0|||
160848071|NCT04961541|580831797|FG008|Overall Study|Withdrawal by Subject|0|||
160848072|NCT04961541|580831798|FG009|Overall Study|Withdrawal by Subject|1|||
160848073|NCT04961541|580831799|FG010|Overall Study|Withdrawal by Subject|0|||
160848074|NCT04961541|580831800|FG011|Overall Study|Withdrawal by Subject|0|||
160848075|NCT04961541|580831801|FG012|Overall Study|Withdrawal by Subject|0|||
160848076|NCT04961541|580831802|FG013|Overall Study|Withdrawal by Subject|0|||
160848077|NCT01684202|580831803|FG000|Dose-escalation Period|Adverse Event|0|||
160848078|NCT01684202|580831804|FG001|Dose-escalation Period|Adverse Event|1|||
160848079|NCT01684202|580831805|FG002|Dose-escalation Period|Adverse Event|0|||
160848080|NCT01684202|580831806|FG003|Dose-escalation Period|Adverse Event|0|||
160848081|NCT01684202|580831803|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
160848082|NCT01684202|580831804|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
160848083|NCT01684202|580831805|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
160848084|NCT01684202|580831806|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
160848085|NCT01684202|580831803|FG000|Maintenance Period|Adverse Event|1|||
160848086|NCT01684202|580831804|FG001|Maintenance Period|Adverse Event|1|||
160848087|NCT01684202|580831805|FG002|Maintenance Period|Adverse Event|1|||
160848088|NCT01684202|580831806|FG003|Maintenance Period|Adverse Event|1|||
160848089|NCT01684202|580831803|FG000|Maintenance Period|Physician Decision|0|||
160848090|NCT01684202|580831804|FG001|Maintenance Period|Physician Decision|1|||
160848091|NCT01684202|580831805|FG002|Maintenance Period|Physician Decision|0|||
160848092|NCT01684202|580831806|FG003|Maintenance Period|Physician Decision|0|||
160848093|NCT01684202|580831803|FG000|Maintenance Period|Withdrawal by Subject|0|||
160848094|NCT01684202|580831804|FG001|Maintenance Period|Withdrawal by Subject|1|||
160848095|NCT01684202|580831805|FG002|Maintenance Period|Withdrawal by Subject|0|||
160848096|NCT01684202|580831806|FG003|Maintenance Period|Withdrawal by Subject|0|||
160848097|NCT00191308|580831807|FG000|Overall Study|Adverse Event|1|||
160848098|NCT00466921|580831808|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
160848099|NCT00466921|580831808|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
160848100|NCT00466921|580831808|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
160848101|NCT00466921|580831808|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
160848102|NCT00466921|580831808|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
160848103|NCT00466921|580831808|FG000|Follow up for a Minimum of 1 Year|Death|6|||
160848104|NCT00779025|580831809|FG000|Overall Study|Withdrawal by Subject|1|||
160848105|NCT03305770|580831810|FG000|Overall Study|Physician Decision - prior to dispense|0|||
160848106|NCT03305770|580831811|FG001|Overall Study|Physician Decision - prior to dispense|1|||
160848107|NCT03305770|580831810|FG000|Overall Study|Subject moved|1|||
160848108|NCT03305770|580831811|FG001|Overall Study|Subject moved|0|||
160848109|NCT03539601|580831812|FG000|Overall Study|Withdraw by parent/guardian|1|||
160848110|NCT03539601|580831813|FG001|Overall Study|Withdraw by parent/guardian|0|||
160848111|NCT03539601|580831814|FG002|Overall Study|Withdraw by parent/guardian|1|||
160848112|NCT03539601|580831815|FG003|Overall Study|Withdraw by parent/guardian|0|||
160848113|NCT03539601|580831812|FG000|Overall Study|Adverse Event|0|||
160848114|NCT03539601|580831813|FG001|Overall Study|Adverse Event|2|||
160848115|NCT03539601|580831814|FG002|Overall Study|Adverse Event|0|||
161141095|NCT02243176|581900947|FG000|Overall Study|Other reason|1|||
161141096|NCT02243176|581900948|FG001|Overall Study|Other reason|2|||
161141097|NCT02243176|581900947|FG000|Overall Study|protocol specified withdrawal critera|1|||
161141098|NCT02243176|581900948|FG001|Overall Study|protocol specified withdrawal critera|3|||
161141099|NCT02243176|581900947|FG000|Overall Study|Protocol Violation|2|||
161141100|NCT02243176|581900948|FG001|Overall Study|Protocol Violation|1|||
161141101|NCT02243176|581900947|FG000|Overall Study|Withdrawal by Subject|8|||
161141102|NCT02243176|581900948|FG001|Overall Study|Withdrawal by Subject|7|||
161141103|NCT02243176|581900947|FG000|Overall Study|Adverse Event|2|||
161141104|NCT02243176|581900948|FG001|Overall Study|Adverse Event|2|||
161141105|NCT03311126|581900949|FG000|Induction|Death|1|||
160848116|NCT03539601|580831815|FG003|Overall Study|Adverse Event|0|||
160848117|NCT03539601|580831812|FG000|Overall Study|Lost to Follow-up|2|||
160848118|NCT03539601|580831813|FG001|Overall Study|Lost to Follow-up|4|||
160848119|NCT03539601|580831814|FG002|Overall Study|Lost to Follow-up|5|||
160848120|NCT03539601|580831815|FG003|Overall Study|Lost to Follow-up|0|||
160848121|NCT03539601|580831812|FG000|Overall Study|Withdrawal by Subject|2|||
160848122|NCT03539601|580831813|FG001|Overall Study|Withdrawal by Subject|0|||
160848123|NCT03539601|580831814|FG002|Overall Study|Withdrawal by Subject|0|||
160848124|NCT03539601|580831815|FG003|Overall Study|Withdrawal by Subject|1|||
160848125|NCT03539601|580831812|FG000|Overall Study|Randomized but not treated|1|||
160848126|NCT03539601|580831813|FG001|Overall Study|Randomized but not treated|1|||
160848127|NCT03539601|580831814|FG002|Overall Study|Randomized but not treated|0|||
160848128|NCT03539601|580831815|FG003|Overall Study|Randomized but not treated|0|||
161141106|NCT03311126|581900949|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
161141107|NCT03839524|581900955|FG000|Overall Study|Adverse Event|1|||
161141108|NCT02037919|581900956|FG000|Overall Study|Lost to Follow-up|30|||
161141109|NCT02037919|581900957|FG001|Overall Study|Lost to Follow-up|45|||
161141110|NCT00886938|581900958|FG000|Overall Study|Adverse Event|1|||
161141111|NCT00886938|581900958|FG000|Overall Study|Withdrawal by Subject|1|||
161141112|NCT00917384|581900959|FG000|Overall Study|Lost to Follow-up|4|||
161141113|NCT00917384|581900960|FG001|Overall Study|Lost to Follow-up|2|||
161141114|NCT00917384|581900959|FG000|Overall Study|Withdrawal by Subject|10|||
161141115|NCT00917384|581900960|FG001|Overall Study|Withdrawal by Subject|2|||
161141116|NCT01458340|581900963|FG000|Overall Study|Adverse Event|5|||
161141117|NCT01458340|581900964|FG001|Overall Study|Adverse Event|4|||
161254588|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161254589|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161254590|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161254591|NCT03110380|582310013|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161254592|NCT03110380|582310014|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
161254593|NCT03110380|582310015|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
161254594|NCT03110380|582310016|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
160848129|NCT03710642|580831816|FG000|Overall Study|Adverse Event|5|||
161141118|NCT01458340|581900965|FG002|Overall Study|Adverse Event|2|||
160848130|NCT03710642|580831817|FG001|Overall Study|Adverse Event|1|||
160848131|NCT03710642|580831816|FG000|Overall Study|non-site physician recommendation|1|||
160848132|NCT03710642|580831817|FG001|Overall Study|non-site physician recommendation|0|||
161141119|NCT01458340|581900963|FG000|Overall Study|Lost to Follow-up|3|||
161141120|NCT01458340|581900964|FG001|Overall Study|Lost to Follow-up|3|||
161141121|NCT01458340|581900965|FG002|Overall Study|Lost to Follow-up|10|||
161141122|NCT01458340|581900963|FG000|Overall Study|Miscellaneous|0|||
161254595|NCT03110380|582310013|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
161254596|NCT03110380|582310014|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
160848133|NCT03710642|580831816|FG000|Overall Study|Participant unwilling or unable to participate|1|||
160848134|NCT03710642|580831817|FG001|Overall Study|Participant unwilling or unable to participate|1|||
161141123|NCT01458340|581900964|FG001|Overall Study|Miscellaneous|1|||
161141124|NCT01458340|581900965|FG002|Overall Study|Miscellaneous|0|||
161254597|NCT03110380|582310015|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
161254598|NCT03110380|582310016|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
161254599|NCT03110380|582310013|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
160848135|NCT03710642|580831816|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
161254600|NCT03110380|582310014|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
161254601|NCT03110380|582310015|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
161254602|NCT03110380|582310016|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
160848136|NCT03710642|580831817|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
160848137|NCT03710642|580831816|FG000|Overall Study|NA-no code provided|1|||
160848138|NCT03710642|580831817|FG001|Overall Study|NA-no code provided|0|||
160848139|NCT03710642|580831816|FG000|Overall Study|Withdrawal by Subject|1|||
160848140|NCT03710642|580831817|FG001|Overall Study|Withdrawal by Subject|0|||
160848141|NCT00226811|580831818|FG000|Overall Study|Death|8|||
160848142|NCT00226811|580831818|FG000|Overall Study|Adverse Event|11|||
160848143|NCT00226811|580831818|FG000|Overall Study|Lack of Efficacy|55|||
160848144|NCT00226811|580831818|FG000|Overall Study|Withdrawal by Subject|2|||
160848145|NCT01633541|580831822|FG000|Overall Study|Death|1|||
160848146|NCT01633541|580831823|FG001|Overall Study|Death|0|||
160848147|NCT01010971|580831824|FG000|Overall Study|Adverse Event|2|||
160848148|NCT01010971|580831825|FG001|Overall Study|Adverse Event|4|||
160848149|NCT01010971|580831826|FG002|Overall Study|Adverse Event|3|||
160848150|NCT01010971|580831824|FG000|Overall Study|Withdrawal by Subject|0|||
160848151|NCT01010971|580831825|FG001|Overall Study|Withdrawal by Subject|2|||
160848152|NCT01010971|580831826|FG002|Overall Study|Withdrawal by Subject|5|||
160848153|NCT01010971|580831824|FG000|Overall Study|Lost to Follow-up|0|||
160848154|NCT01010971|580831825|FG001|Overall Study|Lost to Follow-up|2|||
160848155|NCT01010971|580831826|FG002|Overall Study|Lost to Follow-up|3|||
160848156|NCT01010971|580831824|FG000|Overall Study|Other|1|||
160848157|NCT01010971|580831825|FG001|Overall Study|Other|0|||
160848158|NCT01010971|580831826|FG002|Overall Study|Other|2|||
160848159|NCT00773513|580831828|FG000|Overall Study|Renal Transplant|254|||
160848160|NCT00773513|580831829|FG001|Overall Study|Renal Transplant|263|||
160848161|NCT00773513|580831828|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
160848162|NCT00773513|580831829|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
160848163|NCT00773513|580831828|FG000|Overall Study|Withdrew Consent|68|||
160848164|NCT00773513|580831829|FG001|Overall Study|Withdrew Consent|69|||
160848165|NCT00773513|580831828|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
160848166|NCT00773513|580831829|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
160848167|NCT00773513|580831828|FG000|Overall Study|Failure to Return|22|||
160848168|NCT00773513|580831829|FG001|Overall Study|Failure to Return|8|||
160848169|NCT00773513|580831828|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160848170|NCT00773513|580831829|FG001|Overall Study|Insufficient Therapeutic Response|18|||
160848171|NCT00773513|580831828|FG000|Overall Study|Reason Not Specified|159|||
160848172|NCT00773513|580831829|FG001|Overall Study|Reason Not Specified|126|||
160848173|NCT00773513|580831828|FG000|Overall Study|Death|531|||
160848174|NCT00773513|580831829|FG001|Overall Study|Death|545|||
160848175|NCT00700713|580831830|FG000|Overall Study|Protocol Violation|1|||
160848176|NCT00700713|580831831|FG001|Overall Study|Protocol Violation|0|||
160848177|NCT00700713|580831832|FG002|Overall Study|Protocol Violation|1|||
160848178|NCT00700713|580831830|FG000|Overall Study|Withdrawal by Subject|0|||
160848179|NCT00700713|580831831|FG001|Overall Study|Withdrawal by Subject|0|||
160848180|NCT00700713|580831832|FG002|Overall Study|Withdrawal by Subject|1|||
160848181|NCT02330055|580831834|FG000|Overall Study|technical issues|2|||
160848182|NCT02330055|580831835|FG001|Overall Study|technical issues|0|||
160848183|NCT02330055|580831834|FG000|Overall Study|participant forgot to wear device|5|||
160848184|NCT02330055|580831835|FG001|Overall Study|participant forgot to wear device|5|||
160848185|NCT02330055|580831834|FG000|Overall Study|data for less than 60 minutes|3|||
160848186|NCT02330055|580831835|FG001|Overall Study|data for less than 60 minutes|3|||
160848187|NCT02330055|580831834|FG000|Overall Study|participant did not sleep|0|||
160848188|NCT02330055|580831835|FG001|Overall Study|participant did not sleep|1|||
160848189|NCT05729568|580831837|FG000|Overall Study|Still on Study|52|||
160848190|NCT05729568|580831838|FG001|Overall Study|Still on Study|26|||
161141125|NCT01458340|581900963|FG000|Overall Study|Physician Decision|1|||
161141126|NCT01458340|581900964|FG001|Overall Study|Physician Decision|1|||
161254603|NCT03110380|582310013|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161254604|NCT03110380|582310014|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
161254605|NCT03110380|582310015|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
160848191|NCT05729568|580831837|FG000|Overall Study|Randomized but Never Treated|3|||
160848192|NCT05729568|580831838|FG001|Overall Study|Randomized but Never Treated|0|||
160848193|NCT05729568|580831837|FG000|Overall Study|Adverse Event|0|||
160848194|NCT05729568|580831838|FG001|Overall Study|Adverse Event|1|||
160848195|NCT05729568|580831837|FG000|Overall Study|Investigator's Discretion|1|||
160848196|NCT05729568|580831838|FG001|Overall Study|Investigator's Discretion|0|||
160848197|NCT00550953|580831839|FG000|Overall Study|Adverse Event|4|||
160848198|NCT00550953|580831840|FG001|Overall Study|Adverse Event|3|||
160848199|NCT00550953|580831839|FG000|Overall Study|Not able to visit the site|2|||
160848200|NCT00550953|580831840|FG001|Overall Study|Not able to visit the site|3|||
160848201|NCT02728089|580831841|FG000|Overall Study|Physician Decision|2|||
160848202|NCT02728089|580831841|FG000|Overall Study|Withdrawal by Subject|1|||
161141127|NCT01458340|581900965|FG002|Overall Study|Physician Decision|2|||
161141128|NCT01458340|581900963|FG000|Overall Study|Protocol Violation|6|||
161141129|NCT01458340|581900964|FG001|Overall Study|Protocol Violation|6|||
161141130|NCT01458340|581900965|FG002|Overall Study|Protocol Violation|5|||
161141131|NCT01458340|581900963|FG000|Overall Study|Withdrawal by Subject|12|||
161141132|NCT01458340|581900964|FG001|Overall Study|Withdrawal by Subject|6|||
161141133|NCT01458340|581900965|FG002|Overall Study|Withdrawal by Subject|4|||
161254606|NCT03110380|582310016|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
161254607|NCT01206439|582310021|FG000|Overall Study|subject did not meet inclusion criteria|1|||
161254608|NCT05889039|582310023|FG000|Overall Study|error in completing survey|0|||
161254609|NCT05889039|582310024|FG001|Overall Study|error in completing survey|2|||
161254610|NCT05889039|582310025|FG002|Overall Study|error in completing survey|0|||
161254611|NCT05889039|582310026|FG003|Overall Study|error in completing survey|0|||
161254612|NCT05889039|582310023|FG000|Overall Study|Lost to Follow-up|4|||
161254613|NCT05889039|582310024|FG001|Overall Study|Lost to Follow-up|0|||
160848203|NCT01221350|580831842|FG000|Overall Study|Discontinued intervention (GERD)|1|||
160848204|NCT01221350|580831843|FG001|Overall Study|Discontinued intervention (GERD)|0|||
160848205|NCT01221350|580831842|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
160848206|NCT01221350|580831843|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
160848207|NCT01221350|580831842|FG000|Overall Study|Withdrawal by Subject|4|||
160848208|NCT01221350|580831843|FG001|Overall Study|Withdrawal by Subject|2|||
160848209|NCT04739436|580831846|FG000|Overall Study|Lost to Follow-up|21|||
160848210|NCT04739436|580831847|FG001|Overall Study|Lost to Follow-up|23|||
160848211|NCT04739436|580831846|FG000|Overall Study|Withdrawal by Subject|4|||
160848212|NCT04739436|580831847|FG001|Overall Study|Withdrawal by Subject|6|||
160848213|NCT04739436|580831846|FG000|Overall Study|not randomized properly|1|||
160848214|NCT04739436|580831847|FG001|Overall Study|not randomized properly|0|||
160848215|NCT02915978|580831851|FG000|Overall Study|Adverse Event|2|||
160848216|NCT02915978|580831852|FG001|Overall Study|Adverse Event|1|||
160848217|NCT02915978|580831853|FG002|Overall Study|Adverse Event|0|||
160848218|NCT02119663|580831858|FG000|Overall Study|Disease progression|26|||
160848219|NCT02119663|580831859|FG001|Overall Study|Disease progression|27|||
160848220|NCT02119663|580831858|FG000|Overall Study|Adverse Event|5|||
160848221|NCT02119663|580831859|FG001|Overall Study|Adverse Event|5|||
160848222|NCT02119663|580831858|FG000|Overall Study|Death|3|||
160848223|NCT02119663|580831859|FG001|Overall Study|Death|2|||
160848224|NCT02119663|580831858|FG000|Overall Study|Physician Decision|1|||
160848225|NCT02119663|580831859|FG001|Overall Study|Physician Decision|2|||
160848226|NCT02119663|580831858|FG000|Overall Study|Other unspecified|2|||
160848227|NCT02119663|580831859|FG001|Overall Study|Other unspecified|0|||
160848228|NCT02119663|580831858|FG000|Overall Study|Subject decision|0|||
160848229|NCT02119663|580831859|FG001|Overall Study|Subject decision|1|||
160848230|NCT02119663|580831858|FG000|Overall Study|Study Terminated by the Sponsor|3|||
160848231|NCT02119663|580831859|FG001|Overall Study|Study Terminated by the Sponsor|4|||
160848232|NCT01248949|580831860|FG000|Overall Study|Lost to Follow-up|2|||
160848233|NCT01248949|580831861|FG001|Overall Study|Lost to Follow-up|2|||
160848234|NCT01248949|580831862|FG002|Overall Study|Lost to Follow-up|2|||
160848235|NCT01248949|580831863|FG003|Overall Study|Lost to Follow-up|1|||
160848236|NCT01248949|580831864|FG004|Overall Study|Lost to Follow-up|0|||
160848237|NCT01248949|580831860|FG000|Overall Study|Withdrawal by Subject|5|||
160848238|NCT01248949|580831861|FG001|Overall Study|Withdrawal by Subject|3|||
160848239|NCT01248949|580831862|FG002|Overall Study|Withdrawal by Subject|11|||
160848240|NCT01248949|580831863|FG003|Overall Study|Withdrawal by Subject|3|||
160848241|NCT01248949|580831864|FG004|Overall Study|Withdrawal by Subject|1|||
160848242|NCT01248949|580831860|FG000|Overall Study|Death|22|||
160848243|NCT01248949|580831861|FG001|Overall Study|Death|7|||
160848244|NCT01248949|580831862|FG002|Overall Study|Death|21|||
160848245|NCT01248949|580831863|FG003|Overall Study|Death|6|||
160848246|NCT01248949|580831864|FG004|Overall Study|Death|2|||
160848247|NCT01248949|580831860|FG000|Overall Study|Alternative Therapy|1|||
160848248|NCT01248949|580831861|FG001|Overall Study|Alternative Therapy|0|||
160848249|NCT01248949|580831862|FG002|Overall Study|Alternative Therapy|0|||
160848250|NCT01248949|580831863|FG003|Overall Study|Alternative Therapy|0|||
160848251|NCT01248949|580831864|FG004|Overall Study|Alternative Therapy|0|||
161254614|NCT05889039|582310025|FG002|Overall Study|Lost to Follow-up|0|||
161254615|NCT05889039|582310026|FG003|Overall Study|Lost to Follow-up|0|||
160848252|NCT01248949|580831860|FG000|Overall Study|Alternative Therapy.|1|||
160848253|NCT01248949|580831861|FG001|Overall Study|Alternative Therapy.|0|||
160848254|NCT01248949|580831862|FG002|Overall Study|Alternative Therapy.|0|||
160848255|NCT01248949|580831863|FG003|Overall Study|Alternative Therapy.|0|||
160848256|NCT01248949|580831864|FG004|Overall Study|Alternative Therapy.|0|||
160848257|NCT01248949|580831860|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
160848258|NCT01248949|580831861|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848259|NCT01248949|580831862|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848260|NCT01248949|580831863|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
160848261|NCT01248949|580831864|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
161141134|NCT01021007|581900968|FG000|Overall Study|Lost to Follow-up|1|||
161141135|NCT01021007|581900969|FG001|Overall Study|Lost to Follow-up|1|||
160848262|NCT01248949|580831860|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848263|NCT01248949|580831861|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848264|NCT01248949|580831862|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848265|NCT01248949|580831863|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
160848266|NCT01248949|580831864|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
160848267|NCT01248949|580831860|FG000|Overall Study|Participant Went To Hospice|0|||
160848268|NCT01248949|580831861|FG001|Overall Study|Participant Went To Hospice|0|||
160848269|NCT01248949|580831862|FG002|Overall Study|Participant Went To Hospice|1|||
160848270|NCT01248949|580831863|FG003|Overall Study|Participant Went To Hospice|0|||
160848271|NCT01248949|580831864|FG004|Overall Study|Participant Went To Hospice|0|||
160848272|NCT01248949|580831860|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
160848273|NCT01248949|580831861|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848274|NCT01248949|580831862|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848275|NCT01248949|580831863|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848276|NCT01248949|580831864|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
160848277|NCT01248949|580831860|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
160848278|NCT01248949|580831861|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
160848279|NCT01248949|580831862|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
160848280|NCT01248949|580831863|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
160848281|NCT01248949|580831864|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
160848282|NCT01248949|580831860|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848283|NCT01248949|580831861|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
160848284|NCT01248949|580831862|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848285|NCT01248949|580831863|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848286|NCT01248949|580831864|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
160848287|NCT01248949|580831860|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848288|NCT01248949|580831861|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848289|NCT01248949|580831862|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
160848290|NCT01248949|580831863|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848291|NCT01248949|580831864|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
160848292|NCT03245775|580831867|FG000|Overall Study|Lost to Follow-up|25|||
160848293|NCT03245775|580831868|FG001|Overall Study|Lost to Follow-up|26|||
160848294|NCT03245775|580831869|FG002|Overall Study|Lost to Follow-up|16|||
160848295|NCT03245775|580831870|FG003|Overall Study|Lost to Follow-up|16|||
160906275|NCT01768286|581050392|FG003|Overall Study|Lack of Efficacy|1|||
160906276|NCT01768286|581050389|FG000|Overall Study|Withdrew Consent|0|||
160906277|NCT01768286|581050390|FG001|Overall Study|Withdrew Consent|0|||
160906278|NCT01768286|581050391|FG002|Overall Study|Withdrew Consent|1|||
160906279|NCT01768286|581050392|FG003|Overall Study|Withdrew Consent|0|||
160906280|NCT03344796|581050393|FG000|Overall Study|Lost to Follow-up|0|||
160906281|NCT03344796|581050394|FG001|Overall Study|Lost to Follow-up|0|||
160906282|NCT03344796|581050395|FG002|Overall Study|Lost to Follow-up|0|||
160906283|NCT03344796|581050396|FG003|Overall Study|Lost to Follow-up|0|||
160906284|NCT03344796|581050397|FG004|Overall Study|Lost to Follow-up|0|||
160906285|NCT03344796|581050398|FG005|Overall Study|Lost to Follow-up|2|||
160906286|NCT04066023|581050400|FG000|Overall Study|Adverse Event|0|||
160906287|NCT04066023|581050401|FG001|Overall Study|Adverse Event|0|||
160906288|NCT04066023|581050402|FG002|Overall Study|Adverse Event|1|||
160906289|NCT04066023|581050400|FG000|Overall Study|Sponsor decision|3|||
160906290|NCT04066023|581050401|FG001|Overall Study|Sponsor decision|6|||
160906291|NCT04066023|581050402|FG002|Overall Study|Sponsor decision|2|||
160906292|NCT04066023|581050400|FG000|Overall Study|Physician Decision|0|||
160906293|NCT04066023|581050401|FG001|Overall Study|Physician Decision|0|||
160906294|NCT04066023|581050402|FG002|Overall Study|Physician Decision|1|||
160906295|NCT04066023|581050400|FG000|Overall Study|Lost to Follow-up|0|||
160906296|NCT04066023|581050401|FG001|Overall Study|Lost to Follow-up|1|||
160906297|NCT04066023|581050402|FG002|Overall Study|Lost to Follow-up|1|||
160906298|NCT04066023|581050400|FG000|Overall Study|Noncompliance|0|||
160906299|NCT04066023|581050401|FG001|Overall Study|Noncompliance|1|||
160906300|NCT04066023|581050402|FG002|Overall Study|Noncompliance|1|||
160906301|NCT03338010|581050404|FG000|Overall Study|Withdrawal by Subject|14|||
160906302|NCT03338010|581050405|FG001|Overall Study|Withdrawal by Subject|8|||
160906303|NCT03338010|581050404|FG000|Overall Study|Lost to Follow-up|4|||
160906304|NCT03338010|581050405|FG001|Overall Study|Lost to Follow-up|2|||
161337043|NCT01373164|582625799|FG000|Overall Study|Lost to Follow-up|0|||
160906305|NCT03338010|581050404|FG000|Overall Study|Adverse Event|3|||
160906306|NCT03338010|581050405|FG001|Overall Study|Adverse Event|2|||
160906307|NCT03338010|581050404|FG000|Overall Study|Physician Decision|2|||
160906308|NCT03338010|581050405|FG001|Overall Study|Physician Decision|2|||
161141136|NCT01021007|581900968|FG000|Overall Study|Adverse Event|1|||
160848296|NCT01099397|580831872|FG000|Overall Study|Lost to Follow-up|4|||
160906309|NCT03338010|581050404|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160906310|NCT03338010|581050405|FG001|Overall Study|Non-Compliance with Study Drug|3|||
160906311|NCT03338010|581050404|FG000|Overall Study|Protocol Violation|0|||
160906312|NCT03338010|581050405|FG001|Overall Study|Protocol Violation|1|||
160848297|NCT01099397|580831872|FG000|Overall Study|Protocol Violation|4|||
160848298|NCT01099397|580831872|FG000|Overall Study|Withdrawal by Subject|5|||
160848299|NCT02363959|580831873|FG000|Overall Study|Medical instability|1|||
160848300|NCT02363959|580831874|FG001|Overall Study|Medical instability|0|||
160848301|NCT00950248|580831877|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
160848302|NCT00950248|580831878|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
160848303|NCT00950248|580831879|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
160848304|NCT00950248|580831877|FG000|Year 1: Baseline|worsening of symptoms|2|||
160848305|NCT00950248|580831878|FG001|Year 1: Baseline|worsening of symptoms|0|||
160848306|NCT00950248|580831879|FG002|Year 1: Baseline|worsening of symptoms|0|||
160848307|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
160848308|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
160848309|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
160848310|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
160848311|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
160848312|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
160848313|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|Death|0|||
160848314|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|Death|0|||
160848315|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|Death|1|||
160848316|NCT00950248|580831877|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
160848317|NCT00950248|580831878|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
160848318|NCT00950248|580831879|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
160848319|NCT00650845|580831884|FG000|Overall Study|Withdrawal by Subject|5|||
160848320|NCT00650845|580831885|FG001|Overall Study|Withdrawal by Subject|0|||
160848321|NCT00650845|580831884|FG000|Overall Study|Protocol Violation|0|||
160848322|NCT00650845|580831885|FG001|Overall Study|Protocol Violation|13|||
160848323|NCT01900652|580831886|FG000|Overall Study|Progressive Disease|1|||
160848324|NCT01900652|580831887|FG001|Overall Study|Progressive Disease|0|||
160848325|NCT01900652|580831886|FG000|Overall Study|Consent withdrawn by subject|1|||
160848326|NCT01900652|580831887|FG001|Overall Study|Consent withdrawn by subject|1|||
160848327|NCT01900652|580831886|FG000|Overall Study|Death|3|||
160848328|NCT01900652|580831887|FG001|Overall Study|Death|0|||
160848329|NCT01900652|580831886|FG000|Overall Study|Adverse Event|2|||
160848330|NCT01900652|580831887|FG001|Overall Study|Adverse Event|1|||
160848331|NCT01900652|580831886|FG000|Overall Study|Physician Decision|1|||
160848332|NCT01900652|580831887|FG001|Overall Study|Physician Decision|1|||
160848333|NCT01479868|580833701|FG000|Overall Study|Adverse Event|1|||
160848334|NCT01479868|580833701|FG000|Overall Study|Lost to Follow-up|4|||
160848335|NCT01479868|580833701|FG000|Overall Study|Protocol Violation|1|||
160848336|NCT01479868|580833701|FG000|Overall Study|Withdrawal by Subject|1|||
160848337|NCT01479868|580833701|FG000|Overall Study|Sponsor's Decision|1|||
160848338|NCT01479868|580833701|FG000|Overall Study|Initiation of new HCV Therapy|1|||
160848339|NCT01618669|580833702|FG000|Overall Study|Lost to Follow-up|1|||
160848340|NCT01618669|580833703|FG001|Overall Study|Lost to Follow-up|1|||
160848341|NCT01618669|580833702|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
160848342|NCT01618669|580833703|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
160848343|NCT01618669|580833702|FG000|Overall Study|Adverse Event|16|||
160848344|NCT01618669|580833703|FG001|Overall Study|Adverse Event|7|||
160848345|NCT01618669|580833702|FG000|Overall Study|Protocol Violation|5|||
160848346|NCT01618669|580833703|FG001|Overall Study|Protocol Violation|3|||
160848347|NCT01618669|580833702|FG000|Overall Study|Withdrawal by Subject|9|||
160848348|NCT01618669|580833703|FG001|Overall Study|Withdrawal by Subject|9|||
160848349|NCT01618669|580833702|FG000|Overall Study|Miscellaneous Reason|0|||
160848350|NCT01618669|580833703|FG001|Overall Study|Miscellaneous Reason|1|||
160848351|NCT01508169|580833707|FG000|Overall Study|Adverse Event|1|||
160848352|NCT01508169|580833708|FG001|Overall Study|Adverse Event|0|||
160848353|NCT01508169|580833707|FG000|Overall Study|Withdrawal by Subject|1|||
160848354|NCT01508169|580833708|FG001|Overall Study|Withdrawal by Subject|0|||
160848355|NCT01508169|580833707|FG000|Overall Study|Lost to Follow-up|1|||
160848356|NCT01508169|580833708|FG001|Overall Study|Lost to Follow-up|2|||
160906313|NCT00293033|581050410|FG000|Open-label Titration Period|Adverse Event|10|||
160906314|NCT00293033|581050410|FG000|Open-label Titration Period|Death|3|||
160848357|NCT03600740|580833713|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
160906315|NCT00293033|581050410|FG000|Open-label Titration Period|Lack of Efficacy|5|||
160906316|NCT00293033|581050410|FG000|Open-label Titration Period|Protocol Violation|2|||
160906317|NCT00293033|581050410|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
160906318|NCT00293033|581050410|FG000|Open-label Titration Period|Noncompliance and other|27|||
160906319|NCT00293033|581050410|FG000|Double-blind Treatment Period|Adverse Event|3|||
160848358|NCT02336230|580833718|FG000|Overall Study|Adverse Event|1|||
160848359|NCT02336230|580833718|FG000|Overall Study|Withdrawal of consent|1|||
160848360|NCT02336230|580833718|FG000|Overall Study|Death|9|||
160848361|NCT02336230|580833718|FG000|Overall Study|Dose not received due to shipping delay|1|||
160848362|NCT02336230|580833718|FG000|Overall Study|Discontinuation of MSC infusion|1|||
160848363|NCT01620086|580833723|FG000|Overall Study|Withdrawal by Subject|3|||
160906320|NCT00293033|581050410|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
160848364|NCT01620086|580833724|FG001|Overall Study|Withdrawal by Subject|3|||
160848365|NCT01620086|580833725|FG002|Overall Study|Withdrawal by Subject|0|||
160848366|NCT01620086|580833723|FG000|Overall Study|failed study criteria|1|||
160848367|NCT01620086|580833724|FG001|Overall Study|failed study criteria|4|||
160848368|NCT01620086|580833725|FG002|Overall Study|failed study criteria|0|||
160848369|NCT01620086|580833723|FG000|Overall Study|Physician Decision|1|||
160848370|NCT01620086|580833724|FG001|Overall Study|Physician Decision|0|||
160848371|NCT01620086|580833725|FG002|Overall Study|Physician Decision|0|||
160848372|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Progressive disease|50|||
160848373|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Progressive disease|110|||
160848374|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Progressive disease|0|||
160848375|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Progressive disease|0|||
160848376|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
160848377|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
160848378|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160848379|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160848380|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Adverse Event|7|||
160848381|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Adverse Event|7|||
160848382|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Adverse Event|0|||
160848383|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Adverse Event|0|||
160848384|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Other|1|||
160848385|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Other|3|||
160848386|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Other|0|||
160848387|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Other|0|||
160848388|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Physician Decision|6|||
160848389|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Physician Decision|3|||
160848390|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Physician Decision|0|||
160848391|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Physician Decision|0|||
160848392|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Death|1|||
160848393|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Death|1|||
160848394|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Death|0|||
160848395|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Death|0|||
160848396|NCT01695135|580833726|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
160848397|NCT01695135|580833727|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
160848398|NCT01695135|580833728|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
160848399|NCT01695135|580833729|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
160848400|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
160906321|NCT00293033|581050410|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
160906322|NCT00293033|581050410|FG000|Double-blind Treatment Period|Noncompliance|4|||
160906323|NCT00629707|581050411|FG000|Overall Study|Withdrawal by Subject|0|||
160906324|NCT00629707|581050412|FG001|Overall Study|Withdrawal by Subject|1|||
160906325|NCT00629707|581050411|FG000|Overall Study|Physician Decision|0|||
160906326|NCT00629707|581050412|FG001|Overall Study|Physician Decision|1|||
160906327|NCT00453063|581050413|FG000|Overall Study|Adverse Event|1|||
160906328|NCT00453063|581050414|FG001|Overall Study|Adverse Event|2|||
160906329|NCT00453063|581050413|FG000|Overall Study|Withdrawal by Subject|1|||
160906330|NCT00453063|581050414|FG001|Overall Study|Withdrawal by Subject|1|||
160906331|NCT00453063|581050413|FG000|Overall Study|Protocol Violation|1|||
160906332|NCT00453063|581050414|FG001|Overall Study|Protocol Violation|0|||
160906333|NCT00365508|581050415|FG000|Overall Study|Lost to Follow-up|139|||
160906334|NCT00365508|581050416|FG001|Overall Study|Lost to Follow-up|154|||
160906335|NCT04094883|581050417|FG000|Overall Study|Withdrawal by Subject|1|||
160906336|NCT00837811|581050419|FG000|Overall Study|Adverse Event|4|||
160906337|NCT00837811|581050420|FG001|Overall Study|Adverse Event|6|||
160906338|NCT00837811|581050421|FG002|Overall Study|Adverse Event|0|||
160906339|NCT00837811|581050419|FG000|Overall Study|Death|1|||
160906340|NCT00837811|581050420|FG001|Overall Study|Death|1|||
160906341|NCT00837811|581050421|FG002|Overall Study|Death|0|||
160906342|NCT00837811|581050419|FG000|Overall Study|Lack of Efficacy|0|||
160906343|NCT00837811|581050420|FG001|Overall Study|Lack of Efficacy|11|||
160906344|NCT00837811|581050421|FG002|Overall Study|Lack of Efficacy|0|||
160906345|NCT00837811|581050419|FG000|Overall Study|Lost to Follow-up|1|||
160906346|NCT00837811|581050420|FG001|Overall Study|Lost to Follow-up|3|||
160906347|NCT00837811|581050421|FG002|Overall Study|Lost to Follow-up|0|||
160848401|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
160848402|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
161254616|NCT01808248|582310029|FG000|Overall Study|Lack of Efficacy|3|||
161254617|NCT01808248|582310029|FG000|Overall Study|Withdrawal by Subject|1|||
160906348|NCT00837811|581050419|FG000|Overall Study|Physician Decision|0|||
160906349|NCT00837811|581050420|FG001|Overall Study|Physician Decision|2|||
160906350|NCT00837811|581050421|FG002|Overall Study|Physician Decision|1|||
160906351|NCT00837811|581050419|FG000|Overall Study|Withdrawal by Subject|1|||
160906352|NCT00837811|581050420|FG001|Overall Study|Withdrawal by Subject|9|||
161141137|NCT01021007|581900969|FG001|Overall Study|Adverse Event|3|||
160848403|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
160848404|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
160848405|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
160848406|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
160848407|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
160848408|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
160848409|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
160848410|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
160848411|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
160848412|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Other|0|||
160848413|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Other|0|||
160848414|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Other|4|||
160848415|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Other|7|||
160848416|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
160848417|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
160848418|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
160848419|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
160848420|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Death|0|||
160848421|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Death|0|||
160848422|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Death|2|||
160848423|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Death|7|||
160848424|NCT01695135|580833726|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
160848425|NCT01695135|580833727|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
160848426|NCT01695135|580833728|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
160848427|NCT01695135|580833729|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
160848428|NCT00580723|580833735|FG000|Overall Study|Did not want to participate in extension|3|||
160848429|NCT00580723|580833735|FG000|Overall Study|Lost to Follow-up|5|||
160848430|NCT00684996|580833736|FG000|Overall Study|Adverse Event|1|||
160906353|NCT00837811|581050421|FG002|Overall Study|Withdrawal by Subject|0|||
160906354|NCT00837811|581050419|FG000|Overall Study|Sponsor Decision|0|||
160906355|NCT00837811|581050420|FG001|Overall Study|Sponsor Decision|2|||
161337044|NCT01373164|582625800|FG001|Overall Study|Lost to Follow-up|0|||
161337045|NCT01373164|582625801|FG002|Overall Study|Lost to Follow-up|1|||
161337046|NCT01373164|582625802|FG003|Overall Study|Lost to Follow-up|2|||
161337047|NCT01373164|582625803|FG004|Overall Study|Lost to Follow-up|0|||
161337048|NCT01373164|582625799|FG000|Overall Study|Withdrawal by Subject|0|||
161337049|NCT01373164|582625800|FG001|Overall Study|Withdrawal by Subject|1|||
161337050|NCT01373164|582625801|FG002|Overall Study|Withdrawal by Subject|0|||
161337051|NCT01373164|582625802|FG003|Overall Study|Withdrawal by Subject|10|||
161337052|NCT01373164|582625803|FG004|Overall Study|Withdrawal by Subject|2|||
161337053|NCT00761319|582625804|FG000|Overall Study|Protocol Violation|21|||
161337054|NCT00761319|582625805|FG001|Overall Study|Protocol Violation|14|||
161337055|NCT00761319|582625804|FG000|Overall Study|Adverse Event|11|||
161337056|NCT00761319|582625805|FG001|Overall Study|Adverse Event|7|||
161337057|NCT00761319|582625804|FG000|Overall Study|Withdrawal by Subject|8|||
161337058|NCT00761319|582625805|FG001|Overall Study|Withdrawal by Subject|7|||
161337059|NCT00761319|582625804|FG000|Overall Study|Noncompliance|4|||
161337060|NCT00761319|582625805|FG001|Overall Study|Noncompliance|3|||
161337061|NCT00761319|582625804|FG000|Overall Study|Lost to Follow-up|1|||
161337062|NCT00761319|582625805|FG001|Overall Study|Lost to Follow-up|1|||
161337063|NCT00761319|582625804|FG000|Overall Study|Nonspecified|2|||
161337064|NCT00761319|582625805|FG001|Overall Study|Nonspecified|2|||
160906356|NCT00837811|581050421|FG002|Overall Study|Sponsor Decision|0|||
160906357|NCT04731363|581050427|FG000|Overall Study|Could not obtain samples|0|||
160906358|NCT04731363|581050428|FG001|Overall Study|Could not obtain samples|1|||
160906359|NCT04731363|581050429|FG002|Overall Study|Could not obtain samples|0|||
160906360|NCT04731363|581050430|FG003|Overall Study|Could not obtain samples|0|||
160906361|NCT04731363|581050427|FG000|Overall Study|Physician Decision|0|||
160906362|NCT04731363|581050428|FG001|Overall Study|Physician Decision|1|||
160906363|NCT04731363|581050429|FG002|Overall Study|Physician Decision|0|||
160906364|NCT04731363|581050430|FG003|Overall Study|Physician Decision|0|||
160906365|NCT00307294|581052158|FG000|Overall Study|Withdrawal by Subject|1|||
160906366|NCT03311724|581052159|FG000|Overall Study|Physician Decision|0|||
161337065|NCT00761319|582625804|FG000|Overall Study|Missing|1|||
161337066|NCT00761319|582625805|FG001|Overall Study|Missing|0|||
161337067|NCT01125930|582625810|FG000|Overall Study|Adverse Event|0|||
161337068|NCT01125930|582625811|FG001|Overall Study|Adverse Event|1|||
161337069|NCT01125930|582625810|FG000|Overall Study|Withdrawal by Subject|1|||
161337070|NCT01125930|582625811|FG001|Overall Study|Withdrawal by Subject|6|||
161337071|NCT01125930|582625810|FG000|Overall Study|Protocol Violation|0|||
160906367|NCT03311724|581052160|FG001|Overall Study|Physician Decision|0|||
161337072|NCT01125930|582625811|FG001|Overall Study|Protocol Violation|1|||
161337073|NCT01125930|582625810|FG000|Overall Study|Lost to Follow-up|0|||
161337074|NCT01125930|582625811|FG001|Overall Study|Lost to Follow-up|2|||
160848431|NCT00684996|580833736|FG000|Overall Study|Refusal unrelated to adverse event|1|||
160848432|NCT00684996|580833736|FG000|Overall Study|Progression/relapse|2|||
160848433|NCT00684996|580833736|FG000|Overall Study|Other reasons not protocol specified|1|||
160848434|NCT00556998|580833737|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
160848435|NCT00556998|580833737|FG000|Voriconazole Intravenous (IV)|Other|4|||
160848436|NCT00556998|580833737|FG000|Voriconazole Oral|Adverse Event|1|||
160848437|NCT00556998|580833737|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
160848438|NCT02519439|580833740|FG000|Overall Study|Study Termination|19|||
160848439|NCT02519439|580833740|FG000|Overall Study|Withdrawal by Subject|1|||
160848440|NCT02519439|580833740|FG000|Overall Study|Adverse Event|1|||
160848441|NCT03030417|580833747|FG000|Dose Expansion|Disease progression before treatment|0|||
160848442|NCT03030417|580833748|FG001|Dose Expansion|Disease progression before treatment|0|||
160848443|NCT03030417|580833749|FG002|Dose Expansion|Disease progression before treatment|0|||
160848444|NCT03030417|580833750|FG003|Dose Expansion|Disease progression before treatment|0|||
160848445|NCT03030417|580833751|FG004|Dose Expansion|Disease progression before treatment|0|||
160848446|NCT03030417|580833752|FG005|Dose Expansion|Disease progression before treatment|0|||
160848447|NCT03030417|580833753|FG006|Dose Expansion|Disease progression before treatment|0|||
160848448|NCT03030417|580833754|FG007|Dose Expansion|Disease progression before treatment|0|||
160848449|NCT03030417|580833755|FG008|Dose Expansion|Disease progression before treatment|0|||
160848450|NCT03030417|580833756|FG009|Dose Expansion|Disease progression before treatment|0|||
160848451|NCT03030417|580833757|FG010|Dose Expansion|Disease progression before treatment|0|||
160848452|NCT03030417|580833758|FG011|Dose Expansion|Disease progression before treatment|0|||
160848453|NCT03030417|580833759|FG012|Dose Expansion|Disease progression before treatment|1|||
160848454|NCT01078441|580833760|FG000|Overall Study|Withdrawal by Subject|1|||
160848455|NCT01970306|580833764|FG000|Overall Study|Not eligible|3|||
160848456|NCT01970306|580833764|FG000|Overall Study|Not able to be treated|9|||
160848457|NCT02741635|580833765|FG000|Overall Study|Withdrawal by Subject|1|||
160848458|NCT01427933|580833766|FG000|Overall Study|Withdrawal by Subject|5|||
160848459|NCT01427933|580833767|FG001|Overall Study|Withdrawal by Subject|8|||
160848460|NCT01427933|580833766|FG000|Overall Study|Lost to Follow-up|1|||
160848461|NCT01427933|580833767|FG001|Overall Study|Lost to Follow-up|5|||
160848462|NCT01427933|580833766|FG000|Overall Study|Other|1|||
160848463|NCT01427933|580833767|FG001|Overall Study|Other|0|||
160848464|NCT01427933|580833766|FG000|Overall Study|Investigator's Decision|1|||
160848465|NCT01427933|580833767|FG001|Overall Study|Investigator's Decision|0|||
160848466|NCT03472326|580833768|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
160848467|NCT03472326|580833769|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
160906368|NCT03311724|581052161|FG002|Overall Study|Physician Decision|0|||
160906369|NCT03311724|581052162|FG003|Overall Study|Physician Decision|1|||
160906370|NCT03311724|581052159|FG000|Overall Study|Protocol Violation|1|||
160906371|NCT03311724|581052160|FG001|Overall Study|Protocol Violation|0|||
161337075|NCT01715831|582625816|FG000|Overall Study|Adverse Event|1|||
160906372|NCT03311724|581052161|FG002|Overall Study|Protocol Violation|1|||
160906373|NCT03311724|581052162|FG003|Overall Study|Protocol Violation|0|||
160906374|NCT03311724|581052159|FG000|Overall Study|Withdrawal by Subject|1|||
160906375|NCT03311724|581052160|FG001|Overall Study|Withdrawal by Subject|1|||
160906376|NCT03311724|581052161|FG002|Overall Study|Withdrawal by Subject|0|||
160906377|NCT03311724|581052162|FG003|Overall Study|Withdrawal by Subject|0|||
160906378|NCT03311724|581052159|FG000|Overall Study|Lost to Follow-up|1|||
160906379|NCT03311724|581052160|FG001|Overall Study|Lost to Follow-up|0|||
160906380|NCT03311724|581052161|FG002|Overall Study|Lost to Follow-up|0|||
160906381|NCT03311724|581052162|FG003|Overall Study|Lost to Follow-up|0|||
160906382|NCT03311724|581052159|FG000|Overall Study|Sponsor Decision|0|||
160906383|NCT03311724|581052160|FG001|Overall Study|Sponsor Decision|0|||
160906384|NCT03311724|581052161|FG002|Overall Study|Sponsor Decision|1|||
160906385|NCT03311724|581052162|FG003|Overall Study|Sponsor Decision|0|||
160906386|NCT01581931|581052167|FG000|Washout|Adverse Event|0|||
160848468|NCT03472326|580833770|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
160848469|NCT03472326|580833771|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
160848470|NCT03472326|580833768|FG000|Part 2: Combination Therapy|Pregnancy|0|||
160848471|NCT03472326|580833769|FG001|Part 2: Combination Therapy|Pregnancy|0|||
160848472|NCT03472326|580833770|FG002|Part 2: Combination Therapy|Pregnancy|0|||
160848473|NCT03472326|580833771|FG003|Part 2: Combination Therapy|Pregnancy|1|||
160848474|NCT03386721|580833772|FG000|Overall Study|Death|12|||
160906387|NCT01581931|581052168|FG001|Washout|Adverse Event|1|||
160906388|NCT00395304|581052175|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160848475|NCT03386721|580833773|FG001|Overall Study|Death|21|||
160848476|NCT03386721|580833774|FG002|Overall Study|Death|2|||
160848477|NCT03386721|580833775|FG003|Overall Study|Death|5|||
160906389|NCT00395304|581052176|FG001|Treatment Period 1|Withdrawal by Subject|3|||
160848478|NCT03386721|580833776|FG004|Overall Study|Death|1|||
160848479|NCT03386721|580833777|FG005|Overall Study|Death|12|||
160848480|NCT03386721|580833778|FG006|Overall Study|Death|1|||
160906390|NCT00395304|581052177|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160906391|NCT00395304|581052178|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161141138|NCT01575548|581900970|FG000|Overall Study|Adverse Event|15|||
160848481|NCT03386721|580833779|FG007|Overall Study|Death|1|||
160848482|NCT03386721|580833780|FG008|Overall Study|Death|12|||
160848483|NCT03386721|580833781|FG009|Overall Study|Death|20|||
160848484|NCT03386721|580833782|FG010|Overall Study|Death|21|||
160848485|NCT03386721|580833783|FG011|Overall Study|Death|21|||
160848486|NCT03386721|580833784|FG012|Overall Study|Death|14|||
160848487|NCT03386721|580833785|FG013|Overall Study|Death|2|||
160848488|NCT03386721|580833786|FG014|Overall Study|Death|1|||
160848489|NCT03386721|580833772|FG000|Overall Study|Lost to Follow-up|1|||
160848490|NCT03386721|580833773|FG001|Overall Study|Lost to Follow-up|3|||
160848491|NCT03386721|580833774|FG002|Overall Study|Lost to Follow-up|0|||
160848492|NCT03386721|580833775|FG003|Overall Study|Lost to Follow-up|0|||
160848493|NCT03386721|580833776|FG004|Overall Study|Lost to Follow-up|0|||
160848494|NCT03386721|580833777|FG005|Overall Study|Lost to Follow-up|2|||
160848495|NCT03386721|580833778|FG006|Overall Study|Lost to Follow-up|1|||
160848496|NCT03386721|580833779|FG007|Overall Study|Lost to Follow-up|0|||
160848497|NCT03386721|580833780|FG008|Overall Study|Lost to Follow-up|1|||
160848498|NCT03386721|580833781|FG009|Overall Study|Lost to Follow-up|2|||
160848499|NCT03386721|580833782|FG010|Overall Study|Lost to Follow-up|1|||
160848500|NCT03386721|580833783|FG011|Overall Study|Lost to Follow-up|0|||
160848501|NCT03386721|580833784|FG012|Overall Study|Lost to Follow-up|0|||
160848502|NCT03386721|580833785|FG013|Overall Study|Lost to Follow-up|0|||
160848503|NCT03386721|580833786|FG014|Overall Study|Lost to Follow-up|0|||
160848504|NCT03386721|580833772|FG000|Overall Study|Reason not specified|3|||
160848505|NCT03386721|580833773|FG001|Overall Study|Reason not specified|0|||
160848506|NCT03386721|580833774|FG002|Overall Study|Reason not specified|0|||
160848507|NCT03386721|580833775|FG003|Overall Study|Reason not specified|0|||
160848508|NCT03386721|580833776|FG004|Overall Study|Reason not specified|0|||
160848509|NCT03386721|580833777|FG005|Overall Study|Reason not specified|3|||
160848510|NCT03386721|580833778|FG006|Overall Study|Reason not specified|1|||
160848511|NCT03386721|580833779|FG007|Overall Study|Reason not specified|0|||
160848512|NCT03386721|580833780|FG008|Overall Study|Reason not specified|0|||
160848513|NCT03386721|580833781|FG009|Overall Study|Reason not specified|1|||
160848514|NCT03386721|580833782|FG010|Overall Study|Reason not specified|2|||
160848515|NCT03386721|580833783|FG011|Overall Study|Reason not specified|6|||
160848516|NCT03386721|580833784|FG012|Overall Study|Reason not specified|1|||
160848517|NCT03386721|580833785|FG013|Overall Study|Reason not specified|0|||
160848518|NCT03386721|580833786|FG014|Overall Study|Reason not specified|0|||
160848519|NCT03386721|580833772|FG000|Overall Study|Progressive Disease|0|||
160848520|NCT03386721|580833773|FG001|Overall Study|Progressive Disease|0|||
160848521|NCT03386721|580833774|FG002|Overall Study|Progressive Disease|1|||
160848522|NCT03386721|580833775|FG003|Overall Study|Progressive Disease|0|||
160848523|NCT03386721|580833776|FG004|Overall Study|Progressive Disease|0|||
160848524|NCT03386721|580833777|FG005|Overall Study|Progressive Disease|1|||
160848525|NCT03386721|580833778|FG006|Overall Study|Progressive Disease|0|||
160848526|NCT03386721|580833779|FG007|Overall Study|Progressive Disease|0|||
160848527|NCT03386721|580833780|FG008|Overall Study|Progressive Disease|2|||
160848528|NCT03386721|580833781|FG009|Overall Study|Progressive Disease|1|||
160848529|NCT03386721|580833782|FG010|Overall Study|Progressive Disease|1|||
160848530|NCT03386721|580833783|FG011|Overall Study|Progressive Disease|0|||
160848531|NCT03386721|580833784|FG012|Overall Study|Progressive Disease|1|||
160848532|NCT03386721|580833785|FG013|Overall Study|Progressive Disease|0|||
160848533|NCT03386721|580833786|FG014|Overall Study|Progressive Disease|0|||
160848534|NCT03386721|580833772|FG000|Overall Study|Site Terminated by Sponsor|5|||
160848535|NCT03386721|580833773|FG001|Overall Study|Site Terminated by Sponsor|5|||
160848536|NCT03386721|580833774|FG002|Overall Study|Site Terminated by Sponsor|0|||
160848537|NCT03386721|580833775|FG003|Overall Study|Site Terminated by Sponsor|0|||
160848538|NCT03386721|580833776|FG004|Overall Study|Site Terminated by Sponsor|1|||
160848539|NCT03386721|580833777|FG005|Overall Study|Site Terminated by Sponsor|3|||
160848540|NCT03386721|580833778|FG006|Overall Study|Site Terminated by Sponsor|0|||
160848541|NCT03386721|580833779|FG007|Overall Study|Site Terminated by Sponsor|1|||
160848542|NCT03386721|580833780|FG008|Overall Study|Site Terminated by Sponsor|4|||
160848543|NCT03386721|580833781|FG009|Overall Study|Site Terminated by Sponsor|5|||
160848544|NCT03386721|580833782|FG010|Overall Study|Site Terminated by Sponsor|3|||
160848545|NCT03386721|580833783|FG011|Overall Study|Site Terminated by Sponsor|11|||
160848546|NCT03386721|580833784|FG012|Overall Study|Site Terminated by Sponsor|6|||
160848547|NCT03386721|580833785|FG013|Overall Study|Site Terminated by Sponsor|0|||
160848548|NCT03386721|580833786|FG014|Overall Study|Site Terminated by Sponsor|0|||
160848549|NCT03386721|580833772|FG000|Overall Study|Symptomatic Deterioration|0|||
160848550|NCT03386721|580833773|FG001|Overall Study|Symptomatic Deterioration|0|||
160906392|NCT00395304|581052179|FG004|Treatment Period 1|Withdrawal by Subject|1|||
160906393|NCT00395304|581052180|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160906394|NCT00395304|581052175|FG000|Treatment Period 1|Lost to Follow-up|1|||
160848551|NCT03386721|580833774|FG002|Overall Study|Symptomatic Deterioration|0|||
160848552|NCT03386721|580833775|FG003|Overall Study|Symptomatic Deterioration|0|||
160848553|NCT03386721|580833776|FG004|Overall Study|Symptomatic Deterioration|0|||
160848554|NCT03386721|580833777|FG005|Overall Study|Symptomatic Deterioration|0|||
160848555|NCT03386721|580833778|FG006|Overall Study|Symptomatic Deterioration|0|||
160848556|NCT03386721|580833779|FG007|Overall Study|Symptomatic Deterioration|0|||
160848557|NCT03386721|580833780|FG008|Overall Study|Symptomatic Deterioration|1|||
160848558|NCT03386721|580833781|FG009|Overall Study|Symptomatic Deterioration|0|||
160848559|NCT03386721|580833782|FG010|Overall Study|Symptomatic Deterioration|0|||
160848560|NCT03386721|580833783|FG011|Overall Study|Symptomatic Deterioration|1|||
160848561|NCT03386721|580833784|FG012|Overall Study|Symptomatic Deterioration|0|||
160848562|NCT03386721|580833785|FG013|Overall Study|Symptomatic Deterioration|0|||
160848563|NCT03386721|580833786|FG014|Overall Study|Symptomatic Deterioration|0|||
160848564|NCT03386721|580833772|FG000|Overall Study|Withdrawal by Subject|1|||
160848565|NCT03386721|580833773|FG001|Overall Study|Withdrawal by Subject|2|||
160848566|NCT03386721|580833774|FG002|Overall Study|Withdrawal by Subject|0|||
160848567|NCT03386721|580833775|FG003|Overall Study|Withdrawal by Subject|0|||
160848568|NCT03386721|580833776|FG004|Overall Study|Withdrawal by Subject|0|||
160848569|NCT03386721|580833777|FG005|Overall Study|Withdrawal by Subject|0|||
160848570|NCT03386721|580833778|FG006|Overall Study|Withdrawal by Subject|0|||
160848571|NCT03386721|580833779|FG007|Overall Study|Withdrawal by Subject|0|||
160848572|NCT03386721|580833780|FG008|Overall Study|Withdrawal by Subject|2|||
160848573|NCT03386721|580833781|FG009|Overall Study|Withdrawal by Subject|1|||
160848574|NCT03386721|580833782|FG010|Overall Study|Withdrawal by Subject|3|||
160848575|NCT03386721|580833783|FG011|Overall Study|Withdrawal by Subject|2|||
160848576|NCT03386721|580833784|FG012|Overall Study|Withdrawal by Subject|3|||
160848577|NCT03386721|580833785|FG013|Overall Study|Withdrawal by Subject|0|||
160848578|NCT03386721|580833786|FG014|Overall Study|Withdrawal by Subject|0|||
160848579|NCT03359174|580833789|FG000|Overall Study|Adverse Event|1|||
160848580|NCT02680665|580833790|FG000|Overall Study|No visit after the first prescription|5|||
160848581|NCT02905266|580833791|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
160848582|NCT02905266|580833792|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
160848583|NCT02905266|580833791|FG000|Treatment Phase Part 1|Disease Progression|6|||
160848584|NCT02905266|580833792|FG001|Treatment Phase Part 1|Disease Progression|7|||
160848585|NCT02905266|580833791|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
160848586|NCT02905266|580833792|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
160848587|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
160848588|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
160848589|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
160848590|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
160848591|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
160848592|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
160848593|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Death|0|||
160848594|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Death|1|||
160848595|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
160848596|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
160848597|NCT02905266|580833791|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
160848598|NCT02905266|580833792|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
160848599|NCT02905266|580833791|FG000|Maintenance Phase Part 2|Disease Progression|9|||
160848600|NCT02905266|580833792|FG001|Maintenance Phase Part 2|Disease Progression|2|||
160848601|NCT02905266|580833791|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
160848602|NCT02905266|580833792|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
160848603|NCT02905266|580833791|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
160848604|NCT02905266|580833792|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
160848605|NCT00596752|580833795|FG000|Overall Study|Other Reason|44|||
160848606|NCT00596752|580833796|FG001|Overall Study|Other Reason|49|||
160848607|NCT00596752|580833795|FG000|Overall Study|Adverse Event|34|||
160848608|NCT00596752|580833796|FG001|Overall Study|Adverse Event|34|||
160848609|NCT00596752|580833795|FG000|Overall Study|Lost to Follow-up|22|||
160848610|NCT00596752|580833796|FG001|Overall Study|Lost to Follow-up|38|||
160848611|NCT00596752|580833795|FG000|Overall Study|Withdrawal by Subject|12|||
160848612|NCT00596752|580833796|FG001|Overall Study|Withdrawal by Subject|9|||
160848613|NCT00596752|580833795|FG000|Overall Study|Unsatisfactory Compliance|9|||
160848614|NCT00596752|580833796|FG001|Overall Study|Unsatisfactory Compliance|6|||
160848615|NCT00596752|580833795|FG000|Overall Study|Lack of Efficacy|4|||
160848616|NCT00596752|580833796|FG001|Overall Study|Lack of Efficacy|7|||
160848617|NCT00596752|580833795|FG000|Overall Study|Protocol Violation|1|||
160848618|NCT00596752|580833796|FG001|Overall Study|Protocol Violation|0|||
160848619|NCT04445662|580833799|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
160848620|NCT04445662|580833800|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
160848621|NCT04445662|580833799|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
160848622|NCT04445662|580833800|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
161141139|NCT01575548|581900971|FG001|Overall Study|Adverse Event|2|||
161141140|NCT01575548|581900970|FG000|Overall Study|Disease progression|12|||
161141141|NCT01575548|581900971|FG001|Overall Study|Disease progression|25|||
161141142|NCT01575548|581900970|FG000|Overall Study|Death|1|||
160848623|NCT04445662|580833799|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
160848624|NCT04445662|580833800|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
160848625|NCT04445662|580833799|FG000|Post-treatment (12-24 weeks)|Death|1|||
160848626|NCT04445662|580833800|FG001|Post-treatment (12-24 weeks)|Death|0|||
160848627|NCT02451124|580833811|FG000|Overall Study|Withdrawal by Subject|1|||
160848628|NCT01870726|580833812|FG000|Overall Study|Withdrawal of informed consent|0|||
160848629|NCT01870726|580833813|FG001|Overall Study|Withdrawal of informed consent|0|||
160848630|NCT01870726|580833814|FG002|Overall Study|Withdrawal of informed consent|0|||
160848631|NCT01870726|580833815|FG003|Overall Study|Withdrawal of informed consent|1|||
160848632|NCT01870726|580833816|FG004|Overall Study|Withdrawal of informed consent|0|||
160848633|NCT01870726|580833817|FG005|Overall Study|Withdrawal of informed consent|0|||
160848634|NCT01870726|580833818|FG006|Overall Study|Withdrawal of informed consent|0|||
160848635|NCT01870726|580833812|FG000|Overall Study|Withdrawal by Subject|0|||
160848636|NCT01870726|580833813|FG001|Overall Study|Withdrawal by Subject|1|||
160848637|NCT01870726|580833814|FG002|Overall Study|Withdrawal by Subject|0|||
160848638|NCT01870726|580833815|FG003|Overall Study|Withdrawal by Subject|0|||
160848639|NCT01870726|580833816|FG004|Overall Study|Withdrawal by Subject|0|||
160848640|NCT01870726|580833817|FG005|Overall Study|Withdrawal by Subject|0|||
160848641|NCT01870726|580833818|FG006|Overall Study|Withdrawal by Subject|0|||
160848642|NCT01870726|580833812|FG000|Overall Study|Adverse Event|0|||
160848643|NCT01870726|580833813|FG001|Overall Study|Adverse Event|0|||
160848644|NCT01870726|580833814|FG002|Overall Study|Adverse Event|0|||
160848645|NCT01870726|580833815|FG003|Overall Study|Adverse Event|0|||
160848646|NCT01870726|580833816|FG004|Overall Study|Adverse Event|1|||
160848647|NCT01870726|580833817|FG005|Overall Study|Adverse Event|1|||
160848648|NCT01870726|580833818|FG006|Overall Study|Adverse Event|0|||
160848649|NCT01870726|580833812|FG000|Overall Study|Progressive disease|5|||
160848650|NCT01870726|580833813|FG001|Overall Study|Progressive disease|5|||
160848651|NCT01870726|580833814|FG002|Overall Study|Progressive disease|4|||
160848652|NCT01870726|580833815|FG003|Overall Study|Progressive disease|5|||
160848653|NCT01870726|580833816|FG004|Overall Study|Progressive disease|6|||
160848654|NCT01870726|580833817|FG005|Overall Study|Progressive disease|4|||
160848655|NCT01870726|580833818|FG006|Overall Study|Progressive disease|10|||
160848656|NCT00103740|580833821|FG000|Period 1 - Core|Adverse Event|1|||
160848657|NCT00103740|580833822|FG001|Period 1 - Core|Adverse Event|0|||
160848658|NCT00103740|580833821|FG000|Period 1 - Core|Protocol Violation|3|||
160848659|NCT00103740|580833822|FG001|Period 1 - Core|Protocol Violation|2|||
160848660|NCT00103740|580833821|FG000|Period 1 - Core|Patient withdrew consent|3|||
160848661|NCT00103740|580833822|FG001|Period 1 - Core|Patient withdrew consent|2|||
160848662|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
160848663|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
160848664|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
160848665|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
160848666|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
160848667|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
160848668|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Death|6|||
160848669|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Death|2|||
161254618|NCT01808248|582310029|FG000|Overall Study|Lost to Follow-up|1|||
161254619|NCT04974580|582310032|FG000|Overall Study|Lost to Follow-up|33|||
161254620|NCT04974580|582310033|FG001|Overall Study|Lost to Follow-up|39|||
161254621|NCT04974580|582310034|FG002|Overall Study|Lost to Follow-up|30|||
161254622|NCT04974580|582310035|FG003|Overall Study|Lost to Follow-up|29|||
161254623|NCT02941523|582310039|FG000|Monotherapy|Withdrawal by Subject|0|||
161254624|NCT02941523|582310040|FG001|Monotherapy|Withdrawal by Subject|1|||
161254625|NCT02941523|582310039|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
161254626|NCT02941523|582310040|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
161254627|NCT02941523|582310039|FG000|Carboplatin Combination Therapy|Death|1|||
161254628|NCT02941523|582310040|FG001|Carboplatin Combination Therapy|Death|2|||
161254629|NCT02941523|582310039|FG000|Carboplatin Combination Therapy|Disease progression|2|||
161254630|NCT02941523|582310040|FG001|Carboplatin Combination Therapy|Disease progression|0|||
161254631|NCT02941523|582310039|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
161254632|NCT02941523|582310040|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
161254633|NCT04330157|582310041|FG000|Overall Study|Protocol Violation|4|||
161254634|NCT04330157|582310041|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
161254635|NCT03558139|582310042|FG000|Overall Study|Consent Withdrawn|1|||
161254636|NCT03558139|582310043|FG001|Overall Study|Consent Withdrawn|1|||
161254637|NCT03558139|582310044|FG002|Overall Study|Consent Withdrawn|4|||
161254638|NCT03558139|582310042|FG000|Overall Study|Death|5|||
161254639|NCT03558139|582310043|FG001|Overall Study|Death|3|||
161254640|NCT03558139|582310044|FG002|Overall Study|Death|8|||
161254641|NCT03558139|582310042|FG000|Overall Study|Lost to Follow-up|0|||
161254642|NCT03558139|582310043|FG001|Overall Study|Lost to Follow-up|0|||
161254643|NCT03558139|582310044|FG002|Overall Study|Lost to Follow-up|3|||
161254644|NCT03558139|582310042|FG000|Overall Study|Study Ended Per Protocol|0|||
161254645|NCT03558139|582310043|FG001|Overall Study|Study Ended Per Protocol|3|||
161141143|NCT01575548|581900971|FG001|Overall Study|Death|0|||
161141144|NCT01575548|581900970|FG000|Overall Study|Other complicating disease|1|||
161141145|NCT01575548|581900971|FG001|Overall Study|Other complicating disease|0|||
161141146|NCT01575548|581900970|FG000|Overall Study|Withdrawal by Subject|7|||
161141147|NCT01575548|581900971|FG001|Overall Study|Withdrawal by Subject|3|||
161141148|NCT01575548|581900970|FG000|Overall Study|Noncompliance|1|||
161141149|NCT01575548|581900971|FG001|Overall Study|Noncompliance|0|||
161141150|NCT01575548|581900970|FG000|Overall Study|Anticipated surgery|0|||
161141151|NCT01575548|581900971|FG001|Overall Study|Anticipated surgery|1|||
161141152|NCT01575548|581900970|FG000|Overall Study|Never started protocol therapy|3|||
161141153|NCT01575548|581900971|FG001|Overall Study|Never started protocol therapy|2|||
161141154|NCT03872180|581900976|FG000|Overall Study|Adverse Event|4|||
161141155|NCT03872180|581900976|FG000|Overall Study|Lack of Efficacy|2|||
161141156|NCT00947154|581900977|FG000|Overall Study|Lost to Follow-up|1|||
161141157|NCT03293030|581900978|FG000|Overall Study|Withdrawal by Subject|3|||
161254646|NCT03558139|582310044|FG002|Overall Study|Study Ended Per Protocol|6|||
160848670|NCT00103740|580833821|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
160848671|NCT00103740|580833822|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
160848672|NCT03691571|580833823|FG000|Overall Study|Withdrawal by Subject|9|||
160848673|NCT03691571|580833824|FG001|Overall Study|Withdrawal by Subject|2|||
160848674|NCT01463306|580833825|FG000|Overall Study|Adverse Event|6|||
160848675|NCT01463306|580833826|FG001|Overall Study|Adverse Event|9|||
160848676|NCT01463306|580833827|FG002|Overall Study|Adverse Event|3|||
160848677|NCT01463306|580833825|FG000|Overall Study|Death|3|||
160848678|NCT01463306|580833826|FG001|Overall Study|Death|3|||
160848679|NCT01463306|580833827|FG002|Overall Study|Death|0|||
160848680|NCT01463306|580833825|FG000|Overall Study|Lack of Efficacy|22|||
160848681|NCT01463306|580833826|FG001|Overall Study|Lack of Efficacy|16|||
160848682|NCT01463306|580833827|FG002|Overall Study|Lack of Efficacy|1|||
160848683|NCT01463306|580833825|FG000|Overall Study|Lost to Follow-up|5|||
160848684|NCT01463306|580833826|FG001|Overall Study|Lost to Follow-up|2|||
160848685|NCT01463306|580833827|FG002|Overall Study|Lost to Follow-up|0|||
160848686|NCT01463306|580833825|FG000|Overall Study|Protocol Violation|4|||
160848687|NCT01463306|580833826|FG001|Overall Study|Protocol Violation|0|||
160848688|NCT01463306|580833827|FG002|Overall Study|Protocol Violation|0|||
160848689|NCT01463306|580833825|FG000|Overall Study|Withdrawal by Subject|19|||
160848690|NCT01463306|580833826|FG001|Overall Study|Withdrawal by Subject|9|||
160848691|NCT01463306|580833827|FG002|Overall Study|Withdrawal by Subject|1|||
160848692|NCT01463306|580833825|FG000|Overall Study|Other|26|||
160848693|NCT01463306|580833826|FG001|Overall Study|Other|13|||
160848694|NCT01463306|580833827|FG002|Overall Study|Other|0|||
160906395|NCT00395304|581052176|FG001|Treatment Period 1|Lost to Follow-up|0|||
160906396|NCT00395304|581052177|FG002|Treatment Period 1|Lost to Follow-up|0|||
160906397|NCT00395304|581052178|FG003|Treatment Period 1|Lost to Follow-up|1|||
160906398|NCT00395304|581052179|FG004|Treatment Period 1|Lost to Follow-up|0|||
160906399|NCT00395304|581052180|FG005|Treatment Period 1|Lost to Follow-up|1|||
160906400|NCT00395304|581052175|FG000|Treatment Period 1|Physician Decision|0|||
160906401|NCT00395304|581052176|FG001|Treatment Period 1|Physician Decision|1|||
160906402|NCT00395304|581052177|FG002|Treatment Period 1|Physician Decision|0|||
160906403|NCT00395304|581052178|FG003|Treatment Period 1|Physician Decision|0|||
160906404|NCT00395304|581052179|FG004|Treatment Period 1|Physician Decision|0|||
160906405|NCT00395304|581052180|FG005|Treatment Period 1|Physician Decision|0|||
160906406|NCT00395304|581052175|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160906407|NCT00395304|581052176|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160906408|NCT00395304|581052177|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160906409|NCT00395304|581052178|FG003|Treatment Period 2|Withdrawal by Subject|1|||
160906410|NCT00395304|581052179|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160906411|NCT00395304|581052180|FG005|Treatment Period 2|Withdrawal by Subject|2|||
160906412|NCT00395304|581052175|FG000|Treatment Period 2|Lost to Follow-up|0|||
160906413|NCT00395304|581052176|FG001|Treatment Period 2|Lost to Follow-up|3|||
160906414|NCT00395304|581052177|FG002|Treatment Period 2|Lost to Follow-up|0|||
160906415|NCT00395304|581052178|FG003|Treatment Period 2|Lost to Follow-up|0|||
160906416|NCT00395304|581052179|FG004|Treatment Period 2|Lost to Follow-up|0|||
160906417|NCT00395304|581052180|FG005|Treatment Period 2|Lost to Follow-up|0|||
160906418|NCT00395304|581052175|FG000|Treatment Period 2|Physician Decision|0|||
160906419|NCT00395304|581052176|FG001|Treatment Period 2|Physician Decision|0|||
160906420|NCT00395304|581052177|FG002|Treatment Period 2|Physician Decision|1|||
160906421|NCT00395304|581052178|FG003|Treatment Period 2|Physician Decision|0|||
160906422|NCT00395304|581052179|FG004|Treatment Period 2|Physician Decision|0|||
160906423|NCT00395304|581052180|FG005|Treatment Period 2|Physician Decision|0|||
160906424|NCT00395304|581052175|FG000|Treatment Period 2|Other|0|||
160906425|NCT00395304|581052176|FG001|Treatment Period 2|Other|1|||
160906426|NCT00395304|581052177|FG002|Treatment Period 2|Other|0|||
161254647|NCT02752802|582310045|FG000|Overall Study|Contrast Volume Not Collected|1|||
160848695|NCT01463306|580833825|FG000|Overall Study|Approval expiry at site|1|||
160848696|NCT01463306|580833826|FG001|Overall Study|Approval expiry at site|0|||
160848697|NCT01463306|580833827|FG002|Overall Study|Approval expiry at site|0|||
160848698|NCT00250276|580833832|FG000|Overall Study|Serious Adverse Event|0|||
160848699|NCT00250276|580833833|FG001|Overall Study|Serious Adverse Event|0|||
160848700|NCT00250276|580833834|FG002|Overall Study|Serious Adverse Event|1|||
160848701|NCT00250276|580833835|FG003|Overall Study|Serious Adverse Event|0|||
160848702|NCT00250276|580833832|FG000|Overall Study|Non-serious Adverse Event|2|||
160848703|NCT00250276|580833833|FG001|Overall Study|Non-serious Adverse Event|0|||
160848704|NCT00250276|580833834|FG002|Overall Study|Non-serious Adverse Event|0|||
160848705|NCT00250276|580833835|FG003|Overall Study|Non-serious Adverse Event|2|||
160848706|NCT00250276|580833832|FG000|Overall Study|Protocol Violation|0|||
160848707|NCT00250276|580833833|FG001|Overall Study|Protocol Violation|1|||
160848708|NCT00250276|580833834|FG002|Overall Study|Protocol Violation|0|||
160848709|NCT00250276|580833835|FG003|Overall Study|Protocol Violation|0|||
160848710|NCT00250276|580833832|FG000|Overall Study|Withdrawal by Subject|1|||
160848711|NCT00250276|580833833|FG001|Overall Study|Withdrawal by Subject|2|||
160848712|NCT00250276|580833834|FG002|Overall Study|Withdrawal by Subject|3|||
160848713|NCT00250276|580833835|FG003|Overall Study|Withdrawal by Subject|2|||
160848714|NCT00250276|580833832|FG000|Overall Study|Migrated/moved from study area|3|||
160848715|NCT00250276|580833833|FG001|Overall Study|Migrated/moved from study area|0|||
160848716|NCT00250276|580833834|FG002|Overall Study|Migrated/moved from study area|2|||
160848717|NCT00250276|580833835|FG003|Overall Study|Migrated/moved from study area|7|||
160848718|NCT00250276|580833832|FG000|Overall Study|Lost to Follow-up|11|||
160848719|NCT00250276|580833833|FG001|Overall Study|Lost to Follow-up|18|||
160848720|NCT00250276|580833834|FG002|Overall Study|Lost to Follow-up|13|||
160848721|NCT00250276|580833835|FG003|Overall Study|Lost to Follow-up|8|||
160848722|NCT00555217|580833836|FG000|Overall Study|Withdrawal by Subject|35|||
160848723|NCT00555217|580833837|FG001|Overall Study|Withdrawal by Subject|31|||
160848724|NCT00555217|580833836|FG000|Overall Study|Lost to Follow-up|19|||
160848725|NCT00555217|580833837|FG001|Overall Study|Lost to Follow-up|20|||
160848726|NCT00555217|580833836|FG000|Overall Study|close out sites|21|||
160848727|NCT00555217|580833837|FG001|Overall Study|close out sites|17|||
160848728|NCT01546688|580833838|FG000|Overall Study|Adverse Event|0|||
160848729|NCT01546688|580833839|FG001|Overall Study|Adverse Event|4|||
160848730|NCT01546688|580833838|FG000|Overall Study|Withdrawal by Subject|2|||
160848731|NCT01546688|580833839|FG001|Overall Study|Withdrawal by Subject|1|||
160848732|NCT01546688|580833838|FG000|Overall Study|Lack of Efficacy|1|||
160848733|NCT01546688|580833839|FG001|Overall Study|Lack of Efficacy|0|||
160848734|NCT03543137|580833840|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
160848735|NCT03543137|580833841|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
160848736|NCT03543137|580833840|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
160848737|NCT03543137|580833841|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
160848738|NCT03543137|580833840|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
160848739|NCT03543137|580833841|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
160848740|NCT01045694|580833847|FG000|Overall Study|Withdrawal by Subject|2|||
160848741|NCT01657292|580833848|FG000|Overall Study|Adverse Event|6|||
160848742|NCT01657292|580833848|FG000|Overall Study|Withdrawal by Subject|2|||
160848743|NCT01657292|580833848|FG000|Overall Study|Violation of eligibility criteria|1|||
160848744|NCT01657292|580833848|FG000|Overall Study|Change of therapy|1|||
160848745|NCT03761810|580833849|FG000|Overall Study|Adverse Event|12|||
160848746|NCT03761810|580833850|FG001|Overall Study|Adverse Event|0|||
160848747|NCT03761810|580833849|FG000|Overall Study|Lost to Follow-up|15|||
160848748|NCT03761810|580833850|FG001|Overall Study|Lost to Follow-up|7|||
160848749|NCT03761810|580833849|FG000|Overall Study|Pregnancy|1|||
160848750|NCT03761810|580833850|FG001|Overall Study|Pregnancy|0|||
160848751|NCT03761810|580833849|FG000|Overall Study|Withdrawal by Subject|14|||
160848752|NCT03761810|580833850|FG001|Overall Study|Withdrawal by Subject|5|||
160848753|NCT03761810|580833849|FG000|Overall Study|Physician Decision|1|||
160848754|NCT03761810|580833850|FG001|Overall Study|Physician Decision|0|||
160848755|NCT03761810|580833849|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
160848756|NCT03761810|580833850|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160848757|NCT03761810|580833849|FG000|Overall Study|Other Than Specified|1|||
160848758|NCT03761810|580833850|FG001|Overall Study|Other Than Specified|0|||
160848759|NCT03566082|580833851|FG000|Overall Study|Death|7|||
160848760|NCT03566082|580833851|FG000|Overall Study|Failures (revision required)|2|||
160848761|NCT03566082|580833851|FG000|Overall Study|Lost to Follow-up|8|||
160848762|NCT00983385|580833852|FG000|Observation Period|Not eligible to be dosed|20|||
160848763|NCT00983385|580833852|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
160848764|NCT02663622|580833853|FG000|Overall Study|Death|3|||
160848765|NCT02663622|580833854|FG001|Overall Study|Death|1|||
160848766|NCT02663622|580833855|FG002|Overall Study|Death|1|||
160848767|NCT02663622|580833856|FG003|Overall Study|Death|8|||
160848768|NCT02663622|580833853|FG000|Overall Study|Protocol Violation|0|||
160848769|NCT02663622|580833854|FG001|Overall Study|Protocol Violation|0|||
160848770|NCT02663622|580833855|FG002|Overall Study|Protocol Violation|0|||
160848771|NCT02663622|580833856|FG003|Overall Study|Protocol Violation|1|||
160848772|NCT00930930|580833858|FG000|Overall Study|Death|1|||
160848773|NCT00930930|580833859|FG001|Overall Study|Death|0|||
160848774|NCT00930930|580833858|FG000|Overall Study|Physician Decision|1|||
160848775|NCT00930930|580833859|FG001|Overall Study|Physician Decision|0|||
160848776|NCT00930930|580833858|FG000|Overall Study|Adverse Event|13|||
160848777|NCT00930930|580833859|FG001|Overall Study|Adverse Event|3|||
160848778|NCT00930930|580833858|FG000|Overall Study|Withdrawal by Subject|3|||
160848779|NCT00930930|580833859|FG001|Overall Study|Withdrawal by Subject|1|||
160848780|NCT00930930|580833858|FG000|Overall Study|Disease progression|2|||
160848781|NCT00930930|580833859|FG001|Overall Study|Disease progression|3|||
160848782|NCT00930930|580833858|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
160848783|NCT00930930|580833859|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
160848784|NCT00930930|580833858|FG000|Overall Study|patients not compliant|1|||
160848785|NCT00930930|580833859|FG001|Overall Study|patients not compliant|1|||
160848786|NCT00511238|580833860|FG000|Overall Study|Adverse Event|13|||
161337076|NCT03261401|582625817|FG000|Overall Study|Withdrawal by Subject|0|||
161337077|NCT03261401|582625818|FG001|Overall Study|Withdrawal by Subject|0|||
161337078|NCT03261401|582625819|FG002|Overall Study|Withdrawal by Subject|0|||
161337079|NCT03261401|582625820|FG003|Overall Study|Withdrawal by Subject|0|||
161337080|NCT03261401|582625821|FG004|Overall Study|Withdrawal by Subject|0|||
161337081|NCT03261401|582625822|FG005|Overall Study|Withdrawal by Subject|1|||
161337082|NCT03261401|582625823|FG006|Overall Study|Withdrawal by Subject|0|||
161337083|NCT03261401|582625824|FG007|Overall Study|Withdrawal by Subject|0|||
161337084|NCT03261401|582625825|FG008|Overall Study|Withdrawal by Subject|0|||
161337085|NCT03261401|582625826|FG009|Overall Study|Withdrawal by Subject|0|||
161337086|NCT03261401|582625827|FG010|Overall Study|Withdrawal by Subject|0|||
161337087|NCT03261401|582625828|FG011|Overall Study|Withdrawal by Subject|0|||
161337088|NCT03261401|582625829|FG012|Overall Study|Withdrawal by Subject|0|||
161337089|NCT03261401|582625817|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
161337090|NCT03261401|582625818|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
161337091|NCT03261401|582625819|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
161337092|NCT03261401|582625820|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
161337093|NCT03261401|582625821|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
161337094|NCT03261401|582625822|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
161337095|NCT03261401|582625823|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
161337096|NCT03261401|582625824|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
161337097|NCT03261401|582625825|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
161337098|NCT03261401|582625826|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
161337099|NCT03261401|582625827|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
161337100|NCT03261401|582625828|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
161337101|NCT03261401|582625829|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
161337102|NCT01516216|582625830|FG000|Overall Study|Adverse Event|2|||
161337103|NCT01516216|582625831|FG001|Overall Study|Adverse Event|4|||
161337104|NCT01516216|582625830|FG000|Overall Study|Disease Progression|38|||
161337105|NCT01516216|582625831|FG001|Overall Study|Disease Progression|34|||
161337106|NCT01516216|582625830|FG000|Overall Study|Withdrawal by Subject|9|||
161337107|NCT01516216|582625831|FG001|Overall Study|Withdrawal by Subject|11|||
161337108|NCT01516216|582625830|FG000|Overall Study|Potentially Curative Resection|6|||
161337109|NCT01516216|582625831|FG001|Overall Study|Potentially Curative Resection|12|||
161337110|NCT01516216|582625830|FG000|Overall Study|Nonadherence|2|||
161337111|NCT01516216|582625831|FG001|Overall Study|Nonadherence|3|||
161337112|NCT01516216|582625830|FG000|Overall Study|Physician Decision|6|||
161337113|NCT01516216|582625831|FG001|Overall Study|Physician Decision|3|||
161337114|NCT01516216|582625830|FG000|Overall Study|Prolonged Treatment Delay|5|||
161337115|NCT01516216|582625831|FG001|Overall Study|Prolonged Treatment Delay|1|||
161337116|NCT01516216|582625830|FG000|Overall Study|Intercurrent Illness|1|||
161337117|NCT01516216|582625831|FG001|Overall Study|Intercurrent Illness|0|||
161337118|NCT01516216|582625830|FG000|Overall Study|Death|1|||
161337119|NCT01516216|582625831|FG001|Overall Study|Death|1|||
161337120|NCT01715298|582625832|FG000|Overall Study|Lost to Follow-up|0|||
161337121|NCT01715298|582625833|FG001|Overall Study|Lost to Follow-up|2|||
161337122|NCT01715298|582625832|FG000|Overall Study|Patient/guardian decision|7|||
160848787|NCT00511238|580833861|FG001|Overall Study|Adverse Event|33|||
160848788|NCT00511238|580833860|FG000|Overall Study|Withdrawal by Subject|2|||
160848789|NCT00511238|580833861|FG001|Overall Study|Withdrawal by Subject|22|||
161337123|NCT01715298|582625833|FG001|Overall Study|Patient/guardian decision|9|||
161337124|NCT02419807|582625834|FG000|Overall Study|Withdrawal by Subject|4|||
161337125|NCT02419807|582625834|FG000|Overall Study|Physician Decision|1|||
161337126|NCT02419807|582625834|FG000|Overall Study|Protocol Violation|5|||
160848790|NCT00511238|580833860|FG000|Overall Study|Progressive Disease|23|||
160848791|NCT00511238|580833861|FG001|Overall Study|Progressive Disease|157|||
161337127|NCT01499511|582625837|FG000|Overall Study|Death|1|||
161337128|NCT01499511|582625838|FG001|Overall Study|Death|0|||
161337129|NCT01006629|582625839|FG000|Overall Study|Adverse Event|1|||
161337130|NCT01006629|582625839|FG000|Overall Study|Parent refused to continue participation|1|||
160848792|NCT00511238|580833860|FG000|Overall Study|various reasons|4|||
160848793|NCT00511238|580833861|FG001|Overall Study|various reasons|14|||
160848794|NCT00163020|580833862|FG000|Overall Study|Lost to Follow-up|0|||
160848795|NCT00163020|580833863|FG001|Overall Study|Lost to Follow-up|2|||
160848796|NCT03790111|580835599|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
160848797|NCT00997035|580835603|FG000|3-week Followup Visit|Lost to Follow-up|9|||
160848798|NCT00997035|580835604|FG001|3-week Followup Visit|Lost to Follow-up|6|||
160848799|NCT00997035|580835603|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
160848800|NCT00997035|580835604|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
160848801|NCT02471014|580835605|FG000|Overall Study|Lost to Follow-up|2|||
160848802|NCT02471014|580835606|FG001|Overall Study|Lost to Follow-up|2|||
160848803|NCT00936702|580835609|FG000|Overall Study|Disease progression|34|||
160848804|NCT00936702|580835609|FG000|Overall Study|Adverse Event|8|||
160848805|NCT00936702|580835609|FG000|Overall Study|Withdrawal by Subject|2|||
160848806|NCT00936702|580835609|FG000|Overall Study|Alternative Treatment|1|||
160848807|NCT00936702|580835609|FG000|Overall Study|Other|1|||
160848808|NCT00354679|580835610|FG000|Overall Study|Patient Not Treated|1|||
160848809|NCT03456076|580835611|FG000|Overall Study|Withdrawal by Subject|5|||
160848810|NCT03456076|580835612|FG001|Overall Study|Withdrawal by Subject|9|||
160848811|NCT03456076|580835611|FG000|Overall Study|Protocol deviation|0|||
160848812|NCT03456076|580835612|FG001|Overall Study|Protocol deviation|1|||
160848813|NCT03456076|580835611|FG000|Overall Study|Lost to Follow-up|0|||
160848814|NCT03456076|580835612|FG001|Overall Study|Lost to Follow-up|1|||
160848815|NCT03456076|580835611|FG000|Overall Study|Death|2|||
160848816|NCT03456076|580835612|FG001|Overall Study|Death|5|||
160906427|NCT00395304|581052178|FG003|Treatment Period 2|Other|0|||
160906428|NCT00395304|581052179|FG004|Treatment Period 2|Other|0|||
160906429|NCT00395304|581052180|FG005|Treatment Period 2|Other|0|||
160906430|NCT00395304|581052175|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160906431|NCT00395304|581052176|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160906432|NCT00395304|581052177|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160906433|NCT00395304|581052178|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160906434|NCT00395304|581052179|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160906435|NCT00395304|581052180|FG005|Treatment Period 3|Withdrawal by Subject|1|||
160906436|NCT00395304|581052175|FG000|Treatment Period 3|Lost to Follow-up|1|||
160906437|NCT00395304|581052176|FG001|Treatment Period 3|Lost to Follow-up|1|||
160906438|NCT00395304|581052177|FG002|Treatment Period 3|Lost to Follow-up|0|||
160906439|NCT00395304|581052178|FG003|Treatment Period 3|Lost to Follow-up|0|||
160906440|NCT00395304|581052179|FG004|Treatment Period 3|Lost to Follow-up|0|||
160906441|NCT00395304|581052180|FG005|Treatment Period 3|Lost to Follow-up|0|||
160906442|NCT00395304|581052175|FG000|Treatment Period 3|Physician Decision|0|||
160906443|NCT00395304|581052176|FG001|Treatment Period 3|Physician Decision|1|||
160906444|NCT00395304|581052177|FG002|Treatment Period 3|Physician Decision|0|||
160906445|NCT00395304|581052178|FG003|Treatment Period 3|Physician Decision|0|||
160906446|NCT00395304|581052179|FG004|Treatment Period 3|Physician Decision|0|||
160906447|NCT00395304|581052180|FG005|Treatment Period 3|Physician Decision|0|||
160906448|NCT00395304|581052175|FG000|Treatment Period 3|Other|0|||
160906449|NCT00395304|581052176|FG001|Treatment Period 3|Other|0|||
160906450|NCT00395304|581052177|FG002|Treatment Period 3|Other|0|||
160906451|NCT00395304|581052178|FG003|Treatment Period 3|Other|1|||
160906452|NCT00395304|581052179|FG004|Treatment Period 3|Other|0|||
160906453|NCT00395304|581052180|FG005|Treatment Period 3|Other|0|||
160906454|NCT00980057|581052185|FG000|Overall Study|Death|13|||
160906455|NCT00980057|581052186|FG001|Overall Study|Death|3|||
160906456|NCT00980057|581052185|FG000|Overall Study|Adverse Event|0|||
160906457|NCT00980057|581052186|FG001|Overall Study|Adverse Event|1|||
160906458|NCT00980057|581052185|FG000|Overall Study|Physician Decision|4|||
160906459|NCT00980057|581052186|FG001|Overall Study|Physician Decision|0|||
160906460|NCT00980057|581052185|FG000|Overall Study|Lost to Follow-up|1|||
160906461|NCT00980057|581052186|FG001|Overall Study|Lost to Follow-up|0|||
160906462|NCT00980057|581052185|FG000|Overall Study|Withdrawal by Subject|1|||
160906463|NCT00980057|581052186|FG001|Overall Study|Withdrawal by Subject|1|||
160906464|NCT00691015|581052190|FG000|Overall Study|Refused further treatment|1|||
160906465|NCT03766581|581052195|FG000|Randomization|Other reasons|2|||
160906466|NCT03766581|581052196|FG001|Randomization|Other reasons|1|||
160848817|NCT03456076|580835611|FG000|Overall Study|Study ongoing|123|||
160848818|NCT03456076|580835612|FG001|Overall Study|Study ongoing|111|||
161141158|NCT00900796|581900979|FG000|Phase 1|Lacked sufficient information|4|||
160848819|NCT03187132|580835615|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
160906467|NCT03766581|581052197|FG002|Randomization|Other reasons|0|||
160906468|NCT03766581|581052198|FG003|Randomization|Other reasons|1|||
160906469|NCT03766581|581052199|FG004|Randomization|Other reasons|0|||
161141159|NCT00900796|581900979|FG000|Phase 1|Missing information at Week 16|7|||
160848820|NCT03187132|580835616|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
160848821|NCT03187132|580835615|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
161141160|NCT00900796|581900979|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
161141161|NCT00900796|581900979|FG000|Phase 2|Lost to Follow-up|5|||
160848822|NCT03187132|580835616|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
160906470|NCT03766581|581052200|FG005|Randomization|Other reasons|0|||
160906471|NCT03766581|581052201|FG006|Randomization|Other reasons|0|||
160906472|NCT03766581|581052202|FG007|Randomization|Other reasons|0|||
160906473|NCT03766581|581052195|FG000|Randomization|Participant no longer meets study criteria|5|||
160848823|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
160848824|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
160848825|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
160848826|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
160848827|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
160848828|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
160848829|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
160848830|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
160848831|NCT03187132|580835615|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
160848832|NCT03187132|580835616|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
160848833|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
160848834|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
160848835|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
160848836|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
160848837|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
160848838|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
160848839|NCT03187132|580835615|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
160848840|NCT03187132|580835616|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
160848841|NCT02045095|580835617|FG000|Overall Study|Other|0|||
160848842|NCT02045095|580835618|FG001|Overall Study|Other|0|||
160848843|NCT02045095|580835619|FG002|Overall Study|Other|1|||
160848844|NCT02045095|580835620|FG003|Overall Study|Other|0|||
160848845|NCT02045095|580835621|FG004|Overall Study|Other|0|||
160848846|NCT02045095|580835622|FG005|Overall Study|Other|2|||
160848847|NCT02045095|580835623|FG006|Overall Study|Other|0|||
160848848|NCT02045095|580835617|FG000|Overall Study|Progressive Disease|3|||
160848849|NCT02045095|580835618|FG001|Overall Study|Progressive Disease|3|||
160848850|NCT02045095|580835619|FG002|Overall Study|Progressive Disease|2|||
160848851|NCT02045095|580835620|FG003|Overall Study|Progressive Disease|4|||
160848852|NCT02045095|580835621|FG004|Overall Study|Progressive Disease|2|||
160848853|NCT02045095|580835622|FG005|Overall Study|Progressive Disease|4|||
160848854|NCT02045095|580835623|FG006|Overall Study|Progressive Disease|1|||
160848855|NCT02045095|580835617|FG000|Overall Study|Withdrawal by Subject|0|||
160848856|NCT02045095|580835618|FG001|Overall Study|Withdrawal by Subject|0|||
160848857|NCT02045095|580835619|FG002|Overall Study|Withdrawal by Subject|0|||
160848858|NCT02045095|580835620|FG003|Overall Study|Withdrawal by Subject|0|||
160848859|NCT02045095|580835621|FG004|Overall Study|Withdrawal by Subject|3|||
160848860|NCT02045095|580835622|FG005|Overall Study|Withdrawal by Subject|0|||
160848861|NCT02045095|580835623|FG006|Overall Study|Withdrawal by Subject|0|||
160848862|NCT02045095|580835617|FG000|Overall Study|Adverse Event|0|||
160848863|NCT02045095|580835618|FG001|Overall Study|Adverse Event|1|||
160848864|NCT02045095|580835619|FG002|Overall Study|Adverse Event|1|||
160848865|NCT02045095|580835620|FG003|Overall Study|Adverse Event|0|||
160848866|NCT02045095|580835621|FG004|Overall Study|Adverse Event|0|||
160848867|NCT02045095|580835622|FG005|Overall Study|Adverse Event|2|||
160848868|NCT02045095|580835623|FG006|Overall Study|Adverse Event|0|||
160848869|NCT02525588|580835624|FG000|Overall Study|Death|3|||
160848870|NCT02525588|580835625|FG001|Overall Study|Death|1|||
160848871|NCT02525588|580835624|FG000|Overall Study|Lost to Follow-up|2|||
160848872|NCT02525588|580835625|FG001|Overall Study|Lost to Follow-up|0|||
160848873|NCT02525588|580835624|FG000|Overall Study|Withdrawal by Subject|1|||
160848874|NCT02525588|580835625|FG001|Overall Study|Withdrawal by Subject|1|||
160848875|NCT02525588|580835624|FG000|Overall Study|Adverse Event|0|||
160848876|NCT02525588|580835625|FG001|Overall Study|Adverse Event|1|||
161141162|NCT01244737|581900982|FG000|Overall Study|Physician Decision|2|||
160848877|NCT01450761|580835629|FG000|Randomization|Subject no longer meets study criteria|1|||
160848878|NCT01450761|580835630|FG001|Randomization|Subject no longer meets study criteria|2|||
160848879|NCT01450761|580835629|FG000|Randomization|Withdrawal by Subject|2|||
160848880|NCT01450761|580835630|FG001|Randomization|Withdrawal by Subject|0|||
160848881|NCT01450761|580835629|FG000|Randomization|Disease progression|0|||
160848882|NCT01450761|580835630|FG001|Randomization|Disease progression|2|||
160848883|NCT01450761|580835629|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161141163|NCT01244737|581900983|FG001|Overall Study|Physician Decision|18|||
160848884|NCT01450761|580835630|FG001|Randomization|Adverse Event unrelated to study drug|0|||
160848885|NCT01450761|580835629|FG000|Randomization|Other|0|||
160848886|NCT01450761|580835630|FG001|Randomization|Other|1|||
161141164|NCT01244737|581900984|FG002|Overall Study|Physician Decision|5|||
161141165|NCT01244737|581900982|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
160848887|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Disease progression|33|||
160848888|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Disease progression|32|||
160848889|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
160906474|NCT03766581|581052196|FG001|Randomization|Participant no longer meets study criteria|3|||
160848890|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
160848891|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
160848892|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
160848893|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
160848894|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
160848895|NCT01450761|580835629|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
160848896|NCT01450761|580835630|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
160848897|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Death|3|||
160848898|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Death|3|||
160848899|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Other|2|||
160848900|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Other|2|||
160848901|NCT01450761|580835629|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
160848902|NCT01450761|580835630|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
160848903|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
160848904|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
160848905|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
160848906|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
160848907|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
160848908|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
160848909|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
160848910|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
160848911|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
160848912|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
160848913|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Death|5|||
160848914|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Death|6|||
160848915|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
160848916|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
160848917|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
160848918|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
160848919|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
160848920|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
160848921|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
160848922|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
160848923|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
160848924|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
160848925|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
160848926|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
160848927|NCT01450761|580835629|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
160848928|NCT01450761|580835630|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
160848929|NCT03801174|580835631|FG000|Overall Study|Withdrawal by Subject|14|||
160848930|NCT03801174|580835632|FG001|Overall Study|Withdrawal by Subject|15|||
160848931|NCT03801174|580835631|FG000|Overall Study|Death|1|||
160848932|NCT03801174|580835632|FG001|Overall Study|Death|0|||
160848933|NCT03801174|580835631|FG000|Overall Study|Pregnancy|2|||
160848934|NCT03801174|580835632|FG001|Overall Study|Pregnancy|2|||
160848935|NCT03801174|580835631|FG000|Overall Study|Lost to Follow-up|19|||
160848936|NCT03801174|580835632|FG001|Overall Study|Lost to Follow-up|10|||
160848937|NCT03801174|580835631|FG000|Overall Study|Other|4|||
160848938|NCT03801174|580835632|FG001|Overall Study|Other|3|||
160848939|NCT03801174|580835631|FG000|Overall Study|Lack of Efficacy|4|||
160848940|NCT03801174|580835632|FG001|Overall Study|Lack of Efficacy|0|||
160848941|NCT03801174|580835631|FG000|Overall Study|Unwilling to complete activities|5|||
160848942|NCT03801174|580835632|FG001|Overall Study|Unwilling to complete activities|6|||
160848943|NCT03801174|580835631|FG000|Overall Study|Moved out of area|3|||
160848944|NCT03801174|580835632|FG001|Overall Study|Moved out of area|0|||
160848945|NCT04435366|580835633|FG000|Year 1 (12 Months)|Adverse Event|3|||
160848946|NCT04435366|580835634|FG001|Year 1 (12 Months)|Adverse Event|0|||
160848947|NCT04435366|580835635|FG002|Year 1 (12 Months)|Adverse Event|2|||
160848948|NCT04435366|580835633|FG000|Year 1 (12 Months)|Death|2|||
160848949|NCT04435366|580835634|FG001|Year 1 (12 Months)|Death|0|||
160848950|NCT04435366|580835635|FG002|Year 1 (12 Months)|Death|1|||
160848951|NCT04435366|580835633|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
160848952|NCT04435366|580835634|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
160848953|NCT04435366|580835635|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
160848954|NCT04435366|580835633|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
160848955|NCT04435366|580835634|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
160848956|NCT04435366|580835635|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
160848957|NCT04435366|580835633|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
160848958|NCT04435366|580835634|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
160848959|NCT04435366|580835635|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
160848960|NCT04435366|580835633|FG000|Year 1 (12 Months)|Not treated|0|||
160848961|NCT04435366|580835634|FG001|Year 1 (12 Months)|Not treated|0|||
160848962|NCT04435366|580835635|FG002|Year 1 (12 Months)|Not treated|1|||
160848963|NCT04435366|580835633|FG000|Year 2 (12 Months)|Death|1|||
160848964|NCT04435366|580835634|FG001|Year 2 (12 Months)|Death|4|||
161141166|NCT01244737|581900983|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
161141167|NCT01244737|581900984|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
161141168|NCT01244737|581900982|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
161141169|NCT01244737|581900983|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
161141170|NCT01244737|581900984|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
161141171|NCT01244737|581900982|FG000|Overall Study|MIB immunopathology results not available|3|||
161141172|NCT01244737|581900983|FG001|Overall Study|MIB immunopathology results not available|2|||
161141173|NCT01244737|581900984|FG002|Overall Study|MIB immunopathology results not available|0|||
161141174|NCT01244737|581900982|FG000|Overall Study|PET data failure|0|||
161141175|NCT01244737|581900983|FG001|Overall Study|PET data failure|1|||
161141176|NCT01244737|581900984|FG002|Overall Study|PET data failure|0|||
161141177|NCT01244737|581900982|FG000|Overall Study|Withdrawal by Subject|0|||
161141178|NCT01244737|581900983|FG001|Overall Study|Withdrawal by Subject|0|||
161141179|NCT01244737|581900984|FG002|Overall Study|Withdrawal by Subject|1|||
161141180|NCT00356915|581900991|FG000|Overall Study|Non compliance|1|||
161141181|NCT00356915|581900992|FG001|Overall Study|Non compliance|2|||
161254648|NCT02752802|582310046|FG001|Overall Study|Contrast Volume Not Collected|0|||
161141182|NCT00356915|581900993|FG002|Overall Study|Non compliance|1|||
160906475|NCT03766581|581052197|FG002|Randomization|Participant no longer meets study criteria|4|||
160906476|NCT03766581|581052198|FG003|Randomization|Participant no longer meets study criteria|0|||
160906477|NCT03766581|581052199|FG004|Randomization|Participant no longer meets study criteria|2|||
160906478|NCT03766581|581052200|FG005|Randomization|Participant no longer meets study criteria|3|||
160906479|NCT03766581|581052201|FG006|Randomization|Participant no longer meets study criteria|0|||
160906480|NCT03766581|581052202|FG007|Randomization|Participant no longer meets study criteria|1|||
160906481|NCT03766581|581052195|FG000|Randomization|Participant request to discontinue study treatment|1|||
160906482|NCT03766581|581052196|FG001|Randomization|Participant request to discontinue study treatment|0|||
160906483|NCT03766581|581052197|FG002|Randomization|Participant request to discontinue study treatment|0|||
160906484|NCT03766581|581052198|FG003|Randomization|Participant request to discontinue study treatment|0|||
160906485|NCT03766581|581052199|FG004|Randomization|Participant request to discontinue study treatment|1|||
160906486|NCT03766581|581052200|FG005|Randomization|Participant request to discontinue study treatment|2|||
160906487|NCT03766581|581052201|FG006|Randomization|Participant request to discontinue study treatment|0|||
160906488|NCT03766581|581052202|FG007|Randomization|Participant request to discontinue study treatment|0|||
160906489|NCT03766581|581052195|FG000|Randomization|Participant withdrew consent|1|||
160906490|NCT03766581|581052196|FG001|Randomization|Participant withdrew consent|0|||
160906491|NCT03766581|581052197|FG002|Randomization|Participant withdrew consent|1|||
160906492|NCT03766581|581052198|FG003|Randomization|Participant withdrew consent|2|||
160906493|NCT03766581|581052199|FG004|Randomization|Participant withdrew consent|1|||
160906494|NCT03766581|581052200|FG005|Randomization|Participant withdrew consent|1|||
160906495|NCT03766581|581052201|FG006|Randomization|Participant withdrew consent|0|||
160906496|NCT03766581|581052202|FG007|Randomization|Participant withdrew consent|0|||
160906497|NCT03766581|581052195|FG000|Treatment|Adverse Event|82|||
160906498|NCT03766581|581052196|FG001|Treatment|Adverse Event|44|||
160906499|NCT03766581|581052197|FG002|Treatment|Adverse Event|47|||
160906500|NCT03766581|581052198|FG003|Treatment|Adverse Event|46|||
160906501|NCT03766581|581052199|FG004|Treatment|Adverse Event|50|||
160906502|NCT03766581|581052200|FG005|Treatment|Adverse Event|77|||
160906503|NCT03766581|581052201|FG006|Treatment|Adverse Event|5|||
160906504|NCT03766581|581052202|FG007|Treatment|Adverse Event|2|||
160906505|NCT03766581|581052195|FG000|Treatment|Participant request to discontinue treatment|34|||
160906506|NCT03766581|581052196|FG001|Treatment|Participant request to discontinue treatment|6|||
160906507|NCT03766581|581052197|FG002|Treatment|Participant request to discontinue treatment|10|||
160906508|NCT03766581|581052198|FG003|Treatment|Participant request to discontinue treatment|10|||
160906509|NCT03766581|581052199|FG004|Treatment|Participant request to discontinue treatment|14|||
160906510|NCT03766581|581052200|FG005|Treatment|Participant request to discontinue treatment|15|||
160906511|NCT03766581|581052201|FG006|Treatment|Participant request to discontinue treatment|0|||
160906512|NCT03766581|581052202|FG007|Treatment|Participant request to discontinue treatment|1|||
160906513|NCT03766581|581052195|FG000|Treatment|Participant withdrew consent|11|||
160906514|NCT03766581|581052196|FG001|Treatment|Participant withdrew consent|4|||
160906515|NCT03766581|581052197|FG002|Treatment|Participant withdrew consent|5|||
160906516|NCT03766581|581052198|FG003|Treatment|Participant withdrew consent|5|||
160906517|NCT03766581|581052199|FG004|Treatment|Participant withdrew consent|4|||
160906518|NCT03766581|581052200|FG005|Treatment|Participant withdrew consent|4|||
160906519|NCT03766581|581052201|FG006|Treatment|Participant withdrew consent|0|||
160906520|NCT03766581|581052202|FG007|Treatment|Participant withdrew consent|0|||
160906521|NCT03766581|581052195|FG000|Treatment|Death|1|||
160906522|NCT03766581|581052196|FG001|Treatment|Death|0|||
160906523|NCT03766581|581052197|FG002|Treatment|Death|0|||
160906524|NCT03766581|581052198|FG003|Treatment|Death|0|||
160906525|NCT03766581|581052199|FG004|Treatment|Death|0|||
160906526|NCT03766581|581052200|FG005|Treatment|Death|0|||
161254649|NCT03689894|582310047|FG000|Overall Study|Adverse Event|1|||
160848965|NCT04435366|580835635|FG002|Year 2 (12 Months)|Death|6|||
160848966|NCT04435366|580835633|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
160848967|NCT04435366|580835634|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
160848968|NCT04435366|580835635|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
160848969|NCT04435366|580835633|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
160848970|NCT04435366|580835634|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
160848971|NCT04435366|580835635|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
160848972|NCT04435366|580835633|FG000|Year 2 (12 Months)|Adverse Event|2|||
160906527|NCT03766581|581052201|FG006|Treatment|Death|0|||
160848973|NCT04435366|580835634|FG001|Year 2 (12 Months)|Adverse Event|1|||
160848974|NCT04435366|580835635|FG002|Year 2 (12 Months)|Adverse Event|6|||
160848975|NCT05963022|580835640|FG000|Overall Study|Adverse Event|0|||
160848976|NCT05963022|580835641|FG001|Overall Study|Adverse Event|1|||
160848977|NCT05963022|580835642|FG002|Overall Study|Adverse Event|1|||
160848978|NCT05963022|580835643|FG003|Overall Study|Adverse Event|0|||
160848979|NCT05963022|580835640|FG000|Overall Study|Protocol Violation|0|||
160848980|NCT05963022|580835641|FG001|Overall Study|Protocol Violation|3|||
160848981|NCT05963022|580835642|FG002|Overall Study|Protocol Violation|0|||
160848982|NCT05963022|580835643|FG003|Overall Study|Protocol Violation|0|||
160848983|NCT05963022|580835640|FG000|Overall Study|Pregnancy|0|||
160848984|NCT05963022|580835641|FG001|Overall Study|Pregnancy|1|||
160848985|NCT05963022|580835642|FG002|Overall Study|Pregnancy|1|||
160848986|NCT05963022|580835643|FG003|Overall Study|Pregnancy|1|||
160848987|NCT05963022|580835640|FG000|Overall Study|Withdrawal by Subject|0|||
160848988|NCT05963022|580835641|FG001|Overall Study|Withdrawal by Subject|0|||
160848989|NCT05963022|580835642|FG002|Overall Study|Withdrawal by Subject|2|||
160848990|NCT05963022|580835643|FG003|Overall Study|Withdrawal by Subject|1|||
160848991|NCT05963022|580835640|FG000|Overall Study|Lost to Follow-up|0|||
160848992|NCT05963022|580835641|FG001|Overall Study|Lost to Follow-up|0|||
160848993|NCT05963022|580835642|FG002|Overall Study|Lost to Follow-up|0|||
160848994|NCT05963022|580835643|FG003|Overall Study|Lost to Follow-up|1|||
160848995|NCT05963022|580835640|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
160848996|NCT05963022|580835641|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
160848997|NCT05963022|580835642|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
160848998|NCT05963022|580835643|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
160848999|NCT02478463|580835648|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
160849000|NCT02478463|580835648|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
160849001|NCT02478463|580835648|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
160849002|NCT01177007|580835650|FG000|Overall Study|Lost to Follow-up|2|||
160849003|NCT01177007|580835650|FG000|Overall Study|Death|4|||
160849004|NCT01177007|580835650|FG000|Overall Study|Entered hospice care|5|||
160849005|NCT01177007|580835650|FG000|Overall Study|Required additional Y90 treatment|6|||
160849006|NCT01177007|580835650|FG000|Overall Study|Change in treatment modality|21|||
160849007|NCT01702558|580835652|FG000|Overall Study|Withdrawal by Subject|0|||
160992482|NCT01020838|581361376|FG000|Overall Study|Withdrawal by Subject|9|||
160992483|NCT01020838|581361376|FG000|Overall Study|Lost to Follow-up|6|||
160992484|NCT01020838|581361376|FG000|Overall Study|Most common: Study ended by sponsor|77|||
160992485|NCT02993471|581361377|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
160992486|NCT02993471|581361377|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
160992487|NCT01908634|581361379|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
160849008|NCT01702558|580835653|FG001|Overall Study|Withdrawal by Subject|0|||
160849009|NCT01702558|580835654|FG002|Overall Study|Withdrawal by Subject|0|||
160849010|NCT01702558|580835655|FG003|Overall Study|Withdrawal by Subject|12|||
160906528|NCT03766581|581052202|FG007|Treatment|Death|0|||
160906529|NCT03766581|581052195|FG000|Treatment|Lost to Follow-up|1|||
160906530|NCT03766581|581052196|FG001|Treatment|Lost to Follow-up|0|||
160906531|NCT03766581|581052197|FG002|Treatment|Lost to Follow-up|0|||
160906532|NCT03766581|581052198|FG003|Treatment|Lost to Follow-up|1|||
160906533|NCT03766581|581052199|FG004|Treatment|Lost to Follow-up|0|||
160906534|NCT03766581|581052200|FG005|Treatment|Lost to Follow-up|0|||
160906535|NCT03766581|581052201|FG006|Treatment|Lost to Follow-up|0|||
160906536|NCT03766581|581052202|FG007|Treatment|Lost to Follow-up|0|||
160992488|NCT01908634|581361379|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
160849011|NCT01702558|580835656|FG004|Overall Study|Withdrawal by Subject|4|||
160849012|NCT01702558|580835652|FG000|Overall Study|Lost to Follow-up|0|||
160849013|NCT01702558|580835653|FG001|Overall Study|Lost to Follow-up|0|||
160849014|NCT01702558|580835654|FG002|Overall Study|Lost to Follow-up|0|||
160906537|NCT03766581|581052195|FG000|Treatment|Poor/Non compliance|2|||
160849015|NCT01702558|580835655|FG003|Overall Study|Lost to Follow-up|3|||
160849016|NCT01702558|580835656|FG004|Overall Study|Lost to Follow-up|0|||
160849017|NCT01702558|580835652|FG000|Overall Study|Death|4|||
160849018|NCT01702558|580835653|FG001|Overall Study|Death|3|||
160849019|NCT01702558|580835654|FG002|Overall Study|Death|3|||
160906538|NCT03766581|581052196|FG001|Treatment|Poor/Non compliance|2|||
160906539|NCT03766581|581052197|FG002|Treatment|Poor/Non compliance|1|||
160906540|NCT03766581|581052198|FG003|Treatment|Poor/Non compliance|1|||
160849020|NCT01702558|580835655|FG003|Overall Study|Death|16|||
160849021|NCT01702558|580835656|FG004|Overall Study|Death|20|||
160849022|NCT01702558|580835652|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849023|NCT01702558|580835653|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849024|NCT01702558|580835654|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
160849025|NCT01702558|580835655|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849026|NCT01702558|580835656|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
160849027|NCT01702558|580835652|FG000|Overall Study|Study Terminated by Sponsor|0|||
160849028|NCT01702558|580835653|FG001|Overall Study|Study Terminated by Sponsor|1|||
160849029|NCT01702558|580835654|FG002|Overall Study|Study Terminated by Sponsor|0|||
160849030|NCT01702558|580835655|FG003|Overall Study|Study Terminated by Sponsor|0|||
160849031|NCT01702558|580835656|FG004|Overall Study|Study Terminated by Sponsor|1|||
160849032|NCT01702558|580835652|FG000|Overall Study|Other|0|||
160849033|NCT01702558|580835653|FG001|Overall Study|Other|0|||
160849034|NCT01702558|580835654|FG002|Overall Study|Other|0|||
160849035|NCT01702558|580835655|FG003|Overall Study|Other|16|||
160849036|NCT01702558|580835656|FG004|Overall Study|Other|17|||
160849037|NCT03259087|580835662|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849038|NCT03259087|580835663|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849039|NCT03259087|580835664|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849040|NCT03259087|580835665|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
160849041|NCT03259087|580835666|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
160849042|NCT03259087|580835662|FG000|Period 2 of Part 2|Adverse Event|0|||
160849043|NCT03259087|580835663|FG001|Period 2 of Part 2|Adverse Event|0|||
160849044|NCT03259087|580835664|FG002|Period 2 of Part 2|Adverse Event|0|||
160849045|NCT03259087|580835665|FG003|Period 2 of Part 2|Adverse Event|0|||
160849046|NCT03259087|580835666|FG004|Period 2 of Part 2|Adverse Event|1|||
160849047|NCT04524858|580835667|FG000|Overall Study|Adverse Event|1|||
160849048|NCT03571204|580835668|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
160849049|NCT03571204|580835669|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
160849050|NCT03571204|580835670|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
160849051|NCT03571204|580835668|FG000|Overall Study|Physician Decision|0|||
160849052|NCT03571204|580835669|FG001|Overall Study|Physician Decision|1|||
160849053|NCT03571204|580835670|FG002|Overall Study|Physician Decision|0|||
160849054|NCT02396212|580835671|FG000|Overall Study|Adverse Event|1|||
160849055|NCT02396212|580835671|FG000|Overall Study|Lack of Efficacy|2|||
160849056|NCT01623115|580835672|FG000|Overall Study|Randomized but not treated|0|||
160849057|NCT01623115|580835673|FG001|Overall Study|Randomized but not treated|1|||
160849058|NCT01623115|580835672|FG000|Overall Study|Physician Decision|1|||
160849059|NCT01623115|580835673|FG001|Overall Study|Physician Decision|0|||
160849060|NCT01623115|580835672|FG000|Overall Study|Participants moved|1|||
160849061|NCT01623115|580835673|FG001|Overall Study|Participants moved|5|||
160849062|NCT01623115|580835672|FG000|Overall Study|Adverse Event|10|||
160849063|NCT01623115|580835673|FG001|Overall Study|Adverse Event|13|||
160849064|NCT01623115|580835672|FG000|Overall Study|Poor compliance to protocol|4|||
160849065|NCT01623115|580835673|FG001|Overall Study|Poor compliance to protocol|10|||
160849066|NCT01623115|580835672|FG000|Overall Study|Consent withdrawn by participant|2|||
160849067|NCT01623115|580835673|FG001|Overall Study|Consent withdrawn by participant|6|||
161337131|NCT01006629|582625839|FG000|Overall Study|Parent unable to perform site visit|4|||
160849068|NCT01623115|580835672|FG000|Overall Study|Related to study drug administration|0|||
160849069|NCT01623115|580835673|FG001|Overall Study|Related to study drug administration|2|||
160849070|NCT01623115|580835672|FG000|Overall Study|Last visit outside protocol visit window|14|||
160849071|NCT01623115|580835673|FG001|Overall Study|Last visit outside protocol visit window|26|||
160849072|NCT01623115|580835672|FG000|Overall Study|Site closure|1|||
160849073|NCT01623115|580835673|FG001|Overall Study|Site closure|7|||
160849074|NCT01623115|580835672|FG000|Overall Study|Death|0|||
160849075|NCT01623115|580835673|FG001|Overall Study|Death|4|||
160849076|NCT01623115|580835672|FG000|Overall Study|Other than specified above|0|||
160849077|NCT01623115|580835673|FG001|Overall Study|Other than specified above|3|||
160849078|NCT04950465|580835674|FG000|Overall Study|Lost to Follow-up|1|||
160849079|NCT04950465|580835675|FG001|Overall Study|Lost to Follow-up|0|||
160849080|NCT04950465|580835676|FG002|Overall Study|Lost to Follow-up|0|||
160849081|NCT02721875|580835681|FG000|Overall Study|Progressive disease/relapse|1|||
160849082|NCT02721875|580835682|FG001|Overall Study|Progressive disease/relapse|0|||
160849083|NCT02888106|580835683|FG000|Overall Study|Withdrawal by Subject|1|||
160849084|NCT02888106|580835684|FG001|Overall Study|Withdrawal by Subject|2|||
160849085|NCT02888106|580835685|FG002|Overall Study|Withdrawal by Subject|0|||
160849086|NCT02888106|580835686|FG003|Overall Study|Withdrawal by Subject|1|||
160849087|NCT02888106|580835687|FG004|Overall Study|Withdrawal by Subject|0|||
160849088|NCT02888106|580835688|FG005|Overall Study|Withdrawal by Subject|0|||
160849089|NCT02888106|580835683|FG000|Overall Study|Lost to Follow-up|1|||
160849090|NCT02888106|580835684|FG001|Overall Study|Lost to Follow-up|0|||
160849091|NCT02888106|580835685|FG002|Overall Study|Lost to Follow-up|0|||
160849092|NCT02888106|580835686|FG003|Overall Study|Lost to Follow-up|1|||
160849093|NCT02888106|580835687|FG004|Overall Study|Lost to Follow-up|0|||
160849094|NCT02888106|580835688|FG005|Overall Study|Lost to Follow-up|1|||
160849095|NCT02888106|580835683|FG000|Overall Study|Adverse Event|2|||
160849096|NCT02888106|580835684|FG001|Overall Study|Adverse Event|0|||
160849097|NCT02888106|580835685|FG002|Overall Study|Adverse Event|0|||
160849098|NCT02888106|580835686|FG003|Overall Study|Adverse Event|0|||
160849099|NCT02888106|580835687|FG004|Overall Study|Adverse Event|0|||
160849100|NCT02888106|580835688|FG005|Overall Study|Adverse Event|0|||
160849101|NCT02888106|580835683|FG000|Overall Study|Withdrawal of consent|0|||
160849102|NCT02888106|580835684|FG001|Overall Study|Withdrawal of consent|0|||
160849103|NCT02888106|580835685|FG002|Overall Study|Withdrawal of consent|0|||
160849104|NCT02888106|580835686|FG003|Overall Study|Withdrawal of consent|0|||
160849105|NCT02888106|580835687|FG004|Overall Study|Withdrawal of consent|1|||
160849106|NCT02888106|580835688|FG005|Overall Study|Withdrawal of consent|0|||
160849107|NCT02888106|580835683|FG000|Overall Study|Pregnancy|1|||
160849108|NCT02888106|580835684|FG001|Overall Study|Pregnancy|0|||
160849109|NCT02888106|580835685|FG002|Overall Study|Pregnancy|0|||
160849110|NCT02888106|580835686|FG003|Overall Study|Pregnancy|0|||
160849111|NCT02888106|580835687|FG004|Overall Study|Pregnancy|0|||
160849112|NCT02888106|580835688|FG005|Overall Study|Pregnancy|0|||
160849113|NCT01425801|580835694|FG000|Period 1|Withdrawal by Subject|0|||
160849114|NCT01425801|580835695|FG001|Period 1|Withdrawal by Subject|0|||
160849115|NCT01425801|580835696|FG002|Period 1|Withdrawal by Subject|0|||
160849116|NCT01425801|580835697|FG003|Period 1|Withdrawal by Subject|0|||
160849117|NCT01425801|580835698|FG004|Period 1|Withdrawal by Subject|1|||
160849118|NCT01425801|580835699|FG005|Period 1|Withdrawal by Subject|0|||
160849119|NCT01425801|580835694|FG000|Period 2|Withdrawal by Subject|0|||
160849120|NCT01425801|580835695|FG001|Period 2|Withdrawal by Subject|0|||
160849121|NCT01425801|580835696|FG002|Period 2|Withdrawal by Subject|0|||
160849122|NCT01425801|580835697|FG003|Period 2|Withdrawal by Subject|0|||
160849123|NCT01425801|580835698|FG004|Period 2|Withdrawal by Subject|1|||
160849124|NCT01425801|580835699|FG005|Period 2|Withdrawal by Subject|0|||
160849125|NCT01425801|580835694|FG000|Period 3|Stability criteria not fullfilled|0|||
160849126|NCT01425801|580835695|FG001|Period 3|Stability criteria not fullfilled|0|||
160849127|NCT01425801|580835696|FG002|Period 3|Stability criteria not fullfilled|1|||
160849128|NCT01425801|580835697|FG003|Period 3|Stability criteria not fullfilled|0|||
160849129|NCT01425801|580835698|FG004|Period 3|Stability criteria not fullfilled|0|||
160849130|NCT01425801|580835699|FG005|Period 3|Stability criteria not fullfilled|0|||
160849131|NCT01425801|580835694|FG000|Period 4|Not able to maintain visit schedule|0|||
160849132|NCT01425801|580835695|FG001|Period 4|Not able to maintain visit schedule|0|||
160849133|NCT01425801|580835696|FG002|Period 4|Not able to maintain visit schedule|1|||
160849134|NCT01425801|580835697|FG003|Period 4|Not able to maintain visit schedule|0|||
160849135|NCT01425801|580835698|FG004|Period 4|Not able to maintain visit schedule|0|||
160849136|NCT01425801|580835699|FG005|Period 4|Not able to maintain visit schedule|0|||
160849137|NCT03066596|580835700|FG000|Overall Study|Withdrawal by Subject|4|||
160849138|NCT03066596|580835701|FG001|Overall Study|Withdrawal by Subject|2|||
160849139|NCT03066596|580835700|FG000|Overall Study|Lost to Follow-up|14|||
160849140|NCT03066596|580835701|FG001|Overall Study|Lost to Follow-up|10|||
160849141|NCT03797586|580835702|FG000|Overall Study|Lost to Follow-up|3|||
160849142|NCT03797586|580835703|FG001|Overall Study|Lost to Follow-up|6|||
160849143|NCT03797586|580835702|FG000|Overall Study|Death|1|||
160849144|NCT03797586|580835703|FG001|Overall Study|Death|1|||
160849145|NCT03797586|580835702|FG000|Overall Study|Adverse Event|0|||
160849146|NCT03797586|580835703|FG001|Overall Study|Adverse Event|2|||
160906541|NCT03766581|581052199|FG004|Treatment|Poor/Non compliance|1|||
160906542|NCT03766581|581052200|FG005|Treatment|Poor/Non compliance|1|||
160906543|NCT03766581|581052201|FG006|Treatment|Poor/Non compliance|0|||
160906544|NCT03766581|581052202|FG007|Treatment|Poor/Non compliance|0|||
160906545|NCT03766581|581052195|FG000|Treatment|Participant no longer meets study criteria|9|||
160906546|NCT03766581|581052196|FG001|Treatment|Participant no longer meets study criteria|1|||
160906547|NCT03766581|581052197|FG002|Treatment|Participant no longer meets study criteria|5|||
160906548|NCT03766581|581052198|FG003|Treatment|Participant no longer meets study criteria|4|||
160906549|NCT03766581|581052199|FG004|Treatment|Participant no longer meets study criteria|4|||
160849147|NCT02959437|580835704|FG000|Overall Study|Death|33|||
160849148|NCT02959437|580835705|FG001|Overall Study|Death|3|||
160849149|NCT02959437|580835706|FG002|Overall Study|Death|0|||
160849150|NCT02959437|580835707|FG003|Overall Study|Death|0|||
160849151|NCT02959437|580835704|FG000|Overall Study|Lost to Follow-up|3|||
160849152|NCT02959437|580835705|FG001|Overall Study|Lost to Follow-up|1|||
160849153|NCT02959437|580835706|FG002|Overall Study|Lost to Follow-up|0|||
160849154|NCT02959437|580835707|FG003|Overall Study|Lost to Follow-up|0|||
160849155|NCT02959437|580835704|FG000|Overall Study|Withdrawal by Subject|11|||
160849156|NCT02959437|580835705|FG001|Overall Study|Withdrawal by Subject|3|||
160849157|NCT02959437|580835706|FG002|Overall Study|Withdrawal by Subject|0|||
160906550|NCT03766581|581052200|FG005|Treatment|Participant no longer meets study criteria|4|||
160849158|NCT02959437|580835707|FG003|Overall Study|Withdrawal by Subject|0|||
160849159|NCT02959437|580835704|FG000|Overall Study|Progressive Disease|9|||
160849160|NCT02959437|580835705|FG001|Overall Study|Progressive Disease|1|||
160849161|NCT02959437|580835706|FG002|Overall Study|Progressive Disease|0|||
160849162|NCT02959437|580835707|FG003|Overall Study|Progressive Disease|0|||
160906551|NCT03766581|581052201|FG006|Treatment|Participant no longer meets study criteria|2|||
160849163|NCT02959437|580835704|FG000|Overall Study|Study Terminated by Sponsor|4|||
160849164|NCT02959437|580835705|FG001|Overall Study|Study Terminated by Sponsor|0|||
160849165|NCT02959437|580835706|FG002|Overall Study|Study Terminated by Sponsor|0|||
160849166|NCT02959437|580835707|FG003|Overall Study|Study Terminated by Sponsor|0|||
160849167|NCT02959437|580835704|FG000|Overall Study|Other Unspecified|2|||
160849168|NCT02959437|580835705|FG001|Overall Study|Other Unspecified|0|||
160849169|NCT02959437|580835706|FG002|Overall Study|Other Unspecified|0|||
160849170|NCT02959437|580835707|FG003|Overall Study|Other Unspecified|0|||
160849171|NCT02864901|580835708|FG000|Overall Study|Withdrawal by Subject|1|||
160849172|NCT02864901|580835709|FG001|Overall Study|Withdrawal by Subject|0|||
160849173|NCT01219985|580835714|FG000|Overall Study|Physician Decision|20|||
160849174|NCT01369784|580835715|FG000|Overall Study|Protocol Violation|12|||
160849175|NCT04797780|580835718|FG000|Overall Study|Lost to Follow-up|1|||
160849176|NCT04797780|580835719|FG001|Overall Study|Lost to Follow-up|1|||
160849177|NCT04797780|580835718|FG000|Overall Study|Withdrawal by Subject|14|||
160849178|NCT04797780|580835719|FG001|Overall Study|Withdrawal by Subject|9|||
160849179|NCT04797780|580835718|FG000|Overall Study|Death|49|||
160849180|NCT04797780|580835719|FG001|Overall Study|Death|20|||
160849181|NCT02940496|580835720|FG000|Overall Study|Adverse Event|1|||
160849182|NCT02940496|580835721|FG001|Overall Study|Adverse Event|0|||
160849183|NCT02940496|580835720|FG000|Overall Study|Death|2|||
160849184|NCT02940496|580835721|FG001|Overall Study|Death|0|||
160849185|NCT02940496|580835720|FG000|Overall Study|Hospice Care|1|||
160849186|NCT02940496|580835721|FG001|Overall Study|Hospice Care|0|||
160849187|NCT02940496|580835720|FG000|Overall Study|No MRE Done|1|||
160849188|NCT02940496|580835721|FG001|Overall Study|No MRE Done|0|||
160849189|NCT02940496|580835720|FG000|Overall Study|MRE Failure|1|||
160849190|NCT02940496|580835721|FG001|Overall Study|MRE Failure|0|||
160849191|NCT05973006|580835722|FG000|Overall Study|Early termination|3|||
160849192|NCT05973006|580835723|FG001|Overall Study|Early termination|9|||
160849193|NCT05167825|580835724|FG000|Overall Study|Ongoing|3|||
160849194|NCT01807598|580835725|FG000|Overall Study|Withdrawal by Subject|4|||
160849195|NCT01807598|580835725|FG000|Overall Study|Adverse Event|1|||
160849196|NCT01807598|580835725|FG000|Overall Study|Other Physician Decision|1|||
160849197|NCT04089761|580835728|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
160849198|NCT04089761|580835728|FG000|"Run In Phase"|Lost to Follow-up|1|||
160849199|NCT04089761|580835728|FG000|"Treatment Phase"|No evaluable data|5|||
160849200|NCT04089761|580835728|FG000|"Treatment Phase"|Lost to Follow-up|1|||
160849201|NCT03622814|580835729|FG000|Overall Study|Lost to Follow-up|8|||
160849202|NCT03622814|580835730|FG001|Overall Study|Lost to Follow-up|14|||
160906552|NCT03766581|581052202|FG007|Treatment|Participant no longer meets study criteria|0|||
160906553|NCT03766581|581052195|FG000|Treatment|Other reasons|13|||
160906554|NCT03766581|581052196|FG001|Treatment|Other reasons|8|||
160906555|NCT03766581|581052197|FG002|Treatment|Other reasons|3|||
160906556|NCT03766581|581052198|FG003|Treatment|Other reasons|7|||
160906557|NCT03766581|581052199|FG004|Treatment|Other reasons|3|||
160906558|NCT03766581|581052200|FG005|Treatment|Other reasons|3|||
160906559|NCT03766581|581052201|FG006|Treatment|Other reasons|0|||
160849203|NCT04417361|580835731|FG000|Overall Study|Withdrawal by Subject|1|||
160849204|NCT04417361|580835732|FG001|Overall Study|Withdrawal by Subject|0|||
160849205|NCT04417361|580835731|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
160849206|NCT04417361|580835732|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
160849207|NCT00165672|580835733|FG000|Overall Study|Adverse Event|0|||
160849208|NCT00165672|580835734|FG001|Overall Study|Adverse Event|1|||
160849209|NCT03868943|580835735|FG000|Overall Study|Adverse Event|1|||
160849210|NCT04896593|580835738|FG000|Overall Study|Withdrawal by Subject|2|||
160849211|NCT04896593|580835738|FG000|Overall Study|Lost to Follow-up|1|||
160849212|NCT04896593|580835738|FG000|Overall Study|Did not complete onboarding|2|||
160849213|NCT00892775|580835739|FG000|Overall Study|Protocol Violation|1|||
160849214|NCT00892775|580835740|FG001|Overall Study|Protocol Violation|0|||
160849215|NCT00892775|580835739|FG000|Overall Study|Subject difficulties with blood drawing|1|||
160849216|NCT00892775|580835740|FG001|Overall Study|Subject difficulties with blood drawing|0|||
160906560|NCT03766581|581052202|FG007|Treatment|Other reasons|0|||
160849217|NCT00892775|580835739|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
160849218|NCT00892775|580835740|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
160849219|NCT00892775|580835739|FG000|Overall Study|Migrated/ moved from study area|1|||
160849220|NCT00892775|580835740|FG001|Overall Study|Migrated/ moved from study area|0|||
160849221|NCT00892775|580835739|FG000|Overall Study|Withdrawal by Subject|0|||
160849222|NCT00892775|580835740|FG001|Overall Study|Withdrawal by Subject|1|||
160849223|NCT00892775|580835739|FG000|Overall Study|Lost to Follow-up|1|||
160849224|NCT00892775|580835740|FG001|Overall Study|Lost to Follow-up|0|||
160849225|NCT00869518|580835743|FG000|Overall Study|Lost to Follow-up|1|||
160849226|NCT00869518|580835744|FG001|Overall Study|Lost to Follow-up|1|||
160849227|NCT04178720|580835745|FG000|Overall Study|Withdrawal by Subject|2|||
160849228|NCT04178720|580835746|FG001|Overall Study|Withdrawal by Subject|0|||
160906561|NCT03716024|581052203|FG000|Overall Study|Randomized, not Treated|7|||
160906562|NCT03716024|581052204|FG001|Overall Study|Randomized, not Treated|8|||
160906563|NCT03716024|581052203|FG000|Overall Study|Adverse Event|1|||
160849229|NCT04178720|580835745|FG000|Overall Study|Relocation|0|||
160849230|NCT04178720|580835746|FG001|Overall Study|Relocation|1|||
160849231|NCT03922620|580835747|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
160849232|NCT03922620|580835748|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
160849233|NCT01633788|580837733|FG000|Overall Study|Adverse Event|1|||
160849234|NCT01633788|580837734|FG001|Overall Study|Adverse Event|3|||
160849235|NCT01633788|580837735|FG002|Overall Study|Adverse Event|3|||
160849236|NCT01633788|580837736|FG003|Overall Study|Adverse Event|3|||
160849237|NCT01633788|580837733|FG000|Overall Study|Lost to Follow-up|2|||
160849238|NCT01633788|580837734|FG001|Overall Study|Lost to Follow-up|2|||
160849239|NCT01633788|580837735|FG002|Overall Study|Lost to Follow-up|2|||
160849240|NCT01633788|580837736|FG003|Overall Study|Lost to Follow-up|0|||
160849241|NCT01633788|580837733|FG000|Overall Study|Personal Reasons|3|||
160849242|NCT01633788|580837734|FG001|Overall Study|Personal Reasons|1|||
160849243|NCT01633788|580837735|FG002|Overall Study|Personal Reasons|1|||
160849244|NCT01633788|580837736|FG003|Overall Study|Personal Reasons|3|||
160849245|NCT01633788|580837733|FG000|Overall Study|Protocol Violation|1|||
160849246|NCT01633788|580837734|FG001|Overall Study|Protocol Violation|0|||
160849247|NCT01633788|580837735|FG002|Overall Study|Protocol Violation|1|||
160849248|NCT01633788|580837736|FG003|Overall Study|Protocol Violation|0|||
160849249|NCT01633788|580837733|FG000|Overall Study|Other Reasons|0|||
160849250|NCT01633788|580837734|FG001|Overall Study|Other Reasons|2|||
160849251|NCT01633788|580837735|FG002|Overall Study|Other Reasons|3|||
160849252|NCT01633788|580837736|FG003|Overall Study|Other Reasons|7|||
160849253|NCT01389882|580837741|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
160849254|NCT01389882|580837742|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
160849255|NCT01389882|580837741|FG000|Overall Study|Withdrawal by Subject|0|||
160849256|NCT01389882|580837742|FG001|Overall Study|Withdrawal by Subject|1|||
160849257|NCT03811340|580837743|FG000|Overall Study|subjects did not complete the survey.|90|||
160849258|NCT01045967|580837744|FG000|Second Intervention|Protocol Violation|0|||
160849259|NCT01045967|580837745|FG001|Second Intervention|Protocol Violation|1|||
160849260|NCT00985673|580837746|FG000|Overall Study|Lost to Follow-up|6|||
160849261|NCT00985673|580837747|FG001|Overall Study|Lost to Follow-up|7|||
160849262|NCT00985673|580837748|FG002|Overall Study|Lost to Follow-up|6|||
160849263|NCT00985673|580837749|FG003|Overall Study|Lost to Follow-up|10|||
160849264|NCT00985673|580837750|FG004|Overall Study|Lost to Follow-up|5|||
160849265|NCT00985673|580837751|FG005|Overall Study|Lost to Follow-up|3|||
160849266|NCT00985673|580837746|FG000|Overall Study|Withdrawal by Subject|0|||
160849267|NCT00985673|580837747|FG001|Overall Study|Withdrawal by Subject|4|||
160849268|NCT00985673|580837748|FG002|Overall Study|Withdrawal by Subject|5|||
160849269|NCT00985673|580837749|FG003|Overall Study|Withdrawal by Subject|2|||
160992489|NCT04176458|581361380|FG000|Overall Study|Covid 19|4|||
160992490|NCT00891618|581361381|FG000|Overall Study|Withdrawal by Subject|1|||
160992491|NCT02145182|581361382|FG000|Overall Study|Adverse Event|4|||
160992492|NCT02145182|581361383|FG001|Overall Study|Adverse Event|1|||
160992493|NCT02145182|581361382|FG000|Overall Study|Death|7|||
160992494|NCT02145182|581361383|FG001|Overall Study|Death|7|||
160992495|NCT02145182|581361382|FG000|Overall Study|Lost to Follow-up|2|||
160849270|NCT00985673|580837750|FG004|Overall Study|Withdrawal by Subject|2|||
160849271|NCT00985673|580837751|FG005|Overall Study|Withdrawal by Subject|3|||
160849272|NCT00985673|580837746|FG000|Overall Study|Other|1|||
160849273|NCT00985673|580837747|FG001|Overall Study|Other|0|||
160849274|NCT00985673|580837748|FG002|Overall Study|Other|1|||
160849275|NCT00985673|580837749|FG003|Overall Study|Other|0|||
160849276|NCT00985673|580837750|FG004|Overall Study|Other|1|||
160849277|NCT00985673|580837751|FG005|Overall Study|Other|0|||
160849278|NCT02252146|580837752|FG000|Overall Study|Lack of Efficacy|4|||
160849279|NCT02252146|580837752|FG000|Overall Study|Entered hospice care|1|||
160849280|NCT02252146|580837752|FG000|Overall Study|Inability to travel to study site|1|||
160849281|NCT00531284|580837753|FG000|Overall Study|Progressive Disease|1|||
160849282|NCT00531284|580837754|FG001|Overall Study|Progressive Disease|3|||
160992496|NCT02145182|581361383|FG001|Overall Study|Lost to Follow-up|2|||
160992497|NCT02145182|581361382|FG000|Overall Study|Pre-transplant Withdrawal|0|||
160992498|NCT02145182|581361383|FG001|Overall Study|Pre-transplant Withdrawal|2|||
160992499|NCT02145182|581361382|FG000|Overall Study|Withdrawal by Subject|5|||
160849283|NCT00531284|580837755|FG002|Overall Study|Progressive Disease|5|||
160849284|NCT00531284|580837756|FG003|Overall Study|Progressive Disease|42|||
160849285|NCT00531284|580837757|FG004|Overall Study|Progressive Disease|4|||
160849286|NCT00531284|580837758|FG005|Overall Study|Progressive Disease|4|||
160849287|NCT00531284|580837759|FG006|Overall Study|Progressive Disease|3|||
160849288|NCT00531284|580837760|FG007|Overall Study|Progressive Disease|8|||
160849289|NCT00531284|580837761|FG008|Overall Study|Progressive Disease|6|||
160849290|NCT00531284|580837762|FG009|Overall Study|Progressive Disease|3|||
160992500|NCT02145182|581361383|FG001|Overall Study|Withdrawal by Subject|4|||
160992501|NCT03999554|581361385|FG000|Overall Study|Lost to Follow-up|4|||
160992502|NCT03999554|581361386|FG001|Overall Study|Lost to Follow-up|5|||
160849291|NCT00531284|580837763|FG010|Overall Study|Progressive Disease|3|||
160849292|NCT00531284|580837764|FG011|Overall Study|Progressive Disease|14|||
160849293|NCT00531284|580837765|FG012|Overall Study|Progressive Disease|2|||
160906564|NCT03716024|581052204|FG001|Overall Study|Adverse Event|2|||
160906565|NCT03716024|581052203|FG000|Overall Study|Treatment Failure|1|||
160906566|NCT03716024|581052204|FG001|Overall Study|Treatment Failure|0|||
160906567|NCT03716024|581052203|FG000|Overall Study|Lost to Follow-up|2|||
160906568|NCT03716024|581052204|FG001|Overall Study|Lost to Follow-up|6|||
160906569|NCT03716024|581052203|FG000|Overall Study|Withdrawal by Subject|0|||
160906570|NCT03716024|581052204|FG001|Overall Study|Withdrawal by Subject|1|||
160906571|NCT03716024|581052203|FG000|Overall Study|Missing Reason|0|||
160906572|NCT03716024|581052204|FG001|Overall Study|Missing Reason|1|||
160906573|NCT01651039|581052206|FG000|Overall Study|Non-evaluables|5|||
160906574|NCT01651039|581052206|FG000|Overall Study|Physician Decision|2|||
160906575|NCT01651039|581052206|FG000|Overall Study|Withdrawal by Subject|1|||
160906576|NCT01651039|581052206|FG000|Overall Study|Progressive Disease|22|||
160906577|NCT03600818|581052208|FG000|Overall Study|Adverse Event|4|||
160906578|NCT03600818|581052209|FG001|Overall Study|Adverse Event|7|||
160906579|NCT03600818|581052208|FG000|Overall Study|Lack of Efficacy|9|||
160849294|NCT00531284|580837766|FG013|Overall Study|Progressive Disease|1|||
160849295|NCT00531284|580837767|FG014|Overall Study|Progressive Disease|2|||
160849296|NCT00531284|580837768|FG015|Overall Study|Progressive Disease|11|||
160849297|NCT00531284|580837769|FG016|Overall Study|Progressive Disease|5|||
160849298|NCT00531284|580837753|FG000|Overall Study|Adverse Event|0|||
160849299|NCT00531284|580837754|FG001|Overall Study|Adverse Event|1|||
160849300|NCT00531284|580837755|FG002|Overall Study|Adverse Event|1|||
160849301|NCT00531284|580837756|FG003|Overall Study|Adverse Event|7|||
160849302|NCT00531284|580837757|FG004|Overall Study|Adverse Event|0|||
160849303|NCT00531284|580837758|FG005|Overall Study|Adverse Event|2|||
160849304|NCT00531284|580837759|FG006|Overall Study|Adverse Event|3|||
160849305|NCT00531284|580837760|FG007|Overall Study|Adverse Event|2|||
160849306|NCT00531284|580837761|FG008|Overall Study|Adverse Event|3|||
160849307|NCT00531284|580837762|FG009|Overall Study|Adverse Event|0|||
160849308|NCT00531284|580837763|FG010|Overall Study|Adverse Event|0|||
160849309|NCT00531284|580837764|FG011|Overall Study|Adverse Event|5|||
160849310|NCT00531284|580837765|FG012|Overall Study|Adverse Event|0|||
160849311|NCT00531284|580837766|FG013|Overall Study|Adverse Event|1|||
160849312|NCT00531284|580837767|FG014|Overall Study|Adverse Event|1|||
160849313|NCT00531284|580837768|FG015|Overall Study|Adverse Event|0|||
160849314|NCT00531284|580837769|FG016|Overall Study|Adverse Event|2|||
160849315|NCT00531284|580837753|FG000|Overall Study|Withdrawal by Subject|1|||
160849316|NCT00531284|580837754|FG001|Overall Study|Withdrawal by Subject|0|||
160849317|NCT00531284|580837755|FG002|Overall Study|Withdrawal by Subject|0|||
160849318|NCT00531284|580837756|FG003|Overall Study|Withdrawal by Subject|4|||
160849319|NCT00531284|580837757|FG004|Overall Study|Withdrawal by Subject|0|||
160849320|NCT00531284|580837758|FG005|Overall Study|Withdrawal by Subject|0|||
160849321|NCT00531284|580837759|FG006|Overall Study|Withdrawal by Subject|0|||
160849322|NCT00531284|580837760|FG007|Overall Study|Withdrawal by Subject|0|||
160849323|NCT00531284|580837761|FG008|Overall Study|Withdrawal by Subject|0|||
160849324|NCT00531284|580837762|FG009|Overall Study|Withdrawal by Subject|0|||
160849325|NCT00531284|580837763|FG010|Overall Study|Withdrawal by Subject|0|||
160849326|NCT00531284|580837764|FG011|Overall Study|Withdrawal by Subject|3|||
160849327|NCT00531284|580837765|FG012|Overall Study|Withdrawal by Subject|0|||
160849328|NCT00531284|580837766|FG013|Overall Study|Withdrawal by Subject|1|||
160849329|NCT00531284|580837767|FG014|Overall Study|Withdrawal by Subject|0|||
160849330|NCT00531284|580837768|FG015|Overall Study|Withdrawal by Subject|1|||
160849331|NCT00531284|580837769|FG016|Overall Study|Withdrawal by Subject|1|||
160849332|NCT00531284|580837753|FG000|Overall Study|Other|1|||
160849333|NCT00531284|580837754|FG001|Overall Study|Other|0|||
160849334|NCT00531284|580837755|FG002|Overall Study|Other|0|||
160849335|NCT00531284|580837756|FG003|Overall Study|Other|10|||
160849336|NCT00531284|580837757|FG004|Overall Study|Other|2|||
160849337|NCT00531284|580837758|FG005|Overall Study|Other|1|||
160849338|NCT00531284|580837759|FG006|Overall Study|Other|0|||
160849339|NCT00531284|580837760|FG007|Overall Study|Other|0|||
160849340|NCT00531284|580837761|FG008|Overall Study|Other|2|||
160849341|NCT00531284|580837762|FG009|Overall Study|Other|1|||
160849342|NCT00531284|580837763|FG010|Overall Study|Other|0|||
160849343|NCT00531284|580837764|FG011|Overall Study|Other|2|||
160849344|NCT00531284|580837765|FG012|Overall Study|Other|0|||
160849345|NCT00531284|580837766|FG013|Overall Study|Other|0|||
160849346|NCT00531284|580837767|FG014|Overall Study|Other|1|||
160849347|NCT00531284|580837768|FG015|Overall Study|Other|0|||
160849348|NCT00531284|580837769|FG016|Overall Study|Other|0|||
160849349|NCT03057496|580837770|FG000|Overall Study|Withdrawal by Subject|8|||
160849350|NCT03057496|580837770|FG000|Overall Study|Lost to Follow-up|5|||
160849351|NCT03057496|580837770|FG000|Overall Study|Did not use device during home trial|3|||
160849352|NCT03057496|580837770|FG000|Overall Study|Device failure|2|||
160849353|NCT00280917|580837771|FG000|Overall Study|Adverse Event|1|||
160906580|NCT03600818|581052209|FG001|Overall Study|Lack of Efficacy|4|||
160906581|NCT03600818|581052208|FG000|Overall Study|Withdrawal by Subject|4|||
160906582|NCT03600818|581052209|FG001|Overall Study|Withdrawal by Subject|3|||
160906583|NCT03600818|581052208|FG000|Overall Study|Other-unspecified|5|||
160849354|NCT00280917|580837772|FG001|Overall Study|Adverse Event|1|||
160849355|NCT00280917|580837773|FG002|Overall Study|Adverse Event|4|||
160849356|NCT00280917|580837774|FG003|Overall Study|Adverse Event|1|||
160849357|NCT00280917|580837771|FG000|Overall Study|Change Therapy|1|||
160849358|NCT00280917|580837772|FG001|Overall Study|Change Therapy|2|||
160849359|NCT00280917|580837773|FG002|Overall Study|Change Therapy|0|||
160849360|NCT00280917|580837774|FG003|Overall Study|Change Therapy|0|||
160849361|NCT00280917|580837771|FG000|Overall Study|Withdrawal by Subject|0|||
160849362|NCT00280917|580837772|FG001|Overall Study|Withdrawal by Subject|2|||
160849363|NCT00280917|580837773|FG002|Overall Study|Withdrawal by Subject|0|||
161254650|NCT01378962|582310053|FG000|Overall Study|Death|14|||
161254651|NCT01378962|582310053|FG000|Overall Study|Lost to Follow-up|1|||
160849364|NCT00280917|580837774|FG003|Overall Study|Withdrawal by Subject|1|||
160849365|NCT00280917|580837771|FG000|Overall Study|Noncompliance|0|||
160849366|NCT00280917|580837772|FG001|Overall Study|Noncompliance|1|||
160849367|NCT00280917|580837773|FG002|Overall Study|Noncompliance|2|||
160849368|NCT00280917|580837774|FG003|Overall Study|Noncompliance|0|||
160849369|NCT03310723|580837779|FG000|Overall Study|Withdrawal by Subject|0|||
160849370|NCT03310723|580837780|FG001|Overall Study|Withdrawal by Subject|1|||
160849371|NCT03310723|580837779|FG000|Overall Study|Protocol Violation|0|||
160849372|NCT03310723|580837780|FG001|Overall Study|Protocol Violation|2|||
161254652|NCT01378962|582310053|FG000|Overall Study|Other|2|||
161254653|NCT00983918|582312017|FG000|Overall Study|conversion to open cholecystectomy|0|||
161254654|NCT00983918|582312018|FG001|Overall Study|conversion to open cholecystectomy|2|||
161254655|NCT00983918|582312019|FG002|Overall Study|conversion to open cholecystectomy|2|||
160849373|NCT02098746|580837781|FG000|Overall Study|Changes of Investigator|2|||
160849374|NCT02098746|580837781|FG000|Overall Study|Other Miscellaneous Reasons|1|||
160849375|NCT02098746|580837781|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
160849376|NCT02098746|580837781|FG000|Overall Study|Data Not Available After Treatment|1|||
160849377|NCT01508312|580837784|FG000|Overall Study|Lost to Follow-up|1|||
160849378|NCT01508312|580837785|FG001|Overall Study|Lost to Follow-up|0|||
160849379|NCT01508312|580837786|FG002|Overall Study|Lost to Follow-up|0|||
160849380|NCT01508312|580837787|FG003|Overall Study|Lost to Follow-up|0|||
160849381|NCT01508312|580837784|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
160849382|NCT01508312|580837785|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
160849383|NCT01508312|580837786|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
160849384|NCT01508312|580837787|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
160849385|NCT01508312|580837784|FG000|Overall Study|Adverse Event|0|||
160849386|NCT01508312|580837785|FG001|Overall Study|Adverse Event|0|||
160849387|NCT01508312|580837786|FG002|Overall Study|Adverse Event|2|||
160849388|NCT01508312|580837787|FG003|Overall Study|Adverse Event|0|||
160849389|NCT01508312|580837784|FG000|Overall Study|Lack of Efficacy|0|||
160849390|NCT01508312|580837785|FG001|Overall Study|Lack of Efficacy|0|||
160849391|NCT01508312|580837786|FG002|Overall Study|Lack of Efficacy|1|||
160849392|NCT01508312|580837787|FG003|Overall Study|Lack of Efficacy|0|||
161254656|NCT00983918|582312020|FG003|Overall Study|conversion to open cholecystectomy|2|||
161254657|NCT01796964|582312026|FG000|Overall Study|Adverse Event|1|||
161254658|NCT01796964|582312027|FG001|Overall Study|Adverse Event|1|||
161254659|NCT01796964|582312026|FG000|Overall Study|Death|1|||
161254660|NCT01796964|582312027|FG001|Overall Study|Death|0|||
161254661|NCT01796964|582312026|FG000|Overall Study|Protocol Violation|0|||
161254662|NCT01796964|582312027|FG001|Overall Study|Protocol Violation|1|||
161254663|NCT01796964|582312026|FG000|Overall Study|Withdrawal by Subject|1|||
161254664|NCT01796964|582312027|FG001|Overall Study|Withdrawal by Subject|1|||
161254665|NCT01345318|582312048|FG000|Overall Study|Adverse Event|16|||
161254666|NCT01345318|582312048|FG000|Overall Study|Lack of Efficacy|17|||
161254667|NCT01345318|582312048|FG000|Overall Study|Lost to Follow-up|2|||
161254668|NCT01345318|582312048|FG000|Overall Study|Protocol Violation|1|||
161254669|NCT01345318|582312048|FG000|Overall Study|Withdrawal by Subject|41|||
161254670|NCT01345318|582312048|FG000|Overall Study|Other|3|||
161254671|NCT01685073|582312049|FG000|Overall Study|Lost to Follow-up|6|||
160849393|NCT01508312|580837784|FG000|Overall Study|Withdrawal by Subject|0|||
160849394|NCT01508312|580837785|FG001|Overall Study|Withdrawal by Subject|0|||
160849395|NCT01508312|580837786|FG002|Overall Study|Withdrawal by Subject|1|||
160849396|NCT01508312|580837787|FG003|Overall Study|Withdrawal by Subject|0|||
160849397|NCT02222558|580837788|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
160849398|NCT02222558|580837789|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
160849399|NCT02222558|580837790|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
160849400|NCT02222558|580837791|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
160849401|NCT02222558|580837792|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
160849402|NCT02222558|580837793|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
161254672|NCT01685073|582312050|FG001|Overall Study|Lost to Follow-up|8|||
161254673|NCT01685073|582312049|FG000|Overall Study|Withdrawal by Subject|24|||
161254674|NCT01685073|582312050|FG001|Overall Study|Withdrawal by Subject|24|||
161254675|NCT01239472|582312053|FG000|Overall Study|Withdrawal by Subject|5|||
161254676|NCT01239472|582312054|FG001|Overall Study|Withdrawal by Subject|1|||
161254677|NCT01239472|582312053|FG000|Overall Study|Adverse Event|0|||
161254678|NCT01239472|582312054|FG001|Overall Study|Adverse Event|1|||
161254679|NCT01239472|582312053|FG000|Overall Study|Lack of Efficacy|0|||
161254680|NCT01239472|582312054|FG001|Overall Study|Lack of Efficacy|1|||
161254681|NCT02695719|582312058|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
161254682|NCT02695719|582312059|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
161254683|NCT02695719|582312058|FG000|Overall Study|Significant Protocol Deviation|0|||
161254684|NCT02695719|582312059|FG001|Overall Study|Significant Protocol Deviation|1|||
161254685|NCT02695719|582312058|FG000|Overall Study|Voluntary Withdrawal|1|||
161254686|NCT02695719|582312059|FG001|Overall Study|Voluntary Withdrawal|0|||
161254687|NCT01714739|582312062|FG000|Overall Study|Disease progression|3|||
161254688|NCT01714739|582312063|FG001|Overall Study|Disease progression|5|||
161254689|NCT01714739|582312064|FG002|Overall Study|Disease progression|5|||
161254690|NCT01714739|582312065|FG003|Overall Study|Disease progression|204|||
161254691|NCT01714739|582312066|FG004|Overall Study|Disease progression|1|||
161254692|NCT01714739|582312067|FG005|Overall Study|Disease progression|3|||
161254693|NCT01714739|582312068|FG006|Overall Study|Disease progression|5|||
161254694|NCT01714739|582312062|FG000|Overall Study|Study drug toxicity|1|||
161254695|NCT01714739|582312063|FG001|Overall Study|Study drug toxicity|1|||
161254696|NCT01714739|582312064|FG002|Overall Study|Study drug toxicity|1|||
161254697|NCT01714739|582312065|FG003|Overall Study|Study drug toxicity|15|||
161254698|NCT01714739|582312066|FG004|Overall Study|Study drug toxicity|0|||
161254699|NCT01714739|582312067|FG005|Overall Study|Study drug toxicity|0|||
161254700|NCT01714739|582312068|FG006|Overall Study|Study drug toxicity|5|||
161254701|NCT01714739|582312062|FG000|Overall Study|Death|0|||
161254702|NCT01714739|582312063|FG001|Overall Study|Death|0|||
161254703|NCT01714739|582312064|FG002|Overall Study|Death|0|||
161254704|NCT01714739|582312065|FG003|Overall Study|Death|1|||
161254705|NCT01714739|582312066|FG004|Overall Study|Death|0|||
161254706|NCT01714739|582312067|FG005|Overall Study|Death|0|||
161254707|NCT01714739|582312068|FG006|Overall Study|Death|0|||
161254708|NCT01714739|582312062|FG000|Overall Study|Adverse Event unrelated to drug|0|||
161254709|NCT01714739|582312063|FG001|Overall Study|Adverse Event unrelated to drug|0|||
161254710|NCT01714739|582312064|FG002|Overall Study|Adverse Event unrelated to drug|3|||
161254711|NCT01714739|582312065|FG003|Overall Study|Adverse Event unrelated to drug|21|||
161254712|NCT01714739|582312066|FG004|Overall Study|Adverse Event unrelated to drug|0|||
161254713|NCT01714739|582312067|FG005|Overall Study|Adverse Event unrelated to drug|0|||
160849403|NCT02222558|580837788|FG000|Period 3|Withdrawal by Subject|0|||
160849404|NCT02222558|580837789|FG001|Period 3|Withdrawal by Subject|0|||
160849405|NCT02222558|580837790|FG002|Period 3|Withdrawal by Subject|0|||
160849406|NCT02222558|580837791|FG003|Period 3|Withdrawal by Subject|0|||
160849407|NCT02222558|580837792|FG004|Period 3|Withdrawal by Subject|0|||
160849408|NCT02222558|580837793|FG005|Period 3|Withdrawal by Subject|1|||
160849409|NCT02322281|580837796|FG000|Overall Study|Progressive Disease|42|||
160849410|NCT02322281|580837797|FG001|Overall Study|Progressive Disease|14|||
160849411|NCT02322281|580837798|FG002|Overall Study|Progressive Disease|49|||
160849412|NCT02322281|580837796|FG000|Overall Study|Adverse Event|3|||
160849413|NCT02322281|580837797|FG001|Overall Study|Adverse Event|4|||
160849414|NCT02322281|580837798|FG002|Overall Study|Adverse Event|6|||
160849415|NCT02322281|580837796|FG000|Overall Study|Death|3|||
160849416|NCT02322281|580837797|FG001|Overall Study|Death|3|||
160849417|NCT02322281|580837798|FG002|Overall Study|Death|3|||
160849418|NCT02322281|580837796|FG000|Overall Study|Withdrawal by Subject|1|||
160849419|NCT02322281|580837797|FG001|Overall Study|Withdrawal by Subject|1|||
160849420|NCT02322281|580837798|FG002|Overall Study|Withdrawal by Subject|6|||
160849421|NCT02322281|580837796|FG000|Overall Study|Physician Decision|2|||
160906584|NCT03600818|581052209|FG001|Overall Study|Other-unspecified|3|||
160906585|NCT03600818|581052208|FG000|Overall Study|Randomized and not treated|0|||
160906586|NCT03600818|581052209|FG001|Overall Study|Randomized and not treated|1|||
160906587|NCT04377620|581052212|FG000|Overall Study|Death|42|||
160906588|NCT04377620|581052213|FG001|Overall Study|Death|48|||
160906589|NCT04377620|581052214|FG002|Overall Study|Death|36|||
160906590|NCT04377620|581052212|FG000|Overall Study|Withdrawal by Subject|0|||
161254714|NCT01714739|582312068|FG006|Overall Study|Adverse Event unrelated to drug|0|||
161254715|NCT01714739|582312062|FG000|Overall Study|Participant request to stop therapy|0|||
161254716|NCT01714739|582312063|FG001|Overall Study|Participant request to stop therapy|1|||
161254717|NCT01714739|582312064|FG002|Overall Study|Participant request to stop therapy|0|||
161337132|NCT01065818|582625842|FG000|Overall Study|Withdrawal by Subject|1|||
161337133|NCT01065818|582625842|FG000|Overall Study|Not a candidate for surgery|1|||
161254718|NCT01714739|582312065|FG003|Overall Study|Participant request to stop therapy|6|||
161254719|NCT01714739|582312066|FG004|Overall Study|Participant request to stop therapy|0|||
161254720|NCT01714739|582312067|FG005|Overall Study|Participant request to stop therapy|0|||
161337134|NCT00853385|582625843|FG000|Overall Study|Death|0|||
160849422|NCT02322281|580837797|FG001|Overall Study|Physician Decision|0|||
160849423|NCT02322281|580837798|FG002|Overall Study|Physician Decision|5|||
160849424|NCT02322281|580837796|FG000|Overall Study|Study Terminated by Sponsor|2|||
160906591|NCT04377620|581052213|FG001|Overall Study|Withdrawal by Subject|2|||
160906592|NCT04377620|581052214|FG002|Overall Study|Withdrawal by Subject|0|||
161337135|NCT00853385|582625844|FG001|Overall Study|Death|0|||
160849425|NCT02322281|580837797|FG001|Overall Study|Study Terminated by Sponsor|0|||
160849426|NCT02322281|580837798|FG002|Overall Study|Study Terminated by Sponsor|0|||
160849427|NCT02322281|580837796|FG000|Overall Study|Missing|0|||
160849428|NCT02322281|580837797|FG001|Overall Study|Missing|0|||
160849429|NCT02322281|580837798|FG002|Overall Study|Missing|1|||
160849430|NCT02322281|580837796|FG000|Overall Study|Miscellaneous|0|||
160849431|NCT02322281|580837797|FG001|Overall Study|Miscellaneous|0|||
160849432|NCT02322281|580837798|FG002|Overall Study|Miscellaneous|4|||
160849433|NCT02532465|580837799|FG000|Overall Study|Protocol Violation|1|||
160849434|NCT02532465|580837800|FG001|Overall Study|Protocol Violation|0|||
160849435|NCT02532465|580837799|FG000|Overall Study|Lack of Efficacy|0|||
161254721|NCT01714739|582312068|FG006|Overall Study|Participant request to stop therapy|0|||
161254722|NCT01714739|582312062|FG000|Overall Study|Participant withdrew consent|0|||
161254723|NCT01714739|582312063|FG001|Overall Study|Participant withdrew consent|1|||
161254724|NCT01714739|582312064|FG002|Overall Study|Participant withdrew consent|0|||
161254725|NCT01714739|582312065|FG003|Overall Study|Participant withdrew consent|8|||
161254726|NCT01714739|582312066|FG004|Overall Study|Participant withdrew consent|0|||
161254727|NCT01714739|582312067|FG005|Overall Study|Participant withdrew consent|0|||
161254728|NCT01714739|582312068|FG006|Overall Study|Participant withdrew consent|0|||
161254729|NCT01714739|582312062|FG000|Overall Study|Lost to Follow-up|0|||
161254730|NCT01714739|582312063|FG001|Overall Study|Lost to Follow-up|0|||
160849436|NCT02532465|580837800|FG001|Overall Study|Lack of Efficacy|1|||
160849437|NCT00466440|580837805|FG000|Overall Study|Adverse Event|0|||
160849438|NCT00466440|580837806|FG001|Overall Study|Adverse Event|3|||
160849439|NCT00466440|580837807|FG002|Overall Study|Adverse Event|1|||
160849440|NCT00466440|580837805|FG000|Overall Study|Death|1|||
160849441|NCT00466440|580837806|FG001|Overall Study|Death|1|||
160849442|NCT00466440|580837807|FG002|Overall Study|Death|0|||
160849443|NCT00466440|580837805|FG000|Overall Study|Progressive disease|13|||
160849444|NCT00466440|580837806|FG001|Overall Study|Progressive disease|5|||
161254731|NCT01714739|582312064|FG002|Overall Study|Lost to Follow-up|0|||
161254732|NCT01714739|582312065|FG003|Overall Study|Lost to Follow-up|1|||
161254733|NCT01714739|582312066|FG004|Overall Study|Lost to Follow-up|0|||
161254734|NCT01714739|582312067|FG005|Overall Study|Lost to Follow-up|0|||
161254735|NCT01714739|582312068|FG006|Overall Study|Lost to Follow-up|0|||
160849445|NCT00466440|580837807|FG002|Overall Study|Progressive disease|4|||
160849446|NCT00466440|580837805|FG000|Overall Study|Lost to Follow-up|0|||
161254736|NCT01714739|582312062|FG000|Overall Study|Maximum clinical benefit|0|||
161254737|NCT01714739|582312063|FG001|Overall Study|Maximum clinical benefit|1|||
161254738|NCT01714739|582312064|FG002|Overall Study|Maximum clinical benefit|1|||
161254739|NCT01714739|582312065|FG003|Overall Study|Maximum clinical benefit|3|||
161254740|NCT01714739|582312066|FG004|Overall Study|Maximum clinical benefit|0|||
161254741|NCT01714739|582312067|FG005|Overall Study|Maximum clinical benefit|0|||
161254742|NCT01714739|582312068|FG006|Overall Study|Maximum clinical benefit|0|||
161254743|NCT01714739|582312062|FG000|Overall Study|Poor/non-comliance|0|||
161254744|NCT01714739|582312063|FG001|Overall Study|Poor/non-comliance|1|||
161254745|NCT01714739|582312064|FG002|Overall Study|Poor/non-comliance|0|||
161254746|NCT01714739|582312065|FG003|Overall Study|Poor/non-comliance|1|||
161254747|NCT01714739|582312066|FG004|Overall Study|Poor/non-comliance|0|||
161254748|NCT01714739|582312067|FG005|Overall Study|Poor/non-comliance|0|||
161254749|NCT01714739|582312068|FG006|Overall Study|Poor/non-comliance|0|||
161254750|NCT01714739|582312062|FG000|Overall Study|No longer meets study criteria|0|||
160849447|NCT00466440|580837806|FG001|Overall Study|Lost to Follow-up|1|||
160849448|NCT00466440|580837807|FG002|Overall Study|Lost to Follow-up|0|||
160849449|NCT00466440|580837805|FG000|Overall Study|Physician Decision|0|||
160849450|NCT00466440|580837806|FG001|Overall Study|Physician Decision|1|||
160849451|NCT00466440|580837807|FG002|Overall Study|Physician Decision|2|||
160849452|NCT00466440|580837805|FG000|Overall Study|Protocol entry criteria not met|0|||
160849453|NCT00466440|580837806|FG001|Overall Study|Protocol entry criteria not met|0|||
160849454|NCT00466440|580837807|FG002|Overall Study|Protocol entry criteria not met|4|||
160849455|NCT00466440|580837805|FG000|Overall Study|Withdrawal by Subject|0|||
161254751|NCT01714739|582312063|FG001|Overall Study|No longer meets study criteria|0|||
161254752|NCT01714739|582312064|FG002|Overall Study|No longer meets study criteria|0|||
161254753|NCT01714739|582312065|FG003|Overall Study|No longer meets study criteria|1|||
161254754|NCT01714739|582312066|FG004|Overall Study|No longer meets study criteria|0|||
161254755|NCT01714739|582312067|FG005|Overall Study|No longer meets study criteria|0|||
160849456|NCT00466440|580837806|FG001|Overall Study|Withdrawal by Subject|1|||
160849457|NCT00466440|580837807|FG002|Overall Study|Withdrawal by Subject|0|||
160849458|NCT00466440|580837805|FG000|Overall Study|Sponsor decision|0|||
161254756|NCT01714739|582312068|FG006|Overall Study|No longer meets study criteria|0|||
161254757|NCT01714739|582312062|FG000|Overall Study|Other reason|0|||
161254758|NCT01714739|582312063|FG001|Overall Study|Other reason|0|||
161254759|NCT01714739|582312064|FG002|Overall Study|Other reason|0|||
160849459|NCT00466440|580837806|FG001|Overall Study|Sponsor decision|0|||
160849460|NCT00466440|580837807|FG002|Overall Study|Sponsor decision|1|||
160849461|NCT03191630|580837811|FG000|Overall Study|Lost to Follow-up|7|||
160849462|NCT03191630|580837812|FG001|Overall Study|Lost to Follow-up|7|||
160849463|NCT00714415|580837823|FG000|Overall Study|Lack of Efficacy|1|||
160849464|NCT00714415|580837824|FG001|Overall Study|Lack of Efficacy|0|||
160849465|NCT00714415|580837823|FG000|Overall Study|Death|1|||
160849466|NCT00714415|580837824|FG001|Overall Study|Death|0|||
160849467|NCT01818596|580837831|FG000|Overall Study|Enrolled but Not Treated|4|||
160849468|NCT01818596|580837832|FG001|Overall Study|Enrolled but Not Treated|0|||
160849469|NCT01818596|580837831|FG000|Overall Study|Adverse Event|7|||
160849470|NCT01818596|580837832|FG001|Overall Study|Adverse Event|0|||
160849471|NCT01818596|580837831|FG000|Overall Study|Death|3|||
160849472|NCT01818596|580837832|FG001|Overall Study|Death|0|||
160849473|NCT01818596|580837831|FG000|Overall Study|Investigator's Discretion|4|||
160849474|NCT01818596|580837832|FG001|Overall Study|Investigator's Discretion|0|||
161254760|NCT01714739|582312065|FG003|Overall Study|Other reason|3|||
161254761|NCT01714739|582312066|FG004|Overall Study|Other reason|1|||
161254762|NCT01714739|582312067|FG005|Overall Study|Other reason|0|||
161254763|NCT01714739|582312068|FG006|Overall Study|Other reason|0|||
160849475|NCT01818596|580837831|FG000|Overall Study|Protocol Violation|1|||
160849476|NCT01818596|580837832|FG001|Overall Study|Protocol Violation|0|||
161254764|NCT02250651|582312069|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
161254765|NCT02250651|582312070|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
161254766|NCT02250651|582312071|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
161254767|NCT02250651|582312069|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
160906593|NCT04930965|581052215|FG000|Overall Study|Lost to Follow-up|7|||
160906594|NCT04930965|581052216|FG001|Overall Study|Lost to Follow-up|5|||
160906595|NCT01488370|581052217|FG000|Overall Study|Protocol Violation|0|||
160906596|NCT01488370|581052218|FG001|Overall Study|Protocol Violation|1|||
160906597|NCT01488370|581052219|FG002|Overall Study|Protocol Violation|1|||
160906598|NCT04189081|581052221|FG000|Overall Study|Lost to Follow-up|1|||
160906599|NCT04189081|581052222|FG001|Overall Study|Lost to Follow-up|0|||
160906600|NCT04189081|581052223|FG002|Overall Study|Lost to Follow-up|0|||
160906601|NCT04189081|581052221|FG000|Overall Study|Withdrawal by Subject|0|||
160906602|NCT04189081|581052222|FG001|Overall Study|Withdrawal by Subject|0|||
160906603|NCT04189081|581052223|FG002|Overall Study|Withdrawal by Subject|1|||
160906604|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
160906605|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
160906606|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
160906607|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
160906608|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
160906609|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
160906610|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
160906611|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
160906612|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
160906613|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
160906614|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
160906615|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
160906616|NCT00044083|581052224|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
160906617|NCT00044083|581052225|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
160906618|NCT00044083|581052224|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
160906619|NCT00044083|581052225|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
160906620|NCT00044083|581052224|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
160906621|NCT00044083|581052225|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
160906622|NCT00044083|581052224|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
160906623|NCT00044083|581052225|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
160906624|NCT00444912|581052229|FG000|Overall Study|Death|1|||
160906625|NCT00444912|581052230|FG001|Overall Study|Death|2|||
160906626|NCT00444912|581052229|FG000|Overall Study|Lost to Follow-up|1|||
160906627|NCT00444912|581052230|FG001|Overall Study|Lost to Follow-up|0|||
160906628|NCT00444912|581052229|FG000|Overall Study|Participant Failed Mobilization|1|||
160906629|NCT00444912|581052230|FG001|Overall Study|Participant Failed Mobilization|0|||
160906630|NCT03758066|581052231|FG000|Overall Study|Lost to Follow-up|14|||
160906631|NCT03570697|581052240|FG000|Overall Study|Lost to Follow-up|0|||
160906632|NCT03570697|581052241|FG001|Overall Study|Lost to Follow-up|1|||
160906633|NCT03570697|581052240|FG000|Overall Study|Death|2|||
160906634|NCT03570697|581052241|FG001|Overall Study|Death|0|||
160906635|NCT03570697|581052240|FG000|Overall Study|Withdrawal by Subject|4|||
160906636|NCT03570697|581052241|FG001|Overall Study|Withdrawal by Subject|2|||
160906637|NCT01849783|581052242|FG000|Overall Study|Adverse Event|5|||
160906638|NCT01849783|581052242|FG000|Overall Study|Death|2|||
160906639|NCT01849783|581052242|FG000|Overall Study|Physician Decision|1|||
161254768|NCT02250651|582312070|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
160906640|NCT01849783|581052242|FG000|Overall Study|Withdrawal by Subject|1|||
160906641|NCT01849783|581052242|FG000|Overall Study|Unable to comply|2|||
160906642|NCT01849783|581052242|FG000|Overall Study|Disease progression|11|||
160849477|NCT01818596|580837831|FG000|Overall Study|Withdrew Consent|5|||
160849478|NCT01818596|580837832|FG001|Overall Study|Withdrew Consent|0|||
160849479|NCT01818596|580837831|FG000|Overall Study|Lost to Follow-up|7|||
161254769|NCT02250651|582312071|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
161254770|NCT02250651|582312069|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
161254771|NCT02250651|582312070|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
161254772|NCT02250651|582312071|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
161254773|NCT02250651|582312069|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
161254774|NCT02250651|582312070|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
161254775|NCT02250651|582312071|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
161254776|NCT02250651|582312069|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
161254777|NCT02250651|582312070|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
161254778|NCT02250651|582312071|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
161254779|NCT02250651|582312069|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
161254780|NCT02250651|582312070|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
161254781|NCT02250651|582312071|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
161254782|NCT02250651|582312069|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
161254783|NCT02250651|582312070|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
161254784|NCT02250651|582312071|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
161254785|NCT02250651|582312069|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
161254786|NCT02250651|582312070|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
161254787|NCT02250651|582312071|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
161254788|NCT02250651|582312069|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
161254789|NCT02250651|582312070|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
161254790|NCT02250651|582312071|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
161254791|NCT02250651|582312069|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
161254792|NCT02250651|582312070|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
161254793|NCT02250651|582312071|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
161254794|NCT02250651|582312069|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
161254795|NCT02250651|582312070|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
161254796|NCT02250651|582312071|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
161254797|NCT02250651|582312069|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
161254798|NCT02250651|582312070|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
161254799|NCT02250651|582312071|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
161254800|NCT02250651|582312069|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
161254801|NCT02250651|582312070|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
161254802|NCT02250651|582312071|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
161254803|NCT02250651|582312069|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
161254804|NCT02250651|582312070|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
161254805|NCT02250651|582312071|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
161254806|NCT02250651|582312069|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
161254807|NCT02250651|582312070|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
161254808|NCT02250651|582312071|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
161254809|NCT01264835|582312072|FG000|Overall Study|Lost to Follow-up|1|||
161254810|NCT01557920|582312077|FG000|Overall Study|Withdrawal by Subject|2|||
161254811|NCT01557920|582312078|FG001|Overall Study|Withdrawal by Subject|3|||
161254812|NCT01557920|582312077|FG000|Overall Study|Lack of Efficacy|1|||
161254813|NCT01557920|582312078|FG001|Overall Study|Lack of Efficacy|0|||
161254814|NCT01466036|582312081|FG000|Overall Study|Death|1|||
161254815|NCT01466036|582312082|FG001|Overall Study|Death|1|||
161254816|NCT01466036|582312081|FG000|Overall Study|Physician Decision|0|||
161254817|NCT01466036|582312082|FG001|Overall Study|Physician Decision|4|||
161254818|NCT01466036|582312081|FG000|Overall Study|Adverse Event|2|||
161254819|NCT01466036|582312082|FG001|Overall Study|Adverse Event|6|||
161254820|NCT01466036|582312081|FG000|Overall Study|Withdrawal by Subject|2|||
161254821|NCT01466036|582312082|FG001|Overall Study|Withdrawal by Subject|8|||
161254822|NCT01466036|582312081|FG000|Overall Study|progression/relapse|14|||
161254823|NCT01466036|582312082|FG001|Overall Study|progression/relapse|21|||
161254824|NCT01466036|582312081|FG000|Overall Study|prolonged treatment delay|1|||
161254825|NCT01466036|582312082|FG001|Overall Study|prolonged treatment delay|1|||
161254826|NCT00220727|582312109|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
161254827|NCT00220727|582312110|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
161254828|NCT02508116|582312111|FG000|Overall Study|Lost to Follow-up|2|||
161254829|NCT02508116|582312112|FG001|Overall Study|Lost to Follow-up|3|||
160906643|NCT01042678|581052248|FG000|Overall Study|Physician Decision|1|||
160906644|NCT01042678|581052249|FG001|Overall Study|Physician Decision|0|||
160906645|NCT01042678|581052250|FG002|Overall Study|Physician Decision|0|||
160906646|NCT01042678|581052251|FG003|Overall Study|Physician Decision|0|||
160906647|NCT01042678|581052252|FG004|Overall Study|Physician Decision|0|||
160906648|NCT01042678|581052253|FG005|Overall Study|Physician Decision|0|||
160906649|NCT02197520|581052261|FG000|Period 1|Withdrawal by Subject|1|||
160906650|NCT02197520|581052262|FG001|Period 1|Withdrawal by Subject|0|||
161254830|NCT02508116|582312111|FG000|Overall Study|Withdrawal by Subject|3|||
161254831|NCT02508116|582312112|FG001|Overall Study|Withdrawal by Subject|2|||
161254832|NCT02508116|582312111|FG000|Overall Study|Protocol Violation|1|||
161254833|NCT02508116|582312112|FG001|Overall Study|Protocol Violation|2|||
161254834|NCT02508116|582312111|FG000|Overall Study|Physician Decision|2|||
161254835|NCT02508116|582312112|FG001|Overall Study|Physician Decision|0|||
161254836|NCT00109850|582312118|FG000|Overall Study|Adverse Event|1|||
161254837|NCT00109850|582312118|FG000|Overall Study|Death|2|||
161254838|NCT00109850|582312118|FG000|Overall Study|Ineligible|1|||
161254839|NCT00476593|582312119|FG000|Overall Study|Lost to Follow-up|10|||
161254840|NCT00476593|582312120|FG001|Overall Study|Lost to Follow-up|2|||
161254841|NCT00476593|582312121|FG002|Overall Study|Lost to Follow-up|8|||
161254842|NCT00476593|582312122|FG003|Overall Study|Lost to Follow-up|22|||
161254843|NCT03430011|582312123|FG000|Pre-Treatment|Death|1|||
160849480|NCT01818596|580837832|FG001|Overall Study|Lost to Follow-up|0|||
160849481|NCT02073682|580837843|FG000|Overall Study|Low Creatinine Clearance|1|||
160849482|NCT02073682|580837844|FG001|Overall Study|Low Creatinine Clearance|2|||
160849483|NCT02073682|580837843|FG000|Overall Study|Death|86|||
160849484|NCT02073682|580837844|FG001|Overall Study|Death|100|||
160849485|NCT02073682|580837843|FG000|Overall Study|Cancer Cured|10|||
160849486|NCT02073682|580837844|FG001|Overall Study|Cancer Cured|15|||
160849487|NCT02073682|580837843|FG000|Overall Study|ID: Patient Noncompliance|1|||
160849488|NCT02073682|580837844|FG001|Overall Study|ID: Patient Noncompliance|2|||
160849489|NCT02073682|580837843|FG000|Overall Study|ID: Palliative Treatment Only|10|||
160849490|NCT02073682|580837844|FG001|Overall Study|ID: Palliative Treatment Only|7|||
160849491|NCT02073682|580837843|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
160849492|NCT02073682|580837844|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
160849493|NCT02073682|580837843|FG000|Overall Study|Platelet Count <50,000/mL|1|||
160849494|NCT02073682|580837844|FG001|Overall Study|Platelet Count <50,000/mL|2|||
160849495|NCT02073682|580837843|FG000|Overall Study|Surgery/Medical Procedure|3|||
160849496|NCT02073682|580837844|FG001|Overall Study|Surgery/Medical Procedure|1|||
160849497|NCT02073682|580837843|FG000|Overall Study|Withdrawal by Subject|6|||
160849498|NCT02073682|580837844|FG001|Overall Study|Withdrawal by Subject|8|||
160849499|NCT02073682|580837843|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
160849500|NCT02073682|580837844|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
160849501|NCT02073682|580837843|FG000|Overall Study|Cancer Progression|53|||
160849502|NCT02073682|580837844|FG001|Overall Study|Cancer Progression|33|||
161254844|NCT03430011|582312124|FG001|Pre-Treatment|Death|0|||
161254845|NCT03430011|582312125|FG002|Pre-Treatment|Death|0|||
161254846|NCT03430011|582312126|FG003|Pre-Treatment|Death|0|||
161254847|NCT03430011|582312127|FG004|Pre-Treatment|Death|1|||
161254848|NCT03430011|582312128|FG005|Pre-Treatment|Death|0|||
161254849|NCT03430011|582312129|FG006|Pre-Treatment|Death|1|||
161254850|NCT03430011|582312130|FG007|Pre-Treatment|Death|0|||
161254851|NCT03430011|582312123|FG000|Pre-Treatment|Screen Fail|0|||
161254852|NCT03430011|582312124|FG001|Pre-Treatment|Screen Fail|0|||
161254853|NCT03430011|582312125|FG002|Pre-Treatment|Screen Fail|0|||
161254854|NCT03430011|582312126|FG003|Pre-Treatment|Screen Fail|0|||
161254855|NCT03430011|582312127|FG004|Pre-Treatment|Screen Fail|1|||
161254856|NCT03430011|582312128|FG005|Pre-Treatment|Screen Fail|0|||
161254857|NCT03430011|582312129|FG006|Pre-Treatment|Screen Fail|0|||
161254858|NCT03430011|582312130|FG007|Pre-Treatment|Screen Fail|0|||
161254859|NCT03430011|582312123|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254860|NCT03430011|582312124|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254861|NCT03430011|582312125|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
161254862|NCT03430011|582312126|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254863|NCT03430011|582312127|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254864|NCT03430011|582312128|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254865|NCT03430011|582312129|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254866|NCT03430011|582312130|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
161254867|NCT03430011|582312123|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
161254868|NCT03430011|582312124|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
161254869|NCT03430011|582312125|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
161254870|NCT03430011|582312126|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
161254871|NCT03430011|582312127|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
161254872|NCT03430011|582312128|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
161254873|NCT03430011|582312129|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
161254874|NCT03430011|582312130|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
161254875|NCT03430011|582312123|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
161254876|NCT03430011|582312124|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
161254877|NCT03430011|582312125|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
161337136|NCT00853385|582625845|FG002|Overall Study|Death|0|||
160849503|NCT02073682|580837843|FG000|Overall Study|Protocol Violation|1|||
160849504|NCT02073682|580837844|FG001|Overall Study|Protocol Violation|0|||
160849505|NCT02073682|580837843|FG000|Overall Study|Adverse Event|79|||
160849506|NCT02073682|580837844|FG001|Overall Study|Adverse Event|62|||
160849507|NCT02073682|580837843|FG000|Overall Study|No reason provided|11|||
161254878|NCT03430011|582312126|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
161254879|NCT03430011|582312127|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
161254880|NCT03430011|582312128|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
161254881|NCT03430011|582312129|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
161254882|NCT03430011|582312130|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
161254883|NCT03430011|582312123|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
161254884|NCT03430011|582312124|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
161254885|NCT03430011|582312125|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
161254886|NCT03430011|582312126|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
161254887|NCT03430011|582312127|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
161254888|NCT03430011|582312128|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
161254889|NCT03430011|582312129|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
160849508|NCT02073682|580837844|FG001|Overall Study|No reason provided|9|||
160849509|NCT02073682|580837843|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
160849510|NCT02073682|580837844|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
160849511|NCT02073682|580837843|FG000|Overall Study|Lost to Follow-up|1|||
160849512|NCT02073682|580837844|FG001|Overall Study|Lost to Follow-up|1|||
160849513|NCT02073682|580837843|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
160849514|NCT02073682|580837844|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
160849515|NCT04112810|580837850|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
160849516|NCT01687296|580837851|FG000|Overall Study|Lack of Efficacy|1|||
160849517|NCT01687296|580837852|FG001|Overall Study|Lack of Efficacy|1|||
160849518|NCT01687296|580837851|FG000|Overall Study|Protocol Violation|0|||
160849519|NCT01687296|580837852|FG001|Overall Study|Protocol Violation|1|||
160849520|NCT01687296|580837851|FG000|Overall Study|Withdrawal by Subject|6|||
160849521|NCT01687296|580837852|FG001|Overall Study|Withdrawal by Subject|3|||
160849522|NCT04497116|580837854|FG000|Overall Study|Lost to Follow-up|1|||
160849523|NCT04497116|580837855|FG001|Overall Study|Lost to Follow-up|0|||
160849524|NCT04497116|580837856|FG002|Overall Study|Lost to Follow-up|0|||
160849525|NCT04497116|580837857|FG003|Overall Study|Lost to Follow-up|0|||
160849526|NCT04497116|580837858|FG004|Overall Study|Lost to Follow-up|0|||
160849527|NCT04497116|580837859|FG005|Overall Study|Lost to Follow-up|0|||
160849528|NCT04497116|580837860|FG006|Overall Study|Lost to Follow-up|0|||
160849529|NCT04497116|580837861|FG007|Overall Study|Lost to Follow-up|3|||
160849530|NCT04497116|580837862|FG008|Overall Study|Lost to Follow-up|3|||
160849531|NCT04497116|580837863|FG009|Overall Study|Lost to Follow-up|0|||
160849532|NCT04497116|580837864|FG010|Overall Study|Lost to Follow-up|0|||
160849533|NCT04497116|580837865|FG011|Overall Study|Lost to Follow-up|0|||
160849534|NCT04497116|580837866|FG012|Overall Study|Lost to Follow-up|0|||
160849535|NCT04497116|580837867|FG013|Overall Study|Lost to Follow-up|0|||
160849536|NCT04497116|580837868|FG014|Overall Study|Lost to Follow-up|0|||
160849537|NCT04497116|580837869|FG015|Overall Study|Lost to Follow-up|0|||
160849538|NCT04497116|580837870|FG016|Overall Study|Lost to Follow-up|0|||
160849539|NCT04497116|580837871|FG017|Overall Study|Lost to Follow-up|0|||
160849540|NCT04497116|580837872|FG018|Overall Study|Lost to Follow-up|0|||
160849541|NCT04497116|580837873|FG019|Overall Study|Lost to Follow-up|0|||
160849542|NCT04497116|580837874|FG020|Overall Study|Lost to Follow-up|0|||
160849543|NCT04497116|580837875|FG021|Overall Study|Lost to Follow-up|0|||
160849544|NCT04497116|580837876|FG022|Overall Study|Lost to Follow-up|1|||
160849545|NCT04497116|580837877|FG023|Overall Study|Lost to Follow-up|0|||
160849546|NCT04497116|580837878|FG024|Overall Study|Lost to Follow-up|0|||
160849547|NCT04497116|580837854|FG000|Overall Study|Sponsor decision to terminate study|0|||
160849548|NCT04497116|580837855|FG001|Overall Study|Sponsor decision to terminate study|0|||
160849549|NCT04497116|580837856|FG002|Overall Study|Sponsor decision to terminate study|0|||
160849550|NCT04497116|580837857|FG003|Overall Study|Sponsor decision to terminate study|0|||
160849551|NCT04497116|580837858|FG004|Overall Study|Sponsor decision to terminate study|0|||
160849552|NCT04497116|580837859|FG005|Overall Study|Sponsor decision to terminate study|0|||
160849553|NCT04497116|580837860|FG006|Overall Study|Sponsor decision to terminate study|1|||
160849554|NCT04497116|580837861|FG007|Overall Study|Sponsor decision to terminate study|0|||
160849555|NCT04497116|580837862|FG008|Overall Study|Sponsor decision to terminate study|0|||
161254890|NCT03430011|582312130|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
161254891|NCT03430011|582312123|FG000|JCARH125 Treatment|Death|4|||
161254892|NCT03430011|582312124|FG001|JCARH125 Treatment|Death|19|||
161254893|NCT03430011|582312125|FG002|JCARH125 Treatment|Death|10|||
161254894|NCT03430011|582312126|FG003|JCARH125 Treatment|Death|8|||
160849556|NCT04497116|580837863|FG009|Overall Study|Sponsor decision to terminate study|1|||
160849557|NCT04497116|580837864|FG010|Overall Study|Sponsor decision to terminate study|0|||
160849558|NCT04497116|580837865|FG011|Overall Study|Sponsor decision to terminate study|0|||
160849559|NCT04497116|580837866|FG012|Overall Study|Sponsor decision to terminate study|0|||
160849560|NCT04497116|580837867|FG013|Overall Study|Sponsor decision to terminate study|0|||
160849561|NCT04497116|580837868|FG014|Overall Study|Sponsor decision to terminate study|0|||
160849562|NCT04497116|580837869|FG015|Overall Study|Sponsor decision to terminate study|0|||
160849563|NCT04497116|580837870|FG016|Overall Study|Sponsor decision to terminate study|0|||
161254895|NCT03430011|582312127|FG004|JCARH125 Treatment|Death|5|||
161254896|NCT03430011|582312128|FG005|JCARH125 Treatment|Death|3|||
161254897|NCT03430011|582312129|FG006|JCARH125 Treatment|Death|4|||
160849564|NCT04497116|580837871|FG017|Overall Study|Sponsor decision to terminate study|0|||
161254898|NCT03430011|582312130|FG007|JCARH125 Treatment|Death|2|||
161254899|NCT03430011|582312123|FG000|JCARH125 Treatment|Other reasons|1|||
160849565|NCT04497116|580837872|FG018|Overall Study|Sponsor decision to terminate study|0|||
160849566|NCT04497116|580837873|FG019|Overall Study|Sponsor decision to terminate study|1|||
161254900|NCT03430011|582312124|FG001|JCARH125 Treatment|Other reasons|0|||
161254901|NCT03430011|582312125|FG002|JCARH125 Treatment|Other reasons|4|||
161254902|NCT03430011|582312126|FG003|JCARH125 Treatment|Other reasons|2|||
161254903|NCT03430011|582312127|FG004|JCARH125 Treatment|Other reasons|2|||
161254904|NCT03430011|582312128|FG005|JCARH125 Treatment|Other reasons|1|||
161254905|NCT03430011|582312129|FG006|JCARH125 Treatment|Other reasons|3|||
161254906|NCT03430011|582312130|FG007|JCARH125 Treatment|Other reasons|2|||
161254907|NCT04126343|582312132|FG000|Overall Study|Adverse Event|0|||
161254908|NCT04126343|582312133|FG001|Overall Study|Adverse Event|0|||
161254909|NCT04126343|582312134|FG002|Overall Study|Adverse Event|0|||
161254910|NCT04126343|582312135|FG003|Overall Study|Adverse Event|0|||
161254911|NCT04126343|582312136|FG004|Overall Study|Adverse Event|0|||
161254912|NCT04126343|582312137|FG005|Overall Study|Adverse Event|1|||
161254913|NCT04126343|582312132|FG000|Overall Study|Withdrawal by Subject|0|||
161254914|NCT04126343|582312133|FG001|Overall Study|Withdrawal by Subject|0|||
161254915|NCT04126343|582312134|FG002|Overall Study|Withdrawal by Subject|0|||
161254916|NCT04126343|582312135|FG003|Overall Study|Withdrawal by Subject|1|||
161254917|NCT04126343|582312136|FG004|Overall Study|Withdrawal by Subject|0|||
161254918|NCT04126343|582312137|FG005|Overall Study|Withdrawal by Subject|0|||
160849567|NCT04497116|580837874|FG020|Overall Study|Sponsor decision to terminate study|0|||
160849568|NCT04497116|580837875|FG021|Overall Study|Sponsor decision to terminate study|0|||
160849569|NCT04497116|580837876|FG022|Overall Study|Sponsor decision to terminate study|0|||
161254919|NCT04126343|582312132|FG000|Overall Study|Related to COVID-19 pandemic|3|||
161254920|NCT04126343|582312133|FG001|Overall Study|Related to COVID-19 pandemic|4|||
161254921|NCT04126343|582312134|FG002|Overall Study|Related to COVID-19 pandemic|3|||
160849570|NCT04497116|580837877|FG023|Overall Study|Sponsor decision to terminate study|0|||
161254922|NCT04126343|582312135|FG003|Overall Study|Related to COVID-19 pandemic|3|||
160849571|NCT04497116|580837878|FG024|Overall Study|Sponsor decision to terminate study|0|||
160849572|NCT04497116|580837854|FG000|Overall Study|Death|4|||
160849573|NCT04497116|580837855|FG001|Overall Study|Death|5|||
160849574|NCT04497116|580837856|FG002|Overall Study|Death|2|||
160849575|NCT04497116|580837857|FG003|Overall Study|Death|2|||
160849576|NCT04497116|580837858|FG004|Overall Study|Death|1|||
160849577|NCT04497116|580837859|FG005|Overall Study|Death|1|||
160849578|NCT04497116|580837860|FG006|Overall Study|Death|3|||
160849579|NCT04497116|580837861|FG007|Overall Study|Death|10|||
160849580|NCT04497116|580837862|FG008|Overall Study|Death|37|||
160849581|NCT04497116|580837863|FG009|Overall Study|Death|17|||
160849582|NCT04497116|580837864|FG010|Overall Study|Death|2|||
160849583|NCT04497116|580837865|FG011|Overall Study|Death|1|||
160849584|NCT04497116|580837866|FG012|Overall Study|Death|1|||
160849585|NCT04497116|580837867|FG013|Overall Study|Death|3|||
160849586|NCT04497116|580837868|FG014|Overall Study|Death|18|||
160849587|NCT04497116|580837869|FG015|Overall Study|Death|3|||
160849588|NCT04497116|580837870|FG016|Overall Study|Death|2|||
160849589|NCT04497116|580837871|FG017|Overall Study|Death|1|||
160849590|NCT04497116|580837872|FG018|Overall Study|Death|4|||
160849591|NCT04497116|580837873|FG019|Overall Study|Death|17|||
160849592|NCT04497116|580837874|FG020|Overall Study|Death|1|||
160849593|NCT04497116|580837875|FG021|Overall Study|Death|0|||
160849594|NCT04497116|580837876|FG022|Overall Study|Death|3|||
160849595|NCT04497116|580837877|FG023|Overall Study|Death|5|||
160849596|NCT04497116|580837878|FG024|Overall Study|Death|4|||
160906651|NCT02197520|581052261|FG000|Period 2|Adverse Event|0|||
160906652|NCT02197520|581052262|FG001|Period 2|Adverse Event|2|||
161254923|NCT04126343|582312136|FG004|Overall Study|Related to COVID-19 pandemic|3|||
161254924|NCT04126343|582312137|FG005|Overall Study|Related to COVID-19 pandemic|3|||
161254925|NCT00559364|582312138|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
161254926|NCT00559364|582312139|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
161254927|NCT01235442|582312140|FG000|Overall Study|Lost to Follow-up|12|||
160849597|NCT04497116|580837854|FG000|Overall Study|Withdrawal by Subject|1|||
160849598|NCT04497116|580837855|FG001|Overall Study|Withdrawal by Subject|0|||
160849599|NCT04497116|580837856|FG002|Overall Study|Withdrawal by Subject|1|||
160849600|NCT04497116|580837857|FG003|Overall Study|Withdrawal by Subject|0|||
160849601|NCT04497116|580837858|FG004|Overall Study|Withdrawal by Subject|0|||
160906653|NCT02197520|581052261|FG000|Period 2|Withdrawal by Subject|1|||
161254928|NCT01235442|582312141|FG001|Overall Study|Lost to Follow-up|10|||
161254929|NCT01235442|582312140|FG000|Overall Study|Death|0|||
161254930|NCT01235442|582312141|FG001|Overall Study|Death|2|||
160849602|NCT04497116|580837859|FG005|Overall Study|Withdrawal by Subject|0|||
160849603|NCT04497116|580837860|FG006|Overall Study|Withdrawal by Subject|0|||
160849604|NCT04497116|580837861|FG007|Overall Study|Withdrawal by Subject|7|||
160849605|NCT04497116|580837862|FG008|Overall Study|Withdrawal by Subject|14|||
160906654|NCT02197520|581052262|FG001|Period 2|Withdrawal by Subject|0|||
161254931|NCT01235442|582312140|FG000|Overall Study|Pregnancy|1|||
161254932|NCT01235442|582312141|FG001|Overall Study|Pregnancy|1|||
160849606|NCT04497116|580837863|FG009|Overall Study|Withdrawal by Subject|3|||
160849607|NCT04497116|580837864|FG010|Overall Study|Withdrawal by Subject|3|||
160849608|NCT04497116|580837865|FG011|Overall Study|Withdrawal by Subject|0|||
160849609|NCT04497116|580837866|FG012|Overall Study|Withdrawal by Subject|1|||
160849610|NCT04497116|580837867|FG013|Overall Study|Withdrawal by Subject|0|||
160849611|NCT04497116|580837868|FG014|Overall Study|Withdrawal by Subject|7|||
160849612|NCT04497116|580837869|FG015|Overall Study|Withdrawal by Subject|1|||
160849613|NCT04497116|580837870|FG016|Overall Study|Withdrawal by Subject|3|||
160849614|NCT04497116|580837871|FG017|Overall Study|Withdrawal by Subject|1|||
160849615|NCT04497116|580837872|FG018|Overall Study|Withdrawal by Subject|1|||
160849616|NCT04497116|580837873|FG019|Overall Study|Withdrawal by Subject|5|||
161141183|NCT00356915|581900991|FG000|Overall Study|Protocol Violation|2|||
161141184|NCT00356915|581900992|FG001|Overall Study|Protocol Violation|3|||
161254933|NCT01235442|582312140|FG000|Overall Study|Ineligibility determined|5|||
161254934|NCT01235442|582312141|FG001|Overall Study|Ineligibility determined|4|||
161254935|NCT01235442|582312140|FG000|Overall Study|Protocol Violation|3|||
161254936|NCT01235442|582312141|FG001|Overall Study|Protocol Violation|3|||
161254937|NCT01235442|582312140|FG000|Overall Study|Adverse Event|4|||
161254938|NCT01235442|582312141|FG001|Overall Study|Adverse Event|6|||
161254939|NCT01235442|582312140|FG000|Overall Study|Withdrawal by Subject|15|||
161254940|NCT01235442|582312141|FG001|Overall Study|Withdrawal by Subject|9|||
161254941|NCT01235442|582312140|FG000|Overall Study|Lack of Efficacy|1|||
161254942|NCT01235442|582312141|FG001|Overall Study|Lack of Efficacy|3|||
161254943|NCT01235442|582312140|FG000|Overall Study|Noncompliance|1|||
161254944|NCT01235442|582312141|FG001|Overall Study|Noncompliance|2|||
161254945|NCT01235442|582312140|FG000|Overall Study|Administrative decision|1|||
161254946|NCT01235442|582312141|FG001|Overall Study|Administrative decision|2|||
161254947|NCT01235442|582312140|FG000|Overall Study|Other unspecified|1|||
161254948|NCT01235442|582312141|FG001|Overall Study|Other unspecified|2|||
161254949|NCT00330460|582312146|FG000|Overall Study|Physician Decision|1|||
161254950|NCT00330460|582312147|FG001|Overall Study|Physician Decision|0|||
161254951|NCT00330460|582312146|FG000|Overall Study|Adverse Event|10|||
161254952|NCT00330460|582312147|FG001|Overall Study|Adverse Event|8|||
161254953|NCT00330460|582312146|FG000|Overall Study|Withdrawal by Subject|18|||
161254954|NCT00330460|582312147|FG001|Overall Study|Withdrawal by Subject|17|||
161254955|NCT00330460|582312146|FG000|Overall Study|Death|1|||
161254956|NCT00330460|582312147|FG001|Overall Study|Death|1|||
161254957|NCT00330460|582312146|FG000|Overall Study|Ineligibility determined|1|||
161254958|NCT00330460|582312147|FG001|Overall Study|Ineligibility determined|3|||
161254959|NCT00330460|582312146|FG000|Overall Study|Lost to Follow-up|8|||
160849617|NCT04497116|580837874|FG020|Overall Study|Withdrawal by Subject|2|||
160849618|NCT04497116|580837875|FG021|Overall Study|Withdrawal by Subject|2|||
160849619|NCT04497116|580837876|FG022|Overall Study|Withdrawal by Subject|2|||
160849620|NCT04497116|580837877|FG023|Overall Study|Withdrawal by Subject|4|||
160849621|NCT04497116|580837878|FG024|Overall Study|Withdrawal by Subject|3|||
160849622|NCT04497116|580837854|FG000|Overall Study|Physician Decision|0|||
160849623|NCT04497116|580837855|FG001|Overall Study|Physician Decision|0|||
161254960|NCT00330460|582312147|FG001|Overall Study|Lost to Follow-up|3|||
161254961|NCT00330460|582312146|FG000|Overall Study|Noncompliance|2|||
161254962|NCT00330460|582312147|FG001|Overall Study|Noncompliance|1|||
161254963|NCT00330460|582312146|FG000|Overall Study|Other|1|||
161254964|NCT00330460|582312147|FG001|Overall Study|Other|0|||
161254965|NCT01857973|582312152|FG000|Overall Study|Subject did not meet required BG range|3|||
161254966|NCT01857973|582312152|FG000|Overall Study|drop out after 3 failed attempts|1|||
161254967|NCT01857973|582312152|FG000|Overall Study|Physician Decision|1|||
161254968|NCT02663882|582312153|FG000|Overall Study|Lost to Follow-up|4|||
161254969|NCT02663882|582312154|FG001|Overall Study|Lost to Follow-up|2|||
161254970|NCT01701973|582312155|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161254971|NCT01701973|582312156|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
161254972|NCT01701973|582312157|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161337137|NCT00853385|582625846|FG003|Overall Study|Death|0|||
160849624|NCT04497116|580837856|FG002|Overall Study|Physician Decision|0|||
160849625|NCT04497116|580837857|FG003|Overall Study|Physician Decision|0|||
160849626|NCT04497116|580837858|FG004|Overall Study|Physician Decision|0|||
160849627|NCT04497116|580837859|FG005|Overall Study|Physician Decision|0|||
160849628|NCT04497116|580837860|FG006|Overall Study|Physician Decision|0|||
161141185|NCT00356915|581900993|FG002|Overall Study|Protocol Violation|2|||
160849629|NCT04497116|580837861|FG007|Overall Study|Physician Decision|0|||
160849630|NCT04497116|580837862|FG008|Overall Study|Physician Decision|0|||
160849631|NCT04497116|580837863|FG009|Overall Study|Physician Decision|0|||
161141186|NCT00356915|581900991|FG000|Overall Study|Withdrawal by Subject|14|||
161254973|NCT01701973|582312158|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
160849632|NCT04497116|580837864|FG010|Overall Study|Physician Decision|0|||
161254974|NCT01701973|582312159|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161254975|NCT01701973|582312160|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161254976|NCT01701973|582312161|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161254977|NCT01701973|582312162|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
161254978|NCT03712124|582312167|FG000|Overall Study|Protocol Violation|1|||
160849633|NCT04497116|580837865|FG011|Overall Study|Physician Decision|0|||
160849634|NCT04497116|580837866|FG012|Overall Study|Physician Decision|0|||
160849635|NCT04497116|580837867|FG013|Overall Study|Physician Decision|0|||
160849636|NCT04497116|580837868|FG014|Overall Study|Physician Decision|0|||
160849637|NCT04497116|580837869|FG015|Overall Study|Physician Decision|0|||
160849638|NCT04497116|580837870|FG016|Overall Study|Physician Decision|0|||
160849639|NCT04497116|580837871|FG017|Overall Study|Physician Decision|0|||
160849640|NCT04497116|580837872|FG018|Overall Study|Physician Decision|0|||
160849641|NCT04497116|580837873|FG019|Overall Study|Physician Decision|0|||
160849642|NCT04497116|580837874|FG020|Overall Study|Physician Decision|0|||
160849643|NCT04497116|580837875|FG021|Overall Study|Physician Decision|0|||
160849644|NCT04497116|580837876|FG022|Overall Study|Physician Decision|0|||
160849645|NCT04497116|580837877|FG023|Overall Study|Physician Decision|1|||
160849646|NCT04497116|580837878|FG024|Overall Study|Physician Decision|0|||
160849647|NCT04497116|580837854|FG000|Overall Study|Clinical Progression Related|0|||
160849648|NCT04497116|580837855|FG001|Overall Study|Clinical Progression Related|0|||
160849649|NCT04497116|580837856|FG002|Overall Study|Clinical Progression Related|0|||
160849650|NCT04497116|580837857|FG003|Overall Study|Clinical Progression Related|0|||
160849651|NCT04497116|580837858|FG004|Overall Study|Clinical Progression Related|0|||
160849652|NCT04497116|580837859|FG005|Overall Study|Clinical Progression Related|0|||
160849653|NCT04497116|580837860|FG006|Overall Study|Clinical Progression Related|0|||
160849654|NCT04497116|580837861|FG007|Overall Study|Clinical Progression Related|0|||
160849655|NCT04497116|580837862|FG008|Overall Study|Clinical Progression Related|0|||
160849656|NCT04497116|580837863|FG009|Overall Study|Clinical Progression Related|1|||
160849657|NCT04497116|580837864|FG010|Overall Study|Clinical Progression Related|0|||
160849658|NCT04497116|580837865|FG011|Overall Study|Clinical Progression Related|0|||
160849659|NCT04497116|580837866|FG012|Overall Study|Clinical Progression Related|0|||
160849660|NCT04497116|580837867|FG013|Overall Study|Clinical Progression Related|0|||
160849661|NCT04497116|580837868|FG014|Overall Study|Clinical Progression Related|0|||
160849662|NCT04497116|580837869|FG015|Overall Study|Clinical Progression Related|0|||
160849663|NCT04497116|580837870|FG016|Overall Study|Clinical Progression Related|0|||
160849664|NCT04497116|580837871|FG017|Overall Study|Clinical Progression Related|0|||
160849665|NCT04497116|580837872|FG018|Overall Study|Clinical Progression Related|0|||
161254979|NCT03712124|582312168|FG001|Overall Study|Protocol Violation|0|||
161254980|NCT00602537|582312170|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
161254981|NCT00602537|582312171|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
161254982|NCT00602537|582312170|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
161254983|NCT00602537|582312171|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
161254984|NCT00602537|582312170|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
161254985|NCT00602537|582312171|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
161254986|NCT00602537|582312170|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
161254987|NCT00602537|582312171|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
161254988|NCT00602537|582312170|FG000|Follow Up Study Comparison|Adverse Event|1|||
161254989|NCT00602537|582312171|FG001|Follow Up Study Comparison|Adverse Event|0|||
161254990|NCT00602537|582312170|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
161254991|NCT00602537|582312171|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
161254992|NCT00602537|582312170|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
161254993|NCT00602537|582312171|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
161254994|NCT00388037|582312174|FG000|Overall Study|Protocol Violation|1|||
160849666|NCT04497116|580837873|FG019|Overall Study|Clinical Progression Related|0|||
160849667|NCT04497116|580837874|FG020|Overall Study|Clinical Progression Related|0|||
160849668|NCT04497116|580837875|FG021|Overall Study|Clinical Progression Related|0|||
160849669|NCT04497116|580837876|FG022|Overall Study|Clinical Progression Related|0|||
160849670|NCT04497116|580837877|FG023|Overall Study|Clinical Progression Related|0|||
160849671|NCT04497116|580837878|FG024|Overall Study|Clinical Progression Related|0|||
160849672|NCT02698826|580837879|FG000|Overall Study|Death|13|||
160849673|NCT02698826|580837879|FG000|Overall Study|Adverse Event|1|||
160849674|NCT02915263|580837882|FG000|Overall Study|Covid|3|||
160849675|NCT02915263|580837883|FG001|Overall Study|Covid|2|||
160849676|NCT01358825|580837884|FG000|Overall Study|Blood sample not drawn|0|||
160849677|NCT01358825|580837885|FG001|Overall Study|Blood sample not drawn|1|||
160849678|NCT01788566|580837888|FG000|Overall Study|Death|4|||
160849679|NCT01788566|580837888|FG000|Overall Study|Adverse Event|1|||
160849680|NCT01788566|580837888|FG000|Overall Study|Clinical Progressive Disease|3|||
161254995|NCT00869440|582312175|FG000|Overall Study|Withdrawal by Subject|1|||
160849681|NCT00857285|580837891|FG000|Overall Study|Adverse Event|4|||
160849682|NCT00857285|580837892|FG001|Overall Study|Adverse Event|2|||
160849683|NCT00857285|580837891|FG000|Overall Study|Lack of Efficacy|0|||
160849684|NCT00857285|580837892|FG001|Overall Study|Lack of Efficacy|2|||
160849685|NCT00857285|580837891|FG000|Overall Study|Protocol Violation|3|||
160849686|NCT00857285|580837892|FG001|Overall Study|Protocol Violation|1|||
160849687|NCT00857285|580837891|FG000|Overall Study|Withdrawal by Subject|4|||
160849688|NCT00857285|580837892|FG001|Overall Study|Withdrawal by Subject|0|||
160849689|NCT00857285|580837891|FG000|Overall Study|Randomization criteria not met|1|||
161337138|NCT00853385|582625847|FG004|Overall Study|Death|1|||
160849690|NCT00857285|580837892|FG001|Overall Study|Randomization criteria not met|1|||
160849691|NCT01539759|580837893|FG000|Overall Study|Lost to Follow-up|6|||
160849692|NCT01539759|580837894|FG001|Overall Study|Lost to Follow-up|8|||
160849693|NCT01076959|580837895|FG000|Overall Study|Adverse Event|767|||
160849694|NCT01076959|580837895|FG000|Overall Study|Lack of Efficacy|849|||
160849695|NCT01076959|580837895|FG000|Overall Study|Non-compliance|274|||
160849696|NCT01076959|580837895|FG000|Overall Study|Lost to Follow-up|241|||
160849697|NCT01076959|580837895|FG000|Overall Study|Other|119|||
160849698|NCT02491983|580837896|FG000|Overall Study|Physician Decision|1|||
160849699|NCT02491983|580837897|FG001|Overall Study|Physician Decision|0|||
160849700|NCT02491983|580837896|FG000|Overall Study|Not meet selection criteria|1|||
161254996|NCT00869440|582312176|FG001|Overall Study|Withdrawal by Subject|0|||
161254997|NCT00869440|582312177|FG002|Overall Study|Withdrawal by Subject|0|||
161254998|NCT00869440|582312178|FG003|Overall Study|Withdrawal by Subject|0|||
161254999|NCT00869440|582312175|FG000|Overall Study|Physician Decision|1|||
161255000|NCT00869440|582312176|FG001|Overall Study|Physician Decision|1|||
161255001|NCT00869440|582312177|FG002|Overall Study|Physician Decision|0|||
161255002|NCT00869440|582312178|FG003|Overall Study|Physician Decision|0|||
161255003|NCT04314843|582312179|FG000|Overall Study|Death|2|||
161255004|NCT04314843|582312180|FG001|Overall Study|Death|2|||
161255005|NCT04314843|582312179|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
161255006|NCT04314843|582312180|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
161255007|NCT01899326|582312182|FG000|Overall Study|Withdrawal by Subject|1|||
161255008|NCT01899326|582312182|FG000|Overall Study|Adverse Event|2|||
161255009|NCT01899326|582312182|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
161255010|NCT01435031|582312183|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
161255011|NCT01435031|582312183|FG000|ITT at 1 Month|Death|1|||
161255012|NCT01435031|582312183|FG000|ITT at 1 Month|Lost to Follow-up|4|||
161255013|NCT01435031|582312183|FG000|ITT at 6 Months|Death|2|||
161255014|NCT01435031|582312183|FG000|ITT at 6 Months|Lost to Follow-up|3|||
161255015|NCT01435031|582312183|FG000|ITT at 1 Year|Death|1|||
161255016|NCT01435031|582312183|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
161255017|NCT01435031|582312183|FG000|ITT at 1 Year|Lost to Follow-up|6|||
161255018|NCT01435031|582312183|FG000|ITT at 2 Years|Death|7|||
161255019|NCT01435031|582312183|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
161255020|NCT01435031|582312183|FG000|ITT at 2 Years|Lost to Follow-up|4|||
161255021|NCT01435031|582312183|FG000|ITT at 3 Years|Death|5|||
161255022|NCT01435031|582312183|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
161255023|NCT01435031|582312183|FG000|ITT at 3 Years|Lost to Follow-up|4|||
161255024|NCT01435031|582312183|FG000|ITT at 4 Years|Death|4|||
161255025|NCT01435031|582312183|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
161255026|NCT01435031|582312183|FG000|ITT at 4 Years|Lost to Follow-up|1|||
161255027|NCT00104247|582312184|FG000|Overall Study|Withdrawal by Subject|1|||
161255028|NCT00104247|582312185|FG001|Overall Study|Withdrawal by Subject|0|||
161255029|NCT00104247|582312184|FG000|Overall Study|Noncompliant with dosing|0|||
161255030|NCT00104247|582312185|FG001|Overall Study|Noncompliant with dosing|1|||
161255031|NCT03718117|582312187|FG000|Overall Study|Death|12|||
161255032|NCT03718117|582312188|FG001|Overall Study|Death|11|||
161255033|NCT03718117|582312189|FG002|Overall Study|Death|0|||
161255034|NCT03718117|582312187|FG000|Overall Study|Other|0|||
161255035|NCT03718117|582312188|FG001|Overall Study|Other|1|||
161255036|NCT03718117|582312189|FG002|Overall Study|Other|0|||
161255037|NCT03718117|582312187|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
161255038|NCT03718117|582312188|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
161255039|NCT03718117|582312189|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
161255040|NCT03718117|582312187|FG000|Overall Study|Participant not met eligibility criteria|0|||
161255041|NCT03718117|582312188|FG001|Overall Study|Participant not met eligibility criteria|0|||
161255042|NCT03718117|582312189|FG002|Overall Study|Participant not met eligibility criteria|2|||
161255043|NCT02030535|582312190|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
161255044|NCT01588548|582312191|FG000|Overall Study|Withdrawal by Subject|0|||
161255045|NCT01588548|582312192|FG001|Overall Study|Withdrawal by Subject|1|||
161255046|NCT01588548|582312193|FG002|Overall Study|Withdrawal by Subject|1|||
160849701|NCT02491983|580837897|FG001|Overall Study|Not meet selection criteria|0|||
161255047|NCT01588548|582312194|FG003|Overall Study|Withdrawal by Subject|1|||
161255048|NCT01588548|582312195|FG004|Overall Study|Withdrawal by Subject|2|||
161255049|NCT01588548|582312196|FG005|Overall Study|Withdrawal by Subject|3|||
161255050|NCT01588548|582312191|FG000|Overall Study|Adverse Event|0|||
161255051|NCT01588548|582312192|FG001|Overall Study|Adverse Event|0|||
161255052|NCT01588548|582312193|FG002|Overall Study|Adverse Event|1|||
161255053|NCT01588548|582312194|FG003|Overall Study|Adverse Event|2|||
161255054|NCT01588548|582312195|FG004|Overall Study|Adverse Event|1|||
161255055|NCT01588548|582312196|FG005|Overall Study|Adverse Event|0|||
161255056|NCT01588548|582312191|FG000|Overall Study|Condition Under Investigation Worsened|3|||
161255057|NCT01588548|582312192|FG001|Overall Study|Condition Under Investigation Worsened|6|||
160849702|NCT02491983|580837896|FG000|Overall Study|Withdrawal by Subject|0|||
160906655|NCT00913497|581052263|FG000|Overall Study|Adverse Event|1|||
160849703|NCT02491983|580837897|FG001|Overall Study|Withdrawal by Subject|1|||
160849704|NCT04378270|580837899|FG000|Overall Study|Lack of Efficacy|1|||
160849705|NCT04378270|580837899|FG000|Overall Study|Withdrawal by Subject|1|||
160849706|NCT04378270|580837899|FG000|Overall Study|Screen Failure|1|||
160849707|NCT04378270|580837899|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
160849708|NCT01132313|580837900|FG000|Overall Study|Lack of Efficacy|1|||
160849709|NCT01132313|580837901|FG001|Overall Study|Lack of Efficacy|0|||
160849710|NCT01132313|580837902|FG002|Overall Study|Lack of Efficacy|0|||
160849711|NCT01132313|580837903|FG003|Overall Study|Lack of Efficacy|0|||
160849712|NCT01132313|580837904|FG004|Overall Study|Lack of Efficacy|0|||
160849713|NCT01132313|580837905|FG005|Overall Study|Lack of Efficacy|0|||
160849714|NCT01132313|580837906|FG006|Overall Study|Lack of Efficacy|0|||
160849715|NCT01132313|580837907|FG007|Overall Study|Lack of Efficacy|3|||
160849716|NCT01132313|580837908|FG008|Overall Study|Lack of Efficacy|14|||
160849717|NCT01132313|580837909|FG009|Overall Study|Lack of Efficacy|16|||
160849718|NCT01132313|580837910|FG010|Overall Study|Lack of Efficacy|0|||
160849719|NCT01132313|580837911|FG011|Overall Study|Lack of Efficacy|0|||
160849720|NCT01132313|580837900|FG000|Overall Study|Not treated|2|||
160849721|NCT01132313|580837901|FG001|Overall Study|Not treated|0|||
160849722|NCT01132313|580837902|FG002|Overall Study|Not treated|0|||
160849723|NCT01132313|580837903|FG003|Overall Study|Not treated|0|||
160849724|NCT01132313|580837904|FG004|Overall Study|Not treated|2|||
160849725|NCT01132313|580837905|FG005|Overall Study|Not treated|1|||
160849726|NCT01132313|580837906|FG006|Overall Study|Not treated|3|||
160849727|NCT01132313|580837907|FG007|Overall Study|Not treated|0|||
160849728|NCT01132313|580837908|FG008|Overall Study|Not treated|0|||
160849729|NCT01132313|580837909|FG009|Overall Study|Not treated|0|||
160849730|NCT01132313|580837910|FG010|Overall Study|Not treated|0|||
160849731|NCT01132313|580837911|FG011|Overall Study|Not treated|0|||
160849732|NCT01132313|580837900|FG000|Overall Study|Adverse Event|0|||
160849733|NCT01132313|580837901|FG001|Overall Study|Adverse Event|0|||
160849734|NCT01132313|580837902|FG002|Overall Study|Adverse Event|4|||
160849735|NCT01132313|580837903|FG003|Overall Study|Adverse Event|10|||
160849736|NCT01132313|580837904|FG004|Overall Study|Adverse Event|19|||
160849737|NCT01132313|580837905|FG005|Overall Study|Adverse Event|6|||
161255058|NCT01588548|582312193|FG002|Overall Study|Condition Under Investigation Worsened|4|||
160849738|NCT01132313|580837906|FG006|Overall Study|Adverse Event|5|||
160849739|NCT01132313|580837907|FG007|Overall Study|Adverse Event|3|||
160849740|NCT01132313|580837908|FG008|Overall Study|Adverse Event|7|||
160849741|NCT01132313|580837909|FG009|Overall Study|Adverse Event|2|||
160849742|NCT01132313|580837910|FG010|Overall Study|Adverse Event|0|||
160849743|NCT01132313|580837911|FG011|Overall Study|Adverse Event|0|||
160849744|NCT01132313|580837900|FG000|Overall Study|Protocol Violation|0|||
160849745|NCT01132313|580837901|FG001|Overall Study|Protocol Violation|0|||
160849746|NCT01132313|580837902|FG002|Overall Study|Protocol Violation|0|||
160849747|NCT01132313|580837903|FG003|Overall Study|Protocol Violation|1|||
160849748|NCT01132313|580837904|FG004|Overall Study|Protocol Violation|0|||
160849749|NCT01132313|580837905|FG005|Overall Study|Protocol Violation|0|||
160849750|NCT01132313|580837906|FG006|Overall Study|Protocol Violation|0|||
160849751|NCT01132313|580837907|FG007|Overall Study|Protocol Violation|0|||
160849752|NCT01132313|580837908|FG008|Overall Study|Protocol Violation|0|||
160849753|NCT01132313|580837909|FG009|Overall Study|Protocol Violation|0|||
160849754|NCT01132313|580837910|FG010|Overall Study|Protocol Violation|0|||
160849755|NCT01132313|580837911|FG011|Overall Study|Protocol Violation|0|||
160849756|NCT01132313|580837900|FG000|Overall Study|Lost to Follow-up|0|||
160849757|NCT01132313|580837901|FG001|Overall Study|Lost to Follow-up|0|||
160849758|NCT01132313|580837902|FG002|Overall Study|Lost to Follow-up|1|||
160849759|NCT01132313|580837903|FG003|Overall Study|Lost to Follow-up|0|||
160849760|NCT01132313|580837904|FG004|Overall Study|Lost to Follow-up|0|||
160849761|NCT01132313|580837905|FG005|Overall Study|Lost to Follow-up|0|||
160849762|NCT01132313|580837906|FG006|Overall Study|Lost to Follow-up|0|||
160849763|NCT01132313|580837907|FG007|Overall Study|Lost to Follow-up|1|||
160849764|NCT01132313|580837908|FG008|Overall Study|Lost to Follow-up|0|||
160849765|NCT01132313|580837909|FG009|Overall Study|Lost to Follow-up|0|||
160849766|NCT01132313|580837910|FG010|Overall Study|Lost to Follow-up|0|||
160849767|NCT01132313|580837911|FG011|Overall Study|Lost to Follow-up|0|||
160849768|NCT01132313|580837900|FG000|Overall Study|Withdrawal by Subject|0|||
160849769|NCT01132313|580837901|FG001|Overall Study|Withdrawal by Subject|0|||
160849770|NCT01132313|580837902|FG002|Overall Study|Withdrawal by Subject|3|||
160849771|NCT01132313|580837903|FG003|Overall Study|Withdrawal by Subject|3|||
160849772|NCT01132313|580837904|FG004|Overall Study|Withdrawal by Subject|6|||
160849773|NCT01132313|580837905|FG005|Overall Study|Withdrawal by Subject|0|||
160849774|NCT01132313|580837906|FG006|Overall Study|Withdrawal by Subject|1|||
160849775|NCT01132313|580837907|FG007|Overall Study|Withdrawal by Subject|0|||
160849776|NCT01132313|580837908|FG008|Overall Study|Withdrawal by Subject|0|||
160849777|NCT01132313|580837909|FG009|Overall Study|Withdrawal by Subject|2|||
160849778|NCT01132313|580837910|FG010|Overall Study|Withdrawal by Subject|0|||
160849779|NCT01132313|580837911|FG011|Overall Study|Withdrawal by Subject|0|||
160849780|NCT01132313|580837900|FG000|Overall Study|Lack of antiviral response|0|||
160849781|NCT01132313|580837901|FG001|Overall Study|Lack of antiviral response|0|||
160849782|NCT01132313|580837902|FG002|Overall Study|Lack of antiviral response|12|||
160849783|NCT01132313|580837903|FG003|Overall Study|Lack of antiviral response|18|||
160849784|NCT01132313|580837904|FG004|Overall Study|Lack of antiviral response|18|||
160849785|NCT01132313|580837905|FG005|Overall Study|Lack of antiviral response|18|||
160849786|NCT01132313|580837906|FG006|Overall Study|Lack of antiviral response|21|||
160849787|NCT01132313|580837907|FG007|Overall Study|Lack of antiviral response|0|||
160849788|NCT01132313|580837908|FG008|Overall Study|Lack of antiviral response|0|||
160849789|NCT01132313|580837909|FG009|Overall Study|Lack of antiviral response|0|||
160849790|NCT01132313|580837910|FG010|Overall Study|Lack of antiviral response|1|||
160849791|NCT01132313|580837911|FG011|Overall Study|Lack of antiviral response|0|||
160849792|NCT01132313|580837900|FG000|Overall Study|Other reason not defined above|0|||
160849793|NCT01132313|580837901|FG001|Overall Study|Other reason not defined above|0|||
160849794|NCT01132313|580837902|FG002|Overall Study|Other reason not defined above|0|||
160849795|NCT01132313|580837903|FG003|Overall Study|Other reason not defined above|0|||
160849796|NCT01132313|580837904|FG004|Overall Study|Other reason not defined above|0|||
160849797|NCT01132313|580837905|FG005|Overall Study|Other reason not defined above|0|||
160849798|NCT01132313|580837906|FG006|Overall Study|Other reason not defined above|0|||
160849799|NCT01132313|580837907|FG007|Overall Study|Other reason not defined above|1|||
160849800|NCT01132313|580837908|FG008|Overall Study|Other reason not defined above|0|||
160849801|NCT01132313|580837909|FG009|Overall Study|Other reason not defined above|0|||
160849802|NCT01132313|580837910|FG010|Overall Study|Other reason not defined above|0|||
160849803|NCT01132313|580837911|FG011|Overall Study|Other reason not defined above|0|||
160849804|NCT03201419|580837914|FG000|Overall Study|Adverse Event|3|||
160849805|NCT03201419|580837915|FG001|Overall Study|Adverse Event|1|||
160849806|NCT03201419|580837916|FG002|Overall Study|Adverse Event|0|||
160849807|NCT03201419|580837917|FG003|Overall Study|Adverse Event|0|||
160849808|NCT03201419|580837918|FG004|Overall Study|Adverse Event|1|||
160849809|NCT03201419|580837919|FG005|Overall Study|Adverse Event|1|||
160849810|NCT03201419|580837920|FG006|Overall Study|Adverse Event|5|||
160849811|NCT03201419|580837921|FG007|Overall Study|Adverse Event|0|||
160849812|NCT03201419|580837922|FG008|Overall Study|Adverse Event|0|||
160849813|NCT03201419|580837914|FG000|Overall Study|Lost to Follow-up|1|||
160849814|NCT03201419|580837915|FG001|Overall Study|Lost to Follow-up|0|||
160849815|NCT03201419|580837916|FG002|Overall Study|Lost to Follow-up|0|||
160849816|NCT03201419|580837917|FG003|Overall Study|Lost to Follow-up|0|||
160849817|NCT03201419|580837918|FG004|Overall Study|Lost to Follow-up|0|||
160849818|NCT03201419|580837919|FG005|Overall Study|Lost to Follow-up|0|||
160849819|NCT03201419|580837920|FG006|Overall Study|Lost to Follow-up|0|||
160849820|NCT03201419|580837921|FG007|Overall Study|Lost to Follow-up|0|||
160849821|NCT03201419|580837922|FG008|Overall Study|Lost to Follow-up|0|||
160849822|NCT03201419|580837914|FG000|Overall Study|Protocol Deviation|0|||
160849823|NCT03201419|580837915|FG001|Overall Study|Protocol Deviation|0|||
160849824|NCT03201419|580837916|FG002|Overall Study|Protocol Deviation|0|||
160849825|NCT03201419|580837917|FG003|Overall Study|Protocol Deviation|0|||
160849826|NCT03201419|580837918|FG004|Overall Study|Protocol Deviation|0|||
160849827|NCT03201419|580837919|FG005|Overall Study|Protocol Deviation|0|||
160849828|NCT03201419|580837920|FG006|Overall Study|Protocol Deviation|1|||
160849829|NCT03201419|580837921|FG007|Overall Study|Protocol Deviation|0|||
160849830|NCT03201419|580837922|FG008|Overall Study|Protocol Deviation|0|||
160849831|NCT03201419|580837914|FG000|Overall Study|Withdrawal by Subject|4|||
161255059|NCT01588548|582312194|FG003|Overall Study|Condition Under Investigation Worsened|4|||
161255060|NCT01588548|582312195|FG004|Overall Study|Condition Under Investigation Worsened|3|||
161255061|NCT01588548|582312196|FG005|Overall Study|Condition Under Investigation Worsened|3|||
160849832|NCT03201419|580837915|FG001|Overall Study|Withdrawal by Subject|2|||
160849833|NCT03201419|580837916|FG002|Overall Study|Withdrawal by Subject|1|||
160849834|NCT03201419|580837917|FG003|Overall Study|Withdrawal by Subject|0|||
160849835|NCT03201419|580837918|FG004|Overall Study|Withdrawal by Subject|0|||
160849836|NCT03201419|580837919|FG005|Overall Study|Withdrawal by Subject|0|||
160849837|NCT03201419|580837920|FG006|Overall Study|Withdrawal by Subject|0|||
160849838|NCT03201419|580837921|FG007|Overall Study|Withdrawal by Subject|1|||
160849839|NCT03201419|580837922|FG008|Overall Study|Withdrawal by Subject|2|||
160849840|NCT03201419|580837914|FG000|Overall Study|Other|0|||
160849841|NCT03201419|580837915|FG001|Overall Study|Other|0|||
160849842|NCT03201419|580837916|FG002|Overall Study|Other|1|||
160849843|NCT03201419|580837917|FG003|Overall Study|Other|0|||
160849844|NCT03201419|580837918|FG004|Overall Study|Other|0|||
160849845|NCT03201419|580837919|FG005|Overall Study|Other|0|||
160849846|NCT03201419|580837920|FG006|Overall Study|Other|0|||
160849847|NCT03201419|580837921|FG007|Overall Study|Other|0|||
160849848|NCT03201419|580837922|FG008|Overall Study|Other|0|||
160849849|NCT04965688|580837928|FG000|Overall Study|Withdrawal by Subject|2|||
160849850|NCT00369577|580837929|FG000|Overall Study|Withdrawal by Subject|0|||
160849851|NCT00369577|580837930|FG001|Overall Study|Withdrawal by Subject|0|||
160849852|NCT00369577|580837931|FG002|Overall Study|Withdrawal by Subject|1|||
160849853|NCT00699660|580837932|FG000|Overall Study|Lost to Follow-up|4|||
160849854|NCT00699660|580837933|FG001|Overall Study|Lost to Follow-up|2|||
160849855|NCT00699660|580837932|FG000|Overall Study|missing reports and recording failures|10|||
160849856|NCT00699660|580837933|FG001|Overall Study|missing reports and recording failures|6|||
160849857|NCT03915470|580837934|FG000|Overall Study|Death|3|||
160849858|NCT03915470|580837935|FG001|Overall Study|Death|1|||
160849859|NCT03915470|580837934|FG000|Overall Study|Adverse Event|1|||
160849860|NCT03915470|580837935|FG001|Overall Study|Adverse Event|0|||
160849861|NCT03915470|580837934|FG000|Overall Study|Physician Decision|1|||
160849862|NCT03915470|580837935|FG001|Overall Study|Physician Decision|0|||
160849863|NCT03915470|580837934|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
160849864|NCT03915470|580837935|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
160849865|NCT03160898|580837936|FG000|Overall Study|Adverse Event|4|||
160849866|NCT03160898|580837937|FG001|Overall Study|Adverse Event|8|||
160849867|NCT03160898|580837938|FG002|Overall Study|Adverse Event|7|||
160849868|NCT03160898|580837939|FG003|Overall Study|Adverse Event|10|||
160849869|NCT03160898|580837936|FG000|Overall Study|Death|1|||
160849870|NCT03160898|580837937|FG001|Overall Study|Death|0|||
160849871|NCT03160898|580837938|FG002|Overall Study|Death|0|||
160849872|NCT03160898|580837939|FG003|Overall Study|Death|1|||
160849873|NCT03160898|580837936|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
160849874|NCT03160898|580837937|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
160849875|NCT03160898|580837938|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
160849876|NCT03160898|580837939|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
160849877|NCT03160898|580837936|FG000|Overall Study|Lost to Follow-up|1|||
160849878|NCT03160898|580837937|FG001|Overall Study|Lost to Follow-up|1|||
160849879|NCT03160898|580837938|FG002|Overall Study|Lost to Follow-up|1|||
160849880|NCT03160898|580837939|FG003|Overall Study|Lost to Follow-up|2|||
160849881|NCT03160898|580837936|FG000|Overall Study|Physician Decision|1|||
160849882|NCT03160898|580837937|FG001|Overall Study|Physician Decision|0|||
160849883|NCT03160898|580837938|FG002|Overall Study|Physician Decision|0|||
160849884|NCT03160898|580837939|FG003|Overall Study|Physician Decision|1|||
160849885|NCT03160898|580837936|FG000|Overall Study|Progressive Disease|4|||
160849886|NCT03160898|580837937|FG001|Overall Study|Progressive Disease|1|||
160849887|NCT03160898|580837938|FG002|Overall Study|Progressive Disease|2|||
160849888|NCT03160898|580837939|FG003|Overall Study|Progressive Disease|1|||
160849889|NCT03160898|580837936|FG000|Overall Study|Protocol Violation|1|||
160849890|NCT03160898|580837937|FG001|Overall Study|Protocol Violation|0|||
160849891|NCT03160898|580837938|FG002|Overall Study|Protocol Violation|2|||
160849892|NCT03160898|580837939|FG003|Overall Study|Protocol Violation|0|||
160849893|NCT03160898|580837936|FG000|Overall Study|Sponsor Discretion|2|||
160849894|NCT03160898|580837937|FG001|Overall Study|Sponsor Discretion|0|||
160849895|NCT03160898|580837938|FG002|Overall Study|Sponsor Discretion|0|||
160849896|NCT03160898|580837939|FG003|Overall Study|Sponsor Discretion|0|||
160849897|NCT03160898|580837936|FG000|Overall Study|Withdrawal by Subject|1|||
160849898|NCT03160898|580837937|FG001|Overall Study|Withdrawal by Subject|3|||
160849899|NCT03160898|580837938|FG002|Overall Study|Withdrawal by Subject|2|||
160849900|NCT03160898|580837939|FG003|Overall Study|Withdrawal by Subject|1|||
160849901|NCT03160898|580837936|FG000|Overall Study|Other|2|||
160849902|NCT03160898|580837937|FG001|Overall Study|Other|0|||
160849903|NCT03160898|580837938|FG002|Overall Study|Other|2|||
160849904|NCT03160898|580837939|FG003|Overall Study|Other|2|||
160849905|NCT03405818|580837942|FG000|Overall Study|Withdrawal by Subject|4|||
161255062|NCT01835548|582312199|FG000|Dose Optimization Period|Adverse Event|0|||
161255063|NCT01835548|582312200|FG001|Dose Optimization Period|Adverse Event|0|||
161255064|NCT01835548|582312201|FG002|Dose Optimization Period|Adverse Event|1|||
161255065|NCT01835548|582312199|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
160849906|NCT03405818|580837942|FG000|Overall Study|Lost to Follow-up|4|||
160849907|NCT00434109|580837943|FG000|Overall Study|Physician Decision|9|||
160849908|NCT00434109|580837943|FG000|Overall Study|Adverse Event|5|||
160849909|NCT00434109|580837943|FG000|Overall Study|Protocol Violation|1|||
160849910|NCT00434109|580837943|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
160849911|NCT04186871|580837944|FG000|Overall Study|Lack of Efficacy|0|||
160849912|NCT04186871|580837945|FG001|Overall Study|Lack of Efficacy|1|||
160849913|NCT04186871|580837946|FG002|Overall Study|Lack of Efficacy|0|||
160849914|NCT04186871|580837947|FG003|Overall Study|Lack of Efficacy|0|||
160849915|NCT04186871|580837948|FG004|Overall Study|Lack of Efficacy|1|||
160849916|NCT04186871|580837949|FG005|Overall Study|Lack of Efficacy|1|||
160849917|NCT04186871|580837944|FG000|Overall Study|Adverse Event|1|||
160849918|NCT04186871|580837945|FG001|Overall Study|Adverse Event|1|||
160849919|NCT04186871|580837946|FG002|Overall Study|Adverse Event|0|||
160849920|NCT04186871|580837947|FG003|Overall Study|Adverse Event|0|||
160849921|NCT04186871|580837948|FG004|Overall Study|Adverse Event|0|||
160849922|NCT04186871|580837949|FG005|Overall Study|Adverse Event|2|||
160849923|NCT04186871|580837944|FG000|Overall Study|Study terminated by sponsor|1|||
160849924|NCT04186871|580837945|FG001|Overall Study|Study terminated by sponsor|2|||
160849925|NCT04186871|580837946|FG002|Overall Study|Study terminated by sponsor|0|||
160849926|NCT04186871|580837947|FG003|Overall Study|Study terminated by sponsor|1|||
160849927|NCT04186871|580837948|FG004|Overall Study|Study terminated by sponsor|0|||
160849928|NCT04186871|580837949|FG005|Overall Study|Study terminated by sponsor|0|||
160849929|NCT04186871|580837944|FG000|Overall Study|Other reasons|0|||
160849930|NCT04186871|580837945|FG001|Overall Study|Other reasons|0|||
160849931|NCT04186871|580837946|FG002|Overall Study|Other reasons|0|||
161255066|NCT01835548|582312200|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
161255067|NCT01835548|582312201|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
161255068|NCT01835548|582312199|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161255069|NCT01835548|582312200|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161255070|NCT01835548|582312201|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161255071|NCT01835548|582312199|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161255072|NCT01835548|582312200|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161255073|NCT01835548|582312201|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161255074|NCT01634854|582312202|FG000|Overall Study|Cesarean delivery|2|||
161255075|NCT01634854|582312203|FG001|Overall Study|Cesarean delivery|7|||
160849932|NCT04186871|580837947|FG003|Overall Study|Other reasons|0|||
160849933|NCT04186871|580837948|FG004|Overall Study|Other reasons|0|||
160849934|NCT04186871|580837949|FG005|Overall Study|Other reasons|1|||
160849935|NCT04186871|580837944|FG000|Overall Study|Withdrawal by Subject|0|||
160849936|NCT04186871|580837945|FG001|Overall Study|Withdrawal by Subject|0|||
160849937|NCT04186871|580837946|FG002|Overall Study|Withdrawal by Subject|0|||
160849938|NCT04186871|580837947|FG003|Overall Study|Withdrawal by Subject|0|||
160849939|NCT04186871|580837948|FG004|Overall Study|Withdrawal by Subject|0|||
160849940|NCT04186871|580837949|FG005|Overall Study|Withdrawal by Subject|1|||
160849941|NCT04186871|580837944|FG000|Overall Study|Lost to Follow-up|0|||
160849942|NCT04186871|580837945|FG001|Overall Study|Lost to Follow-up|0|||
160849943|NCT04186871|580837946|FG002|Overall Study|Lost to Follow-up|0|||
160849944|NCT04186871|580837947|FG003|Overall Study|Lost to Follow-up|0|||
160849945|NCT04186871|580837948|FG004|Overall Study|Lost to Follow-up|0|||
160849946|NCT04186871|580837949|FG005|Overall Study|Lost to Follow-up|1|||
160849947|NCT01467505|580839455|FG000|Overall Study|Adverse Event|1|||
160849948|NCT01467505|580839456|FG001|Overall Study|Adverse Event|0|||
160849949|NCT01467505|580839455|FG000|Overall Study|Withdrawal by Subject|4|||
160849950|NCT01467505|580839456|FG001|Overall Study|Withdrawal by Subject|0|||
160849951|NCT01467505|580839455|FG000|Overall Study|Study Terminated by Sponsor|28|||
160849952|NCT01467505|580839456|FG001|Overall Study|Study Terminated by Sponsor|3|||
160849953|NCT00227721|580839457|FG000|Overall Study|On study, but never treated.|1|||
160849954|NCT00984256|580839461|FG000|Overall Study|Withdrawal by Subject|0|||
160849955|NCT00984256|580839462|FG001|Overall Study|Withdrawal by Subject|1|||
160849956|NCT03529110|580839468|FG000|Overall Study|Progressive Disease|66|||
160849957|NCT03529110|580839469|FG001|Overall Study|Progressive Disease|158|||
160849958|NCT03529110|580839468|FG000|Overall Study|Clinical Progression|4|||
160849959|NCT03529110|580839469|FG001|Overall Study|Clinical Progression|12|||
160849960|NCT03529110|580839468|FG000|Overall Study|Adverse Event|35|||
160849961|NCT03529110|580839469|FG001|Overall Study|Adverse Event|17|||
160849962|NCT03529110|580839468|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
160849963|NCT03529110|580839469|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
160849964|NCT03529110|580839468|FG000|Overall Study|Lack of Efficacy|3|||
160849965|NCT03529110|580839469|FG001|Overall Study|Lack of Efficacy|3|||
160849966|NCT03529110|580839468|FG000|Overall Study|Physician Decision|2|||
160849967|NCT03529110|580839469|FG001|Overall Study|Physician Decision|8|||
160849968|NCT03529110|580839468|FG000|Overall Study|Miscellaneous|2|||
160849969|NCT03529110|580839469|FG001|Overall Study|Miscellaneous|5|||
160849970|NCT03493945|580839470|FG000|Phase I Dose Escalation|Ineligible|0|||
160849971|NCT03493945|580839471|FG001|Phase I Dose Escalation|Ineligible|0|||
160849972|NCT03493945|580839472|FG002|Phase I Dose Escalation|Ineligible|1|||
161255076|NCT02490800|582312204|FG000|Overall Study|Adverse Event|0|||
161255077|NCT02490800|582312205|FG001|Overall Study|Adverse Event|0|||
161255078|NCT02490800|582312206|FG002|Overall Study|Adverse Event|0|||
161255079|NCT02490800|582312207|FG003|Overall Study|Adverse Event|2|||
160849973|NCT03493945|580839473|FG003|Phase I Dose Escalation|Ineligible|0|||
160849974|NCT03493945|580839474|FG004|Phase I Dose Escalation|Ineligible|0|||
160906656|NCT00913497|581052263|FG000|Overall Study|Withdrawal by Subject|2|||
160906657|NCT01306942|581052264|FG000|Phase I|Adverse Event|2|||
160906658|NCT01306942|581052265|FG001|Phase I|Adverse Event|2|||
160906659|NCT01306942|581052266|FG002|Phase I|Adverse Event|0|||
160906660|NCT01306942|581052267|FG003|Phase I|Adverse Event|0|||
160906661|NCT01306942|581052264|FG000|Phase I|Physician Decision|3|||
161255080|NCT02490800|582312208|FG004|Overall Study|Adverse Event|3|||
160906662|NCT01306942|581052265|FG001|Phase I|Physician Decision|1|||
161255081|NCT02490800|582312209|FG005|Overall Study|Adverse Event|2|||
161255082|NCT02490800|582312210|FG006|Overall Study|Adverse Event|0|||
160849975|NCT03493945|580839475|FG005|Phase I Dose Escalation|Ineligible|0|||
160849976|NCT03493945|580839476|FG006|Phase I Dose Escalation|Ineligible|0|||
160849977|NCT03493945|580839470|FG000|Phase I Dose Escalation|New therapy|0|||
160849978|NCT03493945|580839471|FG001|Phase I Dose Escalation|New therapy|1|||
160849979|NCT03493945|580839472|FG002|Phase I Dose Escalation|New therapy|0|||
160849980|NCT03493945|580839473|FG003|Phase I Dose Escalation|New therapy|0|||
160849981|NCT03493945|580839474|FG004|Phase I Dose Escalation|New therapy|0|||
160849982|NCT03493945|580839475|FG005|Phase I Dose Escalation|New therapy|0|||
160849983|NCT03493945|580839476|FG006|Phase I Dose Escalation|New therapy|0|||
161255083|NCT02490800|582312211|FG007|Overall Study|Adverse Event|0|||
160849984|NCT03493945|580839470|FG000|Phase II Dose Expansion|Refused further treatment|0|||
160849985|NCT03493945|580839471|FG001|Phase II Dose Expansion|Refused further treatment|0|||
160849986|NCT03493945|580839472|FG002|Phase II Dose Expansion|Refused further treatment|0|||
161255084|NCT02490800|582312212|FG008|Overall Study|Adverse Event|0|||
161255085|NCT02490800|582312213|FG009|Overall Study|Adverse Event|0|||
160849987|NCT03493945|580839473|FG003|Phase II Dose Expansion|Refused further treatment|0|||
160849988|NCT03493945|580839474|FG004|Phase II Dose Expansion|Refused further treatment|1|||
160849989|NCT03493945|580839475|FG005|Phase II Dose Expansion|Refused further treatment|1|||
160849990|NCT03493945|580839476|FG006|Phase II Dose Expansion|Refused further treatment|0|||
160849991|NCT03493945|580839470|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849992|NCT03493945|580839471|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849993|NCT03493945|580839472|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849994|NCT03493945|580839473|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
160849995|NCT03493945|580839474|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849996|NCT03493945|580839475|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849997|NCT03493945|580839476|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
160849998|NCT05104450|580839477|FG000|Overall Study|Death|1|||
160849999|NCT05104450|580839478|FG001|Overall Study|Death|2|||
160850000|NCT05104450|580839477|FG000|Overall Study|Withdrawal by Subject|3|||
160850001|NCT05104450|580839478|FG001|Overall Study|Withdrawal by Subject|1|||
160906663|NCT01306942|581052266|FG002|Phase I|Physician Decision|0|||
160906664|NCT01306942|581052267|FG003|Phase I|Physician Decision|0|||
160906665|NCT01306942|581052264|FG000|Phase II|Adverse Event|0|||
160850002|NCT01584232|580839479|FG000|Overall Study|Adverse Event|3|||
161255086|NCT02490800|582312214|FG010|Overall Study|Adverse Event|0|||
161255087|NCT02490800|582312215|FG011|Overall Study|Adverse Event|2|||
161255088|NCT02490800|582312216|FG012|Overall Study|Adverse Event|2|||
161255089|NCT02490800|582312204|FG000|Overall Study|Withdrawal by Subject|0|||
161255090|NCT02490800|582312205|FG001|Overall Study|Withdrawal by Subject|0|||
161255091|NCT02490800|582312206|FG002|Overall Study|Withdrawal by Subject|0|||
161255092|NCT02490800|582312207|FG003|Overall Study|Withdrawal by Subject|1|||
161255093|NCT02490800|582312208|FG004|Overall Study|Withdrawal by Subject|0|||
161255094|NCT02490800|582312209|FG005|Overall Study|Withdrawal by Subject|0|||
161255095|NCT02490800|582312210|FG006|Overall Study|Withdrawal by Subject|0|||
161255096|NCT02490800|582312211|FG007|Overall Study|Withdrawal by Subject|0|||
161255097|NCT02490800|582312212|FG008|Overall Study|Withdrawal by Subject|1|||
161255098|NCT02490800|582312213|FG009|Overall Study|Withdrawal by Subject|0|||
161255099|NCT02490800|582312214|FG010|Overall Study|Withdrawal by Subject|0|||
161255100|NCT02490800|582312215|FG011|Overall Study|Withdrawal by Subject|0|||
161255101|NCT02490800|582312216|FG012|Overall Study|Withdrawal by Subject|0|||
161255102|NCT02490800|582312204|FG000|Overall Study|Progressive disease|3|||
161255103|NCT02490800|582312205|FG001|Overall Study|Progressive disease|3|||
161255104|NCT02490800|582312206|FG002|Overall Study|Progressive disease|3|||
161255105|NCT02490800|582312207|FG003|Overall Study|Progressive disease|4|||
161255106|NCT02490800|582312208|FG004|Overall Study|Progressive disease|4|||
160906666|NCT01306942|581052265|FG001|Phase II|Adverse Event|0|||
160906667|NCT01306942|581052266|FG002|Phase II|Adverse Event|0|||
160906668|NCT01306942|581052267|FG003|Phase II|Adverse Event|6|||
160906669|NCT01306942|581052264|FG000|Phase II|Physician Decision|2|||
160906670|NCT01306942|581052265|FG001|Phase II|Physician Decision|0|||
160906671|NCT01306942|581052266|FG002|Phase II|Physician Decision|0|||
160906672|NCT01306942|581052267|FG003|Phase II|Physician Decision|5|||
160906673|NCT01306942|581052264|FG000|Phase II|Withdrawal by Subject|0|||
160906674|NCT01306942|581052265|FG001|Phase II|Withdrawal by Subject|0|||
160906675|NCT01306942|581052266|FG002|Phase II|Withdrawal by Subject|0|||
160906676|NCT01306942|581052267|FG003|Phase II|Withdrawal by Subject|2|||
160906677|NCT01306942|581052264|FG000|Phase II|Death|0|||
160906678|NCT01306942|581052265|FG001|Phase II|Death|0|||
160906679|NCT01306942|581052266|FG002|Phase II|Death|0|||
160906680|NCT01306942|581052267|FG003|Phase II|Death|1|||
160906681|NCT01306942|581052264|FG000|Phase II|Not finished treatment|0|||
160906682|NCT01306942|581052265|FG001|Phase II|Not finished treatment|0|||
161255107|NCT02490800|582312209|FG005|Overall Study|Progressive disease|1|||
161255108|NCT02490800|582312210|FG006|Overall Study|Progressive disease|4|||
161255109|NCT02490800|582312211|FG007|Overall Study|Progressive disease|3|||
160906683|NCT01306942|581052266|FG002|Phase II|Not finished treatment|0|||
160906684|NCT01306942|581052267|FG003|Phase II|Not finished treatment|1|||
160906685|NCT01306942|581052264|FG000|Phase II|Protocol Violation|0|||
160906686|NCT01306942|581052265|FG001|Phase II|Protocol Violation|0|||
160906687|NCT01306942|581052266|FG002|Phase II|Protocol Violation|0|||
160906688|NCT01306942|581052267|FG003|Phase II|Protocol Violation|1|||
160992503|NCT03999554|581361387|FG002|Overall Study|Lost to Follow-up|4|||
161255110|NCT02490800|582312212|FG008|Overall Study|Progressive disease|6|||
161255111|NCT02490800|582312213|FG009|Overall Study|Progressive disease|2|||
161255112|NCT02490800|582312214|FG010|Overall Study|Progressive disease|7|||
160906689|NCT03190915|581052268|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
161255113|NCT02490800|582312215|FG011|Overall Study|Progressive disease|1|||
161255114|NCT02490800|582312216|FG012|Overall Study|Progressive disease|10|||
161255115|NCT02490800|582312204|FG000|Overall Study|Patient enrolled in post-trial access|0|||
161255116|NCT02490800|582312205|FG001|Overall Study|Patient enrolled in post-trial access|0|||
161255117|NCT02490800|582312206|FG002|Overall Study|Patient enrolled in post-trial access|0|||
161255118|NCT02490800|582312207|FG003|Overall Study|Patient enrolled in post-trial access|0|||
161255119|NCT02490800|582312208|FG004|Overall Study|Patient enrolled in post-trial access|0|||
161255120|NCT02490800|582312209|FG005|Overall Study|Patient enrolled in post-trial access|0|||
161255121|NCT02490800|582312210|FG006|Overall Study|Patient enrolled in post-trial access|0|||
161255122|NCT02490800|582312211|FG007|Overall Study|Patient enrolled in post-trial access|0|||
161255123|NCT02490800|582312212|FG008|Overall Study|Patient enrolled in post-trial access|0|||
161255124|NCT02490800|582312213|FG009|Overall Study|Patient enrolled in post-trial access|1|||
161255125|NCT02490800|582312214|FG010|Overall Study|Patient enrolled in post-trial access|1|||
161255126|NCT02490800|582312215|FG011|Overall Study|Patient enrolled in post-trial access|0|||
161255127|NCT02490800|582312216|FG012|Overall Study|Patient enrolled in post-trial access|6|||
161255128|NCT01169038|582312217|FG000|Overall Study|Death|1|||
161255129|NCT01169038|582312217|FG000|Overall Study|Adverse Event|5|||
161255130|NCT01169038|582312217|FG000|Overall Study|Required antibiotic administration|1|||
161255131|NCT03257254|582312218|FG000|Overall Study|Withdrawal by Subject|7|||
161255132|NCT03257254|582312218|FG000|Overall Study|Lost to Follow-up|9|||
161255133|NCT03257254|582312218|FG000|Overall Study|Study discontinued by sponsor|5|||
161255134|NCT02219308|582312219|FG000|Overall Study|Withdrawal by Subject|1|||
161255135|NCT02219308|582312220|FG001|Overall Study|Withdrawal by Subject|2|||
161255136|NCT03581188|582314119|FG000|Overall Study|Inclusion criteria not met|3|||
161255137|NCT03581188|582314120|FG001|Overall Study|Inclusion criteria not met|2|||
161255138|NCT03581188|582314119|FG000|Overall Study|Lost to Follow-up|5|||
161255139|NCT03581188|582314120|FG001|Overall Study|Lost to Follow-up|5|||
161255140|NCT03581188|582314119|FG000|Overall Study|Discontinued intervention|11|||
161255141|NCT03581188|582314120|FG001|Overall Study|Discontinued intervention|8|||
161255142|NCT00109837|582314123|FG000|Overall Study|Adverse Event|2|||
161255143|NCT00109837|582314123|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
161255144|NCT00109837|582314123|FG000|Overall Study|Death|1|||
161255145|NCT00109837|582314123|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
161255146|NCT00109837|582314123|FG000|Overall Study|Not treated|1|||
161255147|NCT00109837|582314123|FG000|Overall Study|Ineligible|1|||
160850003|NCT01584232|580839480|FG001|Overall Study|Adverse Event|1|||
160850004|NCT01584232|580839479|FG000|Overall Study|Withdrawal by Subject|2|||
160850005|NCT01584232|580839480|FG001|Overall Study|Withdrawal by Subject|1|||
160850006|NCT01584232|580839479|FG000|Overall Study|Physician Decision|2|||
160850007|NCT01584232|580839480|FG001|Overall Study|Physician Decision|1|||
160850008|NCT01584232|580839479|FG000|Overall Study|Lost to Follow-up|1|||
161255148|NCT01989676|582314124|FG000|Overall Study|Death|52|||
161255149|NCT01989676|582314125|FG001|Overall Study|Death|60|||
161255150|NCT01989676|582314124|FG000|Overall Study|Protocol Violation|2|||
161255151|NCT01989676|582314125|FG001|Overall Study|Protocol Violation|1|||
161255152|NCT01989676|582314124|FG000|Overall Study|Lost to Follow-up|8|||
161255153|NCT01989676|582314125|FG001|Overall Study|Lost to Follow-up|18|||
161255154|NCT01989676|582314124|FG000|Overall Study|No longer willing to participate in study|26|||
161255155|NCT01989676|582314125|FG001|Overall Study|No longer willing to participate in study|26|||
161255156|NCT01989676|582314124|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
161255157|NCT01989676|582314125|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
161255158|NCT01989676|582314124|FG000|Overall Study|Other|4|||
161255159|NCT01989676|582314125|FG001|Overall Study|Other|3|||
161255160|NCT01619579|582314126|FG000|Overall Study|Withdrawal by Subject|0|||
161255161|NCT01619579|582314127|FG001|Overall Study|Withdrawal by Subject|3|||
161255162|NCT02190279|582314129|FG000|Overall Study|Withdrawal consent|1|||
161255163|NCT02190279|582314130|FG001|Overall Study|Withdrawal consent|0|||
161255164|NCT02190279|582314131|FG002|Overall Study|Withdrawal consent|1|||
161255165|NCT02190279|582314129|FG000|Overall Study|Lost to Follow-up|2|||
161255166|NCT02190279|582314130|FG001|Overall Study|Lost to Follow-up|0|||
161255167|NCT02190279|582314131|FG002|Overall Study|Lost to Follow-up|0|||
161255168|NCT02190279|582314129|FG000|Overall Study|Refused further treatment|0|||
161255169|NCT02190279|582314130|FG001|Overall Study|Refused further treatment|0|||
160850009|NCT01584232|580839480|FG001|Overall Study|Lost to Follow-up|0|||
160850010|NCT01307319|580839481|FG000|Overall Study|Adverse Event|2|||
160850011|NCT01307319|580839482|FG001|Overall Study|Adverse Event|2|||
160850012|NCT01307319|580839483|FG002|Overall Study|Adverse Event|1|||
160850013|NCT01307319|580839481|FG000|Overall Study|Lost to Follow-up|1|||
161255170|NCT02190279|582314131|FG002|Overall Study|Refused further treatment|1|||
161255171|NCT02190279|582314129|FG000|Overall Study|Screening failure|0|||
161255172|NCT02190279|582314130|FG001|Overall Study|Screening failure|0|||
161255173|NCT02190279|582314131|FG002|Overall Study|Screening failure|1|||
161255174|NCT02688387|582314132|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255175|NCT02688387|582314133|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255176|NCT02688387|582314134|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
161255177|NCT02688387|582314135|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255178|NCT02688387|582314136|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255179|NCT02688387|582314137|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255180|NCT02688387|582314138|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255181|NCT02688387|582314139|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255182|NCT02688387|582314140|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255183|NCT02688387|582314141|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255184|NCT02688387|582314142|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255185|NCT02688387|582314143|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255186|NCT02688387|582314144|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255187|NCT02688387|582314145|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255188|NCT02688387|582314146|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255189|NCT02688387|582314147|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255190|NCT02688387|582314148|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255191|NCT02688387|582314149|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161337139|NCT00853385|582625843|FG000|Overall Study|Adverse Event|24|||
160850014|NCT01307319|580839482|FG001|Overall Study|Lost to Follow-up|0|||
160850015|NCT01307319|580839483|FG002|Overall Study|Lost to Follow-up|1|||
160850016|NCT01307319|580839481|FG000|Overall Study|Protocol Violation|1|||
160850017|NCT01307319|580839482|FG001|Overall Study|Protocol Violation|1|||
160850018|NCT01307319|580839483|FG002|Overall Study|Protocol Violation|0|||
160850019|NCT01307319|580839481|FG000|Overall Study|Withdrawal by Subject|0|||
160850020|NCT01307319|580839482|FG001|Overall Study|Withdrawal by Subject|1|||
160850021|NCT01307319|580839483|FG002|Overall Study|Withdrawal by Subject|2|||
160850022|NCT01307319|580839481|FG000|Overall Study|Other|0|||
160850023|NCT01307319|580839482|FG001|Overall Study|Other|4|||
160850024|NCT01307319|580839483|FG002|Overall Study|Other|3|||
160850025|NCT02735239|580839485|FG000|Overall Study|Adverse Event|0|||
160850026|NCT02735239|580839486|FG001|Overall Study|Adverse Event|0|||
160850027|NCT02735239|580839487|FG002|Overall Study|Adverse Event|4|||
160850028|NCT02735239|580839488|FG003|Overall Study|Adverse Event|0|||
160850029|NCT02735239|580839489|FG004|Overall Study|Adverse Event|0|||
160850030|NCT02735239|580839490|FG005|Overall Study|Adverse Event|0|||
160850031|NCT02735239|580839485|FG000|Overall Study|Death|1|||
160850032|NCT02735239|580839486|FG001|Overall Study|Death|1|||
160850033|NCT02735239|580839487|FG002|Overall Study|Death|0|||
160850034|NCT02735239|580839488|FG003|Overall Study|Death|0|||
160850035|NCT02735239|580839489|FG004|Overall Study|Death|0|||
160850036|NCT02735239|580839490|FG005|Overall Study|Death|0|||
160850037|NCT02735239|580839485|FG000|Overall Study|Physician Decision|0|||
160850038|NCT02735239|580839486|FG001|Overall Study|Physician Decision|0|||
160850039|NCT02735239|580839487|FG002|Overall Study|Physician Decision|1|||
160850040|NCT02735239|580839488|FG003|Overall Study|Physician Decision|0|||
160850041|NCT02735239|580839489|FG004|Overall Study|Physician Decision|0|||
160850042|NCT02735239|580839490|FG005|Overall Study|Physician Decision|0|||
160850043|NCT02735239|580839485|FG000|Overall Study|Progressive disease|3|||
160850044|NCT02735239|580839486|FG001|Overall Study|Progressive disease|1|||
160850045|NCT02735239|580839487|FG002|Overall Study|Progressive disease|3|||
160850046|NCT02735239|580839488|FG003|Overall Study|Progressive disease|0|||
160850047|NCT02735239|580839489|FG004|Overall Study|Progressive disease|0|||
160850048|NCT02735239|580839490|FG005|Overall Study|Progressive disease|2|||
160850049|NCT02735239|580839485|FG000|Overall Study|Withdrawal by Subject|0|||
160850050|NCT02735239|580839486|FG001|Overall Study|Withdrawal by Subject|1|||
160850051|NCT02735239|580839487|FG002|Overall Study|Withdrawal by Subject|0|||
160850052|NCT02735239|580839488|FG003|Overall Study|Withdrawal by Subject|0|||
160850053|NCT02735239|580839489|FG004|Overall Study|Withdrawal by Subject|0|||
160850054|NCT02735239|580839490|FG005|Overall Study|Withdrawal by Subject|0|||
160850055|NCT02152631|580839496|FG000|Overall Study|Adverse Event|32|||
160850056|NCT02152631|580839497|FG001|Overall Study|Adverse Event|4|||
160850057|NCT02152631|580839496|FG000|Overall Study|Withdrawal by Subject|13|||
160850058|NCT02152631|580839497|FG001|Overall Study|Withdrawal by Subject|16|||
160850059|NCT02152631|580839496|FG000|Overall Study|Noncompliance with study drug|1|||
160850060|NCT02152631|580839497|FG001|Overall Study|Noncompliance with study drug|0|||
160850061|NCT02152631|580839496|FG000|Overall Study|Physician Decision|1|||
160850062|NCT02152631|580839497|FG001|Overall Study|Physician Decision|2|||
160850063|NCT02152631|580839496|FG000|Overall Study|Lost to Follow-up|0|||
160850064|NCT02152631|580839497|FG001|Overall Study|Lost to Follow-up|1|||
160850065|NCT02152631|580839496|FG000|Overall Study|On Treatment|19|||
160850066|NCT02152631|580839497|FG001|Overall Study|On Treatment|3|||
160850067|NCT00404651|580839503|FG000|Overall Study|Serious Adverse Event|0|||
160850068|NCT00404651|580839504|FG001|Overall Study|Serious Adverse Event|0|||
160850069|NCT00404651|580839505|FG002|Overall Study|Serious Adverse Event|2|||
161337140|NCT00853385|582625844|FG001|Overall Study|Adverse Event|24|||
160850070|NCT00404651|580839506|FG003|Overall Study|Serious Adverse Event|0|||
160850071|NCT00404651|580839503|FG000|Overall Study|Protocol Violation|10|||
161337141|NCT00853385|582625845|FG002|Overall Study|Adverse Event|2|||
160850072|NCT00404651|580839504|FG001|Overall Study|Protocol Violation|5|||
160850073|NCT00404651|580839505|FG002|Overall Study|Protocol Violation|14|||
160850074|NCT00404651|580839506|FG003|Overall Study|Protocol Violation|5|||
160850075|NCT00404651|580839503|FG000|Overall Study|Lost to Follow-up|15|||
160850076|NCT00404651|580839504|FG001|Overall Study|Lost to Follow-up|11|||
160850077|NCT00404651|580839505|FG002|Overall Study|Lost to Follow-up|13|||
160850078|NCT00404651|580839506|FG003|Overall Study|Lost to Follow-up|10|||
160850079|NCT00404651|580839503|FG000|Overall Study|Withdrawal by Subject|14|||
160850080|NCT00404651|580839504|FG001|Overall Study|Withdrawal by Subject|12|||
160850081|NCT00404651|580839505|FG002|Overall Study|Withdrawal by Subject|16|||
160850082|NCT00404651|580839506|FG003|Overall Study|Withdrawal by Subject|6|||
160850083|NCT01121146|580839515|FG000|Overall Study|Death|17|||
160850084|NCT01121146|580839516|FG001|Overall Study|Death|15|||
160850085|NCT01121146|580839515|FG000|Overall Study|Adverse Event|2|||
160850086|NCT01121146|580839516|FG001|Overall Study|Adverse Event|11|||
160850087|NCT01121146|580839515|FG000|Overall Study|Lost to Follow-up|7|||
160850088|NCT01121146|580839516|FG001|Overall Study|Lost to Follow-up|16|||
160850089|NCT03922581|580839525|FG000|Overall Study|Lost to Follow-up|20|||
160850090|NCT03922581|580839526|FG001|Overall Study|Lost to Follow-up|9|||
160850091|NCT03922581|580839525|FG000|Overall Study|Physician Decision|1|||
160850092|NCT03922581|580839526|FG001|Overall Study|Physician Decision|1|||
160850093|NCT03922581|580839525|FG000|Overall Study|Withdrawal by Subject|1|||
160850094|NCT03922581|580839526|FG001|Overall Study|Withdrawal by Subject|0|||
160850095|NCT00764699|580839529|FG000|Overall Study|PI left and study terminated|3|||
160850096|NCT02223715|580839535|FG000|Overall Study|Death|31|||
160850097|NCT02223715|580839535|FG000|Overall Study|Lost to Follow-up|73|||
160850098|NCT01745367|580839536|FG000|Overall Study|Death|1|||
160850099|NCT01745367|580839537|FG001|Overall Study|Death|0|||
160850100|NCT01745367|580839536|FG000|Overall Study|Withdrawal by Subject|1|||
160850101|NCT01745367|580839537|FG001|Overall Study|Withdrawal by Subject|2|||
160850102|NCT01745367|580839536|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
160850103|NCT01745367|580839537|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
160850104|NCT01745367|580839536|FG000|Overall Study|Other Reasons Unspecified|0|||
160850105|NCT01745367|580839537|FG001|Overall Study|Other Reasons Unspecified|2|||
160850106|NCT00965081|580839539|FG000|Overall Study|Adverse Event|14|||
160850107|NCT00965081|580839540|FG001|Overall Study|Adverse Event|9|||
160850108|NCT00965081|580839539|FG000|Overall Study|Lack of Efficacy|2|||
160850109|NCT00965081|580839540|FG001|Overall Study|Lack of Efficacy|5|||
160850110|NCT00965081|580839539|FG000|Overall Study|Lost to Follow-up|4|||
160850111|NCT00965081|580839540|FG001|Overall Study|Lost to Follow-up|5|||
160850112|NCT00965081|580839539|FG000|Overall Study|Physician Decision|2|||
160850113|NCT00965081|580839540|FG001|Overall Study|Physician Decision|0|||
160850114|NCT00965081|580839539|FG000|Overall Study|Protocol Violation|2|||
160850115|NCT00965081|580839540|FG001|Overall Study|Protocol Violation|5|||
160850116|NCT00965081|580839539|FG000|Overall Study|Sponsor Decision|1|||
160850117|NCT00965081|580839540|FG001|Overall Study|Sponsor Decision|0|||
160850118|NCT00965081|580839539|FG000|Overall Study|Withdrawal by Subject|4|||
160850119|NCT00965081|580839540|FG001|Overall Study|Withdrawal by Subject|7|||
160850120|NCT00965081|580839539|FG000|Overall Study|Switched to Rescue Arm|5|||
160850121|NCT00965081|580839540|FG001|Overall Study|Switched to Rescue Arm|12|||
160850122|NCT01020786|580839543|FG000|Induction Period|Entry Criteria Not Met|2|||
160850123|NCT01020786|580839543|FG000|Induction Period|Adverse Event|10|||
160850124|NCT01020786|580839543|FG000|Induction Period|Progressive Disease|31|||
160850125|NCT01020786|580839543|FG000|Induction Period|Investigator Decision|3|||
160850126|NCT01020786|580839543|FG000|Induction Period|Withdrawal by Subject|3|||
160850127|NCT01020786|580839543|FG000|Maintenance Period|Adverse Event|8|||
160850128|NCT01020786|580839543|FG000|Maintenance Period|Progressive Disease|43|||
160850129|NCT01020786|580839543|FG000|Maintenance Period|Withdrawal by Subject|8|||
160850130|NCT01020786|580839543|FG000|Maintenance Period|Sponsor Decision|1|||
160850131|NCT02292719|580839546|FG000|Overall Study|Withdrawal by Subject|0|||
160850132|NCT02292719|580839547|FG001|Overall Study|Withdrawal by Subject|0|||
160850133|NCT02292719|580839548|FG002|Overall Study|Withdrawal by Subject|0|||
160850134|NCT02292719|580839549|FG003|Overall Study|Withdrawal by Subject|1|||
160850135|NCT02292719|580839550|FG004|Overall Study|Withdrawal by Subject|1|||
160850136|NCT02292719|580839551|FG005|Overall Study|Withdrawal by Subject|0|||
160850137|NCT02292719|580839546|FG000|Overall Study|Subject enrolled in new study.|0|||
160850138|NCT02292719|580839547|FG001|Overall Study|Subject enrolled in new study.|0|||
160850139|NCT02292719|580839548|FG002|Overall Study|Subject enrolled in new study.|1|||
160850140|NCT02292719|580839549|FG003|Overall Study|Subject enrolled in new study.|0|||
160850141|NCT02292719|580839550|FG004|Overall Study|Subject enrolled in new study.|0|||
160850142|NCT02292719|580839551|FG005|Overall Study|Subject enrolled in new study.|0|||
160850143|NCT04170543|580839557|FG000|Overall Study|Death|1|||
160850144|NCT04170543|580839558|FG001|Overall Study|Death|1|||
160850145|NCT04170543|580839559|FG002|Overall Study|Death|1|||
160850146|NCT04170543|580839560|FG003|Overall Study|Death|1|||
160850147|NCT04170543|580839561|FG004|Overall Study|Death|1|||
160850148|NCT04170543|580839557|FG000|Overall Study|Lost to Follow-up|3|||
160850149|NCT04170543|580839558|FG001|Overall Study|Lost to Follow-up|3|||
160850150|NCT04170543|580839559|FG002|Overall Study|Lost to Follow-up|0|||
160850151|NCT04170543|580839560|FG003|Overall Study|Lost to Follow-up|3|||
160850152|NCT04170543|580839561|FG004|Overall Study|Lost to Follow-up|1|||
160850153|NCT04170543|580839557|FG000|Overall Study|Withdrawal by Subject|13|||
160850154|NCT04170543|580839558|FG001|Overall Study|Withdrawal by Subject|6|||
160850155|NCT04170543|580839559|FG002|Overall Study|Withdrawal by Subject|5|||
160850156|NCT04170543|580839560|FG003|Overall Study|Withdrawal by Subject|4|||
160850157|NCT04170543|580839561|FG004|Overall Study|Withdrawal by Subject|9|||
160850158|NCT04170543|580839557|FG000|Overall Study|Not able to transition to phase 2b|8|||
160850159|NCT04170543|580839558|FG001|Overall Study|Not able to transition to phase 2b|0|||
160850160|NCT04170543|580839559|FG002|Overall Study|Not able to transition to phase 2b|10|||
160850161|NCT04170543|580839560|FG003|Overall Study|Not able to transition to phase 2b|0|||
160850162|NCT04170543|580839561|FG004|Overall Study|Not able to transition to phase 2b|6|||
160850163|NCT04170543|580839557|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
160850164|NCT04170543|580839558|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
160850165|NCT04170543|580839559|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
160850166|NCT04170543|580839560|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
160850167|NCT04170543|580839561|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
160850168|NCT04170543|580839557|FG000|Overall Study|Not Treated|0|||
160850169|NCT04170543|580839558|FG001|Overall Study|Not Treated|0|||
160850170|NCT04170543|580839559|FG002|Overall Study|Not Treated|0|||
160850171|NCT04170543|580839560|FG003|Overall Study|Not Treated|0|||
160850172|NCT04170543|580839561|FG004|Overall Study|Not Treated|2|||
160850173|NCT04170543|580839557|FG000|Overall Study|(CRF)|16|||
160850174|NCT04170543|580839558|FG001|Overall Study|(CRF)|15|||
160850175|NCT04170543|580839559|FG002|Overall Study|(CRF)|12|||
160850176|NCT04170543|580839560|FG003|Overall Study|(CRF)|17|||
160850177|NCT04170543|580839561|FG004|Overall Study|(CRF)|17|||
160850178|NCT04170543|580839557|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
160850179|NCT04170543|580839558|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
160850180|NCT04170543|580839559|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
160850181|NCT04170543|580839560|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
160850182|NCT04170543|580839561|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
160850183|NCT00770601|580839562|FG000|Overall Study|Withdrawal by Subject|1|||
160850184|NCT04628780|580839563|FG000|Overall Study|Death|0|||
160850185|NCT04628780|580839564|FG001|Overall Study|Death|1|||
160850186|NCT04628780|580839565|FG002|Overall Study|Death|0|||
160850187|NCT04628780|580839566|FG003|Overall Study|Death|0|||
160850188|NCT04628780|580839567|FG004|Overall Study|Death|1|||
160850189|NCT04628780|580839568|FG005|Overall Study|Death|0|||
160850190|NCT04628780|580839563|FG000|Overall Study|Physician Decision|2|||
160850191|NCT04628780|580839564|FG001|Overall Study|Physician Decision|0|||
160850192|NCT04628780|580839565|FG002|Overall Study|Physician Decision|0|||
160850193|NCT04628780|580839566|FG003|Overall Study|Physician Decision|0|||
160850194|NCT04628780|580839567|FG004|Overall Study|Physician Decision|2|||
160850195|NCT04628780|580839568|FG005|Overall Study|Physician Decision|0|||
160992504|NCT03999554|581361388|FG003|Overall Study|Lost to Follow-up|5|||
160992505|NCT03999554|581361389|FG004|Overall Study|Lost to Follow-up|8|||
160850196|NCT04628780|580839563|FG000|Overall Study|Progressive disease|2|||
160850197|NCT04628780|580839564|FG001|Overall Study|Progressive disease|2|||
160850198|NCT04628780|580839565|FG002|Overall Study|Progressive disease|2|||
160992506|NCT03999554|581361385|FG000|Overall Study|Protocol Violation|0|||
160850199|NCT04628780|580839566|FG003|Overall Study|Progressive disease|3|||
160850200|NCT04628780|580839567|FG004|Overall Study|Progressive disease|9|||
160850201|NCT04628780|580839568|FG005|Overall Study|Progressive disease|4|||
160850202|NCT04628780|580839563|FG000|Overall Study|Withdrawal by Subject|0|||
160850203|NCT04628780|580839564|FG001|Overall Study|Withdrawal by Subject|1|||
160850204|NCT04628780|580839565|FG002|Overall Study|Withdrawal by Subject|2|||
160850205|NCT04628780|580839566|FG003|Overall Study|Withdrawal by Subject|0|||
160850206|NCT04628780|580839567|FG004|Overall Study|Withdrawal by Subject|3|||
160850207|NCT04628780|580839568|FG005|Overall Study|Withdrawal by Subject|1|||
160850208|NCT04628780|580839563|FG000|Overall Study|Global deterioration of health status|0|||
160850209|NCT04628780|580839564|FG001|Overall Study|Global deterioration of health status|0|||
160850210|NCT04628780|580839565|FG002|Overall Study|Global deterioration of health status|0|||
160850211|NCT04628780|580839566|FG003|Overall Study|Global deterioration of health status|0|||
160850212|NCT04628780|580839567|FG004|Overall Study|Global deterioration of health status|1|||
160850213|NCT04628780|580839568|FG005|Overall Study|Global deterioration of health status|1|||
160850214|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
160850215|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
160850216|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
160850217|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
160850218|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
160850219|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
160850220|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
160850221|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
160850222|NCT01987102|580839573|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
160850223|NCT01987102|580839574|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
160850224|NCT01987102|580839573|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
160850225|NCT01987102|580839574|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
160850226|NCT01327599|580839575|FG000|Overall Study|Adverse Event|1|||
160850227|NCT01327599|580839575|FG000|Overall Study|Could Not Attend Visit|1|||
160850228|NCT01327599|580839575|FG000|Overall Study|Withdrawal of Consent|1|||
160850229|NCT01236521|580839576|FG000|Overall Study|Withdrawal by Subject|12|||
160850230|NCT01236521|580839577|FG001|Overall Study|Withdrawal by Subject|17|||
160850231|NCT01236521|580839576|FG000|Overall Study|Death|2|||
160850232|NCT01236521|580839577|FG001|Overall Study|Death|1|||
160850233|NCT01236521|580839576|FG000|Overall Study|Lost to Follow-up|9|||
160850234|NCT01236521|580839577|FG001|Overall Study|Lost to Follow-up|7|||
160850235|NCT04661150|580839583|FG000|Overall Study|Ongoing in study|19|||
160850236|NCT04661150|580839584|FG001|Overall Study|Ongoing in study|20|||
160850237|NCT04661150|580839583|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
160850238|NCT04661150|580839584|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
160850239|NCT04661150|580839583|FG000|Overall Study|Death|2|||
160850240|NCT04661150|580839584|FG001|Overall Study|Death|0|||
160850241|NCT05864586|580839585|FG000|Overall Study|Ineligible|4|||
160850242|NCT05864586|580839586|FG001|Overall Study|Ineligible|12|||
160850243|NCT05864586|580839585|FG000|Overall Study|Pregnancy|0|||
160850244|NCT05864586|580839586|FG001|Overall Study|Pregnancy|1|||
160850245|NCT05864586|580839585|FG000|Overall Study|Withdrawal by Subject|0|||
160850246|NCT05864586|580839586|FG001|Overall Study|Withdrawal by Subject|1|||
160850247|NCT03635424|580839587|FG000|Overall Study|Adverse Event|1|||
160850248|NCT03635424|580839587|FG000|Overall Study|Death|1|||
160850249|NCT03635424|580839587|FG000|Overall Study|Device not implanted|1|||
160850250|NCT02701283|580839588|FG000|Overall Study|Death|25|||
160850251|NCT02701283|580839589|FG001|Overall Study|Death|29|||
160850252|NCT02701283|580839590|FG002|Overall Study|Death|19|||
160850253|NCT02701283|580839588|FG000|Overall Study|Lost to Follow-up|3|||
160850254|NCT02701283|580839589|FG001|Overall Study|Lost to Follow-up|8|||
160850255|NCT02701283|580839590|FG002|Overall Study|Lost to Follow-up|1|||
160850256|NCT02701283|580839588|FG000|Overall Study|Withdrawal by Subject|12|||
160850257|NCT02701283|580839589|FG001|Overall Study|Withdrawal by Subject|41|||
160850258|NCT02701283|580839590|FG002|Overall Study|Withdrawal by Subject|1|||
160850259|NCT02701283|580839588|FG000|Overall Study|Missed 2-year visit|22|||
160850260|NCT02701283|580839589|FG001|Overall Study|Missed 2-year visit|27|||
160850261|NCT02701283|580839590|FG002|Overall Study|Missed 2-year visit|0|||
160850262|NCT02701283|580839588|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
160850263|NCT02701283|580839589|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
160850264|NCT02701283|580839590|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
160850265|NCT04544956|580839591|FG000|Overall Study|Withdrawal by Subject|1|||
160850266|NCT04266795|580839592|FG000|Overall Study|Adverse Event|10|||
160850267|NCT04266795|580839593|FG001|Overall Study|Adverse Event|19|||
160850268|NCT04266795|580839592|FG000|Overall Study|Death|7|||
160850269|NCT04266795|580839593|FG001|Overall Study|Death|8|||
160850270|NCT04266795|580839592|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
160850271|NCT04266795|580839593|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
160850272|NCT04266795|580839592|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
160850273|NCT04266795|580839593|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
160850274|NCT04266795|580839592|FG000|Overall Study|Progressive Disease|12|||
160850275|NCT04266795|580839593|FG001|Overall Study|Progressive Disease|9|||
160850276|NCT04266795|580839592|FG000|Overall Study|Withdrawal by Patient|5|||
160850277|NCT04266795|580839593|FG001|Overall Study|Withdrawal by Patient|6|||
160906690|NCT03190915|581052268|FG000|Overall Study|Progressive Disease|3|||
160906691|NCT03988088|581052272|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
160906692|NCT03988088|581052273|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
160906693|NCT03988088|581052274|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
160906694|NCT03988088|581052275|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
160850278|NCT04266795|580839592|FG000|Overall Study|Disease Relapse|3|||
160850279|NCT04266795|580839593|FG001|Overall Study|Disease Relapse|6|||
160850280|NCT04266795|580839592|FG000|Overall Study|Reason not Specified|12|||
160850281|NCT04266795|580839593|FG001|Overall Study|Reason not Specified|10|||
160850282|NCT04266795|580839592|FG000|Overall Study|Participants Ongoing on Treatment|25|||
160850283|NCT04266795|580839593|FG001|Overall Study|Participants Ongoing on Treatment|23|||
160906695|NCT03988088|581052272|FG000|Open-Label Addendum|Lost to Follow-up|0|||
160906696|NCT03988088|581052273|FG001|Open-Label Addendum|Lost to Follow-up|0|||
161337142|NCT00853385|582625846|FG003|Overall Study|Adverse Event|5|||
160850284|NCT00549445|580839599|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
160850285|NCT00549445|580839600|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
160850286|NCT03932760|580839601|FG000|Overall Study|Became Ineligible|2|||
160850287|NCT03932760|580839602|FG001|Overall Study|Became Ineligible|5|||
160850288|NCT03932760|580839601|FG000|Overall Study|Withdrawal by Subject|6|||
160850289|NCT03932760|580839602|FG001|Overall Study|Withdrawal by Subject|6|||
160850290|NCT04725500|580839603|FG000|Screening|Screen Failure|26|||
160850291|NCT04725500|580839603|FG000|Screening|Withdrawal by Subject|1|||
160906697|NCT03988088|581052274|FG002|Open-Label Addendum|Lost to Follow-up|1|||
161337143|NCT00853385|582625847|FG004|Overall Study|Adverse Event|22|||
160850292|NCT04725500|580839603|FG000|2 Week Take Home|Screen Fail|5|||
160850293|NCT04618744|580839606|FG000|Overall Study|Adverse Event|0|||
160850294|NCT04618744|580839607|FG001|Overall Study|Adverse Event|1|||
160992507|NCT03999554|581361386|FG001|Overall Study|Protocol Violation|0|||
160850295|NCT04618744|580839606|FG000|Overall Study|Withdrawal by Subject|0|||
160850296|NCT04618744|580839607|FG001|Overall Study|Withdrawal by Subject|1|||
160850297|NCT03553758|580841422|FG000|Overall Study|Lost to Follow-up|1|||
160850298|NCT02807623|580841423|FG000|Overall Study|Lost to Follow-up|23|||
160850299|NCT02807623|580841424|FG001|Overall Study|Lost to Follow-up|18|||
160850300|NCT02807623|580841425|FG002|Overall Study|Lost to Follow-up|22|||
160850301|NCT02807623|580841423|FG000|Overall Study|Drug intolerance|0|||
160850302|NCT02807623|580841424|FG001|Overall Study|Drug intolerance|1|||
160850303|NCT02807623|580841425|FG002|Overall Study|Drug intolerance|0|||
160850304|NCT02807623|580841423|FG000|Overall Study|incomplete blood draw|0|||
160850305|NCT02807623|580841424|FG001|Overall Study|incomplete blood draw|2|||
160850306|NCT02807623|580841425|FG002|Overall Study|incomplete blood draw|1|||
160850307|NCT02614729|580841426|FG000|Overall Study|Withdrawal by Subject|1|||
160850308|NCT02614729|580841427|FG001|Overall Study|Withdrawal by Subject|0|||
160850309|NCT04002960|580841432|FG000|Overall Study|Withdrawn prior to Completion|2|||
160850310|NCT00383786|580841435|FG000|Overall Study|Protocol Violation|2|||
160850311|NCT00383786|580841436|FG001|Overall Study|Protocol Violation|6|||
160850312|NCT00383786|580841435|FG000|Overall Study|Withdrawal by Subject|2|||
160850313|NCT00383786|580841436|FG001|Overall Study|Withdrawal by Subject|5|||
160850314|NCT00383786|580841435|FG000|Overall Study|Physician Decision|0|||
160850315|NCT00383786|580841436|FG001|Overall Study|Physician Decision|1|||
160850316|NCT02219464|580841440|FG000|Overall Study|Withdrawal by Subject|1|||
160850317|NCT02219464|580841441|FG001|Overall Study|Withdrawal by Subject|0|||
160850318|NCT02219464|580841440|FG000|Overall Study|case cancelled|1|||
160850319|NCT02219464|580841441|FG001|Overall Study|case cancelled|0|||
160850320|NCT02219464|580841440|FG000|Overall Study|catheter malfunction|1|||
160850321|NCT02219464|580841441|FG001|Overall Study|catheter malfunction|0|||
160850322|NCT02544321|580841442|FG000|Overall Study|Withdrawal by Subject|1|||
160850323|NCT02544321|580841443|FG001|Overall Study|Withdrawal by Subject|2|||
160850324|NCT02544321|580841442|FG000|Overall Study|Adverse Event|1|||
160850325|NCT02544321|580841443|FG001|Overall Study|Adverse Event|1|||
160850326|NCT02544321|580841442|FG000|Overall Study|Protocol Violation|0|||
160850327|NCT02544321|580841443|FG001|Overall Study|Protocol Violation|1|||
160850328|NCT00527735|580841445|FG000|Overall Study|Disease progression|47|||
160850329|NCT00527735|580841446|FG001|Overall Study|Disease progression|61|||
160850330|NCT00527735|580841447|FG002|Overall Study|Disease progression|53|||
160850331|NCT00527735|580841445|FG000|Overall Study|Death|23|||
160850332|NCT00527735|580841446|FG001|Overall Study|Death|13|||
160850333|NCT00527735|580841447|FG002|Overall Study|Death|15|||
160850334|NCT00527735|580841445|FG000|Overall Study|Completed treatment in treatment phase|14|||
160850335|NCT00527735|580841446|FG001|Overall Study|Completed treatment in treatment phase|13|||
160850336|NCT00527735|580841447|FG002|Overall Study|Completed treatment in treatment phase|18|||
160850337|NCT00527735|580841445|FG000|Overall Study|Adverse Event|10|||
160850338|NCT00527735|580841446|FG001|Overall Study|Adverse Event|6|||
160850339|NCT00527735|580841447|FG002|Overall Study|Adverse Event|7|||
160850340|NCT00527735|580841445|FG000|Overall Study|Not identified|5|||
160850341|NCT00527735|580841446|FG001|Overall Study|Not identified|5|||
160850342|NCT00527735|580841447|FG002|Overall Study|Not identified|5|||
160850343|NCT00527735|580841445|FG000|Overall Study|Withdrawal by Subject|5|||
160850344|NCT00527735|580841446|FG001|Overall Study|Withdrawal by Subject|4|||
160850345|NCT00527735|580841447|FG002|Overall Study|Withdrawal by Subject|3|||
160850346|NCT00527735|580841445|FG000|Overall Study|No longer met study criteria|2|||
160850347|NCT00527735|580841446|FG001|Overall Study|No longer met study criteria|2|||
160850348|NCT00527735|580841447|FG002|Overall Study|No longer met study criteria|1|||
160850349|NCT00527735|580841445|FG000|Overall Study|Lost to Follow-up|0|||
160850350|NCT00527735|580841446|FG001|Overall Study|Lost to Follow-up|0|||
160850351|NCT00527735|580841447|FG002|Overall Study|Lost to Follow-up|3|||
160850352|NCT00527735|580841445|FG000|Overall Study|Poor compliance or noncompliance|0|||
160850353|NCT00527735|580841446|FG001|Overall Study|Poor compliance or noncompliance|1|||
160850354|NCT00527735|580841447|FG002|Overall Study|Poor compliance or noncompliance|1|||
160850355|NCT00527735|580841445|FG000|Overall Study|Completed treatment during maintenance|2|||
160850356|NCT00527735|580841446|FG001|Overall Study|Completed treatment during maintenance|2|||
160850357|NCT00527735|580841447|FG002|Overall Study|Completed treatment during maintenance|1|||
160850358|NCT01080807|580841448|FG000|Overall Study|Adverse Event|9|||
160850359|NCT01080807|580841449|FG001|Overall Study|Adverse Event|1|||
160850360|NCT01080807|580841448|FG000|Overall Study|Lack of Efficacy|0|||
160850361|NCT01080807|580841449|FG001|Overall Study|Lack of Efficacy|1|||
160850362|NCT01080807|580841448|FG000|Overall Study|Withdrawal by Subject|7|||
160850363|NCT01080807|580841449|FG001|Overall Study|Withdrawal by Subject|2|||
160850364|NCT01080807|580841448|FG000|Overall Study|Protocol Violation|7|||
160850365|NCT01080807|580841449|FG001|Overall Study|Protocol Violation|6|||
160850366|NCT01080807|580841448|FG000|Overall Study|Lost to Follow-up|6|||
160850367|NCT01080807|580841449|FG001|Overall Study|Lost to Follow-up|4|||
160850368|NCT01080807|580841448|FG000|Overall Study|Noncompliance with drug administration|1|||
160850369|NCT01080807|580841449|FG001|Overall Study|Noncompliance with drug administration|1|||
160850370|NCT01080807|580841448|FG000|Overall Study|Noncompliance to study procedures|1|||
160850371|NCT01080807|580841449|FG001|Overall Study|Noncompliance to study procedures|1|||
160850372|NCT01080807|580841448|FG000|Overall Study|Began working day shift|0|||
160850373|NCT01080807|580841449|FG001|Overall Study|Began working day shift|2|||
160850374|NCT01080807|580841448|FG000|Overall Study|Laid off or terminated from job|1|||
160850375|NCT01080807|580841449|FG001|Overall Study|Laid off or terminated from job|2|||
160850376|NCT01080807|580841448|FG000|Overall Study|Stopped working consistent night shifts|0|||
160850377|NCT01080807|580841449|FG001|Overall Study|Stopped working consistent night shifts|1|||
160850378|NCT01080807|580841448|FG000|Overall Study|Work schedule changing|1|||
160850379|NCT01080807|580841449|FG001|Overall Study|Work schedule changing|1|||
160850380|NCT01080807|580841448|FG000|Overall Study|Work schedule and travel|0|||
160850381|NCT01080807|580841449|FG001|Overall Study|Work schedule and travel|1|||
160850382|NCT01080807|580841448|FG000|Overall Study|Switched to first shift|1|||
160850383|NCT01080807|580841449|FG001|Overall Study|Switched to first shift|0|||
160850384|NCT01080807|580841448|FG000|Overall Study|Moved away without notifying center|1|||
160850385|NCT01080807|580841449|FG001|Overall Study|Moved away without notifying center|0|||
160850386|NCT02107703|580841456|FG000|Overall Study|Withdrawal by Subject|46|||
160850387|NCT02107703|580841457|FG001|Overall Study|Withdrawal by Subject|21|||
160850388|NCT02107703|580841456|FG000|Overall Study|Lost to Follow-up|20|||
160850389|NCT02107703|580841457|FG001|Overall Study|Lost to Follow-up|9|||
160850390|NCT02107703|580841456|FG000|Overall Study|On study treatment/follow up|48|||
160850391|NCT02107703|580841457|FG001|Overall Study|On study treatment/follow up|5|||
160850392|NCT02366312|580841458|FG000|Overall Study|Lost to Follow-up|0|||
160850393|NCT02366312|580841459|FG001|Overall Study|Lost to Follow-up|1|||
160850394|NCT01879683|580841466|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
160850395|NCT01338818|580841474|FG000|Overall Study|Adverse Event|8|||
160850396|NCT01338818|580841474|FG000|Overall Study|Lack of Efficacy|5|||
160850397|NCT01338818|580841474|FG000|Overall Study|no longer require study drug|1|||
160850398|NCT01338818|580841474|FG000|Overall Study|Withdrawal by Subject|11|||
160850399|NCT01338818|580841474|FG000|Overall Study|Lost to Follow-up|4|||
160850400|NCT01338818|580841474|FG000|Overall Study|Administrative problems|3|||
160850401|NCT01338818|580841474|FG000|Overall Study|Protocol Deviation|4|||
160850402|NCT05202418|580841475|FG000|Overall Study|Withdrawal by Subject|2|||
160850403|NCT05202418|580841476|FG001|Overall Study|Withdrawal by Subject|1|||
160850404|NCT05202418|580841475|FG000|Overall Study|Lost to Follow-up|1|||
160850405|NCT05202418|580841476|FG001|Overall Study|Lost to Follow-up|1|||
160850406|NCT03901144|580841481|FG000|Overall Study|Lost to Follow-up|1|||
160850407|NCT03901144|580841482|FG001|Overall Study|Lost to Follow-up|1|||
160850408|NCT03901144|580841483|FG002|Overall Study|Lost to Follow-up|1|||
160850409|NCT03901144|580841484|FG003|Overall Study|Lost to Follow-up|1|||
160850410|NCT02021565|580841485|FG000|Baseline Through Intervention|Death|0|||
160850411|NCT02021565|580841486|FG001|Baseline Through Intervention|Death|1|||
160850412|NCT02021565|580841485|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
160850413|NCT02021565|580841486|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
160850414|NCT02021565|580841485|FG000|Baseline Through Intervention|Protocol Violation|0|||
160850415|NCT02021565|580841486|FG001|Baseline Through Intervention|Protocol Violation|7|||
160850416|NCT02021565|580841485|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
160850417|NCT02021565|580841486|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
160850418|NCT02021565|580841485|FG000|3-month Follow-up|Death|3|||
160850419|NCT02021565|580841486|FG001|3-month Follow-up|Death|0|||
160850420|NCT02021565|580841485|FG000|3-month Follow-up|Withdrawal by Subject|4|||
160850421|NCT02021565|580841486|FG001|3-month Follow-up|Withdrawal by Subject|0|||
160850422|NCT02021565|580841485|FG000|3-month Follow-up|Protocol Violation|3|||
160850423|NCT02021565|580841486|FG001|3-month Follow-up|Protocol Violation|2|||
160850424|NCT03575403|580841487|FG000|Overall Study|Adverse Event|1|||
160850425|NCT03575403|580841488|FG001|Overall Study|Adverse Event|0|||
160850426|NCT03575403|580841489|FG002|Overall Study|Adverse Event|0|||
160850427|NCT03575403|580841487|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
160850428|NCT03575403|580841488|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
160850429|NCT03575403|580841489|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
160850430|NCT01332994|580841491|FG000|Overall Study|Adverse Event|34|||
160850431|NCT01332994|580841491|FG000|Overall Study|Death|1|||
160850432|NCT01332994|580841491|FG000|Overall Study|Lack of Efficacy|1|||
160850433|NCT01332994|580841491|FG000|Overall Study|Lost to Follow-up|4|||
160850434|NCT01332994|580841491|FG000|Overall Study|Protocol Violation|6|||
160850435|NCT01332994|580841491|FG000|Overall Study|Withdrawal by Subject|15|||
160850436|NCT01332994|580841491|FG000|Overall Study|Administrative Problem|2|||
160850437|NCT01332994|580841491|FG000|Overall Study|Other|8|||
160850438|NCT00279916|580841492|FG000|Overall Study|Withdrawal by Subject|4|||
160850439|NCT00279916|580841493|FG001|Overall Study|Withdrawal by Subject|3|||
160850440|NCT00279916|580841492|FG000|Overall Study|Lost to Follow-up|3|||
160850441|NCT00279916|580841493|FG001|Overall Study|Lost to Follow-up|2|||
160850442|NCT00731679|580841497|FG000|Overall Study|Adverse Event|7|||
160850443|NCT00731679|580841498|FG001|Overall Study|Adverse Event|8|||
160850444|NCT00731679|580841497|FG000|Overall Study|Withdrawal by Subject|8|||
160850445|NCT00731679|580841498|FG001|Overall Study|Withdrawal by Subject|8|||
160850446|NCT00731679|580841497|FG000|Overall Study|Lost to Follow-up|7|||
160850447|NCT00731679|580841498|FG001|Overall Study|Lost to Follow-up|8|||
160850448|NCT00731679|580841497|FG000|Overall Study|Noncompliance|0|||
160850449|NCT00731679|580841498|FG001|Overall Study|Noncompliance|1|||
160850450|NCT00731679|580841497|FG000|Overall Study|Pregnancy|0|||
160850451|NCT00731679|580841498|FG001|Overall Study|Pregnancy|1|||
160850452|NCT02488005|580841499|FG000|Overall Study|Lost to Follow-up|2|||
160850453|NCT03384940|580841506|FG000|Overall Study|Progressive disease|36|||
160850454|NCT03384940|580841507|FG001|Overall Study|Progressive disease|11|||
160850455|NCT03384940|580841508|FG002|Overall Study|Progressive disease|13|||
160850456|NCT03384940|580841506|FG000|Overall Study|Clinical progression|4|||
160850457|NCT03384940|580841507|FG001|Overall Study|Clinical progression|0|||
160850458|NCT03384940|580841508|FG002|Overall Study|Clinical progression|3|||
160850459|NCT03384940|580841506|FG000|Overall Study|Adverse Event|7|||
160850460|NCT03384940|580841507|FG001|Overall Study|Adverse Event|1|||
160850461|NCT03384940|580841508|FG002|Overall Study|Adverse Event|1|||
160850462|NCT03384940|580841506|FG000|Overall Study|Withdrawal by Subject|3|||
160850463|NCT03384940|580841507|FG001|Overall Study|Withdrawal by Subject|1|||
160850464|NCT03384940|580841508|FG002|Overall Study|Withdrawal by Subject|0|||
160850465|NCT03384940|580841506|FG000|Overall Study|Physician Decision|1|||
160850466|NCT03384940|580841507|FG001|Overall Study|Physician Decision|1|||
160850467|NCT03384940|580841508|FG002|Overall Study|Physician Decision|0|||
160850468|NCT03384940|580841506|FG000|Overall Study|Death|2|||
160850469|NCT03384940|580841507|FG001|Overall Study|Death|1|||
160850470|NCT03384940|580841508|FG002|Overall Study|Death|0|||
160850471|NCT03384940|580841506|FG000|Overall Study|Other|0|||
160850472|NCT03384940|580841507|FG001|Overall Study|Other|0|||
160850473|NCT03384940|580841508|FG002|Overall Study|Other|1|||
160850474|NCT03089580|580841511|FG000|Overall Study|Lost to Follow-up|2|||
160850475|NCT03087513|580841512|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
160850476|NCT03269994|580841513|FG000|Overall Study|Withdrawal by Subject|4|||
160850477|NCT03269994|580841514|FG001|Overall Study|Withdrawal by Subject|5|||
160850478|NCT03269994|580841513|FG000|Overall Study|Unresectable at surgery|39|||
160850479|NCT03269994|580841514|FG001|Overall Study|Unresectable at surgery|58|||
160850480|NCT03269994|580841513|FG000|Overall Study|Patient canceled surgery|5|||
160850481|NCT03269994|580841514|FG001|Overall Study|Patient canceled surgery|14|||
160850482|NCT03269994|580841513|FG000|Overall Study|Preoperative progression|14|||
160850483|NCT03269994|580841514|FG001|Overall Study|Preoperative progression|9|||
160850484|NCT03269994|580841513|FG000|Overall Study|Preoperative infection|10|||
160850485|NCT03269994|580841514|FG001|Overall Study|Preoperative infection|4|||
160850486|NCT03269994|580841513|FG000|Overall Study|Kidney insufficiency|1|||
160850487|NCT03269994|580841514|FG001|Overall Study|Kidney insufficiency|0|||
160850488|NCT03269994|580841513|FG000|Overall Study|Drug allergy|0|||
160850489|NCT03269994|580841514|FG001|Overall Study|Drug allergy|2|||
160850490|NCT03269994|580841513|FG000|Overall Study|Operation changed to different resection|9|||
160850491|NCT03269994|580841514|FG001|Overall Study|Operation changed to different resection|0|||
160850492|NCT03269994|580841513|FG000|Overall Study|Preoperative steroid|0|||
160850493|NCT03269994|580841514|FG001|Overall Study|Preoperative steroid|3|||
160850494|NCT03269994|580841513|FG000|Overall Study|Accrual Closed|2|||
160850495|NCT03269994|580841514|FG001|Overall Study|Accrual Closed|0|||
160850496|NCT03269994|580841513|FG000|Overall Study|Operation changed to different resection|0|||
160850497|NCT03269994|580841514|FG001|Overall Study|Operation changed to different resection|10|||
160850498|NCT04303559|580841515|FG000|Overall Study|Study closed due to poor enrollment.|1|||
160850499|NCT01288989|580841518|FG000|Overall Study|Death|0|||
160850500|NCT01288989|580841519|FG001|Overall Study|Death|0|||
160850501|NCT01288989|580841520|FG002|Overall Study|Death|0|||
160850502|NCT01288989|580841521|FG003|Overall Study|Death|1|||
160850503|NCT01288989|580841522|FG004|Overall Study|Death|0|||
160850504|NCT01288989|580841518|FG000|Overall Study|Dose limiting toxicity|1|||
160850505|NCT01288989|580841519|FG001|Overall Study|Dose limiting toxicity|0|||
160850506|NCT01288989|580841520|FG002|Overall Study|Dose limiting toxicity|0|||
160850507|NCT01288989|580841521|FG003|Overall Study|Dose limiting toxicity|0|||
160850508|NCT01288989|580841522|FG004|Overall Study|Dose limiting toxicity|0|||
160850509|NCT01288989|580841518|FG000|Overall Study|Adverse Event|0|||
160850510|NCT01288989|580841519|FG001|Overall Study|Adverse Event|0|||
160850511|NCT01288989|580841520|FG002|Overall Study|Adverse Event|0|||
160850512|NCT01288989|580841521|FG003|Overall Study|Adverse Event|0|||
160850513|NCT01288989|580841522|FG004|Overall Study|Adverse Event|2|||
160850514|NCT01288989|580841518|FG000|Overall Study|Physician Decision|0|||
160850515|NCT01288989|580841519|FG001|Overall Study|Physician Decision|0|||
160850516|NCT01288989|580841520|FG002|Overall Study|Physician Decision|0|||
160850517|NCT01288989|580841521|FG003|Overall Study|Physician Decision|0|||
160850518|NCT01288989|580841522|FG004|Overall Study|Physician Decision|1|||
160850519|NCT01288989|580841518|FG000|Overall Study|Withdrawal by Subject|0|||
160906698|NCT03988088|581052275|FG003|Open-Label Addendum|Lost to Follow-up|0|||
160906699|NCT00622401|581052276|FG000|Overall Study|Disease progression prior to treatment|3|||
160906700|NCT00622401|581052277|FG001|Overall Study|Disease progression prior to treatment|2|||
160906701|NCT00622401|581052278|FG002|Overall Study|Disease progression prior to treatment|0|||
161141187|NCT00356915|581900992|FG001|Overall Study|Withdrawal by Subject|14|||
161141188|NCT00356915|581900993|FG002|Overall Study|Withdrawal by Subject|10|||
161141189|NCT00356915|581900991|FG000|Overall Study|Lack of Efficacy|0|||
160850520|NCT01288989|580841519|FG001|Overall Study|Withdrawal by Subject|0|||
160850521|NCT01288989|580841520|FG002|Overall Study|Withdrawal by Subject|0|||
160850522|NCT01288989|580841521|FG003|Overall Study|Withdrawal by Subject|0|||
160850523|NCT01288989|580841522|FG004|Overall Study|Withdrawal by Subject|3|||
160850524|NCT01156714|580841523|FG000|Overall Study|Withdrawal by Subject|9|||
160850525|NCT01156714|580841524|FG001|Overall Study|Withdrawal by Subject|4|||
160850526|NCT01156714|580841525|FG002|Overall Study|Withdrawal by Subject|3|||
160850527|NCT05907395|580841530|FG000|Period 1|No longer met eligibility criteria|0|||
160850528|NCT05907395|580841531|FG001|Period 1|No longer met eligibility criteria|1|||
160850529|NCT05907395|580841532|FG002|Period 1|No longer met eligibility criteria|0|||
160850530|NCT05907395|580841533|FG003|Period 1|No longer met eligibility criteria|0|||
160850531|NCT05907395|580841534|FG004|Period 1|No longer met eligibility criteria|0|||
160850532|NCT05907395|580841535|FG005|Period 1|No longer met eligibility criteria|1|||
160850533|NCT05907395|580841536|FG006|Period 1|No longer met eligibility criteria|1|||
160850534|NCT05907395|580841537|FG007|Period 1|No longer met eligibility criteria|0|||
160850535|NCT05907395|580841538|FG008|Period 1|No longer met eligibility criteria|0|||
160850536|NCT05907395|580841539|FG009|Period 1|No longer met eligibility criteria|0|||
160850537|NCT05907395|580841540|FG010|Period 1|No longer met eligibility criteria|0|||
160850538|NCT05907395|580841541|FG011|Period 1|No longer met eligibility criteria|0|||
160850539|NCT05907395|580841530|FG000|Period 2|Adverse Event|0|||
160850540|NCT05907395|580841531|FG001|Period 2|Adverse Event|0|||
160850541|NCT05907395|580841532|FG002|Period 2|Adverse Event|0|||
160850542|NCT05907395|580841533|FG003|Period 2|Adverse Event|1|||
160850543|NCT05907395|580841534|FG004|Period 2|Adverse Event|0|||
160850544|NCT05907395|580841535|FG005|Period 2|Adverse Event|0|||
160850545|NCT05907395|580841536|FG006|Period 2|Adverse Event|0|||
160850546|NCT05907395|580841537|FG007|Period 2|Adverse Event|1|||
160850547|NCT05907395|580841538|FG008|Period 2|Adverse Event|0|||
160850548|NCT05907395|580841539|FG009|Period 2|Adverse Event|0|||
160850549|NCT05907395|580841540|FG010|Period 2|Adverse Event|0|||
160850550|NCT05907395|580841541|FG011|Period 2|Adverse Event|0|||
160850551|NCT05907395|580841530|FG000|Period 2|Personal reason|0|||
160850552|NCT05907395|580841531|FG001|Period 2|Personal reason|0|||
160850553|NCT05907395|580841532|FG002|Period 2|Personal reason|0|||
160850554|NCT05907395|580841533|FG003|Period 2|Personal reason|0|||
160850555|NCT05907395|580841534|FG004|Period 2|Personal reason|0|||
160850556|NCT05907395|580841535|FG005|Period 2|Personal reason|0|||
160850557|NCT05907395|580841536|FG006|Period 2|Personal reason|0|||
160850558|NCT05907395|580841537|FG007|Period 2|Personal reason|0|||
160850559|NCT05907395|580841538|FG008|Period 2|Personal reason|0|||
160850560|NCT05907395|580841539|FG009|Period 2|Personal reason|1|||
160850561|NCT05907395|580841540|FG010|Period 2|Personal reason|0|||
160850562|NCT05907395|580841541|FG011|Period 2|Personal reason|0|||
160850563|NCT05907395|580841530|FG000|Period 3|Adverse Event|0|||
160850564|NCT05907395|580841531|FG001|Period 3|Adverse Event|0|||
160850565|NCT05907395|580841532|FG002|Period 3|Adverse Event|0|||
160850566|NCT05907395|580841533|FG003|Period 3|Adverse Event|0|||
160850567|NCT05907395|580841534|FG004|Period 3|Adverse Event|1|||
160850568|NCT05907395|580841535|FG005|Period 3|Adverse Event|0|||
160850569|NCT05907395|580841536|FG006|Period 3|Adverse Event|0|||
160850570|NCT05907395|580841537|FG007|Period 3|Adverse Event|0|||
160850571|NCT05907395|580841538|FG008|Period 3|Adverse Event|0|||
160850572|NCT05907395|580841539|FG009|Period 3|Adverse Event|0|||
160850573|NCT05907395|580841540|FG010|Period 3|Adverse Event|0|||
160850574|NCT05907395|580841541|FG011|Period 3|Adverse Event|0|||
160850575|NCT03043872|580841542|FG000|Overall Study|Withdrawal by Subject|6|||
160850576|NCT03043872|580841543|FG001|Overall Study|Withdrawal by Subject|6|||
160850577|NCT03043872|580841544|FG002|Overall Study|Withdrawal by Subject|15|||
160850578|NCT03043872|580841542|FG000|Overall Study|Lost to Follow-up|2|||
160850579|NCT03043872|580841543|FG001|Overall Study|Lost to Follow-up|1|||
160850580|NCT03043872|580841544|FG002|Overall Study|Lost to Follow-up|1|||
160850581|NCT03043872|580841542|FG000|Overall Study|Death|270|||
160850582|NCT03043872|580841543|FG001|Overall Study|Death|269|||
160850583|NCT03043872|580841544|FG002|Overall Study|Death|296|||
160850584|NCT02777827|580841545|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850585|NCT02777827|580841546|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
161141190|NCT00356915|581900992|FG001|Overall Study|Lack of Efficacy|0|||
160906702|NCT01546883|581052282|FG000|Overall Study|Withdrawal by Subject|3|||
160850586|NCT02777827|580841547|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
160850587|NCT02777827|580841548|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850588|NCT02777827|580841549|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850589|NCT02777827|580841550|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
160850590|NCT04551066|580841551|FG000|Overall Study|Death|5|||
160850591|NCT04551066|580841552|FG001|Overall Study|Death|3|||
160850592|NCT04551066|580841551|FG000|Overall Study|Lost to Follow-up|1|||
160850593|NCT04551066|580841552|FG001|Overall Study|Lost to Follow-up|0|||
160850594|NCT04551066|580841551|FG000|Overall Study|Sponsor Decision|104|||
160850595|NCT04551066|580841552|FG001|Overall Study|Sponsor Decision|117|||
160850596|NCT04551066|580841551|FG000|Overall Study|Withdrawal by Subject|8|||
160850597|NCT04551066|580841552|FG001|Overall Study|Withdrawal by Subject|2|||
160850598|NCT04551066|580841551|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
160850599|NCT04551066|580841552|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
160850600|NCT04551066|580841551|FG000|Overall Study|Adverse Event|2|||
160850601|NCT04551066|580841552|FG001|Overall Study|Adverse Event|0|||
160850602|NCT04551066|580841551|FG000|Overall Study|Physician Decision|2|||
160850603|NCT04551066|580841552|FG001|Overall Study|Physician Decision|0|||
160850604|NCT04551066|580841551|FG000|Overall Study|Protocol Violation|1|||
160850605|NCT04551066|580841552|FG001|Overall Study|Protocol Violation|0|||
160850606|NCT04551066|580841551|FG000|Overall Study|Lack of Efficacy|0|||
160850607|NCT04551066|580841552|FG001|Overall Study|Lack of Efficacy|1|||
160850608|NCT04551066|580841551|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
160850609|NCT04551066|580841552|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
160850610|NCT04491136|580841553|FG000|Overall Study|Patient withdraw informed consent|9|||
160850611|NCT04491136|580841553|FG000|Overall Study|Adverse Event|2|||
160850612|NCT04491136|580841553|FG000|Overall Study|Death|3|||
160850613|NCT04491136|580841553|FG000|Overall Study|Lost to Follow-up|3|||
160850614|NCT04491136|580841553|FG000|Overall Study|Physician Decision|45|||
160850615|NCT04491136|580841553|FG000|Overall Study|sponsor terminated the study early|16|||
160850616|NCT04491136|580841553|FG000|Overall Study|Patient/guardian's decision|1|||
160850617|NCT00398320|580841554|FG000|Overall Study|Death|1|||
160850618|NCT00398320|580841554|FG000|Overall Study|Adverse Event|4|||
160850619|NCT00398320|580841554|FG000|Overall Study|Physician Decision|1|||
160850620|NCT00064792|580841555|FG000|Overall Study|Withdrawal by Subject|2|||
160850621|NCT00064792|580841556|FG001|Overall Study|Withdrawal by Subject|0|||
160850622|NCT00064792|580841555|FG000|Overall Study|Adverse Event|3|||
160850623|NCT00064792|580841556|FG001|Overall Study|Adverse Event|0|||
160850624|NCT00319254|580841561|FG000|Overall Study|Withdrawal by Subject|4|||
160850625|NCT00319254|580841561|FG000|Overall Study|Death|46|||
160850626|NCT00319254|580841561|FG000|Overall Study|Lost to Follow-up|2|||
160850627|NCT00319254|580841561|FG000|Overall Study|Enrolled, Not Treated|2|||
160850628|NCT01712204|580841565|FG000|Overall Study|Adverse Event|3|||
160850629|NCT01712204|580841566|FG001|Overall Study|Adverse Event|1|||
160850630|NCT01712204|580841565|FG000|Overall Study|Withdrawal by Subject|3|||
160850631|NCT01712204|580841566|FG001|Overall Study|Withdrawal by Subject|3|||
160850632|NCT01712204|580841565|FG000|Overall Study|Lost to Follow-up|1|||
160850633|NCT01712204|580841566|FG001|Overall Study|Lost to Follow-up|0|||
160850634|NCT01712204|580841565|FG000|Overall Study|Protocol Violation|1|||
160850635|NCT01712204|580841566|FG001|Overall Study|Protocol Violation|1|||
160850636|NCT02452424|580841567|FG000|Overall Study|Death|2|||
160850637|NCT02452424|580841568|FG001|Overall Study|Death|2|||
160850638|NCT02452424|580841569|FG002|Overall Study|Death|2|||
160850639|NCT02452424|580841570|FG003|Overall Study|Death|6|||
160850640|NCT02452424|580841571|FG004|Overall Study|Death|2|||
160850641|NCT02452424|580841572|FG005|Overall Study|Death|0|||
160850642|NCT02452424|580841573|FG006|Overall Study|Death|5|||
160850643|NCT02452424|580841574|FG007|Overall Study|Death|1|||
160850644|NCT02452424|580841575|FG008|Overall Study|Death|3|||
160850645|NCT02452424|580841576|FG009|Overall Study|Death|1|||
160850646|NCT02452424|580841577|FG010|Overall Study|Death|0|||
160850647|NCT02452424|580841567|FG000|Overall Study|Lost to Follow-up|0|||
160850648|NCT02452424|580841568|FG001|Overall Study|Lost to Follow-up|1|||
160850649|NCT02452424|580841569|FG002|Overall Study|Lost to Follow-up|1|||
160850650|NCT02452424|580841570|FG003|Overall Study|Lost to Follow-up|0|||
160850651|NCT02452424|580841571|FG004|Overall Study|Lost to Follow-up|0|||
160850652|NCT02452424|580841572|FG005|Overall Study|Lost to Follow-up|0|||
160850653|NCT02452424|580841573|FG006|Overall Study|Lost to Follow-up|0|||
160850654|NCT02452424|580841574|FG007|Overall Study|Lost to Follow-up|0|||
160850655|NCT02452424|580841575|FG008|Overall Study|Lost to Follow-up|0|||
160850656|NCT02452424|580841576|FG009|Overall Study|Lost to Follow-up|0|||
161141191|NCT00356915|581900993|FG002|Overall Study|Lack of Efficacy|3|||
160850657|NCT02452424|580841577|FG010|Overall Study|Lost to Follow-up|0|||
160850658|NCT02452424|580841567|FG000|Overall Study|Withdrawal by Subject|0|||
160850659|NCT02452424|580841568|FG001|Overall Study|Withdrawal by Subject|0|||
160850660|NCT02452424|580841569|FG002|Overall Study|Withdrawal by Subject|3|||
160850661|NCT02452424|580841570|FG003|Overall Study|Withdrawal by Subject|2|||
160850662|NCT02452424|580841571|FG004|Overall Study|Withdrawal by Subject|0|||
160850663|NCT02452424|580841572|FG005|Overall Study|Withdrawal by Subject|0|||
160850664|NCT02452424|580841573|FG006|Overall Study|Withdrawal by Subject|1|||
160850665|NCT02452424|580841574|FG007|Overall Study|Withdrawal by Subject|0|||
160850666|NCT02452424|580841575|FG008|Overall Study|Withdrawal by Subject|1|||
160850667|NCT02452424|580841576|FG009|Overall Study|Withdrawal by Subject|1|||
160850668|NCT02452424|580841577|FG010|Overall Study|Withdrawal by Subject|0|||
160850669|NCT02452424|580841567|FG000|Overall Study|Other|0|||
160850670|NCT02452424|580841568|FG001|Overall Study|Other|0|||
160850671|NCT02452424|580841569|FG002|Overall Study|Other|1|||
160850672|NCT02452424|580841570|FG003|Overall Study|Other|0|||
160850673|NCT02452424|580841571|FG004|Overall Study|Other|0|||
160850674|NCT02452424|580841572|FG005|Overall Study|Other|1|||
160850675|NCT02452424|580841573|FG006|Overall Study|Other|4|||
160850676|NCT02452424|580841574|FG007|Overall Study|Other|3|||
160850677|NCT02452424|580841575|FG008|Overall Study|Other|0|||
160850678|NCT02452424|580841576|FG009|Overall Study|Other|0|||
160850679|NCT02452424|580841577|FG010|Overall Study|Other|1|||
160850680|NCT02452424|580841567|FG000|Overall Study|Progressive disease (per RECIST)|0|||
160850681|NCT02452424|580841568|FG001|Overall Study|Progressive disease (per RECIST)|0|||
160850682|NCT02452424|580841569|FG002|Overall Study|Progressive disease (per RECIST)|0|||
160850683|NCT02452424|580841570|FG003|Overall Study|Progressive disease (per RECIST)|0|||
160850684|NCT02452424|580841571|FG004|Overall Study|Progressive disease (per RECIST)|0|||
160850685|NCT02452424|580841572|FG005|Overall Study|Progressive disease (per RECIST)|0|||
160850686|NCT02452424|580841573|FG006|Overall Study|Progressive disease (per RECIST)|0|||
160850687|NCT02452424|580841574|FG007|Overall Study|Progressive disease (per RECIST)|0|||
160850688|NCT02452424|580841575|FG008|Overall Study|Progressive disease (per RECIST)|2|||
160850689|NCT02452424|580841576|FG009|Overall Study|Progressive disease (per RECIST)|0|||
160850690|NCT02452424|580841577|FG010|Overall Study|Progressive disease (per RECIST)|0|||
160850691|NCT02452424|580841567|FG000|Overall Study|Adverse Event|0|||
160850692|NCT02452424|580841568|FG001|Overall Study|Adverse Event|0|||
160850693|NCT02452424|580841569|FG002|Overall Study|Adverse Event|0|||
160850694|NCT02452424|580841570|FG003|Overall Study|Adverse Event|0|||
160850695|NCT02452424|580841571|FG004|Overall Study|Adverse Event|0|||
160850696|NCT02452424|580841572|FG005|Overall Study|Adverse Event|0|||
160850697|NCT02452424|580841573|FG006|Overall Study|Adverse Event|0|||
160850698|NCT02452424|580841574|FG007|Overall Study|Adverse Event|0|||
160850699|NCT02452424|580841575|FG008|Overall Study|Adverse Event|0|||
160850700|NCT02452424|580841576|FG009|Overall Study|Adverse Event|0|||
160850701|NCT02452424|580841577|FG010|Overall Study|Adverse Event|1|||
160850702|NCT01059318|580841578|FG000|Core Study (26 Week)|Adverse Event|3|||
160850703|NCT01059318|580841578|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
160850704|NCT01059318|580841578|FG000|Extension (36 Week)|Adverse Event|3|||
160850705|NCT03790917|580841579|FG000|Overall Study|Death|1|||
160850706|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Death|2|||
160850707|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Death|0|||
160850708|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Death|0|||
160850709|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
160850710|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
160850711|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
160850712|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
160850713|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
160850714|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
160850715|NCT01150097|580841583|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
160850716|NCT01150097|580841584|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
160906703|NCT01546883|581052282|FG000|Overall Study|Adverse Event|4|||
160906704|NCT01546883|581052282|FG000|Overall Study|Lost to Follow-up|2|||
160906705|NCT01546883|581052282|FG000|Overall Study|early closure of study|2|||
160906706|NCT01546883|581052282|FG000|Overall Study|other unrelated illness|1|||
160906707|NCT02243696|581052283|FG000|Overall Study|Death|282|||
160906708|NCT02243696|581052283|FG000|Overall Study|Withdrawal by Subject|79|||
160906709|NCT02243696|581052283|FG000|Overall Study|Lost to Follow-up|57|||
160906710|NCT02243696|581052283|FG000|Overall Study|Subject No Longer has Study System|42|||
160906711|NCT02243696|581052283|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
160906712|NCT02243696|581052283|FG000|Overall Study|Study Terminated for EP PASSION|961|||
160992508|NCT03999554|581361387|FG002|Overall Study|Protocol Violation|5|||
161141192|NCT00356915|581900991|FG000|Overall Study|Lost to Follow-up|27|||
161141193|NCT00356915|581900992|FG001|Overall Study|Lost to Follow-up|34|||
161141194|NCT00356915|581900993|FG002|Overall Study|Lost to Follow-up|14|||
161141195|NCT00356915|581900991|FG000|Overall Study|Administrative Decision|0|||
161141196|NCT00356915|581900992|FG001|Overall Study|Administrative Decision|0|||
160850717|NCT01150097|580841585|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
160850718|NCT01150097|580841583|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
160850719|NCT01150097|580841584|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
160850720|NCT01150097|580841585|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
160850721|NCT01150097|580841583|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
160850722|NCT01150097|580841584|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
160906713|NCT00622284|581052284|FG000|Overall Study|Lack of Efficacy|45|||
160906714|NCT00622284|581052285|FG001|Overall Study|Lack of Efficacy|15|||
161141197|NCT00356915|581900993|FG002|Overall Study|Administrative Decision|1|||
160850723|NCT01150097|580841585|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
160850724|NCT01150097|580841583|FG000|Months 24 to 48 Post-transplantation|Death|2|||
160850725|NCT01150097|580841584|FG001|Months 24 to 48 Post-transplantation|Death|0|||
160850726|NCT01150097|580841585|FG002|Months 24 to 48 Post-transplantation|Death|0|||
160850727|NCT01408459|580841586|FG000|Overall Study|Withdrawal by Subject|1|||
160850728|NCT01408459|580841587|FG001|Overall Study|Withdrawal by Subject|1|||
160850729|NCT00992459|580841588|FG000|Overall Study|Withdrawal by Subject|0|||
160850730|NCT00992459|580841589|FG001|Overall Study|Withdrawal by Subject|1|||
160850731|NCT00992459|580841588|FG000|Overall Study|Adverse Event|1|||
160850732|NCT00992459|580841589|FG001|Overall Study|Adverse Event|0|||
160850733|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Adverse Event|0|||
160850734|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Adverse Event|1|||
160850735|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Adverse Event|0|||
160850736|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Adverse Event|0|||
160850737|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Adverse Event|0|||
160850738|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Adverse Event|0|||
160850739|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Adverse Event|0|||
160850740|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Adverse Event|1|||
160850741|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Adverse Event|1|||
160850742|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Adverse Event|0|||
160850743|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Adverse Event|0|||
160850744|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Physician Decision|0|||
160850745|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Physician Decision|0|||
160850746|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Physician Decision|1|||
160850747|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Physician Decision|0|||
160850748|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Physician Decision|0|||
160850749|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Physician Decision|0|||
160850750|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Physician Decision|0|||
160850751|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Physician Decision|1|||
160850752|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Physician Decision|0|||
160850753|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Physician Decision|0|||
160850754|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Physician Decision|0|||
160850755|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850756|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
160850757|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
160850758|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850759|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850760|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
160850761|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
160850762|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
160850763|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
160850764|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
160850765|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
160850766|NCT00543387|580841594|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850767|NCT00543387|580841595|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850768|NCT00543387|580841596|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850769|NCT00543387|580841597|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850770|NCT00543387|580841598|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850771|NCT00543387|580841599|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850772|NCT00543387|580841600|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
160850773|NCT00543387|580841601|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850774|NCT00543387|580841602|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850775|NCT00543387|580841603|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850776|NCT00543387|580841604|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
160850777|NCT00543387|580841594|FG000|Crossover Participants|Progressive Disease|0|||
160850778|NCT00543387|580841595|FG001|Crossover Participants|Progressive Disease|0|||
160850779|NCT00543387|580841596|FG002|Crossover Participants|Progressive Disease|0|||
160850780|NCT00543387|580841597|FG003|Crossover Participants|Progressive Disease|0|||
160850781|NCT00543387|580841598|FG004|Crossover Participants|Progressive Disease|0|||
160850782|NCT00543387|580841599|FG005|Crossover Participants|Progressive Disease|0|||
160850783|NCT00543387|580841600|FG006|Crossover Participants|Progressive Disease|0|||
160850784|NCT00543387|580841601|FG007|Crossover Participants|Progressive Disease|0|||
160850785|NCT00543387|580841602|FG008|Crossover Participants|Progressive Disease|0|||
160850786|NCT00543387|580841603|FG009|Crossover Participants|Progressive Disease|1|||
160850787|NCT00543387|580841604|FG010|Crossover Participants|Progressive Disease|2|||
160850788|NCT00543387|580841594|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
160850789|NCT00543387|580841595|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
160850790|NCT00543387|580841596|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
160850791|NCT00543387|580841597|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
160850792|NCT00543387|580841598|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
160850793|NCT00543387|580841599|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
160850794|NCT00543387|580841600|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
160992509|NCT03999554|581361388|FG003|Overall Study|Protocol Violation|0|||
160850795|NCT00543387|580841601|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
160850796|NCT00543387|580841602|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
160850797|NCT00543387|580841603|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
160850798|NCT00543387|580841604|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
160850799|NCT01223183|580841610|FG000|Imaging Day 1|Physician Decision|0|||
160850800|NCT01223183|580841611|FG001|Imaging Day 1|Physician Decision|1|||
160850801|NCT01223183|580841610|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
160850802|NCT01223183|580841611|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
160850803|NCT01223183|580841610|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
160850804|NCT01223183|580841611|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
160850805|NCT03772665|580841612|FG000|Overall Study|Protocol Violation|1|||
160850806|NCT03772665|580841613|FG001|Overall Study|Protocol Violation|0|||
160850807|NCT02719171|580843585|FG000|Overall Study|Adverse Event|1|||
160850808|NCT02719171|580843586|FG001|Overall Study|Adverse Event|2|||
160850809|NCT02719171|580843587|FG002|Overall Study|Adverse Event|0|||
160850810|NCT02719171|580843588|FG003|Overall Study|Adverse Event|0|||
160850811|NCT02719171|580843589|FG004|Overall Study|Adverse Event|2|||
160850812|NCT02719171|580843585|FG000|Overall Study|Lost to Follow-up|0|||
160850813|NCT02719171|580843586|FG001|Overall Study|Lost to Follow-up|0|||
160850814|NCT02719171|580843587|FG002|Overall Study|Lost to Follow-up|1|||
160850815|NCT02719171|580843588|FG003|Overall Study|Lost to Follow-up|0|||
160850816|NCT02719171|580843589|FG004|Overall Study|Lost to Follow-up|0|||
160850817|NCT02719171|580843585|FG000|Overall Study|Subject Withdrawal|0|||
160850818|NCT02719171|580843586|FG001|Overall Study|Subject Withdrawal|2|||
160850819|NCT02719171|580843587|FG002|Overall Study|Subject Withdrawal|2|||
160850820|NCT02719171|580843588|FG003|Overall Study|Subject Withdrawal|1|||
160850821|NCT02719171|580843589|FG004|Overall Study|Subject Withdrawal|0|||
160850822|NCT02719171|580843585|FG000|Overall Study|Other|0|||
160850823|NCT02719171|580843586|FG001|Overall Study|Other|0|||
160850824|NCT02719171|580843587|FG002|Overall Study|Other|0|||
160850825|NCT02719171|580843588|FG003|Overall Study|Other|1|||
160850826|NCT02719171|580843589|FG004|Overall Study|Other|0|||
160850827|NCT02539797|580843593|FG000|Overall Study|Lost to Follow-up|0|||
160850828|NCT02539797|580843594|FG001|Overall Study|Lost to Follow-up|1|||
160850829|NCT02539797|580843595|FG002|Overall Study|Lost to Follow-up|0|||
160850830|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850831|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
160850832|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850833|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850834|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
160850835|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
160850836|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
160850837|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
160850838|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
160850839|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
160850840|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
160850841|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
160850842|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
160850843|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
160850844|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
160850845|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
160850846|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
160850847|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
160850848|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
160850849|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
160850850|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
160850851|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
160850852|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
160850853|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
160850854|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
160850855|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
160850856|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
160850857|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
160850858|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
160850859|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
160906715|NCT00622284|581052284|FG000|Overall Study|Adverse Event|61|||
160906716|NCT00622284|581052285|FG001|Overall Study|Adverse Event|90|||
160906717|NCT00622284|581052284|FG000|Overall Study|Protocol Violation|12|||
160906718|NCT00622284|581052285|FG001|Overall Study|Protocol Violation|5|||
160906719|NCT00622284|581052284|FG000|Overall Study|Lost to Follow-up|11|||
160906720|NCT00622284|581052285|FG001|Overall Study|Lost to Follow-up|13|||
160850860|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
160850861|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
160850862|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
160850863|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
160850864|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
160850865|NCT02831764|580843596|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850866|NCT02831764|580843597|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
160850867|NCT02831764|580843598|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850868|NCT02831764|580843599|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850869|NCT02831764|580843600|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
160850870|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160850871|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160850872|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
160850873|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
160850874|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
160850875|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850876|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850877|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
160850878|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850879|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
160850880|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160850881|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160850882|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
160850883|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
160850884|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
160850885|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850886|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850887|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
160850888|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850889|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
160850890|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160850891|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160850892|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
160850893|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
160850894|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
160850895|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160850896|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160850897|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
160850898|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
160850899|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
160850900|NCT02831764|580843596|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160906721|NCT00622284|581052284|FG000|Overall Study|Withdrawal by Subject|27|||
160906722|NCT00622284|581052285|FG001|Overall Study|Withdrawal by Subject|24|||
160906723|NCT00622284|581052284|FG000|Overall Study|Other reason (not specified)|33|||
160906724|NCT00622284|581052285|FG001|Overall Study|Other reason (not specified)|24|||
160906725|NCT02935842|581052286|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
160906726|NCT02935842|581052287|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
160906727|NCT02935842|581052288|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
160906728|NCT02935842|581052289|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
160906729|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
160906730|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
160906731|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
160906732|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
160906733|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
160906734|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
160906735|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
160906736|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
160906737|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
160906738|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
160906739|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
160906740|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
160906741|NCT02935842|581052286|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
160906742|NCT02935842|581052287|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
160906743|NCT02935842|581052288|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
160850901|NCT02831764|580843597|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160850902|NCT02831764|580843598|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
160850903|NCT02831764|580843599|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
160850904|NCT02831764|580843600|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
160850905|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850906|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850907|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850908|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
160850909|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
160850910|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850911|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850912|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850913|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
160850914|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
160850915|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850916|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850917|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850918|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
160850919|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
160850920|NCT02831764|580843596|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850921|NCT02831764|580843597|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850922|NCT02831764|580843598|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850923|NCT02831764|580843599|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
160850924|NCT02831764|580843600|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
160850925|NCT02796677|580843606|FG000|Overall Study|Adverse Event|11|||
160850926|NCT02796677|580843607|FG001|Overall Study|Adverse Event|22|||
160850927|NCT02796677|580843608|FG002|Overall Study|Adverse Event|14|||
160850928|NCT02796677|580843609|FG003|Overall Study|Adverse Event|14|||
160850929|NCT02796677|580843606|FG000|Overall Study|Protocol Violation|7|||
160850930|NCT02796677|580843607|FG001|Overall Study|Protocol Violation|5|||
160850931|NCT02796677|580843608|FG002|Overall Study|Protocol Violation|4|||
160850932|NCT02796677|580843609|FG003|Overall Study|Protocol Violation|8|||
160850933|NCT02796677|580843606|FG000|Overall Study|Lost to Follow-up|1|||
160850934|NCT02796677|580843607|FG001|Overall Study|Lost to Follow-up|5|||
160850935|NCT02796677|580843608|FG002|Overall Study|Lost to Follow-up|2|||
160850936|NCT02796677|580843609|FG003|Overall Study|Lost to Follow-up|2|||
160850937|NCT02796677|580843606|FG000|Overall Study|Lack of Efficacy|7|||
160850938|NCT02796677|580843607|FG001|Overall Study|Lack of Efficacy|9|||
160850939|NCT02796677|580843608|FG002|Overall Study|Lack of Efficacy|14|||
160850940|NCT02796677|580843609|FG003|Overall Study|Lack of Efficacy|20|||
160850941|NCT02796677|580843606|FG000|Overall Study|Withdrawal by Subject|4|||
160850942|NCT02796677|580843607|FG001|Overall Study|Withdrawal by Subject|14|||
160850943|NCT02796677|580843608|FG002|Overall Study|Withdrawal by Subject|6|||
160850944|NCT02796677|580843609|FG003|Overall Study|Withdrawal by Subject|7|||
160850945|NCT02796677|580843606|FG000|Overall Study|Progressive disease|6|||
160850946|NCT02796677|580843607|FG001|Overall Study|Progressive disease|15|||
160850947|NCT02796677|580843608|FG002|Overall Study|Progressive disease|13|||
160850948|NCT02796677|580843609|FG003|Overall Study|Progressive disease|18|||
160850949|NCT02796677|580843606|FG000|Overall Study|Reason not mentioned|2|||
160850950|NCT02796677|580843607|FG001|Overall Study|Reason not mentioned|3|||
160850951|NCT02796677|580843608|FG002|Overall Study|Reason not mentioned|0|||
160850952|NCT02796677|580843609|FG003|Overall Study|Reason not mentioned|5|||
160850953|NCT00961181|580843610|FG000|Overall Study|Death|2|||
160850954|NCT00961181|580843610|FG000|Overall Study|Withdrawal by Subject|2|||
160850955|NCT00961181|580843610|FG000|Overall Study|Lost to Follow-up|1|||
160850956|NCT01777308|580843613|FG000|Overall Study|Withdrawal by Subject|5|||
160850957|NCT01777308|580843614|FG001|Overall Study|Withdrawal by Subject|1|||
160906744|NCT02935842|581052289|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
160906745|NCT00915278|581052292|FG000|Overall Study|Death|1|||
160906746|NCT00915278|581052293|FG001|Overall Study|Death|0|||
160850958|NCT01777308|580843613|FG000|Overall Study|Migrated/moved from study area|1|||
160850959|NCT01777308|580843614|FG001|Overall Study|Migrated/moved from study area|0|||
160850960|NCT01777308|580843613|FG000|Overall Study|Lost to Follow-up|7|||
160850961|NCT01777308|580843614|FG001|Overall Study|Lost to Follow-up|2|||
160906747|NCT00915278|581052294|FG002|Overall Study|Death|0|||
160906748|NCT00915278|581052295|FG003|Overall Study|Death|0|||
160906749|NCT00915278|581052296|FG004|Overall Study|Death|0|||
160906750|NCT00915278|581052297|FG005|Overall Study|Death|0|||
160906751|NCT00915278|581052292|FG000|Overall Study|Lost to Follow-up|0|||
160906752|NCT00915278|581052293|FG001|Overall Study|Lost to Follow-up|1|||
160906753|NCT00915278|581052294|FG002|Overall Study|Lost to Follow-up|0|||
160906754|NCT00915278|581052295|FG003|Overall Study|Lost to Follow-up|0|||
160906755|NCT00915278|581052296|FG004|Overall Study|Lost to Follow-up|0|||
160850962|NCT01777308|580843613|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
160850963|NCT01777308|580843614|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
160850964|NCT03212326|580843616|FG000|Overall Study|Physician Decision|4|||
160850965|NCT01517750|580843628|FG000|Overall Study|Lost to Follow-up|1|||
160850966|NCT01517750|580843629|FG001|Overall Study|Lost to Follow-up|2|||
160850967|NCT01517750|580843630|FG002|Overall Study|Lost to Follow-up|4|||
160850968|NCT01517750|580843631|FG003|Overall Study|Lost to Follow-up|1|||
160850969|NCT01855412|580843632|FG000|Overall Study|Death|77|||
160850970|NCT01855412|580843633|FG001|Overall Study|Death|123|||
160850971|NCT01855412|580843634|FG002|Overall Study|Death|30|||
160850972|NCT01855412|580843632|FG000|Overall Study|Lost to Follow-up|28|||
160850973|NCT01855412|580843633|FG001|Overall Study|Lost to Follow-up|46|||
160850974|NCT01855412|580843634|FG002|Overall Study|Lost to Follow-up|15|||
160850975|NCT01855412|580843632|FG000|Overall Study|Withdrawal by Subject|77|||
160850976|NCT01855412|580843633|FG001|Overall Study|Withdrawal by Subject|123|||
160850977|NCT01855412|580843634|FG002|Overall Study|Withdrawal by Subject|24|||
160906756|NCT00915278|581052297|FG005|Overall Study|Lost to Follow-up|0|||
160906757|NCT00915278|581052292|FG000|Overall Study|Withdrawal by Subject|0|||
160906758|NCT00915278|581052293|FG001|Overall Study|Withdrawal by Subject|1|||
160850978|NCT01855412|580843632|FG000|Overall Study|Physician Decision|25|||
160850979|NCT01855412|580843633|FG001|Overall Study|Physician Decision|31|||
160850980|NCT01855412|580843634|FG002|Overall Study|Physician Decision|3|||
160850981|NCT01855412|580843632|FG000|Overall Study|Site Closure|4|||
160850982|NCT01855412|580843633|FG001|Overall Study|Site Closure|18|||
160850983|NCT01855412|580843634|FG002|Overall Study|Site Closure|1|||
160850984|NCT01855412|580843632|FG000|Overall Study|Reason not Specified|1|||
160850985|NCT01855412|580843633|FG001|Overall Study|Reason not Specified|2|||
160850986|NCT01855412|580843634|FG002|Overall Study|Reason not Specified|3|||
160850987|NCT03347123|580843637|FG000|Overall Study|Death|1|||
160850988|NCT03347123|580843638|FG001|Overall Study|Death|2|||
160850989|NCT03347123|580843639|FG002|Overall Study|Death|0|||
160850990|NCT03347123|580843640|FG003|Overall Study|Death|0|||
160850991|NCT03347123|580843641|FG004|Overall Study|Death|0|||
160850992|NCT03347123|580843642|FG005|Overall Study|Death|0|||
160850993|NCT03347123|580843643|FG006|Overall Study|Death|0|||
160850994|NCT03347123|580843637|FG000|Overall Study|Withdrawal by Subject|1|||
160850995|NCT03347123|580843638|FG001|Overall Study|Withdrawal by Subject|0|||
160850996|NCT03347123|580843639|FG002|Overall Study|Withdrawal by Subject|0|||
160906759|NCT00915278|581052294|FG002|Overall Study|Withdrawal by Subject|0|||
160906760|NCT00915278|581052295|FG003|Overall Study|Withdrawal by Subject|0|||
160906761|NCT00915278|581052296|FG004|Overall Study|Withdrawal by Subject|1|||
160906762|NCT00915278|581052297|FG005|Overall Study|Withdrawal by Subject|4|||
160906763|NCT00915278|581052292|FG000|Overall Study|Adverse Event|4|||
160906764|NCT00915278|581052293|FG001|Overall Study|Adverse Event|1|||
160906765|NCT00915278|581052294|FG002|Overall Study|Adverse Event|0|||
160906766|NCT00915278|581052295|FG003|Overall Study|Adverse Event|0|||
160906767|NCT00915278|581052296|FG004|Overall Study|Adverse Event|0|||
160906768|NCT00915278|581052297|FG005|Overall Study|Adverse Event|0|||
160906769|NCT00915278|581052292|FG000|Overall Study|Progressive disease/clinical progression|0|||
160906770|NCT00915278|581052293|FG001|Overall Study|Progressive disease/clinical progression|0|||
160906771|NCT00915278|581052294|FG002|Overall Study|Progressive disease/clinical progression|0|||
160906772|NCT00915278|581052295|FG003|Overall Study|Progressive disease/clinical progression|3|||
160906773|NCT00915278|581052296|FG004|Overall Study|Progressive disease/clinical progression|1|||
160906774|NCT00915278|581052297|FG005|Overall Study|Progressive disease/clinical progression|2|||
160906775|NCT00915278|581052292|FG000|Overall Study|Infusion related AEs|0|||
160906776|NCT00915278|581052293|FG001|Overall Study|Infusion related AEs|0|||
160906777|NCT00915278|581052294|FG002|Overall Study|Infusion related AEs|0|||
160906778|NCT00915278|581052295|FG003|Overall Study|Infusion related AEs|0|||
160906779|NCT00915278|581052296|FG004|Overall Study|Infusion related AEs|0|||
160850997|NCT03347123|580843640|FG003|Overall Study|Withdrawal by Subject|0|||
161255192|NCT02688387|582314150|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255193|NCT02688387|582314151|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255194|NCT02688387|582314152|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
161255195|NCT02688387|582314153|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
160850998|NCT03347123|580843641|FG004|Overall Study|Withdrawal by Subject|0|||
160850999|NCT03347123|580843642|FG005|Overall Study|Withdrawal by Subject|0|||
160851000|NCT03347123|580843643|FG006|Overall Study|Withdrawal by Subject|0|||
160851001|NCT03347123|580843637|FG000|Overall Study|Reason not Specified|3|||
160906780|NCT00915278|581052297|FG005|Overall Study|Infusion related AEs|2|||
160906781|NCT00915278|581052292|FG000|Overall Study|Admission to hospice|0|||
160906782|NCT00915278|581052293|FG001|Overall Study|Admission to hospice|0|||
160851002|NCT03347123|580843638|FG001|Overall Study|Reason not Specified|4|||
160851003|NCT03347123|580843639|FG002|Overall Study|Reason not Specified|0|||
160851004|NCT03347123|580843640|FG003|Overall Study|Reason not Specified|0|||
160851005|NCT03347123|580843641|FG004|Overall Study|Reason not Specified|0|||
160851006|NCT03347123|580843642|FG005|Overall Study|Reason not Specified|0|||
160851007|NCT03347123|580843643|FG006|Overall Study|Reason not Specified|0|||
161255196|NCT02688387|582314132|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255197|NCT02688387|582314133|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255198|NCT02688387|582314134|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255199|NCT02688387|582314135|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
160851008|NCT01276639|580843649|FG000|Week 0 to 16|Death|1|||
160851009|NCT01276639|580843650|FG001|Week 0 to 16|Death|0|||
160851010|NCT01276639|580843651|FG002|Week 0 to 16|Death|0|||
160851011|NCT01276639|580843652|FG003|Week 0 to 16|Death|0|||
160851012|NCT01276639|580843653|FG004|Week 0 to 16|Death|0|||
160851013|NCT01276639|580843649|FG000|Week 0 to 16|Adverse Event|11|||
161255200|NCT02688387|582314136|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160851014|NCT01276639|580843650|FG001|Week 0 to 16|Adverse Event|8|||
160851015|NCT01276639|580843651|FG002|Week 0 to 16|Adverse Event|11|||
160851016|NCT01276639|580843652|FG003|Week 0 to 16|Adverse Event|0|||
160851017|NCT01276639|580843653|FG004|Week 0 to 16|Adverse Event|0|||
160851018|NCT01276639|580843649|FG000|Week 0 to 16|Lack of Efficacy|20|||
160851019|NCT01276639|580843650|FG001|Week 0 to 16|Lack of Efficacy|15|||
160851020|NCT01276639|580843651|FG002|Week 0 to 16|Lack of Efficacy|25|||
160851021|NCT01276639|580843652|FG003|Week 0 to 16|Lack of Efficacy|0|||
160851022|NCT01276639|580843653|FG004|Week 0 to 16|Lack of Efficacy|0|||
160851023|NCT01276639|580843649|FG000|Week 0 to 16|Lost to Follow-up|3|||
160851024|NCT01276639|580843650|FG001|Week 0 to 16|Lost to Follow-up|5|||
160851025|NCT01276639|580843651|FG002|Week 0 to 16|Lost to Follow-up|3|||
160851026|NCT01276639|580843652|FG003|Week 0 to 16|Lost to Follow-up|0|||
160851027|NCT01276639|580843653|FG004|Week 0 to 16|Lost to Follow-up|0|||
160851028|NCT01276639|580843649|FG000|Week 0 to 16|Withdrawal by Subject|8|||
160851029|NCT01276639|580843650|FG001|Week 0 to 16|Withdrawal by Subject|5|||
160851030|NCT01276639|580843651|FG002|Week 0 to 16|Withdrawal by Subject|4|||
160851031|NCT01276639|580843652|FG003|Week 0 to 16|Withdrawal by Subject|0|||
160851032|NCT01276639|580843653|FG004|Week 0 to 16|Withdrawal by Subject|0|||
160851033|NCT01276639|580843649|FG000|Week 0 to 16|Other|7|||
160851034|NCT01276639|580843650|FG001|Week 0 to 16|Other|7|||
160851035|NCT01276639|580843651|FG002|Week 0 to 16|Other|2|||
160851036|NCT01276639|580843652|FG003|Week 0 to 16|Other|0|||
160851037|NCT01276639|580843653|FG004|Week 0 to 16|Other|0|||
160851038|NCT01276639|580843649|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
160851039|NCT01276639|580843650|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
160851040|NCT01276639|580843651|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
160851041|NCT01276639|580843652|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
160851042|NCT01276639|580843653|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
160851043|NCT01276639|580843649|FG000|Week 16 to 52|Death|1|||
160851044|NCT01276639|580843650|FG001|Week 16 to 52|Death|0|||
160851045|NCT01276639|580843651|FG002|Week 16 to 52|Death|0|||
160851046|NCT01276639|580843652|FG003|Week 16 to 52|Death|0|||
160851047|NCT01276639|580843653|FG004|Week 16 to 52|Death|0|||
160851048|NCT01276639|580843649|FG000|Week 16 to 52|Adverse Event|10|||
160851049|NCT01276639|580843650|FG001|Week 16 to 52|Adverse Event|13|||
160851050|NCT01276639|580843651|FG002|Week 16 to 52|Adverse Event|0|||
160851051|NCT01276639|580843652|FG003|Week 16 to 52|Adverse Event|1|||
160851052|NCT01276639|580843653|FG004|Week 16 to 52|Adverse Event|3|||
160851053|NCT01276639|580843649|FG000|Week 16 to 52|Lack of Efficacy|99|||
160851054|NCT01276639|580843650|FG001|Week 16 to 52|Lack of Efficacy|71|||
160851055|NCT01276639|580843651|FG002|Week 16 to 52|Lack of Efficacy|0|||
160851056|NCT01276639|580843652|FG003|Week 16 to 52|Lack of Efficacy|14|||
160851057|NCT01276639|580843653|FG004|Week 16 to 52|Lack of Efficacy|13|||
160851058|NCT01276639|580843649|FG000|Week 16 to 52|Lost to Follow-up|3|||
160851059|NCT01276639|580843650|FG001|Week 16 to 52|Lost to Follow-up|1|||
160851060|NCT01276639|580843651|FG002|Week 16 to 52|Lost to Follow-up|0|||
160851061|NCT01276639|580843652|FG003|Week 16 to 52|Lost to Follow-up|0|||
160851062|NCT01276639|580843653|FG004|Week 16 to 52|Lost to Follow-up|1|||
160851063|NCT01276639|580843649|FG000|Week 16 to 52|Withdrawal by Subject|4|||
160851064|NCT01276639|580843650|FG001|Week 16 to 52|Withdrawal by Subject|4|||
160851065|NCT01276639|580843651|FG002|Week 16 to 52|Withdrawal by Subject|0|||
160851066|NCT01276639|580843652|FG003|Week 16 to 52|Withdrawal by Subject|0|||
160851067|NCT01276639|580843653|FG004|Week 16 to 52|Withdrawal by Subject|1|||
160851068|NCT01276639|580843649|FG000|Week 16 to 52|Other|10|||
160851069|NCT01276639|580843650|FG001|Week 16 to 52|Other|12|||
160851070|NCT01276639|580843651|FG002|Week 16 to 52|Other|0|||
160851071|NCT01276639|580843652|FG003|Week 16 to 52|Other|1|||
160851072|NCT01276639|580843653|FG004|Week 16 to 52|Other|3|||
160851073|NCT01132807|580843658|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
160851074|NCT01132807|580843659|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
160851075|NCT01132807|580843660|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
160851076|NCT01132807|580843658|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
160851077|NCT01132807|580843659|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
160851078|NCT01132807|580843660|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
160851079|NCT01380769|580843661|FG000|Overall Study|Withdrawal by Subject|7|||
160851080|NCT01380769|580843662|FG001|Overall Study|Withdrawal by Subject|11|||
160851081|NCT01380769|580843661|FG000|Overall Study|Physician Decision|1|||
160851082|NCT01380769|580843662|FG001|Overall Study|Physician Decision|1|||
160851083|NCT01380769|580843661|FG000|Overall Study|Adverse Event|1|||
160851084|NCT01380769|580843662|FG001|Overall Study|Adverse Event|1|||
160851085|NCT01380769|580843661|FG000|Overall Study|Protocol Violation|0|||
160851086|NCT01380769|580843662|FG001|Overall Study|Protocol Violation|1|||
160851087|NCT03654690|580843664|FG000|Overall Study|Withdrawal by Subject|1|||
160851088|NCT03654690|580843665|FG001|Overall Study|Withdrawal by Subject|0|||
160851089|NCT03654690|580843666|FG002|Overall Study|Withdrawal by Subject|0|||
160851090|NCT00742183|580843669|FG000|Overall Study|Adverse Event|2|||
160851091|NCT00742183|580843670|FG001|Overall Study|Adverse Event|2|||
160851092|NCT00742183|580843669|FG000|Overall Study|Death|1|||
160851093|NCT00742183|580843670|FG001|Overall Study|Death|0|||
160851094|NCT00742183|580843669|FG000|Overall Study|Physician Decision|0|||
160851095|NCT00742183|580843670|FG001|Overall Study|Physician Decision|2|||
160851096|NCT00742183|580843669|FG000|Overall Study|Lost to Follow-up|4|||
160851097|NCT00742183|580843670|FG001|Overall Study|Lost to Follow-up|4|||
160851098|NCT00742183|580843669|FG000|Overall Study|Required skin-graft|1|||
160851099|NCT00742183|580843670|FG001|Overall Study|Required skin-graft|1|||
160851100|NCT00742183|580843669|FG000|Overall Study|Withdrawal by Subject|1|||
160851101|NCT00742183|580843670|FG001|Overall Study|Withdrawal by Subject|0|||
160851102|NCT00742183|580843669|FG000|Overall Study|Lack of Efficacy|0|||
160851103|NCT00742183|580843670|FG001|Overall Study|Lack of Efficacy|3|||
160851104|NCT01176058|580843682|FG000|Overall Study|Adverse Event|1|||
160851105|NCT01176058|580843683|FG001|Overall Study|Adverse Event|0|||
160851106|NCT01176058|580843682|FG000|Overall Study|Insufficient clinical response|2|||
160851107|NCT01176058|580843683|FG001|Overall Study|Insufficient clinical response|2|||
160851108|NCT01176058|580843682|FG000|Overall Study|Insufficient mycological response|0|||
160851109|NCT01176058|580843683|FG001|Overall Study|Insufficient mycological response|1|||
160851110|NCT01176058|580843682|FG000|Overall Study|Withdrawal by Subject|1|||
160851111|NCT01176058|580843683|FG001|Overall Study|Withdrawal by Subject|0|||
160851112|NCT00256724|580843686|FG000|Overall Study|Physician Decision|2|||
160851113|NCT00256724|580843687|FG001|Overall Study|Physician Decision|5|||
160851114|NCT00256724|580843686|FG000|Overall Study|Protocol Violation|3|||
160851115|NCT00256724|580843687|FG001|Overall Study|Protocol Violation|3|||
160851116|NCT01217463|580843688|FG000|Overall Study|Adverse Event|8|||
160851117|NCT01217463|580843689|FG001|Overall Study|Adverse Event|5|||
160851118|NCT01217463|580843688|FG000|Overall Study|Physician Decision|0|||
160851119|NCT01217463|580843689|FG001|Overall Study|Physician Decision|1|||
160851120|NCT01217463|580843688|FG000|Overall Study|Withdrawal by Subject|3|||
160851121|NCT01217463|580843689|FG001|Overall Study|Withdrawal by Subject|0|||
160851122|NCT01217463|580843688|FG000|Overall Study|Surgery on the Target Limb|0|||
160851123|NCT01217463|580843689|FG001|Overall Study|Surgery on the Target Limb|1|||
160851124|NCT01217463|580843688|FG000|Overall Study|Patient Non-compliant|1|||
160851125|NCT01217463|580843689|FG001|Overall Study|Patient Non-compliant|0|||
160851126|NCT01217463|580843688|FG000|Overall Study|Other|1|||
160851127|NCT01217463|580843689|FG001|Overall Study|Other|1|||
160851128|NCT01569841|580843690|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
160851129|NCT01569841|580843691|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
160851130|NCT05114473|580843694|FG000|Overall Study|Lost to Follow-up|2|||
160851131|NCT05114473|580843695|FG001|Overall Study|Lost to Follow-up|2|||
160851132|NCT05114473|580843696|FG002|Overall Study|Lost to Follow-up|0|||
160851133|NCT00782717|580843698|FG000|Overall Study|Adverse Event|2|||
160851134|NCT00782717|580843699|FG001|Overall Study|Adverse Event|5|||
160851135|NCT00782717|580843698|FG000|Overall Study|Patient decision unrelated to AE|6|||
160851136|NCT00782717|580843699|FG001|Overall Study|Patient decision unrelated to AE|3|||
160851137|NCT00782717|580843698|FG000|Overall Study|Noncompliance|2|||
160851138|NCT00782717|580843699|FG001|Overall Study|Noncompliance|1|||
160906783|NCT00915278|581052294|FG002|Overall Study|Admission to hospice|1|||
160906784|NCT00915278|581052295|FG003|Overall Study|Admission to hospice|0|||
160906785|NCT00915278|581052296|FG004|Overall Study|Admission to hospice|0|||
160906786|NCT00915278|581052297|FG005|Overall Study|Admission to hospice|0|||
160906787|NCT02412618|581052298|FG000|Overall Study|Withdrawal by Subject|1|||
160906788|NCT02412618|581052299|FG001|Overall Study|Withdrawal by Subject|1|||
160851139|NCT00782717|580843698|FG000|Overall Study|Treatment failure|3|||
160851140|NCT00782717|580843699|FG001|Overall Study|Treatment failure|14|||
160851141|NCT00782717|580843698|FG000|Overall Study|Enrollment close prior to surgery|1|||
160851142|NCT00782717|580843699|FG001|Overall Study|Enrollment close prior to surgery|0|||
160851143|NCT00782717|580843698|FG000|Overall Study|Did not meet entrance criteria|1|||
160851144|NCT00782717|580843699|FG001|Overall Study|Did not meet entrance criteria|3|||
160851145|NCT00782717|580843698|FG000|Overall Study|Exited in error|0|||
160906789|NCT02412618|581052298|FG000|Overall Study|Expulsion|1|||
160906790|NCT02412618|581052299|FG001|Overall Study|Expulsion|1|||
160851146|NCT00782717|580843699|FG001|Overall Study|Exited in error|2|||
160851147|NCT02446717|580843700|FG000|Overall Study|Adverse Event|0|||
160851148|NCT02446717|580843701|FG001|Overall Study|Adverse Event|0|||
160851149|NCT02446717|580843702|FG002|Overall Study|Adverse Event|1|||
160851150|NCT02446717|580843703|FG003|Overall Study|Adverse Event|0|||
160851151|NCT02446717|580843704|FG004|Overall Study|Adverse Event|0|||
160851152|NCT02446717|580843700|FG000|Overall Study|Lost to Follow-up|0|||
160851153|NCT02446717|580843701|FG001|Overall Study|Lost to Follow-up|1|||
160851154|NCT02446717|580843702|FG002|Overall Study|Lost to Follow-up|1|||
160851155|NCT02446717|580843703|FG003|Overall Study|Lost to Follow-up|0|||
160851156|NCT02446717|580843704|FG004|Overall Study|Lost to Follow-up|1|||
160851157|NCT02446717|580843700|FG000|Overall Study|Withdrew consent|0|||
160851158|NCT02446717|580843701|FG001|Overall Study|Withdrew consent|0|||
160851159|NCT02446717|580843702|FG002|Overall Study|Withdrew consent|0|||
160851160|NCT02446717|580843703|FG003|Overall Study|Withdrew consent|1|||
160851161|NCT02446717|580843704|FG004|Overall Study|Withdrew consent|0|||
160851162|NCT00650767|580843713|FG000|Overall Study|Adverse Event|0|||
160851163|NCT00650767|580843714|FG001|Overall Study|Adverse Event|3|||
160851164|NCT00650767|580843715|FG002|Overall Study|Adverse Event|10|||
160851165|NCT00650767|580843716|FG003|Overall Study|Adverse Event|8|||
160851166|NCT00650767|580843713|FG000|Overall Study|Death|1|||
160851167|NCT00650767|580843714|FG001|Overall Study|Death|0|||
160851168|NCT00650767|580843715|FG002|Overall Study|Death|0|||
160851169|NCT00650767|580843716|FG003|Overall Study|Death|0|||
160851170|NCT00650767|580843713|FG000|Overall Study|Withdrawal by Subject|2|||
160851171|NCT00650767|580843714|FG001|Overall Study|Withdrawal by Subject|4|||
160851172|NCT00650767|580843715|FG002|Overall Study|Withdrawal by Subject|3|||
160851173|NCT00650767|580843716|FG003|Overall Study|Withdrawal by Subject|3|||
160851174|NCT00650767|580843713|FG000|Overall Study|Lost to Follow-up|1|||
160851175|NCT00650767|580843714|FG001|Overall Study|Lost to Follow-up|1|||
160851176|NCT00650767|580843715|FG002|Overall Study|Lost to Follow-up|1|||
160851177|NCT00650767|580843716|FG003|Overall Study|Lost to Follow-up|0|||
160851178|NCT00650767|580843713|FG000|Overall Study|Other|1|||
160851179|NCT00650767|580843714|FG001|Overall Study|Other|1|||
160851180|NCT00650767|580843715|FG002|Overall Study|Other|0|||
160851181|NCT00650767|580843716|FG003|Overall Study|Other|0|||
160851182|NCT03649074|580843717|FG000|Overall Study|Lost to Follow-up|2|||
160851183|NCT03649074|580843718|FG001|Overall Study|Lost to Follow-up|1|||
160851184|NCT03649074|580843717|FG000|Overall Study|Adverse Event|1|||
160851185|NCT03649074|580843718|FG001|Overall Study|Adverse Event|0|||
160851186|NCT03649074|580843717|FG000|Overall Study|Physician Decision|1|||
160851187|NCT03649074|580843718|FG001|Overall Study|Physician Decision|0|||
160851188|NCT03649074|580843717|FG000|Overall Study|Withdrawal by Subject|0|||
160851189|NCT03649074|580843718|FG001|Overall Study|Withdrawal by Subject|2|||
160851190|NCT03649074|580843717|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
160851191|NCT03649074|580843718|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
160851192|NCT03649074|580843717|FG000|Overall Study|Other|1|||
160851193|NCT03649074|580843718|FG001|Overall Study|Other|0|||
160851194|NCT03775486|580843719|FG000|Initial Therapy Phase|Other reason provided|0|||
160851195|NCT03775486|580843720|FG001|Initial Therapy Phase|Other reason provided|15|||
160851196|NCT03775486|580843719|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
160851197|NCT03775486|580843720|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
160851198|NCT03775486|580843719|FG000|Initial Therapy Phase|Protocol Violation|0|||
160851199|NCT03775486|580843720|FG001|Initial Therapy Phase|Protocol Violation|2|||
160851200|NCT03775486|580843719|FG000|Initial Therapy Phase|Adverse Event|0|||
160851201|NCT03775486|580843720|FG001|Initial Therapy Phase|Adverse Event|34|||
160851202|NCT03775486|580843719|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
160851203|NCT03775486|580843720|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
160851204|NCT03775486|580843719|FG000|Maintenance Phase|Withdrawal by Subject|13|||
160851205|NCT03775486|580843720|FG001|Maintenance Phase|Withdrawal by Subject|12|||
161141198|NCT00356915|581900991|FG000|Overall Study|Physician Decision|0|||
161141199|NCT00356915|581900992|FG001|Overall Study|Physician Decision|2|||
161141200|NCT00356915|581900993|FG002|Overall Study|Physician Decision|0|||
160851206|NCT03775486|580843719|FG000|Maintenance Phase|Death|44|||
160851207|NCT03775486|580843720|FG001|Maintenance Phase|Death|45|||
160851208|NCT00801216|580843721|FG000|Overall Study|Screening Failure|2|||
160851209|NCT05214768|580843722|FG000|Induction Period|Withdrawal by Subject|1|||
160851210|NCT05214768|580843723|FG001|Induction Period|Withdrawal by Subject|0|||
160851211|NCT05214768|580843724|FG002|Induction Period|Withdrawal by Subject|0|||
161337144|NCT00853385|582625843|FG000|Overall Study|Lack of Efficacy|6|||
160851212|NCT05214768|580843725|FG003|Induction Period|Withdrawal by Subject|0|||
160851213|NCT05214768|580843726|FG004|Induction Period|Withdrawal by Subject|0|||
160851214|NCT05214768|580843727|FG005|Induction Period|Withdrawal by Subject|0|||
160851215|NCT05214768|580843722|FG000|Induction Period|Physician Decision|1|||
160851216|NCT05214768|580843723|FG001|Induction Period|Physician Decision|0|||
160851217|NCT05214768|580843724|FG002|Induction Period|Physician Decision|0|||
160851218|NCT05214768|580843725|FG003|Induction Period|Physician Decision|0|||
160851219|NCT05214768|580843726|FG004|Induction Period|Physician Decision|0|||
160851220|NCT05214768|580843727|FG005|Induction Period|Physician Decision|0|||
160851221|NCT05214768|580843722|FG000|Maintenance Period|Other Reasons|0|||
160851222|NCT05214768|580843723|FG001|Maintenance Period|Other Reasons|0|||
160851223|NCT05214768|580843724|FG002|Maintenance Period|Other Reasons|1|||
160851224|NCT05214768|580843725|FG003|Maintenance Period|Other Reasons|1|||
161141201|NCT00356915|581900991|FG000|Overall Study|Adverse Event|21|||
161141202|NCT00356915|581900992|FG001|Overall Study|Adverse Event|31|||
160851225|NCT05214768|580843726|FG004|Maintenance Period|Other Reasons|0|||
160851226|NCT05214768|580843727|FG005|Maintenance Period|Other Reasons|0|||
160851227|NCT05214768|580843722|FG000|Maintenance Period|Withdrawal by Subject|0|||
160851228|NCT05214768|580843723|FG001|Maintenance Period|Withdrawal by Subject|0|||
160851229|NCT05214768|580843724|FG002|Maintenance Period|Withdrawal by Subject|0|||
160851230|NCT05214768|580843725|FG003|Maintenance Period|Withdrawal by Subject|1|||
160851231|NCT05214768|580843726|FG004|Maintenance Period|Withdrawal by Subject|0|||
160851232|NCT05214768|580843727|FG005|Maintenance Period|Withdrawal by Subject|0|||
160851233|NCT05214768|580843722|FG000|Maintenance Period|Lack of Efficacy|0|||
160851234|NCT05214768|580843723|FG001|Maintenance Period|Lack of Efficacy|0|||
160851235|NCT05214768|580843724|FG002|Maintenance Period|Lack of Efficacy|1|||
160851236|NCT05214768|580843725|FG003|Maintenance Period|Lack of Efficacy|0|||
160851237|NCT05214768|580843726|FG004|Maintenance Period|Lack of Efficacy|1|||
160851238|NCT05214768|580843727|FG005|Maintenance Period|Lack of Efficacy|0|||
160851239|NCT05214768|580843722|FG000|Open Label Extension Period|Physician Decision|0|||
160851240|NCT05214768|580843723|FG001|Open Label Extension Period|Physician Decision|0|||
160851241|NCT05214768|580843724|FG002|Open Label Extension Period|Physician Decision|0|||
160851242|NCT05214768|580843725|FG003|Open Label Extension Period|Physician Decision|0|||
160851243|NCT05214768|580843726|FG004|Open Label Extension Period|Physician Decision|0|||
160851244|NCT05214768|580843727|FG005|Open Label Extension Period|Physician Decision|1|||
160851245|NCT05214768|580843722|FG000|Open Label Extension Period|Lack of Efficacy|0|||
160851246|NCT05214768|580843723|FG001|Open Label Extension Period|Lack of Efficacy|0|||
160851247|NCT05214768|580843724|FG002|Open Label Extension Period|Lack of Efficacy|0|||
160851248|NCT05214768|580843725|FG003|Open Label Extension Period|Lack of Efficacy|0|||
160851249|NCT05214768|580843726|FG004|Open Label Extension Period|Lack of Efficacy|0|||
160851250|NCT05214768|580843727|FG005|Open Label Extension Period|Lack of Efficacy|1|||
160851251|NCT05214768|580843722|FG000|Open Label Extension Period|Ongoing Study|0|||
160851252|NCT05214768|580843723|FG001|Open Label Extension Period|Ongoing Study|0|||
160851253|NCT05214768|580843724|FG002|Open Label Extension Period|Ongoing Study|0|||
160851254|NCT05214768|580843725|FG003|Open Label Extension Period|Ongoing Study|0|||
160851255|NCT05214768|580843726|FG004|Open Label Extension Period|Ongoing Study|0|||
160851256|NCT05214768|580843727|FG005|Open Label Extension Period|Ongoing Study|42|||
160851257|NCT05481359|580843728|FG000|Overall Study|Lost to Follow-up|3|||
160851258|NCT05481359|580843728|FG000|Overall Study|Withdrawal by Subject|1|||
160851259|NCT00291486|580843734|FG000|Overall Study|Adverse Event|0|||
160851260|NCT00291486|580843735|FG001|Overall Study|Adverse Event|3|||
160851261|NCT00291486|580843736|FG002|Overall Study|Adverse Event|0|||
160851262|NCT00291486|580843737|FG003|Overall Study|Adverse Event|1|||
160851263|NCT00291486|580843738|FG004|Overall Study|Adverse Event|0|||
160851264|NCT00291486|580843734|FG000|Overall Study|Withdrawal by Subject|0|||
160851265|NCT00291486|580843735|FG001|Overall Study|Withdrawal by Subject|0|||
160851266|NCT00291486|580843736|FG002|Overall Study|Withdrawal by Subject|0|||
160851267|NCT00291486|580843737|FG003|Overall Study|Withdrawal by Subject|0|||
160851268|NCT00291486|580843738|FG004|Overall Study|Withdrawal by Subject|1|||
160851269|NCT00291486|580843734|FG000|Overall Study|Disease progression|1|||
160851270|NCT00291486|580843735|FG001|Overall Study|Disease progression|0|||
160851271|NCT00291486|580843736|FG002|Overall Study|Disease progression|1|||
160851272|NCT00291486|580843737|FG003|Overall Study|Disease progression|0|||
160851273|NCT00291486|580843738|FG004|Overall Study|Disease progression|0|||
160851274|NCT01232868|580844811|FG000|Overall Study|Lost to Follow-up|2|||
160851275|NCT01232868|580844812|FG001|Overall Study|Lost to Follow-up|4|||
160851276|NCT04481243|580844813|FG000|Overall Study|Withdrawal by Subject|4|||
160851277|NCT01131507|580844816|FG000|Overall Study|Adverse Event|1|||
160851278|NCT01131507|580844816|FG000|Overall Study|Lost to Follow-up|1|||
160851279|NCT01131507|580844816|FG000|Overall Study|Withdrawal by Subject|1|||
160851280|NCT00346216|580844820|FG000|Overall Study|Other|181|||
160906791|NCT00923156|581052302|FG000|Overall Study|Adverse Event|0|||
160906792|NCT00923156|581052303|FG001|Overall Study|Adverse Event|2|||
160906793|NCT00923156|581052304|FG002|Overall Study|Adverse Event|1|||
160906794|NCT00923156|581052302|FG000|Overall Study|Abnormal laboratory values|0|||
160906795|NCT00923156|581052303|FG001|Overall Study|Abnormal laboratory values|0|||
160906796|NCT00923156|581052304|FG002|Overall Study|Abnormal laboratory values|1|||
160906797|NCT00923156|581052302|FG000|Overall Study|Withdrawal by Subject|0|||
160906798|NCT00923156|581052303|FG001|Overall Study|Withdrawal by Subject|1|||
160906799|NCT00923156|581052304|FG002|Overall Study|Withdrawal by Subject|0|||
160906800|NCT00923156|581052302|FG000|Overall Study|Death|0|||
160851281|NCT00346216|580844821|FG001|Overall Study|Other|231|||
160851282|NCT00346216|580844822|FG002|Overall Study|Other|205|||
160851283|NCT00346216|580844820|FG000|Overall Study|No longer willing to participate|600|||
160851284|NCT00346216|580844821|FG001|Overall Study|No longer willing to participate|606|||
160851285|NCT00346216|580844822|FG002|Overall Study|No longer willing to participate|585|||
160851286|NCT00346216|580844820|FG000|Overall Study|Withdrawal by Subject|661|||
160851287|NCT00346216|580844821|FG001|Overall Study|Withdrawal by Subject|692|||
160851288|NCT00346216|580844822|FG002|Overall Study|Withdrawal by Subject|651|||
160851289|NCT00346216|580844820|FG000|Overall Study|Lost to Follow-up|611|||
160906801|NCT00923156|581052303|FG001|Overall Study|Death|1|||
160851290|NCT00346216|580844821|FG001|Overall Study|Lost to Follow-up|588|||
160851291|NCT00346216|580844822|FG002|Overall Study|Lost to Follow-up|542|||
160851292|NCT00346216|580844820|FG000|Overall Study|Physician Decision|80|||
160851293|NCT00346216|580844821|FG001|Overall Study|Physician Decision|76|||
160851294|NCT00346216|580844822|FG002|Overall Study|Physician Decision|59|||
160851295|NCT00346216|580844820|FG000|Overall Study|Does not meet entrance criteria|13|||
160851296|NCT00346216|580844821|FG001|Overall Study|Does not meet entrance criteria|10|||
160851297|NCT00346216|580844822|FG002|Overall Study|Does not meet entrance criteria|8|||
160851298|NCT00346216|580844820|FG000|Overall Study|Death|189|||
160851299|NCT00346216|580844821|FG001|Overall Study|Death|192|||
160851300|NCT00346216|580844822|FG002|Overall Study|Death|228|||
160851301|NCT00346216|580844820|FG000|Overall Study|Study terminated by sponsor|11|||
160851302|NCT00346216|580844821|FG001|Overall Study|Study terminated by sponsor|4|||
160851303|NCT00346216|580844822|FG002|Overall Study|Study terminated by sponsor|8|||
160851304|NCT00346216|580844820|FG000|Overall Study|Missing Subject Summary Status|62|||
160851305|NCT00346216|580844821|FG001|Overall Study|Missing Subject Summary Status|61|||
160851306|NCT00346216|580844822|FG002|Overall Study|Missing Subject Summary Status|62|||
160851307|NCT03431441|580844823|FG000|Overall Study|Withdrawal by Subject|2|||
160851308|NCT03431441|580844823|FG000|Overall Study|Adverse Event|2|||
160851309|NCT03431441|580844823|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
160851310|NCT05030350|580844827|FG000|Overall Study|Adverse Event|13|||
160851311|NCT05030350|580844827|FG000|Overall Study|Lack of Efficacy|8|||
160851312|NCT05030350|580844827|FG000|Overall Study|Lost to Follow-up|35|||
160851313|NCT05030350|580844827|FG000|Overall Study|Pregnancy|2|||
160851314|NCT05030350|580844827|FG000|Overall Study|Protocol Violation|2|||
160851315|NCT05030350|580844827|FG000|Overall Study|Withdrawal by Subject|60|||
160851316|NCT05030350|580844827|FG000|Overall Study|Study terminated by sponsor|349|||
160851317|NCT05030350|580844827|FG000|Overall Study|Positive Drug Screen|4|||
160851318|NCT05030350|580844827|FG000|Overall Study|Other|8|||
160851319|NCT03985761|580844831|FG000|Overall Study|Withdrawal by Subject|2|||
160851320|NCT03985761|580844832|FG001|Overall Study|Withdrawal by Subject|3|||
160851321|NCT01858363|580844838|FG000|Overall Study|Death|35|||
160851322|NCT01858363|580844839|FG001|Overall Study|Death|9|||
160851323|NCT01858363|580844838|FG000|Overall Study|Withdrawal by Subject|28|||
160851324|NCT01858363|580844839|FG001|Overall Study|Withdrawal by Subject|14|||
160851325|NCT01858363|580844838|FG000|Overall Study|Lost to Follow-up|13|||
160851326|NCT01858363|580844839|FG001|Overall Study|Lost to Follow-up|3|||
160851327|NCT01859923|580844840|FG000|Overall Study|Adverse Event|0|||
160851328|NCT01859923|580844841|FG001|Overall Study|Adverse Event|0|||
160851329|NCT01859923|580844842|FG002|Overall Study|Adverse Event|1|||
160851330|NCT01859923|580844843|FG003|Overall Study|Adverse Event|1|||
160851331|NCT00764361|580844849|FG000|Overall Study|Withdrawal by Subject|2|||
160851332|NCT00764361|580844850|FG001|Overall Study|Withdrawal by Subject|3|||
160851333|NCT00764361|580844849|FG000|Overall Study|Adverse Event|0|||
160851334|NCT00764361|580844850|FG001|Overall Study|Adverse Event|1|||
160851335|NCT02090426|580844851|FG000|Overall Study|Lost to Follow-up|12|||
160851336|NCT02090426|580844852|FG001|Overall Study|Lost to Follow-up|6|||
160851337|NCT01141712|580844856|FG000|Overall Study|Disease progression|3|||
160851338|NCT01308736|580844863|FG000|Overall Study|Did not attend a single session|6|||
160851339|NCT01308736|580844864|FG001|Overall Study|Did not attend a single session|5|||
160851340|NCT03634085|580844865|FG000|Overall Study|Adverse Event|1|||
160851341|NCT03634085|580844866|FG001|Overall Study|Adverse Event|0|||
160851342|NCT03634085|580844865|FG000|Overall Study|Withdrawal by Subject|0|||
160851343|NCT03634085|580844866|FG001|Overall Study|Withdrawal by Subject|2|||
160851344|NCT01054456|580844873|FG000|Overall Study|Other|1|||
160851345|NCT04701333|580844874|FG000|Overall Study|Lost to Follow-up|3|||
160851346|NCT04701333|580844875|FG001|Overall Study|Lost to Follow-up|7|||
160851347|NCT04701333|580844874|FG000|Overall Study|Withdrawal by Subject|0|||
160851348|NCT04701333|580844875|FG001|Overall Study|Withdrawal by Subject|1|||
160851349|NCT01012258|580844876|FG000|Overall Study|Death|14|||
160851350|NCT01012258|580844876|FG000|Overall Study|Lost to Follow-up|1|||
160851351|NCT01012258|580844876|FG000|Overall Study|Adverse Event|1|||
160851352|NCT01012258|580844876|FG000|Overall Study|Progressive Disease (PD)|18|||
160851353|NCT01012258|580844876|FG000|Overall Study|Symptomatic Deterioration|1|||
160906802|NCT00923156|581052304|FG002|Overall Study|Death|0|||
160851354|NCT01012258|580844876|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
160851355|NCT01012258|580844876|FG000|Overall Study|Another Tumor Discovered|1|||
160851356|NCT01012258|580844876|FG000|Overall Study|Ongoing|29|||
160851357|NCT01292187|580844877|FG000|Overall Study|Adverse Event|10|||
160851358|NCT01292187|580844878|FG001|Overall Study|Adverse Event|5|||
160851359|NCT01292187|580844877|FG000|Overall Study|Withdrawal by Subject|6|||
160851360|NCT01292187|580844878|FG001|Overall Study|Withdrawal by Subject|5|||
160851361|NCT01292187|580844877|FG000|Overall Study|All other reasons|1|||
160851362|NCT01292187|580844878|FG001|Overall Study|All other reasons|3|||
160851363|NCT01814527|580844880|FG000|Overall Study|RTP greater than 30 days|6|||
160851364|NCT01814527|580844881|FG001|Overall Study|RTP greater than 30 days|1|||
160851365|NCT00687401|580844882|FG000|Overall Study|Protocol Violation|7|||
160851366|NCT00687401|580844882|FG000|Overall Study|Adverse Event|6|||
160851367|NCT00687401|580844882|FG000|Overall Study|Lack of Efficacy|6|||
160851368|NCT00687401|580844882|FG000|Overall Study|Withdrawal by Subject|4|||
160851369|NCT00687401|580844882|FG000|Overall Study|Did not return for visit|3|||
160851370|NCT00687401|580844882|FG000|Overall Study|For reasons different from those above|4|||
160851371|NCT02366195|580844883|FG000|Overall Study|Protocol-specified criteria|3|||
160851372|NCT02366195|580844883|FG000|Overall Study|Withdrawal by Subject|9|||
160851373|NCT02366195|580844883|FG000|Overall Study|Lost to Follow-up|1|||
160851374|NCT02366195|580844883|FG000|Overall Study|Death|41|||
160851375|NCT00113841|580844884|FG000|Overall Study|Disease progression|0|||
160851376|NCT00113841|580844885|FG001|Overall Study|Disease progression|2|||
160851377|NCT00113841|580844884|FG000|Overall Study|Non-compliant|1|||
160851378|NCT00113841|580844885|FG001|Overall Study|Non-compliant|0|||
160851379|NCT02520726|580844886|FG000|Overall Study|Lost to Follow-up|3|||
160851380|NCT02520726|580844887|FG001|Overall Study|Lost to Follow-up|2|||
160851381|NCT00721396|580844888|FG000|Overall Study|Adverse Event|4|||
160851382|NCT00721396|580844889|FG001|Overall Study|Adverse Event|7|||
160851383|NCT00721396|580844890|FG002|Overall Study|Adverse Event|2|||
160851384|NCT00721396|580844891|FG003|Overall Study|Adverse Event|0|||
160851385|NCT00721396|580844888|FG000|Overall Study|Withdrawal by Subject|12|||
160851386|NCT00721396|580844889|FG001|Overall Study|Withdrawal by Subject|15|||
160851387|NCT00721396|580844890|FG002|Overall Study|Withdrawal by Subject|3|||
160851388|NCT00721396|580844891|FG003|Overall Study|Withdrawal by Subject|7|||
160851389|NCT00721396|580844888|FG000|Overall Study|Lost to Follow-up|7|||
160851390|NCT00721396|580844889|FG001|Overall Study|Lost to Follow-up|9|||
160851391|NCT00721396|580844890|FG002|Overall Study|Lost to Follow-up|3|||
160851392|NCT00721396|580844891|FG003|Overall Study|Lost to Follow-up|3|||
160851393|NCT00721396|580844888|FG000|Overall Study|Protocol Violation|4|||
160851394|NCT00721396|580844889|FG001|Overall Study|Protocol Violation|3|||
160851395|NCT00721396|580844890|FG002|Overall Study|Protocol Violation|1|||
160851396|NCT00721396|580844891|FG003|Overall Study|Protocol Violation|0|||
160851397|NCT00721396|580844888|FG000|Overall Study|Inappropriate enrollment|0|||
160851398|NCT00721396|580844889|FG001|Overall Study|Inappropriate enrollment|2|||
160851399|NCT00721396|580844890|FG002|Overall Study|Inappropriate enrollment|0|||
160851400|NCT00721396|580844891|FG003|Overall Study|Inappropriate enrollment|0|||
160851401|NCT00721396|580844888|FG000|Overall Study|Administrative reason|3|||
160851402|NCT00721396|580844889|FG001|Overall Study|Administrative reason|0|||
160851403|NCT00721396|580844890|FG002|Overall Study|Administrative reason|1|||
160851404|NCT00721396|580844891|FG003|Overall Study|Administrative reason|0|||
160851405|NCT00148759|580844892|FG000|Overall Study|Withdrawal by Subject|1|||
160851406|NCT00148759|580844893|FG001|Overall Study|Withdrawal by Subject|1|||
160851407|NCT00148759|580844892|FG000|Overall Study|Lost to Follow-up|1|||
160851408|NCT00148759|580844893|FG001|Overall Study|Lost to Follow-up|0|||
160851409|NCT00430716|580844895|FG000|Double Blind Phase|Death|1|||
160851410|NCT00430716|580844896|FG001|Double Blind Phase|Death|0|||
160851411|NCT00430716|580844897|FG002|Double Blind Phase|Death|0|||
160851412|NCT00430716|580844895|FG000|Double Blind Phase|No longer willing to participate|2|||
160851413|NCT00430716|580844896|FG001|Double Blind Phase|No longer willing to participate|1|||
160851414|NCT00430716|580844897|FG002|Double Blind Phase|No longer willing to participate|1|||
160851415|NCT00430716|580844895|FG000|Double Blind Phase|Other|0|||
160851416|NCT00430716|580844896|FG001|Double Blind Phase|Other|2|||
160851417|NCT00430716|580844897|FG002|Double Blind Phase|Other|0|||
160851418|NCT00430716|580844895|FG000|Double Blind Phase|Study terminated by sponsor|1|||
160851419|NCT00430716|580844896|FG001|Double Blind Phase|Study terminated by sponsor|1|||
160851420|NCT00430716|580844897|FG002|Double Blind Phase|Study terminated by sponsor|2|||
160851421|NCT00430716|580844895|FG000|Double Blind Phase|Adverse Event|1|||
160851422|NCT00430716|580844896|FG001|Double Blind Phase|Adverse Event|1|||
160851423|NCT00430716|580844897|FG002|Double Blind Phase|Adverse Event|3|||
160851424|NCT00430716|580844895|FG000|Double Blind Phase|Not treated|1|||
160851425|NCT00430716|580844896|FG001|Double Blind Phase|Not treated|0|||
160851426|NCT00430716|580844897|FG002|Double Blind Phase|Not treated|0|||
160851427|NCT00430716|580844895|FG000|Open Label Phase|Lost to Follow-up|1|||
160851428|NCT00430716|580844896|FG001|Open Label Phase|Lost to Follow-up|0|||
160851429|NCT00430716|580844897|FG002|Open Label Phase|Lost to Follow-up|1|||
160851430|NCT00430716|580844895|FG000|Open Label Phase|No longer willing to participate|0|||
160906803|NCT00923156|581052302|FG000|Overall Study|Lack of Efficacy|0|||
160851431|NCT00430716|580844896|FG001|Open Label Phase|No longer willing to participate|1|||
160851432|NCT00430716|580844897|FG002|Open Label Phase|No longer willing to participate|1|||
160851433|NCT00430716|580844895|FG000|Open Label Phase|Other|3|||
160851434|NCT00430716|580844896|FG001|Open Label Phase|Other|1|||
160851435|NCT00430716|580844897|FG002|Open Label Phase|Other|1|||
160851436|NCT00430716|580844895|FG000|Open Label Phase|Protocol Violation|1|||
160851437|NCT00430716|580844896|FG001|Open Label Phase|Protocol Violation|0|||
160851438|NCT00430716|580844897|FG002|Open Label Phase|Protocol Violation|0|||
160851439|NCT00430716|580844895|FG000|Open Label Phase|Study terminated by sponsor|4|||
160851440|NCT00430716|580844896|FG001|Open Label Phase|Study terminated by sponsor|5|||
160851441|NCT00430716|580844897|FG002|Open Label Phase|Study terminated by sponsor|4|||
160851442|NCT03948334|580844898|FG000|Overall Study|Adverse Event|1|||
160851443|NCT03948334|580844899|FG001|Overall Study|Adverse Event|4|||
160851444|NCT03948334|580844898|FG000|Overall Study|Lack of Efficacy|2|||
160851445|NCT03948334|580844899|FG001|Overall Study|Lack of Efficacy|0|||
160851446|NCT03948334|580844898|FG000|Overall Study|Lost to Follow-up|1|||
160851447|NCT03948334|580844899|FG001|Overall Study|Lost to Follow-up|0|||
160851448|NCT03948334|580844898|FG000|Overall Study|Physician Decision|1|||
160851449|NCT03948334|580844899|FG001|Overall Study|Physician Decision|0|||
160851450|NCT03948334|580844898|FG000|Overall Study|Pregnancy|0|||
160851451|NCT03948334|580844899|FG001|Overall Study|Pregnancy|1|||
160851452|NCT03948334|580844898|FG000|Overall Study|Protocol Deviation|1|||
160851453|NCT03948334|580844899|FG001|Overall Study|Protocol Deviation|0|||
160851454|NCT03948334|580844898|FG000|Overall Study|Study terminated by Sponsor|50|||
160851455|NCT03948334|580844899|FG001|Overall Study|Study terminated by Sponsor|51|||
160851456|NCT03948334|580844898|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
160851457|NCT03948334|580844899|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
160851458|NCT00154297|580844902|FG000|Overall Study|Death|5|||
160851459|NCT00154297|580844903|FG001|Overall Study|Death|2|||
160851460|NCT00154297|580844902|FG000|Overall Study|Withdrawal by Subject|0|||
160851461|NCT00154297|580844903|FG001|Overall Study|Withdrawal by Subject|5|||
160851462|NCT00154297|580844902|FG000|Overall Study|Lost to Follow-up|3|||
160851463|NCT00154297|580844903|FG001|Overall Study|Lost to Follow-up|0|||
160851464|NCT04332107|580844904|FG000|Day 3|Lost to Follow-up|23|||
160851465|NCT04332107|580844905|FG001|Day 3|Lost to Follow-up|14|||
160851466|NCT04332107|580844904|FG000|Day 3|Missing outcome data|3|||
160851467|NCT04332107|580844905|FG001|Day 3|Missing outcome data|6|||
160851468|NCT04332107|580844904|FG000|Day 14|Lost to Follow-up|13|||
160851469|NCT04332107|580844905|FG001|Day 14|Lost to Follow-up|4|||
160851470|NCT04332107|580844904|FG000|Day 14|Missing outcome data|4|||
160851471|NCT04332107|580844905|FG001|Day 14|Missing outcome data|4|||
160851472|NCT04332107|580844904|FG000|Day 21|Lost to Follow-up|10|||
160851473|NCT04332107|580844905|FG001|Day 21|Lost to Follow-up|2|||
160851474|NCT03116685|580844908|FG000|Overall Study|Physician Decision|0|||
160851475|NCT03116685|580844909|FG001|Overall Study|Physician Decision|1|||
160851476|NCT06235905|580844911|FG000|Overall Study|Adverse Event|1|||
160851477|NCT06235905|580844911|FG000|Overall Study|Non-compliant with protocol procedures|1|||
160851478|NCT01505374|580844915|FG000|Overall Study|Lost to Follow-up|1|||
160851479|NCT01505374|580844916|FG001|Overall Study|Lost to Follow-up|0|||
160851480|NCT00176462|580844919|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
160851481|NCT00176462|580844920|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
160851482|NCT00176462|580844919|FG000|Induction (4 Weeks)|Death|1|||
160851483|NCT00176462|580844920|FG001|Induction (4 Weeks)|Death|2|||
160851484|NCT00176462|580844919|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
160851485|NCT00176462|580844920|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
160851486|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
160851487|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
160851488|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
160851489|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
160851490|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
160851491|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
160851492|NCT00176462|580844919|FG000|Consolidation (12 Weeks)|Not documented|0|||
160851493|NCT00176462|580844920|FG001|Consolidation (12 Weeks)|Not documented|1|||
160851494|NCT00176462|580844919|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
160851495|NCT00176462|580844920|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
160851496|NCT00176462|580844919|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
160851497|NCT00176462|580844920|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
160851498|NCT00320515|580844925|FG000|Overall Study|Death|33|||
160851499|NCT00320515|580844925|FG000|Overall Study|Lost to Follow-up|6|||
160851500|NCT00320515|580844925|FG000|Overall Study|Physician Decision|2|||
160851501|NCT00320515|580844925|FG000|Overall Study|Withdrawal by Subject|8|||
160851502|NCT01114828|580844926|FG000|Overall Study|Adverse Event|1|||
160851503|NCT01114828|580844927|FG001|Overall Study|Adverse Event|1|||
160851504|NCT01114828|580844926|FG000|Overall Study|Lack of Efficacy|0|||
160851505|NCT01114828|580844927|FG001|Overall Study|Lack of Efficacy|2|||
160851506|NCT01114828|580844926|FG000|Overall Study|Protocol Violation|2|||
160851507|NCT01114828|580844927|FG001|Overall Study|Protocol Violation|0|||
160851508|NCT01114828|580844926|FG000|Overall Study|Withdrawal by Subject|0|||
160851509|NCT01114828|580844927|FG001|Overall Study|Withdrawal by Subject|1|||
160851510|NCT00794950|580844928|FG000|BCG Induction|Withdrawal by Subject|2|||
160851511|NCT00794950|580844928|FG000|BCG Induction|ineligible|3|||
160851512|NCT00794950|580844928|FG000|BCG Induction|noncompliant w. BCG|1|||
160851513|NCT00794950|580844928|FG000|BCG Induction|Adverse Event|1|||
160851514|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
160851515|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
160851516|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
160851517|NCT00794950|580844928|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
160851518|NCT02485704|580844929|FG000|Overall Study|Lost to Follow-up|4|||
160851519|NCT02485704|580844930|FG001|Overall Study|Lost to Follow-up|5|||
160851520|NCT02485704|580844929|FG000|Overall Study|Withdrawal by Subject|0|||
160851521|NCT02485704|580844930|FG001|Overall Study|Withdrawal by Subject|3|||
160851522|NCT02485704|580844929|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
160851523|NCT02485704|580844930|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
160851524|NCT00851786|580844933|FG000|Overall Study|Withdrawal by Subject|0|||
160851525|NCT00851786|580844934|FG001|Overall Study|Withdrawal by Subject|1|||
160851526|NCT00851786|580844933|FG000|Overall Study|Protocol Violation|0|||
160851527|NCT00851786|580844934|FG001|Overall Study|Protocol Violation|1|||
160851528|NCT00851786|580844933|FG000|Overall Study|Lost to Follow-up|1|||
160851529|NCT00851786|580844934|FG001|Overall Study|Lost to Follow-up|0|||
160851530|NCT00851786|580844933|FG000|Overall Study|Incarceration|1|||
160851531|NCT00851786|580844934|FG001|Overall Study|Incarceration|0|||
160851532|NCT00851786|580844933|FG000|Overall Study|Site Closure|1|||
160851533|NCT00851786|580844934|FG001|Overall Study|Site Closure|0|||
160851534|NCT00851786|580844933|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
160851535|NCT00851786|580844934|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
160851536|NCT04177212|580844938|FG000|Overall Study|Withdrawal by Subject|9|||
160851537|NCT04177212|580844939|FG001|Overall Study|Withdrawal by Subject|7|||
160851538|NCT04177212|580844938|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
160851539|NCT04177212|580844939|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
160851540|NCT04177212|580844938|FG000|Overall Study|Physician Decision|1|||
160851541|NCT04177212|580844939|FG001|Overall Study|Physician Decision|0|||
160851542|NCT04177212|580844938|FG000|Overall Study|Lost to Follow-up|0|||
160851543|NCT04177212|580844939|FG001|Overall Study|Lost to Follow-up|3|||
160851544|NCT04177212|580844938|FG000|Overall Study|Adverse Event|0|||
160851545|NCT04177212|580844939|FG001|Overall Study|Adverse Event|1|||
160851546|NCT04177212|580844938|FG000|Overall Study|Other|1|||
160851547|NCT04177212|580844939|FG001|Overall Study|Other|2|||
160851548|NCT01792115|580844940|FG000|Overall Study|Lost to Follow-up|0|||
160851549|NCT01792115|580844941|FG001|Overall Study|Lost to Follow-up|1|||
160851550|NCT01792115|580844942|FG002|Overall Study|Lost to Follow-up|0|||
160851551|NCT01279681|580844943|FG000|Overall Study|Disease Progression|9|||
160851552|NCT01279681|580844944|FG001|Overall Study|Disease Progression|6|||
160851553|NCT01279681|580844943|FG000|Overall Study|Withdrawal by Subject|3|||
160851554|NCT01279681|580844944|FG001|Overall Study|Withdrawal by Subject|4|||
160851555|NCT01279681|580844943|FG000|Overall Study|Adverse Event|2|||
160851556|NCT01279681|580844944|FG001|Overall Study|Adverse Event|3|||
160851557|NCT01279681|580844943|FG000|Overall Study|Death|0|||
160851558|NCT01279681|580844944|FG001|Overall Study|Death|1|||
160851559|NCT01279681|580844943|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
160851560|NCT01279681|580844944|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
160851561|NCT01279681|580844943|FG000|Overall Study|Physician Decision|1|||
160851562|NCT01279681|580844944|FG001|Overall Study|Physician Decision|0|||
160851563|NCT01279681|580844943|FG000|Overall Study|Other Reason|0|||
160851564|NCT01279681|580844944|FG001|Overall Study|Other Reason|2|||
160851565|NCT01943591|580844945|FG000|Overall Study|Lost to Follow-up|3|||
160851566|NCT01943591|580844946|FG001|Overall Study|Lost to Follow-up|4|||
160851567|NCT01943591|580844945|FG000|Overall Study|Death|2|||
160851568|NCT01943591|580844946|FG001|Overall Study|Death|7|||
160851569|NCT02711137|580846274|FG000|Overall Study|Death|1|||
160851570|NCT02711137|580846275|FG001|Overall Study|Death|4|||
160851571|NCT02711137|580846276|FG002|Overall Study|Death|5|||
160851572|NCT02711137|580846277|FG003|Overall Study|Death|5|||
160851573|NCT02711137|580846278|FG004|Overall Study|Death|3|||
160851574|NCT02711137|580846279|FG005|Overall Study|Death|1|||
160851575|NCT02711137|580846280|FG006|Overall Study|Death|61|||
160851576|NCT02711137|580846281|FG007|Overall Study|Death|3|||
160851577|NCT02711137|580846282|FG008|Overall Study|Death|0|||
160851578|NCT02711137|580846283|FG009|Overall Study|Death|1|||
160851579|NCT02711137|580846284|FG010|Overall Study|Death|1|||
160851580|NCT02711137|580846285|FG011|Overall Study|Death|1|||
160851581|NCT02711137|580846286|FG012|Overall Study|Death|0|||
160851582|NCT02711137|580846287|FG013|Overall Study|Death|0|||
160851583|NCT02711137|580846288|FG014|Overall Study|Death|0|||
160851584|NCT02711137|580846274|FG000|Overall Study|Study Terminated by Sponsor|0|||
160851585|NCT02711137|580846275|FG001|Overall Study|Study Terminated by Sponsor|0|||
160851586|NCT02711137|580846276|FG002|Overall Study|Study Terminated by Sponsor|1|||
160851587|NCT02711137|580846277|FG003|Overall Study|Study Terminated by Sponsor|0|||
160851588|NCT02711137|580846278|FG004|Overall Study|Study Terminated by Sponsor|0|||
160851589|NCT02711137|580846279|FG005|Overall Study|Study Terminated by Sponsor|0|||
160851590|NCT02711137|580846280|FG006|Overall Study|Study Terminated by Sponsor|1|||
160851591|NCT02711137|580846281|FG007|Overall Study|Study Terminated by Sponsor|0|||
160851592|NCT02711137|580846282|FG008|Overall Study|Study Terminated by Sponsor|0|||
161337145|NCT00853385|582625844|FG001|Overall Study|Lack of Efficacy|7|||
160851593|NCT02711137|580846283|FG009|Overall Study|Study Terminated by Sponsor|0|||
160851594|NCT02711137|580846284|FG010|Overall Study|Study Terminated by Sponsor|0|||
160851595|NCT02711137|580846285|FG011|Overall Study|Study Terminated by Sponsor|0|||
160851596|NCT02711137|580846286|FG012|Overall Study|Study Terminated by Sponsor|0|||
160851597|NCT02711137|580846287|FG013|Overall Study|Study Terminated by Sponsor|0|||
160851598|NCT02711137|580846288|FG014|Overall Study|Study Terminated by Sponsor|0|||
160851599|NCT02711137|580846274|FG000|Overall Study|Physician Decision|1|||
160851600|NCT02711137|580846275|FG001|Overall Study|Physician Decision|0|||
160851601|NCT02711137|580846276|FG002|Overall Study|Physician Decision|2|||
160851602|NCT02711137|580846277|FG003|Overall Study|Physician Decision|1|||
160851603|NCT02711137|580846278|FG004|Overall Study|Physician Decision|1|||
160851604|NCT02711137|580846279|FG005|Overall Study|Physician Decision|0|||
160851605|NCT02711137|580846280|FG006|Overall Study|Physician Decision|12|||
161337146|NCT00853385|582625845|FG002|Overall Study|Lack of Efficacy|3|||
161337147|NCT00853385|582625846|FG003|Overall Study|Lack of Efficacy|3|||
161337148|NCT00853385|582625847|FG004|Overall Study|Lack of Efficacy|6|||
161337149|NCT00853385|582625843|FG000|Overall Study|Lost to Follow-up|2|||
161337150|NCT00853385|582625844|FG001|Overall Study|Lost to Follow-up|1|||
161337151|NCT00853385|582625845|FG002|Overall Study|Lost to Follow-up|0|||
161337152|NCT00853385|582625846|FG003|Overall Study|Lost to Follow-up|0|||
161337153|NCT00853385|582625847|FG004|Overall Study|Lost to Follow-up|0|||
161337154|NCT00853385|582625843|FG000|Overall Study|Withdrawal by Subject|4|||
161337155|NCT00853385|582625844|FG001|Overall Study|Withdrawal by Subject|2|||
161337156|NCT00853385|582625845|FG002|Overall Study|Withdrawal by Subject|0|||
161337157|NCT00853385|582625846|FG003|Overall Study|Withdrawal by Subject|1|||
161337158|NCT00853385|582625847|FG004|Overall Study|Withdrawal by Subject|1|||
161337159|NCT00853385|582625843|FG000|Overall Study|Other|18|||
161337160|NCT00853385|582625844|FG001|Overall Study|Other|9|||
161337161|NCT00853385|582625845|FG002|Overall Study|Other|4|||
161337162|NCT00853385|582625846|FG003|Overall Study|Other|4|||
161337163|NCT00853385|582625847|FG004|Overall Study|Other|12|||
161337164|NCT03435055|582625848|FG000|Screening|Physician Decision|2|||
161337165|NCT03435055|582625848|FG000|Received Intervention|Did not complete nitrous administration|3|||
161337166|NCT03502798|582625849|FG000|Overall Study|equipment failure|0|||
161337167|NCT03502798|582625850|FG001|Overall Study|equipment failure|7|||
161337168|NCT00296335|582625855|FG000|Overall Study|Recurrence|3|||
161337169|NCT00296335|582625856|FG001|Overall Study|Recurrence|51|||
161337170|NCT00296335|582625855|FG000|Overall Study|Adverse Event|17|||
161337171|NCT00296335|582625856|FG001|Overall Study|Adverse Event|27|||
161337172|NCT00296335|582625855|FG000|Overall Study|Lost to Follow-up|7|||
161337173|NCT00296335|582625856|FG001|Overall Study|Lost to Follow-up|33|||
161337174|NCT00296335|582625855|FG000|Overall Study|Physician Decision|3|||
161337175|NCT00296335|582625856|FG001|Overall Study|Physician Decision|11|||
161337176|NCT01027845|582625857|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
161337177|NCT01027845|582625858|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
161337178|NCT01027845|582625859|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
161337179|NCT01027845|582625860|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
161337180|NCT01027845|582625857|FG000|Primary Vaccination Phase|Adverse Event|1|||
161337181|NCT01027845|582625858|FG001|Primary Vaccination Phase|Adverse Event|0|||
161337182|NCT01027845|582625859|FG002|Primary Vaccination Phase|Adverse Event|0|||
161337183|NCT01027845|582625860|FG003|Primary Vaccination Phase|Adverse Event|0|||
161337184|NCT01027845|582625857|FG000|Primary Vaccination Phase|Protocol Violation|1|||
161337185|NCT01027845|582625858|FG001|Primary Vaccination Phase|Protocol Violation|0|||
161337186|NCT01027845|582625859|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161337187|NCT01027845|582625860|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161337188|NCT01027845|582625857|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
161337189|NCT01027845|582625858|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
161337190|NCT01027845|582625859|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
161337191|NCT01027845|582625860|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
161337192|NCT01027845|582625857|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
161337193|NCT01027845|582625858|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161337194|NCT01027845|582625859|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
161337195|NCT01027845|582625860|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
161337196|NCT01027845|582625857|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
161337197|NCT01027845|582625858|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
161337198|NCT01027845|582625859|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
161337199|NCT01027845|582625860|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
161337200|NCT01670292|582625861|FG000|Overall Study|Lost to Follow-up|14|||
161337201|NCT00087178|582625865|FG000|Overall Study|No follow up data|5|||
160851606|NCT02711137|580846281|FG007|Overall Study|Physician Decision|2|||
161337202|NCT00087178|582625866|FG001|Overall Study|No follow up data|15|||
161337203|NCT00087178|582625865|FG000|Overall Study|No clinical assessment|1|||
161337204|NCT00087178|582625866|FG001|Overall Study|No clinical assessment|2|||
161337205|NCT00087178|582625865|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
161337206|NCT00087178|582625866|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
160851607|NCT02711137|580846282|FG008|Overall Study|Physician Decision|1|||
160851608|NCT02711137|580846283|FG009|Overall Study|Physician Decision|1|||
160851609|NCT02711137|580846284|FG010|Overall Study|Physician Decision|3|||
160906804|NCT00923156|581052303|FG001|Overall Study|Lack of Efficacy|0|||
160906805|NCT00923156|581052304|FG002|Overall Study|Lack of Efficacy|1|||
161337207|NCT01692119|582625869|FG000|Overall Study|Protocol Violation|3|||
160851610|NCT02711137|580846285|FG011|Overall Study|Physician Decision|2|||
161337208|NCT01692119|582625870|FG001|Overall Study|Protocol Violation|1|||
161337209|NCT01692119|582625869|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
160851611|NCT02711137|580846286|FG012|Overall Study|Physician Decision|1|||
160851612|NCT02711137|580846287|FG013|Overall Study|Physician Decision|1|||
160851613|NCT02711137|580846288|FG014|Overall Study|Physician Decision|2|||
160851614|NCT02711137|580846274|FG000|Overall Study|Other|0|||
160851615|NCT02711137|580846275|FG001|Overall Study|Other|1|||
160851616|NCT02711137|580846276|FG002|Overall Study|Other|0|||
160851617|NCT02711137|580846277|FG003|Overall Study|Other|0|||
160851618|NCT02711137|580846278|FG004|Overall Study|Other|0|||
160851619|NCT02711137|580846279|FG005|Overall Study|Other|0|||
160851620|NCT02711137|580846280|FG006|Overall Study|Other|3|||
160851621|NCT02711137|580846281|FG007|Overall Study|Other|0|||
160851622|NCT02711137|580846282|FG008|Overall Study|Other|0|||
160851623|NCT02711137|580846283|FG009|Overall Study|Other|0|||
160851624|NCT02711137|580846284|FG010|Overall Study|Other|0|||
160851625|NCT02711137|580846285|FG011|Overall Study|Other|0|||
160851626|NCT02711137|580846286|FG012|Overall Study|Other|0|||
160851627|NCT02711137|580846287|FG013|Overall Study|Other|0|||
160851628|NCT02711137|580846288|FG014|Overall Study|Other|1|||
160851629|NCT02711137|580846274|FG000|Overall Study|Withdrawal by Subject|1|||
160851630|NCT02711137|580846275|FG001|Overall Study|Withdrawal by Subject|0|||
160851631|NCT02711137|580846276|FG002|Overall Study|Withdrawal by Subject|0|||
160851632|NCT02711137|580846277|FG003|Overall Study|Withdrawal by Subject|1|||
160851633|NCT02711137|580846278|FG004|Overall Study|Withdrawal by Subject|1|||
160851634|NCT02711137|580846279|FG005|Overall Study|Withdrawal by Subject|0|||
160851635|NCT02711137|580846280|FG006|Overall Study|Withdrawal by Subject|7|||
160851636|NCT02711137|580846281|FG007|Overall Study|Withdrawal by Subject|0|||
160851637|NCT02711137|580846282|FG008|Overall Study|Withdrawal by Subject|0|||
160851638|NCT02711137|580846283|FG009|Overall Study|Withdrawal by Subject|0|||
160851639|NCT02711137|580846284|FG010|Overall Study|Withdrawal by Subject|0|||
160851640|NCT02711137|580846285|FG011|Overall Study|Withdrawal by Subject|0|||
160851641|NCT02711137|580846286|FG012|Overall Study|Withdrawal by Subject|0|||
160851642|NCT02711137|580846287|FG013|Overall Study|Withdrawal by Subject|1|||
160851643|NCT02711137|580846288|FG014|Overall Study|Withdrawal by Subject|0|||
161337210|NCT01692119|582625870|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
161337211|NCT03895086|582625871|FG000|Overall Study|Early termination study|1|||
161337212|NCT03895086|582625872|FG001|Overall Study|Early termination study|0|||
161337213|NCT04656652|582625873|FG000|Overall Study|Lost to Follow-up|2|||
161337214|NCT04656652|582625874|FG001|Overall Study|Lost to Follow-up|2|||
161337215|NCT04656652|582625873|FG000|Overall Study|Death|213|||
161337216|NCT04656652|582625874|FG001|Overall Study|Death|212|||
161337217|NCT04656652|582625873|FG000|Overall Study|Other|1|||
161337218|NCT04656652|582625874|FG001|Overall Study|Other|0|||
161337219|NCT04656652|582625873|FG000|Overall Study|Withdrawal by Subject|15|||
161337220|NCT04656652|582625874|FG001|Overall Study|Withdrawal by Subject|29|||
161337221|NCT02722967|582625875|FG000|Overall Study|Adverse Event|1|||
161337222|NCT02722967|582625876|FG001|Overall Study|Adverse Event|0|||
161337223|NCT02722967|582625877|FG002|Overall Study|Adverse Event|0|||
161337224|NCT02722967|582625875|FG000|Overall Study|Lost to Follow-up|0|||
160851644|NCT02711137|580846274|FG000|Overall Study|Lost to Follow-up|1|||
160851645|NCT02711137|580846275|FG001|Overall Study|Lost to Follow-up|0|||
160906806|NCT01201850|581052307|FG000|Overall Study|Tumor progression|4|||
160906807|NCT03137537|581052308|FG000|Overall Study|Adverse Event|0|||
160906808|NCT03137537|581052309|FG001|Overall Study|Adverse Event|1|||
160906809|NCT01552694|581052310|FG000|Overall Study|Lost to Follow-up|0|||
160906810|NCT01552694|581052311|FG001|Overall Study|Lost to Follow-up|1|||
160906811|NCT01552694|581052310|FG000|Overall Study|Protocol Violation|0|||
160906812|NCT01552694|581052311|FG001|Overall Study|Protocol Violation|1|||
160906813|NCT00191139|581052312|FG000|Overall Study|Adverse Event|2|||
160906814|NCT00191139|581052313|FG001|Overall Study|Adverse Event|6|||
160906815|NCT00191139|581052312|FG000|Overall Study|Death|2|||
160906816|NCT00191139|581052313|FG001|Overall Study|Death|0|||
160992510|NCT03999554|581361389|FG004|Overall Study|Protocol Violation|0|||
161337225|NCT02722967|582625876|FG001|Overall Study|Lost to Follow-up|1|||
161337226|NCT02722967|582625877|FG002|Overall Study|Lost to Follow-up|0|||
161337227|NCT02722967|582625875|FG000|Overall Study|Non-compliance with patch wearing|2|||
161337228|NCT02722967|582625876|FG001|Overall Study|Non-compliance with patch wearing|1|||
160851646|NCT02711137|580846276|FG002|Overall Study|Lost to Follow-up|0|||
160851647|NCT02711137|580846277|FG003|Overall Study|Lost to Follow-up|0|||
160851648|NCT02711137|580846278|FG004|Overall Study|Lost to Follow-up|0|||
160851649|NCT02711137|580846279|FG005|Overall Study|Lost to Follow-up|0|||
160851650|NCT02711137|580846280|FG006|Overall Study|Lost to Follow-up|2|||
160851651|NCT02711137|580846281|FG007|Overall Study|Lost to Follow-up|0|||
161337229|NCT02722967|582625877|FG002|Overall Study|Non-compliance with patch wearing|1|||
160851652|NCT02711137|580846282|FG008|Overall Study|Lost to Follow-up|0|||
160851653|NCT02711137|580846283|FG009|Overall Study|Lost to Follow-up|0|||
160851654|NCT02711137|580846284|FG010|Overall Study|Lost to Follow-up|0|||
160851655|NCT02711137|580846285|FG011|Overall Study|Lost to Follow-up|0|||
160851656|NCT02711137|580846286|FG012|Overall Study|Lost to Follow-up|0|||
160851657|NCT02711137|580846287|FG013|Overall Study|Lost to Follow-up|0|||
160906817|NCT00191139|581052312|FG000|Overall Study|Withdrawal by Subject|0|||
160851658|NCT02711137|580846288|FG014|Overall Study|Lost to Follow-up|0|||
160851659|NCT01285401|580846289|FG000|Overall Study|Prematurely withdrawn from the study|17|||
160851660|NCT01285401|580846290|FG001|Overall Study|Prematurely withdrawn from the study|29|||
160851661|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
160851662|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
160851663|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Death|1|||
160851664|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Death|2|||
160851665|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
160851666|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
160851667|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
160851668|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
160851669|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
160851670|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
160851671|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
160851672|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
160851673|NCT01794000|580846297|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
160851674|NCT01794000|580846298|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
160851675|NCT01794000|580846297|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
160851676|NCT01794000|580846298|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
160851677|NCT00796666|580846299|FG000|Overall Study|Death|2|||
160851678|NCT00796666|580846300|FG001|Overall Study|Death|4|||
160851679|NCT00796666|580846299|FG000|Overall Study|Withdrawal by Subject|2|||
160851680|NCT00796666|580846300|FG001|Overall Study|Withdrawal by Subject|0|||
160851681|NCT00796666|580846299|FG000|Overall Study|Adverse Event|7|||
160851682|NCT00796666|580846300|FG001|Overall Study|Adverse Event|5|||
160851683|NCT00796666|580846299|FG000|Overall Study|Protocol Violation|1|||
160851684|NCT00796666|580846300|FG001|Overall Study|Protocol Violation|0|||
160851685|NCT00796666|580846299|FG000|Overall Study|Other|1|||
160851686|NCT00796666|580846300|FG001|Overall Study|Other|0|||
160851687|NCT00796666|580846299|FG000|Overall Study|Terminated by sponsor|53|||
160851688|NCT00796666|580846300|FG001|Overall Study|Terminated by sponsor|55|||
160851689|NCT00796666|580846299|FG000|Overall Study|Randomized and not treated|1|||
160851690|NCT00796666|580846300|FG001|Overall Study|Randomized and not treated|0|||
160851691|NCT01367834|580846301|FG000|Overall Study|Withdrawal by Subject|2|||
160851692|NCT01367834|580846302|FG001|Overall Study|Withdrawal by Subject|2|||
160851693|NCT01367834|580846301|FG000|Overall Study|Study was ended.|0|||
160851694|NCT01367834|580846302|FG001|Overall Study|Study was ended.|1|||
160851695|NCT00255190|580846303|FG000|Overall Study|Adverse Event|17|||
160851696|NCT00255190|580846304|FG001|Overall Study|Adverse Event|36|||
160851697|NCT00255190|580846303|FG000|Overall Study|Protocol Violation|2|||
160851698|NCT00255190|580846304|FG001|Overall Study|Protocol Violation|2|||
160851699|NCT00255190|580846303|FG000|Overall Study|Lost to Follow-up|10|||
160851700|NCT00255190|580846304|FG001|Overall Study|Lost to Follow-up|27|||
160851701|NCT00255190|580846303|FG000|Overall Study|Withdrew Consent|17|||
160851702|NCT00255190|580846304|FG001|Overall Study|Withdrew Consent|48|||
160851703|NCT00255190|580846303|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160851704|NCT00255190|580846304|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
160851705|NCT00255190|580846303|FG000|Overall Study|Erosive esophagitis not healed|0|||
160851706|NCT00255190|580846304|FG001|Overall Study|Erosive esophagitis not healed|20|||
160851707|NCT00255190|580846303|FG000|Overall Study|Various|4|||
160851708|NCT00255190|580846304|FG001|Overall Study|Various|23|||
160851709|NCT00628030|580846305|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
160851710|NCT00628030|580846306|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
160851711|NCT00628030|580846305|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
160851712|NCT00628030|580846306|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
160851713|NCT00628030|580846305|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
160851714|NCT00628030|580846306|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
160851715|NCT01156480|580846307|FG000|Overall Study|change in diagnosis|0|||
160851716|NCT01156480|580846308|FG001|Overall Study|change in diagnosis|1|||
160851717|NCT04537793|580846309|FG000|Part B (24 Weeks)|Adverse Event|0|||
160851718|NCT04537793|580846310|FG001|Part B (24 Weeks)|Adverse Event|1|||
160851719|NCT05470387|580846311|FG000|Overall Study|Protocol Violation|0|||
160851720|NCT05470387|580846312|FG001|Overall Study|Protocol Violation|3|||
160851721|NCT01255423|580846313|FG000|Overall Study|Abnormal Laboratory value|3|||
160851722|NCT01255423|580846314|FG001|Overall Study|Abnormal Laboratory value|2|||
160851723|NCT01255423|580846313|FG000|Overall Study|Use of prohibited medications|0|||
160851724|NCT01255423|580846314|FG001|Overall Study|Use of prohibited medications|1|||
160851725|NCT00988598|580846315|FG000|Overall Study|Withdrawal by Subject|2|||
160851726|NCT00988598|580846316|FG001|Overall Study|Withdrawal by Subject|0|||
160851727|NCT03367858|580846317|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
160851728|NCT03367858|580846318|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
160851729|NCT03367858|580846317|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
160851730|NCT03367858|580846318|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
160851731|NCT03367858|580846317|FG000|3 Month Follow Up|Lost to Follow-up|8|||
160851732|NCT03367858|580846318|FG001|3 Month Follow Up|Lost to Follow-up|3|||
160851733|NCT03367858|580846317|FG000|3 Month Follow Up|Moved out of study area|2|||
160851734|NCT03367858|580846318|FG001|3 Month Follow Up|Moved out of study area|6|||
160851735|NCT03367858|580846317|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
160851736|NCT03367858|580846318|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
161337230|NCT02722967|582625875|FG000|Overall Study|Withdrawal by Subject|1|||
161337231|NCT02722967|582625876|FG001|Overall Study|Withdrawal by Subject|0|||
161337232|NCT02722967|582625877|FG002|Overall Study|Withdrawal by Subject|1|||
161337233|NCT02722967|582625875|FG000|Overall Study|Physician Decision|1|||
161337234|NCT02722967|582625876|FG001|Overall Study|Physician Decision|0|||
161337235|NCT02722967|582625877|FG002|Overall Study|Physician Decision|0|||
161337236|NCT02722967|582625875|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
161337237|NCT02722967|582625876|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
161337238|NCT02722967|582625877|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
160851737|NCT03367858|580846317|FG000|3 Month Follow Up|MRI contraindication|2|||
160851738|NCT03367858|580846318|FG001|3 Month Follow Up|MRI contraindication|1|||
160851739|NCT03367858|580846317|FG000|3 Month Follow Up|Incarcerated|0|||
160851740|NCT03367858|580846318|FG001|3 Month Follow Up|Incarcerated|1|||
160851741|NCT03367858|580846317|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
160851742|NCT03367858|580846318|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
160851743|NCT03367858|580846317|FG000|6 Month Follow Up|Lost to Follow-up|5|||
160851744|NCT03367858|580846318|FG001|6 Month Follow Up|Lost to Follow-up|2|||
160851745|NCT03367858|580846317|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
160851746|NCT03367858|580846318|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
160851747|NCT03367858|580846317|FG000|12 Month Follow Up|Lost to Follow-up|3|||
160851748|NCT03367858|580846318|FG001|12 Month Follow Up|Lost to Follow-up|3|||
161337239|NCT04142242|582625878|FG000|Stage I|Non-compliance with the protocol|1|||
161337240|NCT04142242|582625879|FG001|Stage I|Non-compliance with the protocol|0|||
161337241|NCT04142242|582625880|FG002|Stage I|Non-compliance with the protocol|0|||
161337242|NCT04142242|582625881|FG003|Stage I|Non-compliance with the protocol|0|||
161337243|NCT04142242|582625882|FG004|Stage I|Non-compliance with the protocol|0|||
161337244|NCT04142242|582625883|FG005|Stage I|Non-compliance with the protocol|1|||
161337245|NCT04142242|582625878|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161337246|NCT04142242|582625879|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
161337247|NCT04142242|582625880|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161337248|NCT04142242|582625881|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161337249|NCT04142242|582625882|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161337250|NCT04142242|582625883|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
161337251|NCT04142242|582625878|FG000|Stage II|Non-compliance with the protocol|0|||
161337252|NCT04142242|582625879|FG001|Stage II|Non-compliance with the protocol|0|||
161337253|NCT04142242|582625880|FG002|Stage II|Non-compliance with the protocol|0|||
161337254|NCT04142242|582625881|FG003|Stage II|Non-compliance with the protocol|2|||
161337255|NCT04142242|582625882|FG004|Stage II|Non-compliance with the protocol|0|||
161337256|NCT04142242|582625883|FG005|Stage II|Non-compliance with the protocol|0|||
161337257|NCT04142242|582625878|FG000|Stage II|Lost to Follow-up|0|||
161337258|NCT04142242|582625879|FG001|Stage II|Lost to Follow-up|0|||
161337259|NCT04142242|582625880|FG002|Stage II|Lost to Follow-up|1|||
160851749|NCT03367858|580846317|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
160851750|NCT03367858|580846318|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
160851751|NCT00057863|580846341|FG000|Overall Study|Death|1|||
161337260|NCT04142242|582625881|FG003|Stage II|Lost to Follow-up|2|||
161337261|NCT04142242|582625882|FG004|Stage II|Lost to Follow-up|0|||
160851752|NCT00057863|580846341|FG000|Overall Study|Withdrawal by Subject|2|||
160851753|NCT02079038|580846343|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
160851754|NCT02079038|580846344|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
160851755|NCT02079038|580846343|FG000|Modified Intent to Treat Population|Death|1|||
160851756|NCT02079038|580846344|FG001|Modified Intent to Treat Population|Death|0|||
160851757|NCT02079038|580846343|FG000|Completed 6 Months|Lost to Follow-up|2|||
160851758|NCT02079038|580846344|FG001|Completed 6 Months|Lost to Follow-up|1|||
160851759|NCT03480152|580846345|FG000|Phase I|Signed consent. Died before treatment.|1|||
160906818|NCT00191139|581052313|FG001|Overall Study|Withdrawal by Subject|3|||
160906819|NCT00191139|581052312|FG000|Overall Study|Disease Progression|0|||
160906820|NCT00191139|581052313|FG001|Overall Study|Disease Progression|1|||
160906821|NCT00191139|581052312|FG000|Overall Study|Other|1|||
161337262|NCT04142242|582625883|FG005|Stage II|Lost to Follow-up|0|||
161337263|NCT04142242|582625878|FG000|Stage II|Withdrawal by Subject|0|||
161337264|NCT04142242|582625879|FG001|Stage II|Withdrawal by Subject|0|||
161337265|NCT04142242|582625880|FG002|Stage II|Withdrawal by Subject|5|||
160851760|NCT03480152|580846346|FG001|Phase I|Signed consent. Died before treatment.|0|||
160851761|NCT03480152|580846347|FG002|Phase I|Signed consent. Died before treatment.|0|||
161337266|NCT04142242|582625881|FG003|Stage II|Withdrawal by Subject|9|||
161337267|NCT04142242|582625882|FG004|Stage II|Withdrawal by Subject|0|||
160851762|NCT04276233|580846348|FG000|Overall Study|Adverse Event|1|||
160851763|NCT04276233|580846348|FG000|Overall Study|Lost to Follow-up|3|||
160851764|NCT04276233|580846348|FG000|Overall Study|Physician Decision|4|||
160851765|NCT04276233|580846348|FG000|Overall Study|Withdrawal by Subject|2|||
160851766|NCT01946139|580846349|FG000|Overall Study|Withdrawal by Subject|8|||
160851767|NCT01946139|580846349|FG000|Overall Study|ineligible|8|||
160851768|NCT01946139|580846349|FG000|Overall Study|Specimens not available|4|||
160851769|NCT00101686|580846356|FG000|Overall Study|Progressive Disease|37|||
160851770|NCT00101686|580846357|FG001|Overall Study|Progressive Disease|28|||
160851771|NCT00101686|580846358|FG002|Overall Study|Progressive Disease|37|||
160851772|NCT00101686|580846359|FG003|Overall Study|Progressive Disease|38|||
160851773|NCT00101686|580846360|FG004|Overall Study|Progressive Disease|28|||
160851774|NCT00101686|580846361|FG005|Overall Study|Progressive Disease|25|||
160851775|NCT00101686|580846362|FG006|Overall Study|Progressive Disease|5|||
160851776|NCT00101686|580846363|FG007|Overall Study|Progressive Disease|7|||
160851777|NCT00101686|580846364|FG008|Overall Study|Progressive Disease|10|||
160851778|NCT00101686|580846365|FG009|Overall Study|Progressive Disease|8|||
160851779|NCT00101686|580846356|FG000|Overall Study|initiation other anti-cancer treatment|4|||
160851780|NCT00101686|580846357|FG001|Overall Study|initiation other anti-cancer treatment|3|||
160851781|NCT00101686|580846358|FG002|Overall Study|initiation other anti-cancer treatment|4|||
160851782|NCT00101686|580846359|FG003|Overall Study|initiation other anti-cancer treatment|3|||
160851783|NCT00101686|580846360|FG004|Overall Study|initiation other anti-cancer treatment|1|||
160851784|NCT00101686|580846361|FG005|Overall Study|initiation other anti-cancer treatment|1|||
160851785|NCT00101686|580846362|FG006|Overall Study|initiation other anti-cancer treatment|2|||
160851786|NCT00101686|580846363|FG007|Overall Study|initiation other anti-cancer treatment|2|||
160851787|NCT00101686|580846364|FG008|Overall Study|initiation other anti-cancer treatment|3|||
160851788|NCT00101686|580846365|FG009|Overall Study|initiation other anti-cancer treatment|3|||
160851789|NCT00101686|580846356|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
160851790|NCT00101686|580846357|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
160851791|NCT00101686|580846358|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
160851792|NCT00101686|580846359|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
160851793|NCT00101686|580846360|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
160851794|NCT00101686|580846361|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
160851795|NCT00101686|580846362|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
160851796|NCT00101686|580846363|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
160851797|NCT00101686|580846364|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
160851798|NCT00101686|580846365|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
160851799|NCT00101686|580846356|FG000|Overall Study|unacceptable toxicity|3|||
160851800|NCT00101686|580846357|FG001|Overall Study|unacceptable toxicity|9|||
160851801|NCT00101686|580846358|FG002|Overall Study|unacceptable toxicity|10|||
160851802|NCT00101686|580846359|FG003|Overall Study|unacceptable toxicity|6|||
160851803|NCT00101686|580846360|FG004|Overall Study|unacceptable toxicity|16|||
160851804|NCT00101686|580846361|FG005|Overall Study|unacceptable toxicity|10|||
160851805|NCT00101686|580846362|FG006|Overall Study|unacceptable toxicity|4|||
160851806|NCT00101686|580846363|FG007|Overall Study|unacceptable toxicity|2|||
160851807|NCT00101686|580846364|FG008|Overall Study|unacceptable toxicity|1|||
160851808|NCT00101686|580846365|FG009|Overall Study|unacceptable toxicity|4|||
160851809|NCT00101686|580846356|FG000|Overall Study|Randomized but did not receive treament|1|||
160851810|NCT00101686|580846357|FG001|Overall Study|Randomized but did not receive treament|6|||
160851811|NCT00101686|580846358|FG002|Overall Study|Randomized but did not receive treament|2|||
160851812|NCT00101686|580846359|FG003|Overall Study|Randomized but did not receive treament|2|||
160851813|NCT00101686|580846360|FG004|Overall Study|Randomized but did not receive treament|2|||
160851814|NCT00101686|580846361|FG005|Overall Study|Randomized but did not receive treament|2|||
160851815|NCT00101686|580846362|FG006|Overall Study|Randomized but did not receive treament|0|||
160851816|NCT00101686|580846363|FG007|Overall Study|Randomized but did not receive treament|1|||
160851817|NCT00101686|580846364|FG008|Overall Study|Randomized but did not receive treament|0|||
160851818|NCT00101686|580846365|FG009|Overall Study|Randomized but did not receive treament|1|||
160851819|NCT00101686|580846356|FG000|Overall Study|intercurrent non-cancer related illness|0|||
160851820|NCT00101686|580846357|FG001|Overall Study|intercurrent non-cancer related illness|0|||
160851821|NCT00101686|580846358|FG002|Overall Study|intercurrent non-cancer related illness|2|||
161337268|NCT04142242|582625883|FG005|Stage II|Withdrawal by Subject|0|||
161337269|NCT00846053|582625886|FG000|Overall Study|Physician Decision|3|||
161337270|NCT00846053|582625887|FG001|Overall Study|Physician Decision|0|||
161337271|NCT00062166|582625894|FG000|Overall Study|Withdrawal by Subject|6|||
160851822|NCT00101686|580846359|FG003|Overall Study|intercurrent non-cancer related illness|0|||
160851823|NCT00101686|580846360|FG004|Overall Study|intercurrent non-cancer related illness|1|||
160851824|NCT00101686|580846361|FG005|Overall Study|intercurrent non-cancer related illness|3|||
160851825|NCT00101686|580846362|FG006|Overall Study|intercurrent non-cancer related illness|1|||
160851826|NCT00101686|580846363|FG007|Overall Study|intercurrent non-cancer related illness|0|||
160851827|NCT00101686|580846364|FG008|Overall Study|intercurrent non-cancer related illness|1|||
160851828|NCT00101686|580846365|FG009|Overall Study|intercurrent non-cancer related illness|1|||
160851829|NCT00101686|580846356|FG000|Overall Study|Physician Decision|10|||
160851830|NCT00101686|580846357|FG001|Overall Study|Physician Decision|13|||
160851831|NCT00101686|580846358|FG002|Overall Study|Physician Decision|6|||
160851832|NCT00101686|580846359|FG003|Overall Study|Physician Decision|7|||
160851833|NCT00101686|580846360|FG004|Overall Study|Physician Decision|8|||
160851834|NCT00101686|580846361|FG005|Overall Study|Physician Decision|9|||
160851835|NCT00101686|580846362|FG006|Overall Study|Physician Decision|5|||
160851836|NCT00101686|580846363|FG007|Overall Study|Physician Decision|5|||
160851837|NCT00101686|580846364|FG008|Overall Study|Physician Decision|1|||
160851838|NCT00101686|580846365|FG009|Overall Study|Physician Decision|1|||
160851839|NCT00101686|580846356|FG000|Overall Study|Other|1|||
160851840|NCT00101686|580846357|FG001|Overall Study|Other|4|||
160851841|NCT00101686|580846358|FG002|Overall Study|Other|1|||
160851842|NCT00101686|580846359|FG003|Overall Study|Other|6|||
160851843|NCT00101686|580846360|FG004|Overall Study|Other|2|||
160851844|NCT00101686|580846361|FG005|Overall Study|Other|12|||
160851845|NCT00101686|580846362|FG006|Overall Study|Other|1|||
160851846|NCT00101686|580846363|FG007|Overall Study|Other|5|||
160851847|NCT00101686|580846364|FG008|Overall Study|Other|3|||
160851848|NCT00101686|580846365|FG009|Overall Study|Other|3|||
160851849|NCT00101686|580846356|FG000|Overall Study|Withdrawal by Subject|9|||
160851850|NCT00101686|580846357|FG001|Overall Study|Withdrawal by Subject|8|||
160851851|NCT00101686|580846358|FG002|Overall Study|Withdrawal by Subject|6|||
160851852|NCT00101686|580846359|FG003|Overall Study|Withdrawal by Subject|8|||
160851853|NCT00101686|580846360|FG004|Overall Study|Withdrawal by Subject|8|||
160851854|NCT00101686|580846361|FG005|Overall Study|Withdrawal by Subject|7|||
160851855|NCT00101686|580846362|FG006|Overall Study|Withdrawal by Subject|7|||
160851856|NCT00101686|580846363|FG007|Overall Study|Withdrawal by Subject|7|||
160851857|NCT00101686|580846364|FG008|Overall Study|Withdrawal by Subject|8|||
160851858|NCT00101686|580846365|FG009|Overall Study|Withdrawal by Subject|9|||
160851859|NCT00296816|580846366|FG000|Overall Study|Disease Progression|37|||
160851860|NCT00296816|580846366|FG000|Overall Study|Adverse Event|18|||
160851861|NCT00296816|580846366|FG000|Overall Study|Investigator/Participant request|5|||
160851862|NCT00296816|580846366|FG000|Overall Study|Non-compliance|1|||
160851863|NCT00296816|580846366|FG000|Overall Study|Missing for end of treatment|4|||
160851864|NCT00296816|580846366|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
160851865|NCT00296816|580846366|FG000|Overall Study|Poor performance status|1|||
160851866|NCT00296816|580846366|FG000|Overall Study|Relocation to Florida|1|||
160851867|NCT00296816|580846366|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
160851868|NCT00296816|580846366|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
160851869|NCT00296816|580846366|FG000|Overall Study|Neuropathy/patient preference|1|||
160851870|NCT00296816|580846366|FG000|Overall Study|Proteinuria|1|||
160851871|NCT00296816|580846366|FG000|Overall Study|ineligibility due to radiation treatment|1|||
160851872|NCT00985465|580846367|FG000|Overall Study|Withdrawal by Subject|1|||
160851873|NCT00985465|580846368|FG001|Overall Study|Withdrawal by Subject|2|||
160851874|NCT00985465|580846367|FG000|Overall Study|Considered to be part of the other group|0|||
160851875|NCT00985465|580846368|FG001|Overall Study|Considered to be part of the other group|1|||
160851876|NCT01454596|580846373|FG000|Overall Study|Death|0|||
160851877|NCT01454596|580846374|FG001|Overall Study|Death|0|||
160851878|NCT01454596|580846375|FG002|Overall Study|Death|0|||
160851879|NCT01454596|580846376|FG003|Overall Study|Death|0|||
160851880|NCT01454596|580846377|FG004|Overall Study|Death|0|||
160851881|NCT01454596|580846378|FG005|Overall Study|Death|0|||
160851882|NCT01454596|580846379|FG006|Overall Study|Death|0|||
160851883|NCT01454596|580846380|FG007|Overall Study|Death|0|||
160851884|NCT01454596|580846381|FG008|Overall Study|Death|0|||
160851885|NCT01454596|580846382|FG009|Overall Study|Death|1|||
160851886|NCT01454596|580846383|FG010|Overall Study|Death|1|||
160851887|NCT01454596|580846384|FG011|Overall Study|Death|0|||
160851888|NCT02800863|580846390|FG000|Overall Study|Adverse Event|14|||
160851889|NCT02800863|580846390|FG000|Overall Study|Another Device Implanted|1|||
160906822|NCT00191139|581052313|FG001|Overall Study|Other|2|||
160906823|NCT02465515|581052316|FG000|Overall Study|Investigator site closed|4|||
160906824|NCT02465515|581052317|FG001|Overall Study|Investigator site closed|5|||
160906825|NCT02465515|581052316|FG000|Overall Study|Withdrawal by Subject|74|||
160906826|NCT02465515|581052317|FG001|Overall Study|Withdrawal by Subject|43|||
160906827|NCT02465515|581052316|FG000|Overall Study|Physician Decision|8|||
160906828|NCT02465515|581052317|FG001|Overall Study|Physician Decision|12|||
160906829|NCT02465515|581052316|FG000|Overall Study|Lost to Follow-up|68|||
160851890|NCT02800863|580846390|FG000|Overall Study|Device Explanted|1|||
160906830|NCT02465515|581052317|FG001|Overall Study|Lost to Follow-up|51|||
160906831|NCT00816595|581052318|FG000|Overall Study|Withdrawal by Subject|2|||
160906832|NCT00816595|581052319|FG001|Overall Study|Withdrawal by Subject|0|||
160851891|NCT02800863|580846390|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
160851892|NCT02800863|580846390|FG000|Overall Study|Health Issues|1|||
160851893|NCT02800863|580846390|FG000|Overall Study|Insurance Denial|8|||
160851894|NCT02800863|580846390|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
160851895|NCT02800863|580846390|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
160851896|NCT02800863|580846390|FG000|Overall Study|Screen Failure|1|||
160851897|NCT02800863|580846390|FG000|Overall Study|Sponsor Request|6|||
160851898|NCT02800863|580846390|FG000|Overall Study|Death|3|||
160851899|NCT02800863|580846390|FG000|Overall Study|Subject Implant at Another Facility|1|||
160851900|NCT02800863|580846390|FG000|Overall Study|Lost to Follow-up|26|||
160851901|NCT02800863|580846390|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
160851902|NCT02800863|580846390|FG000|Overall Study|Subject and/or Family Request|64|||
160851903|NCT02800863|580846390|FG000|Overall Study|Trial Failure|81|||
160851904|NCT02800863|580846390|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
160851905|NCT00717249|580846391|FG000|Overall Study|Lens Discomfort|4|||
160851906|NCT00717249|580846392|FG001|Overall Study|Lens Discomfort|1|||
160851907|NCT00717249|580846391|FG000|Overall Study|Unsatisfactory visual Response|0|||
160851908|NCT00717249|580846392|FG001|Overall Study|Unsatisfactory visual Response|2|||
160851909|NCT00717249|580846391|FG000|Overall Study|Adverse Event|4|||
160851910|NCT00717249|580846392|FG001|Overall Study|Adverse Event|2|||
160851911|NCT00717249|580846391|FG000|Overall Study|Lost to Follow-up|2|||
160851912|NCT00717249|580846392|FG001|Overall Study|Lost to Follow-up|0|||
160851913|NCT00717249|580846391|FG000|Overall Study|Withdrawal by Subject|1|||
160851914|NCT00717249|580846392|FG001|Overall Study|Withdrawal by Subject|2|||
160851915|NCT00717249|580846391|FG000|Overall Study|Pregnancy|6|||
160851916|NCT00717249|580846392|FG001|Overall Study|Pregnancy|3|||
160851917|NCT00717249|580846391|FG000|Overall Study|Protocol Violation|0|||
160851918|NCT00717249|580846392|FG001|Overall Study|Protocol Violation|2|||
160851919|NCT00717249|580846391|FG000|Overall Study|Subject became Ineligible|1|||
160851920|NCT00717249|580846392|FG001|Overall Study|Subject became Ineligible|1|||
160851921|NCT00717249|580846391|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
160851922|NCT00717249|580846392|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
160851923|NCT00717249|580846391|FG000|Overall Study|Gastric Surgery|0|||
160851924|NCT00717249|580846392|FG001|Overall Study|Gastric Surgery|1|||
160851925|NCT00717249|580846391|FG000|Overall Study|Diagnosed with Diabetes|1|||
160851926|NCT00717249|580846392|FG001|Overall Study|Diagnosed with Diabetes|0|||
160851927|NCT00717249|580846391|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
160851928|NCT00717249|580846392|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
160851929|NCT00717249|580846391|FG000|Overall Study|Subject relocated|1|||
160851930|NCT00717249|580846392|FG001|Overall Study|Subject relocated|0|||
160851931|NCT00717249|580846391|FG000|Overall Study|Headaches|1|||
160851932|NCT00717249|580846392|FG001|Overall Study|Headaches|0|||
160851933|NCT01808196|580846396|FG000|Overall Study|Lost to Follow-up|1|||
160851934|NCT03370718|580846397|FG000|Overall Study|Withdrawal by Subject|1|||
160851935|NCT01670721|580846398|FG000|Overall Study|Participant's decision|15|||
160851936|NCT01670721|580846398|FG000|Overall Study|Other than specified above|38|||
160851937|NCT00479713|580846401|FG000|Overall Study|Adverse Event|8|||
160851938|NCT00479713|580846402|FG001|Overall Study|Adverse Event|6|||
160851939|NCT00479713|580846401|FG000|Overall Study|Death|1|||
160851940|NCT00479713|580846402|FG001|Overall Study|Death|0|||
160851941|NCT00479713|580846401|FG000|Overall Study|Lost to Follow-up|0|||
160851942|NCT00479713|580846402|FG001|Overall Study|Lost to Follow-up|1|||
160851943|NCT00479713|580846401|FG000|Overall Study|Protocol Violation|0|||
160851944|NCT00479713|580846402|FG001|Overall Study|Protocol Violation|1|||
160851945|NCT00479713|580846401|FG000|Overall Study|Withdrawal by Subject|4|||
160851946|NCT00479713|580846402|FG001|Overall Study|Withdrawal by Subject|1|||
160851947|NCT00141102|580846405|FG000|Overall Study|Adverse Event|233|||
160851948|NCT00141102|580846406|FG001|Overall Study|Adverse Event|305|||
160851949|NCT00141102|580846405|FG000|Overall Study|Laboratory Abnormality|9|||
160851950|NCT00141102|580846406|FG001|Overall Study|Laboratory Abnormality|33|||
160851951|NCT00141102|580846405|FG000|Overall Study|Lack of Efficacy|21|||
160851952|NCT00141102|580846406|FG001|Overall Study|Lack of Efficacy|26|||
160851953|NCT00141102|580846405|FG000|Overall Study|Lost to Follow-up|29|||
160851954|NCT00141102|580846406|FG001|Overall Study|Lost to Follow-up|32|||
160851955|NCT00141102|580846405|FG000|Overall Study|Other|87|||
160851956|NCT00141102|580846406|FG001|Overall Study|Other|76|||
160851957|NCT00141102|580846405|FG000|Overall Study|Withdrawal by Subject|112|||
160851958|NCT00141102|580846406|FG001|Overall Study|Withdrawal by Subject|142|||
161337272|NCT06494761|582625898|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
160851959|NCT00141102|580846405|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
160851960|NCT00141102|580846406|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
160851961|NCT00141102|580846405|FG000|Overall Study|Death|2|||
160851962|NCT00141102|580846406|FG001|Overall Study|Death|2|||
160851963|NCT05477485|580846407|FG000|Overall Study|Lost to Follow-up|0|||
160851964|NCT05477485|580846408|FG001|Overall Study|Lost to Follow-up|4|||
160851965|NCT03061201|580846409|FG000|Overall Study|Participants Terminated at Month 36|0|||
160906833|NCT00481078|581052323|FG000|Overall Study|Progression of disease|11|||
160906834|NCT00481078|581052324|FG001|Overall Study|Progression of disease|11|||
160906835|NCT00481078|581052323|FG000|Overall Study|Adverse Event|15|||
160851966|NCT03061201|580846410|FG001|Overall Study|Participants Terminated at Month 36|1|||
160851967|NCT03061201|580846411|FG002|Overall Study|Participants Terminated at Month 36|0|||
160851968|NCT03061201|580846412|FG003|Overall Study|Participants Terminated at Month 36|1|||
160851969|NCT03061201|580846409|FG000|Overall Study|Lost to Follow-up|1|||
160851970|NCT03061201|580846410|FG001|Overall Study|Lost to Follow-up|0|||
160851971|NCT03061201|580846411|FG002|Overall Study|Lost to Follow-up|0|||
160851972|NCT03061201|580846412|FG003|Overall Study|Lost to Follow-up|0|||
160851973|NCT01572480|580846413|FG000|Participants Enrolled|Withdrawal by Subject|1|||
160851974|NCT01572480|580846413|FG000|Drug Administration|Discontinued drug/Off Study|1|||
160851975|NCT01572480|580846413|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
160851976|NCT01572480|580846413|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
160851977|NCT05081219|580846414|FG000|Overall Study|Withdrawal by Subject|4|||
160851978|NCT05081219|580846415|FG001|Overall Study|Withdrawal by Subject|0|||
160851979|NCT05081219|580846416|FG002|Overall Study|Withdrawal by Subject|0|||
160851980|NCT05081219|580846417|FG003|Overall Study|Withdrawal by Subject|1|||
160851981|NCT03446313|580846418|FG000|Overall Study|Lost to Follow-up|1|||
160851982|NCT03446313|580846419|FG001|Overall Study|Lost to Follow-up|2|||
160851983|NCT03446313|580846418|FG000|Overall Study|Failed primary screening|3|||
160851984|NCT03446313|580846419|FG001|Overall Study|Failed primary screening|0|||
160851985|NCT03446313|580846418|FG000|Overall Study|Diagnosed with terminal cancer|1|||
160851986|NCT03446313|580846419|FG001|Overall Study|Diagnosed with terminal cancer|0|||
160851987|NCT03446313|580846418|FG000|Overall Study|Excluded from analysis|1|||
160851988|NCT03446313|580846419|FG001|Overall Study|Excluded from analysis|1|||
160851989|NCT05274958|580846420|FG000|Overall Study|Only completed 1 set of PROMs|22|||
160851990|NCT05274958|580846421|FG001|Overall Study|Only completed 1 set of PROMs|35|||
160851991|NCT00866814|580846422|FG000|Overall Study|Lost to Follow-up|12|||
160851992|NCT00866814|580846422|FG000|Overall Study|Adverse Event|2|||
160851993|NCT00866814|580846422|FG000|Overall Study|Physician Decision|1|||
160851994|NCT00866814|580846422|FG000|Overall Study|Death|1|||
160851995|NCT00866814|580846422|FG000|Overall Study|No longer wished to participate|1|||
160851996|NCT00866814|580846422|FG000|Overall Study|Unable to meet follow-up requirements|2|||
160851997|NCT00866814|580846422|FG000|Overall Study|Moved to area without study site|1|||
160851998|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
160851999|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
160852000|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
160852001|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
160852002|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
160852003|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
160852004|NCT02679287|580846427|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
160852005|NCT02679287|580846428|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
160852006|NCT02679287|580846427|FG000|Period 2|Work/Scheduling Conflict|1|||
160852007|NCT02679287|580846428|FG001|Period 2|Work/Scheduling Conflict|0|||
160852008|NCT02679287|580846427|FG000|Period 2|Disliked Mobile System|2|||
160852009|NCT02679287|580846428|FG001|Period 2|Disliked Mobile System|0|||
160852010|NCT02679287|580846427|FG000|Period 3|Work/Scheduling Conflict|0|||
160852011|NCT02679287|580846428|FG001|Period 3|Work/Scheduling Conflict|1|||
160852012|NCT01790594|580848683|FG000|Overall Study|Death|1|||
160852013|NCT01790594|580848684|FG001|Overall Study|Death|0|||
160852014|NCT01790594|580848685|FG002|Overall Study|Death|0|||
160852015|NCT01790594|580848683|FG000|Overall Study|Physician Decision|2|||
160852016|NCT01790594|580848684|FG001|Overall Study|Physician Decision|1|||
160852017|NCT01790594|580848685|FG002|Overall Study|Physician Decision|0|||
160852018|NCT01790594|580848683|FG000|Overall Study|Withdrawal by Subject|2|||
160852019|NCT01790594|580848684|FG001|Overall Study|Withdrawal by Subject|0|||
160852020|NCT01790594|580848685|FG002|Overall Study|Withdrawal by Subject|0|||
160852021|NCT01790594|580848683|FG000|Overall Study|Transplant was not done|0|||
160852022|NCT01790594|580848684|FG001|Overall Study|Transplant was not done|0|||
160852023|NCT01790594|580848685|FG002|Overall Study|Transplant was not done|3|||
160852024|NCT01790594|580848683|FG000|Overall Study|Terminated prior to week 76|0|||
160852025|NCT01790594|580848684|FG001|Overall Study|Terminated prior to week 76|2|||
160852026|NCT01790594|580848685|FG002|Overall Study|Terminated prior to week 76|0|||
160852027|NCT03956550|580848686|FG000|Overall Study|Sponsor decision|65|||
160852028|NCT03956550|580848687|FG001|Overall Study|Sponsor decision|66|||
160852029|NCT03956550|580848688|FG002|Overall Study|Sponsor decision|64|||
160852030|NCT03956550|580848686|FG000|Overall Study|Adverse Event|0|||
160852031|NCT03956550|580848687|FG001|Overall Study|Adverse Event|1|||
160852032|NCT03956550|580848688|FG002|Overall Study|Adverse Event|0|||
160852033|NCT03956550|580848686|FG000|Overall Study|Withdrawal by Subject|5|||
160852034|NCT03956550|580848687|FG001|Overall Study|Withdrawal by Subject|5|||
160852035|NCT03956550|580848688|FG002|Overall Study|Withdrawal by Subject|6|||
160852036|NCT03400852|580848689|FG000|Blinded Treatment Period|Physician Decision|0|||
160852037|NCT03400852|580848690|FG001|Blinded Treatment Period|Physician Decision|1|||
160852038|NCT03400852|580848691|FG002|Blinded Treatment Period|Physician Decision|0|||
160852039|NCT03400852|580848689|FG000|Blinded Treatment Period|Adverse Event|1|||
160852040|NCT03400852|580848690|FG001|Blinded Treatment Period|Adverse Event|1|||
160852041|NCT03400852|580848691|FG002|Blinded Treatment Period|Adverse Event|0|||
160852042|NCT03400852|580848689|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
160852043|NCT03400852|580848690|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
160906836|NCT00481078|581052324|FG001|Overall Study|Adverse Event|3|||
160852044|NCT03400852|580848691|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
160852045|NCT03400852|580848689|FG000|Open Label Period|Physician Decision|0|||
160852046|NCT03400852|580848690|FG001|Open Label Period|Physician Decision|0|||
160852047|NCT03400852|580848691|FG002|Open Label Period|Physician Decision|1|||
160852048|NCT03400852|580848689|FG000|Open Label Period|Study terminated by sponsor|0|||
160852049|NCT03400852|580848690|FG001|Open Label Period|Study terminated by sponsor|0|||
160852050|NCT03400852|580848691|FG002|Open Label Period|Study terminated by sponsor|21|||
160852051|NCT00248495|580848692|FG000|Overall Study|Withdrawal by Subject|1|||
160852052|NCT03719131|580848694|FG000|Overall Study|Death|1|||
160852053|NCT03719131|580848695|FG001|Overall Study|Death|2|||
160852054|NCT04244253|580848696|FG000|Overall Study|Adverse Event|2|||
160852055|NCT04244253|580848697|FG001|Overall Study|Adverse Event|2|||
160852056|NCT04244253|580848698|FG002|Overall Study|Adverse Event|4|||
160852057|NCT04244253|580848696|FG000|Overall Study|Protocol Violation|1|||
160852058|NCT04244253|580848697|FG001|Overall Study|Protocol Violation|2|||
160852059|NCT04244253|580848698|FG002|Overall Study|Protocol Violation|1|||
160852060|NCT04244253|580848696|FG000|Overall Study|Withdrawal by Subject|0|||
160852061|NCT04244253|580848697|FG001|Overall Study|Withdrawal by Subject|1|||
160852062|NCT04244253|580848698|FG002|Overall Study|Withdrawal by Subject|6|||
160852063|NCT04244253|580848696|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160852064|NCT04244253|580848697|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160852065|NCT04244253|580848698|FG002|Overall Study|Non-Compliance With Study Drug|1|||
160852066|NCT01544920|580848699|FG000|Overall Study|Adverse Event|0|||
160852067|NCT01544920|580848700|FG001|Overall Study|Adverse Event|3|||
160852068|NCT01544920|580848699|FG000|Overall Study|Death|0|||
160852069|NCT01544920|580848700|FG001|Overall Study|Death|1|||
160852070|NCT01544920|580848699|FG000|Overall Study|Lost to Follow-up|11|||
160852071|NCT01544920|580848700|FG001|Overall Study|Lost to Follow-up|12|||
160852072|NCT01544920|580848699|FG000|Overall Study|Protocol Violation|0|||
160852073|NCT01544920|580848700|FG001|Overall Study|Protocol Violation|2|||
160852074|NCT01544920|580848699|FG000|Overall Study|Physician Decision|4|||
160852075|NCT01544920|580848700|FG001|Overall Study|Physician Decision|1|||
160852076|NCT01544920|580848699|FG000|Overall Study|Withdrawal by Subject|4|||
160852077|NCT01544920|580848700|FG001|Overall Study|Withdrawal by Subject|4|||
160852078|NCT02420093|580848701|FG000|Overall Study|Withdrawal by Subject|1|||
160852079|NCT02420093|580848702|FG001|Overall Study|Withdrawal by Subject|1|||
160852080|NCT03244917|580848706|FG000|Overall Study|Lost to Follow-up|2|||
160852081|NCT03244917|580848707|FG001|Overall Study|Lost to Follow-up|2|||
161337273|NCT06494761|582625898|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
161337274|NCT04865289|582625899|FG000|Overall Study|Death|34|||
161337275|NCT04865289|582625900|FG001|Overall Study|Death|25|||
161337276|NCT04865289|582625899|FG000|Overall Study|Physician Decision|27|||
161337277|NCT04865289|582625900|FG001|Overall Study|Physician Decision|27|||
161337278|NCT04865289|582625899|FG000|Overall Study|Sponsor Decision|11|||
161337279|NCT04865289|582625900|FG001|Overall Study|Sponsor Decision|1|||
161337280|NCT04865289|582625899|FG000|Overall Study|Withdrawal by Subject|2|||
161337281|NCT04865289|582625900|FG001|Overall Study|Withdrawal by Subject|3|||
161337282|NCT03104374|582625901|FG000|Period 1|Adverse Event|7|||
161337283|NCT03104374|582625902|FG001|Period 1|Adverse Event|7|||
161337284|NCT03104374|582625903|FG002|Period 1|Adverse Event|12|||
161337285|NCT03104374|582625904|FG003|Period 1|Adverse Event|14|||
161337286|NCT03104374|582625901|FG000|Period 1|Withdrawal by Subject|18|||
161337287|NCT03104374|582625902|FG001|Period 1|Withdrawal by Subject|9|||
161337288|NCT03104374|582625903|FG002|Period 1|Withdrawal by Subject|10|||
161337289|NCT03104374|582625904|FG003|Period 1|Withdrawal by Subject|17|||
160852082|NCT03001557|580848709|FG000|Core Phase|Randomized but not treated|0|||
160852083|NCT03001557|580848710|FG001|Core Phase|Randomized but not treated|0|||
160852084|NCT03001557|580848711|FG002|Core Phase|Randomized but not treated|1|||
160852085|NCT03001557|580848712|FG003|Core Phase|Randomized but not treated|0|||
160852086|NCT03001557|580848713|FG004|Core Phase|Randomized but not treated|0|||
160852087|NCT03001557|580848714|FG005|Core Phase|Randomized but not treated|0|||
160852088|NCT03001557|580848715|FG006|Core Phase|Randomized but not treated|0|||
160852089|NCT03001557|580848716|FG007|Core Phase|Randomized but not treated|0|||
160852090|NCT03001557|580848709|FG000|Extension Phase|Adverse Event|0|||
160852091|NCT03001557|580848710|FG001|Extension Phase|Adverse Event|0|||
161337290|NCT03104374|582625901|FG000|Period 1|Lost to Follow-up|4|||
161337291|NCT03104374|582625902|FG001|Period 1|Lost to Follow-up|4|||
161337292|NCT03104374|582625903|FG002|Period 1|Lost to Follow-up|6|||
161337293|NCT03104374|582625904|FG003|Period 1|Lost to Follow-up|8|||
160852092|NCT03001557|580848711|FG002|Extension Phase|Adverse Event|0|||
160852093|NCT03001557|580848712|FG003|Extension Phase|Adverse Event|0|||
160852094|NCT03001557|580848713|FG004|Extension Phase|Adverse Event|0|||
160852095|NCT03001557|580848714|FG005|Extension Phase|Adverse Event|2|||
160852096|NCT03001557|580848715|FG006|Extension Phase|Adverse Event|0|||
160852097|NCT03001557|580848716|FG007|Extension Phase|Adverse Event|0|||
160852098|NCT03001557|580848709|FG000|Extension Phase|Withdrawal by Subject|0|||
160852099|NCT03001557|580848710|FG001|Extension Phase|Withdrawal by Subject|0|||
161337294|NCT03104374|582625901|FG000|Period 1|Lack of Efficacy|6|||
161337295|NCT03104374|582625902|FG001|Period 1|Lack of Efficacy|7|||
160852100|NCT03001557|580848711|FG002|Extension Phase|Withdrawal by Subject|0|||
160852101|NCT03001557|580848712|FG003|Extension Phase|Withdrawal by Subject|0|||
160852102|NCT03001557|580848713|FG004|Extension Phase|Withdrawal by Subject|0|||
160852103|NCT03001557|580848714|FG005|Extension Phase|Withdrawal by Subject|1|||
160852104|NCT03001557|580848715|FG006|Extension Phase|Withdrawal by Subject|5|||
160852105|NCT03001557|580848716|FG007|Extension Phase|Withdrawal by Subject|2|||
160852106|NCT03001557|580848709|FG000|Extension Phase|Lost to Follow-up|0|||
160852107|NCT03001557|580848710|FG001|Extension Phase|Lost to Follow-up|0|||
160852108|NCT03001557|580848711|FG002|Extension Phase|Lost to Follow-up|0|||
160852109|NCT03001557|580848712|FG003|Extension Phase|Lost to Follow-up|0|||
160852110|NCT03001557|580848713|FG004|Extension Phase|Lost to Follow-up|0|||
160852111|NCT03001557|580848714|FG005|Extension Phase|Lost to Follow-up|0|||
160852112|NCT03001557|580848715|FG006|Extension Phase|Lost to Follow-up|2|||
160852113|NCT03001557|580848716|FG007|Extension Phase|Lost to Follow-up|1|||
160852114|NCT03001557|580848709|FG000|Extension Phase|Administrative Reason|0|||
160852115|NCT03001557|580848710|FG001|Extension Phase|Administrative Reason|0|||
160852116|NCT03001557|580848711|FG002|Extension Phase|Administrative Reason|0|||
160852117|NCT03001557|580848712|FG003|Extension Phase|Administrative Reason|0|||
160852118|NCT03001557|580848713|FG004|Extension Phase|Administrative Reason|0|||
160852119|NCT03001557|580848714|FG005|Extension Phase|Administrative Reason|1|||
160852120|NCT03001557|580848715|FG006|Extension Phase|Administrative Reason|3|||
160852121|NCT03001557|580848716|FG007|Extension Phase|Administrative Reason|3|||
160852122|NCT03001557|580848709|FG000|Extension Phase|Loss of caregiver|0|||
160852123|NCT03001557|580848710|FG001|Extension Phase|Loss of caregiver|0|||
160852124|NCT03001557|580848711|FG002|Extension Phase|Loss of caregiver|0|||
160852125|NCT03001557|580848712|FG003|Extension Phase|Loss of caregiver|0|||
160852126|NCT03001557|580848713|FG004|Extension Phase|Loss of caregiver|0|||
160852127|NCT03001557|580848714|FG005|Extension Phase|Loss of caregiver|0|||
160852128|NCT03001557|580848715|FG006|Extension Phase|Loss of caregiver|1|||
160852129|NCT03001557|580848716|FG007|Extension Phase|Loss of caregiver|0|||
160852130|NCT03001557|580848709|FG000|Extension Phase|Others|0|||
160852131|NCT03001557|580848710|FG001|Extension Phase|Others|0|||
160852132|NCT03001557|580848711|FG002|Extension Phase|Others|0|||
160852133|NCT03001557|580848712|FG003|Extension Phase|Others|0|||
160852134|NCT03001557|580848713|FG004|Extension Phase|Others|0|||
160852135|NCT03001557|580848714|FG005|Extension Phase|Others|1|||
160852136|NCT03001557|580848715|FG006|Extension Phase|Others|3|||
160852137|NCT03001557|580848716|FG007|Extension Phase|Others|0|||
160852138|NCT01272232|580848717|FG000|Weeks 0-56|Adverse Event|39|||
160852139|NCT01272232|580848718|FG001|Weeks 0-56|Adverse Event|18|||
160852140|NCT01272232|580848719|FG002|Weeks 0-56|Adverse Event|7|||
160852141|NCT01272232|580848717|FG000|Weeks 0-56|Lack of Efficacy|0|||
160852142|NCT01272232|580848718|FG001|Weeks 0-56|Lack of Efficacy|0|||
160852143|NCT01272232|580848719|FG002|Weeks 0-56|Lack of Efficacy|3|||
160852144|NCT01272232|580848717|FG000|Weeks 0-56|Protocol Violation|12|||
160852145|NCT01272232|580848718|FG001|Weeks 0-56|Protocol Violation|8|||
160852146|NCT01272232|580848719|FG002|Weeks 0-56|Protocol Violation|13|||
160852147|NCT01272232|580848717|FG000|Weeks 0-56|Withdrawal criteria|32|||
160852148|NCT01272232|580848718|FG001|Weeks 0-56|Withdrawal criteria|14|||
160852149|NCT01272232|580848719|FG002|Weeks 0-56|Withdrawal criteria|37|||
160852150|NCT01272232|580848717|FG000|Weeks 0-56|Unclassified|16|||
160852151|NCT01272232|580848718|FG001|Weeks 0-56|Unclassified|7|||
160852152|NCT01272232|580848719|FG002|Weeks 0-56|Unclassified|12|||
160852153|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
160852154|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
160852155|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
160852156|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
160852157|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
160852158|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
160852159|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
160852160|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
160852161|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
160852162|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
160852163|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
160852164|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
160992511|NCT03999554|581361385|FG000|Overall Study|Pregnancy|0|||
160852165|NCT01272232|580848717|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
160852166|NCT01272232|580848718|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
160852167|NCT01272232|580848719|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
160852168|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852169|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852170|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852171|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852172|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852173|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852174|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852175|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852176|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852177|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852178|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852179|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852180|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
160852181|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852182|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
160852183|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852184|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852185|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852186|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852187|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
160852188|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852189|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
160852190|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
160852191|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852192|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852193|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852194|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852195|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
160852196|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
160852197|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
160852198|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
160852199|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
160852200|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
160852201|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
160852202|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
160852203|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
160852204|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
160852205|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
160852206|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
160852207|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
160852208|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
160852209|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
160852210|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
160852211|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
160852212|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
160852213|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
160852214|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852215|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852216|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
160852217|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852218|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852219|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852220|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852221|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852222|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852223|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
160852224|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852225|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852226|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852227|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
160852228|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852229|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852230|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852231|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852232|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852233|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852234|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852235|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852236|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852237|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852238|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852239|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852240|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852241|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
160852242|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
160852243|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852244|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852245|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852246|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
160852247|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852248|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852249|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852250|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852251|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852252|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852253|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
160852254|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852255|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852256|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852257|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
160852258|NCT01147666|580848720|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852259|NCT01147666|580848721|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852260|NCT01147666|580848722|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852261|NCT01147666|580848723|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852262|NCT01147666|580848724|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852263|NCT01147666|580848725|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852264|NCT01147666|580848726|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852265|NCT01147666|580848727|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852266|NCT01147666|580848728|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852267|NCT01147666|580848729|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852268|NCT01147666|580848730|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852269|NCT01147666|580848731|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
160852270|NCT01147666|580848732|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
160852271|NCT01147666|580848733|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
160852272|NCT01147666|580848734|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
160852273|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
161337296|NCT03104374|582625903|FG002|Period 1|Lack of Efficacy|12|||
161337297|NCT03104374|582625904|FG003|Period 1|Lack of Efficacy|6|||
161337298|NCT03104374|582625901|FG000|Period 1|Other|2|||
161337299|NCT03104374|582625902|FG001|Period 1|Other|2|||
161337300|NCT03104374|582625903|FG002|Period 1|Other|4|||
161337301|NCT03104374|582625904|FG003|Period 1|Other|7|||
161337302|NCT03104374|582625901|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161337303|NCT03104374|582625902|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161337304|NCT03104374|582625903|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
161337305|NCT03104374|582625904|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
161337306|NCT03104374|582625901|FG000|Period 2|Adverse Event|4|||
160852274|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
160852275|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
160852276|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
160852277|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
160852278|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
160852279|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
160852280|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
160852281|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
160906837|NCT00481078|581052323|FG000|Overall Study|Death|5|||
160906838|NCT00481078|581052324|FG001|Overall Study|Death|3|||
160906839|NCT00481078|581052323|FG000|Overall Study|Intercurrent illness|1|||
160906840|NCT00481078|581052324|FG001|Overall Study|Intercurrent illness|0|||
160906841|NCT00481078|581052323|FG000|Overall Study|Withdrawal by Subject|7|||
160906842|NCT00481078|581052324|FG001|Overall Study|Withdrawal by Subject|1|||
160906843|NCT00481078|581052323|FG000|Overall Study|Information not available|1|||
160906844|NCT00481078|581052324|FG001|Overall Study|Information not available|0|||
160906845|NCT00481078|581052323|FG000|Overall Study|Received other treatment|2|||
160906846|NCT00481078|581052324|FG001|Overall Study|Received other treatment|1|||
160906847|NCT00481078|581052323|FG000|Overall Study|Brain metastasis|0|||
160906848|NCT00481078|581052324|FG001|Overall Study|Brain metastasis|1|||
160906849|NCT00228384|581052325|FG000|Overall Study|Death|9|||
160906850|NCT00228384|581052326|FG001|Overall Study|Death|3|||
161337307|NCT03104374|582625902|FG001|Period 2|Adverse Event|7|||
161337308|NCT03104374|582625903|FG002|Period 2|Adverse Event|10|||
161337309|NCT03104374|582625904|FG003|Period 2|Adverse Event|10|||
160906851|NCT00228384|581052325|FG000|Overall Study|Lost to Follow-up|6|||
160906852|NCT00228384|581052326|FG001|Overall Study|Lost to Follow-up|10|||
160992512|NCT03999554|581361386|FG001|Overall Study|Pregnancy|0|||
160852282|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
160852283|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
160852284|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
160852285|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
160852286|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
160852287|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
160852288|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852289|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852290|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852291|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852292|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
160852293|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
160852294|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
160852295|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
160852296|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852297|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
160852298|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852299|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852300|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
160852301|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
160852302|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
160852303|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852304|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852305|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852306|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
160852307|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852308|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852309|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852310|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852311|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852312|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852313|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852314|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852315|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852316|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852317|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
160852318|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852319|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852320|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852321|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852322|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852323|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852324|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852325|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852326|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852327|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852328|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852329|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852330|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852331|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
160852332|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
160852333|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852334|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852335|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852336|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
160852337|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852338|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852339|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852340|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852341|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852342|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
161337310|NCT03104374|582625901|FG000|Period 2|Withdrawal by Subject|3|||
161337311|NCT03104374|582625902|FG001|Period 2|Withdrawal by Subject|7|||
161337312|NCT03104374|582625903|FG002|Period 2|Withdrawal by Subject|13|||
161337313|NCT03104374|582625904|FG003|Period 2|Withdrawal by Subject|16|||
161337314|NCT03104374|582625901|FG000|Period 2|Lost to Follow-up|2|||
160852343|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
160852344|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852345|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852346|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852347|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
160852348|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852349|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852350|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852351|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852352|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852353|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852354|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852355|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852356|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852357|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852358|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852359|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852360|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
160852361|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852362|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
160852363|NCT01147666|580848720|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852364|NCT01147666|580848721|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852365|NCT01147666|580848722|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852366|NCT01147666|580848723|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852367|NCT01147666|580848724|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852368|NCT01147666|580848725|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852369|NCT01147666|580848726|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852370|NCT01147666|580848727|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852371|NCT01147666|580848728|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852372|NCT01147666|580848729|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852373|NCT01147666|580848730|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852374|NCT01147666|580848731|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852375|NCT01147666|580848732|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
160852376|NCT01147666|580848733|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
160852377|NCT01147666|580848734|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
160852378|NCT02159066|580848735|FG000|Part I|Adverse Event|7|||
160852379|NCT02159066|580848736|FG001|Part I|Adverse Event|5|||
160852380|NCT02159066|580848737|FG002|Part I|Adverse Event|0|||
160852381|NCT02159066|580848738|FG003|Part I|Adverse Event|0|||
160852382|NCT02159066|580848739|FG004|Part I|Adverse Event|0|||
160852383|NCT02159066|580848740|FG005|Part I|Adverse Event|0|||
160852384|NCT02159066|580848735|FG000|Part I|Death|11|||
160852385|NCT02159066|580848736|FG001|Part I|Death|9|||
160852386|NCT02159066|580848737|FG002|Part I|Death|0|||
160852387|NCT02159066|580848738|FG003|Part I|Death|0|||
160852388|NCT02159066|580848739|FG004|Part I|Death|0|||
160852389|NCT02159066|580848740|FG005|Part I|Death|0|||
160852390|NCT02159066|580848735|FG000|Part I|Progressive Disease|37|||
160852391|NCT02159066|580848736|FG001|Part I|Progressive Disease|46|||
160852392|NCT02159066|580848737|FG002|Part I|Progressive Disease|0|||
160852393|NCT02159066|580848738|FG003|Part I|Progressive Disease|0|||
160852394|NCT02159066|580848739|FG004|Part I|Progressive Disease|0|||
160852395|NCT02159066|580848740|FG005|Part I|Progressive Disease|0|||
160852396|NCT02159066|580848735|FG000|Part I|New Therapy for Study Indication|5|||
160852397|NCT02159066|580848736|FG001|Part I|New Therapy for Study Indication|4|||
160852398|NCT02159066|580848737|FG002|Part I|New Therapy for Study Indication|0|||
160852399|NCT02159066|580848738|FG003|Part I|New Therapy for Study Indication|0|||
160852400|NCT02159066|580848739|FG004|Part I|New Therapy for Study Indication|0|||
160852401|NCT02159066|580848740|FG005|Part I|New Therapy for Study Indication|0|||
160852402|NCT02159066|580848735|FG000|Part I|Termination of participants from the study|3|||
160852403|NCT02159066|580848736|FG001|Part I|Termination of participants from the study|3|||
160852404|NCT02159066|580848737|FG002|Part I|Termination of participants from the study|0|||
160852405|NCT02159066|580848738|FG003|Part I|Termination of participants from the study|0|||
160852406|NCT02159066|580848739|FG004|Part I|Termination of participants from the study|0|||
160852407|NCT02159066|580848740|FG005|Part I|Termination of participants from the study|0|||
160852408|NCT02159066|580848735|FG000|Part I|Physician Decision|2|||
160852409|NCT02159066|580848736|FG001|Part I|Physician Decision|9|||
160852410|NCT02159066|580848737|FG002|Part I|Physician Decision|0|||
161255201|NCT02688387|582314137|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255202|NCT02688387|582314138|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160852411|NCT02159066|580848738|FG003|Part I|Physician Decision|0|||
160852412|NCT02159066|580848739|FG004|Part I|Physician Decision|0|||
160852413|NCT02159066|580848740|FG005|Part I|Physician Decision|0|||
160852414|NCT02159066|580848735|FG000|Part I|Participant/Guardian Decision|9|||
160852415|NCT02159066|580848736|FG001|Part I|Participant/Guardian Decision|3|||
160852416|NCT02159066|580848737|FG002|Part I|Participant/Guardian Decision|0|||
160852417|NCT02159066|580848738|FG003|Part I|Participant/Guardian Decision|0|||
160852418|NCT02159066|580848739|FG004|Part I|Participant/Guardian Decision|0|||
160852419|NCT02159066|580848740|FG005|Part I|Participant/Guardian Decision|0|||
160852420|NCT02159066|580848735|FG000|Part I|Missing Data|1|||
160852421|NCT02159066|580848736|FG001|Part I|Missing Data|0|||
160852422|NCT02159066|580848737|FG002|Part I|Missing Data|0|||
160852423|NCT02159066|580848738|FG003|Part I|Missing Data|0|||
160852424|NCT02159066|580848739|FG004|Part I|Missing Data|0|||
160852425|NCT02159066|580848740|FG005|Part I|Missing Data|0|||
160852426|NCT02159066|580848735|FG000|Part II|Adverse Event|0|||
160852427|NCT02159066|580848736|FG001|Part II|Adverse Event|0|||
160852428|NCT02159066|580848737|FG002|Part II|Adverse Event|1|||
160852429|NCT02159066|580848738|FG003|Part II|Adverse Event|0|||
160852430|NCT02159066|580848739|FG004|Part II|Adverse Event|1|||
160852431|NCT02159066|580848740|FG005|Part II|Adverse Event|1|||
160852432|NCT02159066|580848735|FG000|Part II|Death|0|||
160852433|NCT02159066|580848736|FG001|Part II|Death|0|||
160852434|NCT02159066|580848737|FG002|Part II|Death|1|||
160852435|NCT02159066|580848738|FG003|Part II|Death|0|||
160852436|NCT02159066|580848739|FG004|Part II|Death|2|||
160852437|NCT02159066|580848740|FG005|Part II|Death|1|||
160852438|NCT02159066|580848735|FG000|Part II|Progressive Disease|0|||
160852439|NCT02159066|580848736|FG001|Part II|Progressive Disease|0|||
160852440|NCT02159066|580848737|FG002|Part II|Progressive Disease|35|||
160852441|NCT02159066|580848738|FG003|Part II|Progressive Disease|1|||
160852442|NCT02159066|580848739|FG004|Part II|Progressive Disease|7|||
160852443|NCT02159066|580848740|FG005|Part II|Progressive Disease|4|||
160852444|NCT02159066|580848735|FG000|Part II|New Therapy for Study Indication|0|||
160852445|NCT02159066|580848736|FG001|Part II|New Therapy for Study Indication|0|||
160852446|NCT02159066|580848737|FG002|Part II|New Therapy for Study Indication|0|||
160852447|NCT02159066|580848738|FG003|Part II|New Therapy for Study Indication|0|||
160852448|NCT02159066|580848739|FG004|Part II|New Therapy for Study Indication|1|||
160852449|NCT02159066|580848740|FG005|Part II|New Therapy for Study Indication|0|||
160852450|NCT02159066|580848735|FG000|Part II|Physician Decision|0|||
160852451|NCT02159066|580848736|FG001|Part II|Physician Decision|0|||
160852452|NCT02159066|580848737|FG002|Part II|Physician Decision|1|||
160852453|NCT02159066|580848738|FG003|Part II|Physician Decision|0|||
160852454|NCT02159066|580848739|FG004|Part II|Physician Decision|0|||
160852455|NCT02159066|580848740|FG005|Part II|Physician Decision|0|||
160852456|NCT02159066|580848735|FG000|Part II|Participant/Guardian Decision|0|||
160852457|NCT02159066|580848736|FG001|Part II|Participant/Guardian Decision|0|||
160852458|NCT02159066|580848737|FG002|Part II|Participant/Guardian Decision|0|||
160852459|NCT02159066|580848738|FG003|Part II|Participant/Guardian Decision|0|||
160852460|NCT02159066|580848739|FG004|Part II|Participant/Guardian Decision|2|||
160852461|NCT02159066|580848740|FG005|Part II|Participant/Guardian Decision|0|||
160852462|NCT02748863|580848741|FG000|Treatment Period 1|Adverse Event|0|||
160852463|NCT02748863|580848742|FG001|Treatment Period 1|Adverse Event|1|||
160852464|NCT02748863|580848743|FG002|Treatment Period 1|Adverse Event|0|||
160852465|NCT02748863|580848744|FG003|Treatment Period 1|Adverse Event|0|||
160852466|NCT02748863|580848745|FG004|Treatment Period 1|Adverse Event|0|||
160852467|NCT02748863|580848741|FG000|Treatment Period 1|Lack of Efficacy|0|||
160852468|NCT02748863|580848742|FG001|Treatment Period 1|Lack of Efficacy|0|||
160852469|NCT02748863|580848743|FG002|Treatment Period 1|Lack of Efficacy|1|||
160852470|NCT02748863|580848744|FG003|Treatment Period 1|Lack of Efficacy|0|||
160852471|NCT02748863|580848745|FG004|Treatment Period 1|Lack of Efficacy|0|||
160852472|NCT02748863|580848741|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160852473|NCT02748863|580848742|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160852474|NCT02748863|580848743|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160852475|NCT02748863|580848744|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160852476|NCT02748863|580848745|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160852477|NCT02748863|580848741|FG000|Treatment Period 2|Lost to Follow-up|2|||
160852478|NCT02748863|580848742|FG001|Treatment Period 2|Lost to Follow-up|0|||
160852479|NCT02748863|580848743|FG002|Treatment Period 2|Lost to Follow-up|0|||
160852480|NCT02748863|580848744|FG003|Treatment Period 2|Lost to Follow-up|0|||
160852481|NCT02748863|580848745|FG004|Treatment Period 2|Lost to Follow-up|0|||
160852482|NCT02748863|580848741|FG000|Treatment Period 2|Adverse Event|3|||
160852483|NCT02748863|580848742|FG001|Treatment Period 2|Adverse Event|2|||
160852484|NCT02748863|580848743|FG002|Treatment Period 2|Adverse Event|0|||
160852485|NCT02748863|580848744|FG003|Treatment Period 2|Adverse Event|2|||
160852486|NCT02748863|580848745|FG004|Treatment Period 2|Adverse Event|0|||
160852487|NCT02748863|580848741|FG000|Treatment Period 2|Lack of Efficacy|0|||
160852488|NCT02748863|580848742|FG001|Treatment Period 2|Lack of Efficacy|1|||
160852489|NCT02748863|580848743|FG002|Treatment Period 2|Lack of Efficacy|0|||
160852490|NCT02748863|580848744|FG003|Treatment Period 2|Lack of Efficacy|0|||
160852491|NCT02748863|580848745|FG004|Treatment Period 2|Lack of Efficacy|0|||
160852492|NCT02748863|580848741|FG000|Treatment Period 2|Pregnancy|0|||
160852493|NCT02748863|580848742|FG001|Treatment Period 2|Pregnancy|0|||
160852494|NCT02748863|580848743|FG002|Treatment Period 2|Pregnancy|0|||
161141203|NCT00356915|581900993|FG002|Overall Study|Adverse Event|8|||
161141204|NCT00356915|581900991|FG000|Overall Study|Miscellaneous reasons|11|||
160852495|NCT02748863|580848744|FG003|Treatment Period 2|Pregnancy|0|||
160852496|NCT02748863|580848745|FG004|Treatment Period 2|Pregnancy|1|||
160852497|NCT01135134|580848747|FG000|Overall Study|Adverse Event|1|||
160852498|NCT01135134|580848748|FG001|Overall Study|Adverse Event|1|||
160852499|NCT01135134|580848747|FG000|Overall Study|Did not meet protocol eligibility|1|||
160852500|NCT01135134|580848748|FG001|Overall Study|Did not meet protocol eligibility|0|||
160852501|NCT02576639|580848749|FG000|Overall Study|Withdrawal by Subject|1|||
160852502|NCT02576639|580848750|FG001|Overall Study|Withdrawal by Subject|2|||
160852503|NCT02576639|580848751|FG002|Overall Study|Withdrawal by Subject|1|||
160852504|NCT02576639|580848752|FG003|Overall Study|Withdrawal by Subject|0|||
160852505|NCT02576639|580848753|FG004|Overall Study|Withdrawal by Subject|1|||
160852506|NCT02576639|580848749|FG000|Overall Study|Adverse Event|1|||
160852507|NCT02576639|580848750|FG001|Overall Study|Adverse Event|0|||
160852508|NCT02576639|580848751|FG002|Overall Study|Adverse Event|1|||
160852509|NCT02576639|580848752|FG003|Overall Study|Adverse Event|1|||
160852510|NCT02576639|580848753|FG004|Overall Study|Adverse Event|2|||
160852511|NCT02576639|580848749|FG000|Overall Study|Physician Decision|0|||
160852512|NCT02576639|580848750|FG001|Overall Study|Physician Decision|0|||
160852513|NCT02576639|580848751|FG002|Overall Study|Physician Decision|0|||
160852514|NCT02576639|580848752|FG003|Overall Study|Physician Decision|0|||
160852515|NCT02576639|580848753|FG004|Overall Study|Physician Decision|1|||
160852516|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
160852517|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
160852518|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
160852519|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
160852520|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
160852521|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
160852522|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
160852523|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
160852524|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
160852525|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
160852526|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
160852527|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
160852528|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
160852529|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
160852530|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
160852531|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852532|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
160852533|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852534|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852535|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
160852536|NCT01329978|580848759|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852537|NCT01329978|580848760|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
160852538|NCT01329978|580848761|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852539|NCT01329978|580848762|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852540|NCT01329978|580848763|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
160852541|NCT01329978|580848759|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
160852542|NCT01329978|580848760|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
160852543|NCT01329978|580848761|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
160852544|NCT01329978|580848762|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
160852545|NCT01329978|580848763|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
160852546|NCT01329978|580848759|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852547|NCT01329978|580848760|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852548|NCT01329978|580848761|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852549|NCT01329978|580848762|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
160852550|NCT01329978|580848763|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
160852551|NCT01188772|580848767|FG000|Overall Study|Randomized but Not Treated|0|||
160852552|NCT01188772|580848768|FG001|Overall Study|Randomized but Not Treated|1|||
160852553|NCT01188772|580848769|FG002|Overall Study|Randomized but Not Treated|0|||
160852554|NCT01188772|580848770|FG003|Overall Study|Randomized but Not Treated|0|||
160852555|NCT01188772|580848767|FG000|Overall Study|Adverse Event|0|||
160852556|NCT01188772|580848768|FG001|Overall Study|Adverse Event|1|||
160852557|NCT01188772|580848769|FG002|Overall Study|Adverse Event|2|||
160852558|NCT01188772|580848770|FG003|Overall Study|Adverse Event|0|||
160852559|NCT01188772|580848767|FG000|Overall Study|Lost to Follow-up|4|||
160852560|NCT01188772|580848768|FG001|Overall Study|Lost to Follow-up|1|||
160852561|NCT01188772|580848769|FG002|Overall Study|Lost to Follow-up|1|||
160852562|NCT01188772|580848770|FG003|Overall Study|Lost to Follow-up|1|||
160852563|NCT01188772|580848767|FG000|Overall Study|Non-responder|0|||
160852564|NCT01188772|580848768|FG001|Overall Study|Non-responder|0|||
160852565|NCT01188772|580848769|FG002|Overall Study|Non-responder|3|||
160852566|NCT01188772|580848770|FG003|Overall Study|Non-responder|0|||
160852567|NCT01188772|580848767|FG000|Overall Study|Physician Decision|0|||
160852568|NCT01188772|580848768|FG001|Overall Study|Physician Decision|0|||
160852569|NCT01188772|580848769|FG002|Overall Study|Physician Decision|1|||
160852570|NCT01188772|580848770|FG003|Overall Study|Physician Decision|0|||
160852571|NCT01188772|580848767|FG000|Overall Study|Terminated by Sponsor|0|||
160852572|NCT01188772|580848768|FG001|Overall Study|Terminated by Sponsor|0|||
160852573|NCT01188772|580848769|FG002|Overall Study|Terminated by Sponsor|1|||
160852574|NCT01188772|580848770|FG003|Overall Study|Terminated by Sponsor|0|||
160852575|NCT01188772|580848767|FG000|Overall Study|Treatment Failure|0|||
160852576|NCT01188772|580848768|FG001|Overall Study|Treatment Failure|0|||
160852577|NCT01188772|580848769|FG002|Overall Study|Treatment Failure|1|||
160852578|NCT01188772|580848770|FG003|Overall Study|Treatment Failure|0|||
160852579|NCT01188772|580848767|FG000|Overall Study|Virologic Failure|1|||
160852580|NCT01188772|580848768|FG001|Overall Study|Virologic Failure|0|||
160852581|NCT01188772|580848769|FG002|Overall Study|Virologic Failure|0|||
160852582|NCT01188772|580848770|FG003|Overall Study|Virologic Failure|0|||
160852583|NCT01188772|580848767|FG000|Overall Study|Withdrawal by Subject|0|||
160852584|NCT01188772|580848768|FG001|Overall Study|Withdrawal by Subject|0|||
160852585|NCT01188772|580848769|FG002|Overall Study|Withdrawal by Subject|2|||
160852586|NCT01188772|580848770|FG003|Overall Study|Withdrawal by Subject|0|||
160852587|NCT03081884|580848774|FG000|Overall Study|deferred prostate cancer treatment|1|||
160852588|NCT03081884|580848774|FG000|Overall Study|metastasis managed with systemic therapy|3|||
160852589|NCT02294058|580848775|FG000|Overall Study|Adverse Event|16|||
160852590|NCT02294058|580848776|FG001|Overall Study|Adverse Event|7|||
160852591|NCT02294058|580848777|FG002|Overall Study|Adverse Event|13|||
160852592|NCT02294058|580848775|FG000|Overall Study|Lack of Efficacy|3|||
160852593|NCT02294058|580848776|FG001|Overall Study|Lack of Efficacy|3|||
160852594|NCT02294058|580848777|FG002|Overall Study|Lack of Efficacy|0|||
160852595|NCT02294058|580848775|FG000|Overall Study|Lost to Follow-up|1|||
160852596|NCT02294058|580848776|FG001|Overall Study|Lost to Follow-up|0|||
160852597|NCT02294058|580848777|FG002|Overall Study|Lost to Follow-up|2|||
160852598|NCT02294058|580848775|FG000|Overall Study|Withdrawal by Subject|10|||
160852599|NCT02294058|580848776|FG001|Overall Study|Withdrawal by Subject|14|||
160852600|NCT02294058|580848777|FG002|Overall Study|Withdrawal by Subject|13|||
160852601|NCT02294058|580848775|FG000|Overall Study|Physician Decision|2|||
160852602|NCT02294058|580848776|FG001|Overall Study|Physician Decision|1|||
160852603|NCT02294058|580848777|FG002|Overall Study|Physician Decision|0|||
160852604|NCT02294058|580848775|FG000|Overall Study|Miscellaneous|4|||
160852605|NCT02294058|580848776|FG001|Overall Study|Miscellaneous|1|||
160906853|NCT00228384|581052325|FG000|Overall Study|Surgical Intervention (bypass)|5|||
160906854|NCT00228384|581052326|FG001|Overall Study|Surgical Intervention (bypass)|5|||
160906855|NCT00228384|581052325|FG000|Overall Study|Withdrawal by Subject|9|||
160852606|NCT02294058|580848777|FG002|Overall Study|Miscellaneous|1|||
160852607|NCT01894607|580848779|FG000|Overall Study|Ineligible|1|||
160906856|NCT00228384|581052326|FG001|Overall Study|Withdrawal by Subject|10|||
160852608|NCT01787461|580848792|FG000|Overall Study|Adverse Event|4|||
160852609|NCT01787461|580848793|FG001|Overall Study|Adverse Event|3|||
160852610|NCT01787461|580848792|FG000|Overall Study|Lost to Follow-up|3|||
160906857|NCT00228384|581052325|FG000|Overall Study|Physician Decision|0|||
160906858|NCT00228384|581052326|FG001|Overall Study|Physician Decision|1|||
160906859|NCT01918774|581053908|FG000|Overall Study|Lost prior to first CBTw session|4|||
160906860|NCT01918774|581053908|FG000|Overall Study|Lost to Follow-up|1|||
160906861|NCT00717197|581053912|FG000|Overall Study|Unable to purchase study drug|5|||
160906862|NCT00717197|581053912|FG000|Overall Study|Tumor Progression|1|||
160906863|NCT00717197|581053912|FG000|Overall Study|Physician Decision|1|||
160906864|NCT01898806|581053915|FG000|Overall Study|Withdrawal by Subject|2|||
160906865|NCT01898806|581053915|FG000|Overall Study|Physician Decision|1|||
160906866|NCT01648101|581053916|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
160906867|NCT01648101|581053917|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
160906868|NCT01648101|581053918|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
160906869|NCT01648101|581053916|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
160906870|NCT01648101|581053917|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
160852611|NCT01787461|580848793|FG001|Overall Study|Lost to Follow-up|2|||
160852612|NCT01787461|580848792|FG000|Overall Study|No longer met eligibility criteria|1|||
160852613|NCT01787461|580848793|FG001|Overall Study|No longer met eligibility criteria|0|||
160852614|NCT01787461|580848792|FG000|Overall Study|Withdrawal by Subject|3|||
160852615|NCT01787461|580848793|FG001|Overall Study|Withdrawal by Subject|4|||
160906871|NCT01648101|581053918|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
160906872|NCT01648101|581053916|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
160906873|NCT01648101|581053917|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
160852616|NCT01787461|580848792|FG000|Overall Study|Protocol Violation|3|||
160992513|NCT03999554|581361387|FG002|Overall Study|Pregnancy|1|||
160852617|NCT01787461|580848793|FG001|Overall Study|Protocol Violation|0|||
160906874|NCT01648101|581053918|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
160852618|NCT00152503|580848794|FG000|Overall Study|Adverse Event|4|||
160852619|NCT03259555|580848795|FG000|Overall Study|Adverse Event|6|||
160852620|NCT03259555|580848796|FG001|Overall Study|Adverse Event|4|||
160852621|NCT03259555|580848795|FG000|Overall Study|Lack of Efficacy|6|||
160852622|NCT03259555|580848796|FG001|Overall Study|Lack of Efficacy|4|||
160852623|NCT03259555|580848795|FG000|Overall Study|Lost to Follow-up|0|||
160852624|NCT03259555|580848796|FG001|Overall Study|Lost to Follow-up|2|||
160852625|NCT03259555|580848795|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160852626|NCT03259555|580848796|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160852627|NCT03259555|580848795|FG000|Overall Study|Progressive Disease|0|||
160852628|NCT03259555|580848796|FG001|Overall Study|Progressive Disease|2|||
160852629|NCT03259555|580848795|FG000|Overall Study|Withdrawal by Subject|19|||
160852630|NCT03259555|580848796|FG001|Overall Study|Withdrawal by Subject|16|||
160852631|NCT03259555|580848795|FG000|Overall Study|Physician Decision|1|||
160852632|NCT03259555|580848796|FG001|Overall Study|Physician Decision|2|||
160852633|NCT03259555|580848795|FG000|Overall Study|Other|1|||
160852634|NCT03259555|580848796|FG001|Overall Study|Other|0|||
160852635|NCT03957551|580848797|FG000|Overall Study|Adverse Event|2|||
160852636|NCT03957551|580848798|FG001|Overall Study|Adverse Event|2|||
160852637|NCT03957551|580848799|FG002|Overall Study|Adverse Event|6|||
160852638|NCT03957551|580848797|FG000|Overall Study|Physician Decision|1|||
160852639|NCT03957551|580848798|FG001|Overall Study|Physician Decision|0|||
160852640|NCT03957551|580848799|FG002|Overall Study|Physician Decision|2|||
160852641|NCT03957551|580848797|FG000|Overall Study|Withdrawal by Subject|1|||
160852642|NCT03957551|580848798|FG001|Overall Study|Withdrawal by Subject|0|||
160852643|NCT03957551|580848799|FG002|Overall Study|Withdrawal by Subject|2|||
160852644|NCT03957551|580848797|FG000|Overall Study|Disease progression|1|||
160852645|NCT03957551|580848798|FG001|Overall Study|Disease progression|0|||
160852646|NCT03957551|580848799|FG002|Overall Study|Disease progression|8|||
160852647|NCT00607087|580848800|FG000|Overall Study|Withdrawal by Subject|9|||
160852648|NCT00607087|580848801|FG001|Overall Study|Withdrawal by Subject|4|||
160852649|NCT00607087|580848802|FG002|Overall Study|Withdrawal by Subject|4|||
160852650|NCT00607087|580848800|FG000|Overall Study|Adverse Event|3|||
160852651|NCT00607087|580848801|FG001|Overall Study|Adverse Event|2|||
160852652|NCT00607087|580848802|FG002|Overall Study|Adverse Event|3|||
160852653|NCT00607087|580848800|FG000|Overall Study|Other reason|1|||
160852654|NCT00607087|580848801|FG001|Overall Study|Other reason|5|||
160852655|NCT00607087|580848802|FG002|Overall Study|Other reason|2|||
160852656|NCT00607087|580848800|FG000|Overall Study|Poor compliance to protocol|1|||
160852657|NCT00607087|580848801|FG001|Overall Study|Poor compliance to protocol|0|||
160852658|NCT00607087|580848802|FG002|Overall Study|Poor compliance to protocol|1|||
160852659|NCT00607087|580848800|FG000|Overall Study|Lost to Follow-up|1|||
160852660|NCT00607087|580848801|FG001|Overall Study|Lost to Follow-up|0|||
160852661|NCT00607087|580848802|FG002|Overall Study|Lost to Follow-up|0|||
160852662|NCT00607087|580848800|FG000|Period 1|Withdrawal by Subject|7|||
160852663|NCT00607087|580848801|FG001|Period 1|Withdrawal by Subject|2|||
160852664|NCT00607087|580848802|FG002|Period 1|Withdrawal by Subject|3|||
160852665|NCT00607087|580848800|FG000|Period 1|Adverse Event|3|||
160852666|NCT00607087|580848801|FG001|Period 1|Adverse Event|0|||
160852667|NCT00607087|580848802|FG002|Period 1|Adverse Event|0|||
160852668|NCT00607087|580848800|FG000|Period 1|Poor compliance to protocol|1|||
160852669|NCT00607087|580848801|FG001|Period 1|Poor compliance to protocol|0|||
160852670|NCT00607087|580848802|FG002|Period 1|Poor compliance to protocol|0|||
160852671|NCT00607087|580848800|FG000|Period 1|Lost to Follow-up|1|||
160852672|NCT00607087|580848801|FG001|Period 1|Lost to Follow-up|0|||
160852673|NCT00607087|580848802|FG002|Period 1|Lost to Follow-up|0|||
160852674|NCT00607087|580848800|FG000|Period 1|Other reason|0|||
160852675|NCT00607087|580848801|FG001|Period 1|Other reason|4|||
160852676|NCT00607087|580848802|FG002|Period 1|Other reason|2|||
160852677|NCT00607087|580848800|FG000|Period 2|Withdrawal by Subject|0|||
160852678|NCT00607087|580848801|FG001|Period 2|Withdrawal by Subject|1|||
160852679|NCT00607087|580848802|FG002|Period 2|Withdrawal by Subject|1|||
160852680|NCT00607087|580848800|FG000|Period 2|Other reason|1|||
160852681|NCT00607087|580848801|FG001|Period 2|Other reason|1|||
160852682|NCT00607087|580848802|FG002|Period 2|Other reason|0|||
160852683|NCT00607087|580848800|FG000|Period 2|Adverse Event|0|||
160852684|NCT00607087|580848801|FG001|Period 2|Adverse Event|1|||
160852685|NCT00607087|580848802|FG002|Period 2|Adverse Event|3|||
160852686|NCT00607087|580848800|FG000|Period 2|Poor compliance to protocol|0|||
160852687|NCT00607087|580848801|FG001|Period 2|Poor compliance to protocol|0|||
160852688|NCT00607087|580848802|FG002|Period 2|Poor compliance to protocol|1|||
160852689|NCT00607087|580848800|FG000|Period 3|Withdrawal by Subject|2|||
160852690|NCT00607087|580848801|FG001|Period 3|Withdrawal by Subject|1|||
160992514|NCT03999554|581361388|FG003|Overall Study|Pregnancy|0|||
160852691|NCT00607087|580848802|FG002|Period 3|Withdrawal by Subject|0|||
160852692|NCT00607087|580848800|FG000|Period 3|Adverse Event|0|||
160852693|NCT00607087|580848801|FG001|Period 3|Adverse Event|1|||
160852694|NCT00607087|580848802|FG002|Period 3|Adverse Event|0|||
160852695|NCT02717494|580848805|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
160852696|NCT02717494|580848806|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
160992515|NCT03999554|581361389|FG004|Overall Study|Pregnancy|0|||
160852697|NCT02717494|580848807|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
160852698|NCT02717494|580848805|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
160852699|NCT02717494|580848806|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
160852700|NCT02717494|580848807|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
160852701|NCT02717494|580848805|FG000|First Intervention (Step 1)|Death|0|||
160852702|NCT02717494|580848806|FG001|First Intervention (Step 1)|Death|0|||
160852703|NCT02717494|580848807|FG002|First Intervention (Step 1)|Death|1|||
160852704|NCT02717494|580848805|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
160852705|NCT02717494|580848806|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
160852706|NCT02717494|580848807|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
160852707|NCT01774799|580848813|FG000|Overall Study|Lost to Follow-up|1|||
160852708|NCT01774799|580848814|FG001|Overall Study|Lost to Follow-up|1|||
160852709|NCT01774799|580848815|FG002|Overall Study|Lost to Follow-up|0|||
160852710|NCT01774799|580848816|FG003|Overall Study|Lost to Follow-up|0|||
160852711|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
160852712|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
160852713|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
160852714|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
160852715|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
160852716|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
160852717|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
160852718|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
160852719|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
160852720|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
160852721|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
160852722|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
160852723|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
160852724|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
160852725|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
160852726|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
160852727|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
160852728|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
160852729|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
160852730|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
160852731|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
160852732|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
160852733|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
160852734|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
160852735|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
160852736|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
160852737|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
160852738|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
160852739|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
160852740|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
160852741|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
160852742|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
160852743|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
160852744|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
160852745|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
160852746|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
160852747|NCT02586623|580848817|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
160852748|NCT02586623|580848818|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
160852749|NCT02586623|580848819|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
160852750|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
160852751|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
160852752|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
160852753|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
160852754|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
160852755|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
160852756|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
160852757|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
160852758|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
160852759|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
160852760|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
160852761|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
160852762|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
160852763|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
160852764|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
160852765|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
160852766|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
160852767|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
160852768|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
160852769|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
160852770|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
160852771|NCT02586623|580848817|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
160852772|NCT02586623|580848818|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
160852773|NCT02586623|580848819|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
160852774|NCT04393493|580848822|FG000|First 4 Days of Intervention|Early improvement|5|||
160852775|NCT04393493|580848823|FG001|First 4 Days of Intervention|Early improvement|7|||
160852776|NCT02910466|580848824|FG000|Overall Study|Adverse Event|1|||
160852777|NCT02910466|580848824|FG000|Overall Study|Withdrawal by Subject|3|||
160852778|NCT02910466|580848824|FG000|Overall Study|Lost to Follow-up|5|||
160852779|NCT02910466|580848824|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
160852780|NCT02910466|580848824|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
160852781|NCT01125800|580848826|FG000|Phase I|Protocol Violation|0|||
160852782|NCT01125800|580848827|FG001|Phase I|Protocol Violation|3|||
160852783|NCT01125800|580848828|FG002|Phase I|Protocol Violation|1|||
160852784|NCT01125800|580848829|FG003|Phase I|Protocol Violation|1|||
160852785|NCT01125800|580848830|FG004|Phase I|Protocol Violation|0|||
160852786|NCT01125800|580848826|FG000|Phase I|Adverse Event|2|||
160852787|NCT01125800|580848827|FG001|Phase I|Adverse Event|2|||
160852788|NCT01125800|580848828|FG002|Phase I|Adverse Event|1|||
160852789|NCT01125800|580848829|FG003|Phase I|Adverse Event|7|||
160852790|NCT01125800|580848830|FG004|Phase I|Adverse Event|0|||
160852791|NCT01125800|580848826|FG000|Phase I|Administrative problems|1|||
160852792|NCT01125800|580848827|FG001|Phase I|Administrative problems|0|||
160852793|NCT01125800|580848828|FG002|Phase I|Administrative problems|0|||
160852794|NCT01125800|580848829|FG003|Phase I|Administrative problems|0|||
160852795|NCT01125800|580848830|FG004|Phase I|Administrative problems|0|||
160852796|NCT01125800|580848826|FG000|Phase I|Withdrawal by Subject|0|||
160852797|NCT01125800|580848827|FG001|Phase I|Withdrawal by Subject|0|||
160852798|NCT01125800|580848828|FG002|Phase I|Withdrawal by Subject|1|||
160852799|NCT01125800|580848829|FG003|Phase I|Withdrawal by Subject|0|||
160852800|NCT01125800|580848830|FG004|Phase I|Withdrawal by Subject|0|||
160852801|NCT01125800|580848826|FG000|Phase I|Disease progression|5|||
160852802|NCT01125800|580848827|FG001|Phase I|Disease progression|4|||
160852803|NCT01125800|580848828|FG002|Phase I|Disease progression|1|||
160852804|NCT01125800|580848829|FG003|Phase I|Disease progression|3|||
160852805|NCT01125800|580848830|FG004|Phase I|Disease progression|0|||
160852806|NCT01125800|580848826|FG000|Phase II|Protocol Violation|0|||
160852807|NCT01125800|580848827|FG001|Phase II|Protocol Violation|0|||
160852808|NCT01125800|580848828|FG002|Phase II|Protocol Violation|0|||
160852809|NCT01125800|580848829|FG003|Phase II|Protocol Violation|0|||
160852810|NCT01125800|580848830|FG004|Phase II|Protocol Violation|1|||
160852811|NCT01125800|580848826|FG000|Phase II|Adverse Event|0|||
160852812|NCT01125800|580848827|FG001|Phase II|Adverse Event|0|||
160852813|NCT01125800|580848828|FG002|Phase II|Adverse Event|0|||
160852814|NCT01125800|580848829|FG003|Phase II|Adverse Event|0|||
160852815|NCT01125800|580848830|FG004|Phase II|Adverse Event|2|||
160852816|NCT01125800|580848826|FG000|Phase II|Disease progression|0|||
161255203|NCT02688387|582314139|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255204|NCT02688387|582314140|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255205|NCT02688387|582314141|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255206|NCT02688387|582314142|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255207|NCT02688387|582314143|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255208|NCT02688387|582314144|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255209|NCT02688387|582314145|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255210|NCT02688387|582314146|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255211|NCT02688387|582314147|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255212|NCT02688387|582314148|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255213|NCT02688387|582314149|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255214|NCT02688387|582314150|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255215|NCT02688387|582314151|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255216|NCT02688387|582314152|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255217|NCT02688387|582314153|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255218|NCT02688387|582314132|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255219|NCT02688387|582314133|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
161255220|NCT02688387|582314134|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255221|NCT02688387|582314135|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255222|NCT02688387|582314136|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161337315|NCT03104374|582625902|FG001|Period 2|Lost to Follow-up|2|||
160852817|NCT01125800|580848827|FG001|Phase II|Disease progression|0|||
160852818|NCT01125800|580848828|FG002|Phase II|Disease progression|0|||
160852819|NCT01125800|580848829|FG003|Phase II|Disease progression|1|||
160852820|NCT01125800|580848830|FG004|Phase II|Disease progression|8|||
160852821|NCT05051579|580848834|FG000|Overall Study|Withdrawal by Subject|3|||
160852822|NCT05051579|580848835|FG001|Overall Study|Withdrawal by Subject|5|||
160992516|NCT03999554|581361385|FG000|Overall Study|Withdrawal by Subject|2|||
160852823|NCT05051579|580848836|FG002|Overall Study|Withdrawal by Subject|2|||
160852824|NCT05051579|580848837|FG003|Overall Study|Withdrawal by Subject|1|||
160852825|NCT05051579|580848838|FG004|Overall Study|Withdrawal by Subject|4|||
160852826|NCT05051579|580848839|FG005|Overall Study|Withdrawal by Subject|0|||
160852827|NCT05051579|580848840|FG006|Overall Study|Withdrawal by Subject|4|||
160852828|NCT05051579|580848834|FG000|Overall Study|Lost to Follow-up|1|||
160852829|NCT05051579|580848835|FG001|Overall Study|Lost to Follow-up|0|||
160852830|NCT05051579|580848836|FG002|Overall Study|Lost to Follow-up|0|||
160852831|NCT05051579|580848837|FG003|Overall Study|Lost to Follow-up|0|||
160852832|NCT05051579|580848838|FG004|Overall Study|Lost to Follow-up|1|||
160852833|NCT05051579|580848839|FG005|Overall Study|Lost to Follow-up|0|||
160852834|NCT05051579|580848840|FG006|Overall Study|Lost to Follow-up|1|||
160852835|NCT05051579|580848834|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852836|NCT05051579|580848835|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852837|NCT05051579|580848836|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852838|NCT05051579|580848837|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852839|NCT05051579|580848838|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852840|NCT05051579|580848839|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
160852841|NCT05051579|580848840|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
160852842|NCT05051579|580848834|FG000|Overall Study|Adverse Event|2|||
160852843|NCT05051579|580848835|FG001|Overall Study|Adverse Event|1|||
160852844|NCT05051579|580848836|FG002|Overall Study|Adverse Event|0|||
160852845|NCT05051579|580848837|FG003|Overall Study|Adverse Event|4|||
160852846|NCT05051579|580848838|FG004|Overall Study|Adverse Event|1|||
160852847|NCT05051579|580848839|FG005|Overall Study|Adverse Event|2|||
160852848|NCT05051579|580848840|FG006|Overall Study|Adverse Event|0|||
160852849|NCT05051579|580848834|FG000|Overall Study|Inadvertent Enrollment|0|||
160852850|NCT05051579|580848835|FG001|Overall Study|Inadvertent Enrollment|0|||
160852851|NCT05051579|580848836|FG002|Overall Study|Inadvertent Enrollment|0|||
160852852|NCT05051579|580848837|FG003|Overall Study|Inadvertent Enrollment|0|||
160852853|NCT05051579|580848838|FG004|Overall Study|Inadvertent Enrollment|0|||
160852854|NCT05051579|580848839|FG005|Overall Study|Inadvertent Enrollment|0|||
160852855|NCT05051579|580848840|FG006|Overall Study|Inadvertent Enrollment|1|||
160852856|NCT05051579|580848834|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852857|NCT05051579|580848835|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
160852858|NCT05051579|580848836|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852859|NCT05051579|580848837|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852860|NCT05051579|580848838|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852861|NCT05051579|580848839|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852862|NCT05051579|580848840|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
160852863|NCT05051579|580848834|FG000|Overall Study|Sponsor Decision|0|||
160852864|NCT05051579|580848835|FG001|Overall Study|Sponsor Decision|0|||
160852865|NCT05051579|580848836|FG002|Overall Study|Sponsor Decision|0|||
160852866|NCT05051579|580848837|FG003|Overall Study|Sponsor Decision|0|||
160852867|NCT05051579|580848838|FG004|Overall Study|Sponsor Decision|1|||
160852868|NCT05051579|580848839|FG005|Overall Study|Sponsor Decision|0|||
160852869|NCT05051579|580848840|FG006|Overall Study|Sponsor Decision|0|||
160852870|NCT05051579|580848834|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852871|NCT05051579|580848835|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852872|NCT05051579|580848836|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852873|NCT05051579|580848837|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852874|NCT05051579|580848838|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
160852875|NCT05051579|580848839|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852876|NCT05051579|580848840|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
160852877|NCT06172348|580848845|FG000|Treatment Period 2|Adverse Event|0|||
161337316|NCT03104374|582625903|FG002|Period 2|Lost to Follow-up|3|||
160852878|NCT06172348|580848846|FG001|Treatment Period 2|Adverse Event|0|||
160852879|NCT06172348|580848847|FG002|Treatment Period 2|Adverse Event|1|||
160852880|NCT06172348|580848848|FG003|Treatment Period 2|Adverse Event|0|||
160852881|NCT06172348|580848849|FG004|Treatment Period 2|Adverse Event|0|||
160852882|NCT06172348|580848850|FG005|Treatment Period 2|Adverse Event|0|||
160992517|NCT03999554|581361386|FG001|Overall Study|Withdrawal by Subject|2|||
160992518|NCT03999554|581361387|FG002|Overall Study|Withdrawal by Subject|2|||
160852883|NCT03799341|580848851|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
160852884|NCT03799341|580848852|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
160852885|NCT03799341|580848853|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
160852886|NCT03799341|580848851|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
160852887|NCT03799341|580848852|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
160852888|NCT03799341|580848853|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
160852889|NCT03799341|580848851|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
160852890|NCT03799341|580848852|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
160852891|NCT03799341|580848853|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
160852892|NCT03799341|580848851|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
160852893|NCT03799341|580848852|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
160852894|NCT03799341|580848853|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
160852895|NCT03799341|580848851|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
160852896|NCT03799341|580848852|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
160852897|NCT03799341|580848853|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
160852898|NCT03799341|580848851|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
160852899|NCT03799341|580848852|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
160852900|NCT03799341|580848853|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
160852901|NCT04539938|580848854|FG000|Overall Study|Death|30|||
160852902|NCT04539938|580848854|FG000|Overall Study|Withdrawal by Subject|4|||
160852903|NCT04037891|580848855|FG000|Open-label Period|Withdrawal by Subject|1|||
160852904|NCT04037891|580848856|FG001|Open-label Period|Withdrawal by Subject|0|||
160906875|NCT01648101|581053916|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
160906876|NCT01648101|581053917|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
160906877|NCT01648101|581053918|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
160906878|NCT01648101|581053916|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
160906879|NCT01648101|581053917|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
160906880|NCT01648101|581053918|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
160906881|NCT01648101|581053916|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
160906882|NCT01648101|581053917|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
160906883|NCT01648101|581053918|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
160906884|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
161255223|NCT02688387|582314137|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255224|NCT02688387|582314138|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255225|NCT02688387|582314139|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160906885|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
160906886|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
160906887|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
160906888|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
160906889|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
160906890|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
160906891|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
160906892|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
160906893|NCT01648101|581053916|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
160906894|NCT01648101|581053917|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
160906895|NCT01648101|581053918|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
160906896|NCT01648101|581053916|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
160906897|NCT01648101|581053917|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
160906898|NCT01648101|581053918|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
160906899|NCT03003390|581053919|FG000|Overall Study|Physician Decision|2|||
160906900|NCT03003390|581053920|FG001|Overall Study|Physician Decision|0|||
160906901|NCT03003390|581053919|FG000|Overall Study|Parent refused intervention|2|||
160906902|NCT03003390|581053920|FG001|Overall Study|Parent refused intervention|0|||
160906903|NCT01970397|581053926|FG000|Overall Study|Adverse Event|0|||
160906904|NCT01970397|581053927|FG001|Overall Study|Adverse Event|1|||
160906905|NCT01970397|581053926|FG000|Overall Study|Lost to Follow-up|0|||
160906906|NCT01970397|581053927|FG001|Overall Study|Lost to Follow-up|1|||
160906907|NCT01970397|581053926|FG000|Overall Study|Personal Reasons|1|||
160906908|NCT01970397|581053927|FG001|Overall Study|Personal Reasons|2|||
160906909|NCT01970397|581053926|FG000|Overall Study|Protocol Violation|1|||
160906910|NCT01970397|581053927|FG001|Overall Study|Protocol Violation|1|||
160906911|NCT01389817|581053928|FG000|Overall Study|Physician Decision|1|||
160906912|NCT01389817|581053929|FG001|Overall Study|Physician Decision|0|||
160906913|NCT01389817|581053928|FG000|Overall Study|Lost to Follow-up|1|||
160906914|NCT01389817|581053929|FG001|Overall Study|Lost to Follow-up|0|||
160906915|NCT01389817|581053928|FG000|Overall Study|Withdrawal by Subject|2|||
161255226|NCT02688387|582314140|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160906916|NCT01389817|581053929|FG001|Overall Study|Withdrawal by Subject|0|||
160852905|NCT04037891|580848857|FG002|Open-label Period|Withdrawal by Subject|0|||
160852906|NCT04037891|580848855|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
160906917|NCT01749137|581053930|FG000|Overall Study|Adverse Event|4|||
160852907|NCT04037891|580848856|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
160852908|NCT04037891|580848857|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
160852909|NCT00990106|580848858|FG000|Overall Study|"too busy to continue"|1|||
160852910|NCT00990106|580848859|FG001|Overall Study|"too busy to continue"|2|||
160852911|NCT00990106|580848858|FG000|Overall Study|Lost to Follow-up|1|||
160852912|NCT00990106|580848859|FG001|Overall Study|Lost to Follow-up|3|||
160852913|NCT00990106|580848858|FG000|Overall Study|Withdrawal by Subject|2|||
160852914|NCT00990106|580848859|FG001|Overall Study|Withdrawal by Subject|1|||
160852915|NCT00990106|580848858|FG000|Overall Study|opted for open label prazosin|1|||
160852916|NCT00990106|580848859|FG001|Overall Study|opted for open label prazosin|1|||
160852917|NCT00990106|580848858|FG000|Overall Study|relocation/deployment|4|||
160852918|NCT00990106|580848859|FG001|Overall Study|relocation/deployment|1|||
160852919|NCT00990106|580848858|FG000|Overall Study|started exclusionary medication|0|||
160852920|NCT00990106|580848859|FG001|Overall Study|started exclusionary medication|1|||
160852921|NCT00990106|580848858|FG000|Overall Study|planned major surgery|0|||
160852922|NCT00990106|580848859|FG001|Overall Study|planned major surgery|1|||
160852923|NCT00990106|580848858|FG000|Overall Study|scheduling conflicts|0|||
160852924|NCT00990106|580848859|FG001|Overall Study|scheduling conflicts|2|||
160852925|NCT04194944|580848860|FG000|Overall Study|Lost to Follow-up|3|||
160852926|NCT04194944|580848861|FG001|Overall Study|Lost to Follow-up|0|||
160852927|NCT04194944|580848860|FG000|Overall Study|Withdrawal by Subject|2|||
161141205|NCT00356915|581900992|FG001|Overall Study|Miscellaneous reasons|8|||
161141206|NCT00356915|581900993|FG002|Overall Study|Miscellaneous reasons|3|||
161141207|NCT02371629|581901002|FG000|Overall Study|Patient decision|14|||
161141208|NCT02371629|581901003|FG001|Overall Study|Patient decision|10|||
161141209|NCT02371629|581901002|FG000|Overall Study|Adverse Event|8|||
161141210|NCT02371629|581901003|FG001|Overall Study|Adverse Event|8|||
161141211|NCT02371629|581901002|FG000|Overall Study|Physician Decision|2|||
161141212|NCT02371629|581901003|FG001|Overall Study|Physician Decision|3|||
161141213|NCT02371629|581901002|FG000|Overall Study|Death|1|||
160852928|NCT04194944|580848861|FG001|Overall Study|Withdrawal by Subject|2|||
160852929|NCT04194944|580848860|FG000|Overall Study|On Treatment|93|||
160852930|NCT04194944|580848861|FG001|Overall Study|On Treatment|30|||
160852931|NCT00348673|580848864|FG000|Stage 1|Randomized but not Treated|0|||
160852932|NCT00348673|580848865|FG001|Stage 1|Randomized but not Treated|0|||
160852933|NCT00348673|580848866|FG002|Stage 1|Randomized but not Treated|1|||
160852934|NCT00348673|580848867|FG003|Stage 1|Randomized but not Treated|0|||
160852935|NCT00348673|580848868|FG004|Stage 1|Randomized but not Treated|0|||
160852936|NCT00348673|580848869|FG005|Stage 1|Randomized but not Treated|0|||
160852937|NCT00348673|580848870|FG006|Stage 1|Randomized but not Treated|0|||
160852938|NCT00348673|580848871|FG007|Stage 1|Randomized but not Treated|0|||
160852939|NCT00348673|580848872|FG008|Stage 1|Randomized but not Treated|0|||
160852940|NCT03798717|580851185|FG000|Overall Study|Failed Screening|0|||
160852941|NCT03798717|580851186|FG001|Overall Study|Failed Screening|0|||
160852942|NCT03798717|580851187|FG002|Overall Study|Failed Screening|0|||
160852943|NCT03798717|580851188|FG003|Overall Study|Failed Screening|0|||
160852944|NCT03798717|580851189|FG004|Overall Study|Failed Screening|0|||
160852945|NCT03798717|580851190|FG005|Overall Study|Failed Screening|1|||
160852946|NCT03798717|580851185|FG000|Overall Study|Physician Decision|1|||
160852947|NCT03798717|580851186|FG001|Overall Study|Physician Decision|0|||
160852948|NCT03798717|580851187|FG002|Overall Study|Physician Decision|1|||
160852949|NCT03798717|580851188|FG003|Overall Study|Physician Decision|0|||
160852950|NCT03798717|580851189|FG004|Overall Study|Physician Decision|0|||
160852951|NCT03798717|580851190|FG005|Overall Study|Physician Decision|0|||
161337317|NCT03104374|582625904|FG003|Period 2|Lost to Follow-up|5|||
161337318|NCT03104374|582625901|FG000|Period 2|Lack of Efficacy|2|||
160852952|NCT03798717|580851185|FG000|Overall Study|Withdrawal by Subject|0|||
160852953|NCT03798717|580851186|FG001|Overall Study|Withdrawal by Subject|0|||
160852954|NCT03798717|580851187|FG002|Overall Study|Withdrawal by Subject|0|||
160906918|NCT01749137|581053931|FG001|Overall Study|Adverse Event|4|||
160906919|NCT01749137|581053930|FG000|Overall Study|Lost to Follow-up|2|||
160906920|NCT01749137|581053931|FG001|Overall Study|Lost to Follow-up|3|||
160906921|NCT01749137|581053930|FG000|Overall Study|Physician Decision|1|||
161141214|NCT02371629|581901003|FG001|Overall Study|Death|1|||
161141215|NCT02371629|581901002|FG000|Overall Study|Noncompliance with study treatment|1|||
160852955|NCT03798717|580851188|FG003|Overall Study|Withdrawal by Subject|1|||
160852956|NCT03798717|580851189|FG004|Overall Study|Withdrawal by Subject|0|||
160906922|NCT01749137|581053931|FG001|Overall Study|Physician Decision|0|||
161141216|NCT02371629|581901003|FG001|Overall Study|Noncompliance with study treatment|0|||
160906923|NCT01749137|581053930|FG000|Overall Study|Withdrawal by Subject|8|||
161141217|NCT02371629|581901002|FG000|Overall Study|Lack of Efficacy|0|||
161141218|NCT02371629|581901003|FG001|Overall Study|Lack of Efficacy|2|||
160852957|NCT03798717|580851190|FG005|Overall Study|Withdrawal by Subject|0|||
160852958|NCT03798717|580851185|FG000|Overall Study|Lost to Follow-up|1|||
160852959|NCT03798717|580851186|FG001|Overall Study|Lost to Follow-up|0|||
160852960|NCT03798717|580851187|FG002|Overall Study|Lost to Follow-up|0|||
160852961|NCT03798717|580851188|FG003|Overall Study|Lost to Follow-up|1|||
161141219|NCT02371629|581901002|FG000|Overall Study|Protocol deviation|0|||
160852962|NCT03798717|580851189|FG004|Overall Study|Lost to Follow-up|0|||
160852963|NCT03798717|580851190|FG005|Overall Study|Lost to Follow-up|0|||
160852964|NCT03798717|580851185|FG000|Overall Study|Adverse Event|0|||
160852965|NCT03798717|580851186|FG001|Overall Study|Adverse Event|1|||
160852966|NCT03798717|580851187|FG002|Overall Study|Adverse Event|0|||
160852967|NCT03798717|580851188|FG003|Overall Study|Adverse Event|0|||
160852968|NCT03798717|580851189|FG004|Overall Study|Adverse Event|0|||
160852969|NCT03798717|580851190|FG005|Overall Study|Adverse Event|0|||
160852970|NCT03798717|580851185|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852971|NCT03798717|580851186|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852972|NCT03798717|580851187|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852973|NCT03798717|580851188|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
161337319|NCT03104374|582625902|FG001|Period 2|Lack of Efficacy|4|||
161337320|NCT03104374|582625903|FG002|Period 2|Lack of Efficacy|7|||
161337321|NCT03104374|582625904|FG003|Period 2|Lack of Efficacy|4|||
160852974|NCT03798717|580851189|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
160852975|NCT03798717|580851190|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
160852976|NCT00445549|580851191|FG000|Overall Study|progressive disease|12|||
160852977|NCT03858049|580851194|FG000|Overall Study|Adverse Event|16|||
160852978|NCT03858049|580851195|FG001|Overall Study|Adverse Event|9|||
160852979|NCT03858049|580851194|FG000|Overall Study|Other|1|||
160852980|NCT03858049|580851195|FG001|Overall Study|Other|1|||
160852981|NCT01600326|580851196|FG000|Overall Study|Lost to Follow-up|1|||
160852982|NCT01600326|580851197|FG001|Overall Study|Lost to Follow-up|1|||
160852983|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
160852984|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
160852985|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
160852986|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
160852987|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
160852988|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
160852989|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
160852990|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
160852991|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
160852992|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
160852993|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
160852994|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
160852995|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
160852996|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
160852997|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
160852998|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
160852999|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
160853000|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
160853001|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
160906924|NCT01749137|581053931|FG001|Overall Study|Withdrawal by Subject|4|||
160853002|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
160853003|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
160853004|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
160906925|NCT04980040|581053933|FG000|Overall Study|Violated the Inclusion Criteria|260|||
160906926|NCT04980040|581053933|FG000|Overall Study|Violated the Administration & Dosage|225|||
160906927|NCT04980040|581053933|FG000|Overall Study|Lost to Safety-Follow-up|4|||
160906928|NCT04980040|581053933|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
160906929|NCT01408485|581053934|FG000|Overall Study|Withdrawal by Subject|21|||
160906930|NCT01397084|581053935|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
160906931|NCT01397084|581053935|FG000|Overall Study|Protocol Violation|2|||
160906932|NCT01397084|581053935|FG000|Overall Study|Adverse Event|2|||
160906933|NCT01397084|581053935|FG000|Overall Study|Withdrawal by Subject|1|||
160906934|NCT01397084|581053935|FG000|Overall Study|Lost to Follow-up|1|||
160906935|NCT01397084|581053935|FG000|Overall Study|Used other proton pump inhibitor|1|||
160906936|NCT04160195|581053936|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
160906937|NCT04160195|581053937|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
160906938|NCT01342796|581053938|FG000|Overall Study|Withdrawal by Subject|2|||
160906939|NCT01342796|581053939|FG001|Overall Study|Withdrawal by Subject|0|||
160906940|NCT01342796|581053938|FG000|Overall Study|Lost to Follow-up|0|||
160906941|NCT01342796|581053939|FG001|Overall Study|Lost to Follow-up|3|||
160853005|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
160853006|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
160853007|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
160853008|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
160906942|NCT01342796|581053938|FG000|Overall Study|Inappropriate enrollment|1|||
160906943|NCT01342796|581053939|FG001|Overall Study|Inappropriate enrollment|0|||
160906944|NCT03130257|581053940|FG000|Overall Study|Withdrawal by Subject|1|||
161141220|NCT02371629|581901003|FG001|Overall Study|Protocol deviation|1|||
161141221|NCT01193335|581901005|FG000|After Infant Series|Lost to Follow-up|1|||
161337322|NCT03104374|582625901|FG000|Period 2|COVID-19 Infection|0|||
160853009|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853010|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853011|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853012|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853013|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853014|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853015|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853016|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
160853017|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853018|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853019|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853020|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853021|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
160853022|NCT02079740|580851198|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853023|NCT02079740|580851199|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853024|NCT02079740|580851200|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853025|NCT02079740|580851201|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853026|NCT02079740|580851202|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853027|NCT02079740|580851203|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853028|NCT02079740|580851204|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853029|NCT02079740|580851205|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
160853030|NCT02079740|580851206|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853031|NCT02079740|580851207|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853032|NCT02079740|580851208|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853033|NCT02079740|580851209|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853034|NCT02079740|580851210|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
160853035|NCT02079740|580851198|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853036|NCT02079740|580851199|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853037|NCT02079740|580851200|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853038|NCT02079740|580851201|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853039|NCT02079740|580851202|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853040|NCT02079740|580851203|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853041|NCT02079740|580851204|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853042|NCT02079740|580851205|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853043|NCT02079740|580851206|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853044|NCT02079740|580851207|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
160853045|NCT02079740|580851208|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
160853046|NCT02079740|580851209|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
160853047|NCT02079740|580851210|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
160853048|NCT04617782|580851211|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
160853049|NCT04617782|580851211|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
160853050|NCT04617782|580851211|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
160853051|NCT04617782|580851211|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
160853052|NCT04617782|580851211|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
160853053|NCT04617782|580851211|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
160853054|NCT01405768|580851224|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
160853055|NCT01405768|580851225|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
160853056|NCT04388111|580851228|FG000|Overall Study|Lost to Follow-up|5|||
160853057|NCT04388111|580851229|FG001|Overall Study|Lost to Follow-up|3|||
160853058|NCT04388111|580851228|FG000|Overall Study|Adverse Event|1|||
160853059|NCT04388111|580851229|FG001|Overall Study|Adverse Event|1|||
160853060|NCT04388111|580851228|FG000|Overall Study|Protocol Violation|2|||
160853061|NCT04388111|580851229|FG001|Overall Study|Protocol Violation|4|||
160853062|NCT04388111|580851228|FG000|Overall Study|Withdrawal by Subject|1|||
160853063|NCT04388111|580851229|FG001|Overall Study|Withdrawal by Subject|0|||
160853064|NCT01474317|580851237|FG000|Overall Study|Adverse Event|1|||
160853065|NCT01474317|580851237|FG000|Overall Study|Subject ineligible for study|1|||
160853066|NCT00387881|580851238|FG000|Overall Study|Lost to Follow-up|23|||
160853067|NCT00387881|580851239|FG001|Overall Study|Lost to Follow-up|23|||
160853068|NCT00387881|580851238|FG000|Overall Study|Protocol Violation|2|||
160853069|NCT00387881|580851239|FG001|Overall Study|Protocol Violation|12|||
160853070|NCT00387881|580851238|FG000|Overall Study|Withdrawal by Subject|15|||
160853071|NCT00387881|580851239|FG001|Overall Study|Withdrawal by Subject|18|||
160853072|NCT00387881|580851238|FG000|Overall Study|Sponsor terminated Study|0|||
160853073|NCT00387881|580851239|FG001|Overall Study|Sponsor terminated Study|1|||
160853074|NCT00387881|580851238|FG000|Overall Study|Not eligible|6|||
160853075|NCT00387881|580851239|FG001|Overall Study|Not eligible|7|||
160853076|NCT00387881|580851238|FG000|Overall Study|No opportunity to treat headache|32|||
161141222|NCT01193335|581901006|FG001|After Infant Series|Lost to Follow-up|2|||
160906945|NCT03130257|581053941|FG001|Overall Study|Withdrawal by Subject|0|||
161337323|NCT03104374|582625902|FG001|Period 2|COVID-19 Infection|0|||
161337324|NCT03104374|582625903|FG002|Period 2|COVID-19 Infection|1|||
161337325|NCT03104374|582625904|FG003|Period 2|COVID-19 Infection|0|||
161337326|NCT03104374|582625901|FG000|Period 2|Other|3|||
161337327|NCT03104374|582625902|FG001|Period 2|Other|2|||
161337328|NCT03104374|582625903|FG002|Period 2|Other|2|||
161337329|NCT03104374|582625904|FG003|Period 2|Other|4|||
161337330|NCT03210714|582625905|FG000|Overall Study|Adverse Event|6|||
161337331|NCT03210714|582625905|FG000|Overall Study|Physician Decision|1|||
161337332|NCT03210714|582625905|FG000|Overall Study|Progressive disease|11|||
161337333|NCT03210714|582625905|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
161337334|NCT00803179|582625906|FG000|Overall Study|Lost to Follow-up|3|||
161337335|NCT04158648|582625907|FG000|Overall Study|Ongoing in the Study|69|||
161337336|NCT04158648|582625907|FG000|Overall Study|Withdrawal by Subject|4|||
161337337|NCT04609514|582625908|FG000|Overall Study|Lost to Follow-up|5|||
161337338|NCT04609514|582625909|FG001|Overall Study|Lost to Follow-up|4|||
161337339|NCT04609514|582625908|FG000|Overall Study|Withdrawal by PI|0|||
161337340|NCT04609514|582625909|FG001|Overall Study|Withdrawal by PI|2|||
161337341|NCT00885118|582625910|FG000|Overall Study|Adverse Event|1|||
161337342|NCT00885118|582625911|FG001|Overall Study|Adverse Event|0|||
161337343|NCT00885118|582625912|FG002|Overall Study|Adverse Event|0|||
161337344|NCT00885118|582625913|FG003|Overall Study|Adverse Event|0|||
161337345|NCT00885118|582625914|FG004|Overall Study|Adverse Event|0|||
161337346|NCT00885118|582625910|FG000|Overall Study|Withdrawal by Subject|0|||
161337347|NCT00885118|582625911|FG001|Overall Study|Withdrawal by Subject|0|||
161337348|NCT00885118|582625912|FG002|Overall Study|Withdrawal by Subject|0|||
161337349|NCT00885118|582625913|FG003|Overall Study|Withdrawal by Subject|0|||
161337350|NCT00885118|582625914|FG004|Overall Study|Withdrawal by Subject|1|||
161337351|NCT00885118|582625910|FG000|Overall Study|Other reason not defined above|0|||
161337352|NCT00885118|582625911|FG001|Overall Study|Other reason not defined above|0|||
161337353|NCT00885118|582625912|FG002|Overall Study|Other reason not defined above|1|||
161337354|NCT00885118|582625913|FG003|Overall Study|Other reason not defined above|0|||
161337355|NCT00885118|582625914|FG004|Overall Study|Other reason not defined above|0|||
161337356|NCT03883386|582625922|FG000|First Assignment|Lost to Follow-up|1|||
161337357|NCT03883386|582625923|FG001|First Assignment|Lost to Follow-up|0|||
161337358|NCT03883386|582625922|FG000|First Assignment|Withdrawal by Subject|1|||
161337359|NCT03883386|582625923|FG001|First Assignment|Withdrawal by Subject|1|||
161337360|NCT01326871|582625925|FG000|Overall Study|Major surgery|0|||
161337361|NCT01326871|582625926|FG001|Overall Study|Major surgery|1|||
161337362|NCT01326871|582625927|FG002|Overall Study|Major surgery|0|||
161337363|NCT01326871|582625925|FG000|Overall Study|SAE and death|0|||
161337364|NCT01326871|582625926|FG001|Overall Study|SAE and death|2|||
161337365|NCT01326871|582625927|FG002|Overall Study|SAE and death|0|||
161337366|NCT01326871|582625925|FG000|Overall Study|Physician decision and decreased performance status|0|||
161337367|NCT01326871|582625926|FG001|Overall Study|Physician decision and decreased performance status|1|||
161337368|NCT01326871|582625927|FG002|Overall Study|Physician decision and decreased performance status|0|||
161337369|NCT01326871|582625925|FG000|Overall Study|Disease progression|0|||
161337370|NCT01326871|582625926|FG001|Overall Study|Disease progression|11|||
161337371|NCT01326871|582625927|FG002|Overall Study|Disease progression|5|||
161337372|NCT01326871|582625925|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
161337373|NCT01326871|582625926|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
161337374|NCT01326871|582625927|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
160853077|NCT00387881|580851239|FG001|Overall Study|No opportunity to treat headache|34|||
160853078|NCT00387881|580851238|FG000|Overall Study|Not otherwise specified|11|||
160853079|NCT00387881|580851239|FG001|Overall Study|Not otherwise specified|7|||
160853080|NCT00453154|580851242|FG000|Double BIind Maintenance|Adverse Event|0|||
160853081|NCT00453154|580851243|FG001|Double BIind Maintenance|Adverse Event|0|||
160853082|NCT00453154|580851244|FG002|Double BIind Maintenance|Adverse Event|3|||
160853083|NCT00453154|580851245|FG003|Double BIind Maintenance|Adverse Event|12|||
160853084|NCT00453154|580851242|FG000|Double BIind Maintenance|Death|0|||
160853085|NCT00453154|580851243|FG001|Double BIind Maintenance|Death|0|||
160853086|NCT00453154|580851244|FG002|Double BIind Maintenance|Death|2|||
160853087|NCT00453154|580851245|FG003|Double BIind Maintenance|Death|1|||
160853088|NCT00453154|580851242|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
160853089|NCT00453154|580851243|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
161337375|NCT01326871|582625925|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
161337376|NCT01326871|582625926|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
161337377|NCT01326871|582625927|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
161337378|NCT01326871|582625925|FG000|Overall Study|Withdrawal by Subject|0|||
161337379|NCT01326871|582625926|FG001|Overall Study|Withdrawal by Subject|1|||
161337380|NCT01326871|582625927|FG002|Overall Study|Withdrawal by Subject|0|||
161337381|NCT01326871|582625925|FG000|Overall Study|DLT|0|||
161337382|NCT01326871|582625926|FG001|Overall Study|DLT|2|||
161337383|NCT01326871|582625927|FG002|Overall Study|DLT|0|||
161337384|NCT01326871|582625925|FG000|Overall Study|SAE, disease progression and subject decision|0|||
161141223|NCT01193335|581901005|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
160906946|NCT03130257|581053942|FG002|Overall Study|Withdrawal by Subject|2|||
160906947|NCT01751867|581053943|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
160906948|NCT01751867|581053944|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
160906949|NCT01751867|581053943|FG000|Overall Study|Diease Progression|4|||
160906950|NCT01751867|581053944|FG001|Overall Study|Diease Progression|18|||
160906951|NCT01751867|581053943|FG000|Overall Study|Adverse Event|8|||
160906952|NCT01751867|581053944|FG001|Overall Study|Adverse Event|15|||
160906953|NCT01751867|581053943|FG000|Overall Study|Poor Compliance|0|||
160906954|NCT01751867|581053944|FG001|Overall Study|Poor Compliance|5|||
160906955|NCT01751867|581053943|FG000|Overall Study|Withdrawal by Subject|3|||
160906956|NCT01751867|581053944|FG001|Overall Study|Withdrawal by Subject|1|||
160906957|NCT01751867|581053943|FG000|Overall Study|Physician Decision|4|||
160906958|NCT01751867|581053944|FG001|Overall Study|Physician Decision|7|||
160906959|NCT01751867|581053943|FG000|Overall Study|Protocol Violation|0|||
160906960|NCT01751867|581053944|FG001|Overall Study|Protocol Violation|2|||
160906961|NCT01751867|581053943|FG000|Overall Study|Death|0|||
160906962|NCT01751867|581053944|FG001|Overall Study|Death|5|||
160906963|NCT01751867|581053943|FG000|Overall Study|Other|11|||
160906964|NCT01751867|581053944|FG001|Overall Study|Other|37|||
160906965|NCT01751867|581053943|FG000|Overall Study|Randomized but not treated.|2|||
160906966|NCT01751867|581053944|FG001|Overall Study|Randomized but not treated.|1|||
160906967|NCT01508650|581053945|FG000|Overall Study|Lost to Follow-up|0|||
160906968|NCT01508650|581053946|FG001|Overall Study|Lost to Follow-up|3|||
160906969|NCT02064894|581053947|FG000|Overall Study|Withdrawal by Subject|43|||
160906970|NCT02064894|581053948|FG001|Overall Study|Withdrawal by Subject|102|||
160906971|NCT02064894|581053949|FG002|Overall Study|Withdrawal by Subject|115|||
160906972|NCT01976338|581053950|FG000|Overall Study|Physician Decision|0|||
160906973|NCT01976338|581053951|FG001|Overall Study|Physician Decision|1|||
160906974|NCT01976338|581053950|FG000|Overall Study|Lost to Follow-up|3|||
160906975|NCT01976338|581053951|FG001|Overall Study|Lost to Follow-up|0|||
160906976|NCT01976338|581053950|FG000|Overall Study|Withdrawal by Subject|5|||
160906977|NCT01976338|581053951|FG001|Overall Study|Withdrawal by Subject|2|||
160906978|NCT01976338|581053950|FG000|Overall Study|Adverse Event|5|||
160906979|NCT01976338|581053951|FG001|Overall Study|Adverse Event|1|||
160906980|NCT05988619|581053952|FG000|Overall Study|Lost to Follow-up|1|||
160906981|NCT05988619|581053953|FG001|Overall Study|Lost to Follow-up|4|||
160906982|NCT05988619|581053952|FG000|Overall Study|Withdrawal by Subject|2|||
160906983|NCT05988619|581053953|FG001|Overall Study|Withdrawal by Subject|9|||
161141224|NCT01193335|581901006|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
160853090|NCT00453154|580851244|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
161141225|NCT01193335|581901005|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
160853091|NCT00453154|580851245|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
160853092|NCT00453154|580851242|FG000|Double BIind Maintenance|Progression|0|||
160853093|NCT00453154|580851243|FG001|Double BIind Maintenance|Progression|0|||
160853094|NCT00453154|580851244|FG002|Double BIind Maintenance|Progression|29|||
160853095|NCT00453154|580851245|FG003|Double BIind Maintenance|Progression|26|||
160853096|NCT00453154|580851242|FG000|Double BIind Maintenance|Medical Issues|0|||
160853097|NCT00453154|580851243|FG001|Double BIind Maintenance|Medical Issues|0|||
160853098|NCT00453154|580851244|FG002|Double BIind Maintenance|Medical Issues|3|||
160853099|NCT00453154|580851245|FG003|Double BIind Maintenance|Medical Issues|1|||
160853100|NCT00453154|580851242|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
160853101|NCT00453154|580851243|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
160853102|NCT00453154|580851244|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
160853103|NCT00453154|580851245|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
160853104|NCT03629886|580851247|FG000|Overall Study|Migrated / moved from the study area|0|||
160853105|NCT03629886|580851248|FG001|Overall Study|Migrated / moved from the study area|55|||
160853106|NCT03629886|580851247|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
160853107|NCT03629886|580851248|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
160853108|NCT03629886|580851247|FG000|Overall Study|Study vaccine not administrated|0|||
160853109|NCT03629886|580851248|FG001|Overall Study|Study vaccine not administrated|3|||
160853110|NCT03629886|580851247|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
160853111|NCT03629886|580851248|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
160853112|NCT03629886|580851247|FG000|Overall Study|Refused vaccination step of the study|0|||
160853113|NCT03629886|580851248|FG001|Overall Study|Refused vaccination step of the study|44|||
160853114|NCT05473026|580851250|FG000|Overall Study|Lost to Follow-up|5|||
160906984|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Death|0|||
160906985|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Death|0|||
160906986|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Death|0|||
160906987|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Death|0|||
160906988|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Death|1|||
160906989|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Death|0|||
160906990|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Death|0|||
160906991|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Death|0|||
161141226|NCT01193335|581901006|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
161255227|NCT02688387|582314141|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
160853115|NCT05473026|580851251|FG001|Overall Study|Lost to Follow-up|2|||
160853116|NCT02038153|580851252|FG000|Overall Study|Withdrawal by Subject|1|||
160853117|NCT03683173|580851253|FG000|Completed Follow-up|Unavailable|235|||
160853118|NCT03683173|580851254|FG001|Completed Follow-up|Unavailable|217|||
160853119|NCT03683173|580851253|FG000|Completed Follow-up|Refused|69|||
160853120|NCT03683173|580851254|FG001|Completed Follow-up|Refused|59|||
160853121|NCT03683173|580851253|FG000|Completed Follow-up|Disconnected phone|65|||
160853122|NCT03683173|580851254|FG001|Completed Follow-up|Disconnected phone|95|||
160853123|NCT03683173|580851253|FG000|Completed Follow-up|Health issue/deceased|10|||
160853124|NCT03683173|580851254|FG001|Completed Follow-up|Health issue/deceased|4|||
160853125|NCT03683173|580851253|FG000|Completed Follow-up|Moved away|8|||
160853126|NCT03683173|580851254|FG001|Completed Follow-up|Moved away|1|||
160853127|NCT02647281|580851255|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853128|NCT02647281|580851256|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853129|NCT02647281|580851257|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853130|NCT02647281|580851258|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853131|NCT02647281|580851259|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853132|NCT02647281|580851260|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853133|NCT02647281|580851261|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853134|NCT02647281|580851262|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
160853135|NCT02647281|580851263|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
160853136|NCT01050634|580851264|FG000|Overall Study|Enrolled, but Not Treated|56|||
160853137|NCT01050634|580851264|FG000|Overall Study|Death|2|||
160853138|NCT01050634|580851264|FG000|Overall Study|Adverse Event|42|||
160853139|NCT01050634|580851264|FG000|Overall Study|Lost to Follow-up|2|||
160853140|NCT01050634|580851264|FG000|Overall Study|Other|21|||
160853141|NCT01050634|580851264|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
160853142|NCT00496015|580851265|FG000|Overall Study|Other|1|||
160853143|NCT00496015|580851266|FG001|Overall Study|Other|0|||
160906992|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
160906993|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
160906994|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
160906995|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
160906996|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
160906997|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
160906998|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
160906999|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
160907000|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
160907001|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907002|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907003|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
160907004|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907005|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
160907006|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907007|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
160907008|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
160907009|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
161255228|NCT02688387|582314142|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255229|NCT02688387|582314143|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255230|NCT02688387|582314144|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255231|NCT02688387|582314145|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255232|NCT02688387|582314146|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255233|NCT02688387|582314147|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255234|NCT02688387|582314148|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255235|NCT02688387|582314149|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255236|NCT02688387|582314150|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255237|NCT02688387|582314151|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255238|NCT02688387|582314152|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255239|NCT02688387|582314153|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
161255240|NCT02688387|582314132|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255241|NCT02688387|582314133|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255242|NCT02688387|582314134|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
160853144|NCT00496015|580851267|FG002|Overall Study|Other|0|||
160853145|NCT00496015|580851268|FG003|Overall Study|Other|1|||
160853146|NCT00496015|580851269|FG004|Overall Study|Other|0|||
160907010|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
160853147|NCT02730728|580851272|FG000|Overall Study|Withdrawal by Subject|0|||
160853148|NCT02730728|580851273|FG001|Overall Study|Withdrawal by Subject|1|||
160853149|NCT02730728|580851274|FG002|Overall Study|Withdrawal by Subject|0|||
160853150|NCT02730728|580851272|FG000|Overall Study|Lack of Efficacy|0|||
160853151|NCT02730728|580851273|FG001|Overall Study|Lack of Efficacy|1|||
160853152|NCT02730728|580851274|FG002|Overall Study|Lack of Efficacy|1|||
160853153|NCT03360682|580851293|FG000|Overall Study|Adverse Event|3|||
160853154|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853155|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853156|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853157|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
160853158|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853159|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853160|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853161|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853162|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853163|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
160853164|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
160853165|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
160853166|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853167|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
160853168|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
160853169|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
160853170|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853171|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853172|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853173|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
160853174|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
160853175|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853176|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853177|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853178|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
160853179|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
160853180|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853181|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853182|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853183|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
160853184|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853185|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853186|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853187|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853188|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853189|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
160853190|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853191|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853192|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853193|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
160853194|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
160853195|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853196|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
160853197|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853198|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
160853199|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853200|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853201|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853202|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853203|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
160853204|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
160853205|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853206|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853207|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853208|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
160853209|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
160853210|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853211|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853212|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853213|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
160853214|NCT02365649|580851303|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853215|NCT02365649|580851304|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853216|NCT02365649|580851305|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
160853217|NCT02365649|580851306|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853218|NCT02365649|580851307|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853219|NCT02365649|580851308|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853220|NCT02365649|580851309|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853221|NCT02365649|580851310|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853222|NCT02365649|580851311|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853223|NCT02365649|580851312|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
160853224|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853225|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853226|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853227|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853228|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853229|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853230|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
160853231|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853232|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853233|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
160853234|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853235|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853236|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853237|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853238|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853239|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853240|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
160853241|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
160853242|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
160853243|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
160853244|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853245|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853246|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853247|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853248|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853249|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
160853250|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
160853251|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
160907011|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
160907012|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
160907013|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
160907014|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
160907015|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
160907016|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
160907017|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
160907018|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
160907019|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
160907020|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
160907021|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
160907022|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
160907023|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
160907024|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
160907025|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907026|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907027|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
160907028|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
160907029|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
160907030|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907031|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
160907032|NCT00726232|581053954|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
160907033|NCT00726232|581053955|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907034|NCT00726232|581053956|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907035|NCT00726232|581053957|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907036|NCT00726232|581053958|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
160853252|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
160853253|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
160853254|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853255|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853256|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853257|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853258|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853259|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853260|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
160853261|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
160853262|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
160853263|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
160853264|NCT02365649|580851303|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853265|NCT02365649|580851304|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853266|NCT02365649|580851305|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853267|NCT02365649|580851306|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853268|NCT02365649|580851307|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853269|NCT02365649|580851308|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853270|NCT02365649|580851309|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
160853271|NCT02365649|580851310|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853272|NCT02365649|580851311|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
160853273|NCT02365649|580851312|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
160853274|NCT01433172|580851325|FG000|Overall Study|Withdrawal by Subject|0|||
160853275|NCT01433172|580851326|FG001|Overall Study|Withdrawal by Subject|1|||
160853276|NCT01433172|580851327|FG002|Overall Study|Withdrawal by Subject|0|||
160853277|NCT01433172|580851325|FG000|Overall Study|Disease Progression|0|||
160853278|NCT01433172|580851326|FG001|Overall Study|Disease Progression|0|||
160853279|NCT01433172|580851327|FG002|Overall Study|Disease Progression|1|||
160853280|NCT01433172|580851325|FG000|Overall Study|Death|0|||
160853281|NCT01433172|580851326|FG001|Overall Study|Death|2|||
160853282|NCT01433172|580851327|FG002|Overall Study|Death|0|||
160853283|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
160853284|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
160853285|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
160853286|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
160853287|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
160853288|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
160853289|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Death|7|||
160853290|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Death|5|||
160853291|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Death|6|||
160853292|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
160853293|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
160853294|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
160853295|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
160853296|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
160853297|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
160853298|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Other|1|||
160853299|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Other|0|||
160853300|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Other|0|||
160853301|NCT00104650|580851328|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
160853302|NCT00104650|580851329|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
160853303|NCT00104650|580851330|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
160853304|NCT00104650|580851328|FG000|Follow-up Period|Physician Decision|1|||
160853305|NCT00104650|580851329|FG001|Follow-up Period|Physician Decision|1|||
160853306|NCT00104650|580851330|FG002|Follow-up Period|Physician Decision|0|||
160853307|NCT00104650|580851328|FG000|Follow-up Period|Adverse Event|1|||
160853308|NCT00104650|580851329|FG001|Follow-up Period|Adverse Event|0|||
160853309|NCT00104650|580851330|FG002|Follow-up Period|Adverse Event|1|||
160853310|NCT00104650|580851328|FG000|Follow-up Period|Withdrawal by Subject|0|||
160853311|NCT00104650|580851329|FG001|Follow-up Period|Withdrawal by Subject|3|||
160853312|NCT00104650|580851330|FG002|Follow-up Period|Withdrawal by Subject|3|||
160853313|NCT00104650|580851328|FG000|Follow-up Period|Death|6|||
160853314|NCT00104650|580851329|FG001|Follow-up Period|Death|6|||
160853315|NCT00104650|580851330|FG002|Follow-up Period|Death|4|||
160853316|NCT00104650|580851328|FG000|Follow-up Period|Disease progression|3|||
160853317|NCT00104650|580851329|FG001|Follow-up Period|Disease progression|1|||
161255243|NCT02688387|582314135|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160907037|NCT00726232|581053959|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907038|NCT00726232|581053960|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
161255244|NCT02688387|582314136|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
160853318|NCT00104650|580851330|FG002|Follow-up Period|Disease progression|0|||
160853319|NCT00104650|580851328|FG000|Follow-up Period|Lost to Follow-up|0|||
160853320|NCT00104650|580851329|FG001|Follow-up Period|Lost to Follow-up|1|||
160853321|NCT00104650|580851330|FG002|Follow-up Period|Lost to Follow-up|2|||
160853322|NCT00104650|580851328|FG000|Follow-up Period|Other|0|||
160853323|NCT00104650|580851329|FG001|Follow-up Period|Other|1|||
160853324|NCT00104650|580851330|FG002|Follow-up Period|Other|0|||
160853325|NCT01391663|580851331|FG000|Overall Study|Withdrawal by Subject|0|||
160853326|NCT01391663|580851332|FG001|Overall Study|Withdrawal by Subject|0|||
160853327|NCT01391663|580851333|FG002|Overall Study|Withdrawal by Subject|1|||
160853328|NCT01391663|580851334|FG003|Overall Study|Withdrawal by Subject|0|||
160853329|NCT03515824|580851335|FG000|Overall Study|Death|3|||
160853330|NCT03515824|580851336|FG001|Overall Study|Death|2|||
160853331|NCT03515824|580851337|FG002|Overall Study|Death|6|||
160853332|NCT03515824|580851338|FG003|Overall Study|Death|0|||
160853333|NCT03515824|580851335|FG000|Overall Study|Lost to Follow-up|0|||
160853334|NCT03515824|580851336|FG001|Overall Study|Lost to Follow-up|1|||
160853335|NCT03515824|580851337|FG002|Overall Study|Lost to Follow-up|1|||
160853336|NCT03515824|580851338|FG003|Overall Study|Lost to Follow-up|0|||
160853337|NCT03515824|580851335|FG000|Overall Study|Study terminated by sponsor|0|||
160853338|NCT03515824|580851336|FG001|Overall Study|Study terminated by sponsor|1|||
160853339|NCT03515824|580851337|FG002|Overall Study|Study terminated by sponsor|6|||
160853340|NCT03515824|580851338|FG003|Overall Study|Study terminated by sponsor|0|||
160853341|NCT03515824|580851335|FG000|Overall Study|Status not recorded|0|||
160853342|NCT03515824|580851336|FG001|Overall Study|Status not recorded|0|||
160853343|NCT03515824|580851337|FG002|Overall Study|Status not recorded|2|||
160853344|NCT03515824|580851338|FG003|Overall Study|Status not recorded|0|||
160853345|NCT00920855|580851339|FG000|Overall Study|Adverse Event|1|||
160853346|NCT00920855|580851340|FG001|Overall Study|Adverse Event|1|||
160853347|NCT00920855|580851341|FG002|Overall Study|Adverse Event|4|||
160853348|NCT00920855|580851339|FG000|Overall Study|Withdrawal by Subject|2|||
160853349|NCT00920855|580851340|FG001|Overall Study|Withdrawal by Subject|1|||
160853350|NCT00920855|580851341|FG002|Overall Study|Withdrawal by Subject|6|||
160853351|NCT00920855|580851339|FG000|Overall Study|Disease progression|2|||
160853352|NCT00920855|580851340|FG001|Overall Study|Disease progression|1|||
160853353|NCT00920855|580851341|FG002|Overall Study|Disease progression|10|||
160853354|NCT00920855|580851339|FG000|Overall Study|Noncompliance to study medication|0|||
160853355|NCT00920855|580851340|FG001|Overall Study|Noncompliance to study medication|0|||
160853356|NCT00920855|580851341|FG002|Overall Study|Noncompliance to study medication|1|||
160853357|NCT00920855|580851339|FG000|Overall Study|Response plateau; started maintenance|0|||
160853358|NCT00920855|580851340|FG001|Overall Study|Response plateau; started maintenance|0|||
160853359|NCT00920855|580851341|FG002|Overall Study|Response plateau; started maintenance|1|||
160853360|NCT00539994|580851342|FG000|Overall Study|Lost to Follow-up|2|||
160853361|NCT00539994|580851343|FG001|Overall Study|Lost to Follow-up|1|||
160853362|NCT00539994|580851344|FG002|Overall Study|Lost to Follow-up|0|||
160853363|NCT00539994|580851342|FG000|Overall Study|Withdrawal by Subject|1|||
160853364|NCT00539994|580851343|FG001|Overall Study|Withdrawal by Subject|0|||
160853365|NCT00539994|580851344|FG002|Overall Study|Withdrawal by Subject|1|||
160853366|NCT00539994|580851342|FG000|Overall Study|Physician Decision|0|||
160853367|NCT00539994|580851343|FG001|Overall Study|Physician Decision|0|||
160853368|NCT00539994|580851344|FG002|Overall Study|Physician Decision|1|||
160853369|NCT03084796|580851345|FG000|Overall Study|Adverse Event|4|||
160853370|NCT03084796|580851346|FG001|Overall Study|Adverse Event|5|||
160853371|NCT03084796|580851347|FG002|Overall Study|Adverse Event|6|||
160853372|NCT03084796|580851348|FG003|Overall Study|Adverse Event|2|||
160853373|NCT03084796|580851349|FG004|Overall Study|Adverse Event|3|||
160853374|NCT03084796|580851350|FG005|Overall Study|Adverse Event|5|||
160853375|NCT03084796|580851345|FG000|Overall Study|Withdrawal by Subject|3|||
160853376|NCT03084796|580851346|FG001|Overall Study|Withdrawal by Subject|5|||
160853377|NCT03084796|580851347|FG002|Overall Study|Withdrawal by Subject|2|||
160853378|NCT03084796|580851348|FG003|Overall Study|Withdrawal by Subject|1|||
160853379|NCT03084796|580851349|FG004|Overall Study|Withdrawal by Subject|3|||
161255245|NCT02688387|582314137|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255246|NCT02688387|582314138|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160853380|NCT03084796|580851350|FG005|Overall Study|Withdrawal by Subject|0|||
160853381|NCT03084796|580851345|FG000|Overall Study|Protocol Violation|0|||
160853382|NCT03084796|580851346|FG001|Overall Study|Protocol Violation|0|||
160853383|NCT03084796|580851347|FG002|Overall Study|Protocol Violation|1|||
160853384|NCT03084796|580851348|FG003|Overall Study|Protocol Violation|0|||
160992519|NCT03999554|581361388|FG003|Overall Study|Withdrawal by Subject|1|||
160853385|NCT03084796|580851349|FG004|Overall Study|Protocol Violation|1|||
160853386|NCT03084796|580851350|FG005|Overall Study|Protocol Violation|1|||
160853387|NCT03084796|580851345|FG000|Overall Study|Lack of Efficacy|0|||
160853388|NCT03084796|580851346|FG001|Overall Study|Lack of Efficacy|0|||
160853389|NCT03084796|580851347|FG002|Overall Study|Lack of Efficacy|1|||
160853390|NCT03084796|580851348|FG003|Overall Study|Lack of Efficacy|0|||
160853391|NCT03084796|580851349|FG004|Overall Study|Lack of Efficacy|1|||
160853392|NCT03084796|580851350|FG005|Overall Study|Lack of Efficacy|0|||
161141227|NCT01193335|581901005|FG000|1-Year Follow-up|Lost to Follow-up|4|||
161141228|NCT01193335|581901006|FG001|1-Year Follow-up|Lost to Follow-up|0|||
161141229|NCT01193335|581901005|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
161141230|NCT01193335|581901006|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
161141231|NCT01193335|581901005|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
161141232|NCT01193335|581901006|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
161141233|NCT03486314|581901008|FG000|Part A|Adverse Event|1|||
161141234|NCT03486314|581901009|FG001|Part A|Adverse Event|0|||
161141235|NCT03486314|581901010|FG002|Part A|Adverse Event|0|||
161141236|NCT03486314|581901008|FG000|Part A|Symptomatic Deterioration|2|||
160853393|NCT03084796|580851345|FG000|Overall Study|Lost to Follow-up|0|||
160853394|NCT03084796|580851346|FG001|Overall Study|Lost to Follow-up|0|||
160853395|NCT03084796|580851347|FG002|Overall Study|Lost to Follow-up|1|||
160853396|NCT03084796|580851348|FG003|Overall Study|Lost to Follow-up|1|||
160853397|NCT03084796|580851349|FG004|Overall Study|Lost to Follow-up|3|||
160853398|NCT03084796|580851350|FG005|Overall Study|Lost to Follow-up|1|||
160853399|NCT03084796|580851345|FG000|Overall Study|Randomization error|0|||
160853400|NCT03084796|580851346|FG001|Overall Study|Randomization error|0|||
160853401|NCT03084796|580851347|FG002|Overall Study|Randomization error|1|||
160853402|NCT03084796|580851348|FG003|Overall Study|Randomization error|0|||
160853403|NCT03084796|580851349|FG004|Overall Study|Randomization error|0|||
160853404|NCT03084796|580851350|FG005|Overall Study|Randomization error|0|||
160853405|NCT05470985|580851351|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
160853406|NCT05470985|580851352|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
160853407|NCT05470985|580851351|FG000|Double Blind Treatment Period|Physician Decision|0|||
160853408|NCT05470985|580851352|FG001|Double Blind Treatment Period|Physician Decision|1|||
160853409|NCT05470985|580851351|FG000|Long Term Extension|Adverse Event|0|||
160907039|NCT00726232|581053961|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
160907040|NCT00726232|581053954|FG000|Expansion Phase|Death|0|||
160907041|NCT00726232|581053955|FG001|Expansion Phase|Death|0|||
160907042|NCT00726232|581053956|FG002|Expansion Phase|Death|0|||
160907043|NCT00726232|581053957|FG003|Expansion Phase|Death|0|||
160907044|NCT00726232|581053958|FG004|Expansion Phase|Death|0|||
160907045|NCT00726232|581053959|FG005|Expansion Phase|Death|0|||
160907046|NCT00726232|581053960|FG006|Expansion Phase|Death|0|||
160907047|NCT00726232|581053961|FG007|Expansion Phase|Death|1|||
160907048|NCT00726232|581053954|FG000|Expansion Phase|Adverse Event|0|||
160907049|NCT00726232|581053955|FG001|Expansion Phase|Adverse Event|0|||
160907050|NCT00726232|581053956|FG002|Expansion Phase|Adverse Event|0|||
160907051|NCT00726232|581053957|FG003|Expansion Phase|Adverse Event|0|||
160907052|NCT00726232|581053958|FG004|Expansion Phase|Adverse Event|0|||
160907053|NCT00726232|581053959|FG005|Expansion Phase|Adverse Event|0|||
160907054|NCT00726232|581053960|FG006|Expansion Phase|Adverse Event|6|||
160907055|NCT00726232|581053961|FG007|Expansion Phase|Adverse Event|11|||
160907056|NCT00726232|581053954|FG000|Expansion Phase|Withdrawal by Subject|0|||
160907057|NCT00726232|581053955|FG001|Expansion Phase|Withdrawal by Subject|0|||
160907058|NCT00726232|581053956|FG002|Expansion Phase|Withdrawal by Subject|0|||
160907059|NCT00726232|581053957|FG003|Expansion Phase|Withdrawal by Subject|0|||
160907060|NCT00726232|581053958|FG004|Expansion Phase|Withdrawal by Subject|0|||
160907061|NCT00726232|581053959|FG005|Expansion Phase|Withdrawal by Subject|0|||
160907062|NCT00726232|581053960|FG006|Expansion Phase|Withdrawal by Subject|2|||
160907063|NCT00726232|581053961|FG007|Expansion Phase|Withdrawal by Subject|3|||
160907064|NCT00726232|581053954|FG000|Expansion Phase|Disease progression|0|||
160907065|NCT00726232|581053955|FG001|Expansion Phase|Disease progression|0|||
160907066|NCT00726232|581053956|FG002|Expansion Phase|Disease progression|0|||
160907067|NCT00726232|581053957|FG003|Expansion Phase|Disease progression|0|||
160907068|NCT00726232|581053958|FG004|Expansion Phase|Disease progression|0|||
160907069|NCT00726232|581053959|FG005|Expansion Phase|Disease progression|0|||
160907070|NCT00726232|581053960|FG006|Expansion Phase|Disease progression|4|||
160907071|NCT00726232|581053961|FG007|Expansion Phase|Disease progression|0|||
160907072|NCT00726232|581053954|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
160907073|NCT00726232|581053955|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
161141237|NCT03486314|581901009|FG001|Part A|Symptomatic Deterioration|0|||
161141238|NCT03486314|581901010|FG002|Part A|Symptomatic Deterioration|0|||
161141239|NCT01985321|581901011|FG000|Overall Study|Protocol Violation|4|||
160853410|NCT05470985|580851352|FG001|Long Term Extension|Adverse Event|1|||
160907074|NCT00726232|581053956|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
160907075|NCT00726232|581053957|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
160907076|NCT00726232|581053958|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
160907077|NCT00726232|581053959|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
160907078|NCT00726232|581053960|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
160907079|NCT00726232|581053961|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
160907080|NCT00726232|581053954|FG000|Expansion Phase|Per Investigator: lack of response|0|||
161141240|NCT01985321|581901012|FG001|Overall Study|Protocol Violation|3|||
161141241|NCT01985321|581901011|FG000|Overall Study|Withdrawal by Subject|1|||
160907081|NCT00726232|581053955|FG001|Expansion Phase|Per Investigator: lack of response|0|||
160853411|NCT05470985|580851351|FG000|Long Term Extension|Study terminated by sponsor|2|||
160853412|NCT05470985|580851352|FG001|Long Term Extension|Study terminated by sponsor|0|||
160853413|NCT02741245|580851360|FG000|Overall Study|Adverse Event|0|||
160853414|NCT02741245|580851361|FG001|Overall Study|Adverse Event|0|||
160853415|NCT02741245|580851362|FG002|Overall Study|Adverse Event|0|||
160853416|NCT02741245|580851363|FG003|Overall Study|Adverse Event|2|||
160853417|NCT02741245|580851364|FG004|Overall Study|Adverse Event|2|||
160853418|NCT02741245|580851360|FG000|Overall Study|Protocol Violation|0|||
160853419|NCT02741245|580851361|FG001|Overall Study|Protocol Violation|1|||
160853420|NCT02741245|580851362|FG002|Overall Study|Protocol Violation|0|||
160853421|NCT02741245|580851363|FG003|Overall Study|Protocol Violation|1|||
160853422|NCT02741245|580851364|FG004|Overall Study|Protocol Violation|0|||
160853423|NCT02741245|580851360|FG000|Overall Study|Withdrawal by Subject|0|||
160853424|NCT02741245|580851361|FG001|Overall Study|Withdrawal by Subject|0|||
160853425|NCT02741245|580851362|FG002|Overall Study|Withdrawal by Subject|0|||
160853426|NCT02741245|580851363|FG003|Overall Study|Withdrawal by Subject|1|||
160853427|NCT02741245|580851364|FG004|Overall Study|Withdrawal by Subject|0|||
160853428|NCT01116648|580851367|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
160853429|NCT01116648|580851368|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
160853430|NCT01116648|580851369|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
160853431|NCT01116648|580851370|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
160853432|NCT01116648|580851371|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
160853433|NCT01116648|580851372|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
160853434|NCT01116648|580851373|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
160853435|NCT01116648|580851374|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
160853436|NCT01116648|580851375|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
160853437|NCT01116648|580851376|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
160853438|NCT01116648|580851377|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
160853439|NCT01116648|580851378|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
160853440|NCT01116648|580851379|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
160853441|NCT01116648|580851380|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
160853442|NCT01116648|580851381|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
160853443|NCT01519323|580853209|FG000|Overall Study|Death|3|||
160853444|NCT01519323|580853210|FG001|Overall Study|Death|2|||
160853445|NCT01519323|580853209|FG000|Overall Study|Study terminated by sponsor|0|||
160853446|NCT01519323|580853210|FG001|Overall Study|Study terminated by sponsor|1|||
160853447|NCT03096834|580853227|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
160853448|NCT03096834|580853228|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
160853449|NCT03096834|580853229|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
160853450|NCT03096834|580853230|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
160853451|NCT03096834|580853227|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
160853452|NCT03096834|580853228|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
160853453|NCT03096834|580853229|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
160853454|NCT03096834|580853230|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
160853455|NCT03096834|580853227|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
160853456|NCT03096834|580853228|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
160853457|NCT03096834|580853229|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
160853458|NCT03096834|580853230|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
160853459|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
160853460|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
160853461|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
160853462|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
160853463|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
160853464|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
160853465|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
161337385|NCT01326871|582625926|FG001|Overall Study|SAE, disease progression and subject decision|1|||
161337386|NCT01326871|582625927|FG002|Overall Study|SAE, disease progression and subject decision|0|||
161337387|NCT01326871|582625925|FG000|Overall Study|Death|0|||
161337388|NCT01326871|582625926|FG001|Overall Study|Death|1|||
161337389|NCT01326871|582625927|FG002|Overall Study|Death|0|||
161337390|NCT01326871|582625925|FG000|Overall Study|Other|0|||
161337391|NCT01326871|582625926|FG001|Overall Study|Other|3|||
161337392|NCT01326871|582625927|FG002|Overall Study|Other|0|||
161337393|NCT01326871|582625925|FG000|Overall Study|SAE and disease progression|0|||
161337394|NCT01326871|582625926|FG001|Overall Study|SAE and disease progression|0|||
161337395|NCT01326871|582625927|FG002|Overall Study|SAE and disease progression|1|||
161337396|NCT01326871|582625925|FG000|Overall Study|SAE and physician decision|0|||
161337397|NCT01326871|582625926|FG001|Overall Study|SAE and physician decision|0|||
161337398|NCT01326871|582625927|FG002|Overall Study|SAE and physician decision|1|||
160853466|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
160853467|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
160853468|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
160853469|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
160853470|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
160853471|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
160853472|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
160853473|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
160853474|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
160853475|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
160853476|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
160853477|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
160853478|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
160853479|NCT03096834|580853227|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
160853480|NCT03096834|580853228|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
160853481|NCT03096834|580853229|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
160853482|NCT03096834|580853230|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
160853483|NCT03096834|580853227|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
160853484|NCT03096834|580853228|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
160853485|NCT03096834|580853229|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
160853486|NCT03096834|580853230|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
160853487|NCT03096834|580853227|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
160853488|NCT03096834|580853228|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
160853489|NCT03096834|580853229|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
160853490|NCT03096834|580853230|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
160853491|NCT03096834|580853227|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
160853492|NCT03096834|580853228|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
160853493|NCT03096834|580853229|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
160853494|NCT03096834|580853230|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
160853495|NCT02313766|580853235|FG000|Overall Study|surgery cancelled|1|||
160853496|NCT02313766|580853236|FG001|Overall Study|surgery cancelled|0|||
160853497|NCT02313766|580853237|FG002|Overall Study|surgery cancelled|0|||
160853498|NCT02313766|580853235|FG000|Overall Study|Lost to Follow-up|0|||
160853499|NCT02313766|580853236|FG001|Overall Study|Lost to Follow-up|2|||
160853500|NCT02313766|580853237|FG002|Overall Study|Lost to Follow-up|0|||
160853501|NCT02313766|580853235|FG000|Overall Study|Adverse Event|0|||
160853502|NCT02313766|580853236|FG001|Overall Study|Adverse Event|1|||
160853503|NCT02313766|580853237|FG002|Overall Study|Adverse Event|0|||
160853504|NCT01005251|580853238|FG000|Overall Study|Withdrawal by Subject|2|||
160853505|NCT01005251|580853239|FG001|Overall Study|Withdrawal by Subject|5|||
160853506|NCT01005251|580853240|FG002|Overall Study|Withdrawal by Subject|3|||
160853507|NCT01005251|580853241|FG003|Overall Study|Withdrawal by Subject|4|||
160853508|NCT01005251|580853242|FG004|Overall Study|Withdrawal by Subject|9|||
160853509|NCT01005251|580853238|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
160853510|NCT01005251|580853239|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160853511|NCT01005251|580853240|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
160853512|NCT01005251|580853241|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160853513|NCT01005251|580853242|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160853514|NCT01005251|580853238|FG000|Overall Study|Adverse Event|2|||
160853515|NCT01005251|580853239|FG001|Overall Study|Adverse Event|6|||
160853516|NCT01005251|580853240|FG002|Overall Study|Adverse Event|8|||
160853517|NCT01005251|580853241|FG003|Overall Study|Adverse Event|5|||
160853518|NCT01005251|580853242|FG004|Overall Study|Adverse Event|4|||
160853519|NCT01005251|580853238|FG000|Overall Study|Protocol Violation|1|||
160853520|NCT01005251|580853239|FG001|Overall Study|Protocol Violation|0|||
160853521|NCT01005251|580853240|FG002|Overall Study|Protocol Violation|0|||
160853522|NCT01005251|580853241|FG003|Overall Study|Protocol Violation|0|||
160853523|NCT01005251|580853242|FG004|Overall Study|Protocol Violation|2|||
160853524|NCT01005251|580853238|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
160853525|NCT01005251|580853239|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
160853526|NCT01005251|580853240|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
160853527|NCT01005251|580853241|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
160853528|NCT01005251|580853242|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
160907082|NCT00726232|581053956|FG002|Expansion Phase|Per Investigator: lack of response|0|||
160907083|NCT00726232|581053957|FG003|Expansion Phase|Per Investigator: lack of response|0|||
160907084|NCT00726232|581053958|FG004|Expansion Phase|Per Investigator: lack of response|0|||
160907085|NCT00726232|581053959|FG005|Expansion Phase|Per Investigator: lack of response|0|||
160907086|NCT00726232|581053960|FG006|Expansion Phase|Per Investigator: lack of response|1|||
160907087|NCT00726232|581053961|FG007|Expansion Phase|Per Investigator: lack of response|7|||
161141242|NCT01985321|581901012|FG001|Overall Study|Withdrawal by Subject|0|||
161141243|NCT01985321|581901011|FG000|Overall Study|Lost to Follow-up|5|||
160853529|NCT01005251|580853238|FG000|Overall Study|Lost to Follow-up|1|||
160853530|NCT01005251|580853239|FG001|Overall Study|Lost to Follow-up|4|||
160853531|NCT01005251|580853240|FG002|Overall Study|Lost to Follow-up|2|||
160853532|NCT01005251|580853241|FG003|Overall Study|Lost to Follow-up|0|||
160853533|NCT01005251|580853242|FG004|Overall Study|Lost to Follow-up|0|||
161141244|NCT01985321|581901012|FG001|Overall Study|Lost to Follow-up|2|||
161141245|NCT01985321|581901011|FG000|Overall Study|Subject treated wrong type of sore|1|||
160853534|NCT01005251|580853238|FG000|Overall Study|Physician Decision|0|||
160853535|NCT01005251|580853239|FG001|Overall Study|Physician Decision|0|||
160853536|NCT01005251|580853240|FG002|Overall Study|Physician Decision|0|||
160853537|NCT01005251|580853241|FG003|Overall Study|Physician Decision|0|||
160853538|NCT01005251|580853242|FG004|Overall Study|Physician Decision|2|||
160853539|NCT01005251|580853238|FG000|Overall Study|Patient moved|1|||
160853540|NCT01005251|580853239|FG001|Overall Study|Patient moved|0|||
160853541|NCT01005251|580853240|FG002|Overall Study|Patient moved|0|||
160853542|NCT01005251|580853241|FG003|Overall Study|Patient moved|0|||
160907088|NCT00726232|581053954|FG000|Expansion Phase|Unspecified reason|0|||
160907089|NCT00726232|581053955|FG001|Expansion Phase|Unspecified reason|0|||
160907090|NCT00726232|581053956|FG002|Expansion Phase|Unspecified reason|0|||
160907091|NCT00726232|581053957|FG003|Expansion Phase|Unspecified reason|0|||
160907092|NCT00726232|581053958|FG004|Expansion Phase|Unspecified reason|0|||
160907093|NCT00726232|581053959|FG005|Expansion Phase|Unspecified reason|0|||
160907094|NCT00726232|581053960|FG006|Expansion Phase|Unspecified reason|1|||
160907095|NCT00726232|581053961|FG007|Expansion Phase|Unspecified reason|0|||
160907096|NCT02864498|581053962|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
160907097|NCT02864498|581053963|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
160907098|NCT02864498|581053964|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
160907099|NCT02864498|581053962|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
160907100|NCT02864498|581053963|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
160907101|NCT02864498|581053964|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
160907102|NCT02864498|581053962|FG000|Overall Study|Investigator Discretion|0|||
160907103|NCT02864498|581053963|FG001|Overall Study|Investigator Discretion|2|||
160907104|NCT02864498|581053964|FG002|Overall Study|Investigator Discretion|1|||
160907105|NCT02864498|581053962|FG000|Overall Study|Lost to Follow-up|8|||
160907106|NCT02864498|581053963|FG001|Overall Study|Lost to Follow-up|6|||
160907107|NCT02864498|581053964|FG002|Overall Study|Lost to Follow-up|3|||
160907108|NCT02864498|581053962|FG000|Overall Study|Lack of Efficacy|5|||
160853543|NCT01005251|580853242|FG004|Overall Study|Patient moved|0|||
160853544|NCT01005251|580853238|FG000|Overall Study|Wrong drug dispensed|0|||
160853545|NCT01005251|580853239|FG001|Overall Study|Wrong drug dispensed|1|||
160853546|NCT01005251|580853240|FG002|Overall Study|Wrong drug dispensed|0|||
160853547|NCT01005251|580853241|FG003|Overall Study|Wrong drug dispensed|0|||
160853548|NCT01005251|580853242|FG004|Overall Study|Wrong drug dispensed|0|||
160853549|NCT01005251|580853238|FG000|Overall Study|Randomized in error|0|||
160853550|NCT01005251|580853239|FG001|Overall Study|Randomized in error|0|||
160853551|NCT01005251|580853240|FG002|Overall Study|Randomized in error|1|||
160853552|NCT01005251|580853241|FG003|Overall Study|Randomized in error|1|||
160853553|NCT01005251|580853242|FG004|Overall Study|Randomized in error|0|||
160853554|NCT01005251|580853238|FG000|Overall Study|Lack of Efficacy|0|||
160853555|NCT01005251|580853239|FG001|Overall Study|Lack of Efficacy|0|||
160853556|NCT01005251|580853240|FG002|Overall Study|Lack of Efficacy|1|||
160853557|NCT01005251|580853241|FG003|Overall Study|Lack of Efficacy|1|||
160853558|NCT01005251|580853242|FG004|Overall Study|Lack of Efficacy|0|||
160853559|NCT02193776|580853243|FG000|Overall Study|Consent withdrawn|1|||
160853560|NCT02193776|580853244|FG001|Overall Study|Consent withdrawn|0|||
160853561|NCT02193776|580853245|FG002|Overall Study|Consent withdrawn|0|||
160853562|NCT02193776|580853246|FG003|Overall Study|Consent withdrawn|0|||
160853563|NCT02193776|580853243|FG000|Overall Study|Failure to comply with protocol|0|||
160853564|NCT02193776|580853244|FG001|Overall Study|Failure to comply with protocol|1|||
160853565|NCT02193776|580853245|FG002|Overall Study|Failure to comply with protocol|0|||
160853566|NCT02193776|580853246|FG003|Overall Study|Failure to comply with protocol|0|||
160853567|NCT02193776|580853243|FG000|Overall Study|Investigator/Sponsor decision|1|||
160853568|NCT02193776|580853244|FG001|Overall Study|Investigator/Sponsor decision|1|||
160853569|NCT02193776|580853245|FG002|Overall Study|Investigator/Sponsor decision|0|||
160853570|NCT02193776|580853246|FG003|Overall Study|Investigator/Sponsor decision|0|||
160853571|NCT02193776|580853243|FG000|Overall Study|Death|1|||
160853572|NCT02193776|580853244|FG001|Overall Study|Death|0|||
160853573|NCT02193776|580853245|FG002|Overall Study|Death|0|||
160907109|NCT02864498|581053963|FG001|Overall Study|Lack of Efficacy|3|||
160907110|NCT02864498|581053964|FG002|Overall Study|Lack of Efficacy|3|||
160907111|NCT02864498|581053962|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
160907112|NCT02864498|581053963|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
160853574|NCT02193776|580853246|FG003|Overall Study|Death|0|||
160853575|NCT02193776|580853243|FG000|Overall Study|Adverse event/Specific toxicity|5|||
160853576|NCT02193776|580853244|FG001|Overall Study|Adverse event/Specific toxicity|5|||
160853577|NCT02193776|580853245|FG002|Overall Study|Adverse event/Specific toxicity|2|||
160853578|NCT02193776|580853246|FG003|Overall Study|Adverse event/Specific toxicity|2|||
160853579|NCT01702844|580853247|FG000|Overall Study|Adverse Event|9|||
160853580|NCT01702844|580853247|FG000|Overall Study|Death|1|||
160907113|NCT02864498|581053964|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
160907114|NCT02864498|581053962|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
160853581|NCT01702844|580853247|FG000|Overall Study|Withdrawal by Subject|3|||
160853582|NCT01702844|580853247|FG000|Overall Study|Physician Decision|6|||
160853583|NCT02995980|580853248|FG000|Overall Study|Lost to Follow-up|14|||
160853584|NCT01169103|580853249|FG000|Overall Study|Lost to Follow-up|3|||
160853585|NCT01169103|580853250|FG001|Overall Study|Lost to Follow-up|3|||
160853586|NCT01169103|580853249|FG000|Overall Study|Withdrawal by Subject|3|||
160853587|NCT01169103|580853250|FG001|Overall Study|Withdrawal by Subject|1|||
160853588|NCT06039579|580853251|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853589|NCT06039579|580853252|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853590|NCT06039579|580853253|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853591|NCT06039579|580853254|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853592|NCT06039579|580853255|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853593|NCT06039579|580853256|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853594|NCT06039579|580853257|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
160853595|NCT06039579|580853258|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
160853596|NCT00981149|580853264|FG000|Overall Study|Lost to Follow-up|1|||
160853597|NCT00981149|580853265|FG001|Overall Study|Lost to Follow-up|2|||
160853598|NCT00981149|580853264|FG000|Overall Study|Withdrawal by Subject|1|||
160853599|NCT00981149|580853265|FG001|Overall Study|Withdrawal by Subject|1|||
160853600|NCT02634333|580853271|FG000|Overall Study|Completed out of Window|3|||
160853601|NCT02634333|580853272|FG001|Overall Study|Completed out of Window|2|||
160853602|NCT02634333|580853271|FG000|Overall Study|Missed Visit|5|||
160853603|NCT02634333|580853272|FG001|Overall Study|Missed Visit|2|||
160853604|NCT02634333|580853271|FG000|Overall Study|Lost to Follow-up|12|||
160853605|NCT02634333|580853272|FG001|Overall Study|Lost to Follow-up|7|||
160853606|NCT02634333|580853271|FG000|Overall Study|Withdrawal by Subject|9|||
160853607|NCT02634333|580853272|FG001|Overall Study|Withdrawal by Subject|13|||
160853608|NCT02634333|580853271|FG000|Overall Study|Death|11|||
160853609|NCT02634333|580853272|FG001|Overall Study|Death|8|||
160853610|NCT00657046|580853275|FG000|Overall Study|Adverse Event|1|||
160853611|NCT00657046|580853276|FG001|Overall Study|Adverse Event|1|||
160853612|NCT00657046|580853277|FG002|Overall Study|Adverse Event|0|||
160853613|NCT00657046|580853275|FG000|Overall Study|Protocol Violation|2|||
160853614|NCT00657046|580853276|FG001|Overall Study|Protocol Violation|2|||
160853615|NCT00657046|580853277|FG002|Overall Study|Protocol Violation|0|||
160853616|NCT00657046|580853275|FG000|Overall Study|Withdrawal by Subject|1|||
160853617|NCT00657046|580853276|FG001|Overall Study|Withdrawal by Subject|0|||
160853618|NCT00657046|580853277|FG002|Overall Study|Withdrawal by Subject|0|||
160853619|NCT00657046|580853275|FG000|Overall Study|Death|0|||
160853620|NCT00657046|580853276|FG001|Overall Study|Death|0|||
160853621|NCT00657046|580853277|FG002|Overall Study|Death|1|||
160853622|NCT00657046|580853275|FG000|Overall Study|Surgery|0|||
160853623|NCT00657046|580853276|FG001|Overall Study|Surgery|0|||
160853624|NCT00657046|580853277|FG002|Overall Study|Surgery|1|||
160853625|NCT03827655|580853278|FG000|Overall Study|Death|0|||
160853626|NCT03827655|580853279|FG001|Overall Study|Death|0|||
160853627|NCT03827655|580853280|FG002|Overall Study|Death|0|||
160853628|NCT03827655|580853281|FG003|Overall Study|Death|0|||
160853629|NCT03827655|580853282|FG004|Overall Study|Death|1|||
160853630|NCT03827655|580853278|FG000|Overall Study|Protocol Deviation|1|||
160853631|NCT03827655|580853279|FG001|Overall Study|Protocol Deviation|0|||
160853632|NCT03827655|580853280|FG002|Overall Study|Protocol Deviation|1|||
160853633|NCT03827655|580853281|FG003|Overall Study|Protocol Deviation|1|||
160853634|NCT03827655|580853282|FG004|Overall Study|Protocol Deviation|0|||
160853635|NCT03827655|580853278|FG000|Overall Study|Withdrawal by Subject|3|||
160853636|NCT03827655|580853279|FG001|Overall Study|Withdrawal by Subject|2|||
160853637|NCT03827655|580853280|FG002|Overall Study|Withdrawal by Subject|2|||
160853638|NCT03827655|580853281|FG003|Overall Study|Withdrawal by Subject|0|||
160853639|NCT03827655|580853282|FG004|Overall Study|Withdrawal by Subject|1|||
160853640|NCT03827655|580853278|FG000|Overall Study|Reason not Specified|3|||
160853641|NCT03827655|580853279|FG001|Overall Study|Reason not Specified|1|||
160853642|NCT03827655|580853280|FG002|Overall Study|Reason not Specified|1|||
160853643|NCT03827655|580853281|FG003|Overall Study|Reason not Specified|1|||
160853644|NCT03827655|580853282|FG004|Overall Study|Reason not Specified|1|||
160853645|NCT03935126|580853285|FG000|Overall Study|Study termination by sponsor|3|||
160853646|NCT01092728|580853286|FG000|Overall Study|Withdrawal by Subject|2|||
160853647|NCT01092728|580853287|FG001|Overall Study|Withdrawal by Subject|0|||
160853648|NCT01092728|580853286|FG000|Overall Study|Adverse Event|0|||
160853649|NCT01092728|580853287|FG001|Overall Study|Adverse Event|1|||
160853650|NCT01092728|580853286|FG000|Overall Study|Disease Progression|1|||
160853651|NCT01092728|580853287|FG001|Overall Study|Disease Progression|13|||
160853652|NCT01092728|580853286|FG000|Overall Study|Prohibited Concomitant Medications|1|||
160853653|NCT01092728|580853287|FG001|Overall Study|Prohibited Concomitant Medications|0|||
160853654|NCT02336607|580853288|FG000|Overall Study|Physician Decision|1|||
160853655|NCT02336607|580853289|FG001|Overall Study|Physician Decision|4|||
160853656|NCT02336607|580853290|FG002|Overall Study|Physician Decision|3|||
160853657|NCT02336607|580853291|FG003|Overall Study|Physician Decision|15|||
160853658|NCT02336607|580853288|FG000|Overall Study|Lack of Efficacy|1|||
160853659|NCT02336607|580853289|FG001|Overall Study|Lack of Efficacy|0|||
160853660|NCT02336607|580853290|FG002|Overall Study|Lack of Efficacy|0|||
161141246|NCT01985321|581901012|FG001|Overall Study|Subject treated wrong type of sore|0|||
160853661|NCT02336607|580853291|FG003|Overall Study|Lack of Efficacy|2|||
160853662|NCT02336607|580853288|FG000|Overall Study|Lost to Follow-up|2|||
160853663|NCT02336607|580853289|FG001|Overall Study|Lost to Follow-up|1|||
160853664|NCT02336607|580853290|FG002|Overall Study|Lost to Follow-up|0|||
160853665|NCT02336607|580853291|FG003|Overall Study|Lost to Follow-up|21|||
160853666|NCT02336607|580853288|FG000|Overall Study|Protocol Violation|0|||
161141247|NCT00498173|581901015|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
161141248|NCT00498173|581901016|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
161141249|NCT00498173|581901017|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
161141250|NCT01364467|581901020|FG000|Overall Study|Lost to Follow-up|1|||
161141251|NCT01364467|581901021|FG001|Overall Study|Lost to Follow-up|2|||
161141252|NCT03228186|581901024|FG000|Overall Study|Patient never started treatment|1|||
161141253|NCT01634243|581901025|FG000|Overall Study|Adverse Event|5|||
161141254|NCT01634243|581901026|FG001|Overall Study|Adverse Event|5|||
161141255|NCT01634243|581901025|FG000|Overall Study|Lack of Efficacy|1|||
161141256|NCT01634243|581901026|FG001|Overall Study|Lack of Efficacy|0|||
161141257|NCT00258154|581901027|FG000|Overall Study|Adverse Event|1|||
161141258|NCT00258154|581901028|FG001|Overall Study|Adverse Event|0|||
161141259|NCT00258154|581901027|FG000|Overall Study|Lost to Follow-up|0|||
161141260|NCT00258154|581901028|FG001|Overall Study|Lost to Follow-up|1|||
161141261|NCT00258154|581901027|FG000|Overall Study|Protocol Violation|2|||
161141262|NCT00258154|581901028|FG001|Overall Study|Protocol Violation|1|||
161141263|NCT00258154|581901027|FG000|Overall Study|Withdrawal by Subject|3|||
161141264|NCT00258154|581901028|FG001|Overall Study|Withdrawal by Subject|4|||
161337399|NCT01326871|582625925|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
160853667|NCT02336607|580853289|FG001|Overall Study|Protocol Violation|1|||
160853668|NCT02336607|580853290|FG002|Overall Study|Protocol Violation|1|||
160853669|NCT02336607|580853291|FG003|Overall Study|Protocol Violation|3|||
160853670|NCT02336607|580853288|FG000|Overall Study|Adverse Event|0|||
160853671|NCT02336607|580853289|FG001|Overall Study|Adverse Event|2|||
160853672|NCT02336607|580853290|FG002|Overall Study|Adverse Event|2|||
160853673|NCT02336607|580853291|FG003|Overall Study|Adverse Event|26|||
160853674|NCT02336607|580853288|FG000|Overall Study|Withdrawal by Subject|0|||
160853675|NCT02336607|580853289|FG001|Overall Study|Withdrawal by Subject|2|||
160853676|NCT02336607|580853290|FG002|Overall Study|Withdrawal by Subject|0|||
160853677|NCT02336607|580853291|FG003|Overall Study|Withdrawal by Subject|20|||
160853678|NCT02552966|580853292|FG000|Overall Study|Lost to Follow-up|2|||
160853679|NCT02552966|580853292|FG000|Overall Study|Withdrawal by Subject|3|||
160853680|NCT01506271|580853304|FG000|Overall Study|Progressive disease|0|||
160853681|NCT01506271|580853305|FG001|Overall Study|Progressive disease|1|||
160853682|NCT01506271|580853306|FG002|Overall Study|Progressive disease|0|||
160853683|NCT01506271|580853304|FG000|Overall Study|Protocol Violation|3|||
160853684|NCT01506271|580853305|FG001|Overall Study|Protocol Violation|1|||
160907115|NCT02864498|581053963|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
160907116|NCT02864498|581053964|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
160907117|NCT02864498|581053962|FG000|Overall Study|Subject moved out of the country.|0|||
160907118|NCT02864498|581053963|FG001|Overall Study|Subject moved out of the country.|0|||
160907119|NCT02864498|581053964|FG002|Overall Study|Subject moved out of the country.|1|||
160907120|NCT00705484|581053967|FG000|Overall Study|Adverse Event|28|||
160907121|NCT00705484|581053968|FG001|Overall Study|Adverse Event|27|||
160907122|NCT00705484|581053967|FG000|Overall Study|Lost to Follow-up|169|||
160907123|NCT00705484|581053968|FG001|Overall Study|Lost to Follow-up|250|||
160907124|NCT00705484|581053967|FG000|Overall Study|Withdrawal by Subject|96|||
160907125|NCT00705484|581053968|FG001|Overall Study|Withdrawal by Subject|72|||
160907126|NCT00705484|581053967|FG000|Overall Study|Administrative|89|||
160907127|NCT00705484|581053968|FG001|Overall Study|Administrative|59|||
160907128|NCT02197247|581053969|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
160907129|NCT02197247|581053969|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
160907130|NCT02197247|581053969|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
160907131|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
160907132|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
160907133|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
160907134|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
160907135|NCT02197247|581053969|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
160907136|NCT01606007|581053970|FG000|Overall Study|Reason 'Other' in the protocol|0|||
161141265|NCT00258154|581901027|FG000|Overall Study|Patient Moved|3|||
160853685|NCT01506271|580853306|FG002|Overall Study|Protocol Violation|0|||
160853686|NCT01506271|580853304|FG000|Overall Study|Death|0|||
160853687|NCT01506271|580853305|FG001|Overall Study|Death|1|||
160853688|NCT01506271|580853306|FG002|Overall Study|Death|0|||
161141266|NCT00258154|581901028|FG001|Overall Study|Patient Moved|1|||
160853689|NCT01506271|580853304|FG000|Overall Study|Adverse Event|0|||
160853690|NCT01506271|580853305|FG001|Overall Study|Adverse Event|2|||
160853691|NCT01506271|580853306|FG002|Overall Study|Adverse Event|0|||
160853692|NCT01506271|580853304|FG000|Overall Study|Insufficient supply of study drug|1|||
160853693|NCT01506271|580853305|FG001|Overall Study|Insufficient supply of study drug|0|||
160853694|NCT01506271|580853306|FG002|Overall Study|Insufficient supply of study drug|0|||
160853695|NCT01506271|580853304|FG000|Overall Study|Withdrawal by Subject|0|||
160853696|NCT01506271|580853305|FG001|Overall Study|Withdrawal by Subject|1|||
160853697|NCT01506271|580853306|FG002|Overall Study|Withdrawal by Subject|1|||
160853698|NCT01506271|580853304|FG000|Overall Study|Lost to Follow-up|0|||
160853699|NCT01506271|580853305|FG001|Overall Study|Lost to Follow-up|1|||
160853700|NCT01506271|580853306|FG002|Overall Study|Lost to Follow-up|2|||
160853701|NCT00689390|580853307|FG000|Overall Study|Adverse Event|19|||
160853702|NCT00689390|580853308|FG001|Overall Study|Adverse Event|0|||
160853703|NCT00689390|580853307|FG000|Overall Study|Lost to Follow-up|179|||
160853704|NCT00689390|580853308|FG001|Overall Study|Lost to Follow-up|7|||
160853705|NCT00689390|580853307|FG000|Overall Study|Withdrawal by Subject|117|||
160853706|NCT00689390|580853308|FG001|Overall Study|Withdrawal by Subject|3|||
160853707|NCT00689390|580853307|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
160853708|NCT00689390|580853308|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
160853709|NCT00689390|580853307|FG000|Overall Study|Non-Compliance With Protocol|21|||
160853710|NCT00689390|580853308|FG001|Overall Study|Non-Compliance With Protocol|0|||
160853711|NCT00689390|580853307|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
160853712|NCT00689390|580853308|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
160853713|NCT00689390|580853307|FG000|Overall Study|Administrative|37|||
160853714|NCT00689390|580853308|FG001|Overall Study|Administrative|0|||
160853715|NCT03318549|580853309|FG000|Overall Study|Withdrawal by Subject|5|||
160853716|NCT03318549|580853310|FG001|Overall Study|Withdrawal by Subject|19|||
160853717|NCT03318549|580853311|FG002|Overall Study|Withdrawal by Subject|2|||
160853718|NCT03318549|580853312|FG003|Overall Study|Withdrawal by Subject|0|||
160853719|NCT03318549|580853313|FG004|Overall Study|Withdrawal by Subject|0|||
160853720|NCT03318549|580853314|FG005|Overall Study|Withdrawal by Subject|0|||
160853721|NCT03318549|580853315|FG006|Overall Study|Withdrawal by Subject|0|||
160853722|NCT03318549|580853309|FG000|Overall Study|Physician Decision|0|||
160853723|NCT03318549|580853310|FG001|Overall Study|Physician Decision|4|||
160853724|NCT03318549|580853311|FG002|Overall Study|Physician Decision|1|||
160853725|NCT03318549|580853312|FG003|Overall Study|Physician Decision|0|||
160853726|NCT03318549|580853313|FG004|Overall Study|Physician Decision|0|||
160853727|NCT03318549|580853314|FG005|Overall Study|Physician Decision|0|||
160853728|NCT03318549|580853315|FG006|Overall Study|Physician Decision|0|||
160853729|NCT03318549|580853309|FG000|Overall Study|Lost to Follow-up|0|||
160853730|NCT03318549|580853310|FG001|Overall Study|Lost to Follow-up|3|||
160853731|NCT03318549|580853311|FG002|Overall Study|Lost to Follow-up|3|||
160853732|NCT03318549|580853312|FG003|Overall Study|Lost to Follow-up|0|||
160853733|NCT03318549|580853313|FG004|Overall Study|Lost to Follow-up|0|||
160853734|NCT03318549|580853314|FG005|Overall Study|Lost to Follow-up|0|||
160853735|NCT03318549|580853315|FG006|Overall Study|Lost to Follow-up|0|||
160853736|NCT00510835|580853317|FG000|Overall Study|Withdrawal by Subject|6|||
160853737|NCT00510835|580853318|FG001|Overall Study|Withdrawal by Subject|2|||
160853738|NCT00510835|580853319|FG002|Overall Study|Withdrawal by Subject|2|||
160853739|NCT01917747|580853320|FG000|Overall Study|Withdrawal by Subject|1|||
160853740|NCT01917747|580853321|FG001|Overall Study|Withdrawal by Subject|2|||
160853741|NCT01917747|580853320|FG000|Overall Study|Lost to Follow-up|18|||
160853742|NCT01917747|580853321|FG001|Overall Study|Lost to Follow-up|9|||
160853743|NCT03064490|580853323|FG000|Overall Study|Physician Decision|5|||
160853744|NCT05579977|580853328|FG000|Treatment Phase|Other|0|||
160853745|NCT05579977|580853329|FG001|Treatment Phase|Other|0|||
160853746|NCT05579977|580853330|FG002|Treatment Phase|Other|0|||
160853747|NCT05579977|580853331|FG003|Treatment Phase|Other|2|||
160853748|NCT05579977|580853332|FG004|Treatment Phase|Other|1|||
160853749|NCT05579977|580853333|FG005|Treatment Phase|Other|2|||
160853750|NCT05579977|580853334|FG006|Treatment Phase|Other|1|||
160853751|NCT05579977|580853335|FG007|Treatment Phase|Other|2|||
160853752|NCT05579977|580853336|FG008|Treatment Phase|Other|2|||
160853753|NCT05579977|580853337|FG009|Treatment Phase|Other|1|||
160853754|NCT05579977|580853338|FG010|Treatment Phase|Other|0|||
161141267|NCT05139030|581901029|FG000|Overall Study|Withdrawal by Subject|1|||
160853755|NCT05579977|580853339|FG011|Treatment Phase|Other|0|||
160853756|NCT05579977|580853340|FG012|Treatment Phase|Other|3|||
160853757|NCT05579977|580853328|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
160853758|NCT05579977|580853329|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
160853759|NCT05579977|580853330|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
160853760|NCT05579977|580853331|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
160853761|NCT05579977|580853332|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
160853762|NCT05579977|580853333|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
160853763|NCT05579977|580853334|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
160853764|NCT05579977|580853335|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
160853765|NCT05579977|580853336|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
161337400|NCT01326871|582625926|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
161337401|NCT01326871|582625927|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
161337402|NCT01326871|582625925|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
161337403|NCT01326871|582625926|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
161337404|NCT01326871|582625927|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
161337405|NCT01326871|582625925|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
161337406|NCT01326871|582625926|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
161337407|NCT01326871|582625927|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
161337408|NCT01326871|582625925|FG000|Overall Study|Physician Decision|0|||
161337409|NCT01326871|582625926|FG001|Overall Study|Physician Decision|0|||
161337410|NCT01326871|582625927|FG002|Overall Study|Physician Decision|1|||
161337411|NCT01326871|582625925|FG000|Overall Study|SAE|0|||
161337412|NCT01326871|582625926|FG001|Overall Study|SAE|0|||
161337413|NCT01326871|582625927|FG002|Overall Study|SAE|1|||
161337414|NCT01326871|582625925|FG000|Overall Study|Disease progression and death|0|||
161337415|NCT01326871|582625926|FG001|Overall Study|Disease progression and death|0|||
161337416|NCT01326871|582625927|FG002|Overall Study|Disease progression and death|1|||
160853766|NCT05579977|580853337|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
160853767|NCT05579977|580853338|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
160853768|NCT05579977|580853339|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
160853769|NCT05579977|580853340|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
160853770|NCT05579977|580853328|FG000|Treatment Phase|Withdrawal by Subject|2|||
160853771|NCT05579977|580853329|FG001|Treatment Phase|Withdrawal by Subject|0|||
160853772|NCT05579977|580853330|FG002|Treatment Phase|Withdrawal by Subject|0|||
160853773|NCT05579977|580853331|FG003|Treatment Phase|Withdrawal by Subject|1|||
160853774|NCT05579977|580853332|FG004|Treatment Phase|Withdrawal by Subject|2|||
160853775|NCT05579977|580853333|FG005|Treatment Phase|Withdrawal by Subject|0|||
160853776|NCT05579977|580853334|FG006|Treatment Phase|Withdrawal by Subject|1|||
160853777|NCT05579977|580853335|FG007|Treatment Phase|Withdrawal by Subject|8|||
160853778|NCT05579977|580853336|FG008|Treatment Phase|Withdrawal by Subject|3|||
160853779|NCT05579977|580853337|FG009|Treatment Phase|Withdrawal by Subject|3|||
160853780|NCT05579977|580853338|FG010|Treatment Phase|Withdrawal by Subject|5|||
160853781|NCT05579977|580853339|FG011|Treatment Phase|Withdrawal by Subject|1|||
160853782|NCT05579977|580853340|FG012|Treatment Phase|Withdrawal by Subject|3|||
160853783|NCT05579977|580853328|FG000|Treatment Phase|Study terminated by sponsor|70|||
160853784|NCT05579977|580853329|FG001|Treatment Phase|Study terminated by sponsor|70|||
160853785|NCT05579977|580853330|FG002|Treatment Phase|Study terminated by sponsor|61|||
160853786|NCT05579977|580853331|FG003|Treatment Phase|Study terminated by sponsor|59|||
160853787|NCT05579977|580853332|FG004|Treatment Phase|Study terminated by sponsor|63|||
160853788|NCT05579977|580853333|FG005|Treatment Phase|Study terminated by sponsor|53|||
160853789|NCT05579977|580853334|FG006|Treatment Phase|Study terminated by sponsor|66|||
160853790|NCT05579977|580853335|FG007|Treatment Phase|Study terminated by sponsor|48|||
160853791|NCT05579977|580853336|FG008|Treatment Phase|Study terminated by sponsor|47|||
160853792|NCT05579977|580853337|FG009|Treatment Phase|Study terminated by sponsor|37|||
160853793|NCT05579977|580853338|FG010|Treatment Phase|Study terminated by sponsor|44|||
160853794|NCT05579977|580853339|FG011|Treatment Phase|Study terminated by sponsor|36|||
160853795|NCT05579977|580853340|FG012|Treatment Phase|Study terminated by sponsor|32|||
160853796|NCT05579977|580853328|FG000|Treatment Phase|Pregnancy|0|||
160853797|NCT05579977|580853329|FG001|Treatment Phase|Pregnancy|0|||
160853798|NCT05579977|580853330|FG002|Treatment Phase|Pregnancy|0|||
160853799|NCT05579977|580853331|FG003|Treatment Phase|Pregnancy|0|||
160853800|NCT05579977|580853332|FG004|Treatment Phase|Pregnancy|0|||
160853801|NCT05579977|580853333|FG005|Treatment Phase|Pregnancy|0|||
160853802|NCT05579977|580853334|FG006|Treatment Phase|Pregnancy|0|||
160853803|NCT05579977|580853335|FG007|Treatment Phase|Pregnancy|0|||
160853804|NCT05579977|580853336|FG008|Treatment Phase|Pregnancy|0|||
160853805|NCT05579977|580853337|FG009|Treatment Phase|Pregnancy|1|||
160853806|NCT05579977|580853338|FG010|Treatment Phase|Pregnancy|0|||
160853807|NCT05579977|580853339|FG011|Treatment Phase|Pregnancy|0|||
160853808|NCT05579977|580853340|FG012|Treatment Phase|Pregnancy|0|||
160853809|NCT05579977|580853328|FG000|Treatment Phase|Physician Decision|0|||
160853810|NCT05579977|580853329|FG001|Treatment Phase|Physician Decision|0|||
160853811|NCT05579977|580853330|FG002|Treatment Phase|Physician Decision|0|||
160853812|NCT05579977|580853331|FG003|Treatment Phase|Physician Decision|0|||
160853813|NCT05579977|580853332|FG004|Treatment Phase|Physician Decision|0|||
160853814|NCT05579977|580853333|FG005|Treatment Phase|Physician Decision|0|||
160853815|NCT05579977|580853334|FG006|Treatment Phase|Physician Decision|0|||
160853816|NCT05579977|580853335|FG007|Treatment Phase|Physician Decision|0|||
160853817|NCT05579977|580853336|FG008|Treatment Phase|Physician Decision|0|||
160853818|NCT05579977|580853337|FG009|Treatment Phase|Physician Decision|0|||
161337417|NCT01326871|582625925|FG000|Overall Study|Subject decision|0|||
161337418|NCT01326871|582625926|FG001|Overall Study|Subject decision|0|||
161337419|NCT01326871|582625927|FG002|Overall Study|Subject decision|1|||
160853819|NCT05579977|580853338|FG010|Treatment Phase|Physician Decision|0|||
160853820|NCT05579977|580853339|FG011|Treatment Phase|Physician Decision|1|||
160853821|NCT05579977|580853340|FG012|Treatment Phase|Physician Decision|0|||
160853822|NCT05579977|580853328|FG000|Treatment Phase|Lost to Follow-up|0|||
160853823|NCT05579977|580853329|FG001|Treatment Phase|Lost to Follow-up|0|||
160853824|NCT05579977|580853330|FG002|Treatment Phase|Lost to Follow-up|0|||
160853825|NCT05579977|580853331|FG003|Treatment Phase|Lost to Follow-up|1|||
160853826|NCT05579977|580853332|FG004|Treatment Phase|Lost to Follow-up|1|||
160853827|NCT05579977|580853333|FG005|Treatment Phase|Lost to Follow-up|1|||
160853828|NCT05579977|580853334|FG006|Treatment Phase|Lost to Follow-up|0|||
160853829|NCT05579977|580853335|FG007|Treatment Phase|Lost to Follow-up|1|||
160853830|NCT05579977|580853336|FG008|Treatment Phase|Lost to Follow-up|2|||
160853831|NCT05579977|580853337|FG009|Treatment Phase|Lost to Follow-up|2|||
160853832|NCT05579977|580853338|FG010|Treatment Phase|Lost to Follow-up|1|||
160853833|NCT05579977|580853339|FG011|Treatment Phase|Lost to Follow-up|4|||
160853834|NCT05579977|580853340|FG012|Treatment Phase|Lost to Follow-up|3|||
160853835|NCT05579977|580853328|FG000|Treatment Phase|Death|1|||
160853836|NCT05579977|580853329|FG001|Treatment Phase|Death|0|||
160853837|NCT05579977|580853330|FG002|Treatment Phase|Death|0|||
160853838|NCT05579977|580853331|FG003|Treatment Phase|Death|0|||
160853839|NCT05579977|580853332|FG004|Treatment Phase|Death|0|||
160853840|NCT05579977|580853333|FG005|Treatment Phase|Death|0|||
160853841|NCT05579977|580853334|FG006|Treatment Phase|Death|0|||
160853842|NCT05579977|580853335|FG007|Treatment Phase|Death|0|||
160853843|NCT05579977|580853336|FG008|Treatment Phase|Death|0|||
160853844|NCT05579977|580853337|FG009|Treatment Phase|Death|0|||
160853845|NCT05579977|580853338|FG010|Treatment Phase|Death|0|||
160853846|NCT05579977|580853339|FG011|Treatment Phase|Death|0|||
160853847|NCT05579977|580853340|FG012|Treatment Phase|Death|0|||
160853848|NCT05579977|580853328|FG000|Treatment Phase|Adverse Event|0|||
160853849|NCT05579977|580853329|FG001|Treatment Phase|Adverse Event|3|||
160853850|NCT05579977|580853330|FG002|Treatment Phase|Adverse Event|11|||
160853851|NCT05579977|580853331|FG003|Treatment Phase|Adverse Event|10|||
160853852|NCT05579977|580853332|FG004|Treatment Phase|Adverse Event|5|||
160853853|NCT05579977|580853333|FG005|Treatment Phase|Adverse Event|17|||
160853854|NCT05579977|580853334|FG006|Treatment Phase|Adverse Event|5|||
160853855|NCT05579977|580853335|FG007|Treatment Phase|Adverse Event|5|||
160853856|NCT05579977|580853336|FG008|Treatment Phase|Adverse Event|12|||
160853857|NCT05579977|580853337|FG009|Treatment Phase|Adverse Event|20|||
160853858|NCT05579977|580853338|FG010|Treatment Phase|Adverse Event|15|||
160853859|NCT05579977|580853339|FG011|Treatment Phase|Adverse Event|24|||
160853860|NCT05579977|580853340|FG012|Treatment Phase|Adverse Event|23|||
160853861|NCT05579977|580853328|FG000|Treatment Phase|Randomized not treated|0|||
160853862|NCT05579977|580853329|FG001|Treatment Phase|Randomized not treated|0|||
160853863|NCT05579977|580853330|FG002|Treatment Phase|Randomized not treated|0|||
160853864|NCT05579977|580853331|FG003|Treatment Phase|Randomized not treated|0|||
160853865|NCT05579977|580853332|FG004|Treatment Phase|Randomized not treated|1|||
160853866|NCT05579977|580853333|FG005|Treatment Phase|Randomized not treated|0|||
160853867|NCT05579977|580853334|FG006|Treatment Phase|Randomized not treated|0|||
160853868|NCT05579977|580853335|FG007|Treatment Phase|Randomized not treated|0|||
160853869|NCT05579977|580853336|FG008|Treatment Phase|Randomized not treated|0|||
160853870|NCT05579977|580853337|FG009|Treatment Phase|Randomized not treated|0|||
160853871|NCT05579977|580853338|FG010|Treatment Phase|Randomized not treated|0|||
160853872|NCT05579977|580853339|FG011|Treatment Phase|Randomized not treated|0|||
160853873|NCT05579977|580853340|FG012|Treatment Phase|Randomized not treated|0|||
160853874|NCT05579977|580853328|FG000|Follow up|Death|1|||
160853875|NCT05579977|580853329|FG001|Follow up|Death|0|||
160853876|NCT05579977|580853330|FG002|Follow up|Death|0|||
160853877|NCT05579977|580853331|FG003|Follow up|Death|0|||
160853878|NCT05579977|580853332|FG004|Follow up|Death|0|||
160853879|NCT05579977|580853333|FG005|Follow up|Death|0|||
160853880|NCT05579977|580853334|FG006|Follow up|Death|0|||
160853881|NCT05579977|580853335|FG007|Follow up|Death|0|||
160853882|NCT05579977|580853336|FG008|Follow up|Death|0|||
160853883|NCT05579977|580853337|FG009|Follow up|Death|0|||
160853884|NCT05579977|580853338|FG010|Follow up|Death|0|||
160853885|NCT05579977|580853339|FG011|Follow up|Death|0|||
160853886|NCT05579977|580853340|FG012|Follow up|Death|0|||
160853887|NCT05579977|580853328|FG000|Follow up|Lost to Follow-up|0|||
160853888|NCT05579977|580853329|FG001|Follow up|Lost to Follow-up|0|||
160853889|NCT05579977|580853330|FG002|Follow up|Lost to Follow-up|0|||
160853890|NCT05579977|580853331|FG003|Follow up|Lost to Follow-up|1|||
160853891|NCT05579977|580853332|FG004|Follow up|Lost to Follow-up|1|||
160853892|NCT05579977|580853333|FG005|Follow up|Lost to Follow-up|2|||
160853893|NCT05579977|580853334|FG006|Follow up|Lost to Follow-up|1|||
160853894|NCT05579977|580853335|FG007|Follow up|Lost to Follow-up|1|||
160853895|NCT05579977|580853336|FG008|Follow up|Lost to Follow-up|3|||
160853896|NCT05579977|580853337|FG009|Follow up|Lost to Follow-up|2|||
160853897|NCT05579977|580853338|FG010|Follow up|Lost to Follow-up|2|||
160853898|NCT05579977|580853339|FG011|Follow up|Lost to Follow-up|4|||
160853899|NCT05579977|580853340|FG012|Follow up|Lost to Follow-up|4|||
160853900|NCT05579977|580853328|FG000|Follow up|Withdrawal by Subject|2|||
160853901|NCT05579977|580853329|FG001|Follow up|Withdrawal by Subject|0|||
160853902|NCT05579977|580853330|FG002|Follow up|Withdrawal by Subject|0|||
160853903|NCT05579977|580853331|FG003|Follow up|Withdrawal by Subject|0|||
160853904|NCT05579977|580853332|FG004|Follow up|Withdrawal by Subject|1|||
160853905|NCT05579977|580853333|FG005|Follow up|Withdrawal by Subject|0|||
160853906|NCT05579977|580853334|FG006|Follow up|Withdrawal by Subject|1|||
160853907|NCT05579977|580853335|FG007|Follow up|Withdrawal by Subject|4|||
160853908|NCT05579977|580853336|FG008|Follow up|Withdrawal by Subject|2|||
160853909|NCT05579977|580853337|FG009|Follow up|Withdrawal by Subject|3|||
160853910|NCT05579977|580853338|FG010|Follow up|Withdrawal by Subject|3|||
160853911|NCT05579977|580853339|FG011|Follow up|Withdrawal by Subject|1|||
160853912|NCT05579977|580853340|FG012|Follow up|Withdrawal by Subject|3|||
160853913|NCT01611194|580853344|FG000|Overall Study|Lost to Follow-up|0|||
160853914|NCT01611194|580853345|FG001|Overall Study|Lost to Follow-up|1|||
160853915|NCT01611194|580853344|FG000|Overall Study|Withdrawal by Subject|0|||
160853916|NCT01611194|580853345|FG001|Overall Study|Withdrawal by Subject|1|||
160853917|NCT01611194|580853344|FG000|Overall Study|drug use|0|||
160853918|NCT01611194|580853345|FG001|Overall Study|drug use|1|||
160853919|NCT00452790|580853346|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
160853920|NCT00452790|580853347|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
160853921|NCT00452790|580853346|FG000|Infant Series|Parent/legal guardian request|8|||
160853922|NCT00452790|580853347|FG001|Infant Series|Parent/legal guardian request|6|||
160853923|NCT00452790|580853346|FG000|Infant Series|Failed to return|4|||
160853924|NCT00452790|580853347|FG001|Infant Series|Failed to return|1|||
160853925|NCT00452790|580853346|FG000|Infant Series|Protocol Violation|1|||
160853926|NCT00452790|580853347|FG001|Infant Series|Protocol Violation|3|||
160853927|NCT00452790|580853346|FG000|Infant Series|Lost to Follow-up|2|||
160853928|NCT00452790|580853347|FG001|Infant Series|Lost to Follow-up|2|||
160853929|NCT00452790|580853346|FG000|Infant Series|Adverse Event|1|||
160853930|NCT00452790|580853347|FG001|Infant Series|Adverse Event|2|||
160853931|NCT00452790|580853346|FG000|Infant Series|Other reasons|1|||
160992520|NCT03999554|581361389|FG004|Overall Study|Withdrawal by Subject|1|||
160992521|NCT03999554|581361385|FG000|Overall Study|failure to comply with protocol requirements|0|||
160992522|NCT03999554|581361386|FG001|Overall Study|failure to comply with protocol requirements|0|||
160992523|NCT03999554|581361387|FG002|Overall Study|failure to comply with protocol requirements|0|||
160992524|NCT03999554|581361388|FG003|Overall Study|failure to comply with protocol requirements|1|||
160992525|NCT03999554|581361389|FG004|Overall Study|failure to comply with protocol requirements|0|||
160992526|NCT02082158|581361390|FG000|Overall Study|Withdrawal by Subject|0|||
160992527|NCT02082158|581361391|FG001|Overall Study|Withdrawal by Subject|0|||
160992528|NCT02082158|581361392|FG002|Overall Study|Withdrawal by Subject|0|||
160992529|NCT02082158|581361393|FG003|Overall Study|Withdrawal by Subject|0|||
160992530|NCT02082158|581361394|FG004|Overall Study|Withdrawal by Subject|1|||
160992531|NCT02082158|581361395|FG005|Overall Study|Withdrawal by Subject|0|||
160992532|NCT02082158|581361390|FG000|Overall Study|Failed Fit-testing|8|||
160992533|NCT02082158|581361391|FG001|Overall Study|Failed Fit-testing|8|||
160992534|NCT02082158|581361392|FG002|Overall Study|Failed Fit-testing|14|||
160992535|NCT02082158|581361393|FG003|Overall Study|Failed Fit-testing|4|||
160992536|NCT02082158|581361394|FG004|Overall Study|Failed Fit-testing|3|||
160992537|NCT02082158|581361395|FG005|Overall Study|Failed Fit-testing|7|||
160992538|NCT01466881|581361398|FG000|Overall Study|Ineligible|5|||
160992539|NCT01466881|581361398|FG000|Overall Study|Adverse Event|6|||
160992540|NCT01466881|581361398|FG000|Overall Study|Progression/relapse|20|||
160992541|NCT01466881|581361398|FG000|Overall Study|Death|4|||
160992542|NCT01466881|581361398|FG000|Overall Study|Other reason not protocol specified|5|||
160992543|NCT00742274|581361399|FG000|Overall Study|Death|1|||
160992544|NCT00742274|581361400|FG001|Overall Study|Death|0|||
160992545|NCT00742274|581361399|FG000|Overall Study|Withdrawal by Subject|1|||
160992546|NCT00742274|581361400|FG001|Overall Study|Withdrawal by Subject|2|||
160992547|NCT00742274|581361399|FG000|Overall Study|Removed for medical reasons|1|||
160992548|NCT00742274|581361400|FG001|Overall Study|Removed for medical reasons|1|||
160992549|NCT01101165|581361401|FG000|Period 1|Adverse Event|1|||
160992550|NCT01101165|581361402|FG001|Period 1|Adverse Event|2|||
160992551|NCT01101165|581361401|FG000|Period 1|Withdrawal by Subject|0|||
160992552|NCT01101165|581361402|FG001|Period 1|Withdrawal by Subject|2|||
160992553|NCT01101165|581361401|FG000|Period 1|Positive Drug Screen|0|||
160992554|NCT01101165|581361402|FG001|Period 1|Positive Drug Screen|1|||
160992555|NCT01101165|581361401|FG000|Period 1|Lost to Follow-up|1|||
160992556|NCT01101165|581361402|FG001|Period 1|Lost to Follow-up|0|||
160992557|NCT01101165|581361401|FG000|Period 2|Withdrawal by Subject|3|||
160992558|NCT01101165|581361402|FG001|Period 2|Withdrawal by Subject|1|||
160853932|NCT00452790|580853347|FG001|Infant Series|Other reasons|2|||
160853933|NCT00452790|580853346|FG000|Infant Series|Investigator request|0|||
160992559|NCT01101165|581361401|FG000|Period 2|Adverse Event|1|||
160992560|NCT01101165|581361402|FG001|Period 2|Adverse Event|0|||
160992561|NCT00619151|581361404|FG000|Overall Study|Study terminated prior to followup|1|||
160992562|NCT00619151|581361405|FG001|Overall Study|Study terminated prior to followup|0|||
160992563|NCT03124108|581361408|FG000|Overall Study|Adverse Event|0|||
160992564|NCT03124108|581361409|FG001|Overall Study|Adverse Event|1|||
160992565|NCT03124108|581361410|FG002|Overall Study|Adverse Event|0|||
160853934|NCT00452790|580853347|FG001|Infant Series|Investigator request|1|||
160853935|NCT00452790|580853346|FG000|Infant Series|Death|0|||
160853936|NCT00452790|580853347|FG001|Infant Series|Death|1|||
160853937|NCT00452790|580853346|FG000|After Infant Series|Investigator request|10|||
160853938|NCT00452790|580853347|FG001|After Infant Series|Investigator request|10|||
160853939|NCT00452790|580853346|FG000|After Infant Series|Adverse Event|4|||
160853940|NCT00452790|580853347|FG001|After Infant Series|Adverse Event|1|||
160853941|NCT00452790|580853346|FG000|After Infant Series|Parent/legal guardian request|1|||
160853942|NCT00452790|580853347|FG001|After Infant Series|Parent/legal guardian request|3|||
160853943|NCT00452790|580853346|FG000|After Infant Series|Lost to Follow-up|4|||
160853944|NCT00452790|580853347|FG001|After Infant Series|Lost to Follow-up|0|||
160853945|NCT00452790|580853346|FG000|After Infant Series|Failed to return|1|||
160853946|NCT00452790|580853347|FG001|After Infant Series|Failed to return|0|||
160853947|NCT00452790|580853346|FG000|After Infant Series|Other reasons|1|||
160853948|NCT00452790|580853347|FG001|After Infant Series|Other reasons|0|||
160853949|NCT00452790|580853346|FG000|Toddler Dose|Failed to return|0|||
160853950|NCT00452790|580853347|FG001|Toddler Dose|Failed to return|1|||
160853951|NCT00452790|580853346|FG000|Toddler Dose|Parent/legal guardian request|0|||
160853952|NCT00452790|580853347|FG001|Toddler Dose|Parent/legal guardian request|1|||
160853953|NCT02926638|580853362|FG000|Overall Study|Progression|2|||
160853954|NCT02926638|580853363|FG001|Overall Study|Progression|5|||
160853955|NCT02926638|580853362|FG000|Overall Study|Ineligible|1|||
160853956|NCT02926638|580853363|FG001|Overall Study|Ineligible|0|||
160853957|NCT02926638|580853362|FG000|Overall Study|Not protocol specified|1|||
160853958|NCT02926638|580853363|FG001|Overall Study|Not protocol specified|0|||
160853959|NCT01928927|580853366|FG000|Overall Study|Lost to Follow-up|1|||
160853960|NCT01928927|580853367|FG001|Overall Study|Lost to Follow-up|0|||
160853961|NCT01928927|580853366|FG000|Overall Study|Withdrawal by Subject|1|||
160853962|NCT01928927|580853367|FG001|Overall Study|Withdrawal by Subject|1|||
160853963|NCT01871519|580853372|FG000|Overall Study|Death|26|||
160853964|NCT01871519|580853372|FG000|Overall Study|Lost to Follow-up|15|||
160853965|NCT01871519|580853372|FG000|Overall Study|Withdrawal by Subject|49|||
160853966|NCT01777776|580853373|FG000|Overall Study|Adverse Event|2|||
160853967|NCT01777776|580853374|FG001|Overall Study|Adverse Event|4|||
160853968|NCT01777776|580853375|FG002|Overall Study|Adverse Event|0|||
160853969|NCT01777776|580853376|FG003|Overall Study|Adverse Event|0|||
160853970|NCT01777776|580853373|FG000|Overall Study|Disease Progression|4|||
160853971|NCT01777776|580853374|FG001|Overall Study|Disease Progression|8|||
160853972|NCT01777776|580853375|FG002|Overall Study|Disease Progression|6|||
160853973|NCT01777776|580853376|FG003|Overall Study|Disease Progression|3|||
160853974|NCT01777776|580853373|FG000|Overall Study|Withdrawal by Subject|0|||
160853975|NCT01777776|580853374|FG001|Overall Study|Withdrawal by Subject|0|||
160853976|NCT01777776|580853375|FG002|Overall Study|Withdrawal by Subject|0|||
160853977|NCT01777776|580853376|FG003|Overall Study|Withdrawal by Subject|1|||
160853978|NCT01420926|580853379|FG000|Overall Study|Adverse Event|6|||
160853979|NCT01420926|580853380|FG001|Overall Study|Adverse Event|4|||
160853980|NCT01420926|580853379|FG000|Overall Study|Death|18|||
160853981|NCT01420926|580853380|FG001|Overall Study|Death|17|||
160853982|NCT01420926|580853379|FG000|Overall Study|Withdrawal by Subject|11|||
160853983|NCT01420926|580853380|FG001|Overall Study|Withdrawal by Subject|17|||
160853984|NCT01420926|580853379|FG000|Overall Study|Non-protocol treatment|17|||
160853985|NCT01420926|580853380|FG001|Overall Study|Non-protocol treatment|20|||
160853986|NCT01420926|580853379|FG000|Overall Study|Physician Decision|8|||
160853987|NCT01420926|580853380|FG001|Overall Study|Physician Decision|5|||
160853988|NCT04564846|580854842|FG000|Overall Study|Withdrawal by Subject|2|||
160853989|NCT04564846|580854843|FG001|Overall Study|Withdrawal by Subject|1|||
160853990|NCT04564846|580854842|FG000|Overall Study|Physician Decision|0|||
160853991|NCT04564846|580854843|FG001|Overall Study|Physician Decision|1|||
160853992|NCT04564846|580854842|FG000|Overall Study|Lost to Follow-up|0|||
160853993|NCT04564846|580854843|FG001|Overall Study|Lost to Follow-up|1|||
160853994|NCT04564846|580854842|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
160853995|NCT04564846|580854843|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
160853996|NCT04564846|580854842|FG000|Overall Study|Subject non-compliance|1|||
160853997|NCT04564846|580854843|FG001|Overall Study|Subject non-compliance|0|||
160853998|NCT00179621|580854844|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
160907137|NCT01606007|581053971|FG001|Overall Study|Reason 'Other' in the protocol|1|||
160907138|NCT01606007|581053972|FG002|Overall Study|Reason 'Other' in the protocol|1|||
160907139|NCT01606007|581053970|FG000|Overall Study|Pregnancy|0|||
160907140|NCT01606007|581053971|FG001|Overall Study|Pregnancy|1|||
160907141|NCT01606007|581053972|FG002|Overall Study|Pregnancy|1|||
160907142|NCT01606007|581053970|FG000|Overall Study|Withdrawal by Subject|8|||
160907143|NCT01606007|581053971|FG001|Overall Study|Withdrawal by Subject|6|||
160907144|NCT01606007|581053972|FG002|Overall Study|Withdrawal by Subject|1|||
160853999|NCT00179621|580854845|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
160854000|NCT00179621|580854846|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
160854001|NCT00179621|580854847|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
160907145|NCT01606007|581053970|FG000|Overall Study|Adverse Event|0|||
160992566|NCT01670019|581361418|FG000|Overall Study|Adverse Event|3|||
160992567|NCT01670019|581361419|FG001|Overall Study|Adverse Event|0|||
160992568|NCT01670019|581361418|FG000|Overall Study|Withdrawal by Subject|6|||
160992569|NCT01670019|581361419|FG001|Overall Study|Withdrawal by Subject|0|||
160992570|NCT05487703|581361420|FG000|Overall Study|Other|19|||
160992571|NCT05487703|581361420|FG000|Overall Study|Participant not well|5|||
160992572|NCT05487703|581361420|FG000|Overall Study|Insurance Reasons|6|||
160992573|NCT05487703|581361420|FG000|Overall Study|Physician Decision|19|||
160992574|NCT05487703|581361420|FG000|Overall Study|Lack of Efficacy|60|||
160992575|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
160992576|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
160992577|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
160992578|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Death|3|||
160992579|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Death|0|||
160992580|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Death|0|||
160992581|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
160992582|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160992583|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160992584|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
160992585|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
160992586|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
160992587|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
160992588|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
160992589|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
160992590|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
160992591|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
160992592|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
160992593|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
160992594|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
160992595|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
160992596|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Other|1|||
160992597|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Other|0|||
160992598|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Other|0|||
160992599|NCT02403323|581361421|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
160992600|NCT02403323|581361422|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160992601|NCT02403323|581361423|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160992602|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160992603|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
160992604|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160992605|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
160992606|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
160992607|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
160992608|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
160992609|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
160992610|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
160992611|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160854002|NCT00179621|580854844|FG000|Double-Blind Period|Adverse Event|2|||
160854003|NCT00179621|580854845|FG001|Double-Blind Period|Adverse Event|7|||
160854004|NCT00179621|580854846|FG002|Double-Blind Period|Adverse Event|4|||
160854005|NCT00179621|580854847|FG003|Double-Blind Period|Adverse Event|0|||
160854006|NCT00179621|580854844|FG000|Double-Blind Period|Withdrawal by Subject|2|||
160854007|NCT00179621|580854845|FG001|Double-Blind Period|Withdrawal by Subject|1|||
160854008|NCT00179621|580854846|FG002|Double-Blind Period|Withdrawal by Subject|3|||
160854009|NCT00179621|580854847|FG003|Double-Blind Period|Withdrawal by Subject|0|||
160854010|NCT00179621|580854844|FG000|Double-Blind Period|Death|0|||
160854011|NCT00179621|580854845|FG001|Double-Blind Period|Death|1|||
160992612|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
160992613|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160992614|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
160992615|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
160992616|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
160992617|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
160992618|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
160992619|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
160992620|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
160992621|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
160992622|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
160992623|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
160992624|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
160992625|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
160854012|NCT00179621|580854846|FG002|Double-Blind Period|Death|2|||
160854013|NCT00179621|580854847|FG003|Double-Blind Period|Death|0|||
160854014|NCT00179621|580854844|FG000|Double-Blind Period|Protocol Violation|1|||
160854015|NCT00179621|580854845|FG001|Double-Blind Period|Protocol Violation|0|||
160854016|NCT00179621|580854846|FG002|Double-Blind Period|Protocol Violation|0|||
160854017|NCT00179621|580854847|FG003|Double-Blind Period|Protocol Violation|0|||
160854018|NCT00179621|580854844|FG000|Double-Blind Period|Other|0|||
160854019|NCT00179621|580854845|FG001|Double-Blind Period|Other|2|||
160854020|NCT00179621|580854846|FG002|Double-Blind Period|Other|2|||
160854021|NCT00179621|580854847|FG003|Double-Blind Period|Other|0|||
160854022|NCT00179621|580854844|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
160854023|NCT00179621|580854845|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
160907146|NCT01606007|581053971|FG001|Overall Study|Adverse Event|1|||
160907147|NCT01606007|581053972|FG002|Overall Study|Adverse Event|1|||
160907148|NCT01606007|581053970|FG000|Overall Study|discontinue study treatment|0|||
160907149|NCT01606007|581053971|FG001|Overall Study|discontinue study treatment|2|||
160907150|NCT01606007|581053972|FG002|Overall Study|discontinue study treatment|1|||
160907151|NCT01606007|581053970|FG000|Overall Study|Lost to Follow-up|6|||
160907152|NCT01606007|581053971|FG001|Overall Study|Lost to Follow-up|8|||
160907153|NCT01606007|581053972|FG002|Overall Study|Lost to Follow-up|5|||
160907154|NCT01606007|581053970|FG000|Overall Study|Poor/Non-compliance|1|||
160907155|NCT01606007|581053971|FG001|Overall Study|Poor/Non-compliance|0|||
160907156|NCT01606007|581053972|FG002|Overall Study|Poor/Non-compliance|0|||
160907157|NCT00851747|581053974|FG000|Overall Study|Physician Decision|6|||
160907158|NCT00851747|581053975|FG001|Overall Study|Physician Decision|6|||
160907159|NCT00851747|581053976|FG002|Overall Study|Physician Decision|6|||
160907160|NCT02499783|581053979|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
160907161|NCT02499783|581053980|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
160907162|NCT02499783|581053981|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
160907163|NCT02499783|581053979|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
160907164|NCT02499783|581053980|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
160907165|NCT02499783|581053981|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
160907166|NCT02499783|581053979|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
160907167|NCT02499783|581053980|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
160907168|NCT02499783|581053981|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
160907169|NCT02499783|581053979|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
160907170|NCT02499783|581053980|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
160907171|NCT02499783|581053981|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
160907172|NCT02499783|581053979|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
160907173|NCT02499783|581053980|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
160907174|NCT02499783|581053981|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
160907175|NCT02499783|581053979|FG000|DB Period: Weeks 0-8|Other|1|||
160907176|NCT02499783|581053980|FG001|DB Period: Weeks 0-8|Other|1|||
160907177|NCT02499783|581053981|FG002|DB Period: Weeks 0-8|Other|0|||
160907178|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
160907179|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
160907180|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
160907181|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
160907182|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
160907183|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
160907184|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
160907185|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
160907186|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
160907187|NCT02499783|581053979|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
160907188|NCT02499783|581053980|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
160907189|NCT02499783|581053981|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
160907190|NCT02228460|581053982|FG000|Overall Study|Adverse Event|1|||
160907191|NCT02228460|581053982|FG000|Overall Study|Lost to Follow-up|1|||
160907192|NCT01243892|581053983|FG000|Overall Study|Did not meet eligibility criteria|2|||
160907193|NCT01243892|581053984|FG001|Overall Study|Did not meet eligibility criteria|0|||
160907194|NCT00119106|581053985|FG000|Overall Study|HIV infected at baseline|179|||
160907195|NCT00119106|581053986|FG001|Overall Study|HIV infected at baseline|178|||
160907196|NCT01866293|581053987|FG000|Overall Study|Adverse Event|2|||
160854024|NCT00179621|580854846|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
160854025|NCT00179621|580854847|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
160854026|NCT00179621|580854844|FG000|Open-Label Period|Adverse Event|0|||
160854027|NCT00179621|580854845|FG001|Open-Label Period|Adverse Event|6|||
160854028|NCT00179621|580854846|FG002|Open-Label Period|Adverse Event|5|||
160907197|NCT01010061|581053988|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
160907198|NCT01010061|581053989|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
160907199|NCT01010061|581053988|FG000|Overall Study|Disease Progression|2|||
160907200|NCT01010061|581053989|FG001|Overall Study|Disease Progression|8|||
160907201|NCT01010061|581053988|FG000|Overall Study|Withdrew Consent|5|||
160907202|NCT01010061|581053989|FG001|Overall Study|Withdrew Consent|1|||
160907203|NCT01010061|581053988|FG000|Overall Study|Death|3|||
160992626|NCT02403323|581361421|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
160992627|NCT02403323|581361422|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
160992628|NCT02403323|581361423|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
160992629|NCT03885596|581361427|FG000|Overall Study|Withdrawal by Subject|2|||
160992630|NCT03885596|581361428|FG001|Overall Study|Withdrawal by Subject|1|||
160992631|NCT03885596|581361429|FG002|Overall Study|Withdrawal by Subject|0|||
160992632|NCT03885596|581361430|FG003|Overall Study|Withdrawal by Subject|0|||
160992633|NCT00746330|581361431|FG000|Period 1|Abnormal test procedure result|0|||
160992634|NCT00746330|581361432|FG001|Period 1|Abnormal test procedure result|0|||
160992635|NCT00746330|581361433|FG002|Period 1|Abnormal test procedure result|1|||
160992636|NCT00746330|581361434|FG003|Period 1|Abnormal test procedure result|0|||
160992637|NCT01076335|581361435|FG000|Overall Study|Withdrawal by Subject|3|||
160992638|NCT01076335|581361435|FG000|Overall Study|Withdrawal without treatment|1|||
160992639|NCT00517933|581361437|FG000|Period 1|Death|2|||
160992640|NCT00517933|581361438|FG001|Period 1|Death|1|||
160992641|NCT00517933|581361437|FG000|Period 1|Adverse Event|4|||
160992642|NCT00517933|581361438|FG001|Period 1|Adverse Event|4|||
160992643|NCT00517933|581361437|FG000|Period 1|Lost to Follow-up|2|||
160992644|NCT00517933|581361438|FG001|Period 1|Lost to Follow-up|0|||
160992645|NCT00517933|581361437|FG000|Period 1|Underwent lung transplant|0|||
160992646|NCT00517933|581361438|FG001|Period 1|Underwent lung transplant|1|||
160992647|NCT00517933|581361437|FG000|Period 2|Death|2|||
160992648|NCT00517933|581361438|FG001|Period 2|Death|4|||
160992649|NCT00517933|581361437|FG000|Period 2|Adverse Event|2|||
160992650|NCT00517933|581361438|FG001|Period 2|Adverse Event|4|||
160992651|NCT00517933|581361437|FG000|Period 2|Physician Decision|1|||
160992652|NCT00517933|581361438|FG001|Period 2|Physician Decision|0|||
160992653|NCT00517933|581361437|FG000|Period 2|Withdrawal by Subject|1|||
160992654|NCT00517933|581361438|FG001|Period 2|Withdrawal by Subject|3|||
160992655|NCT00517933|581361437|FG000|Period 2|Underwent lung transplant|0|||
160992656|NCT00517933|581361438|FG001|Period 2|Underwent lung transplant|2|||
160992657|NCT00235495|581361439|FG000|Overall Study|Death|52|||
160992658|NCT00235495|581361440|FG001|Overall Study|Death|42|||
160992659|NCT00235495|581361439|FG000|Overall Study|Withdrawal by Subject|5|||
160992660|NCT00235495|581361440|FG001|Overall Study|Withdrawal by Subject|3|||
160992661|NCT00235495|581361439|FG000|Overall Study|Lost to Follow-up|11|||
160992662|NCT00235495|581361440|FG001|Overall Study|Lost to Follow-up|13|||
160992663|NCT00235495|581361439|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
160992664|NCT00235495|581361440|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
160992665|NCT01268566|581361445|FG000|Overall Study|Lost to Follow-up|1|||
160992666|NCT01268566|581361445|FG000|Overall Study|Withdrawal by Subject|12|||
160992667|NCT01268566|581361445|FG000|Overall Study|Death|30|||
160992668|NCT05460663|581361452|FG000|Overall Study|Withdrawal by Subject|2|||
160992669|NCT05460663|581361453|FG001|Overall Study|Withdrawal by Subject|5|||
160992670|NCT03068468|581363110|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
160992671|NCT03068468|581363111|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
160992672|NCT03068468|581363112|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
160992673|NCT03068468|581363113|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
160992674|NCT03068468|581363110|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
160992675|NCT03068468|581363111|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
160992676|NCT03068468|581363112|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
160992677|NCT03068468|581363113|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
160992678|NCT03068468|581363110|FG000|Placebo-Controlled Period|Adverse Event|16|||
160992679|NCT03068468|581363111|FG001|Placebo-Controlled Period|Adverse Event|21|||
160992680|NCT03068468|581363112|FG002|Placebo-Controlled Period|Adverse Event|0|||
160992681|NCT03068468|581363113|FG003|Placebo-Controlled Period|Adverse Event|0|||
160992682|NCT03068468|581363110|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
160992683|NCT03068468|581363111|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
160992684|NCT03068468|581363112|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
160992685|NCT03068468|581363113|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
160992686|NCT03068468|581363110|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
160992687|NCT03068468|581363111|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
160992688|NCT03068468|581363112|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160992689|NCT03068468|581363113|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
160992690|NCT03068468|581363110|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
160992691|NCT03068468|581363111|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
161141268|NCT05139030|581901030|FG001|Overall Study|Withdrawal by Subject|3|||
161141269|NCT05139030|581901029|FG000|Overall Study|Adverse Event|0|||
160992692|NCT03068468|581363112|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
160992693|NCT03068468|581363113|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
160992694|NCT03068468|581363110|FG000|Placebo-Controlled Period|Death|0|||
160992695|NCT03068468|581363111|FG001|Placebo-Controlled Period|Death|1|||
160992696|NCT03068468|581363112|FG002|Placebo-Controlled Period|Death|0|||
160992697|NCT03068468|581363113|FG003|Placebo-Controlled Period|Death|0|||
161141270|NCT05139030|581901030|FG001|Overall Study|Adverse Event|1|||
160907204|NCT01010061|581053989|FG001|Overall Study|Death|6|||
160907205|NCT01010061|581053988|FG000|Overall Study|Administrative/Other|0|||
160907206|NCT01010061|581053989|FG001|Overall Study|Administrative/Other|1|||
160907207|NCT01010061|581053988|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
160907208|NCT01010061|581053989|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
160907209|NCT01010061|581053988|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160854029|NCT00179621|580854847|FG003|Open-Label Period|Adverse Event|6|||
160854030|NCT00179621|580854844|FG000|Open-Label Period|Withdrawal by Subject|0|||
160854031|NCT00179621|580854845|FG001|Open-Label Period|Withdrawal by Subject|2|||
160854032|NCT00179621|580854846|FG002|Open-Label Period|Withdrawal by Subject|2|||
160854033|NCT00179621|580854847|FG003|Open-Label Period|Withdrawal by Subject|2|||
160854034|NCT00179621|580854844|FG000|Open-Label Period|Death|0|||
160854035|NCT00179621|580854845|FG001|Open-Label Period|Death|0|||
160854036|NCT00179621|580854846|FG002|Open-Label Period|Death|1|||
160854037|NCT00179621|580854847|FG003|Open-Label Period|Death|2|||
160854038|NCT00179621|580854844|FG000|Open-Label Period|Other|0|||
160854039|NCT00179621|580854845|FG001|Open-Label Period|Other|1|||
160854040|NCT00179621|580854846|FG002|Open-Label Period|Other|1|||
160854041|NCT00179621|580854847|FG003|Open-Label Period|Other|2|||
160854042|NCT00865345|580854849|FG000|Overall Study|Withdrawal by Subject|2|||
160854043|NCT03737123|580854850|FG000|Study Treatment|Adverse Event|2|||
160854044|NCT03737123|580854851|FG001|Study Treatment|Adverse Event|0|||
160854045|NCT03737123|580854850|FG000|Study Treatment|Disease Progression|2|||
160854046|NCT03737123|580854851|FG001|Study Treatment|Disease Progression|0|||
160854047|NCT03737123|580854850|FG000|Study Treatment|Withdrawal by Subject|2|||
160854048|NCT03737123|580854851|FG001|Study Treatment|Withdrawal by Subject|0|||
160854049|NCT03737123|580854850|FG000|Follow up|Death|1|||
160854050|NCT03737123|580854851|FG001|Follow up|Death|0|||
160854051|NCT03737123|580854850|FG000|Follow up|Withdrawal by Subject|1|||
160854052|NCT03737123|580854851|FG001|Follow up|Withdrawal by Subject|0|||
160854053|NCT03737123|580854850|FG000|Follow up|Termination of study|4|||
160854054|NCT03737123|580854851|FG001|Follow up|Termination of study|0|||
160854055|NCT00383552|580854852|FG000|Overall Study|Adverse Event|7|||
160854056|NCT00383552|580854853|FG001|Overall Study|Adverse Event|6|||
160854057|NCT00383552|580854854|FG002|Overall Study|Adverse Event|9|||
160854058|NCT00383552|580854855|FG003|Overall Study|Adverse Event|6|||
160854059|NCT00383552|580854852|FG000|Overall Study|Lack of Efficacy|4|||
160854060|NCT00383552|580854853|FG001|Overall Study|Lack of Efficacy|13|||
160854061|NCT00383552|580854854|FG002|Overall Study|Lack of Efficacy|29|||
160854062|NCT00383552|580854855|FG003|Overall Study|Lack of Efficacy|42|||
160854063|NCT00383552|580854852|FG000|Overall Study|Lost to Follow-up|0|||
160854064|NCT00383552|580854853|FG001|Overall Study|Lost to Follow-up|1|||
160854065|NCT00383552|580854854|FG002|Overall Study|Lost to Follow-up|5|||
160854066|NCT00383552|580854855|FG003|Overall Study|Lost to Follow-up|1|||
160854067|NCT00383552|580854852|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
160854068|NCT00383552|580854853|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
160854069|NCT00383552|580854854|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
160854070|NCT00383552|580854855|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
160854071|NCT00383552|580854852|FG000|Overall Study|Did not wish to continue (related)|1|||
160854072|NCT00383552|580854853|FG001|Overall Study|Did not wish to continue (related)|0|||
160854073|NCT00383552|580854854|FG002|Overall Study|Did not wish to continue (related)|2|||
160854074|NCT00383552|580854855|FG003|Overall Study|Did not wish to continue (related)|3|||
160854075|NCT00383552|580854852|FG000|Overall Study|Noncompliance with the protocol|11|||
160854076|NCT00383552|580854853|FG001|Overall Study|Noncompliance with the protocol|6|||
160854077|NCT00383552|580854854|FG002|Overall Study|Noncompliance with the protocol|8|||
160854078|NCT00383552|580854855|FG003|Overall Study|Noncompliance with the protocol|10|||
160854079|NCT00383552|580854852|FG000|Overall Study|Did not meet protocol eligibility|8|||
160854080|NCT00383552|580854853|FG001|Overall Study|Did not meet protocol eligibility|6|||
160854081|NCT00383552|580854854|FG002|Overall Study|Did not meet protocol eligibility|2|||
160854082|NCT00383552|580854855|FG003|Overall Study|Did not meet protocol eligibility|3|||
160854083|NCT00383552|580854852|FG000|Overall Study|Administrative|1|||
160854084|NCT00383552|580854853|FG001|Overall Study|Administrative|0|||
161337420|NCT00251758|582625928|FG000|Overall Study|Adverse Event|7|||
160854085|NCT00383552|580854854|FG002|Overall Study|Administrative|1|||
160854086|NCT00383552|580854855|FG003|Overall Study|Administrative|1|||
160854087|NCT00966654|580854856|FG000|Overall Study|Study was terminated,PI left institution|12|||
160854088|NCT00762359|580854859|FG000|Overall Study|Adverse Event|20|||
160854089|NCT00762359|580854860|FG001|Overall Study|Adverse Event|23|||
160854090|NCT00762359|580854859|FG000|Overall Study|Protocol Violation|21|||
160907210|NCT01010061|581053989|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160854091|NCT00762359|580854860|FG001|Overall Study|Protocol Violation|13|||
160854092|NCT00762359|580854859|FG000|Overall Study|Withdrawal by Subject|13|||
160854093|NCT00762359|580854860|FG001|Overall Study|Withdrawal by Subject|10|||
160854094|NCT00762359|580854859|FG000|Overall Study|Lack of Efficacy|0|||
160854095|NCT00762359|580854860|FG001|Overall Study|Lack of Efficacy|4|||
160854096|NCT00762359|580854859|FG000|Overall Study|Institution closed|2|||
160907211|NCT01010061|581053988|FG000|Overall Study|Violation of Selection Criteria|0|||
160854097|NCT00762359|580854860|FG001|Overall Study|Institution closed|3|||
160854098|NCT00762359|580854859|FG000|Overall Study|Physician Decision|2|||
160854099|NCT00762359|580854860|FG001|Overall Study|Physician Decision|3|||
160854100|NCT00762359|580854859|FG000|Overall Study|Removal|0|||
160854101|NCT00762359|580854860|FG001|Overall Study|Removal|1|||
160854102|NCT00762359|580854859|FG000|Overall Study|Withdrew consent|1|||
160854103|NCT00762359|580854860|FG001|Overall Study|Withdrew consent|0|||
160854104|NCT00882440|580854861|FG000|Overall Study|Adverse Event|2|||
160854105|NCT00882440|580854862|FG001|Overall Study|Adverse Event|2|||
160854106|NCT00882440|580854863|FG002|Overall Study|Adverse Event|2|||
160854107|NCT00882440|580854864|FG003|Overall Study|Adverse Event|1|||
160854108|NCT00882440|580854865|FG004|Overall Study|Adverse Event|1|||
160854109|NCT00882440|580854866|FG005|Overall Study|Adverse Event|4|||
160854110|NCT00882440|580854867|FG006|Overall Study|Adverse Event|2|||
160854111|NCT00882440|580854861|FG000|Overall Study|Lack of Efficacy|3|||
160854112|NCT00882440|580854862|FG001|Overall Study|Lack of Efficacy|5|||
160854113|NCT00882440|580854863|FG002|Overall Study|Lack of Efficacy|2|||
160854114|NCT00882440|580854864|FG003|Overall Study|Lack of Efficacy|0|||
160854115|NCT00882440|580854865|FG004|Overall Study|Lack of Efficacy|0|||
160854116|NCT00882440|580854866|FG005|Overall Study|Lack of Efficacy|3|||
160854117|NCT00882440|580854867|FG006|Overall Study|Lack of Efficacy|0|||
160854118|NCT00882440|580854861|FG000|Overall Study|Lost to Follow-up|2|||
160854119|NCT00882440|580854862|FG001|Overall Study|Lost to Follow-up|0|||
160854120|NCT00882440|580854863|FG002|Overall Study|Lost to Follow-up|1|||
160854121|NCT00882440|580854864|FG003|Overall Study|Lost to Follow-up|1|||
160854122|NCT00882440|580854865|FG004|Overall Study|Lost to Follow-up|1|||
160854123|NCT00882440|580854866|FG005|Overall Study|Lost to Follow-up|0|||
161141271|NCT05139030|581901029|FG000|Overall Study|Failure to meet continuation criteria|0|||
161337421|NCT00251758|582625929|FG001|Overall Study|Adverse Event|9|||
160854124|NCT00882440|580854867|FG006|Overall Study|Lost to Follow-up|1|||
160854125|NCT00882440|580854861|FG000|Overall Study|Protocol Violation|0|||
160854126|NCT00882440|580854862|FG001|Overall Study|Protocol Violation|0|||
160854127|NCT00882440|580854863|FG002|Overall Study|Protocol Violation|1|||
160854128|NCT00882440|580854864|FG003|Overall Study|Protocol Violation|1|||
160854129|NCT00882440|580854865|FG004|Overall Study|Protocol Violation|1|||
160854130|NCT00882440|580854866|FG005|Overall Study|Protocol Violation|0|||
160854131|NCT00882440|580854867|FG006|Overall Study|Protocol Violation|0|||
160854132|NCT00882440|580854861|FG000|Overall Study|Withdrawal by Subject|2|||
160854133|NCT00882440|580854862|FG001|Overall Study|Withdrawal by Subject|1|||
160854134|NCT00882440|580854863|FG002|Overall Study|Withdrawal by Subject|1|||
160854135|NCT00882440|580854864|FG003|Overall Study|Withdrawal by Subject|0|||
160854136|NCT00882440|580854865|FG004|Overall Study|Withdrawal by Subject|6|||
160854137|NCT00882440|580854866|FG005|Overall Study|Withdrawal by Subject|0|||
160854138|NCT00882440|580854867|FG006|Overall Study|Withdrawal by Subject|1|||
160854139|NCT00882440|580854861|FG000|Overall Study|Patient Uncooperative|2|||
160854140|NCT00882440|580854862|FG001|Overall Study|Patient Uncooperative|0|||
160854141|NCT00882440|580854863|FG002|Overall Study|Patient Uncooperative|0|||
160854142|NCT00882440|580854864|FG003|Overall Study|Patient Uncooperative|0|||
160854143|NCT00882440|580854865|FG004|Overall Study|Patient Uncooperative|1|||
160854144|NCT00882440|580854866|FG005|Overall Study|Patient Uncooperative|0|||
160854145|NCT00882440|580854867|FG006|Overall Study|Patient Uncooperative|0|||
160854146|NCT05482308|580854871|FG000|Overall Study|Withdrawal by Subject|1|||
160854147|NCT05482308|580854872|FG001|Overall Study|Withdrawal by Subject|0|||
160854148|NCT05482308|580854871|FG000|Overall Study|No longer meets eligibility criteria|0|||
160854149|NCT05482308|580854872|FG001|Overall Study|No longer meets eligibility criteria|1|||
160854150|NCT03016312|580854873|FG000|Overall Study|discontinued before the treatment started|0|||
160854151|NCT03016312|580854874|FG001|Overall Study|discontinued before the treatment started|1|||
160854152|NCT03016312|580854873|FG000|Overall Study|Withdrawal by Subject|37|||
160854153|NCT03016312|580854874|FG001|Overall Study|Withdrawal by Subject|44|||
160854154|NCT03016312|580854873|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
160854155|NCT03016312|580854874|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
160854156|NCT03016312|580854873|FG000|Overall Study|Physician Decision|1|||
160854157|NCT03016312|580854874|FG001|Overall Study|Physician Decision|3|||
160854158|NCT03016312|580854873|FG000|Overall Study|Lost to Follow-up|12|||
160854159|NCT03016312|580854874|FG001|Overall Study|Lost to Follow-up|12|||
160854160|NCT03016312|580854873|FG000|Overall Study|Death|210|||
160854161|NCT03016312|580854874|FG001|Overall Study|Death|184|||
160854162|NCT03016312|580854873|FG000|Overall Study|loss to contact|1|||
160854163|NCT03016312|580854874|FG001|Overall Study|loss to contact|0|||
160854164|NCT03016312|580854873|FG000|Overall Study|started a new cancer therapy|1|||
160854165|NCT03016312|580854874|FG001|Overall Study|started a new cancer therapy|0|||
160854166|NCT01631435|580854877|FG000|Overall Study|Adverse Event|2|||
160854167|NCT01631435|580854877|FG000|Overall Study|Withdrawal by Subject|2|||
160854168|NCT01631435|580854877|FG000|Overall Study|incomplete study procedure|5|||
160854169|NCT01421017|580854878|FG000|Overall Study|Withdrawal by Subject|2|||
160854170|NCT01421017|580854879|FG001|Overall Study|Withdrawal by Subject|0|||
160854171|NCT01421017|580854880|FG002|Overall Study|Withdrawal by Subject|0|||
161337422|NCT00251758|582625930|FG002|Overall Study|Adverse Event|11|||
160992698|NCT03068468|581363110|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
160992699|NCT03068468|581363111|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
160992700|NCT03068468|581363112|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
160992701|NCT03068468|581363113|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
160992702|NCT03068468|581363110|FG000|Open-Label Extension Period|Adverse Event|0|||
160992703|NCT03068468|581363111|FG001|Open-Label Extension Period|Adverse Event|0|||
160992704|NCT03068468|581363112|FG002|Open-Label Extension Period|Adverse Event|13|||
160992705|NCT03068468|581363113|FG003|Open-Label Extension Period|Adverse Event|17|||
160992706|NCT03068468|581363110|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
160992707|NCT03068468|581363111|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
160992708|NCT03068468|581363112|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
160992709|NCT03068468|581363113|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
160992710|NCT03068468|581363110|FG000|Open-Label Extension Period|Death|0|||
160992711|NCT03068468|581363111|FG001|Open-Label Extension Period|Death|0|||
160992712|NCT03068468|581363112|FG002|Open-Label Extension Period|Death|0|||
160992713|NCT03068468|581363113|FG003|Open-Label Extension Period|Death|1|||
160992714|NCT03068468|581363110|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
160992715|NCT03068468|581363111|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
160992716|NCT03068468|581363112|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
160992717|NCT03068468|581363113|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
160854172|NCT01421017|580854878|FG000|Overall Study|POD|0|||
160854173|NCT01421017|580854879|FG001|Overall Study|POD|6|||
160854174|NCT01421017|580854880|FG002|Overall Study|POD|3|||
160854175|NCT00416624|580854883|FG000|Overall Study|Withdrawal by Subject|1|||
160854176|NCT00416624|580854884|FG001|Overall Study|Withdrawal by Subject|6|||
160854177|NCT00416624|580854885|FG002|Overall Study|Withdrawal by Subject|4|||
160854178|NCT00416624|580854886|FG003|Overall Study|Withdrawal by Subject|9|||
160854179|NCT00416624|580854883|FG000|Overall Study|Death|4|||
160854180|NCT00416624|580854884|FG001|Overall Study|Death|7|||
160854181|NCT00416624|580854885|FG002|Overall Study|Death|7|||
160854182|NCT00416624|580854886|FG003|Overall Study|Death|1|||
160854183|NCT00416624|580854883|FG000|Overall Study|Adverse Event|8|||
160854184|NCT00416624|580854884|FG001|Overall Study|Adverse Event|3|||
160854185|NCT00416624|580854885|FG002|Overall Study|Adverse Event|2|||
160854186|NCT00416624|580854886|FG003|Overall Study|Adverse Event|2|||
160854187|NCT00416624|580854883|FG000|Overall Study|Other|8|||
160854188|NCT00416624|580854884|FG001|Overall Study|Other|11|||
160907212|NCT01010061|581053989|FG001|Overall Study|Violation of Selection Criteria|1|||
160907213|NCT01010061|581053988|FG000|Overall Study|Did Not Receive Treatment|2|||
160907214|NCT01010061|581053989|FG001|Overall Study|Did Not Receive Treatment|2|||
160907215|NCT03066804|581053990|FG000|Overall Study|Physician Decision|0|||
160907216|NCT03066804|581053991|FG001|Overall Study|Physician Decision|4|||
160907217|NCT03066804|581053990|FG000|Overall Study|Death|23|||
160907218|NCT03066804|581053991|FG001|Overall Study|Death|17|||
160907219|NCT03066804|581053990|FG000|Overall Study|Withdrawal by Subject|19|||
160907220|NCT03066804|581053991|FG001|Overall Study|Withdrawal by Subject|25|||
160907221|NCT03066804|581053990|FG000|Overall Study|Lost to Follow-up|2|||
160907222|NCT03066804|581053991|FG001|Overall Study|Lost to Follow-up|0|||
160907223|NCT03066804|581053990|FG000|Overall Study|Adverse Event|2|||
160907224|NCT03066804|581053991|FG001|Overall Study|Adverse Event|3|||
160907225|NCT03066804|581053990|FG000|Overall Study|Technical problems|5|||
160907226|NCT03066804|581053991|FG001|Overall Study|Technical problems|1|||
160907227|NCT03470441|581053996|FG000|Overall Study|Death|0|||
160907228|NCT03470441|581053997|FG001|Overall Study|Death|1|||
160907229|NCT03470441|581053998|FG002|Overall Study|Death|1|||
160907230|NCT03470441|581053999|FG003|Overall Study|Death|0|||
160907231|NCT03470441|581053996|FG000|Overall Study|Adverse Event|0|||
160907232|NCT03470441|581053997|FG001|Overall Study|Adverse Event|0|||
160907233|NCT03470441|581053998|FG002|Overall Study|Adverse Event|0|||
160907234|NCT03470441|581053999|FG003|Overall Study|Adverse Event|1|||
160907235|NCT03470441|581053996|FG000|Overall Study|Withdrawal by Subject|1|||
160907236|NCT03470441|581053997|FG001|Overall Study|Withdrawal by Subject|4|||
160907237|NCT03470441|581053998|FG002|Overall Study|Withdrawal by Subject|1|||
160907238|NCT03470441|581053999|FG003|Overall Study|Withdrawal by Subject|3|||
161337423|NCT00251758|582625928|FG000|Overall Study|Lost to Follow-up|4|||
160854189|NCT00416624|580854885|FG002|Overall Study|Other|5|||
160854190|NCT00416624|580854886|FG003|Overall Study|Other|5|||
160854191|NCT00416624|580854883|FG000|Overall Study|Cancel|1|||
160854192|NCT00416624|580854884|FG001|Overall Study|Cancel|0|||
160854193|NCT00416624|580854885|FG002|Overall Study|Cancel|0|||
160854194|NCT00416624|580854886|FG003|Overall Study|Cancel|0|||
160854195|NCT01458639|580854893|FG000|Overall Study|Physician Decision|4|||
160854196|NCT01458639|580854893|FG000|Overall Study|Equipment issue|1|||
160907239|NCT03982368|581054000|FG000|Overall Study|Adverse Event|6|||
160907240|NCT03982368|581054001|FG001|Overall Study|Adverse Event|4|||
160907241|NCT03982368|581054002|FG002|Overall Study|Adverse Event|3|||
160907242|NCT03982368|581054000|FG000|Overall Study|Lost to Follow-up|2|||
160907243|NCT03982368|581054001|FG001|Overall Study|Lost to Follow-up|1|||
160907244|NCT03982368|581054002|FG002|Overall Study|Lost to Follow-up|0|||
160907245|NCT03982368|581054000|FG000|Overall Study|Withdrawal by Subject|1|||
161337424|NCT00251758|582625929|FG001|Overall Study|Lost to Follow-up|2|||
161337425|NCT00251758|582625930|FG002|Overall Study|Lost to Follow-up|5|||
160907246|NCT03982368|581054001|FG001|Overall Study|Withdrawal by Subject|2|||
160907247|NCT03982368|581054002|FG002|Overall Study|Withdrawal by Subject|0|||
160907248|NCT03982368|581054000|FG000|Overall Study|unknow|4|||
160907249|NCT03982368|581054001|FG001|Overall Study|unknow|0|||
160907250|NCT03982368|581054002|FG002|Overall Study|unknow|2|||
160907251|NCT00518284|581054003|FG000|Overall Study|Adverse Event|0|||
160907252|NCT00518284|581054004|FG001|Overall Study|Adverse Event|1|||
160907253|NCT00518284|581054005|FG002|Overall Study|Adverse Event|0|||
160907254|NCT00518284|581054006|FG003|Overall Study|Adverse Event|0|||
160907255|NCT00518284|581054003|FG000|Overall Study|Study Termination|0|||
160907256|NCT00518284|581054004|FG001|Overall Study|Study Termination|2|||
160907257|NCT00518284|581054005|FG002|Overall Study|Study Termination|1|||
160907258|NCT00518284|581054006|FG003|Overall Study|Study Termination|2|||
160907259|NCT02571777|581054008|FG000|Overall Study|Subject/guardian decision|34|||
160907260|NCT02571777|581054009|FG001|Overall Study|Subject/guardian decision|26|||
160907261|NCT02571777|581054010|FG002|Overall Study|Subject/guardian decision|26|||
160907262|NCT02571777|581054011|FG003|Overall Study|Subject/guardian decision|25|||
160907263|NCT02571777|581054012|FG004|Overall Study|Subject/guardian decision|27|||
160907264|NCT02571777|581054008|FG000|Overall Study|Protocol Deviation|2|||
160907265|NCT02571777|581054009|FG001|Overall Study|Protocol Deviation|3|||
160907266|NCT02571777|581054010|FG002|Overall Study|Protocol Deviation|4|||
160907267|NCT02571777|581054011|FG003|Overall Study|Protocol Deviation|8|||
160907268|NCT02571777|581054012|FG004|Overall Study|Protocol Deviation|4|||
160907269|NCT02571777|581054008|FG000|Overall Study|Death|1|||
160907270|NCT02571777|581054009|FG001|Overall Study|Death|1|||
160907271|NCT02571777|581054010|FG002|Overall Study|Death|4|||
160907272|NCT02571777|581054011|FG003|Overall Study|Death|0|||
160907273|NCT02571777|581054012|FG004|Overall Study|Death|0|||
160907274|NCT02571777|581054008|FG000|Overall Study|Lost to Follow-up|1|||
160907275|NCT02571777|581054009|FG001|Overall Study|Lost to Follow-up|1|||
160907276|NCT02571777|581054010|FG002|Overall Study|Lost to Follow-up|2|||
160907277|NCT02571777|581054011|FG003|Overall Study|Lost to Follow-up|0|||
160907278|NCT02571777|581054012|FG004|Overall Study|Lost to Follow-up|1|||
160907279|NCT02571777|581054008|FG000|Overall Study|Physician Decision|1|||
160907280|NCT02571777|581054009|FG001|Overall Study|Physician Decision|7|||
160907281|NCT02571777|581054010|FG002|Overall Study|Physician Decision|5|||
160907282|NCT02571777|581054011|FG003|Overall Study|Physician Decision|2|||
160907283|NCT02571777|581054012|FG004|Overall Study|Physician Decision|4|||
160907284|NCT02571777|581054008|FG000|Overall Study|Pregnancy|0|||
160907285|NCT02571777|581054009|FG001|Overall Study|Pregnancy|0|||
160907286|NCT02571777|581054010|FG002|Overall Study|Pregnancy|0|||
160907287|NCT02571777|581054011|FG003|Overall Study|Pregnancy|2|||
160907288|NCT02571777|581054012|FG004|Overall Study|Pregnancy|0|||
160907289|NCT03706079|581054013|FG000|Predecessor Study|Death|0|||
160907290|NCT03706079|581054014|FG001|Predecessor Study|Death|2|||
160907291|NCT03706079|581054015|FG002|Predecessor Study|Death|0|||
160907292|NCT03706079|581054016|FG003|Predecessor Study|Death|1|||
160907293|NCT03706079|581054017|FG004|Predecessor Study|Death|0|||
160907294|NCT03706079|581054018|FG005|Predecessor Study|Death|0|||
160907295|NCT03706079|581054013|FG000|Predecessor Study|Lost to Follow-up|5|||
160907296|NCT03706079|581054014|FG001|Predecessor Study|Lost to Follow-up|2|||
160907297|NCT03706079|581054015|FG002|Predecessor Study|Lost to Follow-up|0|||
160907298|NCT03706079|581054016|FG003|Predecessor Study|Lost to Follow-up|0|||
160907299|NCT03706079|581054017|FG004|Predecessor Study|Lost to Follow-up|1|||
160907300|NCT03706079|581054018|FG005|Predecessor Study|Lost to Follow-up|0|||
160907301|NCT03706079|581054013|FG000|Predecessor Study|Withdrawal by Subject|8|||
160907302|NCT03706079|581054014|FG001|Predecessor Study|Withdrawal by Subject|15|||
160907303|NCT03706079|581054015|FG002|Predecessor Study|Withdrawal by Subject|0|||
160907304|NCT03706079|581054016|FG003|Predecessor Study|Withdrawal by Subject|5|||
160907305|NCT03706079|581054017|FG004|Predecessor Study|Withdrawal by Subject|2|||
160907306|NCT03706079|581054018|FG005|Predecessor Study|Withdrawal by Subject|0|||
160907307|NCT03706079|581054013|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
160907308|NCT03706079|581054014|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
160907309|NCT03706079|581054015|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907310|NCT03706079|581054016|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907311|NCT03706079|581054017|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907312|NCT03706079|581054018|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
160907313|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907314|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907315|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907316|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
161337426|NCT00251758|582625928|FG000|Overall Study|Withdrawal by Subject|13|||
160992718|NCT03068468|581363110|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
160992719|NCT03068468|581363111|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
160992720|NCT03068468|581363112|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
160992721|NCT03068468|581363113|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
160992722|NCT03068468|581363110|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
160992723|NCT03068468|581363111|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
160854197|NCT01458639|580854893|FG000|Overall Study|Inability to obtain subject blood sample|1|||
160854198|NCT04245111|580854894|FG000|Overall Study|Lost to Follow-up|5|||
160854199|NCT04245111|580854895|FG001|Overall Study|Lost to Follow-up|1|||
160854200|NCT04245111|580854896|FG002|Overall Study|Lost to Follow-up|1|||
160854201|NCT02792231|580854897|FG000|Overall Study|Patient/guardian decision|32|||
160854202|NCT02792231|580854898|FG001|Overall Study|Patient/guardian decision|42|||
160854203|NCT02792231|580854897|FG000|Overall Study|Adverse Event|15|||
160854204|NCT02792231|580854898|FG001|Overall Study|Adverse Event|11|||
160854205|NCT02792231|580854897|FG000|Overall Study|Physician Decision|14|||
160854206|NCT02792231|580854898|FG001|Overall Study|Physician Decision|12|||
160854207|NCT02792231|580854897|FG000|Overall Study|Lack of Efficacy|7|||
160854208|NCT02792231|580854898|FG001|Overall Study|Lack of Efficacy|9|||
160854209|NCT02792231|580854897|FG000|Overall Study|Lost to Follow-up|9|||
160854210|NCT02792231|580854898|FG001|Overall Study|Lost to Follow-up|5|||
160854211|NCT02792231|580854897|FG000|Overall Study|Pregnancy|1|||
160854212|NCT02792231|580854898|FG001|Overall Study|Pregnancy|3|||
160854213|NCT02792231|580854897|FG000|Overall Study|Non-compliance with study treatment|2|||
160854214|NCT02792231|580854898|FG001|Overall Study|Non-compliance with study treatment|1|||
160854215|NCT02792231|580854897|FG000|Overall Study|Protocol deviation|2|||
160854216|NCT02792231|580854898|FG001|Overall Study|Protocol deviation|0|||
160854217|NCT02792231|580854897|FG000|Overall Study|Technical problems|0|||
160854218|NCT02792231|580854898|FG001|Overall Study|Technical problems|1|||
160854219|NCT03309878|580854899|FG000|Overall Study|Adverse Event|1|||
160854220|NCT03309878|580854900|FG001|Overall Study|Adverse Event|0|||
160854221|NCT03309878|580854901|FG002|Overall Study|Adverse Event|0|||
160854222|NCT03309878|580854902|FG003|Overall Study|Adverse Event|0|||
160854223|NCT03309878|580854899|FG000|Overall Study|Did not maintain eligibility|2|||
160854224|NCT03309878|580854900|FG001|Overall Study|Did not maintain eligibility|1|||
160854225|NCT03309878|580854901|FG002|Overall Study|Did not maintain eligibility|0|||
160854226|NCT03309878|580854902|FG003|Overall Study|Did not maintain eligibility|0|||
160854227|NCT03309878|580854899|FG000|Overall Study|Withdrawal by Subject|0|||
160854228|NCT03309878|580854900|FG001|Overall Study|Withdrawal by Subject|1|||
160854229|NCT03309878|580854901|FG002|Overall Study|Withdrawal by Subject|0|||
160854230|NCT03309878|580854902|FG003|Overall Study|Withdrawal by Subject|0|||
160854231|NCT01755234|580854903|FG000|Overall Study|Lost to Follow-up|11|||
160854232|NCT01755234|580854904|FG001|Overall Study|Lost to Follow-up|6|||
160854233|NCT01755234|580854903|FG000|Overall Study|Change in surgical case|2|||
160854234|NCT01755234|580854904|FG001|Overall Study|Change in surgical case|1|||
160854235|NCT01755234|580854903|FG000|Overall Study|case cancelled|1|||
160854236|NCT01755234|580854904|FG001|Overall Study|case cancelled|0|||
160854237|NCT01755234|580854903|FG000|Overall Study|Withdrawal by Subject|0|||
160854238|NCT01755234|580854904|FG001|Overall Study|Withdrawal by Subject|1|||
160854239|NCT01755234|580854903|FG000|Overall Study|unblinded|1|||
160854240|NCT01755234|580854904|FG001|Overall Study|unblinded|0|||
160854241|NCT01884077|580854905|FG000|Overall Study|screen fail|0|||
160854242|NCT01884077|580854906|FG001|Overall Study|screen fail|2|||
160854243|NCT01884077|580854905|FG000|Overall Study|canceled surgery|2|||
160854244|NCT01884077|580854906|FG001|Overall Study|canceled surgery|0|||
160854245|NCT01884077|580854905|FG000|Overall Study|Lost to Follow-up|0|||
160854246|NCT01884077|580854906|FG001|Overall Study|Lost to Follow-up|4|||
160854247|NCT01884077|580854905|FG000|Overall Study|study closed|6|||
160854248|NCT01884077|580854906|FG001|Overall Study|study closed|4|||
160854249|NCT03812380|580854907|FG000|Overall Study|Protocol Violation|3|||
160854250|NCT03812380|580854908|FG001|Overall Study|Protocol Violation|3|||
160854251|NCT03812380|580854907|FG000|Overall Study|Withdrawal by Subject|5|||
160992724|NCT03068468|581363112|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
160854252|NCT03812380|580854908|FG001|Overall Study|Withdrawal by Subject|4|||
160992725|NCT03068468|581363113|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
160854253|NCT03812380|580854907|FG000|Overall Study|Early termination of study|14|||
160854254|NCT03812380|580854908|FG001|Overall Study|Early termination of study|14|||
160854255|NCT02836652|580854909|FG000|Overall Study|Death|3|||
160854256|NCT02836652|580854910|FG001|Overall Study|Death|3|||
160854257|NCT02836652|580854909|FG000|Overall Study|Transplant/Explant|3|||
160854258|NCT02836652|580854910|FG001|Overall Study|Transplant/Explant|4|||
160854259|NCT02836652|580854909|FG000|Overall Study|Withdrawn|9|||
160854260|NCT02836652|580854910|FG001|Overall Study|Withdrawn|9|||
160854261|NCT02836652|580854909|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
160854262|NCT02836652|580854910|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
160854263|NCT01220167|580854911|FG000|Period 3|Urine positive for substance abuse|0|||
160854264|NCT01220167|580854912|FG001|Period 3|Urine positive for substance abuse|1|||
160854265|NCT01220167|580854913|FG002|Period 3|Urine positive for substance abuse|0|||
160854266|NCT01008943|580854914|FG000|Overall Study|Withdrawal by Subject|1|||
160854267|NCT00861705|580854915|FG000|Overall Study|Never Began Treatment|7|||
160854268|NCT00861705|580854916|FG001|Overall Study|Never Began Treatment|3|||
160854269|NCT00861705|580854917|FG002|Overall Study|Never Began Treatment|0|||
160854270|NCT00861705|580854918|FG003|Overall Study|Never Began Treatment|1|||
160854271|NCT02611479|580854919|FG000|Baseline Enrollment|Exited study|13|||
160854272|NCT02611479|580854919|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
160854273|NCT02611479|580854919|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
160854274|NCT02611479|580854919|FG000|Data Cleaning|No baseline function or pain metrics|2|||
160854275|NCT00743249|580854920|FG000|Overall Study|Adverse Event|0|||
160907317|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
160907318|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
160907319|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
160907320|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907321|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
160907322|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907323|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907324|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
160907325|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
160907326|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907327|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907328|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907329|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907330|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
160907331|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907332|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907333|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907334|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
160907335|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
160907336|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
160907337|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
160907338|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
160907339|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
160907340|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
160907341|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
160907342|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
160907343|NCT03706079|581054013|FG000|Long Term Extension (DESTINATION)|Death|8|||
160907344|NCT03706079|581054014|FG001|Long Term Extension (DESTINATION)|Death|2|||
160907345|NCT03706079|581054015|FG002|Long Term Extension (DESTINATION)|Death|2|||
160907346|NCT03706079|581054016|FG003|Long Term Extension (DESTINATION)|Death|1|||
160907347|NCT03706079|581054017|FG004|Long Term Extension (DESTINATION)|Death|0|||
160907348|NCT03706079|581054018|FG005|Long Term Extension (DESTINATION)|Death|0|||
160907349|NCT00329238|581054019|FG000|Overall Study|Adverse Event|147|||
160907350|NCT00329238|581054020|FG001|Overall Study|Adverse Event|129|||
160907351|NCT00329238|581054019|FG000|Overall Study|Protocol Violation|23|||
160907352|NCT00329238|581054020|FG001|Overall Study|Protocol Violation|34|||
160907353|NCT00329238|581054019|FG000|Overall Study|Lost to Follow-up|2|||
160907354|NCT00329238|581054020|FG001|Overall Study|Lost to Follow-up|6|||
160907355|NCT00329238|581054019|FG000|Overall Study|Withdrawal by Subject|64|||
160907356|NCT00329238|581054020|FG001|Overall Study|Withdrawal by Subject|58|||
160907357|NCT00329238|581054019|FG000|Overall Study|Other reason (not specified)|40|||
160907358|NCT00329238|581054020|FG001|Overall Study|Other reason (not specified)|54|||
160907359|NCT00801632|581054021|FG000|Overall Study|Re-transplant|1|||
160907360|NCT05393895|581054025|FG000|Overall Study|Adverse Event|2|||
160907361|NCT05393895|581054026|FG001|Overall Study|Adverse Event|3|||
160907362|NCT05393895|581054025|FG000|Overall Study|Lost to Follow-up|4|||
160907363|NCT05393895|581054026|FG001|Overall Study|Lost to Follow-up|3|||
160907364|NCT05393895|581054025|FG000|Overall Study|Protocol Violation|1|||
160907365|NCT05393895|581054026|FG001|Overall Study|Protocol Violation|0|||
160907366|NCT05393895|581054025|FG000|Overall Study|Withdrawal by Subject|1|||
160907367|NCT05393895|581054026|FG001|Overall Study|Withdrawal by Subject|4|||
160907368|NCT01203098|581054035|FG000|Overall Study|Adverse Event|3|||
160907369|NCT01203098|581054036|FG001|Overall Study|Adverse Event|1|||
160907370|NCT01203098|581054037|FG002|Overall Study|Adverse Event|7|||
160907371|NCT01203098|581054035|FG000|Overall Study|Lost to Follow-up|0|||
160907372|NCT01203098|581054036|FG001|Overall Study|Lost to Follow-up|0|||
160907373|NCT01203098|581054037|FG002|Overall Study|Lost to Follow-up|1|||
160907374|NCT01203098|581054035|FG000|Overall Study|Physician Decision|2|||
160854276|NCT00743249|580854921|FG001|Overall Study|Adverse Event|4|||
160854277|NCT00743249|580854920|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
160992726|NCT03068468|581363110|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
160992727|NCT03068468|581363111|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
160992728|NCT03068468|581363112|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
161141272|NCT05139030|581901030|FG001|Overall Study|Failure to meet continuation criteria|1|||
161141273|NCT02502864|581901035|FG000|Overall Study|Withdrawal by Subject|1|||
160854278|NCT00743249|580854921|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
160854279|NCT00743249|580854920|FG000|Overall Study|Unsuccessful insertion of stent|2|||
160854280|NCT00743249|580854921|FG001|Overall Study|Unsuccessful insertion of stent|1|||
160854281|NCT02314052|580854924|FG000|Cycle One|Adverse Event|0|||
160854282|NCT02314052|580854925|FG001|Cycle One|Adverse Event|0|||
160854283|NCT02314052|580854926|FG002|Cycle One|Adverse Event|0|||
160854284|NCT02314052|580854927|FG003|Cycle One|Adverse Event|1|||
160854285|NCT02314052|580854928|FG004|Cycle One|Adverse Event|0|||
160854286|NCT02314052|580854929|FG005|Cycle One|Adverse Event|0|||
160854287|NCT01960140|580854931|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
160854288|NCT00686777|580854935|FG000|Overall Study|Adverse Event|2|||
160854289|NCT00686777|580854935|FG000|Overall Study|Pregnancy|1|||
160854290|NCT00686777|580854935|FG000|Overall Study|Withdrawal by Subject|2|||
160854291|NCT00686777|580854935|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
160854292|NCT00686777|580854935|FG000|Overall Study|No Visit|1|||
160854293|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
160854294|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
160854295|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Disease progression|75|||
160854296|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Disease progression|59|||
160854297|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Adverse Event|16|||
160854298|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Adverse Event|16|||
160854299|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Death|2|||
160854300|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Death|3|||
160854301|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
160854302|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
160854303|NCT00883779|580854936|FG000|Primary Study Treatment Phase|Other|3|||
160854304|NCT00883779|580854937|FG001|Primary Study Treatment Phase|Other|0|||
160854305|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Adverse Event|2|||
160854306|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Adverse Event|3|||
160854307|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Death|1|||
160854308|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Death|3|||
160854309|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
160854310|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
160854311|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
160854312|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
160854313|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Disease progression|103|||
160854314|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Disease progression|122|||
160854315|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Other|3|||
160854316|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Other|0|||
160854317|NCT00883779|580854936|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
160854318|NCT00883779|580854937|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
160854319|NCT00883779|580854936|FG000|Off-study Phase|Death|185|||
160854320|NCT00883779|580854937|FG001|Off-study Phase|Death|174|||
160854321|NCT00883779|580854936|FG000|Off-study Phase|Refused treatment|1|||
160854322|NCT00883779|580854937|FG001|Off-study Phase|Refused treatment|1|||
160854323|NCT00883779|580854936|FG000|Off-study Phase|Failure to return|5|||
160854324|NCT00883779|580854937|FG001|Off-study Phase|Failure to return|6|||
160854325|NCT00883779|580854936|FG000|Off-study Phase|Other|18|||
160854326|NCT00883779|580854937|FG001|Off-study Phase|Other|21|||
160854327|NCT00499681|580854938|FG000|Overall Study|toxicity|0|||
160854328|NCT00499681|580854939|FG001|Overall Study|toxicity|1|||
160854329|NCT00499681|580854938|FG000|Overall Study|disease progression|0|||
160854330|NCT00499681|580854939|FG001|Overall Study|disease progression|1|||
160854331|NCT00739401|580854940|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
160854332|NCT00739401|580854940|FG000|Overall Study|Death|3|||
160854333|NCT00739401|580854940|FG000|Overall Study|Withdrawal by Subject|4|||
160854334|NCT01239381|580854941|FG000|Overall Study|Protocol Violation|1|||
160854335|NCT01239381|580854941|FG000|Overall Study|Withdrawal by Subject|1|||
160854336|NCT06237049|580854942|FG000|Overall Study|Death|0|||
161141274|NCT00613626|581901039|FG000|Overall Study|Ineligible|0|||
160854337|NCT06237049|580854943|FG001|Overall Study|Death|0|||
160854338|NCT06237049|580854944|FG002|Overall Study|Death|0|||
160854339|NCT06237049|580854945|FG003|Overall Study|Death|1|||
160854340|NCT06237049|580854942|FG000|Overall Study|Lost to Follow-up|11|||
160854341|NCT06237049|580854943|FG001|Overall Study|Lost to Follow-up|5|||
160854342|NCT06237049|580854944|FG002|Overall Study|Lost to Follow-up|8|||
160854343|NCT06237049|580854945|FG003|Overall Study|Lost to Follow-up|8|||
160854344|NCT06237049|580854942|FG000|Overall Study|Protocol Violation|0|||
160854345|NCT06237049|580854943|FG001|Overall Study|Protocol Violation|1|||
160854346|NCT06237049|580854944|FG002|Overall Study|Protocol Violation|0|||
160854347|NCT06237049|580854945|FG003|Overall Study|Protocol Violation|1|||
160854348|NCT06237049|580854942|FG000|Overall Study|Withdrawal by Subject|4|||
161141275|NCT00613626|581901040|FG001|Overall Study|Ineligible|1|||
160854349|NCT06237049|580854943|FG001|Overall Study|Withdrawal by Subject|2|||
160854350|NCT06237049|580854944|FG002|Overall Study|Withdrawal by Subject|1|||
160854351|NCT06237049|580854945|FG003|Overall Study|Withdrawal by Subject|0|||
160854352|NCT03748823|580854946|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
160854353|NCT03748823|580854947|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
160854354|NCT03748823|580854946|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
160854355|NCT03748823|580854947|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
160907375|NCT01203098|581054036|FG001|Overall Study|Physician Decision|2|||
160907376|NCT01203098|581054037|FG002|Overall Study|Physician Decision|0|||
160907377|NCT01203098|581054035|FG000|Overall Study|Withdrawal by Subject|1|||
160907378|NCT01203098|581054036|FG001|Overall Study|Withdrawal by Subject|1|||
160907379|NCT01203098|581054037|FG002|Overall Study|Withdrawal by Subject|3|||
160907380|NCT03095612|581054042|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907381|NCT03095612|581054043|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
160907382|NCT03095612|581054044|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907383|NCT03095612|581054045|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907384|NCT03095612|581054046|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907385|NCT03095612|581054047|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907386|NCT03095612|581054048|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
160907387|NCT00621582|581054049|FG000|Overall Study|Adverse Event|7|||
160907388|NCT00621582|581054049|FG000|Overall Study|Protocol Violation|57|||
160907389|NCT00621582|581054049|FG000|Overall Study|Lost to Follow-up|24|||
160907390|NCT00621582|581054049|FG000|Overall Study|issues not identified by investigators|18|||
160907391|NCT03617185|581054050|FG000|Baseline|Lost to Follow-up|0|||
160907392|NCT03617185|581054051|FG001|Baseline|Lost to Follow-up|2|||
160907393|NCT03617185|581054052|FG002|Baseline|Lost to Follow-up|1|||
160907394|NCT03617185|581054053|FG003|Baseline|Lost to Follow-up|1|||
160907395|NCT03617185|581054050|FG000|Baseline|Withdrawal by Subject|0|||
160907396|NCT03617185|581054051|FG001|Baseline|Withdrawal by Subject|1|||
160907397|NCT03617185|581054052|FG002|Baseline|Withdrawal by Subject|0|||
160907398|NCT03617185|581054053|FG003|Baseline|Withdrawal by Subject|1|||
160907399|NCT03617185|581054050|FG000|Baseline|Driving Distance/Travel|0|||
160907400|NCT03617185|581054051|FG001|Baseline|Driving Distance/Travel|0|||
160907401|NCT03617185|581054052|FG002|Baseline|Driving Distance/Travel|2|||
160907402|NCT03617185|581054053|FG003|Baseline|Driving Distance/Travel|0|||
160907403|NCT03617185|581054050|FG000|Baseline|Family Obligations|0|||
160907404|NCT03617185|581054051|FG001|Baseline|Family Obligations|0|||
160907405|NCT03617185|581054052|FG002|Baseline|Family Obligations|0|||
160907406|NCT03617185|581054053|FG003|Baseline|Family Obligations|1|||
160907407|NCT03617185|581054050|FG000|3 Months|Lost to Follow-up|4|||
160907408|NCT03617185|581054051|FG001|3 Months|Lost to Follow-up|1|||
160907409|NCT03617185|581054052|FG002|3 Months|Lost to Follow-up|0|||
160907410|NCT03617185|581054053|FG003|3 Months|Lost to Follow-up|2|||
160907411|NCT03617185|581054050|FG000|3 Months|Withdrawal by Subject|1|||
160907412|NCT03617185|581054051|FG001|3 Months|Withdrawal by Subject|3|||
160907413|NCT03617185|581054052|FG002|3 Months|Withdrawal by Subject|0|||
160907414|NCT03617185|581054053|FG003|3 Months|Withdrawal by Subject|0|||
160907415|NCT03617185|581054050|FG000|3 Months|Driving Distance/Travel|1|||
160907416|NCT03617185|581054051|FG001|3 Months|Driving Distance/Travel|0|||
160907417|NCT03617185|581054052|FG002|3 Months|Driving Distance/Travel|0|||
160907418|NCT03617185|581054053|FG003|3 Months|Driving Distance/Travel|0|||
160907419|NCT03617185|581054050|FG000|3 Months|Family Obligations|0|||
160907420|NCT03617185|581054051|FG001|3 Months|Family Obligations|0|||
160907421|NCT03617185|581054052|FG002|3 Months|Family Obligations|0|||
160907422|NCT03617185|581054053|FG003|3 Months|Family Obligations|1|||
160907423|NCT03617185|581054050|FG000|12 Months|Lost to Follow-up|3|||
160907424|NCT03617185|581054051|FG001|12 Months|Lost to Follow-up|1|||
160907425|NCT03617185|581054052|FG002|12 Months|Lost to Follow-up|3|||
160907426|NCT03617185|581054053|FG003|12 Months|Lost to Follow-up|0|||
160907427|NCT03617185|581054050|FG000|12 Months|Withdrawal by Subject|0|||
160907428|NCT03617185|581054051|FG001|12 Months|Withdrawal by Subject|0|||
161141276|NCT00613626|581901041|FG002|Overall Study|Ineligible|0|||
161141277|NCT00816036|581901042|FG000|Overall Study|Death|47|||
161141278|NCT00816036|581901043|FG001|Overall Study|Death|28|||
160907429|NCT03617185|581054052|FG002|12 Months|Withdrawal by Subject|0|||
160907430|NCT03617185|581054053|FG003|12 Months|Withdrawal by Subject|1|||
161141279|NCT00816036|581901042|FG000|Overall Study|Lost to Follow-up|75|||
160907431|NCT03617185|581054050|FG000|12 Months|Driving Distance/Travel|0|||
160907432|NCT03617185|581054051|FG001|12 Months|Driving Distance/Travel|0|||
160907433|NCT03617185|581054052|FG002|12 Months|Driving Distance/Travel|1|||
160907434|NCT03617185|581054053|FG003|12 Months|Driving Distance/Travel|0|||
160907435|NCT01387932|581054055|FG000|Randomized and Treated|Physician Decision|3|||
161141280|NCT00816036|581901043|FG001|Overall Study|Lost to Follow-up|57|||
161141281|NCT00816036|581901042|FG000|Overall Study|Withdrawal by Subject|54|||
160854356|NCT03748823|580854946|FG000|Extension Period|Withdrawal by Subject|9|||
161141282|NCT00816036|581901043|FG001|Overall Study|Withdrawal by Subject|23|||
161141283|NCT01299025|581901044|FG000|Overall Study|Withdrawal by Subject|2|||
161141284|NCT01299025|581901045|FG001|Overall Study|Withdrawal by Subject|1|||
161141285|NCT01299025|581901044|FG000|Overall Study|Lost to Follow-up|1|||
161141286|NCT01299025|581901045|FG001|Overall Study|Lost to Follow-up|0|||
161141287|NCT01624194|581901046|FG000|Overall Study|Lost to Follow-up|1|||
161141288|NCT01624194|581901047|FG001|Overall Study|Lost to Follow-up|0|||
161141289|NCT01624194|581901046|FG000|Overall Study|Withdrawal by Subject|1|||
161141290|NCT01624194|581901047|FG001|Overall Study|Withdrawal by Subject|0|||
160907436|NCT01387932|581054056|FG001|Randomized and Treated|Physician Decision|2|||
160907437|NCT01387932|581054055|FG000|Randomized and Treated|Withdrawal by Subject|4|||
160907438|NCT01387932|581054056|FG001|Randomized and Treated|Withdrawal by Subject|2|||
160907439|NCT01387932|581054055|FG000|Survival Follow-up|Liver Transplant|24|||
161141291|NCT03212261|581901048|FG000|Overall Study|Became ineligible d/t tech|2|||
161141292|NCT03212261|581901048|FG000|Overall Study|Tech Trouble- No first study visit|1|||
161141293|NCT03212261|581901048|FG000|Overall Study|Lost to Follow-up|7|||
161141294|NCT03212261|581901048|FG000|Overall Study|Family Emergency|1|||
161337427|NCT00251758|582625929|FG001|Overall Study|Withdrawal by Subject|7|||
160992729|NCT03068468|581363113|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
160992730|NCT03068468|581363110|FG000|Open-Label Extension Period|Reason not Specified|0|||
160992731|NCT03068468|581363111|FG001|Open-Label Extension Period|Reason not Specified|0|||
160992732|NCT03068468|581363112|FG002|Open-Label Extension Period|Reason not Specified|1|||
160992733|NCT03068468|581363113|FG003|Open-Label Extension Period|Reason not Specified|4|||
160992734|NCT03895034|581363115|FG000|Overall Study|Lost to Follow-up|2|||
160992735|NCT01118377|581363116|FG000|Overall Study|Did Not Receive Study Medication|1|||
160907440|NCT01387932|581054056|FG001|Survival Follow-up|Liver Transplant|28|||
160907441|NCT01387932|581054055|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
160907442|NCT01387932|581054056|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
160907443|NCT01387932|581054055|FG000|Survival Follow-up|Withdrawal by Subject|2|||
160907444|NCT01387932|581054056|FG001|Survival Follow-up|Withdrawal by Subject|4|||
160907445|NCT01387932|581054055|FG000|Survival Follow-up|Lost to Follow-up|6|||
160907446|NCT01387932|581054056|FG001|Survival Follow-up|Lost to Follow-up|5|||
160992736|NCT01118377|581363116|FG000|Overall Study|Death|38|||
160992737|NCT01118377|581363116|FG000|Overall Study|Failure to Return|3|||
160992738|NCT00739102|581363121|FG000|Overall Study|Death|5|||
160992739|NCT00739102|581363121|FG000|Overall Study|Withdrawal by Subject|10|||
160992740|NCT01331824|581363125|FG000|Overall Study|Adverse Event|2|||
160992741|NCT01331824|581363125|FG000|Overall Study|Death|1|||
160992742|NCT01331824|581363125|FG000|Overall Study|Disease Progression|9|||
160992743|NCT01331824|581363125|FG000|Overall Study|Withdrawal by Subject|1|||
160992744|NCT01091454|581363126|FG000|Overall Study|Ineligible|1|||
160992745|NCT02715258|581363130|FG000|Overall Study|Withdrawal by Subject|6|||
160992746|NCT02715258|581363131|FG001|Overall Study|Withdrawal by Subject|1|||
160992747|NCT02715258|581363130|FG000|Overall Study|Lost to Follow-up|7|||
160992748|NCT02715258|581363131|FG001|Overall Study|Lost to Follow-up|1|||
160992749|NCT02715258|581363130|FG000|Overall Study|Terminated by Sponsor|0|||
160992750|NCT02715258|581363131|FG001|Overall Study|Terminated by Sponsor|1|||
160992751|NCT02715258|581363130|FG000|Overall Study|Death|0|||
160992752|NCT02715258|581363131|FG001|Overall Study|Death|1|||
160992753|NCT02715258|581363130|FG000|Overall Study|Subject non-compliant|1|||
160992754|NCT02715258|581363131|FG001|Overall Study|Subject non-compliant|1|||
160992755|NCT02715258|581363130|FG000|Overall Study|GCP violation|2|||
160992756|NCT02715258|581363131|FG001|Overall Study|GCP violation|1|||
160992757|NCT02236559|581363141|FG000|Overall Study|Met Exclusion|3|||
160992758|NCT02236559|581363142|FG001|Overall Study|Met Exclusion|6|||
160992759|NCT02236559|581363141|FG000|Overall Study|Did not Meet Inclusion|3|||
160992760|NCT02236559|581363142|FG001|Overall Study|Did not Meet Inclusion|3|||
160992761|NCT02236559|581363141|FG000|Overall Study|Subject Did Not Consent|4|||
160992762|NCT02236559|581363142|FG001|Overall Study|Subject Did Not Consent|2|||
160992763|NCT02236559|581363141|FG000|Overall Study|Physician Decision|1|||
160992764|NCT02236559|581363142|FG001|Overall Study|Physician Decision|1|||
160992765|NCT02236559|581363141|FG000|Overall Study|Withdrawal by Subject|1|||
160992766|NCT02236559|581363142|FG001|Overall Study|Withdrawal by Subject|0|||
160992767|NCT02263508|581363144|FG000|Overall Study|Withdrawal by Subject|1|||
161337428|NCT00251758|582625930|FG002|Overall Study|Withdrawal by Subject|3|||
160992768|NCT02263508|581363145|FG001|Overall Study|Withdrawal by Subject|23|||
160907447|NCT01964430|581054057|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
160907448|NCT01964430|581054058|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
160907449|NCT01964430|581054057|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
160907450|NCT01964430|581054058|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
160992769|NCT02263508|581363146|FG002|Overall Study|Withdrawal by Subject|17|||
160992770|NCT02263508|581363144|FG000|Overall Study|Sponsor Decision|12|||
160992771|NCT02263508|581363145|FG001|Overall Study|Sponsor Decision|165|||
161141295|NCT03212261|581901048|FG000|Overall Study|Too busy/ No time|5|||
161141296|NCT05480514|581901049|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
160992772|NCT02263508|581363146|FG002|Overall Study|Sponsor Decision|182|||
160992773|NCT02263508|581363144|FG000|Overall Study|Lost to Follow-up|2|||
160992774|NCT02263508|581363145|FG001|Overall Study|Lost to Follow-up|7|||
160992775|NCT02263508|581363146|FG002|Overall Study|Lost to Follow-up|7|||
160992776|NCT02263508|581363144|FG000|Overall Study|Death|6|||
160992777|NCT02263508|581363145|FG001|Overall Study|Death|151|||
160992778|NCT02263508|581363146|FG002|Overall Study|Death|140|||
160992779|NCT01280591|581363147|FG000|Overall Study|Withdrawal by Subject|0|||
160992780|NCT01280591|581363148|FG001|Overall Study|Withdrawal by Subject|0|||
160992781|NCT01280591|581363149|FG002|Overall Study|Withdrawal by Subject|0|||
160992782|NCT01280591|581363150|FG003|Overall Study|Withdrawal by Subject|2|||
160992783|NCT01280591|581363147|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
160992784|NCT01280591|581363148|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
160992785|NCT01280591|581363149|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
160992786|NCT01280591|581363150|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
160992787|NCT01117480|581363151|FG000|Overall Study|Protocol Violation|8|||
160992788|NCT01117480|581363151|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
160992789|NCT02955069|581363152|FG000|Overall Study|Adverse Event|7|||
160992790|NCT02955069|581363153|FG001|Overall Study|Adverse Event|2|||
160992791|NCT02955069|581363152|FG000|Overall Study|Death|7|||
160992792|NCT02955069|581363153|FG001|Overall Study|Death|3|||
160992793|NCT02955069|581363152|FG000|Overall Study|Physician Decision|10|||
160992794|NCT02955069|581363153|FG001|Overall Study|Physician Decision|2|||
160992795|NCT02955069|581363152|FG000|Overall Study|Progressive disease|64|||
160992796|NCT02955069|581363153|FG001|Overall Study|Progressive disease|13|||
160992797|NCT02955069|581363152|FG000|Overall Study|Study terminated by sponsor|4|||
160992798|NCT02955069|581363153|FG001|Overall Study|Study terminated by sponsor|0|||
160992799|NCT02955069|581363152|FG000|Overall Study|Subject/Guardian decision|3|||
160992800|NCT02955069|581363153|FG001|Overall Study|Subject/Guardian decision|1|||
160992801|NCT03721016|581363154|FG000|Overall Study|Adverse Event|0|||
160992802|NCT03721016|581363155|FG001|Overall Study|Adverse Event|1|||
160992803|NCT03721016|581363156|FG002|Overall Study|Adverse Event|1|||
160992804|NCT03721016|581363154|FG000|Overall Study|Withdrawal by Subject|8|||
160992805|NCT03721016|581363155|FG001|Overall Study|Withdrawal by Subject|16|||
160992806|NCT03721016|581363156|FG002|Overall Study|Withdrawal by Subject|13|||
160992807|NCT03721016|581363154|FG000|Overall Study|Lost to Follow-up|4|||
160992808|NCT03721016|581363155|FG001|Overall Study|Lost to Follow-up|6|||
160992809|NCT03721016|581363156|FG002|Overall Study|Lost to Follow-up|5|||
160992810|NCT03721016|581363154|FG000|Overall Study|Physician Decision|0|||
160992811|NCT03721016|581363155|FG001|Overall Study|Physician Decision|1|||
160992812|NCT03721016|581363156|FG002|Overall Study|Physician Decision|2|||
160992813|NCT03721016|581363154|FG000|Overall Study|Protocol Violation|0|||
160992814|NCT03721016|581363155|FG001|Overall Study|Protocol Violation|1|||
160992815|NCT03721016|581363156|FG002|Overall Study|Protocol Violation|0|||
160992816|NCT03721016|581363154|FG000|Overall Study|Site terminated by sponsor|3|||
160992817|NCT03721016|581363155|FG001|Overall Study|Site terminated by sponsor|7|||
160992818|NCT03721016|581363156|FG002|Overall Study|Site terminated by sponsor|6|||
160992819|NCT03721016|581363154|FG000|Overall Study|Subject exited early due to COVID-19|1|||
160992820|NCT03721016|581363155|FG001|Overall Study|Subject exited early due to COVID-19|0|||
160992821|NCT03721016|581363156|FG002|Overall Study|Subject exited early due to COVID-19|0|||
160992822|NCT04148937|581363157|FG000|Overall Study|Withdrawal by Subject|0|||
160992823|NCT04148937|581363158|FG001|Overall Study|Withdrawal by Subject|0|||
160992824|NCT04148937|581363159|FG002|Overall Study|Withdrawal by Subject|0|||
160992825|NCT04148937|581363160|FG003|Overall Study|Withdrawal by Subject|1|||
161337429|NCT00251758|582625928|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161337430|NCT00251758|582625929|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
160992826|NCT04148937|581363161|FG004|Overall Study|Withdrawal by Subject|0|||
160992827|NCT04148937|581363162|FG005|Overall Study|Withdrawal by Subject|1|||
160992828|NCT04148937|581363163|FG006|Overall Study|Withdrawal by Subject|1|||
160992829|NCT04148937|581363164|FG007|Overall Study|Withdrawal by Subject|0|||
160992830|NCT04148937|581363157|FG000|Overall Study|Lost to Follow-up|0|||
160992831|NCT04148937|581363158|FG001|Overall Study|Lost to Follow-up|0|||
160992832|NCT04148937|581363159|FG002|Overall Study|Lost to Follow-up|1|||
160992833|NCT04148937|581363160|FG003|Overall Study|Lost to Follow-up|0|||
160992834|NCT04148937|581363161|FG004|Overall Study|Lost to Follow-up|0|||
160992835|NCT04148937|581363162|FG005|Overall Study|Lost to Follow-up|2|||
160992836|NCT04148937|581363163|FG006|Overall Study|Lost to Follow-up|0|||
160992837|NCT04148937|581363164|FG007|Overall Study|Lost to Follow-up|0|||
160992838|NCT03357341|581363165|FG000|Overall Study|Withdrawal by Subject|3|||
160992839|NCT03357341|581363166|FG001|Overall Study|Withdrawal by Subject|6|||
160992840|NCT03357341|581363165|FG000|Overall Study|Lost to Follow-up|4|||
160992841|NCT03357341|581363166|FG001|Overall Study|Lost to Follow-up|5|||
161141297|NCT05480514|581901050|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
160992842|NCT03357341|581363165|FG000|Overall Study|Death|0|||
160992843|NCT03357341|581363166|FG001|Overall Study|Death|1|||
160992844|NCT00686517|581363167|FG000|Treatment|Serious Adverse Event|1|||
160992845|NCT00686517|581363168|FG001|Treatment|Serious Adverse Event|2|||
160992846|NCT00686517|581363169|FG002|Treatment|Serious Adverse Event|1|||
160992847|NCT00686517|581363167|FG000|Treatment|Adverse Event|2|||
160992848|NCT00686517|581363168|FG001|Treatment|Adverse Event|0|||
160992849|NCT00686517|581363169|FG002|Treatment|Adverse Event|0|||
160992850|NCT00686517|581363167|FG000|Treatment|Poor Protocol Compliance|1|||
160992851|NCT00686517|581363168|FG001|Treatment|Poor Protocol Compliance|0|||
160992852|NCT00686517|581363169|FG002|Treatment|Poor Protocol Compliance|0|||
160992853|NCT00686517|581363167|FG000|Treatment|Protocol Violation|2|||
160992854|NCT00686517|581363168|FG001|Treatment|Protocol Violation|1|||
160992855|NCT00686517|581363169|FG002|Treatment|Protocol Violation|0|||
160992856|NCT01803646|581363170|FG000|Overall Study|Protocol Violation|1|||
160992857|NCT01803646|581363171|FG001|Overall Study|Protocol Violation|0|||
160992858|NCT01803646|581363170|FG000|Overall Study|Adverse Event|1|||
160992859|NCT01803646|581363171|FG001|Overall Study|Adverse Event|1|||
160992860|NCT01803646|581363170|FG000|Overall Study|Withdrawal by Subject|9|||
160992861|NCT01803646|581363171|FG001|Overall Study|Withdrawal by Subject|6|||
160992862|NCT01803646|581363170|FG000|Overall Study|Randomization error|1|||
160992863|NCT01803646|581363171|FG001|Overall Study|Randomization error|2|||
160992864|NCT01803646|581363170|FG000|Overall Study|Lost to Follow-up|5|||
160992865|NCT01803646|581363171|FG001|Overall Study|Lost to Follow-up|1|||
160992866|NCT01167426|581363172|FG000|Overall Study|Lost to Follow-up|6|||
160992867|NCT01167426|581363172|FG000|Overall Study|Protocol Violation|1|||
160992868|NCT01167426|581363172|FG000|Overall Study|Withdrawal by Subject|2|||
160992869|NCT01167426|581363172|FG000|Overall Study|Sponsor Decision|1|||
160992870|NCT01072357|581363175|FG000|Overall Study|Lost to Follow-up|0|||
160992871|NCT01072357|581363176|FG001|Overall Study|Lost to Follow-up|1|||
160992872|NCT01876511|581363177|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
160992873|NCT01876511|581363178|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
160992874|NCT01876511|581363179|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
160992875|NCT01876511|581363177|FG000|Overall Study|Death (unrelated)|3|||
160992876|NCT01876511|581363178|FG001|Overall Study|Death (unrelated)|0|||
160992877|NCT01876511|581363179|FG002|Overall Study|Death (unrelated)|2|||
160992878|NCT01876511|581363177|FG000|Overall Study|Drug-related Toxicity|5|||
160992879|NCT01876511|581363178|FG001|Overall Study|Drug-related Toxicity|1|||
160992880|NCT01876511|581363179|FG002|Overall Study|Drug-related Toxicity|6|||
160992881|NCT01876511|581363177|FG000|Overall Study|Patient Decision|3|||
160992882|NCT01876511|581363178|FG001|Overall Study|Patient Decision|0|||
160992883|NCT01876511|581363179|FG002|Overall Study|Patient Decision|6|||
160992884|NCT01876511|581363177|FG000|Overall Study|Physician Decision|1|||
160992885|NCT01876511|581363178|FG001|Overall Study|Physician Decision|0|||
160992886|NCT01876511|581363179|FG002|Overall Study|Physician Decision|1|||
160992887|NCT02131324|581363180|FG000|Overall Study|Withdrawal by Subject|1|||
160992888|NCT02131324|581363181|FG001|Overall Study|Withdrawal by Subject|2|||
160992889|NCT02131324|581363180|FG000|Overall Study|Lost to Follow-up|1|||
160992890|NCT02131324|581363181|FG001|Overall Study|Lost to Follow-up|1|||
160992891|NCT05790408|581363182|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
160992892|NCT01048788|581363183|FG000|Overall Study|Adverse Event|5|||
160992893|NCT01048788|581363184|FG001|Overall Study|Adverse Event|1|||
160992894|NCT01048788|581363185|FG002|Overall Study|Adverse Event|1|||
160992895|NCT01048788|581363183|FG000|Overall Study|Lack of Efficacy|0|||
160992896|NCT01048788|581363184|FG001|Overall Study|Lack of Efficacy|0|||
160992897|NCT01048788|581363185|FG002|Overall Study|Lack of Efficacy|1|||
160992898|NCT01048788|581363183|FG000|Overall Study|Withdrawal by Subject|0|||
160992899|NCT01048788|581363184|FG001|Overall Study|Withdrawal by Subject|1|||
160992900|NCT01048788|581363185|FG002|Overall Study|Withdrawal by Subject|0|||
160992901|NCT01233050|581363186|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
160992902|NCT01233050|581363187|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
160992903|NCT04582877|581363192|FG000|Overall Study|Did not use device measurement|5|||
161141298|NCT05480514|581901049|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
161141299|NCT05480514|581901050|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
161141300|NCT05480514|581901049|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160992904|NCT04582877|581363192|FG000|Overall Study|No fractional flow reserve test results|2|||
160992905|NCT04582877|581363192|FG000|Overall Study|Protocol Violation|1|||
160992906|NCT03095508|581363203|FG000|Overall Study|Adverse Event|0|||
160992907|NCT03095508|581363204|FG001|Overall Study|Adverse Event|1|||
160992908|NCT00335556|581363205|FG000|Overall Study|Death|0|||
160992909|NCT00335556|581363206|FG001|Overall Study|Death|5|||
160992910|NCT00335556|581363207|FG002|Overall Study|Death|0|||
160992911|NCT00335556|581363208|FG003|Overall Study|Death|0|||
160992912|NCT00335556|581363209|FG004|Overall Study|Death|1|||
160992913|NCT00335556|581363210|FG005|Overall Study|Death|0|||
161141301|NCT05480514|581901050|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
160992914|NCT00335556|581363205|FG000|Overall Study|Lack of Efficacy|0|||
160992915|NCT00335556|581363206|FG001|Overall Study|Lack of Efficacy|19|||
160992916|NCT00335556|581363207|FG002|Overall Study|Lack of Efficacy|3|||
161141302|NCT05480514|581901049|FG000|Period 1|Covid-19 Related|1|||
160992917|NCT00335556|581363208|FG003|Overall Study|Lack of Efficacy|3|||
160992918|NCT00335556|581363209|FG004|Overall Study|Lack of Efficacy|0|||
160854357|NCT03748823|580854947|FG001|Extension Period|Withdrawal by Subject|12|||
160854358|NCT03748823|580854946|FG000|Extension Period|Death|2|||
160854359|NCT03748823|580854947|FG001|Extension Period|Death|2|||
160854360|NCT03748823|580854946|FG000|Extension Period|Other than Specified|0|||
160854361|NCT03748823|580854947|FG001|Extension Period|Other than Specified|1|||
160854362|NCT03748823|580854946|FG000|Extension Period|Protocol Violation|1|||
160854363|NCT03748823|580854947|FG001|Extension Period|Protocol Violation|0|||
160854364|NCT03748823|580854946|FG000|Extension Period|Lost to Follow-up|0|||
160854365|NCT03748823|580854947|FG001|Extension Period|Lost to Follow-up|1|||
160854366|NCT03748823|580854946|FG000|Extension Period|Lack of Efficacy|0|||
160854367|NCT03748823|580854947|FG001|Extension Period|Lack of Efficacy|1|||
160854368|NCT03748823|580854946|FG000|Extension Period|Physician Decision|1|||
160854369|NCT03748823|580854947|FG001|Extension Period|Physician Decision|2|||
160854370|NCT04678115|580854948|FG000|Overall Study|Lost to Follow-up|1|||
160854371|NCT04678115|580854949|FG001|Overall Study|Lost to Follow-up|0|||
160854372|NCT00890825|580854950|FG000|Overall Study|Withdrawal by Subject|1|||
160854373|NCT00890825|580854951|FG001|Overall Study|Withdrawal by Subject|0|||
160854374|NCT00890825|580854950|FG000|Overall Study|Alive at data cut off (DCO)|13|||
160854375|NCT00890825|580854951|FG001|Overall Study|Alive at data cut off (DCO)|14|||
160854376|NCT01363700|580854952|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854377|NCT01363700|580854953|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
160854378|NCT01363700|580854954|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854379|NCT01363700|580854955|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854380|NCT01363700|580854956|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
160854381|NCT03649217|580854957|FG000|Overall Study|subject had severe ataxia not initially found|1|||
160854382|NCT03649217|580854957|FG000|Overall Study|subject had cognitive issues not initially found|1|||
160854383|NCT01721161|580854958|FG000|Overall Study|Adverse Event|2|||
160854384|NCT01721161|580854959|FG001|Overall Study|Adverse Event|3|||
160854385|NCT01721161|580854958|FG000|Overall Study|Lost to Follow-up|1|||
160854386|NCT01721161|580854959|FG001|Overall Study|Lost to Follow-up|2|||
160854387|NCT01721161|580854958|FG000|Overall Study|Withdrawal by Subject|1|||
160854388|NCT01721161|580854959|FG001|Overall Study|Withdrawal by Subject|1|||
160854389|NCT01721161|580854958|FG000|Overall Study|Other|0|||
160854390|NCT01721161|580854959|FG001|Overall Study|Other|1|||
160854391|NCT01091675|580854962|FG000|Overall Study|Adverse Event|7|||
160854392|NCT01091675|580854962|FG000|Overall Study|Lack of Efficacy|27|||
160854393|NCT00614380|580854965|FG000|Overall Study|Adverse Event|14|||
160854394|NCT00614380|580854966|FG001|Overall Study|Adverse Event|4|||
160854395|NCT00614380|580854967|FG002|Overall Study|Adverse Event|0|||
160854396|NCT00614380|580854968|FG003|Overall Study|Adverse Event|0|||
160854397|NCT00614380|580854965|FG000|Overall Study|Lost to Follow-up|6|||
160854398|NCT00614380|580854966|FG001|Overall Study|Lost to Follow-up|1|||
160854399|NCT00614380|580854967|FG002|Overall Study|Lost to Follow-up|0|||
160854400|NCT00614380|580854968|FG003|Overall Study|Lost to Follow-up|0|||
160854401|NCT00614380|580854965|FG000|Overall Study|Non compliant with the protocol|12|||
160854402|NCT00614380|580854966|FG001|Overall Study|Non compliant with the protocol|2|||
160854403|NCT00614380|580854967|FG002|Overall Study|Non compliant with the protocol|1|||
160854404|NCT00614380|580854968|FG003|Overall Study|Non compliant with the protocol|2|||
160854405|NCT00614380|580854965|FG000|Overall Study|Consent withdrawn|3|||
160854406|NCT00614380|580854966|FG001|Overall Study|Consent withdrawn|1|||
160854407|NCT00614380|580854967|FG002|Overall Study|Consent withdrawn|0|||
160854408|NCT00614380|580854968|FG003|Overall Study|Consent withdrawn|0|||
160854409|NCT04908397|580854973|FG000|Overall Study|Withdrawal by Subject|2|||
160854410|NCT00462306|580854974|FG000|Overall Study|insufficient data|0|||
160854411|NCT00462306|580854975|FG001|Overall Study|insufficient data|13|||
160854412|NCT02360228|580854976|FG000|Overall Study|Withdrawal by Subject|1|||
160854413|NCT02360228|580854977|FG001|Overall Study|Withdrawal by Subject|0|||
160854414|NCT02360228|580854978|FG002|Overall Study|Withdrawal by Subject|0|||
160854415|NCT02360228|580854976|FG000|Overall Study|Self-discontinued medication|0|||
160854416|NCT02360228|580854977|FG001|Overall Study|Self-discontinued medication|1|||
160854417|NCT02360228|580854978|FG002|Overall Study|Self-discontinued medication|0|||
160907451|NCT01964430|581054057|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
160907452|NCT01964430|581054058|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
160907453|NCT01964430|581054057|FG000|Treatment Period|Adverse Event|71|||
160854418|NCT02360228|580854976|FG000|Overall Study|Unstable symptoms during screening|0|||
160854419|NCT02360228|580854977|FG001|Overall Study|Unstable symptoms during screening|0|||
160854420|NCT02360228|580854978|FG002|Overall Study|Unstable symptoms during screening|1|||
160854421|NCT02464410|580854979|FG000|Overall Study|Death|3|||
160854422|NCT02464410|580854980|FG001|Overall Study|Death|4|||
160854423|NCT02464410|580854979|FG000|Overall Study|Lost to Follow-up|7|||
160854424|NCT02464410|580854980|FG001|Overall Study|Lost to Follow-up|9|||
160854425|NCT02464410|580854979|FG000|Overall Study|Withdrawal by Subject|12|||
160854426|NCT02464410|580854980|FG001|Overall Study|Withdrawal by Subject|3|||
160854427|NCT01063153|580854981|FG000|Overall Study|Found Ineligible During Screening|2|||
160854428|NCT01063153|580854982|FG001|Overall Study|Found Ineligible During Screening|0|||
160854429|NCT01063153|580854981|FG000|Overall Study|Lost to Follow-up|0|||
160992919|NCT00335556|581363210|FG005|Overall Study|Lack of Efficacy|1|||
160992920|NCT00335556|581363205|FG000|Overall Study|Physician Decision|0|||
160992921|NCT00335556|581363206|FG001|Overall Study|Physician Decision|6|||
160992922|NCT00335556|581363207|FG002|Overall Study|Physician Decision|2|||
160992923|NCT00335556|581363208|FG003|Overall Study|Physician Decision|1|||
160992924|NCT00335556|581363209|FG004|Overall Study|Physician Decision|0|||
160992925|NCT00335556|581363210|FG005|Overall Study|Physician Decision|0|||
160992926|NCT00335556|581363205|FG000|Overall Study|Ineligible|2|||
160992927|NCT00335556|581363206|FG001|Overall Study|Ineligible|0|||
160992928|NCT00335556|581363207|FG002|Overall Study|Ineligible|0|||
160992929|NCT00335556|581363208|FG003|Overall Study|Ineligible|0|||
160992930|NCT00335556|581363209|FG004|Overall Study|Ineligible|0|||
160992931|NCT00335556|581363210|FG005|Overall Study|Ineligible|0|||
160992932|NCT00335556|581363205|FG000|Overall Study|Refusal of further protocol therapy|0|||
160992933|NCT00335556|581363206|FG001|Overall Study|Refusal of further protocol therapy|4|||
160992934|NCT00335556|581363207|FG002|Overall Study|Refusal of further protocol therapy|0|||
160992935|NCT00335556|581363208|FG003|Overall Study|Refusal of further protocol therapy|1|||
160992936|NCT00335556|581363209|FG004|Overall Study|Refusal of further protocol therapy|0|||
160992937|NCT00335556|581363210|FG005|Overall Study|Refusal of further protocol therapy|0|||
160992938|NCT01878890|581363218|FG000|Overall Study|Protocol Violation|0|||
160992939|NCT01878890|581363219|FG001|Overall Study|Protocol Violation|1|||
160992940|NCT01878890|581363220|FG002|Overall Study|Protocol Violation|0|||
160992941|NCT01878890|581363221|FG003|Overall Study|Protocol Violation|0|||
160992942|NCT01710514|581363223|FG000|Overall Study|Adverse Event|6|||
160992943|NCT01710514|581363224|FG001|Overall Study|Adverse Event|7|||
160992944|NCT01710514|581363223|FG000|Overall Study|Withdrawal by Subject|1|||
160854430|NCT01063153|580854982|FG001|Overall Study|Lost to Follow-up|7|||
160854431|NCT01063153|580854981|FG000|Overall Study|Withdrawal by Subject|0|||
160854432|NCT01063153|580854982|FG001|Overall Study|Withdrawal by Subject|1|||
160854433|NCT01063153|580854981|FG000|Overall Study|Physician Decision|0|||
160854434|NCT01063153|580854982|FG001|Overall Study|Physician Decision|4|||
160854435|NCT00350844|580854983|FG000|Overall Study|Lost to Follow-up|1|||
160854436|NCT01838694|580856540|FG000|Overall Study|Adverse Event|0|||
160854437|NCT01838694|580856541|FG001|Overall Study|Adverse Event|1|||
160854438|NCT01535807|580856542|FG000|Overall Study|Withdrawal by Subject|1|||
160854439|NCT01535807|580856543|FG001|Overall Study|Withdrawal by Subject|1|||
160854440|NCT01535807|580856542|FG000|Overall Study|Data collection error|1|||
160854441|NCT01535807|580856543|FG001|Overall Study|Data collection error|1|||
160854442|NCT01329263|580856544|FG000|Overall Study|Lost to Follow-up|4|||
160854443|NCT01329263|580856545|FG001|Overall Study|Lost to Follow-up|21|||
160854444|NCT01329263|580856544|FG000|Overall Study|Withdrawal by Subject|1|||
160854445|NCT01329263|580856545|FG001|Overall Study|Withdrawal by Subject|2|||
160854446|NCT02123134|580856547|FG000|Overall Study|Withdrawal of consent|3|||
160854447|NCT02123134|580856548|FG001|Overall Study|Withdrawal of consent|2|||
160854448|NCT02123134|580856547|FG000|Overall Study|Administrative decision|0|||
160992945|NCT01710514|581363224|FG001|Overall Study|Withdrawal by Subject|0|||
160992946|NCT03404843|581363227|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
160992947|NCT03404843|581363228|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
160992948|NCT04044664|581363229|FG000|Stage 1|Adverse Event|3|||
160992949|NCT04044664|581363230|FG001|Stage 1|Adverse Event|3|||
160992950|NCT04044664|581363231|FG002|Stage 1|Adverse Event|1|||
160992951|NCT04044664|581363229|FG000|Stage 1|Lost to Follow-up|3|||
160854449|NCT02123134|580856548|FG001|Overall Study|Administrative decision|1|||
160854450|NCT00657540|580856549|FG000|Overall Study|Lost to Follow-up|1|||
160992952|NCT04044664|581363230|FG001|Stage 1|Lost to Follow-up|2|||
160992953|NCT04044664|581363231|FG002|Stage 1|Lost to Follow-up|2|||
160992954|NCT04044664|581363229|FG000|Stage 1|Withdrawal by Subject|9|||
160992955|NCT04044664|581363230|FG001|Stage 1|Withdrawal by Subject|1|||
160992956|NCT04044664|581363231|FG002|Stage 1|Withdrawal by Subject|0|||
160992957|NCT04044664|581363229|FG000|Stage 1|noncompliance, personal reason|2|||
160854451|NCT00657540|580856550|FG001|Overall Study|Lost to Follow-up|4|||
160854452|NCT00141453|580856551|FG000|Overall Study|Protocol Violation|6|||
160992958|NCT04044664|581363230|FG001|Stage 1|noncompliance, personal reason|0|||
160992959|NCT04044664|581363231|FG002|Stage 1|noncompliance, personal reason|0|||
161337431|NCT00251758|582625930|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
160854453|NCT00141453|580856552|FG001|Overall Study|Protocol Violation|5|||
160854454|NCT02043938|580856553|FG000|Overall Study|Withdrawal by Subject|7|||
160854455|NCT02043938|580856553|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
160854456|NCT02043938|580856553|FG000|Overall Study|No show by subject|1|||
160854457|NCT02043938|580856553|FG000|Overall Study|Investigator decision|1|||
160854458|NCT02656017|580856556|FG000|Overall Study|Study burden|3|||
160992960|NCT04044664|581363229|FG000|Stage 1|randomization error|0|||
160992961|NCT04044664|581363230|FG001|Stage 1|randomization error|1|||
160992962|NCT04044664|581363231|FG002|Stage 1|randomization error|0|||
160992963|NCT04044664|581363229|FG000|Stage 2|Adverse Event|2|||
160992964|NCT04044664|581363230|FG001|Stage 2|Adverse Event|0|||
160992965|NCT04044664|581363231|FG002|Stage 2|Adverse Event|0|||
160992966|NCT04044664|581363229|FG000|Stage 2|Lost to Follow-up|3|||
160992967|NCT04044664|581363230|FG001|Stage 2|Lost to Follow-up|2|||
160854459|NCT02656017|580856557|FG001|Overall Study|Study burden|3|||
160992968|NCT04044664|581363231|FG002|Stage 2|Lost to Follow-up|1|||
160992969|NCT04044664|581363229|FG000|Stage 2|Withdrawal by Subject|3|||
160992970|NCT04044664|581363230|FG001|Stage 2|Withdrawal by Subject|0|||
160992971|NCT04044664|581363231|FG002|Stage 2|Withdrawal by Subject|0|||
160992972|NCT04044664|581363229|FG000|Stage 2|protocol deviation|1|||
160992973|NCT04044664|581363230|FG001|Stage 2|protocol deviation|0|||
160992974|NCT04044664|581363231|FG002|Stage 2|protocol deviation|0|||
160992975|NCT00001575|581363235|FG000|Overall Study|Screening failures-Ph I portion|22|||
160992976|NCT00001575|581363235|FG000|Overall Study|Withdrawn/deaths|23|||
160992977|NCT00831792|581363238|FG000|Overall Study|Not Eligible|3|||
160992978|NCT00831792|581363238|FG000|Overall Study|Adverse Event|1|||
160992979|NCT00831792|581363238|FG000|Overall Study|Death|1|||
160992980|NCT00831792|581363238|FG000|Overall Study|Lack of Efficacy|1|||
160992981|NCT03736785|581363239|FG000|Overall Study|Adverse Event|1|||
160992982|NCT03736785|581363240|FG001|Overall Study|Adverse Event|1|||
160992983|NCT03736785|581363241|FG002|Overall Study|Adverse Event|1|||
160992984|NCT03736785|581363239|FG000|Overall Study|Death|1|||
160992985|NCT03736785|581363240|FG001|Overall Study|Death|0|||
160992986|NCT03736785|581363241|FG002|Overall Study|Death|1|||
160992987|NCT03736785|581363239|FG000|Overall Study|Lost to Follow-up|0|||
160992988|NCT03736785|581363240|FG001|Overall Study|Lost to Follow-up|2|||
160992989|NCT03736785|581363241|FG002|Overall Study|Lost to Follow-up|3|||
160992990|NCT03736785|581363239|FG000|Overall Study|Non compliance with study drug|1|||
160992991|NCT03736785|581363240|FG001|Overall Study|Non compliance with study drug|1|||
160992992|NCT03736785|581363241|FG002|Overall Study|Non compliance with study drug|0|||
160992993|NCT03736785|581363239|FG000|Overall Study|Physician Decision|0|||
160854460|NCT02656017|580856556|FG000|Overall Study|Adverse Event|2|||
160992994|NCT03736785|581363240|FG001|Overall Study|Physician Decision|1|||
160992995|NCT03736785|581363241|FG002|Overall Study|Physician Decision|1|||
160992996|NCT03736785|581363239|FG000|Overall Study|Protocol Violation|1|||
160992997|NCT03736785|581363240|FG001|Overall Study|Protocol Violation|4|||
160992998|NCT03736785|581363241|FG002|Overall Study|Protocol Violation|3|||
160992999|NCT03736785|581363239|FG000|Overall Study|Sponsor Decision|1|||
160993000|NCT03736785|581363240|FG001|Overall Study|Sponsor Decision|0|||
160993001|NCT03736785|581363241|FG002|Overall Study|Sponsor Decision|0|||
160993002|NCT03736785|581363239|FG000|Overall Study|Unknown/Missing data|3|||
160993003|NCT03736785|581363240|FG001|Overall Study|Unknown/Missing data|2|||
160993004|NCT03736785|581363241|FG002|Overall Study|Unknown/Missing data|1|||
160993005|NCT03736785|581363239|FG000|Overall Study|Withdrawal by Subject|9|||
160993006|NCT03736785|581363240|FG001|Overall Study|Withdrawal by Subject|6|||
160993007|NCT03736785|581363241|FG002|Overall Study|Withdrawal by Subject|4|||
160993008|NCT02974010|581363243|FG000|Overall Study|Lost to Follow-up|3|||
160993009|NCT02974010|581363244|FG001|Overall Study|Lost to Follow-up|1|||
160993010|NCT02974010|581363245|FG002|Overall Study|Lost to Follow-up|0|||
160993011|NCT02974010|581363246|FG003|Overall Study|Lost to Follow-up|0|||
160993012|NCT02974010|581363243|FG000|Overall Study|Withdrawal by Subject|2|||
160993013|NCT02974010|581363244|FG001|Overall Study|Withdrawal by Subject|1|||
160993014|NCT02974010|581363245|FG002|Overall Study|Withdrawal by Subject|0|||
160993015|NCT02974010|581363246|FG003|Overall Study|Withdrawal by Subject|0|||
160993016|NCT02974010|581363243|FG000|Overall Study|Adverse Event|0|||
160993017|NCT02974010|581363244|FG001|Overall Study|Adverse Event|1|||
160993018|NCT02974010|581363245|FG002|Overall Study|Adverse Event|0|||
160993019|NCT02974010|581363246|FG003|Overall Study|Adverse Event|0|||
160993020|NCT02974010|581363243|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
160993021|NCT02974010|581363244|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
160993022|NCT02974010|581363245|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
160993023|NCT02974010|581363246|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
160993024|NCT02974010|581363243|FG000|Overall Study|Lack of Efficacy|0|||
160993025|NCT02974010|581363244|FG001|Overall Study|Lack of Efficacy|0|||
160993026|NCT02974010|581363245|FG002|Overall Study|Lack of Efficacy|1|||
160993027|NCT02974010|581363246|FG003|Overall Study|Lack of Efficacy|0|||
160993028|NCT03256344|581363249|FG000|Overall Study|Death|6|||
160993029|NCT03256344|581363250|FG001|Overall Study|Death|22|||
160993030|NCT03256344|581363249|FG000|Overall Study|Withdrawal by Subject|3|||
160993031|NCT03256344|581363250|FG001|Overall Study|Withdrawal by Subject|3|||
160854461|NCT02656017|580856557|FG001|Overall Study|Adverse Event|1|||
160993032|NCT03256344|581363249|FG000|Overall Study|Sponsor Decision|1|||
161141303|NCT05480514|581901050|FG001|Period 1|Covid-19 Related|0|||
160854462|NCT02656017|580856556|FG000|Overall Study|Unable/unwilling to take study medication|2|||
160993033|NCT03256344|581363250|FG001|Overall Study|Sponsor Decision|0|||
160993034|NCT00880906|581363251|FG000|Overall Study|Lost to Follow-up|0|||
160993035|NCT00880906|581363252|FG001|Overall Study|Lost to Follow-up|1|||
160993036|NCT00880906|581363251|FG000|Overall Study|Did not meet criteria following patholog|12|||
160993037|NCT00880906|581363252|FG001|Overall Study|Did not meet criteria following patholog|6|||
160993038|NCT01664104|581363253|FG000|Overall Study|Adverse Event|6|||
160993039|NCT01664104|581363253|FG000|Overall Study|Lack of Efficacy|2|||
160993040|NCT01664104|581363253|FG000|Overall Study|Withdrawal by Subject|1|||
160854463|NCT02656017|580856557|FG001|Overall Study|Unable/unwilling to take study medication|1|||
160854464|NCT02656017|580856556|FG000|Overall Study|Began Tolvaptan|1|||
160854465|NCT02656017|580856557|FG001|Overall Study|Began Tolvaptan|1|||
160854466|NCT02656017|580856556|FG000|Overall Study|Withdrawal by Subject|1|||
160854467|NCT02656017|580856557|FG001|Overall Study|Withdrawal by Subject|0|||
160854468|NCT02349633|580856561|FG000|Overall Study|Death|0|||
160854469|NCT02349633|580856562|FG001|Overall Study|Death|1|||
160854470|NCT02349633|580856563|FG002|Overall Study|Death|0|||
160854471|NCT02349633|580856564|FG003|Overall Study|Death|0|||
160854472|NCT02349633|580856565|FG004|Overall Study|Death|0|||
160854473|NCT02349633|580856566|FG005|Overall Study|Death|1|||
160854474|NCT02349633|580856567|FG006|Overall Study|Death|1|||
160854475|NCT02349633|580856568|FG007|Overall Study|Death|1|||
160854476|NCT02349633|580856569|FG008|Overall Study|Death|0|||
160854477|NCT02349633|580856570|FG009|Overall Study|Death|1|||
160854478|NCT02349633|580856571|FG010|Overall Study|Death|0|||
160854479|NCT02349633|580856572|FG011|Overall Study|Death|0|||
160854480|NCT02349633|580856573|FG012|Overall Study|Death|0|||
160854481|NCT02349633|580856574|FG013|Overall Study|Death|0|||
160854482|NCT02349633|580856561|FG000|Overall Study|Withdrawal by Subject|0|||
160854483|NCT02349633|580856562|FG001|Overall Study|Withdrawal by Subject|0|||
160854484|NCT02349633|580856563|FG002|Overall Study|Withdrawal by Subject|0|||
160854485|NCT02349633|580856564|FG003|Overall Study|Withdrawal by Subject|1|||
160854486|NCT02349633|580856565|FG004|Overall Study|Withdrawal by Subject|0|||
160854487|NCT02349633|580856566|FG005|Overall Study|Withdrawal by Subject|0|||
160854488|NCT02349633|580856567|FG006|Overall Study|Withdrawal by Subject|0|||
160854489|NCT02349633|580856568|FG007|Overall Study|Withdrawal by Subject|2|||
160854490|NCT02349633|580856569|FG008|Overall Study|Withdrawal by Subject|2|||
160854491|NCT02349633|580856570|FG009|Overall Study|Withdrawal by Subject|1|||
160854492|NCT02349633|580856571|FG010|Overall Study|Withdrawal by Subject|0|||
160854493|NCT02349633|580856572|FG011|Overall Study|Withdrawal by Subject|0|||
160854494|NCT02349633|580856573|FG012|Overall Study|Withdrawal by Subject|0|||
160854495|NCT02349633|580856574|FG013|Overall Study|Withdrawal by Subject|0|||
160854496|NCT02349633|580856561|FG000|Overall Study|Withdrawal of informed consent|0|||
160854497|NCT02349633|580856562|FG001|Overall Study|Withdrawal of informed consent|0|||
160854498|NCT02349633|580856563|FG002|Overall Study|Withdrawal of informed consent|0|||
160854499|NCT02349633|580856564|FG003|Overall Study|Withdrawal of informed consent|1|||
160854500|NCT02349633|580856565|FG004|Overall Study|Withdrawal of informed consent|1|||
160854501|NCT02349633|580856566|FG005|Overall Study|Withdrawal of informed consent|0|||
160854502|NCT02349633|580856567|FG006|Overall Study|Withdrawal of informed consent|0|||
160854503|NCT02349633|580856568|FG007|Overall Study|Withdrawal of informed consent|3|||
160854504|NCT02349633|580856569|FG008|Overall Study|Withdrawal of informed consent|0|||
160854505|NCT02349633|580856570|FG009|Overall Study|Withdrawal of informed consent|0|||
160854506|NCT02349633|580856571|FG010|Overall Study|Withdrawal of informed consent|0|||
160854507|NCT02349633|580856572|FG011|Overall Study|Withdrawal of informed consent|0|||
160854508|NCT02349633|580856573|FG012|Overall Study|Withdrawal of informed consent|0|||
160854509|NCT02349633|580856574|FG013|Overall Study|Withdrawal of informed consent|0|||
160854510|NCT02349633|580856561|FG000|Overall Study|Transition to compassionate use|0|||
160854511|NCT02349633|580856562|FG001|Overall Study|Transition to compassionate use|0|||
160854512|NCT02349633|580856563|FG002|Overall Study|Transition to compassionate use|0|||
160854513|NCT02349633|580856564|FG003|Overall Study|Transition to compassionate use|0|||
160854514|NCT02349633|580856565|FG004|Overall Study|Transition to compassionate use|1|||
160854515|NCT02349633|580856566|FG005|Overall Study|Transition to compassionate use|0|||
160854516|NCT02349633|580856567|FG006|Overall Study|Transition to compassionate use|0|||
160854517|NCT02349633|580856568|FG007|Overall Study|Transition to compassionate use|3|||
160854518|NCT02349633|580856569|FG008|Overall Study|Transition to compassionate use|0|||
160854519|NCT02349633|580856570|FG009|Overall Study|Transition to compassionate use|1|||
160907454|NCT01964430|581054058|FG001|Treatment Period|Adverse Event|37|||
160907455|NCT01964430|581054057|FG000|Treatment Period|Withdrawal by Subject|36|||
160907456|NCT01964430|581054058|FG001|Treatment Period|Withdrawal by Subject|27|||
160907457|NCT01964430|581054057|FG000|Treatment Period|Death|1|||
160907458|NCT01964430|581054058|FG001|Treatment Period|Death|3|||
160907459|NCT01964430|581054057|FG000|Treatment Period|Protocol Deviation|0|||
160907460|NCT01964430|581054058|FG001|Treatment Period|Protocol Deviation|1|||
160854520|NCT02349633|580856571|FG010|Overall Study|Transition to compassionate use|0|||
160854521|NCT02349633|580856572|FG011|Overall Study|Transition to compassionate use|0|||
160854522|NCT02349633|580856573|FG012|Overall Study|Transition to compassionate use|0|||
160854523|NCT02349633|580856574|FG013|Overall Study|Transition to compassionate use|0|||
160854524|NCT02349633|580856561|FG000|Overall Study|Early termination of survival follow-up|0|||
160854525|NCT02349633|580856562|FG001|Overall Study|Early termination of survival follow-up|0|||
160854526|NCT02349633|580856563|FG002|Overall Study|Early termination of survival follow-up|0|||
160854527|NCT02349633|580856564|FG003|Overall Study|Early termination of survival follow-up|0|||
160907461|NCT01964430|581054057|FG000|Treatment Period|Physician Decision|5|||
160907462|NCT01964430|581054058|FG001|Treatment Period|Physician Decision|4|||
160907463|NCT01964430|581054057|FG000|Treatment Period|Disease Relapse|28|||
160993041|NCT01664104|581363253|FG000|Overall Study|Lost to Follow-up|4|||
160993042|NCT01664104|581363253|FG000|Overall Study|Other|1|||
160993043|NCT01664104|581363253|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
160993044|NCT03586167|581363255|FG000|Overall Study|Other|1|||
160993045|NCT03586167|581363256|FG001|Overall Study|Other|0|||
160993046|NCT04163458|581363259|FG000|Overall Study|Protocol Deviation|7|||
160993047|NCT04163458|581363260|FG001|Overall Study|Protocol Deviation|13|||
160993048|NCT04163458|581363259|FG000|Overall Study|Adverse Event|5|||
160993049|NCT04163458|581363260|FG001|Overall Study|Adverse Event|8|||
160993050|NCT04163458|581363259|FG000|Overall Study|Due to COVID-19 pandemic|4|||
160854528|NCT02349633|580856565|FG004|Overall Study|Early termination of survival follow-up|0|||
160854529|NCT02349633|580856566|FG005|Overall Study|Early termination of survival follow-up|0|||
160854530|NCT02349633|580856567|FG006|Overall Study|Early termination of survival follow-up|0|||
160854531|NCT02349633|580856568|FG007|Overall Study|Early termination of survival follow-up|4|||
160854532|NCT02349633|580856569|FG008|Overall Study|Early termination of survival follow-up|0|||
160993051|NCT04163458|581363260|FG001|Overall Study|Due to COVID-19 pandemic|2|||
160993052|NCT04163458|581363259|FG000|Overall Study|Participant withdrew consent|2|||
160993053|NCT04163458|581363260|FG001|Overall Study|Participant withdrew consent|3|||
160854533|NCT02349633|580856570|FG009|Overall Study|Early termination of survival follow-up|0|||
160854534|NCT02349633|580856571|FG010|Overall Study|Early termination of survival follow-up|0|||
160854535|NCT02349633|580856572|FG011|Overall Study|Early termination of survival follow-up|0|||
160854536|NCT02349633|580856573|FG012|Overall Study|Early termination of survival follow-up|0|||
160854537|NCT02349633|580856574|FG013|Overall Study|Early termination of survival follow-up|0|||
160854538|NCT02349633|580856561|FG000|Overall Study|Termination by sponsor|0|||
160854539|NCT02349633|580856562|FG001|Overall Study|Termination by sponsor|0|||
160854540|NCT02349633|580856563|FG002|Overall Study|Termination by sponsor|0|||
160854541|NCT02349633|580856564|FG003|Overall Study|Termination by sponsor|0|||
160854542|NCT02349633|580856565|FG004|Overall Study|Termination by sponsor|0|||
160854543|NCT02349633|580856566|FG005|Overall Study|Termination by sponsor|0|||
160854544|NCT02349633|580856567|FG006|Overall Study|Termination by sponsor|0|||
160854545|NCT02349633|580856568|FG007|Overall Study|Termination by sponsor|1|||
160854546|NCT02349633|580856569|FG008|Overall Study|Termination by sponsor|0|||
160907464|NCT01964430|581054058|FG001|Treatment Period|Disease Relapse|38|||
160907465|NCT01964430|581054057|FG000|Treatment Period|Other reasons|1|||
160907466|NCT01964430|581054058|FG001|Treatment Period|Other reasons|3|||
160907467|NCT02591290|581054059|FG000|Overall Study|Withdrawal by Subject|2|||
160907468|NCT02571075|581054062|FG000|Overall Study|Lost to Follow-up|20|||
160907469|NCT02571075|581054063|FG001|Overall Study|Lost to Follow-up|24|||
160993054|NCT04163458|581363259|FG000|Overall Study|Randomization failure|2|||
160993055|NCT04163458|581363260|FG001|Overall Study|Randomization failure|2|||
160993056|NCT04163458|581363259|FG000|Overall Study|Other|4|||
160993057|NCT04163458|581363260|FG001|Overall Study|Other|2|||
160993058|NCT03852433|581363266|FG000|Overall Study|Withdrawal of consent|5|||
160993059|NCT03852433|581363267|FG001|Overall Study|Withdrawal of consent|8|||
160993060|NCT03852433|581363268|FG002|Overall Study|Withdrawal of consent|1|||
160993061|NCT03852433|581363269|FG003|Overall Study|Withdrawal of consent|1|||
160993062|NCT03852433|581363266|FG000|Overall Study|Adverse Event|1|||
160993063|NCT03852433|581363267|FG001|Overall Study|Adverse Event|1|||
160993064|NCT03852433|581363268|FG002|Overall Study|Adverse Event|1|||
160993065|NCT03852433|581363269|FG003|Overall Study|Adverse Event|1|||
160993066|NCT03852433|581363266|FG000|Overall Study|Lost to Follow-up|0|||
160993067|NCT03852433|581363267|FG001|Overall Study|Lost to Follow-up|1|||
160993068|NCT03852433|581363268|FG002|Overall Study|Lost to Follow-up|0|||
160993069|NCT03852433|581363269|FG003|Overall Study|Lost to Follow-up|1|||
160993070|NCT03852433|581363266|FG000|Overall Study|Pregnancy|0|||
160907470|NCT01606800|581056273|FG000|Overall Study|Adverse Event|3|||
160907471|NCT01606800|581056274|FG001|Overall Study|Adverse Event|1|||
160907472|NCT01606800|581056273|FG000|Overall Study|Participant withdrew consent|0|||
160907473|NCT01606800|581056274|FG001|Overall Study|Participant withdrew consent|1|||
160907474|NCT01606800|581056273|FG000|Overall Study|Missing completion status|2|||
160993071|NCT03852433|581363267|FG001|Overall Study|Pregnancy|1|||
160993072|NCT03852433|581363268|FG002|Overall Study|Pregnancy|1|||
160993073|NCT03852433|581363269|FG003|Overall Study|Pregnancy|0|||
160993074|NCT03852433|581363266|FG000|Overall Study|Protocol Violation|0|||
160993075|NCT03852433|581363267|FG001|Overall Study|Protocol Violation|0|||
160993076|NCT03852433|581363268|FG002|Overall Study|Protocol Violation|1|||
160993077|NCT03852433|581363269|FG003|Overall Study|Protocol Violation|1|||
160993078|NCT03852433|581363266|FG000|Overall Study|Death|0|||
160907475|NCT01606800|581056274|FG001|Overall Study|Missing completion status|0|||
160907476|NCT02370160|581056277|FG000|Overall Study|Death|3|||
160907477|NCT02370160|581056278|FG001|Overall Study|Death|4|||
160907478|NCT02370160|581056279|FG002|Overall Study|Death|1|||
160993079|NCT03852433|581363267|FG001|Overall Study|Death|0|||
160993080|NCT03852433|581363268|FG002|Overall Study|Death|1|||
160993081|NCT03852433|581363269|FG003|Overall Study|Death|0|||
160993082|NCT03852433|581363266|FG000|Overall Study|Lack of Efficacy|0|||
160993083|NCT03852433|581363267|FG001|Overall Study|Lack of Efficacy|1|||
160993084|NCT03852433|581363268|FG002|Overall Study|Lack of Efficacy|0|||
160854547|NCT02349633|580856570|FG009|Overall Study|Termination by sponsor|2|||
160854548|NCT02349633|580856571|FG010|Overall Study|Termination by sponsor|0|||
160854549|NCT02349633|580856572|FG011|Overall Study|Termination by sponsor|0|||
160854550|NCT02349633|580856573|FG012|Overall Study|Termination by sponsor|0|||
160854551|NCT02349633|580856574|FG013|Overall Study|Termination by sponsor|0|||
160854552|NCT02349633|580856561|FG000|Overall Study|Other|0|||
160854553|NCT02349633|580856562|FG001|Overall Study|Other|0|||
160854554|NCT02349633|580856563|FG002|Overall Study|Other|0|||
160854555|NCT02349633|580856564|FG003|Overall Study|Other|0|||
160854556|NCT02349633|580856565|FG004|Overall Study|Other|0|||
160854557|NCT02349633|580856566|FG005|Overall Study|Other|0|||
160854558|NCT02349633|580856567|FG006|Overall Study|Other|0|||
160854559|NCT02349633|580856568|FG007|Overall Study|Other|2|||
160854560|NCT02349633|580856569|FG008|Overall Study|Other|0|||
160854561|NCT02349633|580856570|FG009|Overall Study|Other|0|||
160854562|NCT02349633|580856571|FG010|Overall Study|Other|0|||
160854563|NCT02349633|580856572|FG011|Overall Study|Other|0|||
160854564|NCT02349633|580856573|FG012|Overall Study|Other|0|||
160854565|NCT02349633|580856574|FG013|Overall Study|Other|0|||
160854566|NCT00667628|580856575|FG000|Overall Study|Lost to Follow-up|1|||
160854567|NCT00667628|580856576|FG001|Overall Study|Lost to Follow-up|0|||
160854568|NCT00667628|580856575|FG000|Overall Study|Death|6|||
160854569|NCT00667628|580856576|FG001|Overall Study|Death|6|||
160854570|NCT00667628|580856575|FG000|Overall Study|Investigator Considers in Best Interest|1|||
160854571|NCT00667628|580856576|FG001|Overall Study|Investigator Considers in Best Interest|0|||
160854572|NCT00667628|580856575|FG000|Overall Study|Sponsor Terminated Study|17|||
160854573|NCT00667628|580856576|FG001|Overall Study|Sponsor Terminated Study|21|||
160854574|NCT05789745|580856577|FG000|Overall Study|Withdrawal by Subject|0|||
160854575|NCT05789745|580856578|FG001|Overall Study|Withdrawal by Subject|0|||
160854576|NCT05789745|580856579|FG002|Overall Study|Withdrawal by Subject|0|||
160854577|NCT05789745|580856580|FG003|Overall Study|Withdrawal by Subject|0|||
160854578|NCT05789745|580856581|FG004|Overall Study|Withdrawal by Subject|1|||
160854579|NCT04663321|580856582|FG000|Overall Study|Study terminated by Sponsor|2|||
160854580|NCT04663321|580856583|FG001|Overall Study|Study terminated by Sponsor|1|||
160854581|NCT04663321|580856584|FG002|Overall Study|Study terminated by Sponsor|2|||
160854582|NCT04663321|580856582|FG000|Overall Study|Withdrawal by Subject|10|||
160854583|NCT04663321|580856583|FG001|Overall Study|Withdrawal by Subject|3|||
160854584|NCT04663321|580856584|FG002|Overall Study|Withdrawal by Subject|2|||
160854585|NCT04663321|580856582|FG000|Overall Study|Not provided|0|||
160854586|NCT04663321|580856583|FG001|Overall Study|Not provided|0|||
160854587|NCT04663321|580856584|FG002|Overall Study|Not provided|1|||
160854588|NCT00622505|580856585|FG000|Overall Study|Adverse Event|9|||
160854589|NCT00622505|580856586|FG001|Overall Study|Adverse Event|7|||
160854590|NCT00622505|580856585|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
160854591|NCT00622505|580856586|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
160854592|NCT00622505|580856585|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160854593|NCT00622505|580856586|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
160854594|NCT00622505|580856585|FG000|Overall Study|Withdrawal by Subject|12|||
160854595|NCT00622505|580856586|FG001|Overall Study|Withdrawal by Subject|5|||
160854596|NCT00622505|580856585|FG000|Overall Study|Administrative Problems|2|||
160854597|NCT00622505|580856586|FG001|Overall Study|Administrative Problems|4|||
160854598|NCT00622505|580856585|FG000|Overall Study|Death|2|||
160854599|NCT00622505|580856586|FG001|Overall Study|Death|2|||
160854600|NCT00619515|580856587|FG000|Overall Study|Study Termination by IRB|73|||
160854601|NCT03294590|580856590|FG000|Overall Study|Lost to Follow-up|105|||
160854602|NCT03294590|580856591|FG001|Overall Study|Lost to Follow-up|107|||
160854603|NCT01962441|580856594|FG000|Randomized Period|Randomized but Never Treated|4|||
160854604|NCT01962441|580856595|FG001|Randomized Period|Randomized but Never Treated|2|||
160854605|NCT01962441|580856596|FG002|Randomized Period|Randomized but Never Treated|3|||
160854606|NCT01962441|580856594|FG000|Randomized Period|Lost to Follow-up|2|||
160854607|NCT01962441|580856595|FG001|Randomized Period|Lost to Follow-up|4|||
160854608|NCT01962441|580856596|FG002|Randomized Period|Lost to Follow-up|4|||
160854609|NCT01962441|580856594|FG000|Randomized Period|Withdrew Consent|3|||
160854610|NCT01962441|580856595|FG001|Randomized Period|Withdrew Consent|3|||
160854611|NCT01962441|580856596|FG002|Randomized Period|Withdrew Consent|2|||
160907479|NCT04487730|581056280|FG000|Overall Study|Withdrawal by Subject|3|||
160907480|NCT04487730|581056281|FG001|Overall Study|Withdrawal by Subject|1|||
160907481|NCT04487730|581056280|FG000|Overall Study|Lost to Follow-up|0|||
161141304|NCT05480514|581901049|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
161141305|NCT05480514|581901050|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
160854612|NCT01962441|580856594|FG000|Randomized Period|Adverse Event|1|||
160854613|NCT01962441|580856595|FG001|Randomized Period|Adverse Event|1|||
160854614|NCT01962441|580856596|FG002|Randomized Period|Adverse Event|0|||
160854615|NCT01962441|580856594|FG000|Randomized Period|Death|0|||
160854616|NCT01962441|580856595|FG001|Randomized Period|Death|0|||
160854617|NCT01962441|580856596|FG002|Randomized Period|Death|2|||
160854618|NCT01962441|580856594|FG000|Randomized Period|Protocol Violation|0|||
160854619|NCT01962441|580856595|FG001|Randomized Period|Protocol Violation|1|||
160854620|NCT01962441|580856596|FG002|Randomized Period|Protocol Violation|0|||
160854621|NCT01962441|580856594|FG000|Retreatment Substudy|Lack of Efficacy|1|||
160854622|NCT01962441|580856595|FG001|Retreatment Substudy|Lack of Efficacy|0|||
160854623|NCT01962441|580856596|FG002|Retreatment Substudy|Lack of Efficacy|0|||
160854624|NCT01962441|580856594|FG000|Retreatment Substudy|Lost to Follow-up|1|||
160854625|NCT01962441|580856595|FG001|Retreatment Substudy|Lost to Follow-up|0|||
160854626|NCT01962441|580856596|FG002|Retreatment Substudy|Lost to Follow-up|0|||
160854627|NCT04862065|580856597|FG000|Screening|Protocol Violation|54|||
160854628|NCT04862065|580856598|FG001|Screening|Protocol Violation|0|||
160854629|NCT04862065|580856599|FG002|Screening|Protocol Violation|0|||
160854630|NCT04862065|580856597|FG000|Screening|Insufficient Sample|1|||
160854631|NCT04862065|580856598|FG001|Screening|Insufficient Sample|0|||
160854632|NCT04862065|580856599|FG002|Screening|Insufficient Sample|0|||
160854633|NCT04862065|580856597|FG000|Follow-Up|Lost to Follow-up|3|||
160854634|NCT04862065|580856598|FG001|Follow-Up|Lost to Follow-up|0|||
160854635|NCT04862065|580856599|FG002|Follow-Up|Lost to Follow-up|0|||
160854636|NCT01453140|580856600|FG000|Overall Study|Adverse Event|3|||
160854637|NCT00474955|580856602|FG000|Overall Study|Adverse Event|2|||
160907482|NCT04487730|581056281|FG001|Overall Study|Lost to Follow-up|1|||
160907483|NCT04487730|581056280|FG000|Overall Study|Physician Decision|0|||
160907484|NCT04487730|581056281|FG001|Overall Study|Physician Decision|1|||
160907485|NCT00907777|581056282|FG000|Overall Study|Withdrawal by Subject|0|||
160907486|NCT00907777|581056283|FG001|Overall Study|Withdrawal by Subject|1|||
160907487|NCT02871297|581056284|FG000|Overall Study|Adverse Event|34|||
160907488|NCT02871297|581056284|FG000|Overall Study|Lack of Efficacy|10|||
160907489|NCT02871297|581056284|FG000|Overall Study|Non-compliance with study drug|15|||
160907490|NCT02871297|581056284|FG000|Overall Study|Protocol Violation|3|||
160907491|NCT02871297|581056284|FG000|Overall Study|Withdrawal by Subject|20|||
160907492|NCT02871297|581056284|FG000|Overall Study|Lost to Follow-up|13|||
160907493|NCT02871297|581056284|FG000|Overall Study|Rolled over to 13546A|2|||
160907494|NCT02871297|581056284|FG000|Overall Study|Other than specified|39|||
160907495|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
160907496|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
160907497|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
160907498|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907499|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907500|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907501|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
160907502|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
160907503|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
160907504|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
160907505|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907506|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907507|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907508|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
160907509|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
160907510|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907511|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907512|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907513|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907514|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907515|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
160907516|NCT04115839|581056285|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907517|NCT04115839|581056286|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907518|NCT04115839|581056287|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
160907519|NCT04115839|581056288|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907520|NCT04115839|581056289|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907521|NCT04115839|581056290|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160907522|NCT04115839|581056291|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
160854638|NCT00474955|580856602|FG000|Overall Study|Drug unavailability|1|||
160854639|NCT00474955|580856602|FG000|Overall Study|Personal reasons|5|||
160854640|NCT02422498|580856603|FG000|Overall Study|Inevaluable|4|||
160907523|NCT04115839|581056285|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
160907524|NCT04115839|581056286|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
160907525|NCT04115839|581056287|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
160854641|NCT02653326|580856604|FG000|Overall Study|Lost to Follow-up|10|||
160854642|NCT02653326|580856605|FG001|Overall Study|Lost to Follow-up|7|||
160854643|NCT01620060|580856607|FG000|Overall Study|Adverse Event|9|||
160854644|NCT01620060|580856607|FG000|Overall Study|Protocol Violation|1|||
160907526|NCT04115839|581056288|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
161337432|NCT00251758|582625928|FG000|Overall Study|Lack of Efficacy|3|||
161337433|NCT00251758|582625929|FG001|Overall Study|Lack of Efficacy|0|||
160854645|NCT01620060|580856607|FG000|Overall Study|Withdrawal by Subject|1|||
160854646|NCT01620060|580856607|FG000|Overall Study|Did not comply with Study Produre|1|||
160854647|NCT01620060|580856607|FG000|Overall Study|Family emergency|1|||
160854648|NCT01620060|580856607|FG000|Overall Study|Per Sponsor Decision|2|||
160854649|NCT03452540|580856608|FG000|Overall Study|Adverse Event|1|||
160854650|NCT03452540|580856608|FG000|Overall Study|Withdrawal by Subject|1|||
160854651|NCT03452540|580856608|FG000|Overall Study|Other SAE and AE|2|||
160854652|NCT04664153|580856609|FG000|Overall Study|Lack of Efficacy|0|||
160854653|NCT04664153|580856610|FG001|Overall Study|Lack of Efficacy|0|||
160854654|NCT04664153|580856611|FG002|Overall Study|Lack of Efficacy|1|||
160854655|NCT04664153|580856612|FG003|Overall Study|Lack of Efficacy|0|||
160854656|NCT04664153|580856609|FG000|Overall Study|Physician Decision|0|||
160854657|NCT04664153|580856610|FG001|Overall Study|Physician Decision|0|||
160854658|NCT04664153|580856611|FG002|Overall Study|Physician Decision|1|||
160854659|NCT04664153|580856612|FG003|Overall Study|Physician Decision|0|||
160854660|NCT04664153|580856609|FG000|Overall Study|Withdrawal by Subject|3|||
160854661|NCT04664153|580856610|FG001|Overall Study|Withdrawal by Subject|2|||
160854662|NCT04664153|580856611|FG002|Overall Study|Withdrawal by Subject|1|||
160854663|NCT04664153|580856612|FG003|Overall Study|Withdrawal by Subject|2|||
160854664|NCT04664153|580856609|FG000|Overall Study|Other|0|||
160854665|NCT04664153|580856610|FG001|Overall Study|Other|1|||
160907527|NCT04115839|581056289|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
160907528|NCT04115839|581056290|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
160907529|NCT04115839|581056291|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
160907530|NCT04115839|581056285|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907531|NCT04115839|581056286|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907532|NCT04115839|581056287|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907533|NCT04115839|581056288|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
160907534|NCT04115839|581056289|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
160907535|NCT04115839|581056290|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907536|NCT04115839|581056291|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
160907537|NCT02966028|581056292|FG000|Overall Study|Adverse Event|7|||
160907538|NCT02966028|581056293|FG001|Overall Study|Adverse Event|13|||
160907539|NCT02966028|581056294|FG002|Overall Study|Adverse Event|10|||
160907540|NCT02966028|581056292|FG000|Overall Study|Physician Decision|1|||
160907541|NCT02966028|581056293|FG001|Overall Study|Physician Decision|0|||
160907542|NCT02966028|581056294|FG002|Overall Study|Physician Decision|2|||
160907543|NCT02966028|581056292|FG000|Overall Study|Withdrawal by Subject|7|||
160907544|NCT02966028|581056293|FG001|Overall Study|Withdrawal by Subject|5|||
160907545|NCT02966028|581056294|FG002|Overall Study|Withdrawal by Subject|5|||
160907546|NCT02966028|581056292|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
160907547|NCT02966028|581056293|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
160907548|NCT02966028|581056294|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
160907549|NCT01396148|581056295|FG000|Overall Study|Patient Decision|1|||
160907550|NCT00224042|581056304|FG000|Overall Study|Adverse Event|2|||
160907551|NCT00224042|581056305|FG001|Overall Study|Adverse Event|1|||
160907552|NCT00224042|581056304|FG000|Overall Study|Protocol Violation|0|||
160907553|NCT00224042|581056305|FG001|Overall Study|Protocol Violation|1|||
160907554|NCT00224042|581056304|FG000|Overall Study|Physician Decision|0|||
160907555|NCT00224042|581056305|FG001|Overall Study|Physician Decision|1|||
160907556|NCT00224042|581056304|FG000|Overall Study|Did not meet lab incusion criteria|2|||
160907557|NCT00224042|581056305|FG001|Overall Study|Did not meet lab incusion criteria|3|||
160907558|NCT00224042|581056304|FG000|Overall Study|Other|2|||
160907559|NCT00224042|581056305|FG001|Overall Study|Other|0|||
160907560|NCT00840450|581056306|FG000|Overall Study|Adverse Event|1|||
160907561|NCT00840450|581056306|FG000|Overall Study|Lack of Efficacy|2|||
160907562|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
160907563|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
160907564|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907565|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907566|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907567|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907568|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907569|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
160907570|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
160907571|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
160907572|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907573|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907574|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907575|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907576|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160907577|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
160854666|NCT04664153|580856611|FG002|Overall Study|Other|0|||
160907578|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
160854667|NCT04664153|580856612|FG003|Overall Study|Other|0|||
160993085|NCT03852433|581363269|FG003|Overall Study|Lack of Efficacy|0|||
160993086|NCT03852433|581363266|FG000|Overall Study|Non-compliance with study drug|0|||
160993087|NCT03852433|581363267|FG001|Overall Study|Non-compliance with study drug|0|||
160993088|NCT03852433|581363268|FG002|Overall Study|Non-compliance with study drug|0|||
160993089|NCT03852433|581363269|FG003|Overall Study|Non-compliance with study drug|1|||
160993090|NCT03852433|581363266|FG000|Overall Study|Physician Decision|1|||
160993091|NCT03852433|581363267|FG001|Overall Study|Physician Decision|0|||
160993092|NCT03852433|581363268|FG002|Overall Study|Physician Decision|0|||
160993093|NCT03852433|581363269|FG003|Overall Study|Physician Decision|0|||
160993094|NCT03852433|581363266|FG000|Overall Study|Randomized but never treated|1|||
160993095|NCT03852433|581363267|FG001|Overall Study|Randomized but never treated|0|||
160993096|NCT03852433|581363268|FG002|Overall Study|Randomized but never treated|0|||
160993097|NCT03852433|581363269|FG003|Overall Study|Randomized but never treated|0|||
160993098|NCT05273801|581363284|FG000|Overall Study|Physician Decision|1|||
160993099|NCT04159506|581363285|FG000|Overall Study|Lost to Follow-up|2|||
160993100|NCT04159506|581363286|FG001|Overall Study|Lost to Follow-up|5|||
160993101|NCT02449044|581363287|FG000|Overall Study|Lost to Follow-up|2|||
161141306|NCT00184054|581901057|FG000|Overall Study|Adverse Event|1|||
161141307|NCT02296840|581901058|FG000|Overall Study|Adverse Event|1|||
161141308|NCT02296840|581901059|FG001|Overall Study|Adverse Event|1|||
160854668|NCT04664153|580856609|FG000|Overall Study|Adverse Event|4|||
160854669|NCT04664153|580856610|FG001|Overall Study|Adverse Event|0|||
160854670|NCT04664153|580856611|FG002|Overall Study|Adverse Event|1|||
160854671|NCT04664153|580856612|FG003|Overall Study|Adverse Event|0|||
160854672|NCT00231777|580856614|FG000|Overall Study|Lost to Follow-up|3|||
160854673|NCT00231777|580856615|FG001|Overall Study|Lost to Follow-up|0|||
160854674|NCT00231777|580856614|FG000|Overall Study|Other|3|||
160854675|NCT00231777|580856615|FG001|Overall Study|Other|2|||
160854676|NCT00524485|580856616|FG000|Overall Study|Withdrawal by Subject|5|||
160854677|NCT01600885|580856617|FG000|First Period|Adverse Event|1|||
160854678|NCT01600885|580856618|FG001|First Period|Adverse Event|1|||
160854679|NCT01600885|580856617|FG000|First Period|moved out of area|1|||
160854680|NCT01600885|580856618|FG001|First Period|moved out of area|0|||
160854681|NCT00642356|580856626|FG000|Overall Study|Adverse Event|1|||
160854682|NCT00642356|580856627|FG001|Overall Study|Adverse Event|0|||
160854683|NCT00642356|580856626|FG000|Overall Study|Protocol Violation|0|||
160854684|NCT00642356|580856627|FG001|Overall Study|Protocol Violation|3|||
160854685|NCT00642356|580856626|FG000|Overall Study|Lack of Efficacy|1|||
160854686|NCT00642356|580856627|FG001|Overall Study|Lack of Efficacy|0|||
160854687|NCT01009060|580856636|FG000|Overall Study|Adverse Event|1|||
160854688|NCT01009060|580856637|FG001|Overall Study|Adverse Event|2|||
160854689|NCT01009060|580856636|FG000|Overall Study|Protocol Violation|0|||
160854690|NCT01009060|580856637|FG001|Overall Study|Protocol Violation|1|||
160854691|NCT01009060|580856636|FG000|Overall Study|Lost to Follow-up|1|||
160854692|NCT01009060|580856637|FG001|Overall Study|Lost to Follow-up|0|||
160854693|NCT01009060|580856636|FG000|Overall Study|Physician Decision|1|||
160854694|NCT01009060|580856637|FG001|Overall Study|Physician Decision|1|||
160854695|NCT01009060|580856636|FG000|Overall Study|Withdrawal by Subject|1|||
160854696|NCT01009060|580856637|FG001|Overall Study|Withdrawal by Subject|1|||
160854697|NCT00005906|580856638|FG000|Overall Study|Lack of Efficacy|3|||
160854698|NCT04551989|580856639|FG000|Overall Study|Adverse Event|4|||
160854699|NCT04551989|580856639|FG000|Overall Study|Protocol Violation|3|||
160854700|NCT04551989|580856639|FG000|Overall Study|Lost to Follow-up|1|||
160854701|NCT04551989|580856639|FG000|Overall Study|Physician Decision|3|||
160854702|NCT04201431|580856640|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
160854703|NCT04201431|580856641|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
160854704|NCT04201431|580856642|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
160854705|NCT00088530|580856647|FG000|Overall Study|Progressive/Relapsed Disease|28|||
160854706|NCT00088530|580856648|FG001|Overall Study|Progressive/Relapsed Disease|39|||
160854707|NCT00088530|580856647|FG000|Overall Study|Adverse Event|15|||
160854708|NCT00088530|580856648|FG001|Overall Study|Adverse Event|9|||
160854709|NCT00088530|580856647|FG000|Overall Study|Withdrawal by Subject|2|||
160854710|NCT00088530|580856648|FG001|Overall Study|Withdrawal by Subject|5|||
160854711|NCT00088530|580856647|FG000|Overall Study|Lost to Follow-up|2|||
160854712|NCT00088530|580856648|FG001|Overall Study|Lost to Follow-up|0|||
160854713|NCT00088530|580856647|FG000|Overall Study|Physician Decision|2|||
160854714|NCT00088530|580856648|FG001|Overall Study|Physician Decision|0|||
160854715|NCT00088530|580856647|FG000|Overall Study|Sponsor decision|0|||
160854716|NCT00088530|580856648|FG001|Overall Study|Sponsor decision|1|||
160854717|NCT00088530|580856647|FG000|Overall Study|Patient never treated|1|||
160993102|NCT02449044|581363287|FG000|Overall Study|Withdrawal by Subject|13|||
160993103|NCT02449044|581363287|FG000|Overall Study|Adverse Event|30|||
160993104|NCT02449044|581363287|FG000|Overall Study|Met Withdrawal Criteria|7|||
160993105|NCT02449044|581363287|FG000|Overall Study|Physician Decision|9|||
160993106|NCT02449044|581363287|FG000|Overall Study|Sponsor Discontinued Trial|3|||
160993107|NCT04257058|581365277|FG000|Overall Study|Lost to Follow-up|31|||
160993108|NCT03227757|581365278|FG000|Overall Study|Death|25|||
161141309|NCT02296840|581901058|FG000|Overall Study|Protocol Violation|2|||
161337434|NCT00251758|582625930|FG002|Overall Study|Lack of Efficacy|0|||
160854718|NCT00088530|580856648|FG001|Overall Study|Patient never treated|0|||
160854719|NCT00300755|580856649|FG000|Overall Study|Adverse Event|1|||
160854720|NCT00300755|580856650|FG001|Overall Study|Adverse Event|2|||
160854721|NCT00300755|580856651|FG002|Overall Study|Adverse Event|1|||
161141310|NCT02296840|581901059|FG001|Overall Study|Protocol Violation|1|||
160854722|NCT00300755|580856649|FG000|Overall Study|Withdrawal by Subject|0|||
160854723|NCT00300755|580856650|FG001|Overall Study|Withdrawal by Subject|2|||
160854724|NCT00300755|580856651|FG002|Overall Study|Withdrawal by Subject|0|||
160854725|NCT00300755|580856649|FG000|Overall Study|Protocol Violation|0|||
160854726|NCT00300755|580856650|FG001|Overall Study|Protocol Violation|0|||
160854727|NCT00300755|580856651|FG002|Overall Study|Protocol Violation|1|||
160854728|NCT04571944|580856652|FG000|Overall Study|Death|1|||
160854729|NCT04571944|580856653|FG001|Overall Study|Death|0|||
160854730|NCT04571944|580856652|FG000|Overall Study|Withdrawal by Subject|3|||
160854731|NCT04571944|580856653|FG001|Overall Study|Withdrawal by Subject|0|||
160854732|NCT04571944|580856652|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
161141311|NCT02296840|581901058|FG000|Overall Study|Lost to Follow-up|6|||
161337435|NCT00251758|582625928|FG000|Overall Study|Noncompliant|0|||
160854733|NCT04571944|580856653|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
160854734|NCT02694744|580856659|FG000|Overall Study|Adverse Event|2|||
160854735|NCT02694744|580856660|FG001|Overall Study|Adverse Event|1|||
160854736|NCT02694744|580856659|FG000|Overall Study|Withdrawal by Subject|2|||
160854737|NCT02694744|580856660|FG001|Overall Study|Withdrawal by Subject|1|||
160854738|NCT02694744|580856659|FG000|Overall Study|Physician Decision|1|||
160854739|NCT02694744|580856660|FG001|Overall Study|Physician Decision|2|||
160854740|NCT02694744|580856659|FG000|Overall Study|Lost to Follow-up|1|||
160854741|NCT02694744|580856660|FG001|Overall Study|Lost to Follow-up|0|||
160854742|NCT02694744|580856659|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
160854743|NCT02694744|580856660|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
160854744|NCT00667888|580856661|FG000|Overall Study|Death|1|||
160854745|NCT00667888|580856662|FG001|Overall Study|Death|1|||
160854746|NCT00667888|580856661|FG000|Overall Study|Withdrawal by Subject|6|||
160854747|NCT00667888|580856662|FG001|Overall Study|Withdrawal by Subject|3|||
160854748|NCT00667888|580856661|FG000|Overall Study|Proceed with other treatment|3|||
160854749|NCT00667888|580856662|FG001|Overall Study|Proceed with other treatment|3|||
160854750|NCT00667888|580856661|FG000|Overall Study|Ineligible after SIM|0|||
160854751|NCT00667888|580856662|FG001|Overall Study|Ineligible after SIM|2|||
160854752|NCT01945021|580856663|FG000|Overall Study|Adverse Event|1|||
160854753|NCT01945021|580856663|FG000|Overall Study|Withdrawal of consent|12|||
160854754|NCT01945021|580856663|FG000|Overall Study|Lost to Follow-up|5|||
160854755|NCT01945021|580856663|FG000|Overall Study|Death|65|||
160854756|NCT04575155|580856664|FG000|2 Month|Withdrawal by Subject|1|||
160854757|NCT04575155|580856665|FG001|2 Month|Withdrawal by Subject|1|||
160854758|NCT04575155|580856664|FG000|2 Month|Lost to Follow-up|5|||
160854759|NCT04575155|580856665|FG001|2 Month|Lost to Follow-up|3|||
160854760|NCT04575155|580856664|FG000|2 Month|Ineligible|1|||
160854761|NCT04575155|580856665|FG001|2 Month|Ineligible|0|||
160854762|NCT02920892|580856667|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
160854763|NCT02920892|580856668|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
160854764|NCT02920892|580856669|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
160854765|NCT02920892|580856667|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
160854766|NCT02920892|580856668|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
160854767|NCT02920892|580856669|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
160854768|NCT02920892|580856667|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
160854769|NCT02920892|580856668|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
160854770|NCT02920892|580856669|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
160854771|NCT02920892|580856667|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
160854772|NCT02920892|580856668|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
160854773|NCT02920892|580856669|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
160854774|NCT02920892|580856667|FG000|Placebo-Controlled Period|Physician Decision|0|||
160854775|NCT02920892|580856668|FG001|Placebo-Controlled Period|Physician Decision|0|||
160854776|NCT02920892|580856669|FG002|Placebo-Controlled Period|Physician Decision|1|||
160854777|NCT02920892|580856667|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
160854778|NCT02920892|580856668|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
160854779|NCT02920892|580856669|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
160854780|NCT02920892|580856667|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
160854781|NCT02920892|580856668|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
160854782|NCT02920892|580856669|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
160854783|NCT02920892|580856667|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
160907579|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
160907580|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907581|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907582|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
161337436|NCT00251758|582625929|FG001|Overall Study|Noncompliant|2|||
160854784|NCT02920892|580856668|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
160854785|NCT02920892|580856669|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
160854786|NCT01216202|580856670|FG000|Overall Study|Withdrawal by Subject|8|||
160854787|NCT01216202|580856671|FG001|Overall Study|Withdrawal by Subject|0|||
160854788|NCT01216202|580856670|FG000|Overall Study|Death|0|||
160854789|NCT01216202|580856671|FG001|Overall Study|Death|2|||
160854790|NCT01216202|580856670|FG000|Overall Study|Lost to Follow-up|14|||
160854791|NCT01216202|580856671|FG001|Overall Study|Lost to Follow-up|0|||
160854792|NCT00360412|580856676|FG000|Overall Study|Adverse Event|37|||
160854793|NCT00360412|580856677|FG001|Overall Study|Adverse Event|65|||
160854794|NCT00360412|580856676|FG000|Overall Study|Protocol Violation|2|||
160854795|NCT00360412|580856677|FG001|Overall Study|Protocol Violation|5|||
160854796|NCT00360412|580856676|FG000|Overall Study|Patient withdrew consent|27|||
160854797|NCT00360412|580856677|FG001|Overall Study|Patient withdrew consent|52|||
160854798|NCT00360412|580856676|FG000|Overall Study|Lack of therapeutic efficacy|46|||
160854799|NCT00360412|580856677|FG001|Overall Study|Lack of therapeutic efficacy|61|||
160854800|NCT00360412|580856676|FG000|Overall Study|Physician Decision|2|||
160854801|NCT00360412|580856677|FG001|Overall Study|Physician Decision|4|||
160854802|NCT00360412|580856676|FG000|Overall Study|Other|5|||
160854803|NCT00360412|580856677|FG001|Overall Study|Other|6|||
160854804|NCT00360412|580856676|FG000|Overall Study|Study termination by Sponsor|214|||
160854805|NCT00360412|580856677|FG001|Overall Study|Study termination by Sponsor|469|||
160854806|NCT03863509|580856678|FG000|Overall Study|COVID-19 shutdown period|0|||
160854807|NCT03863509|580856679|FG001|Overall Study|COVID-19 shutdown period|4|||
160854808|NCT03863509|580856680|FG002|Overall Study|COVID-19 shutdown period|0|||
160854809|NCT03863509|580856678|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
160854810|NCT03863509|580856679|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
160854811|NCT03863509|580856680|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
160854812|NCT03863509|580856678|FG000|Overall Study|Lost to Follow-up|8|||
160854813|NCT03863509|580856679|FG001|Overall Study|Lost to Follow-up|0|||
160854814|NCT03863509|580856680|FG002|Overall Study|Lost to Follow-up|2|||
160854815|NCT03863509|580856678|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
160854816|NCT03863509|580856679|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
160854817|NCT03863509|580856680|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
160854818|NCT03863509|580856678|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
160854819|NCT03863509|580856679|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
160854820|NCT03863509|580856680|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
160854821|NCT03861273|580856681|FG000|Screening Phase (3 Weeks)|Other|1|||
160854822|NCT03861273|580856681|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
160854823|NCT03861273|580856681|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
160854824|NCT03861273|580856681|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
160854825|NCT03861273|580856681|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
160854826|NCT00191334|580856684|FG000|Overall Study|Adverse Event|4|||
160854827|NCT00191334|580856684|FG000|Overall Study|Disease Progression or Relapse|8|||
160854828|NCT00191334|580856684|FG000|Overall Study|Physician Decision|1|||
160854829|NCT00191334|580856684|FG000|Overall Study|Withdrawal by Subject|4|||
160854830|NCT02775916|580856686|FG000|Overall Study|Adverse Event|1|||
160854831|NCT02775916|580856687|FG001|Overall Study|Adverse Event|0|||
160854832|NCT02775916|580856686|FG000|Overall Study|Subject/Guardian Decision|2|||
160854833|NCT02775916|580856687|FG001|Overall Study|Subject/Guardian Decision|0|||
160854834|NCT00770653|580857773|FG000|Overall Study|Adverse Event|13|||
160854835|NCT00770653|580857774|FG001|Overall Study|Adverse Event|5|||
160854836|NCT00770653|580857773|FG000|Overall Study|Protocol Violation|8|||
160854837|NCT00770653|580857774|FG001|Overall Study|Protocol Violation|6|||
160854838|NCT00770653|580857773|FG000|Overall Study|Withdrawal by Subject|4|||
160854839|NCT00770653|580857774|FG001|Overall Study|Withdrawal by Subject|7|||
160854840|NCT00770653|580857773|FG000|Overall Study|Lack of Compliance|1|||
160854841|NCT00770653|580857774|FG001|Overall Study|Lack of Compliance|4|||
160854842|NCT00770653|580857773|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
160854843|NCT00770653|580857774|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
160854844|NCT00770653|580857773|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
160854845|NCT00770653|580857774|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
160854846|NCT00770653|580857773|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
160854847|NCT00770653|580857774|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
160854848|NCT00770653|580857773|FG000|Overall Study|Lost to Follow-up|1|||
160854849|NCT00770653|580857774|FG001|Overall Study|Lost to Follow-up|2|||
160854850|NCT00770653|580857773|FG000|Overall Study|Physician Decision|1|||
160854851|NCT00770653|580857774|FG001|Overall Study|Physician Decision|0|||
160854852|NCT01908426|580857777|FG000|Overall Study|Adverse Event|98|||
160854853|NCT01908426|580857778|FG001|Overall Study|Adverse Event|11|||
160854854|NCT01908426|580857777|FG000|Overall Study|Clinical Deterioration|72|||
160993109|NCT03227757|581365278|FG000|Overall Study|Withdrawal|10|||
160854855|NCT01908426|580857778|FG001|Overall Study|Clinical Deterioration|38|||
160854856|NCT01908426|580857777|FG000|Overall Study|Lack of Efficacy|3|||
160854857|NCT01908426|580857778|FG001|Overall Study|Lack of Efficacy|0|||
160854858|NCT01908426|580857777|FG000|Overall Study|Lost to Follow-up|0|||
160854859|NCT01908426|580857778|FG001|Overall Study|Lost to Follow-up|1|||
160854860|NCT01908426|580857777|FG000|Overall Study|Physician Decision|3|||
160854861|NCT01908426|580857778|FG001|Overall Study|Physician Decision|3|||
160854862|NCT01908426|580857777|FG000|Overall Study|Withdrawal by Subject|11|||
160854863|NCT01908426|580857778|FG001|Overall Study|Withdrawal by Subject|6|||
160854864|NCT01908426|580857777|FG000|Overall Study|Progressive Disease|206|||
160854865|NCT01908426|580857778|FG001|Overall Study|Progressive Disease|152|||
160854866|NCT01908426|580857777|FG000|Overall Study|Protocol Violation|1|||
160854867|NCT01908426|580857778|FG001|Overall Study|Protocol Violation|0|||
160854868|NCT01908426|580857777|FG000|Overall Study|No Study Treatment Given|3|||
160854869|NCT01908426|580857778|FG001|Overall Study|No Study Treatment Given|0|||
160854870|NCT02973100|580857786|FG000|Overall Study|Adverse Event|1|||
160854871|NCT02973100|580857787|FG001|Overall Study|Adverse Event|2|||
160854872|NCT02973100|580857788|FG002|Overall Study|Adverse Event|1|||
160854873|NCT02973100|580857789|FG003|Overall Study|Adverse Event|2|||
160854874|NCT02973100|580857786|FG000|Overall Study|Lost to Follow-up|3|||
160854875|NCT02973100|580857787|FG001|Overall Study|Lost to Follow-up|1|||
160854876|NCT02973100|580857788|FG002|Overall Study|Lost to Follow-up|1|||
160854877|NCT02973100|580857789|FG003|Overall Study|Lost to Follow-up|0|||
160854878|NCT02973100|580857786|FG000|Overall Study|Withdrawal by Subject|3|||
160854879|NCT02973100|580857787|FG001|Overall Study|Withdrawal by Subject|5|||
160854880|NCT02973100|580857788|FG002|Overall Study|Withdrawal by Subject|1|||
160854881|NCT02973100|580857789|FG003|Overall Study|Withdrawal by Subject|4|||
160854882|NCT02973100|580857786|FG000|Overall Study|Notification of change in address|0|||
160854883|NCT02973100|580857787|FG001|Overall Study|Notification of change in address|0|||
160854884|NCT02973100|580857788|FG002|Overall Study|Notification of change in address|0|||
160854885|NCT02973100|580857789|FG003|Overall Study|Notification of change in address|1|||
160854886|NCT02973100|580857786|FG000|Overall Study|Failed to attend Safety followup period|0|||
160854887|NCT02973100|580857787|FG001|Overall Study|Failed to attend Safety followup period|0|||
160854888|NCT02973100|580857788|FG002|Overall Study|Failed to attend Safety followup period|1|||
160854889|NCT02973100|580857789|FG003|Overall Study|Failed to attend Safety followup period|0|||
160854890|NCT02426580|580857790|FG000|Overall Study|Death|2|||
160854891|NCT02426580|580857791|FG001|Overall Study|Death|2|||
160854892|NCT02426580|580857790|FG000|Overall Study|Lost to Follow-up|0|||
160854893|NCT02426580|580857791|FG001|Overall Study|Lost to Follow-up|9|||
160854894|NCT02426580|580857790|FG000|Overall Study|transfer to hemodialysis|5|||
160854895|NCT02426580|580857791|FG001|Overall Study|transfer to hemodialysis|5|||
160854896|NCT02426580|580857790|FG000|Overall Study|Kidney transplant|3|||
160854897|NCT02426580|580857791|FG001|Overall Study|Kidney transplant|0|||
160854898|NCT02426580|580857790|FG000|Overall Study|Allergic to egg white|1|||
160854899|NCT02426580|580857791|FG001|Overall Study|Allergic to egg white|0|||
160854900|NCT04456504|580857794|FG000|Overall Study|Lost to Follow-up|2|||
160854901|NCT01342913|580857795|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
160854902|NCT01342913|580857796|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160854903|NCT01342913|580857797|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
160854904|NCT01342913|580857795|FG000|2-week Run-in Period|Physician Decision|6|||
160854905|NCT01342913|580857796|FG001|2-week Run-in Period|Physician Decision|0|||
160854906|NCT01342913|580857797|FG002|2-week Run-in Period|Physician Decision|0|||
160854907|NCT01342913|580857795|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
160854908|NCT01342913|580857796|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160854909|NCT01342913|580857797|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160854910|NCT01342913|580857795|FG000|2-week Run-in Period|Adverse Event|2|||
160854911|NCT01342913|580857796|FG001|2-week Run-in Period|Adverse Event|0|||
160854912|NCT01342913|580857797|FG002|2-week Run-in Period|Adverse Event|0|||
160907583|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907584|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907585|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
160907586|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907587|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
160907588|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160854913|NCT01342913|580857795|FG000|2-week Run-in Period|Protocol Violation|5|||
160907589|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160993110|NCT03227757|581365278|FG000|Overall Study|Missed visits|1|||
160854914|NCT01342913|580857796|FG001|2-week Run-in Period|Protocol Violation|0|||
160854915|NCT01342913|580857797|FG002|2-week Run-in Period|Protocol Violation|0|||
160854916|NCT01342913|580857795|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
160854917|NCT01342913|580857796|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
160854918|NCT01342913|580857797|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
160854919|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160854920|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Adverse Event|3|||
160993111|NCT03227757|581365278|FG000|Overall Study|Lost to Follow-up|2|||
160993112|NCT01144468|581365281|FG000|Overall Study|Lost to Follow-up|4|||
160993113|NCT01144468|581365282|FG001|Overall Study|Lost to Follow-up|7|||
160993114|NCT01144468|581365281|FG000|Overall Study|Adverse Event|3|||
160993115|NCT01144468|581365282|FG001|Overall Study|Adverse Event|2|||
160993116|NCT01144468|581365281|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
160993117|NCT01144468|581365282|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
160993118|NCT02960659|581365283|FG000|Overall Study|Withdrawal by Subject|1|||
160993119|NCT02960659|581365284|FG001|Overall Study|Withdrawal by Subject|0|||
160993120|NCT02960659|581365283|FG000|Overall Study|Poor compliance|0|||
160993121|NCT02960659|581365284|FG001|Overall Study|Poor compliance|1|||
160993122|NCT04199728|581365290|FG000|Overall Study|Adverse Event|1|||
160993123|NCT04199728|581365291|FG001|Overall Study|Adverse Event|0|||
160993124|NCT04199728|581365290|FG000|Overall Study|Withdrawal by Subject|8|||
160993125|NCT04199728|581365291|FG001|Overall Study|Withdrawal by Subject|3|||
160993126|NCT04199728|581365290|FG000|Overall Study|Screen fail after consent|0|||
160993127|NCT04199728|581365291|FG001|Overall Study|Screen fail after consent|1|||
160993128|NCT04199728|581365290|FG000|Overall Study|Early withdraw criteria met|0|||
160993129|NCT04199728|581365291|FG001|Overall Study|Early withdraw criteria met|1|||
160993130|NCT04199728|581365290|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
160993131|NCT04199728|581365291|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
160993132|NCT01875250|581365294|FG000|Overall Study|Adverse Event|2|||
160993133|NCT01875250|581365295|FG001|Overall Study|Adverse Event|0|||
160993134|NCT04057196|581365299|FG000|Overall Study|Withdrawal by Subject|3|||
160993135|NCT04057196|581365299|FG000|Overall Study|Death|3|||
161141312|NCT02296840|581901059|FG001|Overall Study|Lost to Follow-up|17|||
161141313|NCT02485717|581901060|FG000|Overall Study|Lost to Follow-up|6|||
161141314|NCT02485717|581901061|FG001|Overall Study|Lost to Follow-up|0|||
161141315|NCT02485717|581901062|FG002|Overall Study|Lost to Follow-up|0|||
161141316|NCT02485717|581901060|FG000|Overall Study|Withdrawal by Subject|0|||
161141317|NCT02485717|581901061|FG001|Overall Study|Withdrawal by Subject|0|||
161141318|NCT02485717|581901062|FG002|Overall Study|Withdrawal by Subject|1|||
161141319|NCT02485717|581901060|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
161141320|NCT02485717|581901061|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
161141321|NCT02485717|581901062|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
161141322|NCT02485717|581901060|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
161141323|NCT02485717|581901061|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
161141324|NCT02485717|581901062|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
161141325|NCT02827877|581901063|FG000|Overall Study|Withdrawal by Subject|1|||
161141326|NCT00519532|581901066|FG000|Overall Study|Adverse Event|11|||
161141327|NCT00519532|581901066|FG000|Overall Study|Withdrawal by Subject|5|||
161141328|NCT00519532|581901066|FG000|Overall Study|Lost to Follow-up|2|||
161141329|NCT00814710|581901067|FG000|Overall Study|Adverse Event|1|||
161141330|NCT00814710|581901068|FG001|Overall Study|Adverse Event|0|||
161141331|NCT00814710|581901067|FG000|Overall Study|Lost to Follow-up|7|||
161141332|NCT00814710|581901068|FG001|Overall Study|Lost to Follow-up|3|||
161141333|NCT01450540|581901069|FG000|Overall Study|Withdrawal by Subject|19|||
161141334|NCT01450540|581901070|FG001|Overall Study|Withdrawal by Subject|13|||
161141335|NCT01450540|581901069|FG000|Overall Study|protocol deviation|3|||
161141336|NCT01450540|581901070|FG001|Overall Study|protocol deviation|23|||
161141337|NCT01887210|581901073|FG000|Overall Study|Withdrawal by Subject|1|||
161141338|NCT01887210|581901074|FG001|Overall Study|Withdrawal by Subject|3|||
161141339|NCT01887210|581901073|FG000|Overall Study|Lost to Follow-up|0|||
161141340|NCT01887210|581901074|FG001|Overall Study|Lost to Follow-up|1|||
161141341|NCT02515669|581901081|FG000|228 Week Open-Label Phase|Other|0|||
161141342|NCT02515669|581901082|FG001|228 Week Open-Label Phase|Other|0|||
161141343|NCT02515669|581901083|FG002|228 Week Open-Label Phase|Other|1|||
160993136|NCT03140176|581365303|FG000|Overall Study|Reason missing|23|||
160993137|NCT03140176|581365303|FG000|Overall Study|Death|33|||
160993138|NCT03140176|581365303|FG000|Overall Study|Disease progression|1|||
161141344|NCT02515669|581901084|FG003|228 Week Open-Label Phase|Other|4|||
161141345|NCT02515669|581901081|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
161141346|NCT02515669|581901082|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
161141347|NCT02515669|581901083|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
161141348|NCT02515669|581901084|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
161141349|NCT02515669|581901081|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
161141350|NCT02515669|581901082|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
161141351|NCT02515669|581901083|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
161141352|NCT02515669|581901084|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
160993139|NCT03140176|581365303|FG000|Overall Study|Physician Decision|1|||
160993140|NCT03140176|581365303|FG000|Overall Study|Withdrawal by Subject|1|||
160993141|NCT03140176|581365303|FG000|Overall Study|Lost to Follow-up|15|||
160993142|NCT01268891|581365313|FG000|Overall Study|Adverse Event|3|||
160993143|NCT01268891|581365314|FG001|Overall Study|Adverse Event|7|||
160993144|NCT01268891|581365313|FG000|Overall Study|Lack of Efficacy|1|||
160907590|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907591|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907592|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907593|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
160907594|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
160907595|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
160907596|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907597|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907598|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907599|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907600|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907601|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
160907602|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
160907603|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907604|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907605|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907606|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907607|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907608|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907609|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
160907610|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
160907611|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
160907612|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907613|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907614|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907615|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907616|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907617|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
160907618|NCT03095066|581056307|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
160907619|NCT03095066|581056308|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
160907620|NCT03095066|581056309|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907621|NCT03095066|581056310|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907622|NCT03095066|581056311|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907623|NCT03095066|581056312|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907624|NCT03095066|581056313|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907625|NCT03095066|581056314|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
160907626|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907627|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907628|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
160907629|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907630|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907631|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907632|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
160907633|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
160907634|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907635|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907636|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
160907637|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907638|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907639|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907640|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
160907641|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
160907642|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907643|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907644|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
160907645|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907646|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907647|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907648|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
160907649|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
160907650|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907651|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907652|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
160907653|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907654|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
161337437|NCT00251758|582625930|FG002|Overall Study|Noncompliant|2|||
160854921|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Adverse Event|6|||
160854922|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
160854923|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
160854924|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
160854925|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160854926|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
160854927|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
160854928|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160854929|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160854930|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
160854931|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Physician Decision|0|||
160854932|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Physician Decision|2|||
160854933|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Physician Decision|0|||
160854934|NCT01342913|580857795|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160854935|NCT01342913|580857796|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160854936|NCT01342913|580857797|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
160854937|NCT02869633|580857801|FG000|Overall Study|Death|2|||
160854938|NCT02869633|580857802|FG001|Overall Study|Death|1|||
160854939|NCT02869633|580857801|FG000|Overall Study|Patient refused follow-up|1|||
160854940|NCT02869633|580857802|FG001|Overall Study|Patient refused follow-up|0|||
160907655|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907656|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
160907657|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
160907658|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907659|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907660|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
160907661|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907662|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907663|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907664|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907665|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
160907666|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907667|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907668|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
160907669|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907670|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907671|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907672|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
160907673|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
160907674|NCT03095066|581056307|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907675|NCT03095066|581056308|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907676|NCT03095066|581056309|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907677|NCT03095066|581056310|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907678|NCT03095066|581056311|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907679|NCT03095066|581056312|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907680|NCT03095066|581056313|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
160907681|NCT03095066|581056314|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
160907682|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907683|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907684|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907685|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907686|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907687|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
160907688|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907689|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
160907690|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907691|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907692|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907693|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907694|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
160907695|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907696|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
160907697|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
160907698|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907699|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907700|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907701|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907702|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
160907703|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160854941|NCT02869633|580857801|FG000|Overall Study|Provider discretion|1|||
160854942|NCT02869633|580857802|FG001|Overall Study|Provider discretion|0|||
160854943|NCT02869633|580857801|FG000|Overall Study|Investigator decision|1|||
160993145|NCT01268891|581365314|FG001|Overall Study|Lack of Efficacy|0|||
160854944|NCT02869633|580857802|FG001|Overall Study|Investigator decision|0|||
160854945|NCT02869633|580857801|FG000|Overall Study|Lost to Follow-up|0|||
160854946|NCT02869633|580857802|FG001|Overall Study|Lost to Follow-up|1|||
160854947|NCT02869633|580857801|FG000|Overall Study|Not eligible|6|||
160854948|NCT02869633|580857802|FG001|Overall Study|Not eligible|1|||
160854949|NCT02869633|580857801|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
160854950|NCT02869633|580857802|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
160854951|NCT02869633|580857801|FG000|Overall Study|Withdrawal by Subject|0|||
160854952|NCT02869633|580857802|FG001|Overall Study|Withdrawal by Subject|1|||
160854953|NCT03287791|580857804|FG000|Overall Study|Insufficient Therapeutic Response|0|||
160854954|NCT03287791|580857805|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160854955|NCT03287791|580857806|FG002|Overall Study|Insufficient Therapeutic Response|1|||
160854956|NCT03287791|580857804|FG000|Overall Study|Adverse Event|0|||
160993146|NCT01268891|581365313|FG000|Overall Study|Withdrawal of Consent|3|||
160993147|NCT01268891|581365314|FG001|Overall Study|Withdrawal of Consent|1|||
160993148|NCT01268891|581365313|FG000|Overall Study|Administrative or other reason(s)|1|||
160993149|NCT01268891|581365314|FG001|Overall Study|Administrative or other reason(s)|0|||
160993150|NCT00991276|581365316|FG000|First Intervention Period|Adverse Event|0|||
160993151|NCT00991276|581365317|FG001|First Intervention Period|Adverse Event|1|||
160993152|NCT00991276|581365318|FG002|First Intervention Period|Adverse Event|0|||
160993153|NCT00991276|581365319|FG003|First Intervention Period|Adverse Event|1|||
160993154|NCT00991276|581365320|FG004|First Intervention Period|Adverse Event|0|||
160993155|NCT00991276|581365321|FG005|First Intervention Period|Adverse Event|0|||
160993156|NCT00991276|581365316|FG000|First Intervention Period|Protocol Violation|0|||
160993157|NCT00991276|581365317|FG001|First Intervention Period|Protocol Violation|0|||
160993158|NCT00991276|581365318|FG002|First Intervention Period|Protocol Violation|0|||
160993159|NCT00991276|581365319|FG003|First Intervention Period|Protocol Violation|0|||
160993160|NCT00991276|581365320|FG004|First Intervention Period|Protocol Violation|2|||
160993161|NCT00991276|581365321|FG005|First Intervention Period|Protocol Violation|0|||
160993162|NCT00991276|581365316|FG000|First Intervention Period|Insufficient clinical response|0|||
160993163|NCT00991276|581365317|FG001|First Intervention Period|Insufficient clinical response|0|||
160993164|NCT00991276|581365318|FG002|First Intervention Period|Insufficient clinical response|0|||
160993165|NCT00991276|581365319|FG003|First Intervention Period|Insufficient clinical response|0|||
160993166|NCT00991276|581365320|FG004|First Intervention Period|Insufficient clinical response|1|||
160993167|NCT00991276|581365321|FG005|First Intervention Period|Insufficient clinical response|0|||
160993168|NCT00991276|581365316|FG000|First Intervention Period|Other|0|||
160993169|NCT00991276|581365317|FG001|First Intervention Period|Other|0|||
160993170|NCT00991276|581365318|FG002|First Intervention Period|Other|0|||
160993171|NCT00991276|581365319|FG003|First Intervention Period|Other|1|||
160993172|NCT00991276|581365320|FG004|First Intervention Period|Other|1|||
160993173|NCT00991276|581365321|FG005|First Intervention Period|Other|0|||
160993174|NCT00991276|581365316|FG000|First Intervention Period|Withdrawal by Subject|0|||
160993175|NCT00991276|581365317|FG001|First Intervention Period|Withdrawal by Subject|1|||
160993176|NCT00991276|581365318|FG002|First Intervention Period|Withdrawal by Subject|0|||
160993177|NCT00991276|581365319|FG003|First Intervention Period|Withdrawal by Subject|1|||
160993178|NCT00991276|581365320|FG004|First Intervention Period|Withdrawal by Subject|0|||
160993179|NCT00991276|581365321|FG005|First Intervention Period|Withdrawal by Subject|1|||
160993180|NCT00991276|581365316|FG000|First Intervention Period|Lost to Follow-up|0|||
160993181|NCT00991276|581365317|FG001|First Intervention Period|Lost to Follow-up|1|||
160993182|NCT00991276|581365318|FG002|First Intervention Period|Lost to Follow-up|0|||
160993183|NCT00991276|581365319|FG003|First Intervention Period|Lost to Follow-up|1|||
160993184|NCT00991276|581365320|FG004|First Intervention Period|Lost to Follow-up|0|||
160993185|NCT00991276|581365321|FG005|First Intervention Period|Lost to Follow-up|0|||
160993186|NCT00991276|581365316|FG000|Second Intervention Period|Adverse Event|0|||
160854957|NCT03287791|580857805|FG001|Overall Study|Adverse Event|4|||
160854958|NCT03287791|580857806|FG002|Overall Study|Adverse Event|3|||
160993187|NCT00991276|581365317|FG001|Second Intervention Period|Adverse Event|2|||
160993188|NCT00991276|581365318|FG002|Second Intervention Period|Adverse Event|0|||
160993189|NCT00991276|581365319|FG003|Second Intervention Period|Adverse Event|1|||
160993190|NCT00991276|581365320|FG004|Second Intervention Period|Adverse Event|1|||
161337438|NCT00251758|582625928|FG000|Overall Study|Pregnancy|0|||
160854959|NCT03287791|580857804|FG000|Overall Study|Withdrawal by Subject|12|||
160854960|NCT03287791|580857805|FG001|Overall Study|Withdrawal by Subject|12|||
160854961|NCT03287791|580857806|FG002|Overall Study|Withdrawal by Subject|17|||
160993191|NCT00991276|581365321|FG005|Second Intervention Period|Adverse Event|0|||
160993192|NCT00991276|581365316|FG000|Second Intervention Period|Protocol Violation|1|||
160993193|NCT00991276|581365317|FG001|Second Intervention Period|Protocol Violation|0|||
160993194|NCT00991276|581365318|FG002|Second Intervention Period|Protocol Violation|0|||
161337439|NCT00251758|582625929|FG001|Overall Study|Pregnancy|1|||
161337440|NCT00251758|582625930|FG002|Overall Study|Pregnancy|0|||
160854962|NCT03287791|580857804|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
160854963|NCT03287791|580857805|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
160993195|NCT00991276|581365319|FG003|Second Intervention Period|Protocol Violation|0|||
160993196|NCT00991276|581365320|FG004|Second Intervention Period|Protocol Violation|0|||
160993197|NCT00991276|581365321|FG005|Second Intervention Period|Protocol Violation|0|||
160993198|NCT00991276|581365316|FG000|Second Intervention Period|Other|0|||
160993199|NCT00991276|581365317|FG001|Second Intervention Period|Other|0|||
160993200|NCT00991276|581365318|FG002|Second Intervention Period|Other|0|||
160993201|NCT00991276|581365319|FG003|Second Intervention Period|Other|1|||
160993202|NCT00991276|581365320|FG004|Second Intervention Period|Other|0|||
160993203|NCT00991276|581365321|FG005|Second Intervention Period|Other|1|||
160993204|NCT00991276|581365316|FG000|Third Intervention Period|Protocol Violation|1|||
160993205|NCT00991276|581365317|FG001|Third Intervention Period|Protocol Violation|0|||
160993206|NCT00991276|581365318|FG002|Third Intervention Period|Protocol Violation|0|||
160993207|NCT00991276|581365319|FG003|Third Intervention Period|Protocol Violation|0|||
160993208|NCT00991276|581365320|FG004|Third Intervention Period|Protocol Violation|0|||
160993209|NCT00991276|581365321|FG005|Third Intervention Period|Protocol Violation|0|||
161141353|NCT02515669|581901081|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
161255247|NCT02688387|582314139|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255248|NCT02688387|582314140|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255249|NCT02688387|582314141|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255250|NCT02688387|582314142|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255251|NCT02688387|582314143|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161337441|NCT00251758|582625928|FG000|Overall Study|Per Subject Request|0|||
160854964|NCT03287791|580857806|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
160854965|NCT03287791|580857804|FG000|Overall Study|Lost to Follow-up|8|||
160854966|NCT03287791|580857805|FG001|Overall Study|Lost to Follow-up|14|||
160854967|NCT03287791|580857806|FG002|Overall Study|Lost to Follow-up|11|||
160854968|NCT03287791|580857804|FG000|Overall Study|Protocol Violation|7|||
160854969|NCT03287791|580857805|FG001|Overall Study|Protocol Violation|2|||
160854970|NCT03287791|580857806|FG002|Overall Study|Protocol Violation|1|||
160854971|NCT03287791|580857804|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
160854972|NCT03287791|580857805|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
160854973|NCT03287791|580857806|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
160854974|NCT03287791|580857804|FG000|Overall Study|Too much time between 2 visits|0|||
160854975|NCT03287791|580857805|FG001|Overall Study|Too much time between 2 visits|1|||
160854976|NCT03287791|580857806|FG002|Overall Study|Too much time between 2 visits|0|||
160854977|NCT03287791|580857804|FG000|Overall Study|Non-compliance|0|||
160854978|NCT03287791|580857805|FG001|Overall Study|Non-compliance|1|||
160854979|NCT03287791|580857806|FG002|Overall Study|Non-compliance|0|||
160854980|NCT03287791|580857804|FG000|Overall Study|Did not meet inclusion criteria|1|||
160854981|NCT03287791|580857805|FG001|Overall Study|Did not meet inclusion criteria|0|||
160854982|NCT03287791|580857806|FG002|Overall Study|Did not meet inclusion criteria|0|||
160854983|NCT01381016|580857808|FG000|Overall Study|Lost to Follow-up|1|||
160854984|NCT01381016|580857809|FG001|Overall Study|Lost to Follow-up|1|||
160854985|NCT01381016|580857808|FG000|Overall Study|Screen Failure|2|||
160854986|NCT01381016|580857809|FG001|Overall Study|Screen Failure|2|||
160854987|NCT01381016|580857808|FG000|Overall Study|Withdrawal by Subject|0|||
160854988|NCT01381016|580857809|FG001|Overall Study|Withdrawal by Subject|1|||
160854989|NCT01381016|580857808|FG000|Overall Study|Physician Decision|0|||
160854990|NCT01381016|580857809|FG001|Overall Study|Physician Decision|2|||
160854991|NCT03598036|580857815|FG000|Overall Study|Withdrawal by Subject|1|||
160854992|NCT03598036|580857816|FG001|Overall Study|Withdrawal by Subject|0|||
160854993|NCT02891174|580857817|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
160854994|NCT02891174|580857818|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
160854995|NCT02891174|580857817|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
160854996|NCT02891174|580857818|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
160854997|NCT02891174|580857817|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
160854998|NCT02891174|580857818|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
160854999|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
160855000|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
160855001|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
160855002|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
160855003|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
160855004|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
160855005|NCT02891174|580857817|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
160855006|NCT02891174|580857818|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
160855007|NCT04319198|580857821|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
160855008|NCT04319198|580857822|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
160855009|NCT04319198|580857823|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
160993210|NCT00991276|581365316|FG000|Third Intervention Period|Other|0|||
160993211|NCT00991276|581365317|FG001|Third Intervention Period|Other|0|||
160993212|NCT00991276|581365318|FG002|Third Intervention Period|Other|0|||
160993213|NCT00991276|581365319|FG003|Third Intervention Period|Other|0|||
160993214|NCT00991276|581365320|FG004|Third Intervention Period|Other|0|||
160993215|NCT00991276|581365321|FG005|Third Intervention Period|Other|1|||
160993216|NCT00991276|581365316|FG000|Third Intervention Period|Adverse Event|0|||
160993217|NCT00991276|581365317|FG001|Third Intervention Period|Adverse Event|0|||
160993218|NCT00991276|581365318|FG002|Third Intervention Period|Adverse Event|1|||
160993219|NCT00991276|581365319|FG003|Third Intervention Period|Adverse Event|0|||
160993220|NCT00991276|581365320|FG004|Third Intervention Period|Adverse Event|0|||
160993221|NCT00991276|581365321|FG005|Third Intervention Period|Adverse Event|0|||
160993222|NCT00991276|581365316|FG000|Third Intervention Period|Withdrawal by Subject|0|||
160993223|NCT00991276|581365317|FG001|Third Intervention Period|Withdrawal by Subject|0|||
160993224|NCT00991276|581365318|FG002|Third Intervention Period|Withdrawal by Subject|0|||
160993225|NCT00991276|581365319|FG003|Third Intervention Period|Withdrawal by Subject|1|||
160993226|NCT00991276|581365320|FG004|Third Intervention Period|Withdrawal by Subject|0|||
160993227|NCT00991276|581365321|FG005|Third Intervention Period|Withdrawal by Subject|0|||
160993228|NCT02001623|581365322|FG000|Overall Study|Disease Progression|2|||
160993229|NCT02001623|581365323|FG001|Overall Study|Disease Progression|2|||
160993230|NCT02001623|581365324|FG002|Overall Study|Disease Progression|3|||
160993231|NCT02001623|581365325|FG003|Overall Study|Disease Progression|2|||
160993232|NCT02001623|581365326|FG004|Overall Study|Disease Progression|3|||
160993233|NCT02001623|581365327|FG005|Overall Study|Disease Progression|2|||
160993234|NCT02001623|581365328|FG006|Overall Study|Disease Progression|3|||
160993235|NCT02001623|581365329|FG007|Overall Study|Disease Progression|3|||
160993236|NCT02001623|581365330|FG008|Overall Study|Disease Progression|7|||
160993237|NCT02001623|581365331|FG009|Overall Study|Disease Progression|40|||
160993238|NCT02001623|581365332|FG010|Overall Study|Disease Progression|5|||
160993239|NCT02001623|581365333|FG011|Overall Study|Disease Progression|9|||
160993240|NCT02001623|581365334|FG012|Overall Study|Disease Progression|9|||
160993241|NCT02001623|581365335|FG013|Overall Study|Disease Progression|20|||
160993242|NCT02001623|581365336|FG014|Overall Study|Disease Progression|9|||
160993243|NCT02001623|581365322|FG000|Overall Study|Physician Decision|0|||
160993244|NCT02001623|581365323|FG001|Overall Study|Physician Decision|0|||
160993245|NCT02001623|581365324|FG002|Overall Study|Physician Decision|0|||
160993246|NCT02001623|581365325|FG003|Overall Study|Physician Decision|0|||
160993247|NCT02001623|581365326|FG004|Overall Study|Physician Decision|0|||
160993248|NCT02001623|581365327|FG005|Overall Study|Physician Decision|0|||
160993249|NCT02001623|581365328|FG006|Overall Study|Physician Decision|0|||
160993250|NCT02001623|581365329|FG007|Overall Study|Physician Decision|0|||
160993251|NCT02001623|581365330|FG008|Overall Study|Physician Decision|3|||
160993252|NCT02001623|581365331|FG009|Overall Study|Physician Decision|2|||
160993253|NCT02001623|581365332|FG010|Overall Study|Physician Decision|3|||
160993254|NCT02001623|581365333|FG011|Overall Study|Physician Decision|3|||
160993255|NCT02001623|581365334|FG012|Overall Study|Physician Decision|1|||
160993256|NCT02001623|581365335|FG013|Overall Study|Physician Decision|2|||
160993257|NCT02001623|581365336|FG014|Overall Study|Physician Decision|1|||
160993258|NCT02001623|581365322|FG000|Overall Study|Death|0|||
160993259|NCT02001623|581365323|FG001|Overall Study|Death|1|||
160993260|NCT02001623|581365324|FG002|Overall Study|Death|0|||
160993261|NCT02001623|581365325|FG003|Overall Study|Death|0|||
160993262|NCT02001623|581365326|FG004|Overall Study|Death|0|||
160993263|NCT02001623|581365327|FG005|Overall Study|Death|0|||
160993264|NCT02001623|581365328|FG006|Overall Study|Death|0|||
160993265|NCT02001623|581365329|FG007|Overall Study|Death|0|||
160855010|NCT04319198|580857821|FG000|Overall Study|Death|0|||
160855011|NCT04319198|580857822|FG001|Overall Study|Death|3|||
160855012|NCT04319198|580857823|FG002|Overall Study|Death|3|||
160855013|NCT04319198|580857821|FG000|Overall Study|Reason Not Specified|0|||
160993266|NCT02001623|581365330|FG008|Overall Study|Death|0|||
160993267|NCT02001623|581365331|FG009|Overall Study|Death|0|||
160993268|NCT02001623|581365332|FG010|Overall Study|Death|0|||
160993269|NCT02001623|581365333|FG011|Overall Study|Death|0|||
160993270|NCT02001623|581365334|FG012|Overall Study|Death|0|||
160993271|NCT02001623|581365335|FG013|Overall Study|Death|0|||
160993272|NCT02001623|581365336|FG014|Overall Study|Death|0|||
160993273|NCT02001623|581365322|FG000|Overall Study|Adverse Event|0|||
160993274|NCT02001623|581365323|FG001|Overall Study|Adverse Event|0|||
160993275|NCT02001623|581365324|FG002|Overall Study|Adverse Event|0|||
160993276|NCT02001623|581365325|FG003|Overall Study|Adverse Event|0|||
160993277|NCT02001623|581365326|FG004|Overall Study|Adverse Event|0|||
160993278|NCT02001623|581365327|FG005|Overall Study|Adverse Event|1|||
160993279|NCT02001623|581365328|FG006|Overall Study|Adverse Event|0|||
160993280|NCT02001623|581365329|FG007|Overall Study|Adverse Event|3|||
160993281|NCT02001623|581365330|FG008|Overall Study|Adverse Event|4|||
160993282|NCT02001623|581365331|FG009|Overall Study|Adverse Event|6|||
160855014|NCT04319198|580857822|FG001|Overall Study|Reason Not Specified|2|||
160993283|NCT02001623|581365332|FG010|Overall Study|Adverse Event|4|||
160993284|NCT02001623|581365333|FG011|Overall Study|Adverse Event|0|||
160855015|NCT04319198|580857823|FG002|Overall Study|Reason Not Specified|4|||
161255252|NCT02688387|582314144|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255253|NCT02688387|582314145|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255254|NCT02688387|582314146|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255255|NCT02688387|582314147|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255256|NCT02688387|582314148|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255257|NCT02688387|582314149|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255258|NCT02688387|582314150|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160855016|NCT04319198|580857821|FG000|Overall Study|Withdrawal of Consent|0|||
160855017|NCT04319198|580857822|FG001|Overall Study|Withdrawal of Consent|0|||
160855018|NCT04319198|580857823|FG002|Overall Study|Withdrawal of Consent|5|||
160855019|NCT04319198|580857821|FG000|Overall Study|Site Terminated by Sponsor|0|||
160855020|NCT04319198|580857822|FG001|Overall Study|Site Terminated by Sponsor|1|||
160855021|NCT04319198|580857823|FG002|Overall Study|Site Terminated by Sponsor|0|||
160855022|NCT04607668|580857828|FG000|Overall Study|Death|49|||
160855023|NCT04607668|580857829|FG001|Overall Study|Death|26|||
160855024|NCT04607668|580857828|FG000|Overall Study|Lost to Follow-up|3|||
160855025|NCT04607668|580857829|FG001|Overall Study|Lost to Follow-up|4|||
160855026|NCT04607668|580857828|FG000|Overall Study|Study terminated by Sponsor|92|||
160855027|NCT04607668|580857829|FG001|Overall Study|Study terminated by Sponsor|114|||
160855028|NCT04607668|580857828|FG000|Overall Study|Withdrawal by Subject|12|||
160855029|NCT04607668|580857829|FG001|Overall Study|Withdrawal by Subject|11|||
160855030|NCT04607668|580857828|FG000|Overall Study|Other, unspecified|8|||
160855031|NCT04607668|580857829|FG001|Overall Study|Other, unspecified|7|||
160855032|NCT02250326|580857830|FG000|Treatment|Death|1|||
160855033|NCT02250326|580857831|FG001|Treatment|Death|13|||
160855034|NCT02250326|580857832|FG002|Treatment|Death|2|||
160855035|NCT02250326|580857830|FG000|Treatment|Adverse Event|8|||
160855036|NCT02250326|580857831|FG001|Treatment|Adverse Event|8|||
160855037|NCT02250326|580857832|FG002|Treatment|Adverse Event|9|||
160855038|NCT02250326|580857830|FG000|Treatment|Progressive Disease|42|||
160855039|NCT02250326|580857831|FG001|Treatment|Progressive Disease|40|||
160855040|NCT02250326|580857832|FG002|Treatment|Progressive Disease|47|||
160855041|NCT02250326|580857830|FG000|Treatment|Symptomatic Deterioration|9|||
160855042|NCT02250326|580857831|FG001|Treatment|Symptomatic Deterioration|4|||
160855043|NCT02250326|580857832|FG002|Treatment|Symptomatic Deterioration|10|||
160855044|NCT02250326|580857830|FG000|Treatment|Withdrawal by Subject|11|||
160855045|NCT02250326|580857831|FG001|Treatment|Withdrawal by Subject|6|||
160855046|NCT02250326|580857832|FG002|Treatment|Withdrawal by Subject|4|||
160855047|NCT02250326|580857830|FG000|Treatment|Other reasons|8|||
160855048|NCT02250326|580857831|FG001|Treatment|Other reasons|7|||
160855049|NCT02250326|580857832|FG002|Treatment|Other reasons|7|||
160855050|NCT02250326|580857830|FG000|Extension Period|Progressive Disease|0|||
160855051|NCT02250326|580857831|FG001|Extension Period|Progressive Disease|2|||
160855052|NCT02250326|580857832|FG002|Extension Period|Progressive Disease|0|||
160855053|NCT02250326|580857830|FG000|Extension Period|Withdrawal by Subject|0|||
160855054|NCT02250326|580857831|FG001|Extension Period|Withdrawal by Subject|1|||
160855055|NCT02250326|580857832|FG002|Extension Period|Withdrawal by Subject|0|||
160855056|NCT02250326|580857830|FG000|Extension Period|Withdrawal by investigator|0|||
160855057|NCT02250326|580857831|FG001|Extension Period|Withdrawal by investigator|1|||
160855058|NCT02250326|580857832|FG002|Extension Period|Withdrawal by investigator|0|||
160855059|NCT01693029|580857833|FG000|Overall Study|Withdrawal by Subject|15|||
160855060|NCT01693029|580857834|FG001|Overall Study|Withdrawal by Subject|22|||
160855061|NCT01693029|580857833|FG000|Overall Study|Kidney transplantation|7|||
160855062|NCT01693029|580857834|FG001|Overall Study|Kidney transplantation|7|||
160855063|NCT01693029|580857833|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
160855064|NCT01693029|580857834|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
160855065|NCT01693029|580857833|FG000|Overall Study|Protocol Violation|6|||
160855066|NCT01693029|580857834|FG001|Overall Study|Protocol Violation|7|||
160855067|NCT01693029|580857833|FG000|Overall Study|Change in dialysis modality|2|||
160855068|NCT01693029|580857834|FG001|Overall Study|Change in dialysis modality|1|||
160855069|NCT01693029|580857833|FG000|Overall Study|Physician Decision|0|||
160855070|NCT01693029|580857834|FG001|Overall Study|Physician Decision|2|||
160855071|NCT01693029|580857833|FG000|Overall Study|Lost to Follow-up|0|||
160855072|NCT01693029|580857834|FG001|Overall Study|Lost to Follow-up|1|||
160855073|NCT01693029|580857833|FG000|Overall Study|Adverse Event|1|||
160855074|NCT01693029|580857834|FG001|Overall Study|Adverse Event|6|||
160855075|NCT01693029|580857833|FG000|Overall Study|Death|5|||
160855076|NCT01693029|580857834|FG001|Overall Study|Death|8|||
160855077|NCT01693029|580857833|FG000|Overall Study|Non-compliance|2|||
160855078|NCT01693029|580857834|FG001|Overall Study|Non-compliance|1|||
160855079|NCT05801991|580857835|FG000|Overall Study|Lost to Follow-up|1|||
160855080|NCT05801991|580857836|FG001|Overall Study|Lost to Follow-up|0|||
160855081|NCT04235140|580857837|FG000|Overall Study|Adverse Event|2|||
160855082|NCT04235140|580857837|FG000|Overall Study|Lost to Follow-up|1|||
160855083|NCT04235140|580857837|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
160855084|NCT04235140|580857837|FG000|Overall Study|Commercial drug is available for participants|7|||
161141354|NCT02515669|581901082|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
161255259|NCT02688387|582314151|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255260|NCT02688387|582314152|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
160855085|NCT01451723|580857839|FG000|Overall Study|study halted|6|||
160855086|NCT01451723|580857840|FG001|Overall Study|study halted|5|||
160855087|NCT02210000|580857841|FG000|Overall Study|Study Terminated|11|||
160855088|NCT02210000|580857842|FG001|Overall Study|Study Terminated|12|||
160855089|NCT02210000|580857841|FG000|Overall Study|Withdrawal by Subject|7|||
160855090|NCT02210000|580857842|FG001|Overall Study|Withdrawal by Subject|1|||
160855091|NCT02210000|580857841|FG000|Overall Study|Adverse Event|1|||
160855092|NCT02210000|580857842|FG001|Overall Study|Adverse Event|5|||
160855093|NCT02210000|580857841|FG000|Overall Study|Lost to Follow-up|0|||
160855094|NCT02210000|580857842|FG001|Overall Study|Lost to Follow-up|2|||
160855095|NCT02210000|580857841|FG000|Overall Study|Physician Decision|0|||
160855096|NCT02210000|580857842|FG001|Overall Study|Physician Decision|1|||
160855097|NCT00833040|580857843|FG000|Overall Study|Adverse Event|0|||
160855098|NCT00833040|580857844|FG001|Overall Study|Adverse Event|0|||
160855099|NCT00833040|580857845|FG002|Overall Study|Adverse Event|0|||
160855100|NCT00833040|580857846|FG003|Overall Study|Adverse Event|0|||
160855101|NCT00833040|580857847|FG004|Overall Study|Adverse Event|0|||
160855102|NCT00833040|580857848|FG005|Overall Study|Adverse Event|1|||
160855103|NCT00962208|580857853|FG000|Overall Study|Could not achieve good vision|9|||
160855104|NCT00962208|580857854|FG001|Overall Study|Could not achieve good vision|0|||
160855105|NCT00962208|580857853|FG000|Overall Study|Contraindicated to continue study|5|||
160855106|NCT00962208|580857854|FG001|Overall Study|Contraindicated to continue study|1|||
160855107|NCT00962208|580857853|FG000|Overall Study|Lost to Follow-up|0|||
160855108|NCT00962208|580857854|FG001|Overall Study|Lost to Follow-up|9|||
160855109|NCT01731912|580857855|FG000|Overall Study|noncompliance|2|||
160855110|NCT00443040|580857858|FG000|Overall Study|Withdrawal by Subject|1|||
160855111|NCT00443040|580857859|FG001|Overall Study|Withdrawal by Subject|0|||
160855112|NCT00443040|580857860|FG002|Overall Study|Withdrawal by Subject|0|||
160855113|NCT00443040|580857858|FG000|Overall Study|Converted to an open laparotomy|3|||
160855114|NCT00443040|580857859|FG001|Overall Study|Converted to an open laparotomy|0|||
160855115|NCT00443040|580857860|FG002|Overall Study|Converted to an open laparotomy|1|||
160855116|NCT00718510|580857863|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
160855117|NCT00718510|580857864|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160855118|NCT00718510|580857863|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
160855119|NCT00718510|580857864|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
160855120|NCT00423657|580857865|FG000|Overall Study|Withdrew consent|10|||
160855121|NCT00423657|580857866|FG001|Overall Study|Withdrew consent|8|||
160855122|NCT00423657|580857865|FG000|Overall Study|Non-compliance|0|||
160855123|NCT00423657|580857866|FG001|Overall Study|Non-compliance|1|||
160855124|NCT00423657|580857865|FG000|Overall Study|Other|15|||
160855125|NCT00423657|580857866|FG001|Overall Study|Other|16|||
160855126|NCT00423657|580857865|FG000|Overall Study|Request of sponsor/investigator|1|||
160855127|NCT00423657|580857866|FG001|Overall Study|Request of sponsor/investigator|0|||
160855128|NCT02269124|580857868|FG000|Overall Study|Lost to Follow-up|1|||
160855129|NCT02269124|580857869|FG001|Overall Study|Lost to Follow-up|0|||
160855130|NCT02269124|580857868|FG000|Overall Study|Withdrawal by Subject|0|||
160855131|NCT02269124|580857869|FG001|Overall Study|Withdrawal by Subject|2|||
160855132|NCT01045460|580857872|FG000|Overall Study|Physician Decision|3|||
160855133|NCT01045460|580857873|FG001|Overall Study|Physician Decision|2|||
160855134|NCT01045460|580857872|FG000|Overall Study|Lost to Follow-up|0|||
160855135|NCT01045460|580857873|FG001|Overall Study|Lost to Follow-up|1|||
160855136|NCT01045460|580857872|FG000|Overall Study|Lack of Efficacy|3|||
160855137|NCT01045460|580857873|FG001|Overall Study|Lack of Efficacy|0|||
160855138|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
160855139|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
160855140|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
160855141|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
160855142|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
160855143|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
160855144|NCT00097500|580857874|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
160855145|NCT00097500|580857875|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
160855146|NCT00097500|580857874|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
160855147|NCT00097500|580857875|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
160855148|NCT00097500|580857874|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
160855149|NCT00097500|580857875|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
160855150|NCT00097500|580857874|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
160855151|NCT00097500|580857875|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
160855152|NCT02163902|580857878|FG000|Overall Study|Subject's Request|3|||
160855153|NCT02163902|580857879|FG001|Overall Study|Subject's Request|4|||
160855154|NCT02163902|580857878|FG000|Overall Study|Lost to Follow-up|6|||
160855155|NCT02163902|580857879|FG001|Overall Study|Lost to Follow-up|7|||
160855156|NCT02163902|580857878|FG000|Overall Study|Administrative Decision|2|||
161255261|NCT02688387|582314153|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
161255262|NCT02688387|582314132|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
161255263|NCT02688387|582314133|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255264|NCT02688387|582314134|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255265|NCT02688387|582314135|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255266|NCT02688387|582314136|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255267|NCT02688387|582314137|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255268|NCT02688387|582314138|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255269|NCT02688387|582314139|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255270|NCT02688387|582314140|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160855157|NCT02163902|580857879|FG001|Overall Study|Administrative Decision|2|||
160855158|NCT00844376|580857883|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
160855159|NCT00844376|580857884|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
160855160|NCT01300234|580857885|FG000|Overall Study|Adverse Event|1|||
160855161|NCT01300234|580857886|FG001|Overall Study|Adverse Event|1|||
160855162|NCT01300234|580857885|FG000|Overall Study|Protocol Violation|2|||
160855163|NCT01300234|580857886|FG001|Overall Study|Protocol Violation|3|||
160855164|NCT01300234|580857885|FG000|Overall Study|Withdrawal by Subject|5|||
160855165|NCT01300234|580857886|FG001|Overall Study|Withdrawal by Subject|9|||
160855166|NCT01300234|580857885|FG000|Overall Study|Lost to Follow-up|14|||
160855167|NCT01300234|580857886|FG001|Overall Study|Lost to Follow-up|12|||
160855168|NCT01300234|580857885|FG000|Overall Study|Pregnancy|2|||
160855169|NCT01300234|580857886|FG001|Overall Study|Pregnancy|1|||
160855170|NCT01300234|580857885|FG000|Overall Study|Participant reached stopping critera|2|||
160855171|NCT01300234|580857886|FG001|Overall Study|Participant reached stopping critera|0|||
160855172|NCT01300234|580857885|FG000|Overall Study|Participant stopped medication|1|||
160855173|NCT01300234|580857886|FG001|Overall Study|Participant stopped medication|1|||
160855174|NCT01300234|580857885|FG000|Overall Study|Participant refused return to hospital|1|||
160855175|NCT01300234|580857886|FG001|Overall Study|Participant refused return to hospital|0|||
160855176|NCT03253679|580857887|FG000|Overall Study|Screen Failure|1|||
160855177|NCT04816214|580857888|FG000|Overall Study|Progressive Disease|4|||
160855178|NCT04816214|580857889|FG001|Overall Study|Progressive Disease|0|||
160855179|NCT04816214|580857890|FG002|Overall Study|Progressive Disease|0|||
160855180|NCT04816214|580857888|FG000|Overall Study|Death|1|||
160855181|NCT04816214|580857889|FG001|Overall Study|Death|0|||
160855182|NCT04816214|580857890|FG002|Overall Study|Death|0|||
160855183|NCT04816214|580857888|FG000|Overall Study|Study Terminated by Sponsor|1|||
160855184|NCT04816214|580857889|FG001|Overall Study|Study Terminated by Sponsor|0|||
160855185|NCT04816214|580857890|FG002|Overall Study|Study Terminated by Sponsor|0|||
160855186|NCT04879628|580857891|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
160855187|NCT04879628|580857892|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
160855188|NCT04879628|580857893|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
160855189|NCT04879628|580857894|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
160855190|NCT04879628|580857891|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160855191|NCT04879628|580857892|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160855192|NCT04879628|580857893|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
160855193|NCT04879628|580857894|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
160855194|NCT04879628|580857891|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
160855195|NCT04879628|580857892|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
160855196|NCT04879628|580857893|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
160855197|NCT04879628|580857894|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
160855198|NCT04879628|580857891|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
160855199|NCT04879628|580857892|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
160855200|NCT04879628|580857893|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
160855201|NCT04879628|580857894|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
160855202|NCT00948064|580859248|FG000|Phase I|No treatment received|1|||
160855203|NCT00948064|580859249|FG001|Phase I|No treatment received|0|||
160855204|NCT00948064|580859250|FG002|Phase I|No treatment received|0|||
160855205|NCT00948064|580859248|FG000|Phase II|Physician Decision|0|||
160855206|NCT00948064|580859249|FG001|Phase II|Physician Decision|0|||
160855207|NCT00948064|580859250|FG002|Phase II|Physician Decision|1|||
160855208|NCT00948064|580859248|FG000|Phase II|Withdrawal by Subject|0|||
160855209|NCT00948064|580859249|FG001|Phase II|Withdrawal by Subject|1|||
160907704|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
160907705|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
160907706|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907707|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160855210|NCT00948064|580859250|FG002|Phase II|Withdrawal by Subject|0|||
160855211|NCT03409796|580859264|FG000|Overall Study|Adverse Event|2|||
161141355|NCT02515669|581901083|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
161141356|NCT02515669|581901084|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
161141357|NCT02515669|581901081|FG000|228 Week Open-Label Phase|Missing|0|||
161255271|NCT02688387|582314141|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255272|NCT02688387|582314142|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255273|NCT02688387|582314143|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255274|NCT02688387|582314144|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255275|NCT02688387|582314145|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255276|NCT02688387|582314146|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255277|NCT02688387|582314147|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255278|NCT02688387|582314148|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255279|NCT02688387|582314149|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255280|NCT02688387|582314150|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255281|NCT02688387|582314151|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255282|NCT02688387|582314152|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
160855212|NCT03409796|580859265|FG001|Overall Study|Adverse Event|0|||
160855213|NCT03409796|580859264|FG000|Overall Study|Other|0|||
160855214|NCT03409796|580859265|FG001|Overall Study|Other|1|||
160855215|NCT00740220|580859266|FG000|Overall Study|screen failures (non-COPD patients)|9|||
160855216|NCT04416204|580859279|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
160855217|NCT04416204|580859280|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
160855218|NCT04416204|580859281|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
160855219|NCT04416204|580859282|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
160855220|NCT01959503|580859283|FG000|Overall Study|Death|2|||
160855221|NCT01959503|580859284|FG001|Overall Study|Death|1|||
160855222|NCT01959503|580859283|FG000|Overall Study|Randomized but not treated|1|||
160855223|NCT01959503|580859284|FG001|Overall Study|Randomized but not treated|1|||
160855224|NCT01419236|580859285|FG000|Overall Study|Adverse Event|1|||
160855225|NCT01419236|580859286|FG001|Overall Study|Adverse Event|0|||
160855226|NCT01419236|580859285|FG000|Overall Study|Lack of Efficacy|0|||
160855227|NCT01419236|580859286|FG001|Overall Study|Lack of Efficacy|1|||
160855228|NCT01419236|580859285|FG000|Overall Study|Lost to Follow-up|1|||
160855229|NCT01419236|580859286|FG001|Overall Study|Lost to Follow-up|0|||
160855230|NCT01419236|580859285|FG000|Overall Study|Physician Decision|1|||
160855231|NCT01419236|580859286|FG001|Overall Study|Physician Decision|0|||
160855232|NCT01419236|580859285|FG000|Overall Study|Withdrawal by Subject|1|||
160855233|NCT01419236|580859286|FG001|Overall Study|Withdrawal by Subject|4|||
160855234|NCT01419236|580859285|FG000|Overall Study|Entry Criteria Not Met|1|||
160855235|NCT01419236|580859286|FG001|Overall Study|Entry Criteria Not Met|0|||
160855236|NCT01393158|580859288|FG000|Overall Study|Adverse Event|1|||
160855237|NCT01393158|580859289|FG001|Overall Study|Adverse Event|0|||
160855238|NCT02173769|580859291|FG000|Overall Study|Protocol Violation|4|||
160855239|NCT04233801|580859292|FG000|Overall Study|Other than listed|0|||
160855240|NCT04233801|580859293|FG001|Overall Study|Other than listed|0|||
160855241|NCT04233801|580859294|FG002|Overall Study|Other than listed|1|||
160855242|NCT04233801|580859292|FG000|Overall Study|Withdrawal by Subject|0|||
160855243|NCT04233801|580859293|FG001|Overall Study|Withdrawal by Subject|2|||
160855244|NCT04233801|580859294|FG002|Overall Study|Withdrawal by Subject|3|||
160855245|NCT00683878|580859307|FG000|Overall Study|Lack of Efficacy|3|||
160855246|NCT00683878|580859308|FG001|Overall Study|Lack of Efficacy|0|||
160855247|NCT00683878|580859309|FG002|Overall Study|Lack of Efficacy|1|||
160855248|NCT00683878|580859307|FG000|Overall Study|Adverse Event|4|||
160855249|NCT00683878|580859308|FG001|Overall Study|Adverse Event|3|||
160855250|NCT00683878|580859309|FG002|Overall Study|Adverse Event|3|||
160855251|NCT00683878|580859307|FG000|Overall Study|Withdrawal by Subject|9|||
160855252|NCT00683878|580859308|FG001|Overall Study|Withdrawal by Subject|8|||
160855253|NCT00683878|580859309|FG002|Overall Study|Withdrawal by Subject|6|||
160855254|NCT00683878|580859307|FG000|Overall Study|Death|0|||
160855255|NCT00683878|580859308|FG001|Overall Study|Death|1|||
160855256|NCT00683878|580859309|FG002|Overall Study|Death|0|||
160855257|NCT00683878|580859307|FG000|Overall Study|Lost to Follow-up|4|||
160855258|NCT00683878|580859308|FG001|Overall Study|Lost to Follow-up|2|||
160855259|NCT00683878|580859309|FG002|Overall Study|Lost to Follow-up|4|||
160855260|NCT00683878|580859307|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
161141358|NCT02515669|581901082|FG001|228 Week Open-Label Phase|Missing|2|||
161141359|NCT02515669|581901083|FG002|228 Week Open-Label Phase|Missing|2|||
160855261|NCT00683878|580859308|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
161141360|NCT02515669|581901084|FG003|228 Week Open-Label Phase|Missing|2|||
161141361|NCT00957372|581901085|FG000|PART I|Lost to Follow-up|0|||
160855262|NCT00683878|580859309|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
160855263|NCT04024891|580859310|FG000|Overall Study|Pregnancy|0|||
160855264|NCT04024891|580859311|FG001|Overall Study|Pregnancy|1|||
160855265|NCT03010527|580859325|FG000|Overall Study|Death|0|||
160855266|NCT03010527|580859326|FG001|Overall Study|Death|0|||
160855267|NCT03010527|580859327|FG002|Overall Study|Death|1|||
160855268|NCT03010527|580859325|FG000|Overall Study|Adverse Event|0|||
160855269|NCT03010527|580859326|FG001|Overall Study|Adverse Event|4|||
160855270|NCT03010527|580859327|FG002|Overall Study|Adverse Event|2|||
160855271|NCT03010527|580859325|FG000|Overall Study|Protocol Violation|0|||
160855272|NCT03010527|580859326|FG001|Overall Study|Protocol Violation|1|||
160855273|NCT03010527|580859327|FG002|Overall Study|Protocol Violation|0|||
160855274|NCT03010527|580859325|FG000|Overall Study|Lost to Follow-up|0|||
160855275|NCT03010527|580859326|FG001|Overall Study|Lost to Follow-up|2|||
160855276|NCT03010527|580859327|FG002|Overall Study|Lost to Follow-up|1|||
160855277|NCT03010527|580859325|FG000|Overall Study|Withdrawal by Subject|0|||
160855278|NCT03010527|580859326|FG001|Overall Study|Withdrawal by Subject|3|||
160855279|NCT03010527|580859327|FG002|Overall Study|Withdrawal by Subject|4|||
160855280|NCT03010527|580859325|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
160855281|NCT03010527|580859326|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
160855282|NCT03010527|580859327|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
160855283|NCT03010527|580859325|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
160855284|NCT03010527|580859326|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
160855285|NCT03010527|580859327|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
160855286|NCT03010527|580859325|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
160855287|NCT03010527|580859326|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
160855288|NCT03010527|580859327|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
160855289|NCT02469623|580859328|FG000|Overall Study|Not consented for long-term follow-up|4|||
160855290|NCT02469623|580859328|FG000|Overall Study|Lost to Follow-up|4|||
160855291|NCT02469623|580859328|FG000|Overall Study|Withdrawal by Subject|2|||
160855292|NCT02469623|580859328|FG000|Overall Study|Death|3|||
160855293|NCT04073186|580859329|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
160855294|NCT04073186|580859329|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
160855295|NCT04073186|580859329|FG000|First Wearing Cycle|Protocol Violation|1|||
160855296|NCT04073186|580859329|FG000|First Wearing Cycle|Lens Discomfort|2|||
160855297|NCT04073186|580859329|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
160855298|NCT04073186|580859329|FG000|Second Wearing Cycle|Adverse Event|1|||
160855299|NCT01096316|580859330|FG000|Overall Study|Lost to Follow-up|15|||
160855300|NCT01096316|580859331|FG001|Overall Study|Lost to Follow-up|9|||
160855301|NCT00473434|580859332|FG000|Overall Study|Physician Decision|3|||
160907708|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907709|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907710|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
161255283|NCT02688387|582314153|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
161255284|NCT02688387|582314132|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255285|NCT02688387|582314133|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255286|NCT02688387|582314134|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255287|NCT02688387|582314135|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160907711|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907712|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
160907713|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
160907714|NCT03095066|581056307|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907715|NCT03095066|581056308|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907716|NCT03095066|581056309|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907717|NCT03095066|581056310|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
160907718|NCT03095066|581056311|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907719|NCT03095066|581056312|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
160907720|NCT03095066|581056313|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907721|NCT03095066|581056314|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
160907722|NCT00160693|581056315|FG000|Overall Study|Adverse Event|97|||
160907723|NCT00160693|581056315|FG000|Overall Study|Lack of Efficacy|30|||
160907724|NCT00160693|581056315|FG000|Overall Study|Protocol Violation|24|||
160907725|NCT00160693|581056315|FG000|Overall Study|Lost to Follow-up|15|||
160907726|NCT00160693|581056315|FG000|Overall Study|Withdrawal by Subject|54|||
160907727|NCT00160693|581056315|FG000|Overall Study|Study terminated by sponsor|15|||
160907728|NCT03052725|581056316|FG000|Overall Study|Adverse Event|2|||
160907729|NCT03052725|581056317|FG001|Overall Study|Adverse Event|0|||
160907730|NCT03052725|581056316|FG000|Overall Study|Withdrawal by Subject|3|||
160907731|NCT03052725|581056317|FG001|Overall Study|Withdrawal by Subject|4|||
161255288|NCT02688387|582314136|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255289|NCT02688387|582314137|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160855302|NCT00473434|580859332|FG000|Overall Study|Withdrawal by Subject|9|||
160855303|NCT00473434|580859332|FG000|Overall Study|Compliance|3|||
160907732|NCT03052725|581056316|FG000|Overall Study|Pregnancy|0|||
160855304|NCT00473434|580859332|FG000|Overall Study|Lack of Efficacy|3|||
160855305|NCT00473434|580859332|FG000|Overall Study|Adverse Event|3|||
160855306|NCT00473434|580859332|FG000|Overall Study|Patient was selling medication to others|1|||
160907733|NCT03052725|581056317|FG001|Overall Study|Pregnancy|1|||
160907734|NCT03052725|581056316|FG000|Overall Study|Site closure|0|||
160907735|NCT03052725|581056317|FG001|Overall Study|Site closure|1|||
161337442|NCT00251758|582625929|FG001|Overall Study|Per Subject Request|0|||
160855307|NCT00473434|580859332|FG000|Overall Study|Safety evaluation|1|||
160855308|NCT00473434|580859332|FG000|Overall Study|Reason not specified|6|||
160855309|NCT00473434|580859332|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
160855310|NCT00473434|580859332|FG000|Overall Study|Switching to trial medication|1|||
160855311|NCT00473434|580859332|FG000|Overall Study|No longer required|1|||
160855312|NCT06418152|580859334|FG000|Overall Study|Frequent DBS setting changes|1|||
160855313|NCT06418152|580859334|FG000|Overall Study|Withdrawal by Subject|2|||
160855314|NCT02529852|580859337|FG000|Overall Study|Withdrawal by Subject|2|||
160855315|NCT02055898|580859338|FG000|First Intervention (5 Days)|Physician Decision|2|||
160855316|NCT02055898|580859339|FG001|First Intervention (5 Days)|Physician Decision|0|||
160855317|NCT02055898|580859338|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
160855318|NCT02055898|580859339|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
160855319|NCT02201524|580859341|FG000|Overall Study|Adverse Event|0|||
160855320|NCT02201524|580859342|FG001|Overall Study|Adverse Event|2|||
160855321|NCT02201524|580859343|FG002|Overall Study|Adverse Event|1|||
160855322|NCT02201524|580859344|FG003|Overall Study|Adverse Event|0|||
160855323|NCT02201524|580859341|FG000|Overall Study|Insufficient clinical response|1|||
160855324|NCT02201524|580859342|FG001|Overall Study|Insufficient clinical response|0|||
160855325|NCT02201524|580859343|FG002|Overall Study|Insufficient clinical response|0|||
160855326|NCT02201524|580859344|FG003|Overall Study|Insufficient clinical response|0|||
160855327|NCT02201524|580859341|FG000|Overall Study|Lost to Follow-up|0|||
160855328|NCT02201524|580859342|FG001|Overall Study|Lost to Follow-up|0|||
160855329|NCT02201524|580859343|FG002|Overall Study|Lost to Follow-up|2|||
160855330|NCT02201524|580859344|FG003|Overall Study|Lost to Follow-up|0|||
160855331|NCT02201524|580859341|FG000|Overall Study|No longer meets eligibility criteria|0|||
160855332|NCT02201524|580859342|FG001|Overall Study|No longer meets eligibility criteria|0|||
160855333|NCT02201524|580859343|FG002|Overall Study|No longer meets eligibility criteria|0|||
160855334|NCT02201524|580859344|FG003|Overall Study|No longer meets eligibility criteria|2|||
160855335|NCT02201524|580859341|FG000|Overall Study|Protocol Violation|0|||
160855336|NCT02201524|580859342|FG001|Overall Study|Protocol Violation|0|||
160855337|NCT02201524|580859343|FG002|Overall Study|Protocol Violation|0|||
160855338|NCT02201524|580859344|FG003|Overall Study|Protocol Violation|1|||
160855339|NCT02201524|580859341|FG000|Overall Study|Withdrawal by Subject|0|||
160855340|NCT02201524|580859342|FG001|Overall Study|Withdrawal by Subject|0|||
160855341|NCT02201524|580859343|FG002|Overall Study|Withdrawal by Subject|1|||
160855342|NCT02201524|580859344|FG003|Overall Study|Withdrawal by Subject|1|||
160855343|NCT02201524|580859341|FG000|Overall Study|Other|1|||
160855344|NCT02201524|580859342|FG001|Overall Study|Other|1|||
160855345|NCT02201524|580859343|FG002|Overall Study|Other|0|||
160855346|NCT02201524|580859344|FG003|Overall Study|Other|0|||
160855347|NCT03206216|580859349|FG000|Overall Study|Withdrawal by Subject|0|||
160855348|NCT03206216|580859350|FG001|Overall Study|Withdrawal by Subject|1|||
160855349|NCT01553084|580859356|FG000|Overall Study|Withdrawal by Subject|15|||
160855350|NCT01553084|580859357|FG001|Overall Study|Withdrawal by Subject|13|||
160855351|NCT01553084|580859358|FG002|Overall Study|Withdrawal by Subject|35|||
160855352|NCT03119259|580859360|FG000|Overall Study|Withdrawn as no longer eligible|1|||
160855353|NCT03119259|580859361|FG001|Overall Study|Withdrawn as no longer eligible|0|||
160855354|NCT03119259|580859360|FG000|Overall Study|Withdrawal by Subject|4|||
160855355|NCT03119259|580859361|FG001|Overall Study|Withdrawal by Subject|2|||
160855356|NCT03119259|580859360|FG000|Overall Study|Lost to Follow-up|0|||
160855357|NCT03119259|580859361|FG001|Overall Study|Lost to Follow-up|1|||
160855358|NCT00539981|580859368|FG000|Overall Study|Adverse events (AE)|3|||
160855359|NCT00539981|580859369|FG001|Overall Study|Adverse events (AE)|3|||
160855360|NCT00539981|580859368|FG000|Overall Study|Lost to Follow-up|260|||
160855361|NCT00539981|580859369|FG001|Overall Study|Lost to Follow-up|251|||
160855362|NCT00539981|580859368|FG000|Overall Study|Withdrew consent|22|||
160855363|NCT00539981|580859369|FG001|Overall Study|Withdrew consent|14|||
160855364|NCT00539981|580859368|FG000|Overall Study|Death|1|||
160855365|NCT00539981|580859369|FG001|Overall Study|Death|1|||
160855366|NCT00539981|580859368|FG000|Overall Study|Other reason-unspecified|9|||
160855367|NCT00539981|580859369|FG001|Overall Study|Other reason-unspecified|13|||
160855368|NCT01759420|580859370|FG000|Overall Study|Screen failure|5|||
160855369|NCT01759420|580859370|FG000|Overall Study|Inaccurate EKG machine readings|1|||
160855370|NCT01129622|580859371|FG000|Overall Study|Withdrawal by Subject|2|||
160855371|NCT02051764|580859372|FG000|Overall Study|Study terminated by sponsor|0|||
160855372|NCT02051764|580859373|FG001|Overall Study|Study terminated by sponsor|7|||
160907736|NCT03052725|581056316|FG000|Overall Study|Study terminated by sponsor|143|||
160907737|NCT03052725|581056317|FG001|Overall Study|Study terminated by sponsor|144|||
160907738|NCT01471171|581056320|FG000|Treatment Period 1|Adverse Event|4|||
160907739|NCT01471171|581056321|FG001|Treatment Period 1|Adverse Event|1|||
161255290|NCT02688387|582314138|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160855373|NCT00591006|580859374|FG000|Overall Study|Withdrawal by Subject|0|||
160855374|NCT00591006|580859375|FG001|Overall Study|Withdrawal by Subject|0|||
160855375|NCT00591006|580859376|FG002|Overall Study|Withdrawal by Subject|0|||
160855376|NCT00591006|580859377|FG003|Overall Study|Withdrawal by Subject|0|||
160855377|NCT00591006|580859378|FG004|Overall Study|Withdrawal by Subject|0|||
160855378|NCT00591006|580859379|FG005|Overall Study|Withdrawal by Subject|0|||
160855379|NCT00591006|580859380|FG006|Overall Study|Withdrawal by Subject|0|||
160855380|NCT00591006|580859381|FG007|Overall Study|Withdrawal by Subject|0|||
160855381|NCT00591006|580859382|FG008|Overall Study|Withdrawal by Subject|0|||
160855382|NCT00591006|580859383|FG009|Overall Study|Withdrawal by Subject|0|||
160855383|NCT00591006|580859384|FG010|Overall Study|Withdrawal by Subject|0|||
160855384|NCT00591006|580859385|FG011|Overall Study|Withdrawal by Subject|0|||
160855385|NCT00591006|580859386|FG012|Overall Study|Withdrawal by Subject|0|||
160855386|NCT00591006|580859387|FG013|Overall Study|Withdrawal by Subject|0|||
160855387|NCT00591006|580859388|FG014|Overall Study|Withdrawal by Subject|0|||
160855388|NCT00591006|580859389|FG015|Overall Study|Withdrawal by Subject|1|||
160855389|NCT00591006|580859390|FG016|Overall Study|Withdrawal by Subject|0|||
160855390|NCT00591006|580859391|FG017|Overall Study|Withdrawal by Subject|0|||
160855391|NCT00591006|580859392|FG018|Overall Study|Withdrawal by Subject|0|||
160855392|NCT00591006|580859393|FG019|Overall Study|Withdrawal by Subject|0|||
160855393|NCT00591006|580859394|FG020|Overall Study|Withdrawal by Subject|0|||
160855394|NCT00591006|580859395|FG021|Overall Study|Withdrawal by Subject|0|||
160855395|NCT00591006|580859396|FG022|Overall Study|Withdrawal by Subject|0|||
160855396|NCT00591006|580859397|FG023|Overall Study|Withdrawal by Subject|1|||
160855397|NCT00591006|580859374|FG000|Overall Study|Adverse Event|0|||
160855398|NCT00591006|580859375|FG001|Overall Study|Adverse Event|0|||
160855399|NCT00591006|580859376|FG002|Overall Study|Adverse Event|0|||
160855400|NCT00591006|580859377|FG003|Overall Study|Adverse Event|0|||
160855401|NCT00591006|580859378|FG004|Overall Study|Adverse Event|0|||
160855402|NCT00591006|580859379|FG005|Overall Study|Adverse Event|0|||
160907740|NCT01471171|581056320|FG000|Treatment Period 2|Adverse Event|1|||
160907741|NCT01471171|581056321|FG001|Treatment Period 2|Adverse Event|0|||
160907742|NCT03851705|581056322|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
160907743|NCT03851705|581056323|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160907744|NCT03851705|581056324|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160907745|NCT03851705|581056325|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
160907746|NCT03851705|581056322|FG000|Part 1: Double-Blind Period|Other reason|1|||
160907747|NCT03851705|581056323|FG001|Part 1: Double-Blind Period|Other reason|0|||
160907748|NCT03851705|581056324|FG002|Part 1: Double-Blind Period|Other reason|0|||
160907749|NCT03851705|581056325|FG003|Part 1: Double-Blind Period|Other reason|0|||
160907750|NCT03851705|581056322|FG000|Part 2: Open-Label Period|Other reason|0|||
160907751|NCT03851705|581056323|FG001|Part 2: Open-Label Period|Other reason|0|||
160907752|NCT03851705|581056324|FG002|Part 2: Open-Label Period|Other reason|0|||
160907753|NCT03851705|581056325|FG003|Part 2: Open-Label Period|Other reason|1|||
160907754|NCT03851705|581056322|FG000|Part 2: Open-Label Period|Death|0|||
160907755|NCT03851705|581056323|FG001|Part 2: Open-Label Period|Death|0|||
160907756|NCT03851705|581056324|FG002|Part 2: Open-Label Period|Death|3|||
160907757|NCT03851705|581056325|FG003|Part 2: Open-Label Period|Death|0|||
160907758|NCT03851705|581056322|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
160907759|NCT03851705|581056323|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
160907760|NCT03851705|581056324|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
160907761|NCT03851705|581056325|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
160907762|NCT03208244|581056329|FG000|Overall Study|Death|1|||
160907763|NCT04431453|581056330|FG000|Overall Study|Withdrew Consent|0|||
160907764|NCT04431453|581056331|FG001|Overall Study|Withdrew Consent|1|||
160907765|NCT04431453|581056332|FG002|Overall Study|Withdrew Consent|0|||
160907766|NCT04431453|581056333|FG003|Overall Study|Withdrew Consent|2|||
160907767|NCT04431453|581056334|FG004|Overall Study|Withdrew Consent|0|||
160907768|NCT04431453|581056335|FG005|Overall Study|Withdrew Consent|0|||
160907769|NCT04431453|581056336|FG006|Overall Study|Withdrew Consent|0|||
160907770|NCT04431453|581056337|FG007|Overall Study|Withdrew Consent|0|||
160907771|NCT04431453|581056330|FG000|Overall Study|Death|1|||
160907772|NCT04431453|581056331|FG001|Overall Study|Death|0|||
160907773|NCT04431453|581056332|FG002|Overall Study|Death|0|||
160907774|NCT04431453|581056333|FG003|Overall Study|Death|0|||
160907775|NCT04431453|581056334|FG004|Overall Study|Death|0|||
160907776|NCT04431453|581056335|FG005|Overall Study|Death|0|||
160907777|NCT04431453|581056336|FG006|Overall Study|Death|0|||
160907778|NCT04431453|581056337|FG007|Overall Study|Death|1|||
160907779|NCT04431453|581056330|FG000|Overall Study|Lost to Follow-up|0|||
160907780|NCT04431453|581056331|FG001|Overall Study|Lost to Follow-up|0|||
160907781|NCT04431453|581056332|FG002|Overall Study|Lost to Follow-up|1|||
160907782|NCT04431453|581056333|FG003|Overall Study|Lost to Follow-up|1|||
160907783|NCT04431453|581056334|FG004|Overall Study|Lost to Follow-up|0|||
160907784|NCT04431453|581056335|FG005|Overall Study|Lost to Follow-up|0|||
160907785|NCT04431453|581056336|FG006|Overall Study|Lost to Follow-up|0|||
160907786|NCT04431453|581056337|FG007|Overall Study|Lost to Follow-up|0|||
160907787|NCT04431453|581056330|FG000|Overall Study|Enrolled but Never Treated|0|||
160855403|NCT00591006|580859380|FG006|Overall Study|Adverse Event|0|||
160855404|NCT00591006|580859381|FG007|Overall Study|Adverse Event|0|||
160855405|NCT00591006|580859382|FG008|Overall Study|Adverse Event|0|||
160855406|NCT00591006|580859383|FG009|Overall Study|Adverse Event|0|||
160855407|NCT00591006|580859384|FG010|Overall Study|Adverse Event|0|||
160907788|NCT04431453|581056331|FG001|Overall Study|Enrolled but Never Treated|0|||
160993285|NCT02001623|581365334|FG012|Overall Study|Adverse Event|3|||
160993286|NCT02001623|581365335|FG013|Overall Study|Adverse Event|5|||
160993287|NCT02001623|581365336|FG014|Overall Study|Adverse Event|6|||
160993288|NCT02001623|581365322|FG000|Overall Study|Other - Miscellaneous|0|||
160993289|NCT02001623|581365323|FG001|Overall Study|Other - Miscellaneous|0|||
160993290|NCT02001623|581365324|FG002|Overall Study|Other - Miscellaneous|0|||
160993291|NCT02001623|581365325|FG003|Overall Study|Other - Miscellaneous|0|||
160993292|NCT02001623|581365326|FG004|Overall Study|Other - Miscellaneous|0|||
160993293|NCT02001623|581365327|FG005|Overall Study|Other - Miscellaneous|0|||
160993294|NCT02001623|581365328|FG006|Overall Study|Other - Miscellaneous|0|||
160993295|NCT02001623|581365329|FG007|Overall Study|Other - Miscellaneous|0|||
160993296|NCT02001623|581365330|FG008|Overall Study|Other - Miscellaneous|0|||
160993297|NCT02001623|581365331|FG009|Overall Study|Other - Miscellaneous|1|||
160993298|NCT02001623|581365332|FG010|Overall Study|Other - Miscellaneous|0|||
160993299|NCT02001623|581365333|FG011|Overall Study|Other - Miscellaneous|0|||
160993300|NCT02001623|581365334|FG012|Overall Study|Other - Miscellaneous|0|||
160993301|NCT02001623|581365335|FG013|Overall Study|Other - Miscellaneous|1|||
160993302|NCT02001623|581365336|FG014|Overall Study|Other - Miscellaneous|0|||
160993303|NCT02001623|581365322|FG000|Overall Study|Withdrawal by Subject|1|||
160993304|NCT02001623|581365323|FG001|Overall Study|Withdrawal by Subject|0|||
160993305|NCT02001623|581365324|FG002|Overall Study|Withdrawal by Subject|0|||
160993306|NCT02001623|581365325|FG003|Overall Study|Withdrawal by Subject|0|||
160993307|NCT02001623|581365326|FG004|Overall Study|Withdrawal by Subject|0|||
160993308|NCT02001623|581365327|FG005|Overall Study|Withdrawal by Subject|0|||
160993309|NCT02001623|581365328|FG006|Overall Study|Withdrawal by Subject|0|||
160993310|NCT02001623|581365329|FG007|Overall Study|Withdrawal by Subject|0|||
160993311|NCT02001623|581365330|FG008|Overall Study|Withdrawal by Subject|1|||
160993312|NCT02001623|581365331|FG009|Overall Study|Withdrawal by Subject|3|||
160993313|NCT02001623|581365332|FG010|Overall Study|Withdrawal by Subject|2|||
160993314|NCT02001623|581365333|FG011|Overall Study|Withdrawal by Subject|2|||
160993315|NCT02001623|581365334|FG012|Overall Study|Withdrawal by Subject|1|||
160993316|NCT02001623|581365335|FG013|Overall Study|Withdrawal by Subject|5|||
160993317|NCT02001623|581365336|FG014|Overall Study|Withdrawal by Subject|2|||
160993318|NCT02001623|581365322|FG000|Overall Study|Lost to Follow-up|0|||
160993319|NCT02001623|581365323|FG001|Overall Study|Lost to Follow-up|0|||
160993320|NCT02001623|581365324|FG002|Overall Study|Lost to Follow-up|0|||
160993321|NCT02001623|581365325|FG003|Overall Study|Lost to Follow-up|0|||
160993322|NCT02001623|581365326|FG004|Overall Study|Lost to Follow-up|0|||
160993323|NCT02001623|581365327|FG005|Overall Study|Lost to Follow-up|0|||
160993324|NCT02001623|581365328|FG006|Overall Study|Lost to Follow-up|0|||
160993325|NCT02001623|581365329|FG007|Overall Study|Lost to Follow-up|0|||
160993326|NCT02001623|581365330|FG008|Overall Study|Lost to Follow-up|0|||
160855408|NCT00591006|580859385|FG011|Overall Study|Adverse Event|0|||
160855409|NCT00591006|580859386|FG012|Overall Study|Adverse Event|0|||
160855410|NCT00591006|580859387|FG013|Overall Study|Adverse Event|0|||
161255291|NCT02688387|582314139|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255292|NCT02688387|582314140|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255293|NCT02688387|582314141|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160855411|NCT00591006|580859388|FG014|Overall Study|Adverse Event|0|||
160855412|NCT00591006|580859389|FG015|Overall Study|Adverse Event|0|||
160855413|NCT00591006|580859390|FG016|Overall Study|Adverse Event|0|||
160855414|NCT00591006|580859391|FG017|Overall Study|Adverse Event|0|||
160855415|NCT00591006|580859392|FG018|Overall Study|Adverse Event|0|||
160855416|NCT00591006|580859393|FG019|Overall Study|Adverse Event|0|||
160855417|NCT00591006|580859394|FG020|Overall Study|Adverse Event|0|||
160855418|NCT00591006|580859395|FG021|Overall Study|Adverse Event|0|||
160855419|NCT00591006|580859396|FG022|Overall Study|Adverse Event|1|||
160855420|NCT00591006|580859397|FG023|Overall Study|Adverse Event|0|||
160855421|NCT01384734|580859399|FG000|Overall Study|Adverse Event|0|||
160855422|NCT01384734|580859400|FG001|Overall Study|Adverse Event|3|||
161255294|NCT02688387|582314142|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
161255295|NCT02688387|582314143|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255296|NCT02688387|582314144|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160993327|NCT02001623|581365331|FG009|Overall Study|Lost to Follow-up|1|||
160993328|NCT02001623|581365332|FG010|Overall Study|Lost to Follow-up|0|||
160993329|NCT02001623|581365333|FG011|Overall Study|Lost to Follow-up|0|||
160993330|NCT02001623|581365334|FG012|Overall Study|Lost to Follow-up|0|||
160993331|NCT02001623|581365335|FG013|Overall Study|Lost to Follow-up|0|||
160993332|NCT02001623|581365336|FG014|Overall Study|Lost to Follow-up|0|||
160993333|NCT02001623|581365322|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
160993334|NCT02001623|581365323|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
160993335|NCT02001623|581365324|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
160855423|NCT01384734|580859401|FG002|Overall Study|Adverse Event|0|||
160855424|NCT01384734|580859402|FG003|Overall Study|Adverse Event|2|||
160993336|NCT02001623|581365325|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
160993337|NCT02001623|581365326|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
161141362|NCT00957372|581901086|FG001|PART I|Lost to Follow-up|0|||
160855425|NCT01384734|580859403|FG004|Overall Study|Adverse Event|7|||
160855426|NCT01384734|580859399|FG000|Overall Study|Death|1|||
160855427|NCT01384734|580859400|FG001|Overall Study|Death|0|||
160855428|NCT01384734|580859401|FG002|Overall Study|Death|1|||
160855429|NCT01384734|580859402|FG003|Overall Study|Death|0|||
160855430|NCT01384734|580859403|FG004|Overall Study|Death|0|||
160855431|NCT01384734|580859399|FG000|Overall Study|Continuation criteria not met|0|||
160855432|NCT01384734|580859400|FG001|Overall Study|Continuation criteria not met|0|||
160855433|NCT01384734|580859401|FG002|Overall Study|Continuation criteria not met|1|||
160855434|NCT01384734|580859402|FG003|Overall Study|Continuation criteria not met|1|||
160855435|NCT01384734|580859403|FG004|Overall Study|Continuation criteria not met|0|||
160855436|NCT01384734|580859399|FG000|Overall Study|Lack of Efficacy|3|||
160855437|NCT01384734|580859400|FG001|Overall Study|Lack of Efficacy|7|||
160855438|NCT01384734|580859401|FG002|Overall Study|Lack of Efficacy|4|||
160855439|NCT01384734|580859402|FG003|Overall Study|Lack of Efficacy|4|||
160855440|NCT01384734|580859403|FG004|Overall Study|Lack of Efficacy|2|||
160855441|NCT01384734|580859399|FG000|Overall Study|Lost to Follow-up|5|||
160855442|NCT01384734|580859400|FG001|Overall Study|Lost to Follow-up|3|||
160855443|NCT01384734|580859401|FG002|Overall Study|Lost to Follow-up|3|||
160855444|NCT01384734|580859402|FG003|Overall Study|Lost to Follow-up|8|||
160855445|NCT01384734|580859403|FG004|Overall Study|Lost to Follow-up|5|||
160855446|NCT01384734|580859399|FG000|Overall Study|Non-compliance with study drug|1|||
160855447|NCT01384734|580859400|FG001|Overall Study|Non-compliance with study drug|2|||
160855448|NCT01384734|580859401|FG002|Overall Study|Non-compliance with study drug|6|||
160855449|NCT01384734|580859402|FG003|Overall Study|Non-compliance with study drug|0|||
160855450|NCT01384734|580859403|FG004|Overall Study|Non-compliance with study drug|2|||
160855451|NCT01384734|580859399|FG000|Overall Study|Pregnancy|0|||
160855452|NCT01384734|580859400|FG001|Overall Study|Pregnancy|1|||
160907789|NCT04431453|581056332|FG002|Overall Study|Enrolled but Never Treated|0|||
160907790|NCT04431453|581056333|FG003|Overall Study|Enrolled but Never Treated|0|||
160907791|NCT04431453|581056334|FG004|Overall Study|Enrolled but Never Treated|1|||
160907792|NCT04431453|581056335|FG005|Overall Study|Enrolled but Never Treated|0|||
160907793|NCT04431453|581056336|FG006|Overall Study|Enrolled but Never Treated|0|||
160907794|NCT04431453|581056337|FG007|Overall Study|Enrolled but Never Treated|0|||
160907795|NCT03385564|581056338|FG000|Overall Study|Adverse Event|0|||
160907796|NCT03385564|581056339|FG001|Overall Study|Adverse Event|0|||
160907797|NCT03385564|581056340|FG002|Overall Study|Adverse Event|3|||
160907798|NCT03385564|581056341|FG003|Overall Study|Adverse Event|3|||
160907799|NCT03385564|581056338|FG000|Overall Study|Other than listed|0|||
160907800|NCT03385564|581056339|FG001|Overall Study|Other than listed|0|||
160907801|NCT03385564|581056340|FG002|Overall Study|Other than listed|0|||
160907802|NCT03385564|581056341|FG003|Overall Study|Other than listed|5|||
160907803|NCT03385564|581056338|FG000|Overall Study|Withdrawal by Subject|0|||
160907804|NCT03385564|581056339|FG001|Overall Study|Withdrawal by Subject|1|||
160907805|NCT03385564|581056340|FG002|Overall Study|Withdrawal by Subject|1|||
160907806|NCT03385564|581056341|FG003|Overall Study|Withdrawal by Subject|0|||
160907807|NCT03385564|581056338|FG000|Overall Study|Lack of Efficacy|0|||
160907808|NCT03385564|581056339|FG001|Overall Study|Lack of Efficacy|0|||
160907809|NCT03385564|581056340|FG002|Overall Study|Lack of Efficacy|0|||
160907810|NCT03385564|581056341|FG003|Overall Study|Lack of Efficacy|1|||
160907811|NCT03385564|581056338|FG000|Overall Study|Death|0|||
160907812|NCT03385564|581056339|FG001|Overall Study|Death|0|||
160907813|NCT03385564|581056340|FG002|Overall Study|Death|1|||
160907814|NCT03385564|581056341|FG003|Overall Study|Death|0|||
160907815|NCT02021773|581056357|FG000|Overall Study|Adverse Event|1|||
160907816|NCT02021773|581056358|FG001|Overall Study|Adverse Event|4|||
160855453|NCT01384734|580859401|FG002|Overall Study|Pregnancy|0|||
160907817|NCT02021773|581056359|FG002|Overall Study|Adverse Event|3|||
160907818|NCT02021773|581056357|FG000|Overall Study|Lack of Efficacy|2|||
160907819|NCT02021773|581056358|FG001|Overall Study|Lack of Efficacy|2|||
160907820|NCT02021773|581056359|FG002|Overall Study|Lack of Efficacy|2|||
160907821|NCT02021773|581056357|FG000|Overall Study|Protocol Violation|2|||
160907822|NCT02021773|581056358|FG001|Overall Study|Protocol Violation|3|||
160907823|NCT02021773|581056359|FG002|Overall Study|Protocol Violation|1|||
160907824|NCT02021773|581056357|FG000|Overall Study|Withdrawal by Subject|3|||
160907825|NCT02021773|581056358|FG001|Overall Study|Withdrawal by Subject|4|||
160907826|NCT02021773|581056359|FG002|Overall Study|Withdrawal by Subject|5|||
160907827|NCT02021773|581056357|FG000|Overall Study|Lost to Follow-up|1|||
160907828|NCT02021773|581056358|FG001|Overall Study|Lost to Follow-up|3|||
160907829|NCT02021773|581056359|FG002|Overall Study|Lost to Follow-up|0|||
160907830|NCT02021773|581056357|FG000|Overall Study|Reason not specified|3|||
161337443|NCT00251758|582625930|FG002|Overall Study|Per Subject Request|1|||
160855454|NCT01384734|580859402|FG003|Overall Study|Pregnancy|0|||
160855455|NCT01384734|580859403|FG004|Overall Study|Pregnancy|1|||
160855456|NCT01384734|580859399|FG000|Overall Study|Sponsor terminated|0|||
160855457|NCT01384734|580859400|FG001|Overall Study|Sponsor terminated|0|||
160855458|NCT01384734|580859401|FG002|Overall Study|Sponsor terminated|0|||
160855459|NCT01384734|580859402|FG003|Overall Study|Sponsor terminated|0|||
160855460|NCT01384734|580859403|FG004|Overall Study|Sponsor terminated|1|||
160855461|NCT01384734|580859399|FG000|Overall Study|Withdrawal by Subject|5|||
160855462|NCT01384734|580859400|FG001|Overall Study|Withdrawal by Subject|5|||
160855463|NCT01384734|580859401|FG002|Overall Study|Withdrawal by Subject|6|||
160855464|NCT01384734|580859402|FG003|Overall Study|Withdrawal by Subject|7|||
160855465|NCT01384734|580859403|FG004|Overall Study|Withdrawal by Subject|9|||
160855466|NCT01384734|580859399|FG000|Overall Study|Investigator relocating|0|||
160855467|NCT01384734|580859400|FG001|Overall Study|Investigator relocating|2|||
160855468|NCT01384734|580859401|FG002|Overall Study|Investigator relocating|0|||
160855469|NCT01384734|580859402|FG003|Overall Study|Investigator relocating|3|||
160855470|NCT01384734|580859403|FG004|Overall Study|Investigator relocating|1|||
160855471|NCT01384734|580859399|FG000|Overall Study|Unable to come back for visit|1|||
160855472|NCT01384734|580859400|FG001|Overall Study|Unable to come back for visit|0|||
160855473|NCT01384734|580859401|FG002|Overall Study|Unable to come back for visit|1|||
160855474|NCT01384734|580859402|FG003|Overall Study|Unable to come back for visit|1|||
160855475|NCT01384734|580859403|FG004|Overall Study|Unable to come back for visit|0|||
160855476|NCT01384734|580859399|FG000|Overall Study|Prison|0|||
160855477|NCT01384734|580859400|FG001|Overall Study|Prison|0|||
160855478|NCT01384734|580859401|FG002|Overall Study|Prison|1|||
160855479|NCT01384734|580859402|FG003|Overall Study|Prison|0|||
160855480|NCT01384734|580859403|FG004|Overall Study|Prison|0|||
160855481|NCT01384734|580859399|FG000|Overall Study|As per Exclusion criteria|0|||
160855482|NCT01384734|580859400|FG001|Overall Study|As per Exclusion criteria|1|||
160855483|NCT01384734|580859401|FG002|Overall Study|As per Exclusion criteria|0|||
160855484|NCT01384734|580859402|FG003|Overall Study|As per Exclusion criteria|0|||
160855485|NCT01384734|580859403|FG004|Overall Study|As per Exclusion criteria|0|||
160855486|NCT01384734|580859399|FG000|Overall Study|Missed End of treatment visit|0|||
160855487|NCT01384734|580859400|FG001|Overall Study|Missed End of treatment visit|0|||
160855488|NCT01384734|580859401|FG002|Overall Study|Missed End of treatment visit|0|||
160907831|NCT02021773|581056358|FG001|Overall Study|Reason not specified|0|||
160907832|NCT02021773|581056359|FG002|Overall Study|Reason not specified|0|||
160907833|NCT01253408|581056364|FG000|Overall Study|Adverse Event|0|||
160907834|NCT01253408|581056365|FG001|Overall Study|Adverse Event|1|||
160907835|NCT01253408|581056366|FG002|Overall Study|Adverse Event|0|||
160907836|NCT03408483|581056367|FG000|Overall Study|Physician Decision|3|||
160907837|NCT03408483|581056368|FG001|Overall Study|Physician Decision|3|||
160907838|NCT03408483|581056367|FG000|Overall Study|Lost to Follow-up|3|||
160907839|NCT03408483|581056368|FG001|Overall Study|Lost to Follow-up|0|||
160907840|NCT00478231|581056369|FG000|Overall Study|Death|7|||
160907841|NCT00478231|581056369|FG000|Overall Study|Lack of Efficacy|47|||
160907842|NCT00478231|581056369|FG000|Overall Study|Lost to Follow-up|7|||
160907843|NCT00478231|581056369|FG000|Overall Study|Withdrawal by Subject|6|||
160907844|NCT00478231|581056369|FG000|Overall Study|Other|9|||
160907845|NCT00478231|581056369|FG000|Overall Study|Adverse Event|5|||
160907846|NCT00478231|581056369|FG000|Overall Study|Randomized, not treated|3|||
160907847|NCT01702961|581056370|FG000|Overall Study|Additional treatment|3|||
160907848|NCT01702961|581056370|FG000|Overall Study|Progressive disease|5|||
160907849|NCT01702961|581056370|FG000|Overall Study|Relapse|20|||
160907850|NCT01702961|581056370|FG000|Overall Study|Death|6|||
160907851|NCT01702961|581056370|FG000|Overall Study|Lost to Follow-up|2|||
160907852|NCT01702961|581056370|FG000|Overall Study|Ongoing|11|||
160907853|NCT03724032|581056371|FG000|Overall Study|Physician Decision|1|||
160907854|NCT03724032|581056372|FG001|Overall Study|Physician Decision|0|||
160907855|NCT03724032|581056373|FG002|Overall Study|Physician Decision|0|||
160907856|NCT03724032|581056371|FG000|Overall Study|Protocol Violation|2|||
160907857|NCT03724032|581056372|FG001|Overall Study|Protocol Violation|2|||
160907858|NCT03724032|581056373|FG002|Overall Study|Protocol Violation|1|||
160907859|NCT00751933|581056374|FG000|Overall Study|Withdrawal by Subject|0|||
160907860|NCT00751933|581056375|FG001|Overall Study|Withdrawal by Subject|1|||
160907861|NCT00751933|581056376|FG002|Overall Study|Withdrawal by Subject|0|||
160907862|NCT00751933|581056377|FG003|Overall Study|Withdrawal by Subject|0|||
160907863|NCT00751933|581056374|FG000|Overall Study|Physician Decision|0|||
160907864|NCT00751933|581056375|FG001|Overall Study|Physician Decision|0|||
160907865|NCT00751933|581056376|FG002|Overall Study|Physician Decision|1|||
160907866|NCT00751933|581056377|FG003|Overall Study|Physician Decision|1|||
160907867|NCT01817530|581056379|FG000|Overall Study|Exclusionary Medication Received|0|||
161255297|NCT02688387|582314145|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160855489|NCT01384734|580859402|FG003|Overall Study|Missed End of treatment visit|1|||
160907868|NCT01817530|581056380|FG001|Overall Study|Exclusionary Medication Received|0|||
160907869|NCT01817530|581056381|FG002|Overall Study|Exclusionary Medication Received|0|||
160907870|NCT01817530|581056382|FG003|Overall Study|Exclusionary Medication Received|0|||
160907871|NCT01817530|581056383|FG004|Overall Study|Exclusionary Medication Received|1|||
160907872|NCT01817530|581056384|FG005|Overall Study|Exclusionary Medication Received|0|||
161255298|NCT02688387|582314146|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255299|NCT02688387|582314147|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160907873|NCT01817530|581056385|FG006|Overall Study|Exclusionary Medication Received|0|||
160907874|NCT01817530|581056386|FG007|Overall Study|Exclusionary Medication Received|0|||
160907875|NCT01817530|581056379|FG000|Overall Study|Adverse Event|6|||
160855490|NCT01384734|580859403|FG004|Overall Study|Missed End of treatment visit|0|||
161141363|NCT00957372|581901087|FG002|PART I|Lost to Follow-up|1|||
160855491|NCT01384734|580859399|FG000|Overall Study|Adhesion problem|0|||
160855492|NCT01384734|580859400|FG001|Overall Study|Adhesion problem|0|||
160855493|NCT01384734|580859401|FG002|Overall Study|Adhesion problem|0|||
160855494|NCT01384734|580859402|FG003|Overall Study|Adhesion problem|1|||
160855495|NCT01384734|580859403|FG004|Overall Study|Adhesion problem|0|||
160855496|NCT01384734|580859399|FG000|Overall Study|Early termination|0|||
160855497|NCT01384734|580859400|FG001|Overall Study|Early termination|0|||
160855498|NCT01384734|580859401|FG002|Overall Study|Early termination|0|||
160855499|NCT01384734|580859402|FG003|Overall Study|Early termination|0|||
160855500|NCT01384734|580859403|FG004|Overall Study|Early termination|1|||
160855501|NCT01384734|580859399|FG000|Overall Study|Physician Decision|1|||
160855502|NCT01384734|580859400|FG001|Overall Study|Physician Decision|0|||
160855503|NCT01384734|580859401|FG002|Overall Study|Physician Decision|0|||
160855504|NCT01384734|580859402|FG003|Overall Study|Physician Decision|0|||
160855505|NCT01384734|580859403|FG004|Overall Study|Physician Decision|0|||
160855506|NCT03071263|580859404|FG000|Overall Study|Adverse Event|1|||
160855507|NCT03071263|580859405|FG001|Overall Study|Adverse Event|3|||
160855508|NCT03071263|580859404|FG000|Overall Study|Withdrawal by Subject|1|||
160855509|NCT03071263|580859405|FG001|Overall Study|Withdrawal by Subject|3|||
160855510|NCT03071263|580859404|FG000|Overall Study|Physician Decision|1|||
160855511|NCT03071263|580859405|FG001|Overall Study|Physician Decision|0|||
160855512|NCT03071263|580859404|FG000|Overall Study|Participant moved to another city|0|||
160855513|NCT03071263|580859405|FG001|Overall Study|Participant moved to another city|1|||
160855514|NCT00647296|580859410|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855515|NCT00647296|580859411|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855516|NCT00647296|580859412|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855517|NCT00647296|580859413|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
160855518|NCT00647296|580859410|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
160855519|NCT00647296|580859411|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
160855520|NCT00647296|580859412|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
160855521|NCT00647296|580859413|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
160855522|NCT00647296|580859410|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
160855523|NCT00647296|580859411|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
160855524|NCT00647296|580859412|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
160855525|NCT00647296|580859413|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
160855526|NCT00647296|580859410|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
160855527|NCT00647296|580859411|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
160855528|NCT00647296|580859412|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
160855529|NCT00647296|580859413|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
160855530|NCT00647296|580859410|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
160855531|NCT00647296|580859411|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
160855532|NCT00647296|580859412|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
160855533|NCT00647296|580859413|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
160855534|NCT00647296|580859410|FG000|Part 2: 4-week Placebo Washout|Death|3|||
160855535|NCT00647296|580859411|FG001|Part 2: 4-week Placebo Washout|Death|0|||
160855536|NCT00647296|580859412|FG002|Part 2: 4-week Placebo Washout|Death|0|||
160855537|NCT00647296|580859413|FG003|Part 2: 4-week Placebo Washout|Death|0|||
160907876|NCT01817530|581056380|FG001|Overall Study|Adverse Event|3|||
160907877|NCT01817530|581056381|FG002|Overall Study|Adverse Event|2|||
160907878|NCT01817530|581056382|FG003|Overall Study|Adverse Event|5|||
160907879|NCT01817530|581056383|FG004|Overall Study|Adverse Event|0|||
160907880|NCT01817530|581056384|FG005|Overall Study|Adverse Event|10|||
160907881|NCT01817530|581056385|FG006|Overall Study|Adverse Event|5|||
160907882|NCT01817530|581056386|FG007|Overall Study|Adverse Event|8|||
160907883|NCT01817530|581056379|FG000|Overall Study|Subject Noncompliant|3|||
160907884|NCT01817530|581056380|FG001|Overall Study|Subject Noncompliant|1|||
160907885|NCT01817530|581056381|FG002|Overall Study|Subject Noncompliant|0|||
160907886|NCT01817530|581056382|FG003|Overall Study|Subject Noncompliant|4|||
160907887|NCT01817530|581056383|FG004|Overall Study|Subject Noncompliant|0|||
160907888|NCT01817530|581056384|FG005|Overall Study|Subject Noncompliant|1|||
160993338|NCT02001623|581365327|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
161337444|NCT00251758|582625928|FG000|Overall Study|Per Investigator Request|1|||
160855538|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855539|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
160855540|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
160855541|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
160855542|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
160907889|NCT01817530|581056385|FG006|Overall Study|Subject Noncompliant|1|||
160907890|NCT01817530|581056386|FG007|Overall Study|Subject Noncompliant|1|||
160907891|NCT01817530|581056379|FG000|Overall Study|Lack of Efficacy|1|||
160907892|NCT01817530|581056380|FG001|Overall Study|Lack of Efficacy|0|||
161141364|NCT00957372|581901088|FG003|PART I|Lost to Follow-up|0|||
161141365|NCT00957372|581901085|FG000|PART II|Withdrawal by Subject|0|||
160907893|NCT01817530|581056381|FG002|Overall Study|Lack of Efficacy|0|||
160907894|NCT01817530|581056382|FG003|Overall Study|Lack of Efficacy|0|||
160907895|NCT01817530|581056383|FG004|Overall Study|Lack of Efficacy|0|||
160907896|NCT01817530|581056384|FG005|Overall Study|Lack of Efficacy|1|||
160907897|NCT01817530|581056385|FG006|Overall Study|Lack of Efficacy|0|||
160907898|NCT01817530|581056386|FG007|Overall Study|Lack of Efficacy|1|||
160907899|NCT01817530|581056379|FG000|Overall Study|Pregnancy|0|||
160907900|NCT01817530|581056380|FG001|Overall Study|Pregnancy|0|||
160907901|NCT01817530|581056381|FG002|Overall Study|Pregnancy|0|||
160907902|NCT01817530|581056382|FG003|Overall Study|Pregnancy|0|||
160907903|NCT01817530|581056383|FG004|Overall Study|Pregnancy|0|||
160907904|NCT01817530|581056384|FG005|Overall Study|Pregnancy|1|||
160907905|NCT01817530|581056385|FG006|Overall Study|Pregnancy|0|||
160907906|NCT01817530|581056386|FG007|Overall Study|Pregnancy|0|||
160907907|NCT01817530|581056379|FG000|Overall Study|Other|0|||
160907908|NCT01817530|581056380|FG001|Overall Study|Other|1|||
160907909|NCT01817530|581056381|FG002|Overall Study|Other|0|||
160907910|NCT01817530|581056382|FG003|Overall Study|Other|0|||
160907911|NCT01817530|581056383|FG004|Overall Study|Other|1|||
160907912|NCT01817530|581056384|FG005|Overall Study|Other|0|||
160907913|NCT01817530|581056385|FG006|Overall Study|Other|5|||
160907914|NCT01817530|581056386|FG007|Overall Study|Other|0|||
160907915|NCT01817530|581056379|FG000|Overall Study|Surgery or Invasive Intervention|1|||
160907916|NCT01817530|581056380|FG001|Overall Study|Surgery or Invasive Intervention|0|||
160907917|NCT01817530|581056381|FG002|Overall Study|Surgery or Invasive Intervention|0|||
160907918|NCT01817530|581056382|FG003|Overall Study|Surgery or Invasive Intervention|0|||
160907919|NCT01817530|581056383|FG004|Overall Study|Surgery or Invasive Intervention|1|||
160907920|NCT01817530|581056384|FG005|Overall Study|Surgery or Invasive Intervention|1|||
160907921|NCT01817530|581056385|FG006|Overall Study|Surgery or Invasive Intervention|1|||
160907922|NCT01817530|581056386|FG007|Overall Study|Surgery or Invasive Intervention|0|||
160907923|NCT01817530|581056379|FG000|Overall Study|Consent Withdrawn by Subject|3|||
160907924|NCT01817530|581056380|FG001|Overall Study|Consent Withdrawn by Subject|4|||
160907925|NCT01817530|581056381|FG002|Overall Study|Consent Withdrawn by Subject|7|||
160907926|NCT01817530|581056382|FG003|Overall Study|Consent Withdrawn by Subject|3|||
160907927|NCT01817530|581056383|FG004|Overall Study|Consent Withdrawn by Subject|5|||
160907928|NCT01817530|581056384|FG005|Overall Study|Consent Withdrawn by Subject|3|||
160907929|NCT01817530|581056385|FG006|Overall Study|Consent Withdrawn by Subject|3|||
160907930|NCT01817530|581056386|FG007|Overall Study|Consent Withdrawn by Subject|10|||
160907931|NCT01817530|581056379|FG000|Overall Study|Lost to Follow-up|1|||
160907932|NCT01817530|581056380|FG001|Overall Study|Lost to Follow-up|4|||
160907933|NCT01817530|581056381|FG002|Overall Study|Lost to Follow-up|2|||
160907934|NCT01817530|581056382|FG003|Overall Study|Lost to Follow-up|1|||
160907935|NCT01817530|581056383|FG004|Overall Study|Lost to Follow-up|3|||
160907936|NCT01817530|581056384|FG005|Overall Study|Lost to Follow-up|2|||
160907937|NCT01817530|581056385|FG006|Overall Study|Lost to Follow-up|8|||
160907938|NCT01817530|581056386|FG007|Overall Study|Lost to Follow-up|4|||
160907939|NCT00566995|581056387|FG000|Overall Study|Toxicity|4|||
160907940|NCT00566995|581056387|FG000|Overall Study|Withdrew consent|3|||
160907941|NCT02657369|581056388|FG000|Overall Study|Death|27|||
160907942|NCT02657369|581056388|FG000|Overall Study|Study terminated by sponsor|7|||
160907943|NCT00361569|581056389|FG000|Overall Study|Protocol Violation|3|||
160907944|NCT00361569|581056390|FG001|Overall Study|Protocol Violation|2|||
160907945|NCT00361569|581056391|FG002|Overall Study|Protocol Violation|4|||
160907946|NCT00361569|581056392|FG003|Overall Study|Protocol Violation|2|||
160907947|NCT00361569|581056389|FG000|Overall Study|Withdrawal by Subject|2|||
160907948|NCT00361569|581056390|FG001|Overall Study|Withdrawal by Subject|1|||
160907949|NCT00361569|581056391|FG002|Overall Study|Withdrawal by Subject|9|||
160907950|NCT00361569|581056392|FG003|Overall Study|Withdrawal by Subject|14|||
160907951|NCT00361569|581056389|FG000|Overall Study|Adverse Event|3|||
160907952|NCT00361569|581056390|FG001|Overall Study|Adverse Event|5|||
160907953|NCT00361569|581056391|FG002|Overall Study|Adverse Event|2|||
161255300|NCT02688387|582314148|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255301|NCT02688387|582314149|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255302|NCT02688387|582314150|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255303|NCT02688387|582314151|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
161255304|NCT02688387|582314152|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160907954|NCT00361569|581056392|FG003|Overall Study|Adverse Event|2|||
160907955|NCT00361569|581056389|FG000|Overall Study|Lost to Follow-up|2|||
160907956|NCT00361569|581056390|FG001|Overall Study|Lost to Follow-up|3|||
160907957|NCT00361569|581056391|FG002|Overall Study|Lost to Follow-up|3|||
160907958|NCT00361569|581056392|FG003|Overall Study|Lost to Follow-up|2|||
160907959|NCT00361569|581056389|FG000|Overall Study|Not specified by investigator|2|||
160907960|NCT00361569|581056390|FG001|Overall Study|Not specified by investigator|0|||
160907961|NCT00361569|581056391|FG002|Overall Study|Not specified by investigator|0|||
160907962|NCT00361569|581056392|FG003|Overall Study|Not specified by investigator|1|||
160907963|NCT04875195|581056393|FG000|Overall Study|Death|9|||
160855543|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
160855544|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
160855545|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
160855546|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
160855547|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
160855548|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
160855549|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
160855550|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
160855551|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
160855552|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
160855553|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
160855554|NCT00647296|580859410|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
160855555|NCT00647296|580859411|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
160855556|NCT00647296|580859412|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
160855557|NCT00647296|580859413|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
160855558|NCT02922725|580859414|FG000|Overall Study|Withdrawal by Subject|1|||
160855559|NCT02922725|580859415|FG001|Overall Study|Withdrawal by Subject|0|||
160855560|NCT02922725|580859416|FG002|Overall Study|Withdrawal by Subject|0|||
160855561|NCT00871871|580859417|FG000|Part I|Adverse Event|0|||
160855562|NCT00871871|580859418|FG001|Part I|Adverse Event|2|||
160855563|NCT00871871|580859419|FG002|Part I|Adverse Event|0|||
160855564|NCT00871871|580859420|FG003|Part I|Adverse Event|0|||
160855565|NCT00871871|580859417|FG000|Part I|Withdrawal by Subject|3|||
160855566|NCT00871871|580859418|FG001|Part I|Withdrawal by Subject|0|||
160855567|NCT00871871|580859419|FG002|Part I|Withdrawal by Subject|0|||
160855568|NCT00871871|580859420|FG003|Part I|Withdrawal by Subject|0|||
160855569|NCT00871871|580859417|FG000|Part I|Laboratory abnormality|0|||
160855570|NCT00871871|580859418|FG001|Part I|Laboratory abnormality|1|||
160855571|NCT00871871|580859419|FG002|Part I|Laboratory abnormality|0|||
160855572|NCT00871871|580859420|FG003|Part I|Laboratory abnormality|0|||
160855573|NCT00871871|580859417|FG000|Part II|Lack of Efficacy|0|||
160855574|NCT00871871|580859418|FG001|Part II|Lack of Efficacy|0|||
160855575|NCT00871871|580859419|FG002|Part II|Lack of Efficacy|1|||
160855576|NCT00871871|580859420|FG003|Part II|Lack of Efficacy|0|||
160855577|NCT00871871|580859417|FG000|Part II|Withdrawal by Subject|0|||
160855578|NCT00871871|580859418|FG001|Part II|Withdrawal by Subject|0|||
160855579|NCT00871871|580859419|FG002|Part II|Withdrawal by Subject|2|||
160855580|NCT00871871|580859420|FG003|Part II|Withdrawal by Subject|1|||
160855581|NCT00871871|580859417|FG000|Part II|Adverse Event|0|||
160855582|NCT00871871|580859418|FG001|Part II|Adverse Event|0|||
160855583|NCT00871871|580859419|FG002|Part II|Adverse Event|1|||
160855584|NCT00871871|580859420|FG003|Part II|Adverse Event|2|||
160855585|NCT00871871|580859417|FG000|Part II|Protocol Violation|0|||
160855586|NCT00871871|580859418|FG001|Part II|Protocol Violation|0|||
160855587|NCT00871871|580859419|FG002|Part II|Protocol Violation|0|||
160855588|NCT00871871|580859420|FG003|Part II|Protocol Violation|1|||
160855589|NCT04612725|580859421|FG000|Overall Study|Adverse Event|1|||
160855590|NCT04612725|580859422|FG001|Overall Study|Adverse Event|3|||
160855591|NCT04612725|580859423|FG002|Overall Study|Adverse Event|1|||
160855592|NCT04612725|580859424|FG003|Overall Study|Adverse Event|0|||
160855593|NCT04612725|580859425|FG004|Overall Study|Adverse Event|1|||
160855594|NCT04612725|580859421|FG000|Overall Study|Lost to Follow-up|0|||
160855595|NCT04612725|580859422|FG001|Overall Study|Lost to Follow-up|1|||
160855596|NCT04612725|580859423|FG002|Overall Study|Lost to Follow-up|0|||
160855597|NCT04612725|580859424|FG003|Overall Study|Lost to Follow-up|0|||
160855598|NCT04612725|580859425|FG004|Overall Study|Lost to Follow-up|0|||
160855599|NCT04612725|580859421|FG000|Overall Study|Physician Decision|2|||
160855600|NCT04612725|580859422|FG001|Overall Study|Physician Decision|0|||
160855601|NCT04612725|580859423|FG002|Overall Study|Physician Decision|0|||
160855602|NCT04612725|580859424|FG003|Overall Study|Physician Decision|0|||
160855603|NCT04612725|580859425|FG004|Overall Study|Physician Decision|0|||
160855604|NCT04612725|580859421|FG000|Overall Study|Study terminated by sponsor|3|||
160855605|NCT04612725|580859422|FG001|Overall Study|Study terminated by sponsor|1|||
160855606|NCT04612725|580859423|FG002|Overall Study|Study terminated by sponsor|2|||
160855607|NCT04612725|580859424|FG003|Overall Study|Study terminated by sponsor|4|||
160855608|NCT04612725|580859425|FG004|Overall Study|Study terminated by sponsor|5|||
160855609|NCT04612725|580859421|FG000|Overall Study|Withdrawal by Subject|8|||
160855610|NCT04612725|580859422|FG001|Overall Study|Withdrawal by Subject|3|||
160855611|NCT04612725|580859423|FG002|Overall Study|Withdrawal by Subject|5|||
160855612|NCT04612725|580859424|FG003|Overall Study|Withdrawal by Subject|1|||
160855613|NCT04612725|580859425|FG004|Overall Study|Withdrawal by Subject|9|||
160855614|NCT04612725|580859421|FG000|Overall Study|Other|0|||
160855615|NCT04612725|580859422|FG001|Overall Study|Other|0|||
160855616|NCT04612725|580859423|FG002|Overall Study|Other|0|||
160855617|NCT04612725|580859424|FG003|Overall Study|Other|0|||
160855618|NCT04612725|580859425|FG004|Overall Study|Other|1|||
160855619|NCT03069352|580859426|FG000|Overall Study|Ongoing|12|||
160855620|NCT03069352|580859427|FG001|Overall Study|Ongoing|40|||
160855621|NCT02621424|580859428|FG000|Overall Study|Withdrawal by Subject|1|||
160855622|NCT02621424|580859429|FG001|Overall Study|Withdrawal by Subject|2|||
160855623|NCT05148234|580859431|FG000|Phase I|Ineligible|0|||
160855624|NCT05148234|580859432|FG001|Phase I|Ineligible|0|||
160855625|NCT05148234|580859433|FG002|Phase I|Ineligible|0|||
160855626|NCT05148234|580859434|FG003|Phase I|Ineligible|0|||
160855627|NCT05148234|580859435|FG004|Phase I|Ineligible|0|||
160855628|NCT05148234|580859436|FG005|Phase I|Ineligible|0|||
160855629|NCT05148234|580859437|FG006|Phase I|Ineligible|0|||
160855630|NCT05148234|580859438|FG007|Phase I|Ineligible|1|||
160855631|NCT05148234|580859431|FG000|Phase I|Company closed the trial.|0|||
160855632|NCT05148234|580859432|FG001|Phase I|Company closed the trial.|1|||
160855633|NCT05148234|580859433|FG002|Phase I|Company closed the trial.|0|||
160855634|NCT05148234|580859434|FG003|Phase I|Company closed the trial.|0|||
160855635|NCT05148234|580859435|FG004|Phase I|Company closed the trial.|0|||
160855636|NCT05148234|580859436|FG005|Phase I|Company closed the trial.|0|||
160855637|NCT05148234|580859437|FG006|Phase I|Company closed the trial.|0|||
160855638|NCT05148234|580859438|FG007|Phase I|Company closed the trial.|0|||
160855639|NCT04750642|580859439|FG000|Overall Study|Adverse Event|1|||
161255305|NCT02688387|582314153|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
160855640|NCT04750642|580859440|FG001|Overall Study|Adverse Event|0|||
160855641|NCT04750642|580859439|FG000|Overall Study|Withdrawal by Subject|0|||
160855642|NCT04750642|580859440|FG001|Overall Study|Withdrawal by Subject|1|||
160855643|NCT04750642|580859439|FG000|Overall Study|Protocol Violation|0|||
160855644|NCT04750642|580859440|FG001|Overall Study|Protocol Violation|1|||
160855645|NCT00308139|580862337|FG000|Overall Study|Adverse Event|20|||
160855646|NCT00308139|580862338|FG001|Overall Study|Adverse Event|14|||
160855647|NCT00308139|580862337|FG000|Overall Study|Lost to Follow-up|13|||
160855648|NCT00308139|580862338|FG001|Overall Study|Lost to Follow-up|8|||
160855649|NCT00308139|580862337|FG000|Overall Study|Protocol Violation|3|||
160855650|NCT00308139|580862338|FG001|Overall Study|Protocol Violation|2|||
160855651|NCT00308139|580862337|FG000|Overall Study|Withdrawal of Consent|40|||
160855652|NCT00308139|580862338|FG001|Overall Study|Withdrawal of Consent|42|||
160855653|NCT00308139|580862337|FG000|Overall Study|Investigator Decision|11|||
160855654|NCT00308139|580862338|FG001|Overall Study|Investigator Decision|10|||
160855655|NCT00308139|580862337|FG000|Overall Study|Loss of Glucose Control|5|||
160855656|NCT00308139|580862338|FG001|Overall Study|Loss of Glucose Control|7|||
160855657|NCT00308139|580862337|FG000|Overall Study|Administrative|1|||
160855658|NCT00308139|580862338|FG001|Overall Study|Administrative|4|||
160855659|NCT00308139|580862337|FG000|Overall Study|Other|1|||
160855660|NCT00308139|580862338|FG001|Overall Study|Other|0|||
160855661|NCT00791388|580862343|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855662|NCT00791388|580862344|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
160855663|NCT00791388|580862345|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855664|NCT00791388|580862346|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855665|NCT00791388|580862347|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
160855666|NCT00791388|580862343|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
160855667|NCT00791388|580862344|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855668|NCT00791388|580862345|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855669|NCT00791388|580862346|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855670|NCT00791388|580862347|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
160855671|NCT00791388|580862343|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855672|NCT00791388|580862344|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855673|NCT00791388|580862345|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855674|NCT00791388|580862346|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
160855675|NCT00791388|580862347|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
160855676|NCT00435409|580862356|FG000|Overall Study|Protocol Violation|1|||
160855677|NCT00435409|580862357|FG001|Overall Study|Protocol Violation|2|||
160855678|NCT00435409|580862358|FG002|Overall Study|Protocol Violation|0|||
160855679|NCT00435409|580862356|FG000|Overall Study|Lost to Follow-up|1|||
160855680|NCT00435409|580862357|FG001|Overall Study|Lost to Follow-up|2|||
160855681|NCT00435409|580862358|FG002|Overall Study|Lost to Follow-up|0|||
160855682|NCT00435409|580862356|FG000|Overall Study|Death|8|||
160855683|NCT00435409|580862357|FG001|Overall Study|Death|6|||
160855684|NCT00435409|580862358|FG002|Overall Study|Death|6|||
160855685|NCT00435409|580862356|FG000|Overall Study|Objective progression or relapse|158|||
160855686|NCT00435409|580862357|FG001|Overall Study|Objective progression or relapse|93|||
160855687|NCT00435409|580862358|FG002|Overall Study|Objective progression or relapse|58|||
160855688|NCT00435409|580862356|FG000|Overall Study|Global deterioration of health status|0|||
160855689|NCT00435409|580862357|FG001|Overall Study|Global deterioration of health status|0|||
160855690|NCT00435409|580862358|FG002|Overall Study|Global deterioration of health status|4|||
160855691|NCT00435409|580862356|FG000|Overall Study|Withdrawal by Subject|8|||
160855692|NCT00435409|580862357|FG001|Overall Study|Withdrawal by Subject|7|||
160855693|NCT00435409|580862358|FG002|Overall Study|Withdrawal by Subject|1|||
160855694|NCT00435409|580862356|FG000|Overall Study|Other|45|||
160855695|NCT00435409|580862357|FG001|Overall Study|Other|30|||
160855696|NCT00435409|580862358|FG002|Overall Study|Other|1|||
160855697|NCT00435409|580862356|FG000|Overall Study|Adverse Event|0|||
160855698|NCT00435409|580862357|FG001|Overall Study|Adverse Event|0|||
160855699|NCT00435409|580862358|FG002|Overall Study|Adverse Event|8|||
160855700|NCT00435409|580862356|FG000|Overall Study|Sponsor decision|0|||
160855701|NCT00435409|580862357|FG001|Overall Study|Sponsor decision|3|||
160855702|NCT00435409|580862358|FG002|Overall Study|Sponsor decision|0|||
160855703|NCT04750824|580862359|FG000|Overall Study|Toxicity/intolerability|3|||
160855704|NCT04750824|580862360|FG001|Overall Study|Toxicity/intolerability|1|||
160855705|NCT04750824|580862359|FG000|Overall Study|Death|1|||
160855706|NCT04750824|580862360|FG001|Overall Study|Death|3|||
160855707|NCT04750824|580862359|FG000|Overall Study|Scheduled duration of therapy complete|1|||
160855708|NCT04750824|580862360|FG001|Overall Study|Scheduled duration of therapy complete|9|||
160855709|NCT04750824|580862359|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
160855710|NCT04750824|580862360|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
160855711|NCT05196828|580862361|FG000|Overall Study|Withdrawal by Subject|2|||
160855712|NCT05196828|580862362|FG001|Overall Study|Withdrawal by Subject|0|||
160855713|NCT05196828|580862361|FG000|Overall Study|Lost to Follow-up|0|||
160855714|NCT05196828|580862362|FG001|Overall Study|Lost to Follow-up|4|||
160855715|NCT05196828|580862361|FG000|Overall Study|Adverse Event|1|||
160855716|NCT05196828|580862362|FG001|Overall Study|Adverse Event|0|||
160855717|NCT02763644|580862363|FG000|Overall Study|Patient/guardian decision|1|||
160855718|NCT02763644|580862364|FG001|Overall Study|Patient/guardian decision|0|||
160855719|NCT02763644|580862363|FG000|Overall Study|Death|1|||
160855720|NCT02763644|580862364|FG001|Overall Study|Death|1|||
160855721|NCT02763644|580862363|FG000|Overall Study|Adverse Event|1|||
160855722|NCT02763644|580862364|FG001|Overall Study|Adverse Event|1|||
160855723|NCT02356159|580862365|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855724|NCT02356159|580862366|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855725|NCT02356159|580862367|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855726|NCT02356159|580862368|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855727|NCT02356159|580862369|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
160855728|NCT02356159|580862370|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
160855729|NCT03192176|580862371|FG000|Overall Study|Adverse Event|1|||
160855730|NCT03192176|580862372|FG001|Overall Study|Adverse Event|0|||
160855731|NCT03192176|580862373|FG002|Overall Study|Adverse Event|4|||
160855732|NCT03192176|580862374|FG003|Overall Study|Adverse Event|5|||
160855733|NCT03192176|580862375|FG004|Overall Study|Adverse Event|3|||
160855734|NCT03192176|580862376|FG005|Overall Study|Adverse Event|2|||
160855735|NCT03192176|580862377|FG006|Overall Study|Adverse Event|3|||
160855736|NCT03192176|580862378|FG007|Overall Study|Adverse Event|3|||
160855737|NCT03192176|580862371|FG000|Overall Study|Lost to Follow-up|0|||
160855738|NCT03192176|580862372|FG001|Overall Study|Lost to Follow-up|0|||
160855739|NCT03192176|580862373|FG002|Overall Study|Lost to Follow-up|1|||
160855740|NCT03192176|580862374|FG003|Overall Study|Lost to Follow-up|2|||
160855741|NCT03192176|580862375|FG004|Overall Study|Lost to Follow-up|3|||
160855742|NCT03192176|580862376|FG005|Overall Study|Lost to Follow-up|1|||
160855743|NCT03192176|580862377|FG006|Overall Study|Lost to Follow-up|1|||
160855744|NCT03192176|580862378|FG007|Overall Study|Lost to Follow-up|1|||
160855745|NCT03192176|580862371|FG000|Overall Study|Physician Decision|1|||
160855746|NCT03192176|580862372|FG001|Overall Study|Physician Decision|0|||
160855747|NCT03192176|580862373|FG002|Overall Study|Physician Decision|0|||
160855748|NCT03192176|580862374|FG003|Overall Study|Physician Decision|0|||
160855749|NCT03192176|580862375|FG004|Overall Study|Physician Decision|0|||
160855750|NCT03192176|580862376|FG005|Overall Study|Physician Decision|2|||
160855751|NCT03192176|580862377|FG006|Overall Study|Physician Decision|1|||
160855752|NCT03192176|580862378|FG007|Overall Study|Physician Decision|0|||
160855753|NCT03192176|580862371|FG000|Overall Study|Protocol Deviation|1|||
160855754|NCT03192176|580862372|FG001|Overall Study|Protocol Deviation|1|||
160855755|NCT03192176|580862373|FG002|Overall Study|Protocol Deviation|0|||
161141366|NCT00957372|581901086|FG001|PART II|Withdrawal by Subject|0|||
161141367|NCT00957372|581901087|FG002|PART II|Withdrawal by Subject|0|||
160855756|NCT03192176|580862374|FG003|Overall Study|Protocol Deviation|0|||
160855757|NCT03192176|580862375|FG004|Overall Study|Protocol Deviation|2|||
160855758|NCT03192176|580862376|FG005|Overall Study|Protocol Deviation|0|||
160855759|NCT03192176|580862377|FG006|Overall Study|Protocol Deviation|0|||
160855760|NCT03192176|580862378|FG007|Overall Study|Protocol Deviation|0|||
160855761|NCT03192176|580862371|FG000|Overall Study|Withdrawal by Subject|3|||
160855762|NCT03192176|580862372|FG001|Overall Study|Withdrawal by Subject|4|||
160855763|NCT03192176|580862373|FG002|Overall Study|Withdrawal by Subject|0|||
160855764|NCT03192176|580862374|FG003|Overall Study|Withdrawal by Subject|4|||
160855765|NCT03192176|580862375|FG004|Overall Study|Withdrawal by Subject|3|||
160855766|NCT03192176|580862376|FG005|Overall Study|Withdrawal by Subject|4|||
160855767|NCT03192176|580862377|FG006|Overall Study|Withdrawal by Subject|4|||
161141368|NCT00957372|581901088|FG003|PART II|Withdrawal by Subject|8|||
160855768|NCT03192176|580862378|FG007|Overall Study|Withdrawal by Subject|2|||
160855769|NCT03192176|580862371|FG000|Overall Study|Miscellaneous|1|||
160855770|NCT03192176|580862372|FG001|Overall Study|Miscellaneous|0|||
160855771|NCT03192176|580862373|FG002|Overall Study|Miscellaneous|1|||
160855772|NCT03192176|580862374|FG003|Overall Study|Miscellaneous|1|||
160855773|NCT03192176|580862375|FG004|Overall Study|Miscellaneous|1|||
160855774|NCT03192176|580862376|FG005|Overall Study|Miscellaneous|2|||
160855775|NCT03192176|580862377|FG006|Overall Study|Miscellaneous|0|||
160855776|NCT03192176|580862378|FG007|Overall Study|Miscellaneous|1|||
160855777|NCT00836589|580862383|FG000|Overall Study|Lost to Follow-up|246|||
160855778|NCT00836589|580862383|FG000|Overall Study|Death|429|||
160855779|NCT00836589|580862383|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
160855780|NCT00117637|580862384|FG000|First Intervention (Period 1)|Adverse Event|11|||
160855781|NCT00117637|580862385|FG001|First Intervention (Period 1)|Adverse Event|16|||
160855782|NCT00117637|580862384|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
160855783|NCT00117637|580862385|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
160855784|NCT00117637|580862384|FG000|First Intervention (Period 1)|Protocol Violation|1|||
160855785|NCT00117637|580862385|FG001|First Intervention (Period 1)|Protocol Violation|0|||
160855786|NCT00117637|580862384|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
160855787|NCT00117637|580862385|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
160855788|NCT00117637|580862384|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
160855789|NCT00117637|580862385|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
160855790|NCT00117637|580862384|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
160855791|NCT00117637|580862385|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
160855792|NCT00117637|580862384|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
160855793|NCT00117637|580862385|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
160855794|NCT00117637|580862384|FG000|First Intervention (Period 1)|reason not reported|0|||
160855795|NCT00117637|580862385|FG001|First Intervention (Period 1)|reason not reported|1|||
160855796|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Adverse Event|0|||
160855797|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Adverse Event|9|||
160855798|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
160855799|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
160855800|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
160855801|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
160855802|NCT00117637|580862384|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
160855803|NCT00117637|580862385|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
160855804|NCT00117637|580862384|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
160855805|NCT00117637|580862385|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
160855806|NCT00117637|580862384|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
160855807|NCT00117637|580862385|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
160855808|NCT00117637|580862384|FG000|Second Intervention (Period 2)|reason not reported|1|||
160855809|NCT00117637|580862385|FG001|Second Intervention (Period 2)|reason not reported|0|||
160855810|NCT02914639|580862388|FG000|Overall Study|Withdrawal by Subject|0|||
160855811|NCT02914639|580862389|FG001|Overall Study|Withdrawal by Subject|2|||
160855812|NCT01582061|580862390|FG000|Overall Study|Lack of Efficacy|3|||
160855813|NCT01582061|580862391|FG001|Overall Study|Lack of Efficacy|23|||
160855814|NCT01582061|580862390|FG000|Overall Study|Adverse Event|12|||
160855815|NCT01582061|580862391|FG001|Overall Study|Adverse Event|8|||
160855816|NCT01582061|580862390|FG000|Overall Study|Withdrawal by Subject|10|||
160855817|NCT01582061|580862391|FG001|Overall Study|Withdrawal by Subject|4|||
160855818|NCT01582061|580862390|FG000|Overall Study|Abnormal laboratory value(s)|1|||
160855819|NCT01582061|580862391|FG001|Overall Study|Abnormal laboratory value(s)|0|||
160855820|NCT01582061|580862390|FG000|Overall Study|Death|0|||
160855821|NCT01582061|580862391|FG001|Overall Study|Death|1|||
160855822|NCT01582061|580862390|FG000|Overall Study|condition no longer requires study drug|1|||
160855823|NCT01582061|580862391|FG001|Overall Study|condition no longer requires study drug|0|||
160855824|NCT01582061|580862390|FG000|Overall Study|Lost to Follow-up|1|||
160907964|NCT04875195|581056394|FG001|Overall Study|Death|3|||
161141369|NCT00957372|581901085|FG000|PART II|Physician Decision|0|||
161141370|NCT00957372|581901086|FG001|PART II|Physician Decision|0|||
161141371|NCT00957372|581901087|FG002|PART II|Physician Decision|0|||
161141372|NCT00957372|581901088|FG003|PART II|Physician Decision|1|||
161141373|NCT00957372|581901085|FG000|PART II|Pregnancy|0|||
161141374|NCT00957372|581901086|FG001|PART II|Pregnancy|0|||
161141375|NCT00957372|581901087|FG002|PART II|Pregnancy|0|||
161141376|NCT00957372|581901088|FG003|PART II|Pregnancy|1|||
160855825|NCT01582061|580862391|FG001|Overall Study|Lost to Follow-up|0|||
160855826|NCT00436332|580862395|FG000|Overall Study|Adverse Event|9|||
160855827|NCT00436332|580862395|FG000|Overall Study|Withdrawal by Subject|2|||
160855828|NCT00436332|580862395|FG000|Overall Study|Progression|59|||
161141377|NCT00957372|581901085|FG000|PART II|Not Know|0|||
161141378|NCT00957372|581901086|FG001|PART II|Not Know|0|||
161141379|NCT00957372|581901087|FG002|PART II|Not Know|0|||
161141380|NCT00957372|581901088|FG003|PART II|Not Know|20|||
160855829|NCT00436332|580862395|FG000|Overall Study|Death|2|||
160855830|NCT00436332|580862395|FG000|Overall Study|Not Protocol Specified|6|||
160855831|NCT00436332|580862395|FG000|Overall Study|Ineligible|2|||
160855832|NCT00436332|580862395|FG000|Overall Study|Never Received Treatment|3|||
160855833|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
160855834|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
160855835|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
160855836|NCT00062439|580862396|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
160855837|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Death|1|||
160855838|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Disease progression|2|||
160855839|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
160855840|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
160855841|NCT00062439|580862396|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
160855842|NCT00062439|580862396|FG000|Surgery|Physician Decision|4|||
160855843|NCT00062439|580862396|FG000|Surgery|Death|1|||
160855844|NCT00062439|580862396|FG000|Surgery|Adverse Event|2|||
160855845|NCT00062439|580862396|FG000|Consolidation Chemotherapy|Adverse Event|2|||
160855846|NCT01924845|580862397|FG000|Overall Study|Adverse Event|3|||
160855847|NCT01924845|580862397|FG000|Overall Study|Withdrawal by Subject|2|||
160855848|NCT01924845|580862397|FG000|Overall Study|Protocol Violation|1|||
160855849|NCT03780452|580862398|FG000|Overall Study|Screening failure|2|||
160855850|NCT02388269|580862399|FG000|Overall Study|Adverse Event|2|||
160855851|NCT02388269|580862400|FG001|Overall Study|Adverse Event|0|||
160855852|NCT02388269|580862401|FG002|Overall Study|Adverse Event|0|||
160855853|NCT02388269|580862399|FG000|Overall Study|Withdrawal by Subject|1|||
160855854|NCT02388269|580862400|FG001|Overall Study|Withdrawal by Subject|2|||
160855855|NCT02388269|580862401|FG002|Overall Study|Withdrawal by Subject|0|||
160855856|NCT02388269|580862399|FG000|Overall Study|less than 50% stimulations|1|||
160855857|NCT02388269|580862400|FG001|Overall Study|less than 50% stimulations|0|||
160855858|NCT02388269|580862401|FG002|Overall Study|less than 50% stimulations|0|||
160855859|NCT02388269|580862399|FG000|Overall Study|no diary data|3|||
160855860|NCT02388269|580862400|FG001|Overall Study|no diary data|0|||
160855861|NCT02388269|580862401|FG002|Overall Study|no diary data|0|||
160855862|NCT02388269|580862399|FG000|Overall Study|Protocol Violation|2|||
160855863|NCT02388269|580862400|FG001|Overall Study|Protocol Violation|0|||
160855864|NCT02388269|580862401|FG002|Overall Study|Protocol Violation|0|||
160855865|NCT02388269|580862399|FG000|Overall Study|Screen Failure|0|||
160855866|NCT02388269|580862400|FG001|Overall Study|Screen Failure|0|||
160855867|NCT02388269|580862401|FG002|Overall Study|Screen Failure|10|||
160855868|NCT00265564|580862404|FG000|Overall Study|Lost to Follow-up|5|||
160855869|NCT00265564|580862405|FG001|Overall Study|Lost to Follow-up|7|||
160855870|NCT00265564|580862404|FG000|Overall Study|met exclusion criteria|5|||
160855871|NCT00265564|580862405|FG001|Overall Study|met exclusion criteria|2|||
160855872|NCT04698343|580862406|FG000|Overall Study|Withdrawal by Subject|6|||
160855873|NCT04698343|580862406|FG000|Overall Study|Physician Decision|2|||
160855874|NCT04698343|580862406|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
160855875|NCT04698343|580862406|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
160855876|NCT04698343|580862406|FG000|Overall Study|Personal reasons|3|||
160855877|NCT04698343|580862406|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
160855878|NCT00325897|580862410|FG000|Overall Study|Lost to Follow-up|12|||
160855879|NCT00325897|580862411|FG001|Overall Study|Lost to Follow-up|13|||
160855880|NCT03915717|580862414|FG000|Overall Study|EchoMark Not Implanted|6|||
160855881|NCT04079296|580862415|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
160855882|NCT04079296|580862416|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
160855883|NCT04079296|580862417|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
160855884|NCT04079296|580862418|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
160855885|NCT04079296|580862419|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
160855886|NCT04079296|580862415|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
160855887|NCT04079296|580862416|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
160855888|NCT04079296|580862417|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
160855889|NCT04079296|580862418|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
160855890|NCT04079296|580862419|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
160855891|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855892|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855893|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855894|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
160855895|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
160855896|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855897|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855898|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855899|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
160855900|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
160855901|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855902|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855903|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855904|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
160855905|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
160855906|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
160855907|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
160855908|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
160855909|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
160855910|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
160855911|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
160855912|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
160855913|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
160855914|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
160855915|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
160855916|NCT04079296|580862415|FG000|Dose Expansion Phase (168 Days)|Death|0|||
160855917|NCT04079296|580862416|FG001|Dose Expansion Phase (168 Days)|Death|0|||
160855918|NCT04079296|580862417|FG002|Dose Expansion Phase (168 Days)|Death|0|||
160855919|NCT04079296|580862418|FG003|Dose Expansion Phase (168 Days)|Death|1|||
160855920|NCT04079296|580862419|FG004|Dose Expansion Phase (168 Days)|Death|0|||
160855921|NCT00467740|580862420|FG000|Overall Study|Adverse Event|0|||
160855922|NCT00467740|580862421|FG001|Overall Study|Adverse Event|0|||
160855923|NCT00467740|580862422|FG002|Overall Study|Adverse Event|1|||
160855924|NCT00467740|580862423|FG003|Overall Study|Adverse Event|0|||
160855925|NCT00467740|580862424|FG004|Overall Study|Adverse Event|0|||
160855926|NCT00467740|580862420|FG000|Overall Study|Protocol Violation|0|||
160855927|NCT00467740|580862421|FG001|Overall Study|Protocol Violation|0|||
160855928|NCT00467740|580862422|FG002|Overall Study|Protocol Violation|1|||
160855929|NCT00467740|580862423|FG003|Overall Study|Protocol Violation|0|||
160855930|NCT00467740|580862424|FG004|Overall Study|Protocol Violation|0|||
160855931|NCT00467740|580862420|FG000|Overall Study|Lost to Follow-up|0|||
160855932|NCT00467740|580862421|FG001|Overall Study|Lost to Follow-up|1|||
160855933|NCT00467740|580862422|FG002|Overall Study|Lost to Follow-up|0|||
160855934|NCT00467740|580862423|FG003|Overall Study|Lost to Follow-up|0|||
160855935|NCT00467740|580862424|FG004|Overall Study|Lost to Follow-up|0|||
160855936|NCT00467740|580862420|FG000|Overall Study|Withdrawal by Subject|1|||
160855937|NCT00467740|580862421|FG001|Overall Study|Withdrawal by Subject|1|||
160855938|NCT00467740|580862422|FG002|Overall Study|Withdrawal by Subject|0|||
160855939|NCT00467740|580862423|FG003|Overall Study|Withdrawal by Subject|1|||
160855940|NCT00467740|580862424|FG004|Overall Study|Withdrawal by Subject|0|||
160855941|NCT00467740|580862420|FG000|Overall Study|Lack of Efficacy|0|||
160855942|NCT00467740|580862421|FG001|Overall Study|Lack of Efficacy|1|||
160855943|NCT00467740|580862422|FG002|Overall Study|Lack of Efficacy|0|||
160855944|NCT00467740|580862423|FG003|Overall Study|Lack of Efficacy|0|||
160855945|NCT00467740|580862424|FG004|Overall Study|Lack of Efficacy|0|||
160855946|NCT02903160|580862425|FG000|Overall Study|Adverse Event|2|||
160855947|NCT02903160|580862425|FG000|Overall Study|Death|1|||
160855948|NCT02903160|580862425|FG000|Overall Study|Lost to Follow-up|2|||
160855949|NCT02903160|580862425|FG000|Overall Study|Withdrawal by Subject|1|||
160855950|NCT02903160|580862425|FG000|Overall Study|Medical Insurance Barriers|1|||
160855951|NCT01664910|580862428|FG000|Overall Study|Adverse Event|0|||
160855952|NCT01664910|580862429|FG001|Overall Study|Adverse Event|0|||
160855953|NCT01664910|580862430|FG002|Overall Study|Adverse Event|1|||
160855954|NCT02525471|580862431|FG000|Overall Study|Screen Failure|6|||
161141381|NCT00957372|581901085|FG000|PART II|Adverse Event|0|||
160855955|NCT02525471|580862431|FG000|Overall Study|Withdrawal by Subject|4|||
160855956|NCT02525471|580862431|FG000|Overall Study|Death|1|||
160855957|NCT02240485|580862432|FG000|3 Months Post-admission|Lost to Follow-up|1|||
160855958|NCT02240485|580862433|FG001|3 Months Post-admission|Lost to Follow-up|5|||
160855959|NCT02240485|580862432|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
160855960|NCT02240485|580862433|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
160855961|NCT02240485|580862432|FG000|9 Months Post-admission|Lost to Follow-up|3|||
160855962|NCT02240485|580862433|FG001|9 Months Post-admission|Lost to Follow-up|1|||
160855963|NCT02240485|580862432|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
160855964|NCT02240485|580862433|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
160855965|NCT02240485|580862432|FG000|18 Months Post-admission|Lost to Follow-up|1|||
160855966|NCT02240485|580862433|FG001|18 Months Post-admission|Lost to Follow-up|1|||
160855967|NCT02240485|580862432|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
160855968|NCT02240485|580862433|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
160855969|NCT00867165|580862437|FG000|Overall Study|Adverse Event|3|||
160855970|NCT00867165|580862438|FG001|Overall Study|Adverse Event|0|||
160855971|NCT00867165|580862437|FG000|Overall Study|Withdrawal by Subject|1|||
160855972|NCT00867165|580862438|FG001|Overall Study|Withdrawal by Subject|0|||
160855973|NCT03275740|580862439|FG000|Overall Study|Adverse Event|0|||
160855974|NCT03275740|580862440|FG001|Overall Study|Adverse Event|0|||
160855975|NCT03275740|580862441|FG002|Overall Study|Adverse Event|0|||
160855976|NCT03275740|580862442|FG003|Overall Study|Adverse Event|0|||
160855977|NCT03275740|580862443|FG004|Overall Study|Adverse Event|1|||
160855978|NCT03275740|580862444|FG005|Overall Study|Adverse Event|0|||
160855979|NCT03275740|580862445|FG006|Overall Study|Adverse Event|0|||
160855980|NCT03275740|580862446|FG007|Overall Study|Adverse Event|0|||
160855981|NCT03275740|580862447|FG008|Overall Study|Adverse Event|0|||
160855982|NCT03275740|580862448|FG009|Overall Study|Adverse Event|0|||
160855983|NCT03275740|580862449|FG010|Overall Study|Adverse Event|0|||
160855984|NCT03275740|580862450|FG011|Overall Study|Adverse Event|0|||
161337445|NCT00251758|582625929|FG001|Overall Study|Per Investigator Request|0|||
161337446|NCT00251758|582625930|FG002|Overall Study|Per Investigator Request|0|||
161337447|NCT03642990|582625934|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
161337448|NCT03642990|582625934|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
161337449|NCT01265498|582625941|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
161337450|NCT01265498|582625942|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
161337451|NCT00921024|582625949|FG000|Overall Study|Lost to Follow-up|2|||
161337452|NCT00921024|582625950|FG001|Overall Study|Lost to Follow-up|0|||
160855985|NCT03275740|580862439|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855986|NCT03275740|580862440|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855987|NCT03275740|580862441|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855988|NCT03275740|580862442|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855989|NCT03275740|580862443|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855990|NCT03275740|580862444|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
161337453|NCT00921024|582625949|FG000|Overall Study|Received concomittant therapy|2|||
161337454|NCT00921024|582625950|FG001|Overall Study|Received concomittant therapy|0|||
161337455|NCT00921024|582625949|FG000|Overall Study|Withdrawal by Subject|0|||
161337456|NCT00921024|582625950|FG001|Overall Study|Withdrawal by Subject|3|||
161337457|NCT02097823|582625951|FG000|Overall Study|Withdrawal by Subject|1|||
160855991|NCT03275740|580862445|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855992|NCT03275740|580862446|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855993|NCT03275740|580862447|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855994|NCT03275740|580862448|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855995|NCT03275740|580862449|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855996|NCT03275740|580862450|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
160855997|NCT03275740|580862439|FG000|Overall Study|Withdrawal by Subject|0|||
160855998|NCT03275740|580862440|FG001|Overall Study|Withdrawal by Subject|0|||
160855999|NCT03275740|580862441|FG002|Overall Study|Withdrawal by Subject|0|||
160856000|NCT03275740|580862442|FG003|Overall Study|Withdrawal by Subject|0|||
160856001|NCT03275740|580862443|FG004|Overall Study|Withdrawal by Subject|0|||
160856002|NCT03275740|580862444|FG005|Overall Study|Withdrawal by Subject|0|||
160856003|NCT03275740|580862445|FG006|Overall Study|Withdrawal by Subject|0|||
160856004|NCT03275740|580862446|FG007|Overall Study|Withdrawal by Subject|0|||
160856005|NCT03275740|580862447|FG008|Overall Study|Withdrawal by Subject|1|||
160856006|NCT03275740|580862448|FG009|Overall Study|Withdrawal by Subject|1|||
160856007|NCT03275740|580862449|FG010|Overall Study|Withdrawal by Subject|0|||
160856008|NCT03275740|580862450|FG011|Overall Study|Withdrawal by Subject|0|||
160856009|NCT00988884|580862451|FG000|Overall Study|Adverse Event|0|||
160856010|NCT00988884|580862452|FG001|Overall Study|Adverse Event|1|||
160856011|NCT00988884|580862451|FG000|Overall Study|Lost to Follow-up|20|||
160856012|NCT00988884|580862452|FG001|Overall Study|Lost to Follow-up|16|||
160856013|NCT00988884|580862451|FG000|Overall Study|Protocol Violation|0|||
160856014|NCT00988884|580862452|FG001|Overall Study|Protocol Violation|1|||
160856015|NCT00988884|580862451|FG000|Overall Study|Withdrawal by Subject|15|||
160856016|NCT00988884|580862452|FG001|Overall Study|Withdrawal by Subject|18|||
161141382|NCT00957372|581901086|FG001|PART II|Adverse Event|0|||
160907965|NCT04875195|581056393|FG000|Overall Study|Withdrawal by Subject|2|||
160907966|NCT04875195|581056394|FG001|Overall Study|Withdrawal by Subject|1|||
160907967|NCT04875195|581056393|FG000|Overall Study|Ongoing in study|49|||
161337458|NCT02097823|582625952|FG001|Overall Study|Withdrawal by Subject|1|||
161141383|NCT00957372|581901087|FG002|PART II|Adverse Event|0|||
161141384|NCT00957372|581901088|FG003|PART II|Adverse Event|10|||
161141385|NCT00957372|581901085|FG000|PART II|Patient non-compliance|0|||
160907968|NCT04875195|581056394|FG001|Overall Study|Ongoing in study|2|||
161141386|NCT00957372|581901086|FG001|PART II|Patient non-compliance|0|||
161141387|NCT00957372|581901087|FG002|PART II|Patient non-compliance|0|||
160856023|NCT04621448|580862457|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
160856024|NCT04621448|580862458|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
160856025|NCT04621448|580862459|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
160856026|NCT04621448|580862460|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
160907969|NCT02339584|581056395|FG000|Overall Study|Adverse Event|11|||
161337459|NCT04239924|582625957|FG000|Overall Study|Lost to Follow-up|2|||
161337460|NCT05399680|582627441|FG000|Overall Study|Lost to Follow-up|1|||
161337461|NCT05399680|582627442|FG001|Overall Study|Lost to Follow-up|0|||
161337462|NCT05399680|582627441|FG000|Overall Study|Death|0|||
161337463|NCT05399680|582627442|FG001|Overall Study|Death|1|||
160856027|NCT04621448|580862457|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
160856028|NCT04621448|580862458|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
160856029|NCT04621448|580862459|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
160856030|NCT04621448|580862460|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
160856031|NCT04621448|580862457|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
160856032|NCT04621448|580862458|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
160856033|NCT04621448|580862459|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
160856034|NCT04621448|580862460|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
160856035|NCT04621448|580862457|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
160856036|NCT04621448|580862458|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
160856037|NCT04621448|580862459|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
160856038|NCT04621448|580862460|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
160856039|NCT00549640|580862461|FG000|Overall Study|Withdrawal by Subject|6|||
160856040|NCT00549640|580862462|FG001|Overall Study|Withdrawal by Subject|12|||
160856041|NCT00549640|580862461|FG000|Overall Study|Adverse Event|5|||
160856042|NCT00549640|580862462|FG001|Overall Study|Adverse Event|0|||
160856043|NCT00549640|580862461|FG000|Overall Study|Lost to Follow-up|7|||
160856044|NCT00549640|580862462|FG001|Overall Study|Lost to Follow-up|4|||
160856045|NCT03550378|580862469|FG000|Overall Study|Death|0|||
160856046|NCT03550378|580862470|FG001|Overall Study|Death|1|||
160856047|NCT04486235|580862471|FG000|Overall Study|Pregnancy|1|||
160856048|NCT04486235|580862472|FG001|Overall Study|Pregnancy|0|||
160856049|NCT04486235|580862471|FG000|Overall Study|Lost to Follow-up|1|||
160856050|NCT04486235|580862472|FG001|Overall Study|Lost to Follow-up|0|||
161255306|NCT02688387|582314132|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255307|NCT02688387|582314133|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255308|NCT02688387|582314134|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255309|NCT02688387|582314135|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255310|NCT02688387|582314136|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255311|NCT02688387|582314137|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255312|NCT02688387|582314138|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255313|NCT02688387|582314139|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255314|NCT02688387|582314140|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255315|NCT02688387|582314141|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255316|NCT02688387|582314142|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160856051|NCT00626275|580862473|FG000|Part A - Treatment Period 1|Adverse Event|1|||
160856052|NCT00626275|580862474|FG001|Part A - Treatment Period 1|Adverse Event|0|||
160856053|NCT00626275|580862475|FG002|Part A - Treatment Period 1|Adverse Event|0|||
160856054|NCT00626275|580862476|FG003|Part A - Treatment Period 1|Adverse Event|0|||
160856055|NCT00626275|580862477|FG004|Part A - Treatment Period 1|Adverse Event|0|||
160856056|NCT00626275|580862478|FG005|Part A - Treatment Period 1|Adverse Event|0|||
160856057|NCT00626275|580862479|FG006|Part A - Treatment Period 1|Adverse Event|0|||
160856058|NCT00626275|580862480|FG007|Part A - Treatment Period 1|Adverse Event|0|||
160856059|NCT00626275|580862473|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856060|NCT00626275|580862474|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856061|NCT00626275|580862475|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
160856062|NCT00626275|580862476|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856063|NCT00626275|580862477|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856064|NCT00626275|580862478|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856065|NCT00626275|580862479|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160856066|NCT00626275|580862480|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
160907970|NCT02339584|581056396|FG001|Overall Study|Adverse Event|7|||
160907971|NCT02339584|581056395|FG000|Overall Study|Lack of Efficacy|0|||
160907972|NCT02339584|581056396|FG001|Overall Study|Lack of Efficacy|1|||
160907973|NCT02339584|581056395|FG000|Overall Study|Physician Decision|1|||
160907974|NCT02339584|581056396|FG001|Overall Study|Physician Decision|2|||
160907975|NCT02339584|581056395|FG000|Overall Study|Protocol Violation|1|||
160907976|NCT02339584|581056396|FG001|Overall Study|Protocol Violation|1|||
160907977|NCT02339584|581056395|FG000|Overall Study|Withdrawal by Subject|2|||
160856067|NCT00626275|580862473|FG000|Part B|Lost to Follow-up|0|||
160856068|NCT00626275|580862474|FG001|Part B|Lost to Follow-up|0|||
160856069|NCT00626275|580862475|FG002|Part B|Lost to Follow-up|0|||
160856070|NCT00626275|580862476|FG003|Part B|Lost to Follow-up|0|||
160856071|NCT00626275|580862477|FG004|Part B|Lost to Follow-up|0|||
160856072|NCT00626275|580862478|FG005|Part B|Lost to Follow-up|0|||
160856073|NCT00626275|580862479|FG006|Part B|Lost to Follow-up|1|||
160856074|NCT00626275|580862480|FG007|Part B|Lost to Follow-up|0|||
160856075|NCT00626275|580862473|FG000|Part B|Withdrawal by Subject|0|||
160856076|NCT00626275|580862474|FG001|Part B|Withdrawal by Subject|0|||
160856077|NCT00626275|580862475|FG002|Part B|Withdrawal by Subject|0|||
160856078|NCT00626275|580862476|FG003|Part B|Withdrawal by Subject|0|||
160907978|NCT02339584|581056396|FG001|Overall Study|Withdrawal by Subject|4|||
160907979|NCT00826943|581056397|FG000|Overall Study|Withdrawal by Subject|0|||
161255317|NCT02688387|582314143|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255318|NCT02688387|582314144|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255319|NCT02688387|582314145|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160856079|NCT00626275|580862477|FG004|Part B|Withdrawal by Subject|0|||
160856080|NCT00626275|580862478|FG005|Part B|Withdrawal by Subject|0|||
160856081|NCT00626275|580862479|FG006|Part B|Withdrawal by Subject|0|||
160856082|NCT00626275|580862480|FG007|Part B|Withdrawal by Subject|1|||
160856083|NCT04590014|580862481|FG000|Overall Study|Withdrawal by Subject|1|||
160856084|NCT04590014|580862482|FG001|Overall Study|Withdrawal by Subject|0|||
160856085|NCT00468299|580862483|FG000|Overall Study|Withdrawal by Subject|0|||
160856086|NCT00468299|580862484|FG001|Overall Study|Withdrawal by Subject|1|||
160856087|NCT04999839|580862485|FG000|Overall Study|Adverse Event|1|||
160856088|NCT04999839|580862486|FG001|Overall Study|Adverse Event|1|||
160856089|NCT04999839|580862487|FG002|Overall Study|Adverse Event|1|||
160856090|NCT04999839|580862488|FG003|Overall Study|Adverse Event|1|||
160856091|NCT04999839|580862489|FG004|Overall Study|Adverse Event|1|||
160856092|NCT04999839|580862485|FG000|Overall Study|Lost to Follow-up|2|||
160856093|NCT04999839|580862486|FG001|Overall Study|Lost to Follow-up|0|||
160856094|NCT04999839|580862487|FG002|Overall Study|Lost to Follow-up|2|||
160856095|NCT04999839|580862488|FG003|Overall Study|Lost to Follow-up|4|||
160856096|NCT04999839|580862489|FG004|Overall Study|Lost to Follow-up|1|||
160856097|NCT04999839|580862485|FG000|Overall Study|Withdrawal by Subject|6|||
160856098|NCT04999839|580862486|FG001|Overall Study|Withdrawal by Subject|5|||
160856099|NCT04999839|580862487|FG002|Overall Study|Withdrawal by Subject|3|||
160856100|NCT04999839|580862488|FG003|Overall Study|Withdrawal by Subject|2|||
160856101|NCT04999839|580862489|FG004|Overall Study|Withdrawal by Subject|2|||
160856102|NCT04999839|580862485|FG000|Overall Study|Lack of Efficacy|0|||
160856103|NCT04999839|580862486|FG001|Overall Study|Lack of Efficacy|1|||
160856104|NCT04999839|580862487|FG002|Overall Study|Lack of Efficacy|0|||
160856105|NCT04999839|580862488|FG003|Overall Study|Lack of Efficacy|0|||
160856106|NCT04999839|580862489|FG004|Overall Study|Lack of Efficacy|0|||
160856107|NCT04999839|580862485|FG000|Overall Study|Physician Decision|0|||
160856108|NCT04999839|580862486|FG001|Overall Study|Physician Decision|0|||
160856109|NCT04999839|580862487|FG002|Overall Study|Physician Decision|0|||
160856110|NCT04999839|580862488|FG003|Overall Study|Physician Decision|0|||
160856111|NCT04999839|580862489|FG004|Overall Study|Physician Decision|1|||
160856112|NCT04999839|580862485|FG000|Overall Study|Sponsor request|0|||
160856113|NCT04999839|580862486|FG001|Overall Study|Sponsor request|1|||
160856114|NCT04999839|580862487|FG002|Overall Study|Sponsor request|0|||
160856115|NCT04999839|580862488|FG003|Overall Study|Sponsor request|0|||
160856116|NCT04999839|580862489|FG004|Overall Study|Sponsor request|0|||
160856117|NCT04999839|580862485|FG000|Overall Study|Other|0|||
160856118|NCT04999839|580862486|FG001|Overall Study|Other|0|||
160856119|NCT04999839|580862487|FG002|Overall Study|Other|1|||
160856120|NCT04999839|580862488|FG003|Overall Study|Other|0|||
160856121|NCT04999839|580862489|FG004|Overall Study|Other|0|||
160856122|NCT01362348|580862490|FG000|Overall Study|Protocol-defined stopping criteria|9|||
160856123|NCT01362348|580862490|FG000|Overall Study|Study closed/terminated|5|||
160907980|NCT00826943|581056398|FG001|Overall Study|Withdrawal by Subject|0|||
160907981|NCT00826943|581056399|FG002|Overall Study|Withdrawal by Subject|0|||
160907982|NCT00826943|581056400|FG003|Overall Study|Withdrawal by Subject|0|||
160907983|NCT00826943|581056401|FG004|Overall Study|Withdrawal by Subject|1|||
160907984|NCT00826943|581056402|FG005|Overall Study|Withdrawal by Subject|0|||
160907985|NCT00074152|581056403|FG000|Overall Study|Death|21|||
160907986|NCT00074152|581056404|FG001|Overall Study|Death|9|||
160907987|NCT00074152|581056403|FG000|Overall Study|Lack of Efficacy|34|||
160907988|NCT00074152|581056404|FG001|Overall Study|Lack of Efficacy|24|||
160907989|NCT03715530|581056405|FG000|Overall Study|Lost to Follow-up|3|||
160907990|NCT03715530|581056406|FG001|Overall Study|Lost to Follow-up|1|||
160907991|NCT03715530|581056407|FG002|Overall Study|Lost to Follow-up|2|||
160907992|NCT01594762|581056408|FG000|Overall Study|Withdrawal by Subject|1|||
160907993|NCT01594762|581056409|FG001|Overall Study|Withdrawal by Subject|0|||
160907994|NCT01594762|581056408|FG000|Overall Study|Lost to Follow-up|10|||
160907995|NCT01594762|581056409|FG001|Overall Study|Lost to Follow-up|10|||
161141388|NCT00957372|581901088|FG003|PART II|Patient non-compliance|4|||
161141389|NCT01444391|581901091|FG000|Overall Study|Death|1|||
160856124|NCT00399516|580862491|FG000|Overall Study|Lost to Follow-up|2|||
161141390|NCT03750838|581901092|FG000|Overall Study|Lost to Follow-up|10|||
161255320|NCT02688387|582314146|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
160856125|NCT03546621|580862492|FG000|Overall Study|Withdrawal by Subject|0|||
160907996|NCT01785069|581056413|FG000|Overall Study|Implanted with nonstudy device|1|||
160907997|NCT01785069|581056414|FG001|Overall Study|Implanted with nonstudy device|2|||
161255321|NCT02688387|582314147|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255322|NCT02688387|582314148|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255323|NCT02688387|582314149|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255324|NCT02688387|582314150|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160856126|NCT03546621|580862493|FG001|Overall Study|Withdrawal by Subject|1|||
160856127|NCT03546621|580862494|FG002|Overall Study|Withdrawal by Subject|2|||
160856128|NCT03546621|580862495|FG003|Overall Study|Withdrawal by Subject|1|||
160856129|NCT03546621|580862492|FG000|Overall Study|Lost to Follow-up|0|||
161141391|NCT03750838|581901093|FG001|Overall Study|Lost to Follow-up|6|||
160907998|NCT01785069|581056415|FG002|Overall Study|Implanted with nonstudy device|1|||
160907999|NCT01785069|581056416|FG003|Overall Study|Implanted with nonstudy device|0|||
160908000|NCT01785069|581056413|FG000|Overall Study|Death|0|||
160908001|NCT01785069|581056414|FG001|Overall Study|Death|0|||
160908002|NCT01785069|581056415|FG002|Overall Study|Death|2|||
160908003|NCT01785069|581056416|FG003|Overall Study|Death|0|||
160908004|NCT01785069|581056413|FG000|Overall Study|Subject choice|2|||
160908005|NCT01785069|581056414|FG001|Overall Study|Subject choice|2|||
160908006|NCT01785069|581056415|FG002|Overall Study|Subject choice|0|||
160908007|NCT01785069|581056416|FG003|Overall Study|Subject choice|1|||
160908008|NCT01785069|581056413|FG000|Overall Study|Lost to Follow-up|1|||
160908009|NCT01785069|581056414|FG001|Overall Study|Lost to Follow-up|2|||
160908010|NCT01785069|581056415|FG002|Overall Study|Lost to Follow-up|4|||
160908011|NCT01785069|581056416|FG003|Overall Study|Lost to Follow-up|1|||
160908012|NCT01785069|581056413|FG000|Overall Study|Reason not Specified|1|||
160908013|NCT01785069|581056414|FG001|Overall Study|Reason not Specified|2|||
160908014|NCT01785069|581056415|FG002|Overall Study|Reason not Specified|1|||
160908015|NCT01785069|581056416|FG003|Overall Study|Reason not Specified|4|||
160908016|NCT01785069|581056413|FG000|Overall Study|Not evaluable|7|||
160908017|NCT01785069|581056414|FG001|Overall Study|Not evaluable|4|||
160908018|NCT01785069|581056415|FG002|Overall Study|Not evaluable|5|||
160908019|NCT01785069|581056416|FG003|Overall Study|Not evaluable|8|||
160908020|NCT03338998|581056417|FG000|Treatment Period|Withdrawal by Subject|1|||
160908021|NCT03338998|581056418|FG001|Treatment Period|Withdrawal by Subject|1|||
160908022|NCT03338998|581056417|FG000|Treatment Period|Adverse Event|0|||
160908023|NCT03338998|581056418|FG001|Treatment Period|Adverse Event|2|||
160908024|NCT03338998|581056417|FG000|Treatment Period|Protocol deviation|1|||
160908025|NCT03338998|581056418|FG001|Treatment Period|Protocol deviation|0|||
160908026|NCT03338998|581056417|FG000|Treatment Period|Physician Decision|2|||
160908027|NCT03338998|581056418|FG001|Treatment Period|Physician Decision|0|||
160908028|NCT03338998|581056417|FG000|Treatment Period|Subject failed swallow test|4|||
160908029|NCT03338998|581056418|FG001|Treatment Period|Subject failed swallow test|0|||
160908030|NCT03338998|581056417|FG000|Safety Follow-Up Period|Adverse Event|0|||
160908031|NCT03338998|581056418|FG001|Safety Follow-Up Period|Adverse Event|1|||
160908032|NCT03338998|581056417|FG000|Safety Follow-Up Period|Protocol deviation|1|||
160908033|NCT03338998|581056418|FG001|Safety Follow-Up Period|Protocol deviation|0|||
160908034|NCT03338998|581056417|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
160908035|NCT03338998|581056418|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
160908036|NCT03288129|581056421|FG000|Overall Study|Adverse Event|10|||
160908037|NCT03288129|581056421|FG000|Overall Study|Lost to Follow-up|3|||
160908038|NCT03288129|581056421|FG000|Overall Study|Withdrawal by Subject|3|||
160908039|NCT03288129|581056421|FG000|Overall Study|Withdrawal of consent/assent|1|||
160993339|NCT02001623|581365328|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
160993340|NCT02001623|581365329|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
160993341|NCT02001623|581365330|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
160856130|NCT03546621|580862493|FG001|Overall Study|Lost to Follow-up|1|||
160856131|NCT03546621|580862494|FG002|Overall Study|Lost to Follow-up|0|||
160856132|NCT03546621|580862495|FG003|Overall Study|Lost to Follow-up|0|||
160856133|NCT03546621|580862492|FG000|Overall Study|Adverse Event|0|||
160856134|NCT03546621|580862493|FG001|Overall Study|Adverse Event|1|||
160856135|NCT03546621|580862494|FG002|Overall Study|Adverse Event|0|||
160856136|NCT03546621|580862495|FG003|Overall Study|Adverse Event|1|||
160856137|NCT03546621|580862492|FG000|Overall Study|Progressive disease|0|||
160856138|NCT03546621|580862493|FG001|Overall Study|Progressive disease|0|||
160856139|NCT03546621|580862494|FG002|Overall Study|Progressive disease|0|||
160856140|NCT03546621|580862495|FG003|Overall Study|Progressive disease|1|||
160856141|NCT00660192|580862496|FG000|Overall Study|Lost to Follow-up|2|||
160856142|NCT00660192|580862497|FG001|Overall Study|Lost to Follow-up|3|||
160856143|NCT00377520|580862498|FG000|Overall Study|Ineligible (Prior radiation)|1|||
160856144|NCT00982735|580862499|FG000|Overall Study|Lost to Follow-up|6|||
160856145|NCT00982735|580862499|FG000|Overall Study|Patient ineligible for trial|224|||
161255325|NCT02688387|582314151|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
161255326|NCT02688387|582314152|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160856146|NCT00651924|580862502|FG000|Overall Study|Withdrawal by PI|0|||
160908040|NCT03288129|581056421|FG000|Overall Study|Other|5|||
160908041|NCT01744197|581056424|FG000|Overall Study|Received 1 patch|2|||
160908042|NCT01744197|581056425|FG001|Overall Study|Received 1 patch|1|||
161255327|NCT02688387|582314153|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
160856147|NCT00651924|580862503|FG001|Overall Study|Withdrawal by PI|2|||
160856148|NCT00651924|580862502|FG000|Overall Study|Withdrawal by Subject|0|||
160856149|NCT00651924|580862503|FG001|Overall Study|Withdrawal by Subject|5|||
160908043|NCT01744197|581056424|FG000|Overall Study|No patch received|2|||
160908044|NCT01744197|581056425|FG001|Overall Study|No patch received|2|||
160908045|NCT04706091|581056426|FG000|Treatment 2|Withdrawal by Subject|1|||
160856150|NCT00758771|580862504|FG000|Overall Study|Withdrawal by Subject|1|||
160856151|NCT00758771|580862505|FG001|Overall Study|Withdrawal by Subject|1|||
160856152|NCT00758771|580862504|FG000|Overall Study|Did not meet eligibility criteria|2|||
160856153|NCT00758771|580862505|FG001|Overall Study|Did not meet eligibility criteria|4|||
160856154|NCT00960063|580862506|FG000|Overall Study|Adverse Event|1|||
160856155|NCT00960063|580862507|FG001|Overall Study|Adverse Event|0|||
160856156|NCT00960063|580862508|FG002|Overall Study|Adverse Event|0|||
160856157|NCT00960063|580862506|FG000|Overall Study|Progression of Disease|0|||
160856158|NCT00960063|580862507|FG001|Overall Study|Progression of Disease|0|||
160856159|NCT00960063|580862508|FG002|Overall Study|Progression of Disease|3|||
160856160|NCT02898454|580862515|FG000|Overall Study|Adverse Event|4|||
160856161|NCT02898454|580862516|FG001|Overall Study|Adverse Event|1|||
160856162|NCT02898454|580862517|FG002|Overall Study|Adverse Event|2|||
160856163|NCT02898454|580862515|FG000|Overall Study|Protocol Violation|1|||
160856164|NCT02898454|580862516|FG001|Overall Study|Protocol Violation|0|||
160856165|NCT02898454|580862517|FG002|Overall Study|Protocol Violation|1|||
160856166|NCT02898454|580862515|FG000|Overall Study|Lack of Efficacy|4|||
160856167|NCT02898454|580862516|FG001|Overall Study|Lack of Efficacy|1|||
160856168|NCT02898454|580862517|FG002|Overall Study|Lack of Efficacy|0|||
160856169|NCT02898454|580862515|FG000|Overall Study|Withdrawal by Subject|6|||
160993342|NCT02001623|581365331|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
160993343|NCT02001623|581365332|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
160856170|NCT02898454|580862516|FG001|Overall Study|Withdrawal by Subject|3|||
160856171|NCT02898454|580862517|FG002|Overall Study|Withdrawal by Subject|3|||
160856172|NCT02898454|580862515|FG000|Overall Study|Lost to Follow-up|1|||
160856173|NCT02898454|580862516|FG001|Overall Study|Lost to Follow-up|0|||
160856174|NCT02898454|580862517|FG002|Overall Study|Lost to Follow-up|0|||
160856175|NCT02898454|580862515|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
160856176|NCT02898454|580862516|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
160856177|NCT02898454|580862517|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
160856178|NCT02343263|580862518|FG000|Overall Study|Physician Decision|5|||
160856179|NCT02343263|580862519|FG001|Overall Study|Physician Decision|3|||
160856180|NCT02343263|580862520|FG002|Overall Study|Physician Decision|1|||
160856181|NCT03040141|580862521|FG000|Overall Study|Death|1|||
160856182|NCT03040141|580862522|FG001|Overall Study|Death|2|||
160856183|NCT03040141|580862523|FG002|Overall Study|Death|3|||
160856184|NCT03040141|580862521|FG000|Overall Study|Withdrawal by Subject|3|||
160856185|NCT03040141|580862522|FG001|Overall Study|Withdrawal by Subject|1|||
160856186|NCT03040141|580862523|FG002|Overall Study|Withdrawal by Subject|1|||
160856187|NCT03040141|580862521|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
160856188|NCT03040141|580862522|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
160856189|NCT03040141|580862523|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
160856190|NCT03040141|580862521|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
160856191|NCT03040141|580862522|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
160856192|NCT03040141|580862523|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
160856193|NCT01400698|580862525|FG000|Overall Study|Lost to Follow-up|2|||
160856194|NCT01400698|580862526|FG001|Overall Study|Lost to Follow-up|5|||
160856195|NCT01400698|580862527|FG002|Overall Study|Lost to Follow-up|2|||
160856196|NCT01400698|580862528|FG003|Overall Study|Lost to Follow-up|1|||
160856197|NCT01400698|580862529|FG004|Overall Study|Lost to Follow-up|4|||
160856198|NCT01400698|580862530|FG005|Overall Study|Lost to Follow-up|3|||
160856199|NCT01400698|580862525|FG000|Overall Study|Withdrawal by Subject|8|||
160856200|NCT01400698|580862526|FG001|Overall Study|Withdrawal by Subject|2|||
160856201|NCT01400698|580862527|FG002|Overall Study|Withdrawal by Subject|0|||
160856202|NCT01400698|580862528|FG003|Overall Study|Withdrawal by Subject|4|||
160856203|NCT01400698|580862529|FG004|Overall Study|Withdrawal by Subject|1|||
160856204|NCT01400698|580862530|FG005|Overall Study|Withdrawal by Subject|3|||
160856205|NCT01400698|580862525|FG000|Overall Study|Protocol Violation|0|||
160856206|NCT01400698|580862526|FG001|Overall Study|Protocol Violation|1|||
160993344|NCT02001623|581365333|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
160993345|NCT02001623|581365334|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
160993346|NCT02001623|581365335|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
160993347|NCT02001623|581365336|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
160993348|NCT02001623|581365322|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
160856207|NCT01400698|580862527|FG002|Overall Study|Protocol Violation|0|||
160856208|NCT01400698|580862528|FG003|Overall Study|Protocol Violation|0|||
160856209|NCT01400698|580862529|FG004|Overall Study|Protocol Violation|1|||
160856210|NCT01400698|580862530|FG005|Overall Study|Protocol Violation|0|||
160856211|NCT01400698|580862525|FG000|Overall Study|Non-compliance|0|||
160856212|NCT01400698|580862526|FG001|Overall Study|Non-compliance|1|||
160856213|NCT01400698|580862527|FG002|Overall Study|Non-compliance|0|||
160856214|NCT01400698|580862528|FG003|Overall Study|Non-compliance|1|||
160856215|NCT01400698|580862529|FG004|Overall Study|Non-compliance|0|||
160856216|NCT01400698|580862530|FG005|Overall Study|Non-compliance|0|||
160856217|NCT01400698|580862525|FG000|Overall Study|Adverse Event|1|||
160993349|NCT02001623|581365323|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
160856218|NCT01400698|580862526|FG001|Overall Study|Adverse Event|0|||
160856219|NCT01400698|580862527|FG002|Overall Study|Adverse Event|0|||
160856220|NCT01400698|580862528|FG003|Overall Study|Adverse Event|0|||
160856221|NCT01400698|580862529|FG004|Overall Study|Adverse Event|0|||
160856222|NCT01400698|580862530|FG005|Overall Study|Adverse Event|0|||
160856223|NCT01400698|580862525|FG000|Overall Study|Other|4|||
160856224|NCT01400698|580862526|FG001|Overall Study|Other|2|||
160856225|NCT01400698|580862527|FG002|Overall Study|Other|0|||
160856226|NCT01400698|580862528|FG003|Overall Study|Other|2|||
160856227|NCT01400698|580862529|FG004|Overall Study|Other|1|||
160856228|NCT01400698|580862530|FG005|Overall Study|Other|0|||
160856229|NCT01650194|580862531|FG000|Overall Study|Progressive Disease (PD)|35|||
160856230|NCT01650194|580862531|FG000|Overall Study|Withdrawal by Subject|2|||
160856231|NCT01650194|580862531|FG000|Overall Study|Miscellaneous|10|||
160856232|NCT00633477|580864637|FG000|Overall Study|Death|1|||
160856233|NCT00633477|580864638|FG001|Overall Study|Death|0|||
160856234|NCT00633477|580864637|FG000|Overall Study|Randomized but not treated|1|||
160856235|NCT00633477|580864638|FG001|Overall Study|Randomized but not treated|0|||
160856236|NCT04906499|580864640|FG000|Overall Study|Lack of time|1|||
160856237|NCT00644423|580864641|FG000|Overall Study|Lost to Follow-up|1|||
160856238|NCT00644423|580864642|FG001|Overall Study|Lost to Follow-up|1|||
160856239|NCT03346434|580864643|FG000|Overall Study|Randomized in Error|0|||
160856240|NCT03346434|580864644|FG001|Overall Study|Randomized in Error|0|||
160856241|NCT03346434|580864645|FG002|Overall Study|Randomized in Error|0|||
160856242|NCT03346434|580864646|FG003|Overall Study|Randomized in Error|0|||
160856243|NCT03346434|580864647|FG004|Overall Study|Randomized in Error|1|||
160856244|NCT03346434|580864648|FG005|Overall Study|Randomized in Error|0|||
160856245|NCT03346434|580864643|FG000|Overall Study|Withdrawal by Subject|0|||
160856246|NCT03346434|580864644|FG001|Overall Study|Withdrawal by Subject|0|||
160856247|NCT03346434|580864645|FG002|Overall Study|Withdrawal by Subject|1|||
160856248|NCT03346434|580864646|FG003|Overall Study|Withdrawal by Subject|0|||
160856249|NCT03346434|580864647|FG004|Overall Study|Withdrawal by Subject|1|||
160856250|NCT03346434|580864648|FG005|Overall Study|Withdrawal by Subject|0|||
160856251|NCT03346434|580864643|FG000|Overall Study|Lost to Follow-up|0|||
160856252|NCT03346434|580864644|FG001|Overall Study|Lost to Follow-up|0|||
160856253|NCT03346434|580864645|FG002|Overall Study|Lost to Follow-up|0|||
160856254|NCT03346434|580864646|FG003|Overall Study|Lost to Follow-up|0|||
160856255|NCT03346434|580864647|FG004|Overall Study|Lost to Follow-up|1|||
160856256|NCT03346434|580864648|FG005|Overall Study|Lost to Follow-up|1|||
160856257|NCT03346434|580864643|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856258|NCT03346434|580864644|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856259|NCT03346434|580864645|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856260|NCT03346434|580864646|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
160856261|NCT03346434|580864647|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
160856262|NCT03346434|580864648|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
160856263|NCT03525444|580864649|FG000|Overall Study|Adverse Event|0|||
160856264|NCT03525444|580864650|FG001|Overall Study|Adverse Event|1|||
160856265|NCT03525444|580864649|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160856266|NCT03525444|580864650|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
160856267|NCT03525444|580864649|FG000|Overall Study|Other|0|||
160856268|NCT03525444|580864650|FG001|Overall Study|Other|1|||
160856269|NCT00262860|580864652|FG000|Overall Study|Adverse Event|2|||
160993350|NCT02001623|581365324|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
160993351|NCT02001623|581365325|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
160993352|NCT02001623|581365326|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
160993353|NCT02001623|581365327|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
161255328|NCT02688387|582314132|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160856270|NCT02741128|580864653|FG000|Overall Study|Protocol Violation|4|||
160856271|NCT02741128|580864654|FG001|Overall Study|Protocol Violation|1|||
160856272|NCT02741128|580864653|FG000|Overall Study|Withdrawal by Subject|2|||
160856273|NCT02741128|580864654|FG001|Overall Study|Withdrawal by Subject|0|||
160856274|NCT02741128|580864653|FG000|Overall Study|Lost to Follow-up|1|||
160993354|NCT02001623|581365328|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
160993355|NCT02001623|581365329|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
161255329|NCT02688387|582314133|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160856275|NCT02741128|580864654|FG001|Overall Study|Lost to Follow-up|0|||
160856276|NCT02081677|580864655|FG000|Overall Study|Adverse Event|0|||
160856277|NCT02081677|580864656|FG001|Overall Study|Adverse Event|0|||
160856278|NCT02081677|580864657|FG002|Overall Study|Adverse Event|1|||
160856279|NCT02081677|580864658|FG003|Overall Study|Adverse Event|0|||
160856280|NCT02081677|580864655|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160856281|NCT02081677|580864656|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160856282|NCT02081677|580864657|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
160856283|NCT02081677|580864658|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160993356|NCT02001623|581365330|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
160993357|NCT02001623|581365331|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
160993358|NCT02001623|581365332|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
160856284|NCT02081677|580864655|FG000|Overall Study|Not comfortable with lens care system|1|||
160856285|NCT02081677|580864656|FG001|Overall Study|Not comfortable with lens care system|0|||
160856286|NCT02081677|580864657|FG002|Overall Study|Not comfortable with lens care system|0|||
160856287|NCT02081677|580864658|FG003|Overall Study|Not comfortable with lens care system|0|||
160856288|NCT02081677|580864655|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160856289|NCT02081677|580864656|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160856290|NCT02081677|580864657|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
160856291|NCT02081677|580864658|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
160856292|NCT01419769|580864659|FG000|Overall Study|Did not receive the AXIOS stent|3|||
160856293|NCT01419769|580864659|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
160856294|NCT00878501|580864668|FG000|Overall Study|Adverse Event|11|||
160856295|NCT00878501|580864669|FG001|Overall Study|Adverse Event|3|||
160856296|NCT00878501|580864670|FG002|Overall Study|Adverse Event|3|||
160856297|NCT00878501|580864668|FG000|Overall Study|Lack of Efficacy|2|||
160856298|NCT00878501|580864669|FG001|Overall Study|Lack of Efficacy|1|||
160856299|NCT00878501|580864670|FG002|Overall Study|Lack of Efficacy|0|||
160856300|NCT00878501|580864668|FG000|Overall Study|Withdrawal by Subject|2|||
160856301|NCT00878501|580864669|FG001|Overall Study|Withdrawal by Subject|1|||
160856302|NCT00878501|580864670|FG002|Overall Study|Withdrawal by Subject|2|||
160856303|NCT00878501|580864668|FG000|Overall Study|Protocol Violation|0|||
160856304|NCT00878501|580864669|FG001|Overall Study|Protocol Violation|0|||
160856305|NCT00878501|580864670|FG002|Overall Study|Protocol Violation|1|||
160856306|NCT00878501|580864668|FG000|Overall Study|Incorrect enrolment|1|||
160856307|NCT00878501|580864669|FG001|Overall Study|Incorrect enrolment|2|||
160856308|NCT00878501|580864670|FG002|Overall Study|Incorrect enrolment|0|||
160856309|NCT00878501|580864668|FG000|Overall Study|Intake of prohibited concom. medication|0|||
160856310|NCT00878501|580864669|FG001|Overall Study|Intake of prohibited concom. medication|0|||
160856311|NCT00878501|580864670|FG002|Overall Study|Intake of prohibited concom. medication|1|||
160856312|NCT00878501|580864668|FG000|Overall Study|Mis-randomisation of patient|1|||
160856313|NCT00878501|580864669|FG001|Overall Study|Mis-randomisation of patient|0|||
160856314|NCT00878501|580864670|FG002|Overall Study|Mis-randomisation of patient|0|||
160856315|NCT00878501|580864668|FG000|Overall Study|Administrative|0|||
160856316|NCT00878501|580864669|FG001|Overall Study|Administrative|0|||
160856317|NCT00878501|580864670|FG002|Overall Study|Administrative|1|||
160856318|NCT03224130|580864673|FG000|Overall Study|consent issue|0|||
160856319|NCT03224130|580864674|FG001|Overall Study|consent issue|1|||
160856320|NCT01690052|580864675|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
160856321|NCT01690052|580864676|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
160856322|NCT01453049|580864677|FG000|Overall Study|Protocol Violation|2|||
160856323|NCT01453049|580864678|FG001|Overall Study|Protocol Violation|5|||
160856324|NCT01453049|580864677|FG000|Overall Study|Lost to Follow-up|2|||
160856325|NCT01453049|580864678|FG001|Overall Study|Lost to Follow-up|1|||
160856326|NCT01453049|580864677|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
160856327|NCT01453049|580864678|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
160856328|NCT01453049|580864677|FG000|Overall Study|Withdrawal by Subject|1|||
160856329|NCT01453049|580864678|FG001|Overall Study|Withdrawal by Subject|0|||
160856330|NCT01453049|580864677|FG000|Overall Study|Randomized in Error|1|||
160856331|NCT01453049|580864678|FG001|Overall Study|Randomized in Error|0|||
160856332|NCT02421172|580864679|FG000|Period 1|Adverse Event|1|||
160856333|NCT02421172|580864680|FG001|Period 1|Adverse Event|0|||
160856334|NCT02421172|580864681|FG002|Period 1|Adverse Event|0|||
160856335|NCT02421172|580864682|FG003|Period 1|Adverse Event|0|||
160856336|NCT02421172|580864683|FG004|Period 1|Adverse Event|0|||
160856337|NCT02421172|580864679|FG000|Period 1|Lost to Follow-up|3|||
160856338|NCT02421172|580864680|FG001|Period 1|Lost to Follow-up|1|||
160856339|NCT02421172|580864681|FG002|Period 1|Lost to Follow-up|0|||
160856340|NCT02421172|580864682|FG003|Period 1|Lost to Follow-up|0|||
160856341|NCT02421172|580864683|FG004|Period 1|Lost to Follow-up|0|||
160856342|NCT02421172|580864679|FG000|Period 1|Patient/guardian decision|0|||
160856343|NCT02421172|580864680|FG001|Period 1|Patient/guardian decision|1|||
160856344|NCT02421172|580864681|FG002|Period 1|Patient/guardian decision|0|||
160856345|NCT02421172|580864682|FG003|Period 1|Patient/guardian decision|0|||
160908046|NCT04706091|581056427|FG001|Treatment 2|Withdrawal by Subject|0|||
160908047|NCT03329573|581056428|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
161255330|NCT02688387|582314134|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255331|NCT02688387|582314135|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255332|NCT02688387|582314136|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255333|NCT02688387|582314137|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255334|NCT02688387|582314138|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160908048|NCT03329573|581056429|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
161255335|NCT02688387|582314139|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255336|NCT02688387|582314140|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255337|NCT02688387|582314141|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255338|NCT02688387|582314142|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255339|NCT02688387|582314143|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
160856346|NCT02421172|580864683|FG004|Period 1|Patient/guardian decision|0|||
161255340|NCT02688387|582314144|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255341|NCT02688387|582314145|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255342|NCT02688387|582314146|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255343|NCT02688387|582314147|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255344|NCT02688387|582314148|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255345|NCT02688387|582314149|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255346|NCT02688387|582314150|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255347|NCT02688387|582314151|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255348|NCT02688387|582314152|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
161255349|NCT02688387|582314153|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
161255350|NCT02688387|582314132|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255351|NCT02688387|582314133|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255352|NCT02688387|582314134|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160856347|NCT02421172|580864679|FG000|Period 2|Adverse Event|0|||
160856348|NCT02421172|580864680|FG001|Period 2|Adverse Event|0|||
160856349|NCT02421172|580864681|FG002|Period 2|Adverse Event|4|||
160856350|NCT02421172|580864682|FG003|Period 2|Adverse Event|0|||
160856351|NCT02421172|580864683|FG004|Period 2|Adverse Event|0|||
160856352|NCT02421172|580864679|FG000|Period 2|Lost to Follow-up|0|||
160856353|NCT02421172|580864680|FG001|Period 2|Lost to Follow-up|0|||
160856354|NCT02421172|580864681|FG002|Period 2|Lost to Follow-up|0|||
160856355|NCT02421172|580864682|FG003|Period 2|Lost to Follow-up|1|||
160856356|NCT02421172|580864683|FG004|Period 2|Lost to Follow-up|0|||
160856357|NCT02421172|580864679|FG000|Period 2|Patient/guardian decision|0|||
160856358|NCT02421172|580864680|FG001|Period 2|Patient/guardian decision|0|||
160856359|NCT02421172|580864681|FG002|Period 2|Patient/guardian decision|3|||
160856360|NCT02421172|580864682|FG003|Period 2|Patient/guardian decision|2|||
160856361|NCT02421172|580864683|FG004|Period 2|Patient/guardian decision|1|||
160856362|NCT00928486|580864684|FG000|Overall Study|Adverse Event|2|||
160856363|NCT00928486|580864684|FG000|Overall Study|Disease Progression|7|||
160856364|NCT00928486|580864684|FG000|Overall Study|Withdrawal by Subject|1|||
160856365|NCT03095651|580864685|FG000|Overall Study|Lost to Follow-up|1|||
160856366|NCT03095651|580864686|FG001|Overall Study|Lost to Follow-up|1|||
160856367|NCT03095651|580864687|FG002|Overall Study|Lost to Follow-up|0|||
160856368|NCT03095651|580864688|FG003|Overall Study|Lost to Follow-up|1|||
160856369|NCT03095651|580864689|FG004|Overall Study|Lost to Follow-up|0|||
160856370|NCT03095651|580864690|FG005|Overall Study|Lost to Follow-up|0|||
160856371|NCT03095651|580864691|FG006|Overall Study|Lost to Follow-up|0|||
160856372|NCT03095651|580864692|FG007|Overall Study|Lost to Follow-up|0|||
160856373|NCT03095651|580864685|FG000|Overall Study|Withdrawal by Subject|0|||
160856374|NCT03095651|580864686|FG001|Overall Study|Withdrawal by Subject|0|||
160856375|NCT03095651|580864687|FG002|Overall Study|Withdrawal by Subject|0|||
160856376|NCT03095651|580864688|FG003|Overall Study|Withdrawal by Subject|0|||
160856377|NCT03095651|580864689|FG004|Overall Study|Withdrawal by Subject|0|||
160856378|NCT03095651|580864690|FG005|Overall Study|Withdrawal by Subject|1|||
160856379|NCT03095651|580864691|FG006|Overall Study|Withdrawal by Subject|0|||
160856380|NCT03095651|580864692|FG007|Overall Study|Withdrawal by Subject|0|||
160856381|NCT04124939|580864693|FG000|Overall Study|Lost to Follow-up|1|||
160856382|NCT04124939|580864694|FG001|Overall Study|Lost to Follow-up|3|||
160856383|NCT03489863|580864700|FG000|Overall Study|Withdrawal by Subject|0|||
160856384|NCT03489863|580864701|FG001|Overall Study|Withdrawal by Subject|1|||
160856385|NCT01751061|580864702|FG000|Overall Study|Death|1|||
160856386|NCT01751061|580864703|FG001|Overall Study|Death|0|||
160856387|NCT01751061|580864702|FG000|Overall Study|patient death|5|||
160856388|NCT01751061|580864703|FG001|Overall Study|patient death|0|||
160856389|NCT01751061|580864702|FG000|Overall Study|Lost to Follow-up|40|||
160856390|NCT01751061|580864703|FG001|Overall Study|Lost to Follow-up|25|||
160856391|NCT01751061|580864702|FG000|Overall Study|patient regained decisional capacity|4|||
160856392|NCT01751061|580864703|FG001|Overall Study|patient regained decisional capacity|8|||
160856393|NCT01751061|580864702|FG000|Overall Study|Withdrawal by Subject|4|||
160856394|NCT01751061|580864703|FG001|Overall Study|Withdrawal by Subject|1|||
160856395|NCT01751061|580864702|FG000|Overall Study|Physician Decision|2|||
160856396|NCT01751061|580864703|FG001|Overall Study|Physician Decision|0|||
160856397|NCT00768989|580864706|FG000|Prior to Week 24|Withdrawal by Subject|1|||
160856398|NCT00768989|580864707|FG001|Prior to Week 24|Withdrawal by Subject|0|||
160856399|NCT00768989|580864706|FG000|Prior to Week 24|Adverse Event|3|||
160856400|NCT00768989|580864707|FG001|Prior to Week 24|Adverse Event|0|||
160856401|NCT00768989|580864706|FG000|Prior to Week 24|Lost to Follow-up|0|||
160856402|NCT00768989|580864707|FG001|Prior to Week 24|Lost to Follow-up|1|||
160856403|NCT00768989|580864706|FG000|Prior to Week 24|Protocol Violation|0|||
160856404|NCT00768989|580864707|FG001|Prior to Week 24|Protocol Violation|2|||
160856405|NCT00768989|580864706|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
160856406|NCT00768989|580864707|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
160856407|NCT00768989|580864706|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
160856408|NCT00768989|580864707|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
161141392|NCT00630032|581901096|FG000|Overall Study|Death|55|||
160856409|NCT00768989|580864706|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
160856410|NCT00768989|580864707|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
160856411|NCT00768989|580864706|FG000|On or After Week 36|Lack of Efficacy|1|||
160856412|NCT00768989|580864707|FG001|On or After Week 36|Lack of Efficacy|0|||
160856413|NCT00768989|580864706|FG000|On or After Week 36|Adverse Event|0|||
160856414|NCT00768989|580864707|FG001|On or After Week 36|Adverse Event|1|||
160856415|NCT00768989|580864706|FG000|On or After Week 36|Lost to Follow-up|1|||
160856416|NCT00768989|580864707|FG001|On or After Week 36|Lost to Follow-up|0|||
160856417|NCT00768989|580864706|FG000|On or After Week 36|Poor Compliance|1|||
160856418|NCT00768989|580864707|FG001|On or After Week 36|Poor Compliance|0|||
160856419|NCT00768989|580864706|FG000|On or After Week 36|Protocol Violation|1|||
160856420|NCT00768989|580864707|FG001|On or After Week 36|Protocol Violation|0|||
160856421|NCT00768989|580864706|FG000|On or After Week 36|Did not attend termination visit|2|||
160856422|NCT00768989|580864707|FG001|On or After Week 36|Did not attend termination visit|0|||
160856423|NCT00768989|580864706|FG000|On or After Week 36|Sponsor Termination|45|||
160856424|NCT00768989|580864707|FG001|On or After Week 36|Sponsor Termination|26|||
160856425|NCT02153086|580864708|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
160856426|NCT02153086|580864708|FG000|Overall Study|Other|2|||
160856427|NCT01194830|580864709|FG000|Overall Study|Adverse Event|3|||
160856428|NCT01194830|580864710|FG001|Overall Study|Adverse Event|2|||
160856429|NCT01194830|580864709|FG000|Overall Study|Protocol Violation|5|||
160856430|NCT01194830|580864710|FG001|Overall Study|Protocol Violation|4|||
160856431|NCT01194830|580864709|FG000|Overall Study|Lost to Follow-up|9|||
160856432|NCT01194830|580864710|FG001|Overall Study|Lost to Follow-up|7|||
160856433|NCT01194830|580864709|FG000|Overall Study|Withdrawal by Subject|2|||
160856434|NCT01194830|580864710|FG001|Overall Study|Withdrawal by Subject|1|||
160856435|NCT01194830|580864709|FG000|Overall Study|Lack of Efficacy|1|||
160856436|NCT01194830|580864710|FG001|Overall Study|Lack of Efficacy|1|||
160856437|NCT01194830|580864709|FG000|Overall Study|Non-compliance issues|4|||
160856438|NCT01194830|580864710|FG001|Overall Study|Non-compliance issues|4|||
160856439|NCT01194830|580864709|FG000|Overall Study|Other Reason|12|||
160856440|NCT01194830|580864710|FG001|Overall Study|Other Reason|8|||
160856441|NCT03115359|580864711|FG000|Overall Study|Withdrawal by Subject|29|||
160856442|NCT03115359|580864712|FG001|Overall Study|Withdrawal by Subject|39|||
160856443|NCT03115359|580864711|FG000|Overall Study|Scheduling conflict|25|||
160856444|NCT03115359|580864712|FG001|Overall Study|Scheduling conflict|23|||
160856445|NCT03115359|580864711|FG000|Overall Study|Personal reasons including health|12|||
160856446|NCT03115359|580864712|FG001|Overall Study|Personal reasons including health|9|||
160856447|NCT03115359|580864711|FG000|Overall Study|Transportation barriers|3|||
160856448|NCT03115359|580864712|FG001|Overall Study|Transportation barriers|0|||
160856449|NCT03115359|580864711|FG000|Overall Study|No longer interested|5|||
160856450|NCT03115359|580864712|FG001|Overall Study|No longer interested|4|||
160856451|NCT03115359|580864711|FG000|Overall Study|No reason provided|45|||
160856452|NCT03115359|580864712|FG001|Overall Study|No reason provided|47|||
160856453|NCT01815918|580864713|FG000|Overall Study|Patient samples not analyzable|3|||
160856454|NCT01815918|580864714|FG001|Overall Study|Patient samples not analyzable|4|||
160856455|NCT01815918|580864713|FG000|Overall Study|Lack of Efficacy|15|||
160856456|NCT01815918|580864714|FG001|Overall Study|Lack of Efficacy|15|||
160856457|NCT02412306|580864717|FG000|Overall Study|Lost to Follow-up|0|||
160856458|NCT02412306|580864718|FG001|Overall Study|Lost to Follow-up|1|||
160856459|NCT02412306|580864719|FG002|Overall Study|Lost to Follow-up|0|||
160856460|NCT02412306|580864720|FG003|Overall Study|Lost to Follow-up|0|||
160908049|NCT03329573|581056430|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
160908050|NCT03329573|581056431|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
160908051|NCT03329573|581056428|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
160908052|NCT03329573|581056429|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
160856461|NCT02412306|580864721|FG004|Overall Study|Lost to Follow-up|0|||
160908053|NCT03329573|581056430|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160908054|NCT03329573|581056431|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
160908055|NCT03329573|581056428|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
160908056|NCT03329573|581056429|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
160908057|NCT03329573|581056430|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
160908058|NCT03329573|581056431|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
160908059|NCT03329573|581056428|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
160908060|NCT03329573|581056429|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
161141393|NCT00630032|581901097|FG001|Overall Study|Death|49|||
160856462|NCT02412306|580864717|FG000|Overall Study|Withdrawal by Subject|0|||
160856463|NCT02412306|580864718|FG001|Overall Study|Withdrawal by Subject|0|||
160856464|NCT02412306|580864719|FG002|Overall Study|Withdrawal by Subject|1|||
160856465|NCT02412306|580864720|FG003|Overall Study|Withdrawal by Subject|0|||
160856466|NCT02412306|580864721|FG004|Overall Study|Withdrawal by Subject|0|||
160856467|NCT02412306|580864717|FG000|Overall Study|Death|5|||
160856468|NCT02412306|580864718|FG001|Overall Study|Death|7|||
160856469|NCT02412306|580864719|FG002|Overall Study|Death|15|||
160856470|NCT02412306|580864720|FG003|Overall Study|Death|0|||
160856471|NCT02412306|580864721|FG004|Overall Study|Death|2|||
160856472|NCT00866177|580864724|FG000|Overall Study|Withdrawal by Subject|1|||
160856473|NCT00866177|580864724|FG000|Overall Study|Not Treated|151|||
160856474|NCT05635461|580864725|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856475|NCT05635461|580864726|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856476|NCT05635461|580864727|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856477|NCT05635461|580864728|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856478|NCT05635461|580864729|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
160856479|NCT05635461|580864730|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
160856480|NCT05635461|580864725|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856481|NCT05635461|580864726|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
160856482|NCT05635461|580864727|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856483|NCT05635461|580864728|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856484|NCT05635461|580864729|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856485|NCT05635461|580864730|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
160856486|NCT05635461|580864725|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856487|NCT05635461|580864726|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856488|NCT05635461|580864727|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856489|NCT05635461|580864728|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
160856490|NCT05635461|580864729|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856491|NCT05635461|580864730|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
160856492|NCT03661723|580864731|FG000|Overall Study|Disease Progression|4|||
160856493|NCT03661723|580864732|FG001|Overall Study|Disease Progression|24|||
160856494|NCT03661723|580864733|FG002|Overall Study|Disease Progression|4|||
160856495|NCT03661723|580864734|FG003|Overall Study|Disease Progression|19|||
160856496|NCT03661723|580864731|FG000|Overall Study|Withdrawal by Subject|1|||
160856497|NCT03661723|580864732|FG001|Overall Study|Withdrawal by Subject|0|||
160856498|NCT03661723|580864733|FG002|Overall Study|Withdrawal by Subject|2|||
160856499|NCT03661723|580864734|FG003|Overall Study|Withdrawal by Subject|4|||
160856500|NCT03661723|580864731|FG000|Overall Study|Physician Decision|1|||
160856501|NCT03661723|580864732|FG001|Overall Study|Physician Decision|0|||
160856502|NCT03661723|580864733|FG002|Overall Study|Physician Decision|0|||
160856503|NCT03661723|580864734|FG003|Overall Study|Physician Decision|0|||
160856504|NCT03661723|580864731|FG000|Overall Study|Clinical Deterioration|0|||
160856505|NCT03661723|580864732|FG001|Overall Study|Clinical Deterioration|0|||
160856506|NCT03661723|580864733|FG002|Overall Study|Clinical Deterioration|0|||
160856507|NCT03661723|580864734|FG003|Overall Study|Clinical Deterioration|1|||
160856508|NCT00807911|580864739|FG000|Overall Study|Withdrawal by Subject|12|||
160856509|NCT00807911|580864740|FG001|Overall Study|Withdrawal by Subject|10|||
160856510|NCT00807911|580864739|FG000|Overall Study|Ineligible|0|||
160856511|NCT00807911|580864740|FG001|Overall Study|Ineligible|4|||
160856512|NCT02648204|580864745|FG000|Overall Study|Withdrawal by Subject|12|||
160856513|NCT02648204|580864746|FG001|Overall Study|Withdrawal by Subject|8|||
160856514|NCT02648204|580864747|FG002|Overall Study|Withdrawal by Subject|2|||
160856515|NCT02648204|580864748|FG003|Overall Study|Withdrawal by Subject|6|||
160856516|NCT02648204|580864745|FG000|Overall Study|Lost to Follow-up|5|||
160856517|NCT02648204|580864746|FG001|Overall Study|Lost to Follow-up|8|||
160856518|NCT02648204|580864747|FG002|Overall Study|Lost to Follow-up|4|||
160856519|NCT02648204|580864748|FG003|Overall Study|Lost to Follow-up|6|||
160856520|NCT02648204|580864745|FG000|Overall Study|Missing follow-up information|4|||
160856521|NCT02648204|580864746|FG001|Overall Study|Missing follow-up information|4|||
160856522|NCT02648204|580864747|FG002|Overall Study|Missing follow-up information|4|||
160856523|NCT02648204|580864748|FG003|Overall Study|Missing follow-up information|2|||
160856524|NCT02648204|580864745|FG000|Overall Study|Death|1|||
160856525|NCT02648204|580864746|FG001|Overall Study|Death|1|||
160856526|NCT02648204|580864747|FG002|Overall Study|Death|2|||
160856527|NCT02648204|580864748|FG003|Overall Study|Death|2|||
160856528|NCT02648204|580864745|FG000|Overall Study|Adverse Event|0|||
160856529|NCT02648204|580864746|FG001|Overall Study|Adverse Event|0|||
161337464|NCT02659865|582627443|FG000|Period 1|Withdrawal by Subject|1|||
160856530|NCT02648204|580864747|FG002|Overall Study|Adverse Event|1|||
160856531|NCT02648204|580864748|FG003|Overall Study|Adverse Event|0|||
160856532|NCT03532542|580864749|FG000|Overall Study|Death|1|||
160856533|NCT03532542|580864750|FG001|Overall Study|Death|0|||
160856534|NCT03532542|580864749|FG000|Overall Study|Study Terminated by Sponsor|41|||
160856535|NCT03532542|580864750|FG001|Overall Study|Study Terminated by Sponsor|65|||
160856536|NCT03532542|580864749|FG000|Overall Study|Withdrawal by Subject|6|||
160856537|NCT03532542|580864750|FG001|Overall Study|Withdrawal by Subject|5|||
160856538|NCT00614575|580864751|FG000|Overall Study|Adverse Event|106|||
160856539|NCT00614575|580864751|FG000|Overall Study|Lost to Follow-up|55|||
160856540|NCT00614575|580864751|FG000|Overall Study|Lack of Efficacy|14|||
160856541|NCT00614575|580864751|FG000|Overall Study|Withdrawal by Subject|6|||
160856542|NCT00614575|580864751|FG000|Overall Study|Death|3|||
160856543|NCT00614575|580864751|FG000|Overall Study|Physician Decision|2|||
160856544|NCT00614575|580864751|FG000|Overall Study|No data were collected.|18|||
160856545|NCT00614575|580864751|FG000|Overall Study|Irregularly enrolled patients|23|||
160856546|NCT00614575|580864751|FG000|Overall Study|No treatment|1|||
160908061|NCT03329573|581056430|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
160908062|NCT03329573|581056431|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
160908063|NCT02777333|581056434|FG000|Overall Study|Withdrawal by Subject|0|||
160908064|NCT02777333|581056435|FG001|Overall Study|Withdrawal by Subject|1|||
160908065|NCT02777333|581056434|FG000|Overall Study|Lost to Follow-up|0|||
160908066|NCT02777333|581056435|FG001|Overall Study|Lost to Follow-up|1|||
160908067|NCT05695209|581056445|FG000|3-months|Withdrawal by Subject|2|||
160908068|NCT05695209|581056446|FG001|3-months|Withdrawal by Subject|0|||
160856547|NCT00189540|580864752|FG000|Overall Study|Withdrawal by Subject|3|||
160856548|NCT00189540|580864753|FG001|Overall Study|Withdrawal by Subject|0|||
160856549|NCT00189540|580864752|FG000|Overall Study|Death|4|||
160856550|NCT00189540|580864753|FG001|Overall Study|Death|1|||
160856551|NCT00472108|580864754|FG000|Overall Study|Lost to Follow-up|0|||
160856552|NCT00472108|580864755|FG001|Overall Study|Lost to Follow-up|1|||
160856553|NCT03882021|580864756|FG000|Enrollment|Procedure aborted/cancelled|2|||
160856554|NCT03882021|580864756|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
160856555|NCT03882021|580864756|FG000|Enrollment to 3-Month|Death|1|||
160856556|NCT03882021|580864756|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
160856557|NCT03882021|580864756|FG000|Enrollment to 3-Month|Missed Visit|4|||
160908069|NCT05695209|581056445|FG000|3-months|Unable to contact for 3-month data collection|0|||
160856558|NCT03882021|580864756|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
160856559|NCT03882021|580864756|FG000|6-Month to 12-Month Visit|Death|1|||
160856560|NCT03882021|580864756|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
160856561|NCT00286442|580864757|FG000|Overall Study|Hyperglycemic Rescue|19|||
160856562|NCT00286442|580864758|FG001|Overall Study|Hyperglycemic Rescue|17|||
160856563|NCT00286442|580864759|FG002|Overall Study|Hyperglycemic Rescue|25|||
160856564|NCT00286442|580864757|FG000|Overall Study|Adverse Event|7|||
160856565|NCT00286442|580864758|FG001|Overall Study|Adverse Event|6|||
160856566|NCT00286442|580864759|FG002|Overall Study|Adverse Event|1|||
160856567|NCT00286442|580864757|FG000|Overall Study|Protocol Violation|2|||
160856568|NCT00286442|580864758|FG001|Overall Study|Protocol Violation|4|||
160856569|NCT00286442|580864759|FG002|Overall Study|Protocol Violation|2|||
160856570|NCT00286442|580864757|FG000|Overall Study|Lost to Follow-up|5|||
160908070|NCT05695209|581056446|FG001|3-months|Unable to contact for 3-month data collection|1|||
160908071|NCT05695209|581056445|FG000|6-months|Lost to Follow-up|1|||
160908072|NCT05695209|581056446|FG001|6-months|Lost to Follow-up|1|||
160908073|NCT04698187|581056452|FG000|Overall Study|Withdrawal by Subject|7|||
160908074|NCT04698187|581056452|FG000|Overall Study|Death|21|||
160908075|NCT04698187|581056452|FG000|Overall Study|Sponsor Decision|15|||
160908076|NCT04698187|581056452|FG000|Overall Study|In-transit Disease|1|||
160908077|NCT03069378|581056453|FG000|Overall Study|Withdrawal by Subject|1|||
160908078|NCT02993146|581056454|FG000|Overall Study|Withdrawal by Subject|0|||
161141394|NCT00630032|581901096|FG000|Overall Study|Withdrawal by Subject|3|||
161141395|NCT00630032|581901097|FG001|Overall Study|Withdrawal by Subject|2|||
161141396|NCT00630032|581901096|FG000|Overall Study|Lost to Follow-up|18|||
160993359|NCT02001623|581365333|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
160993360|NCT02001623|581365334|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
160856571|NCT00286442|580864758|FG001|Overall Study|Lost to Follow-up|2|||
160856572|NCT00286442|580864759|FG002|Overall Study|Lost to Follow-up|1|||
160856573|NCT00286442|580864757|FG000|Overall Study|Physician Decision|1|||
160856574|NCT00286442|580864758|FG001|Overall Study|Physician Decision|1|||
160856575|NCT00286442|580864759|FG002|Overall Study|Physician Decision|1|||
160856576|NCT00286442|580864757|FG000|Overall Study|Administrative Error|1|||
160856577|NCT00286442|580864758|FG001|Overall Study|Administrative Error|1|||
160856578|NCT00286442|580864759|FG002|Overall Study|Administrative Error|0|||
160856579|NCT00286442|580864757|FG000|Overall Study|Withdrawal by Subject|2|||
160856580|NCT00286442|580864758|FG001|Overall Study|Withdrawal by Subject|14|||
160856581|NCT00286442|580864759|FG002|Overall Study|Withdrawal by Subject|2|||
160908079|NCT02993146|581056455|FG001|Overall Study|Withdrawal by Subject|0|||
160993361|NCT02001623|581365335|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
160993362|NCT02001623|581365336|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
160993363|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Adverse Event|1|||
160993364|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
160993365|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
160856582|NCT03582215|580864762|FG000|Overall Study|Adverse Event|1|||
160856583|NCT03582215|580864763|FG001|Overall Study|Adverse Event|0|||
160856584|NCT03582215|580864764|FG002|Overall Study|Adverse Event|0|||
160856585|NCT03582215|580864765|FG003|Overall Study|Adverse Event|0|||
160856586|NCT03582215|580864766|FG004|Overall Study|Adverse Event|0|||
160908080|NCT02993146|581056456|FG002|Overall Study|Withdrawal by Subject|1|||
160908081|NCT02993146|581056457|FG003|Overall Study|Withdrawal by Subject|1|||
161141397|NCT00630032|581901097|FG001|Overall Study|Lost to Follow-up|31|||
160856587|NCT03582215|580864767|FG005|Overall Study|Adverse Event|0|||
160856588|NCT03582215|580864768|FG006|Overall Study|Adverse Event|2|||
160856589|NCT03582215|580864769|FG007|Overall Study|Adverse Event|2|||
160856590|NCT02174731|580864770|FG000|Overall Study|Participant decision|67|||
160856591|NCT02174731|580864771|FG001|Overall Study|Participant decision|64|||
160856592|NCT02174731|580864770|FG000|Overall Study|Incorrect enrolment before randomization|0|||
160856593|NCT02174731|580864771|FG001|Overall Study|Incorrect enrolment before randomization|1|||
160856594|NCT02174731|580864770|FG000|Overall Study|Missing|2|||
160856595|NCT02174731|580864771|FG001|Overall Study|Missing|0|||
160856596|NCT00079040|580864772|FG000|Overall Study|Withdrew before treatment|1|||
160856597|NCT00079040|580864772|FG000|Overall Study|Ineligible|1|||
160856598|NCT01046565|580864790|FG000|Overall Study|Adverse Event|2|||
160856599|NCT01046565|580864790|FG000|Overall Study|Withdrawal by Subject|7|||
160856600|NCT03740048|580864791|FG000|Overall Study|Withdrawal by Subject|1|||
160856601|NCT03740048|580864792|FG001|Overall Study|Withdrawal by Subject|1|||
160856602|NCT03740048|580864791|FG000|Overall Study|Death|1|||
160856603|NCT03740048|580864792|FG001|Overall Study|Death|6|||
160856604|NCT03740048|580864791|FG000|Overall Study|Switched to thrice-weekly HD|2|||
160856605|NCT03740048|580864792|FG001|Overall Study|Switched to thrice-weekly HD|0|||
160856606|NCT03740048|580864791|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
160856607|NCT03740048|580864792|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
160856608|NCT03740048|580864791|FG000|Overall Study|Lost to Follow-up|0|||
160856609|NCT03740048|580864792|FG001|Overall Study|Lost to Follow-up|1|||
160856610|NCT03740048|580864791|FG000|Overall Study|Non-compliance with HD|0|||
160856611|NCT03740048|580864792|FG001|Overall Study|Non-compliance with HD|1|||
160856612|NCT03261336|580864793|FG000|Overall Study|Adverse Event|1|||
160856613|NCT01069484|580864794|FG000|Overall Study|Death-in-near-family|1|||
160856614|NCT01069484|580864795|FG001|Overall Study|Death-in-near-family|0|||
160856615|NCT01069484|580864794|FG000|Overall Study|No specific reason|8|||
160856616|NCT01069484|580864795|FG001|Overall Study|No specific reason|2|||
160856617|NCT01069484|580864794|FG000|Overall Study|Illness mother or child|3|||
160856618|NCT01069484|580864795|FG001|Overall Study|Illness mother or child|1|||
160856619|NCT00292942|580864796|FG000|Overall Study|Withdrawal by Subject|0|||
160856620|NCT00292942|580864797|FG001|Overall Study|Withdrawal by Subject|0|||
160856621|NCT00292942|580864798|FG002|Overall Study|Withdrawal by Subject|1|||
160856622|NCT00292942|580864799|FG003|Overall Study|Withdrawal by Subject|0|||
160856623|NCT00292942|580864796|FG000|Overall Study|Adverse Event|0|||
160856624|NCT00292942|580864797|FG001|Overall Study|Adverse Event|0|||
160856625|NCT00292942|580864798|FG002|Overall Study|Adverse Event|0|||
160856626|NCT00292942|580864799|FG003|Overall Study|Adverse Event|1|||
160856627|NCT00644358|580864800|FG000|Overall Study|Adverse Event|124|||
160856628|NCT00644358|580864800|FG000|Overall Study|Lost to Follow-up|105|||
160856629|NCT00644358|580864800|FG000|Overall Study|Consent Withdrawal|64|||
161141398|NCT00630032|581901096|FG000|Overall Study|Protocol Violation|1|||
160856630|NCT00644358|580864800|FG000|Overall Study|Lack of Effectiveness|39|||
160908082|NCT01397708|581056458|FG000|Overall Study|Withdrawal by Subject|0|||
161141399|NCT00630032|581901097|FG001|Overall Study|Protocol Violation|0|||
161141400|NCT00630032|581901096|FG000|Overall Study|Patient has moved|1|||
161141401|NCT00630032|581901097|FG001|Overall Study|Patient has moved|1|||
161141402|NCT00630032|581901096|FG000|Overall Study|Disease progression|1|||
161141403|NCT00630032|581901097|FG001|Overall Study|Disease progression|1|||
161141404|NCT00630032|581901096|FG000|Overall Study|End of monitoring in US centers|11|||
161141405|NCT00630032|581901097|FG001|Overall Study|End of monitoring in US centers|11|||
161141406|NCT02332915|581901098|FG000|Overall Study|Moved out of region|3|||
161141407|NCT02332915|581901099|FG001|Overall Study|Moved out of region|0|||
161141408|NCT02332915|581901098|FG000|Overall Study|Unrelated illness|1|||
161141409|NCT02332915|581901099|FG001|Overall Study|Unrelated illness|1|||
161141410|NCT02332915|581901098|FG000|Overall Study|Travel distance prohibitive|0|||
161141411|NCT02332915|581901099|FG001|Overall Study|Travel distance prohibitive|1|||
161255353|NCT02688387|582314135|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255354|NCT02688387|582314136|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255355|NCT02688387|582314137|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255356|NCT02688387|582314138|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255357|NCT02688387|582314139|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255358|NCT02688387|582314140|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255359|NCT02688387|582314141|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255360|NCT02688387|582314142|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255361|NCT02688387|582314143|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255362|NCT02688387|582314144|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255363|NCT02688387|582314145|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255364|NCT02688387|582314146|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255365|NCT02688387|582314147|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255366|NCT02688387|582314148|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
160856631|NCT00644358|580864800|FG000|Overall Study|Protocol Violation|5|||
160856632|NCT00644358|580864800|FG000|Overall Study|Noncompliance|14|||
160856633|NCT00644358|580864800|FG000|Overall Study|Other Unspecified|11|||
160856634|NCT01290523|580864803|FG000|Overall Study|Death|3|||
160856635|NCT04158583|580864804|FG000|Overall Study|Withdrawal by Subject|1|||
160856636|NCT04158583|580864805|FG001|Overall Study|Withdrawal by Subject|1|||
160856637|NCT04158583|580864806|FG002|Overall Study|Withdrawal by Subject|0|||
160856638|NCT04158583|580864807|FG003|Overall Study|Withdrawal by Subject|0|||
161337465|NCT02659865|582627444|FG001|Period 1|Withdrawal by Subject|0|||
161337466|NCT02659865|582627445|FG002|Period 1|Withdrawal by Subject|0|||
161337467|NCT02659865|582627446|FG003|Period 1|Withdrawal by Subject|0|||
161337468|NCT02659865|582627447|FG004|Period 1|Withdrawal by Subject|0|||
161337469|NCT02659865|582627443|FG000|Period 1|Adverse Event|0|||
161337470|NCT02659865|582627444|FG001|Period 1|Adverse Event|0|||
161337471|NCT02659865|582627445|FG002|Period 1|Adverse Event|0|||
161337472|NCT02659865|582627446|FG003|Period 1|Adverse Event|0|||
161337473|NCT02659865|582627447|FG004|Period 1|Adverse Event|1|||
161337474|NCT02325414|582627448|FG000|Overall Study|Withdrawal by Subject|3|||
161337475|NCT02325414|582627449|FG001|Overall Study|Withdrawal by Subject|1|||
161337476|NCT02325414|582627448|FG000|Overall Study|Lost to Follow-up|5|||
161337477|NCT02325414|582627449|FG001|Overall Study|Lost to Follow-up|5|||
161337478|NCT02775851|582627450|FG000|Overall Study|Adverse Event|1|||
161337479|NCT02775851|582627451|FG001|Overall Study|Adverse Event|10|||
161337480|NCT02775851|582627450|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
161337481|NCT02775851|582627451|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
161337482|NCT02775851|582627450|FG000|Overall Study|Progression/Relapse|0|||
161337483|NCT02775851|582627451|FG001|Overall Study|Progression/Relapse|4|||
161337484|NCT02775851|582627450|FG000|Overall Study|Other - Not Protocol Specified|0|||
161337485|NCT02775851|582627451|FG001|Overall Study|Other - Not Protocol Specified|7|||
161337486|NCT02775851|582627450|FG000|Overall Study|Withdrawal by Subject|1|||
161337487|NCT02775851|582627451|FG001|Overall Study|Withdrawal by Subject|0|||
161337488|NCT00998946|582627452|FG000|Overall Study|Lost to Follow-up|1|||
161337489|NCT00998946|582627452|FG000|Overall Study|Withdrawal by Subject|1|||
161337490|NCT00998946|582627452|FG000|Overall Study|Death|2|||
161337491|NCT00998946|582627452|FG000|Overall Study|Reason Unspecified|3|||
161337492|NCT00998946|582627452|FG000|Overall Study|Enrolled but not Dosed|2|||
161337493|NCT00915525|582627453|FG000|Overall Study|Protocol Violation|9|||
161337494|NCT00915525|582627454|FG001|Overall Study|Protocol Violation|4|||
161337495|NCT00915525|582627453|FG000|Overall Study|Withdrawal by Subject|59|||
161337496|NCT00915525|582627454|FG001|Overall Study|Withdrawal by Subject|21|||
161337497|NCT00915525|582627453|FG000|Overall Study|Lost to Follow-up|27|||
161337498|NCT00915525|582627454|FG001|Overall Study|Lost to Follow-up|16|||
161337499|NCT00915525|582627453|FG000|Overall Study|Pregnancy|2|||
161337500|NCT00915525|582627454|FG001|Overall Study|Pregnancy|0|||
161337501|NCT00915525|582627453|FG000|Overall Study|Lack of Efficacy|15|||
161337502|NCT00915525|582627454|FG001|Overall Study|Lack of Efficacy|32|||
161337503|NCT00915525|582627453|FG000|Overall Study|Adverse Event|29|||
161337504|NCT00915525|582627454|FG001|Overall Study|Adverse Event|13|||
161337505|NCT00915525|582627453|FG000|Overall Study|Missing|12|||
161337506|NCT00915525|582627454|FG001|Overall Study|Missing|1|||
161337507|NCT00915525|582627453|FG000|Overall Study|Other Reason|35|||
161337508|NCT00915525|582627454|FG001|Overall Study|Other Reason|12|||
161337509|NCT00915525|582627453|FG000|Overall Study|Site Closed|27|||
161337510|NCT00915525|582627454|FG001|Overall Study|Site Closed|9|||
161337511|NCT00915525|582627453|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
161337512|NCT00915525|582627454|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
161337513|NCT00915525|582627453|FG000|Overall Study|Study Burden|28|||
161337514|NCT00915525|582627454|FG001|Overall Study|Study Burden|12|||
161337515|NCT00915525|582627453|FG000|Overall Study|Non-Compliance|3|||
161337516|NCT00915525|582627454|FG001|Overall Study|Non-Compliance|1|||
161337517|NCT00915525|582627453|FG000|Overall Study|Patient Moved|15|||
161337518|NCT00915525|582627454|FG001|Overall Study|Patient Moved|9|||
161337519|NCT00577408|582627455|FG000|Overall Study|Stopped attending study visits|9|||
161337520|NCT00577408|582627456|FG001|Overall Study|Stopped attending study visits|11|||
161337521|NCT00577408|582627455|FG000|Overall Study|Continued opioid use|3|||
161337522|NCT00577408|582627456|FG001|Overall Study|Continued opioid use|2|||
161337523|NCT00577408|582627455|FG000|Overall Study|Non-compliance with study meds|0|||
161337524|NCT00577408|582627456|FG001|Overall Study|Non-compliance with study meds|3|||
161337525|NCT00577408|582627455|FG000|Overall Study|Refused Oral Naltrexone|0|||
161337526|NCT00577408|582627456|FG001|Overall Study|Refused Oral Naltrexone|1|||
161337527|NCT00577408|582627455|FG000|Overall Study|Moved out of state|0|||
161337528|NCT00577408|582627456|FG001|Overall Study|Moved out of state|1|||
161337529|NCT00577408|582627455|FG000|Overall Study|Scheduling Issues|0|||
161337530|NCT00577408|582627456|FG001|Overall Study|Scheduling Issues|3|||
161337531|NCT00577408|582627455|FG000|Overall Study|Death|0|||
161337532|NCT00577408|582627456|FG001|Overall Study|Death|1|||
161337533|NCT00577408|582627455|FG000|Overall Study|Psychiatric hospitalization|0|||
161337534|NCT00577408|582627456|FG001|Overall Study|Psychiatric hospitalization|1|||
161337535|NCT03817528|582627457|FG000|Overall Study|Withdrawal by Subject|1|||
161337536|NCT03817528|582627457|FG000|Overall Study|Adverse Event|2|||
161337537|NCT02732639|582627463|FG000|Overall Study|Lost to Follow-up|1|||
161337538|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
161337539|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161337540|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161337541|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
161337542|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
161337543|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161337544|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161337545|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
161337546|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
161337547|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
161337548|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
161337549|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
161337550|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
161337551|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161337552|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161337553|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
161337554|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
161337555|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
161337556|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
161337557|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
161337558|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
161337559|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161337560|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161337561|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
161337562|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
161337563|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161337564|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161337565|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
161337566|NCT01668797|582627464|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
161337567|NCT01668797|582627465|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161337568|NCT01668797|582627466|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161337569|NCT01668797|582627467|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
161337570|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161337571|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
161337572|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161337573|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
161337574|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161337575|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
161337576|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161337577|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
161337578|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
161337579|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
161337580|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
161337581|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
161337582|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161337583|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
161337584|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161337585|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
161337586|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
161337587|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
161337588|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
161337589|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
161337590|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161337591|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
161337592|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161337593|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
161337594|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161337595|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
161337596|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161337597|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
161337598|NCT01668797|582627464|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161337599|NCT01668797|582627465|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
161337600|NCT01668797|582627466|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161337601|NCT01668797|582627467|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
161337602|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
161337603|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
161337604|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
161337605|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
161337606|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
161337607|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
160856639|NCT04158583|580864808|FG004|Overall Study|Withdrawal by Subject|1|||
160856640|NCT04158583|580864809|FG005|Overall Study|Withdrawal by Subject|0|||
160856641|NCT04158583|580864810|FG006|Overall Study|Withdrawal by Subject|0|||
160856642|NCT04158583|580864811|FG007|Overall Study|Withdrawal by Subject|0|||
160856643|NCT04158583|580864812|FG008|Overall Study|Withdrawal by Subject|2|||
160856644|NCT04158583|580864813|FG009|Overall Study|Withdrawal by Subject|0|||
160856645|NCT04158583|580864804|FG000|Overall Study|Study Terminated by Sponsor|0|||
160856646|NCT04158583|580864805|FG001|Overall Study|Study Terminated by Sponsor|0|||
160856647|NCT04158583|580864806|FG002|Overall Study|Study Terminated by Sponsor|0|||
160856648|NCT04158583|580864807|FG003|Overall Study|Study Terminated by Sponsor|1|||
160856649|NCT04158583|580864808|FG004|Overall Study|Study Terminated by Sponsor|0|||
160856650|NCT04158583|580864809|FG005|Overall Study|Study Terminated by Sponsor|0|||
160856651|NCT04158583|580864810|FG006|Overall Study|Study Terminated by Sponsor|0|||
160856652|NCT04158583|580864811|FG007|Overall Study|Study Terminated by Sponsor|0|||
160856653|NCT04158583|580864812|FG008|Overall Study|Study Terminated by Sponsor|0|||
160856654|NCT04158583|580864813|FG009|Overall Study|Study Terminated by Sponsor|0|||
160856655|NCT04158583|580864804|FG000|Overall Study|Progressive Disease|1|||
160856656|NCT04158583|580864805|FG001|Overall Study|Progressive Disease|0|||
160856657|NCT04158583|580864806|FG002|Overall Study|Progressive Disease|3|||
160856658|NCT04158583|580864807|FG003|Overall Study|Progressive Disease|5|||
160856659|NCT04158583|580864808|FG004|Overall Study|Progressive Disease|0|||
160856660|NCT04158583|580864809|FG005|Overall Study|Progressive Disease|1|||
160856661|NCT04158583|580864810|FG006|Overall Study|Progressive Disease|6|||
160856662|NCT04158583|580864811|FG007|Overall Study|Progressive Disease|2|||
160856663|NCT04158583|580864812|FG008|Overall Study|Progressive Disease|1|||
160856664|NCT04158583|580864813|FG009|Overall Study|Progressive Disease|2|||
160856665|NCT04158583|580864804|FG000|Overall Study|Lost to Follow-up|0|||
160856666|NCT04158583|580864805|FG001|Overall Study|Lost to Follow-up|0|||
160908083|NCT01397708|581056459|FG001|Overall Study|Withdrawal by Subject|0|||
160908084|NCT01397708|581056460|FG002|Overall Study|Withdrawal by Subject|1|||
160908085|NCT01397708|581056461|FG003|Overall Study|Withdrawal by Subject|0|||
160908086|NCT01397708|581056462|FG004|Overall Study|Withdrawal by Subject|0|||
160908087|NCT01397708|581056463|FG005|Overall Study|Withdrawal by Subject|0|||
160908088|NCT01397708|581056464|FG006|Overall Study|Withdrawal by Subject|0|||
160908089|NCT01397708|581056465|FG007|Overall Study|Withdrawal by Subject|1|||
160908090|NCT01397708|581056458|FG000|Overall Study|Death|0|||
160908091|NCT01397708|581056459|FG001|Overall Study|Death|0|||
160908092|NCT01397708|581056460|FG002|Overall Study|Death|1|||
160856667|NCT04158583|580864806|FG002|Overall Study|Lost to Follow-up|1|||
160856668|NCT04158583|580864807|FG003|Overall Study|Lost to Follow-up|1|||
160856669|NCT04158583|580864808|FG004|Overall Study|Lost to Follow-up|1|||
161141412|NCT02332915|581901098|FG000|Overall Study|did not meet inclusion criteria|2|||
161141413|NCT02332915|581901099|FG001|Overall Study|did not meet inclusion criteria|4|||
161141414|NCT03232073|581901100|FG000|Overall Study|Death|1|||
161141415|NCT03232073|581901101|FG001|Overall Study|Death|0|||
161141416|NCT03232073|581901100|FG000|Overall Study|Adverse Event|7|||
161141417|NCT03232073|581901101|FG001|Overall Study|Adverse Event|12|||
161141418|NCT03232073|581901100|FG000|Overall Study|Lost to Follow-up|6|||
161141419|NCT03232073|581901101|FG001|Overall Study|Lost to Follow-up|6|||
161141420|NCT03232073|581901100|FG000|Overall Study|Lack of Efficacy|10|||
161141421|NCT03232073|581901101|FG001|Overall Study|Lack of Efficacy|8|||
161141422|NCT03232073|581901100|FG000|Overall Study|Physician Decision|9|||
161141423|NCT03232073|581901101|FG001|Overall Study|Physician Decision|2|||
161141424|NCT03232073|581901100|FG000|Overall Study|Withdrawal by Subject|54|||
161141425|NCT03232073|581901101|FG001|Overall Study|Withdrawal by Subject|39|||
161141426|NCT02032875|581901102|FG000|Treatment Period|Adverse Event|1|||
161141427|NCT02032875|581901103|FG001|Treatment Period|Adverse Event|0|||
161141428|NCT02032875|581901102|FG000|Treatment Period|Liver transplant, No extension needed|0|||
161141429|NCT02032875|581901103|FG001|Treatment Period|Liver transplant, No extension needed|1|||
161141430|NCT02032875|581901102|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
161141431|NCT02032875|581901103|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
161141432|NCT02032875|581901102|FG000|Follow-up Period|Death|0|||
161141433|NCT02032875|581901103|FG001|Follow-up Period|Death|1|||
161141434|NCT02032875|581901102|FG000|Follow-up Period|Virologic Relapse|3|||
161141435|NCT02032875|581901103|FG001|Follow-up Period|Virologic Relapse|10|||
161141436|NCT03191786|581901108|FG000|Overall Study|Death|236|||
161141437|NCT03191786|581901109|FG001|Overall Study|Death|127|||
161141438|NCT03191786|581901108|FG000|Overall Study|Lost to Follow-up|9|||
161141439|NCT03191786|581901109|FG001|Overall Study|Lost to Follow-up|3|||
161141440|NCT03191786|581901108|FG000|Overall Study|Physician Decision|1|||
161141441|NCT03191786|581901109|FG001|Overall Study|Physician Decision|0|||
161141442|NCT03191786|581901108|FG000|Overall Study|Moved to Post Trial Access Program|30|||
161141443|NCT03191786|581901109|FG001|Overall Study|Moved to Post Trial Access Program|5|||
160856670|NCT04158583|580864809|FG005|Overall Study|Lost to Follow-up|0|||
160856671|NCT04158583|580864810|FG006|Overall Study|Lost to Follow-up|0|||
160856672|NCT04158583|580864811|FG007|Overall Study|Lost to Follow-up|0|||
160856673|NCT04158583|580864812|FG008|Overall Study|Lost to Follow-up|0|||
160856674|NCT04158583|580864813|FG009|Overall Study|Lost to Follow-up|0|||
160856675|NCT04158583|580864804|FG000|Overall Study|Due To Patient Status|0|||
160856676|NCT04158583|580864805|FG001|Overall Study|Due To Patient Status|0|||
160856677|NCT04158583|580864806|FG002|Overall Study|Due To Patient Status|0|||
161141444|NCT03191786|581901108|FG000|Overall Study|Withdrawal by Subject|26|||
161141445|NCT03191786|581901109|FG001|Overall Study|Withdrawal by Subject|16|||
161255367|NCT02688387|582314149|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161141446|NCT05847881|581901110|FG000|Overall Study|Principal Investigator Decision|8|||
161141447|NCT05847881|581901110|FG000|Overall Study|Withdrawal by Subject|2|||
161141448|NCT03113500|581902499|FG000|Overall Study|Withdrawal by Subject|1|||
161141449|NCT01348919|581902500|FG000|Overall Study|Adverse Event|3|||
161141450|NCT01348919|581902501|FG001|Overall Study|Adverse Event|1|||
161141451|NCT01348919|581902502|FG002|Overall Study|Adverse Event|0|||
161141452|NCT01348919|581902500|FG000|Overall Study|Withdrawal by Subject|0|||
161141453|NCT01348919|581902501|FG001|Overall Study|Withdrawal by Subject|1|||
161141454|NCT01348919|581902502|FG002|Overall Study|Withdrawal by Subject|0|||
161141455|NCT01348919|581902500|FG000|Overall Study|Disease progression|0|||
161141456|NCT01348919|581902501|FG001|Overall Study|Disease progression|1|||
161141457|NCT01348919|581902502|FG002|Overall Study|Disease progression|1|||
161141458|NCT02517515|581902503|FG000|Overall Study|Adverse Event|0|||
161141459|NCT02517515|581902504|FG001|Overall Study|Adverse Event|1|||
161141460|NCT02517515|581902503|FG000|Overall Study|Withdrew Consent|0|||
161141461|NCT02517515|581902504|FG001|Overall Study|Withdrew Consent|1|||
161141462|NCT02517515|581902503|FG000|Overall Study|Lost to Follow-up|1|||
161255368|NCT02688387|582314150|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
161255369|NCT02688387|582314151|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255370|NCT02688387|582314152|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
161255371|NCT02688387|582314153|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
161255372|NCT02688387|582314132|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255373|NCT02688387|582314133|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255374|NCT02688387|582314134|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255375|NCT02688387|582314135|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255376|NCT02688387|582314136|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255377|NCT02688387|582314137|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255378|NCT02688387|582314138|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255379|NCT02688387|582314139|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255380|NCT02688387|582314140|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255381|NCT02688387|582314141|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160856678|NCT04158583|580864807|FG003|Overall Study|Due To Patient Status|0|||
160856679|NCT04158583|580864808|FG004|Overall Study|Due To Patient Status|0|||
160856680|NCT04158583|580864809|FG005|Overall Study|Due To Patient Status|0|||
160856681|NCT04158583|580864810|FG006|Overall Study|Due To Patient Status|0|||
160856682|NCT04158583|580864811|FG007|Overall Study|Due To Patient Status|0|||
160856683|NCT04158583|580864812|FG008|Overall Study|Due To Patient Status|1|||
160856684|NCT04158583|580864813|FG009|Overall Study|Due To Patient Status|0|||
160908093|NCT01397708|581056461|FG003|Overall Study|Death|1|||
160908094|NCT01397708|581056462|FG004|Overall Study|Death|0|||
160908095|NCT01397708|581056463|FG005|Overall Study|Death|0|||
160908096|NCT01397708|581056464|FG006|Overall Study|Death|0|||
160908097|NCT01397708|581056465|FG007|Overall Study|Death|0|||
160908098|NCT01397708|581056458|FG000|Overall Study|Lost to Follow-up|0|||
160908099|NCT01397708|581056459|FG001|Overall Study|Lost to Follow-up|0|||
160908100|NCT01397708|581056460|FG002|Overall Study|Lost to Follow-up|0|||
160908101|NCT01397708|581056461|FG003|Overall Study|Lost to Follow-up|0|||
160908102|NCT01397708|581056462|FG004|Overall Study|Lost to Follow-up|1|||
160908103|NCT01397708|581056463|FG005|Overall Study|Lost to Follow-up|0|||
160908104|NCT01397708|581056464|FG006|Overall Study|Lost to Follow-up|0|||
160908105|NCT01397708|581056465|FG007|Overall Study|Lost to Follow-up|0|||
160908106|NCT01397708|581056458|FG000|Overall Study|Other|0|||
160908107|NCT01397708|581056459|FG001|Overall Study|Other|0|||
160908108|NCT01397708|581056460|FG002|Overall Study|Other|0|||
160908109|NCT01397708|581056461|FG003|Overall Study|Other|0|||
160908110|NCT01397708|581056462|FG004|Overall Study|Other|0|||
160908111|NCT01397708|581056463|FG005|Overall Study|Other|0|||
160908112|NCT01397708|581056464|FG006|Overall Study|Other|1|||
160908113|NCT01397708|581056465|FG007|Overall Study|Other|0|||
160908114|NCT04362072|581056466|FG000|Treatment|Adverse Event|1|||
160908115|NCT04362072|581056466|FG000|Treatment|Death|9|||
160908116|NCT04362072|581056466|FG000|Treatment|Physician Decision|2|||
160908117|NCT04362072|581056466|FG000|Treatment|Progressive disease|27|||
160908118|NCT04362072|581056466|FG000|Treatment|Withdrawal by Subject|4|||
160908119|NCT04362072|581056466|FG000|Treatment|Global deterioration of health status|1|||
160908120|NCT04362072|581056466|FG000|Treatment|Switched to commercial Lorlatinib|13|||
161141463|NCT02517515|581902504|FG001|Overall Study|Lost to Follow-up|0|||
161141464|NCT02517515|581902503|FG000|Overall Study|Other|1|||
161141465|NCT02517515|581902504|FG001|Overall Study|Other|0|||
161141466|NCT06400238|581902505|FG000|Overall Study|Started Protocol Therapy|2|||
161141467|NCT06400238|581902505|FG000|Overall Study|Adverse Event|1|||
160856685|NCT04158583|580864804|FG000|Overall Study|Death|3|||
160856686|NCT04158583|580864805|FG001|Overall Study|Death|4|||
160856687|NCT04158583|580864806|FG002|Overall Study|Death|2|||
160856688|NCT04158583|580864807|FG003|Overall Study|Death|2|||
160856689|NCT04158583|580864808|FG004|Overall Study|Death|4|||
160856690|NCT04158583|580864809|FG005|Overall Study|Death|3|||
160856691|NCT04158583|580864810|FG006|Overall Study|Death|5|||
160856692|NCT04158583|580864811|FG007|Overall Study|Death|2|||
160856693|NCT04158583|580864812|FG008|Overall Study|Death|0|||
160856694|NCT04158583|580864813|FG009|Overall Study|Death|1|||
160856695|NCT04158583|580864804|FG000|Overall Study|Clinical Progression Disease|0|||
160856696|NCT04158583|580864805|FG001|Overall Study|Clinical Progression Disease|0|||
160856697|NCT04158583|580864806|FG002|Overall Study|Clinical Progression Disease|0|||
160856698|NCT04158583|580864807|FG003|Overall Study|Clinical Progression Disease|1|||
160856699|NCT04158583|580864808|FG004|Overall Study|Clinical Progression Disease|0|||
160856700|NCT04158583|580864809|FG005|Overall Study|Clinical Progression Disease|0|||
160856701|NCT04158583|580864810|FG006|Overall Study|Clinical Progression Disease|0|||
160856702|NCT04158583|580864811|FG007|Overall Study|Clinical Progression Disease|0|||
160856703|NCT04158583|580864812|FG008|Overall Study|Clinical Progression Disease|0|||
160856704|NCT04158583|580864813|FG009|Overall Study|Clinical Progression Disease|0|||
160856705|NCT04158583|580864804|FG000|Overall Study|Clinical Progression|0|||
160856706|NCT04158583|580864805|FG001|Overall Study|Clinical Progression|0|||
160856707|NCT04158583|580864806|FG002|Overall Study|Clinical Progression|0|||
160856708|NCT04158583|580864807|FG003|Overall Study|Clinical Progression|0|||
160856709|NCT04158583|580864808|FG004|Overall Study|Clinical Progression|1|||
160856710|NCT04158583|580864809|FG005|Overall Study|Clinical Progression|0|||
160856711|NCT04158583|580864810|FG006|Overall Study|Clinical Progression|2|||
160856712|NCT04158583|580864811|FG007|Overall Study|Clinical Progression|0|||
160856713|NCT04158583|580864812|FG008|Overall Study|Clinical Progression|0|||
160856714|NCT04158583|580864813|FG009|Overall Study|Clinical Progression|0|||
160856715|NCT04158583|580864804|FG000|Overall Study|Clinical Deterioration|0|||
160856716|NCT04158583|580864805|FG001|Overall Study|Clinical Deterioration|0|||
160856717|NCT04158583|580864806|FG002|Overall Study|Clinical Deterioration|0|||
160856718|NCT04158583|580864807|FG003|Overall Study|Clinical Deterioration|1|||
160856719|NCT04158583|580864808|FG004|Overall Study|Clinical Deterioration|0|||
160856720|NCT04158583|580864809|FG005|Overall Study|Clinical Deterioration|0|||
160856721|NCT04158583|580864810|FG006|Overall Study|Clinical Deterioration|0|||
160856722|NCT04158583|580864811|FG007|Overall Study|Clinical Deterioration|0|||
160856723|NCT04158583|580864812|FG008|Overall Study|Clinical Deterioration|0|||
160856724|NCT04158583|580864813|FG009|Overall Study|Clinical Deterioration|1|||
160856725|NCT01602224|580866487|FG000|Overall Study|Adverse Event|0|||
160856726|NCT01602224|580866488|FG001|Overall Study|Adverse Event|1|||
160856727|NCT01602224|580866489|FG002|Overall Study|Adverse Event|0|||
160856728|NCT01602224|580866487|FG000|Overall Study|Investigator Decison|1|||
160856729|NCT01602224|580866488|FG001|Overall Study|Investigator Decison|0|||
160856730|NCT01602224|580866489|FG002|Overall Study|Investigator Decison|0|||
160856731|NCT01602224|580866487|FG000|Overall Study|Lost to Follow-up|0|||
160856732|NCT01602224|580866488|FG001|Overall Study|Lost to Follow-up|0|||
160856733|NCT01602224|580866489|FG002|Overall Study|Lost to Follow-up|1|||
160856734|NCT01602224|580866487|FG000|Overall Study|Protocol Violation|0|||
160856735|NCT01602224|580866488|FG001|Overall Study|Protocol Violation|1|||
160856736|NCT01602224|580866489|FG002|Overall Study|Protocol Violation|0|||
160856737|NCT01602224|580866487|FG000|Overall Study|Sponsor Decision|2|||
160856738|NCT01602224|580866488|FG001|Overall Study|Sponsor Decision|3|||
160856739|NCT01602224|580866489|FG002|Overall Study|Sponsor Decision|2|||
160856740|NCT01602224|580866487|FG000|Overall Study|Withdrawal by Subject|5|||
160856741|NCT01602224|580866488|FG001|Overall Study|Withdrawal by Subject|3|||
160856742|NCT01602224|580866489|FG002|Overall Study|Withdrawal by Subject|3|||
160856743|NCT01352117|580866490|FG000|Overall Study|Death|15|||
160856744|NCT01352117|580866491|FG001|Overall Study|Death|16|||
161337608|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
160856745|NCT01352117|580866490|FG000|Overall Study|Withdrawal by Subject|1|||
160856746|NCT01352117|580866491|FG001|Overall Study|Withdrawal by Subject|0|||
160856747|NCT01352117|580866490|FG000|Overall Study|Lost to Follow-up|2|||
160856748|NCT01352117|580866491|FG001|Overall Study|Lost to Follow-up|7|||
160856749|NCT01352117|580866490|FG000|Overall Study|Non-adherent to study requirements|1|||
160856750|NCT01352117|580866491|FG001|Overall Study|Non-adherent to study requirements|1|||
160856751|NCT01352117|580866490|FG000|Overall Study|Did not initiate study treatment|1|||
160856752|NCT01352117|580866491|FG001|Overall Study|Did not initiate study treatment|0|||
161141468|NCT06400238|581902505|FG000|Overall Study|Death|1|||
161141469|NCT06400238|581902505|FG000|Overall Study|Disease Progression|27|||
161141470|NCT06400238|581902505|FG000|Overall Study|Withdrawal by Subject|2|||
161141471|NCT06400238|581902505|FG000|Overall Study|Physician Decision|2|||
161141472|NCT01009463|581902511|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
160856753|NCT01352117|580866490|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
160856754|NCT01352117|580866491|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
160856755|NCT01317472|580866500|FG000|Overall Study|Withdrawal by Subject|1|||
160856756|NCT01317472|580866501|FG001|Overall Study|Withdrawal by Subject|0|||
160856757|NCT01317472|580866500|FG000|Overall Study|Unrelated hospitalization|1|||
160856758|NCT01317472|580866501|FG001|Overall Study|Unrelated hospitalization|0|||
160856759|NCT03585660|580866510|FG000|Overall Study|operator error|1|||
160856760|NCT03585660|580866510|FG000|Overall Study|technical error|2|||
160856761|NCT03585660|580866510|FG000|Overall Study|hip prosthesis|2|||
160856762|NCT03585660|580866510|FG000|Overall Study|did not undergo biopsy|8|||
160856763|NCT03585660|580866510|FG000|Overall Study|scanner problem|2|||
160856764|NCT04349891|580866515|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
160856765|NCT04349891|580866516|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
160856766|NCT04349891|580866515|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
160856767|NCT04349891|580866516|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
160856768|NCT04349891|580866515|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
160856769|NCT04349891|580866516|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
160856770|NCT04349891|580866515|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
161255382|NCT02688387|582314142|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255383|NCT02688387|582314143|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255384|NCT02688387|582314144|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255385|NCT02688387|582314145|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255386|NCT02688387|582314146|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255387|NCT02688387|582314147|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255388|NCT02688387|582314148|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255389|NCT02688387|582314149|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255390|NCT02688387|582314150|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
160908121|NCT04362072|581056466|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
160908122|NCT04362072|581056466|FG000|Treatment|Other|3|||
160908123|NCT04362072|581056466|FG000|Follow up|Death|2|||
160908124|NCT04362072|581056466|FG000|Follow up|Other|2|||
160908125|NCT04524689|581056467|FG000|Overall Study|Withdrawal by Subject|1|||
160908126|NCT04524689|581056468|FG001|Overall Study|Withdrawal by Subject|1|||
160993366|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
160993367|NCT01063036|581365339|FG000|Participants Treated With Study Drug|Pregnancy|1|||
161255391|NCT02688387|582314151|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
161255392|NCT02688387|582314152|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255393|NCT02688387|582314153|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
161255394|NCT02938442|582314154|FG000|Overall Study|Death|0|||
160908127|NCT04524689|581056469|FG002|Overall Study|Withdrawal by Subject|0|||
160908128|NCT04524689|581056470|FG003|Overall Study|Withdrawal by Subject|0|||
160908129|NCT04524689|581056471|FG004|Overall Study|Withdrawal by Subject|2|||
160908130|NCT04524689|581056472|FG005|Overall Study|Withdrawal by Subject|0|||
160908131|NCT04524689|581056467|FG000|Overall Study|Study terminated by Sponsor|6|||
160908132|NCT04524689|581056468|FG001|Overall Study|Study terminated by Sponsor|0|||
160908133|NCT04524689|581056469|FG002|Overall Study|Study terminated by Sponsor|1|||
160908134|NCT04524689|581056470|FG003|Overall Study|Study terminated by Sponsor|0|||
160908135|NCT04524689|581056471|FG004|Overall Study|Study terminated by Sponsor|4|||
160908136|NCT04524689|581056472|FG005|Overall Study|Study terminated by Sponsor|0|||
160908137|NCT04524689|581056467|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
160908138|NCT04524689|581056468|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
160908139|NCT04524689|581056469|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
160908140|NCT04524689|581056470|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
160908141|NCT04524689|581056471|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
160908142|NCT04524689|581056472|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
160908143|NCT01133522|581056473|FG000|Overall Study|Withdrawal by Subject|0|||
160908144|NCT01133522|581056474|FG001|Overall Study|Withdrawal by Subject|1|||
160908145|NCT01133522|581056475|FG002|Overall Study|Withdrawal by Subject|0|||
160908146|NCT01133522|581056476|FG003|Overall Study|Withdrawal by Subject|1|||
160908147|NCT01133522|581056477|FG004|Overall Study|Withdrawal by Subject|0|||
160908148|NCT01133522|581056478|FG005|Overall Study|Withdrawal by Subject|0|||
160908149|NCT01133522|581056479|FG006|Overall Study|Withdrawal by Subject|0|||
160908150|NCT01133522|581056480|FG007|Overall Study|Withdrawal by Subject|0|||
161255395|NCT02938442|582314155|FG001|Overall Study|Death|1|||
161255396|NCT02938442|582314154|FG000|Overall Study|Lost to Follow-up|0|||
160908151|NCT01133522|581056481|FG008|Overall Study|Withdrawal by Subject|0|||
160908152|NCT01133522|581056482|FG009|Overall Study|Withdrawal by Subject|0|||
160908153|NCT01133522|581056473|FG000|Overall Study|Physician Decision|0|||
160908154|NCT01133522|581056474|FG001|Overall Study|Physician Decision|0|||
160993368|NCT01063036|581365339|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
161141473|NCT01009463|581902512|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
160856771|NCT04349891|580866516|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
160856772|NCT01018030|580866519|FG000|Overall Study|Adverse Event|10|||
160908155|NCT01133522|581056475|FG002|Overall Study|Physician Decision|0|||
160908156|NCT01133522|581056476|FG003|Overall Study|Physician Decision|0|||
160908157|NCT01133522|581056477|FG004|Overall Study|Physician Decision|1|||
161337609|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
161337610|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
161337611|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
161337612|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
161337613|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
161337614|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
161337615|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
161337616|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
161337617|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
161337618|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161337619|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161337620|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
161337621|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
161337622|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
161337623|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
161337624|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
161337625|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
161337626|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
161337627|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
161337628|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
161337629|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
161337630|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
161337631|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
161337632|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
161337633|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
161337634|NCT01668797|582627464|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
161337635|NCT01668797|582627465|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
161337636|NCT01668797|582627466|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
161337637|NCT01668797|582627467|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
161337638|NCT00827567|582627468|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
161337639|NCT01259245|582627476|FG000|Overall Study|Withdrawal by Subject|27|||
161337640|NCT01259245|582627477|FG001|Overall Study|Withdrawal by Subject|24|||
161337641|NCT01259245|582627476|FG000|Overall Study|Death|1|||
161337642|NCT01259245|582627477|FG001|Overall Study|Death|2|||
161337643|NCT03937778|582627478|FG000|Overall Study|Withdrawal by Subject|1|||
161337644|NCT03937778|582627478|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
161337645|NCT01200355|582627480|FG000|Overall Study|Death|7|||
161337646|NCT01200355|582627481|FG001|Overall Study|Death|2|||
161337647|NCT00485303|582627482|FG000|Overall Study|Adverse Event|5|||
161337648|NCT00485303|582627482|FG000|Overall Study|Progressive Disease|44|||
161337649|NCT00485303|582627482|FG000|Overall Study|Other|3|||
161337650|NCT00485303|582627482|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
161337651|NCT00485303|582627482|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
161337652|NCT01281306|582627485|FG000|Overall Study|Lack of Efficacy|0|||
161337653|NCT01281306|582627486|FG001|Overall Study|Lack of Efficacy|1|||
161337654|NCT01281306|582627487|FG002|Overall Study|Lack of Efficacy|3|||
161337655|NCT01281306|582627488|FG003|Overall Study|Lack of Efficacy|0|||
161337656|NCT01281306|582627489|FG004|Overall Study|Lack of Efficacy|2|||
161337657|NCT01281306|582627490|FG005|Overall Study|Lack of Efficacy|0|||
161337658|NCT01281306|582627491|FG006|Overall Study|Lack of Efficacy|1|||
161337659|NCT01281306|582627485|FG000|Overall Study|Withdrawal by Subject|1|||
161337660|NCT01281306|582627486|FG001|Overall Study|Withdrawal by Subject|0|||
161337661|NCT01281306|582627487|FG002|Overall Study|Withdrawal by Subject|2|||
161337662|NCT01281306|582627488|FG003|Overall Study|Withdrawal by Subject|4|||
161337663|NCT01281306|582627489|FG004|Overall Study|Withdrawal by Subject|1|||
160856773|NCT01018030|580866520|FG001|Overall Study|Adverse Event|5|||
160856774|NCT01018030|580866521|FG002|Overall Study|Adverse Event|5|||
160856775|NCT01018030|580866519|FG000|Overall Study|Withdrawal by Subject|2|||
160856776|NCT01018030|580866520|FG001|Overall Study|Withdrawal by Subject|2|||
160856777|NCT01018030|580866521|FG002|Overall Study|Withdrawal by Subject|4|||
160856778|NCT01018030|580866519|FG000|Overall Study|Lost to Follow-up|2|||
160856779|NCT01018030|580866520|FG001|Overall Study|Lost to Follow-up|0|||
160856780|NCT01018030|580866521|FG002|Overall Study|Lost to Follow-up|3|||
160856781|NCT01018030|580866519|FG000|Overall Study|Protocol Violation|2|||
160856782|NCT01018030|580866520|FG001|Overall Study|Protocol Violation|1|||
160908158|NCT01133522|581056478|FG005|Overall Study|Physician Decision|0|||
160856783|NCT01018030|580866521|FG002|Overall Study|Protocol Violation|0|||
160856784|NCT01018030|580866519|FG000|Overall Study|Physician Decision|1|||
160856785|NCT01018030|580866520|FG001|Overall Study|Physician Decision|0|||
160993369|NCT01063036|581365339|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
160993370|NCT01063036|581365339|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
160993371|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
160993372|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
160993373|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
160993374|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
160993375|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Adverse Event|198|||
160993376|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Adverse Event|0|||
160993377|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Adverse Event|0|||
160993378|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Adverse Event|0|||
160993379|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Death|62|||
160993380|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Death|0|||
160993381|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Death|0|||
160993382|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Death|0|||
160993383|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
160993384|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
160993385|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
160993386|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
160993387|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Complicating disease|13|||
160993388|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Complicating disease|0|||
160993389|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Complicating disease|0|||
160993390|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Complicating disease|0|||
160993391|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
160993392|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
160993393|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
160993394|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
160993395|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
160993396|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
160993397|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
160993398|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
160993399|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Non-compliance|4|||
160993400|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Non-compliance|0|||
160993401|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Non-compliance|0|||
160993402|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Non-compliance|0|||
160993403|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Pain|4|||
160993404|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Pain|0|||
160993405|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Pain|0|||
160993406|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Pain|0|||
160993407|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
160993408|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
160993409|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
160993410|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
160993411|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Hospice care|1|||
160993412|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Hospice care|0|||
160993413|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Hospice care|0|||
160993414|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Hospice care|0|||
160993415|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Physician Decision|1|||
160993416|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Physician Decision|0|||
160993417|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Physician Decision|0|||
160993418|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Physician Decision|0|||
160993419|NCT01107626|581365340|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
160993420|NCT01107626|581365341|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
160993421|NCT01107626|581365342|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
160993422|NCT01107626|581365343|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
160993423|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
160993424|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
160993425|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
160993426|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
160993427|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
160993428|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
160993429|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
160993430|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
160993431|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Death|0|||
160993432|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Death|8|||
161142631|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
160993433|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Death|2|||
160993434|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Death|13|||
160993435|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
160993436|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
160993437|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
161142632|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
160856786|NCT01018030|580866521|FG002|Overall Study|Physician Decision|1|||
160856787|NCT01018030|580866519|FG000|Overall Study|Lack of Efficacy|1|||
160856788|NCT01018030|580866520|FG001|Overall Study|Lack of Efficacy|0|||
160856789|NCT01018030|580866521|FG002|Overall Study|Lack of Efficacy|0|||
160856790|NCT01018030|580866519|FG000|Overall Study|Did Not Receive Study Drug|1|||
160856791|NCT01018030|580866520|FG001|Overall Study|Did Not Receive Study Drug|3|||
160856792|NCT01018030|580866521|FG002|Overall Study|Did Not Receive Study Drug|0|||
160856793|NCT02399215|580866532|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
161255397|NCT02938442|582314155|FG001|Overall Study|Lost to Follow-up|1|||
161255398|NCT02938442|582314154|FG000|Overall Study|Physician Decision|0|||
161255399|NCT02938442|582314155|FG001|Overall Study|Physician Decision|1|||
161255400|NCT02938442|582314154|FG000|Overall Study|Withdrawal by Subject|2|||
161255401|NCT02938442|582314155|FG001|Overall Study|Withdrawal by Subject|0|||
160856794|NCT02399215|580866532|FG000|Overall Study|Withdrawal by Subject|1|||
160993438|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
160993439|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
160993440|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
160993441|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
160993442|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
160993443|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
160993444|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
160993445|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
160993446|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
160993447|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
160993448|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
160993449|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
160993450|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
160993451|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
160993452|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
160993453|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
160993454|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
160993455|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
160993456|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
160993457|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
160993458|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
160993459|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
160993460|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
160993461|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
160993462|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
160993463|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
160993464|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
160993465|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
160993466|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
160993467|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
160993468|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
160993469|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
160993470|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
160993471|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
160993472|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
160993473|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
160993474|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
160993475|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Pain|0|||
160993476|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Pain|0|||
160993477|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Pain|0|||
160993478|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Pain|1|||
160993479|NCT01107626|581365340|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
160993480|NCT01107626|581365341|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
160993481|NCT01107626|581365342|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
160993482|NCT01107626|581365343|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
160993483|NCT04381494|581365344|FG000|Overall Study|Early termination of trial|19|||
160993484|NCT04381494|581365344|FG000|Overall Study|Investigator's discretion|1|||
160993485|NCT04381494|581365344|FG000|Overall Study|Withdrawal by Subject|9|||
160993486|NCT04381494|581365344|FG000|Overall Study|NSCLC disease progression|4|||
161255402|NCT00802178|582314156|FG000|Overall Study|Lack of Efficacy|36|||
161255403|NCT00802178|582314156|FG000|Overall Study|Insufficient tolerability (IT)|17|||
161255404|NCT00802178|582314156|FG000|Overall Study|Withdrawal by Subject|18|||
160856795|NCT01903356|580866535|FG000|Overall Study|Lost to Follow-up|7|||
160856796|NCT01903356|580866535|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
160856797|NCT01903356|580866535|FG000|Overall Study|Violated the dosage and administration|3|||
160993487|NCT04381494|581365344|FG000|Overall Study|Device-Related Adverse Event|2|||
160993488|NCT01977612|581365345|FG000|Overall Study|Lost to Follow-up|1|||
160993489|NCT01977612|581365346|FG001|Overall Study|Lost to Follow-up|1|||
160993490|NCT04310579|581365347|FG000|Overall Study|Adverse Event|0|||
160993491|NCT04310579|581365348|FG001|Overall Study|Adverse Event|0|||
160993492|NCT04310579|581365349|FG002|Overall Study|Adverse Event|0|||
160993493|NCT04310579|581365350|FG003|Overall Study|Adverse Event|0|||
160993494|NCT04310579|581365351|FG004|Overall Study|Adverse Event|0|||
160993495|NCT04310579|581365352|FG005|Overall Study|Adverse Event|0|||
160993496|NCT04310579|581365353|FG006|Overall Study|Adverse Event|2|||
160993497|NCT04310579|581365354|FG007|Overall Study|Adverse Event|0|||
160993498|NCT04310579|581365355|FG008|Overall Study|Adverse Event|1|||
160993499|NCT04310579|581365356|FG009|Overall Study|Adverse Event|1|||
160993500|NCT04310579|581365357|FG010|Overall Study|Adverse Event|0|||
160993501|NCT04310579|581365347|FG000|Overall Study|Withdrawal by Subject|0|||
160993502|NCT04310579|581365348|FG001|Overall Study|Withdrawal by Subject|0|||
160993503|NCT04310579|581365349|FG002|Overall Study|Withdrawal by Subject|0|||
160993504|NCT04310579|581365350|FG003|Overall Study|Withdrawal by Subject|0|||
160993505|NCT04310579|581365351|FG004|Overall Study|Withdrawal by Subject|0|||
160993506|NCT04310579|581365352|FG005|Overall Study|Withdrawal by Subject|1|||
160993507|NCT04310579|581365353|FG006|Overall Study|Withdrawal by Subject|0|||
160993508|NCT04310579|581365354|FG007|Overall Study|Withdrawal by Subject|0|||
160993509|NCT04310579|581365355|FG008|Overall Study|Withdrawal by Subject|0|||
160993510|NCT04310579|581365356|FG009|Overall Study|Withdrawal by Subject|0|||
160993511|NCT04310579|581365357|FG010|Overall Study|Withdrawal by Subject|0|||
160993512|NCT04310579|581365347|FG000|Overall Study|Positive COVID-19 test|0|||
160993513|NCT04310579|581365348|FG001|Overall Study|Positive COVID-19 test|0|||
160993514|NCT04310579|581365349|FG002|Overall Study|Positive COVID-19 test|0|||
160993515|NCT04310579|581365350|FG003|Overall Study|Positive COVID-19 test|0|||
160993516|NCT04310579|581365351|FG004|Overall Study|Positive COVID-19 test|0|||
160993517|NCT04310579|581365352|FG005|Overall Study|Positive COVID-19 test|0|||
160993518|NCT04310579|581365353|FG006|Overall Study|Positive COVID-19 test|0|||
160993519|NCT04310579|581365354|FG007|Overall Study|Positive COVID-19 test|0|||
160993520|NCT04310579|581365355|FG008|Overall Study|Positive COVID-19 test|0|||
160993521|NCT04310579|581365356|FG009|Overall Study|Positive COVID-19 test|0|||
160993522|NCT04310579|581365357|FG010|Overall Study|Positive COVID-19 test|1|||
160993523|NCT04012853|581365358|FG000|Overall Study|Withdrawal by Subject|1|||
160993524|NCT04012853|581365359|FG001|Overall Study|Withdrawal by Subject|1|||
160993525|NCT04012853|581365358|FG000|Overall Study|Protocol Violation|1|||
160993526|NCT04012853|581365359|FG001|Overall Study|Protocol Violation|0|||
160993527|NCT04012853|581365358|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
160993528|NCT04012853|581365359|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
160993529|NCT04304534|581365360|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
160993530|NCT04304534|581365361|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
160993531|NCT04304534|581365362|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
160993532|NCT04304534|581365363|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
160993533|NCT04304534|581365360|FG000|Overall Study|Non-Compliance with study drug|0|||
160993534|NCT04304534|581365361|FG001|Overall Study|Non-Compliance with study drug|1|||
160993535|NCT04304534|581365362|FG002|Overall Study|Non-Compliance with study drug|1|||
160993536|NCT04304534|581365363|FG003|Overall Study|Non-Compliance with study drug|1|||
160993537|NCT04304534|581365360|FG000|Overall Study|Lost to Follow-up|0|||
160993538|NCT04304534|581365361|FG001|Overall Study|Lost to Follow-up|1|||
160993539|NCT04304534|581365362|FG002|Overall Study|Lost to Follow-up|2|||
160993540|NCT04304534|581365363|FG003|Overall Study|Lost to Follow-up|3|||
160993541|NCT04304534|581365360|FG000|Overall Study|Unspecific|4|||
160993542|NCT04304534|581365361|FG001|Overall Study|Unspecific|2|||
160993543|NCT04304534|581365362|FG002|Overall Study|Unspecific|2|||
160993544|NCT04304534|581365363|FG003|Overall Study|Unspecific|2|||
160993545|NCT04304534|581365360|FG000|Overall Study|Technical Problems|2|||
160993546|NCT04304534|581365361|FG001|Overall Study|Technical Problems|2|||
160993547|NCT04304534|581365362|FG002|Overall Study|Technical Problems|3|||
160993548|NCT04304534|581365363|FG003|Overall Study|Technical Problems|4|||
160993549|NCT04304534|581365360|FG000|Overall Study|Death|7|||
160993550|NCT04304534|581365361|FG001|Overall Study|Death|2|||
160993551|NCT04304534|581365362|FG002|Overall Study|Death|4|||
160993552|NCT04304534|581365363|FG003|Overall Study|Death|3|||
160993553|NCT04304534|581365360|FG000|Overall Study|Withdrawal by Subject|7|||
160993554|NCT04304534|581365361|FG001|Overall Study|Withdrawal by Subject|2|||
160993555|NCT04304534|581365362|FG002|Overall Study|Withdrawal by Subject|7|||
160993556|NCT04304534|581365363|FG003|Overall Study|Withdrawal by Subject|4|||
160993557|NCT04304534|581365360|FG000|Overall Study|Physician Decision|4|||
160993558|NCT04304534|581365361|FG001|Overall Study|Physician Decision|9|||
160993559|NCT04304534|581365362|FG002|Overall Study|Physician Decision|9|||
160993560|NCT04304534|581365363|FG003|Overall Study|Physician Decision|5|||
160993561|NCT04304534|581365360|FG000|Overall Study|Subject Decision|34|||
160993562|NCT04304534|581365361|FG001|Overall Study|Subject Decision|25|||
160993563|NCT04304534|581365362|FG002|Overall Study|Subject Decision|25|||
160993564|NCT04304534|581365363|FG003|Overall Study|Subject Decision|26|||
160993565|NCT04304534|581365360|FG000|Overall Study|Adverse Event|35|||
161337664|NCT01281306|582627490|FG005|Overall Study|Withdrawal by Subject|3|||
161337665|NCT01281306|582627491|FG006|Overall Study|Withdrawal by Subject|1|||
161337666|NCT01281306|582627485|FG000|Overall Study|Protocol deviation|0|||
161337667|NCT01281306|582627486|FG001|Overall Study|Protocol deviation|1|||
161337668|NCT01281306|582627487|FG002|Overall Study|Protocol deviation|1|||
161337669|NCT01281306|582627488|FG003|Overall Study|Protocol deviation|1|||
160856798|NCT00713609|580866536|FG000|Overall Study|Adverse Event|2|||
160856799|NCT00713609|580866537|FG001|Overall Study|Adverse Event|0|||
160856800|NCT00713609|580866538|FG002|Overall Study|Adverse Event|2|||
160856801|NCT00713609|580866539|FG003|Overall Study|Adverse Event|2|||
160856802|NCT00713609|580866540|FG004|Overall Study|Adverse Event|3|||
161337670|NCT01281306|582627489|FG004|Overall Study|Protocol deviation|1|||
161337671|NCT01281306|582627490|FG005|Overall Study|Protocol deviation|0|||
161337672|NCT01281306|582627491|FG006|Overall Study|Protocol deviation|0|||
161337673|NCT01281306|582627485|FG000|Overall Study|Condition no longer requires study drug|1|||
161337674|NCT01281306|582627486|FG001|Overall Study|Condition no longer requires study drug|0|||
161337675|NCT01281306|582627487|FG002|Overall Study|Condition no longer requires study drug|0|||
160856803|NCT00713609|580866541|FG005|Overall Study|Adverse Event|1|||
160993566|NCT04304534|581365361|FG001|Overall Study|Adverse Event|40|||
161337676|NCT01281306|582627488|FG003|Overall Study|Condition no longer requires study drug|0|||
161337677|NCT01281306|582627489|FG004|Overall Study|Condition no longer requires study drug|0|||
160856804|NCT00713609|580866536|FG000|Overall Study|Lost to Follow-up|5|||
160993567|NCT04304534|581365362|FG002|Overall Study|Adverse Event|39|||
160993568|NCT04304534|581365363|FG003|Overall Study|Adverse Event|44|||
160993569|NCT01695317|581365364|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
160993570|NCT01695317|581365365|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
160993571|NCT01695317|581365364|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
160993572|NCT01695317|581365365|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
160993573|NCT00003656|581365366|FG000|Overall Study|Adverse Event|0|||
160993574|NCT00003656|581365367|FG001|Overall Study|Adverse Event|1|||
160993575|NCT03055767|581365368|FG000|Open-Label Period|Lost to Follow-up|0|||
160993576|NCT03055767|581365369|FG001|Open-Label Period|Lost to Follow-up|0|||
160993577|NCT03055767|581365370|FG002|Open-Label Period|Lost to Follow-up|2|||
160993578|NCT03055767|581365371|FG003|Open-Label Period|Lost to Follow-up|0|||
160993579|NCT03055767|581365368|FG000|Open-Label Period|Withdrawal by Subject|0|||
160993580|NCT03055767|581365369|FG001|Open-Label Period|Withdrawal by Subject|0|||
160993581|NCT03055767|581365370|FG002|Open-Label Period|Withdrawal by Subject|0|||
160993582|NCT03055767|581365371|FG003|Open-Label Period|Withdrawal by Subject|1|||
160993583|NCT02759731|581365374|FG000|Overall Study|Did not complete treatment.|8|||
160993584|NCT00957229|581365380|FG000|Study Start|Adverse Event|0|||
160993585|NCT00957229|581365381|FG001|Study Start|Adverse Event|3|||
160993586|NCT00957229|581365380|FG000|Study Start|Disease Progression|1|||
160993587|NCT00957229|581365381|FG001|Study Start|Disease Progression|0|||
160993588|NCT00957229|581365380|FG000|Reallocated to or Continued Vismodegib|Death|1|||
160993589|NCT00957229|581365381|FG001|Reallocated to or Continued Vismodegib|Death|1|||
160993590|NCT00957229|581365380|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
160993591|NCT00957229|581365381|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
160993592|NCT00763282|581365382|FG000|Overall Study|Withdrawal by Subject|6|||
160993593|NCT00763282|581365383|FG001|Overall Study|Withdrawal by Subject|5|||
160993594|NCT00763282|581365382|FG000|Overall Study|Death|4|||
160993595|NCT00763282|581365383|FG001|Overall Study|Death|3|||
160993596|NCT00763282|581365382|FG000|Overall Study|Lost to Follow-up|22|||
160993597|NCT00763282|581365383|FG001|Overall Study|Lost to Follow-up|26|||
160993598|NCT04580303|581365384|FG000|Overall Study|Adverse Event|0|||
160993599|NCT04580303|581365385|FG001|Overall Study|Adverse Event|1|||
160993600|NCT04580303|581365386|FG002|Overall Study|Adverse Event|0|||
160993601|NCT04580303|581365387|FG003|Overall Study|Adverse Event|0|||
160993602|NCT04580303|581365384|FG000|Overall Study|Withdrawal by Subject|0|||
160993603|NCT04580303|581365385|FG001|Overall Study|Withdrawal by Subject|0|||
160993604|NCT04580303|581365386|FG002|Overall Study|Withdrawal by Subject|1|||
160993605|NCT04580303|581365387|FG003|Overall Study|Withdrawal by Subject|0|||
160993606|NCT01833065|581365389|FG000|Overall Study|Adverse Event|6|||
160993607|NCT01833065|581365390|FG001|Overall Study|Adverse Event|1|||
160993608|NCT01833065|581365391|FG002|Overall Study|Adverse Event|0|||
160993609|NCT01833065|581365392|FG003|Overall Study|Adverse Event|2|||
160993610|NCT01833065|581365393|FG004|Overall Study|Adverse Event|3|||
160993611|NCT01833065|581365389|FG000|Overall Study|Protocol Violation|1|||
160993612|NCT01833065|581365390|FG001|Overall Study|Protocol Violation|0|||
161337678|NCT01281306|582627490|FG005|Overall Study|Condition no longer requires study drug|1|||
161337679|NCT01281306|582627491|FG006|Overall Study|Condition no longer requires study drug|1|||
161337680|NCT01281306|582627485|FG000|Overall Study|Lost to Follow-up|1|||
161337681|NCT01281306|582627486|FG001|Overall Study|Lost to Follow-up|0|||
160993613|NCT01833065|581365391|FG002|Overall Study|Protocol Violation|0|||
160993614|NCT01833065|581365392|FG003|Overall Study|Protocol Violation|0|||
160993615|NCT01833065|581365393|FG004|Overall Study|Protocol Violation|2|||
160993616|NCT01833065|581365389|FG000|Overall Study|Lost to Follow-up|1|||
160993617|NCT01833065|581365390|FG001|Overall Study|Lost to Follow-up|0|||
160856805|NCT00713609|580866537|FG001|Overall Study|Lost to Follow-up|7|||
160856806|NCT00713609|580866538|FG002|Overall Study|Lost to Follow-up|5|||
160856807|NCT00713609|580866539|FG003|Overall Study|Lost to Follow-up|5|||
160856808|NCT00713609|580866540|FG004|Overall Study|Lost to Follow-up|7|||
160856809|NCT00713609|580866541|FG005|Overall Study|Lost to Follow-up|0|||
160856810|NCT00713609|580866536|FG000|Overall Study|Lack of Efficacy|1|||
160856811|NCT00713609|580866537|FG001|Overall Study|Lack of Efficacy|3|||
160856812|NCT00713609|580866538|FG002|Overall Study|Lack of Efficacy|0|||
160856813|NCT00713609|580866539|FG003|Overall Study|Lack of Efficacy|0|||
160856814|NCT00713609|580866540|FG004|Overall Study|Lack of Efficacy|1|||
160856815|NCT00713609|580866541|FG005|Overall Study|Lack of Efficacy|0|||
160908159|NCT01133522|581056479|FG006|Overall Study|Physician Decision|0|||
160908160|NCT01133522|581056480|FG007|Overall Study|Physician Decision|0|||
160908161|NCT01133522|581056481|FG008|Overall Study|Physician Decision|0|||
160908162|NCT01133522|581056482|FG009|Overall Study|Physician Decision|0|||
160908163|NCT04997304|581056483|FG000|Overall Study|Lost to Follow-up|11|||
160908164|NCT04997304|581056483|FG000|Overall Study|Death|1|||
160908165|NCT04997304|581056483|FG000|Overall Study|Withdrawal by Subject|14|||
160908166|NCT03291808|581058029|FG000|Overall Study|Lost to Follow-up|6|||
160908167|NCT03291808|581058029|FG000|Overall Study|Research burden|4|||
160908168|NCT00638378|581058030|FG000|Overall Study|Death|2|||
160908169|NCT00638378|581058030|FG000|Overall Study|Adverse Event|1|||
160908170|NCT00638378|581058030|FG000|Overall Study|Disease progression|15|||
160908171|NCT00638378|581058030|FG000|Overall Study|Physician Decision|4|||
160908172|NCT03364023|581058033|FG000|Overall Study|Lost to Follow-up|3|||
160908173|NCT03364023|581058033|FG000|Overall Study|Death|14|||
160908174|NCT03797014|581058034|FG000|Overall Study|Withdrawal by Subject|1|||
160908175|NCT03797014|581058034|FG000|Overall Study|Lost to Follow-up|1|||
160908176|NCT03797014|581058034|FG000|Overall Study|Protocol Violation|1|||
160908177|NCT03305575|581058039|FG000|Overall Study|Physician Decision|1|||
160908178|NCT03305575|581058040|FG001|Overall Study|Physician Decision|0|||
160908179|NCT00105469|581058041|FG000|Overall Study|Adverse Event|9|||
160908180|NCT00105469|581058042|FG001|Overall Study|Adverse Event|8|||
160908181|NCT00105469|581058041|FG000|Overall Study|Protocol Violation|4|||
160908182|NCT00105469|581058042|FG001|Overall Study|Protocol Violation|0|||
160908183|NCT00105469|581058041|FG000|Overall Study|Withdrawal by Subject|2|||
160908184|NCT00105469|581058042|FG001|Overall Study|Withdrawal by Subject|3|||
160908185|NCT00105469|581058041|FG000|Overall Study|Lost to Follow-up|1|||
160908186|NCT00105469|581058042|FG001|Overall Study|Lost to Follow-up|0|||
160908187|NCT00105469|581058041|FG000|Overall Study|Lack of Efficacy|2|||
160908188|NCT00105469|581058042|FG001|Overall Study|Lack of Efficacy|0|||
160993618|NCT01833065|581365391|FG002|Overall Study|Lost to Follow-up|0|||
160993619|NCT01833065|581365392|FG003|Overall Study|Lost to Follow-up|0|||
160993620|NCT01833065|581365393|FG004|Overall Study|Lost to Follow-up|3|||
160993621|NCT01833065|581365389|FG000|Overall Study|Withdrawal by Subject|6|||
160993622|NCT01833065|581365390|FG001|Overall Study|Withdrawal by Subject|2|||
161255405|NCT00802178|582314156|FG000|Overall Study|Other|32|||
161255406|NCT00802178|582314156|FG000|Overall Study|Lack of efficacy and patient wish|1|||
161255407|NCT00802178|582314156|FG000|Overall Study|IT and patient wish|8|||
160856816|NCT00713609|580866536|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
160856817|NCT00713609|580866537|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
160908189|NCT00105469|581058041|FG000|Overall Study|Other Reason|4|||
160908190|NCT00105469|581058042|FG001|Overall Study|Other Reason|0|||
160908191|NCT02820753|581058054|FG000|2 Month|Withdrawal by Subject|3|||
160908192|NCT02820753|581058055|FG001|2 Month|Withdrawal by Subject|3|||
160908193|NCT02820753|581058054|FG000|2 Month|Lost to Follow-up|24|||
160993623|NCT01833065|581365391|FG002|Overall Study|Withdrawal by Subject|4|||
160993624|NCT01833065|581365392|FG003|Overall Study|Withdrawal by Subject|3|||
161142633|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142634|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
160908194|NCT02820753|581058055|FG001|2 Month|Lost to Follow-up|26|||
161142635|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142636|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
161142637|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
161142638|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
161142639|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
161142640|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
161142641|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
161142642|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
161142643|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
161142644|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
161142645|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
161142646|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
161142647|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
161142648|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
161142649|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
160993625|NCT01833065|581365393|FG004|Overall Study|Withdrawal by Subject|11|||
160993626|NCT01833065|581365389|FG000|Overall Study|Subject's substantial non-compliance|0|||
160993627|NCT01833065|581365390|FG001|Overall Study|Subject's substantial non-compliance|1|||
160993628|NCT01833065|581365391|FG002|Overall Study|Subject's substantial non-compliance|0|||
160993629|NCT01833065|581365392|FG003|Overall Study|Subject's substantial non-compliance|0|||
160993630|NCT01833065|581365393|FG004|Overall Study|Subject's substantial non-compliance|0|||
160993631|NCT01833065|581365389|FG000|Overall Study|Trial terminated by sponsor|8|||
160993632|NCT01833065|581365390|FG001|Overall Study|Trial terminated by sponsor|8|||
160993633|NCT01833065|581365391|FG002|Overall Study|Trial terminated by sponsor|7|||
160993634|NCT01833065|581365392|FG003|Overall Study|Trial terminated by sponsor|3|||
160993635|NCT01833065|581365393|FG004|Overall Study|Trial terminated by sponsor|13|||
160993636|NCT01833065|581365389|FG000|Overall Study|Others|2|||
160993637|NCT01833065|581365390|FG001|Overall Study|Others|1|||
160993638|NCT01833065|581365391|FG002|Overall Study|Others|1|||
160993639|NCT01833065|581365392|FG003|Overall Study|Others|1|||
160993640|NCT01833065|581365393|FG004|Overall Study|Others|4|||
160993641|NCT01456936|581365397|FG000|Overall Study|Other reason|41|||
160993642|NCT01456936|581365398|FG001|Overall Study|Other reason|30|||
160993643|NCT01456936|581365399|FG002|Overall Study|Other reason|36|||
160993644|NCT01456936|581365400|FG003|Overall Study|Other reason|33|||
160993645|NCT01456936|581365397|FG000|Overall Study|No longer meets eligibility criteria|4|||
160993646|NCT01456936|581365398|FG001|Overall Study|No longer meets eligibility criteria|8|||
160993647|NCT01456936|581365399|FG002|Overall Study|No longer meets eligibility criteria|6|||
160993648|NCT01456936|581365400|FG003|Overall Study|No longer meets eligibility criteria|5|||
160993649|NCT01456936|581365397|FG000|Overall Study|Protocol Violation|4|||
160993650|NCT01456936|581365398|FG001|Overall Study|Protocol Violation|2|||
160993651|NCT01456936|581365399|FG002|Overall Study|Protocol Violation|5|||
160993652|NCT01456936|581365400|FG003|Overall Study|Protocol Violation|5|||
160993653|NCT01456936|581365397|FG000|Overall Study|Pregnancy|1|||
160993654|NCT01456936|581365398|FG001|Overall Study|Pregnancy|0|||
160993655|NCT01456936|581365399|FG002|Overall Study|Pregnancy|0|||
160993656|NCT01456936|581365400|FG003|Overall Study|Pregnancy|1|||
160993657|NCT01456936|581365397|FG000|Overall Study|Insufficient clinical response|4|||
160993658|NCT01456936|581365398|FG001|Overall Study|Insufficient clinical response|4|||
160993659|NCT01456936|581365399|FG002|Overall Study|Insufficient clinical response|14|||
160993660|NCT01456936|581365400|FG003|Overall Study|Insufficient clinical response|13|||
160993661|NCT01456936|581365397|FG000|Overall Study|No longer willing to participate|195|||
160993662|NCT01456936|581365398|FG001|Overall Study|No longer willing to participate|218|||
160993663|NCT01456936|581365399|FG002|Overall Study|No longer willing to participate|224|||
160993664|NCT01456936|581365400|FG003|Overall Study|No longer willing to participate|248|||
160993665|NCT01456936|581365397|FG000|Overall Study|Lost to Follow-up|135|||
160993666|NCT01456936|581365398|FG001|Overall Study|Lost to Follow-up|126|||
160993667|NCT01456936|581365399|FG002|Overall Study|Lost to Follow-up|144|||
160993668|NCT01456936|581365400|FG003|Overall Study|Lost to Follow-up|127|||
160993669|NCT01456936|581365397|FG000|Overall Study|Medication error|0|||
160993670|NCT01456936|581365398|FG001|Overall Study|Medication error|1|||
160993671|NCT01456936|581365399|FG002|Overall Study|Medication error|0|||
160993672|NCT01456936|581365400|FG003|Overall Study|Medication error|1|||
160993673|NCT01456936|581365397|FG000|Overall Study|Adverse event (study drug)|25|||
160993674|NCT01456936|581365398|FG001|Overall Study|Adverse event (study drug)|21|||
161141474|NCT01009463|581902513|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161255408|NCT00802178|582314156|FG000|Overall Study|Patients wish and other reason|1|||
161255409|NCT01606228|582314157|FG000|Overall Study|Lost to Follow-up|20|||
161255410|NCT01606228|582314157|FG000|Overall Study|Withdrawal by Subject|3|||
161255411|NCT01606228|582314157|FG000|Overall Study|Non-compliant|3|||
161255412|NCT01606228|582314157|FG000|Overall Study|Lack of Efficacy|2|||
161255413|NCT01606228|582314157|FG000|Overall Study|Adverse Event|1|||
161255414|NCT01115855|582314158|FG000|Overall Study|Adverse Event|16|||
161255415|NCT01115855|582314159|FG001|Overall Study|Adverse Event|18|||
161255416|NCT01115855|582314158|FG000|Overall Study|Death|6|||
161255417|NCT01115855|582314159|FG001|Overall Study|Death|5|||
161255418|NCT01115855|582314158|FG000|Overall Study|Lab Abnormality|1|||
161255419|NCT01115855|582314159|FG001|Overall Study|Lab Abnormality|1|||
161255420|NCT01115855|582314158|FG000|Overall Study|Protocol Violation|0|||
161255421|NCT01115855|582314159|FG001|Overall Study|Protocol Violation|1|||
161255422|NCT01115855|582314158|FG000|Overall Study|Withdrawal by Subject|5|||
160993675|NCT01456936|581365399|FG002|Overall Study|Adverse event (study drug)|26|||
160993676|NCT01456936|581365400|FG003|Overall Study|Adverse event (study drug)|17|||
160993677|NCT01456936|581365397|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
160993678|NCT01456936|581365398|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
160993679|NCT01456936|581365399|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
161255423|NCT01115855|582314159|FG001|Overall Study|Withdrawal by Subject|5|||
161255424|NCT01115855|582314158|FG000|Overall Study|Other|8|||
161255425|NCT01115855|582314159|FG001|Overall Study|Other|6|||
161255426|NCT04100096|582314160|FG000|Overall Study|Adverse Event|19|||
161255427|NCT04100096|582314161|FG001|Overall Study|Adverse Event|7|||
161337682|NCT01281306|582627487|FG002|Overall Study|Lost to Follow-up|0|||
161337683|NCT01281306|582627488|FG003|Overall Study|Lost to Follow-up|2|||
161337684|NCT01281306|582627489|FG004|Overall Study|Lost to Follow-up|0|||
161337685|NCT01281306|582627490|FG005|Overall Study|Lost to Follow-up|0|||
161337686|NCT01281306|582627491|FG006|Overall Study|Lost to Follow-up|1|||
161337687|NCT01281306|582627485|FG000|Overall Study|Death|1|||
161337688|NCT01281306|582627486|FG001|Overall Study|Death|0|||
161337689|NCT01281306|582627487|FG002|Overall Study|Death|0|||
161337690|NCT01281306|582627488|FG003|Overall Study|Death|0|||
161337691|NCT01281306|582627489|FG004|Overall Study|Death|0|||
161337692|NCT01281306|582627490|FG005|Overall Study|Death|0|||
161337693|NCT01281306|582627491|FG006|Overall Study|Death|0|||
161337694|NCT01281306|582627485|FG000|Overall Study|Adverse Event|3|||
160993680|NCT01456936|581365400|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
160993681|NCT01456936|581365397|FG000|Overall Study|Death|0|||
160993682|NCT01456936|581365398|FG001|Overall Study|Death|3|||
160993683|NCT01456936|581365399|FG002|Overall Study|Death|1|||
160993684|NCT01456936|581365400|FG003|Overall Study|Death|3|||
160993685|NCT01456936|581365397|FG000|Overall Study|Randomized but not treated|21|||
160993686|NCT01456936|581365398|FG001|Overall Study|Randomized but not treated|28|||
160993687|NCT01456936|581365399|FG002|Overall Study|Randomized but not treated|16|||
160993688|NCT01456936|581365400|FG003|Overall Study|Randomized but not treated|21|||
160993689|NCT00906698|581365401|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993690|NCT00906698|581365402|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
160993691|NCT00906698|581365403|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993692|NCT00906698|581365404|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993693|NCT00906698|581365405|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
160993694|NCT00906698|581365406|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
160993695|NCT00906698|581365401|FG000|Overall Study|Adverse Event|0|||
160993696|NCT00906698|581365402|FG001|Overall Study|Adverse Event|0|||
160993697|NCT00906698|581365403|FG002|Overall Study|Adverse Event|2|||
160993698|NCT00906698|581365404|FG003|Overall Study|Adverse Event|0|||
160993699|NCT00906698|581365405|FG004|Overall Study|Adverse Event|4|||
160993700|NCT00906698|581365406|FG005|Overall Study|Adverse Event|1|||
160993701|NCT00906698|581365401|FG000|Overall Study|Disease progression|3|||
160993702|NCT00906698|581365402|FG001|Overall Study|Disease progression|12|||
160993703|NCT00906698|581365403|FG002|Overall Study|Disease progression|4|||
160993704|NCT00906698|581365404|FG003|Overall Study|Disease progression|4|||
160993705|NCT00906698|581365405|FG004|Overall Study|Disease progression|12|||
160993706|NCT00906698|581365406|FG005|Overall Study|Disease progression|4|||
160993707|NCT00906698|581365401|FG000|Overall Study|Withdrawal by Subject|0|||
160993708|NCT00906698|581365402|FG001|Overall Study|Withdrawal by Subject|0|||
160993709|NCT00906698|581365403|FG002|Overall Study|Withdrawal by Subject|0|||
160993710|NCT00906698|581365404|FG003|Overall Study|Withdrawal by Subject|0|||
160993711|NCT00906698|581365405|FG004|Overall Study|Withdrawal by Subject|1|||
160993712|NCT00906698|581365406|FG005|Overall Study|Withdrawal by Subject|0|||
160993713|NCT00906698|581365401|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
160993714|NCT00906698|581365402|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
160993715|NCT00906698|581365403|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
160993716|NCT00906698|581365404|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
160993717|NCT00906698|581365405|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
160993718|NCT00906698|581365406|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
160993719|NCT01250002|581365407|FG000|Overall Study|Change to open surgical procedure|4|||
160993720|NCT01250002|581365408|FG001|Overall Study|Change to open surgical procedure|3|||
160993721|NCT02317705|581365409|FG000|Overall Study|Withdrawal by Subject|3|||
160993722|NCT02317705|581365409|FG000|Overall Study|Physician Decision|1|||
160856818|NCT00713609|580866538|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
160856819|NCT00713609|580866539|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
160856820|NCT00713609|580866540|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
160856821|NCT00713609|580866541|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
160856822|NCT00713609|580866536|FG000|Overall Study|Withdrawal by Subject|6|||
160856823|NCT00713609|580866537|FG001|Overall Study|Withdrawal by Subject|1|||
160856824|NCT00713609|580866538|FG002|Overall Study|Withdrawal by Subject|5|||
160856825|NCT00713609|580866539|FG003|Overall Study|Withdrawal by Subject|1|||
160993723|NCT02317705|581365409|FG000|Overall Study|Drug not usable|1|||
160993724|NCT01599325|581365410|FG000|Primary Parent Phase|Adverse Event|5|||
160993725|NCT01599325|581365410|FG000|Primary Parent Phase|Disease Progression|7|||
160993726|NCT01599325|581365410|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
160993727|NCT01599325|581365410|FG000|Primary Parent Phase|Death|13|||
160993728|NCT01599325|581365410|FG000|Primary Parent Phase|Protocol Violation|1|||
160993729|NCT01599325|581365410|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
160993730|NCT01599325|581365410|FG000|Primary Parent Phase|Other|2|||
161337695|NCT01281306|582627486|FG001|Overall Study|Adverse Event|2|||
161337696|NCT01281306|582627487|FG002|Overall Study|Adverse Event|2|||
160993731|NCT01599325|581365410|FG000|Extension Phase|Study Closure|1|||
161337697|NCT01281306|582627488|FG003|Overall Study|Adverse Event|3|||
161337698|NCT01281306|582627489|FG004|Overall Study|Adverse Event|5|||
160856826|NCT00713609|580866540|FG004|Overall Study|Withdrawal by Subject|5|||
160856827|NCT00713609|580866541|FG005|Overall Study|Withdrawal by Subject|7|||
160856828|NCT00713609|580866536|FG000|Overall Study|Protocol Violation|6|||
160856829|NCT00713609|580866537|FG001|Overall Study|Protocol Violation|3|||
160856830|NCT00713609|580866538|FG002|Overall Study|Protocol Violation|1|||
161255428|NCT04100096|582314160|FG000|Overall Study|Lack of Efficacy|0|||
161255429|NCT04100096|582314161|FG001|Overall Study|Lack of Efficacy|1|||
161255430|NCT04100096|582314160|FG000|Overall Study|Lost to Follow-up|13|||
161255431|NCT04100096|582314161|FG001|Overall Study|Lost to Follow-up|11|||
161255432|NCT04100096|582314160|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161255433|NCT04100096|582314161|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161255434|NCT04100096|582314160|FG000|Overall Study|Protocol Deviation|1|||
161255435|NCT04100096|582314161|FG001|Overall Study|Protocol Deviation|1|||
161255436|NCT04100096|582314160|FG000|Overall Study|Withdrawal by Participant|13|||
161255437|NCT04100096|582314161|FG001|Overall Study|Withdrawal by Participant|15|||
161255438|NCT01684215|582314162|FG000|Phase 1, Part 1|Adverse Event|1|||
161255439|NCT01684215|582314163|FG001|Phase 1, Part 1|Adverse Event|0|||
161255440|NCT01684215|582314164|FG002|Phase 1, Part 1|Adverse Event|0|||
161255441|NCT01684215|582314165|FG003|Phase 1, Part 1|Adverse Event|0|||
161255442|NCT01684215|582314162|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
161255443|NCT01684215|582314163|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
161255444|NCT01684215|582314164|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
161255445|NCT01684215|582314165|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
161255446|NCT01684215|582314162|FG000|Phase 1, Part 2|Adverse Event|0|||
161255447|NCT01684215|582314163|FG001|Phase 1, Part 2|Adverse Event|0|||
161255448|NCT01684215|582314164|FG002|Phase 1, Part 2|Adverse Event|1|||
161255449|NCT01684215|582314165|FG003|Phase 1, Part 2|Adverse Event|0|||
161255450|NCT01684215|582314162|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161255451|NCT01684215|582314163|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161255452|NCT01684215|582314164|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
161255453|NCT01684215|582314165|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
161255454|NCT01684215|582314162|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
161255455|NCT01684215|582314163|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
161255456|NCT01684215|582314164|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
161255457|NCT01684215|582314165|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
161255458|NCT01684215|582314162|FG000|Phase 2|Death|0|||
161255459|NCT01684215|582314163|FG001|Phase 2|Death|0|||
161255460|NCT01684215|582314164|FG002|Phase 2|Death|0|||
161255461|NCT01684215|582314165|FG003|Phase 2|Death|8|||
161255462|NCT01684215|582314162|FG000|Phase 2|Study terminated by sponsor|0|||
161255463|NCT01684215|582314163|FG001|Phase 2|Study terminated by sponsor|0|||
161255464|NCT01684215|582314164|FG002|Phase 2|Study terminated by sponsor|0|||
161255465|NCT01684215|582314165|FG003|Phase 2|Study terminated by sponsor|30|||
161255466|NCT01684215|582314162|FG000|Phase 2|Enrolled but not treated|0|||
161255467|NCT01684215|582314163|FG001|Phase 2|Enrolled but not treated|0|||
161255468|NCT01684215|582314164|FG002|Phase 2|Enrolled but not treated|0|||
161255469|NCT01684215|582314165|FG003|Phase 2|Enrolled but not treated|1|||
161255470|NCT01684215|582314162|FG000|Phase 2|Lost to Follow-up|0|||
161255471|NCT01684215|582314163|FG001|Phase 2|Lost to Follow-up|0|||
161337699|NCT01281306|582627490|FG005|Overall Study|Adverse Event|3|||
161337700|NCT01281306|582627491|FG006|Overall Study|Adverse Event|3|||
161337701|NCT01281306|582627485|FG000|Overall Study|Randomized in error|1|||
161337702|NCT01281306|582627486|FG001|Overall Study|Randomized in error|0|||
160856831|NCT00713609|580866539|FG003|Overall Study|Protocol Violation|1|||
160856832|NCT00713609|580866540|FG004|Overall Study|Protocol Violation|2|||
160856833|NCT00713609|580866541|FG005|Overall Study|Protocol Violation|0|||
160856834|NCT01791244|580866545|FG000|Overall Study|Adverse Event|5|||
160856835|NCT01791244|580866546|FG001|Overall Study|Adverse Event|7|||
160856836|NCT01791244|580866545|FG000|Overall Study|Insufficient clinical response|10|||
160856837|NCT01791244|580866546|FG001|Overall Study|Insufficient clinical response|10|||
160856838|NCT01791244|580866545|FG000|Overall Study|Laboratory Abnormality|0|||
160856839|NCT01791244|580866546|FG001|Overall Study|Laboratory Abnormality|1|||
160856840|NCT02358473|580866548|FG000|Overall Study|Disease Progession|6|||
160856841|NCT02358473|580866548|FG000|Overall Study|Adverse Event|3|||
160856842|NCT02358473|580866548|FG000|Overall Study|Withdrawal by Subject|2|||
160856843|NCT02358473|580866548|FG000|Overall Study|Physician Decision|2|||
160908195|NCT02820753|581058054|FG000|2 Month|Stopped per NIH Hold|51|||
161255472|NCT01684215|582314164|FG002|Phase 2|Lost to Follow-up|0|||
161255473|NCT01684215|582314165|FG003|Phase 2|Lost to Follow-up|4|||
161255474|NCT00480324|582314166|FG000|Overall Study|Adverse Event|1|||
161255475|NCT00480324|582314167|FG001|Overall Study|Adverse Event|1|||
161255476|NCT00480324|582314166|FG000|Overall Study|Protocol Violation|0|||
161255477|NCT00480324|582314167|FG001|Overall Study|Protocol Violation|1|||
161255478|NCT00480324|582314166|FG000|Overall Study|Withdrawal by Subject|14|||
161255479|NCT00480324|582314167|FG001|Overall Study|Withdrawal by Subject|5|||
161255480|NCT00480324|582314166|FG000|Overall Study|Lost to Follow-up|17|||
161255481|NCT00480324|582314167|FG001|Overall Study|Lost to Follow-up|8|||
161255482|NCT00480324|582314166|FG000|Overall Study|Subject's mother pregnant|0|||
161337703|NCT01281306|582627487|FG002|Overall Study|Randomized in error|0|||
161337704|NCT01281306|582627488|FG003|Overall Study|Randomized in error|1|||
161337705|NCT01281306|582627489|FG004|Overall Study|Randomized in error|0|||
161337706|NCT01281306|582627490|FG005|Overall Study|Randomized in error|0|||
161337707|NCT01281306|582627491|FG006|Overall Study|Randomized in error|0|||
161337708|NCT00368550|582627492|FG000|Overall Study|Adverse Event|7|||
161337709|NCT00368550|582627493|FG001|Overall Study|Adverse Event|4|||
161337710|NCT00368550|582627492|FG000|Overall Study|Lack of Efficacy|4|||
161337711|NCT00368550|582627493|FG001|Overall Study|Lack of Efficacy|9|||
161337712|NCT00368550|582627492|FG000|Overall Study|Withdrawal by Subject|17|||
161337713|NCT00368550|582627493|FG001|Overall Study|Withdrawal by Subject|10|||
161337714|NCT01192815|582627494|FG000|Overall Study|Withdrawal by Subject|1|||
161337715|NCT01192815|582627494|FG000|Overall Study|Lack of Efficacy|1|||
161337716|NCT03451045|582627495|FG000|Overall Study|Lack of Efficacy|3|||
161337717|NCT03451045|582627496|FG001|Overall Study|Lack of Efficacy|2|||
161337718|NCT03451045|582627497|FG002|Overall Study|Lack of Efficacy|2|||
161337719|NCT03451045|582627495|FG000|Overall Study|Physician Decision|1|||
161337720|NCT03451045|582627496|FG001|Overall Study|Physician Decision|1|||
161337721|NCT03451045|582627497|FG002|Overall Study|Physician Decision|1|||
161337722|NCT03451045|582627495|FG000|Overall Study|Withdrawal by Subject|4|||
161337723|NCT03451045|582627496|FG001|Overall Study|Withdrawal by Subject|0|||
161337724|NCT03451045|582627497|FG002|Overall Study|Withdrawal by Subject|5|||
161337725|NCT03451045|582627495|FG000|Overall Study|Pregnancy|0|||
161337726|NCT03451045|582627496|FG001|Overall Study|Pregnancy|0|||
161337727|NCT03451045|582627497|FG002|Overall Study|Pregnancy|2|||
161337728|NCT03451045|582627495|FG000|Overall Study|Adverse Event|7|||
161337729|NCT03451045|582627496|FG001|Overall Study|Adverse Event|1|||
161337730|NCT03451045|582627497|FG002|Overall Study|Adverse Event|3|||
161337731|NCT03451045|582627495|FG000|Overall Study|Non-compliance with study|2|||
161337732|NCT03451045|582627496|FG001|Overall Study|Non-compliance with study|0|||
161337733|NCT03451045|582627497|FG002|Overall Study|Non-compliance with study|1|||
161337734|NCT03451045|582627495|FG000|Overall Study|any other reason|10|||
161337735|NCT03451045|582627496|FG001|Overall Study|any other reason|2|||
161337736|NCT03451045|582627497|FG002|Overall Study|any other reason|13|||
161337737|NCT00863707|582627498|FG000|Overall Study|Randomized, but drug not received|4|||
161337738|NCT00863707|582627499|FG001|Overall Study|Randomized, but drug not received|3|||
161337739|NCT00830128|582627500|FG000|Overall Study|Adverse Event|5|||
161337740|NCT00830128|582627500|FG000|Overall Study|Lack of Efficacy|7|||
161337741|NCT00830128|582627500|FG000|Overall Study|Protocol Violation|1|||
161337742|NCT00830128|582627500|FG000|Overall Study|Withdrawal by Subject|2|||
161337743|NCT00830128|582627500|FG000|Overall Study|Family obligation|1|||
161337744|NCT00830128|582627500|FG000|Overall Study|Relocation|1|||
161337745|NCT00830128|582627500|FG000|Overall Study|Work obligation|1|||
161337746|NCT00830128|582627500|FG000|Overall Study|Operating a vehicle|1|||
161337747|NCT01123655|582627503|FG000|Overall Study|Medication for RA had to be changed|1|||
161337748|NCT01123655|582627504|FG001|Overall Study|Medication for RA had to be changed|0|||
161337749|NCT01123655|582627505|FG002|Overall Study|Medication for RA had to be changed|0|||
161337750|NCT01123655|582627503|FG000|Overall Study|new illness|0|||
161337751|NCT01123655|582627504|FG001|Overall Study|new illness|1|||
161337752|NCT01123655|582627505|FG002|Overall Study|new illness|0|||
161337753|NCT01123655|582627503|FG000|Overall Study|began prohibitive drug|0|||
161337754|NCT01123655|582627504|FG001|Overall Study|began prohibitive drug|0|||
161337755|NCT01123655|582627505|FG002|Overall Study|began prohibitive drug|1|||
161337756|NCT05063448|582627510|FG000|Overall Study|Withdrawal by Subject|1|||
161337757|NCT02475369|582627514|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
161337758|NCT02475369|582627515|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
161337759|NCT03329885|582627521|FG000|Overall Study|Sponsor discontinued the study early|0|||
161337760|NCT03329885|582627522|FG001|Overall Study|Sponsor discontinued the study early|0|||
161337761|NCT03329885|582627523|FG002|Overall Study|Sponsor discontinued the study early|0|||
161337762|NCT03329885|582627524|FG003|Overall Study|Sponsor discontinued the study early|0|||
161337763|NCT03329885|582627525|FG004|Overall Study|Sponsor discontinued the study early|0|||
161337764|NCT03329885|582627526|FG005|Overall Study|Sponsor discontinued the study early|0|||
161337765|NCT03329885|582627527|FG006|Overall Study|Sponsor discontinued the study early|1|||
161337766|NCT03329885|582627528|FG007|Overall Study|Sponsor discontinued the study early|1|||
161337767|NCT03329885|582627529|FG008|Overall Study|Sponsor discontinued the study early|0|||
160856844|NCT00703014|580866551|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
160856845|NCT00703014|580866552|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
160856846|NCT00703014|580866553|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160908196|NCT02820753|581058055|FG001|2 Month|Stopped per NIH Hold|13|||
161337768|NCT01991795|582627530|FG000|Overall Study|Lost to Follow-up|6|||
161337769|NCT01991795|582627531|FG001|Overall Study|Lost to Follow-up|4|||
161337770|NCT01991795|582627530|FG000|Overall Study|Withdrawal by Subject|117|||
161337771|NCT01991795|582627531|FG001|Overall Study|Withdrawal by Subject|94|||
161337772|NCT01991795|582627530|FG000|Overall Study|Site prematurely closed by sponsor|26|||
161337773|NCT01991795|582627531|FG001|Overall Study|Site prematurely closed by sponsor|25|||
161337774|NCT01981616|582627533|FG000|Overall Study|Adverse Event|0|||
161337775|NCT01981616|582627534|FG001|Overall Study|Adverse Event|1|||
161337776|NCT01981616|582627533|FG000|Overall Study|Protocol Violation|1|||
161337777|NCT01981616|582627534|FG001|Overall Study|Protocol Violation|0|||
161337778|NCT03641508|582627535|FG000|First Injection|Lost to Follow-up|2|||
161337779|NCT03641508|582627536|FG001|First Injection|Lost to Follow-up|0|||
161337780|NCT02404545|582627537|FG000|Overall Study|Sponsor Termination|6|||
161337781|NCT02404545|582627538|FG001|Overall Study|Sponsor Termination|6|||
161337782|NCT00094445|582627539|FG000|Overall Study|Withdrawal by Subject|3|||
161337783|NCT00094445|582627539|FG000|Overall Study|Lost to Follow-up|1|||
161337784|NCT00094445|582627539|FG000|Overall Study|Progressive Disease|2|||
161337785|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
161337786|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
161337787|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
161337788|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
161337789|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
161337790|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
161337791|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
161337792|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161337793|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161337794|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
161337795|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
161337796|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
161337797|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161337798|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161337799|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
161337800|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
161337801|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
161337802|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161337803|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161337804|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
161337805|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
161337806|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
161337807|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161337808|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161337809|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
161337810|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
161337811|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
161337812|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161337813|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161337814|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
161337815|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
161337816|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
161337817|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161337818|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161337819|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
161337820|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
161337821|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
161337822|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161337823|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161337824|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
161337825|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
161337826|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161337827|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161337828|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161337829|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
161337830|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
161337831|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
161337832|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
161337833|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
160856847|NCT00703014|580866554|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160856848|NCT00703014|580866551|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160856849|NCT00703014|580866552|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
160862054|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161337834|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
161337835|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
161337836|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
161337837|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
161337838|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
161337839|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
161337840|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
161337841|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161337842|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161337843|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161337844|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
161337845|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
161337846|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161337847|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161337848|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161337849|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
161337850|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161337851|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
161337852|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161337853|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161337854|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
161337855|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
161337856|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
161337857|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
161337858|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
161337859|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
161337860|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161337861|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
161337862|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161337863|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161337864|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
161337865|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
161337866|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161337867|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161337868|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161337869|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
161337870|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161337871|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
161337872|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161337873|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161337874|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
161337875|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
161337876|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161337877|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161337878|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161337879|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
161337880|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161337881|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
161337882|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161337883|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161337884|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
161337885|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
161337886|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161337887|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161337888|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
161337889|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
160908197|NCT02820753|581058054|FG000|6 Month|Withdrawal by Subject|2|||
160908198|NCT02820753|581058055|FG001|6 Month|Withdrawal by Subject|2|||
160908199|NCT02820753|581058054|FG000|6 Month|Lost to Follow-up|20|||
160908200|NCT02820753|581058055|FG001|6 Month|Lost to Follow-up|27|||
160908201|NCT02820753|581058054|FG000|6 Month|Stopped per NIH Hold|81|||
160908202|NCT02820753|581058055|FG001|6 Month|Stopped per NIH Hold|81|||
160908203|NCT02820753|581058054|FG000|6 Month|Death|0|||
160908204|NCT02820753|581058055|FG001|6 Month|Death|1|||
160908205|NCT00790023|581058056|FG000|Overall Study|Adverse Event|2|||
160908206|NCT00790023|581058057|FG001|Overall Study|Adverse Event|1|||
160908207|NCT00790023|581058058|FG002|Overall Study|Adverse Event|4|||
160908208|NCT00790023|581058056|FG000|Overall Study|Protocol Violation|2|||
160908209|NCT00790023|581058057|FG001|Overall Study|Protocol Violation|4|||
160908210|NCT00790023|581058058|FG002|Overall Study|Protocol Violation|2|||
160908211|NCT00790023|581058056|FG000|Overall Study|Withdrawal by Subject|2|||
160908212|NCT00790023|581058057|FG001|Overall Study|Withdrawal by Subject|0|||
160908213|NCT00790023|581058058|FG002|Overall Study|Withdrawal by Subject|6|||
160908214|NCT00790023|581058056|FG000|Overall Study|Lost to Follow-up|0|||
160908215|NCT00790023|581058057|FG001|Overall Study|Lost to Follow-up|0|||
160908216|NCT00790023|581058058|FG002|Overall Study|Lost to Follow-up|1|||
160908217|NCT00790023|581058056|FG000|Overall Study|Other|5|||
160908218|NCT00790023|581058057|FG001|Overall Study|Other|5|||
160908219|NCT00790023|581058058|FG002|Overall Study|Other|8|||
160908220|NCT02468414|581058059|FG000|Overall Study|Early Study Termination by Sponsor|1|||
160908221|NCT02468414|581058060|FG001|Overall Study|Early Study Termination by Sponsor|0|||
160908222|NCT02468414|581058059|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
160908223|NCT02468414|581058060|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
160908224|NCT02468414|581058059|FG000|Overall Study|Screen Failure|1|||
160908225|NCT02468414|581058060|FG001|Overall Study|Screen Failure|0|||
160908226|NCT01338792|581058061|FG000|Overall Study|Adverse Event|2|||
160908227|NCT01338792|581058061|FG000|Overall Study|Death|1|||
160908228|NCT01338792|581058061|FG000|Overall Study|Withdrawal by Subject|1|||
160908229|NCT01652703|581058062|FG000|Overall Study|Withdrawal by Subject|0|||
160908230|NCT01652703|581058063|FG001|Overall Study|Withdrawal by Subject|1|||
160908231|NCT01652703|581058064|FG002|Overall Study|Withdrawal by Subject|3|||
160908232|NCT01652703|581058065|FG003|Overall Study|Withdrawal by Subject|1|||
160908233|NCT01652703|581058066|FG004|Overall Study|Withdrawal by Subject|0|||
160908234|NCT01652703|581058067|FG005|Overall Study|Withdrawal by Subject|1|||
160908235|NCT01652703|581058062|FG000|Overall Study|Other|0|||
160908236|NCT01652703|581058063|FG001|Overall Study|Other|0|||
160908237|NCT01652703|581058064|FG002|Overall Study|Other|0|||
160908238|NCT01652703|581058065|FG003|Overall Study|Other|1|||
160908239|NCT01652703|581058066|FG004|Overall Study|Other|1|||
160908240|NCT01652703|581058067|FG005|Overall Study|Other|1|||
160908241|NCT00062374|581058068|FG000|Overall Study|Not treated|12|||
160908242|NCT02151591|581058069|FG000|Overall Study|Lost to Follow-up|6|||
160908243|NCT02151591|581058070|FG001|Overall Study|Lost to Follow-up|3|||
160908244|NCT05035550|581058076|FG000|Overall Study|Withdrawal by Subject|3|||
160908245|NCT05035550|581058077|FG001|Overall Study|Withdrawal by Subject|0|||
160908246|NCT00617123|581058080|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
160908247|NCT00617123|581058081|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
160908248|NCT00617123|581058080|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
160908249|NCT00617123|581058081|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
160908250|NCT00617123|581058080|FG000|Referral Screening Period|Adverse Event|0|||
160908251|NCT00617123|581058081|FG001|Referral Screening Period|Adverse Event|1|||
160908252|NCT00617123|581058080|FG000|Study Treatment Period|Withdrawal by Subject|8|||
160908253|NCT00617123|581058081|FG001|Study Treatment Period|Withdrawal by Subject|12|||
160908254|NCT00617123|581058080|FG000|Study Treatment Period|Adverse Event|7|||
160908255|NCT00617123|581058081|FG001|Study Treatment Period|Adverse Event|3|||
160908256|NCT00617123|581058080|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
160908257|NCT00617123|581058081|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
160908258|NCT00617123|581058080|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
160908259|NCT00617123|581058081|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
160908260|NCT00777608|581058083|FG000|Overall Study|Lost to Follow-up|1|||
160908261|NCT00777608|581058084|FG001|Overall Study|Lost to Follow-up|1|||
160908262|NCT00777608|581058083|FG000|Overall Study|Withdrawal by Subject|1|||
160908263|NCT00777608|581058084|FG001|Overall Study|Withdrawal by Subject|3|||
160908264|NCT00777608|581058083|FG000|Overall Study|Protocol Violation|1|||
160908265|NCT00777608|581058084|FG001|Overall Study|Protocol Violation|0|||
160908266|NCT00777608|581058083|FG000|Overall Study|Investigator Decision|1|||
160908267|NCT00777608|581058084|FG001|Overall Study|Investigator Decision|2|||
160993732|NCT01599325|581365410|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
160993733|NCT01599325|581365410|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
160993734|NCT01599325|581365410|FG000|Extension Phase|Disease Progression|1|||
160993735|NCT01599325|581365410|FG000|Extension Phase|Withdrawal by Subject|8|||
160993736|NCT02365298|581365413|FG000|Period 2|incorrect Rx dispensed|1|||
160993737|NCT02365298|581365414|FG001|Period 2|incorrect Rx dispensed|0|||
160993738|NCT02365298|581365413|FG000|Period 2|Discontinued at request of Sponsor|1|||
160993739|NCT02365298|581365414|FG001|Period 2|Discontinued at request of Sponsor|0|||
160908268|NCT04213079|581058085|FG000|Overall Study|Lost to Follow-up|0|||
160908269|NCT04213079|581058086|FG001|Overall Study|Lost to Follow-up|2|||
160908270|NCT00520936|581058088|FG000|Overall Study|Physician Decision|0|||
160908271|NCT00520936|581058089|FG001|Overall Study|Physician Decision|2|||
160908272|NCT00520936|581058090|FG002|Overall Study|Physician Decision|1|||
160993740|NCT02365298|581365413|FG000|Period 2|Test Article longer available|0|||
160993741|NCT02365298|581365414|FG001|Period 2|Test Article longer available|1|||
160993742|NCT02365298|581365413|FG000|Period 2|Protocol Violation|0|||
160993743|NCT02365298|581365414|FG001|Period 2|Protocol Violation|1|||
160993744|NCT02846415|581365419|FG000|Overall Study|Lost to Follow-up|2|||
160993745|NCT02846415|581365420|FG001|Overall Study|Lost to Follow-up|0|||
160993746|NCT02846415|581365419|FG000|Overall Study|Withdrawal by Subject|1|||
160993747|NCT02846415|581365420|FG001|Overall Study|Withdrawal by Subject|1|||
160993748|NCT00567164|581365421|FG000|Overall Study|Withdrawal by Subject|171|||
160993749|NCT00567164|581365422|FG001|Overall Study|Withdrawal by Subject|21|||
160993750|NCT00567164|581365423|FG002|Overall Study|Withdrawal by Subject|17|||
160993751|NCT00567164|581365421|FG000|Overall Study|Protocol Violation|23|||
160993752|NCT00567164|581365422|FG001|Overall Study|Protocol Violation|4|||
160993753|NCT00567164|581365423|FG002|Overall Study|Protocol Violation|2|||
160993754|NCT00567164|581365421|FG000|Overall Study|Adverse Event|92|||
160993755|NCT00567164|581365422|FG001|Overall Study|Adverse Event|13|||
160993756|NCT00567164|581365423|FG002|Overall Study|Adverse Event|9|||
160993757|NCT00567164|581365421|FG000|Overall Study|Death|0|||
160993758|NCT00567164|581365422|FG001|Overall Study|Death|0|||
160993759|NCT00567164|581365423|FG002|Overall Study|Death|1|||
160993760|NCT00567164|581365421|FG000|Overall Study|Lost to Follow-up|202|||
160993761|NCT00567164|581365422|FG001|Overall Study|Lost to Follow-up|23|||
160993762|NCT00567164|581365423|FG002|Overall Study|Lost to Follow-up|21|||
160993763|NCT00567164|581365421|FG000|Overall Study|Pregnancy|20|||
160993764|NCT00567164|581365422|FG001|Overall Study|Pregnancy|4|||
160993765|NCT00567164|581365423|FG002|Overall Study|Pregnancy|6|||
160993766|NCT00567164|581365421|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
160993767|NCT00567164|581365422|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
160993768|NCT00567164|581365423|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
160993769|NCT00567164|581365421|FG000|Overall Study|Missing|1|||
160993770|NCT00567164|581365422|FG001|Overall Study|Missing|0|||
160993771|NCT00567164|581365423|FG002|Overall Study|Missing|0|||
160993772|NCT03381274|581365430|FG000|Overall Study|Death|2|||
160993773|NCT03381274|581365431|FG001|Overall Study|Death|9|||
160993774|NCT03381274|581365432|FG002|Overall Study|Death|3|||
160993775|NCT03381274|581365433|FG003|Overall Study|Death|2|||
160993776|NCT03381274|581365434|FG004|Overall Study|Death|3|||
160993777|NCT03381274|581365430|FG000|Overall Study|Lost to Follow-up|0|||
160993778|NCT03381274|581365431|FG001|Overall Study|Lost to Follow-up|0|||
160993779|NCT03381274|581365432|FG002|Overall Study|Lost to Follow-up|0|||
160993780|NCT03381274|581365433|FG003|Overall Study|Lost to Follow-up|1|||
160993781|NCT03381274|581365434|FG004|Overall Study|Lost to Follow-up|0|||
160993782|NCT03381274|581365430|FG000|Overall Study|Withdrawal by Subject|2|||
160993783|NCT03381274|581365431|FG001|Overall Study|Withdrawal by Subject|1|||
160993784|NCT03381274|581365432|FG002|Overall Study|Withdrawal by Subject|3|||
160993785|NCT03381274|581365433|FG003|Overall Study|Withdrawal by Subject|1|||
160993786|NCT03381274|581365434|FG004|Overall Study|Withdrawal by Subject|0|||
160993787|NCT03381274|581365430|FG000|Overall Study|Other|1|||
160993788|NCT03381274|581365431|FG001|Overall Study|Other|11|||
160993789|NCT03381274|581365432|FG002|Overall Study|Other|0|||
160993790|NCT03381274|581365433|FG003|Overall Study|Other|2|||
160993791|NCT03381274|581365434|FG004|Overall Study|Other|2|||
160993792|NCT02081391|581365435|FG000|12-hour Treatment|Withdrawal by Subject|3|||
160993793|NCT02081391|581365436|FG001|12-hour Treatment|Withdrawal by Subject|2|||
160993794|NCT02081391|581365437|FG002|12-hour Treatment|Withdrawal by Subject|0|||
160993795|NCT02081391|581365438|FG003|12-hour Treatment|Withdrawal by Subject|0|||
160993796|NCT02081391|581365435|FG000|12-hour Treatment|Physician Decision|4|||
160993797|NCT02081391|581365436|FG001|12-hour Treatment|Physician Decision|1|||
160993798|NCT02081391|581365437|FG002|12-hour Treatment|Physician Decision|0|||
160993799|NCT02081391|581365438|FG003|12-hour Treatment|Physician Decision|0|||
160993800|NCT02081391|581365435|FG000|12-hour Treatment|Lack of Efficacy|3|||
160993801|NCT02081391|581365436|FG001|12-hour Treatment|Lack of Efficacy|0|||
160993802|NCT02081391|581365437|FG002|12-hour Treatment|Lack of Efficacy|0|||
160993803|NCT02081391|581365438|FG003|12-hour Treatment|Lack of Efficacy|0|||
160993804|NCT02081391|581365435|FG000|12-hour Treatment|Adverse Event|4|||
161255483|NCT00480324|582314167|FG001|Overall Study|Subject's mother pregnant|1|||
160993805|NCT02081391|581365436|FG001|12-hour Treatment|Adverse Event|2|||
160993806|NCT02081391|581365437|FG002|12-hour Treatment|Adverse Event|0|||
160993807|NCT02081391|581365438|FG003|12-hour Treatment|Adverse Event|0|||
160993808|NCT02081391|581365435|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
160993809|NCT02081391|581365436|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
160993810|NCT02081391|581365437|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
160993811|NCT02081391|581365438|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
160993812|NCT02081391|581365435|FG000|12-hour Treatment|Further reasons|2|||
160993813|NCT02081391|581365436|FG001|12-hour Treatment|Further reasons|1|||
160993814|NCT02081391|581365437|FG002|12-hour Treatment|Further reasons|0|||
160993815|NCT02081391|581365438|FG003|12-hour Treatment|Further reasons|0|||
160993816|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
160993817|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
161337890|NCT02717195|582627540|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
161337891|NCT02717195|582627541|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161337892|NCT02717195|582627542|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161337893|NCT02717195|582627543|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161337894|NCT02717195|582627544|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
161337895|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
161337896|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
161337897|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
161337898|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
161337899|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
161337900|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
161337901|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
161337902|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
161337903|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
161337904|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
161337905|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
161337906|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
161337907|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
161337908|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
161337909|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
161337910|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161337911|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161337912|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
161337913|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
161337914|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
161337915|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161337916|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161337917|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
161337918|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
161337919|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
161337920|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161337921|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161337922|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
161337923|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
161337924|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
161337925|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161337926|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161337927|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
161337928|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161337929|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
161337930|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
161337931|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
161337932|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
161337933|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
161337934|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
161337935|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161337936|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161337937|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
161337938|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
161337939|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
161337940|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161337941|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161337942|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161337943|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
161337944|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
161337945|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
161337946|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
161337947|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
161337948|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
161337949|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
161337950|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
160856850|NCT00703014|580866553|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
160856851|NCT00703014|580866554|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
160856852|NCT04949191|580866555|FG000|Overall Study|Non-compliance with Study Drug|1|||
160908273|NCT00520936|581058091|FG003|Overall Study|Physician Decision|0|||
160908274|NCT00520936|581058092|FG004|Overall Study|Physician Decision|0|||
160908275|NCT00520936|581058093|FG005|Overall Study|Physician Decision|0|||
160908276|NCT00520936|581058094|FG006|Overall Study|Physician Decision|0|||
160908277|NCT00520936|581058095|FG007|Overall Study|Physician Decision|0|||
160908278|NCT00520936|581058088|FG000|Overall Study|Withdrawal by Subject|0|||
160908279|NCT00520936|581058089|FG001|Overall Study|Withdrawal by Subject|0|||
160908280|NCT00520936|581058090|FG002|Overall Study|Withdrawal by Subject|0|||
160908281|NCT00520936|581058091|FG003|Overall Study|Withdrawal by Subject|0|||
160908282|NCT00520936|581058092|FG004|Overall Study|Withdrawal by Subject|0|||
160908283|NCT00520936|581058093|FG005|Overall Study|Withdrawal by Subject|0|||
160908284|NCT00520936|581058094|FG006|Overall Study|Withdrawal by Subject|0|||
160908285|NCT00520936|581058095|FG007|Overall Study|Withdrawal by Subject|1|||
160908286|NCT00520936|581058088|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
160908287|NCT00520936|581058089|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
160908288|NCT00520936|581058090|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
160908289|NCT00520936|581058091|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
160908290|NCT00520936|581058092|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
160908291|NCT00520936|581058093|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
160908292|NCT00520936|581058094|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
160908293|NCT00520936|581058095|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
160908294|NCT00520936|581058088|FG000|Overall Study|Death|0|||
160908295|NCT00520936|581058089|FG001|Overall Study|Death|0|||
160908296|NCT00520936|581058090|FG002|Overall Study|Death|0|||
160908297|NCT00520936|581058091|FG003|Overall Study|Death|0|||
160908298|NCT00520936|581058092|FG004|Overall Study|Death|0|||
160908299|NCT00520936|581058093|FG005|Overall Study|Death|0|||
160908300|NCT00520936|581058094|FG006|Overall Study|Death|1|||
160908301|NCT00520936|581058095|FG007|Overall Study|Death|0|||
160908302|NCT00520936|581058088|FG000|Overall Study|Protocol Violation|0|||
160908303|NCT00520936|581058089|FG001|Overall Study|Protocol Violation|1|||
160908304|NCT00520936|581058090|FG002|Overall Study|Protocol Violation|1|||
160908305|NCT00520936|581058091|FG003|Overall Study|Protocol Violation|0|||
160908306|NCT00520936|581058092|FG004|Overall Study|Protocol Violation|1|||
160908307|NCT00520936|581058093|FG005|Overall Study|Protocol Violation|0|||
160908308|NCT00520936|581058094|FG006|Overall Study|Protocol Violation|1|||
160908309|NCT00520936|581058095|FG007|Overall Study|Protocol Violation|0|||
160908310|NCT01061177|581058099|FG000|Overall Study|Adverse Event|117|||
160908311|NCT01061177|581058099|FG000|Overall Study|Withdrawal by Subject|27|||
160908312|NCT01061177|581058099|FG000|Overall Study|Disease progression|17|||
160908313|NCT01061177|581058099|FG000|Overall Study|Protocol Violation|11|||
160908314|NCT01061177|581058099|FG000|Overall Study|Lost to Follow-up|9|||
160908315|NCT01061177|581058099|FG000|Overall Study|New cancer therapy|9|||
160908316|NCT01061177|581058099|FG000|Overall Study|Abnormal laboratory values|6|||
160908317|NCT01061177|581058099|FG000|Overall Study|Abnormal test procedure results|4|||
160908318|NCT01061177|581058099|FG000|Overall Study|Administratie problems|4|||
160908319|NCT01061177|581058099|FG000|Overall Study|Death|4|||
160908320|NCT03616600|581058100|FG000|Overall Study|Withdrawal by Subject|1|||
160908321|NCT03616600|581058101|FG001|Overall Study|Withdrawal by Subject|0|||
160908322|NCT03984994|581058102|FG000|Overall Study|Withdrawal by Subject|2|||
160908323|NCT03984994|581058103|FG001|Overall Study|Withdrawal by Subject|1|||
160908324|NCT03010176|581058105|FG000|Overall Study|Death|21|||
160908325|NCT03010176|581058106|FG001|Overall Study|Death|35|||
160908326|NCT03010176|581058107|FG002|Overall Study|Death|19|||
160908327|NCT03010176|581058108|FG003|Overall Study|Death|19|||
160908328|NCT03010176|581058109|FG004|Overall Study|Death|14|||
160908329|NCT03010176|581058110|FG005|Overall Study|Death|0|||
160908330|NCT03010176|581058105|FG000|Overall Study|Lost to Follow-up|0|||
160908331|NCT03010176|581058106|FG001|Overall Study|Lost to Follow-up|0|||
160908332|NCT03010176|581058107|FG002|Overall Study|Lost to Follow-up|0|||
160908333|NCT03010176|581058108|FG003|Overall Study|Lost to Follow-up|0|||
160908334|NCT03010176|581058109|FG004|Overall Study|Lost to Follow-up|1|||
160908335|NCT03010176|581058110|FG005|Overall Study|Lost to Follow-up|0|||
160908336|NCT03010176|581058105|FG000|Overall Study|Physician Decision|0|||
160908337|NCT03010176|581058106|FG001|Overall Study|Physician Decision|4|||
160908338|NCT03010176|581058107|FG002|Overall Study|Physician Decision|0|||
160908339|NCT03010176|581058108|FG003|Overall Study|Physician Decision|1|||
160908340|NCT03010176|581058109|FG004|Overall Study|Physician Decision|0|||
160908341|NCT03010176|581058110|FG005|Overall Study|Physician Decision|0|||
160908342|NCT03010176|581058105|FG000|Overall Study|Sponsor Decision|0|||
160908343|NCT03010176|581058106|FG001|Overall Study|Sponsor Decision|4|||
160908344|NCT03010176|581058107|FG002|Overall Study|Sponsor Decision|4|||
160993818|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
160908345|NCT03010176|581058108|FG003|Overall Study|Sponsor Decision|1|||
160908346|NCT03010176|581058109|FG004|Overall Study|Sponsor Decision|6|||
160908347|NCT03010176|581058110|FG005|Overall Study|Sponsor Decision|0|||
160908348|NCT03010176|581058105|FG000|Overall Study|Withdrawal by Subject|11|||
160908349|NCT03010176|581058106|FG001|Overall Study|Withdrawal by Subject|9|||
160908350|NCT03010176|581058107|FG002|Overall Study|Withdrawal by Subject|3|||
161337951|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161337952|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161337953|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
161337954|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
161337955|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161337956|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161337957|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
161337958|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161337959|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
161337960|NCT02717195|582627540|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161337961|NCT02717195|582627541|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161337962|NCT02717195|582627542|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
161337963|NCT02717195|582627543|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
161337964|NCT02717195|582627544|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
161337965|NCT02078817|582627545|FG000|Overall Study|Withdrawal by Subject|1|||
161337966|NCT00855218|582627546|FG000|Overall Study|Adverse Event|43|||
161337967|NCT00855218|582627547|FG001|Overall Study|Adverse Event|27|||
161337968|NCT00855218|582627546|FG000|Overall Study|Withdrawal by Subject|10|||
161337969|NCT00855218|582627547|FG001|Overall Study|Withdrawal by Subject|6|||
161337970|NCT00855218|582627546|FG000|Overall Study|Physician Decision|18|||
161337971|NCT00855218|582627547|FG001|Overall Study|Physician Decision|11|||
161337972|NCT00855218|582627546|FG000|Overall Study|Lost to Follow-up|0|||
161337973|NCT00855218|582627547|FG001|Overall Study|Lost to Follow-up|1|||
161337974|NCT00855218|582627546|FG000|Overall Study|Protocol Violation|5|||
161337975|NCT00855218|582627547|FG001|Overall Study|Protocol Violation|9|||
161337976|NCT00855218|582627546|FG000|Overall Study|non-compliant with study drug|3|||
161337977|NCT00855218|582627547|FG001|Overall Study|non-compliant with study drug|1|||
160993819|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
160993820|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
160993821|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
160993822|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
160993823|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
160993824|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
160993825|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
160993826|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
160993827|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
160993828|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
160993829|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
160993830|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
160993831|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
160993832|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
160993833|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
160993834|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
160993835|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
160993836|NCT02081391|581365435|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
160993837|NCT02081391|581365436|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
160993838|NCT02081391|581365437|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
160993839|NCT02081391|581365438|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
160993840|NCT01458275|581365439|FG000|Overall Study|Adverse Event|3|||
160993841|NCT01458275|581365440|FG001|Overall Study|Adverse Event|4|||
160993842|NCT01458275|581365441|FG002|Overall Study|Adverse Event|1|||
160993843|NCT01458275|581365439|FG000|Overall Study|Lost to Follow-up|3|||
160993844|NCT01458275|581365440|FG001|Overall Study|Lost to Follow-up|2|||
160993845|NCT01458275|581365441|FG002|Overall Study|Lost to Follow-up|5|||
160993846|NCT01458275|581365439|FG000|Overall Study|Protocol Violation|5|||
160993847|NCT01458275|581365440|FG001|Overall Study|Protocol Violation|5|||
160993848|NCT01458275|581365441|FG002|Overall Study|Protocol Violation|2|||
160993849|NCT01458275|581365439|FG000|Overall Study|Withdrawal by Subject|3|||
160993850|NCT01458275|581365440|FG001|Overall Study|Withdrawal by Subject|2|||
160993851|NCT01458275|581365441|FG002|Overall Study|Withdrawal by Subject|1|||
161141475|NCT01009463|581902514|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161141476|NCT01009463|581902515|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
161141477|NCT01009463|581902511|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
161337978|NCT00855218|582627546|FG000|Overall Study|patient convenience|2|||
161337979|NCT00855218|582627547|FG001|Overall Study|patient convenience|0|||
161337980|NCT00855218|582627546|FG000|Overall Study|technical problems|2|||
161141478|NCT01009463|581902512|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
160993852|NCT00751036|581365443|FG000|Overall Study|Disease Progression|28|||
160993853|NCT00751036|581365444|FG001|Overall Study|Disease Progression|29|||
161337981|NCT00855218|582627547|FG001|Overall Study|technical problems|1|||
161337982|NCT00855218|582627546|FG000|Overall Study|Still treated with study medication|0|||
161337983|NCT00855218|582627547|FG001|Overall Study|Still treated with study medication|1|||
161337984|NCT00855218|582627546|FG000|Overall Study|Untreatable disease progression|54|||
161337985|NCT00855218|582627547|FG001|Overall Study|Untreatable disease progression|67|||
161337986|NCT00855218|582627546|FG000|Overall Study|Second malignancy|0|||
161337987|NCT00855218|582627547|FG001|Overall Study|Second malignancy|1|||
161337988|NCT00855218|582627546|FG000|Overall Study|Progression measurement proven|7|||
161337989|NCT00855218|582627547|FG001|Overall Study|Progression measurement proven|15|||
161337990|NCT00855218|582627546|FG000|Overall Study|Clinical endpoint reached|10|||
161337991|NCT00855218|582627547|FG001|Overall Study|Clinical endpoint reached|13|||
161337992|NCT00769561|582627549|FG000|Overall Study|Withdrawal by Subject|2|||
161337993|NCT00769561|582627550|FG001|Overall Study|Withdrawal by Subject|2|||
161337994|NCT00769561|582627549|FG000|Overall Study|Lost to Follow-up|1|||
161337995|NCT00769561|582627550|FG001|Overall Study|Lost to Follow-up|3|||
161337996|NCT03824561|582627553|FG000|Overall Study|Protocol Violation|19|||
161337997|NCT01773928|582627554|FG000|Overall Study|Adverse Event|0|||
161337998|NCT01773928|582627555|FG001|Overall Study|Adverse Event|0|||
161337999|NCT01773928|582627556|FG002|Overall Study|Adverse Event|0|||
161338000|NCT01773928|582627557|FG003|Overall Study|Adverse Event|0|||
161338001|NCT01773928|582627558|FG004|Overall Study|Adverse Event|0|||
161338002|NCT01773928|582627559|FG005|Overall Study|Adverse Event|0|||
161338003|NCT01773928|582627560|FG006|Overall Study|Adverse Event|0|||
161338004|NCT01773928|582627561|FG007|Overall Study|Adverse Event|1|||
161338005|NCT01773928|582627562|FG008|Overall Study|Adverse Event|0|||
161338006|NCT01773928|582627554|FG000|Overall Study|Physician Decision|0|||
161338007|NCT01773928|582627555|FG001|Overall Study|Physician Decision|0|||
161338008|NCT01773928|582627556|FG002|Overall Study|Physician Decision|0|||
161338009|NCT01773928|582627557|FG003|Overall Study|Physician Decision|1|||
161338010|NCT01773928|582627558|FG004|Overall Study|Physician Decision|0|||
161338011|NCT01773928|582627559|FG005|Overall Study|Physician Decision|0|||
161338012|NCT01773928|582627560|FG006|Overall Study|Physician Decision|0|||
161338013|NCT01773928|582627561|FG007|Overall Study|Physician Decision|0|||
161338014|NCT01773928|582627562|FG008|Overall Study|Physician Decision|0|||
161338015|NCT01773928|582627554|FG000|Overall Study|Withdrawal by Subject|5|||
161338016|NCT01773928|582627555|FG001|Overall Study|Withdrawal by Subject|4|||
161338017|NCT01773928|582627556|FG002|Overall Study|Withdrawal by Subject|4|||
161338018|NCT01773928|582627557|FG003|Overall Study|Withdrawal by Subject|4|||
161338019|NCT01773928|582627558|FG004|Overall Study|Withdrawal by Subject|7|||
161338020|NCT01773928|582627559|FG005|Overall Study|Withdrawal by Subject|1|||
161338021|NCT01773928|582627560|FG006|Overall Study|Withdrawal by Subject|0|||
161338022|NCT01773928|582627561|FG007|Overall Study|Withdrawal by Subject|0|||
161338023|NCT01773928|582627562|FG008|Overall Study|Withdrawal by Subject|1|||
161338024|NCT01773928|582627554|FG000|Overall Study|Lost to Follow-up|0|||
161338025|NCT01773928|582627555|FG001|Overall Study|Lost to Follow-up|0|||
161338026|NCT01773928|582627556|FG002|Overall Study|Lost to Follow-up|0|||
161338027|NCT01773928|582627557|FG003|Overall Study|Lost to Follow-up|0|||
161338028|NCT01773928|582627558|FG004|Overall Study|Lost to Follow-up|0|||
161338029|NCT01773928|582627559|FG005|Overall Study|Lost to Follow-up|1|||
161338030|NCT01773928|582627560|FG006|Overall Study|Lost to Follow-up|0|||
161338031|NCT01773928|582627561|FG007|Overall Study|Lost to Follow-up|0|||
161338032|NCT01773928|582627562|FG008|Overall Study|Lost to Follow-up|0|||
161338033|NCT01773928|582627554|FG000|Overall Study|Subject misrepresented age|0|||
161338034|NCT01773928|582627555|FG001|Overall Study|Subject misrepresented age|1|||
161338035|NCT01773928|582627556|FG002|Overall Study|Subject misrepresented age|0|||
161338036|NCT01773928|582627557|FG003|Overall Study|Subject misrepresented age|0|||
161338037|NCT01773928|582627558|FG004|Overall Study|Subject misrepresented age|0|||
161338038|NCT01773928|582627559|FG005|Overall Study|Subject misrepresented age|0|||
161338039|NCT01773928|582627560|FG006|Overall Study|Subject misrepresented age|0|||
161338040|NCT01773928|582627561|FG007|Overall Study|Subject misrepresented age|0|||
161338041|NCT01773928|582627562|FG008|Overall Study|Subject misrepresented age|0|||
161338042|NCT01773928|582627554|FG000|Overall Study|Subject met exclusion criteria|0|||
161338043|NCT01773928|582627555|FG001|Overall Study|Subject met exclusion criteria|0|||
161338044|NCT01773928|582627556|FG002|Overall Study|Subject met exclusion criteria|0|||
161338045|NCT01773928|582627557|FG003|Overall Study|Subject met exclusion criteria|0|||
161338046|NCT01773928|582627558|FG004|Overall Study|Subject met exclusion criteria|0|||
160856853|NCT04949191|580866556|FG001|Overall Study|Non-compliance with Study Drug|0|||
161338047|NCT01773928|582627559|FG005|Overall Study|Subject met exclusion criteria|0|||
161338048|NCT01773928|582627560|FG006|Overall Study|Subject met exclusion criteria|0|||
161338049|NCT01773928|582627561|FG007|Overall Study|Subject met exclusion criteria|0|||
161338050|NCT01773928|582627562|FG008|Overall Study|Subject met exclusion criteria|1|||
161338051|NCT01773928|582627554|FG000|Overall Study|Randomized, had to leave, never returned|0|||
161338052|NCT01773928|582627555|FG001|Overall Study|Randomized, had to leave, never returned|0|||
161338053|NCT01773928|582627556|FG002|Overall Study|Randomized, had to leave, never returned|0|||
161338054|NCT01773928|582627557|FG003|Overall Study|Randomized, had to leave, never returned|1|||
161338055|NCT01773928|582627558|FG004|Overall Study|Randomized, had to leave, never returned|0|||
160993854|NCT00751036|581365443|FG000|Overall Study|Adverse Event|6|||
160993855|NCT00751036|581365444|FG001|Overall Study|Adverse Event|4|||
161141479|NCT01009463|581902513|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
161141480|NCT01009463|581902514|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
161141481|NCT01009463|581902515|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
161255484|NCT00784134|582314168|FG000|Overall Study|Lost to Follow-up|3|||
161255485|NCT00784134|582314169|FG001|Overall Study|Lost to Follow-up|6|||
161255486|NCT03785145|582314170|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
161255487|NCT03785145|582314171|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
161255488|NCT03785145|582314170|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
161255489|NCT03785145|582314171|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
161255490|NCT03785145|582314170|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
161255491|NCT03785145|582314171|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
161255492|NCT03785145|582314170|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
161255493|NCT03785145|582314171|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
161255494|NCT03785145|582314170|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
161255495|NCT03785145|582314171|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
161255496|NCT03785145|582314170|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
161255497|NCT03785145|582314171|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
161255498|NCT03785145|582314170|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
161255499|NCT03785145|582314171|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
161255500|NCT03785145|582314170|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
161255501|NCT03785145|582314171|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
161255502|NCT03785145|582314170|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
161255503|NCT03785145|582314171|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
161255504|NCT03785145|582314170|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
161255505|NCT03785145|582314171|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
161255506|NCT03785145|582314170|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
161255507|NCT03785145|582314171|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
161255508|NCT00966381|582314172|FG000|Overall Study|Withdrawal by Subject|2|||
161255509|NCT00966381|582314173|FG001|Overall Study|Withdrawal by Subject|2|||
161255510|NCT01915940|582314174|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
161255511|NCT01915940|582314175|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
161255512|NCT01915940|582314176|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
161255513|NCT01915940|582314174|FG000|Treatment Period|Decision of Participant|0|||
161255514|NCT01915940|582314175|FG001|Treatment Period|Decision of Participant|1|||
161255515|NCT01915940|582314176|FG002|Treatment Period|Decision of Participant|3|||
161255516|NCT01915940|582314174|FG000|Treatment Period|Adverse Event|0|||
161255517|NCT01915940|582314175|FG001|Treatment Period|Adverse Event|9|||
161255518|NCT01915940|582314176|FG002|Treatment Period|Adverse Event|1|||
161255519|NCT01915940|582314174|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
161255520|NCT01915940|582314175|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
161255521|NCT01915940|582314176|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
161255522|NCT03686150|582314177|FG000|Overall Study|Withdrawal by Subject|1|||
161255523|NCT03686150|582314178|FG001|Overall Study|Withdrawal by Subject|1|||
161255524|NCT03686150|582314179|FG002|Overall Study|Withdrawal by Subject|1|||
161255525|NCT03686150|582314180|FG003|Overall Study|Withdrawal by Subject|0|||
161255526|NCT03686150|582314181|FG004|Overall Study|Withdrawal by Subject|1|||
161255527|NCT03686150|582314182|FG005|Overall Study|Withdrawal by Subject|2|||
161255528|NCT03686150|582314177|FG000|Overall Study|Physician Decision|1|||
161255529|NCT03686150|582314178|FG001|Overall Study|Physician Decision|0|||
161255530|NCT03686150|582314179|FG002|Overall Study|Physician Decision|0|||
161255531|NCT03686150|582314180|FG003|Overall Study|Physician Decision|0|||
161255532|NCT03686150|582314181|FG004|Overall Study|Physician Decision|0|||
161255533|NCT03686150|582314182|FG005|Overall Study|Physician Decision|1|||
161255534|NCT03686150|582314177|FG000|Overall Study|Lost to Follow-up|0|||
161255535|NCT03686150|582314178|FG001|Overall Study|Lost to Follow-up|1|||
161255536|NCT03686150|582314179|FG002|Overall Study|Lost to Follow-up|0|||
161255537|NCT03686150|582314180|FG003|Overall Study|Lost to Follow-up|0|||
161255538|NCT03686150|582314181|FG004|Overall Study|Lost to Follow-up|0|||
161255539|NCT03686150|582314182|FG005|Overall Study|Lost to Follow-up|0|||
161255540|NCT02443324|582314183|FG000|Overall Study|Death|4|||
161255541|NCT02443324|582314184|FG001|Overall Study|Death|1|||
161255542|NCT02443324|582314185|FG002|Overall Study|Death|0|||
161255543|NCT02443324|582314186|FG003|Overall Study|Death|3|||
161255544|NCT02443324|582314187|FG004|Overall Study|Death|1|||
161255545|NCT02443324|582314188|FG005|Overall Study|Death|3|||
161255546|NCT02443324|582314189|FG006|Overall Study|Death|2|||
161255547|NCT02443324|582314183|FG000|Overall Study|Lost to Follow-up|0|||
161255548|NCT02443324|582314184|FG001|Overall Study|Lost to Follow-up|0|||
161141482|NCT01009463|581902511|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
161338056|NCT01773928|582627559|FG005|Overall Study|Randomized, had to leave, never returned|0|||
161338057|NCT01773928|582627560|FG006|Overall Study|Randomized, had to leave, never returned|0|||
161338058|NCT01773928|582627561|FG007|Overall Study|Randomized, had to leave, never returned|0|||
161338059|NCT01773928|582627562|FG008|Overall Study|Randomized, had to leave, never returned|0|||
161338060|NCT01773928|582627554|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
161338061|NCT01773928|582627555|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
161338062|NCT01773928|582627556|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
161338063|NCT01773928|582627557|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
161338064|NCT01773928|582627558|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
161338065|NCT01773928|582627559|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
161338066|NCT01773928|582627560|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
161338067|NCT01773928|582627561|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
161338068|NCT01773928|582627562|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
161338069|NCT02370511|582627563|FG000|Overall Study|Death|10|||
161338070|NCT02370511|582627564|FG001|Overall Study|Death|7|||
161338071|NCT02370511|582627565|FG002|Overall Study|Death|1|||
161338072|NCT02370511|582627563|FG000|Overall Study|Withdrawal by Subject|2|||
161338073|NCT02370511|582627564|FG001|Overall Study|Withdrawal by Subject|0|||
161338074|NCT02370511|582627565|FG002|Overall Study|Withdrawal by Subject|0|||
161338075|NCT02370511|582627563|FG000|Overall Study|Lost to Follow-up|0|||
161338076|NCT02370511|582627564|FG001|Overall Study|Lost to Follow-up|4|||
161338077|NCT02370511|582627565|FG002|Overall Study|Lost to Follow-up|0|||
161338078|NCT01149655|582627566|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
161338079|NCT01149655|582627567|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161338080|NCT01149655|582627568|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161338081|NCT01149655|582627569|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
161338082|NCT01149655|582627566|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
161338083|NCT01149655|582627567|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161338084|NCT01149655|582627568|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161338085|NCT01149655|582627569|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
161338086|NCT01149655|582627566|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
161338087|NCT01149655|582627567|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161338088|NCT01149655|582627568|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161338089|NCT01149655|582627569|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
161338090|NCT01149655|582627566|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
161338091|NCT01149655|582627567|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
161338092|NCT01149655|582627568|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
161338093|NCT01149655|582627569|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
161338094|NCT01149655|582627566|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
161338095|NCT01149655|582627567|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161338096|NCT01149655|582627568|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161338097|NCT01149655|582627569|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
161338098|NCT01149655|582627566|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
161338099|NCT01149655|582627567|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161338100|NCT01149655|582627568|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161338101|NCT01149655|582627569|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
161338102|NCT01149655|582627566|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161338103|NCT01149655|582627567|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
161338104|NCT01149655|582627568|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161338105|NCT01149655|582627569|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
161338106|NCT01149655|582627566|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161338107|NCT01149655|582627567|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
161338108|NCT01149655|582627568|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161338109|NCT01149655|582627569|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
161338110|NCT01149655|582627566|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
161338111|NCT01149655|582627567|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
161338112|NCT01149655|582627568|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
161338113|NCT01149655|582627569|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
161338114|NCT01149655|582627566|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161338115|NCT01149655|582627567|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
161338116|NCT01149655|582627568|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
160856854|NCT04949191|580866557|FG002|Overall Study|Non-compliance with Study Drug|0|||
160856855|NCT04949191|580866558|FG003|Overall Study|Non-compliance with Study Drug|0|||
160856856|NCT04949191|580866555|FG000|Overall Study|Progressive Disease|0|||
160856857|NCT04949191|580866556|FG001|Overall Study|Progressive Disease|1|||
160856858|NCT04949191|580866557|FG002|Overall Study|Progressive Disease|0|||
160856859|NCT04949191|580866558|FG003|Overall Study|Progressive Disease|0|||
161338117|NCT01149655|582627569|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
161338118|NCT01149655|582627566|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161338119|NCT01149655|582627567|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
160856860|NCT04949191|580866555|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
161255549|NCT02443324|582314185|FG002|Overall Study|Lost to Follow-up|0|||
161255550|NCT02443324|582314186|FG003|Overall Study|Lost to Follow-up|1|||
161255551|NCT02443324|582314187|FG004|Overall Study|Lost to Follow-up|0|||
161255552|NCT02443324|582314188|FG005|Overall Study|Lost to Follow-up|1|||
161255553|NCT02443324|582314189|FG006|Overall Study|Lost to Follow-up|0|||
161255554|NCT02443324|582314183|FG000|Overall Study|Physician Decision|0|||
161255555|NCT02443324|582314184|FG001|Overall Study|Physician Decision|3|||
161255556|NCT02443324|582314185|FG002|Overall Study|Physician Decision|5|||
161255557|NCT02443324|582314186|FG003|Overall Study|Physician Decision|1|||
161255558|NCT02443324|582314187|FG004|Overall Study|Physician Decision|1|||
161255559|NCT02443324|582314188|FG005|Overall Study|Physician Decision|0|||
161255560|NCT02443324|582314189|FG006|Overall Study|Physician Decision|2|||
161255561|NCT02443324|582314183|FG000|Overall Study|Progressive Disease|20|||
161255562|NCT02443324|582314184|FG001|Overall Study|Progressive Disease|20|||
161255563|NCT02443324|582314185|FG002|Overall Study|Progressive Disease|13|||
161255564|NCT02443324|582314186|FG003|Overall Study|Progressive Disease|10|||
161255565|NCT02443324|582314187|FG004|Overall Study|Progressive Disease|13|||
161255566|NCT02443324|582314188|FG005|Overall Study|Progressive Disease|17|||
161255567|NCT02443324|582314189|FG006|Overall Study|Progressive Disease|10|||
161255568|NCT02443324|582314183|FG000|Overall Study|Withdrawal by Subject|0|||
161255569|NCT02443324|582314184|FG001|Overall Study|Withdrawal by Subject|0|||
161255570|NCT02443324|582314185|FG002|Overall Study|Withdrawal by Subject|3|||
161255571|NCT02443324|582314186|FG003|Overall Study|Withdrawal by Subject|1|||
161255572|NCT02443324|582314187|FG004|Overall Study|Withdrawal by Subject|1|||
161255573|NCT02443324|582314188|FG005|Overall Study|Withdrawal by Subject|0|||
161255574|NCT02443324|582314189|FG006|Overall Study|Withdrawal by Subject|1|||
161255575|NCT02443324|582314183|FG000|Overall Study|Adverse Event|0|||
161255576|NCT02443324|582314184|FG001|Overall Study|Adverse Event|1|||
161255577|NCT02443324|582314185|FG002|Overall Study|Adverse Event|3|||
161255578|NCT02443324|582314186|FG003|Overall Study|Adverse Event|0|||
161255579|NCT02443324|582314187|FG004|Overall Study|Adverse Event|4|||
161255580|NCT02443324|582314188|FG005|Overall Study|Adverse Event|3|||
161255581|NCT02443324|582314189|FG006|Overall Study|Adverse Event|3|||
161255582|NCT02443324|582314183|FG000|Overall Study|Enrolled but Never Treated|0|||
161255583|NCT02443324|582314184|FG001|Overall Study|Enrolled but Never Treated|0|||
161255584|NCT02443324|582314185|FG002|Overall Study|Enrolled but Never Treated|1|||
161255585|NCT02443324|582314186|FG003|Overall Study|Enrolled but Never Treated|0|||
161255586|NCT02443324|582314187|FG004|Overall Study|Enrolled but Never Treated|1|||
161255587|NCT02443324|582314188|FG005|Overall Study|Enrolled but Never Treated|0|||
161255588|NCT02443324|582314189|FG006|Overall Study|Enrolled but Never Treated|1|||
161255589|NCT04025684|582314200|FG000|Overall Study|Withdrawal by Subject|1|||
161255590|NCT04025684|582314201|FG001|Overall Study|Withdrawal by Subject|1|||
161255591|NCT04025684|582314202|FG002|Overall Study|Withdrawal by Subject|0|||
161255592|NCT04025684|582314203|FG003|Overall Study|Withdrawal by Subject|0|||
161255593|NCT04025684|582314200|FG000|Overall Study|Multiple reasons|1|||
161255594|NCT04025684|582314201|FG001|Overall Study|Multiple reasons|3|||
161255595|NCT04025684|582314202|FG002|Overall Study|Multiple reasons|0|||
161255596|NCT04025684|582314203|FG003|Overall Study|Multiple reasons|1|||
161255597|NCT01844531|582314204|FG000|Overall Study|Withdrawal by Subject|0|||
161255598|NCT01844531|582314205|FG001|Overall Study|Withdrawal by Subject|1|||
161255599|NCT01844531|582314206|FG002|Overall Study|Withdrawal by Subject|0|||
161255600|NCT01844531|582314207|FG003|Overall Study|Withdrawal by Subject|0|||
161255601|NCT01546922|582314208|FG000|First Period of 10 Weeks|Protocol Violation|3|||
161255602|NCT01546922|582314209|FG001|First Period of 10 Weeks|Protocol Violation|1|||
161255603|NCT01546922|582314208|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
161255604|NCT01546922|582314209|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
161255605|NCT01546922|582314208|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
161255606|NCT01546922|582314209|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
161255607|NCT01546922|582314208|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
161255608|NCT01546922|582314209|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
161255609|NCT01546922|582314208|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
161255610|NCT01546922|582314209|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
161255611|NCT01613378|582314217|FG000|Overall Study|Lack of Efficacy|13|||
161255612|NCT01613378|582314217|FG000|Overall Study|Adverse Event|11|||
161255613|NCT01613378|582314217|FG000|Overall Study|Withdrawal by Subject|8|||
161255614|NCT01613378|582314217|FG000|Overall Study|Death|2|||
161255615|NCT01613378|582314217|FG000|Overall Study|Lost to Follow-up|1|||
161255616|NCT01613378|582314217|FG000|Overall Study|Other Reason|4|||
161255617|NCT00418522|582314218|FG000|Overall Study|Adverse Event|7|||
161255618|NCT00418522|582314219|FG001|Overall Study|Adverse Event|1|||
161255619|NCT00418522|582314218|FG000|Overall Study|Lack of Efficacy|1|||
161255620|NCT00418522|582314219|FG001|Overall Study|Lack of Efficacy|3|||
161255621|NCT00418522|582314218|FG000|Overall Study|Lost to Follow-up|10|||
161255622|NCT00418522|582314219|FG001|Overall Study|Lost to Follow-up|4|||
161255623|NCT00418522|582314218|FG000|Overall Study|Withdrawal by Subject|31|||
161255624|NCT00418522|582314219|FG001|Overall Study|Withdrawal by Subject|7|||
161255625|NCT00418522|582314218|FG000|Overall Study|Other|27|||
161255626|NCT00418522|582314219|FG001|Overall Study|Other|23|||
161255627|NCT00418522|582314218|FG000|Overall Study|Randomized but did not receive treatment|7|||
161255628|NCT00418522|582314219|FG001|Overall Study|Randomized but did not receive treatment|4|||
161255629|NCT01005329|582314220|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
161255630|NCT02147587|582314221|FG000|Overall Study|Adverse Event|9|||
161255631|NCT02147587|582314222|FG001|Overall Study|Adverse Event|4|||
161255632|NCT02147587|582314221|FG000|Overall Study|Lack of Efficacy|2|||
161255633|NCT02147587|582314222|FG001|Overall Study|Lack of Efficacy|1|||
161255634|NCT01315028|582314227|FG000|Overall Study|Lost to Follow-up|1|||
161255635|NCT01315028|582314228|FG001|Overall Study|Lost to Follow-up|0|||
161255636|NCT01315028|582314227|FG000|Overall Study|Death|0|||
161255637|NCT01315028|582314228|FG001|Overall Study|Death|1|||
161255638|NCT02531594|582314229|FG000|Overall Study|Withdrawal by Subject|7|||
161255639|NCT02531594|582314230|FG001|Overall Study|Withdrawal by Subject|8|||
161255640|NCT01175473|582314244|FG000|Overall Study|Adverse Event|2|||
161255641|NCT01175473|582314245|FG001|Overall Study|Adverse Event|2|||
161255642|NCT04234464|582314248|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
161255643|NCT04234464|582314249|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
161255644|NCT00983528|582314250|FG000|Overall Study|Death|4|||
161255645|NCT00983528|582314250|FG000|Overall Study|Lost to Follow-up|1|||
161255646|NCT00983528|582314250|FG000|Overall Study|Study Terminated|1|||
161255647|NCT03635983|582314251|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161255648|NCT03635983|582314252|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
161255649|NCT03635983|582314251|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161255650|NCT03635983|582314252|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161255651|NCT03635983|582314251|FG000|Pre-Treatment Period|Other reasons|0|||
161255652|NCT03635983|582314252|FG001|Pre-Treatment Period|Other reasons|1|||
161255653|NCT03635983|582314251|FG000|Pre-Treatment Period|Disease Progression|0|||
161255654|NCT03635983|582314252|FG001|Pre-Treatment Period|Disease Progression|1|||
161255655|NCT03635983|582314251|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
161255656|NCT03635983|582314252|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
161255657|NCT03635983|582314251|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
161255658|NCT03635983|582314252|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
161255659|NCT03635983|582314251|FG000|Treatment Period|Withdrawal by Subject|3|||
161255660|NCT03635983|582314252|FG001|Treatment Period|Withdrawal by Subject|5|||
161255661|NCT03635983|582314251|FG000|Treatment Period|Death|3|||
161255662|NCT03635983|582314252|FG001|Treatment Period|Death|5|||
161255663|NCT03635983|582314251|FG000|Treatment Period|Poor/Non-compliance|2|||
161255664|NCT03635983|582314252|FG001|Treatment Period|Poor/Non-compliance|1|||
161255665|NCT03635983|582314251|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
161255666|NCT03635983|582314252|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
161255667|NCT03635983|582314251|FG000|Treatment Period|Other reasons|7|||
161255668|NCT03635983|582314252|FG001|Treatment Period|Other reasons|4|||
161255669|NCT03635983|582314251|FG000|Treatment Period|Disease progression|230|||
161255670|NCT03635983|582314252|FG001|Treatment Period|Disease progression|201|||
161255671|NCT03635983|582314251|FG000|Treatment Period|Study drug toxicity|35|||
161255672|NCT03635983|582314252|FG001|Treatment Period|Study drug toxicity|36|||
161255673|NCT03635983|582314251|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
161255674|NCT03635983|582314252|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
161255675|NCT03635983|582314251|FG000|Treatment Period|Maximum clinical benefit|3|||
161255676|NCT03635983|582314252|FG001|Treatment Period|Maximum clinical benefit|5|||
161255677|NCT03635983|582314251|FG000|Treatment Period|Administrative reason by the sponsor|1|||
161255678|NCT03635983|582314252|FG001|Treatment Period|Administrative reason by the sponsor|2|||
161255679|NCT03635983|582314251|FG000|Treatment Period|Lost to Follow-up|0|||
161255680|NCT03635983|582314252|FG001|Treatment Period|Lost to Follow-up|1|||
161255681|NCT03365791|582314254|FG000|Overall Study|Adverse Event|5|||
161255682|NCT03365791|582314254|FG000|Overall Study|Death|1|||
161255683|NCT03365791|582314254|FG000|Overall Study|Lost to Follow-up|1|||
161255684|NCT03365791|582314254|FG000|Overall Study|Physician Decision|9|||
161255685|NCT03365791|582314254|FG000|Overall Study|Progressive disease|51|||
161255686|NCT03365791|582314254|FG000|Overall Study|Subject/guardian decision|5|||
161255687|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
161255688|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255689|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255690|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255691|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255692|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255693|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255694|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
160993856|NCT00751036|581365443|FG000|Overall Study|Administrative Problems|3|||
160993857|NCT00751036|581365444|FG001|Overall Study|Administrative Problems|4|||
160993858|NCT00751036|581365443|FG000|Overall Study|Withdrawal by Subject|5|||
160993859|NCT00751036|581365444|FG001|Overall Study|Withdrawal by Subject|2|||
160993860|NCT00751036|581365443|FG000|Overall Study|Death|3|||
160993861|NCT00751036|581365444|FG001|Overall Study|Death|3|||
160993862|NCT00751036|581365443|FG000|Overall Study|Lost to Follow-up|0|||
160993863|NCT00751036|581365444|FG001|Overall Study|Lost to Follow-up|1|||
160993864|NCT00751036|581365443|FG000|Overall Study|Protocol Violation|1|||
160993865|NCT00751036|581365444|FG001|Overall Study|Protocol Violation|0|||
160993866|NCT00751036|581365443|FG000|Overall Study|Missing end of Treatment Page|2|||
160993867|NCT00751036|581365444|FG001|Overall Study|Missing end of Treatment Page|3|||
160993868|NCT05570006|581367282|FG000|Overall Study|Lost to Follow-up|2|||
160993869|NCT05570006|581367282|FG000|Overall Study|Withdrawal by Subject|5|||
160993870|NCT05570006|581367282|FG000|Overall Study|Other than Specified|5|||
160993871|NCT00149630|581367287|FG000|Overall Study|Incarceration|2|||
160993872|NCT00149630|581367288|FG001|Overall Study|Incarceration|0|||
160993873|NCT00149630|581367287|FG000|Overall Study|Treatment Programs|4|||
160993874|NCT00149630|581367288|FG001|Overall Study|Treatment Programs|5|||
160993875|NCT00149630|581367287|FG000|Overall Study|Adverse Event|2|||
160993876|NCT00149630|581367288|FG001|Overall Study|Adverse Event|0|||
160993877|NCT00109967|581367304|FG000|Overall Study|Cancel Prior to Treatment|2|||
160993878|NCT00109967|581367305|FG001|Overall Study|Cancel Prior to Treatment|0|||
160993879|NCT00109967|581367304|FG000|Overall Study|Adverse Event|12|||
160993880|NCT00109967|581367305|FG001|Overall Study|Adverse Event|1|||
160993881|NCT00109967|581367304|FG000|Overall Study|Withdrawal by Subject|5|||
160993882|NCT00109967|581367305|FG001|Overall Study|Withdrawal by Subject|0|||
160993883|NCT00109967|581367304|FG000|Overall Study|Physician Decision|1|||
160993884|NCT00109967|581367305|FG001|Overall Study|Physician Decision|3|||
160993885|NCT00109967|581367304|FG000|Overall Study|Death|0|||
160993886|NCT00109967|581367305|FG001|Overall Study|Death|2|||
160993887|NCT00943605|581367313|FG000|Overall Study|Study termination|30|||
160993888|NCT00943605|581367314|FG001|Overall Study|Study termination|30|||
160993889|NCT02232178|581367315|FG000|Overall Study|Lost to Follow-up|0|||
160993890|NCT02232178|581367316|FG001|Overall Study|Lost to Follow-up|1|||
160993891|NCT02232178|581367317|FG002|Overall Study|Lost to Follow-up|0|||
160993892|NCT02232178|581367315|FG000|Overall Study|ineligibility|0|||
160993893|NCT02232178|581367316|FG001|Overall Study|ineligibility|0|||
160993894|NCT02232178|581367317|FG002|Overall Study|ineligibility|1|||
160993895|NCT02232178|581367315|FG000|Overall Study|surgical complication|1|||
160993896|NCT02232178|581367316|FG001|Overall Study|surgical complication|0|||
160993897|NCT02232178|581367317|FG002|Overall Study|surgical complication|0|||
161255695|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
161255696|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
161255697|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255698|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255699|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255700|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255701|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255702|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255703|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255704|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
161255705|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
161255706|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255707|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255708|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255709|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255710|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255711|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255712|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255713|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
161255714|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
160993898|NCT01956669|581367320|FG000|Overall Study|Disease Progression|12|||
160993899|NCT01956669|581367321|FG001|Overall Study|Disease Progression|7|||
161141483|NCT01009463|581902512|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160856861|NCT04949191|580866556|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
160993900|NCT01956669|581367322|FG002|Overall Study|Disease Progression|7|||
160993901|NCT01956669|581367323|FG003|Overall Study|Disease Progression|8|||
160993902|NCT01956669|581367324|FG004|Overall Study|Disease Progression|4|||
160993903|NCT01956669|581367325|FG005|Overall Study|Disease Progression|3|||
160993904|NCT01956669|581367326|FG006|Overall Study|Disease Progression|5|||
160993905|NCT01956669|581367320|FG000|Overall Study|Adverse Event|0|||
161338120|NCT01149655|582627568|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161338121|NCT01149655|582627569|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
161338122|NCT01149655|582627566|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
161338123|NCT01149655|582627567|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
161338124|NCT01149655|582627568|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
161338125|NCT01149655|582627569|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
161338126|NCT01149655|582627566|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
161338127|NCT01149655|582627567|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
161338128|NCT01149655|582627568|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
161338129|NCT01149655|582627569|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
161338130|NCT01149655|582627566|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
161338131|NCT01149655|582627567|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
161338132|NCT01149655|582627568|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
161338133|NCT01149655|582627569|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
161338134|NCT01149655|582627566|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
161338135|NCT01149655|582627567|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
161338136|NCT01149655|582627568|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
161338137|NCT01149655|582627569|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
161338138|NCT01149655|582627566|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
161338139|NCT01149655|582627567|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
161338140|NCT01149655|582627568|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
161338141|NCT01149655|582627569|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
161338142|NCT03092752|582627570|FG000|Overall Study|Aged <40 years|14209|||
161338143|NCT03092752|582627570|FG000|Overall Study|At least one claim with T2DM|61299|||
161338144|NCT03092752|582627570|FG000|Overall Study|Having no claim of study drugs|29282|||
161338145|NCT03092752|582627570|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
161338146|NCT03092752|582627570|FG000|Overall Study|<6 month history|245900|||
161338147|NCT03882918|582627572|FG000|Overall Study|Study terminated by sponsor|98|||
161338148|NCT03882918|582627572|FG000|Overall Study|Protocol Violation|1|||
161338149|NCT03882918|582627572|FG000|Overall Study|Other|9|||
161338150|NCT03882918|582627572|FG000|Overall Study|Lack of Efficacy|14|||
161338151|NCT03882918|582627572|FG000|Overall Study|Adverse Event|13|||
161338152|NCT03882918|582627572|FG000|Overall Study|Withdrawal by Subject|5|||
161338153|NCT06996301|582627573|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
161338154|NCT06996301|582627574|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
161338155|NCT06996301|582627573|FG000|Overall Study|Patients with discordant diagnostic results|107|||
161338156|NCT06996301|582627574|FG001|Overall Study|Patients with discordant diagnostic results|90|||
161338157|NCT06996301|582627573|FG000|Overall Study|Lost to Follow-up|31|||
161338158|NCT06996301|582627574|FG001|Overall Study|Lost to Follow-up|56|||
161338159|NCT06996301|582627573|FG000|Overall Study|Withdrawal by Subject|12|||
161338160|NCT06996301|582627574|FG001|Overall Study|Withdrawal by Subject|7|||
161338161|NCT04030598|582627575|FG000|Overall Study|Voluntary Withdrawal|0|||
161338162|NCT04030598|582627576|FG001|Overall Study|Voluntary Withdrawal|1|||
161338163|NCT04030598|582627577|FG002|Overall Study|Voluntary Withdrawal|0|||
161338164|NCT01419535|582627578|FG000|Overall Study|could not maintain iv line|1|||
161338165|NCT01419535|582627579|FG001|Overall Study|could not maintain iv line|1|||
161338166|NCT01419535|582627578|FG000|Overall Study|Withdrawal by Subject|0|||
161338167|NCT01419535|582627579|FG001|Overall Study|Withdrawal by Subject|1|||
161338168|NCT03675308|582628770|FG000|Overall Study|Adverse Event|3|||
161338169|NCT03675308|582628771|FG001|Overall Study|Adverse Event|2|||
161338170|NCT03675308|582628770|FG000|Overall Study|Withdrawal by Subject|6|||
161338171|NCT03675308|582628771|FG001|Overall Study|Withdrawal by Subject|4|||
161338172|NCT03675308|582628770|FG000|Overall Study|Lost to Follow-up|3|||
161338173|NCT03675308|582628771|FG001|Overall Study|Lost to Follow-up|0|||
161338174|NCT03675308|582628770|FG000|Overall Study|Lack of Efficacy|1|||
161338175|NCT03675308|582628771|FG001|Overall Study|Lack of Efficacy|1|||
161338176|NCT03675308|582628770|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
161338177|NCT03675308|582628771|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
161338178|NCT03675308|582628770|FG000|Overall Study|Other|0|||
161338179|NCT03675308|582628771|FG001|Overall Study|Other|1|||
160993906|NCT01956669|581367321|FG001|Overall Study|Adverse Event|2|||
161338180|NCT05722522|582628772|FG000|Overall Study|Adverse Event|0|||
161338181|NCT05722522|582628773|FG001|Overall Study|Adverse Event|1|||
160993907|NCT01956669|581367322|FG002|Overall Study|Adverse Event|2|||
161338182|NCT06125964|582628776|FG000|Overall Study|Lost to Follow-up|0|||
161338183|NCT06125964|582628777|FG001|Overall Study|Lost to Follow-up|1|||
161338184|NCT06125964|582628778|FG002|Overall Study|Lost to Follow-up|0|||
161338185|NCT06125964|582628779|FG003|Overall Study|Lost to Follow-up|0|||
161338186|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
161338187|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
161338188|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
161338189|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Death|1|||
161338190|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Death|1|||
161338191|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Death|0|||
161338192|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
161338193|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
161338194|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
161338195|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
160856862|NCT04949191|580866557|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
160993908|NCT01956669|581367323|FG003|Overall Study|Adverse Event|1|||
161141484|NCT01009463|581902513|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
161141485|NCT01009463|581902514|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160856863|NCT04949191|580866558|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
160856864|NCT04949191|580866555|FG000|Overall Study|Sponsor Terminated Study|0|||
160856865|NCT04949191|580866556|FG001|Overall Study|Sponsor Terminated Study|0|||
160856866|NCT04949191|580866557|FG002|Overall Study|Sponsor Terminated Study|1|||
160856867|NCT04949191|580866558|FG003|Overall Study|Sponsor Terminated Study|1|||
160856868|NCT00730158|580866559|FG000|Overall Study|Withdrawal by Subject|1|||
160908351|NCT03010176|581058108|FG003|Overall Study|Withdrawal by Subject|0|||
160908352|NCT03010176|581058109|FG004|Overall Study|Withdrawal by Subject|4|||
160908353|NCT03010176|581058110|FG005|Overall Study|Withdrawal by Subject|0|||
160908354|NCT04220866|581058111|FG000|Overall Study|Death|4|||
160908355|NCT04220866|581058112|FG001|Overall Study|Death|5|||
160908356|NCT04220866|581058111|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
160908357|NCT04220866|581058112|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
160908358|NCT04220866|581058111|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
160908359|NCT04220866|581058112|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
160908360|NCT04220866|581058111|FG000|Overall Study|Withdrawal by Subject|0|||
160908361|NCT04220866|581058112|FG001|Overall Study|Withdrawal by Subject|1|||
160908362|NCT00709761|581058113|FG000|Overall Study|Withdrawal by Subject|8|||
160908363|NCT00709761|581058113|FG000|Overall Study|study closed/terminated|17|||
160908364|NCT00709761|581058113|FG000|Overall Study|Lost to Follow-up|2|||
160908365|NCT03478930|581058114|FG000|Overall Study|Adverse Event|0|||
160908366|NCT03478930|581058115|FG001|Overall Study|Adverse Event|1|||
160908367|NCT03478930|581058114|FG000|Overall Study|Lack of Efficacy|3|||
160908368|NCT03478930|581058115|FG001|Overall Study|Lack of Efficacy|3|||
160908369|NCT03478930|581058114|FG000|Overall Study|Withdrawal by Subject|6|||
160908370|NCT03478930|581058115|FG001|Overall Study|Withdrawal by Subject|5|||
160908371|NCT01812174|581058116|FG000|Overall Study|Death|1|||
160908372|NCT01812174|581058117|FG001|Overall Study|Death|0|||
160908373|NCT01812174|581058116|FG000|Overall Study|Protocol Violation|2|||
160908374|NCT01812174|581058117|FG001|Overall Study|Protocol Violation|0|||
160908375|NCT00553644|581058120|FG000|Overall Study|Adverse Event|17|||
160908376|NCT00553644|581058120|FG000|Overall Study|Withdrawal by Subject|4|||
160908377|NCT00553644|581058120|FG000|Overall Study|Physician Decision|1|||
160908378|NCT00553644|581058120|FG000|Overall Study|Alternative therapy|6|||
160908379|NCT00730132|581058125|FG000|Overall Study|Protocol Violation|154|||
160908380|NCT00730132|581058125|FG000|Overall Study|Death|1|||
160908381|NCT00370032|581058126|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
160908382|NCT00370032|581058127|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
160908383|NCT00370032|581058126|FG000|Washout Period|Withdrawal by Subject|0|||
160908384|NCT00370032|581058127|FG001|Washout Period|Withdrawal by Subject|1|||
160908385|NCT00370032|581058126|FG000|Washout Period|Lost to Follow-up|0|||
160908386|NCT00370032|581058127|FG001|Washout Period|Lost to Follow-up|1|||
160908387|NCT00370032|581058126|FG000|Washout Period|Adverse Event|1|||
160908388|NCT00370032|581058127|FG001|Washout Period|Adverse Event|0|||
160908389|NCT00370032|581058126|FG000|Follow-up Period|Withdrawal by Subject|1|||
160908390|NCT00370032|581058127|FG001|Follow-up Period|Withdrawal by Subject|0|||
160908391|NCT05469178|581058128|FG000|Overall Study|Death|1|||
160908392|NCT05469178|581058129|FG001|Overall Study|Death|1|||
160908393|NCT05469178|581058130|FG002|Overall Study|Death|3|||
160908394|NCT05469178|581058131|FG003|Overall Study|Death|6|||
160908395|NCT05469178|581058128|FG000|Overall Study|Lack of Efficacy|2|||
160908396|NCT05469178|581058129|FG001|Overall Study|Lack of Efficacy|2|||
160908397|NCT05469178|581058130|FG002|Overall Study|Lack of Efficacy|1|||
160908398|NCT05469178|581058131|FG003|Overall Study|Lack of Efficacy|10|||
160908399|NCT00968513|581058132|FG000|Overall Study|Death|4|||
160908400|NCT00968513|581058133|FG001|Overall Study|Death|10|||
160908401|NCT00968513|581058134|FG002|Overall Study|Death|15|||
160908402|NCT05466682|581058137|FG000|Overall Study|Withdrawal by Subject|0|||
160908403|NCT05466682|581058138|FG001|Overall Study|Withdrawal by Subject|2|||
160908404|NCT05466682|581058137|FG000|Overall Study|Lost to Follow-up|2|||
160908405|NCT05466682|581058138|FG001|Overall Study|Lost to Follow-up|1|||
161141486|NCT01009463|581902515|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
160856869|NCT00730158|580866560|FG001|Overall Study|Withdrawal by Subject|1|||
160908406|NCT02405780|581058150|FG000|Period I|Adverse Event|8|||
160908407|NCT02405780|581058151|FG001|Period I|Adverse Event|0|||
160908408|NCT02405780|581058152|FG002|Period I|Adverse Event|3|||
161338196|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
161338197|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
161338198|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
161338199|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
161338200|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
161338201|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
161338202|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
161338203|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
161338204|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
161338205|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
161338206|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
161338207|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
161338208|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
161338209|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
161338210|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
161338211|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
161338212|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
161338213|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
161338214|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
161338215|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
161338216|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Other|10|||
161338217|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Other|4|||
161338218|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Other|0|||
161338219|NCT04006457|582628780|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
161338220|NCT04006457|582628781|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
161338221|NCT04006457|582628782|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
161338222|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
161338223|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
161338224|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
161338225|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
161338226|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
161338227|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
161338228|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
161338229|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
161338230|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
161338231|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
161338232|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
161338233|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
161338234|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
161338235|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
161338236|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
161338237|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Other|2|||
161338238|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Other|3|||
161338239|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Other|0|||
161338240|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
161338241|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
161338242|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
161338243|NCT04006457|582628780|FG000|Main Study: Treatment Period 2|Ongoing|86|||
161338244|NCT04006457|582628781|FG001|Main Study: Treatment Period 2|Ongoing|96|||
161338245|NCT04006457|582628782|FG002|Main Study: Treatment Period 2|Ongoing|0|||
161338246|NCT04006457|582628780|FG000|Main Study Observation Period|Adverse Event|1|||
161338247|NCT04006457|582628781|FG001|Main Study Observation Period|Adverse Event|1|||
161338248|NCT04006457|582628782|FG002|Main Study Observation Period|Adverse Event|0|||
160856870|NCT03535974|580866562|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
160856871|NCT03535974|580866563|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
161338249|NCT04006457|582628780|FG000|Main Study Observation Period|Lost to Follow-up|0|||
160856872|NCT03535974|580866564|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
160856873|NCT03535974|580866562|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
160856874|NCT03535974|580866563|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
160856875|NCT03535974|580866564|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
160856876|NCT04059549|580866565|FG000|Overall Study|Withdrawal by Subject|2|||
160856877|NCT04059549|580866566|FG001|Overall Study|Withdrawal by Subject|0|||
160856878|NCT02678351|580866567|FG000|Overall Study|Withdrawal by Subject|1|||
160856879|NCT02913482|580866568|FG000|Overall Study|Death|0|||
160856880|NCT02913482|580866569|FG001|Overall Study|Death|2|||
160856881|NCT02913482|580866570|FG002|Overall Study|Death|2|||
160856882|NCT02913482|580866568|FG000|Overall Study|Progressive Disease|1|||
160856883|NCT02913482|580866569|FG001|Overall Study|Progressive Disease|1|||
160908409|NCT02405780|581058153|FG003|Period I|Adverse Event|7|||
160908410|NCT02405780|581058150|FG000|Period I|Medical reasons|1|||
160908411|NCT02405780|581058151|FG001|Period I|Medical reasons|1|||
160908412|NCT02405780|581058152|FG002|Period I|Medical reasons|0|||
160908413|NCT02405780|581058153|FG003|Period I|Medical reasons|1|||
160908414|NCT02405780|581058150|FG000|Period I|Screening Failure|1|||
160908415|NCT02405780|581058151|FG001|Period I|Screening Failure|0|||
160908416|NCT02405780|581058152|FG002|Period I|Screening Failure|1|||
160908417|NCT02405780|581058153|FG003|Period I|Screening Failure|0|||
160908418|NCT02405780|581058150|FG000|Period I|Withdrawal by Subject|9|||
160908419|NCT02405780|581058151|FG001|Period I|Withdrawal by Subject|1|||
160908420|NCT02405780|581058152|FG002|Period I|Withdrawal by Subject|3|||
160908421|NCT02405780|581058153|FG003|Period I|Withdrawal by Subject|4|||
160908422|NCT02405780|581058150|FG000|Period I|Non-compliance with study procedures|8|||
160908423|NCT02405780|581058151|FG001|Period I|Non-compliance with study procedures|6|||
160908424|NCT02405780|581058152|FG002|Period I|Non-compliance with study procedures|8|||
160908425|NCT02405780|581058153|FG003|Period I|Non-compliance with study procedures|11|||
160908426|NCT02405780|581058150|FG000|Period II|Adverse Event|3|||
160908427|NCT02405780|581058151|FG001|Period II|Adverse Event|5|||
160908428|NCT02405780|581058152|FG002|Period II|Adverse Event|4|||
160908429|NCT02405780|581058153|FG003|Period II|Adverse Event|11|||
160908430|NCT02405780|581058150|FG000|Period II|Medical reason|0|||
160908431|NCT02405780|581058151|FG001|Period II|Medical reason|1|||
160908432|NCT02405780|581058152|FG002|Period II|Medical reason|0|||
160908433|NCT02405780|581058153|FG003|Period II|Medical reason|0|||
160908434|NCT02405780|581058150|FG000|Period II|Pregnancy|0|||
160908435|NCT02405780|581058151|FG001|Period II|Pregnancy|0|||
160908436|NCT02405780|581058152|FG002|Period II|Pregnancy|1|||
160908437|NCT02405780|581058153|FG003|Period II|Pregnancy|0|||
160908438|NCT02405780|581058150|FG000|Period II|Withdrawal by Subject|7|||
160908439|NCT02405780|581058151|FG001|Period II|Withdrawal by Subject|4|||
160908440|NCT02405780|581058152|FG002|Period II|Withdrawal by Subject|0|||
160908441|NCT02405780|581058153|FG003|Period II|Withdrawal by Subject|3|||
160908442|NCT02405780|581058150|FG000|Period II|Non-compliance with study procedures|5|||
160908443|NCT02405780|581058151|FG001|Period II|Non-compliance with study procedures|2|||
160908444|NCT02405780|581058152|FG002|Period II|Non-compliance with study procedures|7|||
160908445|NCT02405780|581058153|FG003|Period II|Non-compliance with study procedures|4|||
160908446|NCT01654536|581058154|FG000|Overall Study|Lost to Follow-up|5|||
160908447|NCT01654536|581058155|FG001|Overall Study|Lost to Follow-up|5|||
160908448|NCT01654536|581058154|FG000|Overall Study|Physician Decision|12|||
160908449|NCT01654536|581058155|FG001|Overall Study|Physician Decision|8|||
160908450|NCT01654536|581058154|FG000|Overall Study|Withdrawal by Subject|27|||
160993909|NCT01956669|581367324|FG004|Overall Study|Adverse Event|0|||
160856884|NCT02913482|580866570|FG002|Overall Study|Progressive Disease|1|||
160856885|NCT02913482|580866568|FG000|Overall Study|Reason not specified|0|||
160856886|NCT02913482|580866569|FG001|Overall Study|Reason not specified|0|||
160856887|NCT02913482|580866570|FG002|Overall Study|Reason not specified|1|||
160856888|NCT02913482|580866568|FG000|Overall Study|Withdrawal by Subject|0|||
160856889|NCT02913482|580866569|FG001|Overall Study|Withdrawal by Subject|1|||
160856890|NCT02913482|580866570|FG002|Overall Study|Withdrawal by Subject|1|||
160856891|NCT01919229|580866571|FG000|Overall Study|Subject/guardian decision|0|||
160856892|NCT01919229|580866572|FG001|Overall Study|Subject/guardian decision|0|||
160856893|NCT01919229|580866573|FG002|Overall Study|Subject/guardian decision|1|||
160856894|NCT01011673|580866574|FG000|Randomized|Secondary headache|2|||
160856895|NCT01011673|580866575|FG001|Randomized|Secondary headache|1|||
160856896|NCT01011673|580866574|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
160856897|NCT01011673|580866575|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
160856898|NCT04716426|580866580|FG000|Overall Study|Vaccination|1|||
160856899|NCT04716426|580866581|FG001|Overall Study|Vaccination|1|||
160856900|NCT04716426|580866580|FG000|Overall Study|Contamination|1|||
160908451|NCT01654536|581058155|FG001|Overall Study|Withdrawal by Subject|25|||
160908452|NCT00668707|581058156|FG000|Overall Study|Cancer Recurrence|58|||
161255715|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160908453|NCT00668707|581058157|FG001|Overall Study|Cancer Recurrence|58|||
160908454|NCT00668707|581058156|FG000|Overall Study|Withdrawal by Subject|117|||
160908455|NCT00668707|581058157|FG001|Overall Study|Withdrawal by Subject|100|||
160908456|NCT00668707|581058156|FG000|Overall Study|Lost to Follow-up|3|||
160908457|NCT00668707|581058157|FG001|Overall Study|Lost to Follow-up|6|||
160908458|NCT00668707|581058156|FG000|Overall Study|Protocol Violation|10|||
160908459|NCT00668707|581058157|FG001|Overall Study|Protocol Violation|12|||
160908460|NCT00668707|581058156|FG000|Overall Study|Death|11|||
160908461|NCT00668707|581058157|FG001|Overall Study|Death|4|||
160908462|NCT03846804|581058164|FG000|Overall Study|Refused blood draw|1|||
160856901|NCT04716426|580866581|FG001|Overall Study|Contamination|0|||
160856902|NCT01650558|580866582|FG000|Overall Study|Migration out of study area|61|||
160856903|NCT01650558|580866583|FG001|Overall Study|Migration out of study area|71|||
160908463|NCT03846804|581058164|FG000|Overall Study|Protocol Violation|1|||
160908464|NCT02784431|581058165|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
160908465|NCT02784431|581058165|FG000|Overall Study|Early Study Termination|19|||
160908466|NCT02605824|581058166|FG000|Overall Study|Physician Decision|1|||
160908467|NCT02605824|581058167|FG001|Overall Study|Physician Decision|0|||
160908468|NCT01273597|581058170|FG000|Overall Study|Adverse Event|5|||
160856904|NCT01650558|580866584|FG002|Overall Study|Migration out of study area|56|||
160856905|NCT01650558|580866582|FG000|Overall Study|Lost to Follow-up|10|||
160856906|NCT01650558|580866583|FG001|Overall Study|Lost to Follow-up|13|||
160856907|NCT01650558|580866584|FG002|Overall Study|Lost to Follow-up|6|||
160856908|NCT01650558|580866582|FG000|Overall Study|Death|10|||
160856909|NCT01650558|580866583|FG001|Overall Study|Death|6|||
160856910|NCT01650558|580866584|FG002|Overall Study|Death|8|||
160856911|NCT01650558|580866582|FG000|Overall Study|Withdrawal by Subject|1|||
160856912|NCT01650558|580866583|FG001|Overall Study|Withdrawal by Subject|1|||
160856913|NCT01650558|580866584|FG002|Overall Study|Withdrawal by Subject|3|||
160856914|NCT01650558|580866582|FG000|Overall Study|Non-compliant participant|1|||
160856915|NCT01650558|580866583|FG001|Overall Study|Non-compliant participant|0|||
160856916|NCT01650558|580866584|FG002|Overall Study|Non-compliant participant|2|||
160856917|NCT01650558|580866582|FG000|Overall Study|Physician Decision|0|||
160856918|NCT01650558|580866583|FG001|Overall Study|Physician Decision|1|||
160856919|NCT01650558|580866584|FG002|Overall Study|Physician Decision|0|||
160908469|NCT01273597|581058170|FG000|Overall Study|Underwent Kidney Transplantation|2|||
160908470|NCT01273597|581058170|FG000|Overall Study|Reason Not Reported|1|||
160908471|NCT03547583|581058171|FG000|Overall Study|Adverse Event|16|||
160908472|NCT03547583|581058172|FG001|Overall Study|Adverse Event|11|||
160908473|NCT03547583|581058173|FG002|Overall Study|Adverse Event|10|||
160908474|NCT03547583|581058171|FG000|Overall Study|Death|11|||
160908475|NCT03547583|581058172|FG001|Overall Study|Death|7|||
160908476|NCT03547583|581058173|FG002|Overall Study|Death|4|||
160908477|NCT03547583|581058171|FG000|Overall Study|Lost to Follow-up|1|||
160908478|NCT03547583|581058172|FG001|Overall Study|Lost to Follow-up|0|||
160908479|NCT03547583|581058173|FG002|Overall Study|Lost to Follow-up|0|||
160908480|NCT03547583|581058171|FG000|Overall Study|Non-compliance with study drug|0|||
160908481|NCT03547583|581058172|FG001|Overall Study|Non-compliance with study drug|0|||
160908482|NCT03547583|581058173|FG002|Overall Study|Non-compliance with study drug|1|||
160856920|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
160856921|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
160856922|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
160856923|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
160856924|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
160856925|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
160856926|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
160856927|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
160856928|NCT02960217|580866585|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
160856929|NCT02960217|580866586|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
160856930|NCT02960217|580866585|FG000|Open-Label Extension Phase|Adverse Event|1|||
160856931|NCT02960217|580866586|FG001|Open-Label Extension Phase|Adverse Event|0|||
160856932|NCT02960217|580866585|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
160856933|NCT02960217|580866586|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
160856934|NCT02960217|580866585|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
160856935|NCT02960217|580866586|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
160856936|NCT02960217|580866585|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
160856937|NCT02960217|580866586|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
160856938|NCT02734693|580866587|FG000|Overall Study|Adverse Event|1|||
160856939|NCT02734693|580866588|FG001|Overall Study|Adverse Event|3|||
160856940|NCT02734693|580866589|FG002|Overall Study|Adverse Event|3|||
160856941|NCT02734693|580866587|FG000|Overall Study|Lack of Efficacy|1|||
160856942|NCT02734693|580866588|FG001|Overall Study|Lack of Efficacy|0|||
160856943|NCT02734693|580866589|FG002|Overall Study|Lack of Efficacy|0|||
160856944|NCT02734693|580866587|FG000|Overall Study|Lost to Follow-up|2|||
160856945|NCT02734693|580866588|FG001|Overall Study|Lost to Follow-up|0|||
160856946|NCT02734693|580866589|FG002|Overall Study|Lost to Follow-up|0|||
160856947|NCT02734693|580866587|FG000|Overall Study|Protocol Violation|1|||
160908483|NCT03547583|581058171|FG000|Overall Study|Physician Decision|1|||
160908484|NCT03547583|581058172|FG001|Overall Study|Physician Decision|0|||
160908485|NCT03547583|581058173|FG002|Overall Study|Physician Decision|3|||
161255716|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160908486|NCT03547583|581058171|FG000|Overall Study|Protocol Violation|2|||
161255717|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161255718|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
160856948|NCT02734693|580866588|FG001|Overall Study|Protocol Violation|0|||
160856949|NCT02734693|580866589|FG002|Overall Study|Protocol Violation|0|||
160856950|NCT02734693|580866587|FG000|Overall Study|Withdrawal by Subject|1|||
160908487|NCT03547583|581058172|FG001|Overall Study|Protocol Violation|1|||
160908488|NCT03547583|581058173|FG002|Overall Study|Protocol Violation|1|||
160908489|NCT03547583|581058171|FG000|Overall Study|Withdrawal by Subject|12|||
160908490|NCT03547583|581058172|FG001|Overall Study|Withdrawal by Subject|19|||
160856951|NCT02734693|580866588|FG001|Overall Study|Withdrawal by Subject|0|||
160856952|NCT02734693|580866589|FG002|Overall Study|Withdrawal by Subject|0|||
160856953|NCT00849940|580866599|FG000|Overall Study|Physician Decision|4|||
160856954|NCT03353675|580866603|FG000|Overall Study|Adverse Event|4|||
160856955|NCT00402168|580866604|FG000|Randomized|Lost to Follow-up|1|||
160856956|NCT00402168|580866605|FG001|Randomized|Lost to Follow-up|0|||
160856957|NCT00402168|580866604|FG000|Randomized|Withdrawal by Subject|0|||
160856958|NCT00402168|580866605|FG001|Randomized|Withdrawal by Subject|1|||
160856959|NCT00402168|580866604|FG000|Treatment (up to 12 Months)|Death|0|||
160856960|NCT00402168|580866605|FG001|Treatment (up to 12 Months)|Death|1|||
160856961|NCT00402168|580866604|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
160856962|NCT00402168|580866605|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
160856963|NCT00402168|580866604|FG000|Treatment (up to 12 Months)|non-specified|0|||
160856964|NCT00402168|580866605|FG001|Treatment (up to 12 Months)|non-specified|1|||
160856965|NCT00402168|580866604|FG000|Long Term (LT)|Adverse Event|1|||
160856966|NCT00402168|580866605|FG001|Long Term (LT)|Adverse Event|5|||
160856967|NCT00402168|580866604|FG000|Long Term (LT)|Withdrawal by Subject|4|||
160856968|NCT00402168|580866605|FG001|Long Term (LT)|Withdrawal by Subject|7|||
160856969|NCT00402168|580866604|FG000|Long Term (LT)|Pregnancy|0|||
160856970|NCT00402168|580866605|FG001|Long Term (LT)|Pregnancy|1|||
160856971|NCT00402168|580866604|FG000|Long Term (LT)|Lost to Follow-up|1|||
160856972|NCT00402168|580866605|FG001|Long Term (LT)|Lost to Follow-up|0|||
160856973|NCT00402168|580866604|FG000|Long Term (LT)|Death|4|||
160856974|NCT00402168|580866605|FG001|Long Term (LT)|Death|0|||
160856975|NCT00402168|580866604|FG000|Long Term (LT)|Lack of Efficacy|0|||
160856976|NCT00402168|580866605|FG001|Long Term (LT)|Lack of Efficacy|2|||
160856977|NCT00402168|580866604|FG000|Long Term (LT)|non-specified|1|||
160856978|NCT00402168|580866605|FG001|Long Term (LT)|non-specified|2|||
160856979|NCT00402168|580866604|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
160856980|NCT00402168|580866605|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
160856981|NCT00402168|580866604|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
160856982|NCT00402168|580866605|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
160856983|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
160856984|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
160856985|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
160856986|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
160856987|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
160856988|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
160856989|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
160856990|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
160856991|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
160856992|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
160856993|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
160856994|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
160856995|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
160856996|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
160856997|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
160856998|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
160856999|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
160857000|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
160857001|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
160857002|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
160857003|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
160857004|NCT00550407|580866608|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
160857005|NCT00550407|580866609|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
160857006|NCT00550407|580866610|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
160857007|NCT00550407|580866608|FG000|26-Week Randomized Phase|Adverse Event|0|||
160857008|NCT00550407|580866609|FG001|26-Week Randomized Phase|Adverse Event|5|||
160857009|NCT00550407|580866610|FG002|26-Week Randomized Phase|Adverse Event|2|||
160857010|NCT00550407|580866608|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
160857011|NCT00550407|580866609|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
160857012|NCT00550407|580866610|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
160857013|NCT00550407|580866608|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
160857014|NCT00550407|580866609|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
160857015|NCT00550407|580866610|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
160857016|NCT00550407|580866608|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
160857017|NCT00550407|580866609|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
160857018|NCT00550407|580866610|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
160857019|NCT00584415|580866611|FG000|Overall Study|Adverse Event|7|||
160857020|NCT02370420|580866612|FG000|Overall Study|Physician Decision|3|||
160857021|NCT02370420|580866613|FG001|Overall Study|Physician Decision|3|||
160857022|NCT02370420|580866612|FG000|Overall Study|Lost to Follow-up|11|||
160857023|NCT02370420|580866613|FG001|Overall Study|Lost to Follow-up|9|||
160857024|NCT00556894|580866614|FG000|Overall Study|Adverse Event|2|||
160857025|NCT00556894|580866615|FG001|Overall Study|Adverse Event|3|||
160857026|NCT00556894|580866616|FG002|Overall Study|Adverse Event|3|||
160857027|NCT00556894|580866614|FG000|Overall Study|Death|1|||
160857028|NCT00556894|580866615|FG001|Overall Study|Death|0|||
160857029|NCT00556894|580866616|FG002|Overall Study|Death|0|||
160857030|NCT00556894|580866614|FG000|Overall Study|regulatory decision in Bulgaria|10|||
160857031|NCT00556894|580866615|FG001|Overall Study|regulatory decision in Bulgaria|14|||
160857032|NCT00556894|580866616|FG002|Overall Study|regulatory decision in Bulgaria|13|||
160857033|NCT00556894|580866614|FG000|Overall Study|Change in therapy|2|||
160857034|NCT00556894|580866615|FG001|Overall Study|Change in therapy|1|||
160857035|NCT00556894|580866616|FG002|Overall Study|Change in therapy|2|||
160857036|NCT00556894|580866614|FG000|Overall Study|Withdrawal by Subject|1|||
160857037|NCT00556894|580866615|FG001|Overall Study|Withdrawal by Subject|1|||
160857038|NCT00556894|580866616|FG002|Overall Study|Withdrawal by Subject|1|||
160857039|NCT03883581|580866617|FG000|Overall Study|Withdrawal by Subject|4|||
160857040|NCT05190120|580866621|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
160857041|NCT05190120|580866622|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
160857042|NCT05190120|580866623|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
160857043|NCT05190120|580866624|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
160857044|NCT05190120|580866621|FG000|Overall Study|Lost to Follow-up|5|||
160857045|NCT05190120|580866622|FG001|Overall Study|Lost to Follow-up|0|||
160857046|NCT05190120|580866623|FG002|Overall Study|Lost to Follow-up|2|||
160857047|NCT05190120|580866624|FG003|Overall Study|Lost to Follow-up|3|||
160857048|NCT05893862|580866627|FG000|Overall Study|Physician Decision|0|||
160857049|NCT05893862|580866628|FG001|Overall Study|Physician Decision|1|||
160857050|NCT05893862|580866629|FG002|Overall Study|Physician Decision|0|||
160857051|NCT05893862|580866630|FG003|Overall Study|Physician Decision|0|||
160857052|NCT05893862|580866631|FG004|Overall Study|Physician Decision|1|||
160857053|NCT05893862|580866632|FG005|Overall Study|Physician Decision|0|||
160857054|NCT05893862|580866627|FG000|Overall Study|Withdrawal by Subject|1|||
160857055|NCT05893862|580866628|FG001|Overall Study|Withdrawal by Subject|7|||
160857056|NCT05893862|580866629|FG002|Overall Study|Withdrawal by Subject|1|||
160857057|NCT05893862|580866630|FG003|Overall Study|Withdrawal by Subject|3|||
160857058|NCT05893862|580866631|FG004|Overall Study|Withdrawal by Subject|3|||
160857059|NCT05893862|580866632|FG005|Overall Study|Withdrawal by Subject|2|||
160857060|NCT05893862|580866627|FG000|Overall Study|Adverse Event|1|||
160857061|NCT05893862|580866628|FG001|Overall Study|Adverse Event|4|||
160857062|NCT05893862|580866629|FG002|Overall Study|Adverse Event|2|||
160857063|NCT05893862|580866630|FG003|Overall Study|Adverse Event|2|||
160857064|NCT05893862|580866631|FG004|Overall Study|Adverse Event|1|||
160857065|NCT05893862|580866632|FG005|Overall Study|Adverse Event|0|||
160857066|NCT00410956|580866633|FG000|Overall Study|Adverse Event|1|||
160857067|NCT00410956|580866633|FG000|Overall Study|Death|2|||
160857068|NCT00410956|580866633|FG000|Overall Study|Lack of Efficacy|10|||
160857069|NCT00410956|580866633|FG000|Overall Study|Physician Decision|6|||
160857070|NCT00755183|580868789|FG000|Overall Study|Adverse Event|5|||
160857071|NCT00755183|580868790|FG001|Overall Study|Adverse Event|2|||
160857072|NCT00755183|580868789|FG000|Overall Study|Protocol Violation|0|||
160857073|NCT00755183|580868790|FG001|Overall Study|Protocol Violation|1|||
160857074|NCT00755183|580868789|FG000|Overall Study|Withdrawal by Subject|0|||
160857075|NCT00755183|580868790|FG001|Overall Study|Withdrawal by Subject|2|||
160857076|NCT00755183|580868789|FG000|Overall Study|Administrative|2|||
160857077|NCT00755183|580868790|FG001|Overall Study|Administrative|1|||
160857078|NCT02587520|580868791|FG000|Overall Study|Protocol Violation|2|||
161255719|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161255720|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161255721|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161255722|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
161255723|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
161255724|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255725|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255726|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255727|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255728|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255729|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255730|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255731|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
161255732|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
161255733|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
160857079|NCT02587520|580868792|FG001|Overall Study|Protocol Violation|0|||
161338250|NCT04006457|582628781|FG001|Main Study Observation Period|Lost to Follow-up|1|||
161338251|NCT04006457|582628782|FG002|Main Study Observation Period|Lost to Follow-up|0|||
161255734|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161255735|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161255736|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161255737|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161255738|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161255739|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161255740|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
161338252|NCT04006457|582628780|FG000|Main Study Observation Period|Pregnancy|1|||
161338253|NCT04006457|582628781|FG001|Main Study Observation Period|Pregnancy|0|||
161338254|NCT04006457|582628782|FG002|Main Study Observation Period|Pregnancy|0|||
161338255|NCT04006457|582628780|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
161338256|NCT04006457|582628781|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
161338257|NCT04006457|582628782|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
161338258|NCT04006457|582628780|FG000|Main Study Observation Period|Other|8|||
161338259|NCT04006457|582628781|FG001|Main Study Observation Period|Other|16|||
161338260|NCT04006457|582628782|FG002|Main Study Observation Period|Other|0|||
161338261|NCT04006457|582628780|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
161338262|NCT04006457|582628781|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
161338263|NCT04006457|582628782|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
161338264|NCT04006457|582628780|FG000|Main Study Observation Period|Ongoing|2|||
161338265|NCT04006457|582628781|FG001|Main Study Observation Period|Ongoing|1|||
161338266|NCT04006457|582628782|FG002|Main Study Observation Period|Ongoing|0|||
161338267|NCT04006457|582628780|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
161338268|NCT04006457|582628781|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
161338269|NCT04006457|582628782|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
161338270|NCT03370172|582628783|FG000|Overall Study|Withdrawal by Subject|0|||
161255741|NCT00739973|582314255|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
161255742|NCT00739973|582314256|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161255743|NCT00739973|582314257|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161255744|NCT00739973|582314258|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161255745|NCT00739973|582314259|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160857080|NCT02587520|580868793|FG002|Overall Study|Protocol Violation|0|||
160857081|NCT02587520|580868794|FG003|Overall Study|Protocol Violation|2|||
160857082|NCT02587520|580868795|FG004|Overall Study|Protocol Violation|0|||
160857083|NCT02587520|580868796|FG005|Overall Study|Protocol Violation|1|||
161255746|NCT00739973|582314260|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161255747|NCT00739973|582314261|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161338271|NCT03370172|582628784|FG001|Overall Study|Withdrawal by Subject|1|||
161338272|NCT05918055|582628785|FG000|Phase I - Dose Level 1|Ineligible|0|||
161338273|NCT05918055|582628786|FG001|Phase I - Dose Level 1|Ineligible|0|||
160857084|NCT02587520|580868797|FG006|Overall Study|Protocol Violation|1|||
160857085|NCT02587520|580868798|FG007|Overall Study|Protocol Violation|1|||
160857086|NCT02587520|580868799|FG008|Overall Study|Protocol Violation|3|||
160857087|NCT02587520|580868800|FG009|Overall Study|Protocol Violation|3|||
160857088|NCT02587520|580868801|FG010|Overall Study|Protocol Violation|1|||
160857089|NCT02587520|580868802|FG011|Overall Study|Protocol Violation|2|||
160857090|NCT02587520|580868803|FG012|Overall Study|Protocol Violation|0|||
160857091|NCT02587520|580868804|FG013|Overall Study|Protocol Violation|0|||
160857092|NCT02587520|580868805|FG014|Overall Study|Protocol Violation|0|||
160857093|NCT02587520|580868806|FG015|Overall Study|Protocol Violation|0|||
160857094|NCT02587520|580868807|FG016|Overall Study|Protocol Violation|0|||
160857095|NCT02587520|580868808|FG017|Overall Study|Protocol Violation|0|||
160857096|NCT02587520|580868791|FG000|Overall Study|Adverse Event|0|||
160857097|NCT02587520|580868792|FG001|Overall Study|Adverse Event|0|||
160857098|NCT02587520|580868793|FG002|Overall Study|Adverse Event|0|||
160857099|NCT02587520|580868794|FG003|Overall Study|Adverse Event|0|||
160857100|NCT02587520|580868795|FG004|Overall Study|Adverse Event|0|||
160857101|NCT02587520|580868796|FG005|Overall Study|Adverse Event|0|||
160857102|NCT02587520|580868797|FG006|Overall Study|Adverse Event|0|||
160857103|NCT02587520|580868798|FG007|Overall Study|Adverse Event|0|||
160857104|NCT02587520|580868799|FG008|Overall Study|Adverse Event|0|||
160857105|NCT02587520|580868800|FG009|Overall Study|Adverse Event|0|||
160857106|NCT02587520|580868801|FG010|Overall Study|Adverse Event|0|||
160857107|NCT02587520|580868802|FG011|Overall Study|Adverse Event|1|||
160857108|NCT02587520|580868803|FG012|Overall Study|Adverse Event|0|||
160857109|NCT02587520|580868804|FG013|Overall Study|Adverse Event|0|||
160857110|NCT02587520|580868805|FG014|Overall Study|Adverse Event|0|||
160857111|NCT02587520|580868806|FG015|Overall Study|Adverse Event|0|||
160857112|NCT02587520|580868807|FG016|Overall Study|Adverse Event|0|||
160857113|NCT02587520|580868808|FG017|Overall Study|Adverse Event|0|||
160857114|NCT02587520|580868791|FG000|Overall Study|Withdrawal by Subject|0|||
161338274|NCT05918055|582628787|FG002|Phase I - Dose Level 1|Ineligible|1|||
161255748|NCT00739973|582314262|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
161255749|NCT00739973|582314263|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
160993910|NCT01956669|581367325|FG005|Overall Study|Adverse Event|0|||
160993911|NCT01956669|581367326|FG006|Overall Study|Adverse Event|0|||
160993912|NCT01956669|581367320|FG000|Overall Study|Physician Decision|0|||
160993913|NCT01956669|581367321|FG001|Overall Study|Physician Decision|2|||
160993914|NCT01956669|581367322|FG002|Overall Study|Physician Decision|0|||
160993915|NCT01956669|581367323|FG003|Overall Study|Physician Decision|0|||
160993916|NCT01956669|581367324|FG004|Overall Study|Physician Decision|0|||
160993917|NCT01956669|581367325|FG005|Overall Study|Physician Decision|1|||
160993918|NCT01956669|581367326|FG006|Overall Study|Physician Decision|0|||
160993919|NCT01956669|581367320|FG000|Overall Study|Withdrawal by Subject|0|||
160993920|NCT01956669|581367321|FG001|Overall Study|Withdrawal by Subject|0|||
160993921|NCT01956669|581367322|FG002|Overall Study|Withdrawal by Subject|1|||
160993922|NCT01956669|581367323|FG003|Overall Study|Withdrawal by Subject|1|||
160993923|NCT01956669|581367324|FG004|Overall Study|Withdrawal by Subject|0|||
160993924|NCT01956669|581367325|FG005|Overall Study|Withdrawal by Subject|0|||
160993925|NCT01956669|581367326|FG006|Overall Study|Withdrawal by Subject|1|||
160993926|NCT01570751|581367327|FG000|Period A (16 Weeks)|Protocol Violation|1|||
160993927|NCT01570751|581367328|FG001|Period A (16 Weeks)|Protocol Violation|1|||
160993928|NCT01570751|581367327|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
160993929|NCT01570751|581367328|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
160993930|NCT01570751|581367327|FG000|Period A (16 Weeks)|Unclassified|2|||
160993931|NCT01570751|581367328|FG001|Period A (16 Weeks)|Unclassified|3|||
160993932|NCT01570751|581367327|FG000|Period B (16 Weeks)|Adverse Event|1|||
160993933|NCT01570751|581367328|FG001|Period B (16 Weeks)|Adverse Event|0|||
160993934|NCT01570751|581367327|FG000|Period B (16 Weeks)|Protocol Violation|0|||
160993935|NCT01570751|581367328|FG001|Period B (16 Weeks)|Protocol Violation|1|||
160993936|NCT01131494|581367333|FG000|Overall Study|Withdrawal by Subject|2|||
160993937|NCT05419557|581367334|FG000|Overall Study|Lost to Follow-up|11|||
160993938|NCT05419557|581367335|FG001|Overall Study|Lost to Follow-up|4|||
160993939|NCT01196988|581367337|FG000|Overall Study|Adverse Event|1|||
160993940|NCT01196988|581367338|FG001|Overall Study|Adverse Event|2|||
160993941|NCT01196988|581367339|FG002|Overall Study|Adverse Event|0|||
160993942|NCT01196988|581367340|FG003|Overall Study|Adverse Event|0|||
160993943|NCT01196988|581367337|FG000|Overall Study|Withdrawal by Subject|5|||
160993944|NCT01196988|581367338|FG001|Overall Study|Withdrawal by Subject|1|||
160993945|NCT01196988|581367339|FG002|Overall Study|Withdrawal by Subject|4|||
160993946|NCT01196988|581367340|FG003|Overall Study|Withdrawal by Subject|0|||
160993947|NCT01196988|581367337|FG000|Overall Study|Lost to Follow-up|16|||
160993948|NCT01196988|581367338|FG001|Overall Study|Lost to Follow-up|29|||
160993949|NCT01196988|581367339|FG002|Overall Study|Lost to Follow-up|21|||
160993950|NCT01196988|581367340|FG003|Overall Study|Lost to Follow-up|1|||
160993951|NCT01196988|581367337|FG000|Overall Study|Other|2|||
160993952|NCT01196988|581367338|FG001|Overall Study|Other|0|||
160993953|NCT01196988|581367339|FG002|Overall Study|Other|0|||
160993954|NCT01196988|581367340|FG003|Overall Study|Other|0|||
160993955|NCT02281318|581367342|FG000|Overall Study|Adverse Event|2|||
160993956|NCT02281318|581367343|FG001|Overall Study|Adverse Event|2|||
160993957|NCT02281318|581367342|FG000|Overall Study|Lack of Efficacy|2|||
160993958|NCT02281318|581367343|FG001|Overall Study|Lack of Efficacy|0|||
160993959|NCT02281318|581367342|FG000|Overall Study|Lost to Follow-up|2|||
160993960|NCT02281318|581367343|FG001|Overall Study|Lost to Follow-up|1|||
160993961|NCT02281318|581367342|FG000|Overall Study|Physician Decision|2|||
160993962|NCT02281318|581367343|FG001|Overall Study|Physician Decision|0|||
160993963|NCT02281318|581367342|FG000|Overall Study|Withdrawal by Subject|6|||
160993964|NCT02281318|581367343|FG001|Overall Study|Withdrawal by Subject|2|||
160993965|NCT05257798|581367344|FG000|Follow-up Phase|Lost to Follow-up|1|||
160993966|NCT05257798|581367345|FG001|Follow-up Phase|Lost to Follow-up|0|||
160993967|NCT00703911|581367346|FG000|Overall Study|Death|1|||
160993968|NCT00703911|581367346|FG000|Overall Study|Physician Decision|6|||
160993969|NCT00703911|581367346|FG000|Overall Study|Lost to Follow-up|1|||
160993970|NCT00703911|581367346|FG000|Overall Study|Withdrawal by Subject|2|||
160993971|NCT01064817|581367347|FG000|Study Completion|Physician Decision|1|||
160993972|NCT01064817|581367348|FG001|Study Completion|Physician Decision|0|||
160993973|NCT01064817|581367347|FG000|Study Completion|Withdrawal by Subject|1|||
160993974|NCT01064817|581367348|FG001|Study Completion|Withdrawal by Subject|0|||
160993975|NCT03102710|581367349|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
160993976|NCT03102710|581367350|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
160993977|NCT03102710|581367351|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
161255750|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161255751|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
160993978|NCT03102710|581367349|FG000|Overall Study|Technical issues during final MRI scan|0|||
160993979|NCT03102710|581367350|FG001|Overall Study|Technical issues during final MRI scan|1|||
160993980|NCT03102710|581367351|FG002|Overall Study|Technical issues during final MRI scan|0|||
160993981|NCT03102710|581367349|FG000|Overall Study|Nausea during MRI scan|0|||
160993982|NCT03102710|581367350|FG001|Overall Study|Nausea during MRI scan|1|||
161338275|NCT05918055|582628785|FG000|Phase I - Dose Level -1|Physician Decision|1|||
161338276|NCT05918055|582628786|FG001|Phase I - Dose Level -1|Physician Decision|0|||
161338277|NCT05918055|582628787|FG002|Phase I - Dose Level -1|Physician Decision|0|||
161338278|NCT02194465|582628788|FG000|Overall Study|Adverse Event|6|||
161338279|NCT02194465|582628789|FG001|Overall Study|Adverse Event|1|||
161338280|NCT02194465|582628790|FG002|Overall Study|Adverse Event|4|||
161338281|NCT02194465|582628791|FG003|Overall Study|Adverse Event|4|||
161338282|NCT02194465|582628792|FG004|Overall Study|Adverse Event|4|||
161338283|NCT02194465|582628793|FG005|Overall Study|Adverse Event|2|||
161338284|NCT02194465|582628794|FG006|Overall Study|Adverse Event|0|||
161338285|NCT02194465|582628788|FG000|Overall Study|Lost to Follow-up|0|||
161338286|NCT02194465|582628789|FG001|Overall Study|Lost to Follow-up|0|||
161338287|NCT02194465|582628790|FG002|Overall Study|Lost to Follow-up|0|||
161338288|NCT02194465|582628791|FG003|Overall Study|Lost to Follow-up|1|||
160993983|NCT03102710|581367351|FG002|Overall Study|Nausea during MRI scan|0|||
160993984|NCT03102710|581367349|FG000|Overall Study|Subject unable to attend final session|0|||
160993985|NCT03102710|581367350|FG001|Overall Study|Subject unable to attend final session|1|||
160993986|NCT03102710|581367351|FG002|Overall Study|Subject unable to attend final session|0|||
160993987|NCT01368406|581367352|FG000|Overall Study|Lost to Follow-up|8|||
160993988|NCT01368406|581367353|FG001|Overall Study|Lost to Follow-up|4|||
160993989|NCT01368406|581367352|FG000|Overall Study|Withdrawal by Subject|8|||
161338289|NCT02194465|582628792|FG004|Overall Study|Lost to Follow-up|0|||
160857115|NCT02587520|580868792|FG001|Overall Study|Withdrawal by Subject|0|||
160857116|NCT02587520|580868793|FG002|Overall Study|Withdrawal by Subject|1|||
160857117|NCT02587520|580868794|FG003|Overall Study|Withdrawal by Subject|1|||
160857118|NCT02587520|580868795|FG004|Overall Study|Withdrawal by Subject|0|||
160857119|NCT02587520|580868796|FG005|Overall Study|Withdrawal by Subject|1|||
160857120|NCT02587520|580868797|FG006|Overall Study|Withdrawal by Subject|1|||
160857121|NCT02587520|580868798|FG007|Overall Study|Withdrawal by Subject|0|||
160857122|NCT02587520|580868799|FG008|Overall Study|Withdrawal by Subject|0|||
160857123|NCT02587520|580868800|FG009|Overall Study|Withdrawal by Subject|0|||
160857124|NCT02587520|580868801|FG010|Overall Study|Withdrawal by Subject|0|||
160857125|NCT02587520|580868802|FG011|Overall Study|Withdrawal by Subject|0|||
160857126|NCT02587520|580868803|FG012|Overall Study|Withdrawal by Subject|0|||
160857127|NCT02587520|580868804|FG013|Overall Study|Withdrawal by Subject|1|||
160857128|NCT02587520|580868805|FG014|Overall Study|Withdrawal by Subject|0|||
160857129|NCT02587520|580868806|FG015|Overall Study|Withdrawal by Subject|0|||
160857130|NCT02587520|580868807|FG016|Overall Study|Withdrawal by Subject|0|||
160857131|NCT02587520|580868808|FG017|Overall Study|Withdrawal by Subject|0|||
160857132|NCT02587520|580868791|FG000|Overall Study|Lost to Follow-up|0|||
160857133|NCT02587520|580868792|FG001|Overall Study|Lost to Follow-up|2|||
160908491|NCT03547583|581058173|FG002|Overall Study|Withdrawal by Subject|10|||
160908492|NCT03547583|581058171|FG000|Overall Study|Other|2|||
160908493|NCT03547583|581058172|FG001|Overall Study|Other|2|||
160908494|NCT03547583|581058173|FG002|Overall Study|Other|3|||
160908495|NCT01949506|581058179|FG000|Overall Study|Physician Decision|1|||
160908496|NCT01446289|581058180|FG000|Overall Study|Withdrawal by Subject|1|||
160908497|NCT01446289|581058181|FG001|Overall Study|Withdrawal by Subject|0|||
160908498|NCT01446289|581058182|FG002|Overall Study|Withdrawal by Subject|1|||
160908499|NCT01446289|581058183|FG003|Overall Study|Withdrawal by Subject|0|||
160908500|NCT02513394|581058189|FG000|Overall Study|Withdrawal by Subject|11|||
160908501|NCT02513394|581058190|FG001|Overall Study|Withdrawal by Subject|23|||
160908502|NCT02513394|581058189|FG000|Overall Study|Ineligible|1|||
160908503|NCT02513394|581058190|FG001|Overall Study|Ineligible|0|||
160908504|NCT00612690|581059932|FG000|Overall Study|Lost to Follow-up|72|||
160908505|NCT00612690|581059933|FG001|Overall Study|Lost to Follow-up|98|||
160908506|NCT00612690|581059932|FG000|Overall Study|Withdrawal by Subject|32|||
160908507|NCT00612690|581059933|FG001|Overall Study|Withdrawal by Subject|20|||
160908508|NCT00612690|581059932|FG000|Overall Study|Withdrawal by Site|11|||
160908509|NCT00612690|581059933|FG001|Overall Study|Withdrawal by Site|0|||
160908510|NCT01664533|581059934|FG000|Overall Study|Death|42|||
160908511|NCT01664533|581059934|FG000|Overall Study|Lost to Follow-up|3|||
160908512|NCT01664533|581059934|FG000|Overall Study|Study termination|9|||
160993990|NCT01368406|581367353|FG001|Overall Study|Withdrawal by Subject|4|||
160993991|NCT01368406|581367352|FG000|Overall Study|relapse of the disease|3|||
160857134|NCT02587520|580868793|FG002|Overall Study|Lost to Follow-up|0|||
160857135|NCT02587520|580868794|FG003|Overall Study|Lost to Follow-up|2|||
160857136|NCT02587520|580868795|FG004|Overall Study|Lost to Follow-up|0|||
160857137|NCT02587520|580868796|FG005|Overall Study|Lost to Follow-up|1|||
160908513|NCT01664533|581059934|FG000|Overall Study|Protocol Violation|3|||
160908514|NCT00844831|581059936|FG000|Overall Study|Withdrawal by Subject|4|||
160908515|NCT00844831|581059936|FG000|Overall Study|Adverse Event|1|||
160908516|NCT00844831|581059936|FG000|Overall Study|Physician Decision|1|||
160908517|NCT05255068|581059937|FG000|Overall Study|Lost to Follow-up|0|||
160908518|NCT05255068|581059938|FG001|Overall Study|Lost to Follow-up|1|||
161338290|NCT02194465|582628793|FG005|Overall Study|Lost to Follow-up|1|||
161338291|NCT02194465|582628794|FG006|Overall Study|Lost to Follow-up|0|||
161338292|NCT02194465|582628788|FG000|Overall Study|Physician Decision|1|||
160908519|NCT03156543|581059940|FG000|Overall Study|Withdrawal by Subject|1|||
160908520|NCT03156543|581059941|FG001|Overall Study|Withdrawal by Subject|0|||
160908521|NCT02891850|581059942|FG000|Overall Study|Adverse Event|3|||
160908522|NCT02891850|581059943|FG001|Overall Study|Adverse Event|0|||
160908523|NCT02891850|581059942|FG000|Overall Study|Death|0|||
160908524|NCT02891850|581059943|FG001|Overall Study|Death|4|||
160908525|NCT02891850|581059942|FG000|Overall Study|Physician Decision|1|||
160908526|NCT02891850|581059943|FG001|Overall Study|Physician Decision|0|||
160908527|NCT02891850|581059942|FG000|Overall Study|Pregnancy|1|||
160908528|NCT02891850|581059943|FG001|Overall Study|Pregnancy|0|||
160908529|NCT02891850|581059942|FG000|Overall Study|Withdrawal by Subject|2|||
160908530|NCT02891850|581059943|FG001|Overall Study|Withdrawal by Subject|3|||
160908531|NCT02397278|581059944|FG000|Overall Study|Withdrawal by Subject|0|||
160908532|NCT02397278|581059945|FG001|Overall Study|Withdrawal by Subject|2|||
160908533|NCT02397278|581059944|FG000|Overall Study|Deemed ineligible following surgery|1|||
160908534|NCT02397278|581059945|FG001|Overall Study|Deemed ineligible following surgery|1|||
160908535|NCT00573469|581059946|FG000|Overall Study|Adverse Event|1|||
160908536|NCT00573469|581059947|FG001|Overall Study|Adverse Event|1|||
160908537|NCT00573469|581059948|FG002|Overall Study|Adverse Event|1|||
160908538|NCT00573469|581059946|FG000|Overall Study|Withdrawal by Subject|0|||
160908539|NCT00573469|581059947|FG001|Overall Study|Withdrawal by Subject|2|||
160908540|NCT00573469|581059948|FG002|Overall Study|Withdrawal by Subject|0|||
160908541|NCT00573469|581059946|FG000|Overall Study|Other|5|||
160908542|NCT00573469|581059947|FG001|Overall Study|Other|1|||
160908543|NCT00573469|581059948|FG002|Overall Study|Other|3|||
160908544|NCT00004978|581059949|FG000|Overall Study|Death|107|||
160908545|NCT00004978|581059950|FG001|Overall Study|Death|116|||
160908546|NCT00004978|581059949|FG000|Overall Study|Lost to Follow-up|101|||
160908547|NCT00004978|581059950|FG001|Overall Study|Lost to Follow-up|108|||
160908548|NCT00004978|581059949|FG000|Overall Study|Withdrawal by Subject|17|||
160908549|NCT00004978|581059950|FG001|Overall Study|Withdrawal by Subject|26|||
160908550|NCT00004978|581059949|FG000|Overall Study|site closure - not in analysis cohort|19|||
160908551|NCT00004978|581059950|FG001|Overall Study|site closure - not in analysis cohort|20|||
160908552|NCT02155608|581059957|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
160908553|NCT02155608|581059958|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
160908554|NCT02155608|581059957|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
160908555|NCT02155608|581059958|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
160908556|NCT03555591|581059959|FG000|Overall Study|Protocol Violation|77|||
160908557|NCT01532414|581059962|FG000|Overall Study|Lost to Follow-up|3|||
160908558|NCT01532414|581059963|FG001|Overall Study|Lost to Follow-up|0|||
160908559|NCT01532414|581059964|FG002|Overall Study|Lost to Follow-up|1|||
160908560|NCT01532414|581059962|FG000|Overall Study|Withdrawal by Subject|3|||
160908561|NCT01532414|581059963|FG001|Overall Study|Withdrawal by Subject|0|||
160908562|NCT01532414|581059964|FG002|Overall Study|Withdrawal by Subject|0|||
160908563|NCT01532414|581059962|FG000|Overall Study|No V6 semen sample|0|||
160908564|NCT01532414|581059963|FG001|Overall Study|No V6 semen sample|1|||
160908565|NCT01532414|581059964|FG002|Overall Study|No V6 semen sample|0|||
160908566|NCT01532414|581059962|FG000|Overall Study|Adverse Event|0|||
160908567|NCT01532414|581059963|FG001|Overall Study|Adverse Event|1|||
160908568|NCT01532414|581059964|FG002|Overall Study|Adverse Event|1|||
160908569|NCT01532414|581059962|FG000|Overall Study|Unable to complete 24 hour PK|0|||
160908570|NCT01532414|581059963|FG001|Overall Study|Unable to complete 24 hour PK|0|||
160908571|NCT01532414|581059964|FG002|Overall Study|Unable to complete 24 hour PK|1|||
160908572|NCT01532414|581059962|FG000|Overall Study|Withdrawn by sponsor|1|||
160908573|NCT01532414|581059963|FG001|Overall Study|Withdrawn by sponsor|0|||
160908574|NCT01532414|581059964|FG002|Overall Study|Withdrawn by sponsor|0|||
160908575|NCT00684593|581059965|FG000|Overall Study|Adverse Event|0|||
160908576|NCT00684593|581059966|FG001|Overall Study|Adverse Event|2|||
160908577|NCT02380677|581059974|FG000|Overall Study|Adverse Event|0|||
160908578|NCT02380677|581059975|FG001|Overall Study|Adverse Event|0|||
160908579|NCT02380677|581059976|FG002|Overall Study|Adverse Event|0|||
160908580|NCT02380677|581059977|FG003|Overall Study|Adverse Event|1|||
160908581|NCT02380677|581059978|FG004|Overall Study|Adverse Event|1|||
160908582|NCT02380677|581059979|FG005|Overall Study|Adverse Event|4|||
161141487|NCT01009463|581902511|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
160908583|NCT02380677|581059980|FG006|Overall Study|Adverse Event|2|||
160908584|NCT02380677|581059981|FG007|Overall Study|Adverse Event|2|||
160908585|NCT02380677|581059982|FG008|Overall Study|Adverse Event|2|||
160908586|NCT02380677|581059983|FG009|Overall Study|Adverse Event|1|||
160908587|NCT02380677|581059984|FG010|Overall Study|Adverse Event|2|||
160908588|NCT02380677|581059985|FG011|Overall Study|Adverse Event|1|||
160908589|NCT02380677|581059974|FG000|Overall Study|Physician Decision|1|||
160908590|NCT02380677|581059975|FG001|Overall Study|Physician Decision|0|||
160908591|NCT02380677|581059976|FG002|Overall Study|Physician Decision|1|||
160908592|NCT02380677|581059977|FG003|Overall Study|Physician Decision|1|||
160908593|NCT02380677|581059978|FG004|Overall Study|Physician Decision|0|||
160908594|NCT02380677|581059979|FG005|Overall Study|Physician Decision|0|||
160908595|NCT02380677|581059980|FG006|Overall Study|Physician Decision|0|||
160857138|NCT02587520|580868797|FG006|Overall Study|Lost to Follow-up|1|||
160857139|NCT02587520|580868798|FG007|Overall Study|Lost to Follow-up|1|||
160857140|NCT02587520|580868799|FG008|Overall Study|Lost to Follow-up|0|||
160857141|NCT02587520|580868800|FG009|Overall Study|Lost to Follow-up|2|||
160857142|NCT02587520|580868801|FG010|Overall Study|Lost to Follow-up|2|||
160857143|NCT02587520|580868802|FG011|Overall Study|Lost to Follow-up|1|||
160857144|NCT02587520|580868803|FG012|Overall Study|Lost to Follow-up|0|||
160857145|NCT02587520|580868804|FG013|Overall Study|Lost to Follow-up|0|||
160857146|NCT02587520|580868805|FG014|Overall Study|Lost to Follow-up|0|||
160857147|NCT02587520|580868806|FG015|Overall Study|Lost to Follow-up|0|||
160857148|NCT02587520|580868807|FG016|Overall Study|Lost to Follow-up|0|||
160857149|NCT02587520|580868808|FG017|Overall Study|Lost to Follow-up|0|||
160857150|NCT00672555|580868809|FG000|Overall Study|Lost to Follow-up|4|||
160857151|NCT00672555|580868809|FG000|Overall Study|Did not want to answer questionnaire|2|||
160857152|NCT04516746|580868812|FG000|Overall Study|Randomized but not Treated|51|||
160857153|NCT04516746|580868813|FG001|Overall Study|Randomized but not Treated|19|||
160857154|NCT04516746|580868812|FG000|Overall Study|Adverse Event|0|||
160857155|NCT04516746|580868813|FG001|Overall Study|Adverse Event|1|||
160857156|NCT04516746|580868812|FG000|Overall Study|Death|62|||
160857157|NCT04516746|580868813|FG001|Overall Study|Death|32|||
160857158|NCT04516746|580868812|FG000|Overall Study|Lost to Follow-up|3431|||
160857159|NCT04516746|580868813|FG001|Overall Study|Lost to Follow-up|1831|||
160857160|NCT04516746|580868812|FG000|Overall Study|Withdrawal by Subject|1946|||
160857161|NCT04516746|580868813|FG001|Overall Study|Withdrawal by Subject|1696|||
160857162|NCT04516746|580868812|FG000|Overall Study|Physician Decision|10|||
160857163|NCT04516746|580868813|FG001|Overall Study|Physician Decision|8|||
160857164|NCT04516746|580868812|FG000|Overall Study|Other|35|||
160857165|NCT04516746|580868813|FG001|Overall Study|Other|16|||
160857166|NCT00446849|580868815|FG000|Acute Phase|Lack of Efficacy|64|||
160857167|NCT00446849|580868815|FG000|Acute Phase|Protocol Violation|10|||
160857168|NCT00446849|580868815|FG000|Acute Phase|Consent withdrawn|4|||
160857169|NCT00446849|580868815|FG000|Acute Phase|Lost to Follow-up|2|||
160857170|NCT00446849|580868815|FG000|Acute Phase|Physician Decision|1|||
160857171|NCT00446849|580868815|FG000|Acute Phase|noncompliance|1|||
160857172|NCT00446849|580868815|FG000|Maintenance Phase|Lack of Efficacy|40|||
160857173|NCT00446849|580868815|FG000|Maintenance Phase|Protocol Violation|7|||
160857174|NCT00446849|580868815|FG000|Maintenance Phase|Adverse Event|6|||
160857175|NCT00446849|580868815|FG000|Maintenance Phase|Consent withdrawn|5|||
160857176|NCT00446849|580868815|FG000|Maintenance Phase|Lost to Follow-up|3|||
160857177|NCT00446849|580868815|FG000|Maintenance Phase|Pregnancy|1|||
160857178|NCT00446849|580868815|FG000|Maintenance Phase|noncompliance|2|||
160857179|NCT00446849|580868815|FG000|Maintenance Phase|prohibited medication use|2|||
160857180|NCT00446849|580868815|FG000|Maintenance Phase|antibiotic use|1|||
160857181|NCT00446849|580868815|FG000|Maintenance Phase|study closure|1|||
160857182|NCT00446849|580868815|FG000|Maintenance Phase|hydrocodone use|1|||
160857183|NCT00446849|580868815|FG000|Maintenance Phase|concomitant medication use|1|||
160857184|NCT05546476|580868816|FG000|Period 1: Part A|Adverse Event|2|||
160857185|NCT05546476|580868817|FG001|Period 1: Part A|Adverse Event|0|||
160857186|NCT05546476|580868818|FG002|Period 1: Part A|Adverse Event|0|||
161338293|NCT02194465|582628789|FG001|Overall Study|Physician Decision|0|||
160857187|NCT05546476|580868819|FG003|Period 1: Part A|Adverse Event|1|||
160857188|NCT05546476|580868816|FG000|Period 1: Part A|Death|4|||
160857189|NCT05546476|580868817|FG001|Period 1: Part A|Death|4|||
160857190|NCT05546476|580868818|FG002|Period 1: Part A|Death|5|||
160857191|NCT05546476|580868819|FG003|Period 1: Part A|Death|6|||
160857192|NCT05546476|580868816|FG000|Period 1: Part A|Lack of Efficacy|0|||
160857193|NCT05546476|580868817|FG001|Period 1: Part A|Lack of Efficacy|0|||
160857194|NCT05546476|580868818|FG002|Period 1: Part A|Lack of Efficacy|0|||
160908596|NCT02380677|581059981|FG007|Overall Study|Physician Decision|0|||
160908597|NCT02380677|581059982|FG008|Overall Study|Physician Decision|0|||
160908598|NCT02380677|581059983|FG009|Overall Study|Physician Decision|0|||
160908599|NCT02380677|581059984|FG010|Overall Study|Physician Decision|0|||
160908600|NCT02380677|581059985|FG011|Overall Study|Physician Decision|0|||
160908601|NCT02380677|581059974|FG000|Overall Study|Lack of Efficacy|0|||
160908602|NCT02380677|581059975|FG001|Overall Study|Lack of Efficacy|1|||
160908603|NCT02380677|581059976|FG002|Overall Study|Lack of Efficacy|2|||
160908604|NCT02380677|581059977|FG003|Overall Study|Lack of Efficacy|0|||
160908605|NCT02380677|581059978|FG004|Overall Study|Lack of Efficacy|4|||
160857195|NCT05546476|580868819|FG003|Period 1: Part A|Lack of Efficacy|1|||
160857196|NCT05546476|580868816|FG000|Period 1: Part A|Lost to Follow-up|0|||
160908606|NCT02380677|581059979|FG005|Overall Study|Lack of Efficacy|1|||
160908607|NCT02380677|581059980|FG006|Overall Study|Lack of Efficacy|1|||
160908608|NCT02380677|581059981|FG007|Overall Study|Lack of Efficacy|2|||
160857197|NCT05546476|580868817|FG001|Period 1: Part A|Lost to Follow-up|0|||
160857198|NCT05546476|580868818|FG002|Period 1: Part A|Lost to Follow-up|0|||
160857199|NCT05546476|580868819|FG003|Period 1: Part A|Lost to Follow-up|1|||
160857200|NCT05546476|580868816|FG000|Period 1: Part A|Physician Decision|1|||
160857201|NCT05546476|580868817|FG001|Period 1: Part A|Physician Decision|0|||
160857202|NCT05546476|580868818|FG002|Period 1: Part A|Physician Decision|0|||
160857203|NCT05546476|580868819|FG003|Period 1: Part A|Physician Decision|0|||
160908609|NCT02380677|581059982|FG008|Overall Study|Lack of Efficacy|2|||
160908610|NCT02380677|581059983|FG009|Overall Study|Lack of Efficacy|0|||
161141488|NCT01009463|581902512|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
161141489|NCT01009463|581902513|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
161141490|NCT01009463|581902514|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
160857204|NCT05546476|580868816|FG000|Period 1: Part A|Progressive disease|3|||
160857205|NCT05546476|580868817|FG001|Period 1: Part A|Progressive disease|5|||
160857206|NCT05546476|580868818|FG002|Period 1: Part A|Progressive disease|0|||
160857207|NCT05546476|580868819|FG003|Period 1: Part A|Progressive disease|1|||
160857208|NCT05546476|580868816|FG000|Period 1: Part A|Withdrawal by Subject|1|||
160857209|NCT05546476|580868817|FG001|Period 1: Part A|Withdrawal by Subject|1|||
160857210|NCT05546476|580868818|FG002|Period 1: Part A|Withdrawal by Subject|1|||
160857211|NCT05546476|580868819|FG003|Period 1: Part A|Withdrawal by Subject|2|||
160857212|NCT05546476|580868816|FG000|Period 1: Part A|Global deterioration of health status|2|||
160857213|NCT05546476|580868817|FG001|Period 1: Part A|Global deterioration of health status|2|||
160857214|NCT05546476|580868818|FG002|Period 1: Part A|Global deterioration of health status|1|||
161141491|NCT01009463|581902515|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
161141492|NCT01009463|581902511|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
161141493|NCT01009463|581902512|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161141494|NCT01009463|581902513|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161141495|NCT01009463|581902514|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161141496|NCT01009463|581902515|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
161141497|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
161141498|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
161141499|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
161141500|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
161141501|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
161141502|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161141503|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
161141504|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
161141505|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
161141506|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
161141507|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161141508|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
161141509|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
161141510|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
161141511|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
161141512|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
161141513|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161141514|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161141515|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
161141516|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
161141517|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161141518|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
161141519|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
161141520|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
161141521|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
160857215|NCT05546476|580868819|FG003|Period 1: Part A|Global deterioration of health status|4|||
160908611|NCT02380677|581059984|FG010|Overall Study|Lack of Efficacy|2|||
160908612|NCT02380677|581059985|FG011|Overall Study|Lack of Efficacy|1|||
160908613|NCT02380677|581059974|FG000|Overall Study|Withdrawal by Subject|0|||
161141522|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161255752|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
160908614|NCT02380677|581059975|FG001|Overall Study|Withdrawal by Subject|0|||
160908615|NCT02380677|581059976|FG002|Overall Study|Withdrawal by Subject|0|||
160908616|NCT02380677|581059977|FG003|Overall Study|Withdrawal by Subject|0|||
160908617|NCT02380677|581059978|FG004|Overall Study|Withdrawal by Subject|0|||
160908618|NCT02380677|581059979|FG005|Overall Study|Withdrawal by Subject|0|||
160908619|NCT02380677|581059980|FG006|Overall Study|Withdrawal by Subject|0|||
160908620|NCT02380677|581059981|FG007|Overall Study|Withdrawal by Subject|0|||
160908621|NCT02380677|581059982|FG008|Overall Study|Withdrawal by Subject|0|||
160908622|NCT02380677|581059983|FG009|Overall Study|Withdrawal by Subject|1|||
160908623|NCT02380677|581059984|FG010|Overall Study|Withdrawal by Subject|0|||
161255753|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
160908624|NCT02380677|581059985|FG011|Overall Study|Withdrawal by Subject|3|||
160908625|NCT02380677|581059974|FG000|Overall Study|Other|0|||
160908626|NCT02380677|581059975|FG001|Overall Study|Other|0|||
160908627|NCT02380677|581059976|FG002|Overall Study|Other|0|||
160857216|NCT05546476|580868816|FG000|Period 1: Part A|Other: Unspecified|0|||
160857217|NCT05546476|580868817|FG001|Period 1: Part A|Other: Unspecified|2|||
160857218|NCT05546476|580868818|FG002|Period 1: Part A|Other: Unspecified|0|||
160857219|NCT05546476|580868819|FG003|Period 1: Part A|Other: Unspecified|0|||
160857220|NCT05546476|580868816|FG000|Period 2: Part B|Ongoing|26|||
160857221|NCT05546476|580868817|FG001|Period 2: Part B|Ongoing|27|||
160857222|NCT05546476|580868818|FG002|Period 2: Part B|Ongoing|35|||
160857223|NCT05546476|580868819|FG003|Period 2: Part B|Ongoing|29|||
160857224|NCT03760029|580868827|FG000|Overall Study|Death|1|||
160857225|NCT03760029|580868828|FG001|Overall Study|Death|0|||
160857226|NCT03760029|580868829|FG002|Overall Study|Death|0|||
160857227|NCT03760029|580868827|FG000|Overall Study|Lost to Follow-up|0|||
160857228|NCT03760029|580868828|FG001|Overall Study|Lost to Follow-up|2|||
160857229|NCT03760029|580868829|FG002|Overall Study|Lost to Follow-up|1|||
160857230|NCT03760029|580868827|FG000|Overall Study|Withdrawal by Subject|1|||
160857231|NCT03760029|580868828|FG001|Overall Study|Withdrawal by Subject|4|||
160857232|NCT03760029|580868829|FG002|Overall Study|Withdrawal by Subject|1|||
160857233|NCT03760029|580868827|FG000|Overall Study|Withdrawal by parent/guardian|4|||
160857234|NCT03760029|580868828|FG001|Overall Study|Withdrawal by parent/guardian|4|||
160857235|NCT03760029|580868829|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161255754|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
161255755|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
161255756|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
161255757|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
161255758|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
161255759|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255760|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255761|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255762|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255763|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
161255764|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255765|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255766|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
161255767|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
161255768|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
161255769|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
161255770|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255771|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255772|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255773|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255774|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255775|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255776|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
161255777|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
161255778|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
161255779|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
161255780|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
161255781|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161255782|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161255783|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
161255784|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
161255785|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
161255786|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255787|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255788|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
161255789|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255790|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255791|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255792|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255793|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161338294|NCT02194465|582628790|FG002|Overall Study|Physician Decision|0|||
160857236|NCT03760029|580868827|FG000|Overall Study|Other|2|||
160857237|NCT03760029|580868828|FG001|Overall Study|Other|1|||
160857238|NCT03760029|580868829|FG002|Overall Study|Other|0|||
160857239|NCT04890652|580868835|FG000|Overall Study|Withdrawal by Subject|2|||
160857240|NCT00772538|580868843|FG000|Overall Study|Adverse Event|6|||
160857241|NCT00772538|580868844|FG001|Overall Study|Adverse Event|6|||
160857242|NCT00772538|580868843|FG000|Overall Study|Protocol Violation|3|||
160857243|NCT00772538|580868844|FG001|Overall Study|Protocol Violation|3|||
160857244|NCT00772538|580868843|FG000|Overall Study|Lost to Follow-up|1|||
160857245|NCT00772538|580868844|FG001|Overall Study|Lost to Follow-up|1|||
160857246|NCT00772538|580868843|FG000|Overall Study|Withdrawal by Subject|3|||
160857247|NCT00772538|580868844|FG001|Overall Study|Withdrawal by Subject|8|||
160857248|NCT00772538|580868843|FG000|Overall Study|Lack of Efficacy|0|||
160857249|NCT00772538|580868844|FG001|Overall Study|Lack of Efficacy|1|||
160857250|NCT00772538|580868843|FG000|Overall Study|Other|7|||
160857251|NCT00772538|580868844|FG001|Overall Study|Other|7|||
161255794|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
161255795|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161255796|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
161255797|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161255798|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
161255799|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161255800|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161255801|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
161255802|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
161255803|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
161255804|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
161255805|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161255806|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
161255807|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
161255808|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161255809|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
161255810|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
161255811|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
161255812|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
161255813|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255814|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255815|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255816|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255817|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255818|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255819|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
161255820|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255821|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
161255822|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
161255823|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161255824|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
160857252|NCT01089504|580868845|FG000|Overall Study|Lost to Follow-up|1|||
160857253|NCT01089504|580868846|FG001|Overall Study|Lost to Follow-up|1|||
160857254|NCT01089504|580868845|FG000|Overall Study|Withdrawal by Subject|2|||
160857255|NCT01089504|580868846|FG001|Overall Study|Withdrawal by Subject|0|||
160857256|NCT00001832|580868847|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
160857257|NCT00001832|580868848|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
160857258|NCT00001832|580868849|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
160857259|NCT00001832|580868850|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
160857260|NCT00001832|580868851|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
160857261|NCT00001832|580868852|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
160857262|NCT00001832|580868853|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
160857263|NCT00001832|580868854|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
160857264|NCT00001832|580868855|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
160857265|NCT00001832|580868856|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
160857266|NCT00001832|580868857|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
160857267|NCT00001832|580868858|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
160857268|NCT00001832|580868859|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
160857269|NCT00001832|580868860|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
160857270|NCT00001832|580868861|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
160857271|NCT00001832|580868847|FG000|Treatment Period|Death during treatment|0|||
160857272|NCT00001832|580868848|FG001|Treatment Period|Death during treatment|0|||
160857273|NCT00001832|580868849|FG002|Treatment Period|Death during treatment|0|||
160857274|NCT00001832|580868850|FG003|Treatment Period|Death during treatment|0|||
160857275|NCT00001832|580868851|FG004|Treatment Period|Death during treatment|0|||
160857276|NCT00001832|580868852|FG005|Treatment Period|Death during treatment|1|||
160857277|NCT00001832|580868853|FG006|Treatment Period|Death during treatment|0|||
160857278|NCT00001832|580868854|FG007|Treatment Period|Death during treatment|0|||
161141523|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
161141524|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161255825|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161255826|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161255827|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
161255828|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161255829|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
161255830|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
161255831|NCT00739973|582314255|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255832|NCT00739973|582314256|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
161255833|NCT00739973|582314257|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255834|NCT00739973|582314258|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255835|NCT00739973|582314259|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255836|NCT00739973|582314260|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255837|NCT00739973|582314261|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
161255838|NCT00739973|582314262|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255839|NCT00739973|582314263|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
161255840|NCT04149535|582314264|FG000|Overall Study|Death|11|||
161255841|NCT04149535|582314265|FG001|Overall Study|Death|7|||
161255842|NCT04149535|582314264|FG000|Overall Study|Physician Decision|10|||
161255843|NCT04149535|582314265|FG001|Overall Study|Physician Decision|4|||
161255844|NCT04149535|582314264|FG000|Overall Study|Withdrawal by Subject|6|||
161255845|NCT04149535|582314265|FG001|Overall Study|Withdrawal by Subject|7|||
161255846|NCT04149535|582314264|FG000|Overall Study|Not described|2|||
161255847|NCT04149535|582314265|FG001|Overall Study|Not described|0|||
161255848|NCT02175368|582314266|FG000|Overall Study|Lost to Follow-up|1|||
161255849|NCT02875028|582314267|FG000|Washout Period|Withdrawal by Subject|0|||
161255850|NCT02875028|582314268|FG001|Washout Period|Withdrawal by Subject|1|||
161255851|NCT05068284|582314269|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
161255852|NCT05068284|582314270|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
161255853|NCT05068284|582314271|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161255854|NCT05068284|582314272|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161255855|NCT05068284|582314273|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161255856|NCT05068284|582314274|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161255857|NCT05068284|582314275|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161255858|NCT05068284|582314276|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
161255859|NCT05068284|582314269|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255860|NCT05068284|582314270|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255861|NCT05068284|582314271|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
161255862|NCT05068284|582314272|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255863|NCT05068284|582314273|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255864|NCT05068284|582314274|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255865|NCT05068284|582314275|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255866|NCT05068284|582314276|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
161255867|NCT05068284|582314269|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
161255868|NCT05068284|582314270|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
161255869|NCT05068284|582314271|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
161255870|NCT05068284|582314272|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
161255871|NCT05068284|582314273|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
161255872|NCT05068284|582314274|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161255873|NCT05068284|582314275|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161255874|NCT05068284|582314276|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
161255875|NCT05068284|582314269|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161255876|NCT05068284|582314270|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161255877|NCT05068284|582314271|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
161255878|NCT05068284|582314272|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161255879|NCT05068284|582314273|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
161255880|NCT05068284|582314274|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161255881|NCT05068284|582314275|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161255882|NCT05068284|582314276|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
161255883|NCT05068284|582314269|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
160857279|NCT00001832|580868855|FG008|Treatment Period|Death during treatment|0|||
161338295|NCT02194465|582628791|FG003|Overall Study|Physician Decision|0|||
161338296|NCT02194465|582628792|FG004|Overall Study|Physician Decision|0|||
161338297|NCT02194465|582628793|FG005|Overall Study|Physician Decision|0|||
161338298|NCT02194465|582628794|FG006|Overall Study|Physician Decision|0|||
161338299|NCT02194465|582628788|FG000|Overall Study|Protocol Violation|1|||
161338300|NCT02194465|582628789|FG001|Overall Study|Protocol Violation|1|||
161338301|NCT02194465|582628790|FG002|Overall Study|Protocol Violation|2|||
160857280|NCT00001832|580868856|FG009|Treatment Period|Death during treatment|0|||
160857281|NCT00001832|580868857|FG010|Treatment Period|Death during treatment|0|||
160857282|NCT00001832|580868858|FG011|Treatment Period|Death during treatment|0|||
160857283|NCT00001832|580868859|FG012|Treatment Period|Death during treatment|0|||
161338302|NCT02194465|582628791|FG003|Overall Study|Protocol Violation|1|||
161338303|NCT02194465|582628792|FG004|Overall Study|Protocol Violation|1|||
161338304|NCT02194465|582628793|FG005|Overall Study|Protocol Violation|0|||
161338305|NCT02194465|582628794|FG006|Overall Study|Protocol Violation|0|||
161338306|NCT02194465|582628788|FG000|Overall Study|Withdrawal by Subject|1|||
161338307|NCT02194465|582628789|FG001|Overall Study|Withdrawal by Subject|3|||
160857284|NCT00001832|580868860|FG013|Treatment Period|Death during treatment|0|||
160857285|NCT00001832|580868861|FG014|Treatment Period|Death during treatment|0|||
160857286|NCT00001832|580868847|FG000|Treatment Period|Not treated|0|||
160857287|NCT00001832|580868848|FG001|Treatment Period|Not treated|0|||
160857288|NCT00001832|580868849|FG002|Treatment Period|Not treated|0|||
160857289|NCT00001832|580868850|FG003|Treatment Period|Not treated|0|||
160857290|NCT00001832|580868851|FG004|Treatment Period|Not treated|0|||
160857291|NCT00001832|580868852|FG005|Treatment Period|Not treated|0|||
160857292|NCT00001832|580868853|FG006|Treatment Period|Not treated|0|||
160857293|NCT00001832|580868854|FG007|Treatment Period|Not treated|1|||
160857294|NCT00001832|580868855|FG008|Treatment Period|Not treated|0|||
160857295|NCT00001832|580868856|FG009|Treatment Period|Not treated|0|||
160857296|NCT00001832|580868857|FG010|Treatment Period|Not treated|0|||
160857297|NCT00001832|580868858|FG011|Treatment Period|Not treated|0|||
160857298|NCT00001832|580868859|FG012|Treatment Period|Not treated|0|||
160857299|NCT00001832|580868860|FG013|Treatment Period|Not treated|0|||
160857300|NCT00001832|580868861|FG014|Treatment Period|Not treated|0|||
161338308|NCT02194465|582628790|FG002|Overall Study|Withdrawal by Subject|1|||
161338309|NCT02194465|582628791|FG003|Overall Study|Withdrawal by Subject|2|||
161338310|NCT02194465|582628792|FG004|Overall Study|Withdrawal by Subject|2|||
161338311|NCT02194465|582628793|FG005|Overall Study|Withdrawal by Subject|1|||
160857301|NCT04529083|580868862|FG000|Overall Study|Withdrawal by Subject|3|||
160857302|NCT03305666|580868867|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
160857303|NCT03305666|580868868|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
160857304|NCT04196686|580868869|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
160857305|NCT04196686|580868870|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
160857306|NCT00914849|580868873|FG000|Overall Study|Withdrawal by Subject|1|||
160857307|NCT00914849|580868874|FG001|Overall Study|Withdrawal by Subject|0|||
160857308|NCT00914849|580868873|FG000|Overall Study|Not eligible|0|||
160993992|NCT01368406|581367353|FG001|Overall Study|relapse of the disease|2|||
160993993|NCT01368406|581367352|FG000|Overall Study|started working|2|||
160993994|NCT01368406|581367353|FG001|Overall Study|started working|3|||
160993995|NCT01313182|581367354|FG000|Overall Study|Protocol Violation|66|||
160993996|NCT01313182|581367355|FG001|Overall Study|Protocol Violation|92|||
160993997|NCT00464672|581367356|FG000|Overall Study|withdrawal of consent|0|||
160993998|NCT00464672|581367357|FG001|Overall Study|withdrawal of consent|0|||
160993999|NCT00464672|581367358|FG002|Overall Study|withdrawal of consent|0|||
160994000|NCT00464672|581367359|FG003|Overall Study|withdrawal of consent|1|||
160994001|NCT00464672|581367360|FG004|Overall Study|withdrawal of consent|9|||
160994002|NCT00464672|581367361|FG005|Overall Study|withdrawal of consent|4|||
160994003|NCT00464672|581367356|FG000|Overall Study|Lost to Follow-up|25|||
160994004|NCT00464672|581367357|FG001|Overall Study|Lost to Follow-up|10|||
160994005|NCT00464672|581367358|FG002|Overall Study|Lost to Follow-up|0|||
161338312|NCT02194465|582628794|FG006|Overall Study|Withdrawal by Subject|2|||
161338313|NCT02194465|582628788|FG000|Overall Study|Discontinued follow-up period|0|||
161338314|NCT02194465|582628789|FG001|Overall Study|Discontinued follow-up period|2|||
161338315|NCT02194465|582628790|FG002|Overall Study|Discontinued follow-up period|1|||
161338316|NCT02194465|582628791|FG003|Overall Study|Discontinued follow-up period|0|||
160857309|NCT00914849|580868874|FG001|Overall Study|Not eligible|1|||
160857310|NCT01001221|580868875|FG000|Overall Study|Adverse Event|1|||
160857311|NCT01001221|580868876|FG001|Overall Study|Adverse Event|2|||
160857312|NCT01001221|580868877|FG002|Overall Study|Adverse Event|0|||
160857313|NCT01001221|580868878|FG003|Overall Study|Adverse Event|2|||
160994006|NCT00464672|581367359|FG003|Overall Study|Lost to Follow-up|0|||
161338317|NCT02194465|582628792|FG004|Overall Study|Discontinued follow-up period|2|||
161338318|NCT02194465|582628793|FG005|Overall Study|Discontinued follow-up period|0|||
161338319|NCT02194465|582628794|FG006|Overall Study|Discontinued follow-up period|0|||
161338320|NCT00420745|582628795|FG000|Overall Study|Adverse Event|2|||
161338321|NCT00420745|582628796|FG001|Overall Study|Adverse Event|2|||
160857314|NCT01001221|580868879|FG004|Overall Study|Adverse Event|0|||
160857315|NCT01001221|580868875|FG000|Overall Study|Disease progression|3|||
160857316|NCT01001221|580868876|FG001|Overall Study|Disease progression|2|||
160857317|NCT01001221|580868877|FG002|Overall Study|Disease progression|2|||
160857318|NCT01001221|580868878|FG003|Overall Study|Disease progression|4|||
160857319|NCT01001221|580868879|FG004|Overall Study|Disease progression|0|||
160994007|NCT00464672|581367360|FG004|Overall Study|Lost to Follow-up|1|||
160994008|NCT00464672|581367361|FG005|Overall Study|Lost to Follow-up|0|||
160994009|NCT00606580|581367362|FG000|Overall Study|Lost to Follow-up|1|||
160994010|NCT00606580|581367363|FG001|Overall Study|Lost to Follow-up|1|||
160994011|NCT00606580|581367364|FG002|Overall Study|Lost to Follow-up|4|||
160994012|NCT00606580|581367362|FG000|Overall Study|Clinical failures|1|||
160994013|NCT00606580|581367363|FG001|Overall Study|Clinical failures|0|||
160994014|NCT00606580|581367364|FG002|Overall Study|Clinical failures|12|||
160994015|NCT00606580|581367362|FG000|Overall Study|Withdrawal by investigator|0|||
160994016|NCT00606580|581367363|FG001|Overall Study|Withdrawal by investigator|1|||
160994017|NCT00606580|581367364|FG002|Overall Study|Withdrawal by investigator|6|||
160994018|NCT00606580|581367362|FG000|Overall Study|Withdrawal by Subject|0|||
160994019|NCT00606580|581367363|FG001|Overall Study|Withdrawal by Subject|1|||
160994020|NCT00606580|581367364|FG002|Overall Study|Withdrawal by Subject|0|||
160994021|NCT00601640|581367365|FG000|Overall Study|Withdrawal by Subject|3|||
160994022|NCT00601640|581367366|FG001|Overall Study|Withdrawal by Subject|0|||
160994023|NCT00601640|581367367|FG002|Overall Study|Withdrawal by Subject|7|||
160994024|NCT00601640|581367365|FG000|Overall Study|Death|1|||
160994025|NCT00601640|581367366|FG001|Overall Study|Death|0|||
160994026|NCT00601640|581367367|FG002|Overall Study|Death|0|||
160994027|NCT00601640|581367365|FG000|Overall Study|Adverse Event|0|||
160994028|NCT00601640|581367366|FG001|Overall Study|Adverse Event|4|||
160994029|NCT00601640|581367367|FG002|Overall Study|Adverse Event|2|||
160994030|NCT00601640|581367365|FG000|Overall Study|intercurrent illness|1|||
160994031|NCT00601640|581367366|FG001|Overall Study|intercurrent illness|0|||
160994032|NCT00601640|581367367|FG002|Overall Study|intercurrent illness|0|||
160994033|NCT00601640|581367365|FG000|Overall Study|change in eligibility status|0|||
160994034|NCT00601640|581367366|FG001|Overall Study|change in eligibility status|1|||
160994035|NCT00601640|581367367|FG002|Overall Study|change in eligibility status|1|||
160994036|NCT00015457|581367368|FG000|First Intervention|Adverse Event|0|||
160994037|NCT00015457|581367369|FG001|First Intervention|Adverse Event|2|||
160994038|NCT00015457|581367368|FG000|First Intervention|Lack of Efficacy|0|||
160994039|NCT00015457|581367369|FG001|First Intervention|Lack of Efficacy|1|||
160994040|NCT00015457|581367368|FG000|Second Intervention|Withdrawal by Subject|1|||
160994041|NCT00015457|581367369|FG001|Second Intervention|Withdrawal by Subject|0|||
160994042|NCT00543725|581367370|FG000|Overall Study|Adverse Event|18|||
160994043|NCT00543725|581367371|FG001|Overall Study|Adverse Event|27|||
160994044|NCT00543725|581367370|FG000|Overall Study|Sponsor's Decision|0|||
160994045|NCT00543725|581367371|FG001|Overall Study|Sponsor's Decision|1|||
160994046|NCT00543725|581367370|FG000|Overall Study|Subject Non-Compliant|4|||
160994047|NCT00543725|581367371|FG001|Overall Study|Subject Non-Compliant|4|||
160994048|NCT00543725|581367370|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
160994049|NCT00543725|581367371|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
160994050|NCT00543725|581367370|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
160994051|NCT00543725|581367371|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
160994052|NCT00543725|581367370|FG000|Overall Study|Protocol Violation|0|||
160994053|NCT00543725|581367371|FG001|Overall Study|Protocol Violation|1|||
160994054|NCT00543725|581367370|FG000|Overall Study|Withdrawal by Subject|4|||
160994055|NCT00543725|581367371|FG001|Overall Study|Withdrawal by Subject|13|||
160994056|NCT00543725|581367370|FG000|Overall Study|Lost to Follow-up|15|||
160994057|NCT00543725|581367371|FG001|Overall Study|Lost to Follow-up|11|||
160994058|NCT00543725|581367370|FG000|Overall Study|Other|3|||
160994059|NCT00543725|581367371|FG001|Overall Study|Other|3|||
160994060|NCT01674569|581367372|FG000|Overall Study|Adverse Event|0|||
160994061|NCT01674569|581367373|FG001|Overall Study|Adverse Event|2|||
160994062|NCT01674569|581367374|FG002|Overall Study|Adverse Event|0|||
160857320|NCT01001221|580868875|FG000|Overall Study|Other|1|||
160994063|NCT01674569|581367375|FG003|Overall Study|Adverse Event|1|||
160994064|NCT01674569|581367376|FG004|Overall Study|Adverse Event|2|||
160994065|NCT01674569|581367377|FG005|Overall Study|Adverse Event|2|||
160994066|NCT01674569|581367372|FG000|Overall Study|Protocol Violation|0|||
160857321|NCT01001221|580868876|FG001|Overall Study|Other|1|||
160857322|NCT01001221|580868877|FG002|Overall Study|Other|0|||
160857323|NCT01001221|580868878|FG003|Overall Study|Other|0|||
160857324|NCT01001221|580868879|FG004|Overall Study|Other|0|||
160994067|NCT01674569|581367373|FG001|Overall Study|Protocol Violation|1|||
160994068|NCT01674569|581367374|FG002|Overall Study|Protocol Violation|1|||
160994069|NCT01674569|581367375|FG003|Overall Study|Protocol Violation|0|||
160994070|NCT01674569|581367376|FG004|Overall Study|Protocol Violation|0|||
160994071|NCT01674569|581367377|FG005|Overall Study|Protocol Violation|0|||
160994072|NCT01674569|581367372|FG000|Overall Study|Withdrawal by Subject|0|||
160994073|NCT01674569|581367373|FG001|Overall Study|Withdrawal by Subject|0|||
160994074|NCT01674569|581367374|FG002|Overall Study|Withdrawal by Subject|1|||
160857325|NCT01001221|580868875|FG000|Overall Study|Not treated; protocol exclusion|0|||
160857326|NCT01001221|580868876|FG001|Overall Study|Not treated; protocol exclusion|0|||
160857327|NCT01001221|580868877|FG002|Overall Study|Not treated; protocol exclusion|1|||
160857328|NCT01001221|580868878|FG003|Overall Study|Not treated; protocol exclusion|0|||
160857329|NCT01001221|580868879|FG004|Overall Study|Not treated; protocol exclusion|0|||
160857330|NCT05106959|580868880|FG000|Overall Study|Lost to Follow-up|1|||
160857331|NCT03448406|580868881|FG000|Overall Study|Noncompliance of scheduled visits|1|||
160857332|NCT03448406|580868882|FG001|Overall Study|Noncompliance of scheduled visits|2|||
160857333|NCT03448406|580868881|FG000|Overall Study|Withdrawal by Subject|1|||
160857334|NCT03448406|580868882|FG001|Overall Study|Withdrawal by Subject|2|||
160857335|NCT03448406|580868881|FG000|Overall Study|Protocol Violation|1|||
160857336|NCT03448406|580868882|FG001|Overall Study|Protocol Violation|0|||
160857337|NCT03448406|580868881|FG000|Overall Study|Adverse Event|8|||
160857338|NCT03448406|580868882|FG001|Overall Study|Adverse Event|9|||
160857339|NCT01292486|580868883|FG000|Overall Study|Protocol Violation|2|||
160857340|NCT01292486|580868883|FG000|Overall Study|Did not meet screening criteria|2|||
160857341|NCT01292486|580868883|FG000|Overall Study|Adverse Event|1|||
160857342|NCT01292486|580868883|FG000|Overall Study|Physician Decision|1|||
160857343|NCT00087152|580868884|FG000|Overall Study|Ineligible|6|||
160857344|NCT04602390|580868891|FG000|Overall Study|Withdrawal by Subject|0|||
160857345|NCT04602390|580868892|FG001|Overall Study|Withdrawal by Subject|0|||
160857346|NCT04602390|580868893|FG002|Overall Study|Withdrawal by Subject|0|||
160857347|NCT04602390|580868894|FG003|Overall Study|Withdrawal by Subject|0|||
160857348|NCT04602390|580868895|FG004|Overall Study|Withdrawal by Subject|1|||
160857349|NCT04602390|580868896|FG005|Overall Study|Withdrawal by Subject|0|||
160857350|NCT04602390|580868891|FG000|Overall Study|Adverse Event|0|||
160857351|NCT04602390|580868892|FG001|Overall Study|Adverse Event|0|||
160857352|NCT04602390|580868893|FG002|Overall Study|Adverse Event|0|||
160857353|NCT04602390|580868894|FG003|Overall Study|Adverse Event|0|||
160857354|NCT04602390|580868895|FG004|Overall Study|Adverse Event|0|||
160857355|NCT04602390|580868896|FG005|Overall Study|Adverse Event|1|||
160857356|NCT02756338|580868897|FG000|Overall Study|Withdrawn by Investigator|1|||
160857357|NCT02756338|580868897|FG000|Overall Study|Device Replaced with Pacemaker|4|||
160857358|NCT01546857|580868898|FG000|Overall Study|Withdrawal by Subject|2|||
160857359|NCT01546857|580868899|FG001|Overall Study|Withdrawal by Subject|3|||
160857360|NCT02542865|580868900|FG000|Overall Study|Identified as screen failure|1|||
160857361|NCT02542865|580868901|FG001|Overall Study|Identified as screen failure|0|||
160857362|NCT02542865|580868900|FG000|Overall Study|Withdrawal by Subject|16|||
160857363|NCT02542865|580868901|FG001|Overall Study|Withdrawal by Subject|0|||
160857364|NCT01339689|580868902|FG000|Overall Study|Adverse Event|1|||
160857365|NCT01339689|580868903|FG001|Overall Study|Adverse Event|2|||
160857366|NCT01339689|580868902|FG000|Overall Study|Lost to Follow-up|9|||
160857367|NCT01339689|580868903|FG001|Overall Study|Lost to Follow-up|3|||
160857368|NCT01339689|580868902|FG000|Overall Study|Withdrawal by Subject|3|||
160857369|NCT01339689|580868903|FG001|Overall Study|Withdrawal by Subject|0|||
160857370|NCT01339689|580868902|FG000|Overall Study|Noncompliance|1|||
160857371|NCT01339689|580868903|FG001|Overall Study|Noncompliance|0|||
160857372|NCT01339689|580868902|FG000|Overall Study|Relocated out of area|0|||
160857373|NCT01339689|580868903|FG001|Overall Study|Relocated out of area|1|||
160857374|NCT01339689|580868902|FG000|Overall Study|Other|2|||
160857375|NCT01339689|580868903|FG001|Overall Study|Other|2|||
160857376|NCT01339689|580868902|FG000|Overall Study|multiple reasons|1|||
160857377|NCT01339689|580868903|FG001|Overall Study|multiple reasons|1|||
160857378|NCT00659061|580868904|FG000|Overall Study|Migration due to political unrest|21|||
160857379|NCT00659061|580868905|FG001|Overall Study|Migration due to political unrest|15|||
160857380|NCT01277744|580868914|FG000|Overall Study|Physician Decision|2|||
160857381|NCT05121766|580868917|FG000|Overall Study|Covid reinfection|3|||
160857382|NCT05121766|580868918|FG001|Overall Study|Covid reinfection|0|||
160857383|NCT05121766|580868917|FG000|Overall Study|Withdrawal by Subject|3|||
160857384|NCT05121766|580868918|FG001|Overall Study|Withdrawal by Subject|1|||
160857385|NCT05121766|580868917|FG000|Overall Study|Adverse Event|2|||
160857386|NCT05121766|580868918|FG001|Overall Study|Adverse Event|4|||
160857387|NCT05121766|580868917|FG000|Overall Study|Lost to Follow-up|0|||
160857388|NCT05121766|580868918|FG001|Overall Study|Lost to Follow-up|1|||
160857389|NCT03259230|580868919|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
160857390|NCT03259230|580868920|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
160857391|NCT01632020|580868921|FG000|Overall Study|Withdrawal by Subject|1|||
160857392|NCT01632020|580868922|FG001|Overall Study|Withdrawal by Subject|0|||
160857393|NCT01632020|580868921|FG000|Overall Study|Adverse Event|1|||
160857394|NCT01632020|580868922|FG001|Overall Study|Adverse Event|0|||
160857395|NCT05468814|580868923|FG000|Overall Study|Lost to Follow-up|5|||
160857396|NCT05468814|580868924|FG001|Overall Study|Lost to Follow-up|6|||
160857397|NCT00528957|580868929|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
160857398|NCT00528957|580868930|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
160857399|NCT00528957|580868929|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
160857400|NCT00528957|580868930|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
161141525|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
161141526|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
161141527|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161141528|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
161141529|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
160857401|NCT00528957|580868929|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
160908628|NCT02380677|581059977|FG003|Overall Study|Other|1|||
160994075|NCT01674569|581367375|FG003|Overall Study|Withdrawal by Subject|0|||
160994076|NCT01674569|581367376|FG004|Overall Study|Withdrawal by Subject|0|||
160994077|NCT01674569|581367377|FG005|Overall Study|Withdrawal by Subject|0|||
160994078|NCT02595398|581367378|FG000|Overall Study|Non-compliance|1|||
160994079|NCT02595398|581367379|FG001|Overall Study|Non-compliance|0|||
160994080|NCT02595398|581367378|FG000|Overall Study|Withdrawal by Subject|2|||
160994081|NCT02595398|581367379|FG001|Overall Study|Withdrawal by Subject|1|||
160994082|NCT02595398|581367378|FG000|Overall Study|Lost to Follow-up|1|||
160994083|NCT02595398|581367379|FG001|Overall Study|Lost to Follow-up|0|||
160994084|NCT00502593|581367380|FG000|Overall Study|Withdrawn unspecified reason|1|||
160994085|NCT00502593|581367381|FG001|Overall Study|Withdrawn unspecified reason|1|||
160994086|NCT00502593|581367382|FG002|Overall Study|Withdrawn unspecified reason|3|||
160994087|NCT00502593|581367383|FG003|Overall Study|Withdrawn unspecified reason|1|||
160994088|NCT00502593|581367384|FG004|Overall Study|Withdrawn unspecified reason|2|||
161141530|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
161141531|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
160857402|NCT00528957|580868930|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
160857403|NCT00528957|580868929|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
160857404|NCT00528957|580868930|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
160857405|NCT00528957|580868929|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
160857406|NCT00528957|580868930|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
160857407|NCT00528957|580868929|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
160857408|NCT00528957|580868930|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
160857409|NCT00528957|580868929|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
160857410|NCT00528957|580868930|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
160857411|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
160857412|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
160857413|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
160857414|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
160857415|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
160857416|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
160857417|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
160857418|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
160857419|NCT00528957|580868929|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
160857420|NCT00528957|580868930|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
160857421|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
160857422|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
160908629|NCT02380677|581059978|FG004|Overall Study|Other|1|||
160908630|NCT02380677|581059979|FG005|Overall Study|Other|1|||
160908631|NCT02380677|581059980|FG006|Overall Study|Other|0|||
160908632|NCT02380677|581059981|FG007|Overall Study|Other|0|||
160908633|NCT02380677|581059982|FG008|Overall Study|Other|0|||
160908634|NCT02380677|581059983|FG009|Overall Study|Other|0|||
160908635|NCT02380677|581059984|FG010|Overall Study|Other|0|||
160908636|NCT02380677|581059985|FG011|Overall Study|Other|0|||
160908637|NCT02599129|581059988|FG000|Overall Study|Lack of Efficacy|2|||
160908638|NCT02599129|581059989|FG001|Overall Study|Lack of Efficacy|2|||
160908639|NCT02599129|581059988|FG000|Overall Study|Lost to Follow-up|1|||
160908640|NCT02599129|581059989|FG001|Overall Study|Lost to Follow-up|0|||
160908641|NCT02599129|581059988|FG000|Overall Study|Withdrawal by Subject|2|||
160908642|NCT02599129|581059989|FG001|Overall Study|Withdrawal by Subject|1|||
160908643|NCT00617773|581059990|FG000|Overall Study|Physician Decision|1|||
160908644|NCT00617773|581059990|FG000|Overall Study|Lack of compliance with the protocol|1|||
160908645|NCT00617773|581059990|FG000|Overall Study|Withdrawal by Subject|1|||
160908646|NCT00617773|581059990|FG000|Overall Study|Death|1|||
160908647|NCT00617773|581059990|FG000|Overall Study|Progressive disease|19|||
160908648|NCT00617773|581059990|FG000|Overall Study|Protocol Violation|1|||
160908649|NCT01029795|581059991|FG000|Overall Study|Entry Criteria Not Met|2|||
160908650|NCT01029795|581059992|FG001|Overall Study|Entry Criteria Not Met|1|||
160908651|NCT01029795|581059991|FG000|Overall Study|Physician Decision|2|||
160908652|NCT01029795|581059992|FG001|Overall Study|Physician Decision|1|||
160908653|NCT01029795|581059991|FG000|Overall Study|Sponsor Decision|11|||
160994089|NCT00502593|581367385|FG005|Overall Study|Withdrawn unspecified reason|0|||
161338322|NCT00420745|582628795|FG000|Overall Study|Lost to Follow-up|10|||
161338323|NCT00420745|582628796|FG001|Overall Study|Lost to Follow-up|2|||
160857423|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
160857424|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
160857425|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
160857426|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
160857427|NCT00528957|580868929|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
160857428|NCT00528957|580868930|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
160857429|NCT00625131|580868931|FG000|Overall Study|Lost to Follow-up|3|||
160857430|NCT00625131|580868932|FG001|Overall Study|Lost to Follow-up|2|||
160857431|NCT00625131|580868933|FG002|Overall Study|Lost to Follow-up|0|||
160857432|NCT00625131|580868931|FG000|Overall Study|Withdrawal by Subject|1|||
160857433|NCT00625131|580868932|FG001|Overall Study|Withdrawal by Subject|0|||
160857434|NCT00625131|580868933|FG002|Overall Study|Withdrawal by Subject|5|||
160857435|NCT05083351|580868939|FG000|Overall Study|Adverse Event|3|||
160857436|NCT05083351|580868939|FG000|Overall Study|Did not meet data inclusion criteria|8|||
160857437|NCT05083351|580868939|FG000|Overall Study|Did not meet eligibility criteria|19|||
160857438|NCT05083351|580868939|FG000|Overall Study|Study Staff Decision|19|||
160857439|NCT01611792|580868940|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
160857440|NCT01611792|580868941|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
160857441|NCT01611792|580868940|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
160857442|NCT01611792|580868941|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
160857443|NCT03416868|580868942|FG000|Overall Study|Withdrawal by Subject|2|||
160857444|NCT03416868|580868942|FG000|Overall Study|Lost to Follow-up|1|||
160857445|NCT00960375|580868945|FG000|Overall Study|Lost to Follow-up|20|||
160857446|NCT00960375|580868946|FG001|Overall Study|Lost to Follow-up|22|||
160857447|NCT00083889|580868947|FG000|Overall Study|Adverse Event|76|||
160857448|NCT00083889|580868948|FG001|Overall Study|Adverse Event|86|||
160857449|NCT00083889|580868947|FG000|Overall Study|Protocol Violation|2|||
160857450|NCT00083889|580868948|FG001|Overall Study|Protocol Violation|2|||
160857451|NCT00083889|580868947|FG000|Overall Study|Withdrawal by Subject|22|||
160857452|NCT00083889|580868948|FG001|Overall Study|Withdrawal by Subject|24|||
160857453|NCT00083889|580868947|FG000|Overall Study|Lack of Efficacy|240|||
160857454|NCT00083889|580868948|FG001|Overall Study|Lack of Efficacy|219|||
160857455|NCT00083889|580868947|FG000|Overall Study|Decision of sponsor|32|||
160908654|NCT01029795|581059992|FG001|Overall Study|Sponsor Decision|17|||
160908655|NCT01029795|581059991|FG000|Overall Study|Withdrawal by Subject|1|||
160908656|NCT01029795|581059992|FG001|Overall Study|Withdrawal by Subject|3|||
160908657|NCT00587054|581059998|FG000|Overall Study|Patient not treated|9|||
161338324|NCT00420745|582628795|FG000|Overall Study|Protocol Violation|1|||
161338325|NCT00420745|582628796|FG001|Overall Study|Protocol Violation|0|||
161338326|NCT00420745|582628795|FG000|Overall Study|Physician Decision|1|||
161338327|NCT00420745|582628796|FG001|Overall Study|Physician Decision|1|||
161338328|NCT00420745|582628795|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
161338329|NCT00420745|582628796|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
161338330|NCT00420745|582628795|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
161338331|NCT00420745|582628796|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
161338332|NCT02058095|582628798|FG000|Overall Study|Adverse Event|1|||
161338333|NCT02058095|582628799|FG001|Overall Study|Adverse Event|0|||
161338334|NCT00726453|582628800|FG000|Primary Enrollment Group|Death|18|||
161338335|NCT00726453|582628801|FG001|Primary Enrollment Group|Death|0|||
161338336|NCT00726453|582628800|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
161338337|NCT00726453|582628801|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
161338338|NCT00726453|582628800|FG000|38 mm Length Group|Death|0|||
161338339|NCT00726453|582628801|FG001|38 mm Length Group|Death|3|||
161338340|NCT01588509|582628805|FG000|Overall Study|Lost to Follow-up|1|||
161338341|NCT01588509|582628806|FG001|Overall Study|Lost to Follow-up|0|||
161338342|NCT01983930|582628807|FG000|Overall Study|Withdrawal by Subject|9|||
161338343|NCT01983930|582628808|FG001|Overall Study|Withdrawal by Subject|8|||
160857456|NCT00083889|580868948|FG001|Overall Study|Decision of sponsor|4|||
160857457|NCT00083889|580868947|FG000|Overall Study|Randomized: did not take study drug|0|||
160857458|NCT00083889|580868948|FG001|Overall Study|Randomized: did not take study drug|15|||
160908658|NCT03858309|581060003|FG000|Overall Study|Withdrawal by Subject|2|||
160908659|NCT03858309|581060004|FG001|Overall Study|Withdrawal by Subject|3|||
160908660|NCT01336764|581060005|FG000|Overall Study|Withdrawal by Subject|5|||
160908661|NCT01336764|581060006|FG001|Overall Study|Withdrawal by Subject|5|||
161338344|NCT01983930|582628807|FG000|Overall Study|Adverse Event|0|||
161338345|NCT01983930|582628808|FG001|Overall Study|Adverse Event|1|||
161338346|NCT01454284|582628809|FG000|Overall Study|Adverse Event|20|||
161338347|NCT01454284|582628810|FG001|Overall Study|Adverse Event|7|||
160857459|NCT00083889|580868947|FG000|Overall Study|Completed on marketed sunitinub|3|||
160857460|NCT00083889|580868948|FG001|Overall Study|Completed on marketed sunitinub|0|||
161338348|NCT01454284|582628809|FG000|Overall Study|Death|0|||
161338349|NCT01454284|582628810|FG001|Overall Study|Death|3|||
161338350|NCT01454284|582628809|FG000|Overall Study|Lost to Follow-up|13|||
161338351|NCT01454284|582628810|FG001|Overall Study|Lost to Follow-up|8|||
161338352|NCT01454284|582628809|FG000|Overall Study|Protocol Violation|9|||
161338353|NCT01454284|582628810|FG001|Overall Study|Protocol Violation|6|||
161338354|NCT01454284|582628809|FG000|Overall Study|Withdrawal by Subject|58|||
161338355|NCT01454284|582628810|FG001|Overall Study|Withdrawal by Subject|36|||
161338356|NCT01454284|582628809|FG000|Overall Study|Physician Decision|16|||
161338357|NCT01454284|582628810|FG001|Overall Study|Physician Decision|11|||
161338358|NCT01454284|582628809|FG000|Overall Study|Sponsor Decision|0|||
161338359|NCT01454284|582628810|FG001|Overall Study|Sponsor Decision|2|||
161338360|NCT02842866|582628813|FG000|Overall Study|Serious Adverse Event|0|||
161338361|NCT02842866|582628814|FG001|Overall Study|Serious Adverse Event|1|||
161338362|NCT02842866|582628813|FG000|Overall Study|Protocol Violation|4|||
161338363|NCT02842866|582628814|FG001|Overall Study|Protocol Violation|2|||
161338364|NCT02842866|582628813|FG000|Overall Study|Lost to Follow-up|2|||
161338365|NCT02842866|582628814|FG001|Overall Study|Lost to Follow-up|0|||
161338366|NCT02842866|582628813|FG000|Overall Study|Withdrawal by Subject|1|||
161338367|NCT02842866|582628814|FG001|Overall Study|Withdrawal by Subject|0|||
161338368|NCT01432327|582628815|FG000|Posttest 3 Months|depression|3|||
161338369|NCT01432327|582628816|FG001|Posttest 3 Months|depression|0|||
161338370|NCT01432327|582628817|FG002|Posttest 3 Months|depression|0|||
161338371|NCT01432327|582628818|FG003|Posttest 3 Months|depression|0|||
161338372|NCT01432327|582628815|FG000|Posttest 3 Months|Lost to Follow-up|1|||
161338373|NCT01432327|582628816|FG001|Posttest 3 Months|Lost to Follow-up|0|||
161338374|NCT01432327|582628817|FG002|Posttest 3 Months|Lost to Follow-up|2|||
161338375|NCT01432327|582628818|FG003|Posttest 3 Months|Lost to Follow-up|1|||
161338376|NCT01432327|582628815|FG000|Posttest 3 Months|Allergic reaction|0|||
161338377|NCT01432327|582628816|FG001|Posttest 3 Months|Allergic reaction|2|||
161338378|NCT01432327|582628817|FG002|Posttest 3 Months|Allergic reaction|0|||
161338379|NCT01432327|582628818|FG003|Posttest 3 Months|Allergic reaction|0|||
161338380|NCT01432327|582628815|FG000|Posttest 6 Months|Lost to Follow-up|0|||
161338381|NCT01432327|582628816|FG001|Posttest 6 Months|Lost to Follow-up|0|||
161338382|NCT01432327|582628817|FG002|Posttest 6 Months|Lost to Follow-up|3|||
161338383|NCT01432327|582628818|FG003|Posttest 6 Months|Lost to Follow-up|2|||
161338384|NCT01432327|582628815|FG000|Posttest 6 Months|Allergic reaction|0|||
161338385|NCT01432327|582628816|FG001|Posttest 6 Months|Allergic reaction|0|||
161338386|NCT01432327|582628817|FG002|Posttest 6 Months|Allergic reaction|1|||
161338387|NCT01432327|582628818|FG003|Posttest 6 Months|Allergic reaction|0|||
161338388|NCT01432327|582628815|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
161338389|NCT01432327|582628816|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
161338390|NCT01432327|582628817|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
161338391|NCT01432327|582628818|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
161338392|NCT01432327|582628815|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
161338393|NCT01432327|582628816|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
161338394|NCT01432327|582628817|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
161338395|NCT01432327|582628818|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
161338396|NCT01432327|582628815|FG000|Posttest 1 Year|Lost to Follow-up|0|||
161338397|NCT01432327|582628816|FG001|Posttest 1 Year|Lost to Follow-up|0|||
161338398|NCT01432327|582628817|FG002|Posttest 1 Year|Lost to Follow-up|4|||
161338399|NCT01432327|582628818|FG003|Posttest 1 Year|Lost to Follow-up|2|||
161338400|NCT01432327|582628815|FG000|Posttest 1 Year|Allergic reaction|0|||
161338401|NCT01432327|582628816|FG001|Posttest 1 Year|Allergic reaction|0|||
161338402|NCT01432327|582628817|FG002|Posttest 1 Year|Allergic reaction|1|||
161338403|NCT01432327|582628818|FG003|Posttest 1 Year|Allergic reaction|1|||
161338404|NCT03248037|582628819|FG000|Overall Study|Withdrawal by Subject|6|||
161338405|NCT03248037|582628820|FG001|Overall Study|Withdrawal by Subject|9|||
161338406|NCT03248037|582628819|FG000|Overall Study|Adverse Event|15|||
161338407|NCT03248037|582628820|FG001|Overall Study|Adverse Event|0|||
161338408|NCT02897349|582628824|FG000|Overall Study|Lost to Follow-up|2|||
160908662|NCT01051323|581060007|FG000|Overall Study|Discontinuation of treatment|103|||
160908663|NCT01051323|581060007|FG000|Overall Study|Transplantation|28|||
160908664|NCT01051323|581060007|FG000|Overall Study|Dialysis dependency|22|||
161338409|NCT02897349|582628825|FG001|Overall Study|Lost to Follow-up|2|||
161338410|NCT02897349|582628824|FG000|Overall Study|Adverse Event|3|||
161338411|NCT02897349|582628825|FG001|Overall Study|Adverse Event|3|||
161338412|NCT02897349|582628824|FG000|Overall Study|Other than listed above|0|||
161338413|NCT02897349|582628825|FG001|Overall Study|Other than listed above|1|||
160908665|NCT01051323|581060007|FG000|Overall Study|Withdrawal by Subject|13|||
161338414|NCT03055013|582628828|FG000|Overall Study|Adverse Event|78|||
161338415|NCT03055013|582628829|FG001|Overall Study|Adverse Event|0|||
161338416|NCT03055013|582628828|FG000|Overall Study|Death|6|||
161338417|NCT03055013|582628829|FG001|Overall Study|Death|0|||
161338418|NCT03055013|582628828|FG000|Overall Study|Disease relapse|33|||
160908666|NCT01051323|581060007|FG000|Overall Study|Lost to Follow-up|31|||
161338419|NCT03055013|582628829|FG001|Overall Study|Disease relapse|0|||
161338420|NCT03055013|582628828|FG000|Overall Study|Withdrawal by Subject|28|||
161338421|NCT03055013|582628829|FG001|Overall Study|Withdrawal by Subject|0|||
161338422|NCT03055013|582628828|FG000|Overall Study|Other complicating disease|5|||
160908667|NCT01051323|581060007|FG000|Overall Study|Death|129|||
160908668|NCT01051323|581060007|FG000|Overall Study|Hospitalization|28|||
160908669|NCT01051323|581060007|FG000|Overall Study|Other|148|||
160908670|NCT01051323|581060007|FG000|Overall Study|Missing|37|||
160908671|NCT00555971|581060008|FG000|Overall Study|Adverse Event|1|||
160908672|NCT00555971|581060009|FG001|Overall Study|Adverse Event|1|||
160908673|NCT01626391|581060010|FG000|Overall Study|Physician Decision|1|||
160908674|NCT01626391|581060011|FG001|Overall Study|Physician Decision|0|||
160908675|NCT01626391|581060010|FG000|Overall Study|Withdrawal by Subject|1|||
160908676|NCT01626391|581060011|FG001|Overall Study|Withdrawal by Subject|0|||
160908677|NCT02573311|581060012|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
160908678|NCT02573311|581060013|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
160908679|NCT02573311|581060012|FG000|Disposition for Part 2|Physician Decision|25|||
160908680|NCT02573311|581060013|FG001|Disposition for Part 2|Physician Decision|7|||
160908681|NCT02573311|581060012|FG000|Disposition for Part 2|Adverse Event|36|||
160908682|NCT02573311|581060013|FG001|Disposition for Part 2|Adverse Event|5|||
160908683|NCT02573311|581060012|FG000|Disposition for Part 2|Lost to Follow-up|76|||
160908684|NCT02573311|581060013|FG001|Disposition for Part 2|Lost to Follow-up|7|||
160908685|NCT02573311|581060012|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
160908686|NCT02573311|581060013|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
160908687|NCT02573311|581060012|FG000|Disposition for Part 2|Investigator decision|0|||
160908688|NCT02573311|581060013|FG001|Disposition for Part 2|Investigator decision|1|||
160908689|NCT02573311|581060012|FG000|Disposition for Part 2|Other than specified above|13|||
160908690|NCT02573311|581060013|FG001|Disposition for Part 2|Other than specified above|3|||
160908691|NCT05683249|581060014|FG000|Overall Study|Adverse Event|3|||
160908692|NCT05683249|581060015|FG001|Overall Study|Adverse Event|1|||
160908693|NCT05683249|581060014|FG000|Overall Study|Lack of Efficacy|0|||
160908694|NCT05683249|581060015|FG001|Overall Study|Lack of Efficacy|2|||
160908695|NCT05683249|581060014|FG000|Overall Study|Lost to Follow-up|6|||
160908696|NCT05683249|581060015|FG001|Overall Study|Lost to Follow-up|5|||
160908697|NCT05683249|581060014|FG000|Overall Study|Non-compliance with Study Drug|2|||
160908698|NCT05683249|581060015|FG001|Overall Study|Non-compliance with Study Drug|0|||
160908699|NCT05683249|581060014|FG000|Overall Study|Protocol Violation|6|||
160908700|NCT05683249|581060015|FG001|Overall Study|Protocol Violation|3|||
160908701|NCT05683249|581060014|FG000|Overall Study|Withdrawal by Subject|9|||
160908702|NCT05683249|581060015|FG001|Overall Study|Withdrawal by Subject|8|||
160908703|NCT05683249|581060014|FG000|Overall Study|Other|0|||
160908704|NCT05683249|581060015|FG001|Overall Study|Other|2|||
160908705|NCT01328431|581060016|FG000|Baseline|Protocol Violation|0|||
160908706|NCT01328431|581060017|FG001|Baseline|Protocol Violation|2|||
160908707|NCT01328431|581060016|FG000|1 Month (1M)|Lost to Follow-up|55|||
160908708|NCT01328431|581060017|FG001|1 Month (1M)|Lost to Follow-up|58|||
160908709|NCT01328431|581060016|FG000|3 Month (3M)|Death|2|||
160908710|NCT01328431|581060017|FG001|3 Month (3M)|Death|2|||
160908711|NCT01328431|581060016|FG000|3 Month (3M)|Lost to Follow-up|75|||
160908712|NCT01328431|581060017|FG001|3 Month (3M)|Lost to Follow-up|70|||
160908713|NCT01328431|581060016|FG000|12 Month (12M)|Death|2|||
160908714|NCT01328431|581060017|FG001|12 Month (12M)|Death|6|||
160857461|NCT00083889|580868947|FG000|Overall Study|Crossover to SU011248|0|||
160857462|NCT00083889|580868948|FG001|Overall Study|Crossover to SU011248|25|||
160857463|NCT03624881|580868949|FG000|Overall Study|Screen Failure|14|||
160857464|NCT03624881|580868950|FG001|Overall Study|Screen Failure|0|||
160857465|NCT03624881|580868949|FG000|Overall Study|No Catheter Inserted|6|||
160857466|NCT03624881|580868950|FG001|Overall Study|No Catheter Inserted|1|||
160857467|NCT03624881|580868949|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
160857468|NCT03624881|580868950|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
160857469|NCT03624881|580868949|FG000|Overall Study|Death|2|||
160857470|NCT03624881|580868950|FG001|Overall Study|Death|0|||
160857471|NCT03624881|580868949|FG000|Overall Study|Lost to Follow-up|10|||
160857472|NCT03624881|580868950|FG001|Overall Study|Lost to Follow-up|4|||
160857473|NCT03624881|580868949|FG000|Overall Study|Withdrawal by Subject|12|||
160857474|NCT03624881|580868950|FG001|Overall Study|Withdrawal by Subject|1|||
160857475|NCT03473236|580868951|FG000|Overall Study|Withdrawal by Subject|0|||
160857476|NCT03473236|580868952|FG001|Overall Study|Withdrawal by Subject|0|||
160857477|NCT03473236|580868953|FG002|Overall Study|Withdrawal by Subject|0|||
160857478|NCT03473236|580868954|FG003|Overall Study|Withdrawal by Subject|0|||
160908715|NCT01328431|581060016|FG000|12 Month (12M)|Lost to Follow-up|82|||
160908716|NCT01328431|581060017|FG001|12 Month (12M)|Lost to Follow-up|91|||
160908717|NCT02801396|581060018|FG000|Period 1|Withdrawal by Subject|0|||
160908718|NCT02801396|581060019|FG001|Period 1|Withdrawal by Subject|0|||
160908719|NCT02801396|581060020|FG002|Period 1|Withdrawal by Subject|0|||
160908720|NCT02801396|581060021|FG003|Period 1|Withdrawal by Subject|0|||
160908721|NCT02801396|581060022|FG004|Period 1|Withdrawal by Subject|1|||
160908722|NCT02801396|581060023|FG005|Period 1|Withdrawal by Subject|0|||
160908723|NCT03087643|581060030|FG000|Overall Study|Withdrawal by Subject|2|||
160908724|NCT03087643|581060031|FG001|Overall Study|Withdrawal by Subject|4|||
160908725|NCT03087643|581060030|FG000|Overall Study|Death|2|||
160908726|NCT03087643|581060031|FG001|Overall Study|Death|2|||
161255884|NCT05068284|582314270|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161255885|NCT05068284|582314271|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161255886|NCT05068284|582314272|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
161255887|NCT05068284|582314273|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161255888|NCT05068284|582314274|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161255889|NCT05068284|582314275|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161255890|NCT05068284|582314276|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
161255891|NCT05068284|582314269|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161255892|NCT05068284|582314270|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161255893|NCT05068284|582314271|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
161255894|NCT05068284|582314272|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
161255895|NCT05068284|582314273|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161255896|NCT05068284|582314274|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161255897|NCT05068284|582314275|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161255898|NCT05068284|582314276|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
161255899|NCT05068284|582314269|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255900|NCT05068284|582314270|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255901|NCT05068284|582314271|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
161255902|NCT05068284|582314272|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255903|NCT05068284|582314273|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255904|NCT05068284|582314274|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255905|NCT05068284|582314275|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255906|NCT05068284|582314276|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
161255907|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
161255908|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255909|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255910|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255911|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255912|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255913|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255914|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
161255915|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
161255916|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161255917|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161255918|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
160908727|NCT02083783|581060032|FG000|Overall Study|Withdrawal by Subject|1|||
160908728|NCT02083783|581060033|FG001|Overall Study|Withdrawal by Subject|0|||
160908729|NCT02256631|581060036|FG000|Overall Study|Lost to Follow-up|1|||
160908730|NCT02256631|581060037|FG001|Overall Study|Lost to Follow-up|1|||
160908731|NCT02256631|581060038|FG002|Overall Study|Lost to Follow-up|0|||
160908732|NCT02256631|581060039|FG003|Overall Study|Lost to Follow-up|2|||
160908733|NCT02256631|581060040|FG004|Overall Study|Lost to Follow-up|0|||
160908734|NCT02256631|581060041|FG005|Overall Study|Lost to Follow-up|4|||
160908735|NCT02256631|581060042|FG006|Overall Study|Lost to Follow-up|1|||
160908736|NCT02256631|581060036|FG000|Overall Study|Withdrawal by Subject|0|||
160908737|NCT02256631|581060037|FG001|Overall Study|Withdrawal by Subject|0|||
160908738|NCT02256631|581060038|FG002|Overall Study|Withdrawal by Subject|0|||
160908739|NCT02256631|581060039|FG003|Overall Study|Withdrawal by Subject|1|||
160908740|NCT02256631|581060040|FG004|Overall Study|Withdrawal by Subject|1|||
160908741|NCT02256631|581060041|FG005|Overall Study|Withdrawal by Subject|0|||
160908742|NCT02256631|581060042|FG006|Overall Study|Withdrawal by Subject|1|||
160908743|NCT02256631|581060036|FG000|Overall Study|Unable to get to clinic|0|||
160908744|NCT02256631|581060037|FG001|Overall Study|Unable to get to clinic|2|||
160908745|NCT02256631|581060038|FG002|Overall Study|Unable to get to clinic|0|||
160908746|NCT02256631|581060039|FG003|Overall Study|Unable to get to clinic|1|||
160908747|NCT02256631|581060040|FG004|Overall Study|Unable to get to clinic|0|||
160908748|NCT02256631|581060041|FG005|Overall Study|Unable to get to clinic|1|||
160908749|NCT02256631|581060042|FG006|Overall Study|Unable to get to clinic|2|||
160908750|NCT01427972|581060043|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908751|NCT01427972|581060044|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908752|NCT01427972|581060045|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908753|NCT01427972|581060046|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908754|NCT01427972|581060047|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908755|NCT01427972|581060048|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908756|NCT01427972|581060049|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908757|NCT01427972|581060050|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
160908758|NCT01427972|581060051|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161255919|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161255920|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
161255921|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
161255922|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
161255923|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
161255924|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161255925|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161255926|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161255927|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161255928|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161255929|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
161255930|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
161255931|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
161255932|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255933|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255934|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255935|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255936|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255937|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255938|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
161255939|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
161255940|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255941|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255942|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255943|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255944|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255945|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255946|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
161255947|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
161255948|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161255949|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161255950|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161255951|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
161255952|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
161255953|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
161255954|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
161255955|NCT05068284|582314269|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255956|NCT05068284|582314270|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255957|NCT05068284|582314271|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255958|NCT05068284|582314272|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255959|NCT05068284|582314273|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255960|NCT05068284|582314274|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255961|NCT05068284|582314275|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
161255962|NCT05068284|582314276|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
161255963|NCT04039919|582316303|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161255964|NCT04039919|582316304|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161255965|NCT04039919|582316305|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161255966|NCT04039919|582316306|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161255967|NCT04039919|582316307|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161255968|NCT04039919|582316303|FG000|Treatment Period 1|Sponsor's decision|0|||
161255969|NCT04039919|582316304|FG001|Treatment Period 1|Sponsor's decision|0|||
161255970|NCT04039919|582316305|FG002|Treatment Period 1|Sponsor's decision|0|||
161255971|NCT04039919|582316306|FG003|Treatment Period 1|Sponsor's decision|0|||
161255972|NCT04039919|582316307|FG004|Treatment Period 1|Sponsor's decision|16|||
161255973|NCT04039919|582316303|FG000|Treatment Period 5|Withdrawal by Subject|1|||
161255974|NCT04039919|582316304|FG001|Treatment Period 5|Withdrawal by Subject|0|||
161255975|NCT04039919|582316305|FG002|Treatment Period 5|Withdrawal by Subject|0|||
161255976|NCT04039919|582316306|FG003|Treatment Period 5|Withdrawal by Subject|0|||
161255977|NCT04039919|582316307|FG004|Treatment Period 5|Withdrawal by Subject|0|||
161338423|NCT03055013|582628829|FG001|Overall Study|Other complicating disease|0|||
161338424|NCT03055013|582628828|FG000|Overall Study|Physician Decision|1|||
161338425|NCT03055013|582628829|FG001|Overall Study|Physician Decision|0|||
161338426|NCT03055013|582628828|FG000|Overall Study|Benign mass/non-RCC|4|||
161338427|NCT03055013|582628829|FG001|Overall Study|Benign mass/non-RCC|0|||
161338428|NCT03055013|582628828|FG000|Overall Study|Enrolled in another trial|1|||
161338429|NCT03055013|582628829|FG001|Overall Study|Enrolled in another trial|0|||
161338430|NCT03055013|582628828|FG000|Overall Study|Non-protocol therapy|1|||
161338431|NCT03055013|582628829|FG001|Overall Study|Non-protocol therapy|0|||
161338432|NCT03055013|582628828|FG000|Overall Study|Incompliance|1|||
161338433|NCT03055013|582628829|FG001|Overall Study|Incompliance|0|||
161338434|NCT03055013|582628828|FG000|Overall Study|Insurance issues|1|||
161338435|NCT03055013|582628829|FG001|Overall Study|Insurance issues|0|||
161338436|NCT03055013|582628828|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
161338437|NCT03055013|582628829|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
161338438|NCT03055013|582628828|FG000|Overall Study|Did not receive nivolumab|10|||
161338439|NCT03055013|582628829|FG001|Overall Study|Did not receive nivolumab|0|||
161338440|NCT03055013|582628828|FG000|Overall Study|Did not receive surgery|0|||
161338441|NCT03055013|582628829|FG001|Overall Study|Did not receive surgery|28|||
161338442|NCT02765035|582628840|FG000|First Intervention (90 Days)|Adverse Event|1|||
161338443|NCT02765035|582628841|FG001|First Intervention (90 Days)|Adverse Event|1|||
161338444|NCT02765035|582628840|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
161338445|NCT02765035|582628841|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
161338446|NCT00671749|582628843|FG000|Overall Study|Adverse Event|2|||
161338447|NCT00671749|582628843|FG000|Overall Study|Withdrawal by Subject|4|||
161338448|NCT00671749|582628843|FG000|Overall Study|Protocol Violation|1|||
161338449|NCT00671749|582628843|FG000|Overall Study|Lost to Follow-up|1|||
161338450|NCT01401322|582628845|FG000|Overall Study|Withdrawal by Subject|1|||
161338451|NCT01401322|582628845|FG000|Overall Study|Physician Decision|1|||
161338452|NCT03466346|582628848|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161338453|NCT03466346|582628849|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
161338454|NCT03466346|582628850|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161338455|NCT03466346|582628851|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161338456|NCT03466346|582628852|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
161338457|NCT03466346|582628848|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
160908759|NCT01427972|581060052|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
161255978|NCT03250299|582316315|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
161255979|NCT03250299|582316316|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
161255980|NCT03250299|582316317|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
161255981|NCT03250299|582316318|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
161255982|NCT03250299|582316319|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
161255983|NCT03250299|582316315|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
161255984|NCT03250299|582316316|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
161255985|NCT03250299|582316317|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
161255986|NCT03250299|582316318|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
161255987|NCT03250299|582316319|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
161255988|NCT03250299|582316315|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161255989|NCT03250299|582316316|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161255990|NCT03250299|582316317|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
161255991|NCT03250299|582316318|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161255992|NCT03250299|582316319|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
161255993|NCT03250299|582316315|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
161255994|NCT03250299|582316316|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
161255995|NCT03250299|582316317|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
161255996|NCT03250299|582316318|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
161255997|NCT03250299|582316319|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
161255998|NCT03346070|582316320|FG000|Overall Study|Death|0|||
161255999|NCT03346070|582316321|FG001|Overall Study|Death|0|||
161256000|NCT03346070|582316322|FG002|Overall Study|Death|0|||
161256001|NCT03346070|582316323|FG003|Overall Study|Death|0|||
161256002|NCT03346070|582316324|FG004|Overall Study|Death|1|||
161256003|NCT03346070|582316320|FG000|Overall Study|Lost to Follow-up|0|||
161256004|NCT03346070|582316321|FG001|Overall Study|Lost to Follow-up|1|||
161256005|NCT03346070|582316322|FG002|Overall Study|Lost to Follow-up|2|||
161256006|NCT03346070|582316323|FG003|Overall Study|Lost to Follow-up|0|||
161338458|NCT03466346|582628849|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
161338459|NCT03466346|582628850|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161338460|NCT03466346|582628851|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161338461|NCT03466346|582628852|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
161338462|NCT03466346|582628848|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
161338463|NCT03466346|582628849|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
161338464|NCT03466346|582628850|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161256007|NCT03346070|582316324|FG004|Overall Study|Lost to Follow-up|0|||
161256008|NCT03346070|582316320|FG000|Overall Study|Physician Decision|0|||
161338465|NCT03466346|582628851|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161338466|NCT03466346|582628852|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
161338467|NCT03466346|582628848|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
161338468|NCT03466346|582628849|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
161338469|NCT03466346|582628850|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161338470|NCT03466346|582628851|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161338471|NCT03466346|582628852|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
161338472|NCT03466346|582628848|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
161338473|NCT03466346|582628849|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
161338474|NCT03466346|582628850|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
161338475|NCT03466346|582628851|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
161338476|NCT03466346|582628852|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
161338477|NCT03466346|582628848|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161338478|NCT03466346|582628849|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161338479|NCT03466346|582628850|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
161338480|NCT03466346|582628851|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
161338481|NCT03466346|582628852|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
161338482|NCT03466346|582628848|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
161338483|NCT03466346|582628849|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
161338484|NCT03466346|582628850|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
161338485|NCT03466346|582628851|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
161338486|NCT03466346|582628852|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
161338487|NCT02410629|582628854|FG000|Overall Study|Family cannot commit to the study|2|||
161338488|NCT02410629|582628855|FG001|Overall Study|Family cannot commit to the study|1|||
161338489|NCT02410629|582628854|FG000|Overall Study|Subject returned to work|1|||
161338490|NCT02410629|582628855|FG001|Overall Study|Subject returned to work|0|||
161338491|NCT02410629|582628854|FG000|Overall Study|Subject moved back to home country|0|||
161338492|NCT02410629|582628855|FG001|Overall Study|Subject moved back to home country|1|||
161338493|NCT02410629|582628854|FG000|Overall Study|Subject underwent heart surgery|0|||
161338494|NCT02410629|582628855|FG001|Overall Study|Subject underwent heart surgery|1|||
161338495|NCT01142336|582628856|FG000|Overall Study|Adverse Event|1|||
161338496|NCT01142336|582628857|FG001|Overall Study|Adverse Event|1|||
161338497|NCT01142336|582628856|FG000|Overall Study|Lost to Follow-up|0|||
161338498|NCT01142336|582628857|FG001|Overall Study|Lost to Follow-up|1|||
161338499|NCT03040726|582628858|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
161338500|NCT03040726|582628859|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
161338501|NCT03040726|582628858|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
161338502|NCT03040726|582628859|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
161338503|NCT03040726|582628858|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
161338504|NCT03040726|582628859|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
161338505|NCT03040726|582628858|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
161338506|NCT03040726|582628859|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
161338507|NCT03040726|582628858|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
161338508|NCT03040726|582628859|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
161338509|NCT03025035|582628860|FG000|Overall Study|Death|2|||
161338510|NCT03025035|582628860|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
161338511|NCT01218802|582628861|FG000|Overall Study|Lost to Follow-up|5|||
161338512|NCT01218802|582628862|FG001|Overall Study|Lost to Follow-up|6|||
161338513|NCT01218802|582628861|FG000|Overall Study|Withdrawal by Subject|3|||
161338514|NCT01218802|582628862|FG001|Overall Study|Withdrawal by Subject|10|||
161338515|NCT01218802|582628861|FG000|Overall Study|Adverse Event|0|||
161338516|NCT01218802|582628862|FG001|Overall Study|Adverse Event|2|||
161338517|NCT01218802|582628861|FG000|Overall Study|Incarcerated|2|||
161338518|NCT01218802|582628862|FG001|Overall Study|Incarcerated|0|||
161338519|NCT02121210|582628865|FG000|Overall Study|Adverse Event|5|||
161338520|NCT02121210|582628866|FG001|Overall Study|Adverse Event|7|||
161338521|NCT02121210|582628865|FG000|Overall Study|Lack of Efficacy|2|||
161338522|NCT02121210|582628866|FG001|Overall Study|Lack of Efficacy|0|||
161338523|NCT02121210|582628865|FG000|Overall Study|Other than specified above|0|||
161338524|NCT02121210|582628866|FG001|Overall Study|Other than specified above|2|||
161338525|NCT05117060|582628871|FG000|Overall Study|Adverse Event|3|||
161338526|NCT05117060|582628872|FG001|Overall Study|Adverse Event|5|||
161338527|NCT05117060|582628873|FG002|Overall Study|Adverse Event|6|||
161338528|NCT05117060|582628874|FG003|Overall Study|Adverse Event|1|||
161338529|NCT05117060|582628871|FG000|Overall Study|Lost to Follow-up|0|||
161338530|NCT05117060|582628872|FG001|Overall Study|Lost to Follow-up|0|||
161338531|NCT05117060|582628873|FG002|Overall Study|Lost to Follow-up|0|||
160994090|NCT00502593|581367386|FG006|Overall Study|Withdrawn unspecified reason|2|||
160994091|NCT00502593|581367387|FG007|Overall Study|Withdrawn unspecified reason|0|||
160994092|NCT00502593|581367388|FG008|Overall Study|Withdrawn unspecified reason|0|||
160994093|NCT00502593|581367389|FG009|Overall Study|Withdrawn unspecified reason|0|||
160994094|NCT00502593|581367390|FG010|Overall Study|Withdrawn unspecified reason|0|||
160994095|NCT00502593|581367391|FG011|Overall Study|Withdrawn unspecified reason|0|||
160994096|NCT00502593|581367380|FG000|Overall Study|Withdrawal by Subject|0|||
160994097|NCT00502593|581367381|FG001|Overall Study|Withdrawal by Subject|0|||
160994098|NCT00502593|581367382|FG002|Overall Study|Withdrawal by Subject|6|||
160994099|NCT00502593|581367383|FG003|Overall Study|Withdrawal by Subject|2|||
160994100|NCT00502593|581367384|FG004|Overall Study|Withdrawal by Subject|2|||
160994101|NCT00502593|581367385|FG005|Overall Study|Withdrawal by Subject|0|||
160994102|NCT00502593|581367386|FG006|Overall Study|Withdrawal by Subject|3|||
160994103|NCT00502593|581367387|FG007|Overall Study|Withdrawal by Subject|0|||
160994104|NCT00502593|581367388|FG008|Overall Study|Withdrawal by Subject|3|||
160994105|NCT00502593|581367389|FG009|Overall Study|Withdrawal by Subject|0|||
160994106|NCT00502593|581367390|FG010|Overall Study|Withdrawal by Subject|1|||
160994107|NCT00502593|581367391|FG011|Overall Study|Withdrawal by Subject|0|||
160994108|NCT00502593|581367380|FG000|Overall Study|Lost to Follow-up|2|||
160994109|NCT00502593|581367381|FG001|Overall Study|Lost to Follow-up|1|||
160994110|NCT00502593|581367382|FG002|Overall Study|Lost to Follow-up|1|||
160994111|NCT00502593|581367383|FG003|Overall Study|Lost to Follow-up|1|||
160994112|NCT00502593|581367384|FG004|Overall Study|Lost to Follow-up|0|||
160994113|NCT00502593|581367385|FG005|Overall Study|Lost to Follow-up|0|||
160994114|NCT00502593|581367386|FG006|Overall Study|Lost to Follow-up|0|||
160994115|NCT00502593|581367387|FG007|Overall Study|Lost to Follow-up|0|||
160994116|NCT00502593|581367388|FG008|Overall Study|Lost to Follow-up|3|||
160994117|NCT00502593|581367389|FG009|Overall Study|Lost to Follow-up|0|||
160994118|NCT00502593|581367390|FG010|Overall Study|Lost to Follow-up|1|||
160994119|NCT00502593|581367391|FG011|Overall Study|Lost to Follow-up|0|||
160994120|NCT03601507|581367392|FG000|Overall Study|Adverse Event|1|||
160994121|NCT02107014|581367395|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
160994122|NCT00591838|581367396|FG000|Overall Study|Withdrawal by Subject|0|||
160994123|NCT00591838|581367397|FG001|Overall Study|Withdrawal by Subject|0|||
160994124|NCT00591838|581367398|FG002|Overall Study|Withdrawal by Subject|0|||
160994125|NCT00591838|581367399|FG003|Overall Study|Withdrawal by Subject|1|||
160994126|NCT00591838|581367400|FG004|Overall Study|Withdrawal by Subject|0|||
160994127|NCT00586339|581367401|FG000|Overall Study|Withdrawal by Subject|1|||
160994128|NCT00586339|581367402|FG001|Overall Study|Withdrawal by Subject|3|||
160994129|NCT00586339|581367403|FG002|Overall Study|Withdrawal by Subject|1|||
160994130|NCT00586339|581367401|FG000|Overall Study|Migrated/moved from study area|3|||
160994131|NCT00586339|581367402|FG001|Overall Study|Migrated/moved from study area|2|||
160994132|NCT00586339|581367403|FG002|Overall Study|Migrated/moved from study area|4|||
160994133|NCT00586339|581367401|FG000|Overall Study|Lost to Follow-up|3|||
160994134|NCT00586339|581367402|FG001|Overall Study|Lost to Follow-up|2|||
160994135|NCT00586339|581367403|FG002|Overall Study|Lost to Follow-up|1|||
160994136|NCT00559949|581367404|FG000|Overall Study|Progressive Disease during cycle 1|1|||
160994137|NCT00559949|581367404|FG000|Overall Study|Adverse Event|1|||
160994138|NCT00559949|581367404|FG000|Overall Study|Withdrawal by Subject|4|||
160994139|NCT00559949|581367404|FG000|Overall Study|No disease evaluation per protocol|1|||
160994140|NCT02512042|581367405|FG000|Overall Study|Adverse Event|0|||
160994141|NCT02512042|581367406|FG001|Overall Study|Adverse Event|4|||
160994142|NCT02512042|581367405|FG000|Overall Study|Withdrawal by Subject|6|||
160994143|NCT02512042|581367406|FG001|Overall Study|Withdrawal by Subject|6|||
160994144|NCT02512042|581367405|FG000|Overall Study|Non-compliance with study drug|1|||
160994145|NCT02512042|581367406|FG001|Overall Study|Non-compliance with study drug|2|||
160994146|NCT02512042|581367405|FG000|Overall Study|Lost to Follow-up|5|||
160994147|NCT02512042|581367406|FG001|Overall Study|Lost to Follow-up|2|||
160994148|NCT02512042|581367405|FG000|Overall Study|Other|11|||
160994149|NCT02512042|581367406|FG001|Overall Study|Other|11|||
160994150|NCT01467700|581367408|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
160994151|NCT01467700|581367409|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
160994152|NCT01467700|581367410|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
160994153|NCT01467700|581367411|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
160994154|NCT01467700|581367408|FG000|Overall Study|Major Protocol Deviation|3|||
160994155|NCT01467700|581367409|FG001|Overall Study|Major Protocol Deviation|3|||
160994156|NCT01467700|581367410|FG002|Overall Study|Major Protocol Deviation|2|||
160857479|NCT03473236|580868955|FG004|Overall Study|Withdrawal by Subject|0|||
160857480|NCT03473236|580868956|FG005|Overall Study|Withdrawal by Subject|1|||
160994157|NCT01467700|581367411|FG003|Overall Study|Major Protocol Deviation|3|||
160994158|NCT01467700|581367408|FG000|Overall Study|Lost to Follow-up|6|||
160994159|NCT01467700|581367409|FG001|Overall Study|Lost to Follow-up|5|||
160994160|NCT01467700|581367410|FG002|Overall Study|Lost to Follow-up|2|||
160994161|NCT01467700|581367411|FG003|Overall Study|Lost to Follow-up|3|||
160994162|NCT01467700|581367408|FG000|Overall Study|Voluntary Withdrawal|5|||
160994163|NCT01467700|581367409|FG001|Overall Study|Voluntary Withdrawal|7|||
161338532|NCT05117060|582628874|FG003|Overall Study|Lost to Follow-up|1|||
161338533|NCT05117060|582628871|FG000|Overall Study|Lack of Efficacy|4|||
161338534|NCT05117060|582628872|FG001|Overall Study|Lack of Efficacy|5|||
161338535|NCT05117060|582628873|FG002|Overall Study|Lack of Efficacy|2|||
161338536|NCT05117060|582628874|FG003|Overall Study|Lack of Efficacy|6|||
161338537|NCT05117060|582628871|FG000|Overall Study|Withdrawal by Subject|8|||
161338538|NCT05117060|582628872|FG001|Overall Study|Withdrawal by Subject|5|||
161338539|NCT05117060|582628873|FG002|Overall Study|Withdrawal by Subject|5|||
161338540|NCT05117060|582628874|FG003|Overall Study|Withdrawal by Subject|6|||
161338541|NCT05117060|582628871|FG000|Overall Study|Other|2|||
161338542|NCT05117060|582628872|FG001|Overall Study|Other|1|||
161338543|NCT05117060|582628873|FG002|Overall Study|Other|3|||
161338544|NCT05117060|582628874|FG003|Overall Study|Other|1|||
161338545|NCT03141359|582628875|FG000|Overall Study|Death|32|||
161338546|NCT03141359|582628875|FG000|Overall Study|Still On Study (in follow up)|29|||
161338547|NCT05079321|582628876|FG000|Overall Study|Withdrawal by Subject|2|||
161338548|NCT05079321|582628877|FG001|Overall Study|Withdrawal by Subject|2|||
161338549|NCT05079321|582628876|FG000|Overall Study|Lost to Follow-up|0|||
161338550|NCT05079321|582628877|FG001|Overall Study|Lost to Follow-up|1|||
161338551|NCT01081626|582628878|FG000|Overall Study|Dosing error|1|||
161338552|NCT01081626|582628879|FG001|Overall Study|Dosing error|1|||
161338553|NCT01081626|582628878|FG000|Overall Study|Missing Estradiol|25|||
161338554|NCT01081626|582628879|FG001|Overall Study|Missing Estradiol|28|||
161338555|NCT01081626|582628878|FG000|Overall Study|Low antral follicle count|1|||
161338556|NCT01081626|582628879|FG001|Overall Study|Low antral follicle count|0|||
161338557|NCT01081626|582628878|FG000|Overall Study|Overstimulation|0|||
161338558|NCT01081626|582628879|FG001|Overall Study|Overstimulation|1|||
161338559|NCT01081626|582628878|FG000|Overall Study|Lost to Follow-up|0|||
161338560|NCT01081626|582628879|FG001|Overall Study|Lost to Follow-up|1|||
161338561|NCT01081626|582628878|FG000|Overall Study|Other|33|||
161338562|NCT01081626|582628879|FG001|Overall Study|Other|30|||
161338563|NCT02003144|582628880|FG000|Open Label Maintenance Phase|Other than specified|2|||
161338564|NCT02003144|582628881|FG001|Open Label Maintenance Phase|Other than specified|4|||
161338565|NCT02003144|582628880|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
161338566|NCT02003144|582628881|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
161338567|NCT02003144|582628880|FG000|Open Label Maintenance Phase|Pregnancy|0|||
161338568|NCT02003144|582628881|FG001|Open Label Maintenance Phase|Pregnancy|2|||
161338569|NCT02003144|582628880|FG000|Open Label Maintenance Phase|Physician Decision|1|||
161338570|NCT02003144|582628881|FG001|Open Label Maintenance Phase|Physician Decision|1|||
161338571|NCT02003144|582628880|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
161338572|NCT02003144|582628881|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
161338573|NCT02003144|582628880|FG000|Open Label Maintenance Phase|Adverse Event|2|||
161338574|NCT02003144|582628881|FG001|Open Label Maintenance Phase|Adverse Event|1|||
161338575|NCT05965752|582628885|FG000|Overall Study|Adverse Event|0|||
161338576|NCT05965752|582628886|FG001|Overall Study|Adverse Event|1|||
161338577|NCT05965752|582628887|FG002|Overall Study|Adverse Event|0|||
161338578|NCT05965752|582628888|FG003|Overall Study|Adverse Event|1|||
161338579|NCT05965752|582628889|FG004|Overall Study|Adverse Event|3|||
161338580|NCT05965752|582628885|FG000|Overall Study|Lost to Follow-up|2|||
161338581|NCT05965752|582628886|FG001|Overall Study|Lost to Follow-up|0|||
161338582|NCT05965752|582628887|FG002|Overall Study|Lost to Follow-up|1|||
161338583|NCT05965752|582628888|FG003|Overall Study|Lost to Follow-up|1|||
161338584|NCT05965752|582628889|FG004|Overall Study|Lost to Follow-up|1|||
161338585|NCT05965752|582628885|FG000|Overall Study|Withdrawal by Subject|2|||
161338586|NCT05965752|582628886|FG001|Overall Study|Withdrawal by Subject|2|||
161338587|NCT05965752|582628887|FG002|Overall Study|Withdrawal by Subject|1|||
161338588|NCT05965752|582628888|FG003|Overall Study|Withdrawal by Subject|5|||
161338589|NCT05965752|582628889|FG004|Overall Study|Withdrawal by Subject|0|||
161338590|NCT05965752|582628885|FG000|Overall Study|Disease Relapse|1|||
161338591|NCT05965752|582628886|FG001|Overall Study|Disease Relapse|0|||
161338592|NCT05965752|582628887|FG002|Overall Study|Disease Relapse|1|||
161338593|NCT05965752|582628888|FG003|Overall Study|Disease Relapse|0|||
161338594|NCT05965752|582628889|FG004|Overall Study|Disease Relapse|0|||
161338595|NCT05965752|582628885|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161338596|NCT05965752|582628886|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
161338597|NCT05965752|582628887|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161338598|NCT05965752|582628888|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
161338599|NCT05965752|582628889|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161338600|NCT05965752|582628885|FG000|Overall Study|Unable to Return for Study Visits|0|||
161338601|NCT05965752|582628886|FG001|Overall Study|Unable to Return for Study Visits|1|||
161338602|NCT05965752|582628887|FG002|Overall Study|Unable to Return for Study Visits|0|||
161338603|NCT05965752|582628888|FG003|Overall Study|Unable to Return for Study Visits|3|||
161338604|NCT05965752|582628889|FG004|Overall Study|Unable to Return for Study Visits|1|||
161338605|NCT05965752|582628885|FG000|Overall Study|Early Termination|0|||
161338606|NCT05965752|582628886|FG001|Overall Study|Early Termination|0|||
161338607|NCT05965752|582628887|FG002|Overall Study|Early Termination|1|||
161338608|NCT05965752|582628888|FG003|Overall Study|Early Termination|0|||
161338609|NCT05965752|582628889|FG004|Overall Study|Early Termination|0|||
161338610|NCT05965752|582628885|FG000|Overall Study|Reported Unwanted Symptoms|0|||
161338611|NCT05965752|582628886|FG001|Overall Study|Reported Unwanted Symptoms|0|||
161338612|NCT05965752|582628887|FG002|Overall Study|Reported Unwanted Symptoms|0|||
161338613|NCT05965752|582628888|FG003|Overall Study|Reported Unwanted Symptoms|0|||
161338614|NCT05965752|582628889|FG004|Overall Study|Reported Unwanted Symptoms|1|||
161338615|NCT05965752|582628885|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161338616|NCT05965752|582628886|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161338617|NCT05965752|582628887|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161338618|NCT05965752|582628888|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
161338619|NCT05965752|582628889|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
161338620|NCT02074514|582628891|FG000|Overall Study|Lack of Efficacy|3|||
161338621|NCT02074514|582628892|FG001|Overall Study|Lack of Efficacy|2|||
161338622|NCT02074514|582628891|FG000|Overall Study|Lost to Follow-up|0|||
161338623|NCT02074514|582628892|FG001|Overall Study|Lost to Follow-up|1|||
161338624|NCT02074514|582628891|FG000|Overall Study|Withdrew Consent|0|||
161338625|NCT02074514|582628892|FG001|Overall Study|Withdrew Consent|1|||
161338626|NCT00666237|582628895|FG000|Overall Study|Death|5|||
161338627|NCT00666237|582628896|FG001|Overall Study|Death|5|||
161338628|NCT00666237|582628895|FG000|Overall Study|Lost to Follow-up|29|||
161338629|NCT00666237|582628896|FG001|Overall Study|Lost to Follow-up|25|||
161338630|NCT02839707|582628898|FG000|Phase I|Not eligible for analysis|9|||
161338631|NCT02839707|582628899|FG001|Phase I|Not eligible for analysis|0|||
161338632|NCT02839707|582628900|FG002|Phase I|Not eligible for analysis|0|||
161338633|NCT02839707|582628898|FG000|Phase II|Not treated according to protocol|4|||
161338634|NCT02839707|582628899|FG001|Phase II|Not treated according to protocol|0|||
161338635|NCT02839707|582628900|FG002|Phase II|Not treated according to protocol|2|||
161338636|NCT02839707|582628898|FG000|Phase III|Not treated according to protocol|0|||
161338637|NCT02839707|582628899|FG001|Phase III|Not treated according to protocol|0|||
161338638|NCT02839707|582628900|FG002|Phase III|Not treated according to protocol|4|||
161338639|NCT01721798|582630320|FG000|Overall Study|Death|0|||
161338640|NCT01721798|582630321|FG001|Overall Study|Death|0|||
161338641|NCT01721798|582630322|FG002|Overall Study|Death|1|||
161338642|NCT01721798|582630323|FG003|Overall Study|Death|1|||
161338643|NCT01721798|582630320|FG000|Overall Study|Lost to Follow-up|2|||
161338644|NCT01721798|582630321|FG001|Overall Study|Lost to Follow-up|2|||
161338645|NCT01721798|582630322|FG002|Overall Study|Lost to Follow-up|9|||
161338646|NCT01721798|582630323|FG003|Overall Study|Lost to Follow-up|9|||
161338647|NCT01721798|582630320|FG000|Overall Study|Pregnancy|0|||
161338648|NCT01721798|582630321|FG001|Overall Study|Pregnancy|0|||
161338649|NCT01721798|582630322|FG002|Overall Study|Pregnancy|1|||
161338650|NCT01721798|582630323|FG003|Overall Study|Pregnancy|1|||
161338651|NCT01721798|582630320|FG000|Overall Study|Withdrawal by Subject|1|||
161338652|NCT01721798|582630321|FG001|Overall Study|Withdrawal by Subject|0|||
161338653|NCT01721798|582630322|FG002|Overall Study|Withdrawal by Subject|2|||
161338654|NCT01721798|582630323|FG003|Overall Study|Withdrawal by Subject|1|||
161338655|NCT01721798|582630320|FG000|Overall Study|Not eligible for 24 month visit|1|||
161338656|NCT01721798|582630321|FG001|Overall Study|Not eligible for 24 month visit|0|||
161338657|NCT01721798|582630322|FG002|Overall Study|Not eligible for 24 month visit|8|||
161338658|NCT01721798|582630323|FG003|Overall Study|Not eligible for 24 month visit|7|||
161338659|NCT00961064|582630324|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
161338660|NCT00961064|582630324|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
161338661|NCT00961064|582630324|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
161338662|NCT00961064|582630324|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
161338663|NCT00961064|582630324|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
161338664|NCT00961064|582630324|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
161338665|NCT00961064|582630324|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
161338666|NCT00961064|582630324|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
161338667|NCT01408641|582630325|FG000|Overall Study|Physician Decision|1|||
161338668|NCT01408641|582630326|FG001|Overall Study|Physician Decision|0|||
161338669|NCT01316614|582630327|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
161338670|NCT01316614|582630327|FG000|Overall Study|Cytology slides not available for review|4|||
161338671|NCT01316614|582630327|FG000|Overall Study|Cystic lesion|5|||
161338672|NCT01316614|582630327|FG000|Overall Study|Inadequate number of passes|2|||
161338673|NCT01316614|582630327|FG000|Overall Study|Medically unstable|1|||
161338674|NCT00076570|582630328|FG000|Overall Study|Drug intolerance|8|||
161338675|NCT00076570|582630329|FG001|Overall Study|Drug intolerance|8|||
161338676|NCT03979313|582630330|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
161338677|NCT03979313|582630331|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
161338678|NCT03979313|582630330|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
161338679|NCT03979313|582630331|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
161338680|NCT03979313|582630330|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
161338681|NCT03979313|582630331|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
161338682|NCT03979313|582630330|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
161338683|NCT03979313|582630331|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
161338684|NCT03979313|582630330|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
161338685|NCT03979313|582630331|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
161338686|NCT03979313|582630330|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
161338687|NCT03979313|582630331|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
161338688|NCT03979313|582630330|FG000|All Subjects|Any Other Reason|16|||
161338689|NCT03979313|582630331|FG001|All Subjects|Any Other Reason|23|||
161338690|NCT03979313|582630330|FG000|All Subjects|Covid-19|1|||
161338691|NCT03979313|582630331|FG001|All Subjects|Covid-19|3|||
161338692|NCT03979313|582630330|FG000|All Subjects|Withdrawal by Subject|35|||
161338693|NCT03979313|582630331|FG001|All Subjects|Withdrawal by Subject|44|||
161338694|NCT03979313|582630330|FG000|All Subjects|Death|0|||
161338695|NCT03979313|582630331|FG001|All Subjects|Death|5|||
161338696|NCT03979313|582630330|FG000|All Subjects|Lost to Follow-up|28|||
161338697|NCT03979313|582630331|FG001|All Subjects|Lost to Follow-up|61|||
161338698|NCT00089648|582630332|FG000|Overall Study|Adverse Event|7|||
160908760|NCT01427972|581060053|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908761|NCT01427972|581060054|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
160908762|NCT01427972|581060043|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908763|NCT01427972|581060044|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908764|NCT01427972|581060045|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908765|NCT01427972|581060046|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
161338699|NCT00089648|582630332|FG000|Overall Study|Withdrawal by Subject|1|||
161338700|NCT00089648|582630332|FG000|Overall Study|Lack of Efficacy|33|||
161338701|NCT00423605|582630333|FG000|Overall Study|Adverse Event|129|||
161338702|NCT00423605|582630333|FG000|Overall Study|Withdrawal by Subject|36|||
161338703|NCT00423605|582630333|FG000|Overall Study|Lost to Follow-up|15|||
161338704|NCT00423605|582630333|FG000|Overall Study|Lack of Efficacy|38|||
161338705|NCT00423605|582630333|FG000|Overall Study|Sponsor Decision|3|||
161338706|NCT00423605|582630333|FG000|Overall Study|Physician Decision|8|||
161338707|NCT00423605|582630333|FG000|Overall Study|Protocol Violation|7|||
161338708|NCT00423605|582630333|FG000|Overall Study|Not one of the pre-specified options|5|||
161338709|NCT03183908|582630334|FG000|Overall Study|Missing Symptom Diary Data|0|||
161338710|NCT03183908|582630335|FG001|Overall Study|Missing Symptom Diary Data|2|||
161338711|NCT00393367|582630336|FG000|Overall Study|Protocol Violation|2|||
160908766|NCT01427972|581060047|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908767|NCT01427972|581060048|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
160908768|NCT01427972|581060049|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908769|NCT01427972|581060050|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908770|NCT01427972|581060051|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908771|NCT01427972|581060052|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908772|NCT01427972|581060053|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908773|NCT01427972|581060054|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
160908774|NCT01427972|581060043|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908775|NCT01427972|581060044|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
160908776|NCT01427972|581060045|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908777|NCT01427972|581060046|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908778|NCT01427972|581060047|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908779|NCT01427972|581060048|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908780|NCT01427972|581060049|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908781|NCT01427972|581060050|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908782|NCT01427972|581060051|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908783|NCT01427972|581060052|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908784|NCT01427972|581060053|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908785|NCT01427972|581060054|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
160908786|NCT04528732|581060055|FG000|Overall Study|Death|1|||
160908787|NCT04528732|581060056|FG001|Overall Study|Death|0|||
160908788|NCT04528732|581060057|FG002|Overall Study|Death|1|||
160908789|NCT04528732|581060055|FG000|Overall Study|Lost to Follow-up|0|||
160908790|NCT04528732|581060056|FG001|Overall Study|Lost to Follow-up|1|||
160908791|NCT04528732|581060057|FG002|Overall Study|Lost to Follow-up|2|||
160908792|NCT04967443|581060061|FG000|Open Label Treatment|Death|1|||
161141532|NCT01009463|581902511|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
161141533|NCT01009463|581902512|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
160908793|NCT04967443|581060062|FG001|Open Label Treatment|Death|0|||
160908794|NCT04967443|581060063|FG002|Open Label Treatment|Death|0|||
161141534|NCT01009463|581902513|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
161338712|NCT00393367|582630337|FG001|Overall Study|Protocol Violation|5|||
161338713|NCT00393367|582630336|FG000|Overall Study|Withdrawal by Subject|0|||
161338714|NCT00393367|582630337|FG001|Overall Study|Withdrawal by Subject|2|||
161338715|NCT01712178|582630338|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
161141535|NCT01009463|581902514|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
161338716|NCT01712178|582630339|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
161338717|NCT01712178|582630338|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
161338718|NCT01712178|582630339|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
161338719|NCT01712178|582630338|FG000|Overall Study|Lost to Follow-up|0|||
161338720|NCT01712178|582630339|FG001|Overall Study|Lost to Follow-up|1|||
161338721|NCT00856180|582630340|FG000|Overall Study|Adverse Event|4|||
161338722|NCT00856180|582630340|FG000|Overall Study|Progressive Disease|16|||
161338723|NCT02701634|582630341|FG000|Overall Study|Adverse Event|2|||
161338724|NCT02701634|582630342|FG001|Overall Study|Adverse Event|3|||
161338725|NCT02701634|582630341|FG000|Overall Study|Death|1|||
161338726|NCT02701634|582630342|FG001|Overall Study|Death|0|||
161338727|NCT02701634|582630341|FG000|Overall Study|Investigator's Discretion|7|||
161338728|NCT02701634|582630342|FG001|Overall Study|Investigator's Discretion|4|||
160994164|NCT01467700|581367410|FG002|Overall Study|Voluntary Withdrawal|6|||
160994165|NCT01467700|581367411|FG003|Overall Study|Voluntary Withdrawal|2|||
160994166|NCT01467700|581367408|FG000|Overall Study|Study Termination|6|||
160994167|NCT01467700|581367409|FG001|Overall Study|Study Termination|5|||
160994168|NCT01467700|581367410|FG002|Overall Study|Study Termination|10|||
160994169|NCT01467700|581367411|FG003|Overall Study|Study Termination|7|||
160994170|NCT01467700|581367408|FG000|Overall Study|Pregnancy|0|||
160994171|NCT01467700|581367409|FG001|Overall Study|Pregnancy|1|||
160994172|NCT01467700|581367410|FG002|Overall Study|Pregnancy|1|||
160994173|NCT01467700|581367411|FG003|Overall Study|Pregnancy|0|||
160994174|NCT01467700|581367408|FG000|Overall Study|Lack of Efficacy|2|||
160994175|NCT01467700|581367409|FG001|Overall Study|Lack of Efficacy|0|||
160994176|NCT01467700|581367410|FG002|Overall Study|Lack of Efficacy|2|||
160994177|NCT01467700|581367411|FG003|Overall Study|Lack of Efficacy|1|||
160994178|NCT01467700|581367408|FG000|Overall Study|Reason not Specified|1|||
160994179|NCT01467700|581367409|FG001|Overall Study|Reason not Specified|3|||
160994180|NCT01467700|581367410|FG002|Overall Study|Reason not Specified|2|||
160994181|NCT01467700|581367411|FG003|Overall Study|Reason not Specified|8|||
160994182|NCT00121199|581367412|FG000|Overall Study|Adverse Event|11|||
160994183|NCT00121199|581367412|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
160994184|NCT00121199|581367412|FG000|Overall Study|Progression/Relapse|1|||
160994185|NCT00121199|581367412|FG000|Overall Study|Death|3|||
160994186|NCT00121199|581367412|FG000|Overall Study|Other - Not Protocol Specified|3|||
160994187|NCT00121199|581367412|FG000|Overall Study|Ineligible|9|||
160994188|NCT03168438|581367413|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
160994189|NCT03168438|581367414|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
160994190|NCT04109118|581367417|FG000|Overall Study|Lost to Follow-up|3|||
160994191|NCT03235349|581367420|FG000|Overall Study|Adverse Event|1|||
160994192|NCT03235349|581367420|FG000|Overall Study|Other|1|||
160994193|NCT03394027|581367421|FG000|Overall Study|Ineligible|3|||
160994194|NCT03394027|581367422|FG001|Overall Study|Ineligible|1|||
160994195|NCT03394027|581367423|FG002|Overall Study|Ineligible|3|||
160994196|NCT03394027|581367421|FG000|Overall Study|Participant declined to participate before treatment started|0|||
160994197|NCT03394027|581367422|FG001|Overall Study|Participant declined to participate before treatment started|0|||
160994198|NCT03394027|581367423|FG002|Overall Study|Participant declined to participate before treatment started|1|||
160994199|NCT05663866|581367430|FG000|Overall Study|Adverse Event|0|||
160994200|NCT05663866|581367431|FG001|Overall Study|Adverse Event|0|||
160994201|NCT05663866|581367432|FG002|Overall Study|Adverse Event|1|||
160994202|NCT05663866|581367433|FG003|Overall Study|Adverse Event|0|||
160994203|NCT05663866|581367430|FG000|Overall Study|Physician Decision|0|||
160994204|NCT05663866|581367431|FG001|Overall Study|Physician Decision|0|||
160994205|NCT05663866|581367432|FG002|Overall Study|Physician Decision|0|||
160994206|NCT05663866|581367433|FG003|Overall Study|Physician Decision|1|||
160994207|NCT05663866|581367430|FG000|Overall Study|Withdrawal by Subject|0|||
160994208|NCT05663866|581367431|FG001|Overall Study|Withdrawal by Subject|2|||
160994209|NCT05663866|581367432|FG002|Overall Study|Withdrawal by Subject|1|||
160994210|NCT05663866|581367433|FG003|Overall Study|Withdrawal by Subject|2|||
160994211|NCT05663866|581367430|FG000|Overall Study|Progressive disease|4|||
160994212|NCT05663866|581367431|FG001|Overall Study|Progressive disease|8|||
160994213|NCT05663866|581367432|FG002|Overall Study|Progressive disease|5|||
160994214|NCT05663866|581367433|FG003|Overall Study|Progressive disease|2|||
161338729|NCT02701634|582630341|FG000|Overall Study|Study terminated by Sponsor|15|||
161338730|NCT02701634|582630342|FG001|Overall Study|Study terminated by Sponsor|17|||
161338731|NCT02701634|582630341|FG000|Overall Study|Withdrew Consent|6|||
160994215|NCT05663866|581367430|FG000|Overall Study|Other|1|||
160994216|NCT05663866|581367431|FG001|Overall Study|Other|0|||
160994217|NCT05663866|581367432|FG002|Overall Study|Other|0|||
161338732|NCT02701634|582630342|FG001|Overall Study|Withdrew Consent|7|||
161338733|NCT02701634|582630341|FG000|Overall Study|Randomized but not treated|1|||
160994218|NCT05663866|581367433|FG003|Overall Study|Other|0|||
160994219|NCT05663866|581367430|FG000|Overall Study|Ongoing|1|||
160994220|NCT05663866|581367431|FG001|Overall Study|Ongoing|27|||
160994221|NCT05663866|581367432|FG002|Overall Study|Ongoing|6|||
160994222|NCT05663866|581367433|FG003|Overall Study|Ongoing|1|||
160994223|NCT05803720|581367434|FG000|Overall Study|Lost to Follow-up|3|||
160994224|NCT05803720|581367435|FG001|Overall Study|Lost to Follow-up|4|||
160994225|NCT05803720|581367434|FG000|Overall Study|Family leave/emergency|1|||
160994226|NCT05803720|581367435|FG001|Overall Study|Family leave/emergency|1|||
160994227|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
160994228|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
160994229|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
160994230|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
160994231|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
160994232|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
160994233|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
160994234|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
160994235|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
160994236|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
160994237|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
160994238|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
160994239|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994240|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994241|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994242|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
160994243|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994244|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
160994245|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
160994246|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
160994247|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
160994248|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994249|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
161256009|NCT03346070|582316321|FG001|Overall Study|Physician Decision|0|||
160994250|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994251|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994252|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994253|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
160994254|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
160994255|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
160994256|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
160994257|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994258|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994259|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994260|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994261|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994262|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
160994263|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
160994264|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
161256010|NCT03346070|582316322|FG002|Overall Study|Physician Decision|0|||
161256011|NCT03346070|582316323|FG003|Overall Study|Physician Decision|1|||
161256012|NCT03346070|582316324|FG004|Overall Study|Physician Decision|1|||
161256013|NCT03346070|582316320|FG000|Overall Study|Withdrawal by Subject|1|||
161256014|NCT03346070|582316321|FG001|Overall Study|Withdrawal by Subject|0|||
161256015|NCT03346070|582316322|FG002|Overall Study|Withdrawal by Subject|0|||
161256016|NCT03346070|582316323|FG003|Overall Study|Withdrawal by Subject|1|||
161256017|NCT03346070|582316324|FG004|Overall Study|Withdrawal by Subject|0|||
161256018|NCT03346070|582316320|FG000|Overall Study|Study medication not received as planned|2|||
161256019|NCT03346070|582316321|FG001|Overall Study|Study medication not received as planned|3|||
161256020|NCT03346070|582316322|FG002|Overall Study|Study medication not received as planned|2|||
161256021|NCT03346070|582316323|FG003|Overall Study|Study medication not received as planned|3|||
161256022|NCT03346070|582316324|FG004|Overall Study|Study medication not received as planned|2|||
161256023|NCT03346070|582316320|FG000|Overall Study|Screen Failure|0|||
161256024|NCT03346070|582316321|FG001|Overall Study|Screen Failure|0|||
161256025|NCT03346070|582316322|FG002|Overall Study|Screen Failure|0|||
161256026|NCT03346070|582316323|FG003|Overall Study|Screen Failure|1|||
161256027|NCT03346070|582316324|FG004|Overall Study|Screen Failure|1|||
161256028|NCT00977548|582316326|FG000|Overall Study|Ineligible|4|||
161256029|NCT00977548|582316326|FG000|Overall Study|Adverse Event|8|||
161256030|NCT00977548|582316326|FG000|Overall Study|Withdrawal by Subject|1|||
161256031|NCT00988208|582316327|FG000|Overall Study|Adverse Event|71|||
161256032|NCT00988208|582316328|FG001|Overall Study|Adverse Event|122|||
161256033|NCT00988208|582316327|FG000|Overall Study|Disease Progression|103|||
161256034|NCT00988208|582316328|FG001|Overall Study|Disease Progression|89|||
161256035|NCT00988208|582316327|FG000|Overall Study|Withdrawal by Subject|50|||
160994265|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
161256036|NCT00988208|582316328|FG001|Overall Study|Withdrawal by Subject|57|||
161256037|NCT00988208|582316327|FG000|Overall Study|Death|9|||
161256038|NCT00988208|582316328|FG001|Overall Study|Death|15|||
160857481|NCT03473236|580868957|FG006|Overall Study|Withdrawal by Subject|0|||
160857482|NCT03473236|580868958|FG007|Overall Study|Withdrawal by Subject|0|||
160857483|NCT03473236|580868959|FG008|Overall Study|Withdrawal by Subject|1|||
160857484|NCT03473236|580868960|FG009|Overall Study|Withdrawal by Subject|0|||
160857485|NCT04264442|580868961|FG000|Overall Study|Lack of Efficacy|6|||
160857486|NCT04264442|580868961|FG000|Overall Study|Lost to Follow-up|2|||
160857487|NCT04264442|580868961|FG000|Overall Study|Sponsor Decision|23|||
160857488|NCT04264442|580868961|FG000|Overall Study|Withdrawal by Subject|11|||
160857489|NCT04264442|580868961|FG000|Overall Study|Study Termination|5|||
160857490|NCT03062358|580868964|FG000|Overall Study|Death|269|||
160857491|NCT03062358|580868965|FG001|Overall Study|Death|145|||
160857492|NCT03062358|580868964|FG000|Overall Study|Withdrawal by Subject|2|||
160857493|NCT03062358|580868965|FG001|Overall Study|Withdrawal by Subject|1|||
160857494|NCT03062358|580868964|FG000|Overall Study|Sponsor Decision|29|||
160857495|NCT03062358|580868965|FG001|Overall Study|Sponsor Decision|7|||
160857496|NCT00880698|580868966|FG000|Overall Study|Death|0|||
160857497|NCT00880698|580868967|FG001|Overall Study|Death|0|||
160857498|NCT00880698|580868968|FG002|Overall Study|Death|1|||
160857499|NCT00880698|580868969|FG003|Overall Study|Death|2|||
160857500|NCT00880698|580868966|FG000|Overall Study|Lost to Follow-up|1|||
160857501|NCT00880698|580868967|FG001|Overall Study|Lost to Follow-up|3|||
160857502|NCT00880698|580868968|FG002|Overall Study|Lost to Follow-up|0|||
160857503|NCT00880698|580868969|FG003|Overall Study|Lost to Follow-up|1|||
160857504|NCT01766050|580870859|FG000|Overall Study|Adverse Event|1|||
160857505|NCT01766050|580870859|FG000|Overall Study|Lost to Follow-up|1|||
160857506|NCT01766050|580870859|FG000|Overall Study|Withdrawal by Subject|2|||
160857507|NCT01097668|580870860|FG000|Overall Study|Withdrawal by Subject|1|||
160857508|NCT01097668|580870861|FG001|Overall Study|Withdrawal by Subject|2|||
160857509|NCT01097668|580870860|FG000|Overall Study|Lost to Follow-up|1|||
160857510|NCT01097668|580870861|FG001|Overall Study|Lost to Follow-up|0|||
160857511|NCT00812708|580870862|FG000|Overall Study|Device could not be implanted|2|||
160908795|NCT04967443|581060064|FG003|Open Label Treatment|Death|0|||
160908796|NCT04967443|581060065|FG004|Open Label Treatment|Death|0|||
160908797|NCT04967443|581060066|FG005|Open Label Treatment|Death|0|||
160908798|NCT04967443|581060067|FG006|Open Label Treatment|Death|0|||
160908799|NCT04967443|581060068|FG007|Open Label Treatment|Death|0|||
160908800|NCT04967443|581060061|FG000|Open Label Treatment|Lost to Follow-up|0|||
160908801|NCT04967443|581060062|FG001|Open Label Treatment|Lost to Follow-up|0|||
160908802|NCT04967443|581060063|FG002|Open Label Treatment|Lost to Follow-up|1|||
160908803|NCT04967443|581060064|FG003|Open Label Treatment|Lost to Follow-up|0|||
160908804|NCT04967443|581060065|FG004|Open Label Treatment|Lost to Follow-up|0|||
160908805|NCT04967443|581060066|FG005|Open Label Treatment|Lost to Follow-up|0|||
160908806|NCT04967443|581060067|FG006|Open Label Treatment|Lost to Follow-up|0|||
160908807|NCT04967443|581060068|FG007|Open Label Treatment|Lost to Follow-up|0|||
160908808|NCT04967443|581060061|FG000|Open Label Treatment|Withdrawal by Subject|0|||
160908809|NCT04967443|581060062|FG001|Open Label Treatment|Withdrawal by Subject|1|||
160908810|NCT04967443|581060063|FG002|Open Label Treatment|Withdrawal by Subject|0|||
160908811|NCT04967443|581060064|FG003|Open Label Treatment|Withdrawal by Subject|1|||
160994266|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161256039|NCT00988208|582316327|FG000|Overall Study|Lost to Follow-up|2|||
161256040|NCT00988208|582316328|FG001|Overall Study|Lost to Follow-up|3|||
160857512|NCT00812708|580870862|FG000|Overall Study|Lack of medical insurance|1|||
160857513|NCT00812708|580870862|FG000|Overall Study|Switched to another study|1|||
160857514|NCT00812708|580870862|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
160857515|NCT00812708|580870862|FG000|Overall Study|Signed consent but later withdrew|3|||
160857516|NCT01021020|580870864|FG000|Period I|Protocol Violation|1|||
160857517|NCT01021020|580870864|FG000|Period I|Withdrawal by Subject|1|||
160857518|NCT01021020|580870864|FG000|14 Day Washout Period A|Physician Decision|1|||
160857519|NCT00948246|580870865|FG000|Overall Study|Lost to Follow-up|11|||
160857520|NCT00948246|580870865|FG000|Overall Study|Adverse Event|11|||
160857521|NCT00948246|580870865|FG000|Overall Study|Death|1|||
160857522|NCT00948246|580870865|FG000|Overall Study|Withdrawal by Subject|1|||
161256041|NCT00988208|582316327|FG000|Overall Study|Protocol Violation|9|||
161256042|NCT00988208|582316328|FG001|Overall Study|Protocol Violation|2|||
161256043|NCT00988208|582316327|FG000|Overall Study|Sponsor Decision|102|||
161256044|NCT00988208|582316328|FG001|Overall Study|Sponsor Decision|78|||
160857523|NCT01706458|580870868|FG000|Overall Study|Physician Decision|3|||
160857524|NCT01706458|580870869|FG001|Overall Study|Physician Decision|4|||
160857525|NCT03547518|580870873|FG000|Overall Study|Lost to Follow-up|2|||
160857526|NCT03547518|580870874|FG001|Overall Study|Lost to Follow-up|0|||
160857527|NCT02766023|580870876|FG000|Overall Study|Lost to Follow-up|23|||
160857528|NCT02766023|580870877|FG001|Overall Study|Lost to Follow-up|11|||
160857529|NCT02766023|580870876|FG000|Overall Study|Pregnancy|1|||
160857530|NCT02766023|580870877|FG001|Overall Study|Pregnancy|0|||
160857531|NCT02766023|580870876|FG000|Overall Study|Adverse Event|1|||
160857532|NCT02766023|580870877|FG001|Overall Study|Adverse Event|0|||
160908812|NCT04967443|581060065|FG004|Open Label Treatment|Withdrawal by Subject|0|||
160908813|NCT04967443|581060066|FG005|Open Label Treatment|Withdrawal by Subject|1|||
160857533|NCT02766023|580870876|FG000|Overall Study|Withdrawal by Subject|4|||
160857534|NCT02766023|580870877|FG001|Overall Study|Withdrawal by Subject|5|||
160857535|NCT02766023|580870876|FG000|Overall Study|Physician Decision|1|||
160857536|NCT02766023|580870877|FG001|Overall Study|Physician Decision|0|||
160857537|NCT02766023|580870876|FG000|Overall Study|Not Eligible at Enrollment|0|||
160857538|NCT02766023|580870877|FG001|Overall Study|Not Eligible at Enrollment|1|||
160857539|NCT00286468|580870878|FG000|Overall Study|Hyperglycemic Rescue|28|||
160857540|NCT00286468|580870879|FG001|Overall Study|Hyperglycemic Rescue|30|||
160857541|NCT00286468|580870880|FG002|Overall Study|Hyperglycemic Rescue|31|||
160857542|NCT00286468|580870878|FG000|Overall Study|Adverse Event|2|||
160857543|NCT00286468|580870879|FG001|Overall Study|Adverse Event|6|||
160857544|NCT00286468|580870880|FG002|Overall Study|Adverse Event|4|||
160857545|NCT00286468|580870878|FG000|Overall Study|Protocol Violation|0|||
160857546|NCT00286468|580870879|FG001|Overall Study|Protocol Violation|3|||
160857547|NCT00286468|580870880|FG002|Overall Study|Protocol Violation|1|||
160857548|NCT00286468|580870878|FG000|Overall Study|Lost to Follow-up|1|||
160857549|NCT00286468|580870879|FG001|Overall Study|Lost to Follow-up|1|||
160857550|NCT00286468|580870880|FG002|Overall Study|Lost to Follow-up|2|||
160857551|NCT00286468|580870878|FG000|Overall Study|Withdrawal by Subject|3|||
160857552|NCT00286468|580870879|FG001|Overall Study|Withdrawal by Subject|8|||
160857553|NCT00286468|580870880|FG002|Overall Study|Withdrawal by Subject|11|||
160857554|NCT00286468|580870878|FG000|Overall Study|Physician Decision|3|||
160857555|NCT00286468|580870879|FG001|Overall Study|Physician Decision|2|||
160857556|NCT00286468|580870880|FG002|Overall Study|Physician Decision|1|||
160857557|NCT02953652|580870881|FG000|Overall Study|Adverse Event|18|||
160857558|NCT02953652|580870881|FG000|Overall Study|Withdrawal by Subject|6|||
160857559|NCT02953652|580870881|FG000|Overall Study|Protocol Violation|1|||
160857560|NCT02953652|580870881|FG000|Overall Study|Disease Progression|27|||
160857561|NCT02384551|580870885|FG000|Overall Study|Lost to Follow-up|13|||
160857562|NCT02384551|580870886|FG001|Overall Study|Lost to Follow-up|14|||
160857563|NCT02384551|580870887|FG002|Overall Study|Lost to Follow-up|14|||
160857564|NCT02384551|580870888|FG003|Overall Study|Lost to Follow-up|14|||
160857565|NCT04742556|580870893|FG000|Overall Study|Withdrawal by Subject|0|||
160857566|NCT04742556|580870894|FG001|Overall Study|Withdrawal by Subject|1|||
160857567|NCT04742556|580870895|FG002|Overall Study|Withdrawal by Subject|0|||
160994267|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160994268|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
160994269|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
160994270|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161141536|NCT01009463|581902515|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
161141537|NCT04430348|581902516|FG000|Overall Study|Death|3|||
161256045|NCT00988208|582316327|FG000|Overall Study|Clinical Progression|17|||
161256046|NCT00988208|582316328|FG001|Overall Study|Clinical Progression|16|||
161256047|NCT00988208|582316327|FG000|Overall Study|Biochemical Progression|21|||
161256048|NCT00988208|582316328|FG001|Overall Study|Biochemical Progression|7|||
161256049|NCT00988208|582316327|FG000|Overall Study|Clinical Deterioration|7|||
161256050|NCT00988208|582316328|FG001|Overall Study|Clinical Deterioration|14|||
161256051|NCT00988208|582316327|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
161256052|NCT00988208|582316328|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
161256053|NCT00988208|582316327|FG000|Overall Study|Other|8|||
161256054|NCT00988208|582316328|FG001|Overall Study|Other|3|||
161256055|NCT02000531|582316333|FG000|Overall Study|Lost to Follow-up|1|||
161256056|NCT02000531|582316334|FG001|Overall Study|Lost to Follow-up|0|||
161256057|NCT02000531|582316333|FG000|Overall Study|Discontinued due to data cut-off|3|||
161256058|NCT02000531|582316334|FG001|Overall Study|Discontinued due to data cut-off|8|||
161256059|NCT00794417|582316335|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
161256060|NCT00794417|582316336|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
161256061|NCT00794417|582316337|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
161256062|NCT00794417|582316338|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
161256063|NCT00794417|582316335|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
161256064|NCT00794417|582316336|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
161256065|NCT00794417|582316337|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
161256066|NCT00794417|582316338|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
161256067|NCT00794417|582316335|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161256068|NCT00794417|582316336|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161256069|NCT00794417|582316337|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
161256070|NCT00794417|582316338|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
161256071|NCT00794417|582316335|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161256072|NCT00794417|582316336|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161256073|NCT00794417|582316337|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
161256074|NCT00794417|582316338|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
161256075|NCT00794417|582316335|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161256076|NCT00794417|582316336|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
160857568|NCT04742556|580870893|FG000|Overall Study|Adverse Event|0|||
160857569|NCT04742556|580870894|FG001|Overall Study|Adverse Event|0|||
160857570|NCT04742556|580870895|FG002|Overall Study|Adverse Event|2|||
160857571|NCT04742556|580870893|FG000|Overall Study|Clinical disease progression|0|||
160857572|NCT04742556|580870894|FG001|Overall Study|Clinical disease progression|1|||
160857573|NCT04742556|580870895|FG002|Overall Study|Clinical disease progression|2|||
160857574|NCT04742556|580870893|FG000|Overall Study|Objective disease progression|3|||
160857575|NCT04742556|580870894|FG001|Overall Study|Objective disease progression|2|||
160857576|NCT04742556|580870895|FG002|Overall Study|Objective disease progression|4|||
160857577|NCT04247347|580870896|FG000|Overall Study|Withdrawal by Subject|2|||
160857578|NCT04247347|580870897|FG001|Overall Study|Withdrawal by Subject|3|||
160857579|NCT04247347|580870898|FG002|Overall Study|Withdrawal by Subject|3|||
160857580|NCT04247347|580870896|FG000|Overall Study|Lost to Follow-up|1|||
160857581|NCT04247347|580870897|FG001|Overall Study|Lost to Follow-up|1|||
160857582|NCT04247347|580870898|FG002|Overall Study|Lost to Follow-up|1|||
160857583|NCT03035032|580870899|FG000|Overall Study|Adverse Event|2|||
160857584|NCT03035032|580870899|FG000|Overall Study|Death|9|||
160857585|NCT03035032|580870899|FG000|Overall Study|Lost to Follow-up|1|||
160857586|NCT03035032|580870899|FG000|Overall Study|Progressive Disease|22|||
160857587|NCT03035032|580870899|FG000|Overall Study|Protocol Violation|2|||
160857588|NCT03035032|580870899|FG000|Overall Study|Withdrawal by Subject|2|||
160857589|NCT03035032|580870899|FG000|Overall Study|Physician Decision|5|||
160857590|NCT03562195|580870900|FG000|Overall Study|Adverse Event|0|||
160857591|NCT03562195|580870901|FG001|Overall Study|Adverse Event|6|||
160857592|NCT03562195|580870900|FG000|Overall Study|Lack of Efficacy|0|||
160857593|NCT03562195|580870901|FG001|Overall Study|Lack of Efficacy|5|||
160857594|NCT03562195|580870900|FG000|Overall Study|Protocol Violation|0|||
160857595|NCT03562195|580870901|FG001|Overall Study|Protocol Violation|1|||
160857596|NCT03562195|580870900|FG000|Overall Study|Lost to Follow-up|0|||
160857597|NCT03562195|580870901|FG001|Overall Study|Lost to Follow-up|1|||
160857598|NCT03562195|580870900|FG000|Overall Study|Physician Decision|1|||
160857599|NCT03562195|580870901|FG001|Overall Study|Physician Decision|0|||
160857600|NCT03562195|580870900|FG000|Overall Study|Withdrawal by Subject|3|||
160857601|NCT03562195|580870901|FG001|Overall Study|Withdrawal by Subject|0|||
160857602|NCT02923726|580870902|FG000|Overall Study|Death|196|||
160857603|NCT02923726|580870903|FG001|Overall Study|Death|175|||
160857604|NCT02923726|580870902|FG000|Overall Study|Withdrawal by Subject|337|||
160857605|NCT02923726|580870903|FG001|Overall Study|Withdrawal by Subject|307|||
160857606|NCT01176032|580870916|FG000|Overall Study|Adverse Event|1|||
160857607|NCT01176032|580870917|FG001|Overall Study|Adverse Event|0|||
160857608|NCT01176032|580870916|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160857609|NCT01176032|580870917|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160857610|NCT01176032|580870916|FG000|Overall Study|Protocol Violation|1|||
160857611|NCT01176032|580870917|FG001|Overall Study|Protocol Violation|0|||
160857612|NCT01176032|580870916|FG000|Overall Study|Informed consent withdrawn|3|||
160857613|NCT01176032|580870917|FG001|Overall Study|Informed consent withdrawn|0|||
160857614|NCT01176032|580870916|FG000|Overall Study|Other|1|||
160857615|NCT01176032|580870917|FG001|Overall Study|Other|0|||
160857616|NCT01469221|580870918|FG000|Double Blind Phase|Protocol Violation|1|||
160857617|NCT01469221|580870919|FG001|Double Blind Phase|Protocol Violation|0|||
160857618|NCT01469221|580870920|FG002|Double Blind Phase|Protocol Violation|0|||
160857619|NCT01469221|580870918|FG000|Double Blind Phase|Physician Decision|1|||
160857620|NCT01469221|580870919|FG001|Double Blind Phase|Physician Decision|1|||
160857621|NCT01469221|580870920|FG002|Double Blind Phase|Physician Decision|0|||
160857622|NCT01469221|580870918|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
160857623|NCT01469221|580870919|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
160857624|NCT01469221|580870920|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
160857625|NCT04038359|580870922|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
160857626|NCT04038359|580870923|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
160857627|NCT04038359|580870922|FG000|Overall Study|Death|8|||
160857628|NCT04038359|580870923|FG001|Overall Study|Death|7|||
160857629|NCT04038359|580870922|FG000|Overall Study|Lost to Follow-up|3|||
160857630|NCT04038359|580870923|FG001|Overall Study|Lost to Follow-up|0|||
160857631|NCT04038359|580870922|FG000|Overall Study|Participant Moved|1|||
160857632|NCT04038359|580870923|FG001|Overall Study|Participant Moved|0|||
160857633|NCT04038359|580870922|FG000|Overall Study|Withdrawal by Subject|4|||
160857634|NCT04038359|580870923|FG001|Overall Study|Withdrawal by Subject|3|||
160857635|NCT04038359|580870922|FG000|Overall Study|Physician Decision|3|||
160857636|NCT04038359|580870923|FG001|Overall Study|Physician Decision|2|||
160857637|NCT04038359|580870922|FG000|Overall Study|Adverse Event|0|||
160857638|NCT04038359|580870923|FG001|Overall Study|Adverse Event|2|||
160857639|NCT04038359|580870922|FG000|Overall Study|Progressive Disease|0|||
160857640|NCT04038359|580870923|FG001|Overall Study|Progressive Disease|1|||
160857641|NCT00475670|580870924|FG000|Overall Study|Death|0|||
160857642|NCT00475670|580870925|FG001|Overall Study|Death|1|||
160857643|NCT00475670|580870924|FG000|Overall Study|Lack of Efficacy|3|||
160857644|NCT00475670|580870925|FG001|Overall Study|Lack of Efficacy|34|||
160857645|NCT00475670|580870924|FG000|Overall Study|Refused treatment|0|||
160857646|NCT00475670|580870925|FG001|Overall Study|Refused treatment|2|||
160857647|NCT00475670|580870924|FG000|Overall Study|Failure to Return|0|||
160857648|NCT00475670|580870925|FG001|Overall Study|Failure to Return|1|||
160857649|NCT00475670|580870924|FG000|Overall Study|Other|0|||
160857650|NCT00475670|580870925|FG001|Overall Study|Other|3|||
160857651|NCT01168349|580870926|FG000|Overall Study|Death|157|||
160857652|NCT01168349|580870926|FG000|Overall Study|Lost to Follow-up|34|||
160857653|NCT01168349|580870926|FG000|Overall Study|Withdrawal by Subject|9|||
160857654|NCT01168349|580870926|FG000|Overall Study|Kidney transplantation|3|||
160857655|NCT01168349|580870926|FG000|Overall Study|Other|22|||
160857656|NCT01168349|580870926|FG000|Overall Study|Protocol Violation|76|||
160857657|NCT01033240|580870927|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
160857658|NCT01033240|580870928|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
160857659|NCT01033240|580870929|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
160857660|NCT01033240|580870927|FG000|Overall Study|Death|2|||
160857661|NCT01033240|580870928|FG001|Overall Study|Death|0|||
160857662|NCT01033240|580870929|FG002|Overall Study|Death|0|||
160857663|NCT01033240|580870927|FG000|Overall Study|Withdrew Consent|2|||
160857664|NCT01033240|580870928|FG001|Overall Study|Withdrew Consent|9|||
160857665|NCT01033240|580870929|FG002|Overall Study|Withdrew Consent|2|||
160857666|NCT01033240|580870927|FG000|Overall Study|Disease Progression|35|||
160857667|NCT01033240|580870928|FG001|Overall Study|Disease Progression|32|||
160857668|NCT01033240|580870929|FG002|Overall Study|Disease Progression|41|||
160857669|NCT01033240|580870927|FG000|Overall Study|Investigator Discretion|0|||
160857670|NCT01033240|580870928|FG001|Overall Study|Investigator Discretion|0|||
160857671|NCT01033240|580870929|FG002|Overall Study|Investigator Discretion|2|||
160857672|NCT01033240|580870927|FG000|Overall Study|Other|0|||
160857673|NCT01033240|580870928|FG001|Overall Study|Other|1|||
160857674|NCT01033240|580870929|FG002|Overall Study|Other|2|||
160857675|NCT00918385|580870933|FG000|Monotherapy|Adverse Event|1|||
161256077|NCT00794417|582316337|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
161256078|NCT00794417|582316338|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
161256079|NCT00794417|582316335|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161256080|NCT00794417|582316336|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161256081|NCT00794417|582316337|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
161256082|NCT00794417|582316338|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
161256083|NCT00317642|582316341|FG000|Overall Study|Not Received Either Study Drug|1|||
161256084|NCT00317642|582316342|FG001|Overall Study|Not Received Either Study Drug|3|||
161256085|NCT00317642|582316341|FG000|Overall Study|Physician Decision|15|||
161256086|NCT00317642|582316342|FG001|Overall Study|Physician Decision|7|||
161256087|NCT00317642|582316341|FG000|Overall Study|Participant declined treatment|14|||
161256088|NCT00317642|582316342|FG001|Overall Study|Participant declined treatment|3|||
161256089|NCT00317642|582316341|FG000|Overall Study|Adverse Event|17|||
161256090|NCT00317642|582316342|FG001|Overall Study|Adverse Event|5|||
161256091|NCT00317642|582316341|FG000|Overall Study|Treatment Failure|56|||
161256092|NCT00317642|582316342|FG001|Overall Study|Treatment Failure|102|||
161256093|NCT00317642|582316341|FG000|Overall Study|Disease Recurrence|1|||
161256094|NCT00317642|582316342|FG001|Overall Study|Disease Recurrence|2|||
161256095|NCT00317642|582316341|FG000|Overall Study|Death|14|||
161256096|NCT00317642|582316342|FG001|Overall Study|Death|7|||
161256097|NCT00317642|582316341|FG000|Overall Study|Not Continue to Consolidation|2|||
161256098|NCT00317642|582316342|FG001|Overall Study|Not Continue to Consolidation|0|||
161256099|NCT00317642|582316341|FG000|Overall Study|Withdrawal by Subject|0|||
161256100|NCT00317642|582316342|FG001|Overall Study|Withdrawal by Subject|1|||
161256101|NCT00317642|582316341|FG000|Overall Study|Referred For Transplantation|1|||
161256102|NCT00317642|582316342|FG001|Overall Study|Referred For Transplantation|0|||
161256103|NCT00317642|582316341|FG000|Overall Study|AML Not Centrally Confirmed|1|||
161256104|NCT00317642|582316342|FG001|Overall Study|AML Not Centrally Confirmed|5|||
161256105|NCT00255151|582316344|FG000|Overall Study|Adverse Event|10|||
161256106|NCT00255151|582316345|FG001|Overall Study|Adverse Event|6|||
161256107|NCT00255151|582316346|FG002|Overall Study|Adverse Event|9|||
161256108|NCT00255151|582316344|FG000|Overall Study|Lost to Follow-up|4|||
161256109|NCT00255151|582316345|FG001|Overall Study|Lost to Follow-up|3|||
161256110|NCT00255151|582316346|FG002|Overall Study|Lost to Follow-up|4|||
161256111|NCT00255151|582316344|FG000|Overall Study|Withdrawal by Subject|18|||
161256112|NCT00255151|582316345|FG001|Overall Study|Withdrawal by Subject|17|||
161256113|NCT00255151|582316346|FG002|Overall Study|Withdrawal by Subject|8|||
161256114|NCT00255151|582316344|FG000|Overall Study|Noncompliance|0|||
161338734|NCT02701634|582630342|FG001|Overall Study|Randomized but not treated|0|||
160857676|NCT00918385|580870934|FG001|Monotherapy|Adverse Event|6|||
160857677|NCT00918385|580870933|FG000|Monotherapy|Complicating illness|1|||
160857678|NCT00918385|580870934|FG001|Monotherapy|Complicating illness|0|||
160857679|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
160857680|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
160857681|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
160857682|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
160857683|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
160857684|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
160857685|NCT00918385|580870933|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
160857686|NCT00918385|580870934|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
160857687|NCT01476722|580870937|FG000|Overall Study|Adverse Event|1|||
160857688|NCT02978417|580870941|FG000|Overall Study|Lost to Follow-up|2|||
160857689|NCT02978417|580870942|FG001|Overall Study|Lost to Follow-up|2|||
160857690|NCT02675907|580870945|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
160857691|NCT02675907|580870946|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
160857692|NCT02675907|580870945|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
160857693|NCT02675907|580870946|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
160857694|NCT02675907|580870945|FG000|Study Overall|Lack of Efficacy|1|||
160857695|NCT02675907|580870946|FG001|Study Overall|Lack of Efficacy|0|||
160857696|NCT02675907|580870945|FG000|Study Overall|Withdrawal by Subject|2|||
160857697|NCT02675907|580870946|FG001|Study Overall|Withdrawal by Subject|2|||
160857698|NCT02675907|580870945|FG000|Study Overall|Lost to Follow-up|0|||
160857699|NCT02675907|580870946|FG001|Study Overall|Lost to Follow-up|2|||
160857700|NCT01323582|580870947|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
160857701|NCT01323582|580870948|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
160857702|NCT01323582|580870947|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
161338735|NCT01206764|582630343|FG000|Overall Study|Adverse Event|20|||
160857703|NCT01323582|580870948|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
160857704|NCT01323582|580870947|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
160857705|NCT01323582|580870948|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
160857706|NCT00168844|580870949|FG000|Overall Study|Adverse Event|31|||
160857707|NCT00168844|580870950|FG001|Overall Study|Adverse Event|32|||
160857708|NCT00168844|580870951|FG002|Overall Study|Adverse Event|48|||
160857709|NCT00168844|580870949|FG000|Overall Study|Lost to Follow-up|4|||
160857710|NCT00168844|580870950|FG001|Overall Study|Lost to Follow-up|5|||
160857711|NCT00168844|580870951|FG002|Overall Study|Lost to Follow-up|11|||
160857712|NCT00168844|580870949|FG000|Overall Study|Withdrawal by Subject|12|||
160857713|NCT00168844|580870950|FG001|Overall Study|Withdrawal by Subject|9|||
160857714|NCT00168844|580870951|FG002|Overall Study|Withdrawal by Subject|19|||
160857715|NCT00168844|580870949|FG000|Overall Study|Protocol Violation|2|||
160857716|NCT00168844|580870950|FG001|Overall Study|Protocol Violation|2|||
160857717|NCT00168844|580870951|FG002|Overall Study|Protocol Violation|4|||
160857718|NCT00168844|580870949|FG000|Overall Study|Other|6|||
160857719|NCT00168844|580870950|FG001|Overall Study|Other|7|||
160857720|NCT00168844|580870951|FG002|Overall Study|Other|9|||
160857721|NCT00525512|580870958|FG000|Double-Blind Phase|Adverse Event|48|||
160857722|NCT00525512|580870959|FG001|Double-Blind Phase|Adverse Event|28|||
160857723|NCT00525512|580870960|FG002|Double-Blind Phase|Adverse Event|0|||
160857724|NCT00525512|580870961|FG003|Double-Blind Phase|Adverse Event|0|||
160857725|NCT00525512|580870958|FG000|Double-Blind Phase|Protocol Violation|3|||
160857726|NCT00525512|580870959|FG001|Double-Blind Phase|Protocol Violation|1|||
160857727|NCT00525512|580870960|FG002|Double-Blind Phase|Protocol Violation|0|||
160857728|NCT00525512|580870961|FG003|Double-Blind Phase|Protocol Violation|0|||
160857729|NCT00525512|580870958|FG000|Double-Blind Phase|Lost to Follow-up|3|||
160857730|NCT00525512|580870959|FG001|Double-Blind Phase|Lost to Follow-up|7|||
160857731|NCT00525512|580870960|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160857732|NCT00525512|580870961|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161338736|NCT01206764|582630343|FG000|Overall Study|Abnormal laboratory value|2|||
161338737|NCT01206764|582630343|FG000|Overall Study|Abnormal test procedure result|1|||
160857733|NCT00525512|580870958|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
160857734|NCT00525512|580870959|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
160857735|NCT00525512|580870960|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160857736|NCT00525512|580870961|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160857737|NCT00525512|580870958|FG000|Double-Blind Phase|Lack of Efficacy|13|||
160857738|NCT00525512|580870959|FG001|Double-Blind Phase|Lack of Efficacy|5|||
160857739|NCT00525512|580870960|FG002|Double-Blind Phase|Lack of Efficacy|0|||
160857740|NCT00525512|580870961|FG003|Double-Blind Phase|Lack of Efficacy|0|||
161338738|NCT01206764|582630343|FG000|Overall Study|Patient withdrew consent|5|||
161338739|NCT01206764|582630343|FG000|Overall Study|Lost to Follow-up|6|||
161338740|NCT01206764|582630343|FG000|Overall Study|Death|11|||
160857741|NCT00525512|580870958|FG000|Double-Blind Phase|Other reason (not specified)|12|||
160857742|NCT00525512|580870959|FG001|Double-Blind Phase|Other reason (not specified)|13|||
160857743|NCT00525512|580870960|FG002|Double-Blind Phase|Other reason (not specified)|0|||
160857744|NCT00525512|580870961|FG003|Double-Blind Phase|Other reason (not specified)|0|||
160994271|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
161338741|NCT01206764|582630343|FG000|Overall Study|New cancer therapy|2|||
161338742|NCT01206764|582630343|FG000|Overall Study|Disease progression|88|||
161338743|NCT01206764|582630343|FG000|Overall Study|Protocol deviation|3|||
160857745|NCT00525512|580870958|FG000|Open-Label Phase|Adverse Event|0|||
160857746|NCT00525512|580870959|FG001|Open-Label Phase|Adverse Event|0|||
160857747|NCT00525512|580870960|FG002|Open-Label Phase|Adverse Event|1|||
160857748|NCT00525512|580870961|FG003|Open-Label Phase|Adverse Event|0|||
160857749|NCT00525512|580870958|FG000|Open-Label Phase|Lost to Follow-up|0|||
160857750|NCT00525512|580870959|FG001|Open-Label Phase|Lost to Follow-up|0|||
160857751|NCT00525512|580870960|FG002|Open-Label Phase|Lost to Follow-up|1|||
160857752|NCT00525512|580870961|FG003|Open-Label Phase|Lost to Follow-up|0|||
160857753|NCT00525512|580870958|FG000|Open-Label Phase|Other reason (not specified)|0|||
160857754|NCT00525512|580870959|FG001|Open-Label Phase|Other reason (not specified)|0|||
160857755|NCT00525512|580870960|FG002|Open-Label Phase|Other reason (not specified)|4|||
160857756|NCT00525512|580870961|FG003|Open-Label Phase|Other reason (not specified)|5|||
160857757|NCT01601535|580870966|FG000|Phase 1|Adverse Event|1|||
160857758|NCT01601535|580870967|FG001|Phase 1|Adverse Event|0|||
160857759|NCT01601535|580870968|FG002|Phase 1|Adverse Event|2|||
160857760|NCT01601535|580870969|FG003|Phase 1|Adverse Event|1|||
160857761|NCT01601535|580870970|FG004|Phase 1|Adverse Event|0|||
160857762|NCT01601535|580870971|FG005|Phase 1|Adverse Event|0|||
160857763|NCT01601535|580870966|FG000|Phase 1|Withdrawal by Subject|2|||
160857764|NCT01601535|580870967|FG001|Phase 1|Withdrawal by Subject|1|||
160857765|NCT01601535|580870968|FG002|Phase 1|Withdrawal by Subject|1|||
160857766|NCT01601535|580870969|FG003|Phase 1|Withdrawal by Subject|2|||
160857767|NCT01601535|580870970|FG004|Phase 1|Withdrawal by Subject|0|||
160857768|NCT01601535|580870971|FG005|Phase 1|Withdrawal by Subject|0|||
160857769|NCT01601535|580870966|FG000|Phase 1|Progressive Disease|2|||
160857770|NCT01601535|580870967|FG001|Phase 1|Progressive Disease|3|||
160857771|NCT01601535|580870968|FG002|Phase 1|Progressive Disease|2|||
160857772|NCT01601535|580870969|FG003|Phase 1|Progressive Disease|1|||
160857773|NCT01601535|580870970|FG004|Phase 1|Progressive Disease|0|||
160857774|NCT01601535|580870971|FG005|Phase 1|Progressive Disease|0|||
160857775|NCT01601535|580870966|FG000|Phase 1|Started Another Treatment|1|||
160857776|NCT01601535|580870967|FG001|Phase 1|Started Another Treatment|2|||
160857777|NCT01601535|580870968|FG002|Phase 1|Started Another Treatment|0|||
160857778|NCT01601535|580870969|FG003|Phase 1|Started Another Treatment|0|||
160857779|NCT01601535|580870970|FG004|Phase 1|Started Another Treatment|0|||
161256115|NCT00255151|582316345|FG001|Overall Study|Noncompliance|1|||
161256116|NCT00255151|582316346|FG002|Overall Study|Noncompliance|2|||
161256117|NCT00255151|582316344|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
161256118|NCT00255151|582316345|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
161256119|NCT00255151|582316346|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
161256120|NCT00255151|582316344|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
161256121|NCT00255151|582316345|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
161256122|NCT00255151|582316346|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
161256123|NCT00255151|582316344|FG000|Overall Study|Possible Barrett's Esophagus|1|||
161256124|NCT00255151|582316345|FG001|Overall Study|Possible Barrett's Esophagus|3|||
161256125|NCT00255151|582316346|FG002|Overall Study|Possible Barrett's Esophagus|8|||
161256126|NCT00255151|582316344|FG000|Overall Study|Esophageal Stricture|0|||
161256127|NCT00255151|582316345|FG001|Overall Study|Esophageal Stricture|0|||
161256128|NCT00255151|582316346|FG002|Overall Study|Esophageal Stricture|1|||
161256129|NCT00255151|582316344|FG000|Overall Study|Therapeutic Failure|11|||
161256130|NCT00255151|582316345|FG001|Overall Study|Therapeutic Failure|2|||
161256131|NCT00255151|582316346|FG002|Overall Study|Therapeutic Failure|3|||
161256132|NCT00792623|582316347|FG000|Overall Study|Adverse Event|2|||
161256133|NCT00792623|582316347|FG000|Overall Study|Withdrawal by Subject|5|||
161256134|NCT00880087|582316356|FG000|Overall Study|Lost to Follow-up|0|||
161256135|NCT00880087|582316357|FG001|Overall Study|Lost to Follow-up|2|||
161256136|NCT00743509|582316358|FG000|Overall Study|Withdrawal by Subject|2|||
161256137|NCT00892281|582316363|FG000|Overall Study|Adverse Event|65|||
161256138|NCT00892281|582316364|FG001|Overall Study|Adverse Event|8|||
161256139|NCT00892281|582316363|FG000|Overall Study|Lost to Follow-up|81|||
161256140|NCT00892281|582316364|FG001|Overall Study|Lost to Follow-up|8|||
161256141|NCT00892281|582316363|FG000|Overall Study|Pregnancy|1|||
161256142|NCT00892281|582316364|FG001|Overall Study|Pregnancy|0|||
161256143|NCT00892281|582316363|FG000|Overall Study|Protocol Violation|7|||
161256144|NCT00892281|582316364|FG001|Overall Study|Protocol Violation|2|||
161256145|NCT00892281|582316363|FG000|Overall Study|Withdrawal by Subject|86|||
161256146|NCT00892281|582316364|FG001|Overall Study|Withdrawal by Subject|14|||
161338744|NCT04494646|582630344|FG000|Overall Study|Adverse Event|0|||
160857780|NCT01601535|580870971|FG005|Phase 1|Started Another Treatment|0|||
160857781|NCT01601535|580870966|FG000|Phase 2|Adverse Event|0|||
160857782|NCT01601535|580870967|FG001|Phase 2|Adverse Event|0|||
160857783|NCT01601535|580870968|FG002|Phase 2|Adverse Event|0|||
160857784|NCT01601535|580870969|FG003|Phase 2|Adverse Event|0|||
160857785|NCT01601535|580870970|FG004|Phase 2|Adverse Event|5|||
160857786|NCT01601535|580870971|FG005|Phase 2|Adverse Event|1|||
160857787|NCT01601535|580870966|FG000|Phase 2|Withdrawal by Subject|0|||
161256147|NCT00892281|582316363|FG000|Overall Study|Subject failed to return for final visit|2|||
161256148|NCT00892281|582316364|FG001|Overall Study|Subject failed to return for final visit|0|||
161256149|NCT00892281|582316363|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
161256150|NCT00892281|582316364|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
161256151|NCT00892281|582316363|FG000|Overall Study|Final visit completed 4 weeks late|0|||
160857788|NCT01601535|580870967|FG001|Phase 2|Withdrawal by Subject|0|||
160857789|NCT01601535|580870968|FG002|Phase 2|Withdrawal by Subject|0|||
160857790|NCT01601535|580870969|FG003|Phase 2|Withdrawal by Subject|0|||
160857791|NCT01601535|580870970|FG004|Phase 2|Withdrawal by Subject|8|||
160857792|NCT01601535|580870971|FG005|Phase 2|Withdrawal by Subject|2|||
160857793|NCT01601535|580870966|FG000|Phase 2|Progressive Disease|0|||
160857794|NCT01601535|580870967|FG001|Phase 2|Progressive Disease|0|||
160857795|NCT01601535|580870968|FG002|Phase 2|Progressive Disease|0|||
160857796|NCT01601535|580870969|FG003|Phase 2|Progressive Disease|0|||
160857797|NCT01601535|580870970|FG004|Phase 2|Progressive Disease|5|||
160857798|NCT01601535|580870971|FG005|Phase 2|Progressive Disease|7|||
160857799|NCT01601535|580870966|FG000|Phase 2|Started Another Treatment|0|||
160857800|NCT01601535|580870967|FG001|Phase 2|Started Another Treatment|0|||
160857801|NCT01601535|580870968|FG002|Phase 2|Started Another Treatment|0|||
160857802|NCT01601535|580870969|FG003|Phase 2|Started Another Treatment|0|||
160857803|NCT01601535|580870970|FG004|Phase 2|Started Another Treatment|1|||
160857804|NCT01601535|580870971|FG005|Phase 2|Started Another Treatment|2|||
160857805|NCT03600909|580870974|FG000|Overall Study|Not treated|0|||
160857806|NCT03600909|580870975|FG001|Overall Study|Not treated|3|||
160857807|NCT03600909|580870976|FG002|Overall Study|Not treated|0|||
160857808|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
160857809|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
160857810|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
160857811|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
160857812|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
160857813|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
160857814|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
160857815|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
160857816|NCT04576988|580870977|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
160857817|NCT04576988|580870978|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
160857818|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
160857819|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
160857820|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
160857821|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
160857822|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
160857823|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
160857824|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Death|2|||
160857825|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Death|1|||
160857826|NCT04576988|580870977|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
160857827|NCT04576988|580870978|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
160857828|NCT03309020|580870979|FG000|Overall Study|Death|1|||
160857829|NCT03309020|580870980|FG001|Overall Study|Death|0|||
160857830|NCT03309020|580870979|FG000|Overall Study|Did not undergo surgery|2|||
160857831|NCT03309020|580870980|FG001|Overall Study|Did not undergo surgery|1|||
160857832|NCT02362724|580870989|FG000|Overall Study|Withdrawal by Subject|3|||
160857833|NCT02362724|580870990|FG001|Overall Study|Withdrawal by Subject|1|||
160857834|NCT02362724|580870989|FG000|Overall Study|Adverse Event|3|||
160857835|NCT02362724|580870990|FG001|Overall Study|Adverse Event|0|||
160857836|NCT02919761|580870998|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
160857837|NCT02919761|580870999|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
160857838|NCT02919761|580871000|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
160857839|NCT02919761|580870998|FG000|Part 1: Open Label|Adverse Event|1|||
160857840|NCT02919761|580870999|FG001|Part 1: Open Label|Adverse Event|0|||
160857841|NCT02919761|580871000|FG002|Part 1: Open Label|Adverse Event|0|||
160857842|NCT02919761|580870998|FG000|Part 1: Open Label|Lost to Follow-up|1|||
160857843|NCT02919761|580870999|FG001|Part 1: Open Label|Lost to Follow-up|0|||
160994272|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
161141538|NCT04430348|581902517|FG001|Overall Study|Death|2|||
161141539|NCT04430348|581902518|FG002|Overall Study|Death|2|||
161256152|NCT00892281|582316364|FG001|Overall Study|Final visit completed 4 weeks late|1|||
160857844|NCT02919761|580871000|FG002|Part 1: Open Label|Lost to Follow-up|0|||
160857845|NCT02919761|580870998|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
160857846|NCT02919761|580870999|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
160857847|NCT02919761|580871000|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
160857848|NCT02919761|580870998|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
160857849|NCT02919761|580870999|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
160857850|NCT02919761|580871000|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
160857851|NCT02919761|580870998|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
160857852|NCT02919761|580870999|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
160857853|NCT02919761|580871000|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
160857854|NCT02919761|580870998|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
160857855|NCT02919761|580870999|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
160857856|NCT02919761|580871000|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
161256153|NCT00892281|582316363|FG000|Overall Study|Subject completed day after study closed|1|||
160857857|NCT02919761|580870998|FG000|Part 1: Open Label|Termination by Sponsor|1|||
160857858|NCT02919761|580870999|FG001|Part 1: Open Label|Termination by Sponsor|0|||
160857859|NCT02919761|580871000|FG002|Part 1: Open Label|Termination by Sponsor|0|||
160857860|NCT02919761|580870998|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
160857861|NCT02919761|580870999|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
160857862|NCT02919761|580871000|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
160857863|NCT02919761|580870998|FG000|Part 2: Double-blind|Adverse Event|0|||
160857864|NCT02919761|580870999|FG001|Part 2: Double-blind|Adverse Event|1|||
160857865|NCT02919761|580871000|FG002|Part 2: Double-blind|Adverse Event|0|||
160857866|NCT02919761|580870998|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
160857867|NCT02919761|580870999|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
160857868|NCT02919761|580871000|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
160857869|NCT02919761|580870998|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
160857870|NCT02919761|580870999|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
160857871|NCT02919761|580871000|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
160857872|NCT02919761|580870998|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
160857873|NCT02919761|580870999|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
160857874|NCT02919761|580871000|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
160857875|NCT02919761|580870998|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
160857876|NCT02919761|580870999|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
160857877|NCT02919761|580871000|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
160857878|NCT02919761|580870998|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
160857879|NCT02919761|580870999|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
160857880|NCT02919761|580871000|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
160857881|NCT02919761|580870998|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
160857882|NCT02919761|580870999|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
160857883|NCT02919761|580871000|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
160857884|NCT03724942|580871001|FG000|Overall Study|Adverse Event|20|||
160857885|NCT03724942|580871002|FG001|Overall Study|Adverse Event|14|||
160857886|NCT03724942|580871001|FG000|Overall Study|Lack of Efficacy|0|||
160857887|NCT03724942|580871002|FG001|Overall Study|Lack of Efficacy|1|||
160857888|NCT03724942|580871001|FG000|Overall Study|Physician Decision|5|||
160857889|NCT03724942|580871002|FG001|Overall Study|Physician Decision|2|||
160857890|NCT03724942|580871001|FG000|Overall Study|Protocol Violation|1|||
160857891|NCT03724942|580871002|FG001|Overall Study|Protocol Violation|0|||
160857892|NCT03724942|580871001|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
160857893|NCT03724942|580871002|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
160857894|NCT03724942|580871001|FG000|Overall Study|Withdrawal by Legal Representative|3|||
160857895|NCT03724942|580871002|FG001|Overall Study|Withdrawal by Legal Representative|0|||
160857896|NCT02994108|580872932|FG000|Intervention Messages|Withdrawal by Subject|2|||
160857897|NCT02994108|580872933|FG001|Intervention Messages|Withdrawal by Subject|0|||
160857898|NCT02994108|580872932|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
161338745|NCT04494646|582630345|FG001|Overall Study|Adverse Event|1|||
161338746|NCT04494646|582630344|FG000|Overall Study|Withdrawal by Subject|0|||
161338747|NCT04494646|582630345|FG001|Overall Study|Withdrawal by Subject|1|||
161338748|NCT05282823|582630346|FG000|Overall Study|Withdrawal by Subject|9|||
161338749|NCT05282823|582630346|FG000|Overall Study|Adverse Event|1|||
161338750|NCT05282823|582630346|FG000|Overall Study|did not meet protocol criteria|2|||
161338751|NCT05282823|582630346|FG000|Overall Study|Withdrawal by Subject|7|||
161338752|NCT03620162|582630347|FG000|Overall Study|Physician Decision|4|||
161338753|NCT03620162|582630348|FG001|Overall Study|Physician Decision|0|||
161338754|NCT03620162|582630349|FG002|Overall Study|Physician Decision|1|||
161338755|NCT03620162|582630350|FG003|Overall Study|Physician Decision|0|||
160857899|NCT02994108|580872933|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
160857900|NCT02994108|580872932|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
160857901|NCT02994108|580872933|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
160857902|NCT02994108|580872932|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
160857903|NCT02994108|580872933|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
160857904|NCT00089297|580872934|FG000|Overall Study|Adverse Event|9|||
160857905|NCT00089297|580872934|FG000|Overall Study|Death|1|||
160857906|NCT00089297|580872934|FG000|Overall Study|Withdrawal by Subject|12|||
160908814|NCT04967443|581060067|FG006|Open Label Treatment|Withdrawal by Subject|2|||
160908815|NCT04967443|581060068|FG007|Open Label Treatment|Withdrawal by Subject|3|||
160908816|NCT04967443|581060061|FG000|Follow-Up|Death|1|||
160857907|NCT00089297|580872934|FG000|Overall Study|Disease progression|2|||
160857908|NCT00089297|580872934|FG000|Overall Study|Ineligible|11|||
160857909|NCT00089297|580872934|FG000|Overall Study|Secondary malignancy|1|||
160857910|NCT00089297|580872934|FG000|Overall Study|IRB approval not ready|1|||
160857911|NCT00089297|580872934|FG000|Overall Study|Non-compliance|1|||
160857912|NCT00904969|580872935|FG000|Overall Study|Lost to Follow-up|4|||
160908817|NCT04967443|581060062|FG001|Follow-Up|Death|0|||
160908818|NCT04967443|581060063|FG002|Follow-Up|Death|0|||
161338756|NCT03620162|582630351|FG004|Overall Study|Physician Decision|2|||
161338757|NCT03620162|582630347|FG000|Overall Study|Lost to Follow-up|2|||
161338758|NCT03620162|582630348|FG001|Overall Study|Lost to Follow-up|6|||
161338759|NCT03620162|582630349|FG002|Overall Study|Lost to Follow-up|7|||
161338760|NCT03620162|582630350|FG003|Overall Study|Lost to Follow-up|3|||
161338761|NCT03620162|582630351|FG004|Overall Study|Lost to Follow-up|2|||
161338762|NCT03620162|582630347|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
161338763|NCT03620162|582630348|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
161338764|NCT03620162|582630349|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
161338765|NCT03620162|582630350|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
161338766|NCT03620162|582630351|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
161338767|NCT05569174|582630352|FG000|Overall Study|Adverse Event|0|||
160857913|NCT00904969|580872935|FG000|Overall Study|Withdrawal by Subject|3|||
160857914|NCT00904969|580872935|FG000|Overall Study|Additional Treatments|11|||
160857915|NCT00904969|580872935|FG000|Overall Study|Case Aborted; Subject Exited|1|||
160857916|NCT01295814|580872942|FG000|Overall Study|Lack of Efficacy|0|||
160857917|NCT01295814|580872943|FG001|Overall Study|Lack of Efficacy|2|||
160857918|NCT01295814|580872942|FG000|Overall Study|Withdrawal by Subject|2|||
160857919|NCT01295814|580872943|FG001|Overall Study|Withdrawal by Subject|0|||
160857920|NCT03414983|580872944|FG000|Pre-Treatment|Other reasons|1|||
160857921|NCT03414983|580872945|FG001|Pre-Treatment|Other reasons|0|||
160908819|NCT04967443|581060064|FG003|Follow-Up|Death|0|||
161338768|NCT05569174|582630353|FG001|Overall Study|Adverse Event|1|||
161338769|NCT05569174|582630352|FG000|Overall Study|Lack of compliance|0|||
161338770|NCT05569174|582630353|FG001|Overall Study|Lack of compliance|1|||
161338771|NCT05569174|582630352|FG000|Overall Study|Withdrawal of consent|0|||
161338772|NCT05569174|582630353|FG001|Overall Study|Withdrawal of consent|1|||
161338773|NCT05569174|582630352|FG000|Overall Study|Participant wish|0|||
161338774|NCT05569174|582630353|FG001|Overall Study|Participant wish|1|||
161338775|NCT05569174|582630352|FG000|Overall Study|Lost to Follow-up|0|||
161338776|NCT05569174|582630353|FG001|Overall Study|Lost to Follow-up|1|||
161338777|NCT00112957|582630354|FG000|Overall Study|Progressive disease|18|||
161338778|NCT00112957|582630354|FG000|Overall Study|Physician Decision|1|||
161338779|NCT00961415|582630358|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
161338780|NCT00961415|582630359|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
161338781|NCT00961415|582630360|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
161338782|NCT00961415|582630358|FG000|Induction Treatment Phase|Death|77|||
161338783|NCT00961415|582630359|FG001|Induction Treatment Phase|Death|0|||
161338784|NCT00961415|582630360|FG002|Induction Treatment Phase|Death|0|||
161338785|NCT00961415|582630358|FG000|Induction Treatment Phase|Protocol Violation|1|||
161338786|NCT00961415|582630359|FG001|Induction Treatment Phase|Protocol Violation|0|||
161338787|NCT00961415|582630360|FG002|Induction Treatment Phase|Protocol Violation|0|||
161338788|NCT00961415|582630358|FG000|Induction Treatment Phase|Physician Decision|2|||
161338789|NCT00961415|582630359|FG001|Induction Treatment Phase|Physician Decision|0|||
161338790|NCT00961415|582630360|FG002|Induction Treatment Phase|Physician Decision|0|||
161338791|NCT00961415|582630358|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
161338792|NCT00961415|582630359|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
161338793|NCT00961415|582630360|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
161338794|NCT00961415|582630358|FG000|Induction Treatment Phase|Other Reason|5|||
161338795|NCT00961415|582630359|FG001|Induction Treatment Phase|Other Reason|0|||
161338796|NCT00961415|582630360|FG002|Induction Treatment Phase|Other Reason|0|||
161338797|NCT00961415|582630358|FG000|Maintenance Treatment Phase|Death|0|||
161338798|NCT00961415|582630359|FG001|Maintenance Treatment Phase|Death|42|||
161338799|NCT00961415|582630360|FG002|Maintenance Treatment Phase|Death|34|||
161338800|NCT00961415|582630358|FG000|Maintenance Treatment Phase|Investigators decision|0|||
161338801|NCT00961415|582630359|FG001|Maintenance Treatment Phase|Investigators decision|2|||
161338802|NCT00961415|582630360|FG002|Maintenance Treatment Phase|Investigators decision|0|||
161338803|NCT00961415|582630358|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161338804|NCT00961415|582630359|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
161338805|NCT00961415|582630360|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
161338806|NCT00961415|582630358|FG000|Maintenance Treatment Phase|Other reason|0|||
160908820|NCT04967443|581060065|FG004|Follow-Up|Death|0|||
160908821|NCT04967443|581060066|FG005|Follow-Up|Death|0|||
160908822|NCT04967443|581060067|FG006|Follow-Up|Death|0|||
160908823|NCT04967443|581060068|FG007|Follow-Up|Death|0|||
161338807|NCT00961415|582630359|FG001|Maintenance Treatment Phase|Other reason|1|||
161338808|NCT00961415|582630360|FG002|Maintenance Treatment Phase|Other reason|3|||
161338809|NCT02309359|582630361|FG000|Overall Study|Adverse Event|4|||
161338810|NCT02309359|582630362|FG001|Overall Study|Adverse Event|5|||
161338811|NCT02309359|582630363|FG002|Overall Study|Adverse Event|5|||
161338812|NCT02309359|582630364|FG003|Overall Study|Adverse Event|4|||
161338813|NCT02309359|582630365|FG004|Overall Study|Adverse Event|4|||
160857922|NCT03414983|580872944|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160857923|NCT03414983|580872945|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
160908824|NCT04967443|581060061|FG000|Follow-Up|Lost to Follow-up|0|||
160908825|NCT04967443|581060062|FG001|Follow-Up|Lost to Follow-up|0|||
160908826|NCT04967443|581060063|FG002|Follow-Up|Lost to Follow-up|1|||
160857924|NCT03414983|580872944|FG000|Pre-Treatment|Participant withdrew consent|1|||
160857925|NCT03414983|580872945|FG001|Pre-Treatment|Participant withdrew consent|3|||
160857926|NCT03414983|580872944|FG000|Treatment|Participant withdrew consent|4|||
160857927|NCT03414983|580872945|FG001|Treatment|Participant withdrew consent|3|||
160857928|NCT03414983|580872944|FG000|Treatment|Participant request to discontinue study treatment|8|||
160857929|NCT03414983|580872945|FG001|Treatment|Participant request to discontinue study treatment|10|||
160857930|NCT03414983|580872944|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
160857931|NCT03414983|580872945|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
160857932|NCT03414983|580872944|FG000|Treatment|Death|0|||
160857933|NCT03414983|580872945|FG001|Treatment|Death|1|||
160857934|NCT03414983|580872944|FG000|Treatment|Study Drug Toxicity|10|||
160857935|NCT03414983|580872945|FG001|Treatment|Study Drug Toxicity|5|||
160857936|NCT03414983|580872944|FG000|Treatment|Disease Progression|75|||
160857937|NCT03414983|580872945|FG001|Treatment|Disease Progression|29|||
160857938|NCT03414983|580872944|FG000|Treatment|Not reported|1|||
160857939|NCT03414983|580872945|FG001|Treatment|Not reported|0|||
160857940|NCT03414983|580872944|FG000|Treatment|Other reasons|3|||
160857941|NCT03414983|580872945|FG001|Treatment|Other reasons|2|||
161338814|NCT02309359|582630361|FG000|Overall Study|Death|1|||
160857942|NCT03414983|580872944|FG000|Treatment|Poor/non-compliance|2|||
160857943|NCT03414983|580872945|FG001|Treatment|Poor/non-compliance|0|||
160857944|NCT03414983|580872944|FG000|Treatment|Maximum clinical benefit|5|||
160857945|NCT03414983|580872945|FG001|Treatment|Maximum clinical benefit|9|||
160857946|NCT03414983|580872944|FG000|Treatment|Lost to Follow-up|0|||
160857947|NCT03414983|580872945|FG001|Treatment|Lost to Follow-up|1|||
161338815|NCT02309359|582630362|FG001|Overall Study|Death|0|||
161338816|NCT02309359|582630363|FG002|Overall Study|Death|0|||
161338817|NCT02309359|582630364|FG003|Overall Study|Death|0|||
160857948|NCT03414983|580872944|FG000|Treatment|Administrative reasons by sponsor|1|||
160857949|NCT03414983|580872945|FG001|Treatment|Administrative reasons by sponsor|0|||
160857950|NCT04515771|580872953|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
160857951|NCT04515771|580872954|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
160857952|NCT04515771|580872953|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
160857953|NCT04515771|580872954|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
160857954|NCT04515771|580872953|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
160857955|NCT04515771|580872954|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
160857956|NCT00148317|580872958|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
160857957|NCT00148317|580872958|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
160857958|NCT00148317|580872958|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
160857959|NCT04199351|580872961|FG000|Overall Study|Decision by sponsor|0|||
160857960|NCT04199351|580872962|FG001|Overall Study|Decision by sponsor|0|||
160857961|NCT04199351|580872963|FG002|Overall Study|Decision by sponsor|0|||
160857962|NCT04199351|580872964|FG003|Overall Study|Decision by sponsor|2|||
160857963|NCT04199351|580872965|FG004|Overall Study|Decision by sponsor|0|||
160857964|NCT04199351|580872966|FG005|Overall Study|Decision by sponsor|0|||
160857965|NCT04199351|580872967|FG006|Overall Study|Decision by sponsor|0|||
160857966|NCT04199351|580872968|FG007|Overall Study|Decision by sponsor|0|||
160857967|NCT04199351|580872969|FG008|Overall Study|Decision by sponsor|0|||
160857968|NCT04199351|580872970|FG009|Overall Study|Decision by sponsor|6|||
160908827|NCT04967443|581060064|FG003|Follow-Up|Lost to Follow-up|1|||
160908828|NCT04967443|581060065|FG004|Follow-Up|Lost to Follow-up|0|||
160908829|NCT04967443|581060066|FG005|Follow-Up|Lost to Follow-up|0|||
160908830|NCT04967443|581060067|FG006|Follow-Up|Lost to Follow-up|0|||
160908831|NCT04967443|581060068|FG007|Follow-Up|Lost to Follow-up|0|||
161338818|NCT02309359|582630365|FG004|Overall Study|Death|0|||
160857969|NCT04199351|580872961|FG000|Overall Study|Lost to Follow-up|0|||
160857970|NCT04199351|580872962|FG001|Overall Study|Lost to Follow-up|0|||
160857971|NCT04199351|580872963|FG002|Overall Study|Lost to Follow-up|1|||
160857972|NCT04199351|580872964|FG003|Overall Study|Lost to Follow-up|0|||
160857973|NCT04199351|580872965|FG004|Overall Study|Lost to Follow-up|0|||
160857974|NCT04199351|580872966|FG005|Overall Study|Lost to Follow-up|1|||
160857975|NCT04199351|580872967|FG006|Overall Study|Lost to Follow-up|0|||
160857976|NCT04199351|580872968|FG007|Overall Study|Lost to Follow-up|0|||
160857977|NCT04199351|580872969|FG008|Overall Study|Lost to Follow-up|0|||
160857978|NCT04199351|580872970|FG009|Overall Study|Lost to Follow-up|0|||
160857979|NCT04199351|580872961|FG000|Overall Study|Withdrawal by Subject|0|||
160857980|NCT04199351|580872962|FG001|Overall Study|Withdrawal by Subject|1|||
160857981|NCT04199351|580872963|FG002|Overall Study|Withdrawal by Subject|0|||
160857982|NCT04199351|580872964|FG003|Overall Study|Withdrawal by Subject|0|||
160857983|NCT04199351|580872965|FG004|Overall Study|Withdrawal by Subject|1|||
160908832|NCT04967443|581060061|FG000|Follow-Up|Withdrawal by Subject|0|||
161338819|NCT02309359|582630361|FG000|Overall Study|Withdrawal by Subject|2|||
161338820|NCT02309359|582630362|FG001|Overall Study|Withdrawal by Subject|2|||
160857984|NCT04199351|580872966|FG005|Overall Study|Withdrawal by Subject|4|||
160857985|NCT04199351|580872967|FG006|Overall Study|Withdrawal by Subject|2|||
160908833|NCT04967443|581060062|FG001|Follow-Up|Withdrawal by Subject|1|||
161338821|NCT02309359|582630363|FG002|Overall Study|Withdrawal by Subject|4|||
160857986|NCT04199351|580872968|FG007|Overall Study|Withdrawal by Subject|0|||
160857987|NCT04199351|580872969|FG008|Overall Study|Withdrawal by Subject|3|||
160857988|NCT04199351|580872970|FG009|Overall Study|Withdrawal by Subject|0|||
160857989|NCT03623243|580872973|FG000|Overall Study|Adverse Event|15|||
160857990|NCT03623243|580872973|FG000|Overall Study|Guardian Decision|1|||
160857991|NCT03623243|580872973|FG000|Overall Study|New Therapy for Study Indication|1|||
160857992|NCT03623243|580872973|FG000|Overall Study|Protocol Deviation|3|||
160857993|NCT03623243|580872973|FG000|Overall Study|Physician Decision|4|||
160857994|NCT03623243|580872973|FG000|Overall Study|Patient Decision|15|||
160857995|NCT03007966|580872974|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
160857996|NCT03007966|580872975|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
160857997|NCT00979901|580872979|FG000|Overall Study|Adverse Event|1|||
160857998|NCT00979901|580872980|FG001|Overall Study|Adverse Event|3|||
160857999|NCT00979901|580872981|FG002|Overall Study|Adverse Event|9|||
160858000|NCT00979901|580872982|FG003|Overall Study|Adverse Event|2|||
160858001|NCT00979901|580872979|FG000|Overall Study|Lack of Efficacy|8|||
160858002|NCT00979901|580872980|FG001|Overall Study|Lack of Efficacy|4|||
160858003|NCT00979901|580872981|FG002|Overall Study|Lack of Efficacy|9|||
160858004|NCT00979901|580872982|FG003|Overall Study|Lack of Efficacy|0|||
160858005|NCT00979901|580872979|FG000|Overall Study|Lost to Follow-up|1|||
160858006|NCT00979901|580872980|FG001|Overall Study|Lost to Follow-up|1|||
160858007|NCT00979901|580872981|FG002|Overall Study|Lost to Follow-up|2|||
160858008|NCT00979901|580872982|FG003|Overall Study|Lost to Follow-up|0|||
160858009|NCT00979901|580872979|FG000|Overall Study|Protocol Violation|2|||
160858010|NCT00979901|580872980|FG001|Overall Study|Protocol Violation|2|||
160858011|NCT00979901|580872981|FG002|Overall Study|Protocol Violation|7|||
160858012|NCT00979901|580872982|FG003|Overall Study|Protocol Violation|1|||
160858013|NCT00979901|580872979|FG000|Overall Study|Withdrawal by Subject|2|||
160858014|NCT00979901|580872980|FG001|Overall Study|Withdrawal by Subject|1|||
160858015|NCT00979901|580872981|FG002|Overall Study|Withdrawal by Subject|1|||
160858016|NCT00979901|580872982|FG003|Overall Study|Withdrawal by Subject|1|||
160858017|NCT00979901|580872979|FG000|Overall Study|Noncompliance|1|||
160858018|NCT00979901|580872980|FG001|Overall Study|Noncompliance|0|||
160858019|NCT00979901|580872981|FG002|Overall Study|Noncompliance|0|||
160858020|NCT00979901|580872982|FG003|Overall Study|Noncompliance|0|||
160858021|NCT00979901|580872979|FG000|Overall Study|out-of-state|1|||
160858022|NCT00979901|580872980|FG001|Overall Study|out-of-state|0|||
160858023|NCT00979901|580872981|FG002|Overall Study|out-of-state|0|||
160858024|NCT00979901|580872982|FG003|Overall Study|out-of-state|0|||
160858025|NCT00979901|580872979|FG000|Overall Study|vacation|1|||
160858026|NCT00979901|580872980|FG001|Overall Study|vacation|0|||
160858027|NCT00979901|580872981|FG002|Overall Study|vacation|0|||
160858028|NCT00979901|580872982|FG003|Overall Study|vacation|0|||
160858029|NCT00979901|580872979|FG000|Overall Study|elevated lab values pre-randomization|1|||
160858030|NCT00979901|580872980|FG001|Overall Study|elevated lab values pre-randomization|0|||
160858031|NCT00979901|580872981|FG002|Overall Study|elevated lab values pre-randomization|0|||
160858032|NCT00979901|580872982|FG003|Overall Study|elevated lab values pre-randomization|0|||
160858033|NCT00979901|580872979|FG000|Overall Study|Discontinued in Error|0|||
160858034|NCT00979901|580872980|FG001|Overall Study|Discontinued in Error|1|||
160858035|NCT00979901|580872981|FG002|Overall Study|Discontinued in Error|0|||
160858036|NCT00979901|580872982|FG003|Overall Study|Discontinued in Error|0|||
160858037|NCT00979901|580872979|FG000|Overall Study|Left Country|0|||
160858038|NCT00979901|580872980|FG001|Overall Study|Left Country|0|||
160858039|NCT00979901|580872981|FG002|Overall Study|Left Country|1|||
160858040|NCT00979901|580872982|FG003|Overall Study|Left Country|0|||
160858041|NCT00979901|580872979|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
160858042|NCT00979901|580872980|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
160858043|NCT00979901|580872981|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
160858044|NCT00979901|580872982|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
160858045|NCT00248625|580872983|FG000|Overall Study|Withdrawal by Subject|0|||
160858046|NCT00248625|580872984|FG001|Overall Study|Withdrawal by Subject|2|||
160858047|NCT03284710|580872989|FG000|Overall Study|Withdrawal by Subject|1|||
160858048|NCT03284710|580872990|FG001|Overall Study|Withdrawal by Subject|0|||
160858049|NCT03284710|580872991|FG002|Overall Study|Withdrawal by Subject|1|||
160858050|NCT03284710|580872992|FG003|Overall Study|Withdrawal by Subject|6|||
160858051|NCT03284710|580872989|FG000|Overall Study|Lost to Follow-up|3|||
160858052|NCT03284710|580872990|FG001|Overall Study|Lost to Follow-up|3|||
160858053|NCT03284710|580872991|FG002|Overall Study|Lost to Follow-up|1|||
160858054|NCT03284710|580872992|FG003|Overall Study|Lost to Follow-up|0|||
160858055|NCT03284710|580872989|FG000|Overall Study|Physician Decision|1|||
160858056|NCT03284710|580872990|FG001|Overall Study|Physician Decision|0|||
160858057|NCT03284710|580872991|FG002|Overall Study|Physician Decision|0|||
160858058|NCT03284710|580872992|FG003|Overall Study|Physician Decision|0|||
160858059|NCT03284710|580872989|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
160858060|NCT03284710|580872990|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160858061|NCT03284710|580872991|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
160908834|NCT04967443|581060063|FG002|Follow-Up|Withdrawal by Subject|0|||
160858062|NCT03284710|580872992|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
160858063|NCT03284710|580872989|FG000|Overall Study|HIV Infection|0|||
160858064|NCT03284710|580872990|FG001|Overall Study|HIV Infection|2|||
160858065|NCT03284710|580872991|FG002|Overall Study|HIV Infection|2|||
160858066|NCT03284710|580872992|FG003|Overall Study|HIV Infection|1|||
160858067|NCT02814916|580872994|FG000|Overall Study|Withdrawal of consent|0|||
160858068|NCT02814916|580872995|FG001|Overall Study|Withdrawal of consent|2|||
160858069|NCT02814916|580872996|FG002|Overall Study|Withdrawal of consent|0|||
160858070|NCT02814916|580872994|FG000|Overall Study|Lost to Follow-up|0|||
160858071|NCT02814916|580872995|FG001|Overall Study|Lost to Follow-up|1|||
160858072|NCT02814916|580872996|FG002|Overall Study|Lost to Follow-up|0|||
160858073|NCT02814916|580872994|FG000|Overall Study|Other, not specified|0|||
160858074|NCT02814916|580872995|FG001|Overall Study|Other, not specified|1|||
160858075|NCT02814916|580872996|FG002|Overall Study|Other, not specified|0|||
160858076|NCT05316597|580873001|FG000|First Session|Withdrawal by Subject|0|||
160858077|NCT05316597|580873002|FG001|First Session|Withdrawal by Subject|1|||
160858078|NCT05316597|580873001|FG000|Washout Period|Lost to Follow-up|1|||
160858079|NCT05316597|580873002|FG001|Washout Period|Lost to Follow-up|2|||
160858080|NCT05316597|580873001|FG000|Washout Period|Physician Decision|1|||
160858081|NCT05316597|580873002|FG001|Washout Period|Physician Decision|1|||
160858082|NCT05316597|580873001|FG000|Washout Period|Excluded before second session|1|||
160858083|NCT05316597|580873002|FG001|Washout Period|Excluded before second session|1|||
160858084|NCT05316597|580873001|FG000|Washout Period|Withdrawal by Subject|0|||
160858085|NCT05316597|580873002|FG001|Washout Period|Withdrawal by Subject|4|||
160858086|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
160858087|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
160858088|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
160858089|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Death|9|||
160858090|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Death|0|||
160858091|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Death|0|||
160858092|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
160858093|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160858094|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
160908835|NCT04967443|581060064|FG003|Follow-Up|Withdrawal by Subject|1|||
160908836|NCT04967443|581060065|FG004|Follow-Up|Withdrawal by Subject|0|||
160908837|NCT04967443|581060066|FG005|Follow-Up|Withdrawal by Subject|1|||
160908838|NCT04967443|581060067|FG006|Follow-Up|Withdrawal by Subject|2|||
160908839|NCT04967443|581060068|FG007|Follow-Up|Withdrawal by Subject|3|||
160908840|NCT00602797|581060069|FG000|Overall Study|Adverse Event|1|||
160908841|NCT01063868|581060070|FG000|Overall Study|Adverse Event|9|||
160908842|NCT01063868|581060071|FG001|Overall Study|Adverse Event|7|||
160908843|NCT01063868|581060070|FG000|Overall Study|Withdrawal by Subject|3|||
160908844|NCT01063868|581060071|FG001|Overall Study|Withdrawal by Subject|1|||
160908845|NCT01063868|581060070|FG000|Overall Study|Study Terminated By Sponsor|23|||
160908846|NCT01063868|581060071|FG001|Overall Study|Study Terminated By Sponsor|4|||
160908847|NCT03307967|581060072|FG000|Overall Study|Lost to Follow-up|4|||
160908848|NCT02915016|581060073|FG000|Overall Study|Lost to Follow-up|4|||
160908849|NCT02915016|581060074|FG001|Overall Study|Lost to Follow-up|2|||
160908850|NCT02915016|581060075|FG002|Overall Study|Lost to Follow-up|5|||
160858095|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
160858096|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
160858097|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
160908851|NCT02915016|581060076|FG003|Overall Study|Lost to Follow-up|3|||
160908852|NCT02915016|581060077|FG004|Overall Study|Lost to Follow-up|5|||
160908853|NCT02915016|581060078|FG005|Overall Study|Lost to Follow-up|2|||
160908854|NCT02915016|581060079|FG006|Overall Study|Lost to Follow-up|8|||
160908855|NCT02915016|581060080|FG007|Overall Study|Lost to Follow-up|2|||
160908856|NCT02915016|581060073|FG000|Overall Study|Physician Decision|0|||
160908857|NCT02915016|581060074|FG001|Overall Study|Physician Decision|0|||
160908858|NCT02915016|581060075|FG002|Overall Study|Physician Decision|1|||
160908859|NCT02915016|581060076|FG003|Overall Study|Physician Decision|0|||
160908860|NCT02915016|581060077|FG004|Overall Study|Physician Decision|0|||
160908861|NCT02915016|581060078|FG005|Overall Study|Physician Decision|1|||
160994273|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994274|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994275|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994276|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994277|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994278|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160908862|NCT02915016|581060079|FG006|Overall Study|Physician Decision|2|||
160908863|NCT02915016|581060080|FG007|Overall Study|Physician Decision|0|||
160908864|NCT02915016|581060073|FG000|Overall Study|Withdrawal by Subject|2|||
160908865|NCT02915016|581060074|FG001|Overall Study|Withdrawal by Subject|0|||
160908866|NCT02915016|581060075|FG002|Overall Study|Withdrawal by Subject|1|||
160908867|NCT02915016|581060076|FG003|Overall Study|Withdrawal by Subject|0|||
160908868|NCT02915016|581060077|FG004|Overall Study|Withdrawal by Subject|1|||
160858098|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Other|135|||
160858099|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Other|0|||
160858100|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Other|0|||
160858101|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
160858102|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
160858103|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
160858104|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
160858105|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
160858106|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
160858107|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
160858108|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
160858109|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
160858110|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Other|3|||
160858111|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Other|0|||
160908869|NCT02915016|581060078|FG005|Overall Study|Withdrawal by Subject|3|||
160908870|NCT02915016|581060079|FG006|Overall Study|Withdrawal by Subject|1|||
161141540|NCT04430348|581902519|FG003|Overall Study|Death|2|||
160858112|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Other|0|||
160908871|NCT02915016|581060080|FG007|Overall Study|Withdrawal by Subject|1|||
160908872|NCT02915016|581060073|FG000|Overall Study|Elected not to continue|0|||
160908873|NCT02915016|581060074|FG001|Overall Study|Elected not to continue|0|||
160908874|NCT02915016|581060075|FG002|Overall Study|Elected not to continue|0|||
160908875|NCT02915016|581060076|FG003|Overall Study|Elected not to continue|1|||
160908876|NCT02915016|581060077|FG004|Overall Study|Elected not to continue|0|||
160908877|NCT02915016|581060078|FG005|Overall Study|Elected not to continue|0|||
160908878|NCT02915016|581060079|FG006|Overall Study|Elected not to continue|1|||
160908879|NCT02915016|581060080|FG007|Overall Study|Elected not to continue|0|||
160908880|NCT02915016|581060073|FG000|Overall Study|HIV infection|1|||
160908881|NCT02915016|581060074|FG001|Overall Study|HIV infection|1|||
160908882|NCT02915016|581060075|FG002|Overall Study|HIV infection|1|||
160908883|NCT02915016|581060076|FG003|Overall Study|HIV infection|0|||
160908884|NCT02915016|581060077|FG004|Overall Study|HIV infection|1|||
160908885|NCT02915016|581060078|FG005|Overall Study|HIV infection|0|||
160908886|NCT02915016|581060079|FG006|Overall Study|HIV infection|0|||
160908887|NCT02915016|581060080|FG007|Overall Study|HIV infection|0|||
160908888|NCT02915016|581060073|FG000|Overall Study|Participant unable to adhere|0|||
160908889|NCT02915016|581060074|FG001|Overall Study|Participant unable to adhere|0|||
160908890|NCT02915016|581060075|FG002|Overall Study|Participant unable to adhere|0|||
160908891|NCT02915016|581060076|FG003|Overall Study|Participant unable to adhere|0|||
160908892|NCT02915016|581060077|FG004|Overall Study|Participant unable to adhere|0|||
160908893|NCT02915016|581060078|FG005|Overall Study|Participant unable to adhere|0|||
160908894|NCT02915016|581060079|FG006|Overall Study|Participant unable to adhere|0|||
160908895|NCT02915016|581060080|FG007|Overall Study|Participant unable to adhere|1|||
160908896|NCT02578316|581060081|FG000|Extension Phase|Progression of disease|6|||
160908897|NCT02166905|581060082|FG000|Overall Study|Withdrawal by Subject|1|||
160908898|NCT02166905|581060083|FG001|Overall Study|Withdrawal by Subject|0|||
160908899|NCT02166905|581060084|FG002|Overall Study|Withdrawal by Subject|0|||
160908900|NCT02166905|581060085|FG003|Overall Study|Withdrawal by Subject|0|||
160908901|NCT02617628|581060086|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
160908902|NCT02617628|581060087|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
160908903|NCT03278873|581060089|FG000|Overall Study|Withdrawal by Subject|0|||
160908904|NCT03278873|581060090|FG001|Overall Study|Withdrawal by Subject|1|||
160908905|NCT03278873|581060091|FG002|Overall Study|Withdrawal by Subject|0|||
160908906|NCT03278873|581060092|FG003|Overall Study|Withdrawal by Subject|0|||
160908907|NCT03278873|581060089|FG000|Overall Study|Sponsor's decision|0|||
160908908|NCT03278873|581060090|FG001|Overall Study|Sponsor's decision|1|||
160908909|NCT03278873|581060091|FG002|Overall Study|Sponsor's decision|0|||
160908910|NCT03278873|581060092|FG003|Overall Study|Sponsor's decision|0|||
160908911|NCT03278873|581060089|FG000|Overall Study|Early Termination|2|||
160908912|NCT03278873|581060090|FG001|Overall Study|Early Termination|6|||
160908913|NCT03278873|581060091|FG002|Overall Study|Early Termination|0|||
160908914|NCT03278873|581060092|FG003|Overall Study|Early Termination|4|||
160908915|NCT03278873|581060089|FG000|Overall Study|Lost to Follow-up|0|||
160908916|NCT03278873|581060090|FG001|Overall Study|Lost to Follow-up|0|||
160908917|NCT03278873|581060091|FG002|Overall Study|Lost to Follow-up|2|||
160908918|NCT03278873|581060092|FG003|Overall Study|Lost to Follow-up|0|||
161141541|NCT04430348|581902520|FG004|Overall Study|Death|2|||
161141542|NCT04430348|581902521|FG005|Overall Study|Death|3|||
160858113|NCT02118584|580873003|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
160908919|NCT03278873|581060089|FG000|Overall Study|The patient decided to withdraw via email|1|||
160908920|NCT03278873|581060090|FG001|Overall Study|The patient decided to withdraw via email|0|||
160908921|NCT03278873|581060091|FG002|Overall Study|The patient decided to withdraw via email|0|||
160908922|NCT03278873|581060092|FG003|Overall Study|The patient decided to withdraw via email|0|||
160908923|NCT03278873|581060089|FG000|Overall Study|The patient was unresponsive to contact|0|||
160858114|NCT02118584|580873004|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160858115|NCT02118584|580873005|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
160858116|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160858117|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
160858118|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
160858119|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
160858120|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
160858121|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
160858122|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
160858123|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
160858124|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
160858125|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160858126|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
160858127|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
160858128|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
160858129|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
160858130|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
160858131|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
160858132|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
160858133|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
160858134|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160858135|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
160858136|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
160858137|NCT02118584|580873003|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
160858138|NCT02118584|580873004|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
160858139|NCT02118584|580873005|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
160858140|NCT03103542|580873006|FG000|Overall Study|Physician Decision|2|||
161338822|NCT02309359|582630364|FG003|Overall Study|Withdrawal by Subject|4|||
161338823|NCT02309359|582630365|FG004|Overall Study|Withdrawal by Subject|0|||
161338824|NCT02309359|582630361|FG000|Overall Study|Lack of Efficacy|3|||
161338825|NCT02309359|582630362|FG001|Overall Study|Lack of Efficacy|1|||
161338826|NCT02309359|582630363|FG002|Overall Study|Lack of Efficacy|0|||
161338827|NCT02309359|582630364|FG003|Overall Study|Lack of Efficacy|0|||
161338828|NCT02309359|582630365|FG004|Overall Study|Lack of Efficacy|3|||
161338829|NCT02309359|582630361|FG000|Overall Study|Lost to Follow-up|0|||
160858141|NCT03103542|580873006|FG000|Overall Study|Adverse Event|2|||
160858142|NCT03103542|580873006|FG000|Overall Study|Other|2|||
160858143|NCT03103542|580873006|FG000|Overall Study|Withdrawal by Subject|1|||
160858144|NCT02927301|580873008|FG000|Overall Study|Death|39|||
160858145|NCT02927301|580873008|FG000|Overall Study|Lost to Follow-up|8|||
160858146|NCT02927301|580873008|FG000|Overall Study|Physician Decision|2|||
160858147|NCT02927301|580873008|FG000|Overall Study|Withdrawal by Subject|12|||
160858148|NCT02927301|580873008|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
160858149|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
160858150|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858151|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858152|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858153|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858154|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
160858155|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
160858156|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858157|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
160858158|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858159|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858160|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858161|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858162|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
160858163|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858164|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160908924|NCT03278873|581060090|FG001|Overall Study|The patient was unresponsive to contact|0|||
160908925|NCT03278873|581060091|FG002|Overall Study|The patient was unresponsive to contact|0|||
160908926|NCT03278873|581060092|FG003|Overall Study|The patient was unresponsive to contact|4|||
160908927|NCT03278873|581060089|FG000|Overall Study|The patient wished to participate no longer|0|||
161338830|NCT02309359|582630362|FG001|Overall Study|Lost to Follow-up|0|||
160908928|NCT03278873|581060090|FG001|Overall Study|The patient wished to participate no longer|1|||
160908929|NCT03278873|581060091|FG002|Overall Study|The patient wished to participate no longer|0|||
160908930|NCT03278873|581060092|FG003|Overall Study|The patient wished to participate no longer|0|||
160994279|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
161338831|NCT02309359|582630363|FG002|Overall Study|Lost to Follow-up|0|||
160858165|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
160858166|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858167|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858168|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
160858169|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
160858170|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858171|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858172|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858173|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858174|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
160858175|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858176|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
160858177|NCT02903771|580873009|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858178|NCT02903771|580873010|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858179|NCT02903771|580873011|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858180|NCT02903771|580873012|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858181|NCT02903771|580873013|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858182|NCT02903771|580873014|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
160858183|NCT02903771|580873015|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
160858184|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858185|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858186|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858187|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858188|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
160858189|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858190|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
160858191|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858192|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858193|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858194|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858195|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
160858196|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858197|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
160858198|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858199|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858200|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858201|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858202|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
160858203|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858204|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
160858205|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858206|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858207|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858208|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858209|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
160858210|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858211|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
160858212|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858213|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858214|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858215|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858216|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
160858217|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858218|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
160858219|NCT02903771|580873009|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858220|NCT02903771|580873010|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858221|NCT02903771|580873011|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858222|NCT02903771|580873012|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858223|NCT02903771|580873013|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
160858224|NCT02903771|580873014|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
161141543|NCT04430348|581902516|FG000|Overall Study|Lost to Follow-up|0|||
161141544|NCT04430348|581902517|FG001|Overall Study|Lost to Follow-up|0|||
161141545|NCT04430348|581902518|FG002|Overall Study|Lost to Follow-up|0|||
161141546|NCT04430348|581902519|FG003|Overall Study|Lost to Follow-up|1|||
161141547|NCT04430348|581902520|FG004|Overall Study|Lost to Follow-up|0|||
161141548|NCT04430348|581902521|FG005|Overall Study|Lost to Follow-up|0|||
161141549|NCT04430348|581902516|FG000|Overall Study|Adverse Event|0|||
160858225|NCT02903771|580873015|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
160858226|NCT02218372|580873016|FG000|Overall Study|Adverse Event|1|||
160858227|NCT02218372|580873017|FG001|Overall Study|Adverse Event|1|||
160858228|NCT02218372|580873016|FG000|Overall Study|Miscellaneous|2|||
160858229|NCT02218372|580873017|FG001|Overall Study|Miscellaneous|1|||
160858230|NCT02218372|580873016|FG000|Overall Study|Randomized but did not receive treatment|2|||
160858231|NCT02218372|580873017|FG001|Overall Study|Randomized but did not receive treatment|3|||
160858232|NCT02218372|580873016|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160858233|NCT02218372|580873017|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160858234|NCT03406780|580873022|FG000|Overall Study|Withdrawal by Subject|1|||
160858235|NCT03406780|580873023|FG001|Overall Study|Withdrawal by Subject|1|||
160858236|NCT03406780|580873022|FG000|Overall Study|Other|0|||
160858237|NCT03406780|580873023|FG001|Overall Study|Other|2|||
160858238|NCT02546609|580873026|FG000|Overall Study|Withdrawal by Subject|0|||
160858239|NCT02546609|580873027|FG001|Overall Study|Withdrawal by Subject|1|||
160858240|NCT02546609|580873028|FG002|Overall Study|Withdrawal by Subject|2|||
160858241|NCT02546609|580873026|FG000|Overall Study|Adverse Event|0|||
160858242|NCT02546609|580873027|FG001|Overall Study|Adverse Event|6|||
160858243|NCT02546609|580873028|FG002|Overall Study|Adverse Event|1|||
160858244|NCT02546609|580873026|FG000|Overall Study|Protocol Violation|0|||
160858245|NCT02546609|580873027|FG001|Overall Study|Protocol Violation|1|||
160858246|NCT02546609|580873028|FG002|Overall Study|Protocol Violation|1|||
160858247|NCT02546609|580873026|FG000|Overall Study|Lost to Follow-up|2|||
160858248|NCT02546609|580873027|FG001|Overall Study|Lost to Follow-up|3|||
160858249|NCT02546609|580873028|FG002|Overall Study|Lost to Follow-up|1|||
160858250|NCT02546609|580873026|FG000|Overall Study|travel or work schedule restriction|0|||
160858251|NCT02546609|580873027|FG001|Overall Study|travel or work schedule restriction|0|||
160858252|NCT02546609|580873028|FG002|Overall Study|travel or work schedule restriction|2|||
160858253|NCT02004236|580873037|FG000|Overall Study|Lack of Efficacy|0|||
160858254|NCT02004236|580873038|FG001|Overall Study|Lack of Efficacy|0|||
160858255|NCT02004236|580873039|FG002|Overall Study|Lack of Efficacy|16|||
160858256|NCT00918281|580873042|FG000|Overall Study|Physician Decision|29|||
160858257|NCT03557970|580873047|FG000|Overall Study|Study closure|1|||
160858258|NCT03557970|580873048|FG001|Overall Study|Study closure|0|||
160858259|NCT03557970|580873047|FG000|Overall Study|Physician Decision|0|||
160858260|NCT03557970|580873048|FG001|Overall Study|Physician Decision|1|||
160858261|NCT03557970|580873047|FG000|Overall Study|Death|0|||
160858262|NCT03557970|580873048|FG001|Overall Study|Death|1|||
160858263|NCT00112736|580873049|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
160858264|NCT00112736|580873050|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
160858265|NCT00004563|580873052|FG000|Overall Study|Withdrawal by Subject|20|||
160858266|NCT00004563|580873053|FG001|Overall Study|Withdrawal by Subject|16|||
160858267|NCT00004563|580873052|FG000|Overall Study|Lack of Efficacy|3|||
160858268|NCT00004563|580873053|FG001|Overall Study|Lack of Efficacy|5|||
160858269|NCT00004563|580873052|FG000|Overall Study|Death|2|||
160858270|NCT00004563|580873053|FG001|Overall Study|Death|3|||
160858271|NCT05135871|580873056|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
160858272|NCT05135871|580873057|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
160858273|NCT05135871|580873058|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
160858274|NCT05135871|580873059|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
160858275|NCT04258423|580873060|FG000|Overall Study|Study Closure|2|||
160858276|NCT04258423|580873061|FG001|Overall Study|Study Closure|2|||
160858277|NCT03980730|580873062|FG000|Overall Study|Study Terminated by Sponsor|0|||
161256154|NCT00892281|582316364|FG001|Overall Study|Subject completed day after study closed|0|||
161256155|NCT00892281|582316363|FG000|Overall Study|Family emergency|1|||
161256156|NCT00892281|582316364|FG001|Overall Study|Family emergency|0|||
161256157|NCT00892281|582316363|FG000|Overall Study|Last visit not done - death in family|1|||
161256158|NCT00892281|582316364|FG001|Overall Study|Last visit not done - death in family|0|||
161256159|NCT00892281|582316363|FG000|Overall Study|Did not meet incl/excl criteria|1|||
161256160|NCT00892281|582316364|FG001|Overall Study|Did not meet incl/excl criteria|0|||
161256161|NCT00892281|582316363|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
161256162|NCT00892281|582316364|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
161256163|NCT00892281|582316363|FG000|Overall Study|Unable to redeem the drug voucher|1|||
160858278|NCT03980730|580873063|FG001|Overall Study|Study Terminated by Sponsor|3|||
160858279|NCT03980730|580873062|FG000|Overall Study|Adverse Event|2|||
160858280|NCT03980730|580873063|FG001|Overall Study|Adverse Event|0|||
160858281|NCT03980730|580873062|FG000|Overall Study|Sponsor Request|0|||
160858282|NCT03980730|580873063|FG001|Overall Study|Sponsor Request|1|||
160858283|NCT00880620|580873064|FG000|Overall Study|Adverse Event|4|||
160917938|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
160858284|NCT00880620|580873065|FG001|Overall Study|Adverse Event|5|||
160858285|NCT00880620|580873066|FG002|Overall Study|Adverse Event|15|||
161256164|NCT00892281|582316364|FG001|Overall Study|Unable to redeem the drug voucher|0|||
161338832|NCT02309359|582630364|FG003|Overall Study|Lost to Follow-up|1|||
160858286|NCT00880620|580873067|FG003|Overall Study|Adverse Event|15|||
160858287|NCT00880620|580873064|FG000|Overall Study|Death|0|||
160858288|NCT00880620|580873065|FG001|Overall Study|Death|0|||
160858289|NCT00880620|580873066|FG002|Overall Study|Death|1|||
160858290|NCT00880620|580873067|FG003|Overall Study|Death|0|||
160858291|NCT00880620|580873064|FG000|Overall Study|Lack of Efficacy|12|||
160994280|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
160994281|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160858292|NCT00880620|580873065|FG001|Overall Study|Lack of Efficacy|4|||
160858293|NCT00880620|580873066|FG002|Overall Study|Lack of Efficacy|0|||
160858294|NCT00880620|580873067|FG003|Overall Study|Lack of Efficacy|1|||
160858295|NCT00880620|580873064|FG000|Overall Study|Lost to Follow-up|0|||
160858296|NCT00880620|580873065|FG001|Overall Study|Lost to Follow-up|1|||
160858297|NCT00880620|580873066|FG002|Overall Study|Lost to Follow-up|1|||
160858298|NCT00880620|580873067|FG003|Overall Study|Lost to Follow-up|0|||
160858299|NCT00880620|580873064|FG000|Overall Study|Protocol Violation|0|||
160858300|NCT00880620|580873065|FG001|Overall Study|Protocol Violation|1|||
160858301|NCT00880620|580873066|FG002|Overall Study|Protocol Violation|0|||
160858302|NCT00880620|580873067|FG003|Overall Study|Protocol Violation|2|||
160858303|NCT00880620|580873064|FG000|Overall Study|Withdrawal by Subject|4|||
160858304|NCT00880620|580873065|FG001|Overall Study|Withdrawal by Subject|3|||
160858305|NCT00880620|580873066|FG002|Overall Study|Withdrawal by Subject|1|||
160858306|NCT00880620|580873067|FG003|Overall Study|Withdrawal by Subject|3|||
160858307|NCT00880620|580873064|FG000|Overall Study|Noncompliance|0|||
160858308|NCT00880620|580873065|FG001|Overall Study|Noncompliance|0|||
160858309|NCT00880620|580873066|FG002|Overall Study|Noncompliance|1|||
160858310|NCT00880620|580873067|FG003|Overall Study|Noncompliance|1|||
160858311|NCT00880620|580873064|FG000|Overall Study|Other|1|||
160858312|NCT00880620|580873065|FG001|Overall Study|Other|1|||
160858313|NCT00880620|580873066|FG002|Overall Study|Other|2|||
160858314|NCT00880620|580873067|FG003|Overall Study|Other|2|||
160858315|NCT02016781|580873081|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
160858316|NCT02016781|580873082|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
160858317|NCT02016781|580873081|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
160858318|NCT02016781|580873082|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
160858319|NCT02016781|580873081|FG000|Final Database Lock|Withdrawal by Subject|2|||
160858320|NCT02016781|580873082|FG001|Final Database Lock|Withdrawal by Subject|1|||
160858321|NCT02016781|580873081|FG000|Final Database Lock|Lost to Follow-up|11|||
160858322|NCT02016781|580873082|FG001|Final Database Lock|Lost to Follow-up|4|||
160858323|NCT02016781|580873081|FG000|Final Database Lock|Missing data|0|||
160858324|NCT02016781|580873082|FG001|Final Database Lock|Missing data|3|||
160858325|NCT00945009|580873083|FG000|Overall Study|Lack of Efficacy|10|||
160858326|NCT00945009|580873084|FG001|Overall Study|Lack of Efficacy|0|||
160908931|NCT03278873|581060089|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
160908932|NCT03278873|581060090|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
160908933|NCT03278873|581060091|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
160908934|NCT03278873|581060092|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
160908935|NCT05243641|581060093|FG000|Overall Study|Adverse Event|3|||
160908936|NCT05243641|581060094|FG001|Overall Study|Adverse Event|0|||
160908937|NCT05243641|581060095|FG002|Overall Study|Adverse Event|0|||
160908938|NCT05243641|581060096|FG003|Overall Study|Adverse Event|1|||
160908939|NCT05243641|581060097|FG004|Overall Study|Adverse Event|0|||
160908940|NCT05243641|581060098|FG005|Overall Study|Adverse Event|0|||
160908941|NCT05243641|581060093|FG000|Overall Study|Disease progression|4|||
160908942|NCT05243641|581060094|FG001|Overall Study|Disease progression|0|||
160908943|NCT05243641|581060095|FG002|Overall Study|Disease progression|0|||
160908944|NCT05243641|581060096|FG003|Overall Study|Disease progression|2|||
160908945|NCT05243641|581060097|FG004|Overall Study|Disease progression|0|||
160908946|NCT05243641|581060098|FG005|Overall Study|Disease progression|0|||
160908947|NCT04518306|581060105|FG000|Double-Blind Period|Run in failure|0|||
161141550|NCT04430348|581902517|FG001|Overall Study|Adverse Event|0|||
160858327|NCT00945009|580873085|FG002|Overall Study|Lack of Efficacy|0|||
160858328|NCT00945009|580873083|FG000|Overall Study|Physician Decision|21|||
160908948|NCT04518306|581060106|FG001|Double-Blind Period|Run in failure|0|||
160908949|NCT04518306|581060107|FG002|Double-Blind Period|Run in failure|1|||
161141551|NCT04430348|581902518|FG002|Overall Study|Adverse Event|0|||
161141552|NCT04430348|581902519|FG003|Overall Study|Adverse Event|0|||
161338833|NCT02309359|582630365|FG004|Overall Study|Lost to Follow-up|0|||
160858329|NCT00945009|580873084|FG001|Overall Study|Physician Decision|4|||
160858330|NCT00945009|580873085|FG002|Overall Study|Physician Decision|3|||
160858331|NCT00945009|580873083|FG000|Overall Study|Protocol Violation|6|||
160858332|NCT00945009|580873084|FG001|Overall Study|Protocol Violation|1|||
160858333|NCT00945009|580873085|FG002|Overall Study|Protocol Violation|0|||
160858334|NCT00945009|580873083|FG000|Overall Study|Withdrawal by Subject|1|||
160858335|NCT00945009|580873084|FG001|Overall Study|Withdrawal by Subject|0|||
160858336|NCT00945009|580873085|FG002|Overall Study|Withdrawal by Subject|0|||
160908950|NCT04518306|581060105|FG000|Double-Blind Period|Adverse Event|0|||
160858337|NCT00945009|580873083|FG000|Overall Study|Ineligible|6|||
160858338|NCT00945009|580873084|FG001|Overall Study|Ineligible|1|||
160858339|NCT00945009|580873085|FG002|Overall Study|Ineligible|0|||
160858340|NCT00945009|580873083|FG000|Overall Study|Inevaluable|0|||
160858341|NCT00945009|580873084|FG001|Overall Study|Inevaluable|1|||
160858342|NCT00945009|580873085|FG002|Overall Study|Inevaluable|0|||
160858343|NCT00945009|580873083|FG000|Overall Study|Refusal of further protocol|1|||
160858344|NCT00945009|580873084|FG001|Overall Study|Refusal of further protocol|0|||
160908951|NCT04518306|581060106|FG001|Double-Blind Period|Adverse Event|2|||
160908952|NCT04518306|581060107|FG002|Double-Blind Period|Adverse Event|2|||
160908953|NCT04518306|581060105|FG000|Double-Blind Period|Lost to Follow-up|1|||
160908954|NCT04518306|581060106|FG001|Double-Blind Period|Lost to Follow-up|2|||
160908955|NCT04518306|581060107|FG002|Double-Blind Period|Lost to Follow-up|2|||
160908956|NCT04518306|581060105|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
160908957|NCT04518306|581060106|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
160908958|NCT04518306|581060107|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
161256165|NCT00892281|582316363|FG000|Overall Study|Subject not good candidate for study|1|||
161256166|NCT00892281|582316364|FG001|Overall Study|Subject not good candidate for study|0|||
161256167|NCT00892281|582316363|FG000|Overall Study|Subject did not return for any visits|1|||
161256168|NCT00892281|582316364|FG001|Overall Study|Subject did not return for any visits|0|||
161256169|NCT00892281|582316363|FG000|Overall Study|Subject missed several visits/lost meds|1|||
161256170|NCT00892281|582316364|FG001|Overall Study|Subject missed several visits/lost meds|0|||
161256171|NCT00892281|582316363|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
161256172|NCT00892281|582316364|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
161256173|NCT00892281|582316363|FG000|Overall Study|Scheduled for knee replacement|0|||
161256174|NCT00892281|582316364|FG001|Overall Study|Scheduled for knee replacement|1|||
161256175|NCT00892281|582316363|FG000|Overall Study|PI complained of inadequate compensation|3|||
161256176|NCT00892281|582316364|FG001|Overall Study|PI complained of inadequate compensation|0|||
161256177|NCT00892281|582316363|FG000|Overall Study|Subject lost interest in program|0|||
161256178|NCT00892281|582316364|FG001|Overall Study|Subject lost interest in program|1|||
161256179|NCT00892281|582316363|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
161256180|NCT00892281|582316364|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
161256181|NCT00892281|582316363|FG000|Overall Study|Death in family|1|||
161256182|NCT00892281|582316364|FG001|Overall Study|Death in family|0|||
161256183|NCT00892281|582316363|FG000|Overall Study|Lack of efficacy of study product|2|||
161256184|NCT00892281|582316364|FG001|Overall Study|Lack of efficacy of study product|0|||
161256185|NCT00892281|582316363|FG000|Overall Study|Subject not seen by PI at final visit|1|||
161256186|NCT00892281|582316364|FG001|Overall Study|Subject not seen by PI at final visit|0|||
161256187|NCT00892281|582316363|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
161256188|NCT00892281|582316364|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
161256189|NCT00892281|582316363|FG000|Overall Study|Missed multiple visits|1|||
161256190|NCT00892281|582316364|FG001|Overall Study|Missed multiple visits|0|||
161256191|NCT00892281|582316363|FG000|Overall Study|Missed visits rescheduled out of window|1|||
161256192|NCT00892281|582316364|FG001|Overall Study|Missed visits rescheduled out of window|0|||
161256193|NCT00892281|582316363|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
161256194|NCT00892281|582316364|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
161256195|NCT00892281|582316363|FG000|Overall Study|Subject had history of drug abuse|1|||
161256196|NCT00892281|582316364|FG001|Overall Study|Subject had history of drug abuse|0|||
161256197|NCT00892281|582316363|FG000|Overall Study|Rash on hand|1|||
161256198|NCT00892281|582316364|FG001|Overall Study|Rash on hand|0|||
161256199|NCT00892281|582316363|FG000|Overall Study|Visit 4 date out of window|1|||
161256200|NCT00892281|582316364|FG001|Overall Study|Visit 4 date out of window|0|||
161256201|NCT01534078|582316365|FG000|Overall Study|Death|1|||
161256202|NCT01534078|582316365|FG000|Overall Study|Withdrawal by Subject|1|||
161256203|NCT01280617|582316369|FG000|Overall Study|Adverse Event|0|||
161256204|NCT01280617|582316370|FG001|Overall Study|Adverse Event|1|||
161256205|NCT00986570|582316371|FG000|Overall Study|Lost to Follow-up|6|||
161256206|NCT00986570|582316371|FG000|Overall Study|Potential bias for objective assessment|1|||
161256207|NCT02225665|582316372|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
161256208|NCT02225665|582316373|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
160858345|NCT00945009|580873085|FG002|Overall Study|Refusal of further protocol|0|||
160858346|NCT04875975|580873086|FG000|Overall Study|Adverse Event|1|||
160858347|NCT04875975|580873087|FG001|Overall Study|Adverse Event|2|||
160858348|NCT04875975|580873086|FG000|Overall Study|Lack of Efficacy|2|||
160858349|NCT04875975|580873087|FG001|Overall Study|Lack of Efficacy|2|||
161256209|NCT02225665|582316372|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
161256210|NCT02225665|582316373|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
161256211|NCT01311557|582316374|FG000|Overall Study|Serious adverse event|0|||
161256212|NCT01311557|582316375|FG001|Overall Study|Serious adverse event|1|||
160858350|NCT04875975|580873086|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
160858351|NCT04875975|580873087|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
160994282|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
160994283|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160858352|NCT04875975|580873086|FG000|Overall Study|Relapse With Insults|0|||
160858353|NCT04875975|580873087|FG001|Overall Study|Relapse With Insults|1|||
160858354|NCT04875975|580873086|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
160858355|NCT04875975|580873087|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
160858356|NCT04972162|580873092|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
160858357|NCT04972162|580873093|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
160858358|NCT02429830|580873094|FG000|Overall Study|Lost to Follow-up|1|||
160858359|NCT02429830|580873094|FG000|Overall Study|Device Explant|2|||
160858360|NCT00474487|580874679|FG000|Overall Study|Withdrawal by Subject|6|||
160858361|NCT00474487|580874680|FG001|Overall Study|Withdrawal by Subject|0|||
160858362|NCT00474487|580874681|FG002|Overall Study|Withdrawal by Subject|0|||
160858363|NCT00474487|580874682|FG003|Overall Study|Withdrawal by Subject|0|||
160858364|NCT00474487|580874679|FG000|Overall Study|Lost to Follow-up|20|||
160858365|NCT00474487|580874680|FG001|Overall Study|Lost to Follow-up|1|||
160858366|NCT00474487|580874681|FG002|Overall Study|Lost to Follow-up|7|||
160858367|NCT00474487|580874682|FG003|Overall Study|Lost to Follow-up|0|||
160858368|NCT00474487|580874679|FG000|Overall Study|Inappropriate enrollment|4|||
160858369|NCT00474487|580874680|FG001|Overall Study|Inappropriate enrollment|0|||
160858370|NCT00474487|580874681|FG002|Overall Study|Inappropriate enrollment|7|||
160858371|NCT00474487|580874682|FG003|Overall Study|Inappropriate enrollment|0|||
160858372|NCT00474487|580874679|FG000|Overall Study|Death|0|||
160858373|NCT00474487|580874680|FG001|Overall Study|Death|1|||
160858374|NCT00474487|580874681|FG002|Overall Study|Death|0|||
160858375|NCT00474487|580874682|FG003|Overall Study|Death|0|||
160858376|NCT03924622|580874683|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
160858377|NCT03924622|580874684|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858378|NCT03924622|580874685|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858379|NCT03924622|580874686|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
160858380|NCT03924622|580874687|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858381|NCT03924622|580874688|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
160858382|NCT03085095|580874689|FG000|Overall Study|Adverse Event|23|||
160858383|NCT03085095|580874690|FG001|Overall Study|Adverse Event|8|||
160858384|NCT03085095|580874689|FG000|Overall Study|Protocol Violation|0|||
160858385|NCT03085095|580874690|FG001|Overall Study|Protocol Violation|1|||
160858386|NCT03085095|580874689|FG000|Overall Study|Lost to Follow-up|2|||
160858387|NCT03085095|580874690|FG001|Overall Study|Lost to Follow-up|1|||
160858388|NCT03085095|580874689|FG000|Overall Study|Withdrawal by Subject|17|||
160858389|NCT03085095|580874690|FG001|Overall Study|Withdrawal by Subject|6|||
160858390|NCT03085095|580874689|FG000|Overall Study|Physician Decision|9|||
160858391|NCT03085095|580874690|FG001|Overall Study|Physician Decision|3|||
160858392|NCT03085095|580874689|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
160858393|NCT03085095|580874690|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
160858394|NCT03085095|580874689|FG000|Overall Study|Did not Receive Study Drug|2|||
160858395|NCT03085095|580874690|FG001|Overall Study|Did not Receive Study Drug|2|||
160858396|NCT03085095|580874689|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
160858397|NCT03085095|580874690|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
160858398|NCT05176314|580874693|FG000|Overall Study|Lost to Follow-up|2|||
160858399|NCT05176314|580874693|FG000|Overall Study|Physician Decision|1|||
160858400|NCT05176314|580874693|FG000|Overall Study|Adverse Event|1|||
161256213|NCT01311557|582316374|FG000|Overall Study|Protocol Violation|4|||
160858401|NCT05543265|580874695|FG000|Overall Study|Lost to Follow-up|3|||
160858402|NCT05543265|580874696|FG001|Overall Study|Lost to Follow-up|3|||
160858403|NCT05543265|580874695|FG000|Overall Study|Withdrawal by Subject|0|||
160858404|NCT05543265|580874696|FG001|Overall Study|Withdrawal by Subject|1|||
160858405|NCT02182895|580874697|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
160858406|NCT02182895|580874698|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
160858407|NCT01488045|580874708|FG000|Overall Study|Withdrawal by Subject|6|||
160858408|NCT01488045|580874709|FG001|Overall Study|Withdrawal by Subject|11|||
160858409|NCT01488045|580874708|FG000|Overall Study|Failure to present for colonoscopy|3|||
160858410|NCT01488045|580874709|FG001|Overall Study|Failure to present for colonoscopy|6|||
160858411|NCT01488045|580874708|FG000|Overall Study|Failure to report exclusion criteria|0|||
160858412|NCT01488045|580874709|FG001|Overall Study|Failure to report exclusion criteria|1|||
160858413|NCT00671658|580874711|FG000|Overall Study|Physician Decision|5|||
161256214|NCT01311557|582316375|FG001|Overall Study|Protocol Violation|2|||
161256215|NCT01311557|582316374|FG000|Overall Study|Lost to Follow-up|0|||
160858414|NCT03617172|580874714|FG000|Overall Study|Lost to Follow-up|1|||
160858415|NCT03617172|580874715|FG001|Overall Study|Lost to Follow-up|0|||
160858416|NCT01680341|580874716|FG000|Overall Study|Adverse Event|3|||
160858417|NCT01680341|580874717|FG001|Overall Study|Adverse Event|2|||
161256216|NCT01311557|582316375|FG001|Overall Study|Lost to Follow-up|1|||
161256217|NCT01311557|582316374|FG000|Overall Study|Withdrawal by Subject|1|||
160858418|NCT01680341|580874716|FG000|Overall Study|Unclassified|18|||
160858419|NCT01680341|580874717|FG001|Overall Study|Unclassified|15|||
160858420|NCT02587221|580874719|FG000|Overall Study|Adverse Event|3|||
160858421|NCT02587221|580874720|FG001|Overall Study|Adverse Event|3|||
160858422|NCT02587221|580874719|FG000|Overall Study|Death|33|||
160858423|NCT02587221|580874720|FG001|Overall Study|Death|34|||
160858424|NCT02587221|580874719|FG000|Overall Study|Withdrawal by Subject|66|||
160858425|NCT02587221|580874720|FG001|Overall Study|Withdrawal by Subject|61|||
160858426|NCT02587221|580874719|FG000|Overall Study|Lost to Follow-up|21|||
160858427|NCT02587221|580874720|FG001|Overall Study|Lost to Follow-up|19|||
160858428|NCT02587221|580874719|FG000|Overall Study|Protocol Violation|6|||
160858429|NCT02587221|580874720|FG001|Overall Study|Protocol Violation|5|||
160858430|NCT02587221|580874719|FG000|Overall Study|Other Reason or Unspecified|2|||
160858431|NCT02587221|580874720|FG001|Overall Study|Other Reason or Unspecified|1|||
160858432|NCT03988400|580874721|FG000|Overall Study|Adverse Event|1|||
160858433|NCT03988400|580874722|FG001|Overall Study|Adverse Event|0|||
160858434|NCT03988400|580874721|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
160858435|NCT03988400|580874722|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
160858436|NCT03988400|580874721|FG000|Overall Study|Lost to Follow-up|0|||
160858437|NCT03988400|580874722|FG001|Overall Study|Lost to Follow-up|1|||
160908959|NCT04518306|581060105|FG000|Double-Blind Period|Other|0|||
160908960|NCT04518306|581060106|FG001|Double-Blind Period|Other|2|||
160908961|NCT04518306|581060107|FG002|Double-Blind Period|Other|0|||
160908962|NCT04518306|581060105|FG000|Double-Blind Period|Missing|0|||
160908963|NCT04518306|581060106|FG001|Double-Blind Period|Missing|1|||
160908964|NCT04518306|581060107|FG002|Double-Blind Period|Missing|0|||
160908965|NCT03268954|581060111|FG000|Overall Study|Withdrawal by Subject|27|||
160908966|NCT03268954|581060112|FG001|Overall Study|Withdrawal by Subject|17|||
160908967|NCT03268954|581060111|FG000|Overall Study|Lost to Follow-up|2|||
160908968|NCT03268954|581060112|FG001|Overall Study|Lost to Follow-up|3|||
160908969|NCT03268954|581060111|FG000|Overall Study|Reason Not Specified|3|||
160908970|NCT03268954|581060112|FG001|Overall Study|Reason Not Specified|8|||
160908971|NCT05372419|581060115|FG000|Overall Study|Protocol Deviation|1|||
160908972|NCT05372419|581060115|FG000|Overall Study|Withdrawal by Subject|5|||
160908973|NCT05372419|581060115|FG000|Overall Study|Lost to Follow-up|7|||
160908974|NCT05358444|581060116|FG000|Overall Study|Withdrawal by Subject|0|||
160908975|NCT05358444|581060117|FG001|Overall Study|Withdrawal by Subject|1|||
160908976|NCT05358444|581060116|FG000|Overall Study|Lost to Follow-up|0|||
160908977|NCT05358444|581060117|FG001|Overall Study|Lost to Follow-up|3|||
160908978|NCT02801331|581060118|FG000|Overall Study|Transferred to another hospital|8|||
160908979|NCT02801331|581060119|FG001|Overall Study|Transferred to another hospital|7|||
160908980|NCT02801331|581060118|FG000|Overall Study|Withdrawal by Subject|0|||
160908981|NCT02801331|581060119|FG001|Overall Study|Withdrawal by Subject|4|||
160908982|NCT02801331|581060118|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
160908983|NCT02801331|581060119|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
160908984|NCT02443987|581060120|FG000|Overall Study|Bladder injury|1|||
160908985|NCT02443987|581060121|FG001|Overall Study|Bladder injury|1|||
160908986|NCT02443987|581060120|FG000|Overall Study|Other|0|||
160908987|NCT02443987|581060121|FG001|Overall Study|Other|1|||
160908988|NCT03820986|581060124|FG000|Overall Study|Death|201|||
160908989|NCT03820986|581060125|FG001|Overall Study|Death|175|||
160908990|NCT03820986|581060124|FG000|Overall Study|Lost to Follow-up|1|||
160908991|NCT03820986|581060125|FG001|Overall Study|Lost to Follow-up|1|||
160908992|NCT03820986|581060124|FG000|Overall Study|Physician Decision|1|||
160908993|NCT03820986|581060125|FG001|Overall Study|Physician Decision|0|||
160908994|NCT03820986|581060124|FG000|Overall Study|Sponsor Decision|122|||
160908995|NCT03820986|581060125|FG001|Overall Study|Sponsor Decision|160|||
160908996|NCT03820986|581060124|FG000|Overall Study|Withdrawal by Subject|9|||
160908997|NCT03820986|581060125|FG001|Overall Study|Withdrawal by Subject|4|||
160908998|NCT05766423|581060130|FG000|Overall Study|Withdrawal by Subject|1|||
160908999|NCT05766423|581060131|FG001|Overall Study|Withdrawal by Subject|0|||
160909000|NCT05766423|581060130|FG000|Overall Study|Consented, not scheduled|3|||
160909001|NCT05766423|581060131|FG001|Overall Study|Consented, not scheduled|5|||
160909002|NCT02601469|581061882|FG000|Overall Study|Enrolled in Error|1|||
160909003|NCT02601469|581061883|FG001|Overall Study|Enrolled in Error|0|||
160909004|NCT00056316|581061884|FG000|Overall Study|Withdrawal by Subject|2|||
160909005|NCT00056316|581061885|FG001|Overall Study|Withdrawal by Subject|2|||
160909006|NCT00056316|581061884|FG000|Overall Study|Death/NH placement of pt|1|||
160909007|NCT00056316|581061885|FG001|Overall Study|Death/NH placement of pt|1|||
160994284|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160858438|NCT04913610|580874723|FG000|Randomized Participants|Did Not Receive Treatment|0|||
160858439|NCT04913610|580874724|FG001|Randomized Participants|Did Not Receive Treatment|0|||
160909008|NCT02161731|581061886|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
160909009|NCT02161731|581061887|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
160909010|NCT02161731|581061886|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
160909011|NCT02161731|581061887|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
160909012|NCT01315678|581061892|FG000|Overall Study|Withdrawal by Subject|7|||
160858440|NCT04913610|580874725|FG002|Randomized Participants|Did Not Receive Treatment|1|||
160858441|NCT04913610|580874726|FG003|Randomized Participants|Did Not Receive Treatment|1|||
160858442|NCT04913610|580874727|FG004|Randomized Participants|Did Not Receive Treatment|0|||
160858443|NCT04913610|580874723|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
160858444|NCT04913610|580874724|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
160858445|NCT04913610|580874725|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
160858446|NCT04913610|580874726|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
160858447|NCT04913610|580874727|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
160858448|NCT03186209|580874728|FG000|Overall Study|Withdrawal by Subject|11|||
160858449|NCT03186209|580874729|FG001|Overall Study|Withdrawal by Subject|22|||
160858450|NCT03186209|580874728|FG000|Overall Study|Pregnancy|1|||
160858451|NCT03186209|580874729|FG001|Overall Study|Pregnancy|0|||
160858452|NCT03186209|580874728|FG000|Overall Study|Adverse Event|4|||
160858453|NCT03186209|580874729|FG001|Overall Study|Adverse Event|0|||
160858454|NCT03186209|580874728|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
160858455|NCT03186209|580874729|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
160858456|NCT03186209|580874728|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
160858457|NCT03186209|580874729|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
160858458|NCT03186209|580874728|FG000|Overall Study|Fail to meet randomization criteria|0|||
160858459|NCT03186209|580874729|FG001|Overall Study|Fail to meet randomization criteria|1|||
160858460|NCT03186209|580874728|FG000|Overall Study|Lost to Follow-up|0|||
160858461|NCT03186209|580874729|FG001|Overall Study|Lost to Follow-up|1|||
160858462|NCT00953667|580874732|FG000|Overall Study|Lost to Follow-up|11|||
160858463|NCT00953667|580874732|FG000|Overall Study|Physician Decision|35|||
160858464|NCT00953667|580874732|FG000|Overall Study|Withdrawal by Subject|63|||
160858465|NCT00953667|580874732|FG000|Overall Study|Adverse Event|10|||
160858466|NCT00953667|580874732|FG000|Overall Study|poor venous access,unable to draw blood|4|||
160858467|NCT00551759|580874733|FG000|Overall Study|Adverse Event|7|||
160858468|NCT00551759|580874733|FG000|Overall Study|Death|5|||
160858469|NCT00551759|580874733|FG000|Overall Study|Ineligible|1|||
160858470|NCT03521570|580874734|FG000|Overall Study|Not eligible|11|||
160858471|NCT00322881|580874736|FG000|Overall Study|Death|2|||
160858472|NCT00322881|580874736|FG000|Overall Study|Adverse Event|1|||
160858473|NCT00322881|580874736|FG000|Overall Study|Disease Progression|2|||
160858474|NCT02138890|580874743|FG000|Overall Study|Adverse Event|1|||
160858475|NCT02138890|580874744|FG001|Overall Study|Adverse Event|0|||
160858476|NCT05435339|580874745|FG000|Overall Study|Death|1|||
160858477|NCT05435339|580874746|FG001|Overall Study|Death|0|||
160858478|NCT05435339|580874747|FG002|Overall Study|Death|3|||
160858479|NCT05435339|580874748|FG003|Overall Study|Death|1|||
160858480|NCT05435339|580874749|FG004|Overall Study|Death|3|||
160858481|NCT05435339|580874750|FG005|Overall Study|Death|2|||
160858482|NCT05435339|580874751|FG006|Overall Study|Death|4|||
160858483|NCT05435339|580874752|FG007|Overall Study|Death|6|||
160858484|NCT05435339|580874745|FG000|Overall Study|Sponsor Decision|0|||
160858485|NCT05435339|580874746|FG001|Overall Study|Sponsor Decision|1|||
160858486|NCT05435339|580874747|FG002|Overall Study|Sponsor Decision|0|||
160858487|NCT05435339|580874748|FG003|Overall Study|Sponsor Decision|0|||
160858488|NCT05435339|580874749|FG004|Overall Study|Sponsor Decision|2|||
160858489|NCT05435339|580874750|FG005|Overall Study|Sponsor Decision|1|||
160858490|NCT05435339|580874751|FG006|Overall Study|Sponsor Decision|2|||
160858491|NCT05435339|580874752|FG007|Overall Study|Sponsor Decision|2|||
160858492|NCT05435339|580874745|FG000|Overall Study|Withdrawal by Subject|0|||
160858493|NCT05435339|580874746|FG001|Overall Study|Withdrawal by Subject|0|||
160858494|NCT05435339|580874747|FG002|Overall Study|Withdrawal by Subject|0|||
160858495|NCT05435339|580874748|FG003|Overall Study|Withdrawal by Subject|0|||
160858496|NCT05435339|580874749|FG004|Overall Study|Withdrawal by Subject|1|||
160909013|NCT01315678|581061893|FG001|Overall Study|Withdrawal by Subject|3|||
160909014|NCT01315678|581061892|FG000|Overall Study|Adverse Event|3|||
160909015|NCT01315678|581061893|FG001|Overall Study|Adverse Event|1|||
160909016|NCT01315678|581061892|FG000|Overall Study|Lost to Follow-up|1|||
160858497|NCT05435339|580874750|FG005|Overall Study|Withdrawal by Subject|0|||
160858498|NCT05435339|580874751|FG006|Overall Study|Withdrawal by Subject|1|||
160858499|NCT05435339|580874752|FG007|Overall Study|Withdrawal by Subject|1|||
160858500|NCT01446159|580874753|FG000|Overall Study|Withdrawal by Subject|1|||
160858501|NCT01446159|580874754|FG001|Overall Study|Withdrawal by Subject|0|||
160858502|NCT01446159|580874755|FG002|Overall Study|Withdrawal by Subject|14|||
160858503|NCT01446159|580874756|FG003|Overall Study|Withdrawal by Subject|11|||
160858504|NCT01446159|580874753|FG000|Overall Study|Lost to Follow-up|0|||
160858505|NCT01446159|580874754|FG001|Overall Study|Lost to Follow-up|0|||
160858506|NCT01446159|580874755|FG002|Overall Study|Lost to Follow-up|1|||
160858507|NCT01446159|580874756|FG003|Overall Study|Lost to Follow-up|2|||
160858508|NCT01446159|580874753|FG000|Overall Study|Death|2|||
160858509|NCT01446159|580874754|FG001|Overall Study|Death|3|||
160858510|NCT01446159|580874755|FG002|Overall Study|Death|43|||
160858511|NCT01446159|580874756|FG003|Overall Study|Death|36|||
160909017|NCT01315678|581061893|FG001|Overall Study|Lost to Follow-up|0|||
161141553|NCT04430348|581902520|FG004|Overall Study|Adverse Event|0|||
161141554|NCT04430348|581902521|FG005|Overall Study|Adverse Event|1|||
161141555|NCT04430348|581902516|FG000|Overall Study|Withdrawal by Subject|0|||
160858512|NCT01446159|580874753|FG000|Overall Study|Other|0|||
160858513|NCT01446159|580874754|FG001|Overall Study|Other|0|||
160858514|NCT01446159|580874755|FG002|Overall Study|Other|13|||
160858515|NCT01446159|580874756|FG003|Overall Study|Other|13|||
160858516|NCT00537394|580874763|FG000|First Year of Follow-up|Death|7|||
160858517|NCT00537394|580874764|FG001|First Year of Follow-up|Death|0|||
160858518|NCT00537394|580874765|FG002|First Year of Follow-up|Death|0|||
160858519|NCT00537394|580874763|FG000|First Year of Follow-up|Severe debilitation|1|||
160858520|NCT00537394|580874764|FG001|First Year of Follow-up|Severe debilitation|0|||
160858521|NCT00537394|580874765|FG002|First Year of Follow-up|Severe debilitation|1|||
160858522|NCT00537394|580874763|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
160858523|NCT00537394|580874764|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
160858524|NCT00537394|580874765|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
160858525|NCT00537394|580874763|FG000|First Year of Follow-up|Lost to Follow-up|1|||
160858526|NCT00537394|580874764|FG001|First Year of Follow-up|Lost to Follow-up|5|||
160858527|NCT00537394|580874765|FG002|First Year of Follow-up|Lost to Follow-up|1|||
160858528|NCT00537394|580874763|FG000|2nd Year of Follow-up|Death|4|||
160858529|NCT00537394|580874764|FG001|2nd Year of Follow-up|Death|1|||
160858530|NCT00537394|580874765|FG002|2nd Year of Follow-up|Death|2|||
160858531|NCT00537394|580874763|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
160858532|NCT00537394|580874764|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
160858533|NCT00537394|580874765|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
160858534|NCT00537394|580874763|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
160858535|NCT00537394|580874764|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
160858536|NCT00537394|580874765|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
160858537|NCT00537394|580874763|FG000|2nd Year of Follow-up|Clinic site closure|1|||
160858538|NCT00537394|580874764|FG001|2nd Year of Follow-up|Clinic site closure|0|||
160858539|NCT00537394|580874765|FG002|2nd Year of Follow-up|Clinic site closure|0|||
160858540|NCT01056822|580874770|FG000|Overall Study|Adverse Event|0|||
160858541|NCT01056822|580874771|FG001|Overall Study|Adverse Event|1|||
160858542|NCT01056822|580874770|FG000|Overall Study|Protocol Violation|6|||
160858543|NCT01056822|580874771|FG001|Overall Study|Protocol Violation|5|||
160858544|NCT01056822|580874770|FG000|Overall Study|Withdrawal by Subject|1|||
160858545|NCT01056822|580874771|FG001|Overall Study|Withdrawal by Subject|1|||
160858546|NCT01056822|580874770|FG000|Overall Study|Lost to Follow-up|1|||
160858547|NCT01056822|580874771|FG001|Overall Study|Lost to Follow-up|0|||
160858548|NCT01927497|580874772|FG000|Overall Study|Death|0|||
160858549|NCT01927497|580874773|FG001|Overall Study|Death|1|||
160858550|NCT01927497|580874772|FG000|Overall Study|Protocol Violation|2|||
160858551|NCT01927497|580874773|FG001|Overall Study|Protocol Violation|0|||
160858552|NCT00395746|580874774|FG000|Overall Study|Adverse Event|5|||
160858553|NCT00395746|580874775|FG001|Overall Study|Adverse Event|2|||
160858554|NCT00395746|580874776|FG002|Overall Study|Adverse Event|2|||
160858555|NCT00395746|580874774|FG000|Overall Study|Protocol Violation|0|||
160858556|NCT00395746|580874775|FG001|Overall Study|Protocol Violation|1|||
160858557|NCT00395746|580874776|FG002|Overall Study|Protocol Violation|0|||
160858558|NCT00395746|580874774|FG000|Overall Study|Lack of Efficacy|2|||
160858559|NCT00395746|580874775|FG001|Overall Study|Lack of Efficacy|0|||
160858560|NCT00395746|580874776|FG002|Overall Study|Lack of Efficacy|17|||
160858561|NCT00395746|580874774|FG000|Overall Study|Hypoglycaemia|2|||
160858562|NCT00395746|580874775|FG001|Overall Study|Hypoglycaemia|1|||
160858563|NCT00395746|580874776|FG002|Overall Study|Hypoglycaemia|0|||
160858564|NCT00395746|580874774|FG000|Overall Study|Subject decision|0|||
160858565|NCT00395746|580874775|FG001|Overall Study|Subject decision|0|||
160858566|NCT00395746|580874776|FG002|Overall Study|Subject decision|1|||
160858567|NCT00395746|580874774|FG000|Overall Study|Withdrawal of consent|0|||
160858568|NCT00395746|580874775|FG001|Overall Study|Withdrawal of consent|0|||
160858569|NCT00395746|580874776|FG002|Overall Study|Withdrawal of consent|1|||
160858570|NCT00395746|580874774|FG000|Overall Study|Difficultulty in use of device|0|||
160858571|NCT00395746|580874775|FG001|Overall Study|Difficultulty in use of device|0|||
160858572|NCT00395746|580874776|FG002|Overall Study|Difficultulty in use of device|1|||
160858573|NCT00395746|580874774|FG000|Overall Study|Unable to visit site on schedule|1|||
160858574|NCT00395746|580874775|FG001|Overall Study|Unable to visit site on schedule|0|||
160858575|NCT00395746|580874776|FG002|Overall Study|Unable to visit site on schedule|0|||
160909018|NCT01315678|581061892|FG000|Overall Study|similar reason to those listed above|3|||
161256218|NCT01311557|582316375|FG001|Overall Study|Withdrawal by Subject|2|||
160858576|NCT04528641|580874777|FG000|Overall Study|Withdrawal by Subject|0|||
160858577|NCT04528641|580874778|FG001|Overall Study|Withdrawal by Subject|0|||
160858578|NCT04528641|580874779|FG002|Overall Study|Withdrawal by Subject|0|||
160858579|NCT04528641|580874780|FG003|Overall Study|Withdrawal by Subject|1|||
160858580|NCT04528641|580874781|FG004|Overall Study|Withdrawal by Subject|0|||
160858581|NCT04528641|580874782|FG005|Overall Study|Withdrawal by Subject|1|||
160858582|NCT03914417|580874783|FG000|Overall Study|Withdrawal by Subject|2|||
160858583|NCT00517296|580874788|FG000|Overall Study|Withdrawal by Subject|1|||
161256219|NCT00608517|582316376|FG000|Overall Study|Death|1|||
161256220|NCT00608517|582316377|FG001|Overall Study|Death|0|||
161256221|NCT00608517|582316378|FG002|Overall Study|Death|0|||
160858584|NCT00517296|580874789|FG001|Overall Study|Withdrawal by Subject|0|||
160858585|NCT00795704|580874792|FG000|Overall Study|Withdrawal by Subject|3|||
160858586|NCT00795704|580874793|FG001|Overall Study|Withdrawal by Subject|2|||
160858587|NCT00795704|580874792|FG000|Overall Study|Adverse Event|1|||
160858588|NCT00795704|580874793|FG001|Overall Study|Adverse Event|1|||
160858589|NCT01300728|580874794|FG000|Overall Study|Withdrawal by Subject|1|||
160858590|NCT01300728|580874795|FG001|Overall Study|Withdrawal by Subject|1|||
160858591|NCT01300728|580874794|FG000|Overall Study|Physician Decision|1|||
160858592|NCT01300728|580874795|FG001|Overall Study|Physician Decision|0|||
160858593|NCT01247324|580874796|FG000|Overall Study|Death|6|||
160858594|NCT01247324|580874797|FG001|Overall Study|Death|10|||
160858595|NCT01247324|580874796|FG000|Overall Study|Physician Decision|2|||
160858596|NCT01247324|580874797|FG001|Overall Study|Physician Decision|3|||
160858597|NCT01247324|580874796|FG000|Overall Study|Non-compliance with study drug|3|||
160858598|NCT01247324|580874797|FG001|Overall Study|Non-compliance with study drug|0|||
160858599|NCT01247324|580874796|FG000|Overall Study|Lack of Efficacy|24|||
160858600|NCT01247324|580874797|FG001|Overall Study|Lack of Efficacy|14|||
160858601|NCT01247324|580874796|FG000|Overall Study|Non-compliance|3|||
160858602|NCT01247324|580874797|FG001|Overall Study|Non-compliance|2|||
160858603|NCT01247324|580874796|FG000|Overall Study|Pregnancy|5|||
160858604|NCT01247324|580874797|FG001|Overall Study|Pregnancy|10|||
160858605|NCT01247324|580874796|FG000|Overall Study|Protocol Violation|1|||
160858606|NCT01247324|580874797|FG001|Overall Study|Protocol Violation|1|||
160858607|NCT01247324|580874796|FG000|Overall Study|Reason not specified|42|||
160858608|NCT01247324|580874797|FG001|Overall Study|Reason not specified|32|||
160858609|NCT01247324|580874796|FG000|Overall Study|Consent withdrawn by participant|41|||
160858610|NCT01247324|580874797|FG001|Overall Study|Consent withdrawn by participant|56|||
160858611|NCT01247324|580874796|FG000|Overall Study|Adverse Event|49|||
160858612|NCT01247324|580874797|FG001|Overall Study|Adverse Event|35|||
160858613|NCT01247324|580874796|FG000|Overall Study|Lost to Follow-up|3|||
160858614|NCT01247324|580874797|FG001|Overall Study|Lost to Follow-up|6|||
160858615|NCT01247324|580874796|FG000|Overall Study|Study Terminated by Sponsor|4|||
160858616|NCT01247324|580874797|FG001|Overall Study|Study Terminated by Sponsor|1|||
160858617|NCT01247324|580874796|FG000|Overall Study|Missing|2|||
160858618|NCT01247324|580874797|FG001|Overall Study|Missing|1|||
160858619|NCT00506350|580874798|FG000|Overall Study|Serious Adverse Event|1|||
160858620|NCT00506350|580874799|FG001|Overall Study|Serious Adverse Event|0|||
160858621|NCT00506350|580874800|FG002|Overall Study|Serious Adverse Event|0|||
160858622|NCT00506350|580874801|FG003|Overall Study|Serious Adverse Event|0|||
160858623|NCT00506350|580874802|FG004|Overall Study|Serious Adverse Event|0|||
160858624|NCT00506350|580874803|FG005|Overall Study|Serious Adverse Event|0|||
160858625|NCT00506350|580874804|FG006|Overall Study|Serious Adverse Event|0|||
160858626|NCT00506350|580874805|FG007|Overall Study|Serious Adverse Event|0|||
160858627|NCT00506350|580874806|FG008|Overall Study|Serious Adverse Event|0|||
160858628|NCT00506350|580874798|FG000|Overall Study|Adverse Event|0|||
160858629|NCT00506350|580874799|FG001|Overall Study|Adverse Event|0|||
160858630|NCT00506350|580874800|FG002|Overall Study|Adverse Event|0|||
160858631|NCT00506350|580874801|FG003|Overall Study|Adverse Event|0|||
160858632|NCT00506350|580874802|FG004|Overall Study|Adverse Event|0|||
160858633|NCT00506350|580874803|FG005|Overall Study|Adverse Event|0|||
160858634|NCT00506350|580874804|FG006|Overall Study|Adverse Event|0|||
160858635|NCT00506350|580874805|FG007|Overall Study|Adverse Event|1|||
160858636|NCT00506350|580874806|FG008|Overall Study|Adverse Event|1|||
160858637|NCT00506350|580874798|FG000|Overall Study|Protocol Violation|0|||
160858638|NCT00506350|580874799|FG001|Overall Study|Protocol Violation|0|||
160858639|NCT00506350|580874800|FG002|Overall Study|Protocol Violation|1|||
160858640|NCT00506350|580874801|FG003|Overall Study|Protocol Violation|0|||
160858641|NCT00506350|580874802|FG004|Overall Study|Protocol Violation|0|||
160858642|NCT00506350|580874803|FG005|Overall Study|Protocol Violation|0|||
160909019|NCT01315678|581061893|FG001|Overall Study|similar reason to those listed above|2|||
160909020|NCT03633695|581061897|FG000|Overall Study|Lost to Follow-up|4|||
160858643|NCT00506350|580874804|FG006|Overall Study|Protocol Violation|1|||
160858644|NCT00506350|580874805|FG007|Overall Study|Protocol Violation|0|||
160909021|NCT03633695|581061898|FG001|Overall Study|Lost to Follow-up|5|||
160909022|NCT03633695|581061897|FG000|Overall Study|Discontinued|8|||
160909023|NCT03633695|581061898|FG001|Overall Study|Discontinued|4|||
160909024|NCT03217175|581061902|FG000|Overall Study|Physician Decision|4|||
160909025|NCT03217175|581061903|FG001|Overall Study|Physician Decision|1|||
161256222|NCT00572039|582316379|FG000|Overall Study|Withdrawal by Subject|9|||
161256223|NCT00572039|582316380|FG001|Overall Study|Withdrawal by Subject|6|||
160858645|NCT00506350|580874806|FG008|Overall Study|Protocol Violation|0|||
160858646|NCT00506350|580874798|FG000|Overall Study|Withdrawal by Subject|0|||
160858647|NCT00506350|580874799|FG001|Overall Study|Withdrawal by Subject|1|||
160858648|NCT00506350|580874800|FG002|Overall Study|Withdrawal by Subject|1|||
160858649|NCT00506350|580874801|FG003|Overall Study|Withdrawal by Subject|1|||
160909026|NCT00429273|581061904|FG000|Overall Study|Lost to Follow-up|1|||
160909027|NCT00429273|581061905|FG001|Overall Study|Lost to Follow-up|2|||
161338834|NCT02309359|582630361|FG000|Overall Study|Other|2|||
160909028|NCT00429273|581061906|FG002|Overall Study|Lost to Follow-up|2|||
160909029|NCT00429273|581061904|FG000|Overall Study|Physician Decision|6|||
160909030|NCT00429273|581061905|FG001|Overall Study|Physician Decision|5|||
160909031|NCT00429273|581061906|FG002|Overall Study|Physician Decision|5|||
160909032|NCT00429273|581061904|FG000|Overall Study|Adverse Event|1|||
161256224|NCT00572039|582316379|FG000|Overall Study|Death|2|||
160909033|NCT00429273|581061905|FG001|Overall Study|Adverse Event|1|||
160909034|NCT00429273|581061906|FG002|Overall Study|Adverse Event|2|||
160909035|NCT00407797|581061910|FG000|Overall Study|Lost to Follow-up|2|||
160909036|NCT00407797|581061910|FG000|Overall Study|Adverse Event|6|||
160909037|NCT00407797|581061910|FG000|Overall Study|Other|7|||
160909038|NCT00407797|581061910|FG000|Overall Study|Withdrawal by Subject|3|||
160909039|NCT01402492|581061912|FG000|Overall Study|Withdrawal by Subject|17|||
160909040|NCT01402492|581061913|FG001|Overall Study|Withdrawal by Subject|11|||
160909041|NCT01402492|581061914|FG002|Overall Study|Withdrawal by Subject|11|||
160909042|NCT01402492|581061912|FG000|Overall Study|Adverse Event|2|||
160909043|NCT01402492|581061913|FG001|Overall Study|Adverse Event|3|||
160909044|NCT01402492|581061914|FG002|Overall Study|Adverse Event|4|||
160909045|NCT01402492|581061912|FG000|Overall Study|Physician Decision|0|||
160909046|NCT01402492|581061913|FG001|Overall Study|Physician Decision|3|||
160909047|NCT01402492|581061914|FG002|Overall Study|Physician Decision|0|||
160909048|NCT01402492|581061912|FG000|Overall Study|Incarcerated (N=3)|2|||
160909049|NCT01402492|581061913|FG001|Overall Study|Incarcerated (N=3)|0|||
160909050|NCT01402492|581061914|FG002|Overall Study|Incarcerated (N=3)|1|||
160909051|NCT00601458|581061919|FG000|Overall Study|Dosing Error|1|||
160909052|NCT00601458|581061920|FG001|Overall Study|Dosing Error|0|||
161256225|NCT00572039|582316380|FG001|Overall Study|Death|3|||
161256226|NCT00572039|582316379|FG000|Overall Study|Ill|5|||
161256227|NCT00572039|582316380|FG001|Overall Study|Ill|1|||
161256228|NCT01098110|582316386|FG000|Overall Study|Withdrawal by Subject|14|||
161256229|NCT01098110|582316387|FG001|Overall Study|Withdrawal by Subject|24|||
161256230|NCT01098110|582316388|FG002|Overall Study|Withdrawal by Subject|19|||
161256231|NCT01098110|582316386|FG000|Overall Study|Adverse Event|30|||
161256232|NCT01098110|582316387|FG001|Overall Study|Adverse Event|32|||
161256233|NCT01098110|582316388|FG002|Overall Study|Adverse Event|43|||
161256234|NCT01098110|582316386|FG000|Overall Study|Lack of Efficacy|13|||
161256235|NCT01098110|582316387|FG001|Overall Study|Lack of Efficacy|9|||
161256236|NCT01098110|582316388|FG002|Overall Study|Lack of Efficacy|27|||
161256237|NCT01098110|582316386|FG000|Overall Study|Other|4|||
161256238|NCT01098110|582316387|FG001|Overall Study|Other|7|||
161256239|NCT01098110|582316388|FG002|Overall Study|Other|5|||
161256240|NCT01098110|582316386|FG000|Overall Study|Untreated|1|||
161256241|NCT01098110|582316387|FG001|Overall Study|Untreated|1|||
161256242|NCT01098110|582316388|FG002|Overall Study|Untreated|0|||
161256243|NCT00089076|582316395|FG000|Overall Study|Alternate Therapy|1|||
161256244|NCT00089076|582316395|FG000|Overall Study|Withdrawal by Subject|2|||
161256245|NCT00089076|582316395|FG000|Overall Study|Progression|7|||
161256246|NCT00436917|582316396|FG000|Overall Study|Withdrawal by Subject|13|||
161256247|NCT00436917|582316396|FG000|Overall Study|Adverse Event|2|||
161256248|NCT00436917|582316396|FG000|Overall Study|Physician Decision|1|||
161256249|NCT00436917|582316396|FG000|Overall Study|Death|1|||
161256250|NCT00436917|582316396|FG000|Overall Study|Lost to Follow-up|1|||
161256251|NCT00436917|582316396|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
161256252|NCT00436917|582316396|FG000|Overall Study|Increased creatinine|1|||
161256253|NCT00436917|582316396|FG000|Overall Study|Personal conflicts of patient|1|||
161256254|NCT00931463|582316397|FG000|Overall Study|Death|8|||
161256255|NCT00931463|582316398|FG001|Overall Study|Death|4|||
161256256|NCT00931463|582316397|FG000|Overall Study|Withdrawal by Subject|5|||
161256257|NCT00931463|582316398|FG001|Overall Study|Withdrawal by Subject|0|||
161256258|NCT00931463|582316397|FG000|Overall Study|Lost to Follow-up|4|||
161256259|NCT00931463|582316398|FG001|Overall Study|Lost to Follow-up|1|||
161256260|NCT00808509|582316399|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
161256261|NCT00808509|582316400|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
161256262|NCT00808509|582316399|FG000|Randomized Phase|Reduced methotrexate dose|1|||
161256263|NCT00808509|582316400|FG001|Randomized Phase|Reduced methotrexate dose|2|||
161256264|NCT00808509|582316399|FG000|Randomized Phase|Patient refused rescue therapy|0|||
161256265|NCT00808509|582316400|FG001|Randomized Phase|Patient refused rescue therapy|3|||
161256266|NCT02169791|582316403|FG000|Overall Study|Death|6|||
161256267|NCT02169791|582316403|FG000|Overall Study|patient withdrew consent|1|||
161256268|NCT03170869|582316404|FG000|Overall Study|Protocol Violation|5|||
161256269|NCT03170869|582316404|FG000|Overall Study|Early study termination|3|||
160909053|NCT00601458|581061921|FG002|Overall Study|Dosing Error|0|||
160909054|NCT00601458|581061919|FG000|Overall Study|Incomplete Data|0|||
160909055|NCT00601458|581061920|FG001|Overall Study|Incomplete Data|2|||
160909056|NCT00601458|581061921|FG002|Overall Study|Incomplete Data|0|||
160909057|NCT00601458|581061919|FG000|Overall Study|Protocol Violation|3|||
160909058|NCT00601458|581061920|FG001|Overall Study|Protocol Violation|2|||
160909059|NCT00601458|581061921|FG002|Overall Study|Protocol Violation|1|||
161256270|NCT00373425|582316408|FG000|Overall Study|Relapse of NSCLC|116|||
160994285|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994286|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994287|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994288|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994289|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994290|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994291|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994292|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
160994293|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994294|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994295|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994296|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994297|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994298|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
160994299|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
160994300|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994301|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994302|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994303|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994304|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994305|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994306|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994307|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
160994308|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
160994309|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994310|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994311|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994312|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994313|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994314|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994315|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994316|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
160994317|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
160994318|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994319|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994320|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994321|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994322|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994323|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994324|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994325|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
160994326|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994327|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
160994328|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
160994329|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994330|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994331|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994332|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994333|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994334|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
160994335|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
160994336|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
160858650|NCT00506350|580874802|FG004|Overall Study|Withdrawal by Subject|4|||
160858651|NCT00506350|580874803|FG005|Overall Study|Withdrawal by Subject|1|||
160858652|NCT00506350|580874804|FG006|Overall Study|Withdrawal by Subject|1|||
160858653|NCT00506350|580874805|FG007|Overall Study|Withdrawal by Subject|2|||
160858654|NCT00506350|580874806|FG008|Overall Study|Withdrawal by Subject|0|||
160994337|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994338|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
161338835|NCT02309359|582630362|FG001|Overall Study|Other|0|||
160858655|NCT00506350|580874798|FG000|Overall Study|Lost to Follow-up|1|||
160858656|NCT00506350|580874799|FG001|Overall Study|Lost to Follow-up|1|||
160858657|NCT00506350|580874800|FG002|Overall Study|Lost to Follow-up|1|||
160858658|NCT00506350|580874801|FG003|Overall Study|Lost to Follow-up|1|||
160858659|NCT00506350|580874802|FG004|Overall Study|Lost to Follow-up|2|||
161141556|NCT04430348|581902517|FG001|Overall Study|Withdrawal by Subject|1|||
161141557|NCT04430348|581902518|FG002|Overall Study|Withdrawal by Subject|0|||
160858660|NCT00506350|580874803|FG005|Overall Study|Lost to Follow-up|1|||
160994339|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994340|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994341|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994342|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994343|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
160994344|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994345|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
160994346|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994347|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994348|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994349|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994350|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994351|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994352|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
160994353|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994354|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
160994355|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994356|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994357|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
161141558|NCT04430348|581902519|FG003|Overall Study|Withdrawal by Subject|0|||
161141559|NCT04430348|581902520|FG004|Overall Study|Withdrawal by Subject|0|||
161338836|NCT02309359|582630363|FG002|Overall Study|Other|2|||
160858661|NCT00506350|580874804|FG006|Overall Study|Lost to Follow-up|0|||
160858662|NCT00506350|580874805|FG007|Overall Study|Lost to Follow-up|0|||
160858663|NCT00506350|580874806|FG008|Overall Study|Lost to Follow-up|2|||
160858664|NCT00506350|580874798|FG000|Overall Study|Medical Reason|0|||
160858665|NCT00506350|580874799|FG001|Overall Study|Medical Reason|0|||
160858666|NCT00506350|580874800|FG002|Overall Study|Medical Reason|0|||
160858667|NCT00506350|580874801|FG003|Overall Study|Medical Reason|0|||
160858668|NCT00506350|580874802|FG004|Overall Study|Medical Reason|1|||
160858669|NCT00506350|580874803|FG005|Overall Study|Medical Reason|0|||
160858670|NCT00506350|580874804|FG006|Overall Study|Medical Reason|0|||
160858671|NCT00506350|580874805|FG007|Overall Study|Medical Reason|0|||
160858672|NCT00506350|580874806|FG008|Overall Study|Medical Reason|0|||
160858673|NCT00506350|580874798|FG000|Overall Study|Other|1|||
160858674|NCT00506350|580874799|FG001|Overall Study|Other|1|||
160858675|NCT00506350|580874800|FG002|Overall Study|Other|3|||
160858676|NCT00506350|580874801|FG003|Overall Study|Other|0|||
160858677|NCT00506350|580874802|FG004|Overall Study|Other|3|||
160858678|NCT00506350|580874803|FG005|Overall Study|Other|0|||
160858679|NCT00506350|580874804|FG006|Overall Study|Other|0|||
160858680|NCT00506350|580874805|FG007|Overall Study|Other|2|||
161338837|NCT02309359|582630364|FG003|Overall Study|Other|3|||
160858681|NCT00506350|580874806|FG008|Overall Study|Other|2|||
160858682|NCT03474588|580874807|FG000|Overall Study|Withdrawal by Subject|4|||
160858683|NCT03474588|580874808|FG001|Overall Study|Withdrawal by Subject|3|||
160858684|NCT03474588|580874807|FG000|Overall Study|Death|0|||
160858685|NCT03474588|580874808|FG001|Overall Study|Death|1|||
160858686|NCT01607957|580874809|FG000|Overall Study|Not treated|1|||
160858687|NCT01607957|580874810|FG001|Overall Study|Not treated|1|||
160858688|NCT01607957|580874809|FG000|Overall Study|Death|367|||
160858689|NCT01607957|580874810|FG001|Overall Study|Death|211|||
160858690|NCT01607957|580874809|FG000|Overall Study|Lost to Follow-up|3|||
160858691|NCT01607957|580874810|FG001|Overall Study|Lost to Follow-up|3|||
160858692|NCT01607957|580874809|FG000|Overall Study|Participant refusal|1|||
160858693|NCT01607957|580874810|FG001|Overall Study|Participant refusal|0|||
160858694|NCT01691794|580874811|FG000|Overall Study|Poor/Non-Compliance|1|||
160858695|NCT01691794|580874812|FG001|Overall Study|Poor/Non-Compliance|4|||
160858696|NCT01691794|580874813|FG002|Overall Study|Poor/Non-Compliance|1|||
160858697|NCT01691794|580874811|FG000|Overall Study|Death|0|||
160858698|NCT01691794|580874812|FG001|Overall Study|Death|0|||
160858699|NCT01691794|580874813|FG002|Overall Study|Death|1|||
160858700|NCT01691794|580874811|FG000|Overall Study|Lack of Efficacy|0|||
160858701|NCT01691794|580874812|FG001|Overall Study|Lack of Efficacy|7|||
160858702|NCT01691794|580874813|FG002|Overall Study|Lack of Efficacy|1|||
160858703|NCT01691794|580874811|FG000|Overall Study|Participant request to discontinue|0|||
160858704|NCT01691794|580874812|FG001|Overall Study|Participant request to discontinue|1|||
160858705|NCT01691794|580874813|FG002|Overall Study|Participant request to discontinue|0|||
160858706|NCT01691794|580874811|FG000|Overall Study|Adverse Event|0|||
160858707|NCT01691794|580874812|FG001|Overall Study|Adverse Event|1|||
160858708|NCT01691794|580874813|FG002|Overall Study|Adverse Event|1|||
160909060|NCT00601458|581061919|FG000|Overall Study|Early Termination|0|||
160909061|NCT00601458|581061920|FG001|Overall Study|Early Termination|1|||
160909062|NCT00601458|581061921|FG002|Overall Study|Early Termination|1|||
160909063|NCT00518986|581061922|FG000|Overall Study|Adverse Event|12|||
160909064|NCT00518986|581061923|FG001|Overall Study|Adverse Event|7|||
160909065|NCT00518986|581061922|FG000|Overall Study|Lack of Efficacy|0|||
160909066|NCT00518986|581061923|FG001|Overall Study|Lack of Efficacy|2|||
160909067|NCT00518986|581061922|FG000|Overall Study|Lost to Follow-up|3|||
160909068|NCT00518986|581061923|FG001|Overall Study|Lost to Follow-up|2|||
160909069|NCT00518986|581061922|FG000|Overall Study|Physician Decision|0|||
160909070|NCT00518986|581061923|FG001|Overall Study|Physician Decision|3|||
160909071|NCT00518986|581061922|FG000|Overall Study|Protocol Violation|5|||
160909072|NCT00518986|581061923|FG001|Overall Study|Protocol Violation|7|||
160909073|NCT00518986|581061922|FG000|Overall Study|Withdrawal by Subject|4|||
160909074|NCT00518986|581061923|FG001|Overall Study|Withdrawal by Subject|4|||
160909075|NCT00518986|581061922|FG000|Overall Study|Non-Specific|2|||
160909076|NCT00518986|581061923|FG001|Overall Study|Non-Specific|1|||
160909077|NCT04862585|581061926|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
160909078|NCT04862585|581061927|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
160909079|NCT04862585|581061926|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
160909080|NCT04862585|581061927|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
160909081|NCT04862585|581061926|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
160909082|NCT04862585|581061927|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
160909083|NCT04862585|581061926|FG000|Overall Study|one withdrew without providing a reason|0|||
160909084|NCT04862585|581061927|FG001|Overall Study|one withdrew without providing a reason|1|||
160909085|NCT02099708|581061929|FG000|Overall Study|Data Not Available|30|||
160909086|NCT02099708|581061929|FG000|Overall Study|Lost to Follow-up|141|||
160909087|NCT02099708|581061929|FG000|Overall Study|Other|29|||
160909088|NCT05229406|581061930|FG000|Overall Study|Withdrawal by Subject|1|||
160909089|NCT05229406|581061931|FG001|Overall Study|Withdrawal by Subject|2|||
160909090|NCT01930123|581061932|FG000|Overall Study|Adverse Event|1|||
160909091|NCT01930123|581061933|FG001|Overall Study|Adverse Event|0|||
160909092|NCT01930123|581061932|FG000|Overall Study|Physician Decision|21|||
160909093|NCT01930123|581061933|FG001|Overall Study|Physician Decision|8|||
160909094|NCT01930123|581061932|FG000|Overall Study|Withdrawal by Subject|1|||
160909095|NCT01930123|581061933|FG001|Overall Study|Withdrawal by Subject|0|||
160909096|NCT03310021|581061936|FG000|Overall Study|Withdrawal by Subject|0|||
160909097|NCT03310021|581061937|FG001|Overall Study|Withdrawal by Subject|0|||
160909098|NCT03310021|581061938|FG002|Overall Study|Withdrawal by Subject|0|||
160909099|NCT03310021|581061939|FG003|Overall Study|Withdrawal by Subject|0|||
160909100|NCT03310021|581061940|FG004|Overall Study|Withdrawal by Subject|0|||
160909101|NCT03310021|581061941|FG005|Overall Study|Withdrawal by Subject|0|||
160909102|NCT03310021|581061942|FG006|Overall Study|Withdrawal by Subject|1|||
160909103|NCT03310021|581061943|FG007|Overall Study|Withdrawal by Subject|0|||
160909104|NCT03310021|581061944|FG008|Overall Study|Withdrawal by Subject|0|||
160909105|NCT03310021|581061945|FG009|Overall Study|Withdrawal by Subject|0|||
160909106|NCT03310021|581061946|FG010|Overall Study|Withdrawal by Subject|0|||
160909107|NCT03310021|581061947|FG011|Overall Study|Withdrawal by Subject|0|||
160909108|NCT03310021|581061948|FG012|Overall Study|Withdrawal by Subject|0|||
160909109|NCT03310021|581061949|FG013|Overall Study|Withdrawal by Subject|0|||
160909110|NCT03310021|581061950|FG014|Overall Study|Withdrawal by Subject|0|||
160909111|NCT03310021|581061951|FG015|Overall Study|Withdrawal by Subject|0|||
160909112|NCT03310021|581061952|FG016|Overall Study|Withdrawal by Subject|0|||
160909113|NCT03310021|581061953|FG017|Overall Study|Withdrawal by Subject|0|||
160909114|NCT03310021|581061954|FG018|Overall Study|Withdrawal by Subject|0|||
160909115|NCT03310021|581061955|FG019|Overall Study|Withdrawal by Subject|0|||
160909116|NCT03310021|581061936|FG000|Overall Study|Lost to Follow-up|0|||
160909117|NCT03310021|581061937|FG001|Overall Study|Lost to Follow-up|0|||
160909118|NCT03310021|581061938|FG002|Overall Study|Lost to Follow-up|0|||
160909119|NCT03310021|581061939|FG003|Overall Study|Lost to Follow-up|0|||
160909120|NCT03310021|581061940|FG004|Overall Study|Lost to Follow-up|0|||
160909121|NCT03310021|581061941|FG005|Overall Study|Lost to Follow-up|0|||
160909122|NCT03310021|581061942|FG006|Overall Study|Lost to Follow-up|0|||
160909123|NCT03310021|581061943|FG007|Overall Study|Lost to Follow-up|0|||
160909124|NCT03310021|581061944|FG008|Overall Study|Lost to Follow-up|0|||
160909125|NCT03310021|581061945|FG009|Overall Study|Lost to Follow-up|0|||
160909126|NCT03310021|581061946|FG010|Overall Study|Lost to Follow-up|1|||
160909127|NCT03310021|581061947|FG011|Overall Study|Lost to Follow-up|0|||
160909128|NCT03310021|581061948|FG012|Overall Study|Lost to Follow-up|0|||
160909129|NCT03310021|581061949|FG013|Overall Study|Lost to Follow-up|0|||
160909130|NCT03310021|581061950|FG014|Overall Study|Lost to Follow-up|0|||
160909131|NCT03310021|581061951|FG015|Overall Study|Lost to Follow-up|0|||
160909132|NCT03310021|581061952|FG016|Overall Study|Lost to Follow-up|0|||
160909133|NCT03310021|581061953|FG017|Overall Study|Lost to Follow-up|0|||
160909134|NCT03310021|581061954|FG018|Overall Study|Lost to Follow-up|0|||
160994358|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994359|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994360|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994361|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
160994362|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994363|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160909135|NCT03310021|581061955|FG019|Overall Study|Lost to Follow-up|0|||
160994364|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
160994365|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994366|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994367|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994368|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994369|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994370|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
160994371|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994372|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994373|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
160994374|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994375|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994376|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994377|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994378|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994379|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
160994380|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994381|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994382|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
161256271|NCT00373425|582316409|FG001|Overall Study|Relapse of NSCLC|104|||
160909136|NCT00702923|581061958|FG000|Overall Study|Adverse Event|1|||
160909137|NCT02002091|581061959|FG000|Screening|Lost to Follow-up|10|||
160909138|NCT02002091|581061960|FG001|Screening|Lost to Follow-up|12|||
160909139|NCT02002091|581061959|FG000|Screening|Death|3|||
160909140|NCT02002091|581061960|FG001|Screening|Death|2|||
160909141|NCT03953820|581061961|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
160909142|NCT03953820|581061962|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
160909143|NCT03953820|581061963|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
160909144|NCT03953820|581061961|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
160909145|NCT03953820|581061962|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
160909146|NCT03953820|581061963|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
160909147|NCT01233258|581061966|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909148|NCT01233258|581061967|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909149|NCT01233258|581061968|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909150|NCT01233258|581061969|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
160909151|NCT01233258|581061970|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
160909152|NCT01233258|581061971|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
160909153|NCT01233258|581061966|FG000|First Intervention (6 Months)|Protocol Violation|0|||
160909154|NCT01233258|581061967|FG001|First Intervention (6 Months)|Protocol Violation|0|||
160909155|NCT01233258|581061968|FG002|First Intervention (6 Months)|Protocol Violation|1|||
160909156|NCT01233258|581061969|FG003|First Intervention (6 Months)|Protocol Violation|0|||
160909157|NCT01233258|581061970|FG004|First Intervention (6 Months)|Protocol Violation|0|||
160909158|NCT01233258|581061971|FG005|First Intervention (6 Months)|Protocol Violation|0|||
160909159|NCT01233258|581061966|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
160909160|NCT01233258|581061967|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909161|NCT01233258|581061968|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909162|NCT01233258|581061969|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909163|NCT01233258|581061970|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909164|NCT01233258|581061971|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
160909165|NCT00530946|581061975|FG000|Overall Study|Adverse Event|1|||
160909166|NCT00530946|581061976|FG001|Overall Study|Adverse Event|2|||
160909167|NCT00530946|581061977|FG002|Overall Study|Adverse Event|1|||
160909168|NCT00530946|581061978|FG003|Overall Study|Adverse Event|1|||
160909169|NCT00530946|581061975|FG000|Overall Study|Protocol Violation|0|||
161256272|NCT00373425|582316410|FG002|Overall Study|Relapse of NSCLC|19|||
160909170|NCT00530946|581061976|FG001|Overall Study|Protocol Violation|0|||
160909171|NCT00530946|581061977|FG002|Overall Study|Protocol Violation|0|||
160909172|NCT00530946|581061978|FG003|Overall Study|Protocol Violation|1|||
160858709|NCT01691794|580874811|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
160994383|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994384|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994385|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994386|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994387|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994388|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
160994389|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994390|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994391|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994392|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994393|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994394|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994395|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
160994396|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994397|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
160994398|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
160994399|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
160994400|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994401|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994402|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994403|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994404|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994405|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994406|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
160994407|NCT03598790|581368941|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994408|NCT03598790|581368942|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994409|NCT03598790|581368943|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
160994410|NCT03598790|581368944|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994411|NCT03598790|581368945|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994412|NCT03598790|581368946|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994413|NCT03598790|581368947|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994414|NCT03598790|581368948|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994415|NCT03598790|581368949|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
160994416|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994417|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994418|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994419|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
160994420|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
160994421|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
160994422|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994423|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994424|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160994425|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994426|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994427|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994428|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
160994429|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994430|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994431|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994432|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994433|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
160994434|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994435|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994436|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994437|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
161338838|NCT02309359|582630365|FG004|Overall Study|Other|2|||
161338839|NCT06129149|582630368|FG000|Overall Study|Death|1|||
160858710|NCT01691794|580874812|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
161338840|NCT03307174|582630369|FG000|Overall Study|Unplanned ICU Administrion|5|||
161338841|NCT03307174|582630370|FG001|Overall Study|Unplanned ICU Administrion|3|||
161338842|NCT03307174|582630369|FG000|Overall Study|Aborted Surgery|1|||
161338843|NCT03307174|582630370|FG001|Overall Study|Aborted Surgery|2|||
161338844|NCT03307174|582630369|FG000|Overall Study|Hypotension|6|||
161338845|NCT03307174|582630370|FG001|Overall Study|Hypotension|0|||
161338846|NCT03307174|582630369|FG000|Overall Study|Nonfunctional epidural|1|||
161338847|NCT03307174|582630370|FG001|Overall Study|Nonfunctional epidural|1|||
160858711|NCT01691794|580874813|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
160858712|NCT01691794|580874811|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
160858713|NCT01691794|580874812|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
160858714|NCT01691794|580874813|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
160858715|NCT04972786|580874814|FG000|First Intervention (1 Day)|Adverse Event|1|||
160858716|NCT04972786|580874815|FG001|First Intervention (1 Day)|Adverse Event|0|||
160858717|NCT03905096|580874816|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
160858718|NCT03905096|580874817|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
160858719|NCT00385671|580876882|FG000|Overall Study|Adverse Event|14|||
160858720|NCT00385671|580876883|FG001|Overall Study|Adverse Event|27|||
160858721|NCT00385671|580876884|FG002|Overall Study|Adverse Event|18|||
160858722|NCT00385671|580876882|FG000|Overall Study|Lack of Efficacy|5|||
160858723|NCT00385671|580876883|FG001|Overall Study|Lack of Efficacy|9|||
160858724|NCT00385671|580876884|FG002|Overall Study|Lack of Efficacy|5|||
160858725|NCT00385671|580876882|FG000|Overall Study|Lost to Follow-up|6|||
160858726|NCT00385671|580876883|FG001|Overall Study|Lost to Follow-up|6|||
160858727|NCT00385671|580876884|FG002|Overall Study|Lost to Follow-up|5|||
160858728|NCT00385671|580876882|FG000|Overall Study|Physician Decision|2|||
160858729|NCT00385671|580876883|FG001|Overall Study|Physician Decision|1|||
160858730|NCT00385671|580876884|FG002|Overall Study|Physician Decision|2|||
160858731|NCT00385671|580876882|FG000|Overall Study|Protocol Violation|5|||
160858732|NCT00385671|580876883|FG001|Overall Study|Protocol Violation|2|||
160858733|NCT00385671|580876884|FG002|Overall Study|Protocol Violation|1|||
160858734|NCT00385671|580876882|FG000|Overall Study|Sponsor Decision|2|||
160858735|NCT00385671|580876883|FG001|Overall Study|Sponsor Decision|2|||
160858736|NCT00385671|580876884|FG002|Overall Study|Sponsor Decision|1|||
160858737|NCT00385671|580876882|FG000|Overall Study|Withdrawal by Subject|4|||
160858738|NCT00385671|580876883|FG001|Overall Study|Withdrawal by Subject|4|||
160858739|NCT00385671|580876884|FG002|Overall Study|Withdrawal by Subject|4|||
160858740|NCT02608684|580876885|FG000|Overall Study|Physician Decision|2|||
160858741|NCT02608684|580876885|FG000|Overall Study|Withdrawal by Subject|1|||
160858742|NCT01775501|580876888|FG000|Overall Study|Discontinued prior to treatment|1|||
160858743|NCT03037385|580876889|FG000|Overall Study|Adverse Event|0|||
160858744|NCT03037385|580876890|FG001|Overall Study|Adverse Event|0|||
160858745|NCT03037385|580876891|FG002|Overall Study|Adverse Event|1|||
160858746|NCT03037385|580876892|FG003|Overall Study|Adverse Event|0|||
160858747|NCT03037385|580876893|FG004|Overall Study|Adverse Event|0|||
160858748|NCT03037385|580876894|FG005|Overall Study|Adverse Event|0|||
160858749|NCT03037385|580876895|FG006|Overall Study|Adverse Event|0|||
160858750|NCT03037385|580876896|FG007|Overall Study|Adverse Event|0|||
160858751|NCT03037385|580876897|FG008|Overall Study|Adverse Event|0|||
160858752|NCT03037385|580876898|FG009|Overall Study|Adverse Event|6|||
160858753|NCT03037385|580876889|FG000|Overall Study|Death|1|||
160858754|NCT03037385|580876890|FG001|Overall Study|Death|4|||
160858755|NCT03037385|580876891|FG002|Overall Study|Death|2|||
160858756|NCT03037385|580876892|FG003|Overall Study|Death|2|||
160858757|NCT03037385|580876893|FG004|Overall Study|Death|5|||
160858758|NCT03037385|580876894|FG005|Overall Study|Death|2|||
160858759|NCT03037385|580876895|FG006|Overall Study|Death|1|||
160858760|NCT03037385|580876896|FG007|Overall Study|Death|4|||
160858761|NCT03037385|580876897|FG008|Overall Study|Death|3|||
160858762|NCT03037385|580876898|FG009|Overall Study|Death|240|||
160858763|NCT03037385|580876889|FG000|Overall Study|Initiation of Another Therapy|1|||
160858764|NCT03037385|580876890|FG001|Overall Study|Initiation of Another Therapy|0|||
160858765|NCT03037385|580876891|FG002|Overall Study|Initiation of Another Therapy|0|||
161338848|NCT03307174|582630369|FG000|Overall Study|Planned epidural removal|1|||
160858766|NCT03037385|580876892|FG003|Overall Study|Initiation of Another Therapy|0|||
160858767|NCT03037385|580876893|FG004|Overall Study|Initiation of Another Therapy|0|||
160858768|NCT03037385|580876894|FG005|Overall Study|Initiation of Another Therapy|0|||
160858769|NCT03037385|580876895|FG006|Overall Study|Initiation of Another Therapy|0|||
160858770|NCT03037385|580876896|FG007|Overall Study|Initiation of Another Therapy|1|||
160858771|NCT03037385|580876897|FG008|Overall Study|Initiation of Another Therapy|0|||
160858772|NCT03037385|580876898|FG009|Overall Study|Initiation of Another Therapy|2|||
160858773|NCT03037385|580876889|FG000|Overall Study|Lost to Follow-up|0|||
160858774|NCT03037385|580876890|FG001|Overall Study|Lost to Follow-up|0|||
160858775|NCT03037385|580876891|FG002|Overall Study|Lost to Follow-up|0|||
160858776|NCT03037385|580876892|FG003|Overall Study|Lost to Follow-up|0|||
160858777|NCT03037385|580876893|FG004|Overall Study|Lost to Follow-up|0|||
160858778|NCT03037385|580876894|FG005|Overall Study|Lost to Follow-up|1|||
160858779|NCT03037385|580876895|FG006|Overall Study|Lost to Follow-up|0|||
160994438|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994439|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994440|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994441|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994442|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160994443|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994444|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994445|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994446|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
160994447|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
160994448|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994449|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994450|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994451|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
160994452|NCT03598790|581368941|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160858780|NCT03037385|580876896|FG007|Overall Study|Lost to Follow-up|0|||
160858781|NCT03037385|580876897|FG008|Overall Study|Lost to Follow-up|0|||
160858782|NCT03037385|580876898|FG009|Overall Study|Lost to Follow-up|16|||
160858783|NCT03037385|580876889|FG000|Overall Study|Physician Decision|0|||
160858784|NCT03037385|580876890|FG001|Overall Study|Physician Decision|0|||
160858785|NCT03037385|580876891|FG002|Overall Study|Physician Decision|0|||
160858786|NCT03037385|580876892|FG003|Overall Study|Physician Decision|0|||
160858787|NCT03037385|580876893|FG004|Overall Study|Physician Decision|0|||
160858788|NCT03037385|580876894|FG005|Overall Study|Physician Decision|0|||
160858789|NCT03037385|580876895|FG006|Overall Study|Physician Decision|0|||
160858790|NCT03037385|580876896|FG007|Overall Study|Physician Decision|0|||
160858791|NCT03037385|580876897|FG008|Overall Study|Physician Decision|0|||
160858792|NCT03037385|580876898|FG009|Overall Study|Physician Decision|1|||
160858793|NCT03037385|580876889|FG000|Overall Study|Progressive Disease|0|||
160858794|NCT03037385|580876890|FG001|Overall Study|Progressive Disease|1|||
160858795|NCT03037385|580876891|FG002|Overall Study|Progressive Disease|1|||
160858796|NCT03037385|580876892|FG003|Overall Study|Progressive Disease|5|||
160858797|NCT03037385|580876893|FG004|Overall Study|Progressive Disease|2|||
160858798|NCT03037385|580876894|FG005|Overall Study|Progressive Disease|0|||
160858799|NCT03037385|580876895|FG006|Overall Study|Progressive Disease|1|||
160858800|NCT03037385|580876896|FG007|Overall Study|Progressive Disease|0|||
160858801|NCT03037385|580876897|FG008|Overall Study|Progressive Disease|0|||
160858802|NCT03037385|580876898|FG009|Overall Study|Progressive Disease|30|||
160858803|NCT03037385|580876889|FG000|Overall Study|Withdrawal by Subject|0|||
160858804|NCT03037385|580876890|FG001|Overall Study|Withdrawal by Subject|0|||
160909173|NCT00530946|581061975|FG000|Overall Study|Noncompliance|1|||
160909174|NCT00530946|581061976|FG001|Overall Study|Noncompliance|0|||
160909175|NCT00530946|581061977|FG002|Overall Study|Noncompliance|0|||
160909176|NCT00530946|581061978|FG003|Overall Study|Noncompliance|0|||
160909177|NCT01534962|581061979|FG000|Overall Study|Randomized but did not start treatment|2|||
160909178|NCT01534962|581061980|FG001|Overall Study|Randomized but did not start treatment|0|||
160909179|NCT01534962|581061981|FG002|Overall Study|Randomized but did not start treatment|0|||
160909180|NCT01534962|581061982|FG003|Overall Study|Randomized but did not start treatment|1|||
160909181|NCT01534962|581061979|FG000|Overall Study|Discontinued at AF recurrence|35|||
160909182|NCT01534962|581061980|FG001|Overall Study|Discontinued at AF recurrence|26|||
160909183|NCT01534962|581061981|FG002|Overall Study|Discontinued at AF recurrence|24|||
160909184|NCT01534962|581061982|FG003|Overall Study|Discontinued at AF recurrence|31|||
160909185|NCT00880009|581061983|FG000|Overall Study|Study terminated by sponsor|14|||
160909186|NCT00880009|581061983|FG000|Overall Study|Withdrawal by Subject|1|||
160909187|NCT00880009|581061983|FG000|Overall Study|Protocol Violation|1|||
161256273|NCT00373425|582316411|FG003|Overall Study|Relapse of NSCLC|2|||
161256274|NCT00373425|582316412|FG004|Overall Study|Relapse of NSCLC|26|||
161256275|NCT00373425|582316408|FG000|Overall Study|Adverse Event|191|||
161256276|NCT00373425|582316409|FG001|Overall Study|Adverse Event|22|||
160858805|NCT03037385|580876891|FG002|Overall Study|Withdrawal by Subject|1|||
160858806|NCT03037385|580876892|FG003|Overall Study|Withdrawal by Subject|2|||
160909188|NCT04545385|581061988|FG000|Overall Study|Withdrawal by Subject|2|||
160909189|NCT04545385|581061989|FG001|Overall Study|Withdrawal by Subject|0|||
160909190|NCT04545385|581061988|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
160909191|NCT04545385|581061989|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
160858807|NCT03037385|580876893|FG004|Overall Study|Withdrawal by Subject|1|||
160858808|NCT03037385|580876894|FG005|Overall Study|Withdrawal by Subject|3|||
160909192|NCT04545385|581061988|FG000|Overall Study|Study termination|10|||
160909193|NCT04545385|581061989|FG001|Overall Study|Study termination|10|||
160909194|NCT04545385|581061988|FG000|Overall Study|Sponsor decision|2|||
161256277|NCT00373425|582316410|FG002|Overall Study|Adverse Event|59|||
160858809|NCT03037385|580876895|FG006|Overall Study|Withdrawal by Subject|0|||
160858810|NCT03037385|580876896|FG007|Overall Study|Withdrawal by Subject|0|||
160858811|NCT03037385|580876897|FG008|Overall Study|Withdrawal by Subject|0|||
160858812|NCT03037385|580876898|FG009|Overall Study|Withdrawal by Subject|52|||
160858813|NCT03037385|580876889|FG000|Overall Study|Reason Not Specified|0|||
160858814|NCT03037385|580876890|FG001|Overall Study|Reason Not Specified|1|||
160858815|NCT03037385|580876891|FG002|Overall Study|Reason Not Specified|0|||
160858816|NCT03037385|580876892|FG003|Overall Study|Reason Not Specified|4|||
160858817|NCT03037385|580876893|FG004|Overall Study|Reason Not Specified|3|||
160858818|NCT03037385|580876894|FG005|Overall Study|Reason Not Specified|6|||
160858819|NCT03037385|580876895|FG006|Overall Study|Reason Not Specified|2|||
160858820|NCT03037385|580876896|FG007|Overall Study|Reason Not Specified|0|||
160858821|NCT03037385|580876897|FG008|Overall Study|Reason Not Specified|1|||
160858822|NCT03037385|580876898|FG009|Overall Study|Reason Not Specified|181|||
160858823|NCT02318706|580876899|FG000|Double-blind Phase|Adverse Event|7|||
160858824|NCT02318706|580876900|FG001|Double-blind Phase|Adverse Event|4|||
160858825|NCT02318706|580876901|FG002|Double-blind Phase|Adverse Event|3|||
160858826|NCT02318706|580876902|FG003|Double-blind Phase|Adverse Event|10|||
160858827|NCT02318706|580876903|FG004|Double-blind Phase|Adverse Event|0|||
160858828|NCT02318706|580876899|FG000|Double-blind Phase|Lost to Follow-up|1|||
160858829|NCT02318706|580876900|FG001|Double-blind Phase|Lost to Follow-up|0|||
160858830|NCT02318706|580876901|FG002|Double-blind Phase|Lost to Follow-up|0|||
160858831|NCT02318706|580876902|FG003|Double-blind Phase|Lost to Follow-up|0|||
160858832|NCT02318706|580876903|FG004|Double-blind Phase|Lost to Follow-up|0|||
160858833|NCT02318706|580876899|FG000|Double-blind Phase|Protocol Violation|4|||
160858834|NCT02318706|580876900|FG001|Double-blind Phase|Protocol Violation|2|||
160858835|NCT02318706|580876901|FG002|Double-blind Phase|Protocol Violation|4|||
160858836|NCT02318706|580876902|FG003|Double-blind Phase|Protocol Violation|3|||
160858837|NCT02318706|580876903|FG004|Double-blind Phase|Protocol Violation|0|||
160858838|NCT02318706|580876899|FG000|Double-blind Phase|Withdrawal by Subject|9|||
160858839|NCT02318706|580876900|FG001|Double-blind Phase|Withdrawal by Subject|5|||
160858840|NCT02318706|580876901|FG002|Double-blind Phase|Withdrawal by Subject|7|||
160858841|NCT02318706|580876902|FG003|Double-blind Phase|Withdrawal by Subject|10|||
160858842|NCT02318706|580876903|FG004|Double-blind Phase|Withdrawal by Subject|0|||
160858843|NCT02318706|580876899|FG000|Double-blind Phase|Other|4|||
160858844|NCT02318706|580876900|FG001|Double-blind Phase|Other|1|||
160858845|NCT02318706|580876901|FG002|Double-blind Phase|Other|2|||
160858846|NCT02318706|580876902|FG003|Double-blind Phase|Other|1|||
160858847|NCT02318706|580876903|FG004|Double-blind Phase|Other|0|||
160858848|NCT02318706|580876899|FG000|Double-blind Phase|Death|0|||
160858849|NCT02318706|580876900|FG001|Double-blind Phase|Death|0|||
160858850|NCT02318706|580876901|FG002|Double-blind Phase|Death|2|||
160858851|NCT02318706|580876902|FG003|Double-blind Phase|Death|0|||
160858852|NCT02318706|580876903|FG004|Double-blind Phase|Death|0|||
160858853|NCT02318706|580876899|FG000|Open-label Extension Phase|Adverse Event|0|||
160858854|NCT02318706|580876900|FG001|Open-label Extension Phase|Adverse Event|0|||
160858855|NCT02318706|580876901|FG002|Open-label Extension Phase|Adverse Event|0|||
160858856|NCT02318706|580876902|FG003|Open-label Extension Phase|Adverse Event|0|||
160858857|NCT02318706|580876903|FG004|Open-label Extension Phase|Adverse Event|21|||
160858858|NCT02318706|580876899|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
160858859|NCT02318706|580876900|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
160858860|NCT02318706|580876901|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
160858861|NCT02318706|580876902|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
160858862|NCT02318706|580876903|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
160858863|NCT02318706|580876899|FG000|Open-label Extension Phase|Death|0|||
160858864|NCT02318706|580876900|FG001|Open-label Extension Phase|Death|0|||
160858865|NCT02318706|580876901|FG002|Open-label Extension Phase|Death|0|||
160858866|NCT02318706|580876902|FG003|Open-label Extension Phase|Death|0|||
160858867|NCT02318706|580876903|FG004|Open-label Extension Phase|Death|1|||
160858868|NCT02318706|580876899|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
160858869|NCT02318706|580876900|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
160858870|NCT02318706|580876901|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
160858871|NCT02318706|580876902|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
160994453|NCT03598790|581368942|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994454|NCT03598790|581368943|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994455|NCT03598790|581368944|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
160994456|NCT03598790|581368945|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160858872|NCT02318706|580876903|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
161141560|NCT04430348|581902521|FG005|Overall Study|Withdrawal by Subject|1|||
160858873|NCT04328077|580876904|FG000|Overall Study|Lost to Follow-up|0|||
160858874|NCT04328077|580876905|FG001|Overall Study|Lost to Follow-up|1|||
160858875|NCT04328077|580876906|FG002|Overall Study|Lost to Follow-up|0|||
160858876|NCT04328077|580876907|FG003|Overall Study|Lost to Follow-up|0|||
160858877|NCT04328077|580876904|FG000|Overall Study|Withdrawal by Subject|0|||
160858878|NCT04328077|580876905|FG001|Overall Study|Withdrawal by Subject|1|||
160858879|NCT04328077|580876906|FG002|Overall Study|Withdrawal by Subject|1|||
160858880|NCT04328077|580876907|FG003|Overall Study|Withdrawal by Subject|3|||
160858881|NCT01456039|580876908|FG000|Phase 1 (First Step)|Disease Progression|1|||
160858882|NCT01456039|580876909|FG001|Phase 1 (First Step)|Disease Progression|1|||
160858883|NCT01456039|580876910|FG002|Phase 1 (First Step)|Disease Progression|0|||
160858884|NCT01456039|580876908|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
160858885|NCT01456039|580876909|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
160858886|NCT01456039|580876910|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
160858887|NCT01456039|580876908|FG000|Phase 1 (First Step)|Adverse Event|0|||
160858888|NCT01456039|580876909|FG001|Phase 1 (First Step)|Adverse Event|3|||
160858889|NCT01456039|580876910|FG002|Phase 1 (First Step)|Adverse Event|0|||
160858890|NCT01456039|580876908|FG000|Phase 1 (First Step)|Other|0|||
160858891|NCT01456039|580876909|FG001|Phase 1 (First Step)|Other|1|||
160858892|NCT01456039|580876910|FG002|Phase 1 (First Step)|Other|0|||
160858893|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Disease Progression|0|||
160858894|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Disease Progression|0|||
160858895|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Disease Progression|17|||
160858896|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Adverse Event|0|||
160858897|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Adverse Event|0|||
160858898|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Adverse Event|10|||
160858899|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
160858900|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
160858901|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
160858902|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
160858903|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
160858904|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
160858905|NCT01456039|580876908|FG000|Phase 2 (Second Step)|Other|0|||
160858906|NCT01456039|580876909|FG001|Phase 2 (Second Step)|Other|0|||
160858907|NCT01456039|580876910|FG002|Phase 2 (Second Step)|Other|1|||
160858908|NCT01702311|580876914|FG000|Overall Study|Withdrawal by Subject|3|||
160909195|NCT04545385|581061989|FG001|Overall Study|Sponsor decision|2|||
160909196|NCT04545385|581061988|FG000|Overall Study|Other than specified|1|||
160909197|NCT04545385|581061989|FG001|Overall Study|Other than specified|0|||
160909198|NCT01128842|581061994|FG000|Overall Study|Adverse Event|1|||
160909199|NCT01128842|581061994|FG000|Overall Study|Disease Progression|6|||
160909200|NCT03322631|581061995|FG000|Overall Study|Withdrawal by Subject|0|||
160909201|NCT03322631|581061996|FG001|Overall Study|Withdrawal by Subject|1|||
160909202|NCT03322631|581061997|FG002|Overall Study|Withdrawal by Subject|0|||
160909203|NCT03322631|581061998|FG003|Overall Study|Withdrawal by Subject|0|||
160909204|NCT03322631|581061995|FG000|Overall Study|Adverse Event|0|||
160909205|NCT03322631|581061996|FG001|Overall Study|Adverse Event|0|||
160909206|NCT03322631|581061997|FG002|Overall Study|Adverse Event|1|||
160909207|NCT03322631|581061998|FG003|Overall Study|Adverse Event|0|||
160909208|NCT02378961|581061999|FG000|Overall Study|Lack of Efficacy|4|||
160909209|NCT02378961|581062000|FG001|Overall Study|Lack of Efficacy|2|||
160909210|NCT02378961|581062001|FG002|Overall Study|Lack of Efficacy|0|||
160909211|NCT02378961|581062002|FG003|Overall Study|Lack of Efficacy|1|||
160909212|NCT02378961|581061999|FG000|Overall Study|Death|0|||
160909213|NCT02378961|581062000|FG001|Overall Study|Death|0|||
160909214|NCT02378961|581062001|FG002|Overall Study|Death|1|||
160909215|NCT02378961|581062002|FG003|Overall Study|Death|0|||
160909216|NCT05399641|581062010|FG000|Overall Study|Adverse Event|0|||
160909217|NCT05399641|581062011|FG001|Overall Study|Adverse Event|1|||
160909218|NCT05399641|581062012|FG002|Overall Study|Adverse Event|1|||
160909219|NCT05399641|581062010|FG000|Overall Study|Lost to Follow-up|1|||
160909220|NCT05399641|581062011|FG001|Overall Study|Lost to Follow-up|2|||
160909221|NCT05399641|581062012|FG002|Overall Study|Lost to Follow-up|2|||
160909222|NCT05399641|581062010|FG000|Overall Study|Physician Decision|1|||
160909223|NCT05399641|581062011|FG001|Overall Study|Physician Decision|3|||
160909224|NCT05399641|581062012|FG002|Overall Study|Physician Decision|3|||
160909225|NCT05399641|581062010|FG000|Overall Study|Withdrawal by Subject|4|||
160909226|NCT05399641|581062011|FG001|Overall Study|Withdrawal by Subject|11|||
160909227|NCT05399641|581062012|FG002|Overall Study|Withdrawal by Subject|7|||
160909228|NCT05399641|581062010|FG000|Overall Study|Reason not defined|3|||
160909229|NCT05399641|581062011|FG001|Overall Study|Reason not defined|5|||
160909230|NCT05399641|581062012|FG002|Overall Study|Reason not defined|6|||
160909231|NCT02094677|581062013|FG000|Overall Study|Screening|3|||
160909232|NCT02094677|581062014|FG001|Overall Study|Screening|1|||
160909233|NCT01300650|581062015|FG000|Overall Study|Adverse Event|1|||
160909234|NCT04502693|581062016|FG000|Overall Study|Adverse Event|7|||
160909235|NCT04502693|581062017|FG001|Overall Study|Adverse Event|6|||
160909236|NCT04502693|581062018|FG002|Overall Study|Adverse Event|11|||
160909237|NCT04502693|581062019|FG003|Overall Study|Adverse Event|1|||
161338849|NCT03307174|582630370|FG001|Overall Study|Planned epidural removal|0|||
160858909|NCT01702311|580876915|FG001|Overall Study|Withdrawal by Subject|2|||
160858910|NCT01702311|580876914|FG000|Overall Study|Discharge less than 24 hours|10|||
160858911|NCT01702311|580876915|FG001|Overall Study|Discharge less than 24 hours|7|||
160858912|NCT01702311|580876914|FG000|Overall Study|Physician Decision|3|||
160858913|NCT01702311|580876915|FG001|Overall Study|Physician Decision|4|||
160909238|NCT04502693|581062016|FG000|Overall Study|Lost to Follow-up|32|||
160909239|NCT04502693|581062017|FG001|Overall Study|Lost to Follow-up|36|||
160858914|NCT04106557|580876922|FG000|Overall Study|Physician Decision|0|||
160858915|NCT04106557|580876923|FG001|Overall Study|Physician Decision|1|||
160858916|NCT04106557|580876924|FG002|Overall Study|Physician Decision|0|||
160858917|NCT04106557|580876922|FG000|Overall Study|Protocol Violation|0|||
160858918|NCT04106557|580876923|FG001|Overall Study|Protocol Violation|1|||
160858919|NCT04106557|580876924|FG002|Overall Study|Protocol Violation|0|||
160858920|NCT02326155|580876925|FG000|Overall Study|Adverse Event|21|||
160858921|NCT02326155|580876926|FG001|Overall Study|Adverse Event|5|||
160858922|NCT02326155|580876925|FG000|Overall Study|Death|3|||
160858923|NCT02326155|580876926|FG001|Overall Study|Death|0|||
160858924|NCT02326155|580876925|FG000|Overall Study|Lack of Efficacy|49|||
160858925|NCT02326155|580876926|FG001|Overall Study|Lack of Efficacy|5|||
160858926|NCT02326155|580876925|FG000|Overall Study|Lost to Follow-up|14|||
160858927|NCT02326155|580876926|FG001|Overall Study|Lost to Follow-up|3|||
160858928|NCT02326155|580876925|FG000|Overall Study|Protocol Violation|2|||
160858929|NCT02326155|580876926|FG001|Overall Study|Protocol Violation|0|||
160858930|NCT02326155|580876925|FG000|Overall Study|Withdrawal by Subject|34|||
160858931|NCT02326155|580876926|FG001|Overall Study|Withdrawal by Subject|11|||
160858932|NCT02326155|580876925|FG000|Overall Study|Disease progression|37|||
160858933|NCT02326155|580876926|FG001|Overall Study|Disease progression|4|||
160858934|NCT02326155|580876925|FG000|Overall Study|Study close|188|||
160858935|NCT02326155|580876926|FG001|Overall Study|Study close|21|||
160858936|NCT02326155|580876925|FG000|Overall Study|except for study close|46|||
160858937|NCT02326155|580876926|FG001|Overall Study|except for study close|13|||
160858938|NCT01428258|580876932|FG000|Intervention 1|Withdrawal by Subject|2|||
160858939|NCT01428258|580876933|FG001|Intervention 1|Withdrawal by Subject|0|||
160858940|NCT00419393|580876934|FG000|Overall Study|Adverse Event|5|||
160858941|NCT00419393|580876934|FG000|Overall Study|Protocol Violation|5|||
160858942|NCT00419393|580876934|FG000|Overall Study|Withdrawal by Subject|7|||
160858943|NCT00419393|580876934|FG000|Overall Study|Other: Sponsor request|3|||
160858944|NCT00419393|580876934|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
160858945|NCT00419393|580876934|FG000|Overall Study|Other: Site closure|1|||
160858946|NCT00419393|580876934|FG000|Overall Study|Other: Other health problems|1|||
160858947|NCT00419393|580876934|FG000|Overall Study|Other: Investigator decision|1|||
160858948|NCT01231984|580876939|FG000|Study Period 1|Withdrawal by Subject|0|||
160858949|NCT01231984|580876940|FG001|Study Period 1|Withdrawal by Subject|0|||
160858950|NCT01231984|580876941|FG002|Study Period 1|Withdrawal by Subject|0|||
160858951|NCT01231984|580876942|FG003|Study Period 1|Withdrawal by Subject|1|||
160858952|NCT01231984|580876939|FG000|Study Period 1|Lost to Follow-up|1|||
160858953|NCT01231984|580876940|FG001|Study Period 1|Lost to Follow-up|1|||
160858954|NCT01231984|580876941|FG002|Study Period 1|Lost to Follow-up|1|||
160858955|NCT01231984|580876942|FG003|Study Period 1|Lost to Follow-up|0|||
160858956|NCT01231984|580876939|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858957|NCT01231984|580876940|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858958|NCT01231984|580876941|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858959|NCT01231984|580876942|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
160858960|NCT01231984|580876939|FG000|Study Period 1|Screen Failure|0|||
160858961|NCT01231984|580876940|FG001|Study Period 1|Screen Failure|0|||
160858962|NCT01231984|580876941|FG002|Study Period 1|Screen Failure|0|||
160858963|NCT01231984|580876942|FG003|Study Period 1|Screen Failure|1|||
160858964|NCT01231984|580876939|FG000|Study Period 1|Non-compliance with study requirements|5|||
160858965|NCT01231984|580876940|FG001|Study Period 1|Non-compliance with study requirements|0|||
160858966|NCT01231984|580876941|FG002|Study Period 1|Non-compliance with study requirements|2|||
160858967|NCT01231984|580876942|FG003|Study Period 1|Non-compliance with study requirements|1|||
160858968|NCT01231984|580876939|FG000|Study Period 1|Protocol Violation|3|||
160858969|NCT01231984|580876940|FG001|Study Period 1|Protocol Violation|4|||
160858970|NCT01231984|580876941|FG002|Study Period 1|Protocol Violation|2|||
160858971|NCT01231984|580876942|FG003|Study Period 1|Protocol Violation|3|||
160858972|NCT01231984|580876939|FG000|Study Period 1|Adverse Event|1|||
160858973|NCT01231984|580876940|FG001|Study Period 1|Adverse Event|0|||
160858974|NCT01231984|580876941|FG002|Study Period 1|Adverse Event|0|||
160858975|NCT01231984|580876942|FG003|Study Period 1|Adverse Event|0|||
160858976|NCT01231984|580876939|FG000|Study Period 1|Other|0|||
160858977|NCT01231984|580876940|FG001|Study Period 1|Other|0|||
160858978|NCT01231984|580876941|FG002|Study Period 1|Other|0|||
160858979|NCT01231984|580876942|FG003|Study Period 1|Other|1|||
160858980|NCT01231984|580876939|FG000|Study Period 2|Withdrawal by Subject|1|||
160858981|NCT01231984|580876940|FG001|Study Period 2|Withdrawal by Subject|1|||
160858982|NCT01231984|580876941|FG002|Study Period 2|Withdrawal by Subject|0|||
160858983|NCT01231984|580876942|FG003|Study Period 2|Withdrawal by Subject|0|||
160858984|NCT01231984|580876939|FG000|Study Period 2|Lost to Follow-up|1|||
160858985|NCT01231984|580876940|FG001|Study Period 2|Lost to Follow-up|0|||
160858986|NCT01231984|580876941|FG002|Study Period 2|Lost to Follow-up|0|||
160858987|NCT01231984|580876942|FG003|Study Period 2|Lost to Follow-up|3|||
160858988|NCT01231984|580876939|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
160858989|NCT01231984|580876940|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
160909240|NCT04502693|581062018|FG002|Overall Study|Lost to Follow-up|69|||
160858990|NCT01231984|580876941|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
160858991|NCT01231984|580876942|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
160858992|NCT02939287|580876945|FG000|Overall Study|met exclusion criteria|1|||
160858993|NCT02939287|580876946|FG001|Overall Study|met exclusion criteria|1|||
160858994|NCT02939287|580876947|FG002|Overall Study|met exclusion criteria|1|||
160858995|NCT02939287|580876945|FG000|Overall Study|Did not complete survey|2|||
160858996|NCT02939287|580876946|FG001|Overall Study|Did not complete survey|2|||
160858997|NCT02939287|580876947|FG002|Overall Study|Did not complete survey|0|||
160858998|NCT02939287|580876945|FG000|Overall Study|Withdrawal by Subject|1|||
160858999|NCT02939287|580876946|FG001|Overall Study|Withdrawal by Subject|1|||
160859000|NCT02939287|580876947|FG002|Overall Study|Withdrawal by Subject|0|||
160859001|NCT00333775|580876948|FG000|Overall Study|Death|144|||
160859002|NCT00333775|580876949|FG001|Overall Study|Death|149|||
160859003|NCT00333775|580876950|FG002|Overall Study|Death|143|||
160859004|NCT00333775|580876948|FG000|Overall Study|In Follow-up When Study Stopped|87|||
160859005|NCT00333775|580876949|FG001|Overall Study|In Follow-up When Study Stopped|92|||
160859006|NCT00333775|580876950|FG002|Overall Study|In Follow-up When Study Stopped|96|||
160859007|NCT00333775|580876948|FG000|Overall Study|Lost to Follow-up|10|||
160859008|NCT00333775|580876949|FG001|Overall Study|Lost to Follow-up|7|||
160859009|NCT00333775|580876950|FG002|Overall Study|Lost to Follow-up|8|||
160859010|NCT02476617|580876952|FG000|Overall Study|Adverse Event|1|||
160859011|NCT02476617|580876952|FG000|Overall Study|Lost to Follow-up|1|||
160859012|NCT01383928|580876953|FG000|Overall Study|Initiation of ASCT|2|||
160859013|NCT01383928|580876954|FG001|Overall Study|Initiation of ASCT|1|||
160859014|NCT01383928|580876955|FG002|Overall Study|Initiation of ASCT|18|||
160859015|NCT01383928|580876953|FG000|Overall Study|Adverse Event|1|||
160859016|NCT01383928|580876954|FG001|Overall Study|Adverse Event|2|||
160859017|NCT01383928|580876955|FG002|Overall Study|Adverse Event|8|||
160859018|NCT01383928|580876953|FG000|Overall Study|Other|1|||
160859019|NCT01383928|580876954|FG001|Overall Study|Other|3|||
160859020|NCT01383928|580876955|FG002|Overall Study|Other|4|||
160859021|NCT01383928|580876953|FG000|Overall Study|Progressive Disease|1|||
160859022|NCT01383928|580876954|FG001|Overall Study|Progressive Disease|1|||
160859023|NCT01383928|580876955|FG002|Overall Study|Progressive Disease|5|||
160859024|NCT01383928|580876953|FG000|Overall Study|Withdrawal by Subject|0|||
160859025|NCT01383928|580876954|FG001|Overall Study|Withdrawal by Subject|0|||
160859026|NCT01383928|580876955|FG002|Overall Study|Withdrawal by Subject|4|||
160859027|NCT01383928|580876953|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
160859028|NCT01383928|580876954|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160859029|NCT01383928|580876955|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
160859030|NCT03486912|580876956|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
160859031|NCT03486912|580876957|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
160859032|NCT03486912|580876958|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
160859033|NCT03486912|580876959|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
160859034|NCT03486912|580876956|FG000|Treatment Period|Withdrawal by Subject|3|||
160859035|NCT03486912|580876957|FG001|Treatment Period|Withdrawal by Subject|3|||
160859036|NCT03486912|580876958|FG002|Treatment Period|Withdrawal by Subject|3|||
160859037|NCT03486912|580876959|FG003|Treatment Period|Withdrawal by Subject|2|||
160859038|NCT03486912|580876956|FG000|Treatment Period|Other Reasons|0|||
160859039|NCT03486912|580876957|FG001|Treatment Period|Other Reasons|2|||
160859040|NCT03486912|580876958|FG002|Treatment Period|Other Reasons|1|||
160859041|NCT03486912|580876959|FG003|Treatment Period|Other Reasons|1|||
160859042|NCT03486912|580876956|FG000|Treatment Period|Adverse Event|0|||
160859043|NCT03486912|580876957|FG001|Treatment Period|Adverse Event|1|||
160859044|NCT03486912|580876958|FG002|Treatment Period|Adverse Event|1|||
160859045|NCT03486912|580876959|FG003|Treatment Period|Adverse Event|0|||
160859046|NCT03486912|580876956|FG000|Treatment Period|Lost to Follow-up|1|||
160859047|NCT03486912|580876957|FG001|Treatment Period|Lost to Follow-up|0|||
160859048|NCT03486912|580876958|FG002|Treatment Period|Lost to Follow-up|0|||
160859049|NCT03486912|580876959|FG003|Treatment Period|Lost to Follow-up|2|||
160859050|NCT02491684|580876960|FG000|Treatment Phase|Adverse Event|2|||
160859051|NCT02491684|580876961|FG001|Treatment Phase|Adverse Event|2|||
160859052|NCT02491684|580876960|FG000|Treatment Phase|Incorrect randomisation|1|||
160859053|NCT02491684|580876961|FG001|Treatment Phase|Incorrect randomisation|0|||
160859054|NCT02491684|580876960|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
160859055|NCT02491684|580876961|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
160859056|NCT01499940|580876962|FG000|Overall Study|Study was withdrawn before completion.|9|||
160859057|NCT04739982|580876963|FG000|Overall Study|Lost to Follow-up|176|||
160859058|NCT04739982|580876964|FG001|Overall Study|Lost to Follow-up|65|||
160859059|NCT04739982|580876963|FG000|Overall Study|Withdrawal by Subject|19|||
160859060|NCT04739982|580876964|FG001|Overall Study|Withdrawal by Subject|0|||
160859061|NCT04739982|580876963|FG000|Overall Study|Protocol Violation|0|||
160859062|NCT04739982|580876964|FG001|Overall Study|Protocol Violation|5|||
161141561|NCT04430348|581902516|FG000|Overall Study|Study Terminated by Sponsor|0|||
160859063|NCT04914364|580876966|FG000|Overall Study|No longer eligible for study|1|||
160859064|NCT04914364|580876966|FG000|Overall Study|Lost to Follow-up|2|||
160859065|NCT01283139|580876967|FG000|Overall Study|Lost to Follow-up|5|||
160859066|NCT01283139|580876968|FG001|Overall Study|Lost to Follow-up|2|||
160859067|NCT01283139|580876969|FG002|Overall Study|Lost to Follow-up|3|||
160859068|NCT01283139|580876970|FG003|Overall Study|Lost to Follow-up|1|||
160859069|NCT01283139|580876967|FG000|Overall Study|Withdrawal by Subject|8|||
160859070|NCT01283139|580876968|FG001|Overall Study|Withdrawal by Subject|8|||
160859071|NCT01283139|580876969|FG002|Overall Study|Withdrawal by Subject|6|||
160859072|NCT01283139|580876970|FG003|Overall Study|Withdrawal by Subject|8|||
160859073|NCT01283139|580876967|FG000|Overall Study|Death|2|||
160859074|NCT01283139|580876968|FG001|Overall Study|Death|0|||
160859075|NCT01283139|580876969|FG002|Overall Study|Death|2|||
160859076|NCT01283139|580876970|FG003|Overall Study|Death|2|||
160859077|NCT01283139|580876967|FG000|Overall Study|Lack of Efficacy|1|||
160859078|NCT01283139|580876968|FG001|Overall Study|Lack of Efficacy|2|||
160859079|NCT01283139|580876969|FG002|Overall Study|Lack of Efficacy|2|||
160859080|NCT01283139|580876970|FG003|Overall Study|Lack of Efficacy|1|||
160859081|NCT01283139|580876967|FG000|Overall Study|Early termination due to AE/SAE|1|||
160859082|NCT01283139|580876968|FG001|Overall Study|Early termination due to AE/SAE|1|||
160859083|NCT01283139|580876969|FG002|Overall Study|Early termination due to AE/SAE|0|||
160859084|NCT01283139|580876970|FG003|Overall Study|Early termination due to AE/SAE|0|||
160859085|NCT01283139|580876967|FG000|Overall Study|Participant's refusal to continue|0|||
160859086|NCT01283139|580876968|FG001|Overall Study|Participant's refusal to continue|3|||
160859087|NCT01283139|580876969|FG002|Overall Study|Participant's refusal to continue|1|||
160859088|NCT01283139|580876970|FG003|Overall Study|Participant's refusal to continue|1|||
160859089|NCT01283139|580876967|FG000|Overall Study|Pregnancy|0|||
160859090|NCT01283139|580876968|FG001|Overall Study|Pregnancy|1|||
160859091|NCT01283139|580876969|FG002|Overall Study|Pregnancy|1|||
160859092|NCT01283139|580876970|FG003|Overall Study|Pregnancy|0|||
160859093|NCT01283139|580876967|FG000|Overall Study|Missed follow-up visit|0|||
160859094|NCT01283139|580876968|FG001|Overall Study|Missed follow-up visit|1|||
160859095|NCT01283139|580876969|FG002|Overall Study|Missed follow-up visit|2|||
160859096|NCT01283139|580876970|FG003|Overall Study|Missed follow-up visit|2|||
160859097|NCT01283139|580876967|FG000|Overall Study|Participant randomized in error|0|||
160859098|NCT01283139|580876968|FG001|Overall Study|Participant randomized in error|0|||
160859099|NCT01283139|580876969|FG002|Overall Study|Participant randomized in error|1|||
160859100|NCT01283139|580876970|FG003|Overall Study|Participant randomized in error|0|||
160859101|NCT01844765|580876976|FG000|Overall Study|Adverse Event|6|||
160859102|NCT01844765|580876977|FG001|Overall Study|Adverse Event|8|||
160859103|NCT01844765|580876976|FG000|Overall Study|Withdrawal by Subject|2|||
160859104|NCT01844765|580876977|FG001|Overall Study|Withdrawal by Subject|3|||
160859105|NCT01844765|580876976|FG000|Overall Study|Disease progression|1|||
160859106|NCT01844765|580876977|FG001|Overall Study|Disease progression|0|||
160859107|NCT01844765|580876976|FG000|Overall Study|Administrative problems|3|||
160859108|NCT01844765|580876977|FG001|Overall Study|Administrative problems|4|||
160859109|NCT01844765|580876976|FG000|Overall Study|Protocol deviation|2|||
160859110|NCT01844765|580876977|FG001|Overall Study|Protocol deviation|0|||
160859111|NCT01844765|580876976|FG000|Overall Study|Untreated|1|||
160859112|NCT01844765|580876977|FG001|Overall Study|Untreated|0|||
160859113|NCT02025179|580876978|FG000|Overall Study|Lost to Follow-up|0|||
160859114|NCT02025179|580876979|FG001|Overall Study|Lost to Follow-up|0|||
160859115|NCT02025179|580876980|FG002|Overall Study|Lost to Follow-up|1|||
160859116|NCT00556075|580876981|FG000|Overall Study|Lost to Follow-up|3|||
160859117|NCT00556075|580876982|FG001|Overall Study|Lost to Follow-up|0|||
160859118|NCT00556075|580876983|FG002|Overall Study|Lost to Follow-up|3|||
160859119|NCT00556075|580876981|FG000|Overall Study|Withdrawal by Subject|3|||
160859120|NCT00556075|580876982|FG001|Overall Study|Withdrawal by Subject|3|||
160859121|NCT00556075|580876983|FG002|Overall Study|Withdrawal by Subject|0|||
160859122|NCT00556075|580876981|FG000|Overall Study|Protocol Violation|1|||
160859123|NCT00556075|580876982|FG001|Overall Study|Protocol Violation|1|||
160859124|NCT00556075|580876983|FG002|Overall Study|Protocol Violation|3|||
160859125|NCT00556075|580876981|FG000|Overall Study|Not eligible|1|||
160859126|NCT00556075|580876982|FG001|Overall Study|Not eligible|1|||
160859127|NCT00556075|580876983|FG002|Overall Study|Not eligible|2|||
160859128|NCT00556075|580876981|FG000|Overall Study|Adverse Event|1|||
160859129|NCT00556075|580876982|FG001|Overall Study|Adverse Event|2|||
160859130|NCT00556075|580876983|FG002|Overall Study|Adverse Event|0|||
160859131|NCT00556075|580876981|FG000|Overall Study|Personal issues|4|||
160859132|NCT00556075|580876982|FG001|Overall Study|Personal issues|1|||
160859133|NCT00556075|580876983|FG002|Overall Study|Personal issues|0|||
160859134|NCT00556075|580876981|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
160859135|NCT00556075|580876982|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
160859136|NCT00556075|580876983|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
160859137|NCT00601835|580876984|FG000|Overall Study|Withdrawal by Subject|9|||
160859138|NCT00601835|580876985|FG001|Overall Study|Withdrawal by Subject|6|||
160859139|NCT00601835|580876984|FG000|Overall Study|Physician Decision|1|||
160859140|NCT00601835|580876985|FG001|Overall Study|Physician Decision|0|||
160859141|NCT00601835|580876984|FG000|Overall Study|Lost to Follow-up|37|||
160859142|NCT00601835|580876985|FG001|Overall Study|Lost to Follow-up|5|||
160859143|NCT00601835|580876984|FG000|Overall Study|Adverse Event|1|||
160859144|NCT00601835|580876985|FG001|Overall Study|Adverse Event|1|||
160859145|NCT00601835|580876984|FG000|Overall Study|Relocate|12|||
160859146|NCT00601835|580876985|FG001|Overall Study|Relocate|2|||
160859147|NCT03836625|580876986|FG000|Overall Study|Lost to Follow-up|9|||
160859148|NCT03836625|580876987|FG001|Overall Study|Lost to Follow-up|9|||
160859149|NCT03836625|580876986|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
160859150|NCT03836625|580876987|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
160859151|NCT03836625|580876986|FG000|Overall Study|Death|0|||
160859152|NCT03836625|580876987|FG001|Overall Study|Death|1|||
160859153|NCT03836625|580876986|FG000|Overall Study|Refused follow-up|0|||
160859154|NCT03836625|580876987|FG001|Overall Study|Refused follow-up|1|||
160859155|NCT04764162|580876990|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
160859156|NCT04764162|580876991|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
160859157|NCT03077542|580876996|FG000|Overall Study|Death|4|||
160859158|NCT03077542|580876997|FG001|Overall Study|Death|0|||
160859159|NCT03077542|580876996|FG000|Overall Study|Physician Decision|6|||
160859160|NCT03077542|580876997|FG001|Overall Study|Physician Decision|1|||
160859161|NCT03077542|580876996|FG000|Overall Study|Withdrawal by Subject|0|||
160859162|NCT03077542|580876997|FG001|Overall Study|Withdrawal by Subject|1|||
160859163|NCT00301808|580876998|FG000|Overall Study|Adverse Event|5|||
160859164|NCT00301808|580876998|FG000|Overall Study|Death|3|||
160859165|NCT00301808|580876998|FG000|Overall Study|Lack of Efficacy|4|||
160859166|NCT00844844|580876999|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
160859167|NCT00844844|580876999|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
160859168|NCT00844844|580876999|FG000|Extension Treatment Period|Adverse Event|2|||
160859169|NCT00844844|580876999|FG000|Post Treatment Period|Withdrawal by Subject|1|||
160859170|NCT04886154|580877002|FG000|Overall Study|Adverse Event|0|||
160859171|NCT04886154|580877003|FG001|Overall Study|Adverse Event|0|||
160859172|NCT04886154|580877004|FG002|Overall Study|Adverse Event|0|||
160859173|NCT04886154|580877005|FG003|Overall Study|Adverse Event|0|||
160859174|NCT04886154|580877006|FG004|Overall Study|Adverse Event|1|||
160859175|NCT04886154|580877007|FG005|Overall Study|Adverse Event|0|||
160859176|NCT04886154|580877008|FG006|Overall Study|Adverse Event|0|||
160859177|NCT04886154|580877009|FG007|Overall Study|Adverse Event|1|||
160859178|NCT04886154|580877010|FG008|Overall Study|Adverse Event|1|||
160859179|NCT04886154|580877011|FG009|Overall Study|Adverse Event|0|||
160859180|NCT04886154|580877012|FG010|Overall Study|Adverse Event|0|||
160859181|NCT04886154|580877013|FG011|Overall Study|Adverse Event|1|||
160859182|NCT04886154|580877014|FG012|Overall Study|Adverse Event|0|||
160859183|NCT04886154|580877015|FG013|Overall Study|Adverse Event|0|||
160859184|NCT04886154|580877016|FG014|Overall Study|Adverse Event|3|||
160859185|NCT04886154|580877002|FG000|Overall Study|Lost to Follow-up|1|||
160859186|NCT04886154|580877003|FG001|Overall Study|Lost to Follow-up|0|||
160859187|NCT04886154|580877004|FG002|Overall Study|Lost to Follow-up|2|||
160859188|NCT04886154|580877005|FG003|Overall Study|Lost to Follow-up|0|||
160859189|NCT04886154|580877006|FG004|Overall Study|Lost to Follow-up|17|||
160859190|NCT04886154|580877007|FG005|Overall Study|Lost to Follow-up|7|||
160859191|NCT04886154|580877008|FG006|Overall Study|Lost to Follow-up|8|||
160859192|NCT04886154|580877009|FG007|Overall Study|Lost to Follow-up|7|||
160859193|NCT04886154|580877010|FG008|Overall Study|Lost to Follow-up|8|||
160859194|NCT04886154|580877011|FG009|Overall Study|Lost to Follow-up|0|||
160859195|NCT04886154|580877012|FG010|Overall Study|Lost to Follow-up|2|||
160859196|NCT04886154|580877013|FG011|Overall Study|Lost to Follow-up|0|||
160859197|NCT04886154|580877014|FG012|Overall Study|Lost to Follow-up|0|||
160859198|NCT04886154|580877015|FG013|Overall Study|Lost to Follow-up|0|||
160859199|NCT04886154|580877016|FG014|Overall Study|Lost to Follow-up|0|||
160859200|NCT04886154|580877002|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859201|NCT04886154|580877003|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859202|NCT04886154|580877004|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859203|NCT04886154|580877005|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859204|NCT04886154|580877006|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859205|NCT04886154|580877007|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859206|NCT04886154|580877008|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
160859207|NCT04886154|580877009|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859208|NCT04886154|580877010|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859209|NCT04886154|580877011|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859210|NCT04886154|580877012|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859211|NCT04886154|580877013|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859212|NCT04886154|580877014|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859213|NCT04886154|580877015|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859214|NCT04886154|580877016|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
160859215|NCT04886154|580877002|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859216|NCT04886154|580877003|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859217|NCT04886154|580877004|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859218|NCT04886154|580877005|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859219|NCT04886154|580877006|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160859220|NCT04886154|580877007|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859221|NCT04886154|580877008|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
160859222|NCT04886154|580877009|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160859223|NCT04886154|580877010|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859224|NCT04886154|580877011|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859225|NCT04886154|580877012|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859226|NCT04886154|580877013|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859227|NCT04886154|580877014|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859228|NCT04886154|580877015|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160859229|NCT04886154|580877016|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160859230|NCT04886154|580877002|FG000|Overall Study|Other, Not Specified|0|||
160859231|NCT04886154|580877003|FG001|Overall Study|Other, Not Specified|0|||
160859232|NCT04886154|580877004|FG002|Overall Study|Other, Not Specified|0|||
160859233|NCT04886154|580877005|FG003|Overall Study|Other, Not Specified|0|||
160859234|NCT04886154|580877006|FG004|Overall Study|Other, Not Specified|11|||
160859235|NCT04886154|580877007|FG005|Overall Study|Other, Not Specified|8|||
160859236|NCT04886154|580877008|FG006|Overall Study|Other, Not Specified|9|||
160859237|NCT04886154|580877009|FG007|Overall Study|Other, Not Specified|10|||
160859238|NCT04886154|580877010|FG008|Overall Study|Other, Not Specified|6|||
160859239|NCT04886154|580877011|FG009|Overall Study|Other, Not Specified|1|||
160859240|NCT04886154|580877012|FG010|Overall Study|Other, Not Specified|1|||
160859241|NCT04886154|580877013|FG011|Overall Study|Other, Not Specified|2|||
160859242|NCT04886154|580877014|FG012|Overall Study|Other, Not Specified|1|||
160859243|NCT04886154|580877015|FG013|Overall Study|Other, Not Specified|2|||
160859244|NCT04886154|580877016|FG014|Overall Study|Other, Not Specified|3|||
160859245|NCT03919773|580877025|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
160859246|NCT03919773|580877026|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
160859247|NCT03919773|580877025|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
160859248|NCT03919773|580877026|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
160859249|NCT04659044|580877029|FG000|Induction|Physician Decision|1|||
160859250|NCT04659044|580877029|FG000|Induction|Adverse Event|2|||
160859251|NCT04966013|580877031|FG000|Overall Study|Withdrawal by Subject|0|||
160859252|NCT04966013|580877032|FG001|Overall Study|Withdrawal by Subject|2|||
160859253|NCT04966013|580877033|FG002|Overall Study|Withdrawal by Subject|1|||
160859254|NCT04966013|580877031|FG000|Overall Study|Adverse Event|2|||
160859255|NCT04966013|580877032|FG001|Overall Study|Adverse Event|1|||
160859256|NCT04966013|580877033|FG002|Overall Study|Adverse Event|1|||
160859257|NCT02702492|580877037|FG000|Overall Study|Disease progression|3|||
160859258|NCT02702492|580877038|FG001|Overall Study|Disease progression|3|||
160859259|NCT02702492|580877039|FG002|Overall Study|Disease progression|2|||
160859260|NCT02702492|580877040|FG003|Overall Study|Disease progression|4|||
160859261|NCT02702492|580877041|FG004|Overall Study|Disease progression|4|||
160859262|NCT02702492|580877042|FG005|Overall Study|Disease progression|1|||
160859263|NCT02702492|580877043|FG006|Overall Study|Disease progression|2|||
160859264|NCT02702492|580877044|FG007|Overall Study|Disease progression|8|||
160859265|NCT02702492|580877045|FG008|Overall Study|Disease progression|5|||
160859266|NCT02702492|580877046|FG009|Overall Study|Disease progression|1|||
160909241|NCT04502693|581062019|FG003|Overall Study|Lost to Follow-up|4|||
160909242|NCT04502693|581062016|FG000|Overall Study|Protocol Violation|8|||
160909243|NCT04502693|581062017|FG001|Overall Study|Protocol Violation|8|||
160909244|NCT04502693|581062018|FG002|Overall Study|Protocol Violation|16|||
160909245|NCT04502693|581062019|FG003|Overall Study|Protocol Violation|1|||
160909246|NCT04502693|581062016|FG000|Overall Study|Withdrawal by Subject|46|||
160909247|NCT04502693|581062017|FG001|Overall Study|Withdrawal by Subject|38|||
160909248|NCT04502693|581062018|FG002|Overall Study|Withdrawal by Subject|54|||
160859267|NCT02702492|580877047|FG010|Overall Study|Disease progression|0|||
160859268|NCT02702492|580877048|FG011|Overall Study|Disease progression|3|||
160859269|NCT02702492|580877049|FG012|Overall Study|Disease progression|2|||
160859270|NCT02702492|580877037|FG000|Overall Study|Clinical progression|0|||
160859271|NCT02702492|580877038|FG001|Overall Study|Clinical progression|0|||
160859272|NCT02702492|580877039|FG002|Overall Study|Clinical progression|2|||
160859273|NCT02702492|580877040|FG003|Overall Study|Clinical progression|1|||
160859274|NCT02702492|580877041|FG004|Overall Study|Clinical progression|0|||
160859275|NCT02702492|580877042|FG005|Overall Study|Clinical progression|2|||
160859276|NCT02702492|580877043|FG006|Overall Study|Clinical progression|1|||
160859277|NCT02702492|580877044|FG007|Overall Study|Clinical progression|4|||
160859278|NCT02702492|580877045|FG008|Overall Study|Clinical progression|0|||
160859279|NCT02702492|580877046|FG009|Overall Study|Clinical progression|0|||
160859280|NCT02702492|580877047|FG010|Overall Study|Clinical progression|1|||
160859281|NCT02702492|580877048|FG011|Overall Study|Clinical progression|2|||
160859282|NCT02702492|580877049|FG012|Overall Study|Clinical progression|0|||
160859283|NCT02702492|580877037|FG000|Overall Study|Adverse Event|0|||
160859284|NCT02702492|580877038|FG001|Overall Study|Adverse Event|0|||
160859285|NCT02702492|580877039|FG002|Overall Study|Adverse Event|1|||
160859286|NCT02702492|580877040|FG003|Overall Study|Adverse Event|2|||
160859287|NCT02702492|580877041|FG004|Overall Study|Adverse Event|1|||
160859288|NCT02702492|580877042|FG005|Overall Study|Adverse Event|0|||
160859289|NCT02702492|580877043|FG006|Overall Study|Adverse Event|1|||
160859290|NCT02702492|580877044|FG007|Overall Study|Adverse Event|0|||
160859291|NCT02702492|580877045|FG008|Overall Study|Adverse Event|2|||
160859292|NCT02702492|580877046|FG009|Overall Study|Adverse Event|0|||
160859293|NCT02702492|580877047|FG010|Overall Study|Adverse Event|0|||
160859294|NCT02702492|580877048|FG011|Overall Study|Adverse Event|0|||
160859295|NCT02702492|580877049|FG012|Overall Study|Adverse Event|1|||
160859296|NCT02702492|580877037|FG000|Overall Study|Other|0|||
160859297|NCT02702492|580877038|FG001|Overall Study|Other|0|||
160859298|NCT02702492|580877039|FG002|Overall Study|Other|0|||
160859299|NCT02702492|580877040|FG003|Overall Study|Other|0|||
160859300|NCT02702492|580877041|FG004|Overall Study|Other|0|||
160859301|NCT02702492|580877042|FG005|Overall Study|Other|0|||
160859302|NCT02702492|580877043|FG006|Overall Study|Other|0|||
160859303|NCT02702492|580877044|FG007|Overall Study|Other|0|||
160859304|NCT02702492|580877045|FG008|Overall Study|Other|0|||
160859305|NCT02702492|580877046|FG009|Overall Study|Other|0|||
160859306|NCT02702492|580877047|FG010|Overall Study|Other|0|||
160859307|NCT02702492|580877048|FG011|Overall Study|Other|0|||
160859308|NCT02702492|580877049|FG012|Overall Study|Other|1|||
160859309|NCT01910298|580877050|FG000|Overall Study|Adverse Event|1|||
160859310|NCT01910298|580877051|FG001|Overall Study|Adverse Event|0|||
160859311|NCT01910298|580877050|FG000|Overall Study|Withdrawal by Subject|2|||
160859312|NCT01910298|580877051|FG001|Overall Study|Withdrawal by Subject|7|||
160859313|NCT01910298|580877050|FG000|Overall Study|Protocol Deviation|0|||
160859314|NCT01910298|580877051|FG001|Overall Study|Protocol Deviation|5|||
160859315|NCT01910298|580877050|FG000|Overall Study|Lost to Follow-up|1|||
160859316|NCT01910298|580877051|FG001|Overall Study|Lost to Follow-up|1|||
160859317|NCT01910298|580877050|FG000|Overall Study|Study Terminated by Sponsor|1|||
160859318|NCT01910298|580877051|FG001|Overall Study|Study Terminated by Sponsor|17|||
160859319|NCT01910298|580877050|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160909249|NCT04502693|581062019|FG003|Overall Study|Withdrawal by Subject|7|||
160909250|NCT04502693|581062016|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
160909251|NCT04502693|581062017|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
160909252|NCT04502693|581062018|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
160909253|NCT04502693|581062019|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160909254|NCT04502693|581062016|FG000|Overall Study|Other|1|||
161338850|NCT03307174|582630369|FG000|Overall Study|Intrathecal catheter placement|0|||
161338851|NCT03307174|582630370|FG001|Overall Study|Intrathecal catheter placement|1|||
161338852|NCT05911841|582630371|FG000|Induction Period|Study Terminated by Sponsor|2|||
161338853|NCT05911841|582630372|FG001|Induction Period|Study Terminated by Sponsor|0|||
161338854|NCT05911841|582630373|FG002|Induction Period|Study Terminated by Sponsor|14|||
161338855|NCT05911841|582630374|FG003|Induction Period|Study Terminated by Sponsor|6|||
161338856|NCT05911841|582630375|FG004|Induction Period|Study Terminated by Sponsor|0|||
161338857|NCT05911841|582630376|FG005|Induction Period|Study Terminated by Sponsor|0|||
161338858|NCT05911841|582630377|FG006|Induction Period|Study Terminated by Sponsor|0|||
161338859|NCT05911841|582630378|FG007|Induction Period|Study Terminated by Sponsor|0|||
161338860|NCT05911841|582630379|FG008|Induction Period|Study Terminated by Sponsor|0|||
161338861|NCT05911841|582630380|FG009|Induction Period|Study Terminated by Sponsor|0|||
161338862|NCT05911841|582630371|FG000|Induction Period|Withdrawal by Subject|4|||
161338863|NCT05911841|582630372|FG001|Induction Period|Withdrawal by Subject|3|||
161338864|NCT05911841|582630373|FG002|Induction Period|Withdrawal by Subject|4|||
161338865|NCT05911841|582630374|FG003|Induction Period|Withdrawal by Subject|6|||
161338866|NCT05911841|582630375|FG004|Induction Period|Withdrawal by Subject|0|||
161338867|NCT05911841|582630376|FG005|Induction Period|Withdrawal by Subject|0|||
161338868|NCT05911841|582630377|FG006|Induction Period|Withdrawal by Subject|0|||
161338869|NCT05911841|582630378|FG007|Induction Period|Withdrawal by Subject|0|||
161338870|NCT05911841|582630379|FG008|Induction Period|Withdrawal by Subject|0|||
161338871|NCT05911841|582630380|FG009|Induction Period|Withdrawal by Subject|0|||
161338872|NCT05911841|582630371|FG000|Induction Period|Lack of Efficacy|3|||
160859320|NCT01910298|580877051|FG001|Overall Study|Other Miscellaneous Reasons|2|||
160859321|NCT00781768|580878736|FG000|Overall Study|Not transplanted.|0|||
160859322|NCT00781768|580878737|FG001|Overall Study|Not transplanted.|2|||
160859323|NCT02458313|580878740|FG000|Overall Study|Withdrawal by Subject|6|||
160859324|NCT02458313|580878741|FG001|Overall Study|Withdrawal by Subject|8|||
160859325|NCT02458313|580878740|FG000|Overall Study|Excluded for motion during MRI|1|||
160859326|NCT02458313|580878741|FG001|Overall Study|Excluded for motion during MRI|2|||
160859327|NCT00199381|580878742|FG000|Overall Study|Withdrawal by Subject|38|||
160859328|NCT00199381|580878742|FG000|Overall Study|Adverse Event|73|||
160859329|NCT00199381|580878742|FG000|Overall Study|Protocol Violation|6|||
160859330|NCT00199381|580878742|FG000|Overall Study|Lack of Efficacy|27|||
160859331|NCT00199381|580878742|FG000|Overall Study|Not including due to early termination|37|||
160859332|NCT00199381|580878742|FG000|Overall Study|Study termination by Sponsor|323|||
161338873|NCT05911841|582630372|FG001|Induction Period|Lack of Efficacy|0|||
161338874|NCT05911841|582630373|FG002|Induction Period|Lack of Efficacy|3|||
161338875|NCT05911841|582630374|FG003|Induction Period|Lack of Efficacy|3|||
161338876|NCT05911841|582630375|FG004|Induction Period|Lack of Efficacy|0|||
161338877|NCT05911841|582630376|FG005|Induction Period|Lack of Efficacy|0|||
161338878|NCT05911841|582630377|FG006|Induction Period|Lack of Efficacy|0|||
161338879|NCT05911841|582630378|FG007|Induction Period|Lack of Efficacy|0|||
161338880|NCT05911841|582630379|FG008|Induction Period|Lack of Efficacy|0|||
161338881|NCT05911841|582630380|FG009|Induction Period|Lack of Efficacy|0|||
161141562|NCT04430348|581902517|FG001|Overall Study|Study Terminated by Sponsor|0|||
161338882|NCT05911841|582630371|FG000|Induction Period|Adverse Event|3|||
161338883|NCT05911841|582630372|FG001|Induction Period|Adverse Event|1|||
161338884|NCT05911841|582630373|FG002|Induction Period|Adverse Event|2|||
161338885|NCT05911841|582630374|FG003|Induction Period|Adverse Event|0|||
161338886|NCT05911841|582630375|FG004|Induction Period|Adverse Event|0|||
161338887|NCT05911841|582630376|FG005|Induction Period|Adverse Event|0|||
161338888|NCT05911841|582630377|FG006|Induction Period|Adverse Event|0|||
161338889|NCT05911841|582630378|FG007|Induction Period|Adverse Event|0|||
161338890|NCT05911841|582630379|FG008|Induction Period|Adverse Event|0|||
161338891|NCT05911841|582630380|FG009|Induction Period|Adverse Event|0|||
161338892|NCT05911841|582630371|FG000|Induction Period|Assigned Treatment by Mistake|0|||
161338893|NCT05911841|582630372|FG001|Induction Period|Assigned Treatment by Mistake|1|||
161338894|NCT05911841|582630373|FG002|Induction Period|Assigned Treatment by Mistake|0|||
161338895|NCT05911841|582630374|FG003|Induction Period|Assigned Treatment by Mistake|1|||
161338896|NCT05911841|582630375|FG004|Induction Period|Assigned Treatment by Mistake|0|||
161338897|NCT05911841|582630376|FG005|Induction Period|Assigned Treatment by Mistake|0|||
161338898|NCT05911841|582630377|FG006|Induction Period|Assigned Treatment by Mistake|0|||
161338899|NCT05911841|582630378|FG007|Induction Period|Assigned Treatment by Mistake|0|||
161338900|NCT05911841|582630379|FG008|Induction Period|Assigned Treatment by Mistake|0|||
161338901|NCT05911841|582630380|FG009|Induction Period|Assigned Treatment by Mistake|0|||
161338902|NCT05911841|582630371|FG000|Induction Period|Lost to Follow-up|0|||
161338903|NCT05911841|582630372|FG001|Induction Period|Lost to Follow-up|0|||
161338904|NCT05911841|582630373|FG002|Induction Period|Lost to Follow-up|1|||
161338905|NCT05911841|582630374|FG003|Induction Period|Lost to Follow-up|1|||
161338906|NCT05911841|582630375|FG004|Induction Period|Lost to Follow-up|0|||
161338907|NCT05911841|582630376|FG005|Induction Period|Lost to Follow-up|0|||
161338908|NCT05911841|582630377|FG006|Induction Period|Lost to Follow-up|0|||
161338909|NCT05911841|582630378|FG007|Induction Period|Lost to Follow-up|0|||
161338910|NCT05911841|582630379|FG008|Induction Period|Lost to Follow-up|0|||
161338911|NCT05911841|582630380|FG009|Induction Period|Lost to Follow-up|0|||
161338912|NCT05911841|582630371|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
161338913|NCT05911841|582630372|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
161338914|NCT05911841|582630373|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
161338915|NCT05911841|582630374|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
161338916|NCT05911841|582630375|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
161338917|NCT05911841|582630376|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
161338918|NCT05911841|582630377|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
161338919|NCT05911841|582630378|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
161338920|NCT05911841|582630379|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
161338921|NCT05911841|582630380|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
161338922|NCT05911841|582630371|FG000|Maintenance Period|Lack of Efficacy|0|||
161338923|NCT05911841|582630372|FG001|Maintenance Period|Lack of Efficacy|0|||
161338924|NCT05911841|582630373|FG002|Maintenance Period|Lack of Efficacy|0|||
161338925|NCT05911841|582630374|FG003|Maintenance Period|Lack of Efficacy|0|||
161338926|NCT05911841|582630375|FG004|Maintenance Period|Lack of Efficacy|1|||
161338927|NCT05911841|582630376|FG005|Maintenance Period|Lack of Efficacy|0|||
161338928|NCT05911841|582630377|FG006|Maintenance Period|Lack of Efficacy|1|||
161338929|NCT05911841|582630378|FG007|Maintenance Period|Lack of Efficacy|0|||
161338930|NCT05911841|582630379|FG008|Maintenance Period|Lack of Efficacy|0|||
161338931|NCT05911841|582630380|FG009|Maintenance Period|Lack of Efficacy|0|||
161338932|NCT05911841|582630371|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
161338933|NCT05911841|582630372|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
161338934|NCT05911841|582630373|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
161141563|NCT04430348|581902518|FG002|Overall Study|Study Terminated by Sponsor|2|||
161141564|NCT04430348|581902519|FG003|Overall Study|Study Terminated by Sponsor|0|||
161141565|NCT04430348|581902520|FG004|Overall Study|Study Terminated by Sponsor|1|||
161141566|NCT04430348|581902521|FG005|Overall Study|Study Terminated by Sponsor|1|||
161141567|NCT05408858|581902522|FG000|Overall Study|no longer met eligibility criteria|1|||
161338935|NCT05911841|582630374|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
161338936|NCT05911841|582630375|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
161338937|NCT05911841|582630376|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
161338938|NCT05911841|582630377|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
161338939|NCT05911841|582630378|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
161338940|NCT05911841|582630379|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
161338941|NCT05911841|582630380|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
161141568|NCT04899271|581902526|FG000|Overall Study|Lost to Follow-up|1|||
161141569|NCT04899271|581902527|FG001|Overall Study|Lost to Follow-up|0|||
161141570|NCT04899271|581902526|FG000|Overall Study|Subject request/consent withdrawal|2|||
161141571|NCT04899271|581902527|FG001|Overall Study|Subject request/consent withdrawal|0|||
161141572|NCT02318602|581902528|FG000|Overall Study|Adverse Event|0|||
161141573|NCT02318602|581902529|FG001|Overall Study|Adverse Event|1|||
161141574|NCT02318602|581902530|FG002|Overall Study|Adverse Event|1|||
161141575|NCT02318602|581902528|FG000|Overall Study|Withdrawal by Subject|0|||
160859347|NCT00751296|580878745|FG000|Overall Study|Adverse Event|2|||
160859348|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
160859349|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
160859350|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
160859351|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
160859352|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
160859353|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
160859354|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
160859355|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
160859356|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
160859357|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
160859358|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
160859359|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
160859360|NCT01972217|580878746|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
160859361|NCT01972217|580878747|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
160859362|NCT01972217|580878748|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
160859363|NCT01972217|580878749|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
160859364|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Death|0|||
160859365|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Death|0|||
160859366|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Death|43|||
160859367|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Death|44|||
160859368|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
160859369|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
160859370|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
160859371|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
160859372|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
160859373|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
160859374|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
160859375|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
160859376|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
160859377|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
160859378|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
160859379|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
160859380|NCT01972217|580878746|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
160859381|NCT01972217|580878747|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
160859382|NCT01972217|580878748|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
160859383|NCT01972217|580878749|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
160859384|NCT00313014|580878753|FG000|Overall Study|Withdrawal by Subject|11|||
160859385|NCT00313014|580878754|FG001|Overall Study|Withdrawal by Subject|7|||
160859386|NCT00313014|580878755|FG002|Overall Study|Withdrawal by Subject|5|||
160859387|NCT00313014|580878753|FG000|Overall Study|Adverse Event|14|||
160859388|NCT00313014|580878754|FG001|Overall Study|Adverse Event|29|||
160859389|NCT00313014|580878755|FG002|Overall Study|Adverse Event|16|||
160859390|NCT00313014|580878753|FG000|Overall Study|Lost to Follow-up|7|||
160859391|NCT00313014|580878754|FG001|Overall Study|Lost to Follow-up|6|||
160859392|NCT00313014|580878755|FG002|Overall Study|Lost to Follow-up|10|||
160859393|NCT00313014|580878753|FG000|Overall Study|Administrative|9|||
160859394|NCT00313014|580878754|FG001|Overall Study|Administrative|6|||
160859395|NCT00313014|580878755|FG002|Overall Study|Administrative|14|||
160909255|NCT04502693|581062017|FG001|Overall Study|Other|0|||
160909256|NCT04502693|581062018|FG002|Overall Study|Other|1|||
160909257|NCT04502693|581062019|FG003|Overall Study|Other|1|||
160909258|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
160909259|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
160909260|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
160859396|NCT00313014|580878753|FG000|Overall Study|Lack of Efficacy|52|||
160859397|NCT00313014|580878754|FG001|Overall Study|Lack of Efficacy|25|||
160859398|NCT00313014|580878755|FG002|Overall Study|Lack of Efficacy|16|||
160859399|NCT03714672|580878756|FG000|Overall Study|Adverse Event|0|||
160859400|NCT03714672|580878757|FG001|Overall Study|Adverse Event|0|||
160859401|NCT03714672|580878758|FG002|Overall Study|Adverse Event|3|||
160909261|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
160909262|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
160909263|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
160909264|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
160909265|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
160909266|NCT03943147|581062020|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
160859402|NCT03714672|580878759|FG003|Overall Study|Adverse Event|0|||
160859403|NCT03714672|580878756|FG000|Overall Study|Physician Decision|0|||
160859404|NCT03714672|580878757|FG001|Overall Study|Physician Decision|1|||
160859405|NCT03714672|580878758|FG002|Overall Study|Physician Decision|0|||
160859406|NCT03714672|580878759|FG003|Overall Study|Physician Decision|0|||
160859407|NCT03714672|580878756|FG000|Overall Study|Other Reason|1|||
160859408|NCT03714672|580878757|FG001|Overall Study|Other Reason|2|||
160859409|NCT03714672|580878758|FG002|Overall Study|Other Reason|1|||
160859410|NCT03714672|580878759|FG003|Overall Study|Other Reason|1|||
160859411|NCT03714672|580878756|FG000|Overall Study|Lost to Follow-up|1|||
160859412|NCT03714672|580878757|FG001|Overall Study|Lost to Follow-up|1|||
160859413|NCT03714672|580878758|FG002|Overall Study|Lost to Follow-up|0|||
160859414|NCT03714672|580878759|FG003|Overall Study|Lost to Follow-up|0|||
160859415|NCT01074502|580878760|FG000|Overall Study|Withdrawal by Subject|1|||
160859416|NCT00674817|580878768|FG000|Period 1|Withdrawal by Subject|2|||
160859417|NCT00674817|580878768|FG000|Period 1|Protocol Violation|1|||
160859418|NCT00674817|580878768|FG000|Period 3|Adverse Event|1|||
160859419|NCT00674817|580878768|FG000|Period 3|Protocol Violation|1|||
160859420|NCT00674817|580878768|FG000|Period 4|Adverse Event|1|||
160859421|NCT04945733|580878771|FG000|Overall Study|Physician Decision|1|||
160859422|NCT04945733|580878772|FG001|Overall Study|Physician Decision|3|||
160859423|NCT04945733|580878773|FG002|Overall Study|Physician Decision|0|||
160859424|NCT04945733|580878771|FG000|Overall Study|Withdrawal by Subject|3|||
160859425|NCT04945733|580878772|FG001|Overall Study|Withdrawal by Subject|3|||
160859426|NCT04945733|580878773|FG002|Overall Study|Withdrawal by Subject|0|||
160859427|NCT03566511|580878780|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
160859428|NCT03566511|580878781|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
160859429|NCT00499486|580878783|FG000|Overall Study|Withdrawal by Subject|16|||
160859430|NCT03796728|580878785|FG000|Overall Study|Lost to Follow-up|8|||
160859431|NCT03796728|580878785|FG000|Overall Study|Reason not Specified|16|||
160859432|NCT05236270|580878786|FG000|Overall Study|Lost to Follow-up|3|||
160859433|NCT05236270|580878787|FG001|Overall Study|Lost to Follow-up|2|||
160859434|NCT05236270|580878788|FG002|Overall Study|Lost to Follow-up|0|||
160859435|NCT05236270|580878789|FG003|Overall Study|Lost to Follow-up|0|||
160859436|NCT05236270|580878790|FG004|Overall Study|Lost to Follow-up|2|||
160859437|NCT05236270|580878791|FG005|Overall Study|Lost to Follow-up|0|||
160859438|NCT05236270|580878792|FG006|Overall Study|Lost to Follow-up|1|||
160859439|NCT05236270|580878793|FG007|Overall Study|Lost to Follow-up|3|||
160859440|NCT01149096|580878794|FG000|Overall Study|Lost to Follow-up|0|||
160859441|NCT01149096|580878795|FG001|Overall Study|Lost to Follow-up|1|||
160859442|NCT03651765|580878797|FG000|Overall Study|Adverse Event|6|||
160859443|NCT03651765|580878797|FG000|Overall Study|Lack of Efficacy|18|||
160859444|NCT03651765|580878797|FG000|Overall Study|Lost to Follow-up|5|||
160859445|NCT03651765|580878797|FG000|Overall Study|Non-Compliance with Study Drug|4|||
160859446|NCT03651765|580878797|FG000|Overall Study|Physician Decision|6|||
160859447|NCT03651765|580878797|FG000|Overall Study|Pregnancy|1|||
160859448|NCT03651765|580878797|FG000|Overall Study|Discontinued by Sponsor|40|||
160859449|NCT03651765|580878797|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
160859450|NCT03651765|580878797|FG000|Overall Study|Withdrawal by Subject|24|||
160859451|NCT03651765|580878797|FG000|Overall Study|Miscellaneous|6|||
160859452|NCT01263769|580878800|FG000|Overall Study|Non-Compliant with treatment|1|||
160859453|NCT03267277|580878801|FG000|Overall Study|Withdrawal by Subject|1|||
160859454|NCT01346358|580878802|FG000|Overall Study|Withdrawal by Subject|1|||
160859455|NCT01346358|580878803|FG001|Overall Study|Withdrawal by Subject|0|||
160859456|NCT01346358|580878804|FG002|Overall Study|Withdrawal by Subject|1|||
160859457|NCT01346358|580878805|FG003|Overall Study|Withdrawal by Subject|1|||
160859458|NCT01346358|580878806|FG004|Overall Study|Withdrawal by Subject|0|||
160859459|NCT01346358|580878807|FG005|Overall Study|Withdrawal by Subject|2|||
160859460|NCT01346358|580878808|FG006|Overall Study|Withdrawal by Subject|1|||
160859461|NCT01346358|580878809|FG007|Overall Study|Withdrawal by Subject|1|||
160859462|NCT01346358|580878810|FG008|Overall Study|Withdrawal by Subject|1|||
160859463|NCT01346358|580878802|FG000|Overall Study|Adverse Event|1|||
160859464|NCT01346358|580878803|FG001|Overall Study|Adverse Event|0|||
160859465|NCT01346358|580878804|FG002|Overall Study|Adverse Event|0|||
160859466|NCT01346358|580878805|FG003|Overall Study|Adverse Event|0|||
160859467|NCT01346358|580878806|FG004|Overall Study|Adverse Event|1|||
160859468|NCT01346358|580878807|FG005|Overall Study|Adverse Event|0|||
160859469|NCT01346358|580878808|FG006|Overall Study|Adverse Event|0|||
160859470|NCT01346358|580878809|FG007|Overall Study|Adverse Event|0|||
160859471|NCT01346358|580878810|FG008|Overall Study|Adverse Event|1|||
160859472|NCT01346358|580878802|FG000|Overall Study|Non-Compliance|0|||
161256278|NCT00373425|582316411|FG003|Overall Study|Adverse Event|0|||
160859473|NCT01346358|580878803|FG001|Overall Study|Non-Compliance|0|||
160859474|NCT01346358|580878804|FG002|Overall Study|Non-Compliance|0|||
160859475|NCT01346358|580878805|FG003|Overall Study|Non-Compliance|0|||
160859476|NCT01346358|580878806|FG004|Overall Study|Non-Compliance|0|||
160859477|NCT01346358|580878807|FG005|Overall Study|Non-Compliance|0|||
160859478|NCT01346358|580878808|FG006|Overall Study|Non-Compliance|0|||
160859479|NCT01346358|580878809|FG007|Overall Study|Non-Compliance|2|||
160859480|NCT01346358|580878810|FG008|Overall Study|Non-Compliance|0|||
160859481|NCT01346358|580878802|FG000|Overall Study|Physician Decision|0|||
160859482|NCT01346358|580878803|FG001|Overall Study|Physician Decision|1|||
160859483|NCT01346358|580878804|FG002|Overall Study|Physician Decision|0|||
160859484|NCT01346358|580878805|FG003|Overall Study|Physician Decision|0|||
160859485|NCT01346358|580878806|FG004|Overall Study|Physician Decision|0|||
160859486|NCT01346358|580878807|FG005|Overall Study|Physician Decision|0|||
160859487|NCT01346358|580878808|FG006|Overall Study|Physician Decision|0|||
160859488|NCT01346358|580878809|FG007|Overall Study|Physician Decision|1|||
160859489|NCT01346358|580878810|FG008|Overall Study|Physician Decision|1|||
160859490|NCT05058365|580878813|FG000|Overall Study|Migration|1|||
160859491|NCT05058365|580878814|FG001|Overall Study|Migration|1|||
160859492|NCT00702702|580878815|FG000|Overall Study|Study prematurely terminated|56|||
160859493|NCT00468169|580878816|FG000|Overall Study|Withdrawal by Subject|1|||
160859494|NCT00468169|580878817|FG001|Overall Study|Withdrawal by Subject|0|||
160859495|NCT01126749|580878822|FG000|Phase 1b|Other|0|||
160859496|NCT01126749|580878823|FG001|Phase 1b|Other|1|||
160859497|NCT01126749|580878824|FG002|Phase 1b|Other|0|||
160859498|NCT01126749|580878825|FG003|Phase 1b|Other|0|||
160859499|NCT01126749|580878822|FG000|Phase 1b|Withdrawal by Subject|0|||
160859500|NCT01126749|580878823|FG001|Phase 1b|Withdrawal by Subject|1|||
160859501|NCT01126749|580878824|FG002|Phase 1b|Withdrawal by Subject|0|||
160859502|NCT01126749|580878825|FG003|Phase 1b|Withdrawal by Subject|0|||
160859503|NCT01126749|580878822|FG000|Phase 1b|Death|3|||
160859504|NCT01126749|580878823|FG001|Phase 1b|Death|4|||
160859505|NCT01126749|580878824|FG002|Phase 1b|Death|0|||
160859506|NCT01126749|580878825|FG003|Phase 1b|Death|0|||
160859507|NCT01126749|580878822|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
160859508|NCT01126749|580878823|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
160859509|NCT01126749|580878824|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
160859510|NCT01126749|580878825|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
160859511|NCT01126749|580878822|FG000|Phase 2|Study Termination by Sponsor|0|||
160859512|NCT01126749|580878823|FG001|Phase 2|Study Termination by Sponsor|0|||
160859513|NCT01126749|580878824|FG002|Phase 2|Study Termination by Sponsor|12|||
160859514|NCT01126749|580878825|FG003|Phase 2|Study Termination by Sponsor|6|||
160859515|NCT01126749|580878822|FG000|Phase 2|Other|0|||
160859516|NCT01126749|580878823|FG001|Phase 2|Other|0|||
160859517|NCT01126749|580878824|FG002|Phase 2|Other|4|||
160859518|NCT01126749|580878825|FG003|Phase 2|Other|2|||
160859519|NCT01126749|580878822|FG000|Phase 2|Withdrawal by Subject|0|||
160859520|NCT01126749|580878823|FG001|Phase 2|Withdrawal by Subject|0|||
160859521|NCT01126749|580878824|FG002|Phase 2|Withdrawal by Subject|0|||
160859522|NCT01126749|580878825|FG003|Phase 2|Withdrawal by Subject|2|||
160859523|NCT01126749|580878822|FG000|Phase 2|Lost to Follow-up|0|||
160859524|NCT01126749|580878823|FG001|Phase 2|Lost to Follow-up|0|||
160859525|NCT01126749|580878824|FG002|Phase 2|Lost to Follow-up|0|||
160859526|NCT01126749|580878825|FG003|Phase 2|Lost to Follow-up|1|||
160859527|NCT01126749|580878822|FG000|Phase 2|Death|0|||
160859528|NCT01126749|580878823|FG001|Phase 2|Death|0|||
160859529|NCT01126749|580878824|FG002|Phase 2|Death|22|||
160859530|NCT01126749|580878825|FG003|Phase 2|Death|22|||
161256279|NCT00373425|582316412|FG004|Overall Study|Adverse Event|34|||
160859531|NCT01126749|580878822|FG000|Phase 2|Adverse Event|0|||
160909267|NCT03943147|581062021|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
160909268|NCT03943147|581062020|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
160909269|NCT03943147|581062021|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
160909270|NCT01318993|581062022|FG000|Overall Study|Adverse Event|53|||
160909271|NCT01318993|581062022|FG000|Overall Study|Lack of Efficacy|121|||
161256280|NCT00373425|582316408|FG000|Overall Study|Patient request|35|||
161256281|NCT00373425|582316409|FG001|Overall Study|Patient request|18|||
160859532|NCT01126749|580878823|FG001|Phase 2|Adverse Event|0|||
160859533|NCT01126749|580878824|FG002|Phase 2|Adverse Event|0|||
160859534|NCT01126749|580878825|FG003|Phase 2|Adverse Event|1|||
160859535|NCT03668873|580878826|FG000|Overall Study|Lost to Follow-up|6|||
160859536|NCT03668873|580878827|FG001|Overall Study|Lost to Follow-up|3|||
160859537|NCT02183675|580878828|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859538|NCT02183675|580878829|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859539|NCT02183675|580878830|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859540|NCT02183675|580878831|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859541|NCT02183675|580878832|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
160859542|NCT02183675|580878833|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
160859543|NCT01521117|580878834|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
160909272|NCT01318993|581062022|FG000|Overall Study|Protocol Violation|3|||
161141576|NCT02318602|581902529|FG001|Overall Study|Withdrawal by Subject|3|||
161141577|NCT02318602|581902530|FG002|Overall Study|Withdrawal by Subject|0|||
160859544|NCT01521117|580878835|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
160859545|NCT01521117|580878834|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
160859546|NCT01521117|580878835|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
160859547|NCT01521117|580878834|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160859548|NCT01521117|580878835|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
160859549|NCT00784563|580878838|FG000|Years 1 & 2|Withdrawal by Subject|3|||
160859550|NCT00784563|580878839|FG001|Years 1 & 2|Withdrawal by Subject|2|||
160859551|NCT00784563|580878840|FG002|Years 1 & 2|Withdrawal by Subject|0|||
160859552|NCT00784563|580878838|FG000|Years 1 & 2|Adverse Event|0|||
160859553|NCT00784563|580878839|FG001|Years 1 & 2|Adverse Event|3|||
160859554|NCT00784563|580878840|FG002|Years 1 & 2|Adverse Event|0|||
160859555|NCT00784563|580878838|FG000|Year 3|Withdrawal by Subject|0|||
160859556|NCT00784563|580878839|FG001|Year 3|Withdrawal by Subject|0|||
160859557|NCT00784563|580878840|FG002|Year 3|Withdrawal by Subject|2|||
160859558|NCT00784563|580878838|FG000|Year 3|Adverse Event|0|||
160859559|NCT00784563|580878839|FG001|Year 3|Adverse Event|0|||
160859560|NCT00784563|580878840|FG002|Year 3|Adverse Event|1|||
160859561|NCT00762164|580878841|FG000|Overall Study|Lost to Follow-up|1|||
160859562|NCT00762164|580878842|FG001|Overall Study|Lost to Follow-up|1|||
160859563|NCT00762164|580878841|FG000|Overall Study|Discontinued medication|2|||
160859564|NCT00762164|580878842|FG001|Overall Study|Discontinued medication|0|||
160859565|NCT00762164|580878841|FG000|Overall Study|Withdrawal by Subject|0|||
160859566|NCT00762164|580878842|FG001|Overall Study|Withdrawal by Subject|1|||
160859567|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
160859568|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
160859569|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
160859570|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
160859571|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
160859572|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
160859573|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
160859574|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
160859575|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
160859576|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
160859577|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
160859578|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
160859579|NCT02657889|580878847|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
160859580|NCT02657889|580878848|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
160859581|NCT02657889|580878849|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
160859582|NCT02657889|580878850|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
160859583|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
160859584|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
160859585|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
160859586|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
160859587|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
160859588|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
160859589|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
160859590|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
160859591|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
160859592|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
160859593|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
160859594|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
160859595|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
160859596|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
160859597|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
160859598|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
160859599|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
160859600|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
160859601|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
160859602|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
160859603|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
160859604|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
160909273|NCT01318993|581062022|FG000|Overall Study|Protocol based stopping criteria|6|||
160909274|NCT01318993|581062022|FG000|Overall Study|Study closed or terminated|174|||
161141578|NCT02318602|581902528|FG000|Overall Study|Death|1|||
161141579|NCT02318602|581902529|FG001|Overall Study|Death|0|||
161141580|NCT02318602|581902530|FG002|Overall Study|Death|0|||
161141581|NCT02318602|581902528|FG000|Overall Study|Guardian decision to withdraw|0|||
161141582|NCT02318602|581902529|FG001|Overall Study|Guardian decision to withdraw|0|||
160909275|NCT01318993|581062022|FG000|Overall Study|Lost to Follow-up|4|||
160909276|NCT01318993|581062022|FG000|Overall Study|Physician Decision|13|||
160909277|NCT01318993|581062022|FG000|Overall Study|Withdrawal by Subject|24|||
160909278|NCT03736447|581062026|FG000|Overall Study|Adverse Event|5|||
160909279|NCT03736447|581062027|FG001|Overall Study|Adverse Event|1|||
160909280|NCT03736447|581062026|FG000|Overall Study|Withdrawal by Subject|5|||
160909281|NCT03736447|581062027|FG001|Overall Study|Withdrawal by Subject|1|||
160909282|NCT03736447|581062026|FG000|Overall Study|Lost to Follow-up|1|||
160909283|NCT03736447|581062027|FG001|Overall Study|Lost to Follow-up|0|||
160909284|NCT03736447|581062026|FG000|Overall Study|Physician Decision|1|||
160909285|NCT03736447|581062027|FG001|Overall Study|Physician Decision|0|||
160909286|NCT03736447|581062026|FG000|Overall Study|Continued commitment to study treatment|3|||
160909287|NCT03736447|581062027|FG001|Overall Study|Continued commitment to study treatment|0|||
160909288|NCT03736447|581062026|FG000|Overall Study|Taste aversion to study product|0|||
160909289|NCT03736447|581062027|FG001|Overall Study|Taste aversion to study product|1|||
160909290|NCT02619175|581062029|FG000|Overall Study|Withdrawal by Subject|1|||
160909291|NCT02619175|581062030|FG001|Overall Study|Withdrawal by Subject|0|||
160909292|NCT02619175|581062029|FG000|Overall Study|foot pain|1|||
160909293|NCT02619175|581062030|FG001|Overall Study|foot pain|0|||
160909294|NCT02795832|581062034|FG000|Overall Study|Adverse Event|0|||
160909295|NCT02795832|581062035|FG001|Overall Study|Adverse Event|0|||
160994457|NCT03598790|581368946|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994458|NCT03598790|581368947|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994459|NCT03598790|581368948|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994460|NCT03598790|581368949|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
160994461|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994462|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
160994463|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994464|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994465|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994466|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994467|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994468|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994469|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994470|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994471|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
160994472|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
160994473|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
160994474|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994475|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994476|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994477|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994478|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994479|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994480|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994481|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994482|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
160994483|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
160994484|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
160994485|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994486|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994487|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994488|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994489|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994490|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994491|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994492|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
160994493|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
161256282|NCT00373425|582316410|FG002|Overall Study|Patient request|43|||
160909296|NCT02795832|581062036|FG002|Overall Study|Adverse Event|0|||
160909297|NCT02795832|581062037|FG003|Overall Study|Adverse Event|0|||
160909298|NCT02795832|581062038|FG004|Overall Study|Adverse Event|0|||
160909299|NCT02795832|581062039|FG005|Overall Study|Adverse Event|3|||
160909300|NCT02695329|581062040|FG000|Overall Study|Adverse Event|1|||
160909301|NCT02695329|581062041|FG001|Overall Study|Adverse Event|0|||
160909302|NCT02695329|581062040|FG000|Overall Study|Poor X-ray quality for measurement|4|||
160909303|NCT02695329|581062041|FG001|Overall Study|Poor X-ray quality for measurement|5|||
160909304|NCT01382212|581062042|FG000|Overall Study|Kidney transplant|1|||
160909305|NCT01382212|581062042|FG000|Overall Study|Withdrew consent|1|||
160909306|NCT00393029|581062043|FG000|Overall Study|Not treated|0|||
160859605|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
160859606|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
160859607|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
161141583|NCT02318602|581902530|FG002|Overall Study|Guardian decision to withdraw|1|||
161141584|NCT00693706|581902531|FG000|Overall Study|Protocol Violation|0|||
161141585|NCT00693706|581902532|FG001|Overall Study|Protocol Violation|1|||
161141586|NCT01733329|581902533|FG000|Overall Study|Protocol Violation|1|||
161141587|NCT01733329|581902534|FG001|Overall Study|Protocol Violation|1|||
161141588|NCT01733329|581902533|FG000|Overall Study|Uterine artery injury|1|||
160994494|NCT03410992|581368951|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
160994495|NCT03410992|581368952|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994496|NCT03410992|581368953|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994497|NCT03410992|581368954|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160859608|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
160859609|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
160859610|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
160859611|NCT02657889|580878847|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
160859612|NCT02657889|580878848|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
160859613|NCT02657889|580878849|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
160859614|NCT02657889|580878850|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
160859615|NCT00685165|580878851|FG000|Washout Period of 14 Days|Adverse Event|1|||
160859616|NCT00685165|580878852|FG001|Washout Period of 14 Days|Adverse Event|0|||
160859617|NCT03155724|580878854|FG000|Overall Study|Death|3|||
160859618|NCT03155724|580878854|FG000|Overall Study|Physician Decision|1|||
160859619|NCT03155724|580878854|FG000|Overall Study|Study closure|7|||
160859620|NCT00321789|580878863|FG000|Overall Study|Lost to Follow-up|4|||
160859621|NCT00321789|580878864|FG001|Overall Study|Lost to Follow-up|7|||
160859622|NCT00321789|580878863|FG000|Overall Study|Withdrawal by Subject|6|||
160859623|NCT00321789|580878864|FG001|Overall Study|Withdrawal by Subject|6|||
160994498|NCT03410992|581368955|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994499|NCT03410992|581368956|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994500|NCT03410992|581368957|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994501|NCT03410992|581368958|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994502|NCT03410992|581368959|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994503|NCT03410992|581368960|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994504|NCT03410992|581368961|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
160994505|NCT03410992|581368951|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
160994506|NCT03410992|581368952|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
160994507|NCT03410992|581368953|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994508|NCT03410992|581368954|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994509|NCT03410992|581368955|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994510|NCT03410992|581368956|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994511|NCT03410992|581368957|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994512|NCT03410992|581368958|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994513|NCT03410992|581368959|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994514|NCT03410992|581368960|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994515|NCT03410992|581368961|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
160994516|NCT03410992|581368951|FG000|Week 16 Assessment|Incorrect escapers|0|||
160859624|NCT00321789|580878863|FG000|Overall Study|Protocol Violation|5|||
160859625|NCT00321789|580878864|FG001|Overall Study|Protocol Violation|3|||
160994517|NCT03410992|581368952|FG001|Week 16 Assessment|Incorrect escapers|6|||
161141589|NCT01733329|581902534|FG001|Overall Study|Uterine artery injury|0|||
161141590|NCT00730236|581902535|FG000|Overall Study|Adverse Event|4|||
160859626|NCT03050801|580878865|FG000|Experiment 1|Lost to Follow-up|0|||
160859627|NCT03050801|580878866|FG001|Experiment 1|Lost to Follow-up|1|||
160859628|NCT03050801|580878867|FG002|Experiment 1|Lost to Follow-up|0|||
160859629|NCT03050801|580878868|FG003|Experiment 1|Lost to Follow-up|0|||
160859630|NCT03050801|580878869|FG004|Experiment 1|Lost to Follow-up|0|||
160859631|NCT03050801|580878870|FG005|Experiment 1|Lost to Follow-up|0|||
160859632|NCT03050801|580878865|FG000|Experiment 1|Physician Decision|0|||
160859633|NCT03050801|580878866|FG001|Experiment 1|Physician Decision|3|||
160859634|NCT03050801|580878867|FG002|Experiment 1|Physician Decision|0|||
160859635|NCT03050801|580878868|FG003|Experiment 1|Physician Decision|0|||
160859636|NCT03050801|580878869|FG004|Experiment 1|Physician Decision|0|||
160859637|NCT03050801|580878870|FG005|Experiment 1|Physician Decision|0|||
161141591|NCT00730236|581902535|FG000|Overall Study|Withdrawal by Subject|1|||
161141592|NCT00730236|581902535|FG000|Overall Study|Non-compliance|1|||
160859638|NCT03050801|580878865|FG000|Experiment 1|Change of experimental design|0|||
160859639|NCT03050801|580878866|FG001|Experiment 1|Change of experimental design|3|||
161141593|NCT00542828|581902536|FG000|Overall Study|Physician Decision|1|||
161141594|NCT00542828|581902536|FG000|Overall Study|Need for Prohibited Treatment|3|||
161338942|NCT05911841|582630371|FG000|Maintenance Period|Withdrawal by Subject|0|||
161338943|NCT05911841|582630372|FG001|Maintenance Period|Withdrawal by Subject|0|||
161338944|NCT05911841|582630373|FG002|Maintenance Period|Withdrawal by Subject|0|||
161338945|NCT05911841|582630374|FG003|Maintenance Period|Withdrawal by Subject|0|||
161338946|NCT05911841|582630375|FG004|Maintenance Period|Withdrawal by Subject|0|||
161338947|NCT05911841|582630376|FG005|Maintenance Period|Withdrawal by Subject|1|||
161338948|NCT05911841|582630377|FG006|Maintenance Period|Withdrawal by Subject|0|||
161338949|NCT05911841|582630378|FG007|Maintenance Period|Withdrawal by Subject|1|||
161338950|NCT05911841|582630379|FG008|Maintenance Period|Withdrawal by Subject|0|||
161338951|NCT05911841|582630380|FG009|Maintenance Period|Withdrawal by Subject|0|||
161338952|NCT05911841|582630371|FG000|Maintenance Period|Adverse Event|0|||
161338953|NCT05911841|582630372|FG001|Maintenance Period|Adverse Event|0|||
161338954|NCT05911841|582630373|FG002|Maintenance Period|Adverse Event|0|||
161338955|NCT05911841|582630374|FG003|Maintenance Period|Adverse Event|0|||
161338956|NCT05911841|582630375|FG004|Maintenance Period|Adverse Event|0|||
161338957|NCT05911841|582630376|FG005|Maintenance Period|Adverse Event|0|||
161338958|NCT05911841|582630377|FG006|Maintenance Period|Adverse Event|0|||
161338959|NCT05911841|582630378|FG007|Maintenance Period|Adverse Event|1|||
161338960|NCT05911841|582630379|FG008|Maintenance Period|Adverse Event|0|||
161338961|NCT05911841|582630380|FG009|Maintenance Period|Adverse Event|0|||
161338962|NCT05911841|582630371|FG000|Escape Period|Adverse Event|0|||
161338963|NCT05911841|582630372|FG001|Escape Period|Adverse Event|0|||
160859640|NCT03050801|580878867|FG002|Experiment 1|Change of experimental design|0|||
160859641|NCT03050801|580878868|FG003|Experiment 1|Change of experimental design|0|||
160994518|NCT03410992|581368953|FG002|Week 16 Assessment|Incorrect escapers|0|||
160994519|NCT03410992|581368954|FG003|Week 16 Assessment|Incorrect escapers|0|||
160859642|NCT03050801|580878869|FG004|Experiment 1|Change of experimental design|0|||
160859643|NCT03050801|580878870|FG005|Experiment 1|Change of experimental design|0|||
160859644|NCT03050801|580878865|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
160994520|NCT03410992|581368955|FG004|Week 16 Assessment|Incorrect escapers|0|||
160994521|NCT03410992|581368956|FG005|Week 16 Assessment|Incorrect escapers|0|||
160994522|NCT03410992|581368957|FG006|Week 16 Assessment|Incorrect escapers|0|||
160994523|NCT03410992|581368958|FG007|Week 16 Assessment|Incorrect escapers|0|||
160859645|NCT03050801|580878866|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859646|NCT03050801|580878867|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
160859647|NCT03050801|580878868|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859648|NCT03050801|580878869|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859649|NCT03050801|580878870|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
160859650|NCT03050801|580878865|FG000|Experiment 2|Lost to Follow-up|0|||
160859651|NCT03050801|580878866|FG001|Experiment 2|Lost to Follow-up|0|||
160859652|NCT03050801|580878867|FG002|Experiment 2|Lost to Follow-up|0|||
160859653|NCT03050801|580878868|FG003|Experiment 2|Lost to Follow-up|1|||
160859654|NCT03050801|580878869|FG004|Experiment 2|Lost to Follow-up|1|||
160859655|NCT03050801|580878870|FG005|Experiment 2|Lost to Follow-up|0|||
160859656|NCT03050801|580878865|FG000|Experiment 2|Physician Decision|0|||
160859657|NCT03050801|580878866|FG001|Experiment 2|Physician Decision|0|||
160859658|NCT03050801|580878867|FG002|Experiment 2|Physician Decision|0|||
160859659|NCT03050801|580878868|FG003|Experiment 2|Physician Decision|0|||
160859660|NCT03050801|580878869|FG004|Experiment 2|Physician Decision|1|||
160859661|NCT03050801|580878870|FG005|Experiment 2|Physician Decision|0|||
160859662|NCT03050801|580878865|FG000|Experiment 2|Pregnancy|0|||
160859663|NCT03050801|580878866|FG001|Experiment 2|Pregnancy|0|||
160859664|NCT03050801|580878867|FG002|Experiment 2|Pregnancy|0|||
160859665|NCT03050801|580878868|FG003|Experiment 2|Pregnancy|0|||
160859666|NCT03050801|580878869|FG004|Experiment 2|Pregnancy|1|||
160859667|NCT03050801|580878870|FG005|Experiment 2|Pregnancy|0|||
160859668|NCT03050801|580878865|FG000|Experiment 2|Withdrawal by Subject|0|||
160859669|NCT03050801|580878866|FG001|Experiment 2|Withdrawal by Subject|0|||
160859670|NCT03050801|580878867|FG002|Experiment 2|Withdrawal by Subject|0|||
160859671|NCT03050801|580878868|FG003|Experiment 2|Withdrawal by Subject|1|||
160859672|NCT03050801|580878869|FG004|Experiment 2|Withdrawal by Subject|0|||
160859673|NCT03050801|580878870|FG005|Experiment 2|Withdrawal by Subject|0|||
160859674|NCT03050801|580878865|FG000|Experiment 2|Poor data quality|0|||
160859675|NCT03050801|580878866|FG001|Experiment 2|Poor data quality|0|||
160859676|NCT03050801|580878867|FG002|Experiment 2|Poor data quality|0|||
160859677|NCT03050801|580878868|FG003|Experiment 2|Poor data quality|4|||
160859678|NCT03050801|580878869|FG004|Experiment 2|Poor data quality|1|||
160859679|NCT03050801|580878870|FG005|Experiment 2|Poor data quality|0|||
160859680|NCT03050801|580878865|FG000|Experiment 2|Discomfort during stimulation|0|||
160994524|NCT03410992|581368959|FG008|Week 16 Assessment|Incorrect escapers|0|||
161338964|NCT05911841|582630373|FG002|Escape Period|Adverse Event|0|||
161338965|NCT05911841|582630374|FG003|Escape Period|Adverse Event|0|||
161338966|NCT05911841|582630375|FG004|Escape Period|Adverse Event|0|||
161338967|NCT05911841|582630376|FG005|Escape Period|Adverse Event|0|||
161338968|NCT05911841|582630377|FG006|Escape Period|Adverse Event|0|||
161338969|NCT05911841|582630378|FG007|Escape Period|Adverse Event|0|||
160859681|NCT03050801|580878866|FG001|Experiment 2|Discomfort during stimulation|0|||
160859682|NCT03050801|580878867|FG002|Experiment 2|Discomfort during stimulation|0|||
160859683|NCT03050801|580878868|FG003|Experiment 2|Discomfort during stimulation|0|||
160859684|NCT03050801|580878869|FG004|Experiment 2|Discomfort during stimulation|0|||
160859685|NCT03050801|580878870|FG005|Experiment 2|Discomfort during stimulation|2|||
160859686|NCT01576341|580878871|FG000|Overall Study|Withdrawal by Subject|24|||
160859687|NCT01576341|580878871|FG000|Overall Study|Adverse Event|10|||
160859688|NCT01576341|580878871|FG000|Overall Study|Death|21|||
160859689|NCT01576341|580878871|FG000|Overall Study|Physician Decision|2|||
160859690|NCT01576341|580878871|FG000|Overall Study|Lost to Follow-up|2|||
160859691|NCT01576341|580878871|FG000|Overall Study|Kidney transplantation|10|||
160859692|NCT01576341|580878871|FG000|Overall Study|Protocol Violation|12|||
160859693|NCT01576341|580878871|FG000|Overall Study|Other|12|||
160859694|NCT00617734|580878872|FG000|Overall Study|Withdrew Consent|2|||
160859695|NCT00617734|580878873|FG001|Overall Study|Withdrew Consent|0|||
160859696|NCT00617734|580878872|FG000|Overall Study|Adverse Event|4|||
160859697|NCT00617734|580878873|FG001|Overall Study|Adverse Event|1|||
160859698|NCT00617734|580878872|FG000|Overall Study|Protocol Violation|1|||
160859699|NCT00617734|580878873|FG001|Overall Study|Protocol Violation|0|||
160859700|NCT00617734|580878872|FG000|Overall Study|Found Ineligible After Randomization|1|||
160859701|NCT00617734|580878873|FG001|Overall Study|Found Ineligible After Randomization|4|||
160909307|NCT00393029|581062044|FG001|Overall Study|Not treated|1|||
160909308|NCT00039130|581062046|FG000|Overall Study|Adverse Event|11|||
160909309|NCT00039130|581062046|FG000|Overall Study|Death|9|||
160909310|NCT00039130|581062046|FG000|Overall Study|Withdrawal by Subject|3|||
160909311|NCT00039130|581062046|FG000|Overall Study|Progression|2|||
160909312|NCT00039130|581062046|FG000|Overall Study|Subsequent treatment|2|||
160909313|NCT00039130|581062046|FG000|Overall Study|Physician Decision|3|||
160909314|NCT01269463|581062047|FG000|First Intervention|Withdrawal by Subject|1|||
160909315|NCT01269463|581062048|FG001|First Intervention|Withdrawal by Subject|0|||
160909316|NCT01269463|581062047|FG000|First Intervention|Adverse Event|1|||
160909317|NCT01269463|581062048|FG001|First Intervention|Adverse Event|0|||
160909318|NCT01269463|581062047|FG000|First Intervention|Lack of Efficacy|0|||
160909319|NCT01269463|581062048|FG001|First Intervention|Lack of Efficacy|1|||
160909320|NCT01269463|581062047|FG000|First Intervention|Physician Decision|0|||
160909321|NCT01269463|581062048|FG001|First Intervention|Physician Decision|1|||
160909322|NCT00279305|581062049|FG000|Overall Study|Pregnancy|1|||
160909323|NCT00279305|581062050|FG001|Overall Study|Pregnancy|0|||
160909324|NCT00279305|581062049|FG000|Overall Study|Withdrawal by Subject|2|||
160909325|NCT00279305|581062050|FG001|Overall Study|Withdrawal by Subject|0|||
160909326|NCT00279305|581062049|FG000|Overall Study|Dificulting establishing IV|1|||
160909327|NCT00279305|581062050|FG001|Overall Study|Dificulting establishing IV|0|||
160909328|NCT00279305|581062049|FG000|Overall Study|FDA Safety Alert|4|||
160909329|NCT00279305|581062050|FG001|Overall Study|FDA Safety Alert|1|||
160909330|NCT04404361|581062052|FG000|Overall Study|Death|12|||
160909331|NCT04404361|581062053|FG001|Overall Study|Death|12|||
160909332|NCT04404361|581062052|FG000|Overall Study|Withdrawal by Subject|13|||
160909333|NCT04404361|581062053|FG001|Overall Study|Withdrawal by Subject|5|||
160909334|NCT04404361|581062052|FG000|Overall Study|Lost to Follow-up|6|||
160909335|NCT04404361|581062053|FG001|Overall Study|Lost to Follow-up|3|||
160909336|NCT04404361|581062052|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
160909337|NCT04404361|581062053|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
160909338|NCT02612727|581062055|FG000|Overall Study|Parent request|4|||
160909339|NCT02612727|581062056|FG001|Overall Study|Parent request|1|||
160909340|NCT02612727|581062055|FG000|Overall Study|Needed treatment incompatible with PT|1|||
160909341|NCT02612727|581062056|FG001|Overall Study|Needed treatment incompatible with PT|1|||
160909342|NCT02612727|581062055|FG000|Overall Study|Direct hyperbilirubinemia|0|||
160909343|NCT02612727|581062056|FG001|Overall Study|Direct hyperbilirubinemia|2|||
160909344|NCT01638546|581062067|FG000|Overall Study|Adverse Event|1|||
160909345|NCT01638546|581062068|FG001|Overall Study|Adverse Event|3|||
160909346|NCT00540514|581063909|FG000|Overall Study|Still on treatment|3|||
160909347|NCT00540514|581063910|FG001|Overall Study|Still on treatment|0|||
160909348|NCT00540514|581063909|FG000|Overall Study|Unacceptable Toxicity|61|||
160909349|NCT00540514|581063910|FG001|Overall Study|Unacceptable Toxicity|62|||
160909350|NCT00540514|581063909|FG000|Overall Study|Adverse Event|20|||
160859702|NCT00617734|580878872|FG000|Overall Study|Lost to Follow-up|0|||
160859703|NCT00617734|580878873|FG001|Overall Study|Lost to Follow-up|1|||
160859704|NCT02485691|580878874|FG000|Overall Study|Adverse Event|25|||
160859705|NCT02485691|580878875|FG001|Overall Study|Adverse Event|11|||
160859706|NCT02485691|580878874|FG000|Overall Study|Poor compliance to protocol|0|||
160909351|NCT00540514|581063910|FG001|Overall Study|Adverse Event|24|||
160909352|NCT00540514|581063909|FG000|Overall Study|Physician Decision|86|||
160909353|NCT00540514|581063910|FG001|Overall Study|Physician Decision|99|||
160909354|NCT00540514|581063909|FG000|Overall Study|Protocol Deviation|3|||
160909355|NCT00540514|581063910|FG001|Overall Study|Protocol Deviation|4|||
160909356|NCT00540514|581063909|FG000|Overall Study|Lost to Follow-up|1|||
160909357|NCT00540514|581063910|FG001|Overall Study|Lost to Follow-up|1|||
160909358|NCT00540514|581063909|FG000|Overall Study|Withdrawal by Subject|65|||
160909359|NCT00540514|581063910|FG001|Overall Study|Withdrawal by Subject|67|||
160859707|NCT02485691|580878875|FG001|Overall Study|Poor compliance to protocol|1|||
160859708|NCT02485691|580878874|FG000|Overall Study|Disease progression|57|||
160859709|NCT02485691|580878875|FG001|Overall Study|Disease progression|92|||
160859710|NCT02485691|580878874|FG000|Overall Study|Investigator's decision|23|||
160859711|NCT02485691|580878875|FG001|Overall Study|Investigator's decision|5|||
160859712|NCT02485691|580878874|FG000|Overall Study|Participant's request|13|||
160859713|NCT02485691|580878875|FG001|Overall Study|Participant's request|6|||
160859714|NCT02485691|580878874|FG000|Overall Study|Other reason|8|||
160859715|NCT02485691|580878875|FG001|Overall Study|Other reason|9|||
160859716|NCT02485691|580878874|FG000|Overall Study|Randomized and not treated|3|||
160859717|NCT02485691|580878875|FG001|Overall Study|Randomized and not treated|2|||
160859718|NCT04292535|580878876|FG000|Overall Study|Withdrawal by Subject|0|||
160859719|NCT04292535|580878877|FG001|Overall Study|Withdrawal by Subject|0|||
160859720|NCT04292535|580878878|FG002|Overall Study|Withdrawal by Subject|0|||
160859721|NCT04292535|580878879|FG003|Overall Study|Withdrawal by Subject|0|||
160859722|NCT04292535|580878880|FG004|Overall Study|Withdrawal by Subject|0|||
160859723|NCT04292535|580878881|FG005|Overall Study|Withdrawal by Subject|0|||
160859724|NCT04292535|580878882|FG006|Overall Study|Withdrawal by Subject|0|||
160859725|NCT04292535|580878883|FG007|Overall Study|Withdrawal by Subject|1|||
160859726|NCT04292535|580878884|FG008|Overall Study|Withdrawal by Subject|0|||
160859727|NCT04292535|580878885|FG009|Overall Study|Withdrawal by Subject|0|||
160859728|NCT04292535|580878886|FG010|Overall Study|Withdrawal by Subject|0|||
160859729|NCT04292535|580878887|FG011|Overall Study|Withdrawal by Subject|0|||
160859730|NCT04292535|580878888|FG012|Overall Study|Withdrawal by Subject|0|||
160859731|NCT04292535|580878889|FG013|Overall Study|Withdrawal by Subject|0|||
160859732|NCT04292535|580878876|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859733|NCT04292535|580878877|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859734|NCT04292535|580878878|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859735|NCT04292535|580878879|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859736|NCT04292535|580878880|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859737|NCT04292535|580878881|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859738|NCT04292535|580878882|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859739|NCT04292535|580878883|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
160859740|NCT04292535|580878884|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859741|NCT04292535|580878885|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859742|NCT04292535|580878886|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859743|NCT04292535|580878887|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
160859744|NCT04292535|580878888|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
160859745|NCT04292535|580878889|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
160859746|NCT04292535|580878876|FG000|Overall Study|Report of Dizziness|0|||
160859747|NCT04292535|580878877|FG001|Overall Study|Report of Dizziness|0|||
160859748|NCT04292535|580878878|FG002|Overall Study|Report of Dizziness|0|||
160859749|NCT04292535|580878879|FG003|Overall Study|Report of Dizziness|0|||
160859750|NCT04292535|580878880|FG004|Overall Study|Report of Dizziness|0|||
160859751|NCT04292535|580878881|FG005|Overall Study|Report of Dizziness|0|||
160859752|NCT04292535|580878882|FG006|Overall Study|Report of Dizziness|0|||
160859753|NCT04292535|580878883|FG007|Overall Study|Report of Dizziness|0|||
160859754|NCT04292535|580878884|FG008|Overall Study|Report of Dizziness|0|||
160859755|NCT04292535|580878885|FG009|Overall Study|Report of Dizziness|0|||
160859756|NCT04292535|580878886|FG010|Overall Study|Report of Dizziness|0|||
160859757|NCT04292535|580878887|FG011|Overall Study|Report of Dizziness|0|||
160859758|NCT04292535|580878888|FG012|Overall Study|Report of Dizziness|0|||
160859759|NCT04292535|580878889|FG013|Overall Study|Report of Dizziness|1|||
160859760|NCT04292535|580878876|FG000|Overall Study|Equipment Failure|0|||
160859761|NCT04292535|580878877|FG001|Overall Study|Equipment Failure|0|||
160859762|NCT04292535|580878878|FG002|Overall Study|Equipment Failure|0|||
160859763|NCT04292535|580878879|FG003|Overall Study|Equipment Failure|0|||
160859764|NCT04292535|580878880|FG004|Overall Study|Equipment Failure|0|||
160859765|NCT04292535|580878881|FG005|Overall Study|Equipment Failure|0|||
160859766|NCT04292535|580878882|FG006|Overall Study|Equipment Failure|0|||
160859767|NCT04292535|580878883|FG007|Overall Study|Equipment Failure|0|||
160859768|NCT04292535|580878884|FG008|Overall Study|Equipment Failure|0|||
160859769|NCT04292535|580878885|FG009|Overall Study|Equipment Failure|0|||
160859770|NCT04292535|580878886|FG010|Overall Study|Equipment Failure|0|||
160859771|NCT04292535|580878887|FG011|Overall Study|Equipment Failure|1|||
161141595|NCT00542828|581902536|FG000|Overall Study|Study Prematurely Discontinued|7|||
160859772|NCT04292535|580878888|FG012|Overall Study|Equipment Failure|0|||
161141596|NCT00542828|581902536|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
160859773|NCT04292535|580878889|FG013|Overall Study|Equipment Failure|0|||
160859774|NCT01420861|580878890|FG000|Overall Study|Adverse Event|2|||
160859775|NCT01420861|580878890|FG000|Overall Study|Study terminated by Sponsor|7|||
160859776|NCT01420861|580878890|FG000|Overall Study|Screen failure|7|||
160859777|NCT01420861|580878890|FG000|Overall Study|Randomized not Treated|2|||
160859778|NCT03361137|580878891|FG000|Overall Study|Reason not specified|1|||
160859779|NCT03361137|580878892|FG001|Overall Study|Reason not specified|0|||
160859780|NCT03361137|580878893|FG002|Overall Study|Reason not specified|0|||
160859781|NCT03361137|580878894|FG003|Overall Study|Reason not specified|0|||
160859782|NCT03361137|580878895|FG004|Overall Study|Reason not specified|0|||
160859783|NCT00791934|580878896|FG000|Overall Study|Withdrawal by Subject|2|||
160859784|NCT00791934|580878896|FG000|Overall Study|Did not consent for extended follow-up|13|||
160859785|NCT03413891|580878898|FG000|Overall Study|Lost to Follow-up|2|||
160859786|NCT03413891|580878899|FG001|Overall Study|Lost to Follow-up|1|||
160859787|NCT03413891|580878898|FG000|Overall Study|Protocol Violation|0|||
160859788|NCT03413891|580878899|FG001|Overall Study|Protocol Violation|1|||
160859789|NCT04905134|580878900|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
160859790|NCT04905134|580878900|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
160859791|NCT03009058|580878901|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
160859792|NCT05556265|580878902|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859793|NCT05556265|580878903|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
160859794|NCT05556265|580878904|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859795|NCT05556265|580878905|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859796|NCT05556265|580878906|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
160859797|NCT05556265|580878902|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859798|NCT05556265|580878903|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
160859799|NCT05556265|580878904|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859800|NCT05556265|580878905|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859801|NCT05556265|580878906|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
160859802|NCT05556265|580878902|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859803|NCT05556265|580878903|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
160859804|NCT05556265|580878904|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859805|NCT05556265|580878905|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859806|NCT05556265|580878906|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
160859807|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
160859808|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
160859809|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
160859810|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
160859811|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
160859812|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
160859813|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
160859814|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
160859815|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
160859816|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
160859817|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
160859818|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
160859819|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
160859820|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
160859821|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
160859822|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
160859823|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
160859824|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
160859825|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
160859826|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
160859827|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
160859828|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
160859829|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
160859830|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
160859831|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
160909360|NCT00540514|581063909|FG000|Overall Study|Excluded prior to treatment|7|||
160909361|NCT00540514|581063910|FG001|Overall Study|Excluded prior to treatment|7|||
160909362|NCT00540514|581063909|FG000|Overall Study|Paclitaxel not available|0|||
160909363|NCT00540514|581063910|FG001|Overall Study|Paclitaxel not available|2|||
160909364|NCT01892293|581063921|FG000|Overall Study|Apheresed but not treated|4|||
161256283|NCT00373425|582316411|FG003|Overall Study|Patient request|6|||
161256284|NCT00373425|582316412|FG004|Overall Study|Patient request|7|||
161256285|NCT00373425|582316408|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
161256286|NCT00373425|582316409|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
161256287|NCT00373425|582316410|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
161256288|NCT00373425|582316411|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
161338970|NCT05911841|582630379|FG008|Escape Period|Adverse Event|0|||
161338971|NCT05911841|582630380|FG009|Escape Period|Adverse Event|1|||
161338972|NCT05911841|582630371|FG000|Escape Period|Lack of Efficacy|0|||
161338973|NCT05911841|582630372|FG001|Escape Period|Lack of Efficacy|0|||
161338974|NCT05911841|582630373|FG002|Escape Period|Lack of Efficacy|0|||
161338975|NCT05911841|582630374|FG003|Escape Period|Lack of Efficacy|0|||
160859832|NCT05556265|580878902|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
160859833|NCT05556265|580878903|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
161338976|NCT05911841|582630375|FG004|Escape Period|Lack of Efficacy|0|||
161338977|NCT05911841|582630376|FG005|Escape Period|Lack of Efficacy|0|||
160859834|NCT05556265|580878904|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
160859835|NCT05556265|580878905|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
160859836|NCT05556265|580878906|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
160859837|NCT00079417|580880553|FG000|Overall Study|Physician Decision|2|||
161338978|NCT05911841|582630377|FG006|Escape Period|Lack of Efficacy|0|||
161338979|NCT05911841|582630378|FG007|Escape Period|Lack of Efficacy|0|||
161338980|NCT05911841|582630379|FG008|Escape Period|Lack of Efficacy|0|||
161338981|NCT05911841|582630380|FG009|Escape Period|Lack of Efficacy|31|||
161338982|NCT05911841|582630371|FG000|Escape Period|Lost to Follow-up|0|||
161338983|NCT05911841|582630372|FG001|Escape Period|Lost to Follow-up|0|||
161338984|NCT05911841|582630373|FG002|Escape Period|Lost to Follow-up|0|||
161338985|NCT05911841|582630374|FG003|Escape Period|Lost to Follow-up|0|||
161338986|NCT05911841|582630375|FG004|Escape Period|Lost to Follow-up|0|||
161338987|NCT05911841|582630376|FG005|Escape Period|Lost to Follow-up|0|||
161338988|NCT05911841|582630377|FG006|Escape Period|Lost to Follow-up|0|||
161338989|NCT05911841|582630378|FG007|Escape Period|Lost to Follow-up|0|||
161338990|NCT05911841|582630379|FG008|Escape Period|Lost to Follow-up|0|||
161338991|NCT05911841|582630380|FG009|Escape Period|Lost to Follow-up|1|||
161338992|NCT05911841|582630371|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338993|NCT05911841|582630372|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338994|NCT05911841|582630373|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338995|NCT05911841|582630374|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338996|NCT05911841|582630375|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338997|NCT05911841|582630376|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338998|NCT05911841|582630377|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161338999|NCT05911841|582630378|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161339000|NCT05911841|582630379|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
161339001|NCT05911841|582630380|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
161339002|NCT05911841|582630371|FG000|Escape Period|Site Terminated by Sponsor|0|||
161339003|NCT05911841|582630372|FG001|Escape Period|Site Terminated by Sponsor|0|||
161339004|NCT05911841|582630373|FG002|Escape Period|Site Terminated by Sponsor|0|||
161339005|NCT05911841|582630374|FG003|Escape Period|Site Terminated by Sponsor|0|||
161339006|NCT05911841|582630375|FG004|Escape Period|Site Terminated by Sponsor|0|||
160859838|NCT00079417|580880553|FG000|Overall Study|Ineligible|7|||
160859839|NCT05366738|580880554|FG000|Overall Study|Adverse Event|0|||
160859840|NCT05366738|580880555|FG001|Overall Study|Adverse Event|1|||
160859841|NCT05366738|580880556|FG002|Overall Study|Adverse Event|0|||
160859842|NCT05024032|580880557|FG000|Overall Study|Withdrawal by Subject|0|||
160859843|NCT05024032|580880558|FG001|Overall Study|Withdrawal by Subject|3|||
160859844|NCT05024032|580880559|FG002|Overall Study|Withdrawal by Subject|4|||
160859845|NCT05024032|580880557|FG000|Overall Study|Adverse Event|0|||
160859846|NCT05024032|580880558|FG001|Overall Study|Adverse Event|1|||
160859847|NCT05024032|580880559|FG002|Overall Study|Adverse Event|0|||
160859848|NCT05024032|580880557|FG000|Overall Study|Protocol Deviation|1|||
160859849|NCT05024032|580880558|FG001|Overall Study|Protocol Deviation|0|||
160859850|NCT05024032|580880559|FG002|Overall Study|Protocol Deviation|0|||
160859851|NCT00939393|580880560|FG000|Overall Study|Withdrawal by Subject|1|||
160859852|NCT00939393|580880561|FG001|Overall Study|Withdrawal by Subject|0|||
160859853|NCT00939393|580880560|FG000|Overall Study|Lost to Follow-up|3|||
160859854|NCT00939393|580880561|FG001|Overall Study|Lost to Follow-up|0|||
160859855|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
161339007|NCT05911841|582630376|FG005|Escape Period|Site Terminated by Sponsor|0|||
161339008|NCT05911841|582630377|FG006|Escape Period|Site Terminated by Sponsor|0|||
160859856|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160909365|NCT03602482|581063924|FG000|Overall Study|Withdrawal by Subject|6|||
160909366|NCT03602482|581063925|FG001|Overall Study|Withdrawal by Subject|7|||
160909367|NCT03602482|581063926|FG002|Overall Study|Withdrawal by Subject|0|||
160909368|NCT03602482|581063927|FG003|Overall Study|Withdrawal by Subject|0|||
160909369|NCT03808545|581063939|FG000|Overall Study|Withdrawal by Subject|1|||
160909370|NCT03808545|581063940|FG001|Overall Study|Withdrawal by Subject|1|||
160909371|NCT00618072|581063949|FG000|Overall Study|Lost to Follow-up|2|||
160909372|NCT00618072|581063950|FG001|Overall Study|Lost to Follow-up|0|||
160909373|NCT00618072|581063951|FG002|Overall Study|Lost to Follow-up|3|||
160909374|NCT00618072|581063949|FG000|Overall Study|Physician Decision|0|||
160994525|NCT03410992|581368960|FG009|Week 16 Assessment|Incorrect escapers|0|||
160994526|NCT03410992|581368961|FG010|Week 16 Assessment|Incorrect escapers|0|||
160994527|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994528|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994529|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160859857|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859858|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859859|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859860|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160859861|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
160994530|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
160994531|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
160994532|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994533|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994534|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994535|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994536|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994537|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
160994538|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994539|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994540|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994541|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
160994542|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
160994543|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
160994544|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994545|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994546|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994547|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994548|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
160994549|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994550|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994551|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994552|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994553|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994554|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
160994555|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994556|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994557|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994558|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994559|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
160994560|NCT03410992|581368951|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994561|NCT03410992|581368952|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994562|NCT03410992|581368953|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994563|NCT03410992|581368954|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
160994564|NCT03410992|581368955|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
160994565|NCT03410992|581368956|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
160994566|NCT03410992|581368957|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994567|NCT03410992|581368958|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994568|NCT03410992|581368959|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994569|NCT03410992|581368960|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994570|NCT03410992|581368961|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
160994571|NCT03410992|581368951|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
160859862|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
160859863|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859864|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859865|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859866|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
160994572|NCT03410992|581368952|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994573|NCT03410992|581368953|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994574|NCT03410992|581368954|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
161256289|NCT00373425|582316412|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
160859867|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
161256290|NCT00373425|582316408|FG000|Overall Study|Death|7|||
160859868|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
160859869|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
160859870|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859871|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859872|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859873|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859874|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859875|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
160859876|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
160859877|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859878|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859879|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859880|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859881|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859882|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
160859883|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
160859884|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859885|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859886|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859887|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859888|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859889|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
160859890|NCT01054885|580880562|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
160859891|NCT01054885|580880563|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859892|NCT01054885|580880564|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859893|NCT01054885|580880565|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859894|NCT01054885|580880566|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859895|NCT01054885|580880567|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859896|NCT01054885|580880568|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
160859897|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
160859898|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
160859899|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
160859900|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
160859901|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
160859902|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
160859903|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
160859904|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859905|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859906|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
160859907|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
160859908|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859909|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
160859910|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
160859911|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
160859912|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
160859913|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
160859914|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
160859915|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
160859916|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
160859917|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
160859918|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
160859919|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
160859920|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
160859921|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
160859922|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
160859923|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
160859924|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
160859925|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
160859926|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
160859927|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
160859928|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
160859929|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
160909375|NCT00618072|581063950|FG001|Overall Study|Physician Decision|1|||
160859930|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
160859931|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
160859932|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859933|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859934|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
160859935|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859936|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859937|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
160859938|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
160859939|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160859940|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
160859941|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160859942|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160859943|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
160859944|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
160859945|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
160859946|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
160859947|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
160859948|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
160859949|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
160859950|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
160859951|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
160859952|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
160859953|NCT01054885|580880562|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
160859954|NCT01054885|580880563|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
160859955|NCT01054885|580880564|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160859956|NCT01054885|580880565|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
160859957|NCT01054885|580880566|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
160859958|NCT01054885|580880567|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
160859959|NCT01054885|580880568|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
160859960|NCT00804908|580880569|FG000|Overall Study|Other|115|||
160859961|NCT00804908|580880570|FG001|Overall Study|Other|116|||
160859962|NCT00804908|580880571|FG002|Overall Study|Other|114|||
160859963|NCT01280903|580880572|FG000|Overall Study|Lost to Follow-up|23|||
160859964|NCT01280903|580880573|FG001|Overall Study|Lost to Follow-up|16|||
160859965|NCT03453164|580880574|FG000|Overall Study|Lack of Efficacy|16|||
160859966|NCT03453164|580880574|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
160859967|NCT03829228|580880575|FG000|Overall Study|Protocol Violation|1|||
160859968|NCT02177695|580880576|FG000|ITT Analysis|Ineligible|5|||
160859969|NCT02177695|580880577|FG001|ITT Analysis|Ineligible|5|||
160859970|NCT02177695|580880576|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
160859971|NCT02177695|580880577|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
160859972|NCT02177695|580880576|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
160859973|NCT02177695|580880577|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
160859974|NCT02177695|580880576|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
160859975|NCT02177695|580880577|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
160859976|NCT00744497|580880580|FG000|Overall Study|Withdrawal by Subject|21|||
160859977|NCT00744497|580880581|FG001|Overall Study|Withdrawal by Subject|18|||
160859978|NCT00744497|580880580|FG000|Overall Study|Death|11|||
160859979|NCT00744497|580880581|FG001|Overall Study|Death|9|||
160859980|NCT00744497|580880580|FG000|Overall Study|Lost to Follow-up|4|||
160859981|NCT00744497|580880581|FG001|Overall Study|Lost to Follow-up|2|||
160859982|NCT00744497|580880580|FG000|Overall Study|Poor compliance/noncompliance|9|||
160859983|NCT00744497|580880581|FG001|Overall Study|Poor compliance/noncompliance|5|||
160859984|NCT00744497|580880580|FG000|Overall Study|No longer meets study criteria|7|||
160859985|NCT00744497|580880581|FG001|Overall Study|No longer meets study criteria|3|||
160859986|NCT00744497|580880580|FG000|Overall Study|Administrative Reason By Sponsor|25|||
160859987|NCT00744497|580880581|FG001|Overall Study|Administrative Reason By Sponsor|8|||
160859988|NCT00744497|580880580|FG000|Overall Study|Disease progression|312|||
160859989|NCT00744497|580880581|FG001|Overall Study|Disease progression|219|||
160859990|NCT00744497|580880580|FG000|Overall Study|Study drug toxicity|68|||
160859991|NCT00744497|580880581|FG001|Overall Study|Study drug toxicity|141|||
160859992|NCT00744497|580880580|FG000|Overall Study|Adverse event unrelated to study drug|78|||
160859993|NCT00744497|580880581|FG001|Overall Study|Adverse event unrelated to study drug|122|||
160859994|NCT00744497|580880580|FG000|Overall Study|Patient requested to stop study drug|65|||
160859995|NCT00744497|580880581|FG001|Overall Study|Patient requested to stop study drug|80|||
160859996|NCT00744497|580880580|FG000|Overall Study|Maximum clinical benefit|141|||
160859997|NCT00744497|580880581|FG001|Overall Study|Maximum clinical benefit|142|||
160859998|NCT00744497|580880580|FG000|Overall Study|Not defined|19|||
160994575|NCT03410992|581368955|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994576|NCT03410992|581368956|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
160859999|NCT00744497|580880581|FG001|Overall Study|Not defined|13|||
160860000|NCT02443688|580880582|FG000|Overall Study|Adverse Event|2|||
160860001|NCT02443688|580880583|FG001|Overall Study|Adverse Event|3|||
160860002|NCT02443688|580880584|FG002|Overall Study|Adverse Event|2|||
160860003|NCT02443688|580880582|FG000|Overall Study|Lost to Follow-up|1|||
160860004|NCT02443688|580880583|FG001|Overall Study|Lost to Follow-up|0|||
160860005|NCT02443688|580880584|FG002|Overall Study|Lost to Follow-up|0|||
160860006|NCT02443688|580880582|FG000|Overall Study|Physician Decision|3|||
160860007|NCT02443688|580880583|FG001|Overall Study|Physician Decision|0|||
160860008|NCT02443688|580880584|FG002|Overall Study|Physician Decision|1|||
160860009|NCT02443688|580880582|FG000|Overall Study|Pregnancy|0|||
160860010|NCT02443688|580880583|FG001|Overall Study|Pregnancy|0|||
160860011|NCT02443688|580880584|FG002|Overall Study|Pregnancy|1|||
160860012|NCT02443688|580880582|FG000|Overall Study|Withdrawal by Subject|3|||
160860013|NCT02443688|580880583|FG001|Overall Study|Withdrawal by Subject|3|||
160860014|NCT02443688|580880584|FG002|Overall Study|Withdrawal by Subject|4|||
160860015|NCT02443688|580880582|FG000|Overall Study|Non-compliance with study drug|1|||
160860016|NCT02443688|580880583|FG001|Overall Study|Non-compliance with study drug|2|||
160860017|NCT02443688|580880584|FG002|Overall Study|Non-compliance with study drug|4|||
160860018|NCT02443688|580880582|FG000|Overall Study|Sponsor Request|2|||
160860019|NCT02443688|580880583|FG001|Overall Study|Sponsor Request|1|||
160860020|NCT02443688|580880584|FG002|Overall Study|Sponsor Request|0|||
160860021|NCT03459079|580880586|FG000|Overall Study|Adverse Event|4|||
160860022|NCT03459079|580880587|FG001|Overall Study|Adverse Event|2|||
160860023|NCT03459079|580880588|FG002|Overall Study|Adverse Event|0|||
160860024|NCT03459079|580880586|FG000|Overall Study|Withdrawal by Subject|2|||
160860025|NCT03459079|580880587|FG001|Overall Study|Withdrawal by Subject|2|||
160860026|NCT03459079|580880588|FG002|Overall Study|Withdrawal by Subject|0|||
160860027|NCT00726063|580880590|FG000|Overall Study|Adverse Event|9|||
160860028|NCT00726063|580880591|FG001|Overall Study|Adverse Event|7|||
160860029|NCT02007096|580880592|FG000|Overall Study|medication not available|2|||
160860030|NCT02007096|580880593|FG001|Overall Study|medication not available|0|||
160860031|NCT02007096|580880592|FG000|Overall Study|did not inject saline|0|||
160860032|NCT02007096|580880593|FG001|Overall Study|did not inject saline|3|||
160860033|NCT02007096|580880592|FG000|Overall Study|did not follow postoperative protocol|8|||
160860034|NCT02007096|580880593|FG001|Overall Study|did not follow postoperative protocol|11|||
160860035|NCT02007096|580880592|FG000|Overall Study|converted to open surgery|1|||
160860036|NCT02007096|580880593|FG001|Overall Study|converted to open surgery|1|||
160860037|NCT02007096|580880592|FG000|Overall Study|no mesh placed|0|||
160860038|NCT02007096|580880593|FG001|Overall Study|no mesh placed|1|||
160860039|NCT05660577|580880594|FG000|Overall Study|Discontinued|9|||
160994577|NCT03410992|581368957|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994578|NCT03410992|581368958|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
160994579|NCT03410992|581368959|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994580|NCT03410992|581368960|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994581|NCT03410992|581368961|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
160994582|NCT03410992|581368951|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994583|NCT03410992|581368952|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994584|NCT03410992|581368953|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161256291|NCT00373425|582316409|FG001|Overall Study|Death|0|||
161256292|NCT00373425|582316410|FG002|Overall Study|Death|3|||
161256293|NCT00373425|582316411|FG003|Overall Study|Death|1|||
161256294|NCT00373425|582316412|FG004|Overall Study|Death|0|||
160860040|NCT03363841|580880595|FG000|Overall Study|Adverse Event|1|||
160860041|NCT03363841|580880595|FG000|Overall Study|Withdrawal by Subject|1|||
160860042|NCT03363841|580880595|FG000|Overall Study|Death|7|||
160860043|NCT03363841|580880595|FG000|Overall Study|Physician Decision|1|||
160860044|NCT02156076|580880598|FG000|Treatment Period|no longer meets study criteria|0|||
160860045|NCT02156076|580880599|FG001|Treatment Period|no longer meets study criteria|0|||
160860046|NCT02156076|580880600|FG002|Treatment Period|no longer meets study criteria|1|||
161256295|NCT00551616|582316415|FG000|Overall Study|Lost to Follow-up|48|||
161256296|NCT00551616|582316416|FG001|Overall Study|Lost to Follow-up|40|||
161256297|NCT02808819|582316417|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
160860047|NCT02156076|580880601|FG003|Treatment Period|no longer meets study criteria|0|||
160860048|NCT02156076|580880598|FG000|Treatment Period|Poor/non-compliance|0|||
161256298|NCT02808819|582316418|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
160860049|NCT02156076|580880599|FG001|Treatment Period|Poor/non-compliance|1|||
160860050|NCT02156076|580880600|FG002|Treatment Period|Poor/non-compliance|0|||
160860051|NCT02156076|580880601|FG003|Treatment Period|Poor/non-compliance|0|||
160860052|NCT02156076|580880598|FG000|Treatment Period|Lost to Follow-up|0|||
160860053|NCT02156076|580880599|FG001|Treatment Period|Lost to Follow-up|0|||
160860054|NCT02156076|580880600|FG002|Treatment Period|Lost to Follow-up|0|||
160994585|NCT03410992|581368954|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994586|NCT03410992|581368955|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161256299|NCT02808819|582316417|FG000|Overall Study|Withdrawal by Subject|10|||
160860055|NCT02156076|580880601|FG003|Treatment Period|Lost to Follow-up|1|||
160860056|NCT02156076|580880598|FG000|Treatment Period|Withdrawal by Subject|0|||
160860057|NCT02156076|580880599|FG001|Treatment Period|Withdrawal by Subject|0|||
160860058|NCT02156076|580880600|FG002|Treatment Period|Withdrawal by Subject|1|||
160860059|NCT02156076|580880601|FG003|Treatment Period|Withdrawal by Subject|0|||
160860060|NCT02156076|580880598|FG000|Treatment Period|Subject request to discontinue treatment|0|||
160860061|NCT02156076|580880599|FG001|Treatment Period|Subject request to discontinue treatment|1|||
160860062|NCT02156076|580880600|FG002|Treatment Period|Subject request to discontinue treatment|0|||
160860063|NCT02156076|580880601|FG003|Treatment Period|Subject request to discontinue treatment|0|||
160860064|NCT02156076|580880598|FG000|Treatment Period|Adverse Event|0|||
160860065|NCT02156076|580880599|FG001|Treatment Period|Adverse Event|0|||
160860066|NCT02156076|580880600|FG002|Treatment Period|Adverse Event|0|||
160860067|NCT02156076|580880601|FG003|Treatment Period|Adverse Event|1|||
160860068|NCT02156076|580880598|FG000|Follow-up Period|Withdrawal by Subject|1|||
160860069|NCT02156076|580880599|FG001|Follow-up Period|Withdrawal by Subject|0|||
160860070|NCT02156076|580880600|FG002|Follow-up Period|Withdrawal by Subject|0|||
160860071|NCT02156076|580880601|FG003|Follow-up Period|Withdrawal by Subject|0|||
160860072|NCT00981656|580880610|FG000|Overall Study|Protocol Violation|1|||
160860073|NCT00981656|580880610|FG000|Overall Study|Did not start protocol treatment|2|||
160860074|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
160860075|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
160860076|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
160860077|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
160860078|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
160860079|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
160860080|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
160860081|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
160860082|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
160860083|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160860084|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
160860085|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
160860086|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
160860087|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
160860088|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
160860089|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
160860090|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
160860091|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
160860092|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
160860093|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
160860094|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
160860095|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
160860096|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160860097|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
160860098|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
160860099|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
160860100|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
160860101|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
160860102|NCT04026113|580880611|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160860103|NCT04026113|580880612|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
160860104|NCT04026113|580880613|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160860105|NCT04026113|580880614|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
160860106|NCT04026113|580880611|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
160860107|NCT04026113|580880612|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
160860108|NCT04026113|580880613|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
160860109|NCT04026113|580880614|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
160860110|NCT00687596|580880615|FG000|Overall Study|Adverse Event (AE)|10|||
160860111|NCT00687596|580880616|FG001|Overall Study|Adverse Event (AE)|3|||
160909376|NCT00618072|581063951|FG002|Overall Study|Physician Decision|1|||
160909377|NCT02853604|581063960|FG000|Overall Study|Withdrawal by Subject|12|||
160909378|NCT02853604|581063961|FG001|Overall Study|Withdrawal by Subject|35|||
160909379|NCT02853604|581063960|FG000|Overall Study|Lost to Follow-up|4|||
160909380|NCT02853604|581063961|FG001|Overall Study|Lost to Follow-up|8|||
160909381|NCT02853604|581063960|FG000|Overall Study|Death|1|||
160909382|NCT02853604|581063961|FG001|Overall Study|Death|5|||
160909383|NCT02853604|581063960|FG000|Overall Study|Miscellaneous|11|||
160909384|NCT02853604|581063961|FG001|Overall Study|Miscellaneous|2|||
160909385|NCT02853604|581063960|FG000|Overall Study|Progressive Disease|0|||
160909386|NCT02853604|581063961|FG001|Overall Study|Progressive Disease|2|||
161141597|NCT00095303|581902537|FG000|Main Study|Lost to Follow-up|91|||
161141598|NCT00095303|581902538|FG001|Main Study|Lost to Follow-up|87|||
160860112|NCT00687596|580880615|FG000|Overall Study|Radiological Disease Progression|6|||
160860113|NCT00687596|580880616|FG001|Overall Study|Radiological Disease Progression|2|||
160860114|NCT00687596|580880615|FG000|Overall Study|Clinical Disease Progression|1|||
160860115|NCT00687596|580880616|FG001|Overall Study|Clinical Disease Progression|3|||
160860116|NCT00687596|580880615|FG000|Overall Study|Investigator Discretion|3|||
160860117|NCT00687596|580880616|FG001|Overall Study|Investigator Discretion|1|||
160860118|NCT00687596|580880615|FG000|Overall Study|Sponsor Terminated Study|6|||
160860119|NCT00687596|580880616|FG001|Overall Study|Sponsor Terminated Study|17|||
160860120|NCT00837434|580880618|FG000|Overall Study|Physician Decision|3|||
160860121|NCT00837434|580880619|FG001|Overall Study|Physician Decision|0|||
160860122|NCT00837434|580880618|FG000|Overall Study|Lost to Follow-up|1|||
160860123|NCT00837434|580880619|FG001|Overall Study|Lost to Follow-up|1|||
160860124|NCT00837434|580880618|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
160860125|NCT00837434|580880619|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
160860126|NCT00837434|580880618|FG000|Overall Study|Noncompliant|2|||
160860127|NCT00837434|580880619|FG001|Overall Study|Noncompliant|0|||
160860128|NCT00837434|580880618|FG000|Overall Study|Baseline assessments not done in time|1|||
160860129|NCT00837434|580880619|FG001|Overall Study|Baseline assessments not done in time|0|||
160860130|NCT00837434|580880618|FG000|Overall Study|Unable to obtain study drug|1|||
160860131|NCT00837434|580880619|FG001|Overall Study|Unable to obtain study drug|0|||
160860132|NCT01527149|580880620|FG000|Overall Study|Death|2|||
160860133|NCT01709721|580880621|FG000|Open Label Phase|Withdrawal by Subject|0|||
160860134|NCT01709721|580880622|FG001|Open Label Phase|Withdrawal by Subject|0|||
160860135|NCT01709721|580880623|FG002|Open Label Phase|Withdrawal by Subject|5|||
160860136|NCT01709721|580880621|FG000|Open Label Phase|Adverse Event|0|||
160860137|NCT01709721|580880622|FG001|Open Label Phase|Adverse Event|0|||
160860138|NCT01709721|580880623|FG002|Open Label Phase|Adverse Event|8|||
160860139|NCT01709721|580880621|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
160860140|NCT01709721|580880622|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
160860141|NCT01709721|580880623|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
160860142|NCT01709721|580880621|FG000|Open Label Phase|Investigator Decision|0|||
160860143|NCT01709721|580880622|FG001|Open Label Phase|Investigator Decision|0|||
160860144|NCT01709721|580880623|FG002|Open Label Phase|Investigator Decision|1|||
160860145|NCT01709721|580880621|FG000|Open Label Phase|Sponsor Decision|0|||
160860146|NCT01709721|580880622|FG001|Open Label Phase|Sponsor Decision|0|||
160860147|NCT01709721|580880623|FG002|Open Label Phase|Sponsor Decision|2|||
160860148|NCT01709721|580880621|FG000|Open Label Phase|Protocol Violation|0|||
160860149|NCT01709721|580880622|FG001|Open Label Phase|Protocol Violation|0|||
160860150|NCT01709721|580880623|FG002|Open Label Phase|Protocol Violation|1|||
160860151|NCT01709721|580880621|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
160860152|NCT01709721|580880622|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
160860153|NCT01709721|580880623|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
160860154|NCT01709721|580880621|FG000|Open Label Phase|Inadequate Pain Control|0|||
160860155|NCT01709721|580880622|FG001|Open Label Phase|Inadequate Pain Control|0|||
160860156|NCT01709721|580880623|FG002|Open Label Phase|Inadequate Pain Control|37|||
160860157|NCT01709721|580880621|FG000|Open Label Phase|Other, Specify in text field in database|0|||
160860158|NCT01709721|580880622|FG001|Open Label Phase|Other, Specify in text field in database|0|||
160860159|NCT01709721|580880623|FG002|Open Label Phase|Other, Specify in text field in database|14|||
160860160|NCT01709721|580880621|FG000|Randomized Phase|Adverse Event|0|||
160860161|NCT01709721|580880622|FG001|Randomized Phase|Adverse Event|1|||
160860162|NCT01709721|580880623|FG002|Randomized Phase|Adverse Event|0|||
160860163|NCT01709721|580880621|FG000|Randomized Phase|Lost to Follow-up|1|||
160860164|NCT01709721|580880622|FG001|Randomized Phase|Lost to Follow-up|0|||
160860165|NCT01709721|580880623|FG002|Randomized Phase|Lost to Follow-up|0|||
160860166|NCT01709721|580880621|FG000|Randomized Phase|Inadequate Pain Control|1|||
161141599|NCT00095303|581902537|FG000|Follow Up Study|Lost to Follow-up|59|||
161141600|NCT00095303|581902538|FG001|Follow Up Study|Lost to Follow-up|58|||
161141601|NCT03953118|581902541|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
160860167|NCT01709721|580880622|FG001|Randomized Phase|Inadequate Pain Control|2|||
160860168|NCT01709721|580880623|FG002|Randomized Phase|Inadequate Pain Control|0|||
160860169|NCT01709721|580880621|FG000|Randomized Phase|Other, Specify text field in database|1|||
160860170|NCT01709721|580880622|FG001|Randomized Phase|Other, Specify text field in database|3|||
160860171|NCT01709721|580880623|FG002|Randomized Phase|Other, Specify text field in database|0|||
160860172|NCT02230410|580880626|FG000|Overall Study|Screen Failure|3|||
160860173|NCT02558894|580880632|FG000|Overall Study|Death; any cause, entire study duration|28|||
160860174|NCT02558894|580880633|FG001|Overall Study|Death; any cause, entire study duration|31|||
160860175|NCT02558894|580880632|FG000|Overall Study|Withdrawal by Subject|2|||
160860176|NCT02558894|580880633|FG001|Overall Study|Withdrawal by Subject|1|||
160860177|NCT02558894|580880632|FG000|Overall Study|Closure of Part A|2|||
161142650|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
160994587|NCT03410992|581368956|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994588|NCT03410992|581368957|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
161256300|NCT02808819|582316418|FG001|Overall Study|Withdrawal by Subject|13|||
160909387|NCT02270957|581063962|FG000|Overall Study|Lack of Efficacy|2|||
160909388|NCT02270957|581063963|FG001|Overall Study|Lack of Efficacy|4|||
160909389|NCT02270957|581063962|FG000|Overall Study|Adverse Event|2|||
160909390|NCT02270957|581063963|FG001|Overall Study|Adverse Event|0|||
161256301|NCT02808819|582316417|FG000|Overall Study|Site terminated by sponsor|2|||
160860178|NCT02558894|580880633|FG001|Overall Study|Closure of Part A|1|||
160860179|NCT02992288|580880634|FG000|Overall Study|Adverse Event|8|||
160860180|NCT02992288|580880635|FG001|Overall Study|Adverse Event|2|||
160860181|NCT02992288|580880636|FG002|Overall Study|Adverse Event|2|||
160860182|NCT02992288|580880637|FG003|Overall Study|Adverse Event|2|||
160860183|NCT02992288|580880638|FG004|Overall Study|Adverse Event|2|||
160860184|NCT02992288|580880639|FG005|Overall Study|Adverse Event|7|||
160860185|NCT02992288|580880634|FG000|Overall Study|Non-compliance with study drug|0|||
160860186|NCT02992288|580880635|FG001|Overall Study|Non-compliance with study drug|1|||
160860187|NCT02992288|580880636|FG002|Overall Study|Non-compliance with study drug|1|||
160860188|NCT02992288|580880637|FG003|Overall Study|Non-compliance with study drug|0|||
160860189|NCT02992288|580880638|FG004|Overall Study|Non-compliance with study drug|1|||
160860190|NCT02992288|580880639|FG005|Overall Study|Non-compliance with study drug|0|||
160860191|NCT02992288|580880634|FG000|Overall Study|Physician Decision|3|||
160860192|NCT02992288|580880635|FG001|Overall Study|Physician Decision|0|||
160860193|NCT02992288|580880636|FG002|Overall Study|Physician Decision|1|||
160860194|NCT02992288|580880637|FG003|Overall Study|Physician Decision|0|||
160860195|NCT02992288|580880638|FG004|Overall Study|Physician Decision|0|||
160860196|NCT02992288|580880639|FG005|Overall Study|Physician Decision|1|||
160860197|NCT02992288|580880634|FG000|Overall Study|Death|2|||
160860198|NCT02992288|580880635|FG001|Overall Study|Death|0|||
160860199|NCT02992288|580880636|FG002|Overall Study|Death|2|||
160860200|NCT02992288|580880637|FG003|Overall Study|Death|1|||
160860201|NCT02992288|580880638|FG004|Overall Study|Death|2|||
160860202|NCT02992288|580880639|FG005|Overall Study|Death|0|||
160860203|NCT02992288|580880634|FG000|Overall Study|Lost to Follow-up|0|||
160860204|NCT02992288|580880635|FG001|Overall Study|Lost to Follow-up|0|||
160860205|NCT02992288|580880636|FG002|Overall Study|Lost to Follow-up|0|||
160860206|NCT02992288|580880637|FG003|Overall Study|Lost to Follow-up|1|||
160909391|NCT01218204|581063968|FG000|Part B Washout|Adverse Event|0|||
160909392|NCT01218204|581063969|FG001|Part B Washout|Adverse Event|1|||
160909393|NCT01218204|581063970|FG002|Part B Washout|Adverse Event|0|||
160909394|NCT01218204|581063971|FG003|Part B Washout|Adverse Event|0|||
160909395|NCT01218204|581063968|FG000|Part B Washout|Lost to Follow-up|0|||
160909396|NCT01218204|581063969|FG001|Part B Washout|Lost to Follow-up|2|||
160909397|NCT01218204|581063970|FG002|Part B Washout|Lost to Follow-up|0|||
160909398|NCT01218204|581063971|FG003|Part B Washout|Lost to Follow-up|0|||
160909399|NCT01218204|581063968|FG000|Part B Washout|Physician Decision|0|||
160909400|NCT01218204|581063969|FG001|Part B Washout|Physician Decision|14|||
160909401|NCT01218204|581063970|FG002|Part B Washout|Physician Decision|0|||
160909402|NCT01218204|581063971|FG003|Part B Washout|Physician Decision|0|||
160909403|NCT01218204|581063968|FG000|Part B Washout|Withdrawal by Subject|0|||
160909404|NCT01218204|581063969|FG001|Part B Washout|Withdrawal by Subject|14|||
160909405|NCT01218204|581063970|FG002|Part B Washout|Withdrawal by Subject|0|||
160909406|NCT01218204|581063971|FG003|Part B Washout|Withdrawal by Subject|0|||
160909407|NCT01218204|581063968|FG000|Part B Washout|Reached defined stopping criteria|0|||
160909408|NCT01218204|581063969|FG001|Part B Washout|Reached defined stopping criteria|2|||
160909409|NCT01218204|581063970|FG002|Part B Washout|Reached defined stopping criteria|0|||
160909410|NCT01218204|581063971|FG003|Part B Washout|Reached defined stopping criteria|0|||
160909411|NCT01218204|581063968|FG000|Part B Washout|Did not meet continuation criteria|0|||
160909412|NCT01218204|581063969|FG001|Part B Washout|Did not meet continuation criteria|112|||
160909413|NCT01218204|581063970|FG002|Part B Washout|Did not meet continuation criteria|0|||
160909414|NCT01218204|581063971|FG003|Part B Washout|Did not meet continuation criteria|0|||
160909415|NCT01218204|581063968|FG000|Part B Run-in|Adverse Event|0|||
160909416|NCT01218204|581063969|FG001|Part B Run-in|Adverse Event|0|||
160909417|NCT01218204|581063970|FG002|Part B Run-in|Adverse Event|1|||
160909418|NCT01218204|581063971|FG003|Part B Run-in|Adverse Event|0|||
160909419|NCT01218204|581063968|FG000|Part B Run-in|Protocol Violation|0|||
160909420|NCT01218204|581063969|FG001|Part B Run-in|Protocol Violation|0|||
160909421|NCT01218204|581063970|FG002|Part B Run-in|Protocol Violation|2|||
160860207|NCT02992288|580880638|FG004|Overall Study|Lost to Follow-up|0|||
160860208|NCT02992288|580880639|FG005|Overall Study|Lost to Follow-up|0|||
160860209|NCT02992288|580880634|FG000|Overall Study|Protocol Violation|0|||
160860210|NCT02992288|580880635|FG001|Overall Study|Protocol Violation|0|||
160860211|NCT02992288|580880636|FG002|Overall Study|Protocol Violation|0|||
160860212|NCT02992288|580880637|FG003|Overall Study|Protocol Violation|0|||
160860213|NCT02992288|580880638|FG004|Overall Study|Protocol Violation|0|||
160860214|NCT02992288|580880639|FG005|Overall Study|Protocol Violation|1|||
160860215|NCT02992288|580880634|FG000|Overall Study|Withdrawal by Subject|4|||
160909422|NCT01218204|581063971|FG003|Part B Run-in|Protocol Violation|0|||
161339009|NCT05911841|582630378|FG007|Escape Period|Site Terminated by Sponsor|0|||
161339010|NCT05911841|582630379|FG008|Escape Period|Site Terminated by Sponsor|0|||
161339011|NCT05911841|582630380|FG009|Escape Period|Site Terminated by Sponsor|1|||
161339012|NCT05911841|582630371|FG000|Escape Period|Study Terminated by Sponsor|0|||
161339013|NCT05911841|582630372|FG001|Escape Period|Study Terminated by Sponsor|0|||
161339014|NCT05911841|582630373|FG002|Escape Period|Study Terminated by Sponsor|0|||
161339015|NCT05911841|582630374|FG003|Escape Period|Study Terminated by Sponsor|0|||
161339016|NCT05911841|582630375|FG004|Escape Period|Study Terminated by Sponsor|0|||
161339017|NCT05911841|582630376|FG005|Escape Period|Study Terminated by Sponsor|0|||
161339018|NCT05911841|582630377|FG006|Escape Period|Study Terminated by Sponsor|0|||
161339019|NCT05911841|582630378|FG007|Escape Period|Study Terminated by Sponsor|0|||
161339020|NCT05911841|582630379|FG008|Escape Period|Study Terminated by Sponsor|0|||
161339021|NCT05911841|582630380|FG009|Escape Period|Study Terminated by Sponsor|34|||
161339022|NCT05911841|582630371|FG000|Escape Period|Withdrawal by Subject|0|||
161339023|NCT05911841|582630372|FG001|Escape Period|Withdrawal by Subject|0|||
161339024|NCT05911841|582630373|FG002|Escape Period|Withdrawal by Subject|0|||
161339025|NCT05911841|582630374|FG003|Escape Period|Withdrawal by Subject|0|||
161339026|NCT05911841|582630375|FG004|Escape Period|Withdrawal by Subject|0|||
161339027|NCT05911841|582630376|FG005|Escape Period|Withdrawal by Subject|0|||
161339028|NCT05911841|582630377|FG006|Escape Period|Withdrawal by Subject|0|||
161339029|NCT05911841|582630378|FG007|Escape Period|Withdrawal by Subject|0|||
161339030|NCT05911841|582630379|FG008|Escape Period|Withdrawal by Subject|0|||
161339031|NCT05911841|582630380|FG009|Escape Period|Withdrawal by Subject|10|||
161339032|NCT05595369|582630381|FG000|Overall Study|Adverse Event|2|||
161339033|NCT05595369|582630382|FG001|Overall Study|Adverse Event|0|||
161339034|NCT05595369|582630383|FG002|Overall Study|Adverse Event|0|||
161339035|NCT05595369|582630381|FG000|Overall Study|Lost to Follow-up|11|||
161339036|NCT05595369|582630382|FG001|Overall Study|Lost to Follow-up|10|||
161339037|NCT05595369|582630383|FG002|Overall Study|Lost to Follow-up|10|||
161339038|NCT05595369|582630381|FG000|Overall Study|Physician Decision|1|||
161339039|NCT05595369|582630382|FG001|Overall Study|Physician Decision|0|||
161339040|NCT05595369|582630383|FG002|Overall Study|Physician Decision|0|||
161339041|NCT05595369|582630381|FG000|Overall Study|Withdrawal by Subject|5|||
161339042|NCT05595369|582630382|FG001|Overall Study|Withdrawal by Subject|7|||
161339043|NCT05595369|582630383|FG002|Overall Study|Withdrawal by Subject|6|||
161339044|NCT05595369|582630381|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161339045|NCT05595369|582630382|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
161339046|NCT05595369|582630383|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
161339047|NCT05595369|582630381|FG000|Overall Study|Study Drug Non-compliance|0|||
161339048|NCT05595369|582630382|FG001|Overall Study|Study Drug Non-compliance|1|||
161339049|NCT05595369|582630383|FG002|Overall Study|Study Drug Non-compliance|0|||
161339050|NCT05595369|582630381|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
161339051|NCT05595369|582630382|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
161339052|NCT05595369|582630383|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
161339053|NCT02391337|582630389|FG000|6 Months Follow-up|Death|5|||
161339054|NCT02391337|582630390|FG001|6 Months Follow-up|Death|4|||
161339055|NCT02391337|582630389|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
161339056|NCT02391337|582630390|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
160860216|NCT02992288|580880635|FG001|Overall Study|Withdrawal by Subject|2|||
160860217|NCT02992288|580880636|FG002|Overall Study|Withdrawal by Subject|1|||
160860218|NCT02992288|580880637|FG003|Overall Study|Withdrawal by Subject|5|||
160860219|NCT02992288|580880638|FG004|Overall Study|Withdrawal by Subject|3|||
160860220|NCT02992288|580880639|FG005|Overall Study|Withdrawal by Subject|4|||
160860221|NCT00656513|580880640|FG000|Overall Study|Protocol Violation|1|||
160860222|NCT00656513|580880641|FG001|Overall Study|Protocol Violation|0|||
160909423|NCT01218204|581063968|FG000|Part B Run-in|Withdrawal by Subject|0|||
160909424|NCT01218204|581063969|FG001|Part B Run-in|Withdrawal by Subject|0|||
160909425|NCT01218204|581063970|FG002|Part B Run-in|Withdrawal by Subject|3|||
160909426|NCT01218204|581063971|FG003|Part B Run-in|Withdrawal by Subject|0|||
161339057|NCT02391337|582630389|FG000|12 Months Follow-up|Death|2|||
161339058|NCT02391337|582630390|FG001|12 Months Follow-up|Death|0|||
161339059|NCT02391337|582630389|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
161339060|NCT02391337|582630390|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
161339061|NCT02391337|582630389|FG000|12 Months Follow-up|Lost to Follow-up|0|||
161339062|NCT02391337|582630390|FG001|12 Months Follow-up|Lost to Follow-up|2|||
161339063|NCT00465517|582630392|FG000|Overall Study|Adverse Event|7|||
161339064|NCT00465517|582630393|FG001|Overall Study|Adverse Event|3|||
161339065|NCT00465517|582630392|FG000|Overall Study|Lost to Follow-up|1|||
161339066|NCT00465517|582630393|FG001|Overall Study|Lost to Follow-up|0|||
161339067|NCT00465517|582630392|FG000|Overall Study|Withdrawal by Subject|4|||
161339068|NCT00465517|582630393|FG001|Overall Study|Withdrawal by Subject|1|||
161339069|NCT00471497|582630414|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
160860223|NCT00656513|580880642|FG002|Overall Study|Protocol Violation|2|||
161339070|NCT00471497|582630415|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
160860224|NCT00656513|580880640|FG000|Overall Study|Withdrawal by Subject|0|||
160860225|NCT00656513|580880641|FG001|Overall Study|Withdrawal by Subject|11|||
160860226|NCT00656513|580880642|FG002|Overall Study|Withdrawal by Subject|4|||
160860227|NCT00656513|580880640|FG000|Overall Study|Death|0|||
160860228|NCT00656513|580880641|FG001|Overall Study|Death|0|||
160860229|NCT00656513|580880642|FG002|Overall Study|Death|1|||
160860230|NCT00656513|580880640|FG000|Overall Study|Missing data|0|||
160860231|NCT00656513|580880641|FG001|Overall Study|Missing data|11|||
160860232|NCT00656513|580880642|FG002|Overall Study|Missing data|9|||
160860233|NCT00656513|580880640|FG000|Overall Study|Incomplete treatment|3|||
160860234|NCT00656513|580880641|FG001|Overall Study|Incomplete treatment|0|||
160860235|NCT00656513|580880642|FG002|Overall Study|Incomplete treatment|0|||
160860236|NCT00656513|580880640|FG000|Overall Study|Treatment completed outside of timeframe|0|||
160860237|NCT00656513|580880641|FG001|Overall Study|Treatment completed outside of timeframe|3|||
160860238|NCT00656513|580880642|FG002|Overall Study|Treatment completed outside of timeframe|1|||
160860239|NCT00656513|580880640|FG000|Overall Study|Missing baseline form|0|||
160860240|NCT00656513|580880641|FG001|Overall Study|Missing baseline form|5|||
160860241|NCT00656513|580880642|FG002|Overall Study|Missing baseline form|5|||
160860242|NCT00412984|580880651|FG000|Overall Study|Death|331|||
160860243|NCT00412984|580880652|FG001|Overall Study|Death|349|||
160860244|NCT00412984|580880651|FG000|Overall Study|Adverse Event|679|||
160860245|NCT00412984|580880652|FG001|Overall Study|Adverse Event|738|||
160860246|NCT00412984|580880651|FG000|Overall Study|Withdrawal by Subject|921|||
160860247|NCT00412984|580880652|FG001|Overall Study|Withdrawal by Subject|989|||
160860248|NCT00412984|580880651|FG000|Overall Study|Lost to Follow-up|51|||
160860249|NCT00412984|580880652|FG001|Overall Study|Lost to Follow-up|39|||
160860250|NCT00412984|580880651|FG000|Overall Study|Poor/Noncompliance|57|||
160860251|NCT00412984|580880652|FG001|Overall Study|Poor/Noncompliance|77|||
160860252|NCT00412984|580880651|FG000|Overall Study|Pregnancy|1|||
160860253|NCT00412984|580880652|FG001|Overall Study|Pregnancy|0|||
160860254|NCT00412984|580880651|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
160860255|NCT00412984|580880652|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
160860256|NCT00412984|580880651|FG000|Overall Study|Administrative Reason by Sponsor|11|||
160860257|NCT00412984|580880652|FG001|Overall Study|Administrative Reason by Sponsor|8|||
160860258|NCT00412984|580880651|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
160860259|NCT00412984|580880652|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
160860260|NCT00412984|580880651|FG000|Overall Study|Other Reason|80|||
160860261|NCT00412984|580880652|FG001|Overall Study|Other Reason|92|||
160860262|NCT00412984|580880651|FG000|Overall Study|Not Reported|11|||
160860263|NCT00412984|580880652|FG001|Overall Study|Not Reported|12|||
160860264|NCT04218240|580880653|FG000|Overall Study|Withdrawal by Subject|6|||
160860265|NCT04218240|580880654|FG001|Overall Study|Withdrawal by Subject|0|||
160909427|NCT01218204|581063968|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
160909428|NCT01218204|581063969|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
160909429|NCT01218204|581063970|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
161256302|NCT02808819|582316418|FG001|Overall Study|Site terminated by sponsor|0|||
161256303|NCT02808819|582316417|FG000|Overall Study|Pregnancy|1|||
161256304|NCT02808819|582316418|FG001|Overall Study|Pregnancy|0|||
161256305|NCT02808819|582316417|FG000|Overall Study|Lost to Follow-up|1|||
161256306|NCT02808819|582316418|FG001|Overall Study|Lost to Follow-up|6|||
161256307|NCT02808819|582316417|FG000|Overall Study|Protocol Violation|0|||
161256308|NCT02808819|582316418|FG001|Overall Study|Protocol Violation|1|||
161256309|NCT02808819|582316417|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
161256310|NCT02808819|582316418|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
161256311|NCT02808819|582316417|FG000|Overall Study|Death|1|||
161256312|NCT02808819|582316418|FG001|Overall Study|Death|0|||
161256313|NCT02808819|582316417|FG000|Overall Study|Adverse Event|3|||
161256314|NCT02808819|582316418|FG001|Overall Study|Adverse Event|4|||
161256315|NCT03297294|582316419|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
161256316|NCT03297294|582316420|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
161256317|NCT03297294|582316421|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161256318|NCT03297294|582316422|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161256319|NCT03297294|582316423|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
161256320|NCT03297294|582316419|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
161256321|NCT03297294|582316420|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
160860266|NCT04218240|580880653|FG000|Overall Study|Lack of Efficacy|24|||
160860267|NCT04218240|580880654|FG001|Overall Study|Lack of Efficacy|19|||
160860268|NCT04218240|580880653|FG000|Overall Study|Physician Decision|0|||
160860269|NCT04218240|580880654|FG001|Overall Study|Physician Decision|1|||
161256322|NCT03297294|582316421|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
161256323|NCT03297294|582316422|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160860270|NCT04218240|580880653|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
160860271|NCT04218240|580880654|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
160860272|NCT04097678|580880655|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
160860273|NCT04097678|580880656|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
160909430|NCT01218204|581063971|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
160994589|NCT03410992|581368958|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994590|NCT03410992|581368959|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
160994591|NCT03410992|581368960|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994592|NCT03410992|581368961|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
160994593|NCT05298111|581368965|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
160994594|NCT05298111|581368966|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
160994595|NCT04988295|581368969|FG000|Overall Study|Withdrawal by Subject|9|||
160994596|NCT04988295|581368970|FG001|Overall Study|Withdrawal by Subject|29|||
160994597|NCT04988295|581368971|FG002|Overall Study|Withdrawal by Subject|6|||
160994598|NCT04988295|581368972|FG003|Overall Study|Withdrawal by Subject|0|||
160994599|NCT04988295|581368969|FG000|Overall Study|Lost to Follow-up|1|||
160994600|NCT04988295|581368970|FG001|Overall Study|Lost to Follow-up|0|||
160994601|NCT04988295|581368971|FG002|Overall Study|Lost to Follow-up|0|||
160994602|NCT04988295|581368972|FG003|Overall Study|Lost to Follow-up|0|||
160994603|NCT04988295|581368969|FG000|Overall Study|Study participation ongoing|186|||
160994604|NCT04988295|581368970|FG001|Overall Study|Study participation ongoing|169|||
160994605|NCT04988295|581368971|FG002|Overall Study|Study participation ongoing|99|||
160994606|NCT04988295|581368972|FG003|Overall Study|Study participation ongoing|119|||
160994607|NCT04083976|581368977|FG000|Overall Study|Lost to Follow-up|3|||
160994608|NCT04083976|581368978|FG001|Overall Study|Lost to Follow-up|0|||
160994609|NCT04083976|581368979|FG002|Overall Study|Lost to Follow-up|0|||
160994610|NCT04083976|581368980|FG003|Overall Study|Lost to Follow-up|1|||
160994611|NCT04083976|581368977|FG000|Overall Study|Withdrawal by Subject|16|||
160994612|NCT04083976|581368978|FG001|Overall Study|Withdrawal by Subject|1|||
160994613|NCT04083976|581368979|FG002|Overall Study|Withdrawal by Subject|9|||
160994614|NCT04083976|581368980|FG003|Overall Study|Withdrawal by Subject|0|||
160994615|NCT04083976|581368977|FG000|Overall Study|Sponsor Decision|14|||
160994616|NCT04083976|581368978|FG001|Overall Study|Sponsor Decision|0|||
160994617|NCT04083976|581368979|FG002|Overall Study|Sponsor Decision|0|||
160994618|NCT04083976|581368980|FG003|Overall Study|Sponsor Decision|7|||
160994619|NCT04083976|581368977|FG000|Overall Study|Other|1|||
160994620|NCT04083976|581368978|FG001|Overall Study|Other|0|||
160994621|NCT04083976|581368979|FG002|Overall Study|Other|1|||
160994622|NCT04083976|581368980|FG003|Overall Study|Other|0|||
160994623|NCT00930813|581368982|FG000|Overall Study|Death|4|||
160994624|NCT00930813|581368983|FG001|Overall Study|Death|5|||
160994625|NCT00930813|581368982|FG000|Overall Study|Withdrawal by Subject|2|||
160994626|NCT00930813|581368983|FG001|Overall Study|Withdrawal by Subject|5|||
160994627|NCT00930813|581368982|FG000|Overall Study|Lost to Follow-up|2|||
160994628|NCT00930813|581368983|FG001|Overall Study|Lost to Follow-up|4|||
160994629|NCT01693614|581368984|FG000|Overall Study|Adverse Event|7|||
160994630|NCT01693614|581368985|FG001|Overall Study|Adverse Event|11|||
160994631|NCT01693614|581368986|FG002|Overall Study|Adverse Event|5|||
160994632|NCT01693614|581368984|FG000|Overall Study|Disease progression|11|||
160994633|NCT01693614|581368985|FG001|Overall Study|Disease progression|8|||
160994634|NCT01693614|581368986|FG002|Overall Study|Disease progression|7|||
160994635|NCT01693614|581368984|FG000|Overall Study|Protocol Violation|5|||
160994636|NCT01693614|581368985|FG001|Overall Study|Protocol Violation|2|||
160994637|NCT01693614|581368986|FG002|Overall Study|Protocol Violation|1|||
160994638|NCT01693614|581368984|FG000|Overall Study|Death|1|||
160994639|NCT01693614|581368985|FG001|Overall Study|Death|0|||
160994640|NCT01693614|581368986|FG002|Overall Study|Death|0|||
160994641|NCT01693614|581368984|FG000|Overall Study|Physician Decision|1|||
160994642|NCT01693614|581368985|FG001|Overall Study|Physician Decision|1|||
160994643|NCT01693614|581368986|FG002|Overall Study|Physician Decision|4|||
160994644|NCT01693614|581368984|FG000|Overall Study|Withdrawal by subject/guardian|0|||
160994645|NCT01693614|581368985|FG001|Overall Study|Withdrawal by subject/guardian|0|||
160994646|NCT01693614|581368986|FG002|Overall Study|Withdrawal by subject/guardian|2|||
160994647|NCT01693614|581368984|FG000|Overall Study|Withdrawal by Subject|1|||
160994648|NCT01693614|581368985|FG001|Overall Study|Withdrawal by Subject|0|||
160994649|NCT01693614|581368986|FG002|Overall Study|Withdrawal by Subject|5|||
161141602|NCT03953118|581902542|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
160994650|NCT04618471|581368987|FG000|Overall Study|Screen Failure|62|||
160994651|NCT04618471|581368987|FG000|Overall Study|Withdrawal by Subject|6|||
161141603|NCT00004980|581902545|FG000|Overall Study|Withdrawal by Subject|1|||
161141604|NCT00004980|581902546|FG001|Overall Study|Withdrawal by Subject|0|||
160994652|NCT04618471|581368987|FG000|Overall Study|Physician Decision|2|||
160994653|NCT04618471|581368987|FG000|Overall Study|Lost to Follow-up|1|||
160994654|NCT04618471|581368987|FG000|Overall Study|Various other reasons|2|||
160994655|NCT04618471|581368987|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
160994656|NCT00588666|581368988|FG000|Overall Study|Adverse Event|4|||
160994657|NCT00927823|581368991|FG000|Continuous Dosing Period|Death|0|||
160994658|NCT00927823|581368992|FG001|Continuous Dosing Period|Death|0|||
160994659|NCT00927823|581368993|FG002|Continuous Dosing Period|Death|6|||
160994660|NCT00927823|581368994|FG003|Continuous Dosing Period|Death|0|||
160994661|NCT00927823|581368991|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
160994662|NCT00927823|581368992|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
160994663|NCT00927823|581368993|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
160994664|NCT00927823|581368994|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
160994665|NCT00927823|581368991|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
160994666|NCT00927823|581368992|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
160994667|NCT00927823|581368993|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
160994668|NCT00927823|581368994|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
160994669|NCT00927823|581368991|FG000|Continuous Dosing Period|Other|1|||
160994670|NCT00927823|581368992|FG001|Continuous Dosing Period|Other|2|||
160994671|NCT00927823|581368993|FG002|Continuous Dosing Period|Other|9|||
160994672|NCT00927823|581368994|FG003|Continuous Dosing Period|Other|3|||
160994673|NCT02299635|581368995|FG000|Overall Study|Adverse Event|2|||
160994674|NCT02299635|581368995|FG000|Overall Study|Death|1|||
160994675|NCT02299635|581368995|FG000|Overall Study|Global deterioration of health status|1|||
160994676|NCT02299635|581368995|FG000|Overall Study|Objective progression or relapse|10|||
160994677|NCT02299635|581368995|FG000|Overall Study|Withdrawal by Subject|2|||
160994678|NCT02299635|581368995|FG000|Overall Study|Other|3|||
160994679|NCT04889118|581368996|FG000|Overall Study|Death|49|||
160994680|NCT04889118|581368997|FG001|Overall Study|Death|47|||
160994681|NCT04889118|581368996|FG000|Overall Study|Sponsor Decision|15|||
160994682|NCT04889118|581368997|FG001|Overall Study|Sponsor Decision|20|||
160994683|NCT00828672|581368998|FG000|Study Treatment|Lost to Follow-up|1|||
160994684|NCT00828672|581368999|FG001|Study Treatment|Lost to Follow-up|0|||
160994685|NCT00828672|581368998|FG000|Study Treatment|Adverse Event|0|||
160994686|NCT00828672|581368999|FG001|Study Treatment|Adverse Event|1|||
160994687|NCT00828672|581368998|FG000|Study Treatment|Complete response, no surgery|1|||
160994688|NCT00828672|581368999|FG001|Study Treatment|Complete response, no surgery|1|||
160994689|NCT00828672|581368998|FG000|Post-surgery (<30 Days)|No central review materials|0|||
160994690|NCT00828672|581368999|FG001|Post-surgery (<30 Days)|No central review materials|1|||
160994691|NCT01744691|581369000|FG000|Overall Study|Progressive Disease|18|||
160994692|NCT01744691|581369000|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
160994693|NCT01744691|581369000|FG000|Overall Study|Withdrawal of consent for treatment|3|||
160994694|NCT01744691|581369000|FG000|Overall Study|Physician Decision|4|||
160994695|NCT02701361|581369001|FG000|Overall Study|Lost to Follow-up|5|||
160994696|NCT02701361|581369002|FG001|Overall Study|Lost to Follow-up|2|||
160994697|NCT02701361|581369003|FG002|Overall Study|Lost to Follow-up|1|||
160994698|NCT02701361|581369001|FG000|Overall Study|Withdrawal by Subject|4|||
160994699|NCT02701361|581369002|FG001|Overall Study|Withdrawal by Subject|0|||
160994700|NCT02701361|581369003|FG002|Overall Study|Withdrawal by Subject|0|||
160994701|NCT02701361|581369001|FG000|Overall Study|timed out in rehab center|0|||
160994702|NCT02701361|581369002|FG001|Overall Study|timed out in rehab center|1|||
160994703|NCT02701361|581369003|FG002|Overall Study|timed out in rehab center|0|||
160994704|NCT02701361|581369001|FG000|Overall Study|incarceration|0|||
160994705|NCT02701361|581369002|FG001|Overall Study|incarceration|0|||
160994706|NCT02701361|581369003|FG002|Overall Study|incarceration|1|||
160994707|NCT00404079|581369010|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
160994708|NCT00404079|581369011|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
160994709|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Other|4|||
160994710|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Other|0|||
160994711|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
160994712|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
160994713|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
160994714|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
160994715|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
160994716|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
160994717|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
160994718|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
160994719|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
160994720|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
160994721|NCT00853827|581369018|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
160994722|NCT00853827|581369019|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
160994723|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
160994724|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
160994725|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
160994726|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
160994727|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
161141605|NCT00004980|581902545|FG000|Overall Study|memory difficulties|1|||
160994728|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
160994729|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
160994730|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
160994731|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
160994732|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
161141606|NCT00004980|581902546|FG001|Overall Study|memory difficulties|1|||
161141607|NCT00004980|581902545|FG000|Overall Study|Physician Decision|0|||
160994733|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
160994734|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
160994735|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
160994736|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
160994737|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
160994738|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
160994739|NCT00853827|581369018|FG000|Double Blind Period (103 Weeks)|Death|1|||
160994740|NCT00853827|581369019|FG001|Double Blind Period (103 Weeks)|Death|6|||
160994741|NCT00580801|581369024|FG000|Overall Study|Physician Decision|1|||
160994742|NCT00580801|581369025|FG001|Overall Study|Physician Decision|0|||
160994743|NCT00580801|581369026|FG002|Overall Study|Physician Decision|0|||
160994744|NCT00580801|581369024|FG000|Overall Study|Adverse Event|2|||
160994745|NCT00580801|581369025|FG001|Overall Study|Adverse Event|0|||
160994746|NCT00580801|581369026|FG002|Overall Study|Adverse Event|0|||
160994747|NCT00580801|581369024|FG000|Overall Study|Lost to Follow-up|2|||
160994748|NCT00580801|581369025|FG001|Overall Study|Lost to Follow-up|0|||
160860274|NCT03694678|580880657|FG000|Overall Study|Withdrawal by Subject|2|||
160860275|NCT03694678|580880658|FG001|Overall Study|Withdrawal by Subject|0|||
160860276|NCT03694678|580880657|FG000|Overall Study|Lost to Follow-up|2|||
160860277|NCT03694678|580880658|FG001|Overall Study|Lost to Follow-up|3|||
160994749|NCT00580801|581369026|FG002|Overall Study|Lost to Follow-up|0|||
160994750|NCT00580801|581369024|FG000|Overall Study|Reached a virologic endpoint|0|||
160860278|NCT02435212|580880659|FG000|Core Phase|Adverse Event|8|||
160860279|NCT02435212|580880660|FG001|Core Phase|Adverse Event|5|||
160860280|NCT02435212|580880659|FG000|Core Phase|Withdrawal by Subject|3|||
160994751|NCT00580801|581369025|FG001|Overall Study|Reached a virologic endpoint|1|||
160994752|NCT00580801|581369026|FG002|Overall Study|Reached a virologic endpoint|2|||
160994753|NCT00580801|581369024|FG000|Overall Study|Participant non-compliant|0|||
160994754|NCT00580801|581369025|FG001|Overall Study|Participant non-compliant|0|||
160994755|NCT00580801|581369026|FG002|Overall Study|Participant non-compliant|1|||
160994756|NCT00580801|581369024|FG000|Overall Study|Travel|1|||
160994757|NCT00580801|581369025|FG001|Overall Study|Travel|0|||
160994758|NCT00580801|581369026|FG002|Overall Study|Travel|0|||
160994759|NCT05576051|581369027|FG000|Overall Study|Lack of Efficacy|543|||
160994760|NCT05576051|581369028|FG001|Overall Study|Lack of Efficacy|343|||
160994761|NCT05576051|581369029|FG002|Overall Study|Lack of Efficacy|108|||
160994762|NCT05576051|581369030|FG003|Overall Study|Lack of Efficacy|72|||
160994763|NCT05576051|581369031|FG004|Overall Study|Lack of Efficacy|28|||
160994764|NCT05576051|581369032|FG005|Overall Study|Lack of Efficacy|50|||
160994765|NCT05576051|581369027|FG000|Overall Study|Safety|78|||
160994766|NCT05576051|581369028|FG001|Overall Study|Safety|74|||
160994767|NCT05576051|581369029|FG002|Overall Study|Safety|16|||
160994768|NCT05576051|581369030|FG003|Overall Study|Safety|14|||
160994769|NCT05576051|581369031|FG004|Overall Study|Safety|4|||
160994770|NCT05576051|581369032|FG005|Overall Study|Safety|5|||
160994771|NCT05576051|581369027|FG000|Overall Study|Efficacy + Safety|10|||
160994772|NCT05576051|581369028|FG001|Overall Study|Efficacy + Safety|7|||
160994773|NCT05576051|581369029|FG002|Overall Study|Efficacy + Safety|3|||
160994774|NCT05576051|581369030|FG003|Overall Study|Efficacy + Safety|0|||
160994775|NCT05576051|581369031|FG004|Overall Study|Efficacy + Safety|0|||
160994776|NCT05576051|581369032|FG005|Overall Study|Efficacy + Safety|0|||
160994777|NCT05576051|581369027|FG000|Overall Study|Other|231|||
160994778|NCT05576051|581369028|FG001|Overall Study|Other|127|||
160994779|NCT05576051|581369029|FG002|Overall Study|Other|35|||
160994780|NCT05576051|581369030|FG003|Overall Study|Other|14|||
160994781|NCT05576051|581369031|FG004|Overall Study|Other|6|||
160994782|NCT05576051|581369032|FG005|Overall Study|Other|0|||
160994783|NCT04154943|581369033|FG000|Overall Study|Study Ongoing|68|||
160994784|NCT04154943|581369033|FG000|Overall Study|Lost to Follow-up|1|||
160994785|NCT04154943|581369033|FG000|Overall Study|Decision by the Investigator|1|||
160994786|NCT04154943|581369033|FG000|Overall Study|Death|5|||
160994787|NCT04154943|581369033|FG000|Overall Study|Withdrawal by Subject|4|||
160994788|NCT00544440|581369034|FG000|Overall Study|Other|1|||
160994789|NCT00544440|581369034|FG000|Overall Study|Adverse Event|1|||
160994790|NCT00544440|581369034|FG000|Overall Study|Withdrawal by Subject|2|||
160994791|NCT00544440|581369034|FG000|Overall Study|Subject Non-compliance|1|||
160994792|NCT00544440|581369034|FG000|Overall Study|Progressive Disease|47|||
160994793|NCT00544440|581369034|FG000|Overall Study|Other|5|||
160994794|NCT05650333|581369035|FG000|Treatment Period (7 Days)|Adverse Event|1|||
160994795|NCT01460342|581369036|FG000|Overall Study|Adverse Event|5|||
160994796|NCT01460342|581369037|FG001|Overall Study|Adverse Event|4|||
160860281|NCT02435212|580880660|FG001|Core Phase|Withdrawal by Subject|0|||
160860282|NCT02435212|580880659|FG000|Core Phase|Withdrawal by parent/guardian|9|||
160994797|NCT01460342|581369036|FG000|Overall Study|Lost to Follow-up|1|||
160994798|NCT01460342|581369037|FG001|Overall Study|Lost to Follow-up|2|||
160994799|NCT01460342|581369036|FG000|Overall Study|Protocol Violation|0|||
160994800|NCT01460342|581369037|FG001|Overall Study|Protocol Violation|1|||
160994801|NCT01460342|581369036|FG000|Overall Study|Withdrawal by Subject|3|||
160994802|NCT01460342|581369037|FG001|Overall Study|Withdrawal by Subject|4|||
160994803|NCT01460342|581369036|FG000|Overall Study|Physician Decision|1|||
161339071|NCT00471497|582630416|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
160860283|NCT02435212|580880660|FG001|Core Phase|Withdrawal by parent/guardian|4|||
161339072|NCT00471497|582630414|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
160860284|NCT02435212|580880659|FG000|Core Phase|Protocol Violation|1|||
160860285|NCT02435212|580880660|FG001|Core Phase|Protocol Violation|2|||
160860286|NCT02435212|580880659|FG000|Core Phase|Physician Decision|3|||
160860287|NCT02435212|580880660|FG001|Core Phase|Physician Decision|0|||
160860288|NCT02435212|580880659|FG000|Core Phase|Lost to Follow-up|0|||
160860289|NCT02435212|580880660|FG001|Core Phase|Lost to Follow-up|1|||
160860290|NCT02435212|580880659|FG000|Core Phase|Lack of Efficacy|0|||
160860291|NCT02435212|580880660|FG001|Core Phase|Lack of Efficacy|1|||
160860292|NCT02435212|580880659|FG000|Core Phase|Recovery|1|||
160860293|NCT02435212|580880660|FG001|Core Phase|Recovery|0|||
160860294|NCT02435212|580880659|FG000|Optional Extension Phase|Adverse Event|3|||
160860295|NCT02435212|580880660|FG001|Optional Extension Phase|Adverse Event|9|||
160860296|NCT02435212|580880659|FG000|Optional Extension Phase|Physician Decision|6|||
160860297|NCT02435212|580880660|FG001|Optional Extension Phase|Physician Decision|8|||
160860298|NCT02435212|580880659|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
160860299|NCT02435212|580880660|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
160860300|NCT02435212|580880659|FG000|Optional Extension Phase|Lack of Efficacy|2|||
160860301|NCT02435212|580880660|FG001|Optional Extension Phase|Lack of Efficacy|3|||
160860302|NCT02435212|580880659|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
160860303|NCT02435212|580880660|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
160860304|NCT02435212|580880659|FG000|Optional Extension Phase|Protocol Violation|0|||
160860305|NCT02435212|580880660|FG001|Optional Extension Phase|Protocol Violation|1|||
160860306|NCT02435212|580880659|FG000|Optional Extension Phase|Recovery|1|||
160860307|NCT02435212|580880660|FG001|Optional Extension Phase|Recovery|1|||
160860308|NCT02435212|580880659|FG000|Optional Extension Phase|Death|1|||
160860309|NCT02435212|580880660|FG001|Optional Extension Phase|Death|0|||
160860310|NCT02435212|580880659|FG000|Optional Extension Phase|Technical problems|2|||
160860311|NCT02435212|580880660|FG001|Optional Extension Phase|Technical problems|0|||
160860312|NCT04819945|580880661|FG000|Overall Study|Lost to Follow-up|1|||
160860313|NCT04531176|580880664|FG000|Overall Study|Study was stopped early|24|||
160860314|NCT04531176|580880665|FG001|Overall Study|Study was stopped early|26|||
160860315|NCT04531176|580880666|FG002|Overall Study|Study was stopped early|24|||
160860316|NCT00561652|580880671|FG000|Overall Study|Withdrawal by Subject|0|||
160860317|NCT00561652|580880672|FG001|Overall Study|Withdrawal by Subject|1|||
160860318|NCT00771914|580880675|FG000|Overall Study|Physician Decision|0|||
160860319|NCT00771914|580880676|FG001|Overall Study|Physician Decision|0|||
160860320|NCT00771914|580880677|FG002|Overall Study|Physician Decision|0|||
160860321|NCT00771914|580880678|FG003|Overall Study|Physician Decision|1|||
160860322|NCT00771914|580880675|FG000|Overall Study|Lost to Follow-up|0|||
160860323|NCT00771914|580880676|FG001|Overall Study|Lost to Follow-up|0|||
160860324|NCT00771914|580880677|FG002|Overall Study|Lost to Follow-up|0|||
160860325|NCT00771914|580880678|FG003|Overall Study|Lost to Follow-up|1|||
160860326|NCT01743469|580880681|FG000|Active Treatment Phase|Adverse Event|10|||
160860327|NCT01743469|580880682|FG001|Active Treatment Phase|Adverse Event|5|||
160860328|NCT01743469|580880683|FG002|Active Treatment Phase|Adverse Event|8|||
160860329|NCT01743469|580880684|FG003|Active Treatment Phase|Adverse Event|1|||
160860330|NCT01743469|580880681|FG000|Active Treatment Phase|Disease Progression|40|||
160860331|NCT01743469|580880682|FG001|Active Treatment Phase|Disease Progression|47|||
160860332|NCT01743469|580880683|FG002|Active Treatment Phase|Disease Progression|30|||
160860333|NCT01743469|580880684|FG003|Active Treatment Phase|Disease Progression|20|||
160860334|NCT01743469|580880681|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
160860335|NCT01743469|580880682|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
160860336|NCT01743469|580880683|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
160860337|NCT01743469|580880684|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
160860338|NCT01743469|580880681|FG000|Active Treatment Phase|Missing|1|||
160860339|NCT01743469|580880682|FG001|Active Treatment Phase|Missing|0|||
160860340|NCT01743469|580880683|FG002|Active Treatment Phase|Missing|0|||
161339073|NCT00471497|582630415|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
160860341|NCT01743469|580880684|FG003|Active Treatment Phase|Missing|0|||
160860342|NCT01743469|580880681|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
160860343|NCT01743469|580880682|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
160860344|NCT01743469|580880683|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
160860345|NCT01743469|580880684|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
160860346|NCT01743469|580880681|FG000|Follow-up Period - Post-Treatment|Death|43|||
160860347|NCT01743469|580880682|FG001|Follow-up Period - Post-Treatment|Death|47|||
161141608|NCT00004980|581902546|FG001|Overall Study|Physician Decision|1|||
160860348|NCT01743469|580880683|FG002|Follow-up Period - Post-Treatment|Death|22|||
160860349|NCT01743469|580880684|FG003|Follow-up Period - Post-Treatment|Death|16|||
160860350|NCT01743469|580880681|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
160860351|NCT01743469|580880682|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
160860352|NCT01743469|580880683|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
161141609|NCT00820040|581902553|FG000|Overall Study|Death|1|||
160860353|NCT01743469|580880684|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
160860354|NCT01451606|580880687|FG000|Overall Study|Withdrawal by Subject|4|||
160860355|NCT01451606|580880688|FG001|Overall Study|Withdrawal by Subject|3|||
160860356|NCT01667900|580880692|FG000|Part B|Death|0|||
160860357|NCT01667900|580880693|FG001|Part B|Death|0|||
160860358|NCT01667900|580880694|FG002|Part B|Death|0|||
160860359|NCT01667900|580880695|FG003|Part B|Death|0|||
160860360|NCT01667900|580880696|FG004|Part B|Death|0|||
160860361|NCT01667900|580880697|FG005|Part B|Death|0|||
160860362|NCT01667900|580880698|FG006|Part B|Death|0|||
160860363|NCT01667900|580880699|FG007|Part B|Death|0|||
160860364|NCT01667900|580880700|FG008|Part B|Death|0|||
160860365|NCT01667900|580880701|FG009|Part B|Death|0|||
160860366|NCT01667900|580880702|FG010|Part B|Death|0|||
160860367|NCT01667900|580880703|FG011|Part B|Death|0|||
160860368|NCT01667900|580880704|FG012|Part B|Death|0|||
160860369|NCT01667900|580880705|FG013|Part B|Death|0|||
160860370|NCT01667900|580880706|FG014|Part B|Death|0|||
160860371|NCT01667900|580880707|FG015|Part B|Death|0|||
160860372|NCT01667900|580880708|FG016|Part B|Death|1|||
160860373|NCT01667900|580880709|FG017|Part B|Death|0|||
160860374|NCT01667900|580880710|FG018|Part B|Death|0|||
160860375|NCT01667900|580880711|FG019|Part B|Death|0|||
160860376|NCT01345240|580880712|FG000|Overall Study|Adverse Event|3|||
160860377|NCT01345240|580880713|FG001|Overall Study|Adverse Event|5|||
160860378|NCT01345240|580880714|FG002|Overall Study|Adverse Event|4|||
160860379|NCT01345240|580880715|FG003|Overall Study|Adverse Event|2|||
160860380|NCT01345240|580880716|FG004|Overall Study|Adverse Event|1|||
160860381|NCT01345240|580880712|FG000|Overall Study|Lost to Follow-up|8|||
160860382|NCT01345240|580880713|FG001|Overall Study|Lost to Follow-up|9|||
160860383|NCT01345240|580880714|FG002|Overall Study|Lost to Follow-up|14|||
160860384|NCT01345240|580880715|FG003|Overall Study|Lost to Follow-up|7|||
160860385|NCT01345240|580880716|FG004|Overall Study|Lost to Follow-up|9|||
160860386|NCT00774046|580880719|FG000|Screening|Not eligible|56|||
160860387|NCT00774046|580880719|FG000|Enrollment|Desired other therapy/refused|28|||
160860388|NCT00774046|580880719|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
160860389|NCT01614249|580880720|FG000|Overall Study|Lost to Follow-up|11|||
160860390|NCT01614249|580880721|FG001|Overall Study|Lost to Follow-up|23|||
160860391|NCT05498649|580880722|FG000|Overall Study|Lost to Follow-up|1|||
160860392|NCT03094416|580880723|FG000|Run-in|Screening failure|8|||
160860393|NCT03094416|580880723|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
160860394|NCT03094416|580880723|FG000|Run-in|Withdrawal by Subject|3|||
160860395|NCT03094416|580880723|FG000|Treatment Period|Withdrawal by Subject|2|||
160860396|NCT00005780|580880725|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
160860397|NCT00374140|580880726|FG000|Overall Study|Lost to Follow-up|1|||
160860398|NCT00374140|580880726|FG000|Overall Study|Protocol Violation|1|||
160860399|NCT02651675|580880727|FG000|Overall Study|Death|0|||
160860400|NCT02651675|580880728|FG001|Overall Study|Death|0|||
160860401|NCT02651675|580880729|FG002|Overall Study|Death|1|||
160860402|NCT02246530|580880730|FG000|Overall Study|Lost to Follow-up|4|||
160860403|NCT02246530|580880731|FG001|Overall Study|Lost to Follow-up|0|||
160860404|NCT01615939|580883030|FG000|Overall Study|Lost to Follow-up|5|||
160860405|NCT01615939|580883031|FG001|Overall Study|Lost to Follow-up|0|||
160860406|NCT01586364|580883035|FG000|Overall Study|Withdrawal by Subject|40|||
160860407|NCT01586364|580883035|FG000|Overall Study|Adverse Event|37|||
160860408|NCT01586364|580883035|FG000|Overall Study|Lost to Follow-up|17|||
160860409|NCT01586364|580883035|FG000|Overall Study|Protocol Violation|16|||
160860410|NCT01586364|580883035|FG000|Overall Study|Lack of Efficacy|1|||
160860411|NCT01586364|580883035|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
160860412|NCT01586364|580883035|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
160860413|NCT01586364|580883035|FG000|Overall Study|Other-Site closure due to PI illness|1|||
160860414|NCT01586364|580883035|FG000|Overall Study|Other-PI discretion, site closing|2|||
160860415|NCT01586364|580883035|FG000|Overall Study|Other-Not specified|1|||
160860416|NCT02121535|580883036|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
160860417|NCT02121535|580883037|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
160860418|NCT02121535|580883036|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
160860419|NCT02121535|580883037|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
160860420|NCT04944992|580883038|FG000|Overall Study|Lost to Follow-up|1|||
160860421|NCT04944992|580883039|FG001|Overall Study|Lost to Follow-up|1|||
160860422|NCT04944992|580883038|FG000|Overall Study|Physician Decision|1|||
160860423|NCT04944992|580883039|FG001|Overall Study|Physician Decision|0|||
160860424|NCT04944992|580883038|FG000|Overall Study|Withdrawal by Subject|6|||
160860425|NCT04944992|580883039|FG001|Overall Study|Withdrawal by Subject|1|||
160860426|NCT02345070|580883046|FG000|Overall Study|Adverse Event|12|||
160860427|NCT02345070|580883047|FG001|Overall Study|Adverse Event|8|||
160860428|NCT02345070|580883048|FG002|Overall Study|Adverse Event|16|||
160860429|NCT02345070|580883046|FG000|Overall Study|Poor compliance to protocol|2|||
160860430|NCT02345070|580883047|FG001|Overall Study|Poor compliance to protocol|0|||
160860431|NCT02345070|580883048|FG002|Overall Study|Poor compliance to protocol|0|||
160860432|NCT02345070|580883046|FG000|Overall Study|Other than specified above|6|||
160860433|NCT02345070|580883047|FG001|Overall Study|Other than specified above|3|||
160860434|NCT02345070|580883048|FG002|Overall Study|Other than specified above|7|||
160860435|NCT03044106|580883051|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
160860436|NCT03044106|580883052|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
160860437|NCT01207414|580883053|FG000|Overall Study|Adverse Event|25|||
160860438|NCT01207414|580883054|FG001|Overall Study|Adverse Event|39|||
160860439|NCT01207414|580883053|FG000|Overall Study|Abnormal test procedure results|0|||
160860440|NCT01207414|580883054|FG001|Overall Study|Abnormal test procedure results|1|||
160860441|NCT01207414|580883053|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
160860442|NCT01207414|580883054|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160860443|NCT01207414|580883053|FG000|Overall Study|Patient withdrew consent|14|||
160860444|NCT01207414|580883054|FG001|Overall Study|Patient withdrew consent|11|||
160860445|NCT01207414|580883053|FG000|Overall Study|Lost to Follow-up|15|||
160860446|NCT01207414|580883054|FG001|Overall Study|Lost to Follow-up|17|||
160860447|NCT01207414|580883053|FG000|Overall Study|Administrative problems|1|||
160860448|NCT01207414|580883054|FG001|Overall Study|Administrative problems|1|||
160860449|NCT01207414|580883053|FG000|Overall Study|Protocol deviation|12|||
160860450|NCT01207414|580883054|FG001|Overall Study|Protocol deviation|9|||
160860451|NCT01207414|580883053|FG000|Overall Study|Randomized in error|1|||
160860452|NCT01207414|580883054|FG001|Overall Study|Randomized in error|0|||
160860453|NCT01748292|580883055|FG000|Overall Study|Adverse Event|2|||
160994804|NCT01460342|581369037|FG001|Overall Study|Physician Decision|3|||
160994805|NCT01460342|581369036|FG000|Overall Study|Lack of Efficacy|1|||
160994806|NCT01460342|581369037|FG001|Overall Study|Lack of Efficacy|0|||
160994807|NCT03761784|581369038|FG000|Overall Study|Adverse Event|4|||
160994808|NCT03761784|581369039|FG001|Overall Study|Adverse Event|0|||
160860454|NCT01748292|580883056|FG001|Overall Study|Adverse Event|4|||
160860455|NCT01748292|580883055|FG000|Overall Study|Lost to Follow-up|0|||
160860456|NCT01748292|580883056|FG001|Overall Study|Lost to Follow-up|3|||
160860457|NCT01748292|580883055|FG000|Overall Study|Death|0|||
160860458|NCT01748292|580883056|FG001|Overall Study|Death|3|||
160994809|NCT03761784|581369038|FG000|Overall Study|Lost to Follow-up|10|||
160994810|NCT03761784|581369039|FG001|Overall Study|Lost to Follow-up|7|||
160994811|NCT03761784|581369038|FG000|Overall Study|Pregnancy|1|||
160994812|NCT03761784|581369039|FG001|Overall Study|Pregnancy|0|||
160994813|NCT03761784|581369038|FG000|Overall Study|Protocol Violation|2|||
160994814|NCT03761784|581369039|FG001|Overall Study|Protocol Violation|0|||
160994815|NCT03761784|581369038|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
160994816|NCT03761784|581369039|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
160994817|NCT03761784|581369038|FG000|Overall Study|Withdrawal by Subject|9|||
160994818|NCT03761784|581369039|FG001|Overall Study|Withdrawal by Subject|4|||
160994819|NCT03761784|581369038|FG000|Overall Study|Physician Decision|1|||
160994820|NCT03761784|581369039|FG001|Overall Study|Physician Decision|0|||
160994821|NCT03761784|581369038|FG000|Overall Study|Other Than Specified|1|||
160994822|NCT03761784|581369039|FG001|Overall Study|Other Than Specified|0|||
160994823|NCT01194258|581369042|FG000|Titration Period|Withdrawal by Subject|6|||
161256324|NCT03297294|582316423|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
160860459|NCT01748292|580883055|FG000|Overall Study|Withdrawal by Subject|0|||
160860460|NCT01748292|580883056|FG001|Overall Study|Withdrawal by Subject|2|||
160860461|NCT02057250|580883057|FG000|AID Assessment Phase|Adverse Event|3|||
160860462|NCT02057250|580883058|FG001|AID Assessment Phase|Adverse Event|2|||
160860463|NCT02057250|580883059|FG002|AID Assessment Phase|Adverse Event|6|||
160860464|NCT02057250|580883060|FG003|AID Assessment Phase|Adverse Event|1|||
160860465|NCT02057250|580883061|FG004|AID Assessment Phase|Adverse Event|0|||
160860466|NCT02057250|580883057|FG000|AID Assessment Phase|Other than specified above|1|||
160860467|NCT02057250|580883058|FG001|AID Assessment Phase|Other than specified above|1|||
160860468|NCT02057250|580883059|FG002|AID Assessment Phase|Other than specified above|1|||
160860469|NCT02057250|580883060|FG003|AID Assessment Phase|Other than specified above|1|||
160860470|NCT02057250|580883061|FG004|AID Assessment Phase|Other than specified above|0|||
160860471|NCT02057250|580883057|FG000|Extension Phase|Adverse Event|0|||
160860472|NCT02057250|580883058|FG001|Extension Phase|Adverse Event|0|||
160860473|NCT02057250|580883059|FG002|Extension Phase|Adverse Event|0|||
160860474|NCT02057250|580883060|FG003|Extension Phase|Adverse Event|0|||
160860475|NCT02057250|580883061|FG004|Extension Phase|Adverse Event|15|||
160994824|NCT01194258|581369043|FG001|Titration Period|Withdrawal by Subject|0|||
160994825|NCT01194258|581369044|FG002|Titration Period|Withdrawal by Subject|0|||
160994826|NCT01194258|581369045|FG003|Titration Period|Withdrawal by Subject|0|||
160994827|NCT01194258|581369046|FG004|Titration Period|Withdrawal by Subject|0|||
160994828|NCT01194258|581369042|FG000|Titration Period|Lost to Follow-up|2|||
160860476|NCT02057250|580883057|FG000|Extension Phase|Lack of Efficacy|0|||
160994829|NCT01194258|581369043|FG001|Titration Period|Lost to Follow-up|0|||
160994830|NCT01194258|581369044|FG002|Titration Period|Lost to Follow-up|0|||
160994831|NCT01194258|581369045|FG003|Titration Period|Lost to Follow-up|0|||
160994832|NCT01194258|581369046|FG004|Titration Period|Lost to Follow-up|0|||
161256325|NCT03297294|582316419|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
160860477|NCT02057250|580883058|FG001|Extension Phase|Lack of Efficacy|0|||
160860478|NCT02057250|580883059|FG002|Extension Phase|Lack of Efficacy|0|||
160860479|NCT02057250|580883060|FG003|Extension Phase|Lack of Efficacy|0|||
160860480|NCT02057250|580883061|FG004|Extension Phase|Lack of Efficacy|10|||
160860481|NCT02057250|580883057|FG000|Extension Phase|Entered in this period but not treated|0|||
160860482|NCT02057250|580883058|FG001|Extension Phase|Entered in this period but not treated|0|||
160860483|NCT02057250|580883059|FG002|Extension Phase|Entered in this period but not treated|0|||
160860484|NCT02057250|580883060|FG003|Extension Phase|Entered in this period but not treated|0|||
160860485|NCT02057250|580883061|FG004|Extension Phase|Entered in this period but not treated|4|||
160860486|NCT02057250|580883057|FG000|Extension Phase|Other than specified above|0|||
160860487|NCT02057250|580883058|FG001|Extension Phase|Other than specified above|0|||
160860488|NCT02057250|580883059|FG002|Extension Phase|Other than specified above|0|||
160860489|NCT02057250|580883060|FG003|Extension Phase|Other than specified above|0|||
160860490|NCT02057250|580883061|FG004|Extension Phase|Other than specified above|7|||
160860491|NCT03367793|580883065|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860492|NCT03367793|580883066|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860493|NCT03367793|580883067|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
160860494|NCT03367793|580883068|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860495|NCT03367793|580883069|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860496|NCT03367793|580883070|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
160860497|NCT03199976|580883071|FG000|Overall Study|Lack of Efficacy|3|||
160860498|NCT03199976|580883072|FG001|Overall Study|Lack of Efficacy|6|||
160860499|NCT03199976|580883073|FG002|Overall Study|Lack of Efficacy|13|||
160860500|NCT03199976|580883071|FG000|Overall Study|Withdrawal by Subject|1|||
160860501|NCT03199976|580883072|FG001|Overall Study|Withdrawal by Subject|0|||
160860502|NCT03199976|580883073|FG002|Overall Study|Withdrawal by Subject|0|||
160860503|NCT03199976|580883071|FG000|Overall Study|Lost to Follow-up|0|||
160860504|NCT03199976|580883072|FG001|Overall Study|Lost to Follow-up|1|||
160860505|NCT03199976|580883073|FG002|Overall Study|Lost to Follow-up|1|||
160860506|NCT00260533|580883076|FG000|Overall Study|Other|3|||
160860507|NCT00260533|580883077|FG001|Overall Study|Other|3|||
160860508|NCT01761877|580883078|FG000|Overall Study|Adverse Event|7|||
160860509|NCT01761877|580883079|FG001|Overall Study|Adverse Event|0|||
160860510|NCT01761877|580883078|FG000|Overall Study|Withdrawal by Subject|6|||
160860511|NCT01761877|580883079|FG001|Overall Study|Withdrawal by Subject|4|||
160860512|NCT01761877|580883078|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
160860513|NCT01761877|580883079|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
160860514|NCT01761877|580883078|FG000|Overall Study|Death|0|||
160860515|NCT01761877|580883079|FG001|Overall Study|Death|1|||
160860516|NCT01761877|580883078|FG000|Overall Study|MRI intolerant|1|||
160860517|NCT01761877|580883079|FG001|Overall Study|MRI intolerant|6|||
160860518|NCT00003475|580883080|FG000|Overall Study|Not evaluable|13|||
160860519|NCT03962491|580883081|FG000|Overall Study|Lost to Follow-up|4|||
160860520|NCT03962491|580883082|FG001|Overall Study|Lost to Follow-up|5|||
160860521|NCT00106704|580883089|FG000|Overall Study|Adverse Event|10|||
160860522|NCT00106704|580883090|FG001|Overall Study|Adverse Event|7|||
160860523|NCT00106704|580883089|FG000|Overall Study|Death|2|||
160860524|NCT00106704|580883090|FG001|Overall Study|Death|1|||
160860525|NCT00106704|580883089|FG000|Overall Study|Lack of Efficacy|67|||
160860526|NCT00106704|580883090|FG001|Overall Study|Lack of Efficacy|69|||
160860527|NCT00106704|580883089|FG000|Overall Study|Lost to Follow-up|7|||
160860528|NCT00106704|580883090|FG001|Overall Study|Lost to Follow-up|3|||
160860529|NCT00106704|580883089|FG000|Overall Study|Pregnancy|1|||
160860530|NCT00106704|580883090|FG001|Overall Study|Pregnancy|0|||
160860531|NCT00106704|580883089|FG000|Overall Study|Protocol Violation|4|||
160860532|NCT00106704|580883090|FG001|Overall Study|Protocol Violation|7|||
160860533|NCT00106704|580883089|FG000|Overall Study|Withdrawal by Subject|14|||
160860534|NCT00106704|580883090|FG001|Overall Study|Withdrawal by Subject|21|||
160860535|NCT00106704|580883089|FG000|Overall Study|Patient moved|1|||
160860536|NCT00106704|580883090|FG001|Overall Study|Patient moved|0|||
160860537|NCT00106704|580883089|FG000|Overall Study|Site terminated|0|||
160860538|NCT00106704|580883090|FG001|Overall Study|Site terminated|1|||
160860539|NCT00106704|580883089|FG000|Overall Study|Planned major surgery|1|||
160860540|NCT00106704|580883090|FG001|Overall Study|Planned major surgery|0|||
160860541|NCT00106704|580883089|FG000|Overall Study|Patient Received Glycemic Medication|22|||
160909431|NCT01218204|581063968|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
160909432|NCT01218204|581063969|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
160909433|NCT01218204|581063970|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
160909434|NCT01218204|581063971|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
160860542|NCT00106704|580883090|FG001|Overall Study|Patient Received Glycemic Medication|41|||
160860543|NCT00106704|580883089|FG000|Overall Study|Unable to re-enter US|1|||
160860544|NCT00106704|580883090|FG001|Overall Study|Unable to re-enter US|0|||
160860545|NCT00106704|580883089|FG000|Overall Study|Laboratory test|1|||
160860546|NCT00106704|580883090|FG001|Overall Study|Laboratory test|1|||
160909435|NCT01539538|581063982|FG000|Overall Study|Adverse Event|13|||
160860547|NCT01780506|580883091|FG000|Double-Blind Phase|Randomized but not Treated|3|||
160860548|NCT01780506|580883092|FG001|Double-Blind Phase|Randomized but not Treated|2|||
160909436|NCT01539538|581063983|FG001|Overall Study|Adverse Event|18|||
160909437|NCT01539538|581063982|FG000|Overall Study|Lack of Efficacy|13|||
160909438|NCT01539538|581063983|FG001|Overall Study|Lack of Efficacy|16|||
160909439|NCT01539538|581063982|FG000|Overall Study|Withdrawal by Subject|2|||
160909440|NCT01539538|581063983|FG001|Overall Study|Withdrawal by Subject|3|||
160909441|NCT01539538|581063982|FG000|Overall Study|PCA no longer required or PCA problem|3|||
160909442|NCT01539538|581063983|FG001|Overall Study|PCA no longer required or PCA problem|7|||
160909443|NCT03897465|581063984|FG000|Overall Study|Lost to Follow-up|2|||
160909444|NCT03897465|581063985|FG001|Overall Study|Lost to Follow-up|1|||
160909445|NCT03897465|581063984|FG000|Overall Study|Adverse Event|2|||
160909446|NCT03897465|581063985|FG001|Overall Study|Adverse Event|0|||
160909447|NCT03897465|581063984|FG000|Overall Study|complete healing by V2|1|||
160909448|NCT03897465|581063985|FG001|Overall Study|complete healing by V2|0|||
160909449|NCT03897465|581063984|FG000|Overall Study|occurence of exclusion criterion|1|||
160909450|NCT03897465|581063985|FG001|Overall Study|occurence of exclusion criterion|1|||
160909451|NCT03897465|581063984|FG000|Overall Study|Other|1|||
160909452|NCT03897465|581063985|FG001|Overall Study|Other|0|||
160909453|NCT00847379|581063986|FG000|Overall Study|Study terminated by Sponsor|59|||
160909454|NCT00847379|581063987|FG001|Overall Study|Study terminated by Sponsor|57|||
160909455|NCT00847379|581063988|FG002|Overall Study|Study terminated by Sponsor|57|||
160909456|NCT00521014|581063989|FG000|Overall Study|Inevaluable, not treated|1|||
160909457|NCT04390191|581063990|FG000|Overall Study|Withdrawal by Subject|1|||
160909458|NCT04390191|581063991|FG001|Overall Study|Withdrawal by Subject|0|||
160909459|NCT03978832|581063994|FG000|Overall Study|Adverse Event|1|||
160909460|NCT03978832|581063994|FG000|Overall Study|Lost to Follow-up|1|||
160909461|NCT03978832|581063994|FG000|Overall Study|Withdrawal by Subject|6|||
160909462|NCT03978832|581063994|FG000|Overall Study|Physician Decision|2|||
160909463|NCT03978832|581063994|FG000|Overall Study|did not pass screening criteria|44|||
160909464|NCT00003499|581063995|FG000|Overall Study|Not evaluable|8|||
160909465|NCT02042183|581064000|FG000|Overall Study|Physician Decision|7|||
160909466|NCT02042183|581064001|FG001|Overall Study|Physician Decision|2|||
160909467|NCT02042183|581064000|FG000|Overall Study|Lack of Efficacy|4|||
160909468|NCT02042183|581064001|FG001|Overall Study|Lack of Efficacy|3|||
160909469|NCT02042183|581064000|FG000|Overall Study|Non-compliance with Study Drug|2|||
160909470|NCT02042183|581064001|FG001|Overall Study|Non-compliance with Study Drug|3|||
160909471|NCT02042183|581064000|FG000|Overall Study|Adverse Event|17|||
160909472|NCT02042183|581064001|FG001|Overall Study|Adverse Event|6|||
160909473|NCT02042183|581064000|FG000|Overall Study|Other|3|||
160909474|NCT02042183|581064001|FG001|Overall Study|Other|3|||
160909475|NCT02042183|581064000|FG000|Overall Study|Withdrawal by Subject|21|||
160909476|NCT02042183|581064001|FG001|Overall Study|Withdrawal by Subject|16|||
160909477|NCT02042183|581064000|FG000|Overall Study|Site Terminated by Sponsor|2|||
160909478|NCT02042183|581064001|FG001|Overall Study|Site Terminated by Sponsor|1|||
160909479|NCT02042183|581064000|FG000|Overall Study|Lost to Follow-up|9|||
160909480|NCT02042183|581064001|FG001|Overall Study|Lost to Follow-up|2|||
160909481|NCT01256008|581064002|FG000|Overall Study|Lost to Follow-up|6|||
160909482|NCT01256008|581064003|FG001|Overall Study|Lost to Follow-up|4|||
160909483|NCT01256008|581064004|FG002|Overall Study|Lost to Follow-up|11|||
160909484|NCT01256008|581064002|FG000|Overall Study|Withdrawal by Subject|2|||
160909485|NCT01256008|581064003|FG001|Overall Study|Withdrawal by Subject|3|||
160909486|NCT01256008|581064004|FG002|Overall Study|Withdrawal by Subject|10|||
160909487|NCT00378378|581064007|FG000|Overall Study|Withdrawal by Subject|0|||
160909488|NCT00378378|581064008|FG001|Overall Study|Withdrawal by Subject|1|||
160909489|NCT00378378|581064009|FG002|Overall Study|Withdrawal by Subject|0|||
160909490|NCT00378378|581064007|FG000|Overall Study|Treatment Failure|0|||
160909491|NCT00378378|581064008|FG001|Overall Study|Treatment Failure|0|||
160909492|NCT00378378|581064009|FG002|Overall Study|Treatment Failure|1|||
160909493|NCT00378378|581064007|FG000|Overall Study|Non-compliance with protocol|0|||
160909494|NCT00378378|581064008|FG001|Overall Study|Non-compliance with protocol|0|||
160909495|NCT00378378|581064009|FG002|Overall Study|Non-compliance with protocol|1|||
160909496|NCT01854710|581064019|FG000|Overall Study|Withdrawal by Subject|2|||
160909497|NCT01854710|581064020|FG001|Overall Study|Withdrawal by Subject|1|||
160909498|NCT01854710|581064021|FG002|Overall Study|Withdrawal by Subject|0|||
160909499|NCT01854710|581064022|FG003|Overall Study|Withdrawal by Subject|0|||
160909500|NCT01854710|581064023|FG004|Overall Study|Withdrawal by Subject|0|||
160909501|NCT01854710|581064024|FG005|Overall Study|Withdrawal by Subject|0|||
160909502|NCT01854710|581064019|FG000|Overall Study|CRI procedural error|2|||
160909503|NCT01854710|581064020|FG001|Overall Study|CRI procedural error|2|||
160909504|NCT01854710|581064021|FG002|Overall Study|CRI procedural error|2|||
160909505|NCT01854710|581064022|FG003|Overall Study|CRI procedural error|2|||
160909506|NCT01854710|581064023|FG004|Overall Study|CRI procedural error|2|||
160909507|NCT01854710|581064024|FG005|Overall Study|CRI procedural error|2|||
160909508|NCT03132220|581064029|FG000|Overall Study|Lost to Follow-up|17|||
160909509|NCT03132220|581064030|FG001|Overall Study|Lost to Follow-up|8|||
160909510|NCT03132220|581064029|FG000|Overall Study|Withdrawal by Subject|1|||
160909511|NCT03132220|581064030|FG001|Overall Study|Withdrawal by Subject|4|||
160909512|NCT02296320|581064035|FG000|Overall Study|Withdrawal by Subject|4|||
160909513|NCT02296320|581064036|FG001|Overall Study|Withdrawal by Subject|0|||
160994833|NCT01194258|581369042|FG000|Titration Period|Titration failure|3|||
160994834|NCT01194258|581369043|FG001|Titration Period|Titration failure|0|||
160994835|NCT01194258|581369044|FG002|Titration Period|Titration failure|0|||
160994836|NCT01194258|581369045|FG003|Titration Period|Titration failure|0|||
160994837|NCT01194258|581369046|FG004|Titration Period|Titration failure|0|||
160994838|NCT01194258|581369042|FG000|Period 1 (12 Weeks)|Death|0|||
160994839|NCT01194258|581369043|FG001|Period 1 (12 Weeks)|Death|0|||
160994840|NCT01194258|581369044|FG002|Period 1 (12 Weeks)|Death|0|||
160994841|NCT01194258|581369045|FG003|Period 1 (12 Weeks)|Death|0|||
160994842|NCT01194258|581369046|FG004|Period 1 (12 Weeks)|Death|1|||
160994843|NCT01194258|581369042|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994844|NCT01194258|581369043|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994845|NCT01194258|581369044|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994846|NCT01194258|581369045|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
160994847|NCT01194258|581369046|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
160994848|NCT01194258|581369042|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
160994849|NCT01194258|581369043|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
160994850|NCT01194258|581369044|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
160994851|NCT01194258|581369045|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
160994852|NCT01194258|581369046|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
160994853|NCT01194258|581369042|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160994854|NCT01194258|581369043|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160994855|NCT01194258|581369044|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
160994856|NCT01194258|581369045|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160994857|NCT01194258|581369046|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160994858|NCT02873754|581369048|FG000|Overall Study|Lost to Follow-up|5|||
160994859|NCT02873754|581369048|FG000|Overall Study|Couldn't complete study procedures|1|||
160994860|NCT01981850|581369049|FG000|Main Phase Stage 1|Death|2|||
160994861|NCT01981850|581369050|FG001|Main Phase Stage 1|Death|0|||
160994862|NCT01981850|581369051|FG002|Main Phase Stage 1|Death|0|||
160994863|NCT01981850|581369052|FG003|Main Phase Stage 1|Death|0|||
160994864|NCT01981850|581369053|FG004|Main Phase Stage 1|Death|0|||
160994865|NCT01981850|581369054|FG005|Main Phase Stage 1|Death|0|||
160994866|NCT01981850|581369055|FG006|Main Phase Stage 1|Death|0|||
160994867|NCT01981850|581369056|FG007|Main Phase Stage 1|Death|0|||
160994868|NCT01981850|581369057|FG008|Main Phase Stage 1|Death|0|||
160994869|NCT01981850|581369058|FG009|Main Phase Stage 1|Death|0|||
160994870|NCT01981850|581369049|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
160994871|NCT01981850|581369050|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994872|NCT01981850|581369051|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994873|NCT01981850|581369052|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994874|NCT01981850|581369053|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994875|NCT01981850|581369054|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994876|NCT01981850|581369055|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994877|NCT01981850|581369056|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994878|NCT01981850|581369057|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994879|NCT01981850|581369058|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
160994880|NCT01981850|581369049|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
160994881|NCT01981850|581369050|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
160994882|NCT01981850|581369051|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
160994883|NCT01981850|581369052|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
160994884|NCT01981850|581369053|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
160994885|NCT01981850|581369054|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
160994886|NCT01981850|581369055|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
160994887|NCT01981850|581369056|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
160994888|NCT01981850|581369057|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
160994889|NCT01981850|581369058|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
160994890|NCT01981850|581369049|FG000|Main Phase Stage 1|Various reasons|0|||
160994891|NCT01981850|581369050|FG001|Main Phase Stage 1|Various reasons|0|||
160994892|NCT01981850|581369051|FG002|Main Phase Stage 1|Various reasons|2|||
160994893|NCT01981850|581369052|FG003|Main Phase Stage 1|Various reasons|0|||
160994894|NCT01981850|581369053|FG004|Main Phase Stage 1|Various reasons|0|||
160994895|NCT01981850|581369054|FG005|Main Phase Stage 1|Various reasons|0|||
160994896|NCT01981850|581369055|FG006|Main Phase Stage 1|Various reasons|0|||
160994897|NCT01981850|581369056|FG007|Main Phase Stage 1|Various reasons|0|||
160994898|NCT01981850|581369057|FG008|Main Phase Stage 1|Various reasons|0|||
160994899|NCT01981850|581369058|FG009|Main Phase Stage 1|Various reasons|0|||
160994900|NCT01981850|581369049|FG000|Main Phase Stage 2|Adverse Event|0|||
160994901|NCT01981850|581369050|FG001|Main Phase Stage 2|Adverse Event|0|||
160994902|NCT01981850|581369051|FG002|Main Phase Stage 2|Adverse Event|0|||
160994903|NCT01981850|581369052|FG003|Main Phase Stage 2|Adverse Event|0|||
160994904|NCT01981850|581369053|FG004|Main Phase Stage 2|Adverse Event|6|||
160994905|NCT01981850|581369054|FG005|Main Phase Stage 2|Adverse Event|5|||
160994906|NCT01981850|581369055|FG006|Main Phase Stage 2|Adverse Event|7|||
160994907|NCT01981850|581369056|FG007|Main Phase Stage 2|Adverse Event|0|||
160994908|NCT01981850|581369057|FG008|Main Phase Stage 2|Adverse Event|0|||
160994909|NCT01981850|581369058|FG009|Main Phase Stage 2|Adverse Event|0|||
160994910|NCT01981850|581369049|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994911|NCT01981850|581369050|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994912|NCT01981850|581369051|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994913|NCT01981850|581369052|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994914|NCT01981850|581369053|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
160994915|NCT01981850|581369054|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
160994916|NCT01981850|581369055|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
160994917|NCT01981850|581369056|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994918|NCT01981850|581369057|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994919|NCT01981850|581369058|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
160994920|NCT01981850|581369049|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
160994921|NCT01981850|581369050|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
160994922|NCT01981850|581369051|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
160994923|NCT01981850|581369052|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
160994924|NCT01981850|581369053|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
160994925|NCT01981850|581369054|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
160994926|NCT01981850|581369055|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
160994927|NCT01981850|581369056|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
160994928|NCT01981850|581369057|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
160994929|NCT01981850|581369058|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
160994930|NCT01981850|581369049|FG000|Main Phase Stage 2|Various reasons|0|||
161141610|NCT00820040|581902553|FG000|Overall Study|Sponsor terminated study|1|||
161141611|NCT00820040|581902553|FG000|Overall Study|Screen failure|1|||
161141612|NCT01259466|581902556|FG000|Overall Study|Withdrawal by Subject|1|||
161141613|NCT01259466|581902557|FG001|Overall Study|Withdrawal by Subject|9|||
160860549|NCT01780506|580883091|FG000|Double-Blind Phase|Adverse Event|4|||
160860550|NCT01780506|580883092|FG001|Double-Blind Phase|Adverse Event|14|||
160860551|NCT01780506|580883091|FG000|Double-Blind Phase|Death|1|||
160860552|NCT01780506|580883092|FG001|Double-Blind Phase|Death|2|||
160860553|NCT01780506|580883091|FG000|Double-Blind Phase|Pregnancy|2|||
160860554|NCT01780506|580883092|FG001|Double-Blind Phase|Pregnancy|1|||
160860555|NCT01780506|580883091|FG000|Double-Blind Phase|Lack of Efficacy|1|||
160860556|NCT01780506|580883092|FG001|Double-Blind Phase|Lack of Efficacy|1|||
160860557|NCT01780506|580883091|FG000|Double-Blind Phase|Investigator's Discretion|5|||
160860558|NCT01780506|580883092|FG001|Double-Blind Phase|Investigator's Discretion|2|||
160860559|NCT01780506|580883091|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
160860560|NCT01780506|580883092|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
160860561|NCT01780506|580883091|FG000|Double-Blind Phase|Protocol Violation|4|||
160860562|NCT01780506|580883092|FG001|Double-Blind Phase|Protocol Violation|3|||
160860563|NCT01780506|580883091|FG000|Double-Blind Phase|Withdrew Consent|23|||
160860564|NCT01780506|580883092|FG001|Double-Blind Phase|Withdrew Consent|24|||
160860565|NCT01780506|580883091|FG000|Double-Blind Phase|Lost to Follow-up|23|||
160860566|NCT01780506|580883092|FG001|Double-Blind Phase|Lost to Follow-up|26|||
160860567|NCT01780506|580883091|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
160860568|NCT01780506|580883092|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
160860569|NCT01867671|580883096|FG000|Overall Study|Adverse Event|5|||
160860570|NCT01867671|580883097|FG001|Overall Study|Adverse Event|3|||
160860571|NCT01867671|580883096|FG000|Overall Study|Anaphylaxis|0|||
160860572|NCT01867671|580883097|FG001|Overall Study|Anaphylaxis|1|||
160860573|NCT01867671|580883096|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
160860574|NCT01867671|580883097|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
160860575|NCT01867671|580883096|FG000|Overall Study|Lost to Follow-up|0|||
160860576|NCT01867671|580883097|FG001|Overall Study|Lost to Follow-up|1|||
160860577|NCT01867671|580883096|FG000|Overall Study|Non-compliance with Study Drug|1|||
160860578|NCT01867671|580883097|FG001|Overall Study|Non-compliance with Study Drug|2|||
160860579|NCT01867671|580883096|FG000|Overall Study|Withdrawal by Subject|21|||
160860580|NCT01867671|580883097|FG001|Overall Study|Withdrawal by Subject|21|||
160994931|NCT01981850|581369050|FG001|Main Phase Stage 2|Various reasons|0|||
161141614|NCT03914300|581902558|FG000|Overall Study|Adverse Event|1|||
160860581|NCT04852302|580883103|FG000|Overall Study|Withdrawal by Subject|2|||
160860582|NCT04852302|580883103|FG000|Overall Study|Did not complete CALM therapy.|2|||
160860583|NCT04711850|580883104|FG000|Overall Study|Graft loss|2|||
160860584|NCT04711850|580883105|FG001|Overall Study|Graft loss|1|||
160860585|NCT04711850|580883104|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
160994932|NCT01981850|581369051|FG002|Main Phase Stage 2|Various reasons|0|||
160994933|NCT01981850|581369052|FG003|Main Phase Stage 2|Various reasons|0|||
160994934|NCT01981850|581369053|FG004|Main Phase Stage 2|Various reasons|2|||
160860586|NCT04711850|580883105|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
160860587|NCT04711850|580883104|FG000|Overall Study|Study terminated by sponsor|5|||
160994935|NCT01981850|581369054|FG005|Main Phase Stage 2|Various reasons|0|||
160860588|NCT04711850|580883105|FG001|Overall Study|Study terminated by sponsor|3|||
160860589|NCT04711850|580883104|FG000|Overall Study|Sponsor decision|0|||
160860590|NCT04711850|580883105|FG001|Overall Study|Sponsor decision|2|||
160860591|NCT05249582|580883106|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
161141615|NCT00457639|581902564|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
160994936|NCT01981850|581369055|FG006|Main Phase Stage 2|Various reasons|1|||
160994937|NCT01981850|581369056|FG007|Main Phase Stage 2|Various reasons|0|||
160994938|NCT01981850|581369057|FG008|Main Phase Stage 2|Various reasons|0|||
160994939|NCT01981850|581369058|FG009|Main Phase Stage 2|Various reasons|0|||
160994940|NCT01981850|581369049|FG000|Main Phase Stage 2|Progressive Disease|0|||
160994941|NCT01981850|581369050|FG001|Main Phase Stage 2|Progressive Disease|0|||
160994942|NCT01981850|581369051|FG002|Main Phase Stage 2|Progressive Disease|0|||
160994943|NCT01981850|581369052|FG003|Main Phase Stage 2|Progressive Disease|0|||
160994944|NCT01981850|581369053|FG004|Main Phase Stage 2|Progressive Disease|0|||
160994945|NCT01981850|581369054|FG005|Main Phase Stage 2|Progressive Disease|6|||
160994946|NCT01981850|581369055|FG006|Main Phase Stage 2|Progressive Disease|6|||
160994947|NCT01981850|581369056|FG007|Main Phase Stage 2|Progressive Disease|0|||
160994948|NCT01981850|581369057|FG008|Main Phase Stage 2|Progressive Disease|0|||
160994949|NCT01981850|581369058|FG009|Main Phase Stage 2|Progressive Disease|0|||
160994950|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Adverse Event|0|||
160994951|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Adverse Event|0|||
160860592|NCT05249582|580883107|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
160860593|NCT05249582|580883106|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
160860594|NCT05249582|580883107|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
160860595|NCT05249582|580883106|FG000|Overall Study|Declined to use virtual reality headset|1|||
160860596|NCT05249582|580883107|FG001|Overall Study|Declined to use virtual reality headset|0|||
160860597|NCT02738801|580883130|FG000|Overall Study|Adverse Event|1|||
160860598|NCT02738801|580883131|FG001|Overall Study|Adverse Event|1|||
160860599|NCT02738801|580883130|FG000|Overall Study|Withdrawal by Subject|0|||
160860600|NCT02738801|580883131|FG001|Overall Study|Withdrawal by Subject|1|||
160860601|NCT03279081|580883132|FG000|Overall Study|Withdrawal by Subject|12|||
160860602|NCT03279081|580883133|FG001|Overall Study|Withdrawal by Subject|20|||
160860603|NCT03279081|580883132|FG000|Overall Study|Physician Decision|4|||
160860604|NCT03279081|580883133|FG001|Overall Study|Physician Decision|1|||
160860605|NCT03279081|580883132|FG000|Overall Study|Lost to Follow-up|8|||
160860606|NCT03279081|580883133|FG001|Overall Study|Lost to Follow-up|8|||
160860607|NCT03279081|580883132|FG000|Overall Study|Death|0|||
160860608|NCT03279081|580883133|FG001|Overall Study|Death|1|||
160860609|NCT03279081|580883132|FG000|Overall Study|Adverse Event|1|||
160860610|NCT03279081|580883133|FG001|Overall Study|Adverse Event|0|||
160860611|NCT03279081|580883132|FG000|Overall Study|Reason not Specified|14|||
160860612|NCT03279081|580883133|FG001|Overall Study|Reason not Specified|4|||
160860613|NCT02163538|580883136|FG000|Overall Study|Protocol Violation|1|||
160860614|NCT02163538|580883137|FG001|Overall Study|Protocol Violation|0|||
160860615|NCT02163538|580883136|FG000|Overall Study|Physician Decision|0|||
160860616|NCT02163538|580883137|FG001|Overall Study|Physician Decision|1|||
160860617|NCT04484961|580883140|FG000|Overall Study|Lost to Follow-up|9|||
160860618|NCT04484961|580883141|FG001|Overall Study|Lost to Follow-up|9|||
160860619|NCT00388349|580883142|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
160860620|NCT00388349|580883143|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
160860621|NCT00976274|580883145|FG000|Overall Study|Lost to Follow-up|5|||
160860622|NCT00976274|580883146|FG001|Overall Study|Lost to Follow-up|5|||
160860623|NCT00976274|580883145|FG000|Overall Study|Withdrawal by Subject|1|||
160860624|NCT00976274|580883146|FG001|Overall Study|Withdrawal by Subject|1|||
160860625|NCT00976274|580883145|FG000|Overall Study|Physician Decision|1|||
160860626|NCT00976274|580883146|FG001|Overall Study|Physician Decision|2|||
160860627|NCT02954536|580883148|FG000|Overall Study|Adverse Event|2|||
160860628|NCT02954536|580883148|FG000|Overall Study|Death|12|||
160860629|NCT02946580|580883149|FG000|Overall Study|Withdrawal by Subject|1|||
160860630|NCT02946580|580883150|FG001|Overall Study|Withdrawal by Subject|2|||
160860631|NCT02946580|580883149|FG000|Overall Study|Adverse Event|0|||
160860632|NCT02946580|580883150|FG001|Overall Study|Adverse Event|2|||
160860633|NCT02946580|580883149|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
160860634|NCT02946580|580883150|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
160860635|NCT02158442|580883151|FG000|Overall Study|Withdrawal by Subject|1|||
160860636|NCT02158442|580883152|FG001|Overall Study|Withdrawal by Subject|0|||
160860637|NCT02158442|580883151|FG000|Overall Study|Perfusion staff not available|1|||
160994952|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Adverse Event|0|||
160994953|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Adverse Event|0|||
160860638|NCT02158442|580883152|FG001|Overall Study|Perfusion staff not available|0|||
160860639|NCT02761330|580883153|FG000|Treatment Week 1|Withdrawal by Subject|0|||
160860640|NCT02761330|580883154|FG001|Treatment Week 1|Withdrawal by Subject|0|||
160860641|NCT02761330|580883155|FG002|Treatment Week 1|Withdrawal by Subject|0|||
160860642|NCT02761330|580883156|FG003|Treatment Week 1|Withdrawal by Subject|1|||
160860643|NCT02761330|580883157|FG004|Treatment Week 1|Withdrawal by Subject|0|||
160860644|NCT02761330|580883158|FG005|Treatment Week 1|Withdrawal by Subject|1|||
160860645|NCT03043313|580883163|FG000|Overall Study|Withdrawal by Subject|5|||
160860646|NCT03043313|580883164|FG001|Overall Study|Withdrawal by Subject|1|||
160860647|NCT03043313|580883165|FG002|Overall Study|Withdrawal by Subject|1|||
160994954|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Adverse Event|0|||
160860648|NCT03043313|580883163|FG000|Overall Study|Lost to Follow-up|1|||
160860649|NCT03043313|580883164|FG001|Overall Study|Lost to Follow-up|1|||
160860650|NCT03043313|580883165|FG002|Overall Study|Lost to Follow-up|0|||
160860651|NCT03043313|580883163|FG000|Overall Study|Death|28|||
160860652|NCT03043313|580883164|FG001|Overall Study|Death|26|||
160860653|NCT03043313|580883165|FG002|Overall Study|Death|17|||
160860654|NCT03043313|580883163|FG000|Overall Study|Participation terminated by sponsor|11|||
160860655|NCT03043313|580883164|FG001|Overall Study|Participation terminated by sponsor|13|||
160860656|NCT03043313|580883165|FG002|Overall Study|Participation terminated by sponsor|13|||
160860657|NCT01506596|580883166|FG000|Overall Study|ineligible pathology|1|||
160860658|NCT05712460|580883168|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860659|NCT05712460|580883169|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860660|NCT05712460|580883170|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860661|NCT05712460|580883171|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860662|NCT05712460|580883172|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860663|NCT05712460|580883173|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860664|NCT05712460|580883174|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860665|NCT05712460|580883175|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
160860666|NCT05712460|580883176|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860667|NCT05712460|580883177|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860668|NCT05712460|580883178|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860669|NCT05712460|580883179|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
160860670|NCT05135767|580883183|FG000|Baseline|Lost to Follow-up|1|||
160860671|NCT05135767|580883184|FG001|Baseline|Lost to Follow-up|1|||
160860672|NCT05135767|580883183|FG000|Baseline|Withdrawal by Subject|0|||
160860673|NCT05135767|580883184|FG001|Baseline|Withdrawal by Subject|2|||
160860674|NCT05135767|580883183|FG000|Active Study Phase|Lost to Follow-up|2|||
160860675|NCT05135767|580883184|FG001|Active Study Phase|Lost to Follow-up|0|||
160860676|NCT02694185|580883185|FG000|Overall Study|Withdrawal by Subject|45|||
160860677|NCT02694185|580883186|FG001|Overall Study|Withdrawal by Subject|0|||
160860678|NCT05082857|580883187|FG000|Overall Study|participants relocated and could not continue|2|||
160860679|NCT05082857|580883188|FG001|Overall Study|participants relocated and could not continue|1|||
160909514|NCT02296320|581064037|FG002|Overall Study|Withdrawal by Subject|2|||
160909515|NCT02296320|581064035|FG000|Overall Study|Death|24|||
160909516|NCT02296320|581064036|FG001|Overall Study|Death|3|||
160909517|NCT02296320|581064037|FG002|Overall Study|Death|27|||
160909518|NCT02296320|581064035|FG000|Overall Study|Lost to Follow-up|5|||
160909519|NCT02296320|581064036|FG001|Overall Study|Lost to Follow-up|2|||
160909520|NCT02296320|581064037|FG002|Overall Study|Lost to Follow-up|7|||
160909521|NCT02296320|581064035|FG000|Overall Study|Not treated|2|||
160909522|NCT02296320|581064036|FG001|Overall Study|Not treated|0|||
160909523|NCT02296320|581064037|FG002|Overall Study|Not treated|0|||
160909524|NCT02296320|581064035|FG000|Overall Study|Not - specified|0|||
160909525|NCT02296320|581064036|FG001|Overall Study|Not - specified|0|||
160909526|NCT02296320|581064037|FG002|Overall Study|Not - specified|1|||
160909527|NCT00390468|581064040|FG000|Overall Study|Protocol Violation|2|||
160909528|NCT00390468|581064040|FG000|Overall Study|Lack of Efficacy|1|||
160909529|NCT01049308|581064041|FG000|Pill Counts|Withdrawal by Subject|83|||
160909530|NCT01348165|581064042|FG000|Overall Study|Adverse Event|0|||
160909531|NCT01348165|581064043|FG001|Overall Study|Adverse Event|0|||
160909532|NCT01348165|581064044|FG002|Overall Study|Adverse Event|0|||
160909533|NCT01348165|581064045|FG003|Overall Study|Adverse Event|0|||
160909534|NCT01348165|581064046|FG004|Overall Study|Adverse Event|0|||
160909535|NCT01348165|581064047|FG005|Overall Study|Adverse Event|0|||
160909536|NCT01348165|581064048|FG006|Overall Study|Adverse Event|1|||
160909537|NCT02439138|581064053|FG000|Overall Study|Adverse Event|1|||
160909538|NCT02439138|581064053|FG000|Overall Study|PI decision to terminate the study|2|||
160909539|NCT04659161|581064054|FG000|Overall Study|Adverse Event|10|||
160909540|NCT04659161|581064055|FG001|Overall Study|Adverse Event|6|||
160860680|NCT05082857|580883187|FG000|Overall Study|Lost to Follow-up|1|||
160860681|NCT05082857|580883188|FG001|Overall Study|Lost to Follow-up|3|||
160860682|NCT04366349|580883189|FG000|Overall Study|Withdrawal by Subject|1|||
160909541|NCT04659161|581064054|FG000|Overall Study|Withdrawal by Subject|13|||
160909542|NCT04659161|581064055|FG001|Overall Study|Withdrawal by Subject|12|||
160909543|NCT04659161|581064054|FG000|Overall Study|Other|9|||
160909544|NCT04659161|581064055|FG001|Overall Study|Other|8|||
160909545|NCT01929343|581064056|FG000|Overall Study|Physician Decision|0|||
160909546|NCT01929343|581064057|FG001|Overall Study|Physician Decision|2|||
160909547|NCT01929343|581064058|FG002|Overall Study|Physician Decision|0|||
160909548|NCT01929343|581064056|FG000|Overall Study|Withdrawal by Subject|1|||
160909549|NCT01929343|581064057|FG001|Overall Study|Withdrawal by Subject|0|||
160909550|NCT01929343|581064058|FG002|Overall Study|Withdrawal by Subject|0|||
160909551|NCT02197130|581064061|FG000|Overall Study|Adverse Event|13|||
160909552|NCT02197130|581064062|FG001|Overall Study|Adverse Event|4|||
160994955|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Adverse Event|0|||
160909553|NCT02197130|581064063|FG002|Overall Study|Adverse Event|23|||
160909554|NCT02197130|581064061|FG000|Overall Study|Death|0|||
161339074|NCT00471497|582630416|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
161339075|NCT00471497|582630414|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
161339076|NCT00471497|582630415|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
161339077|NCT00471497|582630416|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
161339078|NCT00471497|582630414|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
161339079|NCT00471497|582630415|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
161339080|NCT00471497|582630416|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
161339081|NCT00471497|582630414|FG000|Core Treatment Phase|Lost to Follow-up|6|||
161339082|NCT00471497|582630415|FG001|Core Treatment Phase|Lost to Follow-up|6|||
161339083|NCT00471497|582630416|FG002|Core Treatment Phase|Lost to Follow-up|3|||
161339084|NCT00471497|582630414|FG000|Core Treatment Phase|Death|3|||
161339085|NCT00471497|582630415|FG001|Core Treatment Phase|Death|9|||
161339086|NCT00471497|582630416|FG002|Core Treatment Phase|Death|3|||
161339087|NCT00471497|582630414|FG000|Core Treatment Phase|Disease Progression|10|||
161339088|NCT00471497|582630415|FG001|Core Treatment Phase|Disease Progression|2|||
161339089|NCT00471497|582630416|FG002|Core Treatment Phase|Disease Progression|4|||
161339090|NCT00471497|582630414|FG000|Core Treatment Phase|Protocol Violation|6|||
161339091|NCT00471497|582630415|FG001|Core Treatment Phase|Protocol Violation|15|||
161339092|NCT00471497|582630416|FG002|Core Treatment Phase|Protocol Violation|11|||
161339093|NCT00471497|582630414|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
161339094|NCT00471497|582630415|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
161339095|NCT00471497|582630416|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
161339096|NCT00471497|582630414|FG000|Core Treatment Phase|Administrative problems|14|||
161339097|NCT00471497|582630415|FG001|Core Treatment Phase|Administrative problems|14|||
161339098|NCT00471497|582630416|FG002|Core Treatment Phase|Administrative problems|12|||
161339099|NCT00471497|582630414|FG000|Core Treatment Phase|Adverse Event|43|||
161339100|NCT00471497|582630415|FG001|Core Treatment Phase|Adverse Event|53|||
161339101|NCT00471497|582630416|FG002|Core Treatment Phase|Adverse Event|89|||
161339102|NCT00471497|582630414|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
161339103|NCT00471497|582630415|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
161339104|NCT00471497|582630416|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
161339105|NCT00471497|582630414|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
161339106|NCT00471497|582630415|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
161339107|NCT00471497|582630416|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
161339108|NCT00471497|582630414|FG000|Extension Phase|Adverse Event|9|||
161339109|NCT00471497|582630415|FG001|Extension Phase|Adverse Event|5|||
161339110|NCT00471497|582630416|FG002|Extension Phase|Adverse Event|1|||
161339111|NCT00471497|582630414|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
161339112|NCT00471497|582630415|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
161339113|NCT00471497|582630416|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161339114|NCT00471497|582630414|FG000|Extension Phase|Withdrawal by Subject|3|||
161339115|NCT00471497|582630415|FG001|Extension Phase|Withdrawal by Subject|1|||
161339116|NCT00471497|582630416|FG002|Extension Phase|Withdrawal by Subject|0|||
161339117|NCT00471497|582630414|FG000|Extension Phase|Lost to Follow-up|2|||
161339118|NCT00471497|582630415|FG001|Extension Phase|Lost to Follow-up|0|||
161339119|NCT00471497|582630416|FG002|Extension Phase|Lost to Follow-up|0|||
161339120|NCT00471497|582630414|FG000|Extension Phase|Death|1|||
161339121|NCT00471497|582630415|FG001|Extension Phase|Death|0|||
161339122|NCT00471497|582630416|FG002|Extension Phase|Death|0|||
161339123|NCT00471497|582630414|FG000|Extension Phase|Disease progression|2|||
161339124|NCT00471497|582630415|FG001|Extension Phase|Disease progression|0|||
161339125|NCT00471497|582630416|FG002|Extension Phase|Disease progression|0|||
161339126|NCT00471497|582630414|FG000|Extension Phase|Protocol Violation|2|||
161339127|NCT00471497|582630415|FG001|Extension Phase|Protocol Violation|2|||
161339128|NCT00471497|582630416|FG002|Extension Phase|Protocol Violation|0|||
161339129|NCT04004000|582630417|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
161339130|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
161339131|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
160860683|NCT04366349|580883190|FG001|Overall Study|Withdrawal by Subject|0|||
160860684|NCT04366349|580883191|FG002|Overall Study|Withdrawal by Subject|0|||
160860685|NCT04366349|580883192|FG003|Overall Study|Withdrawal by Subject|0|||
160860686|NCT04366349|580883193|FG004|Overall Study|Withdrawal by Subject|0|||
160860687|NCT04366349|580883194|FG005|Overall Study|Withdrawal by Subject|0|||
160860688|NCT03341299|580883195|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
160860689|NCT03341299|580883196|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
160860690|NCT03341299|580883197|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
160860691|NCT03341299|580883198|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
160860692|NCT01486966|580883211|FG000|Overall Study|Adverse Event|0|||
160860693|NCT01486966|580883212|FG001|Overall Study|Adverse Event|1|||
160860694|NCT01486966|580883211|FG000|Overall Study|Withdrawal by Subject|0|||
160860695|NCT01486966|580883212|FG001|Overall Study|Withdrawal by Subject|1|||
160860696|NCT03518086|580883215|FG000|Overall Study|Adverse Event|23|||
160860697|NCT03518086|580883216|FG001|Overall Study|Adverse Event|15|||
160860698|NCT03518086|580883217|FG002|Overall Study|Adverse Event|3|||
160860699|NCT03518086|580883218|FG003|Overall Study|Adverse Event|2|||
160860700|NCT03518086|580883215|FG000|Overall Study|Withdrawal by Subject|8|||
160860701|NCT03518086|580883216|FG001|Overall Study|Withdrawal by Subject|5|||
160994956|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Adverse Event|0|||
160994957|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Adverse Event|2|||
160994958|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Adverse Event|1|||
160994959|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Adverse Event|8|||
160994960|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994961|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994962|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994963|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994964|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994965|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994966|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
160994967|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
160994968|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
160860702|NCT03518086|580883217|FG002|Overall Study|Withdrawal by Subject|1|||
160860703|NCT03518086|580883218|FG003|Overall Study|Withdrawal by Subject|0|||
160860704|NCT03518086|580883215|FG000|Overall Study|Lack of Efficacy|5|||
160860705|NCT03518086|580883216|FG001|Overall Study|Lack of Efficacy|5|||
160860706|NCT03518086|580883217|FG002|Overall Study|Lack of Efficacy|0|||
160860707|NCT03518086|580883218|FG003|Overall Study|Lack of Efficacy|2|||
160860708|NCT03518086|580883215|FG000|Overall Study|Protocol Violation|1|||
160860709|NCT03518086|580883216|FG001|Overall Study|Protocol Violation|5|||
160860710|NCT03518086|580883217|FG002|Overall Study|Protocol Violation|1|||
160860711|NCT03518086|580883218|FG003|Overall Study|Protocol Violation|3|||
160860712|NCT03518086|580883215|FG000|Overall Study|Lost to Follow-up|0|||
160860713|NCT03518086|580883216|FG001|Overall Study|Lost to Follow-up|3|||
160860714|NCT03518086|580883217|FG002|Overall Study|Lost to Follow-up|0|||
160860715|NCT03518086|580883218|FG003|Overall Study|Lost to Follow-up|0|||
160909555|NCT02197130|581064062|FG001|Overall Study|Death|1|||
160909556|NCT02197130|581064063|FG002|Overall Study|Death|0|||
160909557|NCT02197130|581064061|FG000|Overall Study|Lost to Follow-up|2|||
160909558|NCT02197130|581064062|FG001|Overall Study|Lost to Follow-up|0|||
160909559|NCT02197130|581064063|FG002|Overall Study|Lost to Follow-up|1|||
160909560|NCT02197130|581064061|FG000|Overall Study|Does not meet entrance criteria|0|||
160909561|NCT02197130|581064062|FG001|Overall Study|Does not meet entrance criteria|0|||
160909562|NCT02197130|581064063|FG002|Overall Study|Does not meet entrance criteria|1|||
160909563|NCT02197130|581064061|FG000|Overall Study|Withdrawal by Subject|0|||
160909564|NCT02197130|581064062|FG001|Overall Study|Withdrawal by Subject|3|||
160909565|NCT02197130|581064063|FG002|Overall Study|Withdrawal by Subject|4|||
160909566|NCT02197130|581064061|FG000|Overall Study|Other|1|||
160909567|NCT02197130|581064062|FG001|Overall Study|Other|0|||
160909568|NCT02197130|581064063|FG002|Overall Study|Other|3|||
160909569|NCT02615145|581064064|FG000|Overall Study|Did Not Start Treatment|0|||
160909570|NCT02615145|581064065|FG001|Overall Study|Did Not Start Treatment|0|||
160909571|NCT02615145|581064066|FG002|Overall Study|Did Not Start Treatment|1|||
160909572|NCT02615145|581064067|FG003|Overall Study|Did Not Start Treatment|1|||
160909573|NCT02615145|581064064|FG000|Overall Study|Failure to Return|20|||
160909574|NCT02615145|581064065|FG001|Overall Study|Failure to Return|10|||
160909575|NCT02615145|581064066|FG002|Overall Study|Failure to Return|7|||
160909576|NCT02615145|581064067|FG003|Overall Study|Failure to Return|0|||
160909577|NCT02615145|581064064|FG000|Overall Study|Death|2|||
160909578|NCT02615145|581064065|FG001|Overall Study|Death|3|||
160909579|NCT02615145|581064066|FG002|Overall Study|Death|0|||
160909580|NCT02615145|581064067|FG003|Overall Study|Death|0|||
160994969|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
160994970|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Various reasons|0|||
160994971|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Various reasons|0|||
160994972|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Various reasons|0|||
160994973|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Various reasons|0|||
160860716|NCT03518086|580883215|FG000|Overall Study|Insufficient Diary Data|0|||
160994974|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Various reasons|0|||
161339132|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161339133|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160860717|NCT03518086|580883216|FG001|Overall Study|Insufficient Diary Data|2|||
160860718|NCT03518086|580883217|FG002|Overall Study|Insufficient Diary Data|0|||
160860719|NCT03518086|580883218|FG003|Overall Study|Insufficient Diary Data|0|||
160860720|NCT03518086|580883215|FG000|Overall Study|Non- compliance to Protocol|0|||
160909581|NCT02615145|581064064|FG000|Overall Study|Other, Not Specified|5|||
160909582|NCT02615145|581064065|FG001|Overall Study|Other, Not Specified|2|||
160909583|NCT02615145|581064066|FG002|Overall Study|Other, Not Specified|0|||
160909584|NCT02615145|581064067|FG003|Overall Study|Other, Not Specified|0|||
160909585|NCT00006237|581064070|FG000|Overall Study|Adverse Event|39|||
160994975|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Various reasons|0|||
160994976|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Various reasons|0|||
160994977|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Various reasons|3|||
160994978|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Various reasons|1|||
160994979|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Various reasons|3|||
160994980|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
160860721|NCT03518086|580883216|FG001|Overall Study|Non- compliance to Protocol|1|||
160860722|NCT03518086|580883217|FG002|Overall Study|Non- compliance to Protocol|0|||
160860723|NCT03518086|580883218|FG003|Overall Study|Non- compliance to Protocol|0|||
160860724|NCT03518086|580883215|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
160860725|NCT03518086|580883216|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
160860726|NCT03518086|580883217|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
160860727|NCT03518086|580883218|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
160860728|NCT03518086|580883215|FG000|Overall Study|Site Terminated by Sponsor|0|||
160860729|NCT03518086|580883216|FG001|Overall Study|Site Terminated by Sponsor|1|||
160860730|NCT03518086|580883217|FG002|Overall Study|Site Terminated by Sponsor|0|||
160860731|NCT03518086|580883218|FG003|Overall Study|Site Terminated by Sponsor|0|||
160860732|NCT03518086|580883215|FG000|Overall Study|Pregnancy|0|||
160860733|NCT03518086|580883216|FG001|Overall Study|Pregnancy|0|||
160860734|NCT03518086|580883217|FG002|Overall Study|Pregnancy|0|||
160860735|NCT03518086|580883218|FG003|Overall Study|Pregnancy|2|||
160860736|NCT02336282|580883219|FG000|Overall Study|Unrelated illness|1|||
160860737|NCT02336282|580883219|FG000|Overall Study|Uncomfortable with technology|1|||
160860738|NCT02336282|580883219|FG000|Overall Study|Lost to Follow-up|1|||
160860739|NCT02336282|580883219|FG000|Overall Study|Not enough time to complete sessions|2|||
160860740|NCT05565742|580883221|FG000|Overall Study|Withdrawal by Subject|0|||
160860741|NCT05565742|580883222|FG001|Overall Study|Withdrawal by Subject|0|||
160860742|NCT05565742|580883223|FG002|Overall Study|Withdrawal by Subject|2|||
160860743|NCT05565742|580883224|FG003|Overall Study|Withdrawal by Subject|2|||
160860744|NCT05565742|580883225|FG004|Overall Study|Withdrawal by Subject|2|||
160909586|NCT00006237|581064071|FG001|Overall Study|Adverse Event|29|||
160909587|NCT00006237|581064070|FG000|Overall Study|Death|1|||
160909588|NCT00006237|581064071|FG001|Overall Study|Death|0|||
160909589|NCT00006237|581064070|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
160909590|NCT00006237|581064071|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
160909591|NCT00006237|581064070|FG000|Overall Study|Progression/relapse|54|||
160909592|NCT00006237|581064071|FG001|Overall Study|Progression/relapse|2|||
160909593|NCT00006237|581064070|FG000|Overall Study|Not eligible|9|||
160909594|NCT00006237|581064071|FG001|Overall Study|Not eligible|20|||
160909595|NCT00006237|581064070|FG000|Overall Study|Withdrawal by Subject|0|||
160909596|NCT00006237|581064071|FG001|Overall Study|Withdrawal by Subject|1|||
160909597|NCT00006237|581064070|FG000|Overall Study|Not protocol specified|14|||
160909598|NCT00006237|581064071|FG001|Overall Study|Not protocol specified|5|||
160909599|NCT01846416|581064074|FG000|Treatment Phase|Death|2|||
160909600|NCT01846416|581064075|FG001|Treatment Phase|Death|9|||
160909601|NCT01846416|581064076|FG002|Treatment Phase|Death|1|||
160909602|NCT01846416|581064074|FG000|Treatment Phase|Withdrawal by Subject|2|||
160909603|NCT01846416|581064075|FG001|Treatment Phase|Withdrawal by Subject|4|||
160909604|NCT01846416|581064076|FG002|Treatment Phase|Withdrawal by Subject|2|||
160994981|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
160994982|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
160994983|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
160994984|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
160994985|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
160994986|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
160994987|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
160994988|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
160994989|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
160994990|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994991|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994992|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994993|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994994|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994995|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994996|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994997|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160860745|NCT05565742|580883221|FG000|Overall Study|Death|1|||
160860746|NCT05565742|580883222|FG001|Overall Study|Death|0|||
160909605|NCT01846416|581064074|FG000|Treatment Phase|Other|1|||
160909606|NCT01846416|581064075|FG001|Treatment Phase|Other|5|||
160909607|NCT01846416|581064076|FG002|Treatment Phase|Other|1|||
160909608|NCT01846416|581064074|FG000|Treatment Phase|Physician Decision|1|||
160909609|NCT01846416|581064075|FG001|Treatment Phase|Physician Decision|2|||
160860747|NCT05565742|580883223|FG002|Overall Study|Death|0|||
161141616|NCT00457639|581902565|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
161141617|NCT00457639|581902564|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
161141618|NCT00457639|581902565|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
160994998|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
160994999|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
160995000|NCT01981850|581369049|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
160860748|NCT05565742|580883224|FG003|Overall Study|Death|0|||
160860749|NCT05565742|580883225|FG004|Overall Study|Death|0|||
160860750|NCT05565742|580883221|FG000|Overall Study|Participant Travelled Abroad|0|||
160860751|NCT05565742|580883222|FG001|Overall Study|Participant Travelled Abroad|0|||
160860752|NCT05565742|580883223|FG002|Overall Study|Participant Travelled Abroad|0|||
160860753|NCT05565742|580883224|FG003|Overall Study|Participant Travelled Abroad|0|||
160860754|NCT05565742|580883225|FG004|Overall Study|Participant Travelled Abroad|1|||
160860755|NCT04163341|580883226|FG000|Overall Study|Withdrawal by Subject|2|||
160860756|NCT04163341|580883227|FG001|Overall Study|Withdrawal by Subject|0|||
160860757|NCT04163341|580883226|FG000|Overall Study|Lost to Follow-up|3|||
160860758|NCT04163341|580883227|FG001|Overall Study|Lost to Follow-up|4|||
160860759|NCT00668148|580883242|FG000|Overall Study|Adverse Event|5|||
160860760|NCT00668148|580883242|FG000|Overall Study|Subject Non-compliance|1|||
160860761|NCT00668148|580883242|FG000|Overall Study|Progressive Disease Before Treatment|2|||
160860762|NCT00668148|580883242|FG000|Overall Study|Withdrawal of Consent|2|||
160860763|NCT05472090|580883244|FG000|Overall Study|Adverse Event|2|||
160860764|NCT05472090|580883245|FG001|Overall Study|Adverse Event|3|||
160860765|NCT05472090|580883244|FG000|Overall Study|Lack of Efficacy|1|||
160860766|NCT05472090|580883245|FG001|Overall Study|Lack of Efficacy|0|||
160860767|NCT05472090|580883244|FG000|Overall Study|Physician Decision|1|||
160860768|NCT05472090|580883245|FG001|Overall Study|Physician Decision|0|||
160860769|NCT05472090|580883244|FG000|Overall Study|Withdrawal by Subject|2|||
160860770|NCT05472090|580883245|FG001|Overall Study|Withdrawal by Subject|0|||
160860771|NCT05472090|580883244|FG000|Overall Study|Lost to Follow-up|0|||
160860772|NCT05472090|580883245|FG001|Overall Study|Lost to Follow-up|3|||
160860773|NCT00303069|580885098|FG000|Overall Study|Lost to Follow-up|1|||
160860774|NCT00303069|580885099|FG001|Overall Study|Lost to Follow-up|0|||
160860775|NCT00303069|580885100|FG002|Overall Study|Lost to Follow-up|0|||
160860776|NCT00303069|580885101|FG003|Overall Study|Lost to Follow-up|2|||
160860777|NCT00303069|580885098|FG000|Overall Study|subject moved|1|||
160860778|NCT00303069|580885099|FG001|Overall Study|subject moved|0|||
160860779|NCT00303069|580885100|FG002|Overall Study|subject moved|0|||
160860780|NCT00303069|580885101|FG003|Overall Study|subject moved|0|||
160860781|NCT00303069|580885098|FG000|Overall Study|Recruitment into Army Reserves|0|||
160860782|NCT00303069|580885099|FG001|Overall Study|Recruitment into Army Reserves|0|||
160860783|NCT00303069|580885100|FG002|Overall Study|Recruitment into Army Reserves|1|||
160860784|NCT00303069|580885101|FG003|Overall Study|Recruitment into Army Reserves|0|||
160860785|NCT00092417|580885102|FG000|Overall Study|Lost to Follow-up|2|||
160860786|NCT00092417|580885103|FG001|Overall Study|Lost to Follow-up|0|||
160860787|NCT00092417|580885102|FG000|Overall Study|Withdrawal by Subject|2|||
160860788|NCT00092417|580885103|FG001|Overall Study|Withdrawal by Subject|1|||
160860789|NCT00092417|580885102|FG000|Overall Study|Other|1|||
160860790|NCT00092417|580885103|FG001|Overall Study|Other|0|||
160860791|NCT00425269|580885104|FG000|Overall Study|Pregnancy|5|||
160860792|NCT00425269|580885105|FG001|Overall Study|Pregnancy|7|||
160860793|NCT00425269|580885104|FG000|Overall Study|Lost to Follow-up|9|||
160860794|NCT00425269|580885105|FG001|Overall Study|Lost to Follow-up|9|||
160995001|NCT01981850|581369050|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995002|NCT01981850|581369051|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995003|NCT01981850|581369052|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995004|NCT01981850|581369053|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
160860795|NCT00425269|580885104|FG000|Overall Study|moved or medical reason|5|||
160995005|NCT01981850|581369054|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995006|NCT01981850|581369055|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995007|NCT01981850|581369056|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995008|NCT01981850|581369057|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
160995009|NCT01981850|581369058|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
160995010|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
160995011|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
160860796|NCT00425269|580885105|FG001|Overall Study|moved or medical reason|4|||
160860797|NCT01084655|580885108|FG000|Overall Study|Radiographic disease progression|3|||
160860798|NCT01084655|580885109|FG001|Overall Study|Radiographic disease progression|2|||
160860799|NCT01084655|580885110|FG002|Overall Study|Radiographic disease progression|8|||
160860800|NCT01084655|580885108|FG000|Overall Study|Withdrawal by Subject|1|||
160860801|NCT01084655|580885109|FG001|Overall Study|Withdrawal by Subject|0|||
160995012|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
161141619|NCT00457639|581902564|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
161141620|NCT00457639|581902565|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
160860802|NCT01084655|580885110|FG002|Overall Study|Withdrawal by Subject|4|||
160860803|NCT01084655|580885108|FG000|Overall Study|Adverse Event|2|||
160860804|NCT01084655|580885109|FG001|Overall Study|Adverse Event|1|||
160860805|NCT01084655|580885110|FG002|Overall Study|Adverse Event|2|||
160860806|NCT01084655|580885108|FG000|Overall Study|Other|0|||
160860807|NCT01084655|580885109|FG001|Overall Study|Other|3|||
160860808|NCT01084655|580885110|FG002|Overall Study|Other|2|||
160860809|NCT01084655|580885108|FG000|Overall Study|Symptomatic deterioration|0|||
160860810|NCT01084655|580885109|FG001|Overall Study|Symptomatic deterioration|0|||
160860811|NCT01084655|580885110|FG002|Overall Study|Symptomatic deterioration|2|||
160860812|NCT01084655|580885108|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
160860813|NCT01084655|580885109|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
160860814|NCT01084655|580885110|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
160860815|NCT00335777|580885111|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
160860816|NCT00335777|580885111|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
160860817|NCT00335777|580885111|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
160860818|NCT00335777|580885111|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
160860819|NCT00335777|580885111|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
161141621|NCT03885284|581902566|FG000|Overall Study|Disease Progression|1|||
161141622|NCT03885284|581902567|FG001|Overall Study|Disease Progression|3|||
161141623|NCT03885284|581902566|FG000|Overall Study|Physician Decision|0|||
161141624|NCT03885284|581902567|FG001|Overall Study|Physician Decision|1|||
161141625|NCT00002850|581902572|FG000|Overall Study|Death|4|||
161141626|NCT00002850|581902573|FG001|Overall Study|Death|1|||
161141627|NCT00002850|581902574|FG002|Overall Study|Death|3|||
161141628|NCT00002850|581902572|FG000|Overall Study|Protocol Violation|1|||
161141629|NCT00002850|581902573|FG001|Overall Study|Protocol Violation|0|||
161141630|NCT00002850|581902574|FG002|Overall Study|Protocol Violation|1|||
161141631|NCT00002850|581902572|FG000|Overall Study|Withdrawal by Subject|0|||
161141632|NCT00002850|581902573|FG001|Overall Study|Withdrawal by Subject|1|||
161141633|NCT00002850|581902574|FG002|Overall Study|Withdrawal by Subject|0|||
161141634|NCT02932267|581902581|FG000|Overall Study|Withdrawal by Subject|3|||
161141635|NCT02932267|581902581|FG000|Overall Study|Lost to Follow-up|4|||
161339134|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161339135|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
160860820|NCT00535496|580885112|FG000|Overall Study|Lost to Follow-up|0|||
161141636|NCT02932267|581902581|FG000|Overall Study|Pregnancy|1|||
161141637|NCT01687673|581902584|FG000|Overall Study|Physician Decision|1|||
161141638|NCT02234622|581902585|FG000|Overall Study|Withdrawal by Subject|16|||
161141639|NCT02234622|581902586|FG001|Overall Study|Withdrawal by Subject|22|||
161141640|NCT02234622|581902585|FG000|Overall Study|Lost to Follow-up|27|||
161141641|NCT02234622|581902586|FG001|Overall Study|Lost to Follow-up|14|||
160860821|NCT00535496|580885113|FG001|Overall Study|Lost to Follow-up|1|||
160860822|NCT00535496|580885114|FG002|Overall Study|Lost to Follow-up|0|||
160860823|NCT00535496|580885115|FG003|Overall Study|Lost to Follow-up|0|||
160860824|NCT00535496|580885112|FG000|Overall Study|Not treated with sugammadex|0|||
160860825|NCT00535496|580885113|FG001|Overall Study|Not treated with sugammadex|1|||
160860826|NCT00535496|580885114|FG002|Overall Study|Not treated with sugammadex|0|||
160860827|NCT00535496|580885115|FG003|Overall Study|Not treated with sugammadex|0|||
160860828|NCT01209689|580885121|FG000|Overall Study|Insufficient Therapeutic Response|7|||
160860829|NCT01209689|580885122|FG001|Overall Study|Insufficient Therapeutic Response|2|||
160860830|NCT01209689|580885121|FG000|Overall Study|Refused Treatment|8|||
160860831|NCT01209689|580885122|FG001|Overall Study|Refused Treatment|3|||
160860832|NCT01209689|580885121|FG000|Overall Study|Adverse Event|4|||
160860833|NCT01209689|580885122|FG001|Overall Study|Adverse Event|0|||
160860834|NCT01209689|580885121|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160860835|NCT01209689|580885122|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
160860836|NCT01209689|580885121|FG000|Overall Study|Failure to Return|3|||
160860837|NCT01209689|580885122|FG001|Overall Study|Failure to Return|0|||
160860838|NCT01209689|580885121|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
160860839|NCT01209689|580885122|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
160860840|NCT03780244|580885123|FG000|Overall Study|Lost to Follow-up|1|||
160860841|NCT03780244|580885124|FG001|Overall Study|Lost to Follow-up|0|||
160860842|NCT01083771|580885125|FG000|Overall Study|non-compliant|2|||
160860843|NCT01083771|580885125|FG000|Overall Study|Withdrawal by Subject|3|||
160860844|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860845|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860846|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
161141642|NCT03476239|581902587|FG000|Overall Study|Withdrawal by Subject|10|||
161141643|NCT03476239|581902587|FG000|Overall Study|Death|80|||
161141644|NCT03476239|581902587|FG000|Overall Study|Lost to Follow-up|8|||
161141645|NCT00618956|581902588|FG000|Overall Study|Adverse Event|10|||
161141646|NCT00618956|581902589|FG001|Overall Study|Adverse Event|34|||
161141647|NCT00618956|581902588|FG000|Overall Study|Lack of Efficacy|2|||
161141648|NCT00618956|581902589|FG001|Overall Study|Lack of Efficacy|1|||
161141649|NCT00618956|581902588|FG000|Overall Study|Withdrawal by Subject|5|||
160995013|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
160995014|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
160860847|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
160860848|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860849|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
160860850|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
160860851|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860852|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860853|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
160860854|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
160860855|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
160860856|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860857|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
160860858|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160860859|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160860860|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
160860861|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
160860862|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160860863|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
160860864|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
160995015|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
160995016|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
160995017|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
160995018|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
160995019|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
160995020|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
160995021|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
160995022|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
160995023|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
160860865|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
160909610|NCT01846416|581064076|FG002|Treatment Phase|Physician Decision|0|||
160995024|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
160995025|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
160995026|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
160995027|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
160995028|NCT03412747|581369059|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
160995029|NCT03412747|581369060|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
160995030|NCT03412747|581369061|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
160995031|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
160995032|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
160995033|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
160995034|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
160909611|NCT01846416|581064074|FG000|Treatment Phase|Adverse Event|3|||
160995035|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
160995036|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
160995037|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
160995038|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
160995039|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
160995040|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
160995041|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
160995042|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
160995043|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
160860866|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
160860867|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
160860868|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
160909612|NCT01846416|581064075|FG001|Treatment Phase|Adverse Event|4|||
160909613|NCT01846416|581064076|FG002|Treatment Phase|Adverse Event|0|||
160909614|NCT01846416|581064074|FG000|Treatment Phase|Non-compliance|0|||
160909615|NCT01846416|581064075|FG001|Treatment Phase|Non-compliance|2|||
160909616|NCT01846416|581064076|FG002|Treatment Phase|Non-compliance|0|||
160909617|NCT01846416|581064074|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
160909618|NCT01846416|581064075|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
160909619|NCT01846416|581064076|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
160909620|NCT01846416|581064074|FG000|Treatment Phase|Progressive Disease|21|||
160909621|NCT01846416|581064075|FG001|Treatment Phase|Progressive Disease|63|||
160909622|NCT01846416|581064076|FG002|Treatment Phase|Progressive Disease|9|||
160909623|NCT01846416|581064074|FG000|Survival Follow-up|Death|21|||
160860869|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160860870|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160860871|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
160860872|NCT03175367|580885128|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860873|NCT03175367|580885129|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860874|NCT03175367|580885130|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
160860875|NCT03175367|580885131|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860876|NCT03175367|580885132|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
160860877|NCT03175367|580885133|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860878|NCT03175367|580885134|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
160860879|NCT03175367|580885128|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860880|NCT03175367|580885129|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860881|NCT03175367|580885130|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860882|NCT03175367|580885131|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860883|NCT03175367|580885132|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860884|NCT03175367|580885133|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
160860885|NCT03175367|580885134|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
160860886|NCT03175367|580885128|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860887|NCT03175367|580885129|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860888|NCT03175367|580885130|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860889|NCT03175367|580885131|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860890|NCT03175367|580885132|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160860891|NCT03175367|580885133|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
160860892|NCT03175367|580885134|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
160860893|NCT03182374|580885137|FG000|Overall Study|Lost to Follow-up|3|||
160860894|NCT03182374|580885138|FG001|Overall Study|Lost to Follow-up|2|||
160860895|NCT03182374|580885137|FG000|Overall Study|Lack of Efficacy|8|||
160860896|NCT03182374|580885138|FG001|Overall Study|Lack of Efficacy|14|||
160860897|NCT03182374|580885137|FG000|Overall Study|Withdrawal by Subject|1|||
160860898|NCT03182374|580885138|FG001|Overall Study|Withdrawal by Subject|1|||
160860899|NCT03182374|580885137|FG000|Overall Study|exit for non-compliance|1|||
160860900|NCT03182374|580885138|FG001|Overall Study|exit for non-compliance|1|||
160860901|NCT03182374|580885137|FG000|Overall Study|one subject was randomized but not treated|1|||
160860902|NCT03182374|580885138|FG001|Overall Study|one subject was randomized but not treated|0|||
160860903|NCT03182374|580885137|FG000|Overall Study|Other reasons|0|||
160860904|NCT03182374|580885138|FG001|Overall Study|Other reasons|3|||
160860905|NCT01462370|580885139|FG000|Overall Study|Lack of Qualifying Event|1|||
160860906|NCT01462370|580885140|FG001|Overall Study|Lack of Qualifying Event|1|||
160860907|NCT01462370|580885139|FG000|Overall Study|Physician Decision|0|||
160860908|NCT01462370|580885140|FG001|Overall Study|Physician Decision|1|||
160860909|NCT01462370|580885139|FG000|Overall Study|Withdrawal by Subject|0|||
160860910|NCT01462370|580885140|FG001|Overall Study|Withdrawal by Subject|3|||
160860911|NCT00853307|580885143|FG000|Overall Study|Adverse Event|1|||
160860912|NCT00853307|580885144|FG001|Overall Study|Adverse Event|2|||
160860913|NCT00853307|580885143|FG000|Overall Study|Withdrawal by Subject|1|||
160860914|NCT00853307|580885144|FG001|Overall Study|Withdrawal by Subject|2|||
160860915|NCT00853307|580885143|FG000|Overall Study|Reason Not Specified|0|||
160860916|NCT00853307|580885144|FG001|Overall Study|Reason Not Specified|1|||
161256326|NCT03297294|582316420|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
161256327|NCT03297294|582316421|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160860917|NCT00473564|580885145|FG000|Overall Study|robot surgery aborted in OR|23|||
160860918|NCT02379728|580885146|FG000|Overall Study|Lost to Follow-up|1|||
160860919|NCT02379728|580885147|FG001|Overall Study|Lost to Follow-up|0|||
160860920|NCT02379728|580885148|FG002|Overall Study|Lost to Follow-up|3|||
160860921|NCT02379728|580885149|FG003|Overall Study|Lost to Follow-up|0|||
160860922|NCT02379728|580885146|FG000|Overall Study|Withdrawal by Subject|5|||
160860923|NCT02379728|580885147|FG001|Overall Study|Withdrawal by Subject|0|||
160860924|NCT02379728|580885148|FG002|Overall Study|Withdrawal by Subject|5|||
160860925|NCT02379728|580885149|FG003|Overall Study|Withdrawal by Subject|3|||
160860926|NCT02379728|580885146|FG000|Overall Study|Protocol Violation|0|||
160860927|NCT02379728|580885147|FG001|Overall Study|Protocol Violation|0|||
160860928|NCT02379728|580885148|FG002|Overall Study|Protocol Violation|2|||
160860929|NCT02379728|580885149|FG003|Overall Study|Protocol Violation|0|||
160860930|NCT00914316|580885152|FG000|Phase 1|Physician Decision|4|||
160860931|NCT00914316|580885153|FG001|Phase 1|Physician Decision|0|||
160860932|NCT00914316|580885154|FG002|Phase 1|Physician Decision|1|||
160860933|NCT00914316|580885155|FG003|Phase 1|Physician Decision|2|||
160860934|NCT00914316|580885152|FG000|Phase 1|Withdrawal by Subject|0|||
160860935|NCT00914316|580885153|FG001|Phase 1|Withdrawal by Subject|2|||
160860936|NCT00914316|580885154|FG002|Phase 1|Withdrawal by Subject|4|||
160860937|NCT00914316|580885155|FG003|Phase 1|Withdrawal by Subject|0|||
160860938|NCT00914316|580885152|FG000|Phase 1|Adverse Event|1|||
161256328|NCT03297294|582316422|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160860939|NCT00914316|580885153|FG001|Phase 1|Adverse Event|0|||
160860940|NCT00914316|580885154|FG002|Phase 1|Adverse Event|0|||
160860941|NCT00914316|580885155|FG003|Phase 1|Adverse Event|0|||
160995044|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
160995045|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
160860942|NCT00914316|580885152|FG000|Phase 2|Withdrawal by Subject|1|||
160860943|NCT00914316|580885153|FG001|Phase 2|Withdrawal by Subject|0|||
160860944|NCT00914316|580885154|FG002|Phase 2|Withdrawal by Subject|1|||
160860945|NCT00914316|580885155|FG003|Phase 2|Withdrawal by Subject|0|||
160860946|NCT01112917|580885156|FG000|Overall Study|Death|2|||
160860947|NCT01112917|580885157|FG001|Overall Study|Death|11|||
160860948|NCT01112917|580885156|FG000|Overall Study|Lost to Follow-up|1|||
160860949|NCT01112917|580885157|FG001|Overall Study|Lost to Follow-up|1|||
160860950|NCT01112917|580885156|FG000|Overall Study|Withdrawal by Subject|1|||
160860951|NCT01112917|580885157|FG001|Overall Study|Withdrawal by Subject|3|||
160860952|NCT01112917|580885156|FG000|Overall Study|Unable to Convert Filter|3|||
160860953|NCT01112917|580885157|FG001|Overall Study|Unable to Convert Filter|0|||
160860954|NCT05101122|580885158|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
160860955|NCT05101122|580885158|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
160860956|NCT05101122|580885158|FG000|AD313 80/5|Withdrawal by Subject|1|||
160860957|NCT05101122|580885158|FG000|AD313 80/10|Physician Decision|1|||
160995046|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
160995047|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
160995048|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
160995049|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
160995050|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
160995051|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
160995052|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
161256329|NCT03297294|582316423|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
160860958|NCT03131219|580885159|FG000|Initial Evaluation Period|Adverse Event|2|||
160860959|NCT03131219|580885160|FG001|Initial Evaluation Period|Adverse Event|0|||
160860960|NCT03131219|580885159|FG000|Initial Evaluation Period|Protocol Violation|1|||
160860961|NCT03131219|580885160|FG001|Initial Evaluation Period|Protocol Violation|0|||
160860962|NCT03131219|580885159|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
160860963|NCT03131219|580885160|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
160860964|NCT03131219|580885159|FG000|Initial Evaluation Period|Physician Decision|1|||
160860965|NCT03131219|580885160|FG001|Initial Evaluation Period|Physician Decision|0|||
160860966|NCT03131219|580885159|FG000|Extension Period|Physician Decision|1|||
160860967|NCT03131219|580885160|FG001|Extension Period|Physician Decision|0|||
160860968|NCT00616759|580885162|FG000|Overall Study|Physician Decision|2|||
160860969|NCT00616759|580885163|FG001|Overall Study|Physician Decision|0|||
160860970|NCT00616759|580885162|FG000|Overall Study|Withdrawal by Subject|1|||
160860971|NCT00616759|580885163|FG001|Overall Study|Withdrawal by Subject|2|||
160860972|NCT02399163|580885166|FG000|Overall Study|Adverse Event|2|||
160860973|NCT02399163|580885166|FG000|Overall Study|Protocol Deviation|2|||
160860974|NCT02399163|580885166|FG000|Overall Study|Withdrawal by Participant|5|||
160860975|NCT02177123|580885172|FG000|Overall Study|Lost to Follow-up|6|||
160860976|NCT02177123|580885172|FG000|Overall Study|Withdrawal by Subject|4|||
160860977|NCT02177123|580885172|FG000|Overall Study|Adverse Event|4|||
160860978|NCT02177123|580885172|FG000|Overall Study|Physician Decision|3|||
160860979|NCT02177123|580885172|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
160860980|NCT02177123|580885172|FG000|Overall Study|Excluded for medical reasons|2|||
160860981|NCT02177123|580885172|FG000|Overall Study|Death|1|||
160860982|NCT02177123|580885172|FG000|Overall Study|Other|1|||
160860983|NCT02177123|580885172|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
160860984|NCT01391546|580885173|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
160860985|NCT01391546|580885174|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
160860986|NCT06271993|580885176|FG000|Overall Study|Not reactive to histamine|5|||
160860987|NCT06271993|580885177|FG001|Overall Study|Not reactive to histamine|5|||
160860988|NCT06271993|580885178|FG002|Overall Study|Not reactive to histamine|5|||
160860989|NCT01980017|580885187|FG000|Overall Study|Lost to Follow-up|30|||
160860990|NCT01980017|580885188|FG001|Overall Study|Lost to Follow-up|21|||
160860991|NCT01980017|580885187|FG000|Overall Study|Death|0|||
160860992|NCT01980017|580885188|FG001|Overall Study|Death|1|||
160860993|NCT01435382|580885190|FG000|Overall Study|Lost to Follow-up|1|||
160860994|NCT01435382|580885191|FG001|Overall Study|Lost to Follow-up|0|||
160860995|NCT01435382|580885192|FG002|Overall Study|Lost to Follow-up|1|||
160860996|NCT01435382|580885193|FG003|Overall Study|Lost to Follow-up|0|||
161256330|NCT03297294|582316419|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
160860997|NCT01435382|580885190|FG000|Overall Study|Withdrawal by Subject|0|||
160860998|NCT01435382|580885191|FG001|Overall Study|Withdrawal by Subject|2|||
160860999|NCT01435382|580885192|FG002|Overall Study|Withdrawal by Subject|0|||
160861000|NCT01435382|580885193|FG003|Overall Study|Withdrawal by Subject|1|||
160861001|NCT03379818|580885194|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
160861002|NCT03379818|580885195|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
160861003|NCT03379818|580885194|FG000|Overall Study|Withdrawal by Subject|2|||
160861004|NCT03379818|580885195|FG001|Overall Study|Withdrawal by Subject|3|||
161339136|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161339137|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161339138|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161339139|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
161339140|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
161339141|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
161339142|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339143|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339144|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339145|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339146|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339147|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339148|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339149|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161339150|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
161339151|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339152|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339153|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339154|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339155|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339156|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339157|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339158|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339159|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
161339160|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
161339161|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
161339162|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339163|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339164|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339165|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339166|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339167|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339168|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339169|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161339170|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
161339171|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
161339172|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161339173|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161339174|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161339175|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160861005|NCT03379818|580885194|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
160861006|NCT03379818|580885195|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
160861007|NCT00910650|580885196|FG000|Overall Study|Death|2|||
160861008|NCT00423579|580885197|FG000|Overall Study|Lost to Follow-up|3|||
160861009|NCT00423579|580885198|FG001|Overall Study|Lost to Follow-up|0|||
160861010|NCT00423579|580885197|FG000|Overall Study|Protocol Violation|1|||
160861011|NCT00423579|580885198|FG001|Overall Study|Protocol Violation|3|||
160861012|NCT00423579|580885197|FG000|Overall Study|Diagnosis of diabetes|0|||
160861013|NCT00423579|580885198|FG001|Overall Study|Diagnosis of diabetes|1|||
160861014|NCT01310777|580885200|FG000|Overall Study|Adverse Event|23|||
160861015|NCT01310777|580885201|FG001|Overall Study|Adverse Event|1|||
160861016|NCT01310777|580885202|FG002|Overall Study|Adverse Event|15|||
160861017|NCT01310777|580885200|FG000|Overall Study|Lost to Follow-up|0|||
160861018|NCT01310777|580885201|FG001|Overall Study|Lost to Follow-up|4|||
160861019|NCT01310777|580885202|FG002|Overall Study|Lost to Follow-up|1|||
160861020|NCT01310777|580885200|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
160861021|NCT01310777|580885201|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
160861022|NCT01310777|580885202|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
160861023|NCT01310777|580885200|FG000|Overall Study|Inadequate Control of IOP|5|||
160861024|NCT01310777|580885201|FG001|Overall Study|Inadequate Control of IOP|7|||
160861025|NCT01310777|580885202|FG002|Overall Study|Inadequate Control of IOP|10|||
160861026|NCT01310777|580885200|FG000|Overall Study|Other|4|||
160861027|NCT01310777|580885201|FG001|Overall Study|Other|1|||
160861028|NCT01310777|580885202|FG002|Overall Study|Other|2|||
161141650|NCT00618956|581902589|FG001|Overall Study|Withdrawal by Subject|7|||
161141651|NCT00618956|581902588|FG000|Overall Study|Lost to Follow-up|4|||
161141652|NCT00618956|581902589|FG001|Overall Study|Lost to Follow-up|5|||
161141653|NCT00618956|581902588|FG000|Overall Study|Protocol Violation|2|||
161141654|NCT00618956|581902589|FG001|Overall Study|Protocol Violation|2|||
161141655|NCT00618956|581902588|FG000|Overall Study|did not meet criteria, non-compliance|2|||
161141656|NCT00618956|581902589|FG001|Overall Study|did not meet criteria, non-compliance|1|||
161141657|NCT03598777|581902590|FG000|Overall Study|Study Terminated by Sponsor|3|||
161141658|NCT03598777|581902591|FG001|Overall Study|Study Terminated by Sponsor|0|||
161141659|NCT03598777|581902592|FG002|Overall Study|Study Terminated by Sponsor|0|||
161141660|NCT03598777|581902593|FG003|Overall Study|Study Terminated by Sponsor|0|||
161141661|NCT03598777|581902594|FG004|Overall Study|Study Terminated by Sponsor|15|||
161141662|NCT03598777|581902590|FG000|Overall Study|Withdrawal by Subject|1|||
161141663|NCT03598777|581902591|FG001|Overall Study|Withdrawal by Subject|1|||
161141664|NCT03598777|581902592|FG002|Overall Study|Withdrawal by Subject|0|||
161141665|NCT03598777|581902593|FG003|Overall Study|Withdrawal by Subject|0|||
161141666|NCT03598777|581902594|FG004|Overall Study|Withdrawal by Subject|0|||
161141667|NCT03598777|581902590|FG000|Overall Study|Adverse Event|1|||
161141668|NCT03598777|581902591|FG001|Overall Study|Adverse Event|0|||
161141669|NCT03598777|581902592|FG002|Overall Study|Adverse Event|0|||
161141670|NCT03598777|581902593|FG003|Overall Study|Adverse Event|0|||
161141671|NCT03598777|581902594|FG004|Overall Study|Adverse Event|0|||
161141672|NCT03598777|581902590|FG000|Overall Study|Lost to Follow-up|1|||
161141673|NCT03598777|581902591|FG001|Overall Study|Lost to Follow-up|0|||
161141674|NCT03598777|581902592|FG002|Overall Study|Lost to Follow-up|0|||
161141675|NCT03598777|581902593|FG003|Overall Study|Lost to Follow-up|0|||
160909624|NCT01846416|581064075|FG001|Survival Follow-up|Death|62|||
160909625|NCT01846416|581064076|FG002|Survival Follow-up|Death|9|||
160909626|NCT01846416|581064074|FG000|Survival Follow-up|Lost to Follow-up|0|||
160909627|NCT01846416|581064075|FG001|Survival Follow-up|Lost to Follow-up|2|||
160909628|NCT01846416|581064076|FG002|Survival Follow-up|Lost to Follow-up|2|||
160909629|NCT01846416|581064074|FG000|Survival Follow-up|Withdrawal by Subject|2|||
160909630|NCT01846416|581064075|FG001|Survival Follow-up|Withdrawal by Subject|7|||
160909631|NCT01846416|581064076|FG002|Survival Follow-up|Withdrawal by Subject|0|||
160909632|NCT01846416|581064074|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
160909633|NCT01846416|581064075|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
160909634|NCT01846416|581064076|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
160909635|NCT01846416|581064074|FG000|Survival Follow-up|Other|3|||
160909636|NCT01846416|581064075|FG001|Survival Follow-up|Other|1|||
160909637|NCT01846416|581064076|FG002|Survival Follow-up|Other|1|||
160909638|NCT00382252|581064079|FG000|Overall Study|Death|4|||
160909639|NCT00382252|581064079|FG000|Overall Study|Protocol Violation|8|||
160909640|NCT00382252|581064079|FG000|Overall Study|Not treated by RFA|1|||
160909641|NCT00833794|581064080|FG000|Open-label Phase|Adverse Event|225|||
160909642|NCT00833794|581064081|FG001|Open-label Phase|Adverse Event|0|||
160909643|NCT00833794|581064080|FG000|Open-label Phase|Lack of Efficacy|28|||
160909644|NCT00833794|581064081|FG001|Open-label Phase|Lack of Efficacy|0|||
160909645|NCT00833794|581064080|FG000|Open-label Phase|Withdrawal by Subject|48|||
160909646|NCT00833794|581064081|FG001|Open-label Phase|Withdrawal by Subject|0|||
160909647|NCT00833794|581064080|FG000|Open-label Phase|Physician Decision|20|||
160909648|NCT00833794|581064081|FG001|Open-label Phase|Physician Decision|0|||
160909649|NCT00833794|581064080|FG000|Open-label Phase|Administrative reason|1|||
160909650|NCT00833794|581064081|FG001|Open-label Phase|Administrative reason|0|||
160909651|NCT00833794|581064080|FG000|Open-label Phase|Protocol Violation|47|||
160909652|NCT00833794|581064081|FG001|Open-label Phase|Protocol Violation|0|||
160909653|NCT00833794|581064080|FG000|Open-label Phase|Did not complete wash-out period|12|||
160909654|NCT00833794|581064081|FG001|Open-label Phase|Did not complete wash-out period|0|||
160909655|NCT00833794|581064080|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
160909656|NCT00833794|581064081|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
160909657|NCT00833794|581064080|FG000|Double-blind Phase|Adverse Event|44|||
160909658|NCT00833794|581064081|FG001|Double-blind Phase|Adverse Event|11|||
160909659|NCT00833794|581064080|FG000|Double-blind Phase|Lack of Efficacy|34|||
160909660|NCT00833794|581064081|FG001|Double-blind Phase|Lack of Efficacy|22|||
160909661|NCT00833794|581064080|FG000|Double-blind Phase|Withdrawal by Subject|23|||
160909662|NCT00833794|581064081|FG001|Double-blind Phase|Withdrawal by Subject|6|||
160909663|NCT00833794|581064080|FG000|Double-blind Phase|Physician Decision|4|||
160909664|NCT00833794|581064081|FG001|Double-blind Phase|Physician Decision|7|||
160909665|NCT00833794|581064080|FG000|Double-blind Phase|Administrative reason|1|||
160909666|NCT00833794|581064081|FG001|Double-blind Phase|Administrative reason|3|||
160909667|NCT03648983|581064086|FG000|Overall Study|Study was terminated due to PI departure|95|||
160909668|NCT01411774|581066164|FG000|Overall Study|Withdrawal by Subject|0|||
160909669|NCT01411774|581066165|FG001|Overall Study|Withdrawal by Subject|3|||
160909670|NCT03292588|581066166|FG000|Overall Study|Death|1|||
160909671|NCT03292588|581066167|FG001|Overall Study|Death|0|||
160909672|NCT03292588|581066166|FG000|Overall Study|Lost to Follow-up|12|||
160909673|NCT03292588|581066167|FG001|Overall Study|Lost to Follow-up|16|||
160909674|NCT03292588|581066166|FG000|Overall Study|Physician Decision|0|||
160861029|NCT03697252|580885203|FG000|Overall Study|Adverse Event|3|||
160861030|NCT03697252|580885204|FG001|Overall Study|Adverse Event|2|||
160861031|NCT03697252|580885203|FG000|Overall Study|Withdrawal by Subject|14|||
160861032|NCT03697252|580885204|FG001|Overall Study|Withdrawal by Subject|14|||
160861033|NCT03697252|580885203|FG000|Overall Study|Lost to Follow-up|0|||
160861034|NCT03697252|580885204|FG001|Overall Study|Lost to Follow-up|1|||
160861035|NCT03697252|580885203|FG000|Overall Study|Physician Decision|1|||
160861036|NCT03697252|580885204|FG001|Overall Study|Physician Decision|1|||
160861037|NCT03697252|580885203|FG000|Overall Study|Other|0|||
160861038|NCT03697252|580885204|FG001|Overall Study|Other|1|||
160861039|NCT00317473|580885205|FG000|Overall Study|Withdrawal by Subject|2|||
160861040|NCT00317473|580885206|FG001|Overall Study|Withdrawal by Subject|1|||
160861041|NCT00317473|580885207|FG002|Overall Study|Withdrawal by Subject|2|||
160861042|NCT00317473|580885208|FG003|Overall Study|Withdrawal by Subject|1|||
160861043|NCT00317473|580885209|FG004|Overall Study|Withdrawal by Subject|3|||
160861044|NCT00317473|580885210|FG005|Overall Study|Withdrawal by Subject|1|||
160861045|NCT00317473|580885205|FG000|Overall Study|Relocation|1|||
160861046|NCT00317473|580885206|FG001|Overall Study|Relocation|0|||
160861047|NCT00317473|580885207|FG002|Overall Study|Relocation|1|||
160861048|NCT00317473|580885208|FG003|Overall Study|Relocation|1|||
160861049|NCT00317473|580885209|FG004|Overall Study|Relocation|5|||
160861050|NCT00317473|580885210|FG005|Overall Study|Relocation|2|||
160861051|NCT00317473|580885205|FG000|Overall Study|Death|1|||
160861052|NCT00317473|580885206|FG001|Overall Study|Death|0|||
160861053|NCT00317473|580885207|FG002|Overall Study|Death|0|||
160861054|NCT00317473|580885208|FG003|Overall Study|Death|0|||
160861055|NCT00317473|580885209|FG004|Overall Study|Death|0|||
160861056|NCT00317473|580885210|FG005|Overall Study|Death|0|||
160861057|NCT00317473|580885205|FG000|Overall Study|Other|0|||
160861058|NCT00317473|580885206|FG001|Overall Study|Other|2|||
160861059|NCT00317473|580885207|FG002|Overall Study|Other|0|||
160861060|NCT00317473|580885208|FG003|Overall Study|Other|0|||
160861061|NCT00317473|580885209|FG004|Overall Study|Other|0|||
160861062|NCT00317473|580885210|FG005|Overall Study|Other|0|||
160861063|NCT03253796|580885211|FG000|Period 1: Run-In|Adverse Event|4|||
160861064|NCT03253796|580885212|FG001|Period 1: Run-In|Adverse Event|0|||
160861065|NCT03253796|580885213|FG002|Period 1: Run-In|Adverse Event|0|||
160861066|NCT03253796|580885214|FG003|Period 1: Run-In|Adverse Event|0|||
160861067|NCT03253796|580885215|FG004|Period 1: Run-In|Adverse Event|0|||
160861068|NCT03253796|580885211|FG000|Period 1: Run-In|Lack of Efficacy|1|||
160861069|NCT03253796|580885212|FG001|Period 1: Run-In|Lack of Efficacy|0|||
160861070|NCT03253796|580885213|FG002|Period 1: Run-In|Lack of Efficacy|0|||
160861071|NCT03253796|580885214|FG003|Period 1: Run-In|Lack of Efficacy|0|||
160861072|NCT03253796|580885215|FG004|Period 1: Run-In|Lack of Efficacy|0|||
160861073|NCT03253796|580885211|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
160861074|NCT03253796|580885212|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
160861075|NCT03253796|580885213|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
160861076|NCT03253796|580885214|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
160861077|NCT03253796|580885215|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
160861078|NCT03253796|580885211|FG000|Period 1: Run-In|Protocol Violation|5|||
160861079|NCT03253796|580885212|FG001|Period 1: Run-In|Protocol Violation|0|||
160861080|NCT03253796|580885213|FG002|Period 1: Run-In|Protocol Violation|0|||
160861081|NCT03253796|580885214|FG003|Period 1: Run-In|Protocol Violation|0|||
160861082|NCT03253796|580885215|FG004|Period 1: Run-In|Protocol Violation|0|||
160861083|NCT03253796|580885211|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
160861084|NCT03253796|580885212|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
160861085|NCT03253796|580885213|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
160861086|NCT03253796|580885214|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
160861087|NCT03253796|580885215|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
160861088|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160861089|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160909675|NCT03292588|581066167|FG001|Overall Study|Physician Decision|1|||
160909676|NCT03292588|581066166|FG000|Overall Study|Withdrawal by Subject|4|||
160861090|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
160861091|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160861092|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
160861093|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861094|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861095|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
160861096|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861097|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
160861098|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
160861099|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
160861100|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
160861101|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
160861102|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
160909677|NCT03292588|581066167|FG001|Overall Study|Withdrawal by Subject|4|||
161339176|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161339177|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161339178|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
160861103|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861104|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861105|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
160861106|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861107|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
160861108|NCT03253796|580885211|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
160861109|NCT03253796|580885212|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
160861110|NCT03253796|580885213|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
160861111|NCT03253796|580885214|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
160861112|NCT03253796|580885215|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
160861113|NCT03253796|580885211|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861114|NCT03253796|580885212|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861115|NCT03253796|580885213|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861116|NCT03253796|580885214|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
160861117|NCT03253796|580885215|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
160861118|NCT02285855|580885216|FG000|Overall Study|Withdrawal by Subject|2|||
160861119|NCT02285855|580885217|FG001|Overall Study|Withdrawal by Subject|1|||
160861120|NCT00528112|580885218|FG000|Treatment up to 3 Years|Adverse Event|313|||
160861121|NCT00528112|580885219|FG001|Treatment up to 3 Years|Adverse Event|278|||
160861122|NCT00528112|580885218|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
160861123|NCT00528112|580885219|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
160861124|NCT00528112|580885218|FG000|Treatment up to 3 Years|Protocol Violation|16|||
160861125|NCT00528112|580885219|FG001|Treatment up to 3 Years|Protocol Violation|16|||
160861126|NCT00528112|580885218|FG000|Treatment up to 3 Years|Death|0|||
160861127|NCT00528112|580885219|FG001|Treatment up to 3 Years|Death|1|||
160861128|NCT00528112|580885218|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
160861129|NCT00528112|580885219|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
160861130|NCT00528112|580885218|FG000|Treatment up to 3 Years|Pregnancy|9|||
160861131|NCT00528112|580885219|FG001|Treatment up to 3 Years|Pregnancy|10|||
160861132|NCT00528112|580885218|FG000|Treatment up to 3 Years|Other reasons|186|||
160861133|NCT00528112|580885219|FG001|Treatment up to 3 Years|Other reasons|186|||
160861134|NCT00528112|580885218|FG000|Extension Phase|Withdrawal by Subject|0|||
160861135|NCT00528112|580885219|FG001|Extension Phase|Withdrawal by Subject|3|||
160861136|NCT00528112|580885218|FG000|Extension Phase|Other reasons|0|||
160861137|NCT00528112|580885219|FG001|Extension Phase|Other reasons|100|||
160861138|NCT00528112|580885218|FG000|Extension Phase|Pregnancy|0|||
160861139|NCT00528112|580885219|FG001|Extension Phase|Pregnancy|3|||
160861140|NCT00528112|580885218|FG000|Extension Phase|Lost to Follow-up|0|||
160861141|NCT00528112|580885219|FG001|Extension Phase|Lost to Follow-up|12|||
160861142|NCT00528112|580885218|FG000|Extension Phase|Death|0|||
160861143|NCT00528112|580885219|FG001|Extension Phase|Death|1|||
160861144|NCT00528112|580885218|FG000|Extension Phase|Adverse Event|0|||
160861145|NCT00528112|580885219|FG001|Extension Phase|Adverse Event|36|||
160861146|NCT00528112|580885218|FG000|Extension Phase|Protocol Violation|0|||
160861147|NCT00528112|580885219|FG001|Extension Phase|Protocol Violation|2|||
160861148|NCT02718898|580885222|FG000|Blinded Treatment Period|Adverse Event|5|||
160861149|NCT02718898|580885223|FG001|Blinded Treatment Period|Adverse Event|1|||
160861150|NCT02718898|580885224|FG002|Blinded Treatment Period|Adverse Event|0|||
160861151|NCT02718898|580885225|FG003|Blinded Treatment Period|Adverse Event|0|||
160861152|NCT02718898|580885226|FG004|Blinded Treatment Period|Adverse Event|0|||
160861153|NCT02718898|580885227|FG005|Blinded Treatment Period|Adverse Event|0|||
160861154|NCT02718898|580885228|FG006|Blinded Treatment Period|Adverse Event|0|||
160861155|NCT02718898|580885222|FG000|Blinded Treatment Period|Physician Decision|1|||
160861156|NCT02718898|580885223|FG001|Blinded Treatment Period|Physician Decision|0|||
161339179|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
161339180|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
161339181|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
161339182|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160861157|NCT02718898|580885224|FG002|Blinded Treatment Period|Physician Decision|0|||
160861158|NCT02718898|580885225|FG003|Blinded Treatment Period|Physician Decision|0|||
160861159|NCT02718898|580885226|FG004|Blinded Treatment Period|Physician Decision|0|||
160909678|NCT03292588|581066166|FG000|Overall Study|Move out of town|1|||
160909679|NCT03292588|581066167|FG001|Overall Study|Move out of town|0|||
161339183|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160861160|NCT02718898|580885227|FG005|Blinded Treatment Period|Physician Decision|0|||
160909680|NCT03292588|581066166|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
160995053|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
160995054|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
160995055|NCT03412747|581369059|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
160995056|NCT03412747|581369060|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
160995057|NCT03412747|581369061|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
160995058|NCT04982575|581369062|FG000|Overall Study|Withdrawal by Subject|2|||
160995059|NCT04982575|581369063|FG001|Overall Study|Withdrawal by Subject|0|||
160995060|NCT04982575|581369064|FG002|Overall Study|Withdrawal by Subject|2|||
160995061|NCT06269367|581369067|FG000|Phase I|Unable to perform study procedures|0|||
160995062|NCT06269367|581369068|FG001|Phase I|Unable to perform study procedures|1|||
161141676|NCT03598777|581902594|FG004|Overall Study|Lost to Follow-up|0|||
160995063|NCT06269367|581369067|FG000|Phase I|Could not continue study for personal reasons.|1|||
160995064|NCT06269367|581369068|FG001|Phase I|Could not continue study for personal reasons.|0|||
160995065|NCT02824432|581369073|FG000|Overall Study|Major Protocol Deviation|1|||
160995066|NCT02824432|581369074|FG001|Overall Study|Major Protocol Deviation|0|||
160995067|NCT01348087|581369076|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
160995068|NCT01348087|581369076|FG000|Overall Study|Administrative problems|79|||
160995069|NCT01348087|581369076|FG000|Overall Study|protocol deviation|1|||
160995070|NCT01348087|581369076|FG000|Overall Study|Lost to Follow-up|1|||
161141677|NCT02006576|581902595|FG000|Overall Study|Withdrawal by Subject|4|||
161141678|NCT02006576|581902596|FG001|Overall Study|Withdrawal by Subject|6|||
161141679|NCT02006576|581902597|FG002|Overall Study|Withdrawal by Subject|2|||
161141680|NCT02006576|581902595|FG000|Overall Study|Death|0|||
161141681|NCT02006576|581902596|FG001|Overall Study|Death|0|||
160995071|NCT01348087|581369076|FG000|Overall Study|Subject withdrew consent|7|||
160995072|NCT01348087|581369076|FG000|Overall Study|Adverse Event|25|||
160995073|NCT00117988|581369079|FG000|Overall Study|Death|3|||
160995074|NCT00117988|581369079|FG000|Overall Study|Adverse Event|1|||
160995075|NCT05824351|581369080|FG000|Overall Study|Adverse Event|6|||
160995076|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
160995077|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
160995078|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
160995079|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
160995080|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
160995081|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
161141682|NCT02006576|581902597|FG002|Overall Study|Death|1|||
161256331|NCT03297294|582316420|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
161256332|NCT03297294|582316421|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161256333|NCT03297294|582316422|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161256334|NCT03297294|582316423|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
161256335|NCT03297294|582316419|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161256336|NCT03297294|582316420|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161256337|NCT03297294|582316421|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161256338|NCT03297294|582316422|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
161256339|NCT03297294|582316423|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
161256340|NCT02692482|582316424|FG000|Overall Study|Death|2|||
161256341|NCT02692482|582316425|FG001|Overall Study|Death|2|||
161256342|NCT02692482|582316424|FG000|Overall Study|Withdrawal by Subject|1|||
161256343|NCT02692482|582316425|FG001|Overall Study|Withdrawal by Subject|2|||
161256344|NCT00127166|582316428|FG000|Period I|Protocol Violation|0|||
161256345|NCT00127166|582316429|FG001|Period I|Protocol Violation|2|||
161256346|NCT00127166|582316428|FG000|Period I|Withdrawal by Subject|2|||
161256347|NCT00127166|582316429|FG001|Period I|Withdrawal by Subject|0|||
161256348|NCT00127166|582316428|FG000|Period I|Patient did not meet inclusion criteria|1|||
161256349|NCT00127166|582316429|FG001|Period I|Patient did not meet inclusion criteria|0|||
161256350|NCT00127166|582316428|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
161256351|NCT00127166|582316429|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
160861161|NCT02718898|580885228|FG006|Blinded Treatment Period|Physician Decision|0|||
160861162|NCT02718898|580885222|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
160861163|NCT02718898|580885223|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
161141683|NCT02006576|581902595|FG000|Overall Study|Lost to Follow-up|1|||
161141684|NCT02006576|581902596|FG001|Overall Study|Lost to Follow-up|0|||
161141685|NCT02006576|581902597|FG002|Overall Study|Lost to Follow-up|1|||
161339184|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
160995082|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
160861164|NCT02718898|580885224|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
160995083|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
160995084|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
161256352|NCT00127166|582316428|FG000|Period II|Withdrawal by Subject|2|||
161141686|NCT02006576|581902595|FG000|Overall Study|Screen Failure, too sick, other|13|||
161256353|NCT00127166|582316429|FG001|Period II|Withdrawal by Subject|0|||
161256354|NCT00127166|582316428|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
161339185|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161339186|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161339187|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161339188|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161339189|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
161339190|NCT01232283|582630420|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
161339191|NCT01232283|582630421|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
161339192|NCT01232283|582630422|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339193|NCT01232283|582630423|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339194|NCT01232283|582630424|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339195|NCT01232283|582630425|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339196|NCT01232283|582630426|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339197|NCT01232283|582630427|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339198|NCT01232283|582630428|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339199|NCT01232283|582630429|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
161339200|NCT01232283|582630420|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339201|NCT01232283|582630421|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339202|NCT01232283|582630422|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
161339203|NCT01232283|582630423|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
161339204|NCT01232283|582630424|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339205|NCT01232283|582630425|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339206|NCT01232283|582630426|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339207|NCT01232283|582630427|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339208|NCT01232283|582630428|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339209|NCT01232283|582630429|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
161339210|NCT01232283|582630420|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339211|NCT01232283|582630421|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339212|NCT01232283|582630422|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
161339213|NCT01232283|582630423|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
161339214|NCT01232283|582630424|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339215|NCT01232283|582630425|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339216|NCT01232283|582630426|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339217|NCT01232283|582630427|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
160995085|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
160995086|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
160995087|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
160995088|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
160995089|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
160995090|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
160995091|NCT02137850|581369081|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
160995092|NCT02137850|581369082|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
160995093|NCT02137850|581369083|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
160995094|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
161256355|NCT00127166|582316429|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
161256356|NCT00105157|582316430|FG000|Double-Blind (DB)|Never Treated|1|||
161256357|NCT00105157|582316431|FG001|Double-Blind (DB)|Never Treated|0|||
161256358|NCT00105157|582316432|FG002|Double-Blind (DB)|Never Treated|0|||
161256359|NCT00105157|582316433|FG003|Double-Blind (DB)|Never Treated|0|||
161256360|NCT00105157|582316430|FG000|Double-Blind (DB)|Adverse Event|2|||
161256361|NCT00105157|582316431|FG001|Double-Blind (DB)|Adverse Event|0|||
161256362|NCT00105157|582316432|FG002|Double-Blind (DB)|Adverse Event|1|||
161256363|NCT00105157|582316433|FG003|Double-Blind (DB)|Adverse Event|1|||
161256364|NCT00105157|582316430|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
161256365|NCT00105157|582316431|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
161256366|NCT00105157|582316432|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
161256367|NCT00105157|582316433|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
161339218|NCT01232283|582630428|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339219|NCT01232283|582630429|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
161339220|NCT01232283|582630420|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160995095|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
160995096|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
161256368|NCT00105157|582316430|FG000|Open-Label Continuation of DB|Adverse Event|3|||
161256369|NCT00105157|582316431|FG001|Open-Label Continuation of DB|Adverse Event|1|||
161256370|NCT00105157|582316432|FG002|Open-Label Continuation of DB|Adverse Event|0|||
161256371|NCT00105157|582316433|FG003|Open-Label Continuation of DB|Adverse Event|0|||
161256372|NCT00105157|582316430|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
161256373|NCT00105157|582316431|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
161339221|NCT01232283|582630421|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161339222|NCT01232283|582630422|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
160995097|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
161256374|NCT00105157|582316432|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
161256375|NCT00105157|582316433|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
161256376|NCT00105157|582316430|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
161256377|NCT00105157|582316431|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
161256378|NCT00105157|582316432|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
161256379|NCT00105157|582316433|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
161256380|NCT00105157|582316430|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
161256381|NCT00105157|582316431|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
161256382|NCT00105157|582316432|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
161256383|NCT00105157|582316433|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
161256384|NCT00105157|582316430|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
161256385|NCT00105157|582316431|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161256386|NCT00105157|582316432|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161256387|NCT00105157|582316433|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
161256388|NCT00105157|582316430|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
161256389|NCT00105157|582316431|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
161256390|NCT00105157|582316432|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
161256391|NCT00105157|582316433|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
161256392|NCT00105157|582316430|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161256393|NCT00105157|582316431|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161256394|NCT00105157|582316432|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
161256395|NCT00105157|582316433|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
161256396|NCT00105157|582316430|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
161256397|NCT00105157|582316431|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
161256398|NCT00105157|582316432|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
161256399|NCT00105157|582316433|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
161256400|NCT00105157|582316430|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
161256401|NCT00105157|582316431|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
161256402|NCT00105157|582316432|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
161256403|NCT00105157|582316433|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
161256404|NCT00105157|582316430|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161256405|NCT00105157|582316431|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161256406|NCT00105157|582316432|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
161256407|NCT00105157|582316433|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
161256408|NCT00105157|582316430|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161256409|NCT00105157|582316431|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
161256410|NCT00105157|582316432|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161256411|NCT00105157|582316433|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
161339223|NCT01232283|582630423|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160861165|NCT02718898|580885225|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
160861166|NCT02718898|580885226|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
160861167|NCT02718898|580885227|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
160861168|NCT02718898|580885228|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
160861169|NCT02718898|580885222|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
160861170|NCT02718898|580885223|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
160861171|NCT02718898|580885224|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
160861172|NCT02718898|580885225|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
160861173|NCT02718898|580885226|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
160861174|NCT02718898|580885227|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
160861175|NCT02718898|580885228|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
160861176|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861177|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861178|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
160861179|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
160861180|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861181|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861182|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
160861183|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861184|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861185|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861186|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
160861187|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861188|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861189|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
160861190|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861191|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861192|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
160861193|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
160861194|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861195|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861196|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
160861197|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861198|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861199|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
160861200|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
160861201|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861202|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861203|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
160861204|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861205|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861206|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861207|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
160861208|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861209|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861210|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
160861211|NCT02718898|580885222|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861212|NCT02718898|580885223|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861213|NCT02718898|580885224|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861214|NCT02718898|580885225|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
160861215|NCT02718898|580885226|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861216|NCT02718898|580885227|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861217|NCT02718898|580885228|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
160861218|NCT02718898|580885222|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
160861219|NCT02718898|580885223|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
160861220|NCT02718898|580885224|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
160861221|NCT02718898|580885225|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
160861222|NCT02718898|580885226|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
160861223|NCT02718898|580885227|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
160861224|NCT02718898|580885228|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
160861225|NCT02718898|580885222|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861226|NCT02718898|580885223|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861227|NCT02718898|580885224|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861228|NCT02718898|580885225|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
160861229|NCT02718898|580885226|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
160861230|NCT02718898|580885227|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
160861231|NCT02718898|580885228|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
160861232|NCT02718898|580885222|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861233|NCT02718898|580885223|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861234|NCT02718898|580885224|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861235|NCT02718898|580885225|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160861236|NCT02718898|580885226|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
160909681|NCT03292588|581066167|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
160909682|NCT00684307|581066168|FG000|Overall Study|Adverse Event|11|||
160909683|NCT00684307|581066169|FG001|Overall Study|Adverse Event|6|||
160909684|NCT00684307|581066170|FG002|Overall Study|Adverse Event|15|||
160909685|NCT00684307|581066171|FG003|Overall Study|Adverse Event|16|||
160909686|NCT00684307|581066172|FG004|Overall Study|Adverse Event|8|||
160909687|NCT00684307|581066168|FG000|Overall Study|Development of increasing Liver Function|0|||
160909688|NCT00684307|581066169|FG001|Overall Study|Development of increasing Liver Function|2|||
160909689|NCT00684307|581066170|FG002|Overall Study|Development of increasing Liver Function|0|||
160909690|NCT00684307|581066171|FG003|Overall Study|Development of increasing Liver Function|1|||
160909691|NCT00684307|581066172|FG004|Overall Study|Development of increasing Liver Function|0|||
160909692|NCT00684307|581066168|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
160909693|NCT00684307|581066169|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
160909694|NCT00684307|581066170|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
160909695|NCT00684307|581066171|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
160909696|NCT00684307|581066172|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
160909697|NCT00684307|581066168|FG000|Overall Study|Incorrect enrolment or randomization|4|||
160909698|NCT00684307|581066169|FG001|Overall Study|Incorrect enrolment or randomization|0|||
160909699|NCT00684307|581066170|FG002|Overall Study|Incorrect enrolment or randomization|0|||
161256412|NCT01396421|582316434|FG000|Overall Study|Lost to Follow-up|0|||
161256413|NCT01396421|582316435|FG001|Overall Study|Lost to Follow-up|0|||
160861237|NCT02718898|580885227|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
160861238|NCT02718898|580885228|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
160861239|NCT00231816|580885231|FG000|Overall Study|Adverse Event|1|||
160861240|NCT00231816|580885232|FG001|Overall Study|Adverse Event|0|||
160861241|NCT00231816|580885231|FG000|Overall Study|Lost to Follow-up|8|||
160861242|NCT00231816|580885232|FG001|Overall Study|Lost to Follow-up|5|||
160861243|NCT00231816|580885231|FG000|Overall Study|Protocol Violation|2|||
160861244|NCT00231816|580885232|FG001|Overall Study|Protocol Violation|3|||
160861245|NCT00231816|580885231|FG000|Overall Study|Withdrawal by Subject|3|||
160861246|NCT00231816|580885232|FG001|Overall Study|Withdrawal by Subject|3|||
160861247|NCT00231816|580885231|FG000|Overall Study|Other|2|||
160861248|NCT00231816|580885232|FG001|Overall Study|Other|1|||
160861249|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
160861250|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
160861251|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
160861252|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
160861253|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
160861254|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
160861255|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
160861256|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
160861257|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
160861258|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
160861259|NCT01668784|580885247|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
160861260|NCT01668784|580885248|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
160861261|NCT01668784|580885247|FG000|Treatment Period|Disease Progression|316|||
160861262|NCT01668784|580885248|FG001|Treatment Period|Disease Progression|293|||
160861263|NCT01668784|580885247|FG000|Treatment Period|Study Drug Toxicity|46|||
160861264|NCT01668784|580885248|FG001|Treatment Period|Study Drug Toxicity|53|||
160861265|NCT01668784|580885247|FG000|Treatment Period|Death|1|||
160861266|NCT01668784|580885248|FG001|Treatment Period|Death|1|||
160861267|NCT01668784|580885247|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
160861268|NCT01668784|580885248|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
160861269|NCT01668784|580885247|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
160861270|NCT01668784|580885248|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
160861271|NCT01668784|580885247|FG000|Treatment Period|Withdrawal by Subject|5|||
160861272|NCT01668784|580885248|FG001|Treatment Period|Withdrawal by Subject|3|||
160861273|NCT01668784|580885247|FG000|Treatment Period|Maximal Clinical Benefit|3|||
160861274|NCT01668784|580885248|FG001|Treatment Period|Maximal Clinical Benefit|3|||
160861275|NCT01668784|580885247|FG000|Treatment Period|Other|2|||
160861276|NCT01668784|580885248|FG001|Treatment Period|Other|8|||
160861277|NCT01668784|580885247|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
160861278|NCT01668784|580885248|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
160861279|NCT03137992|580885249|FG000|Washout Period 1|Adverse Event|1|||
160861280|NCT03137992|580885250|FG001|Washout Period 1|Adverse Event|1|||
160861281|NCT03137992|580885251|FG002|Washout Period 1|Adverse Event|0|||
160861282|NCT03137992|580885252|FG003|Washout Period 1|Adverse Event|0|||
160861283|NCT03137992|580885253|FG004|Washout Period 1|Adverse Event|0|||
160861284|NCT03137992|580885254|FG005|Washout Period 1|Adverse Event|1|||
160861285|NCT03137992|580885249|FG000|Washout Period 1|Withdrawal by Subject|0|||
160861286|NCT03137992|580885250|FG001|Washout Period 1|Withdrawal by Subject|1|||
160861287|NCT03137992|580885251|FG002|Washout Period 1|Withdrawal by Subject|1|||
160861288|NCT03137992|580885252|FG003|Washout Period 1|Withdrawal by Subject|0|||
160861289|NCT03137992|580885253|FG004|Washout Period 1|Withdrawal by Subject|0|||
160861290|NCT03137992|580885254|FG005|Washout Period 1|Withdrawal by Subject|0|||
160861291|NCT03137992|580885249|FG000|Washout Period 1|Principal Investigator Discretion|0|||
160861292|NCT03137992|580885250|FG001|Washout Period 1|Principal Investigator Discretion|1|||
160861293|NCT03137992|580885251|FG002|Washout Period 1|Principal Investigator Discretion|0|||
160909700|NCT00684307|581066171|FG003|Overall Study|Incorrect enrolment or randomization|0|||
160909701|NCT00684307|581066172|FG004|Overall Study|Incorrect enrolment or randomization|0|||
160909702|NCT00684307|581066168|FG000|Overall Study|Interupted IP for more than 7 days|0|||
160909703|NCT00684307|581066169|FG001|Overall Study|Interupted IP for more than 7 days|4|||
160909704|NCT00684307|581066170|FG002|Overall Study|Interupted IP for more than 7 days|1|||
160909705|NCT00684307|581066171|FG003|Overall Study|Interupted IP for more than 7 days|3|||
160909706|NCT00684307|581066172|FG004|Overall Study|Interupted IP for more than 7 days|3|||
160909707|NCT00684307|581066168|FG000|Overall Study|Severe non compliance to protocol|1|||
160909708|NCT00684307|581066169|FG001|Overall Study|Severe non compliance to protocol|0|||
161339224|NCT01232283|582630424|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160861294|NCT03137992|580885252|FG003|Washout Period 1|Principal Investigator Discretion|0|||
160861295|NCT03137992|580885253|FG004|Washout Period 1|Principal Investigator Discretion|0|||
160909709|NCT00684307|581066170|FG002|Overall Study|Severe non compliance to protocol|0|||
160909710|NCT00684307|581066171|FG003|Overall Study|Severe non compliance to protocol|1|||
160861296|NCT03137992|580885254|FG005|Washout Period 1|Principal Investigator Discretion|0|||
160909711|NCT00684307|581066172|FG004|Overall Study|Severe non compliance to protocol|2|||
160909712|NCT00684307|581066168|FG000|Overall Study|Participant not willing to continue|7|||
160909713|NCT00684307|581066169|FG001|Overall Study|Participant not willing to continue|10|||
160909714|NCT00684307|581066170|FG002|Overall Study|Participant not willing to continue|11|||
160909715|NCT00684307|581066171|FG003|Overall Study|Participant not willing to continue|5|||
160909716|NCT00684307|581066172|FG004|Overall Study|Participant not willing to continue|8|||
160909717|NCT00684307|581066168|FG000|Overall Study|Criteria from the CSR|0|||
160909718|NCT00684307|581066169|FG001|Overall Study|Criteria from the CSR|0|||
160909719|NCT00684307|581066170|FG002|Overall Study|Criteria from the CSR|1|||
160909720|NCT00684307|581066171|FG003|Overall Study|Criteria from the CSR|3|||
160909721|NCT00684307|581066172|FG004|Overall Study|Criteria from the CSR|3|||
160909722|NCT05526716|581066174|FG000|Overall Study|Death|1|||
160909723|NCT05526716|581066175|FG001|Overall Study|Death|2|||
160909724|NCT05526716|581066174|FG000|Overall Study|Lost to Follow-up|17|||
160909725|NCT05526716|581066175|FG001|Overall Study|Lost to Follow-up|15|||
160909726|NCT05526716|581066174|FG000|Overall Study|Physician Decision|0|||
160909727|NCT05526716|581066175|FG001|Overall Study|Physician Decision|1|||
160909728|NCT05526716|581066174|FG000|Overall Study|Randomized by mistake without study treatment|0|||
160909729|NCT05526716|581066175|FG001|Overall Study|Randomized by mistake without study treatment|1|||
160909730|NCT05526716|581066174|FG000|Overall Study|Withdrawal by Subject|12|||
160909731|NCT05526716|581066175|FG001|Overall Study|Withdrawal by Subject|12|||
160909732|NCT05526716|581066174|FG000|Overall Study|Not reported|0|||
160909733|NCT05526716|581066175|FG001|Overall Study|Not reported|2|||
160909734|NCT04932096|581066178|FG000|Overall Study|Withdrawal by Subject|1|||
160909735|NCT04932096|581066179|FG001|Overall Study|Withdrawal by Subject|1|||
160909736|NCT04932096|581066178|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
160909737|NCT04932096|581066179|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
160909738|NCT01438957|581066180|FG000|Overall Study|Physician Decision|1|||
160909739|NCT01438957|581066181|FG001|Overall Study|Physician Decision|1|||
160909740|NCT01438957|581066182|FG002|Overall Study|Physician Decision|0|||
160909741|NCT01438957|581066183|FG003|Overall Study|Physician Decision|1|||
160909742|NCT01438957|581066184|FG004|Overall Study|Physician Decision|0|||
160909743|NCT03902574|581066185|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
160909744|NCT03902574|581066186|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
160909745|NCT03902574|581066187|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
160909746|NCT00133952|581066188|FG000|Overall Study|Adverse Event|1|||
160909747|NCT00133952|581066189|FG001|Overall Study|Adverse Event|2|||
160909748|NCT00133952|581066188|FG000|Overall Study|Death|3|||
160909749|NCT00133952|581066189|FG001|Overall Study|Death|2|||
160909750|NCT00133952|581066188|FG000|Overall Study|Lost to Follow-up|9|||
160909751|NCT00133952|581066189|FG001|Overall Study|Lost to Follow-up|14|||
160909752|NCT00133952|581066188|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
160909753|NCT00133952|581066189|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
160909754|NCT00133952|581066188|FG000|Overall Study|Protocol Violation|1|||
160909755|NCT00133952|581066189|FG001|Overall Study|Protocol Violation|1|||
160909756|NCT00133952|581066188|FG000|Overall Study|Withdrawal by Subject|20|||
160909757|NCT00133952|581066189|FG001|Overall Study|Withdrawal by Subject|4|||
160909758|NCT00133952|581066188|FG000|Overall Study|Physician Decision|4|||
160909759|NCT00133952|581066189|FG001|Overall Study|Physician Decision|3|||
160909760|NCT00133952|581066188|FG000|Overall Study|Sponsor Decision|0|||
160909761|NCT00133952|581066189|FG001|Overall Study|Sponsor Decision|1|||
160909762|NCT02170298|581066194|FG000|Overall Study|Withdrawal by Subject|0|||
160909763|NCT02170298|581066195|FG001|Overall Study|Withdrawal by Subject|1|||
160909764|NCT02170298|581066194|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
160909765|NCT02170298|581066195|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
160909766|NCT05048784|581066196|FG000|Period 1|Adverse Event|3|||
160909767|NCT05048784|581066197|FG001|Period 1|Adverse Event|1|||
160909768|NCT05048784|581066198|FG002|Period 1|Adverse Event|0|||
160909769|NCT05048784|581066199|FG003|Period 1|Adverse Event|0|||
160909770|NCT05048784|581066196|FG000|Period 2|Lost to Follow-up|0|||
160909771|NCT05048784|581066197|FG001|Period 2|Lost to Follow-up|1|||
160909772|NCT05048784|581066198|FG002|Period 2|Lost to Follow-up|0|||
160909773|NCT05048784|581066199|FG003|Period 2|Lost to Follow-up|0|||
160909774|NCT00727025|581066202|FG000|Overall Study|Physician Decision|23|||
160909775|NCT02269241|581066203|FG000|Overall Study|Lost to Follow-up|269|||
160909776|NCT02269241|581066203|FG000|Overall Study|Withdrawal by Subject|155|||
160909777|NCT02269241|581066203|FG000|Overall Study|Protocol Violation|1|||
160909778|NCT02269241|581066203|FG000|Overall Study|Physician Decision|7|||
160909779|NCT02269241|581066203|FG000|Overall Study|Pregnancy|15|||
160909780|NCT02269241|581066203|FG000|Overall Study|Wish for pregnancy|5|||
160909781|NCT02269241|581066203|FG000|Overall Study|Development of an exclusion criteria|16|||
160909782|NCT02269241|581066203|FG000|Overall Study|Adverse Event|113|||
160909783|NCT02269241|581066203|FG000|Overall Study|At the specific request of the sponsor|20|||
160909784|NCT02269241|581066203|FG000|Overall Study|Several reasons not classified|53|||
160909785|NCT02269241|581066203|FG000|Overall Study|Screening failures|546|||
160909786|NCT03020160|581066204|FG000|Overall Study|Withdrawal by Subject|1|||
161256414|NCT01396421|582316436|FG002|Overall Study|Lost to Follow-up|0|||
161256415|NCT01396421|582316437|FG003|Overall Study|Lost to Follow-up|1|||
161256416|NCT01396421|582316434|FG000|Overall Study|Adverse Event|17|||
161256417|NCT01396421|582316435|FG001|Overall Study|Adverse Event|15|||
161256418|NCT01396421|582316436|FG002|Overall Study|Adverse Event|12|||
161256419|NCT01396421|582316437|FG003|Overall Study|Adverse Event|32|||
161256420|NCT01396421|582316434|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161256421|NCT01396421|582316435|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
160995098|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
160995099|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
160995100|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
160995101|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
160995102|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
160995103|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
160995104|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
160995105|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
160995106|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Other|0|||
160995107|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Other|1|||
160995108|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Other|0|||
160995109|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
160995110|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
160995111|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
160995112|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Early site closure|0|||
160995113|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Early site closure|2|||
160995114|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Early site closure|0|||
160995115|NCT02137850|581369081|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
160995116|NCT02137850|581369082|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
160995117|NCT02137850|581369083|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
160995118|NCT02137850|581369081|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
160995119|NCT02137850|581369082|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
160995120|NCT02137850|581369083|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
160995121|NCT02137850|581369081|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
160995122|NCT02137850|581369082|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
160995123|NCT02137850|581369083|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
160995124|NCT02137850|581369081|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
160995125|NCT02137850|581369082|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
160995126|NCT02137850|581369083|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
160995127|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
160995128|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
160995129|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
160995130|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
160995131|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
160995132|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
160995133|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
160995134|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
160995135|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
160995136|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Other|0|||
160995137|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Other|1|||
160995138|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Other|0|||
160995139|NCT02137850|581369081|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
160995140|NCT02137850|581369082|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
160995141|NCT02137850|581369083|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
160995142|NCT02912260|581369084|FG000|Main Study|Lost to Follow-up|5|||
160995143|NCT02912260|581369085|FG001|Main Study|Lost to Follow-up|4|||
160995144|NCT02912260|581369084|FG000|Main Study|Withdrawal by Subject|2|||
160995145|NCT02912260|581369085|FG001|Main Study|Withdrawal by Subject|2|||
160995146|NCT02912260|581369084|FG000|Main Study|Adverse Event|3|||
160995147|NCT02912260|581369085|FG001|Main Study|Adverse Event|0|||
160995148|NCT02912260|581369084|FG000|Main Study|Physician Decision|0|||
160995149|NCT02912260|581369085|FG001|Main Study|Physician Decision|1|||
160995150|NCT02912260|581369084|FG000|Extension Study|Withdrawal by Subject|1|||
160995151|NCT02912260|581369085|FG001|Extension Study|Withdrawal by Subject|1|||
160995152|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
160995153|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
161256422|NCT01396421|582316436|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
161256423|NCT01396421|582316437|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
161256424|NCT01396421|582316434|FG000|Overall Study|Physician Decision|1|||
161256425|NCT01396421|582316435|FG001|Overall Study|Physician Decision|1|||
161256426|NCT01396421|582316436|FG002|Overall Study|Physician Decision|0|||
160995154|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
160995155|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
160995156|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
161141687|NCT02006576|581902596|FG001|Overall Study|Screen Failure, too sick, other|1|||
161141688|NCT02006576|581902597|FG002|Overall Study|Screen Failure, too sick, other|13|||
161141689|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
161141690|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
161256427|NCT01396421|582316437|FG003|Overall Study|Physician Decision|3|||
161141691|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
161141692|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
161141693|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
161141694|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161141695|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161141696|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161141697|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
161141698|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
161141699|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161141700|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161141701|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161141702|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
161141703|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
161141704|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
161141705|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
161141706|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
161141707|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
161141708|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
161141709|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
161141710|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
161141711|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
161256428|NCT01396421|582316434|FG000|Overall Study|Withdrawal by Subject|31|||
161256429|NCT01396421|582316435|FG001|Overall Study|Withdrawal by Subject|24|||
161256430|NCT01396421|582316436|FG002|Overall Study|Withdrawal by Subject|13|||
161256431|NCT01396421|582316437|FG003|Overall Study|Withdrawal by Subject|21|||
161256432|NCT01396421|582316434|FG000|Overall Study|Protocol Deviation|2|||
161256433|NCT01396421|582316435|FG001|Overall Study|Protocol Deviation|1|||
161256434|NCT01396421|582316436|FG002|Overall Study|Protocol Deviation|1|||
161256435|NCT01396421|582316437|FG003|Overall Study|Protocol Deviation|0|||
161256436|NCT01396421|582316434|FG000|Overall Study|Lack of Efficacy|7|||
161256437|NCT01396421|582316435|FG001|Overall Study|Lack of Efficacy|17|||
161256438|NCT01396421|582316436|FG002|Overall Study|Lack of Efficacy|7|||
161256439|NCT01396421|582316437|FG003|Overall Study|Lack of Efficacy|18|||
161256440|NCT01610063|582316448|FG000|Overall Study|Lost to Follow-up|42|||
161256441|NCT01610063|582316449|FG001|Overall Study|Lost to Follow-up|20|||
161256442|NCT03314662|582316450|FG000|Overall Study|Withdrawal by Subject|1|||
161256443|NCT03314662|582316451|FG001|Overall Study|Withdrawal by Subject|1|||
161256444|NCT03314662|582316452|FG002|Overall Study|Withdrawal by Subject|1|||
161256445|NCT03314662|582316450|FG000|Overall Study|Lost to Follow-up|5|||
161256446|NCT03314662|582316451|FG001|Overall Study|Lost to Follow-up|4|||
161256447|NCT03314662|582316452|FG002|Overall Study|Lost to Follow-up|4|||
161256448|NCT03314662|582316450|FG000|Overall Study|Death|2|||
161256449|NCT03314662|582316451|FG001|Overall Study|Death|0|||
161256450|NCT03314662|582316452|FG002|Overall Study|Death|0|||
161256451|NCT01117766|582316457|FG000|First Intervention|Adverse Event|0|||
161256452|NCT01117766|582316458|FG001|First Intervention|Adverse Event|1|||
160909787|NCT03020160|581066205|FG001|Overall Study|Withdrawal by Subject|0|||
160909788|NCT00545168|581066212|FG000|Overall Study|Lost to Follow-up|5|||
160909789|NCT00545168|581066213|FG001|Overall Study|Lost to Follow-up|5|||
160909790|NCT00545168|581066214|FG002|Overall Study|Lost to Follow-up|5|||
160909791|NCT00545168|581066212|FG000|Overall Study|Withdrawal by Subject|9|||
160909792|NCT00545168|581066213|FG001|Overall Study|Withdrawal by Subject|0|||
160909793|NCT00545168|581066214|FG002|Overall Study|Withdrawal by Subject|13|||
160909794|NCT00545168|581066212|FG000|Overall Study|Protocol Violation|1|||
160909795|NCT00545168|581066213|FG001|Overall Study|Protocol Violation|0|||
160909796|NCT00545168|581066214|FG002|Overall Study|Protocol Violation|1|||
160995157|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
161141712|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
161141713|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
161141714|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
161256453|NCT01117766|582316457|FG000|First Intervention|Protocol Violation|1|||
160909797|NCT00545168|581066212|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
160909798|NCT00545168|581066213|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
160909799|NCT00545168|581066214|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
160909800|NCT01833520|581066217|FG000|Overall Study|Lack of Efficacy|3|||
160909801|NCT01833520|581066218|FG001|Overall Study|Lack of Efficacy|3|||
160909802|NCT01833520|581066219|FG002|Overall Study|Lack of Efficacy|8|||
161256454|NCT01117766|582316458|FG001|First Intervention|Protocol Violation|0|||
161256455|NCT01117766|582316457|FG000|Washout Period|Protocol Violation|0|||
161256456|NCT01117766|582316458|FG001|Washout Period|Protocol Violation|2|||
161141715|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161141716|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161141717|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
161141718|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
161141719|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161141720|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
161141721|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161141722|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
161141723|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
161141724|NCT00785577|581902598|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161141725|NCT00785577|581902599|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
161256457|NCT01117766|582316457|FG000|Second Intervention|Lost to Follow-up|1|||
161256458|NCT01117766|582316458|FG001|Second Intervention|Lost to Follow-up|0|||
160909803|NCT01833520|581066220|FG003|Overall Study|Lack of Efficacy|3|||
161256459|NCT01117766|582316457|FG000|Second Intervention|Other|1|||
160909804|NCT04182763|581066230|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909805|NCT04182763|581066231|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909806|NCT04182763|581066232|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909807|NCT04182763|581066233|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
160909808|NCT04182763|581066234|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
160909809|NCT04182763|581066230|FG000|Double-Blind Period, initial 6 months|Death|0|||
160909810|NCT04182763|581066231|FG001|Double-Blind Period, initial 6 months|Death|1|||
160909811|NCT04182763|581066232|FG002|Double-Blind Period, initial 6 months|Death|0|||
160909812|NCT04182763|581066233|FG003|Double-Blind Period, initial 6 months|Death|0|||
160909813|NCT04182763|581066234|FG004|Double-Blind Period, initial 6 months|Death|0|||
160909814|NCT04182763|581066230|FG000|Open-Label Period, subsequent 18 months|Death|3|||
160909815|NCT04182763|581066231|FG001|Open-Label Period, subsequent 18 months|Death|2|||
160909816|NCT04182763|581066232|FG002|Open-Label Period, subsequent 18 months|Death|2|||
160909817|NCT04182763|581066233|FG003|Open-Label Period, subsequent 18 months|Death|0|||
160909818|NCT04182763|581066234|FG004|Open-Label Period, subsequent 18 months|Death|1|||
160909819|NCT04182763|581066230|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
160909820|NCT04182763|581066231|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
160909821|NCT04182763|581066232|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
160909822|NCT04182763|581066233|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
160909823|NCT04182763|581066234|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
160909824|NCT04182763|581066230|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
160909825|NCT04182763|581066231|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
160909826|NCT04182763|581066232|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
160909827|NCT04182763|581066233|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
160909828|NCT04182763|581066234|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
160909829|NCT00003479|581066238|FG000|Overall Study|Not evaluable|3|||
160909830|NCT01484197|581066251|FG000|Treatment Period 1|Adverse Event|1|||
160909831|NCT01484197|581066252|FG001|Treatment Period 1|Adverse Event|0|||
160909832|NCT01484197|581066253|FG002|Treatment Period 1|Adverse Event|0|||
160909833|NCT01484197|581066254|FG003|Treatment Period 1|Adverse Event|0|||
160909834|NCT01484197|581066251|FG000|Treatment Period 2|Subject withdrew consent|0|||
160909835|NCT01484197|581066252|FG001|Treatment Period 2|Subject withdrew consent|0|||
160909836|NCT01484197|581066253|FG002|Treatment Period 2|Subject withdrew consent|0|||
160909837|NCT01484197|581066254|FG003|Treatment Period 2|Subject withdrew consent|1|||
160909838|NCT01727297|581066255|FG000|Overall Study|Death|13|||
160909839|NCT01727297|581066256|FG001|Overall Study|Death|0|||
160909840|NCT01727297|581066255|FG000|Overall Study|Protocol Violation|1|||
160909841|NCT01727297|581066256|FG001|Overall Study|Protocol Violation|10|||
160909842|NCT01727297|581066255|FG000|Overall Study|Adverse Event|3|||
160909843|NCT01727297|581066256|FG001|Overall Study|Adverse Event|1|||
160909844|NCT01727297|581066255|FG000|Overall Study|Lost to Follow-up|11|||
160909845|NCT01727297|581066256|FG001|Overall Study|Lost to Follow-up|0|||
160909846|NCT01727297|581066255|FG000|Overall Study|Withdrawal by Subject|26|||
160909847|NCT01727297|581066256|FG001|Overall Study|Withdrawal by Subject|27|||
160909848|NCT01727297|581066255|FG000|Overall Study|Physician Decision|19|||
160909849|NCT01727297|581066256|FG001|Overall Study|Physician Decision|5|||
161141726|NCT00785577|581902600|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161256460|NCT01117766|582316458|FG001|Second Intervention|Other|2|||
161256461|NCT01117766|582316457|FG000|Second Intervention|Adverse Event|0|||
160909850|NCT01727297|581066255|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
160909851|NCT01727297|581066256|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
161256462|NCT01117766|582316458|FG001|Second Intervention|Adverse Event|2|||
161256463|NCT01117766|582316457|FG000|Second Intervention|Withdrawal by Subject|0|||
160909852|NCT02244606|581066257|FG000|Overall Study|Adverse Event|0|||
160909853|NCT02244606|581066258|FG001|Overall Study|Adverse Event|1|||
160909854|NCT02244606|581066259|FG002|Overall Study|Adverse Event|1|||
160909855|NCT02244606|581066260|FG003|Overall Study|Adverse Event|0|||
160909856|NCT02244606|581066257|FG000|Overall Study|Lost to Follow-up|2|||
160909857|NCT02244606|581066258|FG001|Overall Study|Lost to Follow-up|2|||
160909858|NCT02244606|581066259|FG002|Overall Study|Lost to Follow-up|1|||
160909859|NCT02244606|581066260|FG003|Overall Study|Lost to Follow-up|0|||
160909860|NCT02244606|581066257|FG000|Overall Study|Protocol Violation|0|||
160909861|NCT02244606|581066258|FG001|Overall Study|Protocol Violation|0|||
160909862|NCT02244606|581066259|FG002|Overall Study|Protocol Violation|0|||
160909863|NCT02244606|581066260|FG003|Overall Study|Protocol Violation|1|||
160909864|NCT02244606|581066257|FG000|Overall Study|Withdrawal by Subject|1|||
160909865|NCT02244606|581066258|FG001|Overall Study|Withdrawal by Subject|1|||
160909866|NCT02244606|581066259|FG002|Overall Study|Withdrawal by Subject|0|||
160909867|NCT02244606|581066260|FG003|Overall Study|Withdrawal by Subject|0|||
160909868|NCT02244606|581066257|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
160909869|NCT02244606|581066258|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
160909870|NCT02244606|581066259|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
160909871|NCT02244606|581066260|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
160909872|NCT02321800|581066266|FG000|Overall Study|Withdrawal by Subject|3|||
160909873|NCT02321800|581066267|FG001|Overall Study|Withdrawal by Subject|3|||
160909874|NCT02321800|581066266|FG000|Overall Study|Death|1|||
160909875|NCT02321800|581066267|FG001|Overall Study|Death|0|||
160909876|NCT02321800|581066266|FG000|Overall Study|Protocol Violation|1|||
160909877|NCT02321800|581066267|FG001|Overall Study|Protocol Violation|0|||
160909878|NCT02321800|581066266|FG000|Overall Study|Lost to Follow-up|10|||
160909879|NCT02321800|581066267|FG001|Overall Study|Lost to Follow-up|4|||
160909880|NCT02321800|581066266|FG000|Overall Study|Adverse Event|2|||
160909881|NCT02321800|581066267|FG001|Overall Study|Adverse Event|3|||
160909882|NCT02321800|581066266|FG000|Overall Study|Other, Miscellaneous|3|||
160909883|NCT02321800|581066267|FG001|Overall Study|Other, Miscellaneous|1|||
160909884|NCT00982878|581066268|FG000|Overall Study|Physician Decision|1|||
160909885|NCT00642460|581066272|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909886|NCT00642460|581066273|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
160909887|NCT00642460|581066274|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
160909888|NCT00642460|581066275|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909889|NCT00642460|581066276|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909890|NCT00642460|581066277|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
160909891|NCT00642460|581066272|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
160909892|NCT00642460|581066273|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909893|NCT00642460|581066274|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909894|NCT00642460|581066275|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909895|NCT00642460|581066276|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909896|NCT00642460|581066277|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
160909897|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
160909898|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
160909899|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909900|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909901|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909902|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
160909903|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Death|0|||
160909904|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Death|1|||
160909905|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Death|0|||
160909906|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Death|2|||
160909907|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Death|0|||
161141727|NCT00785577|581902601|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
161141728|NCT00785577|581902602|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
161141729|NCT00785577|581902598|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161141730|NCT00785577|581902599|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161141731|NCT00785577|581902600|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
161141732|NCT00785577|581902601|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
161141733|NCT00785577|581902602|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
160909908|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Death|0|||
160909909|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
160909910|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
161141734|NCT00785577|581902598|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
160909911|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909912|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909913|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909914|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
160909915|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
161256464|NCT01117766|582316458|FG001|Second Intervention|Withdrawal by Subject|1|||
161256465|NCT04405739|582316459|FG000|Overall Study|Adverse Event|0|||
161256466|NCT04405739|582316460|FG001|Overall Study|Adverse Event|1|||
161256467|NCT04405739|582316461|FG002|Overall Study|Adverse Event|0|||
161256468|NCT04405739|582316462|FG003|Overall Study|Adverse Event|0|||
161256469|NCT04405739|582316459|FG000|Overall Study|Lost to Follow-up|0|||
161256470|NCT04405739|582316460|FG001|Overall Study|Lost to Follow-up|2|||
161256471|NCT04405739|582316461|FG002|Overall Study|Lost to Follow-up|1|||
161256472|NCT04405739|582316462|FG003|Overall Study|Lost to Follow-up|3|||
161256473|NCT04405739|582316459|FG000|Overall Study|Withdrawal by Subject|0|||
161256474|NCT04405739|582316460|FG001|Overall Study|Withdrawal by Subject|2|||
161256475|NCT04405739|582316461|FG002|Overall Study|Withdrawal by Subject|1|||
161256476|NCT04405739|582316462|FG003|Overall Study|Withdrawal by Subject|1|||
161256477|NCT04405739|582316459|FG000|Overall Study|Death|0|||
161256478|NCT04405739|582316460|FG001|Overall Study|Death|0|||
161256479|NCT04405739|582316461|FG002|Overall Study|Death|1|||
161256480|NCT04405739|582316462|FG003|Overall Study|Death|0|||
161256481|NCT04405739|582316459|FG000|Overall Study|Transferred to rehab|0|||
161256482|NCT04405739|582316460|FG001|Overall Study|Transferred to rehab|0|||
161256483|NCT04405739|582316461|FG002|Overall Study|Transferred to rehab|0|||
161256484|NCT04405739|582316462|FG003|Overall Study|Transferred to rehab|1|||
161256485|NCT04405739|582316459|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
161256486|NCT04405739|582316460|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
161256487|NCT04405739|582316461|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
161256488|NCT04405739|582316462|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
161256489|NCT05766787|582316463|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
161256490|NCT05766787|582316464|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
160909916|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
160909917|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909918|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909919|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909920|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
160909921|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909922|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
160909923|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909924|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909925|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909926|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
160909927|NCT00642460|581066272|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909928|NCT00642460|581066273|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909929|NCT00642460|581066274|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909930|NCT00642460|581066275|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
160909931|NCT00642460|581066276|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909932|NCT00642460|581066277|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
160909933|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909934|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909935|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909936|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
160909937|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
160909938|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
160909939|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909940|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909941|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909942|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
160909943|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
160909944|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
160909945|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909946|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909947|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909948|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
160909949|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
161256491|NCT05766787|582316463|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
160909950|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
161256492|NCT05766787|582316464|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
161256493|NCT05766787|582316463|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
161256494|NCT05766787|582316464|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
161256495|NCT00438659|582316465|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
161256496|NCT00438659|582316466|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
161256497|NCT00438659|582316465|FG000|Overall Study|Cancel|5|||
161141735|NCT00785577|581902599|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
160909951|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909952|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909953|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909954|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
160909955|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
160909956|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
160909957|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Other|0|||
160909958|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Other|0|||
160909959|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Other|0|||
160909960|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Other|0|||
160909961|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Other|2|||
160909962|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Other|2|||
160909963|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Death|0|||
160909964|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Death|0|||
160909965|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Death|0|||
160909966|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Death|0|||
160909967|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Death|0|||
160909968|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Death|3|||
160909969|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909970|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909971|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909972|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909973|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
160909974|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
160909975|NCT00642460|581066272|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909976|NCT00642460|581066273|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909977|NCT00642460|581066274|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909978|NCT00642460|581066275|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
160909979|NCT00642460|581066276|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
160909980|NCT00642460|581066277|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
160909981|NCT04605484|581066280|FG000|Overall Study|Lost to Follow-up|0|||
160909982|NCT04605484|581066281|FG001|Overall Study|Lost to Follow-up|1|||
160909983|NCT04605484|581066282|FG002|Overall Study|Lost to Follow-up|1|||
160909984|NCT04605484|581066280|FG000|Overall Study|Other|0|||
160909985|NCT04605484|581066281|FG001|Overall Study|Other|1|||
160909986|NCT04605484|581066282|FG002|Overall Study|Other|0|||
160909987|NCT04171531|581066285|FG000|Overall Study|Lost to Follow-up|4|||
160909988|NCT04171531|581066286|FG001|Overall Study|Lost to Follow-up|5|||
160909989|NCT04171531|581066285|FG000|Overall Study|Consent only through 6 months|1|||
160909990|NCT04171531|581066286|FG001|Overall Study|Consent only through 6 months|1|||
160909991|NCT04171531|581066285|FG000|Overall Study|Insurance did not cover procedure|0|||
160909992|NCT04171531|581066286|FG001|Overall Study|Insurance did not cover procedure|1|||
160909993|NCT04171531|581066285|FG000|Overall Study|Physician Decision|0|||
160909994|NCT04171531|581066286|FG001|Overall Study|Physician Decision|3|||
160909995|NCT04171531|581066285|FG000|Overall Study|Withdrawal by Subject|1|||
160909996|NCT04171531|581066286|FG001|Overall Study|Withdrawal by Subject|5|||
160909997|NCT05537883|581066287|FG000|Overall Study|revisional surgery|4|||
160909998|NCT05537883|581066288|FG001|Overall Study|revisional surgery|2|||
160995158|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Death|1|||
160995159|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Death|1|||
160995160|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Death|1|||
160995161|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Death|0|||
160995162|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Death|0|||
160995163|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Death|0|||
160995164|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
160995165|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
160995166|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160995167|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160995168|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
160995169|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
161141736|NCT00785577|581902600|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
161141737|NCT00785577|581902601|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
161141738|NCT00785577|581902602|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
161141739|NCT01650805|581902607|FG000|Overall Study|Withdrawal by Subject|1|||
161141740|NCT01650805|581902608|FG001|Overall Study|Withdrawal by Subject|0|||
160909999|NCT05537883|581066287|FG000|Overall Study|surgeries were cancelled|0|||
161141741|NCT04070378|581902614|FG000|Overall Study|Withdrawal by Subject|2|||
161141742|NCT04070378|581902614|FG000|Overall Study|Screen Failure|6|||
161141743|NCT04070378|581902614|FG000|Overall Study|Physician Decision|1|||
161141744|NCT04070378|581902614|FG000|Overall Study|Adverse Event|1|||
160910000|NCT05537883|581066288|FG001|Overall Study|surgeries were cancelled|2|||
161141745|NCT01901328|581902615|FG000|Overall Study|Lost to Follow-up|1|||
160910001|NCT05537883|581066287|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
160910002|NCT05537883|581066288|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
160910003|NCT03366337|581066289|FG000|Overall Study|Lost to Follow-up|1|||
160910004|NCT03366337|581066290|FG001|Overall Study|Lost to Follow-up|0|||
160910005|NCT03366337|581066291|FG002|Overall Study|Lost to Follow-up|1|||
160910006|NCT03366337|581066292|FG003|Overall Study|Lost to Follow-up|0|||
160910007|NCT03366337|581066289|FG000|Overall Study|Withdrawal by Subject|2|||
160910008|NCT03366337|581066290|FG001|Overall Study|Withdrawal by Subject|0|||
160910009|NCT03366337|581066291|FG002|Overall Study|Withdrawal by Subject|1|||
160910010|NCT03366337|581066292|FG003|Overall Study|Withdrawal by Subject|1|||
160910011|NCT05288062|581066293|FG000|Overall Study|Ineligible|0|||
160910012|NCT05288062|581066294|FG001|Overall Study|Ineligible|0|||
160910013|NCT05288062|581066295|FG002|Overall Study|Ineligible|1|||
160910014|NCT05288062|581066296|FG003|Overall Study|Ineligible|0|||
160910015|NCT05288062|581066293|FG000|Overall Study|Withdrawal by Subject|0|||
160910016|NCT05288062|581066294|FG001|Overall Study|Withdrawal by Subject|0|||
160910017|NCT05288062|581066295|FG002|Overall Study|Withdrawal by Subject|1|||
160910018|NCT05288062|581066296|FG003|Overall Study|Withdrawal by Subject|0|||
160910019|NCT00040664|581066303|FG000|Overall Study|Adverse Event|12|||
160910020|NCT00040664|581066304|FG001|Overall Study|Adverse Event|3|||
160910021|NCT00040664|581066305|FG002|Overall Study|Adverse Event|2|||
160910022|NCT00040664|581066306|FG003|Overall Study|Adverse Event|7|||
160910023|NCT00040664|581066303|FG000|Overall Study|Lack of Efficacy|9|||
160910024|NCT00040664|581066304|FG001|Overall Study|Lack of Efficacy|2|||
160910025|NCT00040664|581066305|FG002|Overall Study|Lack of Efficacy|3|||
160910026|NCT00040664|581066306|FG003|Overall Study|Lack of Efficacy|4|||
160910027|NCT00040664|581066303|FG000|Overall Study|Insufficient CD4 response|1|||
160910028|NCT00040664|581066304|FG001|Overall Study|Insufficient CD4 response|0|||
160910029|NCT00040664|581066305|FG002|Overall Study|Insufficient CD4 response|1|||
160910030|NCT00040664|581066306|FG003|Overall Study|Insufficient CD4 response|0|||
160910031|NCT00040664|581066303|FG000|Overall Study|Lost to Follow-up|4|||
160910032|NCT00040664|581066304|FG001|Overall Study|Lost to Follow-up|2|||
160910033|NCT00040664|581066305|FG002|Overall Study|Lost to Follow-up|0|||
160910034|NCT00040664|581066306|FG003|Overall Study|Lost to Follow-up|2|||
160910035|NCT00040664|581066303|FG000|Overall Study|Protocol Violation|2|||
160910036|NCT00040664|581066304|FG001|Overall Study|Protocol Violation|1|||
160910037|NCT00040664|581066305|FG002|Overall Study|Protocol Violation|0|||
160910038|NCT00040664|581066306|FG003|Overall Study|Protocol Violation|1|||
160910039|NCT00040664|581066303|FG000|Overall Study|Withdrawal by Subject|7|||
160910040|NCT00040664|581066304|FG001|Overall Study|Withdrawal by Subject|0|||
160910041|NCT00040664|581066305|FG002|Overall Study|Withdrawal by Subject|3|||
160910042|NCT00040664|581066306|FG003|Overall Study|Withdrawal by Subject|4|||
160910043|NCT00040664|581066303|FG000|Overall Study|Pregnancy|3|||
160910044|NCT00040664|581066304|FG001|Overall Study|Pregnancy|0|||
160910045|NCT00040664|581066305|FG002|Overall Study|Pregnancy|0|||
160910046|NCT00040664|581066306|FG003|Overall Study|Pregnancy|3|||
160910047|NCT00040664|581066303|FG000|Overall Study|Medication adherence/compliance problems|8|||
160910048|NCT00040664|581066304|FG001|Overall Study|Medication adherence/compliance problems|2|||
160910049|NCT00040664|581066305|FG002|Overall Study|Medication adherence/compliance problems|1|||
160910050|NCT00040664|581066306|FG003|Overall Study|Medication adherence/compliance problems|5|||
160910051|NCT00040664|581066303|FG000|Overall Study|Poor taste|2|||
160910052|NCT00040664|581066304|FG001|Overall Study|Poor taste|0|||
160910053|NCT00040664|581066305|FG002|Overall Study|Poor taste|2|||
160910054|NCT00040664|581066306|FG003|Overall Study|Poor taste|0|||
160910055|NCT00040664|581066303|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
160910056|NCT00040664|581066304|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
160910057|NCT00040664|581066305|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
160910058|NCT00040664|581066306|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
160910059|NCT00040664|581066303|FG000|Overall Study|Change of formulation|2|||
160910060|NCT00040664|581066304|FG001|Overall Study|Change of formulation|2|||
160910061|NCT00040664|581066305|FG002|Overall Study|Change of formulation|0|||
160910062|NCT00040664|581066306|FG003|Overall Study|Change of formulation|0|||
160910063|NCT00040664|581066303|FG000|Overall Study|Non-viability of oral suspension|1|||
160910064|NCT00040664|581066304|FG001|Overall Study|Non-viability of oral suspension|0|||
160910065|NCT00040664|581066305|FG002|Overall Study|Non-viability of oral suspension|1|||
160910066|NCT00040664|581066306|FG003|Overall Study|Non-viability of oral suspension|0|||
160910067|NCT00729651|581066307|FG000|Overall Study|Withdrawal by Subject|5|||
160910068|NCT00729651|581066308|FG001|Overall Study|Withdrawal by Subject|6|||
160910069|NCT00729651|581066307|FG000|Overall Study|Lost to Follow-up|5|||
160910070|NCT00729651|581066308|FG001|Overall Study|Lost to Follow-up|4|||
160910071|NCT00729651|581066307|FG000|Overall Study|Protocol Violation|0|||
160910072|NCT00729651|581066308|FG001|Overall Study|Protocol Violation|1|||
160910073|NCT00729651|581066307|FG000|Overall Study|Adverse Event|7|||
160910074|NCT00729651|581066308|FG001|Overall Study|Adverse Event|3|||
161256498|NCT00438659|582316466|FG001|Overall Study|Cancel|2|||
161256499|NCT01867606|582316467|FG000|Overall Study|Withdrawal by Subject|10|||
161256500|NCT01867606|582316468|FG001|Overall Study|Withdrawal by Subject|14|||
160910075|NCT00729651|581066307|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
160910076|NCT00729651|581066308|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
160910077|NCT00729651|581066307|FG000|Overall Study|Subject's private reason|2|||
160910078|NCT00729651|581066308|FG001|Overall Study|Subject's private reason|0|||
160910079|NCT01874054|581066309|FG000|Overall Study|Withdrawal by Subject|3|||
160910080|NCT01874054|581066309|FG000|Overall Study|Study Termination by Sponsor|42|||
160910081|NCT01874054|581066309|FG000|Overall Study|Lost to Follow-up|5|||
160910082|NCT01874054|581066309|FG000|Overall Study|Death|5|||
160910083|NCT03334539|581066311|FG000|Overall Study|Adverse Event|3|||
160910084|NCT03334539|581066312|FG001|Overall Study|Adverse Event|5|||
160910085|NCT03334539|581066313|FG002|Overall Study|Adverse Event|0|||
160910086|NCT03334539|581066311|FG000|Overall Study|Withdrawal by Subject|0|||
160910087|NCT03334539|581066312|FG001|Overall Study|Withdrawal by Subject|1|||
160910088|NCT03334539|581066313|FG002|Overall Study|Withdrawal by Subject|1|||
160910089|NCT03334539|581066311|FG000|Overall Study|Administrative Reasons|1|||
160910090|NCT03334539|581066312|FG001|Overall Study|Administrative Reasons|0|||
160910091|NCT03334539|581066313|FG002|Overall Study|Administrative Reasons|0|||
160910092|NCT03334539|581066311|FG000|Overall Study|Hypertension Not Controlled|0|||
160910093|NCT03334539|581066312|FG001|Overall Study|Hypertension Not Controlled|1|||
160910094|NCT03334539|581066313|FG002|Overall Study|Hypertension Not Controlled|0|||
160910095|NCT00256750|581066315|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
160910096|NCT00256750|581066316|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
160910097|NCT00256750|581066317|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
160910098|NCT00256750|581066315|FG000|Transplanted Pre-Treatment|Other|2|||
160910099|NCT00256750|581066316|FG001|Transplanted Pre-Treatment|Other|0|||
160910100|NCT00256750|581066317|FG002|Transplanted Pre-Treatment|Other|0|||
160910101|NCT00256750|581066315|FG000|Transplanted Pre-Treatment|Death|1|||
160910102|NCT00256750|581066316|FG001|Transplanted Pre-Treatment|Death|0|||
160910103|NCT00256750|581066317|FG002|Transplanted Pre-Treatment|Death|0|||
160910104|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
160910105|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
160910106|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
160910107|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Death|3|||
160910108|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Death|2|||
160910109|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Death|4|||
160910110|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
160910111|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
160910112|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
160910113|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
160910114|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
160910115|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
160910116|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Other|5|||
160910117|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Other|4|||
160910118|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Other|2|||
160910119|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
160910120|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
160910121|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
160910122|NCT00256750|581066315|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
160910123|NCT00256750|581066316|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
160995170|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995171|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995172|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
160995173|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995174|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995175|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
160995176|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995177|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
160995178|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
161256501|NCT01867606|582316467|FG000|Overall Study|Protocol Violation|0|||
161256502|NCT01867606|582316468|FG001|Overall Study|Protocol Violation|1|||
161256503|NCT00206102|582316469|FG000|Overall Study|Adverse Event|119|||
161256504|NCT00206102|582316470|FG001|Overall Study|Adverse Event|82|||
161256505|NCT00206102|582316469|FG000|Overall Study|Protocol Violation|0|||
160910124|NCT00256750|581066317|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
161256506|NCT00206102|582316470|FG001|Overall Study|Protocol Violation|2|||
161256507|NCT00206102|582316469|FG000|Overall Study|Lack of therapeutic response|16|||
161256508|NCT00206102|582316470|FG001|Overall Study|Lack of therapeutic response|11|||
160910125|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
160910126|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
160910127|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
160910128|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
161256509|NCT00206102|582316469|FG000|Overall Study|Lost to Follow-up|95|||
160910129|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
160910130|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
160910131|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Death|3|||
160910132|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Death|0|||
160910133|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Death|0|||
160910134|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
160910135|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
160910136|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
160910137|NCT00256750|581066315|FG000|Post-Transplant Treated (24 Months)|Other|2|||
160910138|NCT00256750|581066316|FG001|Post-Transplant Treated (24 Months)|Other|0|||
160910139|NCT00256750|581066317|FG002|Post-Transplant Treated (24 Months)|Other|1|||
160910140|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
160910141|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
160910142|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
160910143|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
160910144|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
160910145|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
160910146|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Death|0|||
160910147|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Death|2|||
160910148|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Death|1|||
160910149|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
160910150|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
160910151|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
161256510|NCT00206102|582316470|FG001|Overall Study|Lost to Follow-up|66|||
161256511|NCT00206102|582316469|FG000|Overall Study|Withdrawal by Subject|118|||
161256512|NCT00206102|582316470|FG001|Overall Study|Withdrawal by Subject|101|||
161256513|NCT00206102|582316469|FG000|Overall Study|Study-specific discontinuation criteria|18|||
161256514|NCT00206102|582316470|FG001|Overall Study|Study-specific discontinuation criteria|17|||
161256515|NCT00206102|582316469|FG000|Overall Study|None of those categories|42|||
161256516|NCT00206102|582316470|FG001|Overall Study|None of those categories|36|||
161256517|NCT01917968|582316471|FG000|Overall Study|Death|3|||
161256518|NCT01917968|582316472|FG001|Overall Study|Death|2|||
161256519|NCT01917968|582316471|FG000|Overall Study|Lost to Follow-up|21|||
161256520|NCT01917968|582316472|FG001|Overall Study|Lost to Follow-up|39|||
161256521|NCT01917968|582316471|FG000|Overall Study|Physician Decision|1|||
160910152|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
160910153|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
160910154|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
160910155|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
160910156|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
160910157|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
160910158|NCT00256750|581066315|FG000|Post-Transplant Treated (36 Months)|Other|0|||
160910159|NCT00256750|581066316|FG001|Post-Transplant Treated (36 Months)|Other|1|||
160910160|NCT00256750|581066317|FG002|Post-Transplant Treated (36 Months)|Other|1|||
160910161|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
160910162|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
160910163|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
160910164|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
160910165|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
160910166|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
160910167|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
161256522|NCT01917968|582316472|FG001|Overall Study|Physician Decision|2|||
161256523|NCT01917968|582316471|FG000|Overall Study|Withdrawal by Subject|20|||
160910168|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
160910169|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
160910170|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
160910171|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
160910172|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
160910173|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
160910174|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
160910175|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
160910176|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
160910177|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
160910178|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
160910179|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
160910180|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
161141746|NCT01901328|581902616|FG001|Overall Study|Lost to Follow-up|0|||
161141747|NCT01901328|581902615|FG000|Overall Study|Physician Decision|0|||
161256524|NCT01917968|582316472|FG001|Overall Study|Withdrawal by Subject|35|||
161256525|NCT01917968|582316471|FG000|Overall Study|Subject Relocation|5|||
160995179|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995180|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995181|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
160995182|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
160995183|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
160995184|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
160995185|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
160995186|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
160910181|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
160910182|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
160910183|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
160910184|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
160910185|NCT00256750|581066315|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
160910186|NCT00256750|581066316|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
160910187|NCT00256750|581066317|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
160910188|NCT00558558|581066321|FG000|Overall Study|Unable to swallow|1|||
160910189|NCT00558558|581066321|FG000|Overall Study|Withdrawal by Subject|1|||
160910190|NCT00558558|581066321|FG000|Overall Study|Lack of Efficacy|4|||
160910191|NCT02549937|581066323|FG000|Overall Study|Death|0|||
160995187|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
160995188|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995189|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
160995190|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995191|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
160910192|NCT02549937|581066324|FG001|Overall Study|Death|1|||
160910193|NCT02549937|581066325|FG002|Overall Study|Death|0|||
160910194|NCT02549937|581066326|FG003|Overall Study|Death|1|||
160910195|NCT02549937|581066327|FG004|Overall Study|Death|0|||
160910196|NCT02549937|581066328|FG005|Overall Study|Death|8|||
160910197|NCT02549937|581066329|FG006|Overall Study|Death|0|||
160910198|NCT02549937|581066330|FG007|Overall Study|Death|0|||
160910199|NCT02549937|581066331|FG008|Overall Study|Death|19|||
160910200|NCT02549937|581066323|FG000|Overall Study|No follow up required|3|||
160910201|NCT02549937|581066324|FG001|Overall Study|No follow up required|6|||
160910202|NCT02549937|581066325|FG002|Overall Study|No follow up required|3|||
160910203|NCT02549937|581066326|FG003|Overall Study|No follow up required|8|||
160910204|NCT02549937|581066327|FG004|Overall Study|No follow up required|12|||
160910205|NCT02549937|581066328|FG005|Overall Study|No follow up required|21|||
160910206|NCT02549937|581066329|FG006|Overall Study|No follow up required|9|||
160910207|NCT02549937|581066330|FG007|Overall Study|No follow up required|11|||
160910208|NCT02549937|581066331|FG008|Overall Study|No follow up required|0|||
160910209|NCT02549937|581066323|FG000|Overall Study|Other|0|||
160910210|NCT02549937|581066324|FG001|Overall Study|Other|0|||
160910211|NCT02549937|581066325|FG002|Overall Study|Other|0|||
160910212|NCT02549937|581066326|FG003|Overall Study|Other|0|||
160910213|NCT02549937|581066327|FG004|Overall Study|Other|1|||
160910214|NCT02549937|581066328|FG005|Overall Study|Other|0|||
160861297|NCT03137992|580885249|FG000|Washout Period 1|COPD Exacerbation|1|||
160861298|NCT03137992|580885250|FG001|Washout Period 1|COPD Exacerbation|1|||
160861299|NCT03137992|580885251|FG002|Washout Period 1|COPD Exacerbation|1|||
160861300|NCT03137992|580885252|FG003|Washout Period 1|COPD Exacerbation|0|||
160910215|NCT02549937|581066329|FG006|Overall Study|Other|3|||
160910216|NCT02549937|581066330|FG007|Overall Study|Other|2|||
160910217|NCT02549937|581066331|FG008|Overall Study|Other|3|||
160910218|NCT02549937|581066323|FG000|Overall Study|Lost to Follow-up|0|||
160910219|NCT02549937|581066324|FG001|Overall Study|Lost to Follow-up|0|||
160910220|NCT02549937|581066325|FG002|Overall Study|Lost to Follow-up|0|||
161141748|NCT01901328|581902616|FG001|Overall Study|Physician Decision|1|||
161141749|NCT01901328|581902615|FG000|Overall Study|Protocol Violation|1|||
160861301|NCT03137992|580885253|FG004|Washout Period 1|COPD Exacerbation|1|||
160861302|NCT03137992|580885254|FG005|Washout Period 1|COPD Exacerbation|1|||
160861303|NCT03137992|580885249|FG000|Washout Period 1|Subject Noncompliance|1|||
160861304|NCT03137992|580885250|FG001|Washout Period 1|Subject Noncompliance|0|||
160861305|NCT03137992|580885251|FG002|Washout Period 1|Subject Noncompliance|0|||
160861306|NCT03137992|580885252|FG003|Washout Period 1|Subject Noncompliance|0|||
160861307|NCT03137992|580885253|FG004|Washout Period 1|Subject Noncompliance|1|||
160861308|NCT03137992|580885254|FG005|Washout Period 1|Subject Noncompliance|0|||
160861309|NCT03137992|580885249|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
160861310|NCT03137992|580885250|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
160861311|NCT03137992|580885251|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
160861312|NCT03137992|580885252|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
160861313|NCT03137992|580885253|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
160861314|NCT03137992|580885254|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
160861315|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
160861316|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
160910221|NCT02549937|581066326|FG003|Overall Study|Lost to Follow-up|0|||
160910222|NCT02549937|581066327|FG004|Overall Study|Lost to Follow-up|0|||
160910223|NCT02549937|581066328|FG005|Overall Study|Lost to Follow-up|0|||
160910224|NCT02549937|581066329|FG006|Overall Study|Lost to Follow-up|0|||
160910225|NCT02549937|581066330|FG007|Overall Study|Lost to Follow-up|0|||
160910226|NCT02549937|581066331|FG008|Overall Study|Lost to Follow-up|3|||
160910227|NCT02549937|581066323|FG000|Overall Study|Withdrawal by Subject|0|||
160910228|NCT02549937|581066324|FG001|Overall Study|Withdrawal by Subject|0|||
160910229|NCT02549937|581066325|FG002|Overall Study|Withdrawal by Subject|0|||
160910230|NCT02549937|581066326|FG003|Overall Study|Withdrawal by Subject|0|||
160910231|NCT02549937|581066327|FG004|Overall Study|Withdrawal by Subject|0|||
160910232|NCT02549937|581066328|FG005|Overall Study|Withdrawal by Subject|1|||
160910233|NCT02549937|581066329|FG006|Overall Study|Withdrawal by Subject|4|||
160910234|NCT02549937|581066330|FG007|Overall Study|Withdrawal by Subject|3|||
160910235|NCT02549937|581066331|FG008|Overall Study|Withdrawal by Subject|2|||
160910236|NCT02549937|581066323|FG000|Overall Study|Sponsor Decision|0|||
160910237|NCT02549937|581066324|FG001|Overall Study|Sponsor Decision|0|||
160910238|NCT02549937|581066325|FG002|Overall Study|Sponsor Decision|0|||
160910239|NCT02549937|581066326|FG003|Overall Study|Sponsor Decision|0|||
160910240|NCT02549937|581066327|FG004|Overall Study|Sponsor Decision|0|||
160910241|NCT02549937|581066328|FG005|Overall Study|Sponsor Decision|0|||
160910242|NCT02549937|581066329|FG006|Overall Study|Sponsor Decision|0|||
160910243|NCT02549937|581066330|FG007|Overall Study|Sponsor Decision|0|||
160910244|NCT02549937|581066331|FG008|Overall Study|Sponsor Decision|6|||
160910245|NCT02144012|581066332|FG000|Overall Study|Adverse Event|1|||
160910246|NCT02144012|581066333|FG001|Overall Study|Adverse Event|0|||
160910247|NCT02144012|581066332|FG000|Overall Study|Death|1|||
160910248|NCT02144012|581066333|FG001|Overall Study|Death|0|||
160910249|NCT02144012|581066332|FG000|Overall Study|Withdrawal by Subject|11|||
160910250|NCT02144012|581066333|FG001|Overall Study|Withdrawal by Subject|3|||
160910251|NCT02144012|581066332|FG000|Overall Study|Study Terminated by Sponsor|18|||
160910252|NCT02144012|581066333|FG001|Overall Study|Study Terminated by Sponsor|12|||
160910253|NCT02144012|581066332|FG000|Overall Study|Other|3|||
160910254|NCT02144012|581066333|FG001|Overall Study|Other|0|||
160910255|NCT00317356|581066334|FG000|Overall Study|Adverse Event|0|||
160910256|NCT00317356|581066335|FG001|Overall Study|Adverse Event|0|||
160910257|NCT00317356|581066336|FG002|Overall Study|Adverse Event|1|||
160910258|NCT00317356|581066337|FG003|Overall Study|Adverse Event|0|||
160910259|NCT00317356|581066334|FG000|Overall Study|Lack of Efficacy|1|||
160910260|NCT00317356|581066335|FG001|Overall Study|Lack of Efficacy|1|||
160910261|NCT00317356|581066336|FG002|Overall Study|Lack of Efficacy|0|||
160910262|NCT00317356|581066337|FG003|Overall Study|Lack of Efficacy|3|||
160910263|NCT00317356|581066334|FG000|Overall Study|Physician Decision|0|||
160910264|NCT00317356|581066335|FG001|Overall Study|Physician Decision|1|||
160910265|NCT00317356|581066336|FG002|Overall Study|Physician Decision|0|||
160910266|NCT00317356|581066337|FG003|Overall Study|Physician Decision|0|||
160910267|NCT01943292|581067861|FG000|Overall Study|Withdrawal by Subject|1|||
160910268|NCT01943292|581067862|FG001|Overall Study|Withdrawal by Subject|0|||
160910269|NCT01943292|581067863|FG002|Overall Study|Withdrawal by Subject|0|||
160910270|NCT00911820|581067864|FG000|Overall Study|RECIST progression|12|||
160910271|NCT00911820|581067865|FG001|Overall Study|RECIST progression|8|||
160910272|NCT00911820|581067864|FG000|Overall Study|Adverse Event|8|||
160910273|NCT00911820|581067865|FG001|Overall Study|Adverse Event|8|||
160910274|NCT00911820|581067864|FG000|Overall Study|Clinical Progression|7|||
160910275|NCT00911820|581067865|FG001|Overall Study|Clinical Progression|5|||
160910276|NCT00911820|581067864|FG000|Overall Study|Physician Decision|5|||
160910277|NCT00911820|581067865|FG001|Overall Study|Physician Decision|9|||
160910278|NCT00911820|581067864|FG000|Overall Study|Decline in Performance Status|4|||
160910279|NCT00911820|581067865|FG001|Overall Study|Decline in Performance Status|2|||
160910280|NCT00911820|581067864|FG000|Overall Study|Withdrawal by Subject|3|||
160910281|NCT00911820|581067865|FG001|Overall Study|Withdrawal by Subject|4|||
160910282|NCT00911820|581067864|FG000|Overall Study|Death|1|||
160910283|NCT00911820|581067865|FG001|Overall Study|Death|2|||
160910284|NCT00911820|581067864|FG000|Overall Study|Pursue surgery|1|||
160910285|NCT00911820|581067865|FG001|Overall Study|Pursue surgery|1|||
160910286|NCT00911820|581067864|FG000|Overall Study|Pursue Radiation|1|||
160910287|NCT00911820|581067865|FG001|Overall Study|Pursue Radiation|0|||
160910288|NCT00911820|581067864|FG000|Overall Study|Still on Therapy|2|||
160910289|NCT00911820|581067865|FG001|Overall Study|Still on Therapy|2|||
160910290|NCT00911820|581067864|FG000|Overall Study|Pathology Not Confirmed|1|||
160910291|NCT00911820|581067865|FG001|Overall Study|Pathology Not Confirmed|0|||
160910292|NCT00911820|581067864|FG000|Overall Study|Withdraw before Receive Treatment|0|||
160910293|NCT00911820|581067865|FG001|Overall Study|Withdraw before Receive Treatment|2|||
160910294|NCT00996216|581067866|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
160910295|NCT00996216|581067866|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
160910296|NCT00996216|581067866|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
160910297|NCT00187486|581067873|FG000|Overall Study|Protocol Violation|1|||
160910298|NCT02483520|581067874|FG000|Overall Study|Lost to Follow-up|3|||
160910299|NCT02483520|581067875|FG001|Overall Study|Lost to Follow-up|4|||
160910300|NCT02483520|581067874|FG000|Overall Study|Withdrawal by Subject|4|||
160910301|NCT02483520|581067875|FG001|Overall Study|Withdrawal by Subject|14|||
160910302|NCT02483520|581067874|FG000|Overall Study|Hospitalized|2|||
160910303|NCT02483520|581067875|FG001|Overall Study|Hospitalized|3|||
160910304|NCT02483520|581067874|FG000|Overall Study|Moved to LTC|2|||
160910305|NCT02483520|581067875|FG001|Overall Study|Moved to LTC|3|||
160910306|NCT01104493|581067882|FG000|Overall Study|Lost to Follow-up|0|||
160910307|NCT01104493|581067883|FG001|Overall Study|Lost to Follow-up|2|||
160910308|NCT03489720|581067885|FG000|Overall Study|Withdrawal by Subject|2|||
160910309|NCT03489720|581067886|FG001|Overall Study|Withdrawal by Subject|0|||
160910310|NCT02511184|581067887|FG000|Overall Study|Death|1|||
160910311|NCT02511184|581067888|FG001|Overall Study|Death|0|||
160910312|NCT02511184|581067887|FG000|Overall Study|Lost to Follow-up|0|||
160910313|NCT02511184|581067888|FG001|Overall Study|Lost to Follow-up|1|||
160910314|NCT02511184|581067887|FG000|Overall Study|Study terminated by sponsor|1|||
160910315|NCT02511184|581067888|FG001|Overall Study|Study terminated by sponsor|5|||
160910316|NCT02511184|581067887|FG000|Overall Study|Withdrawal by Subject|0|||
160910317|NCT02511184|581067888|FG001|Overall Study|Withdrawal by Subject|1|||
160910318|NCT01806545|581067889|FG000|Overall Study|Adverse Event|2|||
160910319|NCT01806545|581067890|FG001|Overall Study|Adverse Event|3|||
160910320|NCT01806545|581067889|FG000|Overall Study|Lost to Follow-up|1|||
160910321|NCT01806545|581067890|FG001|Overall Study|Lost to Follow-up|0|||
160910322|NCT01806545|581067889|FG000|Overall Study|Withdrawal by Subject|3|||
160910323|NCT01806545|581067890|FG001|Overall Study|Withdrawal by Subject|2|||
160910324|NCT00884312|581067892|FG000|Overall Study|Non-fatal Progressive Disease|0|||
160910325|NCT00884312|581067893|FG001|Overall Study|Non-fatal Progressive Disease|8|||
160910326|NCT00884312|581067892|FG000|Overall Study|Fatal Progressive Disease|0|||
160910327|NCT00884312|581067893|FG001|Overall Study|Fatal Progressive Disease|1|||
160910328|NCT00884312|581067892|FG000|Overall Study|Non-fatal Adverse Event|1|||
160910329|NCT00884312|581067893|FG001|Overall Study|Non-fatal Adverse Event|0|||
160910330|NCT00884312|581067892|FG000|Overall Study|Fatal Adverse Event|1|||
160910331|NCT00884312|581067893|FG001|Overall Study|Fatal Adverse Event|4|||
160910332|NCT00884312|581067892|FG000|Overall Study|Withdrawal by Subject|0|||
160910333|NCT00884312|581067893|FG001|Overall Study|Withdrawal by Subject|6|||
160910334|NCT00884312|581067892|FG000|Overall Study|Physician Decision|0|||
160910335|NCT00884312|581067893|FG001|Overall Study|Physician Decision|1|||
160910336|NCT00884312|581067892|FG000|Overall Study|Other|0|||
160910337|NCT00884312|581067893|FG001|Overall Study|Other|4|||
160910338|NCT00884312|581067892|FG000|Overall Study|Did Not Receive Study Drug|0|||
160910339|NCT00884312|581067893|FG001|Overall Study|Did Not Receive Study Drug|1|||
160910340|NCT03521934|581067904|FG000|Overall Study|Death|65|||
160910341|NCT03521934|581067905|FG001|Overall Study|Death|73|||
160910342|NCT03521934|581067904|FG000|Overall Study|Withdrawal by Subject|18|||
160910343|NCT03521934|581067905|FG001|Overall Study|Withdrawal by Subject|23|||
160910344|NCT03521934|581067904|FG000|Overall Study|Site Terminated by Sponsor|39|||
160910345|NCT03521934|581067905|FG001|Overall Study|Site Terminated by Sponsor|35|||
160910346|NCT03521934|581067904|FG000|Overall Study|Study Terminated by Sponsor|483|||
160910347|NCT03521934|581067905|FG001|Overall Study|Study Terminated by Sponsor|477|||
160910348|NCT03521934|581067904|FG000|Overall Study|Reason not Specified|3|||
160910349|NCT03521934|581067905|FG001|Overall Study|Reason not Specified|6|||
160910350|NCT02101060|581067906|FG000|Overall Study|Adverse Event|1|||
160910351|NCT02101060|581067907|FG001|Overall Study|Adverse Event|0|||
160910352|NCT02101060|581067906|FG000|Overall Study|Withdrawal by Subject|1|||
160910353|NCT02101060|581067907|FG001|Overall Study|Withdrawal by Subject|1|||
160910354|NCT02101060|581067906|FG000|Overall Study|Lost to Follow-up|3|||
160910355|NCT02101060|581067907|FG001|Overall Study|Lost to Follow-up|3|||
160910356|NCT00284050|581067910|FG000|Overall Study|Adverse Event|1|||
160910357|NCT00284050|581067911|FG001|Overall Study|Adverse Event|1|||
160910358|NCT00284050|581067912|FG002|Overall Study|Adverse Event|1|||
160910359|NCT00284050|581067910|FG000|Overall Study|Lack of Efficacy|0|||
160910360|NCT00284050|581067911|FG001|Overall Study|Lack of Efficacy|1|||
160910361|NCT00284050|581067912|FG002|Overall Study|Lack of Efficacy|3|||
160910362|NCT00284050|581067910|FG000|Overall Study|Protocol Violation|0|||
160910363|NCT00284050|581067911|FG001|Overall Study|Protocol Violation|1|||
160910364|NCT00284050|581067912|FG002|Overall Study|Protocol Violation|2|||
160910365|NCT00284050|581067910|FG000|Overall Study|Withdrawal by Subject|2|||
160910366|NCT00284050|581067911|FG001|Overall Study|Withdrawal by Subject|2|||
160910367|NCT00284050|581067912|FG002|Overall Study|Withdrawal by Subject|2|||
160910368|NCT00284050|581067910|FG000|Overall Study|Lost to Follow-up|1|||
160910369|NCT00284050|581067911|FG001|Overall Study|Lost to Follow-up|0|||
160910370|NCT00284050|581067912|FG002|Overall Study|Lost to Follow-up|1|||
160910371|NCT00284050|581067910|FG000|Overall Study|Death|1|||
160910372|NCT00284050|581067911|FG001|Overall Study|Death|0|||
160910373|NCT00284050|581067912|FG002|Overall Study|Death|0|||
160910374|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
160910375|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
160910376|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
161141750|NCT01901328|581902616|FG001|Overall Study|Protocol Violation|1|||
160861317|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
160861318|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
160910377|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
160910378|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
160910379|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
160910380|NCT00489541|581067915|FG000|12-Month Clinical Follow-up|Death|3|||
160910381|NCT00489541|581067916|FG001|12-Month Clinical Follow-up|Death|2|||
160910382|NCT00489541|581067915|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
160910383|NCT00489541|581067916|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
160910384|NCT00489541|581067915|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
160910385|NCT00489541|581067916|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
160910386|NCT01192516|581067918|FG000|Overall Study|Lost to Follow-up|7|||
160910387|NCT01192516|581067919|FG001|Overall Study|Lost to Follow-up|10|||
160910388|NCT01192516|581067920|FG002|Overall Study|Lost to Follow-up|7|||
160910389|NCT01192516|581067918|FG000|Overall Study|Withdrawal by Subject|4|||
160910390|NCT01192516|581067919|FG001|Overall Study|Withdrawal by Subject|4|||
160910391|NCT01192516|581067920|FG002|Overall Study|Withdrawal by Subject|1|||
160910392|NCT01192516|581067918|FG000|Overall Study|started new treatment|5|||
160910393|NCT01192516|581067919|FG001|Overall Study|started new treatment|1|||
160910394|NCT01192516|581067920|FG002|Overall Study|started new treatment|0|||
160910395|NCT01192516|581067918|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
160910396|NCT01192516|581067919|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
160910397|NCT01192516|581067920|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
160910398|NCT02627144|581067928|FG000|Overall Study|Serious adverse event|32|||
160910399|NCT02627144|581067928|FG000|Overall Study|Cancer progression|171|||
160910400|NCT02627144|581067928|FG000|Overall Study|Death from cancer|20|||
160910401|NCT02627144|581067928|FG000|Overall Study|Death from other cause|8|||
160910402|NCT02627144|581067928|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
160910403|NCT02627144|581067928|FG000|Overall Study|Administrative reasons|65|||
160910404|NCT02627144|581067928|FG000|Overall Study|Lost to Follow-up|8|||
160910405|NCT02627144|581067928|FG000|Overall Study|Enrolled, not treated|6|||
160910406|NCT02627144|581067928|FG000|Overall Study|Other|17|||
160910407|NCT01697566|581067936|FG000|Overall Study|Withdrawal by Subject|0|||
160910408|NCT01697566|581067937|FG001|Overall Study|Withdrawal by Subject|0|||
160910409|NCT01697566|581067938|FG002|Overall Study|Withdrawal by Subject|1|||
160861319|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
160861320|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
160861321|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Adverse Event|0|||
160861322|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Adverse Event|1|||
160861323|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Adverse Event|0|||
160861324|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Adverse Event|0|||
160861325|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Adverse Event|0|||
160861326|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Adverse Event|0|||
160861327|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861328|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861329|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861330|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
160861331|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861332|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
160861333|NCT03137992|580885249|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861334|NCT03137992|580885250|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
160861335|NCT03137992|580885251|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861336|NCT03137992|580885252|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861337|NCT03137992|580885253|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
160861338|NCT03137992|580885254|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
160861339|NCT03137992|580885249|FG000|Washout Period 2|COPD Exacerbation|1|||
160861340|NCT03137992|580885250|FG001|Washout Period 2|COPD Exacerbation|1|||
160861341|NCT03137992|580885251|FG002|Washout Period 2|COPD Exacerbation|0|||
160861342|NCT03137992|580885252|FG003|Washout Period 2|COPD Exacerbation|0|||
160861343|NCT03137992|580885253|FG004|Washout Period 2|COPD Exacerbation|1|||
160861344|NCT03137992|580885254|FG005|Washout Period 2|COPD Exacerbation|0|||
160861345|NCT03137992|580885249|FG000|Washout Period 2|Subject Non-compliance|0|||
160861346|NCT03137992|580885250|FG001|Washout Period 2|Subject Non-compliance|1|||
160861347|NCT03137992|580885251|FG002|Washout Period 2|Subject Non-compliance|0|||
160861348|NCT03137992|580885252|FG003|Washout Period 2|Subject Non-compliance|0|||
160861349|NCT03137992|580885253|FG004|Washout Period 2|Subject Non-compliance|0|||
160861350|NCT03137992|580885254|FG005|Washout Period 2|Subject Non-compliance|0|||
160861351|NCT03137992|580885249|FG000|Washout Period 2|Adverse Event|0|||
160861352|NCT03137992|580885250|FG001|Washout Period 2|Adverse Event|0|||
160861353|NCT03137992|580885251|FG002|Washout Period 2|Adverse Event|0|||
160861354|NCT03137992|580885252|FG003|Washout Period 2|Adverse Event|1|||
160861355|NCT03137992|580885253|FG004|Washout Period 2|Adverse Event|1|||
160861356|NCT03137992|580885254|FG005|Washout Period 2|Adverse Event|0|||
161141751|NCT01901328|581902615|FG000|Overall Study|Study Terminated by Sponsor|19|||
161141752|NCT01901328|581902616|FG001|Overall Study|Study Terminated by Sponsor|16|||
161141753|NCT01901328|581902615|FG000|Overall Study|Withdrawal by Subject|1|||
161141754|NCT01901328|581902616|FG001|Overall Study|Withdrawal by Subject|2|||
161141755|NCT01901328|581902615|FG000|Overall Study|Lack of Efficacy|0|||
161141756|NCT01901328|581902616|FG001|Overall Study|Lack of Efficacy|1|||
161141757|NCT02462889|581902617|FG000|Overall Study|Withdrawal by Subject|2|||
161141758|NCT02462889|581902618|FG001|Overall Study|Withdrawal by Subject|6|||
161141759|NCT02462889|581902617|FG000|Overall Study|Death|1|||
161141760|NCT02462889|581902618|FG001|Overall Study|Death|5|||
161141761|NCT04358458|581902621|FG000|Overall Study|Death|1|||
161141762|NCT04358458|581902622|FG001|Overall Study|Death|1|||
161141763|NCT04358458|581902623|FG002|Overall Study|Death|3|||
161141764|NCT04358458|581902624|FG003|Overall Study|Death|8|||
161141765|NCT04358458|581902625|FG004|Overall Study|Death|1|||
161141766|NCT04358458|581902626|FG005|Overall Study|Death|6|||
161141767|NCT04358458|581902627|FG006|Overall Study|Death|2|||
161141768|NCT04358458|581902628|FG007|Overall Study|Death|3|||
161141769|NCT04358458|581902621|FG000|Overall Study|Lost to Follow-up|0|||
161141770|NCT04358458|581902622|FG001|Overall Study|Lost to Follow-up|0|||
161141771|NCT04358458|581902623|FG002|Overall Study|Lost to Follow-up|0|||
161141772|NCT04358458|581902624|FG003|Overall Study|Lost to Follow-up|0|||
161141773|NCT04358458|581902625|FG004|Overall Study|Lost to Follow-up|0|||
161141774|NCT04358458|581902626|FG005|Overall Study|Lost to Follow-up|0|||
161141775|NCT04358458|581902627|FG006|Overall Study|Lost to Follow-up|0|||
161141776|NCT04358458|581902628|FG007|Overall Study|Lost to Follow-up|1|||
161141777|NCT04358458|581902621|FG000|Overall Study|Site is closing study participation|0|||
160995192|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995193|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
160995194|NCT03370133|581369089|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
160995195|NCT03370133|581369090|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
160995196|NCT03370133|581369091|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
160995197|NCT03370133|581369092|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
160995198|NCT03370133|581369093|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
160995199|NCT03370133|581369094|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
160995200|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
160995201|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
161141778|NCT04358458|581902622|FG001|Overall Study|Site is closing study participation|0|||
161141779|NCT04358458|581902623|FG002|Overall Study|Site is closing study participation|0|||
161141780|NCT04358458|581902624|FG003|Overall Study|Site is closing study participation|1|||
161141781|NCT04358458|581902625|FG004|Overall Study|Site is closing study participation|0|||
161141782|NCT04358458|581902626|FG005|Overall Study|Site is closing study participation|0|||
161141783|NCT04358458|581902627|FG006|Overall Study|Site is closing study participation|0|||
161141784|NCT04358458|581902628|FG007|Overall Study|Site is closing study participation|0|||
161141785|NCT04358458|581902621|FG000|Overall Study|Sponsor request|2|||
161141786|NCT04358458|581902622|FG001|Overall Study|Sponsor request|3|||
161141787|NCT04358458|581902623|FG002|Overall Study|Sponsor request|3|||
161141788|NCT04358458|581902624|FG003|Overall Study|Sponsor request|0|||
161141789|NCT04358458|581902625|FG004|Overall Study|Sponsor request|2|||
161141790|NCT04358458|581902626|FG005|Overall Study|Sponsor request|3|||
160910410|NCT01697566|581067939|FG003|Overall Study|Withdrawal by Subject|1|||
160910411|NCT01697566|581067936|FG000|Overall Study|Final biopsy not obtained|0|||
160910412|NCT01697566|581067937|FG001|Overall Study|Final biopsy not obtained|0|||
160910413|NCT01697566|581067938|FG002|Overall Study|Final biopsy not obtained|1|||
160910414|NCT01697566|581067939|FG003|Overall Study|Final biopsy not obtained|0|||
160910415|NCT01447433|581067942|FG000|Overall Study|Lost to Follow-up|0|||
160910416|NCT01447433|581067943|FG001|Overall Study|Lost to Follow-up|2|||
160910417|NCT01447433|581067942|FG000|Overall Study|Withdrawal by Subject|3|||
160910418|NCT01447433|581067943|FG001|Overall Study|Withdrawal by Subject|3|||
160995202|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
160910419|NCT01447433|581067942|FG000|Overall Study|Protocol Violation|1|||
160995203|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
160995204|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
161141791|NCT04358458|581902627|FG006|Overall Study|Sponsor request|1|||
161141792|NCT04358458|581902628|FG007|Overall Study|Sponsor request|1|||
161141793|NCT04358458|581902621|FG000|Overall Study|Withdrawal by Subject|0|||
161141794|NCT04358458|581902622|FG001|Overall Study|Withdrawal by Subject|0|||
160910420|NCT01447433|581067943|FG001|Overall Study|Protocol Violation|1|||
161141795|NCT04358458|581902623|FG002|Overall Study|Withdrawal by Subject|1|||
161141796|NCT04358458|581902624|FG003|Overall Study|Withdrawal by Subject|1|||
161141797|NCT04358458|581902625|FG004|Overall Study|Withdrawal by Subject|0|||
161141798|NCT04358458|581902626|FG005|Overall Study|Withdrawal by Subject|1|||
161141799|NCT04358458|581902627|FG006|Overall Study|Withdrawal by Subject|0|||
161141800|NCT04358458|581902628|FG007|Overall Study|Withdrawal by Subject|1|||
161141801|NCT05781542|581904169|FG000|Overall Study|Lost to Follow-up|1|||
161141802|NCT05781542|581904170|FG001|Overall Study|Lost to Follow-up|0|||
161141803|NCT05781542|581904171|FG002|Overall Study|Lost to Follow-up|1|||
160910421|NCT01578187|581067944|FG000|Usability Phase|Withdrawal by Subject|1|||
160910422|NCT00496470|581067945|FG000|Overall Study|Adverse Event|8|||
160910423|NCT00496470|581067946|FG001|Overall Study|Adverse Event|10|||
160910424|NCT00496470|581067945|FG000|Overall Study|Withdrawal by Subject|5|||
160910425|NCT00496470|581067946|FG001|Overall Study|Withdrawal by Subject|12|||
160910426|NCT00496470|581067945|FG000|Overall Study|Incorrectly enrolled|13|||
160910427|NCT00496470|581067946|FG001|Overall Study|Incorrectly enrolled|5|||
160910428|NCT00496470|581067945|FG000|Overall Study|Other reason|0|||
160910429|NCT00496470|581067946|FG001|Overall Study|Other reason|2|||
160910430|NCT02516163|581067951|FG000|Overall Study|Withdrawal by Subject|1|||
160910431|NCT02516163|581067951|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
160910432|NCT02516163|581067951|FG000|Overall Study|Unfit/delay in surgery|3|||
160910433|NCT02516163|581067951|FG000|Overall Study|Use of incorrect measurement technique|5|||
160910434|NCT02516163|581067951|FG000|Overall Study|Data not recorded|2|||
160910435|NCT02516163|581067951|FG000|Overall Study|MRI contraindication exclusion|6|||
160910436|NCT01217814|581067952|FG000|Overall Study|Adverse Event|1|||
160910437|NCT01217814|581067953|FG001|Overall Study|Adverse Event|1|||
160910438|NCT01217814|581067954|FG002|Overall Study|Adverse Event|0|||
160910439|NCT01217814|581067952|FG000|Overall Study|Lack of Efficacy|0|||
160910440|NCT01217814|581067953|FG001|Overall Study|Lack of Efficacy|0|||
160910441|NCT01217814|581067954|FG002|Overall Study|Lack of Efficacy|1|||
160910442|NCT01658072|581067955|FG000|Overall Study|Protocol Violation|4|||
160910443|NCT01658072|581067956|FG001|Overall Study|Protocol Violation|2|||
160910444|NCT01709162|581067959|FG000|Overall Study|Disease progression|3|||
160910445|NCT01709162|581067960|FG001|Overall Study|Disease progression|3|||
160910446|NCT01709162|581067959|FG000|Overall Study|Study drug toxicity|2|||
160910447|NCT01709162|581067960|FG001|Overall Study|Study drug toxicity|0|||
160910448|NCT01709162|581067959|FG000|Overall Study|Administrative reason by sponsor|0|||
160910449|NCT01709162|581067960|FG001|Overall Study|Administrative reason by sponsor|1|||
160910450|NCT01709162|581067959|FG000|Overall Study|Other|1|||
160910451|NCT01709162|581067960|FG001|Overall Study|Other|0|||
160910452|NCT01709162|581067959|FG000|Overall Study|Withdrawal by Subject|0|||
160910453|NCT01709162|581067960|FG001|Overall Study|Withdrawal by Subject|1|||
160910454|NCT01637272|581067966|FG000|Overall Study|Adverse Event|6|||
160910455|NCT01637272|581067966|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160910456|NCT01637272|581067966|FG000|Overall Study|Withdrawal by Subject|3|||
160910457|NCT01637272|581067966|FG000|Overall Study|Lost to Follow-up|2|||
160910458|NCT01637272|581067966|FG000|Overall Study|completed core, did not enter ext. phase|4|||
160910459|NCT01637272|581067966|FG000|Overall Study|Administrative problems|1|||
160910460|NCT01637272|581067966|FG000|Overall Study|Protocol Violation|2|||
160910461|NCT01844518|581067967|FG000|Overall Study|Adverse Event|7|||
160910462|NCT01844518|581067968|FG001|Overall Study|Adverse Event|1|||
160910463|NCT01844518|581067967|FG000|Overall Study|Lack of Efficacy|17|||
160910464|NCT01844518|581067968|FG001|Overall Study|Lack of Efficacy|5|||
160910465|NCT01844518|581067967|FG000|Overall Study|Participant's request to discontinue|4|||
160910466|NCT01844518|581067968|FG001|Overall Study|Participant's request to discontinue|1|||
160910467|NCT01844518|581067967|FG000|Overall Study|Poor/Non-compliance|1|||
160910468|NCT01844518|581067968|FG001|Overall Study|Poor/Non-compliance|0|||
160910469|NCT01844518|581067967|FG000|Overall Study|No Longer Met Study Criteria|2|||
160910470|NCT01844518|581067968|FG001|Overall Study|No Longer Met Study Criteria|0|||
160910471|NCT01844518|581067967|FG000|Overall Study|Withdrawal by Subject|9|||
160910472|NCT01844518|581067968|FG001|Overall Study|Withdrawal by Subject|0|||
160910473|NCT01844518|581067967|FG000|Overall Study|Pregnancy|1|||
160910474|NCT01844518|581067968|FG001|Overall Study|Pregnancy|0|||
160910475|NCT01217801|581067969|FG000|Period 1|Protocol Violation|1|||
160910476|NCT01217801|581067970|FG001|Period 1|Protocol Violation|1|||
160910477|NCT01217801|581067969|FG000|Period 1|Withdrawal by Subject|0|||
160910478|NCT01217801|581067970|FG001|Period 1|Withdrawal by Subject|1|||
160910479|NCT04584645|581067971|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
160910480|NCT04584645|581067972|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
160910481|NCT03845985|581067983|FG000|Overall Study|Lost to Follow-up|2|||
160910482|NCT03845985|581067984|FG001|Overall Study|Lost to Follow-up|1|||
160910483|NCT03845985|581067983|FG000|Overall Study|Physician Decision|1|||
160910484|NCT03845985|581067984|FG001|Overall Study|Physician Decision|0|||
160910485|NCT03845985|581067983|FG000|Overall Study|Withdrawal by Subject|4|||
160910486|NCT03845985|581067984|FG001|Overall Study|Withdrawal by Subject|1|||
160910487|NCT02756013|581067985|FG000|Overall Study|Adverse Event|1|||
160995205|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
161339225|NCT01232283|582630425|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160910488|NCT02756013|581067985|FG000|Overall Study|Hypersensitivity|1|||
160910489|NCT03926169|581067986|FG000|Period A|Adverse Event|2|||
160910490|NCT03926169|581067987|FG001|Period A|Adverse Event|2|||
160910491|NCT03926169|581067988|FG002|Period A|Adverse Event|1|||
160910492|NCT03926169|581067986|FG000|Period A|Withdrawal by Subject|2|||
160910493|NCT03926169|581067987|FG001|Period A|Withdrawal by Subject|2|||
160910494|NCT03926169|581067988|FG002|Period A|Withdrawal by Subject|2|||
161141804|NCT05405166|581904174|FG000|Overall Study|Death|49|||
161141805|NCT05405166|581904175|FG001|Overall Study|Death|50|||
161141806|NCT05405166|581904174|FG000|Overall Study|Withdrawal by Subject|10|||
161141807|NCT05405166|581904175|FG001|Overall Study|Withdrawal by Subject|3|||
160861357|NCT03137992|580885249|FG000|Washout Period 2|Withdrawal by Subject|1|||
160861358|NCT03137992|580885250|FG001|Washout Period 2|Withdrawal by Subject|0|||
160861359|NCT03137992|580885251|FG002|Washout Period 2|Withdrawal by Subject|0|||
160861360|NCT03137992|580885252|FG003|Washout Period 2|Withdrawal by Subject|0|||
160861361|NCT03137992|580885253|FG004|Washout Period 2|Withdrawal by Subject|1|||
160861362|NCT03137992|580885254|FG005|Washout Period 2|Withdrawal by Subject|0|||
160861363|NCT03137992|580885249|FG000|Washout Period 2|Sponsor Decision|0|||
160861364|NCT03137992|580885250|FG001|Washout Period 2|Sponsor Decision|0|||
160861365|NCT03137992|580885251|FG002|Washout Period 2|Sponsor Decision|0|||
160861366|NCT03137992|580885252|FG003|Washout Period 2|Sponsor Decision|0|||
160861367|NCT03137992|580885253|FG004|Washout Period 2|Sponsor Decision|0|||
160861368|NCT03137992|580885254|FG005|Washout Period 2|Sponsor Decision|1|||
160861369|NCT03137992|580885249|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
160861370|NCT03137992|580885250|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
160861371|NCT03137992|580885251|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
160861372|NCT03137992|580885252|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
160861373|NCT03137992|580885253|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
160861374|NCT03137992|580885254|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
160861375|NCT03137992|580885249|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
160861376|NCT03137992|580885250|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
160861377|NCT03137992|580885251|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
160861378|NCT03137992|580885252|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
160861379|NCT03137992|580885253|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
160861380|NCT03137992|580885254|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
160861381|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
160861382|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861383|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
160861384|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861385|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861386|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
160861387|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861388|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861389|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861390|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
160861391|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861392|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
160861393|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|Per study team|1|||
160861394|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|Per study team|0|||
160861395|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|Per study team|0|||
160861396|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|Per study team|0|||
160861397|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|Per study team|0|||
160861398|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|Per study team|0|||
160861399|NCT03137992|580885249|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861400|NCT03137992|580885250|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861401|NCT03137992|580885251|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861402|NCT03137992|580885252|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861403|NCT03137992|580885253|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
160861404|NCT03137992|580885254|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
160861405|NCT04609319|580885255|FG000|Overall Study|Death|64|||
160861406|NCT04609319|580885256|FG001|Overall Study|Death|49|||
160861407|NCT04609319|580885257|FG002|Overall Study|Death|1|||
160861408|NCT04609319|580885255|FG000|Overall Study|Withdrawal of consent|15|||
160861409|NCT04609319|580885256|FG001|Overall Study|Withdrawal of consent|3|||
160861410|NCT04609319|580885257|FG002|Overall Study|Withdrawal of consent|0|||
160861411|NCT04609319|580885255|FG000|Overall Study|Lost to Follow-up|20|||
160861412|NCT04609319|580885256|FG001|Overall Study|Lost to Follow-up|33|||
160861413|NCT04609319|580885257|FG002|Overall Study|Lost to Follow-up|0|||
160861414|NCT04609319|580885255|FG000|Overall Study|Alive until end of follow-up|60|||
160861415|NCT04609319|580885256|FG001|Overall Study|Alive until end of follow-up|53|||
160861416|NCT04609319|580885257|FG002|Overall Study|Alive until end of follow-up|1|||
160861417|NCT03221556|580885258|FG000|Allocation|post-randomization exclusion|0|||
160861418|NCT03221556|580885259|FG001|Allocation|post-randomization exclusion|1|||
160861419|NCT03221556|580885258|FG000|Follow-Up|Withdrawal by Subject|0|||
160861420|NCT03221556|580885259|FG001|Follow-Up|Withdrawal by Subject|1|||
160861421|NCT02234843|580885260|FG000|Overall Study|Death|1|||
160861422|NCT02234843|580885261|FG001|Overall Study|Death|0|||
160861423|NCT02234843|580885262|FG002|Overall Study|Death|0|||
161141808|NCT05405166|581904174|FG000|Overall Study|Ongoing at the time of PCD|209|||
161141809|NCT05405166|581904175|FG001|Overall Study|Ongoing at the time of PCD|210|||
161141810|NCT01843374|581904178|FG000|Overall Study|Death|155|||
161141811|NCT01843374|581904179|FG001|Overall Study|Death|313|||
161141812|NCT01843374|581904178|FG000|Overall Study|Withdrawal by Subject|14|||
161141813|NCT01843374|581904179|FG001|Overall Study|Withdrawal by Subject|20|||
161141814|NCT01843374|581904178|FG000|Overall Study|Withdrawing due to Other reason|20|||
161141815|NCT01843374|581904179|FG001|Overall Study|Withdrawing due to Other reason|46|||
161141816|NCT01826214|581904180|FG000|Overall Study|Adverse Event|7|||
161141817|NCT01826214|581904181|FG001|Overall Study|Adverse Event|6|||
161141818|NCT01826214|581904180|FG000|Overall Study|Death|3|||
161141819|NCT01826214|581904181|FG001|Overall Study|Death|1|||
161141820|NCT01826214|581904180|FG000|Overall Study|Lost to Follow-up|1|||
161141821|NCT01826214|581904181|FG001|Overall Study|Lost to Follow-up|0|||
161141822|NCT01826214|581904180|FG000|Overall Study|Physician Decision|0|||
161141823|NCT01826214|581904181|FG001|Overall Study|Physician Decision|2|||
161141824|NCT01826214|581904180|FG000|Overall Study|Progressive disease|22|||
161141825|NCT01826214|581904181|FG001|Overall Study|Progressive disease|21|||
161141826|NCT01826214|581904180|FG000|Overall Study|Study terminated by Sponsor|0|||
161141827|NCT01826214|581904181|FG001|Overall Study|Study terminated by Sponsor|1|||
161141828|NCT01826214|581904180|FG000|Overall Study|Subject/guardian decision|2|||
161141829|NCT01826214|581904181|FG001|Overall Study|Subject/guardian decision|3|||
161141830|NCT00955110|581904182|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
161141831|NCT00955110|581904182|FG000|Treatment Phase|Adverse Event|2|||
161141832|NCT00955110|581904182|FG000|Treatment Phase|Administrative reasons|2|||
161141833|NCT00955110|581904182|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
161141834|NCT00955110|581904182|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
161141835|NCT03704051|581904187|FG000|Overall Study|Withdrawal by Subject|4|||
161141836|NCT03704051|581904188|FG001|Overall Study|Withdrawal by Subject|0|||
161141837|NCT03167619|581904199|FG000|Overall Study|Death|11|||
161141838|NCT03167619|581904200|FG001|Overall Study|Death|8|||
161141839|NCT03167619|581904199|FG000|Overall Study|Withdrawal by Subject|1|||
161141840|NCT03167619|581904200|FG001|Overall Study|Withdrawal by Subject|2|||
161141841|NCT03167619|581904199|FG000|Overall Study|Physician Decision|0|||
161141842|NCT03167619|581904200|FG001|Overall Study|Physician Decision|1|||
161141843|NCT01981187|581904202|FG000|Overall Study|Participant/guardian decision|2|||
161141844|NCT01981187|581904202|FG000|Overall Study|Physician Decision|1|||
161141845|NCT01981187|581904202|FG000|Overall Study|Disease progression|2|||
161141846|NCT01981187|581904202|FG000|Overall Study|Adverse Event|7|||
161141847|NCT02082184|581904204|FG000|Overall Study|Adverse Event|1|||
161141848|NCT02082184|581904205|FG001|Overall Study|Adverse Event|0|||
161141849|NCT02082184|581904204|FG000|Overall Study|Medical diagnosis|1|||
161141850|NCT02082184|581904205|FG001|Overall Study|Medical diagnosis|2|||
161141851|NCT02082184|581904204|FG000|Overall Study|Device associated symptoms|5|||
161141852|NCT02082184|581904205|FG001|Overall Study|Device associated symptoms|0|||
161141853|NCT02082184|581904204|FG000|Overall Study|Withdrawal by Subject|3|||
161141854|NCT02082184|581904205|FG001|Overall Study|Withdrawal by Subject|2|||
161141855|NCT02082184|581904204|FG000|Overall Study|Protocol Violation|0|||
161141856|NCT02082184|581904205|FG001|Overall Study|Protocol Violation|6|||
161141857|NCT02082184|581904204|FG000|Overall Study|Lost to Follow-up|0|||
161141858|NCT02082184|581904205|FG001|Overall Study|Lost to Follow-up|2|||
161141859|NCT02082184|581904204|FG000|Overall Study|Subject non-compliance|0|||
161141860|NCT02082184|581904205|FG001|Overall Study|Subject non-compliance|1|||
161141861|NCT01943539|581904208|FG000|Overall Study|Non-compliance with at-home intervention|4|||
161141862|NCT01943539|581904209|FG001|Overall Study|Non-compliance with at-home intervention|0|||
161141863|NCT01362322|581904210|FG000|Overall Study|Withdrawal by Subject|3|||
161141864|NCT01362322|581904211|FG001|Overall Study|Withdrawal by Subject|1|||
160861424|NCT02234843|580885263|FG003|Overall Study|Death|0|||
160995206|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995207|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995208|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995209|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
160995210|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
160995211|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
160995212|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160995213|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160995214|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
161141865|NCT01362322|581904210|FG000|Overall Study|Lost to Follow-up|2|||
161141866|NCT01362322|581904211|FG001|Overall Study|Lost to Follow-up|6|||
161141867|NCT02413398|581904214|FG000|Overall Study|Lost to Follow-up|2|||
160995215|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
161141868|NCT02413398|581904215|FG001|Overall Study|Lost to Follow-up|4|||
161141869|NCT02413398|581904214|FG000|Overall Study|Withdrawal by Subject|1|||
161141870|NCT02413398|581904215|FG001|Overall Study|Withdrawal by Subject|1|||
161141871|NCT02413398|581904214|FG000|Overall Study|Other Eligibility criteria|1|||
161141872|NCT02413398|581904215|FG001|Overall Study|Other Eligibility criteria|2|||
160910495|NCT03926169|581067986|FG000|Period A|Lost to Follow-up|3|||
160910496|NCT03926169|581067987|FG001|Period A|Lost to Follow-up|1|||
160910497|NCT03926169|581067988|FG002|Period A|Lost to Follow-up|0|||
160910498|NCT03926169|581067986|FG000|Period A|Lack of Efficacy|0|||
160910499|NCT03926169|581067987|FG001|Period A|Lack of Efficacy|2|||
160910500|NCT03926169|581067988|FG002|Period A|Lack of Efficacy|2|||
160910501|NCT03926169|581067986|FG000|Period A|COVID-19 Infection|0|||
160910502|NCT03926169|581067987|FG001|Period A|COVID-19 Infection|1|||
160910503|NCT03926169|581067988|FG002|Period A|COVID-19 Infection|0|||
160910504|NCT03926169|581067986|FG000|Period A|COVID-19 Logistical Restrictions|0|||
160910505|NCT03926169|581067987|FG001|Period A|COVID-19 Logistical Restrictions|2|||
160910506|NCT03926169|581067988|FG002|Period A|COVID-19 Logistical Restrictions|1|||
160910507|NCT03926169|581067986|FG000|Period A|Other, Not Specified|1|||
160910508|NCT03926169|581067987|FG001|Period A|Other, Not Specified|0|||
160910509|NCT03926169|581067988|FG002|Period A|Other, Not Specified|0|||
160910510|NCT03926169|581067986|FG000|Period B|Adverse Event|3|||
160861425|NCT02234843|580885264|FG004|Overall Study|Death|0|||
160861426|NCT02234843|580885265|FG005|Overall Study|Death|0|||
160861427|NCT02234843|580885266|FG006|Overall Study|Death|0|||
160861428|NCT02234843|580885267|FG007|Overall Study|Death|0|||
160861429|NCT02234843|580885268|FG008|Overall Study|Death|0|||
160861430|NCT02234843|580885269|FG009|Overall Study|Death|0|||
160861431|NCT02234843|580885260|FG000|Overall Study|Protocol Violation|1|||
160861432|NCT02234843|580885261|FG001|Overall Study|Protocol Violation|0|||
160861433|NCT02234843|580885262|FG002|Overall Study|Protocol Violation|1|||
160861434|NCT02234843|580885263|FG003|Overall Study|Protocol Violation|0|||
160861435|NCT02234843|580885264|FG004|Overall Study|Protocol Violation|0|||
160861436|NCT02234843|580885265|FG005|Overall Study|Protocol Violation|0|||
160861437|NCT02234843|580885266|FG006|Overall Study|Protocol Violation|0|||
160861438|NCT02234843|580885267|FG007|Overall Study|Protocol Violation|0|||
160861439|NCT02234843|580885268|FG008|Overall Study|Protocol Violation|0|||
160861440|NCT02234843|580885269|FG009|Overall Study|Protocol Violation|0|||
160861441|NCT02234843|580885260|FG000|Overall Study|Efficacy outcome reached|2|||
160861442|NCT02234843|580885261|FG001|Overall Study|Efficacy outcome reached|0|||
160861443|NCT02234843|580885262|FG002|Overall Study|Efficacy outcome reached|0|||
160861444|NCT02234843|580885263|FG003|Overall Study|Efficacy outcome reached|0|||
160861445|NCT02234843|580885264|FG004|Overall Study|Efficacy outcome reached|0|||
160861446|NCT02234843|580885265|FG005|Overall Study|Efficacy outcome reached|2|||
160861447|NCT02234843|580885266|FG006|Overall Study|Efficacy outcome reached|0|||
160861448|NCT02234843|580885267|FG007|Overall Study|Efficacy outcome reached|0|||
160861449|NCT02234843|580885268|FG008|Overall Study|Efficacy outcome reached|0|||
160861450|NCT02234843|580885269|FG009|Overall Study|Efficacy outcome reached|0|||
160861451|NCT02234843|580885260|FG000|Overall Study|Patient convenience|2|||
160861452|NCT02234843|580885261|FG001|Overall Study|Patient convenience|0|||
160861453|NCT02234843|580885262|FG002|Overall Study|Patient convenience|0|||
160861454|NCT02234843|580885263|FG003|Overall Study|Patient convenience|0|||
160861455|NCT02234843|580885264|FG004|Overall Study|Patient convenience|0|||
160861456|NCT02234843|580885265|FG005|Overall Study|Patient convenience|1|||
160861457|NCT02234843|580885266|FG006|Overall Study|Patient convenience|0|||
160861458|NCT02234843|580885267|FG007|Overall Study|Patient convenience|0|||
160861459|NCT02234843|580885268|FG008|Overall Study|Patient convenience|0|||
160861460|NCT02234843|580885269|FG009|Overall Study|Patient convenience|0|||
160861461|NCT02234843|580885260|FG000|Overall Study|Withdrawal by Subject|5|||
160861462|NCT02234843|580885261|FG001|Overall Study|Withdrawal by Subject|1|||
160861463|NCT02234843|580885262|FG002|Overall Study|Withdrawal by Subject|1|||
160861464|NCT02234843|580885263|FG003|Overall Study|Withdrawal by Subject|0|||
160861465|NCT02234843|580885264|FG004|Overall Study|Withdrawal by Subject|0|||
160861466|NCT02234843|580885265|FG005|Overall Study|Withdrawal by Subject|7|||
160861467|NCT02234843|580885266|FG006|Overall Study|Withdrawal by Subject|0|||
160861468|NCT02234843|580885267|FG007|Overall Study|Withdrawal by Subject|0|||
160861469|NCT02234843|580885268|FG008|Overall Study|Withdrawal by Subject|0|||
160861470|NCT02234843|580885269|FG009|Overall Study|Withdrawal by Subject|0|||
160861471|NCT02234843|580885260|FG000|Overall Study|Recovery|1|||
160861472|NCT02234843|580885261|FG001|Overall Study|Recovery|0|||
160861473|NCT02234843|580885262|FG002|Overall Study|Recovery|0|||
160861474|NCT02234843|580885263|FG003|Overall Study|Recovery|0|||
160861475|NCT02234843|580885264|FG004|Overall Study|Recovery|0|||
160861476|NCT02234843|580885265|FG005|Overall Study|Recovery|0|||
160861477|NCT02234843|580885266|FG006|Overall Study|Recovery|0|||
160861478|NCT02234843|580885267|FG007|Overall Study|Recovery|0|||
160861479|NCT02234843|580885268|FG008|Overall Study|Recovery|0|||
160861480|NCT02234843|580885269|FG009|Overall Study|Recovery|0|||
160861481|NCT02234843|580885260|FG000|Overall Study|Other|0|||
160861482|NCT02234843|580885261|FG001|Overall Study|Other|2|||
160861483|NCT02234843|580885262|FG002|Overall Study|Other|0|||
160861484|NCT02234843|580885263|FG003|Overall Study|Other|1|||
160861485|NCT02234843|580885264|FG004|Overall Study|Other|0|||
160861486|NCT02234843|580885265|FG005|Overall Study|Other|1|||
160861487|NCT02234843|580885266|FG006|Overall Study|Other|0|||
160910511|NCT03926169|581067987|FG001|Period B|Adverse Event|1|||
160910512|NCT03926169|581067988|FG002|Period B|Adverse Event|1|||
160910513|NCT03926169|581067986|FG000|Period B|Withdrawal by Subject|1|||
160910514|NCT03926169|581067987|FG001|Period B|Withdrawal by Subject|3|||
160910515|NCT03926169|581067988|FG002|Period B|Withdrawal by Subject|0|||
160910516|NCT03926169|581067986|FG000|Period B|Lack of Efficacy|3|||
160910517|NCT03926169|581067987|FG001|Period B|Lack of Efficacy|1|||
160910518|NCT03926169|581067988|FG002|Period B|Lack of Efficacy|1|||
160910519|NCT03926169|581067986|FG000|Period B|Lost to Follow-up|1|||
160910520|NCT03926169|581067987|FG001|Period B|Lost to Follow-up|1|||
160910521|NCT03926169|581067988|FG002|Period B|Lost to Follow-up|4|||
160910522|NCT03926169|581067986|FG000|Period B|Other, Not Specified|62|||
160910523|NCT03926169|581067987|FG001|Period B|Other, Not Specified|57|||
160910524|NCT03926169|581067988|FG002|Period B|Other, Not Specified|65|||
160910525|NCT00968201|581067989|FG000|Base Study - (Period II)|Adverse Event|8|||
160910526|NCT00968201|581067990|FG001|Base Study - (Period II)|Adverse Event|0|||
160910527|NCT00968201|581067991|FG002|Base Study - (Period II)|Adverse Event|16|||
160910528|NCT00968201|581067989|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
160910529|NCT00968201|581067990|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
160910530|NCT00968201|581067991|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
160910531|NCT00968201|581067989|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
160910532|NCT00968201|581067990|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
160910533|NCT00968201|581067991|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
160910534|NCT00968201|581067989|FG000|Base Study - (Period II)|Protocol Violation|12|||
160910535|NCT00968201|581067990|FG001|Base Study - (Period II)|Protocol Violation|0|||
160910536|NCT00968201|581067991|FG002|Base Study - (Period II)|Protocol Violation|12|||
160910537|NCT00968201|581067989|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
160910538|NCT00968201|581067990|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
160910539|NCT00968201|581067991|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
160910540|NCT00968201|581067989|FG000|Base Study - (Period II)|Site Error|0|||
160910541|NCT00968201|581067990|FG001|Base Study - (Period II)|Site Error|0|||
160910542|NCT00968201|581067991|FG002|Base Study - (Period II)|Site Error|1|||
160910543|NCT00968201|581067989|FG000|Extension Study - (Period III)|Adverse Event|0|||
160910544|NCT00968201|581067990|FG001|Extension Study - (Period III)|Adverse Event|5|||
160910545|NCT00968201|581067991|FG002|Extension Study - (Period III)|Adverse Event|22|||
160910546|NCT00968201|581067989|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
160910547|NCT00968201|581067990|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
160910548|NCT00968201|581067991|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
160910549|NCT00968201|581067989|FG000|Extension Study - (Period III)|Protocol Violation|0|||
160910550|NCT00968201|581067990|FG001|Extension Study - (Period III)|Protocol Violation|17|||
160910551|NCT00968201|581067991|FG002|Extension Study - (Period III)|Protocol Violation|14|||
160910552|NCT00968201|581067989|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
160910553|NCT00968201|581067990|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
160910554|NCT00968201|581067991|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
160910555|NCT00968201|581067989|FG000|Extension Study - (Period III)|Patient Relocated|0|||
160910556|NCT00968201|581067990|FG001|Extension Study - (Period III)|Patient Relocated|1|||
160910557|NCT00968201|581067991|FG002|Extension Study - (Period III)|Patient Relocated|1|||
160910558|NCT00968201|581067989|FG000|Extension Study - (Period III)|Noncompliance|0|||
160910559|NCT00968201|581067990|FG001|Extension Study - (Period III)|Noncompliance|0|||
160910560|NCT00968201|581067991|FG002|Extension Study - (Period III)|Noncompliance|3|||
160910561|NCT00968201|581067989|FG000|Extension Study - (Period III)|Other|0|||
160910562|NCT00968201|581067990|FG001|Extension Study - (Period III)|Other|0|||
160910563|NCT00968201|581067991|FG002|Extension Study - (Period III)|Other|2|||
160910564|NCT00968201|581067989|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
160910565|NCT00968201|581067990|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
160910566|NCT00968201|581067991|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
160910567|NCT04974697|581067995|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
160910568|NCT04974697|581067995|FG000|Overall Study|Lens discomfort|1|||
160910569|NCT03706456|581067996|FG000|Overall Study|Adverse Event|1|||
160910570|NCT03706456|581067996|FG000|Overall Study|Lack of Efficacy|2|||
160910571|NCT03302234|581067997|FG000|Overall Study|Death|191|||
160910572|NCT03302234|581067998|FG001|Overall Study|Death|192|||
160910573|NCT03302234|581067997|FG000|Overall Study|Withdrawal by Subject|2|||
160910574|NCT03302234|581067998|FG001|Overall Study|Withdrawal by Subject|2|||
160910575|NCT03302234|581067997|FG000|Overall Study|Sponsor Decision|90|||
160910576|NCT03302234|581067998|FG001|Overall Study|Sponsor Decision|89|||
160910577|NCT03302234|581067997|FG000|Overall Study|Laryngeal carcinoma|0|||
160910578|NCT03302234|581067998|FG001|Overall Study|Laryngeal carcinoma|1|||
160910579|NCT03302234|581067997|FG000|Overall Study|Not Reported|1|||
160910580|NCT03302234|581067998|FG001|Overall Study|Not Reported|0|||
160910581|NCT04523220|581068000|FG000|Main Treatment Period|Physician Decision|1|||
160910582|NCT04523220|581068001|FG001|Main Treatment Period|Physician Decision|1|||
160910583|NCT04523220|581068002|FG002|Main Treatment Period|Physician Decision|0|||
160910584|NCT04523220|581068000|FG000|Main Treatment Period|Other|5|||
160910585|NCT04523220|581068001|FG001|Main Treatment Period|Other|2|||
160910586|NCT04523220|581068002|FG002|Main Treatment Period|Other|4|||
160910587|NCT04523220|581068000|FG000|Main Treatment Period|Subject Decision|5|||
160910588|NCT04523220|581068001|FG001|Main Treatment Period|Subject Decision|7|||
160910589|NCT04523220|581068002|FG002|Main Treatment Period|Subject Decision|3|||
160910590|NCT04523220|581068000|FG000|Main Treatment Period|Death|5|||
160910591|NCT04523220|581068001|FG001|Main Treatment Period|Death|11|||
160910592|NCT04523220|581068002|FG002|Main Treatment Period|Death|4|||
160910593|NCT04523220|581068000|FG000|Main Treatment Period|Adverse Event|11|||
160910594|NCT04523220|581068001|FG001|Main Treatment Period|Adverse Event|9|||
160910595|NCT04523220|581068002|FG002|Main Treatment Period|Adverse Event|9|||
160910596|NCT04523220|581068000|FG000|Main Treatment Period|Withdrawal by Subject|3|||
160910597|NCT04523220|581068001|FG001|Main Treatment Period|Withdrawal by Subject|3|||
160910598|NCT04523220|581068002|FG002|Main Treatment Period|Withdrawal by Subject|4|||
160910599|NCT04523220|581068000|FG000|Main Treatment Period|Study drug never adminstered|10|||
160910600|NCT04523220|581068001|FG001|Main Treatment Period|Study drug never adminstered|3|||
160910601|NCT04523220|581068002|FG002|Main Treatment Period|Study drug never adminstered|5|||
160910602|NCT04523220|581068000|FG000|Extension Treatment Period|Physician Decision|1|||
160910603|NCT04523220|581068001|FG001|Extension Treatment Period|Physician Decision|0|||
160910604|NCT04523220|581068002|FG002|Extension Treatment Period|Physician Decision|3|||
160910605|NCT04523220|581068000|FG000|Extension Treatment Period|Other|2|||
160910606|NCT04523220|581068001|FG001|Extension Treatment Period|Other|6|||
160910607|NCT04523220|581068002|FG002|Extension Treatment Period|Other|6|||
160910608|NCT04523220|581068000|FG000|Extension Treatment Period|Subject Decision|5|||
160910609|NCT04523220|581068001|FG001|Extension Treatment Period|Subject Decision|2|||
160910610|NCT04523220|581068002|FG002|Extension Treatment Period|Subject Decision|4|||
160910611|NCT04523220|581068000|FG000|Extension Treatment Period|Death|6|||
160910612|NCT04523220|581068001|FG001|Extension Treatment Period|Death|4|||
160910613|NCT04523220|581068002|FG002|Extension Treatment Period|Death|7|||
160910614|NCT04523220|581068000|FG000|Extension Treatment Period|Adverse Event|6|||
160910615|NCT04523220|581068001|FG001|Extension Treatment Period|Adverse Event|7|||
160910616|NCT04523220|581068002|FG002|Extension Treatment Period|Adverse Event|9|||
160910617|NCT04523220|581068000|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
160910618|NCT04523220|581068001|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
160910619|NCT04523220|581068002|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
160910620|NCT04523220|581068000|FG000|Extension Treatment Period|Study drug never administered|0|||
160910621|NCT04523220|581068001|FG001|Extension Treatment Period|Study drug never administered|1|||
160910622|NCT04523220|581068002|FG002|Extension Treatment Period|Study drug never administered|0|||
160910623|NCT04112784|581068003|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
160910624|NCT04112784|581068003|FG000|Overall Study|Screen Failures|4|||
160910625|NCT00221403|581068004|FG000|Overall Study|Protocol Violation|1|||
160910626|NCT00221403|581068005|FG001|Overall Study|Protocol Violation|0|||
160910627|NCT00221403|581068006|FG002|Overall Study|Protocol Violation|0|||
160910628|NCT00221403|581068004|FG000|Overall Study|Physician Decision|1|||
160910629|NCT00221403|581068005|FG001|Overall Study|Physician Decision|0|||
160910630|NCT00221403|581068006|FG002|Overall Study|Physician Decision|0|||
160910631|NCT00221403|581068004|FG000|Overall Study|Withdrawal by Subject|0|||
160910632|NCT00221403|581068005|FG001|Overall Study|Withdrawal by Subject|3|||
160910633|NCT00221403|581068006|FG002|Overall Study|Withdrawal by Subject|0|||
160910634|NCT00221403|581068004|FG000|Overall Study|Lack of Efficacy|0|||
160910635|NCT00221403|581068005|FG001|Overall Study|Lack of Efficacy|1|||
160910636|NCT00221403|581068006|FG002|Overall Study|Lack of Efficacy|0|||
160910637|NCT00221403|581068004|FG000|Overall Study|Adverse Event|0|||
160910638|NCT00221403|581068005|FG001|Overall Study|Adverse Event|1|||
160910639|NCT00221403|581068006|FG002|Overall Study|Adverse Event|0|||
160910640|NCT00753415|581068007|FG000|Part A|Disease progression|1|||
160910641|NCT00753415|581068008|FG001|Part A|Disease progression|0|||
160910642|NCT00753415|581068009|FG002|Part A|Disease progression|1|||
160910643|NCT00753415|581068010|FG003|Part A|Disease progression|2|||
160995216|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
160995217|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
160995218|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995219|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995220|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995221|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
160995222|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
160995223|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
160910644|NCT00753415|581068011|FG004|Part A|Disease progression|0|||
160910645|NCT00753415|581068012|FG005|Part A|Disease progression|0|||
160910646|NCT00753415|581068013|FG006|Part A|Disease progression|0|||
160910647|NCT00753415|581068014|FG007|Part A|Disease progression|0|||
160910648|NCT00753415|581068015|FG008|Part A|Disease progression|0|||
160910649|NCT00753415|581068016|FG009|Part A|Disease progression|0|||
160910650|NCT00753415|581068007|FG000|Part A|Withdrawal by Subject|0|||
160910651|NCT00753415|581068008|FG001|Part A|Withdrawal by Subject|0|||
160910652|NCT00753415|581068009|FG002|Part A|Withdrawal by Subject|1|||
161141873|NCT03715465|581904218|FG000|Overall Study|Withdrawal by Subject|1|||
161141874|NCT03715465|581904219|FG001|Overall Study|Withdrawal by Subject|2|||
161141875|NCT02158533|581904220|FG000|Stage 1|Adverse Event|6|||
161141876|NCT02158533|581904221|FG001|Stage 1|Adverse Event|4|||
161141877|NCT02158533|581904222|FG002|Stage 1|Adverse Event|7|||
161141878|NCT02158533|581904223|FG003|Stage 1|Adverse Event|0|||
161141879|NCT02158533|581904224|FG004|Stage 1|Adverse Event|0|||
161141880|NCT02158533|581904225|FG005|Stage 1|Adverse Event|0|||
161141881|NCT02158533|581904220|FG000|Stage 1|Withdrawal by Subject|3|||
161141882|NCT02158533|581904221|FG001|Stage 1|Withdrawal by Subject|2|||
161141883|NCT02158533|581904222|FG002|Stage 1|Withdrawal by Subject|1|||
160861488|NCT02234843|580885267|FG007|Overall Study|Other|1|||
160861489|NCT02234843|580885268|FG008|Overall Study|Other|0|||
160910653|NCT00753415|581068010|FG003|Part A|Withdrawal by Subject|0|||
160910654|NCT00753415|581068011|FG004|Part A|Withdrawal by Subject|0|||
160910655|NCT00753415|581068012|FG005|Part A|Withdrawal by Subject|0|||
160910656|NCT00753415|581068013|FG006|Part A|Withdrawal by Subject|0|||
160910657|NCT00753415|581068014|FG007|Part A|Withdrawal by Subject|0|||
160910658|NCT00753415|581068015|FG008|Part A|Withdrawal by Subject|0|||
160910659|NCT00753415|581068016|FG009|Part A|Withdrawal by Subject|0|||
160910660|NCT00753415|581068007|FG000|Part B|Lost to Follow-up|0|||
160910661|NCT00753415|581068008|FG001|Part B|Lost to Follow-up|0|||
160910662|NCT00753415|581068009|FG002|Part B|Lost to Follow-up|0|||
160910663|NCT00753415|581068010|FG003|Part B|Lost to Follow-up|0|||
160910664|NCT00753415|581068011|FG004|Part B|Lost to Follow-up|0|||
160910665|NCT00753415|581068012|FG005|Part B|Lost to Follow-up|0|||
160910666|NCT00753415|581068013|FG006|Part B|Lost to Follow-up|0|||
160910667|NCT00753415|581068014|FG007|Part B|Lost to Follow-up|1|||
160910668|NCT00753415|581068015|FG008|Part B|Lost to Follow-up|1|||
160910669|NCT00753415|581068016|FG009|Part B|Lost to Follow-up|0|||
160910670|NCT00753415|581068007|FG000|Part B|Disease progression|0|||
160910671|NCT00753415|581068008|FG001|Part B|Disease progression|0|||
160910672|NCT00753415|581068009|FG002|Part B|Disease progression|0|||
160910673|NCT00753415|581068010|FG003|Part B|Disease progression|0|||
160910674|NCT00753415|581068011|FG004|Part B|Disease progression|0|||
160910675|NCT00753415|581068012|FG005|Part B|Disease progression|0|||
160910676|NCT00753415|581068013|FG006|Part B|Disease progression|0|||
160910677|NCT00753415|581068014|FG007|Part B|Disease progression|0|||
160910678|NCT00753415|581068015|FG008|Part B|Disease progression|2|||
160910679|NCT00753415|581068016|FG009|Part B|Disease progression|1|||
160910680|NCT03727347|581068020|FG000|Overall Study|Withdrawal by Subject|2|||
160910681|NCT03727347|581068020|FG000|Overall Study|Lost to Follow-up|1|||
160910682|NCT04292743|581068021|FG000|Overall Study|Physician Decision|1|||
160910683|NCT04292743|581068022|FG001|Overall Study|Physician Decision|3|||
160910684|NCT04292743|581068023|FG002|Overall Study|Physician Decision|0|||
160910685|NCT04292743|581068024|FG003|Overall Study|Physician Decision|0|||
160910686|NCT04292743|581068021|FG000|Overall Study|Withdrawal by Subject|0|||
160910687|NCT04292743|581068022|FG001|Overall Study|Withdrawal by Subject|5|||
160910688|NCT04292743|581068023|FG002|Overall Study|Withdrawal by Subject|0|||
160910689|NCT04292743|581068024|FG003|Overall Study|Withdrawal by Subject|0|||
160910690|NCT04292743|581068021|FG000|Overall Study|Death|0|||
160910691|NCT04292743|581068022|FG001|Overall Study|Death|1|||
160910692|NCT04292743|581068023|FG002|Overall Study|Death|0|||
160910693|NCT04292743|581068024|FG003|Overall Study|Death|0|||
160910694|NCT04292743|581068021|FG000|Overall Study|Progression of Disease|2|||
160910695|NCT04292743|581068022|FG001|Overall Study|Progression of Disease|5|||
160910696|NCT04292743|581068023|FG002|Overall Study|Progression of Disease|0|||
160910697|NCT04292743|581068024|FG003|Overall Study|Progression of Disease|0|||
160910698|NCT04292743|581068021|FG000|Overall Study|No Treatment per protocol|0|||
160910699|NCT04292743|581068022|FG001|Overall Study|No Treatment per protocol|2|||
160910700|NCT04292743|581068023|FG002|Overall Study|No Treatment per protocol|0|||
160861490|NCT02234843|580885269|FG009|Overall Study|Other|0|||
160910701|NCT04292743|581068024|FG003|Overall Study|No Treatment per protocol|0|||
160910702|NCT05330702|581068025|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
160910703|NCT05330702|581068026|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
161141884|NCT02158533|581904223|FG003|Stage 1|Withdrawal by Subject|0|||
161141885|NCT02158533|581904224|FG004|Stage 1|Withdrawal by Subject|0|||
161141886|NCT02158533|581904225|FG005|Stage 1|Withdrawal by Subject|0|||
160861491|NCT02234843|580885260|FG000|Overall Study|Physician Decision|4|||
160910704|NCT05330702|581068027|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
160861492|NCT02234843|580885261|FG001|Overall Study|Physician Decision|1|||
160861493|NCT02234843|580885262|FG002|Overall Study|Physician Decision|0|||
160861494|NCT02234843|580885263|FG003|Overall Study|Physician Decision|1|||
160861495|NCT02234843|580885264|FG004|Overall Study|Physician Decision|0|||
160861496|NCT02234843|580885265|FG005|Overall Study|Physician Decision|0|||
160861497|NCT02234843|580885266|FG006|Overall Study|Physician Decision|0|||
160910705|NCT02881554|581068028|FG000|Overall Study|Withdrawal by Subject|2|||
160910706|NCT02881554|581068029|FG001|Overall Study|Withdrawal by Subject|0|||
161141887|NCT02158533|581904220|FG000|Stage 1|Lack of Efficacy|1|||
161141888|NCT02158533|581904221|FG001|Stage 1|Lack of Efficacy|0|||
160910707|NCT02674529|581070017|FG000|Overall Study|Lost to Follow-up|1|||
160910708|NCT02674529|581070018|FG001|Overall Study|Lost to Follow-up|2|||
160910709|NCT02674529|581070017|FG000|Overall Study|Withdrawal by Subject|2|||
160910710|NCT02674529|581070018|FG001|Overall Study|Withdrawal by Subject|1|||
160910711|NCT02674529|581070017|FG000|Overall Study|Physician Decision|0|||
160910712|NCT02674529|581070018|FG001|Overall Study|Physician Decision|1|||
160910713|NCT02674529|581070017|FG000|Overall Study|Protocol Violation|0|||
160910714|NCT02674529|581070018|FG001|Overall Study|Protocol Violation|1|||
160910715|NCT00963547|581070019|FG000|Overall Study|Adverse Event|0|||
160910716|NCT00963547|581070020|FG001|Overall Study|Adverse Event|1|||
160910717|NCT00963547|581070021|FG002|Overall Study|Adverse Event|0|||
160910718|NCT00963547|581070022|FG003|Overall Study|Adverse Event|1|||
160910719|NCT00963547|581070023|FG004|Overall Study|Adverse Event|0|||
160910720|NCT00963547|581070024|FG005|Overall Study|Adverse Event|0|||
160910721|NCT00963547|581070025|FG006|Overall Study|Adverse Event|0|||
160910722|NCT00963547|581070019|FG000|Overall Study|Physician Decision|1|||
160910723|NCT00963547|581070020|FG001|Overall Study|Physician Decision|1|||
160910724|NCT00963547|581070021|FG002|Overall Study|Physician Decision|0|||
160910725|NCT00963547|581070022|FG003|Overall Study|Physician Decision|0|||
160910726|NCT00963547|581070023|FG004|Overall Study|Physician Decision|0|||
160910727|NCT00963547|581070024|FG005|Overall Study|Physician Decision|0|||
160910728|NCT00963547|581070025|FG006|Overall Study|Physician Decision|0|||
160910729|NCT00963547|581070019|FG000|Overall Study|Progressive Disease|3|||
160910730|NCT00963547|581070020|FG001|Overall Study|Progressive Disease|8|||
160910731|NCT00963547|581070021|FG002|Overall Study|Progressive Disease|9|||
160910732|NCT00963547|581070022|FG003|Overall Study|Progressive Disease|5|||
160910733|NCT00963547|581070023|FG004|Overall Study|Progressive Disease|0|||
160910734|NCT00963547|581070024|FG005|Overall Study|Progressive Disease|0|||
160910735|NCT00963547|581070025|FG006|Overall Study|Progressive Disease|0|||
160910736|NCT00963547|581070019|FG000|Overall Study|Withdrawal by Subject|0|||
160910737|NCT00963547|581070020|FG001|Overall Study|Withdrawal by Subject|0|||
160910738|NCT00963547|581070021|FG002|Overall Study|Withdrawal by Subject|3|||
160910739|NCT00963547|581070022|FG003|Overall Study|Withdrawal by Subject|0|||
160910740|NCT00963547|581070023|FG004|Overall Study|Withdrawal by Subject|0|||
160910741|NCT00963547|581070024|FG005|Overall Study|Withdrawal by Subject|0|||
160910742|NCT00963547|581070025|FG006|Overall Study|Withdrawal by Subject|0|||
160910743|NCT00963547|581070019|FG000|Overall Study|Reason Unknown|0|||
160910744|NCT00963547|581070020|FG001|Overall Study|Reason Unknown|1|||
160910745|NCT00963547|581070021|FG002|Overall Study|Reason Unknown|0|||
160910746|NCT00963547|581070022|FG003|Overall Study|Reason Unknown|0|||
160910747|NCT00963547|581070023|FG004|Overall Study|Reason Unknown|0|||
160910748|NCT00963547|581070024|FG005|Overall Study|Reason Unknown|0|||
160910749|NCT00963547|581070025|FG006|Overall Study|Reason Unknown|0|||
160910750|NCT00331682|581070026|FG000|Overall Study|Adverse Event|1|||
160910751|NCT03761277|581070027|FG000|Enrollment to Implant|Screen Failure|17|||
160910752|NCT03761277|581070027|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
160910753|NCT03761277|581070027|FG000|Enrollment to Implant|Physician Decision|2|||
160910754|NCT03761277|581070027|FG000|Enrollment to Implant|Site Closure|3|||
160910755|NCT03761277|581070027|FG000|Enrollment to Implant|Sponsor Request|2|||
160910756|NCT03761277|581070027|FG000|Post-Implant to 6 Months|Adverse Event|2|||
160910757|NCT03761277|581070027|FG000|Post-Implant to 6 Months|Death|1|||
160910758|NCT03761277|581070027|FG000|Post-Implant to 6 Months|Site Closure|2|||
160910759|NCT03761277|581070027|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
160910760|NCT03761277|581070027|FG000|6 Months to 12 Months|Physician Decision|2|||
160910761|NCT03761277|581070027|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
160910762|NCT00759031|581070028|FG000|First Intervention (1 Day)|Physician Decision|1|||
160910763|NCT00759031|581070029|FG001|First Intervention (1 Day)|Physician Decision|0|||
160995224|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
160995225|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
160995226|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
160910764|NCT00759031|581070028|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
160910765|NCT00759031|581070029|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
160910766|NCT00759031|581070028|FG000|First Intervention (1 Day)|Screening failure|1|||
160910767|NCT00759031|581070029|FG001|First Intervention (1 Day)|Screening failure|0|||
160910768|NCT00543140|581070030|FG000|Overall Study|Lost to Follow-up|33|||
160995227|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
160910769|NCT00543140|581070030|FG000|Overall Study|Withdrawal by Subject|13|||
160910770|NCT00543140|581070030|FG000|Overall Study|Protocol Violation|10|||
160910771|NCT00543140|581070030|FG000|Overall Study|Insufficient weight loss|10|||
160910772|NCT00543140|581070030|FG000|Overall Study|SAE leading to explant of SAGB|3|||
160910773|NCT00543140|581070030|FG000|Overall Study|Death|1|||
160910774|NCT00543140|581070030|FG000|Overall Study|Subject moved|1|||
160910775|NCT00543140|581070030|FG000|Overall Study|Conversion to different procedure|1|||
160910776|NCT04532164|581070031|FG000|Overall Study|Adverse Event|1|||
160910777|NCT04532164|581070031|FG000|Overall Study|Protocol Violation|5|||
160910778|NCT04532164|581070031|FG000|Overall Study|Lost to Follow-up|1|||
160910779|NCT04532164|581070031|FG000|Overall Study|Found to be Ineligible|3|||
160910780|NCT04532164|581070031|FG000|Overall Study|Withdrawal by Subject|14|||
160910781|NCT01599234|581070032|FG000|Overall Study|Adverse Event|9|||
160910782|NCT01599234|581070033|FG001|Overall Study|Adverse Event|5|||
160910783|NCT01599234|581070032|FG000|Overall Study|Withdrawal by Subject|2|||
160910784|NCT01599234|581070033|FG001|Overall Study|Withdrawal by Subject|1|||
160910785|NCT01599234|581070032|FG000|Overall Study|Lost to Follow-up|1|||
160910786|NCT01599234|581070033|FG001|Overall Study|Lost to Follow-up|2|||
160910787|NCT01599234|581070032|FG000|Overall Study|Lack of Efficacy|2|||
160910788|NCT01599234|581070033|FG001|Overall Study|Lack of Efficacy|4|||
160910789|NCT01599234|581070032|FG000|Overall Study|Unable to operate spray|1|||
160910790|NCT01599234|581070033|FG001|Overall Study|Unable to operate spray|0|||
160910791|NCT01599234|581070032|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
160995228|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
160995229|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
160995230|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995231|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995232|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995233|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995234|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
160995235|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
160995236|NCT03370133|581369089|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995237|NCT03370133|581369090|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995238|NCT03370133|581369091|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995239|NCT03370133|581369092|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995240|NCT03370133|581369093|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
160995241|NCT03370133|581369094|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
160995242|NCT06688370|581369095|FG000|Overall Study|Discontinued the treatment|1|||
160995243|NCT06688370|581369095|FG000|Overall Study|Prohibited treatment taken|4|||
160995244|NCT02501811|581369096|FG000|Overall Study|Death|1|||
160995245|NCT02501811|581369097|FG001|Overall Study|Death|3|||
160995246|NCT02501811|581369098|FG002|Overall Study|Death|2|||
160995247|NCT02501811|581369099|FG003|Overall Study|Death|3|||
160995248|NCT02501811|581369096|FG000|Overall Study|Withdrawal by Subject|3|||
160995249|NCT02501811|581369097|FG001|Overall Study|Withdrawal by Subject|3|||
160995250|NCT02501811|581369098|FG002|Overall Study|Withdrawal by Subject|2|||
160995251|NCT02501811|581369099|FG003|Overall Study|Withdrawal by Subject|3|||
160995252|NCT02501811|581369096|FG000|Overall Study|Lost to Follow-up|0|||
160995253|NCT02501811|581369097|FG001|Overall Study|Lost to Follow-up|0|||
160995254|NCT02501811|581369098|FG002|Overall Study|Lost to Follow-up|2|||
160995255|NCT02501811|581369099|FG003|Overall Study|Lost to Follow-up|1|||
160995256|NCT04018066|581370896|FG000|Overall Study|participants started taking medications during the study period|3|||
160995257|NCT04018066|581370896|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
160995258|NCT03568318|581370897|FG000|Overall Study|Adverse Event|3|||
160995259|NCT03568318|581370898|FG001|Overall Study|Adverse Event|1|||
160995260|NCT03568318|581370899|FG002|Overall Study|Adverse Event|1|||
160910792|NCT01599234|581070033|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
160910793|NCT01599234|581070032|FG000|Overall Study|Death|1|||
160910794|NCT01599234|581070033|FG001|Overall Study|Death|0|||
160910795|NCT01599234|581070032|FG000|Overall Study|Patient would not stop driving|1|||
160995261|NCT03568318|581370900|FG003|Overall Study|Adverse Event|0|||
160995262|NCT03568318|581370901|FG004|Overall Study|Adverse Event|1|||
160995263|NCT03568318|581370902|FG005|Overall Study|Adverse Event|0|||
160995264|NCT03568318|581370897|FG000|Overall Study|Withdrawal by Subject|6|||
160995265|NCT03568318|581370898|FG001|Overall Study|Withdrawal by Subject|5|||
160995266|NCT03568318|581370899|FG002|Overall Study|Withdrawal by Subject|2|||
160995267|NCT03568318|581370900|FG003|Overall Study|Withdrawal by Subject|1|||
160995268|NCT03568318|581370901|FG004|Overall Study|Withdrawal by Subject|0|||
160995269|NCT03568318|581370902|FG005|Overall Study|Withdrawal by Subject|0|||
160995270|NCT03568318|581370897|FG000|Overall Study|Lost to Follow-up|3|||
160995271|NCT03568318|581370898|FG001|Overall Study|Lost to Follow-up|2|||
160995272|NCT03568318|581370899|FG002|Overall Study|Lost to Follow-up|2|||
160995273|NCT03568318|581370900|FG003|Overall Study|Lost to Follow-up|2|||
160995274|NCT03568318|581370901|FG004|Overall Study|Lost to Follow-up|1|||
160995275|NCT03568318|581370902|FG005|Overall Study|Lost to Follow-up|0|||
160995276|NCT03568318|581370897|FG000|Overall Study|Other|3|||
160995277|NCT03568318|581370898|FG001|Overall Study|Other|1|||
160995278|NCT03568318|581370899|FG002|Overall Study|Other|3|||
160995279|NCT03568318|581370900|FG003|Overall Study|Other|0|||
160995280|NCT03568318|581370901|FG004|Overall Study|Other|0|||
160910796|NCT01599234|581070033|FG001|Overall Study|Patient would not stop driving|0|||
160910797|NCT01599234|581070032|FG000|Overall Study|Contra-indication discovered|0|||
160910798|NCT01599234|581070033|FG001|Overall Study|Contra-indication discovered|1|||
160995281|NCT03568318|581370902|FG005|Overall Study|Other|0|||
160995282|NCT03568318|581370897|FG000|Overall Study|Ongoing at Time of Analysis|5|||
160995283|NCT03568318|581370898|FG001|Overall Study|Ongoing at Time of Analysis|3|||
161141889|NCT02158533|581904222|FG002|Stage 1|Lack of Efficacy|0|||
161141890|NCT02158533|581904223|FG003|Stage 1|Lack of Efficacy|0|||
161141891|NCT02158533|581904224|FG004|Stage 1|Lack of Efficacy|0|||
161141892|NCT02158533|581904225|FG005|Stage 1|Lack of Efficacy|0|||
161141893|NCT02158533|581904220|FG000|Stage 1|Lost to Follow-up|3|||
161141894|NCT02158533|581904221|FG001|Stage 1|Lost to Follow-up|1|||
161141895|NCT02158533|581904222|FG002|Stage 1|Lost to Follow-up|0|||
161141896|NCT02158533|581904223|FG003|Stage 1|Lost to Follow-up|0|||
161141897|NCT02158533|581904224|FG004|Stage 1|Lost to Follow-up|0|||
161141898|NCT02158533|581904225|FG005|Stage 1|Lost to Follow-up|0|||
161141899|NCT02158533|581904220|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
161141900|NCT02158533|581904221|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
161141901|NCT02158533|581904222|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
161141902|NCT02158533|581904223|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
161141903|NCT02158533|581904224|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
161141904|NCT02158533|581904225|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
161141905|NCT02158533|581904220|FG000|Stage 1|Non-compliance with study visits|1|||
161141906|NCT02158533|581904221|FG001|Stage 1|Non-compliance with study visits|0|||
161141907|NCT02158533|581904222|FG002|Stage 1|Non-compliance with study visits|0|||
161141908|NCT02158533|581904223|FG003|Stage 1|Non-compliance with study visits|0|||
161141909|NCT02158533|581904224|FG004|Stage 1|Non-compliance with study visits|0|||
161141910|NCT02158533|581904225|FG005|Stage 1|Non-compliance with study visits|0|||
161141911|NCT02158533|581904220|FG000|Stage 2|Adverse Event|0|||
161141912|NCT02158533|581904221|FG001|Stage 2|Adverse Event|0|||
161141913|NCT02158533|581904222|FG002|Stage 2|Adverse Event|0|||
161141914|NCT02158533|581904223|FG003|Stage 2|Adverse Event|0|||
161141915|NCT02158533|581904224|FG004|Stage 2|Adverse Event|0|||
161141916|NCT02158533|581904225|FG005|Stage 2|Adverse Event|1|||
161141917|NCT02158533|581904220|FG000|Stage 2|Lack of Efficacy|0|||
160861498|NCT02234843|580885267|FG007|Overall Study|Physician Decision|1|||
161141918|NCT02158533|581904221|FG001|Stage 2|Lack of Efficacy|0|||
161141919|NCT02158533|581904222|FG002|Stage 2|Lack of Efficacy|0|||
161141920|NCT02158533|581904223|FG003|Stage 2|Lack of Efficacy|0|||
161141921|NCT02158533|581904224|FG004|Stage 2|Lack of Efficacy|1|||
161141922|NCT02158533|581904225|FG005|Stage 2|Lack of Efficacy|0|||
161141923|NCT02158533|581904220|FG000|Stage 2|Lost to Follow-up|0|||
161141924|NCT02158533|581904221|FG001|Stage 2|Lost to Follow-up|0|||
161141925|NCT02158533|581904222|FG002|Stage 2|Lost to Follow-up|0|||
161141926|NCT02158533|581904223|FG003|Stage 2|Lost to Follow-up|1|||
161141927|NCT02158533|581904224|FG004|Stage 2|Lost to Follow-up|1|||
161141928|NCT02158533|581904225|FG005|Stage 2|Lost to Follow-up|2|||
161141929|NCT02158533|581904220|FG000|Stage 2|Withdrawal by Subject|0|||
161141930|NCT02158533|581904221|FG001|Stage 2|Withdrawal by Subject|0|||
161141931|NCT02158533|581904222|FG002|Stage 2|Withdrawal by Subject|0|||
161141932|NCT02158533|581904223|FG003|Stage 2|Withdrawal by Subject|0|||
161141933|NCT02158533|581904224|FG004|Stage 2|Withdrawal by Subject|1|||
160861499|NCT02234843|580885268|FG008|Overall Study|Physician Decision|0|||
160861500|NCT02234843|580885269|FG009|Overall Study|Physician Decision|0|||
160861501|NCT02234843|580885260|FG000|Overall Study|Adverse Event|5|||
160861502|NCT02234843|580885261|FG001|Overall Study|Adverse Event|1|||
160861503|NCT02234843|580885262|FG002|Overall Study|Adverse Event|1|||
160861504|NCT02234843|580885263|FG003|Overall Study|Adverse Event|3|||
160861505|NCT02234843|580885264|FG004|Overall Study|Adverse Event|2|||
160861506|NCT02234843|580885265|FG005|Overall Study|Adverse Event|1|||
160861507|NCT02234843|580885266|FG006|Overall Study|Adverse Event|0|||
160861508|NCT02234843|580885267|FG007|Overall Study|Adverse Event|0|||
160861509|NCT02234843|580885268|FG008|Overall Study|Adverse Event|1|||
160861510|NCT02234843|580885269|FG009|Overall Study|Adverse Event|0|||
160861511|NCT02234843|580885260|FG000|Overall Study|Non-compliance with study drug|1|||
160861512|NCT02234843|580885261|FG001|Overall Study|Non-compliance with study drug|0|||
160861513|NCT02234843|580885262|FG002|Overall Study|Non-compliance with study drug|0|||
160861514|NCT02234843|580885263|FG003|Overall Study|Non-compliance with study drug|0|||
160861515|NCT02234843|580885264|FG004|Overall Study|Non-compliance with study drug|0|||
160861516|NCT02234843|580885265|FG005|Overall Study|Non-compliance with study drug|1|||
160861517|NCT02234843|580885266|FG006|Overall Study|Non-compliance with study drug|1|||
160861518|NCT02234843|580885267|FG007|Overall Study|Non-compliance with study drug|0|||
160861519|NCT02234843|580885268|FG008|Overall Study|Non-compliance with study drug|0|||
160861520|NCT02234843|580885269|FG009|Overall Study|Non-compliance with study drug|0|||
160861521|NCT02234843|580885260|FG000|Overall Study|Lost to Follow-up|0|||
160861522|NCT02234843|580885261|FG001|Overall Study|Lost to Follow-up|1|||
160861523|NCT02234843|580885262|FG002|Overall Study|Lost to Follow-up|0|||
160861524|NCT02234843|580885263|FG003|Overall Study|Lost to Follow-up|0|||
160861525|NCT02234843|580885264|FG004|Overall Study|Lost to Follow-up|0|||
160861526|NCT02234843|580885265|FG005|Overall Study|Lost to Follow-up|0|||
160861527|NCT02234843|580885266|FG006|Overall Study|Lost to Follow-up|1|||
160861528|NCT02234843|580885267|FG007|Overall Study|Lost to Follow-up|0|||
160861529|NCT02234843|580885268|FG008|Overall Study|Lost to Follow-up|0|||
160861530|NCT02234843|580885269|FG009|Overall Study|Lost to Follow-up|0|||
160861531|NCT02331134|580885276|FG000|Overall Study|Withdrawal by Subject|1|||
160861532|NCT04825574|580885280|FG000|Overall Study|Commercial treatment became available|1|||
160861533|NCT04825574|580885280|FG000|Overall Study|Disease progression|1|||
160861534|NCT05967260|580885281|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
161256526|NCT01917968|582316472|FG001|Overall Study|Subject Relocation|1|||
161256527|NCT01917968|582316471|FG000|Overall Study|36M Missed Visit|3|||
161256528|NCT01917968|582316472|FG001|Overall Study|36M Missed Visit|2|||
161256529|NCT01917968|582316471|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
161256530|NCT01917968|582316472|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
161256531|NCT01917968|582316471|FG000|Overall Study|Change in Family Circumstances|0|||
161256532|NCT01917968|582316472|FG001|Overall Study|Change in Family Circumstances|1|||
161256533|NCT01917968|582316471|FG000|Overall Study|No Data Available|0|||
161256534|NCT01917968|582316472|FG001|Overall Study|No Data Available|2|||
161256535|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
161256536|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
161256537|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
160910799|NCT01599234|581070032|FG000|Overall Study|Pregnancy|0|||
160910800|NCT01599234|581070033|FG001|Overall Study|Pregnancy|1|||
160910801|NCT02551731|581070035|FG000|Overall Study|Withdrawal by Subject|2|||
160910802|NCT02128113|581070036|FG000|Overall Study|Withdrawal by Subject|3|||
160910803|NCT02128113|581070037|FG001|Overall Study|Withdrawal by Subject|1|||
160910804|NCT02128113|581070038|FG002|Overall Study|Withdrawal by Subject|0|||
160910805|NCT02128113|581070036|FG000|Overall Study|Protocol Violation|0|||
160910806|NCT02128113|581070037|FG001|Overall Study|Protocol Violation|1|||
160910807|NCT02128113|581070038|FG002|Overall Study|Protocol Violation|0|||
160910808|NCT02128113|581070036|FG000|Overall Study|Surgery cancelled|0|||
160910809|NCT02128113|581070037|FG001|Overall Study|Surgery cancelled|1|||
160910810|NCT02128113|581070038|FG002|Overall Study|Surgery cancelled|0|||
160910811|NCT02128113|581070036|FG000|Overall Study|Adverse Event|0|||
160910812|NCT02128113|581070037|FG001|Overall Study|Adverse Event|0|||
160910813|NCT02128113|581070038|FG002|Overall Study|Adverse Event|1|||
160910814|NCT01750242|581070039|FG000|Overall Study|Unreadable Images|3|||
160910815|NCT03765918|581070040|FG000|Overall Study|Death|109|||
160910816|NCT03765918|581070041|FG001|Overall Study|Death|127|||
160910817|NCT03765918|581070040|FG000|Overall Study|Lost to Follow-up|2|||
160910818|NCT03765918|581070041|FG001|Overall Study|Lost to Follow-up|3|||
160910819|NCT03765918|581070040|FG000|Overall Study|Withdrawal by Subject|12|||
160910820|NCT03765918|581070041|FG001|Overall Study|Withdrawal by Subject|16|||
160910821|NCT03765918|581070040|FG000|Overall Study|Participants Ongoing|240|||
160910822|NCT03765918|581070041|FG001|Overall Study|Participants Ongoing|205|||
160910823|NCT04202965|581070042|FG000|Overall Study|Adverse Event|3|||
160910824|NCT04202965|581070042|FG000|Overall Study|Did not meet inclusion criteria|1|||
160910825|NCT02969369|581070043|FG000|Study|Adverse Event|1|||
160910826|NCT02969369|581070044|FG001|Study|Adverse Event|6|||
161256538|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
161256539|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
160861535|NCT05967260|580885282|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
160861536|NCT00992108|580887748|FG000|Overall Study|Lost to Follow-up|0|||
160861537|NCT00992108|580887749|FG001|Overall Study|Lost to Follow-up|1|||
160861538|NCT04639245|580887750|FG000|Overall Study|Death|1|||
160861539|NCT02419001|580887753|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
160861540|NCT02419001|580887754|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
160861541|NCT02851615|580887755|FG000|Overall Study|Cognitive Issue|1|||
160861542|NCT02851615|580887756|FG001|Overall Study|Cognitive Issue|0|||
160861543|NCT02851615|580887755|FG000|Overall Study|Lost to Follow-up|0|||
160861544|NCT02851615|580887756|FG001|Overall Study|Lost to Follow-up|4|||
160861545|NCT00371150|580887758|FG000|Overall Study|Lost to Follow-up|3|||
160861546|NCT00371150|580887759|FG001|Overall Study|Lost to Follow-up|2|||
160861547|NCT02151058|580887761|FG000|Overall Study|Withdrawal by Subject|1|||
160861548|NCT02151058|580887762|FG001|Overall Study|Withdrawal by Subject|1|||
160861549|NCT02151058|580887763|FG002|Overall Study|Withdrawal by Subject|3|||
160861550|NCT02151058|580887761|FG000|Overall Study|Lost to Follow-up|1|||
160861551|NCT02151058|580887762|FG001|Overall Study|Lost to Follow-up|0|||
160861552|NCT02151058|580887763|FG002|Overall Study|Lost to Follow-up|2|||
160861553|NCT00321620|580887767|FG000|Overall Study|Death|269|||
160861554|NCT00321620|580887768|FG001|Overall Study|Death|294|||
160861555|NCT00321620|580887767|FG000|Overall Study|Withdrawal by Subject|164|||
160861556|NCT00321620|580887768|FG001|Overall Study|Withdrawal by Subject|147|||
160861557|NCT00321620|580887767|FG000|Overall Study|Disease progression|113|||
160861558|NCT00321620|580887768|FG001|Overall Study|Disease progression|117|||
160861559|NCT00321620|580887767|FG000|Overall Study|Adverse Event|43|||
160861560|NCT00321620|580887768|FG001|Overall Study|Adverse Event|56|||
160861561|NCT00321620|580887767|FG000|Overall Study|Lost to Follow-up|13|||
160861562|NCT00321620|580887768|FG001|Overall Study|Lost to Follow-up|9|||
160861563|NCT00321620|580887767|FG000|Overall Study|Physician Decision|4|||
161256540|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
161256541|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
161256542|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
161256543|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
161256544|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
161256545|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
161256546|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
161256547|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
161256548|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
160995284|NCT03568318|581370899|FG002|Overall Study|Ongoing at Time of Analysis|2|||
160995285|NCT03568318|581370900|FG003|Overall Study|Ongoing at Time of Analysis|1|||
160995286|NCT03568318|581370901|FG004|Overall Study|Ongoing at Time of Analysis|0|||
160995287|NCT03568318|581370902|FG005|Overall Study|Ongoing at Time of Analysis|0|||
160995288|NCT01249092|581370904|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
160995289|NCT01249092|581370904|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
160995290|NCT03518112|581370905|FG000|Overall Study|Withdrawal by Subject|1|||
160995291|NCT00420316|581370911|FG000|Overall Study|Withdrawal by Subject|0|||
160995292|NCT00420316|581370912|FG001|Overall Study|Withdrawal by Subject|1|||
160995293|NCT00420316|581370911|FG000|Overall Study|Lost to Follow-up|12|||
160995294|NCT00420316|581370912|FG001|Overall Study|Lost to Follow-up|8|||
160995295|NCT03546907|581370913|FG000|Overall Study|Lack of Efficacy|1|||
160995296|NCT03546907|581370914|FG001|Overall Study|Lack of Efficacy|1|||
160995297|NCT03546907|581370913|FG000|Overall Study|Withdrawal by Subject|8|||
160995298|NCT03546907|581370914|FG001|Overall Study|Withdrawal by Subject|9|||
160995299|NCT03546907|581370913|FG000|Overall Study|Adverse events (AEs)|7|||
160995300|NCT03546907|581370914|FG001|Overall Study|Adverse events (AEs)|10|||
160995301|NCT03546907|581370913|FG000|Overall Study|Other-unspecified|1|||
160995302|NCT03546907|581370914|FG001|Overall Study|Other-unspecified|1|||
160995303|NCT03720210|581370915|FG000|Overall Study|Lost to Follow-up|1|||
160995304|NCT04033432|581370916|FG000|Overall Study|Progressive Disease|8|||
160995305|NCT04033432|581370916|FG000|Overall Study|Adverse Event|4|||
160995306|NCT04033432|581370916|FG000|Overall Study|Death|1|||
160995307|NCT02274493|581370922|FG000|Overall Study|Withdrawal by Subject|1|||
160995308|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995309|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
160995310|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995311|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995312|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995313|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995314|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995315|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995316|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995317|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995318|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995319|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995320|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
160995321|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Death|0|||
160995322|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Death|0|||
160995323|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Death|0|||
160995324|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Death|1|||
160995325|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Death|0|||
160995326|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Death|0|||
160995327|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Death|0|||
160995328|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Death|0|||
160995329|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Death|0|||
160995330|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Death|0|||
160995331|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Death|0|||
160995332|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Death|0|||
160995333|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Death|0|||
160995334|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995335|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
160995336|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
161256549|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
161256550|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
161256551|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
161256552|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
160995337|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
160995338|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
160995339|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161256553|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
160995340|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995341|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995342|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995343|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995344|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995345|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
161256554|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
161256555|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
161256556|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
160995346|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
160995347|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995348|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
160995349|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
161256557|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
161256558|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
161256559|NCT01435928|582316474|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
161256560|NCT01435928|582316475|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
161256561|NCT01435928|582316476|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
161256562|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
161256563|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
161256564|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
160995350|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995351|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995352|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995353|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995354|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995355|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995356|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995357|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995358|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995359|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
160995360|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995361|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995362|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
160995363|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995364|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161256565|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
161256566|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
161256567|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
161256568|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
161256569|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
161256570|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
161256571|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
160910827|NCT02969369|581070043|FG000|Study|Lack of Efficacy|0|||
160910828|NCT02969369|581070044|FG001|Study|Lack of Efficacy|1|||
160910829|NCT02969369|581070043|FG000|Study|Lost to Follow-up|0|||
160910830|NCT02969369|581070044|FG001|Study|Lost to Follow-up|1|||
160910831|NCT02969369|581070043|FG000|Study|Withdrawal by Subject|3|||
160910832|NCT02969369|581070044|FG001|Study|Withdrawal by Subject|5|||
160910833|NCT02969369|581070043|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
160910834|NCT02969369|581070044|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
160910835|NCT02969369|581070043|FG000|Double-blind Period|Adverse Event|1|||
160910836|NCT02969369|581070044|FG001|Double-blind Period|Adverse Event|5|||
160910837|NCT02969369|581070043|FG000|Double-blind Period|Lost to Follow-up|0|||
160910838|NCT02969369|581070044|FG001|Double-blind Period|Lost to Follow-up|1|||
160910839|NCT02969369|581070043|FG000|Double-blind Period|Withdrawal by Subject|2|||
160995365|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995366|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995367|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995368|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995369|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995370|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995371|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
160995372|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
161256572|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
160910840|NCT02969369|581070044|FG001|Double-blind Period|Withdrawal by Subject|3|||
160910841|NCT02969369|581070043|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
160910842|NCT02969369|581070044|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
160995373|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
160910843|NCT02969369|581070043|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
160910844|NCT02969369|581070044|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
160910845|NCT02969369|581070043|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
160910846|NCT02969369|581070044|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
160910847|NCT02969369|581070043|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
160910848|NCT02969369|581070044|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
160910849|NCT01980992|581070047|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
160910850|NCT01980992|581070048|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
160910851|NCT01980992|581070047|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
160910852|NCT01980992|581070048|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
160910853|NCT01980992|581070047|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
160910854|NCT01980992|581070048|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
160910855|NCT01980992|581070047|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
160910856|NCT01980992|581070048|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
160910857|NCT01980992|581070047|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
160910858|NCT01980992|581070048|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
160910859|NCT01980992|581070047|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
160910860|NCT01980992|581070048|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
160910861|NCT00299975|581070049|FG000|Overall Study|Adverse Event|1|||
160910862|NCT00299975|581070050|FG001|Overall Study|Adverse Event|0|||
160910863|NCT00299975|581070051|FG002|Overall Study|Adverse Event|2|||
160910864|NCT00299975|581070049|FG000|Overall Study|Pregnancy|0|||
160910865|NCT00299975|581070050|FG001|Overall Study|Pregnancy|0|||
160910866|NCT00299975|581070051|FG002|Overall Study|Pregnancy|1|||
160910867|NCT00299975|581070049|FG000|Overall Study|Lack of Efficacy|1|||
160910868|NCT00299975|581070050|FG001|Overall Study|Lack of Efficacy|0|||
160910869|NCT00299975|581070051|FG002|Overall Study|Lack of Efficacy|1|||
160910870|NCT00299975|581070049|FG000|Overall Study|Lost to Follow-up|1|||
160910871|NCT00299975|581070050|FG001|Overall Study|Lost to Follow-up|0|||
160910872|NCT00299975|581070051|FG002|Overall Study|Lost to Follow-up|0|||
160910873|NCT00299975|581070049|FG000|Overall Study|Withdrawal by Subject|0|||
160910874|NCT00299975|581070050|FG001|Overall Study|Withdrawal by Subject|1|||
160910875|NCT00299975|581070051|FG002|Overall Study|Withdrawal by Subject|3|||
160910876|NCT00299975|581070049|FG000|Overall Study|Physician Decision|0|||
160910877|NCT00299975|581070050|FG001|Overall Study|Physician Decision|0|||
160910878|NCT00299975|581070051|FG002|Overall Study|Physician Decision|1|||
160910879|NCT01169493|581070055|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
160910880|NCT01169493|581070056|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
160910881|NCT01169493|581070057|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
160910882|NCT01169493|581070058|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
160910883|NCT01169493|581070059|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
160910884|NCT01169493|581070060|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
160910885|NCT01169493|581070055|FG000|Period 3 (6 Months)|Adverse Event|0|||
160910886|NCT01169493|581070056|FG001|Period 3 (6 Months)|Adverse Event|1|||
160910887|NCT01169493|581070057|FG002|Period 3 (6 Months)|Adverse Event|0|||
160910888|NCT01169493|581070058|FG003|Period 3 (6 Months)|Adverse Event|0|||
160910889|NCT01169493|581070059|FG004|Period 3 (6 Months)|Adverse Event|0|||
160910890|NCT01169493|581070060|FG005|Period 3 (6 Months)|Adverse Event|0|||
160910891|NCT01169493|581070055|FG000|Period 3 (6 Months)|Physician Decision|0|||
160910892|NCT01169493|581070056|FG001|Period 3 (6 Months)|Physician Decision|1|||
160910893|NCT01169493|581070057|FG002|Period 3 (6 Months)|Physician Decision|1|||
160910894|NCT01169493|581070058|FG003|Period 3 (6 Months)|Physician Decision|0|||
160910895|NCT01169493|581070059|FG004|Period 3 (6 Months)|Physician Decision|0|||
160910896|NCT01169493|581070060|FG005|Period 3 (6 Months)|Physician Decision|0|||
160910897|NCT05228132|581070061|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
160910898|NCT05228132|581070061|FG000|Overall Study|Adverse Event|3|||
160910899|NCT05228132|581070061|FG000|Overall Study|Lost to Follow-up|1|||
160910900|NCT05228132|581070061|FG000|Overall Study|Arteriovenous-fistula mature|1|||
160910901|NCT00211809|581070070|FG000|Overall Study|Lack of Efficacy|1|||
160910902|NCT00211809|581070070|FG000|Overall Study|Lost to Follow-up|2|||
160910903|NCT00211809|581070070|FG000|Overall Study|Pregnancy|1|||
160910904|NCT00211809|581070070|FG000|Overall Study|side effects|2|||
160910905|NCT00036270|581070072|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
160910906|NCT00036270|581070073|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
160910907|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
161339226|NCT01232283|582630426|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160910908|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
160910909|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
160910910|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
160995374|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
160995375|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
161339227|NCT01232283|582630427|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161141934|NCT02158533|581904225|FG005|Stage 2|Withdrawal by Subject|2|||
161141935|NCT02158533|581904220|FG000|Stage 2|Physician Decision|0|||
161141936|NCT02158533|581904221|FG001|Stage 2|Physician Decision|0|||
161141937|NCT02158533|581904222|FG002|Stage 2|Physician Decision|0|||
161141938|NCT02158533|581904223|FG003|Stage 2|Physician Decision|0|||
161141939|NCT02158533|581904224|FG004|Stage 2|Physician Decision|1|||
161141940|NCT02158533|581904225|FG005|Stage 2|Physician Decision|0|||
161141941|NCT02158533|581904220|FG000|Stage 2|Pregnancy|0|||
161141942|NCT02158533|581904221|FG001|Stage 2|Pregnancy|0|||
161141943|NCT02158533|581904222|FG002|Stage 2|Pregnancy|0|||
161141944|NCT02158533|581904223|FG003|Stage 2|Pregnancy|1|||
161141945|NCT02158533|581904224|FG004|Stage 2|Pregnancy|0|||
161141946|NCT02158533|581904225|FG005|Stage 2|Pregnancy|0|||
161141947|NCT02158533|581904220|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
161141948|NCT02158533|581904221|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
161141949|NCT02158533|581904222|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
161141950|NCT02158533|581904223|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
161141951|NCT02158533|581904224|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
161141952|NCT02158533|581904225|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
161141953|NCT02158533|581904220|FG000|Stage 2|Non-adherence with study visits|0|||
161141954|NCT02158533|581904221|FG001|Stage 2|Non-adherence with study visits|0|||
160910911|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
160910912|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
160910913|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Other|277|||
160910914|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Other|288|||
160910915|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
160910916|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
160910917|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
160910918|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
160910919|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
160910920|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
160910921|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
160910922|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
160910923|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
160910924|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
160910925|NCT00036270|581070072|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
160910926|NCT00036270|581070073|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
160910927|NCT01370356|581070074|FG000|Overall Study|Death|1|||
160910928|NCT01370356|581070075|FG001|Overall Study|Death|0|||
160910929|NCT01370356|581070074|FG000|Overall Study|Lack of Efficacy|6|||
160910930|NCT01370356|581070075|FG001|Overall Study|Lack of Efficacy|28|||
160910931|NCT01370356|581070074|FG000|Overall Study|Lost to Follow-up|76|||
160910932|NCT01370356|581070075|FG001|Overall Study|Lost to Follow-up|81|||
160910933|NCT01370356|581070074|FG000|Overall Study|Withdrawal by Subject|54|||
160910934|NCT01370356|581070075|FG001|Overall Study|Withdrawal by Subject|59|||
160910935|NCT01370356|581070074|FG000|Overall Study|Reason not specified|39|||
160910936|NCT01370356|581070075|FG001|Overall Study|Reason not specified|43|||
160910937|NCT01370356|581070074|FG000|Overall Study|Protocol Violation|3|||
160910938|NCT01370356|581070075|FG001|Overall Study|Protocol Violation|3|||
160910939|NCT01370356|581070074|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
160910940|NCT01370356|581070075|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
160910941|NCT01370356|581070074|FG000|Overall Study|AE Not Related to Study Drug|1|||
160910942|NCT01370356|581070075|FG001|Overall Study|AE Not Related to Study Drug|4|||
160910943|NCT01218243|581070076|FG000|Overall Study|Lack of Efficacy|1|||
160910944|NCT01218243|581070077|FG001|Overall Study|Lack of Efficacy|1|||
160910945|NCT01218243|581070076|FG000|Overall Study|Lost to Follow-up|3|||
160910946|NCT01218243|581070077|FG001|Overall Study|Lost to Follow-up|3|||
160910947|NCT01218243|581070076|FG000|Overall Study|Protocol Violation|5|||
160910948|NCT01218243|581070077|FG001|Overall Study|Protocol Violation|10|||
160910949|NCT00799422|581070081|FG000|First Week of Wear|Lost to Follow-up|0|||
160910950|NCT00799422|581070082|FG001|First Week of Wear|Lost to Follow-up|0|||
160910951|NCT00799422|581070083|FG002|First Week of Wear|Lost to Follow-up|1|||
160910952|NCT00799422|581070084|FG003|First Week of Wear|Lost to Follow-up|0|||
160910953|NCT00799422|581070085|FG004|First Week of Wear|Lost to Follow-up|0|||
161141955|NCT02158533|581904222|FG002|Stage 2|Non-adherence with study visits|0|||
161141956|NCT02158533|581904223|FG003|Stage 2|Non-adherence with study visits|0|||
161141957|NCT02158533|581904224|FG004|Stage 2|Non-adherence with study visits|0|||
161141958|NCT02158533|581904225|FG005|Stage 2|Non-adherence with study visits|1|||
161141959|NCT00384956|581904228|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
161141960|NCT00881205|581904237|FG000|Overall Study|Adverse Event|8|||
161141961|NCT00881205|581904238|FG001|Overall Study|Adverse Event|3|||
160910954|NCT00799422|581070086|FG005|First Week of Wear|Lost to Follow-up|0|||
160910955|NCT00799422|581070081|FG000|First Week of Wear|Adverse Event|0|||
160910956|NCT00799422|581070082|FG001|First Week of Wear|Adverse Event|0|||
160910957|NCT00799422|581070083|FG002|First Week of Wear|Adverse Event|0|||
160995376|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
160995377|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
160910958|NCT00799422|581070084|FG003|First Week of Wear|Adverse Event|1|||
160910959|NCT00799422|581070085|FG004|First Week of Wear|Adverse Event|0|||
160910960|NCT00799422|581070086|FG005|First Week of Wear|Adverse Event|0|||
160910961|NCT01496612|581070088|FG000|1st Intervention|Adverse Event|1|||
160910962|NCT01496612|581070089|FG001|1st Intervention|Adverse Event|0|||
160910963|NCT01496612|581070088|FG000|1st Intervention|Withdrawal by Subject|1|||
160910964|NCT01496612|581070089|FG001|1st Intervention|Withdrawal by Subject|0|||
160910965|NCT00291577|581070090|FG000|Overall Study|Adverse Event|1|||
160910966|NCT00291577|581070090|FG000|Overall Study|Other|4|||
160910967|NCT00291577|581070090|FG000|Overall Study|Withdrawal by Subject|2|||
160910968|NCT00291577|581070090|FG000|Overall Study|Lack of Efficacy|14|||
160910969|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
160910970|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
160910971|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
160910972|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
160910973|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
160910974|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
160910975|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
160910976|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
160910977|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
160910978|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
160910979|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
160910980|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
160910981|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
160910982|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
160910983|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
160910984|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
160910985|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
160910986|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
160910987|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
160910988|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
160910989|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
160910990|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
160910991|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
160910992|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
160910993|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
160910994|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
160910995|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
160910996|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160910997|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160910998|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160910999|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911000|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911001|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911002|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911003|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911004|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911005|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911006|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911007|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911008|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911009|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911010|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911011|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911012|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911013|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911014|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911015|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911016|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911017|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160995378|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995379|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
161141962|NCT00881205|581904237|FG000|Overall Study|Withdrawal by Subject|1|||
161141963|NCT00881205|581904238|FG001|Overall Study|Withdrawal by Subject|2|||
160911018|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
161141964|NCT00881205|581904237|FG000|Overall Study|Lost to Follow-up|0|||
160911019|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911020|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
160911021|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
161141965|NCT00881205|581904238|FG001|Overall Study|Lost to Follow-up|1|||
160911022|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
160911023|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911024|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911025|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911026|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911027|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911028|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911029|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911030|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911031|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911032|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911033|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911034|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911035|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911036|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911037|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911038|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911039|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911040|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911041|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911042|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911043|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911044|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911045|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911046|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
160911047|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
160911048|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
160911049|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911050|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911051|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911052|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911053|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911054|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911055|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911056|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911057|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911058|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911059|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911060|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911061|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911062|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911063|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911064|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911065|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911066|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911067|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911068|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911069|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911070|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911071|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911072|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
160911073|NCT03129100|581070091|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911074|NCT03129100|581070092|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
160911075|NCT03129100|581070093|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911076|NCT03129100|581070094|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911077|NCT03129100|581070095|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911078|NCT03129100|581070096|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911079|NCT03129100|581070097|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911080|NCT03129100|581070098|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911081|NCT03129100|581070099|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911082|NCT03129100|581070100|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911083|NCT03129100|581070101|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911084|NCT03129100|581070102|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911085|NCT03129100|581070103|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911086|NCT03129100|581070104|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911087|NCT03129100|581070105|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911088|NCT03129100|581070106|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911089|NCT03129100|581070107|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911090|NCT03129100|581070108|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911091|NCT03129100|581070109|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911092|NCT03129100|581070110|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911093|NCT03129100|581070111|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911094|NCT03129100|581070112|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911095|NCT03129100|581070113|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911096|NCT03129100|581070114|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911097|NCT03129100|581070115|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911098|NCT03129100|581070116|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
160911099|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160995380|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160911100|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911101|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
160911102|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
160911103|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911104|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
160911105|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911106|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911107|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911108|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911109|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911110|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911111|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911112|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911113|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911114|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911115|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911116|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911117|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911118|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911119|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911120|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911121|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911122|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911123|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911124|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
160911125|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Death|0|||
160911126|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Death|0|||
160911127|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Death|1|||
160911128|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Death|0|||
160911129|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Death|0|||
160911130|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Death|0|||
160911131|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Death|0|||
160911132|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Death|0|||
160911133|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Death|0|||
160911134|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Death|0|||
160911135|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Death|0|||
160911136|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Death|0|||
160911137|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Death|0|||
160911138|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Death|0|||
160911139|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Death|0|||
160911140|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Death|0|||
160911141|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Death|0|||
160911142|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Death|0|||
160911143|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Death|0|||
160911144|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Death|0|||
160995381|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995382|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995383|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995384|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995385|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
160995386|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995387|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995388|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995389|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
161256573|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
160911145|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Death|0|||
160911146|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Death|0|||
160911147|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Death|0|||
160911148|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Death|0|||
160911149|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Death|0|||
160911150|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Death|0|||
160911151|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911152|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911153|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
160911154|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
160911155|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
160911156|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
160911157|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
160911158|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911159|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911160|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911161|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911162|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911163|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911164|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911165|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911166|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911167|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911168|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
161339228|NCT01232283|582630428|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
160911169|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911170|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911171|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911172|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911173|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911174|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911175|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911176|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
160911177|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911178|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911179|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
160911180|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911181|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911182|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911183|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911184|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911185|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911186|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911187|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911188|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911189|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911190|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911191|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911192|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911193|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911194|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911195|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911196|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911197|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911198|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911199|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911200|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911201|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911202|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
160911203|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911204|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911205|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
160911206|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
161339229|NCT01232283|582630429|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
161256574|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
161256575|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
160911207|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911208|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911209|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911210|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911211|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911212|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911213|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911214|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911215|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911216|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911217|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911218|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911219|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911220|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911221|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911222|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911223|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911224|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911225|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911226|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911227|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911228|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
160911229|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911230|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911231|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
160911232|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911233|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911234|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911235|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911236|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911237|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911238|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911239|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911240|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911241|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911242|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911243|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911244|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911245|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911246|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911247|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911248|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911249|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911250|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911251|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911252|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911253|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911254|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
160911255|NCT03129100|581070091|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911256|NCT03129100|581070092|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911257|NCT03129100|581070093|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911258|NCT03129100|581070094|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911259|NCT03129100|581070095|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
160911260|NCT03129100|581070096|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
160911261|NCT03129100|581070097|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
160911262|NCT03129100|581070098|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911263|NCT03129100|581070099|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911264|NCT03129100|581070100|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
161256576|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
161256577|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
161256578|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
160995390|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
160995391|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995392|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995393|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995394|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995395|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995396|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995397|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995398|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
160995399|NCT04936035|581370927|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
160995400|NCT04936035|581370928|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995401|NCT04936035|581370929|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995402|NCT04936035|581370930|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995403|NCT04936035|581370931|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995404|NCT04936035|581370932|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995405|NCT04936035|581370933|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995406|NCT04936035|581370934|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995407|NCT04936035|581370935|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995408|NCT04936035|581370936|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995409|NCT04936035|581370937|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995410|NCT04936035|581370938|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995411|NCT04936035|581370939|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
160995412|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995413|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995414|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995415|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995416|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995417|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
160995418|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
160995419|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995420|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
160995421|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
160995422|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
160995423|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
160995424|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
160995425|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995426|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995427|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995428|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995429|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995430|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995431|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995432|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995433|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
160995434|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
160995435|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995436|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
160995437|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
160995438|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995439|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995440|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995441|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995442|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995443|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995444|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995445|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995446|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995447|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
160995448|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
160995449|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
160995450|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
161141966|NCT00881205|581904237|FG000|Overall Study|Administrative problems|1|||
160911265|NCT03129100|581070101|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911266|NCT03129100|581070102|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911267|NCT03129100|581070103|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911268|NCT03129100|581070104|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911269|NCT03129100|581070105|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911270|NCT03129100|581070106|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911271|NCT03129100|581070107|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911272|NCT03129100|581070108|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911273|NCT03129100|581070109|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911274|NCT03129100|581070110|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911275|NCT03129100|581070111|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911276|NCT03129100|581070112|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911277|NCT03129100|581070113|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911278|NCT03129100|581070114|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911279|NCT03129100|581070115|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911280|NCT03129100|581070116|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
160911281|NCT03129100|581070091|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911282|NCT03129100|581070092|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911283|NCT03129100|581070093|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911284|NCT03129100|581070094|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911285|NCT03129100|581070095|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911286|NCT03129100|581070096|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911287|NCT03129100|581070097|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911288|NCT03129100|581070098|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911289|NCT03129100|581070099|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911290|NCT03129100|581070100|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
160911291|NCT03129100|581070101|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911292|NCT03129100|581070102|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911293|NCT03129100|581070103|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911294|NCT03129100|581070104|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911295|NCT03129100|581070105|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911296|NCT03129100|581070106|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911297|NCT03129100|581070107|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911298|NCT03129100|581070108|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911299|NCT03129100|581070109|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911300|NCT03129100|581070110|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911301|NCT03129100|581070111|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911302|NCT03129100|581070112|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911303|NCT03129100|581070113|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911304|NCT03129100|581070114|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911305|NCT03129100|581070115|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911306|NCT03129100|581070116|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
160911307|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911308|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911309|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911310|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911311|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911312|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911313|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911314|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911315|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911316|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911317|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911318|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
160911319|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911320|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911321|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911322|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911323|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911324|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911325|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911326|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911327|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911328|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911329|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911330|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911331|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911332|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
160911333|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911334|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911335|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911336|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911337|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911338|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911339|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911340|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911341|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911342|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911343|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911344|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
160911345|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
160911346|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
160911347|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
160911348|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911349|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911350|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911351|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911352|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911353|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911354|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911355|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911356|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911357|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911358|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
160911359|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911360|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911361|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911362|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911363|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911364|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911365|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911366|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911367|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911368|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911369|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911370|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
160911371|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911372|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
160911373|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
160911374|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911375|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911376|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911377|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911378|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911379|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911380|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911381|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911382|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911383|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911384|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
160911385|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911386|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911387|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911388|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911389|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911390|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911391|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911392|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911393|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911394|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911395|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911396|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911397|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911398|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911399|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911400|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
160911401|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911402|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911403|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911404|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911405|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911406|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911407|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911408|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911409|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911410|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
160911411|NCT03129100|581070091|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911412|NCT03129100|581070092|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911413|NCT03129100|581070093|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911414|NCT03129100|581070094|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911415|NCT03129100|581070095|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911416|NCT03129100|581070096|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911417|NCT03129100|581070097|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911418|NCT03129100|581070098|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911419|NCT03129100|581070099|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911420|NCT03129100|581070100|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911421|NCT03129100|581070101|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911422|NCT03129100|581070102|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911423|NCT03129100|581070103|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
160911424|NCT03129100|581070104|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911425|NCT03129100|581070105|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
160911426|NCT03129100|581070106|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
160911427|NCT03129100|581070107|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911428|NCT03129100|581070108|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911429|NCT03129100|581070109|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911430|NCT03129100|581070110|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911431|NCT03129100|581070111|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911432|NCT03129100|581070112|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911433|NCT03129100|581070113|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911434|NCT03129100|581070114|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911435|NCT03129100|581070115|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911436|NCT03129100|581070116|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
160911437|NCT03129100|581070091|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911438|NCT03129100|581070092|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911439|NCT03129100|581070093|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911440|NCT03129100|581070094|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911441|NCT03129100|581070095|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911442|NCT03129100|581070096|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911443|NCT03129100|581070097|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911444|NCT03129100|581070098|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911445|NCT03129100|581070099|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911446|NCT03129100|581070100|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911447|NCT03129100|581070101|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911448|NCT03129100|581070102|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911449|NCT03129100|581070103|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911450|NCT03129100|581070104|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911451|NCT03129100|581070105|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911452|NCT03129100|581070106|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911453|NCT03129100|581070107|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160995451|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995452|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
160911454|NCT03129100|581070108|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
160911455|NCT03129100|581070109|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911456|NCT03129100|581070110|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
160911457|NCT03129100|581070111|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911458|NCT03129100|581070112|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911459|NCT03129100|581070113|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911460|NCT03129100|581070114|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911461|NCT03129100|581070115|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911462|NCT03129100|581070116|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
160911463|NCT03129100|581070091|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911464|NCT03129100|581070092|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911465|NCT03129100|581070093|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911466|NCT03129100|581070094|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911467|NCT03129100|581070095|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911468|NCT03129100|581070096|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911469|NCT03129100|581070097|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911470|NCT03129100|581070098|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911471|NCT03129100|581070099|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911472|NCT03129100|581070100|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911473|NCT03129100|581070101|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911474|NCT03129100|581070102|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911475|NCT03129100|581070103|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911476|NCT03129100|581070104|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911477|NCT03129100|581070105|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911478|NCT03129100|581070106|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911479|NCT03129100|581070107|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911480|NCT03129100|581070108|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911481|NCT03129100|581070109|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911482|NCT03129100|581070110|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911483|NCT03129100|581070111|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
160911484|NCT03129100|581070112|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911485|NCT03129100|581070113|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911486|NCT03129100|581070114|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911487|NCT03129100|581070115|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911488|NCT03129100|581070116|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
160911489|NCT03129100|581070091|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
160911490|NCT03129100|581070092|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
160911491|NCT03129100|581070093|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
160911492|NCT03129100|581070094|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
160911493|NCT03129100|581070095|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
160911494|NCT03129100|581070096|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
160911495|NCT03129100|581070097|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
160911496|NCT03129100|581070098|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
160911497|NCT03129100|581070099|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
160911498|NCT03129100|581070100|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
160911499|NCT03129100|581070101|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
160911500|NCT03129100|581070102|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
160911501|NCT03129100|581070103|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
160911502|NCT03129100|581070104|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
160911503|NCT03129100|581070105|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
160911504|NCT03129100|581070106|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
160911505|NCT03129100|581070107|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
160911506|NCT03129100|581070108|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
160911507|NCT03129100|581070109|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
160911508|NCT03129100|581070110|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
160911509|NCT03129100|581070111|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
160911510|NCT03129100|581070112|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
160911511|NCT03129100|581070113|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
160911512|NCT03129100|581070114|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
160911513|NCT03129100|581070115|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
160911514|NCT03129100|581070116|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
160911515|NCT03129100|581070091|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911516|NCT03129100|581070092|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911517|NCT03129100|581070093|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911518|NCT03129100|581070094|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911519|NCT03129100|581070095|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911520|NCT03129100|581070096|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911521|NCT03129100|581070097|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911522|NCT03129100|581070098|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911523|NCT03129100|581070099|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911524|NCT03129100|581070100|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
161141967|NCT00881205|581904238|FG001|Overall Study|Administrative problems|1|||
161141968|NCT00881205|581904237|FG000|Overall Study|Condition no longer requires drug|1|||
161141969|NCT00881205|581904238|FG001|Overall Study|Condition no longer requires drug|0|||
161141970|NCT02498652|581904243|FG000|Overall Study|Protocol Violation|0|||
161141971|NCT02498652|581904244|FG001|Overall Study|Protocol Violation|1|||
161141972|NCT01184989|581904249|FG000|Overall Study|Adverse Event|11|||
161141973|NCT01184989|581904249|FG000|Overall Study|Withdrawal by Subject|1|||
161141974|NCT00465569|581904250|FG000|Overall Study|persistent eczema during dose escalation|1|||
160995453|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995454|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995455|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995456|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
160995457|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995458|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
160995459|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995460|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995461|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995462|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995463|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
160995464|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Death|0|||
160911525|NCT03129100|581070101|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911526|NCT03129100|581070102|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911527|NCT03129100|581070103|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911528|NCT03129100|581070104|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911529|NCT03129100|581070105|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911530|NCT03129100|581070106|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911531|NCT03129100|581070107|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911532|NCT03129100|581070108|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911533|NCT03129100|581070109|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911534|NCT03129100|581070110|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911535|NCT03129100|581070111|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
160911536|NCT03129100|581070112|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911537|NCT03129100|581070113|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911538|NCT03129100|581070114|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911539|NCT03129100|581070115|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911540|NCT03129100|581070116|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
160911541|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
160911542|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
160911543|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
160911544|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
160911545|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
160911546|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
160995465|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Death|0|||
160995466|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Death|0|||
160995467|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Death|0|||
160995468|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Death|0|||
160995469|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Death|0|||
160995470|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Death|0|||
160995471|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Death|0|||
160995472|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Death|0|||
160911547|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
160911548|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
160911549|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
160911550|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
160911551|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
160911552|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
160911553|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
160911554|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
160911555|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
160911556|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
160911557|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
160911558|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
160911559|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
160911560|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
160995473|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Death|1|||
160995474|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Death|0|||
161141975|NCT00465569|581904251|FG001|Overall Study|persistent eczema during dose escalation|0|||
160995475|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Death|0|||
160995476|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Death|0|||
160995477|NCT04936035|581370927|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160911561|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
160911562|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
161256579|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
160911563|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
160911564|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
160911565|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
160911566|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
160911567|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911568|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911569|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911570|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911571|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911572|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911573|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911574|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911575|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911576|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911577|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911578|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911579|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911580|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911581|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911582|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911583|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911584|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911585|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911586|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911587|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911588|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911589|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911590|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
160911591|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
160911592|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
160911593|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911594|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911595|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911596|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911597|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911598|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911599|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911600|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911601|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911602|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911603|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911604|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911605|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911606|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911607|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911608|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911609|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911610|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911611|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911612|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911613|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911614|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911615|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
160911616|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
160911617|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
160911618|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
160911619|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911620|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911621|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911622|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911623|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911624|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911625|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911626|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911627|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911628|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911629|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911630|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911631|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911632|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911633|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911634|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911635|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911636|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911637|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911638|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911639|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911640|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911641|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911642|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911643|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
160911644|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
160911645|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911646|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911647|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911648|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911649|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911650|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911651|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911652|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911653|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911654|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911655|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911656|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911657|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911658|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911659|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911660|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911661|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911662|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911663|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911664|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911665|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911666|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911667|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911668|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911669|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
160911670|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
160911671|NCT03129100|581070091|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
160911672|NCT03129100|581070092|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
160911673|NCT03129100|581070093|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
160911674|NCT03129100|581070094|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
160911675|NCT03129100|581070095|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
160911676|NCT03129100|581070096|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
160911677|NCT03129100|581070097|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
160911678|NCT03129100|581070098|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
160911679|NCT03129100|581070099|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
160911680|NCT03129100|581070100|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
160911681|NCT03129100|581070101|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
160911682|NCT03129100|581070102|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
160911683|NCT03129100|581070103|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
160995478|NCT04936035|581370928|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995479|NCT04936035|581370929|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995480|NCT04936035|581370930|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995481|NCT04936035|581370931|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995482|NCT04936035|581370932|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
160995483|NCT04936035|581370933|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
161141976|NCT00482001|581904253|FG000|Overall Study|Protocol Violation|1|||
160911684|NCT03129100|581070104|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
160911685|NCT03129100|581070105|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
160911686|NCT03129100|581070106|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
160911687|NCT03129100|581070107|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
161141977|NCT00482001|581904254|FG001|Overall Study|Protocol Violation|1|||
160911688|NCT03129100|581070108|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
160911689|NCT03129100|581070109|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
160911690|NCT03129100|581070110|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
160911691|NCT03129100|581070111|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
160911692|NCT03129100|581070112|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
160911693|NCT03129100|581070113|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
160911694|NCT03129100|581070114|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
160911695|NCT03129100|581070115|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
160911696|NCT03129100|581070116|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
160911697|NCT03708328|581070119|FG000|Overall Study|Death|3|||
160911698|NCT03708328|581070120|FG001|Overall Study|Death|3|||
160911699|NCT03708328|581070121|FG002|Overall Study|Death|4|||
160911700|NCT03708328|581070122|FG003|Overall Study|Death|2|||
160911701|NCT03708328|581070123|FG004|Overall Study|Death|2|||
160911702|NCT03708328|581070124|FG005|Overall Study|Death|13|||
160911703|NCT03708328|581070125|FG006|Overall Study|Death|26|||
160911704|NCT03708328|581070126|FG007|Overall Study|Death|18|||
160911705|NCT03708328|581070127|FG008|Overall Study|Death|13|||
160911706|NCT03708328|581070128|FG009|Overall Study|Death|8|||
160911707|NCT03708328|581070119|FG000|Overall Study|Lost to Follow-up|0|||
160911708|NCT03708328|581070120|FG001|Overall Study|Lost to Follow-up|1|||
160911709|NCT03708328|581070121|FG002|Overall Study|Lost to Follow-up|0|||
160911710|NCT03708328|581070122|FG003|Overall Study|Lost to Follow-up|1|||
160911711|NCT03708328|581070123|FG004|Overall Study|Lost to Follow-up|0|||
160911712|NCT03708328|581070124|FG005|Overall Study|Lost to Follow-up|3|||
160911713|NCT03708328|581070125|FG006|Overall Study|Lost to Follow-up|3|||
160911714|NCT03708328|581070126|FG007|Overall Study|Lost to Follow-up|0|||
160911715|NCT03708328|581070127|FG008|Overall Study|Lost to Follow-up|0|||
160911716|NCT03708328|581070128|FG009|Overall Study|Lost to Follow-up|1|||
160911717|NCT03708328|581070119|FG000|Overall Study|Physician Decision|0|||
160911718|NCT03708328|581070120|FG001|Overall Study|Physician Decision|0|||
160911719|NCT03708328|581070121|FG002|Overall Study|Physician Decision|0|||
160911720|NCT03708328|581070122|FG003|Overall Study|Physician Decision|0|||
160911721|NCT03708328|581070123|FG004|Overall Study|Physician Decision|0|||
160911722|NCT03708328|581070124|FG005|Overall Study|Physician Decision|1|||
160911723|NCT03708328|581070125|FG006|Overall Study|Physician Decision|0|||
160911724|NCT03708328|581070126|FG007|Overall Study|Physician Decision|0|||
160911725|NCT03708328|581070127|FG008|Overall Study|Physician Decision|0|||
160911726|NCT03708328|581070128|FG009|Overall Study|Physician Decision|0|||
160911727|NCT03708328|581070119|FG000|Overall Study|Withdrawal by Subject|0|||
160911728|NCT03708328|581070120|FG001|Overall Study|Withdrawal by Subject|0|||
160911729|NCT03708328|581070121|FG002|Overall Study|Withdrawal by Subject|0|||
160911730|NCT03708328|581070122|FG003|Overall Study|Withdrawal by Subject|0|||
160911731|NCT03708328|581070123|FG004|Overall Study|Withdrawal by Subject|1|||
160911732|NCT03708328|581070124|FG005|Overall Study|Withdrawal by Subject|0|||
160911733|NCT03708328|581070125|FG006|Overall Study|Withdrawal by Subject|2|||
160911734|NCT03708328|581070126|FG007|Overall Study|Withdrawal by Subject|4|||
160911735|NCT03708328|581070127|FG008|Overall Study|Withdrawal by Subject|1|||
160911736|NCT03708328|581070128|FG009|Overall Study|Withdrawal by Subject|5|||
160911737|NCT03708328|581070119|FG000|Overall Study|Study Closed Locally|0|||
160911738|NCT03708328|581070120|FG001|Overall Study|Study Closed Locally|0|||
160911739|NCT03708328|581070121|FG002|Overall Study|Study Closed Locally|0|||
160911740|NCT03708328|581070122|FG003|Overall Study|Study Closed Locally|0|||
160911741|NCT03708328|581070123|FG004|Overall Study|Study Closed Locally|0|||
160911742|NCT03708328|581070124|FG005|Overall Study|Study Closed Locally|0|||
160911743|NCT03708328|581070125|FG006|Overall Study|Study Closed Locally|0|||
160911744|NCT03708328|581070126|FG007|Overall Study|Study Closed Locally|1|||
160995484|NCT04936035|581370934|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995485|NCT04936035|581370935|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160995486|NCT04936035|581370936|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
160995487|NCT04936035|581370937|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
160911745|NCT03708328|581070127|FG008|Overall Study|Study Closed Locally|0|||
160911746|NCT03708328|581070128|FG009|Overall Study|Study Closed Locally|0|||
160911747|NCT03708328|581070119|FG000|Overall Study|Study Ended By Sponsor|0|||
160911748|NCT03708328|581070120|FG001|Overall Study|Study Ended By Sponsor|0|||
160911749|NCT03708328|581070121|FG002|Overall Study|Study Ended By Sponsor|0|||
160911750|NCT03708328|581070122|FG003|Overall Study|Study Ended By Sponsor|0|||
160911751|NCT03708328|581070123|FG004|Overall Study|Study Ended By Sponsor|0|||
160911752|NCT03708328|581070124|FG005|Overall Study|Study Ended By Sponsor|1|||
160911753|NCT03708328|581070125|FG006|Overall Study|Study Ended By Sponsor|0|||
160911754|NCT03708328|581070126|FG007|Overall Study|Study Ended By Sponsor|1|||
160995488|NCT04936035|581370938|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160911755|NCT03708328|581070127|FG008|Overall Study|Study Ended By Sponsor|0|||
160911756|NCT03708328|581070128|FG009|Overall Study|Study Ended By Sponsor|0|||
160911757|NCT03708328|581070119|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911758|NCT03708328|581070120|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911759|NCT03708328|581070121|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911760|NCT03708328|581070122|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911761|NCT03708328|581070123|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911762|NCT03708328|581070124|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911763|NCT03708328|581070125|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911764|NCT03708328|581070126|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911765|NCT03708328|581070127|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
160911766|NCT03708328|581070128|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
160911767|NCT00571948|581070129|FG000|Overall Study|Lost to Follow-up|2|||
160911768|NCT00571948|581070130|FG001|Overall Study|Lost to Follow-up|0|||
160911769|NCT00571948|581070129|FG000|Overall Study|Withdrawal by Subject|1|||
160911770|NCT00571948|581070130|FG001|Overall Study|Withdrawal by Subject|2|||
160911771|NCT00571948|581070129|FG000|Overall Study|Protocol Violation|3|||
160911772|NCT00571948|581070130|FG001|Overall Study|Protocol Violation|3|||
160911773|NCT00571948|581070129|FG000|Overall Study|infant refused study meal|3|||
160911774|NCT00571948|581070130|FG001|Overall Study|infant refused study meal|4|||
160911775|NCT00571948|581070129|FG000|Overall Study|Parent were afraid of blood colection|2|||
160911776|NCT00571948|581070130|FG001|Overall Study|Parent were afraid of blood colection|5|||
160911777|NCT01845831|581070131|FG000|Inpatient Phase|Withdrawal by Subject|1|||
160911778|NCT01845831|581070132|FG001|Inpatient Phase|Withdrawal by Subject|1|||
160911779|NCT01845831|581070133|FG002|Inpatient Phase|Withdrawal by Subject|0|||
160911780|NCT01845831|581070134|FG003|Inpatient Phase|Withdrawal by Subject|0|||
160911781|NCT01845831|581070135|FG004|Inpatient Phase|Withdrawal by Subject|0|||
160911782|NCT02010775|581070137|FG000|Overall Study|Adverse Event|0|||
160911783|NCT02010775|581070138|FG001|Overall Study|Adverse Event|0|||
160911784|NCT02010775|581070139|FG002|Overall Study|Adverse Event|0|||
160911785|NCT02010775|581070140|FG003|Overall Study|Adverse Event|0|||
160911786|NCT02010775|581070141|FG004|Overall Study|Adverse Event|1|||
160911787|NCT02010775|581070137|FG000|Overall Study|Pregnancy|0|||
160911788|NCT02010775|581070138|FG001|Overall Study|Pregnancy|0|||
160911789|NCT02010775|581070139|FG002|Overall Study|Pregnancy|2|||
160911790|NCT02010775|581070140|FG003|Overall Study|Pregnancy|0|||
160911791|NCT02010775|581070141|FG004|Overall Study|Pregnancy|0|||
160911792|NCT02010775|581070137|FG000|Overall Study|Lost to Follow-up|2|||
160911793|NCT02010775|581070138|FG001|Overall Study|Lost to Follow-up|0|||
160911794|NCT02010775|581070139|FG002|Overall Study|Lost to Follow-up|0|||
160911795|NCT02010775|581070140|FG003|Overall Study|Lost to Follow-up|1|||
160911796|NCT02010775|581070141|FG004|Overall Study|Lost to Follow-up|1|||
160911797|NCT02010775|581070137|FG000|Overall Study|Personal Reasons|3|||
160911798|NCT02010775|581070138|FG001|Overall Study|Personal Reasons|3|||
160911799|NCT02010775|581070139|FG002|Overall Study|Personal Reasons|1|||
160911800|NCT02010775|581070140|FG003|Overall Study|Personal Reasons|2|||
160911801|NCT02010775|581070141|FG004|Overall Study|Personal Reasons|4|||
160911802|NCT02030041|581070143|FG000|Overall Study|Withdrawal by Subject|2|||
160911803|NCT02030041|581070144|FG001|Overall Study|Withdrawal by Subject|2|||
160911804|NCT02030041|581070145|FG002|Overall Study|Withdrawal by Subject|1|||
160911805|NCT02006719|581070146|FG000|Overall Study|Withdrawal by Subject|10|||
160911806|NCT02006719|581070147|FG001|Overall Study|Withdrawal by Subject|2|||
160911807|NCT02006719|581070146|FG000|Overall Study|Lost to Follow-up|5|||
160911808|NCT02006719|581070147|FG001|Overall Study|Lost to Follow-up|1|||
160911809|NCT02006719|581070146|FG000|Overall Study|Protocol Violation|2|||
160911810|NCT02006719|581070147|FG001|Overall Study|Protocol Violation|0|||
160911811|NCT02006719|581070146|FG000|Overall Study|Adverse Event|1|||
160911812|NCT02006719|581070147|FG001|Overall Study|Adverse Event|1|||
160911813|NCT02006719|581070146|FG000|Overall Study|Other/Unknown|0|||
160911814|NCT02006719|581070147|FG001|Overall Study|Other/Unknown|1|||
160911815|NCT00496054|581070153|FG000|Overall Study|Adverse Event|1|||
160911816|NCT00496054|581070153|FG000|Overall Study|Lost to Follow-up|7|||
160911817|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911818|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
160911819|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911820|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
160911821|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
160911822|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911823|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911824|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911825|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911826|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911827|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911828|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911829|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911830|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911831|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
160911832|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
160911833|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
160911834|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
160911835|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911836|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911837|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911838|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911839|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911840|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911841|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911842|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911843|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911844|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911845|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911846|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
160911847|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911848|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911849|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911850|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
160911851|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911852|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911853|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911854|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911855|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911856|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911857|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911858|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911859|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911860|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911861|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
160911862|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911863|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
160911864|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911865|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911866|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911867|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911868|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911869|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911870|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911871|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911872|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911873|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911874|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911875|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911876|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
160911877|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911878|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911879|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911880|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911881|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
160911882|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911883|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911884|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911885|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911886|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911887|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911888|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911889|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911890|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911891|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
160911892|NCT01737697|581070154|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911893|NCT01737697|581070155|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
160911894|NCT01737697|581070156|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
161256580|NCT01435928|582316474|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
161256581|NCT01435928|582316475|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
161256582|NCT01435928|582316476|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
161256583|NCT00576303|582316480|FG000|Dose Titration Period|Early withdrawal|17|||
160911895|NCT01737697|581070157|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
160911896|NCT01737697|581070158|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
160911897|NCT01737697|581070159|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911898|NCT01737697|581070160|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911899|NCT01737697|581070161|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911900|NCT01737697|581070162|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911901|NCT01737697|581070163|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911902|NCT01737697|581070164|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911903|NCT01737697|581070165|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911904|NCT01737697|581070166|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911905|NCT01737697|581070167|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911906|NCT01737697|581070168|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
160911907|NCT01737697|581070154|FG000|Subacute Phase|Adverse Event|0|||
160911908|NCT01737697|581070155|FG001|Subacute Phase|Adverse Event|0|||
160911909|NCT01737697|581070156|FG002|Subacute Phase|Adverse Event|0|||
160911910|NCT01737697|581070157|FG003|Subacute Phase|Adverse Event|0|||
160911911|NCT01737697|581070158|FG004|Subacute Phase|Adverse Event|0|||
160911912|NCT01737697|581070159|FG005|Subacute Phase|Adverse Event|1|||
160911913|NCT01737697|581070160|FG006|Subacute Phase|Adverse Event|1|||
160911914|NCT01737697|581070161|FG007|Subacute Phase|Adverse Event|1|||
160911915|NCT01737697|581070162|FG008|Subacute Phase|Adverse Event|1|||
160911916|NCT01737697|581070163|FG009|Subacute Phase|Adverse Event|1|||
160911917|NCT01737697|581070164|FG010|Subacute Phase|Adverse Event|4|||
160911918|NCT01737697|581070165|FG011|Subacute Phase|Adverse Event|1|||
160911919|NCT01737697|581070166|FG012|Subacute Phase|Adverse Event|1|||
160911920|NCT01737697|581070167|FG013|Subacute Phase|Adverse Event|0|||
160911921|NCT01737697|581070168|FG014|Subacute Phase|Adverse Event|0|||
160911922|NCT01737697|581070154|FG000|Subacute Phase|Withdrawal by Subject|0|||
160911923|NCT01737697|581070155|FG001|Subacute Phase|Withdrawal by Subject|0|||
160911924|NCT01737697|581070156|FG002|Subacute Phase|Withdrawal by Subject|0|||
160911925|NCT01737697|581070157|FG003|Subacute Phase|Withdrawal by Subject|0|||
160911926|NCT01737697|581070158|FG004|Subacute Phase|Withdrawal by Subject|0|||
160911927|NCT01737697|581070159|FG005|Subacute Phase|Withdrawal by Subject|1|||
160911928|NCT01737697|581070160|FG006|Subacute Phase|Withdrawal by Subject|0|||
160911929|NCT01737697|581070161|FG007|Subacute Phase|Withdrawal by Subject|2|||
160911930|NCT01737697|581070162|FG008|Subacute Phase|Withdrawal by Subject|0|||
160911931|NCT01737697|581070163|FG009|Subacute Phase|Withdrawal by Subject|1|||
160911932|NCT01737697|581070164|FG010|Subacute Phase|Withdrawal by Subject|0|||
160911933|NCT01737697|581070165|FG011|Subacute Phase|Withdrawal by Subject|1|||
160911934|NCT01737697|581070166|FG012|Subacute Phase|Withdrawal by Subject|1|||
160911935|NCT01737697|581070167|FG013|Subacute Phase|Withdrawal by Subject|1|||
160911936|NCT01737697|581070168|FG014|Subacute Phase|Withdrawal by Subject|0|||
160911937|NCT01737697|581070154|FG000|Subacute Phase|Lost to Follow-up|0|||
160911938|NCT01737697|581070155|FG001|Subacute Phase|Lost to Follow-up|0|||
160911939|NCT01737697|581070156|FG002|Subacute Phase|Lost to Follow-up|0|||
160911940|NCT01737697|581070157|FG003|Subacute Phase|Lost to Follow-up|0|||
160911941|NCT01737697|581070158|FG004|Subacute Phase|Lost to Follow-up|0|||
160911942|NCT01737697|581070159|FG005|Subacute Phase|Lost to Follow-up|0|||
160911943|NCT01737697|581070160|FG006|Subacute Phase|Lost to Follow-up|0|||
160911944|NCT01737697|581070161|FG007|Subacute Phase|Lost to Follow-up|0|||
160911945|NCT01737697|581070162|FG008|Subacute Phase|Lost to Follow-up|0|||
160911946|NCT01737697|581070163|FG009|Subacute Phase|Lost to Follow-up|0|||
160911947|NCT01737697|581070164|FG010|Subacute Phase|Lost to Follow-up|0|||
160911948|NCT01737697|581070165|FG011|Subacute Phase|Lost to Follow-up|0|||
160911949|NCT01737697|581070166|FG012|Subacute Phase|Lost to Follow-up|0|||
160911950|NCT01737697|581070167|FG013|Subacute Phase|Lost to Follow-up|0|||
160911951|NCT01737697|581070168|FG014|Subacute Phase|Lost to Follow-up|1|||
160911952|NCT01737697|581070154|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
160911953|NCT01737697|581070155|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
160911954|NCT01737697|581070156|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
160911955|NCT01737697|581070157|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
160911956|NCT01737697|581070158|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
160911957|NCT01737697|581070159|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
160911958|NCT01737697|581070160|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
160911959|NCT01737697|581070161|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
160911960|NCT01737697|581070162|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
160911961|NCT01737697|581070163|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
160911962|NCT01737697|581070164|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
160911963|NCT01737697|581070165|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
160911964|NCT01737697|581070166|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
160911965|NCT01737697|581070167|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
160911966|NCT01737697|581070168|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
160911967|NCT01737697|581070154|FG000|Subacute Phase|Protocol Violation|0|||
160911968|NCT01737697|581070155|FG001|Subacute Phase|Protocol Violation|0|||
160911969|NCT01737697|581070156|FG002|Subacute Phase|Protocol Violation|0|||
160911970|NCT01737697|581070157|FG003|Subacute Phase|Protocol Violation|0|||
160911971|NCT01737697|581070158|FG004|Subacute Phase|Protocol Violation|0|||
160911972|NCT01737697|581070159|FG005|Subacute Phase|Protocol Violation|1|||
160911973|NCT01737697|581070160|FG006|Subacute Phase|Protocol Violation|0|||
160911974|NCT01737697|581070161|FG007|Subacute Phase|Protocol Violation|0|||
160911975|NCT01737697|581070162|FG008|Subacute Phase|Protocol Violation|0|||
160911976|NCT01737697|581070163|FG009|Subacute Phase|Protocol Violation|0|||
160911977|NCT01737697|581070164|FG010|Subacute Phase|Protocol Violation|1|||
160911978|NCT01737697|581070165|FG011|Subacute Phase|Protocol Violation|0|||
160911979|NCT01737697|581070166|FG012|Subacute Phase|Protocol Violation|0|||
160911980|NCT01737697|581070167|FG013|Subacute Phase|Protocol Violation|0|||
160911981|NCT01737697|581070168|FG014|Subacute Phase|Protocol Violation|0|||
160911982|NCT01737697|581070154|FG000|Subacute Phase|Physician Decision|0|||
160911983|NCT01737697|581070155|FG001|Subacute Phase|Physician Decision|0|||
160911984|NCT01737697|581070156|FG002|Subacute Phase|Physician Decision|0|||
160911985|NCT01737697|581070157|FG003|Subacute Phase|Physician Decision|0|||
160911986|NCT01737697|581070158|FG004|Subacute Phase|Physician Decision|0|||
160911987|NCT01737697|581070159|FG005|Subacute Phase|Physician Decision|0|||
160911988|NCT01737697|581070160|FG006|Subacute Phase|Physician Decision|0|||
160911989|NCT01737697|581070161|FG007|Subacute Phase|Physician Decision|0|||
160911990|NCT01737697|581070162|FG008|Subacute Phase|Physician Decision|1|||
160911991|NCT01737697|581070163|FG009|Subacute Phase|Physician Decision|0|||
160911992|NCT01737697|581070164|FG010|Subacute Phase|Physician Decision|0|||
160911993|NCT01737697|581070165|FG011|Subacute Phase|Physician Decision|0|||
160911994|NCT01737697|581070166|FG012|Subacute Phase|Physician Decision|0|||
160911995|NCT01737697|581070167|FG013|Subacute Phase|Physician Decision|0|||
160911996|NCT01737697|581070168|FG014|Subacute Phase|Physician Decision|0|||
160911997|NCT01737697|581070154|FG000|Subacute Phase|Death|0|||
160911998|NCT01737697|581070155|FG001|Subacute Phase|Death|0|||
160911999|NCT01737697|581070156|FG002|Subacute Phase|Death|0|||
160912000|NCT01737697|581070157|FG003|Subacute Phase|Death|0|||
160912001|NCT01737697|581070158|FG004|Subacute Phase|Death|0|||
160912002|NCT01737697|581070159|FG005|Subacute Phase|Death|0|||
160912003|NCT01737697|581070160|FG006|Subacute Phase|Death|0|||
160912004|NCT01737697|581070161|FG007|Subacute Phase|Death|0|||
160912005|NCT01737697|581070162|FG008|Subacute Phase|Death|0|||
160912006|NCT01737697|581070163|FG009|Subacute Phase|Death|0|||
160912007|NCT01737697|581070164|FG010|Subacute Phase|Death|1|||
160912008|NCT01737697|581070165|FG011|Subacute Phase|Death|0|||
160912009|NCT01737697|581070166|FG012|Subacute Phase|Death|0|||
160912010|NCT01737697|581070167|FG013|Subacute Phase|Death|0|||
160912011|NCT01737697|581070168|FG014|Subacute Phase|Death|0|||
160912012|NCT02216591|581070171|FG000|Overall Study|Lost to Follow-up|0|||
160912013|NCT02216591|581070172|FG001|Overall Study|Lost to Follow-up|1|||
160912014|NCT01950741|581070175|FG000|Overall Study|Lost to Follow-up|1|||
160912015|NCT01950741|581070175|FG000|Overall Study|Death|1|||
160912016|NCT01950741|581070175|FG000|Overall Study|Withdrawal by Subject|1|||
160912017|NCT01866930|581070178|FG000|Treatment Period|Other|1|||
160912018|NCT01866930|581070179|FG001|Treatment Period|Other|0|||
160912019|NCT01866930|581070178|FG000|Treatment Period|Death|0|||
160912020|NCT01866930|581070179|FG001|Treatment Period|Death|2|||
160912021|NCT01866930|581070178|FG000|Treatment Period|Poor/non compliance|0|||
160912022|NCT01866930|581070179|FG001|Treatment Period|Poor/non compliance|2|||
160912023|NCT01866930|581070178|FG000|Treatment Period|No longer meets study criteria|0|||
160912024|NCT01866930|581070179|FG001|Treatment Period|No longer meets study criteria|1|||
160912025|NCT01866930|581070178|FG000|Treatment Period|Withdrawal by Subject|2|||
160912026|NCT01866930|581070179|FG001|Treatment Period|Withdrawal by Subject|8|||
160912027|NCT01866930|581070178|FG000|Treatment Period|Lack of Efficacy|1|||
160912028|NCT01866930|581070179|FG001|Treatment Period|Lack of Efficacy|9|||
160912029|NCT01866930|581070178|FG000|Treatment Period|Adverse Event|4|||
160912030|NCT01866930|581070179|FG001|Treatment Period|Adverse Event|12|||
160912031|NCT01866930|581070178|FG000|Treatment Period|Lost to Follow-up|1|||
160912032|NCT01866930|581070179|FG001|Treatment Period|Lost to Follow-up|1|||
160912033|NCT01866930|581070178|FG000|Follow-up Period|Lost to Follow-up|1|||
160912034|NCT01866930|581070179|FG001|Follow-up Period|Lost to Follow-up|1|||
160912035|NCT01866930|581070178|FG000|Follow-up Period|Other|1|||
160912036|NCT01866930|581070179|FG001|Follow-up Period|Other|5|||
160912037|NCT01866930|581070178|FG000|Follow-up Period|No longer required per protocol|1|||
160912038|NCT01866930|581070179|FG001|Follow-up Period|No longer required per protocol|0|||
160912039|NCT01866930|581070178|FG000|Follow-up Period|Withdrawal by Subject|3|||
160912040|NCT01866930|581070179|FG001|Follow-up Period|Withdrawal by Subject|3|||
160912041|NCT02521870|581070182|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912042|NCT02521870|581070183|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
160912043|NCT02521870|581070184|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912044|NCT02521870|581070185|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912045|NCT02521870|581070186|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912046|NCT02521870|581070187|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161141978|NCT04786210|581904255|FG000|Overall Study|Lost to Follow-up|2|||
160912047|NCT02521870|581070188|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912048|NCT02521870|581070189|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912049|NCT02521870|581070190|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912050|NCT02521870|581070191|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912051|NCT02521870|581070192|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160912052|NCT02521870|581070193|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
161141979|NCT04786210|581904255|FG000|Overall Study|Withdrawal by Subject|4|||
160912053|NCT02521870|581070182|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
160912054|NCT02521870|581070183|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
160912055|NCT02521870|581070184|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
160912056|NCT02521870|581070185|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
160912057|NCT02521870|581070186|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
160912058|NCT02521870|581070187|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
160912059|NCT02521870|581070188|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
160912060|NCT02521870|581070189|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
160912061|NCT02521870|581070190|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
160912062|NCT02521870|581070191|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
160912063|NCT02521870|581070192|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
160912064|NCT02521870|581070193|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
160912065|NCT02521870|581070182|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
160912066|NCT02521870|581070183|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
160912067|NCT02521870|581070184|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
160912068|NCT02521870|581070185|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
160912069|NCT02521870|581070186|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
160912070|NCT02521870|581070187|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
160912071|NCT02521870|581070188|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
160912072|NCT02521870|581070189|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
160912073|NCT02521870|581070190|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
160912074|NCT02521870|581070191|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
160912075|NCT02521870|581070192|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
160912076|NCT02521870|581070193|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
160912077|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912078|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912079|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912080|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912081|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
160912082|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912083|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912084|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912085|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912086|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
160912087|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
160912088|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160912089|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
160912090|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
160912091|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
160912092|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
160912093|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
160912094|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
160912095|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
160912096|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
160912097|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
160912098|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
160912099|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
160912100|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
160912101|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
160912102|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
160912103|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
160912104|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
160912105|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
160912106|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
160912107|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
160912108|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
160995489|NCT04936035|581370939|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
160912109|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
160995490|NCT05827926|581370944|FG000|Overall Study|Lost to Follow-up|1|||
160912110|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
160912111|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
160912112|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
160912113|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Death|0|||
160912114|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Death|0|||
160912115|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Death|0|||
160912116|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Death|0|||
160912117|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Death|1|||
160912118|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Death|1|||
160912119|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Death|3|||
160912120|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Death|1|||
160912121|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Death|1|||
160912122|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Death|5|||
160912123|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Death|2|||
160995491|NCT05827926|581370945|FG001|Overall Study|Lost to Follow-up|0|||
160912124|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Death|2|||
160912125|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Other|0|||
160912126|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Other|0|||
160912127|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Other|0|||
160912128|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Other|0|||
160912129|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Other|10|||
160912130|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Other|3|||
160912131|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Other|2|||
160912132|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Other|0|||
160912133|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Other|10|||
160912134|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Other|5|||
160912135|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Other|1|||
160912136|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Other|7|||
160912137|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912138|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912139|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912140|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912141|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
160912142|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912143|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912144|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912145|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912146|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912147|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912148|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160912149|NCT02521870|581070182|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912150|NCT02521870|581070183|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912151|NCT02521870|581070184|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912152|NCT02521870|581070185|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912153|NCT02521870|581070186|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
160912154|NCT02521870|581070187|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912155|NCT02521870|581070188|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912156|NCT02521870|581070189|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912157|NCT02521870|581070190|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912158|NCT02521870|581070191|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912159|NCT02521870|581070192|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912160|NCT02521870|581070193|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
160912161|NCT00519831|581070196|FG000|Overall Study|Adverse Event|3|||
160912162|NCT00471328|581070197|FG000|Core Phase|Adverse Event|18|||
160912163|NCT00471328|581070198|FG001|Core Phase|Adverse Event|6|||
160912164|NCT00471328|581070197|FG000|Core Phase|Death|8|||
160912165|NCT00471328|581070198|FG001|Core Phase|Death|4|||
160912166|NCT00471328|581070197|FG000|Core Phase|Withdrawal by Subject|2|||
160912167|NCT00471328|581070198|FG001|Core Phase|Withdrawal by Subject|2|||
160912168|NCT00471328|581070197|FG000|Core Phase|Abnormal laboratory value|1|||
160912169|NCT00471328|581070198|FG001|Core Phase|Abnormal laboratory value|0|||
160912170|NCT00471328|581070197|FG000|Core Phase|Disease Progression|78|||
160912171|NCT00471328|581070198|FG001|Core Phase|Disease Progression|53|||
160912172|NCT00471328|581070197|FG000|Core Phase|Administrative Problem|0|||
160912173|NCT00471328|581070198|FG001|Core Phase|Administrative Problem|1|||
160912174|NCT00471328|581070197|FG000|Core Phase|Protocol Deviation|0|||
160912175|NCT00471328|581070198|FG001|Core Phase|Protocol Deviation|1|||
160912176|NCT00471328|581070197|FG000|Extension Phase|Adverse Event|3|||
160912177|NCT00471328|581070198|FG001|Extension Phase|Adverse Event|12|||
160912178|NCT00471328|581070197|FG000|Extension Phase|Withdrawal by Subject|0|||
160912179|NCT00471328|581070198|FG001|Extension Phase|Withdrawal by Subject|2|||
160912180|NCT00471328|581070197|FG000|Extension Phase|Death|1|||
160912181|NCT00471328|581070198|FG001|Extension Phase|Death|7|||
160912182|NCT00471328|581070197|FG000|Extension Phase|Protocol Deviation|3|||
160912183|NCT00471328|581070198|FG001|Extension Phase|Protocol Deviation|1|||
160912184|NCT00471328|581070197|FG000|Extension Phase|Treatment duration as per protocol|0|||
160912185|NCT00471328|581070198|FG001|Extension Phase|Treatment duration as per protocol|1|||
160912186|NCT00471328|581070197|FG000|Extension Phase|Disease Progression|32|||
160912187|NCT00471328|581070198|FG001|Extension Phase|Disease Progression|44|||
160912188|NCT00471328|581070197|FG000|Extension Phase|New cancer Therapy|1|||
160912189|NCT00471328|581070198|FG001|Extension Phase|New cancer Therapy|0|||
160912190|NCT00471328|581070197|FG000|Extension Phase|Administrative Problem|1|||
160912191|NCT00471328|581070198|FG001|Extension Phase|Administrative Problem|0|||
160912192|NCT02854631|581070199|FG000|Overall Study|Adverse Event|1|||
160912193|NCT02854631|581070200|FG001|Overall Study|Adverse Event|2|||
160912194|NCT02854631|581070199|FG000|Overall Study|Withdrew Consent|3|||
160912195|NCT02854631|581070200|FG001|Overall Study|Withdrew Consent|2|||
160912196|NCT02854631|581070199|FG000|Overall Study|Investigator's Discretion|2|||
160912197|NCT02854631|581070200|FG001|Overall Study|Investigator's Discretion|0|||
160912198|NCT02854631|581070199|FG000|Overall Study|Death|12|||
160912199|NCT02854631|581070200|FG001|Overall Study|Death|8|||
160995492|NCT05827926|581370946|FG002|Overall Study|Lost to Follow-up|0|||
160912200|NCT02854631|581070199|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
160912201|NCT02854631|581070200|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
160912202|NCT02854631|581070199|FG000|Overall Study|Protocol Violation|0|||
160912203|NCT02854631|581070200|FG001|Overall Study|Protocol Violation|1|||
160912204|NCT02854631|581070199|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
160912205|NCT02854631|581070200|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
160912206|NCT02854631|581070199|FG000|Overall Study|Lost to Follow-up|4|||
160912207|NCT02854631|581070200|FG001|Overall Study|Lost to Follow-up|2|||
160912208|NCT03930797|581070201|FG000|Overall Study|Lost to Follow-up|3|||
160912209|NCT03930797|581070202|FG001|Overall Study|Lost to Follow-up|10|||
160912210|NCT01962896|581070203|FG000|Overall Study|Lack of Efficacy|4|||
160912211|NCT00662012|581070204|FG000|Overall Study|Lost to Follow-up|85|||
160912212|NCT00662012|581070204|FG000|Overall Study|Death|1|||
160912213|NCT00662012|581070204|FG000|Overall Study|Withdrawal by Subject|1|||
160912214|NCT04342897|581070207|FG000|Overall Study|Death|7|||
160912215|NCT04342897|581070208|FG001|Overall Study|Death|4|||
160912216|NCT04342897|581070207|FG000|Overall Study|Lost to Follow-up|6|||
160912217|NCT04342897|581070208|FG001|Overall Study|Lost to Follow-up|6|||
160912218|NCT04342897|581070207|FG000|Overall Study|Withdrawal by Subject|1|||
160912219|NCT04342897|581070208|FG001|Overall Study|Withdrawal by Subject|2|||
160912220|NCT00621153|581070210|FG000|Overall Study|Safety Reason|8|||
160912221|NCT00621153|581070211|FG001|Overall Study|Safety Reason|7|||
160912222|NCT00621153|581070210|FG000|Overall Study|Adverse Event|3|||
160912223|NCT00621153|581070211|FG001|Overall Study|Adverse Event|2|||
160912224|NCT00621153|581070210|FG000|Overall Study|Lost to Follow-up|5|||
160912225|NCT00621153|581070211|FG001|Overall Study|Lost to Follow-up|1|||
160912226|NCT00621153|581070210|FG000|Overall Study|Withdrawal by Subject|4|||
160912227|NCT00621153|581070211|FG001|Overall Study|Withdrawal by Subject|5|||
160912228|NCT04212650|581070212|FG000|Overall Study|Withdrawal by Subject|1|||
160912229|NCT04212650|581070213|FG001|Overall Study|Withdrawal by Subject|0|||
160912230|NCT00598832|581070218|FG000|Overall Study|Lack of Efficacy|3|||
160912231|NCT00598832|581070219|FG001|Overall Study|Lack of Efficacy|7|||
160912232|NCT00598832|581070218|FG000|Overall Study|Adverse Event|6|||
160912233|NCT00598832|581070219|FG001|Overall Study|Adverse Event|2|||
160912234|NCT00598832|581070218|FG000|Overall Study|Withdrawal by Subject|25|||
160912235|NCT00598832|581070219|FG001|Overall Study|Withdrawal by Subject|36|||
160912236|NCT00598832|581070218|FG000|Overall Study|Protocol Violation|0|||
160912237|NCT00598832|581070219|FG001|Overall Study|Protocol Violation|2|||
160912238|NCT00598832|581070218|FG000|Overall Study|Lost to Follow-up|24|||
160912239|NCT00598832|581070219|FG001|Overall Study|Lost to Follow-up|29|||
160912240|NCT00598832|581070218|FG000|Overall Study|Pregnancy|2|||
160912241|NCT00598832|581070219|FG001|Overall Study|Pregnancy|2|||
160912242|NCT00598832|581070218|FG000|Overall Study|Physician Decision|1|||
160912243|NCT00598832|581070219|FG001|Overall Study|Physician Decision|4|||
160912244|NCT00598832|581070218|FG000|Overall Study|Non compliance|1|||
160912245|NCT00598832|581070219|FG001|Overall Study|Non compliance|0|||
160912246|NCT02142959|581070220|FG000|Overall Study|Adverse Event|1|||
160912247|NCT02142959|581070221|FG001|Overall Study|Adverse Event|0|||
160912248|NCT02142959|581070222|FG002|Overall Study|Adverse Event|0|||
160912249|NCT02142959|581070220|FG000|Overall Study|Death|0|||
160912250|NCT02142959|581070221|FG001|Overall Study|Death|1|||
160912251|NCT02142959|581070222|FG002|Overall Study|Death|0|||
160912252|NCT02142959|581070220|FG000|Overall Study|Withdrawal by Subject|3|||
160912253|NCT02142959|581070221|FG001|Overall Study|Withdrawal by Subject|1|||
160912254|NCT02142959|581070222|FG002|Overall Study|Withdrawal by Subject|3|||
160912255|NCT02142959|581070220|FG000|Overall Study|Administrative Reasons|1|||
160912256|NCT02142959|581070221|FG001|Overall Study|Administrative Reasons|0|||
160912257|NCT02142959|581070222|FG002|Overall Study|Administrative Reasons|1|||
160912258|NCT02142959|581070220|FG000|Overall Study|Missing|0|||
160912259|NCT02142959|581070221|FG001|Overall Study|Missing|1|||
160912260|NCT02142959|581070222|FG002|Overall Study|Missing|0|||
160912261|NCT02142959|581070220|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
160912262|NCT02142959|581070221|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
160912263|NCT02142959|581070222|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
160912264|NCT02142959|581070220|FG000|Overall Study|Patient didn't complete end of study visit|0|||
160912265|NCT02142959|581070221|FG001|Overall Study|Patient didn't complete end of study visit|0|||
160912266|NCT02142959|581070222|FG002|Overall Study|Patient didn't complete end of study visit|1|||
160912267|NCT01753856|581070228|FG000|Overall Study|Adverse Event|1|||
160912268|NCT01753856|581070229|FG001|Overall Study|Adverse Event|0|||
160912269|NCT01753856|581070228|FG000|Overall Study|Withdrawal by Subject|0|||
160912270|NCT01753856|581070229|FG001|Overall Study|Withdrawal by Subject|2|||
160912271|NCT01753856|581070228|FG000|Overall Study|Sponsor Decision|2|||
160912272|NCT01753856|581070229|FG001|Overall Study|Sponsor Decision|0|||
160912273|NCT05980182|581070230|FG000|Overall Study|Lost to Follow-up|10|||
160912274|NCT01852110|581072212|FG000|Overall Study|Adverse Event|12|||
160912275|NCT01852110|581072213|FG001|Overall Study|Adverse Event|5|||
160912276|NCT01852110|581072214|FG002|Overall Study|Adverse Event|0|||
160912277|NCT01852110|581072215|FG003|Overall Study|Adverse Event|0|||
160912278|NCT01852110|581072216|FG004|Overall Study|Adverse Event|0|||
160912279|NCT01852110|581072217|FG005|Overall Study|Adverse Event|0|||
160912280|NCT01852110|581072212|FG000|Overall Study|Lost to Follow-up|1|||
160912281|NCT01852110|581072213|FG001|Overall Study|Lost to Follow-up|3|||
160912282|NCT01852110|581072214|FG002|Overall Study|Lost to Follow-up|0|||
160912283|NCT01852110|581072215|FG003|Overall Study|Lost to Follow-up|0|||
160912284|NCT01852110|581072216|FG004|Overall Study|Lost to Follow-up|0|||
160912285|NCT01852110|581072217|FG005|Overall Study|Lost to Follow-up|0|||
160912286|NCT01852110|581072212|FG000|Overall Study|Non-compliance with Study Drug|2|||
160912287|NCT01852110|581072213|FG001|Overall Study|Non-compliance with Study Drug|1|||
160912288|NCT01852110|581072214|FG002|Overall Study|Non-compliance with Study Drug|0|||
160912289|NCT01852110|581072215|FG003|Overall Study|Non-compliance with Study Drug|0|||
160912290|NCT01852110|581072216|FG004|Overall Study|Non-compliance with Study Drug|0|||
160912291|NCT01852110|581072217|FG005|Overall Study|Non-compliance with Study Drug|0|||
160912292|NCT01852110|581072212|FG000|Overall Study|Physician Decision|1|||
160912293|NCT01852110|581072213|FG001|Overall Study|Physician Decision|0|||
160912294|NCT01852110|581072214|FG002|Overall Study|Physician Decision|0|||
160912295|NCT01852110|581072215|FG003|Overall Study|Physician Decision|0|||
160912296|NCT01852110|581072216|FG004|Overall Study|Physician Decision|0|||
160912297|NCT01852110|581072217|FG005|Overall Study|Physician Decision|0|||
161141980|NCT03826914|581904256|FG000|Overall Study|Withdrawal by Subject|1|||
161141981|NCT03826914|581904257|FG001|Overall Study|Withdrawal by Subject|1|||
160912298|NCT01852110|581072212|FG000|Overall Study|Protocol Violation|0|||
160912299|NCT01852110|581072213|FG001|Overall Study|Protocol Violation|1|||
160912300|NCT01852110|581072214|FG002|Overall Study|Protocol Violation|0|||
160912301|NCT01852110|581072215|FG003|Overall Study|Protocol Violation|0|||
160912302|NCT01852110|581072216|FG004|Overall Study|Protocol Violation|0|||
160912303|NCT01852110|581072217|FG005|Overall Study|Protocol Violation|0|||
160912304|NCT01852110|581072212|FG000|Overall Study|Study Terminated by Sponsor|30|||
160912305|NCT01852110|581072213|FG001|Overall Study|Study Terminated by Sponsor|32|||
160912306|NCT01852110|581072214|FG002|Overall Study|Study Terminated by Sponsor|0|||
160912307|NCT01852110|581072215|FG003|Overall Study|Study Terminated by Sponsor|0|||
160912308|NCT01852110|581072216|FG004|Overall Study|Study Terminated by Sponsor|0|||
160912309|NCT01852110|581072217|FG005|Overall Study|Study Terminated by Sponsor|0|||
160912310|NCT01852110|581072212|FG000|Overall Study|Withdrawal by Subject|4|||
160912311|NCT01852110|581072213|FG001|Overall Study|Withdrawal by Subject|4|||
160912312|NCT01852110|581072214|FG002|Overall Study|Withdrawal by Subject|0|||
160912313|NCT01852110|581072215|FG003|Overall Study|Withdrawal by Subject|0|||
160912314|NCT01852110|581072216|FG004|Overall Study|Withdrawal by Subject|0|||
160912315|NCT01852110|581072217|FG005|Overall Study|Withdrawal by Subject|0|||
160912316|NCT02961751|581072228|FG000|Overall Study|Lost to Follow-up|11|||
160912317|NCT02961751|581072228|FG000|Overall Study|Physician Decision|2|||
160912318|NCT02961751|581072228|FG000|Overall Study|Not Eligible at Enrollment|1|||
160912319|NCT02961751|581072228|FG000|Overall Study|Protocol Violation|1|||
160912320|NCT00842712|581072229|FG000|Safety Run-in Part|Adverse Event|0|||
160912321|NCT00842712|581072230|FG001|Safety Run-in Part|Adverse Event|1|||
160912322|NCT00842712|581072231|FG002|Safety Run-in Part|Adverse Event|0|||
160912323|NCT00842712|581072232|FG003|Safety Run-in Part|Adverse Event|0|||
160912324|NCT00842712|581072233|FG004|Safety Run-in Part|Adverse Event|0|||
160912325|NCT00842712|581072234|FG005|Safety Run-in Part|Adverse Event|0|||
160912326|NCT00842712|581072235|FG006|Safety Run-in Part|Adverse Event|0|||
160912327|NCT00842712|581072229|FG000|Safety Run-in Part|Progressive disease|3|||
160912328|NCT00842712|581072230|FG001|Safety Run-in Part|Progressive disease|1|||
160912329|NCT00842712|581072231|FG002|Safety Run-in Part|Progressive disease|0|||
160912330|NCT00842712|581072232|FG003|Safety Run-in Part|Progressive disease|1|||
160912331|NCT00842712|581072233|FG004|Safety Run-in Part|Progressive disease|0|||
161141982|NCT04334148|581904259|FG000|Overall Study|positive nasal swab at baseline|0|||
161339230|NCT01232283|582630420|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161339231|NCT01232283|582630421|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160912332|NCT00842712|581072234|FG005|Safety Run-in Part|Progressive disease|0|||
160912333|NCT00842712|581072235|FG006|Safety Run-in Part|Progressive disease|0|||
160912334|NCT00842712|581072229|FG000|Randomized Part|Randomized but not treated|0|||
160912335|NCT00842712|581072230|FG001|Randomized Part|Randomized but not treated|0|||
160912336|NCT00842712|581072231|FG002|Randomized Part|Randomized but not treated|0|||
160912337|NCT00842712|581072232|FG003|Randomized Part|Randomized but not treated|0|||
160912338|NCT00842712|581072233|FG004|Randomized Part|Randomized but not treated|0|||
160912339|NCT00842712|581072234|FG005|Randomized Part|Randomized but not treated|1|||
160912340|NCT00842712|581072235|FG006|Randomized Part|Randomized but not treated|4|||
160912341|NCT00842712|581072229|FG000|Randomized Part|Ongoing at cut-off date|0|||
160912342|NCT00842712|581072230|FG001|Randomized Part|Ongoing at cut-off date|0|||
160912343|NCT00842712|581072231|FG002|Randomized Part|Ongoing at cut-off date|0|||
160912344|NCT00842712|581072232|FG003|Randomized Part|Ongoing at cut-off date|0|||
160912345|NCT00842712|581072233|FG004|Randomized Part|Ongoing at cut-off date|0|||
160912346|NCT00842712|581072234|FG005|Randomized Part|Ongoing at cut-off date|0|||
160912347|NCT00842712|581072235|FG006|Randomized Part|Ongoing at cut-off date|2|||
160912348|NCT02141282|581072237|FG000|Overall Study|Adverse event, not related to progression|8|||
160912349|NCT02141282|581072238|FG001|Overall Study|Adverse event, not related to progression|1|||
160912350|NCT02141282|581072239|FG002|Overall Study|Adverse event, not related to progression|3|||
160912351|NCT02141282|581072240|FG003|Overall Study|Adverse event, not related to progression|1|||
160912352|NCT02141282|581072237|FG000|Overall Study|Adverse event, related to progression|1|||
160912353|NCT02141282|581072238|FG001|Overall Study|Adverse event, related to progression|0|||
160912354|NCT02141282|581072239|FG002|Overall Study|Adverse event, related to progression|2|||
160912355|NCT02141282|581072240|FG003|Overall Study|Adverse event, related to progression|0|||
160912356|NCT02141282|581072237|FG000|Overall Study|COVID-19 infection|1|||
160912357|NCT02141282|581072238|FG001|Overall Study|COVID-19 infection|0|||
160912358|NCT02141282|581072239|FG002|Overall Study|COVID-19 infection|0|||
160912359|NCT02141282|581072240|FG003|Overall Study|COVID-19 infection|0|||
160912360|NCT02141282|581072237|FG000|Overall Study|Lost to Follow-up|0|||
160912361|NCT02141282|581072238|FG001|Overall Study|Lost to Follow-up|0|||
160912362|NCT02141282|581072239|FG002|Overall Study|Lost to Follow-up|4|||
160912363|NCT02141282|581072240|FG003|Overall Study|Lost to Follow-up|2|||
160912364|NCT02141282|581072237|FG000|Overall Study|Other, not specified|14|||
160912365|NCT02141282|581072238|FG001|Overall Study|Other, not specified|11|||
160912366|NCT02141282|581072239|FG002|Overall Study|Other, not specified|23|||
160912367|NCT02141282|581072240|FG003|Overall Study|Other, not specified|9|||
160912368|NCT02141282|581072237|FG000|Overall Study|Progressive disease, Richter's|4|||
160912369|NCT02141282|581072238|FG001|Overall Study|Progressive disease, Richter's|1|||
160912370|NCT02141282|581072239|FG002|Overall Study|Progressive disease, Richter's|1|||
160912371|NCT02141282|581072240|FG003|Overall Study|Progressive disease, Richter's|1|||
160912372|NCT02141282|581072237|FG000|Overall Study|Progressive disease per protocol|12|||
160912373|NCT02141282|581072238|FG001|Overall Study|Progressive disease per protocol|7|||
160912374|NCT02141282|581072239|FG002|Overall Study|Progressive disease per protocol|9|||
160912375|NCT02141282|581072240|FG003|Overall Study|Progressive disease per protocol|2|||
160912376|NCT02141282|581072237|FG000|Overall Study|Stem cell transplant|1|||
160912377|NCT02141282|581072238|FG001|Overall Study|Stem cell transplant|0|||
160912378|NCT02141282|581072239|FG002|Overall Study|Stem cell transplant|1|||
160912379|NCT02141282|581072240|FG003|Overall Study|Stem cell transplant|0|||
160912380|NCT02141282|581072237|FG000|Overall Study|Study terminated by Sponsor|0|||
160912381|NCT02141282|581072238|FG001|Overall Study|Study terminated by Sponsor|1|||
160912382|NCT02141282|581072239|FG002|Overall Study|Study terminated by Sponsor|0|||
160912383|NCT02141282|581072240|FG003|Overall Study|Study terminated by Sponsor|0|||
160912384|NCT02141282|581072237|FG000|Overall Study|Subject non-compliance|0|||
160912385|NCT02141282|581072238|FG001|Overall Study|Subject non-compliance|0|||
160912386|NCT02141282|581072239|FG002|Overall Study|Subject non-compliance|1|||
160912387|NCT02141282|581072240|FG003|Overall Study|Subject non-compliance|0|||
160912388|NCT02141282|581072237|FG000|Overall Study|Withdrew consent|2|||
160912389|NCT02141282|581072238|FG001|Overall Study|Withdrew consent|0|||
160912390|NCT02141282|581072239|FG002|Overall Study|Withdrew consent|4|||
160912391|NCT02141282|581072240|FG003|Overall Study|Withdrew consent|0|||
160912392|NCT01384760|581072248|FG000|Overall Study|Lost to Follow-up|0|||
160912393|NCT01384760|581072249|FG001|Overall Study|Lost to Follow-up|6|||
160912394|NCT01384760|581072248|FG000|Overall Study|Protocol Violation|16|||
160912395|NCT01384760|581072249|FG001|Overall Study|Protocol Violation|0|||
160912396|NCT00903695|581072253|FG000|Overall Study|medical exclusion after 1st testing|1|||
161256584|NCT00576303|582316480|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
161256585|NCT00576303|582316480|FG000|Long Term Safety Period|Early withdrawal|16|||
161256586|NCT02843659|582316484|FG000|Overall Study|Subject Withdrew Consent|0|||
161256587|NCT02843659|582316485|FG001|Overall Study|Subject Withdrew Consent|0|||
161256588|NCT02843659|582316486|FG002|Overall Study|Subject Withdrew Consent|1|||
161256589|NCT02843659|582316484|FG000|Overall Study|Administrative Reason by Sponsor|4|||
161256590|NCT02843659|582316485|FG001|Overall Study|Administrative Reason by Sponsor|5|||
161256591|NCT02843659|582316486|FG002|Overall Study|Administrative Reason by Sponsor|4|||
161256592|NCT02843659|582316484|FG000|Overall Study|Adverse Event|0|||
161256593|NCT02843659|582316485|FG001|Overall Study|Adverse Event|1|||
161256594|NCT02843659|582316486|FG002|Overall Study|Adverse Event|0|||
161256595|NCT03203642|582316487|FG000|Overall Study|Adverse Event|3|||
161256596|NCT03203642|582316488|FG001|Overall Study|Adverse Event|1|||
161256597|NCT03203642|582316487|FG000|Overall Study|Withdrawal by Subject|6|||
161256598|NCT03203642|582316488|FG001|Overall Study|Withdrawal by Subject|6|||
161256599|NCT03203642|582316487|FG000|Overall Study|Lost to Follow-up|2|||
161256600|NCT03203642|582316488|FG001|Overall Study|Lost to Follow-up|1|||
160912397|NCT00903695|581072254|FG001|Overall Study|medical exclusion after 1st testing|0|||
160912398|NCT00903695|581072253|FG000|Overall Study|lung cancer|1|||
160912399|NCT00903695|581072254|FG001|Overall Study|lung cancer|0|||
160912400|NCT01549860|581072255|FG000|Overall Study|Withdrawal by Subject|1|||
160912401|NCT01549860|581072256|FG001|Overall Study|Withdrawal by Subject|0|||
160912402|NCT01549860|581072255|FG000|Overall Study|Physician Decision|1|||
160912403|NCT01549860|581072256|FG001|Overall Study|Physician Decision|1|||
160912404|NCT01366521|581072258|FG000|Overall Study|Adverse Event|1|||
160912405|NCT01366521|581072259|FG001|Overall Study|Adverse Event|0|||
160912406|NCT01366521|581072260|FG002|Overall Study|Adverse Event|0|||
160912407|NCT01366521|581072261|FG003|Overall Study|Adverse Event|0|||
160912408|NCT01366521|581072258|FG000|Overall Study|Protocol Violation|0|||
160912409|NCT01366521|581072259|FG001|Overall Study|Protocol Violation|0|||
160912410|NCT01366521|581072260|FG002|Overall Study|Protocol Violation|1|||
160912411|NCT01366521|581072261|FG003|Overall Study|Protocol Violation|0|||
160912412|NCT01366521|581072258|FG000|Overall Study|Physician Decision|0|||
160912413|NCT01366521|581072259|FG001|Overall Study|Physician Decision|0|||
160912414|NCT01366521|581072260|FG002|Overall Study|Physician Decision|1|||
160912415|NCT01366521|581072261|FG003|Overall Study|Physician Decision|0|||
160912416|NCT01366521|581072258|FG000|Overall Study|Withdrawal by Subject|0|||
160912417|NCT01366521|581072259|FG001|Overall Study|Withdrawal by Subject|1|||
160912418|NCT01366521|581072260|FG002|Overall Study|Withdrawal by Subject|0|||
160912419|NCT01366521|581072261|FG003|Overall Study|Withdrawal by Subject|0|||
160912420|NCT02430311|581072262|FG000|Part A|Adverse Event|0|||
160912421|NCT02430311|581072263|FG001|Part A|Adverse Event|1|||
160912422|NCT02430311|581072262|FG000|Part A|Withdrawal by Subject|1|||
160912423|NCT02430311|581072263|FG001|Part A|Withdrawal by Subject|0|||
160912424|NCT02430311|581072262|FG000|Part B|Meet study-specific withdrawal criteria|6|||
160912425|NCT02430311|581072263|FG001|Part B|Meet study-specific withdrawal criteria|6|||
160912426|NCT02430311|581072262|FG000|Part B|Withdrawal by Subject|2|||
160912427|NCT02430311|581072263|FG001|Part B|Withdrawal by Subject|2|||
160912428|NCT02430311|581072262|FG000|Part B|Adverse Event|1|||
160912429|NCT02430311|581072263|FG001|Part B|Adverse Event|0|||
160912430|NCT02430311|581072262|FG000|Part B|Death|1|||
160912431|NCT02430311|581072263|FG001|Part B|Death|0|||
160912432|NCT00578812|581072264|FG000|Overall Study|Not treated|6|||
160912433|NCT00578812|581072265|FG001|Overall Study|Not treated|7|||
160912434|NCT02041286|581072284|FG000|Overall Study|Adverse Event|1|||
160912435|NCT00085631|581072293|FG000|Overall Study|Missing Data|4|||
160912436|NCT00085631|581072294|FG001|Overall Study|Missing Data|11|||
160912437|NCT00085631|581072295|FG002|Overall Study|Missing Data|7|||
160912438|NCT00411645|581072296|FG000|Overall Study|Consent Withdrawn|13|||
160912439|NCT00411645|581072297|FG001|Overall Study|Consent Withdrawn|22|||
160912440|NCT00411645|581072296|FG000|Overall Study|Death|56|||
160912441|NCT00411645|581072297|FG001|Overall Study|Death|135|||
160912442|NCT00411645|581072296|FG000|Overall Study|Investigator/Sponsor Decision|10|||
160912443|NCT00411645|581072297|FG001|Overall Study|Investigator/Sponsor Decision|7|||
160912444|NCT00411645|581072296|FG000|Overall Study|Lost to Follow-up|2|||
160912445|NCT00411645|581072297|FG001|Overall Study|Lost to Follow-up|0|||
160912446|NCT01349790|581072298|FG000|Overall Study|Investigator Judgement|3|||
160912447|NCT01349790|581072298|FG000|Overall Study|Death|2|||
160912448|NCT01349790|581072298|FG000|Overall Study|Withdrawal by Patient|2|||
160912449|NCT01349790|581072298|FG000|Overall Study|Adverse Event|1|||
160912450|NCT01349790|581072298|FG000|Overall Study|Lost to Follow-up|1|||
160912451|NCT01513473|581072299|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
160912452|NCT01513473|581072300|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
160912453|NCT01513473|581072299|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
160912454|NCT01513473|581072300|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
160912455|NCT01513473|581072299|FG000|Main Trial (26 Weeks)|Unclassified|0|||
160912456|NCT01513473|581072300|FG001|Main Trial (26 Weeks)|Unclassified|2|||
160912457|NCT01513473|581072299|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
160912458|NCT01513473|581072300|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
160912459|NCT01513473|581072299|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
160912460|NCT01513473|581072300|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
160912461|NCT03462082|581072301|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912462|NCT03462082|581072302|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912463|NCT03462082|581072303|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912464|NCT03462082|581072304|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912465|NCT03462082|581072305|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
161256601|NCT03203642|582316487|FG000|Overall Study|Termination of the study by sponsor|1|||
161256602|NCT03203642|582316488|FG001|Overall Study|Termination of the study by sponsor|1|||
161256603|NCT03203642|582316487|FG000|Overall Study|Participant moved|0|||
161256604|NCT03203642|582316488|FG001|Overall Study|Participant moved|1|||
160912466|NCT03462082|581072306|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
160912467|NCT03462082|581072307|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
160912468|NCT03462082|581072308|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
160912469|NCT00166114|581072311|FG000|Overall Study|Protocol Violation|2|||
160912470|NCT00166114|581072312|FG001|Overall Study|Protocol Violation|1|||
160912471|NCT00166114|581072311|FG000|Overall Study|Withdrawal by Subject|10|||
160912472|NCT00166114|581072312|FG001|Overall Study|Withdrawal by Subject|4|||
160912473|NCT00166114|581072311|FG000|Overall Study|Adverse Event|2|||
160912474|NCT00166114|581072312|FG001|Overall Study|Adverse Event|1|||
160912475|NCT00743340|581072317|FG000|Overall Study|Study medication non-compliance|1|||
160912476|NCT00743340|581072317|FG000|Overall Study|Lost to Follow-up|1|||
160912477|NCT00743340|581072317|FG000|Overall Study|Withdrawal from the Study|5|||
160912478|NCT00743340|581072317|FG000|Overall Study|Protocol Violation|1|||
160912479|NCT00743340|581072317|FG000|Overall Study|Virologic failure|8|||
160912480|NCT00743340|581072317|FG000|Overall Study|Pregnancy|1|||
160912481|NCT00743340|581072317|FG000|Overall Study|Rolled over to other Gilead Study|23|||
160912482|NCT00743340|581072317|FG000|Overall Study|Participant Relocated|1|||
161141983|NCT04334148|581904260|FG001|Overall Study|positive nasal swab at baseline|1|||
160912483|NCT02708121|581072318|FG000|Overall Study|Withdrawn by Study Team|1|||
160912484|NCT02708121|581072319|FG001|Overall Study|Withdrawn by Study Team|1|||
160912485|NCT02708121|581072318|FG000|Overall Study|Withdrawal by Subject|0|||
160912486|NCT02708121|581072319|FG001|Overall Study|Withdrawal by Subject|4|||
160912487|NCT00127660|581072322|FG000|Overall Study|Protocol Violation|3|||
160912488|NCT00127660|581072323|FG001|Overall Study|Protocol Violation|3|||
160912489|NCT00127660|581072324|FG002|Overall Study|Protocol Violation|5|||
160912490|NCT00127660|581072325|FG003|Overall Study|Protocol Violation|0|||
160912491|NCT01987505|581072326|FG000|Overall Study|Other|9|||
160912492|NCT01987505|581072326|FG000|Overall Study|Withdrawal by Subject|2|||
160912493|NCT01987505|581072326|FG000|Overall Study|Other Reason|2|||
160912494|NCT01987505|581072326|FG000|Overall Study|Lost to Follow-up|15|||
160912495|NCT01987505|581072326|FG000|Overall Study|Investigator Decision|2|||
160912496|NCT01987505|581072326|FG000|Overall Study|Death|4|||
160912497|NCT01425281|581072327|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
160912498|NCT01425281|581072328|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
160912499|NCT01425281|581072327|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
160912500|NCT01425281|581072328|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
160912501|NCT01425281|581072327|FG000|At 180-day Clinical Follow-up|Death|0|||
160912502|NCT01425281|581072328|FG001|At 180-day Clinical Follow-up|Death|1|||
160912503|NCT01425281|581072327|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
160912504|NCT01425281|581072328|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
160912505|NCT01425281|581072327|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
160912506|NCT01425281|581072328|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
160912507|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
160912508|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
160912509|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Death|2|||
160912510|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Death|0|||
160912511|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
160912512|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
160912513|NCT01425281|581072327|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
160912514|NCT01425281|581072328|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
160912515|NCT01425281|581072327|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
160912516|NCT01425281|581072328|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
160912517|NCT01425281|581072327|FG000|At 3-year Clinical Follow-up|Death|2|||
160912518|NCT01425281|581072328|FG001|At 3-year Clinical Follow-up|Death|3|||
160912519|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Death|7|||
160912520|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Death|3|||
160912521|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
160912522|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
160912523|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
160912524|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
160912525|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
160912526|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
160912527|NCT01425281|581072327|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
160912528|NCT01425281|581072328|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
160912529|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Death|2|||
160912530|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Death|0|||
160912531|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
160912532|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
160912533|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
160912534|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
161141984|NCT05370157|581904263|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
160912535|NCT01425281|581072327|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
160912536|NCT01425281|581072328|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
160912537|NCT01749514|581072329|FG000|Overall Study|Lost to Follow-up|0|||
160912538|NCT01749514|581072330|FG001|Overall Study|Lost to Follow-up|0|||
160912539|NCT01749514|581072331|FG002|Overall Study|Lost to Follow-up|0|||
160912540|NCT01749514|581072332|FG003|Overall Study|Lost to Follow-up|0|||
160912541|NCT01749514|581072333|FG004|Overall Study|Lost to Follow-up|0|||
160912542|NCT01749514|581072334|FG005|Overall Study|Lost to Follow-up|0|||
160912543|NCT01749514|581072335|FG006|Overall Study|Lost to Follow-up|0|||
160912544|NCT01749514|581072336|FG007|Overall Study|Lost to Follow-up|1|||
160912545|NCT01749514|581072329|FG000|Overall Study|Withdrawal by Subject|0|||
160912546|NCT01749514|581072330|FG001|Overall Study|Withdrawal by Subject|0|||
160912547|NCT01749514|581072331|FG002|Overall Study|Withdrawal by Subject|0|||
160912548|NCT01749514|581072332|FG003|Overall Study|Withdrawal by Subject|0|||
160912549|NCT01749514|581072333|FG004|Overall Study|Withdrawal by Subject|0|||
160912550|NCT01749514|581072334|FG005|Overall Study|Withdrawal by Subject|1|||
161141985|NCT05370157|581904264|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
161141986|NCT05370157|581904263|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
161141987|NCT05370157|581904264|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
161141988|NCT01508676|581904265|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
161141989|NCT01508676|581904266|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
161141990|NCT01508676|581904265|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
161141991|NCT01508676|581904266|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
161141992|NCT01508676|581904265|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
161141993|NCT01508676|581904266|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
161141994|NCT01508676|581904265|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
161141995|NCT01508676|581904266|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
161141996|NCT01508676|581904265|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
161141997|NCT01508676|581904266|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
161141998|NCT06129487|581904268|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
161141999|NCT06129487|581904269|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
161142000|NCT03772327|581904270|FG000|Overall Study|Lost to Follow-up|3|||
161142001|NCT03772327|581904271|FG001|Overall Study|Lost to Follow-up|4|||
161142002|NCT03772327|581904270|FG000|Overall Study|Withdrawal by Subject|2|||
161142003|NCT03772327|581904271|FG001|Overall Study|Withdrawal by Subject|3|||
161142004|NCT04689828|581904272|FG000|Overall Study|Subject decision|5|||
161142005|NCT04689828|581904273|FG001|Overall Study|Subject decision|5|||
161142006|NCT04689828|581904272|FG000|Overall Study|Adverse Event|12|||
161142007|NCT04689828|581904273|FG001|Overall Study|Adverse Event|12|||
161142008|NCT04689828|581904272|FG000|Overall Study|Physician Decision|24|||
161142009|NCT04689828|581904273|FG001|Overall Study|Physician Decision|32|||
161142010|NCT04689828|581904272|FG000|Overall Study|Progressive disease|54|||
161142011|NCT04689828|581904273|FG001|Overall Study|Progressive disease|173|||
161142012|NCT04689828|581904272|FG000|Overall Study|Death|0|||
161142013|NCT04689828|581904273|FG001|Overall Study|Death|1|||
161142014|NCT04689828|581904272|FG000|Overall Study|Lost to Follow-up|1|||
161142015|NCT04689828|581904273|FG001|Overall Study|Lost to Follow-up|0|||
161142016|NCT04689828|581904272|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
161142017|NCT04689828|581904273|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
161142018|NCT04689828|581904272|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
161142019|NCT04689828|581904273|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
161142020|NCT04689828|581904272|FG000|Overall Study|Participants not treated|7|||
161142021|NCT04689828|581904273|FG001|Overall Study|Participants not treated|2|||
161142022|NCT00195351|581904280|FG000|Overall Study|Lost to Follow-up|9|||
161142023|NCT00195351|581904281|FG001|Overall Study|Lost to Follow-up|9|||
161142024|NCT00195351|581904280|FG000|Overall Study|Withdrawal by Subject|6|||
161142025|NCT00195351|581904281|FG001|Overall Study|Withdrawal by Subject|3|||
161142026|NCT00195351|581904280|FG000|Overall Study|Protocol Deviation|3|||
161142027|NCT00195351|581904281|FG001|Overall Study|Protocol Deviation|2|||
161142028|NCT00195351|581904280|FG000|Overall Study|Death|3|||
161142029|NCT00195351|581904281|FG001|Overall Study|Death|1|||
161142030|NCT00195351|581904280|FG000|Overall Study|Lack of Efficacy|0|||
161142031|NCT00195351|581904281|FG001|Overall Study|Lack of Efficacy|1|||
161142032|NCT04332419|581904284|FG000|Overall Study|Withdrawal by Subject|1|||
161142033|NCT02493751|581904285|FG000|Overall Study|Withdrawal by Subject|2|||
161142034|NCT02493751|581904286|FG001|Overall Study|Withdrawal by Subject|8|||
161142035|NCT02493751|581904285|FG000|Overall Study|Death|6|||
160912551|NCT01749514|581072335|FG006|Overall Study|Withdrawal by Subject|0|||
160912552|NCT01749514|581072336|FG007|Overall Study|Withdrawal by Subject|1|||
160912553|NCT01749514|581072329|FG000|Overall Study|Not Reported|0|||
160912554|NCT01749514|581072330|FG001|Overall Study|Not Reported|0|||
160912555|NCT01749514|581072331|FG002|Overall Study|Not Reported|0|||
160912556|NCT01749514|581072332|FG003|Overall Study|Not Reported|0|||
160912557|NCT01749514|581072333|FG004|Overall Study|Not Reported|0|||
160912558|NCT01749514|581072334|FG005|Overall Study|Not Reported|0|||
160912559|NCT01749514|581072335|FG006|Overall Study|Not Reported|0|||
160912560|NCT01749514|581072336|FG007|Overall Study|Not Reported|5|||
160912561|NCT02509156|581072337|FG000|Randomized Phase|Death|1|||
160912562|NCT02509156|581072338|FG001|Randomized Phase|Death|0|||
161339232|NCT01232283|582630422|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
160912563|NCT02509156|581072337|FG000|Randomized Phase|Withdrawal by Subject|1|||
160912564|NCT02509156|581072338|FG001|Randomized Phase|Withdrawal by Subject|1|||
161142036|NCT02493751|581904286|FG001|Overall Study|Death|13|||
161142037|NCT02493751|581904285|FG000|Overall Study|Lost to Follow-up|2|||
161142038|NCT02493751|581904286|FG001|Overall Study|Lost to Follow-up|3|||
161142039|NCT02493751|581904285|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
161142651|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
160912565|NCT05131646|581072339|FG000|Overall Study|Withdrawal by Subject|1|||
160912566|NCT05131646|581072340|FG001|Overall Study|Withdrawal by Subject|0|||
160912567|NCT05131646|581072341|FG002|Overall Study|Withdrawal by Subject|0|||
160912568|NCT03266107|581072342|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
160912569|NCT03266107|581072342|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
160912570|NCT03266107|581072342|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
160912571|NCT03266107|581072342|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
160912572|NCT02548650|581072345|FG000|Triple Therapy|Adverse Event|1|||
160912573|NCT02548650|581072346|FG001|Triple Therapy|Adverse Event|0|||
160912574|NCT02548650|581072345|FG000|Triple Therapy|Withdrawal by Subject|0|||
160912575|NCT02548650|581072346|FG001|Triple Therapy|Withdrawal by Subject|4|||
160912576|NCT02548650|581072345|FG000|Double Therapy|Adverse Event|1|||
160912577|NCT02548650|581072346|FG001|Double Therapy|Adverse Event|1|||
160912578|NCT02548650|581072345|FG000|Double Therapy|Withdrawal by Subject|0|||
160912579|NCT02548650|581072346|FG001|Double Therapy|Withdrawal by Subject|1|||
160912580|NCT01191801|581072347|FG000|Overall Study|Death|36|||
160912581|NCT01191801|581072348|FG001|Overall Study|Death|12|||
160912582|NCT01191801|581072347|FG000|Overall Study|Lack of Efficacy|176|||
160912583|NCT01191801|581072348|FG001|Overall Study|Lack of Efficacy|258|||
160912584|NCT01191801|581072347|FG000|Overall Study|Adverse Event|9|||
160912585|NCT01191801|581072348|FG001|Overall Study|Adverse Event|8|||
160912586|NCT01191801|581072347|FG000|Overall Study|Protocol Violation|2|||
160912587|NCT01191801|581072348|FG001|Overall Study|Protocol Violation|4|||
160912588|NCT01191801|581072347|FG000|Overall Study|Physician Decision|47|||
160912589|NCT01191801|581072348|FG001|Overall Study|Physician Decision|24|||
160912590|NCT01191801|581072347|FG000|Overall Study|Withdrawal by Subject|1|||
160912591|NCT01191801|581072348|FG001|Overall Study|Withdrawal by Subject|4|||
160912592|NCT01191801|581072347|FG000|Overall Study|Not Provided|45|||
160912593|NCT01191801|581072348|FG001|Overall Study|Not Provided|27|||
160912594|NCT00299104|581072349|FG000|Treatment Period|Adverse Event|14|||
160912595|NCT00299104|581072350|FG001|Treatment Period|Adverse Event|9|||
160912596|NCT00299104|581072351|FG002|Treatment Period|Adverse Event|7|||
160912597|NCT00299104|581072349|FG000|Treatment Period|Death|1|||
160912598|NCT00299104|581072350|FG001|Treatment Period|Death|1|||
160912599|NCT00299104|581072351|FG002|Treatment Period|Death|1|||
160912600|NCT00299104|581072349|FG000|Treatment Period|Insufficient therapeutic response|34|||
160912601|NCT00299104|581072350|FG001|Treatment Period|Insufficient therapeutic response|13|||
160912602|NCT00299104|581072351|FG002|Treatment Period|Insufficient therapeutic response|8|||
160912603|NCT00299104|581072349|FG000|Treatment Period|Failure to return|9|||
160912604|NCT00299104|581072350|FG001|Treatment Period|Failure to return|8|||
160912605|NCT00299104|581072351|FG002|Treatment Period|Failure to return|8|||
160912606|NCT00299104|581072349|FG000|Treatment Period|Violation of selection criteria|1|||
160912607|NCT00299104|581072350|FG001|Treatment Period|Violation of selection criteria|2|||
160912608|NCT00299104|581072351|FG002|Treatment Period|Violation of selection criteria|0|||
160912609|NCT00299104|581072349|FG000|Treatment Period|Protocol Violation|1|||
160912610|NCT00299104|581072350|FG001|Treatment Period|Protocol Violation|1|||
160912611|NCT00299104|581072351|FG002|Treatment Period|Protocol Violation|0|||
160912612|NCT00299104|581072349|FG000|Treatment Period|Refused treatment|9|||
160912613|NCT00299104|581072350|FG001|Treatment Period|Refused treatment|2|||
160912614|NCT00299104|581072351|FG002|Treatment Period|Refused treatment|2|||
160912615|NCT00299104|581072349|FG000|Treatment Period|Withdrew consent|14|||
160912616|NCT00299104|581072350|FG001|Treatment Period|Withdrew consent|19|||
160912617|NCT00299104|581072351|FG002|Treatment Period|Withdrew consent|9|||
160912618|NCT00299104|581072349|FG000|Treatment Period|Administrative reasons|106|||
160912619|NCT00299104|581072350|FG001|Treatment Period|Administrative reasons|120|||
160912620|NCT00299104|581072351|FG002|Treatment Period|Administrative reasons|137|||
160912621|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Death|3|||
160912622|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Death|2|||
160912623|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Death|1|||
160912624|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
160912625|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
160912626|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
160912627|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
160912628|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
160912629|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
160912630|NCT00299104|581072349|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
160912631|NCT00299104|581072350|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
160912632|NCT00299104|581072351|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
160912633|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
160912634|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
160912635|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
160912636|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
160912637|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
160912638|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
160912639|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
160912640|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
160995493|NCT05827926|581370947|FG003|Overall Study|Lost to Follow-up|0|||
160995494|NCT05827926|581370948|FG004|Overall Study|Lost to Follow-up|0|||
160995495|NCT05827926|581370949|FG005|Overall Study|Lost to Follow-up|1|||
160995496|NCT05827926|581370950|FG006|Overall Study|Lost to Follow-up|0|||
160995497|NCT05827926|581370951|FG007|Overall Study|Lost to Follow-up|0|||
160995498|NCT05827926|581370952|FG008|Overall Study|Lost to Follow-up|0|||
160995499|NCT05827926|581370953|FG009|Overall Study|Lost to Follow-up|0|||
160912641|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
160912642|NCT00299104|581072349|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
160912643|NCT00299104|581072350|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
160912644|NCT00299104|581072351|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
160912645|NCT00814164|581072355|FG000|Overall Study|Progression|7|||
160912646|NCT00814164|581072355|FG000|Overall Study|not stated|7|||
160912647|NCT00814164|581072355|FG000|Overall Study|Death|5|||
160912648|NCT01053221|581072356|FG000|Overall Study|The study was closed prematurely|5|||
160912649|NCT01053221|581072357|FG001|Overall Study|The study was closed prematurely|9|||
160912650|NCT01417234|581072358|FG000|Overall Study|Subject non-compliant|3|||
160912651|NCT01537393|581072359|FG000|Overall Study|Exclude prior to study|32|||
160995500|NCT05827926|581370954|FG010|Overall Study|Lost to Follow-up|0|||
160995501|NCT05827926|581370955|FG011|Overall Study|Lost to Follow-up|0|||
160995502|NCT05827926|581370956|FG012|Overall Study|Lost to Follow-up|1|||
160995503|NCT05827926|581370957|FG013|Overall Study|Lost to Follow-up|1|||
160912652|NCT01537393|581072360|FG001|Overall Study|Exclude prior to study|44|||
160912653|NCT01537393|581072359|FG000|Overall Study|Death|20|||
160912654|NCT01537393|581072360|FG001|Overall Study|Death|32|||
160912655|NCT01537393|581072359|FG000|Overall Study|Withdrawal by Subject|18|||
160912656|NCT01537393|581072360|FG001|Overall Study|Withdrawal by Subject|17|||
160912657|NCT01537393|581072359|FG000|Overall Study|Lost to Follow-up|53|||
160912658|NCT01537393|581072360|FG001|Overall Study|Lost to Follow-up|48|||
160912659|NCT01537393|581072359|FG000|Overall Study|Failure - Regrafted|28|||
160912660|NCT01537393|581072360|FG001|Overall Study|Failure - Regrafted|43|||
160912661|NCT01537393|581072359|FG000|Overall Study|Failure - Not regrafted|2|||
160912662|NCT01537393|581072360|FG001|Overall Study|Failure - Not regrafted|6|||
160912663|NCT01537393|581072359|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
160912664|NCT01537393|581072360|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
160912665|NCT00459953|581072361|FG000|Overall Study|not analyzed-household member in study|1|||
160995504|NCT05827926|581370958|FG014|Overall Study|Lost to Follow-up|0|||
160995505|NCT05827926|581370959|FG015|Overall Study|Lost to Follow-up|1|||
160995506|NCT05827926|581370960|FG016|Overall Study|Lost to Follow-up|2|||
160995507|NCT05827926|581370961|FG017|Overall Study|Lost to Follow-up|0|||
160995508|NCT05827926|581370962|FG018|Overall Study|Lost to Follow-up|0|||
160995509|NCT05827926|581370963|FG019|Overall Study|Lost to Follow-up|0|||
160995510|NCT05827926|581370964|FG020|Overall Study|Lost to Follow-up|1|||
160995511|NCT05827926|581370965|FG021|Overall Study|Lost to Follow-up|2|||
160995512|NCT05827926|581370966|FG022|Overall Study|Lost to Follow-up|1|||
160995513|NCT05827926|581370967|FG023|Overall Study|Lost to Follow-up|1|||
160995514|NCT05827926|581370968|FG024|Overall Study|Lost to Follow-up|2|||
160995515|NCT05827926|581370969|FG025|Overall Study|Lost to Follow-up|1|||
160995516|NCT05827926|581370970|FG026|Overall Study|Lost to Follow-up|4|||
160995517|NCT05827926|581370971|FG027|Overall Study|Lost to Follow-up|1|||
160995518|NCT05827926|581370972|FG028|Overall Study|Lost to Follow-up|2|||
160995519|NCT05827926|581370973|FG029|Overall Study|Lost to Follow-up|1|||
160995520|NCT05827926|581370974|FG030|Overall Study|Lost to Follow-up|5|||
160995521|NCT05827926|581370975|FG031|Overall Study|Lost to Follow-up|0|||
160995522|NCT05827926|581370976|FG032|Overall Study|Lost to Follow-up|3|||
160995523|NCT05827926|581370977|FG033|Overall Study|Lost to Follow-up|2|||
160995524|NCT05827926|581370978|FG034|Overall Study|Lost to Follow-up|1|||
160995525|NCT05827926|581370979|FG035|Overall Study|Lost to Follow-up|3|||
161256605|NCT03203642|582316487|FG000|Overall Study|Investigator's decision|3|||
161256606|NCT03203642|582316488|FG001|Overall Study|Investigator's decision|0|||
161256607|NCT03203642|582316487|FG000|Overall Study|Other than above specified|0|||
161256608|NCT03203642|582316488|FG001|Overall Study|Other than above specified|1|||
160995526|NCT05827926|581370980|FG036|Overall Study|Lost to Follow-up|4|||
160995527|NCT05827926|581370944|FG000|Overall Study|Withdrawal by Subject|1|||
161256609|NCT01546142|582318615|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
161256610|NCT01546142|582318616|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
160912666|NCT00459953|581072362|FG001|Overall Study|not analyzed-household member in study|1|||
160912667|NCT01197560|581072365|FG000|Overall Study|Adverse Event|6|||
160912668|NCT01197560|581072366|FG001|Overall Study|Adverse Event|8|||
160912669|NCT01197560|581072365|FG000|Overall Study|Death|3|||
160912670|NCT01197560|581072366|FG001|Overall Study|Death|5|||
160912671|NCT01197560|581072365|FG000|Overall Study|Withdrawal by Subject|1|||
160912672|NCT01197560|581072366|FG001|Overall Study|Withdrawal by Subject|1|||
160912673|NCT01197560|581072365|FG000|Overall Study|Disease progression|40|||
160995528|NCT05827926|581370945|FG001|Overall Study|Withdrawal by Subject|0|||
160995529|NCT05827926|581370946|FG002|Overall Study|Withdrawal by Subject|1|||
160995530|NCT05827926|581370947|FG003|Overall Study|Withdrawal by Subject|1|||
160912674|NCT01197560|581072366|FG001|Overall Study|Disease progression|35|||
160912675|NCT01197560|581072365|FG000|Overall Study|Miscellaneous|4|||
160912676|NCT01197560|581072366|FG001|Overall Study|Miscellaneous|3|||
160912677|NCT01197560|581072365|FG000|Overall Study|Missing|0|||
160912678|NCT01197560|581072366|FG001|Overall Study|Missing|1|||
160912679|NCT00211510|581072369|FG000|Overall Study|Physician Decision|3|||
160912680|NCT00211510|581072370|FG001|Overall Study|Physician Decision|1|||
160912681|NCT00211510|581072369|FG000|Overall Study|Withdrawal by Subject|3|||
160912682|NCT00211510|581072370|FG001|Overall Study|Withdrawal by Subject|1|||
160912683|NCT01487200|581072371|FG000|Overall Study|Withdrawal by Subject|0|||
160912684|NCT01487200|581072372|FG001|Overall Study|Withdrawal by Subject|1|||
160912685|NCT01487200|581072373|FG002|Overall Study|Withdrawal by Subject|0|||
160912686|NCT01487200|581072374|FG003|Overall Study|Withdrawal by Subject|0|||
160912687|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
160912688|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
160912689|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
160912690|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912691|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912692|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912693|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912694|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160995531|NCT05827926|581370948|FG004|Overall Study|Withdrawal by Subject|0|||
160995532|NCT05827926|581370949|FG005|Overall Study|Withdrawal by Subject|0|||
160995533|NCT05827926|581370950|FG006|Overall Study|Withdrawal by Subject|0|||
160912695|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912696|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912697|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
160912698|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
160912699|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912700|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
160912701|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912702|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912703|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912704|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912705|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912706|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912707|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912708|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
160912709|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
160912710|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
160912711|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
160912712|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912713|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912714|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912715|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912716|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912717|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912718|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912719|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
160912720|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
160912721|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
160912722|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912723|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912724|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912725|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912726|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912727|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912728|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912729|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912730|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
160912731|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
160995534|NCT05827926|581370951|FG007|Overall Study|Withdrawal by Subject|0|||
160995535|NCT05827926|581370952|FG008|Overall Study|Withdrawal by Subject|0|||
160995536|NCT05827926|581370953|FG009|Overall Study|Withdrawal by Subject|0|||
160995537|NCT05827926|581370954|FG010|Overall Study|Withdrawal by Subject|0|||
160995538|NCT05827926|581370955|FG011|Overall Study|Withdrawal by Subject|0|||
160995539|NCT05827926|581370956|FG012|Overall Study|Withdrawal by Subject|1|||
160912732|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
160912733|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
160912734|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912735|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912736|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912737|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912738|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912739|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912740|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912741|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
160912742|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912743|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
160912744|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
160912745|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912746|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912747|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912748|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912749|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912750|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912751|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912752|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
160912753|NCT02207244|581072377|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912754|NCT02207244|581072378|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
160912755|NCT02207244|581072379|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912756|NCT02207244|581072380|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912757|NCT02207244|581072381|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912758|NCT02207244|581072382|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912759|NCT02207244|581072383|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912760|NCT02207244|581072384|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912761|NCT02207244|581072385|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912762|NCT02207244|581072386|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912763|NCT02207244|581072387|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
160912764|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912765|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912766|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912767|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912768|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
160912769|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
160912770|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912771|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912772|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912773|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912774|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
160912775|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912776|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912777|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912778|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912779|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912780|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
160912781|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912782|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912783|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912784|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912785|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
160912786|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912787|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912788|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
161256611|NCT01546142|582318615|FG000|Overall Study|Subject Noncompliance|1|||
161256612|NCT01546142|582318616|FG001|Overall Study|Subject Noncompliance|1|||
161256613|NCT01546142|582318615|FG000|Overall Study|Adverse Event|6|||
161256614|NCT01546142|582318616|FG001|Overall Study|Adverse Event|3|||
161256615|NCT01546142|582318615|FG000|Overall Study|Lost to Follow-up|20|||
161256616|NCT01546142|582318616|FG001|Overall Study|Lost to Follow-up|15|||
161256617|NCT01546142|582318615|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
161256618|NCT01546142|582318616|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
161256619|NCT01546142|582318615|FG000|Overall Study|Subject Randomized but Not Treated|1|||
161256620|NCT01546142|582318616|FG001|Overall Study|Subject Randomized but Not Treated|0|||
161256621|NCT01213836|582318617|FG000|Period 1, First Intervention|Adverse Event|2|||
161142040|NCT02493751|581904286|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
161142041|NCT01824602|581904288|FG000|Overall Study|Withdrawal by Subject|0|||
161142042|NCT01824602|581904289|FG001|Overall Study|Withdrawal by Subject|0|||
161142043|NCT01824602|581904290|FG002|Overall Study|Withdrawal by Subject|1|||
161142044|NCT01824602|581904291|FG003|Overall Study|Withdrawal by Subject|2|||
161142045|NCT01824602|581904288|FG000|Overall Study|Patient non-compliance|0|||
161142046|NCT01824602|581904289|FG001|Overall Study|Patient non-compliance|0|||
161142047|NCT01824602|581904290|FG002|Overall Study|Patient non-compliance|1|||
161142048|NCT01824602|581904291|FG003|Overall Study|Patient non-compliance|0|||
161142049|NCT01824602|581904288|FG000|Overall Study|Adverse Event|1|||
161142050|NCT01824602|581904289|FG001|Overall Study|Adverse Event|0|||
161142051|NCT01824602|581904290|FG002|Overall Study|Adverse Event|2|||
161142052|NCT01824602|581904291|FG003|Overall Study|Adverse Event|2|||
161142053|NCT01824602|581904288|FG000|Overall Study|Treatment failure|0|||
161142054|NCT01824602|581904289|FG001|Overall Study|Treatment failure|0|||
161142055|NCT01824602|581904290|FG002|Overall Study|Treatment failure|0|||
161142056|NCT01824602|581904291|FG003|Overall Study|Treatment failure|1|||
161142057|NCT00104871|581904292|FG000|Overall Study|Not evaluable|1|||
161142058|NCT02192359|581904295|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
160861564|NCT00321620|580887768|FG001|Overall Study|Physician Decision|1|||
160861565|NCT00321620|580887767|FG000|Overall Study|Noncompliance|14|||
160861566|NCT00321620|580887768|FG001|Overall Study|Noncompliance|7|||
160861567|NCT00321620|580887767|FG000|Overall Study|Protocol deviation|4|||
160861568|NCT00321620|580887768|FG001|Overall Study|Protocol deviation|3|||
160912789|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
160912790|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
160912791|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
160912792|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912793|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912794|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912795|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912796|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
160912797|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912798|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912799|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912800|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
160912801|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
160912802|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
160912803|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912804|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912805|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912806|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912807|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
160912808|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912809|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912810|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912811|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
160912812|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912813|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
160912814|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912815|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912816|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912817|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912818|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
160912819|NCT02207244|581072377|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912820|NCT02207244|581072378|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912821|NCT02207244|581072379|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912822|NCT02207244|581072380|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
160912823|NCT02207244|581072381|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912824|NCT02207244|581072382|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912825|NCT02207244|581072383|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912826|NCT02207244|581072384|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912827|NCT02207244|581072385|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
160861569|NCT00321620|580887767|FG000|Overall Study|Ineligibility determined|2|||
160861570|NCT00321620|580887768|FG001|Overall Study|Ineligibility determined|3|||
160861571|NCT00321620|580887767|FG000|Overall Study|Participant request|75|||
160861572|NCT00321620|580887768|FG001|Overall Study|Participant request|52|||
160861573|NCT00321620|580887767|FG000|Overall Study|Other|42|||
160861574|NCT00321620|580887768|FG001|Overall Study|Other|33|||
160995540|NCT05827926|581370957|FG013|Overall Study|Withdrawal by Subject|1|||
160995541|NCT05827926|581370958|FG014|Overall Study|Withdrawal by Subject|1|||
160995542|NCT05827926|581370959|FG015|Overall Study|Withdrawal by Subject|2|||
160995543|NCT05827926|581370960|FG016|Overall Study|Withdrawal by Subject|1|||
160995544|NCT05827926|581370961|FG017|Overall Study|Withdrawal by Subject|1|||
160995545|NCT05827926|581370962|FG018|Overall Study|Withdrawal by Subject|0|||
160995546|NCT05827926|581370963|FG019|Overall Study|Withdrawal by Subject|0|||
160995547|NCT05827926|581370964|FG020|Overall Study|Withdrawal by Subject|1|||
160995548|NCT05827926|581370965|FG021|Overall Study|Withdrawal by Subject|0|||
160995549|NCT05827926|581370966|FG022|Overall Study|Withdrawal by Subject|0|||
160995550|NCT05827926|581370967|FG023|Overall Study|Withdrawal by Subject|2|||
160995551|NCT05827926|581370968|FG024|Overall Study|Withdrawal by Subject|1|||
160995552|NCT05827926|581370969|FG025|Overall Study|Withdrawal by Subject|0|||
160995553|NCT05827926|581370970|FG026|Overall Study|Withdrawal by Subject|0|||
160995554|NCT05827926|581370971|FG027|Overall Study|Withdrawal by Subject|1|||
160995555|NCT05827926|581370972|FG028|Overall Study|Withdrawal by Subject|0|||
160995556|NCT05827926|581370973|FG029|Overall Study|Withdrawal by Subject|0|||
160995557|NCT05827926|581370974|FG030|Overall Study|Withdrawal by Subject|0|||
160995558|NCT05827926|581370975|FG031|Overall Study|Withdrawal by Subject|2|||
160995559|NCT05827926|581370976|FG032|Overall Study|Withdrawal by Subject|0|||
160995560|NCT05827926|581370977|FG033|Overall Study|Withdrawal by Subject|0|||
160995561|NCT05827926|581370978|FG034|Overall Study|Withdrawal by Subject|0|||
160995562|NCT05827926|581370979|FG035|Overall Study|Withdrawal by Subject|0|||
160995563|NCT05827926|581370980|FG036|Overall Study|Withdrawal by Subject|1|||
160995564|NCT05827926|581370944|FG000|Overall Study|Other Than Specified|0|||
160995565|NCT05827926|581370945|FG001|Overall Study|Other Than Specified|0|||
160912828|NCT02207244|581072386|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912829|NCT02207244|581072387|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
160912830|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912831|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912832|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912833|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912834|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912835|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912836|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
160912837|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
160912838|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
160912839|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
160912840|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
160912841|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912842|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912843|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912844|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912845|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912846|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912847|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912848|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
160912849|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912850|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912851|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
160912852|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912853|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912854|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912855|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912856|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912857|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912858|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
160912859|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
160912860|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
160912861|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
160912862|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
160912863|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912864|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160995566|NCT05827926|581370946|FG002|Overall Study|Other Than Specified|0|||
160995567|NCT05827926|581370947|FG003|Overall Study|Other Than Specified|1|||
160995568|NCT05827926|581370948|FG004|Overall Study|Other Than Specified|0|||
160995569|NCT05827926|581370949|FG005|Overall Study|Other Than Specified|0|||
160995570|NCT05827926|581370950|FG006|Overall Study|Other Than Specified|1|||
160912865|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160995571|NCT05827926|581370951|FG007|Overall Study|Other Than Specified|0|||
160912866|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912867|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912868|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912869|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
160912870|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
160912871|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912872|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
160912873|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
160912874|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912875|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912876|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912877|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912878|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912879|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912880|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
160912881|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
160912882|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
160912883|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
160912884|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
160912885|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912886|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912887|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912888|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912889|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912890|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912891|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912892|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
160912893|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
160912894|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912895|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
160912896|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912897|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912898|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912899|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912900|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912901|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912902|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912903|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912904|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
160912905|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912906|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
160912907|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912908|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912909|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912910|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912911|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912912|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912913|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912914|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
160912915|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912916|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912917|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
160912918|NCT02207244|581072377|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912919|NCT02207244|581072378|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912920|NCT02207244|581072379|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912921|NCT02207244|581072380|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912922|NCT02207244|581072381|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912923|NCT02207244|581072382|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912924|NCT02207244|581072383|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
160912925|NCT02207244|581072384|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912926|NCT02207244|581072385|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912927|NCT02207244|581072386|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912928|NCT02207244|581072387|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
160912929|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912930|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912931|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912932|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912933|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912934|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912935|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912936|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912937|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
160912938|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
160912939|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
160912940|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912941|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912942|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912943|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912944|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912945|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912946|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912947|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912948|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
160912949|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
160912950|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
160912951|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912952|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912953|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912954|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912955|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912956|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912957|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912958|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160861575|NCT03337477|580887769|FG000|Overall Study|not categorized into the listed ones|11|||
160861576|NCT03337477|580887770|FG001|Overall Study|not categorized into the listed ones|9|||
160861577|NCT03337477|580887769|FG000|Overall Study|Withdrawal by Subject|0|||
160912959|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
160912960|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
160912961|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
160912962|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912963|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912964|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160995572|NCT05827926|581370952|FG008|Overall Study|Other Than Specified|0|||
161142059|NCT02192359|581904296|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161142652|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
160861578|NCT03337477|580887770|FG001|Overall Study|Withdrawal by Subject|1|||
160861579|NCT03337477|580887769|FG000|Overall Study|Death|0|||
160861580|NCT03337477|580887770|FG001|Overall Study|Death|1|||
160861581|NCT03337477|580887769|FG000|Overall Study|Lost to Follow-up|0|||
160861582|NCT03337477|580887770|FG001|Overall Study|Lost to Follow-up|2|||
160861583|NCT03304626|580887771|FG000|Overall Study|Adverse Event|1|||
160861584|NCT03304626|580887772|FG001|Overall Study|Adverse Event|0|||
160861585|NCT03304626|580887771|FG000|Overall Study|Lack of Efficacy|1|||
160861586|NCT03304626|580887772|FG001|Overall Study|Lack of Efficacy|1|||
160861587|NCT01747876|580887774|FG000|Overall Study|Adverse Event|1|||
160861588|NCT01747876|580887775|FG001|Overall Study|Adverse Event|0|||
160861589|NCT01747876|580887776|FG002|Overall Study|Adverse Event|2|||
160861590|NCT01747876|580887774|FG000|Overall Study|Withdrawal by Subject|0|||
160861591|NCT01747876|580887775|FG001|Overall Study|Withdrawal by Subject|1|||
160861592|NCT01747876|580887776|FG002|Overall Study|Withdrawal by Subject|1|||
160861593|NCT01747876|580887774|FG000|Overall Study|Disease progression|4|||
160861594|NCT01747876|580887775|FG001|Overall Study|Disease progression|13|||
160861595|NCT01747876|580887776|FG002|Overall Study|Disease progression|8|||
160861596|NCT01747876|580887774|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
160861597|NCT01747876|580887775|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
160861598|NCT01747876|580887776|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
160861599|NCT03198715|580887779|FG000|Overall Study|Death|0|||
160861600|NCT03198715|580887780|FG001|Overall Study|Death|0|||
160861601|NCT03198715|580887781|FG002|Overall Study|Death|1|||
160861602|NCT03198715|580887782|FG003|Overall Study|Death|0|||
160861603|NCT03198715|580887783|FG004|Overall Study|Death|2|||
160912965|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912966|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912967|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912968|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912969|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912970|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
160912971|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
160912972|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
160912973|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
160912974|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
160912975|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
160912976|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
160912977|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
160912978|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
160912979|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
160912980|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
160912981|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
160912982|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
160912983|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
160912984|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
160912985|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
160912986|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
160912987|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
160912988|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
160912989|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
160912990|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
160912991|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
160912992|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
160912993|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
160912994|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
160912995|NCT02207244|581072377|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912996|NCT02207244|581072378|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912997|NCT02207244|581072379|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912998|NCT02207244|581072380|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160912999|NCT02207244|581072381|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913000|NCT02207244|581072382|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913001|NCT02207244|581072383|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913002|NCT02207244|581072384|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913003|NCT02207244|581072385|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913004|NCT02207244|581072386|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
160913005|NCT02207244|581072387|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
160913006|NCT04051008|581072390|FG000|Overall Study|Withdrawal by Subject|2|||
160913007|NCT04051008|581072391|FG001|Overall Study|Withdrawal by Subject|0|||
160913008|NCT04051008|581072392|FG002|Overall Study|Withdrawal by Subject|1|||
160913009|NCT02862171|581072393|FG000|Overall Study|Death|1|||
160913010|NCT02862171|581072393|FG000|Overall Study|Lost to Follow-up|13|||
160913011|NCT02862171|581072393|FG000|Overall Study|Withdrawal by Subject|57|||
160913012|NCT02862171|581072393|FG000|Overall Study|Non-compliance|4|||
160913013|NCT02862171|581072393|FG000|Overall Study|HIV-1 seroconversion|18|||
160913014|NCT02700815|581074335|FG000|Overall Study|Adverse Event|0|||
160913015|NCT02700815|581074336|FG001|Overall Study|Adverse Event|6|||
160913016|NCT02700815|581074337|FG002|Overall Study|Adverse Event|2|||
160913017|NCT02700815|581074338|FG003|Overall Study|Adverse Event|3|||
160913018|NCT02700815|581074335|FG000|Overall Study|Lack of Efficacy|0|||
160913019|NCT02700815|581074336|FG001|Overall Study|Lack of Efficacy|0|||
160913020|NCT02700815|581074337|FG002|Overall Study|Lack of Efficacy|1|||
160913021|NCT02700815|581074338|FG003|Overall Study|Lack of Efficacy|2|||
160913022|NCT02700815|581074335|FG000|Overall Study|Lost to Follow-up|1|||
160913023|NCT02700815|581074336|FG001|Overall Study|Lost to Follow-up|0|||
160913024|NCT02700815|581074337|FG002|Overall Study|Lost to Follow-up|0|||
160913025|NCT02700815|581074338|FG003|Overall Study|Lost to Follow-up|1|||
160913026|NCT02700815|581074335|FG000|Overall Study|Refusal to continue medication|0|||
160913027|NCT02700815|581074336|FG001|Overall Study|Refusal to continue medication|1|||
160913028|NCT02700815|581074337|FG002|Overall Study|Refusal to continue medication|0|||
160913029|NCT02700815|581074338|FG003|Overall Study|Refusal to continue medication|1|||
160913030|NCT02700815|581074335|FG000|Overall Study|Withdrawal by Subject|0|||
160913031|NCT02700815|581074336|FG001|Overall Study|Withdrawal by Subject|0|||
160913032|NCT02700815|581074337|FG002|Overall Study|Withdrawal by Subject|1|||
160913033|NCT02700815|581074338|FG003|Overall Study|Withdrawal by Subject|0|||
160913034|NCT04023526|581074339|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
160913035|NCT04023526|581074340|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
160913036|NCT04023526|581074339|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
160913037|NCT04023526|581074340|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
160913038|NCT01955733|581074344|FG000|Period 1|Lost to Follow-up|1|||
160913039|NCT01955733|581074345|FG001|Period 1|Lost to Follow-up|0|||
160913040|NCT01955733|581074346|FG002|Period 1|Lost to Follow-up|0|||
160913041|NCT01955733|581074344|FG000|Period 2|Adverse Event|1|||
160913042|NCT01955733|581074345|FG001|Period 2|Adverse Event|0|||
160913043|NCT01955733|581074346|FG002|Period 2|Adverse Event|0|||
160913044|NCT01955733|581074344|FG000|Period 2|Physician Decision|0|||
160913045|NCT01955733|581074345|FG001|Period 2|Physician Decision|0|||
160913046|NCT01955733|581074346|FG002|Period 2|Physician Decision|1|||
160913047|NCT01955733|581074344|FG000|Period 2|Withdrawal by Subject|1|||
160913048|NCT01955733|581074345|FG001|Period 2|Withdrawal by Subject|3|||
160913049|NCT01955733|581074346|FG002|Period 2|Withdrawal by Subject|2|||
160913050|NCT01955733|581074344|FG000|Period 2|Study terminated by sponsor|8|||
160913051|NCT01955733|581074345|FG001|Period 2|Study terminated by sponsor|14|||
160913052|NCT01955733|581074346|FG002|Period 2|Study terminated by sponsor|16|||
160913053|NCT01955733|581074344|FG000|Period 2|Lost to Follow-up|2|||
160913054|NCT01955733|581074345|FG001|Period 2|Lost to Follow-up|0|||
160913055|NCT01955733|581074346|FG002|Period 2|Lost to Follow-up|0|||
160913056|NCT01955733|581074344|FG000|Period 2|Other not defined above|0|||
160913057|NCT01955733|581074345|FG001|Period 2|Other not defined above|2|||
160913058|NCT01955733|581074346|FG002|Period 2|Other not defined above|2|||
160913059|NCT02239978|581074349|FG000|Overall Study|Withdrawal by Subject|2|||
160913060|NCT02239978|581074350|FG001|Overall Study|Withdrawal by Subject|0|||
160913061|NCT02324569|581074361|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
160913062|NCT02324569|581074362|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
160913063|NCT02324569|581074361|FG000|Overall Study|Voluntary Withdrawal|3|||
160913064|NCT02324569|581074362|FG001|Overall Study|Voluntary Withdrawal|6|||
160913065|NCT02324569|581074361|FG000|Overall Study|Lack of Efficacy|2|||
160913066|NCT02324569|581074362|FG001|Overall Study|Lack of Efficacy|3|||
160913067|NCT02324569|581074361|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
160913068|NCT02324569|581074362|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
160913069|NCT02324569|581074361|FG000|Overall Study|Inconvenient Schedule|2|||
160913070|NCT02324569|581074362|FG001|Overall Study|Inconvenient Schedule|0|||
160913071|NCT00793403|581074371|FG000|Overall Study|Other|73|||
160913072|NCT00309387|581074375|FG000|Overall Study|Death|72|||
160913073|NCT00309387|581074376|FG001|Overall Study|Death|73|||
160913074|NCT00309387|581074375|FG000|Overall Study|Lost to Follow-up|70|||
160913075|NCT00309387|581074376|FG001|Overall Study|Lost to Follow-up|86|||
160913076|NCT02899988|581074378|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
160913077|NCT02899988|581074379|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
160913078|NCT02899988|581074380|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913079|NCT02899988|581074381|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913080|NCT02899988|581074382|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913081|NCT02899988|581074383|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913082|NCT02899988|581074384|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913083|NCT02899988|581074385|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913084|NCT02899988|581074386|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913085|NCT02899988|581074387|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913086|NCT02899988|581074388|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
160913087|NCT02899988|581074378|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
160913088|NCT02899988|581074379|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
160913089|NCT02899988|581074380|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
160913090|NCT02899988|581074381|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
160913091|NCT02899988|581074382|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
160913092|NCT02899988|581074383|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
160913093|NCT02899988|581074384|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
160913094|NCT02899988|581074385|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
160913095|NCT02899988|581074386|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
160913096|NCT02899988|581074387|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
160913097|NCT02899988|581074388|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
160913098|NCT02899988|581074378|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
160913099|NCT02899988|581074379|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
160913100|NCT02899988|581074380|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
161339233|NCT01232283|582630423|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
160913101|NCT02899988|581074381|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
160913102|NCT02899988|581074382|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
160913103|NCT02899988|581074383|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
160913104|NCT02899988|581074384|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
160913105|NCT02899988|581074385|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
160913106|NCT02899988|581074386|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
160913107|NCT02899988|581074387|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
160913108|NCT02899988|581074388|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
160913109|NCT02899988|581074378|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
160913110|NCT02899988|581074379|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
160913111|NCT02899988|581074380|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
160995573|NCT05827926|581370953|FG009|Overall Study|Other Than Specified|0|||
160913112|NCT02899988|581074381|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
160913113|NCT02899988|581074382|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
160913114|NCT02899988|581074383|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913115|NCT02899988|581074384|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
160913116|NCT02899988|581074385|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913117|NCT02899988|581074386|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913118|NCT02899988|581074387|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
160913119|NCT02899988|581074388|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
160913120|NCT02899988|581074378|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913121|NCT02899988|581074379|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913122|NCT02899988|581074380|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913123|NCT02899988|581074381|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913124|NCT02899988|581074382|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913125|NCT02899988|581074383|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
160913126|NCT02899988|581074384|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913127|NCT02899988|581074385|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
160913128|NCT02899988|581074386|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913129|NCT02899988|581074387|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913130|NCT02899988|581074388|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
160913131|NCT02899988|581074378|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913132|NCT02899988|581074379|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913133|NCT02899988|581074380|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913134|NCT02899988|581074381|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913135|NCT02899988|581074382|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
160913136|NCT02899988|581074383|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913137|NCT02899988|581074384|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
160913138|NCT02899988|581074385|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
160913139|NCT02899988|581074386|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
160913140|NCT02899988|581074387|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
160913141|NCT02899988|581074388|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
160913142|NCT04492618|581074389|FG000|Overall Study|Withdrawal by Subject|1|||
160913143|NCT00856284|581074391|FG000|Overall Study|Hyperglycemic rescue|231|||
160913144|NCT00856284|581074392|FG001|Overall Study|Hyperglycemic rescue|201|||
160913145|NCT00856284|581074393|FG002|Overall Study|Hyperglycemic rescue|235|||
160913146|NCT00856284|581074391|FG000|Overall Study|Adverse Event|60|||
160913147|NCT00856284|581074392|FG001|Overall Study|Adverse Event|74|||
160913148|NCT00856284|581074393|FG002|Overall Study|Adverse Event|82|||
160913149|NCT00856284|581074391|FG000|Overall Study|Major protocol deviation|24|||
160913150|NCT00856284|581074392|FG001|Overall Study|Major protocol deviation|16|||
160913151|NCT00856284|581074393|FG002|Overall Study|Major protocol deviation|15|||
160913152|NCT00856284|581074391|FG000|Overall Study|Lost to Follow-up|20|||
160913153|NCT00856284|581074392|FG001|Overall Study|Lost to Follow-up|22|||
160913154|NCT00856284|581074393|FG002|Overall Study|Lost to Follow-up|28|||
160913155|NCT00856284|581074391|FG000|Overall Study|Voluntary withdrawal|48|||
160913156|NCT00856284|581074392|FG001|Overall Study|Voluntary withdrawal|52|||
160913157|NCT00856284|581074393|FG002|Overall Study|Voluntary withdrawal|62|||
160913158|NCT00856284|581074391|FG000|Overall Study|Pregnancy|1|||
160913159|NCT00856284|581074392|FG001|Overall Study|Pregnancy|2|||
160913160|NCT00856284|581074393|FG002|Overall Study|Pregnancy|0|||
160913161|NCT00856284|581074391|FG000|Overall Study|Investigator discretion|9|||
160913162|NCT00856284|581074392|FG001|Overall Study|Investigator discretion|8|||
160913163|NCT00856284|581074393|FG002|Overall Study|Investigator discretion|10|||
160913164|NCT00856284|581074391|FG000|Overall Study|Other|15|||
160913165|NCT00856284|581074392|FG001|Overall Study|Other|17|||
160913166|NCT00856284|581074393|FG002|Overall Study|Other|14|||
160913167|NCT00856284|581074391|FG000|Overall Study|Randomized in error|0|||
160913168|NCT00856284|581074392|FG001|Overall Study|Randomized in error|0|||
160913169|NCT00856284|581074393|FG002|Overall Study|Randomized in error|1|||
160913170|NCT02485301|581074394|FG000|Overall Study|Serious Adverse Events|2|||
160913171|NCT02485301|581074395|FG001|Overall Study|Serious Adverse Events|1|||
160913172|NCT02485301|581074394|FG000|Overall Study|Protocol Violation|0|||
160913173|NCT02485301|581074395|FG001|Overall Study|Protocol Violation|1|||
160913174|NCT02485301|581074394|FG000|Overall Study|Withdrawal by Subject|6|||
160913175|NCT02485301|581074395|FG001|Overall Study|Withdrawal by Subject|7|||
160913176|NCT02485301|581074394|FG000|Overall Study|Migrated/moved from study area|10|||
160913177|NCT02485301|581074395|FG001|Overall Study|Migrated/moved from study area|19|||
161142653|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Other|0|||
160913178|NCT02485301|581074394|FG000|Overall Study|Lost to Follow-up|17|||
160913179|NCT02485301|581074395|FG001|Overall Study|Lost to Follow-up|17|||
160913180|NCT02485301|581074394|FG000|Overall Study|Other|3|||
160913181|NCT02485301|581074395|FG001|Overall Study|Other|4|||
160913182|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913183|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160995574|NCT05827926|581370954|FG010|Overall Study|Other Than Specified|0|||
160995575|NCT05827926|581370955|FG011|Overall Study|Other Than Specified|0|||
160995576|NCT05827926|581370956|FG012|Overall Study|Other Than Specified|0|||
160995577|NCT05827926|581370957|FG013|Overall Study|Other Than Specified|1|||
160913184|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913185|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913186|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913187|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
160913188|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
160913189|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913190|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913191|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913192|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913193|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913194|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
160913195|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
160913196|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913197|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913198|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913199|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913200|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913201|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
160913202|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
160913203|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913204|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913205|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913206|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913207|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913208|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
160913209|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
160913210|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
160913211|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
160913212|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
160913213|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
160913214|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
160913215|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
160913216|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
160913217|NCT01059825|581074396|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
160913218|NCT01059825|581074397|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
160913219|NCT01059825|581074398|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
160913220|NCT01059825|581074399|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
160913221|NCT01059825|581074400|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
160913222|NCT01059825|581074401|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
160913223|NCT01059825|581074402|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
160913224|NCT01059825|581074396|FG000|Treatment Period|Lost to Follow-up|2|||
160913225|NCT01059825|581074397|FG001|Treatment Period|Lost to Follow-up|1|||
160913226|NCT01059825|581074398|FG002|Treatment Period|Lost to Follow-up|0|||
160913227|NCT01059825|581074399|FG003|Treatment Period|Lost to Follow-up|1|||
160913228|NCT01059825|581074400|FG004|Treatment Period|Lost to Follow-up|2|||
160913229|NCT01059825|581074401|FG005|Treatment Period|Lost to Follow-up|0|||
160913230|NCT01059825|581074402|FG006|Treatment Period|Lost to Follow-up|0|||
160913231|NCT01059825|581074396|FG000|Treatment Period|Withdrawal by Subject|3|||
160913232|NCT01059825|581074397|FG001|Treatment Period|Withdrawal by Subject|0|||
160913233|NCT01059825|581074398|FG002|Treatment Period|Withdrawal by Subject|1|||
160913234|NCT01059825|581074399|FG003|Treatment Period|Withdrawal by Subject|5|||
160913235|NCT01059825|581074400|FG004|Treatment Period|Withdrawal by Subject|4|||
160913236|NCT01059825|581074401|FG005|Treatment Period|Withdrawal by Subject|1|||
160913237|NCT01059825|581074402|FG006|Treatment Period|Withdrawal by Subject|0|||
160913238|NCT01059825|581074396|FG000|Treatment Period|Other reason not specified|1|||
160913239|NCT01059825|581074397|FG001|Treatment Period|Other reason not specified|2|||
160913240|NCT01059825|581074398|FG002|Treatment Period|Other reason not specified|1|||
160913241|NCT01059825|581074399|FG003|Treatment Period|Other reason not specified|2|||
160913242|NCT01059825|581074400|FG004|Treatment Period|Other reason not specified|0|||
160913243|NCT01059825|581074401|FG005|Treatment Period|Other reason not specified|0|||
160913244|NCT01059825|581074402|FG006|Treatment Period|Other reason not specified|0|||
160913245|NCT01059825|581074396|FG000|Treatment Period|Protocol Violation|0|||
160995578|NCT05827926|581370958|FG014|Overall Study|Other Than Specified|0|||
160995579|NCT05827926|581370959|FG015|Overall Study|Other Than Specified|1|||
160995580|NCT05827926|581370960|FG016|Overall Study|Other Than Specified|0|||
161256622|NCT01213836|582318618|FG001|Period 1, First Intervention|Adverse Event|1|||
160913246|NCT01059825|581074397|FG001|Treatment Period|Protocol Violation|0|||
160913247|NCT01059825|581074398|FG002|Treatment Period|Protocol Violation|1|||
160913248|NCT01059825|581074399|FG003|Treatment Period|Protocol Violation|1|||
160913249|NCT01059825|581074400|FG004|Treatment Period|Protocol Violation|1|||
160913250|NCT01059825|581074401|FG005|Treatment Period|Protocol Violation|1|||
160913251|NCT01059825|581074402|FG006|Treatment Period|Protocol Violation|0|||
160913252|NCT01059825|581074396|FG000|Treatment Period|Adverse event related to study drug|1|||
160913253|NCT01059825|581074397|FG001|Treatment Period|Adverse event related to study drug|0|||
160913254|NCT01059825|581074398|FG002|Treatment Period|Adverse event related to study drug|1|||
160913255|NCT01059825|581074399|FG003|Treatment Period|Adverse event related to study drug|1|||
160913256|NCT01059825|581074400|FG004|Treatment Period|Adverse event related to study drug|0|||
160913257|NCT01059825|581074401|FG005|Treatment Period|Adverse event related to study drug|0|||
160913258|NCT01059825|581074402|FG006|Treatment Period|Adverse event related to study drug|0|||
160913259|NCT01059825|581074396|FG000|Treatment Period|Insufficient clinical response|3|||
160913260|NCT01059825|581074397|FG001|Treatment Period|Insufficient clinical response|0|||
160913261|NCT01059825|581074398|FG002|Treatment Period|Insufficient clinical response|0|||
160913262|NCT01059825|581074399|FG003|Treatment Period|Insufficient clinical response|0|||
160913263|NCT01059825|581074400|FG004|Treatment Period|Insufficient clinical response|0|||
160913264|NCT01059825|581074401|FG005|Treatment Period|Insufficient clinical response|0|||
160913265|NCT01059825|581074402|FG006|Treatment Period|Insufficient clinical response|0|||
160913266|NCT01059825|581074396|FG000|Treatment Period|Adverse event not related to study drug|0|||
160913267|NCT01059825|581074397|FG001|Treatment Period|Adverse event not related to study drug|1|||
160913268|NCT01059825|581074398|FG002|Treatment Period|Adverse event not related to study drug|2|||
160913269|NCT01059825|581074399|FG003|Treatment Period|Adverse event not related to study drug|1|||
160913270|NCT01059825|581074400|FG004|Treatment Period|Adverse event not related to study drug|1|||
160913271|NCT01059825|581074401|FG005|Treatment Period|Adverse event not related to study drug|1|||
160913272|NCT01059825|581074402|FG006|Treatment Period|Adverse event not related to study drug|0|||
160913273|NCT03342690|581074403|FG000|Overall Study|Missing Information|9|||
160913274|NCT03342690|581074403|FG000|Overall Study|Protocol Violation|16|||
160913275|NCT03138889|581074407|FG000|Overall Study|Withdrawal by Subject|5|||
160913276|NCT03138889|581074408|FG001|Overall Study|Withdrawal by Subject|5|||
160913277|NCT03138889|581074409|FG002|Overall Study|Withdrawal by Subject|0|||
160913278|NCT03138889|581074410|FG003|Overall Study|Withdrawal by Subject|2|||
160913279|NCT03138889|581074411|FG004|Overall Study|Withdrawal by Subject|1|||
160913280|NCT03138889|581074412|FG005|Overall Study|Withdrawal by Subject|3|||
160913281|NCT03138889|581074413|FG006|Overall Study|Withdrawal by Subject|0|||
160913282|NCT03138889|581074414|FG007|Overall Study|Withdrawal by Subject|1|||
160913283|NCT02495168|581074415|FG000|Overall Study|Other than Specified|18|||
160913284|NCT02495168|581074416|FG001|Overall Study|Other than Specified|22|||
160913285|NCT02495168|581074417|FG002|Overall Study|Other than Specified|5|||
160913286|NCT02495168|581074415|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
160913287|NCT02495168|581074416|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
160913288|NCT02495168|581074417|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
160913289|NCT02495168|581074415|FG000|Overall Study|Physician Decision|1|||
160913290|NCT02495168|581074416|FG001|Overall Study|Physician Decision|1|||
160913291|NCT02495168|581074417|FG002|Overall Study|Physician Decision|0|||
160913292|NCT02495168|581074415|FG000|Overall Study|Lost to Follow-up|10|||
160913293|NCT02495168|581074416|FG001|Overall Study|Lost to Follow-up|6|||
160913294|NCT02495168|581074417|FG002|Overall Study|Lost to Follow-up|1|||
160913295|NCT02495168|581074415|FG000|Overall Study|Withdrawal by Subject|1|||
160913296|NCT02495168|581074416|FG001|Overall Study|Withdrawal by Subject|4|||
160913297|NCT02495168|581074417|FG002|Overall Study|Withdrawal by Subject|2|||
160913298|NCT02495168|581074415|FG000|Overall Study|Protocol Violation|0|||
160913299|NCT02495168|581074416|FG001|Overall Study|Protocol Violation|10|||
160913300|NCT02495168|581074417|FG002|Overall Study|Protocol Violation|1|||
160913301|NCT02495168|581074415|FG000|Overall Study|Adverse Event|4|||
161142060|NCT02192359|581904297|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
161142061|NCT02192359|581904298|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
161142062|NCT02192359|581904295|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
160913302|NCT02495168|581074416|FG001|Overall Study|Adverse Event|8|||
160913303|NCT02495168|581074417|FG002|Overall Study|Adverse Event|3|||
160913304|NCT02495168|581074415|FG000|Overall Study|Lack of Efficacy|0|||
160913305|NCT02495168|581074416|FG001|Overall Study|Lack of Efficacy|0|||
160913306|NCT02495168|581074417|FG002|Overall Study|Lack of Efficacy|3|||
160913307|NCT04016285|581074420|FG000|Overall Study|Did not progress to surgery|2|||
160913308|NCT04016285|581074421|FG001|Overall Study|Did not progress to surgery|5|||
160913309|NCT04016285|581074420|FG000|Overall Study|Failed to collect outcome data|5|||
160913310|NCT04016285|581074421|FG001|Overall Study|Failed to collect outcome data|3|||
160913311|NCT04166435|581074422|FG000|Overall Study|2 patients ineligible for response|2|||
160913312|NCT03042533|581074423|FG000|Overall Study|MD left program|1|||
160913313|NCT03042533|581074424|FG001|Overall Study|MD left program|4|||
161256623|NCT01213836|582318617|FG000|Period 1, First Intervention|Protocol Violation|0|||
160913314|NCT03042533|581074425|FG002|Overall Study|MD left program|1|||
160913315|NCT03167411|581074429|FG000|Overall Study|Adverse Event|0|||
160913316|NCT03167411|581074430|FG001|Overall Study|Adverse Event|1|||
160913317|NCT02651922|581074431|FG000|Overall Study|due to exclusion criteria|2|||
160913318|NCT01366209|581074432|FG000|Overall Study|Adverse Event|6|||
160913319|NCT01366209|581074433|FG001|Overall Study|Adverse Event|7|||
160913320|NCT01366209|581074432|FG000|Overall Study|Withdrawal by Subject|4|||
160913321|NCT01366209|581074433|FG001|Overall Study|Withdrawal by Subject|4|||
160913322|NCT01366209|581074432|FG000|Overall Study|Death|12|||
160913323|NCT01366209|581074433|FG001|Overall Study|Death|19|||
160913324|NCT01366209|581074432|FG000|Overall Study|Lung transplantation|6|||
160913325|NCT01366209|581074433|FG001|Overall Study|Lung transplantation|1|||
160913326|NCT01366209|581074432|FG000|Overall Study|Lost to Follow-up|2|||
160913327|NCT01366209|581074433|FG001|Overall Study|Lost to Follow-up|1|||
160913328|NCT01366209|581074432|FG000|Overall Study|Physician Decision|1|||
160913329|NCT01366209|581074433|FG001|Overall Study|Physician Decision|0|||
160913330|NCT01366209|581074432|FG000|Overall Study|Sponsors decision|0|||
160913331|NCT01366209|581074433|FG001|Overall Study|Sponsors decision|1|||
160913332|NCT01366209|581074432|FG000|Overall Study|Withdrew consent|4|||
160913333|NCT01366209|581074433|FG001|Overall Study|Withdrew consent|3|||
160913334|NCT00420927|581074434|FG000|Period 1|Adverse Event|19|||
160913335|NCT00420927|581074435|FG001|Period 1|Adverse Event|15|||
160913336|NCT00420927|581074436|FG002|Period 1|Adverse Event|0|||
160913337|NCT00420927|581074437|FG003|Period 1|Adverse Event|0|||
160913338|NCT00420927|581074438|FG004|Period 1|Adverse Event|0|||
160913339|NCT00420927|581074439|FG005|Period 1|Adverse Event|0|||
160913340|NCT00420927|581074440|FG006|Period 1|Adverse Event|0|||
160913341|NCT00420927|581074434|FG000|Period 1|Withdrawal by Subject|7|||
160913342|NCT00420927|581074435|FG001|Period 1|Withdrawal by Subject|12|||
160913343|NCT00420927|581074436|FG002|Period 1|Withdrawal by Subject|0|||
160913344|NCT00420927|581074437|FG003|Period 1|Withdrawal by Subject|0|||
160913345|NCT00420927|581074438|FG004|Period 1|Withdrawal by Subject|0|||
160913346|NCT00420927|581074439|FG005|Period 1|Withdrawal by Subject|0|||
160913347|NCT00420927|581074440|FG006|Period 1|Withdrawal by Subject|0|||
160913348|NCT00420927|581074434|FG000|Period 1|Lost to Follow-up|8|||
160913349|NCT00420927|581074435|FG001|Period 1|Lost to Follow-up|6|||
160913350|NCT00420927|581074436|FG002|Period 1|Lost to Follow-up|0|||
160913351|NCT00420927|581074437|FG003|Period 1|Lost to Follow-up|0|||
160913352|NCT00420927|581074438|FG004|Period 1|Lost to Follow-up|0|||
160913353|NCT00420927|581074439|FG005|Period 1|Lost to Follow-up|0|||
160913354|NCT00420927|581074440|FG006|Period 1|Lost to Follow-up|0|||
160913355|NCT00420927|581074434|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
160913356|NCT00420927|581074435|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
160913357|NCT00420927|581074436|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913358|NCT00420927|581074437|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913359|NCT00420927|581074438|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913360|NCT00420927|581074439|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913361|NCT00420927|581074440|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
160913362|NCT00420927|581074434|FG000|Period 1|Death|2|||
160913363|NCT00420927|581074435|FG001|Period 1|Death|0|||
160913364|NCT00420927|581074436|FG002|Period 1|Death|0|||
160913365|NCT00420927|581074437|FG003|Period 1|Death|0|||
160913366|NCT00420927|581074438|FG004|Period 1|Death|0|||
160913367|NCT00420927|581074439|FG005|Period 1|Death|0|||
160913368|NCT00420927|581074440|FG006|Period 1|Death|0|||
160913369|NCT00420927|581074434|FG000|Period 1|Subject moved/relocated|0|||
160913370|NCT00420927|581074435|FG001|Period 1|Subject moved/relocated|2|||
160913371|NCT00420927|581074436|FG002|Period 1|Subject moved/relocated|0|||
160913372|NCT00420927|581074437|FG003|Period 1|Subject moved/relocated|0|||
160913373|NCT00420927|581074438|FG004|Period 1|Subject moved/relocated|0|||
160913374|NCT00420927|581074439|FG005|Period 1|Subject moved/relocated|0|||
160913375|NCT00420927|581074440|FG006|Period 1|Subject moved/relocated|0|||
160913376|NCT00420927|581074434|FG000|Period 1|Noncompliant with study drug|1|||
160913377|NCT00420927|581074435|FG001|Period 1|Noncompliant with study drug|1|||
160913378|NCT00420927|581074436|FG002|Period 1|Noncompliant with study drug|0|||
160913379|NCT00420927|581074437|FG003|Period 1|Noncompliant with study drug|0|||
160913380|NCT00420927|581074438|FG004|Period 1|Noncompliant with study drug|0|||
160913381|NCT00420927|581074439|FG005|Period 1|Noncompliant with study drug|0|||
160913382|NCT00420927|581074440|FG006|Period 1|Noncompliant with study drug|0|||
160913383|NCT00420927|581074434|FG000|Period 1|Randomization error|1|||
160913384|NCT00420927|581074435|FG001|Period 1|Randomization error|0|||
160913385|NCT00420927|581074436|FG002|Period 1|Randomization error|0|||
160913386|NCT00420927|581074437|FG003|Period 1|Randomization error|0|||
160913387|NCT00420927|581074438|FG004|Period 1|Randomization error|0|||
160913388|NCT00420927|581074439|FG005|Period 1|Randomization error|0|||
160913389|NCT00420927|581074440|FG006|Period 1|Randomization error|0|||
160913390|NCT00420927|581074434|FG000|Period 1|Suspected tuberculosis/positive test|1|||
160913391|NCT00420927|581074435|FG001|Period 1|Suspected tuberculosis/positive test|1|||
160913392|NCT00420927|581074436|FG002|Period 1|Suspected tuberculosis/positive test|0|||
160913393|NCT00420927|581074437|FG003|Period 1|Suspected tuberculosis/positive test|0|||
160913394|NCT00420927|581074438|FG004|Period 1|Suspected tuberculosis/positive test|0|||
160913395|NCT00420927|581074439|FG005|Period 1|Suspected tuberculosis/positive test|0|||
160913396|NCT00420927|581074440|FG006|Period 1|Suspected tuberculosis/positive test|0|||
160913397|NCT00420927|581074434|FG000|Period 1|Study site closure|0|||
160913398|NCT00420927|581074435|FG001|Period 1|Study site closure|1|||
160913399|NCT00420927|581074436|FG002|Period 1|Study site closure|0|||
160913400|NCT00420927|581074437|FG003|Period 1|Study site closure|0|||
160913401|NCT00420927|581074438|FG004|Period 1|Study site closure|0|||
160913402|NCT00420927|581074439|FG005|Period 1|Study site closure|0|||
160913403|NCT00420927|581074440|FG006|Period 1|Study site closure|0|||
160913404|NCT00420927|581074434|FG000|Period 1|Subject received new diagnosis|0|||
160913405|NCT00420927|581074435|FG001|Period 1|Subject received new diagnosis|2|||
160913406|NCT00420927|581074436|FG002|Period 1|Subject received new diagnosis|0|||
160913407|NCT00420927|581074437|FG003|Period 1|Subject received new diagnosis|0|||
160913408|NCT00420927|581074438|FG004|Period 1|Subject received new diagnosis|0|||
160913409|NCT00420927|581074439|FG005|Period 1|Subject received new diagnosis|0|||
160913410|NCT00420927|581074440|FG006|Period 1|Subject received new diagnosis|0|||
160913411|NCT00420927|581074434|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
160913412|NCT00420927|581074435|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
160913413|NCT00420927|581074436|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
160913414|NCT00420927|581074437|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
160913415|NCT00420927|581074438|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
160913416|NCT00420927|581074439|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
160913417|NCT00420927|581074440|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
160913418|NCT00420927|581074434|FG000|Period 1|Failed to meet entry criteria|8|||
160913419|NCT00420927|581074435|FG001|Period 1|Failed to meet entry criteria|7|||
160913420|NCT00420927|581074436|FG002|Period 1|Failed to meet entry criteria|0|||
160913421|NCT00420927|581074437|FG003|Period 1|Failed to meet entry criteria|0|||
160913422|NCT00420927|581074438|FG004|Period 1|Failed to meet entry criteria|0|||
160913423|NCT00420927|581074439|FG005|Period 1|Failed to meet entry criteria|0|||
160913424|NCT00420927|581074440|FG006|Period 1|Failed to meet entry criteria|0|||
160913425|NCT00420927|581074434|FG000|Period 1|Took prohibited medication|1|||
160913426|NCT00420927|581074435|FG001|Period 1|Took prohibited medication|3|||
160913427|NCT00420927|581074436|FG002|Period 1|Took prohibited medication|0|||
160913428|NCT00420927|581074437|FG003|Period 1|Took prohibited medication|0|||
160913429|NCT00420927|581074438|FG004|Period 1|Took prohibited medication|0|||
160913430|NCT00420927|581074439|FG005|Period 1|Took prohibited medication|0|||
160913431|NCT00420927|581074440|FG006|Period 1|Took prohibited medication|0|||
160913432|NCT00420927|581074434|FG000|Period 2|Adverse Event|0|||
160913433|NCT00420927|581074435|FG001|Period 2|Adverse Event|0|||
160913434|NCT00420927|581074436|FG002|Period 2|Adverse Event|7|||
160913435|NCT00420927|581074437|FG003|Period 2|Adverse Event|3|||
160913436|NCT00420927|581074438|FG004|Period 2|Adverse Event|17|||
160913437|NCT00420927|581074439|FG005|Period 2|Adverse Event|6|||
160913438|NCT00420927|581074440|FG006|Period 2|Adverse Event|20|||
160913439|NCT00420927|581074434|FG000|Period 2|Withdrawal by Subject|0|||
160913440|NCT00420927|581074435|FG001|Period 2|Withdrawal by Subject|0|||
160913441|NCT00420927|581074436|FG002|Period 2|Withdrawal by Subject|1|||
160913442|NCT00420927|581074437|FG003|Period 2|Withdrawal by Subject|3|||
160913443|NCT00420927|581074438|FG004|Period 2|Withdrawal by Subject|11|||
160913444|NCT00420927|581074439|FG005|Period 2|Withdrawal by Subject|2|||
160913445|NCT00420927|581074440|FG006|Period 2|Withdrawal by Subject|12|||
160913446|NCT00420927|581074434|FG000|Period 2|Lost to Follow-up|0|||
160913447|NCT00420927|581074435|FG001|Period 2|Lost to Follow-up|0|||
160913448|NCT00420927|581074436|FG002|Period 2|Lost to Follow-up|2|||
160913449|NCT00420927|581074437|FG003|Period 2|Lost to Follow-up|2|||
160913450|NCT00420927|581074438|FG004|Period 2|Lost to Follow-up|6|||
160913451|NCT00420927|581074439|FG005|Period 2|Lost to Follow-up|3|||
160913452|NCT00420927|581074440|FG006|Period 2|Lost to Follow-up|9|||
161142063|NCT02192359|581904296|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161142064|NCT02192359|581904297|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
161142065|NCT02192359|581904298|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
160913453|NCT00420927|581074434|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
160913454|NCT00420927|581074435|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
160913455|NCT00420927|581074436|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
160913456|NCT00420927|581074437|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
160913457|NCT00420927|581074438|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
160913458|NCT00420927|581074439|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
160913459|NCT00420927|581074440|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
160913460|NCT00420927|581074434|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
160913461|NCT00420927|581074435|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
160913462|NCT00420927|581074436|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
160913463|NCT00420927|581074437|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
160913464|NCT00420927|581074438|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
160913465|NCT00420927|581074439|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
160913466|NCT00420927|581074440|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
160913467|NCT00420927|581074434|FG000|Period 2|Subject unable to find transportation|0|||
160913468|NCT00420927|581074435|FG001|Period 2|Subject unable to find transportation|0|||
160913469|NCT00420927|581074436|FG002|Period 2|Subject unable to find transportation|0|||
160913470|NCT00420927|581074437|FG003|Period 2|Subject unable to find transportation|0|||
160913471|NCT00420927|581074438|FG004|Period 2|Subject unable to find transportation|0|||
160913472|NCT00420927|581074439|FG005|Period 2|Subject unable to find transportation|0|||
160913473|NCT00420927|581074440|FG006|Period 2|Subject unable to find transportation|1|||
160913474|NCT00420927|581074434|FG000|Period 2|Physician Decision|0|||
160913475|NCT00420927|581074435|FG001|Period 2|Physician Decision|0|||
160913476|NCT00420927|581074436|FG002|Period 2|Physician Decision|0|||
160913477|NCT00420927|581074437|FG003|Period 2|Physician Decision|0|||
160913478|NCT00420927|581074438|FG004|Period 2|Physician Decision|1|||
160913479|NCT00420927|581074439|FG005|Period 2|Physician Decision|1|||
160913480|NCT00420927|581074440|FG006|Period 2|Physician Decision|0|||
160913481|NCT00420927|581074434|FG000|Period 2|Sponsor decision|0|||
160913482|NCT00420927|581074435|FG001|Period 2|Sponsor decision|0|||
160913483|NCT00420927|581074436|FG002|Period 2|Sponsor decision|1|||
160913484|NCT00420927|581074437|FG003|Period 2|Sponsor decision|0|||
160913485|NCT00420927|581074438|FG004|Period 2|Sponsor decision|0|||
160913486|NCT00420927|581074439|FG005|Period 2|Sponsor decision|0|||
160913487|NCT00420927|581074440|FG006|Period 2|Sponsor decision|1|||
160913488|NCT00420927|581074434|FG000|Period 2|Randomization error|0|||
160913489|NCT00420927|581074435|FG001|Period 2|Randomization error|0|||
160913490|NCT00420927|581074436|FG002|Period 2|Randomization error|0|||
160913491|NCT00420927|581074437|FG003|Period 2|Randomization error|0|||
160913492|NCT00420927|581074438|FG004|Period 2|Randomization error|1|||
160913493|NCT00420927|581074439|FG005|Period 2|Randomization error|1|||
160913494|NCT00420927|581074440|FG006|Period 2|Randomization error|0|||
160913495|NCT00420927|581074434|FG000|Period 2|Noncompliant with study drug|0|||
160913496|NCT00420927|581074435|FG001|Period 2|Noncompliant with study drug|0|||
160913497|NCT00420927|581074436|FG002|Period 2|Noncompliant with study drug|0|||
160913498|NCT00420927|581074437|FG003|Period 2|Noncompliant with study drug|1|||
160913499|NCT00420927|581074438|FG004|Period 2|Noncompliant with study drug|0|||
160913500|NCT00420927|581074439|FG005|Period 2|Noncompliant with study drug|0|||
160913501|NCT00420927|581074440|FG006|Period 2|Noncompliant with study drug|2|||
160913502|NCT00420927|581074434|FG000|Period 2|Methotrexate intolerance|0|||
160913503|NCT00420927|581074435|FG001|Period 2|Methotrexate intolerance|0|||
160913504|NCT00420927|581074436|FG002|Period 2|Methotrexate intolerance|0|||
160913505|NCT00420927|581074437|FG003|Period 2|Methotrexate intolerance|0|||
160913506|NCT00420927|581074438|FG004|Period 2|Methotrexate intolerance|0|||
160913507|NCT00420927|581074439|FG005|Period 2|Methotrexate intolerance|0|||
160913508|NCT00420927|581074440|FG006|Period 2|Methotrexate intolerance|1|||
160913509|NCT00420927|581074434|FG000|Period 2|Took prohibited medication|0|||
160913510|NCT00420927|581074435|FG001|Period 2|Took prohibited medication|0|||
160913511|NCT00420927|581074436|FG002|Period 2|Took prohibited medication|0|||
160913512|NCT00420927|581074437|FG003|Period 2|Took prohibited medication|0|||
160913513|NCT00420927|581074438|FG004|Period 2|Took prohibited medication|1|||
160913514|NCT00420927|581074439|FG005|Period 2|Took prohibited medication|0|||
160913515|NCT00420927|581074440|FG006|Period 2|Took prohibited medication|0|||
160913516|NCT03018704|581074441|FG000|Overall Study|Lost to Follow-up|1|||
160913517|NCT03018704|581074442|FG001|Overall Study|Lost to Follow-up|1|||
160913518|NCT00320411|581074443|FG000|Overall Study|No investigational product admin.|4|||
160913519|NCT04448171|581074446|FG000|Overall Study|Procedure Cancelled|1|||
160913520|NCT04448171|581074447|FG001|Overall Study|Procedure Cancelled|0|||
160913521|NCT04448171|581074446|FG000|Overall Study|Protocol Violation|1|||
160913522|NCT04448171|581074447|FG001|Overall Study|Protocol Violation|0|||
160913523|NCT02088047|581074448|FG000|Overall Study|Withdrawal by Subject|1|||
160913524|NCT02088047|581074449|FG001|Overall Study|Withdrawal by Subject|0|||
160913525|NCT01025752|581074450|FG000|Overall Study|Lost to Follow-up|7|||
160913526|NCT01025752|581074451|FG001|Overall Study|Lost to Follow-up|10|||
160913527|NCT01025752|581074450|FG000|Overall Study|Physician Decision|1|||
160913528|NCT01025752|581074451|FG001|Overall Study|Physician Decision|3|||
160913529|NCT00023764|581074452|FG000|Overall Study|Other|1|||
160913530|NCT00023764|581074452|FG000|Overall Study|Adverse Event|4|||
160913531|NCT00023764|581074452|FG000|Overall Study|Withdrawal by Subject|1|||
160913532|NCT00023764|581074452|FG000|Overall Study|Progression of disease|6|||
160913533|NCT00023764|581074452|FG000|Overall Study|patient received other treatment|1|||
160913534|NCT00023764|581074452|FG000|Overall Study|delay in obtaining staging images|1|||
160913535|NCT00855920|581074453|FG000|Overall Study|Protocol Violation|0|||
160913536|NCT00855920|581074454|FG001|Overall Study|Protocol Violation|0|||
160913537|NCT00855920|581074455|FG002|Overall Study|Protocol Violation|2|||
160913538|NCT00855920|581074453|FG000|Overall Study|Adverse Event|2|||
160913539|NCT00855920|581074454|FG001|Overall Study|Adverse Event|1|||
160913540|NCT00855920|581074455|FG002|Overall Study|Adverse Event|1|||
160913541|NCT00855920|581074453|FG000|Overall Study|Lack of Efficacy|2|||
160913542|NCT00855920|581074454|FG001|Overall Study|Lack of Efficacy|2|||
160913543|NCT00855920|581074455|FG002|Overall Study|Lack of Efficacy|2|||
160913544|NCT00855920|581074453|FG000|Overall Study|Withdrawal by Subject|2|||
160913545|NCT00855920|581074454|FG001|Overall Study|Withdrawal by Subject|3|||
160913546|NCT00855920|581074455|FG002|Overall Study|Withdrawal by Subject|2|||
160913547|NCT00855920|581074453|FG000|Overall Study|Lost to Follow-up|1|||
160913548|NCT00855920|581074454|FG001|Overall Study|Lost to Follow-up|0|||
160913549|NCT00855920|581074455|FG002|Overall Study|Lost to Follow-up|2|||
160913550|NCT00855920|581074453|FG000|Overall Study|Death|0|||
160913551|NCT00855920|581074454|FG001|Overall Study|Death|1|||
160913552|NCT00855920|581074455|FG002|Overall Study|Death|0|||
160913553|NCT00855920|581074453|FG000|Overall Study|Decision by the sponsor|0|||
160913554|NCT00855920|581074454|FG001|Overall Study|Decision by the sponsor|1|||
160913555|NCT00855920|581074455|FG002|Overall Study|Decision by the sponsor|1|||
160913556|NCT00855920|581074453|FG000|Overall Study|Other than specified above|1|||
160913557|NCT00855920|581074454|FG001|Overall Study|Other than specified above|1|||
160913558|NCT00855920|581074455|FG002|Overall Study|Other than specified above|1|||
160913559|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
160913560|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
160913561|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913562|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913563|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913564|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
160913565|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
160913566|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
160913567|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913568|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913569|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913570|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
160913571|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
160913572|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
160913573|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913574|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913575|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913576|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
160913577|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
160913578|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
160913579|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913580|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913581|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913582|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
160913583|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
160913584|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
160913585|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913586|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913587|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913588|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
160913589|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913590|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
160913591|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913592|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913593|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913594|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
160913595|NCT00843024|581074458|FG000|Single-blind Placebo Run-In Phase|Other|0|||
160913596|NCT00843024|581074459|FG001|Single-blind Placebo Run-In Phase|Other|1|||
160913597|NCT00843024|581074460|FG002|Single-blind Placebo Run-In Phase|Other|0|||
160913598|NCT00843024|581074461|FG003|Single-blind Placebo Run-In Phase|Other|0|||
160995581|NCT05827926|581370961|FG017|Overall Study|Other Than Specified|0|||
160995582|NCT05827926|581370962|FG018|Overall Study|Other Than Specified|0|||
160913599|NCT00843024|581074462|FG004|Single-blind Placebo Run-In Phase|Other|0|||
160913600|NCT00843024|581074463|FG005|Single-blind Placebo Run-In Phase|Other|0|||
160913601|NCT00843024|581074458|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
160913602|NCT00843024|581074459|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
160913603|NCT00843024|581074460|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
160913604|NCT00843024|581074461|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
160913605|NCT00843024|581074462|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
160913606|NCT00843024|581074463|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
160913607|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160913608|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
160995583|NCT05827926|581370963|FG019|Overall Study|Other Than Specified|0|||
160995584|NCT05827926|581370964|FG020|Overall Study|Other Than Specified|0|||
160913609|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
160913610|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
160913611|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
160913612|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
160913613|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913614|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913615|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913616|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
160913617|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160913618|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
160913619|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
160913620|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
160913621|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
160913622|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
160913623|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
160913624|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
160913625|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Physician Decision|0|||
160913626|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Physician Decision|0|||
160913627|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Physician Decision|0|||
160913628|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Physician Decision|3|||
160913629|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Physician Decision|1|||
160913630|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Physician Decision|1|||
160913631|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160913632|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Adverse Event|0|||
160913633|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Adverse Event|0|||
160913634|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Adverse Event|0|||
160913635|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Adverse Event|1|||
160913636|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Adverse Event|1|||
160913637|NCT00843024|581074458|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913638|NCT00843024|581074459|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913639|NCT00843024|581074460|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913640|NCT00843024|581074461|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913641|NCT00843024|581074462|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
160913642|NCT00843024|581074463|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
160913643|NCT01032837|581074464|FG000|Overall Study|Adverse event/internal illness|0|||
160913644|NCT01032837|581074465|FG001|Overall Study|Adverse event/internal illness|1|||
160913645|NCT01032837|581074466|FG002|Overall Study|Adverse event/internal illness|0|||
160913646|NCT01032837|581074467|FG003|Overall Study|Adverse event/internal illness|1|||
160913647|NCT01032837|581074464|FG000|Overall Study|Withdrew consent|0|||
160913648|NCT01032837|581074465|FG001|Overall Study|Withdrew consent|2|||
160913649|NCT01032837|581074466|FG002|Overall Study|Withdrew consent|0|||
160913650|NCT01032837|581074467|FG003|Overall Study|Withdrew consent|1|||
160913651|NCT01032837|581074464|FG000|Overall Study|Failed to return|0|||
160913652|NCT01032837|581074465|FG001|Overall Study|Failed to return|0|||
160913653|NCT01032837|581074466|FG002|Overall Study|Failed to return|1|||
160913654|NCT01032837|581074467|FG003|Overall Study|Failed to return|0|||
160913655|NCT01032837|581074464|FG000|Overall Study|Refused treatment|0|||
160913656|NCT01032837|581074465|FG001|Overall Study|Refused treatment|0|||
160913657|NCT01032837|581074466|FG002|Overall Study|Refused treatment|0|||
160913658|NCT01032837|581074467|FG003|Overall Study|Refused treatment|1|||
160913659|NCT05201703|581074468|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
160913660|NCT05201703|581074469|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
160913661|NCT05201703|581074468|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
160913662|NCT05201703|581074469|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
160913663|NCT00844896|581074470|FG000|Overall Study|Lost to Follow-up|12|||
160913664|NCT00844896|581074471|FG001|Overall Study|Lost to Follow-up|16|||
160913665|NCT00844896|581074470|FG000|Overall Study|Parents did not have time to complete|0|||
160913666|NCT00844896|581074471|FG001|Overall Study|Parents did not have time to complete|1|||
160913667|NCT02233647|581074472|FG000|Overall Study|Adverse Event|1|||
160913668|NCT00458211|581074473|FG000|Overall Study|Lack of Efficacy|12|||
160913669|NCT00458211|581074473|FG000|Overall Study|Withdrawal by Subject|2|||
160913670|NCT00458211|581074473|FG000|Overall Study|Protocol Violation|2|||
160913671|NCT00838578|581074477|FG000|Overall Study|Protocol Violation|2|||
160913672|NCT00357968|581074482|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
160913673|NCT00357968|581074483|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
160913674|NCT00357968|581074482|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
160913675|NCT00357968|581074483|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
160913676|NCT03919799|581074484|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
160913677|NCT03919799|581074485|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
160913678|NCT03919799|581074486|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
160913679|NCT03919799|581074487|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
160913680|NCT03919799|581074488|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
160913681|NCT03919799|581074484|FG000|DB Period (28 Weeks)|Adverse Event|1|||
160913682|NCT03919799|581074485|FG001|DB Period (28 Weeks)|Adverse Event|1|||
160913683|NCT03919799|581074486|FG002|DB Period (28 Weeks)|Adverse Event|1|||
160913684|NCT03919799|581074487|FG003|DB Period (28 Weeks)|Adverse Event|0|||
160913685|NCT03919799|581074488|FG004|DB Period (28 Weeks)|Adverse Event|0|||
160913686|NCT03919799|581074484|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913687|NCT03919799|581074485|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
160913688|NCT03919799|581074486|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913689|NCT03919799|581074487|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913690|NCT03919799|581074488|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
160913691|NCT03919799|581074484|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913692|NCT03919799|581074485|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
160913693|NCT03919799|581074486|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913694|NCT03919799|581074487|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913695|NCT03919799|581074488|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
160913696|NCT03919799|581074484|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
160913697|NCT03919799|581074485|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
160913698|NCT03919799|581074486|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
160913699|NCT03919799|581074487|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
160913700|NCT03919799|581074488|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
160913701|NCT00679302|581074490|FG000|Overall Study|Lost to Follow-up|8|||
160913702|NCT00679302|581074491|FG001|Overall Study|Lost to Follow-up|4|||
160913703|NCT03547687|581074492|FG000|Overall Study|Withdrawal by Subject|1|||
160913704|NCT03547687|581074492|FG000|Overall Study|Death|1|||
160913705|NCT00646776|581074493|FG000|Overall Study|Adverse Event|1|||
160913706|NCT00646776|581074494|FG001|Overall Study|Adverse Event|9|||
160913707|NCT00646776|581074493|FG000|Overall Study|Investigator discretion|0|||
160913708|NCT00646776|581074494|FG001|Overall Study|Investigator discretion|4|||
160913709|NCT04600921|581074495|FG000|Overall Study|Withdrawal by Subject|3|||
160913710|NCT04600921|581074496|FG001|Overall Study|Withdrawal by Subject|5|||
160913711|NCT04600921|581074495|FG000|Overall Study|Death|0|||
160913712|NCT04600921|581074496|FG001|Overall Study|Death|1|||
160913713|NCT04419714|581074497|FG000|Overall Study|Technical Fault|5|||
160913714|NCT04419714|581074497|FG000|Overall Study|Protocol Deviation|2|||
160913715|NCT04419714|581074497|FG000|Overall Study|Withdrawal by Subject|1|||
160913716|NCT05425745|581074501|FG000|Overall Study|Withdrawal of Consent|3|||
160913717|NCT05425745|581074502|FG001|Overall Study|Withdrawal of Consent|3|||
160913718|NCT05425745|581074501|FG000|Overall Study|Death|2|||
160913719|NCT05425745|581074502|FG001|Overall Study|Death|3|||
160913720|NCT05425745|581074501|FG000|Overall Study|Lost to Follow-up|1|||
160913721|NCT05425745|581074502|FG001|Overall Study|Lost to Follow-up|2|||
160913722|NCT05425745|581074501|FG000|Overall Study|Adverse Event|0|||
160913723|NCT05425745|581074502|FG001|Overall Study|Adverse Event|1|||
160913724|NCT05425745|581074501|FG000|Overall Study|Did not return for end of study visit|0|||
160913725|NCT05425745|581074502|FG001|Overall Study|Did not return for end of study visit|1|||
160913726|NCT05425745|581074501|FG000|Overall Study|End of study visit completed by phone|1|||
160913727|NCT05425745|581074502|FG001|Overall Study|End of study visit completed by phone|0|||
160913728|NCT05425745|581074501|FG000|Overall Study|Subject decision|1|||
160913729|NCT05425745|581074502|FG001|Overall Study|Subject decision|0|||
160913730|NCT00524368|581075701|FG000|Overall Study|Adverse Event|10|||
160913731|NCT00524368|581075702|FG001|Overall Study|Adverse Event|12|||
160913732|NCT00524368|581075701|FG000|Overall Study|Lost to Follow-up|9|||
160913733|NCT00524368|581075702|FG001|Overall Study|Lost to Follow-up|13|||
160913734|NCT00524368|581075701|FG000|Overall Study|Withdrawal by Subject|4|||
160913735|NCT00524368|581075702|FG001|Overall Study|Withdrawal by Subject|5|||
161142066|NCT02192359|581904295|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161142067|NCT02192359|581904296|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161142068|NCT02192359|581904297|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
161142654|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Other|0|||
160913736|NCT00524368|581075701|FG000|Overall Study|Non-compliant|8|||
160913737|NCT00524368|581075702|FG001|Overall Study|Non-compliant|9|||
160913738|NCT00524368|581075701|FG000|Overall Study|Reached a Virologic Endpoint|3|||
160913739|NCT00524368|581075702|FG001|Overall Study|Reached a Virologic Endpoint|2|||
160995585|NCT05827926|581370965|FG021|Overall Study|Other Than Specified|1|||
160995586|NCT05827926|581370966|FG022|Overall Study|Other Than Specified|1|||
160913740|NCT00524368|581075701|FG000|Overall Study|Sponsor's Decision|2|||
160913741|NCT00524368|581075702|FG001|Overall Study|Sponsor's Decision|0|||
160913742|NCT00524368|581075701|FG000|Overall Study|Ineligible to Continue the study|2|||
160913743|NCT00524368|581075702|FG001|Overall Study|Ineligible to Continue the study|5|||
160913744|NCT00524368|581075701|FG000|Overall Study|Other|3|||
160913745|NCT00524368|581075702|FG001|Overall Study|Other|2|||
160995587|NCT05827926|581370967|FG023|Overall Study|Other Than Specified|0|||
160913746|NCT03010254|581075705|FG000|Overall Study|Adverse Event|0|||
160913747|NCT03010254|581075706|FG001|Overall Study|Adverse Event|1|||
160913748|NCT03010254|581075705|FG000|Overall Study|Lost to Follow-up|4|||
160913749|NCT03010254|581075706|FG001|Overall Study|Lost to Follow-up|0|||
160913750|NCT03010254|581075705|FG000|Overall Study|Withdrawal by Subject|1|||
160913751|NCT03010254|581075706|FG001|Overall Study|Withdrawal by Subject|1|||
160913752|NCT03010254|581075705|FG000|Overall Study|Other|2|||
160913753|NCT03010254|581075706|FG001|Overall Study|Other|3|||
160913754|NCT03312933|581075707|FG000|Overall Study|Protocol Violation|15|||
160913755|NCT03312933|581075707|FG000|Overall Study|Lost to Follow-up|36|||
160913756|NCT03312933|581075707|FG000|Overall Study|Withdrawal by Subject|3|||
160913757|NCT00848081|581075709|FG000|Overall Study|Adverse Event|6|||
160913758|NCT00848081|581075710|FG001|Overall Study|Adverse Event|7|||
160913759|NCT00848081|581075709|FG000|Overall Study|Protocol Violation|8|||
160913760|NCT00848081|581075710|FG001|Overall Study|Protocol Violation|5|||
160913761|NCT00848081|581075709|FG000|Overall Study|Lost to Follow-up|1|||
160913762|NCT00848081|581075710|FG001|Overall Study|Lost to Follow-up|0|||
160913763|NCT00848081|581075709|FG000|Overall Study|Physician Decision|0|||
160913764|NCT00848081|581075710|FG001|Overall Study|Physician Decision|3|||
160913765|NCT00848081|581075709|FG000|Overall Study|Withdrawal by Subject|5|||
160913766|NCT00848081|581075710|FG001|Overall Study|Withdrawal by Subject|3|||
160913767|NCT01752907|581075711|FG000|Overall Study|Withdrawal by Subject|4|||
160913768|NCT01752907|581075712|FG001|Overall Study|Withdrawal by Subject|10|||
160913769|NCT01752907|581075711|FG000|Overall Study|Lost to Follow-up|2|||
160913770|NCT01752907|581075712|FG001|Overall Study|Lost to Follow-up|1|||
160913771|NCT01752907|581075711|FG000|Overall Study|Decision by Sponsor|6|||
160913772|NCT01752907|581075712|FG001|Overall Study|Decision by Sponsor|9|||
160913773|NCT03098550|581075713|FG000|Overall Study|Disease Progression|30|||
160913774|NCT03098550|581075714|FG001|Overall Study|Disease Progression|19|||
160913775|NCT03098550|581075715|FG002|Overall Study|Disease Progression|41|||
160913776|NCT03098550|581075713|FG000|Overall Study|Study Drug Toxicity|2|||
160913777|NCT03098550|581075714|FG001|Overall Study|Study Drug Toxicity|1|||
160995588|NCT05827926|581370968|FG024|Overall Study|Other Than Specified|0|||
160995589|NCT05827926|581370969|FG025|Overall Study|Other Than Specified|1|||
160995590|NCT05827926|581370970|FG026|Overall Study|Other Than Specified|0|||
160995591|NCT05827926|581370971|FG027|Overall Study|Other Than Specified|0|||
160995592|NCT05827926|581370972|FG028|Overall Study|Other Than Specified|0|||
160995593|NCT05827926|581370973|FG029|Overall Study|Other Than Specified|0|||
160995594|NCT05827926|581370974|FG030|Overall Study|Other Than Specified|0|||
160995595|NCT05827926|581370975|FG031|Overall Study|Other Than Specified|1|||
160995596|NCT05827926|581370976|FG032|Overall Study|Other Than Specified|0|||
160995597|NCT05827926|581370977|FG033|Overall Study|Other Than Specified|0|||
160995598|NCT05827926|581370978|FG034|Overall Study|Other Than Specified|0|||
160995599|NCT05827926|581370979|FG035|Overall Study|Other Than Specified|0|||
160995600|NCT05827926|581370980|FG036|Overall Study|Other Than Specified|0|||
160995601|NCT05827926|581370944|FG000|Overall Study|Physician Decision|0|||
160995602|NCT05827926|581370945|FG001|Overall Study|Physician Decision|0|||
160995603|NCT05827926|581370946|FG002|Overall Study|Physician Decision|0|||
160995604|NCT05827926|581370947|FG003|Overall Study|Physician Decision|0|||
160995605|NCT05827926|581370948|FG004|Overall Study|Physician Decision|0|||
160995606|NCT05827926|581370949|FG005|Overall Study|Physician Decision|0|||
160995607|NCT05827926|581370950|FG006|Overall Study|Physician Decision|0|||
160995608|NCT05827926|581370951|FG007|Overall Study|Physician Decision|0|||
160995609|NCT05827926|581370952|FG008|Overall Study|Physician Decision|0|||
160995610|NCT05827926|581370953|FG009|Overall Study|Physician Decision|0|||
160995611|NCT05827926|581370954|FG010|Overall Study|Physician Decision|0|||
161142655|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Other|0|||
161256624|NCT01213836|582318618|FG001|Period 1, First Intervention|Protocol Violation|1|||
161256625|NCT01213836|582318617|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
160995612|NCT05827926|581370955|FG011|Overall Study|Physician Decision|0|||
160995613|NCT05827926|581370956|FG012|Overall Study|Physician Decision|0|||
160995614|NCT05827926|581370957|FG013|Overall Study|Physician Decision|0|||
160995615|NCT05827926|581370958|FG014|Overall Study|Physician Decision|0|||
160995616|NCT05827926|581370959|FG015|Overall Study|Physician Decision|0|||
160913778|NCT03098550|581075715|FG002|Overall Study|Study Drug Toxicity|0|||
160913779|NCT03098550|581075713|FG000|Overall Study|Death|1|||
160913780|NCT03098550|581075714|FG001|Overall Study|Death|0|||
160913781|NCT03098550|581075715|FG002|Overall Study|Death|0|||
160913782|NCT03098550|581075713|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
160913783|NCT03098550|581075714|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
160913784|NCT03098550|581075715|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
160913785|NCT03098550|581075713|FG000|Overall Study|Administrative reason by sponsor|0|||
160995617|NCT05827926|581370960|FG016|Overall Study|Physician Decision|0|||
160995618|NCT05827926|581370961|FG017|Overall Study|Physician Decision|0|||
160995619|NCT05827926|581370962|FG018|Overall Study|Physician Decision|1|||
160995620|NCT05827926|581370963|FG019|Overall Study|Physician Decision|0|||
160995621|NCT05827926|581370964|FG020|Overall Study|Physician Decision|0|||
160995622|NCT05827926|581370965|FG021|Overall Study|Physician Decision|0|||
160913786|NCT03098550|581075714|FG001|Overall Study|Administrative reason by sponsor|0|||
160913787|NCT03098550|581075715|FG002|Overall Study|Administrative reason by sponsor|1|||
160913788|NCT03098550|581075713|FG000|Overall Study|Other reasons|2|||
160913789|NCT03098550|581075714|FG001|Overall Study|Other reasons|0|||
160913790|NCT03098550|581075715|FG002|Overall Study|Other reasons|0|||
160913791|NCT00630396|581075716|FG000|Overall Study|Death|4|||
160913792|NCT00630396|581075716|FG000|Overall Study|Lost to Follow-up|3|||
160913793|NCT00381095|581075726|FG000|Overall Study|Death|3|||
160913794|NCT00381095|581075727|FG001|Overall Study|Death|4|||
160913795|NCT00381095|581075726|FG000|Overall Study|Lack of Efficacy|2|||
160913796|NCT00381095|581075727|FG001|Overall Study|Lack of Efficacy|4|||
160913797|NCT00381095|581075726|FG000|Overall Study|Other|2|||
160913798|NCT00381095|581075727|FG001|Overall Study|Other|2|||
160913799|NCT00381095|581075726|FG000|Overall Study|Protocol Violation|1|||
160913800|NCT00381095|581075727|FG001|Overall Study|Protocol Violation|1|||
160913801|NCT00381095|581075726|FG000|Overall Study|Withdrawal by Subject|3|||
160913802|NCT00381095|581075727|FG001|Overall Study|Withdrawal by Subject|3|||
160913803|NCT00381095|581075726|FG000|Overall Study|Adverse Event|2|||
160913804|NCT00381095|581075727|FG001|Overall Study|Adverse Event|7|||
160913805|NCT03562481|581075728|FG000|First Intervention|Lost to Follow-up|1|||
160913806|NCT03562481|581075729|FG001|First Intervention|Lost to Follow-up|0|||
160913807|NCT01327885|581075734|FG000|Overall Study|Disease progression-according to RECIST|173|||
160913808|NCT01327885|581075735|FG001|Overall Study|Disease progression-according to RECIST|165|||
160913809|NCT01327885|581075734|FG000|Overall Study|Clinical progression|24|||
160913810|NCT01327885|581075735|FG001|Overall Study|Clinical progression|27|||
160913811|NCT01327885|581075734|FG000|Overall Study|Adverse Event|14|||
160913812|NCT01327885|581075735|FG001|Overall Study|Adverse Event|10|||
160913813|NCT01327885|581075734|FG000|Overall Study|Subject choice|5|||
160913814|NCT01327885|581075735|FG001|Overall Study|Subject choice|10|||
160913815|NCT01327885|581075734|FG000|Overall Study|Other|8|||
160913816|NCT01327885|581075735|FG001|Overall Study|Other|6|||
160913817|NCT01327885|581075734|FG000|Overall Study|Withdrawal of consent from study|3|||
160913818|NCT01327885|581075735|FG001|Overall Study|Withdrawal of consent from study|4|||
160913819|NCT01327885|581075734|FG000|Overall Study|Not treated|1|||
160913820|NCT01327885|581075735|FG001|Overall Study|Not treated|1|||
160913821|NCT01327885|581075734|FG000|Overall Study|Administrative decision|0|||
160913822|NCT01327885|581075735|FG001|Overall Study|Administrative decision|1|||
160913823|NCT03824912|581075741|FG000|Overall Study|Lost to Follow-up|18|||
160913824|NCT03824912|581075742|FG001|Overall Study|Lost to Follow-up|15|||
160913825|NCT03824912|581075743|FG002|Overall Study|Lost to Follow-up|8|||
160913826|NCT03824912|581075741|FG000|Overall Study|Negative Baseline Culture Result|118|||
160913827|NCT03824912|581075742|FG001|Overall Study|Negative Baseline Culture Result|112|||
160913828|NCT03824912|581075743|FG002|Overall Study|Negative Baseline Culture Result|57|||
160913829|NCT03824912|581075741|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160913830|NCT03824912|581075742|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160913831|NCT03824912|581075743|FG002|Overall Study|Non-Compliance with Study Drug|1|||
160913832|NCT03824912|581075741|FG000|Overall Study|Protocol Violation|1|||
160913833|NCT03824912|581075742|FG001|Overall Study|Protocol Violation|4|||
160913834|NCT03824912|581075743|FG002|Overall Study|Protocol Violation|1|||
160913835|NCT03824912|581075741|FG000|Overall Study|Withdrawal by Subject|3|||
160913836|NCT03824912|581075742|FG001|Overall Study|Withdrawal by Subject|2|||
160913837|NCT03824912|581075743|FG002|Overall Study|Withdrawal by Subject|1|||
160913838|NCT03824912|581075741|FG000|Overall Study|Participation in another study|0|||
160913839|NCT03824912|581075742|FG001|Overall Study|Participation in another study|1|||
160913840|NCT03824912|581075743|FG002|Overall Study|Participation in another study|0|||
160913841|NCT04271605|581075744|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
160913842|NCT00105482|581075759|FG000|Overall Study|Adverse Event|1|||
160913843|NCT00105482|581075760|FG001|Overall Study|Adverse Event|1|||
160913844|NCT00105482|581075759|FG000|Overall Study|Lost to Follow-up|26|||
160913845|NCT00105482|581075760|FG001|Overall Study|Lost to Follow-up|17|||
160913846|NCT00105482|581075759|FG000|Overall Study|Withdrawal by Subject|0|||
160913847|NCT00105482|581075760|FG001|Overall Study|Withdrawal by Subject|1|||
160913848|NCT00105482|581075759|FG000|Overall Study|Lost Interest|29|||
161256626|NCT01213836|582318618|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
160913849|NCT00105482|581075760|FG001|Overall Study|Lost Interest|32|||
160913850|NCT00105482|581075759|FG000|Overall Study|Scheduling Conflict|2|||
160913851|NCT00105482|581075760|FG001|Overall Study|Scheduling Conflict|3|||
160913852|NCT00105482|581075759|FG000|Overall Study|Withdrawn by PI|1|||
161256627|NCT01470417|582318619|FG000|Overall Study|Disease progression|0|||
161256628|NCT01470417|582318620|FG001|Overall Study|Disease progression|2|||
160913853|NCT00105482|581075760|FG001|Overall Study|Withdrawn by PI|1|||
160913854|NCT02289690|581075766|FG000|Overall Study|Adverse Event Related to Progression|0|||
160913855|NCT02289690|581075767|FG001|Overall Study|Adverse Event Related to Progression|1|||
160913856|NCT02289690|581075768|FG002|Overall Study|Adverse Event Related to Progression|1|||
160913857|NCT02289690|581075769|FG003|Overall Study|Adverse Event Related to Progression|0|||
160913858|NCT02289690|581075770|FG004|Overall Study|Adverse Event Related to Progression|1|||
160913859|NCT02289690|581075771|FG005|Overall Study|Adverse Event Related to Progression|0|||
160913860|NCT02289690|581075772|FG006|Overall Study|Adverse Event Related to Progression|1|||
160913861|NCT02289690|581075773|FG007|Overall Study|Adverse Event Related to Progression|0|||
160913862|NCT02289690|581075774|FG008|Overall Study|Adverse Event Related to Progression|0|||
160913863|NCT02289690|581075775|FG009|Overall Study|Adverse Event Related to Progression|0|||
160913864|NCT02289690|581075766|FG000|Overall Study|Withdrawal by Subject|1|||
160913865|NCT02289690|581075767|FG001|Overall Study|Withdrawal by Subject|0|||
160913866|NCT02289690|581075768|FG002|Overall Study|Withdrawal by Subject|0|||
160913867|NCT02289690|581075769|FG003|Overall Study|Withdrawal by Subject|0|||
160913868|NCT02289690|581075770|FG004|Overall Study|Withdrawal by Subject|1|||
160913869|NCT02289690|581075771|FG005|Overall Study|Withdrawal by Subject|1|||
160913870|NCT02289690|581075772|FG006|Overall Study|Withdrawal by Subject|0|||
160913871|NCT02289690|581075773|FG007|Overall Study|Withdrawal by Subject|0|||
160913872|NCT02289690|581075774|FG008|Overall Study|Withdrawal by Subject|4|||
160913873|NCT02289690|581075775|FG009|Overall Study|Withdrawal by Subject|2|||
160913874|NCT02289690|581075766|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
160913875|NCT02289690|581075767|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
160913876|NCT02289690|581075768|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
160913877|NCT02289690|581075769|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
160913878|NCT02289690|581075770|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
160913879|NCT02289690|581075771|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
160913880|NCT02289690|581075772|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
160913881|NCT02289690|581075773|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
160913882|NCT02289690|581075774|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
160913883|NCT02289690|581075775|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
160913884|NCT02289690|581075766|FG000|Overall Study|Lost to Follow-up|0|||
160913885|NCT02289690|581075767|FG001|Overall Study|Lost to Follow-up|0|||
160913886|NCT02289690|581075768|FG002|Overall Study|Lost to Follow-up|0|||
160913887|NCT02289690|581075769|FG003|Overall Study|Lost to Follow-up|0|||
160913888|NCT02289690|581075770|FG004|Overall Study|Lost to Follow-up|0|||
160913889|NCT02289690|581075771|FG005|Overall Study|Lost to Follow-up|0|||
160913890|NCT02289690|581075772|FG006|Overall Study|Lost to Follow-up|0|||
160913891|NCT02289690|581075773|FG007|Overall Study|Lost to Follow-up|1|||
160913892|NCT02289690|581075774|FG008|Overall Study|Lost to Follow-up|0|||
160913893|NCT02289690|581075775|FG009|Overall Study|Lost to Follow-up|2|||
160913894|NCT02289690|581075766|FG000|Overall Study|Death|0|||
160913895|NCT02289690|581075767|FG001|Overall Study|Death|0|||
160913896|NCT02289690|581075768|FG002|Overall Study|Death|0|||
160913897|NCT02289690|581075769|FG003|Overall Study|Death|0|||
160913898|NCT02289690|581075770|FG004|Overall Study|Death|0|||
160913899|NCT02289690|581075771|FG005|Overall Study|Death|0|||
160913900|NCT02289690|581075772|FG006|Overall Study|Death|0|||
160913901|NCT02289690|581075773|FG007|Overall Study|Death|49|||
160913902|NCT02289690|581075774|FG008|Overall Study|Death|45|||
160913903|NCT02289690|581075775|FG009|Overall Study|Death|41|||
160913904|NCT02289690|581075766|FG000|Overall Study|Sponsor Discontinued Study|0|||
160913905|NCT02289690|581075767|FG001|Overall Study|Sponsor Discontinued Study|0|||
160913906|NCT02289690|581075768|FG002|Overall Study|Sponsor Discontinued Study|0|||
160913907|NCT02289690|581075769|FG003|Overall Study|Sponsor Discontinued Study|0|||
160913908|NCT02289690|581075770|FG004|Overall Study|Sponsor Discontinued Study|0|||
160913909|NCT02289690|581075771|FG005|Overall Study|Sponsor Discontinued Study|0|||
160913910|NCT02289690|581075772|FG006|Overall Study|Sponsor Discontinued Study|0|||
160913911|NCT02289690|581075773|FG007|Overall Study|Sponsor Discontinued Study|9|||
160913912|NCT02289690|581075774|FG008|Overall Study|Sponsor Discontinued Study|7|||
160913913|NCT02289690|581075775|FG009|Overall Study|Sponsor Discontinued Study|15|||
160913914|NCT02289690|581075766|FG000|Overall Study|Other|0|||
160913915|NCT02289690|581075767|FG001|Overall Study|Other|0|||
160913916|NCT02289690|581075768|FG002|Overall Study|Other|0|||
160913917|NCT02289690|581075769|FG003|Overall Study|Other|1|||
160913918|NCT02289690|581075770|FG004|Overall Study|Other|1|||
160913919|NCT02289690|581075771|FG005|Overall Study|Other|0|||
160913920|NCT02289690|581075772|FG006|Overall Study|Other|1|||
160913921|NCT02289690|581075773|FG007|Overall Study|Other|2|||
161339234|NCT01232283|582630424|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160913922|NCT02289690|581075774|FG008|Overall Study|Other|3|||
160913923|NCT02289690|581075775|FG009|Overall Study|Other|1|||
160913924|NCT00644995|581075776|FG000|Overall Study|Lost to Follow-up|1|||
160913925|NCT00644995|581075777|FG001|Overall Study|Lost to Follow-up|4|||
160913926|NCT00644995|581075776|FG000|Overall Study|Refused|1|||
160913927|NCT00644995|581075777|FG001|Overall Study|Refused|0|||
160913928|NCT03247530|581075778|FG000|Overall Study|Withdrawal by caregiver|19|||
160913929|NCT03247530|581075779|FG001|Overall Study|Withdrawal by caregiver|8|||
161339235|NCT01232283|582630425|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161339236|NCT01232283|582630426|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160913930|NCT03247530|581075780|FG002|Overall Study|Withdrawal by caregiver|10|||
160913931|NCT03247530|581075778|FG000|Overall Study|Lost to Follow-up|3|||
160913932|NCT03247530|581075779|FG001|Overall Study|Lost to Follow-up|9|||
160913933|NCT03247530|581075780|FG002|Overall Study|Lost to Follow-up|6|||
160913934|NCT03247530|581075778|FG000|Overall Study|Adverse Event|2|||
160913935|NCT03247530|581075779|FG001|Overall Study|Adverse Event|5|||
160913936|NCT03247530|581075780|FG002|Overall Study|Adverse Event|2|||
160913937|NCT03247530|581075778|FG000|Overall Study|Failure to follow procedure|1|||
160913938|NCT03247530|581075779|FG001|Overall Study|Failure to follow procedure|1|||
160913939|NCT03247530|581075780|FG002|Overall Study|Failure to follow procedure|1|||
160913940|NCT03247530|581075778|FG000|Overall Study|Withdrawal by Subject|1|||
160913941|NCT03247530|581075779|FG001|Overall Study|Withdrawal by Subject|1|||
160913942|NCT03247530|581075780|FG002|Overall Study|Withdrawal by Subject|0|||
160913943|NCT03247530|581075778|FG000|Overall Study|Study medication misuse|0|||
160913944|NCT03247530|581075779|FG001|Overall Study|Study medication misuse|1|||
160913945|NCT03247530|581075780|FG002|Overall Study|Study medication misuse|0|||
160913946|NCT03247530|581075778|FG000|Overall Study|Other, multiple categories|1|||
160913947|NCT03247530|581075779|FG001|Overall Study|Other, multiple categories|3|||
160913948|NCT03247530|581075780|FG002|Overall Study|Other, multiple categories|1|||
160913949|NCT01587001|581075781|FG000|Overall Study|Lost to Follow-up|2|||
160913950|NCT01587001|581075782|FG001|Overall Study|Lost to Follow-up|0|||
160913951|NCT01587001|581075781|FG000|Overall Study|Insufficient samples to complete testing|4|||
160913952|NCT01587001|581075782|FG001|Overall Study|Insufficient samples to complete testing|1|||
160913953|NCT04786990|581075783|FG000|Overall Study|Withdrawal by Subject|1|||
160913954|NCT04786990|581075783|FG000|Overall Study|Adverse Event|1|||
160913955|NCT04786990|581075783|FG000|Overall Study|Lost to Follow-up|1|||
160913956|NCT04786990|581075783|FG000|Overall Study|Noncompliance|1|||
160913957|NCT04786990|581075783|FG000|Overall Study|Unable to complete site visits|1|||
160913958|NCT04786990|581075783|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
160913959|NCT02132130|581075784|FG000|Overall Study|Lost to Follow-up|0|||
160913960|NCT02132130|581075785|FG001|Overall Study|Lost to Follow-up|2|||
160913961|NCT02132130|581075786|FG002|Overall Study|Lost to Follow-up|0|||
160913962|NCT02132130|581075787|FG003|Overall Study|Lost to Follow-up|0|||
160913963|NCT02132130|581075784|FG000|Overall Study|Withdrawal by Subject|0|||
160913964|NCT02132130|581075785|FG001|Overall Study|Withdrawal by Subject|0|||
160913965|NCT02132130|581075786|FG002|Overall Study|Withdrawal by Subject|0|||
160913966|NCT02132130|581075787|FG003|Overall Study|Withdrawal by Subject|1|||
160913967|NCT04656691|581075791|FG000|Overall Study|Adverse Event|1|||
160913968|NCT00439244|581075794|FG000|Overall Study|Adverse Event|5|||
160913969|NCT00439244|581075795|FG001|Overall Study|Adverse Event|2|||
160913970|NCT00439244|581075796|FG002|Overall Study|Adverse Event|3|||
160913971|NCT00439244|581075794|FG000|Overall Study|Withdrawal by Subject|3|||
160913972|NCT00439244|581075795|FG001|Overall Study|Withdrawal by Subject|1|||
160913973|NCT00439244|581075796|FG002|Overall Study|Withdrawal by Subject|2|||
160913974|NCT00439244|581075794|FG000|Overall Study|Lost to Follow-up|2|||
160913975|NCT00439244|581075795|FG001|Overall Study|Lost to Follow-up|1|||
160913976|NCT00439244|581075796|FG002|Overall Study|Lost to Follow-up|2|||
160913977|NCT00439244|581075794|FG000|Overall Study|Death|0|||
160913978|NCT00439244|581075795|FG001|Overall Study|Death|1|||
160913979|NCT00439244|581075796|FG002|Overall Study|Death|0|||
160913980|NCT00439244|581075794|FG000|Overall Study|Protocol Violation|0|||
160913981|NCT00439244|581075795|FG001|Overall Study|Protocol Violation|1|||
160913982|NCT00439244|581075796|FG002|Overall Study|Protocol Violation|0|||
160913983|NCT00439244|581075794|FG000|Overall Study|Administrative problems|1|||
160913984|NCT00439244|581075795|FG001|Overall Study|Administrative problems|0|||
160913985|NCT00439244|581075796|FG002|Overall Study|Administrative problems|0|||
160913986|NCT02846779|581075797|FG000|Overall Study|Lost Enrollment|83|||
160913987|NCT02846779|581075798|FG001|Overall Study|Lost Enrollment|82|||
160913988|NCT02846779|581075799|FG002|Overall Study|Lost Enrollment|86|||
160913989|NCT02846779|581075797|FG000|Overall Study|Less than 31 days of follow-up|56|||
160913990|NCT02846779|581075798|FG001|Overall Study|Less than 31 days of follow-up|45|||
160913991|NCT02846779|581075799|FG002|Overall Study|Less than 31 days of follow-up|52|||
160913992|NCT00887978|581075802|FG000|Overall Study|Adverse Event|18|||
160913993|NCT00887978|581075803|FG001|Overall Study|Adverse Event|5|||
160913994|NCT00887978|581075802|FG000|Overall Study|Clinical Worsening|4|||
160913995|NCT00887978|581075803|FG001|Overall Study|Clinical Worsening|4|||
160913996|NCT00887978|581075802|FG000|Overall Study|Death|2|||
160913997|NCT00887978|581075803|FG001|Overall Study|Death|3|||
160913998|NCT00887978|581075802|FG000|Overall Study|Withdrawal by Subject|1|||
160913999|NCT00887978|581075803|FG001|Overall Study|Withdrawal by Subject|2|||
160914000|NCT00887978|581075802|FG000|Overall Study|Lost to Follow-up|0|||
160914001|NCT00887978|581075803|FG001|Overall Study|Lost to Follow-up|1|||
160914002|NCT05353985|581075806|FG000|Overall Study|Adverse Event|5|||
160914003|NCT05353985|581075807|FG001|Overall Study|Adverse Event|7|||
161142656|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Other|0|||
160914004|NCT05353985|581075806|FG000|Overall Study|Lost to Follow-up|1|||
160914005|NCT05353985|581075807|FG001|Overall Study|Lost to Follow-up|1|||
160914006|NCT05353985|581075806|FG000|Overall Study|Protocol Violation|1|||
160914007|NCT05353985|581075807|FG001|Overall Study|Protocol Violation|0|||
160914008|NCT05353985|581075806|FG000|Overall Study|Withdrawal by Subject|13|||
160914009|NCT05353985|581075807|FG001|Overall Study|Withdrawal by Subject|17|||
160914010|NCT05353985|581075806|FG000|Overall Study|Reason Not Specified|1|||
160914011|NCT05353985|581075807|FG001|Overall Study|Reason Not Specified|0|||
160914012|NCT05353985|581075806|FG000|Overall Study|Randomized in Error & Not Treated|0|||
160914013|NCT05353985|581075807|FG001|Overall Study|Randomized in Error & Not Treated|1|||
160914014|NCT04221009|581077536|FG000|Overall Study|Withdrawal by Subject|4|||
160914015|NCT00793598|581077537|FG000|Overall Study|Patient Request|0|||
160914016|NCT00793598|581077538|FG001|Overall Study|Patient Request|1|||
160914017|NCT00793598|581077539|FG002|Overall Study|Patient Request|0|||
160914018|NCT00793598|581077540|FG003|Overall Study|Patient Request|0|||
160914019|NCT00793598|581077541|FG004|Overall Study|Patient Request|0|||
160914020|NCT00793598|581077542|FG005|Overall Study|Patient Request|0|||
160914021|NCT00793598|581077543|FG006|Overall Study|Patient Request|0|||
160914022|NCT00793598|581077544|FG007|Overall Study|Patient Request|0|||
160914023|NCT00793598|581077537|FG000|Overall Study|Protocol Violation|0|||
160914024|NCT00793598|581077538|FG001|Overall Study|Protocol Violation|0|||
160914025|NCT00793598|581077539|FG002|Overall Study|Protocol Violation|0|||
160914026|NCT00793598|581077540|FG003|Overall Study|Protocol Violation|0|||
160914027|NCT00793598|581077541|FG004|Overall Study|Protocol Violation|0|||
160914028|NCT00793598|581077542|FG005|Overall Study|Protocol Violation|0|||
160914029|NCT00793598|581077543|FG006|Overall Study|Protocol Violation|0|||
160914030|NCT00793598|581077544|FG007|Overall Study|Protocol Violation|1|||
160914031|NCT00793598|581077537|FG000|Overall Study|Subject not dosed|0|||
160914032|NCT00793598|581077538|FG001|Overall Study|Subject not dosed|0|||
160914033|NCT00793598|581077539|FG002|Overall Study|Subject not dosed|0|||
160914034|NCT00793598|581077540|FG003|Overall Study|Subject not dosed|0|||
160914035|NCT00793598|581077541|FG004|Overall Study|Subject not dosed|0|||
160914036|NCT00793598|581077542|FG005|Overall Study|Subject not dosed|1|||
160914037|NCT00793598|581077543|FG006|Overall Study|Subject not dosed|0|||
160914038|NCT00793598|581077544|FG007|Overall Study|Subject not dosed|0|||
160914039|NCT02762266|581077545|FG000|Overall Study|Physician Decision|2|||
160914040|NCT02762266|581077546|FG001|Overall Study|Physician Decision|0|||
160914041|NCT02373202|581077547|FG000|Overall Study|Adverse Event|2|||
160914042|NCT02373202|581077548|FG001|Overall Study|Adverse Event|5|||
160914043|NCT02373202|581077549|FG002|Overall Study|Adverse Event|2|||
160914044|NCT02373202|581077550|FG003|Overall Study|Adverse Event|1|||
160914045|NCT02373202|581077547|FG000|Overall Study|Lack of Efficacy|0|||
160914046|NCT02373202|581077548|FG001|Overall Study|Lack of Efficacy|0|||
160914047|NCT02373202|581077549|FG002|Overall Study|Lack of Efficacy|1|||
160914048|NCT02373202|581077550|FG003|Overall Study|Lack of Efficacy|0|||
160914049|NCT02373202|581077547|FG000|Overall Study|Other|0|||
160914050|NCT02373202|581077548|FG001|Overall Study|Other|1|||
160914051|NCT02373202|581077549|FG002|Overall Study|Other|0|||
160914052|NCT02373202|581077550|FG003|Overall Study|Other|0|||
160914053|NCT00410046|581077551|FG000|Overall Study|Adverse Event|3|||
160914054|NCT00410046|581077551|FG000|Overall Study|Withdrawal by Subject|1|||
160914055|NCT00410046|581077551|FG000|Overall Study|Lost to Follow-up|1|||
160914056|NCT01404325|581077558|FG000|Overall Study|Lost to Follow-up|1|||
160914057|NCT01404325|581077559|FG001|Overall Study|Lost to Follow-up|0|||
160914058|NCT01404325|581077558|FG000|Overall Study|Death|2|||
160914059|NCT01404325|581077559|FG001|Overall Study|Death|0|||
160914060|NCT01404325|581077558|FG000|Overall Study|Graft loss/Retransplantation|1|||
160914061|NCT01404325|581077559|FG001|Overall Study|Graft loss/Retransplantation|0|||
160914062|NCT01404325|581077558|FG000|Overall Study|non-specified reason|0|||
160914063|NCT01404325|581077559|FG001|Overall Study|non-specified reason|2|||
160914064|NCT03909295|581077564|FG000|Overall Study|Adverse Event|2|||
160914065|NCT03909295|581077564|FG000|Overall Study|Study terminated by sponsor|50|||
160914066|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914067|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914068|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914069|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
160914070|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
160914071|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
160914072|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914073|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914074|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914075|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
160914076|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Other|1|||
160914077|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Other|1|||
160914078|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Other|0|||
160914079|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Other|0|||
160914080|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Other|0|||
160914081|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
160914082|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
160914083|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
160914084|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
160914085|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
160914086|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914087|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914088|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914089|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
160914090|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
160914091|NCT02310568|581077569|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914092|NCT02310568|581077570|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914093|NCT02310568|581077571|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914094|NCT02310568|581077572|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
160914095|NCT02310568|581077573|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
160914096|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
160914097|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
160914098|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
160914099|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
160914100|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
160914101|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Other|0|||
160914102|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Other|1|||
160914103|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Other|1|||
160914104|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Other|0|||
160914105|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Other|0|||
160914106|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
160914107|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
160914108|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
160914109|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
160914110|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
160914111|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914112|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914113|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914114|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
160914115|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
160914116|NCT02310568|581077569|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160914117|NCT02310568|581077570|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160914118|NCT02310568|581077571|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160914119|NCT02310568|581077572|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
160914120|NCT02310568|581077573|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
160995623|NCT05827926|581370966|FG022|Overall Study|Physician Decision|0|||
160995624|NCT05827926|581370967|FG023|Overall Study|Physician Decision|0|||
160995625|NCT05827926|581370968|FG024|Overall Study|Physician Decision|0|||
160995626|NCT05827926|581370969|FG025|Overall Study|Physician Decision|0|||
160995627|NCT05827926|581370970|FG026|Overall Study|Physician Decision|0|||
160995628|NCT05827926|581370971|FG027|Overall Study|Physician Decision|0|||
160995629|NCT05827926|581370972|FG028|Overall Study|Physician Decision|0|||
160995630|NCT05827926|581370973|FG029|Overall Study|Physician Decision|0|||
160995631|NCT05827926|581370974|FG030|Overall Study|Physician Decision|0|||
160995632|NCT05827926|581370975|FG031|Overall Study|Physician Decision|0|||
160995633|NCT05827926|581370976|FG032|Overall Study|Physician Decision|0|||
160995634|NCT05827926|581370977|FG033|Overall Study|Physician Decision|0|||
160995635|NCT05827926|581370978|FG034|Overall Study|Physician Decision|0|||
160995636|NCT05827926|581370979|FG035|Overall Study|Physician Decision|0|||
160995637|NCT05827926|581370980|FG036|Overall Study|Physician Decision|0|||
160995638|NCT05197049|581370981|FG000|Overall Study|Death|0|||
160995639|NCT05197049|581370982|FG001|Overall Study|Death|1|||
160995640|NCT05197049|581370983|FG002|Overall Study|Death|0|||
160995641|NCT05197049|581370981|FG000|Overall Study|Lost to Follow-up|3|||
160914121|NCT02990910|581077580|FG000|Overall Study|Lack of Efficacy|6|||
160914122|NCT02990910|581077581|FG001|Overall Study|Lack of Efficacy|10|||
160914123|NCT02989194|581077586|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
160995642|NCT05197049|581370982|FG001|Overall Study|Lost to Follow-up|1|||
160995643|NCT05197049|581370983|FG002|Overall Study|Lost to Follow-up|0|||
160995644|NCT05197049|581370981|FG000|Overall Study|Withdrawal by Subject|15|||
161256629|NCT02973321|582318621|FG000|Overall Study|Other than specified|0|||
160914124|NCT02989194|581077587|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
160914125|NCT02989194|581077588|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
160914126|NCT02989194|581077586|FG000|Overall Study|Lost to Follow-up|0|||
160914127|NCT02989194|581077587|FG001|Overall Study|Lost to Follow-up|1|||
160914128|NCT02989194|581077588|FG002|Overall Study|Lost to Follow-up|0|||
160914129|NCT02989194|581077586|FG000|Overall Study|Withdrawal by Subject|0|||
160995645|NCT05197049|581370982|FG001|Overall Study|Withdrawal by Subject|3|||
160995646|NCT05197049|581370983|FG002|Overall Study|Withdrawal by Subject|1|||
160995647|NCT05197049|581370981|FG000|Overall Study|GCP non-compliance|1|||
161256630|NCT02973321|582318622|FG001|Overall Study|Other than specified|5|||
160914130|NCT02989194|581077587|FG001|Overall Study|Withdrawal by Subject|1|||
160914131|NCT02989194|581077588|FG002|Overall Study|Withdrawal by Subject|0|||
160995648|NCT05197049|581370982|FG001|Overall Study|GCP non-compliance|2|||
160995649|NCT05197049|581370983|FG002|Overall Study|GCP non-compliance|0|||
160995650|NCT00608907|581370986|FG000|Overall Study|Adverse Event|6|||
160995651|NCT00608907|581370987|FG001|Overall Study|Adverse Event|0|||
160995652|NCT00608907|581370988|FG002|Overall Study|Adverse Event|1|||
160995653|NCT00608907|581370986|FG000|Overall Study|Death|1|||
160995654|NCT00608907|581370987|FG001|Overall Study|Death|0|||
160995655|NCT00608907|581370988|FG002|Overall Study|Death|0|||
160995656|NCT00608907|581370986|FG000|Overall Study|Withdrawal by Subject|4|||
160914132|NCT02064868|581077590|FG000|Overall Study|Lost to Follow-up|14|||
160914133|NCT02064868|581077591|FG001|Overall Study|Lost to Follow-up|8|||
160914134|NCT02064868|581077590|FG000|Overall Study|Physician Decision|1|||
160914135|NCT02064868|581077591|FG001|Overall Study|Physician Decision|0|||
160914136|NCT02064868|581077590|FG000|Overall Study|Withdrawal by Subject|14|||
160914137|NCT02064868|581077591|FG001|Overall Study|Withdrawal by Subject|3|||
160914138|NCT02064868|581077590|FG000|Overall Study|Technical Problems or Missing|5|||
160914139|NCT02064868|581077591|FG001|Overall Study|Technical Problems or Missing|2|||
160914140|NCT00482612|581077594|FG000|In-treatment Period|No study medication administered|0|||
160914141|NCT00482612|581077595|FG001|In-treatment Period|No study medication administered|0|||
160914142|NCT00482612|581077596|FG002|In-treatment Period|No study medication administered|1|||
160914143|NCT00482612|581077597|FG003|In-treatment Period|No study medication administered|0|||
160914144|NCT00482612|581077594|FG000|Follow-up Period|Other|4|||
160914145|NCT00482612|581077595|FG001|Follow-up Period|Other|2|||
160914146|NCT00482612|581077596|FG002|Follow-up Period|Other|1|||
160914147|NCT00482612|581077597|FG003|Follow-up Period|Other|2|||
160914148|NCT00482612|581077594|FG000|Follow-up Period|Lack of compliance|0|||
160914149|NCT00482612|581077595|FG001|Follow-up Period|Lack of compliance|0|||
160914150|NCT00482612|581077596|FG002|Follow-up Period|Lack of compliance|1|||
160914151|NCT00482612|581077597|FG003|Follow-up Period|Lack of compliance|0|||
160914152|NCT00482612|581077594|FG000|Follow-up Period|Lost to Follow-up|0|||
160914153|NCT00482612|581077595|FG001|Follow-up Period|Lost to Follow-up|4|||
160914154|NCT00482612|581077596|FG002|Follow-up Period|Lost to Follow-up|2|||
160914155|NCT00482612|581077597|FG003|Follow-up Period|Lost to Follow-up|1|||
160914156|NCT00482612|581077594|FG000|Follow-up Period|Adverse Event|4|||
160914157|NCT00482612|581077595|FG001|Follow-up Period|Adverse Event|7|||
160914158|NCT00482612|581077596|FG002|Follow-up Period|Adverse Event|9|||
160914159|NCT00482612|581077597|FG003|Follow-up Period|Adverse Event|0|||
160914160|NCT00482612|581077594|FG000|Follow-up Period|Lack of Efficacy|2|||
160914161|NCT00482612|581077595|FG001|Follow-up Period|Lack of Efficacy|0|||
160914162|NCT00482612|581077596|FG002|Follow-up Period|Lack of Efficacy|1|||
160914163|NCT00482612|581077597|FG003|Follow-up Period|Lack of Efficacy|0|||
160914164|NCT00482612|581077594|FG000|Follow-up Period|Withdrawal by Subject|3|||
160914165|NCT00482612|581077595|FG001|Follow-up Period|Withdrawal by Subject|5|||
160914166|NCT00482612|581077596|FG002|Follow-up Period|Withdrawal by Subject|7|||
160914167|NCT00482612|581077597|FG003|Follow-up Period|Withdrawal by Subject|2|||
160914168|NCT00482612|581077594|FG000|Follow-up Period|Reasons not related to trial|1|||
160914169|NCT00482612|581077595|FG001|Follow-up Period|Reasons not related to trial|0|||
160914170|NCT00482612|581077596|FG002|Follow-up Period|Reasons not related to trial|1|||
160914171|NCT00482612|581077597|FG003|Follow-up Period|Reasons not related to trial|3|||
160914172|NCT00660023|581077598|FG000|Overall Study|Adverse Event|2|||
160914173|NCT00660023|581077598|FG000|Overall Study|Death|8|||
160914174|NCT00660023|581077598|FG000|Overall Study|Blood Transfusion|5|||
160914175|NCT00660023|581077598|FG000|Overall Study|Renal Transplantation|3|||
160914176|NCT00660023|581077598|FG000|Overall Study|Withdrawal by Subject|1|||
160914177|NCT00660023|581077598|FG000|Overall Study|Missed Pregnancy Test|1|||
160914178|NCT00660023|581077598|FG000|Overall Study|Other Screening Failure|9|||
160914179|NCT04180488|581077600|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
160914180|NCT04180488|581077601|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
160914181|NCT04180488|581077602|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
160914182|NCT04180488|581077603|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
160914183|NCT04180488|581077604|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
160914184|NCT04180488|581077605|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
160914185|NCT04180488|581077600|FG000|Overall Study|Withdrawal by Subject|8|||
160914186|NCT04180488|581077601|FG001|Overall Study|Withdrawal by Subject|4|||
160914187|NCT04180488|581077602|FG002|Overall Study|Withdrawal by Subject|5|||
160914188|NCT04180488|581077603|FG003|Overall Study|Withdrawal by Subject|2|||
160914189|NCT04180488|581077604|FG004|Overall Study|Withdrawal by Subject|8|||
160914190|NCT04180488|581077605|FG005|Overall Study|Withdrawal by Subject|6|||
160914191|NCT04180488|581077600|FG000|Overall Study|Adverse Event|3|||
160914192|NCT04180488|581077601|FG001|Overall Study|Adverse Event|2|||
160914193|NCT04180488|581077602|FG002|Overall Study|Adverse Event|0|||
160914194|NCT04180488|581077603|FG003|Overall Study|Adverse Event|0|||
160914195|NCT04180488|581077604|FG004|Overall Study|Adverse Event|0|||
160914196|NCT04180488|581077605|FG005|Overall Study|Adverse Event|0|||
160914197|NCT04180488|581077600|FG000|Overall Study|Poor compliance to protocol|0|||
160914198|NCT04180488|581077601|FG001|Overall Study|Poor compliance to protocol|0|||
160914199|NCT04180488|581077602|FG002|Overall Study|Poor compliance to protocol|1|||
160914200|NCT04180488|581077603|FG003|Overall Study|Poor compliance to protocol|0|||
160914201|NCT04180488|581077604|FG004|Overall Study|Poor compliance to protocol|0|||
160914202|NCT04180488|581077605|FG005|Overall Study|Poor compliance to protocol|0|||
160914203|NCT03506815|581077606|FG000|Overall Study|Adverse Event|8|||
160914204|NCT03506815|581077607|FG001|Overall Study|Adverse Event|0|||
160914205|NCT03506815|581077606|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
161142657|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Other|0|||
160995657|NCT00608907|581370987|FG001|Overall Study|Withdrawal by Subject|0|||
160995658|NCT00608907|581370988|FG002|Overall Study|Withdrawal by Subject|0|||
160995659|NCT00608907|581370986|FG000|Overall Study|Progressive Disease|1|||
160995660|NCT00608907|581370987|FG001|Overall Study|Progressive Disease|0|||
160995661|NCT00608907|581370988|FG002|Overall Study|Progressive Disease|0|||
160995662|NCT02982213|581370991|FG000|Overall Study|Did not complete follow up questionnaire|5|||
160995663|NCT02982213|581370992|FG001|Overall Study|Did not complete follow up questionnaire|1|||
160995664|NCT01549652|581370993|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
160995665|NCT01549652|581370994|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
160995666|NCT01549652|581370995|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
160995667|NCT01549652|581370996|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
160995668|NCT01549652|581370993|FG000|Overall Study|Study Drug Titration Failure|5|||
160995669|NCT01549652|581370994|FG001|Overall Study|Study Drug Titration Failure|6|||
160995670|NCT01549652|581370995|FG002|Overall Study|Study Drug Titration Failure|0|||
160995671|NCT01549652|581370996|FG003|Overall Study|Study Drug Titration Failure|0|||
160995672|NCT01549652|581370993|FG000|Overall Study|Withdrawal Effect|0|||
160995673|NCT01549652|581370994|FG001|Overall Study|Withdrawal Effect|2|||
160995674|NCT01549652|581370995|FG002|Overall Study|Withdrawal Effect|0|||
160995675|NCT01549652|581370996|FG003|Overall Study|Withdrawal Effect|0|||
160995676|NCT01549652|581370993|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
160995677|NCT01549652|581370994|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
160995678|NCT01549652|581370995|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
160995679|NCT01549652|581370996|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
160995680|NCT01549652|581370993|FG000|Overall Study|Problem with Infusion|1|||
160995681|NCT01549652|581370994|FG001|Overall Study|Problem with Infusion|0|||
160995682|NCT01549652|581370995|FG002|Overall Study|Problem with Infusion|0|||
160995683|NCT01549652|581370996|FG003|Overall Study|Problem with Infusion|0|||
160995684|NCT01549652|581370993|FG000|Overall Study|Titration Non-Compliance|1|||
160995685|NCT01549652|581370994|FG001|Overall Study|Titration Non-Compliance|3|||
160995686|NCT01549652|581370995|FG002|Overall Study|Titration Non-Compliance|4|||
160995687|NCT01549652|581370996|FG003|Overall Study|Titration Non-Compliance|5|||
160995688|NCT01549652|581370993|FG000|Overall Study|Titration Side Effects|0|||
160995689|NCT01549652|581370994|FG001|Overall Study|Titration Side Effects|0|||
160995690|NCT01549652|581370995|FG002|Overall Study|Titration Side Effects|6|||
160995691|NCT01549652|581370996|FG003|Overall Study|Titration Side Effects|3|||
160995692|NCT01549652|581370993|FG000|Overall Study|Withdrawal by Subject|0|||
160995693|NCT01549652|581370994|FG001|Overall Study|Withdrawal by Subject|0|||
160995694|NCT01549652|581370995|FG002|Overall Study|Withdrawal by Subject|5|||
160995695|NCT01549652|581370996|FG003|Overall Study|Withdrawal by Subject|3|||
160995696|NCT03247543|581370997|FG000|Overall Study|Adverse Event|3|||
160995697|NCT03247543|581370998|FG001|Overall Study|Adverse Event|6|||
160995698|NCT03247543|581370999|FG002|Overall Study|Adverse Event|4|||
160995699|NCT03247543|581370997|FG000|Overall Study|Lost to Follow-up|10|||
160995700|NCT03247543|581370998|FG001|Overall Study|Lost to Follow-up|7|||
160995701|NCT03247543|581370999|FG002|Overall Study|Lost to Follow-up|8|||
160995702|NCT03247543|581370997|FG000|Overall Study|Consent withdrawn by caregiver|2|||
160995703|NCT03247543|581370998|FG001|Overall Study|Consent withdrawn by caregiver|2|||
160995704|NCT03247543|581370999|FG002|Overall Study|Consent withdrawn by caregiver|9|||
160995705|NCT03247543|581370997|FG000|Overall Study|Withdrawal by Subject|0|||
160995706|NCT03247543|581370998|FG001|Overall Study|Withdrawal by Subject|0|||
160995707|NCT03247543|581370999|FG002|Overall Study|Withdrawal by Subject|1|||
160995708|NCT03247543|581370997|FG000|Overall Study|Failure to Follow study procedures|1|||
160995709|NCT03247543|581370998|FG001|Overall Study|Failure to Follow study procedures|3|||
160995710|NCT03247543|581370999|FG002|Overall Study|Failure to Follow study procedures|1|||
160995711|NCT03247543|581370997|FG000|Overall Study|Lack of Efficacy|1|||
160995712|NCT03247543|581370998|FG001|Overall Study|Lack of Efficacy|0|||
160995713|NCT03247543|581370999|FG002|Overall Study|Lack of Efficacy|0|||
160995714|NCT03247543|581370997|FG000|Overall Study|Non-compliance with study visits|0|||
160995715|NCT03247543|581370998|FG001|Overall Study|Non-compliance with study visits|1|||
160995716|NCT03247543|581370999|FG002|Overall Study|Non-compliance with study visits|0|||
161339237|NCT01232283|582630427|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
161339238|NCT01232283|582630428|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160995717|NCT02059980|581371006|FG000|Overall Study|Lost to Follow-up|2|||
160995718|NCT02059980|581371007|FG001|Overall Study|Lost to Follow-up|1|||
160995719|NCT01321606|581371008|FG000|Overall Study|Lost to Follow-up|0|||
160995720|NCT01321606|581371009|FG001|Overall Study|Lost to Follow-up|0|||
160995721|NCT01321606|581371010|FG002|Overall Study|Lost to Follow-up|0|||
160995722|NCT01321606|581371011|FG003|Overall Study|Lost to Follow-up|1|||
160995723|NCT01253226|581371015|FG000|Overall Study|Adverse Event|0|||
160995724|NCT01253226|581371016|FG001|Overall Study|Adverse Event|0|||
160995725|NCT01253226|581371017|FG002|Overall Study|Adverse Event|1|||
160995726|NCT01253226|581371018|FG003|Overall Study|Adverse Event|0|||
160995727|NCT01253226|581371019|FG004|Overall Study|Adverse Event|0|||
160995728|NCT01253226|581371015|FG000|Overall Study|Death|0|||
160995729|NCT01253226|581371016|FG001|Overall Study|Death|1|||
160914206|NCT03506815|581077607|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
160914207|NCT03506815|581077606|FG000|Overall Study|Protocol Violation|1|||
160914208|NCT03506815|581077607|FG001|Overall Study|Protocol Violation|0|||
160914209|NCT03506815|581077606|FG000|Overall Study|Elective Surgery|1|||
160914210|NCT03506815|581077607|FG001|Overall Study|Elective Surgery|0|||
160914211|NCT04160091|581077608|FG000|Overall Study|Terminated by Sponsor|7|||
160914212|NCT04160091|581077609|FG001|Overall Study|Terminated by Sponsor|3|||
160914213|NCT04160091|581077610|FG002|Overall Study|Terminated by Sponsor|5|||
160914214|NCT04160091|581077611|FG003|Overall Study|Terminated by Sponsor|2|||
160914215|NCT04160091|581077608|FG000|Overall Study|Noncompliance|0|||
160914216|NCT04160091|581077609|FG001|Overall Study|Noncompliance|0|||
160914217|NCT04160091|581077610|FG002|Overall Study|Noncompliance|0|||
160914218|NCT04160091|581077611|FG003|Overall Study|Noncompliance|1|||
160914219|NCT04160091|581077608|FG000|Overall Study|Withdrawal by Subject|0|||
160914220|NCT04160091|581077609|FG001|Overall Study|Withdrawal by Subject|0|||
160914221|NCT04160091|581077610|FG002|Overall Study|Withdrawal by Subject|0|||
160914222|NCT04160091|581077611|FG003|Overall Study|Withdrawal by Subject|1|||
160914223|NCT00609492|581077616|FG000|Overall Study|Withdrawal by Subject|0|||
160914224|NCT00609492|581077617|FG001|Overall Study|Withdrawal by Subject|2|||
160914225|NCT00609492|581077618|FG002|Overall Study|Withdrawal by Subject|3|||
160914226|NCT00609492|581077616|FG000|Overall Study|Lost to Follow-up|1|||
160914227|NCT00609492|581077617|FG001|Overall Study|Lost to Follow-up|1|||
160914228|NCT00609492|581077618|FG002|Overall Study|Lost to Follow-up|4|||
160914229|NCT01224431|581077619|FG000|Overall Study|not randomized|0|||
160914230|NCT01224431|581077620|FG001|Overall Study|not randomized|4|||
160914231|NCT01224431|581077619|FG000|Overall Study|no video record|0|||
160914232|NCT01224431|581077620|FG001|Overall Study|no video record|1|||
160914233|NCT02057406|581077621|FG000|Overall Study|Physician Decision|0|||
160914234|NCT02057406|581077622|FG001|Overall Study|Physician Decision|0|||
160914235|NCT02057406|581077623|FG002|Overall Study|Physician Decision|2|||
160914236|NCT02057406|581077621|FG000|Overall Study|Withdrawal by Subject|0|||
160914237|NCT02057406|581077622|FG001|Overall Study|Withdrawal by Subject|2|||
160914238|NCT02057406|581077623|FG002|Overall Study|Withdrawal by Subject|0|||
160914239|NCT02057406|581077621|FG000|Overall Study|Lost to Follow-up|0|||
160914240|NCT02057406|581077622|FG001|Overall Study|Lost to Follow-up|0|||
160914241|NCT02057406|581077623|FG002|Overall Study|Lost to Follow-up|1|||
160914242|NCT02057406|581077621|FG000|Overall Study|Death|1|||
160914243|NCT02057406|581077622|FG001|Overall Study|Death|0|||
160914244|NCT02057406|581077623|FG002|Overall Study|Death|0|||
160914245|NCT02057406|581077621|FG000|Overall Study|Protocol Violation|0|||
160914246|NCT02057406|581077622|FG001|Overall Study|Protocol Violation|1|||
160914247|NCT02057406|581077623|FG002|Overall Study|Protocol Violation|0|||
160914248|NCT02057406|581077621|FG000|Overall Study|Patient transportation issues|0|||
160914249|NCT02057406|581077622|FG001|Overall Study|Patient transportation issues|0|||
160914250|NCT02057406|581077623|FG002|Overall Study|Patient transportation issues|1|||
160914251|NCT01401283|581077624|FG000|Overall Study|surgery cancelled|5|||
160914252|NCT01401283|581077625|FG001|Overall Study|surgery cancelled|8|||
160914253|NCT01401283|581077624|FG000|Overall Study|preoperative arrhythmia|5|||
160914254|NCT01401283|581077625|FG001|Overall Study|preoperative arrhythmia|0|||
160914255|NCT01401283|581077624|FG000|Overall Study|no central venous access|0|||
160914256|NCT01401283|581077625|FG001|Overall Study|no central venous access|1|||
160914257|NCT01401283|581077624|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
160914258|NCT01401283|581077625|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
160914259|NCT02433483|581077626|FG000|Overall Study|Unacceptable toxicity|1|||
160914260|NCT02433483|581077626|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
160914261|NCT00549302|581077635|FG000|Double-Blind|Death|2|||
160914262|NCT00549302|581077636|FG001|Double-Blind|Death|9|||
160914263|NCT00549302|581077637|FG002|Double-Blind|Death|0|||
160914264|NCT00549302|581077635|FG000|Double-Blind|Adverse Event|3|||
160914265|NCT00549302|581077636|FG001|Double-Blind|Adverse Event|16|||
160914266|NCT00549302|581077637|FG002|Double-Blind|Adverse Event|0|||
160914267|NCT00549302|581077635|FG000|Double-Blind|Withdrawal by Subject|3|||
160914268|NCT00549302|581077636|FG001|Double-Blind|Withdrawal by Subject|8|||
160914269|NCT00549302|581077637|FG002|Double-Blind|Withdrawal by Subject|0|||
160914270|NCT00549302|581077635|FG000|Double-Blind|Investigator Decision|1|||
160914271|NCT00549302|581077636|FG001|Double-Blind|Investigator Decision|5|||
161339239|NCT01232283|582630429|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
160914272|NCT00549302|581077637|FG002|Double-Blind|Investigator Decision|0|||
160914273|NCT00549302|581077635|FG000|Double-Blind|Sponsor Decision|0|||
160914274|NCT00549302|581077636|FG001|Double-Blind|Sponsor Decision|1|||
160914275|NCT00549302|581077637|FG002|Double-Blind|Sponsor Decision|0|||
160914276|NCT00549302|581077635|FG000|Double-Blind|Lost to Follow-up|1|||
160914277|NCT00549302|581077636|FG001|Double-Blind|Lost to Follow-up|2|||
160914278|NCT00549302|581077637|FG002|Double-Blind|Lost to Follow-up|0|||
160914279|NCT00549302|581077635|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
160914280|NCT00549302|581077636|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
160995730|NCT01253226|581371017|FG002|Overall Study|Death|0|||
161339240|NCT01232283|582630420|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160914281|NCT00549302|581077637|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
160914282|NCT00549302|581077635|FG000|Double-Blind|New condition or starts new therapy|0|||
160914283|NCT00549302|581077636|FG001|Double-Blind|New condition or starts new therapy|2|||
160914284|NCT00549302|581077637|FG002|Double-Blind|New condition or starts new therapy|0|||
160914285|NCT00549302|581077635|FG000|Open-Label|Adverse Event|0|||
160914286|NCT00549302|581077636|FG001|Open-Label|Adverse Event|0|||
160914287|NCT00549302|581077637|FG002|Open-Label|Adverse Event|11|||
160914288|NCT00549302|581077635|FG000|Open-Label|Death|0|||
160914289|NCT00549302|581077636|FG001|Open-Label|Death|0|||
160914290|NCT00549302|581077637|FG002|Open-Label|Death|40|||
160914291|NCT00549302|581077635|FG000|Open-Label|Investigator Decision|0|||
160914292|NCT00549302|581077636|FG001|Open-Label|Investigator Decision|0|||
160914293|NCT00549302|581077637|FG002|Open-Label|Investigator Decision|5|||
160914294|NCT00549302|581077635|FG000|Open-Label|Lost to Follow-up|0|||
160914295|NCT00549302|581077636|FG001|Open-Label|Lost to Follow-up|0|||
160914296|NCT00549302|581077637|FG002|Open-Label|Lost to Follow-up|2|||
160914297|NCT00549302|581077635|FG000|Open-Label|Other|0|||
160914298|NCT00549302|581077636|FG001|Open-Label|Other|0|||
160914299|NCT00549302|581077637|FG002|Open-Label|Other|3|||
160914300|NCT00549302|581077635|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
160914301|NCT00549302|581077636|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
160914302|NCT00549302|581077637|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
160914303|NCT00549302|581077635|FG000|Open-Label|Withdrawal by Subject|0|||
160914304|NCT00549302|581077636|FG001|Open-Label|Withdrawal by Subject|0|||
160914305|NCT00549302|581077637|FG002|Open-Label|Withdrawal by Subject|6|||
160914306|NCT01414114|581077638|FG000|Overall Study|Adverse Event|2|||
160914307|NCT01414114|581077638|FG000|Overall Study|Withdrawal by Subject|1|||
160914308|NCT01414114|581077638|FG000|Overall Study|Other|2|||
160914309|NCT05620563|581077639|FG000|Overall Study|Adverse Event|3|||
160914310|NCT05620563|581077640|FG001|Overall Study|Adverse Event|1|||
160914311|NCT05620563|581077639|FG000|Overall Study|Lost to Follow-up|0|||
160914312|NCT05620563|581077640|FG001|Overall Study|Lost to Follow-up|2|||
160914313|NCT05620563|581077639|FG000|Overall Study|Protocol Deviation|1|||
160914314|NCT05620563|581077640|FG001|Overall Study|Protocol Deviation|2|||
160914315|NCT05620563|581077639|FG000|Overall Study|Withdrawal by Subject|3|||
160914316|NCT05620563|581077640|FG001|Overall Study|Withdrawal by Subject|3|||
160914317|NCT05620563|581077639|FG000|Overall Study|Physician Decision|0|||
160914318|NCT05620563|581077640|FG001|Overall Study|Physician Decision|1|||
160914319|NCT00865124|581077641|FG000|Overall Study|Physician Decision|2|||
160914320|NCT00865124|581077642|FG001|Overall Study|Physician Decision|1|||
160914321|NCT00865124|581077643|FG002|Overall Study|Physician Decision|0|||
160914322|NCT00865124|581077641|FG000|Overall Study|Withdrawn consent|2|||
160914323|NCT00865124|581077642|FG001|Overall Study|Withdrawn consent|0|||
161339241|NCT01232283|582630421|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
160914324|NCT00865124|581077643|FG002|Overall Study|Withdrawn consent|0|||
160914325|NCT02743520|581077644|FG000|Overall Study|Withdrawal by Subject|1|||
160914326|NCT02547649|581077648|FG000|Overall Study|Lost to Follow-up|3|||
160914327|NCT02547649|581077649|FG001|Overall Study|Lost to Follow-up|1|||
160914328|NCT02547649|581077650|FG002|Overall Study|Lost to Follow-up|1|||
160914329|NCT02547649|581077648|FG000|Overall Study|Not vaccinated|0|||
160914330|NCT02547649|581077649|FG001|Overall Study|Not vaccinated|0|||
160914331|NCT02547649|581077650|FG002|Overall Study|Not vaccinated|1|||
160914332|NCT02547649|581077648|FG000|Overall Study|Withdrawal by Subject|0|||
160914333|NCT02547649|581077649|FG001|Overall Study|Withdrawal by Subject|4|||
160914334|NCT02547649|581077650|FG002|Overall Study|Withdrawal by Subject|2|||
160914335|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Left Oranization|1|||
160914336|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Left Oranization|1|||
160914337|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
160914338|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
160914339|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
160914340|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
160914341|NCT03454997|581077651|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
160914342|NCT03454997|581077652|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
160914343|NCT03454997|581077651|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
160914344|NCT03454997|581077652|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
160914345|NCT03454997|581077651|FG000|Overall Study|Client with SMI - Left organization|0|||
160914346|NCT03454997|581077652|FG001|Overall Study|Client with SMI - Left organization|1|||
160914347|NCT03454997|581077651|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
160914348|NCT03454997|581077652|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
160914349|NCT01111149|581077657|FG000|Overall Study|Protocol Violation|1|||
160914350|NCT01111149|581077658|FG001|Overall Study|Protocol Violation|1|||
160914351|NCT01111149|581077659|FG002|Overall Study|Protocol Violation|2|||
160914352|NCT01111149|581077657|FG000|Overall Study|Withdrawal by Subject|1|||
160914353|NCT01111149|581077658|FG001|Overall Study|Withdrawal by Subject|0|||
160914354|NCT01111149|581077659|FG002|Overall Study|Withdrawal by Subject|2|||
160914355|NCT01909674|581077664|FG000|Overall Study|Withdrawal by Subject|5|||
160995731|NCT01253226|581371018|FG003|Overall Study|Death|0|||
160995732|NCT01253226|581371019|FG004|Overall Study|Death|0|||
160995733|NCT01253226|581371015|FG000|Overall Study|Physician Decision|0|||
160995734|NCT01253226|581371016|FG001|Overall Study|Physician Decision|0|||
160995735|NCT01253226|581371017|FG002|Overall Study|Physician Decision|0|||
160995736|NCT01253226|581371018|FG003|Overall Study|Physician Decision|0|||
160995737|NCT01253226|581371019|FG004|Overall Study|Physician Decision|2|||
160995738|NCT01253226|581371015|FG000|Overall Study|Withdrawal by Subject|0|||
160995739|NCT01253226|581371016|FG001|Overall Study|Withdrawal by Subject|0|||
160995740|NCT01253226|581371017|FG002|Overall Study|Withdrawal by Subject|0|||
160995741|NCT01253226|581371018|FG003|Overall Study|Withdrawal by Subject|1|||
160995742|NCT01253226|581371019|FG004|Overall Study|Withdrawal by Subject|0|||
160995743|NCT05916170|581371020|FG000|No Warning Control|Lost to Follow-up|12|||
160995744|NCT05916170|581371020|FG000|No Warning Control|Withdrawal by Subject|15|||
160995745|NCT05916170|581371020|FG000|No Warning Control|Noncompliance with protocol|1|||
160995746|NCT05916170|581371020|FG000|Health Warning Intervention|Lost to Follow-up|15|||
160995747|NCT05916170|581371020|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
160995748|NCT05916170|581371020|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
160995749|NCT04075266|581371022|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
160995750|NCT04075266|581371023|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
160995751|NCT04075266|581371022|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
160995752|NCT04075266|581371023|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
160995753|NCT01582945|581371024|FG000|Overall Study|Intolerable side-effects|1|||
160995754|NCT01582945|581371024|FG000|Overall Study|Scheduling conflicts|1|||
160995755|NCT03643211|581371025|FG000|Overall Study|Contract violation/deficiency|12|||
160995756|NCT03643211|581371025|FG000|Overall Study|Invalid registration|3|||
160995757|NCT03643211|581371025|FG000|Overall Study|No treatment information|2|||
160995758|NCT03643211|581371025|FG000|Overall Study|No adverse event information - No revisit|4|||
160995759|NCT02864992|581371030|FG000|Overall Study|still on treatment|15|||
160995760|NCT02864992|581371031|FG001|Overall Study|still on treatment|1|||
160995761|NCT02864992|581371032|FG002|Overall Study|still on treatment|33|||
160995762|NCT04948333|581371033|FG000|Overall Study|Adverse Event|6|||
160995763|NCT04948333|581371034|FG001|Overall Study|Adverse Event|4|||
160995764|NCT04948333|581371035|FG002|Overall Study|Adverse Event|0|||
160995765|NCT04948333|581371036|FG003|Overall Study|Adverse Event|2|||
160995766|NCT04948333|581371033|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
160995767|NCT04948333|581371034|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
160995768|NCT04948333|581371035|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160995769|NCT04948333|581371036|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
160995770|NCT04948333|581371033|FG000|Overall Study|Progressive Disease|1|||
160995771|NCT04948333|581371034|FG001|Overall Study|Progressive Disease|5|||
160995772|NCT04948333|581371035|FG002|Overall Study|Progressive Disease|0|||
160995773|NCT04948333|581371036|FG003|Overall Study|Progressive Disease|0|||
160995774|NCT04948333|581371033|FG000|Overall Study|Physician Decision|2|||
160995775|NCT04948333|581371034|FG001|Overall Study|Physician Decision|2|||
160995776|NCT04948333|581371035|FG002|Overall Study|Physician Decision|0|||
160995777|NCT04948333|581371036|FG003|Overall Study|Physician Decision|0|||
160995778|NCT04948333|581371033|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
160995779|NCT04948333|581371034|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
160995780|NCT04948333|581371035|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
160995781|NCT04948333|581371036|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
160995782|NCT04948333|581371033|FG000|Overall Study|Withdrawal by Subject|2|||
160995783|NCT04948333|581371034|FG001|Overall Study|Withdrawal by Subject|0|||
160995784|NCT04948333|581371035|FG002|Overall Study|Withdrawal by Subject|0|||
160995785|NCT04948333|581371036|FG003|Overall Study|Withdrawal by Subject|1|||
160995786|NCT04948333|581371033|FG000|Overall Study|Protocol Violation|0|||
160995787|NCT04948333|581371034|FG001|Overall Study|Protocol Violation|1|||
160995788|NCT04948333|581371035|FG002|Overall Study|Protocol Violation|0|||
160995789|NCT04948333|581371036|FG003|Overall Study|Protocol Violation|0|||
160995790|NCT04948333|581371033|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
160995791|NCT04948333|581371034|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
160995792|NCT04948333|581371035|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
160995793|NCT04948333|581371036|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
161142069|NCT02192359|581904298|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
160995794|NCT03038022|581371038|FG000|Overall Study|Withdrawal by Subject|2|||
160995795|NCT03038022|581371039|FG001|Overall Study|Withdrawal by Subject|0|||
160995796|NCT03038022|581371038|FG000|Overall Study|Adverse Event|4|||
160995797|NCT03038022|581371039|FG001|Overall Study|Adverse Event|2|||
160995798|NCT01467427|581371042|FG000|Overall Study|Withdrawal by Subject|1|||
160995799|NCT01467427|581371043|FG001|Overall Study|Withdrawal by Subject|0|||
160995800|NCT01467427|581371042|FG000|Overall Study|Not continuing in extension phase|0|||
160995801|NCT01467427|581371043|FG001|Overall Study|Not continuing in extension phase|2|||
160995802|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
161142070|NCT02117687|581904304|FG000|Overall Study|Lost to Follow-up|0|||
160914356|NCT01909674|581077665|FG001|Overall Study|Withdrawal by Subject|2|||
160914357|NCT02794883|581077666|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
160914358|NCT02794883|581077667|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
160914359|NCT02794883|581077668|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
160914360|NCT02794883|581077666|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
160914361|NCT02794883|581077667|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
160914362|NCT02794883|581077668|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
160914363|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
160914364|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
160914365|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
160914366|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
160914367|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
160914368|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
160914369|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
160914370|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
160914371|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
160914372|NCT02794883|581077666|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
160914373|NCT02794883|581077667|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
160914374|NCT02794883|581077668|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
160914375|NCT02794883|581077666|FG000|Follow-up Period (up to 2 Years)|Death|12|||
160914376|NCT02794883|581077667|FG001|Follow-up Period (up to 2 Years)|Death|10|||
160914377|NCT02794883|581077668|FG002|Follow-up Period (up to 2 Years)|Death|10|||
160914378|NCT01678911|581077672|FG000|Second Intervention|Lost to Follow-up|2|||
160914379|NCT01678911|581077673|FG001|Second Intervention|Lost to Follow-up|0|||
160914380|NCT01906008|581077674|FG000|Overall Study|Lost to Follow-up|2|||
160914381|NCT01906008|581077675|FG001|Overall Study|Lost to Follow-up|0|||
160914382|NCT01906008|581077674|FG000|Overall Study|Oxaliplatin toxicity|2|||
160914383|NCT01906008|581077675|FG001|Overall Study|Oxaliplatin toxicity|0|||
160914384|NCT01906008|581077674|FG000|Overall Study|Protocol Violation|0|||
160914385|NCT01906008|581077675|FG001|Overall Study|Protocol Violation|1|||
160914386|NCT01906008|581077674|FG000|Overall Study|Withdrawal by Subject|1|||
160914387|NCT01906008|581077675|FG001|Overall Study|Withdrawal by Subject|5|||
160914388|NCT01906008|581077674|FG000|Overall Study|Did not start study med|3|||
160914389|NCT01906008|581077675|FG001|Overall Study|Did not start study med|4|||
160914390|NCT01906008|581077674|FG000|Overall Study|Oxaliplatin stops|10|||
160914391|NCT01906008|581077675|FG001|Overall Study|Oxaliplatin stops|8|||
160914392|NCT01906008|581077674|FG000|Overall Study|Hospice|1|||
160914393|NCT01906008|581077675|FG001|Overall Study|Hospice|0|||
160914394|NCT01906008|581077674|FG000|Overall Study|Physician Decision|3|||
160914395|NCT01906008|581077675|FG001|Overall Study|Physician Decision|3|||
160914396|NCT01906008|581077674|FG000|Overall Study|Lack of compliance of study med|5|||
160914397|NCT01906008|581077675|FG001|Overall Study|Lack of compliance of study med|3|||
160914398|NCT01906008|581077674|FG000|Overall Study|Adverse Event|0|||
160914399|NCT01906008|581077675|FG001|Overall Study|Adverse Event|3|||
160914400|NCT02117648|581077676|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
160914401|NCT02117648|581077676|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
160914402|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
160914403|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
160914404|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
160914405|NCT02117648|581077676|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
160914406|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
160914407|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
160914408|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
160914409|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
160914410|NCT02117648|581077676|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
160914411|NCT05025241|581077678|FG000|Screening|Failed Screening|5|||
160914412|NCT05025241|581077678|FG000|Treatment and Follow Up|Adverse Event|3|||
160914413|NCT02670837|581077679|FG000|Overall Study|Death|2|||
160914414|NCT02670837|581077680|FG001|Overall Study|Death|0|||
160914415|NCT02670837|581077681|FG002|Overall Study|Death|0|||
160914416|NCT02220205|581077682|FG000|Overall Study|Withdrawal by Subject|1|||
160914417|NCT02220205|581077683|FG001|Overall Study|Withdrawal by Subject|0|||
160914418|NCT02266225|581077684|FG000|Overall Study|Lost to Follow-up|2|||
160914419|NCT02266225|581077684|FG000|Overall Study|Death|1|||
160914420|NCT02266225|581077684|FG000|Overall Study|Withdrawal by Subject|13|||
160914421|NCT01574326|581077685|FG000|Overall Study|Randomized but not treated|0|||
160914422|NCT01574326|581077686|FG001|Overall Study|Randomized but not treated|1|||
160914423|NCT01574326|581077685|FG000|Overall Study|Withdrawal by Participant|2|||
160914424|NCT01574326|581077686|FG001|Overall Study|Withdrawal by Participant|4|||
160914425|NCT01574326|581077685|FG000|Overall Study|Physician Decision|5|||
160914426|NCT01574326|581077686|FG001|Overall Study|Physician Decision|3|||
160914427|NCT01574326|581077685|FG000|Overall Study|Adverse Event|1|||
160914428|NCT01574326|581077686|FG001|Overall Study|Adverse Event|3|||
160914429|NCT01574326|581077685|FG000|Overall Study|Other: Mainly kidney transplant|8|||
160914430|NCT01574326|581077686|FG001|Overall Study|Other: Mainly kidney transplant|8|||
160914431|NCT00137046|581077687|FG000|Overall Study|Death|2|||
160914432|NCT00137046|581077688|FG001|Overall Study|Death|1|||
160914433|NCT00137046|581077687|FG000|Overall Study|Adverse Event|16|||
160914434|NCT00137046|581077688|FG001|Overall Study|Adverse Event|5|||
160914435|NCT00137046|581077687|FG000|Overall Study|Laboratory Abnormality|2|||
160914436|NCT00137046|581077688|FG001|Overall Study|Laboratory Abnormality|0|||
160914437|NCT00137046|581077687|FG000|Overall Study|Lack of Efficacy|13|||
160914438|NCT00137046|581077688|FG001|Overall Study|Lack of Efficacy|1|||
160914439|NCT00137046|581077687|FG000|Overall Study|Lost to Follow-up|8|||
160914440|NCT00137046|581077688|FG001|Overall Study|Lost to Follow-up|24|||
160914441|NCT00137046|581077687|FG000|Overall Study|Other|23|||
160914442|NCT00137046|581077688|FG001|Overall Study|Other|19|||
160914443|NCT00137046|581077687|FG000|Overall Study|Withdrawal by Subject|33|||
160914444|NCT00137046|581077688|FG001|Overall Study|Withdrawal by Subject|42|||
160914445|NCT00137046|581077687|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
160914446|NCT00137046|581077688|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
160914447|NCT00137046|581077687|FG000|Overall Study|Withdrew prior to study treatment|1|||
160914448|NCT00137046|581077688|FG001|Overall Study|Withdrew prior to study treatment|1|||
160914449|NCT02268084|581077693|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
160914450|NCT02268084|581077694|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
160914451|NCT02268084|581077693|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
160914452|NCT02268084|581077694|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
160914453|NCT05227027|581077695|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
160914454|NCT05227027|581077696|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
160914455|NCT06149247|581077697|FG000|Overall Study|Adverse Event|0|||
160914456|NCT06149247|581077698|FG001|Overall Study|Adverse Event|1|||
160914457|NCT00371137|581077703|FG000|Overall Study|Adverse Event|20|||
160914458|NCT00371137|581077704|FG001|Overall Study|Adverse Event|35|||
160914459|NCT00371137|581077705|FG002|Overall Study|Adverse Event|42|||
160914460|NCT00371137|581077703|FG000|Overall Study|Withdrawal by Subject|11|||
160914461|NCT00371137|581077704|FG001|Overall Study|Withdrawal by Subject|10|||
160914462|NCT00371137|581077705|FG002|Overall Study|Withdrawal by Subject|15|||
160914463|NCT00371137|581077703|FG000|Overall Study|Lost to Follow-up|6|||
160914464|NCT00371137|581077704|FG001|Overall Study|Lost to Follow-up|3|||
160914465|NCT00371137|581077705|FG002|Overall Study|Lost to Follow-up|5|||
160914466|NCT00371137|581077703|FG000|Overall Study|Lack of Efficacy|30|||
160914467|NCT00371137|581077704|FG001|Overall Study|Lack of Efficacy|12|||
160914468|NCT00371137|581077705|FG002|Overall Study|Lack of Efficacy|13|||
160914469|NCT00371137|581077703|FG000|Overall Study|Sponsor Decision|2|||
160914470|NCT00371137|581077704|FG001|Overall Study|Sponsor Decision|1|||
160914471|NCT00371137|581077705|FG002|Overall Study|Sponsor Decision|2|||
160914472|NCT00371137|581077703|FG000|Overall Study|Physician Decision|1|||
160914473|NCT00371137|581077704|FG001|Overall Study|Physician Decision|1|||
160914474|NCT00371137|581077705|FG002|Overall Study|Physician Decision|1|||
160914475|NCT00371137|581077703|FG000|Overall Study|Protocol Violation|2|||
160914476|NCT00371137|581077704|FG001|Overall Study|Protocol Violation|1|||
160914477|NCT00371137|581077705|FG002|Overall Study|Protocol Violation|1|||
160914478|NCT01756898|581077708|FG000|Overall Study|Adverse Event|7|||
160914479|NCT01756898|581077709|FG001|Overall Study|Adverse Event|1|||
160914480|NCT01756898|581077710|FG002|Overall Study|Adverse Event|0|||
160914481|NCT01756898|581077711|FG003|Overall Study|Adverse Event|0|||
160914482|NCT01756898|581077708|FG000|Overall Study|Lack of Efficacy|4|||
160914483|NCT01756898|581077709|FG001|Overall Study|Lack of Efficacy|7|||
160914484|NCT01756898|581077710|FG002|Overall Study|Lack of Efficacy|6|||
160914485|NCT01756898|581077711|FG003|Overall Study|Lack of Efficacy|6|||
160914486|NCT01756898|581077708|FG000|Overall Study|Lost to Follow-up|2|||
160914487|NCT01756898|581077709|FG001|Overall Study|Lost to Follow-up|4|||
160914488|NCT01756898|581077710|FG002|Overall Study|Lost to Follow-up|2|||
160914489|NCT01756898|581077711|FG003|Overall Study|Lost to Follow-up|3|||
160914490|NCT01756898|581077708|FG000|Overall Study|Protocol Violation|1|||
160914491|NCT01756898|581077709|FG001|Overall Study|Protocol Violation|2|||
160914492|NCT01756898|581077710|FG002|Overall Study|Protocol Violation|2|||
160914493|NCT01756898|581077711|FG003|Overall Study|Protocol Violation|1|||
160914494|NCT01756898|581077708|FG000|Overall Study|Withdrew Consent|5|||
160914495|NCT01756898|581077709|FG001|Overall Study|Withdrew Consent|3|||
160914496|NCT01756898|581077710|FG002|Overall Study|Withdrew Consent|5|||
160914497|NCT01756898|581077711|FG003|Overall Study|Withdrew Consent|6|||
160914498|NCT01756898|581077708|FG000|Overall Study|Other|0|||
160914499|NCT01756898|581077709|FG001|Overall Study|Other|2|||
160914500|NCT01756898|581077710|FG002|Overall Study|Other|2|||
161256631|NCT02973321|582318623|FG002|Overall Study|Other than specified|3|||
161256632|NCT02973321|582318624|FG003|Overall Study|Other than specified|3|||
160914501|NCT01756898|581077711|FG003|Overall Study|Other|0|||
160914502|NCT01500694|581077712|FG000|Overall Study|Adverse Event|4|||
161142071|NCT02117687|581904305|FG001|Overall Study|Lost to Follow-up|1|||
160914503|NCT01500694|581077713|FG001|Overall Study|Adverse Event|3|||
160914504|NCT01500694|581077712|FG000|Overall Study|Protocol Violation|0|||
160914505|NCT01500694|581077713|FG001|Overall Study|Protocol Violation|1|||
160914506|NCT01500694|581077712|FG000|Overall Study|Withdrawal by Subject|23|||
160914507|NCT01500694|581077713|FG001|Overall Study|Withdrawal by Subject|14|||
160914508|NCT01500694|581077712|FG000|Overall Study|Lost to Follow-up|2|||
160914509|NCT01500694|581077713|FG001|Overall Study|Lost to Follow-up|3|||
160914510|NCT01500694|581077712|FG000|Overall Study|Lack of Efficacy|14|||
160914511|NCT01500694|581077713|FG001|Overall Study|Lack of Efficacy|5|||
160914512|NCT01500694|581077712|FG000|Overall Study|Other|9|||
160914513|NCT01500694|581077713|FG001|Overall Study|Other|3|||
160914514|NCT01963403|581079476|FG000|Overall Study|Lost to Follow-up|2|||
160914515|NCT01963403|581079477|FG001|Overall Study|Lost to Follow-up|3|||
160914516|NCT01963403|581079476|FG000|Overall Study|Implant removal|0|||
160914517|NCT01963403|581079477|FG001|Overall Study|Implant removal|1|||
160914518|NCT02743806|581079478|FG000|Overall Study|Adverse Event|9|||
160914519|NCT02743806|581079478|FG000|Overall Study|Lost to Follow-up|8|||
160914520|NCT02743806|581079478|FG000|Overall Study|Voluntary Withdrawal|54|||
160914521|NCT02743806|581079478|FG000|Overall Study|Study Termination|65|||
160914522|NCT02743806|581079478|FG000|Overall Study|Pregnancy|6|||
160914523|NCT02743806|581079478|FG000|Overall Study|No Longer Clinically Benefiting|27|||
160914524|NCT02743806|581079478|FG000|Overall Study|Reason Not Specified|12|||
160914525|NCT00267046|581079487|FG000|Overall Study|Disease progression|4|||
160914526|NCT00267046|581079488|FG001|Overall Study|Disease progression|2|||
160914527|NCT00267046|581079487|FG000|Overall Study|Chemotoxicity|2|||
160914528|NCT00267046|581079488|FG001|Overall Study|Chemotoxicity|0|||
160914529|NCT00267046|581079487|FG000|Overall Study|Open-label palifermin|2|||
160914530|NCT00267046|581079488|FG001|Overall Study|Open-label palifermin|7|||
160914531|NCT00267046|581079487|FG000|Overall Study|Surgery|3|||
160914532|NCT00267046|581079488|FG001|Overall Study|Surgery|1|||
160914533|NCT00267046|581079487|FG000|Overall Study|Withdrawal by Subject|1|||
160914534|NCT00267046|581079488|FG001|Overall Study|Withdrawal by Subject|0|||
160914535|NCT00267046|581079487|FG000|Overall Study|Radiation|0|||
160914536|NCT00267046|581079488|FG001|Overall Study|Radiation|1|||
160914537|NCT00460408|581079489|FG000|Overall Study|Adverse Event|1|||
160914538|NCT00460408|581079490|FG001|Overall Study|Adverse Event|0|||
160914539|NCT00460408|581079491|FG002|Overall Study|Adverse Event|0|||
160914540|NCT00460408|581079492|FG003|Overall Study|Adverse Event|0|||
160914541|NCT00460408|581079489|FG000|Overall Study|Death|7|||
160914542|NCT00460408|581079490|FG001|Overall Study|Death|0|||
160914543|NCT00460408|581079491|FG002|Overall Study|Death|0|||
160914544|NCT00460408|581079492|FG003|Overall Study|Death|0|||
160914545|NCT00460408|581079489|FG000|Overall Study|Lost to Follow-up|11|||
160914546|NCT00460408|581079490|FG001|Overall Study|Lost to Follow-up|0|||
160914547|NCT00460408|581079491|FG002|Overall Study|Lost to Follow-up|1|||
160914548|NCT00460408|581079492|FG003|Overall Study|Lost to Follow-up|0|||
160914549|NCT00460408|581079489|FG000|Overall Study|Withdrawal by Subject|31|||
160914550|NCT00460408|581079490|FG001|Overall Study|Withdrawal by Subject|0|||
160914551|NCT00460408|581079491|FG002|Overall Study|Withdrawal by Subject|0|||
160914552|NCT00460408|581079492|FG003|Overall Study|Withdrawal by Subject|0|||
160914553|NCT00460408|581079489|FG000|Overall Study|Insufficient clinical response|5|||
160914554|NCT00460408|581079490|FG001|Overall Study|Insufficient clinical response|1|||
160914555|NCT00460408|581079491|FG002|Overall Study|Insufficient clinical response|5|||
160914556|NCT00460408|581079492|FG003|Overall Study|Insufficient clinical response|0|||
160914557|NCT00460408|581079489|FG000|Overall Study|Other|12|||
160914558|NCT00460408|581079490|FG001|Overall Study|Other|2|||
160914559|NCT00460408|581079491|FG002|Overall Study|Other|0|||
160914560|NCT00460408|581079492|FG003|Overall Study|Other|0|||
160914561|NCT02573350|581079493|FG000|Overall Study|Lost to Follow-up|2|||
160914562|NCT02573350|581079494|FG001|Overall Study|Lost to Follow-up|1|||
160914563|NCT02573350|581079493|FG000|Overall Study|Adverse Event|3|||
160914564|NCT02573350|581079494|FG001|Overall Study|Adverse Event|4|||
160914565|NCT02573350|581079493|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
160914566|NCT02573350|581079494|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
160914567|NCT02573350|581079493|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
160914568|NCT02573350|581079494|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
160914569|NCT02573350|581079493|FG000|Overall Study|Subject withdrew consent to participate|6|||
160914570|NCT02573350|581079494|FG001|Overall Study|Subject withdrew consent to participate|1|||
160914571|NCT02573350|581079493|FG000|Overall Study|Protocol Deviation|1|||
160914572|NCT02573350|581079494|FG001|Overall Study|Protocol Deviation|1|||
160914573|NCT04326231|581079495|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
160914574|NCT03303079|581079496|FG000|Overall Study|Adverse Event|0|||
160914575|NCT03303079|581079497|FG001|Overall Study|Adverse Event|1|||
160914576|NCT03303079|581079498|FG002|Overall Study|Adverse Event|3|||
160914577|NCT03303079|581079496|FG000|Overall Study|Protocol Violation|5|||
160914578|NCT03303079|581079497|FG001|Overall Study|Protocol Violation|4|||
160914579|NCT03303079|581079498|FG002|Overall Study|Protocol Violation|7|||
160995803|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
160995804|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
160995805|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
160995806|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
160995807|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
160995808|NCT01467427|581371042|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
160914580|NCT03303079|581079496|FG000|Overall Study|Withdrawal by Subject|2|||
160914581|NCT03303079|581079497|FG001|Overall Study|Withdrawal by Subject|4|||
160914582|NCT03303079|581079498|FG002|Overall Study|Withdrawal by Subject|2|||
160914583|NCT03303079|581079496|FG000|Overall Study|Other than specified|0|||
160914584|NCT03303079|581079497|FG001|Overall Study|Other than specified|2|||
160914585|NCT03303079|581079498|FG002|Overall Study|Other than specified|0|||
160914586|NCT01741701|581079505|FG000|Overall Study|Adverse Event|5|||
160914587|NCT01741701|581079506|FG001|Overall Study|Adverse Event|1|||
160914588|NCT01741701|581079505|FG000|Overall Study|Withdrawal by Subject|0|||
160914589|NCT01741701|581079506|FG001|Overall Study|Withdrawal by Subject|1|||
160914590|NCT00006903|581079512|FG000|Overall Study|Still receiving treatment|0|||
160914591|NCT00006903|581079513|FG001|Overall Study|Still receiving treatment|0|||
160914592|NCT00006903|581079514|FG002|Overall Study|Still receiving treatment|1|||
160914593|NCT00006903|581079512|FG000|Overall Study|Refused further treatment|0|||
160914594|NCT00006903|581079513|FG001|Overall Study|Refused further treatment|2|||
160914595|NCT00006903|581079514|FG002|Overall Study|Refused further treatment|1|||
160914596|NCT00006903|581079512|FG000|Overall Study|Adverse Event|0|||
160995809|NCT01467427|581371043|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
160995810|NCT04269200|581371044|FG000|Global Cohort|Death|72|||
160995811|NCT04269200|581371045|FG001|Global Cohort|Death|54|||
160995812|NCT04269200|581371046|FG002|Global Cohort|Death|49|||
160995813|NCT04269200|581371044|FG000|Global Cohort|Lost to Follow-up|0|||
160995814|NCT04269200|581371045|FG001|Global Cohort|Lost to Follow-up|0|||
160995815|NCT04269200|581371046|FG002|Global Cohort|Lost to Follow-up|2|||
160995816|NCT04269200|581371044|FG000|Global Cohort|Withdrawal by Subject|22|||
160995817|NCT04269200|581371045|FG001|Global Cohort|Withdrawal by Subject|25|||
160995818|NCT04269200|581371046|FG002|Global Cohort|Withdrawal by Subject|18|||
160995819|NCT04269200|581371044|FG000|China Cohort|Death|12|||
160995820|NCT04269200|581371045|FG001|China Cohort|Death|11|||
160995821|NCT04269200|581371046|FG002|China Cohort|Death|13|||
160995822|NCT04269200|581371044|FG000|China Cohort|Lost to Follow-up|0|||
160995823|NCT04269200|581371045|FG001|China Cohort|Lost to Follow-up|1|||
160995824|NCT04269200|581371046|FG002|China Cohort|Lost to Follow-up|1|||
160995825|NCT04269200|581371044|FG000|China Cohort|Withdrawal by Subject|2|||
160995826|NCT04269200|581371045|FG001|China Cohort|Withdrawal by Subject|2|||
160995827|NCT04269200|581371046|FG002|China Cohort|Withdrawal by Subject|4|||
160995828|NCT04181827|581371047|FG000|Overall Study|Ongoing|124|||
160995829|NCT04181827|581371048|FG001|Overall Study|Ongoing|157|||
160995830|NCT04181827|581371047|FG000|Overall Study|Death|82|||
160995831|NCT04181827|581371048|FG001|Overall Study|Death|50|||
160995832|NCT04181827|581371047|FG000|Overall Study|Lost to Follow-up|0|||
160995833|NCT04181827|581371048|FG001|Overall Study|Lost to Follow-up|1|||
160995834|NCT04181827|581371047|FG000|Overall Study|Withdrawal by Subject|5|||
160995835|NCT04181827|581371048|FG001|Overall Study|Withdrawal by Subject|0|||
160995836|NCT03887936|581371049|FG000|Overall Study|Relocation|2|||
160995837|NCT03887936|581371050|FG001|Overall Study|Relocation|2|||
160914597|NCT00006903|581079513|FG001|Overall Study|Adverse Event|0|||
160995838|NCT03887936|581371049|FG000|Overall Study|Physician Decision|0|||
160995839|NCT03887936|581371050|FG001|Overall Study|Physician Decision|1|||
160995840|NCT03887936|581371049|FG000|Overall Study|Withdrawal by Subject|0|||
160995841|NCT03887936|581371050|FG001|Overall Study|Withdrawal by Subject|1|||
160995842|NCT00539591|581371051|FG000|Overall Study|Toxicity|3|||
160995843|NCT00539591|581371052|FG001|Overall Study|Toxicity|0|||
160995844|NCT00539591|581371053|FG002|Overall Study|Toxicity|0|||
160995845|NCT00539591|581371051|FG000|Overall Study|Disease progression|2|||
160995846|NCT00539591|581371052|FG001|Overall Study|Disease progression|2|||
160995847|NCT00539591|581371053|FG002|Overall Study|Disease progression|3|||
160995848|NCT03331250|581371054|FG000|Overall Study|Withdrawal by Subject|1|||
160995849|NCT04305912|581371055|FG000|First Intervention|COVID-19 Suspension|2|||
160995850|NCT04305912|581371056|FG001|First Intervention|COVID-19 Suspension|0|||
160995851|NCT04305912|581371055|FG000|First Intervention|Withdrawal by Subject|0|||
160995852|NCT04305912|581371056|FG001|First Intervention|Withdrawal by Subject|1|||
160914598|NCT00006903|581079514|FG002|Overall Study|Adverse Event|1|||
160914599|NCT00006903|581079512|FG000|Overall Study|Death|0|||
160914600|NCT00006903|581079513|FG001|Overall Study|Death|1|||
160914601|NCT00006903|581079514|FG002|Overall Study|Death|0|||
160914602|NCT00006903|581079512|FG000|Overall Study|Patient never treated|0|||
160995853|NCT04305912|581371055|FG000|Second Intervention|Adverse Event|0|||
160995854|NCT04305912|581371056|FG001|Second Intervention|Adverse Event|1|||
160995855|NCT03563053|581371057|FG000|Overall Study|Withdrawal by Subject|17|||
160995856|NCT03563053|581371057|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
160995857|NCT03563053|581371057|FG000|Overall Study|Adverse Event|3|||
160995858|NCT03563053|581371057|FG000|Overall Study|Physician Decision|1|||
160995859|NCT03563053|581371057|FG000|Overall Study|study terminated by sponsor|71|||
160914603|NCT00006903|581079513|FG001|Overall Study|Patient never treated|0|||
160914604|NCT00006903|581079514|FG002|Overall Study|Patient never treated|1|||
160914605|NCT00006903|581079512|FG000|Overall Study|Ineligible|10|||
160914606|NCT00006903|581079513|FG001|Overall Study|Ineligible|1|||
160995860|NCT00124982|581371058|FG000|Short-term Period|Death|1|||
160995861|NCT00124982|581371059|FG001|Short-term Period|Death|1|||
160995862|NCT00124982|581371060|FG002|Short-term Period|Death|0|||
160995863|NCT00124982|581371058|FG000|Short-term Period|Adverse Event|17|||
160995864|NCT00124982|581371059|FG001|Short-term Period|Adverse Event|22|||
160995865|NCT00124982|581371060|FG002|Short-term Period|Adverse Event|0|||
160995866|NCT00124982|581371058|FG000|Short-term Period|Lack of Efficacy|32|||
160995867|NCT00124982|581371059|FG001|Short-term Period|Lack of Efficacy|73|||
160995868|NCT00124982|581371060|FG002|Short-term Period|Lack of Efficacy|0|||
160995869|NCT00124982|581371058|FG000|Short-term Period|Lost to Follow-up|8|||
160995870|NCT00124982|581371059|FG001|Short-term Period|Lost to Follow-up|5|||
160995871|NCT00124982|581371060|FG002|Short-term Period|Lost to Follow-up|0|||
160995872|NCT00124982|581371058|FG000|Short-term Period|Withdrawal of Consent|7|||
160995873|NCT00124982|581371059|FG001|Short-term Period|Withdrawal of Consent|9|||
160995874|NCT00124982|581371060|FG002|Short-term Period|Withdrawal of Consent|0|||
160995875|NCT00124982|581371058|FG000|Short-term Period|Poor/Non-compliance|3|||
160995876|NCT00124982|581371059|FG001|Short-term Period|Poor/Non-compliance|1|||
160995877|NCT00124982|581371060|FG002|Short-term Period|Poor/Non-compliance|0|||
160995878|NCT00124982|581371058|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
160995879|NCT00124982|581371059|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
160995880|NCT00124982|581371060|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
160995881|NCT00124982|581371058|FG000|Short-term Period|Participant Decision|1|||
160995882|NCT00124982|581371059|FG001|Short-term Period|Participant Decision|0|||
160914607|NCT00006903|581079514|FG002|Overall Study|Ineligible|2|||
160914608|NCT00726661|581079515|FG000|Overall Study|Lost to Follow-up|36|||
160914609|NCT00726661|581079516|FG001|Overall Study|Lost to Follow-up|11|||
160914610|NCT00726661|581079515|FG000|Overall Study|Withdrawal by Subject|17|||
160914611|NCT00726661|581079516|FG001|Overall Study|Withdrawal by Subject|13|||
160914612|NCT00726661|581079515|FG000|Overall Study|Trial terminated by sponsor|214|||
160914613|NCT00726661|581079516|FG001|Overall Study|Trial terminated by sponsor|187|||
160914614|NCT00726661|581079515|FG000|Overall Study|Death|475|||
160914615|NCT00726661|581079516|FG001|Overall Study|Death|159|||
160914616|NCT00726661|581079515|FG000|Overall Study|Physician Decision|25|||
160914617|NCT00726661|581079516|FG001|Overall Study|Physician Decision|13|||
160914618|NCT00726661|581079515|FG000|Overall Study|Other|47|||
160914619|NCT00726661|581079516|FG001|Overall Study|Other|35|||
160914620|NCT02557646|581079519|FG000|Overall Study|Adverse Event|40|||
160914621|NCT02557646|581079519|FG000|Overall Study|Death|1|||
160914622|NCT02557646|581079519|FG000|Overall Study|Lack of Efficacy|186|||
160914623|NCT02557646|581079519|FG000|Overall Study|Withdrawal by Subject|18|||
160914624|NCT02557646|581079519|FG000|Overall Study|Lost to Follow-up|17|||
160914625|NCT02557646|581079519|FG000|Overall Study|Other|14|||
160914626|NCT00660309|581079522|FG000|Overall Study|Adverse Event|2|||
160914627|NCT00660309|581079523|FG001|Overall Study|Adverse Event|0|||
160914628|NCT00660309|581079522|FG000|Overall Study|Withdrawal by Subject|0|||
160914629|NCT00660309|581079523|FG001|Overall Study|Withdrawal by Subject|3|||
160914630|NCT02532972|581079527|FG000|Overall Study|Withdrawal by Subject|1|||
160914631|NCT00110149|581079528|FG000|Overall Study|Physician Decision|3|||
160914632|NCT00748033|581079531|FG000|Overall Study|Adverse Event|0|||
160995883|NCT00124982|581371060|FG002|Short-term Period|Participant Decision|0|||
160914633|NCT00748033|581079532|FG001|Overall Study|Adverse Event|1|||
160914634|NCT01018186|581079533|FG000|2-week Run-in Period|Protocol Violation|1|||
160914635|NCT01018186|581079534|FG001|2-week Run-in Period|Protocol Violation|0|||
160914636|NCT01018186|581079535|FG002|2-week Run-in Period|Protocol Violation|0|||
160914637|NCT01018186|581079536|FG003|2-week Run-in Period|Protocol Violation|0|||
160995884|NCT00124982|581371058|FG000|Short-term Period|Participant Chose Own Doctor|0|||
160995885|NCT00124982|581371059|FG001|Short-term Period|Participant Chose Own Doctor|1|||
160995886|NCT00124982|581371060|FG002|Short-term Period|Participant Chose Own Doctor|0|||
160995887|NCT00124982|581371058|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
160995888|NCT00124982|581371059|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
160914638|NCT01018186|581079533|FG000|2-week Run-in Period|Lost to Follow-up|2|||
160914639|NCT01018186|581079534|FG001|2-week Run-in Period|Lost to Follow-up|0|||
160914640|NCT01018186|581079535|FG002|2-week Run-in Period|Lost to Follow-up|0|||
160995889|NCT00124982|581371060|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
160995890|NCT00124982|581371058|FG000|Short-term Period|Participant Had Lymphopenia|1|||
160914641|NCT01018186|581079536|FG003|2-week Run-in Period|Lost to Follow-up|0|||
160914642|NCT01018186|581079533|FG000|2-week Run-in Period|Physician Decision|3|||
160914643|NCT01018186|581079534|FG001|2-week Run-in Period|Physician Decision|0|||
160914644|NCT01018186|581079535|FG002|2-week Run-in Period|Physician Decision|0|||
160914645|NCT01018186|581079536|FG003|2-week Run-in Period|Physician Decision|0|||
160995891|NCT00124982|581371059|FG001|Short-term Period|Participant Had Lymphopenia|0|||
160914646|NCT01018186|581079533|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
160914647|NCT01018186|581079534|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
160914648|NCT01018186|581079535|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
160914649|NCT01018186|581079536|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
160914650|NCT01018186|581079533|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
160914651|NCT01018186|581079534|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160914652|NCT01018186|581079535|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160914653|NCT01018186|581079536|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
160914654|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
160914655|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
160914656|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
160914657|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
160914658|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
160914659|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
160914660|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
160914661|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
160914662|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
160914663|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
160914664|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
160914665|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
160914666|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
160914667|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
160914668|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
160914669|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
160914670|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
160914671|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
160914672|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
160914673|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
160914674|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
160914675|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
160914676|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
160914677|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
160914678|NCT01018186|581079533|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
160914679|NCT01018186|581079534|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
160914680|NCT01018186|581079535|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
160914681|NCT01018186|581079536|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
160914682|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914683|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
160914684|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914685|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914686|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914687|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
160914688|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
160914689|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
160914690|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
160914691|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
160914692|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
160914693|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
160914694|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
160914695|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
160914696|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
160914697|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
160914698|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
160914699|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
160914700|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914701|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914702|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914703|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914704|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
160914705|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
160914706|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914707|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
161256633|NCT02973321|582318625|FG004|Overall Study|Other than specified|1|||
161256634|NCT02973321|582318621|FG000|Overall Study|Lack of Efficacy|0|||
161256635|NCT02973321|582318622|FG001|Overall Study|Lack of Efficacy|0|||
160914708|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914709|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914710|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914711|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
160914712|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
160914713|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
160914714|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
160914715|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
160914716|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
160914717|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
160914718|NCT02603419|581079537|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914719|NCT02603419|581079538|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914720|NCT02603419|581079539|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914721|NCT02603419|581079540|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
160914722|NCT02603419|581079541|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914723|NCT02603419|581079542|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
160914724|NCT02603419|581079537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914725|NCT02603419|581079538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914726|NCT02603419|581079539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914727|NCT02603419|581079540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914728|NCT02603419|581079541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
160914729|NCT02603419|581079542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
160914730|NCT02603419|581079537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914731|NCT02603419|581079538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914732|NCT02603419|581079539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914733|NCT02603419|581079540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914734|NCT02603419|581079541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
160914735|NCT02603419|581079542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
160914736|NCT02603419|581079537|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914737|NCT02603419|581079538|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914738|NCT02603419|581079539|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914739|NCT02603419|581079540|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914740|NCT02603419|581079541|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
160914741|NCT02603419|581079542|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
160914742|NCT03552198|581079543|FG000|Overall Study|Lost to Follow-up|42|||
160914743|NCT03552198|581079544|FG001|Overall Study|Lost to Follow-up|48|||
160914744|NCT03552198|581079545|FG002|Overall Study|Lost to Follow-up|15|||
160914745|NCT03552198|581079546|FG003|Overall Study|Lost to Follow-up|19|||
160914746|NCT03552198|581079543|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
160914747|NCT03552198|581079544|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
160914748|NCT03552198|581079545|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
160914749|NCT03552198|581079546|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
160914750|NCT03552198|581079543|FG000|Overall Study|Did not receive air alerts|1|||
160914751|NCT03552198|581079544|FG001|Overall Study|Did not receive air alerts|0|||
160914752|NCT03552198|581079545|FG002|Overall Study|Did not receive air alerts|0|||
160914753|NCT03552198|581079546|FG003|Overall Study|Did not receive air alerts|1|||
160914754|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
160914755|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
160914756|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
160914757|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
160914758|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
160914759|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160914760|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
160914761|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
160914762|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Other|1|||
160914763|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Other|4|||
160914764|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Other|3|||
160914765|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Other|6|||
160914766|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
160914767|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
160914768|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
160914769|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
160914770|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
160914771|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
160914772|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
160914773|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
160914774|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160914775|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
160914776|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
160914777|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
160914778|NCT02925494|581079547|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
160914779|NCT02925494|581079548|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
160914780|NCT02925494|581079549|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
160914781|NCT02925494|581079550|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
160914782|NCT01666782|581079556|FG000|Overall Study|Received 2 doses of vaccine|0|||
160914783|NCT01666782|581079557|FG001|Overall Study|Received 2 doses of vaccine|1|||
160914784|NCT01666782|581079556|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
160914785|NCT01666782|581079557|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
160914786|NCT02007109|581079560|FG000|Overall Study|Diary not returned or excluded|102|||
160914787|NCT02007109|581079560|FG000|Overall Study|Excluded - Age<7yo|9|||
160914788|NCT03572062|581079561|FG000|Overall Study|Adverse Event|0|||
160914789|NCT03572062|581079562|FG001|Overall Study|Adverse Event|0|||
160914790|NCT03572062|581079563|FG002|Overall Study|Adverse Event|0|||
160914791|NCT03572062|581079564|FG003|Overall Study|Adverse Event|0|||
160914792|NCT03572062|581079565|FG004|Overall Study|Adverse Event|0|||
160914793|NCT03572062|581079566|FG005|Overall Study|Adverse Event|0|||
160914794|NCT03572062|581079567|FG006|Overall Study|Adverse Event|0|||
160914795|NCT03572062|581079568|FG007|Overall Study|Adverse Event|0|||
160914796|NCT03572062|581079569|FG008|Overall Study|Adverse Event|1|||
160914797|NCT03572062|581079570|FG009|Overall Study|Adverse Event|3|||
160914798|NCT03572062|581079561|FG000|Overall Study|Death|0|||
160914799|NCT03572062|581079562|FG001|Overall Study|Death|0|||
160914800|NCT03572062|581079563|FG002|Overall Study|Death|0|||
160914801|NCT03572062|581079564|FG003|Overall Study|Death|0|||
160914802|NCT03572062|581079565|FG004|Overall Study|Death|0|||
160914803|NCT03572062|581079566|FG005|Overall Study|Death|1|||
160914804|NCT03572062|581079567|FG006|Overall Study|Death|0|||
160914805|NCT03572062|581079568|FG007|Overall Study|Death|0|||
160914806|NCT03572062|581079569|FG008|Overall Study|Death|0|||
160914807|NCT03572062|581079570|FG009|Overall Study|Death|0|||
160914808|NCT03572062|581079561|FG000|Overall Study|Lost to Follow-up|0|||
160914809|NCT03572062|581079562|FG001|Overall Study|Lost to Follow-up|0|||
160914810|NCT03572062|581079563|FG002|Overall Study|Lost to Follow-up|0|||
160914811|NCT03572062|581079564|FG003|Overall Study|Lost to Follow-up|0|||
160914812|NCT03572062|581079565|FG004|Overall Study|Lost to Follow-up|0|||
160914813|NCT03572062|581079566|FG005|Overall Study|Lost to Follow-up|1|||
160914814|NCT03572062|581079567|FG006|Overall Study|Lost to Follow-up|1|||
160914815|NCT03572062|581079568|FG007|Overall Study|Lost to Follow-up|0|||
160914816|NCT03572062|581079569|FG008|Overall Study|Lost to Follow-up|0|||
160914817|NCT03572062|581079570|FG009|Overall Study|Lost to Follow-up|0|||
160914818|NCT03572062|581079561|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914819|NCT03572062|581079562|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914820|NCT03572062|581079563|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914821|NCT03572062|581079564|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914822|NCT03572062|581079565|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914823|NCT03572062|581079566|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914824|NCT03572062|581079567|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914825|NCT03572062|581079568|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914826|NCT03572062|581079569|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
160914827|NCT03572062|581079570|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
160914828|NCT03572062|581079561|FG000|Overall Study|Study Terminated By Sponsor|0|||
160914829|NCT03572062|581079562|FG001|Overall Study|Study Terminated By Sponsor|0|||
160914830|NCT03572062|581079563|FG002|Overall Study|Study Terminated By Sponsor|0|||
160914831|NCT03572062|581079564|FG003|Overall Study|Study Terminated By Sponsor|0|||
160914832|NCT03572062|581079565|FG004|Overall Study|Study Terminated By Sponsor|0|||
160914833|NCT03572062|581079566|FG005|Overall Study|Study Terminated By Sponsor|0|||
160914834|NCT03572062|581079567|FG006|Overall Study|Study Terminated By Sponsor|0|||
160914835|NCT03572062|581079568|FG007|Overall Study|Study Terminated By Sponsor|0|||
160914836|NCT03572062|581079569|FG008|Overall Study|Study Terminated By Sponsor|29|||
160914837|NCT03572062|581079570|FG009|Overall Study|Study Terminated By Sponsor|27|||
160914838|NCT03572062|581079561|FG000|Overall Study|Physician Decision|0|||
160914839|NCT03572062|581079562|FG001|Overall Study|Physician Decision|0|||
160914840|NCT03572062|581079563|FG002|Overall Study|Physician Decision|0|||
160914841|NCT03572062|581079564|FG003|Overall Study|Physician Decision|0|||
160914842|NCT03572062|581079565|FG004|Overall Study|Physician Decision|0|||
160914843|NCT03572062|581079566|FG005|Overall Study|Physician Decision|0|||
160914844|NCT03572062|581079567|FG006|Overall Study|Physician Decision|0|||
160914845|NCT03572062|581079568|FG007|Overall Study|Physician Decision|0|||
160914846|NCT03572062|581079569|FG008|Overall Study|Physician Decision|1|||
160914847|NCT03572062|581079570|FG009|Overall Study|Physician Decision|0|||
160914848|NCT03572062|581079561|FG000|Overall Study|Withdrawal by Subject|0|||
160914849|NCT03572062|581079562|FG001|Overall Study|Withdrawal by Subject|0|||
160914850|NCT03572062|581079563|FG002|Overall Study|Withdrawal by Subject|0|||
160914851|NCT03572062|581079564|FG003|Overall Study|Withdrawal by Subject|0|||
160914852|NCT03572062|581079565|FG004|Overall Study|Withdrawal by Subject|0|||
160914853|NCT03572062|581079566|FG005|Overall Study|Withdrawal by Subject|0|||
160914854|NCT03572062|581079567|FG006|Overall Study|Withdrawal by Subject|0|||
160914855|NCT03572062|581079568|FG007|Overall Study|Withdrawal by Subject|0|||
160914856|NCT03572062|581079569|FG008|Overall Study|Withdrawal by Subject|0|||
160914857|NCT03572062|581079570|FG009|Overall Study|Withdrawal by Subject|1|||
160914858|NCT03572062|581079561|FG000|Overall Study|Randomized But Not Treated|0|||
160914859|NCT03572062|581079562|FG001|Overall Study|Randomized But Not Treated|0|||
160914860|NCT03572062|581079563|FG002|Overall Study|Randomized But Not Treated|0|||
160914861|NCT03572062|581079564|FG003|Overall Study|Randomized But Not Treated|0|||
160914862|NCT03572062|581079565|FG004|Overall Study|Randomized But Not Treated|1|||
160914863|NCT03572062|581079566|FG005|Overall Study|Randomized But Not Treated|2|||
160914864|NCT03572062|581079567|FG006|Overall Study|Randomized But Not Treated|0|||
160914865|NCT03572062|581079568|FG007|Overall Study|Randomized But Not Treated|1|||
160914866|NCT03572062|581079569|FG008|Overall Study|Randomized But Not Treated|0|||
160914867|NCT03572062|581079570|FG009|Overall Study|Randomized But Not Treated|0|||
160914868|NCT01858389|581079571|FG000|Overall Study|Death|1|||
160914869|NCT01858389|581079572|FG001|Overall Study|Death|3|||
160914870|NCT01858389|581079571|FG000|Overall Study|Study terminated by sponsor|0|||
160914871|NCT01858389|581079572|FG001|Overall Study|Study terminated by sponsor|2|||
160914872|NCT01858389|581079571|FG000|Overall Study|Withdrawal by Subject|0|||
160914873|NCT01858389|581079572|FG001|Overall Study|Withdrawal by Subject|1|||
160914874|NCT01858389|581079571|FG000|Overall Study|Progressive disease|10|||
160914875|NCT01858389|581079572|FG001|Overall Study|Progressive disease|11|||
160914876|NCT01858389|581079571|FG000|Overall Study|Other|2|||
160914877|NCT01858389|581079572|FG001|Overall Study|Other|4|||
160914878|NCT01858389|581079571|FG000|Overall Study|Adverse Event|3|||
160914879|NCT01858389|581079572|FG001|Overall Study|Adverse Event|1|||
160914880|NCT01858389|581079571|FG000|Overall Study|Did not receive treatment|0|||
160914881|NCT01858389|581079572|FG001|Overall Study|Did not receive treatment|3|||
160914882|NCT01691781|581079573|FG000|Overall Study|Withdrawal by Subject|4|||
160914883|NCT01691781|581079574|FG001|Overall Study|Withdrawal by Subject|3|||
160914884|NCT01691781|581079573|FG000|Overall Study|Physician Decision|1|||
160914885|NCT01691781|581079574|FG001|Overall Study|Physician Decision|1|||
160914886|NCT01691781|581079573|FG000|Overall Study|Protocol Violation|2|||
160914887|NCT01691781|581079574|FG001|Overall Study|Protocol Violation|2|||
160914888|NCT01691781|581079573|FG000|Overall Study|Adverse Event|0|||
160914889|NCT01691781|581079574|FG001|Overall Study|Adverse Event|1|||
160914890|NCT03978520|581079575|FG000|Overall Study|Adverse Event|2|||
160914891|NCT03978520|581079576|FG001|Overall Study|Adverse Event|5|||
160914892|NCT03978520|581079577|FG002|Overall Study|Adverse Event|3|||
160914893|NCT03978520|581079578|FG003|Overall Study|Adverse Event|5|||
160914894|NCT03978520|581079579|FG004|Overall Study|Adverse Event|6|||
160914895|NCT03978520|581079575|FG000|Overall Study|Withdrawal by Subject|10|||
160914896|NCT03978520|581079576|FG001|Overall Study|Withdrawal by Subject|4|||
160995892|NCT00124982|581371060|FG002|Short-term Period|Participant Had Lymphopenia|0|||
160995893|NCT00124982|581371058|FG000|Long-term Period|Death|0|||
160995894|NCT00124982|581371059|FG001|Long-term Period|Death|0|||
160995895|NCT00124982|581371060|FG002|Long-term Period|Death|1|||
160995896|NCT00124982|581371058|FG000|Long-term Period|Adverse Event|0|||
160995897|NCT00124982|581371059|FG001|Long-term Period|Adverse Event|0|||
160995898|NCT00124982|581371060|FG002|Long-term Period|Adverse Event|17|||
160995899|NCT00124982|581371058|FG000|Long-term Period|Lack of Efficacy|0|||
160995900|NCT00124982|581371059|FG001|Long-term Period|Lack of Efficacy|0|||
160995901|NCT00124982|581371060|FG002|Long-term Period|Lack of Efficacy|46|||
160995902|NCT00124982|581371058|FG000|Long-term Period|Lost to Follow-up|0|||
160995903|NCT00124982|581371059|FG001|Long-term Period|Lost to Follow-up|0|||
160995904|NCT00124982|581371060|FG002|Long-term Period|Lost to Follow-up|4|||
160995905|NCT00124982|581371058|FG000|Long-term Period|Withdrawal by Subject|0|||
160995906|NCT00124982|581371059|FG001|Long-term Period|Withdrawal by Subject|0|||
160995907|NCT00124982|581371060|FG002|Long-term Period|Withdrawal by Subject|16|||
160995908|NCT00124982|581371058|FG000|Long-term Period|Pregnancy|0|||
160995909|NCT00124982|581371059|FG001|Long-term Period|Pregnancy|0|||
160995910|NCT00124982|581371060|FG002|Long-term Period|Pregnancy|1|||
160914897|NCT03978520|581079577|FG002|Overall Study|Withdrawal by Subject|5|||
160914898|NCT03978520|581079578|FG003|Overall Study|Withdrawal by Subject|6|||
160914899|NCT03978520|581079579|FG004|Overall Study|Withdrawal by Subject|5|||
160914900|NCT03978520|581079575|FG000|Overall Study|Lost to Follow-up|2|||
160914901|NCT03978520|581079576|FG001|Overall Study|Lost to Follow-up|2|||
160914902|NCT03978520|581079577|FG002|Overall Study|Lost to Follow-up|2|||
160914903|NCT03978520|581079578|FG003|Overall Study|Lost to Follow-up|0|||
160914904|NCT03978520|581079579|FG004|Overall Study|Lost to Follow-up|1|||
160995911|NCT00124982|581371058|FG000|Long-term Period|Poor/Non-compliance|0|||
160995912|NCT00124982|581371059|FG001|Long-term Period|Poor/Non-compliance|0|||
160995913|NCT00124982|581371060|FG002|Long-term Period|Poor/Non-compliance|2|||
160914905|NCT03978520|581079575|FG000|Overall Study|COVID-19 infection|0|||
160914906|NCT03978520|581079576|FG001|Overall Study|COVID-19 infection|1|||
160914907|NCT03978520|581079577|FG002|Overall Study|COVID-19 infection|0|||
161142072|NCT02117687|581904304|FG000|Overall Study|Adverse Event|0|||
160914908|NCT03978520|581079578|FG003|Overall Study|COVID-19 infection|0|||
160914909|NCT03978520|581079579|FG004|Overall Study|COVID-19 infection|0|||
160914910|NCT03978520|581079575|FG000|Overall Study|Other, not specified|9|||
160914911|NCT03978520|581079576|FG001|Overall Study|Other, not specified|4|||
160914912|NCT03978520|581079577|FG002|Overall Study|Other, not specified|1|||
160914913|NCT03978520|581079578|FG003|Overall Study|Other, not specified|1|||
160914914|NCT03978520|581079579|FG004|Overall Study|Other, not specified|2|||
160914915|NCT03978520|581079575|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
160914916|NCT03978520|581079576|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
160914917|NCT03978520|581079577|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
160914918|NCT03978520|581079578|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
160914919|NCT03978520|581079579|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
160914920|NCT02837783|581079580|FG000|Overall Study|Adverse Event|1|||
160914921|NCT02837783|581079581|FG001|Overall Study|Adverse Event|0|||
160914922|NCT02837783|581079580|FG000|Overall Study|Other, Not Specified|1|||
160914923|NCT02837783|581079581|FG001|Overall Study|Other, Not Specified|2|||
160914924|NCT03200860|581079582|FG000|Overall Study|Withdrawal by Subject|1|||
160914925|NCT03200860|581079583|FG001|Overall Study|Withdrawal by Subject|0|||
160914926|NCT02634320|581079592|FG000|Overall Study|Adverse Event|2|||
160914927|NCT02634320|581079592|FG000|Overall Study|Lost to Follow-up|3|||
160914928|NCT02634320|581079592|FG000|Overall Study|Moved out of area|2|||
160914929|NCT02634320|581079592|FG000|Overall Study|Out of window for study visits|1|||
160914930|NCT02634320|581079592|FG000|Overall Study|Protocol Violation|1|||
160914931|NCT02634320|581079592|FG000|Overall Study|Withdrawal by Subject|5|||
160914932|NCT02634320|581079592|FG000|Overall Study|Lack of Efficacy|2|||
160914933|NCT02760069|581079593|FG000|Overall Study|Withdrawal by Subject|0|||
160914934|NCT02760069|581079594|FG001|Overall Study|Withdrawal by Subject|1|||
160914935|NCT02760069|581079595|FG002|Overall Study|Withdrawal by Subject|1|||
160914936|NCT00600483|581079606|FG000|Overall Study|Lost to Follow-up|26|||
160914937|NCT00600483|581079607|FG001|Overall Study|Lost to Follow-up|47|||
160914938|NCT00600483|581079606|FG000|Overall Study|Randomized but not treated|10|||
160914939|NCT00600483|581079607|FG001|Overall Study|Randomized but not treated|0|||
160914940|NCT03031678|581079613|FG000|Overall Study|Study closed prior to completion|1|||
160914941|NCT03694821|581079614|FG000|Overall Study|Study terminated|4|||
160914942|NCT03694821|581079615|FG001|Overall Study|Study terminated|8|||
160914943|NCT03694821|581079616|FG002|Overall Study|Study terminated|4|||
160914944|NCT05109442|581079621|FG000|Overall Study|Withdrawal by Subject|0|||
160914945|NCT05109442|581079622|FG001|Overall Study|Withdrawal by Subject|0|||
160914946|NCT05109442|581079623|FG002|Overall Study|Withdrawal by Subject|1|||
160914947|NCT05109442|581079624|FG003|Overall Study|Withdrawal by Subject|0|||
160914948|NCT05109442|581079625|FG004|Overall Study|Withdrawal by Subject|0|||
160914949|NCT05109442|581079626|FG005|Overall Study|Withdrawal by Subject|0|||
160914950|NCT05109442|581079621|FG000|Overall Study|Adverse Event|0|||
160914951|NCT05109442|581079622|FG001|Overall Study|Adverse Event|1|||
160914952|NCT05109442|581079623|FG002|Overall Study|Adverse Event|5|||
160914953|NCT05109442|581079624|FG003|Overall Study|Adverse Event|0|||
160914954|NCT05109442|581079625|FG004|Overall Study|Adverse Event|0|||
160914955|NCT05109442|581079626|FG005|Overall Study|Adverse Event|2|||
160914956|NCT05109442|581079621|FG000|Overall Study|Death|0|||
160914957|NCT05109442|581079622|FG001|Overall Study|Death|0|||
160914958|NCT05109442|581079623|FG002|Overall Study|Death|4|||
160914959|NCT05109442|581079624|FG003|Overall Study|Death|0|||
160914960|NCT05109442|581079625|FG004|Overall Study|Death|0|||
160914961|NCT05109442|581079626|FG005|Overall Study|Death|1|||
160914962|NCT05109442|581079621|FG000|Overall Study|Physician Decision|1|||
160914963|NCT05109442|581079622|FG001|Overall Study|Physician Decision|0|||
160914964|NCT05109442|581079623|FG002|Overall Study|Physician Decision|1|||
160914965|NCT05109442|581079624|FG003|Overall Study|Physician Decision|0|||
160914966|NCT05109442|581079625|FG004|Overall Study|Physician Decision|0|||
160914967|NCT05109442|581079626|FG005|Overall Study|Physician Decision|2|||
160914968|NCT05109442|581079621|FG000|Overall Study|Other than listed|0|||
160995914|NCT00124982|581371058|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
160995915|NCT00124982|581371059|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
160995916|NCT00124982|581371060|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
160995917|NCT00124982|581371058|FG000|Long-term Period|Neurologist Recommendation|0|||
160914969|NCT05109442|581079622|FG001|Overall Study|Other than listed|0|||
160914970|NCT05109442|581079623|FG002|Overall Study|Other than listed|9|||
160914971|NCT05109442|581079624|FG003|Overall Study|Other than listed|2|||
160914972|NCT05109442|581079625|FG004|Overall Study|Other than listed|0|||
160914973|NCT05109442|581079626|FG005|Overall Study|Other than listed|8|||
160914974|NCT05109442|581079621|FG000|Overall Study|Lack of Efficacy|3|||
160914975|NCT05109442|581079622|FG001|Overall Study|Lack of Efficacy|5|||
160914976|NCT05109442|581079623|FG002|Overall Study|Lack of Efficacy|29|||
160914977|NCT05109442|581079624|FG003|Overall Study|Lack of Efficacy|10|||
160914978|NCT05109442|581079625|FG004|Overall Study|Lack of Efficacy|11|||
160914979|NCT05109442|581079626|FG005|Overall Study|Lack of Efficacy|17|||
160914980|NCT03278613|581079636|FG000|Overall Study|Lost to Follow-up|3|||
160914981|NCT03278613|581079637|FG001|Overall Study|Lost to Follow-up|1|||
160914982|NCT01405456|581079638|FG000|Overall Study|Lost to Follow-up|2|||
160914983|NCT01405456|581079639|FG001|Overall Study|Lost to Follow-up|1|||
160914984|NCT01405456|581079638|FG000|Overall Study|Physician Decision|1|||
160914985|NCT01405456|581079639|FG001|Overall Study|Physician Decision|0|||
160914986|NCT05475236|581079641|FG000|Overall Study|Withdrawal by Subject|0|||
160914987|NCT05475236|581079642|FG001|Overall Study|Withdrawal by Subject|1|||
160914988|NCT01438424|581081724|FG000|Overall Study|Continuing treatment|29|||
160914989|NCT01438424|581081724|FG000|Overall Study|Minimal virologic response|95|||
160914990|NCT01438424|581081724|FG000|Overall Study|Not identified|55|||
160914991|NCT01438424|581081724|FG000|Overall Study|Withdrawal by Subject|104|||
160914992|NCT01438424|581081724|FG000|Overall Study|Progression of chronic hepatitis B|22|||
160914993|NCT01438424|581081724|FG000|Overall Study|Death|22|||
160914994|NCT01438424|581081724|FG000|Overall Study|Adverse Event|17|||
160914995|NCT01438424|581081724|FG000|Overall Study|Lost to Follow-up|17|||
160914996|NCT01438424|581081724|FG000|Overall Study|Abnormal laboratory test result|14|||
160914997|NCT01438424|581081724|FG000|Overall Study|Need for drug prohibited by protocol|14|||
160914998|NCT01438424|581081724|FG000|Overall Study|Pregnancy|7|||
160914999|NCT01438424|581081724|FG000|Overall Study|No longer met inclusion criteria|1|||
160915000|NCT01438424|581081724|FG000|Overall Study|Participant noncompliance|20|||
160915001|NCT02154490|581081725|FG000|Overall Study|No tissue submitted|23|||
160915002|NCT02154490|581081725|FG000|Overall Study|No biomarker results|167|||
160915003|NCT02154490|581081725|FG000|Overall Study|Not assigned to a sub-study|270|||
160915004|NCT02154490|581081725|FG000|Overall Study|Did not register to a sub-study|749|||
160915005|NCT02927080|581081726|FG000|Overall Study|Withdrawal by Subject|0|||
160915006|NCT02927080|581081727|FG001|Overall Study|Withdrawal by Subject|0|||
160915007|NCT02927080|581081728|FG002|Overall Study|Withdrawal by Subject|0|||
160915008|NCT02927080|581081729|FG003|Overall Study|Withdrawal by Subject|0|||
160915009|NCT02927080|581081730|FG004|Overall Study|Withdrawal by Subject|1|||
160915010|NCT02927080|581081731|FG005|Overall Study|Withdrawal by Subject|0|||
160915011|NCT02927080|581081732|FG006|Overall Study|Withdrawal by Subject|1|||
160915012|NCT02927080|581081733|FG007|Overall Study|Withdrawal by Subject|1|||
160915013|NCT02927080|581081734|FG008|Overall Study|Withdrawal by Subject|0|||
160915014|NCT02927080|581081735|FG009|Overall Study|Withdrawal by Subject|2|||
160915015|NCT02927080|581081726|FG000|Overall Study|Willingness to comply with protocol|0|||
160915016|NCT02927080|581081727|FG001|Overall Study|Willingness to comply with protocol|0|||
160915017|NCT02927080|581081728|FG002|Overall Study|Willingness to comply with protocol|0|||
160915018|NCT02927080|581081729|FG003|Overall Study|Willingness to comply with protocol|0|||
160915019|NCT02927080|581081730|FG004|Overall Study|Willingness to comply with protocol|0|||
160915020|NCT02927080|581081731|FG005|Overall Study|Willingness to comply with protocol|0|||
160915021|NCT02927080|581081732|FG006|Overall Study|Willingness to comply with protocol|0|||
160915022|NCT02927080|581081733|FG007|Overall Study|Willingness to comply with protocol|0|||
160915023|NCT02927080|581081734|FG008|Overall Study|Willingness to comply with protocol|0|||
160915024|NCT02927080|581081735|FG009|Overall Study|Willingness to comply with protocol|1|||
160915025|NCT02927080|581081726|FG000|Overall Study|Study terminated by Sponsor|0|||
160915026|NCT02927080|581081727|FG001|Overall Study|Study terminated by Sponsor|0|||
160915027|NCT02927080|581081728|FG002|Overall Study|Study terminated by Sponsor|0|||
160915028|NCT02927080|581081729|FG003|Overall Study|Study terminated by Sponsor|0|||
160915029|NCT02927080|581081730|FG004|Overall Study|Study terminated by Sponsor|0|||
160915030|NCT02927080|581081731|FG005|Overall Study|Study terminated by Sponsor|0|||
160915031|NCT02927080|581081732|FG006|Overall Study|Study terminated by Sponsor|6|||
161339242|NCT01232283|582630422|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
160915032|NCT02927080|581081733|FG007|Overall Study|Study terminated by Sponsor|7|||
160915033|NCT02927080|581081734|FG008|Overall Study|Study terminated by Sponsor|2|||
160915034|NCT02927080|581081735|FG009|Overall Study|Study terminated by Sponsor|3|||
160915035|NCT02927080|581081726|FG000|Overall Study|Adverse Event|0|||
160915036|NCT02927080|581081727|FG001|Overall Study|Adverse Event|1|||
160915037|NCT02927080|581081728|FG002|Overall Study|Adverse Event|0|||
160915038|NCT02927080|581081729|FG003|Overall Study|Adverse Event|0|||
161339243|NCT01232283|582630423|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
161339244|NCT01232283|582630424|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161339245|NCT01232283|582630425|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161339246|NCT01232283|582630426|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161339247|NCT01232283|582630427|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161339248|NCT01232283|582630428|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161339249|NCT01232283|582630429|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
161339250|NCT01232283|582630420|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
160915039|NCT02927080|581081730|FG004|Overall Study|Adverse Event|0|||
160915040|NCT02927080|581081731|FG005|Overall Study|Adverse Event|0|||
160915041|NCT02927080|581081732|FG006|Overall Study|Adverse Event|0|||
160915042|NCT02927080|581081733|FG007|Overall Study|Adverse Event|1|||
160915043|NCT02927080|581081734|FG008|Overall Study|Adverse Event|0|||
160915044|NCT02927080|581081735|FG009|Overall Study|Adverse Event|1|||
160915045|NCT02927080|581081726|FG000|Overall Study|Other|0|||
160915046|NCT02927080|581081727|FG001|Overall Study|Other|0|||
160915047|NCT02927080|581081728|FG002|Overall Study|Other|0|||
160915048|NCT02927080|581081729|FG003|Overall Study|Other|0|||
160915049|NCT02927080|581081730|FG004|Overall Study|Other|0|||
160915050|NCT02927080|581081731|FG005|Overall Study|Other|0|||
160915051|NCT02927080|581081732|FG006|Overall Study|Other|1|||
160915052|NCT02927080|581081733|FG007|Overall Study|Other|0|||
160915053|NCT02927080|581081734|FG008|Overall Study|Other|1|||
160915054|NCT02927080|581081735|FG009|Overall Study|Other|0|||
160915055|NCT01411228|581081737|FG000|Overall Study|Lost to Follow-up|0|||
160915056|NCT01411228|581081738|FG001|Overall Study|Lost to Follow-up|0|||
160915057|NCT01411228|581081739|FG002|Overall Study|Lost to Follow-up|1|||
160915058|NCT01411228|581081737|FG000|Overall Study|Withdrawal by Subject|1|||
160915059|NCT01411228|581081738|FG001|Overall Study|Withdrawal by Subject|0|||
160915060|NCT01411228|581081739|FG002|Overall Study|Withdrawal by Subject|0|||
160915061|NCT00664742|581081740|FG000|Overall Study|Withdrawn due to adverse events|3|||
160915062|NCT00664742|581081740|FG000|Overall Study|Withdrawal by Subject|31|||
160915063|NCT00664742|581081740|FG000|Overall Study|Lost to Follow-up|92|||
160915064|NCT02670083|581081741|FG000|Overall Study|Adverse Event|16|||
160915065|NCT02670083|581081742|FG001|Overall Study|Adverse Event|13|||
160915066|NCT02670083|581081741|FG000|Overall Study|Death|4|||
160915067|NCT02670083|581081742|FG001|Overall Study|Death|6|||
160915068|NCT02670083|581081741|FG000|Overall Study|Lost to Follow-up|2|||
160915069|NCT02670083|581081742|FG001|Overall Study|Lost to Follow-up|2|||
160915070|NCT02670083|581081741|FG000|Overall Study|Multiple Reasons|9|||
160915071|NCT02670083|581081742|FG001|Overall Study|Multiple Reasons|9|||
160915072|NCT02670083|581081741|FG000|Overall Study|Physician Decision|0|||
160915073|NCT02670083|581081742|FG001|Overall Study|Physician Decision|2|||
160915074|NCT02670083|581081741|FG000|Overall Study|Study Terminated By Sponsor|257|||
160915075|NCT02670083|581081742|FG001|Overall Study|Study Terminated By Sponsor|254|||
160915076|NCT02670083|581081741|FG000|Overall Study|Symptomatic Deterioration|0|||
160915077|NCT02670083|581081742|FG001|Overall Study|Symptomatic Deterioration|2|||
160915078|NCT02670083|581081741|FG000|Overall Study|Withdrawal by Subject|32|||
160915079|NCT02670083|581081742|FG001|Overall Study|Withdrawal by Subject|31|||
160915080|NCT02670083|581081741|FG000|Overall Study|Non-Compliance With Study Drug|1|||
160915081|NCT02670083|581081742|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160915082|NCT02825992|581081743|FG000|Overall Study|Withdrawal by Subject|4|||
160915083|NCT02825992|581081743|FG000|Overall Study|Lost to Follow-up|2|||
160915084|NCT02825992|581081743|FG000|Overall Study|Procedure terminated|2|||
160915085|NCT00418314|581081745|FG000|Overall Study|Withdrawal by Subject|1|||
160915086|NCT00418314|581081746|FG001|Overall Study|Withdrawal by Subject|2|||
160915087|NCT02692716|581081747|FG000|Overall Study|Lost to Follow-up|2|||
160915088|NCT02692716|581081748|FG001|Overall Study|Lost to Follow-up|5|||
160915089|NCT02692716|581081747|FG000|Overall Study|Withdrawal by Subject|3|||
160915090|NCT02692716|581081748|FG001|Overall Study|Withdrawal by Subject|1|||
160915091|NCT02904512|581081753|FG000|Overall Study|Withdrawal by Subject|1|||
160915092|NCT02904512|581081754|FG001|Overall Study|Withdrawal by Subject|0|||
160915093|NCT02904512|581081753|FG000|Overall Study|Transferred to ICU|1|||
160915094|NCT02904512|581081754|FG001|Overall Study|Transferred to ICU|0|||
160915095|NCT02904512|581081753|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
160915096|NCT02904512|581081754|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
160915097|NCT00589914|581081763|FG000|Overall Study|Adverse Event|19|||
160915098|NCT00589914|581081764|FG001|Overall Study|Adverse Event|10|||
160915099|NCT00589914|581081763|FG000|Overall Study|Death|2|||
160915100|NCT00589914|581081764|FG001|Overall Study|Death|0|||
160915101|NCT00589914|581081763|FG000|Overall Study|Lack of Efficacy|40|||
160915102|NCT00589914|581081764|FG001|Overall Study|Lack of Efficacy|43|||
160915103|NCT00589914|581081763|FG000|Overall Study|Lost to Follow-up|11|||
160915104|NCT00589914|581081764|FG001|Overall Study|Lost to Follow-up|18|||
160915105|NCT00589914|581081763|FG000|Overall Study|Pregnancy|1|||
160915106|NCT00589914|581081764|FG001|Overall Study|Pregnancy|0|||
160915107|NCT00589914|581081763|FG000|Overall Study|Withdrawal by Subject|55|||
160915108|NCT00589914|581081764|FG001|Overall Study|Withdrawal by Subject|49|||
160915109|NCT00589914|581081763|FG000|Overall Study|Other|22|||
160915110|NCT00589914|581081764|FG001|Overall Study|Other|17|||
160915111|NCT03585504|581081765|FG000|Overall Study|Lost to Follow-up|26|||
160915112|NCT03585504|581081766|FG001|Overall Study|Lost to Follow-up|29|||
160915113|NCT02564042|581081767|FG000|Overall Study|Adverse Event|4|||
160915114|NCT02564042|581081768|FG001|Overall Study|Adverse Event|4|||
160915115|NCT02564042|581081769|FG002|Overall Study|Adverse Event|3|||
160915116|NCT02564042|581081770|FG003|Overall Study|Adverse Event|0|||
160915117|NCT02564042|581081771|FG004|Overall Study|Adverse Event|0|||
160915118|NCT02564042|581081772|FG005|Overall Study|Adverse Event|1|||
160915119|NCT02564042|581081767|FG000|Overall Study|Lost to Follow-up|1|||
160915120|NCT02564042|581081768|FG001|Overall Study|Lost to Follow-up|1|||
160915121|NCT02564042|581081769|FG002|Overall Study|Lost to Follow-up|1|||
160915122|NCT02564042|581081770|FG003|Overall Study|Lost to Follow-up|0|||
160915123|NCT02564042|581081771|FG004|Overall Study|Lost to Follow-up|1|||
160915124|NCT02564042|581081772|FG005|Overall Study|Lost to Follow-up|1|||
160915125|NCT02564042|581081767|FG000|Overall Study|Physician Decision|1|||
160915126|NCT02564042|581081768|FG001|Overall Study|Physician Decision|0|||
161142073|NCT02117687|581904305|FG001|Overall Study|Adverse Event|2|||
161142074|NCT02117687|581904304|FG000|Overall Study|Other Reasons|1|||
161142075|NCT02117687|581904305|FG001|Overall Study|Other Reasons|1|||
161142076|NCT00537940|581906095|FG000|Overall Study|Adverse Event|20|||
161142077|NCT00537940|581906096|FG001|Overall Study|Adverse Event|19|||
161142078|NCT00537940|581906095|FG000|Overall Study|Lack of Efficacy|8|||
161142079|NCT00537940|581906096|FG001|Overall Study|Lack of Efficacy|16|||
161142080|NCT00537940|581906095|FG000|Overall Study|Lost to Follow-up|23|||
161142081|NCT00537940|581906096|FG001|Overall Study|Lost to Follow-up|29|||
161142082|NCT00537940|581906095|FG000|Overall Study|Withdrawal by Subject|113|||
161142083|NCT00537940|581906096|FG001|Overall Study|Withdrawal by Subject|95|||
161142084|NCT00537940|581906095|FG000|Overall Study|Protocol Violation|6|||
161142085|NCT00537940|581906096|FG001|Overall Study|Protocol Violation|4|||
161142086|NCT00537940|581906095|FG000|Overall Study|Pregnancy|1|||
161142087|NCT00537940|581906096|FG001|Overall Study|Pregnancy|1|||
161142088|NCT00537940|581906095|FG000|Overall Study|Study terminated by sponsor|2|||
161142089|NCT00537940|581906096|FG001|Overall Study|Study terminated by sponsor|3|||
161142090|NCT00537940|581906095|FG000|Overall Study|Other|10|||
161142091|NCT00537940|581906096|FG001|Overall Study|Other|12|||
161142092|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
161142093|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
161142094|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
161142095|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
161142096|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
161142097|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
161142098|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
161142099|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
161142100|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
161142101|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
161142102|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
161142103|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
161142104|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
161142105|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
161142106|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
161142107|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
161142108|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
161256636|NCT02973321|582318623|FG002|Overall Study|Lack of Efficacy|0|||
160915127|NCT02564042|581081769|FG002|Overall Study|Physician Decision|0|||
160915128|NCT02564042|581081770|FG003|Overall Study|Physician Decision|1|||
160915129|NCT02564042|581081771|FG004|Overall Study|Physician Decision|0|||
160915130|NCT02564042|581081772|FG005|Overall Study|Physician Decision|0|||
160915131|NCT02564042|581081767|FG000|Overall Study|Withdrawal by Subject|5|||
160915132|NCT02564042|581081768|FG001|Overall Study|Withdrawal by Subject|3|||
160915133|NCT02564042|581081769|FG002|Overall Study|Withdrawal by Subject|2|||
160915134|NCT02564042|581081770|FG003|Overall Study|Withdrawal by Subject|2|||
160915135|NCT02564042|581081771|FG004|Overall Study|Withdrawal by Subject|10|||
160915136|NCT02564042|581081772|FG005|Overall Study|Withdrawal by Subject|12|||
160915137|NCT01356966|581081773|FG000|Overall Study|Withdrawal by Subject|1|||
160915138|NCT01356966|581081774|FG001|Overall Study|Withdrawal by Subject|2|||
160915139|NCT01356966|581081773|FG000|Overall Study|Physician Decision|1|||
160915140|NCT01356966|581081774|FG001|Overall Study|Physician Decision|0|||
160915141|NCT00849381|581081776|FG000|Overall Study|Adverse Event|1|||
160915142|NCT00849381|581081776|FG000|Overall Study|Lost to Follow-up|129|||
160915143|NCT00849381|581081776|FG000|Overall Study|Protocol Violation|5|||
160915144|NCT00849381|581081776|FG000|Overall Study|Withdrawal by Subject|6|||
160915145|NCT00849381|581081776|FG000|Overall Study|Other|4|||
160915146|NCT02085785|581081780|FG000|Overall Study|Withdrawal by Subject|2|||
160915147|NCT02085785|581081781|FG001|Overall Study|Withdrawal by Subject|1|||
160915148|NCT02085785|581081780|FG000|Overall Study|Lost to Follow-up|0|||
160915149|NCT02085785|581081781|FG001|Overall Study|Lost to Follow-up|1|||
160915150|NCT00779467|581081782|FG000|Overall Study|Lack of Efficacy|11|||
160915151|NCT00779467|581081783|FG001|Overall Study|Lack of Efficacy|2|||
160915152|NCT00779467|581081784|FG002|Overall Study|Lack of Efficacy|6|||
160915153|NCT00779467|581081785|FG003|Overall Study|Lack of Efficacy|11|||
160915154|NCT00779467|581081782|FG000|Overall Study|failed inclusion criteria|3|||
160915155|NCT00779467|581081783|FG001|Overall Study|failed inclusion criteria|3|||
160995918|NCT00124982|581371059|FG001|Long-term Period|Neurologist Recommendation|0|||
161142109|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
161142110|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Death|0|||
161142111|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Death|1|||
161142112|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Death|0|||
161142113|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
161142114|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
161142658|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Other|0|||
160915156|NCT00779467|581081784|FG002|Overall Study|failed inclusion criteria|1|||
160915157|NCT00779467|581081785|FG003|Overall Study|failed inclusion criteria|2|||
160915158|NCT00779467|581081782|FG000|Overall Study|missing data|1|||
160915159|NCT00779467|581081783|FG001|Overall Study|missing data|0|||
160915160|NCT00779467|581081784|FG002|Overall Study|missing data|1|||
160915161|NCT00779467|581081785|FG003|Overall Study|missing data|4|||
160915162|NCT00779467|581081782|FG000|Overall Study|technical issue|0|||
160915163|NCT00779467|581081783|FG001|Overall Study|technical issue|0|||
160915164|NCT00779467|581081784|FG002|Overall Study|technical issue|2|||
160915165|NCT00779467|581081785|FG003|Overall Study|technical issue|1|||
160915166|NCT00779467|581081782|FG000|Overall Study|unavailable research staff|0|||
160915167|NCT00779467|581081783|FG001|Overall Study|unavailable research staff|0|||
160915168|NCT00779467|581081784|FG002|Overall Study|unavailable research staff|0|||
160915169|NCT00779467|581081785|FG003|Overall Study|unavailable research staff|1|||
160915170|NCT03590041|581081786|FG000|Overall Study|Protocol Violation|4|||
160915171|NCT03590041|581081787|FG001|Overall Study|Protocol Violation|3|||
160915172|NCT03590041|581081786|FG000|Overall Study|No session data recorded|14|||
160915173|NCT03590041|581081787|FG001|Overall Study|No session data recorded|2|||
160915174|NCT02692703|581081788|FG000|Overall Study|Lost to Follow-up|1|||
160915175|NCT02692703|581081788|FG000|Overall Study|Other|1|||
160915176|NCT04118166|581081789|FG000|Overall Study|Adverse Event|1|||
160915177|NCT00103142|581081792|FG000|Overall Study|Adverse Event|1|||
160915178|NCT00103142|581081793|FG001|Overall Study|Adverse Event|0|||
160995919|NCT00124982|581371060|FG002|Long-term Period|Neurologist Recommendation|1|||
160995920|NCT01137292|581371061|FG000|Overall Study|Death|30|||
160995921|NCT01137292|581371061|FG000|Overall Study|Adverse Event|3|||
160995922|NCT01137292|581371061|FG000|Overall Study|Lack of Efficacy|13|||
160995923|NCT01137292|581371061|FG000|Overall Study|Lost to Follow-up|1|||
160995924|NCT01137292|581371061|FG000|Overall Study|Other|7|||
160995925|NCT01311713|581371062|FG000|Overall Study|Death|0|||
160995926|NCT01311713|581371063|FG001|Overall Study|Death|0|||
160995927|NCT01311713|581371064|FG002|Overall Study|Death|1|||
160995928|NCT01311713|581371065|FG003|Overall Study|Death|1|||
160995929|NCT01311713|581371066|FG004|Overall Study|Death|0|||
160995930|NCT01311713|581371067|FG005|Overall Study|Death|1|||
160995931|NCT01311713|581371068|FG006|Overall Study|Death|0|||
160995932|NCT01311713|581371062|FG000|Overall Study|Adverse Event|0|||
160995933|NCT01311713|581371063|FG001|Overall Study|Adverse Event|1|||
160995934|NCT01311713|581371064|FG002|Overall Study|Adverse Event|0|||
160995935|NCT01311713|581371065|FG003|Overall Study|Adverse Event|2|||
160995936|NCT01311713|581371066|FG004|Overall Study|Adverse Event|0|||
160995937|NCT01311713|581371067|FG005|Overall Study|Adverse Event|0|||
160995938|NCT01311713|581371068|FG006|Overall Study|Adverse Event|2|||
160915179|NCT00103142|581081792|FG000|Overall Study|Progression of disease|2|||
160915180|NCT00103142|581081793|FG001|Overall Study|Progression of disease|1|||
160915181|NCT02772081|581081794|FG000|Overall Study|Physician Decision|1|||
160915182|NCT02772081|581081795|FG001|Overall Study|Physician Decision|1|||
160915183|NCT02772081|581081794|FG000|Overall Study|Death|1|||
160915184|NCT02772081|581081795|FG001|Overall Study|Death|1|||
160915185|NCT01979016|581081803|FG000|Overall Study|Withdrawal by Subject|2|||
160915186|NCT01979016|581081804|FG001|Overall Study|Withdrawal by Subject|0|||
160915187|NCT01979016|581081803|FG000|Overall Study|Adverse Event|0|||
160915188|NCT01979016|581081804|FG001|Overall Study|Adverse Event|1|||
160915189|NCT01442493|581081805|FG000|Overall Study|withdrawn from study|3|||
160915190|NCT01442493|581081806|FG001|Overall Study|withdrawn from study|2|||
160915191|NCT00938639|581081807|FG000|Overall Study|Moved away from study area|0|||
160915192|NCT00938639|581081808|FG001|Overall Study|Moved away from study area|1|||
160915193|NCT00938639|581081807|FG000|Overall Study|Lost to Follow-up|1|||
160915194|NCT00938639|581081808|FG001|Overall Study|Lost to Follow-up|2|||
160915195|NCT00938639|581081807|FG000|Overall Study|Family issues|1|||
160915196|NCT00938639|581081808|FG001|Overall Study|Family issues|1|||
160995939|NCT01311713|581371062|FG000|Overall Study|Withdrawal by Subject|0|||
160915197|NCT00938639|581081807|FG000|Overall Study|Participant noncompliance|1|||
160915198|NCT00938639|581081808|FG001|Overall Study|Participant noncompliance|0|||
160915199|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
160915200|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
160995940|NCT01311713|581371063|FG001|Overall Study|Withdrawal by Subject|1|||
160995941|NCT01311713|581371064|FG002|Overall Study|Withdrawal by Subject|1|||
161256637|NCT02973321|582318624|FG003|Overall Study|Lack of Efficacy|0|||
161256638|NCT02973321|582318625|FG004|Overall Study|Lack of Efficacy|1|||
160915201|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
160915202|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
160915203|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
160915204|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
160915205|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
160915206|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
160995942|NCT01311713|581371065|FG003|Overall Study|Withdrawal by Subject|0|||
160915207|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Patient Request|1|||
160915208|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Patient Request|0|||
160995943|NCT01311713|581371066|FG004|Overall Study|Withdrawal by Subject|0|||
160915209|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
160915210|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
160995944|NCT01311713|581371067|FG005|Overall Study|Withdrawal by Subject|1|||
160995945|NCT01311713|581371068|FG006|Overall Study|Withdrawal by Subject|2|||
160915211|NCT04649060|581081813|FG000|Arm A/Arm B Treatment|Other|1|||
160915212|NCT04649060|581081814|FG001|Arm A/Arm B Treatment|Other|0|||
160915213|NCT04649060|581081813|FG000|Crossover (Arm B)|Adverse Event|0|||
160915214|NCT04649060|581081814|FG001|Crossover (Arm B)|Adverse Event|1|||
160915215|NCT04649060|581081813|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
160915216|NCT04649060|581081814|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
160915217|NCT02706691|581081815|FG000|Overall Study|Adverse Event|1|||
160915218|NCT01830972|581081821|FG000|Part II|Withdrawal by Subject|2|||
160915219|NCT01830972|581081822|FG001|Part II|Withdrawal by Subject|2|||
160915220|NCT01830972|581081821|FG000|Part III|Withdrawal by Subject|1|||
160915221|NCT01830972|581081822|FG001|Part III|Withdrawal by Subject|0|||
160915222|NCT01830972|581081821|FG000|Part III|Noncompliance|1|||
160915223|NCT01830972|581081822|FG001|Part III|Noncompliance|0|||
160915224|NCT01830972|581081821|FG000|Part IV|Withdrawal by Subject|2|||
160915225|NCT01830972|581081822|FG001|Part IV|Withdrawal by Subject|1|||
160915226|NCT01830972|581081821|FG000|Part IV|Non-Compliance|1|||
160915227|NCT01830972|581081822|FG001|Part IV|Non-Compliance|0|||
160915228|NCT00171730|581081823|FG000|Overall Study|Adverse Event|3|||
160915229|NCT00171730|581081823|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
160915230|NCT00171730|581081823|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
160995946|NCT01311713|581371062|FG000|Overall Study|Disease progression|3|||
160995947|NCT01311713|581371063|FG001|Overall Study|Disease progression|4|||
160995948|NCT01311713|581371064|FG002|Overall Study|Disease progression|3|||
160995949|NCT01311713|581371065|FG003|Overall Study|Disease progression|2|||
160995950|NCT01311713|581371066|FG004|Overall Study|Disease progression|4|||
160995951|NCT01311713|581371067|FG005|Overall Study|Disease progression|4|||
160995952|NCT01311713|581371068|FG006|Overall Study|Disease progression|5|||
160995953|NCT01311713|581371062|FG000|Overall Study|Lost to Follow-up|0|||
160995954|NCT01311713|581371063|FG001|Overall Study|Lost to Follow-up|0|||
160995955|NCT01311713|581371064|FG002|Overall Study|Lost to Follow-up|1|||
160915231|NCT00171730|581081823|FG000|Overall Study|Withdrawal by Subject|3|||
160915232|NCT01985867|581081824|FG000|Overall Study|Lost to Follow-up|3|||
160915233|NCT01985867|581081825|FG001|Overall Study|Lost to Follow-up|4|||
160915234|NCT01985867|581081824|FG000|Overall Study|Adverse Event|3|||
160915235|NCT01985867|581081825|FG001|Overall Study|Adverse Event|2|||
160915236|NCT01985867|581081824|FG000|Overall Study|Lack of Efficacy|1|||
160995956|NCT01311713|581371065|FG003|Overall Study|Lost to Follow-up|0|||
160995957|NCT01311713|581371066|FG004|Overall Study|Lost to Follow-up|0|||
160995958|NCT01311713|581371067|FG005|Overall Study|Lost to Follow-up|0|||
160995959|NCT01311713|581371068|FG006|Overall Study|Lost to Follow-up|0|||
160995960|NCT01311713|581371062|FG000|Overall Study|Stopped taking study medication|0|||
160995961|NCT01311713|581371063|FG001|Overall Study|Stopped taking study medication|0|||
160995962|NCT01311713|581371064|FG002|Overall Study|Stopped taking study medication|0|||
160995963|NCT01311713|581371065|FG003|Overall Study|Stopped taking study medication|1|||
160995964|NCT01311713|581371066|FG004|Overall Study|Stopped taking study medication|1|||
160995965|NCT01311713|581371067|FG005|Overall Study|Stopped taking study medication|0|||
160995966|NCT01311713|581371068|FG006|Overall Study|Stopped taking study medication|0|||
160995967|NCT01311713|581371062|FG000|Overall Study|Enrolled but not treated|0|||
160995968|NCT01311713|581371063|FG001|Overall Study|Enrolled but not treated|0|||
160915237|NCT01985867|581081825|FG001|Overall Study|Lack of Efficacy|0|||
160915238|NCT01829191|581081826|FG000|Overall Study|Relocation|0|||
160915239|NCT01829191|581081827|FG001|Overall Study|Relocation|1|||
160915240|NCT01829191|581081826|FG000|Overall Study|Lens discomfort|0|||
160915241|NCT01829191|581081827|FG001|Overall Study|Lens discomfort|3|||
160915242|NCT01829191|581081826|FG000|Overall Study|Lens handling difficulty|1|||
160915243|NCT01829191|581081827|FG001|Overall Study|Lens handling difficulty|4|||
160915244|NCT01829191|581081826|FG000|Overall Study|Protocol Violation|4|||
160915245|NCT01829191|581081827|FG001|Overall Study|Protocol Violation|1|||
160915246|NCT01829191|581081826|FG000|Overall Study|Withdrawal by Subject|2|||
160995969|NCT01311713|581371064|FG002|Overall Study|Enrolled but not treated|1|||
160995970|NCT01311713|581371065|FG003|Overall Study|Enrolled but not treated|0|||
161339251|NCT01232283|582630421|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
160915247|NCT01829191|581081827|FG001|Overall Study|Withdrawal by Subject|3|||
160915248|NCT01829191|581081826|FG000|Overall Study|Lost to Follow-up|0|||
160915249|NCT01829191|581081827|FG001|Overall Study|Lost to Follow-up|1|||
160915250|NCT01829191|581081826|FG000|Overall Study|Subject was fit for ortho - k|0|||
160915251|NCT01829191|581081827|FG001|Overall Study|Subject was fit for ortho - k|1|||
160915252|NCT01276353|581081828|FG000|Double-blind|Adverse Event|2|||
160915253|NCT01276353|581081829|FG001|Double-blind|Adverse Event|0|||
160915254|NCT01276353|581081828|FG000|Double-blind|Withdrawal by Subject|1|||
160995971|NCT01311713|581371066|FG004|Overall Study|Enrolled but not treated|0|||
160915255|NCT01276353|581081829|FG001|Double-blind|Withdrawal by Subject|0|||
160915256|NCT01276353|581081828|FG000|Extension|Adverse Event|2|||
160995972|NCT01311713|581371067|FG005|Overall Study|Enrolled but not treated|0|||
161142115|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
161142116|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
161142117|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
161142118|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
161142119|NCT00430781|581906100|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
160915257|NCT01276353|581081829|FG001|Extension|Adverse Event|5|||
160915258|NCT01276353|581081828|FG000|Extension|Withdrawal by Subject|1|||
160915259|NCT01276353|581081829|FG001|Extension|Withdrawal by Subject|2|||
160915260|NCT01276353|581081828|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
160915261|NCT01276353|581081829|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
160915262|NCT01276353|581081828|FG000|Extension|Physician Decision|1|||
160915263|NCT01276353|581081829|FG001|Extension|Physician Decision|0|||
160915264|NCT01276353|581081828|FG000|Extension|Prohibited concomitant medications|0|||
161142120|NCT00430781|581906101|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
161142121|NCT00430781|581906102|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
161142122|NCT00430781|581906100|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
161142123|NCT00430781|581906101|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
161142124|NCT00430781|581906102|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
161142125|NCT00430781|581906100|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
161142126|NCT00430781|581906101|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
161142127|NCT00430781|581906102|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
161142128|NCT00430781|581906100|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
161142129|NCT00430781|581906101|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
161142130|NCT00430781|581906102|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
161142131|NCT00430781|581906100|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
161142132|NCT00430781|581906101|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
161142133|NCT00430781|581906102|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
161142134|NCT00430781|581906100|FG000|Final Analysis; 31 July 2008|Other|0|||
161142135|NCT00430781|581906101|FG001|Final Analysis; 31 July 2008|Other|1|||
161142136|NCT00430781|581906102|FG002|Final Analysis; 31 July 2008|Other|0|||
161142137|NCT00430781|581906100|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
161142138|NCT00430781|581906101|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
161142139|NCT00430781|581906102|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
160915265|NCT01276353|581081829|FG001|Extension|Prohibited concomitant medications|1|||
160915266|NCT00553514|581081835|FG000|Overall Study|Protocol deviation|0|||
161142140|NCT00430781|581906100|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
161142141|NCT00430781|581906101|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
161142142|NCT00430781|581906102|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
161142143|NCT00430781|581906100|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
161142144|NCT00430781|581906101|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
160915267|NCT00553514|581081836|FG001|Overall Study|Protocol deviation|0|||
160915268|NCT00553514|581081837|FG002|Overall Study|Protocol deviation|0|||
160915269|NCT00553514|581081838|FG003|Overall Study|Protocol deviation|1|||
160915270|NCT00553514|581081839|FG004|Overall Study|Protocol deviation|0|||
160915271|NCT00553514|581081835|FG000|Overall Study|Lack of ovarian response|4|||
160915272|NCT00553514|581081836|FG001|Overall Study|Lack of ovarian response|5|||
160915273|NCT00553514|581081837|FG002|Overall Study|Lack of ovarian response|5|||
160915274|NCT00553514|581081838|FG003|Overall Study|Lack of ovarian response|5|||
160915275|NCT00553514|581081839|FG004|Overall Study|Lack of ovarian response|6|||
160915276|NCT00553514|581081835|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
160915277|NCT00553514|581081836|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160915278|NCT00553514|581081837|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
160915279|NCT00553514|581081838|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160915280|NCT00553514|581081839|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
160915281|NCT00553514|581081835|FG000|Overall Study|Risk of multiple pregnancy|0|||
160915282|NCT00553514|581081836|FG001|Overall Study|Risk of multiple pregnancy|2|||
160915283|NCT00553514|581081837|FG002|Overall Study|Risk of multiple pregnancy|0|||
160915284|NCT00553514|581081838|FG003|Overall Study|Risk of multiple pregnancy|1|||
160915285|NCT00553514|581081839|FG004|Overall Study|Risk of multiple pregnancy|0|||
160915286|NCT00553514|581081835|FG000|Overall Study|Other|1|||
160915287|NCT00553514|581081836|FG001|Overall Study|Other|1|||
160915288|NCT00553514|581081837|FG002|Overall Study|Other|0|||
160915289|NCT00553514|581081838|FG003|Overall Study|Other|0|||
160915290|NCT00553514|581081839|FG004|Overall Study|Other|1|||
160915291|NCT01465997|581081840|FG000|Overall Study|Adverse Event|12|||
160915292|NCT01465997|581081841|FG001|Overall Study|Adverse Event|22|||
160915293|NCT01465997|581081840|FG000|Overall Study|Lack of Efficacy|13|||
160915294|NCT01465997|581081841|FG001|Overall Study|Lack of Efficacy|1|||
160915295|NCT01465997|581081840|FG000|Overall Study|Protocol Violation|1|||
160915296|NCT01465997|581081841|FG001|Overall Study|Protocol Violation|4|||
161142145|NCT00430781|581906102|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
161142146|NCT00430781|581906100|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
160915297|NCT01465997|581081840|FG000|Overall Study|Lost to Follow-up|6|||
161142147|NCT00430781|581906101|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
161142148|NCT00430781|581906102|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
161142149|NCT00430781|581906100|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
161142150|NCT00430781|581906101|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
161142151|NCT00430781|581906102|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
161142152|NCT00430781|581906100|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
161142153|NCT00430781|581906101|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
161142154|NCT00430781|581906102|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
161142155|NCT00430781|581906100|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
161142156|NCT00430781|581906101|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
161142157|NCT00430781|581906102|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
161142158|NCT01389128|581906105|FG000|Overall Study|Fetal distress|1|||
161142159|NCT01389128|581906106|FG001|Overall Study|Fetal distress|0|||
161142160|NCT01389128|581906105|FG000|Overall Study|Cervix dilation stop|1|||
161142161|NCT01389128|581906106|FG001|Overall Study|Cervix dilation stop|2|||
161142162|NCT01389128|581906105|FG000|Overall Study|Rapid labor evolution|3|||
161142163|NCT01389128|581906106|FG001|Overall Study|Rapid labor evolution|2|||
160915298|NCT01465997|581081841|FG001|Overall Study|Lost to Follow-up|9|||
160915299|NCT01465997|581081840|FG000|Overall Study|Withdrawal by Subject|32|||
160915300|NCT01465997|581081841|FG001|Overall Study|Withdrawal by Subject|35|||
160915301|NCT01465997|581081840|FG000|Overall Study|investigator's decision|1|||
160915302|NCT01465997|581081841|FG001|Overall Study|investigator's decision|1|||
160915303|NCT01465997|581081840|FG000|Overall Study|Death|0|||
160915304|NCT01465997|581081841|FG001|Overall Study|Death|1|||
160915305|NCT01465997|581081840|FG000|Overall Study|sponsor's decision|1|||
160915306|NCT01465997|581081841|FG001|Overall Study|sponsor's decision|1|||
160915307|NCT01465997|581081840|FG000|Overall Study|subject withdrew consent|1|||
160915308|NCT01465997|581081841|FG001|Overall Study|subject withdrew consent|0|||
160915309|NCT01465997|581081840|FG000|Overall Study|local lab unblinded site|1|||
160915310|NCT01465997|581081841|FG001|Overall Study|local lab unblinded site|0|||
160915311|NCT01465997|581081840|FG000|Overall Study|withdrew before follow-up|0|||
160915312|NCT01465997|581081841|FG001|Overall Study|withdrew before follow-up|13|||
160915313|NCT01465997|581081840|FG000|Overall Study|decision by site staff|0|||
160915314|NCT01465997|581081841|FG001|Overall Study|decision by site staff|1|||
160915315|NCT01465997|581081840|FG000|Overall Study|subject left participation SP0993|0|||
160915316|NCT01465997|581081841|FG001|Overall Study|subject left participation SP0993|1|||
160915317|NCT01426373|581081842|FG000|Overall Study|Adverse Event|6|||
160915318|NCT01426373|581081842|FG000|Overall Study|Lost to Follow-up|14|||
160915319|NCT01426373|581081842|FG000|Overall Study|Participant Convenience|10|||
160915320|NCT01426373|581081842|FG000|Overall Study|Miscellaneous Reasons|4|||
160915321|NCT00005937|581081850|FG000|Overall Study|Lack of Efficacy|5|||
160915322|NCT00160251|581081851|FG000|Prior to Amendment 2|Adverse Event|2|||
160915323|NCT00160251|581081852|FG001|Prior to Amendment 2|Adverse Event|1|||
160915324|NCT00160251|581081853|FG002|Prior to Amendment 2|Adverse Event|3|||
160915325|NCT00160251|581081854|FG003|Prior to Amendment 2|Adverse Event|1|||
160915326|NCT00160251|581081855|FG004|Prior to Amendment 2|Adverse Event|1|||
160915327|NCT00160251|581081856|FG005|Prior to Amendment 2|Adverse Event|1|||
160915328|NCT00160251|581081857|FG006|Prior to Amendment 2|Adverse Event|1|||
160915329|NCT00160251|581081858|FG007|Prior to Amendment 2|Adverse Event|0|||
160915330|NCT00160251|581081851|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
160915331|NCT00160251|581081852|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
160915332|NCT00160251|581081853|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
160915333|NCT00160251|581081854|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
160915334|NCT00160251|581081855|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
160915335|NCT00160251|581081856|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
160915336|NCT00160251|581081857|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
160915337|NCT00160251|581081858|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
160915338|NCT00160251|581081851|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
160915339|NCT00160251|581081852|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
160915340|NCT00160251|581081853|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
160915341|NCT00160251|581081854|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
160915342|NCT00160251|581081855|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
160915343|NCT00160251|581081856|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
160915344|NCT00160251|581081857|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
160915345|NCT00160251|581081858|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
160915346|NCT00160251|581081851|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
160915347|NCT00160251|581081852|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
160915348|NCT00160251|581081853|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
160915349|NCT00160251|581081854|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
161142164|NCT01389128|581906105|FG000|Overall Study|Intolerance to procedure|0|||
161142165|NCT01389128|581906106|FG001|Overall Study|Intolerance to procedure|2|||
161142166|NCT01451515|581906107|FG000|Overall Study|Death|0|||
160915350|NCT00160251|581081855|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
160915351|NCT00160251|581081856|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
160915352|NCT00160251|581081857|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
160915353|NCT00160251|581081858|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
160915354|NCT00160251|581081851|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
160915355|NCT00160251|581081852|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
160915356|NCT00160251|581081853|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
160915357|NCT00160251|581081854|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
161339252|NCT01232283|582630422|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
160915358|NCT00160251|581081855|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
160915359|NCT00160251|581081856|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
160915360|NCT00160251|581081857|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
160915361|NCT00160251|581081858|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
160915362|NCT00160251|581081851|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
160915363|NCT00160251|581081852|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
160915364|NCT00160251|581081853|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
160915365|NCT00160251|581081854|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
160915366|NCT00160251|581081855|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
160915367|NCT00160251|581081856|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
160915368|NCT00160251|581081857|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
160915369|NCT00160251|581081858|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
160915370|NCT00160251|581081851|FG000|Post-amendment 2|Adverse Event|0|||
160915371|NCT00160251|581081852|FG001|Post-amendment 2|Adverse Event|0|||
160915372|NCT00160251|581081853|FG002|Post-amendment 2|Adverse Event|0|||
160915373|NCT00160251|581081854|FG003|Post-amendment 2|Adverse Event|0|||
160915374|NCT00160251|581081855|FG004|Post-amendment 2|Adverse Event|0|||
160915375|NCT00160251|581081856|FG005|Post-amendment 2|Adverse Event|0|||
160915376|NCT00160251|581081857|FG006|Post-amendment 2|Adverse Event|0|||
160915377|NCT00160251|581081858|FG007|Post-amendment 2|Adverse Event|20|||
160915378|NCT00160251|581081851|FG000|Post-amendment 2|Lack of Efficacy|0|||
160915379|NCT00160251|581081852|FG001|Post-amendment 2|Lack of Efficacy|0|||
160915380|NCT00160251|581081853|FG002|Post-amendment 2|Lack of Efficacy|0|||
160915381|NCT00160251|581081854|FG003|Post-amendment 2|Lack of Efficacy|0|||
160915382|NCT00160251|581081855|FG004|Post-amendment 2|Lack of Efficacy|0|||
160915383|NCT00160251|581081856|FG005|Post-amendment 2|Lack of Efficacy|0|||
160915384|NCT00160251|581081857|FG006|Post-amendment 2|Lack of Efficacy|0|||
160915385|NCT00160251|581081858|FG007|Post-amendment 2|Lack of Efficacy|24|||
160915386|NCT00160251|581081851|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915387|NCT00160251|581081852|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915388|NCT00160251|581081853|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915389|NCT00160251|581081854|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915390|NCT00160251|581081855|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915391|NCT00160251|581081856|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915392|NCT00160251|581081857|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
160915393|NCT00160251|581081858|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
160915394|NCT01288469|581081859|FG000|Overall Study|Adverse Event|4|||
160915395|NCT01288469|581081860|FG001|Overall Study|Adverse Event|1|||
160915396|NCT01288469|581081861|FG002|Overall Study|Adverse Event|1|||
160915397|NCT01288469|581081859|FG000|Overall Study|Poor compliance to protocol|0|||
160915398|NCT01288469|581081860|FG001|Overall Study|Poor compliance to protocol|1|||
160915399|NCT01288469|581081861|FG002|Overall Study|Poor compliance to protocol|0|||
160915400|NCT01288469|581081859|FG000|Overall Study|Participant Moved|1|||
160915401|NCT01288469|581081860|FG001|Overall Study|Participant Moved|0|||
160915402|NCT01288469|581081861|FG002|Overall Study|Participant Moved|0|||
160915403|NCT01288469|581081859|FG000|Overall Study|Consent withdrawn by subject|1|||
160915404|NCT01288469|581081860|FG001|Overall Study|Consent withdrawn by subject|1|||
160915405|NCT01288469|581081861|FG002|Overall Study|Consent withdrawn by subject|1|||
160915406|NCT01288469|581081859|FG000|Overall Study|Exclusion criteria finally met|1|||
160915407|NCT01288469|581081860|FG001|Overall Study|Exclusion criteria finally met|0|||
160915408|NCT01288469|581081861|FG002|Overall Study|Exclusion criteria finally met|0|||
160915409|NCT00582166|581081862|FG000|Overall Study|Death|1|||
160915410|NCT00582166|581081862|FG000|Overall Study|Ineligible pathology|1|||
160915411|NCT01606436|581081863|FG000|Overall Study|Withdrawal by Subject|0|||
161339253|NCT01232283|582630423|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
160915412|NCT01606436|581081864|FG001|Overall Study|Withdrawal by Subject|0|||
160915413|NCT01606436|581081865|FG002|Overall Study|Withdrawal by Subject|1|||
160915414|NCT01606436|581081866|FG003|Overall Study|Withdrawal by Subject|1|||
160915415|NCT01606436|581081867|FG004|Overall Study|Withdrawal by Subject|1|||
160915416|NCT01606436|581081868|FG005|Overall Study|Withdrawal by Subject|0|||
160915417|NCT01606436|581081863|FG000|Overall Study|Adverse Event|0|||
160915418|NCT01606436|581081864|FG001|Overall Study|Adverse Event|0|||
161142167|NCT01451515|581906108|FG001|Overall Study|Death|1|||
160915419|NCT01606436|581081865|FG002|Overall Study|Adverse Event|1|||
160915420|NCT01606436|581081866|FG003|Overall Study|Adverse Event|0|||
160915421|NCT01606436|581081867|FG004|Overall Study|Adverse Event|0|||
160915422|NCT01606436|581081868|FG005|Overall Study|Adverse Event|0|||
161339254|NCT01232283|582630424|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
161142168|NCT01451515|581906109|FG002|Overall Study|Death|0|||
161142169|NCT01451515|581906107|FG000|Overall Study|Withdrawal by Subject|0|||
161142170|NCT01451515|581906108|FG001|Overall Study|Withdrawal by Subject|1|||
161142171|NCT01451515|581906109|FG002|Overall Study|Withdrawal by Subject|0|||
161142172|NCT01451515|581906107|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
161142173|NCT01451515|581906108|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
161142174|NCT01451515|581906109|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
161142175|NCT01451515|581906107|FG000|Overall Study|Relapse (except CNS)|1|||
161142176|NCT01451515|581906108|FG001|Overall Study|Relapse (except CNS)|1|||
161142177|NCT01451515|581906109|FG002|Overall Study|Relapse (except CNS)|0|||
161142178|NCT00174941|581906113|FG000|Overall Study|Adverse Event|1|||
161142179|NCT00174941|581906114|FG001|Overall Study|Adverse Event|10|||
161142180|NCT00174941|581906115|FG002|Overall Study|Adverse Event|2|||
161142181|NCT00174941|581906116|FG003|Overall Study|Adverse Event|13|||
160915423|NCT01606436|581081863|FG000|Overall Study|Sponsor Decision|0|||
160915424|NCT01606436|581081864|FG001|Overall Study|Sponsor Decision|0|||
160915425|NCT01606436|581081865|FG002|Overall Study|Sponsor Decision|0|||
160915426|NCT01606436|581081866|FG003|Overall Study|Sponsor Decision|1|||
161142182|NCT00174941|581906113|FG000|Overall Study|Protocol Violation|0|||
161142183|NCT00174941|581906114|FG001|Overall Study|Protocol Violation|1|||
161142184|NCT00174941|581906115|FG002|Overall Study|Protocol Violation|0|||
160915427|NCT01606436|581081867|FG004|Overall Study|Sponsor Decision|0|||
160915428|NCT01606436|581081868|FG005|Overall Study|Sponsor Decision|0|||
160915429|NCT03334448|581081871|FG000|Washout|Personal Reason|0|||
160915430|NCT03334448|581081872|FG001|Washout|Personal Reason|1|||
160915431|NCT03334448|581081873|FG002|Washout|Personal Reason|0|||
160915432|NCT03334448|581081874|FG003|Washout|Personal Reason|0|||
160915433|NCT03334448|581081871|FG000|Washout|Protocol Violation|0|||
160915434|NCT03334448|581081872|FG001|Washout|Protocol Violation|0|||
161142185|NCT00174941|581906116|FG003|Overall Study|Protocol Violation|1|||
160915435|NCT03334448|581081873|FG002|Washout|Protocol Violation|0|||
160915436|NCT03334448|581081874|FG003|Washout|Protocol Violation|1|||
160915437|NCT02326025|581081875|FG000|Overall Study|Adverse Event|3|||
160915438|NCT02326025|581081876|FG001|Overall Study|Adverse Event|0|||
160915439|NCT02326025|581081875|FG000|Overall Study|Physician Decision|1|||
160915440|NCT02326025|581081876|FG001|Overall Study|Physician Decision|2|||
160915441|NCT02326025|581081875|FG000|Overall Study|Physician and Participant Decision|1|||
160915442|NCT02326025|581081876|FG001|Overall Study|Physician and Participant Decision|0|||
160915443|NCT02326025|581081875|FG000|Overall Study|Withdrawal by Subject|0|||
160915444|NCT02326025|581081876|FG001|Overall Study|Withdrawal by Subject|2|||
160915445|NCT02326025|581081875|FG000|Overall Study|Protocol Violation|0|||
160915446|NCT02326025|581081876|FG001|Overall Study|Protocol Violation|1|||
160915447|NCT01365910|581081877|FG000|Overall Study|Withdrawal by Subject|7|||
160915448|NCT01365910|581081877|FG000|Overall Study|disease progression|18|||
160915449|NCT01365910|581081877|FG000|Overall Study|Adverse Event|3|||
160915450|NCT01365910|581081877|FG000|Overall Study|other complicating disease|1|||
160915451|NCT01365910|581081877|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
160915452|NCT02013791|581081878|FG000|Period 1|Lost to Follow-up|0|||
160915453|NCT02013791|581081879|FG001|Period 1|Lost to Follow-up|0|||
160915454|NCT02013791|581081880|FG002|Period 1|Lost to Follow-up|0|||
160915455|NCT02013791|581081881|FG003|Period 1|Lost to Follow-up|1|||
160915456|NCT02013791|581081882|FG004|Period 1|Lost to Follow-up|0|||
160915457|NCT02013791|581081883|FG005|Period 1|Lost to Follow-up|0|||
160915458|NCT02013791|581081884|FG006|Period 1|Lost to Follow-up|1|||
160915459|NCT02013791|581081885|FG007|Period 1|Lost to Follow-up|1|||
160915460|NCT02013791|581081886|FG008|Period 1|Lost to Follow-up|0|||
160915461|NCT02013791|581081878|FG000|Period 1|Other Miscellaneous Reasons|0|||
160915462|NCT02013791|581081879|FG001|Period 1|Other Miscellaneous Reasons|2|||
160915463|NCT02013791|581081880|FG002|Period 1|Other Miscellaneous Reasons|0|||
160915464|NCT02013791|581081881|FG003|Period 1|Other Miscellaneous Reasons|0|||
160915465|NCT02013791|581081882|FG004|Period 1|Other Miscellaneous Reasons|0|||
160915466|NCT02013791|581081883|FG005|Period 1|Other Miscellaneous Reasons|0|||
160915467|NCT02013791|581081884|FG006|Period 1|Other Miscellaneous Reasons|0|||
161142186|NCT00174941|581906113|FG000|Overall Study|Lost to Follow-up|0|||
161142187|NCT00174941|581906114|FG001|Overall Study|Lost to Follow-up|3|||
161142188|NCT00174941|581906115|FG002|Overall Study|Lost to Follow-up|2|||
161142189|NCT00174941|581906116|FG003|Overall Study|Lost to Follow-up|5|||
160915468|NCT02013791|581081885|FG007|Period 1|Other Miscellaneous Reasons|0|||
160915469|NCT02013791|581081886|FG008|Period 1|Other Miscellaneous Reasons|0|||
160915470|NCT03798483|581081887|FG000|Overall Study|Lost to Follow-up|2|||
160915471|NCT02643082|581081888|FG000|Period 1|Adverse Event|1|||
160915472|NCT02643082|581081889|FG001|Period 1|Adverse Event|0|||
160915473|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
160915474|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915475|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
160915476|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
161142190|NCT00174941|581906113|FG000|Overall Study|Personal Reason(s)|0|||
161142191|NCT00174941|581906114|FG001|Overall Study|Personal Reason(s)|14|||
160915477|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915478|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915479|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915480|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915481|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
160915482|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
160915483|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
160915484|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
160915485|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915486|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915487|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915488|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915489|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915490|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
160915491|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915492|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
160915493|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915494|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915495|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915496|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915497|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915498|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915499|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
160915500|NCT02289417|581081890|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
160915501|NCT02289417|581081891|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915502|NCT02289417|581081892|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915503|NCT02289417|581081893|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915504|NCT02289417|581081894|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915505|NCT02289417|581081895|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915506|NCT02289417|581081896|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915507|NCT02289417|581081897|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915508|NCT02289417|581081898|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
160915509|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915510|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
160915511|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
160915512|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
160915513|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
160915514|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
160915515|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915516|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915517|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
160915518|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915519|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915520|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
160915521|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915522|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915523|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915524|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915525|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915526|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
160915527|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915528|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
160915529|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
160915530|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
160915531|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
160915532|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
160915533|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915534|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915535|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
160915536|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915537|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915538|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
160915539|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915540|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
160915541|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
160915542|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915543|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160995973|NCT01311713|581371068|FG006|Overall Study|Enrolled but not treated|0|||
160995974|NCT01311713|581371062|FG000|Overall Study|Other than specified|0|||
160995975|NCT01311713|581371063|FG001|Overall Study|Other than specified|1|||
160995976|NCT01311713|581371064|FG002|Overall Study|Other than specified|2|||
160995977|NCT01311713|581371065|FG003|Overall Study|Other than specified|0|||
160995978|NCT01311713|581371066|FG004|Overall Study|Other than specified|0|||
160995979|NCT01311713|581371067|FG005|Overall Study|Other than specified|0|||
160995980|NCT01311713|581371068|FG006|Overall Study|Other than specified|0|||
160995981|NCT00980538|581371070|FG000|Overall Study|Lost to Follow-up|20|||
160995982|NCT00980538|581371070|FG000|Overall Study|Sponsor's Decision|4|||
160995983|NCT00980538|581371070|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
160995984|NCT00980538|581371070|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
160995985|NCT00980538|581371070|FG000|Overall Study|Switch to Commercially Available Medication|25|||
160995986|NCT00980538|581371070|FG000|Overall Study|Participant Non-Compliant|9|||
160995987|NCT00980538|581371070|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
160995988|NCT00980538|581371070|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
160995989|NCT00980538|581371070|FG000|Overall Study|Other|60|||
160995990|NCT00980538|581371070|FG000|Overall Study|Other|1|||
160995991|NCT03878446|581371071|FG000|Overall Study|Withdrawn by parent or guardian|1|||
160995992|NCT03878446|581371072|FG001|Overall Study|Withdrawn by parent or guardian|0|||
160995993|NCT03878446|581371073|FG002|Overall Study|Withdrawn by parent or guardian|0|||
160995994|NCT03878446|581371074|FG003|Overall Study|Withdrawn by parent or guardian|0|||
160995995|NCT03878446|581371075|FG004|Overall Study|Withdrawn by parent or guardian|0|||
160995996|NCT04540835|581371076|FG000|Week 1|Lost to Follow-up|1|||
160995997|NCT04540835|581371076|FG000|Week 6|Pregnancy|1|||
160995998|NCT04540835|581371076|FG000|Week 6|Lack of Efficacy|1|||
160995999|NCT04804605|581372083|FG000|Overall Study|Withdrawal by Subject|46|||
160996000|NCT04804605|581372084|FG001|Overall Study|Withdrawal by Subject|26|||
160996001|NCT04804605|581372085|FG002|Overall Study|Withdrawal by Subject|37|||
160996002|NCT04804605|581372086|FG003|Overall Study|Withdrawal by Subject|21|||
160996003|NCT04804605|581372083|FG000|Overall Study|Lost to Follow-up|47|||
160996004|NCT04804605|581372084|FG001|Overall Study|Lost to Follow-up|21|||
160996005|NCT04804605|581372085|FG002|Overall Study|Lost to Follow-up|30|||
160996006|NCT04804605|581372086|FG003|Overall Study|Lost to Follow-up|17|||
160996007|NCT04804605|581372083|FG000|Overall Study|Lack of Efficacy|28|||
160996008|NCT04804605|581372084|FG001|Overall Study|Lack of Efficacy|11|||
160996009|NCT04804605|581372085|FG002|Overall Study|Lack of Efficacy|37|||
160996010|NCT04804605|581372086|FG003|Overall Study|Lack of Efficacy|8|||
160861604|NCT03198715|580887779|FG000|Overall Study|Other|0|||
160861605|NCT03198715|580887780|FG001|Overall Study|Other|1|||
160861606|NCT03198715|580887781|FG002|Overall Study|Other|1|||
160861607|NCT03198715|580887782|FG003|Overall Study|Other|0|||
160861608|NCT03198715|580887783|FG004|Overall Study|Other|0|||
160861609|NCT04613362|580887784|FG000|3 Month Follow-up|Lost to Follow-up|1|||
160861610|NCT04613362|580887785|FG001|3 Month Follow-up|Lost to Follow-up|2|||
160861611|NCT04613362|580887784|FG000|6 Month Follow-up|Lost to Follow-up|0|||
160861612|NCT04613362|580887785|FG001|6 Month Follow-up|Lost to Follow-up|1|||
160861613|NCT04225897|580887786|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861614|NCT04225897|580887787|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
160861615|NCT04225897|580887788|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861616|NCT04225897|580887789|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861617|NCT04225897|580887790|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861618|NCT04225897|580887791|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861619|NCT04225897|580887792|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861620|NCT04225897|580887793|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861621|NCT04225897|580887794|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861622|NCT04225897|580887795|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861623|NCT04225897|580887796|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861624|NCT04225897|580887797|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
160861625|NCT04225897|580887786|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861626|NCT04225897|580887787|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861627|NCT04225897|580887788|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
160861628|NCT04225897|580887789|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861629|NCT04225897|580887790|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861630|NCT04225897|580887791|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861631|NCT04225897|580887792|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861632|NCT04225897|580887793|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861633|NCT04225897|580887794|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861634|NCT04225897|580887795|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160996011|NCT04804605|581372083|FG000|Overall Study|Adverse Event|10|||
160996012|NCT04804605|581372084|FG001|Overall Study|Adverse Event|10|||
160996013|NCT04804605|581372085|FG002|Overall Study|Adverse Event|10|||
160996014|NCT04804605|581372086|FG003|Overall Study|Adverse Event|7|||
160996015|NCT04804605|581372083|FG000|Overall Study|Non-compliance|8|||
160915544|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
160915545|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915546|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915547|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915548|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915549|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915550|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915551|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
160996016|NCT04804605|581372084|FG001|Overall Study|Non-compliance|3|||
160996017|NCT04804605|581372085|FG002|Overall Study|Non-compliance|5|||
160996018|NCT04804605|581372086|FG003|Overall Study|Non-compliance|1|||
160996019|NCT04804605|581372083|FG000|Overall Study|Physician Decision|3|||
160996020|NCT04804605|581372084|FG001|Overall Study|Physician Decision|0|||
160996021|NCT04804605|581372085|FG002|Overall Study|Physician Decision|5|||
160996022|NCT04804605|581372086|FG003|Overall Study|Physician Decision|0|||
160996023|NCT04804605|581372083|FG000|Overall Study|Protocol Violation|1|||
160996024|NCT04804605|581372084|FG001|Overall Study|Protocol Violation|0|||
160996025|NCT04804605|581372085|FG002|Overall Study|Protocol Violation|0|||
160996026|NCT04804605|581372086|FG003|Overall Study|Protocol Violation|1|||
160996027|NCT04804605|581372083|FG000|Overall Study|Miscellaneous|7|||
160996028|NCT04804605|581372084|FG001|Overall Study|Miscellaneous|3|||
160915552|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915553|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
160915554|NCT02289417|581081890|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915555|NCT02289417|581081891|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160996029|NCT04804605|581372085|FG002|Overall Study|Miscellaneous|4|||
160915556|NCT02289417|581081892|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915557|NCT02289417|581081893|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
160915558|NCT02289417|581081894|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915559|NCT02289417|581081895|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915560|NCT02289417|581081896|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
160915561|NCT02289417|581081897|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915562|NCT02289417|581081898|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
160915563|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
160915564|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
160915565|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
160915566|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
160915567|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
160915568|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
160915569|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
160915570|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
160915571|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
160915572|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915573|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915574|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915575|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915576|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915577|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915578|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
160915579|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
160915580|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
160915581|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915582|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915583|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915584|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915585|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915586|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915587|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
160915588|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
160915589|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
160915590|NCT02289417|581081890|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915591|NCT02289417|581081891|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915592|NCT02289417|581081892|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
160996030|NCT04804605|581372086|FG003|Overall Study|Miscellaneous|2|||
160996031|NCT00567879|581372089|FG000|Overall Study|Adverse Event|2|||
161142192|NCT00174941|581906115|FG002|Overall Study|Personal Reason(s)|8|||
160915593|NCT02289417|581081893|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
160996032|NCT00567879|581372090|FG001|Overall Study|Adverse Event|0|||
160996033|NCT00567879|581372091|FG002|Overall Study|Adverse Event|1|||
160996034|NCT00567879|581372092|FG003|Overall Study|Adverse Event|0|||
160996035|NCT00567879|581372093|FG004|Overall Study|Adverse Event|1|||
161256639|NCT02973321|582318621|FG000|Overall Study|Adverse Event|1|||
160915594|NCT02289417|581081894|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
161142193|NCT00174941|581906116|FG003|Overall Study|Personal Reason(s)|22|||
161142194|NCT00174941|581906113|FG000|Overall Study|Gout Flare|0|||
161142195|NCT00174941|581906114|FG001|Overall Study|Gout Flare|4|||
161142196|NCT00174941|581906115|FG002|Overall Study|Gout Flare|4|||
161142197|NCT00174941|581906116|FG003|Overall Study|Gout Flare|8|||
161142198|NCT00174941|581906113|FG000|Overall Study|Reason Not Specified|1|||
161142199|NCT00174941|581906114|FG001|Overall Study|Reason Not Specified|6|||
161142200|NCT00174941|581906115|FG002|Overall Study|Reason Not Specified|2|||
161142201|NCT00174941|581906116|FG003|Overall Study|Reason Not Specified|9|||
161142202|NCT03230097|581906121|FG000|Overall Study|Adverse Event|2|||
161142203|NCT03230097|581906122|FG001|Overall Study|Adverse Event|1|||
161142204|NCT03230097|581906121|FG000|Overall Study|non-compliance|0|||
161142205|NCT03230097|581906122|FG001|Overall Study|non-compliance|1|||
161142206|NCT03230097|581906121|FG000|Overall Study|Lost to Follow-up|2|||
161142207|NCT03230097|581906122|FG001|Overall Study|Lost to Follow-up|4|||
161142208|NCT03230097|581906121|FG000|Overall Study|Withdrawal by Subject|7|||
161142209|NCT03230097|581906122|FG001|Overall Study|Withdrawal by Subject|3|||
161142210|NCT03230097|581906121|FG000|Overall Study|Trial termination|4|||
161142211|NCT03230097|581906122|FG001|Overall Study|Trial termination|5|||
161142212|NCT03230097|581906121|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
161142213|NCT03230097|581906122|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
161142214|NCT03230097|581906121|FG000|Overall Study|outcome event|0|||
161142215|NCT03230097|581906122|FG001|Overall Study|outcome event|1|||
161142216|NCT00635102|581906135|FG000|Overall Study|Withdrawal by Subject|7|||
161142217|NCT00635102|581906136|FG001|Overall Study|Withdrawal by Subject|8|||
161142218|NCT00440401|581906138|FG000|Overall Study|Adverse Event|2|||
161142219|NCT00440401|581906139|FG001|Overall Study|Adverse Event|1|||
161142220|NCT00440401|581906138|FG000|Overall Study|Other|2|||
161142221|NCT00440401|581906139|FG001|Overall Study|Other|5|||
161142222|NCT01925703|581906140|FG000|Overall Study|Physician Decision|1|||
161142223|NCT01925703|581906140|FG000|Overall Study|Lost to Follow-up|2|||
161142224|NCT01925703|581906140|FG000|Overall Study|Discharge prior to full iron repletion|1|||
161142225|NCT01938625|581906141|FG000|Overall Study|Withdrawal by Subject|0|||
161142226|NCT01938625|581906142|FG001|Overall Study|Withdrawal by Subject|1|||
161142227|NCT01938625|581906141|FG000|Overall Study|Adverse Event|0|||
161142228|NCT01938625|581906142|FG001|Overall Study|Adverse Event|1|||
161142229|NCT01937312|581906143|FG000|Overall Study|Adverse Event|10|||
161142230|NCT01937312|581906144|FG001|Overall Study|Adverse Event|1|||
161142231|NCT01937312|581906143|FG000|Overall Study|Lack of Efficacy|0|||
161142232|NCT01937312|581906144|FG001|Overall Study|Lack of Efficacy|1|||
161142233|NCT01937312|581906143|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
161339255|NCT01232283|582630425|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
161339256|NCT01232283|582630426|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
160915595|NCT02289417|581081895|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915596|NCT02289417|581081896|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915597|NCT02289417|581081897|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
160915598|NCT02289417|581081898|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
160915599|NCT02725710|581081899|FG000|Overall Study|Lost to Follow-up|1|||
160915600|NCT02725710|581081900|FG001|Overall Study|Lost to Follow-up|0|||
160915601|NCT01782222|581081901|FG000|Overall Study|Adverse Event|4|||
160915602|NCT01782222|581081902|FG001|Overall Study|Adverse Event|5|||
160915603|NCT01782222|581081903|FG002|Overall Study|Adverse Event|3|||
160915604|NCT01782222|581081901|FG000|Overall Study|Lack of Efficacy|2|||
160915605|NCT01782222|581081902|FG001|Overall Study|Lack of Efficacy|1|||
160915606|NCT01782222|581081903|FG002|Overall Study|Lack of Efficacy|0|||
160915607|NCT01782222|581081901|FG000|Overall Study|Protocol Violation|1|||
160915608|NCT01782222|581081902|FG001|Overall Study|Protocol Violation|0|||
160915609|NCT01782222|581081903|FG002|Overall Study|Protocol Violation|0|||
160915610|NCT01782222|581081901|FG000|Overall Study|Withdrawal by Subject|1|||
160915611|NCT01782222|581081902|FG001|Overall Study|Withdrawal by Subject|4|||
160996036|NCT00567879|581372094|FG005|Overall Study|Adverse Event|0|||
161142234|NCT01937312|581906144|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
161142235|NCT00091793|581906145|FG000|Overall Study|Adverse Event|1|||
161142236|NCT00091793|581906146|FG001|Overall Study|Adverse Event|2|||
161142237|NCT00091793|581906145|FG000|Overall Study|Withdrawal by Subject|10|||
161142238|NCT00091793|581906146|FG001|Overall Study|Withdrawal by Subject|15|||
161142239|NCT00091793|581906145|FG000|Overall Study|Ineligibility determined|2|||
161142240|NCT00091793|581906146|FG001|Overall Study|Ineligibility determined|0|||
161339257|NCT01232283|582630427|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
160915612|NCT01782222|581081903|FG002|Overall Study|Withdrawal by Subject|1|||
160915613|NCT01782222|581081901|FG000|Overall Study|Moved to other state|0|||
160915614|NCT01782222|581081902|FG001|Overall Study|Moved to other state|1|||
160915615|NCT01782222|581081903|FG002|Overall Study|Moved to other state|0|||
160915616|NCT01918085|581081904|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
160915617|NCT01918085|581081905|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
160915618|NCT00687323|581081906|FG000|Overall Study|Death|25|||
161142241|NCT00091793|581906145|FG000|Overall Study|Lost to Follow-up|7|||
161142242|NCT00091793|581906146|FG001|Overall Study|Lost to Follow-up|5|||
161142243|NCT00091793|581906145|FG000|Overall Study|Noncompliance|2|||
161142244|NCT00091793|581906146|FG001|Overall Study|Noncompliance|0|||
161142245|NCT00091793|581906145|FG000|Overall Study|Other|2|||
161142246|NCT00091793|581906146|FG001|Overall Study|Other|0|||
161142247|NCT05309083|581906148|FG000|Overall Study|Withdrawal by Subject|2|||
161142248|NCT01238120|581906149|FG000|Overall Study|Withdrawal by Subject|4|||
161142249|NCT01238120|581906150|FG001|Overall Study|Withdrawal by Subject|1|||
161142250|NCT01238120|581906151|FG002|Overall Study|Withdrawal by Subject|2|||
161142251|NCT01238120|581906152|FG003|Overall Study|Withdrawal by Subject|5|||
161142252|NCT01238120|581906149|FG000|Overall Study|Lost to Follow-up|2|||
161142253|NCT01238120|581906150|FG001|Overall Study|Lost to Follow-up|0|||
161142254|NCT01238120|581906151|FG002|Overall Study|Lost to Follow-up|1|||
161142255|NCT01238120|581906152|FG003|Overall Study|Lost to Follow-up|1|||
161142256|NCT01238120|581906149|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
161142257|NCT01238120|581906150|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
161142258|NCT01238120|581906151|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
161142259|NCT01238120|581906152|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
161142260|NCT02388776|581906153|FG000|Overall Study|Death|1|||
161142261|NCT02388776|581906153|FG000|Overall Study|Lost to Follow-up|1|||
161142262|NCT04246047|581906154|FG000|Overall Study|Death|50|||
161142263|NCT04246047|581906155|FG001|Overall Study|Death|77|||
161142264|NCT04246047|581906154|FG000|Overall Study|Lost to Follow-up|1|||
161142265|NCT04246047|581906155|FG001|Overall Study|Lost to Follow-up|3|||
161142266|NCT04246047|581906154|FG000|Overall Study|Physician Decision|4|||
161142267|NCT04246047|581906155|FG001|Overall Study|Physician Decision|10|||
161142268|NCT04246047|581906154|FG000|Overall Study|Withdrawal by Subject|19|||
161142269|NCT04246047|581906155|FG001|Overall Study|Withdrawal by Subject|26|||
161142270|NCT04246047|581906154|FG000|Overall Study|Ongoing|169|||
161142271|NCT04246047|581906155|FG001|Overall Study|Ongoing|135|||
161142272|NCT00845429|581906165|FG000|Overall Study|Protocol Violation|5|||
161142273|NCT00845429|581906166|FG001|Overall Study|Protocol Violation|4|||
161142274|NCT00845429|581906167|FG002|Overall Study|Protocol Violation|7|||
161142275|NCT00845429|581906165|FG000|Overall Study|Lost to Follow-up|7|||
161142276|NCT00845429|581906166|FG001|Overall Study|Lost to Follow-up|9|||
161142277|NCT00845429|581906167|FG002|Overall Study|Lost to Follow-up|10|||
161142278|NCT00845429|581906165|FG000|Overall Study|Withdrawal by Subject|2|||
161142279|NCT00845429|581906166|FG001|Overall Study|Withdrawal by Subject|2|||
161142280|NCT00845429|581906167|FG002|Overall Study|Withdrawal by Subject|2|||
161142281|NCT00845429|581906165|FG000|Overall Study|Serious adverse event|0|||
161142282|NCT00845429|581906166|FG001|Overall Study|Serious adverse event|0|||
161142283|NCT00845429|581906167|FG002|Overall Study|Serious adverse event|1|||
161142284|NCT00587223|581906170|FG000|Overall Study|Adverse Event|1|||
161142285|NCT01480180|581906171|FG000|Main Phase|Withdrawal criteria|12|||
161142286|NCT01480180|581906172|FG001|Main Phase|Withdrawal criteria|1|||
161142287|NCT01480180|581906173|FG002|Main Phase|Withdrawal criteria|0|||
161142288|NCT01480180|581906174|FG003|Main Phase|Withdrawal criteria|0|||
161142289|NCT01480180|581906175|FG004|Main Phase|Withdrawal criteria|0|||
161142290|NCT01480180|581906176|FG005|Main Phase|Withdrawal criteria|0|||
161142291|NCT01480180|581906171|FG000|Main Phase|Lack of Efficacy|1|||
161142292|NCT01480180|581906172|FG001|Main Phase|Lack of Efficacy|0|||
161142293|NCT01480180|581906173|FG002|Main Phase|Lack of Efficacy|0|||
161142294|NCT01480180|581906174|FG003|Main Phase|Lack of Efficacy|0|||
161142295|NCT01480180|581906175|FG004|Main Phase|Lack of Efficacy|0|||
161142296|NCT01480180|581906176|FG005|Main Phase|Lack of Efficacy|0|||
161256640|NCT02973321|582318622|FG001|Overall Study|Adverse Event|10|||
161256641|NCT02973321|582318623|FG002|Overall Study|Adverse Event|11|||
161256642|NCT02973321|582318624|FG003|Overall Study|Adverse Event|13|||
161256643|NCT02973321|582318625|FG004|Overall Study|Adverse Event|3|||
161256644|NCT01355302|582318629|FG000|Phase 1b|Death|4|||
161142297|NCT01480180|581906171|FG000|Main Phase|Non-compliance|3|||
161142298|NCT01480180|581906172|FG001|Main Phase|Non-compliance|0|||
161142299|NCT01480180|581906173|FG002|Main Phase|Non-compliance|0|||
161142300|NCT01480180|581906174|FG003|Main Phase|Non-compliance|0|||
161142301|NCT01480180|581906175|FG004|Main Phase|Non-compliance|0|||
161142302|NCT01480180|581906176|FG005|Main Phase|Non-compliance|0|||
161142303|NCT01480180|581906171|FG000|Main Phase|Unclassified|3|||
161142304|NCT01480180|581906172|FG001|Main Phase|Unclassified|0|||
161142305|NCT01480180|581906173|FG002|Main Phase|Unclassified|0|||
161142306|NCT01480180|581906174|FG003|Main Phase|Unclassified|0|||
161142307|NCT01480180|581906175|FG004|Main Phase|Unclassified|0|||
161142308|NCT01480180|581906176|FG005|Main Phase|Unclassified|0|||
161142309|NCT01480180|581906171|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
161142310|NCT01480180|581906172|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
161142311|NCT01480180|581906173|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
161142312|NCT01480180|581906174|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
161142313|NCT01480180|581906175|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
161142314|NCT01480180|581906176|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
161142315|NCT01480180|581906171|FG000|Extension Phase, Part 1|Unclassified|0|||
161142316|NCT01480180|581906172|FG001|Extension Phase, Part 1|Unclassified|0|||
160996037|NCT00567879|581372089|FG000|Overall Study|Abnormal test procedure(s)|0|||
160996038|NCT00567879|581372090|FG001|Overall Study|Abnormal test procedure(s)|0|||
160996039|NCT00567879|581372091|FG002|Overall Study|Abnormal test procedure(s)|1|||
160996040|NCT00567879|581372092|FG003|Overall Study|Abnormal test procedure(s)|0|||
160996041|NCT00567879|581372093|FG004|Overall Study|Abnormal test procedure(s)|0|||
160996042|NCT00567879|581372094|FG005|Overall Study|Abnormal test procedure(s)|0|||
160996043|NCT00567879|581372089|FG000|Overall Study|Withdrawal by Subject|0|||
160996044|NCT00567879|581372090|FG001|Overall Study|Withdrawal by Subject|0|||
160996045|NCT00567879|581372091|FG002|Overall Study|Withdrawal by Subject|3|||
160996046|NCT00567879|581372092|FG003|Overall Study|Withdrawal by Subject|1|||
160996047|NCT00567879|581372093|FG004|Overall Study|Withdrawal by Subject|0|||
160996048|NCT00567879|581372094|FG005|Overall Study|Withdrawal by Subject|0|||
160996049|NCT00567879|581372089|FG000|Overall Study|New cancer therapy|0|||
160996050|NCT00567879|581372090|FG001|Overall Study|New cancer therapy|0|||
160996051|NCT00567879|581372091|FG002|Overall Study|New cancer therapy|1|||
160996052|NCT00567879|581372092|FG003|Overall Study|New cancer therapy|0|||
160996053|NCT00567879|581372093|FG004|Overall Study|New cancer therapy|0|||
160996054|NCT00567879|581372094|FG005|Overall Study|New cancer therapy|0|||
160996055|NCT00567879|581372089|FG000|Overall Study|Disease progression|5|||
160996056|NCT00567879|581372090|FG001|Overall Study|Disease progression|7|||
160996057|NCT00567879|581372091|FG002|Overall Study|Disease progression|15|||
160996058|NCT00567879|581372092|FG003|Overall Study|Disease progression|5|||
160996059|NCT00567879|581372093|FG004|Overall Study|Disease progression|11|||
160996060|NCT00567879|581372094|FG005|Overall Study|Disease progression|3|||
160996061|NCT01546155|581372097|FG000|Overall Study|could not tolerate long scan duration|3|||
160996062|NCT00151996|581372098|FG000|Overall Study|Adverse Event|3|||
160996063|NCT00151996|581372099|FG001|Overall Study|Adverse Event|2|||
160996064|NCT00151996|581372098|FG000|Overall Study|Withdrawal by Subject|1|||
160996065|NCT00151996|581372099|FG001|Overall Study|Withdrawal by Subject|1|||
160996066|NCT00151996|581372098|FG000|Overall Study|Protocol Violation|1|||
160996067|NCT00151996|581372099|FG001|Overall Study|Protocol Violation|2|||
160996068|NCT00151996|581372098|FG000|Overall Study|Sponsor's decision|0|||
160996069|NCT00151996|581372099|FG001|Overall Study|Sponsor's decision|2|||
160996070|NCT02930343|581372100|FG000|Overall Study|Lost to Follow-up|9|||
160996071|NCT02930343|581372101|FG001|Overall Study|Lost to Follow-up|7|||
160996072|NCT04588480|581372112|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
160996073|NCT04588480|581372113|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
160996074|NCT04588480|581372114|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
160996075|NCT04588480|581372112|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
160996076|NCT04588480|581372113|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
160996077|NCT04588480|581372114|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
160996078|NCT01242085|581372115|FG000|Overall Study|Withdrawal by Subject|4|||
160996079|NCT01242085|581372116|FG001|Overall Study|Withdrawal by Subject|2|||
160996080|NCT01242085|581372117|FG002|Overall Study|Withdrawal by Subject|0|||
160996081|NCT01242085|581372115|FG000|Overall Study|medically unable to have surgery|4|||
160996082|NCT01242085|581372116|FG001|Overall Study|medically unable to have surgery|5|||
160996083|NCT01242085|581372117|FG002|Overall Study|medically unable to have surgery|0|||
160996084|NCT01178762|581372118|FG000|Overall Study|Lost to Follow-up|15|||
160996085|NCT02322216|581372119|FG000|Overall Study|Adverse Event|1|||
160996086|NCT02322216|581372120|FG001|Overall Study|Adverse Event|0|||
160996087|NCT02322216|581372119|FG000|Overall Study|Withdrawal by Subject|1|||
160996088|NCT02322216|581372120|FG001|Overall Study|Withdrawal by Subject|4|||
160996089|NCT02430532|581372124|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
160996090|NCT02430532|581372125|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
160996091|NCT02430532|581372124|FG000|Overall Study|Consent Withdrawn|0|||
160996092|NCT02430532|581372125|FG001|Overall Study|Consent Withdrawn|2|||
160996093|NCT02430532|581372124|FG000|Overall Study|Adverse Event|0|||
160996094|NCT02430532|581372125|FG001|Overall Study|Adverse Event|1|||
160996095|NCT01190150|581372126|FG000|First Treatment|Withdrawal by Subject|1|||
160996096|NCT01190150|581372127|FG001|First Treatment|Withdrawal by Subject|0|||
160996097|NCT01190150|581372126|FG000|Washout|Withdrawal by Subject|0|||
160996098|NCT01190150|581372127|FG001|Washout|Withdrawal by Subject|1|||
160996099|NCT01190150|581372126|FG000|Washout|Difficulty in adherence|0|||
160996100|NCT01190150|581372127|FG001|Washout|Difficulty in adherence|1|||
160996101|NCT01726023|581372128|FG000|Overall Study|Death|1|||
160996102|NCT01726023|581372129|FG001|Overall Study|Death|1|||
160996103|NCT01726023|581372128|FG000|Overall Study|Lost to Follow-up|5|||
160996104|NCT01726023|581372129|FG001|Overall Study|Lost to Follow-up|10|||
160996105|NCT01726023|581372128|FG000|Overall Study|Other Eligibility criteria|7|||
160996106|NCT01726023|581372129|FG001|Overall Study|Other Eligibility criteria|7|||
160996107|NCT01726023|581372128|FG000|Overall Study|Withdrawal by Subject|16|||
160996108|NCT01726023|581372129|FG001|Overall Study|Withdrawal by Subject|8|||
160996109|NCT04858425|581372132|FG000|Overall Study|Adverse Event|2|||
160996110|NCT04858425|581372133|FG001|Overall Study|Adverse Event|2|||
160996111|NCT04858425|581372132|FG000|Overall Study|Withdrawal by Subject|3|||
160996112|NCT04858425|581372133|FG001|Overall Study|Withdrawal by Subject|1|||
160996113|NCT04858425|581372132|FG000|Overall Study|Lost to Follow-up|4|||
161256645|NCT01355302|582318630|FG001|Phase 1b|Death|0|||
161256646|NCT01355302|582318631|FG002|Phase 1b|Death|0|||
161256647|NCT01355302|582318629|FG000|Phase 1b|Study terminated by sponsor|2|||
160915619|NCT00687323|581081906|FG000|Overall Study|Withdrawal by Subject|1|||
160915620|NCT00687323|581081906|FG000|Overall Study|Excluded from efficacy evaluations|6|||
160915621|NCT00687323|581081906|FG000|Overall Study|Screen failure|148|||
160915622|NCT03655691|581081912|FG000|Overall Study|Adverse Event|0|||
160915623|NCT03655691|581081913|FG001|Overall Study|Adverse Event|0|||
160915624|NCT03655691|581081914|FG002|Overall Study|Adverse Event|1|||
160915625|NCT03655691|581081912|FG000|Overall Study|Lost to Follow-up|1|||
160915626|NCT03655691|581081913|FG001|Overall Study|Lost to Follow-up|1|||
160915627|NCT03655691|581081914|FG002|Overall Study|Lost to Follow-up|2|||
160915628|NCT03655691|581081912|FG000|Overall Study|Protocol Violation|0|||
160915629|NCT03655691|581081913|FG001|Overall Study|Protocol Violation|1|||
160915630|NCT03655691|581081914|FG002|Overall Study|Protocol Violation|0|||
160915631|NCT03655691|581081912|FG000|Overall Study|Withdrawal by Subject|1|||
160915632|NCT03655691|581081913|FG001|Overall Study|Withdrawal by Subject|1|||
160915633|NCT03655691|581081914|FG002|Overall Study|Withdrawal by Subject|0|||
160915634|NCT04557371|581081915|FG000|Overall Study|Covid-19-related|0|||
160915635|NCT04557371|581081916|FG001|Overall Study|Covid-19-related|1|||
160915636|NCT04557371|581081917|FG002|Overall Study|Covid-19-related|0|||
160915637|NCT04557371|581081915|FG000|Overall Study|Withdrawal by Subject|0|||
160915638|NCT04557371|581081916|FG001|Overall Study|Withdrawal by Subject|1|||
160915639|NCT04557371|581081917|FG002|Overall Study|Withdrawal by Subject|0|||
160915640|NCT04557371|581081915|FG000|Overall Study|Adverse Event|1|||
160915641|NCT04557371|581081916|FG001|Overall Study|Adverse Event|0|||
160915642|NCT04557371|581081917|FG002|Overall Study|Adverse Event|0|||
160915643|NCT03918447|581081918|FG000|Overall Study|Death|1|||
160915644|NCT03918447|581081919|FG001|Overall Study|Death|0|||
160915645|NCT03918447|581081918|FG000|Overall Study|Lost to Follow-up|13|||
160915646|NCT03918447|581081919|FG001|Overall Study|Lost to Follow-up|6|||
160915647|NCT03918447|581081918|FG000|Overall Study|Withdrawal by Subject|19|||
160915648|NCT03918447|581081919|FG001|Overall Study|Withdrawal by Subject|17|||
160915649|NCT03918447|581081918|FG000|Overall Study|Study Terminated by Sponsor|195|||
160915650|NCT03918447|581081919|FG001|Overall Study|Study Terminated by Sponsor|197|||
160915651|NCT03918447|581081918|FG000|Overall Study|Reason not Specified|0|||
160915652|NCT03918447|581081919|FG001|Overall Study|Reason not Specified|1|||
160915653|NCT05355805|581081920|FG000|Overall Study|Lost to Follow-up|6|||
160915654|NCT05355805|581081921|FG001|Overall Study|Lost to Follow-up|11|||
160915655|NCT05355805|581081922|FG002|Overall Study|Lost to Follow-up|10|||
160915656|NCT05355805|581081923|FG003|Overall Study|Lost to Follow-up|6|||
160915657|NCT05355805|581081920|FG000|Overall Study|Decision by Sponsor|0|||
160915658|NCT05355805|581081921|FG001|Overall Study|Decision by Sponsor|0|||
160915659|NCT05355805|581081922|FG002|Overall Study|Decision by Sponsor|1|||
160915660|NCT05355805|581081923|FG003|Overall Study|Decision by Sponsor|0|||
160915661|NCT05355805|581081920|FG000|Overall Study|Withdrawal by Subject|7|||
160915662|NCT05355805|581081921|FG001|Overall Study|Withdrawal by Subject|14|||
160915663|NCT05355805|581081922|FG002|Overall Study|Withdrawal by Subject|15|||
160915664|NCT05355805|581081923|FG003|Overall Study|Withdrawal by Subject|13|||
160915665|NCT04232124|581083646|FG000|Overall Study|Lost to Follow-up|3|||
160915666|NCT01986855|581083649|FG000|Overall Study|Adverse Event|1|||
160915667|NCT01986855|581083650|FG001|Overall Study|Adverse Event|0|||
160915668|NCT01986855|581083651|FG002|Overall Study|Adverse Event|0|||
160915669|NCT01986855|581083649|FG000|Overall Study|Death|3|||
160915670|NCT01986855|581083650|FG001|Overall Study|Death|4|||
160915671|NCT01986855|581083651|FG002|Overall Study|Death|4|||
160915672|NCT01986855|581083649|FG000|Overall Study|Lost to Follow-up|2|||
160915673|NCT01986855|581083650|FG001|Overall Study|Lost to Follow-up|1|||
160915674|NCT01986855|581083651|FG002|Overall Study|Lost to Follow-up|0|||
160915675|NCT01986855|581083649|FG000|Overall Study|Screen Failure|0|||
161256648|NCT01355302|582318630|FG001|Phase 1b|Study terminated by sponsor|0|||
161256649|NCT01355302|582318631|FG002|Phase 1b|Study terminated by sponsor|0|||
161256650|NCT00263887|582318632|FG000|Overall Study|Withdrawal by Subject|1|||
161256651|NCT00263887|582318633|FG001|Overall Study|Withdrawal by Subject|1|||
160915676|NCT01986855|581083650|FG001|Overall Study|Screen Failure|1|||
160915677|NCT01986855|581083651|FG002|Overall Study|Screen Failure|0|||
160915678|NCT01986855|581083649|FG000|Overall Study|Participant Moved|0|||
160915679|NCT01986855|581083650|FG001|Overall Study|Participant Moved|0|||
160915680|NCT01986855|581083651|FG002|Overall Study|Participant Moved|2|||
160915681|NCT01986855|581083649|FG000|Overall Study|Withdrawal by Subject|7|||
160915682|NCT01986855|581083650|FG001|Overall Study|Withdrawal by Subject|8|||
160915683|NCT01986855|581083651|FG002|Overall Study|Withdrawal by Subject|5|||
160915684|NCT04317066|581083652|FG000|Overall Study|Sponsor decision|5|||
160915685|NCT04317066|581083652|FG000|Overall Study|Death|2|||
160915686|NCT02014597|581083656|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
160915687|NCT02014597|581083657|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
160915688|NCT02279173|581083659|FG000|Overall Study|Protocol-specified Criteria|67|||
161256652|NCT00263887|582318632|FG000|Overall Study|Lung transplantation|1|||
160915689|NCT02279173|581083659|FG000|Overall Study|Withdrawal by Subject|20|||
160996114|NCT04858425|581372133|FG001|Overall Study|Lost to Follow-up|2|||
160996115|NCT04858425|581372132|FG000|Overall Study|Lost to Follow-up|1|||
160996116|NCT04858425|581372133|FG001|Overall Study|Lost to Follow-up|0|||
160996117|NCT03473743|581372134|FG000|Overall Study|Withdrawal by Subject|0|||
160996118|NCT03473743|581372135|FG001|Overall Study|Withdrawal by Subject|0|||
160996119|NCT03473743|581372136|FG002|Overall Study|Withdrawal by Subject|0|||
160996120|NCT03473743|581372137|FG003|Overall Study|Withdrawal by Subject|0|||
160996121|NCT03473743|581372138|FG004|Overall Study|Withdrawal by Subject|0|||
160996122|NCT03473743|581372139|FG005|Overall Study|Withdrawal by Subject|0|||
160996123|NCT03473743|581372140|FG006|Overall Study|Withdrawal by Subject|0|||
160996124|NCT03473743|581372141|FG007|Overall Study|Withdrawal by Subject|3|||
160996125|NCT03473743|581372134|FG000|Overall Study|Other|0|||
160996126|NCT03473743|581372135|FG001|Overall Study|Other|0|||
160996127|NCT03473743|581372136|FG002|Overall Study|Other|0|||
160996128|NCT03473743|581372137|FG003|Overall Study|Other|1|||
160996129|NCT03473743|581372138|FG004|Overall Study|Other|0|||
160996130|NCT03473743|581372139|FG005|Overall Study|Other|0|||
160915690|NCT02279173|581083659|FG000|Overall Study|Decision by Sponsor|4|||
160915691|NCT02279173|581083659|FG000|Overall Study|Lost to Follow-up|3|||
160915692|NCT00464087|581083661|FG000|Overall Study|No PCI per inclusion criteria|0|||
160915693|NCT00464087|581083662|FG001|Overall Study|No PCI per inclusion criteria|0|||
160996131|NCT03473743|581372140|FG006|Overall Study|Other|0|||
160915694|NCT00464087|581083663|FG002|Overall Study|No PCI per inclusion criteria|29|||
160915695|NCT01164956|581083664|FG000|Overall Study|Side Effects|1|||
160915696|NCT01164956|581083665|FG001|Overall Study|Side Effects|0|||
160915697|NCT01164956|581083666|FG002|Overall Study|Side Effects|1|||
160915698|NCT00720434|581083667|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
160915699|NCT00720434|581083668|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
160915700|NCT00720434|581083669|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
160915701|NCT00720434|581083670|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
160915702|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
160915703|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
160915704|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
160996132|NCT03473743|581372141|FG007|Overall Study|Other|0|||
160996133|NCT03473743|581372134|FG000|Overall Study|Ongoing|0|||
160996134|NCT03473743|581372135|FG001|Overall Study|Ongoing|0|||
160996135|NCT03473743|581372136|FG002|Overall Study|Ongoing|6|||
160996136|NCT03473743|581372137|FG003|Overall Study|Ongoing|8|||
160996137|NCT03473743|581372138|FG004|Overall Study|Ongoing|1|||
160996138|NCT03473743|581372139|FG005|Overall Study|Ongoing|1|||
160996139|NCT03473743|581372140|FG006|Overall Study|Ongoing|22|||
160996140|NCT03473743|581372141|FG007|Overall Study|Ongoing|24|||
160996141|NCT03473743|581372134|FG000|Overall Study|Randomized but not treated|0|||
160996142|NCT03473743|581372135|FG001|Overall Study|Randomized but not treated|0|||
160996143|NCT03473743|581372136|FG002|Overall Study|Randomized but not treated|0|||
160996144|NCT03473743|581372137|FG003|Overall Study|Randomized but not treated|0|||
160996145|NCT03473743|581372138|FG004|Overall Study|Randomized but not treated|0|||
160996146|NCT03473743|581372139|FG005|Overall Study|Randomized but not treated|0|||
160996147|NCT03473743|581372140|FG006|Overall Study|Randomized but not treated|1|||
160996148|NCT03473743|581372141|FG007|Overall Study|Randomized but not treated|1|||
160996149|NCT04536077|581372143|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
160996150|NCT04536077|581372144|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
160996151|NCT04536077|581372143|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
160996152|NCT04536077|581372144|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
160996153|NCT03805295|581372145|FG000|Overall Study|Lost to Follow-up|17|||
160996154|NCT03805295|581372146|FG001|Overall Study|Lost to Follow-up|43|||
160996155|NCT04925752|581372147|FG000|Overall Study|Still on Study|1826|||
160996156|NCT04925752|581372148|FG001|Overall Study|Still on Study|926|||
160996157|NCT04925752|581372147|FG000|Overall Study|Withdrew Consent|128|||
160996158|NCT04925752|581372148|FG001|Overall Study|Withdrew Consent|59|||
160996159|NCT04925752|581372147|FG000|Overall Study|Lost to Follow-up|73|||
160996160|NCT04925752|581372148|FG001|Overall Study|Lost to Follow-up|47|||
160996161|NCT04925752|581372147|FG000|Overall Study|Randomized but Never Treated|12|||
160996162|NCT04925752|581372148|FG001|Overall Study|Randomized but Never Treated|9|||
160996163|NCT04925752|581372147|FG000|Overall Study|Hiv-1 Infection|6|||
160996164|NCT04925752|581372148|FG001|Overall Study|Hiv-1 Infection|7|||
161256653|NCT00263887|582318633|FG001|Overall Study|Lung transplantation|2|||
160915705|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
160915706|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
160915707|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
160915708|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
160996165|NCT04925752|581372147|FG000|Overall Study|Investigator's discretion|8|||
160996166|NCT04925752|581372148|FG001|Overall Study|Investigator's discretion|5|||
160996167|NCT04925752|581372147|FG000|Overall Study|Non-compliance with Study Drug|8|||
161142659|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Other|0|||
160915709|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
160915710|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
160915711|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
160915712|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
160915713|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
160915714|NCT00720434|581083667|FG000|Open-Label Period (Week 5-72)|Other|4|||
160915715|NCT00720434|581083668|FG001|Open-Label Period (Week 5-72)|Other|3|||
161256654|NCT00263887|582318632|FG000|Overall Study|Too ill to attend visit|1|||
161256655|NCT00263887|582318633|FG001|Overall Study|Too ill to attend visit|0|||
161256656|NCT00263887|582318632|FG000|Overall Study|Adverse Event|0|||
160915716|NCT00720434|581083669|FG002|Open-Label Period (Week 5-72)|Other|3|||
160915717|NCT00720434|581083670|FG003|Open-Label Period (Week 5-72)|Other|2|||
160915718|NCT00754624|581083671|FG000|Overall Study|Adverse Event|16|||
160915719|NCT00754624|581083671|FG000|Overall Study|Death|1|||
160915720|NCT00754624|581083671|FG000|Overall Study|Physician Decision|8|||
160915721|NCT00754624|581083671|FG000|Overall Study|Protocol Violation|1|||
160915722|NCT00754624|581083671|FG000|Overall Study|Withdrawal by Subject|28|||
160915723|NCT00754624|581083671|FG000|Overall Study|Various|12|||
160915724|NCT00754624|581083671|FG000|Overall Study|Lost to Follow-up|3|||
160915725|NCT00967798|581083672|FG000|Overall Study|Withdrawal by Subject|5|||
160915726|NCT00967798|581083673|FG001|Overall Study|Withdrawal by Subject|2|||
160915727|NCT00967798|581083672|FG000|Overall Study|Lost to Follow-up|4|||
160915728|NCT00967798|581083673|FG001|Overall Study|Lost to Follow-up|1|||
160915729|NCT02425046|581083674|FG000|Overall Study|Lost to Follow-up|52|||
160915730|NCT02425046|581083675|FG001|Overall Study|Lost to Follow-up|50|||
160915731|NCT02425046|581083676|FG002|Overall Study|Lost to Follow-up|56|||
160915732|NCT02425046|581083674|FG000|Overall Study|Withdrawal by Subject|16|||
160915733|NCT02425046|581083675|FG001|Overall Study|Withdrawal by Subject|12|||
160915734|NCT02425046|581083676|FG002|Overall Study|Withdrawal by Subject|0|||
160915735|NCT02782780|581083677|FG000|Overall Study|dropped out after randomization.|7|||
160915736|NCT02782780|581083678|FG001|Overall Study|dropped out after randomization.|5|||
160915737|NCT02782780|581083677|FG000|Overall Study|Protocol Violation|0|||
160915738|NCT02782780|581083678|FG001|Overall Study|Protocol Violation|2|||
160915739|NCT01413191|581083679|FG000|Overall Study|Lost to Follow-up|5|||
160915740|NCT01413191|581083679|FG000|Overall Study|Disease Progression|5|||
160915741|NCT01413191|581083679|FG000|Overall Study|Death|1|||
160915742|NCT03654651|581083680|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
160915743|NCT03654651|581083681|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
160915744|NCT03045328|581083682|FG000|Overall Study|Withdrawal by Subject|2|||
160915745|NCT04429061|581083690|FG000|Overall Study|Lost to Follow-up|62|||
160915746|NCT04429061|581083691|FG001|Overall Study|Lost to Follow-up|87|||
160915747|NCT04429061|581083690|FG000|Overall Study|Withdrawal by Subject|3|||
160915748|NCT04429061|581083691|FG001|Overall Study|Withdrawal by Subject|4|||
160915749|NCT02289898|581083698|FG000|Overall Study|Death|5|||
160915750|NCT02289898|581083699|FG001|Overall Study|Death|4|||
160915751|NCT02289898|581083700|FG002|Overall Study|Death|3|||
160915752|NCT02289898|581083698|FG000|Overall Study|Physician Decision|2|||
160915753|NCT02289898|581083699|FG001|Overall Study|Physician Decision|5|||
160915754|NCT02289898|581083700|FG002|Overall Study|Physician Decision|2|||
160915755|NCT02289898|581083698|FG000|Overall Study|Withdrawal by Subject|0|||
160915756|NCT02289898|581083699|FG001|Overall Study|Withdrawal by Subject|4|||
160915757|NCT02289898|581083700|FG002|Overall Study|Withdrawal by Subject|1|||
160915758|NCT02289898|581083698|FG000|Overall Study|Adverse Event|3|||
160915759|NCT02289898|581083699|FG001|Overall Study|Adverse Event|5|||
160915760|NCT02289898|581083700|FG002|Overall Study|Adverse Event|5|||
160915761|NCT02289898|581083698|FG000|Overall Study|Disease progression|34|||
160915762|NCT02289898|581083699|FG001|Overall Study|Disease progression|28|||
160915763|NCT02289898|581083700|FG002|Overall Study|Disease progression|34|||
160915764|NCT02289898|581083698|FG000|Overall Study|Use of another anticancer therapy|0|||
160915765|NCT02289898|581083699|FG001|Overall Study|Use of another anticancer therapy|0|||
160915766|NCT02289898|581083700|FG002|Overall Study|Use of another anticancer therapy|1|||
160915767|NCT02289898|581083698|FG000|Overall Study|Other|8|||
161256657|NCT00263887|582318633|FG001|Overall Study|Adverse Event|2|||
160915768|NCT02289898|581083699|FG001|Overall Study|Other|7|||
160915769|NCT02289898|581083700|FG002|Overall Study|Other|10|||
160915770|NCT00885105|581083701|FG000|Overall Study|Withdrawal by Subject|0|||
160915771|NCT00885105|581083702|FG001|Overall Study|Withdrawal by Subject|8|||
160996168|NCT04925752|581372148|FG001|Overall Study|Non-compliance with Study Drug|5|||
160915772|NCT00885105|581083701|FG000|Overall Study|Adverse Event|1|||
160915773|NCT00885105|581083702|FG001|Overall Study|Adverse Event|0|||
160915774|NCT00885105|581083701|FG000|Overall Study|Protocol Violation|0|||
160915775|NCT00885105|581083702|FG001|Overall Study|Protocol Violation|2|||
160915776|NCT03519932|581083703|FG000|First Intervention|Adverse Event|1|||
160915777|NCT03519932|581083704|FG001|First Intervention|Adverse Event|3|||
160915778|NCT02254486|581083705|FG000|Overall Study|Adverse Event|1|||
160915779|NCT02254486|581083706|FG001|Overall Study|Adverse Event|1|||
160915780|NCT02254486|581083705|FG000|Overall Study|Lack of Efficacy|1|||
160915781|NCT02254486|581083706|FG001|Overall Study|Lack of Efficacy|0|||
160996169|NCT04925752|581372147|FG000|Overall Study|Adverse Event|5|||
160996170|NCT04925752|581372148|FG001|Overall Study|Adverse Event|2|||
160996171|NCT04925752|581372147|FG000|Overall Study|Death|4|||
160996172|NCT04925752|581372148|FG001|Overall Study|Death|2|||
160996173|NCT04925752|581372147|FG000|Overall Study|Protocol Violation|1|||
160996174|NCT04925752|581372148|FG001|Overall Study|Protocol Violation|3|||
160996175|NCT04925752|581372147|FG000|Overall Study|Withdrew Assent|1|||
160996176|NCT04925752|581372148|FG001|Overall Study|Withdrew Assent|0|||
160996177|NCT01155869|581372154|FG000|Overall Study|Lost to Follow-up|3|||
160996178|NCT01155869|581372155|FG001|Overall Study|Lost to Follow-up|1|||
160996179|NCT04538664|581372157|FG000|Overall Study|Withdrawal by Subject|5|||
160996180|NCT04538664|581372158|FG001|Overall Study|Withdrawal by Subject|9|||
160996181|NCT04538664|581372157|FG000|Overall Study|Lost to Follow-up|2|||
160996182|NCT04538664|581372158|FG001|Overall Study|Lost to Follow-up|1|||
160996183|NCT04538664|581372157|FG000|Overall Study|Ongoing|106|||
160996184|NCT04538664|581372158|FG001|Overall Study|Ongoing|115|||
160996185|NCT03431350|581372161|FG000|Overall Study|ONGOING|0|||
160996186|NCT03431350|581372162|FG001|Overall Study|ONGOING|0|||
160996187|NCT03431350|581372163|FG002|Overall Study|ONGOING|2|||
160996188|NCT03431350|581372164|FG003|Overall Study|ONGOING|0|||
160996189|NCT03431350|581372165|FG004|Overall Study|ONGOING|1|||
160996190|NCT03431350|581372166|FG005|Overall Study|ONGOING|3|||
160996191|NCT03431350|581372167|FG006|Overall Study|ONGOING|0|||
160996192|NCT03431350|581372168|FG007|Overall Study|ONGOING|1|||
160996193|NCT03431350|581372169|FG008|Overall Study|ONGOING|3|||
160996194|NCT03431350|581372170|FG009|Overall Study|ONGOING|4|||
160996195|NCT03431350|581372171|FG010|Overall Study|ONGOING|2|||
160996196|NCT03431350|581372172|FG011|Overall Study|ONGOING|1|||
160996197|NCT03431350|581372161|FG000|Overall Study|Death|6|||
160996198|NCT03431350|581372162|FG001|Overall Study|Death|5|||
160996199|NCT03431350|581372163|FG002|Overall Study|Death|18|||
160996200|NCT03431350|581372164|FG003|Overall Study|Death|7|||
160996201|NCT03431350|581372165|FG004|Overall Study|Death|4|||
160996202|NCT03431350|581372166|FG005|Overall Study|Death|3|||
160996203|NCT03431350|581372167|FG006|Overall Study|Death|2|||
160996204|NCT03431350|581372168|FG007|Overall Study|Death|0|||
160996205|NCT03431350|581372169|FG008|Overall Study|Death|0|||
161142317|NCT01480180|581906173|FG002|Extension Phase, Part 1|Unclassified|1|||
161142318|NCT01480180|581906174|FG003|Extension Phase, Part 1|Unclassified|0|||
161142319|NCT01480180|581906175|FG004|Extension Phase, Part 1|Unclassified|0|||
160996206|NCT03431350|581372170|FG009|Overall Study|Death|0|||
160996207|NCT03431350|581372171|FG010|Overall Study|Death|4|||
161142320|NCT01480180|581906176|FG005|Extension Phase, Part 1|Unclassified|0|||
161142321|NCT01480180|581906171|FG000|Extension Phase, Part 1|Adverse Event|0|||
160996208|NCT03431350|581372172|FG011|Overall Study|Death|0|||
160996209|NCT03431350|581372161|FG000|Overall Study|Lost to Follow-up|0|||
160996210|NCT03431350|581372162|FG001|Overall Study|Lost to Follow-up|1|||
160996211|NCT03431350|581372163|FG002|Overall Study|Lost to Follow-up|0|||
160996212|NCT03431350|581372164|FG003|Overall Study|Lost to Follow-up|0|||
160996213|NCT03431350|581372165|FG004|Overall Study|Lost to Follow-up|0|||
160996214|NCT03431350|581372166|FG005|Overall Study|Lost to Follow-up|0|||
160996215|NCT03431350|581372167|FG006|Overall Study|Lost to Follow-up|0|||
160996216|NCT03431350|581372168|FG007|Overall Study|Lost to Follow-up|0|||
160996217|NCT03431350|581372169|FG008|Overall Study|Lost to Follow-up|0|||
160996218|NCT03431350|581372170|FG009|Overall Study|Lost to Follow-up|0|||
160996219|NCT03431350|581372171|FG010|Overall Study|Lost to Follow-up|0|||
160996220|NCT03431350|581372172|FG011|Overall Study|Lost to Follow-up|0|||
160996221|NCT03431350|581372161|FG000|Overall Study|Withdrawal by Subject|0|||
160996222|NCT03431350|581372162|FG001|Overall Study|Withdrawal by Subject|0|||
160996223|NCT03431350|581372163|FG002|Overall Study|Withdrawal by Subject|0|||
160996224|NCT03431350|581372164|FG003|Overall Study|Withdrawal by Subject|1|||
160996225|NCT03431350|581372165|FG004|Overall Study|Withdrawal by Subject|1|||
160996226|NCT03431350|581372166|FG005|Overall Study|Withdrawal by Subject|1|||
160996227|NCT03431350|581372167|FG006|Overall Study|Withdrawal by Subject|0|||
160996228|NCT03431350|581372168|FG007|Overall Study|Withdrawal by Subject|0|||
160996229|NCT03431350|581372169|FG008|Overall Study|Withdrawal by Subject|0|||
160996230|NCT03431350|581372170|FG009|Overall Study|Withdrawal by Subject|2|||
161142322|NCT01480180|581906172|FG001|Extension Phase, Part 1|Adverse Event|0|||
161142323|NCT01480180|581906173|FG002|Extension Phase, Part 1|Adverse Event|4|||
161142324|NCT01480180|581906174|FG003|Extension Phase, Part 1|Adverse Event|1|||
161339258|NCT01232283|582630428|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
160996231|NCT03431350|581372171|FG010|Overall Study|Withdrawal by Subject|0|||
160996232|NCT03431350|581372172|FG011|Overall Study|Withdrawal by Subject|1|||
160996233|NCT03431350|581372161|FG000|Overall Study|Other|0|||
160996234|NCT03431350|581372162|FG001|Overall Study|Other|0|||
160996235|NCT03431350|581372163|FG002|Overall Study|Other|1|||
160996236|NCT03431350|581372164|FG003|Overall Study|Other|3|||
160996237|NCT03431350|581372165|FG004|Overall Study|Other|2|||
160996238|NCT03431350|581372166|FG005|Overall Study|Other|2|||
160996239|NCT03431350|581372167|FG006|Overall Study|Other|4|||
160996240|NCT03431350|581372168|FG007|Overall Study|Other|0|||
160996241|NCT03431350|581372169|FG008|Overall Study|Other|14|||
161256658|NCT00263887|582318632|FG000|Overall Study|Disease progression|0|||
161256659|NCT00263887|582318633|FG001|Overall Study|Disease progression|1|||
161256660|NCT00263887|582318632|FG000|Overall Study|Lack of Efficacy|0|||
161256661|NCT00263887|582318633|FG001|Overall Study|Lack of Efficacy|1|||
161256662|NCT02274948|582318636|FG000|Overall Study|Lost to Follow-up|28|||
161256663|NCT02274948|582318637|FG001|Overall Study|Lost to Follow-up|25|||
161256664|NCT02274948|582318636|FG000|Overall Study|Withdrawal by Subject|64|||
161256665|NCT02274948|582318637|FG001|Overall Study|Withdrawal by Subject|58|||
161256666|NCT02274948|582318636|FG000|Overall Study|Stopped on family Practitioner advice|2|||
161256667|NCT02274948|582318637|FG001|Overall Study|Stopped on family Practitioner advice|5|||
161256668|NCT02274948|582318636|FG000|Overall Study|Left the area|4|||
161256669|NCT02274948|582318637|FG001|Overall Study|Left the area|3|||
161256670|NCT00707434|582318638|FG000|Overall Study|Adverse Event|1|||
161256671|NCT05212883|582318639|FG000|Overall Study|Invalid test result|125|||
161256672|NCT02502734|582318640|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
161256673|NCT02502734|582318641|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
161256674|NCT02502734|582318640|FG000|Washout Period|Adverse Event|1|||
161256675|NCT02502734|582318641|FG001|Washout Period|Adverse Event|0|||
161256676|NCT00614822|582318642|FG000|Overall Study|Adverse Event|3|||
161256677|NCT00865514|582318651|FG000|Overall Study|Infusion cost exceeded funding|2|||
161256678|NCT03649412|582318652|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
161339259|NCT01232283|582630429|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
160915782|NCT02254486|581083705|FG000|Overall Study|Lost to Follow-up|2|||
160915783|NCT02254486|581083706|FG001|Overall Study|Lost to Follow-up|4|||
160915784|NCT02254486|581083705|FG000|Overall Study|Protocol Violation|1|||
160996242|NCT03431350|581372170|FG009|Overall Study|Other|11|||
160996243|NCT03431350|581372171|FG010|Overall Study|Other|11|||
160996244|NCT03431350|581372172|FG011|Overall Study|Other|15|||
160915785|NCT02254486|581083706|FG001|Overall Study|Protocol Violation|2|||
160915786|NCT02254486|581083705|FG000|Overall Study|Withdrawal by Subject|17|||
160915787|NCT02254486|581083706|FG001|Overall Study|Withdrawal by Subject|15|||
160915788|NCT02254486|581083705|FG000|Overall Study|GFR<60mL/min|16|||
160915789|NCT02254486|581083706|FG001|Overall Study|GFR<60mL/min|21|||
160915790|NCT02254486|581083705|FG000|Overall Study|Various|12|||
160915791|NCT02254486|581083706|FG001|Overall Study|Various|12|||
160915792|NCT01350414|581083707|FG000|Overall Study|Lost to Follow-up|13|||
160915793|NCT01350414|581083707|FG000|Overall Study|Withdrawal by Subject|4|||
160915794|NCT01350414|581083707|FG000|Overall Study|Physician Decision|2|||
160915795|NCT00759954|581083715|FG000|Overall Study|Personal reason|1|||
160915796|NCT00759954|581083716|FG001|Overall Study|Personal reason|0|||
160915797|NCT00759954|581083715|FG000|Overall Study|Adverse Event|1|||
160915798|NCT00759954|581083716|FG001|Overall Study|Adverse Event|2|||
160915799|NCT00022633|581083720|FG000|Overall Study|Adverse Event|11|||
160915800|NCT00022633|581083721|FG001|Overall Study|Adverse Event|1|||
160915801|NCT00022633|581083720|FG000|Overall Study|Refusal unrelated to adverse event|1|||
160915802|NCT00022633|581083721|FG001|Overall Study|Refusal unrelated to adverse event|0|||
160915803|NCT00022633|581083720|FG000|Overall Study|Progression/relapse|9|||
160915804|NCT00022633|581083721|FG001|Overall Study|Progression/relapse|2|||
160915805|NCT00022633|581083720|FG000|Overall Study|Death|4|||
160915806|NCT00022633|581083721|FG001|Overall Study|Death|0|||
160915807|NCT00022633|581083720|FG000|Overall Study|Other - not protocol specified|3|||
160915808|NCT00022633|581083721|FG001|Overall Study|Other - not protocol specified|2|||
160915809|NCT00022633|581083720|FG000|Overall Study|Ineligible|4|||
160915810|NCT00022633|581083721|FG001|Overall Study|Ineligible|0|||
160915811|NCT00372112|581083726|FG000|Overall Study|Adverse Event|0|||
160915812|NCT00372112|581083727|FG001|Overall Study|Adverse Event|1|||
160915813|NCT00372112|581083728|FG002|Overall Study|Adverse Event|1|||
160996245|NCT04487080|581372175|FG000|Overall Study|Withdrawal by Subject|19|||
160996246|NCT04487080|581372176|FG001|Overall Study|Withdrawal by Subject|18|||
160996247|NCT04487080|581372177|FG002|Overall Study|Withdrawal by Subject|13|||
160996248|NCT04487080|581372175|FG000|Overall Study|Lost to Follow-up|3|||
160996249|NCT04487080|581372176|FG001|Overall Study|Lost to Follow-up|1|||
160996250|NCT04487080|581372177|FG002|Overall Study|Lost to Follow-up|0|||
160996251|NCT04487080|581372175|FG000|Overall Study|Ongoing|313|||
161142325|NCT01480180|581906175|FG004|Extension Phase, Part 1|Adverse Event|0|||
160915814|NCT00372112|581083729|FG003|Overall Study|Adverse Event|1|||
160915815|NCT00372112|581083726|FG000|Overall Study|Withdrawal by Subject|0|||
160915816|NCT00372112|581083727|FG001|Overall Study|Withdrawal by Subject|0|||
161142326|NCT01480180|581906176|FG005|Extension Phase, Part 1|Adverse Event|0|||
160915817|NCT00372112|581083728|FG002|Overall Study|Withdrawal by Subject|2|||
160915818|NCT00372112|581083729|FG003|Overall Study|Withdrawal by Subject|1|||
160915819|NCT00372112|581083726|FG000|Overall Study|Exacerbation|0|||
160915820|NCT00372112|581083727|FG001|Overall Study|Exacerbation|0|||
160915821|NCT00372112|581083728|FG002|Overall Study|Exacerbation|0|||
161256679|NCT03649412|582318653|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
161256680|NCT03649412|582318652|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
161256681|NCT03649412|582318653|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
161256682|NCT03649412|582318652|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
160915822|NCT00372112|581083729|FG003|Overall Study|Exacerbation|1|||
160915823|NCT00372112|581083726|FG000|Overall Study|PR >240 at Visit 3|0|||
160915824|NCT00372112|581083727|FG001|Overall Study|PR >240 at Visit 3|0|||
160915825|NCT00372112|581083728|FG002|Overall Study|PR >240 at Visit 3|0|||
160915826|NCT00372112|581083729|FG003|Overall Study|PR >240 at Visit 3|1|||
160915827|NCT00372112|581083726|FG000|Overall Study|Hepatitis B|1|||
160915828|NCT00372112|581083727|FG001|Overall Study|Hepatitis B|0|||
160915829|NCT00372112|581083728|FG002|Overall Study|Hepatitis B|0|||
160915830|NCT00372112|581083729|FG003|Overall Study|Hepatitis B|0|||
160915831|NCT00372112|581083726|FG000|Overall Study|Other-protocol violation|0|||
160915832|NCT00372112|581083727|FG001|Overall Study|Other-protocol violation|0|||
160915833|NCT00372112|581083728|FG002|Overall Study|Other-protocol violation|1|||
160915834|NCT00372112|581083729|FG003|Overall Study|Other-protocol violation|0|||
160915835|NCT02927431|581083730|FG000|Overall Study|Withdrawal by Subject|0|||
160915836|NCT02927431|581083731|FG001|Overall Study|Withdrawal by Subject|0|||
160915837|NCT02927431|581083732|FG002|Overall Study|Withdrawal by Subject|1|||
160915838|NCT02205814|581083733|FG000|Overall Study|Lost to Follow-up|0|||
160915839|NCT02205814|581083734|FG001|Overall Study|Lost to Follow-up|0|||
160915840|NCT02205814|581083735|FG002|Overall Study|Lost to Follow-up|0|||
160915841|NCT02205814|581083736|FG003|Overall Study|Lost to Follow-up|1|||
160915842|NCT02205814|581083733|FG000|Overall Study|Lack of Efficacy|1|||
160915843|NCT02205814|581083734|FG001|Overall Study|Lack of Efficacy|0|||
160915844|NCT02205814|581083735|FG002|Overall Study|Lack of Efficacy|1|||
160915845|NCT02205814|581083736|FG003|Overall Study|Lack of Efficacy|1|||
160915846|NCT02205814|581083733|FG000|Overall Study|Physician Decision|0|||
160915847|NCT02205814|581083734|FG001|Overall Study|Physician Decision|0|||
160915848|NCT02205814|581083735|FG002|Overall Study|Physician Decision|1|||
160915849|NCT02205814|581083736|FG003|Overall Study|Physician Decision|0|||
160915850|NCT02205814|581083733|FG000|Overall Study|Protocol Violation|1|||
160915851|NCT02205814|581083734|FG001|Overall Study|Protocol Violation|0|||
160915852|NCT02205814|581083735|FG002|Overall Study|Protocol Violation|0|||
160915853|NCT02205814|581083736|FG003|Overall Study|Protocol Violation|1|||
160915854|NCT02205814|581083733|FG000|Overall Study|Withdrawal by Subject|0|||
160915855|NCT02205814|581083734|FG001|Overall Study|Withdrawal by Subject|1|||
160915856|NCT02205814|581083735|FG002|Overall Study|Withdrawal by Subject|2|||
160915857|NCT02205814|581083736|FG003|Overall Study|Withdrawal by Subject|1|||
160915858|NCT02205814|581083733|FG000|Overall Study|not compliant with study procedures|0|||
160915859|NCT02205814|581083734|FG001|Overall Study|not compliant with study procedures|0|||
160915860|NCT02205814|581083735|FG002|Overall Study|not compliant with study procedures|1|||
160915861|NCT02205814|581083736|FG003|Overall Study|not compliant with study procedures|0|||
160915862|NCT02246660|581083737|FG000|Overall Study|Withdrawal by Subject|0|||
160915863|NCT02246660|581083738|FG001|Overall Study|Withdrawal by Subject|1|||
160915864|NCT02246660|581083739|FG002|Overall Study|Withdrawal by Subject|0|||
160915865|NCT02246660|581083737|FG000|Overall Study|Death|0|||
160915866|NCT02246660|581083738|FG001|Overall Study|Death|0|||
160915867|NCT02246660|581083739|FG002|Overall Study|Death|1|||
160915868|NCT04952402|581083740|FG000|Overall Study|Lost to Follow-up|1|||
160915869|NCT04952402|581083741|FG001|Overall Study|Lost to Follow-up|3|||
160996252|NCT04487080|581372176|FG001|Overall Study|Ongoing|297|||
160996253|NCT04487080|581372177|FG002|Overall Study|Ongoing|149|||
160996254|NCT01838200|581372178|FG000|Overall Study|Adverse Event|0|||
161256683|NCT03649412|582318653|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161256684|NCT03649412|582318652|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
161256685|NCT03649412|582318653|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
161256686|NCT03649412|582318652|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
161256687|NCT03649412|582318653|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
161256688|NCT03649412|582318652|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
161256689|NCT03649412|582318653|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
161256690|NCT03095118|582318654|FG000|Overall Study|Adverse Event|1|||
161256691|NCT03095118|582318654|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
161256692|NCT02865395|582318655|FG000|Overall Study|Physician Decision|6|||
161256693|NCT02865395|582318656|FG001|Overall Study|Physician Decision|10|||
161256694|NCT02865395|582318657|FG002|Overall Study|Physician Decision|7|||
161256695|NCT00530348|582318658|FG000|Overall Study|Adverse Event|5|||
161256696|NCT00530348|582318659|FG001|Overall Study|Adverse Event|1|||
161256697|NCT00530348|582318658|FG000|Overall Study|Death|0|||
160915870|NCT04952402|581083740|FG000|Overall Study|Lack Of Venous Access|0|||
161256698|NCT00530348|582318659|FG001|Overall Study|Death|1|||
161256699|NCT00530348|582318658|FG000|Overall Study|Lack of Efficacy|2|||
160915871|NCT04952402|581083741|FG001|Overall Study|Lack Of Venous Access|1|||
160915872|NCT00143403|581083742|FG000|Overall Study|Adverse Event|3|||
160915873|NCT00143403|581083743|FG001|Overall Study|Adverse Event|8|||
160915874|NCT00143403|581083742|FG000|Overall Study|Death|1|||
160915875|NCT00143403|581083743|FG001|Overall Study|Death|0|||
160915876|NCT00143403|581083742|FG000|Overall Study|Withdrawal by Subject|3|||
160915877|NCT00143403|581083743|FG001|Overall Study|Withdrawal by Subject|12|||
160915878|NCT00143403|581083742|FG000|Overall Study|Relapse|15|||
160915879|NCT00143403|581083743|FG001|Overall Study|Relapse|7|||
160996255|NCT01838200|581372179|FG001|Overall Study|Adverse Event|2|||
161256700|NCT00530348|582318659|FG001|Overall Study|Lack of Efficacy|0|||
161256701|NCT00530348|582318658|FG000|Overall Study|Lost to Follow-up|0|||
161256702|NCT00530348|582318659|FG001|Overall Study|Lost to Follow-up|2|||
161256703|NCT00530348|582318658|FG000|Overall Study|Physician Decision|1|||
161256704|NCT00530348|582318659|FG001|Overall Study|Physician Decision|2|||
161256705|NCT00530348|582318658|FG000|Overall Study|Pregnancy|1|||
161256706|NCT00530348|582318659|FG001|Overall Study|Pregnancy|0|||
161256707|NCT00530348|582318658|FG000|Overall Study|Withdrawal by Subject|12|||
161256708|NCT00530348|582318659|FG001|Overall Study|Withdrawal by Subject|12|||
161256709|NCT00530348|582318658|FG000|Overall Study|Randomised in error|1|||
161256710|NCT00530348|582318659|FG001|Overall Study|Randomised in error|0|||
161256711|NCT00530348|582318658|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
161256712|NCT00530348|582318659|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
161256713|NCT04364763|582318660|FG000|Overall Study|Death|1|||
161256714|NCT04364763|582318661|FG001|Overall Study|Death|2|||
161256715|NCT04364763|582318660|FG000|Overall Study|Lost to Follow-up|1|||
161256716|NCT04364763|582318661|FG001|Overall Study|Lost to Follow-up|0|||
161256717|NCT01256060|582318663|FG000|Overall Study|Lost to Follow-up|0|||
161256718|NCT01256060|582318664|FG001|Overall Study|Lost to Follow-up|1|||
161256719|NCT01256060|582318665|FG002|Overall Study|Lost to Follow-up|0|||
161256720|NCT01256060|582318666|FG003|Overall Study|Lost to Follow-up|0|||
161256721|NCT00985231|582318669|FG000|Overall Study|ineligible|1|||
161256722|NCT00985231|582318670|FG001|Overall Study|ineligible|0|||
161256723|NCT00985231|582318669|FG000|Overall Study|Protocol Violation|1|||
161256724|NCT00985231|582318670|FG001|Overall Study|Protocol Violation|0|||
161256725|NCT00985231|582318669|FG000|Overall Study|Withdrawal by Subject|1|||
161256726|NCT00985231|582318670|FG001|Overall Study|Withdrawal by Subject|0|||
161256727|NCT00985231|582318669|FG000|Overall Study|Lost to Follow-up|0|||
161256728|NCT00985231|582318670|FG001|Overall Study|Lost to Follow-up|1|||
161256729|NCT00985231|582318669|FG000|Overall Study|Study related symptoms & complaints|0|||
160915880|NCT00143403|581083742|FG000|Overall Study|Protocol Violation|2|||
160915881|NCT00143403|581083743|FG001|Overall Study|Protocol Violation|2|||
160915882|NCT00143403|581083742|FG000|Overall Study|specified by site|4|||
160915883|NCT00143403|581083743|FG001|Overall Study|specified by site|9|||
160915884|NCT00143403|581083742|FG000|Overall Study|Randomized Not Treated|7|||
160915885|NCT00143403|581083743|FG001|Overall Study|Randomized Not Treated|8|||
160915886|NCT00587639|581083744|FG000|Overall Study|Withdrawal by Subject|1|||
160915887|NCT01442675|581083745|FG000|Overall Study|Protocol Violation|6|||
160915888|NCT01442675|581083745|FG000|Overall Study|Lost to Follow-up|2|||
160915889|NCT01442675|581083745|FG000|Overall Study|Withdrawal by Subject|4|||
160915890|NCT01574612|581083750|FG000|Overall Study|Adverse Event|3|||
160915891|NCT01574612|581083750|FG000|Overall Study|non compliant with drug|2|||
160915892|NCT01574612|581083750|FG000|Overall Study|Withdrawal by Subject|1|||
160915893|NCT01574612|581083750|FG000|Overall Study|Lost to Follow-up|2|||
160915894|NCT02859454|581083751|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
160915895|NCT02452398|581083756|FG000|Overall Study|Adverse Event|1|||
160915896|NCT02452398|581083756|FG000|Overall Study|Lost to Follow-up|28|||
160915897|NCT02452398|581083756|FG000|Overall Study|Physician Decision|2|||
160915898|NCT02452398|581083756|FG000|Overall Study|Withdrawal by Subject|6|||
160915899|NCT02452398|581083756|FG000|Overall Study|Moved away|4|||
160915900|NCT03944954|581083757|FG000|Overall Study|Withdrawal by Subject|22|||
160915901|NCT03944954|581083758|FG001|Overall Study|Withdrawal by Subject|4|||
160915902|NCT03944954|581083757|FG000|Overall Study|Lost to Follow-up|18|||
160915903|NCT03944954|581083758|FG001|Overall Study|Lost to Follow-up|0|||
160915904|NCT03944954|581083757|FG000|Overall Study|Failed Medical Screening|7|||
160915905|NCT03944954|581083758|FG001|Overall Study|Failed Medical Screening|0|||
160915906|NCT02505867|581083759|FG000|Overall Study|Lack of Efficacy|6|||
160915907|NCT02505867|581083760|FG001|Overall Study|Lack of Efficacy|6|||
160915908|NCT01605877|581083776|FG000|Overall Study|Withdrawal by Subject|1|||
160915909|NCT02547454|581083780|FG000|Overall Study|Due to hemodialysis|53|||
160915910|NCT02547454|581083780|FG000|Overall Study|Due to transplantation|1|||
160915911|NCT02547454|581083780|FG000|Overall Study|Due to no further need to treat|4|||
160915912|NCT02547454|581083780|FG000|Overall Study|Death|38|||
160915913|NCT02547454|581083780|FG000|Overall Study|Lost to Follow-up|26|||
160915914|NCT02547454|581083780|FG000|Overall Study|Other|39|||
160915915|NCT02547454|581083780|FG000|Overall Study|No data|11|||
160915916|NCT01428453|581083783|FG000|Overall Study|Adverse Event|2|||
160915917|NCT01428453|581083784|FG001|Overall Study|Adverse Event|7|||
160915918|NCT01428453|581083783|FG000|Overall Study|Protocol Violation|1|||
160915919|NCT01428453|581083784|FG001|Overall Study|Protocol Violation|0|||
160915920|NCT01428453|581083783|FG000|Overall Study|Lost to Follow-up|0|||
160915921|NCT01428453|581083784|FG001|Overall Study|Lost to Follow-up|1|||
160915922|NCT01428453|581083783|FG000|Overall Study|Withdrawal by Subject|3|||
161256730|NCT00985231|582318670|FG001|Overall Study|Study related symptoms & complaints|2|||
161256731|NCT01009515|582318671|FG000|Overall Study|Withdrawal by Subject|3|||
161256732|NCT01501110|582318674|FG000|Overall Study|Death|0|||
161256733|NCT01501110|582318675|FG001|Overall Study|Death|1|||
161256734|NCT02075606|582318679|FG000|Overall Study|Adverse Event|5|||
161256735|NCT02075606|582318679|FG000|Overall Study|Withdrawal by Subject|1|||
160996256|NCT01838200|581372178|FG000|Overall Study|Progressive disease|3|||
160996257|NCT01838200|581372179|FG001|Overall Study|Progressive disease|0|||
160996258|NCT03105336|581372180|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
160996259|NCT03105336|581372181|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
160996260|NCT03105336|581372180|FG000|Overall Study|Death|40|||
160996261|NCT03105336|581372181|FG001|Overall Study|Death|8|||
160996262|NCT03105336|581372180|FG000|Overall Study|Lost to Follow-up|13|||
160996263|NCT03105336|581372181|FG001|Overall Study|Lost to Follow-up|2|||
160996264|NCT03105336|581372180|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
160996265|NCT03105336|581372181|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
161256736|NCT02075606|582318679|FG000|Overall Study|Death|1|||
161256737|NCT02075606|582318679|FG000|Overall Study|Investigator's decision|1|||
161256738|NCT02075606|582318679|FG000|Overall Study|Symptom management|1|||
161256739|NCT02075606|582318679|FG000|Overall Study|Increasing Symptoms|1|||
161256740|NCT00983476|582318680|FG000|Overall Study|Did not receive intervention|17|||
160996266|NCT03105336|581372180|FG000|Overall Study|Reason Not Specified|3|||
160996267|NCT03105336|581372181|FG001|Overall Study|Reason Not Specified|3|||
160996268|NCT03105336|581372180|FG000|Overall Study|Investigator Decision|3|||
160996269|NCT03105336|581372181|FG001|Overall Study|Investigator Decision|0|||
160996270|NCT03451851|581372182|FG000|PCP: Week 0 -16|Adverse Event|1|||
160996271|NCT03451851|581372183|FG001|PCP: Week 0 -16|Adverse Event|0|||
160996272|NCT03451851|581372184|FG002|PCP: Week 0 -16|Adverse Event|0|||
161256741|NCT00983476|582318681|FG001|Overall Study|Did not receive intervention|22|||
161256742|NCT00983476|582318682|FG002|Overall Study|Did not receive intervention|0|||
161256743|NCT01439724|582318684|FG000|Overall Study|missing consultation|9|||
161256744|NCT01439724|582318685|FG001|Overall Study|missing consultation|8|||
161256745|NCT00575380|582318690|FG000|Overall Study|Withdrawal by Subject|1|||
161256746|NCT00575380|582318691|FG001|Overall Study|Withdrawal by Subject|0|||
161256747|NCT00575380|582318690|FG000|Overall Study|Adverse Event|0|||
161256748|NCT00575380|582318691|FG001|Overall Study|Adverse Event|1|||
161256749|NCT00575380|582318690|FG000|Overall Study|Various|0|||
161256750|NCT00575380|582318691|FG001|Overall Study|Various|2|||
161256751|NCT04019054|582318692|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
161256752|NCT04019054|582318693|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
161256753|NCT04019054|582318692|FG000|Overall Study|Withdrawal by Subject|3|||
161256754|NCT04019054|582318693|FG001|Overall Study|Withdrawal by Subject|1|||
161256755|NCT01040793|582318694|FG000|Overall Study|Adverse Event|5|||
161256756|NCT01040793|582318695|FG001|Overall Study|Adverse Event|3|||
161256757|NCT01040793|582318696|FG002|Overall Study|Adverse Event|0|||
161256758|NCT01040793|582318697|FG003|Overall Study|Adverse Event|2|||
161256759|NCT01040793|582318698|FG004|Overall Study|Adverse Event|2|||
161256760|NCT01040793|582318699|FG005|Overall Study|Adverse Event|1|||
161256761|NCT01040793|582318694|FG000|Overall Study|Protocol Violation|1|||
161256762|NCT01040793|582318695|FG001|Overall Study|Protocol Violation|1|||
161256763|NCT01040793|582318696|FG002|Overall Study|Protocol Violation|1|||
161256764|NCT01040793|582318697|FG003|Overall Study|Protocol Violation|0|||
161256765|NCT01040793|582318698|FG004|Overall Study|Protocol Violation|1|||
161256766|NCT01040793|582318699|FG005|Overall Study|Protocol Violation|0|||
161256767|NCT01040793|582318694|FG000|Overall Study|Lost to Follow-up|0|||
161256768|NCT01040793|582318695|FG001|Overall Study|Lost to Follow-up|1|||
161256769|NCT01040793|582318696|FG002|Overall Study|Lost to Follow-up|1|||
161256770|NCT01040793|582318697|FG003|Overall Study|Lost to Follow-up|0|||
161256771|NCT01040793|582318698|FG004|Overall Study|Lost to Follow-up|0|||
161256772|NCT01040793|582318699|FG005|Overall Study|Lost to Follow-up|0|||
161256773|NCT01040793|582318694|FG000|Overall Study|Withdrawal by Subject|0|||
161256774|NCT01040793|582318695|FG001|Overall Study|Withdrawal by Subject|0|||
161256775|NCT01040793|582318696|FG002|Overall Study|Withdrawal by Subject|0|||
161256776|NCT01040793|582318697|FG003|Overall Study|Withdrawal by Subject|2|||
161256777|NCT01040793|582318698|FG004|Overall Study|Withdrawal by Subject|0|||
161256778|NCT01040793|582318699|FG005|Overall Study|Withdrawal by Subject|0|||
161256779|NCT01040793|582318694|FG000|Overall Study|Other reasons not listed above|0|||
161256780|NCT01040793|582318695|FG001|Overall Study|Other reasons not listed above|0|||
160996273|NCT03451851|581372185|FG003|PCP: Week 0 -16|Adverse Event|0|||
160996274|NCT03451851|581372186|FG004|PCP: Week 0 -16|Adverse Event|0|||
160996275|NCT03451851|581372187|FG005|PCP: Week 0 -16|Adverse Event|0|||
160996276|NCT03451851|581372188|FG006|PCP: Week 0 -16|Adverse Event|1|||
160996277|NCT03451851|581372189|FG007|PCP: Week 0 -16|Adverse Event|0|||
160996278|NCT03451851|581372182|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
161256781|NCT01040793|582318696|FG002|Overall Study|Other reasons not listed above|1|||
161256782|NCT01040793|582318697|FG003|Overall Study|Other reasons not listed above|0|||
161256783|NCT01040793|582318698|FG004|Overall Study|Other reasons not listed above|1|||
161256784|NCT01040793|582318699|FG005|Overall Study|Other reasons not listed above|0|||
161256785|NCT02412722|582318704|FG000|Overall Study|Adverse Event|0|||
161256786|NCT02412722|582318705|FG001|Overall Study|Adverse Event|2|||
161256787|NCT02412722|582318706|FG002|Overall Study|Adverse Event|0|||
161256788|NCT02412722|582318707|FG003|Overall Study|Adverse Event|3|||
161256789|NCT02412722|582318708|FG004|Overall Study|Adverse Event|0|||
161256790|NCT02412722|582318709|FG005|Overall Study|Adverse Event|3|||
161256791|NCT02412722|582318704|FG000|Overall Study|Progressive Disease|6|||
161256792|NCT02412722|582318705|FG001|Overall Study|Progressive Disease|4|||
161256793|NCT02412722|582318706|FG002|Overall Study|Progressive Disease|4|||
161256794|NCT02412722|582318707|FG003|Overall Study|Progressive Disease|9|||
161256795|NCT02412722|582318708|FG004|Overall Study|Progressive Disease|3|||
161256796|NCT02412722|582318709|FG005|Overall Study|Progressive Disease|3|||
161256797|NCT02412722|582318704|FG000|Overall Study|Withdrawal by Subject|2|||
161256798|NCT02412722|582318705|FG001|Overall Study|Withdrawal by Subject|0|||
161256799|NCT02412722|582318706|FG002|Overall Study|Withdrawal by Subject|1|||
161256800|NCT02412722|582318707|FG003|Overall Study|Withdrawal by Subject|2|||
161256801|NCT02412722|582318708|FG004|Overall Study|Withdrawal by Subject|1|||
161256802|NCT02412722|582318709|FG005|Overall Study|Withdrawal by Subject|1|||
161256803|NCT02412722|582318704|FG000|Overall Study|Lost to Follow-up|0|||
161256804|NCT02412722|582318705|FG001|Overall Study|Lost to Follow-up|0|||
161256805|NCT02412722|582318706|FG002|Overall Study|Lost to Follow-up|0|||
161256806|NCT02412722|582318707|FG003|Overall Study|Lost to Follow-up|0|||
161256807|NCT02412722|582318708|FG004|Overall Study|Lost to Follow-up|1|||
161256808|NCT02412722|582318709|FG005|Overall Study|Lost to Follow-up|0|||
161256809|NCT02412722|582318704|FG000|Overall Study|Received drug in run-in and discontinued|0|||
161339260|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339261|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339262|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339263|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339264|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
161339265|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
161339266|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339267|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
161339268|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339269|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
161339270|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339271|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339272|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339273|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339274|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
161339275|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339276|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
161339277|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
161339278|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339279|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
161339280|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161339281|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161339282|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161339283|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161339284|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161339285|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161339286|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
161339287|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
161339288|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
161339289|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
160915923|NCT01428453|581083784|FG001|Overall Study|Withdrawal by Subject|1|||
161256810|NCT02412722|582318705|FG001|Overall Study|Received drug in run-in and discontinued|2|||
161256811|NCT02412722|582318706|FG002|Overall Study|Received drug in run-in and discontinued|0|||
160915924|NCT01996709|581083785|FG000|Overall Study|Withdrawal by Subject|1|||
160915925|NCT01996709|581083786|FG001|Overall Study|Withdrawal by Subject|0|||
160915926|NCT01996709|581083785|FG000|Overall Study|Lost to Follow-up|3|||
161142660|NCT03519178|581906195|FG007|Fulvestrant. Treatment|Other|0|||
161339290|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339291|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339292|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339293|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339294|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
161339295|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339296|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339297|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339298|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
160915927|NCT01996709|581083786|FG001|Overall Study|Lost to Follow-up|0|||
160915928|NCT01996709|581083785|FG000|Overall Study|Subject Non-Compliant|1|||
161256812|NCT02412722|582318707|FG003|Overall Study|Received drug in run-in and discontinued|0|||
160915929|NCT01996709|581083786|FG001|Overall Study|Subject Non-Compliant|0|||
160915930|NCT01996709|581083785|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
160915931|NCT01996709|581083786|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
160915932|NCT01482884|581083787|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
160915933|NCT01482884|581083788|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
160915934|NCT01482884|581083787|FG000|Overall Study|Protocol Violation|1|||
160915935|NCT01482884|581083788|FG001|Overall Study|Protocol Violation|0|||
160915936|NCT01482884|581083787|FG000|Overall Study|Lost to Follow-up|2|||
160915937|NCT01482884|581083788|FG001|Overall Study|Lost to Follow-up|2|||
160915938|NCT01482884|581083787|FG000|Overall Study|Lack of Efficacy|0|||
160915939|NCT01482884|581083788|FG001|Overall Study|Lack of Efficacy|1|||
160915940|NCT01482884|581083787|FG000|Overall Study|Adverse Event|2|||
160915941|NCT01482884|581083788|FG001|Overall Study|Adverse Event|1|||
160915942|NCT01482884|581083787|FG000|Overall Study|Withdrawal by Subject|8|||
160915943|NCT01482884|581083788|FG001|Overall Study|Withdrawal by Subject|13|||
160915944|NCT04102020|581083789|FG000|Overall Study|Adverse Event|1|||
160915945|NCT04102020|581083790|FG001|Overall Study|Adverse Event|0|||
160915946|NCT04102020|581083791|FG002|Overall Study|Adverse Event|0|||
160915947|NCT04102020|581083792|FG003|Overall Study|Adverse Event|1|||
160915948|NCT04102020|581083793|FG004|Overall Study|Adverse Event|0|||
160915949|NCT04102020|581083789|FG000|Overall Study|Withdrawal by Subject|0|||
160915950|NCT04102020|581083790|FG001|Overall Study|Withdrawal by Subject|1|||
160915951|NCT04102020|581083791|FG002|Overall Study|Withdrawal by Subject|1|||
160915952|NCT04102020|581083792|FG003|Overall Study|Withdrawal by Subject|1|||
160915953|NCT04102020|581083793|FG004|Overall Study|Withdrawal by Subject|1|||
160915954|NCT04102020|581083789|FG000|Overall Study|Death|1|||
161256813|NCT02412722|582318708|FG004|Overall Study|Received drug in run-in and discontinued|0|||
161256814|NCT02412722|582318709|FG005|Overall Study|Received drug in run-in and discontinued|0|||
161256815|NCT02412722|582318704|FG000|Overall Study|Reason not Specified|3|||
161256816|NCT02412722|582318705|FG001|Overall Study|Reason not Specified|0|||
161256817|NCT02412722|582318706|FG002|Overall Study|Reason not Specified|2|||
161256818|NCT02412722|582318707|FG003|Overall Study|Reason not Specified|1|||
161256819|NCT02412722|582318708|FG004|Overall Study|Reason not Specified|2|||
161256820|NCT02412722|582318709|FG005|Overall Study|Reason not Specified|6|||
161256821|NCT00124462|582318710|FG000|Overall Study|Lost to Follow-up|3|||
161256822|NCT00124462|582318711|FG001|Overall Study|Lost to Follow-up|3|||
161256823|NCT00124462|582318710|FG000|Overall Study|Physician Decision|3|||
161256824|NCT00124462|582318711|FG001|Overall Study|Physician Decision|4|||
161256825|NCT00124462|582318710|FG000|Overall Study|Withdrawal by Subject|4|||
161256826|NCT00124462|582318711|FG001|Overall Study|Withdrawal by Subject|5|||
161256827|NCT00124462|582318710|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
161256828|NCT00124462|582318711|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
161256829|NCT02400476|582318712|FG000|Overall Study|Adverse Event|57|||
161256830|NCT02400476|582318713|FG001|Overall Study|Adverse Event|10|||
161256831|NCT02400476|582318714|FG002|Overall Study|Adverse Event|22|||
161256832|NCT02400476|582318715|FG003|Overall Study|Adverse Event|19|||
161256833|NCT02400476|582318716|FG004|Overall Study|Adverse Event|5|||
161256834|NCT02400476|582318717|FG005|Overall Study|Adverse Event|8|||
161256835|NCT02400476|582318712|FG000|Overall Study|Withdrawal by Subject|4|||
161256836|NCT02400476|582318713|FG001|Overall Study|Withdrawal by Subject|1|||
161256837|NCT02400476|582318714|FG002|Overall Study|Withdrawal by Subject|12|||
161256838|NCT02400476|582318715|FG003|Overall Study|Withdrawal by Subject|7|||
161256839|NCT02400476|582318716|FG004|Overall Study|Withdrawal by Subject|5|||
161256840|NCT02400476|582318717|FG005|Overall Study|Withdrawal by Subject|5|||
161256841|NCT02400476|582318712|FG000|Overall Study|Lost to Follow-up|0|||
161256842|NCT02400476|582318713|FG001|Overall Study|Lost to Follow-up|0|||
161256843|NCT02400476|582318714|FG002|Overall Study|Lost to Follow-up|0|||
161256844|NCT02400476|582318715|FG003|Overall Study|Lost to Follow-up|1|||
161256845|NCT02400476|582318716|FG004|Overall Study|Lost to Follow-up|3|||
161256846|NCT02400476|582318717|FG005|Overall Study|Lost to Follow-up|1|||
160861635|NCT04225897|580887796|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861636|NCT04225897|580887797|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
160861637|NCT04225897|580887786|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861638|NCT04225897|580887787|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861639|NCT04225897|580887788|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
160861640|NCT04225897|580887789|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861641|NCT04225897|580887790|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861642|NCT04225897|580887791|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861643|NCT04225897|580887792|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861644|NCT04225897|580887793|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160915955|NCT04102020|581083790|FG001|Overall Study|Death|4|||
160915956|NCT04102020|581083791|FG002|Overall Study|Death|1|||
161256847|NCT02400476|582318712|FG000|Overall Study|Physician Decision|0|||
161256848|NCT02400476|582318713|FG001|Overall Study|Physician Decision|0|||
161256849|NCT02400476|582318714|FG002|Overall Study|Physician Decision|1|||
161256850|NCT02400476|582318715|FG003|Overall Study|Physician Decision|1|||
161256851|NCT02400476|582318716|FG004|Overall Study|Physician Decision|0|||
161256852|NCT02400476|582318717|FG005|Overall Study|Physician Decision|1|||
161256853|NCT02400476|582318712|FG000|Overall Study|Other, Disease Progression|0|||
161256854|NCT02400476|582318713|FG001|Overall Study|Other, Disease Progression|1|||
161256855|NCT02400476|582318714|FG002|Overall Study|Other, Disease Progression|2|||
161256856|NCT02400476|582318715|FG003|Overall Study|Other, Disease Progression|1|||
160915957|NCT04102020|581083792|FG003|Overall Study|Death|1|||
160915958|NCT04102020|581083793|FG004|Overall Study|Death|0|||
160915959|NCT04102020|581083789|FG000|Overall Study|Physician Decision|1|||
160915960|NCT04102020|581083790|FG001|Overall Study|Physician Decision|2|||
160915961|NCT04102020|581083791|FG002|Overall Study|Physician Decision|2|||
160915962|NCT04102020|581083792|FG003|Overall Study|Physician Decision|0|||
160915963|NCT04102020|581083793|FG004|Overall Study|Physician Decision|1|||
160915964|NCT04102020|581083789|FG000|Overall Study|COVID-19 Infection|1|||
160915965|NCT04102020|581083790|FG001|Overall Study|COVID-19 Infection|0|||
160915966|NCT04102020|581083791|FG002|Overall Study|COVID-19 Infection|0|||
160915967|NCT04102020|581083792|FG003|Overall Study|COVID-19 Infection|0|||
160915968|NCT04102020|581083793|FG004|Overall Study|COVID-19 Infection|0|||
160915969|NCT04102020|581083789|FG000|Overall Study|Not disclosed|5|||
160915970|NCT04102020|581083790|FG001|Overall Study|Not disclosed|3|||
160915971|NCT04102020|581083791|FG002|Overall Study|Not disclosed|8|||
160915972|NCT04102020|581083792|FG003|Overall Study|Not disclosed|0|||
160915973|NCT04102020|581083793|FG004|Overall Study|Not disclosed|1|||
160915974|NCT04102020|581083789|FG000|Overall Study|MIssing|1|||
160915975|NCT04102020|581083790|FG001|Overall Study|MIssing|0|||
160915976|NCT04102020|581083791|FG002|Overall Study|MIssing|1|||
160915977|NCT04102020|581083792|FG003|Overall Study|MIssing|1|||
160915978|NCT04102020|581083793|FG004|Overall Study|MIssing|1|||
160915979|NCT04102020|581083789|FG000|Overall Study|Continuing in ongoing study|13|||
160915980|NCT04102020|581083790|FG001|Overall Study|Continuing in ongoing study|13|||
160915981|NCT04102020|581083791|FG002|Overall Study|Continuing in ongoing study|7|||
160915982|NCT04102020|581083792|FG003|Overall Study|Continuing in ongoing study|26|||
160915983|NCT04102020|581083793|FG004|Overall Study|Continuing in ongoing study|12|||
160915984|NCT04853225|581083794|FG000|Overall Study|Withdrawal by Subject|81|||
160915985|NCT04853225|581083795|FG001|Overall Study|Withdrawal by Subject|4|||
160915986|NCT04853225|581083796|FG002|Overall Study|Withdrawal by Subject|1|||
160915987|NCT04853225|581083794|FG000|Overall Study|Physician Decision|12|||
160915988|NCT04853225|581083795|FG001|Overall Study|Physician Decision|4|||
160915989|NCT04853225|581083796|FG002|Overall Study|Physician Decision|1|||
160915990|NCT04853225|581083794|FG000|Overall Study|Lost to Follow-up|50|||
160915991|NCT04853225|581083795|FG001|Overall Study|Lost to Follow-up|0|||
160915992|NCT04853225|581083796|FG002|Overall Study|Lost to Follow-up|0|||
160915993|NCT04853225|581083794|FG000|Overall Study|Other|102|||
160915994|NCT04853225|581083795|FG001|Overall Study|Other|11|||
160915995|NCT04853225|581083796|FG002|Overall Study|Other|5|||
160915996|NCT04853225|581083794|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
161256857|NCT02400476|582318716|FG004|Overall Study|Other, Disease Progression|2|||
161256858|NCT02400476|582318717|FG005|Overall Study|Other, Disease Progression|1|||
161256859|NCT02400476|582318712|FG000|Overall Study|Other, Decreased Quality of Life|0|||
161256860|NCT02400476|582318713|FG001|Overall Study|Other, Decreased Quality of Life|0|||
161256861|NCT02400476|582318714|FG002|Overall Study|Other, Decreased Quality of Life|2|||
161256862|NCT02400476|582318715|FG003|Overall Study|Other, Decreased Quality of Life|0|||
161256863|NCT02400476|582318716|FG004|Overall Study|Other, Decreased Quality of Life|0|||
161256864|NCT02400476|582318717|FG005|Overall Study|Other, Decreased Quality of Life|0|||
161256865|NCT02400476|582318712|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161256866|NCT02400476|582318713|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161256867|NCT02400476|582318714|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
161256868|NCT02400476|582318715|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
161256869|NCT02400476|582318716|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161256870|NCT02400476|582318717|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
161256871|NCT00003531|582318718|FG000|Overall Study|Not evaluable|10|||
161256872|NCT02487082|582318719|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
161256873|NCT02487082|582318720|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
161256874|NCT02487082|582318719|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
161256875|NCT02487082|582318720|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
160915997|NCT04853225|581083795|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
160915998|NCT04853225|581083796|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
160915999|NCT04853225|581083794|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
160916000|NCT04853225|581083795|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
160916001|NCT04853225|581083796|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
160916002|NCT03789318|581083797|FG000|Overall Study|Adverse Event|0|||
160916003|NCT03789318|581083798|FG001|Overall Study|Adverse Event|0|||
161256876|NCT00588731|582318721|FG000|Overall Study|Withdrawal by Subject|3|||
160916004|NCT03789318|581083799|FG002|Overall Study|Adverse Event|1|||
161339299|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
161339300|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161339301|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161256877|NCT00588731|582318722|FG001|Overall Study|Withdrawal by Subject|2|||
161256878|NCT00346164|582318723|FG000|Overall Study|Adverse Event|0|||
161256879|NCT00346164|582318724|FG001|Overall Study|Adverse Event|0|||
161256880|NCT00346164|582318725|FG002|Overall Study|Adverse Event|0|||
161256881|NCT00346164|582318726|FG003|Overall Study|Adverse Event|1|||
161256882|NCT00346164|582318723|FG000|Overall Study|Lack of Efficacy|0|||
161256883|NCT00346164|582318724|FG001|Overall Study|Lack of Efficacy|1|||
161256884|NCT00346164|582318725|FG002|Overall Study|Lack of Efficacy|7|||
161256885|NCT00346164|582318726|FG003|Overall Study|Lack of Efficacy|25|||
161256886|NCT00346164|582318723|FG000|Overall Study|Physician Decision|0|||
161256887|NCT00346164|582318724|FG001|Overall Study|Physician Decision|1|||
161256888|NCT00346164|582318725|FG002|Overall Study|Physician Decision|2|||
161256889|NCT00346164|582318726|FG003|Overall Study|Physician Decision|27|||
161256890|NCT00346164|582318723|FG000|Overall Study|Protocol Violation|6|||
161256891|NCT00346164|582318724|FG001|Overall Study|Protocol Violation|2|||
161256892|NCT00346164|582318725|FG002|Overall Study|Protocol Violation|10|||
161256893|NCT00346164|582318726|FG003|Overall Study|Protocol Violation|4|||
161256894|NCT00346164|582318723|FG000|Overall Study|Withdrawal by Subject|0|||
161256895|NCT00346164|582318724|FG001|Overall Study|Withdrawal by Subject|0|||
161256896|NCT00346164|582318725|FG002|Overall Study|Withdrawal by Subject|2|||
161256897|NCT00346164|582318726|FG003|Overall Study|Withdrawal by Subject|0|||
161256898|NCT00346164|582318723|FG000|Overall Study|Ineligible|11|||
161256899|NCT00346164|582318724|FG001|Overall Study|Ineligible|2|||
161256900|NCT00346164|582318725|FG002|Overall Study|Ineligible|2|||
161256901|NCT00346164|582318726|FG003|Overall Study|Ineligible|23|||
161256902|NCT00346164|582318723|FG000|Overall Study|Refusal of further protocol therapy|0|||
161256903|NCT00346164|582318724|FG001|Overall Study|Refusal of further protocol therapy|1|||
161256904|NCT00346164|582318725|FG002|Overall Study|Refusal of further protocol therapy|3|||
161256905|NCT00346164|582318726|FG003|Overall Study|Refusal of further protocol therapy|15|||
161256906|NCT00346164|582318723|FG000|Overall Study|Inability to start week 16 tx on time|0|||
161256907|NCT00346164|582318724|FG001|Overall Study|Inability to start week 16 tx on time|0|||
161256908|NCT00346164|582318725|FG002|Overall Study|Inability to start week 16 tx on time|0|||
161256909|NCT00346164|582318726|FG003|Overall Study|Inability to start week 16 tx on time|11|||
161256910|NCT01684878|582318730|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
161256911|NCT01684878|582318731|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
161256912|NCT01684878|582318732|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
161256913|NCT01684878|582318733|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
161256914|NCT01684878|582318730|FG000|Part 1: Safety Run in Phase|Death|15|||
161256915|NCT01684878|582318731|FG001|Part 1: Safety Run in Phase|Death|20|||
161256916|NCT01684878|582318732|FG002|Part 1: Safety Run in Phase|Death|0|||
161256917|NCT01684878|582318733|FG003|Part 1: Safety Run in Phase|Death|0|||
161256918|NCT01684878|582318730|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161256919|NCT01684878|582318731|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
161256920|NCT01684878|582318732|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161256921|NCT01684878|582318733|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
161256922|NCT01684878|582318730|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
161256923|NCT01684878|582318731|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
161256924|NCT01684878|582318732|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
161256925|NCT01684878|582318733|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
161256926|NCT01684878|582318730|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
161256927|NCT01684878|582318731|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
161339302|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161339303|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161339304|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
161339305|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161339306|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
161339307|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
161339308|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161339309|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
161339310|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339311|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161256928|NCT01684878|582318732|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
161256929|NCT01684878|582318733|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
161256930|NCT01684878|582318730|FG000|Part 2: Randomized Phase|Death|0|||
161256931|NCT01684878|582318731|FG001|Part 2: Randomized Phase|Death|0|||
161256932|NCT01684878|582318732|FG002|Part 2: Randomized Phase|Death|62|||
161256933|NCT01684878|582318733|FG003|Part 2: Randomized Phase|Death|68|||
161256934|NCT01684878|582318730|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
161256935|NCT01684878|582318731|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
161256936|NCT01684878|582318732|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
161256937|NCT01684878|582318733|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
161256938|NCT01684878|582318730|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
161256939|NCT01684878|582318731|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
161256940|NCT01684878|582318732|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
161256941|NCT01684878|582318733|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
161256942|NCT02087176|582318734|FG000|Overall Study|Withdrawal by Subject|1|||
161256943|NCT02087176|582318734|FG000|Overall Study|Death|10|||
161256944|NCT02087176|582318734|FG000|Overall Study|Censored|19|||
161256945|NCT02087176|582318734|FG000|Overall Study|Study Terminated by Sponsor|2|||
161256946|NCT02927834|582318735|FG000|Overall Study|Lost to Follow-up|1|||
161256947|NCT02927834|582318736|FG001|Overall Study|Lost to Follow-up|2|||
161256948|NCT02927834|582318737|FG002|Overall Study|Lost to Follow-up|2|||
161256949|NCT03812991|582318739|FG000|Overall Study|Lost to Follow-up|3|||
161339312|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339313|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339314|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339315|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339316|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339317|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
161339318|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339319|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
161339320|NCT01232283|582630420|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339321|NCT01232283|582630421|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339322|NCT01232283|582630422|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339323|NCT01232283|582630423|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339324|NCT01232283|582630424|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339325|NCT01232283|582630425|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
161339326|NCT01232283|582630426|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339327|NCT01232283|582630427|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161256950|NCT03812991|582318740|FG001|Overall Study|Lost to Follow-up|1|||
161256951|NCT03942211|582318741|FG000|Overall Study|Death|1|||
161256952|NCT03942211|582318742|FG001|Overall Study|Death|0|||
161256953|NCT03942211|582318741|FG000|Overall Study|Study terminated by sponsor|5|||
160916005|NCT03789318|581083800|FG003|Overall Study|Adverse Event|1|||
161256954|NCT03942211|582318742|FG001|Overall Study|Study terminated by sponsor|3|||
160916006|NCT03789318|581083801|FG004|Overall Study|Adverse Event|0|||
160916007|NCT03789318|581083797|FG000|Overall Study|Lost to Follow-up|0|||
160916008|NCT03789318|581083798|FG001|Overall Study|Lost to Follow-up|0|||
160916009|NCT03789318|581083799|FG002|Overall Study|Lost to Follow-up|1|||
160916010|NCT03789318|581083800|FG003|Overall Study|Lost to Follow-up|0|||
160916011|NCT03789318|581083801|FG004|Overall Study|Lost to Follow-up|0|||
160916012|NCT03789318|581083797|FG000|Overall Study|Withdrawal by Subject|0|||
160916013|NCT03789318|581083798|FG001|Overall Study|Withdrawal by Subject|0|||
160916014|NCT03789318|581083799|FG002|Overall Study|Withdrawal by Subject|1|||
160916015|NCT03789318|581083800|FG003|Overall Study|Withdrawal by Subject|0|||
160916016|NCT03789318|581083801|FG004|Overall Study|Withdrawal by Subject|0|||
160916017|NCT00477971|581083802|FG000|Overall Study|Disease progression|6|||
160916018|NCT00477971|581083803|FG001|Overall Study|Disease progression|0|||
160916019|NCT00477971|581083802|FG000|Overall Study|Withdrawal by Subject|3|||
160916020|NCT00477971|581083803|FG001|Overall Study|Withdrawal by Subject|1|||
160916021|NCT00477971|581083802|FG000|Overall Study|Adverse Event|3|||
160916022|NCT00477971|581083803|FG001|Overall Study|Adverse Event|0|||
160916023|NCT00477971|581083802|FG000|Overall Study|Death|2|||
160916024|NCT00477971|581083803|FG001|Overall Study|Death|4|||
160916025|NCT00477971|581083802|FG000|Overall Study|Alternative treatment|3|||
160916026|NCT00477971|581083803|FG001|Overall Study|Alternative treatment|1|||
160916027|NCT01774968|581083804|FG000|Overall Study|Adverse Event|4|||
160916028|NCT01774968|581083805|FG001|Overall Study|Adverse Event|4|||
160916029|NCT01774968|581083804|FG000|Overall Study|Death|0|||
160916030|NCT01774968|581083805|FG001|Overall Study|Death|1|||
160916031|NCT01774968|581083804|FG000|Overall Study|Lost to Follow-up|1|||
160916032|NCT01774968|581083805|FG001|Overall Study|Lost to Follow-up|3|||
160916033|NCT01774968|581083804|FG000|Overall Study|Physician Decision|5|||
160916034|NCT01774968|581083805|FG001|Overall Study|Physician Decision|1|||
161256955|NCT03942211|582318741|FG000|Overall Study|Adverse Event|0|||
161339328|NCT01232283|582630428|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
160916035|NCT01774968|581083804|FG000|Overall Study|Protocol Violation|14|||
160916036|NCT01774968|581083805|FG001|Overall Study|Protocol Violation|13|||
160916037|NCT01774968|581083804|FG000|Overall Study|Sponsor Decision|0|||
160916038|NCT01774968|581083805|FG001|Overall Study|Sponsor Decision|2|||
160916039|NCT01774968|581083804|FG000|Overall Study|Withdrawal by Subject|6|||
161256956|NCT03942211|582318742|FG001|Overall Study|Adverse Event|1|||
161256957|NCT01955044|582318743|FG000|Overall Study|Death|1|||
161142327|NCT01480180|581906171|FG000|Extension Phase, Part 1|Change of treatment|0|||
161142328|NCT01480180|581906172|FG001|Extension Phase, Part 1|Change of treatment|0|||
161142329|NCT01480180|581906173|FG002|Extension Phase, Part 1|Change of treatment|0|||
161142330|NCT01480180|581906174|FG003|Extension Phase, Part 1|Change of treatment|9|||
161142331|NCT01480180|581906175|FG004|Extension Phase, Part 1|Change of treatment|0|||
161142332|NCT01480180|581906176|FG005|Extension Phase, Part 1|Change of treatment|0|||
161142333|NCT01480180|581906171|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
161142334|NCT01480180|581906172|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
161142335|NCT01480180|581906173|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
161142336|NCT01480180|581906174|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
161142337|NCT01480180|581906175|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
161142338|NCT01480180|581906176|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
161142339|NCT01480180|581906171|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
161142340|NCT01480180|581906172|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
161142341|NCT01480180|581906173|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
161142342|NCT01480180|581906174|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
161142343|NCT01480180|581906175|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
161142344|NCT01480180|581906176|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
161142345|NCT01480180|581906171|FG000|Extension Phase, Part 2|Unclassified|0|||
161142346|NCT01480180|581906172|FG001|Extension Phase, Part 2|Unclassified|0|||
161142347|NCT01480180|581906173|FG002|Extension Phase, Part 2|Unclassified|3|||
161142348|NCT01480180|581906174|FG003|Extension Phase, Part 2|Unclassified|1|||
161142349|NCT01480180|581906175|FG004|Extension Phase, Part 2|Unclassified|1|||
161142350|NCT01480180|581906176|FG005|Extension Phase, Part 2|Unclassified|0|||
161142351|NCT00519623|581906177|FG000|Overall Study|Adverse Event|1|||
161142352|NCT04222725|581906180|FG000|Overall Study|Adverse Event|0|||
161142353|NCT04222725|581906181|FG001|Overall Study|Adverse Event|1|||
161142354|NCT04222725|581906182|FG002|Overall Study|Adverse Event|0|||
161142355|NCT04222725|581906183|FG003|Overall Study|Adverse Event|0|||
161142356|NCT03819140|581906184|FG000|Overall Study|Lost to Follow-up|1|||
161256958|NCT01955044|582318744|FG001|Overall Study|Death|1|||
161256959|NCT01955044|582318745|FG002|Overall Study|Death|0|||
161256960|NCT01148225|582318746|FG000|Overall Study|Other|185|||
161256961|NCT00925301|582318750|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161256962|NCT00925301|582318751|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
161256963|NCT00925301|582318752|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161256964|NCT00925301|582318753|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
161256965|NCT00925301|582318750|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161256966|NCT00925301|582318751|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
161256967|NCT00925301|582318752|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161256968|NCT00925301|582318753|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
161256969|NCT00925301|582318750|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161256970|NCT00925301|582318751|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161256971|NCT00925301|582318752|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
161256972|NCT00925301|582318753|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
161256973|NCT00925301|582318750|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
161256974|NCT00925301|582318751|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
161256975|NCT00925301|582318752|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
161256976|NCT00925301|582318753|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
161256977|NCT00925301|582318750|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161256978|NCT00925301|582318751|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161256979|NCT00925301|582318752|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
161256980|NCT00925301|582318753|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
160916040|NCT01774968|581083805|FG001|Overall Study|Withdrawal by Subject|11|||
161142357|NCT03819140|581906185|FG001|Overall Study|Lost to Follow-up|2|||
161142358|NCT03819140|581906184|FG000|Overall Study|Withdrawal by Subject|3|||
161142359|NCT03819140|581906185|FG001|Overall Study|Withdrawal by Subject|2|||
161142360|NCT03819140|581906184|FG000|Overall Study|Adverse Event|0|||
161142361|NCT03819140|581906185|FG001|Overall Study|Adverse Event|1|||
161142362|NCT03819140|581906184|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
161142363|NCT03819140|581906185|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
161142364|NCT03819140|581906184|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
161142365|NCT03819140|581906185|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
161256981|NCT00925301|582318750|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161256982|NCT00925301|582318751|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161142366|NCT00658333|581906186|FG000|Overall Study|Adverse Event|2|||
161142367|NCT00658333|581906187|FG001|Overall Study|Adverse Event|1|||
161142368|NCT03519178|581906188|FG000|PF-06873600 Treatment|Adverse Event|0|||
161142369|NCT03519178|581906189|FG001|PF-06873600 Treatment|Adverse Event|0|||
161142370|NCT03519178|581906190|FG002|PF-06873600 Treatment|Adverse Event|0|||
161142371|NCT03519178|581906191|FG003|PF-06873600 Treatment|Adverse Event|0|||
161256983|NCT00925301|582318752|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
161256984|NCT00925301|582318753|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
161256985|NCT00925301|582318750|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161256986|NCT00925301|582318751|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161256987|NCT00925301|582318752|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
161256988|NCT00925301|582318753|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
161256989|NCT03043560|582318754|FG000|Overall Study|Discontinued Intervention|1|||
161256990|NCT03043560|582318755|FG001|Overall Study|Discontinued Intervention|2|||
160916041|NCT00407563|581085061|FG000|Overall Study|Patient continues on treatment|1|||
160916042|NCT01409564|581085062|FG000|Overall Study|low medication compliance|4|||
160916043|NCT01409564|581085063|FG001|Overall Study|low medication compliance|3|||
160916044|NCT01409564|581085062|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
160916045|NCT01409564|581085063|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
160916046|NCT05040386|581085064|FG000|Overall Study|Withdrawal by Subject|1|||
160916047|NCT05040386|581085065|FG001|Overall Study|Withdrawal by Subject|0|||
160916048|NCT05040386|581085066|FG002|Overall Study|Withdrawal by Subject|1|||
160916049|NCT05040386|581085067|FG003|Overall Study|Withdrawal by Subject|0|||
160916050|NCT05040386|581085064|FG000|Overall Study|Lost to Follow-up|0|||
160916051|NCT05040386|581085065|FG001|Overall Study|Lost to Follow-up|0|||
160916052|NCT05040386|581085066|FG002|Overall Study|Lost to Follow-up|1|||
160916053|NCT05040386|581085067|FG003|Overall Study|Lost to Follow-up|0|||
160916054|NCT02618434|581085070|FG000|Overall Study|Withdrawal by Subject|0|||
160916055|NCT02618434|581085071|FG001|Overall Study|Withdrawal by Subject|2|||
160916056|NCT02618434|581085072|FG002|Overall Study|Withdrawal by Subject|3|||
160916057|NCT02618434|581085070|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
160916058|NCT02618434|581085071|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
160916059|NCT02618434|581085072|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
160916060|NCT02618434|581085070|FG000|Overall Study|Lost to Follow-up|3|||
160916061|NCT02618434|581085071|FG001|Overall Study|Lost to Follow-up|1|||
160916062|NCT02618434|581085072|FG002|Overall Study|Lost to Follow-up|3|||
160916063|NCT02618434|581085070|FG000|Overall Study|Adverse Event|1|||
160916064|NCT02618434|581085071|FG001|Overall Study|Adverse Event|0|||
161256991|NCT03043560|582318754|FG000|Overall Study|Lost to Follow-up|0|||
161256992|NCT03043560|582318755|FG001|Overall Study|Lost to Follow-up|1|||
161256993|NCT00442546|582318756|FG000|Overall Study|Adverse Event|11|||
161256994|NCT00442546|582318757|FG001|Overall Study|Adverse Event|17|||
161256995|NCT00442546|582318758|FG002|Overall Study|Adverse Event|13|||
161256996|NCT00442546|582318756|FG000|Overall Study|Lost to Follow-up|1|||
161256997|NCT00442546|582318757|FG001|Overall Study|Lost to Follow-up|2|||
161256998|NCT00442546|582318758|FG002|Overall Study|Lost to Follow-up|1|||
161256999|NCT00442546|582318756|FG000|Overall Study|Other|4|||
161257000|NCT00442546|582318757|FG001|Overall Study|Other|9|||
161257001|NCT00442546|582318758|FG002|Overall Study|Other|6|||
161257002|NCT00442546|582318756|FG000|Overall Study|Withdrawal by Subject|5|||
160861645|NCT04225897|580887794|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861646|NCT04225897|580887795|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861647|NCT04225897|580887796|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861648|NCT04225897|580887797|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
160861649|NCT04225897|580887786|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861650|NCT04225897|580887787|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861651|NCT04225897|580887788|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861652|NCT04225897|580887789|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861653|NCT04225897|580887790|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861654|NCT04225897|580887791|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861655|NCT04225897|580887792|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861656|NCT04225897|580887793|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
160861657|NCT04225897|580887794|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861658|NCT04225897|580887795|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861659|NCT04225897|580887796|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861660|NCT04225897|580887797|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
160861661|NCT00074711|580887799|FG000|Overall Study|Withdrawal by Subject|1|||
160861662|NCT00074711|580887800|FG001|Overall Study|Withdrawal by Subject|1|||
160861663|NCT00074711|580887799|FG000|Overall Study|Lost to Follow-up|10|||
160861664|NCT00074711|580887800|FG001|Overall Study|Lost to Follow-up|8|||
160861665|NCT00074711|580887799|FG000|Overall Study|Participant stopped study drug|4|||
160861666|NCT00074711|580887800|FG001|Overall Study|Participant stopped study drug|6|||
160861667|NCT03466658|580887801|FG000|Overall Study|Withdrawal by Subject|3|||
160861668|NCT01921205|580887802|FG000|Overall Study|Adverse Event|12|||
160861669|NCT01921205|580887803|FG001|Overall Study|Adverse Event|7|||
160861670|NCT01921205|580887802|FG000|Overall Study|Lack of Efficacy|1|||
160916065|NCT02618434|581085072|FG002|Overall Study|Adverse Event|12|||
161257003|NCT00442546|582318757|FG001|Overall Study|Withdrawal by Subject|5|||
161142372|NCT03519178|581906192|FG004|PF-06873600 Treatment|Adverse Event|0|||
161142373|NCT03519178|581906193|FG005|PF-06873600 Treatment|Adverse Event|0|||
161142374|NCT03519178|581906194|FG006|PF-06873600 Treatment|Adverse Event|0|||
161142375|NCT03519178|581906195|FG007|PF-06873600 Treatment|Adverse Event|2|||
161142376|NCT03519178|581906196|FG008|PF-06873600 Treatment|Adverse Event|1|||
161142377|NCT03519178|581906197|FG009|PF-06873600 Treatment|Adverse Event|0|||
161142378|NCT03519178|581906198|FG010|PF-06873600 Treatment|Adverse Event|0|||
161142379|NCT03519178|581906199|FG011|PF-06873600 Treatment|Adverse Event|0|||
161142380|NCT03519178|581906200|FG012|PF-06873600 Treatment|Adverse Event|1|||
161142381|NCT03519178|581906201|FG013|PF-06873600 Treatment|Adverse Event|3|||
161142382|NCT03519178|581906202|FG014|PF-06873600 Treatment|Adverse Event|2|||
161142383|NCT03519178|581906188|FG000|PF-06873600 Treatment|Death|0|||
161142384|NCT03519178|581906189|FG001|PF-06873600 Treatment|Death|0|||
161142385|NCT03519178|581906190|FG002|PF-06873600 Treatment|Death|0|||
161142386|NCT03519178|581906191|FG003|PF-06873600 Treatment|Death|0|||
161142387|NCT03519178|581906192|FG004|PF-06873600 Treatment|Death|0|||
161142388|NCT03519178|581906193|FG005|PF-06873600 Treatment|Death|0|||
161142389|NCT03519178|581906194|FG006|PF-06873600 Treatment|Death|0|||
161142390|NCT03519178|581906195|FG007|PF-06873600 Treatment|Death|0|||
161142391|NCT03519178|581906196|FG008|PF-06873600 Treatment|Death|1|||
161142392|NCT03519178|581906197|FG009|PF-06873600 Treatment|Death|1|||
161142393|NCT03519178|581906198|FG010|PF-06873600 Treatment|Death|0|||
161142394|NCT03519178|581906199|FG011|PF-06873600 Treatment|Death|0|||
161142395|NCT03519178|581906200|FG012|PF-06873600 Treatment|Death|0|||
161142396|NCT03519178|581906201|FG013|PF-06873600 Treatment|Death|0|||
161142397|NCT03519178|581906202|FG014|PF-06873600 Treatment|Death|1|||
161142398|NCT03519178|581906188|FG000|PF-06873600 Treatment|Physician Decision|0|||
161142399|NCT03519178|581906189|FG001|PF-06873600 Treatment|Physician Decision|0|||
161142400|NCT03519178|581906190|FG002|PF-06873600 Treatment|Physician Decision|0|||
161142401|NCT03519178|581906191|FG003|PF-06873600 Treatment|Physician Decision|0|||
161142402|NCT03519178|581906192|FG004|PF-06873600 Treatment|Physician Decision|0|||
161142403|NCT03519178|581906193|FG005|PF-06873600 Treatment|Physician Decision|0|||
161142404|NCT03519178|581906194|FG006|PF-06873600 Treatment|Physician Decision|0|||
161142405|NCT03519178|581906195|FG007|PF-06873600 Treatment|Physician Decision|1|||
161142406|NCT03519178|581906196|FG008|PF-06873600 Treatment|Physician Decision|0|||
161142407|NCT03519178|581906197|FG009|PF-06873600 Treatment|Physician Decision|0|||
161142408|NCT03519178|581906198|FG010|PF-06873600 Treatment|Physician Decision|1|||
161142409|NCT03519178|581906199|FG011|PF-06873600 Treatment|Physician Decision|0|||
161142410|NCT03519178|581906200|FG012|PF-06873600 Treatment|Physician Decision|0|||
161142411|NCT03519178|581906201|FG013|PF-06873600 Treatment|Physician Decision|4|||
161142412|NCT03519178|581906202|FG014|PF-06873600 Treatment|Physician Decision|1|||
161142413|NCT03519178|581906188|FG000|PF-06873600 Treatment|Progressive disease|1|||
161142414|NCT03519178|581906189|FG001|PF-06873600 Treatment|Progressive disease|1|||
161142415|NCT03519178|581906190|FG002|PF-06873600 Treatment|Progressive disease|1|||
161142416|NCT03519178|581906191|FG003|PF-06873600 Treatment|Progressive disease|1|||
161257004|NCT00442546|582318758|FG002|Overall Study|Withdrawal by Subject|7|||
161257005|NCT00442546|582318756|FG000|Overall Study|Randomized But Not Treated|5|||
161257006|NCT00442546|582318757|FG001|Overall Study|Randomized But Not Treated|4|||
161257007|NCT00442546|582318758|FG002|Overall Study|Randomized But Not Treated|6|||
161257008|NCT01557582|582318760|FG000|Overall Study|Protocol Violation|4|||
161257009|NCT01557582|582318760|FG000|Overall Study|Operator error|2|||
161257010|NCT00546910|582320624|FG000|Overall Study|Adverse Event|2|||
160916066|NCT02618434|581085070|FG000|Overall Study|Physician Decision|0|||
160916067|NCT02618434|581085071|FG001|Overall Study|Physician Decision|1|||
160916068|NCT02618434|581085072|FG002|Overall Study|Physician Decision|0|||
160916069|NCT02618434|581085070|FG000|Overall Study|Protocol Violation|0|||
160916070|NCT02618434|581085071|FG001|Overall Study|Protocol Violation|0|||
160916071|NCT02618434|581085072|FG002|Overall Study|Protocol Violation|1|||
160916072|NCT02618434|581085070|FG000|Overall Study|Other, Multiple categories|1|||
160916073|NCT02618434|581085071|FG001|Overall Study|Other, Multiple categories|1|||
160916074|NCT02618434|581085072|FG002|Overall Study|Other, Multiple categories|1|||
160916075|NCT04626297|581085076|FG000|Overall Study|Adverse Event|5|||
161142417|NCT03519178|581906192|FG004|PF-06873600 Treatment|Progressive disease|6|||
161142418|NCT03519178|581906193|FG005|PF-06873600 Treatment|Progressive disease|7|||
161257011|NCT00546910|582320625|FG001|Overall Study|Adverse Event|3|||
161142419|NCT03519178|581906194|FG006|PF-06873600 Treatment|Progressive disease|3|||
161142420|NCT03519178|581906195|FG007|PF-06873600 Treatment|Progressive disease|7|||
161142421|NCT03519178|581906196|FG008|PF-06873600 Treatment|Progressive disease|3|||
161142422|NCT03519178|581906197|FG009|PF-06873600 Treatment|Progressive disease|5|||
161142423|NCT03519178|581906198|FG010|PF-06873600 Treatment|Progressive disease|4|||
161142424|NCT03519178|581906199|FG011|PF-06873600 Treatment|Progressive disease|3|||
161142425|NCT03519178|581906200|FG012|PF-06873600 Treatment|Progressive disease|4|||
160916076|NCT04626297|581085077|FG001|Overall Study|Adverse Event|3|||
160916077|NCT04626297|581085076|FG000|Overall Study|Lost to Follow-up|7|||
161142426|NCT03519178|581906201|FG013|PF-06873600 Treatment|Progressive disease|28|||
161142427|NCT03519178|581906202|FG014|PF-06873600 Treatment|Progressive disease|8|||
161142428|NCT03519178|581906188|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
161257012|NCT00546910|582320624|FG000|Overall Study|Lack of Efficacy|5|||
161257013|NCT00546910|582320625|FG001|Overall Study|Lack of Efficacy|7|||
161257014|NCT00546910|582320624|FG000|Overall Study|Physician Decision|0|||
161257015|NCT00546910|582320625|FG001|Overall Study|Physician Decision|1|||
161257016|NCT00546910|582320624|FG000|Overall Study|Withdrawal by Subject|2|||
161257017|NCT00546910|582320625|FG001|Overall Study|Withdrawal by Subject|0|||
161257018|NCT01301482|582320626|FG000|Overall Study|Withdrawal by Subject|1|||
161257019|NCT04086641|582320634|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
161257020|NCT04086641|582320635|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
161257021|NCT00706095|582320636|FG000|Overall Study|Progressive Disease|4|||
161257022|NCT00706095|582320637|FG001|Overall Study|Progressive Disease|5|||
161257023|NCT00706095|582320638|FG002|Overall Study|Progressive Disease|3|||
161257024|NCT00706095|582320636|FG000|Overall Study|Clinical Progression|1|||
161257025|NCT00706095|582320637|FG001|Overall Study|Clinical Progression|2|||
161257026|NCT00706095|582320638|FG002|Overall Study|Clinical Progression|2|||
161257027|NCT00706095|582320636|FG000|Overall Study|Withdrawal by Subject|1|||
161257028|NCT00706095|582320637|FG001|Overall Study|Withdrawal by Subject|0|||
161257029|NCT00706095|582320638|FG002|Overall Study|Withdrawal by Subject|0|||
161257030|NCT01011556|582320644|FG000|Overall Study|Adverse Event|1|||
161257031|NCT01011556|582320645|FG001|Overall Study|Adverse Event|3|||
161257032|NCT01011556|582320646|FG002|Overall Study|Adverse Event|2|||
161257033|NCT01011556|582320647|FG003|Overall Study|Adverse Event|1|||
161257034|NCT01011556|582320644|FG000|Overall Study|Lost to Follow-up|1|||
161257035|NCT01011556|582320645|FG001|Overall Study|Lost to Follow-up|0|||
161257036|NCT01011556|582320646|FG002|Overall Study|Lost to Follow-up|0|||
161257037|NCT01011556|582320647|FG003|Overall Study|Lost to Follow-up|0|||
161257038|NCT01011556|582320644|FG000|Overall Study|Physician Decision|1|||
161257039|NCT01011556|582320645|FG001|Overall Study|Physician Decision|0|||
161257040|NCT01011556|582320646|FG002|Overall Study|Physician Decision|0|||
161257041|NCT01011556|582320647|FG003|Overall Study|Physician Decision|1|||
161257042|NCT01011556|582320644|FG000|Overall Study|Protocol Violation|0|||
161257043|NCT01011556|582320645|FG001|Overall Study|Protocol Violation|1|||
161257044|NCT01011556|582320646|FG002|Overall Study|Protocol Violation|0|||
161257045|NCT01011556|582320647|FG003|Overall Study|Protocol Violation|0|||
161257046|NCT01011556|582320644|FG000|Overall Study|Withdrawal by Subject|1|||
161257047|NCT01011556|582320645|FG001|Overall Study|Withdrawal by Subject|2|||
161257048|NCT01011556|582320646|FG002|Overall Study|Withdrawal by Subject|4|||
161257049|NCT01011556|582320647|FG003|Overall Study|Withdrawal by Subject|4|||
161257050|NCT01011556|582320644|FG000|Overall Study|Sponsor decision|0|||
161257051|NCT01011556|582320645|FG001|Overall Study|Sponsor decision|1|||
161257052|NCT01011556|582320646|FG002|Overall Study|Sponsor decision|1|||
161257053|NCT01011556|582320647|FG003|Overall Study|Sponsor decision|2|||
161257054|NCT01011556|582320644|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
161257055|NCT01011556|582320645|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161257056|NCT01011556|582320646|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
161257057|NCT01011556|582320647|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
161257058|NCT03920280|582320648|FG000|Overall Study|Adverse Event|2|||
161257059|NCT03920280|582320649|FG001|Overall Study|Adverse Event|3|||
161257060|NCT03920280|582320648|FG000|Overall Study|Lost to Follow-up|0|||
161257061|NCT03920280|582320649|FG001|Overall Study|Lost to Follow-up|1|||
161257062|NCT03920280|582320648|FG000|Overall Study|Withdrawal by Subject|1|||
161257063|NCT03920280|582320649|FG001|Overall Study|Withdrawal by Subject|1|||
161257064|NCT03920280|582320648|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
161257065|NCT03920280|582320649|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
161257066|NCT00271024|582320660|FG000|Overall Study|Lost Interest|3|||
161257067|NCT00271024|582320661|FG001|Overall Study|Lost Interest|4|||
161257068|NCT00271024|582320662|FG002|Overall Study|Lost Interest|2|||
161257069|NCT00271024|582320663|FG003|Overall Study|Lost Interest|3|||
161257070|NCT00271024|582320660|FG000|Overall Study|Unknown/Unspecified|11|||
160916078|NCT04626297|581085077|FG001|Overall Study|Lost to Follow-up|3|||
160916079|NCT04626297|581085076|FG000|Overall Study|Protocol Violation|5|||
160916080|NCT04626297|581085077|FG001|Overall Study|Protocol Violation|1|||
160916081|NCT04626297|581085076|FG000|Overall Study|Withdrawal by Subject|20|||
160916082|NCT04626297|581085077|FG001|Overall Study|Withdrawal by Subject|6|||
160916083|NCT04626297|581085076|FG000|Overall Study|Sponsor decision|2|||
160916084|NCT04626297|581085077|FG001|Overall Study|Sponsor decision|1|||
161142661|NCT03519178|581906196|FG008|Fulvestrant. Treatment|Other|0|||
161257071|NCT00271024|582320661|FG001|Overall Study|Unknown/Unspecified|11|||
161257072|NCT00271024|582320662|FG002|Overall Study|Unknown/Unspecified|8|||
161257073|NCT00271024|582320663|FG003|Overall Study|Unknown/Unspecified|4|||
161257074|NCT00271024|582320660|FG000|Overall Study|Protocol Violation|1|||
161257075|NCT00271024|582320661|FG001|Overall Study|Protocol Violation|6|||
161257076|NCT00271024|582320662|FG002|Overall Study|Protocol Violation|5|||
161257077|NCT00271024|582320663|FG003|Overall Study|Protocol Violation|11|||
161257078|NCT00271024|582320660|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
161257079|NCT00271024|582320661|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
160916085|NCT02066233|581085078|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
160916086|NCT02066233|581085079|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
161142429|NCT03519178|581906189|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
161142430|NCT03519178|581906190|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
161142431|NCT03519178|581906191|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
161142432|NCT03519178|581906192|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
161142433|NCT03519178|581906193|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
161142434|NCT03519178|581906194|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
161257080|NCT00271024|582320662|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
161257081|NCT00271024|582320663|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
161257082|NCT00271024|582320660|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
161339329|NCT01232283|582630429|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
161339330|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339331|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339332|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339333|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161257083|NCT00271024|582320661|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
161257084|NCT00271024|582320662|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
161257085|NCT00271024|582320663|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
161257086|NCT04449341|582320664|FG000|Overall Study|Protocol Violation|1|||
161257087|NCT04449341|582320665|FG001|Overall Study|Protocol Violation|0|||
161257088|NCT04499482|582320666|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
161257089|NCT01020526|582320668|FG000|Overall Study|Withdrawal by Subject|5|||
161257090|NCT01020526|582320668|FG000|Overall Study|Other reasons|3|||
161257091|NCT01020526|582320668|FG000|Overall Study|Insufficient clinical response|3|||
161257092|NCT01020526|582320668|FG000|Overall Study|Lost to Follow-up|1|||
161257093|NCT01020526|582320668|FG000|Overall Study|Adverse Event|2|||
161257094|NCT03573817|582320669|FG000|Overall Study|Adverse Event|0|||
161257095|NCT03573817|582320670|FG001|Overall Study|Adverse Event|2|||
161257096|NCT03573817|582320669|FG000|Overall Study|Protocol Violation|0|||
161257097|NCT03573817|582320670|FG001|Overall Study|Protocol Violation|1|||
161257098|NCT03573817|582320669|FG000|Overall Study|Withdrawal by Subject|1|||
161257099|NCT03573817|582320670|FG001|Overall Study|Withdrawal by Subject|1|||
161257100|NCT01083680|582320679|FG000|Overall Study|Lost to Follow-up|2758|||
161257101|NCT01083680|582320679|FG000|Overall Study|Withdrawal by Subject|1086|||
161257102|NCT01719562|582320680|FG000|Overall Study|Lost to Follow-up|1|||
161257103|NCT01719562|582320681|FG001|Overall Study|Lost to Follow-up|0|||
161257104|NCT01719562|582320680|FG000|Overall Study|Death|1|||
161257105|NCT01719562|582320681|FG001|Overall Study|Death|0|||
161257106|NCT01719562|582320680|FG000|Overall Study|New cancer diagnosis|1|||
161257107|NCT01719562|582320681|FG001|Overall Study|New cancer diagnosis|0|||
161257108|NCT00508027|582320682|FG000|Dose Level 1|Lost to Follow-up|4|||
161257109|NCT00508027|582320682|FG000|Dose Level 1|Withdrawal by Subject|2|||
161257110|NCT00508027|582320682|FG000|Dose Level 1|Physician Decision|2|||
161257111|NCT00508027|582320682|FG000|Dose Level 2|Lost to Follow-up|2|||
161339334|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339335|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339336|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339337|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
161339338|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
161339339|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
161339340|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339341|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339342|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339343|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339344|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339345|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339346|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339347|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
161339348|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
161339349|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
161257112|NCT00508027|582320682|FG000|Dose Level 2|Withdrawal by Subject|2|||
161257113|NCT03877926|582320683|FG000|Overall Study|Adverse Event|1|||
161257114|NCT03877926|582320684|FG001|Overall Study|Adverse Event|0|||
161257115|NCT03877926|582320685|FG002|Overall Study|Adverse Event|0|||
161257116|NCT03877926|582320686|FG003|Overall Study|Adverse Event|0|||
161339350|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
160916087|NCT02598076|581085080|FG000|Overall Study|Lost to Follow-up|2|||
160916088|NCT02598076|581085081|FG001|Overall Study|Lost to Follow-up|3|||
160916089|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Death|3|||
161142435|NCT03519178|581906195|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
161257117|NCT03877926|582320683|FG000|Overall Study|Death|2|||
161257118|NCT03877926|582320684|FG001|Overall Study|Death|2|||
161257119|NCT03877926|582320685|FG002|Overall Study|Death|2|||
161142436|NCT03519178|581906196|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
161142437|NCT03519178|581906197|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
161257120|NCT03877926|582320686|FG003|Overall Study|Death|0|||
161257121|NCT03877926|582320683|FG000|Overall Study|Lost to Follow-up|41|||
161257122|NCT03877926|582320684|FG001|Overall Study|Lost to Follow-up|52|||
161257123|NCT03877926|582320685|FG002|Overall Study|Lost to Follow-up|45|||
161257124|NCT03877926|582320686|FG003|Overall Study|Lost to Follow-up|17|||
161257125|NCT03877926|582320683|FG000|Overall Study|Physician Decision|2|||
161257126|NCT03877926|582320684|FG001|Overall Study|Physician Decision|0|||
161257127|NCT03877926|582320685|FG002|Overall Study|Physician Decision|2|||
161257128|NCT03877926|582320686|FG003|Overall Study|Physician Decision|0|||
161257129|NCT03877926|582320683|FG000|Overall Study|Withdrawal by Subject|18|||
161257130|NCT03877926|582320684|FG001|Overall Study|Withdrawal by Subject|21|||
161257131|NCT03877926|582320685|FG002|Overall Study|Withdrawal by Subject|12|||
161257132|NCT03877926|582320686|FG003|Overall Study|Withdrawal by Subject|4|||
161257133|NCT03877926|582320683|FG000|Overall Study|Other - Various|4|||
161257134|NCT03877926|582320684|FG001|Overall Study|Other - Various|1|||
161257135|NCT03877926|582320685|FG002|Overall Study|Other - Various|1|||
161257136|NCT03877926|582320686|FG003|Overall Study|Other - Various|0|||
161257137|NCT03877926|582320683|FG000|Overall Study|Not Treated|3|||
161257138|NCT03877926|582320684|FG001|Overall Study|Not Treated|1|||
161257139|NCT03877926|582320685|FG002|Overall Study|Not Treated|1|||
161257140|NCT03877926|582320686|FG003|Overall Study|Not Treated|0|||
161257141|NCT03546647|582320687|FG000|Overall Study|Adverse Event|1|||
161257142|NCT03546647|582320688|FG001|Overall Study|Adverse Event|0|||
161257143|NCT00612677|582320690|FG000|Overall Study|study closed before treatment started|1|||
161257144|NCT00268892|582320697|FG000|Overall Study|Adverse Event|14|||
161257145|NCT00268892|582320698|FG001|Overall Study|Adverse Event|17|||
161257146|NCT00268892|582320699|FG002|Overall Study|Adverse Event|20|||
161257147|NCT00268892|582320697|FG000|Overall Study|Lack of Efficacy|1|||
161257148|NCT00268892|582320698|FG001|Overall Study|Lack of Efficacy|3|||
161257149|NCT00268892|582320699|FG002|Overall Study|Lack of Efficacy|0|||
161257150|NCT00268892|582320697|FG000|Overall Study|Withdrawal by Subject|14|||
161257151|NCT00268892|582320698|FG001|Overall Study|Withdrawal by Subject|15|||
161257152|NCT00268892|582320699|FG002|Overall Study|Withdrawal by Subject|13|||
161257153|NCT00268892|582320697|FG000|Overall Study|Physician Decision|0|||
161257154|NCT00268892|582320698|FG001|Overall Study|Physician Decision|1|||
160996279|NCT03451851|581372183|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996280|NCT03451851|581372184|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
160996281|NCT03451851|581372185|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996282|NCT03451851|581372186|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996283|NCT03451851|581372187|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996284|NCT03451851|581372188|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996285|NCT03451851|581372189|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
160996286|NCT03451851|581372182|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996287|NCT03451851|581372183|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996288|NCT03451851|581372184|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
160996289|NCT03451851|581372185|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996290|NCT03451851|581372186|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996291|NCT03451851|581372187|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996292|NCT03451851|581372188|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996293|NCT03451851|581372189|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
160996294|NCT03451851|581372182|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996295|NCT03451851|581372183|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996296|NCT03451851|581372184|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996297|NCT03451851|581372185|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996298|NCT03451851|581372186|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
160996299|NCT03451851|581372187|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
160996300|NCT03451851|581372188|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
160996301|NCT03451851|581372189|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
161257155|NCT00268892|582320699|FG002|Overall Study|Physician Decision|0|||
161257156|NCT00268892|582320697|FG000|Overall Study|Lost to Follow-up|5|||
161257157|NCT00268892|582320698|FG001|Overall Study|Lost to Follow-up|2|||
161257158|NCT00268892|582320699|FG002|Overall Study|Lost to Follow-up|4|||
160861671|NCT01921205|580887803|FG001|Overall Study|Lack of Efficacy|0|||
160996302|NCT03451851|581372182|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160996303|NCT03451851|581372183|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161257159|NCT00268892|582320697|FG000|Overall Study|Protocol Violation|0|||
161257160|NCT00268892|582320698|FG001|Overall Study|Protocol Violation|1|||
161257161|NCT00268892|582320699|FG002|Overall Study|Protocol Violation|0|||
161257162|NCT00268892|582320697|FG000|Overall Study|Disease Progression|1|||
161257163|NCT00268892|582320698|FG001|Overall Study|Disease Progression|1|||
161257164|NCT00268892|582320699|FG002|Overall Study|Disease Progression|0|||
161257165|NCT00268892|582320697|FG000|Overall Study|Trial Site Closed|4|||
161257166|NCT00268892|582320698|FG001|Overall Study|Trial Site Closed|2|||
160916090|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Death|3|||
160916091|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Death|0|||
160916092|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Death|0|||
161257167|NCT00268892|582320699|FG002|Overall Study|Trial Site Closed|2|||
161257168|NCT04569786|582320702|FG000|Overall Study|Lost to Follow-up|1|||
161257169|NCT04569786|582320703|FG001|Overall Study|Lost to Follow-up|0|||
160916093|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
160916094|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
160916095|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
160916096|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
160916097|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
160916098|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
160916099|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
160916100|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
160916101|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
160916102|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
160916103|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
160916104|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
160916105|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
160916106|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
160916107|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
160916108|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
160916109|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
160916110|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
160916111|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
160916112|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
160916113|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
160916114|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
160916115|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
160916116|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
160916117|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Other|6|||
160916118|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Other|3|||
160916119|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Other|0|||
160916120|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Other|0|||
160916121|NCT02051608|581085084|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
160916122|NCT02051608|581085085|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
160916123|NCT02051608|581085086|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
160916124|NCT02051608|581085087|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
160916125|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Adverse Event|0|||
160916126|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Adverse Event|0|||
160916127|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Adverse Event|6|||
160916128|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Adverse Event|8|||
160916129|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Death|0|||
160916130|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Death|0|||
160916131|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Death|7|||
160916132|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Death|4|||
160916133|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
160916134|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
160916135|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
160916136|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
160916137|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
160916138|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
160916139|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
160916140|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
160916141|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
160916142|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
160916143|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
160916144|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
160916145|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
160916146|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
160916147|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
160916148|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
160916149|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Physician Decision|0|||
160916150|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Physician Decision|0|||
160916151|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Physician Decision|8|||
160916152|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Physician Decision|5|||
160916153|NCT02051608|581085084|FG000|Part 2: Open-label Extension|Other|0|||
160916154|NCT02051608|581085085|FG001|Part 2: Open-label Extension|Other|0|||
161257170|NCT04569786|582320704|FG002|Overall Study|Lost to Follow-up|4|||
161257171|NCT04569786|582320705|FG003|Overall Study|Lost to Follow-up|1|||
161257172|NCT04569786|582320706|FG004|Overall Study|Lost to Follow-up|0|||
161257173|NCT04569786|582320702|FG000|Overall Study|Withdrawal by Subject|0|||
161257174|NCT04569786|582320703|FG001|Overall Study|Withdrawal by Subject|0|||
161257175|NCT04569786|582320704|FG002|Overall Study|Withdrawal by Subject|0|||
161257176|NCT04569786|582320705|FG003|Overall Study|Withdrawal by Subject|5|||
161257177|NCT04569786|582320706|FG004|Overall Study|Withdrawal by Subject|1|||
161257178|NCT04569786|582320702|FG000|Overall Study|Physician Decision|0|||
161257179|NCT04569786|582320703|FG001|Overall Study|Physician Decision|0|||
161257180|NCT04569786|582320704|FG002|Overall Study|Physician Decision|0|||
161257181|NCT04569786|582320705|FG003|Overall Study|Physician Decision|1|||
161257182|NCT04569786|582320706|FG004|Overall Study|Physician Decision|0|||
161257183|NCT01640184|582320713|FG000|Overall Study|Death|1|||
161257184|NCT01640184|582320714|FG001|Overall Study|Death|0|||
161257185|NCT01640184|582320715|FG002|Overall Study|Death|0|||
161257186|NCT01640184|582320713|FG000|Overall Study|Lost to Follow-up|4|||
161257187|NCT01640184|582320714|FG001|Overall Study|Lost to Follow-up|1|||
161257188|NCT01640184|582320715|FG002|Overall Study|Lost to Follow-up|0|||
161257189|NCT01640184|582320713|FG000|Overall Study|Physician Decision|3|||
161257190|NCT01640184|582320714|FG001|Overall Study|Physician Decision|0|||
161257191|NCT01640184|582320715|FG002|Overall Study|Physician Decision|0|||
161257192|NCT01640184|582320713|FG000|Overall Study|Withdrawal by Subject|0|||
161257193|NCT01640184|582320714|FG001|Overall Study|Withdrawal by Subject|1|||
161257194|NCT01640184|582320715|FG002|Overall Study|Withdrawal by Subject|1|||
161257195|NCT01640184|582320713|FG000|Overall Study|Protocol Violation|0|||
161257196|NCT01640184|582320714|FG001|Overall Study|Protocol Violation|0|||
161257197|NCT01640184|582320715|FG002|Overall Study|Protocol Violation|1|||
161257198|NCT01876368|582320718|FG000|Overall Study|Adverse Event|2|||
161257199|NCT01876368|582320719|FG001|Overall Study|Adverse Event|5|||
161257200|NCT01876368|582320718|FG000|Overall Study|Lack of Efficacy|1|||
161257201|NCT01876368|582320719|FG001|Overall Study|Lack of Efficacy|0|||
161257202|NCT01876368|582320718|FG000|Overall Study|Lost to Follow-up|0|||
161257203|NCT01876368|582320719|FG001|Overall Study|Lost to Follow-up|1|||
161257204|NCT01876368|582320718|FG000|Overall Study|Non-compliance with study treatment|0|||
161257205|NCT01876368|582320719|FG001|Overall Study|Non-compliance with study treatment|1|||
161257206|NCT01876368|582320718|FG000|Overall Study|Physician Decision|0|||
161257207|NCT01876368|582320719|FG001|Overall Study|Physician Decision|2|||
161257208|NCT01876368|582320718|FG000|Overall Study|Protocol deviation|3|||
161257209|NCT01876368|582320719|FG001|Overall Study|Protocol deviation|3|||
161257210|NCT01876368|582320718|FG000|Overall Study|Subject/guardian decision|3|||
161257211|NCT01876368|582320719|FG001|Overall Study|Subject/guardian decision|1|||
161257212|NCT02260258|582320720|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
161257213|NCT02260258|582320721|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
161257214|NCT01644149|582320722|FG000|Overall Study|Withdrawal by Subject|1|||
161257215|NCT01644149|582320723|FG001|Overall Study|Withdrawal by Subject|0|||
161257216|NCT01644149|582320722|FG000|Overall Study|Lost to Follow-up|3|||
161257217|NCT01644149|582320723|FG001|Overall Study|Lost to Follow-up|1|||
161257218|NCT04798482|582320726|FG000|Overall Study|Physician Decision|1|||
161257219|NCT04798482|582320726|FG000|Overall Study|Lost eligibility|1|||
161257220|NCT00690482|582320727|FG000|Overall Study|Adverse Event|2|||
161257221|NCT00690482|582320728|FG001|Overall Study|Adverse Event|1|||
161257222|NCT00690482|582320727|FG000|Overall Study|Incorrect enrolment|0|||
161257223|NCT00690482|582320728|FG001|Overall Study|Incorrect enrolment|1|||
161257224|NCT00690482|582320727|FG000|Overall Study|Study-specific discontinuation criteria|1|||
161257225|NCT00690482|582320728|FG001|Overall Study|Study-specific discontinuation criteria|0|||
161257226|NCT00690482|582320727|FG000|Overall Study|Intake of prohibited medicine|1|||
161257227|NCT00690482|582320728|FG001|Overall Study|Intake of prohibited medicine|0|||
161257228|NCT00690482|582320727|FG000|Overall Study|withdrew consent at rand.day|0|||
160916155|NCT02051608|581085086|FG002|Part 2: Open-label Extension|Other|9|||
160916156|NCT02051608|581085087|FG003|Part 2: Open-label Extension|Other|9|||
160916157|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
161257229|NCT00690482|582320728|FG001|Overall Study|withdrew consent at rand.day|1|||
161257230|NCT00605917|582320731|FG000|Overall Study|Protocol Violation|79|||
161257231|NCT01506908|582320732|FG000|Overall Study|Adverse Event|1|||
161257232|NCT01506908|582320733|FG001|Overall Study|Adverse Event|0|||
161257233|NCT00292227|582320736|FG000|Patch Period|Adverse Event|1|||
161257234|NCT00292227|582320737|FG001|Patch Period|Adverse Event|0|||
161257235|NCT00292227|582320738|FG002|Patch Period|Adverse Event|2|||
161257236|NCT00292227|582320736|FG000|Patch Period|Withdrawal by Subject|0|||
161257237|NCT00292227|582320737|FG001|Patch Period|Withdrawal by Subject|0|||
161257238|NCT00292227|582320738|FG002|Patch Period|Withdrawal by Subject|1|||
160916158|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
161257239|NCT04232540|582320742|FG000|Overall Study|Lost to Follow-up|1|||
161257240|NCT04232540|582320743|FG001|Overall Study|Lost to Follow-up|0|||
161257241|NCT00537017|582320744|FG000|Treatment Phase|Adverse Event|19|||
161257242|NCT00537017|582320744|FG000|Treatment Phase|Withdrawal by Subject|13|||
161257243|NCT00537017|582320744|FG000|Treatment Phase|Protocol Violation|2|||
161257244|NCT00537017|582320744|FG000|Follow-up Phase|Withdrawal by Subject|9|||
161257245|NCT02105701|582320746|FG000|Overall Study|Lost to Follow-up|1|||
161257246|NCT02105701|582320747|FG001|Overall Study|Lost to Follow-up|0|||
161257247|NCT02105701|582320748|FG002|Overall Study|Lost to Follow-up|2|||
161257248|NCT02105701|582320749|FG003|Overall Study|Lost to Follow-up|1|||
161257249|NCT02105701|582320746|FG000|Overall Study|Protocol Violation|0|||
161257250|NCT02105701|582320747|FG001|Overall Study|Protocol Violation|0|||
161257251|NCT02105701|582320748|FG002|Overall Study|Protocol Violation|1|||
161257252|NCT02105701|582320749|FG003|Overall Study|Protocol Violation|0|||
161257253|NCT02105701|582320746|FG000|Overall Study|Withdrawal by Subject|2|||
161257254|NCT02105701|582320747|FG001|Overall Study|Withdrawal by Subject|1|||
161257255|NCT02105701|582320748|FG002|Overall Study|Withdrawal by Subject|0|||
161257256|NCT02105701|582320749|FG003|Overall Study|Withdrawal by Subject|1|||
161257257|NCT02105701|582320746|FG000|Overall Study|Death|1|||
161257258|NCT02105701|582320747|FG001|Overall Study|Death|0|||
161257259|NCT02105701|582320748|FG002|Overall Study|Death|0|||
161257260|NCT02105701|582320749|FG003|Overall Study|Death|0|||
161257261|NCT03234608|582320750|FG000|Overall Study|Lost to Follow-up|23|||
161257262|NCT03234608|582320751|FG001|Overall Study|Lost to Follow-up|21|||
161257263|NCT02329431|582320752|FG000|Overall Study|Lost to Follow-up|20|||
161257264|NCT02329431|582320753|FG001|Overall Study|Lost to Follow-up|13|||
161257265|NCT01362296|582320754|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
161257266|NCT01362296|582320755|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
161257267|NCT01362296|582320756|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
161257268|NCT01362296|582320757|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
161257269|NCT01362296|582320754|FG000|Randomized Phase (RP)|Physician Decision|1|||
161257270|NCT01362296|582320755|FG001|Randomized Phase (RP)|Physician Decision|9|||
161257271|NCT01362296|582320756|FG002|Randomized Phase (RP)|Physician Decision|0|||
161257272|NCT01362296|582320757|FG003|Randomized Phase (RP)|Physician Decision|0|||
161257273|NCT01362296|582320754|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
161257274|NCT01362296|582320755|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
161257275|NCT01362296|582320756|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
161257276|NCT01362296|582320757|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
161257277|NCT01362296|582320754|FG000|Randomized Phase (RP)|Adverse Event|20|||
161257278|NCT01362296|582320755|FG001|Randomized Phase (RP)|Adverse Event|4|||
161257279|NCT01362296|582320756|FG002|Randomized Phase (RP)|Adverse Event|0|||
161257280|NCT01362296|582320757|FG003|Randomized Phase (RP)|Adverse Event|0|||
161257281|NCT01362296|582320754|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
161257282|NCT01362296|582320755|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
161257283|NCT01362296|582320756|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
161257284|NCT01362296|582320757|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
161257285|NCT01362296|582320754|FG000|Crossover Phase|PD including Death due to PD|0|||
161257286|NCT01362296|582320755|FG001|Crossover Phase|PD including Death due to PD|0|||
161257287|NCT01362296|582320756|FG002|Crossover Phase|PD including Death due to PD|16|||
161257288|NCT01362296|582320757|FG003|Crossover Phase|PD including Death due to PD|1|||
161257289|NCT01362296|582320754|FG000|Crossover Phase|Withdrawal by Subject|0|||
161257290|NCT01362296|582320755|FG001|Crossover Phase|Withdrawal by Subject|0|||
161257291|NCT01362296|582320756|FG002|Crossover Phase|Withdrawal by Subject|2|||
161257292|NCT01362296|582320757|FG003|Crossover Phase|Withdrawal by Subject|1|||
161257293|NCT01362296|582320754|FG000|Crossover Phase|Adverse Event|0|||
161257294|NCT01362296|582320755|FG001|Crossover Phase|Adverse Event|0|||
161257295|NCT01362296|582320756|FG002|Crossover Phase|Adverse Event|4|||
161257296|NCT01362296|582320757|FG003|Crossover Phase|Adverse Event|0|||
161257297|NCT01362296|582320754|FG000|Crossover Phase|Study Closed/Terminated|0|||
161257298|NCT01362296|582320755|FG001|Crossover Phase|Study Closed/Terminated|0|||
161257299|NCT01362296|582320756|FG002|Crossover Phase|Study Closed/Terminated|1|||
161257300|NCT01362296|582320757|FG003|Crossover Phase|Study Closed/Terminated|0|||
161257301|NCT03693950|582320758|FG000|Overall Study|Withdrawal by Subject|1|||
161257302|NCT03693950|582320759|FG001|Overall Study|Withdrawal by Subject|0|||
161257303|NCT04230876|582320760|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
161257304|NCT04230876|582320761|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
161257305|NCT01662362|582320763|FG000|Overall Study|Lost to Follow-up|38|||
161257306|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161257307|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
160916159|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
160916160|NCT03033394|581085092|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
160916161|NCT03033394|581085092|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
160916162|NCT00533845|581085097|FG000|Overall Study|Physician Decision|1|||
160916163|NCT00533845|581085098|FG001|Overall Study|Physician Decision|0|||
160916164|NCT01919723|581085099|FG000|Overall Study|Blood Samples Hemolyzed|2|||
160916165|NCT01919723|581085100|FG001|Overall Study|Blood Samples Hemolyzed|2|||
161142438|NCT03519178|581906198|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
161257308|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161257309|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
161257310|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161257311|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161257312|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
161257313|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
161257314|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
161257315|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161257316|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161257317|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
161257318|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Death|0|||
161257319|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Death|1|||
161257320|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Death|0|||
161257321|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Death|0|||
161257322|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
161257323|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
161257324|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
161257325|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
161257326|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
161257327|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161257328|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161257329|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
161257330|NCT00545688|582320765|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
161257331|NCT00545688|582320766|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
161257332|NCT00545688|582320767|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
161257333|NCT00545688|582320768|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
161257334|NCT00545688|582320765|FG000|Adjuvant Treatment Period|Disease Progression|3|||
161257335|NCT00545688|582320766|FG001|Adjuvant Treatment Period|Disease Progression|3|||
161257336|NCT00545688|582320767|FG002|Adjuvant Treatment Period|Disease Progression|0|||
161257337|NCT00545688|582320768|FG003|Adjuvant Treatment Period|Disease Progression|7|||
161257338|NCT00545688|582320765|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
161257339|NCT00545688|582320766|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
161257340|NCT00545688|582320767|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
161257341|NCT00545688|582320768|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
161257342|NCT00545688|582320765|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
161257343|NCT00545688|582320766|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
161257344|NCT00545688|582320767|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
161257345|NCT00545688|582320768|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
161257346|NCT00545688|582320765|FG000|Adjuvant Treatment Period|Adverse Event|0|||
161257347|NCT00545688|582320766|FG001|Adjuvant Treatment Period|Adverse Event|3|||
161257348|NCT00545688|582320767|FG002|Adjuvant Treatment Period|Adverse Event|2|||
161257349|NCT00545688|582320768|FG003|Adjuvant Treatment Period|Adverse Event|2|||
161257350|NCT00545688|582320765|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
161257351|NCT00545688|582320766|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
161257352|NCT00545688|582320767|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
161257353|NCT00545688|582320768|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
161257354|NCT00545688|582320765|FG000|Follow-Up Period|Death|4|||
161257355|NCT00545688|582320766|FG001|Follow-Up Period|Death|2|||
161257356|NCT00545688|582320767|FG002|Follow-Up Period|Death|2|||
161257357|NCT00545688|582320768|FG003|Follow-Up Period|Death|6|||
161257358|NCT00545688|582320765|FG000|Follow-Up Period|Disease Progression|6|||
161257359|NCT00545688|582320766|FG001|Follow-Up Period|Disease Progression|5|||
161257360|NCT00545688|582320767|FG002|Follow-Up Period|Disease Progression|9|||
161257361|NCT00545688|582320768|FG003|Follow-Up Period|Disease Progression|9|||
161257362|NCT00545688|582320765|FG000|Follow-Up Period|Refused Treatment|6|||
161257363|NCT00545688|582320766|FG001|Follow-Up Period|Refused Treatment|2|||
161257364|NCT00545688|582320767|FG002|Follow-Up Period|Refused Treatment|0|||
161257365|NCT00545688|582320768|FG003|Follow-Up Period|Refused Treatment|2|||
161257366|NCT00545688|582320765|FG000|Follow-Up Period|Lost to Follow-up|3|||
161257367|NCT00545688|582320766|FG001|Follow-Up Period|Lost to Follow-up|3|||
161257368|NCT00545688|582320767|FG002|Follow-Up Period|Lost to Follow-up|3|||
161257369|NCT00545688|582320768|FG003|Follow-Up Period|Lost to Follow-up|1|||
161339351|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161257370|NCT00545688|582320765|FG000|Follow-Up Period|Unspecified Reason|2|||
160861672|NCT01921205|580887802|FG000|Overall Study|Protocol Violation|1|||
161257371|NCT00545688|582320766|FG001|Follow-Up Period|Unspecified Reason|5|||
161257372|NCT00545688|582320767|FG002|Follow-Up Period|Unspecified Reason|6|||
161257373|NCT00545688|582320768|FG003|Follow-Up Period|Unspecified Reason|8|||
161257374|NCT00545688|582320765|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
161257375|NCT00545688|582320766|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
161257376|NCT00545688|582320767|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
161257377|NCT00545688|582320768|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
161257378|NCT02339090|582320769|FG000|Overall Study|Adverse Event|1|||
161257379|NCT02339090|582320770|FG001|Overall Study|Adverse Event|0|||
160916166|NCT04294472|581085108|FG000|Overall Study|Adverse Event|0|||
160916167|NCT04294472|581085109|FG001|Overall Study|Adverse Event|1|||
160916168|NCT04294472|581085110|FG002|Overall Study|Adverse Event|1|||
160916169|NCT04294472|581085108|FG000|Overall Study|Randomized but not treated|0|||
160916170|NCT04294472|581085109|FG001|Overall Study|Randomized but not treated|1|||
160916171|NCT04294472|581085110|FG002|Overall Study|Randomized but not treated|1|||
160996304|NCT03451851|581372184|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
160996305|NCT03451851|581372185|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161257380|NCT02339090|582320769|FG000|Overall Study|Lost to Follow-up|0|||
161257381|NCT02339090|582320770|FG001|Overall Study|Lost to Follow-up|1|||
161257382|NCT02339090|582320769|FG000|Overall Study|Non-compliance With Study Drug|0|||
161257383|NCT02339090|582320770|FG001|Overall Study|Non-compliance With Study Drug|1|||
161257384|NCT02339090|582320769|FG000|Overall Study|Withdrawal by Subject|2|||
161257385|NCT02339090|582320770|FG001|Overall Study|Withdrawal by Subject|1|||
161257386|NCT02339090|582320769|FG000|Overall Study|Poor Growth|3|||
161257387|NCT02339090|582320770|FG001|Overall Study|Poor Growth|0|||
161257388|NCT02339090|582320769|FG000|Overall Study|Randomized but not treated|0|||
161257389|NCT02339090|582320770|FG001|Overall Study|Randomized but not treated|2|||
161257390|NCT02792218|582320774|FG000|Overall Study|Patient/guardian decision|15|||
161257391|NCT02792218|582320775|FG001|Overall Study|Patient/guardian decision|42|||
161257392|NCT02792218|582320774|FG000|Overall Study|Adverse Event|15|||
161257393|NCT02792218|582320775|FG001|Overall Study|Adverse Event|14|||
161257394|NCT02792218|582320774|FG000|Overall Study|Lost to Follow-up|10|||
161257395|NCT02792218|582320775|FG001|Overall Study|Lost to Follow-up|5|||
161257396|NCT02792218|582320774|FG000|Overall Study|Lack of Efficacy|1|||
161257397|NCT02792218|582320775|FG001|Overall Study|Lack of Efficacy|12|||
161257398|NCT02792218|582320774|FG000|Overall Study|Physician Decision|4|||
161257399|NCT02792218|582320775|FG001|Overall Study|Physician Decision|4|||
161257400|NCT02792218|582320774|FG000|Overall Study|Protocol deviation|3|||
161257401|NCT02792218|582320775|FG001|Overall Study|Protocol deviation|2|||
161257402|NCT02792218|582320774|FG000|Overall Study|New therapy for study indication|0|||
161257403|NCT02792218|582320775|FG001|Overall Study|New therapy for study indication|1|||
161257404|NCT02792218|582320774|FG000|Overall Study|Non-compliance with study treatment|0|||
161257405|NCT02792218|582320775|FG001|Overall Study|Non-compliance with study treatment|1|||
161257406|NCT02792218|582320774|FG000|Overall Study|Pregnancy|1|||
161257407|NCT02792218|582320775|FG001|Overall Study|Pregnancy|0|||
161257408|NCT00248170|582320776|FG000|Overall Study|Withdrawal by Subject|71|||
161257409|NCT00248170|582320777|FG001|Overall Study|Withdrawal by Subject|79|||
161257410|NCT00248170|582320776|FG000|Overall Study|Protocol Violation|35|||
161257411|NCT00248170|582320777|FG001|Overall Study|Protocol Violation|30|||
161257412|NCT00248170|582320776|FG000|Overall Study|Lost to Follow-up|28|||
161257413|NCT00248170|582320777|FG001|Overall Study|Lost to Follow-up|35|||
161257414|NCT00248170|582320776|FG000|Overall Study|Disease progression|196|||
161257415|NCT00248170|582320777|FG001|Overall Study|Disease progression|216|||
161257416|NCT00248170|582320776|FG000|Overall Study|Death|28|||
161257417|NCT00248170|582320777|FG001|Overall Study|Death|47|||
161257418|NCT00248170|582320776|FG000|Overall Study|Adverse Event|311|||
161257419|NCT00248170|582320777|FG001|Overall Study|Adverse Event|296|||
161257420|NCT00248170|582320776|FG000|Overall Study|Administrative problems|22|||
161257421|NCT00248170|582320777|FG001|Overall Study|Administrative problems|25|||
161257422|NCT00248170|582320776|FG000|Overall Study|Abnormal test procedure(s) result|49|||
161257423|NCT00248170|582320777|FG001|Overall Study|Abnormal test procedure(s) result|61|||
161257424|NCT00248170|582320776|FG000|Overall Study|Abnormal laboratory values|4|||
161257425|NCT00248170|582320777|FG001|Overall Study|Abnormal laboratory values|0|||
161257426|NCT00248170|582320776|FG000|Overall Study|Protocol deviation|17|||
161257427|NCT00248170|582320777|FG001|Overall Study|Protocol deviation|19|||
161257428|NCT03123783|582320778|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161257429|NCT03123783|582320779|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
161257430|NCT03123783|582320780|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161257431|NCT03123783|582320781|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161257432|NCT03123783|582320782|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
160916172|NCT00563381|581085112|FG000|Overall Study|Adverse Event|264|||
160996306|NCT03451851|581372186|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
161257433|NCT03123783|582320783|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161257434|NCT03123783|582320784|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
161257435|NCT03123783|582320778|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
161257436|NCT03123783|582320779|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
161257437|NCT03123783|582320780|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
161257438|NCT03123783|582320781|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
160916173|NCT00563381|581085113|FG001|Overall Study|Adverse Event|292|||
161257439|NCT03123783|582320782|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
161257440|NCT03123783|582320783|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
161257441|NCT03123783|582320784|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
161257442|NCT03123783|582320778|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
160916174|NCT00563381|581085112|FG000|Overall Study|Protocol Violation|66|||
161257443|NCT03123783|582320779|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
161257444|NCT03123783|582320780|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
161257445|NCT03123783|582320781|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
161257446|NCT03123783|582320782|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
161257447|NCT03123783|582320783|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
161257448|NCT03123783|582320784|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
161257449|NCT03123783|582320778|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161257450|NCT03123783|582320779|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161257451|NCT03123783|582320780|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161257452|NCT03123783|582320781|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161257453|NCT03123783|582320782|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
161257454|NCT03123783|582320783|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161257455|NCT03123783|582320784|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
161257456|NCT01253317|582320790|FG000|Overall Study|Adverse Event|2|||
161257457|NCT00749411|582320793|FG000|Overall Study|Adverse Event|0|||
161257458|NCT00749411|582320794|FG001|Overall Study|Adverse Event|2|||
161257459|NCT00749411|582320793|FG000|Overall Study|Lack of Efficacy|0|||
161257460|NCT00749411|582320794|FG001|Overall Study|Lack of Efficacy|1|||
161257461|NCT00749411|582320793|FG000|Overall Study|Protocol Violation|1|||
161257462|NCT00749411|582320794|FG001|Overall Study|Protocol Violation|1|||
160916175|NCT00563381|581085113|FG001|Overall Study|Protocol Violation|74|||
160916176|NCT00563381|581085112|FG000|Overall Study|Lost to Follow-up|7|||
160916177|NCT00563381|581085113|FG001|Overall Study|Lost to Follow-up|15|||
161142439|NCT03519178|581906199|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
161142440|NCT03519178|581906200|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
161142441|NCT03519178|581906201|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
160861673|NCT01921205|580887803|FG001|Overall Study|Protocol Violation|3|||
160861674|NCT01921205|580887802|FG000|Overall Study|Lost to Follow-up|1|||
160861675|NCT01921205|580887803|FG001|Overall Study|Lost to Follow-up|1|||
160861676|NCT01921205|580887802|FG000|Overall Study|Withdrawal by Subject|6|||
160861677|NCT01921205|580887803|FG001|Overall Study|Withdrawal by Subject|5|||
160861678|NCT01921205|580887802|FG000|Overall Study|Use Of Prohibited Medication|0|||
160861679|NCT01921205|580887803|FG001|Overall Study|Use Of Prohibited Medication|1|||
160861680|NCT01921205|580887802|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
160861681|NCT01921205|580887803|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
160861682|NCT01921205|580887802|FG000|Overall Study|Non Compliance Of The Parent|0|||
160861683|NCT01921205|580887803|FG001|Overall Study|Non Compliance Of The Parent|1|||
160861684|NCT01921205|580887802|FG000|Overall Study|Non Compliance Of Child|0|||
160861685|NCT01921205|580887803|FG001|Overall Study|Non Compliance Of Child|1|||
160861686|NCT03331315|580887804|FG000|Overall Study|Physician Decision|18|||
160861687|NCT03331315|580887805|FG001|Overall Study|Physician Decision|14|||
160861688|NCT00481832|580887806|FG000|Enrollment|Physician Decision|8|||
160861689|NCT00481832|580887806|FG000|Enrollment|Unable to collect enough stem cells|2|||
160861690|NCT00481832|580887806|FG000|Inter-transplant Period|Adverse Event|4|||
160861691|NCT00481832|580887806|FG000|Inter-transplant Period|Death|3|||
160861692|NCT00481832|580887806|FG000|Inter-transplant Period|Physician Decision|4|||
160861693|NCT00481832|580887806|FG000|Inter-transplant Period|Disease relapse|11|||
160861694|NCT00481832|580887806|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
160861695|NCT00456846|580887807|FG000|Overall Study|Adverse Event|2|||
160861696|NCT00456846|580887808|FG001|Overall Study|Adverse Event|15|||
160861697|NCT00456846|580887807|FG000|Overall Study|Physician Decision|11|||
160861698|NCT00456846|580887808|FG001|Overall Study|Physician Decision|6|||
160861699|NCT00456846|580887807|FG000|Overall Study|Protocol Deviation|2|||
160861700|NCT00456846|580887808|FG001|Overall Study|Protocol Deviation|0|||
160861701|NCT00456846|580887807|FG000|Overall Study|Participant Discretion|1|||
160861702|NCT00456846|580887808|FG001|Overall Study|Participant Discretion|5|||
160861703|NCT00456846|580887807|FG000|Overall Study|Other|0|||
160861704|NCT00456846|580887808|FG001|Overall Study|Other|2|||
160861705|NCT00886379|580887812|FG000|Overall Study|Transferred Schools|0|||
160861706|NCT00886379|580887813|FG001|Overall Study|Transferred Schools|0|||
160861707|NCT00886379|580887814|FG002|Overall Study|Transferred Schools|2|||
160861708|NCT00886379|580887815|FG003|Overall Study|Transferred Schools|1|||
160861709|NCT00886379|580887816|FG004|Overall Study|Transferred Schools|1|||
160861710|NCT00886379|580887812|FG000|Overall Study|Final blood draw not obtained|3|||
160861711|NCT00886379|580887813|FG001|Overall Study|Final blood draw not obtained|3|||
160861712|NCT00886379|580887814|FG002|Overall Study|Final blood draw not obtained|4|||
160861713|NCT00886379|580887815|FG003|Overall Study|Final blood draw not obtained|2|||
160861714|NCT00886379|580887816|FG004|Overall Study|Final blood draw not obtained|2|||
161142662|NCT03519178|581906197|FG009|Fulvestrant. Treatment|Other|0|||
161257463|NCT00749411|582320793|FG000|Overall Study|Protocol-defined stopping criteria|0|||
161257464|NCT00749411|582320794|FG001|Overall Study|Protocol-defined stopping criteria|1|||
160916178|NCT00563381|581085112|FG000|Overall Study|Withdrawal by Subject|192|||
160916179|NCT00563381|581085113|FG001|Overall Study|Withdrawal by Subject|209|||
160916180|NCT00563381|581085112|FG000|Overall Study|Lack of Efficacy|32|||
160916181|NCT00563381|581085113|FG001|Overall Study|Lack of Efficacy|24|||
161257465|NCT03183141|582320795|FG000|Overall Study|Withdrawal by Subject|2|||
161257466|NCT03183141|582320796|FG001|Overall Study|Withdrawal by Subject|4|||
161257467|NCT03183141|582320795|FG000|Overall Study|Death|0|||
161257468|NCT03183141|582320796|FG001|Overall Study|Death|8|||
161257469|NCT01507090|582320800|FG000|Overall Study|incomplete dataset|18|||
161257470|NCT02953678|582320801|FG000|Overall Study|Adverse Event|20|||
161257471|NCT02953678|582320801|FG000|Overall Study|Death|7|||
161257472|NCT02953678|582320801|FG000|Overall Study|Physician Decision|23|||
161257473|NCT02953678|582320801|FG000|Overall Study|Progressive Disease of GVHD|7|||
161257474|NCT02953678|582320801|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
161257475|NCT02953678|582320801|FG000|Overall Study|Withdrawal by participant|3|||
161257476|NCT02953678|582320801|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
161257477|NCT02953678|582320801|FG000|Overall Study|Participants were transferred to commercial product.|3|||
161257478|NCT02070757|582322339|FG000|Overall Study|Adverse Event|107|||
161257479|NCT02070757|582322340|FG001|Overall Study|Adverse Event|99|||
161257480|NCT02070757|582322339|FG000|Overall Study|Lost to Follow-up|7|||
161257481|NCT02070757|582322340|FG001|Overall Study|Lost to Follow-up|4|||
161257482|NCT02070757|582322339|FG000|Overall Study|Protocol Violation|0|||
161257483|NCT02070757|582322340|FG001|Overall Study|Protocol Violation|4|||
161257484|NCT02070757|582322339|FG000|Overall Study|Withdrawal by Subject|1|||
161257485|NCT02070757|582322340|FG001|Overall Study|Withdrawal by Subject|3|||
161257486|NCT02070757|582322339|FG000|Overall Study|Investigator Decision|0|||
161257487|NCT02070757|582322340|FG001|Overall Study|Investigator Decision|2|||
161257488|NCT02070757|582322339|FG000|Overall Study|Discharged from Study Hospital|2|||
161257489|NCT02070757|582322340|FG001|Overall Study|Discharged from Study Hospital|2|||
161257490|NCT00126126|582322344|FG000|Overall Study|Lost to Follow-up|0|||
161257491|NCT00126126|582322345|FG001|Overall Study|Lost to Follow-up|2|||
161257492|NCT01570283|582322349|FG000|Cohort 1: Dose Level 1|Death|0|||
161257493|NCT01570283|582322350|FG001|Cohort 1: Dose Level 1|Death|1|||
161257494|NCT01570283|582322351|FG002|Cohort 1: Dose Level 1|Death|0|||
161257495|NCT01570283|582322352|FG003|Cohort 1: Dose Level 1|Death|0|||
161257496|NCT01570283|582322353|FG004|Cohort 1: Dose Level 1|Death|0|||
160916182|NCT00563381|581085112|FG000|Overall Study|Individual different reasons|24|||
160916183|NCT00563381|581085113|FG001|Overall Study|Individual different reasons|34|||
160916184|NCT00667368|581085114|FG000|Overall Study|Lost to Follow-up|176|||
160916185|NCT00667368|581085115|FG001|Overall Study|Lost to Follow-up|155|||
160916186|NCT00667368|581085114|FG000|Overall Study|Discontinued early|24|||
160916187|NCT00667368|581085115|FG001|Overall Study|Discontinued early|17|||
160916188|NCT02407704|581085116|FG000|Overall Study|Lost to Follow-up|0|||
160916189|NCT02407704|581085117|FG001|Overall Study|Lost to Follow-up|0|||
160916190|NCT02407704|581085118|FG002|Overall Study|Lost to Follow-up|0|||
160916191|NCT02407704|581085119|FG003|Overall Study|Lost to Follow-up|2|||
160916192|NCT02407704|581085116|FG000|Overall Study|Protocol Violation|0|||
160916193|NCT02407704|581085117|FG001|Overall Study|Protocol Violation|0|||
160916194|NCT02407704|581085118|FG002|Overall Study|Protocol Violation|0|||
160916195|NCT02407704|581085119|FG003|Overall Study|Protocol Violation|1|||
160916196|NCT02407704|581085116|FG000|Overall Study|Withdrawal by Subject|0|||
160916197|NCT02407704|581085117|FG001|Overall Study|Withdrawal by Subject|0|||
160916198|NCT02407704|581085118|FG002|Overall Study|Withdrawal by Subject|1|||
160916199|NCT02407704|581085119|FG003|Overall Study|Withdrawal by Subject|0|||
160916200|NCT01957644|581085120|FG000|Overall Study|Adverse Event|4|||
160916201|NCT01957644|581085121|FG001|Overall Study|Adverse Event|2|||
160916202|NCT01957644|581085122|FG002|Overall Study|Adverse Event|0|||
160916203|NCT01957644|581085123|FG003|Overall Study|Adverse Event|0|||
160916204|NCT01957644|581085124|FG004|Overall Study|Adverse Event|1|||
160916205|NCT01957644|581085120|FG000|Overall Study|Progressive disease / relapse|0|||
160916206|NCT01957644|581085121|FG001|Overall Study|Progressive disease / relapse|1|||
160916207|NCT01957644|581085122|FG002|Overall Study|Progressive disease / relapse|0|||
161257497|NCT01570283|582322354|FG005|Cohort 1: Dose Level 1|Death|0|||
161257498|NCT01570283|582322349|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161257499|NCT01570283|582322350|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
161257500|NCT01570283|582322351|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161257501|NCT01570283|582322352|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161257502|NCT01570283|582322353|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
160916208|NCT01957644|581085123|FG003|Overall Study|Progressive disease / relapse|1|||
160916209|NCT01957644|581085124|FG004|Overall Study|Progressive disease / relapse|0|||
161257503|NCT01570283|582322354|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
161257504|NCT01570283|582322349|FG000|Cohort 2: Dose Level 2|Death|0|||
160916210|NCT01957644|581085120|FG000|Overall Study|Other reason|1|||
160916211|NCT01957644|581085121|FG001|Overall Study|Other reason|2|||
161142442|NCT03519178|581906202|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
161142443|NCT03519178|581906188|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
161142444|NCT03519178|581906189|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
161142445|NCT03519178|581906190|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
161142446|NCT03519178|581906191|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
161142447|NCT03519178|581906192|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
161142448|NCT03519178|581906193|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
161142449|NCT03519178|581906194|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
161142450|NCT03519178|581906195|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
161142451|NCT03519178|581906196|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
161142452|NCT03519178|581906197|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
161142453|NCT03519178|581906198|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
161142454|NCT03519178|581906199|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
161142455|NCT03519178|581906200|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
161142456|NCT03519178|581906201|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
161142457|NCT03519178|581906202|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
161142458|NCT03519178|581906188|FG000|PF-06873600 Treatment|Refused further treatment|0|||
161142459|NCT03519178|581906189|FG001|PF-06873600 Treatment|Refused further treatment|1|||
161142460|NCT03519178|581906190|FG002|PF-06873600 Treatment|Refused further treatment|0|||
161142461|NCT03519178|581906191|FG003|PF-06873600 Treatment|Refused further treatment|0|||
161339352|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161339353|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161339354|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161339355|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161339356|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161339357|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
161339358|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
161339359|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
161339360|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339361|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339362|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339363|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339364|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339365|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339366|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339367|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
161339368|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
161339369|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
161339370|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161339371|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161339372|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161339373|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160916212|NCT01957644|581085122|FG002|Overall Study|Other reason|1|||
160916213|NCT01957644|581085123|FG003|Overall Study|Other reason|1|||
160916214|NCT01957644|581085124|FG004|Overall Study|Other reason|0|||
160916215|NCT01957644|581085120|FG000|Overall Study|Withdrawal by Subject|1|||
160916216|NCT01957644|581085121|FG001|Overall Study|Withdrawal by Subject|0|||
160916217|NCT01957644|581085122|FG002|Overall Study|Withdrawal by Subject|0|||
160916218|NCT01957644|581085123|FG003|Overall Study|Withdrawal by Subject|0|||
160916219|NCT01957644|581085124|FG004|Overall Study|Withdrawal by Subject|0|||
160916220|NCT01957644|581085120|FG000|Overall Study|Protocol Violation|0|||
160916221|NCT01957644|581085121|FG001|Overall Study|Protocol Violation|1|||
160916222|NCT01957644|581085122|FG002|Overall Study|Protocol Violation|0|||
160916223|NCT01957644|581085123|FG003|Overall Study|Protocol Violation|0|||
160916224|NCT01957644|581085124|FG004|Overall Study|Protocol Violation|0|||
160916225|NCT04044716|581085125|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
160916226|NCT04044716|581085126|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
160916227|NCT04044716|581085127|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
160916228|NCT04044716|581085125|FG000|Overall Study|Lost to Follow-up|2|||
160916229|NCT04044716|581085126|FG001|Overall Study|Lost to Follow-up|3|||
160916230|NCT04044716|581085127|FG002|Overall Study|Lost to Follow-up|0|||
160916231|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
160916232|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
160916233|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
160996307|NCT03451851|581372187|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161142462|NCT03519178|581906192|FG004|PF-06873600 Treatment|Refused further treatment|1|||
161142663|NCT03519178|581906198|FG010|Fulvestrant. Treatment|Other|0|||
161339374|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
160916234|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
161339375|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161339376|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161339377|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
161339378|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
161339379|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
161339380|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339381|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339382|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339383|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339384|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339385|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339386|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339387|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339388|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
161339389|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
161339390|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339391|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339392|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339393|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339394|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339395|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339396|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339397|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339398|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
161339399|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
161339400|NCT01232283|582630420|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339401|NCT01232283|582630421|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339402|NCT01232283|582630422|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339403|NCT01232283|582630423|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339404|NCT01232283|582630424|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339405|NCT01232283|582630425|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339406|NCT01232283|582630426|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339407|NCT01232283|582630427|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
161339408|NCT01232283|582630428|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
161339409|NCT01232283|582630429|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
161339410|NCT03191552|582630436|FG000|Overall Study|Lost to Follow-up|1|||
161339411|NCT03191552|582630437|FG001|Overall Study|Lost to Follow-up|0|||
161339412|NCT03191552|582630438|FG002|Overall Study|Lost to Follow-up|0|||
161339413|NCT03191552|582630436|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
161339414|NCT03191552|582630437|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
161339415|NCT03191552|582630438|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
161339416|NCT01499810|582630441|FG000|Overall Study|Lost to Follow-up|10|||
161339417|NCT01499810|582630441|FG000|Overall Study|Protocol Violation|1|||
161339418|NCT01499810|582630441|FG000|Overall Study|Withdrawal by Subject|1|||
161339419|NCT01884597|582630442|FG000|Overall Study|Adverse Event|0|||
161339420|NCT01884597|582630443|FG001|Overall Study|Adverse Event|0|||
161339421|NCT01884597|582630444|FG002|Overall Study|Adverse Event|1|||
161339422|NCT01884597|582630442|FG000|Overall Study|Lack of Efficacy|1|||
160916235|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
160916236|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
160916237|NCT01957553|581085128|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
160916238|NCT01957553|581085129|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
160916239|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
160916240|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
160916241|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
160916242|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
160916243|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
160916244|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
160916245|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
160916246|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
160916247|NCT01957553|581085128|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
160996308|NCT03451851|581372188|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161339423|NCT01884597|582630443|FG001|Overall Study|Lack of Efficacy|0|||
161339424|NCT01884597|582630444|FG002|Overall Study|Lack of Efficacy|0|||
161339425|NCT01884597|582630442|FG000|Overall Study|Death|0|||
160916248|NCT01957553|581085129|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
161257505|NCT01570283|582322350|FG001|Cohort 2: Dose Level 2|Death|0|||
160916249|NCT03235154|581085133|FG000|Overall Study|Withdrawal by Subject|1|||
160916250|NCT03235154|581085133|FG000|Overall Study|Adverse Event|1|||
160916251|NCT03235154|581085133|FG000|Overall Study|Lost to Follow-up|2|||
160916252|NCT01683383|581085138|FG000|Overall Study|Infant was not transported|1|||
160916253|NCT01683383|581085139|FG001|Overall Study|Infant was not transported|0|||
161257506|NCT01570283|582322351|FG002|Cohort 2: Dose Level 2|Death|1|||
160916254|NCT02496611|581085140|FG000|Overall Study|Lost to Follow-up|2|||
160916255|NCT02496611|581085141|FG001|Overall Study|Lost to Follow-up|1|||
160916256|NCT02496611|581085140|FG000|Overall Study|Withdrawal by Subject|5|||
160916257|NCT02496611|581085141|FG001|Overall Study|Withdrawal by Subject|2|||
160916258|NCT02850965|581085142|FG000|Overall Study|Other than listed|3|||
160916259|NCT02850965|581085143|FG001|Overall Study|Other than listed|4|||
160916260|NCT02850965|581085142|FG000|Overall Study|Protocol Violation|0|||
160916261|NCT02850965|581085143|FG001|Overall Study|Protocol Violation|2|||
160916262|NCT02850965|581085142|FG000|Overall Study|Lost to Follow-up|5|||
160916263|NCT02850965|581085143|FG001|Overall Study|Lost to Follow-up|3|||
160916264|NCT02850965|581085142|FG000|Overall Study|Lack of Efficacy|4|||
160916265|NCT02850965|581085143|FG001|Overall Study|Lack of Efficacy|8|||
160916266|NCT02850965|581085142|FG000|Overall Study|Adverse Event|3|||
160916267|NCT02850965|581085143|FG001|Overall Study|Adverse Event|2|||
160916268|NCT02850965|581085142|FG000|Overall Study|Withdrawal by Subject|3|||
160916269|NCT02850965|581085143|FG001|Overall Study|Withdrawal by Subject|4|||
160916270|NCT02850965|581085142|FG000|Overall Study|Physician Decision|0|||
160916271|NCT02850965|581085143|FG001|Overall Study|Physician Decision|1|||
160916272|NCT02850965|581085142|FG000|Overall Study|Randomized but not treated|0|||
160916273|NCT02850965|581085143|FG001|Overall Study|Randomized but not treated|1|||
160916274|NCT00536198|581085144|FG000|Overall Study|Lost to Follow-up|15|||
160916275|NCT00536198|581085145|FG001|Overall Study|Lost to Follow-up|14|||
160916276|NCT00536198|581085144|FG000|Overall Study|Withdrawal by Subject|16|||
161257507|NCT01570283|582322352|FG003|Cohort 2: Dose Level 2|Death|0|||
161257508|NCT01570283|582322353|FG004|Cohort 2: Dose Level 2|Death|0|||
161257509|NCT01570283|582322354|FG005|Cohort 2: Dose Level 2|Death|0|||
161257510|NCT01570283|582322349|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161257511|NCT01570283|582322350|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161257512|NCT01570283|582322351|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161257513|NCT01570283|582322352|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
161257514|NCT01570283|582322353|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161257515|NCT01570283|582322354|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
161257516|NCT01570283|582322349|FG000|Cohort 3: Dose Level 3|Death|0|||
161257517|NCT01570283|582322350|FG001|Cohort 3: Dose Level 3|Death|0|||
161257518|NCT01570283|582322351|FG002|Cohort 3: Dose Level 3|Death|0|||
161257519|NCT01570283|582322352|FG003|Cohort 3: Dose Level 3|Death|0|||
161257520|NCT01570283|582322353|FG004|Cohort 3: Dose Level 3|Death|0|||
161257521|NCT01570283|582322354|FG005|Cohort 3: Dose Level 3|Death|1|||
161339426|NCT01884597|582630443|FG001|Overall Study|Death|1|||
161339427|NCT01884597|582630444|FG002|Overall Study|Death|0|||
161339428|NCT02634710|582630445|FG000|Overall Study|Death|4|||
161339429|NCT00109343|582631879|FG000|Overall Study|Adverse Event|1|||
161339430|NCT00109343|582631880|FG001|Overall Study|Adverse Event|0|||
161339431|NCT00109343|582631881|FG002|Overall Study|Adverse Event|2|||
160916277|NCT00536198|581085145|FG001|Overall Study|Withdrawal by Subject|12|||
160916278|NCT00536198|581085144|FG000|Overall Study|Adverse Event|2|||
160916279|NCT00536198|581085145|FG001|Overall Study|Adverse Event|2|||
160916280|NCT00536198|581085144|FG000|Overall Study|Rescue|3|||
160916281|NCT00536198|581085145|FG001|Overall Study|Rescue|9|||
160916282|NCT00536198|581085144|FG000|Overall Study|Pregnancy|1|||
160916283|NCT00536198|581085145|FG001|Overall Study|Pregnancy|1|||
160916284|NCT00536198|581085144|FG000|Overall Study|Protocol Violation|0|||
160916285|NCT00536198|581085145|FG001|Overall Study|Protocol Violation|1|||
160996309|NCT03451851|581372189|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
161257522|NCT01570283|582322349|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161257523|NCT01570283|582322350|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161339432|NCT00109343|582631879|FG000|Overall Study|Lack of Efficacy|1|||
161339433|NCT00109343|582631880|FG001|Overall Study|Lack of Efficacy|0|||
161339434|NCT00109343|582631881|FG002|Overall Study|Lack of Efficacy|0|||
160916286|NCT00881712|581085146|FG000|Overall Study|Death|1|||
160916287|NCT00881712|581085147|FG001|Overall Study|Death|0|||
160916288|NCT00881712|581085148|FG002|Overall Study|Death|0|||
160916289|NCT00881712|581085146|FG000|Overall Study|Withdrawal by Subject|1|||
160916290|NCT00881712|581085147|FG001|Overall Study|Withdrawal by Subject|0|||
160916291|NCT00881712|581085148|FG002|Overall Study|Withdrawal by Subject|0|||
160916292|NCT00276744|581085149|FG000|PART A|Reason unknown|98|||
160916293|NCT00965718|581085160|FG000|Overall Study|Withdrawal by Subject|4|||
160916294|NCT03667924|581085161|FG000|Baseline Completed|Lost to Follow-up|0|||
160916295|NCT03667924|581085162|FG001|Baseline Completed|Lost to Follow-up|2|||
160916296|NCT03667924|581085163|FG002|Baseline Completed|Lost to Follow-up|0|||
161257524|NCT01570283|582322351|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161257525|NCT01570283|582322352|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161257526|NCT01570283|582322353|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
161257527|NCT01570283|582322354|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
161257528|NCT01833533|582322355|FG000|Overall Study|Adverse Event|0|||
161257529|NCT01833533|582322356|FG001|Overall Study|Adverse Event|1|||
161257530|NCT01833533|582322355|FG000|Overall Study|Lost to Follow-up|4|||
161257531|NCT01833533|582322356|FG001|Overall Study|Lost to Follow-up|9|||
161257532|NCT01833533|582322355|FG000|Overall Study|To Enter an Extension Study|0|||
161257533|NCT01833533|582322356|FG001|Overall Study|To Enter an Extension Study|4|||
161257534|NCT01833533|582322355|FG000|Overall Study|Other|2|||
161257535|NCT01833533|582322356|FG001|Overall Study|Other|7|||
161257536|NCT02017860|582322357|FG000|Overall Study|Adverse Event|1|||
161257537|NCT02017860|582322357|FG000|Overall Study|Withdrawal by Subject|1|||
161257538|NCT01048502|582322360|FG000|Overall Study|Lost to Follow-up|2|||
161257539|NCT01048502|582322361|FG001|Overall Study|Lost to Follow-up|0|||
161257540|NCT01048502|582322362|FG002|Overall Study|Lost to Follow-up|0|||
161257541|NCT01048502|582322363|FG003|Overall Study|Lost to Follow-up|0|||
161257542|NCT01048502|582322360|FG000|Overall Study|Adverse Event|1|||
161257543|NCT01048502|582322361|FG001|Overall Study|Adverse Event|0|||
161257544|NCT01048502|582322362|FG002|Overall Study|Adverse Event|0|||
161257545|NCT01048502|582322363|FG003|Overall Study|Adverse Event|0|||
161257546|NCT01048502|582322360|FG000|Overall Study|Withdrawal by Subject|1|||
161257547|NCT01048502|582322361|FG001|Overall Study|Withdrawal by Subject|4|||
161257548|NCT01048502|582322362|FG002|Overall Study|Withdrawal by Subject|5|||
161257549|NCT01048502|582322363|FG003|Overall Study|Withdrawal by Subject|3|||
161257550|NCT01048502|582322360|FG000|Overall Study|Physician Decision|0|||
161257551|NCT01048502|582322361|FG001|Overall Study|Physician Decision|3|||
161257552|NCT01048502|582322362|FG002|Overall Study|Physician Decision|0|||
161257553|NCT01048502|582322363|FG003|Overall Study|Physician Decision|1|||
161257554|NCT01333072|582322365|FG000|Overall Study|Lost to Follow-up|3|||
161257555|NCT01333072|582322366|FG001|Overall Study|Lost to Follow-up|0|||
161257556|NCT01333072|582322365|FG000|Overall Study|Adverse Event|2|||
161257557|NCT01333072|582322366|FG001|Overall Study|Adverse Event|4|||
161257558|NCT01333072|582322365|FG000|Overall Study|Physician Decision|1|||
161257559|NCT01333072|582322366|FG001|Overall Study|Physician Decision|0|||
161257560|NCT02457611|582322367|FG000|Overall Study|Lost to Follow-up|3|||
161257561|NCT00493454|582322368|FG000|Overall Study|Withdrawal by Subject|1|||
161257562|NCT04220775|582322369|FG000|Overall Study|Adverse Event|1|||
161257563|NCT04220775|582322370|FG001|Overall Study|Adverse Event|0|||
161257564|NCT04220775|582322369|FG000|Overall Study|Disease Progression|1|||
161257565|NCT04220775|582322370|FG001|Overall Study|Disease Progression|0|||
161257566|NCT01857206|582322372|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
161257567|NCT01857206|582322373|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
161257568|NCT01857206|582322372|FG000|Overall Study|Lost to Follow-up|9|||
161257569|NCT01857206|582322373|FG001|Overall Study|Lost to Follow-up|6|||
161257570|NCT01857206|582322372|FG000|Overall Study|Unclassified|3|||
161257571|NCT01857206|582322373|FG001|Overall Study|Unclassified|3|||
161257572|NCT01857206|582322372|FG000|Overall Study|Withdrawal by Subject|1|||
161257573|NCT01857206|582322373|FG001|Overall Study|Withdrawal by Subject|0|||
161257574|NCT01483625|582322376|FG000|Overall Study|Adverse Event|1|||
161257575|NCT01483625|582322377|FG001|Overall Study|Adverse Event|1|||
161257576|NCT01483625|582322376|FG000|Overall Study|Refused to continue medication|2|||
161257577|NCT01483625|582322377|FG001|Overall Study|Refused to continue medication|1|||
161257578|NCT01483625|582322376|FG000|Overall Study|Due to other reason|1|||
160916297|NCT03667924|581085161|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
160916298|NCT03667924|581085162|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
160916299|NCT03667924|581085163|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
160916300|NCT03667924|581085161|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
160916301|NCT03667924|581085162|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
160916302|NCT03667924|581085163|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
161142664|NCT03519178|581906199|FG011|Fulvestrant. Treatment|Other|0|||
161257579|NCT01483625|582322377|FG001|Overall Study|Due to other reason|0|||
161257580|NCT00084799|582322378|FG000|Overall Study|Disease Progression|1|||
161257581|NCT00084799|582322379|FG001|Overall Study|Disease Progression|0|||
161257582|NCT01261624|582322380|FG000|Week 0 to Week 12|Disease Progression|1|||
161257583|NCT01261624|582322381|FG001|Week 0 to Week 12|Disease Progression|1|||
161257584|NCT01261624|582322380|FG000|Week 0 to Week 12|Insufficient Response|0|||
161257585|NCT01261624|582322381|FG001|Week 0 to Week 12|Insufficient Response|2|||
161257586|NCT01261624|582322380|FG000|Week 13 to Week 24|Insufficient Response|0|||
161339435|NCT00109343|582631879|FG000|Overall Study|Lost to Follow-up|35|||
161257587|NCT01261624|582322381|FG001|Week 13 to Week 24|Insufficient Response|1|||
161257588|NCT02094261|582322385|FG000|Overall Study|Death|24|||
161257589|NCT02094261|582322385|FG000|Overall Study|Lost to Follow-up|1|||
161257590|NCT02094261|582322385|FG000|Overall Study|Withdrawal by Subject|4|||
161257591|NCT02094261|582322385|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
161257592|NCT02363439|582322386|FG000|Overall Study|Lack of Efficacy|4|||
161257593|NCT02010255|582322391|FG000|Overall Study|Death|0|||
161257594|NCT02010255|582322392|FG001|Overall Study|Death|1|||
161257595|NCT02010255|582322393|FG002|Overall Study|Death|4|||
161257596|NCT02010255|582322394|FG003|Overall Study|Death|4|||
161257597|NCT02010255|582322395|FG004|Overall Study|Death|2|||
161257598|NCT02010255|582322396|FG005|Overall Study|Death|0|||
161257599|NCT02010255|582322397|FG006|Overall Study|Death|1|||
161257600|NCT02010255|582322398|FG007|Overall Study|Death|1|||
161257601|NCT02010255|582322399|FG008|Overall Study|Death|1|||
161257602|NCT02010255|582322400|FG009|Overall Study|Death|0|||
161257603|NCT02010255|582322401|FG010|Overall Study|Death|1|||
161257604|NCT02010255|582322402|FG011|Overall Study|Death|1|||
161257605|NCT02010255|582322403|FG012|Overall Study|Death|0|||
161257606|NCT02010255|582322404|FG013|Overall Study|Death|0|||
161257607|NCT02010255|582322391|FG000|Overall Study|Lack of Efficacy|4|||
161257608|NCT02010255|582322392|FG001|Overall Study|Lack of Efficacy|1|||
161257609|NCT02010255|582322393|FG002|Overall Study|Lack of Efficacy|2|||
161257610|NCT02010255|582322394|FG003|Overall Study|Lack of Efficacy|1|||
161257611|NCT02010255|582322395|FG004|Overall Study|Lack of Efficacy|1|||
161257612|NCT02010255|582322396|FG005|Overall Study|Lack of Efficacy|0|||
161257613|NCT02010255|582322397|FG006|Overall Study|Lack of Efficacy|0|||
161257614|NCT02010255|582322398|FG007|Overall Study|Lack of Efficacy|0|||
161257615|NCT02010255|582322399|FG008|Overall Study|Lack of Efficacy|0|||
161257616|NCT02010255|582322400|FG009|Overall Study|Lack of Efficacy|0|||
161257617|NCT02010255|582322401|FG010|Overall Study|Lack of Efficacy|1|||
161257618|NCT02010255|582322402|FG011|Overall Study|Lack of Efficacy|0|||
161257619|NCT02010255|582322403|FG012|Overall Study|Lack of Efficacy|0|||
161257620|NCT02010255|582322404|FG013|Overall Study|Lack of Efficacy|0|||
161257621|NCT02010255|582322391|FG000|Overall Study|Withdrew Consent|1|||
161257622|NCT02010255|582322392|FG001|Overall Study|Withdrew Consent|0|||
161257623|NCT02010255|582322393|FG002|Overall Study|Withdrew Consent|0|||
161257624|NCT02010255|582322394|FG003|Overall Study|Withdrew Consent|1|||
161257625|NCT02010255|582322395|FG004|Overall Study|Withdrew Consent|0|||
161257626|NCT02010255|582322396|FG005|Overall Study|Withdrew Consent|0|||
161257627|NCT02010255|582322397|FG006|Overall Study|Withdrew Consent|0|||
161257628|NCT02010255|582322398|FG007|Overall Study|Withdrew Consent|0|||
161257629|NCT02010255|582322399|FG008|Overall Study|Withdrew Consent|0|||
161257630|NCT02010255|582322400|FG009|Overall Study|Withdrew Consent|0|||
160916303|NCT03667924|581085161|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
160916304|NCT03667924|581085162|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
160916305|NCT03667924|581085163|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
160916306|NCT03667924|581085161|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
160916307|NCT03667924|581085162|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
160916308|NCT03667924|581085163|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
160916309|NCT03667924|581085161|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
160916310|NCT03667924|581085162|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
160916311|NCT03667924|581085163|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
160916312|NCT03667924|581085161|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
160916313|NCT03667924|581085162|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
160916314|NCT03667924|581085163|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
160916315|NCT00126568|581085164|FG000|Overall Study|Death|2|||
160916316|NCT01244425|581085165|FG000|Overall Study|Withdrawal by Subject|2|||
160916317|NCT01244425|581085166|FG001|Overall Study|Withdrawal by Subject|2|||
160916318|NCT01244425|581085165|FG000|Overall Study|Adverse Event|1|||
160916319|NCT01244425|581085166|FG001|Overall Study|Adverse Event|1|||
160916320|NCT02167893|581085167|FG000|Overall Study|Investigator transferred|85|||
160916321|NCT02167893|581085167|FG000|Overall Study|Investigator health reasons|10|||
160916322|NCT02167893|581085167|FG000|Overall Study|Case report forms not collected|68|||
160916323|NCT04847557|581085168|FG000|Overall Study|Adverse Event|1|||
160996310|NCT03451851|581372182|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996311|NCT03451851|581372183|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996312|NCT03451851|581372184|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
161257631|NCT02010255|582322401|FG010|Overall Study|Withdrew Consent|0|||
161257632|NCT02010255|582322402|FG011|Overall Study|Withdrew Consent|0|||
161257633|NCT02010255|582322403|FG012|Overall Study|Withdrew Consent|0|||
161257634|NCT02010255|582322404|FG013|Overall Study|Withdrew Consent|0|||
161257635|NCT02010255|582322391|FG000|Overall Study|Adverse Event|1|||
161257636|NCT02010255|582322392|FG001|Overall Study|Adverse Event|0|||
161257637|NCT02010255|582322393|FG002|Overall Study|Adverse Event|0|||
161257638|NCT02010255|582322394|FG003|Overall Study|Adverse Event|0|||
161257639|NCT02010255|582322395|FG004|Overall Study|Adverse Event|0|||
161257640|NCT02010255|582322396|FG005|Overall Study|Adverse Event|0|||
161257641|NCT02010255|582322397|FG006|Overall Study|Adverse Event|0|||
161257642|NCT02010255|582322398|FG007|Overall Study|Adverse Event|0|||
161257643|NCT02010255|582322399|FG008|Overall Study|Adverse Event|0|||
161257644|NCT02010255|582322400|FG009|Overall Study|Adverse Event|0|||
160916324|NCT04847557|581085169|FG001|Overall Study|Adverse Event|0|||
160916325|NCT04847557|581085168|FG000|Overall Study|Death|19|||
160916326|NCT04847557|581085169|FG001|Overall Study|Death|15|||
160916327|NCT04847557|581085168|FG000|Overall Study|Lost to Follow-up|3|||
160916328|NCT04847557|581085169|FG001|Overall Study|Lost to Follow-up|6|||
160916329|NCT04847557|581085168|FG000|Overall Study|Physician Decision|1|||
160916330|NCT04847557|581085169|FG001|Overall Study|Physician Decision|0|||
160916331|NCT04847557|581085168|FG000|Overall Study|Protocol Violation|0|||
160916332|NCT04847557|581085169|FG001|Overall Study|Protocol Violation|1|||
160916333|NCT04847557|581085168|FG000|Overall Study|Withdrawal by Subject|8|||
160916334|NCT04847557|581085169|FG001|Overall Study|Withdrawal by Subject|14|||
160916335|NCT01325584|581085170|FG000|Overall Study|Death|1|||
160916336|NCT00733408|581086665|FG000|Overall Study|Adverse Event|4|||
160916337|NCT01134783|581086666|FG000|Overall Study|Pregnancy|16|||
160916338|NCT01134783|581086667|FG001|Overall Study|Pregnancy|8|||
160916339|NCT01134783|581086666|FG000|Overall Study|Withdrawal by Subject|15|||
160916340|NCT01134783|581086667|FG001|Overall Study|Withdrawal by Subject|9|||
160916341|NCT01134783|581086666|FG000|Overall Study|Lost to Follow-up|5|||
160916342|NCT01134783|581086667|FG001|Overall Study|Lost to Follow-up|20|||
160916343|NCT00531232|581086670|FG000|Overall Study|Investigator decision|0|||
160916344|NCT00531232|581086671|FG001|Overall Study|Investigator decision|0|||
160916345|NCT00531232|581086672|FG002|Overall Study|Investigator decision|4|||
160916346|NCT00531232|581086670|FG000|Overall Study|Participants refused further treatment|0|||
160916347|NCT00531232|581086671|FG001|Overall Study|Participants refused further treatment|1|||
160916348|NCT00531232|581086672|FG002|Overall Study|Participants refused further treatment|2|||
160916349|NCT00531232|581086670|FG000|Overall Study|Adverse events (AEs)|1|||
160916350|NCT00531232|581086671|FG001|Overall Study|Adverse events (AEs)|2|||
160916351|NCT00531232|581086672|FG002|Overall Study|Adverse events (AEs)|2|||
160916352|NCT00531232|581086670|FG000|Overall Study|Treatment failure|1|||
160916353|NCT00531232|581086671|FG001|Overall Study|Treatment failure|3|||
160916354|NCT00531232|581086672|FG002|Overall Study|Treatment failure|7|||
160916355|NCT00531232|581086670|FG000|Overall Study|Disease recurrence|0|||
160916356|NCT00531232|581086671|FG001|Overall Study|Disease recurrence|0|||
160916357|NCT00531232|581086672|FG002|Overall Study|Disease recurrence|1|||
160916358|NCT00531232|581086670|FG000|Overall Study|Deceased|2|||
160916359|NCT00531232|581086671|FG001|Overall Study|Deceased|2|||
160916360|NCT00531232|581086672|FG002|Overall Study|Deceased|2|||
160916361|NCT00531232|581086670|FG000|Overall Study|Withdrawal by Subject|0|||
160916362|NCT00531232|581086671|FG001|Overall Study|Withdrawal by Subject|1|||
160916363|NCT00531232|581086672|FG002|Overall Study|Withdrawal by Subject|2|||
160916364|NCT00531232|581086670|FG000|Overall Study|Other|0|||
160916365|NCT00531232|581086671|FG001|Overall Study|Other|0|||
160916366|NCT00531232|581086672|FG002|Overall Study|Other|5|||
160916367|NCT00397982|581086673|FG000|Overall Study|Withdrawal by Subject|1|||
160916368|NCT00397982|581086673|FG000|Overall Study|Adverse Event|1|||
160916369|NCT00397982|581086673|FG000|Overall Study|noncompliance|1|||
160916370|NCT00397982|581086673|FG000|Overall Study|Unrelated health issues|1|||
160916371|NCT02345850|581086674|FG000|Overall Study|Not transplanted|10|||
161257645|NCT02010255|582322401|FG010|Overall Study|Adverse Event|0|||
161257646|NCT02010255|582322402|FG011|Overall Study|Adverse Event|0|||
161257647|NCT02010255|582322403|FG012|Overall Study|Adverse Event|0|||
161257648|NCT02010255|582322404|FG013|Overall Study|Adverse Event|0|||
161257649|NCT02010255|582322391|FG000|Overall Study|Lost to Follow-up|0|||
161257650|NCT02010255|582322392|FG001|Overall Study|Lost to Follow-up|0|||
161257651|NCT02010255|582322393|FG002|Overall Study|Lost to Follow-up|1|||
161257652|NCT02010255|582322394|FG003|Overall Study|Lost to Follow-up|0|||
161257653|NCT02010255|582322395|FG004|Overall Study|Lost to Follow-up|1|||
161257654|NCT02010255|582322396|FG005|Overall Study|Lost to Follow-up|0|||
160916372|NCT02345850|581086675|FG001|Overall Study|Not transplanted|5|||
160916373|NCT02345850|581086676|FG002|Overall Study|Not transplanted|4|||
160916374|NCT02345850|581086674|FG000|Overall Study|Lost to Follow-up|2|||
160916375|NCT02345850|581086675|FG001|Overall Study|Lost to Follow-up|3|||
160916376|NCT02345850|581086676|FG002|Overall Study|Lost to Follow-up|2|||
160916377|NCT02345850|581086674|FG000|Overall Study|Withdrawal by Subject|1|||
160916378|NCT02345850|581086675|FG001|Overall Study|Withdrawal by Subject|0|||
161257655|NCT02010255|582322397|FG006|Overall Study|Lost to Follow-up|0|||
161257656|NCT02010255|582322398|FG007|Overall Study|Lost to Follow-up|0|||
160916379|NCT02345850|581086676|FG002|Overall Study|Withdrawal by Subject|0|||
160916380|NCT00463346|581086678|FG000|Overall Study|Withdrawal by Subject|3|||
160916381|NCT00463346|581086679|FG001|Overall Study|Withdrawal by Subject|3|||
160916382|NCT02392247|581086680|FG000|Overall Study|Withdrawal by Subject|1|||
160916383|NCT02392247|581086680|FG000|Overall Study|Surgery cancelled; no data|1|||
160916384|NCT03641651|581086681|FG000|Overall Study|organizational issues at one study site|1|||
160916385|NCT01991067|581086683|FG000|Overall Study|Lost to Follow-up|6|||
160916386|NCT01991067|581086684|FG001|Overall Study|Lost to Follow-up|5|||
160916387|NCT00951665|581086686|FG000|Phase 1b|Adverse Event|2|||
161257657|NCT02010255|582322399|FG008|Overall Study|Lost to Follow-up|0|||
160916388|NCT00951665|581086687|FG001|Phase 1b|Adverse Event|1|||
161257658|NCT02010255|582322400|FG009|Overall Study|Lost to Follow-up|0|||
161257659|NCT02010255|582322401|FG010|Overall Study|Lost to Follow-up|0|||
160916389|NCT00951665|581086688|FG002|Phase 1b|Adverse Event|0|||
160916390|NCT00951665|581086689|FG003|Phase 1b|Adverse Event|1|||
160916391|NCT00951665|581086690|FG004|Phase 1b|Adverse Event|0|||
160916392|NCT00951665|581086691|FG005|Phase 1b|Adverse Event|0|||
160916393|NCT00951665|581086686|FG000|Phase 1b|Death|1|||
160916394|NCT00951665|581086687|FG001|Phase 1b|Death|0|||
160916395|NCT00951665|581086688|FG002|Phase 1b|Death|2|||
160916396|NCT00951665|581086689|FG003|Phase 1b|Death|0|||
160916397|NCT00951665|581086690|FG004|Phase 1b|Death|0|||
160916398|NCT00951665|581086691|FG005|Phase 1b|Death|0|||
160916399|NCT00951665|581086686|FG000|Phase 1b|Physician Decision|4|||
160916400|NCT00951665|581086687|FG001|Phase 1b|Physician Decision|0|||
160916401|NCT00951665|581086688|FG002|Phase 1b|Physician Decision|1|||
160916402|NCT00951665|581086689|FG003|Phase 1b|Physician Decision|0|||
160916403|NCT00951665|581086690|FG004|Phase 1b|Physician Decision|0|||
160916404|NCT00951665|581086691|FG005|Phase 1b|Physician Decision|0|||
160916405|NCT00951665|581086686|FG000|Phase 1b|Withdrawal by Subject|0|||
160916406|NCT00951665|581086687|FG001|Phase 1b|Withdrawal by Subject|1|||
160916407|NCT00951665|581086688|FG002|Phase 1b|Withdrawal by Subject|0|||
160916408|NCT00951665|581086689|FG003|Phase 1b|Withdrawal by Subject|0|||
160916409|NCT00951665|581086690|FG004|Phase 1b|Withdrawal by Subject|0|||
160916410|NCT00951665|581086691|FG005|Phase 1b|Withdrawal by Subject|0|||
160916411|NCT00951665|581086686|FG000|Phase 1b|Disease Progression|13|||
160916412|NCT00951665|581086687|FG001|Phase 1b|Disease Progression|2|||
160916413|NCT00951665|581086688|FG002|Phase 1b|Disease Progression|14|||
160916414|NCT00951665|581086689|FG003|Phase 1b|Disease Progression|0|||
160916415|NCT00951665|581086690|FG004|Phase 1b|Disease Progression|0|||
160916416|NCT00951665|581086691|FG005|Phase 1b|Disease Progression|0|||
160916417|NCT00951665|581086686|FG000|Phase 1b|Protocol Violation|2|||
160916418|NCT00951665|581086687|FG001|Phase 1b|Protocol Violation|0|||
160916419|NCT00951665|581086688|FG002|Phase 1b|Protocol Violation|0|||
160916420|NCT00951665|581086689|FG003|Phase 1b|Protocol Violation|0|||
160916421|NCT00951665|581086690|FG004|Phase 1b|Protocol Violation|0|||
160916422|NCT00951665|581086691|FG005|Phase 1b|Protocol Violation|0|||
160916423|NCT00951665|581086686|FG000|Phase 2a|Adverse Event|0|||
160916424|NCT00951665|581086687|FG001|Phase 2a|Adverse Event|0|||
160916425|NCT00951665|581086688|FG002|Phase 2a|Adverse Event|0|||
160916426|NCT00951665|581086689|FG003|Phase 2a|Adverse Event|0|||
160916427|NCT00951665|581086690|FG004|Phase 2a|Adverse Event|2|||
160916428|NCT00951665|581086691|FG005|Phase 2a|Adverse Event|0|||
160916429|NCT00951665|581086686|FG000|Phase 2a|Death|0|||
160916430|NCT00951665|581086687|FG001|Phase 2a|Death|0|||
160916431|NCT00951665|581086688|FG002|Phase 2a|Death|0|||
160916432|NCT00951665|581086689|FG003|Phase 2a|Death|0|||
160916433|NCT00951665|581086690|FG004|Phase 2a|Death|1|||
160916434|NCT00951665|581086691|FG005|Phase 2a|Death|1|||
160916435|NCT00951665|581086686|FG000|Phase 2a|Lost to Follow-up|0|||
160916436|NCT00951665|581086687|FG001|Phase 2a|Lost to Follow-up|0|||
160916437|NCT00951665|581086688|FG002|Phase 2a|Lost to Follow-up|0|||
160916438|NCT00951665|581086689|FG003|Phase 2a|Lost to Follow-up|0|||
160916439|NCT00951665|581086690|FG004|Phase 2a|Lost to Follow-up|1|||
160916440|NCT00951665|581086691|FG005|Phase 2a|Lost to Follow-up|0|||
160916441|NCT00951665|581086686|FG000|Phase 2a|Physician Decision|0|||
160916442|NCT00951665|581086687|FG001|Phase 2a|Physician Decision|0|||
160916443|NCT00951665|581086688|FG002|Phase 2a|Physician Decision|0|||
160916444|NCT00951665|581086689|FG003|Phase 2a|Physician Decision|0|||
160916445|NCT00951665|581086690|FG004|Phase 2a|Physician Decision|0|||
160916446|NCT00951665|581086691|FG005|Phase 2a|Physician Decision|1|||
160916447|NCT00951665|581086686|FG000|Phase 2a|Withdrawal by Subject|0|||
160916448|NCT00951665|581086687|FG001|Phase 2a|Withdrawal by Subject|0|||
160916449|NCT00951665|581086688|FG002|Phase 2a|Withdrawal by Subject|0|||
160916450|NCT00951665|581086689|FG003|Phase 2a|Withdrawal by Subject|0|||
160916451|NCT00951665|581086690|FG004|Phase 2a|Withdrawal by Subject|2|||
160916452|NCT00951665|581086691|FG005|Phase 2a|Withdrawal by Subject|0|||
160916453|NCT00951665|581086686|FG000|Phase 2a|Disease Progression|0|||
160916454|NCT00951665|581086687|FG001|Phase 2a|Disease Progression|0|||
160916455|NCT00951665|581086688|FG002|Phase 2a|Disease Progression|0|||
160916456|NCT00951665|581086689|FG003|Phase 2a|Disease Progression|0|||
160916457|NCT00951665|581086690|FG004|Phase 2a|Disease Progression|6|||
160916458|NCT00951665|581086691|FG005|Phase 2a|Disease Progression|5|||
160916459|NCT02450903|581086692|FG000|Overall Study|Adverse Event|3|||
160916460|NCT02450903|581086692|FG000|Overall Study|Progressive disease|15|||
160916461|NCT02450903|581086692|FG000|Overall Study|Switched to commercial drug|1|||
160916462|NCT02450903|581086692|FG000|Overall Study|Subject/guardian decision|1|||
160916463|NCT00592839|581086693|FG000|Overall Study|Withdrawal by Subject|1|||
160916464|NCT00592839|581086694|FG001|Overall Study|Withdrawal by Subject|1|||
160916465|NCT00592839|581086695|FG002|Overall Study|Withdrawal by Subject|3|||
160916466|NCT00592839|581086693|FG000|Overall Study|Protocol Violation|1|||
160916467|NCT00592839|581086694|FG001|Overall Study|Protocol Violation|1|||
160916468|NCT00592839|581086695|FG002|Overall Study|Protocol Violation|2|||
160916469|NCT00592839|581086693|FG000|Overall Study|Adverse Event|0|||
160916470|NCT00592839|581086694|FG001|Overall Study|Adverse Event|1|||
160916471|NCT00592839|581086695|FG002|Overall Study|Adverse Event|0|||
160916472|NCT00592839|581086693|FG000|Overall Study|Lost to Follow-up|0|||
160996313|NCT03451851|581372185|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996314|NCT03451851|581372186|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
160996315|NCT03451851|581372187|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996316|NCT03451851|581372188|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996317|NCT03451851|581372189|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
160996318|NCT03354390|581372190|FG000|Level 1|Death|2|||
160996319|NCT03354390|581372191|FG001|Level 1|Death|0|||
160996320|NCT03354390|581372192|FG002|Level 1|Death|0|||
160996321|NCT03354390|581372193|FG003|Level 1|Death|0|||
160996322|NCT03354390|581372190|FG000|Level 1|Physician Decision|1|||
160996323|NCT03354390|581372191|FG001|Level 1|Physician Decision|0|||
160996324|NCT03354390|581372192|FG002|Level 1|Physician Decision|0|||
160996325|NCT03354390|581372193|FG003|Level 1|Physician Decision|0|||
160996326|NCT03354390|581372190|FG000|Level 2|Physician Decision|0|||
160996327|NCT03354390|581372191|FG001|Level 2|Physician Decision|2|||
161257660|NCT02010255|582322402|FG011|Overall Study|Lost to Follow-up|0|||
161257661|NCT02010255|582322403|FG012|Overall Study|Lost to Follow-up|0|||
161257662|NCT02010255|582322404|FG013|Overall Study|Lost to Follow-up|0|||
161257663|NCT02010255|582322391|FG000|Overall Study|Randomized but Not Treated|0|||
161257664|NCT02010255|582322392|FG001|Overall Study|Randomized but Not Treated|0|||
161257665|NCT02010255|582322393|FG002|Overall Study|Randomized but Not Treated|0|||
161257666|NCT02010255|582322394|FG003|Overall Study|Randomized but Not Treated|0|||
160916473|NCT00592839|581086694|FG001|Overall Study|Lost to Follow-up|1|||
160916474|NCT00592839|581086695|FG002|Overall Study|Lost to Follow-up|1|||
160916475|NCT03454893|581086696|FG000|Overall Study|Study Terminated by the Sponsor|5|||
160916476|NCT03454893|581086696|FG000|Overall Study|Did not pass screening|4|||
160916477|NCT04876274|581086697|FG000|Overall Study|Lost to Follow-up|9|||
160916478|NCT04876274|581086698|FG001|Overall Study|Lost to Follow-up|12|||
160916479|NCT00142584|581086699|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
160916480|NCT00142584|581086700|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
160916481|NCT00142584|581086699|FG000|Overall Study|Withdrawal by Subject|30|||
160916482|NCT00142584|581086700|FG001|Overall Study|Withdrawal by Subject|16|||
160916483|NCT00142584|581086699|FG000|Overall Study|Lost to Follow-up|22|||
160916484|NCT00142584|581086700|FG001|Overall Study|Lost to Follow-up|12|||
160916485|NCT00142584|581086699|FG000|Overall Study|Adverse Event|14|||
160916486|NCT00142584|581086700|FG001|Overall Study|Adverse Event|5|||
160916487|NCT00142584|581086699|FG000|Overall Study|Protocol Violation|4|||
160916488|NCT00142584|581086700|FG001|Overall Study|Protocol Violation|7|||
160916489|NCT00142584|581086699|FG000|Overall Study|Treatment Failure|2|||
160916490|NCT00142584|581086700|FG001|Overall Study|Treatment Failure|0|||
160916491|NCT03070782|581086701|FG000|Overall Study|Adverse Event|3|||
160916492|NCT03070782|581086702|FG001|Overall Study|Adverse Event|0|||
160916493|NCT03070782|581086703|FG002|Overall Study|Adverse Event|3|||
160916494|NCT03070782|581086704|FG003|Overall Study|Adverse Event|1|||
160916495|NCT03070782|581086705|FG004|Overall Study|Adverse Event|6|||
160916496|NCT03070782|581086706|FG005|Overall Study|Adverse Event|2|||
160916497|NCT03070782|581086701|FG000|Overall Study|Withdrawal by Subject|2|||
160916498|NCT03070782|581086702|FG001|Overall Study|Withdrawal by Subject|1|||
160916499|NCT03070782|581086703|FG002|Overall Study|Withdrawal by Subject|1|||
160916500|NCT03070782|581086704|FG003|Overall Study|Withdrawal by Subject|0|||
160916501|NCT03070782|581086705|FG004|Overall Study|Withdrawal by Subject|4|||
160916502|NCT03070782|581086706|FG005|Overall Study|Withdrawal by Subject|3|||
160916503|NCT03070782|581086701|FG000|Overall Study|Reason Not Specified|2|||
160916504|NCT03070782|581086702|FG001|Overall Study|Reason Not Specified|0|||
160916505|NCT03070782|581086703|FG002|Overall Study|Reason Not Specified|0|||
160916506|NCT03070782|581086704|FG003|Overall Study|Reason Not Specified|1|||
160916507|NCT03070782|581086705|FG004|Overall Study|Reason Not Specified|2|||
160916508|NCT03070782|581086706|FG005|Overall Study|Reason Not Specified|1|||
160916509|NCT03070782|581086701|FG000|Overall Study|Ineligibility|0|||
160916510|NCT03070782|581086702|FG001|Overall Study|Ineligibility|0|||
160996328|NCT03354390|581372192|FG002|Level 2|Physician Decision|0|||
160996329|NCT03354390|581372193|FG003|Level 2|Physician Decision|0|||
160996330|NCT03354390|581372190|FG000|Level 2|Lack of Efficacy|0|||
160996331|NCT03354390|581372191|FG001|Level 2|Lack of Efficacy|1|||
160996332|NCT03354390|581372192|FG002|Level 2|Lack of Efficacy|0|||
160996333|NCT03354390|581372193|FG003|Level 2|Lack of Efficacy|0|||
161257667|NCT02010255|582322395|FG004|Overall Study|Randomized but Not Treated|0|||
160916511|NCT03070782|581086703|FG002|Overall Study|Ineligibility|0|||
160916512|NCT03070782|581086704|FG003|Overall Study|Ineligibility|1|||
160916513|NCT03070782|581086705|FG004|Overall Study|Ineligibility|0|||
160916514|NCT03070782|581086706|FG005|Overall Study|Ineligibility|1|||
160916515|NCT03070782|581086701|FG000|Overall Study|Pregnancy|0|||
160916516|NCT03070782|581086702|FG001|Overall Study|Pregnancy|0|||
160916517|NCT03070782|581086703|FG002|Overall Study|Pregnancy|0|||
160916518|NCT03070782|581086704|FG003|Overall Study|Pregnancy|1|||
160916519|NCT03070782|581086705|FG004|Overall Study|Pregnancy|0|||
160916520|NCT03070782|581086706|FG005|Overall Study|Pregnancy|0|||
160916521|NCT03070782|581086701|FG000|Overall Study|Investigator Judgement|0|||
160916522|NCT03070782|581086702|FG001|Overall Study|Investigator Judgement|0|||
160916523|NCT03070782|581086703|FG002|Overall Study|Investigator Judgement|0|||
160916524|NCT03070782|581086704|FG003|Overall Study|Investigator Judgement|1|||
160916525|NCT03070782|581086705|FG004|Overall Study|Investigator Judgement|0|||
160916526|NCT03070782|581086706|FG005|Overall Study|Investigator Judgement|0|||
160916527|NCT01083576|581086711|FG000|Overall Study|Treatment Failure|6|||
160916528|NCT01083576|581086712|FG001|Overall Study|Treatment Failure|1|||
160916529|NCT01986985|581086713|FG000|Overall Study|Withdrawal by Subject|4|||
160916530|NCT01986985|581086713|FG000|Overall Study|Scan not completed due to malfunction|3|||
160916531|NCT03527966|581086714|FG000|Overall Study|Lost to Follow-up|3|||
160916532|NCT03527966|581086715|FG001|Overall Study|Lost to Follow-up|0|||
160916533|NCT01948050|581086716|FG000|Overall Study|Withdrawal by Subject|0|||
160916534|NCT01948050|581086717|FG001|Overall Study|Withdrawal by Subject|1|||
160916535|NCT00558025|581086718|FG000|Overall Study|Adverse Event|1|||
160916536|NCT00558025|581086719|FG001|Overall Study|Adverse Event|1|||
160916537|NCT00558025|581086718|FG000|Overall Study|Withdrawal by Subject|2|||
160916538|NCT00558025|581086719|FG001|Overall Study|Withdrawal by Subject|2|||
160916539|NCT00558025|581086718|FG000|Overall Study|Protocol Violation|1|||
160916540|NCT00558025|581086719|FG001|Overall Study|Protocol Violation|0|||
160916541|NCT02288559|581086720|FG000|Overall Study|Adverse Event|1|||
160916542|NCT02288559|581086721|FG001|Overall Study|Adverse Event|1|||
160916543|NCT02288559|581086722|FG002|Overall Study|Adverse Event|5|||
160916544|NCT02288559|581086723|FG003|Overall Study|Adverse Event|0|||
160916545|NCT02288559|581086720|FG000|Overall Study|Death|0|||
160916546|NCT02288559|581086721|FG001|Overall Study|Death|0|||
160916547|NCT02288559|581086722|FG002|Overall Study|Death|1|||
160916548|NCT02288559|581086723|FG003|Overall Study|Death|0|||
160916549|NCT02288559|581086720|FG000|Overall Study|Lost to Follow-up|0|||
160916550|NCT02288559|581086721|FG001|Overall Study|Lost to Follow-up|0|||
160916551|NCT02288559|581086722|FG002|Overall Study|Lost to Follow-up|0|||
160916552|NCT02288559|581086723|FG003|Overall Study|Lost to Follow-up|1|||
160916553|NCT02288559|581086720|FG000|Overall Study|Withdrawal by Subject|0|||
160916554|NCT02288559|581086721|FG001|Overall Study|Withdrawal by Subject|0|||
160916555|NCT02288559|581086722|FG002|Overall Study|Withdrawal by Subject|2|||
160916556|NCT02288559|581086723|FG003|Overall Study|Withdrawal by Subject|1|||
160916557|NCT02288559|581086720|FG000|Overall Study|Reason Not Specified|0|||
160916558|NCT02288559|581086721|FG001|Overall Study|Reason Not Specified|0|||
160916559|NCT02288559|581086722|FG002|Overall Study|Reason Not Specified|3|||
160916560|NCT02288559|581086723|FG003|Overall Study|Reason Not Specified|0|||
160916561|NCT02005445|581086724|FG000|Overall Study|Dual study enrollment|0|||
160916562|NCT02005445|581086725|FG001|Overall Study|Dual study enrollment|1|||
160916563|NCT00449540|581086726|FG000|Pretreatment Phase|No migraine experienced|66|||
160916564|NCT00449540|581086727|FG001|Pretreatment Phase|No migraine experienced|0|||
160916565|NCT00449540|581086728|FG002|Pretreatment Phase|No migraine experienced|0|||
160916566|NCT00449540|581086726|FG000|Treatment Phase|did not experience or treat migraine|0|||
160916567|NCT00449540|581086727|FG001|Treatment Phase|did not experience or treat migraine|20|||
160916568|NCT00449540|581086728|FG002|Treatment Phase|did not experience or treat migraine|17|||
160916569|NCT00010374|581086729|FG000|Overall Study|False positive phrenic nerve test|1|||
160916570|NCT00640601|581086736|FG000|Overall Study|Adverse Event|43|||
160916571|NCT00640601|581086736|FG000|Overall Study|Withdrawal by Subject|20|||
160916572|NCT00640601|581086736|FG000|Overall Study|Protocol Violation|6|||
160916573|NCT00640601|581086736|FG000|Overall Study|Lack of Efficacy|16|||
160916574|NCT00640601|581086736|FG000|Overall Study|Lost to Follow-up|9|||
160916575|NCT00640601|581086736|FG000|Overall Study|Physician Decision|8|||
160916576|NCT00640601|581086736|FG000|Overall Study|treatment naive, combination therapy|10|||
160916577|NCT00230607|581086737|FG000|Overall Study|Other|3|||
160916578|NCT03672747|581086738|FG000|Overall Study|Lost to Follow-up|1|||
160916579|NCT03672747|581086739|FG001|Overall Study|Lost to Follow-up|1|||
160916580|NCT03672747|581086740|FG002|Overall Study|Lost to Follow-up|2|||
160916581|NCT03672747|581086741|FG003|Overall Study|Lost to Follow-up|2|||
160916582|NCT03672747|581086742|FG004|Overall Study|Lost to Follow-up|2|||
160916583|NCT03672747|581086743|FG005|Overall Study|Lost to Follow-up|1|||
160916584|NCT03198234|581086744|FG000|Overall Study|Relapse of primary disease|0|||
160916585|NCT03198234|581086745|FG001|Overall Study|Relapse of primary disease|1|||
160916586|NCT03198234|581086746|FG002|Overall Study|Relapse of primary disease|0|||
160916587|NCT00165776|581086747|FG000|Overall Study|Lack of Efficacy|0|||
160916588|NCT00165776|581086748|FG001|Overall Study|Lack of Efficacy|0|||
160916589|NCT00165776|581086749|FG002|Overall Study|Lack of Efficacy|0|||
160916590|NCT00165776|581086750|FG003|Overall Study|Lack of Efficacy|1|||
160916591|NCT00165776|581086747|FG000|Overall Study|Withdrawal by Subject|4|||
160916592|NCT00165776|581086748|FG001|Overall Study|Withdrawal by Subject|1|||
160916593|NCT00165776|581086749|FG002|Overall Study|Withdrawal by Subject|2|||
160916594|NCT00165776|581086750|FG003|Overall Study|Withdrawal by Subject|0|||
160916595|NCT00165776|581086747|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
160916596|NCT00165776|581086748|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
160916597|NCT00165776|581086749|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
160916598|NCT00165776|581086750|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
160916599|NCT03228537|581086758|FG000|Neoadjuvant|Adverse Event|2|||
160916600|NCT03228537|581086758|FG000|Neoadjuvant|Progression/Relapse|4|||
161257668|NCT02010255|582322396|FG005|Overall Study|Randomized but Not Treated|0|||
161257669|NCT02010255|582322397|FG006|Overall Study|Randomized but Not Treated|0|||
161257670|NCT02010255|582322398|FG007|Overall Study|Randomized but Not Treated|0|||
161257671|NCT02010255|582322399|FG008|Overall Study|Randomized but Not Treated|0|||
161257672|NCT02010255|582322400|FG009|Overall Study|Randomized but Not Treated|0|||
161257673|NCT02010255|582322401|FG010|Overall Study|Randomized but Not Treated|0|||
160916601|NCT03228537|581086758|FG000|Neoadjuvant|Death|1|||
160916602|NCT03228537|581086758|FG000|Surgery|Death|1|||
160916603|NCT03228537|581086758|FG000|Surgery|Other - Not Protocol Specified|2|||
160916604|NCT03228537|581086758|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
160916605|NCT03228537|581086758|FG000|Maintenance|Progression/Relapse|10|||
160916606|NCT03310775|581086765|FG000|Overall Study|Lost to Follow-up|2|||
160916607|NCT03310775|581086766|FG001|Overall Study|Lost to Follow-up|3|||
160916608|NCT03310775|581086765|FG000|Overall Study|aggravation of depression|0|||
160916609|NCT03310775|581086766|FG001|Overall Study|aggravation of depression|1|||
160916610|NCT01648205|581086767|FG000|Placebo|Pregnancy|1|||
160916611|NCT01648205|581086767|FG000|Placebo|Withdrawal by Subject|1|||
160916612|NCT01648205|581086767|FG000|Placebo|Protocol Violation|2|||
160916613|NCT01648205|581086767|FG000|Ranolazine|Death|1|||
160916614|NCT01648205|581086767|FG000|Ranolazine|Withdrawal by Subject|1|||
160916615|NCT01648205|581086767|FG000|Ranolazine|Protocol Violation|3|||
160916616|NCT02260921|581086776|FG000|Overall Study|Adverse Event|1|||
160916617|NCT02260921|581086777|FG001|Overall Study|Adverse Event|0|||
160916618|NCT02260921|581086776|FG000|Overall Study|Lost to Follow-up|4|||
160916619|NCT02260921|581086777|FG001|Overall Study|Lost to Follow-up|3|||
160916620|NCT02260921|581086776|FG000|Overall Study|Withdraw Consent|4|||
160916621|NCT02260921|581086777|FG001|Overall Study|Withdraw Consent|1|||
160916622|NCT02260921|581086776|FG000|Overall Study|Death|1|||
160916623|NCT02260921|581086777|FG001|Overall Study|Death|0|||
160916624|NCT02260921|581086776|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
160916625|NCT02260921|581086777|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
160916626|NCT00580606|581086787|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
160916627|NCT00580606|581086788|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
160916628|NCT00580606|581086787|FG000|Open Label (OL)|Withdrawal by Subject|4|||
160916629|NCT00580606|581086788|FG001|Open Label (OL)|Withdrawal by Subject|6|||
160916630|NCT00580606|581086787|FG000|Open Label (OL)|Dosing Symptoms|0|||
160916631|NCT00580606|581086788|FG001|Open Label (OL)|Dosing Symptoms|1|||
160996334|NCT03354390|581372190|FG000|Level 2|Lost to Follow-up|0|||
160996335|NCT03354390|581372191|FG001|Level 2|Lost to Follow-up|1|||
160996336|NCT03354390|581372192|FG002|Level 2|Lost to Follow-up|0|||
160996337|NCT03354390|581372193|FG003|Level 2|Lost to Follow-up|0|||
160996338|NCT03354390|581372190|FG000|Level 3|Death|0|||
160996339|NCT03354390|581372191|FG001|Level 3|Death|0|||
160996340|NCT03354390|581372192|FG002|Level 3|Death|1|||
160996341|NCT03354390|581372193|FG003|Level 3|Death|0|||
161257674|NCT02010255|582322402|FG011|Overall Study|Randomized but Not Treated|0|||
161257675|NCT02010255|582322403|FG012|Overall Study|Randomized but Not Treated|0|||
161257676|NCT02010255|582322404|FG013|Overall Study|Randomized but Not Treated|1|||
161257677|NCT02013531|582322405|FG000|Overall Study|Lost to Follow-up|3|||
161257678|NCT02013531|582322405|FG000|Overall Study|Met Withdrawal Criteria|1|||
161257679|NCT02013531|582322405|FG000|Overall Study|Withdrawal by Subject|1|||
160916632|NCT00580606|581086787|FG000|Open Label (OL)|Lost to Follow-up|0|||
160916633|NCT00580606|581086788|FG001|Open Label (OL)|Lost to Follow-up|1|||
160916634|NCT00580606|581086787|FG000|Open Label (OL)|Pregnancy|0|||
160916635|NCT00580606|581086788|FG001|Open Label (OL)|Pregnancy|1|||
160916636|NCT00580606|581086787|FG000|Open Label (OL)|Non-compliance|2|||
160916637|NCT00580606|581086788|FG001|Open Label (OL)|Non-compliance|0|||
160916638|NCT00580606|581086787|FG000|Open Label (OL)|Physician Decision|1|||
161339436|NCT00109343|582631880|FG001|Overall Study|Lost to Follow-up|20|||
161339437|NCT00109343|582631881|FG002|Overall Study|Lost to Follow-up|14|||
160916639|NCT00580606|581086788|FG001|Open Label (OL)|Physician Decision|1|||
160916640|NCT00580606|581086787|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
160916641|NCT00580606|581086788|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
161339438|NCT00109343|582631879|FG000|Overall Study|Protocol Violation|1|||
160916642|NCT03358290|581086790|FG000|Overall Study|Study discontinued by Sponsor|0|||
160916643|NCT03358290|581086791|FG001|Overall Study|Study discontinued by Sponsor|1|||
160916644|NCT03358290|581086792|FG002|Overall Study|Study discontinued by Sponsor|1|||
160916645|NCT03358290|581086793|FG003|Overall Study|Study discontinued by Sponsor|0|||
160916646|NCT03358290|581086794|FG004|Overall Study|Study discontinued by Sponsor|0|||
160916647|NCT03358290|581086790|FG000|Overall Study|Adverse Event|0|||
160916648|NCT03358290|581086791|FG001|Overall Study|Adverse Event|0|||
160916649|NCT03358290|581086792|FG002|Overall Study|Adverse Event|1|||
160916650|NCT03358290|581086793|FG003|Overall Study|Adverse Event|2|||
160996342|NCT03354390|581372190|FG000|Level 3|Physician Decision|0|||
160996343|NCT03354390|581372191|FG001|Level 3|Physician Decision|0|||
160996344|NCT03354390|581372192|FG002|Level 3|Physician Decision|2|||
161257680|NCT03554317|582322409|FG000|Overall Study|Withdrawal by Subject|1|||
161257681|NCT03554317|582322409|FG000|Overall Study|PSA Progression|3|||
161142463|NCT03519178|581906193|FG005|PF-06873600 Treatment|Refused further treatment|0|||
161142464|NCT03519178|581906194|FG006|PF-06873600 Treatment|Refused further treatment|0|||
161142465|NCT03519178|581906195|FG007|PF-06873600 Treatment|Refused further treatment|0|||
161142466|NCT03519178|581906196|FG008|PF-06873600 Treatment|Refused further treatment|0|||
161142467|NCT03519178|581906197|FG009|PF-06873600 Treatment|Refused further treatment|0|||
161142468|NCT03519178|581906198|FG010|PF-06873600 Treatment|Refused further treatment|0|||
161142469|NCT03519178|581906199|FG011|PF-06873600 Treatment|Refused further treatment|0|||
161142470|NCT03519178|581906200|FG012|PF-06873600 Treatment|Refused further treatment|0|||
161142471|NCT03519178|581906201|FG013|PF-06873600 Treatment|Refused further treatment|0|||
161142472|NCT03519178|581906202|FG014|PF-06873600 Treatment|Refused further treatment|1|||
161142473|NCT03519178|581906188|FG000|PF-06873600 Treatment|Other|0|||
161142474|NCT03519178|581906189|FG001|PF-06873600 Treatment|Other|0|||
161142475|NCT03519178|581906190|FG002|PF-06873600 Treatment|Other|0|||
161142476|NCT03519178|581906191|FG003|PF-06873600 Treatment|Other|0|||
161142477|NCT03519178|581906192|FG004|PF-06873600 Treatment|Other|0|||
161142478|NCT03519178|581906193|FG005|PF-06873600 Treatment|Other|0|||
161142479|NCT03519178|581906194|FG006|PF-06873600 Treatment|Other|0|||
161142480|NCT03519178|581906195|FG007|PF-06873600 Treatment|Other|0|||
161142481|NCT03519178|581906196|FG008|PF-06873600 Treatment|Other|1|||
161142482|NCT03519178|581906197|FG009|PF-06873600 Treatment|Other|0|||
161142483|NCT03519178|581906198|FG010|PF-06873600 Treatment|Other|0|||
161142484|NCT03519178|581906199|FG011|PF-06873600 Treatment|Other|0|||
161142485|NCT03519178|581906200|FG012|PF-06873600 Treatment|Other|0|||
161142486|NCT03519178|581906201|FG013|PF-06873600 Treatment|Other|1|||
161142487|NCT03519178|581906202|FG014|PF-06873600 Treatment|Other|3|||
161142488|NCT03519178|581906188|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
161142489|NCT03519178|581906189|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
161142490|NCT03519178|581906190|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
161142491|NCT03519178|581906191|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
161142492|NCT03519178|581906192|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
161142493|NCT03519178|581906193|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
161142494|NCT03519178|581906194|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
161142495|NCT03519178|581906195|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
161142496|NCT03519178|581906196|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
161142497|NCT03519178|581906197|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
161142498|NCT03519178|581906198|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
161142499|NCT03519178|581906199|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
161142500|NCT03519178|581906200|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
161142501|NCT03519178|581906201|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
161142502|NCT03519178|581906202|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
161339439|NCT00109343|582631880|FG001|Overall Study|Protocol Violation|2|||
161339440|NCT00109343|582631881|FG002|Overall Study|Protocol Violation|2|||
161339441|NCT00109343|582631879|FG000|Overall Study|Withdrawal by Subject|15|||
160861715|NCT03219723|580887817|FG000|Overall Study|Case Report Forms Uncollected|6|||
161142503|NCT03519178|581906188|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142504|NCT03519178|581906189|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142505|NCT03519178|581906190|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142506|NCT03519178|581906191|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142507|NCT03519178|581906192|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142508|NCT03519178|581906193|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
161339442|NCT00109343|582631880|FG001|Overall Study|Withdrawal by Subject|11|||
160861716|NCT03219723|580887817|FG000|Overall Study|Protocol Deviation|4|||
160861717|NCT04558125|580887818|FG000|Overall Study|Death|1|||
160861718|NCT03137381|580887819|FG000|Overall Study|Adverse Event|3|||
160861719|NCT03137381|580887820|FG001|Overall Study|Adverse Event|0|||
160861720|NCT03137381|580887821|FG002|Overall Study|Adverse Event|2|||
160861721|NCT03137381|580887822|FG003|Overall Study|Adverse Event|0|||
160861722|NCT03137381|580887819|FG000|Overall Study|Lost to Follow-up|2|||
160861723|NCT03137381|580887820|FG001|Overall Study|Lost to Follow-up|1|||
160861724|NCT03137381|580887821|FG002|Overall Study|Lost to Follow-up|1|||
160861725|NCT03137381|580887822|FG003|Overall Study|Lost to Follow-up|0|||
160861726|NCT03137381|580887819|FG000|Overall Study|Protocol deviation|1|||
160861727|NCT03137381|580887820|FG001|Overall Study|Protocol deviation|1|||
160861728|NCT03137381|580887821|FG002|Overall Study|Protocol deviation|0|||
160861729|NCT03137381|580887822|FG003|Overall Study|Protocol deviation|1|||
160861730|NCT03137381|580887819|FG000|Overall Study|Withdrawal by Investigator|0|||
160861731|NCT03137381|580887820|FG001|Overall Study|Withdrawal by Investigator|1|||
160861732|NCT03137381|580887821|FG002|Overall Study|Withdrawal by Investigator|1|||
160861733|NCT03137381|580887822|FG003|Overall Study|Withdrawal by Investigator|0|||
160861734|NCT03137381|580887819|FG000|Overall Study|Withdrawal by Subject|3|||
160861735|NCT03137381|580887820|FG001|Overall Study|Withdrawal by Subject|4|||
160861736|NCT03137381|580887821|FG002|Overall Study|Withdrawal by Subject|3|||
160861737|NCT03137381|580887822|FG003|Overall Study|Withdrawal by Subject|0|||
160861738|NCT03137381|580887819|FG000|Overall Study|Pregnancy|0|||
160861739|NCT03137381|580887820|FG001|Overall Study|Pregnancy|0|||
160861740|NCT03137381|580887821|FG002|Overall Study|Pregnancy|1|||
160861741|NCT03137381|580887822|FG003|Overall Study|Pregnancy|0|||
160916651|NCT03358290|581086794|FG004|Overall Study|Adverse Event|0|||
160916652|NCT03358290|581086790|FG000|Overall Study|Withdrawal by Subject|0|||
160916653|NCT03358290|581086791|FG001|Overall Study|Withdrawal by Subject|0|||
160916654|NCT03358290|581086792|FG002|Overall Study|Withdrawal by Subject|0|||
160916655|NCT03358290|581086793|FG003|Overall Study|Withdrawal by Subject|0|||
160916656|NCT03358290|581086794|FG004|Overall Study|Withdrawal by Subject|1|||
160916657|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
160916658|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
160916659|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
160916660|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
160916661|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Death|7|||
160916662|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Death|5|||
160916663|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
160916664|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
160916665|NCT02999854|581086795|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
160916666|NCT02999854|581086796|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
160916667|NCT02999854|581086795|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
160916668|NCT02999854|581086796|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
160916669|NCT02999854|581086795|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
160916670|NCT02999854|581086796|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
160916671|NCT02999854|581086795|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
160916672|NCT02999854|581086796|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
160916673|NCT00203996|581086797|FG000|Overall Study|Lost to Follow-up|0|||
160916674|NCT00203996|581086798|FG001|Overall Study|Lost to Follow-up|0|||
160916675|NCT00203996|581086799|FG002|Overall Study|Lost to Follow-up|0|||
160916676|NCT00203996|581086800|FG003|Overall Study|Lost to Follow-up|1|||
160916677|NCT00203996|581086801|FG004|Overall Study|Lost to Follow-up|0|||
160916678|NCT00203996|581086802|FG005|Overall Study|Lost to Follow-up|0|||
160916679|NCT00203996|581086803|FG006|Overall Study|Lost to Follow-up|0|||
160916680|NCT00203996|581086804|FG007|Overall Study|Lost to Follow-up|0|||
160916681|NCT00203996|581086805|FG008|Overall Study|Lost to Follow-up|0|||
160916682|NCT00203996|581086806|FG009|Overall Study|Lost to Follow-up|0|||
160916683|NCT00203996|581086797|FG000|Overall Study|Protocol Violation|0|||
160916684|NCT00203996|581086798|FG001|Overall Study|Protocol Violation|0|||
160916685|NCT00203996|581086799|FG002|Overall Study|Protocol Violation|0|||
160916686|NCT00203996|581086800|FG003|Overall Study|Protocol Violation|6|||
160916687|NCT00203996|581086801|FG004|Overall Study|Protocol Violation|1|||
160916688|NCT00203996|581086802|FG005|Overall Study|Protocol Violation|0|||
160916689|NCT00203996|581086803|FG006|Overall Study|Protocol Violation|0|||
160916690|NCT00203996|581086804|FG007|Overall Study|Protocol Violation|0|||
160916691|NCT00203996|581086805|FG008|Overall Study|Protocol Violation|0|||
160916692|NCT00203996|581086806|FG009|Overall Study|Protocol Violation|0|||
160916693|NCT00203996|581086797|FG000|Overall Study|Physician Decision|0|||
160916694|NCT00203996|581086798|FG001|Overall Study|Physician Decision|0|||
160916695|NCT00203996|581086799|FG002|Overall Study|Physician Decision|0|||
160916696|NCT00203996|581086800|FG003|Overall Study|Physician Decision|2|||
160916697|NCT00203996|581086801|FG004|Overall Study|Physician Decision|0|||
160916698|NCT00203996|581086802|FG005|Overall Study|Physician Decision|0|||
160916699|NCT00203996|581086803|FG006|Overall Study|Physician Decision|0|||
160916700|NCT00203996|581086804|FG007|Overall Study|Physician Decision|0|||
160916701|NCT00203996|581086805|FG008|Overall Study|Physician Decision|0|||
160916702|NCT00203996|581086806|FG009|Overall Study|Physician Decision|1|||
160916703|NCT00203996|581086797|FG000|Overall Study|CPAP machine malfunction|0|||
160916704|NCT00203996|581086798|FG001|Overall Study|CPAP machine malfunction|0|||
160916705|NCT00203996|581086799|FG002|Overall Study|CPAP machine malfunction|0|||
160916706|NCT00203996|581086800|FG003|Overall Study|CPAP machine malfunction|1|||
160916707|NCT00203996|581086801|FG004|Overall Study|CPAP machine malfunction|0|||
160916708|NCT00203996|581086802|FG005|Overall Study|CPAP machine malfunction|0|||
160916709|NCT00203996|581086803|FG006|Overall Study|CPAP machine malfunction|0|||
160916710|NCT00203996|581086804|FG007|Overall Study|CPAP machine malfunction|0|||
160916711|NCT00203996|581086805|FG008|Overall Study|CPAP machine malfunction|0|||
160916712|NCT00203996|581086806|FG009|Overall Study|CPAP machine malfunction|0|||
160916713|NCT00203996|581086797|FG000|Overall Study|Scheduling issue|0|||
160916714|NCT00203996|581086798|FG001|Overall Study|Scheduling issue|0|||
160916715|NCT00203996|581086799|FG002|Overall Study|Scheduling issue|0|||
160916716|NCT00203996|581086800|FG003|Overall Study|Scheduling issue|0|||
160916717|NCT00203996|581086801|FG004|Overall Study|Scheduling issue|0|||
160916718|NCT00203996|581086802|FG005|Overall Study|Scheduling issue|0|||
160916719|NCT00203996|581086803|FG006|Overall Study|Scheduling issue|0|||
160916720|NCT00203996|581086804|FG007|Overall Study|Scheduling issue|2|||
160916721|NCT00203996|581086805|FG008|Overall Study|Scheduling issue|0|||
160916722|NCT00203996|581086806|FG009|Overall Study|Scheduling issue|0|||
160916723|NCT03064451|581086807|FG000|Overall Study|Lost to Follow-up|1|||
160916724|NCT03064451|581086807|FG000|Overall Study|Mapping Failure|4|||
160996345|NCT03354390|581372193|FG003|Level 3|Physician Decision|0|||
161257682|NCT03554317|582322409|FG000|Overall Study|Radiographic Progression|4|||
161257683|NCT00537199|582322412|FG000|Overall Study|Study Terminated|1|||
161257684|NCT03139240|582322413|FG000|Overall Study|Lost to Follow-up|0|||
161257685|NCT03139240|582322414|FG001|Overall Study|Lost to Follow-up|1|||
161257686|NCT03139240|582322415|FG002|Overall Study|Lost to Follow-up|1|||
161257687|NCT03139240|582322416|FG003|Overall Study|Lost to Follow-up|0|||
161257688|NCT00860743|582322418|FG000|Overall Study|Withdrawal by Subject|3|||
161257689|NCT00860743|582322419|FG001|Overall Study|Withdrawal by Subject|0|||
161257690|NCT00823199|582322423|FG000|Overall Study|Withdrawal by Subject|2|||
161257691|NCT02776553|582322424|FG000|Overall Study|Lost to Follow-up|1|||
161257692|NCT02776553|582322425|FG001|Overall Study|Lost to Follow-up|0|||
161257693|NCT02776553|582322424|FG000|Overall Study|got liver transplant|1|||
161257694|NCT02776553|582322425|FG001|Overall Study|got liver transplant|2|||
161257695|NCT02776553|582322424|FG000|Overall Study|had other surgery|1|||
161257696|NCT02776553|582322425|FG001|Overall Study|had other surgery|0|||
161257697|NCT02776553|582322424|FG000|Overall Study|Protocol Violation|0|||
161257698|NCT02776553|582322425|FG001|Overall Study|Protocol Violation|1|||
161257699|NCT00941720|582322426|FG000|Overall Study|Withdrawal by Subject|1|||
161257700|NCT00941720|582322426|FG000|Overall Study|Insurance denied participation|11|||
161257701|NCT00941720|582322426|FG000|Overall Study|ineligible|2|||
161257702|NCT00171340|582322427|FG000|Overall Study|Adverse Event|46|||
161257703|NCT00171340|582322428|FG001|Overall Study|Adverse Event|42|||
161257704|NCT00171340|582322427|FG000|Overall Study|Lack of Efficacy|29|||
161257705|NCT00171340|582322428|FG001|Overall Study|Lack of Efficacy|41|||
161257706|NCT00171340|582322427|FG000|Overall Study|Protocol Violation|7|||
161257707|NCT00171340|582322428|FG001|Overall Study|Protocol Violation|8|||
161257708|NCT00171340|582322427|FG000|Overall Study|Withdrawal by Subject|22|||
161257709|NCT00171340|582322428|FG001|Overall Study|Withdrawal by Subject|19|||
161257710|NCT00171340|582322427|FG000|Overall Study|Lost to Follow-up|0|||
161257711|NCT00171340|582322428|FG001|Overall Study|Lost to Follow-up|5|||
161257712|NCT00171340|582322427|FG000|Overall Study|Abnormal Laboratory Results|2|||
161257713|NCT00171340|582322428|FG001|Overall Study|Abnormal Laboratory Results|0|||
161257714|NCT00171340|582322427|FG000|Overall Study|Abnormal Test Procedure Results|6|||
161257715|NCT00171340|582322428|FG001|Overall Study|Abnormal Test Procedure Results|11|||
161257716|NCT00171340|582322427|FG000|Overall Study|No Longer Required Study Drug|1|||
161257717|NCT00171340|582322428|FG001|Overall Study|No Longer Required Study Drug|1|||
161257718|NCT00171340|582322427|FG000|Overall Study|Administrative Problems|5|||
161257719|NCT00171340|582322428|FG001|Overall Study|Administrative Problems|2|||
161257720|NCT00171340|582322427|FG000|Overall Study|Death|6|||
161257721|NCT00171340|582322428|FG001|Overall Study|Death|6|||
161257722|NCT03827018|582322429|FG000|Overall Study|Adverse Event|1|||
161257723|NCT03827018|582322430|FG001|Overall Study|Adverse Event|0|||
161257724|NCT03827018|582322429|FG000|Overall Study|Withdrawal by Subject|2|||
161257725|NCT03827018|582322430|FG001|Overall Study|Withdrawal by Subject|2|||
161257726|NCT03827018|582322429|FG000|Overall Study|Lack of Efficacy|0|||
161257727|NCT03827018|582322430|FG001|Overall Study|Lack of Efficacy|1|||
161257728|NCT01998243|582322433|FG000|Overall Study|Pregnancy|0|||
160916725|NCT03064451|581086807|FG000|Overall Study|Exited prior to procedure|8|||
160916726|NCT03064451|581086807|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
160916727|NCT00897104|581086808|FG000|Overall Study|Lost to Follow-up|12|||
160916728|NCT00897104|581086809|FG001|Overall Study|Lost to Follow-up|17|||
160916729|NCT00897104|581086810|FG002|Overall Study|Lost to Follow-up|2|||
160916730|NCT00897104|581086808|FG000|Overall Study|Pregnancy|0|||
160916731|NCT00897104|581086809|FG001|Overall Study|Pregnancy|1|||
160916732|NCT00897104|581086810|FG002|Overall Study|Pregnancy|0|||
160916733|NCT00897104|581086808|FG000|Overall Study|Protocol Violation|0|||
160916734|NCT00897104|581086809|FG001|Overall Study|Protocol Violation|1|||
160916735|NCT00897104|581086810|FG002|Overall Study|Protocol Violation|0|||
160916736|NCT00897104|581086808|FG000|Overall Study|Withdrawal by Subject|23|||
160916737|NCT00897104|581086809|FG001|Overall Study|Withdrawal by Subject|27|||
160916738|NCT00897104|581086810|FG002|Overall Study|Withdrawal by Subject|3|||
160916739|NCT00897104|581086808|FG000|Overall Study|Abnormal Prestudy Labs|2|||
160916740|NCT00897104|581086809|FG001|Overall Study|Abnormal Prestudy Labs|0|||
161257729|NCT01998243|582322434|FG001|Overall Study|Pregnancy|1|||
161257730|NCT01998243|582322433|FG000|Overall Study|Protocol Violation|5|||
161257731|NCT01998243|582322434|FG001|Overall Study|Protocol Violation|2|||
160916741|NCT00897104|581086810|FG002|Overall Study|Abnormal Prestudy Labs|0|||
160916742|NCT00897104|581086808|FG000|Overall Study|Abnormal Baseline ECG|2|||
160916743|NCT00897104|581086809|FG001|Overall Study|Abnormal Baseline ECG|2|||
160916744|NCT00897104|581086810|FG002|Overall Study|Abnormal Baseline ECG|0|||
160916745|NCT00897104|581086808|FG000|Overall Study|Need for Concom. Med.|0|||
161257732|NCT01998243|582322433|FG000|Overall Study|Withdrawal by Subject|3|||
161257733|NCT01998243|582322434|FG001|Overall Study|Withdrawal by Subject|4|||
161257734|NCT00680186|582322435|FG000|Overall Study|Adverse Event|47|||
161257735|NCT00680186|582322436|FG001|Overall Study|Adverse Event|44|||
161257736|NCT00680186|582322435|FG000|Overall Study|Protocol Violation|31|||
161257737|NCT00680186|582322436|FG001|Overall Study|Protocol Violation|26|||
161257738|NCT00680186|582322435|FG000|Overall Study|Lost to Follow-up|11|||
161257739|NCT00680186|582322436|FG001|Overall Study|Lost to Follow-up|6|||
160916746|NCT00897104|581086809|FG001|Overall Study|Need for Concom. Med.|1|||
160916747|NCT00897104|581086810|FG002|Overall Study|Need for Concom. Med.|1|||
160916748|NCT00897104|581086808|FG000|Overall Study|Lack of Migraine Attack|20|||
160916749|NCT00897104|581086809|FG001|Overall Study|Lack of Migraine Attack|22|||
160916750|NCT00897104|581086810|FG002|Overall Study|Lack of Migraine Attack|1|||
160916751|NCT00897104|581086808|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
160916752|NCT00897104|581086809|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160916753|NCT00897104|581086810|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
160916754|NCT00897104|581086808|FG000|Overall Study|Other|3|||
160916755|NCT00897104|581086809|FG001|Overall Study|Other|0|||
160916756|NCT00897104|581086810|FG002|Overall Study|Other|0|||
160916757|NCT00897104|581086808|FG000|Overall Study|Protocol Violation|1|||
160916758|NCT00897104|581086809|FG001|Overall Study|Protocol Violation|0|||
160916759|NCT00897104|581086810|FG002|Overall Study|Protocol Violation|0|||
160916760|NCT00897104|581086808|FG000|Overall Study|Withdrawal by Subject|0|||
160916761|NCT00897104|581086809|FG001|Overall Study|Withdrawal by Subject|0|||
160916762|NCT00897104|581086810|FG002|Overall Study|Withdrawal by Subject|1|||
160916763|NCT00750204|581086811|FG000|Overall Study|study halted prematurely|1|||
160916764|NCT00750204|581086812|FG001|Overall Study|study halted prematurely|1|||
160916765|NCT00434330|581086813|FG000|Overall Study|Adverse Event|0|||
160916766|NCT00434330|581086814|FG001|Overall Study|Adverse Event|0|||
160916767|NCT00434330|581086815|FG002|Overall Study|Adverse Event|1|||
160916768|NCT00434330|581086816|FG003|Overall Study|Adverse Event|0|||
160916769|NCT00434330|581086817|FG004|Overall Study|Adverse Event|0|||
160916770|NCT00434330|581086818|FG005|Overall Study|Adverse Event|0|||
160916771|NCT00434330|581086813|FG000|Overall Study|Death|1|||
160916772|NCT00434330|581086814|FG001|Overall Study|Death|0|||
160916773|NCT00434330|581086815|FG002|Overall Study|Death|0|||
160916774|NCT00434330|581086816|FG003|Overall Study|Death|0|||
160916775|NCT00434330|581086817|FG004|Overall Study|Death|1|||
160916776|NCT00434330|581086818|FG005|Overall Study|Death|1|||
160916777|NCT00434330|581086813|FG000|Overall Study|Withdrawal by Subject|0|||
160916778|NCT00434330|581086814|FG001|Overall Study|Withdrawal by Subject|0|||
160916779|NCT00434330|581086815|FG002|Overall Study|Withdrawal by Subject|1|||
160916780|NCT00434330|581086816|FG003|Overall Study|Withdrawal by Subject|1|||
160916781|NCT00434330|581086817|FG004|Overall Study|Withdrawal by Subject|0|||
160916782|NCT00434330|581086818|FG005|Overall Study|Withdrawal by Subject|0|||
160916783|NCT00434330|581086813|FG000|Overall Study|Renal transplant|0|||
160916784|NCT00434330|581086814|FG001|Overall Study|Renal transplant|0|||
160916785|NCT00434330|581086815|FG002|Overall Study|Renal transplant|0|||
160916786|NCT00434330|581086816|FG003|Overall Study|Renal transplant|1|||
160916787|NCT00434330|581086817|FG004|Overall Study|Renal transplant|0|||
160916788|NCT00434330|581086818|FG005|Overall Study|Renal transplant|0|||
160916789|NCT00434330|581086813|FG000|Overall Study|Subject Not Compliant With Study|0|||
160916790|NCT00434330|581086814|FG001|Overall Study|Subject Not Compliant With Study|0|||
160916791|NCT00434330|581086815|FG002|Overall Study|Subject Not Compliant With Study|1|||
160916792|NCT00434330|581086816|FG003|Overall Study|Subject Not Compliant With Study|0|||
160916793|NCT00434330|581086817|FG004|Overall Study|Subject Not Compliant With Study|0|||
160916794|NCT00434330|581086818|FG005|Overall Study|Subject Not Compliant With Study|0|||
160916795|NCT00850564|581086821|FG000|Overall Study|Withdrawal by Subject|2|||
160916796|NCT03032705|581086822|FG000|Overall Study|Lost to Follow-up|16|||
160916797|NCT03032705|581086823|FG001|Overall Study|Lost to Follow-up|17|||
160916798|NCT03032705|581086822|FG000|Overall Study|did not quality|6|||
160916799|NCT03032705|581086823|FG001|Overall Study|did not quality|6|||
160916800|NCT01937559|581086826|FG000|Overall Study|Physician Decision|3|||
160916801|NCT01937559|581086827|FG001|Overall Study|Physician Decision|3|||
160916802|NCT01937559|581086828|FG002|Overall Study|Physician Decision|0|||
160916803|NCT01937559|581086826|FG000|Overall Study|Withdrawal by Subject|6|||
160916804|NCT01937559|581086827|FG001|Overall Study|Withdrawal by Subject|4|||
160916805|NCT01937559|581086828|FG002|Overall Study|Withdrawal by Subject|0|||
160916806|NCT01937559|581086826|FG000|Overall Study|screen fail|2|||
160916807|NCT01937559|581086827|FG001|Overall Study|screen fail|4|||
160916808|NCT01937559|581086828|FG002|Overall Study|screen fail|0|||
160916809|NCT04818840|581086829|FG000|Overall Study|Lost to Follow-up|0|||
160916810|NCT04818840|581086830|FG001|Overall Study|Lost to Follow-up|5|||
160916811|NCT04818840|581086829|FG000|Overall Study|Physician Decision|1|||
160916812|NCT04818840|581086830|FG001|Overall Study|Physician Decision|0|||
160916813|NCT04818840|581086829|FG000|Overall Study|Site Terminated by Sponsor|0|||
160916814|NCT04818840|581086830|FG001|Overall Study|Site Terminated by Sponsor|3|||
160916815|NCT04818840|581086829|FG000|Overall Study|Study Terminated by Sponsor|43|||
160916816|NCT04818840|581086830|FG001|Overall Study|Study Terminated by Sponsor|7|||
161142665|NCT03519178|581906200|FG012|Fulvestrant. Treatment|Other|0|||
160916817|NCT04818840|581086829|FG000|Overall Study|Withdrawal by Subject|0|||
160916818|NCT04818840|581086830|FG001|Overall Study|Withdrawal by Subject|1|||
160916819|NCT02329730|581089381|FG000|Overall Study|Protocol Violation|0|||
160916820|NCT02329730|581089382|FG001|Overall Study|Protocol Violation|0|||
160916821|NCT02329730|581089383|FG002|Overall Study|Protocol Violation|0|||
160916822|NCT02329730|581089384|FG003|Overall Study|Protocol Violation|0|||
160916823|NCT02329730|581089385|FG004|Overall Study|Protocol Violation|2|||
160916824|NCT02329730|581089386|FG005|Overall Study|Protocol Violation|2|||
160916825|NCT02329730|581089387|FG006|Overall Study|Protocol Violation|0|||
160916826|NCT02329730|581089388|FG007|Overall Study|Protocol Violation|0|||
160916827|NCT02329730|581089389|FG008|Overall Study|Protocol Violation|0|||
160916828|NCT02329730|581089390|FG009|Overall Study|Protocol Violation|0|||
160916829|NCT02329730|581089391|FG010|Overall Study|Protocol Violation|0|||
160916830|NCT02329730|581089392|FG011|Overall Study|Protocol Violation|0|||
160916831|NCT02329730|581089381|FG000|Overall Study|Withdrawal by Subject|0|||
160916832|NCT02329730|581089382|FG001|Overall Study|Withdrawal by Subject|0|||
160916833|NCT02329730|581089383|FG002|Overall Study|Withdrawal by Subject|0|||
160916834|NCT02329730|581089384|FG003|Overall Study|Withdrawal by Subject|0|||
160916835|NCT02329730|581089385|FG004|Overall Study|Withdrawal by Subject|1|||
160916836|NCT02329730|581089386|FG005|Overall Study|Withdrawal by Subject|0|||
160916837|NCT02329730|581089387|FG006|Overall Study|Withdrawal by Subject|1|||
160916838|NCT02329730|581089388|FG007|Overall Study|Withdrawal by Subject|1|||
160916839|NCT02329730|581089389|FG008|Overall Study|Withdrawal by Subject|1|||
160916840|NCT02329730|581089390|FG009|Overall Study|Withdrawal by Subject|1|||
160916841|NCT02329730|581089391|FG010|Overall Study|Withdrawal by Subject|0|||
160916842|NCT02329730|581089392|FG011|Overall Study|Withdrawal by Subject|0|||
160916843|NCT00224055|581089393|FG000|Overall Study|Adverse Event|9|||
160916844|NCT00224055|581089394|FG001|Overall Study|Adverse Event|3|||
160916845|NCT00224055|581089393|FG000|Overall Study|Lost to Follow-up|1|||
160916846|NCT00224055|581089394|FG001|Overall Study|Lost to Follow-up|2|||
160916847|NCT00224055|581089393|FG000|Overall Study|Protocol Violation|1|||
160916848|NCT00224055|581089394|FG001|Overall Study|Protocol Violation|1|||
160916849|NCT00224055|581089393|FG000|Overall Study|Inclusion Violation|3|||
160916850|NCT00224055|581089394|FG001|Overall Study|Inclusion Violation|6|||
160916851|NCT00224055|581089393|FG000|Overall Study|Withdrawal by Subject|0|||
160916852|NCT00224055|581089394|FG001|Overall Study|Withdrawal by Subject|2|||
160916853|NCT00224055|581089393|FG000|Overall Study|Other|1|||
160916854|NCT00224055|581089394|FG001|Overall Study|Other|0|||
160916855|NCT00127712|581089395|FG000|Overall Study|Adverse Event|3|||
160916856|NCT00127712|581089396|FG001|Overall Study|Adverse Event|0|||
160916857|NCT00127712|581089395|FG000|Overall Study|Lack of GI access to continue|2|||
160916858|NCT00127712|581089396|FG001|Overall Study|Lack of GI access to continue|0|||
160916859|NCT03055260|581089399|FG000|Overall Study|Withdrawal by Subject|1|||
160916860|NCT03055260|581089400|FG001|Overall Study|Withdrawal by Subject|0|||
160916861|NCT00799487|581089402|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
160916862|NCT00799487|581089403|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
160916863|NCT00799487|581089404|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
160916864|NCT00799487|581089402|FG000|Dose Adjustment Period|Adverse Event|2|||
160916865|NCT00799487|581089403|FG001|Dose Adjustment Period|Adverse Event|0|||
160916866|NCT00799487|581089404|FG002|Dose Adjustment Period|Adverse Event|0|||
160916867|NCT00799487|581089402|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
160916868|NCT00799487|581089403|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
160916869|NCT00799487|581089404|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
160916870|NCT00799487|581089402|FG000|Dose Adjustment Period|Investigator Discretion|2|||
160916871|NCT00799487|581089403|FG001|Dose Adjustment Period|Investigator Discretion|0|||
160916872|NCT00799487|581089404|FG002|Dose Adjustment Period|Investigator Discretion|0|||
160916873|NCT00799487|581089402|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
160916874|NCT00799487|581089403|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
160916875|NCT00799487|581089404|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
160916876|NCT00799487|581089402|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
160916877|NCT00799487|581089403|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
160916878|NCT00799487|581089404|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
160916879|NCT00799487|581089402|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
160916880|NCT00799487|581089403|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
160916881|NCT00799487|581089404|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
160916882|NCT00799487|581089402|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
160916883|NCT00799487|581089403|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
160916884|NCT00799487|581089404|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
160916885|NCT00799487|581089402|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
160916886|NCT00799487|581089403|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
160916887|NCT00799487|581089404|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
160916888|NCT00799487|581089402|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
160916889|NCT00799487|581089403|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
160916890|NCT00799487|581089404|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
160916891|NCT00799487|581089402|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
160916892|NCT00799487|581089403|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
160916893|NCT00799487|581089404|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
160916894|NCT00799487|581089402|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
160916895|NCT00799487|581089403|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
160996346|NCT03354390|581372190|FG000|Level 4|Death|0|||
161257740|NCT00680186|582322435|FG000|Overall Study|Withdrawal by Subject|32|||
161257741|NCT00680186|582322436|FG001|Overall Study|Withdrawal by Subject|39|||
161257742|NCT00680186|582322435|FG000|Overall Study|Other|4|||
161257743|NCT00680186|582322436|FG001|Overall Study|Other|1|||
161257744|NCT01351350|582322437|FG000|Overall Study|Disease Progression|5|||
161257745|NCT01351350|582322438|FG001|Overall Study|Disease Progression|13|||
161257746|NCT01351350|582322439|FG002|Overall Study|Disease Progression|6|||
161257747|NCT01351350|582322440|FG003|Overall Study|Disease Progression|8|||
161257748|NCT01351350|582322441|FG004|Overall Study|Disease Progression|5|||
161257749|NCT01351350|582322437|FG000|Overall Study|Adverse Event|1|||
161257750|NCT01351350|582322438|FG001|Overall Study|Adverse Event|10|||
161257751|NCT01351350|582322439|FG002|Overall Study|Adverse Event|1|||
161257752|NCT01351350|582322440|FG003|Overall Study|Adverse Event|2|||
161257753|NCT01351350|582322441|FG004|Overall Study|Adverse Event|0|||
161257754|NCT01351350|582322437|FG000|Overall Study|Participant Decision|2|||
161257755|NCT01351350|582322438|FG001|Overall Study|Participant Decision|6|||
161257756|NCT01351350|582322439|FG002|Overall Study|Participant Decision|3|||
161257757|NCT01351350|582322440|FG003|Overall Study|Participant Decision|3|||
161257758|NCT01351350|582322441|FG004|Overall Study|Participant Decision|2|||
161257759|NCT01351350|582322437|FG000|Overall Study|Enrolled but not Treated|0|||
161257760|NCT01351350|582322438|FG001|Overall Study|Enrolled but not Treated|0|||
161257761|NCT01351350|582322439|FG002|Overall Study|Enrolled but not Treated|1|||
161257762|NCT01351350|582322440|FG003|Overall Study|Enrolled but not Treated|0|||
161257763|NCT01351350|582322441|FG004|Overall Study|Enrolled but not Treated|0|||
161257764|NCT04647383|582322444|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
161257765|NCT04647383|582322445|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
161257766|NCT04647383|582322446|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
160916896|NCT00799487|581089404|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
160916897|NCT01463878|581089408|FG000|Overall Study|no longer met criteria for tube feed|2|||
160916898|NCT01463878|581089409|FG001|Overall Study|no longer met criteria for tube feed|2|||
160916899|NCT01084174|581089410|FG000|Overall Study|gastrointestinal symptoms|1|||
160916900|NCT01084174|581089411|FG001|Overall Study|gastrointestinal symptoms|1|||
160916901|NCT01084174|581089410|FG000|Overall Study|Eosinophilic esophagitis|0|||
160916902|NCT01084174|581089411|FG001|Overall Study|Eosinophilic esophagitis|1|||
160916903|NCT01084174|581089410|FG000|Overall Study|Anaphylaxis|0|||
160916904|NCT01084174|581089411|FG001|Overall Study|Anaphylaxis|1|||
160916905|NCT01084174|581089410|FG000|Overall Study|Participant noncompliance|0|||
160916906|NCT01084174|581089411|FG001|Overall Study|Participant noncompliance|1|||
160916907|NCT04273217|581089412|FG000|Overall Study|Lost to Follow-up|0|||
160916908|NCT04273217|581089413|FG001|Overall Study|Lost to Follow-up|0|||
160916909|NCT04273217|581089414|FG002|Overall Study|Lost to Follow-up|0|||
160916910|NCT04273217|581089415|FG003|Overall Study|Lost to Follow-up|0|||
160916911|NCT04273217|581089416|FG004|Overall Study|Lost to Follow-up|0|||
160916912|NCT04273217|581089417|FG005|Overall Study|Lost to Follow-up|1|||
160916913|NCT04273217|581089412|FG000|Overall Study|Participant non-compliance|0|||
160916914|NCT04273217|581089413|FG001|Overall Study|Participant non-compliance|0|||
160916915|NCT04273217|581089414|FG002|Overall Study|Participant non-compliance|0|||
160916916|NCT04273217|581089415|FG003|Overall Study|Participant non-compliance|0|||
160916917|NCT04273217|581089416|FG004|Overall Study|Participant non-compliance|1|||
160916918|NCT04273217|581089417|FG005|Overall Study|Participant non-compliance|0|||
160916919|NCT04273217|581089412|FG000|Overall Study|Positive urine drug screen|1|||
160916920|NCT04273217|581089413|FG001|Overall Study|Positive urine drug screen|0|||
160916921|NCT04273217|581089414|FG002|Overall Study|Positive urine drug screen|1|||
160916922|NCT04273217|581089415|FG003|Overall Study|Positive urine drug screen|0|||
160916923|NCT04273217|581089416|FG004|Overall Study|Positive urine drug screen|0|||
160916924|NCT04273217|581089417|FG005|Overall Study|Positive urine drug screen|1|||
161257767|NCT04647383|582322447|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
160916925|NCT04532099|581089418|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
160916926|NCT04532099|581089419|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
160916927|NCT04532099|581089420|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
160916928|NCT02506153|581089421|FG000|Overall Study|Adverse Event|359|||
160916929|NCT02506153|581089422|FG001|Overall Study|Adverse Event|114|||
160916930|NCT02506153|581089421|FG000|Overall Study|Refused unrelated to adverse event|127|||
160916931|NCT02506153|581089422|FG001|Overall Study|Refused unrelated to adverse event|18|||
160916932|NCT02506153|581089421|FG000|Overall Study|Progression/relapse|91|||
160916933|NCT02506153|581089422|FG001|Overall Study|Progression/relapse|136|||
160916934|NCT02506153|581089421|FG000|Overall Study|Death|2|||
161257768|NCT00479388|582322450|FG000|Overall Study|Adverse Event|90|||
160916935|NCT02506153|581089422|FG001|Overall Study|Death|1|||
160916936|NCT02506153|581089421|FG000|Overall Study|Other - not protocol specified|23|||
160916937|NCT02506153|581089422|FG001|Overall Study|Other - not protocol specified|12|||
160916938|NCT03998189|581089423|FG000|Overall Study|Lack of Efficacy|0|||
161257769|NCT00479388|582322451|FG001|Overall Study|Adverse Event|45|||
161257770|NCT00479388|582322450|FG000|Overall Study|Lost to Follow-up|0|||
161257771|NCT00479388|582322451|FG001|Overall Study|Lost to Follow-up|2|||
161257772|NCT00479388|582322450|FG000|Overall Study|Protocol Violation|10|||
161257773|NCT00479388|582322451|FG001|Overall Study|Protocol Violation|9|||
160916939|NCT03998189|581089424|FG001|Overall Study|Lack of Efficacy|1|||
160916940|NCT04983264|581089425|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
160916941|NCT04983264|581089426|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
160916942|NCT04983264|581089427|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
160916943|NCT04983264|581089425|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
160916944|NCT04983264|581089426|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
161257774|NCT00479388|582322450|FG000|Overall Study|Withdrawal by Subject|32|||
161257775|NCT00479388|582322451|FG001|Overall Study|Withdrawal by Subject|17|||
161257776|NCT00895037|582322461|FG000|Overall Study|Death|0|||
161257777|NCT00895037|582322462|FG001|Overall Study|Death|2|||
161257778|NCT00895037|582322463|FG002|Overall Study|Death|1|||
160916945|NCT04983264|581089427|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
160916946|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
160916947|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
160916948|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
160916949|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
160916950|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
160916951|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
160916952|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
160916953|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
160916954|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
160916955|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
160916956|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
160916957|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
160916958|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
160916959|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
160916960|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
160916961|NCT01124422|581089428|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
160916962|NCT01124422|581089429|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
160916963|NCT01124422|581089430|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
160916964|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
160916965|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
160916966|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
160916967|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
160916968|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
160916969|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
160916970|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
160916971|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
160916972|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
160916973|NCT01124422|581089428|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
160916974|NCT01124422|581089429|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
160916975|NCT01124422|581089430|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
160916976|NCT01828281|581089431|FG000|Overall Study|Withdrawal by Subject|1|||
160916977|NCT01828281|581089432|FG001|Overall Study|Withdrawal by Subject|0|||
160916978|NCT02709785|581089439|FG000|Overall Study|Withdrawal by Subject|1|||
160916979|NCT02709785|581089440|FG001|Overall Study|Withdrawal by Subject|2|||
160916980|NCT02709785|581089441|FG002|Overall Study|Withdrawal by Subject|1|||
160916981|NCT04577118|581089444|FG000|Overall Study|Withdrawal by Subject|4|||
160916982|NCT01961323|581089445|FG000|Overall Study|Withdrawal by Subject|7|||
160916983|NCT01961323|581089445|FG000|Overall Study|Lost to Follow-up|8|||
160916984|NCT01961323|581089445|FG000|Overall Study|screen failure|34|||
160916985|NCT03315208|581089446|FG000|Overall Study|Lost to Follow-up|11|||
160916986|NCT03315208|581089447|FG001|Overall Study|Lost to Follow-up|6|||
160916987|NCT03315208|581089446|FG000|Overall Study|Withdrawal by Subject|2|||
160916988|NCT03315208|581089447|FG001|Overall Study|Withdrawal by Subject|0|||
160916989|NCT02320149|581089448|FG000|Overall Study|Adverse Event|3|||
160916990|NCT02320149|581089449|FG001|Overall Study|Adverse Event|7|||
160916991|NCT02320149|581089448|FG000|Overall Study|Withdrawal of Consent|28|||
160916992|NCT02320149|581089449|FG001|Overall Study|Withdrawal of Consent|32|||
160916993|NCT02320149|581089448|FG000|Overall Study|Lost to Follow-up|21|||
160916994|NCT02320149|581089449|FG001|Overall Study|Lost to Follow-up|34|||
160916995|NCT02320149|581089448|FG000|Overall Study|Protocol Violation|2|||
160916996|NCT02320149|581089449|FG001|Overall Study|Protocol Violation|1|||
160916997|NCT02320149|581089448|FG000|Overall Study|Noncompliance with Study Treatment|7|||
160916998|NCT02320149|581089449|FG001|Overall Study|Noncompliance with Study Treatment|2|||
160916999|NCT02320149|581089448|FG000|Overall Study|Lack of Efficacy|0|||
160917000|NCT02320149|581089449|FG001|Overall Study|Lack of Efficacy|1|||
160917001|NCT02320149|581089448|FG000|Overall Study|Other Miscellaneous Reasons|2|||
160917002|NCT02320149|581089449|FG001|Overall Study|Other Miscellaneous Reasons|3|||
160917003|NCT06133348|581089450|FG000|Overall Study|Death|3|||
160917004|NCT06133348|581089450|FG000|Overall Study|Lost to Follow-up|1|||
160917005|NCT06133348|581089450|FG000|Overall Study|Physician Decision|1|||
161257779|NCT01930175|582322465|FG000|Core Study|Lost to Follow-up|0|||
160917006|NCT06133348|581089450|FG000|Overall Study|Withdrawal by Subject|5|||
160917007|NCT02036294|581089451|FG000|Overall Study|Death|7|||
160917008|NCT02036294|581089452|FG001|Overall Study|Death|8|||
160917009|NCT02036294|581089451|FG000|Overall Study|Withdrawal by Subject|2|||
160917010|NCT02036294|581089452|FG001|Overall Study|Withdrawal by Subject|3|||
160917011|NCT00356369|581089453|FG000|Active Phase|Withdrawal by Subject|2|||
160917012|NCT00356369|581089454|FG001|Active Phase|Withdrawal by Subject|1|||
160917013|NCT00673465|581089457|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917014|NCT00673465|581089458|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917015|NCT00673465|581089459|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917016|NCT00673465|581089460|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917017|NCT00673465|581089461|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
160917018|NCT00673465|581089462|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
160917019|NCT00673465|581089463|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917020|NCT00673465|581089464|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917021|NCT00673465|581089465|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917022|NCT00673465|581089466|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917023|NCT00673465|581089467|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917024|NCT00673465|581089468|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
160917025|NCT00673465|581089457|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917026|NCT00673465|581089458|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917027|NCT00673465|581089459|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917028|NCT00673465|581089460|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917029|NCT00673465|581089461|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
160917030|NCT00673465|581089462|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917031|NCT00673465|581089463|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917032|NCT00673465|581089464|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917033|NCT00673465|581089465|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917034|NCT00673465|581089466|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917035|NCT00673465|581089467|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917036|NCT00673465|581089468|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
160917037|NCT01996982|581089469|FG000|Overall Study|PI/team left institution|7|||
160917038|NCT01195415|581089488|FG000|Overall Study|No repeat biopsy due to progression|2|||
160917039|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
160917040|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
160917041|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
160917042|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
160917043|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
160917044|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
160917045|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
160917046|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
160917047|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
160917048|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
160917049|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Death|2|||
160917050|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Death|1|||
160917051|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Death|4|||
160917052|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Death|0|||
160917053|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Death|0|||
160917054|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
160917055|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
160917056|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
160917057|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
160917058|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
160917059|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Other Reason|1|||
160917060|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Other Reason|3|||
160917061|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Other Reason|2|||
160917062|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Other Reason|0|||
160917063|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Other Reason|0|||
160917064|NCT00555321|581089493|FG000|Treatment Phase up to 12-months|Never treated|2|||
160917065|NCT00555321|581089494|FG001|Treatment Phase up to 12-months|Never treated|3|||
160917066|NCT00555321|581089495|FG002|Treatment Phase up to 12-months|Never treated|1|||
160917067|NCT00555321|581089496|FG003|Treatment Phase up to 12-months|Never treated|0|||
160917068|NCT00555321|581089497|FG004|Treatment Phase up to 12-months|Never treated|4|||
160917069|NCT00555321|581089493|FG000|Long-term Extension Phase|Adverse Event|2|||
160917070|NCT00555321|581089494|FG001|Long-term Extension Phase|Adverse Event|5|||
160917071|NCT00555321|581089495|FG002|Long-term Extension Phase|Adverse Event|2|||
160917072|NCT00555321|581089496|FG003|Long-term Extension Phase|Adverse Event|1|||
160917073|NCT00555321|581089497|FG004|Long-term Extension Phase|Adverse Event|0|||
160917074|NCT00555321|581089493|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
160996347|NCT03354390|581372191|FG001|Level 4|Death|0|||
161257780|NCT01930175|582322466|FG001|Core Study|Lost to Follow-up|1|||
161257781|NCT01930175|582322467|FG002|Core Study|Lost to Follow-up|0|||
161257782|NCT01930175|582322465|FG000|Core Study|Adverse Event|0|||
161257783|NCT01930175|582322466|FG001|Core Study|Adverse Event|0|||
161257784|NCT01930175|582322467|FG002|Core Study|Adverse Event|1|||
161257785|NCT02820740|582322468|FG000|Overall Study|Did not have procedure|2|||
161257786|NCT00890552|582322469|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
160917075|NCT00555321|581089494|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
160917076|NCT00555321|581089495|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
160917077|NCT00555321|581089496|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
160917078|NCT00555321|581089497|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
160917079|NCT00555321|581089493|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
160917080|NCT00555321|581089494|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
160917081|NCT00555321|581089495|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
160917082|NCT00555321|581089496|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
160917083|NCT00555321|581089497|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
160917084|NCT00555321|581089493|FG000|Long-term Extension Phase|Death|2|||
160917085|NCT00555321|581089494|FG001|Long-term Extension Phase|Death|0|||
160917086|NCT00555321|581089495|FG002|Long-term Extension Phase|Death|0|||
160917087|NCT00555321|581089496|FG003|Long-term Extension Phase|Death|3|||
160917088|NCT00555321|581089497|FG004|Long-term Extension Phase|Death|0|||
160917089|NCT00555321|581089493|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917090|NCT00555321|581089494|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917091|NCT00555321|581089495|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917092|NCT00555321|581089496|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
160917093|NCT00555321|581089497|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
160917094|NCT00555321|581089493|FG000|Long-term Extension Phase|Other Reason|1|||
160917095|NCT00555321|581089494|FG001|Long-term Extension Phase|Other Reason|0|||
160917096|NCT00555321|581089495|FG002|Long-term Extension Phase|Other Reason|2|||
160917097|NCT00555321|581089496|FG003|Long-term Extension Phase|Other Reason|0|||
160917098|NCT00555321|581089497|FG004|Long-term Extension Phase|Other Reason|0|||
160917099|NCT02733367|581089498|FG000|Overall Study|Withdrawal by Subject|6|||
160917100|NCT01348347|581089499|FG000|Overall Study|Withdrawal by Subject|1|||
160917101|NCT01348347|581089500|FG001|Overall Study|Withdrawal by Subject|1|||
160917102|NCT01348347|581089501|FG002|Overall Study|Withdrawal by Subject|1|||
160917103|NCT01348347|581089499|FG000|Overall Study|Progressive disease|2|||
160917104|NCT01348347|581089500|FG001|Overall Study|Progressive disease|5|||
160917105|NCT01348347|581089501|FG002|Overall Study|Progressive disease|5|||
160917106|NCT00191789|581089505|FG000|Overall Study|Adverse Event|5|||
160917107|NCT00191789|581089505|FG000|Overall Study|Patient: Satisfactory Response|5|||
160917108|NCT00191789|581089505|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
160917109|NCT00191789|581089505|FG000|Overall Study|Withdrawal by Subject|4|||
160917110|NCT00191789|581089505|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
160917111|NCT00191789|581089505|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
160917112|NCT00191789|581089505|FG000|Overall Study|Death - Not Study-Drug Related|1|||
160917113|NCT01922089|581089506|FG000|Overall Study|Adverse Event|18|||
160917114|NCT01922089|581089507|FG001|Overall Study|Adverse Event|13|||
160917115|NCT01922089|581089506|FG000|Overall Study|Protocol Deviation|10|||
160917116|NCT01922089|581089507|FG001|Overall Study|Protocol Deviation|7|||
160917117|NCT01922089|581089506|FG000|Overall Study|Withdrawal by Subject|3|||
160917118|NCT01922089|581089507|FG001|Overall Study|Withdrawal by Subject|4|||
160917119|NCT01922089|581089506|FG000|Overall Study|administrative problems|4|||
160917120|NCT01922089|581089507|FG001|Overall Study|administrative problems|1|||
160917121|NCT01922089|581089506|FG000|Overall Study|Physician Decision|2|||
161257787|NCT00890552|582322469|FG000|On-treatment|Early prog disease/ death|10|||
161257788|NCT03903159|582322470|FG000|Overall Study|Discharged with Staff Approval|2|||
161257789|NCT03903159|582322470|FG000|Overall Study|Discharged at Staff Request|2|||
161257790|NCT03903159|582322470|FG000|Overall Study|Discharged Against Staff Advice|1|||
160917122|NCT01922089|581089507|FG001|Overall Study|Physician Decision|3|||
160917123|NCT01922089|581089506|FG000|Overall Study|Death|2|||
160917124|NCT01922089|581089507|FG001|Overall Study|Death|1|||
160917125|NCT01922089|581089506|FG000|Overall Study|Lost to Follow-up|0|||
160917126|NCT01922089|581089507|FG001|Overall Study|Lost to Follow-up|1|||
160917127|NCT00996307|581089509|FG000|Overall Study|Adverse Event|0|||
161257791|NCT01382251|582322473|FG000|Overall Study|Surgeries cancelled or delayed|16|||
160917128|NCT00996307|581089510|FG001|Overall Study|Adverse Event|1|||
160917129|NCT00996307|581089511|FG002|Overall Study|Adverse Event|0|||
160917130|NCT00996307|581089512|FG003|Overall Study|Adverse Event|0|||
160917131|NCT00996307|581089509|FG000|Overall Study|Withdrawal by Subject|3|||
161257792|NCT01382251|582322474|FG001|Overall Study|Surgeries cancelled or delayed|16|||
160917132|NCT00996307|581089510|FG001|Overall Study|Withdrawal by Subject|2|||
160917133|NCT00996307|581089511|FG002|Overall Study|Withdrawal by Subject|5|||
161257793|NCT01382251|582322473|FG000|Overall Study|Lost to Follow-up|4|||
160917134|NCT00996307|581089512|FG003|Overall Study|Withdrawal by Subject|5|||
160917135|NCT00996307|581089509|FG000|Overall Study|Lost to Follow-up|13|||
160917136|NCT00996307|581089510|FG001|Overall Study|Lost to Follow-up|13|||
160917137|NCT00996307|581089511|FG002|Overall Study|Lost to Follow-up|7|||
160917138|NCT00996307|581089512|FG003|Overall Study|Lost to Follow-up|15|||
160917139|NCT00996307|581089509|FG000|Overall Study|Administrative reason|0|||
160917140|NCT00996307|581089510|FG001|Overall Study|Administrative reason|1|||
160917141|NCT00996307|581089511|FG002|Overall Study|Administrative reason|0|||
160917142|NCT00996307|581089512|FG003|Overall Study|Administrative reason|0|||
160917143|NCT00996307|581089509|FG000|Overall Study|Unable to classify|4|||
161257794|NCT01382251|582322474|FG001|Overall Study|Lost to Follow-up|4|||
161257795|NCT01382251|582322473|FG000|Overall Study|Contacted after study closed|1|||
161257796|NCT01382251|582322474|FG001|Overall Study|Contacted after study closed|1|||
161257797|NCT00702208|582322475|FG000|Overall Study|Lost to Follow-up|28|||
161257798|NCT00702208|582322475|FG000|Overall Study|Did not self-lavage|1|||
161257799|NCT00702208|582322475|FG000|Overall Study|Unsatisfactory colposcopy|2|||
161257800|NCT00562120|582322476|FG000|First Intervention Period|Adverse Event|1|||
161257801|NCT00562120|582322477|FG001|First Intervention Period|Adverse Event|0|||
161257802|NCT00562120|582322478|FG002|First Intervention Period|Adverse Event|0|||
161257803|NCT00562120|582322479|FG003|First Intervention Period|Adverse Event|0|||
160917144|NCT00996307|581089510|FG001|Overall Study|Unable to classify|0|||
160917145|NCT00996307|581089511|FG002|Overall Study|Unable to classify|2|||
160917146|NCT00996307|581089512|FG003|Overall Study|Unable to classify|1|||
160917147|NCT02788357|581089513|FG000|Overall Study|Lost to Follow-up|3|||
160917148|NCT02788357|581089514|FG001|Overall Study|Lost to Follow-up|0|||
160917149|NCT02170051|581089515|FG000|Overall Study|Withdrawal by Subject|10|||
160917150|NCT02170051|581089516|FG001|Overall Study|Withdrawal by Subject|10|||
160917151|NCT02170051|581089515|FG000|Overall Study|Lost to Follow-up|1|||
160917152|NCT02170051|581089516|FG001|Overall Study|Lost to Follow-up|3|||
160917153|NCT01712490|581089517|FG000|Overall Study|Ongoing|601|||
160917154|NCT01712490|581089518|FG001|Overall Study|Ongoing|586|||
160917155|NCT01712490|581089517|FG000|Overall Study|Other|11|||
160917156|NCT01712490|581089518|FG001|Overall Study|Other|11|||
160917157|NCT01712490|581089517|FG000|Overall Study|Withdrawal by Subject|36|||
160917158|NCT01712490|581089518|FG001|Overall Study|Withdrawal by Subject|44|||
160917159|NCT01712490|581089517|FG000|Overall Study|Lost to Follow-up|16|||
160917160|NCT01712490|581089518|FG001|Overall Study|Lost to Follow-up|29|||
160917161|NCT01129960|581089526|FG000|Overall Study|Withdrawal by Subject|3|||
160917162|NCT01129960|581089527|FG001|Overall Study|Withdrawal by Subject|0|||
160917163|NCT01129960|581089528|FG002|Overall Study|Withdrawal by Subject|3|||
160917164|NCT01129960|581089529|FG003|Overall Study|Withdrawal by Subject|2|||
160917165|NCT01129960|581089526|FG000|Overall Study|Lack of Efficacy|1|||
160917166|NCT01129960|581089527|FG001|Overall Study|Lack of Efficacy|1|||
160917167|NCT01129960|581089528|FG002|Overall Study|Lack of Efficacy|1|||
160917168|NCT01129960|581089529|FG003|Overall Study|Lack of Efficacy|1|||
160917169|NCT01129960|581089526|FG000|Overall Study|Adverse Event|23|||
160917170|NCT01129960|581089527|FG001|Overall Study|Adverse Event|16|||
160917171|NCT01129960|581089528|FG002|Overall Study|Adverse Event|16|||
160917172|NCT01129960|581089529|FG003|Overall Study|Adverse Event|7|||
160917173|NCT01129960|581089526|FG000|Overall Study|Protocol Violation|1|||
160917174|NCT01129960|581089527|FG001|Overall Study|Protocol Violation|2|||
160917175|NCT01129960|581089528|FG002|Overall Study|Protocol Violation|3|||
160917176|NCT01129960|581089529|FG003|Overall Study|Protocol Violation|0|||
160917177|NCT01129960|581089526|FG000|Overall Study|Lost to Follow-up|0|||
160917178|NCT01129960|581089527|FG001|Overall Study|Lost to Follow-up|2|||
160917179|NCT01129960|581089528|FG002|Overall Study|Lost to Follow-up|3|||
160917180|NCT01129960|581089529|FG003|Overall Study|Lost to Follow-up|3|||
160917181|NCT01129960|581089526|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
160917182|NCT01129960|581089527|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
160917183|NCT01129960|581089528|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
160917184|NCT01129960|581089529|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
160917185|NCT01129960|581089526|FG000|Overall Study|Physician Decision|1|||
160996348|NCT03354390|581372192|FG002|Level 4|Death|0|||
161257804|NCT00562120|582322476|FG000|First Intervention Period|Randomized but not Treated|1|||
161257805|NCT00562120|582322477|FG001|First Intervention Period|Randomized but not Treated|0|||
161257806|NCT00562120|582322478|FG002|First Intervention Period|Randomized but not Treated|0|||
161257807|NCT00562120|582322479|FG003|First Intervention Period|Randomized but not Treated|0|||
160917186|NCT01129960|581089527|FG001|Overall Study|Physician Decision|0|||
160917187|NCT01129960|581089528|FG002|Overall Study|Physician Decision|0|||
160917188|NCT01129960|581089529|FG003|Overall Study|Physician Decision|0|||
160917189|NCT01129960|581089526|FG000|Overall Study|Pregnancy|1|||
160917190|NCT01129960|581089527|FG001|Overall Study|Pregnancy|0|||
161257808|NCT02148445|582322480|FG000|Overall Study|Death|1|||
161257809|NCT02148445|582322481|FG001|Overall Study|Death|3|||
160917191|NCT01129960|581089528|FG002|Overall Study|Pregnancy|0|||
160917192|NCT01129960|581089529|FG003|Overall Study|Pregnancy|0|||
160917193|NCT02860169|581089530|FG000|Part A|Withdrawal by Subject|1|||
160917194|NCT02860169|581089530|FG000|Part A|Other (Screening failure)|6|||
160917195|NCT02860169|581089530|FG000|Part A|Other (Survey not completed)|3|||
160996349|NCT03354390|581372193|FG003|Level 4|Death|3|||
161257810|NCT03450629|582322482|FG000|Overall Study|Adverse Event|15|||
161257811|NCT03450629|582322483|FG001|Overall Study|Adverse Event|14|||
161257812|NCT03450629|582322482|FG000|Overall Study|Physician Decision|2|||
161257813|NCT03450629|582322483|FG001|Overall Study|Physician Decision|2|||
161257814|NCT03450629|582322482|FG000|Overall Study|Lack of Efficacy|2|||
161257815|NCT03450629|582322483|FG001|Overall Study|Lack of Efficacy|0|||
161257816|NCT03450629|582322482|FG000|Overall Study|Lost to Follow-up|4|||
161257817|NCT03450629|582322483|FG001|Overall Study|Lost to Follow-up|2|||
160917196|NCT02860169|581089530|FG000|Part A|Other (did not completed consent)|1|||
160917197|NCT02860169|581089530|FG000|Part B|Other (Screening failure)|10|||
160917198|NCT02860169|581089530|FG000|Part B|Withdrawal by Subject|1|||
160917199|NCT02860169|581089530|FG000|Part C|Other (Screening failure)|1|||
160917200|NCT04285879|581089531|FG000|Overall Study|Lost to Follow-up|1|||
160917201|NCT04285879|581089532|FG001|Overall Study|Lost to Follow-up|8|||
160917202|NCT04285879|581089531|FG000|Overall Study|medical/surgical exclusion|16|||
160917203|NCT04285879|581089532|FG001|Overall Study|medical/surgical exclusion|0|||
160917204|NCT01835587|581089535|FG000|Overall Study|Disease Recurrence or Relapse|0|||
160917205|NCT01835587|581089536|FG001|Overall Study|Disease Recurrence or Relapse|3|||
160917206|NCT01835587|581089537|FG002|Overall Study|Disease Recurrence or Relapse|0|||
160917207|NCT01835587|581089538|FG003|Overall Study|Disease Recurrence or Relapse|3|||
160917208|NCT01835587|581089535|FG000|Overall Study|Withdrawal by Subject|2|||
160917209|NCT01835587|581089536|FG001|Overall Study|Withdrawal by Subject|0|||
160917210|NCT01835587|581089537|FG002|Overall Study|Withdrawal by Subject|0|||
160917211|NCT01835587|581089538|FG003|Overall Study|Withdrawal by Subject|3|||
160917212|NCT01835587|581089535|FG000|Overall Study|Adverse Event|0|||
160917213|NCT01835587|581089536|FG001|Overall Study|Adverse Event|0|||
160917214|NCT01835587|581089537|FG002|Overall Study|Adverse Event|2|||
160917215|NCT01835587|581089538|FG003|Overall Study|Adverse Event|2|||
160917216|NCT01835587|581089535|FG000|Overall Study|Death|0|||
160917217|NCT01835587|581089536|FG001|Overall Study|Death|0|||
160917218|NCT01835587|581089537|FG002|Overall Study|Death|0|||
160917219|NCT01835587|581089538|FG003|Overall Study|Death|1|||
160917220|NCT01835587|581089535|FG000|Overall Study|Miscellaneous|0|||
160917221|NCT01835587|581089536|FG001|Overall Study|Miscellaneous|1|||
160917222|NCT01835587|581089537|FG002|Overall Study|Miscellaneous|0|||
160917223|NCT01835587|581089538|FG003|Overall Study|Miscellaneous|0|||
160917224|NCT01782495|581089539|FG000|Overall Study|Adverse Event|0|||
160917225|NCT01782495|581089540|FG001|Overall Study|Adverse Event|0|||
160917226|NCT01782495|581089541|FG002|Overall Study|Adverse Event|0|||
160917227|NCT01782495|581089542|FG003|Overall Study|Adverse Event|0|||
160917228|NCT01782495|581089543|FG004|Overall Study|Adverse Event|0|||
160917229|NCT01782495|581089544|FG005|Overall Study|Adverse Event|0|||
161257818|NCT03450629|582322482|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161257819|NCT03450629|582322483|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161257820|NCT03450629|582322482|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161257821|NCT03450629|582322483|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161257822|NCT03450629|582322482|FG000|Overall Study|Protocol Violation|11|||
161257823|NCT03450629|582322483|FG001|Overall Study|Protocol Violation|8|||
161257824|NCT03450629|582322482|FG000|Overall Study|Withdrawal by Subject|12|||
161257825|NCT03450629|582322483|FG001|Overall Study|Withdrawal by Subject|6|||
160917230|NCT01782495|581089545|FG006|Overall Study|Adverse Event|0|||
160917231|NCT01782495|581089546|FG007|Overall Study|Adverse Event|2|||
160917232|NCT01782495|581089547|FG008|Overall Study|Adverse Event|0|||
160917233|NCT01782495|581089548|FG009|Overall Study|Adverse Event|0|||
160917234|NCT01782495|581089549|FG010|Overall Study|Adverse Event|0|||
160917235|NCT01782495|581089539|FG000|Overall Study|Withdrew Consent|0|||
160917236|NCT01782495|581089540|FG001|Overall Study|Withdrew Consent|1|||
160917237|NCT01782495|581089541|FG002|Overall Study|Withdrew Consent|0|||
160917238|NCT01782495|581089542|FG003|Overall Study|Withdrew Consent|0|||
160917239|NCT01782495|581089543|FG004|Overall Study|Withdrew Consent|0|||
160917240|NCT01782495|581089544|FG005|Overall Study|Withdrew Consent|0|||
160917241|NCT01782495|581089545|FG006|Overall Study|Withdrew Consent|0|||
160917242|NCT01782495|581089546|FG007|Overall Study|Withdrew Consent|1|||
160917243|NCT01782495|581089547|FG008|Overall Study|Withdrew Consent|0|||
160917244|NCT01782495|581089548|FG009|Overall Study|Withdrew Consent|0|||
160917245|NCT01782495|581089549|FG010|Overall Study|Withdrew Consent|0|||
160917246|NCT01927367|581089550|FG000|Overall Study|Withdrawal by Subject|7|||
160917247|NCT01927367|581089551|FG001|Overall Study|Withdrawal by Subject|4|||
160917248|NCT01927367|581089550|FG000|Overall Study|No baseline data|0|||
160917249|NCT01927367|581089551|FG001|Overall Study|No baseline data|1|||
160917250|NCT00071513|581089554|FG000|Intervention Component|Withdrawal by Subject|2|||
160917251|NCT00071513|581089555|FG001|Intervention Component|Withdrawal by Subject|3|||
160917252|NCT00071513|581089554|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
160917253|NCT00071513|581089555|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
160917254|NCT02622321|581089556|FG000|Overall Study|Withdrawal by Subject|2|||
161257826|NCT03366194|582322484|FG000|Overall Study|Lost to Follow-up|2|||
161257827|NCT02093923|582322485|FG000|Overall Study|Lost to Follow-up|0|||
160917255|NCT02622321|581089557|FG001|Overall Study|Withdrawal by Subject|0|||
160917256|NCT02622321|581089558|FG002|Overall Study|Withdrawal by Subject|0|||
160917257|NCT02622321|581089559|FG003|Overall Study|Withdrawal by Subject|0|||
160917258|NCT02622321|581089556|FG000|Overall Study|Death|0|||
160917259|NCT02622321|581089557|FG001|Overall Study|Death|0|||
160917260|NCT02622321|581089558|FG002|Overall Study|Death|1|||
160917261|NCT02622321|581089559|FG003|Overall Study|Death|0|||
160917262|NCT02622321|581089556|FG000|Overall Study|Physician Decision|1|||
160917263|NCT02622321|581089557|FG001|Overall Study|Physician Decision|0|||
160917264|NCT02622321|581089558|FG002|Overall Study|Physician Decision|0|||
160917265|NCT02622321|581089559|FG003|Overall Study|Physician Decision|0|||
160917266|NCT00241280|581089560|FG000|Overall Study|Adverse Event|2|||
160917267|NCT00241280|581089561|FG001|Overall Study|Adverse Event|6|||
160917268|NCT00241280|581089560|FG000|Overall Study|Discomfort|11|||
160917269|NCT00241280|581089561|FG001|Overall Study|Discomfort|16|||
160917270|NCT00241280|581089560|FG000|Overall Study|Pregnancy|1|||
160917271|NCT00241280|581089561|FG001|Overall Study|Pregnancy|5|||
160917272|NCT00241280|581089560|FG000|Overall Study|Lost to Follow-up|5|||
160917273|NCT00241280|581089561|FG001|Overall Study|Lost to Follow-up|8|||
160917274|NCT00241280|581089560|FG000|Overall Study|Withdrawal by Subject|7|||
160917275|NCT00241280|581089561|FG001|Overall Study|Withdrawal by Subject|4|||
160917276|NCT00241280|581089560|FG000|Overall Study|Protocol Violation|4|||
160917277|NCT00241280|581089561|FG001|Overall Study|Protocol Violation|10|||
160917278|NCT00241280|581089560|FG000|Overall Study|Relocation|4|||
160917279|NCT00241280|581089561|FG001|Overall Study|Relocation|4|||
160917280|NCT00241280|581089560|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
160917281|NCT00241280|581089561|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
160917282|NCT00241280|581089560|FG000|Overall Study|Unsatisfactory Visual Response|1|||
160917283|NCT00241280|581089561|FG001|Overall Study|Unsatisfactory Visual Response|1|||
160917284|NCT00241280|581089560|FG000|Overall Study|Diabetic|1|||
160917285|NCT00241280|581089561|FG001|Overall Study|Diabetic|0|||
160917286|NCT00241280|581089560|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
160917287|NCT00241280|581089561|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
160917288|NCT00241280|581089560|FG000|Overall Study|Dispensed incorrect test article|1|||
160917289|NCT00241280|581089561|FG001|Overall Study|Dispensed incorrect test article|2|||
160917290|NCT00241280|581089560|FG000|Overall Study|Unacceptable Fit|0|||
160917291|NCT00241280|581089561|FG001|Overall Study|Unacceptable Fit|1|||
160917292|NCT00241280|581089560|FG000|Overall Study|Scheduling Conflict|0|||
160917293|NCT00241280|581089561|FG001|Overall Study|Scheduling Conflict|2|||
160917294|NCT00241280|581089560|FG000|Overall Study|History of Ocular Surgery|0|||
160917295|NCT00241280|581089561|FG001|Overall Study|History of Ocular Surgery|1|||
160917296|NCT00241280|581089560|FG000|Overall Study|Coating on Lens|1|||
160917297|NCT00241280|581089561|FG001|Overall Study|Coating on Lens|0|||
160917298|NCT00241280|581089560|FG000|Overall Study|Excessive Dryness|0|||
160917299|NCT00241280|581089561|FG001|Overall Study|Excessive Dryness|1|||
160917300|NCT01958008|581089562|FG000|Overall Study|Worsening of disease under study|0|||
160917301|NCT01958008|581089563|FG001|Overall Study|Worsening of disease under study|0|||
160917302|NCT01958008|581089564|FG002|Overall Study|Worsening of disease under study|1|||
160917303|NCT01958008|581089565|FG003|Overall Study|Worsening of disease under study|0|||
160917304|NCT01958008|581089562|FG000|Overall Study|Other adverse event|1|||
160917305|NCT01958008|581089563|FG001|Overall Study|Other adverse event|0|||
160917306|NCT01958008|581089564|FG002|Overall Study|Other adverse event|0|||
160917307|NCT01958008|581089565|FG003|Overall Study|Other adverse event|0|||
160917308|NCT01634360|581089566|FG000|Overall Study|Adverse Event|10|||
160917309|NCT01634360|581089567|FG001|Overall Study|Adverse Event|34|||
160917310|NCT01634360|581089566|FG000|Overall Study|subject withdrew consent|13|||
160917311|NCT01634360|581089567|FG001|Overall Study|subject withdrew consent|23|||
160917312|NCT01634360|581089566|FG000|Overall Study|Protocol Violation|1|||
160917313|NCT01634360|581089567|FG001|Overall Study|Protocol Violation|1|||
160917314|NCT01634360|581089566|FG000|Overall Study|Lack of Efficacy|4|||
160917315|NCT01634360|581089567|FG001|Overall Study|Lack of Efficacy|14|||
160917316|NCT01634360|581089566|FG000|Overall Study|Other|3|||
160917317|NCT01634360|581089567|FG001|Overall Study|Other|20|||
160917318|NCT01634360|581089566|FG000|Overall Study|Study termination by sponsor|18|||
160917319|NCT01634360|581089567|FG001|Overall Study|Study termination by sponsor|44|||
160917320|NCT01414855|581089568|FG000|Overall Study|Death|17|||
160917321|NCT01414855|581089568|FG000|Overall Study|Lost to Follow-up|5|||
160917322|NCT01414855|581089568|FG000|Overall Study|Withdrawal by Subject|7|||
160917323|NCT02743871|581089569|FG000|Overall Study|Lost to Follow-up|0|||
160917324|NCT02743871|581089570|FG001|Overall Study|Lost to Follow-up|0|||
160917325|NCT02743871|581089571|FG002|Overall Study|Lost to Follow-up|0|||
160917326|NCT02743871|581089572|FG003|Overall Study|Lost to Follow-up|1|||
160917327|NCT02743871|581089573|FG004|Overall Study|Lost to Follow-up|0|||
160917328|NCT02743871|581089574|FG005|Overall Study|Lost to Follow-up|0|||
160917329|NCT02743871|581089575|FG006|Overall Study|Lost to Follow-up|1|||
160917330|NCT02743871|581089576|FG007|Overall Study|Lost to Follow-up|0|||
160917331|NCT02743871|581089577|FG008|Overall Study|Lost to Follow-up|0|||
160917332|NCT02743871|581089578|FG009|Overall Study|Lost to Follow-up|0|||
160917333|NCT02743871|581089579|FG010|Overall Study|Lost to Follow-up|0|||
160917334|NCT02743871|581089580|FG011|Overall Study|Lost to Follow-up|2|||
160917335|NCT02743871|581089581|FG012|Overall Study|Lost to Follow-up|0|||
160917336|NCT02743871|581089582|FG013|Overall Study|Lost to Follow-up|0|||
160917337|NCT02743871|581089569|FG000|Overall Study|Withdrawal by Subject|0|||
161257828|NCT02093923|582322486|FG001|Overall Study|Lost to Follow-up|0|||
160917338|NCT02743871|581089570|FG001|Overall Study|Withdrawal by Subject|0|||
160917339|NCT02743871|581089571|FG002|Overall Study|Withdrawal by Subject|0|||
160917340|NCT02743871|581089572|FG003|Overall Study|Withdrawal by Subject|0|||
160917341|NCT02743871|581089573|FG004|Overall Study|Withdrawal by Subject|0|||
160917342|NCT02743871|581089574|FG005|Overall Study|Withdrawal by Subject|0|||
160917343|NCT02743871|581089575|FG006|Overall Study|Withdrawal by Subject|0|||
160917344|NCT02743871|581089576|FG007|Overall Study|Withdrawal by Subject|0|||
160917345|NCT02743871|581089577|FG008|Overall Study|Withdrawal by Subject|0|||
160917346|NCT02743871|581089578|FG009|Overall Study|Withdrawal by Subject|0|||
160917347|NCT02743871|581089579|FG010|Overall Study|Withdrawal by Subject|1|||
160917348|NCT02743871|581089580|FG011|Overall Study|Withdrawal by Subject|0|||
160917349|NCT02743871|581089581|FG012|Overall Study|Withdrawal by Subject|12|||
160917350|NCT02743871|581089582|FG013|Overall Study|Withdrawal by Subject|6|||
160917351|NCT02743871|581089569|FG000|Overall Study|Adverse Event|1|||
160917352|NCT02743871|581089570|FG001|Overall Study|Adverse Event|0|||
160917353|NCT02743871|581089571|FG002|Overall Study|Adverse Event|0|||
160917354|NCT02743871|581089572|FG003|Overall Study|Adverse Event|0|||
160917355|NCT02743871|581089573|FG004|Overall Study|Adverse Event|0|||
160917356|NCT02743871|581089574|FG005|Overall Study|Adverse Event|0|||
160917357|NCT02743871|581089575|FG006|Overall Study|Adverse Event|0|||
160917358|NCT02743871|581089576|FG007|Overall Study|Adverse Event|0|||
160917359|NCT02743871|581089577|FG008|Overall Study|Adverse Event|0|||
160917360|NCT02743871|581089578|FG009|Overall Study|Adverse Event|0|||
160917361|NCT02743871|581089579|FG010|Overall Study|Adverse Event|0|||
160917362|NCT02743871|581089580|FG011|Overall Study|Adverse Event|0|||
160917363|NCT02743871|581089581|FG012|Overall Study|Adverse Event|0|||
160917364|NCT02743871|581089582|FG013|Overall Study|Adverse Event|0|||
160917365|NCT02743871|581089569|FG000|Overall Study|Other|0|||
160917366|NCT02743871|581089570|FG001|Overall Study|Other|0|||
160917367|NCT02743871|581089571|FG002|Overall Study|Other|0|||
160917368|NCT02743871|581089572|FG003|Overall Study|Other|0|||
160917369|NCT02743871|581089573|FG004|Overall Study|Other|0|||
160917370|NCT02743871|581089574|FG005|Overall Study|Other|0|||
160917371|NCT02743871|581089575|FG006|Overall Study|Other|0|||
160917372|NCT02743871|581089576|FG007|Overall Study|Other|0|||
160917373|NCT02743871|581089577|FG008|Overall Study|Other|0|||
160917374|NCT02743871|581089578|FG009|Overall Study|Other|0|||
160917375|NCT02743871|581089579|FG010|Overall Study|Other|0|||
160917376|NCT02743871|581089580|FG011|Overall Study|Other|1|||
160917377|NCT02743871|581089581|FG012|Overall Study|Other|1|||
160917378|NCT02743871|581089582|FG013|Overall Study|Other|1|||
160917379|NCT02743871|581089569|FG000|Overall Study|Protocol Violation|0|||
160917380|NCT02743871|581089570|FG001|Overall Study|Protocol Violation|0|||
160917381|NCT02743871|581089571|FG002|Overall Study|Protocol Violation|0|||
160917382|NCT02743871|581089572|FG003|Overall Study|Protocol Violation|0|||
160917383|NCT02743871|581089573|FG004|Overall Study|Protocol Violation|0|||
160917384|NCT02743871|581089574|FG005|Overall Study|Protocol Violation|0|||
160917385|NCT02743871|581089575|FG006|Overall Study|Protocol Violation|0|||
160917386|NCT02743871|581089576|FG007|Overall Study|Protocol Violation|0|||
160917387|NCT02743871|581089577|FG008|Overall Study|Protocol Violation|0|||
160917388|NCT02743871|581089578|FG009|Overall Study|Protocol Violation|0|||
160917389|NCT02743871|581089579|FG010|Overall Study|Protocol Violation|0|||
160917390|NCT02743871|581089580|FG011|Overall Study|Protocol Violation|0|||
160917391|NCT02743871|581089581|FG012|Overall Study|Protocol Violation|2|||
160917392|NCT02743871|581089582|FG013|Overall Study|Protocol Violation|0|||
160917393|NCT04779489|581091610|FG000|Overall Study|Physician Decision|1|||
160917394|NCT05126901|581091611|FG000|Overall Study|Withdrawal by Subject|1|||
160917395|NCT05126901|581091612|FG001|Overall Study|Withdrawal by Subject|1|||
160917396|NCT05126901|581091613|FG002|Overall Study|Withdrawal by Subject|4|||
160917397|NCT05126901|581091611|FG000|Overall Study|Adverse Event|0|||
160917398|NCT05126901|581091612|FG001|Overall Study|Adverse Event|0|||
160917399|NCT05126901|581091613|FG002|Overall Study|Adverse Event|1|||
160917400|NCT05126901|581091611|FG000|Overall Study|Lost to Follow-up|0|||
160917401|NCT05126901|581091612|FG001|Overall Study|Lost to Follow-up|2|||
161257829|NCT02093923|582322487|FG002|Overall Study|Lost to Follow-up|0|||
161257830|NCT02093923|582322488|FG003|Overall Study|Lost to Follow-up|1|||
160917402|NCT05126901|581091613|FG002|Overall Study|Lost to Follow-up|0|||
160917403|NCT00254540|581091614|FG000|Overall Study|Adverse Event|6|||
160917404|NCT00254540|581091615|FG001|Overall Study|Adverse Event|7|||
160917405|NCT00254540|581091614|FG000|Overall Study|Lack of Efficacy|13|||
160917406|NCT00254540|581091615|FG001|Overall Study|Lack of Efficacy|13|||
160917407|NCT00254540|581091614|FG000|Overall Study|Death|0|||
160917408|NCT00254540|581091615|FG001|Overall Study|Death|1|||
160917409|NCT00254540|581091614|FG000|Overall Study|Laboratory Test Abnormality|0|||
160917410|NCT00254540|581091615|FG001|Overall Study|Laboratory Test Abnormality|1|||
160917411|NCT00710710|581091616|FG000|Overall Study|Consent withdrawn|2|||
160917412|NCT00710710|581091617|FG001|Overall Study|Consent withdrawn|2|||
161339443|NCT00109343|582631881|FG002|Overall Study|Withdrawal by Subject|10|||
161339444|NCT00109343|582631879|FG000|Overall Study|Subject Moved|6|||
161339445|NCT00109343|582631880|FG001|Overall Study|Subject Moved|2|||
161339446|NCT00109343|582631881|FG002|Overall Study|Subject Moved|1|||
161339447|NCT00109343|582631879|FG000|Overall Study|Other|5|||
161339448|NCT00109343|582631880|FG001|Overall Study|Other|2|||
161339449|NCT00109343|582631881|FG002|Overall Study|Other|1|||
161339450|NCT05001620|582631884|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
161339451|NCT05001620|582631885|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
161339452|NCT00819039|582631886|FG000|Overall Study|Physician Decision|1|||
161339453|NCT00819039|582631887|FG001|Overall Study|Physician Decision|0|||
161339454|NCT00819039|582631888|FG002|Overall Study|Physician Decision|1|||
161339455|NCT00819039|582631886|FG000|Overall Study|Protocol Violation|1|||
161339456|NCT00819039|582631887|FG001|Overall Study|Protocol Violation|0|||
161339457|NCT00819039|582631888|FG002|Overall Study|Protocol Violation|0|||
161339458|NCT04796415|582631889|FG000|Overall Study|not interested|12|||
161339459|NCT04796415|582631889|FG000|Overall Study|health issue|8|||
161339460|NCT04796415|582631889|FG000|Overall Study|Other|4|||
161339461|NCT04796415|582631889|FG000|Overall Study|discharged from home health service|3|||
161339462|NCT04796415|582631889|FG000|Overall Study|re-hospitalization|2|||
161339463|NCT04796415|582631889|FG000|Overall Study|moving to nursing home|1|||
161339464|NCT04796415|582631889|FG000|Overall Study|lost contact|1|||
161339465|NCT00486044|582631893|FG000|Overall Study|Withdrawal by Subject|2|||
161339466|NCT00486044|582631894|FG001|Overall Study|Withdrawal by Subject|1|||
161339467|NCT00486044|582631893|FG000|Overall Study|Adverse Event|0|||
161339468|NCT00486044|582631894|FG001|Overall Study|Adverse Event|1|||
161339469|NCT00486044|582631893|FG000|Overall Study|Lost to Follow-up|0|||
161339470|NCT00486044|582631894|FG001|Overall Study|Lost to Follow-up|1|||
161339471|NCT00537277|582631897|FG000|Overall Study|Adverse Event|1|||
161339472|NCT00537277|582631897|FG000|Overall Study|Lack of Efficacy|2|||
161339473|NCT00537277|582631897|FG000|Overall Study|Lost to Follow-up|12|||
161339474|NCT00537277|582631897|FG000|Overall Study|Protocol Violation|11|||
161339475|NCT00537277|582631897|FG000|Overall Study|Unclassified|4|||
161339476|NCT00537277|582631897|FG000|Overall Study|Inability to tolerate trial medication|4|||
161339477|NCT00537277|582631897|FG000|Overall Study|Non-compliance with trial procedures|15|||
161339478|NCT00997893|582631898|FG000|Overall Study|Adverse Event|1|||
161339479|NCT00997893|582631899|FG001|Overall Study|Adverse Event|0|||
161339480|NCT00997893|582631900|FG002|Overall Study|Adverse Event|0|||
161339481|NCT00997893|582631898|FG000|Overall Study|Unable to meet study timelines|1|||
161339482|NCT00997893|582631899|FG001|Overall Study|Unable to meet study timelines|0|||
161339483|NCT00997893|582631900|FG002|Overall Study|Unable to meet study timelines|0|||
161339484|NCT00997893|582631898|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
161339485|NCT00997893|582631899|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
161339486|NCT00997893|582631900|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
161339487|NCT04009837|582631903|FG000|Overall Study|Withdrawal by Subject|5|||
161339488|NCT04009837|582631904|FG001|Overall Study|Withdrawal by Subject|4|||
161339489|NCT04009837|582631903|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
161339490|NCT04009837|582631904|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
161339491|NCT05352815|582631905|FG000|Overall Study|Withdrawal by Subject|28|||
161339492|NCT05352815|582631906|FG001|Overall Study|Withdrawal by Subject|24|||
161339493|NCT05352815|582631905|FG000|Overall Study|Lost to Follow-up|4|||
161339494|NCT05352815|582631906|FG001|Overall Study|Lost to Follow-up|7|||
161339495|NCT05352815|582631905|FG000|Overall Study|Death|2|||
161339496|NCT05352815|582631906|FG001|Overall Study|Death|3|||
161339497|NCT05352815|582631905|FG000|Overall Study|Site closure|1|||
161339498|NCT05352815|582631906|FG001|Overall Study|Site closure|0|||
161339499|NCT00226655|582631908|FG000|Overall Study|Death|13|||
161339500|NCT00226655|582631908|FG000|Overall Study|Withdrawal by Subject|15|||
161339501|NCT00226655|582631908|FG000|Overall Study|Adverse Event|35|||
161339502|NCT00226655|582631908|FG000|Overall Study|Physician Decision|6|||
161339503|NCT00226655|582631908|FG000|Overall Study|Clinical deterioration|10|||
161339504|NCT05144945|582631909|FG000|Overall Study|Withdrawal by Subject|1|||
161339505|NCT05144945|582631910|FG001|Overall Study|Withdrawal by Subject|0|||
161339506|NCT04649359|582631911|FG000|Overall Study|Withdrawal by Subject|7|||
161339507|NCT04649359|582631912|FG001|Overall Study|Withdrawal by Subject|7|||
161339508|NCT04649359|582631911|FG000|Overall Study|Death|41|||
161339509|NCT04649359|582631912|FG001|Overall Study|Death|26|||
160861742|NCT00459316|580887827|FG000|Steps 1 & 2|Other eligibility failure|1|||
161142509|NCT03519178|581906194|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
161339510|NCT04649359|582631911|FG000|Overall Study|Ongoing in the study|75|||
161339511|NCT04649359|582631912|FG001|Overall Study|Ongoing in the study|31|||
161339512|NCT02592824|582631917|FG000|Overall Study|Protocol Violation|5|||
161339513|NCT02592824|582631918|FG001|Overall Study|Protocol Violation|3|||
161339514|NCT02592824|582631917|FG000|Overall Study|Lost to Follow-up|2|||
161339515|NCT02592824|582631918|FG001|Overall Study|Lost to Follow-up|1|||
161339516|NCT01704261|582631919|FG000|Overall Study|Withdrawal by Subject|12|||
161339517|NCT01704261|582631920|FG001|Overall Study|Withdrawal by Subject|15|||
160917413|NCT00710710|581091616|FG000|Overall Study|Protocol Violation|0|||
160917414|NCT00710710|581091617|FG001|Overall Study|Protocol Violation|1|||
160917415|NCT00710710|581091616|FG000|Overall Study|Adverse Event|3|||
160917416|NCT00710710|581091617|FG001|Overall Study|Adverse Event|3|||
160917417|NCT00710710|581091616|FG000|Overall Study|Progressive disease|40|||
160917418|NCT00710710|581091617|FG001|Overall Study|Progressive disease|38|||
160917419|NCT01313767|581091618|FG000|Overall Study|Adverse Event|1|||
160917420|NCT01313767|581091619|FG001|Overall Study|Adverse Event|0|||
160917421|NCT01313767|581091618|FG000|Overall Study|Lost to Follow-up|1|||
160917422|NCT01313767|581091619|FG001|Overall Study|Lost to Follow-up|0|||
160917423|NCT01313767|581091618|FG000|Overall Study|Withdrawal by Subject|2|||
160917424|NCT01313767|581091619|FG001|Overall Study|Withdrawal by Subject|1|||
160917425|NCT01313767|581091618|FG000|Overall Study|Protocol Violation|3|||
160917426|NCT01313767|581091619|FG001|Overall Study|Protocol Violation|1|||
160917427|NCT01529346|581091620|FG000|Overall Study|Lost to Follow-up|2|||
160917428|NCT01529346|581091621|FG001|Overall Study|Lost to Follow-up|0|||
160917429|NCT01529346|581091622|FG002|Overall Study|Lost to Follow-up|1|||
161142510|NCT03519178|581906195|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142511|NCT03519178|581906196|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
160917430|NCT01529346|581091623|FG003|Overall Study|Lost to Follow-up|0|||
160917431|NCT01529346|581091624|FG004|Overall Study|Lost to Follow-up|0|||
160917432|NCT01529346|581091620|FG000|Overall Study|Other|0|||
160917433|NCT01529346|581091621|FG001|Overall Study|Other|1|||
160917434|NCT01529346|581091622|FG002|Overall Study|Other|1|||
160917435|NCT01529346|581091623|FG003|Overall Study|Other|0|||
160917436|NCT01529346|581091624|FG004|Overall Study|Other|0|||
160917437|NCT01287897|581091625|FG000|Overall Study|Adverse Event|5|||
160917438|NCT01287897|581091626|FG001|Overall Study|Adverse Event|3|||
160917439|NCT01287897|581091627|FG002|Overall Study|Adverse Event|6|||
160917440|NCT01287897|581091628|FG003|Overall Study|Adverse Event|4|||
160917441|NCT01287897|581091625|FG000|Overall Study|Lack of Efficacy|2|||
160917442|NCT01287897|581091626|FG001|Overall Study|Lack of Efficacy|0|||
160917443|NCT01287897|581091627|FG002|Overall Study|Lack of Efficacy|0|||
160917444|NCT01287897|581091628|FG003|Overall Study|Lack of Efficacy|0|||
160917445|NCT01287897|581091625|FG000|Overall Study|Protocol Violation|1|||
160917446|NCT01287897|581091626|FG001|Overall Study|Protocol Violation|1|||
160917447|NCT01287897|581091627|FG002|Overall Study|Protocol Violation|0|||
160917448|NCT01287897|581091628|FG003|Overall Study|Protocol Violation|1|||
160917449|NCT01287897|581091625|FG000|Overall Study|Lost to Follow-up|0|||
160917450|NCT01287897|581091626|FG001|Overall Study|Lost to Follow-up|0|||
160861743|NCT00459316|580887828|FG001|Steps 1 & 2|Other eligibility failure|1|||
160861744|NCT00459316|580887829|FG002|Steps 1 & 2|Other eligibility failure|0|||
160861745|NCT00459316|580887827|FG000|Steps 1 & 2|Death|1|||
160861746|NCT00459316|580887828|FG001|Steps 1 & 2|Death|1|||
160861747|NCT00459316|580887829|FG002|Steps 1 & 2|Death|0|||
160861748|NCT00459316|580887827|FG000|Steps 1 & 2|Not able to get to clinic|7|||
160861749|NCT00459316|580887828|FG001|Steps 1 & 2|Not able to get to clinic|4|||
160861750|NCT00459316|580887829|FG002|Steps 1 & 2|Not able to get to clinic|0|||
160861751|NCT00459316|580887827|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
160861752|NCT00459316|580887828|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
160861753|NCT00459316|580887829|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
160861754|NCT00459316|580887827|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
160861755|NCT00459316|580887828|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
160861756|NCT00459316|580887829|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
160861757|NCT00459316|580887827|FG000|Steps 1 & 2|Lost to Follow-up|5|||
160861758|NCT00459316|580887828|FG001|Steps 1 & 2|Lost to Follow-up|0|||
160861759|NCT00459316|580887829|FG002|Steps 1 & 2|Lost to Follow-up|2|||
160861760|NCT00459316|580887827|FG000|Step 3|Withdrawal by Subject|3|||
160861761|NCT00459316|580887828|FG001|Step 3|Withdrawal by Subject|0|||
160861762|NCT00459316|580887829|FG002|Step 3|Withdrawal by Subject|1|||
160861763|NCT01614886|580887830|FG000|Overall Study|Adverse Event|15|||
160861764|NCT01614886|580887831|FG001|Overall Study|Adverse Event|20|||
160861765|NCT01614886|580887830|FG000|Overall Study|Withdrawal by Subject|4|||
160861766|NCT01614886|580887831|FG001|Overall Study|Withdrawal by Subject|4|||
160861767|NCT01614886|580887830|FG000|Overall Study|Death|1|||
160861768|NCT01614886|580887831|FG001|Overall Study|Death|0|||
160861769|NCT01614886|580887830|FG000|Overall Study|Protocol deviation|0|||
160861770|NCT01614886|580887831|FG001|Overall Study|Protocol deviation|2|||
160861771|NCT04004988|580887834|FG000|Period 1|Physician Decision|2|||
160861772|NCT04004988|580887835|FG001|Period 1|Physician Decision|0|||
160861773|NCT04004988|580887834|FG000|Period 1|Withdrawal by Subject|0|||
160861774|NCT04004988|580887835|FG001|Period 1|Withdrawal by Subject|1|||
160861775|NCT04004988|580887834|FG000|Period 1|Adverse Event|1|||
160861776|NCT04004988|580887835|FG001|Period 1|Adverse Event|2|||
160861777|NCT03873116|580887836|FG000|Part 1|Study drug discontinuation due to rash|0|||
160861778|NCT03873116|580887837|FG001|Part 1|Study drug discontinuation due to rash|0|||
160861779|NCT03873116|580887838|FG002|Part 1|Study drug discontinuation due to rash|0|||
160861780|NCT03873116|580887839|FG003|Part 1|Study drug discontinuation due to rash|0|||
160861781|NCT03873116|580887840|FG004|Part 1|Study drug discontinuation due to rash|0|||
160996350|NCT03944512|581372194|FG000|Overall Study|Death|0|||
160996351|NCT03944512|581372195|FG001|Overall Study|Death|0|||
160996352|NCT03944512|581372196|FG002|Overall Study|Death|1|||
160996353|NCT03944512|581372197|FG003|Overall Study|Death|2|||
160996354|NCT03944512|581372194|FG000|Overall Study|Lost to Follow-up|0|||
160996355|NCT03944512|581372195|FG001|Overall Study|Lost to Follow-up|0|||
160996356|NCT03944512|581372196|FG002|Overall Study|Lost to Follow-up|4|||
160996357|NCT03944512|581372197|FG003|Overall Study|Lost to Follow-up|4|||
160996358|NCT03944512|581372194|FG000|Overall Study|refused follow-up|0|||
160996359|NCT03944512|581372195|FG001|Overall Study|refused follow-up|0|||
160996360|NCT03944512|581372196|FG002|Overall Study|refused follow-up|2|||
160996361|NCT03944512|581372197|FG003|Overall Study|refused follow-up|2|||
160996362|NCT02380742|581373577|FG000|Overall Study|Withdrawal by Subject|1|||
160996363|NCT02380742|581373578|FG001|Overall Study|Withdrawal by Subject|0|||
160996364|NCT01185522|581373579|FG000|Overall Study|Lack of Efficacy|28|||
160996365|NCT01185522|581373579|FG000|Overall Study|Lost to Follow-up|19|||
160996366|NCT01185522|581373579|FG000|Overall Study|Withdrawal by Subject|10|||
160917451|NCT01287897|581091627|FG002|Overall Study|Lost to Follow-up|2|||
160917452|NCT01287897|581091628|FG003|Overall Study|Lost to Follow-up|0|||
160917453|NCT01287897|581091625|FG000|Overall Study|Withdrawal by Subject|1|||
160917454|NCT01287897|581091626|FG001|Overall Study|Withdrawal by Subject|5|||
160917455|NCT01287897|581091627|FG002|Overall Study|Withdrawal by Subject|3|||
160917456|NCT01287897|581091628|FG003|Overall Study|Withdrawal by Subject|2|||
160917457|NCT01287897|581091625|FG000|Overall Study|Not consented properly|0|||
160917458|NCT01287897|581091626|FG001|Overall Study|Not consented properly|1|||
160917459|NCT01287897|581091627|FG002|Overall Study|Not consented properly|0|||
160917460|NCT01287897|581091628|FG003|Overall Study|Not consented properly|0|||
160917461|NCT01287897|581091625|FG000|Overall Study|Not meeting entrance criteria|1|||
160917462|NCT01287897|581091626|FG001|Overall Study|Not meeting entrance criteria|1|||
160917463|NCT01287897|581091627|FG002|Overall Study|Not meeting entrance criteria|0|||
160917464|NCT01287897|581091628|FG003|Overall Study|Not meeting entrance criteria|0|||
160917465|NCT01287897|581091625|FG000|Overall Study|Other|1|||
160917466|NCT01287897|581091626|FG001|Overall Study|Other|0|||
160917467|NCT01287897|581091627|FG002|Overall Study|Other|1|||
160917468|NCT01287897|581091628|FG003|Overall Study|Other|0|||
160917469|NCT00386776|581091635|FG000|Overall Study|Withdrawal by Subject|8|||
160917470|NCT02282020|581091636|FG000|Overall Study|Objective Disease Progression|128|||
160917471|NCT02282020|581091637|FG001|Overall Study|Objective Disease Progression|30|||
160917472|NCT02282020|581091636|FG000|Overall Study|Adverse Event|18|||
160917473|NCT02282020|581091637|FG001|Overall Study|Adverse Event|15|||
160917474|NCT02282020|581091636|FG000|Overall Study|Withdrawal by Subject|7|||
160917475|NCT02282020|581091637|FG001|Overall Study|Withdrawal by Subject|10|||
160917476|NCT02282020|581091636|FG000|Overall Study|Miscellaneous|5|||
160917477|NCT02282020|581091637|FG001|Overall Study|Miscellaneous|19|||
160917478|NCT02282020|581091636|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
160917479|NCT02282020|581091637|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
160917480|NCT02282020|581091636|FG000|Overall Study|Developed Discontinuation Criteria|0|||
160917481|NCT02282020|581091637|FG001|Overall Study|Developed Discontinuation Criteria|2|||
160917482|NCT02282020|581091636|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
160917483|NCT02282020|581091637|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
160917484|NCT00249444|581091638|FG000|Overall Study|Lost to Follow-up|2|||
160917485|NCT00249444|581091639|FG001|Overall Study|Lost to Follow-up|2|||
160917486|NCT00249444|581091638|FG000|Overall Study|non-compliant|9|||
160917487|NCT00249444|581091639|FG001|Overall Study|non-compliant|11|||
160917488|NCT00249444|581091638|FG000|Overall Study|Adverse Event|1|||
160917489|NCT00249444|581091639|FG001|Overall Study|Adverse Event|1|||
160917490|NCT00249444|581091638|FG000|Overall Study|life event|0|||
160917491|NCT00249444|581091639|FG001|Overall Study|life event|1|||
160996367|NCT01185522|581373579|FG000|Overall Study|Poor tolerance|39|||
160917492|NCT00232817|581091640|FG000|Overall Study|Protocol Violation|2|||
160917493|NCT00232817|581091641|FG001|Overall Study|Protocol Violation|1|||
160917494|NCT05492942|581091642|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
160917495|NCT05492942|581091643|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
160917496|NCT05492942|581091644|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
160917497|NCT05492942|581091645|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
160917498|NCT00311623|581091646|FG000|Overall Study|Physician Decision|0|||
160917499|NCT00311623|581091647|FG001|Overall Study|Physician Decision|0|||
160996368|NCT01185522|581373579|FG000|Overall Study|Other reasons|12|||
160917500|NCT00311623|581091648|FG002|Overall Study|Physician Decision|2|||
160917501|NCT03103919|581091649|FG000|Overall Study|Adverse Event|2|||
160996369|NCT01729819|581373580|FG000|Overall Study|Adverse Event|2|||
160996370|NCT01729819|581373581|FG001|Overall Study|Adverse Event|4|||
160996371|NCT01729819|581373580|FG000|Overall Study|Lack of Efficacy|1|||
160996372|NCT01729819|581373581|FG001|Overall Study|Lack of Efficacy|0|||
160996373|NCT01729819|581373580|FG000|Overall Study|Lost to Follow-up|2|||
160996374|NCT01729819|581373581|FG001|Overall Study|Lost to Follow-up|0|||
161339518|NCT01704261|582631919|FG000|Overall Study|Lost to Follow-up|1|||
161339519|NCT01704261|582631920|FG001|Overall Study|Lost to Follow-up|0|||
161339520|NCT02855268|582631921|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
161339521|NCT02855268|582631922|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
161339522|NCT02855268|582631921|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
161339523|NCT02855268|582631922|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
161339524|NCT02855268|582631921|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
161339525|NCT02855268|582631922|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
161339526|NCT02855268|582631921|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
161339527|NCT02855268|582631922|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
161339528|NCT02855268|582631921|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
161339529|NCT02855268|582631922|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
161339530|NCT02855268|582631921|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
161339531|NCT02855268|582631922|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
161339532|NCT03704064|582631925|FG000|Overall Study|Lost to Follow-up|8|||
161339533|NCT03704064|582631926|FG001|Overall Study|Lost to Follow-up|4|||
161339534|NCT03704064|582631925|FG000|Overall Study|Withdrawal by Subject|1|||
161339535|NCT03704064|582631926|FG001|Overall Study|Withdrawal by Subject|1|||
161339536|NCT03704064|582631925|FG000|Overall Study|No longer available for study visits|0|||
161339537|NCT03704064|582631926|FG001|Overall Study|No longer available for study visits|1|||
161339538|NCT03704064|582631925|FG000|Overall Study|Censoring event|1|||
161339539|NCT03704064|582631926|FG001|Overall Study|Censoring event|0|||
161339540|NCT01286129|582631927|FG000|Overall Study|Withdrawal by Subject|4|||
161339541|NCT01286129|582631928|FG001|Overall Study|Withdrawal by Subject|1|||
160917502|NCT03103919|581091650|FG001|Overall Study|Adverse Event|2|||
160917503|NCT00810407|581091651|FG000|Overall Study|Protocol Violation|3|||
160917504|NCT00810407|581091651|FG000|Overall Study|No Visit After First Day of Treatment|3|||
160917505|NCT02875860|581091653|FG000|Overall Study|Withdrawal by Subject|0|||
160917506|NCT02875860|581091654|FG001|Overall Study|Withdrawal by Subject|1|||
160917507|NCT02746874|581091655|FG000|Overall Study|Withdrawal by Subject|0|||
160917508|NCT02746874|581091656|FG001|Overall Study|Withdrawal by Subject|1|||
160917509|NCT02746874|581091655|FG000|Overall Study|Surgery Date Changed|0|||
160917510|NCT02746874|581091656|FG001|Overall Study|Surgery Date Changed|2|||
160917511|NCT01881776|581091657|FG000|Overall Study|Lost to Follow-up|1|||
160917512|NCT01881776|581091658|FG001|Overall Study|Lost to Follow-up|2|||
160917513|NCT01881776|581091659|FG002|Overall Study|Lost to Follow-up|1|||
160917514|NCT01881776|581091657|FG000|Overall Study|Protocol Violation|0|||
160917515|NCT01881776|581091658|FG001|Overall Study|Protocol Violation|2|||
160917516|NCT01881776|581091659|FG002|Overall Study|Protocol Violation|1|||
160917517|NCT01156311|581091663|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
160917518|NCT01156311|581091664|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
160917519|NCT01156311|581091665|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
161142512|NCT03519178|581906197|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
160917520|NCT01156311|581091666|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
160917521|NCT01156311|581091663|FG000|2-Month Monotherapy Period|Physician Decision|0|||
160917522|NCT01156311|581091664|FG001|2-Month Monotherapy Period|Physician Decision|1|||
160917523|NCT01156311|581091665|FG002|2-Month Monotherapy Period|Physician Decision|0|||
160917524|NCT01156311|581091666|FG003|2-Month Monotherapy Period|Physician Decision|0|||
160917525|NCT01156311|581091663|FG000|2-Month Monotherapy Period|Other|1|||
160917526|NCT01156311|581091664|FG001|2-Month Monotherapy Period|Other|0|||
160917527|NCT01156311|581091665|FG002|2-Month Monotherapy Period|Other|0|||
160917528|NCT01156311|581091666|FG003|2-Month Monotherapy Period|Other|0|||
160917529|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
160917530|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
160917531|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
160917532|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
160917533|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
160917534|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
160917535|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
160917536|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
161142513|NCT03519178|581906198|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
161339542|NCT01286129|582631927|FG000|Overall Study|Could not comply with study requirements|4|||
161339543|NCT01286129|582631928|FG001|Overall Study|Could not comply with study requirements|4|||
160917537|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
160917538|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
160917539|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
160917540|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
161339544|NCT00111761|582631929|FG000|Part 1|Physician Decision|0|||
160917541|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
160917542|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
161339545|NCT00111761|582631930|FG001|Part 1|Physician Decision|1|||
161339546|NCT00111761|582631929|FG000|Part 1|Death|0|||
161339547|NCT00111761|582631930|FG001|Part 1|Death|2|||
161339548|NCT00111761|582631929|FG000|Part 1|Other|0|||
161142514|NCT03519178|581906199|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
161142515|NCT03519178|581906200|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
160861782|NCT03873116|580887841|FG005|Part 1|Study drug discontinuation due to rash|1|||
160861783|NCT03873116|580887836|FG000|Part 2|Withdrawal by Subject|0|||
160861784|NCT03873116|580887837|FG001|Part 2|Withdrawal by Subject|0|||
160861785|NCT03873116|580887838|FG002|Part 2|Withdrawal by Subject|1|||
160861786|NCT03873116|580887839|FG003|Part 2|Withdrawal by Subject|0|||
160861787|NCT03873116|580887840|FG004|Part 2|Withdrawal by Subject|0|||
160861788|NCT03873116|580887841|FG005|Part 2|Withdrawal by Subject|0|||
160861789|NCT03873116|580887836|FG000|Part 2|Lab abnormality or AE|0|||
160861790|NCT03873116|580887837|FG001|Part 2|Lab abnormality or AE|0|||
160861791|NCT03873116|580887838|FG002|Part 2|Lab abnormality or AE|0|||
160861792|NCT03873116|580887839|FG003|Part 2|Lab abnormality or AE|0|||
160861793|NCT03873116|580887840|FG004|Part 2|Lab abnormality or AE|1|||
160861794|NCT03873116|580887841|FG005|Part 2|Lab abnormality or AE|0|||
160861795|NCT03873116|580887836|FG000|Part 3|Withdrawal by Subject|0|||
160861796|NCT03873116|580887837|FG001|Part 3|Withdrawal by Subject|0|||
160861797|NCT03873116|580887838|FG002|Part 3|Withdrawal by Subject|0|||
160861798|NCT03873116|580887839|FG003|Part 3|Withdrawal by Subject|0|||
160861799|NCT03873116|580887840|FG004|Part 3|Withdrawal by Subject|1|||
160861800|NCT03873116|580887841|FG005|Part 3|Withdrawal by Subject|0|||
160861801|NCT04682366|580887842|FG000|Overall Study|Lost to Follow-up|1|||
160861802|NCT04682366|580887843|FG001|Overall Study|Lost to Follow-up|1|||
160861803|NCT03125395|580887844|FG000|Overall Study|Adverse Event|2|||
160861804|NCT03125395|580887844|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160861805|NCT03125395|580887844|FG000|Overall Study|Physician Decision|2|||
160861806|NCT03125395|580887844|FG000|Overall Study|Commercial drug is available|5|||
160861807|NCT02531802|580887845|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
160861808|NCT02531802|580887846|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
160861809|NCT02531802|580887847|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
160861810|NCT02531802|580887848|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
160861811|NCT02531802|580887849|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
160861812|NCT02531802|580887850|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
160861813|NCT02531802|580887851|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
160861814|NCT02531802|580887852|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
160861815|NCT02531802|580887853|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
160861816|NCT02531802|580887854|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
160861817|NCT02531802|580887855|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
160861818|NCT02531802|580887856|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
160861819|NCT02531802|580887857|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
160861820|NCT02531802|580887858|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
160861821|NCT02531802|580887859|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
160861822|NCT02531802|580887860|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
160861823|NCT02531802|580887861|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
160861824|NCT02531802|580887862|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
160861825|NCT02531802|580887863|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
160861826|NCT02531802|580887864|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
160861827|NCT02531802|580887865|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
160861828|NCT02531802|580887845|FG000|Received Vaccination 2|Physician Decision|0|||
160861829|NCT02531802|580887846|FG001|Received Vaccination 2|Physician Decision|0|||
160861830|NCT02531802|580887847|FG002|Received Vaccination 2|Physician Decision|0|||
160861831|NCT02531802|580887848|FG003|Received Vaccination 2|Physician Decision|0|||
160861832|NCT02531802|580887849|FG004|Received Vaccination 2|Physician Decision|0|||
160861833|NCT02531802|580887850|FG005|Received Vaccination 2|Physician Decision|1|||
160861834|NCT02531802|580887851|FG006|Received Vaccination 2|Physician Decision|0|||
160861835|NCT02531802|580887852|FG007|Received Vaccination 2|Physician Decision|0|||
160861836|NCT02531802|580887853|FG008|Received Vaccination 2|Physician Decision|0|||
160861837|NCT02531802|580887854|FG009|Received Vaccination 2|Physician Decision|2|||
160861838|NCT02531802|580887855|FG010|Received Vaccination 2|Physician Decision|0|||
160861839|NCT02531802|580887856|FG011|Received Vaccination 2|Physician Decision|0|||
160861840|NCT02531802|580887857|FG012|Received Vaccination 2|Physician Decision|0|||
160861841|NCT02531802|580887858|FG013|Received Vaccination 2|Physician Decision|1|||
160861842|NCT02531802|580887859|FG014|Received Vaccination 2|Physician Decision|0|||
160861843|NCT02531802|580887860|FG015|Received Vaccination 2|Physician Decision|0|||
160861844|NCT02531802|580887861|FG016|Received Vaccination 2|Physician Decision|0|||
160861845|NCT02531802|580887862|FG017|Received Vaccination 2|Physician Decision|1|||
160861846|NCT02531802|580887863|FG018|Received Vaccination 2|Physician Decision|0|||
160861847|NCT02531802|580887864|FG019|Received Vaccination 2|Physician Decision|0|||
160861848|NCT02531802|580887865|FG020|Received Vaccination 2|Physician Decision|0|||
160917543|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
160917544|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
160917545|NCT01156311|581091663|FG000|6-month Add-on Therapy Period|Other|0|||
160917546|NCT01156311|581091664|FG001|6-month Add-on Therapy Period|Other|0|||
160917547|NCT01156311|581091665|FG002|6-month Add-on Therapy Period|Other|1|||
160917548|NCT01156311|581091666|FG003|6-month Add-on Therapy Period|Other|2|||
160917549|NCT00276159|581091667|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
160917550|NCT00333866|581091670|FG000|Overall Study|Adverse Event|23|||
160917551|NCT00333866|581091671|FG001|Overall Study|Adverse Event|37|||
160917552|NCT00333866|581091672|FG002|Overall Study|Adverse Event|38|||
160917553|NCT00333866|581091673|FG003|Overall Study|Adverse Event|47|||
160917554|NCT00333866|581091670|FG000|Overall Study|Other|3|||
160917555|NCT00333866|581091671|FG001|Overall Study|Other|2|||
160917556|NCT00333866|581091672|FG002|Overall Study|Other|2|||
160917557|NCT00333866|581091673|FG003|Overall Study|Other|2|||
160917558|NCT00333866|581091670|FG000|Overall Study|Lack of Efficacy|8|||
160917559|NCT00333866|581091671|FG001|Overall Study|Lack of Efficacy|6|||
160917560|NCT00333866|581091672|FG002|Overall Study|Lack of Efficacy|3|||
160917561|NCT00333866|581091673|FG003|Overall Study|Lack of Efficacy|5|||
160917562|NCT00333866|581091670|FG000|Overall Study|Lost to Follow-up|1|||
160917563|NCT00333866|581091671|FG001|Overall Study|Lost to Follow-up|2|||
160917564|NCT00333866|581091672|FG002|Overall Study|Lost to Follow-up|2|||
160917565|NCT00333866|581091673|FG003|Overall Study|Lost to Follow-up|2|||
160917566|NCT00333866|581091670|FG000|Overall Study|Withdrawal by Subject|8|||
160917567|NCT00333866|581091671|FG001|Overall Study|Withdrawal by Subject|14|||
160917568|NCT00333866|581091672|FG002|Overall Study|Withdrawal by Subject|4|||
160917569|NCT00333866|581091673|FG003|Overall Study|Withdrawal by Subject|9|||
160917570|NCT00333866|581091670|FG000|Overall Study|Randomized but not Treated|5|||
160917571|NCT00333866|581091671|FG001|Overall Study|Randomized but not Treated|3|||
160917572|NCT00333866|581091672|FG002|Overall Study|Randomized but not Treated|2|||
160917573|NCT00333866|581091673|FG003|Overall Study|Randomized but not Treated|1|||
160917574|NCT06073119|581091674|FG000|Overall Study|Adverse Event|1|||
160917575|NCT06073119|581091675|FG001|Overall Study|Adverse Event|3|||
160917576|NCT06073119|581091676|FG002|Overall Study|Adverse Event|0|||
160917577|NCT06073119|581091677|FG003|Overall Study|Adverse Event|0|||
160917578|NCT06073119|581091678|FG004|Overall Study|Adverse Event|1|||
160917579|NCT06073119|581091679|FG005|Overall Study|Adverse Event|0|||
160917580|NCT06073119|581091674|FG000|Overall Study|Non-compliance with study schedule|1|||
160917581|NCT06073119|581091675|FG001|Overall Study|Non-compliance with study schedule|0|||
160917582|NCT06073119|581091676|FG002|Overall Study|Non-compliance with study schedule|0|||
160917583|NCT06073119|581091677|FG003|Overall Study|Non-compliance with study schedule|0|||
160917584|NCT06073119|581091678|FG004|Overall Study|Non-compliance with study schedule|1|||
160917585|NCT06073119|581091679|FG005|Overall Study|Non-compliance with study schedule|0|||
160917586|NCT06073119|581091674|FG000|Overall Study|Withdrawal by Subject|4|||
160917587|NCT06073119|581091675|FG001|Overall Study|Withdrawal by Subject|4|||
160917588|NCT06073119|581091676|FG002|Overall Study|Withdrawal by Subject|3|||
160917589|NCT06073119|581091677|FG003|Overall Study|Withdrawal by Subject|5|||
160917590|NCT06073119|581091678|FG004|Overall Study|Withdrawal by Subject|3|||
160917591|NCT06073119|581091679|FG005|Overall Study|Withdrawal by Subject|1|||
160917592|NCT06073119|581091674|FG000|Overall Study|Other|2|||
160917593|NCT06073119|581091675|FG001|Overall Study|Other|4|||
160917594|NCT06073119|581091676|FG002|Overall Study|Other|1|||
160917595|NCT06073119|581091677|FG003|Overall Study|Other|0|||
160917596|NCT06073119|581091678|FG004|Overall Study|Other|1|||
160917597|NCT06073119|581091679|FG005|Overall Study|Other|0|||
160917598|NCT01359449|581091680|FG000|Overall Study|Lost to Follow-up|1|||
160917599|NCT01359449|581091681|FG001|Overall Study|Lost to Follow-up|0|||
160917600|NCT01359449|581091680|FG000|Overall Study|Protocol Violation|0|||
160917601|NCT01359449|581091681|FG001|Overall Study|Protocol Violation|2|||
160917602|NCT01359449|581091680|FG000|Overall Study|Withdrawal by Subject|3|||
160917603|NCT01359449|581091681|FG001|Overall Study|Withdrawal by Subject|2|||
160917604|NCT02393547|581091699|FG000|Overall Study|Adverse Event|2|||
160917605|NCT02393547|581091699|FG000|Overall Study|Withdrawal by Subject|3|||
160917606|NCT02393547|581091699|FG000|Overall Study|Lost to Follow-up|1|||
160917607|NCT00429104|581091703|FG000|Overall Study|Protocol Violation|1|||
160917608|NCT01907815|581091704|FG000|Overall Study|Withdrawal by Subject|1|||
160917609|NCT01907815|581091705|FG001|Overall Study|Withdrawal by Subject|0|||
160917610|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
160917611|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
160917612|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
160917613|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
160917614|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
160917615|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
160917616|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
160917617|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
160917618|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
160996375|NCT01729819|581373580|FG000|Overall Study|Other reason|1|||
160996376|NCT01729819|581373581|FG001|Overall Study|Other reason|0|||
160996377|NCT01729819|581373580|FG000|Overall Study|Protocol Violation|0|||
160996378|NCT01729819|581373581|FG001|Overall Study|Protocol Violation|1|||
160996379|NCT01729819|581373580|FG000|Overall Study|Withdrawal by Subject|0|||
160996380|NCT01729819|581373581|FG001|Overall Study|Withdrawal by Subject|2|||
160996381|NCT01025843|581373582|FG000|Washout 4|Withdrawal by Subject|0|||
160996382|NCT01025843|581373583|FG001|Washout 4|Withdrawal by Subject|0|||
160996383|NCT01025843|581373584|FG002|Washout 4|Withdrawal by Subject|1|||
160996384|NCT01025843|581373585|FG003|Washout 4|Withdrawal by Subject|1|||
160996385|NCT01025843|581373586|FG004|Washout 4|Withdrawal by Subject|0|||
160996386|NCT01025843|581373587|FG005|Washout 4|Withdrawal by Subject|0|||
160996387|NCT01025843|581373588|FG006|Washout 4|Withdrawal by Subject|0|||
160996388|NCT01025843|581373589|FG007|Washout 4|Withdrawal by Subject|0|||
160996389|NCT01025843|581373590|FG008|Washout 4|Withdrawal by Subject|0|||
160996390|NCT01025843|581373591|FG009|Washout 4|Withdrawal by Subject|0|||
160996391|NCT01649791|581373592|FG000|Overall Study|Disease Progression|2|||
160996392|NCT01649791|581373592|FG000|Overall Study|Adverse Event|1|||
160996393|NCT00771667|581373595|FG000|Induction Phase|Adverse Event|5|||
160996394|NCT00771667|581373596|FG001|Induction Phase|Adverse Event|2|||
160996395|NCT00771667|581373597|FG002|Induction Phase|Adverse Event|4|||
160996396|NCT00771667|581373598|FG003|Induction Phase|Adverse Event|1|||
160917619|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
160917620|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
160917621|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
160917622|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
160917623|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
160917624|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
160917625|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
160917626|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
160917627|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
160917628|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
160917629|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
160917630|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
160917631|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
160917632|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
160917633|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
160917634|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
160996397|NCT00771667|581373599|FG004|Induction Phase|Adverse Event|0|||
160996398|NCT00771667|581373600|FG005|Induction Phase|Adverse Event|0|||
160996399|NCT00771667|581373601|FG006|Induction Phase|Adverse Event|0|||
160996400|NCT00771667|581373602|FG007|Induction Phase|Adverse Event|0|||
160996401|NCT00771667|581373603|FG008|Induction Phase|Adverse Event|0|||
160996402|NCT00771667|581373604|FG009|Induction Phase|Adverse Event|0|||
160996403|NCT00771667|581373595|FG000|Induction Phase|Lack of Efficacy|9|||
160996404|NCT00771667|581373596|FG001|Induction Phase|Lack of Efficacy|2|||
160996405|NCT00771667|581373597|FG002|Induction Phase|Lack of Efficacy|4|||
160996406|NCT00771667|581373598|FG003|Induction Phase|Lack of Efficacy|3|||
160996407|NCT00771667|581373599|FG004|Induction Phase|Lack of Efficacy|0|||
160996408|NCT00771667|581373600|FG005|Induction Phase|Lack of Efficacy|0|||
160996409|NCT00771667|581373601|FG006|Induction Phase|Lack of Efficacy|0|||
160996410|NCT00771667|581373602|FG007|Induction Phase|Lack of Efficacy|0|||
160996411|NCT00771667|581373603|FG008|Induction Phase|Lack of Efficacy|0|||
160996412|NCT00771667|581373604|FG009|Induction Phase|Lack of Efficacy|0|||
160996413|NCT00771667|581373595|FG000|Induction Phase|Lost to Follow-up|1|||
160996414|NCT00771667|581373596|FG001|Induction Phase|Lost to Follow-up|0|||
160996415|NCT00771667|581373597|FG002|Induction Phase|Lost to Follow-up|1|||
160996416|NCT00771667|581373598|FG003|Induction Phase|Lost to Follow-up|0|||
160996417|NCT00771667|581373599|FG004|Induction Phase|Lost to Follow-up|0|||
160996418|NCT00771667|581373600|FG005|Induction Phase|Lost to Follow-up|0|||
160996419|NCT00771667|581373601|FG006|Induction Phase|Lost to Follow-up|0|||
160996420|NCT00771667|581373602|FG007|Induction Phase|Lost to Follow-up|0|||
160996421|NCT00771667|581373603|FG008|Induction Phase|Lost to Follow-up|0|||
160996422|NCT00771667|581373604|FG009|Induction Phase|Lost to Follow-up|0|||
161142516|NCT03519178|581906201|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
160996423|NCT00771667|581373595|FG000|Induction Phase|Other|4|||
160996424|NCT00771667|581373596|FG001|Induction Phase|Other|6|||
160996425|NCT00771667|581373597|FG002|Induction Phase|Other|3|||
161142517|NCT03519178|581906202|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
160917635|NCT01285310|581091706|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
160996426|NCT00771667|581373598|FG003|Induction Phase|Other|4|||
160996427|NCT00771667|581373599|FG004|Induction Phase|Other|0|||
160996428|NCT00771667|581373600|FG005|Induction Phase|Other|0|||
160996429|NCT00771667|581373601|FG006|Induction Phase|Other|0|||
160996430|NCT00771667|581373602|FG007|Induction Phase|Other|0|||
160996431|NCT00771667|581373603|FG008|Induction Phase|Other|0|||
161142518|NCT03519178|581906188|FG000|Fulvestrant. Treatment|Adverse Event|0|||
160996432|NCT00771667|581373604|FG009|Induction Phase|Other|0|||
160996433|NCT00771667|581373595|FG000|Maintenance Phase|Adverse Event|0|||
160996434|NCT00771667|581373596|FG001|Maintenance Phase|Adverse Event|0|||
160996435|NCT00771667|581373597|FG002|Maintenance Phase|Adverse Event|0|||
160996436|NCT00771667|581373598|FG003|Maintenance Phase|Adverse Event|0|||
160996437|NCT00771667|581373599|FG004|Maintenance Phase|Adverse Event|1|||
160996438|NCT00771667|581373600|FG005|Maintenance Phase|Adverse Event|3|||
160996439|NCT00771667|581373601|FG006|Maintenance Phase|Adverse Event|5|||
160996440|NCT00771667|581373602|FG007|Maintenance Phase|Adverse Event|1|||
160996441|NCT00771667|581373603|FG008|Maintenance Phase|Adverse Event|8|||
160996442|NCT00771667|581373604|FG009|Maintenance Phase|Adverse Event|7|||
160996443|NCT00771667|581373595|FG000|Maintenance Phase|Lack of Efficacy|0|||
160996444|NCT00771667|581373596|FG001|Maintenance Phase|Lack of Efficacy|0|||
160996445|NCT00771667|581373597|FG002|Maintenance Phase|Lack of Efficacy|0|||
160996446|NCT00771667|581373598|FG003|Maintenance Phase|Lack of Efficacy|0|||
160996447|NCT00771667|581373599|FG004|Maintenance Phase|Lack of Efficacy|1|||
160996448|NCT00771667|581373600|FG005|Maintenance Phase|Lack of Efficacy|3|||
160996449|NCT00771667|581373601|FG006|Maintenance Phase|Lack of Efficacy|3|||
160996450|NCT00771667|581373602|FG007|Maintenance Phase|Lack of Efficacy|2|||
160996451|NCT00771667|581373603|FG008|Maintenance Phase|Lack of Efficacy|11|||
160996452|NCT00771667|581373604|FG009|Maintenance Phase|Lack of Efficacy|7|||
160996453|NCT00771667|581373595|FG000|Maintenance Phase|Other|0|||
160996454|NCT00771667|581373596|FG001|Maintenance Phase|Other|0|||
160996455|NCT00771667|581373597|FG002|Maintenance Phase|Other|0|||
160996456|NCT00771667|581373598|FG003|Maintenance Phase|Other|0|||
160996457|NCT00771667|581373599|FG004|Maintenance Phase|Other|0|||
160996458|NCT00771667|581373600|FG005|Maintenance Phase|Other|1|||
160996459|NCT00771667|581373601|FG006|Maintenance Phase|Other|2|||
160996460|NCT00771667|581373602|FG007|Maintenance Phase|Other|2|||
160996461|NCT00771667|581373603|FG008|Maintenance Phase|Other|3|||
160996462|NCT00771667|581373604|FG009|Maintenance Phase|Other|3|||
160996463|NCT00364286|581373605|FG000|Overall Study|Withdrawal by Subject|1|||
160996464|NCT00364286|581373605|FG000|Overall Study|Adverse Event|2|||
160996465|NCT01897233|581373606|FG000|Part B (24 Weeks)|Adverse Event|1|||
160996466|NCT01897233|581373606|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
160996467|NCT01897233|581373606|FG000|Part B (24 Weeks)|Physician Decision|1|||
160996468|NCT00628862|581373611|FG000|Overall Study|Adverse Event|6|||
160996469|NCT00628862|581373612|FG001|Overall Study|Adverse Event|8|||
160996470|NCT00628862|581373613|FG002|Overall Study|Adverse Event|10|||
160996471|NCT00628862|581373611|FG000|Overall Study|Withdrawal by Subject|4|||
160996472|NCT00628862|581373612|FG001|Overall Study|Withdrawal by Subject|6|||
160996473|NCT00628862|581373613|FG002|Overall Study|Withdrawal by Subject|11|||
160996474|NCT00628862|581373611|FG000|Overall Study|Lost to Follow-up|0|||
160996475|NCT00628862|581373612|FG001|Overall Study|Lost to Follow-up|2|||
160996476|NCT00628862|581373613|FG002|Overall Study|Lost to Follow-up|1|||
160996477|NCT00628862|581373611|FG000|Overall Study|Protocol Violation|1|||
160996478|NCT00628862|581373612|FG001|Overall Study|Protocol Violation|0|||
160996479|NCT00628862|581373613|FG002|Overall Study|Protocol Violation|0|||
160996480|NCT00628862|581373611|FG000|Overall Study|COPD Exacerbation|0|||
160996481|NCT00628862|581373612|FG001|Overall Study|COPD Exacerbation|1|||
160996482|NCT00628862|581373613|FG002|Overall Study|COPD Exacerbation|0|||
160996483|NCT02814643|581373614|FG000|Overall Study|Lost to Follow-up|0|||
160996484|NCT02814643|581373615|FG001|Overall Study|Lost to Follow-up|1|||
160996485|NCT02814643|581373614|FG000|Overall Study|Withdrawal by Subject|1|||
160996486|NCT02814643|581373615|FG001|Overall Study|Withdrawal by Subject|2|||
160917636|NCT01285310|581091707|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
160917637|NCT01285310|581091708|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
160917638|NCT01285310|581091709|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
160917639|NCT01285310|581091710|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
160917640|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
160917641|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
160917642|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
160917643|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
160917644|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
160996487|NCT01227278|581373618|FG000|Overall Study|Withdrawal by Subject|4|||
160996488|NCT01227278|581373619|FG001|Overall Study|Withdrawal by Subject|4|||
160996489|NCT01227278|581373618|FG000|Overall Study|Death|0|||
161142519|NCT03519178|581906189|FG001|Fulvestrant. Treatment|Adverse Event|0|||
160917645|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
160996490|NCT01227278|581373619|FG001|Overall Study|Death|2|||
160996491|NCT01227278|581373618|FG000|Overall Study|Other|1|||
160996492|NCT01227278|581373619|FG001|Overall Study|Other|2|||
160996493|NCT01281813|581373634|FG000|Overall Study|Adverse Event|0|||
160996494|NCT01281813|581373635|FG001|Overall Study|Adverse Event|0|||
160996495|NCT01281813|581373636|FG002|Overall Study|Adverse Event|10|||
160996496|NCT01281813|581373634|FG000|Overall Study|Lost to Follow-up|0|||
160996497|NCT01281813|581373635|FG001|Overall Study|Lost to Follow-up|0|||
160996498|NCT01281813|581373636|FG002|Overall Study|Lost to Follow-up|31|||
160996499|NCT01281813|581373634|FG000|Overall Study|Withdrawal by Subject|0|||
161339549|NCT00111761|582631930|FG001|Part 1|Other|1|||
161339550|NCT00111761|582631929|FG000|Part 1|Withdrawal by Subject|0|||
161339551|NCT00111761|582631930|FG001|Part 1|Withdrawal by Subject|1|||
161339552|NCT00111761|582631929|FG000|Part 2|Adverse Event|1|||
161339553|NCT00111761|582631930|FG001|Part 2|Adverse Event|0|||
161339554|NCT00111761|582631929|FG000|Part 2|Physician Decision|1|||
161339555|NCT00111761|582631930|FG001|Part 2|Physician Decision|0|||
161339556|NCT00111761|582631929|FG000|Part 2|Death|1|||
161339557|NCT00111761|582631930|FG001|Part 2|Death|0|||
161339558|NCT00111761|582631929|FG000|Part 2|Disease progression|3|||
161339559|NCT00111761|582631930|FG001|Part 2|Disease progression|0|||
161339560|NCT00111761|582631929|FG000|Part 2|Protocol-specified criteria|1|||
161339561|NCT00111761|582631930|FG001|Part 2|Protocol-specified criteria|0|||
161339562|NCT00111761|582631929|FG000|Part 2|Other|1|||
161339563|NCT00111761|582631930|FG001|Part 2|Other|0|||
161339564|NCT00726609|582631933|FG000|Overall Study|Adverse Event|10|||
161339565|NCT00726609|582631933|FG000|Overall Study|Withdrawal by Subject|2|||
161339566|NCT00726609|582631933|FG000|Overall Study|Lack of Efficacy|25|||
161339567|NCT00726609|582631933|FG000|Overall Study|Other|16|||
161339568|NCT00726609|582631933|FG000|Overall Study|Missing|42|||
161339569|NCT00726609|582631933|FG000|Overall Study|Other|3|||
161339570|NCT02029417|582631936|FG000|Overall Study|Death|1|||
161339571|NCT02029417|582631936|FG000|Overall Study|Adverse Event|1|||
161339572|NCT00071981|582631937|FG000|Overall Study|Lack of Efficacy|37|||
161339573|NCT00071981|582631938|FG001|Overall Study|Lack of Efficacy|29|||
161339574|NCT00071981|582631939|FG002|Overall Study|Lack of Efficacy|30|||
161339575|NCT00071981|582631940|FG003|Overall Study|Lack of Efficacy|43|||
161339576|NCT00071981|582631937|FG000|Overall Study|Adverse Event|4|||
161339577|NCT00071981|582631938|FG001|Overall Study|Adverse Event|4|||
161339578|NCT00071981|582631939|FG002|Overall Study|Adverse Event|3|||
161339579|NCT00071981|582631940|FG003|Overall Study|Adverse Event|1|||
161339580|NCT00071981|582631937|FG000|Overall Study|Death|0|||
161339581|NCT00071981|582631938|FG001|Overall Study|Death|0|||
161339582|NCT00071981|582631939|FG002|Overall Study|Death|1|||
161339583|NCT00071981|582631940|FG003|Overall Study|Death|1|||
161339584|NCT00071981|582631937|FG000|Overall Study|Withdrawal by Subject|3|||
161339585|NCT00071981|582631938|FG001|Overall Study|Withdrawal by Subject|1|||
161339586|NCT00071981|582631939|FG002|Overall Study|Withdrawal by Subject|0|||
161339587|NCT00071981|582631940|FG003|Overall Study|Withdrawal by Subject|0|||
161339588|NCT00071981|582631937|FG000|Overall Study|No protocol therapy|2|||
160996500|NCT01281813|581373635|FG001|Overall Study|Withdrawal by Subject|0|||
160996501|NCT01281813|581373636|FG002|Overall Study|Withdrawal by Subject|13|||
160996502|NCT01281813|581373634|FG000|Overall Study|Subject Non-Compliant|0|||
160996503|NCT01281813|581373635|FG001|Overall Study|Subject Non-Compliant|0|||
160996504|NCT01281813|581373636|FG002|Overall Study|Subject Non-Compliant|6|||
160996505|NCT01281813|581373634|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
160996506|NCT01281813|581373635|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
160996507|NCT01281813|581373636|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
160996508|NCT01281813|581373634|FG000|Overall Study|Sponsor's Decision|4|||
160996509|NCT01281813|581373635|FG001|Overall Study|Sponsor's Decision|3|||
160996510|NCT01281813|581373636|FG002|Overall Study|Sponsor's Decision|7|||
160996511|NCT01281813|581373634|FG000|Overall Study|Switched to Commercially Available Medication|0|||
160996512|NCT01281813|581373635|FG001|Overall Study|Switched to Commercially Available Medication|0|||
160996513|NCT01281813|581373636|FG002|Overall Study|Switched to Commercially Available Medication|26|||
160996514|NCT01281813|581373634|FG000|Overall Study|Other|0|||
160996515|NCT01281813|581373635|FG001|Overall Study|Other|1|||
160996516|NCT01281813|581373636|FG002|Overall Study|Other|39|||
160996517|NCT00558363|581373637|FG000|Overall Study|Physician Decision|18|||
160996518|NCT00558363|581373638|FG001|Overall Study|Physician Decision|4|||
160996519|NCT00558363|581373637|FG000|Overall Study|Withdrawal by Subject|11|||
160996520|NCT00558363|581373638|FG001|Overall Study|Withdrawal by Subject|4|||
160996521|NCT00558363|581373637|FG000|Overall Study|Adverse Event|5|||
160996522|NCT00558363|581373638|FG001|Overall Study|Adverse Event|5|||
160996523|NCT00558363|581373637|FG000|Overall Study|Lack of Efficacy|2|||
160996524|NCT00558363|581373638|FG001|Overall Study|Lack of Efficacy|2|||
160996525|NCT00558363|581373637|FG000|Overall Study|Protocol Violation|2|||
160996526|NCT00558363|581373638|FG001|Overall Study|Protocol Violation|1|||
160996527|NCT00558363|581373637|FG000|Overall Study|Lost to Follow-up|0|||
161339589|NCT00071981|582631938|FG001|Overall Study|No protocol therapy|5|||
161339590|NCT00071981|582631939|FG002|Overall Study|No protocol therapy|1|||
161339591|NCT00071981|582631940|FG003|Overall Study|No protocol therapy|0|||
161339592|NCT00071981|582631937|FG000|Overall Study|others (not specified in the study)|0|||
161339593|NCT00071981|582631938|FG001|Overall Study|others (not specified in the study)|2|||
161339594|NCT00071981|582631939|FG002|Overall Study|others (not specified in the study)|2|||
161339595|NCT00071981|582631940|FG003|Overall Study|others (not specified in the study)|0|||
161339596|NCT04458922|582631941|FG000|Overall Study|Withdrawal by Subject|1|||
160996528|NCT00558363|581373638|FG001|Overall Study|Lost to Follow-up|1|||
161339597|NCT04458922|582631942|FG001|Overall Study|Withdrawal by Subject|0|||
161339598|NCT04458922|582631943|FG002|Overall Study|Withdrawal by Subject|2|||
161339599|NCT04458922|582631941|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
161339600|NCT04458922|582631942|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
161339601|NCT04458922|582631943|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
161339602|NCT04458922|582631941|FG000|Overall Study|Adverse Event|1|||
161339603|NCT04458922|582631942|FG001|Overall Study|Adverse Event|0|||
161339604|NCT04458922|582631943|FG002|Overall Study|Adverse Event|0|||
161339605|NCT04458922|582631941|FG000|Overall Study|Started new study|0|||
161339606|NCT04458922|582631942|FG001|Overall Study|Started new study|0|||
161339607|NCT04458922|582631943|FG002|Overall Study|Started new study|1|||
161339608|NCT04458922|582631941|FG000|Overall Study|Progressive disease|6|||
161339609|NCT04458922|582631942|FG001|Overall Study|Progressive disease|8|||
161339610|NCT04458922|582631943|FG002|Overall Study|Progressive disease|2|||
161339611|NCT04458922|582631941|FG000|Overall Study|Death|1|||
160917646|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
160917647|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
160917648|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
160917649|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
161339612|NCT04458922|582631942|FG001|Overall Study|Death|0|||
161339613|NCT04458922|582631943|FG002|Overall Study|Death|2|||
161339614|NCT04458922|582631941|FG000|Overall Study|Participant started chemotherapy|0|||
161339615|NCT04458922|582631942|FG001|Overall Study|Participant started chemotherapy|1|||
161339616|NCT04458922|582631943|FG002|Overall Study|Participant started chemotherapy|0|||
161339617|NCT00465179|582631946|FG000|Overall Study|Adverse Event|4|||
161339618|NCT00465179|582631946|FG000|Overall Study|Withdrawal by Subject|2|||
161339619|NCT00465179|582631946|FG000|Overall Study|Progression of Disease|47|||
161339620|NCT00833755|582631949|FG000|Overall Study|Physician Decision|4|||
161339621|NCT00833755|582631950|FG001|Overall Study|Physician Decision|4|||
161339622|NCT00833755|582631951|FG002|Overall Study|Physician Decision|2|||
161339623|NCT00833755|582631952|FG003|Overall Study|Physician Decision|6|||
161339624|NCT00833755|582631949|FG000|Overall Study|Subject had scheduling issues|0|||
161339625|NCT00833755|582631950|FG001|Overall Study|Subject had scheduling issues|1|||
161339626|NCT00833755|582631951|FG002|Overall Study|Subject had scheduling issues|0|||
161339627|NCT00833755|582631952|FG003|Overall Study|Subject had scheduling issues|0|||
161339628|NCT04108468|582631953|FG000|Overall Study|Physician Decision|0|||
161339629|NCT04108468|582631954|FG001|Overall Study|Physician Decision|1|||
161339630|NCT04108468|582631953|FG000|Overall Study|Lost to Follow-up|0|||
161339631|NCT04108468|582631954|FG001|Overall Study|Lost to Follow-up|1|||
161339632|NCT04108468|582631953|FG000|Overall Study|Non-compliance|1|||
161339633|NCT04108468|582631954|FG001|Overall Study|Non-compliance|1|||
161339634|NCT04108468|582631953|FG000|Overall Study|Unable to attend final visit|2|||
161339635|NCT04108468|582631954|FG001|Overall Study|Unable to attend final visit|0|||
161339636|NCT04108468|582631953|FG000|Overall Study|Missed study medication|0|||
161339637|NCT04108468|582631954|FG001|Overall Study|Missed study medication|1|||
160917650|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
160917651|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
160917652|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
160917653|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
160917654|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
160917655|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
160917656|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
160917657|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
160917658|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
160917659|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
160917660|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
160917661|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
160917662|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
160917663|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
160917664|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
160917665|NCT01285310|581091706|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
160917666|NCT01285310|581091707|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
160917667|NCT01285310|581091708|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
160917668|NCT01285310|581091709|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
160917669|NCT01285310|581091710|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
160917670|NCT00514540|581091711|FG000|First-Line Chemo|Withdrawal by Subject|1|||
160917671|NCT00514540|581091711|FG000|First-Line Chemo|Protocol Violation|7|||
160996529|NCT00558363|581373637|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
161339638|NCT06121609|582631956|FG000|Overall Study|Lack of Efficacy|0|||
160917672|NCT00514540|581091711|FG000|Second-Line|Physician/Patient Decision|31|||
160996530|NCT00558363|581373638|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
161339639|NCT06121609|582631957|FG001|Overall Study|Lack of Efficacy|0|||
161339640|NCT06121609|582631958|FG002|Overall Study|Lack of Efficacy|45|||
161339641|NCT02867592|582631960|FG000|Overall Study|Adverse Event|3|||
161339642|NCT02867592|582631961|FG001|Overall Study|Adverse Event|0|||
160996531|NCT00558363|581373637|FG000|Overall Study|Randomized in Error|1|||
160996532|NCT00558363|581373638|FG001|Overall Study|Randomized in Error|2|||
160996533|NCT00558363|581373637|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
160917673|NCT05185089|581091718|FG000|First Intervention (4 weeks)|Adverse Event|0|||
160917674|NCT05185089|581091719|FG001|First Intervention (4 weeks)|Adverse Event|0|||
160917675|NCT05185089|581091720|FG002|First Intervention (4 weeks)|Adverse Event|0|||
160917676|NCT05185089|581091721|FG003|First Intervention (4 weeks)|Adverse Event|1|||
160917677|NCT05185089|581091718|FG000|Second Intervention (4 weeks)|Death|0|||
160917678|NCT05185089|581091719|FG001|Second Intervention (4 weeks)|Death|1|||
160917679|NCT05185089|581091720|FG002|Second Intervention (4 weeks)|Death|0|||
160917680|NCT05185089|581091721|FG003|Second Intervention (4 weeks)|Death|0|||
160917681|NCT05185089|581091718|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
160917682|NCT05185089|581091719|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
160917683|NCT05185089|581091720|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
160917684|NCT05185089|581091721|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
160917685|NCT04997161|581091734|FG000|Overall Study|Study terminated by sponsor|3|||
160917686|NCT00752232|581091735|FG000|Overall Study|Protocol Violation|0|||
160917687|NCT00752232|581091736|FG001|Overall Study|Protocol Violation|0|||
160917688|NCT00752232|581091737|FG002|Overall Study|Protocol Violation|0|||
160917689|NCT00752232|581091738|FG003|Overall Study|Protocol Violation|0|||
160917690|NCT00752232|581091739|FG004|Overall Study|Protocol Violation|0|||
160917691|NCT00752232|581091740|FG005|Overall Study|Protocol Violation|1|||
160917692|NCT00752232|581091741|FG006|Overall Study|Protocol Violation|0|||
160917693|NCT00752232|581091735|FG000|Overall Study|Caregiver request|2|||
160917694|NCT00752232|581091736|FG001|Overall Study|Caregiver request|0|||
160917695|NCT00752232|581091737|FG002|Overall Study|Caregiver request|0|||
160917696|NCT00752232|581091738|FG003|Overall Study|Caregiver request|0|||
160917697|NCT00752232|581091739|FG004|Overall Study|Caregiver request|1|||
160917698|NCT00752232|581091740|FG005|Overall Study|Caregiver request|0|||
160917699|NCT00752232|581091741|FG006|Overall Study|Caregiver request|0|||
160917700|NCT00752232|581091735|FG000|Overall Study|Investigator request|0|||
160917701|NCT00752232|581091736|FG001|Overall Study|Investigator request|0|||
160917702|NCT00752232|581091737|FG002|Overall Study|Investigator request|0|||
160917703|NCT00752232|581091738|FG003|Overall Study|Investigator request|0|||
160917704|NCT00752232|581091739|FG004|Overall Study|Investigator request|1|||
160917705|NCT00752232|581091740|FG005|Overall Study|Investigator request|0|||
160917706|NCT00752232|581091741|FG006|Overall Study|Investigator request|0|||
160917707|NCT00752232|581091735|FG000|Overall Study|Subject request|0|||
160917708|NCT00752232|581091736|FG001|Overall Study|Subject request|0|||
160917709|NCT00752232|581091737|FG002|Overall Study|Subject request|1|||
160917710|NCT00752232|581091738|FG003|Overall Study|Subject request|0|||
160917711|NCT00752232|581091739|FG004|Overall Study|Subject request|0|||
160917712|NCT00752232|581091740|FG005|Overall Study|Subject request|0|||
160917713|NCT00752232|581091741|FG006|Overall Study|Subject request|0|||
160917714|NCT00752232|581091735|FG000|Overall Study|Group home admission|0|||
160917715|NCT00752232|581091736|FG001|Overall Study|Group home admission|0|||
160917716|NCT00752232|581091737|FG002|Overall Study|Group home admission|0|||
160917717|NCT00752232|581091738|FG003|Overall Study|Group home admission|1|||
160917718|NCT00752232|581091739|FG004|Overall Study|Group home admission|0|||
160917719|NCT00752232|581091740|FG005|Overall Study|Group home admission|0|||
160917720|NCT00752232|581091741|FG006|Overall Study|Group home admission|0|||
160917721|NCT00752232|581091735|FG000|Overall Study|Caregiver could not attend the subject|0|||
160917722|NCT00752232|581091736|FG001|Overall Study|Caregiver could not attend the subject|0|||
160917723|NCT00752232|581091737|FG002|Overall Study|Caregiver could not attend the subject|0|||
160917724|NCT00752232|581091738|FG003|Overall Study|Caregiver could not attend the subject|0|||
160917725|NCT00752232|581091739|FG004|Overall Study|Caregiver could not attend the subject|1|||
160917726|NCT00752232|581091740|FG005|Overall Study|Caregiver could not attend the subject|0|||
160917727|NCT00752232|581091741|FG006|Overall Study|Caregiver could not attend the subject|0|||
160917728|NCT04502589|581091742|FG000|Overall Study|Physician Decision|1|||
160917729|NCT04502589|581091743|FG001|Overall Study|Physician Decision|0|||
160917730|NCT02730455|581091745|FG000|Overall Study|Death|5|||
160917731|NCT02730455|581091746|FG001|Overall Study|Death|6|||
160917732|NCT02730455|581091747|FG002|Overall Study|Death|4|||
160917733|NCT02730455|581091745|FG000|Overall Study|Consent withdrawn|2|||
160917734|NCT02730455|581091746|FG001|Overall Study|Consent withdrawn|4|||
160917735|NCT02730455|581091747|FG002|Overall Study|Consent withdrawn|1|||
160996534|NCT00558363|581373638|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
160996535|NCT00868192|581373639|FG000|Overall Study|Ineligible|4|||
160996536|NCT03673124|581373641|FG000|Overall Study|Eligible with no protocol therapy|2|||
160996537|NCT02174562|581373642|FG000|Overall Study|Withdrawal by Subject|7|||
161142520|NCT03519178|581906190|FG002|Fulvestrant. Treatment|Adverse Event|0|||
160917736|NCT02730455|581091745|FG000|Overall Study|Lost to Follow-up|3|||
160917737|NCT02730455|581091746|FG001|Overall Study|Lost to Follow-up|1|||
160917738|NCT02730455|581091747|FG002|Overall Study|Lost to Follow-up|4|||
160917739|NCT02730455|581091745|FG000|Overall Study|Other|1|||
160917740|NCT02730455|581091746|FG001|Overall Study|Other|1|||
161142666|NCT03519178|581906201|FG013|Fulvestrant. Treatment|Other|1|||
160996538|NCT02174562|581373643|FG001|Overall Study|Withdrawal by Subject|2|||
160996539|NCT02174562|581373642|FG000|Overall Study|Death|2|||
160996540|NCT02174562|581373643|FG001|Overall Study|Death|0|||
160996541|NCT02174562|581373642|FG000|Overall Study|Lost to Follow-up|0|||
160996542|NCT02174562|581373643|FG001|Overall Study|Lost to Follow-up|3|||
160996543|NCT00798096|581373645|FG000|Overall Study|Ongoing|2|||
160996544|NCT00290732|581373649|FG000|Overall Study|Inability to instill drug intraductally.|0|||
160996545|NCT00290732|581373650|FG001|Overall Study|Inability to instill drug intraductally.|1|||
160996546|NCT00290732|581373651|FG002|Overall Study|Inability to instill drug intraductally.|1|||
160996547|NCT00290732|581373652|FG003|Overall Study|Inability to instill drug intraductally.|0|||
160996548|NCT00290732|581373653|FG004|Overall Study|Inability to instill drug intraductally.|0|||
160996549|NCT02736799|581373657|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
160996550|NCT02736799|581373658|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
160996551|NCT02736799|581373659|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
160996552|NCT02736799|581373660|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
160996553|NCT01833832|581373661|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
160996554|NCT00843193|581373662|FG000|Overall Study|Adverse Event|2|||
160996555|NCT00843193|581373663|FG001|Overall Study|Adverse Event|4|||
160996556|NCT00843193|581373662|FG000|Overall Study|Lack of Efficacy|1|||
161339643|NCT02867592|582631962|FG002|Overall Study|Adverse Event|2|||
161339644|NCT02867592|582631963|FG003|Overall Study|Adverse Event|1|||
161339645|NCT02867592|582631964|FG004|Overall Study|Adverse Event|1|||
161339646|NCT02867592|582631965|FG005|Overall Study|Adverse Event|5|||
161339647|NCT02867592|582631960|FG000|Overall Study|Death|0|||
161339648|NCT02867592|582631961|FG001|Overall Study|Death|0|||
161339649|NCT02867592|582631962|FG002|Overall Study|Death|0|||
161339650|NCT02867592|582631963|FG003|Overall Study|Death|1|||
161339651|NCT02867592|582631964|FG004|Overall Study|Death|0|||
160996557|NCT00843193|581373663|FG001|Overall Study|Lack of Efficacy|1|||
160996558|NCT00843193|581373662|FG000|Overall Study|Protocol Violation|1|||
160996559|NCT00843193|581373663|FG001|Overall Study|Protocol Violation|2|||
160996560|NCT00843193|581373662|FG000|Overall Study|Lost to Follow-up|1|||
160996561|NCT00843193|581373663|FG001|Overall Study|Lost to Follow-up|0|||
160996562|NCT00843193|581373662|FG000|Overall Study|Physician Decision|0|||
160996563|NCT00843193|581373663|FG001|Overall Study|Physician Decision|1|||
160996564|NCT00843193|581373662|FG000|Overall Study|Withdrawal by Subject|3|||
160996565|NCT00843193|581373663|FG001|Overall Study|Withdrawal by Subject|3|||
160996566|NCT00197015|581373664|FG000|Overall Study|Adverse Event|3|||
160996567|NCT00197015|581373665|FG001|Overall Study|Adverse Event|0|||
160996568|NCT00197015|581373666|FG002|Overall Study|Adverse Event|1|||
160996569|NCT00197015|581373664|FG000|Overall Study|Protocol Violation|0|||
160996570|NCT00197015|581373665|FG001|Overall Study|Protocol Violation|3|||
160996571|NCT00197015|581373666|FG002|Overall Study|Protocol Violation|3|||
160996572|NCT00197015|581373664|FG000|Overall Study|Withdrawal by Subject|17|||
160996573|NCT00197015|581373665|FG001|Overall Study|Withdrawal by Subject|37|||
160996574|NCT00197015|581373666|FG002|Overall Study|Withdrawal by Subject|34|||
160996575|NCT00197015|581373664|FG000|Overall Study|Lost to Follow-up|28|||
160996576|NCT00197015|581373665|FG001|Overall Study|Lost to Follow-up|46|||
160996577|NCT00197015|581373666|FG002|Overall Study|Lost to Follow-up|37|||
160996578|NCT00197015|581373664|FG000|Overall Study|Other|2|||
160996579|NCT00197015|581373665|FG001|Overall Study|Other|3|||
160996580|NCT00197015|581373666|FG002|Overall Study|Other|2|||
160996581|NCT04511650|581373667|FG000|Overall Study|Lost to Follow-up|1|||
160996582|NCT04511650|581373668|FG001|Overall Study|Lost to Follow-up|0|||
161339652|NCT02867592|582631965|FG005|Overall Study|Death|1|||
161339653|NCT02867592|582631960|FG000|Overall Study|Lack of Efficacy|8|||
161339654|NCT02867592|582631961|FG001|Overall Study|Lack of Efficacy|10|||
161339655|NCT02867592|582631962|FG002|Overall Study|Lack of Efficacy|8|||
160996583|NCT04511650|581373669|FG002|Overall Study|Lost to Follow-up|0|||
160996584|NCT04511650|581373667|FG000|Overall Study|Withdrawal by Subject|1|||
160996585|NCT04511650|581373668|FG001|Overall Study|Withdrawal by Subject|0|||
160996586|NCT04511650|581373669|FG002|Overall Study|Withdrawal by Subject|0|||
161339656|NCT02867592|582631963|FG003|Overall Study|Lack of Efficacy|8|||
161339657|NCT02867592|582631964|FG004|Overall Study|Lack of Efficacy|12|||
161339658|NCT02867592|582631965|FG005|Overall Study|Lack of Efficacy|17|||
160996587|NCT04511650|581373667|FG000|Overall Study|reason not provided|0|||
160996588|NCT04511650|581373668|FG001|Overall Study|reason not provided|0|||
160996589|NCT04511650|581373669|FG002|Overall Study|reason not provided|1|||
160996590|NCT04511650|581373667|FG000|Overall Study|Death|1|||
160996591|NCT04511650|581373668|FG001|Overall Study|Death|1|||
160996592|NCT04511650|581373669|FG002|Overall Study|Death|1|||
160996593|NCT02596035|581373673|FG000|Overall Study|Disease Progression|64|||
160996594|NCT02596035|581373674|FG001|Overall Study|Disease Progression|32|||
160996595|NCT02596035|581373675|FG002|Overall Study|Disease Progression|1|||
161339659|NCT02867592|582631960|FG000|Overall Study|Physician Decision|1|||
161339660|NCT02867592|582631961|FG001|Overall Study|Physician Decision|2|||
161339661|NCT02867592|582631962|FG002|Overall Study|Physician Decision|2|||
161339662|NCT02867592|582631963|FG003|Overall Study|Physician Decision|0|||
161339663|NCT02867592|582631964|FG004|Overall Study|Physician Decision|5|||
161339664|NCT02867592|582631965|FG005|Overall Study|Physician Decision|1|||
161339665|NCT02867592|582631960|FG000|Overall Study|Protocol Violation|0|||
161339666|NCT02867592|582631961|FG001|Overall Study|Protocol Violation|0|||
161339667|NCT02867592|582631962|FG002|Overall Study|Protocol Violation|0|||
161339668|NCT02867592|582631963|FG003|Overall Study|Protocol Violation|0|||
161339669|NCT02867592|582631964|FG004|Overall Study|Protocol Violation|1|||
161339670|NCT02867592|582631965|FG005|Overall Study|Protocol Violation|1|||
161339671|NCT02867592|582631960|FG000|Overall Study|Withdrawal by Subject|0|||
161339672|NCT02867592|582631961|FG001|Overall Study|Withdrawal by Subject|1|||
161339673|NCT02867592|582631962|FG002|Overall Study|Withdrawal by Subject|0|||
161339674|NCT02867592|582631963|FG003|Overall Study|Withdrawal by Subject|1|||
161339675|NCT02867592|582631964|FG004|Overall Study|Withdrawal by Subject|3|||
161339676|NCT02867592|582631965|FG005|Overall Study|Withdrawal by Subject|3|||
161339677|NCT02867592|582631960|FG000|Overall Study|Ineligible|1|||
161339678|NCT02867592|582631961|FG001|Overall Study|Ineligible|1|||
161339679|NCT02867592|582631962|FG002|Overall Study|Ineligible|0|||
161339680|NCT02867592|582631963|FG003|Overall Study|Ineligible|0|||
161339681|NCT02867592|582631964|FG004|Overall Study|Ineligible|2|||
161339682|NCT02867592|582631965|FG005|Overall Study|Ineligible|0|||
161339683|NCT02867592|582631960|FG000|Overall Study|No Treatment|1|||
161339684|NCT02867592|582631961|FG001|Overall Study|No Treatment|0|||
161339685|NCT02867592|582631962|FG002|Overall Study|No Treatment|0|||
161339686|NCT02867592|582631963|FG003|Overall Study|No Treatment|0|||
161339687|NCT02867592|582631964|FG004|Overall Study|No Treatment|0|||
161339688|NCT02867592|582631965|FG005|Overall Study|No Treatment|0|||
161339689|NCT02867592|582631960|FG000|Overall Study|Still on Therapy|0|||
161339690|NCT02867592|582631961|FG001|Overall Study|Still on Therapy|0|||
161339691|NCT02867592|582631962|FG002|Overall Study|Still on Therapy|0|||
161339692|NCT02867592|582631963|FG003|Overall Study|Still on Therapy|0|||
161339693|NCT02867592|582631964|FG004|Overall Study|Still on Therapy|1|||
161339694|NCT02867592|582631965|FG005|Overall Study|Still on Therapy|0|||
161339695|NCT02867592|582631960|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161339696|NCT02867592|582631961|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161339697|NCT02867592|582631962|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161339698|NCT02867592|582631963|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161339699|NCT02867592|582631964|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
161339700|NCT02867592|582631965|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
161339701|NCT02867592|582631960|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
161339702|NCT02867592|582631961|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161339703|NCT02867592|582631962|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
161339704|NCT02867592|582631963|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
161339705|NCT02867592|582631964|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161339706|NCT02867592|582631965|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
161339707|NCT00909870|582631966|FG000|Overall Study|Adverse Event|13|||
161339708|NCT00909870|582631967|FG001|Overall Study|Adverse Event|7|||
161339709|NCT00909870|582631966|FG000|Overall Study|Protocol Violation|1|||
161339710|NCT00909870|582631967|FG001|Overall Study|Protocol Violation|2|||
161339711|NCT00909870|582631966|FG000|Overall Study|Withdrawal by Subject|5|||
161339712|NCT00909870|582631967|FG001|Overall Study|Withdrawal by Subject|8|||
161339713|NCT00909870|582631966|FG000|Overall Study|Lost to Follow-up|3|||
161339714|NCT00909870|582631967|FG001|Overall Study|Lost to Follow-up|3|||
161339715|NCT00909870|582631966|FG000|Overall Study|Physician Decision|0|||
161339716|NCT00909870|582631967|FG001|Overall Study|Physician Decision|2|||
161339717|NCT00909870|582631966|FG000|Overall Study|Other|1|||
161339718|NCT00909870|582631967|FG001|Overall Study|Other|5|||
161339719|NCT00848497|582631968|FG000|Overall Study|Screen failure|2|||
161339720|NCT00848497|582631969|FG001|Overall Study|Screen failure|0|||
161339721|NCT00848497|582631968|FG000|Overall Study|Withdrawal by Subject|0|||
161339722|NCT00848497|582631969|FG001|Overall Study|Withdrawal by Subject|1|||
161339723|NCT01420536|582631978|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
161339724|NCT01420536|582631979|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
161339725|NCT04711005|582631982|FG000|Overall Study|Withdrawal by Subject|0|||
161339726|NCT04711005|582631983|FG001|Overall Study|Withdrawal by Subject|0|||
161339727|NCT04711005|582631984|FG002|Overall Study|Withdrawal by Subject|0|||
161339728|NCT04711005|582631985|FG003|Overall Study|Withdrawal by Subject|0|||
161339729|NCT04711005|582631986|FG004|Overall Study|Withdrawal by Subject|0|||
161339730|NCT04711005|582631987|FG005|Overall Study|Withdrawal by Subject|0|||
161339731|NCT04711005|582631988|FG006|Overall Study|Withdrawal by Subject|0|||
161339732|NCT04711005|582631989|FG007|Overall Study|Withdrawal by Subject|1|||
161339733|NCT04711005|582631990|FG008|Overall Study|Withdrawal by Subject|0|||
161339734|NCT04711005|582631991|FG009|Overall Study|Withdrawal by Subject|0|||
161339735|NCT04711005|582631982|FG000|Overall Study|Physician Decision|0|||
161339736|NCT04711005|582631983|FG001|Overall Study|Physician Decision|0|||
161339737|NCT04711005|582631984|FG002|Overall Study|Physician Decision|0|||
161339738|NCT04711005|582631985|FG003|Overall Study|Physician Decision|0|||
161339739|NCT04711005|582631986|FG004|Overall Study|Physician Decision|0|||
161339740|NCT04711005|582631987|FG005|Overall Study|Physician Decision|0|||
161339741|NCT04711005|582631988|FG006|Overall Study|Physician Decision|0|||
161339742|NCT04711005|582631989|FG007|Overall Study|Physician Decision|2|||
161339743|NCT04711005|582631990|FG008|Overall Study|Physician Decision|1|||
160996596|NCT02596035|581373673|FG000|Overall Study|study drug toxicity|12|||
160996597|NCT02596035|581373674|FG001|Overall Study|study drug toxicity|3|||
160996598|NCT02596035|581373675|FG002|Overall Study|study drug toxicity|0|||
160996599|NCT02596035|581373673|FG000|Overall Study|AE unrelated to study drug|5|||
160996600|NCT02596035|581373674|FG001|Overall Study|AE unrelated to study drug|2|||
160996601|NCT02596035|581373675|FG002|Overall Study|AE unrelated to study drug|0|||
160996602|NCT02596035|581373673|FG000|Overall Study|participant request to discontinue study treatment|2|||
160996603|NCT02596035|581373674|FG001|Overall Study|participant request to discontinue study treatment|0|||
160996604|NCT02596035|581373675|FG002|Overall Study|participant request to discontinue study treatment|0|||
160996605|NCT02596035|581373673|FG000|Overall Study|participant withdrew consent|2|||
161142521|NCT03519178|581906191|FG003|Fulvestrant. Treatment|Adverse Event|0|||
160996606|NCT02596035|581373674|FG001|Overall Study|participant withdrew consent|2|||
161339744|NCT04711005|582631991|FG009|Overall Study|Physician Decision|0|||
161339745|NCT00764790|582631992|FG000|Overall Study|Protocol Violation|0|||
161339746|NCT00764790|582631993|FG001|Overall Study|Protocol Violation|0|||
161339747|NCT00764790|582631994|FG002|Overall Study|Protocol Violation|1|||
161339748|NCT00764790|582631992|FG000|Overall Study|Withdrawal by Subject|10|||
161339749|NCT00764790|582631993|FG001|Overall Study|Withdrawal by Subject|12|||
161339750|NCT00764790|582631994|FG002|Overall Study|Withdrawal by Subject|6|||
161339751|NCT00764790|582631992|FG000|Overall Study|Lost to Follow-up|28|||
161339752|NCT00764790|582631993|FG001|Overall Study|Lost to Follow-up|29|||
161339753|NCT00764790|582631994|FG002|Overall Study|Lost to Follow-up|23|||
161339754|NCT04935879|582631995|FG000|Overall Study|Adverse Event|2|||
161339755|NCT04935879|582631996|FG001|Overall Study|Adverse Event|1|||
161339756|NCT04935879|582631995|FG000|Overall Study|Lost to Follow-up|1|||
161339757|NCT04935879|582631996|FG001|Overall Study|Lost to Follow-up|1|||
161339758|NCT04935879|582631995|FG000|Overall Study|Pregnancy|2|||
161339759|NCT04935879|582631996|FG001|Overall Study|Pregnancy|3|||
161339760|NCT04935879|582631995|FG000|Overall Study|Withdrawal by Subject|8|||
161339761|NCT04935879|582631996|FG001|Overall Study|Withdrawal by Subject|6|||
161339762|NCT04935879|582631995|FG000|Overall Study|Other|3|||
161339763|NCT04935879|582631996|FG001|Overall Study|Other|3|||
161339764|NCT03054428|582631997|FG000|Overall Study|Physician Decision|0|||
161339765|NCT03054428|582631998|FG001|Overall Study|Physician Decision|1|||
161339766|NCT03054428|582631999|FG002|Overall Study|Physician Decision|1|||
161339767|NCT03054428|582631997|FG000|Overall Study|Lack of Efficacy|3|||
161339768|NCT03054428|582631998|FG001|Overall Study|Lack of Efficacy|1|||
161339769|NCT03054428|582631999|FG002|Overall Study|Lack of Efficacy|0|||
161339770|NCT03054428|582631997|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
161339771|NCT03054428|582631998|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
161339772|NCT03054428|582631999|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
161339773|NCT03054428|582631997|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
161339774|NCT03054428|582631998|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
160996607|NCT02596035|581373675|FG002|Overall Study|participant withdrew consent|0|||
160996608|NCT02596035|581373673|FG000|Overall Study|Poor/Non Comlpiance|0|||
160996609|NCT02596035|581373674|FG001|Overall Study|Poor/Non Comlpiance|1|||
160996610|NCT02596035|581373675|FG002|Overall Study|Poor/Non Comlpiance|0|||
160996611|NCT02596035|581373673|FG000|Overall Study|participant no longer meets study criteria|1|||
160996612|NCT02596035|581373674|FG001|Overall Study|participant no longer meets study criteria|0|||
160996613|NCT02596035|581373675|FG002|Overall Study|participant no longer meets study criteria|0|||
160996614|NCT02596035|581373673|FG000|Overall Study|other reasons|11|||
160996615|NCT02596035|581373674|FG001|Overall Study|other reasons|4|||
160996616|NCT02596035|581373675|FG002|Overall Study|other reasons|0|||
160996617|NCT03523962|581373679|FG000|Closed Fractures|Death|86|||
161339775|NCT03054428|582631999|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
161339776|NCT03054428|582631997|FG000|Overall Study|Transitioned to OLE study|76|||
161339777|NCT03054428|582631998|FG001|Overall Study|Transitioned to OLE study|76|||
161339778|NCT03054428|582631999|FG002|Overall Study|Transitioned to OLE study|73|||
161339779|NCT03054428|582631997|FG000|Overall Study|Withdrawal by Subject|3|||
161339780|NCT03054428|582631998|FG001|Overall Study|Withdrawal by Subject|2|||
161339781|NCT03054428|582631999|FG002|Overall Study|Withdrawal by Subject|3|||
161339782|NCT03054428|582631997|FG000|Overall Study|Lost to Follow-up|0|||
161339783|NCT03054428|582631998|FG001|Overall Study|Lost to Follow-up|0|||
161339784|NCT03054428|582631999|FG002|Overall Study|Lost to Follow-up|1|||
161339785|NCT01652690|582632000|FG000|Overall Study|Withdrawal by Subject|16|||
160996618|NCT03523962|581373680|FG001|Closed Fractures|Death|71|||
160996619|NCT03523962|581373681|FG002|Closed Fractures|Death|0|||
160996620|NCT03523962|581373682|FG003|Closed Fractures|Death|0|||
160996621|NCT03523962|581373679|FG000|Closed Fractures|Lost to Follow-up|62|||
160996622|NCT03523962|581373680|FG001|Closed Fractures|Lost to Follow-up|36|||
160996623|NCT03523962|581373681|FG002|Closed Fractures|Lost to Follow-up|0|||
160996624|NCT03523962|581373682|FG003|Closed Fractures|Lost to Follow-up|0|||
160996625|NCT03523962|581373679|FG000|Closed Fractures|Withdrawal by Subject|19|||
160996626|NCT03523962|581373680|FG001|Closed Fractures|Withdrawal by Subject|29|||
160996627|NCT03523962|581373681|FG002|Closed Fractures|Withdrawal by Subject|0|||
160996628|NCT03523962|581373682|FG003|Closed Fractures|Withdrawal by Subject|0|||
160996629|NCT03523962|581373679|FG000|Closed Fractures|Incarceration|1|||
160996630|NCT03523962|581373680|FG001|Closed Fractures|Incarceration|4|||
160996631|NCT03523962|581373681|FG002|Closed Fractures|Incarceration|0|||
160996632|NCT03523962|581373682|FG003|Closed Fractures|Incarceration|0|||
160996633|NCT03523962|581373679|FG000|Open Fractures|Death|0|||
160996634|NCT03523962|581373680|FG001|Open Fractures|Death|0|||
160996635|NCT03523962|581373681|FG002|Open Fractures|Death|11|||
160996636|NCT03523962|581373682|FG003|Open Fractures|Death|6|||
160996637|NCT03523962|581373679|FG000|Open Fractures|Lost to Follow-up|0|||
160996638|NCT03523962|581373680|FG001|Open Fractures|Lost to Follow-up|0|||
160996639|NCT03523962|581373681|FG002|Open Fractures|Lost to Follow-up|15|||
160996640|NCT03523962|581373682|FG003|Open Fractures|Lost to Follow-up|8|||
160996641|NCT03523962|581373679|FG000|Open Fractures|Withdrawal by Subject|0|||
160996642|NCT03523962|581373680|FG001|Open Fractures|Withdrawal by Subject|0|||
160996643|NCT03523962|581373681|FG002|Open Fractures|Withdrawal by Subject|6|||
160996644|NCT03523962|581373682|FG003|Open Fractures|Withdrawal by Subject|2|||
160996645|NCT03523962|581373679|FG000|Open Fractures|Incarceration|0|||
160996646|NCT03523962|581373680|FG001|Open Fractures|Incarceration|0|||
160996647|NCT03523962|581373681|FG002|Open Fractures|Incarceration|1|||
160996648|NCT03523962|581373682|FG003|Open Fractures|Incarceration|0|||
160996649|NCT00835380|581373683|FG000|Overall Study|Withdrawal by Subject|2|||
160996650|NCT01081145|581373684|FG000|Open-Label Phase|Lack of Efficacy|56|||
160996651|NCT01081145|581373685|FG001|Open-Label Phase|Lack of Efficacy|0|||
160996652|NCT01081145|581373684|FG000|Open-Label Phase|Response criteria not met|46|||
160996653|NCT01081145|581373685|FG001|Open-Label Phase|Response criteria not met|0|||
160996654|NCT01081145|581373684|FG000|Open-Label Phase|Adverse Event|42|||
160996655|NCT01081145|581373685|FG001|Open-Label Phase|Adverse Event|0|||
160996656|NCT01081145|581373684|FG000|Open-Label Phase|Withdrawal by Subject|41|||
160996657|NCT01081145|581373685|FG001|Open-Label Phase|Withdrawal by Subject|0|||
160996658|NCT01081145|581373684|FG000|Open-Label Phase|Other|12|||
160996659|NCT01081145|581373685|FG001|Open-Label Phase|Other|0|||
160996660|NCT01081145|581373684|FG000|Open-Label Phase|Lost to Follow-up|11|||
160996661|NCT01081145|581373685|FG001|Open-Label Phase|Lost to Follow-up|0|||
160996662|NCT01081145|581373684|FG000|Open-Label Phase|Protocol Violation|4|||
160996663|NCT01081145|581373685|FG001|Open-Label Phase|Protocol Violation|0|||
160996664|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
160996665|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
160996666|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
160996667|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
160996668|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
160996669|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
160996670|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
160996671|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
160996672|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
160996673|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
160996674|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
160996675|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
160996676|NCT01081145|581373684|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
160996677|NCT01081145|581373685|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
160996678|NCT03593070|581373686|FG000|Overall Study|administrative withdrawal|1|||
160996679|NCT03593070|581373687|FG001|Overall Study|administrative withdrawal|1|||
160996680|NCT00881335|581373688|FG000|Overall Study|Lost to Follow-up|3|||
160996681|NCT00881335|581373689|FG001|Overall Study|Lost to Follow-up|2|||
160996682|NCT03681678|581373690|FG000|Overall Study|Lost to Follow-up|20|||
160996683|NCT00828945|581373693|FG000|Overall Study|Death|4|||
160996684|NCT00828945|581373693|FG000|Overall Study|Participant was missing|1|||
160996685|NCT00828945|581373693|FG000|Overall Study|Other|36|||
160996686|NCT02141074|581373696|FG000|Pre-prophylaxis|Adverse Event|3|||
160996687|NCT02141074|581373697|FG001|Pre-prophylaxis|Adverse Event|0|||
161142522|NCT03519178|581906192|FG004|Fulvestrant. Treatment|Adverse Event|0|||
161339786|NCT01652690|582632001|FG001|Overall Study|Withdrawal by Subject|4|||
160996688|NCT02141074|581373696|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
160996689|NCT02141074|581373697|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
160996690|NCT02141074|581373696|FG000|Prophylaxis|Adverse Event|0|||
160996691|NCT02141074|581373697|FG001|Prophylaxis|Adverse Event|4|||
160996692|NCT02141074|581373696|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
160996693|NCT02141074|581373697|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
160996694|NCT02141074|581373696|FG000|Prophylaxis|Withdrawal by Subject|0|||
160996695|NCT02141074|581373697|FG001|Prophylaxis|Withdrawal by Subject|1|||
160996696|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
160996697|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
160996698|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996699|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
161142523|NCT03519178|581906193|FG005|Fulvestrant. Treatment|Adverse Event|0|||
160996700|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996701|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996702|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996703|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996704|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996705|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996706|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996707|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
160996708|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996709|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
160996710|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996711|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996712|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996713|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996714|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996715|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996716|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996717|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996718|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996719|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
160996720|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
160996721|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
160996722|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996723|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996724|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996725|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996726|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996727|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996728|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996729|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996730|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996731|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
160996732|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996733|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
160996734|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996735|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996736|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996737|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996738|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996739|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996740|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996741|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996742|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996743|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
160996744|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996745|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
160996746|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996747|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996748|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996749|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996750|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996751|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996752|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
161142524|NCT03519178|581906194|FG006|Fulvestrant. Treatment|Adverse Event|0|||
161339787|NCT01652690|582632000|FG000|Overall Study|Other|8|||
161339788|NCT01652690|582632001|FG001|Overall Study|Other|9|||
161339789|NCT01652690|582632000|FG000|Overall Study|Lost to Follow-up|6|||
161339790|NCT01652690|582632001|FG001|Overall Study|Lost to Follow-up|6|||
160917741|NCT02730455|581091747|FG002|Overall Study|Other|2|||
160917742|NCT02730455|581091745|FG000|Overall Study|Other|2|||
160917743|NCT02730455|581091746|FG001|Overall Study|Other|2|||
160917744|NCT02730455|581091747|FG002|Overall Study|Other|0|||
160917745|NCT05582889|581091750|FG000|Overall Study|Health event|3|||
160917746|NCT05582889|581091751|FG001|Overall Study|Health event|2|||
160917747|NCT05582889|581091750|FG000|Overall Study|Lost to Follow-up|2|||
160917748|NCT05582889|581091751|FG001|Overall Study|Lost to Follow-up|4|||
160917749|NCT00001723|581091752|FG000|Overall Study|Lack of Efficacy|6|||
160917750|NCT00001723|581091753|FG001|Overall Study|Lack of Efficacy|7|||
160917751|NCT00001723|581091752|FG000|Overall Study|Lack of family interest|4|||
160917752|NCT00001723|581091753|FG001|Overall Study|Lack of family interest|5|||
160917753|NCT00001723|581091752|FG000|Overall Study|Lost to Follow-up|2|||
160917754|NCT00001723|581091753|FG001|Overall Study|Lost to Follow-up|2|||
160917755|NCT00001723|581091752|FG000|Overall Study|medication intolerance|1|||
160917756|NCT00001723|581091753|FG001|Overall Study|medication intolerance|2|||
160917757|NCT04551092|581091754|FG000|Overall Study|Lost to Follow-up|7|||
160917758|NCT04551092|581091754|FG000|Overall Study|Withdrawal by Subject|4|||
160917759|NCT01324999|581091755|FG000|Overall Study|Adverse Event|3|||
160917760|NCT01324999|581091755|FG000|Overall Study|Withdrawal by Subject|2|||
160917761|NCT01714635|581091761|FG000|Overall Study|Discontinued|1|||
160917762|NCT01714635|581091762|FG001|Overall Study|Discontinued|0|||
160917763|NCT01714635|581091763|FG002|Overall Study|Discontinued|2|||
160917764|NCT01714635|581091761|FG000|Overall Study|Missed 6-month exam|1|||
160917765|NCT01714635|581091762|FG001|Overall Study|Missed 6-month exam|0|||
160917766|NCT01714635|581091763|FG002|Overall Study|Missed 6-month exam|0|||
160917767|NCT02848651|581091765|FG000|Overall Study|Death|85|||
160917768|NCT02848651|581091765|FG000|Overall Study|Lost to Follow-up|1|||
160917769|NCT02848651|581091765|FG000|Overall Study|Non-Compliance|1|||
160917770|NCT02848651|581091765|FG000|Overall Study|Symptomatic Deterioration|1|||
160917771|NCT02848651|581091765|FG000|Overall Study|Physician Decision|4|||
160917772|NCT02848651|581091765|FG000|Overall Study|Withdrawal by Subject|14|||
160917773|NCT00396591|581091770|FG000|Overall Study|Disease Progression|13|||
160917774|NCT00396591|581091770|FG000|Overall Study|Adverse Event|2|||
160917775|NCT00396591|581091770|FG000|Overall Study|Participant request|1|||
160917776|NCT01535053|581091773|FG000|Overall Study|Ineligible|1|||
160917777|NCT01535053|581091774|FG001|Overall Study|Ineligible|2|||
160917778|NCT00512707|581091775|FG000|Overall Study|Lost to Follow-up|5|||
160917779|NCT00512707|581091776|FG001|Overall Study|Lost to Follow-up|11|||
160917780|NCT00512707|581091775|FG000|Overall Study|Developed skin irritation|2|||
160917781|NCT00512707|581091776|FG001|Overall Study|Developed skin irritation|1|||
160917782|NCT00512707|581091775|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
160917783|NCT00512707|581091776|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
160917784|NCT00512707|581091775|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
160917785|NCT00512707|581091776|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
160917786|NCT01853826|581094094|FG000|Overall Study|Patients who switched to commercial drug|11|||
160917787|NCT01853826|581094094|FG000|Overall Study|Patient refused to continue medication|21|||
160917788|NCT01853826|581094094|FG000|Overall Study|Lost to Follow-up|2|||
160917789|NCT01853826|581094094|FG000|Overall Study|Non-compliant with protocol|4|||
160917790|NCT01853826|581094094|FG000|Overall Study|Other adverse events (AE)|62|||
160917791|NCT01853826|581094094|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
160917792|NCT01853826|581094094|FG000|Overall Study|Progressive disease|342|||
160917793|NCT01853826|581094094|FG000|Overall Study|Other than listed|13|||
160917794|NCT01853826|581094094|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
160917795|NCT03653637|581094095|FG000|Overall Study|Death|1|||
160917796|NCT03653637|581094096|FG001|Overall Study|Death|3|||
160917797|NCT03653637|581094095|FG000|Overall Study|Lost to Follow-up|29|||
160917798|NCT03653637|581094096|FG001|Overall Study|Lost to Follow-up|30|||
160917799|NCT03653637|581094095|FG000|Overall Study|Physician Decision|1|||
160917800|NCT03653637|581094096|FG001|Overall Study|Physician Decision|1|||
160917801|NCT03653637|581094095|FG000|Overall Study|Withdrawal by Subject|7|||
160917802|NCT03653637|581094096|FG001|Overall Study|Withdrawal by Subject|4|||
160917803|NCT02068443|581094107|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160917804|NCT02068443|581094108|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
160917805|NCT02068443|581094109|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
160917806|NCT02068443|581094107|FG000|Overall Study|Voluntary Withdrawal|4|||
160917807|NCT02068443|581094108|FG001|Overall Study|Voluntary Withdrawal|0|||
160917808|NCT02068443|581094109|FG002|Overall Study|Voluntary Withdrawal|1|||
160917809|NCT02068443|581094107|FG000|Overall Study|Lack of Efficacy|2|||
160917810|NCT02068443|581094108|FG001|Overall Study|Lack of Efficacy|1|||
160917811|NCT02068443|581094109|FG002|Overall Study|Lack of Efficacy|0|||
160917812|NCT02068443|581094107|FG000|Overall Study|Other Reason Not Specified|1|||
161339791|NCT01652690|582632000|FG000|Overall Study|Death|5|||
161339792|NCT01652690|582632001|FG001|Overall Study|Death|2|||
161339793|NCT03225287|582632004|FG000|Overall Study|Adverse Event|0|||
161339794|NCT03225287|582632005|FG001|Overall Study|Adverse Event|0|||
161339795|NCT03225287|582632006|FG002|Overall Study|Adverse Event|1|||
161339796|NCT03225287|582632004|FG000|Overall Study|Protocol non-compliance|0|||
161339797|NCT03225287|582632005|FG001|Overall Study|Protocol non-compliance|0|||
161339798|NCT03225287|582632006|FG002|Overall Study|Protocol non-compliance|1|||
161339799|NCT03225287|582632004|FG000|Overall Study|Subject withdraws consent|3|||
161339800|NCT03225287|582632005|FG001|Overall Study|Subject withdraws consent|0|||
161339801|NCT03225287|582632006|FG002|Overall Study|Subject withdraws consent|0|||
161339802|NCT03225287|582632004|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
161339803|NCT03225287|582632005|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
161339804|NCT03225287|582632006|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
161339805|NCT03225287|582632004|FG000|Overall Study|Trial drug not effective|0|||
161339806|NCT03225287|582632005|FG001|Overall Study|Trial drug not effective|1|||
161339807|NCT03225287|582632006|FG002|Overall Study|Trial drug not effective|0|||
161339808|NCT03225287|582632004|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
161339809|NCT03225287|582632005|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
161339810|NCT03225287|582632006|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
160996753|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996754|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996755|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
160996756|NCT03536884|581373698|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996757|NCT03536884|581373699|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
160996758|NCT03536884|581373700|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996759|NCT03536884|581373701|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996760|NCT03536884|581373702|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996761|NCT03536884|581373703|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996762|NCT03536884|581373704|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996763|NCT03536884|581373705|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996764|NCT03536884|581373706|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996765|NCT03536884|581373707|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996766|NCT03536884|581373708|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996767|NCT03536884|581373709|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
160996768|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996769|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996770|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
160996771|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996772|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
160996773|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996774|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996775|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996776|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996777|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996778|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996779|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
160996780|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996781|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996782|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
160996783|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
160996784|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
160996785|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996786|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996787|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996788|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
161339811|NCT03225287|582632004|FG000|Overall Study|Stem cell transplantation|0|||
161339812|NCT03225287|582632005|FG001|Overall Study|Stem cell transplantation|1|||
161339813|NCT03225287|582632006|FG002|Overall Study|Stem cell transplantation|0|||
161339814|NCT06070610|582632009|FG000|Washout period|Adverse Event|1|||
161339815|NCT06070610|582632009|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
161339816|NCT00834041|582632010|FG000|Overall Study|Withdrawal by Subject|1|||
161339817|NCT00834041|582632011|FG001|Overall Study|Withdrawal by Subject|0|||
160996789|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996790|NCT03536884|581373708|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996791|NCT03536884|581373709|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
160996792|NCT03536884|581373698|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
161142667|NCT03519178|581906202|FG014|Fulvestrant. Treatment|Other|3|||
161339818|NCT00834041|582632010|FG000|Overall Study|Lost to Follow-up|0|||
160861849|NCT02531802|580887845|FG000|Received Vaccination 2|Adverse Event|0|||
161339819|NCT00834041|582632011|FG001|Overall Study|Lost to Follow-up|1|||
161339820|NCT04530630|582633382|FG000|Overall Study|Physician Decision|1|||
161339821|NCT03834961|582633385|FG000|Overall Study|Lack of Efficacy|1|||
161339822|NCT03834961|582633386|FG001|Overall Study|Lack of Efficacy|1|||
161339823|NCT03834961|582633387|FG002|Overall Study|Lack of Efficacy|0|||
161339824|NCT03834961|582633385|FG000|Overall Study|Physician Decision|0|||
161339825|NCT03834961|582633386|FG001|Overall Study|Physician Decision|1|||
161339826|NCT03834961|582633387|FG002|Overall Study|Physician Decision|0|||
160996793|NCT03536884|581373699|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996794|NCT03536884|581373700|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996795|NCT03536884|581373701|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
160996796|NCT03536884|581373702|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
160996797|NCT03536884|581373703|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996798|NCT03536884|581373704|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996799|NCT03536884|581373705|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996800|NCT03536884|581373706|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160996801|NCT03536884|581373707|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
160917813|NCT02068443|581094108|FG001|Overall Study|Other Reason Not Specified|0|||
160917814|NCT02068443|581094109|FG002|Overall Study|Other Reason Not Specified|0|||
160917815|NCT02723084|581094111|FG000|Overall Study|Withdrawal by Subject|1|||
160917816|NCT02723084|581094112|FG001|Overall Study|Withdrawal by Subject|1|||
160917817|NCT02723084|581094111|FG000|Overall Study|Lost to Follow-up|3|||
160917818|NCT02723084|581094112|FG001|Overall Study|Lost to Follow-up|0|||
160917819|NCT04067544|581094117|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
160917820|NCT01320085|581094118|FG000|Overall Study|Disease Progression|26|||
160917821|NCT01320085|581094119|FG001|Overall Study|Disease Progression|93|||
160917822|NCT01320085|581094120|FG002|Overall Study|Disease Progression|17|||
160917823|NCT01320085|581094118|FG000|Overall Study|Adverse Event|12|||
160917824|NCT01320085|581094119|FG001|Overall Study|Adverse Event|20|||
160917825|NCT01320085|581094120|FG002|Overall Study|Adverse Event|5|||
160917826|NCT01320085|581094118|FG000|Overall Study|Withdrawal by Subject|2|||
160917827|NCT01320085|581094119|FG001|Overall Study|Withdrawal by Subject|4|||
160917828|NCT01320085|581094120|FG002|Overall Study|Withdrawal by Subject|1|||
160917829|NCT01320085|581094118|FG000|Overall Study|Protocol Deviation|1|||
160917830|NCT01320085|581094119|FG001|Overall Study|Protocol Deviation|0|||
160917831|NCT01320085|581094120|FG002|Overall Study|Protocol Deviation|1|||
160917832|NCT01320085|581094118|FG000|Overall Study|Administrative problems|0|||
160917833|NCT01320085|581094119|FG001|Overall Study|Administrative problems|0|||
160917834|NCT01320085|581094120|FG002|Overall Study|Administrative problems|1|||
160917835|NCT00225251|581094123|FG000|Overall Study|Withdrawal by Subject|1|||
160917836|NCT00225251|581094124|FG001|Overall Study|Withdrawal by Subject|1|||
160917837|NCT01702454|581094125|FG000|Overall Study|Consent withdrawal|0|||
160917838|NCT01702454|581094126|FG001|Overall Study|Consent withdrawal|1|||
160917839|NCT01702454|581094125|FG000|Overall Study|Migrated/moved from study area|0|||
160917840|NCT01702454|581094126|FG001|Overall Study|Migrated/moved from study area|1|||
160917841|NCT01702454|581094125|FG000|Overall Study|Lost to Follow-up|3|||
160917842|NCT01702454|581094126|FG001|Overall Study|Lost to Follow-up|6|||
160917843|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
160917844|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
160917845|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
160917846|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
160917847|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
160917848|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
160917849|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
160917850|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
160917851|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
160917852|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
160917853|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
160917854|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
160917855|NCT03510884|581094127|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
160917856|NCT03510884|581094128|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
160917857|NCT03510884|581094129|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
160917858|NCT03510884|581094130|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
161339978|NCT00042289|582633407|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161339979|NCT00042289|582633408|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161339980|NCT00042289|582633409|FG005|Overall Study|Severe debilitation, unable to continue|0|||
161339981|NCT00042289|582633410|FG006|Overall Study|Severe debilitation, unable to continue|0|||
161339982|NCT00042289|582633411|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161339983|NCT00042289|582633412|FG008|Overall Study|Severe debilitation, unable to continue|0|||
161339984|NCT00042289|582633413|FG009|Overall Study|Severe debilitation, unable to continue|0|||
161339985|NCT00042289|582633414|FG010|Overall Study|Severe debilitation, unable to continue|0|||
161339986|NCT00042289|582633415|FG011|Overall Study|Severe debilitation, unable to continue|0|||
161339987|NCT00042289|582633416|FG012|Overall Study|Severe debilitation, unable to continue|0|||
161339988|NCT00042289|582633417|FG013|Overall Study|Severe debilitation, unable to continue|0|||
161339989|NCT00042289|582633418|FG014|Overall Study|Severe debilitation, unable to continue|0|||
161339990|NCT00042289|582633419|FG015|Overall Study|Severe debilitation, unable to continue|0|||
161339991|NCT00042289|582633420|FG016|Overall Study|Severe debilitation, unable to continue|0|||
161339992|NCT00042289|582633421|FG017|Overall Study|Severe debilitation, unable to continue|0|||
161339993|NCT00042289|582633422|FG018|Overall Study|Severe debilitation, unable to continue|0|||
161339994|NCT00042289|582633423|FG019|Overall Study|Severe debilitation, unable to continue|0|||
161339995|NCT00042289|582633424|FG020|Overall Study|Severe debilitation, unable to continue|0|||
161339996|NCT00042289|582633425|FG021|Overall Study|Severe debilitation, unable to continue|1|||
161339997|NCT00042289|582633426|FG022|Overall Study|Severe debilitation, unable to continue|0|||
161339998|NCT00042289|582633427|FG023|Overall Study|Severe debilitation, unable to continue|1|||
161339999|NCT00042289|582633428|FG024|Overall Study|Severe debilitation, unable to continue|0|||
161340000|NCT00042289|582633429|FG025|Overall Study|Severe debilitation, unable to continue|0|||
161340001|NCT00042289|582633430|FG026|Overall Study|Severe debilitation, unable to continue|0|||
161340002|NCT00042289|582633431|FG027|Overall Study|Severe debilitation, unable to continue|1|||
161340003|NCT00042289|582633432|FG028|Overall Study|Severe debilitation, unable to continue|0|||
161340004|NCT00042289|582633433|FG029|Overall Study|Severe debilitation, unable to continue|0|||
161340005|NCT00042289|582633434|FG030|Overall Study|Severe debilitation, unable to continue|0|||
161340006|NCT00042289|582633435|FG031|Overall Study|Severe debilitation, unable to continue|1|||
161340007|NCT00042289|582633436|FG032|Overall Study|Severe debilitation, unable to continue|1|||
161340008|NCT00042289|582633437|FG033|Overall Study|Severe debilitation, unable to continue|0|||
161340009|NCT00042289|582633438|FG034|Overall Study|Severe debilitation, unable to continue|0|||
161340010|NCT00042289|582633439|FG035|Overall Study|Severe debilitation, unable to continue|0|||
161340011|NCT00042289|582633440|FG036|Overall Study|Severe debilitation, unable to continue|0|||
161340012|NCT00042289|582633441|FG037|Overall Study|Severe debilitation, unable to continue|0|||
161340013|NCT00042289|582633442|FG038|Overall Study|Severe debilitation, unable to continue|0|||
161340014|NCT00042289|582633443|FG039|Overall Study|Severe debilitation, unable to continue|0|||
161340015|NCT00042289|582633444|FG040|Overall Study|Severe debilitation, unable to continue|0|||
161340016|NCT00042289|582633445|FG041|Overall Study|Severe debilitation, unable to continue|0|||
161340017|NCT00042289|582633446|FG042|Overall Study|Severe debilitation, unable to continue|0|||
161340018|NCT00042289|582633447|FG043|Overall Study|Severe debilitation, unable to continue|0|||
161340019|NCT00042289|582633448|FG044|Overall Study|Severe debilitation, unable to continue|0|||
161340020|NCT00042289|582633449|FG045|Overall Study|Severe debilitation, unable to continue|0|||
161340021|NCT00042289|582633450|FG046|Overall Study|Severe debilitation, unable to continue|0|||
161340022|NCT00042289|582633404|FG000|Overall Study|Site closed|0|||
161340023|NCT00042289|582633405|FG001|Overall Study|Site closed|0|||
161340024|NCT00042289|582633406|FG002|Overall Study|Site closed|0|||
161340025|NCT00042289|582633407|FG003|Overall Study|Site closed|0|||
161340026|NCT00042289|582633408|FG004|Overall Study|Site closed|0|||
161340027|NCT00042289|582633409|FG005|Overall Study|Site closed|0|||
161340028|NCT00042289|582633410|FG006|Overall Study|Site closed|0|||
161340029|NCT00042289|582633411|FG007|Overall Study|Site closed|0|||
161340030|NCT00042289|582633412|FG008|Overall Study|Site closed|0|||
161340031|NCT00042289|582633413|FG009|Overall Study|Site closed|0|||
161340032|NCT00042289|582633414|FG010|Overall Study|Site closed|0|||
161340033|NCT00042289|582633415|FG011|Overall Study|Site closed|0|||
161340034|NCT00042289|582633416|FG012|Overall Study|Site closed|0|||
161340035|NCT00042289|582633417|FG013|Overall Study|Site closed|0|||
161340036|NCT00042289|582633418|FG014|Overall Study|Site closed|0|||
161340037|NCT00042289|582633419|FG015|Overall Study|Site closed|0|||
161340038|NCT00042289|582633420|FG016|Overall Study|Site closed|0|||
161340039|NCT00042289|582633421|FG017|Overall Study|Site closed|0|||
161340040|NCT00042289|582633422|FG018|Overall Study|Site closed|0|||
161340041|NCT00042289|582633423|FG019|Overall Study|Site closed|0|||
161340042|NCT00042289|582633424|FG020|Overall Study|Site closed|0|||
161340043|NCT00042289|582633425|FG021|Overall Study|Site closed|0|||
161340044|NCT00042289|582633426|FG022|Overall Study|Site closed|0|||
161340045|NCT00042289|582633427|FG023|Overall Study|Site closed|0|||
161340046|NCT00042289|582633428|FG024|Overall Study|Site closed|0|||
161340047|NCT00042289|582633429|FG025|Overall Study|Site closed|0|||
161340048|NCT00042289|582633430|FG026|Overall Study|Site closed|0|||
161340049|NCT00042289|582633431|FG027|Overall Study|Site closed|0|||
161091089|NCT01718353|581723807|FG001|Overall Study|Lost to Follow-up|1|||
161340050|NCT00042289|582633432|FG028|Overall Study|Site closed|0|||
161340051|NCT00042289|582633433|FG029|Overall Study|Site closed|0|||
161340052|NCT00042289|582633434|FG030|Overall Study|Site closed|0|||
161340053|NCT00042289|582633435|FG031|Overall Study|Site closed|3|||
161340054|NCT00042289|582633436|FG032|Overall Study|Site closed|0|||
161340055|NCT00042289|582633437|FG033|Overall Study|Site closed|0|||
161340056|NCT00042289|582633438|FG034|Overall Study|Site closed|0|||
161340057|NCT00042289|582633439|FG035|Overall Study|Site closed|0|||
161340058|NCT00042289|582633440|FG036|Overall Study|Site closed|1|||
161340059|NCT00042289|582633441|FG037|Overall Study|Site closed|0|||
161340060|NCT00042289|582633442|FG038|Overall Study|Site closed|0|||
161340061|NCT00042289|582633443|FG039|Overall Study|Site closed|0|||
161340062|NCT00042289|582633444|FG040|Overall Study|Site closed|0|||
161340063|NCT00042289|582633445|FG041|Overall Study|Site closed|0|||
161340064|NCT00042289|582633446|FG042|Overall Study|Site closed|1|||
161340065|NCT00042289|582633447|FG043|Overall Study|Site closed|0|||
161340066|NCT00042289|582633448|FG044|Overall Study|Site closed|0|||
161340067|NCT00042289|582633449|FG045|Overall Study|Site closed|0|||
161340068|NCT00042289|582633450|FG046|Overall Study|Site closed|0|||
161340069|NCT00042289|582633404|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
161340070|NCT00042289|582633405|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
161340071|NCT00042289|582633406|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
161340072|NCT00042289|582633407|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
161340073|NCT00042289|582633408|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
161340074|NCT00042289|582633409|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
161340075|NCT00042289|582633410|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
161340076|NCT00042289|582633411|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
161340077|NCT00042289|582633412|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
161340078|NCT00042289|582633413|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
161340079|NCT00042289|582633414|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
161340080|NCT00042289|582633415|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
161340081|NCT00042289|582633416|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
161340082|NCT00042289|582633417|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
161340083|NCT00042289|582633418|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
161340084|NCT00042289|582633419|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
161340085|NCT00042289|582633420|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
161340086|NCT00042289|582633421|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
161340087|NCT00042289|582633422|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
161340088|NCT00042289|582633423|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
161340089|NCT00042289|582633424|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
161340090|NCT00042289|582633425|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
161340091|NCT00042289|582633426|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
161340092|NCT00042289|582633427|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
161340093|NCT00042289|582633428|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
161340094|NCT00042289|582633429|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
161340095|NCT00042289|582633430|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
161340096|NCT00042289|582633431|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
161340097|NCT00042289|582633432|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
161340098|NCT00042289|582633433|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
161340099|NCT00042289|582633434|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
161340100|NCT00042289|582633435|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
161340101|NCT00042289|582633436|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
161340102|NCT00042289|582633437|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
161142668|NCT03519178|581906188|FG000|Letrozole Treatment|Physician Decision|0|||
161142669|NCT03519178|581906189|FG001|Letrozole Treatment|Physician Decision|0|||
161142670|NCT03519178|581906190|FG002|Letrozole Treatment|Physician Decision|0|||
161142671|NCT03519178|581906191|FG003|Letrozole Treatment|Physician Decision|0|||
161142672|NCT03519178|581906192|FG004|Letrozole Treatment|Physician Decision|0|||
161142673|NCT03519178|581906193|FG005|Letrozole Treatment|Physician Decision|0|||
161142674|NCT03519178|581906194|FG006|Letrozole Treatment|Physician Decision|0|||
161142675|NCT03519178|581906195|FG007|Letrozole Treatment|Physician Decision|0|||
161142676|NCT03519178|581906196|FG008|Letrozole Treatment|Physician Decision|0|||
161142677|NCT03519178|581906197|FG009|Letrozole Treatment|Physician Decision|0|||
161142678|NCT03519178|581906198|FG010|Letrozole Treatment|Physician Decision|1|||
161340103|NCT00042289|582633438|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
161340104|NCT00042289|582633439|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
161142679|NCT03519178|581906199|FG011|Letrozole Treatment|Physician Decision|0|||
161340105|NCT00042289|582633440|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
161340106|NCT00042289|582633441|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
161340107|NCT00042289|582633442|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
161340108|NCT00042289|582633443|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
161340109|NCT00042289|582633444|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
161340110|NCT00042289|582633445|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
161340111|NCT00042289|582633446|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
161340112|NCT00042289|582633447|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
161340113|NCT00042289|582633448|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
161340114|NCT00042289|582633449|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
161340115|NCT00042289|582633450|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
161340116|NCT00042289|582633404|FG000|Overall Study|Protocol Violation|0|||
161340117|NCT00042289|582633405|FG001|Overall Study|Protocol Violation|0|||
161340118|NCT00042289|582633406|FG002|Overall Study|Protocol Violation|0|||
161340119|NCT00042289|582633407|FG003|Overall Study|Protocol Violation|0|||
161340120|NCT00042289|582633408|FG004|Overall Study|Protocol Violation|0|||
161340121|NCT00042289|582633409|FG005|Overall Study|Protocol Violation|1|||
161340122|NCT00042289|582633410|FG006|Overall Study|Protocol Violation|0|||
161340123|NCT00042289|582633411|FG007|Overall Study|Protocol Violation|1|||
161340124|NCT00042289|582633412|FG008|Overall Study|Protocol Violation|0|||
161340125|NCT00042289|582633413|FG009|Overall Study|Protocol Violation|0|||
161340126|NCT00042289|582633414|FG010|Overall Study|Protocol Violation|0|||
161340127|NCT00042289|582633415|FG011|Overall Study|Protocol Violation|0|||
161340128|NCT00042289|582633416|FG012|Overall Study|Protocol Violation|0|||
161340129|NCT00042289|582633417|FG013|Overall Study|Protocol Violation|0|||
161340130|NCT00042289|582633418|FG014|Overall Study|Protocol Violation|0|||
161340131|NCT00042289|582633419|FG015|Overall Study|Protocol Violation|0|||
161340132|NCT00042289|582633420|FG016|Overall Study|Protocol Violation|0|||
161340133|NCT00042289|582633421|FG017|Overall Study|Protocol Violation|0|||
161340134|NCT00042289|582633422|FG018|Overall Study|Protocol Violation|0|||
161340135|NCT00042289|582633423|FG019|Overall Study|Protocol Violation|0|||
161340136|NCT00042289|582633424|FG020|Overall Study|Protocol Violation|0|||
161340137|NCT00042289|582633425|FG021|Overall Study|Protocol Violation|0|||
161340138|NCT00042289|582633426|FG022|Overall Study|Protocol Violation|0|||
161340139|NCT00042289|582633427|FG023|Overall Study|Protocol Violation|1|||
161340140|NCT00042289|582633428|FG024|Overall Study|Protocol Violation|1|||
161340141|NCT00042289|582633429|FG025|Overall Study|Protocol Violation|0|||
161340142|NCT00042289|582633430|FG026|Overall Study|Protocol Violation|2|||
161340143|NCT00042289|582633431|FG027|Overall Study|Protocol Violation|0|||
161340144|NCT00042289|582633432|FG028|Overall Study|Protocol Violation|0|||
161340145|NCT00042289|582633433|FG029|Overall Study|Protocol Violation|0|||
161340146|NCT00042289|582633434|FG030|Overall Study|Protocol Violation|1|||
161340147|NCT00042289|582633435|FG031|Overall Study|Protocol Violation|0|||
161340148|NCT00042289|582633436|FG032|Overall Study|Protocol Violation|0|||
161340149|NCT00042289|582633437|FG033|Overall Study|Protocol Violation|0|||
161340150|NCT00042289|582633438|FG034|Overall Study|Protocol Violation|0|||
161340151|NCT00042289|582633439|FG035|Overall Study|Protocol Violation|0|||
161340152|NCT00042289|582633440|FG036|Overall Study|Protocol Violation|0|||
161340153|NCT00042289|582633441|FG037|Overall Study|Protocol Violation|0|||
161340154|NCT00042289|582633442|FG038|Overall Study|Protocol Violation|0|||
161340155|NCT00042289|582633443|FG039|Overall Study|Protocol Violation|0|||
161340156|NCT00042289|582633444|FG040|Overall Study|Protocol Violation|0|||
161340157|NCT00042289|582633445|FG041|Overall Study|Protocol Violation|1|||
161340158|NCT00042289|582633446|FG042|Overall Study|Protocol Violation|1|||
161340159|NCT00042289|582633447|FG043|Overall Study|Protocol Violation|1|||
161340160|NCT00042289|582633448|FG044|Overall Study|Protocol Violation|0|||
161340161|NCT00042289|582633449|FG045|Overall Study|Protocol Violation|0|||
161340162|NCT00042289|582633450|FG046|Overall Study|Protocol Violation|0|||
161340163|NCT00042289|582633404|FG000|Overall Study|Withdrawal by Subject|4|||
161340164|NCT00042289|582633405|FG001|Overall Study|Withdrawal by Subject|1|||
161340165|NCT00042289|582633406|FG002|Overall Study|Withdrawal by Subject|0|||
161340166|NCT00042289|582633407|FG003|Overall Study|Withdrawal by Subject|2|||
161340167|NCT00042289|582633408|FG004|Overall Study|Withdrawal by Subject|0|||
161340168|NCT00042289|582633409|FG005|Overall Study|Withdrawal by Subject|2|||
161340169|NCT00042289|582633410|FG006|Overall Study|Withdrawal by Subject|0|||
161340170|NCT00042289|582633411|FG007|Overall Study|Withdrawal by Subject|0|||
161340171|NCT00042289|582633412|FG008|Overall Study|Withdrawal by Subject|0|||
161340172|NCT00042289|582633413|FG009|Overall Study|Withdrawal by Subject|1|||
161340173|NCT00042289|582633414|FG010|Overall Study|Withdrawal by Subject|0|||
161340174|NCT00042289|582633415|FG011|Overall Study|Withdrawal by Subject|0|||
161340175|NCT00042289|582633416|FG012|Overall Study|Withdrawal by Subject|2|||
161340176|NCT00042289|582633417|FG013|Overall Study|Withdrawal by Subject|0|||
161340177|NCT00042289|582633418|FG014|Overall Study|Withdrawal by Subject|0|||
161340178|NCT00042289|582633419|FG015|Overall Study|Withdrawal by Subject|0|||
161340179|NCT00042289|582633420|FG016|Overall Study|Withdrawal by Subject|0|||
161340180|NCT00042289|582633421|FG017|Overall Study|Withdrawal by Subject|0|||
161340181|NCT00042289|582633422|FG018|Overall Study|Withdrawal by Subject|0|||
161340182|NCT00042289|582633423|FG019|Overall Study|Withdrawal by Subject|0|||
161340183|NCT00042289|582633424|FG020|Overall Study|Withdrawal by Subject|0|||
161340184|NCT00042289|582633425|FG021|Overall Study|Withdrawal by Subject|1|||
161340185|NCT00042289|582633426|FG022|Overall Study|Withdrawal by Subject|1|||
161340186|NCT00042289|582633427|FG023|Overall Study|Withdrawal by Subject|1|||
161340187|NCT00042289|582633428|FG024|Overall Study|Withdrawal by Subject|0|||
161340188|NCT00042289|582633429|FG025|Overall Study|Withdrawal by Subject|0|||
161340189|NCT00042289|582633430|FG026|Overall Study|Withdrawal by Subject|1|||
161340190|NCT00042289|582633431|FG027|Overall Study|Withdrawal by Subject|0|||
161340191|NCT00042289|582633432|FG028|Overall Study|Withdrawal by Subject|2|||
161340192|NCT00042289|582633433|FG029|Overall Study|Withdrawal by Subject|0|||
161340193|NCT00042289|582633434|FG030|Overall Study|Withdrawal by Subject|0|||
161340194|NCT00042289|582633435|FG031|Overall Study|Withdrawal by Subject|1|||
161340195|NCT00042289|582633436|FG032|Overall Study|Withdrawal by Subject|2|||
161340196|NCT00042289|582633437|FG033|Overall Study|Withdrawal by Subject|1|||
161340197|NCT00042289|582633438|FG034|Overall Study|Withdrawal by Subject|0|||
161340198|NCT00042289|582633439|FG035|Overall Study|Withdrawal by Subject|0|||
161340199|NCT00042289|582633440|FG036|Overall Study|Withdrawal by Subject|0|||
161340200|NCT00042289|582633441|FG037|Overall Study|Withdrawal by Subject|1|||
161340201|NCT00042289|582633442|FG038|Overall Study|Withdrawal by Subject|0|||
161340202|NCT00042289|582633443|FG039|Overall Study|Withdrawal by Subject|0|||
161340203|NCT00042289|582633444|FG040|Overall Study|Withdrawal by Subject|0|||
161340204|NCT00042289|582633445|FG041|Overall Study|Withdrawal by Subject|0|||
161340205|NCT00042289|582633446|FG042|Overall Study|Withdrawal by Subject|1|||
161340206|NCT00042289|582633447|FG043|Overall Study|Withdrawal by Subject|0|||
161340207|NCT00042289|582633448|FG044|Overall Study|Withdrawal by Subject|0|||
161340208|NCT00042289|582633449|FG045|Overall Study|Withdrawal by Subject|0|||
161340209|NCT00042289|582633450|FG046|Overall Study|Withdrawal by Subject|0|||
161340210|NCT01171534|582633454|FG000|Overall Study|Lost to Follow-up|0|||
161340211|NCT01171534|582633455|FG001|Overall Study|Lost to Follow-up|2|||
161340212|NCT01171534|582633454|FG000|Overall Study|screen failure|0|||
161340213|NCT01171534|582633455|FG001|Overall Study|screen failure|1|||
161340214|NCT00548327|582633457|FG000|Overall Study|Adverse Event|0|||
161340215|NCT00548327|582633458|FG001|Overall Study|Adverse Event|1|||
161340216|NCT01673386|582633459|FG000|Overall Study|Study terminated by sponsor|16|||
161340217|NCT01673386|582633460|FG001|Overall Study|Study terminated by sponsor|22|||
161340218|NCT01673386|582633459|FG000|Overall Study|Adverse Event|5|||
161340219|NCT01673386|582633460|FG001|Overall Study|Adverse Event|2|||
161340220|NCT01673386|582633459|FG000|Overall Study|Progressive disease|4|||
161340221|NCT01673386|582633460|FG001|Overall Study|Progressive disease|1|||
161340222|NCT01673386|582633459|FG000|Overall Study|Withdrawal by Subject|0|||
161340223|NCT01673386|582633460|FG001|Overall Study|Withdrawal by Subject|2|||
161340224|NCT00274456|582633461|FG000|Overall Study|Still on treatment|2|||
161340225|NCT00274456|582633462|FG001|Overall Study|Still on treatment|3|||
161340226|NCT00274456|582633463|FG002|Overall Study|Still on treatment|5|||
161340227|NCT00274456|582633464|FG003|Overall Study|Still on treatment|1|||
161340228|NCT00274456|582633461|FG000|Overall Study|Unacceptable toxicity|10|||
161340229|NCT00274456|582633462|FG001|Overall Study|Unacceptable toxicity|5|||
161340230|NCT00274456|582633463|FG002|Overall Study|Unacceptable toxicity|12|||
161340231|NCT00274456|582633464|FG003|Overall Study|Unacceptable toxicity|16|||
161340232|NCT00274456|582633461|FG000|Overall Study|Adverse Event|0|||
161340233|NCT00274456|582633462|FG001|Overall Study|Adverse Event|1|||
161340234|NCT00274456|582633463|FG002|Overall Study|Adverse Event|2|||
161340235|NCT00274456|582633464|FG003|Overall Study|Adverse Event|2|||
161340236|NCT00274456|582633461|FG000|Overall Study|Physician Decision|7|||
161340237|NCT00274456|582633462|FG001|Overall Study|Physician Decision|5|||
161340238|NCT00274456|582633463|FG002|Overall Study|Physician Decision|6|||
161340239|NCT00274456|582633464|FG003|Overall Study|Physician Decision|13|||
161340240|NCT00274456|582633461|FG000|Overall Study|Lost to Follow-up|0|||
161340241|NCT00274456|582633462|FG001|Overall Study|Lost to Follow-up|0|||
161340242|NCT00274456|582633463|FG002|Overall Study|Lost to Follow-up|1|||
161340243|NCT00274456|582633464|FG003|Overall Study|Lost to Follow-up|0|||
161340244|NCT00274456|582633461|FG000|Overall Study|Withdrawal by Subject|18|||
161340245|NCT00274456|582633462|FG001|Overall Study|Withdrawal by Subject|13|||
161340246|NCT00274456|582633463|FG002|Overall Study|Withdrawal by Subject|9|||
161340247|NCT00274456|582633464|FG003|Overall Study|Withdrawal by Subject|13|||
160917939|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
160917940|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
161142680|NCT03519178|581906200|FG012|Letrozole Treatment|Physician Decision|0|||
161340248|NCT04460885|582633469|FG000|Overall Study|Withdrawal by Subject|6|||
161340249|NCT04460885|582633470|FG001|Overall Study|Withdrawal by Subject|8|||
161340250|NCT04460885|582633469|FG000|Overall Study|Site closure|1|||
161340251|NCT04460885|582633470|FG001|Overall Study|Site closure|0|||
161340252|NCT04460885|582633469|FG000|Overall Study|Death|5|||
161340253|NCT04460885|582633470|FG001|Overall Study|Death|4|||
161340254|NCT04460885|582633469|FG000|Overall Study|Physician Decision|2|||
161340255|NCT04460885|582633470|FG001|Overall Study|Physician Decision|1|||
160917941|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
161340256|NCT04460885|582633469|FG000|Overall Study|Lost to Follow-up|4|||
160917942|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
160917943|NCT00293254|581094150|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
160917944|NCT00293254|581094151|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
160917945|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
160917946|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
160917947|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Death|4|||
160917948|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Death|1|||
160917949|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
160917950|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
160917951|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
160917952|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
160917953|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
160917954|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
160996831|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996832|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996833|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
160996834|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
160996835|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
160996836|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
160996837|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996838|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996839|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
160996840|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996841|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996842|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996843|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996844|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996845|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
160996846|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
160996847|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
160996848|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
160996849|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996850|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996851|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
160996852|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996853|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996854|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996855|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
161257898|NCT03756883|582323520|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
161257899|NCT03756883|582323518|FG000|Overall Study|Withdrawal by Subject|4|||
161257900|NCT03756883|582323519|FG001|Overall Study|Withdrawal by Subject|1|||
161257901|NCT03756883|582323520|FG002|Overall Study|Withdrawal by Subject|0|||
161257902|NCT03756883|582323518|FG000|Overall Study|Other Reasons|2|||
161257903|NCT03756883|582323519|FG001|Overall Study|Other Reasons|4|||
161257904|NCT03756883|582323520|FG002|Overall Study|Other Reasons|0|||
161257905|NCT01463982|582323521|FG000|Overall Study|Withdrawal by Subject|0|||
161257906|NCT01463982|582323522|FG001|Overall Study|Withdrawal by Subject|1|||
161257907|NCT01463982|582323523|FG002|Overall Study|Withdrawal by Subject|1|||
161257908|NCT01463982|582323524|FG003|Overall Study|Withdrawal by Subject|0|||
161257909|NCT01463982|582323521|FG000|Overall Study|Treatment delay over 5 week|0|||
161257910|NCT01463982|582323522|FG001|Overall Study|Treatment delay over 5 week|0|||
161257911|NCT01463982|582323523|FG002|Overall Study|Treatment delay over 5 week|1|||
161257912|NCT01463982|582323524|FG003|Overall Study|Treatment delay over 5 week|0|||
161257913|NCT04668274|582323525|FG000|Part 1 Study Period 1|Adverse Event|3|||
161257914|NCT04668274|582323526|FG001|Part 1 Study Period 1|Adverse Event|0|||
161257915|NCT04668274|582323527|FG002|Part 1 Study Period 1|Adverse Event|0|||
160996856|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996857|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
160996858|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996859|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
160996860|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996861|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996862|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996863|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
160996864|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996865|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996866|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996867|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996868|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996869|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
160996870|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996871|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
160996872|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
161340257|NCT04460885|582633470|FG001|Overall Study|Lost to Follow-up|4|||
161340258|NCT02100631|582633474|FG000|Overall Study|Withdrawal by Subject|1|||
161340259|NCT02100631|582633475|FG001|Overall Study|Withdrawal by Subject|0|||
161340260|NCT02100631|582633476|FG002|Overall Study|Withdrawal by Subject|0|||
161340261|NCT02100631|582633474|FG000|Overall Study|Lost to Follow-up|3|||
161340262|NCT02100631|582633475|FG001|Overall Study|Lost to Follow-up|4|||
161340263|NCT02100631|582633476|FG002|Overall Study|Lost to Follow-up|0|||
161340264|NCT02100631|582633474|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
161340265|NCT02100631|582633475|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
161340266|NCT02100631|582633476|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
161340267|NCT00336544|582633477|FG000|Overall Study|Lack of Efficacy|8|||
161340268|NCT00336544|582633478|FG001|Overall Study|Lack of Efficacy|5|||
161340269|NCT00336544|582633477|FG000|Overall Study|Adverse Event|4|||
161340270|NCT00336544|582633478|FG001|Overall Study|Adverse Event|9|||
161340271|NCT00336544|582633477|FG000|Overall Study|Withdrawal by Subject|4|||
160917955|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
160917956|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
160917957|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
160917958|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
160917959|NCT00293254|581094150|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
160917960|NCT00293254|581094151|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
160917961|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
160917962|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
160917963|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
160917964|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
161340272|NCT00336544|582633478|FG001|Overall Study|Withdrawal by Subject|3|||
160917965|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
160917966|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
160917967|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
160917968|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
160917969|NCT00293254|581094150|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
160917970|NCT00293254|581094151|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
160917971|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
160917972|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
160917973|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
160917974|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
160917975|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
160917976|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
160917977|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
160917978|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
160917979|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
160917980|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
160917981|NCT00293254|581094150|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
160917982|NCT00293254|581094151|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
160917983|NCT00082355|581094152|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
160917984|NCT00082355|581094152|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
160917985|NCT00082355|581094152|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
160917986|NCT00531050|581094154|FG000|Part 1: Period 1|Adverse Event|0|||
160917987|NCT00531050|581094155|FG001|Part 1: Period 1|Adverse Event|1|||
160917988|NCT00531050|581094156|FG002|Part 1: Period 1|Adverse Event|0|||
160917989|NCT00531050|581094157|FG003|Part 1: Period 1|Adverse Event|0|||
160917990|NCT00531050|581094158|FG004|Part 1: Period 1|Adverse Event|0|||
160917991|NCT00531050|581094159|FG005|Part 1: Period 1|Adverse Event|0|||
160917992|NCT00531050|581094154|FG000|Part 1: Period 1|Protocol Deviation|0|||
160917993|NCT00531050|581094155|FG001|Part 1: Period 1|Protocol Deviation|0|||
160917994|NCT00531050|581094156|FG002|Part 1: Period 1|Protocol Deviation|0|||
160917995|NCT00531050|581094157|FG003|Part 1: Period 1|Protocol Deviation|1|||
160917996|NCT00531050|581094158|FG004|Part 1: Period 1|Protocol Deviation|0|||
160917997|NCT00531050|581094159|FG005|Part 1: Period 1|Protocol Deviation|0|||
160917998|NCT00531050|581094154|FG000|Part 1: Period 3|Adverse Event|1|||
160917999|NCT00531050|581094155|FG001|Part 1: Period 3|Adverse Event|0|||
160918000|NCT00531050|581094156|FG002|Part 1: Period 3|Adverse Event|0|||
160918001|NCT00531050|581094157|FG003|Part 1: Period 3|Adverse Event|0|||
161340273|NCT00336544|582633477|FG000|Overall Study|Other|3|||
161340274|NCT00336544|582633478|FG001|Overall Study|Other|5|||
161340275|NCT03427411|582633479|FG000|Overall Study|Screen failure - platelets too low|0|||
160918002|NCT00531050|581094158|FG004|Part 1: Period 3|Adverse Event|0|||
160996873|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996874|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160918003|NCT00531050|581094159|FG005|Part 1: Period 3|Adverse Event|0|||
161340276|NCT03427411|582633480|FG001|Overall Study|Screen failure - platelets too low|1|||
161340277|NCT00903968|582633481|FG000|Overall Study|Adverse Event|0|||
161340278|NCT00903968|582633482|FG001|Overall Study|Adverse Event|0|||
161340279|NCT00903968|582633483|FG002|Overall Study|Adverse Event|0|||
161340280|NCT00903968|582633484|FG003|Overall Study|Adverse Event|0|||
161340281|NCT00903968|582633485|FG004|Overall Study|Adverse Event|0|||
161340282|NCT00903968|582633486|FG005|Overall Study|Adverse Event|0|||
161340283|NCT00903968|582633487|FG006|Overall Study|Adverse Event|1|||
161340284|NCT00903968|582633488|FG007|Overall Study|Adverse Event|8|||
161340285|NCT00903968|582633481|FG000|Overall Study|DLT|0|||
161340286|NCT00903968|582633482|FG001|Overall Study|DLT|0|||
161340287|NCT00903968|582633483|FG002|Overall Study|DLT|0|||
161340288|NCT00903968|582633484|FG003|Overall Study|DLT|0|||
161340289|NCT00903968|582633485|FG004|Overall Study|DLT|0|||
161340290|NCT00903968|582633486|FG005|Overall Study|DLT|0|||
161340291|NCT00903968|582633487|FG006|Overall Study|DLT|2|||
161340292|NCT00903968|582633488|FG007|Overall Study|DLT|0|||
161340293|NCT00903968|582633481|FG000|Overall Study|Withdrawal by Subject|1|||
161340294|NCT00903968|582633482|FG001|Overall Study|Withdrawal by Subject|0|||
161340295|NCT00903968|582633483|FG002|Overall Study|Withdrawal by Subject|1|||
161340296|NCT00903968|582633484|FG003|Overall Study|Withdrawal by Subject|0|||
161340297|NCT00903968|582633485|FG004|Overall Study|Withdrawal by Subject|1|||
161340298|NCT00903968|582633486|FG005|Overall Study|Withdrawal by Subject|1|||
161340299|NCT00903968|582633487|FG006|Overall Study|Withdrawal by Subject|0|||
161340300|NCT00903968|582633488|FG007|Overall Study|Withdrawal by Subject|4|||
161340301|NCT00903968|582633481|FG000|Overall Study|Non-Compliance|0|||
161340302|NCT00903968|582633482|FG001|Overall Study|Non-Compliance|0|||
161340303|NCT00903968|582633483|FG002|Overall Study|Non-Compliance|0|||
161340304|NCT00903968|582633484|FG003|Overall Study|Non-Compliance|0|||
161340305|NCT00903968|582633485|FG004|Overall Study|Non-Compliance|0|||
161340306|NCT00903968|582633486|FG005|Overall Study|Non-Compliance|1|||
161340307|NCT00903968|582633487|FG006|Overall Study|Non-Compliance|0|||
161340308|NCT00903968|582633488|FG007|Overall Study|Non-Compliance|0|||
161340309|NCT00903968|582633481|FG000|Overall Study|Physician Decision|0|||
161340310|NCT00903968|582633482|FG001|Overall Study|Physician Decision|0|||
161340311|NCT00903968|582633483|FG002|Overall Study|Physician Decision|0|||
161340312|NCT00903968|582633484|FG003|Overall Study|Physician Decision|0|||
161340313|NCT00903968|582633485|FG004|Overall Study|Physician Decision|0|||
161340314|NCT00903968|582633486|FG005|Overall Study|Physician Decision|1|||
161340315|NCT00903968|582633487|FG006|Overall Study|Physician Decision|0|||
161340316|NCT00903968|582633488|FG007|Overall Study|Physician Decision|0|||
161340317|NCT00903968|582633481|FG000|Overall Study|Progressive Disease|2|||
161340318|NCT00903968|582633482|FG001|Overall Study|Progressive Disease|3|||
161340319|NCT00903968|582633483|FG002|Overall Study|Progressive Disease|2|||
161340320|NCT00903968|582633484|FG003|Overall Study|Progressive Disease|3|||
161340321|NCT00903968|582633485|FG004|Overall Study|Progressive Disease|3|||
161340322|NCT00903968|582633486|FG005|Overall Study|Progressive Disease|3|||
161340323|NCT00903968|582633487|FG006|Overall Study|Progressive Disease|0|||
161340324|NCT00903968|582633488|FG007|Overall Study|Progressive Disease|18|||
161340325|NCT00903968|582633481|FG000|Overall Study|Lack of Efficacy|0|||
161340326|NCT00903968|582633482|FG001|Overall Study|Lack of Efficacy|0|||
161340327|NCT00903968|582633483|FG002|Overall Study|Lack of Efficacy|0|||
161340328|NCT00903968|582633484|FG003|Overall Study|Lack of Efficacy|0|||
161142681|NCT03519178|581906201|FG013|Letrozole Treatment|Physician Decision|0|||
161142682|NCT03519178|581906202|FG014|Letrozole Treatment|Physician Decision|0|||
161142683|NCT03519178|581906188|FG000|Letrozole Treatment|Progressive disease|0|||
161142684|NCT03519178|581906189|FG001|Letrozole Treatment|Progressive disease|0|||
161142685|NCT03519178|581906190|FG002|Letrozole Treatment|Progressive disease|0|||
161142686|NCT03519178|581906191|FG003|Letrozole Treatment|Progressive disease|0|||
161142687|NCT03519178|581906192|FG004|Letrozole Treatment|Progressive disease|0|||
161142688|NCT03519178|581906193|FG005|Letrozole Treatment|Progressive disease|0|||
161142689|NCT03519178|581906194|FG006|Letrozole Treatment|Progressive disease|0|||
161142690|NCT03519178|581906195|FG007|Letrozole Treatment|Progressive disease|0|||
161142691|NCT03519178|581906196|FG008|Letrozole Treatment|Progressive disease|0|||
161142692|NCT03519178|581906197|FG009|Letrozole Treatment|Progressive disease|0|||
161142693|NCT03519178|581906198|FG010|Letrozole Treatment|Progressive disease|4|||
161340329|NCT00903968|582633485|FG004|Overall Study|Lack of Efficacy|0|||
161340330|NCT00903968|582633486|FG005|Overall Study|Lack of Efficacy|0|||
161340331|NCT00903968|582633487|FG006|Overall Study|Lack of Efficacy|0|||
161340332|NCT00903968|582633488|FG007|Overall Study|Lack of Efficacy|3|||
161340333|NCT01294046|582633489|FG000|Overall Study|Infection and surgical explant|1|||
161142694|NCT03519178|581906199|FG011|Letrozole Treatment|Progressive disease|0|||
161340334|NCT01294046|582633489|FG000|Overall Study|Eligibility criteria expanded|1|||
161340335|NCT01294046|582633489|FG000|Overall Study|Stimulation response inadqequate|1|||
161340336|NCT02690727|582633497|FG000|Overall Study|Adverse Event|2|||
161340337|NCT02690727|582633498|FG001|Overall Study|Adverse Event|2|||
161340338|NCT00091819|582633499|FG000|Overall Study|Adverse Event|1|||
161340339|NCT00091819|582633500|FG001|Overall Study|Adverse Event|1|||
161340340|NCT00091819|582633499|FG000|Overall Study|Death|4|||
161340341|NCT00091819|582633500|FG001|Overall Study|Death|5|||
161340342|NCT00091819|582633499|FG000|Overall Study|Lost to Follow-up|26|||
161340343|NCT00091819|582633500|FG001|Overall Study|Lost to Follow-up|23|||
161340344|NCT00091819|582633499|FG000|Overall Study|Withdrawal by Subject|5|||
161340345|NCT00091819|582633500|FG001|Overall Study|Withdrawal by Subject|8|||
161340346|NCT00091819|582633499|FG000|Overall Study|Protocol Violation|1|||
161340347|NCT00091819|582633500|FG001|Overall Study|Protocol Violation|2|||
161340348|NCT00091819|582633499|FG000|Overall Study|Other|2|||
161340349|NCT00091819|582633500|FG001|Overall Study|Other|3|||
161340350|NCT00091819|582633499|FG000|Overall Study|Never received study treatment|3|||
161340351|NCT00091819|582633500|FG001|Overall Study|Never received study treatment|4|||
161340352|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
161340353|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
161340354|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
161340355|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
161340356|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
161340357|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
161340358|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
161340359|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
161340360|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
161340361|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
161340362|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Death|3|||
161340363|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Death|1|||
161340364|NCT01056276|582633501|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
161340365|NCT01056276|582633502|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
161340366|NCT01056276|582633501|FG000|Maintenance Therapy|Toxicity|0|||
161340367|NCT01056276|582633502|FG001|Maintenance Therapy|Toxicity|2|||
161340368|NCT01056276|582633501|FG000|Maintenance Therapy|Progressive Disease|0|||
161340369|NCT01056276|582633502|FG001|Maintenance Therapy|Progressive Disease|9|||
161340370|NCT01056276|582633501|FG000|Maintenance Therapy|Physician Decision|0|||
161340371|NCT01056276|582633502|FG001|Maintenance Therapy|Physician Decision|1|||
161340372|NCT01056276|582633501|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
161340373|NCT01056276|582633502|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
161340374|NCT01056276|582633501|FG000|Maintenance Therapy|Intercurrent Illness|0|||
161340375|NCT01056276|582633502|FG001|Maintenance Therapy|Intercurrent Illness|1|||
161340376|NCT01056276|582633501|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
161340377|NCT01056276|582633502|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
161340378|NCT01859741|582633503|FG000|Overall Study|Death|3|||
161340379|NCT01859741|582633504|FG001|Overall Study|Death|2|||
161340380|NCT01859741|582633505|FG002|Overall Study|Death|4|||
161340381|NCT01859741|582633506|FG003|Overall Study|Death|3|||
161340382|NCT01859741|582633507|FG004|Overall Study|Death|5|||
161340383|NCT01859741|582633508|FG005|Overall Study|Death|4|||
161340384|NCT01859741|582633509|FG006|Overall Study|Death|51|||
161340385|NCT01859741|582633510|FG007|Overall Study|Death|51|||
161340386|NCT01859741|582633503|FG000|Overall Study|Lost to Follow-up|0|||
161340387|NCT01859741|582633504|FG001|Overall Study|Lost to Follow-up|0|||
161340388|NCT01859741|582633505|FG002|Overall Study|Lost to Follow-up|0|||
161340389|NCT01859741|582633506|FG003|Overall Study|Lost to Follow-up|0|||
161340390|NCT01859741|582633507|FG004|Overall Study|Lost to Follow-up|0|||
161340391|NCT01859741|582633508|FG005|Overall Study|Lost to Follow-up|1|||
161340392|NCT01859741|582633509|FG006|Overall Study|Lost to Follow-up|0|||
161340393|NCT01859741|582633510|FG007|Overall Study|Lost to Follow-up|4|||
161340394|NCT01859741|582633503|FG000|Overall Study|Withdrawal by Subject|0|||
161340395|NCT01859741|582633504|FG001|Overall Study|Withdrawal by Subject|1|||
161340396|NCT01859741|582633505|FG002|Overall Study|Withdrawal by Subject|2|||
161340397|NCT01859741|582633506|FG003|Overall Study|Withdrawal by Subject|0|||
161340398|NCT01859741|582633507|FG004|Overall Study|Withdrawal by Subject|0|||
161340399|NCT01859741|582633508|FG005|Overall Study|Withdrawal by Subject|1|||
161340400|NCT01859741|582633509|FG006|Overall Study|Withdrawal by Subject|1|||
161340401|NCT01859741|582633510|FG007|Overall Study|Withdrawal by Subject|1|||
161340402|NCT01859741|582633503|FG000|Overall Study|Study Terminated by Sponsor|0|||
161340403|NCT01859741|582633504|FG001|Overall Study|Study Terminated by Sponsor|0|||
161340404|NCT01859741|582633505|FG002|Overall Study|Study Terminated by Sponsor|0|||
161340405|NCT01859741|582633506|FG003|Overall Study|Study Terminated by Sponsor|0|||
161340406|NCT01859741|582633507|FG004|Overall Study|Study Terminated by Sponsor|1|||
161340407|NCT01859741|582633508|FG005|Overall Study|Study Terminated by Sponsor|0|||
161340408|NCT01859741|582633509|FG006|Overall Study|Study Terminated by Sponsor|16|||
161340409|NCT01859741|582633510|FG007|Overall Study|Study Terminated by Sponsor|14|||
161340410|NCT01859741|582633503|FG000|Overall Study|Other|0|||
161340411|NCT01859741|582633504|FG001|Overall Study|Other|0|||
161340412|NCT01859741|582633505|FG002|Overall Study|Other|0|||
161340413|NCT01859741|582633506|FG003|Overall Study|Other|0|||
161340414|NCT01859741|582633507|FG004|Overall Study|Other|0|||
161340415|NCT01859741|582633508|FG005|Overall Study|Other|0|||
161340416|NCT01859741|582633509|FG006|Overall Study|Other|2|||
161340417|NCT01859741|582633510|FG007|Overall Study|Other|0|||
161340418|NCT02606253|582633511|FG000|Overall Study|Adverse Event|2|||
161340419|NCT02606253|582633512|FG001|Overall Study|Adverse Event|0|||
161340420|NCT02606253|582633513|FG002|Overall Study|Adverse Event|0|||
161340421|NCT02606253|582633511|FG000|Overall Study|Protocol Violation|2|||
161340422|NCT02606253|582633512|FG001|Overall Study|Protocol Violation|1|||
161340423|NCT02606253|582633513|FG002|Overall Study|Protocol Violation|0|||
161340424|NCT02606253|582633511|FG000|Overall Study|Physician Decision|1|||
161340425|NCT02606253|582633512|FG001|Overall Study|Physician Decision|1|||
161340426|NCT02606253|582633513|FG002|Overall Study|Physician Decision|0|||
161340427|NCT00701363|582633514|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
161340428|NCT00701363|582633515|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161340429|NCT00701363|582633516|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161340430|NCT00701363|582633517|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
161340431|NCT00701363|582633514|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
161340432|NCT00701363|582633515|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
161340433|NCT00701363|582633516|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
161340434|NCT00701363|582633517|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
161340435|NCT00701363|582633514|FG000|Treatment Phase 1|Adverse Event|7|||
161340436|NCT00701363|582633515|FG001|Treatment Phase 1|Adverse Event|0|||
161340437|NCT00701363|582633516|FG002|Treatment Phase 1|Adverse Event|0|||
161340438|NCT00701363|582633517|FG003|Treatment Phase 1|Adverse Event|0|||
161340439|NCT00701363|582633514|FG000|Treatment Phase 1|Protocol Violation|1|||
161340440|NCT00701363|582633515|FG001|Treatment Phase 1|Protocol Violation|0|||
161340441|NCT00701363|582633516|FG002|Treatment Phase 1|Protocol Violation|0|||
161340442|NCT00701363|582633517|FG003|Treatment Phase 1|Protocol Violation|0|||
161340443|NCT00701363|582633514|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
161340444|NCT00701363|582633515|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
161340445|NCT00701363|582633516|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
161340446|NCT00701363|582633517|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
161340447|NCT00701363|582633514|FG000|Treatment Phase 1|Lack of Efficacy|1|||
161340448|NCT00701363|582633515|FG001|Treatment Phase 1|Lack of Efficacy|0|||
161340449|NCT00701363|582633516|FG002|Treatment Phase 1|Lack of Efficacy|0|||
161340450|NCT00701363|582633517|FG003|Treatment Phase 1|Lack of Efficacy|0|||
161340451|NCT00701363|582633514|FG000|Treatment Phase 2|Adverse Event|0|||
161340452|NCT00701363|582633515|FG001|Treatment Phase 2|Adverse Event|0|||
161340453|NCT00701363|582633516|FG002|Treatment Phase 2|Adverse Event|1|||
161340454|NCT00701363|582633517|FG003|Treatment Phase 2|Adverse Event|0|||
161340455|NCT00701363|582633514|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
161340456|NCT00701363|582633515|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
161340457|NCT00701363|582633516|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
161340458|NCT00701363|582633517|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
161340459|NCT03426878|582633518|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
161340460|NCT03426878|582633518|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
161340461|NCT03426878|582633518|FG000|Overall Study|Declined to receive results|3|||
161340462|NCT03426878|582633518|FG000|Overall Study|Received negative results by mailed letter|65|||
161340463|NCT03426878|582633518|FG000|Overall Study|Lost to Follow-up|177|||
161340464|NCT00746551|582633525|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
161340465|NCT00746551|582633526|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
161340466|NCT00746551|582633525|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
161340467|NCT00746551|582633526|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
161340468|NCT00746551|582633525|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
161340469|NCT00746551|582633526|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
161340470|NCT00262925|582633529|FG000|Overall Study|Lack of Efficacy|3|||
161340471|NCT00262925|582633529|FG000|Overall Study|Adverse Event|4|||
161340472|NCT00262925|582633529|FG000|Overall Study|Death|2|||
161340473|NCT00262925|582633529|FG000|Overall Study|alternative therapy|1|||
161340474|NCT00262925|582633529|FG000|Overall Study|Other|1|||
161340475|NCT04682301|582633531|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
161340476|NCT04682301|582633531|FG000|Overall Study|Death|2|||
161340477|NCT00560404|582633532|FG000|Overall Study|Adverse Event|2|||
160996875|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
160996876|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996877|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996878|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996879|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161340478|NCT00560404|582633533|FG001|Overall Study|Adverse Event|3|||
161340479|NCT00560404|582633532|FG000|Overall Study|Death|3|||
161340480|NCT00560404|582633533|FG001|Overall Study|Death|3|||
161340481|NCT00560404|582633532|FG000|Overall Study|Protocol Violation|12|||
161340482|NCT00560404|582633533|FG001|Overall Study|Protocol Violation|7|||
161340483|NCT00560404|582633532|FG000|Overall Study|Administrative Reasons|1|||
161340484|NCT00560404|582633533|FG001|Overall Study|Administrative Reasons|1|||
161340485|NCT00560404|582633532|FG000|Overall Study|Withdrew Consent|4|||
160996880|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161340486|NCT00560404|582633533|FG001|Overall Study|Withdrew Consent|0|||
161340487|NCT00560404|582633532|FG000|Overall Study|Failure to return|1|||
161340488|NCT00560404|582633533|FG001|Overall Study|Failure to return|2|||
161142695|NCT03519178|581906200|FG012|Letrozole Treatment|Progressive disease|0|||
161142696|NCT03519178|581906201|FG013|Letrozole Treatment|Progressive disease|0|||
161142697|NCT03519178|581906202|FG014|Letrozole Treatment|Progressive disease|0|||
161142698|NCT03519178|581906188|FG000|Letrozole Treatment|Global deterioration of health status|0|||
161142699|NCT03519178|581906189|FG001|Letrozole Treatment|Global deterioration of health status|0|||
161142700|NCT03519178|581906190|FG002|Letrozole Treatment|Global deterioration of health status|0|||
161142701|NCT03519178|581906191|FG003|Letrozole Treatment|Global deterioration of health status|0|||
161142702|NCT03519178|581906192|FG004|Letrozole Treatment|Global deterioration of health status|0|||
161142703|NCT03519178|581906193|FG005|Letrozole Treatment|Global deterioration of health status|0|||
161142704|NCT03519178|581906194|FG006|Letrozole Treatment|Global deterioration of health status|0|||
161142705|NCT03519178|581906195|FG007|Letrozole Treatment|Global deterioration of health status|0|||
161142706|NCT03519178|581906196|FG008|Letrozole Treatment|Global deterioration of health status|0|||
161142707|NCT03519178|581906197|FG009|Letrozole Treatment|Global deterioration of health status|0|||
161142708|NCT03519178|581906198|FG010|Letrozole Treatment|Global deterioration of health status|2|||
161142709|NCT03519178|581906199|FG011|Letrozole Treatment|Global deterioration of health status|0|||
161142710|NCT03519178|581906200|FG012|Letrozole Treatment|Global deterioration of health status|0|||
161142711|NCT03519178|581906201|FG013|Letrozole Treatment|Global deterioration of health status|0|||
161142712|NCT03519178|581906202|FG014|Letrozole Treatment|Global deterioration of health status|0|||
161142713|NCT03519178|581906188|FG000|Follow-Up|Death|0|||
161142714|NCT03519178|581906189|FG001|Follow-Up|Death|0|||
161142715|NCT03519178|581906190|FG002|Follow-Up|Death|0|||
161142716|NCT03519178|581906191|FG003|Follow-Up|Death|0|||
161142717|NCT03519178|581906192|FG004|Follow-Up|Death|0|||
161142718|NCT03519178|581906193|FG005|Follow-Up|Death|0|||
161142719|NCT03519178|581906194|FG006|Follow-Up|Death|0|||
161142720|NCT03519178|581906195|FG007|Follow-Up|Death|0|||
161142721|NCT03519178|581906196|FG008|Follow-Up|Death|3|||
161142722|NCT03519178|581906197|FG009|Follow-Up|Death|1|||
161142723|NCT03519178|581906198|FG010|Follow-Up|Death|0|||
161142724|NCT03519178|581906199|FG011|Follow-Up|Death|0|||
161142725|NCT03519178|581906200|FG012|Follow-Up|Death|2|||
161142726|NCT03519178|581906201|FG013|Follow-Up|Death|0|||
161142727|NCT03519178|581906202|FG014|Follow-Up|Death|0|||
161142728|NCT03519178|581906188|FG000|Follow-Up|Lost to Follow-up|0|||
161142729|NCT03519178|581906189|FG001|Follow-Up|Lost to Follow-up|0|||
161142730|NCT03519178|581906190|FG002|Follow-Up|Lost to Follow-up|0|||
161142731|NCT03519178|581906191|FG003|Follow-Up|Lost to Follow-up|0|||
161142732|NCT03519178|581906192|FG004|Follow-Up|Lost to Follow-up|0|||
161142733|NCT03519178|581906193|FG005|Follow-Up|Lost to Follow-up|3|||
161142734|NCT03519178|581906194|FG006|Follow-Up|Lost to Follow-up|1|||
161142735|NCT03519178|581906195|FG007|Follow-Up|Lost to Follow-up|4|||
161142736|NCT03519178|581906196|FG008|Follow-Up|Lost to Follow-up|1|||
161142737|NCT03519178|581906197|FG009|Follow-Up|Lost to Follow-up|0|||
161142738|NCT03519178|581906198|FG010|Follow-Up|Lost to Follow-up|0|||
160918004|NCT00531050|581094154|FG000|Part 2: Period 1|Adverse Event|0|||
160918005|NCT00531050|581094155|FG001|Part 2: Period 1|Adverse Event|0|||
160918006|NCT00531050|581094156|FG002|Part 2: Period 1|Adverse Event|0|||
160918007|NCT00531050|581094157|FG003|Part 2: Period 1|Adverse Event|0|||
160918008|NCT00531050|581094158|FG004|Part 2: Period 1|Adverse Event|0|||
160918009|NCT00531050|581094159|FG005|Part 2: Period 1|Adverse Event|1|||
160918010|NCT00531050|581094154|FG000|Part 2: Period 3|Abnormal test procedure|1|||
160918011|NCT00531050|581094155|FG001|Part 2: Period 3|Abnormal test procedure|0|||
160918012|NCT00531050|581094156|FG002|Part 2: Period 3|Abnormal test procedure|0|||
160918013|NCT00531050|581094157|FG003|Part 2: Period 3|Abnormal test procedure|0|||
160918014|NCT00531050|581094158|FG004|Part 2: Period 3|Abnormal test procedure|0|||
160918015|NCT00531050|581094159|FG005|Part 2: Period 3|Abnormal test procedure|1|||
160918016|NCT02233309|581094163|FG000|Overall Study|Physician Decision|5|||
160918017|NCT00475176|581094166|FG000|Overall Study|Adverse Event|2|||
160918018|NCT00475176|581094166|FG000|Overall Study|Withdrawal by Subject|1|||
160918019|NCT00475176|581094166|FG000|Overall Study|Protocol Violation|1|||
160918020|NCT01484873|581094167|FG000|Overall Study|Withdrawal by Subject|2|||
160918021|NCT01549392|581094168|FG000|Overall Study|Withdrawal by Subject|1|||
160918022|NCT01549392|581094169|FG001|Overall Study|Withdrawal by Subject|0|||
161142739|NCT03519178|581906199|FG011|Follow-Up|Lost to Follow-up|0|||
161142740|NCT03519178|581906200|FG012|Follow-Up|Lost to Follow-up|0|||
161142741|NCT03519178|581906201|FG013|Follow-Up|Lost to Follow-up|0|||
161142742|NCT03519178|581906202|FG014|Follow-Up|Lost to Follow-up|0|||
161142743|NCT03519178|581906188|FG000|Follow-Up|Withdrawal by Subject|1|||
161142744|NCT03519178|581906189|FG001|Follow-Up|Withdrawal by Subject|2|||
161142745|NCT03519178|581906190|FG002|Follow-Up|Withdrawal by Subject|2|||
161142746|NCT03519178|581906191|FG003|Follow-Up|Withdrawal by Subject|3|||
161142747|NCT03519178|581906192|FG004|Follow-Up|Withdrawal by Subject|5|||
161142748|NCT03519178|581906193|FG005|Follow-Up|Withdrawal by Subject|1|||
161142749|NCT03519178|581906194|FG006|Follow-Up|Withdrawal by Subject|2|||
161142750|NCT03519178|581906195|FG007|Follow-Up|Withdrawal by Subject|6|||
161142751|NCT03519178|581906196|FG008|Follow-Up|Withdrawal by Subject|5|||
161142752|NCT03519178|581906197|FG009|Follow-Up|Withdrawal by Subject|2|||
161142753|NCT03519178|581906198|FG010|Follow-Up|Withdrawal by Subject|3|||
161142754|NCT03519178|581906199|FG011|Follow-Up|Withdrawal by Subject|5|||
161142755|NCT03519178|581906200|FG012|Follow-Up|Withdrawal by Subject|2|||
161142756|NCT03519178|581906201|FG013|Follow-Up|Withdrawal by Subject|0|||
161142757|NCT03519178|581906202|FG014|Follow-Up|Withdrawal by Subject|0|||
161142758|NCT03519178|581906188|FG000|Follow-Up|Other|0|||
161142759|NCT03519178|581906189|FG001|Follow-Up|Other|0|||
161142760|NCT03519178|581906190|FG002|Follow-Up|Other|0|||
161142761|NCT03519178|581906191|FG003|Follow-Up|Other|0|||
161142762|NCT03519178|581906192|FG004|Follow-Up|Other|0|||
161142763|NCT03519178|581906193|FG005|Follow-Up|Other|0|||
161142764|NCT03519178|581906194|FG006|Follow-Up|Other|0|||
161142765|NCT03519178|581906195|FG007|Follow-Up|Other|1|||
161142766|NCT03519178|581906196|FG008|Follow-Up|Other|0|||
161142767|NCT03519178|581906197|FG009|Follow-Up|Other|0|||
161142768|NCT03519178|581906198|FG010|Follow-Up|Other|0|||
161142769|NCT03519178|581906199|FG011|Follow-Up|Other|0|||
161142770|NCT03519178|581906200|FG012|Follow-Up|Other|0|||
161142771|NCT03519178|581906201|FG013|Follow-Up|Other|0|||
161142772|NCT03519178|581906202|FG014|Follow-Up|Other|0|||
161257916|NCT04668274|582323528|FG003|Part 1 Study Period 1|Adverse Event|0|||
161257917|NCT04668274|582323525|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
161257918|NCT04668274|582323526|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
161257919|NCT04668274|582323527|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
161257920|NCT04668274|582323528|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
161257921|NCT04668274|582323525|FG000|Part 1 Study Period 2|Other|0|||
161257922|NCT04668274|582323526|FG001|Part 1 Study Period 2|Other|1|||
161257923|NCT04668274|582323527|FG002|Part 1 Study Period 2|Other|0|||
161257924|NCT04668274|582323528|FG003|Part 1 Study Period 2|Other|0|||
161257925|NCT04668274|582323525|FG000|Part 1 Study Period 3|Adverse Event|0|||
161257926|NCT04668274|582323526|FG001|Part 1 Study Period 3|Adverse Event|0|||
161257927|NCT04668274|582323527|FG002|Part 1 Study Period 3|Adverse Event|1|||
161257928|NCT04668274|582323528|FG003|Part 1 Study Period 3|Adverse Event|0|||
161257929|NCT04668274|582323525|FG000|Part 1 Study Period 3|Other|0|||
161257930|NCT04668274|582323526|FG001|Part 1 Study Period 3|Other|0|||
161257931|NCT04668274|582323527|FG002|Part 1 Study Period 3|Other|2|||
161257932|NCT04668274|582323528|FG003|Part 1 Study Period 3|Other|0|||
161257933|NCT04668274|582323525|FG000|Part 2 Study Period 4|Other|0|||
161257934|NCT04668274|582323526|FG001|Part 2 Study Period 4|Other|0|||
161257935|NCT04668274|582323527|FG002|Part 2 Study Period 4|Other|0|||
161257936|NCT04668274|582323528|FG003|Part 2 Study Period 4|Other|1|||
161257937|NCT00939627|582323535|FG000|Overall Study|Disease Progression|16|||
161257938|NCT00939627|582323536|FG001|Overall Study|Disease Progression|12|||
161257939|NCT00939627|582323537|FG002|Overall Study|Disease Progression|0|||
161257940|NCT00939627|582323535|FG000|Overall Study|Adverse Event|6|||
161257941|NCT00939627|582323536|FG001|Overall Study|Adverse Event|7|||
161257942|NCT00939627|582323537|FG002|Overall Study|Adverse Event|0|||
161257943|NCT00939627|582323535|FG000|Overall Study|Death|0|||
161257944|NCT00939627|582323536|FG001|Overall Study|Death|2|||
161257945|NCT00939627|582323537|FG002|Overall Study|Death|0|||
161257946|NCT00939627|582323535|FG000|Overall Study|Withdrawal by Subject|2|||
161257947|NCT00939627|582323536|FG001|Overall Study|Withdrawal by Subject|4|||
161257948|NCT00939627|582323537|FG002|Overall Study|Withdrawal by Subject|0|||
161257949|NCT00939627|582323535|FG000|Overall Study|Other complicating disease|1|||
161257950|NCT00939627|582323536|FG001|Overall Study|Other complicating disease|1|||
161257951|NCT00939627|582323537|FG002|Overall Study|Other complicating disease|0|||
161257952|NCT00939627|582323535|FG000|Overall Study|Not compliant|2|||
161257953|NCT00939627|582323536|FG001|Overall Study|Not compliant|0|||
161257954|NCT00939627|582323537|FG002|Overall Study|Not compliant|0|||
161142773|NCT03519178|581906188|FG000|Long-term Follow-up|Death|0|||
161142774|NCT03519178|581906189|FG001|Long-term Follow-up|Death|0|||
161142775|NCT03519178|581906190|FG002|Long-term Follow-up|Death|0|||
161142776|NCT03519178|581906191|FG003|Long-term Follow-up|Death|0|||
161142777|NCT03519178|581906192|FG004|Long-term Follow-up|Death|0|||
161142778|NCT03519178|581906193|FG005|Long-term Follow-up|Death|0|||
161142779|NCT03519178|581906194|FG006|Long-term Follow-up|Death|0|||
161142780|NCT03519178|581906195|FG007|Long-term Follow-up|Death|0|||
161142781|NCT03519178|581906196|FG008|Long-term Follow-up|Death|0|||
161142782|NCT03519178|581906197|FG009|Long-term Follow-up|Death|0|||
161142783|NCT03519178|581906198|FG010|Long-term Follow-up|Death|0|||
161257955|NCT00939627|582323535|FG000|Overall Study|No off-tx reason given|0|||
161257956|NCT00939627|582323536|FG001|Overall Study|No off-tx reason given|2|||
161257957|NCT00939627|582323537|FG002|Overall Study|No off-tx reason given|0|||
161257958|NCT02039063|582323540|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
161257959|NCT02039063|582323541|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
161142784|NCT03519178|581906199|FG011|Long-term Follow-up|Death|0|||
161142785|NCT03519178|581906200|FG012|Long-term Follow-up|Death|0|||
161257960|NCT02039063|582323542|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
161142786|NCT03519178|581906201|FG013|Long-term Follow-up|Death|4|||
161142787|NCT03519178|581906202|FG014|Long-term Follow-up|Death|4|||
161142788|NCT03519178|581906188|FG000|Long-term Follow-up|Lost to Follow-up|0|||
161142789|NCT03519178|581906189|FG001|Long-term Follow-up|Lost to Follow-up|0|||
161142790|NCT03519178|581906190|FG002|Long-term Follow-up|Lost to Follow-up|0|||
161142791|NCT03519178|581906191|FG003|Long-term Follow-up|Lost to Follow-up|0|||
160996881|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
160996882|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
160996883|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
160996884|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
160996885|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996886|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
160996887|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
161257961|NCT02039063|582323543|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
161257962|NCT02039063|582323540|FG000|Treatment Phase|Progression of disease|0|||
161257963|NCT02039063|582323541|FG001|Treatment Phase|Progression of disease|0|||
161257964|NCT02039063|582323542|FG002|Treatment Phase|Progression of disease|1|||
161257965|NCT02039063|582323543|FG003|Treatment Phase|Progression of disease|1|||
161257966|NCT02039063|582323540|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161257967|NCT02039063|582323541|FG001|Extension Phase|Inadequate therapeutic effect|1|||
161257968|NCT02039063|582323542|FG002|Extension Phase|Inadequate therapeutic effect|2|||
161257969|NCT02039063|582323543|FG003|Extension Phase|Inadequate therapeutic effect|0|||
161257970|NCT02039063|582323540|FG000|Extension Phase|Progression of disease|0|||
161257971|NCT02039063|582323541|FG001|Extension Phase|Progression of disease|0|||
161257972|NCT02039063|582323542|FG002|Extension Phase|Progression of disease|0|||
161257973|NCT02039063|582323543|FG003|Extension Phase|Progression of disease|1|||
161257974|NCT02039063|582323540|FG000|Extension Phase|Adverse Event|0|||
161257975|NCT02039063|582323541|FG001|Extension Phase|Adverse Event|0|||
161257976|NCT02039063|582323542|FG002|Extension Phase|Adverse Event|1|||
161257977|NCT02039063|582323543|FG003|Extension Phase|Adverse Event|0|||
161257978|NCT00467831|582323546|FG000|Overall Study|Death|2|||
161257979|NCT00467831|582323546|FG000|Overall Study|Withdrawal by Subject|1|||
161257980|NCT01832402|582323549|FG000|Overall Study|Lost to Follow-up|2|||
161257981|NCT01832402|582323550|FG001|Overall Study|Lost to Follow-up|0|||
161257982|NCT01832402|582323549|FG000|Overall Study|Withdrawal by Subject|3|||
161257983|NCT01832402|582323550|FG001|Overall Study|Withdrawal by Subject|3|||
161257984|NCT01832402|582323549|FG000|Overall Study|Declining Performance status|2|||
161257985|NCT01832402|582323550|FG001|Overall Study|Declining Performance status|1|||
161257986|NCT01198873|582323551|FG000|Overall Study|Adverse Event|4|||
161257987|NCT01198873|582323552|FG001|Overall Study|Adverse Event|7|||
161257988|NCT01198873|582323551|FG000|Overall Study|Study closure|29|||
161257989|NCT01198873|582323552|FG001|Overall Study|Study closure|23|||
161257990|NCT01198873|582323551|FG000|Overall Study|Other than above|4|||
161257991|NCT01198873|582323552|FG001|Overall Study|Other than above|2|||
161257992|NCT00775528|582323558|FG000|Overall Study|Protocol Violation|1|||
161257993|NCT02492841|582323559|FG000|Overall Study|Lost to Follow-up|34|||
161257994|NCT02492841|582323560|FG001|Overall Study|Lost to Follow-up|31|||
161257995|NCT02492841|582323561|FG002|Overall Study|Lost to Follow-up|35|||
161257996|NCT00613730|582323564|FG000|Overall Study|Disease progression|2|||
161257997|NCT00613730|582323564|FG000|Overall Study|Administrative decision|1|||
161257998|NCT04965389|582323573|FG000|Overall Study|Other reasons|1|||
161257999|NCT04965389|582323574|FG001|Overall Study|Other reasons|0|||
161258000|NCT04965389|582323575|FG002|Overall Study|Other reasons|0|||
161258001|NCT04965389|582323576|FG003|Overall Study|Other reasons|0|||
161258002|NCT04965389|582323573|FG000|Overall Study|Participant withdrew consent|0|||
161258003|NCT04965389|582323574|FG001|Overall Study|Participant withdrew consent|1|||
161258004|NCT04965389|582323575|FG002|Overall Study|Participant withdrew consent|0|||
161258005|NCT04965389|582323576|FG003|Overall Study|Participant withdrew consent|0|||
161258006|NCT04965389|582323573|FG000|Overall Study|Poor/Non-compliance|0|||
161258007|NCT04965389|582323574|FG001|Overall Study|Poor/Non-compliance|1|||
161258008|NCT04965389|582323575|FG002|Overall Study|Poor/Non-compliance|0|||
161258009|NCT04965389|582323576|FG003|Overall Study|Poor/Non-compliance|0|||
161258010|NCT02083926|582323579|FG000|Overall Study|Withdrawal by Subject|1|||
161258011|NCT02083926|582323580|FG001|Overall Study|Withdrawal by Subject|0|||
161258012|NCT01436643|582323581|FG000|2-week Pre-treatment|Abnormal test result|0|||
161258013|NCT01436643|582323582|FG001|2-week Pre-treatment|Abnormal test result|0|||
161258014|NCT01436643|582323583|FG002|2-week Pre-treatment|Abnormal test result|0|||
161258015|NCT01436643|582323584|FG003|2-week Pre-treatment|Abnormal test result|1|||
161258016|NCT01436643|582323581|FG000|2-week Pre-treatment|Adverse Event|0|||
161258017|NCT01436643|582323582|FG001|2-week Pre-treatment|Adverse Event|0|||
161258018|NCT01436643|582323583|FG002|2-week Pre-treatment|Adverse Event|0|||
161258019|NCT01436643|582323584|FG003|2-week Pre-treatment|Adverse Event|5|||
161258020|NCT01436643|582323581|FG000|2-week Pre-treatment|Protocol Violation|0|||
161258021|NCT01436643|582323582|FG001|2-week Pre-treatment|Protocol Violation|0|||
161258022|NCT01436643|582323583|FG002|2-week Pre-treatment|Protocol Violation|0|||
161258023|NCT01436643|582323584|FG003|2-week Pre-treatment|Protocol Violation|4|||
161258024|NCT01436643|582323581|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
161258025|NCT01436643|582323582|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
161258026|NCT01436643|582323583|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
161258027|NCT01436643|582323584|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
160996888|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161340489|NCT00560404|582633532|FG000|Overall Study|Other withdrawal reason|13|||
161258028|NCT01436643|582323581|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
161258029|NCT01436643|582323582|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
161258030|NCT01436643|582323583|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
161258031|NCT01436643|582323584|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
161258032|NCT01436643|582323581|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
161258033|NCT01436643|582323582|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
161258034|NCT01436643|582323583|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
161258035|NCT01436643|582323584|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
161258036|NCT01117987|582323585|FG000|Overall Study|Protocol deviation|0|||
161258037|NCT01117987|582323586|FG001|Overall Study|Protocol deviation|1|||
161258038|NCT01117987|582323585|FG000|Overall Study|Subject no longer requires study drug|1|||
161258039|NCT01117987|582323586|FG001|Overall Study|Subject no longer requires study drug|0|||
161258040|NCT01117987|582323585|FG000|Overall Study|Lost to Follow-up|1|||
161258041|NCT01117987|582323586|FG001|Overall Study|Lost to Follow-up|1|||
161258042|NCT01117987|582323585|FG000|Overall Study|Abnormal test procedure result|2|||
161258043|NCT01117987|582323586|FG001|Overall Study|Abnormal test procedure result|0|||
161258044|NCT01117987|582323585|FG000|Overall Study|Lack of Efficacy|3|||
161258045|NCT01117987|582323586|FG001|Overall Study|Lack of Efficacy|4|||
161258046|NCT01117987|582323585|FG000|Overall Study|Death|5|||
161258047|NCT01117987|582323586|FG001|Overall Study|Death|10|||
161258048|NCT01117987|582323585|FG000|Overall Study|Withdrawal by Subject|5|||
161258049|NCT01117987|582323586|FG001|Overall Study|Withdrawal by Subject|10|||
161258050|NCT01117987|582323585|FG000|Overall Study|Adverse Event|19|||
161258051|NCT01117987|582323586|FG001|Overall Study|Adverse Event|26|||
161258052|NCT01117987|582323585|FG000|Overall Study|Administrative problems|25|||
161258053|NCT01117987|582323586|FG001|Overall Study|Administrative problems|22|||
161258054|NCT02244424|582323587|FG000|Overall Study|Lost to Follow-up|20|||
161258055|NCT02244424|582323588|FG001|Overall Study|Lost to Follow-up|10|||
161258056|NCT04117945|582323591|FG000|Overall Study|Death|1|||
161258057|NCT04117945|582323592|FG001|Overall Study|Death|0|||
161258058|NCT04117945|582323591|FG000|Overall Study|Withdrawal by Subject|3|||
161258059|NCT04117945|582323592|FG001|Overall Study|Withdrawal by Subject|1|||
161258060|NCT04117945|582323591|FG000|Overall Study|Disease Progression|0|||
161258061|NCT04117945|582323592|FG001|Overall Study|Disease Progression|2|||
161258062|NCT04117945|582323591|FG000|Overall Study|Ineligible|8|||
161258063|NCT04117945|582323592|FG001|Overall Study|Ineligible|7|||
161258064|NCT01181531|582323596|FG000|Overall Study|Other|17|||
161258065|NCT01181531|582323597|FG001|Overall Study|Other|12|||
161258066|NCT01181531|582323596|FG000|Overall Study|Partial consent by subject withdrawn|0|||
161258067|NCT01181531|582323597|FG001|Overall Study|Partial consent by subject withdrawn|1|||
161258068|NCT01181531|582323596|FG000|Overall Study|Physician Decision|3|||
161258069|NCT01181531|582323597|FG001|Overall Study|Physician Decision|1|||
161258070|NCT01181531|582323596|FG000|Overall Study|Noncompliance|2|||
161258071|NCT01181531|582323597|FG001|Overall Study|Noncompliance|2|||
161258072|NCT01181531|582323596|FG000|Overall Study|Ineligibility determined|1|||
161258073|NCT01181531|582323597|FG001|Overall Study|Ineligibility determined|2|||
161258074|NCT01181531|582323596|FG000|Overall Study|Protocol Specified Criteria|15|||
161258075|NCT01181531|582323597|FG001|Overall Study|Protocol Specified Criteria|8|||
161258076|NCT01181531|582323596|FG000|Overall Study|Pregnancy|0|||
161258077|NCT01181531|582323597|FG001|Overall Study|Pregnancy|1|||
161258078|NCT01181531|582323596|FG000|Overall Study|Withdrawal by Subject|8|||
161258079|NCT01181531|582323597|FG001|Overall Study|Withdrawal by Subject|7|||
161258080|NCT01181531|582323596|FG000|Overall Study|Protocol Violation|6|||
161258081|NCT01181531|582323597|FG001|Overall Study|Protocol Violation|6|||
161258082|NCT01181531|582323596|FG000|Overall Study|Death|9|||
161258083|NCT01181531|582323597|FG001|Overall Study|Death|12|||
161258084|NCT01181531|582323596|FG000|Overall Study|Adverse Event|0|||
161258085|NCT01181531|582323597|FG001|Overall Study|Adverse Event|1|||
161258086|NCT00955721|582323598|FG000|Overall Study|Physician Decision|1|||
161258087|NCT00955721|582323599|FG001|Overall Study|Physician Decision|0|||
161258088|NCT00955721|582323598|FG000|Overall Study|Death|1|||
161258089|NCT00955721|582323599|FG001|Overall Study|Death|0|||
161258090|NCT00955721|582323598|FG000|Overall Study|Withdrawal by Subject|1|||
161258091|NCT00955721|582323599|FG001|Overall Study|Withdrawal by Subject|0|||
161258092|NCT04034355|582323604|FG000|Overall Study|Study terminated by Sponsor|10|||
161258093|NCT04034355|582323605|FG001|Overall Study|Study terminated by Sponsor|17|||
161258094|NCT04034355|582323604|FG000|Overall Study|Withdrawal by Subject|12|||
161258095|NCT04034355|582323605|FG001|Overall Study|Withdrawal by Subject|11|||
161258096|NCT04034355|582323604|FG000|Overall Study|Site terminated by Sponsor|4|||
161258097|NCT04034355|582323605|FG001|Overall Study|Site terminated by Sponsor|5|||
161258098|NCT04034355|582323604|FG000|Overall Study|Adverse Event|2|||
161258099|NCT04034355|582323605|FG001|Overall Study|Adverse Event|0|||
161258100|NCT04034355|582323604|FG000|Overall Study|Death|1|||
161258101|NCT04034355|582323605|FG001|Overall Study|Death|1|||
161258102|NCT04034355|582323604|FG000|Overall Study|Not reported|2|||
161258103|NCT04034355|582323605|FG001|Overall Study|Not reported|0|||
161258104|NCT04034355|582323604|FG000|Overall Study|Lost to Follow-up|1|||
160918023|NCT00227903|581094170|FG000|Overall Study|Withdrawal by Subject|2|||
160918024|NCT00227903|581094171|FG001|Overall Study|Withdrawal by Subject|5|||
160918025|NCT00227903|581094170|FG000|Overall Study|Subject moved out of area|1|||
160918026|NCT00227903|581094171|FG001|Overall Study|Subject moved out of area|2|||
160918027|NCT00227903|581094170|FG000|Overall Study|Lost to Follow-up|1|||
160918028|NCT00227903|581094171|FG001|Overall Study|Lost to Follow-up|3|||
160918029|NCT00227903|581094170|FG000|Overall Study|Miscarriage|1|||
160918030|NCT00227903|581094171|FG001|Overall Study|Miscarriage|0|||
160918031|NCT01475331|581094172|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
160918032|NCT01475331|581094173|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
160918033|NCT01475331|581094172|FG000|Overall Study|excessive main duct communication|1|||
160918034|NCT01475331|581094173|FG001|Overall Study|excessive main duct communication|1|||
160918035|NCT01475331|581094172|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
160918036|NCT01475331|581094173|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
160918037|NCT01475331|581094172|FG000|Overall Study|Sign of malignancy during the procedure|2|||
160918038|NCT01475331|581094173|FG001|Overall Study|Sign of malignancy during the procedure|0|||
160918039|NCT01475331|581094172|FG000|Overall Study|cyst found to be prohibitively small|0|||
160918040|NCT01475331|581094173|FG001|Overall Study|cyst found to be prohibitively small|1|||
160918041|NCT00462761|581094174|FG000|Overall Study|Adverse Event|6|||
160918042|NCT00462761|581094174|FG000|Overall Study|Withdrawal by Subject|9|||
160918043|NCT00462761|581094174|FG000|Overall Study|Physician Decision|5|||
160918044|NCT00462761|581094174|FG000|Overall Study|Disease progression|43|||
160918045|NCT00462761|581094174|FG000|Overall Study|Death|12|||
160918046|NCT00462761|581094174|FG000|Overall Study|Other|1|||
160918047|NCT02877082|581094175|FG000|Overall Study|Trial was closed early|5|||
160918048|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
160918049|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
160918050|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
160918051|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
160918052|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
160918053|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
160996889|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161258105|NCT04034355|582323605|FG001|Overall Study|Lost to Follow-up|0|||
161258106|NCT04034355|582323604|FG000|Overall Study|Physician Decision|1|||
161258107|NCT04034355|582323605|FG001|Overall Study|Physician Decision|0|||
161258108|NCT04034355|582323604|FG000|Overall Study|Protocol Violation|0|||
161258109|NCT04034355|582323605|FG001|Overall Study|Protocol Violation|1|||
161258110|NCT04034355|582323604|FG000|Overall Study|Progressive disease|1|||
161258111|NCT04034355|582323605|FG001|Overall Study|Progressive disease|0|||
161258112|NCT02723773|582325292|FG000|Overall Study|Adverse Event|934|||
161258113|NCT02723773|582325293|FG001|Overall Study|Adverse Event|3|||
161258114|NCT02723773|582325294|FG002|Overall Study|Adverse Event|1|||
161258115|NCT02723773|582325295|FG003|Overall Study|Adverse Event|9|||
161258116|NCT02723773|582325292|FG000|Overall Study|Protocol Violation|1|||
161258117|NCT02723773|582325293|FG001|Overall Study|Protocol Violation|0|||
161258118|NCT02723773|582325294|FG002|Overall Study|Protocol Violation|0|||
161258119|NCT02723773|582325295|FG003|Overall Study|Protocol Violation|0|||
161258120|NCT02723773|582325292|FG000|Overall Study|Withdrawal by Subject|360|||
161258121|NCT02723773|582325293|FG001|Overall Study|Withdrawal by Subject|5|||
161258122|NCT02723773|582325294|FG002|Overall Study|Withdrawal by Subject|6|||
161258123|NCT02723773|582325295|FG003|Overall Study|Withdrawal by Subject|10|||
161258124|NCT02723773|582325292|FG000|Overall Study|Migrated/moved from study area|37|||
161258125|NCT02723773|582325293|FG001|Overall Study|Migrated/moved from study area|0|||
161258126|NCT02723773|582325294|FG002|Overall Study|Migrated/moved from study area|0|||
161258127|NCT02723773|582325295|FG003|Overall Study|Migrated/moved from study area|1|||
161258128|NCT02723773|582325292|FG000|Overall Study|Lost to Follow-up|198|||
161258129|NCT02723773|582325293|FG001|Overall Study|Lost to Follow-up|0|||
161258130|NCT02723773|582325294|FG002|Overall Study|Lost to Follow-up|0|||
161258131|NCT02723773|582325295|FG003|Overall Study|Lost to Follow-up|0|||
161258132|NCT02723773|582325292|FG000|Overall Study|Other|189|||
161258133|NCT02723773|582325293|FG001|Overall Study|Other|1|||
161258134|NCT02723773|582325294|FG002|Overall Study|Other|2|||
161258135|NCT02723773|582325295|FG003|Overall Study|Other|2|||
161258136|NCT05168774|582325296|FG000|Overall Study|Lack of Efficacy|1|||
161258137|NCT05168774|582325297|FG001|Overall Study|Lack of Efficacy|2|||
161258138|NCT05168774|582325296|FG000|Overall Study|Withdrawal by Subject|1|||
161258139|NCT05168774|582325297|FG001|Overall Study|Withdrawal by Subject|2|||
161258140|NCT05168774|582325296|FG000|Overall Study|Adverse Event|2|||
160918054|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
161258141|NCT05168774|582325297|FG001|Overall Study|Adverse Event|0|||
161258142|NCT03064438|582325299|FG000|Overall Study|Lost to Follow-up|1|||
161258143|NCT03064438|582325300|FG001|Overall Study|Lost to Follow-up|0|||
161258144|NCT03064438|582325299|FG000|Overall Study|Withdrawal by Subject|0|||
161258145|NCT03064438|582325300|FG001|Overall Study|Withdrawal by Subject|1|||
161258146|NCT02124902|582325301|FG000|Overall Study|Adverse Event|7|||
161258147|NCT02124902|582325302|FG001|Overall Study|Adverse Event|2|||
161258148|NCT02124902|582325301|FG000|Overall Study|Went to alternative treatment|4|||
161258149|NCT02124902|582325302|FG001|Overall Study|Went to alternative treatment|0|||
161258150|NCT02124902|582325301|FG000|Overall Study|Withdrawal by Subject|2|||
160918055|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
160918056|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
161142792|NCT03519178|581906192|FG004|Long-term Follow-up|Lost to Follow-up|0|||
161142793|NCT03519178|581906193|FG005|Long-term Follow-up|Lost to Follow-up|0|||
161142794|NCT03519178|581906194|FG006|Long-term Follow-up|Lost to Follow-up|0|||
161258151|NCT02124902|582325302|FG001|Overall Study|Withdrawal by Subject|1|||
161258152|NCT02124902|582325301|FG000|Overall Study|Physician Decision|2|||
161258153|NCT02124902|582325302|FG001|Overall Study|Physician Decision|0|||
161258154|NCT02124902|582325301|FG000|Overall Study|Not eligible|1|||
161258155|NCT02124902|582325302|FG001|Overall Study|Not eligible|0|||
161258156|NCT02124902|582325301|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
161258157|NCT02124902|582325302|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
161258158|NCT01937351|582325303|FG000|Overall Study|Withdrawal by Subject|4|||
161258159|NCT01937351|582325304|FG001|Overall Study|Withdrawal by Subject|2|||
161258160|NCT01937351|582325303|FG000|Overall Study|Death|1|||
161258161|NCT01937351|582325304|FG001|Overall Study|Death|0|||
161258162|NCT01937351|582325303|FG000|Overall Study|Not treated w device, per protocol fail|4|||
161258163|NCT01937351|582325304|FG001|Overall Study|Not treated w device, per protocol fail|0|||
161258164|NCT01314118|582325305|FG000|Overall Study|Adverse Event|10|||
161258165|NCT01314118|582325305|FG000|Overall Study|Progressive disease|3|||
161258166|NCT01314118|582325305|FG000|Overall Study|Death|8|||
161258167|NCT01314118|582325305|FG000|Overall Study|Physician Decision|13|||
161258168|NCT01314118|582325305|FG000|Overall Study|Sponsor Decision|1|||
161258169|NCT01314118|582325305|FG000|Overall Study|Protocol Violation|2|||
161258170|NCT01314118|582325305|FG000|Overall Study|Withdrawal by Subject|26|||
161258171|NCT01314118|582325305|FG000|Overall Study|Other|21|||
161258172|NCT04079712|582325306|FG000|Overall Study|Disease progression before starting treatment|1|||
161258173|NCT01467479|582325312|FG000|Overall Study|No Study Medication|1|||
161258174|NCT01467479|582325313|FG001|Overall Study|No Study Medication|0|||
161258175|NCT01467479|582325314|FG002|Overall Study|No Study Medication|2|||
161258176|NCT01467479|582325312|FG000|Overall Study|Adverse Event|1|||
161258177|NCT01467479|582325313|FG001|Overall Study|Adverse Event|2|||
161258178|NCT01467479|582325314|FG002|Overall Study|Adverse Event|0|||
161258179|NCT01467479|582325312|FG000|Overall Study|Death|0|||
161258180|NCT01467479|582325313|FG001|Overall Study|Death|0|||
161258181|NCT01467479|582325314|FG002|Overall Study|Death|1|||
161258182|NCT01467479|582325312|FG000|Overall Study|Lost to Follow-up|2|||
161258183|NCT01467479|582325313|FG001|Overall Study|Lost to Follow-up|5|||
161258184|NCT01467479|582325314|FG002|Overall Study|Lost to Follow-up|3|||
161258185|NCT01467479|582325312|FG000|Overall Study|Withdrawal of Consent|3|||
161258186|NCT01467479|582325313|FG001|Overall Study|Withdrawal of Consent|7|||
161258187|NCT01467479|582325314|FG002|Overall Study|Withdrawal of Consent|7|||
161258188|NCT01467479|582325312|FG000|Overall Study|Study Terminated by Sponsor|1|||
161258189|NCT01467479|582325313|FG001|Overall Study|Study Terminated by Sponsor|3|||
161258190|NCT01467479|582325314|FG002|Overall Study|Study Terminated by Sponsor|3|||
161258191|NCT01467479|582325312|FG000|Overall Study|Other|1|||
161258192|NCT01467479|582325313|FG001|Overall Study|Other|0|||
161258193|NCT01467479|582325314|FG002|Overall Study|Other|0|||
161258194|NCT02284347|582325325|FG000|Overall Study|Lost to Follow-up|2|||
161142795|NCT03519178|581906195|FG007|Long-term Follow-up|Lost to Follow-up|0|||
161142796|NCT03519178|581906196|FG008|Long-term Follow-up|Lost to Follow-up|0|||
161142797|NCT03519178|581906197|FG009|Long-term Follow-up|Lost to Follow-up|0|||
161142798|NCT03519178|581906198|FG010|Long-term Follow-up|Lost to Follow-up|0|||
161142799|NCT03519178|581906199|FG011|Long-term Follow-up|Lost to Follow-up|0|||
161142800|NCT03519178|581906200|FG012|Long-term Follow-up|Lost to Follow-up|0|||
161142801|NCT03519178|581906201|FG013|Long-term Follow-up|Lost to Follow-up|1|||
161142802|NCT03519178|581906202|FG014|Long-term Follow-up|Lost to Follow-up|1|||
161142803|NCT03519178|581906188|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
161142804|NCT03519178|581906189|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
161142805|NCT03519178|581906190|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
161142806|NCT03519178|581906191|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
161142807|NCT03519178|581906192|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
161142808|NCT03519178|581906193|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
161142809|NCT03519178|581906194|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
161142810|NCT03519178|581906195|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
161142811|NCT03519178|581906196|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
161142812|NCT03519178|581906197|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
161142813|NCT03519178|581906198|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
161142814|NCT03519178|581906199|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
161258195|NCT02284347|582325325|FG000|Overall Study|Withdrawn prior to treatment|1|||
161142815|NCT03519178|581906200|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
161258196|NCT01730040|582325326|FG000|Overall Study|Randomized but not treated|0|||
161258197|NCT01730040|582325327|FG001|Overall Study|Randomized but not treated|0|||
161142816|NCT03519178|581906201|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
161142817|NCT03519178|581906202|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
161142818|NCT03519178|581906188|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
161142819|NCT03519178|581906189|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
161142820|NCT03519178|581906190|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
161142821|NCT03519178|581906191|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
161142822|NCT03519178|581906192|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
161142823|NCT03519178|581906193|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
161142824|NCT03519178|581906194|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
161142825|NCT03519178|581906195|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
161142826|NCT03519178|581906196|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
161142827|NCT03519178|581906197|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
161142828|NCT03519178|581906198|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
161142829|NCT03519178|581906199|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
161142830|NCT03519178|581906200|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
161142831|NCT03519178|581906201|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
161142832|NCT03519178|581906202|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
161142833|NCT03519178|581906188|FG000|Long-term Follow-up|Other|0|||
161142834|NCT03519178|581906189|FG001|Long-term Follow-up|Other|0|||
161142835|NCT03519178|581906190|FG002|Long-term Follow-up|Other|0|||
161142836|NCT03519178|581906191|FG003|Long-term Follow-up|Other|0|||
161142837|NCT03519178|581906192|FG004|Long-term Follow-up|Other|0|||
161142838|NCT03519178|581906193|FG005|Long-term Follow-up|Other|0|||
161142839|NCT03519178|581906194|FG006|Long-term Follow-up|Other|0|||
161142840|NCT03519178|581906195|FG007|Long-term Follow-up|Other|0|||
161142841|NCT03519178|581906196|FG008|Long-term Follow-up|Other|0|||
161142842|NCT03519178|581906197|FG009|Long-term Follow-up|Other|0|||
161142843|NCT03519178|581906198|FG010|Long-term Follow-up|Other|0|||
161142844|NCT03519178|581906199|FG011|Long-term Follow-up|Other|0|||
161142845|NCT03519178|581906200|FG012|Long-term Follow-up|Other|0|||
161142846|NCT03519178|581906201|FG013|Long-term Follow-up|Other|0|||
161142847|NCT03519178|581906202|FG014|Long-term Follow-up|Other|1|||
161142848|NCT03519178|581906188|FG000|Long-term Follow-up|Global deterioration of health status|0|||
161142849|NCT03519178|581906189|FG001|Long-term Follow-up|Global deterioration of health status|0|||
161142850|NCT03519178|581906190|FG002|Long-term Follow-up|Global deterioration of health status|0|||
161142851|NCT03519178|581906191|FG003|Long-term Follow-up|Global deterioration of health status|0|||
161142852|NCT03519178|581906192|FG004|Long-term Follow-up|Global deterioration of health status|0|||
161142853|NCT03519178|581906193|FG005|Long-term Follow-up|Global deterioration of health status|0|||
161142854|NCT03519178|581906194|FG006|Long-term Follow-up|Global deterioration of health status|0|||
161142855|NCT03519178|581906195|FG007|Long-term Follow-up|Global deterioration of health status|0|||
161142856|NCT03519178|581906196|FG008|Long-term Follow-up|Global deterioration of health status|0|||
161142857|NCT03519178|581906197|FG009|Long-term Follow-up|Global deterioration of health status|0|||
161142858|NCT03519178|581906198|FG010|Long-term Follow-up|Global deterioration of health status|0|||
161142859|NCT03519178|581906199|FG011|Long-term Follow-up|Global deterioration of health status|0|||
161142860|NCT03519178|581906200|FG012|Long-term Follow-up|Global deterioration of health status|0|||
161142861|NCT03519178|581906201|FG013|Long-term Follow-up|Global deterioration of health status|1|||
161142862|NCT03519178|581906202|FG014|Long-term Follow-up|Global deterioration of health status|0|||
161142863|NCT03256539|581906207|FG000|Overall Study|Withdrawal by Subject|0|||
161142864|NCT03256539|581906208|FG001|Overall Study|Withdrawal by Subject|3|||
161142865|NCT03256539|581906207|FG000|Overall Study|Unexpected closure of study components|8|||
161142866|NCT03256539|581906208|FG001|Overall Study|Unexpected closure of study components|4|||
161142867|NCT00828451|581906209|FG000|Overall Study|Death|2|||
161142868|NCT00828451|581906209|FG000|Overall Study|Lack of intravenous line|7|||
161142869|NCT00828451|581906209|FG000|Overall Study|Withdrawal by Subject|1|||
161142870|NCT00828451|581906209|FG000|Overall Study|Deterioration in clinical status|1|||
161142871|NCT05755438|581906212|FG000|12-week DBVC Period|Adverse Event|4|||
161142872|NCT05755438|581906213|FG001|12-week DBVC Period|Adverse Event|1|||
161142873|NCT05755438|581906212|FG000|12-week DBVC Period|Physician Decision|1|||
161258198|NCT01730040|582325328|FG002|Overall Study|Randomized but not treated|0|||
161142874|NCT05755438|581906213|FG001|12-week DBVC Period|Physician Decision|1|||
161142875|NCT05755438|581906212|FG000|12-week DBVC Period|Protocol Violation|4|||
161142876|NCT05755438|581906213|FG001|12-week DBVC Period|Protocol Violation|2|||
161142877|NCT05755438|581906212|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
161142878|NCT05755438|581906213|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
161142879|NCT05755438|581906212|FG000|12-week DBVC Period|Sponsor Decision|1|||
161142880|NCT05755438|581906213|FG001|12-week DBVC Period|Sponsor Decision|0|||
161142881|NCT05755438|581906212|FG000|40-week OLE Period|Adverse Event|0|||
161142882|NCT05755438|581906213|FG001|40-week OLE Period|Adverse Event|2|||
161142883|NCT05755438|581906212|FG000|40-week OLE Period|Lack of Efficacy|1|||
161142884|NCT05755438|581906213|FG001|40-week OLE Period|Lack of Efficacy|1|||
161142885|NCT05755438|581906212|FG000|40-week OLE Period|Lost to Follow-up|1|||
161142886|NCT05755438|581906213|FG001|40-week OLE Period|Lost to Follow-up|0|||
161142887|NCT05755438|581906212|FG000|40-week OLE Period|Physician Decision|1|||
161142888|NCT05755438|581906213|FG001|40-week OLE Period|Physician Decision|1|||
161142889|NCT05755438|581906212|FG000|40-week OLE Period|Protocol Violation|1|||
161258199|NCT01730040|582325329|FG003|Overall Study|Randomized but not treated|0|||
161258200|NCT01730040|582325330|FG004|Overall Study|Randomized but not treated|0|||
160918057|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
160918058|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
160918059|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
160918060|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
160918061|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
160918062|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
160918063|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
160918064|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
160918065|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
160918066|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160918067|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
161258201|NCT01730040|582325331|FG005|Overall Study|Randomized but not treated|1|||
161258202|NCT01730040|582325332|FG006|Overall Study|Randomized but not treated|0|||
161258203|NCT01730040|582325326|FG000|Overall Study|Subject moved|0|||
161258204|NCT01730040|582325327|FG001|Overall Study|Subject moved|0|||
161258205|NCT01730040|582325328|FG002|Overall Study|Subject moved|1|||
161258206|NCT01730040|582325329|FG003|Overall Study|Subject moved|0|||
161258207|NCT01730040|582325330|FG004|Overall Study|Subject moved|0|||
161258208|NCT01730040|582325331|FG005|Overall Study|Subject moved|0|||
161258209|NCT01730040|582325332|FG006|Overall Study|Subject moved|1|||
161258210|NCT01730040|582325326|FG000|Overall Study|Physician Decision|0|||
161258211|NCT01730040|582325327|FG001|Overall Study|Physician Decision|0|||
161258212|NCT01730040|582325328|FG002|Overall Study|Physician Decision|0|||
161258213|NCT01730040|582325329|FG003|Overall Study|Physician Decision|0|||
161258214|NCT01730040|582325330|FG004|Overall Study|Physician Decision|0|||
161258215|NCT01730040|582325331|FG005|Overall Study|Physician Decision|1|||
161258216|NCT01730040|582325332|FG006|Overall Study|Physician Decision|1|||
161258217|NCT01730040|582325326|FG000|Overall Study|Other than specified|7|||
161258218|NCT01730040|582325327|FG001|Overall Study|Other than specified|8|||
161258219|NCT01730040|582325328|FG002|Overall Study|Other than specified|5|||
161258220|NCT01730040|582325329|FG003|Overall Study|Other than specified|5|||
161258221|NCT01730040|582325330|FG004|Overall Study|Other than specified|5|||
161258222|NCT01730040|582325331|FG005|Overall Study|Other than specified|4|||
161258223|NCT01730040|582325332|FG006|Overall Study|Other than specified|4|||
161258224|NCT01730040|582325326|FG000|Overall Study|Adverse Event|4|||
161258225|NCT01730040|582325327|FG001|Overall Study|Adverse Event|3|||
161258226|NCT01730040|582325328|FG002|Overall Study|Adverse Event|5|||
161258227|NCT01730040|582325329|FG003|Overall Study|Adverse Event|3|||
161258228|NCT01730040|582325330|FG004|Overall Study|Adverse Event|1|||
161258229|NCT01730040|582325331|FG005|Overall Study|Adverse Event|1|||
161258230|NCT01730040|582325332|FG006|Overall Study|Adverse Event|2|||
161258231|NCT01730040|582325326|FG000|Overall Study|Poor compliance to protocol|2|||
161258232|NCT01730040|582325327|FG001|Overall Study|Poor compliance to protocol|4|||
161258233|NCT01730040|582325328|FG002|Overall Study|Poor compliance to protocol|0|||
161142890|NCT05755438|581906213|FG001|40-week OLE Period|Protocol Violation|1|||
161142891|NCT05755438|581906212|FG000|40-week OLE Period|Withdrawal by Subject|6|||
161142892|NCT05755438|581906213|FG001|40-week OLE Period|Withdrawal by Subject|6|||
161142893|NCT05755438|581906212|FG000|40-week OLE Period|Sponsor Decision|3|||
161142894|NCT05755438|581906213|FG001|40-week OLE Period|Sponsor Decision|0|||
161142895|NCT05755438|581906212|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
161142896|NCT05755438|581906213|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
161142897|NCT05755438|581906212|FG000|40-week OLE Period|Ongoing|46|||
161142898|NCT05755438|581906213|FG001|40-week OLE Period|Ongoing|58|||
161142899|NCT00624338|581906218|FG000|Overall Study|Adverse Event|14|||
161142900|NCT00624338|581906219|FG001|Overall Study|Adverse Event|14|||
161142901|NCT00624338|581906220|FG002|Overall Study|Adverse Event|18|||
161142902|NCT00624338|581906218|FG000|Overall Study|Lost to Follow-up|1|||
161142903|NCT00624338|581906219|FG001|Overall Study|Lost to Follow-up|0|||
161142904|NCT00624338|581906220|FG002|Overall Study|Lost to Follow-up|0|||
161142905|NCT00624338|581906218|FG000|Overall Study|Lack of Efficacy|11|||
161142906|NCT00624338|581906219|FG001|Overall Study|Lack of Efficacy|3|||
161142907|NCT00624338|581906220|FG002|Overall Study|Lack of Efficacy|14|||
161142908|NCT00624338|581906218|FG000|Overall Study|Protocol Violation|3|||
161142909|NCT00624338|581906219|FG001|Overall Study|Protocol Violation|3|||
161142910|NCT00624338|581906220|FG002|Overall Study|Protocol Violation|2|||
161142911|NCT00624338|581906218|FG000|Overall Study|Death|0|||
161142912|NCT00624338|581906219|FG001|Overall Study|Death|2|||
161142913|NCT00624338|581906220|FG002|Overall Study|Death|0|||
161142914|NCT00624338|581906218|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
161142915|NCT00624338|581906219|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
161142916|NCT00624338|581906220|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
161142917|NCT00624338|581906218|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
161258234|NCT01730040|582325329|FG003|Overall Study|Poor compliance to protocol|0|||
161142918|NCT00624338|581906219|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
161142919|NCT00624338|581906220|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
161142920|NCT00624338|581906218|FG000|Overall Study|Other|15|||
161142921|NCT00624338|581906219|FG001|Overall Study|Other|5|||
161142922|NCT00624338|581906220|FG002|Overall Study|Other|9|||
161142923|NCT00624338|581906218|FG000|Overall Study|Randomized but not treated|2|||
161142924|NCT00624338|581906219|FG001|Overall Study|Randomized but not treated|1|||
161142925|NCT00624338|581906220|FG002|Overall Study|Randomized but not treated|3|||
161142926|NCT01548638|581906221|FG000|Overall Study|Protocol Violation|3|||
161142927|NCT01548638|581906221|FG000|Overall Study|Withdrawal by Subject|1|||
161142928|NCT01476787|581906225|FG000|Treatment|Progression|64|||
161142929|NCT01476787|581906226|FG001|Treatment|Progression|71|||
161142930|NCT01476787|581906225|FG000|Treatment|Toxicity|44|||
161142931|NCT01476787|581906226|FG001|Treatment|Toxicity|16|||
161142932|NCT01476787|581906225|FG000|Treatment|Death|0|||
161142933|NCT01476787|581906226|FG001|Treatment|Death|1|||
161142934|NCT01476787|581906225|FG000|Treatment|Withdrawal by Subject|3|||
161142935|NCT01476787|581906226|FG001|Treatment|Withdrawal by Subject|14|||
161142936|NCT01476787|581906225|FG000|Treatment|Major protocol violation|1|||
161142937|NCT01476787|581906226|FG001|Treatment|Major protocol violation|6|||
161142938|NCT01476787|581906225|FG000|Treatment|Other reasons|10|||
161142939|NCT01476787|581906226|FG001|Treatment|Other reasons|22|||
161142940|NCT01476787|581906225|FG000|Treatment|Concurrent illness|12|||
161142941|NCT01476787|581906226|FG001|Treatment|Concurrent illness|9|||
161142942|NCT01476787|581906225|FG000|Treatment|Insufficient response|15|||
161142943|NCT01476787|581906226|FG001|Treatment|Insufficient response|3|||
161142944|NCT01476787|581906225|FG000|Treatment|Voluntary treatment discontinuation|8|||
161142945|NCT01476787|581906226|FG001|Treatment|Voluntary treatment discontinuation|4|||
161142946|NCT01919411|581906237|FG000|Overall Study|Lost to Follow-up|2|||
161142947|NCT01919411|581906238|FG001|Overall Study|Lost to Follow-up|4|||
161142948|NCT01919411|581906237|FG000|Overall Study|Physician Decision|1|||
161142949|NCT01919411|581906238|FG001|Overall Study|Physician Decision|0|||
161142950|NCT01919411|581906237|FG000|Overall Study|Protocol Violation|2|||
161142951|NCT01919411|581906238|FG001|Overall Study|Protocol Violation|1|||
161142952|NCT02403206|581906240|FG000|Overall Study|Lost to Follow-up|4|||
161142953|NCT02403206|581906241|FG001|Overall Study|Lost to Follow-up|3|||
161142954|NCT02403206|581906240|FG000|Overall Study|Physician Decision|2|||
161142955|NCT02403206|581906241|FG001|Overall Study|Physician Decision|0|||
161142956|NCT02403206|581906240|FG000|Overall Study|Withdrawal by Subject|3|||
161142957|NCT02403206|581906241|FG001|Overall Study|Withdrawal by Subject|3|||
161142958|NCT02403206|581906240|FG000|Overall Study|Reason not given|2|||
161142959|NCT02403206|581906241|FG001|Overall Study|Reason not given|4|||
161142960|NCT03567187|581906247|FG000|Overall Study|Lost to Follow-up|18|||
161142961|NCT03497689|581906248|FG000|Overall Study|Adverse Event|2|||
161142962|NCT03497689|581906248|FG000|Overall Study|Death|1|||
161142963|NCT03497689|581906248|FG000|Overall Study|Physician Decision|1|||
161142964|NCT03497689|581906248|FG000|Overall Study|Withdrawal by Subject|1|||
161142965|NCT03497689|581906248|FG000|Overall Study|Protocol Violation|2|||
161142966|NCT04636177|581906253|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
161142967|NCT04636177|581906254|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
161142968|NCT04636177|581906253|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
161142969|NCT04636177|581906254|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
161142970|NCT04636177|581906253|FG000|Single-arm portion|Withdrawal by Subject|1|||
161142971|NCT04636177|581906254|FG001|Single-arm portion|Withdrawal by Subject|0|||
161142972|NCT04636177|581906253|FG000|Single-arm portion|Adverse Event|1|||
161142973|NCT04636177|581906254|FG001|Single-arm portion|Adverse Event|0|||
161142974|NCT05165394|581907478|FG000|Overall Study|Withdrawal by Subject|5|||
161142975|NCT05165394|581907479|FG001|Overall Study|Withdrawal by Subject|1|||
161142976|NCT05165394|581907478|FG000|Overall Study|Lost to Follow-up|1|||
161142977|NCT05165394|581907479|FG001|Overall Study|Lost to Follow-up|2|||
161142978|NCT05165394|581907478|FG000|Overall Study|Other Than Specified|0|||
161142979|NCT05165394|581907479|FG001|Overall Study|Other Than Specified|1|||
161142980|NCT02495077|581907480|FG000|Overall Study|Adverse Event|0|||
161142981|NCT02495077|581907481|FG001|Overall Study|Adverse Event|1|||
161142982|NCT02495077|581907482|FG002|Overall Study|Adverse Event|1|||
161142983|NCT02495077|581907483|FG003|Overall Study|Adverse Event|0|||
161142984|NCT02495077|581907480|FG000|Overall Study|Death|3|||
161142985|NCT02495077|581907481|FG001|Overall Study|Death|5|||
161142986|NCT02495077|581907482|FG002|Overall Study|Death|0|||
161142987|NCT02495077|581907483|FG003|Overall Study|Death|0|||
161142988|NCT02495077|581907480|FG000|Overall Study|Lost to Follow-up|6|||
161142989|NCT02495077|581907481|FG001|Overall Study|Lost to Follow-up|4|||
161142990|NCT02495077|581907482|FG002|Overall Study|Lost to Follow-up|0|||
161142991|NCT02495077|581907483|FG003|Overall Study|Lost to Follow-up|0|||
161142992|NCT02495077|581907480|FG000|Overall Study|Physician Decision|2|||
161142993|NCT02495077|581907481|FG001|Overall Study|Physician Decision|1|||
161142994|NCT02495077|581907482|FG002|Overall Study|Physician Decision|4|||
161142995|NCT02495077|581907483|FG003|Overall Study|Physician Decision|0|||
161142996|NCT02495077|581907480|FG000|Overall Study|Protocol Violation|0|||
160918068|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160918069|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
160918070|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
160918071|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
160918072|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
160918073|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
161258235|NCT01730040|582325330|FG004|Overall Study|Poor compliance to protocol|0|||
161258236|NCT01730040|582325331|FG005|Overall Study|Poor compliance to protocol|0|||
161258237|NCT01730040|582325332|FG006|Overall Study|Poor compliance to protocol|1|||
161258238|NCT00544817|582325336|FG000|Combined Modality|Lack of Efficacy|2|||
161258239|NCT00544817|582325336|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
161258240|NCT00544817|582325336|FG000|Combined Modality|Adverse Event|2|||
161258241|NCT00544817|582325336|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
161258242|NCT00544817|582325336|FG000|No Treatment Interval|Lack of Efficacy|8|||
161258243|NCT00544817|582325336|FG000|No Treatment Interval|Physician Decision|3|||
161258244|NCT00544817|582325336|FG000|No Treatment Interval|Adverse Event|1|||
161258245|NCT00544817|582325336|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
161258246|NCT00544817|582325336|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
161258247|NCT00544817|582325336|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
161258248|NCT01552369|582325337|FG000|Overall Study|Did not consent to extended follow up|8|||
161258249|NCT01552369|582325338|FG001|Overall Study|Did not consent to extended follow up|9|||
161258250|NCT00754013|582325350|FG000|Overall Study|Lost to Follow-up|1|||
161258251|NCT00754013|582325351|FG001|Overall Study|Lost to Follow-up|1|||
161258252|NCT00754013|582325350|FG000|Overall Study|didn't return after study termed|3|||
161258253|NCT00754013|582325351|FG001|Overall Study|didn't return after study termed|4|||
161258254|NCT01432574|582325355|FG000|Overall Study|Moved|2|||
161258255|NCT01432574|582325355|FG000|Overall Study|Not interested|1|||
161258256|NCT03135899|582325362|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258257|NCT03135899|582325363|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258258|NCT03135899|582325364|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258259|NCT03135899|582325365|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258260|NCT03135899|582325366|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258261|NCT03135899|582325367|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258262|NCT03135899|582325368|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
161258263|NCT03135899|582325369|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
161258264|NCT03135899|582325362|FG000|Overall Study|Withdrawal by Subject|0|||
161258265|NCT03135899|582325363|FG001|Overall Study|Withdrawal by Subject|0|||
161258266|NCT03135899|582325364|FG002|Overall Study|Withdrawal by Subject|0|||
161258267|NCT03135899|582325365|FG003|Overall Study|Withdrawal by Subject|0|||
161258268|NCT03135899|582325366|FG004|Overall Study|Withdrawal by Subject|0|||
161258269|NCT03135899|582325367|FG005|Overall Study|Withdrawal by Subject|2|||
161258270|NCT03135899|582325368|FG006|Overall Study|Withdrawal by Subject|0|||
161258271|NCT03135899|582325369|FG007|Overall Study|Withdrawal by Subject|0|||
161258272|NCT04373551|582325370|FG000|Overall Study|Lost to Follow-up|15|||
161258273|NCT04373551|582325370|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
161258274|NCT02914236|582325371|FG000|Overall Study|Lost to Follow-up|1|||
161258275|NCT01042535|582325372|FG000|Overall Study|disease progression prior to treatment|3|||
161258276|NCT01042535|582325372|FG000|Overall Study|disease progression during treatment|3|||
161258277|NCT01042535|582325372|FG000|Overall Study|complications from other disease|2|||
161258278|NCT03438539|582325373|FG000|Overall Study|Lost to Follow-up|8|||
161258279|NCT03438539|582325374|FG001|Overall Study|Lost to Follow-up|4|||
161258280|NCT03438539|582325375|FG002|Overall Study|Lost to Follow-up|10|||
161258281|NCT03438539|582325376|FG003|Overall Study|Lost to Follow-up|9|||
161258282|NCT03438539|582325377|FG004|Overall Study|Lost to Follow-up|3|||
161258283|NCT03438539|582325378|FG005|Overall Study|Lost to Follow-up|8|||
161258284|NCT00655850|582325379|FG000|Overall Study|Death|2|||
161258285|NCT00655850|582325379|FG000|Overall Study|Withdrawal by Subject|1|||
161258286|NCT00918463|582325380|FG000|Overall Study|Death|1|||
161258287|NCT00918463|582325380|FG000|Overall Study|Lack of Efficacy|1|||
161258288|NCT01715896|582325381|FG000|Overall Study|Lost to Follow-up|0|||
161258289|NCT01715896|582325382|FG001|Overall Study|Lost to Follow-up|2|||
161258290|NCT01715896|582325381|FG000|Overall Study|Withdrawal by Subject|1|||
161258291|NCT01715896|582325382|FG001|Overall Study|Withdrawal by Subject|4|||
161258292|NCT01715896|582325381|FG000|Overall Study|Other|2|||
161258293|NCT01715896|582325382|FG001|Overall Study|Other|5|||
161258294|NCT01045993|582325384|FG000|Overall Study|Treated-later found eligibility not met|0|||
161258295|NCT01045993|582325385|FG001|Overall Study|Treated-later found eligibility not met|1|||
161258296|NCT01045993|582325386|FG002|Overall Study|Treated-later found eligibility not met|0|||
160918074|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
160918075|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
161258297|NCT01045993|582325387|FG003|Overall Study|Treated-later found eligibility not met|0|||
161258298|NCT01659736|582325388|FG000|Treatment Period|Adverse Event|1|||
161258299|NCT01659736|582325389|FG001|Treatment Period|Adverse Event|1|||
160918076|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
160918077|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
160918078|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
160918079|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
160918080|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
160918081|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
160918082|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
160918083|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
160918084|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918085|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918086|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918087|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
160918088|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
160918089|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
160918090|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
160918091|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
160918092|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
160996890|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996891|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996892|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996893|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
160996894|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996895|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996896|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996897|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996898|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
161091090|NCT01718353|581723806|FG000|Overall Study|Principal Investigator's Decision|10|||
161091091|NCT01718353|581723807|FG001|Overall Study|Principal Investigator's Decision|4|||
161142997|NCT02495077|581907481|FG001|Overall Study|Protocol Violation|1|||
161142998|NCT02495077|581907482|FG002|Overall Study|Protocol Violation|0|||
161142999|NCT02495077|581907483|FG003|Overall Study|Protocol Violation|0|||
161143000|NCT02495077|581907480|FG000|Overall Study|Screen Failure|0|||
161143001|NCT02495077|581907481|FG001|Overall Study|Screen Failure|0|||
161143002|NCT02495077|581907482|FG002|Overall Study|Screen Failure|0|||
161143003|NCT02495077|581907483|FG003|Overall Study|Screen Failure|48|||
161143004|NCT02495077|581907480|FG000|Overall Study|Withdrawal by Subject|7|||
161143005|NCT02495077|581907481|FG001|Overall Study|Withdrawal by Subject|7|||
161143006|NCT02495077|581907482|FG002|Overall Study|Withdrawal by Subject|7|||
161143007|NCT02495077|581907483|FG003|Overall Study|Withdrawal by Subject|0|||
161091092|NCT01718353|581723806|FG000|Overall Study|Randomized but not treated|2|||
161091093|NCT01718353|581723807|FG001|Overall Study|Randomized but not treated|0|||
161091094|NCT01959516|581723808|FG000|Epoch 1|Adverse Event|4|||
161091095|NCT01959516|581723809|FG001|Epoch 1|Adverse Event|1|||
161091096|NCT01959516|581723808|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
161091097|NCT01959516|581723809|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
161091098|NCT01959516|581723808|FG000|Epoch 1|Subject withdrew consent|3|||
161091099|NCT01959516|581723809|FG001|Epoch 1|Subject withdrew consent|2|||
161091100|NCT01959516|581723808|FG000|Epoch 1|Administrative problems|1|||
161091101|NCT01959516|581723809|FG001|Epoch 1|Administrative problems|0|||
161091102|NCT01959516|581723808|FG000|Epoch 1|Use of prohibited treatment|1|||
161091103|NCT01959516|581723809|FG001|Epoch 1|Use of prohibited treatment|0|||
161091104|NCT01959516|581723808|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
161091105|NCT01959516|581723809|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
161091106|NCT01959516|581723808|FG000|Epoch 1|Protocol deviation|0|||
161091107|NCT01959516|581723809|FG001|Epoch 1|Protocol deviation|1|||
161091108|NCT01959516|581723808|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
161091109|NCT01959516|581723809|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
161091110|NCT01959516|581723808|FG000|Epoch 2|Subject withdrew consent|1|||
161091111|NCT01959516|581723809|FG001|Epoch 2|Subject withdrew consent|0|||
161091112|NCT01959516|581723808|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
161091113|NCT01959516|581723809|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
161091114|NCT02581631|581723818|FG000|Overall Study|Disease progression|29|||
161091115|NCT02581631|581723819|FG001|Overall Study|Disease progression|19|||
161091116|NCT02581631|581723820|FG002|Overall Study|Disease progression|13|||
161091117|NCT02581631|581723821|FG003|Overall Study|Disease progression|5|||
161091118|NCT02581631|581723822|FG004|Overall Study|Disease progression|8|||
161091119|NCT02581631|581723818|FG000|Overall Study|Study drug toxicity|4|||
161091120|NCT02581631|581723819|FG001|Overall Study|Study drug toxicity|6|||
160918093|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
160918094|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
160918095|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
160918096|NCT03720470|581094180|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918097|NCT03720470|581094181|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918098|NCT03720470|581094182|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918099|NCT03720470|581094183|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918100|NCT03720470|581094184|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
160918101|NCT03720470|581094185|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
160918102|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
160918103|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
160918104|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
160918105|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
160918106|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
160996899|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
160996900|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996901|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996902|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996903|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996904|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996905|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996906|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
160996907|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996908|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996909|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996910|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996911|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
160996912|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996913|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996914|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161143008|NCT02495077|581907480|FG000|Overall Study|Covid-19 research restrictions|1|||
161143009|NCT02495077|581907481|FG001|Overall Study|Covid-19 research restrictions|0|||
161143010|NCT02495077|581907482|FG002|Overall Study|Covid-19 research restrictions|0|||
161143011|NCT02495077|581907483|FG003|Overall Study|Covid-19 research restrictions|0|||
161143012|NCT02495077|581907480|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
161143013|NCT02495077|581907481|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
161143014|NCT02495077|581907482|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
161143015|NCT02495077|581907483|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
161143016|NCT02495077|581907480|FG000|Overall Study|Incarcerated|0|||
161143017|NCT02495077|581907481|FG001|Overall Study|Incarcerated|1|||
161143018|NCT02495077|581907482|FG002|Overall Study|Incarcerated|0|||
161143019|NCT02495077|581907483|FG003|Overall Study|Incarcerated|0|||
161143020|NCT02495077|581907480|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
161143021|NCT02495077|581907481|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
161143022|NCT02495077|581907482|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
161143023|NCT02495077|581907483|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
161143024|NCT02495077|581907480|FG000|Overall Study|Timing of transplant and randomization|0|||
161143025|NCT02495077|581907481|FG001|Overall Study|Timing of transplant and randomization|0|||
161143026|NCT02495077|581907482|FG002|Overall Study|Timing of transplant and randomization|5|||
161143027|NCT02495077|581907483|FG003|Overall Study|Timing of transplant and randomization|0|||
161143028|NCT02742649|581907484|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
161143029|NCT02742649|581907485|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161143030|NCT02742649|581907486|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161143031|NCT02742649|581907487|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161143032|NCT02742649|581907488|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
161143033|NCT02742649|581907484|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161143034|NCT02742649|581907485|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161143035|NCT02742649|581907486|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161143036|NCT02742649|581907487|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161143037|NCT02742649|581907488|FG004|Double-Blind Treatment Period|Adverse Event|0|||
161143038|NCT02742649|581907484|FG000|Open-Label Period|Lost to Follow-up|0|||
161143039|NCT02742649|581907485|FG001|Open-Label Period|Lost to Follow-up|0|||
161143040|NCT02742649|581907486|FG002|Open-Label Period|Lost to Follow-up|0|||
161143041|NCT02742649|581907487|FG003|Open-Label Period|Lost to Follow-up|0|||
161143042|NCT02742649|581907488|FG004|Open-Label Period|Lost to Follow-up|1|||
161143043|NCT00443560|581907490|FG000|Overall Study|No intrathecal dose|58|||
160918107|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
160918108|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918109|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918110|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
160918111|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918112|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918113|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
160918114|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918115|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918116|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918117|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
160918118|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
160918119|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
160918120|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918121|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
161091121|NCT02581631|581723820|FG002|Overall Study|Study drug toxicity|7|||
161258300|NCT01659736|582325388|FG000|Treatment Period|Protocol Violation|3|||
161258301|NCT01659736|582325389|FG001|Treatment Period|Protocol Violation|1|||
161258302|NCT01659736|582325388|FG000|Treatment Period|Withdrawal by Subject|1|||
161258303|NCT01659736|582325389|FG001|Treatment Period|Withdrawal by Subject|0|||
161258304|NCT01659736|582325388|FG000|3-month Follow-up|Lost to Follow-up|0|||
161258305|NCT01659736|582325389|FG001|3-month Follow-up|Lost to Follow-up|1|||
161258306|NCT00685802|582325396|FG000|Washout Period of 7 Days|Protocol Violation|2|||
161258307|NCT00685802|582325397|FG001|Washout Period of 7 Days|Protocol Violation|0|||
161258308|NCT00685802|582325396|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
161258309|NCT00685802|582325397|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161258310|NCT03336242|582325398|FG000|Overall Study|Adverse Event|0|||
161258311|NCT03336242|582325399|FG001|Overall Study|Adverse Event|1|||
161258312|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
161258313|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
161258314|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
161258315|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
161258316|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
161258317|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
161258318|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
161258319|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
161258320|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
161258321|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
161258322|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
161258323|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
161258324|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
161258325|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
161258326|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
161258327|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
161258328|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
161258329|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
161258330|NCT00384293|582325400|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
161258331|NCT00384293|582325401|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
161258332|NCT00384293|582325402|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
161258333|NCT00384293|582325400|FG000|Post-randomization Period|Adverse Event|0|||
161258334|NCT00384293|582325401|FG001|Post-randomization Period|Adverse Event|23|||
161258335|NCT00384293|582325402|FG002|Post-randomization Period|Adverse Event|7|||
161258336|NCT00384293|582325400|FG000|Post-randomization Period|Lost to Follow-up|0|||
161258337|NCT00384293|582325401|FG001|Post-randomization Period|Lost to Follow-up|2|||
161258338|NCT00384293|582325402|FG002|Post-randomization Period|Lost to Follow-up|1|||
161258339|NCT00384293|582325400|FG000|Post-randomization Period|Protocol Violation|0|||
161258340|NCT00384293|582325401|FG001|Post-randomization Period|Protocol Violation|1|||
161258341|NCT00384293|582325402|FG002|Post-randomization Period|Protocol Violation|0|||
161258342|NCT00384293|582325400|FG000|Post-randomization Period|Withdrawal by Subject|0|||
161258343|NCT00384293|582325401|FG001|Post-randomization Period|Withdrawal by Subject|8|||
161258344|NCT00384293|582325402|FG002|Post-randomization Period|Withdrawal by Subject|6|||
161258345|NCT00384293|582325400|FG000|Post-randomization Period|Trial Termination|0|||
161258346|NCT00384293|582325401|FG001|Post-randomization Period|Trial Termination|180|||
161258347|NCT00384293|582325402|FG002|Post-randomization Period|Trial Termination|204|||
161258348|NCT00384293|582325400|FG000|Post-randomization Period|Patient Randomized in Error|0|||
160918122|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918123|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918124|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
160918125|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
160918126|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918127|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918128|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
160918129|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918130|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918131|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
160918132|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
160918133|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
160918134|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
160918135|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
161091122|NCT02581631|581723821|FG003|Overall Study|Study drug toxicity|0|||
161258349|NCT00384293|582325401|FG001|Post-randomization Period|Patient Randomized in Error|0|||
161258350|NCT00384293|582325402|FG002|Post-randomization Period|Patient Randomized in Error|1|||
161258351|NCT03005067|582325403|FG000|Overall Study|Withdrawal by Subject|3|||
161258352|NCT03005067|582325404|FG001|Overall Study|Withdrawal by Subject|2|||
161258353|NCT03005067|582325403|FG000|Overall Study|Adverse Event|4|||
161258354|NCT03005067|582325404|FG001|Overall Study|Adverse Event|3|||
161258355|NCT03005067|582325403|FG000|Overall Study|Other (reason not specified)|3|||
161258356|NCT03005067|582325404|FG001|Overall Study|Other (reason not specified)|1|||
161258357|NCT03005067|582325403|FG000|Overall Study|Protocol Violation|0|||
161258358|NCT03005067|582325404|FG001|Overall Study|Protocol Violation|1|||
161258359|NCT00103038|582325410|FG000|Overall Study|Withdrawal by Subject|8|||
161258360|NCT00103038|582325410|FG000|Overall Study|Screen failure|3|||
161258361|NCT00103038|582325410|FG000|Overall Study|Death|1|||
161258362|NCT00103038|582325410|FG000|Overall Study|Physician Decision|1|||
161258363|NCT00355472|582325413|FG000|Overall Study|Physician Decision|1|||
161258364|NCT05445843|582325414|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
161258365|NCT05445843|582325415|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
161258366|NCT05445843|582325414|FG000|Overall Study|Progressive disease|17|||
161258367|NCT05445843|582325415|FG001|Overall Study|Progressive disease|9|||
161258368|NCT05445843|582325414|FG000|Overall Study|Physician Decision|16|||
161258369|NCT05445843|582325415|FG001|Overall Study|Physician Decision|4|||
161258370|NCT05445843|582325414|FG000|Overall Study|Death|6|||
161258371|NCT05445843|582325415|FG001|Overall Study|Death|3|||
161258372|NCT05445843|582325414|FG000|Overall Study|Subject decision|6|||
161258373|NCT05445843|582325415|FG001|Overall Study|Subject decision|2|||
161258374|NCT05445843|582325414|FG000|Overall Study|Adverse Event|2|||
161258375|NCT05445843|582325415|FG001|Overall Study|Adverse Event|0|||
161258376|NCT05307679|582325420|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
161258377|NCT05307679|582325421|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
161258378|NCT02310763|582325424|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161258379|NCT02310763|582325425|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161258380|NCT02310763|582325426|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
161258381|NCT02310763|582325424|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
161258382|NCT02310763|582325425|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
161258383|NCT02310763|582325426|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
161258384|NCT02310763|582325424|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
161258385|NCT02310763|582325425|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161258386|NCT02310763|582325426|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
161258387|NCT02310763|582325424|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
161258388|NCT02310763|582325425|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
161258389|NCT02310763|582325426|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
161258390|NCT02310763|582325424|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161258391|NCT02310763|582325425|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161258392|NCT02310763|582325426|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
161258393|NCT01731886|582325428|FG000|Overall Study|Death|1|||
161258394|NCT01731886|582325429|FG001|Overall Study|Death|0|||
161258395|NCT01731886|582325428|FG000|Overall Study|Never started treatment|0|||
161258396|NCT01731886|582325429|FG001|Overall Study|Never started treatment|1|||
161258397|NCT01731886|582325428|FG000|Overall Study|Non-compliant|1|||
161258398|NCT01731886|582325429|FG001|Overall Study|Non-compliant|0|||
161258399|NCT02280187|582325430|FG000|Overall Study|Lost to Follow-up|218|||
161258400|NCT03417830|582325433|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
161258401|NCT03417830|582325434|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
161258402|NCT02563769|582325435|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
161258403|NCT02563769|582325436|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
161258404|NCT02563769|582325437|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
161258405|NCT01192399|582325449|FG000|Overall Study|Lack of Efficacy|2|||
161258406|NCT00724373|582325451|FG000|Overall Study|Adverse Event|41|||
161258407|NCT00724373|582325451|FG000|Overall Study|Lack of Efficacy|82|||
160996915|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996916|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996917|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996918|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
160996919|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996920|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996921|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996922|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
160996923|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
161143044|NCT00443560|581907491|FG001|Overall Study|No intrathecal dose|26|||
161258408|NCT00724373|582325451|FG000|Overall Study|Lost to Follow-up|7|||
161258409|NCT00724373|582325451|FG000|Overall Study|Non-compliance|2|||
161258410|NCT00724373|582325451|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
161258411|NCT00724373|582325451|FG000|Overall Study|Participant moved away|1|||
161258412|NCT00724373|582325451|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
161258413|NCT00724373|582325451|FG000|Overall Study|Only to have 24 week regimen|1|||
161258414|NCT00724373|582325451|FG000|Overall Study|Viral Relapse|1|||
161258415|NCT00724373|582325451|FG000|Overall Study|Acute HCV infection|1|||
161258416|NCT00724373|582325451|FG000|Overall Study|Drug Relapse|1|||
161258417|NCT00724373|582325451|FG000|Overall Study|Tolerability|23|||
161258418|NCT02377063|582325452|FG000|Overall Study|Non-compliance|5|||
161258419|NCT01524913|582325453|FG000|Overall Study|Lost to Follow-up|4|||
161258420|NCT01524913|582325454|FG001|Overall Study|Lost to Follow-up|0|||
161258421|NCT01524913|582325455|FG002|Overall Study|Lost to Follow-up|0|||
161258422|NCT01221090|582327422|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
161258423|NCT01221090|582327423|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
161258424|NCT01221090|582327424|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
161258425|NCT01221090|582327425|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
161258426|NCT01221090|582327422|FG000|Overall Study|Withdrawal by Subject|0|||
161258427|NCT01221090|582327423|FG001|Overall Study|Withdrawal by Subject|22|||
161258428|NCT01221090|582327424|FG002|Overall Study|Withdrawal by Subject|27|||
161258429|NCT01221090|582327425|FG003|Overall Study|Withdrawal by Subject|2|||
161258430|NCT04507126|582327426|FG000|Overall Study|Withdrawal by Subject|3|||
161258431|NCT04507126|582327426|FG000|Overall Study|Protocol Violation|4|||
161258432|NCT04213209|582327427|FG000|Overall Study|Protocol Violation|1|||
161258433|NCT04213209|582327428|FG001|Overall Study|Protocol Violation|0|||
161258434|NCT04213209|582327429|FG002|Overall Study|Protocol Violation|0|||
161258435|NCT04213209|582327430|FG003|Overall Study|Protocol Violation|0|||
161258436|NCT04213209|582327431|FG004|Overall Study|Protocol Violation|0|||
161258437|NCT04213209|582327432|FG005|Overall Study|Protocol Violation|0|||
161258438|NCT00440466|582327434|FG000|Overall Study|Death|3|||
161258439|NCT00440466|582327435|FG001|Overall Study|Death|2|||
161258440|NCT00440466|582327436|FG002|Overall Study|Death|9|||
161258441|NCT00440466|582327434|FG000|Overall Study|Adverse Event|3|||
161258442|NCT00440466|582327435|FG001|Overall Study|Adverse Event|4|||
161258443|NCT00440466|582327436|FG002|Overall Study|Adverse Event|11|||
161258444|NCT00440466|582327434|FG000|Overall Study|Lost to Follow-up|1|||
161258445|NCT00440466|582327435|FG001|Overall Study|Lost to Follow-up|0|||
161258446|NCT00440466|582327436|FG002|Overall Study|Lost to Follow-up|2|||
161258447|NCT00440466|582327434|FG000|Overall Study|Physician Decision|2|||
161258448|NCT00440466|582327435|FG001|Overall Study|Physician Decision|0|||
161258449|NCT00440466|582327436|FG002|Overall Study|Physician Decision|1|||
161258450|NCT00440466|582327434|FG000|Overall Study|Protocol Violation|2|||
161258451|NCT00440466|582327435|FG001|Overall Study|Protocol Violation|0|||
161258452|NCT00440466|582327436|FG002|Overall Study|Protocol Violation|4|||
161258453|NCT00440466|582327434|FG000|Overall Study|Withdrawal by Subject|2|||
161258454|NCT00440466|582327435|FG001|Overall Study|Withdrawal by Subject|5|||
161258455|NCT00440466|582327436|FG002|Overall Study|Withdrawal by Subject|9|||
161258456|NCT00440466|582327434|FG000|Overall Study|Began Dialysis|0|||
161258457|NCT00440466|582327435|FG001|Overall Study|Began Dialysis|0|||
161258458|NCT00440466|582327436|FG002|Overall Study|Began Dialysis|1|||
161258459|NCT00440466|582327434|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
161258460|NCT00440466|582327435|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
161258461|NCT00440466|582327436|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
161340490|NCT00560404|582633533|FG001|Overall Study|Other withdrawal reason|5|||
161258462|NCT02065713|582327437|FG000|Overall Study|Adverse Event|0|||
161258463|NCT02065713|582327438|FG001|Overall Study|Adverse Event|1|||
161258464|NCT02065713|582327437|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161258465|NCT02065713|582327438|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161258466|NCT01223235|582327441|FG000|Overall Study|Withdrawal by Subject|1|||
161258467|NCT01014624|582327444|FG000|Overall Study|Adverse Event|0|||
161258468|NCT01014624|582327445|FG001|Overall Study|Adverse Event|1|||
161258469|NCT01014624|582327444|FG000|Overall Study|Protocol Violation|1|||
161258470|NCT01014624|582327445|FG001|Overall Study|Protocol Violation|0|||
161258471|NCT01014624|582327444|FG000|Overall Study|Withdrawal by Subject|1|||
161258472|NCT01014624|582327445|FG001|Overall Study|Withdrawal by Subject|0|||
161258473|NCT00754442|582327448|FG000|Overall Study|Withdrawal by Subject|5|||
161258474|NCT00754442|582327449|FG001|Overall Study|Withdrawal by Subject|3|||
161258475|NCT05560763|582327454|FG000|Overall Study|Withdrawal by Subject|4|||
161258476|NCT00296491|582327457|FG000|Overall Study|Low Pollen Counts|18|||
161258477|NCT00296491|582327458|FG001|Overall Study|Low Pollen Counts|26|||
161258478|NCT00296491|582327459|FG002|Overall Study|Low Pollen Counts|25|||
161258479|NCT00296491|582327460|FG003|Overall Study|Low Pollen Counts|16|||
161258480|NCT00296491|582327457|FG000|Overall Study|Protocol Violation|4|||
161340491|NCT02642042|582633540|FG000|Overall Study|Adverse Event|22|||
161340492|NCT02642042|582633540|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161340493|NCT02642042|582633540|FG000|Overall Study|Progression/Relapse|28|||
161340494|NCT02642042|582633540|FG000|Overall Study|Death|1|||
161340495|NCT02642042|582633540|FG000|Overall Study|Not Protocol Specified|2|||
161340496|NCT03260023|582633541|FG000|Overall Study|Adverse Event|0|||
161340497|NCT03260023|582633542|FG001|Overall Study|Adverse Event|0|||
161340498|NCT03260023|582633543|FG002|Overall Study|Adverse Event|4|||
161340499|NCT03260023|582633544|FG003|Overall Study|Adverse Event|4|||
161340500|NCT03260023|582633545|FG004|Overall Study|Adverse Event|4|||
161340501|NCT03260023|582633546|FG005|Overall Study|Adverse Event|1|||
161340502|NCT03260023|582633547|FG006|Overall Study|Adverse Event|2|||
161340503|NCT03260023|582633541|FG000|Overall Study|Clinical Progression|0|||
160918136|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
160918137|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
160918138|NCT03720470|581094180|FG000|Treatment Period: Final 4 Weeks|Other|0|||
160918139|NCT03720470|581094181|FG001|Treatment Period: Final 4 Weeks|Other|1|||
160918140|NCT03720470|581094182|FG002|Treatment Period: Final 4 Weeks|Other|0|||
160918141|NCT03720470|581094183|FG003|Treatment Period: Final 4 Weeks|Other|2|||
160918142|NCT03720470|581094184|FG004|Treatment Period: Final 4 Weeks|Other|1|||
160918143|NCT03720470|581094185|FG005|Treatment Period: Final 4 Weeks|Other|0|||
160918144|NCT00460031|581094186|FG000|Overall Study|Adverse Event|5|||
160918145|NCT00460031|581094186|FG000|Overall Study|Withdrawal by Subject|5|||
160918146|NCT00460031|581094186|FG000|Overall Study|Death|1|||
160918147|NCT01988103|581094191|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
160918148|NCT01988103|581094192|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
160918149|NCT01988103|581094193|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
160918150|NCT01988103|581094194|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
160918151|NCT01988103|581094195|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
160918152|NCT01988103|581094191|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
160918153|NCT01988103|581094192|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
160918154|NCT01988103|581094193|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
160918155|NCT01988103|581094194|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
160918156|NCT01988103|581094195|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
160918157|NCT01988103|581094191|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
160918158|NCT01988103|581094192|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
161258481|NCT00296491|582327458|FG001|Overall Study|Protocol Violation|6|||
161258482|NCT00296491|582327459|FG002|Overall Study|Protocol Violation|2|||
161258483|NCT00296491|582327460|FG003|Overall Study|Protocol Violation|3|||
161258484|NCT00296491|582327457|FG000|Overall Study|Adverse Event|1|||
161258485|NCT00296491|582327458|FG001|Overall Study|Adverse Event|3|||
161258486|NCT00296491|582327459|FG002|Overall Study|Adverse Event|1|||
161258487|NCT00296491|582327460|FG003|Overall Study|Adverse Event|4|||
161258488|NCT00296491|582327457|FG000|Overall Study|Withdrawn due to Asthma|0|||
161258489|NCT00296491|582327458|FG001|Overall Study|Withdrawn due to Asthma|0|||
161258490|NCT00296491|582327459|FG002|Overall Study|Withdrawn due to Asthma|0|||
161258491|NCT00296491|582327460|FG003|Overall Study|Withdrawn due to Asthma|4|||
161258492|NCT00296491|582327457|FG000|Overall Study|Withdrawal by Subject|7|||
161258493|NCT00296491|582327458|FG001|Overall Study|Withdrawal by Subject|3|||
161258494|NCT00296491|582327459|FG002|Overall Study|Withdrawal by Subject|3|||
161340504|NCT03260023|582633542|FG001|Overall Study|Clinical Progression|1|||
161340505|NCT03260023|582633543|FG002|Overall Study|Clinical Progression|3|||
161340506|NCT03260023|582633544|FG003|Overall Study|Clinical Progression|1|||
161258495|NCT00296491|582327460|FG003|Overall Study|Withdrawal by Subject|2|||
161258496|NCT00296491|582327457|FG000|Overall Study|Non-Compliance|12|||
161258497|NCT00296491|582327458|FG001|Overall Study|Non-Compliance|13|||
161258498|NCT00296491|582327459|FG002|Overall Study|Non-Compliance|10|||
161258499|NCT00296491|582327460|FG003|Overall Study|Non-Compliance|14|||
161258500|NCT00296491|582327457|FG000|Overall Study|Lost to Follow-up|0|||
161258501|NCT00296491|582327458|FG001|Overall Study|Lost to Follow-up|2|||
161258502|NCT00296491|582327459|FG002|Overall Study|Lost to Follow-up|2|||
161258503|NCT00296491|582327460|FG003|Overall Study|Lost to Follow-up|0|||
161340507|NCT03260023|582633545|FG004|Overall Study|Clinical Progression|0|||
161258504|NCT01929395|582327463|FG000|Overall Study|Did not complete - non-related toxicity|1|||
161258505|NCT01929395|582327464|FG001|Overall Study|Did not complete - non-related toxicity|0|||
161258506|NCT01929395|582327465|FG002|Overall Study|Did not complete - non-related toxicity|0|||
161258507|NCT01929395|582327463|FG000|Overall Study|Withdrawal by Subject|0|||
161258508|NCT01929395|582327464|FG001|Overall Study|Withdrawal by Subject|1|||
161258509|NCT01929395|582327465|FG002|Overall Study|Withdrawal by Subject|0|||
161258510|NCT01929395|582327463|FG000|Overall Study|Screen Fail|0|||
161258511|NCT01929395|582327464|FG001|Overall Study|Screen Fail|0|||
161258512|NCT01929395|582327465|FG002|Overall Study|Screen Fail|1|||
161258513|NCT03604341|582327466|FG000|Overall Study|Withdrawal by Subject|1|||
161258514|NCT03604341|582327467|FG001|Overall Study|Withdrawal by Subject|1|||
161258515|NCT03604341|582327466|FG000|Overall Study|Adverse Event|1|||
161258516|NCT03604341|582327467|FG001|Overall Study|Adverse Event|0|||
161258517|NCT03604341|582327466|FG000|Overall Study|Protocol Violation|0|||
161258518|NCT03604341|582327467|FG001|Overall Study|Protocol Violation|1|||
161258519|NCT00484419|582327468|FG000|Overall Study|Adverse Event|3|||
161258520|NCT00484419|582327469|FG001|Overall Study|Adverse Event|0|||
161258521|NCT00484419|582327470|FG002|Overall Study|Adverse Event|0|||
161258522|NCT00484419|582327468|FG000|Overall Study|Lost to Follow-up|1|||
161258523|NCT00484419|582327469|FG001|Overall Study|Lost to Follow-up|0|||
161258524|NCT00484419|582327470|FG002|Overall Study|Lost to Follow-up|2|||
161258525|NCT00484419|582327468|FG000|Overall Study|Withdrawal by Subject|3|||
161258526|NCT00484419|582327469|FG001|Overall Study|Withdrawal by Subject|1|||
161258527|NCT00484419|582327470|FG002|Overall Study|Withdrawal by Subject|1|||
161258528|NCT00484419|582327468|FG000|Overall Study|subject met discontinuation criteria|2|||
161258529|NCT00484419|582327469|FG001|Overall Study|subject met discontinuation criteria|2|||
161258530|NCT00484419|582327470|FG002|Overall Study|subject met discontinuation criteria|4|||
161258531|NCT00484419|582327468|FG000|Overall Study|required restricted medication|1|||
161258532|NCT00484419|582327469|FG001|Overall Study|required restricted medication|0|||
161258533|NCT00484419|582327470|FG002|Overall Study|required restricted medication|1|||
161258534|NCT00484419|582327468|FG000|Overall Study|Physician Decision|1|||
161258535|NCT00484419|582327469|FG001|Overall Study|Physician Decision|1|||
161258536|NCT00484419|582327470|FG002|Overall Study|Physician Decision|1|||
161258537|NCT00484419|582327468|FG000|Overall Study|subject unable to receive medication|1|||
161258538|NCT00484419|582327469|FG001|Overall Study|subject unable to receive medication|0|||
161258539|NCT00484419|582327470|FG002|Overall Study|subject unable to receive medication|0|||
161258540|NCT00484419|582327468|FG000|Overall Study|subject relocated|0|||
161258541|NCT00484419|582327469|FG001|Overall Study|subject relocated|1|||
161258542|NCT00484419|582327470|FG002|Overall Study|subject relocated|0|||
161258543|NCT00484419|582327468|FG000|Overall Study|sponsor decision, randomized in error|0|||
161258544|NCT00484419|582327469|FG001|Overall Study|sponsor decision, randomized in error|0|||
161258545|NCT00484419|582327470|FG002|Overall Study|sponsor decision, randomized in error|2|||
161258546|NCT01829113|582327471|FG000|Overall Study|Disease Progression|37|||
161258547|NCT01829113|582327472|FG001|Overall Study|Disease Progression|48|||
161258548|NCT01829113|582327471|FG000|Overall Study|Adverse Event|14|||
161258549|NCT01829113|582327472|FG001|Overall Study|Adverse Event|10|||
161258550|NCT01829113|582327471|FG000|Overall Study|Withdrawal by Subject|17|||
161258551|NCT01829113|582327472|FG001|Overall Study|Withdrawal by Subject|10|||
161258552|NCT01829113|582327471|FG000|Overall Study|Death|4|||
161258553|NCT01829113|582327472|FG001|Overall Study|Death|6|||
161258554|NCT01829113|582327471|FG000|Overall Study|Sponsor Decision|1|||
161258555|NCT01829113|582327472|FG001|Overall Study|Sponsor Decision|1|||
161258556|NCT01829113|582327471|FG000|Overall Study|No Study Treatment Received|3|||
161258557|NCT01829113|582327472|FG001|Overall Study|No Study Treatment Received|2|||
161258558|NCT01829113|582327471|FG000|Overall Study|Physician Decision|1|||
161258559|NCT01829113|582327472|FG001|Overall Study|Physician Decision|1|||
161258560|NCT01740791|582327473|FG000|Overall Study|Randomized but never treated|5|||
161258561|NCT01740791|582327474|FG001|Overall Study|Randomized but never treated|3|||
161258562|NCT01740791|582327475|FG002|Overall Study|Randomized but never treated|2|||
161258563|NCT01740791|582327476|FG003|Overall Study|Randomized but never treated|2|||
161258564|NCT01740791|582327477|FG004|Overall Study|Randomized but never treated|1|||
161258565|NCT01740791|582327478|FG005|Overall Study|Randomized but never treated|3|||
161258566|NCT01740791|582327473|FG000|Overall Study|Lost to Follow-up|2|||
161258567|NCT01740791|582327474|FG001|Overall Study|Lost to Follow-up|0|||
161258568|NCT01740791|582327475|FG002|Overall Study|Lost to Follow-up|2|||
161258569|NCT01740791|582327476|FG003|Overall Study|Lost to Follow-up|3|||
161340508|NCT03260023|582633546|FG005|Overall Study|Clinical Progression|0|||
161340509|NCT03260023|582633547|FG006|Overall Study|Clinical Progression|0|||
161258570|NCT01740791|582327477|FG004|Overall Study|Lost to Follow-up|2|||
161258571|NCT01740791|582327478|FG005|Overall Study|Lost to Follow-up|3|||
161258572|NCT01740791|582327473|FG000|Overall Study|Withdrew Consent|4|||
161258573|NCT01740791|582327474|FG001|Overall Study|Withdrew Consent|0|||
161258574|NCT01740791|582327475|FG002|Overall Study|Withdrew Consent|1|||
161258575|NCT01740791|582327476|FG003|Overall Study|Withdrew Consent|2|||
161340510|NCT03260023|582633541|FG000|Overall Study|Physician Decision|0|||
160918159|NCT01988103|581094193|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
160918160|NCT01988103|581094194|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160918161|NCT01988103|581094195|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
161258576|NCT01740791|582327477|FG004|Overall Study|Withdrew Consent|0|||
160996924|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996925|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996926|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996927|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996928|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996929|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
161143045|NCT00443560|581907490|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
161143046|NCT00443560|581907491|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
161143047|NCT01494038|581907496|FG000|Overall Study|Protocol Violation|1|||
161143048|NCT01494038|581907497|FG001|Overall Study|Protocol Violation|1|||
161143049|NCT01494038|581907496|FG000|Overall Study|Lost to Follow-up|18|||
161143050|NCT01494038|581907497|FG001|Overall Study|Lost to Follow-up|20|||
161143051|NCT01494038|581907496|FG000|Overall Study|Withdrawal by Subject|44|||
161143052|NCT01494038|581907497|FG001|Overall Study|Withdrawal by Subject|34|||
161143053|NCT01494038|581907496|FG000|Overall Study|Not able to get to clinic|21|||
161143054|NCT01494038|581907497|FG001|Overall Study|Not able to get to clinic|15|||
161143055|NCT01494038|581907496|FG000|Overall Study|Not willing to adhere to reqs|2|||
161143056|NCT01494038|581907497|FG001|Overall Study|Not willing to adhere to reqs|9|||
161143057|NCT01494038|581907496|FG000|Overall Study|Death|2|||
161143058|NCT01494038|581907497|FG001|Overall Study|Death|4|||
161143059|NCT02138110|581907502|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
161143060|NCT02138110|581907502|FG000|Overall Scaffold Implantation|Death|3|||
161143061|NCT01059812|581907505|FG000|Overall Study|Adverse Event|9|||
161143062|NCT01059812|581907506|FG001|Overall Study|Adverse Event|5|||
161143063|NCT01059812|581907505|FG000|Overall Study|Lack of Efficacy|2|||
161143064|NCT01059812|581907506|FG001|Overall Study|Lack of Efficacy|2|||
161143065|NCT01059812|581907505|FG000|Overall Study|Protocol Violation|3|||
161143066|NCT01059812|581907506|FG001|Overall Study|Protocol Violation|1|||
161143067|NCT01059812|581907505|FG000|Overall Study|Withdrawal Criteria|9|||
161143068|NCT01059812|581907506|FG001|Overall Study|Withdrawal Criteria|4|||
161143069|NCT01059812|581907505|FG000|Overall Study|Unclassified|14|||
161143070|NCT01059812|581907506|FG001|Overall Study|Unclassified|4|||
161143071|NCT00756002|581907510|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
161143072|NCT00756002|581907511|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161143073|NCT00756002|581907510|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161143074|NCT00756002|581907511|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161143075|NCT00756002|581907510|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161143076|NCT00756002|581907511|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
161143077|NCT00756002|581907510|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
161143078|NCT00756002|581907511|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
161143079|NCT00756002|581907510|FG000|Double-Blind Treatment Period|Other|2|||
161143080|NCT00756002|581907511|FG001|Double-Blind Treatment Period|Other|2|||
161143081|NCT04329923|581907515|FG000|Overall Study|Withdrawal by Subject|1|||
161143082|NCT04329923|581907516|FG001|Overall Study|Withdrawal by Subject|4|||
161143083|NCT04329923|581907517|FG002|Overall Study|Withdrawal by Subject|1|||
161143084|NCT04329923|581907518|FG003|Overall Study|Withdrawal by Subject|1|||
161143085|NCT04329923|581907519|FG004|Overall Study|Withdrawal by Subject|1|||
161143086|NCT04329923|581907520|FG005|Overall Study|Withdrawal by Subject|1|||
161143087|NCT04329923|581907515|FG000|Overall Study|early termination of study|0|||
161143088|NCT04329923|581907516|FG001|Overall Study|early termination of study|0|||
161143089|NCT04329923|581907517|FG002|Overall Study|early termination of study|0|||
161143090|NCT04329923|581907518|FG003|Overall Study|early termination of study|0|||
161143091|NCT04329923|581907519|FG004|Overall Study|early termination of study|1|||
161143092|NCT04329923|581907520|FG005|Overall Study|early termination of study|2|||
161143093|NCT04329923|581907515|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161143094|NCT04329923|581907516|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161143095|NCT04329923|581907517|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161143096|NCT04329923|581907518|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161143097|NCT04329923|581907519|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
161143098|NCT04329923|581907520|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
161143099|NCT03334214|581907521|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161143100|NCT03334214|581907522|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
161143101|NCT03334214|581907521|FG000|Overall Study|Withdrawal by Subject|0|||
161143102|NCT03334214|581907522|FG001|Overall Study|Withdrawal by Subject|1|||
161143103|NCT03334214|581907521|FG000|Overall Study|Other|1|||
161143104|NCT03334214|581907522|FG001|Overall Study|Other|0|||
161143105|NCT01702805|581907527|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
161143106|NCT01702805|581907528|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
161143107|NCT01702805|581907527|FG000|Overall Study|Incomplete Follow-up|18|||
161143108|NCT01702805|581907528|FG001|Overall Study|Incomplete Follow-up|15|||
161143109|NCT01702805|581907527|FG000|Overall Study|Vital Status Assessment Only|40|||
161258577|NCT01740791|582327478|FG005|Overall Study|Withdrew Consent|3|||
161143110|NCT01702805|581907528|FG001|Overall Study|Vital Status Assessment Only|39|||
161143111|NCT01702805|581907527|FG000|Overall Study|Lost to Follow-up|5|||
160996930|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996931|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996932|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996933|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996934|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996935|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
160996936|NCT03536884|581373698|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996937|NCT03536884|581373699|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996938|NCT03536884|581373700|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996939|NCT03536884|581373701|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996940|NCT03536884|581373702|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996941|NCT03536884|581373703|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996942|NCT03536884|581373704|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996943|NCT03536884|581373705|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996944|NCT03536884|581373706|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
160996945|NCT03536884|581373707|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996946|NCT03536884|581373708|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996947|NCT03536884|581373709|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
160996948|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996949|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996950|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996951|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996952|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996953|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996954|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996955|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996956|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
160996957|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
160996958|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
160996959|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
160996960|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996961|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996962|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996963|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996964|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996965|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996966|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996967|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996968|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
160996969|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
160996970|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
160996971|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
160996972|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996973|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996974|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996975|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996976|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996977|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996978|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996979|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996980|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996981|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996982|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
160996983|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
160996984|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996985|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996986|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996987|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996988|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996989|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996990|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996991|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996992|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996993|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996994|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
160996995|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
160996996|NCT03536884|581373698|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160996997|NCT03536884|581373699|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160996998|NCT03536884|581373700|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160996999|NCT03536884|581373701|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997000|NCT03536884|581373702|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997001|NCT03536884|581373703|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997002|NCT03536884|581373704|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997003|NCT03536884|581373705|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161258578|NCT01740791|582327473|FG000|Overall Study|Investigator's discretion|1|||
161258579|NCT01740791|582327474|FG001|Overall Study|Investigator's discretion|0|||
161258580|NCT01740791|582327475|FG002|Overall Study|Investigator's discretion|1|||
161258581|NCT01740791|582327476|FG003|Overall Study|Investigator's discretion|0|||
161258582|NCT01740791|582327477|FG004|Overall Study|Investigator's discretion|0|||
161258583|NCT01740791|582327478|FG005|Overall Study|Investigator's discretion|1|||
161258584|NCT01740791|582327473|FG000|Overall Study|Adverse Event|0|||
161258585|NCT01740791|582327474|FG001|Overall Study|Adverse Event|0|||
161258586|NCT01740791|582327475|FG002|Overall Study|Adverse Event|0|||
161258587|NCT01740791|582327476|FG003|Overall Study|Adverse Event|0|||
161258588|NCT01740791|582327477|FG004|Overall Study|Adverse Event|0|||
161258589|NCT01740791|582327478|FG005|Overall Study|Adverse Event|1|||
161258590|NCT02674386|582327481|FG000|Overall Study|Lost to Follow-up|0|||
161258591|NCT02674386|582327482|FG001|Overall Study|Lost to Follow-up|1|||
161258592|NCT02674386|582327483|FG002|Overall Study|Lost to Follow-up|1|||
161258593|NCT02674386|582327481|FG000|Overall Study|Withdrawal by Subject|0|||
161258594|NCT02674386|582327482|FG001|Overall Study|Withdrawal by Subject|4|||
161258595|NCT02674386|582327483|FG002|Overall Study|Withdrawal by Subject|0|||
161258596|NCT02674386|582327481|FG000|Overall Study|Other|0|||
161258597|NCT02674386|582327482|FG001|Overall Study|Other|1|||
161258598|NCT02674386|582327483|FG002|Overall Study|Other|0|||
161258599|NCT02674386|582327481|FG000|Overall Study|Enrolled but not evaluated|0|||
161258600|NCT02674386|582327482|FG001|Overall Study|Enrolled but not evaluated|4|||
161258601|NCT02674386|582327483|FG002|Overall Study|Enrolled but not evaluated|0|||
161258602|NCT02462486|582327484|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161258603|NCT02462486|582327485|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
161258604|NCT02462486|582327486|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
161258605|NCT02462486|582327484|FG000|Overall Study|Adverse Event|53|||
161258606|NCT02462486|582327485|FG001|Overall Study|Adverse Event|48|||
161258607|NCT02462486|582327486|FG002|Overall Study|Adverse Event|21|||
161258608|NCT02462486|582327484|FG000|Overall Study|Lack of Efficacy|6|||
161258609|NCT02462486|582327485|FG001|Overall Study|Lack of Efficacy|12|||
161258610|NCT02462486|582327486|FG002|Overall Study|Lack of Efficacy|3|||
161258611|NCT02462486|582327484|FG000|Overall Study|Lost to Follow-up|3|||
161258612|NCT02462486|582327485|FG001|Overall Study|Lost to Follow-up|4|||
161258613|NCT02462486|582327486|FG002|Overall Study|Lost to Follow-up|2|||
161258614|NCT02462486|582327484|FG000|Overall Study|Withdrawal by Subject|25|||
161258615|NCT02462486|582327485|FG001|Overall Study|Withdrawal by Subject|22|||
161258616|NCT02462486|582327486|FG002|Overall Study|Withdrawal by Subject|19|||
161258617|NCT02462486|582327484|FG000|Overall Study|Protocol Violation|3|||
161258618|NCT02462486|582327485|FG001|Overall Study|Protocol Violation|1|||
161258619|NCT02462486|582327486|FG002|Overall Study|Protocol Violation|1|||
161258620|NCT02462486|582327484|FG000|Overall Study|Reason not Specified|3|||
161258621|NCT02462486|582327485|FG001|Overall Study|Reason not Specified|4|||
161258622|NCT02462486|582327486|FG002|Overall Study|Reason not Specified|3|||
161258623|NCT04706507|582327491|FG000|Overall Study|Death|45|||
161258624|NCT04706507|582327492|FG001|Overall Study|Death|22|||
161258625|NCT04706507|582327491|FG000|Overall Study|Unable to adhere|0|||
160997004|NCT03536884|581373706|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997005|NCT03536884|581373707|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
160997006|NCT03536884|581373708|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
161091123|NCT02581631|581723822|FG004|Overall Study|Study drug toxicity|3|||
161258626|NCT04706507|582327492|FG001|Overall Study|Unable to adhere|2|||
161258627|NCT04706507|582327491|FG000|Overall Study|Lost to Follow-up|13|||
161258628|NCT04706507|582327492|FG001|Overall Study|Lost to Follow-up|12|||
161258629|NCT04706507|582327491|FG000|Overall Study|Withdrawal of consent|1|||
161258630|NCT04706507|582327492|FG001|Overall Study|Withdrawal of consent|1|||
161258631|NCT04706507|582327491|FG000|Overall Study|Patient or LAR refuses further participation|0|||
161258632|NCT04706507|582327492|FG001|Overall Study|Patient or LAR refuses further participation|3|||
161258633|NCT04099641|582327497|FG000|Overall Study|Death|46|||
161258634|NCT04099641|582327498|FG001|Overall Study|Death|12|||
161258635|NCT04099641|582327497|FG000|Overall Study|Lost to Follow-up|1|||
160997007|NCT03536884|581373709|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
160997008|NCT03722446|581373710|FG000|Overall Study|Protocol Violation|15|||
160997009|NCT03722446|581373711|FG001|Overall Study|Protocol Violation|2|||
160997010|NCT03425643|581373718|FG000|Overall Study|Withdrawal by Subject|10|||
160997011|NCT03425643|581373719|FG001|Overall Study|Withdrawal by Subject|12|||
160997012|NCT03425643|581373718|FG000|Overall Study|Lost to Follow-up|2|||
160997013|NCT03425643|581373719|FG001|Overall Study|Lost to Follow-up|0|||
160997014|NCT03425643|581373718|FG000|Overall Study|Death|109|||
160997015|NCT03425643|581373719|FG001|Overall Study|Death|141|||
160997016|NCT03425643|581373718|FG000|Overall Study|Ongoing in study|276|||
160997017|NCT03425643|581373719|FG001|Overall Study|Ongoing in study|247|||
160997018|NCT04133363|581373720|FG000|Overall Study|Lost to Follow-up|2|||
160997019|NCT04133363|581373721|FG001|Overall Study|Lost to Follow-up|1|||
160997020|NCT04133363|581373722|FG002|Overall Study|Lost to Follow-up|4|||
160997021|NCT07214922|581373729|FG000|Overall Study|Adverse Event|0|||
160997022|NCT07214922|581373730|FG001|Overall Study|Adverse Event|0|||
160997023|NCT07214922|581373731|FG002|Overall Study|Adverse Event|1|||
160997024|NCT07214922|581373732|FG003|Overall Study|Adverse Event|0|||
160997025|NCT07214922|581373729|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
160997026|NCT07214922|581373730|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
160997027|NCT07214922|581373731|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
160997028|NCT07214922|581373732|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
161143112|NCT01702805|581907528|FG001|Overall Study|Lost to Follow-up|5|||
161143113|NCT01588197|581907537|FG000|Overall Study|Lack of Efficacy|0|||
161143114|NCT01588197|581907538|FG001|Overall Study|Lack of Efficacy|1|||
161258636|NCT04099641|582327498|FG001|Overall Study|Lost to Follow-up|0|||
161258637|NCT04099641|582327497|FG000|Overall Study|Withdrawal by Subject|2|||
161258638|NCT04099641|582327498|FG001|Overall Study|Withdrawal by Subject|0|||
161258639|NCT02470091|582327500|FG000|Overall Study|Withdrawal by Subject|1|||
161258640|NCT02470091|582327501|FG001|Overall Study|Withdrawal by Subject|0|||
161258641|NCT02470091|582327500|FG000|Overall Study|Ineligible|0|||
161258642|NCT02470091|582327501|FG001|Overall Study|Ineligible|2|||
161143115|NCT01588197|581907537|FG000|Overall Study|No MRI|1|||
161143116|NCT01588197|581907538|FG001|Overall Study|No MRI|0|||
161143117|NCT01844076|581907545|FG000|Overall Study|Adverse Event|1|||
161143118|NCT01844076|581907546|FG001|Overall Study|Adverse Event|0|||
161143119|NCT01844076|581907547|FG002|Overall Study|Adverse Event|0|||
161143120|NCT01844076|581907548|FG003|Overall Study|Adverse Event|0|||
161143121|NCT01844076|581907545|FG000|Overall Study|Withdrawal by Subject|1|||
161143122|NCT01844076|581907546|FG001|Overall Study|Withdrawal by Subject|0|||
161143123|NCT01844076|581907547|FG002|Overall Study|Withdrawal by Subject|0|||
161143124|NCT01844076|581907548|FG003|Overall Study|Withdrawal by Subject|0|||
161143125|NCT02088034|581907556|FG000|Overall Study|Lost to Follow-up|1|||
161143126|NCT02088034|581907557|FG001|Overall Study|Lost to Follow-up|1|||
161143127|NCT02088034|581907558|FG002|Overall Study|Lost to Follow-up|0|||
161143128|NCT02088034|581907556|FG000|Overall Study|Pregnancy|2|||
161143129|NCT02088034|581907557|FG001|Overall Study|Pregnancy|1|||
161143130|NCT02088034|581907558|FG002|Overall Study|Pregnancy|2|||
161143131|NCT00308620|581907559|FG000|Overall Study|Death|1|||
161143132|NCT00308620|581907560|FG001|Overall Study|Death|1|||
161143133|NCT00308620|581907561|FG002|Overall Study|Death|0|||
161143134|NCT00308620|581907559|FG000|Overall Study|Lost to Follow-up|0|||
161143135|NCT00308620|581907560|FG001|Overall Study|Lost to Follow-up|0|||
161143136|NCT00308620|581907561|FG002|Overall Study|Lost to Follow-up|1|||
161143137|NCT02424149|581907565|FG000|Overall Study|surgery cancelled|2|||
161143138|NCT02424149|581907566|FG001|Overall Study|surgery cancelled|0|||
161143139|NCT02424149|581907565|FG000|Overall Study|Withdrawal by Subject|0|||
161258643|NCT00303667|582327503|FG000|Overall Study|Death|0|||
161258644|NCT00303667|582327504|FG001|Overall Study|Death|4|||
161258645|NCT01029392|582327505|FG000|Overall Study|Withdrawal by Subject|18|||
161258646|NCT01029392|582327506|FG001|Overall Study|Withdrawal by Subject|11|||
161258647|NCT01029392|582327505|FG000|Overall Study|Physician Decision|2|||
161258648|NCT01029392|582327506|FG001|Overall Study|Physician Decision|0|||
161258649|NCT01103479|582327507|FG000|Overall Study|Up to date with CRC screening|1|||
161143140|NCT02424149|581907566|FG001|Overall Study|Withdrawal by Subject|1|||
161143141|NCT01025336|581907567|FG000|Overall Study|Protocol Violation|0|||
161258650|NCT01103479|582327508|FG001|Overall Study|Up to date with CRC screening|9|||
161258651|NCT01103479|582327509|FG002|Overall Study|Up to date with CRC screening|12|||
161258652|NCT01103479|582327507|FG000|Overall Study|Family history of CRC|1|||
161258653|NCT01103479|582327508|FG001|Overall Study|Family history of CRC|0|||
160997029|NCT00482729|581374851|FG000|Overall Study|Adverse Event|29|||
160997030|NCT00482729|581374852|FG001|Overall Study|Adverse Event|33|||
160997031|NCT00482729|581374851|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
160997032|NCT00482729|581374852|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
161143142|NCT01025336|581907568|FG001|Overall Study|Protocol Violation|0|||
161143143|NCT01025336|581907569|FG002|Overall Study|Protocol Violation|0|||
161258654|NCT01103479|582327509|FG002|Overall Study|Family history of CRC|2|||
161258655|NCT01103479|582327507|FG000|Overall Study|Active cancer|1|||
161258656|NCT01103479|582327508|FG001|Overall Study|Active cancer|0|||
161258657|NCT01103479|582327509|FG002|Overall Study|Active cancer|0|||
161258658|NCT01103479|582327507|FG000|Overall Study|Saw non-study physician|2|||
161340511|NCT03260023|582633542|FG001|Overall Study|Physician Decision|0|||
161340512|NCT03260023|582633543|FG002|Overall Study|Physician Decision|0|||
161340513|NCT03260023|582633544|FG003|Overall Study|Physician Decision|1|||
161340514|NCT03260023|582633545|FG004|Overall Study|Physician Decision|1|||
161258659|NCT01103479|582327508|FG001|Overall Study|Saw non-study physician|0|||
161258660|NCT01103479|582327509|FG002|Overall Study|Saw non-study physician|0|||
161258661|NCT01523587|582327510|FG000|Overall Study|Other than listed|5|||
161258662|NCT01523587|582327511|FG001|Overall Study|Other than listed|5|||
161258663|NCT01523587|582327510|FG000|Overall Study|Worsening of underlying cancer disease|19|||
161258664|NCT01523587|582327511|FG001|Overall Study|Worsening of underlying cancer disease|34|||
161258665|NCT01523587|582327510|FG000|Overall Study|Adverse Event|68|||
161258666|NCT01523587|582327511|FG001|Overall Study|Adverse Event|52|||
161258667|NCT01523587|582327510|FG000|Overall Study|Protocol Violation|5|||
161258668|NCT01523587|582327511|FG001|Overall Study|Protocol Violation|3|||
161258669|NCT01523587|582327510|FG000|Overall Study|Lost to Follow-up|2|||
161258670|NCT01523587|582327511|FG001|Overall Study|Lost to Follow-up|2|||
161258671|NCT01523587|582327510|FG000|Overall Study|Withdrawal by Subject|28|||
161258672|NCT01523587|582327511|FG001|Overall Study|Withdrawal by Subject|20|||
161258673|NCT01523587|582327510|FG000|Overall Study|Withdrew due to Progressive disease|265|||
161258674|NCT01523587|582327511|FG001|Overall Study|Withdrew due to Progressive disease|279|||
161258675|NCT01523587|582327510|FG000|Overall Study|Randomised but bot treated|6|||
161258676|NCT01523587|582327511|FG001|Overall Study|Randomised but bot treated|2|||
161258677|NCT01298778|582327512|FG000|Overall Study|Lost to Follow-up|2|||
161340515|NCT03260023|582633546|FG005|Overall Study|Physician Decision|0|||
161258678|NCT01298778|582327513|FG001|Overall Study|Lost to Follow-up|3|||
161258679|NCT01298778|582327512|FG000|Overall Study|Incorrect use of VAS|1|||
161258680|NCT01298778|582327513|FG001|Overall Study|Incorrect use of VAS|0|||
161258681|NCT01298778|582327512|FG000|Overall Study|Withdrawal by Subject|0|||
161258682|NCT01298778|582327513|FG001|Overall Study|Withdrawal by Subject|1|||
161258683|NCT01298778|582327512|FG000|Overall Study|Protocol Violation|0|||
161258684|NCT01298778|582327513|FG001|Overall Study|Protocol Violation|1|||
161258685|NCT01298778|582327512|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
161258686|NCT01298778|582327513|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
161258687|NCT02709486|582327514|FG000|Overall Study|Adverse Event|2|||
161258688|NCT02709486|582327515|FG001|Overall Study|Adverse Event|5|||
161258689|NCT02709486|582327516|FG002|Overall Study|Adverse Event|3|||
161258690|NCT02709486|582327514|FG000|Overall Study|Death|0|||
161258691|NCT02709486|582327515|FG001|Overall Study|Death|0|||
161258692|NCT02709486|582327516|FG002|Overall Study|Death|2|||
161258693|NCT02709486|582327514|FG000|Overall Study|Insufficient clinical response|7|||
161258694|NCT02709486|582327515|FG001|Overall Study|Insufficient clinical response|3|||
161258695|NCT02709486|582327516|FG002|Overall Study|Insufficient clinical response|3|||
161258696|NCT02709486|582327514|FG000|Overall Study|Lost to Follow-up|3|||
161258697|NCT02709486|582327515|FG001|Overall Study|Lost to Follow-up|2|||
161258698|NCT02709486|582327516|FG002|Overall Study|Lost to Follow-up|2|||
161258699|NCT02709486|582327514|FG000|Overall Study|Other|0|||
161258700|NCT02709486|582327515|FG001|Overall Study|Other|2|||
161258701|NCT02709486|582327516|FG002|Overall Study|Other|3|||
161258702|NCT02709486|582327514|FG000|Overall Study|Withdrawal by Subject|32|||
161258703|NCT02709486|582327515|FG001|Overall Study|Withdrawal by Subject|22|||
161258704|NCT02709486|582327516|FG002|Overall Study|Withdrawal by Subject|32|||
161258705|NCT00384176|582327523|FG000|Overall Study|Death|239|||
161258706|NCT00384176|582327524|FG001|Overall Study|Death|247|||
161258707|NCT00384176|582327525|FG002|Overall Study|Death|105|||
161340516|NCT03260023|582633547|FG006|Overall Study|Physician Decision|0|||
161340517|NCT03260023|582633541|FG000|Overall Study|Withdrawal by Subject|0|||
161340518|NCT03260023|582633542|FG001|Overall Study|Withdrawal by Subject|0|||
161258708|NCT00384176|582327523|FG000|Overall Study|Withdrawal by Subject|52|||
161258709|NCT00384176|582327524|FG001|Overall Study|Withdrawal by Subject|48|||
161258710|NCT00384176|582327525|FG002|Overall Study|Withdrawal by Subject|22|||
161258711|NCT00384176|582327523|FG000|Overall Study|Lost to Follow-up|16|||
161258712|NCT00384176|582327524|FG001|Overall Study|Lost to Follow-up|18|||
161258713|NCT00384176|582327525|FG002|Overall Study|Lost to Follow-up|4|||
161258714|NCT00384176|582327523|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
161258715|NCT00384176|582327524|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
161258716|NCT00384176|582327525|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
161258717|NCT00384176|582327523|FG000|Overall Study|Longer QTC as Visit 1|1|||
161258718|NCT00384176|582327524|FG001|Overall Study|Longer QTC as Visit 1|0|||
161258719|NCT00384176|582327525|FG002|Overall Study|Longer QTC as Visit 1|0|||
161258720|NCT00384176|582327523|FG000|Overall Study|Toxicity of treatment|1|||
161258721|NCT00384176|582327524|FG001|Overall Study|Toxicity of treatment|0|||
161258722|NCT00384176|582327525|FG002|Overall Study|Toxicity of treatment|0|||
161258723|NCT00384176|582327523|FG000|Overall Study|Did not receive study treatment|0|||
161258724|NCT00384176|582327524|FG001|Overall Study|Did not receive study treatment|1|||
161258725|NCT00384176|582327525|FG002|Overall Study|Did not receive study treatment|1|||
161258726|NCT00384176|582327523|FG000|Overall Study|Physician Decision|0|||
161258727|NCT00384176|582327524|FG001|Overall Study|Physician Decision|2|||
161258728|NCT00384176|582327525|FG002|Overall Study|Physician Decision|0|||
161258729|NCT00384176|582327523|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
161258730|NCT00384176|582327524|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
161258731|NCT00384176|582327525|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
161258732|NCT02691741|582327526|FG000|Overall Study|Adverse Event|0|||
161258733|NCT02691741|582327527|FG001|Overall Study|Adverse Event|2|||
161258734|NCT02691741|582327526|FG000|Overall Study|Lost to Follow-up|1|||
161258735|NCT02691741|582327527|FG001|Overall Study|Lost to Follow-up|0|||
161258736|NCT02691741|582327526|FG000|Overall Study|Physician Decision|0|||
161258737|NCT02691741|582327527|FG001|Overall Study|Physician Decision|1|||
161258738|NCT02691741|582327526|FG000|Overall Study|Withdrawal by Subject|0|||
161258739|NCT02691741|582327527|FG001|Overall Study|Withdrawal by Subject|4|||
161258740|NCT03465436|582327528|FG000|Period 1|Protocol Violation|0|||
161258741|NCT03465436|582327529|FG001|Period 1|Protocol Violation|0|||
161258742|NCT03465436|582327530|FG002|Period 1|Protocol Violation|1|||
161258743|NCT03465436|582327531|FG003|Period 1|Protocol Violation|0|||
161258744|NCT03465436|582327528|FG000|Period 2|Protocol Violation|0|||
161258745|NCT03465436|582327529|FG001|Period 2|Protocol Violation|1|||
161258746|NCT03465436|582327530|FG002|Period 2|Protocol Violation|0|||
161258747|NCT03465436|582327531|FG003|Period 2|Protocol Violation|0|||
161258748|NCT03465436|582327528|FG000|Period 3|Protocol Violation|1|||
161258749|NCT03465436|582327529|FG001|Period 3|Protocol Violation|1|||
161258750|NCT03465436|582327530|FG002|Period 3|Protocol Violation|0|||
161258751|NCT03465436|582327531|FG003|Period 3|Protocol Violation|0|||
161258752|NCT03465436|582327528|FG000|Period 4|Protocol Violation|0|||
161258753|NCT03465436|582327529|FG001|Period 4|Protocol Violation|0|||
161258754|NCT03465436|582327530|FG002|Period 4|Protocol Violation|1|||
161258755|NCT03465436|582327531|FG003|Period 4|Protocol Violation|0|||
161258756|NCT02697773|582327532|FG000|Overall Study|Adverse Event|2|||
161258757|NCT02697773|582327533|FG001|Overall Study|Adverse Event|1|||
161258758|NCT02697773|582327534|FG002|Overall Study|Adverse Event|2|||
161258759|NCT02697773|582327532|FG000|Overall Study|Death|0|||
161258760|NCT02697773|582327533|FG001|Overall Study|Death|0|||
161258761|NCT02697773|582327534|FG002|Overall Study|Death|2|||
161258762|NCT02697773|582327532|FG000|Overall Study|Lack of Efficacy|4|||
161258763|NCT02697773|582327533|FG001|Overall Study|Lack of Efficacy|6|||
161258764|NCT02697773|582327534|FG002|Overall Study|Lack of Efficacy|6|||
161258765|NCT02697773|582327532|FG000|Overall Study|Lost to Follow-up|5|||
161258766|NCT02697773|582327533|FG001|Overall Study|Lost to Follow-up|5|||
161258767|NCT02697773|582327534|FG002|Overall Study|Lost to Follow-up|7|||
161258768|NCT02697773|582327532|FG000|Overall Study|Other|15|||
161258769|NCT02697773|582327533|FG001|Overall Study|Other|11|||
161258770|NCT02697773|582327534|FG002|Overall Study|Other|10|||
161258771|NCT02697773|582327532|FG000|Overall Study|Protocol Violation|1|||
161258772|NCT02697773|582327533|FG001|Overall Study|Protocol Violation|1|||
161258773|NCT02697773|582327534|FG002|Overall Study|Protocol Violation|0|||
161258774|NCT02697773|582327532|FG000|Overall Study|Withdrawal by Subject|10|||
161258775|NCT02697773|582327533|FG001|Overall Study|Withdrawal by Subject|13|||
161258776|NCT02697773|582327534|FG002|Overall Study|Withdrawal by Subject|13|||
161258777|NCT02697773|582327532|FG000|Overall Study|Randomized but not treated|1|||
161258778|NCT02697773|582327533|FG001|Overall Study|Randomized but not treated|1|||
161258779|NCT02697773|582327534|FG002|Overall Study|Randomized but not treated|0|||
161258780|NCT00842530|582327535|FG000|Overall Study|Serious adverse event|0|||
161258781|NCT00842530|582327536|FG001|Overall Study|Serious adverse event|6|||
160997033|NCT00482729|581374851|FG000|Overall Study|Hyperglycemia Criteria|7|||
160997034|NCT00482729|581374852|FG001|Overall Study|Hyperglycemia Criteria|5|||
160997035|NCT00482729|581374851|FG000|Overall Study|Lack of Efficacy|4|||
160997036|NCT00482729|581374852|FG001|Overall Study|Lack of Efficacy|16|||
160997037|NCT00482729|581374851|FG000|Overall Study|Lost to Follow-up|86|||
160997038|NCT00482729|581374852|FG001|Overall Study|Lost to Follow-up|66|||
161258782|NCT00842530|582327535|FG000|Overall Study|Other adverse event|6|||
161258783|NCT00842530|582327536|FG001|Overall Study|Other adverse event|1|||
161258784|NCT00842530|582327535|FG000|Overall Study|Protocol Violation|32|||
161258785|NCT00842530|582327536|FG001|Overall Study|Protocol Violation|14|||
161258786|NCT00842530|582327535|FG000|Overall Study|Lost to Follow-up|6|||
161258787|NCT00842530|582327536|FG001|Overall Study|Lost to Follow-up|8|||
161258788|NCT00842530|582327535|FG000|Overall Study|Withdrawal by Subject|73|||
161258789|NCT00842530|582327536|FG001|Overall Study|Withdrawal by Subject|28|||
160997039|NCT00482729|581374851|FG000|Overall Study|Physician Decision|10|||
161258790|NCT02939950|582327537|FG000|Overall Study|Lost to Follow-up|13|||
161258791|NCT02939950|582327538|FG001|Overall Study|Lost to Follow-up|16|||
161258792|NCT02939950|582327537|FG000|Overall Study|Positive slit lamp findings|0|||
161258793|NCT02939950|582327538|FG001|Overall Study|Positive slit lamp findings|1|||
161258794|NCT02939950|582327537|FG000|Overall Study|Chalazion upper lid|0|||
161258795|NCT02939950|582327538|FG001|Overall Study|Chalazion upper lid|1|||
161258796|NCT02939950|582327537|FG000|Overall Study|Lack of motivation|0|||
161258797|NCT02939950|582327538|FG001|Overall Study|Lack of motivation|2|||
161258798|NCT02939950|582327537|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
161258799|NCT02939950|582327538|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
161258800|NCT02939950|582327537|FG000|Overall Study|Military orders|1|||
161258801|NCT02939950|582327538|FG001|Overall Study|Military orders|0|||
161258802|NCT02939950|582327537|FG000|Overall Study|Participant Relocated|5|||
161258803|NCT02939950|582327538|FG001|Overall Study|Participant Relocated|3|||
161143144|NCT01025336|581907570|FG003|Overall Study|Protocol Violation|2|||
161143145|NCT01025336|581907571|FG004|Overall Study|Protocol Violation|0|||
161143146|NCT03794986|581907572|FG000|Overall Study|0 Sessions Attended|34|||
161143147|NCT03794986|581907573|FG001|Overall Study|0 Sessions Attended|37|||
161143148|NCT03794986|581907572|FG000|Overall Study|Withdrawal by Subject|4|||
161258804|NCT02939950|582327537|FG000|Overall Study|Study related symptoms|8|||
161258805|NCT02939950|582327538|FG001|Overall Study|Study related symptoms|8|||
161258806|NCT02939950|582327537|FG000|Overall Study|Unacceptable lens movement|2|||
161258807|NCT02939950|582327538|FG001|Overall Study|Unacceptable lens movement|0|||
161258808|NCT02939950|582327537|FG000|Overall Study|Protocol Violation|6|||
161258809|NCT02939950|582327538|FG001|Overall Study|Protocol Violation|3|||
161258810|NCT02939950|582327537|FG000|Overall Study|Physician Decision|2|||
161258811|NCT02939950|582327538|FG001|Overall Study|Physician Decision|0|||
161258812|NCT02939950|582327537|FG000|Overall Study|Pregnancy|6|||
161258813|NCT02939950|582327538|FG001|Overall Study|Pregnancy|7|||
160997040|NCT00482729|581374852|FG001|Overall Study|Physician Decision|7|||
161143149|NCT03794986|581907573|FG001|Overall Study|Withdrawal by Subject|6|||
161143150|NCT03794986|581907572|FG000|Overall Study|Protocol Violation|1|||
161143151|NCT03794986|581907573|FG001|Overall Study|Protocol Violation|0|||
161143152|NCT00923091|581907574|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
161143153|NCT00923091|581907575|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
161143154|NCT00923091|581907576|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
161143155|NCT00923091|581907577|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
161143156|NCT00923091|581907578|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
161143157|NCT00923091|581907579|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
161143158|NCT00923091|581907580|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
161143159|NCT00923091|581907581|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
161143160|NCT00923091|581907582|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161143161|NCT00923091|581907583|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161143162|NCT00923091|581907584|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161143163|NCT00923091|581907585|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161143164|NCT00923091|581907586|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
161143165|NCT00923091|581907574|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
161258814|NCT02939950|582327537|FG000|Overall Study|Withdrawal by Subject|12|||
161258815|NCT02939950|582327538|FG001|Overall Study|Withdrawal by Subject|28|||
161258816|NCT02939950|582327537|FG000|Overall Study|Adverse Event|7|||
160997041|NCT00482729|581374851|FG000|Overall Study|Pregnancy|4|||
160997042|NCT00482729|581374852|FG001|Overall Study|Pregnancy|2|||
160997043|NCT00482729|581374851|FG000|Overall Study|Protocol Violation|10|||
160997044|NCT00482729|581374852|FG001|Overall Study|Protocol Violation|18|||
160997045|NCT00482729|581374851|FG000|Overall Study|Withdrawal by Subject|67|||
160997046|NCT00482729|581374852|FG001|Overall Study|Withdrawal by Subject|69|||
160997047|NCT01090024|581374857|FG000|Period 1|Met exclusion criteria|0|||
160997048|NCT01090024|581374858|FG001|Period 1|Met exclusion criteria|0|||
160997049|NCT01090024|581374859|FG002|Period 1|Met exclusion criteria|0|||
160997050|NCT01090024|581374860|FG003|Period 1|Met exclusion criteria|0|||
160997051|NCT01090024|581374861|FG004|Period 1|Met exclusion criteria|0|||
160997052|NCT01090024|581374862|FG005|Period 1|Met exclusion criteria|0|||
160997053|NCT01090024|581374863|FG006|Period 1|Met exclusion criteria|0|||
160997054|NCT01090024|581374864|FG007|Period 1|Met exclusion criteria|0|||
160997055|NCT01090024|581374865|FG008|Period 1|Met exclusion criteria|0|||
160997056|NCT01090024|581374866|FG009|Period 1|Met exclusion criteria|0|||
160997057|NCT01090024|581374867|FG010|Period 1|Met exclusion criteria|0|||
160997058|NCT01090024|581374868|FG011|Period 1|Met exclusion criteria|0|||
160997059|NCT01090024|581374869|FG012|Period 1|Met exclusion criteria|0|||
160997060|NCT01090024|581374870|FG013|Period 1|Met exclusion criteria|0|||
160997061|NCT01090024|581374871|FG014|Period 1|Met exclusion criteria|1|||
160997062|NCT01090024|581374872|FG015|Period 1|Met exclusion criteria|0|||
160997063|NCT01090024|581374873|FG016|Period 1|Met exclusion criteria|0|||
160997064|NCT01090024|581374874|FG017|Period 1|Met exclusion criteria|0|||
160997065|NCT01090024|581374857|FG000|Period 1|Adverse Event|0|||
160997066|NCT01090024|581374858|FG001|Period 1|Adverse Event|0|||
161258817|NCT02939950|582327538|FG001|Overall Study|Adverse Event|3|||
161258818|NCT02939950|582327537|FG000|Overall Study|Randomized, not dispensed|1|||
160997067|NCT01090024|581374859|FG002|Period 1|Adverse Event|0|||
160997068|NCT01090024|581374860|FG003|Period 1|Adverse Event|0|||
160997069|NCT01090024|581374861|FG004|Period 1|Adverse Event|0|||
160997070|NCT01090024|581374862|FG005|Period 1|Adverse Event|0|||
160997071|NCT01090024|581374863|FG006|Period 1|Adverse Event|0|||
160997072|NCT01090024|581374864|FG007|Period 1|Adverse Event|0|||
160997073|NCT01090024|581374865|FG008|Period 1|Adverse Event|0|||
161258819|NCT02939950|582327538|FG001|Overall Study|Randomized, not dispensed|0|||
161258820|NCT02939950|582327537|FG000|Overall Study|Ineligible at Baseline|2|||
161258821|NCT02939950|582327538|FG001|Overall Study|Ineligible at Baseline|8|||
161258822|NCT02243293|582327539|FG000|Overall Study|Adverse Event|1|||
161258823|NCT02243293|582327540|FG001|Overall Study|Adverse Event|0|||
161258824|NCT02243293|582327541|FG002|Overall Study|Adverse Event|0|||
161143166|NCT00923091|581907575|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
161143167|NCT00923091|581907576|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161143168|NCT00923091|581907577|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
161143169|NCT00923091|581907578|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
161143170|NCT00923091|581907579|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
161143171|NCT00923091|581907580|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161143172|NCT00923091|581907581|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
161143173|NCT00923091|581907582|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161143174|NCT00923091|581907583|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161143175|NCT00923091|581907584|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161143176|NCT00923091|581907585|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161258825|NCT02243293|582327542|FG003|Overall Study|Adverse Event|0|||
161258826|NCT02243293|582327543|FG004|Overall Study|Adverse Event|0|||
161258827|NCT02243293|582327544|FG005|Overall Study|Adverse Event|0|||
161258828|NCT02243293|582327545|FG006|Overall Study|Adverse Event|0|||
161258829|NCT02243293|582327546|FG007|Overall Study|Adverse Event|0|||
161258830|NCT02243293|582327547|FG008|Overall Study|Adverse Event|0|||
161258831|NCT02243293|582327548|FG009|Overall Study|Adverse Event|0|||
161258832|NCT02243293|582327549|FG010|Overall Study|Adverse Event|0|||
161258833|NCT02243293|582327550|FG011|Overall Study|Adverse Event|0|||
161258834|NCT02243293|582327551|FG012|Overall Study|Adverse Event|0|||
161258835|NCT02243293|582327552|FG013|Overall Study|Adverse Event|0|||
161258836|NCT02243293|582327553|FG014|Overall Study|Adverse Event|0|||
161258837|NCT02243293|582327554|FG015|Overall Study|Adverse Event|1|||
161258838|NCT02243293|582327555|FG016|Overall Study|Adverse Event|0|||
161258839|NCT02243293|582327556|FG017|Overall Study|Adverse Event|0|||
161258840|NCT02243293|582327557|FG018|Overall Study|Adverse Event|0|||
161258841|NCT02243293|582327558|FG019|Overall Study|Adverse Event|0|||
161258842|NCT02243293|582327559|FG020|Overall Study|Adverse Event|1|||
161258843|NCT02243293|582327560|FG021|Overall Study|Adverse Event|0|||
161258844|NCT02243293|582327539|FG000|Overall Study|Withdrawal by Subject|1|||
161258845|NCT02243293|582327540|FG001|Overall Study|Withdrawal by Subject|0|||
161143177|NCT00923091|581907586|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
161143178|NCT00923091|581907574|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161143179|NCT00923091|581907575|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161143180|NCT00923091|581907576|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
161143181|NCT00923091|581907577|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
161143182|NCT00923091|581907578|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
161143183|NCT00923091|581907579|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
161143184|NCT00923091|581907580|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
161143185|NCT00923091|581907581|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
161143186|NCT00923091|581907582|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161143187|NCT00923091|581907583|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161143188|NCT00923091|581907584|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161143189|NCT00923091|581907585|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161143190|NCT00923091|581907586|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
161258846|NCT02243293|582327541|FG002|Overall Study|Withdrawal by Subject|0|||
161258847|NCT02243293|582327542|FG003|Overall Study|Withdrawal by Subject|0|||
161258848|NCT02243293|582327543|FG004|Overall Study|Withdrawal by Subject|0|||
161258849|NCT02243293|582327544|FG005|Overall Study|Withdrawal by Subject|0|||
161258850|NCT02243293|582327545|FG006|Overall Study|Withdrawal by Subject|0|||
160918162|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
160918163|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
160918164|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
160918165|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
160918166|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
160918167|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
161258851|NCT02243293|582327546|FG007|Overall Study|Withdrawal by Subject|0|||
160918168|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
161258852|NCT02243293|582327547|FG008|Overall Study|Withdrawal by Subject|0|||
161258853|NCT02243293|582327548|FG009|Overall Study|Withdrawal by Subject|1|||
161258854|NCT02243293|582327549|FG010|Overall Study|Withdrawal by Subject|0|||
161258855|NCT02243293|582327550|FG011|Overall Study|Withdrawal by Subject|1|||
161258856|NCT02243293|582327551|FG012|Overall Study|Withdrawal by Subject|0|||
161340519|NCT03260023|582633543|FG002|Overall Study|Withdrawal by Subject|0|||
160918169|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
160918170|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
161258857|NCT02243293|582327552|FG013|Overall Study|Withdrawal by Subject|0|||
161258858|NCT02243293|582327553|FG014|Overall Study|Withdrawal by Subject|0|||
161258859|NCT02243293|582327554|FG015|Overall Study|Withdrawal by Subject|0|||
161258860|NCT02243293|582327555|FG016|Overall Study|Withdrawal by Subject|0|||
161258861|NCT02243293|582327556|FG017|Overall Study|Withdrawal by Subject|0|||
161258862|NCT02243293|582327557|FG018|Overall Study|Withdrawal by Subject|0|||
161258863|NCT02243293|582327558|FG019|Overall Study|Withdrawal by Subject|0|||
161258864|NCT02243293|582327559|FG020|Overall Study|Withdrawal by Subject|0|||
161258865|NCT02243293|582327560|FG021|Overall Study|Withdrawal by Subject|1|||
161258866|NCT02243293|582327539|FG000|Overall Study|Lost to Follow-up|0|||
161258867|NCT02243293|582327540|FG001|Overall Study|Lost to Follow-up|1|||
161258868|NCT02243293|582327541|FG002|Overall Study|Lost to Follow-up|1|||
161258869|NCT02243293|582327542|FG003|Overall Study|Lost to Follow-up|1|||
161258870|NCT02243293|582327543|FG004|Overall Study|Lost to Follow-up|0|||
161258871|NCT02243293|582327544|FG005|Overall Study|Lost to Follow-up|0|||
161258872|NCT02243293|582327545|FG006|Overall Study|Lost to Follow-up|3|||
161258873|NCT02243293|582327546|FG007|Overall Study|Lost to Follow-up|0|||
161258874|NCT02243293|582327547|FG008|Overall Study|Lost to Follow-up|0|||
161258875|NCT02243293|582327548|FG009|Overall Study|Lost to Follow-up|0|||
161258876|NCT02243293|582327549|FG010|Overall Study|Lost to Follow-up|0|||
161258877|NCT02243293|582327550|FG011|Overall Study|Lost to Follow-up|2|||
161258878|NCT02243293|582327551|FG012|Overall Study|Lost to Follow-up|0|||
161258879|NCT02243293|582327552|FG013|Overall Study|Lost to Follow-up|0|||
161258880|NCT02243293|582327553|FG014|Overall Study|Lost to Follow-up|0|||
161258881|NCT02243293|582327554|FG015|Overall Study|Lost to Follow-up|0|||
161258882|NCT02243293|582327555|FG016|Overall Study|Lost to Follow-up|3|||
161258883|NCT02243293|582327556|FG017|Overall Study|Lost to Follow-up|1|||
161258884|NCT02243293|582327557|FG018|Overall Study|Lost to Follow-up|0|||
161258885|NCT02243293|582327558|FG019|Overall Study|Lost to Follow-up|0|||
161258886|NCT02243293|582327559|FG020|Overall Study|Lost to Follow-up|1|||
161258887|NCT02243293|582327560|FG021|Overall Study|Lost to Follow-up|2|||
161258888|NCT02243293|582327539|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
161258889|NCT02243293|582327540|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
161258890|NCT02243293|582327541|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
161258891|NCT02243293|582327542|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
161258892|NCT02243293|582327543|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
161258893|NCT02243293|582327544|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
161258894|NCT02243293|582327545|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
161258895|NCT02243293|582327546|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
161258896|NCT02243293|582327547|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
161258897|NCT02243293|582327548|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
161258898|NCT02243293|582327549|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
161258899|NCT02243293|582327550|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
161258900|NCT02243293|582327551|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
161258901|NCT02243293|582327552|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
161258902|NCT02243293|582327553|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
161258903|NCT02243293|582327554|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
161258904|NCT02243293|582327555|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
161258905|NCT02243293|582327556|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
161258906|NCT02243293|582327557|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
161258907|NCT02243293|582327558|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
161258908|NCT02243293|582327559|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
161258909|NCT02243293|582327560|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
161258910|NCT02243293|582327539|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
161258911|NCT02243293|582327540|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
161258912|NCT02243293|582327541|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
161258913|NCT02243293|582327542|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
161258914|NCT02243293|582327543|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
161258915|NCT02243293|582327544|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
161258916|NCT02243293|582327545|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
161258917|NCT02243293|582327546|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
161258918|NCT02243293|582327547|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
161258919|NCT02243293|582327548|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
161258920|NCT02243293|582327549|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
161258921|NCT02243293|582327550|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
161258922|NCT02243293|582327551|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
161258923|NCT02243293|582327552|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
161258924|NCT02243293|582327553|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
161258925|NCT02243293|582327554|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
161258926|NCT02243293|582327555|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
160918171|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
160918172|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
160918173|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
160918174|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
160918175|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
160918176|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
160918177|NCT01988103|581094191|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
160918178|NCT01988103|581094192|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
160918179|NCT01988103|581094193|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
160918180|NCT01988103|581094194|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
160918181|NCT01988103|581094195|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
160918182|NCT01946425|581094199|FG000|Overall Study|Protocol Violation|1|||
160918183|NCT01946425|581094200|FG001|Overall Study|Protocol Violation|0|||
160918184|NCT01946425|581094199|FG000|Overall Study|Withdrawal by Subject|1|||
160918185|NCT01946425|581094200|FG001|Overall Study|Withdrawal by Subject|0|||
160918186|NCT05682326|581094206|FG000|Overall Study|Withdrawal by Subject|1|||
160918187|NCT05682326|581094207|FG001|Overall Study|Withdrawal by Subject|0|||
160918188|NCT01402544|581094208|FG000|Overall Study|Withdrawal by Subject|6|||
160918189|NCT01113801|581094209|FG000|Overall Study|Adverse Event|4|||
160918190|NCT01113801|581094210|FG001|Overall Study|Adverse Event|0|||
160918191|NCT01113801|581094211|FG002|Overall Study|Adverse Event|2|||
160918192|NCT01113801|581094212|FG003|Overall Study|Adverse Event|6|||
160918193|NCT01113801|581094209|FG000|Overall Study|Death|4|||
160918194|NCT01113801|581094210|FG001|Overall Study|Death|5|||
160918195|NCT01113801|581094211|FG002|Overall Study|Death|3|||
160918196|NCT01113801|581094212|FG003|Overall Study|Death|4|||
160918197|NCT01113801|581094209|FG000|Overall Study|Protocol Violation|0|||
160918198|NCT01113801|581094210|FG001|Overall Study|Protocol Violation|1|||
160918199|NCT01113801|581094211|FG002|Overall Study|Protocol Violation|0|||
160918200|NCT01113801|581094212|FG003|Overall Study|Protocol Violation|0|||
160918201|NCT01113801|581094209|FG000|Overall Study|Withdrawal by Subject|9|||
160918202|NCT01113801|581094210|FG001|Overall Study|Withdrawal by Subject|7|||
160918203|NCT01113801|581094211|FG002|Overall Study|Withdrawal by Subject|7|||
160918204|NCT01113801|581094212|FG003|Overall Study|Withdrawal by Subject|8|||
160918205|NCT01113801|581094209|FG000|Overall Study|Physician Decision|2|||
160918206|NCT01113801|581094210|FG001|Overall Study|Physician Decision|2|||
160918207|NCT01113801|581094211|FG002|Overall Study|Physician Decision|3|||
160918208|NCT01113801|581094212|FG003|Overall Study|Physician Decision|3|||
160918209|NCT01113801|581094209|FG000|Overall Study|Sponsor Decision|15|||
160918210|NCT01113801|581094210|FG001|Overall Study|Sponsor Decision|21|||
160918211|NCT01113801|581094211|FG002|Overall Study|Sponsor Decision|20|||
160918212|NCT01113801|581094212|FG003|Overall Study|Sponsor Decision|15|||
160918213|NCT01113801|581094209|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
160918214|NCT01113801|581094210|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
160918215|NCT01113801|581094211|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
160918216|NCT01113801|581094212|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
160918217|NCT01949051|581094216|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
160918218|NCT01949051|581094217|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160918219|NCT01949051|581094218|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
161340520|NCT03260023|582633544|FG003|Overall Study|Withdrawal by Subject|0|||
160918220|NCT01949051|581094219|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
160918221|NCT01949051|581094220|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160918222|NCT01949051|581094221|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
160918223|NCT01949051|581094216|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
160918224|NCT01949051|581094217|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
161258927|NCT02243293|582327556|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
161258928|NCT02243293|582327557|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
161258929|NCT02243293|582327558|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
161258930|NCT02243293|582327559|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
161258931|NCT02243293|582327560|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
161258932|NCT00402025|582327564|FG000|Overall Study|Adverse Event|0|||
161258933|NCT00402025|582327565|FG001|Overall Study|Adverse Event|0|||
161258934|NCT00402025|582327566|FG002|Overall Study|Adverse Event|2|||
161258935|NCT00402025|582327564|FG000|Overall Study|Death|0|||
161258936|NCT00402025|582327565|FG001|Overall Study|Death|1|||
161258937|NCT00402025|582327566|FG002|Overall Study|Death|5|||
161258938|NCT00402025|582327564|FG000|Overall Study|Disease Progression|1|||
160918225|NCT01949051|581094218|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160918226|NCT01949051|581094219|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160997074|NCT01090024|581374866|FG009|Period 1|Adverse Event|1|||
161143191|NCT00923091|581907574|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161258939|NCT00402025|582327565|FG001|Overall Study|Disease Progression|1|||
161258940|NCT00402025|582327566|FG002|Overall Study|Disease Progression|2|||
160918227|NCT01949051|581094220|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160918228|NCT01949051|581094221|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
160918229|NCT01949051|581094216|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918230|NCT01949051|581094217|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918231|NCT01949051|581094218|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918232|NCT01949051|581094219|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918233|NCT01949051|581094220|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
160918234|NCT01949051|581094221|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
161340521|NCT03260023|582633545|FG004|Overall Study|Withdrawal by Subject|3|||
161340522|NCT03260023|582633546|FG005|Overall Study|Withdrawal by Subject|0|||
161340523|NCT03260023|582633547|FG006|Overall Study|Withdrawal by Subject|0|||
161340524|NCT03260023|582633541|FG000|Overall Study|Under trial intervention|0|||
161340525|NCT03260023|582633542|FG001|Overall Study|Under trial intervention|0|||
161340526|NCT03260023|582633543|FG002|Overall Study|Under trial intervention|2|||
161340527|NCT03260023|582633544|FG003|Overall Study|Under trial intervention|5|||
161340528|NCT03260023|582633545|FG004|Overall Study|Under trial intervention|3|||
161340529|NCT03260023|582633546|FG005|Overall Study|Under trial intervention|0|||
161340530|NCT03260023|582633547|FG006|Overall Study|Under trial intervention|0|||
161340531|NCT05035407|582633550|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
161340532|NCT05035407|582633551|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161340533|NCT05035407|582633552|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161340534|NCT05035407|582633553|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
160918235|NCT01949051|581094216|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918236|NCT01949051|581094217|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
160918237|NCT01949051|581094218|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
161340535|NCT05035407|582633554|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161340536|NCT05035407|582633555|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
161340537|NCT04220021|582633556|FG000|Overall Study|Withdrawal by Subject|11|||
161340538|NCT04220021|582633556|FG000|Overall Study|Physician Decision|2|||
161340539|NCT04220021|582633556|FG000|Overall Study|Non-study related illness|5|||
161340540|NCT04513366|582633557|FG000|Treatment Phase|Withdrawal by Subject|6|||
161340541|NCT04513366|582633558|FG001|Treatment Phase|Withdrawal by Subject|8|||
161340542|NCT04513366|582633559|FG002|Treatment Phase|Withdrawal by Subject|3|||
161340543|NCT04513366|582633557|FG000|Treatment Phase|Lost to Follow-up|1|||
161340544|NCT04513366|582633558|FG001|Treatment Phase|Lost to Follow-up|2|||
161340545|NCT04513366|582633559|FG002|Treatment Phase|Lost to Follow-up|5|||
161340546|NCT04513366|582633557|FG000|Treatment Phase|Other than Specified|1|||
161340547|NCT04513366|582633558|FG001|Treatment Phase|Other than Specified|0|||
161340548|NCT04513366|582633559|FG002|Treatment Phase|Other than Specified|2|||
161340549|NCT04513366|582633557|FG000|Treatment Phase|Physician Decision|2|||
160918238|NCT01949051|581094219|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918239|NCT01949051|581094220|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918240|NCT01949051|581094221|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
160918241|NCT01949051|581094216|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918242|NCT01949051|581094217|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918243|NCT01949051|581094218|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
160918244|NCT01949051|581094219|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918245|NCT01949051|581094220|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918246|NCT01949051|581094221|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
160918247|NCT01506479|581094223|FG000|Overall Study|Lost to Follow-up|1|||
160918248|NCT01506479|581094224|FG001|Overall Study|Lost to Follow-up|2|||
160918249|NCT01506479|581094225|FG002|Overall Study|Lost to Follow-up|2|||
160918250|NCT01506479|581094223|FG000|Overall Study|Withdrawal by Subject|1|||
160918251|NCT01506479|581094224|FG001|Overall Study|Withdrawal by Subject|2|||
160918252|NCT01506479|581094225|FG002|Overall Study|Withdrawal by Subject|1|||
160918253|NCT01506479|581094223|FG000|Overall Study|Missing assessment|1|||
160918254|NCT01506479|581094224|FG001|Overall Study|Missing assessment|0|||
160918255|NCT01506479|581094225|FG002|Overall Study|Missing assessment|0|||
160918256|NCT01506479|581094223|FG000|Overall Study|Adverse Event|0|||
160918257|NCT01506479|581094224|FG001|Overall Study|Adverse Event|1|||
160918258|NCT01506479|581094225|FG002|Overall Study|Adverse Event|0|||
160918259|NCT01846507|581094226|FG000|Overall Study|Lost to Follow-up|4|||
160918260|NCT01846507|581094226|FG000|Overall Study|Protocol Violation|1|||
160918261|NCT01846507|581094226|FG000|Overall Study|Missing data|2|||
160918262|NCT01314443|581094227|FG000|Overall Study|Withdrawal by Subject|2|||
160918263|NCT01314443|581094228|FG001|Overall Study|Withdrawal by Subject|1|||
160918264|NCT01314443|581094229|FG002|Overall Study|Withdrawal by Subject|1|||
160918265|NCT01314443|581094230|FG003|Overall Study|Withdrawal by Subject|1|||
160918266|NCT01314443|581094227|FG000|Overall Study|Protocol Violation|2|||
160918267|NCT01314443|581094228|FG001|Overall Study|Protocol Violation|2|||
160918268|NCT01314443|581094229|FG002|Overall Study|Protocol Violation|1|||
160918269|NCT01314443|581094230|FG003|Overall Study|Protocol Violation|1|||
160918270|NCT04545866|581094232|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
160918271|NCT04545866|581094233|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
160918272|NCT04545866|581094232|FG000|Overall Study|Withdrawal by Physician|1|||
160918273|NCT04545866|581094233|FG001|Overall Study|Withdrawal by Physician|0|||
160918274|NCT05247866|581094234|FG000|Overall Study|Adverse Event|2|||
160918275|NCT05247866|581094234|FG000|Overall Study|Lack of Efficacy|1|||
160918276|NCT05247866|581094234|FG000|Overall Study|Protocol Violation|1|||
160918277|NCT05247866|581094234|FG000|Overall Study|Withdrawal by Subject|3|||
160918278|NCT04463719|581094239|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
160918279|NCT04463719|581094240|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
161258941|NCT00402025|582327564|FG000|Overall Study|Physician Decision|1|||
161258942|NCT00402025|582327565|FG001|Overall Study|Physician Decision|1|||
161258943|NCT00402025|582327566|FG002|Overall Study|Physician Decision|0|||
161258944|NCT00402025|582327564|FG000|Overall Study|Participant Decision|0|||
161258945|NCT00402025|582327565|FG001|Overall Study|Participant Decision|0|||
161258946|NCT00402025|582327566|FG002|Overall Study|Participant Decision|1|||
161258947|NCT02985879|582327601|FG000|Overall Study|Adverse Event|7|||
161258948|NCT02985879|582327602|FG001|Overall Study|Adverse Event|9|||
161258949|NCT02985879|582327603|FG002|Overall Study|Adverse Event|7|||
161258950|NCT02985879|582327601|FG000|Overall Study|Withdrew consent|6|||
161258951|NCT02985879|582327602|FG001|Overall Study|Withdrew consent|8|||
161258952|NCT02985879|582327603|FG002|Overall Study|Withdrew consent|10|||
161258953|NCT02985879|582327601|FG000|Overall Study|Lost to Follow-up|1|||
161258954|NCT02985879|582327602|FG001|Overall Study|Lost to Follow-up|0|||
161258955|NCT02985879|582327603|FG002|Overall Study|Lost to Follow-up|2|||
161258956|NCT02985879|582327601|FG000|Overall Study|Other, not specified|62|||
161258957|NCT02985879|582327602|FG001|Overall Study|Other, not specified|58|||
161258958|NCT02985879|582327603|FG002|Overall Study|Other, not specified|58|||
161258959|NCT03940703|582328934|FG000|Overall Study|Still under treatment|31|||
161258960|NCT03940703|582328935|FG001|Overall Study|Still under treatment|0|||
161258961|NCT02658487|582328936|FG000|Overall Study|Death|2|||
161258962|NCT02658487|582328936|FG000|Overall Study|Disease progression|10|||
161258963|NCT02658487|582328936|FG000|Overall Study|Alternative therapy|1|||
161258964|NCT02658487|582328936|FG000|Overall Study|Adverse Event|1|||
161258965|NCT02658487|582328936|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
161258966|NCT02658487|582328936|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
161258967|NCT01885182|582328937|FG000|Overall Study|Adverse Event|11|||
161258968|NCT01885182|582328938|FG001|Overall Study|Adverse Event|13|||
161258969|NCT01885182|582328937|FG000|Overall Study|Withdrawal by Subject|13|||
161258970|NCT01885182|582328938|FG001|Overall Study|Withdrawal by Subject|6|||
161258971|NCT01885182|582328937|FG000|Overall Study|Lost to Follow-up|2|||
161258972|NCT01885182|582328938|FG001|Overall Study|Lost to Follow-up|2|||
161258973|NCT01885182|582328937|FG000|Overall Study|Lack of Efficacy|8|||
161258974|NCT01885182|582328938|FG001|Overall Study|Lack of Efficacy|1|||
161258975|NCT04146363|582328939|FG000|Induction Period|Adverse Event|1|||
161258976|NCT04146363|582328940|FG001|Induction Period|Adverse Event|2|||
161258977|NCT04146363|582328941|FG002|Induction Period|Adverse Event|0|||
161258978|NCT04146363|582328942|FG003|Induction Period|Adverse Event|0|||
161258979|NCT04146363|582328943|FG004|Induction Period|Adverse Event|0|||
161258980|NCT04146363|582328944|FG005|Induction Period|Adverse Event|0|||
161258981|NCT04146363|582328945|FG006|Induction Period|Adverse Event|0|||
161258982|NCT04146363|582328946|FG007|Induction Period|Adverse Event|0|||
161258983|NCT04146363|582328947|FG008|Induction Period|Adverse Event|0|||
161258984|NCT04146363|582328948|FG009|Induction Period|Adverse Event|0|||
161258985|NCT04146363|582328949|FG010|Induction Period|Adverse Event|0|||
161258986|NCT04146363|582328939|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
161258987|NCT04146363|582328940|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
160918280|NCT04463719|581094241|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
160918281|NCT02436356|581094242|FG000|Overall Study|Excluded by MRI Screening|0|||
160918282|NCT02436356|581094243|FG001|Overall Study|Excluded by MRI Screening|0|||
160918283|NCT02436356|581094244|FG002|Overall Study|Excluded by MRI Screening|2|||
160918284|NCT02436356|581094242|FG000|Overall Study|Lost to Follow-up|0|||
160997075|NCT01090024|581374867|FG010|Period 1|Adverse Event|0|||
160918285|NCT02436356|581094243|FG001|Overall Study|Lost to Follow-up|1|||
160918286|NCT02436356|581094244|FG002|Overall Study|Lost to Follow-up|0|||
161258988|NCT04146363|582328941|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
161258989|NCT04146363|582328942|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
161258990|NCT04146363|582328943|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
161258991|NCT04146363|582328944|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
161258992|NCT04146363|582328945|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
161258993|NCT04146363|582328946|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
161258994|NCT04146363|582328947|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
161258995|NCT04146363|582328948|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
161258996|NCT04146363|582328949|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
160918287|NCT02436356|581094242|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
160997076|NCT01090024|581374868|FG011|Period 1|Adverse Event|1|||
160918288|NCT02436356|581094243|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
160918289|NCT02436356|581094244|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
160918290|NCT02436356|581094242|FG000|Overall Study|Excluded due to other medical conditions|3|||
160918291|NCT02436356|581094243|FG001|Overall Study|Excluded due to other medical conditions|0|||
160918292|NCT02436356|581094244|FG002|Overall Study|Excluded due to other medical conditions|0|||
161258997|NCT04146363|582328939|FG000|Induction Period|Lack of Efficacy|7|||
161258998|NCT04146363|582328940|FG001|Induction Period|Lack of Efficacy|2|||
161258999|NCT04146363|582328941|FG002|Induction Period|Lack of Efficacy|0|||
161259000|NCT04146363|582328942|FG003|Induction Period|Lack of Efficacy|0|||
161259001|NCT04146363|582328943|FG004|Induction Period|Lack of Efficacy|0|||
161259002|NCT04146363|582328944|FG005|Induction Period|Lack of Efficacy|0|||
161259003|NCT04146363|582328945|FG006|Induction Period|Lack of Efficacy|0|||
161259004|NCT04146363|582328946|FG007|Induction Period|Lack of Efficacy|0|||
161259005|NCT04146363|582328947|FG008|Induction Period|Lack of Efficacy|0|||
161259006|NCT04146363|582328948|FG009|Induction Period|Lack of Efficacy|0|||
161259007|NCT04146363|582328949|FG010|Induction Period|Lack of Efficacy|0|||
161259008|NCT04146363|582328939|FG000|Induction Period|Lost to Follow-up|1|||
161259009|NCT04146363|582328940|FG001|Induction Period|Lost to Follow-up|4|||
161259010|NCT04146363|582328941|FG002|Induction Period|Lost to Follow-up|0|||
161259011|NCT04146363|582328942|FG003|Induction Period|Lost to Follow-up|0|||
161259012|NCT04146363|582328943|FG004|Induction Period|Lost to Follow-up|0|||
161259013|NCT04146363|582328944|FG005|Induction Period|Lost to Follow-up|0|||
161259014|NCT04146363|582328945|FG006|Induction Period|Lost to Follow-up|0|||
161259015|NCT04146363|582328946|FG007|Induction Period|Lost to Follow-up|0|||
160918293|NCT02436356|581094242|FG000|Overall Study|Withdrawal by Subject|1|||
160918294|NCT02436356|581094243|FG001|Overall Study|Withdrawal by Subject|0|||
160918295|NCT02436356|581094244|FG002|Overall Study|Withdrawal by Subject|0|||
160918296|NCT00487747|581094247|FG000|Overall Study|Adverse Event|1|||
160918297|NCT00487747|581094247|FG000|Overall Study|Lost to Follow-up|9|||
160918298|NCT00487747|581094247|FG000|Overall Study|Lack of Efficacy|1|||
160918299|NCT04483011|581094248|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
160918300|NCT04483011|581094249|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
160918301|NCT02979522|581094261|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
160918302|NCT02979522|581094262|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
160918303|NCT02979522|581094261|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
160918304|NCT02979522|581094262|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
160918305|NCT01896531|581094263|FG000|Overall Study|Death|57|||
160918306|NCT01896531|581094264|FG001|Overall Study|Death|59|||
160918307|NCT01896531|581094263|FG000|Overall Study|Lost to Follow-up|3|||
160918308|NCT01896531|581094264|FG001|Overall Study|Lost to Follow-up|0|||
160918309|NCT01896531|581094263|FG000|Overall Study|Non-compliance|0|||
160918310|NCT01896531|581094264|FG001|Overall Study|Non-compliance|1|||
160918311|NCT01896531|581094263|FG000|Overall Study|Study Ended by Sponsor|7|||
160918312|NCT01896531|581094264|FG001|Overall Study|Study Ended by Sponsor|20|||
160918313|NCT01896531|581094263|FG000|Overall Study|Withdrawal by Subject|3|||
160918314|NCT01896531|581094264|FG001|Overall Study|Withdrawal by Subject|2|||
160918315|NCT01896531|581094263|FG000|Overall Study|Death Prior to Treatment|1|||
160918316|NCT01896531|581094264|FG001|Overall Study|Death Prior to Treatment|0|||
160918317|NCT00770289|581094265|FG000|Overall Study|Other|6|||
160918318|NCT02733991|581094266|FG000|Overall Study|Adverse Event|1|||
160918319|NCT02733991|581094267|FG001|Overall Study|Adverse Event|0|||
160918320|NCT02733991|581094266|FG000|Overall Study|Withdrawal by Subject|0|||
160918321|NCT02733991|581094267|FG001|Overall Study|Withdrawal by Subject|5|||
160918322|NCT00680745|581094270|FG000|Overall Study|Withdrawal by Subject|8|||
160918323|NCT00680745|581094271|FG001|Overall Study|Withdrawal by Subject|3|||
160918324|NCT00680745|581094272|FG002|Overall Study|Withdrawal by Subject|2|||
160918325|NCT00680745|581094273|FG003|Overall Study|Withdrawal by Subject|8|||
160918326|NCT00680745|581094270|FG000|Overall Study|Lost to Follow-up|0|||
161259016|NCT04146363|582328947|FG008|Induction Period|Lost to Follow-up|0|||
161259017|NCT04146363|582328948|FG009|Induction Period|Lost to Follow-up|0|||
161259018|NCT04146363|582328949|FG010|Induction Period|Lost to Follow-up|0|||
161259019|NCT04146363|582328939|FG000|Induction Period|Positive quantiferon test|0|||
161259020|NCT04146363|582328940|FG001|Induction Period|Positive quantiferon test|1|||
160918327|NCT00680745|581094271|FG001|Overall Study|Lost to Follow-up|1|||
160918328|NCT00680745|581094272|FG002|Overall Study|Lost to Follow-up|1|||
160997077|NCT01090024|581374869|FG012|Period 1|Adverse Event|0|||
161259021|NCT04146363|582328941|FG002|Induction Period|Positive quantiferon test|0|||
161259022|NCT04146363|582328942|FG003|Induction Period|Positive quantiferon test|0|||
161259023|NCT04146363|582328943|FG004|Induction Period|Positive quantiferon test|0|||
161259024|NCT04146363|582328944|FG005|Induction Period|Positive quantiferon test|0|||
161259025|NCT04146363|582328945|FG006|Induction Period|Positive quantiferon test|0|||
160918329|NCT00680745|581094273|FG003|Overall Study|Lost to Follow-up|0|||
160918330|NCT00680745|581094270|FG000|Overall Study|Death|1|||
160918331|NCT00680745|581094271|FG001|Overall Study|Death|0|||
161259026|NCT04146363|582328946|FG007|Induction Period|Positive quantiferon test|0|||
161259027|NCT04146363|582328947|FG008|Induction Period|Positive quantiferon test|0|||
161259028|NCT04146363|582328948|FG009|Induction Period|Positive quantiferon test|0|||
161259029|NCT04146363|582328949|FG010|Induction Period|Positive quantiferon test|0|||
161259030|NCT04146363|582328939|FG000|Induction Period|Protocol Deviation|5|||
161259031|NCT04146363|582328940|FG001|Induction Period|Protocol Deviation|6|||
161259032|NCT04146363|582328941|FG002|Induction Period|Protocol Deviation|0|||
161259033|NCT04146363|582328942|FG003|Induction Period|Protocol Deviation|0|||
161259034|NCT04146363|582328943|FG004|Induction Period|Protocol Deviation|0|||
161259035|NCT04146363|582328944|FG005|Induction Period|Protocol Deviation|0|||
161259036|NCT04146363|582328945|FG006|Induction Period|Protocol Deviation|0|||
161259037|NCT04146363|582328946|FG007|Induction Period|Protocol Deviation|0|||
161259038|NCT04146363|582328947|FG008|Induction Period|Protocol Deviation|0|||
161259039|NCT04146363|582328948|FG009|Induction Period|Protocol Deviation|0|||
161259040|NCT04146363|582328949|FG010|Induction Period|Protocol Deviation|0|||
161259041|NCT04146363|582328939|FG000|Induction Period|Withdrawal by Subject|6|||
161259042|NCT04146363|582328940|FG001|Induction Period|Withdrawal by Subject|3|||
161259043|NCT04146363|582328941|FG002|Induction Period|Withdrawal by Subject|0|||
161259044|NCT04146363|582328942|FG003|Induction Period|Withdrawal by Subject|0|||
161259045|NCT04146363|582328943|FG004|Induction Period|Withdrawal by Subject|0|||
161259046|NCT04146363|582328944|FG005|Induction Period|Withdrawal by Subject|0|||
161259047|NCT04146363|582328945|FG006|Induction Period|Withdrawal by Subject|0|||
161259048|NCT04146363|582328946|FG007|Induction Period|Withdrawal by Subject|0|||
161259049|NCT04146363|582328947|FG008|Induction Period|Withdrawal by Subject|0|||
161259050|NCT04146363|582328948|FG009|Induction Period|Withdrawal by Subject|0|||
161259051|NCT04146363|582328949|FG010|Induction Period|Withdrawal by Subject|0|||
161259052|NCT04146363|582328939|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259053|NCT04146363|582328940|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259054|NCT04146363|582328941|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259055|NCT04146363|582328942|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259056|NCT04146363|582328943|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259057|NCT04146363|582328944|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259058|NCT04146363|582328945|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
161259059|NCT04146363|582328946|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
161259060|NCT04146363|582328947|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259061|NCT04146363|582328948|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259062|NCT04146363|582328949|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
161259063|NCT04146363|582328939|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259064|NCT04146363|582328940|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259065|NCT04146363|582328941|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259066|NCT04146363|582328942|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259067|NCT04146363|582328943|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259068|NCT04146363|582328944|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259069|NCT04146363|582328945|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259070|NCT04146363|582328946|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
161259071|NCT04146363|582328947|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259072|NCT04146363|582328948|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259073|NCT04146363|582328949|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
161259074|NCT04146363|582328939|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259075|NCT04146363|582328940|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259076|NCT04146363|582328941|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259077|NCT04146363|582328942|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259078|NCT04146363|582328943|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259079|NCT04146363|582328944|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259080|NCT04146363|582328945|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161259081|NCT04146363|582328946|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
161259082|NCT04146363|582328947|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259083|NCT04146363|582328948|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259084|NCT04146363|582328949|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
161259085|NCT04146363|582328939|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259086|NCT04146363|582328940|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
160918332|NCT00680745|581094272|FG002|Overall Study|Death|1|||
160918333|NCT00680745|581094273|FG003|Overall Study|Death|0|||
160918334|NCT00680745|581094270|FG000|Overall Study|Adverse Event|5|||
160918335|NCT00680745|581094271|FG001|Overall Study|Adverse Event|3|||
160918336|NCT00680745|581094272|FG002|Overall Study|Adverse Event|3|||
160918337|NCT00680745|581094273|FG003|Overall Study|Adverse Event|3|||
161259087|NCT04146363|582328941|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
161259088|NCT04146363|582328942|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
160918338|NCT00680745|581094270|FG000|Overall Study|Poor/Non-compliance|0|||
160918339|NCT00680745|581094271|FG001|Overall Study|Poor/Non-compliance|3|||
160918340|NCT00680745|581094272|FG002|Overall Study|Poor/Non-compliance|0|||
161259089|NCT04146363|582328943|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259090|NCT04146363|582328944|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
161259091|NCT04146363|582328945|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259092|NCT04146363|582328946|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259093|NCT04146363|582328947|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259094|NCT04146363|582328948|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259095|NCT04146363|582328949|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
161259096|NCT04146363|582328939|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259097|NCT04146363|582328940|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259098|NCT04146363|582328941|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259099|NCT04146363|582328942|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259100|NCT04146363|582328943|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
161259101|NCT04146363|582328944|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
161259102|NCT04146363|582328945|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
161259103|NCT04146363|582328946|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
161259104|NCT04146363|582328947|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259105|NCT04146363|582328948|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259106|NCT04146363|582328949|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
161259107|NCT04146363|582328939|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259108|NCT04146363|582328940|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259109|NCT04146363|582328941|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
161259110|NCT04146363|582328942|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259111|NCT04146363|582328943|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259112|NCT04146363|582328944|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
161259113|NCT04146363|582328945|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
161259114|NCT04146363|582328946|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
161259115|NCT04146363|582328947|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259116|NCT04146363|582328948|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259117|NCT04146363|582328949|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
161259118|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259119|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259120|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259121|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259122|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259123|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259124|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259125|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259126|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
161259127|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
161259128|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161259129|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259130|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259131|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259132|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259133|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259134|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259135|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259136|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161259137|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
161259138|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
161259139|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
161259140|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259141|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259142|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259143|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259144|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259145|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259146|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259147|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161259148|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
161259149|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
161259150|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
160997078|NCT01090024|581374870|FG013|Period 1|Adverse Event|0|||
161259151|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259152|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259153|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
161340550|NCT04513366|582633558|FG001|Treatment Phase|Physician Decision|0|||
161340551|NCT04513366|582633559|FG002|Treatment Phase|Physician Decision|0|||
161340552|NCT04513366|582633557|FG000|Treatment Phase|Adverse Event|0|||
161340553|NCT04513366|582633558|FG001|Treatment Phase|Adverse Event|1|||
161340554|NCT04513366|582633559|FG002|Treatment Phase|Adverse Event|1|||
161340555|NCT04513366|582633557|FG000|Extension Phase|Withdrawal by Subject|3|||
161340556|NCT04513366|582633558|FG001|Extension Phase|Withdrawal by Subject|1|||
161340557|NCT04513366|582633559|FG002|Extension Phase|Withdrawal by Subject|1|||
161340558|NCT04513366|582633557|FG000|Extension Phase|Other than Specified|4|||
161340559|NCT04513366|582633558|FG001|Extension Phase|Other than Specified|0|||
161340560|NCT04513366|582633559|FG002|Extension Phase|Other than Specified|1|||
161340561|NCT04513366|582633557|FG000|Extension Phase|Lost to Follow-up|1|||
161340562|NCT04513366|582633558|FG001|Extension Phase|Lost to Follow-up|1|||
161340563|NCT04513366|582633559|FG002|Extension Phase|Lost to Follow-up|1|||
161340564|NCT04513366|582633557|FG000|Extension Phase|Sponsor Decision|0|||
161340565|NCT04513366|582633558|FG001|Extension Phase|Sponsor Decision|1|||
161340566|NCT04513366|582633559|FG002|Extension Phase|Sponsor Decision|0|||
161340567|NCT04513366|582633557|FG000|Extension Phase|Death|0|||
161340568|NCT04513366|582633558|FG001|Extension Phase|Death|1|||
161340569|NCT04513366|582633559|FG002|Extension Phase|Death|0|||
161340570|NCT04513366|582633557|FG000|Extension Phase|Adverse Event|0|||
161340571|NCT04513366|582633558|FG001|Extension Phase|Adverse Event|0|||
161340572|NCT04513366|582633559|FG002|Extension Phase|Adverse Event|1|||
161340573|NCT03344757|582633560|FG000|Overall Study|Withdrawal by Subject|18|||
161340574|NCT03344757|582633561|FG001|Overall Study|Withdrawal by Subject|16|||
161340575|NCT03344757|582633560|FG000|Overall Study|Lost to Follow-up|0|||
161340576|NCT03344757|582633561|FG001|Overall Study|Lost to Follow-up|2|||
161340577|NCT00269152|582633562|FG000|Overall Study|Adverse Event|9|||
161340578|NCT00269152|582633563|FG001|Overall Study|Adverse Event|3|||
161340579|NCT00269152|582633562|FG000|Overall Study|Withdrawal by Subject|7|||
161340580|NCT00269152|582633563|FG001|Overall Study|Withdrawal by Subject|3|||
161340581|NCT00269152|582633562|FG000|Overall Study|Physician Decision|2|||
161340582|NCT00269152|582633563|FG001|Overall Study|Physician Decision|3|||
161340583|NCT00269152|582633562|FG000|Overall Study|Protocol Violation|0|||
161340584|NCT00269152|582633563|FG001|Overall Study|Protocol Violation|1|||
161340585|NCT01832766|582633566|FG000|Washout|Lost to Follow-up|0|||
161340586|NCT01832766|582633567|FG001|Washout|Lost to Follow-up|1|||
161340587|NCT03533751|582633570|FG000|Overall Study|Withdrawal by Subject|12|||
161340588|NCT03533751|582633571|FG001|Overall Study|Withdrawal by Subject|6|||
161340589|NCT03533751|582633572|FG002|Overall Study|Withdrawal by Subject|11|||
161259154|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259155|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259156|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259157|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259158|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259159|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
161259160|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
161259161|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
161259162|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259163|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259164|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259165|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259166|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259167|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259168|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161259169|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161340590|NCT03533751|582633573|FG003|Overall Study|Withdrawal by Subject|9|||
161340591|NCT03533751|582633574|FG004|Overall Study|Withdrawal by Subject|10|||
161340592|NCT03533751|582633570|FG000|Overall Study|Adverse Event|4|||
161340593|NCT03533751|582633571|FG001|Overall Study|Adverse Event|7|||
161340594|NCT03533751|582633572|FG002|Overall Study|Adverse Event|2|||
161340595|NCT03533751|582633573|FG003|Overall Study|Adverse Event|4|||
161340596|NCT03533751|582633574|FG004|Overall Study|Adverse Event|5|||
160918341|NCT00680745|581094273|FG003|Overall Study|Poor/Non-compliance|0|||
160918342|NCT00680745|581094270|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
160918343|NCT00680745|581094271|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
160918344|NCT00680745|581094272|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
161340597|NCT03533751|582633570|FG000|Overall Study|Physician Decision|0|||
161340598|NCT03533751|582633571|FG001|Overall Study|Physician Decision|2|||
161340599|NCT03533751|582633572|FG002|Overall Study|Physician Decision|1|||
161340600|NCT03533751|582633573|FG003|Overall Study|Physician Decision|2|||
161340601|NCT03533751|582633574|FG004|Overall Study|Physician Decision|1|||
161340602|NCT03533751|582633570|FG000|Overall Study|Sponsor Decision|0|||
161340603|NCT03533751|582633571|FG001|Overall Study|Sponsor Decision|0|||
161340604|NCT03533751|582633572|FG002|Overall Study|Sponsor Decision|1|||
161340605|NCT03533751|582633573|FG003|Overall Study|Sponsor Decision|1|||
161340606|NCT03533751|582633574|FG004|Overall Study|Sponsor Decision|0|||
161340607|NCT03533751|582633570|FG000|Overall Study|Lost to Follow-up|3|||
161340608|NCT03533751|582633571|FG001|Overall Study|Lost to Follow-up|7|||
160918345|NCT00680745|581094273|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
160918346|NCT00680745|581094270|FG000|Overall Study|False Treatment|0|||
160918347|NCT00680745|581094271|FG001|Overall Study|False Treatment|1|||
160918348|NCT00680745|581094272|FG002|Overall Study|False Treatment|3|||
160918349|NCT00680745|581094273|FG003|Overall Study|False Treatment|0|||
160918350|NCT02485574|581094276|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
160918351|NCT00255047|581094278|FG000|Overall Study|Serious Adverse Events|2|||
160918352|NCT00255047|581094279|FG001|Overall Study|Serious Adverse Events|1|||
160918353|NCT00255047|581094280|FG002|Overall Study|Serious Adverse Events|2|||
160918354|NCT00255047|581094281|FG003|Overall Study|Serious Adverse Events|1|||
160918355|NCT00255047|581094278|FG000|Overall Study|Adverse Event|0|||
160918356|NCT00255047|581094279|FG001|Overall Study|Adverse Event|3|||
160918357|NCT00255047|581094280|FG002|Overall Study|Adverse Event|2|||
160918358|NCT00255047|581094281|FG003|Overall Study|Adverse Event|1|||
160918359|NCT00255047|581094278|FG000|Overall Study|Protocol Violation|13|||
160918360|NCT00255047|581094279|FG001|Overall Study|Protocol Violation|13|||
160918361|NCT00255047|581094280|FG002|Overall Study|Protocol Violation|16|||
160918362|NCT00255047|581094281|FG003|Overall Study|Protocol Violation|20|||
160918363|NCT00255047|581094278|FG000|Overall Study|Lost to Follow-up|9|||
160918364|NCT00255047|581094279|FG001|Overall Study|Lost to Follow-up|8|||
160918365|NCT00255047|581094280|FG002|Overall Study|Lost to Follow-up|5|||
160918366|NCT00255047|581094281|FG003|Overall Study|Lost to Follow-up|6|||
160918367|NCT00255047|581094278|FG000|Overall Study|Withdrawal by Subject|24|||
160918368|NCT00255047|581094279|FG001|Overall Study|Withdrawal by Subject|23|||
160918369|NCT00255047|581094280|FG002|Overall Study|Withdrawal by Subject|25|||
160918370|NCT00255047|581094281|FG003|Overall Study|Withdrawal by Subject|18|||
160918371|NCT03049280|581094284|FG000|Overall Study|Physician Decision|1|||
160918372|NCT01867021|581094285|FG000|Overall Study|Adverse Event|0|||
160918373|NCT01867021|581094286|FG001|Overall Study|Adverse Event|1|||
160918374|NCT01867021|581094285|FG000|Overall Study|Not Eligible|0|||
160918375|NCT01867021|581094286|FG001|Overall Study|Not Eligible|1|||
160918376|NCT01867021|581094285|FG000|Overall Study|Death|1|||
160918377|NCT01867021|581094286|FG001|Overall Study|Death|0|||
160918378|NCT01867021|581094285|FG000|Overall Study|Lost to Follow-up|0|||
160918379|NCT01867021|581094286|FG001|Overall Study|Lost to Follow-up|2|||
160918380|NCT01867021|581094285|FG000|Overall Study|Withdrawal by Subject|1|||
160918381|NCT01867021|581094286|FG001|Overall Study|Withdrawal by Subject|6|||
160918382|NCT02480114|581094290|FG000|Overall Study|Not completing surveys|3|||
160918383|NCT02480114|581094291|FG001|Overall Study|Not completing surveys|2|||
160918384|NCT02480114|581094290|FG000|Overall Study|Withdrawal by Subject|2|||
160918385|NCT02480114|581094291|FG001|Overall Study|Withdrawal by Subject|4|||
160918386|NCT02480114|581094290|FG000|Overall Study|Disease progression|3|||
160918387|NCT02480114|581094291|FG001|Overall Study|Disease progression|0|||
160918388|NCT02480114|581094290|FG000|Overall Study|Improper completion of survey|1|||
160918389|NCT02480114|581094291|FG001|Overall Study|Improper completion of survey|1|||
160918390|NCT02480114|581094290|FG000|Overall Study|Not eligible|0|||
160918391|NCT02480114|581094291|FG001|Overall Study|Not eligible|1|||
160918392|NCT01031069|581094292|FG000|Overall Study|Serious Adverse Event|0|||
160918393|NCT01031069|581094293|FG001|Overall Study|Serious Adverse Event|1|||
160918394|NCT01031069|581094294|FG002|Overall Study|Serious Adverse Event|0|||
160918395|NCT01031069|581094295|FG003|Overall Study|Serious Adverse Event|0|||
160918396|NCT01031069|581094292|FG000|Overall Study|Withdrawal by Subject|2|||
160918397|NCT01031069|581094293|FG001|Overall Study|Withdrawal by Subject|3|||
160918398|NCT01031069|581094294|FG002|Overall Study|Withdrawal by Subject|18|||
160918399|NCT01031069|581094295|FG003|Overall Study|Withdrawal by Subject|18|||
160918400|NCT01031069|581094292|FG000|Overall Study|Migrated/moved from study area|1|||
160918401|NCT01031069|581094293|FG001|Overall Study|Migrated/moved from study area|2|||
160918402|NCT01031069|581094294|FG002|Overall Study|Migrated/moved from study area|1|||
160918403|NCT01031069|581094295|FG003|Overall Study|Migrated/moved from study area|1|||
160918404|NCT01031069|581094292|FG000|Overall Study|Lost to Follow-up|9|||
160918405|NCT01031069|581094293|FG001|Overall Study|Lost to Follow-up|5|||
160918406|NCT01031069|581094294|FG002|Overall Study|Lost to Follow-up|21|||
160918407|NCT01031069|581094295|FG003|Overall Study|Lost to Follow-up|15|||
160918408|NCT01031069|581094292|FG000|Overall Study|Other|0|||
160918409|NCT01031069|581094293|FG001|Overall Study|Other|0|||
160918410|NCT01031069|581094294|FG002|Overall Study|Other|1|||
160918411|NCT01031069|581094295|FG003|Overall Study|Other|0|||
160918412|NCT01317160|581094296|FG000|Overall Study|Incorrect inclusion|1|||
160918413|NCT01317160|581094297|FG001|Overall Study|Incorrect inclusion|1|||
160997079|NCT01090024|581374871|FG014|Period 1|Adverse Event|0|||
161340609|NCT03533751|582633572|FG002|Overall Study|Lost to Follow-up|6|||
160918414|NCT01317160|581094296|FG000|Overall Study|Lost to Follow-up|3|||
160918415|NCT01317160|581094297|FG001|Overall Study|Lost to Follow-up|3|||
160918416|NCT01317160|581094296|FG000|Overall Study|Withdrawal by Subject|0|||
160918417|NCT01317160|581094297|FG001|Overall Study|Withdrawal by Subject|2|||
161259170|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
161259171|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
161259172|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
161259173|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259174|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259175|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259176|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259177|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259178|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259179|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259180|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259181|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259182|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
161259183|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
161259184|NCT04146363|582328939|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259185|NCT04146363|582328940|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259186|NCT04146363|582328941|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259187|NCT04146363|582328942|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259188|NCT04146363|582328943|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259189|NCT04146363|582328944|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259190|NCT04146363|582328945|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259191|NCT04146363|582328946|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259192|NCT04146363|582328947|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259193|NCT04146363|582328948|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
161259194|NCT04146363|582328949|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
161259195|NCT00380692|582328956|FG000|Study Period II - Double Blind|Adverse Event|1|||
161259196|NCT00380692|582328957|FG001|Study Period II - Double Blind|Adverse Event|0|||
161259197|NCT00380692|582328956|FG000|Study Period II - Double Blind|Protocol Violation|2|||
161259198|NCT00380692|582328957|FG001|Study Period II - Double Blind|Protocol Violation|2|||
161259199|NCT00380692|582328956|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
161259200|NCT00380692|582328957|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
161259201|NCT00380692|582328956|FG000|Study Period II - Double Blind|Physician Decision|0|||
161259202|NCT00380692|582328957|FG001|Study Period II - Double Blind|Physician Decision|1|||
161259203|NCT00380692|582328956|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
161259204|NCT00380692|582328957|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
161259205|NCT00380692|582328956|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
161259206|NCT00380692|582328957|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
161259207|NCT00380692|582328956|FG000|Study Period III - Open Label|Adverse Event|5|||
161259208|NCT00380692|582328957|FG001|Study Period III - Open Label|Adverse Event|3|||
161259209|NCT00380692|582328956|FG000|Study Period III - Open Label|Protocol Violation|0|||
161259210|NCT00380692|582328957|FG001|Study Period III - Open Label|Protocol Violation|0|||
161259211|NCT00380692|582328956|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
161259212|NCT00380692|582328957|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
161259213|NCT00380692|582328956|FG000|Study Period III - Open Label|Physician Decision|0|||
161259214|NCT00380692|582328957|FG001|Study Period III - Open Label|Physician Decision|3|||
161259215|NCT00380692|582328956|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
161259216|NCT00380692|582328957|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
161259217|NCT00380692|582328956|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
161259218|NCT00380692|582328957|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
161259219|NCT00107042|582328958|FG000|Overall Study|Lost to Follow-up|9|||
161259220|NCT00107042|582328959|FG001|Overall Study|Lost to Follow-up|7|||
161259221|NCT00107042|582328958|FG000|Overall Study|Withdrawal by Subject|6|||
161259222|NCT00107042|582328959|FG001|Overall Study|Withdrawal by Subject|1|||
161259223|NCT00107042|582328958|FG000|Overall Study|Moved out of area|5|||
161259224|NCT00107042|582328959|FG001|Overall Study|Moved out of area|3|||
161259225|NCT00107042|582328958|FG000|Overall Study|Pregnancy|1|||
161259226|NCT00107042|582328959|FG001|Overall Study|Pregnancy|1|||
161259227|NCT00107042|582328958|FG000|Overall Study|Inadvertent enrollment|0|||
161259228|NCT00107042|582328959|FG001|Overall Study|Inadvertent enrollment|1|||
161259229|NCT00107042|582328958|FG000|Overall Study|vaccinated outside window|1|||
161259230|NCT00107042|582328959|FG001|Overall Study|vaccinated outside window|1|||
161259231|NCT00107042|582328958|FG000|Overall Study|Disallowed medications|0|||
161259232|NCT00107042|582328959|FG001|Overall Study|Disallowed medications|2|||
161340610|NCT03533751|582633573|FG003|Overall Study|Lost to Follow-up|4|||
161340611|NCT03533751|582633574|FG004|Overall Study|Lost to Follow-up|3|||
161259233|NCT00708708|582328960|FG000|Overall Study|Another therapy instead of Enbrel|141|||
161259234|NCT00708708|582328960|FG000|Overall Study|Lost to Follow-up|52|||
161259235|NCT00708708|582328960|FG000|Overall Study|Withdrawal by Subject|51|||
161259236|NCT00708708|582328960|FG000|Overall Study|Intolerance|42|||
161259237|NCT00708708|582328960|FG000|Overall Study|Another therapy along with Enbrel|15|||
161340612|NCT03533751|582633570|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
160918418|NCT03578367|581094299|FG000|Overall Study|Adverse Event|0|||
160918419|NCT03578367|581094300|FG001|Overall Study|Adverse Event|3|||
160918420|NCT03578367|581094301|FG002|Overall Study|Adverse Event|0|||
160918421|NCT03578367|581094302|FG003|Overall Study|Adverse Event|5|||
160918422|NCT03578367|581094299|FG000|Overall Study|Withdrawal by Subject|2|||
160918423|NCT03578367|581094300|FG001|Overall Study|Withdrawal by Subject|2|||
160918424|NCT03578367|581094301|FG002|Overall Study|Withdrawal by Subject|1|||
160918425|NCT03578367|581094302|FG003|Overall Study|Withdrawal by Subject|3|||
160918426|NCT03578367|581094299|FG000|Overall Study|Physician Decision|0|||
160918427|NCT03578367|581094300|FG001|Overall Study|Physician Decision|0|||
160918428|NCT03578367|581094301|FG002|Overall Study|Physician Decision|14|||
160918429|NCT03578367|581094302|FG003|Overall Study|Physician Decision|0|||
160918430|NCT03578367|581094299|FG000|Overall Study|Death|1|||
160918431|NCT03578367|581094300|FG001|Overall Study|Death|0|||
160918432|NCT03578367|581094301|FG002|Overall Study|Death|0|||
160918433|NCT03578367|581094302|FG003|Overall Study|Death|0|||
160918434|NCT03578367|581094299|FG000|Overall Study|Not treated|0|||
160918435|NCT03578367|581094300|FG001|Overall Study|Not treated|0|||
160918436|NCT03578367|581094301|FG002|Overall Study|Not treated|1|||
160918437|NCT03578367|581094302|FG003|Overall Study|Not treated|0|||
160918438|NCT02734810|581095958|FG000|Overall Study|Adverse Event|1|||
160918439|NCT02734810|581095959|FG001|Overall Study|Adverse Event|0|||
160918440|NCT02734810|581095958|FG000|Overall Study|Lack of Efficacy|1|||
160918441|NCT02734810|581095959|FG001|Overall Study|Lack of Efficacy|0|||
160918442|NCT02507505|581095960|FG000|Overall Study|Withdrawal by Subject|13|||
160918443|NCT02507505|581095961|FG001|Overall Study|Withdrawal by Subject|11|||
160918444|NCT02507505|581095960|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
160918445|NCT02507505|581095961|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
160918446|NCT02507505|581095960|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
160918447|NCT02507505|581095961|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
160918448|NCT02507505|581095960|FG000|Overall Study|Death before receipt of anesthesia|0|||
160918449|NCT02507505|581095961|FG001|Overall Study|Death before receipt of anesthesia|1|||
160918450|NCT00931762|581095962|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
160918451|NCT00931762|581095962|FG000|Overall Study|Administrative Problems|5|||
160918452|NCT00931762|581095962|FG000|Overall Study|Death|1|||
160918453|NCT00931762|581095962|FG000|Overall Study|Disease Progression|3|||
160918454|NCT00931762|581095962|FG000|Overall Study|Adverse Event (s)|11|||
160918455|NCT00931762|581095962|FG000|Overall Study|Subject withdrew consent|13|||
160918456|NCT03182829|581095963|FG000|Overall Study|Protocol Violation|12|||
160918457|NCT03182829|581095964|FG001|Overall Study|Protocol Violation|12|||
160918458|NCT03182829|581095963|FG000|Overall Study|Other|4|||
160918459|NCT03182829|581095964|FG001|Overall Study|Other|3|||
160918460|NCT02664441|581095965|FG000|Randomization|Withdrawal by Subject|0|||
160918461|NCT02664441|581095966|FG001|Randomization|Withdrawal by Subject|1|||
160918462|NCT02664441|581095965|FG000|36-week Randomized Trial|Adverse Event|2|||
160918463|NCT02664441|581095966|FG001|36-week Randomized Trial|Adverse Event|0|||
160918464|NCT02664441|581095965|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
160918465|NCT02664441|581095966|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
160918466|NCT02664441|581095965|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
160918467|NCT02664441|581095966|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
160918468|NCT02664441|581095965|FG000|18-week Open Label Extension|Adverse Event|1|||
160918469|NCT02664441|581095966|FG001|18-week Open Label Extension|Adverse Event|0|||
160918470|NCT02664441|581095965|FG000|18-week Open Label Extension|Physician Decision|1|||
160918471|NCT02664441|581095966|FG001|18-week Open Label Extension|Physician Decision|0|||
160918472|NCT02664441|581095965|FG000|18-week Open Label Extension|Death|1|||
160918473|NCT02664441|581095966|FG001|18-week Open Label Extension|Death|0|||
160918474|NCT02664441|581095965|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
160918475|NCT02664441|581095966|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
160918476|NCT02259582|581095971|FG000|Overall Study|Physician Decision|0|||
160918477|NCT02259582|581095972|FG001|Overall Study|Physician Decision|1|||
160918478|NCT02259582|581095973|FG002|Overall Study|Physician Decision|0|||
160918479|NCT02259582|581095971|FG000|Overall Study|Death|0|||
160918480|NCT02259582|581095972|FG001|Overall Study|Death|0|||
160918481|NCT02259582|581095973|FG002|Overall Study|Death|1|||
160918482|NCT02259582|581095971|FG000|Overall Study|Adverse Event|1|||
160918483|NCT02259582|581095972|FG001|Overall Study|Adverse Event|0|||
160918484|NCT02259582|581095973|FG002|Overall Study|Adverse Event|1|||
160918485|NCT02259582|581095971|FG000|Overall Study|Withdrawal by Subject|0|||
160918486|NCT02259582|581095972|FG001|Overall Study|Withdrawal by Subject|0|||
160918487|NCT02259582|581095973|FG002|Overall Study|Withdrawal by Subject|1|||
160918488|NCT02259582|581095971|FG000|Overall Study|Disease progression|14|||
160918489|NCT02259582|581095972|FG001|Overall Study|Disease progression|15|||
160997080|NCT01090024|581374872|FG015|Period 1|Adverse Event|0|||
160918490|NCT02259582|581095973|FG002|Overall Study|Disease progression|17|||
160918491|NCT02259582|581095971|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
160918492|NCT02259582|581095972|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
160997081|NCT01090024|581374873|FG016|Period 1|Adverse Event|0|||
161259238|NCT00708708|582328960|FG000|Overall Study|Other unspecified|11|||
161259239|NCT00708708|582328960|FG000|Overall Study|Good effectiveness|9|||
161259240|NCT00708708|582328960|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
161259241|NCT00708708|582328960|FG000|Overall Study|Administrative reasons|7|||
161259242|NCT00708708|582328960|FG000|Overall Study|Lack of effectiveness|4|||
161259243|NCT00708708|582328960|FG000|Overall Study|Lack of compliance|3|||
161259244|NCT00708708|582328960|FG000|Overall Study|Pregnancy|3|||
161259245|NCT00708708|582328960|FG000|Overall Study|Adverse Event|3|||
161259246|NCT00708708|582328960|FG000|Overall Study|Missing values|392|||
161259247|NCT00140413|582328961|FG000|Overall Study|Lost to Follow-up|1|||
161259248|NCT00140413|582328962|FG001|Overall Study|Lost to Follow-up|0|||
161259249|NCT00140413|582328961|FG000|Overall Study|Withdrawal by Subject|2|||
161259250|NCT00140413|582328962|FG001|Overall Study|Withdrawal by Subject|0|||
161259251|NCT02459665|582328963|FG000|Overall Study|Withdrawal by Subject|0|||
161259252|NCT02459665|582328964|FG001|Overall Study|Withdrawal by Subject|1|||
161259253|NCT02459665|582328965|FG002|Overall Study|Withdrawal by Subject|1|||
161259254|NCT02459665|582328966|FG003|Overall Study|Withdrawal by Subject|2|||
161259255|NCT00865098|582328970|FG000|Overall Study|Progressive disease|1|||
161259256|NCT01117337|582328987|FG000|Overall Study|Lost to Follow-up|4|||
161259257|NCT01117337|582328988|FG001|Overall Study|Lost to Follow-up|0|||
161259258|NCT05444556|582328989|FG000|Overall Study|Withdrawal by Subject|0|||
161259259|NCT05444556|582328990|FG001|Overall Study|Withdrawal by Subject|0|||
161259260|NCT05444556|582328991|FG002|Overall Study|Withdrawal by Subject|2|||
161259261|NCT05444556|582328992|FG003|Overall Study|Withdrawal by Subject|1|||
161259262|NCT02791893|582328994|FG000|Blinded Phase|Lost to Follow-up|2|||
161259263|NCT02791893|582328995|FG001|Blinded Phase|Lost to Follow-up|2|||
161259264|NCT02791893|582328994|FG000|Blinded Phase|Withdrawal by Subject|1|||
161259265|NCT02791893|582328995|FG001|Blinded Phase|Withdrawal by Subject|2|||
160918493|NCT02259582|581095973|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
160918494|NCT02335489|581095974|FG000|Overall Study|Sponsor terminated study|4|||
160918495|NCT02335489|581095974|FG000|Overall Study|Lost to Follow-up|1|||
160918496|NCT02335489|581095974|FG000|Overall Study|Withdrawal by Subject|2|||
161259266|NCT02791893|582328994|FG000|Open Label Phase|Lost to Follow-up|3|||
160918497|NCT02335489|581095974|FG000|Overall Study|Physician Decision|2|||
160918498|NCT02335489|581095974|FG000|Overall Study|Lack of Efficacy|1|||
161259267|NCT02791893|582328995|FG001|Open Label Phase|Lost to Follow-up|0|||
161259268|NCT02791893|582328994|FG000|Open Label Phase|Withdrawal by Subject|0|||
161259269|NCT02791893|582328995|FG001|Open Label Phase|Withdrawal by Subject|2|||
161259270|NCT04319159|582329001|FG000|Overall Study|Screening failure|13|||
161259271|NCT04319159|582329001|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
161259272|NCT04319159|582329001|FG000|Overall Study|Withdrawal by Subject|1|||
161259273|NCT05575063|582329009|FG000|Overall Study|Withdrawal by Subject|1|||
161259274|NCT00949988|582329014|FG000|Overall Study|Withdrawal by Subject|3|||
161259275|NCT00396331|582329017|FG000|Overall Study|Failed to mobilize - no transplant|8|||
161259276|NCT00396331|582329017|FG000|Overall Study|Did not go on to transplant|5|||
161259277|NCT00396331|582329017|FG000|Overall Study|Lost to Follow-up|3|||
161259278|NCT00396331|582329017|FG000|Overall Study|Death|16|||
161259279|NCT00873119|582329024|FG000|Overall Study|Patient request|4|||
161259280|NCT00873119|582329025|FG001|Overall Study|Patient request|2|||
161259281|NCT00873119|582329024|FG000|Overall Study|Adverse Event|8|||
161259282|NCT00873119|582329025|FG001|Overall Study|Adverse Event|0|||
161259283|NCT00873119|582329024|FG000|Overall Study|Progressive disease|26|||
161259284|NCT00873119|582329025|FG001|Overall Study|Progressive disease|18|||
161259285|NCT00873119|582329024|FG000|Overall Study|Death|2|||
160918499|NCT00759863|581095977|FG000|Overall Study|Death, moved, or lost contact|20|||
160918500|NCT00759863|581095978|FG001|Overall Study|Death, moved, or lost contact|18|||
160918501|NCT00412854|581095982|FG000|Overall Study|Withdrawn due to adverse events|1|||
160918502|NCT00412854|581095983|FG001|Overall Study|Withdrawn due to adverse events|5|||
160918503|NCT00412854|581095982|FG000|Overall Study|Withdrawn for other reasons|13|||
160918504|NCT00412854|581095983|FG001|Overall Study|Withdrawn for other reasons|11|||
160918505|NCT00503308|581095984|FG000|Overall Study|Protocol Violation|2|||
160918506|NCT00503308|581095985|FG001|Overall Study|Protocol Violation|1|||
160918507|NCT03263442|581095987|FG000|Inpatient Phase|Death|1|||
160918508|NCT03263442|581095988|FG001|Inpatient Phase|Death|0|||
161259286|NCT00873119|582329025|FG001|Overall Study|Death|1|||
160918509|NCT03263442|581095987|FG000|Inpatient Phase|Withdrawal by Subject|1|||
160918510|NCT03263442|581095988|FG001|Inpatient Phase|Withdrawal by Subject|0|||
161259287|NCT00873119|582329024|FG000|Overall Study|Other|2|||
161259288|NCT00873119|582329025|FG001|Overall Study|Other|5|||
161259289|NCT00873119|582329024|FG000|Overall Study|Not treated|2|||
161259290|NCT00873119|582329025|FG001|Overall Study|Not treated|0|||
161259291|NCT03648879|582329026|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
161259292|NCT00285584|582329027|FG000|Month 3|Lost to Follow-up|3|||
161259293|NCT00285584|582329028|FG001|Month 3|Lost to Follow-up|3|||
161259294|NCT00285584|582329027|FG000|Month 3|Withdrawal by Subject|1|||
161259295|NCT00285584|582329028|FG001|Month 3|Withdrawal by Subject|0|||
161259296|NCT00285584|582329027|FG000|Month 6|Lost to Follow-up|0|||
161259297|NCT00285584|582329028|FG001|Month 6|Lost to Follow-up|1|||
161143192|NCT00923091|581907575|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143193|NCT00923091|581907576|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143194|NCT00923091|581907577|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143195|NCT00923091|581907578|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143196|NCT00923091|581907579|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
161143197|NCT00923091|581907580|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143198|NCT00923091|581907581|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143199|NCT00923091|581907582|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143200|NCT00923091|581907583|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143201|NCT00923091|581907584|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143202|NCT00923091|581907585|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143203|NCT00923091|581907586|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
161143204|NCT00923091|581907574|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143205|NCT00923091|581907575|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161143206|NCT00923091|581907576|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143207|NCT00923091|581907577|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161143208|NCT00923091|581907578|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143209|NCT00923091|581907579|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
161143210|NCT00923091|581907580|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143211|NCT00923091|581907581|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143212|NCT00923091|581907582|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143213|NCT00923091|581907583|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143214|NCT00923091|581907584|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143215|NCT00923091|581907585|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143216|NCT00923091|581907586|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
161143217|NCT00923091|581907574|FG000|Period III (Single-Blind)|Adverse Event|5|||
161143218|NCT00923091|581907575|FG001|Period III (Single-Blind)|Adverse Event|0|||
161143219|NCT00923091|581907576|FG002|Period III (Single-Blind)|Adverse Event|0|||
161143220|NCT00923091|581907577|FG003|Period III (Single-Blind)|Adverse Event|0|||
161143221|NCT00923091|581907578|FG004|Period III (Single-Blind)|Adverse Event|0|||
161143222|NCT00923091|581907579|FG005|Period III (Single-Blind)|Adverse Event|0|||
161143223|NCT00923091|581907580|FG006|Period III (Single-Blind)|Adverse Event|0|||
161259298|NCT01884688|582329029|FG000|Overall Study|Screen Failure|2|||
160918511|NCT03263442|581095987|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
160918512|NCT03263442|581095988|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
160918513|NCT03263442|581095987|FG000|1-month Follow-Up|Lost to Follow-up|1|||
160918514|NCT03263442|581095988|FG001|1-month Follow-Up|Lost to Follow-up|0|||
160918515|NCT03263442|581095987|FG000|3-month Follow-Up|Lost to Follow-up|1|||
160918516|NCT03263442|581095988|FG001|3-month Follow-Up|Lost to Follow-up|3|||
160918517|NCT03263442|581095987|FG000|6-month Follow-Up|Lost to Follow-up|2|||
160918518|NCT03263442|581095988|FG001|6-month Follow-Up|Lost to Follow-up|2|||
160918519|NCT02436889|581095989|FG000|Overall Study|No improvement in symptoms|1|||
160918520|NCT02436889|581095990|FG001|Overall Study|No improvement in symptoms|0|||
160918521|NCT02436889|581095989|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
160918522|NCT02436889|581095990|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
160918523|NCT00708643|581095991|FG000|Overall Study|Adverse Event|0|||
160918524|NCT00708643|581095992|FG001|Overall Study|Adverse Event|1|||
160918525|NCT01594125|581095993|FG000|Overall Study|Withdrawal by Subject|1|||
160918526|NCT01594125|581095994|FG001|Overall Study|Withdrawal by Subject|0|||
160918527|NCT01594125|581095995|FG002|Overall Study|Withdrawal by Subject|0|||
160918528|NCT01594125|581095996|FG003|Overall Study|Withdrawal by Subject|1|||
160918529|NCT01594125|581095997|FG004|Overall Study|Withdrawal by Subject|0|||
160918530|NCT01594125|581095993|FG000|Overall Study|Progressive Disease|3|||
160918531|NCT01594125|581095994|FG001|Overall Study|Progressive Disease|12|||
160918532|NCT01594125|581095995|FG002|Overall Study|Progressive Disease|3|||
160918533|NCT01594125|581095996|FG003|Overall Study|Progressive Disease|3|||
160918534|NCT01594125|581095997|FG004|Overall Study|Progressive Disease|7|||
160918535|NCT01710033|581096000|FG000|Stage 2|Adverse Event|0|||
160918536|NCT01710033|581096001|FG001|Stage 2|Adverse Event|0|||
160918537|NCT01710033|581096002|FG002|Stage 2|Adverse Event|0|||
160918538|NCT01710033|581096003|FG003|Stage 2|Adverse Event|0|||
160918539|NCT01710033|581096004|FG004|Stage 2|Adverse Event|1|||
160918540|NCT03045887|581096005|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
160918541|NCT03045887|581096006|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918542|NCT03045887|581096007|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918543|NCT03045887|581096008|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918544|NCT03045887|581096009|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918545|NCT03045887|581096010|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918546|NCT03045887|581096011|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918547|NCT03045887|581096012|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918548|NCT03045887|581096013|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918549|NCT03045887|581096014|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
160918550|NCT03045887|581096005|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918551|NCT03045887|581096006|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
161259299|NCT00536484|582329030|FG000|Overall Study|Adverse Event|21|||
161259300|NCT00536484|582329031|FG001|Overall Study|Adverse Event|34|||
161259301|NCT00536484|582329030|FG000|Overall Study|Withdrawal by Subject|11|||
161259302|NCT00536484|582329031|FG001|Overall Study|Withdrawal by Subject|11|||
161259303|NCT00536484|582329030|FG000|Overall Study|Lost to Follow-up|8|||
161259304|NCT00536484|582329031|FG001|Overall Study|Lost to Follow-up|6|||
161259305|NCT00536484|582329030|FG000|Overall Study|Lack of Efficacy|16|||
161259306|NCT00536484|582329031|FG001|Overall Study|Lack of Efficacy|5|||
161259307|NCT00536484|582329030|FG000|Overall Study|Other|4|||
161259308|NCT00536484|582329031|FG001|Overall Study|Other|0|||
161259309|NCT00706355|582329032|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
161259310|NCT00706355|582329033|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161259311|NCT00706355|582329034|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161259312|NCT00706355|582329035|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
161259313|NCT00706355|582329032|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
161259314|NCT00706355|582329033|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161259315|NCT00706355|582329034|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161259316|NCT00706355|582329035|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
161259317|NCT00706355|582329032|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161259318|NCT00706355|582329033|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
161259319|NCT00706355|582329034|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161259320|NCT00706355|582329035|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
161259321|NCT00706355|582329032|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161259322|NCT00706355|582329033|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
161259323|NCT00706355|582329034|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161259324|NCT00706355|582329035|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
161259325|NCT00706355|582329032|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161259326|NCT00706355|582329033|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
161259327|NCT00706355|582329034|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161259328|NCT00706355|582329035|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
161259329|NCT00706355|582329032|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161259330|NCT00706355|582329033|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161259331|NCT00706355|582329034|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
161259332|NCT00706355|582329035|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
161259333|NCT00706355|582329032|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
161259334|NCT00706355|582329033|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
160918552|NCT03045887|581096007|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918553|NCT03045887|581096008|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
160918554|NCT03045887|581096009|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918555|NCT03045887|581096010|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918556|NCT03045887|581096011|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918557|NCT03045887|581096012|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918558|NCT03045887|581096013|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918559|NCT03045887|581096014|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
160918560|NCT03045887|581096005|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
160918561|NCT03045887|581096006|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918562|NCT03045887|581096007|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918563|NCT03045887|581096008|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918564|NCT03045887|581096009|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918565|NCT03045887|581096010|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918566|NCT03045887|581096011|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918567|NCT03045887|581096012|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918568|NCT03045887|581096013|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918569|NCT03045887|581096014|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
160918570|NCT03045887|581096005|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918571|NCT03045887|581096006|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918572|NCT03045887|581096007|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
160918573|NCT03045887|581096008|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
160918574|NCT03045887|581096009|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918575|NCT03045887|581096010|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918576|NCT03045887|581096011|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918577|NCT03045887|581096012|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918578|NCT03045887|581096013|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160918579|NCT03045887|581096014|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
160997082|NCT01090024|581374874|FG017|Period 1|Adverse Event|1|||
160918580|NCT03045887|581096005|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918581|NCT03045887|581096006|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918582|NCT03045887|581096007|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918583|NCT03045887|581096008|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
160918584|NCT03045887|581096009|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918585|NCT03045887|581096010|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918586|NCT03045887|581096011|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918587|NCT03045887|581096012|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918588|NCT03045887|581096013|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918589|NCT03045887|581096014|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
160918590|NCT03414424|581096015|FG000|Overall Study|Screened out after consent|0|||
160918591|NCT03414424|581096016|FG001|Overall Study|Screened out after consent|2|||
160918592|NCT03414424|581096015|FG000|Overall Study|Lost to Follow-up|0|||
160918593|NCT03414424|581096016|FG001|Overall Study|Lost to Follow-up|1|||
160918594|NCT01782859|581096017|FG000|Overall Study|Protocol Violation|6|||
160918595|NCT01782859|581096018|FG001|Overall Study|Protocol Violation|6|||
160918596|NCT01782859|581096017|FG000|Overall Study|Withdrawal by Subject|0|||
160918597|NCT01782859|581096018|FG001|Overall Study|Withdrawal by Subject|1|||
160918598|NCT03287804|581096019|FG000|Overall Study|Death|1|||
160918599|NCT03287804|581096019|FG000|Overall Study|Physician Decision|2|||
160918600|NCT03287804|581096019|FG000|Overall Study|Progressive disease|8|||
160918601|NCT02956486|581096020|FG000|Core Phase|Adverse Event|51|||
160918602|NCT02956486|581096021|FG001|Core Phase|Adverse Event|88|||
160918603|NCT02956486|581096022|FG002|Core Phase|Adverse Event|0|||
160918604|NCT02956486|581096020|FG000|Core Phase|Lost to Follow-up|8|||
160918605|NCT02956486|581096021|FG001|Core Phase|Lost to Follow-up|6|||
160918606|NCT02956486|581096022|FG002|Core Phase|Lost to Follow-up|0|||
160918607|NCT02956486|581096020|FG000|Core Phase|Inadequate therapeutic effect|4|||
160918608|NCT02956486|581096021|FG001|Core Phase|Inadequate therapeutic effect|5|||
161143224|NCT00923091|581907581|FG007|Period III (Single-Blind)|Adverse Event|0|||
161143225|NCT00923091|581907582|FG008|Period III (Single-Blind)|Adverse Event|0|||
161143226|NCT00923091|581907583|FG009|Period III (Single-Blind)|Adverse Event|0|||
161143227|NCT00923091|581907584|FG010|Period III (Single-Blind)|Adverse Event|0|||
161143228|NCT00923091|581907585|FG011|Period III (Single-Blind)|Adverse Event|0|||
161143229|NCT00923091|581907586|FG012|Period III (Single-Blind)|Adverse Event|0|||
161143230|NCT00923091|581907574|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
161143231|NCT00923091|581907575|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143232|NCT00923091|581907576|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143233|NCT00923091|581907577|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143234|NCT00923091|581907578|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143235|NCT00923091|581907579|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143236|NCT00923091|581907580|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143237|NCT00923091|581907581|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143238|NCT00923091|581907582|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143239|NCT00923091|581907583|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
161259335|NCT00706355|582329034|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
161259336|NCT00706355|582329035|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
160997083|NCT01090024|581374857|FG000|Period 1|Withdrawal by Subject|0|||
160997084|NCT01090024|581374858|FG001|Period 1|Withdrawal by Subject|0|||
160997085|NCT01090024|581374859|FG002|Period 1|Withdrawal by Subject|0|||
160997086|NCT01090024|581374860|FG003|Period 1|Withdrawal by Subject|1|||
160997087|NCT01090024|581374861|FG004|Period 1|Withdrawal by Subject|0|||
160997088|NCT01090024|581374862|FG005|Period 1|Withdrawal by Subject|0|||
160997089|NCT01090024|581374863|FG006|Period 1|Withdrawal by Subject|0|||
160997090|NCT01090024|581374864|FG007|Period 1|Withdrawal by Subject|0|||
160997091|NCT01090024|581374865|FG008|Period 1|Withdrawal by Subject|0|||
160997092|NCT01090024|581374866|FG009|Period 1|Withdrawal by Subject|0|||
160997093|NCT01090024|581374867|FG010|Period 1|Withdrawal by Subject|0|||
160997094|NCT01090024|581374868|FG011|Period 1|Withdrawal by Subject|0|||
160997095|NCT01090024|581374869|FG012|Period 1|Withdrawal by Subject|0|||
160997096|NCT01090024|581374870|FG013|Period 1|Withdrawal by Subject|0|||
160997097|NCT01090024|581374871|FG014|Period 1|Withdrawal by Subject|0|||
160997098|NCT01090024|581374872|FG015|Period 1|Withdrawal by Subject|0|||
160997099|NCT01090024|581374873|FG016|Period 1|Withdrawal by Subject|0|||
160997100|NCT01090024|581374874|FG017|Period 1|Withdrawal by Subject|0|||
160997101|NCT01090024|581374857|FG000|Period 1|Lost to Follow-up|0|||
160997102|NCT01090024|581374858|FG001|Period 1|Lost to Follow-up|1|||
160997103|NCT01090024|581374859|FG002|Period 1|Lost to Follow-up|0|||
160997104|NCT01090024|581374860|FG003|Period 1|Lost to Follow-up|0|||
160997105|NCT01090024|581374861|FG004|Period 1|Lost to Follow-up|0|||
160997106|NCT01090024|581374862|FG005|Period 1|Lost to Follow-up|0|||
160997107|NCT01090024|581374863|FG006|Period 1|Lost to Follow-up|0|||
160997108|NCT01090024|581374864|FG007|Period 1|Lost to Follow-up|0|||
161143240|NCT00923091|581907584|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
160997109|NCT01090024|581374865|FG008|Period 1|Lost to Follow-up|0|||
160997110|NCT01090024|581374866|FG009|Period 1|Lost to Follow-up|0|||
161259337|NCT00706355|582329032|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161259338|NCT00706355|582329033|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161259339|NCT00706355|582329034|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
161259340|NCT00706355|582329035|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
161259341|NCT00706355|582329032|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161259342|NCT00706355|582329033|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161259343|NCT00706355|582329034|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
161259344|NCT00706355|582329035|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
161259345|NCT02549573|582329038|FG000|Overall Study|Withdrawal by Subject|0|||
161259346|NCT02549573|582329039|FG001|Overall Study|Withdrawal by Subject|2|||
161259347|NCT02549573|582329038|FG000|Overall Study|Protocol Violation|0|||
161259348|NCT02549573|582329039|FG001|Overall Study|Protocol Violation|1|||
161259349|NCT02610816|582329042|FG000|Phase 1|Withdrawal by Subject|2|||
161259350|NCT02610816|582329043|FG001|Phase 1|Withdrawal by Subject|6|||
161259351|NCT02610816|582329044|FG002|Phase 1|Withdrawal by Subject|0|||
161259352|NCT02610816|582329045|FG003|Phase 1|Withdrawal by Subject|0|||
161259353|NCT02610816|582329042|FG000|Phase 1|Lost to Follow-up|2|||
161259354|NCT02610816|582329043|FG001|Phase 1|Lost to Follow-up|1|||
161259355|NCT02610816|582329044|FG002|Phase 1|Lost to Follow-up|0|||
161259356|NCT02610816|582329045|FG003|Phase 1|Lost to Follow-up|0|||
161259357|NCT02610816|582329042|FG000|Phase 1|Physician Decision|0|||
161259358|NCT02610816|582329043|FG001|Phase 1|Physician Decision|1|||
161259359|NCT02610816|582329044|FG002|Phase 1|Physician Decision|0|||
161259360|NCT02610816|582329045|FG003|Phase 1|Physician Decision|0|||
161259361|NCT02610816|582329042|FG000|Phase 2|Withdrawal by Subject|0|||
161259362|NCT02610816|582329043|FG001|Phase 2|Withdrawal by Subject|0|||
161259363|NCT02610816|582329044|FG002|Phase 2|Withdrawal by Subject|9|||
161259364|NCT02610816|582329045|FG003|Phase 2|Withdrawal by Subject|3|||
161259365|NCT02610816|582329042|FG000|Phase 2|Lost to Follow-up|0|||
161259366|NCT02610816|582329043|FG001|Phase 2|Lost to Follow-up|0|||
161259367|NCT02610816|582329044|FG002|Phase 2|Lost to Follow-up|2|||
161259368|NCT02610816|582329045|FG003|Phase 2|Lost to Follow-up|0|||
161259369|NCT02610816|582329042|FG000|Phase 2|Physician Decision|0|||
161259370|NCT02610816|582329043|FG001|Phase 2|Physician Decision|0|||
161259371|NCT02610816|582329044|FG002|Phase 2|Physician Decision|0|||
161259372|NCT02610816|582329045|FG003|Phase 2|Physician Decision|2|||
161259373|NCT02610816|582329042|FG000|Phase 2|Pregnancy|0|||
161259374|NCT02610816|582329043|FG001|Phase 2|Pregnancy|0|||
161259375|NCT02610816|582329044|FG002|Phase 2|Pregnancy|0|||
161259376|NCT02610816|582329045|FG003|Phase 2|Pregnancy|1|||
161259377|NCT01425528|582329046|FG000|Overall Study|Withdrawal by Subject|1|||
161259378|NCT01425528|582329047|FG001|Overall Study|Withdrawal by Subject|1|||
161259379|NCT01172821|582329048|FG000|Overall Study|Adverse Event|5|||
160918609|NCT02956486|581096022|FG002|Core Phase|Inadequate therapeutic effect|0|||
160918610|NCT02956486|581096020|FG000|Core Phase|Withdrawal by Subject|101|||
160918611|NCT02956486|581096021|FG001|Core Phase|Withdrawal by Subject|104|||
160918612|NCT02956486|581096022|FG002|Core Phase|Withdrawal by Subject|0|||
160918613|NCT02956486|581096020|FG000|Core Phase|Study terminated by sponsor|888|||
160918614|NCT02956486|581096021|FG001|Core Phase|Study terminated by sponsor|848|||
160918615|NCT02956486|581096022|FG002|Core Phase|Study terminated by sponsor|0|||
160918616|NCT02956486|581096020|FG000|Core Phase|Other|27|||
160918617|NCT02956486|581096021|FG001|Core Phase|Other|18|||
160918618|NCT02956486|581096022|FG002|Core Phase|Other|0|||
160918619|NCT02956486|581096020|FG000|Core Phase|Not treated|0|||
160918620|NCT02956486|581096021|FG001|Core Phase|Not treated|3|||
160918621|NCT02956486|581096022|FG002|Core Phase|Not treated|0|||
160918622|NCT02956486|581096020|FG000|Extension Phase|Adverse Event|0|||
160918623|NCT02956486|581096021|FG001|Extension Phase|Adverse Event|0|||
160918624|NCT02956486|581096022|FG002|Extension Phase|Adverse Event|2|||
160918625|NCT02956486|581096020|FG000|Extension Phase|Study terminated by sponsor|0|||
161259380|NCT01172821|582329049|FG001|Overall Study|Adverse Event|2|||
161259381|NCT01172821|582329050|FG002|Overall Study|Adverse Event|2|||
161259382|NCT01172821|582329051|FG003|Overall Study|Adverse Event|7|||
161259383|NCT01172821|582329048|FG000|Overall Study|Protocol Violation|0|||
160918626|NCT02956486|581096021|FG001|Extension Phase|Study terminated by sponsor|0|||
160918627|NCT02956486|581096022|FG002|Extension Phase|Study terminated by sponsor|16|||
160918628|NCT02956486|581096020|FG000|Extension Phase|Not Treated|0|||
160918629|NCT02956486|581096021|FG001|Extension Phase|Not Treated|0|||
161259384|NCT01172821|582329049|FG001|Overall Study|Protocol Violation|2|||
161259385|NCT01172821|582329050|FG002|Overall Study|Protocol Violation|1|||
161259386|NCT01172821|582329051|FG003|Overall Study|Protocol Violation|2|||
161259387|NCT01172821|582329048|FG000|Overall Study|Lost to Follow-up|4|||
161259388|NCT01172821|582329049|FG001|Overall Study|Lost to Follow-up|1|||
161259389|NCT01172821|582329050|FG002|Overall Study|Lost to Follow-up|2|||
160918630|NCT02956486|581096022|FG002|Extension Phase|Not Treated|1|||
160918631|NCT01408914|581096025|FG000|Overall Study|Could not complete tx in protocol period|5|||
161259390|NCT01172821|582329051|FG003|Overall Study|Lost to Follow-up|2|||
161259391|NCT01172821|582329048|FG000|Overall Study|Withdrawal by Subject|2|||
161259392|NCT01172821|582329049|FG001|Overall Study|Withdrawal by Subject|3|||
161259393|NCT01172821|582329050|FG002|Overall Study|Withdrawal by Subject|3|||
161259394|NCT01172821|582329051|FG003|Overall Study|Withdrawal by Subject|3|||
161259395|NCT01172821|582329048|FG000|Overall Study|Other|3|||
161259396|NCT01172821|582329049|FG001|Overall Study|Other|4|||
161259397|NCT01172821|582329050|FG002|Overall Study|Other|5|||
161259398|NCT01172821|582329051|FG003|Overall Study|Other|3|||
161259399|NCT02756637|582329054|FG000|Overall Study|Not eligible for initial SWOG study|10|||
161259400|NCT02756637|582329055|FG001|Overall Study|Not eligible for initial SWOG study|10|||
161259401|NCT02756637|582329054|FG000|Overall Study|No available NLR value|44|||
161259402|NCT02756637|582329055|FG001|Overall Study|No available NLR value|44|||
161259403|NCT02756637|582329054|FG000|Overall Study|Did not complete curative therapy|33|||
161259404|NCT02756637|582329055|FG001|Overall Study|Did not complete curative therapy|0|||
161259405|NCT03310957|582330147|FG000|Overall Study|Withdrawal by Subject|1|||
161259406|NCT03310957|582330148|FG001|Overall Study|Withdrawal by Subject|1|||
161259407|NCT03310957|582330149|FG002|Overall Study|Withdrawal by Subject|1|||
161259408|NCT03310957|582330150|FG003|Overall Study|Withdrawal by Subject|5|||
161259409|NCT03310957|582330151|FG004|Overall Study|Withdrawal by Subject|0|||
161259410|NCT03310957|582330152|FG005|Overall Study|Withdrawal by Subject|4|||
161259411|NCT03310957|582330153|FG006|Overall Study|Withdrawal by Subject|3|||
161259412|NCT03310957|582330147|FG000|Overall Study|Site Terminated|0|||
161259413|NCT03310957|582330148|FG001|Overall Study|Site Terminated|1|||
161259414|NCT03310957|582330149|FG002|Overall Study|Site Terminated|1|||
161259415|NCT03310957|582330150|FG003|Overall Study|Site Terminated|1|||
161259416|NCT03310957|582330151|FG004|Overall Study|Site Terminated|0|||
161259417|NCT03310957|582330152|FG005|Overall Study|Site Terminated|2|||
161259418|NCT03310957|582330153|FG006|Overall Study|Site Terminated|8|||
161259419|NCT03310957|582330147|FG000|Overall Study|Lost to Follow-up|1|||
161259420|NCT03310957|582330148|FG001|Overall Study|Lost to Follow-up|1|||
161259421|NCT03310957|582330149|FG002|Overall Study|Lost to Follow-up|1|||
161259422|NCT03310957|582330150|FG003|Overall Study|Lost to Follow-up|4|||
161259423|NCT03310957|582330151|FG004|Overall Study|Lost to Follow-up|0|||
161259424|NCT03310957|582330152|FG005|Overall Study|Lost to Follow-up|4|||
161259425|NCT03310957|582330153|FG006|Overall Study|Lost to Follow-up|2|||
161259426|NCT03310957|582330147|FG000|Overall Study|Death|5|||
161259427|NCT03310957|582330148|FG001|Overall Study|Death|8|||
161259428|NCT03310957|582330149|FG002|Overall Study|Death|18|||
161259429|NCT03310957|582330150|FG003|Overall Study|Death|31|||
161259430|NCT03310957|582330151|FG004|Overall Study|Death|1|||
161259431|NCT03310957|582330152|FG005|Overall Study|Death|29|||
161259432|NCT03310957|582330153|FG006|Overall Study|Death|7|||
161259433|NCT03310957|582330147|FG000|Overall Study|Discontinuation per sponsor|0|||
161259434|NCT03310957|582330148|FG001|Overall Study|Discontinuation per sponsor|1|||
161259435|NCT03310957|582330149|FG002|Overall Study|Discontinuation per sponsor|2|||
161259436|NCT03310957|582330150|FG003|Overall Study|Discontinuation per sponsor|4|||
161259437|NCT03310957|582330151|FG004|Overall Study|Discontinuation per sponsor|1|||
161259438|NCT03310957|582330152|FG005|Overall Study|Discontinuation per sponsor|9|||
161259439|NCT03310957|582330153|FG006|Overall Study|Discontinuation per sponsor|12|||
161259440|NCT03310957|582330147|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
161259441|NCT03310957|582330148|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
161259442|NCT03310957|582330149|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
161340613|NCT03533751|582633571|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
160918632|NCT01408914|581096026|FG001|Overall Study|Could not complete tx in protocol period|5|||
160918633|NCT01408914|581096027|FG002|Overall Study|Could not complete tx in protocol period|6|||
160918634|NCT01408914|581096025|FG000|Overall Study|Lost to Follow-up|4|||
160918635|NCT01408914|581096026|FG001|Overall Study|Lost to Follow-up|1|||
160918636|NCT01408914|581096027|FG002|Overall Study|Lost to Follow-up|2|||
160918637|NCT01408914|581096025|FG000|Overall Study|Physician Decision|1|||
160918638|NCT01408914|581096026|FG001|Overall Study|Physician Decision|1|||
160918639|NCT01408914|581096027|FG002|Overall Study|Physician Decision|0|||
160997111|NCT01090024|581374867|FG010|Period 1|Lost to Follow-up|0|||
160997112|NCT01090024|581374868|FG011|Period 1|Lost to Follow-up|0|||
160918640|NCT01408914|581096025|FG000|Overall Study|Withdrawal by Subject|1|||
160997113|NCT01090024|581374869|FG012|Period 1|Lost to Follow-up|0|||
160997114|NCT01090024|581374870|FG013|Period 1|Lost to Follow-up|0|||
161259443|NCT03310957|582330150|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
161259444|NCT03310957|582330151|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
161259445|NCT03310957|582330152|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
161259446|NCT03310957|582330153|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
160918641|NCT01408914|581096026|FG001|Overall Study|Withdrawal by Subject|0|||
160918642|NCT01408914|581096027|FG002|Overall Study|Withdrawal by Subject|1|||
160997115|NCT01090024|581374871|FG014|Period 1|Lost to Follow-up|0|||
161259447|NCT03310957|582330147|FG000|Overall Study|Treatment landscape|0|||
161259448|NCT03310957|582330148|FG001|Overall Study|Treatment landscape|0|||
161259449|NCT03310957|582330149|FG002|Overall Study|Treatment landscape|1|||
161259450|NCT03310957|582330150|FG003|Overall Study|Treatment landscape|1|||
161259451|NCT03310957|582330151|FG004|Overall Study|Treatment landscape|0|||
161259452|NCT03310957|582330152|FG005|Overall Study|Treatment landscape|1|||
160918643|NCT01408914|581096025|FG000|Overall Study|Moved out of study jurisdiction|1|||
160918644|NCT01408914|581096026|FG001|Overall Study|Moved out of study jurisdiction|1|||
160918645|NCT01408914|581096027|FG002|Overall Study|Moved out of study jurisdiction|0|||
160918646|NCT01408914|581096025|FG000|Overall Study|Late exclusion|0|||
160918647|NCT01408914|581096026|FG001|Overall Study|Late exclusion|3|||
160918648|NCT01408914|581096027|FG002|Overall Study|Late exclusion|3|||
160918649|NCT01408914|581096025|FG000|Overall Study|Change in local TB/HIV norms|0|||
160918650|NCT01408914|581096026|FG001|Overall Study|Change in local TB/HIV norms|1|||
160918651|NCT01408914|581096027|FG002|Overall Study|Change in local TB/HIV norms|1|||
160918652|NCT01585194|581096034|FG000|Overall Study|Withdrawal by Subject|1|||
160918653|NCT01585194|581096034|FG000|Overall Study|Physician Decision|2|||
160918654|NCT01585194|581096034|FG000|Overall Study|Lack of insurance|1|||
160918655|NCT00993291|581096035|FG000|Overall Study|Withdrawal by Subject|1|||
160918656|NCT00003492|581096036|FG000|Overall Study|Not evaluable|6|||
160918657|NCT04446377|581096038|FG000|Overall Study|Withdrawal by Subject|6|||
160918658|NCT04446377|581096039|FG001|Overall Study|Withdrawal by Subject|1|||
160918659|NCT04446377|581096038|FG000|Overall Study|Physician Decision|1|||
160997116|NCT01090024|581374872|FG015|Period 1|Lost to Follow-up|0|||
160997117|NCT01090024|581374873|FG016|Period 1|Lost to Follow-up|0|||
160997118|NCT01090024|581374874|FG017|Period 1|Lost to Follow-up|0|||
160997119|NCT01090024|581374857|FG000|Period 2|Lost to Follow-up|0|||
160997120|NCT01090024|581374858|FG001|Period 2|Lost to Follow-up|0|||
160997121|NCT01090024|581374859|FG002|Period 2|Lost to Follow-up|0|||
160997122|NCT01090024|581374860|FG003|Period 2|Lost to Follow-up|1|||
160997123|NCT01090024|581374861|FG004|Period 2|Lost to Follow-up|0|||
160997124|NCT01090024|581374862|FG005|Period 2|Lost to Follow-up|0|||
160997125|NCT01090024|581374863|FG006|Period 2|Lost to Follow-up|0|||
160997126|NCT01090024|581374864|FG007|Period 2|Lost to Follow-up|0|||
160997127|NCT01090024|581374865|FG008|Period 2|Lost to Follow-up|0|||
160997128|NCT01090024|581374866|FG009|Period 2|Lost to Follow-up|0|||
160997129|NCT01090024|581374867|FG010|Period 2|Lost to Follow-up|0|||
160997130|NCT01090024|581374868|FG011|Period 2|Lost to Follow-up|0|||
160997131|NCT01090024|581374869|FG012|Period 2|Lost to Follow-up|0|||
160997132|NCT01090024|581374870|FG013|Period 2|Lost to Follow-up|0|||
160997133|NCT01090024|581374871|FG014|Period 2|Lost to Follow-up|0|||
160997134|NCT01090024|581374872|FG015|Period 2|Lost to Follow-up|0|||
160997135|NCT01090024|581374873|FG016|Period 2|Lost to Follow-up|0|||
160997136|NCT01090024|581374874|FG017|Period 2|Lost to Follow-up|0|||
160997137|NCT01090024|581374857|FG000|Period 2|Adverse Event|1|||
160997138|NCT01090024|581374858|FG001|Period 2|Adverse Event|0|||
160997139|NCT01090024|581374859|FG002|Period 2|Adverse Event|0|||
160997140|NCT01090024|581374860|FG003|Period 2|Adverse Event|0|||
160997141|NCT01090024|581374861|FG004|Period 2|Adverse Event|0|||
160997142|NCT01090024|581374862|FG005|Period 2|Adverse Event|0|||
160997143|NCT01090024|581374863|FG006|Period 2|Adverse Event|0|||
160997144|NCT01090024|581374864|FG007|Period 2|Adverse Event|0|||
160997145|NCT01090024|581374865|FG008|Period 2|Adverse Event|0|||
160997146|NCT01090024|581374866|FG009|Period 2|Adverse Event|0|||
160997147|NCT01090024|581374867|FG010|Period 2|Adverse Event|0|||
160997148|NCT01090024|581374868|FG011|Period 2|Adverse Event|0|||
160997149|NCT01090024|581374869|FG012|Period 2|Adverse Event|0|||
160997150|NCT01090024|581374870|FG013|Period 2|Adverse Event|0|||
160997151|NCT01090024|581374871|FG014|Period 2|Adverse Event|0|||
160997152|NCT01090024|581374872|FG015|Period 2|Adverse Event|0|||
160997153|NCT01090024|581374873|FG016|Period 2|Adverse Event|0|||
160997154|NCT01090024|581374874|FG017|Period 2|Adverse Event|0|||
160997155|NCT01090024|581374857|FG000|Period 3|Withdrawal by Subject|0|||
160997156|NCT01090024|581374858|FG001|Period 3|Withdrawal by Subject|0|||
160997157|NCT01090024|581374859|FG002|Period 3|Withdrawal by Subject|0|||
160997158|NCT01090024|581374860|FG003|Period 3|Withdrawal by Subject|0|||
160997159|NCT01090024|581374861|FG004|Period 3|Withdrawal by Subject|0|||
160997160|NCT01090024|581374862|FG005|Period 3|Withdrawal by Subject|0|||
160997161|NCT01090024|581374863|FG006|Period 3|Withdrawal by Subject|0|||
160997162|NCT01090024|581374864|FG007|Period 3|Withdrawal by Subject|0|||
160997163|NCT01090024|581374865|FG008|Period 3|Withdrawal by Subject|0|||
160918660|NCT04446377|581096039|FG001|Overall Study|Physician Decision|1|||
160918661|NCT04446377|581096038|FG000|Overall Study|Lost to Follow-up|0|||
160918662|NCT04446377|581096039|FG001|Overall Study|Lost to Follow-up|2|||
161340614|NCT03533751|582633572|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
160997164|NCT01090024|581374866|FG009|Period 3|Withdrawal by Subject|0|||
160997165|NCT01090024|581374867|FG010|Period 3|Withdrawal by Subject|0|||
160918663|NCT04446377|581096038|FG000|Overall Study|Not eligible|0|||
160918664|NCT04446377|581096039|FG001|Overall Study|Not eligible|1|||
160918665|NCT01414075|581096047|FG000|Overall Study|Adverse Event|1|||
160997166|NCT01090024|581374868|FG011|Period 3|Withdrawal by Subject|0|||
160997167|NCT01090024|581374869|FG012|Period 3|Withdrawal by Subject|0|||
160997168|NCT01090024|581374870|FG013|Period 3|Withdrawal by Subject|0|||
160997169|NCT01090024|581374871|FG014|Period 3|Withdrawal by Subject|0|||
160997170|NCT01090024|581374872|FG015|Period 3|Withdrawal by Subject|1|||
160997171|NCT01090024|581374873|FG016|Period 3|Withdrawal by Subject|0|||
160997172|NCT01090024|581374874|FG017|Period 3|Withdrawal by Subject|0|||
160918666|NCT01414075|581096048|FG001|Overall Study|Adverse Event|0|||
160918667|NCT01414075|581096049|FG002|Overall Study|Adverse Event|1|||
160918668|NCT01414075|581096050|FG003|Overall Study|Adverse Event|0|||
160918669|NCT01414075|581096047|FG000|Overall Study|Death|1|||
160918670|NCT01414075|581096048|FG001|Overall Study|Death|0|||
160918671|NCT01414075|581096049|FG002|Overall Study|Death|0|||
160918672|NCT01414075|581096050|FG003|Overall Study|Death|1|||
160918673|NCT01414075|581096047|FG000|Overall Study|Withdrawal by Subject|0|||
160918674|NCT01414075|581096048|FG001|Overall Study|Withdrawal by Subject|0|||
160918675|NCT01414075|581096049|FG002|Overall Study|Withdrawal by Subject|0|||
160918676|NCT01414075|581096050|FG003|Overall Study|Withdrawal by Subject|1|||
160918677|NCT01414075|581096047|FG000|Overall Study|Other than specified|1|||
160918678|NCT01414075|581096048|FG001|Overall Study|Other than specified|0|||
160918679|NCT01414075|581096049|FG002|Overall Study|Other than specified|1|||
160918680|NCT01414075|581096050|FG003|Overall Study|Other than specified|0|||
160918681|NCT04903626|581096052|FG000|Overall Study|Lost to Follow-up|6|||
160918682|NCT04903626|581096052|FG000|Overall Study|Withdrawal by Subject|1|||
160918683|NCT04903626|581096052|FG000|Overall Study|Other, Not Specified|1|||
161259453|NCT03310957|582330153|FG006|Overall Study|Treatment landscape|0|||
161259454|NCT03310957|582330147|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161259455|NCT03310957|582330148|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161340615|NCT03533751|582633573|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
161340616|NCT03533751|582633574|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
161340617|NCT03533751|582633570|FG000|Overall Study|Other|0|||
161340618|NCT03533751|582633571|FG001|Overall Study|Other|2|||
161340619|NCT03533751|582633572|FG002|Overall Study|Other|1|||
161340620|NCT03533751|582633573|FG003|Overall Study|Other|0|||
161340621|NCT03533751|582633574|FG004|Overall Study|Other|3|||
161340622|NCT01288430|582635516|FG000|Part 1|Progressive disease|2|||
161340623|NCT01288430|582635517|FG001|Part 1|Progressive disease|1|||
161259456|NCT03310957|582330149|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161259457|NCT03310957|582330150|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161340624|NCT01288430|582635518|FG002|Part 1|Progressive disease|1|||
161340625|NCT01288430|582635519|FG003|Part 1|Progressive disease|6|||
161259458|NCT03310957|582330151|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
161259459|NCT03310957|582330152|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161259460|NCT03310957|582330153|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
161259461|NCT03310957|582330147|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161259462|NCT03310957|582330148|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161259463|NCT03310957|582330149|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
161259464|NCT03310957|582330150|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161259465|NCT03310957|582330151|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161259466|NCT03310957|582330152|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161259467|NCT03310957|582330153|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
161259468|NCT03310957|582330147|FG000|Overall Study|Hospice|0|||
161259469|NCT03310957|582330148|FG001|Overall Study|Hospice|0|||
161259470|NCT03310957|582330149|FG002|Overall Study|Hospice|0|||
161259471|NCT03310957|582330150|FG003|Overall Study|Hospice|0|||
161340626|NCT01288430|582635520|FG004|Part 1|Progressive disease|2|||
161340627|NCT01288430|582635521|FG005|Part 1|Progressive disease|4|||
161340628|NCT01288430|582635522|FG006|Part 1|Progressive disease|2|||
161340629|NCT01288430|582635523|FG007|Part 1|Progressive disease|0|||
161340630|NCT01288430|582635524|FG008|Part 1|Progressive disease|0|||
161340631|NCT01288430|582635525|FG009|Part 1|Progressive disease|0|||
161340632|NCT01288430|582635516|FG000|Part 1|Clinical disease progression|0|||
161340633|NCT01288430|582635517|FG001|Part 1|Clinical disease progression|0|||
161340634|NCT01288430|582635518|FG002|Part 1|Clinical disease progression|1|||
161340635|NCT01288430|582635519|FG003|Part 1|Clinical disease progression|0|||
161340636|NCT01288430|582635520|FG004|Part 1|Clinical disease progression|0|||
161340637|NCT01288430|582635521|FG005|Part 1|Clinical disease progression|2|||
161340638|NCT01288430|582635522|FG006|Part 1|Clinical disease progression|2|||
161340639|NCT01288430|582635523|FG007|Part 1|Clinical disease progression|0|||
160918684|NCT06112756|581096055|FG000|Overall Study|Withdrawal by Subject|0|||
160918685|NCT06112756|581096056|FG001|Overall Study|Withdrawal by Subject|2|||
161259472|NCT03310957|582330151|FG004|Overall Study|Hospice|0|||
161259473|NCT03310957|582330152|FG005|Overall Study|Hospice|1|||
161259474|NCT03310957|582330153|FG006|Overall Study|Hospice|0|||
161259475|NCT03310957|582330147|FG000|Overall Study|Progressive|0|||
161259476|NCT03310957|582330148|FG001|Overall Study|Progressive|0|||
161340640|NCT01288430|582635524|FG008|Part 1|Clinical disease progression|0|||
160918686|NCT06112756|581096055|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
160918687|NCT06112756|581096056|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
160918688|NCT06112756|581096055|FG000|Overall Study|Adverse Event|2|||
160918689|NCT06112756|581096056|FG001|Overall Study|Adverse Event|2|||
160918690|NCT03060629|581096057|FG000|Overall Study|Death|4|||
161340641|NCT01288430|582635525|FG009|Part 1|Clinical disease progression|0|||
160918691|NCT03060629|581096058|FG001|Overall Study|Death|5|||
160918692|NCT03060629|581096057|FG000|Overall Study|Withdrawal by Subject|50|||
160918693|NCT03060629|581096058|FG001|Overall Study|Withdrawal by Subject|35|||
160918694|NCT03060629|581096057|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
160918695|NCT03060629|581096058|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
160918696|NCT03060629|581096057|FG000|Overall Study|Participant Relocate|15|||
160918697|NCT03060629|581096058|FG001|Overall Study|Participant Relocate|15|||
160918698|NCT03060629|581096057|FG000|Overall Study|Unable to Contact Participant|34|||
160918699|NCT03060629|581096058|FG001|Overall Study|Unable to Contact Participant|23|||
160918700|NCT03060629|581096057|FG000|Overall Study|Investigator Decision|7|||
160918701|NCT03060629|581096058|FG001|Overall Study|Investigator Decision|7|||
160918702|NCT03060629|581096057|FG000|Overall Study|Study Terminated by Sponsor|1100|||
160918703|NCT03060629|581096058|FG001|Overall Study|Study Terminated by Sponsor|1123|||
160918704|NCT03060629|581096057|FG000|Overall Study|Other|4|||
160918705|NCT03060629|581096058|FG001|Overall Study|Other|4|||
160918706|NCT01862874|581096059|FG000|Overall Study|Randomized not treated|1|||
160918707|NCT01862874|581096060|FG001|Overall Study|Randomized not treated|0|||
160918708|NCT01862874|581096059|FG000|Overall Study|Adverse Event|0|||
160918709|NCT01862874|581096060|FG001|Overall Study|Adverse Event|3|||
160918710|NCT01862874|581096059|FG000|Overall Study|Lost to Follow-up|26|||
160918711|NCT01862874|581096060|FG001|Overall Study|Lost to Follow-up|29|||
160918712|NCT01862874|581096059|FG000|Overall Study|Physician Decision|5|||
160918713|NCT01862874|581096060|FG001|Overall Study|Physician Decision|3|||
160918714|NCT01862874|581096059|FG000|Overall Study|Withdrawn by parent/guardian|1|||
160918715|NCT01862874|581096060|FG001|Overall Study|Withdrawn by parent/guardian|1|||
160918716|NCT01862874|581096059|FG000|Overall Study|Withdrawal by Subject|46|||
160918717|NCT01862874|581096060|FG001|Overall Study|Withdrawal by Subject|40|||
160918718|NCT01862874|581096059|FG000|Overall Study|Death|0|||
160918719|NCT01862874|581096060|FG001|Overall Study|Death|1|||
160918720|NCT03681405|581096061|FG000|Overall Study|Found to be ineligible after randomized|1|||
160918721|NCT03681405|581096062|FG001|Overall Study|Found to be ineligible after randomized|0|||
160918722|NCT02056340|581096064|FG000|Overall Study|Lost to Follow-up|5|||
160918723|NCT02056340|581096065|FG001|Overall Study|Lost to Follow-up|5|||
160918724|NCT02056340|581096064|FG000|Overall Study|Withdrawal by Subject|2|||
160918725|NCT02056340|581096065|FG001|Overall Study|Withdrawal by Subject|6|||
160918726|NCT04851314|581096070|FG000|Overall Study|Unable to complete research set-up procedures|0|||
160918727|NCT04851314|581096071|FG001|Overall Study|Unable to complete research set-up procedures|2|||
160918728|NCT04851314|581096070|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
160918729|NCT04851314|581096071|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
160918730|NCT00867009|581096072|FG000|Induction Period|Nonserious Adverse Event|5|||
160918731|NCT00867009|581096072|FG000|Induction Period|Serious Adverse Event|10|||
160918732|NCT00867009|581096072|FG000|Induction Period|Death due to serious adverse event|6|||
160918733|NCT00867009|581096072|FG000|Induction Period|Death due to Study Disease|4|||
160918734|NCT00867009|581096072|FG000|Induction Period|Protocol Violation|1|||
160918735|NCT00867009|581096072|FG000|Induction Period|Withdrawal by Subject|8|||
160918736|NCT00867009|581096072|FG000|Induction Period|Physician Decision|3|||
160918737|NCT00867009|581096072|FG000|Induction Period|Progressive Disease (PD)|25|||
160918738|NCT00867009|581096072|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
160918739|NCT03266094|581096075|FG000|Overall Study|Lost to Follow-up|1|||
160918740|NCT03266094|581096075|FG000|Overall Study|Withdrawal by Subject|1|||
160918741|NCT03171415|581096076|FG000|Overall Study|Lost to Follow-up|0|||
160918742|NCT03171415|581096077|FG001|Overall Study|Lost to Follow-up|0|||
160918743|NCT03171415|581096078|FG002|Overall Study|Lost to Follow-up|0|||
160918744|NCT03171415|581096079|FG003|Overall Study|Lost to Follow-up|0|||
160918745|NCT03171415|581096080|FG004|Overall Study|Lost to Follow-up|2|||
160918746|NCT04140292|581096081|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
160918747|NCT04140292|581096082|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
160918748|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
161259477|NCT03310957|582330149|FG002|Overall Study|Progressive|1|||
161259478|NCT03310957|582330150|FG003|Overall Study|Progressive|0|||
161259479|NCT03310957|582330151|FG004|Overall Study|Progressive|0|||
160918749|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
160918750|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
161259480|NCT03310957|582330152|FG005|Overall Study|Progressive|0|||
161259481|NCT03310957|582330153|FG006|Overall Study|Progressive|0|||
161259482|NCT01475253|582330158|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
161259483|NCT01475253|582330159|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
161259484|NCT01475253|582330160|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
160918751|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
160918752|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
160918753|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
160918754|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
160918755|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
160918756|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
160918757|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
160918758|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
160918759|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
160918760|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
160918761|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
160918762|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
160918763|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
160918764|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
160918765|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
160918766|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
160918767|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
160918768|NCT01962207|581096084|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
160918769|NCT01962207|581096085|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
160918770|NCT01962207|581096086|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
161143241|NCT00923091|581907585|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143242|NCT00923091|581907586|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
161143243|NCT00923091|581907574|FG000|Period III (Single-Blind)|Protocol Violation|3|||
161143244|NCT00923091|581907575|FG001|Period III (Single-Blind)|Protocol Violation|0|||
160918771|NCT01962207|581096087|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
160918772|NCT03036072|581096088|FG000|Overall Study|Death|0|||
160918773|NCT03036072|581096089|FG001|Overall Study|Death|1|||
160918774|NCT03036072|581096088|FG000|Overall Study|Withdrawal by Subject|0|||
160918775|NCT03036072|581096089|FG001|Overall Study|Withdrawal by Subject|1|||
160918776|NCT03036072|581096088|FG000|Overall Study|Physician Decision|0|||
160918777|NCT03036072|581096089|FG001|Overall Study|Physician Decision|1|||
160918778|NCT00680043|581096090|FG000|Overall Study|Withdrawal by Subject|1|||
160918779|NCT00680043|581096091|FG001|Overall Study|Withdrawal by Subject|0|||
160918780|NCT00680043|581096092|FG002|Overall Study|Withdrawal by Subject|0|||
160918781|NCT00680043|581096090|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
160918782|NCT00680043|581096091|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
160918783|NCT00680043|581096092|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
160918784|NCT00680043|581096090|FG000|Overall Study|Renal Transplant|1|||
160918785|NCT00680043|581096091|FG001|Overall Study|Renal Transplant|0|||
160918786|NCT00680043|581096092|FG002|Overall Study|Renal Transplant|4|||
160918787|NCT02484729|581096093|FG000|Overall Study|Failure of IntelliCap Error|0|||
160918788|NCT02484729|581096094|FG001|Overall Study|Failure of IntelliCap Error|0|||
160918789|NCT02484729|581096095|FG002|Overall Study|Failure of IntelliCap Error|0|||
160918790|NCT02484729|581096096|FG003|Overall Study|Failure of IntelliCap Error|0|||
160918791|NCT02484729|581096097|FG004|Overall Study|Failure of IntelliCap Error|0|||
160918792|NCT02484729|581096098|FG005|Overall Study|Failure of IntelliCap Error|0|||
160918793|NCT02484729|581096099|FG006|Overall Study|Failure of IntelliCap Error|0|||
160918794|NCT02484729|581096100|FG007|Overall Study|Failure of IntelliCap Error|0|||
160918795|NCT02484729|581096101|FG008|Overall Study|Failure of IntelliCap Error|0|||
160918796|NCT02484729|581096102|FG009|Overall Study|Failure of IntelliCap Error|1|||
160918797|NCT00670800|581097915|FG000|Overall Study|2 controls were insulin resistant|0|||
160918798|NCT00670800|581097916|FG001|Overall Study|2 controls were insulin resistant|2|||
160918799|NCT00587561|581097917|FG000|Overall Study|Lost to Follow-up|6|||
160918800|NCT00587561|581097918|FG001|Overall Study|Lost to Follow-up|4|||
160918801|NCT05661942|581097919|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
160918802|NCT05661942|581097920|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
160918803|NCT02081690|581097932|FG000|Overall Study|Death|3|||
160918804|NCT02081690|581097932|FG000|Overall Study|Physician Decision|3|||
160918805|NCT02081690|581097932|FG000|Overall Study|Withdrawal by Subject|1|||
160918806|NCT00982488|581097934|FG000|Overall Study|Administrative reason by sponsor|81|||
160918807|NCT00982488|581097935|FG001|Overall Study|Administrative reason by sponsor|3|||
160918808|NCT00982488|581097936|FG002|Overall Study|Administrative reason by sponsor|11|||
160918809|NCT00982488|581097937|FG003|Overall Study|Administrative reason by sponsor|0|||
160918810|NCT00982488|581097938|FG004|Overall Study|Administrative reason by sponsor|0|||
160918811|NCT00982488|581097934|FG000|Overall Study|Adverse event unrelated to study drug|5|||
160918812|NCT00982488|581097935|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160918813|NCT00982488|581097936|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160918814|NCT00982488|581097937|FG003|Overall Study|Adverse event unrelated to study drug|0|||
160918815|NCT00982488|581097938|FG004|Overall Study|Adverse event unrelated to study drug|0|||
160918816|NCT00982488|581097934|FG000|Overall Study|Death|11|||
160918817|NCT00982488|581097935|FG001|Overall Study|Death|0|||
160918818|NCT00982488|581097936|FG002|Overall Study|Death|2|||
160918819|NCT00982488|581097937|FG003|Overall Study|Death|0|||
160918820|NCT00982488|581097938|FG004|Overall Study|Death|0|||
160918821|NCT00982488|581097934|FG000|Overall Study|Disease progression|30|||
160918822|NCT00982488|581097935|FG001|Overall Study|Disease progression|5|||
161259485|NCT01475253|582330161|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
161259486|NCT01475253|582330158|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
161259487|NCT01475253|582330159|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
161259488|NCT01475253|582330160|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
161259489|NCT01475253|582330161|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
161259490|NCT02676284|582330162|FG000|Overall Study|Withdrawal by Subject|1|||
161259491|NCT03919448|582330164|FG000|Overall Study|Withdrawal by Subject|1|||
160918823|NCT00982488|581097936|FG002|Overall Study|Disease progression|10|||
160918824|NCT00982488|581097937|FG003|Overall Study|Disease progression|1|||
160918825|NCT00982488|581097938|FG004|Overall Study|Disease progression|1|||
160918826|NCT00982488|581097934|FG000|Overall Study|Lost to Follow-up|1|||
160918827|NCT00982488|581097935|FG001|Overall Study|Lost to Follow-up|0|||
160918828|NCT00982488|581097936|FG002|Overall Study|Lost to Follow-up|0|||
160918829|NCT00982488|581097937|FG003|Overall Study|Lost to Follow-up|0|||
160918830|NCT00982488|581097938|FG004|Overall Study|Lost to Follow-up|0|||
160918831|NCT00982488|581097934|FG000|Overall Study|Maximum clinical benefit|1|||
160918832|NCT00982488|581097935|FG001|Overall Study|Maximum clinical benefit|1|||
160918833|NCT00982488|581097936|FG002|Overall Study|Maximum clinical benefit|1|||
160918834|NCT00982488|581097937|FG003|Overall Study|Maximum clinical benefit|0|||
160918835|NCT00982488|581097938|FG004|Overall Study|Maximum clinical benefit|0|||
160918836|NCT00982488|581097934|FG000|Overall Study|Other|15|||
160918837|NCT00982488|581097935|FG001|Overall Study|Other|1|||
160918838|NCT00982488|581097936|FG002|Overall Study|Other|3|||
160918839|NCT00982488|581097937|FG003|Overall Study|Other|1|||
160918840|NCT00982488|581097938|FG004|Overall Study|Other|0|||
160918841|NCT00982488|581097934|FG000|Overall Study|Poor compliance/noncompliance|0|||
160918842|NCT00982488|581097935|FG001|Overall Study|Poor compliance/noncompliance|1|||
160918843|NCT00982488|581097936|FG002|Overall Study|Poor compliance/noncompliance|0|||
160918844|NCT00982488|581097937|FG003|Overall Study|Poor compliance/noncompliance|0|||
160918845|NCT00982488|581097938|FG004|Overall Study|Poor compliance/noncompliance|0|||
160918846|NCT00982488|581097934|FG000|Overall Study|Stem cell transplant|2|||
160918847|NCT00982488|581097935|FG001|Overall Study|Stem cell transplant|0|||
160918848|NCT00982488|581097936|FG002|Overall Study|Stem cell transplant|0|||
160918849|NCT00982488|581097937|FG003|Overall Study|Stem cell transplant|1|||
160918850|NCT00982488|581097938|FG004|Overall Study|Stem cell transplant|0|||
160918851|NCT00982488|581097934|FG000|Overall Study|Study drug toxicity|34|||
160918852|NCT00982488|581097935|FG001|Overall Study|Study drug toxicity|1|||
160918853|NCT00982488|581097936|FG002|Overall Study|Study drug toxicity|6|||
160918854|NCT00982488|581097937|FG003|Overall Study|Study drug toxicity|0|||
160918855|NCT00982488|581097938|FG004|Overall Study|Study drug toxicity|0|||
160918856|NCT00982488|581097934|FG000|Overall Study|Withdrawal by Subject|5|||
160918857|NCT00982488|581097935|FG001|Overall Study|Withdrawal by Subject|1|||
160918858|NCT00982488|581097936|FG002|Overall Study|Withdrawal by Subject|1|||
160918859|NCT00982488|581097937|FG003|Overall Study|Withdrawal by Subject|0|||
160918860|NCT00982488|581097938|FG004|Overall Study|Withdrawal by Subject|0|||
160918861|NCT03204981|581097939|FG000|Overall Study|Physician Decision|2|||
160918862|NCT03204981|581097939|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
160918863|NCT04203238|581097940|FG000|Overall Study|Withdrawal by Subject|1|||
160918864|NCT04203238|581097941|FG001|Overall Study|Withdrawal by Subject|1|||
160918865|NCT04203238|581097940|FG000|Overall Study|Covid-19|3|||
160918866|NCT04203238|581097941|FG001|Overall Study|Covid-19|0|||
160918867|NCT04244786|581097944|FG000|Overall Study|Adverse Event|0|||
160918868|NCT04244786|581097945|FG001|Overall Study|Adverse Event|0|||
160918869|NCT04244786|581097946|FG002|Overall Study|Adverse Event|2|||
160918870|NCT04244786|581097944|FG000|Overall Study|Withdrawal by Subject|0|||
160918871|NCT04244786|581097945|FG001|Overall Study|Withdrawal by Subject|0|||
161259492|NCT03919448|582330165|FG001|Overall Study|Withdrawal by Subject|0|||
161259493|NCT03919448|582330166|FG002|Overall Study|Withdrawal by Subject|0|||
161259494|NCT04776746|582330168|FG000|Overall Study|Study terminated by sponsor|61|||
161259495|NCT04776746|582330168|FG000|Overall Study|Adverse Event|5|||
160918872|NCT04244786|581097946|FG002|Overall Study|Withdrawal by Subject|5|||
160918873|NCT00001596|581097947|FG000|Overall Study|Death|1|||
160918874|NCT00001596|581097948|FG001|Overall Study|Death|0|||
160918875|NCT00001596|581097947|FG000|Overall Study|Withdrawal by Subject|3|||
160997173|NCT01090024|581374857|FG000|Period 3|Protocol Violation|0|||
160997174|NCT01090024|581374858|FG001|Period 3|Protocol Violation|0|||
160918876|NCT00001596|581097948|FG001|Overall Study|Withdrawal by Subject|1|||
160918877|NCT00001596|581097947|FG000|Overall Study|Study Termination|12|||
160918878|NCT00001596|581097948|FG001|Overall Study|Study Termination|9|||
160918879|NCT00001596|581097947|FG000|Overall Study|Adverse Event|1|||
160918880|NCT00001596|581097948|FG001|Overall Study|Adverse Event|0|||
160918881|NCT03274687|581097949|FG000|Overall Study|Protocol Violation|1|||
161259496|NCT04776746|582330168|FG000|Overall Study|Death|4|||
160918882|NCT03274687|581097950|FG001|Overall Study|Protocol Violation|1|||
160918883|NCT01572909|581097953|FG000|Overall Study|Adverse Event|7|||
160918884|NCT01572909|581097954|FG001|Overall Study|Adverse Event|2|||
160918885|NCT01572909|581097953|FG000|Overall Study|Death|3|||
160997175|NCT01090024|581374859|FG002|Period 3|Protocol Violation|0|||
160918886|NCT01572909|581097954|FG001|Overall Study|Death|1|||
160918887|NCT01572909|581097953|FG000|Overall Study|Lost to Follow-up|8|||
160918888|NCT01572909|581097954|FG001|Overall Study|Lost to Follow-up|7|||
160918889|NCT01572909|581097953|FG000|Overall Study|Physician Decision|1|||
160918890|NCT01572909|581097954|FG001|Overall Study|Physician Decision|1|||
160918891|NCT01572909|581097953|FG000|Overall Study|Technical Issues|1|||
161259497|NCT04776746|582330168|FG000|Overall Study|Lack of Efficacy|3|||
161259498|NCT04776746|582330168|FG000|Overall Study|Noncompliance with study drug|2|||
161259499|NCT04776746|582330168|FG000|Overall Study|Not related to COVID-19|2|||
161259500|NCT01567826|582330171|FG000|Overall Study|Lost to Follow-up|3|||
161259501|NCT01567826|582330172|FG001|Overall Study|Lost to Follow-up|2|||
161259502|NCT03265288|582330175|FG000|Overall Study|Adverse Event|0|||
161259503|NCT03265288|582330176|FG001|Overall Study|Adverse Event|1|||
161259504|NCT03265288|582330175|FG000|Overall Study|Withdrawal by Subject|13|||
161259505|NCT03265288|582330176|FG001|Overall Study|Withdrawal by Subject|5|||
161259506|NCT03265288|582330175|FG000|Overall Study|Drug Withdrawn|3|||
161259507|NCT03265288|582330176|FG001|Overall Study|Drug Withdrawn|3|||
161259508|NCT03265288|582330175|FG000|Overall Study|Any Other Reason|7|||
161259509|NCT03265288|582330176|FG001|Overall Study|Any Other Reason|3|||
161259510|NCT00171301|582330177|FG000|Overall Study|Death|1|||
161259511|NCT00171301|582330178|FG001|Overall Study|Death|2|||
161259512|NCT00171301|582330177|FG000|Overall Study|Adverse Event|1|||
161259513|NCT00171301|582330178|FG001|Overall Study|Adverse Event|2|||
161259514|NCT00171301|582330177|FG000|Overall Study|Lost to Follow-up|6|||
161259515|NCT00171301|582330178|FG001|Overall Study|Lost to Follow-up|2|||
161259516|NCT00171301|582330177|FG000|Overall Study|Protocol Violation|0|||
161259517|NCT00171301|582330178|FG001|Overall Study|Protocol Violation|2|||
161259518|NCT00171301|582330177|FG000|Overall Study|Withdrawal by Subject|0|||
161259519|NCT00171301|582330178|FG001|Overall Study|Withdrawal by Subject|1|||
161259520|NCT02100319|582330181|FG000|Overall Study|Case Report Forms Uncollected|11|||
161259521|NCT02100319|582330181|FG000|Overall Study|Protocol Deviation|5|||
161259522|NCT04976621|582330184|FG000|Overall Study|Lost to Follow-up|2|||
161259523|NCT04976621|582330185|FG001|Overall Study|Lost to Follow-up|2|||
161259524|NCT04976621|582330184|FG000|Overall Study|Withdrawal by Subject|1|||
161259525|NCT04976621|582330185|FG001|Overall Study|Withdrawal by Subject|1|||
161259526|NCT02589522|582330186|FG000|Overall Study|Physician Decision|1|||
161259527|NCT02589522|582330187|FG001|Overall Study|Physician Decision|2|||
161259528|NCT02589522|582330188|FG002|Overall Study|Physician Decision|0|||
161259529|NCT02589522|582330186|FG000|Overall Study|Did not start treatment|1|||
161259530|NCT02589522|582330187|FG001|Overall Study|Did not start treatment|0|||
161340642|NCT01288430|582635516|FG000|Part 1|Death due to disease progression|0|||
161340643|NCT01288430|582635517|FG001|Part 1|Death due to disease progression|0|||
160918892|NCT01572909|581097954|FG001|Overall Study|Technical Issues|0|||
160918893|NCT01572909|581097953|FG000|Overall Study|Withdrawal by Subject|12|||
160918894|NCT01572909|581097954|FG001|Overall Study|Withdrawal by Subject|11|||
160918895|NCT01572909|581097953|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
160918896|NCT01572909|581097954|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
160918897|NCT01199289|581097955|FG000|Overall Study|Ineligibility determined|2|||
160918898|NCT01199289|581097956|FG001|Overall Study|Ineligibility determined|1|||
160918899|NCT01199289|581097957|FG002|Overall Study|Ineligibility determined|0|||
160918900|NCT01199289|581097958|FG003|Overall Study|Ineligibility determined|0|||
160918901|NCT01199289|581097955|FG000|Overall Study|Protocol Violation|1|||
160918902|NCT01199289|581097956|FG001|Overall Study|Protocol Violation|0|||
160918903|NCT01199289|581097957|FG002|Overall Study|Protocol Violation|0|||
160918904|NCT01199289|581097958|FG003|Overall Study|Protocol Violation|1|||
160918905|NCT01199289|581097955|FG000|Overall Study|Noncompliance|1|||
160918906|NCT01199289|581097956|FG001|Overall Study|Noncompliance|0|||
160918907|NCT01199289|581097957|FG002|Overall Study|Noncompliance|2|||
160918908|NCT01199289|581097958|FG003|Overall Study|Noncompliance|0|||
160918909|NCT01199289|581097955|FG000|Overall Study|Adverse Event|0|||
160918910|NCT01199289|581097956|FG001|Overall Study|Adverse Event|3|||
161340644|NCT01288430|582635518|FG002|Part 1|Death due to disease progression|0|||
161340645|NCT01288430|582635519|FG003|Part 1|Death due to disease progression|0|||
160918911|NCT01199289|581097957|FG002|Overall Study|Adverse Event|1|||
160918912|NCT01199289|581097958|FG003|Overall Study|Adverse Event|4|||
161340646|NCT01288430|582635520|FG004|Part 1|Death due to disease progression|1|||
160918913|NCT01199289|581097955|FG000|Overall Study|Full consent withdrawn|2|||
160918914|NCT01199289|581097956|FG001|Overall Study|Full consent withdrawn|2|||
160918915|NCT01199289|581097957|FG002|Overall Study|Full consent withdrawn|2|||
160918916|NCT01199289|581097958|FG003|Overall Study|Full consent withdrawn|3|||
160918917|NCT01199289|581097955|FG000|Overall Study|Administrative decision|0|||
161259531|NCT02589522|582330188|FG002|Overall Study|Did not start treatment|0|||
161259532|NCT01478828|582330189|FG000|Overall Study|Adverse Event|1|||
161259533|NCT01557842|582330190|FG000|Overall Study|Lost to Follow-up|0|||
161259534|NCT01557842|582330191|FG001|Overall Study|Lost to Follow-up|1|||
161259535|NCT01557842|582330190|FG000|Overall Study|Death|1|||
161259536|NCT01557842|582330191|FG001|Overall Study|Death|0|||
161259537|NCT01557842|582330190|FG000|Overall Study|Lack of Efficacy|0|||
161340647|NCT01288430|582635521|FG005|Part 1|Death due to disease progression|0|||
160918918|NCT01199289|581097956|FG001|Overall Study|Administrative decision|0|||
160918919|NCT01199289|581097957|FG002|Overall Study|Administrative decision|0|||
160918920|NCT01199289|581097958|FG003|Overall Study|Administrative decision|1|||
160918921|NCT01199289|581097955|FG000|Overall Study|Lost to Follow-up|0|||
160918922|NCT01199289|581097956|FG001|Overall Study|Lost to Follow-up|0|||
160918923|NCT01199289|581097957|FG002|Overall Study|Lost to Follow-up|0|||
160918924|NCT01199289|581097958|FG003|Overall Study|Lost to Follow-up|1|||
160918925|NCT01199289|581097955|FG000|Overall Study|Protocol-specified criteria|3|||
160918926|NCT01199289|581097956|FG001|Overall Study|Protocol-specified criteria|0|||
160918927|NCT01199289|581097957|FG002|Overall Study|Protocol-specified criteria|0|||
160918928|NCT01199289|581097958|FG003|Overall Study|Protocol-specified criteria|1|||
160918929|NCT01199289|581097955|FG000|Overall Study|Pregnancy|0|||
160918930|NCT01199289|581097956|FG001|Overall Study|Pregnancy|1|||
160918931|NCT01199289|581097957|FG002|Overall Study|Pregnancy|0|||
160918932|NCT01199289|581097958|FG003|Overall Study|Pregnancy|1|||
160918933|NCT02636868|581097959|FG000|Overall Study|Death|0|||
160918934|NCT02636868|581097960|FG001|Overall Study|Death|1|||
160918935|NCT02636868|581097961|FG002|Overall Study|Death|2|||
160918936|NCT00415909|581097962|FG000|Overall Study|Withdrawal by Subject|2|||
160918937|NCT00415909|581097962|FG000|Overall Study|Death|1|||
161259538|NCT01557842|582330191|FG001|Overall Study|Lack of Efficacy|1|||
161259539|NCT01557842|582330190|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
161259540|NCT01557842|582330191|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
161259541|NCT01557842|582330190|FG000|Overall Study|Study Terminated by Sponsor|3|||
161259542|NCT01557842|582330191|FG001|Overall Study|Study Terminated by Sponsor|4|||
161259543|NCT01557842|582330190|FG000|Overall Study|Not Ablated|2|||
161259544|NCT01557842|582330191|FG001|Overall Study|Not Ablated|0|||
161259545|NCT05611996|582330192|FG000|Overall Study|Ineligible|1|||
161259546|NCT05611996|582330192|FG000|Overall Study|Withdrawal by Subject|9|||
161259547|NCT04479475|582330196|FG000|Overall Study|Withdrawal by Subject|7|||
161259548|NCT00619359|582330199|FG000|Overall Study|Adverse Event|32|||
161259549|NCT00619359|582330200|FG001|Overall Study|Adverse Event|36|||
161259550|NCT00619359|582330199|FG000|Overall Study|Lost to Follow-up|12|||
161259551|NCT00619359|582330200|FG001|Overall Study|Lost to Follow-up|16|||
161259552|NCT00619359|582330199|FG000|Overall Study|Physician Decision|0|||
161259553|NCT00619359|582330200|FG001|Overall Study|Physician Decision|7|||
161259554|NCT00619359|582330199|FG000|Overall Study|Protocol Violation|1|||
161259555|NCT00619359|582330200|FG001|Overall Study|Protocol Violation|1|||
161259556|NCT00619359|582330199|FG000|Overall Study|Withdrawal by Subject|19|||
161259557|NCT00619359|582330200|FG001|Overall Study|Withdrawal by Subject|20|||
161259558|NCT00619359|582330199|FG000|Overall Study|Progressive Disease|3|||
161259559|NCT00619359|582330200|FG001|Overall Study|Progressive Disease|1|||
161259560|NCT06972251|582330201|FG000|Overall Study|Withdrawal by Subject|1|||
161259561|NCT06972251|582330202|FG001|Overall Study|Withdrawal by Subject|0|||
161259562|NCT06972251|582330201|FG000|Overall Study|Lost to Follow-up|10|||
161259563|NCT06972251|582330202|FG001|Overall Study|Lost to Follow-up|2|||
161259564|NCT00351351|582330204|FG000|Overall Study|surgical access pbs; device issues|9|||
161259565|NCT00351351|582330205|FG001|Overall Study|surgical access pbs; device issues|4|||
161259566|NCT03891329|582330206|FG000|Overall Study|Death|5|||
161259567|NCT03891329|582330206|FG000|Overall Study|Lost to Follow-up|4|||
161259568|NCT03891329|582330206|FG000|Overall Study|Physician Decision|4|||
161259569|NCT03891329|582330206|FG000|Overall Study|Device explanted|3|||
161259570|NCT03891329|582330206|FG000|Overall Study|No study device implanted|3|||
161259571|NCT03176784|582330207|FG000|Overall Study|Lost to Follow-up|77|||
161259572|NCT03176784|582330208|FG001|Overall Study|Lost to Follow-up|79|||
161259573|NCT03176784|582330209|FG002|Overall Study|Lost to Follow-up|79|||
160918938|NCT05024058|581097963|FG000|Treatment|Study terminated by sponsor|5|||
160918939|NCT05024058|581097964|FG001|Treatment|Study terminated by sponsor|6|||
160918940|NCT05024058|581097965|FG002|Treatment|Study terminated by sponsor|4|||
160918941|NCT05024058|581097966|FG003|Treatment|Study terminated by sponsor|2|||
160918942|NCT05024058|581097967|FG004|Treatment|Study terminated by sponsor|3|||
160918943|NCT05024058|581097968|FG005|Treatment|Study terminated by sponsor|3|||
160918944|NCT05024058|581097969|FG006|Treatment|Study terminated by sponsor|1|||
160918945|NCT05024058|581097970|FG007|Treatment|Study terminated by sponsor|3|||
160918946|NCT05024058|581097971|FG008|Treatment|Study terminated by sponsor|6|||
161259574|NCT03176784|582330210|FG003|Overall Study|Lost to Follow-up|49|||
161259575|NCT03176784|582330207|FG000|Overall Study|Withdrawal by Subject|28|||
161259576|NCT03176784|582330208|FG001|Overall Study|Withdrawal by Subject|34|||
161259577|NCT03176784|582330209|FG002|Overall Study|Withdrawal by Subject|34|||
160918947|NCT05024058|581097972|FG009|Treatment|Study terminated by sponsor|6|||
160918948|NCT05024058|581097963|FG000|Follow-up|Withdrawal by Subject|1|||
160918949|NCT05024058|581097964|FG001|Follow-up|Withdrawal by Subject|0|||
161259578|NCT03176784|582330210|FG003|Overall Study|Withdrawal by Subject|21|||
161259579|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
161259580|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
161259581|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
161259582|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
161259583|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
160918950|NCT05024058|581097965|FG002|Follow-up|Withdrawal by Subject|1|||
160918951|NCT05024058|581097966|FG003|Follow-up|Withdrawal by Subject|0|||
160918952|NCT05024058|581097967|FG004|Follow-up|Withdrawal by Subject|0|||
160918953|NCT05024058|581097968|FG005|Follow-up|Withdrawal by Subject|0|||
160918954|NCT05024058|581097969|FG006|Follow-up|Withdrawal by Subject|0|||
161259584|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
161259585|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
161259586|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
161259587|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
161259588|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
161259589|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
161259590|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
161259591|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161259592|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161259593|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161259594|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161259595|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
161259596|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
161259597|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
161259598|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
161259599|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
161259600|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
161259601|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
161259602|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
161259603|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
161259604|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
161259605|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
161259606|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
161259607|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Death|0|||
161259608|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Death|1|||
161259609|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Death|0|||
161259610|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Death|0|||
161259611|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161259612|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
161259613|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161259614|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
161259615|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
161259616|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
161259617|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
161259618|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
161259619|NCT02990806|582330211|FG000|Stage 1 (22 Weeks)|Other|1|||
161259620|NCT02990806|582330212|FG001|Stage 1 (22 Weeks)|Other|3|||
161259621|NCT02990806|582330213|FG002|Stage 1 (22 Weeks)|Other|0|||
161259622|NCT02990806|582330214|FG003|Stage 1 (22 Weeks)|Other|0|||
161259623|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
161259624|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
161259625|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
161259626|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
161259627|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Death|1|||
161259628|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Death|0|||
161259629|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Death|0|||
161259630|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Death|0|||
161259631|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
161259632|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
161259633|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
161259634|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
161259635|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
161259636|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
161259637|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
161259638|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
161259639|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161259640|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
161259641|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161259642|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
161259643|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
161259644|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
161340648|NCT01288430|582635522|FG006|Part 1|Death due to disease progression|0|||
160918955|NCT05024058|581097970|FG007|Follow-up|Withdrawal by Subject|1|||
161259645|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
161259646|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
161259647|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
160918956|NCT05024058|581097971|FG008|Follow-up|Withdrawal by Subject|0|||
160918957|NCT05024058|581097972|FG009|Follow-up|Withdrawal by Subject|1|||
160918958|NCT00903617|581097977|FG000|Overall Study|Adverse Event|0|||
160918959|NCT00903617|581097978|FG001|Overall Study|Adverse Event|1|||
160918960|NCT00903617|581097979|FG002|Overall Study|Adverse Event|1|||
160918961|NCT00903617|581097980|FG003|Overall Study|Adverse Event|0|||
160918962|NCT00903617|581097977|FG000|Overall Study|Protocol-defined stopping criteria|0|||
160918963|NCT00903617|581097978|FG001|Overall Study|Protocol-defined stopping criteria|2|||
160918964|NCT00903617|581097979|FG002|Overall Study|Protocol-defined stopping criteria|0|||
160918965|NCT00903617|581097980|FG003|Overall Study|Protocol-defined stopping criteria|0|||
160918966|NCT00903617|581097977|FG000|Overall Study|Lost to Follow-up|2|||
160918967|NCT00903617|581097978|FG001|Overall Study|Lost to Follow-up|0|||
160918968|NCT00903617|581097979|FG002|Overall Study|Lost to Follow-up|1|||
160918969|NCT00903617|581097980|FG003|Overall Study|Lost to Follow-up|1|||
160918970|NCT00903617|581097977|FG000|Overall Study|Withdrawal by Subject|1|||
160918971|NCT00903617|581097978|FG001|Overall Study|Withdrawal by Subject|2|||
160918972|NCT00903617|581097979|FG002|Overall Study|Withdrawal by Subject|3|||
160918973|NCT00903617|581097980|FG003|Overall Study|Withdrawal by Subject|0|||
160918974|NCT01104636|581097981|FG000|Overall Study|Lack of Efficacy|43|||
160918975|NCT01104636|581097981|FG000|Overall Study|Lost to Follow-up|24|||
160918976|NCT01104636|581097981|FG000|Overall Study|Withdrawal by Subject|4|||
160918977|NCT01104636|581097981|FG000|Overall Study|Other|43|||
160918978|NCT01104636|581097981|FG000|Overall Study|Study terminated by sponsor|1|||
160918979|NCT01104636|581097981|FG000|Overall Study|Pregnancy|2|||
160918980|NCT01104636|581097981|FG000|Overall Study|Adverse Event|40|||
160918981|NCT01104636|581097981|FG000|Overall Study|Ongoing|21|||
160918982|NCT01706003|581097982|FG000|Overall Study|Withdrawal by Subject|2|||
160918983|NCT01706003|581097983|FG001|Overall Study|Withdrawal by Subject|0|||
160918984|NCT01706003|581097982|FG000|Overall Study|Not scheduled|3|||
160918985|NCT01706003|581097983|FG001|Overall Study|Not scheduled|0|||
160918986|NCT01706003|581097982|FG000|Overall Study|Lost to Follow-up|6|||
160918987|NCT01706003|581097983|FG001|Overall Study|Lost to Follow-up|4|||
160918988|NCT03316131|581097984|FG000|Treatment Period 2|Protocol deviation|1|||
160918989|NCT03316131|581097985|FG001|Treatment Period 2|Protocol deviation|0|||
160918990|NCT05608005|581097987|FG000|Overall Study|Adverse Event|2|||
160918991|NCT05608005|581097988|FG001|Overall Study|Adverse Event|1|||
160918992|NCT05608005|581097989|FG002|Overall Study|Adverse Event|3|||
160918993|NCT05608005|581097987|FG000|Overall Study|Protocol Violation|2|||
160918994|NCT05608005|581097988|FG001|Overall Study|Protocol Violation|3|||
160918995|NCT05608005|581097989|FG002|Overall Study|Protocol Violation|0|||
160918996|NCT05608005|581097987|FG000|Overall Study|Withdrawal by Subject|10|||
160918997|NCT05608005|581097988|FG001|Overall Study|Withdrawal by Subject|12|||
160918998|NCT05608005|581097989|FG002|Overall Study|Withdrawal by Subject|4|||
160918999|NCT05608005|581097987|FG000|Overall Study|Lost to Follow-up|25|||
160919000|NCT05608005|581097988|FG001|Overall Study|Lost to Follow-up|27|||
160919001|NCT05608005|581097989|FG002|Overall Study|Lost to Follow-up|15|||
160919002|NCT05608005|581097987|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
160919003|NCT05608005|581097988|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
160919004|NCT05608005|581097989|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
160919005|NCT03518073|581097990|FG000|Overall Study|Adverse Event|2|||
160919006|NCT03518073|581097991|FG001|Overall Study|Adverse Event|4|||
160919007|NCT03518073|581097992|FG002|Overall Study|Adverse Event|2|||
160919008|NCT03518073|581097990|FG000|Overall Study|Death|2|||
160919009|NCT03518073|581097991|FG001|Overall Study|Death|1|||
160919010|NCT03518073|581097992|FG002|Overall Study|Death|3|||
160919011|NCT03518073|581097990|FG000|Overall Study|Lost to Follow-up|1|||
160919012|NCT03518073|581097991|FG001|Overall Study|Lost to Follow-up|0|||
160919013|NCT03518073|581097992|FG002|Overall Study|Lost to Follow-up|1|||
160919014|NCT03518073|581097990|FG000|Overall Study|Physician Decision|5|||
160919015|NCT03518073|581097991|FG001|Overall Study|Physician Decision|0|||
160919016|NCT03518073|581097992|FG002|Overall Study|Physician Decision|2|||
160919017|NCT03518073|581097990|FG000|Overall Study|Progressive disease|1|||
160919018|NCT03518073|581097991|FG001|Overall Study|Progressive disease|1|||
160919019|NCT03518073|581097992|FG002|Overall Study|Progressive disease|1|||
160919020|NCT03518073|581097990|FG000|Overall Study|Protocol Violation|1|||
160919021|NCT03518073|581097991|FG001|Overall Study|Protocol Violation|0|||
160919022|NCT03518073|581097992|FG002|Overall Study|Protocol Violation|0|||
160919023|NCT03518073|581097990|FG000|Overall Study|Withdrawal by Subject|30|||
160919024|NCT03518073|581097991|FG001|Overall Study|Withdrawal by Subject|34|||
160919025|NCT03518073|581097992|FG002|Overall Study|Withdrawal by Subject|29|||
160919026|NCT03518073|581097990|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
160919027|NCT03518073|581097991|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
160919028|NCT03518073|581097992|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
160919029|NCT03518073|581097990|FG000|Overall Study|Covid-19|1|||
160919030|NCT03518073|581097991|FG001|Overall Study|Covid-19|2|||
160919031|NCT03518073|581097992|FG002|Overall Study|Covid-19|1|||
160919032|NCT03045081|581097993|FG000|Overall Study|Withdrawal by Subject|6|||
160919033|NCT03045081|581097994|FG001|Overall Study|Withdrawal by Subject|11|||
161259648|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
160919034|NCT03804879|581097995|FG000|Overall Study|Adverse Event|3|||
160919035|NCT03804879|581097996|FG001|Overall Study|Adverse Event|0|||
160919036|NCT03804879|581097995|FG000|Overall Study|Study Terminated By Sponsor|10|||
160919037|NCT03804879|581097996|FG001|Overall Study|Study Terminated By Sponsor|12|||
160919038|NCT03804879|581097995|FG000|Overall Study|Withdrawal by Subject|3|||
160919039|NCT03804879|581097996|FG001|Overall Study|Withdrawal by Subject|1|||
160919040|NCT01034462|581097997|FG000|Overall Study|Adverse Event|7|||
160919041|NCT01034462|581097998|FG001|Overall Study|Adverse Event|17|||
160919042|NCT01034462|581097997|FG000|Overall Study|Lack of Efficacy|4|||
160919043|NCT01034462|581097998|FG001|Overall Study|Lack of Efficacy|4|||
160919044|NCT01034462|581097997|FG000|Overall Study|Protocol Violation|10|||
160919045|NCT01034462|581097998|FG001|Overall Study|Protocol Violation|7|||
160919046|NCT01034462|581097997|FG000|Overall Study|Withdrawal by Subject|9|||
160919047|NCT01034462|581097998|FG001|Overall Study|Withdrawal by Subject|8|||
160919048|NCT01034462|581097997|FG000|Overall Study|Lost to Follow-up|14|||
160919049|NCT01034462|581097998|FG001|Overall Study|Lost to Follow-up|16|||
160919050|NCT01034462|581097997|FG000|Overall Study|Other reasons|1|||
160919051|NCT01034462|581097998|FG001|Overall Study|Other reasons|2|||
160919052|NCT03635957|581097999|FG000|Run-In Period|Lost to Follow-up|1|||
160919053|NCT03635957|581097999|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
160919054|NCT01525550|581098001|FG000|Overall Study|Lost to Follow-up|8|||
160919055|NCT01525550|581098002|FG001|Overall Study|Lost to Follow-up|2|||
160919056|NCT01525550|581098001|FG000|Overall Study|Death|19|||
160919057|NCT01525550|581098002|FG001|Overall Study|Death|28|||
160919058|NCT01525550|581098001|FG000|Overall Study|Other|0|||
160919059|NCT01525550|581098002|FG001|Overall Study|Other|4|||
160919060|NCT01525550|581098001|FG000|Overall Study|Sponsor's Decision|30|||
160919061|NCT01525550|581098002|FG001|Overall Study|Sponsor's Decision|11|||
160919062|NCT01525550|581098001|FG000|Overall Study|Withdrawal by Subject|4|||
160919063|NCT01525550|581098002|FG001|Overall Study|Withdrawal by Subject|0|||
160919064|NCT00174915|581098005|FG000|Overall Study|Lost to Follow-up|19|||
160919065|NCT00174915|581098006|FG001|Overall Study|Lost to Follow-up|17|||
160919066|NCT00174915|581098007|FG002|Overall Study|Lost to Follow-up|9|||
160919067|NCT00174915|581098008|FG003|Overall Study|Lost to Follow-up|17|||
160919068|NCT00174915|581098009|FG004|Overall Study|Lost to Follow-up|10|||
160919069|NCT00174915|581098005|FG000|Overall Study|Adverse Event|18|||
160919070|NCT00174915|581098006|FG001|Overall Study|Adverse Event|16|||
160919071|NCT00174915|581098007|FG002|Overall Study|Adverse Event|11|||
160919072|NCT00174915|581098008|FG003|Overall Study|Adverse Event|18|||
160919073|NCT00174915|581098009|FG004|Overall Study|Adverse Event|5|||
160919074|NCT00174915|581098005|FG000|Overall Study|Personal Reason(s)|16|||
160919075|NCT00174915|581098006|FG001|Overall Study|Personal Reason(s)|16|||
160919076|NCT00174915|581098007|FG002|Overall Study|Personal Reason(s)|9|||
160919077|NCT00174915|581098008|FG003|Overall Study|Personal Reason(s)|9|||
160919078|NCT00174915|581098009|FG004|Overall Study|Personal Reason(s)|9|||
160919079|NCT00174915|581098005|FG000|Overall Study|Other|15|||
160919080|NCT00174915|581098006|FG001|Overall Study|Other|8|||
160919081|NCT00174915|581098007|FG002|Overall Study|Other|6|||
160919082|NCT00174915|581098008|FG003|Overall Study|Other|5|||
160919083|NCT00174915|581098009|FG004|Overall Study|Other|3|||
160919084|NCT00174915|581098005|FG000|Overall Study|Gout Flare|13|||
160919085|NCT00174915|581098006|FG001|Overall Study|Gout Flare|6|||
160919086|NCT00174915|581098007|FG002|Overall Study|Gout Flare|8|||
160997176|NCT01090024|581374860|FG003|Period 3|Protocol Violation|0|||
160997177|NCT01090024|581374861|FG004|Period 3|Protocol Violation|0|||
160997178|NCT01090024|581374862|FG005|Period 3|Protocol Violation|0|||
161259649|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
161259650|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
160997179|NCT01090024|581374863|FG006|Period 3|Protocol Violation|0|||
160997180|NCT01090024|581374864|FG007|Period 3|Protocol Violation|0|||
160997181|NCT01090024|581374865|FG008|Period 3|Protocol Violation|1|||
160997182|NCT01090024|581374866|FG009|Period 3|Protocol Violation|0|||
160997183|NCT01090024|581374867|FG010|Period 3|Protocol Violation|0|||
160919087|NCT00174915|581098008|FG003|Overall Study|Gout Flare|1|||
160997184|NCT01090024|581374868|FG011|Period 3|Protocol Violation|0|||
160919088|NCT00174915|581098009|FG004|Overall Study|Gout Flare|0|||
160919089|NCT00174915|581098005|FG000|Overall Study|Protocol Violation|6|||
160919090|NCT00174915|581098006|FG001|Overall Study|Protocol Violation|3|||
160919091|NCT00174915|581098007|FG002|Overall Study|Protocol Violation|3|||
160919092|NCT00174915|581098008|FG003|Overall Study|Protocol Violation|6|||
160919093|NCT00174915|581098009|FG004|Overall Study|Protocol Violation|3|||
160919094|NCT00174915|581098005|FG000|Overall Study|Therapeutic Failure|6|||
160919095|NCT00174915|581098006|FG001|Overall Study|Therapeutic Failure|3|||
160919096|NCT00174915|581098007|FG002|Overall Study|Therapeutic Failure|2|||
160919097|NCT00174915|581098008|FG003|Overall Study|Therapeutic Failure|1|||
160919098|NCT00174915|581098009|FG004|Overall Study|Therapeutic Failure|3|||
160919099|NCT03060447|581098010|FG000|Overall Study|Withdrawal by Subject|2|||
160997185|NCT01090024|581374869|FG012|Period 3|Protocol Violation|0|||
160997186|NCT01090024|581374870|FG013|Period 3|Protocol Violation|0|||
160919100|NCT03060447|581098011|FG001|Overall Study|Withdrawal by Subject|0|||
160919101|NCT00546637|581098012|FG000|Overall Study|Adverse Event|46|||
160919102|NCT00546637|581098013|FG001|Overall Study|Adverse Event|20|||
160919103|NCT00546637|581098012|FG000|Overall Study|Lack of Efficacy|5|||
160919104|NCT00546637|581098013|FG001|Overall Study|Lack of Efficacy|5|||
160919105|NCT00546637|581098012|FG000|Overall Study|Lost to Follow-up|2|||
160919106|NCT00546637|581098013|FG001|Overall Study|Lost to Follow-up|2|||
160919107|NCT00546637|581098012|FG000|Overall Study|Other|10|||
160919108|NCT00546637|581098013|FG001|Overall Study|Other|12|||
160919109|NCT00546637|581098012|FG000|Overall Study|Withdrawal by Subject|7|||
160919110|NCT00546637|581098013|FG001|Overall Study|Withdrawal by Subject|9|||
160919111|NCT00546637|581098012|FG000|Overall Study|Randomized, but not treated|3|||
160919112|NCT00546637|581098013|FG001|Overall Study|Randomized, but not treated|1|||
160919113|NCT03108027|581098021|FG000|Period 1|Subject/Guardian Decision|0|||
160919114|NCT03108027|581098022|FG001|Period 1|Subject/Guardian Decision|0|||
160919115|NCT03108027|581098023|FG002|Period 1|Subject/Guardian Decision|0|||
160919116|NCT03108027|581098024|FG003|Period 1|Subject/Guardian Decision|2|||
160919117|NCT03108027|581098025|FG004|Period 1|Subject/Guardian Decision|0|||
160919118|NCT03108027|581098026|FG005|Period 1|Subject/Guardian Decision|0|||
160919119|NCT03108027|581098021|FG000|Period 3|Adverse Event|0|||
160919120|NCT03108027|581098022|FG001|Period 3|Adverse Event|1|||
160919121|NCT03108027|581098023|FG002|Period 3|Adverse Event|0|||
160919122|NCT03108027|581098024|FG003|Period 3|Adverse Event|0|||
160919123|NCT03108027|581098025|FG004|Period 3|Adverse Event|0|||
160919124|NCT03108027|581098026|FG005|Period 3|Adverse Event|0|||
160919125|NCT02426892|581098027|FG000|Overall Study|Adverse Event|2|||
160919126|NCT02426892|581098027|FG000|Overall Study|Lack of Efficacy|17|||
160919127|NCT02426892|581098027|FG000|Overall Study|Withdrawal by Subject|1|||
160919128|NCT03178773|581098028|FG000|Overall Study|Death|0|||
160919129|NCT03178773|581098029|FG001|Overall Study|Death|1|||
160919130|NCT03178773|581098028|FG000|Overall Study|Lost to Follow-up|29|||
160919131|NCT03178773|581098029|FG001|Overall Study|Lost to Follow-up|25|||
160919132|NCT03178773|581098028|FG000|Overall Study|Withdrawal by Subject|10|||
160919133|NCT03178773|581098029|FG001|Overall Study|Withdrawal by Subject|14|||
160919134|NCT01382446|581098030|FG000|Overall Study|Withdrawal by Subject|0|||
160919135|NCT01382446|581098031|FG001|Overall Study|Withdrawal by Subject|1|||
160919136|NCT01382446|581098030|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
160919137|NCT01382446|581098031|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
160919138|NCT00003901|581098032|FG000|Overall Study|Adverse Event|1|||
160919139|NCT00003901|581098032|FG000|Overall Study|Withdrawal by Subject|1|||
160919140|NCT00003901|581098032|FG000|Overall Study|Ineligible|6|||
160919141|NCT00003901|581098032|FG000|Overall Study|CT Scan not within protocol requirement|2|||
160919142|NCT00003901|581098032|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
160919143|NCT00003901|581098032|FG000|Overall Study|Medical problems|6|||
160919144|NCT03325075|581098037|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
160919145|NCT03325075|581098038|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
160919146|NCT03325075|581098039|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
160919147|NCT03325075|581098040|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
160919148|NCT03325075|581098037|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
160919149|NCT03325075|581098038|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
160919150|NCT03325075|581098039|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
160919151|NCT03325075|581098040|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
160919152|NCT03325075|581098037|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
161143245|NCT00923091|581907576|FG002|Period III (Single-Blind)|Protocol Violation|0|||
161143246|NCT00923091|581907577|FG003|Period III (Single-Blind)|Protocol Violation|0|||
161143247|NCT00923091|581907578|FG004|Period III (Single-Blind)|Protocol Violation|0|||
161143248|NCT00923091|581907579|FG005|Period III (Single-Blind)|Protocol Violation|0|||
161143249|NCT00923091|581907580|FG006|Period III (Single-Blind)|Protocol Violation|0|||
161143250|NCT00923091|581907581|FG007|Period III (Single-Blind)|Protocol Violation|0|||
161143251|NCT00923091|581907582|FG008|Period III (Single-Blind)|Protocol Violation|0|||
161143252|NCT00923091|581907583|FG009|Period III (Single-Blind)|Protocol Violation|0|||
161143253|NCT00923091|581907584|FG010|Period III (Single-Blind)|Protocol Violation|0|||
161143254|NCT00923091|581907585|FG011|Period III (Single-Blind)|Protocol Violation|0|||
161143255|NCT00923091|581907586|FG012|Period III (Single-Blind)|Protocol Violation|0|||
161143256|NCT00923091|581907574|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
161143257|NCT00923091|581907575|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
161143258|NCT00923091|581907576|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
161143259|NCT00923091|581907577|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
160997187|NCT01090024|581374871|FG014|Period 3|Protocol Violation|0|||
160919153|NCT03325075|581098038|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
160919154|NCT03325075|581098039|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
160919155|NCT03325075|581098040|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
160919156|NCT00422591|581098041|FG000|Overall Study|Physician Decision|4|||
161143260|NCT00923091|581907578|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
161340649|NCT01288430|582635523|FG007|Part 1|Death due to disease progression|0|||
161340650|NCT01288430|582635524|FG008|Part 1|Death due to disease progression|0|||
161340651|NCT01288430|582635525|FG009|Part 1|Death due to disease progression|0|||
161340652|NCT01288430|582635516|FG000|Part 1|Adverse Event|0|||
161340653|NCT01288430|582635517|FG001|Part 1|Adverse Event|0|||
161340654|NCT01288430|582635518|FG002|Part 1|Adverse Event|3|||
161340655|NCT01288430|582635519|FG003|Part 1|Adverse Event|1|||
161340656|NCT01288430|582635520|FG004|Part 1|Adverse Event|0|||
161340657|NCT01288430|582635521|FG005|Part 1|Adverse Event|0|||
161340658|NCT01288430|582635522|FG006|Part 1|Adverse Event|2|||
161340659|NCT01288430|582635523|FG007|Part 1|Adverse Event|0|||
161340660|NCT01288430|582635524|FG008|Part 1|Adverse Event|0|||
161340661|NCT01288430|582635525|FG009|Part 1|Adverse Event|0|||
161340662|NCT01288430|582635516|FG000|Part 1|Other|0|||
161340663|NCT01288430|582635517|FG001|Part 1|Other|2|||
161340664|NCT01288430|582635518|FG002|Part 1|Other|0|||
161340665|NCT01288430|582635519|FG003|Part 1|Other|0|||
161340666|NCT01288430|582635520|FG004|Part 1|Other|0|||
161340667|NCT01288430|582635521|FG005|Part 1|Other|0|||
161340668|NCT01288430|582635522|FG006|Part 1|Other|1|||
161340669|NCT01288430|582635523|FG007|Part 1|Other|0|||
161340670|NCT01288430|582635524|FG008|Part 1|Other|0|||
161340671|NCT01288430|582635525|FG009|Part 1|Other|0|||
160919157|NCT00422591|581098041|FG000|Overall Study|Withdrawal by Subject|2|||
160919158|NCT00883116|581098044|FG000|Overall Study|Adverse event unrelated to study drug|5|||
160919159|NCT00883116|581098045|FG001|Overall Study|Adverse event unrelated to study drug|10|||
160919160|NCT00883116|581098044|FG000|Overall Study|Death|6|||
160919161|NCT00883116|581098045|FG001|Overall Study|Death|2|||
160919162|NCT00883116|581098044|FG000|Overall Study|Disease progression|130|||
160919163|NCT00883116|581098045|FG001|Overall Study|Disease progression|128|||
160919164|NCT00883116|581098044|FG000|Overall Study|Lost to Follow-up|0|||
160919165|NCT00883116|581098045|FG001|Overall Study|Lost to Follow-up|1|||
160919166|NCT00883116|581098044|FG000|Overall Study|Maximum clinical benefit|13|||
160919167|NCT00883116|581098045|FG001|Overall Study|Maximum clinical benefit|46|||
160919168|NCT00883116|581098044|FG000|Overall Study|Not identified|3|||
160919169|NCT00883116|581098045|FG001|Overall Study|Not identified|6|||
160919170|NCT00883116|581098044|FG000|Overall Study|Study drug toxicity|36|||
160919171|NCT00883116|581098045|FG001|Overall Study|Study drug toxicity|16|||
160919172|NCT00883116|581098044|FG000|Overall Study|Withdrawal by Subject|14|||
160919173|NCT00883116|581098045|FG001|Overall Study|Withdrawal by Subject|8|||
160919174|NCT00883116|581098044|FG000|Overall Study|No longer meets study criteria|2|||
160919175|NCT00883116|581098045|FG001|Overall Study|No longer meets study criteria|2|||
160919176|NCT03241342|581098048|FG000|Overall Study|Adverse Event|5|||
160919177|NCT03241342|581098049|FG001|Overall Study|Adverse Event|8|||
160919178|NCT03241342|581098050|FG002|Overall Study|Adverse Event|4|||
160919179|NCT03241342|581098048|FG000|Overall Study|Lack of Efficacy|0|||
160919180|NCT03241342|581098049|FG001|Overall Study|Lack of Efficacy|0|||
160919181|NCT03241342|581098050|FG002|Overall Study|Lack of Efficacy|1|||
160919182|NCT03241342|581098048|FG000|Overall Study|noncompliance with study drug|2|||
160919183|NCT03241342|581098049|FG001|Overall Study|noncompliance with study drug|1|||
160919184|NCT03241342|581098050|FG002|Overall Study|noncompliance with study drug|1|||
160919185|NCT03241342|581098048|FG000|Overall Study|sponsor decision|0|||
160919186|NCT03241342|581098049|FG001|Overall Study|sponsor decision|1|||
160919187|NCT03241342|581098050|FG002|Overall Study|sponsor decision|2|||
160919188|NCT03241342|581098048|FG000|Overall Study|not reported|15|||
160919189|NCT03241342|581098049|FG001|Overall Study|not reported|21|||
160919190|NCT03241342|581098050|FG002|Overall Study|not reported|19|||
160919191|NCT00541034|581098054|FG000|Overall Study|Non-Compliance|3|||
160919192|NCT00847704|581098055|FG000|Overall Study|Withdrawal by Subject|1|||
160919193|NCT05838742|581098059|FG000|Overall Study|Adverse Event|2|||
160919194|NCT05838742|581098060|FG001|Overall Study|Adverse Event|0|||
160919195|NCT05838742|581098061|FG002|Overall Study|Adverse Event|1|||
160919196|NCT05838742|581098062|FG003|Overall Study|Adverse Event|0|||
160919197|NCT05838742|581098063|FG004|Overall Study|Adverse Event|1|||
160919198|NCT05838742|581098059|FG000|Overall Study|Lost to Follow-up|1|||
160919199|NCT05838742|581098060|FG001|Overall Study|Lost to Follow-up|1|||
160919200|NCT05838742|581098061|FG002|Overall Study|Lost to Follow-up|1|||
160919201|NCT05838742|581098062|FG003|Overall Study|Lost to Follow-up|0|||
160919202|NCT05838742|581098063|FG004|Overall Study|Lost to Follow-up|0|||
160919203|NCT05838742|581098059|FG000|Overall Study|Physician Decision|0|||
160919204|NCT05838742|581098060|FG001|Overall Study|Physician Decision|0|||
161340672|NCT01288430|582635516|FG000|Part 2|Progressive disease|0|||
161340673|NCT01288430|582635517|FG001|Part 2|Progressive disease|0|||
161340674|NCT01288430|582635518|FG002|Part 2|Progressive disease|0|||
160919205|NCT05838742|581098061|FG002|Overall Study|Physician Decision|0|||
160919206|NCT05838742|581098062|FG003|Overall Study|Physician Decision|0|||
160919207|NCT05838742|581098063|FG004|Overall Study|Physician Decision|1|||
160919208|NCT05838742|581098059|FG000|Overall Study|Withdrawal by Subject|8|||
161340675|NCT01288430|582635519|FG003|Part 2|Progressive disease|0|||
161340676|NCT01288430|582635520|FG004|Part 2|Progressive disease|0|||
161340677|NCT01288430|582635521|FG005|Part 2|Progressive disease|0|||
161340678|NCT01288430|582635522|FG006|Part 2|Progressive disease|0|||
160997188|NCT01090024|581374872|FG015|Period 3|Protocol Violation|0|||
160997189|NCT01090024|581374873|FG016|Period 3|Protocol Violation|0|||
160997190|NCT01090024|581374874|FG017|Period 3|Protocol Violation|0|||
160997191|NCT01090024|581374857|FG000|Period 3|Adverse Event|0|||
160997192|NCT01090024|581374858|FG001|Period 3|Adverse Event|0|||
160997193|NCT01090024|581374859|FG002|Period 3|Adverse Event|0|||
160997194|NCT01090024|581374860|FG003|Period 3|Adverse Event|0|||
160997195|NCT01090024|581374861|FG004|Period 3|Adverse Event|0|||
160997196|NCT01090024|581374862|FG005|Period 3|Adverse Event|1|||
160997197|NCT01090024|581374863|FG006|Period 3|Adverse Event|0|||
160997198|NCT01090024|581374864|FG007|Period 3|Adverse Event|0|||
160997199|NCT01090024|581374865|FG008|Period 3|Adverse Event|0|||
160997200|NCT01090024|581374866|FG009|Period 3|Adverse Event|0|||
160997201|NCT01090024|581374867|FG010|Period 3|Adverse Event|0|||
160997202|NCT01090024|581374868|FG011|Period 3|Adverse Event|0|||
160997203|NCT01090024|581374869|FG012|Period 3|Adverse Event|0|||
160997204|NCT01090024|581374870|FG013|Period 3|Adverse Event|0|||
160997205|NCT01090024|581374871|FG014|Period 3|Adverse Event|0|||
160919209|NCT05838742|581098060|FG001|Overall Study|Withdrawal by Subject|3|||
160919210|NCT05838742|581098061|FG002|Overall Study|Withdrawal by Subject|3|||
160919211|NCT05838742|581098062|FG003|Overall Study|Withdrawal by Subject|1|||
160919212|NCT05838742|581098063|FG004|Overall Study|Withdrawal by Subject|4|||
160919213|NCT05838742|581098059|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
160919214|NCT05838742|581098060|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
160919215|NCT05838742|581098061|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
160919216|NCT05838742|581098062|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
160919217|NCT05838742|581098063|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
160919218|NCT05838742|581098059|FG000|Overall Study|Lack of Efficacy|0|||
160919219|NCT05838742|581098060|FG001|Overall Study|Lack of Efficacy|0|||
160919220|NCT05838742|581098061|FG002|Overall Study|Lack of Efficacy|0|||
160919221|NCT05838742|581098062|FG003|Overall Study|Lack of Efficacy|1|||
160919222|NCT05838742|581098063|FG004|Overall Study|Lack of Efficacy|0|||
160919223|NCT05838742|581098059|FG000|Overall Study|Randomized, not treated|2|||
160919224|NCT05838742|581098060|FG001|Overall Study|Randomized, not treated|1|||
160919225|NCT05838742|581098061|FG002|Overall Study|Randomized, not treated|0|||
160919226|NCT05838742|581098062|FG003|Overall Study|Randomized, not treated|1|||
160919227|NCT05838742|581098063|FG004|Overall Study|Randomized, not treated|0|||
160919228|NCT02045797|581098064|FG000|Overall Study|Adverse Event|3|||
160919229|NCT02045797|581098065|FG001|Overall Study|Adverse Event|1|||
160919230|NCT02045797|581098066|FG002|Overall Study|Adverse Event|0|||
160919231|NCT02045797|581098064|FG000|Overall Study|Lack of Efficacy|1|||
160997206|NCT01090024|581374872|FG015|Period 3|Adverse Event|0|||
160997207|NCT01090024|581374873|FG016|Period 3|Adverse Event|0|||
160997208|NCT01090024|581374874|FG017|Period 3|Adverse Event|0|||
160997209|NCT00470626|581374876|FG000|Overall Study|Lost to Follow-up|10|||
160997210|NCT00470626|581374876|FG000|Overall Study|Withdrawal by Subject|7|||
160997211|NCT00777556|581374877|FG000|Overall Study|Inappropriate self-selection|34|||
160997212|NCT00777556|581374877|FG000|Overall Study|Dispensed but did not use product|12|||
160997213|NCT00777556|581374877|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
160997214|NCT02689349|581374878|FG000|Overall Study|Not implanted|4|||
160997215|NCT02689349|581374879|FG001|Overall Study|Not implanted|0|||
160997216|NCT02689349|581374878|FG000|Overall Study|Withdrawal by Subject|9|||
160997217|NCT02689349|581374879|FG001|Overall Study|Withdrawal by Subject|0|||
160997218|NCT00486759|581374885|FG000|Treatment|Adverse event/intercurrent illness|86|||
160997219|NCT00486759|581374886|FG001|Treatment|Adverse event/intercurrent illness|39|||
160997220|NCT00486759|581374885|FG000|Treatment|Insufficient therapeutic response|37|||
160997221|NCT00486759|581374886|FG001|Treatment|Insufficient therapeutic response|39|||
160997222|NCT00486759|581374885|FG000|Treatment|Death|17|||
160997223|NCT00486759|581374886|FG001|Treatment|Death|10|||
160997224|NCT00486759|581374885|FG000|Treatment|Withdrew consent|15|||
160997225|NCT00486759|581374886|FG001|Treatment|Withdrew consent|12|||
160997226|NCT00486759|581374885|FG000|Treatment|Administrative/reason not specified|17|||
160997227|NCT00486759|581374886|FG001|Treatment|Administrative/reason not specified|21|||
160997228|NCT00486759|581374885|FG000|Treatment|Refused treatment|10|||
160919232|NCT02045797|581098065|FG001|Overall Study|Lack of Efficacy|0|||
160997229|NCT00486759|581374886|FG001|Treatment|Refused treatment|7|||
160997230|NCT00486759|581374885|FG000|Treatment|Violation of selection criteria at entry|3|||
160919233|NCT02045797|581098066|FG002|Overall Study|Lack of Efficacy|0|||
160919234|NCT02045797|581098064|FG000|Overall Study|Lost to Follow-up|2|||
160919235|NCT02045797|581098065|FG001|Overall Study|Lost to Follow-up|3|||
160919236|NCT02045797|581098066|FG002|Overall Study|Lost to Follow-up|1|||
160919237|NCT02045797|581098064|FG000|Overall Study|Physician Decision|0|||
160919238|NCT02045797|581098065|FG001|Overall Study|Physician Decision|1|||
160919239|NCT02045797|581098066|FG002|Overall Study|Physician Decision|0|||
160919240|NCT02045797|581098064|FG000|Overall Study|Withdrawal by Subject|1|||
160997231|NCT00486759|581374886|FG001|Treatment|Violation of selection criteria at entry|3|||
160997232|NCT00486759|581374885|FG000|Treatment|Other protocol violation|1|||
160997233|NCT00486759|581374886|FG001|Treatment|Other protocol violation|5|||
160997234|NCT00486759|581374885|FG000|Treatment|Failure to return|1|||
160919241|NCT02045797|581098065|FG001|Overall Study|Withdrawal by Subject|2|||
160919242|NCT02045797|581098066|FG002|Overall Study|Withdrawal by Subject|0|||
160919243|NCT03334903|581098067|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
160919244|NCT03334903|581098068|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
160919245|NCT03334903|581098067|FG000|Overall Study|Protocol Violation|1|||
160919246|NCT03334903|581098068|FG001|Overall Study|Protocol Violation|3|||
160919247|NCT03334903|581098067|FG000|Overall Study|Surgery postponed|1|||
160919248|NCT03334903|581098068|FG001|Overall Study|Surgery postponed|0|||
160919249|NCT03334903|581098067|FG000|Overall Study|Adverse Event|1|||
160919250|NCT03334903|581098068|FG001|Overall Study|Adverse Event|1|||
160919251|NCT03334903|581098067|FG000|Overall Study|Withdrawal by Subject|0|||
160919252|NCT03334903|581098068|FG001|Overall Study|Withdrawal by Subject|1|||
160919253|NCT04405037|581098069|FG000|Overall Study|Withdrawal by Subject|1|||
160919254|NCT04405037|581098070|FG001|Overall Study|Withdrawal by Subject|0|||
160919255|NCT04405037|581098069|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
160919256|NCT04405037|581098070|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
160919257|NCT02169739|581099335|FG000|Overall Study|Lost to Follow-up|0|||
160919258|NCT02169739|581099336|FG001|Overall Study|Lost to Follow-up|4|||
160919259|NCT01244906|581099338|FG000|Overall Study|Death|2|||
160919260|NCT01244906|581099338|FG000|Overall Study|Progression of disease post treatment|6|||
160919261|NCT03480750|581099339|FG000|Overall Study|Withdrawal by Subject|0|||
160919262|NCT03480750|581099340|FG001|Overall Study|Withdrawal by Subject|1|||
160919263|NCT03480750|581099341|FG002|Overall Study|Withdrawal by Subject|0|||
160919264|NCT03480750|581099342|FG003|Overall Study|Withdrawal by Subject|0|||
160919265|NCT03480750|581099343|FG004|Overall Study|Withdrawal by Subject|0|||
160919266|NCT03480750|581099344|FG005|Overall Study|Withdrawal by Subject|0|||
160919267|NCT03480750|581099339|FG000|Overall Study|The interruption in Trientine shippment|0|||
160919268|NCT03480750|581099340|FG001|Overall Study|The interruption in Trientine shippment|0|||
160919269|NCT03480750|581099341|FG002|Overall Study|The interruption in Trientine shippment|0|||
160919270|NCT03480750|581099342|FG003|Overall Study|The interruption in Trientine shippment|0|||
160919271|NCT03480750|581099343|FG004|Overall Study|The interruption in Trientine shippment|0|||
160919272|NCT03480750|581099344|FG005|Overall Study|The interruption in Trientine shippment|1|||
160919273|NCT00723892|581099351|FG000|Overall Study|Participant not tracked|33|||
160919274|NCT00723892|581099352|FG001|Overall Study|Participant not tracked|35|||
160919275|NCT00723892|581099351|FG000|Overall Study|Virological criterion|24|||
160919276|NCT00723892|581099352|FG001|Overall Study|Virological criterion|9|||
160919277|NCT00723892|581099351|FG000|Overall Study|Withdrawal by Subject|6|||
160919278|NCT00723892|581099352|FG001|Overall Study|Withdrawal by Subject|9|||
160919279|NCT00723892|581099351|FG000|Overall Study|End planned|11|||
160919280|NCT00723892|581099352|FG001|Overall Study|End planned|7|||
160919281|NCT00723892|581099351|FG000|Overall Study|Bad tolerance|5|||
160919282|NCT00723892|581099352|FG001|Overall Study|Bad tolerance|5|||
160919283|NCT00723892|581099351|FG000|Overall Study|Multiple reasons|17|||
160919284|NCT00723892|581099352|FG001|Overall Study|Multiple reasons|12|||
160919285|NCT00723892|581099351|FG000|Overall Study|Other|6|||
160919286|NCT00723892|581099352|FG001|Overall Study|Other|3|||
160919287|NCT00723892|581099351|FG000|Overall Study|Study end|1|||
160919288|NCT00723892|581099352|FG001|Overall Study|Study end|3|||
160919289|NCT00723892|581099351|FG000|Overall Study|Weight loss|1|||
160919290|NCT00723892|581099352|FG001|Overall Study|Weight loss|3|||
160919291|NCT00723892|581099351|FG000|Overall Study|Alcohol abuse|0|||
160919292|NCT00723892|581099352|FG001|Overall Study|Alcohol abuse|1|||
160919293|NCT00723892|581099351|FG000|Overall Study|Intercurrent infection|2|||
160919294|NCT00723892|581099352|FG001|Overall Study|Intercurrent infection|0|||
160919295|NCT00723892|581099351|FG000|Overall Study|Drug addiction|1|||
160919296|NCT00723892|581099352|FG001|Overall Study|Drug addiction|0|||
160919297|NCT03683758|581099353|FG000|Overall Study|Non-study commitment conflict|1|||
160919298|NCT03683758|581099354|FG001|Overall Study|Non-study commitment conflict|3|||
160919299|NCT03683758|581099353|FG000|Overall Study|Illness preventing participation|1|||
160919300|NCT03683758|581099354|FG001|Overall Study|Illness preventing participation|0|||
160919301|NCT03683758|581099353|FG000|Overall Study|Adverse Event|1|||
160919302|NCT03683758|581099354|FG001|Overall Study|Adverse Event|0|||
160919303|NCT02411292|581099355|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
160919304|NCT02411292|581099355|FG000|Overall Study|Death|2|||
160919305|NCT02411292|581099355|FG000|Overall Study|Lost to Follow-up|3|||
161340679|NCT01288430|582635523|FG007|Part 2|Progressive disease|8|||
160919306|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
160919307|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
160919308|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
160919309|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
161340680|NCT01288430|582635524|FG008|Part 2|Progressive disease|7|||
160919310|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
160919311|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
160919312|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
160919313|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
160919314|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Other|4|||
160919315|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Other|1|||
160919316|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
160919317|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
160919318|NCT00303498|581099356|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
160919319|NCT00303498|581099357|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
160919320|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
160919321|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
160919322|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Death|1|||
160919323|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Death|0|||
160919324|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
160919325|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
160919326|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
160919327|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
160919328|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
160919329|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
160919330|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
160919331|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
160919332|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Other|1|||
160919333|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Other|0|||
160919334|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
160919335|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
160919336|NCT00303498|581099356|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
160919337|NCT00303498|581099357|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
160919338|NCT00453921|581099358|FG000|Overall Study|Withdrawal by Subject|1|||
160919339|NCT00453921|581099359|FG001|Overall Study|Withdrawal by Subject|1|||
160919340|NCT00453921|581099360|FG002|Overall Study|Withdrawal by Subject|1|||
160919341|NCT00453921|581099361|FG003|Overall Study|Withdrawal by Subject|1|||
160919342|NCT00453921|581099358|FG000|Overall Study|Lost to Follow-up|0|||
160919343|NCT00453921|581099359|FG001|Overall Study|Lost to Follow-up|0|||
160919344|NCT00453921|581099360|FG002|Overall Study|Lost to Follow-up|1|||
160919345|NCT00453921|581099361|FG003|Overall Study|Lost to Follow-up|0|||
160919346|NCT02232425|581099362|FG000|Overall Study|Lost to Follow-up|6|||
160919347|NCT02232425|581099363|FG001|Overall Study|Lost to Follow-up|2|||
160919348|NCT02232425|581099362|FG000|Overall Study|Adverse Event|2|||
160919349|NCT02232425|581099363|FG001|Overall Study|Adverse Event|0|||
160919350|NCT02232425|581099362|FG000|Overall Study|Withdrawal by Subject|5|||
160919351|NCT02232425|581099363|FG001|Overall Study|Withdrawal by Subject|6|||
160919352|NCT02232425|581099362|FG000|Overall Study|Lack of Efficacy|1|||
160919353|NCT02232425|581099363|FG001|Overall Study|Lack of Efficacy|0|||
160919354|NCT01601626|581099366|FG000|Overall Study|Death|1|||
160919355|NCT01601626|581099367|FG001|Overall Study|Death|1|||
160919356|NCT01601626|581099368|FG002|Overall Study|Death|1|||
160919357|NCT01601626|581099366|FG000|Overall Study|Lost to Follow-up|1|||
160919358|NCT01601626|581099367|FG001|Overall Study|Lost to Follow-up|2|||
160919359|NCT01601626|581099368|FG002|Overall Study|Lost to Follow-up|0|||
160919360|NCT01601626|581099366|FG000|Overall Study|Unable to Get to Clinic|0|||
160919361|NCT01601626|581099367|FG001|Overall Study|Unable to Get to Clinic|1|||
160919362|NCT01601626|581099368|FG002|Overall Study|Unable to Get to Clinic|0|||
160919363|NCT01601626|581099366|FG000|Overall Study|Withdrawal by Subject|0|||
160919364|NCT01601626|581099367|FG001|Overall Study|Withdrawal by Subject|1|||
160919365|NCT01601626|581099368|FG002|Overall Study|Withdrawal by Subject|1|||
160919366|NCT01601626|581099366|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
160919367|NCT01601626|581099367|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
160919368|NCT01601626|581099368|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
160919369|NCT00498602|581099369|FG000|Overall Study|Death|0|||
160919370|NCT00498602|581099370|FG001|Overall Study|Death|0|||
160919371|NCT00498602|581099371|FG002|Overall Study|Death|0|||
160919372|NCT00498602|581099372|FG003|Overall Study|Death|0|||
160919373|NCT00498602|581099373|FG004|Overall Study|Death|0|||
160919374|NCT00498602|581099374|FG005|Overall Study|Death|1|||
160919375|NCT00498602|581099375|FG006|Overall Study|Death|0|||
161340681|NCT01288430|582635525|FG009|Part 2|Progressive disease|2|||
160919376|NCT00498602|581099369|FG000|Overall Study|Lack of Efficacy|1|||
160919377|NCT00498602|581099370|FG001|Overall Study|Lack of Efficacy|0|||
160919378|NCT00498602|581099371|FG002|Overall Study|Lack of Efficacy|0|||
160919379|NCT00498602|581099372|FG003|Overall Study|Lack of Efficacy|0|||
160919380|NCT00498602|581099373|FG004|Overall Study|Lack of Efficacy|0|||
160919381|NCT00498602|581099374|FG005|Overall Study|Lack of Efficacy|0|||
160919382|NCT00498602|581099375|FG006|Overall Study|Lack of Efficacy|0|||
160919383|NCT00498602|581099369|FG000|Overall Study|Lost to Follow-up|0|||
160919384|NCT00498602|581099370|FG001|Overall Study|Lost to Follow-up|2|||
160919385|NCT00498602|581099371|FG002|Overall Study|Lost to Follow-up|0|||
160919386|NCT00498602|581099372|FG003|Overall Study|Lost to Follow-up|2|||
160997235|NCT00486759|581374886|FG001|Treatment|Failure to return|1|||
161340682|NCT01288430|582635516|FG000|Part 2|Clinical disease progression|0|||
161340683|NCT01288430|582635517|FG001|Part 2|Clinical disease progression|0|||
161340684|NCT01288430|582635518|FG002|Part 2|Clinical disease progression|0|||
161340685|NCT01288430|582635519|FG003|Part 2|Clinical disease progression|0|||
161340686|NCT01288430|582635520|FG004|Part 2|Clinical disease progression|0|||
161340687|NCT01288430|582635521|FG005|Part 2|Clinical disease progression|0|||
161340688|NCT01288430|582635522|FG006|Part 2|Clinical disease progression|0|||
161340689|NCT01288430|582635523|FG007|Part 2|Clinical disease progression|2|||
161340690|NCT01288430|582635524|FG008|Part 2|Clinical disease progression|0|||
161340691|NCT01288430|582635525|FG009|Part 2|Clinical disease progression|0|||
161340692|NCT01288430|582635516|FG000|Part 2|Withdrawal by Subject|0|||
161340693|NCT01288430|582635517|FG001|Part 2|Withdrawal by Subject|0|||
161340694|NCT01288430|582635518|FG002|Part 2|Withdrawal by Subject|0|||
161340695|NCT01288430|582635519|FG003|Part 2|Withdrawal by Subject|0|||
161340696|NCT01288430|582635520|FG004|Part 2|Withdrawal by Subject|0|||
161340697|NCT01288430|582635521|FG005|Part 2|Withdrawal by Subject|0|||
161340698|NCT01288430|582635522|FG006|Part 2|Withdrawal by Subject|0|||
161340699|NCT01288430|582635523|FG007|Part 2|Withdrawal by Subject|1|||
160919387|NCT00498602|581099373|FG004|Overall Study|Lost to Follow-up|0|||
160919388|NCT00498602|581099374|FG005|Overall Study|Lost to Follow-up|0|||
160919389|NCT00498602|581099375|FG006|Overall Study|Lost to Follow-up|0|||
160919390|NCT00498602|581099369|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
160919391|NCT00498602|581099370|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160919392|NCT00498602|581099371|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
160919393|NCT00498602|581099372|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
160919394|NCT00498602|581099373|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160919395|NCT00498602|581099374|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
160919396|NCT00498602|581099375|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
160997236|NCT00486759|581374885|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
160997237|NCT00486759|581374886|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
160997238|NCT00486759|581374885|FG000|Safety Follow-up|Death|40|||
160997239|NCT00486759|581374886|FG001|Safety Follow-up|Death|29|||
160997240|NCT00486759|581374885|FG000|Safety Follow-up|Withdrew consent|32|||
160997241|NCT00486759|581374886|FG001|Safety Follow-up|Withdrew consent|23|||
160997242|NCT00486759|581374885|FG000|Safety Follow-up|Failure to return|9|||
160997243|NCT00486759|581374886|FG001|Safety Follow-up|Failure to return|6|||
160997244|NCT00486759|581374885|FG000|Safety Follow-up|Administrative/not specified|8|||
160997245|NCT00486759|581374886|FG001|Safety Follow-up|Administrative/not specified|6|||
160997246|NCT00486759|581374885|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
160997247|NCT00486759|581374886|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
161259651|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
161259652|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
161259653|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
161259654|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
161259655|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
161259656|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
161259657|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
161259658|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
161259659|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
161259660|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
161259661|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
161259662|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
161259663|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
161259664|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
161259665|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
161259666|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
161259667|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Other|3|||
161259668|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Other|0|||
161259669|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Other|4|||
161259670|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Other|1|||
161259671|NCT02990806|582330211|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161259672|NCT02990806|582330212|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161259673|NCT02990806|582330213|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
161259674|NCT02990806|582330214|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
161259675|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
160919397|NCT00498602|581099369|FG000|Overall Study|AE not related to Study Drug|1|||
160919398|NCT00498602|581099370|FG001|Overall Study|AE not related to Study Drug|3|||
160919399|NCT00498602|581099371|FG002|Overall Study|AE not related to Study Drug|0|||
160997248|NCT00486759|581374885|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
161259676|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
161340700|NCT01288430|582635524|FG008|Part 2|Withdrawal by Subject|4|||
161340701|NCT01288430|582635525|FG009|Part 2|Withdrawal by Subject|0|||
161340702|NCT01288430|582635516|FG000|Part 2|Adverse Event|0|||
161340703|NCT01288430|582635517|FG001|Part 2|Adverse Event|0|||
160919400|NCT00498602|581099372|FG003|Overall Study|AE not related to Study Drug|0|||
160919401|NCT00498602|581099373|FG004|Overall Study|AE not related to Study Drug|2|||
160919402|NCT00498602|581099374|FG005|Overall Study|AE not related to Study Drug|2|||
160919403|NCT00498602|581099375|FG006|Overall Study|AE not related to Study Drug|1|||
160919404|NCT00498602|581099369|FG000|Overall Study|Caregiver Request|2|||
160919405|NCT00498602|581099370|FG001|Overall Study|Caregiver Request|2|||
160919406|NCT00498602|581099371|FG002|Overall Study|Caregiver Request|2|||
160919407|NCT00498602|581099372|FG003|Overall Study|Caregiver Request|0|||
160919408|NCT00498602|581099373|FG004|Overall Study|Caregiver Request|1|||
160919409|NCT00498602|581099374|FG005|Overall Study|Caregiver Request|2|||
160919410|NCT00498602|581099375|FG006|Overall Study|Caregiver Request|0|||
160919411|NCT00498602|581099369|FG000|Overall Study|Investigator Request|0|||
160919412|NCT00498602|581099370|FG001|Overall Study|Investigator Request|0|||
160919413|NCT00498602|581099371|FG002|Overall Study|Investigator Request|1|||
160919414|NCT00498602|581099372|FG003|Overall Study|Investigator Request|0|||
160919415|NCT00498602|581099373|FG004|Overall Study|Investigator Request|0|||
160919416|NCT00498602|581099374|FG005|Overall Study|Investigator Request|0|||
160919417|NCT00498602|581099375|FG006|Overall Study|Investigator Request|0|||
160919418|NCT00498602|581099369|FG000|Overall Study|Subject Request|3|||
160919419|NCT00498602|581099370|FG001|Overall Study|Subject Request|0|||
160919420|NCT00498602|581099371|FG002|Overall Study|Subject Request|1|||
160919421|NCT00498602|581099372|FG003|Overall Study|Subject Request|1|||
160919422|NCT00498602|581099373|FG004|Overall Study|Subject Request|1|||
160919423|NCT00498602|581099374|FG005|Overall Study|Subject Request|4|||
160919424|NCT00498602|581099375|FG006|Overall Study|Subject Request|1|||
160919425|NCT00498602|581099369|FG000|Overall Study|Other|2|||
160919426|NCT00498602|581099370|FG001|Overall Study|Other|3|||
160919427|NCT00498602|581099371|FG002|Overall Study|Other|1|||
160919428|NCT00498602|581099372|FG003|Overall Study|Other|0|||
160919429|NCT00498602|581099373|FG004|Overall Study|Other|0|||
160919430|NCT00498602|581099374|FG005|Overall Study|Other|3|||
160919431|NCT00498602|581099375|FG006|Overall Study|Other|0|||
160919432|NCT04984993|581099376|FG000|Overall Study|Withdrawal by Subject|8|||
160919433|NCT04984993|581099377|FG001|Overall Study|Withdrawal by Subject|2|||
161259677|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
161259678|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
161259679|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161259680|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
161259681|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161259682|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
161259683|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161259684|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
161259685|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161259686|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
161259687|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
161259688|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
161259689|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
161259690|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
160919434|NCT04984993|581099376|FG000|Overall Study|Lost to Follow-up|2|||
160919435|NCT04984993|581099377|FG001|Overall Study|Lost to Follow-up|2|||
160919436|NCT04984993|581099376|FG000|Overall Study|Both patients moved to another country|4|||
160919437|NCT04984993|581099377|FG001|Overall Study|Both patients moved to another country|0|||
160919438|NCT01110707|581099378|FG000|Overall Study|Protocol Violation|0|||
160919439|NCT01110707|581099379|FG001|Overall Study|Protocol Violation|3|||
160919440|NCT03318315|581099380|FG000|Overall Study|Lost to Follow-up|3|||
160919441|NCT03318315|581099381|FG001|Overall Study|Lost to Follow-up|2|||
160919442|NCT03318315|581099382|FG002|Overall Study|Lost to Follow-up|1|||
160919443|NCT03318315|581099380|FG000|Overall Study|Protocol Violation|1|||
160919444|NCT03318315|581099381|FG001|Overall Study|Protocol Violation|1|||
160919445|NCT03318315|581099382|FG002|Overall Study|Protocol Violation|1|||
160919446|NCT03318315|581099380|FG000|Overall Study|Withdrawal by Subject|0|||
160919447|NCT03318315|581099381|FG001|Overall Study|Withdrawal by Subject|0|||
160919448|NCT03318315|581099382|FG002|Overall Study|Withdrawal by Subject|2|||
160919449|NCT00268996|581099393|FG000|Overall Study|Adverse Event|11|||
160919450|NCT00268996|581099394|FG001|Overall Study|Adverse Event|7|||
160919451|NCT00268996|581099393|FG000|Overall Study|Lost to Follow-up|3|||
160919452|NCT00268996|581099394|FG001|Overall Study|Lost to Follow-up|1|||
160919453|NCT00268996|581099393|FG000|Overall Study|Withdrawal by Subject|5|||
160919454|NCT00268996|581099394|FG001|Overall Study|Withdrawal by Subject|11|||
160919455|NCT00268996|581099393|FG000|Overall Study|Non-compliance|1|||
160919456|NCT00268996|581099394|FG001|Overall Study|Non-compliance|0|||
160919457|NCT00268996|581099393|FG000|Overall Study|Other|1|||
160919458|NCT00268996|581099394|FG001|Overall Study|Other|1|||
160919459|NCT02617511|581099397|FG000|Overall Study|Withdrawal by Subject|1|||
160919460|NCT02617511|581099398|FG001|Overall Study|Withdrawal by Subject|0|||
161259691|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
161259692|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
161259693|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
161259694|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
161259695|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161259696|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161259697|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
161259698|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
161259699|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161259700|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161259701|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
161259702|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
161259703|NCT02990806|582330211|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161259704|NCT02990806|582330212|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161259705|NCT02990806|582330213|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
161259706|NCT02990806|582330214|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
161259707|NCT02654587|582330215|FG000|Overall Study|patient alive at end of study|22|||
161259708|NCT02654587|582330216|FG001|Overall Study|patient alive at end of study|8|||
161259709|NCT02654587|582330215|FG000|Overall Study|Withdrawal by Subject|1|||
161259710|NCT02654587|582330216|FG001|Overall Study|Withdrawal by Subject|7|||
161259711|NCT01825837|582330217|FG000|PART I|Withdrawal by Subject|0|||
161259712|NCT01825837|582330218|FG001|PART I|Withdrawal by Subject|0|||
161259713|NCT01825837|582330219|FG002|PART I|Withdrawal by Subject|0|||
161259714|NCT01825837|582330220|FG003|PART I|Withdrawal by Subject|6|||
161259715|NCT01825837|582330217|FG000|PART I|Patient non-compliance|0|||
161259716|NCT01825837|582330218|FG001|PART I|Patient non-compliance|0|||
161259717|NCT01825837|582330219|FG002|PART I|Patient non-compliance|0|||
161259718|NCT01825837|582330220|FG003|PART I|Patient non-compliance|1|||
161259719|NCT01825837|582330217|FG000|PART I|Treatment failure|0|||
161259720|NCT01825837|582330218|FG001|PART I|Treatment failure|0|||
161259721|NCT01825837|582330219|FG002|PART I|Treatment failure|0|||
161259722|NCT01825837|582330220|FG003|PART I|Treatment failure|7|||
161259723|NCT01825837|582330217|FG000|PART I|reason unspecified|0|||
161259724|NCT01825837|582330218|FG001|PART I|reason unspecified|0|||
161259725|NCT01825837|582330219|FG002|PART I|reason unspecified|0|||
161259726|NCT01825837|582330220|FG003|PART I|reason unspecified|3|||
161259727|NCT01825837|582330217|FG000|PART II|Withdrawal by Subject|3|||
161259728|NCT01825837|582330218|FG001|PART II|Withdrawal by Subject|3|||
161259729|NCT01825837|582330219|FG002|PART II|Withdrawal by Subject|7|||
161259730|NCT01825837|582330220|FG003|PART II|Withdrawal by Subject|0|||
161259731|NCT01825837|582330217|FG000|PART II|Patient non-compliance|5|||
161259732|NCT01825837|582330218|FG001|PART II|Patient non-compliance|2|||
161259733|NCT01825837|582330219|FG002|PART II|Patient non-compliance|4|||
161259734|NCT01825837|582330220|FG003|PART II|Patient non-compliance|0|||
161259735|NCT01825837|582330217|FG000|PART II|Adverse Event|3|||
161259736|NCT01825837|582330218|FG001|PART II|Adverse Event|3|||
161259737|NCT01825837|582330219|FG002|PART II|Adverse Event|1|||
161259738|NCT01825837|582330220|FG003|PART II|Adverse Event|0|||
161259739|NCT01825837|582330217|FG000|PART II|Treatment failure|6|||
161259740|NCT01825837|582330218|FG001|PART II|Treatment failure|4|||
161259741|NCT01825837|582330219|FG002|PART II|Treatment failure|5|||
161340704|NCT01288430|582635518|FG002|Part 2|Adverse Event|0|||
161340705|NCT01288430|582635519|FG003|Part 2|Adverse Event|0|||
160919461|NCT00811473|581099399|FG000|Overall Study|Adverse Event|3|||
160919462|NCT00811473|581099400|FG001|Overall Study|Adverse Event|12|||
160919463|NCT00811473|581099399|FG000|Overall Study|Lost to Follow-up|5|||
160919464|NCT00811473|581099400|FG001|Overall Study|Lost to Follow-up|1|||
160919465|NCT00811473|581099399|FG000|Overall Study|Withdrawal by Subject|2|||
160919466|NCT00811473|581099400|FG001|Overall Study|Withdrawal by Subject|4|||
160919467|NCT00811473|581099399|FG000|Overall Study|Severe non-compliance to protocol|2|||
160919468|NCT00811473|581099400|FG001|Overall Study|Severe non-compliance to protocol|4|||
160919469|NCT00811473|581099399|FG000|Overall Study|Lack of therapeutic response|4|||
161259742|NCT01825837|582330220|FG003|PART II|Treatment failure|0|||
161259743|NCT01825837|582330217|FG000|PART II|reason unspecified|2|||
161259744|NCT01825837|582330218|FG001|PART II|reason unspecified|2|||
161259745|NCT01825837|582330219|FG002|PART II|reason unspecified|2|||
161259746|NCT01825837|582330220|FG003|PART II|reason unspecified|0|||
161259747|NCT00904748|582330223|FG000|Overall Study|Withdrawal by Subject|1|||
161259748|NCT00904748|582330224|FG001|Overall Study|Withdrawal by Subject|1|||
161259749|NCT00904748|582330225|FG002|Overall Study|Withdrawal by Subject|1|||
161259750|NCT00904748|582330226|FG003|Overall Study|Withdrawal by Subject|2|||
161259751|NCT00904748|582330227|FG004|Overall Study|Withdrawal by Subject|0|||
161259752|NCT00904748|582330228|FG005|Overall Study|Withdrawal by Subject|0|||
161259753|NCT00904748|582330223|FG000|Overall Study|Adverse Event|0|||
161259754|NCT00904748|582330224|FG001|Overall Study|Adverse Event|0|||
161340706|NCT01288430|582635520|FG004|Part 2|Adverse Event|0|||
160919470|NCT00811473|581099400|FG001|Overall Study|Lack of therapeutic response|1|||
160919471|NCT00811473|581099399|FG000|Overall Study|Condition under investigation worsened|1|||
160919472|NCT00811473|581099400|FG001|Overall Study|Condition under investigation worsened|3|||
160919473|NCT00811473|581099399|FG000|Overall Study|Other 2|4|||
160919474|NCT00811473|581099400|FG001|Overall Study|Other 2|1|||
160919475|NCT00811473|581099399|FG000|Overall Study|Incorrect Enrollment|1|||
160919476|NCT00811473|581099400|FG001|Overall Study|Incorrect Enrollment|0|||
160919477|NCT00811473|581099399|FG000|Overall Study|Safety Reasons|1|||
160919478|NCT00811473|581099400|FG001|Overall Study|Safety Reasons|0|||
160919479|NCT01119131|581099404|FG000|Overall Study|Adverse Event|1|||
160919480|NCT01119131|581099405|FG001|Overall Study|Adverse Event|1|||
160919481|NCT01119131|581099406|FG002|Overall Study|Adverse Event|1|||
160919482|NCT01119131|581099404|FG000|Overall Study|Non-Compliance|1|||
160919483|NCT01119131|581099405|FG001|Overall Study|Non-Compliance|0|||
160919484|NCT01119131|581099406|FG002|Overall Study|Non-Compliance|4|||
160919485|NCT01119131|581099404|FG000|Overall Study|Physician Decision|0|||
160919486|NCT01119131|581099405|FG001|Overall Study|Physician Decision|0|||
160919487|NCT01119131|581099406|FG002|Overall Study|Physician Decision|1|||
160919488|NCT01187043|581099408|FG000|Overall Study|Adverse Event|0|||
160919489|NCT01187043|581099409|FG001|Overall Study|Adverse Event|0|||
160919490|NCT01187043|581099410|FG002|Overall Study|Adverse Event|0|||
160919491|NCT01187043|581099411|FG003|Overall Study|Adverse Event|0|||
160919492|NCT01187043|581099412|FG004|Overall Study|Adverse Event|1|||
160919493|NCT01187043|581099408|FG000|Overall Study|Unable to make scheduled visits|1|||
160919494|NCT01187043|581099409|FG001|Overall Study|Unable to make scheduled visits|0|||
160919495|NCT01187043|581099410|FG002|Overall Study|Unable to make scheduled visits|4|||
160919496|NCT01187043|581099411|FG003|Overall Study|Unable to make scheduled visits|0|||
160919497|NCT01187043|581099412|FG004|Overall Study|Unable to make scheduled visits|1|||
160919498|NCT00573534|581099413|FG000|Overall Study|oppositional behavior|3|||
160919499|NCT03035409|581099414|FG000|Overall Study|Adverse Event|5|||
160919500|NCT03035409|581099414|FG000|Overall Study|Death|2|||
160919501|NCT03035409|581099414|FG000|Overall Study|Withdrawal by Subject|2|||
160919502|NCT03035409|581099414|FG000|Overall Study|Non compliance|4|||
160919503|NCT03035409|581099414|FG000|Overall Study|Patient was jittery|1|||
160919504|NCT03035409|581099414|FG000|Overall Study|Did not like Questionnaire|1|||
160919505|NCT03035409|581099414|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
160919506|NCT03035409|581099414|FG000|Overall Study|Did not like taking drugs|1|||
160919507|NCT00927784|581099417|FG000|Overall Study|Death|1|||
160919508|NCT00927784|581099418|FG001|Overall Study|Death|0|||
160919509|NCT00927784|581099417|FG000|Overall Study|Withdrawal by Subject|1|||
160919510|NCT00927784|581099418|FG001|Overall Study|Withdrawal by Subject|0|||
160919511|NCT02457910|581099419|FG000|Overall Study|Withdrawal by Subject|0|||
160919512|NCT02457910|581099420|FG001|Overall Study|Withdrawal by Subject|0|||
160919513|NCT02457910|581099421|FG002|Overall Study|Withdrawal by Subject|0|||
160919514|NCT02457910|581099422|FG003|Overall Study|Withdrawal by Subject|0|||
160919515|NCT02457910|581099423|FG004|Overall Study|Withdrawal by Subject|0|||
160919516|NCT02457910|581099424|FG005|Overall Study|Withdrawal by Subject|1|||
160919517|NCT02457910|581099419|FG000|Overall Study|Adverse Event|0|||
160919518|NCT02457910|581099420|FG001|Overall Study|Adverse Event|2|||
160919519|NCT02457910|581099421|FG002|Overall Study|Adverse Event|1|||
160919520|NCT02457910|581099422|FG003|Overall Study|Adverse Event|1|||
160919521|NCT02457910|581099423|FG004|Overall Study|Adverse Event|1|||
160919522|NCT02457910|581099424|FG005|Overall Study|Adverse Event|3|||
160919523|NCT02457910|581099419|FG000|Overall Study|Disease progression|3|||
160919524|NCT02457910|581099420|FG001|Overall Study|Disease progression|3|||
160919525|NCT02457910|581099421|FG002|Overall Study|Disease progression|1|||
160919526|NCT02457910|581099422|FG003|Overall Study|Disease progression|1|||
160919527|NCT02457910|581099423|FG004|Overall Study|Disease progression|4|||
160919528|NCT02457910|581099424|FG005|Overall Study|Disease progression|6|||
160919529|NCT02457910|581099419|FG000|Overall Study|Other complicating illness|0|||
160919530|NCT02457910|581099420|FG001|Overall Study|Other complicating illness|0|||
160919531|NCT02457910|581099421|FG002|Overall Study|Other complicating illness|0|||
160919532|NCT02457910|581099422|FG003|Overall Study|Other complicating illness|0|||
160919533|NCT02457910|581099423|FG004|Overall Study|Other complicating illness|0|||
160919534|NCT02457910|581099424|FG005|Overall Study|Other complicating illness|1|||
160919535|NCT02457910|581099419|FG000|Overall Study|Death|0|||
160919536|NCT02457910|581099420|FG001|Overall Study|Death|0|||
160919537|NCT02457910|581099421|FG002|Overall Study|Death|1|||
160919538|NCT02457910|581099422|FG003|Overall Study|Death|0|||
160919539|NCT02457910|581099423|FG004|Overall Study|Death|0|||
160919540|NCT02457910|581099424|FG005|Overall Study|Death|0|||
160919541|NCT00467259|581099425|FG000|Overall Study|Adverse Event|24|||
160919542|NCT00467259|581099426|FG001|Overall Study|Adverse Event|90|||
160919543|NCT00467259|581099425|FG000|Overall Study|Protocol Violation|1|||
160919544|NCT00467259|581099426|FG001|Overall Study|Protocol Violation|7|||
160919545|NCT00467259|581099425|FG000|Overall Study|Withdrawal by Subject|34|||
160919546|NCT00467259|581099426|FG001|Overall Study|Withdrawal by Subject|108|||
160919547|NCT00467259|581099425|FG000|Overall Study|Physician Decision|0|||
160919548|NCT00467259|581099426|FG001|Overall Study|Physician Decision|2|||
160919549|NCT00467259|581099425|FG000|Overall Study|Lost to Follow-up|14|||
160919550|NCT00467259|581099426|FG001|Overall Study|Lost to Follow-up|34|||
160919551|NCT00467259|581099425|FG000|Overall Study|Site Closed|2|||
160919552|NCT00467259|581099426|FG001|Overall Study|Site Closed|1|||
160919553|NCT01339429|581099429|FG000|Overall Study|Withdrawal by Subject|1|||
160919554|NCT01339429|581099429|FG000|Overall Study|Physician Decision|3|||
160919555|NCT00459667|581099430|FG000|Overall Study|Adverse Event|9|||
160919556|NCT00459667|581099431|FG001|Overall Study|Adverse Event|12|||
160919557|NCT00459667|581099432|FG002|Overall Study|Adverse Event|8|||
160919558|NCT00459667|581099430|FG000|Overall Study|Lost to Follow-up|5|||
160919559|NCT00459667|581099431|FG001|Overall Study|Lost to Follow-up|9|||
160919560|NCT00459667|581099432|FG002|Overall Study|Lost to Follow-up|3|||
160919561|NCT00459667|581099430|FG000|Overall Study|Pregnancy|1|||
160919562|NCT00459667|581099431|FG001|Overall Study|Pregnancy|1|||
160919563|NCT00459667|581099432|FG002|Overall Study|Pregnancy|1|||
160919564|NCT00459667|581099430|FG000|Overall Study|Protocol Violation|1|||
160919565|NCT00459667|581099431|FG001|Overall Study|Protocol Violation|0|||
160919566|NCT00459667|581099432|FG002|Overall Study|Protocol Violation|0|||
160919567|NCT00459667|581099430|FG000|Overall Study|Withdrawal by Subject|3|||
160919568|NCT00459667|581099431|FG001|Overall Study|Withdrawal by Subject|5|||
160919569|NCT00459667|581099432|FG002|Overall Study|Withdrawal by Subject|5|||
160919570|NCT00459667|581099430|FG000|Overall Study|Other disease modifying treatment|1|||
160919571|NCT00459667|581099431|FG001|Overall Study|Other disease modifying treatment|2|||
160919572|NCT00459667|581099432|FG002|Overall Study|Other disease modifying treatment|1|||
160919573|NCT00459667|581099430|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
160919574|NCT00459667|581099431|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
160919575|NCT00459667|581099432|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
160919576|NCT00459667|581099430|FG000|Overall Study|No treatment administered|6|||
160919577|NCT00459667|581099431|FG001|Overall Study|No treatment administered|3|||
160919578|NCT00459667|581099432|FG002|Overall Study|No treatment administered|1|||
160919579|NCT00818662|581099434|FG000|Overall Study|Adverse Event|5|||
160919580|NCT00818662|581099435|FG001|Overall Study|Adverse Event|14|||
160919581|NCT00818662|581099436|FG002|Overall Study|Adverse Event|4|||
160919582|NCT00818662|581099437|FG003|Overall Study|Adverse Event|3|||
160919583|NCT00818662|581099434|FG000|Overall Study|Withdrawal by Subject|5|||
160919584|NCT00818662|581099435|FG001|Overall Study|Withdrawal by Subject|4|||
160919585|NCT00818662|581099436|FG002|Overall Study|Withdrawal by Subject|2|||
160919586|NCT00818662|581099437|FG003|Overall Study|Withdrawal by Subject|2|||
160919587|NCT00818662|581099434|FG000|Overall Study|Death|1|||
160919588|NCT00818662|581099435|FG001|Overall Study|Death|3|||
160919589|NCT00818662|581099436|FG002|Overall Study|Death|0|||
160919590|NCT00818662|581099437|FG003|Overall Study|Death|0|||
160919591|NCT00818662|581099434|FG000|Overall Study|Physician Decision|1|||
160919592|NCT00818662|581099435|FG001|Overall Study|Physician Decision|0|||
160919593|NCT00818662|581099436|FG002|Overall Study|Physician Decision|0|||
160919594|NCT00818662|581099437|FG003|Overall Study|Physician Decision|0|||
160919595|NCT00818662|581099434|FG000|Overall Study|Lost to Follow-up|0|||
160919596|NCT00818662|581099435|FG001|Overall Study|Lost to Follow-up|0|||
160919597|NCT00818662|581099436|FG002|Overall Study|Lost to Follow-up|0|||
160919598|NCT00818662|581099437|FG003|Overall Study|Lost to Follow-up|1|||
160919599|NCT00818662|581099434|FG000|Overall Study|Unwilling or Unable to Participate|4|||
160919600|NCT00818662|581099435|FG001|Overall Study|Unwilling or Unable to Participate|6|||
160919601|NCT00818662|581099436|FG002|Overall Study|Unwilling or Unable to Participate|2|||
160919602|NCT00818662|581099437|FG003|Overall Study|Unwilling or Unable to Participate|4|||
160919603|NCT00818662|581099434|FG000|Overall Study|Protocol Violation|1|||
160919604|NCT00818662|581099435|FG001|Overall Study|Protocol Violation|1|||
160919605|NCT00818662|581099436|FG002|Overall Study|Protocol Violation|0|||
160997249|NCT00486759|581374886|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
160997250|NCT00954707|581374887|FG000|Overall Study|Death|34|||
160997251|NCT00954707|581374887|FG000|Overall Study|Withdrawal by Subject|100|||
160997252|NCT00954707|581374887|FG000|Overall Study|Lost to Follow-up|33|||
160997253|NCT02987543|581374888|FG000|Overall Study|Ongoing study at data cut off|49|||
160997254|NCT02987543|581374889|FG001|Overall Study|Ongoing study at data cut off|21|||
160919606|NCT00818662|581099437|FG003|Overall Study|Protocol Violation|0|||
160919607|NCT00818662|581099434|FG000|Overall Study|Requires a Prohibited Medication|1|||
160919608|NCT00818662|581099435|FG001|Overall Study|Requires a Prohibited Medication|0|||
160997255|NCT02987543|581374890|FG002|Overall Study|Ongoing study at data cut off|19|||
161340707|NCT01288430|582635521|FG005|Part 2|Adverse Event|0|||
161340708|NCT01288430|582635522|FG006|Part 2|Adverse Event|0|||
160997256|NCT02987543|581374891|FG003|Overall Study|Ongoing study at data cut off|12|||
160997257|NCT02987543|581374888|FG000|Overall Study|Death|88|||
161143261|NCT00923091|581907579|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
161340709|NCT01288430|582635523|FG007|Part 2|Adverse Event|1|||
160919609|NCT00818662|581099436|FG002|Overall Study|Requires a Prohibited Medication|0|||
160919610|NCT00818662|581099437|FG003|Overall Study|Requires a Prohibited Medication|0|||
160919611|NCT00818662|581099434|FG000|Overall Study|Safety Risk|1|||
160919612|NCT00818662|581099435|FG001|Overall Study|Safety Risk|1|||
160919613|NCT00818662|581099436|FG002|Overall Study|Safety Risk|0|||
160919614|NCT00818662|581099437|FG003|Overall Study|Safety Risk|1|||
160919615|NCT00818662|581099434|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
160919616|NCT00818662|581099435|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
160919617|NCT00818662|581099436|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
160919618|NCT00818662|581099437|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
160919619|NCT00818662|581099434|FG000|Overall Study|Participant's health declined|0|||
160919620|NCT00818662|581099435|FG001|Overall Study|Participant's health declined|0|||
160919621|NCT00818662|581099436|FG002|Overall Study|Participant's health declined|0|||
160919622|NCT00818662|581099437|FG003|Overall Study|Participant's health declined|1|||
160919623|NCT00818662|581099434|FG000|Overall Study|Caregiver to pursue other treatment|0|||
160919624|NCT00818662|581099435|FG001|Overall Study|Caregiver to pursue other treatment|1|||
160919625|NCT00818662|581099436|FG002|Overall Study|Caregiver to pursue other treatment|0|||
160919626|NCT00818662|581099437|FG003|Overall Study|Caregiver to pursue other treatment|0|||
160919627|NCT00818662|581099434|FG000|Overall Study|Moving out of state|0|||
160919628|NCT00818662|581099435|FG001|Overall Study|Moving out of state|0|||
160919629|NCT00818662|581099436|FG002|Overall Study|Moving out of state|0|||
160919630|NCT00818662|581099437|FG003|Overall Study|Moving out of state|1|||
160919631|NCT00818662|581099434|FG000|Overall Study|Declined move to another study site|1|||
160919632|NCT00818662|581099435|FG001|Overall Study|Declined move to another study site|0|||
160919633|NCT00818662|581099436|FG002|Overall Study|Declined move to another study site|0|||
160919634|NCT00818662|581099437|FG003|Overall Study|Declined move to another study site|0|||
160919635|NCT00818662|581099434|FG000|Overall Study|Change in living situation|0|||
160919636|NCT00818662|581099435|FG001|Overall Study|Change in living situation|0|||
160919637|NCT00818662|581099436|FG002|Overall Study|Change in living situation|0|||
160919638|NCT00818662|581099437|FG003|Overall Study|Change in living situation|1|||
160919639|NCT00818662|581099434|FG000|Overall Study|Study partner decision|0|||
160919640|NCT00818662|581099435|FG001|Overall Study|Study partner decision|0|||
160919641|NCT00818662|581099436|FG002|Overall Study|Study partner decision|0|||
160919642|NCT00818662|581099437|FG003|Overall Study|Study partner decision|1|||
160919643|NCT00818662|581099434|FG000|Overall Study|Admitted to long term nursing care|0|||
160919644|NCT00818662|581099435|FG001|Overall Study|Admitted to long term nursing care|1|||
160919645|NCT00818662|581099436|FG002|Overall Study|Admitted to long term nursing care|0|||
160919646|NCT00818662|581099437|FG003|Overall Study|Admitted to long term nursing care|0|||
160919647|NCT00662363|581099440|FG000|Overall Study|Withdrawal by Subject|6|||
160919648|NCT00662363|581099441|FG001|Overall Study|Withdrawal by Subject|5|||
160919649|NCT00662363|581099440|FG000|Overall Study|Adverse Event|0|||
160919650|NCT00662363|581099441|FG001|Overall Study|Adverse Event|3|||
160919651|NCT00662363|581099440|FG000|Overall Study|Discharged early from rehab|4|||
160919652|NCT00662363|581099441|FG001|Overall Study|Discharged early from rehab|1|||
160919653|NCT00662363|581099440|FG000|Overall Study|Protocol Violation|1|||
160919654|NCT00662363|581099441|FG001|Overall Study|Protocol Violation|1|||
160919655|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Adverse Event|82|||
160919656|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Death|6|||
160919657|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
160919658|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
160919659|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
160919660|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
160919661|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
160919662|NCT00195676|581099442|FG000|Period O - Open-label Treatment|Other reasons|68|||
160919663|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
160919664|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
160919665|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
160919666|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
160919667|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
160919668|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
160919669|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
160919670|NCT00195676|581099442|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
160919671|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
160919672|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
160919673|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
160919674|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
160919675|NCT00195676|581099442|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
161259755|NCT00904748|582330225|FG002|Overall Study|Adverse Event|0|||
161259756|NCT00904748|582330226|FG003|Overall Study|Adverse Event|0|||
161259757|NCT00904748|582330227|FG004|Overall Study|Adverse Event|1|||
160919676|NCT01905657|581099443|FG000|Overall Study|Adverse Event|23|||
160919677|NCT01905657|581099444|FG001|Overall Study|Adverse Event|17|||
160919678|NCT01905657|581099445|FG002|Overall Study|Adverse Event|18|||
160919679|NCT01905657|581099443|FG000|Overall Study|Clinical Progression|103|||
160919680|NCT01905657|581099444|FG001|Overall Study|Clinical Progression|78|||
161259758|NCT00904748|582330228|FG005|Overall Study|Adverse Event|0|||
161259759|NCT01682148|582330229|FG000|Overall Study|Withdrawal by Subject|2|||
161340710|NCT01288430|582635524|FG008|Part 2|Adverse Event|1|||
161259760|NCT01682148|582330230|FG001|Overall Study|Withdrawal by Subject|0|||
161259761|NCT01682148|582330229|FG000|Overall Study|Lost to Follow-up|1|||
160919681|NCT01905657|581099445|FG002|Overall Study|Clinical Progression|59|||
160919682|NCT01905657|581099443|FG000|Overall Study|Death|40|||
160919683|NCT01905657|581099444|FG001|Overall Study|Death|43|||
160919684|NCT01905657|581099445|FG002|Overall Study|Death|47|||
160919685|NCT01905657|581099443|FG000|Overall Study|Excluded Medication|13|||
160919686|NCT01905657|581099444|FG001|Overall Study|Excluded Medication|16|||
160919687|NCT01905657|581099445|FG002|Overall Study|Excluded Medication|9|||
160919688|NCT01905657|581099443|FG000|Overall Study|Lost to Follow-up|1|||
160919689|NCT01905657|581099444|FG001|Overall Study|Lost to Follow-up|2|||
160919690|NCT01905657|581099445|FG002|Overall Study|Lost to Follow-up|1|||
160919691|NCT01905657|581099443|FG000|Overall Study|Physician Decision|5|||
160919692|NCT01905657|581099444|FG001|Overall Study|Physician Decision|8|||
160919693|NCT01905657|581099445|FG002|Overall Study|Physician Decision|12|||
160919694|NCT01905657|581099443|FG000|Overall Study|Protocol Violation|2|||
160919695|NCT01905657|581099444|FG001|Overall Study|Protocol Violation|1|||
160919696|NCT01905657|581099445|FG002|Overall Study|Protocol Violation|1|||
160919697|NCT01905657|581099443|FG000|Overall Study|Screen Failure|0|||
160919698|NCT01905657|581099444|FG001|Overall Study|Screen Failure|1|||
160919699|NCT01905657|581099445|FG002|Overall Study|Screen Failure|0|||
160919700|NCT01905657|581099443|FG000|Overall Study|Withdrawal by Subject|15|||
160919701|NCT01905657|581099444|FG001|Overall Study|Withdrawal by Subject|21|||
160919702|NCT01905657|581099445|FG002|Overall Study|Withdrawal by Subject|53|||
160919703|NCT01905657|581099443|FG000|Overall Study|Sponsor Decision|1|||
160919704|NCT01905657|581099444|FG001|Overall Study|Sponsor Decision|0|||
160919705|NCT01905657|581099445|FG002|Overall Study|Sponsor Decision|0|||
160919706|NCT01189812|581099446|FG000|Overall Study|Withdrawal by Subject|2|||
160919707|NCT01189812|581099447|FG001|Overall Study|Withdrawal by Subject|3|||
160919708|NCT01189812|581099446|FG000|Overall Study|Adverse Event|1|||
160919709|NCT01189812|581099447|FG001|Overall Study|Adverse Event|0|||
160919710|NCT01189812|581099446|FG000|Overall Study|Out of Window|4|||
160919711|NCT01189812|581099447|FG001|Overall Study|Out of Window|3|||
160919712|NCT01189812|581099446|FG000|Overall Study|Moved out of State|1|||
160919713|NCT01189812|581099447|FG001|Overall Study|Moved out of State|2|||
160919714|NCT03761147|581099449|FG000|Overall Study|Withdrawal by Subject|6|||
160919715|NCT03761147|581099450|FG001|Overall Study|Withdrawal by Subject|1|||
160919716|NCT03761147|581099449|FG000|Overall Study|Adverse Event|1|||
160919717|NCT03761147|581099450|FG001|Overall Study|Adverse Event|3|||
160919718|NCT02744391|581099451|FG000|Overall Study|Lost to Follow-up|9|||
160919719|NCT02744391|581099451|FG000|Overall Study|Physician Decision|2|||
160919720|NCT02744391|581099451|FG000|Overall Study|Withdrawal by Subject|3|||
160919721|NCT05119569|581099452|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
160919722|NCT05119569|581099453|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
160919723|NCT05119569|581099454|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
160919724|NCT05119569|581099455|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
160919725|NCT05119569|581099452|FG000|Double Blind Treatment Phase|Adverse Event|6|||
160919726|NCT05119569|581099453|FG001|Double Blind Treatment Phase|Adverse Event|0|||
160919727|NCT05119569|581099454|FG002|Double Blind Treatment Phase|Adverse Event|0|||
160919728|NCT05119569|581099455|FG003|Double Blind Treatment Phase|Adverse Event|0|||
160919729|NCT05119569|581099452|FG000|Open Label Extension Phase|Ongoing in the study|0|||
160919730|NCT05119569|581099453|FG001|Open Label Extension Phase|Ongoing in the study|0|||
160919731|NCT05119569|581099454|FG002|Open Label Extension Phase|Ongoing in the study|65|||
160919732|NCT05119569|581099455|FG003|Open Label Extension Phase|Ongoing in the study|34|||
160919733|NCT02623439|581099456|FG000|Overall Study|Withdrawal by Subject|1|||
160919734|NCT02623439|581099456|FG000|Overall Study|Screen Failure|1|||
160919735|NCT02200445|581099460|FG000|Overall Study|Lack of Efficacy|1|||
160919736|NCT02200445|581099461|FG001|Overall Study|Lack of Efficacy|2|||
160919737|NCT02200445|581099462|FG002|Overall Study|Lack of Efficacy|2|||
160919738|NCT02200445|581099460|FG000|Overall Study|Adverse Event|0|||
160919739|NCT02200445|581099461|FG001|Overall Study|Adverse Event|2|||
160997258|NCT02987543|581374889|FG001|Overall Study|Death|54|||
160997259|NCT02987543|581374890|FG002|Overall Study|Death|67|||
161259762|NCT01682148|582330230|FG001|Overall Study|Lost to Follow-up|2|||
161259763|NCT01682148|582330229|FG000|Overall Study|Protocol Violation|1|||
161259764|NCT01682148|582330230|FG001|Overall Study|Protocol Violation|1|||
160919740|NCT02200445|581099462|FG002|Overall Study|Adverse Event|0|||
160919741|NCT03700671|581099463|FG000|Overall Study|Lack of Efficacy|1|||
160919742|NCT03700671|581099464|FG001|Overall Study|Lack of Efficacy|2|||
160919743|NCT03851302|581099471|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
160919744|NCT03851302|581099472|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
160919745|NCT03851302|581099473|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
160919746|NCT03851302|581099474|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
160919747|NCT03851302|581099475|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
160919748|NCT03851302|581099476|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
160919749|NCT03851302|581099471|FG000|Screening (1 Day)|Screened out|0|||
160997260|NCT02987543|581374891|FG003|Overall Study|Death|28|||
161259765|NCT01202877|582330231|FG000|Overall Study|Disease Progression|0|||
160919750|NCT03851302|581099472|FG001|Screening (1 Day)|Screened out|0|||
160919751|NCT03851302|581099473|FG002|Screening (1 Day)|Screened out|1|||
160919752|NCT03851302|581099474|FG003|Screening (1 Day)|Screened out|1|||
160919753|NCT03851302|581099475|FG004|Screening (1 Day)|Screened out|0|||
160919754|NCT03851302|581099476|FG005|Screening (1 Day)|Screened out|0|||
160919755|NCT03851302|581099471|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
160919756|NCT03851302|581099472|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919757|NCT03851302|581099473|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919758|NCT03851302|581099474|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919759|NCT03851302|581099475|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919760|NCT03851302|581099476|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
160919761|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
160919762|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
160919763|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
160919764|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
160919765|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
160919766|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
160919767|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
160919768|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
160919769|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
160919770|NCT04434092|581099477|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
160919771|NCT04434092|581099478|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
160919772|NCT04434092|581099479|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
160919773|NCT04434092|581099477|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
160919774|NCT04434092|581099478|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
160919775|NCT04434092|581099479|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
160919776|NCT04434092|581099477|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
160919777|NCT04434092|581099478|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
160919778|NCT04434092|581099479|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
160919779|NCT04434092|581099477|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
160919780|NCT04434092|581099478|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
160919781|NCT04434092|581099479|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
160919782|NCT03220217|581101306|FG000|Overall Study|Withdrawal by Subject|0|||
160919783|NCT03220217|581101307|FG001|Overall Study|Withdrawal by Subject|1|||
160919784|NCT03220217|581101308|FG002|Overall Study|Withdrawal by Subject|0|||
160919785|NCT03220217|581101306|FG000|Overall Study|Subject Missed Procedure|0|||
160919786|NCT03220217|581101307|FG001|Overall Study|Subject Missed Procedure|0|||
160919787|NCT03220217|581101308|FG002|Overall Study|Subject Missed Procedure|1|||
160919788|NCT00312494|581101309|FG000|Overall Study|Randomized; not treated with study drug|9|||
160919789|NCT00312494|581101310|FG001|Overall Study|Randomized; not treated with study drug|10|||
160919790|NCT00312494|581101311|FG002|Overall Study|Randomized; not treated with study drug|5|||
160919791|NCT00312494|581101309|FG000|Overall Study|Adverse Event|33|||
160919792|NCT00312494|581101310|FG001|Overall Study|Adverse Event|15|||
160919793|NCT00312494|581101311|FG002|Overall Study|Adverse Event|11|||
160919794|NCT00312494|581101309|FG000|Overall Study|Lack of Efficacy|4|||
160919795|NCT00312494|581101310|FG001|Overall Study|Lack of Efficacy|6|||
160919796|NCT00312494|581101311|FG002|Overall Study|Lack of Efficacy|8|||
160919797|NCT00312494|581101309|FG000|Overall Study|Laboratory abnormality|1|||
160919798|NCT00312494|581101310|FG001|Overall Study|Laboratory abnormality|0|||
160919799|NCT00312494|581101311|FG002|Overall Study|Laboratory abnormality|0|||
160919800|NCT00312494|581101309|FG000|Overall Study|Lost to Follow-up|8|||
160919801|NCT00312494|581101310|FG001|Overall Study|Lost to Follow-up|8|||
160919802|NCT00312494|581101311|FG002|Overall Study|Lost to Follow-up|8|||
160919803|NCT00312494|581101309|FG000|Overall Study|Withdrawal by Subject|6|||
160919804|NCT00312494|581101310|FG001|Overall Study|Withdrawal by Subject|9|||
160919805|NCT00312494|581101311|FG002|Overall Study|Withdrawal by Subject|10|||
160919806|NCT00312494|581101309|FG000|Overall Study|Other|10|||
160919807|NCT00312494|581101310|FG001|Overall Study|Other|10|||
160919808|NCT00312494|581101311|FG002|Overall Study|Other|1|||
160919809|NCT00501293|581101312|FG000|Optimization Period|Enrolled in error|1|||
160919810|NCT00501293|581101313|FG001|Optimization Period|Enrolled in error|0|||
160919811|NCT00501293|581101312|FG000|Maintenance Period|Withdrawal by Subject|14|||
160997261|NCT02987543|581374888|FG000|Overall Study|Lost to Follow-up|3|||
161259766|NCT01202877|582330232|FG001|Overall Study|Disease Progression|1|||
160997262|NCT02987543|581374889|FG001|Overall Study|Lost to Follow-up|0|||
161259767|NCT01202877|582330233|FG002|Overall Study|Disease Progression|2|||
161259768|NCT01202877|582330231|FG000|Overall Study|Adverse Event|0|||
161259769|NCT01202877|582330232|FG001|Overall Study|Adverse Event|0|||
161259770|NCT01202877|582330233|FG002|Overall Study|Adverse Event|2|||
160997263|NCT02987543|581374890|FG002|Overall Study|Lost to Follow-up|1|||
161259771|NCT01202877|582330231|FG000|Overall Study|Withdrawal by Subject|0|||
161259772|NCT01202877|582330232|FG001|Overall Study|Withdrawal by Subject|0|||
160919812|NCT00501293|581101313|FG001|Maintenance Period|Withdrawal by Subject|13|||
160919813|NCT00501293|581101312|FG000|Maintenance Period|Lost to Follow-up|12|||
160919814|NCT00501293|581101313|FG001|Maintenance Period|Lost to Follow-up|7|||
160919815|NCT00501293|581101312|FG000|Maintenance Period|Adverse Event|6|||
160919816|NCT00501293|581101313|FG001|Maintenance Period|Adverse Event|6|||
160919817|NCT00501293|581101312|FG000|Maintenance Period|Protocol Violation|2|||
160919818|NCT00501293|581101313|FG001|Maintenance Period|Protocol Violation|1|||
160919819|NCT00501293|581101312|FG000|Maintenance Period|Lack of Efficacy|4|||
160919820|NCT00501293|581101313|FG001|Maintenance Period|Lack of Efficacy|1|||
160919821|NCT00501293|581101312|FG000|Maintenance Period|Noncompliant with study medication|5|||
160919822|NCT00501293|581101313|FG001|Maintenance Period|Noncompliant with study medication|0|||
160919823|NCT00501293|581101312|FG000|Maintenance Period|Went into rehabilitation|1|||
160919824|NCT00501293|581101313|FG001|Maintenance Period|Went into rehabilitation|0|||
160919825|NCT00501293|581101312|FG000|Maintenance Period|Would not wear patch|1|||
160919826|NCT00501293|581101313|FG001|Maintenance Period|Would not wear patch|0|||
160919827|NCT00501293|581101312|FG000|Maintenance Period|Application site reaction|1|||
160919828|NCT00501293|581101313|FG001|Maintenance Period|Application site reaction|0|||
160919829|NCT02865187|581101321|FG000|Overall Study|Lost to Follow-up|12|||
160919830|NCT02865187|581101322|FG001|Overall Study|Lost to Follow-up|7|||
160919831|NCT02865187|581101321|FG000|Overall Study|Adverse Event|1|||
160919832|NCT02865187|581101322|FG001|Overall Study|Adverse Event|0|||
160919833|NCT04267133|581101323|FG000|Overall Study|Withdrawal by Subject|1|||
160919834|NCT04267133|581101323|FG000|Overall Study|Adverse Event|4|||
160919835|NCT02968563|581101324|FG000|Overall Study|Adverse Event|0|||
160919836|NCT02968563|581101325|FG001|Overall Study|Adverse Event|6|||
160919837|NCT02968563|581101324|FG000|Overall Study|Death|1|||
160919838|NCT02968563|581101325|FG001|Overall Study|Death|1|||
160919839|NCT02968563|581101324|FG000|Overall Study|Lost to Follow-up|0|||
160919840|NCT02968563|581101325|FG001|Overall Study|Lost to Follow-up|1|||
160919841|NCT00674661|581101326|FG000|Overall Study|Other|5|||
160919842|NCT00674661|581101327|FG001|Overall Study|Other|7|||
160919843|NCT00674661|581101326|FG000|Overall Study|Lost to Follow-up|6|||
160919844|NCT00674661|581101327|FG001|Overall Study|Lost to Follow-up|3|||
160919845|NCT00674661|581101326|FG000|Overall Study|Withdrawal by Subject|0|||
160919846|NCT00674661|581101327|FG001|Overall Study|Withdrawal by Subject|5|||
160919847|NCT03566823|581101333|FG000|Overall Study|Lack of Efficacy|0|||
160919848|NCT03566823|581101334|FG001|Overall Study|Lack of Efficacy|1|||
160919849|NCT03566823|581101335|FG002|Overall Study|Lack of Efficacy|0|||
160919850|NCT03566823|581101333|FG000|Overall Study|Withdrawal by Subject|1|||
160919851|NCT03566823|581101334|FG001|Overall Study|Withdrawal by Subject|2|||
160919852|NCT03566823|581101335|FG002|Overall Study|Withdrawal by Subject|0|||
160919853|NCT03566823|581101333|FG000|Overall Study|Adverse Event|1|||
160919854|NCT03566823|581101334|FG001|Overall Study|Adverse Event|0|||
160919855|NCT03566823|581101335|FG002|Overall Study|Adverse Event|2|||
160919856|NCT01909479|581101336|FG000|From Baseline to Week 26|Adverse Event|3|||
160919857|NCT01909479|581101337|FG001|From Baseline to Week 26|Adverse Event|2|||
160919858|NCT01909479|581101336|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
160919859|NCT01909479|581101337|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
160919860|NCT01909479|581101336|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
160919861|NCT01909479|581101337|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
160919862|NCT01909479|581101336|FG000|26 - 52 Weeks|Adverse Event|0|||
160919863|NCT01909479|581101337|FG001|26 - 52 Weeks|Adverse Event|1|||
160919864|NCT01909479|581101336|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
160997264|NCT02987543|581374891|FG003|Overall Study|Lost to Follow-up|0|||
160997265|NCT02987543|581374888|FG000|Overall Study|Screen failure|0|||
160997266|NCT02987543|581374889|FG001|Overall Study|Screen failure|0|||
160997267|NCT02987543|581374890|FG002|Overall Study|Screen failure|0|||
160997268|NCT02987543|581374891|FG003|Overall Study|Screen failure|1|||
160997269|NCT02987543|581374888|FG000|Overall Study|Withdrawal by Subject|21|||
160997270|NCT02987543|581374889|FG001|Overall Study|Withdrawal by Subject|7|||
160997271|NCT02987543|581374890|FG002|Overall Study|Withdrawal by Subject|7|||
160997272|NCT02987543|581374891|FG003|Overall Study|Withdrawal by Subject|6|||
160997273|NCT02987543|581374888|FG000|Overall Study|Study terminated by sponsor|1|||
161143262|NCT00923091|581907580|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
161143263|NCT00923091|581907581|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
160919865|NCT01909479|581101337|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
160919866|NCT01909479|581101336|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
160997274|NCT02987543|581374889|FG001|Overall Study|Study terminated by sponsor|0|||
160997275|NCT02987543|581374890|FG002|Overall Study|Study terminated by sponsor|0|||
161143264|NCT00923091|581907582|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
160919867|NCT01909479|581101337|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
160919868|NCT01909479|581101336|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
160919869|NCT01909479|581101337|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
160997276|NCT02987543|581374891|FG003|Overall Study|Study terminated by sponsor|0|||
160997277|NCT02987543|581374888|FG000|Overall Study|Investigator decision|0|||
160919870|NCT01909479|581101336|FG000|52 Weeks to End of Study|Adverse Event|2|||
160919871|NCT01909479|581101337|FG001|52 Weeks to End of Study|Adverse Event|1|||
160919872|NCT01909479|581101336|FG000|52 Weeks to End of Study|Death|0|||
160919873|NCT01909479|581101337|FG001|52 Weeks to End of Study|Death|1|||
160919874|NCT01909479|581101336|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
160919875|NCT01909479|581101337|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
160919876|NCT01909479|581101336|FG000|52 Weeks to End of Study|Protocol Violation|1|||
160919877|NCT01909479|581101337|FG001|52 Weeks to End of Study|Protocol Violation|0|||
160919878|NCT01909479|581101336|FG000|52 Weeks to End of Study|Progressive disease|1|||
160919879|NCT01909479|581101337|FG001|52 Weeks to End of Study|Progressive disease|1|||
160919880|NCT01909479|581101336|FG000|52 Weeks to End of Study|Personal reasons|2|||
160919881|NCT01909479|581101337|FG001|52 Weeks to End of Study|Personal reasons|1|||
160919882|NCT01909479|581101336|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
160919883|NCT01909479|581101337|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
160919884|NCT01909479|581101336|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
160919885|NCT01909479|581101337|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
160919886|NCT01909479|581101336|FG000|52 Weeks to End of Study|Lack of contact|1|||
160919887|NCT01909479|581101337|FG001|52 Weeks to End of Study|Lack of contact|0|||
160919888|NCT01909479|581101336|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
160919889|NCT01909479|581101337|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
160919890|NCT01909479|581101336|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
160919891|NCT01909479|581101337|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
160919892|NCT03557151|581101339|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
160919893|NCT03557151|581101340|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
160919894|NCT03557151|581101339|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
160919895|NCT03557151|581101340|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
160919896|NCT03557151|581101339|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
160919897|NCT03557151|581101340|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
160919898|NCT02810392|581101341|FG000|Overall Study|Subject too ill to continue|1|||
160919899|NCT02810392|581101342|FG001|Overall Study|Subject too ill to continue|0|||
160919900|NCT02810392|581101341|FG000|Overall Study|COVID 19 research restrictions|0|||
160919901|NCT02810392|581101342|FG001|Overall Study|COVID 19 research restrictions|1|||
160919902|NCT06079320|581101345|FG000|Follow up Phase|Lost to Follow-up|1|||
160919903|NCT06079320|581101346|FG001|Follow up Phase|Lost to Follow-up|0|||
160919904|NCT01405742|581101347|FG000|Overall Study|Lost to Follow-up|1|||
160919905|NCT01405742|581101348|FG001|Overall Study|Lost to Follow-up|0|||
160919906|NCT04900220|581101349|FG000|Overall Study|Lost to Follow-up|1|||
160919907|NCT04900220|581101350|FG001|Overall Study|Lost to Follow-up|1|||
160919908|NCT02196558|581101351|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
160919909|NCT02196558|581101352|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
160919910|NCT02196558|581101353|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
160919911|NCT02196558|581101351|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
160919912|NCT02196558|581101352|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
160919913|NCT02196558|581101353|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
160919914|NCT02196558|581101351|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
160919915|NCT02196558|581101352|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
160919916|NCT02196558|581101353|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
160919917|NCT02196558|581101351|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
160919918|NCT02196558|581101352|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
160919919|NCT02196558|581101353|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
160919920|NCT02196558|581101351|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
160919921|NCT02196558|581101352|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
160919922|NCT02196558|581101353|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
160919923|NCT03428360|581101355|FG000|Overall Study|Informed consent withdrawn|5|||
160919924|NCT03428360|581101355|FG000|Overall Study|Withdrawal by Subject|4|||
160919925|NCT03428360|581101355|FG000|Overall Study|Lost to Follow-up|5|||
160919926|NCT03428360|581101355|FG000|Overall Study|Physician Decision|2|||
160919927|NCT03428360|581101355|FG000|Overall Study|Informed consent withdrawn|5|||
160919928|NCT03428360|581101355|FG000|Overall Study|Study terminated by sponsor|10|||
160919929|NCT03428360|581101355|FG000|Overall Study|Non-compliant with study|1|||
160919930|NCT03428360|581101355|FG000|Overall Study|Non-compliant with study drug|3|||
160919931|NCT03428360|581101355|FG000|Overall Study|Death|3|||
160919932|NCT03428360|581101355|FG000|Overall Study|Adverse Event|1|||
160919933|NCT03428360|581101355|FG000|Overall Study|Not on antiepileptic drug|1|||
160919934|NCT02107482|581101359|FG000|Overall Study|inconveinence|2|||
160919935|NCT02107482|581101359|FG000|Overall Study|Lost to Follow-up|1|||
160919936|NCT02107482|581101359|FG000|Overall Study|Lack of Efficacy|1|||
160919937|NCT00576927|581101362|FG000|Clinical Assessment|Lack of Efficacy|24|||
160919938|NCT00576927|581101362|FG000|Clinical Assessment|Death|1|||
160919939|NCT00576927|581101362|FG000|Clinical Assessment|Withdrawal by Subject|10|||
160919940|NCT00576927|581101362|FG000|Clinical Assessment|Physician Decision|1|||
160919941|NCT00576927|581101362|FG000|Baseline|Physician Decision|9|||
160919942|NCT00576927|581101362|FG000|Baseline|Medication Change by PCP of subject|1|||
160919943|NCT00576927|581101362|FG000|Baseline|Withdrawal by Subject|3|||
160919944|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
160919945|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
160919946|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
160919947|NCT00576927|581101362|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
160919948|NCT00576927|581101362|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
160919949|NCT03128892|581101363|FG000|Overall Study|Withdrawal by Subject|2|||
160919950|NCT03128892|581101363|FG000|Overall Study|Physician Decision|1|||
160919951|NCT01850524|581101365|FG000|Overall Study|Lost to Follow-up|5|||
160919952|NCT01850524|581101366|FG001|Overall Study|Lost to Follow-up|10|||
160919953|NCT01850524|581101365|FG000|Overall Study|Withdrawal by Subject|24|||
160919954|NCT01850524|581101366|FG001|Overall Study|Withdrawal by Subject|22|||
160919955|NCT01850524|581101365|FG000|Overall Study|Reason not Specified|142|||
160919956|NCT01850524|581101366|FG001|Overall Study|Reason not Specified|141|||
160919957|NCT00368355|581101367|FG000|Overall Study|Adverse Event|1|||
160919958|NCT00368355|581101368|FG001|Overall Study|Adverse Event|0|||
160919959|NCT00368355|581101367|FG000|Overall Study|Death|2|||
160919960|NCT00368355|581101368|FG001|Overall Study|Death|4|||
160919961|NCT00368355|581101367|FG000|Overall Study|Relapse|6|||
160919962|NCT00368355|581101368|FG001|Overall Study|Relapse|10|||
160919963|NCT00368355|581101367|FG000|Overall Study|Subsequent transplant|0|||
160919964|NCT00368355|581101368|FG001|Overall Study|Subsequent transplant|3|||
160919965|NCT00368355|581101367|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
160919966|NCT00368355|581101368|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
160919967|NCT03473808|581101378|FG000|Overall Study|Withdrawal by Subject|1|||
160919968|NCT02157298|581101381|FG000|Overall Study|Adverse Event|1|||
160919969|NCT02157298|581101382|FG001|Overall Study|Adverse Event|0|||
160919970|NCT02157298|581101381|FG000|Overall Study|Subject no longer meets study criteria|1|||
160919971|NCT02157298|581101382|FG001|Overall Study|Subject no longer meets study criteria|2|||
160919972|NCT02157298|581101381|FG000|Overall Study|Poor/Non-compliance|1|||
160919973|NCT02157298|581101382|FG001|Overall Study|Poor/Non-compliance|0|||
160919974|NCT02157298|581101381|FG000|Overall Study|Withdrawal by Subject|1|||
160919975|NCT02157298|581101382|FG001|Overall Study|Withdrawal by Subject|0|||
160919976|NCT04059094|581101383|FG000|Overall Study|Adverse Event|0|||
160919977|NCT04059094|581101384|FG001|Overall Study|Adverse Event|0|||
160919978|NCT04059094|581101385|FG002|Overall Study|Adverse Event|0|||
160919979|NCT04059094|581101386|FG003|Overall Study|Adverse Event|0|||
160919980|NCT04059094|581101387|FG004|Overall Study|Adverse Event|1|||
160919981|NCT04059094|581101383|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919982|NCT04059094|581101384|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
160919983|NCT04059094|581101385|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919984|NCT04059094|581101386|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919985|NCT04059094|581101387|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
160919986|NCT01085591|581101388|FG000|Overall Study|Adverse Event|0|||
160919987|NCT01085591|581101389|FG001|Overall Study|Adverse Event|1|||
160919988|NCT01085591|581101390|FG002|Overall Study|Adverse Event|3|||
160919989|NCT01085591|581101388|FG000|Overall Study|Physician Decision|1|||
160919990|NCT01085591|581101389|FG001|Overall Study|Physician Decision|0|||
160919991|NCT01085591|581101390|FG002|Overall Study|Physician Decision|1|||
160919992|NCT01085591|581101388|FG000|Overall Study|Withdrawal by Subject|0|||
160919993|NCT01085591|581101389|FG001|Overall Study|Withdrawal by Subject|2|||
160919994|NCT01085591|581101390|FG002|Overall Study|Withdrawal by Subject|1|||
160919995|NCT01085591|581101388|FG000|Overall Study|Lost to Follow-up|0|||
160919996|NCT01085591|581101389|FG001|Overall Study|Lost to Follow-up|1|||
160919997|NCT01085591|581101390|FG002|Overall Study|Lost to Follow-up|1|||
160919998|NCT01085591|581101388|FG000|Overall Study|Protocol Violation|1|||
160919999|NCT01085591|581101389|FG001|Overall Study|Protocol Violation|1|||
160997278|NCT02987543|581374889|FG001|Overall Study|Investigator decision|1|||
160997279|NCT02987543|581374890|FG002|Overall Study|Investigator decision|0|||
160920000|NCT01085591|581101390|FG002|Overall Study|Protocol Violation|1|||
160920001|NCT01085591|581101388|FG000|Overall Study|Other|0|||
160920002|NCT01085591|581101389|FG001|Overall Study|Other|1|||
160920003|NCT01085591|581101390|FG002|Overall Study|Other|0|||
160920004|NCT01085591|581101388|FG000|Overall Study|Not Properly Consented|1|||
160997280|NCT02987543|581374891|FG003|Overall Study|Investigator decision|0|||
161143265|NCT00923091|581907583|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
161259773|NCT01202877|582330233|FG002|Overall Study|Withdrawal by Subject|1|||
160920005|NCT01085591|581101389|FG001|Overall Study|Not Properly Consented|0|||
160920006|NCT01085591|581101390|FG002|Overall Study|Not Properly Consented|0|||
160920007|NCT03715764|581101395|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
160920008|NCT03715764|581101396|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
160920009|NCT03715764|581101395|FG000|3 Month Follow-up|Lost to Follow-up|2|||
160920010|NCT03715764|581101396|FG001|3 Month Follow-up|Lost to Follow-up|2|||
160920011|NCT03715764|581101395|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
160997281|NCT02987543|581374888|FG000|Overall Study|Disease progression|0|||
160920012|NCT03715764|581101396|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
160920013|NCT03715764|581101395|FG000|6 Month Follow-up|Lost to Follow-up|3|||
160920014|NCT03715764|581101396|FG001|6 Month Follow-up|Lost to Follow-up|0|||
160920015|NCT03715764|581101395|FG000|12 Month Follow-up|Lost to Follow-up|2|||
160920016|NCT03715764|581101396|FG001|12 Month Follow-up|Lost to Follow-up|3|||
160920017|NCT03715764|581101395|FG000|12 Month Follow-up|Pregnancy|0|||
160920018|NCT03715764|581101396|FG001|12 Month Follow-up|Pregnancy|1|||
160920019|NCT03715764|581101395|FG000|12 Month Follow-up|Surgery|2|||
160920020|NCT03715764|581101396|FG001|12 Month Follow-up|Surgery|0|||
160920021|NCT03715764|581101395|FG000|12 Month Follow-up|Wrong address|1|||
160920022|NCT03715764|581101396|FG001|12 Month Follow-up|Wrong address|0|||
160920023|NCT03715764|581101395|FG000|12 Month Follow-up|No symptoms|1|||
160920024|NCT03715764|581101396|FG001|12 Month Follow-up|No symptoms|0|||
161259774|NCT01202877|582330231|FG000|Overall Study|Death|0|||
161259775|NCT01202877|582330232|FG001|Overall Study|Death|0|||
160920025|NCT03715764|581101395|FG000|12 Month Follow-up|Changed primary care centre|0|||
160920026|NCT03715764|581101396|FG001|12 Month Follow-up|Changed primary care centre|1|||
160920027|NCT01013701|581101397|FG000|Overall Study|study prematurely terminated|7|||
160920028|NCT00556712|581101401|FG000|Overall Study|Adverse Event|7|||
160920029|NCT00556712|581101402|FG001|Overall Study|Adverse Event|19|||
160920030|NCT00556712|581101401|FG000|Overall Study|Death|5|||
160920031|NCT00556712|581101402|FG001|Overall Study|Death|10|||
160920032|NCT00556712|581101401|FG000|Overall Study|Progressive Disease|383|||
160920033|NCT00556712|581101402|FG001|Overall Study|Progressive Disease|320|||
160920034|NCT00556712|581101401|FG000|Overall Study|Protocol Violation|3|||
160920035|NCT00556712|581101402|FG001|Overall Study|Protocol Violation|2|||
160920036|NCT00556712|581101401|FG000|Overall Study|Refused Treatment|17|||
160920037|NCT00556712|581101402|FG001|Overall Study|Refused Treatment|16|||
160920038|NCT00556712|581101401|FG000|Overall Study|Failure to Return|2|||
160920039|NCT00556712|581101402|FG001|Overall Study|Failure to Return|3|||
160920040|NCT00556712|581101401|FG000|Overall Study|Other|2|||
160920041|NCT00556712|581101402|FG001|Overall Study|Other|2|||
160920042|NCT00556712|581101401|FG000|Overall Study|Ongoing at Data Cutoff|32|||
160920043|NCT00556712|581101402|FG001|Overall Study|Ongoing at Data Cutoff|66|||
160920044|NCT01059799|581101404|FG000|Overall Study|Adverse Event|2|||
160920045|NCT01059799|581101405|FG001|Overall Study|Adverse Event|3|||
160920046|NCT01059799|581101404|FG000|Overall Study|Lack of Efficacy|1|||
160920047|NCT01059799|581101405|FG001|Overall Study|Lack of Efficacy|0|||
160920048|NCT01059799|581101404|FG000|Overall Study|Protocol Violation|3|||
160920049|NCT01059799|581101405|FG001|Overall Study|Protocol Violation|2|||
160920050|NCT01059799|581101404|FG000|Overall Study|Withdrawal criteria|13|||
160920051|NCT01059799|581101405|FG001|Overall Study|Withdrawal criteria|2|||
160920052|NCT01059799|581101404|FG000|Overall Study|Other|12|||
160920053|NCT01059799|581101405|FG001|Overall Study|Other|3|||
160920054|NCT01361464|581101406|FG000|Overall Study|Death|1|||
160920055|NCT01361464|581101406|FG000|Overall Study|Withdrawal by Subject|2|||
160920056|NCT03021265|581101410|FG000|Overall Study|Adverse Event|29|||
160920057|NCT03021265|581101410|FG000|Overall Study|Lack of Efficacy|3|||
160920058|NCT03021265|581101410|FG000|Overall Study|Improved|17|||
160920059|NCT03021265|581101410|FG000|Overall Study|Lost to Follow-up|67|||
160920060|NCT03021265|581101410|FG000|Overall Study|No reason given|2|||
160920061|NCT03021265|581101410|FG000|Overall Study|No visit since the first visit|4|||
160920062|NCT01106898|581101411|FG000|Overall Study|Adverse Event|6|||
160920063|NCT01722071|581101412|FG000|Overall Study|Protocol Violation|1|||
160920064|NCT01722071|581101413|FG001|Overall Study|Protocol Violation|0|||
160920065|NCT01338493|581101414|FG000|Enrolled|Withdrawal by Subject|1|||
160920066|NCT01338493|581101414|FG000|Enrolled|Patient not implanted|4|||
160920067|NCT01338493|581101414|FG000|Discharge|Death|1|||
160920068|NCT01338493|581101414|FG000|Discharge|Missed visit|1|||
160920069|NCT01338493|581101414|FG000|6 Months Follow up|Lost to Follow-up|11|||
160920070|NCT01338493|581101414|FG000|6 Months Follow up|Missed visit|8|||
160920071|NCT01338493|581101414|FG000|12 Months Follow up|Lost to Follow-up|9|||
160920072|NCT01846611|581101415|FG000|Overall Study|Lost to Follow-up|4|||
161259776|NCT01202877|582330233|FG002|Overall Study|Death|1|||
161259777|NCT04403763|582330234|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
161259778|NCT04403763|582330235|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
161259779|NCT04403763|582330236|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
160920073|NCT01846611|581101416|FG001|Overall Study|Lost to Follow-up|6|||
160920074|NCT01846611|581101415|FG000|Overall Study|Withdrawal by Subject|15|||
160920075|NCT01846611|581101416|FG001|Overall Study|Withdrawal by Subject|19|||
160920076|NCT01846611|581101415|FG000|Overall Study|Other|19|||
160920077|NCT01846611|581101416|FG001|Overall Study|Other|18|||
160920078|NCT01614067|581101417|FG000|Overall Study|Pregnancy|1|||
160920079|NCT01614067|581101418|FG001|Overall Study|Pregnancy|0|||
160920080|NCT01614067|581101417|FG000|Overall Study|Physician Decision|6|||
160920081|NCT01614067|581101418|FG001|Overall Study|Physician Decision|5|||
160920082|NCT01614067|581101417|FG000|Overall Study|Withdrawal by Subject|0|||
160920083|NCT01614067|581101418|FG001|Overall Study|Withdrawal by Subject|1|||
160920084|NCT01614067|581101417|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
160920085|NCT01614067|581101418|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
160920086|NCT02289079|581101419|FG000|Overall Study|Physician Decision|2|||
160920087|NCT02289079|581101420|FG001|Overall Study|Physician Decision|0|||
160920088|NCT02289079|581101419|FG000|Overall Study|Lost to Follow-up|0|||
161259780|NCT04403763|582330237|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
160920089|NCT02289079|581101420|FG001|Overall Study|Lost to Follow-up|1|||
160920090|NCT02671422|581101421|FG000|Overall Study|Lost to Follow-up|1|||
160920091|NCT02671422|581101421|FG000|Overall Study|Adverse Event|68|||
160920092|NCT02671422|581101421|FG000|Overall Study|Lack of Efficacy|1|||
160920093|NCT02671422|581101421|FG000|Overall Study|Lost to Follow-up|4|||
160920094|NCT02671422|581101421|FG000|Overall Study|Withdrawal by Subject|7|||
160920095|NCT02671422|581101421|FG000|Overall Study|Progressive Disease|156|||
160920096|NCT02671422|581101421|FG000|Overall Study|Worsening of Disease|4|||
160920097|NCT02671422|581101421|FG000|Overall Study|Sponsor decision|5|||
160920098|NCT02671422|581101421|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
160920099|NCT02671422|581101421|FG000|Overall Study|Not treated with Vargatef®|3|||
160920100|NCT02671422|581101421|FG000|Overall Study|Other not defined above|3|||
160920101|NCT02111850|581101422|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920102|NCT02111850|581101423|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920103|NCT02111850|581101424|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920104|NCT02111850|581101425|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920105|NCT02111850|581101426|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
160920106|NCT02111850|581101427|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920107|NCT02111850|581101428|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920108|NCT02111850|581101429|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920109|NCT02111850|581101430|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920110|NCT02111850|581101431|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920111|NCT02111850|581101432|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
160920112|NCT03061331|581101433|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
160920113|NCT03061331|581101434|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
160920114|NCT02625259|581101435|FG000|First Intervention (Day 1)|Other|0|||
160920115|NCT02625259|581101436|FG001|First Intervention (Day 1)|Other|0|||
160920116|NCT02625259|581101437|FG002|First Intervention (Day 1)|Other|1|||
160920117|NCT02625259|581101438|FG003|First Intervention (Day 1)|Other|0|||
160920118|NCT02625259|581101439|FG004|First Intervention (Day 1)|Other|0|||
160920119|NCT02625259|581101435|FG000|First Intervention (Day 1)|Adverse Event|2|||
160920120|NCT02625259|581101436|FG001|First Intervention (Day 1)|Adverse Event|1|||
160920121|NCT02625259|581101437|FG002|First Intervention (Day 1)|Adverse Event|0|||
160920122|NCT02625259|581101438|FG003|First Intervention (Day 1)|Adverse Event|0|||
160920123|NCT02625259|581101439|FG004|First Intervention (Day 1)|Adverse Event|0|||
160920124|NCT02625259|581101435|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920125|NCT02625259|581101436|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920126|NCT02625259|581101437|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920127|NCT02625259|581101438|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
160920128|NCT02625259|581101439|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
160920129|NCT01980875|581101440|FG000|Overall Study|Withdrew Consent|1|||
160920130|NCT01980875|581101441|FG001|Overall Study|Withdrew Consent|1|||
160920131|NCT01980875|581101442|FG002|Overall Study|Withdrew Consent|1|||
160920132|NCT01980875|581101440|FG000|Overall Study|Study Terminated by Sponsor|7|||
160920133|NCT01980875|581101441|FG001|Overall Study|Study Terminated by Sponsor|24|||
160920134|NCT01980875|581101442|FG002|Overall Study|Study Terminated by Sponsor|22|||
160920135|NCT01980875|581101440|FG000|Overall Study|Lost to Follow-up|0|||
160920136|NCT01980875|581101441|FG001|Overall Study|Lost to Follow-up|0|||
161259781|NCT04403763|582330238|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
161259782|NCT04403763|582330239|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
161259783|NCT04403763|582330240|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
161259784|NCT04403763|582330234|FG000|Stage 1|Early termination due to PK tube failure|0|||
161259785|NCT04403763|582330235|FG001|Stage 1|Early termination due to PK tube failure|0|||
161259786|NCT04403763|582330236|FG002|Stage 1|Early termination due to PK tube failure|1|||
160920137|NCT01980875|581101442|FG002|Overall Study|Lost to Follow-up|1|||
160920138|NCT00513474|581101443|FG000|Overall Study|Death|6|||
160920139|NCT00513474|581101444|FG001|Overall Study|Death|9|||
161259787|NCT04403763|582330237|FG003|Stage 1|Early termination due to PK tube failure|0|||
161259788|NCT04403763|582330238|FG004|Stage 1|Early termination due to PK tube failure|0|||
161259789|NCT04403763|582330239|FG005|Stage 1|Early termination due to PK tube failure|0|||
161259790|NCT04403763|582330240|FG006|Stage 1|Early termination due to PK tube failure|0|||
161259791|NCT04403763|582330234|FG000|Stage 2A|Adverse Event|0|||
161259792|NCT04403763|582330235|FG001|Stage 2A|Adverse Event|0|||
161259793|NCT04403763|582330236|FG002|Stage 2A|Adverse Event|0|||
161259794|NCT04403763|582330237|FG003|Stage 2A|Adverse Event|0|||
161259795|NCT04403763|582330238|FG004|Stage 2A|Adverse Event|0|||
160920140|NCT00513474|581101443|FG000|Overall Study|Participant Withdrew Consent|1|||
160920141|NCT00513474|581101444|FG001|Overall Study|Participant Withdrew Consent|0|||
161259796|NCT04403763|582330239|FG005|Stage 2A|Adverse Event|0|||
161259797|NCT04403763|582330240|FG006|Stage 2A|Adverse Event|1|||
160920142|NCT04772755|581101445|FG000|Overall Study|Withdrawal by Subject|1|||
160920143|NCT04772755|581101446|FG001|Overall Study|Withdrawal by Subject|0|||
160920144|NCT04772755|581101445|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
160920145|NCT04772755|581101446|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
160920146|NCT04080297|581101448|FG000|Overall Study|Adverse Event|1|||
160920147|NCT04080297|581101449|FG001|Overall Study|Adverse Event|3|||
160920148|NCT04080297|581101448|FG000|Overall Study|concurrent illness|1|||
160920149|NCT04080297|581101449|FG001|Overall Study|concurrent illness|0|||
160920150|NCT04484142|581101455|FG000|Overall Study|Adverse Event|13|||
160920151|NCT04484142|581101455|FG000|Overall Study|Progressive Disease|87|||
160920152|NCT04484142|581101455|FG000|Overall Study|Clinical Progression|10|||
160920153|NCT04484142|581101455|FG000|Overall Study|Withdrawal by Subject|6|||
160920154|NCT04484142|581101455|FG000|Overall Study|Physician Decision|1|||
160920155|NCT05371509|581101456|FG000|Overall Study|Physician Decision|1|||
160920156|NCT05371509|581101457|FG001|Overall Study|Physician Decision|0|||
160920157|NCT02554812|581101458|FG000|Overall Study|Adverse Event|2|||
160920158|NCT02554812|581101459|FG001|Overall Study|Adverse Event|5|||
160920159|NCT02554812|581101460|FG002|Overall Study|Adverse Event|3|||
160920160|NCT02554812|581101461|FG003|Overall Study|Adverse Event|0|||
160920161|NCT02554812|581101462|FG004|Overall Study|Adverse Event|5|||
160920162|NCT02554812|581101463|FG005|Overall Study|Adverse Event|0|||
160920163|NCT02554812|581101464|FG006|Overall Study|Adverse Event|1|||
160920164|NCT02554812|581101465|FG007|Overall Study|Adverse Event|6|||
160920165|NCT02554812|581101466|FG008|Overall Study|Adverse Event|2|||
160920166|NCT02554812|581101467|FG009|Overall Study|Adverse Event|2|||
160920167|NCT02554812|581101468|FG010|Overall Study|Adverse Event|1|||
160920168|NCT02554812|581101469|FG011|Overall Study|Adverse Event|2|||
160920169|NCT02554812|581101470|FG012|Overall Study|Adverse Event|0|||
160920170|NCT02554812|581101471|FG013|Overall Study|Adverse Event|3|||
160920171|NCT02554812|581101472|FG014|Overall Study|Adverse Event|2|||
160920172|NCT02554812|581101473|FG015|Overall Study|Adverse Event|1|||
160920173|NCT02554812|581101474|FG016|Overall Study|Adverse Event|0|||
160920174|NCT02554812|581101475|FG017|Overall Study|Adverse Event|1|||
160920175|NCT02554812|581101476|FG018|Overall Study|Adverse Event|0|||
160920176|NCT02554812|581101477|FG019|Overall Study|Adverse Event|0|||
160920177|NCT02554812|581101478|FG020|Overall Study|Adverse Event|0|||
160920178|NCT02554812|581101479|FG021|Overall Study|Adverse Event|2|||
160920179|NCT02554812|581101480|FG022|Overall Study|Adverse Event|1|||
160920180|NCT02554812|581101481|FG023|Overall Study|Adverse Event|1|||
160920181|NCT02554812|581101482|FG024|Overall Study|Adverse Event|1|||
160920182|NCT02554812|581101483|FG025|Overall Study|Adverse Event|2|||
160920183|NCT02554812|581101484|FG026|Overall Study|Adverse Event|1|||
160920184|NCT02554812|581101458|FG000|Overall Study|Death|1|||
160920185|NCT02554812|581101459|FG001|Overall Study|Death|2|||
160920186|NCT02554812|581101460|FG002|Overall Study|Death|2|||
160920187|NCT02554812|581101461|FG003|Overall Study|Death|2|||
160920188|NCT02554812|581101462|FG004|Overall Study|Death|0|||
160920189|NCT02554812|581101463|FG005|Overall Study|Death|1|||
160920190|NCT02554812|581101464|FG006|Overall Study|Death|1|||
160920191|NCT02554812|581101465|FG007|Overall Study|Death|1|||
160920192|NCT02554812|581101466|FG008|Overall Study|Death|0|||
160920193|NCT02554812|581101467|FG009|Overall Study|Death|0|||
160920194|NCT02554812|581101468|FG010|Overall Study|Death|0|||
160920195|NCT02554812|581101469|FG011|Overall Study|Death|0|||
160920196|NCT02554812|581101470|FG012|Overall Study|Death|0|||
160920197|NCT02554812|581101471|FG013|Overall Study|Death|0|||
161259798|NCT00350402|582330241|FG000|Overall Study|Lost to Follow-up|1|||
161259799|NCT00350402|582330242|FG001|Overall Study|Lost to Follow-up|1|||
161259800|NCT01376310|582330243|FG000|Overall Study|Study closed/terminated|1|||
161259801|NCT01376310|582330244|FG001|Overall Study|Study closed/terminated|2|||
161259802|NCT01376310|582330243|FG000|Overall Study|Withdrawal by Subject|8|||
161259803|NCT01376310|582330244|FG001|Overall Study|Withdrawal by Subject|2|||
161259804|NCT01376310|582330243|FG000|Overall Study|Physician Decision|26|||
161259805|NCT01376310|582330244|FG001|Overall Study|Physician Decision|7|||
161259806|NCT01376310|582330243|FG000|Overall Study|Lost to Follow-up|1|||
161259807|NCT01376310|582330244|FG001|Overall Study|Lost to Follow-up|0|||
161259808|NCT00834899|582330247|FG000|Overall Study|Withdrawal by Subject|1|||
161340711|NCT01288430|582635525|FG009|Part 2|Adverse Event|0|||
160920198|NCT02554812|581101472|FG014|Overall Study|Death|1|||
160920199|NCT02554812|581101473|FG015|Overall Study|Death|1|||
160920200|NCT02554812|581101474|FG016|Overall Study|Death|1|||
160920201|NCT02554812|581101475|FG017|Overall Study|Death|0|||
160920202|NCT02554812|581101476|FG018|Overall Study|Death|1|||
160920203|NCT02554812|581101477|FG019|Overall Study|Death|2|||
160920204|NCT02554812|581101478|FG020|Overall Study|Death|0|||
160920205|NCT02554812|581101479|FG021|Overall Study|Death|1|||
160920206|NCT02554812|581101480|FG022|Overall Study|Death|1|||
160920207|NCT02554812|581101481|FG023|Overall Study|Death|0|||
160920208|NCT02554812|581101482|FG024|Overall Study|Death|0|||
160920209|NCT02554812|581101483|FG025|Overall Study|Death|0|||
160920210|NCT02554812|581101484|FG026|Overall Study|Death|0|||
160920211|NCT02554812|581101458|FG000|Overall Study|Lost to Follow-up|0|||
160920212|NCT02554812|581101459|FG001|Overall Study|Lost to Follow-up|1|||
160920213|NCT02554812|581101460|FG002|Overall Study|Lost to Follow-up|0|||
160920214|NCT02554812|581101461|FG003|Overall Study|Lost to Follow-up|0|||
160920215|NCT02554812|581101462|FG004|Overall Study|Lost to Follow-up|0|||
160920216|NCT02554812|581101463|FG005|Overall Study|Lost to Follow-up|0|||
160920217|NCT02554812|581101464|FG006|Overall Study|Lost to Follow-up|0|||
160920218|NCT02554812|581101465|FG007|Overall Study|Lost to Follow-up|0|||
160920219|NCT02554812|581101466|FG008|Overall Study|Lost to Follow-up|0|||
160920220|NCT02554812|581101467|FG009|Overall Study|Lost to Follow-up|0|||
160920221|NCT02554812|581101468|FG010|Overall Study|Lost to Follow-up|0|||
160920222|NCT02554812|581101469|FG011|Overall Study|Lost to Follow-up|0|||
160920223|NCT02554812|581101470|FG012|Overall Study|Lost to Follow-up|0|||
160920224|NCT02554812|581101471|FG013|Overall Study|Lost to Follow-up|0|||
160920225|NCT02554812|581101472|FG014|Overall Study|Lost to Follow-up|0|||
160920226|NCT02554812|581101473|FG015|Overall Study|Lost to Follow-up|0|||
160920227|NCT02554812|581101474|FG016|Overall Study|Lost to Follow-up|0|||
160920228|NCT02554812|581101475|FG017|Overall Study|Lost to Follow-up|0|||
160920229|NCT02554812|581101476|FG018|Overall Study|Lost to Follow-up|0|||
160920230|NCT02554812|581101477|FG019|Overall Study|Lost to Follow-up|0|||
160920231|NCT02554812|581101478|FG020|Overall Study|Lost to Follow-up|0|||
160920232|NCT02554812|581101479|FG021|Overall Study|Lost to Follow-up|0|||
160920233|NCT02554812|581101480|FG022|Overall Study|Lost to Follow-up|0|||
160920234|NCT02554812|581101481|FG023|Overall Study|Lost to Follow-up|0|||
160920235|NCT02554812|581101482|FG024|Overall Study|Lost to Follow-up|0|||
160920236|NCT02554812|581101483|FG025|Overall Study|Lost to Follow-up|0|||
160920237|NCT02554812|581101484|FG026|Overall Study|Lost to Follow-up|0|||
160920238|NCT02554812|581101458|FG000|Overall Study|Global deterioration of health status|4|||
160920239|NCT02554812|581101459|FG001|Overall Study|Global deterioration of health status|3|||
160920240|NCT02554812|581101460|FG002|Overall Study|Global deterioration of health status|3|||
160920241|NCT02554812|581101461|FG003|Overall Study|Global deterioration of health status|2|||
160920242|NCT02554812|581101462|FG004|Overall Study|Global deterioration of health status|5|||
161259809|NCT00834899|582330248|FG001|Overall Study|Withdrawal by Subject|1|||
161259810|NCT01534637|582330249|FG000|Overall Study|Physician Decision|3|||
161259811|NCT01534637|582330249|FG000|Overall Study|Lack of Efficacy|3|||
161259812|NCT01534637|582330249|FG000|Overall Study|Withdrawal by Subject|1|||
161259813|NCT01534637|582330249|FG000|Overall Study|Adverse Event|1|||
161259814|NCT01534637|582330249|FG000|Overall Study|Liver Mets before treatment|1|||
160920243|NCT02554812|581101463|FG005|Overall Study|Global deterioration of health status|0|||
160920244|NCT02554812|581101464|FG006|Overall Study|Global deterioration of health status|2|||
160920245|NCT02554812|581101465|FG007|Overall Study|Global deterioration of health status|1|||
160920246|NCT02554812|581101466|FG008|Overall Study|Global deterioration of health status|1|||
160920247|NCT02554812|581101467|FG009|Overall Study|Global deterioration of health status|1|||
160920248|NCT02554812|581101468|FG010|Overall Study|Global deterioration of health status|2|||
160920249|NCT02554812|581101469|FG011|Overall Study|Global deterioration of health status|1|||
160920250|NCT02554812|581101470|FG012|Overall Study|Global deterioration of health status|0|||
160920251|NCT02554812|581101471|FG013|Overall Study|Global deterioration of health status|0|||
160920252|NCT02554812|581101472|FG014|Overall Study|Global deterioration of health status|0|||
160920253|NCT02554812|581101473|FG015|Overall Study|Global deterioration of health status|1|||
160920254|NCT02554812|581101474|FG016|Overall Study|Global deterioration of health status|0|||
160920255|NCT02554812|581101475|FG017|Overall Study|Global deterioration of health status|0|||
160920256|NCT02554812|581101476|FG018|Overall Study|Global deterioration of health status|0|||
160920257|NCT02554812|581101477|FG019|Overall Study|Global deterioration of health status|0|||
160920258|NCT02554812|581101478|FG020|Overall Study|Global deterioration of health status|0|||
160920259|NCT02554812|581101479|FG021|Overall Study|Global deterioration of health status|0|||
160920260|NCT02554812|581101480|FG022|Overall Study|Global deterioration of health status|0|||
160920261|NCT02554812|581101481|FG023|Overall Study|Global deterioration of health status|0|||
160920262|NCT02554812|581101482|FG024|Overall Study|Global deterioration of health status|0|||
160920263|NCT02554812|581101483|FG025|Overall Study|Global deterioration of health status|0|||
160920264|NCT02554812|581101484|FG026|Overall Study|Global deterioration of health status|0|||
160920265|NCT02554812|581101458|FG000|Overall Study|Progressive disease|20|||
160920266|NCT02554812|581101459|FG001|Overall Study|Progressive disease|16|||
160920267|NCT02554812|581101460|FG002|Overall Study|Progressive disease|19|||
160920268|NCT02554812|581101461|FG003|Overall Study|Progressive disease|18|||
160920269|NCT02554812|581101462|FG004|Overall Study|Progressive disease|21|||
160920270|NCT02554812|581101463|FG005|Overall Study|Progressive disease|15|||
160920271|NCT02554812|581101464|FG006|Overall Study|Progressive disease|6|||
160920272|NCT02554812|581101465|FG007|Overall Study|Progressive disease|13|||
160920273|NCT02554812|581101466|FG008|Overall Study|Progressive disease|6|||
160920274|NCT02554812|581101467|FG009|Overall Study|Progressive disease|6|||
161259815|NCT00606502|582330250|FG000|Randomization|Randomized but not treated|3|||
161259816|NCT00606502|582330251|FG001|Randomization|Randomized but not treated|0|||
160920275|NCT02554812|581101468|FG010|Overall Study|Progressive disease|8|||
161259817|NCT00606502|582330250|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
161259818|NCT00606502|582330251|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
161259819|NCT02377921|582330254|FG000|Overall Study|Subject non-compliance|1|||
160920276|NCT02554812|581101469|FG011|Overall Study|Progressive disease|8|||
160920277|NCT02554812|581101470|FG012|Overall Study|Progressive disease|6|||
160920278|NCT02554812|581101471|FG013|Overall Study|Progressive disease|10|||
160920279|NCT02554812|581101472|FG014|Overall Study|Progressive disease|20|||
160920280|NCT02554812|581101473|FG015|Overall Study|Progressive disease|6|||
160920281|NCT02554812|581101474|FG016|Overall Study|Progressive disease|3|||
160920282|NCT02554812|581101475|FG017|Overall Study|Progressive disease|3|||
160920283|NCT02554812|581101476|FG018|Overall Study|Progressive disease|11|||
160920284|NCT02554812|581101477|FG019|Overall Study|Progressive disease|7|||
160920285|NCT02554812|581101478|FG020|Overall Study|Progressive disease|11|||
160920286|NCT02554812|581101479|FG021|Overall Study|Progressive disease|6|||
160920287|NCT02554812|581101480|FG022|Overall Study|Progressive disease|9|||
160920288|NCT02554812|581101481|FG023|Overall Study|Progressive disease|9|||
160920289|NCT02554812|581101482|FG024|Overall Study|Progressive disease|4|||
160920290|NCT02554812|581101483|FG025|Overall Study|Progressive disease|5|||
160920291|NCT02554812|581101484|FG026|Overall Study|Progressive disease|5|||
160920292|NCT02554812|581101458|FG000|Overall Study|Other|0|||
160920293|NCT02554812|581101459|FG001|Overall Study|Other|0|||
160920294|NCT02554812|581101460|FG002|Overall Study|Other|2|||
160920295|NCT02554812|581101461|FG003|Overall Study|Other|3|||
160920296|NCT02554812|581101462|FG004|Overall Study|Other|2|||
160920297|NCT02554812|581101463|FG005|Overall Study|Other|1|||
160920298|NCT02554812|581101464|FG006|Overall Study|Other|0|||
160920299|NCT02554812|581101465|FG007|Overall Study|Other|0|||
160920300|NCT02554812|581101466|FG008|Overall Study|Other|1|||
160920301|NCT02554812|581101467|FG009|Overall Study|Other|1|||
160920302|NCT02554812|581101468|FG010|Overall Study|Other|0|||
160920303|NCT02554812|581101469|FG011|Overall Study|Other|0|||
160920304|NCT02554812|581101470|FG012|Overall Study|Other|1|||
160920305|NCT02554812|581101471|FG013|Overall Study|Other|0|||
160920306|NCT02554812|581101472|FG014|Overall Study|Other|1|||
160920307|NCT02554812|581101473|FG015|Overall Study|Other|0|||
160920308|NCT02554812|581101474|FG016|Overall Study|Other|0|||
160920309|NCT02554812|581101475|FG017|Overall Study|Other|0|||
160920310|NCT02554812|581101476|FG018|Overall Study|Other|0|||
160920311|NCT02554812|581101477|FG019|Overall Study|Other|0|||
160920312|NCT02554812|581101478|FG020|Overall Study|Other|0|||
160920313|NCT02554812|581101479|FG021|Overall Study|Other|2|||
160920314|NCT02554812|581101480|FG022|Overall Study|Other|0|||
160920315|NCT02554812|581101481|FG023|Overall Study|Other|0|||
160920316|NCT02554812|581101482|FG024|Overall Study|Other|0|||
160920317|NCT02554812|581101483|FG025|Overall Study|Other|0|||
160920318|NCT02554812|581101484|FG026|Overall Study|Other|0|||
160920319|NCT02554812|581101458|FG000|Overall Study|Withdrawal by Subject|1|||
160920320|NCT02554812|581101459|FG001|Overall Study|Withdrawal by Subject|0|||
160920321|NCT02554812|581101460|FG002|Overall Study|Withdrawal by Subject|0|||
160920322|NCT02554812|581101461|FG003|Overall Study|Withdrawal by Subject|2|||
160920323|NCT02554812|581101462|FG004|Overall Study|Withdrawal by Subject|2|||
160920324|NCT02554812|581101463|FG005|Overall Study|Withdrawal by Subject|3|||
160920325|NCT02554812|581101464|FG006|Overall Study|Withdrawal by Subject|0|||
160920326|NCT02554812|581101465|FG007|Overall Study|Withdrawal by Subject|0|||
160920327|NCT02554812|581101466|FG008|Overall Study|Withdrawal by Subject|1|||
160920328|NCT02554812|581101467|FG009|Overall Study|Withdrawal by Subject|1|||
160920329|NCT02554812|581101468|FG010|Overall Study|Withdrawal by Subject|0|||
160920330|NCT02554812|581101469|FG011|Overall Study|Withdrawal by Subject|1|||
160920331|NCT02554812|581101470|FG012|Overall Study|Withdrawal by Subject|1|||
160920332|NCT02554812|581101471|FG013|Overall Study|Withdrawal by Subject|1|||
160920333|NCT02554812|581101472|FG014|Overall Study|Withdrawal by Subject|1|||
161259820|NCT02377921|582330255|FG001|Overall Study|Subject non-compliance|1|||
161259821|NCT02443545|582330256|FG000|Overall Study|Adverse Event|1|||
161259822|NCT02443545|582330257|FG001|Overall Study|Adverse Event|1|||
161259823|NCT02443545|582330256|FG000|Overall Study|Lost to Follow-up|0|||
161259824|NCT02443545|582330257|FG001|Overall Study|Lost to Follow-up|2|||
161259825|NCT02443545|582330256|FG000|Overall Study|Physician Decision|3|||
161259826|NCT02443545|582330257|FG001|Overall Study|Physician Decision|0|||
160920334|NCT02554812|581101473|FG015|Overall Study|Withdrawal by Subject|1|||
160920335|NCT02554812|581101474|FG016|Overall Study|Withdrawal by Subject|3|||
160920336|NCT02554812|581101475|FG017|Overall Study|Withdrawal by Subject|1|||
160920337|NCT02554812|581101476|FG018|Overall Study|Withdrawal by Subject|0|||
160920338|NCT02554812|581101477|FG019|Overall Study|Withdrawal by Subject|2|||
160920339|NCT02554812|581101478|FG020|Overall Study|Withdrawal by Subject|0|||
160920340|NCT02554812|581101479|FG021|Overall Study|Withdrawal by Subject|1|||
160920341|NCT02554812|581101480|FG022|Overall Study|Withdrawal by Subject|0|||
160920342|NCT02554812|581101481|FG023|Overall Study|Withdrawal by Subject|1|||
160920343|NCT02554812|581101482|FG024|Overall Study|Withdrawal by Subject|0|||
160920344|NCT02554812|581101483|FG025|Overall Study|Withdrawal by Subject|0|||
160920345|NCT02554812|581101484|FG026|Overall Study|Withdrawal by Subject|1|||
160920346|NCT02554812|581101458|FG000|Overall Study|Physician Decision|1|||
161259827|NCT02443545|582330256|FG000|Overall Study|Protocol Violation|8|||
161259828|NCT02443545|582330257|FG001|Overall Study|Protocol Violation|1|||
161259829|NCT02443545|582330256|FG000|Overall Study|Pregnancy|1|||
161259830|NCT02443545|582330257|FG001|Overall Study|Pregnancy|1|||
161259831|NCT02443545|582330256|FG000|Overall Study|Withdrawal by Subject|6|||
161259832|NCT02443545|582330257|FG001|Overall Study|Withdrawal by Subject|3|||
161259833|NCT02443545|582330256|FG000|Overall Study|Termination of study|20|||
161259834|NCT02443545|582330257|FG001|Overall Study|Termination of study|11|||
161259835|NCT04179019|582330263|FG000|Overall Study|Lost to Follow-up|2|||
161259836|NCT04179019|582330263|FG000|Overall Study|Physician Decision|2|||
161259837|NCT04179019|582330263|FG000|Overall Study|Withdrawal by Subject|5|||
161259838|NCT04179019|582330263|FG000|Overall Study|Adverse Event|4|||
161259839|NCT02139124|582330264|FG000|Overall Study|Adverse Event|2|||
161259840|NCT02139124|582330265|FG001|Overall Study|Adverse Event|0|||
161259841|NCT02139124|582330266|FG002|Overall Study|Adverse Event|1|||
161259842|NCT02139124|582330267|FG003|Overall Study|Adverse Event|2|||
161259843|NCT02139124|582330268|FG004|Overall Study|Adverse Event|5|||
161259844|NCT02139124|582330264|FG000|Overall Study|Withdrawal by Subject|2|||
161259845|NCT02139124|582330265|FG001|Overall Study|Withdrawal by Subject|2|||
161259846|NCT02139124|582330266|FG002|Overall Study|Withdrawal by Subject|2|||
161340712|NCT01288430|582635516|FG000|Part 2|Other|0|||
161340713|NCT01288430|582635517|FG001|Part 2|Other|0|||
161340714|NCT01288430|582635518|FG002|Part 2|Other|0|||
160920347|NCT02554812|581101459|FG001|Overall Study|Physician Decision|0|||
160920348|NCT02554812|581101460|FG002|Overall Study|Physician Decision|0|||
160920349|NCT02554812|581101461|FG003|Overall Study|Physician Decision|1|||
160920350|NCT02554812|581101462|FG004|Overall Study|Physician Decision|0|||
160920351|NCT02554812|581101463|FG005|Overall Study|Physician Decision|1|||
160920352|NCT02554812|581101464|FG006|Overall Study|Physician Decision|0|||
160920353|NCT02554812|581101465|FG007|Overall Study|Physician Decision|0|||
160920354|NCT02554812|581101466|FG008|Overall Study|Physician Decision|0|||
160920355|NCT02554812|581101467|FG009|Overall Study|Physician Decision|0|||
160920356|NCT02554812|581101468|FG010|Overall Study|Physician Decision|1|||
160920357|NCT02554812|581101469|FG011|Overall Study|Physician Decision|0|||
160920358|NCT02554812|581101470|FG012|Overall Study|Physician Decision|0|||
160920359|NCT02554812|581101471|FG013|Overall Study|Physician Decision|0|||
160920360|NCT02554812|581101472|FG014|Overall Study|Physician Decision|0|||
160920361|NCT02554812|581101473|FG015|Overall Study|Physician Decision|0|||
160920362|NCT02554812|581101474|FG016|Overall Study|Physician Decision|1|||
160920363|NCT02554812|581101475|FG017|Overall Study|Physician Decision|1|||
160920364|NCT02554812|581101476|FG018|Overall Study|Physician Decision|0|||
160920365|NCT02554812|581101477|FG019|Overall Study|Physician Decision|1|||
160920366|NCT02554812|581101478|FG020|Overall Study|Physician Decision|1|||
160920367|NCT02554812|581101479|FG021|Overall Study|Physician Decision|0|||
160920368|NCT02554812|581101480|FG022|Overall Study|Physician Decision|1|||
160920369|NCT02554812|581101481|FG023|Overall Study|Physician Decision|0|||
160920370|NCT02554812|581101482|FG024|Overall Study|Physician Decision|0|||
160920371|NCT02554812|581101483|FG025|Overall Study|Physician Decision|0|||
160920372|NCT02554812|581101484|FG026|Overall Study|Physician Decision|0|||
160920373|NCT02554812|581101458|FG000|Overall Study|Study terminated by sponsor|0|||
160920374|NCT02554812|581101459|FG001|Overall Study|Study terminated by sponsor|0|||
160920375|NCT02554812|581101460|FG002|Overall Study|Study terminated by sponsor|0|||
160920376|NCT02554812|581101461|FG003|Overall Study|Study terminated by sponsor|0|||
160920377|NCT02554812|581101462|FG004|Overall Study|Study terminated by sponsor|0|||
160920378|NCT02554812|581101463|FG005|Overall Study|Study terminated by sponsor|0|||
160920379|NCT02554812|581101464|FG006|Overall Study|Study terminated by sponsor|0|||
160920380|NCT02554812|581101465|FG007|Overall Study|Study terminated by sponsor|0|||
160920381|NCT02554812|581101466|FG008|Overall Study|Study terminated by sponsor|0|||
160920382|NCT02554812|581101467|FG009|Overall Study|Study terminated by sponsor|0|||
160920383|NCT02554812|581101468|FG010|Overall Study|Study terminated by sponsor|0|||
160920384|NCT02554812|581101469|FG011|Overall Study|Study terminated by sponsor|0|||
160920385|NCT02554812|581101470|FG012|Overall Study|Study terminated by sponsor|0|||
160920386|NCT02554812|581101471|FG013|Overall Study|Study terminated by sponsor|0|||
160920387|NCT02554812|581101472|FG014|Overall Study|Study terminated by sponsor|0|||
160997282|NCT02987543|581374889|FG001|Overall Study|Disease progression|0|||
161259847|NCT02139124|582330267|FG003|Overall Study|Withdrawal by Subject|2|||
161259848|NCT02139124|582330268|FG004|Overall Study|Withdrawal by Subject|3|||
161259849|NCT02139124|582330264|FG000|Overall Study|Protocol Violation|0|||
161259850|NCT02139124|582330265|FG001|Overall Study|Protocol Violation|0|||
161259851|NCT02139124|582330266|FG002|Overall Study|Protocol Violation|0|||
160920388|NCT02554812|581101473|FG015|Overall Study|Study terminated by sponsor|0|||
160920389|NCT02554812|581101474|FG016|Overall Study|Study terminated by sponsor|0|||
161259852|NCT02139124|582330267|FG003|Overall Study|Protocol Violation|1|||
161259853|NCT02139124|582330268|FG004|Overall Study|Protocol Violation|1|||
161259854|NCT02139124|582330264|FG000|Overall Study|non-compliant|1|||
161259855|NCT02139124|582330265|FG001|Overall Study|non-compliant|0|||
161340715|NCT01288430|582635519|FG003|Part 2|Other|0|||
160997283|NCT02987543|581374890|FG002|Overall Study|Disease progression|0|||
161340716|NCT01288430|582635520|FG004|Part 2|Other|0|||
161340717|NCT01288430|582635521|FG005|Part 2|Other|0|||
161259856|NCT02139124|582330266|FG002|Overall Study|non-compliant|0|||
160920390|NCT02554812|581101475|FG017|Overall Study|Study terminated by sponsor|0|||
160920391|NCT02554812|581101476|FG018|Overall Study|Study terminated by sponsor|0|||
160920392|NCT02554812|581101477|FG019|Overall Study|Study terminated by sponsor|0|||
160920393|NCT02554812|581101478|FG020|Overall Study|Study terminated by sponsor|0|||
160920394|NCT02554812|581101479|FG021|Overall Study|Study terminated by sponsor|0|||
160920395|NCT02554812|581101480|FG022|Overall Study|Study terminated by sponsor|0|||
160920396|NCT02554812|581101481|FG023|Overall Study|Study terminated by sponsor|0|||
160920397|NCT02554812|581101482|FG024|Overall Study|Study terminated by sponsor|1|||
161259857|NCT02139124|582330267|FG003|Overall Study|non-compliant|2|||
161259858|NCT02139124|582330268|FG004|Overall Study|non-compliant|0|||
160920398|NCT02554812|581101483|FG025|Overall Study|Study terminated by sponsor|0|||
160920399|NCT02554812|581101484|FG026|Overall Study|Study terminated by sponsor|0|||
160920400|NCT02554812|581101458|FG000|Overall Study|No longer meets eligibility criteria|0|||
160920401|NCT02554812|581101459|FG001|Overall Study|No longer meets eligibility criteria|1|||
160920402|NCT02554812|581101460|FG002|Overall Study|No longer meets eligibility criteria|0|||
160920403|NCT02554812|581101461|FG003|Overall Study|No longer meets eligibility criteria|0|||
160920404|NCT02554812|581101462|FG004|Overall Study|No longer meets eligibility criteria|0|||
160920405|NCT02554812|581101463|FG005|Overall Study|No longer meets eligibility criteria|0|||
160920406|NCT02554812|581101464|FG006|Overall Study|No longer meets eligibility criteria|0|||
160920407|NCT02554812|581101465|FG007|Overall Study|No longer meets eligibility criteria|0|||
160920408|NCT02554812|581101466|FG008|Overall Study|No longer meets eligibility criteria|0|||
160920409|NCT02554812|581101467|FG009|Overall Study|No longer meets eligibility criteria|0|||
160920410|NCT02554812|581101468|FG010|Overall Study|No longer meets eligibility criteria|0|||
160920411|NCT02554812|581101469|FG011|Overall Study|No longer meets eligibility criteria|0|||
160920412|NCT02554812|581101470|FG012|Overall Study|No longer meets eligibility criteria|0|||
160920413|NCT02554812|581101471|FG013|Overall Study|No longer meets eligibility criteria|0|||
160920414|NCT02554812|581101472|FG014|Overall Study|No longer meets eligibility criteria|0|||
160920415|NCT02554812|581101473|FG015|Overall Study|No longer meets eligibility criteria|0|||
160920416|NCT02554812|581101474|FG016|Overall Study|No longer meets eligibility criteria|0|||
160920417|NCT02554812|581101475|FG017|Overall Study|No longer meets eligibility criteria|0|||
160920418|NCT02554812|581101476|FG018|Overall Study|No longer meets eligibility criteria|0|||
160920419|NCT02554812|581101477|FG019|Overall Study|No longer meets eligibility criteria|0|||
160920420|NCT02554812|581101478|FG020|Overall Study|No longer meets eligibility criteria|0|||
160920421|NCT02554812|581101479|FG021|Overall Study|No longer meets eligibility criteria|0|||
160920422|NCT02554812|581101480|FG022|Overall Study|No longer meets eligibility criteria|0|||
160920423|NCT02554812|581101481|FG023|Overall Study|No longer meets eligibility criteria|0|||
160920424|NCT02554812|581101482|FG024|Overall Study|No longer meets eligibility criteria|0|||
160920425|NCT02554812|581101483|FG025|Overall Study|No longer meets eligibility criteria|0|||
160920426|NCT02554812|581101484|FG026|Overall Study|No longer meets eligibility criteria|0|||
160920427|NCT02879305|581101485|FG000|Overall Study|Investigator Site Closed|55|||
160920428|NCT02879305|581101486|FG001|Overall Study|Investigator Site Closed|57|||
160920429|NCT02879305|581101485|FG000|Overall Study|Withdrawal by Subject|44|||
160920430|NCT02879305|581101486|FG001|Overall Study|Withdrawal by Subject|42|||
160920431|NCT02879305|581101485|FG000|Overall Study|Lost to Follow-up|17|||
160920432|NCT02879305|581101486|FG001|Overall Study|Lost to Follow-up|12|||
160920433|NCT02879305|581101485|FG000|Overall Study|Other|1|||
160920434|NCT02879305|581101486|FG001|Overall Study|Other|0|||
160920435|NCT01786629|581103238|FG000|Overall Study|Lack of Efficacy|0|||
160920436|NCT01786629|581103239|FG001|Overall Study|Lack of Efficacy|4|||
160920437|NCT01786629|581103238|FG000|Overall Study|Adverse Event|0|||
160920438|NCT01786629|581103239|FG001|Overall Study|Adverse Event|1|||
160920439|NCT00180414|581103240|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
160920440|NCT00180414|581103241|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
160920441|NCT00613938|581103242|FG000|Overall Study|Withdrawal by Subject|2|||
160920442|NCT00613938|581103243|FG001|Overall Study|Withdrawal by Subject|4|||
160920443|NCT00613938|581103244|FG002|Overall Study|Withdrawal by Subject|9|||
160920444|NCT00613938|581103245|FG003|Overall Study|Withdrawal by Subject|9|||
160920445|NCT00613938|581103242|FG000|Overall Study|Adverse Event|1|||
160920446|NCT00613938|581103243|FG001|Overall Study|Adverse Event|4|||
160920447|NCT00613938|581103244|FG002|Overall Study|Adverse Event|8|||
160920448|NCT00613938|581103245|FG003|Overall Study|Adverse Event|5|||
160920449|NCT00613938|581103242|FG000|Overall Study|Lack of Efficacy|16|||
161259859|NCT02139124|582330264|FG000|Overall Study|incarceration|0|||
161259860|NCT02139124|582330265|FG001|Overall Study|incarceration|0|||
160920450|NCT00613938|581103243|FG001|Overall Study|Lack of Efficacy|18|||
160920451|NCT00613938|581103244|FG002|Overall Study|Lack of Efficacy|5|||
160920452|NCT00613938|581103245|FG003|Overall Study|Lack of Efficacy|9|||
160920453|NCT00613938|581103242|FG000|Overall Study|Other|1|||
160920454|NCT00613938|581103243|FG001|Overall Study|Other|2|||
160920455|NCT00613938|581103244|FG002|Overall Study|Other|1|||
161259861|NCT02139124|582330266|FG002|Overall Study|incarceration|1|||
161259862|NCT02139124|582330267|FG003|Overall Study|incarceration|0|||
160920456|NCT00613938|581103245|FG003|Overall Study|Other|3|||
160920457|NCT03025542|581103246|FG000|Overall Study|Adverse Event|0|||
160920458|NCT03025542|581103247|FG001|Overall Study|Adverse Event|2|||
160920459|NCT03025542|581103246|FG000|Overall Study|Lost to Follow-up|1|||
160920460|NCT03025542|581103247|FG001|Overall Study|Lost to Follow-up|0|||
160920461|NCT03025542|581103246|FG000|Overall Study|Withdrawal by Subject|1|||
160920462|NCT03025542|581103247|FG001|Overall Study|Withdrawal by Subject|0|||
160920463|NCT00488345|581103248|FG000|Overall Study|Adverse Event|0|||
160920464|NCT00488345|581103249|FG001|Overall Study|Adverse Event|1|||
160920465|NCT00488345|581103250|FG002|Overall Study|Adverse Event|1|||
160920466|NCT00488345|581103248|FG000|Overall Study|Unable to administer antibiotics at home|0|||
160920467|NCT00488345|581103249|FG001|Overall Study|Unable to administer antibiotics at home|1|||
160920468|NCT00488345|581103250|FG002|Overall Study|Unable to administer antibiotics at home|0|||
160920469|NCT00488345|581103248|FG000|Overall Study|Institutional Review Board review|0|||
160920470|NCT00488345|581103249|FG001|Overall Study|Institutional Review Board review|0|||
160920471|NCT00488345|581103250|FG002|Overall Study|Institutional Review Board review|1|||
160920472|NCT00488345|581103248|FG000|Overall Study|Surgical team recommendation|0|||
160920473|NCT00488345|581103249|FG001|Overall Study|Surgical team recommendation|1|||
160920474|NCT00488345|581103250|FG002|Overall Study|Surgical team recommendation|0|||
160920475|NCT00488345|581103248|FG000|Overall Study|Parent/legal guardian request|0|||
160920476|NCT00488345|581103249|FG001|Overall Study|Parent/legal guardian request|1|||
160920477|NCT00488345|581103250|FG002|Overall Study|Parent/legal guardian request|1|||
160920478|NCT04708886|581103256|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
160920479|NCT04708886|581103256|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
160920480|NCT01853046|581103257|FG000|Overall Study|Withdrawal by Subject|1|||
160920481|NCT01853046|581103258|FG001|Overall Study|Withdrawal by Subject|1|||
160920482|NCT01853046|581103257|FG000|Overall Study|Adverse Event|4|||
160920483|NCT01853046|581103258|FG001|Overall Study|Adverse Event|2|||
160920484|NCT01853046|581103257|FG000|Overall Study|Disease progression|13|||
160920485|NCT01853046|581103258|FG001|Overall Study|Disease progression|3|||
160920486|NCT03020407|581103260|FG000|Overall Study|Withdrawal by Subject|2|||
160920487|NCT03020407|581103261|FG001|Overall Study|Withdrawal by Subject|1|||
160920488|NCT03020407|581103260|FG000|Overall Study|Lost to Follow-up|2|||
160920489|NCT03020407|581103261|FG001|Overall Study|Lost to Follow-up|3|||
160920490|NCT03020407|581103260|FG000|Overall Study|Protocol Violation|0|||
160920491|NCT03020407|581103261|FG001|Overall Study|Protocol Violation|1|||
160920492|NCT01585428|581103262|FG000|Overall Study|Death during treatment|1|||
160920493|NCT01585428|581103263|FG001|Overall Study|Death during treatment|0|||
160920494|NCT00708162|581103264|FG000|Randomized Phase|Randomized but Not Treated|7|||
160920495|NCT00708162|581103265|FG001|Randomized Phase|Randomized but Not Treated|5|||
160920496|NCT00708162|581103264|FG000|Randomized Phase|Participant Noncompliance|40|||
160920497|NCT00708162|581103265|FG001|Randomized Phase|Participant Noncompliance|32|||
160920498|NCT00708162|581103264|FG000|Randomized Phase|Lost to Follow-up|34|||
160920499|NCT00708162|581103265|FG001|Randomized Phase|Lost to Follow-up|34|||
160920500|NCT00708162|581103264|FG000|Randomized Phase|Withdrew Consent|31|||
160920501|NCT00708162|581103265|FG001|Randomized Phase|Withdrew Consent|22|||
160920502|NCT00708162|581103264|FG000|Randomized Phase|Lack of Efficacy|14|||
160920503|NCT00708162|581103265|FG001|Randomized Phase|Lack of Efficacy|19|||
160920504|NCT00708162|581103264|FG000|Randomized Phase|Protocol Violation|10|||
160920505|NCT00708162|581103265|FG001|Randomized Phase|Protocol Violation|11|||
160920506|NCT00708162|581103264|FG000|Randomized Phase|Adverse Event|8|||
160997284|NCT02987543|581374891|FG003|Overall Study|Disease progression|1|||
160997285|NCT03646669|581374892|FG000|Overall Study|Withdrawal by Subject|5|||
160997286|NCT03646669|581374893|FG001|Overall Study|Withdrawal by Subject|0|||
160997287|NCT00377455|581374894|FG000|Overall Study|Withdrawal by Subject|1|||
160997288|NCT00309452|581374895|FG000|Overall Study|Withdrawal by Subject|3|||
161259863|NCT02139124|582330268|FG004|Overall Study|incarceration|0|||
161259864|NCT02139124|582330264|FG000|Overall Study|subject moved|1|||
161259865|NCT02139124|582330265|FG001|Overall Study|subject moved|0|||
161259866|NCT02139124|582330266|FG002|Overall Study|subject moved|0|||
160920507|NCT00708162|581103265|FG001|Randomized Phase|Adverse Event|12|||
160920508|NCT00708162|581103264|FG000|Randomized Phase|Investigator's Discretion|7|||
160920509|NCT00708162|581103265|FG001|Randomized Phase|Investigator's Discretion|10|||
160920510|NCT00708162|581103264|FG000|Randomized Phase|Death|2|||
160920511|NCT00708162|581103265|FG001|Randomized Phase|Death|9|||
160920512|NCT00708162|581103264|FG000|Randomized Phase|Pregnancy|3|||
160920513|NCT00708162|581103265|FG001|Randomized Phase|Pregnancy|0|||
161259867|NCT02139124|582330267|FG003|Overall Study|subject moved|0|||
161259868|NCT02139124|582330268|FG004|Overall Study|subject moved|0|||
161259869|NCT02139124|582330264|FG000|Overall Study|Lost to Follow-up|3|||
160920514|NCT00708162|581103264|FG000|Open-Label Phase|Lost to Follow-up|10|||
160920515|NCT00708162|581103265|FG001|Open-Label Phase|Lost to Follow-up|8|||
160920516|NCT00708162|581103264|FG000|Open-Label Phase|Withdrew Consent|12|||
160920517|NCT00708162|581103265|FG001|Open-Label Phase|Withdrew Consent|6|||
160997289|NCT00309452|581374896|FG001|Overall Study|Withdrawal by Subject|0|||
160920518|NCT00708162|581103264|FG000|Open-Label Phase|Participant Noncompliance|7|||
161259870|NCT02139124|582330265|FG001|Overall Study|Lost to Follow-up|2|||
161259871|NCT02139124|582330266|FG002|Overall Study|Lost to Follow-up|0|||
161259872|NCT02139124|582330267|FG003|Overall Study|Lost to Follow-up|5|||
161259873|NCT02139124|582330268|FG004|Overall Study|Lost to Follow-up|4|||
161259874|NCT00613834|582330269|FG000|Overall Study|Withdrawal by Subject|0|||
161259875|NCT00613834|582330270|FG001|Overall Study|Withdrawal by Subject|3|||
161259876|NCT01560507|582330271|FG000|Overall Study|Lost to Follow-up|3|||
161259877|NCT01560507|582330272|FG001|Overall Study|Lost to Follow-up|1|||
161259878|NCT01560507|582330273|FG002|Overall Study|Lost to Follow-up|2|||
161259879|NCT01560507|582330271|FG000|Overall Study|Withdrawal by Subject|1|||
161259880|NCT01560507|582330272|FG001|Overall Study|Withdrawal by Subject|1|||
161259881|NCT01560507|582330273|FG002|Overall Study|Withdrawal by Subject|0|||
161259882|NCT00440115|582330274|FG000|Overall Study|Death|7|||
161259883|NCT00440115|582330275|FG001|Overall Study|Death|9|||
161259884|NCT00440115|582330276|FG002|Overall Study|Death|5|||
161259885|NCT00440115|582330274|FG000|Overall Study|Incarceration|0|||
161259886|NCT00440115|582330275|FG001|Overall Study|Incarceration|2|||
161259887|NCT00440115|582330276|FG002|Overall Study|Incarceration|1|||
161259888|NCT03078478|582330277|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
161259889|NCT03078478|582330278|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
161259890|NCT03078478|582330277|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
161259891|NCT03078478|582330278|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
161259892|NCT03078478|582330277|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
161259893|NCT03078478|582330278|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
161259894|NCT03078478|582330277|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
161259895|NCT03078478|582330278|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
161259896|NCT03078478|582330277|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
161259897|NCT03078478|582330278|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
161259898|NCT03078478|582330277|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
161259899|NCT03078478|582330278|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
161259900|NCT03078478|582330277|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
161259901|NCT03078478|582330278|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
161259902|NCT03078478|582330277|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
161259903|NCT03078478|582330278|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
161259904|NCT01688726|582330279|FG000|Overall Study|Adverse Event|1|||
161259905|NCT01688726|582330280|FG001|Overall Study|Adverse Event|0|||
161259906|NCT01688726|582330279|FG000|Overall Study|Relocated abroad|0|||
161259907|NCT01688726|582330280|FG001|Overall Study|Relocated abroad|1|||
161259908|NCT05904769|582331582|FG000|Overall Study|Physician Decision|0|||
161259909|NCT05904769|582331583|FG001|Overall Study|Physician Decision|6|||
161259910|NCT05626803|582331589|FG000|Overall Study|Lost to Follow-up|0|||
161259911|NCT05626803|582331590|FG001|Overall Study|Lost to Follow-up|1|||
161259912|NCT05626803|582331591|FG002|Overall Study|Lost to Follow-up|0|||
161259913|NCT05626803|582331592|FG003|Overall Study|Lost to Follow-up|0|||
161259914|NCT04974619|582331593|FG000|Overall Study|Lost to Follow-up|0|||
161259915|NCT04974619|582331594|FG001|Overall Study|Lost to Follow-up|0|||
161259916|NCT04974619|582331595|FG002|Overall Study|Lost to Follow-up|1|||
161259917|NCT04974619|582331593|FG000|Overall Study|Withdrawal by Subject|0|||
161259918|NCT04974619|582331594|FG001|Overall Study|Withdrawal by Subject|0|||
161259919|NCT04974619|582331595|FG002|Overall Study|Withdrawal by Subject|1|||
161259920|NCT04974619|582331593|FG000|Overall Study|Protocol Violation|0|||
161259921|NCT04974619|582331594|FG001|Overall Study|Protocol Violation|1|||
161259922|NCT04974619|582331595|FG002|Overall Study|Protocol Violation|0|||
161259923|NCT02516410|582331600|FG000|Overall Study|Adverse Event|0|||
161259924|NCT02516410|582331601|FG001|Overall Study|Adverse Event|1|||
161259925|NCT02516410|582331600|FG000|Overall Study|Withdrawal by Subject|0|||
160920519|NCT00708162|581103265|FG001|Open-Label Phase|Participant Noncompliance|7|||
160920520|NCT00708162|581103264|FG000|Open-Label Phase|Lack of Efficacy|7|||
160920521|NCT00708162|581103265|FG001|Open-Label Phase|Lack of Efficacy|4|||
160920522|NCT00708162|581103264|FG000|Open-Label Phase|Investigator's Discretion|3|||
160920523|NCT00708162|581103265|FG001|Open-Label Phase|Investigator's Discretion|2|||
161259926|NCT02516410|582331601|FG001|Overall Study|Withdrawal by Subject|1|||
161259927|NCT01286558|582331608|FG000|Overall Study|Adverse Event|1|||
161259928|NCT01286558|582331609|FG001|Overall Study|Adverse Event|1|||
161259929|NCT01286558|582331608|FG000|Overall Study|Withdrawal by Subject|0|||
161259930|NCT01286558|582331609|FG001|Overall Study|Withdrawal by Subject|1|||
161259931|NCT01220297|582331610|FG000|Overall Study|Death|2|||
161259932|NCT01220297|582331610|FG000|Overall Study|Lost to Follow-up|1|||
161259933|NCT01787279|582331612|FG000|Overall Study|Lost to Follow-up|2|||
161259934|NCT01787279|582331612|FG000|Overall Study|Lack of Efficacy|1|||
161259935|NCT02148913|582331613|FG000|Overall Study|Death|0|||
160920524|NCT00708162|581103264|FG000|Open-Label Phase|Death|3|||
161259936|NCT02148913|582331614|FG001|Overall Study|Death|1|||
161259937|NCT02148913|582331615|FG002|Overall Study|Death|0|||
161259938|NCT02148913|582331616|FG003|Overall Study|Death|0|||
161259939|NCT01287039|582331618|FG000|Overall Study|Noncompliance with study procedures|0|||
161259940|NCT01287039|582331619|FG001|Overall Study|Noncompliance with study procedures|1|||
161259941|NCT01287039|582331618|FG000|Overall Study|Change of location/residence|0|||
161259942|NCT01287039|582331619|FG001|Overall Study|Change of location/residence|3|||
161259943|NCT01287039|582331618|FG000|Overall Study|Elective surgery|0|||
161259944|NCT01287039|582331619|FG001|Overall Study|Elective surgery|1|||
161259945|NCT01287039|582331618|FG000|Overall Study|Protocol Violation|2|||
161259946|NCT01287039|582331619|FG001|Overall Study|Protocol Violation|3|||
161259947|NCT01287039|582331618|FG000|Overall Study|Excluded medication taken|1|||
161259948|NCT01287039|582331619|FG001|Overall Study|Excluded medication taken|0|||
161259949|NCT01287039|582331618|FG000|Overall Study|Noncompliance with study medication|0|||
161259950|NCT01287039|582331619|FG001|Overall Study|Noncompliance with study medication|1|||
161259951|NCT01287039|582331618|FG000|Overall Study|Problem with travel|0|||
161259952|NCT01287039|582331619|FG001|Overall Study|Problem with travel|1|||
161259953|NCT01287039|582331618|FG000|Overall Study|Death|1|||
161259954|NCT01287039|582331619|FG001|Overall Study|Death|0|||
161259955|NCT01287039|582331618|FG000|Overall Study|Change of residence|1|||
161259956|NCT01287039|582331619|FG001|Overall Study|Change of residence|0|||
161259957|NCT01287039|582331618|FG000|Overall Study|Adverse Event|7|||
161259958|NCT01287039|582331619|FG001|Overall Study|Adverse Event|4|||
161259959|NCT01287039|582331618|FG000|Overall Study|Withdrawal by Subject|14|||
161259960|NCT01287039|582331619|FG001|Overall Study|Withdrawal by Subject|11|||
161259961|NCT01287039|582331618|FG000|Overall Study|Lost to Follow-up|3|||
161259962|NCT01287039|582331619|FG001|Overall Study|Lost to Follow-up|2|||
161259963|NCT01360866|582331620|FG000|Overall Study|Lost to Follow-up|11|||
161259964|NCT01360866|582331621|FG001|Overall Study|Lost to Follow-up|28|||
161259965|NCT01360866|582331622|FG002|Overall Study|Lost to Follow-up|41|||
161259966|NCT01360866|582331623|FG003|Overall Study|Lost to Follow-up|0|||
161259967|NCT01360866|582331620|FG000|Overall Study|Adverse Event|56|||
161259968|NCT01360866|582331621|FG001|Overall Study|Adverse Event|61|||
161259969|NCT01360866|582331622|FG002|Overall Study|Adverse Event|134|||
161259970|NCT01360866|582331623|FG003|Overall Study|Adverse Event|6|||
161259971|NCT01360866|582331620|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
161259972|NCT01360866|582331621|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
161259973|NCT01360866|582331622|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
161259974|NCT01360866|582331623|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
161259975|NCT01360866|582331620|FG000|Overall Study|Withdrawn by Investigator|9|||
161259976|NCT01360866|582331621|FG001|Overall Study|Withdrawn by Investigator|8|||
161259977|NCT01360866|582331622|FG002|Overall Study|Withdrawn by Investigator|31|||
161259978|NCT01360866|582331623|FG003|Overall Study|Withdrawn by Investigator|2|||
161259979|NCT01360866|582331620|FG000|Overall Study|Withdrawal by participant|79|||
161259980|NCT01360866|582331621|FG001|Overall Study|Withdrawal by participant|89|||
161259981|NCT01360866|582331622|FG002|Overall Study|Withdrawal by participant|168|||
161259982|NCT01360866|582331623|FG003|Overall Study|Withdrawal by participant|8|||
161259983|NCT01360866|582331620|FG000|Overall Study|Protocol Deviation|25|||
161259984|NCT01360866|582331621|FG001|Overall Study|Protocol Deviation|33|||
161259985|NCT01360866|582331622|FG002|Overall Study|Protocol Deviation|61|||
161259986|NCT01360866|582331623|FG003|Overall Study|Protocol Deviation|2|||
161259987|NCT01360866|582331620|FG000|Overall Study|Lack of Efficacy|30|||
161259988|NCT01360866|582331621|FG001|Overall Study|Lack of Efficacy|40|||
161259989|NCT01360866|582331622|FG002|Overall Study|Lack of Efficacy|30|||
161259990|NCT01360866|582331623|FG003|Overall Study|Lack of Efficacy|4|||
161259991|NCT05016622|582331624|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
161259992|NCT05016622|582331624|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
161259993|NCT03575871|582331633|FG000|Overall Study|Adverse Event|5|||
161259994|NCT03575871|582331634|FG001|Overall Study|Adverse Event|5|||
161259995|NCT03575871|582331635|FG002|Overall Study|Adverse Event|8|||
161259996|NCT03575871|582331633|FG000|Overall Study|Death|1|||
161259997|NCT03575871|582331634|FG001|Overall Study|Death|0|||
161259998|NCT03575871|582331635|FG002|Overall Study|Death|0|||
161259999|NCT03575871|582331633|FG000|Overall Study|Lack of Efficacy|5|||
161260000|NCT03575871|582331634|FG001|Overall Study|Lack of Efficacy|4|||
161260001|NCT03575871|582331635|FG002|Overall Study|Lack of Efficacy|7|||
161260002|NCT03575871|582331633|FG000|Overall Study|Lost to Follow-up|1|||
161260003|NCT03575871|582331634|FG001|Overall Study|Lost to Follow-up|1|||
161260004|NCT03575871|582331635|FG002|Overall Study|Lost to Follow-up|1|||
161260005|NCT03575871|582331633|FG000|Overall Study|Protocol Deviation|1|||
161260006|NCT03575871|582331634|FG001|Overall Study|Protocol Deviation|1|||
161260007|NCT03575871|582331635|FG002|Overall Study|Protocol Deviation|1|||
161260008|NCT03575871|582331633|FG000|Overall Study|Withdrawal by Subject|6|||
160920525|NCT00708162|581103265|FG001|Open-Label Phase|Death|1|||
161260009|NCT03575871|582331634|FG001|Overall Study|Withdrawal by Subject|1|||
161260010|NCT03575871|582331635|FG002|Overall Study|Withdrawal by Subject|9|||
161260011|NCT03575871|582331633|FG000|Overall Study|Other than specified|2|||
161260012|NCT03575871|582331634|FG001|Overall Study|Other than specified|2|||
161260013|NCT03575871|582331635|FG002|Overall Study|Other than specified|0|||
161260014|NCT05506358|582331636|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
160920526|NCT00708162|581103264|FG000|Open-Label Phase|Adverse Event|1|||
161260015|NCT05506358|582331637|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161340718|NCT01288430|582635522|FG006|Part 2|Other|0|||
160920527|NCT00708162|581103265|FG001|Open-Label Phase|Adverse Event|2|||
160920528|NCT00708162|581103264|FG000|Open-Label Phase|Other|1|||
160920529|NCT00708162|581103265|FG001|Open-Label Phase|Other|0|||
160920530|NCT02699554|581103266|FG000|Overall Study|Lost to Follow-up|9|||
160920531|NCT00788151|581103267|FG000|Overall Study|Other adverse event|0|||
160920532|NCT00788151|581103268|FG001|Overall Study|Other adverse event|2|||
160920533|NCT00788151|581103267|FG000|Overall Study|Protocol Violation|0|||
160920534|NCT00788151|581103268|FG001|Overall Study|Protocol Violation|1|||
160920535|NCT00788151|581103267|FG000|Overall Study|Withdrawal by Subject|13|||
160920536|NCT00788151|581103268|FG001|Overall Study|Withdrawal by Subject|6|||
160920537|NCT00788151|581103267|FG000|Overall Study|Enrolled but not treated|1|||
160920538|NCT00788151|581103268|FG001|Overall Study|Enrolled but not treated|1|||
160920539|NCT00503009|581103269|FG000|Overall Study|Protocol Violation|1|||
160920540|NCT00503009|581103270|FG001|Overall Study|Protocol Violation|0|||
160920541|NCT00503009|581103271|FG002|Overall Study|Protocol Violation|1|||
160920542|NCT00503009|581103269|FG000|Overall Study|Withdrawal by Subject|0|||
160920543|NCT00503009|581103270|FG001|Overall Study|Withdrawal by Subject|1|||
160920544|NCT00503009|581103271|FG002|Overall Study|Withdrawal by Subject|1|||
160920545|NCT00503009|581103269|FG000|Overall Study|Physician Decision|0|||
160920546|NCT00503009|581103270|FG001|Overall Study|Physician Decision|1|||
160920547|NCT00503009|581103271|FG002|Overall Study|Physician Decision|1|||
160920548|NCT02057198|581103272|FG000|Overall Study|Death|0|||
160920549|NCT02057198|581103273|FG001|Overall Study|Death|0|||
160920550|NCT02057198|581103274|FG002|Overall Study|Death|1|||
160920551|NCT02057198|581103272|FG000|Overall Study|Discharged early; lost to followup|0|||
160920552|NCT02057198|581103273|FG001|Overall Study|Discharged early; lost to followup|1|||
160920553|NCT02057198|581103274|FG002|Overall Study|Discharged early; lost to followup|0|||
160920554|NCT02355691|581103278|FG000|Overall Study|Loss of Research Personnel|7|||
160920555|NCT02355691|581103279|FG001|Overall Study|Loss of Research Personnel|9|||
160920556|NCT00065507|581103280|FG000|Overall Study|Death|16|||
160920557|NCT00065507|581103281|FG001|Overall Study|Death|17|||
160920558|NCT00065507|581103280|FG000|Overall Study|Adverse Event|4|||
160920559|NCT00065507|581103281|FG001|Overall Study|Adverse Event|3|||
160920560|NCT00065507|581103280|FG000|Overall Study|Lack of Efficacy|0|||
160920561|NCT00065507|581103281|FG001|Overall Study|Lack of Efficacy|6|||
160920562|NCT00065507|581103280|FG000|Overall Study|Poor/Non-compliance|3|||
160920563|NCT00065507|581103281|FG001|Overall Study|Poor/Non-compliance|2|||
160920564|NCT00065507|581103280|FG000|Overall Study|Lost to Follow-up|3|||
160920565|NCT00065507|581103281|FG001|Overall Study|Lost to Follow-up|0|||
160920566|NCT00065507|581103280|FG000|Overall Study|Subject Withdrew Consent|2|||
160920567|NCT00065507|581103281|FG001|Overall Study|Subject Withdrew Consent|1|||
160920568|NCT00065507|581103280|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
160920569|NCT00065507|581103281|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
160920570|NCT00350636|581103282|FG000|Overall Study|Adverse Event|19|||
160920571|NCT00350636|581103283|FG001|Overall Study|Adverse Event|13|||
160920572|NCT00350636|581103282|FG000|Overall Study|Protocol Violation|1|||
160920573|NCT00350636|581103283|FG001|Overall Study|Protocol Violation|3|||
160920574|NCT00350636|581103282|FG000|Overall Study|Withdrawal by Subject|13|||
160920575|NCT00350636|581103283|FG001|Overall Study|Withdrawal by Subject|17|||
160920576|NCT00350636|581103282|FG000|Overall Study|Lost to Follow-up|9|||
160920577|NCT00350636|581103283|FG001|Overall Study|Lost to Follow-up|8|||
160920578|NCT00350636|581103282|FG000|Overall Study|Physician Decision|0|||
160920579|NCT00350636|581103283|FG001|Overall Study|Physician Decision|2|||
160920580|NCT00350636|581103282|FG000|Overall Study|Other|1|||
160920581|NCT00350636|581103283|FG001|Overall Study|Other|2|||
160920582|NCT00100815|581103284|FG000|Overall Study|Progression|24|||
160920583|NCT00100815|581103284|FG000|Overall Study|Adverse Event|18|||
160920584|NCT00100815|581103284|FG000|Overall Study|Death|4|||
160920585|NCT00100815|581103284|FG000|Overall Study|Other|3|||
160920586|NCT01647282|581103290|FG000|Overall Study|Physician Decision|7|||
160920587|NCT01647282|581103291|FG001|Overall Study|Physician Decision|5|||
160920588|NCT01042236|581103292|FG000|Treatment Period 1|Adverse Event|0|||
160920589|NCT01042236|581103293|FG001|Treatment Period 1|Adverse Event|1|||
160920590|NCT01042236|581103294|FG002|Treatment Period 1|Adverse Event|0|||
161340719|NCT01288430|582635523|FG007|Part 2|Other|0|||
160920591|NCT01042236|581103295|FG003|Treatment Period 1|Adverse Event|0|||
160920592|NCT01042236|581103296|FG004|Treatment Period 1|Adverse Event|1|||
160920593|NCT01042236|581103297|FG005|Treatment Period 1|Adverse Event|0|||
160920594|NCT01042236|581103292|FG000|Treatment Period 3|Adverse Event|0|||
160920595|NCT01042236|581103293|FG001|Treatment Period 3|Adverse Event|0|||
160920596|NCT01042236|581103294|FG002|Treatment Period 3|Adverse Event|0|||
160920597|NCT01042236|581103295|FG003|Treatment Period 3|Adverse Event|1|||
160920598|NCT01042236|581103296|FG004|Treatment Period 3|Adverse Event|0|||
160920599|NCT01042236|581103297|FG005|Treatment Period 3|Adverse Event|0|||
160920600|NCT01042236|581103292|FG000|Treatment Period 3|Protocol Violation|0|||
160920601|NCT01042236|581103293|FG001|Treatment Period 3|Protocol Violation|0|||
160920602|NCT01042236|581103294|FG002|Treatment Period 3|Protocol Violation|0|||
160920603|NCT01042236|581103295|FG003|Treatment Period 3|Protocol Violation|1|||
160920604|NCT01042236|581103296|FG004|Treatment Period 3|Protocol Violation|0|||
160920605|NCT01042236|581103297|FG005|Treatment Period 3|Protocol Violation|0|||
161260016|NCT05506358|582331638|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161260017|NCT05506358|582331639|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161260018|NCT05506358|582331640|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
161260019|NCT05506358|582331636|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
161260020|NCT05506358|582331637|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161260021|NCT05506358|582331638|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161260022|NCT05506358|582331639|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161260023|NCT05506358|582331640|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
161260024|NCT05506358|582331636|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161260025|NCT05506358|582331637|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161260026|NCT05506358|582331638|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161260027|NCT05506358|582331639|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
161260028|NCT05506358|582331640|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
161260029|NCT05506358|582331636|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
161260030|NCT05506358|582331637|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
161260031|NCT05506358|582331638|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
161260032|NCT05506358|582331639|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
161260033|NCT05506358|582331640|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
161260034|NCT05506358|582331636|FG000|Overall Study|HbE trait|0|||
161260035|NCT05506358|582331637|FG001|Overall Study|HbE trait|0|||
161260036|NCT05506358|582331638|FG002|Overall Study|HbE trait|0|||
161260037|NCT05506358|582331639|FG003|Overall Study|HbE trait|1|||
161260038|NCT05506358|582331640|FG004|Overall Study|HbE trait|0|||
161260039|NCT01173471|582331646|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161260040|NCT01173471|582331647|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161260041|NCT01173471|582331648|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161260042|NCT01173471|582331649|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
161260043|NCT01173471|582331646|FG000|Overall Study|Condition under investigation worsened|2|||
161260044|NCT01173471|582331647|FG001|Overall Study|Condition under investigation worsened|0|||
161260045|NCT01173471|582331648|FG002|Overall Study|Condition under investigation worsened|0|||
161260046|NCT01173471|582331649|FG003|Overall Study|Condition under investigation worsened|0|||
161260047|NCT01173471|582331646|FG000|Overall Study|Lost to Follow-up|0|||
161260048|NCT01173471|582331647|FG001|Overall Study|Lost to Follow-up|0|||
161260049|NCT01173471|582331648|FG002|Overall Study|Lost to Follow-up|1|||
161260050|NCT01173471|582331649|FG003|Overall Study|Lost to Follow-up|0|||
161260051|NCT01173471|582331646|FG000|Overall Study|Reason given as Other|0|||
161260052|NCT01173471|582331647|FG001|Overall Study|Reason given as Other|0|||
161260053|NCT01173471|582331648|FG002|Overall Study|Reason given as Other|1|||
161260054|NCT01173471|582331649|FG003|Overall Study|Reason given as Other|0|||
161260055|NCT00584844|582331651|FG000|Overall Study|Withdrawal by Subject|59|||
161260056|NCT00584844|582331651|FG000|Overall Study|Screen Failure|20|||
161260057|NCT03028740|582331652|FG000|Overall Study|Did not Receive Study Drug|4|||
161260058|NCT03028740|582331653|FG001|Overall Study|Did not Receive Study Drug|5|||
161260059|NCT03028740|582331652|FG000|Overall Study|Adverse Event|8|||
161260060|NCT03028740|582331653|FG001|Overall Study|Adverse Event|26|||
161260061|NCT03028740|582331652|FG000|Overall Study|Lack of Efficacy|0|||
161260062|NCT03028740|582331653|FG001|Overall Study|Lack of Efficacy|1|||
160920606|NCT01172847|581103300|FG000|Overall Study|Withdrawal by Subject|3|||
160920607|NCT00665353|581103305|FG000|Study Step 1|Adverse Event|1|||
160920608|NCT00665353|581103305|FG000|Study Step 1|Withdrawal by Subject|2|||
161143266|NCT00923091|581907584|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
161143267|NCT00923091|581907585|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
161143268|NCT00923091|581907586|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
161143269|NCT00923091|581907574|FG000|Period IV (Double-Blind)|Adverse Event|2|||
161143270|NCT00923091|581907575|FG001|Period IV (Double-Blind)|Adverse Event|0|||
161143271|NCT00923091|581907576|FG002|Period IV (Double-Blind)|Adverse Event|0|||
161143272|NCT00923091|581907577|FG003|Period IV (Double-Blind)|Adverse Event|0|||
161143273|NCT00923091|581907578|FG004|Period IV (Double-Blind)|Adverse Event|0|||
161143274|NCT00923091|581907579|FG005|Period IV (Double-Blind)|Adverse Event|0|||
161143275|NCT00923091|581907580|FG006|Period IV (Double-Blind)|Adverse Event|0|||
161143276|NCT00923091|581907581|FG007|Period IV (Double-Blind)|Adverse Event|0|||
161143277|NCT00923091|581907582|FG008|Period IV (Double-Blind)|Adverse Event|0|||
161143278|NCT00923091|581907583|FG009|Period IV (Double-Blind)|Adverse Event|0|||
161143279|NCT00923091|581907584|FG010|Period IV (Double-Blind)|Adverse Event|0|||
161143280|NCT00923091|581907585|FG011|Period IV (Double-Blind)|Adverse Event|0|||
161143281|NCT00923091|581907586|FG012|Period IV (Double-Blind)|Adverse Event|0|||
161143282|NCT00923091|581907574|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143283|NCT00923091|581907575|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
161143284|NCT00923091|581907576|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161091124|NCT02581631|581723818|FG000|Overall Study|AE unrelated to study drug|3|||
161260063|NCT03028740|582331652|FG000|Overall Study|Withdrawal by Subject|48|||
161260064|NCT03028740|582331653|FG001|Overall Study|Withdrawal by Subject|101|||
161260065|NCT03028740|582331652|FG000|Overall Study|Lost to Follow-up|30|||
161260066|NCT03028740|582331653|FG001|Overall Study|Lost to Follow-up|54|||
161260067|NCT03028740|582331652|FG000|Overall Study|Physician Decision|4|||
161260068|NCT03028740|582331653|FG001|Overall Study|Physician Decision|11|||
161260069|NCT03028740|582331652|FG000|Overall Study|Protocol Violation|4|||
161260070|NCT03028740|582331653|FG001|Overall Study|Protocol Violation|8|||
161260071|NCT03028740|582331652|FG000|Overall Study|Non-compliance with Study Drug|0|||
161260072|NCT03028740|582331653|FG001|Overall Study|Non-compliance with Study Drug|2|||
161260073|NCT03028740|582331652|FG000|Overall Study|Study Terminated by Sponsor|467|||
161260074|NCT03028740|582331653|FG001|Overall Study|Study Terminated by Sponsor|917|||
161260075|NCT03028740|582331652|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
161260076|NCT03028740|582331653|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
161260077|NCT03028740|582331652|FG000|Overall Study|Reason not Specified|1|||
161260078|NCT03028740|582331653|FG001|Overall Study|Reason not Specified|5|||
161260079|NCT05224544|582331656|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
161260080|NCT05224544|582331657|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
161260081|NCT01341587|582331658|FG000|Overall Study|Lost to Follow-up|2|||
161260082|NCT01341587|582331659|FG001|Overall Study|Lost to Follow-up|0|||
161260083|NCT01341587|582331658|FG000|Overall Study|stopped using the meters|2|||
161260084|NCT01341587|582331659|FG001|Overall Study|stopped using the meters|10|||
161260085|NCT00645944|582331662|FG000|Randomized|Withdrawal by Subject|1|||
161260086|NCT00645944|582331663|FG001|Randomized|Withdrawal by Subject|2|||
161260087|NCT00645944|582331662|FG000|Received Medication|Adverse Event|2|||
161260088|NCT00645944|582331663|FG001|Received Medication|Adverse Event|1|||
161260089|NCT00645944|582331662|FG000|Received Medication|Withdrawal by Subject|1|||
161260090|NCT00645944|582331663|FG001|Received Medication|Withdrawal by Subject|1|||
161260091|NCT00645944|582331662|FG000|Received Medication|Lost to Follow-up|1|||
161260092|NCT00645944|582331663|FG001|Received Medication|Lost to Follow-up|0|||
161260093|NCT00645944|582331662|FG000|Received Medication|Protocol Violation|2|||
161260094|NCT00645944|582331663|FG001|Received Medication|Protocol Violation|1|||
161260095|NCT02080832|582331668|FG000|Overall Study|Excluded from analysis by MRI|9|||
161260096|NCT02080832|582331669|FG001|Overall Study|Excluded from analysis by MRI|10|||
161260097|NCT02080832|582331670|FG002|Overall Study|Excluded from analysis by MRI|14|||
161260098|NCT02080832|582331668|FG000|Overall Study|Lost to Follow-up|0|||
161260099|NCT02080832|582331669|FG001|Overall Study|Lost to Follow-up|2|||
161260100|NCT02080832|582331670|FG002|Overall Study|Lost to Follow-up|2|||
161260101|NCT00560937|582331674|FG000|Overall Study|Withdrawal by Subject|0|||
161260102|NCT00560937|582331675|FG001|Overall Study|Withdrawal by Subject|1|||
161260103|NCT00560937|582331674|FG000|Overall Study|Physician Decision|1|||
161260104|NCT00560937|582331675|FG001|Overall Study|Physician Decision|1|||
161260105|NCT03069417|582331676|FG000|Overall Study|Lost to Follow-up|2|||
161260106|NCT03069417|582331677|FG001|Overall Study|Lost to Follow-up|0|||
161260107|NCT03069417|582331676|FG000|Overall Study|Reason Unknown|4|||
161260108|NCT03069417|582331677|FG001|Overall Study|Reason Unknown|7|||
161260109|NCT01660022|582331679|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
161260110|NCT01660022|582331680|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
161260111|NCT01660022|582331681|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
161260112|NCT01660022|582331682|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
161260113|NCT01660022|582331683|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
161260114|NCT01660022|582331684|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
161260115|NCT01660022|582331679|FG000|First Sequence (7 Days)|Adverse Event|0|||
161260116|NCT01660022|582331680|FG001|First Sequence (7 Days)|Adverse Event|0|||
161260117|NCT01660022|582331681|FG002|First Sequence (7 Days)|Adverse Event|0|||
161260118|NCT01660022|582331682|FG003|First Sequence (7 Days)|Adverse Event|0|||
161260119|NCT01660022|582331683|FG004|First Sequence (7 Days)|Adverse Event|1|||
161260120|NCT01660022|582331684|FG005|First Sequence (7 Days)|Adverse Event|3|||
161260121|NCT01660022|582331679|FG000|First Sequence (7 Days)|Protocol Violation|0|||
161260122|NCT01660022|582331680|FG001|First Sequence (7 Days)|Protocol Violation|0|||
161260123|NCT01660022|582331681|FG002|First Sequence (7 Days)|Protocol Violation|0|||
161260124|NCT01660022|582331682|FG003|First Sequence (7 Days)|Protocol Violation|0|||
161260125|NCT01660022|582331683|FG004|First Sequence (7 Days)|Protocol Violation|0|||
161260126|NCT01660022|582331684|FG005|First Sequence (7 Days)|Protocol Violation|1|||
161260127|NCT03545191|582331687|FG000|Overall Study|Death|1|||
161260128|NCT03545191|582331688|FG001|Overall Study|Death|0|||
161260129|NCT03545191|582331689|FG002|Overall Study|Death|0|||
161260130|NCT03545191|582331687|FG000|Overall Study|Adverse Event|4|||
161260131|NCT03545191|582331688|FG001|Overall Study|Adverse Event|2|||
161260132|NCT03545191|582331689|FG002|Overall Study|Adverse Event|7|||
161260133|NCT03545191|582331687|FG000|Overall Study|Other reasons|3|||
161260134|NCT03545191|582331688|FG001|Overall Study|Other reasons|11|||
161260135|NCT03545191|582331689|FG002|Overall Study|Other reasons|8|||
161260136|NCT03545191|582331687|FG000|Overall Study|Withdrawal by Subject|13|||
161260137|NCT03545191|582331688|FG001|Overall Study|Withdrawal by Subject|10|||
161260138|NCT03545191|582331689|FG002|Overall Study|Withdrawal by Subject|12|||
161260139|NCT03545191|582331687|FG000|Overall Study|Lost to Follow-up|1|||
161260140|NCT03545191|582331688|FG001|Overall Study|Lost to Follow-up|2|||
161260141|NCT03545191|582331689|FG002|Overall Study|Lost to Follow-up|3|||
161260142|NCT01277718|582331692|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
161260143|NCT01277718|582331693|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
161260144|NCT01277718|582331692|FG000|Period 2 - Second Intervention|Physician Decision|0|||
161260145|NCT01277718|582331693|FG001|Period 2 - Second Intervention|Physician Decision|2|||
161260146|NCT03919162|582331696|FG000|Overall Study|Adverse Event|3|||
161260147|NCT03919162|582331697|FG001|Overall Study|Adverse Event|2|||
161260148|NCT03919162|582331696|FG000|Overall Study|Death|2|||
161260149|NCT03919162|582331697|FG001|Overall Study|Death|0|||
161260150|NCT03919162|582331696|FG000|Overall Study|Lost to Follow-up|1|||
161260151|NCT03919162|582331697|FG001|Overall Study|Lost to Follow-up|0|||
161260152|NCT03919162|582331696|FG000|Overall Study|Withdrawal by Subject|12|||
161260153|NCT03919162|582331697|FG001|Overall Study|Withdrawal by Subject|12|||
161260154|NCT03919162|582331696|FG000|Overall Study|Study terminated by Sponsor|20|||
161260155|NCT03919162|582331697|FG001|Overall Study|Study terminated by Sponsor|24|||
161260156|NCT03919162|582331696|FG000|Overall Study|Screen failure|1|||
161260157|NCT03919162|582331697|FG001|Overall Study|Screen failure|0|||
161260158|NCT03919162|582331696|FG000|Overall Study|Missing|1|||
161260159|NCT03919162|582331697|FG001|Overall Study|Missing|1|||
161260160|NCT02746627|582331699|FG000|Overall Study|Withdrawal by Subject|1|||
161260161|NCT02746627|582331700|FG001|Overall Study|Withdrawal by Subject|1|||
161260162|NCT02746627|582331701|FG002|Overall Study|Withdrawal by Subject|1|||
161260163|NCT00233987|582331706|FG000|Overall Study|Withdrawal by Subject|1|||
161260164|NCT00233987|582331706|FG000|Overall Study|Lack of Efficacy|2|||
161260165|NCT00233987|582331706|FG000|Overall Study|Reason Under Review|1|||
161260166|NCT00233987|582331706|FG000|Overall Study|Other - Not Protocol Specified|5|||
161260167|NCT00233987|582331706|FG000|Overall Study|Eligible but No Treatment Received|2|||
161260168|NCT00233987|582331706|FG000|Overall Study|Ineligible|4|||
161260169|NCT04553913|582331709|FG000|Overall Study|patient's block resolved prior to PACU|1|||
161260170|NCT04553913|582331709|FG000|Overall Study|did not use the device properly|5|||
161260171|NCT01481324|582331711|FG000|Overall Study|Missing Data|0|||
161260172|NCT01481324|582331712|FG001|Overall Study|Missing Data|2|||
161260173|NCT01481324|582331713|FG002|Overall Study|Missing Data|2|||
161260174|NCT00710749|582331715|FG000|First Intervention|Withdrawal by Subject|1|||
161260175|NCT00710749|582331716|FG001|First Intervention|Withdrawal by Subject|0|||
161260176|NCT05478252|582331717|FG000|Overall Study|Withdrawal by Subject|2|||
161260177|NCT05478252|582331718|FG001|Overall Study|Withdrawal by Subject|3|||
161260178|NCT05478252|582331717|FG000|Overall Study|Lost to Follow-up|4|||
161260179|NCT05478252|582331718|FG001|Overall Study|Lost to Follow-up|2|||
161260180|NCT05478252|582331717|FG000|Overall Study|Physician Decision|1|||
161260181|NCT05478252|582331718|FG001|Overall Study|Physician Decision|1|||
161260182|NCT05478252|582331717|FG000|Overall Study|Death|1|||
161260183|NCT05478252|582331718|FG001|Overall Study|Death|0|||
161260184|NCT04846881|582331719|FG000|Overall Study|Adverse Event|14|||
161260185|NCT04846881|582331720|FG001|Overall Study|Adverse Event|15|||
161260186|NCT04846881|582331719|FG000|Overall Study|Burden of study procedures|7|||
161260187|NCT04846881|582331720|FG001|Overall Study|Burden of study procedures|3|||
161260188|NCT04846881|582331719|FG000|Overall Study|Protocol deviation|6|||
161260189|NCT04846881|582331720|FG001|Overall Study|Protocol deviation|4|||
161260190|NCT04846881|582331719|FG000|Overall Study|Perceived lack of efficacy|5|||
161260191|NCT04846881|582331720|FG001|Overall Study|Perceived lack of efficacy|2|||
161260192|NCT04846881|582331719|FG000|Overall Study|Change of residence|2|||
161260193|NCT04846881|582331720|FG001|Overall Study|Change of residence|0|||
161260194|NCT04846881|582331719|FG000|Overall Study|Technical problems|0|||
161260195|NCT04846881|582331720|FG001|Overall Study|Technical problems|1|||
161260196|NCT04846881|582331719|FG000|Overall Study|Other than listed|3|||
161260197|NCT04846881|582331720|FG001|Overall Study|Other than listed|10|||
161260198|NCT04846881|582331719|FG000|Overall Study|No reason available|1|||
161260199|NCT04846881|582331720|FG001|Overall Study|No reason available|3|||
161260200|NCT04846881|582331719|FG000|Overall Study|Patient randomised in error|1|||
161260201|NCT04846881|582331720|FG001|Overall Study|Patient randomised in error|0|||
161260202|NCT03821272|582333716|FG000|Overall Study|Death|1|||
161260203|NCT03821272|582333717|FG001|Overall Study|Death|0|||
161260204|NCT03821272|582333716|FG000|Overall Study|Physician Decision|1|||
161260205|NCT03821272|582333717|FG001|Overall Study|Physician Decision|0|||
161260206|NCT03821272|582333716|FG000|Overall Study|Withdrawal by Subject|1|||
161260207|NCT03821272|582333717|FG001|Overall Study|Withdrawal by Subject|0|||
161260208|NCT01688466|582333719|FG000|Overall Study|Withdrawal by Subject|2|||
161260209|NCT01688466|582333720|FG001|Overall Study|Withdrawal by Subject|1|||
161260210|NCT01688466|582333719|FG000|Overall Study|Death|0|||
161340720|NCT01288430|582635524|FG008|Part 2|Other|0|||
161260211|NCT01688466|582333720|FG001|Overall Study|Death|1|||
161260212|NCT01688466|582333719|FG000|Overall Study|Adverse Event|0|||
161260213|NCT01688466|582333720|FG001|Overall Study|Adverse Event|4|||
161260214|NCT01688466|582333719|FG000|Overall Study|Not evaluable|0|||
161260215|NCT01688466|582333720|FG001|Overall Study|Not evaluable|1|||
161260216|NCT01000610|582333721|FG000|Overall Study|Adverse Event|1|||
161260217|NCT01000610|582333721|FG000|Overall Study|Lost to Follow-up|4|||
161260218|NCT01000610|582333721|FG000|Overall Study|Treatment failure|1|||
161260219|NCT01010126|582333722|FG000|Overall Study|Withdrawal by Subject|1|||
161260220|NCT01010126|582333723|FG001|Overall Study|Withdrawal by Subject|0|||
161260221|NCT01010126|582333724|FG002|Overall Study|Withdrawal by Subject|1|||
161260222|NCT01010126|582333725|FG003|Overall Study|Withdrawal by Subject|0|||
161260223|NCT01010126|582333726|FG004|Overall Study|Withdrawal by Subject|3|||
161260224|NCT01010126|582333727|FG005|Overall Study|Withdrawal by Subject|0|||
161260225|NCT04495283|582333730|FG000|Overall Study|Physician Decision|0|||
161260226|NCT04495283|582333731|FG001|Overall Study|Physician Decision|0|||
161260227|NCT04495283|582333732|FG002|Overall Study|Physician Decision|1|||
161260228|NCT04495283|582333730|FG000|Overall Study|Withdrawal by Subject|0|||
161260229|NCT04495283|582333731|FG001|Overall Study|Withdrawal by Subject|1|||
161260230|NCT04495283|582333732|FG002|Overall Study|Withdrawal by Subject|1|||
161260231|NCT04495283|582333730|FG000|Overall Study|Other|1|||
161260232|NCT04495283|582333731|FG001|Overall Study|Other|0|||
161260233|NCT04495283|582333732|FG002|Overall Study|Other|1|||
161260234|NCT03341000|582333746|FG000|Overall Study|Adverse Event|1|||
161260235|NCT04718194|582333747|FG000|Overall Study|Withdrawal by Subject|3|||
161260236|NCT04718194|582333748|FG001|Overall Study|Withdrawal by Subject|0|||
161260237|NCT04718194|582333747|FG000|Overall Study|Lost to Follow-up|3|||
161260238|NCT04718194|582333748|FG001|Overall Study|Lost to Follow-up|0|||
161260239|NCT01215513|582333749|FG000|Overall Study|Not completed CS42|9|||
161260240|NCT01215513|582333749|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
161260241|NCT01215513|582333749|FG000|Overall Study|Adverse event (CS42A)|2|||
161260242|NCT01215513|582333749|FG000|Overall Study|Physician decision (CS42A)|6|||
161260243|NCT01215513|582333749|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
161260244|NCT01215513|582333749|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
161260245|NCT03861481|582333751|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
161260246|NCT03861481|582333752|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
161260247|NCT03861481|582333751|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
161260248|NCT03861481|582333752|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
161260249|NCT03861481|582333751|FG000|Overall Study|Relapse|1|||
161260250|NCT03861481|582333752|FG001|Overall Study|Relapse|0|||
161260251|NCT03861481|582333751|FG000|Overall Study|Withdrawal by Subject|0|||
161260252|NCT03861481|582333752|FG001|Overall Study|Withdrawal by Subject|1|||
161260253|NCT03861481|582333751|FG000|Overall Study|Lack of Efficacy|4|||
161260254|NCT03861481|582333752|FG001|Overall Study|Lack of Efficacy|5|||
161260255|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
161260256|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
161260257|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
161260258|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
161260259|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
161260260|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
161260261|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
161260262|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
161260263|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
161260264|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
161260265|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
161260266|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
161260267|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
161260268|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
161260269|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
161260270|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
161260271|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160920609|NCT00665353|581103305|FG000|Study Step 2|Lost to Follow-up|2|||
160920610|NCT00665353|581103305|FG000|Study Step 2|Lack of Efficacy|12|||
160920611|NCT01851720|581103306|FG000|Overall Study|Lost to Follow-up|0|||
160920612|NCT01851720|581103307|FG001|Overall Study|Lost to Follow-up|1|||
160920613|NCT02132767|581103312|FG000|Overall Study|Death|3|||
160920614|NCT02132767|581103313|FG001|Overall Study|Death|2|||
160920615|NCT02132767|581103312|FG000|Overall Study|Withdrawal by Subject|10|||
160920616|NCT02132767|581103313|FG001|Overall Study|Withdrawal by Subject|9|||
160920617|NCT02132767|581103312|FG000|Overall Study|Lost to Follow-up|4|||
160920618|NCT02132767|581103313|FG001|Overall Study|Lost to Follow-up|4|||
160920619|NCT00390858|581103314|FG000|Overall Study|Adverse Event|6|||
161143285|NCT00923091|581907577|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161260272|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
160920620|NCT00390858|581103315|FG001|Overall Study|Adverse Event|2|||
160920621|NCT00390858|581103314|FG000|Overall Study|Lack of Efficacy|0|||
160920622|NCT00390858|581103315|FG001|Overall Study|Lack of Efficacy|1|||
160920623|NCT00390858|581103314|FG000|Overall Study|Withdrawal by Subject|3|||
160997290|NCT02962674|581374897|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
160997291|NCT03265210|581374902|FG000|Overall Study|Withdrawal by Subject|7|||
160997292|NCT03265210|581374903|FG001|Overall Study|Withdrawal by Subject|9|||
160997293|NCT03265210|581374902|FG000|Overall Study|Lost to Follow-up|2|||
160997294|NCT03265210|581374903|FG001|Overall Study|Lost to Follow-up|0|||
160997295|NCT03265210|581374902|FG000|Overall Study|Physician Decision|2|||
160997296|NCT03265210|581374903|FG001|Overall Study|Physician Decision|0|||
160997297|NCT03265210|581374902|FG000|Overall Study|Adverse Event|1|||
160997298|NCT03265210|581374903|FG001|Overall Study|Adverse Event|0|||
160997299|NCT01883492|581374904|FG000|Overall Study|Lost to Follow-up|3|||
160997300|NCT01883492|581374905|FG001|Overall Study|Lost to Follow-up|4|||
160997301|NCT01883492|581374904|FG000|Overall Study|Surgery on contra-lateral hip|0|||
160997302|NCT01883492|581374905|FG001|Overall Study|Surgery on contra-lateral hip|1|||
160997303|NCT01883492|581374904|FG000|Overall Study|Poor X-ray quality|7|||
160997304|NCT01883492|581374905|FG001|Overall Study|Poor X-ray quality|4|||
160997305|NCT01883492|581374904|FG000|Overall Study|Withdrawal by Subject|1|||
160997306|NCT01883492|581374905|FG001|Overall Study|Withdrawal by Subject|0|||
160997307|NCT01883492|581374904|FG000|Overall Study|inappropriate implant used|1|||
160997308|NCT01883492|581374905|FG001|Overall Study|inappropriate implant used|1|||
160997309|NCT01883492|581374904|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
160997310|NCT01883492|581374905|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
160997311|NCT02488980|581374911|FG000|Overall Study|Protocol Violation|2|||
160997312|NCT02488980|581374912|FG001|Overall Study|Protocol Violation|2|||
160997313|NCT02488980|581374913|FG002|Overall Study|Protocol Violation|2|||
160997314|NCT00549848|581374917|FG000|Overall Study|Death|1|||
160997315|NCT00549848|581374918|FG001|Overall Study|Death|4|||
160997316|NCT00549848|581374919|FG002|Overall Study|Death|13|||
160997317|NCT00549848|581374917|FG000|Overall Study|Physician Decision|0|||
160997318|NCT00549848|581374918|FG001|Overall Study|Physician Decision|0|||
160997319|NCT00549848|581374919|FG002|Overall Study|Physician Decision|4|||
160997320|NCT00549848|581374917|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
160997321|NCT00549848|581374918|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
160997322|NCT00549848|581374919|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
160997323|NCT00549848|581374917|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
160997324|NCT00549848|581374918|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
160997325|NCT00549848|581374919|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
160997326|NCT00549848|581374917|FG000|Overall Study|Participant/Family Withdraw|2|||
160997327|NCT00549848|581374918|FG001|Overall Study|Participant/Family Withdraw|3|||
160997328|NCT00549848|581374919|FG002|Overall Study|Participant/Family Withdraw|5|||
160997329|NCT00549848|581374917|FG000|Overall Study|Second Malignancy|1|||
160997330|NCT00549848|581374918|FG001|Overall Study|Second Malignancy|0|||
160997331|NCT00549848|581374919|FG002|Overall Study|Second Malignancy|0|||
160997332|NCT00549848|581374917|FG000|Overall Study|Transplant|3|||
160997333|NCT00549848|581374918|FG001|Overall Study|Transplant|3|||
160997334|NCT00549848|581374919|FG002|Overall Study|Transplant|18|||
160997335|NCT00549848|581374917|FG000|Overall Study|Unacceptable Toxicity|1|||
160997336|NCT00549848|581374918|FG001|Overall Study|Unacceptable Toxicity|6|||
160997337|NCT00549848|581374919|FG002|Overall Study|Unacceptable Toxicity|6|||
160997338|NCT05193318|581374920|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
160997339|NCT05193318|581374920|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
160997340|NCT03670602|581374921|FG000|Overall Study|Lost to Follow-up|1|||
160997341|NCT03670602|581374922|FG001|Overall Study|Lost to Follow-up|0|||
160997342|NCT03670602|581374921|FG000|Overall Study|Withdrawal by Subject|0|||
160997343|NCT03670602|581374922|FG001|Overall Study|Withdrawal by Subject|3|||
160997344|NCT00957658|581374923|FG000|Overall Study|Death|1|||
160997345|NCT00957658|581374923|FG000|Overall Study|Lost to Follow-up|4|||
160997346|NCT00957658|581374923|FG000|Overall Study|Withdrawal by Subject|12|||
160997347|NCT00957658|581374923|FG000|Overall Study|Revision|1|||
160997348|NCT00957658|581374923|FG000|Overall Study|Incomplete 2 yr data|28|||
160997349|NCT00957658|581374923|FG000|Overall Study|Site termination|10|||
160997350|NCT00957658|581374923|FG000|Overall Study|unwilling/unable to return|2|||
160997351|NCT00957658|581374923|FG000|Overall Study|surgery cancelled|2|||
160997352|NCT00957658|581374923|FG000|Overall Study|Protocol Violation|5|||
160997353|NCT00975806|581374924|FG000|Overall Study|Adverse Event|2|||
160997354|NCT00975806|581374925|FG001|Overall Study|Adverse Event|1|||
160997355|NCT00975806|581374926|FG002|Overall Study|Adverse Event|2|||
160997356|NCT00975806|581374924|FG000|Overall Study|Disease Progression|1|||
160997357|NCT00975806|581374925|FG001|Overall Study|Disease Progression|5|||
160997358|NCT00975806|581374926|FG002|Overall Study|Disease Progression|1|||
160997359|NCT00975806|581374924|FG000|Overall Study|Withdrawal by Subject|1|||
160997360|NCT00975806|581374925|FG001|Overall Study|Withdrawal by Subject|0|||
160997361|NCT00975806|581374926|FG002|Overall Study|Withdrawal by Subject|0|||
160997362|NCT00975806|581374924|FG000|Overall Study|Death|0|||
160997363|NCT00975806|581374925|FG001|Overall Study|Death|1|||
160997364|NCT00975806|581374926|FG002|Overall Study|Death|0|||
160997365|NCT00975806|581374924|FG000|Overall Study|Physician decision and disease related|1|||
161340721|NCT01288430|582635525|FG009|Part 2|Other|1|||
161340722|NCT04770753|582635528|FG000|Overall Study|Randomized, never treated|1|||
161340723|NCT04770753|582635529|FG001|Overall Study|Randomized, never treated|1|||
161340724|NCT04770753|582635528|FG000|Overall Study|Withdrawal by Subject|3|||
161340725|NCT04770753|582635529|FG001|Overall Study|Withdrawal by Subject|1|||
161340726|NCT04770753|582635528|FG000|Overall Study|Adverse Event|2|||
161340727|NCT04770753|582635529|FG001|Overall Study|Adverse Event|0|||
161340728|NCT04770753|582635528|FG000|Overall Study|Pregnancy|1|||
161340729|NCT04770753|582635529|FG001|Overall Study|Pregnancy|0|||
161340730|NCT04770753|582635528|FG000|Overall Study|Other un-specified|1|||
161340731|NCT04770753|582635529|FG001|Overall Study|Other un-specified|0|||
161340732|NCT00788671|582635530|FG000|Overall Study|Death|2|||
161340733|NCT00788671|582635530|FG000|Overall Study|Unable to biopsy|1|||
161340734|NCT00788671|582635530|FG000|Overall Study|Withdrawal by Subject|4|||
161340735|NCT00788671|582635530|FG000|Overall Study|IUD expulsed|1|||
160920624|NCT00390858|581103315|FG001|Overall Study|Withdrawal by Subject|4|||
160920625|NCT00937157|581103316|FG000|Overall Study|Pregnancy|1|||
161143286|NCT00923091|581907578|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143287|NCT00923091|581907579|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161260273|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
161260274|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161260275|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161260276|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161260277|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161260278|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
161260279|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
161260280|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161260281|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161260282|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
161260283|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161260284|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
161260285|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
161260286|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
161260287|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
161260288|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161260289|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161260290|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
161260291|NCT00773734|582333753|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161260292|NCT00773734|582333754|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161260293|NCT00773734|582333755|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161260294|NCT00773734|582333756|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
161260295|NCT00773734|582333757|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
161260296|NCT00773734|582333758|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
161260297|NCT00773734|582333753|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161260298|NCT00773734|582333754|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
161260299|NCT00773734|582333755|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161260300|NCT00773734|582333756|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
161260301|NCT00773734|582333757|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
161260302|NCT00773734|582333758|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
161260303|NCT00773734|582333753|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161260304|NCT00773734|582333754|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
161260305|NCT00773734|582333755|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
161260306|NCT00773734|582333756|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
161260307|NCT00773734|582333757|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161260308|NCT00773734|582333758|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
161260309|NCT00773734|582333753|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161260310|NCT00773734|582333754|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
161260311|NCT00773734|582333755|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
161260312|NCT00773734|582333756|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161260313|NCT00773734|582333757|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
161260314|NCT00773734|582333758|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
161340736|NCT00788671|582635530|FG000|Overall Study|Lost to follow up|2|||
161340737|NCT04780659|582635531|FG000|Overall Study|Adverse event, serious fatal|3|||
161340738|NCT04780659|582635532|FG001|Overall Study|Adverse event, serious fatal|0|||
161340739|NCT04780659|582635531|FG000|Overall Study|Withdrawal by Subject|3|||
161340740|NCT04780659|582635532|FG001|Overall Study|Withdrawal by Subject|0|||
161340741|NCT04780659|582635531|FG000|Overall Study|Physician Decision|1|||
161340742|NCT04780659|582635532|FG001|Overall Study|Physician Decision|0|||
161340743|NCT04780659|582635531|FG000|Overall Study|Died in original disease|2|||
160920626|NCT00937157|581103316|FG000|Overall Study|Lost to Follow-up|3|||
161340744|NCT04780659|582635532|FG001|Overall Study|Died in original disease|0|||
160920627|NCT02377466|581103319|FG000|Overall Study|Other: Randomized and not treated|0|||
161260315|NCT00773734|582333753|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161260316|NCT00773734|582333754|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
161260317|NCT00773734|582333755|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
161260318|NCT00773734|582333756|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161260319|NCT00773734|582333757|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161260320|NCT00773734|582333758|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
161260321|NCT00773734|582333753|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
161260322|NCT00773734|582333754|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
160920628|NCT02377466|581103320|FG001|Overall Study|Other: Randomized and not treated|2|||
160920629|NCT04210310|581103321|FG000|Overall Study|Lost to Follow-up|32|||
160920630|NCT04210310|581103322|FG001|Overall Study|Lost to Follow-up|1|||
160920631|NCT00495170|581103323|FG000|Overall Study|Lost to Follow-up|9|||
160920632|NCT00495170|581103323|FG000|Overall Study|Withdrawal by Subject|3|||
160920633|NCT00495170|581103323|FG000|Overall Study|Inappropriate staging|8|||
160920634|NCT01928329|581103324|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
160920635|NCT01928329|581103325|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
160920636|NCT01928329|581103324|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
160920637|NCT01928329|581103325|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
160920638|NCT01928329|581103324|FG000|Overall Study|Adverse Event|5|||
160920639|NCT01928329|581103325|FG001|Overall Study|Adverse Event|3|||
160920640|NCT01928329|581103324|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
160920641|NCT01928329|581103325|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
160920642|NCT01928329|581103324|FG000|Overall Study|Withdrawal by Subject|1|||
160920643|NCT01928329|581103325|FG001|Overall Study|Withdrawal by Subject|5|||
160920644|NCT01928329|581103324|FG000|Overall Study|Physician Decision|1|||
160920645|NCT01928329|581103325|FG001|Overall Study|Physician Decision|1|||
160920646|NCT00330616|581103326|FG000|Overall Study|Adverse Event|13|||
160920647|NCT00330616|581103326|FG000|Overall Study|Lack of Efficacy|1|||
160920648|NCT00330616|581103326|FG000|Overall Study|Lost to Follow-up|2|||
160920649|NCT00330616|581103326|FG000|Overall Study|Withdrawal by Subject|4|||
160920650|NCT00330616|581103326|FG000|Overall Study|Other|1|||
160920651|NCT02141997|581103331|FG000|Overall Study|Adverse Event|0|||
160920652|NCT02141997|581103332|FG001|Overall Study|Adverse Event|2|||
160920653|NCT02141997|581103333|FG002|Overall Study|Adverse Event|0|||
160920654|NCT02141997|581103334|FG003|Overall Study|Adverse Event|1|||
160920655|NCT02141997|581103331|FG000|Overall Study|Participant noncompliance|1|||
160920656|NCT02141997|581103332|FG001|Overall Study|Participant noncompliance|0|||
160920657|NCT02141997|581103333|FG002|Overall Study|Participant noncompliance|0|||
160920658|NCT02141997|581103334|FG003|Overall Study|Participant noncompliance|0|||
160920659|NCT02141997|581103331|FG000|Overall Study|Withdrew consent|1|||
160920660|NCT02141997|581103332|FG001|Overall Study|Withdrew consent|0|||
160920661|NCT02141997|581103333|FG002|Overall Study|Withdrew consent|3|||
160920662|NCT02141997|581103334|FG003|Overall Study|Withdrew consent|0|||
160920663|NCT02141997|581103331|FG000|Overall Study|Other|1|||
160920664|NCT02141997|581103332|FG001|Overall Study|Other|4|||
160920665|NCT02141997|581103333|FG002|Overall Study|Other|0|||
160920666|NCT02141997|581103334|FG003|Overall Study|Other|0|||
160920667|NCT00732615|581103342|FG000|Overall Study|Withdrawal by Subject|3|||
160920668|NCT00732615|581103343|FG001|Overall Study|Withdrawal by Subject|1|||
160920669|NCT00732615|581103342|FG000|Overall Study|Lost to Follow-up|0|||
160920670|NCT00732615|581103343|FG001|Overall Study|Lost to Follow-up|1|||
160920671|NCT00732615|581103342|FG000|Overall Study|Adverse Event|0|||
160920672|NCT00732615|581103343|FG001|Overall Study|Adverse Event|2|||
160920673|NCT00732615|581103342|FG000|Overall Study|Physician Decision|3|||
160920674|NCT00732615|581103343|FG001|Overall Study|Physician Decision|0|||
160920675|NCT00732615|581103342|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
160920676|NCT00732615|581103343|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
160920677|NCT00597766|581103344|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
161260323|NCT00773734|582333755|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161260324|NCT00773734|582333756|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161340745|NCT04780659|582635531|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
160920678|NCT00597766|581103345|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
160920679|NCT00597766|581103346|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
160920680|NCT00597766|581103344|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
160920681|NCT00597766|581103345|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
160920682|NCT00597766|581103346|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
160920683|NCT01333059|581103347|FG000|Overall Study|Physician Decision|3|||
160920684|NCT01333059|581103348|FG001|Overall Study|Physician Decision|3|||
160920685|NCT01333059|581103347|FG000|Overall Study|Protocol Violation|3|||
160920686|NCT01333059|581103348|FG001|Overall Study|Protocol Violation|0|||
160920687|NCT00737282|581103349|FG000|Overall Study|Study prematurely terminated|175|||
160920688|NCT02763189|581103350|FG000|Overall Study|Device failure|0|||
160920689|NCT02763189|581103351|FG001|Overall Study|Device failure|2|||
161340746|NCT04780659|582635532|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
161340747|NCT03729362|582635533|FG000|Overall Study|Withdrawal by Subject|2|||
161340748|NCT03729362|582635534|FG001|Overall Study|Withdrawal by Subject|0|||
161340749|NCT03729362|582635533|FG000|Overall Study|Physician Decision|1|||
160997366|NCT00975806|581374925|FG001|Overall Study|Physician decision and disease related|0|||
160997367|NCT00975806|581374926|FG002|Overall Study|Physician decision and disease related|1|||
161260325|NCT00773734|582333757|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
161260326|NCT00773734|582333758|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
161260327|NCT00773734|582333753|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
161260328|NCT00773734|582333754|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
161260329|NCT00773734|582333755|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
161260330|NCT00773734|582333756|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
161260331|NCT00773734|582333757|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
161260332|NCT00773734|582333758|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
161260333|NCT00773734|582333753|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161260334|NCT00773734|582333754|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161260335|NCT00773734|582333755|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161260336|NCT00773734|582333756|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
161260337|NCT00773734|582333757|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
161260338|NCT00773734|582333758|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
161260339|NCT00773734|582333753|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
161260340|NCT00773734|582333754|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
161260341|NCT00773734|582333755|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
161260342|NCT00773734|582333756|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
161260343|NCT00773734|582333757|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
161260344|NCT00773734|582333758|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
161260345|NCT00773734|582333753|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
161260346|NCT00773734|582333754|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
161260347|NCT00773734|582333755|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
161260348|NCT00773734|582333756|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
161260349|NCT00773734|582333757|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
161260350|NCT00773734|582333758|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
161260351|NCT00773734|582333753|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
161260352|NCT00773734|582333754|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
161260353|NCT00773734|582333755|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
161260354|NCT00773734|582333756|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
161260355|NCT00773734|582333757|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
161260356|NCT00773734|582333758|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
161260357|NCT00773734|582333753|FG000|Extension: Active Treatment Week 24-52|Other|0|||
161260358|NCT00773734|582333754|FG001|Extension: Active Treatment Week 24-52|Other|0|||
161260359|NCT00773734|582333755|FG002|Extension: Active Treatment Week 24-52|Other|1|||
161260360|NCT00773734|582333756|FG003|Extension: Active Treatment Week 24-52|Other|2|||
161260361|NCT00773734|582333757|FG004|Extension: Active Treatment Week 24-52|Other|0|||
161260362|NCT00773734|582333758|FG005|Extension: Active Treatment Week 24-52|Other|1|||
161260363|NCT00773734|582333753|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161260364|NCT00773734|582333754|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161260365|NCT00773734|582333755|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161260366|NCT00773734|582333756|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
161260367|NCT00773734|582333757|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161260368|NCT00773734|582333758|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
161260369|NCT00773734|582333753|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161260370|NCT00773734|582333754|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161260371|NCT00773734|582333755|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
161260372|NCT00773734|582333756|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
161260373|NCT00773734|582333757|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161260374|NCT00773734|582333758|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
161260375|NCT00773734|582333753|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161260376|NCT00773734|582333754|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161260377|NCT00773734|582333755|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
161260378|NCT00773734|582333756|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
161260379|NCT00773734|582333757|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161260380|NCT00773734|582333758|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
161260381|NCT00773734|582333753|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161260382|NCT00773734|582333754|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161260383|NCT00773734|582333755|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
161340750|NCT03729362|582635534|FG001|Overall Study|Physician Decision|0|||
161340751|NCT03729362|582635533|FG000|Overall Study|COVID-19 Pandemic|1|||
161340752|NCT03729362|582635534|FG001|Overall Study|COVID-19 Pandemic|0|||
160997368|NCT02750709|581374927|FG000|Treatment Period 1|Adverse Event|0|||
160997369|NCT02750709|581374928|FG001|Treatment Period 1|Adverse Event|0|||
160997370|NCT02750709|581374929|FG002|Treatment Period 1|Adverse Event|0|||
160997371|NCT02750709|581374930|FG003|Treatment Period 1|Adverse Event|0|||
160997372|NCT02750709|581374931|FG004|Treatment Period 1|Adverse Event|0|||
160997373|NCT02750709|581374932|FG005|Treatment Period 1|Adverse Event|1|||
160997374|NCT01120275|581374935|FG000|Overall Study|Adverse Event|3|||
160997375|NCT01120275|581374935|FG000|Overall Study|Progression|27|||
160997376|NCT01120275|581374935|FG000|Overall Study|Ineligible|3|||
160997377|NCT01120275|581374935|FG000|Overall Study|Withdrawal by Subject|1|||
160997378|NCT01120275|581374935|FG000|Overall Study|Refusal|1|||
160997379|NCT01120275|581374935|FG000|Overall Study|Not specific|1|||
160997380|NCT00771849|581374936|FG000|Overall Study|Lost to Follow-up|1|||
160997381|NCT00771849|581374937|FG001|Overall Study|Lost to Follow-up|2|||
160997382|NCT00771849|581374936|FG000|Overall Study|Withdrawal by Subject|1|||
160997383|NCT00771849|581374937|FG001|Overall Study|Withdrawal by Subject|1|||
160997384|NCT00771849|581374936|FG000|Overall Study|Not vaccinated|0|||
161260384|NCT00773734|582333756|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
161340753|NCT03729362|582635533|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
161340754|NCT03729362|582635534|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
161340755|NCT03729362|582635533|FG000|Overall Study|Adverse Event|0|||
161340756|NCT03729362|582635534|FG001|Overall Study|Adverse Event|1|||
161340757|NCT03729362|582635533|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
161340758|NCT03729362|582635534|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
161340759|NCT03405870|582635535|FG000|Overall Study|Withdrawal|1|||
161340760|NCT03405870|582635536|FG001|Overall Study|Withdrawal|0|||
161340761|NCT03405870|582635537|FG002|Overall Study|Withdrawal|1|||
161340762|NCT03405870|582635538|FG003|Overall Study|Withdrawal|0|||
161340763|NCT03405870|582635539|FG004|Overall Study|Withdrawal|0|||
161340764|NCT03405870|582635540|FG005|Overall Study|Withdrawal|0|||
161340765|NCT03405870|582635541|FG006|Overall Study|Withdrawal|1|||
161340766|NCT03405870|582635542|FG007|Overall Study|Withdrawal|0|||
161340767|NCT02807259|582635545|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
161340768|NCT02807259|582635546|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
161340769|NCT02807259|582635545|FG000|Midline (3 Months)|migration, refusal, not available|30|||
161340770|NCT02807259|582635546|FG001|Midline (3 Months)|migration, refusal, not available|34|||
161340771|NCT02807259|582635545|FG000|Endline (3 Months)|migration, refusal, not available|35|||
161340772|NCT02807259|582635546|FG001|Endline (3 Months)|migration, refusal, not available|87|||
161340773|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
161340774|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
161340775|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
161340776|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
161340777|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
161340778|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
161340779|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
161260385|NCT00773734|582333757|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161260386|NCT00773734|582333758|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
161260387|NCT00856830|582333762|FG000|Irinotecan & Bendamustine|Death|0|||
161260388|NCT00856830|582333763|FG001|Irinotecan & Bendamustine|Death|0|||
161260389|NCT00856830|582333764|FG002|Irinotecan & Bendamustine|Death|0|||
161260390|NCT00856830|582333765|FG003|Irinotecan & Bendamustine|Death|2|||
161260391|NCT00856830|582333762|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
161260392|NCT00856830|582333763|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
161260393|NCT00856830|582333764|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
161260394|NCT00856830|582333765|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
161260395|NCT03768726|582333766|FG000|Treatment Phase|Adverse Event|2|||
161260396|NCT03768726|582333767|FG001|Treatment Phase|Adverse Event|2|||
161260397|NCT03768726|582333766|FG000|Treatment Phase|Lost to Follow-up|1|||
161260398|NCT03768726|582333767|FG001|Treatment Phase|Lost to Follow-up|0|||
161260399|NCT03768726|582333766|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
161260400|NCT03768726|582333767|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
161260401|NCT03768726|582333766|FG000|Treatment Phase|Withdrawal by Subject|3|||
161260402|NCT03768726|582333767|FG001|Treatment Phase|Withdrawal by Subject|1|||
161260403|NCT03768726|582333766|FG000|Follow-Up|Adverse Event|2|||
161260404|NCT03768726|582333767|FG001|Follow-Up|Adverse Event|2|||
161260405|NCT03768726|582333766|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
161340780|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
161340781|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
161340782|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
161340783|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
161260406|NCT03768726|582333767|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
161340784|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
160997385|NCT00771849|581374937|FG001|Overall Study|Not vaccinated|1|||
160997386|NCT01156116|581374938|FG000|Overall Study|Withdrawal by Subject|3|||
161260407|NCT03768726|582333766|FG000|Follow-Up|Withdrawal by Subject|2|||
161340785|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
161260408|NCT03768726|582333767|FG001|Follow-Up|Withdrawal by Subject|0|||
161260409|NCT03768726|582333766|FG000|Follow-Up|Other|1|||
161260410|NCT03768726|582333767|FG001|Follow-Up|Other|0|||
161260411|NCT01744093|582333769|FG000|Overall Study|Withdrawal by Subject|6|||
161260412|NCT01744093|582333770|FG001|Overall Study|Withdrawal by Subject|1|||
161260413|NCT02006628|582333771|FG000|Overall Study|Adverse Event|1|||
161260414|NCT02006628|582333772|FG001|Overall Study|Adverse Event|1|||
161260415|NCT02006628|582333771|FG000|Overall Study|Withdrawal by Subject|2|||
161260416|NCT02006628|582333772|FG001|Overall Study|Withdrawal by Subject|1|||
161260417|NCT03578237|582333775|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
161260418|NCT03578237|582333776|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
161260419|NCT02370914|582333782|FG000|Overall Study|Protocol Violation|2|||
161260420|NCT00252174|582333783|FG000|Overall Study|Withdrawal by Subject|0|||
161260421|NCT00252174|582333784|FG001|Overall Study|Withdrawal by Subject|1|||
161260422|NCT00252174|582333785|FG002|Overall Study|Withdrawal by Subject|0|||
161260423|NCT01138826|582333786|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161260424|NCT01138826|582333787|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161260425|NCT01138826|582333788|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161260426|NCT01138826|582333789|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161260427|NCT01138826|582333790|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
161260428|NCT01138826|582333791|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
161260429|NCT02566993|582333792|FG000|Overall Study|Randomized but not treated|5|||
161260430|NCT02566993|582333793|FG001|Overall Study|Randomized but not treated|16|||
161260431|NCT02566993|582333792|FG000|Overall Study|Progressive disease|213|||
161260432|NCT02566993|582333793|FG001|Overall Study|Progressive disease|152|||
161260433|NCT02566993|582333792|FG000|Overall Study|Withdrawal by Subject|12|||
161260434|NCT02566993|582333793|FG001|Overall Study|Withdrawal by Subject|28|||
161260435|NCT02566993|582333792|FG000|Overall Study|Death|17|||
161260436|NCT02566993|582333793|FG001|Overall Study|Death|23|||
161260437|NCT02566993|582333792|FG000|Overall Study|Physician Decision|10|||
161260438|NCT02566993|582333793|FG001|Overall Study|Physician Decision|17|||
161260439|NCT02566993|582333792|FG000|Overall Study|Study drug-related adverse event|20|||
161260440|NCT02566993|582333793|FG001|Overall Study|Study drug-related adverse event|41|||
161260441|NCT02566993|582333792|FG000|Overall Study|Non study drug-related adverse event|9|||
161260442|NCT02566993|582333793|FG001|Overall Study|Non study drug-related adverse event|9|||
161260443|NCT02566993|582333792|FG000|Overall Study|Symptomatic deterioration|9|||
161260444|NCT02566993|582333793|FG001|Overall Study|Symptomatic deterioration|16|||
161260445|NCT02566993|582333792|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
161260446|NCT02566993|582333793|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
161260447|NCT02566993|582333792|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
161260448|NCT02566993|582333793|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
161260449|NCT02566993|582333792|FG000|Overall Study|Screening failure|2|||
161260450|NCT02566993|582333793|FG001|Overall Study|Screening failure|0|||
161260451|NCT02566993|582333792|FG000|Overall Study|Lost to Follow-up|0|||
161260452|NCT02566993|582333793|FG001|Overall Study|Lost to Follow-up|1|||
161260453|NCT02566993|582333792|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
161260454|NCT02566993|582333793|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
161340786|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
160920690|NCT02049957|581103356|FG000|Overall Study|Progressive Disease|5|||
160920691|NCT02049957|581103357|FG001|Overall Study|Progressive Disease|4|||
160920692|NCT02049957|581103358|FG002|Overall Study|Progressive Disease|2|||
160920693|NCT02049957|581103359|FG003|Overall Study|Progressive Disease|2|||
160920694|NCT02049957|581103360|FG004|Overall Study|Progressive Disease|6|||
160920695|NCT02049957|581103361|FG005|Overall Study|Progressive Disease|35|||
160920696|NCT02049957|581103362|FG006|Overall Study|Progressive Disease|7|||
160920697|NCT02049957|581103363|FG007|Overall Study|Progressive Disease|26|||
160920698|NCT02049957|581103364|FG008|Overall Study|Progressive Disease|6|||
160920699|NCT02049957|581103356|FG000|Overall Study|Adverse Event|1|||
160920700|NCT02049957|581103357|FG001|Overall Study|Adverse Event|1|||
160920701|NCT02049957|581103358|FG002|Overall Study|Adverse Event|1|||
160920702|NCT02049957|581103359|FG003|Overall Study|Adverse Event|0|||
160920703|NCT02049957|581103360|FG004|Overall Study|Adverse Event|0|||
160920704|NCT02049957|581103361|FG005|Overall Study|Adverse Event|5|||
160920705|NCT02049957|581103362|FG006|Overall Study|Adverse Event|0|||
160920706|NCT02049957|581103363|FG007|Overall Study|Adverse Event|6|||
161260455|NCT05206448|582333794|FG000|Overall Study|Lost to Follow-up|2|||
161260456|NCT05206448|582333795|FG001|Overall Study|Lost to Follow-up|2|||
161340787|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
160920707|NCT02049957|581103364|FG008|Overall Study|Adverse Event|1|||
160920708|NCT02049957|581103356|FG000|Overall Study|Study Terminated by Sponsor|0|||
160920709|NCT02049957|581103357|FG001|Overall Study|Study Terminated by Sponsor|1|||
160997387|NCT01156116|581374939|FG001|Overall Study|Withdrawal by Subject|1|||
160997388|NCT01156116|581374938|FG000|Overall Study|CPAP intolerance|2|||
160997389|NCT01156116|581374939|FG001|Overall Study|CPAP intolerance|0|||
160997390|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
160997391|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
160997392|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
160997393|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
160997394|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
161143288|NCT00923091|581907580|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143289|NCT00923091|581907581|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143290|NCT00923091|581907582|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143291|NCT00923091|581907583|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161260457|NCT05206448|582333794|FG000|Overall Study|Withdrawal by Subject|2|||
161260458|NCT05206448|582333795|FG001|Overall Study|Withdrawal by Subject|0|||
161260459|NCT05206448|582333794|FG000|Overall Study|found ineligible after randomization|1|||
161260460|NCT05206448|582333795|FG001|Overall Study|found ineligible after randomization|1|||
161260461|NCT05206448|582333794|FG000|Overall Study|unable to complete study due to personal constraints|1|||
161260462|NCT05206448|582333795|FG001|Overall Study|unable to complete study due to personal constraints|0|||
161260463|NCT05206448|582333794|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
161260464|NCT05206448|582333795|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
161260465|NCT04572243|582333798|FG000|Core Study: 14 Weeks|Adverse Event|1|||
161260466|NCT04572243|582333799|FG001|Core Study: 14 Weeks|Adverse Event|2|||
161260467|NCT04572243|582333800|FG002|Core Study: 14 Weeks|Adverse Event|0|||
161260468|NCT04572243|582333801|FG003|Core Study: 14 Weeks|Adverse Event|0|||
161260469|NCT04572243|582333798|FG000|Core Study: 14 Weeks|Subject choice|0|||
161260470|NCT04572243|582333799|FG001|Core Study: 14 Weeks|Subject choice|2|||
161260471|NCT04572243|582333800|FG002|Core Study: 14 Weeks|Subject choice|0|||
161260472|NCT04572243|582333801|FG003|Core Study: 14 Weeks|Subject choice|0|||
161260473|NCT04572243|582333798|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
161260474|NCT04572243|582333799|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
161260475|NCT04572243|582333800|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
161260476|NCT04572243|582333801|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
161260477|NCT04572243|582333798|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
161260478|NCT04572243|582333799|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
161260479|NCT04572243|582333800|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
161260480|NCT04572243|582333801|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
161260481|NCT01661881|582333802|FG000|Overall Study|Disease Progression|1|||
161260482|NCT01790113|582333803|FG000|Overall Study|Adverse Event|2|||
161260483|NCT01790113|582333804|FG001|Overall Study|Adverse Event|7|||
161260484|NCT01790113|582333803|FG000|Overall Study|Study ended due to FDA clearance|1|||
161260485|NCT01790113|582333804|FG001|Overall Study|Study ended due to FDA clearance|68|||
161260486|NCT03451006|582333805|FG000|Overall Study|Withdrawal by Subject|2|||
161260487|NCT03451006|582333806|FG001|Overall Study|Withdrawal by Subject|2|||
161260488|NCT00775606|582333807|FG000|Overall Study|Study sponsor terminated funding|3|||
161260489|NCT00775606|582333808|FG001|Overall Study|Study sponsor terminated funding|0|||
161260490|NCT02278718|582333809|FG000|Overall Study|Adverse Event|1|||
161260491|NCT02278718|582333810|FG001|Overall Study|Adverse Event|0|||
161260492|NCT02278718|582333809|FG000|Overall Study|Lost to Follow-up|2|||
161260493|NCT02278718|582333810|FG001|Overall Study|Lost to Follow-up|4|||
161260494|NCT02278718|582333809|FG000|Overall Study|Withdrawal by Subject|1|||
161260495|NCT02278718|582333810|FG001|Overall Study|Withdrawal by Subject|4|||
161260496|NCT02278718|582333809|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
161260497|NCT02278718|582333810|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
161260498|NCT02278718|582333809|FG000|Overall Study|Missing|0|||
161260499|NCT02278718|582333810|FG001|Overall Study|Missing|1|||
161260500|NCT04440449|582333811|FG000|Overall Study|Lost to Follow-up|2|||
161260501|NCT04440449|582333812|FG001|Overall Study|Lost to Follow-up|0|||
161260502|NCT02547766|582333813|FG000|Overall Study|Withdrawal by Subject|1|||
161260503|NCT03212794|582333814|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
161260504|NCT03212794|582333815|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
161260505|NCT03212794|582333814|FG000|Overall Study|Lost to Follow-up|5|||
161260506|NCT03212794|582333815|FG001|Overall Study|Lost to Follow-up|6|||
161260507|NCT03212794|582333814|FG000|Overall Study|Incarcerated; unable to participate|2|||
161260508|NCT03212794|582333815|FG001|Overall Study|Incarcerated; unable to participate|0|||
161260509|NCT03212794|582333814|FG000|Overall Study|Withdrawal by Subject|1|||
161260510|NCT03212794|582333815|FG001|Overall Study|Withdrawal by Subject|0|||
161260511|NCT03212794|582333814|FG000|Overall Study|Death|0|||
161260512|NCT03212794|582333815|FG001|Overall Study|Death|1|||
161260513|NCT03212794|582333814|FG000|Overall Study|Found to be ineligible after allocation|0|||
161260514|NCT03212794|582333815|FG001|Overall Study|Found to be ineligible after allocation|1|||
161260515|NCT03212794|582333814|FG000|Overall Study|Relocated out of area|2|||
161260516|NCT03212794|582333815|FG001|Overall Study|Relocated out of area|0|||
161260517|NCT01763918|582333818|FG000|Overall Study|Withdrawal by Subject|2|||
161260518|NCT01763918|582333819|FG001|Overall Study|Withdrawal by Subject|1|||
161260519|NCT01763918|582333820|FG002|Overall Study|Withdrawal by Subject|1|||
161260520|NCT01763918|582333821|FG003|Overall Study|Withdrawal by Subject|2|||
161260521|NCT01763918|582333818|FG000|Overall Study|Sponsor Decision|4|||
161260522|NCT01763918|582333819|FG001|Overall Study|Sponsor Decision|0|||
161260523|NCT01763918|582333820|FG002|Overall Study|Sponsor Decision|9|||
161260524|NCT01763918|582333821|FG003|Overall Study|Sponsor Decision|0|||
161260525|NCT00897949|582333822|FG000|Overall Study|Adverse Event|1|||
161260526|NCT00897949|582333823|FG001|Overall Study|Adverse Event|1|||
161260527|NCT00897949|582333824|FG002|Overall Study|Adverse Event|0|||
161260528|NCT00897949|582333822|FG000|Overall Study|Lost to Follow-up|0|||
161260529|NCT00897949|582333823|FG001|Overall Study|Lost to Follow-up|2|||
161260530|NCT00897949|582333824|FG002|Overall Study|Lost to Follow-up|1|||
161260531|NCT00897949|582333822|FG000|Overall Study|Protocol Violation|6|||
161260532|NCT00897949|582333823|FG001|Overall Study|Protocol Violation|3|||
161260533|NCT00897949|582333824|FG002|Overall Study|Protocol Violation|1|||
161260534|NCT00897949|582333822|FG000|Overall Study|Withdrawal by Subject|1|||
161260535|NCT00897949|582333823|FG001|Overall Study|Withdrawal by Subject|2|||
161260536|NCT00897949|582333824|FG002|Overall Study|Withdrawal by Subject|0|||
161260537|NCT00897949|582333822|FG000|Overall Study|Patient Uncoorperative|0|||
161260538|NCT00897949|582333823|FG001|Overall Study|Patient Uncoorperative|2|||
161260539|NCT00897949|582333824|FG002|Overall Study|Patient Uncoorperative|1|||
161260540|NCT00897949|582333822|FG000|Overall Study|Lost to Follow-up|30|||
161260541|NCT00897949|582333823|FG001|Overall Study|Lost to Follow-up|23|||
161260542|NCT00897949|582333824|FG002|Overall Study|Lost to Follow-up|17|||
160920710|NCT02049957|581103358|FG002|Overall Study|Study Terminated by Sponsor|0|||
160920711|NCT02049957|581103359|FG003|Overall Study|Study Terminated by Sponsor|0|||
160920712|NCT02049957|581103360|FG004|Overall Study|Study Terminated by Sponsor|0|||
160920713|NCT02049957|581103361|FG005|Overall Study|Study Terminated by Sponsor|0|||
160920714|NCT02049957|581103362|FG006|Overall Study|Study Terminated by Sponsor|1|||
160920715|NCT02049957|581103363|FG007|Overall Study|Study Terminated by Sponsor|0|||
160920716|NCT02049957|581103364|FG008|Overall Study|Study Terminated by Sponsor|0|||
160920717|NCT02049957|581103356|FG000|Overall Study|Withdrawal by Subject|0|||
160920718|NCT02049957|581103357|FG001|Overall Study|Withdrawal by Subject|0|||
160920719|NCT02049957|581103358|FG002|Overall Study|Withdrawal by Subject|0|||
160920720|NCT02049957|581103359|FG003|Overall Study|Withdrawal by Subject|1|||
160920721|NCT02049957|581103360|FG004|Overall Study|Withdrawal by Subject|0|||
160920722|NCT02049957|581103361|FG005|Overall Study|Withdrawal by Subject|2|||
160920723|NCT02049957|581103362|FG006|Overall Study|Withdrawal by Subject|0|||
160920724|NCT02049957|581103363|FG007|Overall Study|Withdrawal by Subject|3|||
160920725|NCT02049957|581103364|FG008|Overall Study|Withdrawal by Subject|1|||
160920726|NCT02049957|581103356|FG000|Overall Study|Physician Decision|0|||
160920727|NCT02049957|581103357|FG001|Overall Study|Physician Decision|0|||
160920728|NCT02049957|581103358|FG002|Overall Study|Physician Decision|0|||
160920729|NCT02049957|581103359|FG003|Overall Study|Physician Decision|0|||
160920730|NCT02049957|581103360|FG004|Overall Study|Physician Decision|0|||
160920731|NCT02049957|581103361|FG005|Overall Study|Physician Decision|1|||
160920732|NCT02049957|581103362|FG006|Overall Study|Physician Decision|0|||
160920733|NCT02049957|581103363|FG007|Overall Study|Physician Decision|0|||
160920734|NCT02049957|581103364|FG008|Overall Study|Physician Decision|0|||
160920735|NCT00840294|581103365|FG000|Overall Study|Withdrawal by Subject|2|||
160920736|NCT00840294|581103366|FG001|Overall Study|Withdrawal by Subject|1|||
160920737|NCT00840294|581103365|FG000|Overall Study|Protocol Violation|1|||
160920738|NCT00840294|581103366|FG001|Overall Study|Protocol Violation|3|||
160920739|NCT00840294|581103365|FG000|Overall Study|Illness|0|||
160920740|NCT00840294|581103366|FG001|Overall Study|Illness|1|||
160920741|NCT00383149|581103368|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
160920742|NCT00383149|581103368|FG000|Overall Study|Death|2|||
160920743|NCT00383149|581103368|FG000|Overall Study|Disease Progression|38|||
160920744|NCT00383149|581103368|FG000|Overall Study|Lost to Follow-up|1|||
160920745|NCT00383149|581103368|FG000|Overall Study|Other|1|||
161260543|NCT00897949|582333822|FG000|Overall Study|Withdrawal by Subject|24|||
161260544|NCT00897949|582333823|FG001|Overall Study|Withdrawal by Subject|31|||
161260545|NCT00897949|582333824|FG002|Overall Study|Withdrawal by Subject|17|||
160920746|NCT00383149|581103368|FG000|Overall Study|Study Drug Toxicity|4|||
161260546|NCT00897949|582333822|FG000|Overall Study|Abnormal Prestudy Labs|2|||
161260547|NCT00897949|582333823|FG001|Overall Study|Abnormal Prestudy Labs|3|||
161260548|NCT00897949|582333824|FG002|Overall Study|Abnormal Prestudy Labs|4|||
161260549|NCT00897949|582333822|FG000|Overall Study|Abnormal Baseline ECG|2|||
160920747|NCT00383149|581103368|FG000|Overall Study|Request to Discontinue Treatment|4|||
160920748|NCT00383149|581103368|FG000|Overall Study|Participant Withdrew Consent|1|||
160920749|NCT02028065|581103369|FG000|Randomization Through Start Treatment|Not treated|1|||
160920750|NCT02028065|581103370|FG001|Randomization Through Start Treatment|Not treated|3|||
161260550|NCT00897949|582333823|FG001|Overall Study|Abnormal Baseline ECG|2|||
160997395|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
160997396|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
160997397|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
160997398|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
160997399|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
160997400|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
160997401|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
160997402|NCT02057718|581374940|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
160997403|NCT02057718|581374941|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
160997404|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
160997405|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
160997406|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
160997407|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
160997408|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
160997409|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
160997410|NCT02057718|581374940|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
160997411|NCT02057718|581374941|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
160997412|NCT00906035|581374946|FG000|Overall Study|Withdrawal by Subject|2|||
160997413|NCT00906035|581374947|FG001|Overall Study|Withdrawal by Subject|3|||
160997414|NCT00906035|581374948|FG002|Overall Study|Withdrawal by Subject|0|||
160997415|NCT01972152|581374949|FG000|First Treatment Visit|Lost to Follow-up|0|||
160997416|NCT01972152|581374950|FG001|First Treatment Visit|Lost to Follow-up|1|||
160997417|NCT01972152|581374951|FG002|First Treatment Visit|Lost to Follow-up|0|||
160997418|NCT01972152|581374952|FG003|First Treatment Visit|Lost to Follow-up|0|||
160997419|NCT01972152|581374953|FG004|First Treatment Visit|Lost to Follow-up|0|||
160997420|NCT01972152|581374954|FG005|First Treatment Visit|Lost to Follow-up|0|||
160997421|NCT01972152|581374949|FG000|Second Treatment Visit|Protocol Violation|0|||
160997422|NCT01972152|581374950|FG001|Second Treatment Visit|Protocol Violation|1|||
160997423|NCT01972152|581374951|FG002|Second Treatment Visit|Protocol Violation|0|||
160997424|NCT01972152|581374952|FG003|Second Treatment Visit|Protocol Violation|0|||
160997425|NCT01972152|581374953|FG004|Second Treatment Visit|Protocol Violation|0|||
160997426|NCT01972152|581374954|FG005|Second Treatment Visit|Protocol Violation|0|||
160997427|NCT00383188|581374955|FG000|Overall Study|Adverse Event|4|||
160997428|NCT00383188|581374956|FG001|Overall Study|Adverse Event|7|||
160997429|NCT00383188|581374957|FG002|Overall Study|Adverse Event|9|||
160997430|NCT00383188|581374958|FG003|Overall Study|Adverse Event|8|||
160997431|NCT00383188|581374959|FG004|Overall Study|Adverse Event|8|||
160997432|NCT00383188|581374955|FG000|Overall Study|Lack of Efficacy|9|||
160997433|NCT00383188|581374956|FG001|Overall Study|Lack of Efficacy|3|||
160997434|NCT00383188|581374957|FG002|Overall Study|Lack of Efficacy|3|||
160997435|NCT00383188|581374958|FG003|Overall Study|Lack of Efficacy|2|||
160997436|NCT00383188|581374959|FG004|Overall Study|Lack of Efficacy|6|||
160997437|NCT00383188|581374955|FG000|Overall Study|Other|3|||
160997438|NCT00383188|581374956|FG001|Overall Study|Other|1|||
160997439|NCT00383188|581374957|FG002|Overall Study|Other|0|||
160997440|NCT00383188|581374958|FG003|Overall Study|Other|2|||
161260551|NCT00897949|582333824|FG002|Overall Study|Abnormal Baseline ECG|4|||
161260552|NCT00897949|582333822|FG000|Overall Study|Need for Concom. Med.|0|||
161260553|NCT00897949|582333823|FG001|Overall Study|Need for Concom. Med.|1|||
161260554|NCT00897949|582333824|FG002|Overall Study|Need for Concom. Med.|1|||
161260555|NCT00897949|582333822|FG000|Overall Study|Lack of Migraine Attack|29|||
161260556|NCT00897949|582333823|FG001|Overall Study|Lack of Migraine Attack|30|||
161260557|NCT00897949|582333824|FG002|Overall Study|Lack of Migraine Attack|19|||
161260558|NCT00897949|582333822|FG000|Overall Study|Did not take study drug|9|||
161260559|NCT00897949|582333823|FG001|Overall Study|Did not take study drug|3|||
161260560|NCT00897949|582333824|FG002|Overall Study|Did not take study drug|4|||
161340788|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
161340789|NCT00849056|582635547|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161340790|NCT00849056|582635548|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
161340791|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
160997441|NCT00383188|581374959|FG004|Overall Study|Other|6|||
160997442|NCT00383188|581374955|FG000|Overall Study|No longer willing to participate|1|||
160997443|NCT00383188|581374956|FG001|Overall Study|No longer willing to participate|0|||
160997444|NCT00383188|581374957|FG002|Overall Study|No longer willing to participate|1|||
160997445|NCT00383188|581374958|FG003|Overall Study|No longer willing to participate|0|||
160997446|NCT00383188|581374959|FG004|Overall Study|No longer willing to participate|2|||
160997447|NCT00383188|581374955|FG000|Overall Study|Lost to Follow-up|0|||
160997448|NCT00383188|581374956|FG001|Overall Study|Lost to Follow-up|0|||
160997449|NCT00383188|581374957|FG002|Overall Study|Lost to Follow-up|0|||
160997450|NCT00383188|581374958|FG003|Overall Study|Lost to Follow-up|0|||
160997451|NCT00383188|581374959|FG004|Overall Study|Lost to Follow-up|1|||
161260561|NCT01553747|582333825|FG000|Overall Study|Protocol Violation|0|||
161260562|NCT01553747|582333826|FG001|Overall Study|Protocol Violation|2|||
161260563|NCT01553747|582333827|FG002|Overall Study|Protocol Violation|0|||
161260564|NCT01553747|582333825|FG000|Overall Study|Voluntarily withdrew|70|||
161260565|NCT01553747|582333826|FG001|Overall Study|Voluntarily withdrew|66|||
161260566|NCT01553747|582333827|FG002|Overall Study|Voluntarily withdrew|74|||
161260567|NCT01553747|582333825|FG000|Overall Study|Adverse event or SAE|32|||
161260568|NCT01553747|582333826|FG001|Overall Study|Adverse event or SAE|28|||
161260569|NCT01553747|582333827|FG002|Overall Study|Adverse event or SAE|19|||
161260570|NCT01553747|582333825|FG000|Overall Study|Physician decision: other|10|||
161260571|NCT01553747|582333826|FG001|Overall Study|Physician decision: other|8|||
161260572|NCT01553747|582333827|FG002|Overall Study|Physician decision: other|7|||
161260573|NCT01553747|582333825|FG000|Overall Study|Lost to Follow-up|11|||
161260574|NCT01553747|582333826|FG001|Overall Study|Lost to Follow-up|5|||
161260575|NCT01553747|582333827|FG002|Overall Study|Lost to Follow-up|6|||
161260576|NCT01553747|582333825|FG000|Overall Study|Sponsor decision, specify|7|||
161260577|NCT01553747|582333826|FG001|Overall Study|Sponsor decision, specify|5|||
161260578|NCT01553747|582333827|FG002|Overall Study|Sponsor decision, specify|0|||
161260579|NCT01553747|582333825|FG000|Overall Study|Physician decision: lack of efficacy|1|||
161260580|NCT01553747|582333826|FG001|Overall Study|Physician decision: lack of efficacy|5|||
161260581|NCT01553747|582333827|FG002|Overall Study|Physician decision: lack of efficacy|3|||
161260582|NCT00102687|582333828|FG000|Initial Period|Withdrawal by Subject|6|||
161260583|NCT00102687|582333829|FG001|Initial Period|Withdrawal by Subject|3|||
161260584|NCT00102687|582333830|FG002|Initial Period|Withdrawal by Subject|5|||
161260585|NCT00102687|582333831|FG003|Initial Period|Withdrawal by Subject|0|||
161260586|NCT00102687|582333832|FG004|Initial Period|Withdrawal by Subject|0|||
161260587|NCT00102687|582333828|FG000|Initial Period|Adverse Event|4|||
161260588|NCT00102687|582333829|FG001|Initial Period|Adverse Event|7|||
161260589|NCT00102687|582333830|FG002|Initial Period|Adverse Event|9|||
161260590|NCT00102687|582333831|FG003|Initial Period|Adverse Event|0|||
161260591|NCT00102687|582333832|FG004|Initial Period|Adverse Event|0|||
161260592|NCT00102687|582333828|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
161260593|NCT00102687|582333829|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
161260594|NCT00102687|582333830|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
161260595|NCT00102687|582333831|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
161260596|NCT00102687|582333832|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
161260597|NCT00102687|582333828|FG000|Initial Period|Protocol Violation|0|||
161260598|NCT00102687|582333829|FG001|Initial Period|Protocol Violation|0|||
161260599|NCT00102687|582333830|FG002|Initial Period|Protocol Violation|2|||
161260600|NCT00102687|582333831|FG003|Initial Period|Protocol Violation|0|||
161260601|NCT00102687|582333832|FG004|Initial Period|Protocol Violation|0|||
161260602|NCT00102687|582333828|FG000|Initial Period|Physician Decision|2|||
161260603|NCT00102687|582333829|FG001|Initial Period|Physician Decision|9|||
161260604|NCT00102687|582333830|FG002|Initial Period|Physician Decision|6|||
161260605|NCT00102687|582333831|FG003|Initial Period|Physician Decision|0|||
161260606|NCT00102687|582333832|FG004|Initial Period|Physician Decision|0|||
161260607|NCT00102687|582333828|FG000|Initial Period|Sponsor's decision|0|||
161260608|NCT00102687|582333829|FG001|Initial Period|Sponsor's decision|1|||
161260609|NCT00102687|582333830|FG002|Initial Period|Sponsor's decision|1|||
161260610|NCT00102687|582333831|FG003|Initial Period|Sponsor's decision|0|||
161260611|NCT00102687|582333832|FG004|Initial Period|Sponsor's decision|0|||
161260612|NCT00102687|582333828|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
161260613|NCT00102687|582333829|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
161260614|NCT00102687|582333830|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
161260615|NCT00102687|582333831|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
161260616|NCT00102687|582333832|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
161260617|NCT00102687|582333828|FG000|Initial Period|Death|1|||
161260618|NCT00102687|582333829|FG001|Initial Period|Death|1|||
161260619|NCT00102687|582333830|FG002|Initial Period|Death|1|||
161260620|NCT00102687|582333831|FG003|Initial Period|Death|0|||
161260621|NCT00102687|582333832|FG004|Initial Period|Death|0|||
161260622|NCT00102687|582333828|FG000|Maintenance Period|Withdrawal by Subject|4|||
161260623|NCT00102687|582333829|FG001|Maintenance Period|Withdrawal by Subject|0|||
161260624|NCT00102687|582333830|FG002|Maintenance Period|Withdrawal by Subject|2|||
161260625|NCT00102687|582333831|FG003|Maintenance Period|Withdrawal by Subject|3|||
161260626|NCT00102687|582333832|FG004|Maintenance Period|Withdrawal by Subject|1|||
161260627|NCT00102687|582333828|FG000|Maintenance Period|Adverse Event|1|||
161260628|NCT00102687|582333829|FG001|Maintenance Period|Adverse Event|0|||
161260629|NCT00102687|582333830|FG002|Maintenance Period|Adverse Event|0|||
161260630|NCT00102687|582333831|FG003|Maintenance Period|Adverse Event|1|||
160920751|NCT02028065|581103371|FG002|Randomization Through Start Treatment|Not treated|3|||
160920752|NCT02028065|581103369|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
160920753|NCT02028065|581103370|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
161260631|NCT00102687|582333832|FG004|Maintenance Period|Adverse Event|3|||
161260632|NCT00102687|582333828|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161260633|NCT00102687|582333829|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
161260634|NCT00102687|582333830|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161260635|NCT00102687|582333831|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
161260636|NCT00102687|582333832|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
161260637|NCT00102687|582333828|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161260638|NCT00102687|582333829|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161260639|NCT00102687|582333830|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
161260640|NCT00102687|582333831|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
161260641|NCT00102687|582333832|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
161260642|NCT00102687|582333828|FG000|Maintenance Period|Death|0|||
161260643|NCT00102687|582333829|FG001|Maintenance Period|Death|0|||
161260644|NCT00102687|582333830|FG002|Maintenance Period|Death|0|||
161260645|NCT00102687|582333831|FG003|Maintenance Period|Death|1|||
161260646|NCT00102687|582333832|FG004|Maintenance Period|Death|1|||
161260647|NCT00102687|582333828|FG000|Maintenance Period|Physician Decision|1|||
161260648|NCT00102687|582333829|FG001|Maintenance Period|Physician Decision|2|||
161260649|NCT00102687|582333830|FG002|Maintenance Period|Physician Decision|3|||
161260650|NCT00102687|582333831|FG003|Maintenance Period|Physician Decision|0|||
161260651|NCT00102687|582333832|FG004|Maintenance Period|Physician Decision|4|||
161260652|NCT03253744|582333838|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
161260653|NCT03253744|582333839|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
161260654|NCT03253744|582333840|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
161260655|NCT03253744|582333841|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
161260656|NCT06279871|582333842|FG000|Overall Study|Death|0|||
161260657|NCT06279871|582333843|FG001|Overall Study|Death|0|||
161260658|NCT06279871|582333844|FG002|Overall Study|Death|0|||
161260659|NCT06279871|582333845|FG003|Overall Study|Death|0|||
161260660|NCT06279871|582333846|FG004|Overall Study|Death|0|||
161260661|NCT06279871|582333847|FG005|Overall Study|Death|1|||
161260662|NCT06279871|582333848|FG006|Overall Study|Death|0|||
161260663|NCT06279871|582333842|FG000|Overall Study|Other than Specified|1|||
161260664|NCT06279871|582333843|FG001|Overall Study|Other than Specified|0|||
161260665|NCT06279871|582333844|FG002|Overall Study|Other than Specified|4|||
161260666|NCT06279871|582333845|FG003|Overall Study|Other than Specified|0|||
161260667|NCT06279871|582333846|FG004|Overall Study|Other than Specified|0|||
161260668|NCT06279871|582333847|FG005|Overall Study|Other than Specified|0|||
161260669|NCT06279871|582333848|FG006|Overall Study|Other than Specified|0|||
161260670|NCT06279871|582333842|FG000|Overall Study|Withdrawal by Subject|4|||
161260671|NCT06279871|582333843|FG001|Overall Study|Withdrawal by Subject|8|||
161260672|NCT06279871|582333844|FG002|Overall Study|Withdrawal by Subject|4|||
161260673|NCT06279871|582333845|FG003|Overall Study|Withdrawal by Subject|2|||
161260674|NCT06279871|582333846|FG004|Overall Study|Withdrawal by Subject|0|||
161260675|NCT06279871|582333847|FG005|Overall Study|Withdrawal by Subject|0|||
161260676|NCT06279871|582333848|FG006|Overall Study|Withdrawal by Subject|0|||
161260677|NCT06279871|582333842|FG000|Overall Study|Lost to Follow-up|11|||
161260678|NCT06279871|582333843|FG001|Overall Study|Lost to Follow-up|10|||
161260679|NCT06279871|582333844|FG002|Overall Study|Lost to Follow-up|8|||
161260680|NCT06279871|582333845|FG003|Overall Study|Lost to Follow-up|0|||
161260681|NCT06279871|582333846|FG004|Overall Study|Lost to Follow-up|0|||
161260682|NCT06279871|582333847|FG005|Overall Study|Lost to Follow-up|0|||
161260683|NCT06279871|582333848|FG006|Overall Study|Lost to Follow-up|0|||
161260684|NCT06279871|582333842|FG000|Overall Study|Adverse Event|0|||
161260685|NCT06279871|582333843|FG001|Overall Study|Adverse Event|1|||
161260686|NCT06279871|582333844|FG002|Overall Study|Adverse Event|0|||
161260687|NCT06279871|582333845|FG003|Overall Study|Adverse Event|0|||
161260688|NCT06279871|582333846|FG004|Overall Study|Adverse Event|0|||
161260689|NCT06279871|582333847|FG005|Overall Study|Adverse Event|0|||
161260690|NCT06279871|582333848|FG006|Overall Study|Adverse Event|0|||
161260691|NCT03847194|582333851|FG000|Overall Study|Lost to Follow-up|2|||
161260692|NCT03847194|582333852|FG001|Overall Study|Lost to Follow-up|5|||
161260693|NCT03847194|582333851|FG000|Overall Study|Withdrawal by Subject|1|||
161260694|NCT03847194|582333852|FG001|Overall Study|Withdrawal by Subject|2|||
161260695|NCT03847194|582333851|FG000|Overall Study|Death|0|||
161260696|NCT03847194|582333852|FG001|Overall Study|Death|1|||
161260697|NCT01144403|582333856|FG000|Overall Study|Lost to Follow-up|3|||
161260698|NCT01144403|582333856|FG000|Overall Study|Death|1|||
161260699|NCT01144403|582333856|FG000|Overall Study|Adverse Event|1|||
161260700|NCT01807117|582333858|FG000|Overall Study|Physician Decision|2|||
161260701|NCT01807117|582333858|FG000|Overall Study|Disease diagnosis not a study disease|1|||
161260702|NCT02777918|582333859|FG000|Overall Study|Medical reasons|1|||
161260703|NCT02777918|582333860|FG001|Overall Study|Medical reasons|2|||
161260704|NCT02777918|582333859|FG000|Overall Study|Too busy / stressed|1|||
161260705|NCT02777918|582333860|FG001|Overall Study|Too busy / stressed|1|||
161260706|NCT02777918|582333859|FG000|Overall Study|Withdrawal by Subject|1|||
161260707|NCT02777918|582333860|FG001|Overall Study|Withdrawal by Subject|1|||
161260708|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
161260709|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
161260710|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
161260711|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
160997452|NCT01751724|581374962|FG000|Overall Study|extubated bef.start assigned treatment|1|||
160997453|NCT01751724|581374963|FG001|Overall Study|extubated bef.start assigned treatment|0|||
160997454|NCT01751724|581374962|FG000|Overall Study|withdrawn by parent|0|||
160997455|NCT01751724|581374963|FG001|Overall Study|withdrawn by parent|2|||
160997456|NCT03395353|581374964|FG000|Overall Study|Adverse Event|20|||
160997457|NCT03395353|581374964|FG000|Overall Study|Protocol Violation|1|||
160997458|NCT03395353|581374964|FG000|Overall Study|Lack of Efficacy|3|||
160997459|NCT03395353|581374964|FG000|Overall Study|Withdrawal by Subject|24|||
160997460|NCT03395353|581374964|FG000|Overall Study|Discontinued visit|1|||
160997461|NCT03395353|581374964|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
160997462|NCT03395353|581374964|FG000|Overall Study|Physician Decision|4|||
160997463|NCT03395353|581374964|FG000|Overall Study|Early termination of overall study|33|||
160997464|NCT03301220|581374965|FG000|Overall Study|Death|26|||
160997465|NCT03301220|581374966|FG001|Overall Study|Death|15|||
160997466|NCT03301220|581374965|FG000|Overall Study|Withdrawal by Subject|23|||
161143292|NCT00923091|581907584|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143293|NCT00923091|581907585|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143294|NCT00923091|581907586|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
161143295|NCT00923091|581907574|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
161143296|NCT00923091|581907575|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
161143297|NCT00923091|581907576|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
161260712|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
161260713|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
161260714|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
161260715|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
161260716|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
161260717|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
161260718|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
161260719|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
161260720|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
161260721|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
161260722|NCT02510014|582333863|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
161260723|NCT02510014|582333864|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
161260724|NCT02510014|582333863|FG000|Treatment Period|Adverse Event|11|||
161260725|NCT02510014|582333864|FG001|Treatment Period|Adverse Event|4|||
161260726|NCT02510014|582333863|FG000|Treatment Period|Withdrawal symptoms|3|||
161260727|NCT02510014|582333864|FG001|Treatment Period|Withdrawal symptoms|0|||
161260728|NCT02510014|582333863|FG000|Treatment Period|Lost to Follow-up|80|||
161260729|NCT02510014|582333864|FG001|Treatment Period|Lost to Follow-up|19|||
161260730|NCT02510014|582333863|FG000|Treatment Period|Physician Decision|5|||
161260731|NCT02510014|582333864|FG001|Treatment Period|Physician Decision|0|||
161260732|NCT02510014|582333863|FG000|Treatment Period|Withdrawal by Subject|67|||
161260733|NCT02510014|582333864|FG001|Treatment Period|Withdrawal by Subject|24|||
161260734|NCT02510014|582333863|FG000|Treatment Period|Withdrawn by the investigator|7|||
161260735|NCT02510014|582333864|FG001|Treatment Period|Withdrawn by the investigator|1|||
161260736|NCT02510014|582333863|FG000|Treatment Period|Protocol Violation|4|||
161260737|NCT02510014|582333864|FG001|Treatment Period|Protocol Violation|4|||
161260738|NCT02510014|582333863|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
161260739|NCT02510014|582333864|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
161260740|NCT01949116|582333866|FG000|Overall Study|Death|2|||
161260741|NCT01949116|582333867|FG001|Overall Study|Death|0|||
161260742|NCT01949116|582333866|FG000|Overall Study|Lost to Follow-up|1|||
161260743|NCT01949116|582333867|FG001|Overall Study|Lost to Follow-up|3|||
161260744|NCT01949116|582333866|FG000|Overall Study|Withdrawal by Subject|5|||
161260745|NCT01949116|582333867|FG001|Overall Study|Withdrawal by Subject|3|||
161260746|NCT05486065|582333868|FG000|Overall Study|Withdrawal by Subject|1|||
161260747|NCT05486065|582333869|FG001|Overall Study|Withdrawal by Subject|5|||
161260748|NCT05486065|582333870|FG002|Overall Study|Withdrawal by Subject|4|||
161260749|NCT05486065|582333871|FG003|Overall Study|Withdrawal by Subject|3|||
161260750|NCT05486065|582333868|FG000|Overall Study|Lost to Follow-up|4|||
160997467|NCT03301220|581374966|FG001|Overall Study|Withdrawal by Subject|12|||
160997468|NCT03301220|581374965|FG000|Overall Study|Lost to Follow-up|1|||
160997469|NCT03301220|581374966|FG001|Overall Study|Lost to Follow-up|1|||
160997470|NCT03301220|581374965|FG000|Overall Study|Randomized in error|1|||
160997471|NCT03301220|581374966|FG001|Overall Study|Randomized in error|1|||
160997472|NCT03301220|581374965|FG000|Overall Study|Randomized but not treated|0|||
160997473|NCT03301220|581374966|FG001|Overall Study|Randomized but not treated|1|||
161260751|NCT05486065|582333869|FG001|Overall Study|Lost to Follow-up|2|||
161260752|NCT05486065|582333870|FG002|Overall Study|Lost to Follow-up|2|||
161260753|NCT05486065|582333871|FG003|Overall Study|Lost to Follow-up|2|||
160997474|NCT03301220|581374965|FG000|Overall Study|Ongoing followup|145|||
161260754|NCT05486065|582333868|FG000|Overall Study|Physician Decision|0|||
161260755|NCT05486065|582333869|FG001|Overall Study|Physician Decision|1|||
161260756|NCT05486065|582333870|FG002|Overall Study|Physician Decision|1|||
160997475|NCT03301220|581374966|FG001|Overall Study|Ongoing followup|163|||
160997476|NCT03301220|581374965|FG000|Overall Study|Principal Investigator and participant decision|0|||
160997477|NCT03301220|581374966|FG001|Overall Study|Principal Investigator and participant decision|1|||
160997478|NCT02685033|581374967|FG000|Overall Study|Withdrawal of Consent|0|||
160997479|NCT02685033|581374968|FG001|Overall Study|Withdrawal of Consent|1|||
160997480|NCT02685033|581374967|FG000|Overall Study|Lost to Follow-up|2|||
160997481|NCT02685033|581374968|FG001|Overall Study|Lost to Follow-up|1|||
160997482|NCT02685033|581374967|FG000|Overall Study|Adverse Event|1|||
160997483|NCT02685033|581374968|FG001|Overall Study|Adverse Event|0|||
160997484|NCT04845620|581374973|FG000|Overall Study|Withdrawal by Subject|11|||
160997485|NCT04845620|581374974|FG001|Overall Study|Withdrawal by Subject|10|||
160997486|NCT04845620|581374973|FG000|Overall Study|Adverse Event|5|||
160997487|NCT04845620|581374974|FG001|Overall Study|Adverse Event|4|||
160997488|NCT04845620|581374973|FG000|Overall Study|Lost to Follow-up|5|||
160997489|NCT04845620|581374974|FG001|Overall Study|Lost to Follow-up|4|||
160997490|NCT04845620|581374973|FG000|Overall Study|Lack of Efficacy|4|||
160997491|NCT04845620|581374974|FG001|Overall Study|Lack of Efficacy|4|||
160997492|NCT04845620|581374973|FG000|Overall Study|Physician Decision|2|||
160997493|NCT04845620|581374974|FG001|Overall Study|Physician Decision|1|||
160997494|NCT00708097|581374975|FG000|Period 1|Protocol Violation|0|||
160997495|NCT00708097|581374976|FG001|Period 1|Protocol Violation|1|||
160997496|NCT00708097|581374977|FG002|Period 1|Protocol Violation|0|||
160997497|NCT00708097|581374978|FG003|Period 1|Protocol Violation|2|||
160997498|NCT00708097|581374979|FG004|Period 1|Protocol Violation|0|||
160997499|NCT00708097|581374975|FG000|Period 1|Other Reason|0|||
160997500|NCT00708097|581374976|FG001|Period 1|Other Reason|0|||
160997501|NCT00708097|581374977|FG002|Period 1|Other Reason|0|||
160997502|NCT00708097|581374978|FG003|Period 1|Other Reason|0|||
160997503|NCT00708097|581374979|FG004|Period 1|Other Reason|1|||
160997504|NCT00708097|581374975|FG000|Period 2|Protocol Violation|0|||
160997505|NCT00708097|581374976|FG001|Period 2|Protocol Violation|1|||
160997506|NCT00708097|581374977|FG002|Period 2|Protocol Violation|1|||
160997507|NCT00708097|581374978|FG003|Period 2|Protocol Violation|1|||
160997508|NCT00708097|581374979|FG004|Period 2|Protocol Violation|0|||
160997509|NCT00603447|581374980|FG000|Overall Study|Adverse Event|0|||
161143298|NCT00923091|581907577|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
161143299|NCT00923091|581907578|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
161143300|NCT00923091|581907579|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
161260757|NCT05486065|582333871|FG003|Overall Study|Physician Decision|0|||
161260758|NCT05486065|582333868|FG000|Overall Study|Failure to meet randomization criteria|0|||
161260759|NCT05486065|582333869|FG001|Overall Study|Failure to meet randomization criteria|0|||
161260760|NCT05486065|582333870|FG002|Overall Study|Failure to meet randomization criteria|0|||
161260761|NCT05486065|582333871|FG003|Overall Study|Failure to meet randomization criteria|1|||
161260762|NCT02858726|582333876|FG000|Overall Study|Adverse Event|4|||
161260763|NCT02858726|582333877|FG001|Overall Study|Adverse Event|4|||
161260764|NCT02858726|582333878|FG002|Overall Study|Adverse Event|9|||
161260765|NCT02858726|582333879|FG003|Overall Study|Adverse Event|1|||
160920754|NCT02028065|581103371|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
160920755|NCT02028065|581103369|FG000|Treatment Through Study Completion|Physician Decision|1|||
160920756|NCT02028065|581103370|FG001|Treatment Through Study Completion|Physician Decision|0|||
160920757|NCT02028065|581103371|FG002|Treatment Through Study Completion|Physician Decision|0|||
160920758|NCT02028065|581103369|FG000|Treatment Through Study Completion|Protocol Violation|1|||
160920759|NCT02028065|581103370|FG001|Treatment Through Study Completion|Protocol Violation|4|||
160920760|NCT02028065|581103371|FG002|Treatment Through Study Completion|Protocol Violation|0|||
160920761|NCT02028065|581103369|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
160920762|NCT02028065|581103370|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
160920763|NCT02028065|581103371|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
160920764|NCT02028065|581103369|FG000|Treatment Through Study Completion|Adverse Event|3|||
160920765|NCT02028065|581103370|FG001|Treatment Through Study Completion|Adverse Event|3|||
160920766|NCT02028065|581103371|FG002|Treatment Through Study Completion|Adverse Event|5|||
160920767|NCT04868890|581103374|FG000|Overall Study|Death|2|||
160920768|NCT04868890|581103375|FG001|Overall Study|Death|1|||
160920769|NCT04868890|581103374|FG000|Overall Study|Withdrawal by Subject|1|||
160997510|NCT00603447|581374981|FG001|Overall Study|Adverse Event|1|||
160997511|NCT00603447|581374982|FG002|Overall Study|Adverse Event|1|||
160997512|NCT00603447|581374983|FG003|Overall Study|Adverse Event|2|||
160997513|NCT00603447|581374984|FG004|Overall Study|Adverse Event|1|||
160997514|NCT00603447|581374985|FG005|Overall Study|Adverse Event|2|||
160997515|NCT00603447|581374986|FG006|Overall Study|Adverse Event|10|||
161260766|NCT02858726|582333876|FG000|Overall Study|Physician Decision|0|||
160920770|NCT04868890|581103375|FG001|Overall Study|Withdrawal by Subject|5|||
160920771|NCT02669433|581103378|FG000|Overall Study|Protocol Violation|0|||
160920772|NCT02669433|581103379|FG001|Overall Study|Protocol Violation|4|||
160920773|NCT02669433|581103380|FG002|Overall Study|Protocol Violation|1|||
160997516|NCT00603447|581374980|FG000|Overall Study|Other|0|||
160997517|NCT00603447|581374981|FG001|Overall Study|Other|0|||
160997518|NCT00603447|581374982|FG002|Overall Study|Other|1|||
161340792|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
161340793|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
161340794|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
161340795|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
161340796|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
161340797|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
161340798|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
161340799|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161340800|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161340801|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
161340802|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
161340803|NCT00849056|582635547|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
161340804|NCT00849056|582635548|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
161340805|NCT04588259|582635549|FG000|Run-in period|Run-in failure|0|||
161340806|NCT04588259|582635550|FG001|Run-in period|Run-in failure|23|||
161340807|NCT04588259|582635549|FG000|Run-in period|Withdrawn before randomisation|0|||
161340808|NCT04588259|582635550|FG001|Run-in period|Withdrawn before randomisation|8|||
160997519|NCT00603447|581374983|FG003|Overall Study|Other|0|||
160997520|NCT00603447|581374984|FG004|Overall Study|Other|3|||
160997521|NCT00603447|581374985|FG005|Overall Study|Other|0|||
161143301|NCT00923091|581907580|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
161260767|NCT02858726|582333877|FG001|Overall Study|Physician Decision|0|||
161260768|NCT02858726|582333878|FG002|Overall Study|Physician Decision|1|||
161260769|NCT02858726|582333879|FG003|Overall Study|Physician Decision|0|||
161260770|NCT02858726|582333876|FG000|Overall Study|Protocol Violation|0|||
161260771|NCT02858726|582333877|FG001|Overall Study|Protocol Violation|0|||
161260772|NCT02858726|582333878|FG002|Overall Study|Protocol Violation|0|||
161260773|NCT02858726|582333879|FG003|Overall Study|Protocol Violation|1|||
161260774|NCT02858726|582333876|FG000|Overall Study|Study Terminated by Sponsor|0|||
161260775|NCT02858726|582333877|FG001|Overall Study|Study Terminated by Sponsor|0|||
161260776|NCT02858726|582333878|FG002|Overall Study|Study Terminated by Sponsor|0|||
161260777|NCT02858726|582333879|FG003|Overall Study|Study Terminated by Sponsor|1|||
161260778|NCT02858726|582333876|FG000|Overall Study|Withdrawal by Subject|1|||
161260779|NCT02858726|582333877|FG001|Overall Study|Withdrawal by Subject|2|||
161260780|NCT02858726|582333878|FG002|Overall Study|Withdrawal by Subject|1|||
161260781|NCT02858726|582333879|FG003|Overall Study|Withdrawal by Subject|0|||
161260782|NCT02858726|582333876|FG000|Overall Study|Noncompliance|0|||
161260783|NCT02858726|582333877|FG001|Overall Study|Noncompliance|1|||
161260784|NCT02858726|582333878|FG002|Overall Study|Noncompliance|0|||
161260785|NCT02858726|582333879|FG003|Overall Study|Noncompliance|0|||
161260786|NCT04560998|582333880|FG000|Overall Study|Withdrawal by Subject|18|||
161260787|NCT04560998|582333881|FG001|Overall Study|Withdrawal by Subject|12|||
161260788|NCT04560998|582333880|FG000|Overall Study|Lost to Follow-up|8|||
161260789|NCT04560998|582333881|FG001|Overall Study|Lost to Follow-up|5|||
161260790|NCT04560998|582333880|FG000|Overall Study|Physician Decision|4|||
161260791|NCT04560998|582333881|FG001|Overall Study|Physician Decision|0|||
161260792|NCT00493246|582336083|FG000|Overall Study|Withdrawal by Subject|0|||
161260793|NCT00493246|582336084|FG001|Overall Study|Withdrawal by Subject|0|||
161260794|NCT00493246|582336085|FG002|Overall Study|Withdrawal by Subject|0|||
161260795|NCT00493246|582336086|FG003|Overall Study|Withdrawal by Subject|0|||
161260796|NCT00493246|582336087|FG004|Overall Study|Withdrawal by Subject|1|||
161260797|NCT00493246|582336088|FG005|Overall Study|Withdrawal by Subject|0|||
161260798|NCT00493246|582336089|FG006|Overall Study|Withdrawal by Subject|0|||
161260799|NCT00493246|582336090|FG007|Overall Study|Withdrawal by Subject|0|||
161260800|NCT00493246|582336083|FG000|Overall Study|No access to draw blood|0|||
161260801|NCT00493246|582336084|FG001|Overall Study|No access to draw blood|0|||
161260802|NCT00493246|582336085|FG002|Overall Study|No access to draw blood|0|||
161260803|NCT00493246|582336086|FG003|Overall Study|No access to draw blood|0|||
161260804|NCT00493246|582336087|FG004|Overall Study|No access to draw blood|0|||
161260805|NCT00493246|582336088|FG005|Overall Study|No access to draw blood|1|||
161260806|NCT00493246|582336089|FG006|Overall Study|No access to draw blood|0|||
161260807|NCT00493246|582336090|FG007|Overall Study|No access to draw blood|0|||
161260808|NCT00493246|582336083|FG000|Overall Study|Lost to Follow-up|0|||
161260809|NCT00493246|582336084|FG001|Overall Study|Lost to Follow-up|0|||
161260810|NCT00493246|582336085|FG002|Overall Study|Lost to Follow-up|0|||
161340809|NCT04588259|582635549|FG000|Treatment period|Withdrawal by Subject|6|||
161143302|NCT00923091|581907581|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
161260811|NCT00493246|582336086|FG003|Overall Study|Lost to Follow-up|0|||
161260812|NCT00493246|582336087|FG004|Overall Study|Lost to Follow-up|0|||
161260813|NCT00493246|582336088|FG005|Overall Study|Lost to Follow-up|0|||
161260814|NCT00493246|582336089|FG006|Overall Study|Lost to Follow-up|1|||
160997522|NCT00603447|581374986|FG006|Overall Study|Other|13|||
161260815|NCT00493246|582336090|FG007|Overall Study|Lost to Follow-up|0|||
161260816|NCT00595335|582336091|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
161260817|NCT00595335|582336092|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
161340810|NCT04588259|582635550|FG001|Treatment period|Withdrawal by Subject|6|||
161340811|NCT04476043|582635554|FG000|Overall Study|Withdrawal by Subject|1|||
161340812|NCT04476043|582635555|FG001|Overall Study|Withdrawal by Subject|3|||
161340813|NCT04476043|582635556|FG002|Overall Study|Withdrawal by Subject|4|||
161340814|NCT04476043|582635557|FG003|Overall Study|Withdrawal by Subject|1|||
161340815|NCT04476043|582635554|FG000|Overall Study|Lost to Follow-up|1|||
161340816|NCT04476043|582635555|FG001|Overall Study|Lost to Follow-up|1|||
161340817|NCT04476043|582635556|FG002|Overall Study|Lost to Follow-up|2|||
161340818|NCT04476043|582635557|FG003|Overall Study|Lost to Follow-up|1|||
161340819|NCT04476043|582635554|FG000|Overall Study|Adverse Event|2|||
161340820|NCT04476043|582635555|FG001|Overall Study|Adverse Event|0|||
161340821|NCT04476043|582635556|FG002|Overall Study|Adverse Event|1|||
161340822|NCT04476043|582635557|FG003|Overall Study|Adverse Event|0|||
161340823|NCT04476043|582635554|FG000|Overall Study|Protocol Violation|0|||
161340824|NCT04476043|582635555|FG001|Overall Study|Protocol Violation|1|||
161340825|NCT04476043|582635556|FG002|Overall Study|Protocol Violation|0|||
161340826|NCT04476043|582635557|FG003|Overall Study|Protocol Violation|0|||
161340827|NCT00715208|582635558|FG000|Overall Study|Withdrawal by Subject|1|||
161340828|NCT00715208|582635559|FG001|Overall Study|Withdrawal by Subject|1|||
161340829|NCT00715208|582635558|FG000|Overall Study|Adverse Event|0|||
161340830|NCT00715208|582635559|FG001|Overall Study|Adverse Event|6|||
161340831|NCT00715208|582635558|FG000|Overall Study|Lack of Efficacy|0|||
161340832|NCT00715208|582635559|FG001|Overall Study|Lack of Efficacy|2|||
161340833|NCT00576758|582635560|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
161340834|NCT00576758|582635561|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
161340835|NCT00576758|582635560|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
161340836|NCT00576758|582635561|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
161340837|NCT00576758|582635560|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
161340838|NCT00576758|582635561|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
161340839|NCT00576758|582635560|FG000|Induction Treatment Period|Death|1|||
161340840|NCT00576758|582635561|FG001|Induction Treatment Period|Death|0|||
161340841|NCT00576758|582635560|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
161340842|NCT00576758|582635561|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
161340843|NCT00576758|582635560|FG000|Induction Treatment Period|Withdrew consent|1|||
161340844|NCT00576758|582635561|FG001|Induction Treatment Period|Withdrew consent|0|||
161340845|NCT00576758|582635560|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
161340846|NCT00576758|582635561|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
161340847|NCT00576758|582635560|FG000|Extension Treatment Period|Death|1|||
161340848|NCT00576758|582635561|FG001|Extension Treatment Period|Death|1|||
161340849|NCT00576758|582635560|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
161340850|NCT00576758|582635561|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
161340851|NCT00576758|582635560|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
161340852|NCT00576758|582635561|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
161340853|NCT00576758|582635560|FG000|Extension Treatment Period|Administrative/Other|3|||
161340854|NCT00576758|582635561|FG001|Extension Treatment Period|Administrative/Other|1|||
161340855|NCT00576758|582635560|FG000|Follow-up Period|Administrative/Other|6|||
161340856|NCT00576758|582635561|FG001|Follow-up Period|Administrative/Other|8|||
161340857|NCT00576758|582635560|FG000|Follow-up Period|Death|3|||
161340858|NCT00576758|582635561|FG001|Follow-up Period|Death|3|||
161340859|NCT00576758|582635560|FG000|Follow-up Period|Insufficient therapeutic response|16|||
161340860|NCT00576758|582635561|FG001|Follow-up Period|Insufficient therapeutic response|5|||
160997523|NCT00603447|581374980|FG000|Overall Study|Withdrew Consent|0|||
161260818|NCT00595335|582336091|FG000|Baseline to Six Months|Disease Progression|1|||
161260819|NCT00595335|582336092|FG001|Baseline to Six Months|Disease Progression|1|||
161260820|NCT00595335|582336091|FG000|Baseline to Six Months|Adverse Event|1|||
161260821|NCT00595335|582336092|FG001|Baseline to Six Months|Adverse Event|0|||
161260822|NCT00595335|582336091|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
161260823|NCT00595335|582336092|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
161260824|NCT00595335|582336091|FG000|Six Months to Twelve Months|Disease Progression|1|||
161260825|NCT00595335|582336092|FG001|Six Months to Twelve Months|Disease Progression|0|||
161260826|NCT01013649|582336095|FG000|First Step|Withdrawal by Subject|36|||
161260827|NCT01013649|582336096|FG001|First Step|Withdrawal by Subject|19|||
161260828|NCT01013649|582336097|FG002|First Step|Withdrawal by Subject|0|||
161260829|NCT01013649|582336098|FG003|First Step|Withdrawal by Subject|0|||
161340861|NCT00576758|582635560|FG000|Follow-up Period|Withdrew consent|2|||
161340862|NCT00576758|582635561|FG001|Follow-up Period|Withdrew consent|1|||
161340863|NCT03738696|582635562|FG000|Overall Study|Withdrawal by Subject|0|||
161340864|NCT03738696|582635563|FG001|Overall Study|Withdrawal by Subject|1|||
161340865|NCT03738696|582635562|FG000|Overall Study|Lost to Follow-up|8|||
161340866|NCT03738696|582635563|FG001|Overall Study|Lost to Follow-up|14|||
161340867|NCT04757636|582635564|FG000|Overall Study|Adverse Event|25|||
161340868|NCT04757636|582635565|FG001|Overall Study|Adverse Event|8|||
161260830|NCT01013649|582336095|FG000|First Step|Progression|58|||
161260831|NCT01013649|582336096|FG001|First Step|Progression|23|||
161260832|NCT01013649|582336097|FG002|First Step|Progression|0|||
161260833|NCT01013649|582336098|FG003|First Step|Progression|0|||
161260834|NCT01013649|582336095|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
161260835|NCT01013649|582336096|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
161260836|NCT01013649|582336097|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
161260837|NCT01013649|582336098|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
161260838|NCT01013649|582336095|FG000|First Step|Death|3|||
161260839|NCT01013649|582336096|FG001|First Step|Death|4|||
161260840|NCT01013649|582336097|FG002|First Step|Death|0|||
161260841|NCT01013649|582336098|FG003|First Step|Death|0|||
161260842|NCT01013649|582336095|FG000|First Step|Adverse Event|9|||
161260843|NCT01013649|582336096|FG001|First Step|Adverse Event|5|||
161260844|NCT01013649|582336097|FG002|First Step|Adverse Event|0|||
161260845|NCT01013649|582336098|FG003|First Step|Adverse Event|0|||
161260846|NCT01013649|582336095|FG000|First Step|Other|4|||
161260847|NCT01013649|582336096|FG001|First Step|Other|6|||
161260848|NCT01013649|582336097|FG002|First Step|Other|0|||
161260849|NCT01013649|582336098|FG003|First Step|Other|0|||
161260850|NCT01647958|582336099|FG000|Initial Study|Lost to Follow-up|2|||
161260851|NCT01647958|582336100|FG001|Initial Study|Lost to Follow-up|3|||
161260852|NCT01647958|582336099|FG000|Continuation Phase|treatment received during Overall Study|39|||
161260853|NCT01647958|582336100|FG001|Continuation Phase|treatment received during Overall Study|0|||
161260854|NCT01647958|582336099|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
161260855|NCT01647958|582336100|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
161260856|NCT01131299|582336101|FG000|Overall Study|Withdrawal by Subject|4|||
161260857|NCT01131299|582336102|FG001|Overall Study|Withdrawal by Subject|7|||
161260858|NCT01207440|582336110|FG000|Overall Study|Adverse Event|46|||
161260859|NCT01207440|582336111|FG001|Overall Study|Adverse Event|11|||
161260860|NCT01207440|582336112|FG002|Overall Study|Adverse Event|7|||
161260861|NCT01207440|582336113|FG003|Overall Study|Adverse Event|2|||
161260862|NCT01207440|582336114|FG004|Overall Study|Adverse Event|6|||
161260863|NCT01207440|582336115|FG005|Overall Study|Adverse Event|6|||
161260864|NCT01207440|582336116|FG006|Overall Study|Adverse Event|2|||
161260865|NCT01207440|582336110|FG000|Overall Study|Death|6|||
161260866|NCT01207440|582336111|FG001|Overall Study|Death|3|||
161260867|NCT01207440|582336112|FG002|Overall Study|Death|2|||
161260868|NCT01207440|582336113|FG003|Overall Study|Death|2|||
161260869|NCT01207440|582336114|FG004|Overall Study|Death|7|||
161260870|NCT01207440|582336115|FG005|Overall Study|Death|5|||
161260871|NCT01207440|582336116|FG006|Overall Study|Death|1|||
161260872|NCT01207440|582336110|FG000|Overall Study|Lack of Efficacy|13|||
161260873|NCT01207440|582336111|FG001|Overall Study|Lack of Efficacy|2|||
161260874|NCT01207440|582336112|FG002|Overall Study|Lack of Efficacy|5|||
161260875|NCT01207440|582336113|FG003|Overall Study|Lack of Efficacy|1|||
161260876|NCT01207440|582336114|FG004|Overall Study|Lack of Efficacy|2|||
161260877|NCT01207440|582336115|FG005|Overall Study|Lack of Efficacy|3|||
161260878|NCT01207440|582336116|FG006|Overall Study|Lack of Efficacy|0|||
161260879|NCT01207440|582336110|FG000|Overall Study|Lost to Follow-up|0|||
161260880|NCT01207440|582336111|FG001|Overall Study|Lost to Follow-up|0|||
161260881|NCT01207440|582336112|FG002|Overall Study|Lost to Follow-up|2|||
161260882|NCT01207440|582336113|FG003|Overall Study|Lost to Follow-up|1|||
161260883|NCT01207440|582336114|FG004|Overall Study|Lost to Follow-up|0|||
161260884|NCT01207440|582336115|FG005|Overall Study|Lost to Follow-up|0|||
161260885|NCT01207440|582336116|FG006|Overall Study|Lost to Follow-up|0|||
161260886|NCT01207440|582336110|FG000|Overall Study|Non-compliance with Study Drug|3|||
161260887|NCT01207440|582336111|FG001|Overall Study|Non-compliance with Study Drug|0|||
161260888|NCT01207440|582336112|FG002|Overall Study|Non-compliance with Study Drug|1|||
161260889|NCT01207440|582336113|FG003|Overall Study|Non-compliance with Study Drug|0|||
161260890|NCT01207440|582336114|FG004|Overall Study|Non-compliance with Study Drug|0|||
161260891|NCT01207440|582336115|FG005|Overall Study|Non-compliance with Study Drug|0|||
161260892|NCT01207440|582336116|FG006|Overall Study|Non-compliance with Study Drug|0|||
161260893|NCT01207440|582336110|FG000|Overall Study|Physician Decision|6|||
161260894|NCT01207440|582336111|FG001|Overall Study|Physician Decision|5|||
161260895|NCT01207440|582336112|FG002|Overall Study|Physician Decision|5|||
161260896|NCT01207440|582336113|FG003|Overall Study|Physician Decision|0|||
161260897|NCT01207440|582336114|FG004|Overall Study|Physician Decision|1|||
161260898|NCT01207440|582336115|FG005|Overall Study|Physician Decision|0|||
161260899|NCT01207440|582336116|FG006|Overall Study|Physician Decision|0|||
161260900|NCT01207440|582336110|FG000|Overall Study|Progressive Disease|19|||
161260901|NCT01207440|582336111|FG001|Overall Study|Progressive Disease|10|||
161260902|NCT01207440|582336112|FG002|Overall Study|Progressive Disease|19|||
161260903|NCT01207440|582336113|FG003|Overall Study|Progressive Disease|7|||
161260904|NCT01207440|582336114|FG004|Overall Study|Progressive Disease|23|||
161260905|NCT01207440|582336115|FG005|Overall Study|Progressive Disease|27|||
161260906|NCT01207440|582336116|FG006|Overall Study|Progressive Disease|0|||
161260907|NCT01207440|582336110|FG000|Overall Study|Protocol Violation|2|||
161260908|NCT01207440|582336111|FG001|Overall Study|Protocol Violation|0|||
161260909|NCT01207440|582336112|FG002|Overall Study|Protocol Violation|0|||
161260910|NCT01207440|582336113|FG003|Overall Study|Protocol Violation|0|||
161260911|NCT01207440|582336114|FG004|Overall Study|Protocol Violation|0|||
161340869|NCT04757636|582635566|FG002|Overall Study|Adverse Event|11|||
161340870|NCT04757636|582635564|FG000|Overall Study|Death|9|||
161340871|NCT04757636|582635565|FG001|Overall Study|Death|12|||
161340872|NCT04757636|582635566|FG002|Overall Study|Death|6|||
161340873|NCT04757636|582635564|FG000|Overall Study|Lack of Efficacy|2|||
161340874|NCT04757636|582635565|FG001|Overall Study|Lack of Efficacy|0|||
161340875|NCT04757636|582635566|FG002|Overall Study|Lack of Efficacy|0|||
161340876|NCT04757636|582635564|FG000|Overall Study|Lost to Follow-up|1|||
161340877|NCT04757636|582635565|FG001|Overall Study|Lost to Follow-up|6|||
161340878|NCT04757636|582635566|FG002|Overall Study|Lost to Follow-up|7|||
161340879|NCT04757636|582635564|FG000|Overall Study|Physician Decision|1|||
161340880|NCT04757636|582635565|FG001|Overall Study|Physician Decision|3|||
161340881|NCT04757636|582635566|FG002|Overall Study|Physician Decision|4|||
161340882|NCT04757636|582635564|FG000|Overall Study|Withdrawal by Subject|20|||
161340883|NCT04757636|582635565|FG001|Overall Study|Withdrawal by Subject|23|||
161340884|NCT04757636|582635566|FG002|Overall Study|Withdrawal by Subject|18|||
161340885|NCT04757636|582635564|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
161340886|NCT04757636|582635565|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
161340887|NCT04757636|582635566|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
161340888|NCT04757636|582635564|FG000|Overall Study|Study Terminated by Sponsor|103|||
161340889|NCT04757636|582635565|FG001|Overall Study|Study Terminated by Sponsor|104|||
161340890|NCT04757636|582635566|FG002|Overall Study|Study Terminated by Sponsor|114|||
161340891|NCT04757636|582635564|FG000|Overall Study|Sponsor Decision|0|||
161340892|NCT04757636|582635565|FG001|Overall Study|Sponsor Decision|0|||
161340893|NCT04757636|582635566|FG002|Overall Study|Sponsor Decision|1|||
161340894|NCT04757636|582635564|FG000|Overall Study|Randomized in Error|0|||
161340895|NCT04757636|582635565|FG001|Overall Study|Randomized in Error|0|||
161340896|NCT04757636|582635566|FG002|Overall Study|Randomized in Error|2|||
161340897|NCT01732692|582635570|FG000|Overall Study|Adverse Event|0|||
161340898|NCT01732692|582635571|FG001|Overall Study|Adverse Event|1|||
160920774|NCT02669433|581103378|FG000|Overall Study|Disease Progression|1|||
160920775|NCT02669433|581103379|FG001|Overall Study|Disease Progression|0|||
160920776|NCT02669433|581103380|FG002|Overall Study|Disease Progression|0|||
160920777|NCT02669433|581103378|FG000|Overall Study|Physician Decision|1|||
160920778|NCT02669433|581103379|FG001|Overall Study|Physician Decision|1|||
160920779|NCT02669433|581103380|FG002|Overall Study|Physician Decision|0|||
160920780|NCT02669433|581103378|FG000|Overall Study|Adverse Event|6|||
160920781|NCT02669433|581103379|FG001|Overall Study|Adverse Event|7|||
160920782|NCT02669433|581103380|FG002|Overall Study|Adverse Event|10|||
160920783|NCT02669433|581103378|FG000|Overall Study|Sponsor Termination|1|||
160920784|NCT02669433|581103379|FG001|Overall Study|Sponsor Termination|0|||
160920785|NCT02669433|581103380|FG002|Overall Study|Sponsor Termination|1|||
160920786|NCT02669433|581103378|FG000|Overall Study|Withdrawal by Subject|5|||
160920787|NCT02669433|581103379|FG001|Overall Study|Withdrawal by Subject|1|||
160920788|NCT02669433|581103380|FG002|Overall Study|Withdrawal by Subject|0|||
160920789|NCT02669433|581103378|FG000|Overall Study|Withdrawal by Caregiver|1|||
160920790|NCT02669433|581103379|FG001|Overall Study|Withdrawal by Caregiver|0|||
160920791|NCT02669433|581103380|FG002|Overall Study|Withdrawal by Caregiver|2|||
160920792|NCT02669433|581103378|FG000|Overall Study|Death|0|||
160920793|NCT02669433|581103379|FG001|Overall Study|Death|1|||
160920794|NCT02669433|581103380|FG002|Overall Study|Death|1|||
160920795|NCT01698801|581103383|FG000|Treatment Phase|Adverse Event|4|||
160920796|NCT01698801|581103383|FG000|Treatment Phase|Protocol Violation|1|||
160920797|NCT01698801|581103383|FG000|Treatment Phase|Other|4|||
160920798|NCT01698801|581103383|FG000|Treatment Phase|Withdrawal by Subject|1|||
160920799|NCT01698801|581103383|FG000|Treatment Phase|Disease progression|1|||
160920800|NCT01698801|581103383|FG000|Follow Up Phase|Withdrawal by Subject|1|||
160920801|NCT01698801|581103383|FG000|Follow Up Phase|Death|4|||
160920802|NCT00656474|581103384|FG000|Overall Study|Other Reason|1|||
160920803|NCT02062879|581103385|FG000|Overall Study|Withdrawal by Subject|4|||
160997524|NCT00603447|581374981|FG001|Overall Study|Withdrew Consent|2|||
160997525|NCT00603447|581374982|FG002|Overall Study|Withdrew Consent|0|||
161340899|NCT01027949|582635572|FG000|Overall Study|Death|174|||
161340900|NCT01027949|582635572|FG000|Overall Study|Progressive Disease|163|||
161340901|NCT01027949|582635572|FG000|Overall Study|Adverse Event|172|||
161340902|NCT01027949|582635572|FG000|Overall Study|Withdrawal by Subject|113|||
161340903|NCT01027949|582635572|FG000|Overall Study|Lost to Follow-up|17|||
161340904|NCT01027949|582635572|FG000|Overall Study|Protocol Violation|13|||
161340905|NCT01027949|582635572|FG000|Overall Study|PI Decision|8|||
161340906|NCT01027949|582635572|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
160920804|NCT02062879|581103386|FG001|Overall Study|Withdrawal by Subject|1|||
160920805|NCT02998840|581103387|FG000|Overall Study|Lost to Follow-up|1|||
160920806|NCT02998840|581103388|FG001|Overall Study|Lost to Follow-up|1|||
160920807|NCT02998840|581103389|FG002|Overall Study|Lost to Follow-up|2|||
160920808|NCT02998840|581103390|FG003|Overall Study|Lost to Follow-up|3|||
160920809|NCT02998840|581103387|FG000|Overall Study|Withdrawal by Subject|1|||
160920810|NCT02998840|581103388|FG001|Overall Study|Withdrawal by Subject|1|||
160920811|NCT02998840|581103389|FG002|Overall Study|Withdrawal by Subject|0|||
160920812|NCT02998840|581103390|FG003|Overall Study|Withdrawal by Subject|1|||
161143303|NCT00923091|581907582|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
161143304|NCT00923091|581907583|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
161260912|NCT01207440|582336115|FG005|Overall Study|Protocol Violation|0|||
161260913|NCT01207440|582336116|FG006|Overall Study|Protocol Violation|0|||
161260914|NCT01207440|582336110|FG000|Overall Study|Site Terminated by Sponsor|69|||
161260915|NCT01207440|582336111|FG001|Overall Study|Site Terminated by Sponsor|19|||
161260916|NCT01207440|582336112|FG002|Overall Study|Site Terminated by Sponsor|12|||
161260917|NCT01207440|582336113|FG003|Overall Study|Site Terminated by Sponsor|2|||
161260918|NCT01207440|582336114|FG004|Overall Study|Site Terminated by Sponsor|3|||
161260919|NCT01207440|582336115|FG005|Overall Study|Site Terminated by Sponsor|0|||
161260920|NCT01207440|582336116|FG006|Overall Study|Site Terminated by Sponsor|2|||
161260921|NCT01207440|582336110|FG000|Overall Study|Withdrawal by Subject|29|||
161260922|NCT01207440|582336111|FG001|Overall Study|Withdrawal by Subject|4|||
161260923|NCT01207440|582336112|FG002|Overall Study|Withdrawal by Subject|5|||
161260924|NCT01207440|582336113|FG003|Overall Study|Withdrawal by Subject|3|||
161260925|NCT01207440|582336114|FG004|Overall Study|Withdrawal by Subject|2|||
161260926|NCT01207440|582336115|FG005|Overall Study|Withdrawal by Subject|2|||
161260927|NCT01207440|582336116|FG006|Overall Study|Withdrawal by Subject|0|||
161260928|NCT01207440|582336110|FG000|Overall Study|Reason Not Specified|10|||
161260929|NCT01207440|582336111|FG001|Overall Study|Reason Not Specified|10|||
161260930|NCT01207440|582336112|FG002|Overall Study|Reason Not Specified|7|||
161260931|NCT01207440|582336113|FG003|Overall Study|Reason Not Specified|0|||
161260932|NCT01207440|582336114|FG004|Overall Study|Reason Not Specified|4|||
161260933|NCT01207440|582336115|FG005|Overall Study|Reason Not Specified|3|||
161260934|NCT01207440|582336116|FG006|Overall Study|Reason Not Specified|0|||
161260935|NCT01592721|582336117|FG000|Long-term Follow-up|Death|1|||
161260936|NCT00821873|582336124|FG000|Overall Study|Lost to Follow-up|4|||
161260937|NCT02698865|582336129|FG000|Overall Study|Other|11|||
161260938|NCT02698865|582336130|FG001|Overall Study|Other|11|||
161260939|NCT02698865|582336129|FG000|Overall Study|Withdrawal by Subject|20|||
161260940|NCT02698865|582336130|FG001|Overall Study|Withdrawal by Subject|16|||
161260941|NCT02698865|582336129|FG000|Overall Study|Physician Decision|0|||
161260942|NCT02698865|582336130|FG001|Overall Study|Physician Decision|4|||
161260943|NCT02698865|582336129|FG000|Overall Study|Lost to Follow-up|4|||
161260944|NCT02698865|582336130|FG001|Overall Study|Lost to Follow-up|2|||
161260945|NCT02694549|582336136|FG000|Overall Study|screen failures|2|||
160920813|NCT02998840|581103387|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
160920814|NCT02998840|581103388|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
160920815|NCT02998840|581103389|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
160920816|NCT02998840|581103390|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
160920817|NCT00665847|581103394|FG000|Overall Study|Adverse Event|8|||
160920818|NCT00665847|581103394|FG000|Overall Study|Withdrawal by Subject|2|||
160920819|NCT00665847|581103394|FG000|Overall Study|Subject non-compliant|8|||
160920820|NCT00665847|581103394|FG000|Overall Study|Subject reached a virologic endpoint|4|||
160920821|NCT00665847|581103394|FG000|Overall Study|Resistance to TMC125|1|||
160920822|NCT00665847|581103394|FG000|Overall Study|Subject ineligible to continue the trial|1|||
160920823|NCT00665847|581103394|FG000|Overall Study|Switch to Commercial Medication|1|||
160920824|NCT01686633|581103395|FG000|Overall Study|Lack of Efficacy|33|||
160920825|NCT01686633|581103396|FG001|Overall Study|Lack of Efficacy|13|||
160920826|NCT01686633|581103397|FG002|Overall Study|Lack of Efficacy|11|||
160920827|NCT01686633|581103395|FG000|Overall Study|Withdrawal by Subject|8|||
160920828|NCT01686633|581103396|FG001|Overall Study|Withdrawal by Subject|8|||
160920829|NCT01686633|581103397|FG002|Overall Study|Withdrawal by Subject|5|||
160920830|NCT01686633|581103395|FG000|Overall Study|Physician Decision|3|||
160920831|NCT01686633|581103396|FG001|Overall Study|Physician Decision|4|||
160920832|NCT01686633|581103397|FG002|Overall Study|Physician Decision|4|||
160920833|NCT01686633|581103395|FG000|Overall Study|Adverse Event|4|||
160920834|NCT01686633|581103396|FG001|Overall Study|Adverse Event|3|||
160920835|NCT01686633|581103397|FG002|Overall Study|Adverse Event|3|||
160920836|NCT01686633|581103395|FG000|Overall Study|Protocol Violation|2|||
160920837|NCT01686633|581103396|FG001|Overall Study|Protocol Violation|3|||
160920838|NCT01686633|581103397|FG002|Overall Study|Protocol Violation|0|||
160920839|NCT01686633|581103395|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
160920840|NCT01686633|581103396|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
160997526|NCT00603447|581374983|FG003|Overall Study|Withdrew Consent|0|||
160997527|NCT00603447|581374984|FG004|Overall Study|Withdrew Consent|1|||
160997528|NCT00603447|581374985|FG005|Overall Study|Withdrew Consent|0|||
161260946|NCT01996332|582336137|FG000|Overall Study|Adverse Event|117|||
161260947|NCT01996332|582336137|FG000|Overall Study|Lack of Efficacy|1245|||
161260948|NCT01996332|582336137|FG000|Overall Study|Death|264|||
160920841|NCT01686633|581103397|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
160920842|NCT01686633|581103395|FG000|Overall Study|Lost to Follow-up|0|||
160920843|NCT01686633|581103396|FG001|Overall Study|Lost to Follow-up|1|||
160920844|NCT01686633|581103397|FG002|Overall Study|Lost to Follow-up|1|||
160920845|NCT00511667|581103402|FG000|Overall Study|Adverse Event|1|||
160920846|NCT00511667|581103403|FG001|Overall Study|Adverse Event|0|||
160997529|NCT00603447|581374986|FG006|Overall Study|Withdrew Consent|1|||
160997530|NCT00726596|581376538|FG000|Overall Study|Adverse Event|2|||
160997531|NCT00726596|581376539|FG001|Overall Study|Adverse Event|1|||
160997532|NCT00726596|581376538|FG000|Overall Study|Withdrawal by Subject|3|||
160997533|NCT00726596|581376539|FG001|Overall Study|Withdrawal by Subject|3|||
160997534|NCT02614560|581376547|FG000|Overall Study|Death|6|||
160997535|NCT02614560|581376548|FG001|Overall Study|Death|2|||
161143305|NCT00923091|581907584|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
161143306|NCT00923091|581907585|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
161143307|NCT00923091|581907586|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
161143308|NCT00923091|581907574|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143309|NCT00923091|581907575|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143310|NCT00923091|581907576|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143311|NCT00923091|581907577|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143312|NCT00923091|581907578|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143313|NCT00923091|581907579|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143314|NCT00923091|581907580|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
160920847|NCT00511667|581103402|FG000|Overall Study|Protocol Violation|1|||
160920848|NCT00511667|581103403|FG001|Overall Study|Protocol Violation|1|||
160920849|NCT00511667|581103402|FG000|Overall Study|Withdrawal by Subject|2|||
160920850|NCT00511667|581103403|FG001|Overall Study|Withdrawal by Subject|0|||
160920851|NCT00511667|581103402|FG000|Overall Study|Site terminated|6|||
160920852|NCT00511667|581103403|FG001|Overall Study|Site terminated|1|||
160920853|NCT00511667|581103402|FG000|Overall Study|Other|2|||
160920854|NCT00511667|581103403|FG001|Overall Study|Other|1|||
161143315|NCT00923091|581907581|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143316|NCT00923091|581907582|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
161143317|NCT00923091|581907583|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143318|NCT00923091|581907584|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143319|NCT00923091|581907585|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
161143320|NCT00923091|581907586|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
161143321|NCT00923091|581907574|FG000|Period V (Double -Blind)|Protocol Violation|0|||
161143322|NCT00923091|581907575|FG001|Period V (Double -Blind)|Protocol Violation|0|||
161143323|NCT00923091|581907576|FG002|Period V (Double -Blind)|Protocol Violation|0|||
161143324|NCT00923091|581907577|FG003|Period V (Double -Blind)|Protocol Violation|0|||
161143325|NCT00923091|581907578|FG004|Period V (Double -Blind)|Protocol Violation|0|||
161143326|NCT00923091|581907579|FG005|Period V (Double -Blind)|Protocol Violation|0|||
161143327|NCT00923091|581907580|FG006|Period V (Double -Blind)|Protocol Violation|0|||
161143328|NCT00923091|581907581|FG007|Period V (Double -Blind)|Protocol Violation|0|||
161143329|NCT00923091|581907582|FG008|Period V (Double -Blind)|Protocol Violation|0|||
161143330|NCT00923091|581907583|FG009|Period V (Double -Blind)|Protocol Violation|0|||
161143331|NCT00923091|581907584|FG010|Period V (Double -Blind)|Protocol Violation|0|||
161143332|NCT00923091|581907585|FG011|Period V (Double -Blind)|Protocol Violation|0|||
161143333|NCT00923091|581907586|FG012|Period V (Double -Blind)|Protocol Violation|1|||
161143334|NCT00923091|581907574|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
161143335|NCT00923091|581907575|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
161143336|NCT00923091|581907576|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
161143337|NCT00923091|581907577|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
161143338|NCT00923091|581907578|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
161143339|NCT00923091|581907579|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
161143340|NCT00923091|581907580|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
161143341|NCT00923091|581907581|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
161143342|NCT00923091|581907582|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
161143343|NCT00923091|581907583|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
161143344|NCT00923091|581907584|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
161143345|NCT00923091|581907585|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
161143346|NCT00923091|581907586|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
161143347|NCT00923091|581907574|FG000|Period VI (Open-Label)|Adverse Event|17|||
161143348|NCT00923091|581907575|FG001|Period VI (Open-Label)|Adverse Event|0|||
161143349|NCT00923091|581907576|FG002|Period VI (Open-Label)|Adverse Event|4|||
161143350|NCT00923091|581907577|FG003|Period VI (Open-Label)|Adverse Event|1|||
161143351|NCT00923091|581907578|FG004|Period VI (Open-Label)|Adverse Event|1|||
161143352|NCT00923091|581907579|FG005|Period VI (Open-Label)|Adverse Event|0|||
161143353|NCT00923091|581907580|FG006|Period VI (Open-Label)|Adverse Event|0|||
161143354|NCT00923091|581907581|FG007|Period VI (Open-Label)|Adverse Event|0|||
160997536|NCT02192606|581376549|FG000|Overall Study|surgery type was changed|1|||
160997537|NCT02192606|581376550|FG001|Overall Study|surgery type was changed|1|||
160997538|NCT02192606|581376549|FG000|Overall Study|Physician Decision|1|||
161143355|NCT00923091|581907582|FG008|Period VI (Open-Label)|Adverse Event|0|||
161143356|NCT00923091|581907583|FG009|Period VI (Open-Label)|Adverse Event|0|||
161260949|NCT01996332|582336137|FG000|Overall Study|Protocol Violation|9|||
161260950|NCT01996332|582336137|FG000|Overall Study|Withdrawal by Subject|71|||
161260951|NCT01996332|582336137|FG000|Overall Study|Other|20|||
161260952|NCT01996332|582336137|FG000|Overall Study|Clinical Deterioration|28|||
161260953|NCT01996332|582336137|FG000|Overall Study|Physician Decision|17|||
161260954|NCT01996332|582336137|FG000|Overall Study|Lost to Follow-up|34|||
161260955|NCT02113189|582336138|FG000|Overall Study|Lost to follow up|2|||
161260956|NCT02113189|582336139|FG001|Overall Study|Lost to follow up|1|||
161260957|NCT02113189|582336140|FG002|Overall Study|Lost to follow up|3|||
161260958|NCT00099268|582336143|FG000|Overall Study|Withdrawal by Subject|46|||
161260959|NCT00099268|582336144|FG001|Overall Study|Withdrawal by Subject|28|||
161260960|NCT00099268|582336143|FG000|Overall Study|Adverse Event|19|||
161260961|NCT00099268|582336144|FG001|Overall Study|Adverse Event|19|||
161260962|NCT00099268|582336143|FG000|Overall Study|Protocol Violation|9|||
161260963|NCT00099268|582336144|FG001|Overall Study|Protocol Violation|8|||
161260964|NCT00099268|582336143|FG000|Overall Study|Lost to Follow-up|6|||
161260965|NCT00099268|582336144|FG001|Overall Study|Lost to Follow-up|4|||
161260966|NCT00099268|582336143|FG000|Overall Study|Lack of Efficacy|5|||
161260967|NCT00099268|582336144|FG001|Overall Study|Lack of Efficacy|18|||
161260968|NCT00099268|582336143|FG000|Overall Study|Administrative problems|4|||
161260969|NCT00099268|582336144|FG001|Overall Study|Administrative problems|4|||
161260970|NCT00099268|582336143|FG000|Overall Study|Death|3|||
161260971|NCT00099268|582336144|FG001|Overall Study|Death|1|||
161260972|NCT03702049|582336145|FG000|Overall Study|Lost to Follow-up|4|||
161260973|NCT03702049|582336145|FG000|Overall Study|Physician Decision|1|||
161260974|NCT02954159|582336146|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
161260975|NCT02954159|582336147|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
161260976|NCT02954159|582336146|FG000|Overall Study|Withdrawal by Subject|0|||
161260977|NCT02954159|582336147|FG001|Overall Study|Withdrawal by Subject|1|||
161260978|NCT03438396|582336148|FG000|Overall Study|Reason Not Specified|9|||
161260979|NCT03438396|582336148|FG000|Overall Study|Withdrawal by Subject|5|||
161260980|NCT03438396|582336148|FG000|Overall Study|Lost to Follow-up|2|||
161260981|NCT03438396|582336148|FG000|Overall Study|Death|85|||
161260982|NCT03438396|582336148|FG000|Overall Study|Not treated|1|||
161260983|NCT00262041|582336149|FG000|Overall Study|Withdrawal by Subject|0|||
161260984|NCT00262041|582336150|FG001|Overall Study|Withdrawal by Subject|3|||
161260985|NCT00262041|582336151|FG002|Overall Study|Withdrawal by Subject|1|||
161260986|NCT00262041|582336149|FG000|Overall Study|Lost to Follow-up|1|||
161260987|NCT00262041|582336150|FG001|Overall Study|Lost to Follow-up|1|||
161260988|NCT00262041|582336151|FG002|Overall Study|Lost to Follow-up|5|||
161260989|NCT00262041|582336149|FG000|Overall Study|Unable to classify|1|||
161260990|NCT00262041|582336150|FG001|Overall Study|Unable to classify|0|||
161260991|NCT00262041|582336151|FG002|Overall Study|Unable to classify|0|||
161260992|NCT04132336|582336152|FG000|Overall Study|Investigator Decision|0|||
161260993|NCT04132336|582336153|FG001|Overall Study|Investigator Decision|1|||
161260994|NCT04132336|582336154|FG002|Overall Study|Investigator Decision|0|||
161260995|NCT04132336|582336155|FG003|Overall Study|Investigator Decision|0|||
161260996|NCT04132336|582336156|FG004|Overall Study|Investigator Decision|0|||
161260997|NCT04132336|582336157|FG005|Overall Study|Investigator Decision|0|||
161260998|NCT04132336|582336158|FG006|Overall Study|Investigator Decision|0|||
161260999|NCT02488330|582336159|FG000|Overall Study|Adverse Event|1|||
161261000|NCT02488330|582336159|FG000|Overall Study|Physician Decision|2|||
161261001|NCT02488330|582336159|FG000|Overall Study|Death|2|||
161261002|NCT02488330|582336159|FG000|Overall Study|Disease Progression|3|||
161261003|NCT02488330|582336159|FG000|Overall Study|Study Termination by Sponsor|4|||
161261004|NCT02384941|582336162|FG000|Overall Study|Adverse Event|11|||
161261005|NCT02384941|582336163|FG001|Overall Study|Adverse Event|13|||
161261006|NCT02384941|582336164|FG002|Overall Study|Adverse Event|17|||
161261007|NCT02384941|582336162|FG000|Overall Study|Lost to Follow-up|3|||
161261008|NCT02384941|582336163|FG001|Overall Study|Lost to Follow-up|2|||
161261009|NCT02384941|582336164|FG002|Overall Study|Lost to Follow-up|1|||
161261010|NCT02384941|582336162|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161261011|NCT02384941|582336163|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161261012|NCT02384941|582336164|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161261013|NCT02384941|582336162|FG000|Overall Study|Physician Decision|1|||
161261014|NCT02384941|582336163|FG001|Overall Study|Physician Decision|1|||
161261015|NCT02384941|582336164|FG002|Overall Study|Physician Decision|0|||
161261016|NCT02384941|582336162|FG000|Overall Study|Protocol Violation|3|||
161261017|NCT02384941|582336163|FG001|Overall Study|Protocol Violation|0|||
161261018|NCT02384941|582336164|FG002|Overall Study|Protocol Violation|0|||
161261019|NCT02384941|582336162|FG000|Overall Study|Withdrawal by Subject|26|||
161261020|NCT02384941|582336163|FG001|Overall Study|Withdrawal by Subject|19|||
161261021|NCT02384941|582336164|FG002|Overall Study|Withdrawal by Subject|20|||
161261022|NCT02384941|582336162|FG000|Overall Study|Pregnancy|0|||
161261023|NCT02384941|582336163|FG001|Overall Study|Pregnancy|0|||
161261024|NCT02384941|582336164|FG002|Overall Study|Pregnancy|1|||
161261025|NCT02384941|582336162|FG000|Overall Study|Other than specified above|4|||
161261026|NCT02384941|582336163|FG001|Overall Study|Other than specified above|0|||
161261027|NCT02384941|582336164|FG002|Overall Study|Other than specified above|1|||
161261028|NCT02493777|582336165|FG000|Overall Study|Lost to Follow-up|0|||
161261029|NCT02493777|582336166|FG001|Overall Study|Lost to Follow-up|1|||
161261030|NCT00468728|582336167|FG000|Treatment|criteria for mITT population|4|||
160997539|NCT02192606|581376550|FG001|Overall Study|Physician Decision|2|||
160997540|NCT02192606|581376549|FG000|Overall Study|3D equipment rep unable to join|0|||
160997541|NCT02192606|581376550|FG001|Overall Study|3D equipment rep unable to join|1|||
160997542|NCT00738699|581376551|FG000|Overall Study|Withdrawal by Subject|5|||
160997543|NCT00738699|581376552|FG001|Overall Study|Withdrawal by Subject|0|||
160997544|NCT00738699|581376551|FG000|Overall Study|Lost to Follow-up|1|||
160997545|NCT00738699|581376552|FG001|Overall Study|Lost to Follow-up|0|||
160997546|NCT00738699|581376551|FG000|Overall Study|Death|144|||
160997547|NCT00738699|581376552|FG001|Overall Study|Death|68|||
160997548|NCT00738699|581376551|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
160997549|NCT00738699|581376552|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
160997550|NCT00738699|581376551|FG000|Overall Study|Other|2|||
160997551|NCT00738699|581376552|FG001|Overall Study|Other|0|||
160997552|NCT03201809|581376553|FG000|Overall Study|Lost to Follow-up|2|||
160997553|NCT03201809|581376554|FG001|Overall Study|Lost to Follow-up|0|||
160997554|NCT03383887|581376555|FG000|Overall Study|Lost to Follow-up|0|||
160997555|NCT03383887|581376556|FG001|Overall Study|Lost to Follow-up|1|||
160997556|NCT00246012|581376563|FG000|Overall Study|Adverse Event|0|||
160997557|NCT00246012|581376564|FG001|Overall Study|Adverse Event|0|||
160997558|NCT00246012|581376565|FG002|Overall Study|Adverse Event|0|||
160997559|NCT00246012|581376566|FG003|Overall Study|Adverse Event|0|||
160997560|NCT00246012|581376567|FG004|Overall Study|Adverse Event|0|||
160997561|NCT00246012|581376568|FG005|Overall Study|Adverse Event|1|||
160997562|NCT00246012|581376569|FG006|Overall Study|Adverse Event|0|||
161261031|NCT00468728|582336168|FG001|Treatment|criteria for mITT population|11|||
161261032|NCT00468728|582336167|FG000|Follow-up|mITT failure|34|||
161261033|NCT00468728|582336168|FG001|Follow-up|mITT failure|31|||
161261034|NCT01705236|582336169|FG000|Overall Study|Lost to Follow-up|1|||
161261035|NCT01705236|582336169|FG000|Overall Study|Administrative problems|2|||
161261036|NCT01705236|582336169|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
161261037|NCT01705236|582336169|FG000|Overall Study|Protocol Violation|3|||
161261038|NCT01705236|582336169|FG000|Overall Study|Abnormal test procedure result(s)|4|||
161261039|NCT01705236|582336169|FG000|Overall Study|Abnormal laboratory value(s)|4|||
161261040|NCT01705236|582336169|FG000|Overall Study|Withdrawal by Subject|5|||
161261041|NCT01705236|582336169|FG000|Overall Study|Adverse Event|5|||
161261042|NCT06005597|582336170|FG000|Overall Study|Lost to Follow-up|1|||
161261043|NCT06005597|582336171|FG001|Overall Study|Lost to Follow-up|2|||
161261044|NCT06005597|582336172|FG002|Overall Study|Lost to Follow-up|1|||
161261045|NCT06005597|582336173|FG003|Overall Study|Lost to Follow-up|2|||
161261046|NCT06005597|582336170|FG000|Overall Study|Death|1|||
161261047|NCT06005597|582336171|FG001|Overall Study|Death|1|||
161261048|NCT06005597|582336172|FG002|Overall Study|Death|1|||
161261049|NCT06005597|582336173|FG003|Overall Study|Death|0|||
161261050|NCT02224573|582336174|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
161261051|NCT02224573|582336175|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
161261052|NCT02224573|582336174|FG000|Treatment Phase|Started on Other IMP|1|||
161261053|NCT02224573|582336175|FG001|Treatment Phase|Started on Other IMP|0|||
161261054|NCT02224573|582336174|FG000|Treatment Phase|Participant Discontinued IMP|0|||
161261055|NCT02224573|582336175|FG001|Treatment Phase|Participant Discontinued IMP|1|||
161261056|NCT02224573|582336174|FG000|Treatment Phase|Lack of Efficacy|15|||
161261057|NCT02224573|582336175|FG001|Treatment Phase|Lack of Efficacy|8|||
161261058|NCT02224573|582336174|FG000|Treatment Phase|Began Commercial Product|1|||
161261059|NCT02224573|582336175|FG001|Treatment Phase|Began Commercial Product|0|||
161261060|NCT02224573|582336174|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
161261061|NCT02224573|582336175|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
161261062|NCT02224573|582336174|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
161261063|NCT02224573|582336175|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
161261064|NCT02224573|582336174|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
161261065|NCT02224573|582336175|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
161261066|NCT02224573|582336174|FG000|Treatment Phase|Continued Compassionate Use|1|||
161261067|NCT02224573|582336175|FG001|Treatment Phase|Continued Compassionate Use|0|||
160997563|NCT00246012|581376570|FG007|Overall Study|Adverse Event|0|||
160997564|NCT00246012|581376571|FG008|Overall Study|Adverse Event|2|||
160997565|NCT00246012|581376563|FG000|Overall Study|Withdrawal by Subject|0|||
160997566|NCT00246012|581376564|FG001|Overall Study|Withdrawal by Subject|0|||
161261068|NCT02224573|582336174|FG000|Treatment Phase|Lack of Efficiency|2|||
160997567|NCT00246012|581376565|FG002|Overall Study|Withdrawal by Subject|0|||
160997568|NCT00246012|581376566|FG003|Overall Study|Withdrawal by Subject|0|||
161261069|NCT02224573|582336175|FG001|Treatment Phase|Lack of Efficiency|1|||
161261070|NCT02224573|582336174|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
161261071|NCT02224573|582336175|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
161261072|NCT02224573|582336174|FG000|Treatment Phase|Participant Moved|2|||
161261073|NCT02224573|582336175|FG001|Treatment Phase|Participant Moved|0|||
161261074|NCT02224573|582336174|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
161261075|NCT02224573|582336175|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
161261076|NCT02224573|582336174|FG000|Treatment Phase|Refused Medication|1|||
161261077|NCT02224573|582336175|FG001|Treatment Phase|Refused Medication|1|||
161261078|NCT02224573|582336174|FG000|Treatment Phase|Adverse Event|26|||
161261079|NCT02224573|582336175|FG001|Treatment Phase|Adverse Event|38|||
161261080|NCT02224573|582336174|FG000|Treatment Phase|Placed in Group Home|0|||
161261081|NCT02224573|582336175|FG001|Treatment Phase|Placed in Group Home|1|||
161261082|NCT02224573|582336174|FG000|Treatment Phase|Pursued Other Trials|1|||
161261083|NCT02224573|582336175|FG001|Treatment Phase|Pursued Other Trials|0|||
161261084|NCT02224573|582336174|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
161261085|NCT02224573|582336175|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
161261086|NCT02224573|582336174|FG000|Treatment Phase|Lost to Follow-up|2|||
161261087|NCT02224573|582336175|FG001|Treatment Phase|Lost to Follow-up|1|||
161261088|NCT02224573|582336174|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
161261089|NCT02224573|582336175|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
161261090|NCT02224573|582336174|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
161261091|NCT02224573|582336175|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
161261092|NCT02224573|582336174|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
161261093|NCT02224573|582336175|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
161261094|NCT02224573|582336174|FG000|Taper Phase|Adverse Event|1|||
161261095|NCT02224573|582336175|FG001|Taper Phase|Adverse Event|1|||
161261096|NCT02546362|582336176|FG000|4-week Treatment Period|Lost to Follow-up|1|||
161261097|NCT02546362|582336176|FG000|4-week Treatment Period|Change in medication|2|||
161261098|NCT02546362|582336176|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
161261099|NCT02546362|582336176|FG000|12-week Treatment Period|Lost to Follow-up|2|||
161261100|NCT02546362|582336176|FG000|12-week Treatment Period|Change in medication|1|||
161261101|NCT02025010|582336177|FG000|Overall Study|Symptomatic or radiographic progression|36|||
161261102|NCT02025010|582336177|FG000|Overall Study|Adverse Event|6|||
161261103|NCT02025010|582336177|FG000|Overall Study|Physician Decision|7|||
161261104|NCT02025010|582336177|FG000|Overall Study|Withdrawal by Subject|3|||
161261105|NCT02025010|582336177|FG000|Overall Study|Intercurrent illness|3|||
161261106|NCT02025010|582336177|FG000|Overall Study|Patients still on treatment|3|||
161261107|NCT02025010|582336177|FG000|Overall Study|Never initiate the treatment|2|||
160920855|NCT01729754|581105215|FG000|Part 1|Adverse Event|2|||
160920856|NCT01729754|581105216|FG001|Part 1|Adverse Event|0|||
160920857|NCT01729754|581105217|FG002|Part 1|Adverse Event|0|||
160920858|NCT01729754|581105218|FG003|Part 1|Adverse Event|1|||
160920859|NCT01729754|581105219|FG004|Part 1|Adverse Event|0|||
160920860|NCT01729754|581105220|FG005|Part 1|Adverse Event|0|||
160920861|NCT01729754|581105221|FG006|Part 1|Adverse Event|2|||
160920862|NCT01729754|581105222|FG007|Part 1|Adverse Event|0|||
160920863|NCT01729754|581105223|FG008|Part 1|Adverse Event|0|||
160920864|NCT01729754|581105224|FG009|Part 1|Adverse Event|5|||
160920865|NCT01729754|581105215|FG000|Part 1|Lack of Efficacy|1|||
160920866|NCT01729754|581105216|FG001|Part 1|Lack of Efficacy|0|||
160920867|NCT01729754|581105217|FG002|Part 1|Lack of Efficacy|0|||
160920868|NCT01729754|581105218|FG003|Part 1|Lack of Efficacy|0|||
160920869|NCT01729754|581105219|FG004|Part 1|Lack of Efficacy|0|||
160920870|NCT01729754|581105220|FG005|Part 1|Lack of Efficacy|0|||
160920871|NCT01729754|581105221|FG006|Part 1|Lack of Efficacy|2|||
160920872|NCT01729754|581105222|FG007|Part 1|Lack of Efficacy|0|||
160920873|NCT01729754|581105223|FG008|Part 1|Lack of Efficacy|0|||
160920874|NCT01729754|581105224|FG009|Part 1|Lack of Efficacy|0|||
160920875|NCT01729754|581105215|FG000|Part 1|Lost to Follow-up|1|||
160920876|NCT01729754|581105216|FG001|Part 1|Lost to Follow-up|0|||
160920877|NCT01729754|581105217|FG002|Part 1|Lost to Follow-up|0|||
160920878|NCT01729754|581105218|FG003|Part 1|Lost to Follow-up|2|||
160920879|NCT01729754|581105219|FG004|Part 1|Lost to Follow-up|0|||
160920880|NCT01729754|581105220|FG005|Part 1|Lost to Follow-up|0|||
160920881|NCT01729754|581105221|FG006|Part 1|Lost to Follow-up|3|||
160920882|NCT01729754|581105222|FG007|Part 1|Lost to Follow-up|0|||
160920883|NCT01729754|581105223|FG008|Part 1|Lost to Follow-up|0|||
160920884|NCT01729754|581105224|FG009|Part 1|Lost to Follow-up|3|||
160920885|NCT01729754|581105215|FG000|Part 1|Non-compliance with Study Drug|1|||
160920886|NCT01729754|581105216|FG001|Part 1|Non-compliance with Study Drug|0|||
160920887|NCT01729754|581105217|FG002|Part 1|Non-compliance with Study Drug|0|||
160920888|NCT01729754|581105218|FG003|Part 1|Non-compliance with Study Drug|0|||
160920889|NCT01729754|581105219|FG004|Part 1|Non-compliance with Study Drug|0|||
160920890|NCT01729754|581105220|FG005|Part 1|Non-compliance with Study Drug|0|||
160997569|NCT00246012|581376567|FG004|Overall Study|Withdrawal by Subject|0|||
160920891|NCT01729754|581105221|FG006|Part 1|Non-compliance with Study Drug|0|||
160920892|NCT01729754|581105222|FG007|Part 1|Non-compliance with Study Drug|0|||
160920893|NCT01729754|581105223|FG008|Part 1|Non-compliance with Study Drug|0|||
160920894|NCT01729754|581105224|FG009|Part 1|Non-compliance with Study Drug|0|||
160920895|NCT01729754|581105215|FG000|Part 1|Physician Decision|0|||
161261108|NCT01134627|582336182|FG000|Overall Study|Adverse Event|47|||
161261109|NCT01134627|582336183|FG001|Overall Study|Adverse Event|31|||
161261110|NCT01134627|582336182|FG000|Overall Study|Lost to Follow-up|1|||
161261111|NCT01134627|582336183|FG001|Overall Study|Lost to Follow-up|2|||
161261112|NCT01134627|582336182|FG000|Overall Study|Protocol Violation|3|||
161261113|NCT01134627|582336183|FG001|Overall Study|Protocol Violation|5|||
161340907|NCT01027949|582635572|FG000|Overall Study|Non-compliance with Study Procedures|7|||
161340908|NCT01027949|582635572|FG000|Overall Study|Lung Transplant|5|||
161340909|NCT01027949|582635572|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
161340910|NCT01027949|582635572|FG000|Overall Study|Use of Excluded Medication|2|||
161340911|NCT01027949|582635572|FG000|Overall Study|Patient Self-discontinuation|1|||
161340912|NCT01027949|582635572|FG000|Overall Study|Pregnancy|1|||
161340913|NCT01027949|582635572|FG000|Overall Study|Surgery|1|||
161340914|NCT00656617|582635575|FG000|Overall Study|Adverse Event|1|||
161340915|NCT00656617|582635575|FG000|Overall Study|Death|2|||
161340916|NCT00656617|582635575|FG000|Overall Study|Insurance Issues|2|||
161340917|NCT00656617|582635575|FG000|Overall Study|Move to different clinical trial|2|||
161340918|NCT02030600|582635576|FG000|Treatment Period 1|Adverse Event|5|||
161340919|NCT02030600|582635577|FG001|Treatment Period 1|Adverse Event|7|||
161340920|NCT02030600|582635576|FG000|Treatment Period 1|Lack of Efficacy|0|||
161340921|NCT02030600|582635577|FG001|Treatment Period 1|Lack of Efficacy|1|||
161340922|NCT02030600|582635576|FG000|Treatment Period 1|Lost to Follow-up|11|||
161340923|NCT02030600|582635577|FG001|Treatment Period 1|Lost to Follow-up|3|||
161340924|NCT02030600|582635576|FG000|Treatment Period 1|Protocol Violation|22|||
161340925|NCT02030600|582635577|FG001|Treatment Period 1|Protocol Violation|17|||
161340926|NCT02030600|582635576|FG000|Treatment Period 1|Withdrawal by Subject|13|||
161340927|NCT02030600|582635577|FG001|Treatment Period 1|Withdrawal by Subject|17|||
161340928|NCT02030600|582635576|FG000|Treatment Period 1|Casebook Unsigned|1|||
161340929|NCT02030600|582635577|FG001|Treatment Period 1|Casebook Unsigned|0|||
161340930|NCT02030600|582635576|FG000|Treatment Period 1|Unclassified|1|||
161340931|NCT02030600|582635577|FG001|Treatment Period 1|Unclassified|0|||
161340932|NCT02030600|582635576|FG000|Treatment Period 2|Adverse Event|4|||
161340933|NCT02030600|582635577|FG001|Treatment Period 2|Adverse Event|4|||
161340934|NCT02030600|582635576|FG000|Treatment Period 2|Lack of Efficacy|2|||
161340935|NCT02030600|582635577|FG001|Treatment Period 2|Lack of Efficacy|1|||
161340936|NCT02030600|582635576|FG000|Treatment Period 2|Lost to Follow-up|4|||
161340937|NCT02030600|582635577|FG001|Treatment Period 2|Lost to Follow-up|2|||
161340938|NCT02030600|582635576|FG000|Treatment Period 2|Protocol Violation|1|||
161340939|NCT02030600|582635577|FG001|Treatment Period 2|Protocol Violation|2|||
161340940|NCT02030600|582635576|FG000|Treatment Period 2|Withdrawal by Subject|13|||
161340941|NCT02030600|582635577|FG001|Treatment Period 2|Withdrawal by Subject|9|||
161340942|NCT02030600|582635576|FG000|Treatment Period 2|Unclassified|1|||
161340943|NCT02030600|582635577|FG001|Treatment Period 2|Unclassified|0|||
161340944|NCT01155323|582635584|FG000|First Intervention|exclusion criteria|1|||
161340945|NCT01155323|582635585|FG001|First Intervention|exclusion criteria|1|||
161340946|NCT01155323|582635584|FG000|Second Intervention|Lost to Follow-up|1|||
161340947|NCT01155323|582635585|FG001|Second Intervention|Lost to Follow-up|1|||
161340948|NCT01208051|582635588|FG000|Total Enrollment|Withdrawal by Subject|0|||
161340949|NCT01208051|582635589|FG001|Total Enrollment|Withdrawal by Subject|1|||
161340950|NCT01208051|582635590|FG002|Total Enrollment|Withdrawal by Subject|0|||
161340951|NCT01208051|582635591|FG003|Total Enrollment|Withdrawal by Subject|0|||
161340952|NCT01208051|582635592|FG004|Total Enrollment|Withdrawal by Subject|2|||
161340953|NCT01208051|582635588|FG000|Total Enrollment|Brain metastases|0|||
161340954|NCT01208051|582635589|FG001|Total Enrollment|Brain metastases|0|||
160920896|NCT01729754|581105216|FG001|Part 1|Physician Decision|0|||
160920897|NCT01729754|581105217|FG002|Part 1|Physician Decision|0|||
160920898|NCT01729754|581105218|FG003|Part 1|Physician Decision|0|||
160920899|NCT01729754|581105219|FG004|Part 1|Physician Decision|0|||
160920900|NCT01729754|581105220|FG005|Part 1|Physician Decision|0|||
160920901|NCT01729754|581105221|FG006|Part 1|Physician Decision|0|||
160920902|NCT01729754|581105222|FG007|Part 1|Physician Decision|0|||
160920903|NCT01729754|581105223|FG008|Part 1|Physician Decision|0|||
160920904|NCT01729754|581105224|FG009|Part 1|Physician Decision|4|||
160920905|NCT01729754|581105215|FG000|Part 1|Pregnancy|0|||
160920906|NCT01729754|581105216|FG001|Part 1|Pregnancy|0|||
160920907|NCT01729754|581105217|FG002|Part 1|Pregnancy|0|||
160920908|NCT01729754|581105218|FG003|Part 1|Pregnancy|1|||
160920909|NCT01729754|581105219|FG004|Part 1|Pregnancy|0|||
161340955|NCT01208051|582635590|FG002|Total Enrollment|Brain metastases|1|||
161340956|NCT01208051|582635591|FG003|Total Enrollment|Brain metastases|0|||
161340957|NCT01208051|582635592|FG004|Total Enrollment|Brain metastases|0|||
161340958|NCT02349386|582635593|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
161340959|NCT02349386|582635594|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
161340960|NCT02349386|582635595|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
161340961|NCT02349386|582635596|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
160920910|NCT01729754|581105220|FG005|Part 1|Pregnancy|0|||
160920911|NCT01729754|581105221|FG006|Part 1|Pregnancy|0|||
160920912|NCT01729754|581105222|FG007|Part 1|Pregnancy|0|||
161340962|NCT02349386|582635593|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
161340963|NCT02349386|582635594|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
161340964|NCT02349386|582635595|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
161340965|NCT02349386|582635596|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
160920913|NCT01729754|581105223|FG008|Part 1|Pregnancy|0|||
160920914|NCT01729754|581105224|FG009|Part 1|Pregnancy|1|||
160920915|NCT01729754|581105215|FG000|Part 1|Progressive Disease|0|||
161340966|NCT02349386|582635593|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161340967|NCT02349386|582635594|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161340968|NCT02349386|582635595|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
161340969|NCT02349386|582635596|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
161340970|NCT02349386|582635593|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161340971|NCT02349386|582635594|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161340972|NCT02349386|582635595|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
161340973|NCT02349386|582635596|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
161340974|NCT02349386|582635593|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
161340975|NCT02349386|582635594|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
161340976|NCT02349386|582635595|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
161340977|NCT02349386|582635596|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
161340978|NCT02349386|582635593|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161340979|NCT02349386|582635594|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161340980|NCT02349386|582635595|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
161340981|NCT02349386|582635596|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
161340982|NCT00973973|582635597|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
161340983|NCT00973973|582635598|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
161340984|NCT00973973|582635597|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
161340985|NCT00973973|582635598|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
161340986|NCT00973973|582635597|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
161340987|NCT00973973|582635598|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
161340988|NCT00973973|582635597|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
161340989|NCT00973973|582635598|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
161340990|NCT00973973|582635597|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
161340991|NCT00973973|582635598|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
161340992|NCT00973973|582635597|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
161340993|NCT00973973|582635598|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
161340994|NCT00973973|582635597|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
161340995|NCT00973973|582635598|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
161340996|NCT00973973|582635597|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
161340997|NCT00973973|582635598|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
161340998|NCT00973973|582635597|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
161340999|NCT00973973|582635598|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
161341000|NCT00973973|582635597|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
161341001|NCT00973973|582635598|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
161341002|NCT00973973|582635597|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
161341003|NCT00973973|582635598|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
161341004|NCT00973973|582635597|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
161341005|NCT00973973|582635598|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
161341006|NCT02471339|582635599|FG000|Overall Study|Did not provide follow-up data|2|||
161341007|NCT02471339|582635600|FG001|Overall Study|Did not provide follow-up data|0|||
161341008|NCT06057064|582635601|FG000|Overall Study|Death|2|||
161341009|NCT06057064|582635602|FG001|Overall Study|Death|0|||
161341010|NCT06057064|582635601|FG000|Overall Study|Physician Decision|1|||
161341011|NCT06057064|582635602|FG001|Overall Study|Physician Decision|0|||
161341012|NCT06057064|582635601|FG000|Overall Study|Withdrawal by Subject|1|||
161261114|NCT01134627|582336182|FG000|Overall Study|Lack of Efficacy|2|||
161261115|NCT01134627|582336183|FG001|Overall Study|Lack of Efficacy|12|||
161261116|NCT01134627|582336182|FG000|Overall Study|Withdrawal by Subject|4|||
161261117|NCT01134627|582336183|FG001|Overall Study|Withdrawal by Subject|3|||
161261118|NCT01134627|582336182|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
161261119|NCT01134627|582336183|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
161261120|NCT01134627|582336182|FG000|Overall Study|Other|11|||
161261121|NCT01134627|582336183|FG001|Overall Study|Other|14|||
161261122|NCT01010750|582336184|FG000|Second Intervention|Adverse Event|0|||
161261123|NCT01010750|582336185|FG001|Second Intervention|Adverse Event|1|||
161261124|NCT01010750|582336186|FG002|Second Intervention|Adverse Event|0|||
161261125|NCT01010750|582336187|FG003|Second Intervention|Adverse Event|0|||
161261126|NCT01010750|582336188|FG004|Second Intervention|Adverse Event|0|||
161143357|NCT00923091|581907584|FG010|Period VI (Open-Label)|Adverse Event|0|||
161143358|NCT00923091|581907585|FG011|Period VI (Open-Label)|Adverse Event|0|||
161261127|NCT01010750|582336189|FG005|Second Intervention|Adverse Event|0|||
161261128|NCT01056640|582336190|FG000|Overall Study|Withdrawal by Subject|11|||
161261129|NCT01056640|582336191|FG001|Overall Study|Withdrawal by Subject|8|||
161261130|NCT01056640|582336190|FG000|Overall Study|Death|15|||
161261131|NCT01056640|582336191|FG001|Overall Study|Death|4|||
161261132|NCT01803269|582336192|FG000|Overall Study|Withdrawal by Subject|3|||
161261133|NCT01803269|582336193|FG001|Overall Study|Withdrawal by Subject|0|||
161261134|NCT01803269|582336194|FG002|Overall Study|Withdrawal by Subject|0|||
161261135|NCT00466726|582336200|FG000|Overall Study|Not evaluable for response|14|||
161261136|NCT02696031|582336201|FG000|Up to Week 24|Adverse Event|2|||
161261137|NCT02696031|582336202|FG001|Up to Week 24|Adverse Event|4|||
161261138|NCT02696031|582336203|FG002|Up to Week 24|Adverse Event|2|||
161261139|NCT02696031|582336204|FG003|Up to Week 24|Adverse Event|0|||
161261140|NCT02696031|582336205|FG004|Up to Week 24|Adverse Event|0|||
161261141|NCT02696031|582336206|FG005|Up to Week 24|Adverse Event|0|||
161261142|NCT02696031|582336201|FG000|Up to Week 24|Lack of Efficacy|2|||
161261143|NCT02696031|582336202|FG001|Up to Week 24|Lack of Efficacy|1|||
161261144|NCT02696031|582336203|FG002|Up to Week 24|Lack of Efficacy|2|||
161261145|NCT02696031|582336204|FG003|Up to Week 24|Lack of Efficacy|0|||
161261146|NCT02696031|582336205|FG004|Up to Week 24|Lack of Efficacy|0|||
161261147|NCT02696031|582336206|FG005|Up to Week 24|Lack of Efficacy|0|||
161261148|NCT02696031|582336201|FG000|Up to Week 24|Lost to Follow-up|0|||
161261149|NCT02696031|582336202|FG001|Up to Week 24|Lost to Follow-up|1|||
161261150|NCT02696031|582336203|FG002|Up to Week 24|Lost to Follow-up|1|||
161261151|NCT02696031|582336204|FG003|Up to Week 24|Lost to Follow-up|0|||
161261152|NCT02696031|582336205|FG004|Up to Week 24|Lost to Follow-up|0|||
161261153|NCT02696031|582336206|FG005|Up to Week 24|Lost to Follow-up|0|||
161261154|NCT02696031|582336201|FG000|Up to Week 24|Physician Decision|1|||
161261155|NCT02696031|582336202|FG001|Up to Week 24|Physician Decision|0|||
161261156|NCT02696031|582336203|FG002|Up to Week 24|Physician Decision|1|||
161261157|NCT02696031|582336204|FG003|Up to Week 24|Physician Decision|0|||
161261158|NCT02696031|582336205|FG004|Up to Week 24|Physician Decision|0|||
161261159|NCT02696031|582336206|FG005|Up to Week 24|Physician Decision|0|||
161261160|NCT02696031|582336201|FG000|Up to Week 24|Protocol Violation|1|||
161261161|NCT02696031|582336202|FG001|Up to Week 24|Protocol Violation|0|||
161261162|NCT02696031|582336203|FG002|Up to Week 24|Protocol Violation|0|||
161261163|NCT02696031|582336204|FG003|Up to Week 24|Protocol Violation|0|||
160920916|NCT01729754|581105216|FG001|Part 1|Progressive Disease|0|||
160920917|NCT01729754|581105217|FG002|Part 1|Progressive Disease|0|||
160920918|NCT01729754|581105218|FG003|Part 1|Progressive Disease|0|||
160920919|NCT01729754|581105219|FG004|Part 1|Progressive Disease|0|||
160920920|NCT01729754|581105220|FG005|Part 1|Progressive Disease|0|||
160920921|NCT01729754|581105221|FG006|Part 1|Progressive Disease|0|||
160920922|NCT01729754|581105222|FG007|Part 1|Progressive Disease|0|||
160920923|NCT01729754|581105223|FG008|Part 1|Progressive Disease|0|||
160920924|NCT01729754|581105224|FG009|Part 1|Progressive Disease|1|||
160920925|NCT01729754|581105215|FG000|Part 1|Protocol Violation|2|||
160920926|NCT01729754|581105216|FG001|Part 1|Protocol Violation|0|||
160920927|NCT01729754|581105217|FG002|Part 1|Protocol Violation|0|||
160920928|NCT01729754|581105218|FG003|Part 1|Protocol Violation|1|||
160920929|NCT01729754|581105219|FG004|Part 1|Protocol Violation|0|||
160920930|NCT01729754|581105220|FG005|Part 1|Protocol Violation|0|||
160920931|NCT01729754|581105221|FG006|Part 1|Protocol Violation|1|||
160920932|NCT01729754|581105222|FG007|Part 1|Protocol Violation|0|||
160920933|NCT01729754|581105223|FG008|Part 1|Protocol Violation|0|||
160920934|NCT01729754|581105224|FG009|Part 1|Protocol Violation|0|||
160920935|NCT01729754|581105215|FG000|Part 1|Withdrawal by Subject|5|||
160920936|NCT01729754|581105216|FG001|Part 1|Withdrawal by Subject|0|||
160920937|NCT01729754|581105217|FG002|Part 1|Withdrawal by Subject|0|||
160920938|NCT01729754|581105218|FG003|Part 1|Withdrawal by Subject|7|||
160920939|NCT01729754|581105219|FG004|Part 1|Withdrawal by Subject|0|||
160920940|NCT01729754|581105220|FG005|Part 1|Withdrawal by Subject|0|||
160920941|NCT01729754|581105221|FG006|Part 1|Withdrawal by Subject|5|||
160920942|NCT01729754|581105222|FG007|Part 1|Withdrawal by Subject|0|||
160920943|NCT01729754|581105223|FG008|Part 1|Withdrawal by Subject|0|||
160920944|NCT01729754|581105224|FG009|Part 1|Withdrawal by Subject|6|||
160920945|NCT01729754|581105215|FG000|Part 1|Other Protocol Specified Criteria|2|||
161261164|NCT02696031|582336205|FG004|Up to Week 24|Protocol Violation|0|||
161261165|NCT02696031|582336206|FG005|Up to Week 24|Protocol Violation|0|||
161261166|NCT02696031|582336201|FG000|Up to Week 24|Withdrawal by Subject|4|||
160920946|NCT01729754|581105216|FG001|Part 1|Other Protocol Specified Criteria|0|||
160920947|NCT01729754|581105217|FG002|Part 1|Other Protocol Specified Criteria|0|||
160920948|NCT01729754|581105218|FG003|Part 1|Other Protocol Specified Criteria|0|||
160920949|NCT01729754|581105219|FG004|Part 1|Other Protocol Specified Criteria|0|||
160920950|NCT01729754|581105220|FG005|Part 1|Other Protocol Specified Criteria|0|||
160920951|NCT01729754|581105221|FG006|Part 1|Other Protocol Specified Criteria|1|||
160920952|NCT01729754|581105222|FG007|Part 1|Other Protocol Specified Criteria|0|||
160920953|NCT01729754|581105223|FG008|Part 1|Other Protocol Specified Criteria|0|||
161261167|NCT02696031|582336202|FG001|Up to Week 24|Withdrawal by Subject|1|||
160920954|NCT01729754|581105224|FG009|Part 1|Other Protocol Specified Criteria|4|||
160920955|NCT01729754|581105215|FG000|Part 2|Adverse Event|2|||
160920956|NCT01729754|581105216|FG001|Part 2|Adverse Event|0|||
161261168|NCT02696031|582336203|FG002|Up to Week 24|Withdrawal by Subject|5|||
161261169|NCT02696031|582336204|FG003|Up to Week 24|Withdrawal by Subject|0|||
160920957|NCT01729754|581105217|FG002|Part 2|Adverse Event|0|||
160920958|NCT01729754|581105218|FG003|Part 2|Adverse Event|0|||
160920959|NCT01729754|581105219|FG004|Part 2|Adverse Event|0|||
160920960|NCT01729754|581105220|FG005|Part 2|Adverse Event|0|||
160920961|NCT01729754|581105221|FG006|Part 2|Adverse Event|0|||
160920962|NCT01729754|581105222|FG007|Part 2|Adverse Event|0|||
160920963|NCT01729754|581105223|FG008|Part 2|Adverse Event|1|||
160920964|NCT01729754|581105224|FG009|Part 2|Adverse Event|2|||
160920965|NCT01729754|581105215|FG000|Part 2|Lack of Efficacy|0|||
160920966|NCT01729754|581105216|FG001|Part 2|Lack of Efficacy|0|||
160920967|NCT01729754|581105217|FG002|Part 2|Lack of Efficacy|0|||
160920968|NCT01729754|581105218|FG003|Part 2|Lack of Efficacy|0|||
160920969|NCT01729754|581105219|FG004|Part 2|Lack of Efficacy|0|||
160920970|NCT01729754|581105220|FG005|Part 2|Lack of Efficacy|0|||
160920971|NCT01729754|581105221|FG006|Part 2|Lack of Efficacy|0|||
160920972|NCT01729754|581105222|FG007|Part 2|Lack of Efficacy|0|||
160920973|NCT01729754|581105223|FG008|Part 2|Lack of Efficacy|2|||
160920974|NCT01729754|581105224|FG009|Part 2|Lack of Efficacy|2|||
160920975|NCT01729754|581105215|FG000|Part 2|Lost to Follow-up|0|||
160920976|NCT01729754|581105216|FG001|Part 2|Lost to Follow-up|0|||
160920977|NCT01729754|581105217|FG002|Part 2|Lost to Follow-up|0|||
160920978|NCT01729754|581105218|FG003|Part 2|Lost to Follow-up|2|||
160920979|NCT01729754|581105219|FG004|Part 2|Lost to Follow-up|0|||
160920980|NCT01729754|581105220|FG005|Part 2|Lost to Follow-up|0|||
160920981|NCT01729754|581105221|FG006|Part 2|Lost to Follow-up|0|||
160920982|NCT01729754|581105222|FG007|Part 2|Lost to Follow-up|1|||
160920983|NCT01729754|581105223|FG008|Part 2|Lost to Follow-up|0|||
160920984|NCT01729754|581105224|FG009|Part 2|Lost to Follow-up|2|||
160920985|NCT01729754|581105215|FG000|Part 2|Non-Compliance with Study Drug|0|||
160920986|NCT01729754|581105216|FG001|Part 2|Non-Compliance with Study Drug|0|||
160920987|NCT01729754|581105217|FG002|Part 2|Non-Compliance with Study Drug|0|||
160920988|NCT01729754|581105218|FG003|Part 2|Non-Compliance with Study Drug|0|||
160920989|NCT01729754|581105219|FG004|Part 2|Non-Compliance with Study Drug|0|||
160920990|NCT01729754|581105220|FG005|Part 2|Non-Compliance with Study Drug|0|||
160920991|NCT01729754|581105221|FG006|Part 2|Non-Compliance with Study Drug|0|||
160920992|NCT01729754|581105222|FG007|Part 2|Non-Compliance with Study Drug|0|||
160920993|NCT01729754|581105223|FG008|Part 2|Non-Compliance with Study Drug|0|||
160920994|NCT01729754|581105224|FG009|Part 2|Non-Compliance with Study Drug|1|||
160920995|NCT01729754|581105215|FG000|Part 2|Pregnancy|0|||
160920996|NCT01729754|581105216|FG001|Part 2|Pregnancy|0|||
160920997|NCT01729754|581105217|FG002|Part 2|Pregnancy|0|||
160920998|NCT01729754|581105218|FG003|Part 2|Pregnancy|1|||
160920999|NCT01729754|581105219|FG004|Part 2|Pregnancy|0|||
160921000|NCT01729754|581105220|FG005|Part 2|Pregnancy|0|||
160921001|NCT01729754|581105221|FG006|Part 2|Pregnancy|0|||
160921002|NCT01729754|581105222|FG007|Part 2|Pregnancy|0|||
160921003|NCT01729754|581105223|FG008|Part 2|Pregnancy|0|||
160921004|NCT01729754|581105224|FG009|Part 2|Pregnancy|1|||
161261170|NCT02696031|582336205|FG004|Up to Week 24|Withdrawal by Subject|0|||
161261171|NCT02696031|582336206|FG005|Up to Week 24|Withdrawal by Subject|0|||
161261172|NCT02696031|582336201|FG000|Up to Week 52|Adverse Event|4|||
161261173|NCT02696031|582336202|FG001|Up to Week 52|Adverse Event|5|||
161261174|NCT02696031|582336203|FG002|Up to Week 52|Adverse Event|3|||
161261175|NCT02696031|582336204|FG003|Up to Week 52|Adverse Event|0|||
161261176|NCT02696031|582336205|FG004|Up to Week 52|Adverse Event|0|||
161261177|NCT02696031|582336206|FG005|Up to Week 52|Adverse Event|0|||
161261178|NCT02696031|582336201|FG000|Up to Week 52|Lack of Efficacy|10|||
161261179|NCT02696031|582336202|FG001|Up to Week 52|Lack of Efficacy|7|||
160921005|NCT01729754|581105215|FG000|Part 2|Withdrawal by Subject|3|||
160921006|NCT01729754|581105216|FG001|Part 2|Withdrawal by Subject|0|||
161261180|NCT02696031|582336203|FG002|Up to Week 52|Lack of Efficacy|11|||
161261181|NCT02696031|582336204|FG003|Up to Week 52|Lack of Efficacy|0|||
161261182|NCT02696031|582336205|FG004|Up to Week 52|Lack of Efficacy|0|||
161261183|NCT02696031|582336206|FG005|Up to Week 52|Lack of Efficacy|0|||
160921007|NCT01729754|581105217|FG002|Part 2|Withdrawal by Subject|0|||
160921008|NCT01729754|581105218|FG003|Part 2|Withdrawal by Subject|2|||
160921009|NCT01729754|581105219|FG004|Part 2|Withdrawal by Subject|0|||
160921010|NCT01729754|581105220|FG005|Part 2|Withdrawal by Subject|0|||
160921011|NCT01729754|581105221|FG006|Part 2|Withdrawal by Subject|0|||
160921012|NCT01729754|581105222|FG007|Part 2|Withdrawal by Subject|1|||
160921013|NCT01729754|581105223|FG008|Part 2|Withdrawal by Subject|1|||
160921014|NCT01729754|581105224|FG009|Part 2|Withdrawal by Subject|4|||
160921015|NCT01729754|581105215|FG000|Part 2|Other Protocol Specified Criteria|1|||
160921016|NCT01729754|581105216|FG001|Part 2|Other Protocol Specified Criteria|0|||
160921017|NCT01729754|581105217|FG002|Part 2|Other Protocol Specified Criteria|0|||
160921018|NCT01729754|581105218|FG003|Part 2|Other Protocol Specified Criteria|0|||
160921019|NCT01729754|581105219|FG004|Part 2|Other Protocol Specified Criteria|0|||
160921020|NCT01729754|581105220|FG005|Part 2|Other Protocol Specified Criteria|0|||
160921021|NCT01729754|581105221|FG006|Part 2|Other Protocol Specified Criteria|0|||
160921022|NCT01729754|581105222|FG007|Part 2|Other Protocol Specified Criteria|1|||
161261184|NCT02696031|582336201|FG000|Up to Week 52|Lost to Follow-up|1|||
161261185|NCT02696031|582336202|FG001|Up to Week 52|Lost to Follow-up|1|||
161261186|NCT02696031|582336203|FG002|Up to Week 52|Lost to Follow-up|1|||
160921023|NCT01729754|581105223|FG008|Part 2|Other Protocol Specified Criteria|0|||
160921024|NCT01729754|581105224|FG009|Part 2|Other Protocol Specified Criteria|0|||
160921025|NCT01729754|581105215|FG000|Part 3|Adverse Event|0|||
160921026|NCT01729754|581105216|FG001|Part 3|Adverse Event|0|||
160921027|NCT01729754|581105217|FG002|Part 3|Adverse Event|1|||
160921028|NCT01729754|581105218|FG003|Part 3|Adverse Event|0|||
160921029|NCT01729754|581105219|FG004|Part 3|Adverse Event|0|||
160921030|NCT01729754|581105220|FG005|Part 3|Adverse Event|5|||
160921031|NCT01729754|581105221|FG006|Part 3|Adverse Event|0|||
160997570|NCT00246012|581376568|FG005|Overall Study|Withdrawal by Subject|1|||
160997571|NCT00246012|581376569|FG006|Overall Study|Withdrawal by Subject|0|||
160997572|NCT00246012|581376570|FG007|Overall Study|Withdrawal by Subject|0|||
160997573|NCT00246012|581376571|FG008|Overall Study|Withdrawal by Subject|0|||
160997574|NCT00246012|581376563|FG000|Overall Study|Disease progression|3|||
160997575|NCT00246012|581376564|FG001|Overall Study|Disease progression|1|||
160997576|NCT00246012|581376565|FG002|Overall Study|Disease progression|2|||
160997577|NCT00246012|581376566|FG003|Overall Study|Disease progression|3|||
160997578|NCT00246012|581376567|FG004|Overall Study|Disease progression|3|||
160997579|NCT00246012|581376568|FG005|Overall Study|Disease progression|25|||
160997580|NCT00246012|581376569|FG006|Overall Study|Disease progression|30|||
160997581|NCT00246012|581376570|FG007|Overall Study|Disease progression|27|||
160997582|NCT00246012|581376571|FG008|Overall Study|Disease progression|26|||
160997583|NCT00246012|581376563|FG000|Overall Study|Other|0|||
160997584|NCT00246012|581376564|FG001|Overall Study|Other|0|||
160997585|NCT00246012|581376565|FG002|Overall Study|Other|0|||
160997586|NCT00246012|581376566|FG003|Overall Study|Other|0|||
160997587|NCT00246012|581376567|FG004|Overall Study|Other|0|||
160997588|NCT00246012|581376568|FG005|Overall Study|Other|0|||
160997589|NCT00246012|581376569|FG006|Overall Study|Other|0|||
160997590|NCT00246012|581376570|FG007|Overall Study|Other|1|||
160997591|NCT00246012|581376571|FG008|Overall Study|Other|0|||
160997592|NCT00246012|581376563|FG000|Overall Study|Randomly assigned but not treated|0|||
160997593|NCT00246012|581376564|FG001|Overall Study|Randomly assigned but not treated|0|||
160997594|NCT00246012|581376565|FG002|Overall Study|Randomly assigned but not treated|0|||
160997595|NCT00246012|581376566|FG003|Overall Study|Randomly assigned but not treated|0|||
160997596|NCT00246012|581376567|FG004|Overall Study|Randomly assigned but not treated|0|||
160997597|NCT00246012|581376568|FG005|Overall Study|Randomly assigned but not treated|1|||
160997598|NCT00246012|581376569|FG006|Overall Study|Randomly assigned but not treated|1|||
160997599|NCT00246012|581376570|FG007|Overall Study|Randomly assigned but not treated|0|||
160997600|NCT00246012|581376571|FG008|Overall Study|Randomly assigned but not treated|0|||
160997601|NCT02377362|581376572|FG000|Part A Second Treatment|Protocol Violation|0|||
160997602|NCT02377362|581376573|FG001|Part A Second Treatment|Protocol Violation|0|||
160997603|NCT02377362|581376574|FG002|Part A Second Treatment|Protocol Violation|0|||
160997604|NCT02377362|581376575|FG003|Part A Second Treatment|Protocol Violation|0|||
160997605|NCT02377362|581376576|FG004|Part A Second Treatment|Protocol Violation|1|||
160997606|NCT02377362|581376577|FG005|Part A Second Treatment|Protocol Violation|0|||
160997607|NCT02377362|581376578|FG006|Part A Second Treatment|Protocol Violation|0|||
160997608|NCT02377362|581376579|FG007|Part A Second Treatment|Protocol Violation|0|||
160997609|NCT02377362|581376580|FG008|Part A Second Treatment|Protocol Violation|0|||
160997610|NCT02377362|581376581|FG009|Part A Second Treatment|Protocol Violation|0|||
160997611|NCT02377362|581376582|FG010|Part A Second Treatment|Protocol Violation|0|||
160997612|NCT02377362|581376583|FG011|Part A Second Treatment|Protocol Violation|0|||
160997613|NCT02377362|581376584|FG012|Part A Second Treatment|Protocol Violation|0|||
160997614|NCT02377362|581376572|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997615|NCT02377362|581376573|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997616|NCT02377362|581376574|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997617|NCT02377362|581376575|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
160997618|NCT02377362|581376576|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
160997619|NCT02377362|581376577|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
160997620|NCT02377362|581376578|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
161261187|NCT02696031|582336204|FG003|Up to Week 52|Lost to Follow-up|0|||
160997621|NCT02377362|581376579|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
161261188|NCT02696031|582336205|FG004|Up to Week 52|Lost to Follow-up|0|||
160997622|NCT02377362|581376580|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997623|NCT02377362|581376581|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997624|NCT02377362|581376582|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
160921032|NCT01729754|581105222|FG007|Part 3|Adverse Event|0|||
160921033|NCT01729754|581105223|FG008|Part 3|Adverse Event|0|||
160997625|NCT02377362|581376583|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997626|NCT02377362|581376584|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
160997627|NCT02377362|581376572|FG000|Part B Overall|Protocol Violation|0|||
160997628|NCT02377362|581376573|FG001|Part B Overall|Protocol Violation|0|||
161261189|NCT02696031|582336206|FG005|Up to Week 52|Lost to Follow-up|0|||
160921034|NCT01729754|581105224|FG009|Part 3|Adverse Event|3|||
160921035|NCT01729754|581105215|FG000|Part 3|Death|0|||
160921036|NCT01729754|581105216|FG001|Part 3|Death|0|||
160921037|NCT01729754|581105217|FG002|Part 3|Death|0|||
160921038|NCT01729754|581105218|FG003|Part 3|Death|0|||
160921039|NCT01729754|581105219|FG004|Part 3|Death|0|||
160921040|NCT01729754|581105220|FG005|Part 3|Death|2|||
160921041|NCT01729754|581105221|FG006|Part 3|Death|0|||
160921042|NCT01729754|581105222|FG007|Part 3|Death|0|||
160921043|NCT01729754|581105223|FG008|Part 3|Death|0|||
160921044|NCT01729754|581105224|FG009|Part 3|Death|0|||
160921045|NCT01729754|581105215|FG000|Part 3|Lack of Efficacy|0|||
160921046|NCT01729754|581105216|FG001|Part 3|Lack of Efficacy|0|||
160921047|NCT01729754|581105217|FG002|Part 3|Lack of Efficacy|0|||
160921048|NCT01729754|581105218|FG003|Part 3|Lack of Efficacy|0|||
160921049|NCT01729754|581105219|FG004|Part 3|Lack of Efficacy|2|||
160921050|NCT01729754|581105220|FG005|Part 3|Lack of Efficacy|0|||
160921051|NCT01729754|581105221|FG006|Part 3|Lack of Efficacy|0|||
160921052|NCT01729754|581105222|FG007|Part 3|Lack of Efficacy|0|||
160921053|NCT01729754|581105223|FG008|Part 3|Lack of Efficacy|0|||
160921054|NCT01729754|581105224|FG009|Part 3|Lack of Efficacy|4|||
160921055|NCT01729754|581105215|FG000|Part 3|Lost to Follow-up|0|||
160921056|NCT01729754|581105216|FG001|Part 3|Lost to Follow-up|1|||
160921057|NCT01729754|581105217|FG002|Part 3|Lost to Follow-up|2|||
160921058|NCT01729754|581105218|FG003|Part 3|Lost to Follow-up|0|||
160921059|NCT01729754|581105219|FG004|Part 3|Lost to Follow-up|0|||
160921060|NCT01729754|581105220|FG005|Part 3|Lost to Follow-up|3|||
160921061|NCT01729754|581105221|FG006|Part 3|Lost to Follow-up|0|||
160921062|NCT01729754|581105222|FG007|Part 3|Lost to Follow-up|0|||
160921063|NCT01729754|581105223|FG008|Part 3|Lost to Follow-up|1|||
160921064|NCT01729754|581105224|FG009|Part 3|Lost to Follow-up|0|||
160921065|NCT01729754|581105215|FG000|Part 3|Physician Decision|0|||
160921066|NCT01729754|581105216|FG001|Part 3|Physician Decision|0|||
160921067|NCT01729754|581105217|FG002|Part 3|Physician Decision|1|||
160921068|NCT01729754|581105218|FG003|Part 3|Physician Decision|0|||
160921069|NCT01729754|581105219|FG004|Part 3|Physician Decision|0|||
160921070|NCT01729754|581105220|FG005|Part 3|Physician Decision|0|||
160921071|NCT01729754|581105221|FG006|Part 3|Physician Decision|0|||
160921072|NCT01729754|581105222|FG007|Part 3|Physician Decision|0|||
160921073|NCT01729754|581105223|FG008|Part 3|Physician Decision|0|||
160921074|NCT01729754|581105224|FG009|Part 3|Physician Decision|0|||
160921075|NCT01729754|581105215|FG000|Part 3|Withdrawal by Subject|0|||
160921076|NCT01729754|581105216|FG001|Part 3|Withdrawal by Subject|4|||
160921077|NCT01729754|581105217|FG002|Part 3|Withdrawal by Subject|1|||
160921078|NCT01729754|581105218|FG003|Part 3|Withdrawal by Subject|0|||
160921079|NCT01729754|581105219|FG004|Part 3|Withdrawal by Subject|2|||
160921080|NCT01729754|581105220|FG005|Part 3|Withdrawal by Subject|1|||
160921081|NCT01729754|581105221|FG006|Part 3|Withdrawal by Subject|0|||
160921082|NCT01729754|581105222|FG007|Part 3|Withdrawal by Subject|2|||
160921083|NCT01729754|581105223|FG008|Part 3|Withdrawal by Subject|0|||
160921084|NCT01729754|581105224|FG009|Part 3|Withdrawal by Subject|0|||
160921085|NCT01729754|581105215|FG000|Part 3|Other Protocol Specified Criteria|0|||
160921086|NCT01729754|581105216|FG001|Part 3|Other Protocol Specified Criteria|0|||
160921087|NCT01729754|581105217|FG002|Part 3|Other Protocol Specified Criteria|0|||
160921088|NCT01729754|581105218|FG003|Part 3|Other Protocol Specified Criteria|0|||
160921089|NCT01729754|581105219|FG004|Part 3|Other Protocol Specified Criteria|0|||
160921090|NCT01729754|581105220|FG005|Part 3|Other Protocol Specified Criteria|2|||
160921091|NCT01729754|581105221|FG006|Part 3|Other Protocol Specified Criteria|0|||
160921092|NCT01729754|581105222|FG007|Part 3|Other Protocol Specified Criteria|1|||
160921093|NCT01729754|581105223|FG008|Part 3|Other Protocol Specified Criteria|0|||
160921094|NCT01729754|581105224|FG009|Part 3|Other Protocol Specified Criteria|0|||
160921095|NCT00936910|581105225|FG000|Overall Study|Lack of Efficacy|3|||
160921096|NCT01349803|581105227|FG000|Overall Study|Adverse Event|0|||
160921097|NCT01349803|581105228|FG001|Overall Study|Adverse Event|0|||
160921098|NCT01349803|581105229|FG002|Overall Study|Adverse Event|0|||
160921099|NCT01349803|581105230|FG003|Overall Study|Adverse Event|2|||
160921100|NCT01349803|581105227|FG000|Overall Study|Withdrawal by Subject|1|||
160921101|NCT01349803|581105228|FG001|Overall Study|Withdrawal by Subject|0|||
160921102|NCT01349803|581105229|FG002|Overall Study|Withdrawal by Subject|0|||
160921103|NCT01349803|581105230|FG003|Overall Study|Withdrawal by Subject|0|||
160921104|NCT01349803|581105227|FG000|Overall Study|Protocol-specified criteria|0|||
160921105|NCT01349803|581105228|FG001|Overall Study|Protocol-specified criteria|1|||
160921106|NCT01349803|581105229|FG002|Overall Study|Protocol-specified criteria|3|||
160921107|NCT01349803|581105230|FG003|Overall Study|Protocol-specified criteria|0|||
160921108|NCT02345811|581105231|FG000|First Intervention|Withdrawal by Subject|1|||
160921109|NCT02345811|581105232|FG001|First Intervention|Withdrawal by Subject|1|||
160921110|NCT02522286|581105233|FG000|Overall Study|Withdrawal by Subject|3|||
160921111|NCT02522286|581105234|FG001|Overall Study|Withdrawal by Subject|0|||
160921112|NCT02522286|581105235|FG002|Overall Study|Withdrawal by Subject|0|||
160921113|NCT02522286|581105236|FG003|Overall Study|Withdrawal by Subject|3|||
160921114|NCT00605813|581105238|FG000|Overall Study|Protocol Violation|25|||
160921115|NCT01163279|581105239|FG000|Overall Study|Withdrawal by Subject|2|||
160921116|NCT01163279|581105240|FG001|Overall Study|Withdrawal by Subject|0|||
160921117|NCT01870583|581105242|FG000|Overall Study|Protocol Violation|0|||
160921118|NCT01870583|581105243|FG001|Overall Study|Protocol Violation|5|||
160921119|NCT01870583|581105244|FG002|Overall Study|Protocol Violation|3|||
160921120|NCT01870583|581105242|FG000|Overall Study|Lost to Follow-up|11|||
160921121|NCT01870583|581105243|FG001|Overall Study|Lost to Follow-up|13|||
160921122|NCT01870583|581105244|FG002|Overall Study|Lost to Follow-up|5|||
160921123|NCT01394523|581105245|FG000|Overall Study|Unable to place block|1|||
160921124|NCT01394523|581105246|FG001|Overall Study|Unable to place block|0|||
160921125|NCT01394523|581105247|FG002|Overall Study|Unable to place block|0|||
160921126|NCT02389998|581105251|FG000|Overall Study|car accident|1|||
160921127|NCT02389998|581105252|FG001|Overall Study|car accident|0|||
160921128|NCT04741074|581105255|FG000|Overall Study|Withdrawal by Subject|1|||
160921129|NCT04741074|581105256|FG001|Overall Study|Withdrawal by Subject|1|||
160921130|NCT04741074|581105255|FG000|Overall Study|Study terminated prematurely|1|||
160921131|NCT04741074|581105256|FG001|Overall Study|Study terminated prematurely|0|||
160921132|NCT01770379|581105258|FG000|Overall Study|Technical issues|1|||
160921133|NCT01770379|581105259|FG001|Overall Study|Technical issues|0|||
160921134|NCT01770379|581105260|FG002|Overall Study|Technical issues|0|||
160921135|NCT01770379|581105258|FG000|Overall Study|Withdrawal by Subject|7|||
160921136|NCT01770379|581105259|FG001|Overall Study|Withdrawal by Subject|10|||
160921137|NCT01770379|581105260|FG002|Overall Study|Withdrawal by Subject|7|||
160921138|NCT01770379|581105258|FG000|Overall Study|study terminated by sponsor|22|||
160921139|NCT01770379|581105259|FG001|Overall Study|study terminated by sponsor|23|||
160921140|NCT01770379|581105260|FG002|Overall Study|study terminated by sponsor|22|||
160921141|NCT01770379|581105258|FG000|Overall Study|Protocol Violation|0|||
160921142|NCT01770379|581105259|FG001|Overall Study|Protocol Violation|1|||
160921143|NCT01770379|581105260|FG002|Overall Study|Protocol Violation|1|||
160921144|NCT01770379|581105258|FG000|Overall Study|Physician Decision|0|||
160921145|NCT01770379|581105259|FG001|Overall Study|Physician Decision|1|||
160921146|NCT01770379|581105260|FG002|Overall Study|Physician Decision|2|||
160921147|NCT01770379|581105258|FG000|Overall Study|Lost to Follow-up|0|||
160921148|NCT01770379|581105259|FG001|Overall Study|Lost to Follow-up|0|||
160921149|NCT01770379|581105260|FG002|Overall Study|Lost to Follow-up|2|||
160921150|NCT01770379|581105258|FG000|Overall Study|Lack of Efficacy|8|||
160921151|NCT01770379|581105259|FG001|Overall Study|Lack of Efficacy|6|||
160921152|NCT01770379|581105260|FG002|Overall Study|Lack of Efficacy|6|||
160921153|NCT01770379|581105258|FG000|Overall Study|Adverse Event|1|||
160921154|NCT01770379|581105259|FG001|Overall Study|Adverse Event|3|||
160921155|NCT01770379|581105260|FG002|Overall Study|Adverse Event|2|||
160921156|NCT02632552|581105261|FG000|Overall Study|Lost to Follow-up|14|||
160921157|NCT02632552|581105262|FG001|Overall Study|Lost to Follow-up|8|||
160921158|NCT02632552|581105261|FG000|Overall Study|Withdrawal by Subject|2|||
160921159|NCT02632552|581105262|FG001|Overall Study|Withdrawal by Subject|0|||
160921160|NCT02632552|581105261|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
160921161|NCT02632552|581105262|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
160921162|NCT00778700|581105269|FG000|Overall Study|Adverse Event|6|||
160921163|NCT00778700|581105270|FG001|Overall Study|Adverse Event|1|||
160921164|NCT00778700|581105271|FG002|Overall Study|Adverse Event|3|||
160921165|NCT00778700|581105272|FG003|Overall Study|Adverse Event|5|||
160921166|NCT00778700|581105269|FG000|Overall Study|Protocol Violation|1|||
160921167|NCT00778700|581105270|FG001|Overall Study|Protocol Violation|1|||
160921168|NCT00778700|581105271|FG002|Overall Study|Protocol Violation|0|||
160921169|NCT00778700|581105272|FG003|Overall Study|Protocol Violation|0|||
160921170|NCT00778700|581105269|FG000|Overall Study|Subject Withdrew Consent|6|||
160921171|NCT00778700|581105270|FG001|Overall Study|Subject Withdrew Consent|4|||
160921172|NCT00778700|581105271|FG002|Overall Study|Subject Withdrew Consent|1|||
160921173|NCT00778700|581105272|FG003|Overall Study|Subject Withdrew Consent|4|||
160921174|NCT00778700|581105269|FG000|Overall Study|Lost to Follow-up|3|||
160921175|NCT00778700|581105270|FG001|Overall Study|Lost to Follow-up|1|||
160921176|NCT00778700|581105271|FG002|Overall Study|Lost to Follow-up|0|||
160921177|NCT00778700|581105272|FG003|Overall Study|Lost to Follow-up|1|||
160921178|NCT00778700|581105269|FG000|Overall Study|Reason not Specified|2|||
160921179|NCT00778700|581105270|FG001|Overall Study|Reason not Specified|0|||
160921180|NCT00778700|581105271|FG002|Overall Study|Reason not Specified|1|||
160921181|NCT00778700|581105272|FG003|Overall Study|Reason not Specified|3|||
160921182|NCT00778700|581105269|FG000|Overall Study|Other|0|||
160921183|NCT00778700|581105270|FG001|Overall Study|Other|0|||
160921184|NCT00778700|581105271|FG002|Overall Study|Other|1|||
160921185|NCT00778700|581105272|FG003|Overall Study|Other|0|||
160921186|NCT03274440|581105275|FG000|Overall Study|Time commitment too great|1|||
160921187|NCT03274440|581105276|FG001|Overall Study|Time commitment too great|0|||
160921188|NCT03274440|581105277|FG002|Overall Study|Time commitment too great|0|||
160921189|NCT03274440|581105278|FG003|Overall Study|Time commitment too great|1|||
160921190|NCT03274440|581105279|FG004|Overall Study|Time commitment too great|0|||
160921191|NCT03274440|581105280|FG005|Overall Study|Time commitment too great|0|||
160921192|NCT00450450|581105281|FG000|Overall Study|Death|1|||
160921193|NCT00450450|581105282|FG001|Overall Study|Death|3|||
160921194|NCT00450450|581105281|FG000|Overall Study|Relapse|2|||
160921195|NCT00450450|581105282|FG001|Overall Study|Relapse|0|||
160921196|NCT00450450|581105281|FG000|Overall Study|Missing Data|2|||
160921197|NCT00450450|581105282|FG001|Overall Study|Missing Data|0|||
160921198|NCT02150954|581105285|FG000|Overall Study|Protocol Violation|1|||
160921199|NCT02150954|581105286|FG001|Overall Study|Protocol Violation|0|||
160921200|NCT02611778|581105292|FG000|Overall Study|Withdrawal by Subject|2|||
160921201|NCT02611778|581105293|FG001|Overall Study|Withdrawal by Subject|8|||
160921202|NCT02611778|581105292|FG000|Overall Study|Adverse Event|1|||
160921203|NCT02611778|581105293|FG001|Overall Study|Adverse Event|2|||
160921204|NCT02611778|581105292|FG000|Overall Study|Death|2|||
160921205|NCT02611778|581105293|FG001|Overall Study|Death|1|||
160921206|NCT02611778|581105292|FG000|Overall Study|Protocol Violation|1|||
160921207|NCT02611778|581105293|FG001|Overall Study|Protocol Violation|0|||
160921208|NCT02611778|581105292|FG000|Overall Study|Lost to Follow-up|3|||
160921209|NCT02611778|581105293|FG001|Overall Study|Lost to Follow-up|1|||
160921210|NCT02611778|581105292|FG000|Overall Study|Need for alternative treatment|1|||
160921211|NCT02611778|581105293|FG001|Overall Study|Need for alternative treatment|0|||
160921212|NCT02611778|581105292|FG000|Overall Study|Other Reason|2|||
160921213|NCT02611778|581105293|FG001|Overall Study|Other Reason|1|||
160921214|NCT02369341|581105294|FG000|Overall Study|Migrated/moved from study area|1|||
160921215|NCT02369341|581105295|FG001|Overall Study|Migrated/moved from study area|0|||
160921216|NCT04008030|581105297|FG000|Pre-Treatment|Withdrawal by Subject|0|||
160921217|NCT04008030|581105298|FG001|Pre-Treatment|Withdrawal by Subject|0|||
160921218|NCT04008030|581105299|FG002|Pre-Treatment|Withdrawal by Subject|9|||
160921219|NCT04008030|581105297|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160921220|NCT04008030|581105298|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
160921221|NCT04008030|581105299|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
160921222|NCT04008030|581105297|FG000|Pre-Treatment|Other reasons|0|||
160921223|NCT04008030|581105298|FG001|Pre-Treatment|Other reasons|1|||
160921224|NCT04008030|581105299|FG002|Pre-Treatment|Other reasons|6|||
160921225|NCT04008030|581105297|FG000|Treatment|Withdrawal by Subject|1|||
160921226|NCT04008030|581105298|FG001|Treatment|Withdrawal by Subject|1|||
160921227|NCT04008030|581105299|FG002|Treatment|Withdrawal by Subject|1|||
160921228|NCT04008030|581105297|FG000|Treatment|Death|2|||
160921229|NCT04008030|581105298|FG001|Treatment|Death|4|||
160921230|NCT04008030|581105299|FG002|Treatment|Death|0|||
160921231|NCT04008030|581105297|FG000|Treatment|Pregnancy|0|||
160921232|NCT04008030|581105298|FG001|Treatment|Pregnancy|1|||
160921233|NCT04008030|581105299|FG002|Treatment|Pregnancy|0|||
160921234|NCT04008030|581105297|FG000|Treatment|Participant no longer meets study criteria|0|||
160921235|NCT04008030|581105298|FG001|Treatment|Participant no longer meets study criteria|1|||
160921236|NCT04008030|581105299|FG002|Treatment|Participant no longer meets study criteria|0|||
160921237|NCT04008030|581105297|FG000|Treatment|Other reasons|5|||
160921238|NCT04008030|581105298|FG001|Treatment|Other reasons|13|||
160921239|NCT04008030|581105299|FG002|Treatment|Other reasons|6|||
160921240|NCT04008030|581105297|FG000|Treatment|Disease Progression|137|||
160921241|NCT04008030|581105298|FG001|Treatment|Disease Progression|82|||
160921242|NCT04008030|581105299|FG002|Treatment|Disease Progression|85|||
160921243|NCT04008030|581105297|FG000|Treatment|Study drug toxicity|28|||
160921244|NCT04008030|581105298|FG001|Treatment|Study drug toxicity|48|||
160921245|NCT04008030|581105299|FG002|Treatment|Study drug toxicity|8|||
160921246|NCT04008030|581105297|FG000|Treatment|Adverse Event unrelated to study drug|28|||
160921247|NCT04008030|581105298|FG001|Treatment|Adverse Event unrelated to study drug|22|||
160921248|NCT04008030|581105299|FG002|Treatment|Adverse Event unrelated to study drug|6|||
160921249|NCT04008030|581105297|FG000|Treatment|Maximum Clinical Benefit|0|||
160997629|NCT02377362|581376574|FG002|Part B Overall|Protocol Violation|0|||
160997630|NCT02377362|581376575|FG003|Part B Overall|Protocol Violation|0|||
160997631|NCT02377362|581376576|FG004|Part B Overall|Protocol Violation|0|||
160997632|NCT02377362|581376577|FG005|Part B Overall|Protocol Violation|0|||
160921250|NCT04008030|581105298|FG001|Treatment|Maximum Clinical Benefit|1|||
160921251|NCT04008030|581105299|FG002|Treatment|Maximum Clinical Benefit|9|||
160921252|NCT04008030|581105297|FG000|Treatment|On-going treatment|13|||
160921253|NCT04008030|581105298|FG001|Treatment|On-going treatment|20|||
160921254|NCT04008030|581105299|FG002|Treatment|On-going treatment|0|||
160921255|NCT02574247|581105300|FG000|Overall Study|Withdrawal by Subject|1|||
160921256|NCT02574247|581105301|FG001|Overall Study|Withdrawal by Subject|0|||
160921257|NCT02574247|581105302|FG002|Overall Study|Withdrawal by Subject|0|||
160921258|NCT02574247|581105300|FG000|Overall Study|Did not meet inclusion criteria|4|||
160921259|NCT02574247|581105301|FG001|Overall Study|Did not meet inclusion criteria|3|||
160921260|NCT02574247|581105302|FG002|Overall Study|Did not meet inclusion criteria|5|||
160921261|NCT02659631|581105305|FG000|Overall Study|Lost to Follow-up|0|||
160997633|NCT02377362|581376578|FG006|Part B Overall|Protocol Violation|0|||
161261190|NCT02696031|582336201|FG000|Up to Week 52|Physician Decision|1|||
161261191|NCT02696031|582336202|FG001|Up to Week 52|Physician Decision|1|||
160921262|NCT02659631|581105306|FG001|Overall Study|Lost to Follow-up|0|||
160921263|NCT02659631|581105307|FG002|Overall Study|Lost to Follow-up|2|||
160921264|NCT02659631|581105308|FG003|Overall Study|Lost to Follow-up|0|||
160921265|NCT02659631|581105309|FG004|Overall Study|Lost to Follow-up|0|||
160921266|NCT02659631|581105310|FG005|Overall Study|Lost to Follow-up|1|||
160997634|NCT02377362|581376579|FG007|Part B Overall|Protocol Violation|0|||
160997635|NCT02377362|581376580|FG008|Part B Overall|Protocol Violation|0|||
160997636|NCT02377362|581376581|FG009|Part B Overall|Protocol Violation|1|||
160997637|NCT02377362|581376582|FG010|Part B Overall|Protocol Violation|0|||
160997638|NCT02377362|581376583|FG011|Part B Overall|Protocol Violation|0|||
160997639|NCT02377362|581376584|FG012|Part B Overall|Protocol Violation|0|||
160997640|NCT02377362|581376572|FG000|Part B Overall|Adverse Event|0|||
160997641|NCT02377362|581376573|FG001|Part B Overall|Adverse Event|0|||
160997642|NCT02377362|581376574|FG002|Part B Overall|Adverse Event|0|||
160997643|NCT02377362|581376575|FG003|Part B Overall|Adverse Event|0|||
160997644|NCT02377362|581376576|FG004|Part B Overall|Adverse Event|0|||
160997645|NCT02377362|581376577|FG005|Part B Overall|Adverse Event|0|||
160997646|NCT02377362|581376578|FG006|Part B Overall|Adverse Event|1|||
160997647|NCT02377362|581376579|FG007|Part B Overall|Adverse Event|1|||
160997648|NCT02377362|581376580|FG008|Part B Overall|Adverse Event|0|||
160997649|NCT02377362|581376581|FG009|Part B Overall|Adverse Event|0|||
160997650|NCT02377362|581376582|FG010|Part B Overall|Adverse Event|0|||
160997651|NCT02377362|581376583|FG011|Part B Overall|Adverse Event|0|||
160997652|NCT02377362|581376584|FG012|Part B Overall|Adverse Event|0|||
160997653|NCT02377362|581376572|FG000|Part B Overall|Withdrawal by Subject|0|||
160997654|NCT02377362|581376573|FG001|Part B Overall|Withdrawal by Subject|0|||
160997655|NCT02377362|581376574|FG002|Part B Overall|Withdrawal by Subject|0|||
160921267|NCT02659631|581105311|FG006|Overall Study|Lost to Follow-up|0|||
160921268|NCT02659631|581105312|FG007|Overall Study|Lost to Follow-up|0|||
161261192|NCT02696031|582336203|FG002|Up to Week 52|Physician Decision|2|||
160921269|NCT02659631|581105313|FG008|Overall Study|Lost to Follow-up|0|||
160921270|NCT02659631|581105314|FG009|Overall Study|Lost to Follow-up|0|||
160921271|NCT02659631|581105305|FG000|Overall Study|Withdrawal prior to treatment|0|||
160921272|NCT02659631|581105306|FG001|Overall Study|Withdrawal prior to treatment|0|||
160921273|NCT02659631|581105307|FG002|Overall Study|Withdrawal prior to treatment|0|||
160921274|NCT02659631|581105308|FG003|Overall Study|Withdrawal prior to treatment|0|||
160921275|NCT02659631|581105309|FG004|Overall Study|Withdrawal prior to treatment|1|||
160921276|NCT02659631|581105310|FG005|Overall Study|Withdrawal prior to treatment|0|||
160921277|NCT02659631|581105311|FG006|Overall Study|Withdrawal prior to treatment|0|||
160921278|NCT02659631|581105312|FG007|Overall Study|Withdrawal prior to treatment|0|||
160921279|NCT02659631|581105313|FG008|Overall Study|Withdrawal prior to treatment|0|||
160921280|NCT02659631|581105314|FG009|Overall Study|Withdrawal prior to treatment|0|||
160921281|NCT02659631|581105305|FG000|Overall Study|Participant refused further follow-up|0|||
160921282|NCT02659631|581105306|FG001|Overall Study|Participant refused further follow-up|0|||
160921283|NCT02659631|581105307|FG002|Overall Study|Participant refused further follow-up|0|||
160921284|NCT02659631|581105308|FG003|Overall Study|Participant refused further follow-up|1|||
160921285|NCT02659631|581105309|FG004|Overall Study|Participant refused further follow-up|0|||
160921286|NCT02659631|581105310|FG005|Overall Study|Participant refused further follow-up|0|||
160921287|NCT02659631|581105311|FG006|Overall Study|Participant refused further follow-up|0|||
160921288|NCT02659631|581105312|FG007|Overall Study|Participant refused further follow-up|0|||
160921289|NCT02659631|581105313|FG008|Overall Study|Participant refused further follow-up|1|||
160921290|NCT02659631|581105314|FG009|Overall Study|Participant refused further follow-up|0|||
160921291|NCT02659631|581105305|FG000|Overall Study|Death (follow-up phase)|1|||
160921292|NCT02659631|581105306|FG001|Overall Study|Death (follow-up phase)|2|||
160921293|NCT02659631|581105307|FG002|Overall Study|Death (follow-up phase)|1|||
160921294|NCT02659631|581105308|FG003|Overall Study|Death (follow-up phase)|1|||
160921295|NCT02659631|581105309|FG004|Overall Study|Death (follow-up phase)|3|||
160921296|NCT02659631|581105310|FG005|Overall Study|Death (follow-up phase)|2|||
160921297|NCT02659631|581105311|FG006|Overall Study|Death (follow-up phase)|0|||
160997656|NCT02377362|581376575|FG003|Part B Overall|Withdrawal by Subject|0|||
160997657|NCT02377362|581376576|FG004|Part B Overall|Withdrawal by Subject|0|||
160997658|NCT02377362|581376577|FG005|Part B Overall|Withdrawal by Subject|0|||
160997659|NCT02377362|581376578|FG006|Part B Overall|Withdrawal by Subject|1|||
160997660|NCT02377362|581376579|FG007|Part B Overall|Withdrawal by Subject|0|||
160921298|NCT02659631|581105312|FG007|Overall Study|Death (follow-up phase)|3|||
160921299|NCT02659631|581105313|FG008|Overall Study|Death (follow-up phase)|1|||
160921300|NCT02659631|581105314|FG009|Overall Study|Death (follow-up phase)|0|||
160921301|NCT02659631|581105305|FG000|Overall Study|Death (treatment phase)|0|||
160921302|NCT02659631|581105306|FG001|Overall Study|Death (treatment phase)|0|||
161261193|NCT02696031|582336204|FG003|Up to Week 52|Physician Decision|0|||
161261194|NCT02696031|582336205|FG004|Up to Week 52|Physician Decision|0|||
160921303|NCT02659631|581105307|FG002|Overall Study|Death (treatment phase)|0|||
160997661|NCT02377362|581376580|FG008|Part B Overall|Withdrawal by Subject|0|||
160997662|NCT02377362|581376581|FG009|Part B Overall|Withdrawal by Subject|0|||
160997663|NCT02377362|581376582|FG010|Part B Overall|Withdrawal by Subject|0|||
161261195|NCT02696031|582336206|FG005|Up to Week 52|Physician Decision|0|||
161261196|NCT02696031|582336201|FG000|Up to Week 52|Pregnancy|0|||
160997664|NCT02377362|581376583|FG011|Part B Overall|Withdrawal by Subject|1|||
161261197|NCT02696031|582336202|FG001|Up to Week 52|Pregnancy|2|||
160997665|NCT02377362|581376584|FG012|Part B Overall|Withdrawal by Subject|0|||
160997666|NCT01651949|581376587|FG000|Overall Study|Unknown status|4|||
161261198|NCT02696031|582336203|FG002|Up to Week 52|Pregnancy|0|||
161261199|NCT02696031|582336204|FG003|Up to Week 52|Pregnancy|0|||
161261200|NCT02696031|582336205|FG004|Up to Week 52|Pregnancy|0|||
161261201|NCT02696031|582336206|FG005|Up to Week 52|Pregnancy|0|||
161261202|NCT02696031|582336201|FG000|Up to Week 52|Protocol Violation|1|||
161261203|NCT02696031|582336202|FG001|Up to Week 52|Protocol Violation|0|||
160921304|NCT02659631|581105308|FG003|Overall Study|Death (treatment phase)|0|||
160921305|NCT02659631|581105309|FG004|Overall Study|Death (treatment phase)|1|||
160921306|NCT02659631|581105310|FG005|Overall Study|Death (treatment phase)|0|||
160921307|NCT02659631|581105311|FG006|Overall Study|Death (treatment phase)|1|||
160921308|NCT02659631|581105312|FG007|Overall Study|Death (treatment phase)|0|||
160921309|NCT02659631|581105313|FG008|Overall Study|Death (treatment phase)|0|||
160921310|NCT02659631|581105314|FG009|Overall Study|Death (treatment phase)|0|||
160921311|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
160921312|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
160921313|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921314|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921315|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921316|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
160921317|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
160921318|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
160921319|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921320|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921321|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921322|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
160921323|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921324|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
160921325|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921326|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921327|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921328|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
160921329|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
160921330|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
160921331|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921332|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921333|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921334|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
160921335|NCT01496313|581105315|FG000|Randomized Period (up to 14 Months)|Other|1|||
160921336|NCT01496313|581105316|FG001|Randomized Period (up to 14 Months)|Other|2|||
160921337|NCT01496313|581105317|FG002|Randomized Period (up to 14 Months)|Other|0|||
160921338|NCT01496313|581105318|FG003|Randomized Period (up to 14 Months)|Other|0|||
160921339|NCT01496313|581105319|FG004|Randomized Period (up to 14 Months)|Other|0|||
160921340|NCT01496313|581105320|FG005|Randomized Period (up to 14 Months)|Other|0|||
160921341|NCT01496313|581105315|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921342|NCT01496313|581105316|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921343|NCT01496313|581105317|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921344|NCT01496313|581105318|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921345|NCT01496313|581105319|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
160921346|NCT01496313|581105320|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
160921347|NCT01496313|581105315|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921348|NCT01496313|581105316|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921349|NCT01496313|581105317|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921350|NCT01496313|581105318|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921351|NCT01496313|581105319|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
160921352|NCT01496313|581105320|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
160921353|NCT01496313|581105315|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
160921354|NCT01496313|581105316|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
160921355|NCT01496313|581105317|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
160921356|NCT01496313|581105318|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
160921357|NCT01496313|581105319|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
160921358|NCT01496313|581105320|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
161261204|NCT02696031|582336203|FG002|Up to Week 52|Protocol Violation|0|||
161261205|NCT02696031|582336204|FG003|Up to Week 52|Protocol Violation|0|||
161261206|NCT02696031|582336205|FG004|Up to Week 52|Protocol Violation|0|||
161261207|NCT02696031|582336206|FG005|Up to Week 52|Protocol Violation|0|||
161261208|NCT02696031|582336201|FG000|Up to Week 52|Withdrawal by Subject|12|||
161341013|NCT06057064|582635602|FG001|Overall Study|Withdrawal by Subject|1|||
160921359|NCT00171223|581105325|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
160921360|NCT00171223|581105326|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
160921361|NCT00171223|581105327|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
160921362|NCT00171223|581105325|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
160921363|NCT00171223|581105326|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
160921364|NCT00171223|581105327|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
160921365|NCT00171223|581105325|FG000|Overall Study|Abnormal Procedure|1|||
160921366|NCT00171223|581105326|FG001|Overall Study|Abnormal Procedure|0|||
160921367|NCT00171223|581105327|FG002|Overall Study|Abnormal Procedure|0|||
160921368|NCT00171223|581105325|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
160921369|NCT00171223|581105326|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
160921370|NCT00171223|581105327|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
160921371|NCT00171223|581105325|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
160921372|NCT00171223|581105326|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
160921373|NCT00171223|581105327|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
160921374|NCT00171223|581105325|FG000|Overall Study|Protocol Violation|2|||
160921375|NCT00171223|581105326|FG001|Overall Study|Protocol Violation|2|||
160921376|NCT00171223|581105327|FG002|Overall Study|Protocol Violation|3|||
160921377|NCT00171223|581105325|FG000|Overall Study|Participant Withdrew Consent|12|||
160921378|NCT00171223|581105326|FG001|Overall Study|Participant Withdrew Consent|21|||
160921379|NCT00171223|581105327|FG002|Overall Study|Participant Withdrew Consent|15|||
160921380|NCT00171223|581105325|FG000|Overall Study|Lost to Follow-up|5|||
160921381|NCT00171223|581105326|FG001|Overall Study|Lost to Follow-up|2|||
160921382|NCT00171223|581105327|FG002|Overall Study|Lost to Follow-up|3|||
160921383|NCT00171223|581105325|FG000|Overall Study|Administrative Problems|4|||
160921384|NCT00171223|581105326|FG001|Overall Study|Administrative Problems|7|||
160921385|NCT00171223|581105327|FG002|Overall Study|Administrative Problems|6|||
160921386|NCT00171223|581105325|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
160921387|NCT00171223|581105326|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
160921388|NCT00171223|581105327|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
160921389|NCT00171223|581105325|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
160921390|NCT00171223|581105326|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
160921391|NCT00171223|581105327|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
160921392|NCT00451321|581105328|FG000|Overall Study|Lost to Follow-up|3|||
160921393|NCT00451321|581105329|FG001|Overall Study|Lost to Follow-up|3|||
160921394|NCT00451321|581105330|FG002|Overall Study|Lost to Follow-up|1|||
160921395|NCT00451321|581105331|FG003|Overall Study|Lost to Follow-up|3|||
160921396|NCT00451321|581105332|FG004|Overall Study|Lost to Follow-up|0|||
160921397|NCT00451321|581105333|FG005|Overall Study|Lost to Follow-up|1|||
160921398|NCT00451321|581105334|FG006|Overall Study|Lost to Follow-up|0|||
160921399|NCT00451321|581105335|FG007|Overall Study|Lost to Follow-up|0|||
160921400|NCT00451321|581105328|FG000|Overall Study|Withdrawal by Subject|3|||
160921401|NCT00451321|581105329|FG001|Overall Study|Withdrawal by Subject|1|||
160921402|NCT00451321|581105330|FG002|Overall Study|Withdrawal by Subject|0|||
160921403|NCT00451321|581105331|FG003|Overall Study|Withdrawal by Subject|4|||
160921404|NCT00451321|581105332|FG004|Overall Study|Withdrawal by Subject|0|||
160921405|NCT00451321|581105333|FG005|Overall Study|Withdrawal by Subject|0|||
160921406|NCT00451321|581105334|FG006|Overall Study|Withdrawal by Subject|0|||
160921407|NCT00451321|581105335|FG007|Overall Study|Withdrawal by Subject|0|||
160921408|NCT00451321|581105328|FG000|Overall Study|Study closed/terminated|1|||
160921409|NCT00451321|581105329|FG001|Overall Study|Study closed/terminated|1|||
160921410|NCT00451321|581105330|FG002|Overall Study|Study closed/terminated|17|||
160921411|NCT00451321|581105331|FG003|Overall Study|Study closed/terminated|5|||
160921412|NCT00451321|581105332|FG004|Overall Study|Study closed/terminated|7|||
160921413|NCT00451321|581105333|FG005|Overall Study|Study closed/terminated|7|||
160921414|NCT00451321|581105334|FG006|Overall Study|Study closed/terminated|5|||
160921415|NCT00451321|581105335|FG007|Overall Study|Study closed/terminated|3|||
160921416|NCT00451321|581105328|FG000|Overall Study|Sponsor decision to amend protocol|0|||
160921417|NCT00451321|581105329|FG001|Overall Study|Sponsor decision to amend protocol|0|||
160921418|NCT00451321|581105330|FG002|Overall Study|Sponsor decision to amend protocol|0|||
160997667|NCT01651949|581376588|FG001|Overall Study|Unknown status|4|||
160997668|NCT01651949|581376589|FG002|Overall Study|Unknown status|0|||
160997669|NCT01651949|581376587|FG000|Overall Study|Lost to Follow-up|30|||
161143359|NCT00923091|581907586|FG012|Period VI (Open-Label)|Adverse Event|0|||
161143360|NCT00923091|581907574|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
161341014|NCT00851591|582635604|FG000|Overall Study|Withdrawal by Subject|2|||
160921419|NCT00451321|581105331|FG003|Overall Study|Sponsor decision to amend protocol|0|||
160921420|NCT00451321|581105332|FG004|Overall Study|Sponsor decision to amend protocol|0|||
160921421|NCT00451321|581105333|FG005|Overall Study|Sponsor decision to amend protocol|1|||
160921422|NCT00451321|581105334|FG006|Overall Study|Sponsor decision to amend protocol|1|||
160921423|NCT00451321|581105335|FG007|Overall Study|Sponsor decision to amend protocol|3|||
161341015|NCT00851591|582635605|FG001|Overall Study|Withdrawal by Subject|0|||
160921424|NCT02064166|581105336|FG000|Overall Study|Adverse Event|1|||
160921425|NCT02064166|581105337|FG001|Overall Study|Adverse Event|0|||
160997670|NCT01651949|581376588|FG001|Overall Study|Lost to Follow-up|56|||
160997671|NCT01651949|581376589|FG002|Overall Study|Lost to Follow-up|20|||
160997672|NCT01651949|581376587|FG000|Overall Study|Protocol Violation|0|||
160997673|NCT01651949|581376588|FG001|Overall Study|Protocol Violation|2|||
160997674|NCT01651949|581376589|FG002|Overall Study|Protocol Violation|1|||
160997675|NCT01651949|581376587|FG000|Overall Study|Physician Decision|0|||
160997676|NCT01651949|581376588|FG001|Overall Study|Physician Decision|2|||
160997677|NCT01651949|581376589|FG002|Overall Study|Physician Decision|0|||
160997678|NCT01651949|581376587|FG000|Overall Study|Adverse Event|0|||
160997679|NCT01651949|581376588|FG001|Overall Study|Adverse Event|2|||
160997680|NCT01651949|581376589|FG002|Overall Study|Adverse Event|1|||
160997681|NCT01651949|581376587|FG000|Overall Study|Screen failure|2|||
160997682|NCT01651949|581376588|FG001|Overall Study|Screen failure|2|||
160997683|NCT01651949|581376589|FG002|Overall Study|Screen failure|0|||
160997684|NCT01651949|581376587|FG000|Overall Study|Withdrawal by Subject|17|||
160997685|NCT01651949|581376588|FG001|Overall Study|Withdrawal by Subject|18|||
160997686|NCT01651949|581376589|FG002|Overall Study|Withdrawal by Subject|9|||
160997687|NCT01806714|581376590|FG000|Overall Study|No functioning phone number|200|||
160997688|NCT01806714|581376591|FG001|Overall Study|No functioning phone number|170|||
160997689|NCT02155829|581376592|FG000|Overall Study|Adverse Event|1|||
160997690|NCT02155829|581376593|FG001|Overall Study|Adverse Event|0|||
160997691|NCT02155829|581376592|FG000|Overall Study|Withdrawal by Subject|3|||
160997692|NCT02155829|581376593|FG001|Overall Study|Withdrawal by Subject|3|||
160997693|NCT02155829|581376592|FG000|Overall Study|Protocol Violation|2|||
160997694|NCT02155829|581376593|FG001|Overall Study|Protocol Violation|0|||
160997695|NCT01585038|581376594|FG000|Overall Study|Adverse Event|2|||
160997696|NCT01585038|581376595|FG001|Overall Study|Adverse Event|2|||
160997697|NCT00678795|581376596|FG000|Overall Study|Adverse Event|7|||
160997698|NCT00678795|581376597|FG001|Overall Study|Adverse Event|3|||
160997699|NCT00678795|581376596|FG000|Overall Study|Withdrawal by Subject|3|||
160997700|NCT00678795|581376597|FG001|Overall Study|Withdrawal by Subject|0|||
160997701|NCT00678795|581376596|FG000|Overall Study|Protocol Violation|0|||
160997702|NCT00678795|581376597|FG001|Overall Study|Protocol Violation|1|||
160997703|NCT00678795|581376596|FG000|Overall Study|Lost to Follow-up|0|||
160997704|NCT00678795|581376597|FG001|Overall Study|Lost to Follow-up|1|||
160921426|NCT00909389|581105343|FG000|Overall Study|Adverse Event|6|||
160921427|NCT00909389|581105343|FG000|Overall Study|Death|4|||
160921428|NCT00909389|581105343|FG000|Overall Study|Poor Compliance|16|||
160921429|NCT00909389|581105343|FG000|Overall Study|Lost to Follow-up|4|||
160921430|NCT00909389|581105343|FG000|Overall Study|No Information|103|||
160921431|NCT01166763|581105346|FG000|Overall Study|Withdrawal by Subject|3|||
160921432|NCT01528254|581105347|FG000|Overall Study|Administrative problems|96|||
160921433|NCT01528254|581105348|FG001|Overall Study|Administrative problems|94|||
160921434|NCT01528254|581105347|FG000|Overall Study|Adverse Event|28|||
160921435|NCT01528254|581105348|FG001|Overall Study|Adverse Event|44|||
160921436|NCT01528254|581105347|FG000|Overall Study|Lost to Follow-up|17|||
160921437|NCT01528254|581105348|FG001|Overall Study|Lost to Follow-up|24|||
160921438|NCT01528254|581105347|FG000|Overall Study|Death|13|||
160921439|NCT01528254|581105348|FG001|Overall Study|Death|9|||
160921440|NCT01528254|581105347|FG000|Overall Study|Protocol deviation|9|||
160921441|NCT01528254|581105348|FG001|Overall Study|Protocol deviation|19|||
160921442|NCT01528254|581105347|FG000|Overall Study|New therapy for study indication|8|||
160921443|NCT01528254|581105348|FG001|Overall Study|New therapy for study indication|6|||
160921444|NCT01528254|581105347|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160921445|NCT01528254|581105348|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
160921446|NCT01528254|581105347|FG000|Overall Study|Withdrawal by Subject|5|||
160921447|NCT01528254|581105348|FG001|Overall Study|Withdrawal by Subject|4|||
160921448|NCT01528254|581105347|FG000|Overall Study|Abnormal laboratory value(s)|3|||
160921449|NCT01528254|581105348|FG001|Overall Study|Abnormal laboratory value(s)|7|||
160921450|NCT01528254|581105347|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160921451|NCT01528254|581105348|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160997705|NCT00678795|581376596|FG000|Overall Study|Lack of Efficacy|1|||
160997706|NCT00678795|581376597|FG001|Overall Study|Lack of Efficacy|1|||
160997707|NCT04107805|581376598|FG000|Overall Study|Adverse Event|0|||
160997708|NCT04107805|581376599|FG001|Overall Study|Adverse Event|0|||
161143361|NCT00923091|581907575|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
160997709|NCT04107805|581376600|FG002|Overall Study|Adverse Event|0|||
160997710|NCT04107805|581376601|FG003|Overall Study|Adverse Event|1|||
160997711|NCT04107805|581376602|FG004|Overall Study|Adverse Event|0|||
160921452|NCT01528254|581105347|FG000|Overall Study|No longer requires study drug|1|||
160921453|NCT01528254|581105348|FG001|Overall Study|No longer requires study drug|1|||
160921454|NCT04447755|581105349|FG000|Overall Study|Death|9|||
160921455|NCT04447755|581105350|FG001|Overall Study|Death|16|||
160997712|NCT04107805|581376603|FG005|Overall Study|Adverse Event|1|||
161143362|NCT00923091|581907576|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
160921456|NCT04447755|581105351|FG002|Overall Study|Death|8|||
160921457|NCT04447755|581105352|FG003|Overall Study|Death|9|||
160921458|NCT04447755|581105353|FG004|Overall Study|Death|8|||
160997713|NCT04107805|581376604|FG006|Overall Study|Adverse Event|0|||
161261209|NCT02696031|582336202|FG001|Up to Week 52|Withdrawal by Subject|3|||
161261210|NCT02696031|582336203|FG002|Up to Week 52|Withdrawal by Subject|9|||
161261211|NCT02696031|582336204|FG003|Up to Week 52|Withdrawal by Subject|0|||
161261212|NCT02696031|582336205|FG004|Up to Week 52|Withdrawal by Subject|0|||
161261213|NCT02696031|582336206|FG005|Up to Week 52|Withdrawal by Subject|0|||
161261214|NCT02696031|582336201|FG000|Up to Week 104|Pregnancy|0|||
161261215|NCT02696031|582336202|FG001|Up to Week 104|Pregnancy|2|||
161261216|NCT02696031|582336203|FG002|Up to Week 104|Pregnancy|1|||
161261217|NCT02696031|582336204|FG003|Up to Week 104|Pregnancy|0|||
161261218|NCT02696031|582336205|FG004|Up to Week 104|Pregnancy|0|||
161261219|NCT02696031|582336206|FG005|Up to Week 104|Pregnancy|0|||
161261220|NCT02696031|582336201|FG000|Up to Week 104|Withdrawal by Subject|15|||
161261221|NCT02696031|582336202|FG001|Up to Week 104|Withdrawal by Subject|10|||
161261222|NCT02696031|582336203|FG002|Up to Week 104|Withdrawal by Subject|16|||
161261223|NCT02696031|582336204|FG003|Up to Week 104|Withdrawal by Subject|0|||
161261224|NCT02696031|582336205|FG004|Up to Week 104|Withdrawal by Subject|0|||
161261225|NCT02696031|582336206|FG005|Up to Week 104|Withdrawal by Subject|0|||
161261226|NCT02696031|582336201|FG000|Up to Week 104|Protocol Violation|1|||
161261227|NCT02696031|582336202|FG001|Up to Week 104|Protocol Violation|0|||
161261228|NCT02696031|582336203|FG002|Up to Week 104|Protocol Violation|0|||
161261229|NCT02696031|582336204|FG003|Up to Week 104|Protocol Violation|0|||
161261230|NCT02696031|582336205|FG004|Up to Week 104|Protocol Violation|0|||
161261231|NCT02696031|582336206|FG005|Up to Week 104|Protocol Violation|0|||
160921459|NCT04447755|581105354|FG005|Overall Study|Death|9|||
161261232|NCT02696031|582336201|FG000|Up to Week 104|Physician Decision|1|||
161261233|NCT02696031|582336202|FG001|Up to Week 104|Physician Decision|2|||
161261234|NCT02696031|582336203|FG002|Up to Week 104|Physician Decision|3|||
161261235|NCT02696031|582336204|FG003|Up to Week 104|Physician Decision|0|||
161261236|NCT02696031|582336205|FG004|Up to Week 104|Physician Decision|0|||
161261237|NCT02696031|582336206|FG005|Up to Week 104|Physician Decision|0|||
161261238|NCT02696031|582336201|FG000|Up to Week 104|Lost to Follow-up|2|||
161261239|NCT02696031|582336202|FG001|Up to Week 104|Lost to Follow-up|3|||
161261240|NCT02696031|582336203|FG002|Up to Week 104|Lost to Follow-up|1|||
161261241|NCT02696031|582336204|FG003|Up to Week 104|Lost to Follow-up|0|||
161261242|NCT02696031|582336205|FG004|Up to Week 104|Lost to Follow-up|0|||
161261243|NCT02696031|582336206|FG005|Up to Week 104|Lost to Follow-up|0|||
161261244|NCT02696031|582336201|FG000|Up to Week 104|Lack of Efficacy|13|||
161261245|NCT02696031|582336202|FG001|Up to Week 104|Lack of Efficacy|12|||
161261246|NCT02696031|582336203|FG002|Up to Week 104|Lack of Efficacy|11|||
160921460|NCT04447755|581105355|FG006|Overall Study|Death|55|||
160921461|NCT04447755|581105349|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160921462|NCT04447755|581105350|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160921463|NCT04447755|581105351|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
160921464|NCT04447755|581105352|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
160921465|NCT04447755|581105353|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
160921466|NCT04447755|581105354|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
160921467|NCT04447755|581105355|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
160921468|NCT04447755|581105349|FG000|Overall Study|Sponsor Decision|0|||
160921469|NCT04447755|581105350|FG001|Overall Study|Sponsor Decision|0|||
161261247|NCT02696031|582336204|FG003|Up to Week 104|Lack of Efficacy|0|||
161261248|NCT02696031|582336205|FG004|Up to Week 104|Lack of Efficacy|0|||
161261249|NCT02696031|582336206|FG005|Up to Week 104|Lack of Efficacy|0|||
161261250|NCT02696031|582336201|FG000|Up to Week 104|Adverse Event|7|||
161261251|NCT02696031|582336202|FG001|Up to Week 104|Adverse Event|11|||
161261252|NCT02696031|582336203|FG002|Up to Week 104|Adverse Event|5|||
161261253|NCT02696031|582336204|FG003|Up to Week 104|Adverse Event|0|||
161261254|NCT02696031|582336205|FG004|Up to Week 104|Adverse Event|0|||
161261255|NCT02696031|582336206|FG005|Up to Week 104|Adverse Event|0|||
161261256|NCT02696031|582336201|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161261257|NCT02696031|582336202|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
161261258|NCT02696031|582336203|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161261259|NCT02696031|582336204|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161261260|NCT02696031|582336205|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161261261|NCT02696031|582336206|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
161261262|NCT02696031|582336201|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161261263|NCT02696031|582336202|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161261264|NCT02696031|582336203|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
161261265|NCT02696031|582336204|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
161261266|NCT02696031|582336205|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
161341016|NCT02736617|582635606|FG000|Treatment|Adverse Event|1|||
161341017|NCT02736617|582635606|FG000|Treatment|Lack of Efficacy|1|||
160921470|NCT04447755|581105351|FG002|Overall Study|Sponsor Decision|0|||
160921471|NCT04447755|581105352|FG003|Overall Study|Sponsor Decision|0|||
160921472|NCT04447755|581105353|FG004|Overall Study|Sponsor Decision|1|||
161261267|NCT02696031|582336206|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
161341018|NCT02736617|582635606|FG000|Treatment|Withdrawal by Subject|1|||
160997714|NCT04107805|581376605|FG007|Overall Study|Adverse Event|0|||
161261268|NCT02696031|582336201|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161261269|NCT02696031|582336202|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161261270|NCT02696031|582336203|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161261271|NCT02696031|582336204|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
161261272|NCT02696031|582336205|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
161261273|NCT02696031|582336206|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
161261274|NCT02696031|582336201|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161261275|NCT02696031|582336202|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161261276|NCT02696031|582336203|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161261277|NCT02696031|582336204|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
161261278|NCT02696031|582336205|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161261279|NCT02696031|582336206|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
161261280|NCT02696031|582336201|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161261281|NCT02696031|582336202|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161261282|NCT02696031|582336203|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161261283|NCT02696031|582336204|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161261284|NCT02696031|582336205|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
161261285|NCT02696031|582336206|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
161261286|NCT02696031|582336201|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161261287|NCT02696031|582336202|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161261288|NCT02696031|582336203|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
161261289|NCT02696031|582336204|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
161261290|NCT02696031|582336205|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
161261291|NCT02696031|582336206|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
161261292|NCT02696031|582336201|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161261293|NCT02696031|582336202|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161261294|NCT02696031|582336203|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
161261295|NCT02696031|582336204|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
161261296|NCT02696031|582336205|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
161261297|NCT02696031|582336206|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
161261298|NCT00597116|582336207|FG000|Overall Study|Adverse Event|2|||
161261299|NCT00597116|582336208|FG001|Overall Study|Adverse Event|1|||
161261300|NCT00597116|582336207|FG000|Overall Study|Withdrawal by Subject|0|||
161261301|NCT00597116|582336208|FG001|Overall Study|Withdrawal by Subject|2|||
161261302|NCT00597116|582336207|FG000|Overall Study|Physician Decision|0|||
161261303|NCT00597116|582336208|FG001|Overall Study|Physician Decision|1|||
161261304|NCT00597116|582336207|FG000|Overall Study|Death|0|||
161261305|NCT00597116|582336208|FG001|Overall Study|Death|1|||
161261306|NCT00597116|582336207|FG000|Overall Study|Lost to Follow-up|1|||
161261307|NCT00597116|582336208|FG001|Overall Study|Lost to Follow-up|0|||
161261308|NCT00597116|582336207|FG000|Overall Study|Progressive disease|11|||
161261309|NCT00597116|582336208|FG001|Overall Study|Progressive disease|6|||
161261310|NCT02339740|582336209|FG000|Overall Study|Death|1|||
161261311|NCT02339740|582336210|FG001|Overall Study|Death|0|||
161261312|NCT02339740|582336209|FG000|Overall Study|Physician Decision|0|||
161261313|NCT02339740|582336210|FG001|Overall Study|Physician Decision|2|||
161261314|NCT02339740|582336209|FG000|Overall Study|Withdrawal by Subject|5|||
161261315|NCT02339740|582336210|FG001|Overall Study|Withdrawal by Subject|1|||
161261316|NCT02339740|582336209|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
161261317|NCT02339740|582336210|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
161261318|NCT00063882|582336213|FG000|Overall Study|Protocol Violation|3|||
161261319|NCT00063882|582336214|FG001|Overall Study|Protocol Violation|3|||
161261320|NCT00063882|582336213|FG000|Overall Study|Withdrawal by Subject|2|||
161261321|NCT00063882|582336214|FG001|Overall Study|Withdrawal by Subject|1|||
161261322|NCT02903238|582336215|FG000|Overall Study|Lost to Follow-up|4|||
161261323|NCT01855048|582336235|FG000|Overall Study|Withdrawal by Subject|0|||
161261324|NCT01855048|582336236|FG001|Overall Study|Withdrawal by Subject|1|||
161261325|NCT01855048|582336237|FG002|Overall Study|Withdrawal by Subject|0|||
161261326|NCT01855048|582336238|FG003|Overall Study|Withdrawal by Subject|0|||
161341019|NCT02736617|582635606|FG000|Maintenance|Lack of Efficacy|4|||
160997715|NCT04107805|581376606|FG008|Overall Study|Adverse Event|1|||
161261327|NCT01855048|582336239|FG004|Overall Study|Withdrawal by Subject|1|||
161261328|NCT01855048|582336240|FG005|Overall Study|Withdrawal by Subject|0|||
161261329|NCT02972502|582336245|FG000|Overall Study|Lost to Follow-up|3|||
161261330|NCT02972502|582336246|FG001|Overall Study|Lost to Follow-up|1|||
161261331|NCT02972502|582336245|FG000|Overall Study|Withdrawal by Subject|1|||
161261332|NCT02972502|582336246|FG001|Overall Study|Withdrawal by Subject|1|||
161261333|NCT03832738|582336247|FG000|Overall Study|Withdrawal by Subject|6|||
161261334|NCT03832738|582336248|FG001|Overall Study|Withdrawal by Subject|7|||
160997716|NCT01191086|581376610|FG000|Overall Study|Adverse Event|20|||
161341020|NCT02736617|582635606|FG000|Maintenance|Physician Decision|1|||
161341021|NCT00481676|582635609|FG000|Overall Study|Adverse Event|0|||
161341022|NCT00481676|582635610|FG001|Overall Study|Adverse Event|1|||
161341023|NCT00481676|582635609|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161341024|NCT00481676|582635610|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161341025|NCT00481676|582635609|FG000|Overall Study|Administrative problem|1|||
161341026|NCT00481676|582635610|FG001|Overall Study|Administrative problem|0|||
161341027|NCT02911116|582635611|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161341028|NCT02911116|582635612|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161341029|NCT02911116|582635611|FG000|Overall Study|Lost to Follow-up|0|||
161341030|NCT02911116|582635612|FG001|Overall Study|Lost to Follow-up|1|||
161341031|NCT01240694|582635613|FG000|Overall Study|Adverse Event|9|||
161341032|NCT01240694|582635613|FG000|Overall Study|Lack of Efficacy|6|||
161341033|NCT01240694|582635613|FG000|Overall Study|Withdrawal by Subject|6|||
161341034|NCT01240694|582635613|FG000|Overall Study|Protocol Violation|2|||
161341035|NCT01240694|582635613|FG000|Overall Study|Lost to Follow-up|2|||
161341036|NCT01240694|582635613|FG000|Overall Study|Other than specified|3|||
161341037|NCT01240694|582635613|FG000|Overall Study|Withdrawn due to early study termination|107|||
161341038|NCT01513590|582635614|FG000|Overall Study|Adverse Event|2|||
161341039|NCT01513590|582635615|FG001|Overall Study|Adverse Event|3|||
161341040|NCT01513590|582635614|FG000|Overall Study|Withdrawal Criteria|3|||
161341041|NCT01513590|582635615|FG001|Overall Study|Withdrawal Criteria|0|||
161341042|NCT01513590|582635614|FG000|Overall Study|Unclassified|5|||
161341043|NCT01513590|582635615|FG001|Overall Study|Unclassified|10|||
161341044|NCT02110693|582635616|FG000|Overall Study|Withdrawal by Subject|6|||
161341045|NCT02110693|582635617|FG001|Overall Study|Withdrawal by Subject|7|||
161341046|NCT02110693|582635616|FG000|Overall Study|skipped assessment|15|||
161341047|NCT02110693|582635617|FG001|Overall Study|skipped assessment|18|||
161341048|NCT02110693|582635616|FG000|Overall Study|technical difficulties|6|||
161341049|NCT02110693|582635617|FG001|Overall Study|technical difficulties|4|||
161341050|NCT02110693|582635616|FG000|Overall Study|Other|1|||
161341051|NCT02110693|582635617|FG001|Overall Study|Other|0|||
161341052|NCT01881425|582635618|FG000|Overall Study|Death|5|||
161341053|NCT01881425|582635619|FG001|Overall Study|Death|1|||
161341054|NCT01881425|582635618|FG000|Overall Study|Withdrawal by Subject|8|||
161341055|NCT01881425|582635619|FG001|Overall Study|Withdrawal by Subject|3|||
161341056|NCT01881425|582635618|FG000|Overall Study|Physician Decision|2|||
161341057|NCT01881425|582635619|FG001|Overall Study|Physician Decision|1|||
161341058|NCT01881425|582635618|FG000|Overall Study|Adverse Event|3|||
161341059|NCT01881425|582635619|FG001|Overall Study|Adverse Event|0|||
161341060|NCT01881425|582635618|FG000|Overall Study|General Anesthesia panic attack|0|||
161341061|NCT01881425|582635619|FG001|Overall Study|General Anesthesia panic attack|1|||
161341062|NCT01881425|582635618|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
161341063|NCT01881425|582635619|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
161341064|NCT01881425|582635618|FG000|Overall Study|Lost to Follow-up|7|||
161341065|NCT01881425|582635619|FG001|Overall Study|Lost to Follow-up|2|||
161341066|NCT04154956|582635624|FG000|Overall Study|Death|109|||
161341067|NCT04154956|582635625|FG001|Overall Study|Death|110|||
161341068|NCT04154956|582635624|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
161341069|NCT04154956|582635625|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
161341070|NCT04154956|582635624|FG000|Overall Study|Withdrawal by Subject|1|||
161341071|NCT04154956|582635625|FG001|Overall Study|Withdrawal by Subject|7|||
161341072|NCT04154956|582635624|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
161341073|NCT04154956|582635625|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
161341074|NCT00147238|582635626|FG000|Overall Study|Inevaluable|8|||
161341075|NCT04424901|582635627|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
161341076|NCT04424901|582635628|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
161341077|NCT04810962|582635629|FG000|Overall Study|Adverse Event|0|||
161341078|NCT04810962|582635630|FG001|Overall Study|Adverse Event|1|||
161341079|NCT04810962|582635629|FG000|Overall Study|Lost to Follow-up|2|||
161341080|NCT04810962|582635630|FG001|Overall Study|Lost to Follow-up|1|||
161341081|NCT04810962|582635629|FG000|Overall Study|Physician Decision|1|||
161341082|NCT04810962|582635630|FG001|Overall Study|Physician Decision|0|||
161341083|NCT04810962|582635629|FG000|Overall Study|Withdrawal by Subject|1|||
161341084|NCT04810962|582635630|FG001|Overall Study|Withdrawal by Subject|3|||
161341085|NCT04810962|582635629|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
161341086|NCT04810962|582635630|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
161341087|NCT01348269|582635631|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
161341088|NCT01348269|582635632|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
161341089|NCT01348269|582635631|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
161341090|NCT01348269|582635632|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
161341091|NCT01348269|582635631|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
161341092|NCT01348269|582635632|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
161341093|NCT00805532|582635633|FG000|Overall Study|invalid data|0|||
161261335|NCT03832738|582336249|FG002|Overall Study|Withdrawal by Subject|16|||
161261336|NCT03832738|582336247|FG000|Overall Study|Physician Decision|0|||
161261337|NCT03832738|582336248|FG001|Overall Study|Physician Decision|1|||
161261338|NCT03832738|582336249|FG002|Overall Study|Physician Decision|2|||
161261339|NCT03832738|582336247|FG000|Overall Study|Adverse Event|2|||
161143363|NCT00923091|581907577|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
161143364|NCT00923091|581907578|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
161143365|NCT00923091|581907579|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
161261340|NCT03832738|582336248|FG001|Overall Study|Adverse Event|3|||
161261341|NCT03832738|582336249|FG002|Overall Study|Adverse Event|1|||
161261342|NCT03832738|582336247|FG000|Overall Study|Pregnancy|0|||
161261343|NCT03832738|582336248|FG001|Overall Study|Pregnancy|1|||
161261344|NCT03832738|582336249|FG002|Overall Study|Pregnancy|0|||
161261345|NCT03852459|582336250|FG000|Overall Study|Adverse Event|2|||
161261346|NCT03852459|582336251|FG001|Overall Study|Adverse Event|2|||
161261347|NCT03852459|582336250|FG000|Overall Study|Withdrawal by Subject|1|||
161261348|NCT03852459|582336251|FG001|Overall Study|Withdrawal by Subject|1|||
161261349|NCT00049842|582336252|FG000|Treatment Phase|Adverse Event|47|||
161261350|NCT00049842|582336253|FG001|Treatment Phase|Adverse Event|12|||
161261351|NCT00049842|582336252|FG000|Treatment Phase|Withdrawal by Subject|35|||
161261352|NCT00049842|582336253|FG001|Treatment Phase|Withdrawal by Subject|46|||
161261353|NCT00049842|582336252|FG000|Treatment Phase|Non-compliance with protocol|7|||
161261354|NCT00049842|582336253|FG001|Treatment Phase|Non-compliance with protocol|8|||
161261355|NCT00049842|582336252|FG000|Treatment Phase|Lost to Follow-up|4|||
161261356|NCT00049842|582336253|FG001|Treatment Phase|Lost to Follow-up|8|||
161261357|NCT00049842|582336252|FG000|Treatment Phase|Administrative|0|||
161261358|NCT00049842|582336253|FG001|Treatment Phase|Administrative|3|||
161261359|NCT00049842|582336252|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
161261360|NCT00049842|582336253|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
161261361|NCT00049842|582336252|FG000|Follow-up Phase|Adverse Event|6|||
161261362|NCT00049842|582336253|FG001|Follow-up Phase|Adverse Event|1|||
161261363|NCT00049842|582336252|FG000|Follow-up Phase|Other|1|||
161261364|NCT00049842|582336253|FG001|Follow-up Phase|Other|4|||
161261365|NCT01813071|582336254|FG000|Overall Study|Protocol Violation|0|||
161261366|NCT01813071|582336255|FG001|Overall Study|Protocol Violation|0|||
161261367|NCT01813071|582336256|FG002|Overall Study|Protocol Violation|0|||
161261368|NCT01813071|582336257|FG003|Overall Study|Protocol Violation|0|||
161261369|NCT01813071|582336258|FG004|Overall Study|Protocol Violation|1|||
161261370|NCT01813071|582336259|FG005|Overall Study|Protocol Violation|4|||
161261371|NCT01813071|582336260|FG006|Overall Study|Protocol Violation|2|||
161261372|NCT01813071|582336261|FG007|Overall Study|Protocol Violation|4|||
161261373|NCT01813071|582336262|FG008|Overall Study|Protocol Violation|2|||
161261374|NCT01813071|582336254|FG000|Overall Study|Withdrawal by Subject|0|||
161261375|NCT01813071|582336255|FG001|Overall Study|Withdrawal by Subject|0|||
161261376|NCT01813071|582336256|FG002|Overall Study|Withdrawal by Subject|0|||
161261377|NCT01813071|582336257|FG003|Overall Study|Withdrawal by Subject|0|||
161261378|NCT01813071|582336258|FG004|Overall Study|Withdrawal by Subject|0|||
161261379|NCT01813071|582336259|FG005|Overall Study|Withdrawal by Subject|1|||
161261380|NCT01813071|582336260|FG006|Overall Study|Withdrawal by Subject|0|||
161261381|NCT01813071|582336261|FG007|Overall Study|Withdrawal by Subject|0|||
161261382|NCT01813071|582336262|FG008|Overall Study|Withdrawal by Subject|0|||
161261383|NCT01813071|582336254|FG000|Overall Study|Adverse Event|0|||
161261384|NCT01813071|582336255|FG001|Overall Study|Adverse Event|0|||
161261385|NCT01813071|582336256|FG002|Overall Study|Adverse Event|0|||
161261386|NCT01813071|582336257|FG003|Overall Study|Adverse Event|0|||
161261387|NCT01813071|582336258|FG004|Overall Study|Adverse Event|0|||
161261388|NCT01813071|582336259|FG005|Overall Study|Adverse Event|1|||
161261389|NCT01813071|582336260|FG006|Overall Study|Adverse Event|0|||
161261390|NCT01813071|582336261|FG007|Overall Study|Adverse Event|0|||
161261391|NCT01813071|582336262|FG008|Overall Study|Adverse Event|0|||
161261392|NCT01813071|582336254|FG000|Overall Study|Physician Decision|0|||
161261393|NCT01813071|582336255|FG001|Overall Study|Physician Decision|0|||
161261394|NCT01813071|582336256|FG002|Overall Study|Physician Decision|0|||
161341094|NCT00805532|582635634|FG001|Overall Study|invalid data|1|||
161143366|NCT00923091|581907580|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
161143367|NCT00923091|581907581|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
161143368|NCT00923091|581907582|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
161261395|NCT01813071|582336257|FG003|Overall Study|Physician Decision|0|||
161261396|NCT01813071|582336258|FG004|Overall Study|Physician Decision|0|||
161261397|NCT01813071|582336259|FG005|Overall Study|Physician Decision|0|||
161261398|NCT01813071|582336260|FG006|Overall Study|Physician Decision|1|||
161261399|NCT01813071|582336261|FG007|Overall Study|Physician Decision|0|||
161261400|NCT01813071|582336262|FG008|Overall Study|Physician Decision|0|||
161261401|NCT01813071|582336254|FG000|Overall Study|Met inc/exc criteria|0|||
161261402|NCT01813071|582336255|FG001|Overall Study|Met inc/exc criteria|0|||
161261403|NCT01813071|582336256|FG002|Overall Study|Met inc/exc criteria|0|||
161261404|NCT01813071|582336257|FG003|Overall Study|Met inc/exc criteria|0|||
161261405|NCT01813071|582336258|FG004|Overall Study|Met inc/exc criteria|0|||
161261406|NCT01813071|582336259|FG005|Overall Study|Met inc/exc criteria|1|||
161261407|NCT01813071|582336260|FG006|Overall Study|Met inc/exc criteria|0|||
161261408|NCT01813071|582336261|FG007|Overall Study|Met inc/exc criteria|1|||
161261409|NCT01813071|582336262|FG008|Overall Study|Met inc/exc criteria|1|||
161261410|NCT00307931|582336266|FG000|Overall Study|Adverse Event|1|||
161261411|NCT02442271|582336271|FG000|Overall Study|Adverse Event|1|||
161261412|NCT02442271|582336271|FG000|Overall Study|Withdrew Consent|1|||
161261413|NCT02442271|582336271|FG000|Overall Study|Lost to Follow-up|1|||
161261414|NCT02442271|582336271|FG000|Overall Study|Other|1|||
161261415|NCT00831623|582336275|FG000|Overall Study|Withdrawal by Subject|9|||
161261416|NCT00831623|582336275|FG000|Overall Study|Lost to Follow-up|1|||
161261417|NCT00831623|582336275|FG000|Overall Study|Not 2 years post-treatment|12|||
161261418|NCT01138111|582336277|FG000|Overall Study|Withdrawal by Subject|5|||
161261419|NCT01138111|582336277|FG000|Overall Study|Adverse Event|1|||
161261420|NCT01138111|582336277|FG000|Overall Study|Death|1|||
161261421|NCT01138111|582336277|FG000|Overall Study|Lost to Follow-up|2|||
161261422|NCT01118117|582336278|FG000|Overall Study|Death|8|||
161261423|NCT01118117|582336279|FG001|Overall Study|Death|0|||
161261424|NCT01118117|582336278|FG000|Overall Study|Lost to Follow-up|6|||
161261425|NCT01118117|582336279|FG001|Overall Study|Lost to Follow-up|0|||
161261426|NCT01118117|582336278|FG000|Overall Study|Missed 12 Month Visit|7|||
161261427|NCT01118117|582336279|FG001|Overall Study|Missed 12 Month Visit|0|||
161261428|NCT02149121|582336280|FG000|Main Study Period|Lack of Efficacy|2|||
161261429|NCT02149121|582336281|FG001|Main Study Period|Lack of Efficacy|2|||
161261430|NCT02149121|582336282|FG002|Main Study Period|Lack of Efficacy|1|||
161261431|NCT02149121|582336283|FG003|Main Study Period|Lack of Efficacy|0|||
161261432|NCT02149121|582336284|FG004|Main Study Period|Lack of Efficacy|0|||
161261433|NCT02149121|582336285|FG005|Main Study Period|Lack of Efficacy|0|||
161261434|NCT02149121|582336286|FG006|Main Study Period|Lack of Efficacy|0|||
161261435|NCT02149121|582336280|FG000|Main Study Period|Withdrawal by Subject|9|||
161261436|NCT02149121|582336281|FG001|Main Study Period|Withdrawal by Subject|5|||
161261437|NCT02149121|582336282|FG002|Main Study Period|Withdrawal by Subject|1|||
161261438|NCT02149121|582336283|FG003|Main Study Period|Withdrawal by Subject|0|||
161261439|NCT02149121|582336284|FG004|Main Study Period|Withdrawal by Subject|0|||
161261440|NCT02149121|582336285|FG005|Main Study Period|Withdrawal by Subject|0|||
161261441|NCT02149121|582336286|FG006|Main Study Period|Withdrawal by Subject|0|||
161261442|NCT02149121|582336280|FG000|Main Study Period|Adverse Event|2|||
161261443|NCT02149121|582336281|FG001|Main Study Period|Adverse Event|5|||
161261444|NCT02149121|582336282|FG002|Main Study Period|Adverse Event|1|||
161261445|NCT02149121|582336283|FG003|Main Study Period|Adverse Event|0|||
161261446|NCT02149121|582336284|FG004|Main Study Period|Adverse Event|0|||
161261447|NCT02149121|582336285|FG005|Main Study Period|Adverse Event|0|||
161261448|NCT02149121|582336286|FG006|Main Study Period|Adverse Event|0|||
161261449|NCT02149121|582336280|FG000|Main Study Period|Protocol Violation|2|||
161261450|NCT02149121|582336281|FG001|Main Study Period|Protocol Violation|0|||
161261451|NCT02149121|582336282|FG002|Main Study Period|Protocol Violation|0|||
161261452|NCT02149121|582336283|FG003|Main Study Period|Protocol Violation|0|||
161261453|NCT02149121|582336284|FG004|Main Study Period|Protocol Violation|0|||
161261454|NCT02149121|582336285|FG005|Main Study Period|Protocol Violation|0|||
161261455|NCT02149121|582336286|FG006|Main Study Period|Protocol Violation|0|||
161261456|NCT02149121|582336280|FG000|Main Study Period|Lost to Follow-up|2|||
161261457|NCT02149121|582336281|FG001|Main Study Period|Lost to Follow-up|1|||
161261458|NCT02149121|582336282|FG002|Main Study Period|Lost to Follow-up|0|||
161261459|NCT02149121|582336283|FG003|Main Study Period|Lost to Follow-up|0|||
161261460|NCT02149121|582336284|FG004|Main Study Period|Lost to Follow-up|0|||
161261461|NCT02149121|582336285|FG005|Main Study Period|Lost to Follow-up|0|||
161261462|NCT02149121|582336286|FG006|Main Study Period|Lost to Follow-up|0|||
161261463|NCT02149121|582336280|FG000|Main Study Period|Death|1|||
161261464|NCT02149121|582336281|FG001|Main Study Period|Death|0|||
161261465|NCT02149121|582336282|FG002|Main Study Period|Death|0|||
161261466|NCT02149121|582336283|FG003|Main Study Period|Death|0|||
161261467|NCT02149121|582336284|FG004|Main Study Period|Death|0|||
161261468|NCT02149121|582336285|FG005|Main Study Period|Death|0|||
161261469|NCT02149121|582336286|FG006|Main Study Period|Death|0|||
161261470|NCT02149121|582336280|FG000|Main Study Period|Physician Decision|1|||
161261471|NCT02149121|582336281|FG001|Main Study Period|Physician Decision|0|||
161261472|NCT02149121|582336282|FG002|Main Study Period|Physician Decision|0|||
161261473|NCT02149121|582336283|FG003|Main Study Period|Physician Decision|0|||
161261474|NCT02149121|582336284|FG004|Main Study Period|Physician Decision|0|||
161261475|NCT02149121|582336285|FG005|Main Study Period|Physician Decision|0|||
161261476|NCT02149121|582336286|FG006|Main Study Period|Physician Decision|0|||
161261477|NCT02149121|582336280|FG000|Main Study Period|Developed any malignancy|0|||
161261478|NCT02149121|582336281|FG001|Main Study Period|Developed any malignancy|1|||
161261479|NCT02149121|582336282|FG002|Main Study Period|Developed any malignancy|1|||
161261480|NCT02149121|582336283|FG003|Main Study Period|Developed any malignancy|0|||
161261481|NCT02149121|582336284|FG004|Main Study Period|Developed any malignancy|0|||
161261482|NCT02149121|582336285|FG005|Main Study Period|Developed any malignancy|0|||
161341095|NCT02412657|582635635|FG000|Overall Study|Lost to Follow-up|1|||
161261483|NCT02149121|582336286|FG006|Main Study Period|Developed any malignancy|0|||
161261484|NCT02149121|582336280|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
161261485|NCT02149121|582336281|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
161261486|NCT02149121|582336282|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
161261487|NCT02149121|582336283|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
161261488|NCT02149121|582336284|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
161261489|NCT02149121|582336285|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
161261490|NCT02149121|582336286|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
161261491|NCT02149121|582336280|FG000|Main Study Period|Disease progression|0|||
161261492|NCT02149121|582336281|FG001|Main Study Period|Disease progression|1|||
161261493|NCT02149121|582336282|FG002|Main Study Period|Disease progression|0|||
161261494|NCT02149121|582336283|FG003|Main Study Period|Disease progression|0|||
161261495|NCT02149121|582336284|FG004|Main Study Period|Disease progression|0|||
161261496|NCT02149121|582336285|FG005|Main Study Period|Disease progression|0|||
161261497|NCT02149121|582336286|FG006|Main Study Period|Disease progression|0|||
161261498|NCT02149121|582336280|FG000|Extension Study Period|Withdrawal by Subject|0|||
161261499|NCT02149121|582336281|FG001|Extension Study Period|Withdrawal by Subject|0|||
161261500|NCT02149121|582336282|FG002|Extension Study Period|Withdrawal by Subject|0|||
161261501|NCT02149121|582336283|FG003|Extension Study Period|Withdrawal by Subject|1|||
161261502|NCT02149121|582336284|FG004|Extension Study Period|Withdrawal by Subject|0|||
161261503|NCT02149121|582336285|FG005|Extension Study Period|Withdrawal by Subject|2|||
161261504|NCT02149121|582336286|FG006|Extension Study Period|Withdrawal by Subject|0|||
161261505|NCT01408563|582337732|FG000|Overall Study|Ineligible after consent/ registration|2|||
161261506|NCT01386684|582337735|FG000|Overall Study|Lost to Follow-up|51|||
161261507|NCT01386684|582337735|FG000|Overall Study|Other|51|||
161261508|NCT01386684|582337735|FG000|Overall Study|Death|47|||
161261509|NCT01386684|582337735|FG000|Overall Study|Withdrawal of Consent|44|||
161261510|NCT01386684|582337735|FG000|Overall Study|Alternative Therapy Required|37|||
161261511|NCT01386684|582337735|FG000|Overall Study|Disease Progression|28|||
161261512|NCT01386684|582337735|FG000|Overall Study|Adverse Event|20|||
161261513|NCT01386684|582337735|FG000|Overall Study|Noncompliance|8|||
161261514|NCT01386684|582337735|FG000|Overall Study|Protocol Violation|4|||
161261515|NCT01386684|582337735|FG000|Overall Study|Missing|3|||
161261516|NCT02119286|582337741|FG000|Overall Study|Adverse Event|9|||
161261517|NCT02119286|582337742|FG001|Overall Study|Adverse Event|7|||
161261518|NCT02119286|582337743|FG002|Overall Study|Adverse Event|2|||
161261519|NCT02119286|582337741|FG000|Overall Study|Lack of Efficacy|11|||
161261520|NCT02119286|582337742|FG001|Overall Study|Lack of Efficacy|3|||
161261521|NCT02119286|582337743|FG002|Overall Study|Lack of Efficacy|4|||
161261522|NCT02119286|582337741|FG000|Overall Study|Lost to Follow-up|2|||
161261523|NCT02119286|582337742|FG001|Overall Study|Lost to Follow-up|0|||
161261524|NCT02119286|582337743|FG002|Overall Study|Lost to Follow-up|1|||
161261525|NCT02119286|582337741|FG000|Overall Study|Withdrawal by Subject|4|||
161261526|NCT02119286|582337742|FG001|Overall Study|Withdrawal by Subject|1|||
161261527|NCT02119286|582337743|FG002|Overall Study|Withdrawal by Subject|0|||
161261528|NCT04109313|582337744|FG000|Overall Study|Pregnancy|1|||
161261529|NCT04109313|582337744|FG000|Overall Study|Adverse Event|11|||
161261530|NCT04109313|582337744|FG000|Overall Study|Lack of Efficacy|11|||
161261531|NCT04109313|582337744|FG000|Overall Study|Lost to Follow-up|1|||
161261532|NCT04109313|582337744|FG000|Overall Study|Physician Decision|2|||
161261533|NCT04109313|582337744|FG000|Overall Study|Subject Decision|13|||
161261534|NCT04109313|582337744|FG000|Overall Study|Covid-19 situation|2|||
161261535|NCT01272921|582337745|FG000|Overall Study|Protocol Violation|2|||
161261536|NCT01272921|582337746|FG001|Overall Study|Protocol Violation|1|||
161261537|NCT01132664|582337747|FG000|Phase lb|Adverse Event|0|||
161261538|NCT01132664|582337748|FG001|Phase lb|Adverse Event|1|||
161261539|NCT01132664|582337749|FG002|Phase lb|Adverse Event|0|||
161261540|NCT01132664|582337750|FG003|Phase lb|Adverse Event|0|||
161261541|NCT01132664|582337751|FG004|Phase lb|Adverse Event|0|||
161261542|NCT01132664|582337747|FG000|Phase lb|Withdrawal by Subject|1|||
161261543|NCT01132664|582337748|FG001|Phase lb|Withdrawal by Subject|2|||
161261544|NCT01132664|582337749|FG002|Phase lb|Withdrawal by Subject|0|||
161261545|NCT01132664|582337750|FG003|Phase lb|Withdrawal by Subject|0|||
161261546|NCT01132664|582337751|FG004|Phase lb|Withdrawal by Subject|0|||
161261547|NCT01132664|582337747|FG000|Phase lb|Disease Progression|4|||
161261548|NCT01132664|582337748|FG001|Phase lb|Disease Progression|9|||
161261549|NCT01132664|582337749|FG002|Phase lb|Disease Progression|0|||
161261550|NCT01132664|582337750|FG003|Phase lb|Disease Progression|0|||
161261551|NCT01132664|582337751|FG004|Phase lb|Disease Progression|0|||
161261552|NCT01132664|582337747|FG000|Phase ll|Death|0|||
161261553|NCT01132664|582337748|FG001|Phase ll|Death|0|||
161261554|NCT01132664|582337749|FG002|Phase ll|Death|2|||
161261555|NCT01132664|582337750|FG003|Phase ll|Death|0|||
161261556|NCT01132664|582337751|FG004|Phase ll|Death|0|||
161261557|NCT01132664|582337747|FG000|Phase ll|Adverse Event|0|||
161261558|NCT01132664|582337748|FG001|Phase ll|Adverse Event|0|||
161261559|NCT01132664|582337749|FG002|Phase ll|Adverse Event|10|||
161261560|NCT01132664|582337750|FG003|Phase ll|Adverse Event|0|||
161261561|NCT01132664|582337751|FG004|Phase ll|Adverse Event|0|||
161261562|NCT01132664|582337747|FG000|Phase ll|Withdrawal by Subject|0|||
161261563|NCT01132664|582337748|FG001|Phase ll|Withdrawal by Subject|0|||
161261564|NCT01132664|582337749|FG002|Phase ll|Withdrawal by Subject|3|||
161261565|NCT01132664|582337750|FG003|Phase ll|Withdrawal by Subject|0|||
161261566|NCT01132664|582337751|FG004|Phase ll|Withdrawal by Subject|0|||
161261567|NCT01132664|582337747|FG000|Phase ll|Disease progression|0|||
161261568|NCT01132664|582337748|FG001|Phase ll|Disease progression|0|||
161261569|NCT01132664|582337749|FG002|Phase ll|Disease progression|35|||
161261570|NCT01132664|582337750|FG003|Phase ll|Disease progression|0|||
161261571|NCT01132664|582337751|FG004|Phase ll|Disease progression|0|||
161261572|NCT01132664|582337747|FG000|BM Cohort|Disease progression|0|||
161261573|NCT01132664|582337748|FG001|BM Cohort|Disease progression|0|||
161261574|NCT01132664|582337749|FG002|BM Cohort|Disease progression|0|||
161261575|NCT01132664|582337750|FG003|BM Cohort|Disease progression|3|||
161261576|NCT01132664|582337751|FG004|BM Cohort|Disease progression|4|||
161261577|NCT01132664|582337747|FG000|BM Cohort|Adverse Event|0|||
161261578|NCT01132664|582337748|FG001|BM Cohort|Adverse Event|0|||
161261579|NCT01132664|582337749|FG002|BM Cohort|Adverse Event|0|||
161261580|NCT01132664|582337750|FG003|BM Cohort|Adverse Event|0|||
161261581|NCT01132664|582337751|FG004|BM Cohort|Adverse Event|1|||
161261582|NCT01132664|582337747|FG000|BM Cohort|Withdrawal by Subject|0|||
161261583|NCT01132664|582337748|FG001|BM Cohort|Withdrawal by Subject|0|||
161261584|NCT01132664|582337749|FG002|BM Cohort|Withdrawal by Subject|0|||
161261585|NCT01132664|582337750|FG003|BM Cohort|Withdrawal by Subject|0|||
161261586|NCT01132664|582337751|FG004|BM Cohort|Withdrawal by Subject|1|||
161261587|NCT04271735|582337753|FG000|Overall Study|Physician Decision|2|||
161261588|NCT04271735|582337754|FG001|Overall Study|Physician Decision|0|||
161261589|NCT04268316|582337755|FG000|Overall Study|Withdrawal by Subject|2|||
161261590|NCT04268316|582337756|FG001|Overall Study|Withdrawal by Subject|1|||
161261591|NCT04268316|582337757|FG002|Overall Study|Withdrawal by Subject|0|||
161261592|NCT02040779|582337759|FG000|Overall Study|Adverse Event|1|||
161261593|NCT02040779|582337760|FG001|Overall Study|Adverse Event|0|||
161261594|NCT02040779|582337761|FG002|Overall Study|Adverse Event|0|||
161261595|NCT02040779|582337759|FG000|Overall Study|Withdrawal by Subject|4|||
161261596|NCT02040779|582337760|FG001|Overall Study|Withdrawal by Subject|1|||
161261597|NCT02040779|582337761|FG002|Overall Study|Withdrawal by Subject|3|||
161261598|NCT02040779|582337759|FG000|Overall Study|Non-compliance|0|||
161261599|NCT02040779|582337760|FG001|Overall Study|Non-compliance|1|||
161261600|NCT02040779|582337761|FG002|Overall Study|Non-compliance|0|||
161261601|NCT02040779|582337759|FG000|Overall Study|Protocol Violation|2|||
161261602|NCT02040779|582337760|FG001|Overall Study|Protocol Violation|1|||
161261603|NCT02040779|582337761|FG002|Overall Study|Protocol Violation|0|||
161261604|NCT02040779|582337759|FG000|Overall Study|Lost to Follow-up|1|||
161261605|NCT02040779|582337760|FG001|Overall Study|Lost to Follow-up|2|||
161261606|NCT02040779|582337761|FG002|Overall Study|Lost to Follow-up|1|||
161261607|NCT02040779|582337759|FG000|Overall Study|Lack of Efficacy|4|||
161261608|NCT02040779|582337760|FG001|Overall Study|Lack of Efficacy|2|||
161261609|NCT02040779|582337761|FG002|Overall Study|Lack of Efficacy|0|||
161261610|NCT02132637|582337762|FG000|Study Period 1|Withdrawal by Subject|0|||
161261611|NCT02132637|582337763|FG001|Study Period 1|Withdrawal by Subject|4|||
161261612|NCT02132637|582337762|FG000|Study Period 1|Physician Decision|1|||
161261613|NCT02132637|582337763|FG001|Study Period 1|Physician Decision|0|||
161261614|NCT02132637|582337762|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
161261615|NCT02132637|582337763|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
161261616|NCT02132637|582337762|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
161261617|NCT02132637|582337763|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
161261618|NCT00922272|582337766|FG000|Open-label Phase|Adverse Event|5|||
161261619|NCT00922272|582337767|FG001|Open-label Phase|Adverse Event|0|||
161261620|NCT00922272|582337766|FG000|Open-label Phase|Protocol Violation|1|||
161261621|NCT00922272|582337767|FG001|Open-label Phase|Protocol Violation|0|||
161261622|NCT00922272|582337766|FG000|Open-label Phase|Withdrawal by Subject|11|||
161261623|NCT00922272|582337767|FG001|Open-label Phase|Withdrawal by Subject|0|||
161261624|NCT00922272|582337766|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
161261625|NCT00922272|582337767|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
161261626|NCT00922272|582337766|FG000|Open-label Phase|Withdrawal criteria met|5|||
161261627|NCT00922272|582337767|FG001|Open-label Phase|Withdrawal criteria met|0|||
161261628|NCT00922272|582337766|FG000|Double-blind Phase|Adverse Event|1|||
161261629|NCT00922272|582337767|FG001|Double-blind Phase|Adverse Event|1|||
161261630|NCT00922272|582337766|FG000|Double-blind Phase|Withdrawal by Subject|1|||
161261631|NCT00922272|582337767|FG001|Double-blind Phase|Withdrawal by Subject|1|||
161261632|NCT00922272|582337766|FG000|Double-blind Phase|Lost to Follow-up|2|||
161261633|NCT00922272|582337767|FG001|Double-blind Phase|Lost to Follow-up|1|||
161261634|NCT00922272|582337766|FG000|Double-blind Phase|Withdrawal criteria met|1|||
161261635|NCT00922272|582337767|FG001|Double-blind Phase|Withdrawal criteria met|1|||
161261636|NCT00922272|582337766|FG000|Double-blind Phase|Noncompliance|1|||
161261637|NCT00922272|582337767|FG001|Double-blind Phase|Noncompliance|1|||
161341096|NCT02412657|582635636|FG001|Overall Study|Lost to Follow-up|0|||
161261638|NCT00922272|582337766|FG000|Double-blind Phase|Positive urine drug screen|1|||
161261639|NCT00922272|582337767|FG001|Double-blind Phase|Positive urine drug screen|1|||
161341097|NCT02412657|582635637|FG002|Overall Study|Lost to Follow-up|0|||
161341098|NCT02412657|582635635|FG000|Overall Study|Protocol Violation|0|||
161341099|NCT02412657|582635636|FG001|Overall Study|Protocol Violation|2|||
161341100|NCT02412657|582635637|FG002|Overall Study|Protocol Violation|3|||
161341101|NCT00920816|582635641|FG000|Overall Study|Death|116|||
161341102|NCT00920816|582635642|FG001|Overall Study|Death|63|||
161341103|NCT00920816|582635643|FG002|Overall Study|Death|8|||
161341104|NCT00920816|582635644|FG003|Overall Study|Death|3|||
161341105|NCT00920816|582635641|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
161341106|NCT00920816|582635642|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
161341107|NCT00920816|582635643|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
161341108|NCT00920816|582635644|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
161341109|NCT00920816|582635641|FG000|Overall Study|Global deterioration of health status|2|||
161341110|NCT00920816|582635642|FG001|Overall Study|Global deterioration of health status|0|||
161341111|NCT00920816|582635643|FG002|Overall Study|Global deterioration of health status|0|||
161341112|NCT00920816|582635644|FG003|Overall Study|Global deterioration of health status|0|||
161341113|NCT00920816|582635641|FG000|Overall Study|Objective progression or relapse|6|||
161341114|NCT00920816|582635642|FG001|Overall Study|Objective progression or relapse|2|||
161341115|NCT00920816|582635643|FG002|Overall Study|Objective progression or relapse|0|||
161341116|NCT00920816|582635644|FG003|Overall Study|Objective progression or relapse|0|||
161341117|NCT00920816|582635641|FG000|Overall Study|Other|26|||
161341118|NCT00920816|582635642|FG001|Overall Study|Other|15|||
161341119|NCT00920816|582635643|FG002|Overall Study|Other|1|||
161341120|NCT00920816|582635644|FG003|Overall Study|Other|2|||
161341121|NCT00920816|582635641|FG000|Overall Study|Lost to Follow-up|11|||
161341122|NCT00920816|582635642|FG001|Overall Study|Lost to Follow-up|2|||
161341123|NCT00920816|582635643|FG002|Overall Study|Lost to Follow-up|0|||
161341124|NCT00920816|582635644|FG003|Overall Study|Lost to Follow-up|0|||
161341125|NCT00920816|582635641|FG000|Overall Study|Adverse Event|1|||
161341126|NCT00920816|582635642|FG001|Overall Study|Adverse Event|1|||
161341127|NCT00920816|582635643|FG002|Overall Study|Adverse Event|1|||
161341128|NCT00920816|582635644|FG003|Overall Study|Adverse Event|0|||
161341129|NCT00920816|582635641|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
161341130|NCT00920816|582635642|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
161341131|NCT00920816|582635643|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
161341132|NCT00920816|582635644|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
161341133|NCT00920816|582635641|FG000|Overall Study|Randomized but not treated|3|||
161341134|NCT00920816|582635642|FG001|Overall Study|Randomized but not treated|0|||
161341135|NCT00920816|582635643|FG002|Overall Study|Randomized but not treated|0|||
161341136|NCT00920816|582635644|FG003|Overall Study|Randomized but not treated|0|||
161341137|NCT03185208|582635645|FG000|Overall Study|Did not start study medication|0|||
161341138|NCT03185208|582635646|FG001|Overall Study|Did not start study medication|3|||
161341139|NCT03834350|582635647|FG000|Overall Study|Withdrawal by Subject|1|||
161341140|NCT02382939|582635654|FG000|Overall Study|Adverse Event|1|||
161341141|NCT02382939|582635655|FG001|Overall Study|Adverse Event|1|||
161341142|NCT02382939|582635654|FG000|Overall Study|Withdrawal by Subject|2|||
161341143|NCT02382939|582635655|FG001|Overall Study|Withdrawal by Subject|2|||
161341144|NCT00321763|582635656|FG000|Overall Study|Adverse Event|1|||
161341145|NCT00321763|582635657|FG001|Overall Study|Adverse Event|1|||
161341146|NCT00321763|582635658|FG002|Overall Study|Adverse Event|0|||
161341147|NCT00321763|582635659|FG003|Overall Study|Adverse Event|1|||
161341148|NCT00321763|582635656|FG000|Overall Study|Withdrawal by Subject|2|||
161341149|NCT00321763|582635657|FG001|Overall Study|Withdrawal by Subject|0|||
161341150|NCT00321763|582635658|FG002|Overall Study|Withdrawal by Subject|1|||
161341151|NCT00321763|582635659|FG003|Overall Study|Withdrawal by Subject|0|||
161341152|NCT00321763|582635656|FG000|Overall Study|Lost to Follow-up|3|||
161341153|NCT00321763|582635657|FG001|Overall Study|Lost to Follow-up|1|||
161341154|NCT00321763|582635658|FG002|Overall Study|Lost to Follow-up|5|||
161341155|NCT00321763|582635659|FG003|Overall Study|Lost to Follow-up|4|||
161341156|NCT04759131|582635663|FG000|Overall Study|Investigator's discretion|1|||
161341157|NCT04759131|582635664|FG001|Overall Study|Investigator's discretion|0|||
161341158|NCT04759131|582635663|FG000|Overall Study|Subject withdrawal|1|||
161341159|NCT04759131|582635664|FG001|Overall Study|Subject withdrawal|0|||
160997717|NCT01191086|581376610|FG000|Overall Study|Lack of Efficacy|10|||
161341160|NCT00289276|582635666|FG000|Second Part of FAST Study (Expansion)|Death|0|||
161341161|NCT00289276|582635667|FG001|Second Part of FAST Study (Expansion)|Death|2|||
161341162|NCT00289276|582635666|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
161341163|NCT00289276|582635667|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
161341164|NCT00869960|582635668|FG000|Overall Study|Lost to Follow-up|2|||
161341165|NCT02187783|582635669|FG000|Overall Study|Adverse Event|8|||
161341166|NCT02187783|582635669|FG000|Overall Study|Death|3|||
161341167|NCT02187783|582635669|FG000|Overall Study|Progressive disease|80|||
161341168|NCT02187783|582635669|FG000|Overall Study|Protocol Violation|3|||
160997718|NCT01191086|581376610|FG000|Overall Study|Lost to Follow-up|4|||
160997719|NCT01191086|581376610|FG000|Overall Study|Physician Decision|2|||
160997720|NCT01191086|581376610|FG000|Overall Study|Withdrawal by Subject|24|||
160997721|NCT01191086|581376610|FG000|Overall Study|Discontinuation criterion met|1|||
160997722|NCT01191086|581376610|FG000|Overall Study|Other|1|||
160997723|NCT03058991|581376618|FG000|Overall Study|Lost to Follow-up|17|||
160997724|NCT03058991|581376619|FG001|Overall Study|Lost to Follow-up|12|||
160997725|NCT03058991|581376620|FG002|Overall Study|Lost to Follow-up|12|||
160997726|NCT03058991|581376618|FG000|Overall Study|Withdrawal by Subject|1|||
160997727|NCT03058991|581376619|FG001|Overall Study|Withdrawal by Subject|0|||
160997728|NCT03058991|581376620|FG002|Overall Study|Withdrawal by Subject|0|||
160997729|NCT00130637|581376621|FG000|Overall Study|Adverse Event|2|||
160997730|NCT00130637|581376621|FG000|Overall Study|Withdrawal by Subject|1|||
160997731|NCT00139737|581376622|FG000|Overall Study|Withdrawal by Subject|190|||
160997732|NCT00139737|581376622|FG000|Overall Study|Adverse Event|58|||
161143369|NCT00923091|581907583|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
161261640|NCT03197558|582337768|FG000|Overall Study|Tubes not placed|1|||
161261641|NCT02581163|582337770|FG000|Overall Study|Failure to return|15|||
161261642|NCT02581163|582337770|FG000|Overall Study|Insufficient virological response|3|||
161261643|NCT02581163|582337770|FG000|Overall Study|Withdrew consent|1|||
161261644|NCT02581163|582337770|FG000|Overall Study|Death|1|||
161261645|NCT02581163|582337770|FG000|Overall Study|Other, not specified|9|||
161261646|NCT00977431|582337778|FG000|Overall Study|Other than listed|1|||
161261647|NCT00977431|582337779|FG001|Overall Study|Other than listed|0|||
161261648|NCT00977431|582337780|FG002|Overall Study|Other than listed|0|||
161261649|NCT00977431|582337781|FG003|Overall Study|Other than listed|0|||
161261650|NCT00977431|582337782|FG004|Overall Study|Other than listed|2|||
161261651|NCT00977431|582337778|FG000|Overall Study|Protocol Violation|0|||
161261652|NCT00977431|582337779|FG001|Overall Study|Protocol Violation|0|||
161261653|NCT00977431|582337780|FG002|Overall Study|Protocol Violation|1|||
161261654|NCT00977431|582337781|FG003|Overall Study|Protocol Violation|0|||
161261655|NCT00977431|582337782|FG004|Overall Study|Protocol Violation|0|||
161261656|NCT00977431|582337778|FG000|Overall Study|Adverse Event|3|||
161261657|NCT00977431|582337779|FG001|Overall Study|Adverse Event|0|||
161261658|NCT00977431|582337780|FG002|Overall Study|Adverse Event|4|||
161261659|NCT00977431|582337781|FG003|Overall Study|Adverse Event|0|||
161261660|NCT00977431|582337782|FG004|Overall Study|Adverse Event|6|||
161261661|NCT00977431|582337778|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
161261662|NCT00977431|582337779|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
161261663|NCT00977431|582337780|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
161261664|NCT00977431|582337781|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
161261665|NCT00977431|582337782|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
161261666|NCT00977431|582337778|FG000|Overall Study|Progressive disease|2|||
161261667|NCT00977431|582337779|FG001|Overall Study|Progressive disease|6|||
161261668|NCT00977431|582337780|FG002|Overall Study|Progressive disease|1|||
161261669|NCT00977431|582337781|FG003|Overall Study|Progressive disease|3|||
161261670|NCT00977431|582337782|FG004|Overall Study|Progressive disease|5|||
161261671|NCT03739138|582337789|FG000|Overall Study|Death|0|||
161261672|NCT03739138|582337790|FG001|Overall Study|Death|7|||
161261673|NCT03739138|582337791|FG002|Overall Study|Death|4|||
161261674|NCT03739138|582337792|FG003|Overall Study|Death|13|||
161261675|NCT03739138|582337793|FG004|Overall Study|Death|0|||
161261676|NCT03739138|582337789|FG000|Overall Study|Lost to Follow-up|0|||
161261677|NCT03739138|582337790|FG001|Overall Study|Lost to Follow-up|0|||
161261678|NCT03739138|582337791|FG002|Overall Study|Lost to Follow-up|1|||
161261679|NCT03739138|582337792|FG003|Overall Study|Lost to Follow-up|0|||
161261680|NCT03739138|582337793|FG004|Overall Study|Lost to Follow-up|0|||
161261681|NCT03739138|582337789|FG000|Overall Study|Study Terminated By Sponsor|0|||
161261682|NCT03739138|582337790|FG001|Overall Study|Study Terminated By Sponsor|0|||
161261683|NCT03739138|582337791|FG002|Overall Study|Study Terminated By Sponsor|0|||
161261684|NCT03739138|582337792|FG003|Overall Study|Study Terminated By Sponsor|4|||
161261685|NCT03739138|582337793|FG004|Overall Study|Study Terminated By Sponsor|0|||
161261686|NCT03739138|582337789|FG000|Overall Study|Withdrawal by Subject|0|||
161261687|NCT03739138|582337790|FG001|Overall Study|Withdrawal by Subject|0|||
161261688|NCT03739138|582337791|FG002|Overall Study|Withdrawal by Subject|0|||
161261689|NCT03739138|582337792|FG003|Overall Study|Withdrawal by Subject|1|||
161261690|NCT03739138|582337793|FG004|Overall Study|Withdrawal by Subject|0|||
161261691|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
160997733|NCT00139737|581376622|FG000|Overall Study|Lack of Efficacy|40|||
160997734|NCT00139737|581376622|FG000|Overall Study|Lost to Follow-up|8|||
160997735|NCT00139737|581376622|FG000|Overall Study|Death|3|||
160997736|NCT00139737|581376622|FG000|Overall Study|Laboratory Abnormality|2|||
160997737|NCT00139737|581376622|FG000|Overall Study|Protocol Violation|18|||
160997738|NCT00139737|581376622|FG000|Overall Study|Withdrew During Screening Phase|8|||
161261692|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
161261693|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
160997739|NCT00139737|581376622|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160997740|NCT00139737|581376622|FG000|Overall Study|Screened, Not Treated|13|||
161261694|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
161143370|NCT00923091|581907584|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
161341169|NCT02187783|582635669|FG000|Overall Study|Physician Decision|2|||
161341170|NCT02187783|582635669|FG000|Overall Study|Withdrawal by Subject|9|||
161341171|NCT02187783|582635669|FG000|Overall Study|Study terminated by sponsor|1|||
161341172|NCT00171249|582635670|FG000|Overall Study|Withdrawal by Subject|2|||
161341173|NCT00171249|582635671|FG001|Overall Study|Withdrawal by Subject|0|||
161341174|NCT00171249|582635672|FG002|Overall Study|Withdrawal by Subject|0|||
161341175|NCT00171249|582635673|FG003|Overall Study|Withdrawal by Subject|6|||
161341176|NCT00171249|582635674|FG004|Overall Study|Withdrawal by Subject|0|||
161341177|NCT00171249|582635675|FG005|Overall Study|Withdrawal by Subject|0|||
161341178|NCT00171249|582635676|FG006|Overall Study|Withdrawal by Subject|0|||
161341179|NCT00171249|582635670|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
161341180|NCT00171249|582635671|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161341181|NCT00171249|582635672|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
161341182|NCT00171249|582635673|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
161341183|NCT00171249|582635674|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161341184|NCT00171249|582635675|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
161341185|NCT00171249|582635676|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161341186|NCT00171249|582635670|FG000|Overall Study|Death|7|||
161341187|NCT00171249|582635671|FG001|Overall Study|Death|1|||
161341188|NCT00171249|582635672|FG002|Overall Study|Death|0|||
161341189|NCT00171249|582635673|FG003|Overall Study|Death|4|||
161341190|NCT00171249|582635674|FG004|Overall Study|Death|0|||
161341191|NCT00171249|582635675|FG005|Overall Study|Death|3|||
161341192|NCT00171249|582635676|FG006|Overall Study|Death|1|||
161341193|NCT00171249|582635670|FG000|Overall Study|Other|10|||
161341194|NCT00171249|582635671|FG001|Overall Study|Other|0|||
161341195|NCT00171249|582635672|FG002|Overall Study|Other|0|||
161341196|NCT00171249|582635673|FG003|Overall Study|Other|43|||
161341197|NCT00171249|582635674|FG004|Overall Study|Other|0|||
161341198|NCT00171249|582635675|FG005|Overall Study|Other|2|||
161341199|NCT00171249|582635676|FG006|Overall Study|Other|0|||
161341200|NCT00171249|582635670|FG000|Overall Study|No Longer Requires Study Drug|4|||
161341201|NCT00171249|582635671|FG001|Overall Study|No Longer Requires Study Drug|0|||
161341202|NCT00171249|582635672|FG002|Overall Study|No Longer Requires Study Drug|0|||
161341203|NCT00171249|582635673|FG003|Overall Study|No Longer Requires Study Drug|3|||
161341204|NCT00171249|582635674|FG004|Overall Study|No Longer Requires Study Drug|0|||
161341205|NCT00171249|582635675|FG005|Overall Study|No Longer Requires Study Drug|5|||
161341206|NCT00171249|582635676|FG006|Overall Study|No Longer Requires Study Drug|0|||
161341207|NCT00171249|582635670|FG000|Overall Study|Administrative Problems|1|||
161341208|NCT00171249|582635671|FG001|Overall Study|Administrative Problems|0|||
161341209|NCT00171249|582635672|FG002|Overall Study|Administrative Problems|0|||
161341210|NCT00171249|582635673|FG003|Overall Study|Administrative Problems|2|||
161341211|NCT00171249|582635674|FG004|Overall Study|Administrative Problems|0|||
161341212|NCT00171249|582635675|FG005|Overall Study|Administrative Problems|0|||
161341213|NCT00171249|582635676|FG006|Overall Study|Administrative Problems|0|||
161341214|NCT00171249|582635670|FG000|Overall Study|Adverse Event|3|||
161341215|NCT00171249|582635671|FG001|Overall Study|Adverse Event|1|||
161341216|NCT00171249|582635672|FG002|Overall Study|Adverse Event|0|||
161341217|NCT00171249|582635673|FG003|Overall Study|Adverse Event|15|||
161341218|NCT00171249|582635674|FG004|Overall Study|Adverse Event|0|||
161341219|NCT00171249|582635675|FG005|Overall Study|Adverse Event|2|||
161341220|NCT00171249|582635676|FG006|Overall Study|Adverse Event|0|||
161341221|NCT00171249|582635670|FG000|Overall Study|Lost to Follow-up|5|||
161341222|NCT00171249|582635671|FG001|Overall Study|Lost to Follow-up|0|||
161341223|NCT00171249|582635672|FG002|Overall Study|Lost to Follow-up|0|||
161341224|NCT00171249|582635673|FG003|Overall Study|Lost to Follow-up|9|||
161341225|NCT00171249|582635674|FG004|Overall Study|Lost to Follow-up|0|||
161341226|NCT00171249|582635675|FG005|Overall Study|Lost to Follow-up|0|||
161341227|NCT00171249|582635676|FG006|Overall Study|Lost to Follow-up|0|||
161341228|NCT00392223|582635677|FG000|Overall Study|Adverse Event|5|||
161341229|NCT00392223|582635678|FG001|Overall Study|Adverse Event|4|||
161341230|NCT00392223|582635677|FG000|Overall Study|Lost to Follow-up|1|||
161341231|NCT00392223|582635678|FG001|Overall Study|Lost to Follow-up|4|||
161341232|NCT00392223|582635677|FG000|Overall Study|Protocol Violation|0|||
161341233|NCT00392223|582635678|FG001|Overall Study|Protocol Violation|3|||
161341234|NCT00392223|582635677|FG000|Overall Study|Withdrawal by Subject|3|||
161341235|NCT00392223|582635678|FG001|Overall Study|Withdrawal by Subject|2|||
161341236|NCT02908347|582635679|FG000|Overall Study|Adverse Event|0|||
161341237|NCT02908347|582635680|FG001|Overall Study|Adverse Event|1|||
161341238|NCT02908347|582635679|FG000|Overall Study|Lost to Follow-up|1|||
161341239|NCT02908347|582635680|FG001|Overall Study|Lost to Follow-up|0|||
161341240|NCT01316575|582635683|FG000|Overall Study|Withdrawal by Subject|2|||
161341241|NCT01316575|582635684|FG001|Overall Study|Withdrawal by Subject|0|||
161341242|NCT01316575|582635683|FG000|Overall Study|Required alternate treatment|0|||
161341243|NCT01316575|582635684|FG001|Overall Study|Required alternate treatment|1|||
161341244|NCT00402831|582635685|FG000|Overall Study|Lost to Follow-up|1|||
161143371|NCT00923091|581907585|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
161261695|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
161261696|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
161261697|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
161261698|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
161261699|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
161261700|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
161261701|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Subject decision|1|||
161261702|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Subject decision|1|||
161261703|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
161261704|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
161261705|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
161261706|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
161261707|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
161261708|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
161261709|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
161261710|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
161261711|NCT00518882|582337794|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
161261712|NCT00518882|582337795|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
161261713|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
161261714|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
161261715|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
161261716|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
161261717|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
161261718|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
161261719|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
161261720|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
161261721|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
161261722|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
161261723|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
161261724|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
161261725|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
161261726|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
161261727|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
161261728|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
161261729|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
161261730|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
161261731|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
161261732|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
161261733|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
161261734|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
161261735|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
161261736|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
161261737|NCT00518882|582337794|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
161261738|NCT00518882|582337795|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
161261739|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
161261740|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
161261741|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
161261742|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
161261743|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
161261744|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
161261745|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
161261746|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
161261747|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161261748|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
161261749|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
161261750|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
161261751|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
161261752|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
161261753|NCT04740931|582337797|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
161261754|NCT04740931|582337798|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
161261755|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
161261756|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
161261757|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
161261758|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
161261759|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
161261760|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
161261761|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
161341245|NCT00402831|582635686|FG001|Overall Study|Lost to Follow-up|2|||
160921473|NCT04447755|581105354|FG005|Overall Study|Sponsor Decision|0|||
161261762|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
161261763|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
161261764|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
161261765|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
161261766|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
161261767|NCT04740931|582337797|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
161261768|NCT04740931|582337798|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
161261769|NCT02096588|582337799|FG000|Overall Study|Lack of Efficacy|2|||
161261770|NCT02096588|582337800|FG001|Overall Study|Lack of Efficacy|0|||
161261771|NCT02096588|582337799|FG000|Overall Study|Withdrawal by Subject|0|||
161261772|NCT02096588|582337800|FG001|Overall Study|Withdrawal by Subject|1|||
161261773|NCT01258101|582337801|FG000|Overall Study|Adverse Event|5|||
161261774|NCT01258101|582337802|FG001|Overall Study|Adverse Event|6|||
161261775|NCT01258101|582337803|FG002|Overall Study|Adverse Event|0|||
161261776|NCT01258101|582337804|FG003|Overall Study|Adverse Event|0|||
161261777|NCT01258101|582337801|FG000|Overall Study|Extra exclusion criterion amended|2|||
161261778|NCT01258101|582337802|FG001|Overall Study|Extra exclusion criterion amended|1|||
161261779|NCT01258101|582337803|FG002|Overall Study|Extra exclusion criterion amended|1|||
161261780|NCT01258101|582337804|FG003|Overall Study|Extra exclusion criterion amended|1|||
161261781|NCT01258101|582337801|FG000|Overall Study|Informed consent has been withdrawn|2|||
161261782|NCT01258101|582337802|FG001|Overall Study|Informed consent has been withdrawn|2|||
161261783|NCT01258101|582337803|FG002|Overall Study|Informed consent has been withdrawn|1|||
161261784|NCT01258101|582337804|FG003|Overall Study|Informed consent has been withdrawn|1|||
161261785|NCT01258101|582337801|FG000|Overall Study|Patient is not able to attend visits|8|||
161261786|NCT01258101|582337802|FG001|Overall Study|Patient is not able to attend visits|9|||
161261787|NCT01258101|582337803|FG002|Overall Study|Patient is not able to attend visits|7|||
161261788|NCT01258101|582337804|FG003|Overall Study|Patient is not able to attend visits|6|||
161261789|NCT01258101|582337801|FG000|Overall Study|Patient´s compliance|4|||
161261790|NCT01258101|582337802|FG001|Overall Study|Patient´s compliance|3|||
161261791|NCT01258101|582337803|FG002|Overall Study|Patient´s compliance|1|||
161261792|NCT01258101|582337804|FG003|Overall Study|Patient´s compliance|2|||
161261793|NCT01258101|582337801|FG000|Overall Study|Lost to Follow-up|5|||
161261794|NCT01258101|582337802|FG001|Overall Study|Lost to Follow-up|5|||
161261795|NCT01258101|582337803|FG002|Overall Study|Lost to Follow-up|0|||
161261796|NCT01258101|582337804|FG003|Overall Study|Lost to Follow-up|6|||
161261797|NCT01258101|582337801|FG000|Overall Study|PCR positive at week 24|0|||
161261798|NCT01258101|582337802|FG001|Overall Study|PCR positive at week 24|0|||
161261799|NCT01258101|582337803|FG002|Overall Study|PCR positive at week 24|0|||
161261800|NCT01258101|582337804|FG003|Overall Study|PCR positive at week 24|1|||
161261801|NCT01258101|582337801|FG000|Overall Study|Other reason|7|||
161261802|NCT01258101|582337802|FG001|Overall Study|Other reason|8|||
161261803|NCT01258101|582337803|FG002|Overall Study|Other reason|1|||
161261804|NCT01258101|582337804|FG003|Overall Study|Other reason|8|||
161261805|NCT01020799|582337810|FG000|Overall Study|Adverse Event|4|||
161261806|NCT01020799|582337811|FG001|Overall Study|Adverse Event|3|||
161261807|NCT01020799|582337812|FG002|Overall Study|Adverse Event|2|||
161261808|NCT01020799|582337810|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
161261809|NCT01020799|582337811|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
161261810|NCT01020799|582337812|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
161261811|NCT01020799|582337810|FG000|Overall Study|Protocol Violation|3|||
161261812|NCT01020799|582337811|FG001|Overall Study|Protocol Violation|2|||
161261813|NCT01020799|582337812|FG002|Overall Study|Protocol Violation|0|||
161261814|NCT01020799|582337810|FG000|Overall Study|Withdrawal by Subject|2|||
161261815|NCT01020799|582337811|FG001|Overall Study|Withdrawal by Subject|2|||
161261816|NCT01020799|582337812|FG002|Overall Study|Withdrawal by Subject|3|||
161261817|NCT01020799|582337810|FG000|Overall Study|Lost to Follow-up|6|||
161261818|NCT01020799|582337811|FG001|Overall Study|Lost to Follow-up|4|||
161261819|NCT01020799|582337812|FG002|Overall Study|Lost to Follow-up|2|||
161261820|NCT02556307|582337815|FG000|Overall Study|Premature treatment interruption|11|||
161261821|NCT02556307|582337815|FG000|Overall Study|Lost to Follow-up|36|||
161261822|NCT02556307|582337815|FG000|Overall Study|Change to triple therapy|4|||
161261823|NCT02556307|582337815|FG000|Overall Study|Enrolled but not treated|2|||
161261824|NCT03438227|582337816|FG000|Overall Study|Withdrawal by Subject|10|||
161261825|NCT03438227|582337817|FG001|Overall Study|Withdrawal by Subject|5|||
161261826|NCT00706992|582337818|FG000|Overall Study|Study termination|5|||
161261827|NCT00706992|582337819|FG001|Overall Study|Study termination|5|||
161261828|NCT00706992|582337820|FG002|Overall Study|Study termination|6|||
161261829|NCT00706992|582337821|FG003|Overall Study|Study termination|2|||
161261830|NCT00706992|582337822|FG004|Overall Study|Study termination|3|||
161261831|NCT00706992|582337823|FG005|Overall Study|Study termination|2|||
161261832|NCT00706992|582337824|FG006|Overall Study|Study termination|3|||
161261833|NCT00706992|582337818|FG000|Overall Study|Disease progression before treatment|0|||
161261834|NCT00706992|582337819|FG001|Overall Study|Disease progression before treatment|0|||
161261835|NCT00706992|582337820|FG002|Overall Study|Disease progression before treatment|0|||
161261836|NCT00706992|582337821|FG003|Overall Study|Disease progression before treatment|0|||
160921474|NCT04447755|581105355|FG006|Overall Study|Sponsor Decision|10|||
160921475|NCT04447755|581105349|FG000|Overall Study|Lost to Follow-up|0|||
160921476|NCT04447755|581105350|FG001|Overall Study|Lost to Follow-up|0|||
160921477|NCT04447755|581105351|FG002|Overall Study|Lost to Follow-up|0|||
160921478|NCT04447755|581105352|FG003|Overall Study|Lost to Follow-up|0|||
160921479|NCT04447755|581105353|FG004|Overall Study|Lost to Follow-up|0|||
160921480|NCT04447755|581105354|FG005|Overall Study|Lost to Follow-up|0|||
160921481|NCT04447755|581105355|FG006|Overall Study|Lost to Follow-up|1|||
160921482|NCT03721276|581105356|FG000|Overall Study|Lost to Follow-up|5|||
160921483|NCT03721276|581105357|FG001|Overall Study|Lost to Follow-up|3|||
160921484|NCT03721276|581105356|FG000|Overall Study|Adverse Event|0|||
160921485|NCT03721276|581105357|FG001|Overall Study|Adverse Event|1|||
160921486|NCT01340898|581105362|FG000|Primary Phase|Serious Adverse Events|0|||
160921487|NCT01340898|581105363|FG001|Primary Phase|Serious Adverse Events|0|||
160921488|NCT01340898|581105364|FG002|Primary Phase|Serious Adverse Events|1|||
160921489|NCT01340898|581105362|FG000|Primary Phase|Withdrawal by Subject|8|||
160921490|NCT01340898|581105363|FG001|Primary Phase|Withdrawal by Subject|7|||
160921491|NCT01340898|581105364|FG002|Primary Phase|Withdrawal by Subject|5|||
160921492|NCT01340898|581105362|FG000|Primary Phase|Migrated/moved from study area|4|||
160921493|NCT01340898|581105363|FG001|Primary Phase|Migrated/moved from study area|1|||
160921494|NCT01340898|581105364|FG002|Primary Phase|Migrated/moved from study area|0|||
160921495|NCT01340898|581105362|FG000|Primary Phase|Lost to Follow-up|4|||
160921496|NCT01340898|581105363|FG001|Primary Phase|Lost to Follow-up|1|||
160921497|NCT01340898|581105364|FG002|Primary Phase|Lost to Follow-up|0|||
160921498|NCT01340898|581105362|FG000|Booster Phase|Withdrawal by Subject|3|||
160921499|NCT01340898|581105363|FG001|Booster Phase|Withdrawal by Subject|0|||
160921500|NCT01340898|581105364|FG002|Booster Phase|Withdrawal by Subject|4|||
160921501|NCT01340898|581105362|FG000|Booster Phase|Migrated/moved from study area|3|||
160921502|NCT01340898|581105363|FG001|Booster Phase|Migrated/moved from study area|0|||
160921503|NCT01340898|581105364|FG002|Booster Phase|Migrated/moved from study area|0|||
160921504|NCT01340898|581105362|FG000|Booster Phase|Lost to Follow-up|4|||
160921505|NCT01340898|581105363|FG001|Booster Phase|Lost to Follow-up|2|||
160921506|NCT01340898|581105364|FG002|Booster Phase|Lost to Follow-up|3|||
160921507|NCT00416078|581105367|FG000|Overall Study|Death|3|||
160921508|NCT00416078|581105368|FG001|Overall Study|Death|4|||
160921509|NCT00416078|581105367|FG000|Overall Study|Withdrawal by Subject|3|||
160921510|NCT00416078|581105368|FG001|Overall Study|Withdrawal by Subject|2|||
160921511|NCT00416078|581105367|FG000|Overall Study|Physician Decision|1|||
160921512|NCT00416078|581105368|FG001|Overall Study|Physician Decision|0|||
160921513|NCT00416078|581105367|FG000|Overall Study|Lost to Follow-up|4|||
160921514|NCT00416078|581105368|FG001|Overall Study|Lost to Follow-up|2|||
160921515|NCT03564145|581105377|FG000|Overall Study|Adverse Event|4|||
160921516|NCT03564145|581105377|FG000|Overall Study|Lost to Follow-up|21|||
160921517|NCT03564145|581105377|FG000|Overall Study|Protocol Violation|2|||
160921518|NCT03564145|581105377|FG000|Overall Study|Withdrawal by Subject|48|||
161261837|NCT00706992|582337822|FG004|Overall Study|Disease progression before treatment|1|||
161261838|NCT00706992|582337823|FG005|Overall Study|Disease progression before treatment|0|||
161261839|NCT00706992|582337824|FG006|Overall Study|Disease progression before treatment|0|||
161261840|NCT01244061|582337827|FG000|Overall Study|Death|1|||
161261841|NCT01244061|582337828|FG001|Overall Study|Death|0|||
161261842|NCT01244061|582337827|FG000|Overall Study|Did not meet entrance criteria|1|||
161261843|NCT01244061|582337828|FG001|Overall Study|Did not meet entrance criteria|0|||
161261844|NCT01244061|582337827|FG000|Overall Study|Lack of Efficacy|1|||
161261845|NCT01244061|582337828|FG001|Overall Study|Lack of Efficacy|3|||
161261846|NCT01244061|582337827|FG000|Overall Study|Lost to Follow-up|34|||
161261847|NCT01244061|582337828|FG001|Overall Study|Lost to Follow-up|30|||
161261848|NCT01244061|582337827|FG000|Overall Study|Withdrawal by Subject|29|||
161261849|NCT01244061|582337828|FG001|Overall Study|Withdrawal by Subject|46|||
161261850|NCT01244061|582337827|FG000|Overall Study|Other|8|||
161261851|NCT01244061|582337828|FG001|Overall Study|Other|19|||
161261852|NCT01244061|582337827|FG000|Overall Study|Protocol Violation|1|||
161261853|NCT01244061|582337828|FG001|Overall Study|Protocol Violation|1|||
161261854|NCT01244061|582337827|FG000|Overall Study|Adverse Event|5|||
161261855|NCT01244061|582337828|FG001|Overall Study|Adverse Event|2|||
161261856|NCT01244061|582337827|FG000|Overall Study|Randomized but not treated|2|||
161261857|NCT01244061|582337828|FG001|Overall Study|Randomized but not treated|2|||
161261858|NCT03166124|582337829|FG000|Treatment Period 1|Adverse Event|0|||
160921519|NCT03564145|581105377|FG000|Overall Study|Study Terminated by Sponsor|146|||
160921520|NCT03564145|581105377|FG000|Overall Study|Physician Decision|1|||
160921521|NCT03564145|581105377|FG000|Overall Study|Other Than Specified|1|||
160921522|NCT03564145|581105377|FG000|Overall Study|Pregnancy|1|||
160921523|NCT00410761|581107355|FG000|Randomized Treatment Period|Adverse Event|34|||
160921524|NCT00410761|581107356|FG001|Randomized Treatment Period|Adverse Event|3|||
160921525|NCT00410761|581107355|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
161261859|NCT03166124|582337830|FG001|Treatment Period 1|Adverse Event|0|||
161261860|NCT03166124|582337831|FG002|Treatment Period 1|Adverse Event|1|||
160921526|NCT00410761|581107356|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
161261861|NCT03166124|582337832|FG003|Treatment Period 1|Adverse Event|0|||
160921527|NCT00410761|581107355|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
160921528|NCT00410761|581107356|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
160921529|NCT00410761|581107355|FG000|Randomized Treatment Period|Other|69|||
160921530|NCT00410761|581107356|FG001|Randomized Treatment Period|Other|21|||
160921531|NCT00410761|581107355|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
160921532|NCT00410761|581107356|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
160921533|NCT00410761|581107355|FG000|Open-Label Treatment Period|Adverse Event|13|||
160921534|NCT00410761|581107356|FG001|Open-Label Treatment Period|Adverse Event|15|||
160921535|NCT00410761|581107355|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
160921536|NCT00410761|581107356|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
160921537|NCT00410761|581107355|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
160921538|NCT00410761|581107356|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
161261862|NCT03166124|582337829|FG000|Wash-out Period|Withdrawal by Subject|0|||
161261863|NCT03166124|582337830|FG001|Wash-out Period|Withdrawal by Subject|1|||
161261864|NCT03166124|582337831|FG002|Wash-out Period|Withdrawal by Subject|0|||
161261865|NCT03166124|582337832|FG003|Wash-out Period|Withdrawal by Subject|1|||
160921539|NCT00410761|581107355|FG000|Open-Label Treatment Period|Other|18|||
160921540|NCT00410761|581107356|FG001|Open-Label Treatment Period|Other|9|||
160921541|NCT00623727|581107357|FG000|Double Blind (DB)|Adverse Event|1|||
160921542|NCT00623727|581107358|FG001|Double Blind (DB)|Adverse Event|3|||
160921543|NCT00623727|581107357|FG000|Double Blind (DB)|Physician Decision|0|||
160921544|NCT00623727|581107358|FG001|Double Blind (DB)|Physician Decision|1|||
160921545|NCT00623727|581107357|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
160921546|NCT00623727|581107358|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
160921547|NCT00623727|581107357|FG000|Double Blind (DB)|Lack of Efficacy|2|||
160921548|NCT00623727|581107358|FG001|Double Blind (DB)|Lack of Efficacy|2|||
160921549|NCT00623727|581107357|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
160921550|NCT00623727|581107358|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
160921551|NCT00623727|581107357|FG000|Double Blind (DB)|Lost to Follow-up|1|||
160921552|NCT00623727|581107358|FG001|Double Blind (DB)|Lost to Follow-up|1|||
160921553|NCT00623727|581107357|FG000|Double Blind (DB)|Protocol Violation|2|||
160921554|NCT00623727|581107358|FG001|Double Blind (DB)|Protocol Violation|2|||
160921555|NCT00623727|581107357|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
160921556|NCT00623727|581107358|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
160921557|NCT00623727|581107357|FG000|Open Label Follow-up|Study termination|0|||
160921558|NCT00623727|581107358|FG001|Open Label Follow-up|Study termination|6|||
160921559|NCT00623727|581107357|FG000|Open Label Follow-up|Participant convenience|0|||
160921560|NCT00623727|581107358|FG001|Open Label Follow-up|Participant convenience|1|||
160921561|NCT01852942|581107359|FG000|Overall Study|Physician Decision|1|||
160921562|NCT01852942|581107360|FG001|Overall Study|Physician Decision|0|||
160921563|NCT01852942|581107359|FG000|Overall Study|Death|1|||
160921564|NCT01852942|581107360|FG001|Overall Study|Death|1|||
160921565|NCT01852942|581107359|FG000|Overall Study|Withdrawal by Subject|2|||
160921566|NCT01852942|581107360|FG001|Overall Study|Withdrawal by Subject|3|||
160921567|NCT01852942|581107359|FG000|Overall Study|Lost to Follow-up|1|||
160921568|NCT01852942|581107360|FG001|Overall Study|Lost to Follow-up|2|||
160921569|NCT03745937|581107362|FG000|Overall Study|Withdrawal by Subject|0|||
160921570|NCT03745937|581107363|FG001|Overall Study|Withdrawal by Subject|0|||
160921571|NCT03745937|581107364|FG002|Overall Study|Withdrawal by Subject|0|||
160921572|NCT03745937|581107365|FG003|Overall Study|Withdrawal by Subject|1|||
160921573|NCT03745937|581107362|FG000|Overall Study|Not-specifed|0|||
160921574|NCT03745937|581107363|FG001|Overall Study|Not-specifed|1|||
160921575|NCT03745937|581107364|FG002|Overall Study|Not-specifed|0|||
160921576|NCT03745937|581107365|FG003|Overall Study|Not-specifed|1|||
160921577|NCT00696696|581107371|FG000|Overall Study|Adverse Event|5|||
160921578|NCT00696696|581107371|FG000|Overall Study|Withdrawal by Subject|8|||
160921579|NCT00696696|581107371|FG000|Overall Study|Physician Decision|2|||
160921580|NCT00696696|581107371|FG000|Overall Study|Death|3|||
160921581|NCT02642614|581107372|FG000|Overall Study|Adverse Event|1|||
160921582|NCT02642614|581107373|FG001|Overall Study|Adverse Event|1|||
160921583|NCT02642614|581107374|FG002|Overall Study|Adverse Event|2|||
160921584|NCT02642614|581107375|FG003|Overall Study|Adverse Event|2|||
160921585|NCT02642614|581107372|FG000|Overall Study|Lost to Follow-up|1|||
160921586|NCT02642614|581107373|FG001|Overall Study|Lost to Follow-up|0|||
160921587|NCT02642614|581107374|FG002|Overall Study|Lost to Follow-up|0|||
160921588|NCT02642614|581107375|FG003|Overall Study|Lost to Follow-up|0|||
160921589|NCT02642614|581107372|FG000|Overall Study|Withdrawal by Subject|1|||
160921590|NCT02642614|581107373|FG001|Overall Study|Withdrawal by Subject|1|||
160921591|NCT02642614|581107374|FG002|Overall Study|Withdrawal by Subject|0|||
160921592|NCT02642614|581107375|FG003|Overall Study|Withdrawal by Subject|0|||
160921593|NCT03227029|581107378|FG000|Overall Study|Child Wheezed (no treatment)|0|||
160921594|NCT03227029|581107379|FG001|Overall Study|Child Wheezed (no treatment)|1|||
160921595|NCT03227029|581107380|FG002|Overall Study|Child Wheezed (no treatment)|0|||
160921596|NCT03227029|581107378|FG000|Overall Study|No post RSV season visit due to COVID|3|||
160921597|NCT03227029|581107379|FG001|Overall Study|No post RSV season visit due to COVID|3|||
160997741|NCT01689519|581376623|FG000|Intent to Treat|Death|157|||
160997742|NCT01689519|581376624|FG001|Intent to Treat|Death|167|||
161261866|NCT03166124|582337829|FG000|Wash-out Period|Adverse Event|0|||
161261867|NCT03166124|582337830|FG001|Wash-out Period|Adverse Event|1|||
160997743|NCT01689519|581376623|FG000|Intent to Treat|Lost to Follow-up|4|||
160997744|NCT01689519|581376624|FG001|Intent to Treat|Lost to Follow-up|8|||
160997745|NCT01689519|581376623|FG000|Intent to Treat|Other|2|||
160997746|NCT01689519|581376624|FG001|Intent to Treat|Other|4|||
161261868|NCT03166124|582337831|FG002|Wash-out Period|Adverse Event|1|||
161261869|NCT03166124|582337832|FG003|Wash-out Period|Adverse Event|0|||
161261870|NCT00788593|582337833|FG000|Placebo Run-in Phase|Adverse Event|2|||
161261871|NCT00788593|582337834|FG001|Placebo Run-in Phase|Adverse Event|0|||
161261872|NCT00788593|582337835|FG002|Placebo Run-in Phase|Adverse Event|0|||
160921598|NCT03227029|581107380|FG002|Overall Study|No post RSV season visit due to COVID|2|||
160921599|NCT03227029|581107378|FG000|Overall Study|Not able to get to clinic|0|||
160921600|NCT03227029|581107379|FG001|Overall Study|Not able to get to clinic|0|||
160921601|NCT03227029|581107380|FG002|Overall Study|Not able to get to clinic|1|||
160921602|NCT03227029|581107378|FG000|Overall Study|Withdrawal by Subject|1|||
160921603|NCT03227029|581107379|FG001|Overall Study|Withdrawal by Subject|0|||
160921604|NCT03227029|581107380|FG002|Overall Study|Withdrawal by Subject|0|||
160921605|NCT03227029|581107378|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
160921606|NCT03227029|581107379|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
160921607|NCT03227029|581107380|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
160921608|NCT01291173|581107381|FG000|Overall Study|Adverse Event|0|||
160921609|NCT01291173|581107382|FG001|Overall Study|Adverse Event|3|||
160921610|NCT01291173|581107383|FG002|Overall Study|Adverse Event|1|||
160921611|NCT01291173|581107384|FG003|Overall Study|Adverse Event|3|||
160921612|NCT01291173|581107381|FG000|Overall Study|Protocol Violation|7|||
160921613|NCT01291173|581107382|FG001|Overall Study|Protocol Violation|2|||
160921614|NCT01291173|581107383|FG002|Overall Study|Protocol Violation|2|||
160921615|NCT01291173|581107384|FG003|Overall Study|Protocol Violation|5|||
160921616|NCT01291173|581107381|FG000|Overall Study|Withdrawal by Subject|6|||
160921617|NCT01291173|581107382|FG001|Overall Study|Withdrawal by Subject|4|||
160921618|NCT01291173|581107383|FG002|Overall Study|Withdrawal by Subject|4|||
160921619|NCT01291173|581107384|FG003|Overall Study|Withdrawal by Subject|2|||
160921620|NCT01291173|581107381|FG000|Overall Study|Lost to Follow-up|4|||
160921621|NCT01291173|581107382|FG001|Overall Study|Lost to Follow-up|6|||
160921622|NCT01291173|581107383|FG002|Overall Study|Lost to Follow-up|3|||
160921623|NCT01291173|581107384|FG003|Overall Study|Lost to Follow-up|2|||
160921624|NCT01291173|581107381|FG000|Overall Study|Unable to meet visit schedule|0|||
160921625|NCT01291173|581107382|FG001|Overall Study|Unable to meet visit schedule|0|||
160921626|NCT01291173|581107383|FG002|Overall Study|Unable to meet visit schedule|1|||
160921627|NCT01291173|581107384|FG003|Overall Study|Unable to meet visit schedule|0|||
160921628|NCT01291173|581107381|FG000|Overall Study|Lack of compliance|0|||
160921629|NCT01291173|581107382|FG001|Overall Study|Lack of compliance|0|||
160921630|NCT01291173|581107383|FG002|Overall Study|Lack of compliance|0|||
160921631|NCT01291173|581107384|FG003|Overall Study|Lack of compliance|1|||
160921632|NCT01291173|581107381|FG000|Overall Study|Subject was unblinded|0|||
160921633|NCT01291173|581107382|FG001|Overall Study|Subject was unblinded|0|||
160921634|NCT01291173|581107383|FG002|Overall Study|Subject was unblinded|1|||
160921635|NCT01291173|581107384|FG003|Overall Study|Subject was unblinded|0|||
160921636|NCT01291173|581107381|FG000|Overall Study|Excluded therapy|0|||
160921637|NCT01291173|581107382|FG001|Overall Study|Excluded therapy|0|||
160921638|NCT01291173|581107383|FG002|Overall Study|Excluded therapy|1|||
160921639|NCT01291173|581107384|FG003|Overall Study|Excluded therapy|0|||
160921640|NCT01074450|581107390|FG000|First Intervention|Emesis in Dosing Interval|0|||
160921641|NCT01074450|581107391|FG001|First Intervention|Emesis in Dosing Interval|2|||
160921642|NCT01074450|581107390|FG000|Second Intervention|Protocol Violation|1|||
160921643|NCT01074450|581107391|FG001|Second Intervention|Protocol Violation|0|||
160921644|NCT01074450|581107390|FG000|Second Intervention|Physician Decision|0|||
160921645|NCT01074450|581107391|FG001|Second Intervention|Physician Decision|1|||
161143372|NCT00923091|581907586|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
160997747|NCT01689519|581376623|FG000|Intent to Treat|Physician Decision|4|||
160997748|NCT01689519|581376624|FG001|Intent to Treat|Physician Decision|1|||
161261873|NCT00788593|582337833|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
161261874|NCT00788593|582337834|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
161261875|NCT00788593|582337835|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
161261876|NCT00788593|582337833|FG000|Placebo Run-in Phase|Protocol Violation|2|||
161143373|NCT00923091|581907574|FG000|Period VI (Open-Label)|Protocol Violation|6|||
161143374|NCT00923091|581907575|FG001|Period VI (Open-Label)|Protocol Violation|1|||
160997749|NCT01689519|581376623|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
160997750|NCT01689519|581376624|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
160997751|NCT01689519|581376623|FG000|Intent to Treat|Withdrawal by Subject|21|||
161143375|NCT00923091|581907576|FG002|Period VI (Open-Label)|Protocol Violation|3|||
161143376|NCT00923091|581907577|FG003|Period VI (Open-Label)|Protocol Violation|1|||
161261877|NCT00788593|582337834|FG001|Placebo Run-in Phase|Protocol Violation|0|||
161261878|NCT00788593|582337835|FG002|Placebo Run-in Phase|Protocol Violation|0|||
161261879|NCT00788593|582337833|FG000|First Intervention Period|Adverse Event|0|||
161261880|NCT00788593|582337834|FG001|First Intervention Period|Adverse Event|1|||
161261881|NCT00788593|582337835|FG002|First Intervention Period|Adverse Event|0|||
161261882|NCT00788593|582337833|FG000|Second Intervention Period|Lost to Follow-up|0|||
161261883|NCT00788593|582337834|FG001|Second Intervention Period|Lost to Follow-up|1|||
161261884|NCT00788593|582337835|FG002|Second Intervention Period|Lost to Follow-up|0|||
161261885|NCT00788593|582337833|FG000|Second Intervention Period|Other|0|||
161143377|NCT00923091|581907578|FG004|Period VI (Open-Label)|Protocol Violation|4|||
161143378|NCT00923091|581907579|FG005|Period VI (Open-Label)|Protocol Violation|0|||
161143379|NCT00923091|581907580|FG006|Period VI (Open-Label)|Protocol Violation|0|||
161143380|NCT00923091|581907581|FG007|Period VI (Open-Label)|Protocol Violation|0|||
161143381|NCT00923091|581907582|FG008|Period VI (Open-Label)|Protocol Violation|0|||
161143382|NCT00923091|581907583|FG009|Period VI (Open-Label)|Protocol Violation|0|||
161143383|NCT00923091|581907584|FG010|Period VI (Open-Label)|Protocol Violation|0|||
161143384|NCT00923091|581907585|FG011|Period VI (Open-Label)|Protocol Violation|0|||
161261886|NCT00788593|582337834|FG001|Second Intervention Period|Other|0|||
160921658|NCT02728895|581107394|FG000|Overall Study|Other|1|||
160921659|NCT02728895|581107395|FG001|Overall Study|Other|2|||
160921660|NCT02728895|581107394|FG000|Overall Study|Withdrawal by Subject|0|||
160921661|NCT02728895|581107395|FG001|Overall Study|Withdrawal by Subject|3|||
160921662|NCT04788953|581107396|FG000|Overall Study|Adverse Event|1|||
160921663|NCT04788953|581107397|FG001|Overall Study|Adverse Event|1|||
160921664|NCT04788953|581107396|FG000|Overall Study|Withdrawal by Subject|1|||
160921665|NCT04788953|581107397|FG001|Overall Study|Withdrawal by Subject|0|||
160921666|NCT04788953|581107396|FG000|Overall Study|Protocol Violation|0|||
160921667|NCT04788953|581107397|FG001|Overall Study|Protocol Violation|1|||
160921668|NCT00469092|581107398|FG000|Overall Study|Adverse Event|5|||
160921669|NCT00469092|581107399|FG001|Overall Study|Adverse Event|4|||
160921670|NCT00469092|581107398|FG000|Overall Study|Lack of Efficacy|1|||
160921671|NCT00469092|581107399|FG001|Overall Study|Lack of Efficacy|0|||
160921672|NCT00469092|581107398|FG000|Overall Study|Lost to Follow-up|1|||
160921673|NCT00469092|581107399|FG001|Overall Study|Lost to Follow-up|2|||
160921674|NCT00469092|581107398|FG000|Overall Study|Protocol Violation|3|||
160921675|NCT00469092|581107399|FG001|Overall Study|Protocol Violation|3|||
160921676|NCT00469092|581107398|FG000|Overall Study|Withdrawal by Subject|4|||
160921677|NCT00469092|581107399|FG001|Overall Study|Withdrawal by Subject|4|||
160921678|NCT00469092|581107398|FG000|Overall Study|Withdrawal Criteria|3|||
160921679|NCT00469092|581107399|FG001|Overall Study|Withdrawal Criteria|4|||
160921680|NCT00469092|581107398|FG000|Overall Study|Incorrectly Randomised|4|||
160921681|NCT00469092|581107399|FG001|Overall Study|Incorrectly Randomised|3|||
160921682|NCT00469092|581107398|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
160921683|NCT00469092|581107399|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
160921684|NCT00469092|581107398|FG000|Overall Study|Use of lipid lowering drug|1|||
160921685|NCT00469092|581107399|FG001|Overall Study|Use of lipid lowering drug|0|||
160921686|NCT00469092|581107398|FG000|Overall Study|Hypoglycaemic Episodes|1|||
160921687|NCT00469092|581107399|FG001|Overall Study|Hypoglycaemic Episodes|1|||
160921688|NCT00469092|581107398|FG000|Overall Study|Abnormal lab value|1|||
160921689|NCT00469092|581107399|FG001|Overall Study|Abnormal lab value|0|||
160921690|NCT00469092|581107398|FG000|Overall Study|Use of Corticosteroid|1|||
160921691|NCT00469092|581107399|FG001|Overall Study|Use of Corticosteroid|0|||
160921692|NCT02707991|581107408|FG000|Overall Study|Protocol Violation|1|||
160921693|NCT02707991|581107409|FG001|Overall Study|Protocol Violation|0|||
160921694|NCT02707991|581107408|FG000|Overall Study|Became ineligible|0|||
160921695|NCT02707991|581107409|FG001|Overall Study|Became ineligible|1|||
160921696|NCT02268864|581107410|FG000|Overall Study|Withdrawal by Subject|2|||
160921697|NCT02268864|581107411|FG001|Overall Study|Withdrawal by Subject|0|||
160921698|NCT02268864|581107412|FG002|Overall Study|Withdrawal by Subject|0|||
160921699|NCT02268864|581107410|FG000|Overall Study|Death|0|||
160921700|NCT02268864|581107411|FG001|Overall Study|Death|1|||
160921701|NCT02268864|581107412|FG002|Overall Study|Death|0|||
160921702|NCT05407675|581107415|FG000|Overall Study|Withdrawal by Subject|0|||
160921703|NCT05407675|581107416|FG001|Overall Study|Withdrawal by Subject|2|||
160921704|NCT05407675|581107417|FG002|Overall Study|Withdrawal by Subject|3|||
160921705|NCT05407675|581107418|FG003|Overall Study|Withdrawal by Subject|5|||
160921706|NCT05407675|581107419|FG004|Overall Study|Withdrawal by Subject|0|||
160921707|NCT05407675|581107420|FG005|Overall Study|Withdrawal by Subject|2|||
160921708|NCT05407675|581107421|FG006|Overall Study|Withdrawal by Subject|0|||
160921709|NCT05407675|581107422|FG007|Overall Study|Withdrawal by Subject|0|||
160921710|NCT05407675|581107423|FG008|Overall Study|Withdrawal by Subject|2|||
160921711|NCT05407675|581107424|FG009|Overall Study|Withdrawal by Subject|0|||
160921712|NCT05407675|581107425|FG010|Overall Study|Withdrawal by Subject|1|||
160921713|NCT05407675|581107426|FG011|Overall Study|Withdrawal by Subject|0|||
160921714|NCT05407675|581107427|FG012|Overall Study|Withdrawal by Subject|0|||
160921715|NCT05407675|581107415|FG000|Overall Study|Site terminated by sponsor|0|||
160921716|NCT05407675|581107416|FG001|Overall Study|Site terminated by sponsor|0|||
160921717|NCT05407675|581107417|FG002|Overall Study|Site terminated by sponsor|1|||
160921718|NCT05407675|581107418|FG003|Overall Study|Site terminated by sponsor|0|||
160921719|NCT05407675|581107419|FG004|Overall Study|Site terminated by sponsor|2|||
160921720|NCT05407675|581107420|FG005|Overall Study|Site terminated by sponsor|0|||
160921721|NCT05407675|581107421|FG006|Overall Study|Site terminated by sponsor|1|||
160921722|NCT05407675|581107422|FG007|Overall Study|Site terminated by sponsor|0|||
160921723|NCT05407675|581107423|FG008|Overall Study|Site terminated by sponsor|0|||
160921724|NCT05407675|581107424|FG009|Overall Study|Site terminated by sponsor|2|||
160921725|NCT05407675|581107425|FG010|Overall Study|Site terminated by sponsor|2|||
160921726|NCT05407675|581107426|FG011|Overall Study|Site terminated by sponsor|2|||
160921727|NCT05407675|581107427|FG012|Overall Study|Site terminated by sponsor|1|||
160921728|NCT05407675|581107415|FG000|Overall Study|Disease Progression|0|||
160921729|NCT05407675|581107416|FG001|Overall Study|Disease Progression|0|||
160921730|NCT05407675|581107417|FG002|Overall Study|Disease Progression|0|||
160921731|NCT05407675|581107418|FG003|Overall Study|Disease Progression|0|||
160921732|NCT05407675|581107419|FG004|Overall Study|Disease Progression|0|||
160921733|NCT05407675|581107420|FG005|Overall Study|Disease Progression|0|||
160921734|NCT05407675|581107421|FG006|Overall Study|Disease Progression|0|||
160921735|NCT05407675|581107422|FG007|Overall Study|Disease Progression|0|||
160921736|NCT05407675|581107423|FG008|Overall Study|Disease Progression|0|||
160921737|NCT05407675|581107424|FG009|Overall Study|Disease Progression|0|||
160921738|NCT05407675|581107425|FG010|Overall Study|Disease Progression|1|||
160921739|NCT05407675|581107426|FG011|Overall Study|Disease Progression|0|||
160921740|NCT05407675|581107427|FG012|Overall Study|Disease Progression|0|||
160921741|NCT05407675|581107415|FG000|Overall Study|Physician Decision|0|||
160921742|NCT05407675|581107416|FG001|Overall Study|Physician Decision|0|||
161261887|NCT00788593|582337835|FG002|Second Intervention Period|Other|1|||
161261888|NCT01392326|582337836|FG000|Overall Study|Death|2|||
160921743|NCT05407675|581107417|FG002|Overall Study|Physician Decision|0|||
160921744|NCT05407675|581107418|FG003|Overall Study|Physician Decision|0|||
160921745|NCT05407675|581107419|FG004|Overall Study|Physician Decision|0|||
160921746|NCT05407675|581107420|FG005|Overall Study|Physician Decision|0|||
160921747|NCT05407675|581107421|FG006|Overall Study|Physician Decision|0|||
160921748|NCT05407675|581107422|FG007|Overall Study|Physician Decision|0|||
160921749|NCT05407675|581107423|FG008|Overall Study|Physician Decision|0|||
160921750|NCT05407675|581107424|FG009|Overall Study|Physician Decision|0|||
160921751|NCT05407675|581107425|FG010|Overall Study|Physician Decision|1|||
160921752|NCT05407675|581107426|FG011|Overall Study|Physician Decision|0|||
160921753|NCT05407675|581107427|FG012|Overall Study|Physician Decision|0|||
160921754|NCT05407675|581107415|FG000|Overall Study|Other reasons|0|||
160921755|NCT05407675|581107416|FG001|Overall Study|Other reasons|0|||
160921756|NCT05407675|581107417|FG002|Overall Study|Other reasons|0|||
160921757|NCT05407675|581107418|FG003|Overall Study|Other reasons|0|||
161261889|NCT01392326|582337837|FG001|Overall Study|Death|0|||
160921758|NCT05407675|581107419|FG004|Overall Study|Other reasons|0|||
160921759|NCT05407675|581107420|FG005|Overall Study|Other reasons|0|||
160921760|NCT05407675|581107421|FG006|Overall Study|Other reasons|0|||
160921761|NCT05407675|581107422|FG007|Overall Study|Other reasons|0|||
160921762|NCT05407675|581107423|FG008|Overall Study|Other reasons|1|||
160921763|NCT05407675|581107424|FG009|Overall Study|Other reasons|1|||
160921764|NCT05407675|581107425|FG010|Overall Study|Other reasons|1|||
160921765|NCT05407675|581107426|FG011|Overall Study|Other reasons|1|||
160921766|NCT05407675|581107427|FG012|Overall Study|Other reasons|0|||
160921767|NCT05407675|581107415|FG000|Overall Study|Death|3|||
160921768|NCT05407675|581107416|FG001|Overall Study|Death|4|||
160921769|NCT05407675|581107417|FG002|Overall Study|Death|3|||
160921770|NCT05407675|581107418|FG003|Overall Study|Death|6|||
160921771|NCT05407675|581107419|FG004|Overall Study|Death|0|||
160921772|NCT05407675|581107420|FG005|Overall Study|Death|2|||
160921773|NCT05407675|581107421|FG006|Overall Study|Death|4|||
160997752|NCT01689519|581376624|FG001|Intent to Treat|Withdrawal by Subject|20|||
160997753|NCT01689519|581376623|FG000|Safety Population|Death|158|||
160921774|NCT05407675|581107422|FG007|Overall Study|Death|2|||
160921775|NCT05407675|581107423|FG008|Overall Study|Death|2|||
160921776|NCT05407675|581107424|FG009|Overall Study|Death|4|||
160921777|NCT05407675|581107425|FG010|Overall Study|Death|2|||
160921778|NCT05407675|581107426|FG011|Overall Study|Death|1|||
160997754|NCT01689519|581376624|FG001|Safety Population|Death|165|||
160997755|NCT01689519|581376623|FG000|Safety Population|Lost to Follow-up|4|||
160997756|NCT01689519|581376624|FG001|Safety Population|Lost to Follow-up|8|||
161261890|NCT01392326|582337838|FG002|Overall Study|Death|0|||
160921779|NCT05407675|581107427|FG012|Overall Study|Death|0|||
160921780|NCT05407675|581107415|FG000|Overall Study|Adverse Event|0|||
160921781|NCT05407675|581107416|FG001|Overall Study|Adverse Event|0|||
160921782|NCT05407675|581107417|FG002|Overall Study|Adverse Event|0|||
160997757|NCT01689519|581376623|FG000|Safety Population|Other|2|||
160997758|NCT01689519|581376624|FG001|Safety Population|Other|4|||
161261891|NCT01392326|582337836|FG000|Overall Study|Withdrawal by Subject|12|||
160921783|NCT05407675|581107418|FG003|Overall Study|Adverse Event|0|||
160921784|NCT05407675|581107419|FG004|Overall Study|Adverse Event|1|||
160921785|NCT05407675|581107420|FG005|Overall Study|Adverse Event|0|||
160921786|NCT05407675|581107421|FG006|Overall Study|Adverse Event|0|||
161261892|NCT01392326|582337837|FG001|Overall Study|Withdrawal by Subject|11|||
160921787|NCT05407675|581107422|FG007|Overall Study|Adverse Event|0|||
160921788|NCT05407675|581107423|FG008|Overall Study|Adverse Event|0|||
160921789|NCT05407675|581107424|FG009|Overall Study|Adverse Event|0|||
160921790|NCT05407675|581107425|FG010|Overall Study|Adverse Event|0|||
160921791|NCT05407675|581107426|FG011|Overall Study|Adverse Event|1|||
160921792|NCT05407675|581107427|FG012|Overall Study|Adverse Event|0|||
160921793|NCT05407675|581107415|FG000|Overall Study|Ongoing Treatment|0|||
160921794|NCT05407675|581107416|FG001|Overall Study|Ongoing Treatment|0|||
160921795|NCT05407675|581107417|FG002|Overall Study|Ongoing Treatment|0|||
160921796|NCT05407675|581107418|FG003|Overall Study|Ongoing Treatment|0|||
160921797|NCT05407675|581107419|FG004|Overall Study|Ongoing Treatment|0|||
160921798|NCT05407675|581107420|FG005|Overall Study|Ongoing Treatment|0|||
160921799|NCT05407675|581107421|FG006|Overall Study|Ongoing Treatment|0|||
160921800|NCT05407675|581107422|FG007|Overall Study|Ongoing Treatment|0|||
160921801|NCT05407675|581107423|FG008|Overall Study|Ongoing Treatment|1|||
160921802|NCT05407675|581107424|FG009|Overall Study|Ongoing Treatment|0|||
160921803|NCT05407675|581107425|FG010|Overall Study|Ongoing Treatment|0|||
160921804|NCT05407675|581107426|FG011|Overall Study|Ongoing Treatment|0|||
160921805|NCT05407675|581107427|FG012|Overall Study|Ongoing Treatment|0|||
160921806|NCT00857220|581107428|FG000|Overall Study|Adverse Event|35|||
160921807|NCT00857220|581107428|FG000|Overall Study|Death|1|||
160921808|NCT00857220|581107428|FG000|Overall Study|Lack of Efficacy|11|||
160921809|NCT00857220|581107428|FG000|Overall Study|Lost to Follow-up|30|||
160921810|NCT00857220|581107428|FG000|Overall Study|Physician Decision|4|||
160921811|NCT00857220|581107428|FG000|Overall Study|Protocol Violation|16|||
160921812|NCT00857220|581107428|FG000|Overall Study|Withdrawal by Subject|67|||
160921813|NCT00857220|581107428|FG000|Overall Study|Clinical Hold|6|||
160921814|NCT00857220|581107428|FG000|Overall Study|Site Closed|5|||
160921815|NCT00857220|581107428|FG000|Overall Study|Miscellaneous|8|||
160921816|NCT02612428|581107429|FG000|VTL-308|Death|14|||
160921817|NCT02612428|581107430|FG001|VTL-308|Death|16|||
160921818|NCT02612428|581107429|FG000|VTL-308|Withdrawal by Subject|0|||
160921819|NCT02612428|581107430|FG001|VTL-308|Withdrawal by Subject|1|||
160921820|NCT02612428|581107429|FG000|VTL-308E|Death|9|||
160921821|NCT02612428|581107430|FG001|VTL-308E|Death|7|||
160921822|NCT02612428|581107429|FG000|VTL-308E|Lost to Follow-up|2|||
160921823|NCT02612428|581107430|FG001|VTL-308E|Lost to Follow-up|0|||
160921824|NCT00742001|581107433|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
160921825|NCT00742001|581107434|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
160921826|NCT00742001|581107435|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
160921827|NCT00137423|581107436|FG000|Overall Study|Adverse Event|7|||
160921828|NCT00137423|581107437|FG001|Overall Study|Adverse Event|9|||
160921829|NCT00137423|581107436|FG000|Overall Study|consent withdrawn|1|||
160921830|NCT00137423|581107437|FG001|Overall Study|consent withdrawn|1|||
160921831|NCT00137423|581107436|FG000|Overall Study|Lack of Efficacy|31|||
160921832|NCT00137423|581107437|FG001|Overall Study|Lack of Efficacy|33|||
160921833|NCT00137423|581107436|FG000|Overall Study|Death|0|||
160921834|NCT00137423|581107437|FG001|Overall Study|Death|1|||
160921835|NCT03187262|581107439|FG000|Induction|Lack of Efficacy|2|||
160921836|NCT03187262|581107439|FG000|Induction|Progressive Disease|4|||
160921837|NCT03187262|581107439|FG000|Consolidation|Progressive Disease|5|||
160921838|NCT01050257|581107441|FG000|Overall Study|Adverse Event|4|||
160921839|NCT01050257|581107442|FG001|Overall Study|Adverse Event|4|||
160921840|NCT01050257|581107443|FG002|Overall Study|Adverse Event|2|||
160921841|NCT01050257|581107441|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
160921842|NCT01050257|581107442|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
160921843|NCT01050257|581107443|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
160921844|NCT01050257|581107441|FG000|Overall Study|Withdrawal by Subject|0|||
160921845|NCT01050257|581107442|FG001|Overall Study|Withdrawal by Subject|3|||
161143385|NCT00923091|581907586|FG012|Period VI (Open-Label)|Protocol Violation|0|||
161143386|NCT00923091|581907574|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
161261893|NCT01392326|582337838|FG002|Overall Study|Withdrawal by Subject|15|||
161261894|NCT01392326|582337836|FG000|Overall Study|Protocol Violation|2|||
161261895|NCT01392326|582337837|FG001|Overall Study|Protocol Violation|0|||
160921846|NCT01050257|581107443|FG002|Overall Study|Withdrawal by Subject|0|||
160921847|NCT01050257|581107441|FG000|Overall Study|No reason specified|0|||
160921848|NCT01050257|581107442|FG001|Overall Study|No reason specified|0|||
160921849|NCT01050257|581107443|FG002|Overall Study|No reason specified|2|||
160921850|NCT01050257|581107441|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
160921851|NCT01050257|581107442|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
160921852|NCT01050257|581107443|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
160921853|NCT01050257|581107441|FG000|Overall Study|Violation criteria|0|||
160921854|NCT01050257|581107442|FG001|Overall Study|Violation criteria|1|||
160921855|NCT01050257|581107443|FG002|Overall Study|Violation criteria|0|||
160921856|NCT01050257|581107441|FG000|Overall Study|Failure to return|0|||
160921857|NCT01050257|581107442|FG001|Overall Study|Failure to return|2|||
160921858|NCT01050257|581107443|FG002|Overall Study|Failure to return|0|||
160921859|NCT01050257|581107441|FG000|Overall Study|Death|0|||
160921860|NCT01050257|581107442|FG001|Overall Study|Death|0|||
160921861|NCT01050257|581107443|FG002|Overall Study|Death|1|||
161261896|NCT01392326|582337838|FG002|Overall Study|Protocol Violation|0|||
161261897|NCT01392326|582337836|FG000|Overall Study|Pregnancy|0|||
161261898|NCT01392326|582337837|FG001|Overall Study|Pregnancy|0|||
160921862|NCT00278109|581107444|FG000|Overall Study|Adverse Event|3|||
160921863|NCT00278109|581107444|FG000|Overall Study|social circumstances|1|||
160921864|NCT02580357|581107445|FG000|Overall Study|Lost to Follow-up|2|||
160921865|NCT02580357|581107446|FG001|Overall Study|Lost to Follow-up|0|||
160921866|NCT02580357|581107447|FG002|Overall Study|Lost to Follow-up|0|||
160921867|NCT02580357|581107445|FG000|Overall Study|Protocol Violation|1|||
160921868|NCT02580357|581107446|FG001|Overall Study|Protocol Violation|0|||
160921869|NCT02580357|581107447|FG002|Overall Study|Protocol Violation|0|||
160921870|NCT04128267|581107448|FG000|Overall Study|Withdrawal by Subject|6|||
160921871|NCT04128267|581107448|FG000|Overall Study|Death|2|||
160921872|NCT04128267|581107448|FG000|Overall Study|Disease progression|1|||
160921873|NCT04128267|581107448|FG000|Overall Study|Participant had other medical issues|4|||
160921874|NCT04128267|581107448|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
160921875|NCT01705652|581107452|FG000|Overall Study|Adverse Event|1|||
160921876|NCT01705652|581107453|FG001|Overall Study|Adverse Event|0|||
160921877|NCT01705652|581107452|FG000|Overall Study|Withdrawal by Subject|1|||
160921878|NCT01705652|581107453|FG001|Overall Study|Withdrawal by Subject|2|||
160921879|NCT01705652|581107452|FG000|Overall Study|non-compliance|1|||
160921880|NCT01705652|581107453|FG001|Overall Study|non-compliance|1|||
160921881|NCT00056407|581107455|FG000|Overall Study|Adverse Event|282|||
160921882|NCT00056407|581107456|FG001|Overall Study|Adverse Event|364|||
160921883|NCT00056407|581107455|FG000|Overall Study|Withdrawal by Subject|377|||
160921884|NCT00056407|581107456|FG001|Overall Study|Withdrawal by Subject|361|||
160921885|NCT00056407|581107455|FG000|Overall Study|Lost to Follow-up|123|||
160921886|NCT00056407|581107456|FG001|Overall Study|Lost to Follow-up|113|||
160921887|NCT00056407|581107455|FG000|Overall Study|Protocol Violation|104|||
160921888|NCT00056407|581107456|FG001|Overall Study|Protocol Violation|95|||
161261899|NCT01392326|582337838|FG002|Overall Study|Pregnancy|1|||
161261900|NCT01392326|582337836|FG000|Overall Study|Physician Decision|7|||
161261901|NCT01392326|582337837|FG001|Overall Study|Physician Decision|5|||
161261902|NCT01392326|582337838|FG002|Overall Study|Physician Decision|2|||
161261903|NCT01392326|582337836|FG000|Overall Study|Lost to Follow-up|1|||
161261904|NCT01392326|582337837|FG001|Overall Study|Lost to Follow-up|3|||
161261905|NCT01392326|582337838|FG002|Overall Study|Lost to Follow-up|4|||
161261906|NCT01392326|582337836|FG000|Overall Study|Lack of Efficacy|14|||
161341246|NCT00402831|582635685|FG000|Overall Study|Non-compliance with protocol|0|||
161341247|NCT00402831|582635686|FG001|Overall Study|Non-compliance with protocol|1|||
161341248|NCT02814526|582635693|FG000|Overall Study|Adverse Event|4|||
161341249|NCT02814526|582635694|FG001|Overall Study|Adverse Event|3|||
161341250|NCT02814526|582635693|FG000|Overall Study|Death|1|||
161341251|NCT02814526|582635694|FG001|Overall Study|Death|1|||
161341252|NCT02814526|582635693|FG000|Overall Study|Lost to Follow-up|3|||
161341253|NCT02814526|582635694|FG001|Overall Study|Lost to Follow-up|4|||
161341254|NCT02814526|582635693|FG000|Overall Study|non site physician decision|1|||
160921889|NCT00056407|581107455|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
160921890|NCT00056407|581107456|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
161261907|NCT01392326|582337837|FG001|Overall Study|Lack of Efficacy|10|||
161261908|NCT01392326|582337838|FG002|Overall Study|Lack of Efficacy|15|||
161261909|NCT01392326|582337836|FG000|Overall Study|Adverse Event|9|||
161261910|NCT01392326|582337837|FG001|Overall Study|Adverse Event|6|||
161261911|NCT01392326|582337838|FG002|Overall Study|Adverse Event|11|||
161261912|NCT03487848|582337841|FG000|Overall Study|Lost to Follow-up|1|||
161261913|NCT00123955|582337842|FG000|Overall Study|Adverse Event|1|||
161261914|NCT00123955|582337843|FG001|Overall Study|Adverse Event|0|||
161341255|NCT02814526|582635694|FG001|Overall Study|non site physician decision|0|||
161341256|NCT02814526|582635693|FG000|Overall Study|participant noncompliance|1|||
161341257|NCT02814526|582635694|FG001|Overall Study|participant noncompliance|1|||
160921891|NCT00056407|581107455|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
160921892|NCT00056407|581107456|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
160921893|NCT00056407|581107455|FG000|Overall Study|Missing|25|||
160921894|NCT00056407|581107456|FG001|Overall Study|Missing|34|||
160921895|NCT00616655|581107457|FG000|Overall Study|Adverse Event|10|||
160921896|NCT00616655|581107458|FG001|Overall Study|Adverse Event|7|||
161261915|NCT00123955|582337842|FG000|Overall Study|Withdrawal by Subject|4|||
160921897|NCT00616655|581107459|FG002|Overall Study|Adverse Event|12|||
160921898|NCT00616655|581107457|FG000|Overall Study|Lack of Efficacy|5|||
160921899|NCT00616655|581107458|FG001|Overall Study|Lack of Efficacy|5|||
160921900|NCT00616655|581107459|FG002|Overall Study|Lack of Efficacy|5|||
161261916|NCT00123955|582337843|FG001|Overall Study|Withdrawal by Subject|3|||
161261917|NCT00123955|582337842|FG000|Overall Study|Death|0|||
161261918|NCT00123955|582337843|FG001|Overall Study|Death|1|||
161261919|NCT00094094|582337846|FG000|Overall Study|Death|2|||
161261920|NCT00094094|582337846|FG000|Overall Study|Lack of Efficacy|23|||
161261921|NCT00094094|582337846|FG000|Overall Study|Adverse Event|7|||
161341258|NCT02814526|582635693|FG000|Overall Study|Withdrawal by Subject|20|||
161341259|NCT02814526|582635694|FG001|Overall Study|Withdrawal by Subject|14|||
160921901|NCT00616655|581107457|FG000|Overall Study|Lost to Follow-up|3|||
160921902|NCT00616655|581107458|FG001|Overall Study|Lost to Follow-up|12|||
160921903|NCT00616655|581107459|FG002|Overall Study|Lost to Follow-up|10|||
160921904|NCT00616655|581107457|FG000|Overall Study|Protocol Violation|2|||
160921905|NCT00616655|581107458|FG001|Overall Study|Protocol Violation|4|||
160921906|NCT00616655|581107459|FG002|Overall Study|Protocol Violation|3|||
160921907|NCT00616655|581107457|FG000|Overall Study|Withdrawal by Subject|9|||
160921908|NCT00616655|581107458|FG001|Overall Study|Withdrawal by Subject|7|||
160921909|NCT00616655|581107459|FG002|Overall Study|Withdrawal by Subject|11|||
160921910|NCT00616655|581107457|FG000|Overall Study|Does not meet in/ex criteria|0|||
160921911|NCT00616655|581107458|FG001|Overall Study|Does not meet in/ex criteria|0|||
160921912|NCT00616655|581107459|FG002|Overall Study|Does not meet in/ex criteria|2|||
160921913|NCT00616655|581107457|FG000|Overall Study|Other|6|||
160921914|NCT00616655|581107458|FG001|Overall Study|Other|6|||
160921915|NCT00616655|581107459|FG002|Overall Study|Other|5|||
160921916|NCT00309842|581107460|FG000|Overall Study|Lost to Follow-up|1|||
160921917|NCT01026792|581107461|FG000|Overall Study|Protocol Violation|1|||
160921918|NCT02335099|581107464|FG000|Treatment|Withdrawal by Subject|1|||
160921919|NCT02335099|581107465|FG001|Treatment|Withdrawal by Subject|3|||
160921920|NCT02335099|581107464|FG000|Treatment|Lost to Follow-up|2|||
160921921|NCT02335099|581107465|FG001|Treatment|Lost to Follow-up|0|||
160921922|NCT02335099|581107464|FG000|Treatment|Death|1|||
160921923|NCT02335099|581107465|FG001|Treatment|Death|0|||
160921924|NCT02335099|581107464|FG000|Treatment|Adverse Event|1|||
160921925|NCT02335099|581107465|FG001|Treatment|Adverse Event|2|||
160921926|NCT02335099|581107464|FG000|Follow-up|Death|0|||
160921927|NCT02335099|581107465|FG001|Follow-up|Death|1|||
160921928|NCT01472081|581107466|FG000|Overall Study|Continuing treatment at time of analysis|1|||
160921929|NCT01472081|581107467|FG001|Overall Study|Continuing treatment at time of analysis|4|||
160921930|NCT01472081|581107468|FG002|Overall Study|Continuing treatment at time of analysis|1|||
160921931|NCT01472081|581107469|FG003|Overall Study|Continuing treatment at time of analysis|8|||
160921932|NCT01472081|581107470|FG004|Overall Study|Continuing treatment at time of analysis|9|||
160921933|NCT01472081|581107471|FG005|Overall Study|Continuing treatment at time of analysis|0|||
160921934|NCT01472081|581107466|FG000|Overall Study|Disease Progression|4|||
160921935|NCT01472081|581107467|FG001|Overall Study|Disease Progression|10|||
160921936|NCT01472081|581107468|FG002|Overall Study|Disease Progression|12|||
160921937|NCT01472081|581107469|FG003|Overall Study|Disease Progression|31|||
160921938|NCT01472081|581107470|FG004|Overall Study|Disease Progression|22|||
160921939|NCT01472081|581107471|FG005|Overall Study|Disease Progression|3|||
160921940|NCT01472081|581107466|FG000|Overall Study|Study drug toxicity|2|||
160921941|NCT01472081|581107467|FG001|Overall Study|Study drug toxicity|9|||
160921942|NCT01472081|581107468|FG002|Overall Study|Study drug toxicity|4|||
160921943|NCT01472081|581107469|FG003|Overall Study|Study drug toxicity|6|||
160921944|NCT01472081|581107470|FG004|Overall Study|Study drug toxicity|13|||
160921945|NCT01472081|581107471|FG005|Overall Study|Study drug toxicity|2|||
160921946|NCT01472081|581107466|FG000|Overall Study|Death|0|||
160921947|NCT01472081|581107467|FG001|Overall Study|Death|0|||
160921948|NCT01472081|581107468|FG002|Overall Study|Death|0|||
160921949|NCT01472081|581107469|FG003|Overall Study|Death|0|||
160921950|NCT01472081|581107470|FG004|Overall Study|Death|1|||
160921951|NCT01472081|581107471|FG005|Overall Study|Death|0|||
160921952|NCT01472081|581107466|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
160921953|NCT01472081|581107467|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
160921954|NCT01472081|581107468|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
160921955|NCT01472081|581107469|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
160921956|NCT01472081|581107470|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
160921957|NCT01472081|581107471|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
160921958|NCT01472081|581107466|FG000|Overall Study|Withdrawal by Subject|0|||
160997759|NCT01689519|581376623|FG000|Safety Population|Physician Decision|4|||
160997760|NCT01689519|581376624|FG001|Safety Population|Physician Decision|1|||
160921959|NCT01472081|581107467|FG001|Overall Study|Withdrawal by Subject|0|||
160921960|NCT01472081|581107468|FG002|Overall Study|Withdrawal by Subject|0|||
160921961|NCT01472081|581107469|FG003|Overall Study|Withdrawal by Subject|0|||
160921962|NCT01472081|581107470|FG004|Overall Study|Withdrawal by Subject|0|||
160921963|NCT01472081|581107471|FG005|Overall Study|Withdrawal by Subject|1|||
160997761|NCT01689519|581376623|FG000|Safety Population|Study Terminated By Sponsor|60|||
161261922|NCT04459715|582337849|FG000|Overall Study|Adverse Event|3|||
160921964|NCT01472081|581107466|FG000|Overall Study|Poor/non-compliance|0|||
160921965|NCT01472081|581107467|FG001|Overall Study|Poor/non-compliance|0|||
160921966|NCT01472081|581107468|FG002|Overall Study|Poor/non-compliance|1|||
160921967|NCT01472081|581107469|FG003|Overall Study|Poor/non-compliance|0|||
160921968|NCT01472081|581107470|FG004|Overall Study|Poor/non-compliance|1|||
160921969|NCT01472081|581107471|FG005|Overall Study|Poor/non-compliance|0|||
160921970|NCT01472081|581107466|FG000|Overall Study|No longer meets study criteria|0|||
160921971|NCT01472081|581107467|FG001|Overall Study|No longer meets study criteria|0|||
160921972|NCT01472081|581107468|FG002|Overall Study|No longer meets study criteria|1|||
160921973|NCT01472081|581107469|FG003|Overall Study|No longer meets study criteria|0|||
161261923|NCT04459715|582337850|FG001|Overall Study|Adverse Event|3|||
160921974|NCT01472081|581107470|FG004|Overall Study|No longer meets study criteria|0|||
160921975|NCT01472081|581107471|FG005|Overall Study|No longer meets study criteria|0|||
160921976|NCT01472081|581107466|FG000|Overall Study|Subject request to discontinue treatment|0|||
160921977|NCT01472081|581107467|FG001|Overall Study|Subject request to discontinue treatment|3|||
160921978|NCT01472081|581107468|FG002|Overall Study|Subject request to discontinue treatment|1|||
160921979|NCT01472081|581107469|FG003|Overall Study|Subject request to discontinue treatment|1|||
160921980|NCT01472081|581107470|FG004|Overall Study|Subject request to discontinue treatment|0|||
160921981|NCT01472081|581107471|FG005|Overall Study|Subject request to discontinue treatment|0|||
160921982|NCT01367158|581107472|FG000|Overall Study|Withdrew consent|0|||
160921983|NCT01367158|581107473|FG001|Overall Study|Withdrew consent|2|||
160921984|NCT01367158|581107474|FG002|Overall Study|Withdrew consent|1|||
160921985|NCT01367158|581107475|FG003|Overall Study|Withdrew consent|0|||
160921986|NCT01367158|581107476|FG004|Overall Study|Withdrew consent|2|||
160921987|NCT01367158|581107477|FG005|Overall Study|Withdrew consent|0|||
160921988|NCT01367158|581107478|FG006|Overall Study|Withdrew consent|0|||
160921989|NCT01367158|581107479|FG007|Overall Study|Withdrew consent|1|||
160921990|NCT01367158|581107480|FG008|Overall Study|Withdrew consent|0|||
160921991|NCT01367158|581107481|FG009|Overall Study|Withdrew consent|0|||
160921992|NCT01367158|581107482|FG010|Overall Study|Withdrew consent|0|||
160921993|NCT01367158|581107472|FG000|Overall Study|Lost to Follow-up|0|||
160921994|NCT01367158|581107473|FG001|Overall Study|Lost to Follow-up|0|||
160921995|NCT01367158|581107474|FG002|Overall Study|Lost to Follow-up|0|||
160921996|NCT01367158|581107475|FG003|Overall Study|Lost to Follow-up|1|||
160921997|NCT01367158|581107476|FG004|Overall Study|Lost to Follow-up|0|||
160921998|NCT01367158|581107477|FG005|Overall Study|Lost to Follow-up|2|||
160921999|NCT01367158|581107478|FG006|Overall Study|Lost to Follow-up|0|||
160922000|NCT01367158|581107479|FG007|Overall Study|Lost to Follow-up|1|||
160922001|NCT01367158|581107480|FG008|Overall Study|Lost to Follow-up|0|||
160922002|NCT01367158|581107481|FG009|Overall Study|Lost to Follow-up|0|||
160922003|NCT01367158|581107482|FG010|Overall Study|Lost to Follow-up|1|||
160922004|NCT01367158|581107472|FG000|Overall Study|Protocol Violation|0|||
161261924|NCT04459715|582337849|FG000|Overall Study|Death|111|||
161261925|NCT04459715|582337850|FG001|Overall Study|Death|93|||
161261926|NCT04459715|582337849|FG000|Overall Study|Lost to Follow-up|10|||
160922005|NCT01367158|581107473|FG001|Overall Study|Protocol Violation|1|||
160922006|NCT01367158|581107474|FG002|Overall Study|Protocol Violation|0|||
160922007|NCT01367158|581107475|FG003|Overall Study|Protocol Violation|0|||
161143387|NCT00923091|581907575|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
161143388|NCT00923091|581907576|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
161143389|NCT00923091|581907577|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
161143390|NCT00923091|581907578|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
161143391|NCT00923091|581907579|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
161143392|NCT00923091|581907580|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
161143393|NCT00923091|581907581|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
161143394|NCT00923091|581907582|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
161261927|NCT04459715|582337850|FG001|Overall Study|Lost to Follow-up|9|||
161261928|NCT04459715|582337849|FG000|Overall Study|Other Reasons|4|||
161261929|NCT04459715|582337850|FG001|Overall Study|Other Reasons|5|||
161261930|NCT04459715|582337849|FG000|Overall Study|PROTOCOL DEVIATION|0|||
160922008|NCT01367158|581107476|FG004|Overall Study|Protocol Violation|0|||
160922009|NCT01367158|581107477|FG005|Overall Study|Protocol Violation|0|||
160922010|NCT01367158|581107478|FG006|Overall Study|Protocol Violation|0|||
160922011|NCT01367158|581107479|FG007|Overall Study|Protocol Violation|0|||
160922012|NCT01367158|581107480|FG008|Overall Study|Protocol Violation|0|||
160922013|NCT01367158|581107481|FG009|Overall Study|Protocol Violation|0|||
160922014|NCT01367158|581107482|FG010|Overall Study|Protocol Violation|0|||
160922015|NCT01765153|581107483|FG000|Training Phase 1|Format of intervention differed|1|||
160922016|NCT01765153|581107484|FG001|Training Phase 1|Format of intervention differed|0|||
160922017|NCT01765153|581107483|FG000|Training Phase 1|Poor participation in intervention|0|||
160922018|NCT01765153|581107484|FG001|Training Phase 1|Poor participation in intervention|1|||
160922019|NCT01765153|581107483|FG000|Rest Phase 1|Withdrawal by Subject|0|||
160922020|NCT01765153|581107484|FG001|Rest Phase 1|Withdrawal by Subject|1|||
160922021|NCT01765153|581107483|FG000|Training Phase 2|Withdrawal by Subject|0|||
160922022|NCT01765153|581107484|FG001|Training Phase 2|Withdrawal by Subject|1|||
160922023|NCT01765153|581107483|FG000|Rest Phase 2|Lost to Follow-up|2|||
160922024|NCT01765153|581107484|FG001|Rest Phase 2|Lost to Follow-up|1|||
160922025|NCT04702997|581107485|FG000|Overall Study|Withdrawal by Subject|1|||
161143395|NCT00923091|581907583|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
161143396|NCT00923091|581907584|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
160922026|NCT04702997|581107486|FG001|Overall Study|Withdrawal by Subject|1|||
160922027|NCT03915496|581107487|FG000|Overall Study|Adverse Event|2|||
160922028|NCT03915496|581107488|FG001|Overall Study|Adverse Event|1|||
160922029|NCT03915496|581107489|FG002|Overall Study|Adverse Event|2|||
160922030|NCT02663674|581107490|FG000|Overall Study|Lost to Follow-up|5|||
160922031|NCT02663674|581107491|FG001|Overall Study|Lost to Follow-up|4|||
160922032|NCT02663674|581107490|FG000|Overall Study|Withdrawal by Subject|1|||
161261931|NCT04459715|582337850|FG001|Overall Study|PROTOCOL DEVIATION|1|||
161261932|NCT04459715|582337849|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
161261933|NCT04459715|582337850|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
161261934|NCT04459715|582337849|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
161261935|NCT04459715|582337850|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
161261936|NCT04459715|582337849|FG000|Overall Study|Withdrawal by Subject|22|||
161261937|NCT04459715|582337850|FG001|Overall Study|Withdrawal by Subject|22|||
161261938|NCT02177136|582339420|FG000|DB Phase|Withdrawal by Subject|2|||
161261939|NCT02177136|582339421|FG001|DB Phase|Withdrawal by Subject|0|||
161261940|NCT02177136|582339422|FG002|DB Phase|Withdrawal by Subject|0|||
161261941|NCT02177136|582339423|FG003|DB Phase|Withdrawal by Subject|0|||
161261942|NCT02177136|582339420|FG000|DB Phase|Discontinued Due to Pruritus|1|||
161261943|NCT02177136|582339421|FG001|DB Phase|Discontinued Due to Pruritus|3|||
161261944|NCT02177136|582339422|FG002|DB Phase|Discontinued Due to Pruritus|0|||
161261945|NCT02177136|582339423|FG003|DB Phase|Discontinued Due to Pruritus|0|||
161261946|NCT02177136|582339420|FG000|DB Phase|Adverse Event|3|||
161261947|NCT02177136|582339421|FG001|DB Phase|Adverse Event|2|||
161261948|NCT02177136|582339422|FG002|DB Phase|Adverse Event|3|||
161261949|NCT02177136|582339423|FG003|DB Phase|Adverse Event|0|||
161261950|NCT02177136|582339420|FG000|DB Phase|Protocol Violation|0|||
161261951|NCT02177136|582339421|FG001|DB Phase|Protocol Violation|0|||
161261952|NCT02177136|582339422|FG002|DB Phase|Protocol Violation|1|||
161261953|NCT02177136|582339423|FG003|DB Phase|Protocol Violation|0|||
161261954|NCT02177136|582339420|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
161261955|NCT02177136|582339421|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
161261956|NCT02177136|582339422|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
161261957|NCT02177136|582339423|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
161261958|NCT02177136|582339420|FG000|LTSE Phase|Withdrawal by Subject|0|||
161261959|NCT02177136|582339421|FG001|LTSE Phase|Withdrawal by Subject|0|||
161261960|NCT02177136|582339422|FG002|LTSE Phase|Withdrawal by Subject|0|||
161261961|NCT02177136|582339423|FG003|LTSE Phase|Withdrawal by Subject|6|||
161261962|NCT02177136|582339420|FG000|LTSE Phase|Adverse Event|0|||
161261963|NCT02177136|582339421|FG001|LTSE Phase|Adverse Event|0|||
161261964|NCT02177136|582339422|FG002|LTSE Phase|Adverse Event|0|||
161261965|NCT02177136|582339423|FG003|LTSE Phase|Adverse Event|10|||
161261966|NCT02177136|582339420|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
161261967|NCT02177136|582339421|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
161261968|NCT02177136|582339422|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
161261969|NCT02177136|582339423|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
161261970|NCT02177136|582339420|FG000|LTSE Phase|Physician Decision|0|||
161261971|NCT02177136|582339421|FG001|LTSE Phase|Physician Decision|0|||
161261972|NCT02177136|582339422|FG002|LTSE Phase|Physician Decision|0|||
161261973|NCT02177136|582339423|FG003|LTSE Phase|Physician Decision|2|||
161261974|NCT02177136|582339420|FG000|LTSE Phase|Lost to Follow-up|0|||
161261975|NCT02177136|582339421|FG001|LTSE Phase|Lost to Follow-up|0|||
160922033|NCT02663674|581107491|FG001|Overall Study|Withdrawal by Subject|4|||
160922034|NCT02663674|581107490|FG000|Overall Study|Physician Decision|1|||
160922035|NCT02663674|581107491|FG001|Overall Study|Physician Decision|1|||
160922036|NCT02663674|581107490|FG000|Overall Study|Other Event (Health Related)|0|||
160922037|NCT02663674|581107491|FG001|Overall Study|Other Event (Health Related)|1|||
160922038|NCT01386554|581107494|FG000|Overall Study|Lost to Follow-up|0|||
160922039|NCT01386554|581107495|FG001|Overall Study|Lost to Follow-up|0|||
160922040|NCT01386554|581107496|FG002|Overall Study|Lost to Follow-up|1|||
160922041|NCT01386554|581107494|FG000|Overall Study|Adverse Event|2|||
160922042|NCT01386554|581107495|FG001|Overall Study|Adverse Event|5|||
160922043|NCT01386554|581107496|FG002|Overall Study|Adverse Event|2|||
160922044|NCT01386554|581107494|FG000|Overall Study|Progressive disease|1|||
160922045|NCT01386554|581107495|FG001|Overall Study|Progressive disease|2|||
160922046|NCT01386554|581107496|FG002|Overall Study|Progressive disease|2|||
160922047|NCT01386554|581107494|FG000|Overall Study|Administration of live vaccines|0|||
161261976|NCT02177136|582339422|FG002|LTSE Phase|Lost to Follow-up|0|||
161261977|NCT02177136|582339423|FG003|LTSE Phase|Lost to Follow-up|1|||
161261978|NCT02177136|582339420|FG000|LTSE Phase|Participant Moved|0|||
161261979|NCT02177136|582339421|FG001|LTSE Phase|Participant Moved|0|||
161261980|NCT02177136|582339422|FG002|LTSE Phase|Participant Moved|0|||
161261981|NCT02177136|582339423|FG003|LTSE Phase|Participant Moved|1|||
161261982|NCT02054130|582339424|FG000|Overall Study|Withdrawal by Subject|4|||
161261983|NCT02054130|582339425|FG001|Overall Study|Withdrawal by Subject|4|||
161261984|NCT02054130|582339426|FG002|Overall Study|Withdrawal by Subject|7|||
161261985|NCT02054130|582339427|FG003|Overall Study|Withdrawal by Subject|10|||
161261986|NCT02054130|582339424|FG000|Overall Study|Death|0|||
161261987|NCT02054130|582339425|FG001|Overall Study|Death|1|||
160922048|NCT01386554|581107495|FG001|Overall Study|Administration of live vaccines|1|||
160922049|NCT01386554|581107496|FG002|Overall Study|Administration of live vaccines|0|||
160922050|NCT01386554|581107494|FG000|Overall Study|Investigator discretion|0|||
161261988|NCT02054130|582339426|FG002|Overall Study|Death|0|||
161261989|NCT02054130|582339427|FG003|Overall Study|Death|0|||
161261990|NCT02054130|582339424|FG000|Overall Study|Lost to Follow-up|0|||
161261991|NCT02054130|582339425|FG001|Overall Study|Lost to Follow-up|0|||
161261992|NCT02054130|582339426|FG002|Overall Study|Lost to Follow-up|1|||
160997762|NCT01689519|581376624|FG001|Safety Population|Study Terminated By Sponsor|47|||
160997763|NCT01689519|581376623|FG000|Safety Population|Withdrawal by Subject|20|||
160997764|NCT01689519|581376624|FG001|Safety Population|Withdrawal by Subject|20|||
160997765|NCT00217672|581376626|FG000|Allocation|Ineligible|2|||
160997766|NCT00217672|581376627|FG001|Allocation|Ineligible|0|||
160997767|NCT00217672|581376626|FG000|Treatment|disease progression|33|||
160997768|NCT00217672|581376627|FG001|Treatment|disease progression|4|||
160997769|NCT00217672|581376626|FG000|Treatment|Adverse Event|18|||
160997770|NCT00217672|581376627|FG001|Treatment|Adverse Event|2|||
160997771|NCT00217672|581376626|FG000|Treatment|reqd treatment not permitted by protocol|6|||
160997772|NCT00217672|581376627|FG001|Treatment|reqd treatment not permitted by protocol|0|||
160997773|NCT00217672|581376626|FG000|Treatment|Physician Decision|6|||
160997774|NCT00217672|581376627|FG001|Treatment|Physician Decision|0|||
160997775|NCT00217672|581376626|FG000|Treatment|insurance issues|1|||
160997776|NCT00217672|581376627|FG001|Treatment|insurance issues|1|||
160997777|NCT00217672|581376626|FG000|Treatment|Death|2|||
160997778|NCT00217672|581376627|FG001|Treatment|Death|0|||
160997779|NCT00217672|581376626|FG000|Treatment|secondary malignancy|1|||
160997780|NCT00217672|581376627|FG001|Treatment|secondary malignancy|0|||
160997781|NCT00217672|581376626|FG000|Follow-up|Withdrawal by Subject|4|||
160997782|NCT00217672|581376627|FG001|Follow-up|Withdrawal by Subject|0|||
160997783|NCT00217672|581376626|FG000|Follow-up|Lost to Follow-up|1|||
160997784|NCT00217672|581376627|FG001|Follow-up|Lost to Follow-up|0|||
160997785|NCT01959412|581376631|FG000|Overall Study|Protocol deviation|1|||
160997786|NCT01959412|581376632|FG001|Overall Study|Protocol deviation|1|||
160997787|NCT01959412|581376633|FG002|Overall Study|Protocol deviation|0|||
160997788|NCT01959412|581376634|FG003|Overall Study|Protocol deviation|1|||
160997789|NCT01959412|581376635|FG004|Overall Study|Protocol deviation|3|||
160997790|NCT01959412|581376636|FG005|Overall Study|Protocol deviation|0|||
160997791|NCT01959412|581376631|FG000|Overall Study|Adverse Event|0|||
160997792|NCT01959412|581376632|FG001|Overall Study|Adverse Event|0|||
160997793|NCT01959412|581376633|FG002|Overall Study|Adverse Event|0|||
160997794|NCT01959412|581376634|FG003|Overall Study|Adverse Event|1|||
160922051|NCT01386554|581107495|FG001|Overall Study|Investigator discretion|0|||
160922052|NCT01386554|581107496|FG002|Overall Study|Investigator discretion|1|||
160922053|NCT01386554|581107494|FG000|Overall Study|Reason not collected|0|||
160922054|NCT01386554|581107495|FG001|Overall Study|Reason not collected|1|||
160922055|NCT01386554|581107496|FG002|Overall Study|Reason not collected|0|||
160922056|NCT00353262|581107497|FG000|Overall Study|Adverse Event|8|||
160922057|NCT00353262|581107497|FG000|Overall Study|Withdrawal by Subject|2|||
160922058|NCT00353262|581107497|FG000|Overall Study|Insufficient Therapeutic Response|13|||
160922059|NCT00353262|581107497|FG000|Overall Study|Progression|1|||
160922060|NCT00353262|581107497|FG000|Overall Study|Surgery|4|||
160922061|NCT00353262|581107497|FG000|Overall Study|Break from Chemotherapy|1|||
160922062|NCT04166513|581107498|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
160922063|NCT04166513|581107499|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
160922064|NCT04166513|581107500|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
160922065|NCT04166513|581107501|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
160922066|NCT04166513|581107498|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
160922067|NCT04166513|581107499|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
160922068|NCT04166513|581107500|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
160922069|NCT04166513|581107501|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
160922070|NCT04166513|581107498|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
160922071|NCT04166513|581107499|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
160922072|NCT04166513|581107500|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
160922073|NCT04166513|581107501|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
160922074|NCT04166513|581107498|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
160922075|NCT04166513|581107499|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
160922076|NCT04166513|581107500|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
160922077|NCT04166513|581107501|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
160922078|NCT04166513|581107498|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
160922079|NCT04166513|581107499|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
160922080|NCT04166513|581107500|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
160997795|NCT01959412|581376635|FG004|Overall Study|Adverse Event|0|||
161341260|NCT02814526|582635693|FG000|Overall Study|safety risk|2|||
160997796|NCT01959412|581376636|FG005|Overall Study|Adverse Event|0|||
160997797|NCT04379713|581376640|FG000|Overall Study|Adverse Event|2|||
160997798|NCT04379713|581376641|FG001|Overall Study|Adverse Event|0|||
160997799|NCT04379713|581376640|FG000|Overall Study|Physician Decision|2|||
160997800|NCT04379713|581376641|FG001|Overall Study|Physician Decision|1|||
160997801|NCT04379713|581376640|FG000|Overall Study|Protocol Violation|11|||
160997802|NCT04379713|581376641|FG001|Overall Study|Protocol Violation|6|||
160997803|NCT04379713|581376640|FG000|Overall Study|No longer met eligibility criteria|14|||
160922081|NCT04166513|581107501|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
160922082|NCT05286307|581107502|FG000|Overall Study|Incomplete outcome assessments|2|||
160997804|NCT04379713|581376641|FG001|Overall Study|No longer met eligibility criteria|11|||
160997805|NCT04379713|581376640|FG000|Overall Study|Withdrawal by parent/guardian|36|||
161143397|NCT00923091|581907585|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
161143398|NCT00923091|581907586|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
161143399|NCT00923091|581907574|FG000|Period VI (Open-Label)|Other Reason|0|||
161261993|NCT02054130|582339427|FG003|Overall Study|Lost to Follow-up|2|||
161261994|NCT02054130|582339424|FG000|Overall Study|Missed dose|4|||
161261995|NCT02054130|582339425|FG001|Overall Study|Missed dose|6|||
160922083|NCT05286307|581107503|FG001|Overall Study|Incomplete outcome assessments|1|||
160922084|NCT05286307|581107502|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
160922085|NCT05286307|581107503|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
160922086|NCT05286307|581107502|FG000|Overall Study|Lost to follow up at 6 months|25|||
160922087|NCT05286307|581107503|FG001|Overall Study|Lost to follow up at 6 months|35|||
160922088|NCT05286307|581107502|FG000|Overall Study|Study medication not available|1|||
160922089|NCT05286307|581107503|FG001|Overall Study|Study medication not available|1|||
160922090|NCT04219891|581107504|FG000|Overall Study|Lost to Follow-up|3|||
160922091|NCT04219891|581107504|FG000|Overall Study|Withdrawal by Subject|2|||
160922092|NCT03712904|581108420|FG000|Overall Study|Death|0|||
160922093|NCT03712904|581108421|FG001|Overall Study|Death|1|||
160922094|NCT03712904|581108420|FG000|Overall Study|Withdrawal by Subject|0|||
160922095|NCT03712904|581108421|FG001|Overall Study|Withdrawal by Subject|1|||
160922096|NCT03712904|581108420|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
160922097|NCT03712904|581108421|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
160922098|NCT04568590|581108422|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
160922099|NCT01190254|581108425|FG000|Overall Study|Adverse Event|3|||
160922100|NCT01190254|581108426|FG001|Overall Study|Adverse Event|6|||
160922101|NCT01190254|581108427|FG002|Overall Study|Adverse Event|8|||
160922102|NCT01190254|581108425|FG000|Overall Study|Lack of Efficacy|7|||
160922103|NCT01190254|581108426|FG001|Overall Study|Lack of Efficacy|4|||
160922104|NCT01190254|581108427|FG002|Overall Study|Lack of Efficacy|5|||
160922105|NCT01190254|581108425|FG000|Overall Study|Lost to Follow-up|4|||
160922106|NCT01190254|581108426|FG001|Overall Study|Lost to Follow-up|2|||
160922107|NCT01190254|581108427|FG002|Overall Study|Lost to Follow-up|0|||
160922108|NCT01190254|581108425|FG000|Overall Study|Withdrawal by Subject|4|||
160922109|NCT01190254|581108426|FG001|Overall Study|Withdrawal by Subject|5|||
160922110|NCT01190254|581108427|FG002|Overall Study|Withdrawal by Subject|7|||
160922111|NCT01190254|581108425|FG000|Overall Study|Protocol Violation|2|||
160922112|NCT01190254|581108426|FG001|Overall Study|Protocol Violation|0|||
160922113|NCT01190254|581108427|FG002|Overall Study|Protocol Violation|2|||
160922114|NCT01190254|581108425|FG000|Overall Study|Did not meet protocol eligibility|1|||
160922115|NCT01190254|581108426|FG001|Overall Study|Did not meet protocol eligibility|0|||
160922116|NCT01190254|581108427|FG002|Overall Study|Did not meet protocol eligibility|0|||
160922117|NCT00773292|581108428|FG000|Treatment 48 Weeks|Adverse Event|1|||
160922118|NCT00773292|581108428|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
160922119|NCT01485640|581108429|FG000|Overall Study|Adverse Event|10|||
160922120|NCT01485640|581108429|FG000|Overall Study|Lack of Efficacy|2|||
160922121|NCT01485640|581108429|FG000|Overall Study|Protocol Violation|1|||
160922122|NCT01485640|581108429|FG000|Overall Study|Withdrawal by Subject|14|||
160922123|NCT01485640|581108429|FG000|Overall Study|Terminated by Sponsor|95|||
160922124|NCT00202644|581108432|FG000|Overall Study|Adverse Event|12|||
160922125|NCT00202644|581108433|FG001|Overall Study|Adverse Event|13|||
160922126|NCT00202644|581108432|FG000|Overall Study|Withdrawal by Subject|8|||
160922127|NCT00202644|581108433|FG001|Overall Study|Withdrawal by Subject|6|||
160922128|NCT00202644|581108432|FG000|Overall Study|Lack of Efficacy|6|||
160922129|NCT00202644|581108433|FG001|Overall Study|Lack of Efficacy|6|||
160922130|NCT00202644|581108432|FG000|Overall Study|Lost to Follow-up|0|||
160922131|NCT00202644|581108433|FG001|Overall Study|Lost to Follow-up|1|||
160922132|NCT00202644|581108432|FG000|Overall Study|Other|9|||
160922133|NCT00202644|581108433|FG001|Overall Study|Other|1|||
160922134|NCT03232281|581108439|FG000|Overall Study|Adverse Event|1|||
160922135|NCT03232281|581108440|FG001|Overall Study|Adverse Event|1|||
160922136|NCT03232281|581108439|FG000|Overall Study|Withdrawal by Subject|5|||
160922137|NCT03232281|581108440|FG001|Overall Study|Withdrawal by Subject|4|||
160922138|NCT03232281|581108439|FG000|Overall Study|Protocol Deviation|1|||
160922139|NCT03232281|581108440|FG001|Overall Study|Protocol Deviation|1|||
160922140|NCT01372501|581108444|FG000|Overall Study|Adverse Event|4|||
160922141|NCT01372501|581108444|FG000|Overall Study|Device migration|1|||
160922142|NCT02489344|581108445|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
160922143|NCT02489344|581108445|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
160922144|NCT02489344|581108445|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
160922145|NCT02489344|581108445|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
160922146|NCT01132482|581108446|FG000|Overall Study|Adverse Event|1|||
160922147|NCT01132482|581108447|FG001|Overall Study|Adverse Event|0|||
160922148|NCT05333900|581108448|FG000|Overall Study|Protocol Violation|0|||
160922149|NCT05333900|581108449|FG001|Overall Study|Protocol Violation|1|||
160922150|NCT05333900|581108448|FG000|Overall Study|Withdrawal by Subject|0|||
161261996|NCT02054130|582339426|FG002|Overall Study|Missed dose|7|||
161261997|NCT02054130|582339427|FG003|Overall Study|Missed dose|10|||
160922151|NCT05333900|581108449|FG001|Overall Study|Withdrawal by Subject|1|||
160922152|NCT05333900|581108448|FG000|Overall Study|COVID-19 Pandemic|1|||
160922153|NCT05333900|581108449|FG001|Overall Study|COVID-19 Pandemic|1|||
160922154|NCT00573755|581108450|FG000|Overall Study|Still receiving treatment|1|||
160922155|NCT00573755|581108451|FG001|Overall Study|Still receiving treatment|0|||
160922156|NCT03724812|581108452|FG000|Overall Study|Missed Visit|1|||
160922157|NCT03724812|581108452|FG000|Overall Study|Death|2|||
160922158|NCT03724812|581108452|FG000|Overall Study|Withdrawal by Subject|1|||
160922159|NCT03525574|581108456|FG000|Overall Study|Adverse Event|15|||
160922160|NCT03525574|581108457|FG001|Overall Study|Adverse Event|0|||
160922161|NCT03525574|581108456|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
160922162|NCT03525574|581108457|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
160922163|NCT03525574|581108456|FG000|Overall Study|Lost to Follow-up|4|||
160922164|NCT03525574|581108457|FG001|Overall Study|Lost to Follow-up|0|||
160922165|NCT03525574|581108456|FG000|Overall Study|Commercial drug is Available for participant|48|||
160922166|NCT03525574|581108457|FG001|Overall Study|Commercial drug is Available for participant|0|||
160922167|NCT03525574|581108456|FG000|Overall Study|Death|1|||
160922168|NCT03525574|581108457|FG001|Overall Study|Death|0|||
160922169|NCT03525574|581108456|FG000|Overall Study|Other non-compliance|2|||
160922170|NCT03525574|581108457|FG001|Overall Study|Other non-compliance|0|||
160922171|NCT03525574|581108456|FG000|Overall Study|Physician Decision|6|||
161261998|NCT01304693|582339442|FG000|Overall Study|Adverse Event|0|||
161261999|NCT01304693|582339443|FG001|Overall Study|Adverse Event|0|||
160922172|NCT03525574|581108457|FG001|Overall Study|Physician Decision|0|||
160922173|NCT03525574|581108456|FG000|Overall Study|Other|58|||
160922174|NCT03525574|581108457|FG001|Overall Study|Other|0|||
160922175|NCT03525574|581108456|FG000|Overall Study|Enrolled but never dosed|1|||
160922176|NCT03525574|581108457|FG001|Overall Study|Enrolled but never dosed|0|||
160922177|NCT03525574|581108456|FG000|Overall Study|Not enrolled in 105 study|0|||
160922178|NCT03525574|581108457|FG001|Overall Study|Not enrolled in 105 study|3|||
160922179|NCT02769247|581108463|FG000|Overall Study|Withdrawal by Subject|1|||
160922180|NCT02769247|581108464|FG001|Overall Study|Withdrawal by Subject|0|||
160922181|NCT02769247|581108465|FG002|Overall Study|Withdrawal by Subject|0|||
160922182|NCT02769247|581108466|FG003|Overall Study|Withdrawal by Subject|1|||
160922183|NCT02769247|581108463|FG000|Overall Study|Protocol Violation|0|||
160922184|NCT02769247|581108464|FG001|Overall Study|Protocol Violation|0|||
160922185|NCT02769247|581108465|FG002|Overall Study|Protocol Violation|1|||
160922186|NCT02769247|581108466|FG003|Overall Study|Protocol Violation|0|||
160922187|NCT02769247|581108463|FG000|Overall Study|Physician Decision|1|||
160922188|NCT02769247|581108464|FG001|Overall Study|Physician Decision|0|||
160922189|NCT02769247|581108465|FG002|Overall Study|Physician Decision|0|||
160922190|NCT02769247|581108466|FG003|Overall Study|Physician Decision|0|||
160922191|NCT02024867|581108467|FG000|Overall Study|Protocol Violation|3|||
160922192|NCT02024867|581108468|FG001|Overall Study|Protocol Violation|3|||
160922193|NCT02024867|581108467|FG000|Overall Study|Lost to Follow-up|6|||
160922194|NCT02024867|581108468|FG001|Overall Study|Lost to Follow-up|4|||
160922195|NCT01086540|581108471|FG000|Overall Study|Death|3|||
160922196|NCT01086540|581108472|FG001|Overall Study|Death|1|||
160922197|NCT01086540|581108471|FG000|Overall Study|Physician Decision|2|||
160922198|NCT01086540|581108472|FG001|Overall Study|Physician Decision|1|||
160922199|NCT01086540|581108471|FG000|Overall Study|Addition of new therapy for PAH|1|||
160922200|NCT01086540|581108472|FG001|Overall Study|Addition of new therapy for PAH|0|||
160922201|NCT01998737|581108473|FG000|Overall Study|Corrupted database|23|||
160922202|NCT01998737|581108474|FG001|Overall Study|Corrupted database|0|||
161143400|NCT00923091|581907575|FG001|Period VI (Open-Label)|Other Reason|0|||
161143401|NCT00923091|581907576|FG002|Period VI (Open-Label)|Other Reason|0|||
160922205|NCT02092662|581108477|FG000|Overall Study|Lost to Follow-up|13|||
160922206|NCT02092662|581108478|FG001|Overall Study|Lost to Follow-up|0|||
160922207|NCT02710045|581108479|FG000|Overall Study|Death|1|||
160922208|NCT02710045|581108480|FG001|Overall Study|Death|2|||
160997806|NCT04379713|581376641|FG001|Overall Study|Withdrawal by parent/guardian|15|||
160997807|NCT04379713|581376640|FG000|Overall Study|Lost to Follow-up|31|||
160922209|NCT02710045|581108481|FG002|Overall Study|Death|0|||
160922210|NCT02710045|581108479|FG000|Overall Study|Withdrawal by Subject|6|||
160922211|NCT02710045|581108480|FG001|Overall Study|Withdrawal by Subject|6|||
160922212|NCT02710045|581108481|FG002|Overall Study|Withdrawal by Subject|2|||
160922213|NCT02710045|581108479|FG000|Overall Study|Protocol Violation|1|||
160922214|NCT02710045|581108480|FG001|Overall Study|Protocol Violation|2|||
160922215|NCT02710045|581108481|FG002|Overall Study|Protocol Violation|3|||
160922216|NCT02710045|581108479|FG000|Overall Study|Lost to Follow-up|3|||
160922217|NCT02710045|581108480|FG001|Overall Study|Lost to Follow-up|6|||
160922218|NCT02710045|581108481|FG002|Overall Study|Lost to Follow-up|7|||
160922219|NCT02710045|581108479|FG000|Overall Study|Physician Decision|0|||
160922220|NCT02710045|581108480|FG001|Overall Study|Physician Decision|0|||
160922221|NCT02710045|581108481|FG002|Overall Study|Physician Decision|1|||
160922222|NCT02710045|581108479|FG000|Overall Study|Poor Attendance|0|||
160922223|NCT02710045|581108480|FG001|Overall Study|Poor Attendance|1|||
160922224|NCT02710045|581108481|FG002|Overall Study|Poor Attendance|0|||
160922225|NCT00227305|581108484|FG000|Overall Study|Adverse Event|40|||
160922226|NCT00227305|581108484|FG000|Overall Study|Withdrawal by Subject|42|||
160922227|NCT00227305|581108484|FG000|Overall Study|Lost to Follow-up|33|||
160922228|NCT00227305|581108484|FG000|Overall Study|Study specific discontinuation|13|||
160922229|NCT00227305|581108484|FG000|Overall Study|MOVED OUT OF AREA|3|||
160922230|NCT00227305|581108484|FG000|Overall Study|Lack of Efficacy|7|||
160922231|NCT00227305|581108484|FG000|Overall Study|Physician Decision|3|||
160922232|NCT00227305|581108484|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
160922233|NCT00227305|581108484|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
160922234|NCT00227305|581108484|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
160922235|NCT04339296|581108491|FG000|Overall Study|Refuse to participate after allocation|1|||
160922236|NCT04339296|581108492|FG001|Overall Study|Refuse to participate after allocation|1|||
160922237|NCT04339296|581108491|FG000|Overall Study|Withdrew after completion of baseline|2|||
160922238|NCT04339296|581108492|FG001|Overall Study|Withdrew after completion of baseline|1|||
160922239|NCT04339296|581108491|FG000|Overall Study|Lost to Follow-up|0|||
160922240|NCT04339296|581108492|FG001|Overall Study|Lost to Follow-up|4|||
160922241|NCT04339296|581108491|FG000|Overall Study|Discontinued intervention|5|||
160922242|NCT04339296|581108492|FG001|Overall Study|Discontinued intervention|3|||
160922243|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922244|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
160922245|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922246|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922247|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922248|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922249|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
160922250|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
160922251|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
160922252|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
160922253|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
160922254|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
160922255|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
160922256|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
160922257|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
160922258|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
160922259|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
160922260|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
160922261|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
160922262|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
160922263|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
160922264|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922265|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
160922266|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922267|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922268|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160997808|NCT04379713|581376641|FG001|Overall Study|Lost to Follow-up|21|||
160997809|NCT00158054|581376642|FG000|Overall Study|Refused to continue|3|||
161262000|NCT01304693|582339444|FG002|Overall Study|Adverse Event|0|||
161262001|NCT01304693|582339445|FG003|Overall Study|Adverse Event|0|||
161262002|NCT01304693|582339446|FG004|Overall Study|Adverse Event|1|||
161262003|NCT01304693|582339442|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
161262004|NCT01304693|582339443|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
161262005|NCT01304693|582339444|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
161262006|NCT01304693|582339445|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
161262007|NCT01304693|582339446|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
161262008|NCT00931268|582339447|FG000|Overall Study|Lost to Follow-up|6|||
161262009|NCT02072148|582339448|FG000|Overall Study|withdrew prior to surgery|23|||
161262010|NCT02072148|582339449|FG001|Overall Study|withdrew prior to surgery|0|||
161262011|NCT02072148|582339450|FG002|Overall Study|withdrew prior to surgery|0|||
161262012|NCT02072148|582339448|FG000|Overall Study|Death|0|||
161262013|NCT02072148|582339449|FG001|Overall Study|Death|0|||
161262014|NCT02072148|582339450|FG002|Overall Study|Death|1|||
161262015|NCT02072148|582339448|FG000|Overall Study|Withdrawal by Subject|0|||
160922269|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
160922270|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
160922271|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
161262016|NCT02072148|582339449|FG001|Overall Study|Withdrawal by Subject|13|||
161262017|NCT02072148|582339450|FG002|Overall Study|Withdrawal by Subject|12|||
161262018|NCT03656874|582339451|FG000|Overall Study|Lost to Follow-up|3|||
161262019|NCT03656874|582339452|FG001|Overall Study|Lost to Follow-up|17|||
160922272|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
160922273|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
160922274|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
160922275|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
160922276|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
160922277|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
160922278|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922279|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922280|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
161262020|NCT01206816|582339453|FG000|Overall Study|Protocol Violation|0|||
161262021|NCT01206816|582339454|FG001|Overall Study|Protocol Violation|0|||
161262022|NCT01206816|582339455|FG002|Overall Study|Protocol Violation|1|||
161262023|NCT01206816|582339456|FG003|Overall Study|Protocol Violation|0|||
161262024|NCT01206816|582339457|FG004|Overall Study|Protocol Violation|0|||
160922281|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922282|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922283|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
160922284|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
160922285|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
160922286|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
160922287|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
160922288|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
160922289|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
160922290|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
160922291|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
160922292|NCT03742037|581108494|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922293|NCT03742037|581108495|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922294|NCT03742037|581108496|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922295|NCT03742037|581108497|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922296|NCT03742037|581108498|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922297|NCT03742037|581108499|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
160922298|NCT03742037|581108500|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
160922299|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
160922300|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
160922301|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
160922302|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
160922303|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
160922304|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
160922305|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
160922306|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922307|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922308|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
160922309|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
160922310|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922311|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
160922312|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
160922313|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922314|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
160922315|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
160922316|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922317|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922318|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922319|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
160922320|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
160922321|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922322|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922323|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922324|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
161262025|NCT01206816|582339458|FG005|Overall Study|Protocol Violation|0|||
160922325|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
160922326|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
160922327|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
160922328|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
160922329|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
160922330|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
160922331|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
160922332|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
160922333|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
160922334|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
160922335|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922336|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
160922337|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922338|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922339|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
160922340|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
160922341|NCT03742037|581108494|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922342|NCT03742037|581108495|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922343|NCT03742037|581108496|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
160922344|NCT03742037|581108497|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922345|NCT03742037|581108498|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922346|NCT03742037|581108499|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922347|NCT03742037|581108500|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
160922348|NCT03424265|581108501|FG000|Overall Study|screening failure|1|||
160922349|NCT03424265|581108502|FG001|Overall Study|screening failure|0|||
160922350|NCT03424265|581108501|FG000|Overall Study|Withdrawal by Subject|0|||
160922351|NCT03424265|581108502|FG001|Overall Study|Withdrawal by Subject|2|||
160922352|NCT00453544|581108503|FG000|Overall Study|Withdrawal by Subject|1|||
160922353|NCT00453544|581108504|FG001|Overall Study|Withdrawal by Subject|0|||
160922354|NCT00453544|581108505|FG002|Overall Study|Withdrawal by Subject|0|||
160922355|NCT00453544|581108506|FG003|Overall Study|Withdrawal by Subject|0|||
160922356|NCT00453544|581108503|FG000|Overall Study|Primary outcome measure not completed|1|||
160922357|NCT00453544|581108504|FG001|Overall Study|Primary outcome measure not completed|1|||
160922358|NCT00453544|581108505|FG002|Overall Study|Primary outcome measure not completed|0|||
160922359|NCT00453544|581108506|FG003|Overall Study|Primary outcome measure not completed|1|||
160922360|NCT01558752|581108507|FG000|Overall Study|Physician Decision|2|||
160922361|NCT01558752|581108508|FG001|Overall Study|Physician Decision|0|||
160922362|NCT01829230|581108509|FG000|Overall Study|Protocol Violation|0|||
160922363|NCT01829230|581108510|FG001|Overall Study|Protocol Violation|2|||
160922364|NCT01829230|581108509|FG000|Overall Study|Withdrawal by Subject|0|||
160922365|NCT01829230|581108510|FG001|Overall Study|Withdrawal by Subject|1|||
160922366|NCT01829230|581108509|FG000|Overall Study|Lost to Follow-up|1|||
160922367|NCT01829230|581108510|FG001|Overall Study|Lost to Follow-up|1|||
160922368|NCT00969150|581108511|FG000|Overall Study|Adverse Event|4|||
160922369|NCT00969150|581108512|FG001|Overall Study|Adverse Event|14|||
160922370|NCT00969150|581108511|FG000|Overall Study|Lack of Efficacy|1|||
160997810|NCT00158054|581376643|FG001|Overall Study|Refused to continue|0|||
160997811|NCT00158054|581376642|FG000|Overall Study|Unavailable for follow up|7|||
160997812|NCT00158054|581376643|FG001|Overall Study|Unavailable for follow up|3|||
160997813|NCT00509769|581376644|FG000|Overall Study|Progressive disease|77|||
160997814|NCT00509769|581376644|FG000|Overall Study|Adverse Event|4|||
160997815|NCT00509769|581376644|FG000|Overall Study|Patient's decision|1|||
160997816|NCT00509769|581376644|FG000|Overall Study|Physician Decision|8|||
160997817|NCT00509769|581376644|FG000|Overall Study|Use of prohibited therapies during study|1|||
160997818|NCT04567888|581376645|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
160997819|NCT04567888|581376646|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
160922371|NCT00969150|581108512|FG001|Overall Study|Lack of Efficacy|1|||
160922372|NCT00969150|581108511|FG000|Overall Study|Protocol Violation|9|||
160922373|NCT00969150|581108512|FG001|Overall Study|Protocol Violation|12|||
160922374|NCT00969150|581108511|FG000|Overall Study|Withdrawal by Subject|13|||
160922375|NCT00969150|581108512|FG001|Overall Study|Withdrawal by Subject|9|||
160922376|NCT00969150|581108511|FG000|Overall Study|Lost to Follow-up|5|||
160922377|NCT00969150|581108512|FG001|Overall Study|Lost to Follow-up|4|||
160922378|NCT00969150|581108511|FG000|Overall Study|Other reasons|1|||
160922379|NCT00969150|581108512|FG001|Overall Study|Other reasons|0|||
160997820|NCT04567888|581376645|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
160997821|NCT04567888|581376646|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
160997822|NCT04567888|581376645|FG000|Overall Study|Reported Unusual Birth Year|2|||
160997823|NCT04567888|581376646|FG001|Overall Study|Reported Unusual Birth Year|3|||
161143402|NCT00923091|581907577|FG003|Period VI (Open-Label)|Other Reason|1|||
161143403|NCT00923091|581907578|FG004|Period VI (Open-Label)|Other Reason|1|||
160922380|NCT00461682|581108513|FG000|Overall Study|Protocol Violation|1|||
160997824|NCT04567888|581376645|FG000|Overall Study|Duplicate Responses|0|||
160997825|NCT04567888|581376646|FG001|Overall Study|Duplicate Responses|1|||
161143404|NCT00923091|581907579|FG005|Period VI (Open-Label)|Other Reason|0|||
161262026|NCT01206816|582339459|FG006|Overall Study|Protocol Violation|0|||
161262027|NCT01206816|582339453|FG000|Overall Study|Withdrawal by Subject|0|||
161262028|NCT01206816|582339454|FG001|Overall Study|Withdrawal by Subject|0|||
161262029|NCT01206816|582339455|FG002|Overall Study|Withdrawal by Subject|1|||
160922381|NCT02759471|581108519|FG000|Overall Study|discomfort|2|||
160922382|NCT00597012|581108520|FG000|Overall Study|Death|1|||
160922383|NCT00597012|581108521|FG001|Overall Study|Death|1|||
160922384|NCT00597012|581108520|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
160922385|NCT00597012|581108521|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
160922386|NCT00597012|581108520|FG000|Overall Study|Withdrawal by Subject|7|||
160922387|NCT00597012|581108521|FG001|Overall Study|Withdrawal by Subject|4|||
160922388|NCT00597012|581108520|FG000|Overall Study|Ineligible|2|||
160922389|NCT00597012|581108521|FG001|Overall Study|Ineligible|0|||
160922390|NCT00597012|581108520|FG000|Overall Study|Lost to Follow-up|0|||
160922391|NCT00597012|581108521|FG001|Overall Study|Lost to Follow-up|2|||
160922392|NCT01103284|581108523|FG000|Overall Study|Death|2|||
160922393|NCT01103284|581108524|FG001|Overall Study|Death|0|||
160922394|NCT01103284|581108523|FG000|Overall Study|Lost to Follow-up|9|||
160922395|NCT01103284|581108524|FG001|Overall Study|Lost to Follow-up|10|||
160922396|NCT01103284|581108523|FG000|Overall Study|Pregnancy|3|||
160922397|NCT01103284|581108524|FG001|Overall Study|Pregnancy|1|||
160922398|NCT01103284|581108523|FG000|Overall Study|Protocol Violation|12|||
160922399|NCT01103284|581108524|FG001|Overall Study|Protocol Violation|5|||
160922400|NCT01103284|581108523|FG000|Overall Study|Adverse Event|0|||
160922401|NCT01103284|581108524|FG001|Overall Study|Adverse Event|5|||
160922402|NCT01103284|581108523|FG000|Overall Study|Withdrawal by Subject|14|||
160922403|NCT01103284|581108524|FG001|Overall Study|Withdrawal by Subject|18|||
160922404|NCT01103284|581108523|FG000|Overall Study|Dermal Hypersensitivity|0|||
160922405|NCT01103284|581108524|FG001|Overall Study|Dermal Hypersensitivity|1|||
160922406|NCT01103284|581108523|FG000|Overall Study|Termination by the Sponsor|0|||
160922407|NCT01103284|581108524|FG001|Overall Study|Termination by the Sponsor|1|||
160922408|NCT01103284|581108523|FG000|Overall Study|Not described|2|||
160922409|NCT01103284|581108524|FG001|Overall Study|Not described|1|||
160922410|NCT01103284|581108523|FG000|Overall Study|Missing CRF entries for study completion|0|||
160922411|NCT01103284|581108524|FG001|Overall Study|Missing CRF entries for study completion|2|||
160922412|NCT02356783|581109732|FG000|Overall Study|Lost to Follow-up|1|||
160922413|NCT02356783|581109733|FG001|Overall Study|Lost to Follow-up|3|||
160922414|NCT01462084|581109734|FG000|Overall Study|Withdrawal by Subject|1|||
160922415|NCT01462084|581109735|FG001|Overall Study|Withdrawal by Subject|0|||
160922416|NCT01462084|581109734|FG000|Overall Study|Protocol Violation|1|||
160922417|NCT01462084|581109735|FG001|Overall Study|Protocol Violation|1|||
160922418|NCT02278263|581109736|FG000|Overall Study|Protocol Violation|7|||
160922419|NCT02278263|581109737|FG001|Overall Study|Protocol Violation|0|||
160922420|NCT02278263|581109738|FG002|Overall Study|Protocol Violation|9|||
160922421|NCT00772707|581109740|FG000|Overall Study|Withdrawn|3|||
160922422|NCT01266460|581109742|FG000|Overall Study|Adverse Event|3|||
160922423|NCT01266460|581109742|FG000|Overall Study|Withdrawal by Subject|5|||
160922424|NCT01266460|581109742|FG000|Overall Study|Disease Progression|18|||
160922425|NCT01266460|581109742|FG000|Overall Study|Not otherwise specified|8|||
160922426|NCT01132547|581109743|FG000|Overall Study|Withdrawal by Subject|3|||
160922427|NCT01132547|581109744|FG001|Overall Study|Withdrawal by Subject|1|||
160922428|NCT01132547|581109743|FG000|Overall Study|Death|1|||
160922429|NCT01132547|581109744|FG001|Overall Study|Death|0|||
160922430|NCT05811234|581109745|FG000|Overall Study|Loss of Effectiveness|2|||
160922431|NCT05811234|581109745|FG000|Overall Study|Adverse Event|4|||
161262030|NCT01206816|582339456|FG003|Overall Study|Withdrawal by Subject|0|||
161262031|NCT01206816|582339457|FG004|Overall Study|Withdrawal by Subject|0|||
161262032|NCT01206816|582339458|FG005|Overall Study|Withdrawal by Subject|0|||
161262033|NCT01206816|582339459|FG006|Overall Study|Withdrawal by Subject|0|||
161262034|NCT01206816|582339453|FG000|Overall Study|Progressive disease|3|||
161262035|NCT01206816|582339454|FG001|Overall Study|Progressive disease|3|||
161262036|NCT01206816|582339455|FG002|Overall Study|Progressive disease|13|||
161262037|NCT01206816|582339456|FG003|Overall Study|Progressive disease|3|||
161262038|NCT01206816|582339457|FG004|Overall Study|Progressive disease|3|||
161262039|NCT01206816|582339458|FG005|Overall Study|Progressive disease|16|||
161262040|NCT01206816|582339459|FG006|Overall Study|Progressive disease|3|||
161262041|NCT01206816|582339453|FG000|Overall Study|Other AE|0|||
160922432|NCT05811234|581109745|FG000|Overall Study|Pregnancy|1|||
160922433|NCT05811234|581109745|FG000|Overall Study|Disease progression|1|||
160922434|NCT05811234|581109745|FG000|Overall Study|Withdrawal by Subject|4|||
160922435|NCT05811234|581109745|FG000|Overall Study|Lost to Follow-up|13|||
160922436|NCT05811234|581109745|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
160922437|NCT04499781|581109746|FG000|Overall Study|Lost to Follow-up|2|||
160922438|NCT04499781|581109747|FG001|Overall Study|Lost to Follow-up|3|||
160922439|NCT04499781|581109746|FG000|Overall Study|Withdrawal by Subject|2|||
160922440|NCT04499781|581109747|FG001|Overall Study|Withdrawal by Subject|0|||
160922441|NCT04105998|581109753|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
160997826|NCT00414648|581376647|FG000|Overall Study|Adverse Event|5|||
161341261|NCT02814526|582635694|FG001|Overall Study|safety risk|1|||
161341262|NCT02814526|582635693|FG000|Overall Study|early termination-study terminated|1|||
161341263|NCT02814526|582635694|FG001|Overall Study|early termination-study terminated|2|||
161262042|NCT01206816|582339454|FG001|Overall Study|Other AE|0|||
161262043|NCT01206816|582339455|FG002|Overall Study|Other AE|4|||
161262044|NCT01206816|582339456|FG003|Overall Study|Other AE|0|||
161262045|NCT01206816|582339457|FG004|Overall Study|Other AE|0|||
161341264|NCT02814526|582635693|FG000|Overall Study|Other|0|||
161341265|NCT02814526|582635694|FG001|Overall Study|Other|4|||
161341266|NCT01416571|582635695|FG000|Overall Study|Lost to Follow-up|2|||
161341267|NCT03608163|582635696|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
161341268|NCT03608163|582635697|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
161341269|NCT03454555|582637468|FG000|Overall Study|Death|6|||
161341270|NCT03454555|582637469|FG001|Overall Study|Death|6|||
161341271|NCT03454555|582637468|FG000|Overall Study|Lost to Follow-up|31|||
161341272|NCT03454555|582637469|FG001|Overall Study|Lost to Follow-up|12|||
161341273|NCT03454555|582637468|FG000|Overall Study|Physician Decision|2|||
161341274|NCT03454555|582637469|FG001|Overall Study|Physician Decision|6|||
161341275|NCT03454555|582637468|FG000|Overall Study|Withdrawal by Subject|34|||
161341276|NCT03454555|582637469|FG001|Overall Study|Withdrawal by Subject|5|||
160922442|NCT04105998|581109754|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
161143405|NCT00923091|581907580|FG006|Period VI (Open-Label)|Other Reason|0|||
161143406|NCT00923091|581907581|FG007|Period VI (Open-Label)|Other Reason|0|||
161143407|NCT00923091|581907582|FG008|Period VI (Open-Label)|Other Reason|0|||
161143408|NCT00923091|581907583|FG009|Period VI (Open-Label)|Other Reason|0|||
161143409|NCT00923091|581907584|FG010|Period VI (Open-Label)|Other Reason|0|||
161143410|NCT00923091|581907585|FG011|Period VI (Open-Label)|Other Reason|0|||
161143411|NCT00923091|581907586|FG012|Period VI (Open-Label)|Other Reason|0|||
161143412|NCT02111369|581907594|FG000|Overall Study|Lost to Follow-up|2|||
160922451|NCT00613015|581109760|FG000|Overall Study|Lost to Follow-up|0|||
160922452|NCT00613015|581109761|FG001|Overall Study|Lost to Follow-up|1|||
160922453|NCT00613015|581109762|FG002|Overall Study|Lost to Follow-up|3|||
160922454|NCT00613015|581109763|FG003|Overall Study|Lost to Follow-up|3|||
160922455|NCT00613015|581109764|FG004|Overall Study|Lost to Follow-up|2|||
160922456|NCT00613015|581109765|FG005|Overall Study|Lost to Follow-up|3|||
160922457|NCT00071760|581109768|FG000|Overall Study|Adverse Event|2|||
160922458|NCT00071760|581109769|FG001|Overall Study|Adverse Event|1|||
160922459|NCT00071760|581109768|FG000|Overall Study|Lost to Follow-up|0|||
160922460|NCT00071760|581109769|FG001|Overall Study|Lost to Follow-up|3|||
160922461|NCT00071760|581109768|FG000|Overall Study|Protocol Violation|1|||
160922462|NCT00071760|581109769|FG001|Overall Study|Protocol Violation|0|||
160922463|NCT00071760|581109768|FG000|Overall Study|Withdrawal by Subject|0|||
160922464|NCT00071760|581109769|FG001|Overall Study|Withdrawal by Subject|1|||
160922465|NCT00071760|581109768|FG000|Overall Study|Insufficient Viral Load Response|1|||
160922466|NCT00071760|581109769|FG001|Overall Study|Insufficient Viral Load Response|1|||
160922467|NCT00071760|581109768|FG000|Overall Study|Lack of availability of RTV|1|||
160922468|NCT00071760|581109769|FG001|Overall Study|Lack of availability of RTV|0|||
160922469|NCT00071760|581109768|FG000|Overall Study|Physician Decision|2|||
160922470|NCT00071760|581109769|FG001|Overall Study|Physician Decision|1|||
160922471|NCT00071760|581109768|FG000|Overall Study|Relocation|0|||
160922472|NCT00071760|581109769|FG001|Overall Study|Relocation|1|||
160922473|NCT02073279|581109770|FG000|Double-blind Period|Adverse Event|1|||
160922474|NCT02073279|581109771|FG001|Double-blind Period|Adverse Event|1|||
160922475|NCT02073279|581109770|FG000|Double-blind Period|Switched to another treatment|1|||
160922476|NCT02073279|581109771|FG001|Double-blind Period|Switched to another treatment|2|||
160922477|NCT02073279|581109770|FG000|Double-blind Period|Protocol Violation|0|||
160922478|NCT02073279|581109771|FG001|Double-blind Period|Protocol Violation|1|||
160922479|NCT02073279|581109770|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
160922480|NCT02073279|581109771|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
161262046|NCT01206816|582339458|FG005|Overall Study|Other AE|3|||
161262047|NCT01206816|582339459|FG006|Overall Study|Other AE|2|||
161262048|NCT01206816|582339453|FG000|Overall Study|other than stated above|0|||
161262049|NCT01206816|582339454|FG001|Overall Study|other than stated above|0|||
161262050|NCT01206816|582339455|FG002|Overall Study|other than stated above|1|||
161262051|NCT01206816|582339456|FG003|Overall Study|other than stated above|0|||
161262052|NCT01206816|582339457|FG004|Overall Study|other than stated above|0|||
161341277|NCT03454555|582637468|FG000|Overall Study|Ineligible|1|||
161341278|NCT03454555|582637469|FG001|Overall Study|Ineligible|5|||
161341279|NCT05493111|582637470|FG000|Overall Study|Adverse Event|3|||
161341280|NCT05493111|582637471|FG001|Overall Study|Adverse Event|4|||
160922481|NCT02073279|581109770|FG000|Double-blind Period|Withdrawal by Subject|2|||
160922482|NCT02073279|581109771|FG001|Double-blind Period|Withdrawal by Subject|2|||
160922483|NCT02073279|581109770|FG000|Open-label Extension Period|Adverse Event|1|||
160922484|NCT02073279|581109771|FG001|Open-label Extension Period|Adverse Event|0|||
160997827|NCT00414648|581376648|FG001|Overall Study|Adverse Event|5|||
161262053|NCT01206816|582339458|FG005|Overall Study|other than stated above|0|||
161341281|NCT05493111|582637470|FG000|Overall Study|Withdrawal of Consent|19|||
161341282|NCT05493111|582637471|FG001|Overall Study|Withdrawal of Consent|10|||
160922485|NCT02073279|581109770|FG000|Open-label Extension Period|Lack of Efficacy|1|||
160922486|NCT02073279|581109771|FG001|Open-label Extension Period|Lack of Efficacy|0|||
160922487|NCT02073279|581109770|FG000|Open-label Extension Period|Lost to Follow-up|0|||
160922488|NCT02073279|581109771|FG001|Open-label Extension Period|Lost to Follow-up|4|||
160922489|NCT02073279|581109770|FG000|Open-label Extension Period|Switched to another treatment|1|||
160922490|NCT02073279|581109771|FG001|Open-label Extension Period|Switched to another treatment|4|||
160922491|NCT02073279|581109770|FG000|Open-label Extension Period|Protocol Violation|0|||
160922492|NCT02073279|581109771|FG001|Open-label Extension Period|Protocol Violation|1|||
160922493|NCT02073279|581109770|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
160922494|NCT02073279|581109771|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
160922495|NCT02073279|581109770|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
160922496|NCT02073279|581109771|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
160922497|NCT01994629|581109772|FG000|Overall Study|Withdrawal by Subject|1|||
160922498|NCT01994629|581109773|FG001|Overall Study|Withdrawal by Subject|0|||
160922499|NCT01994629|581109772|FG000|Overall Study|Lost to Follow-up|0|||
160922500|NCT01994629|581109773|FG001|Overall Study|Lost to Follow-up|3|||
160922501|NCT03338062|581109776|FG000|Overall Study|Alternative Therapy|1|||
160922502|NCT03338062|581109777|FG001|Overall Study|Alternative Therapy|0|||
160922503|NCT00877383|581109780|FG000|Overall Study|Adverse Event|13|||
160922504|NCT00877383|581109781|FG001|Overall Study|Adverse Event|14|||
160922505|NCT00877383|581109780|FG000|Overall Study|Lost to Follow-up|5|||
160922506|NCT00877383|581109781|FG001|Overall Study|Lost to Follow-up|3|||
160922507|NCT00877383|581109780|FG000|Overall Study|Subject withdrew consent|3|||
160922508|NCT00877383|581109781|FG001|Overall Study|Subject withdrew consent|12|||
160922509|NCT00877383|581109780|FG000|Overall Study|Subject no longer requires study drug|2|||
160922510|NCT00877383|581109781|FG001|Overall Study|Subject no longer requires study drug|0|||
160922511|NCT00877383|581109780|FG000|Overall Study|Administrative problems|2|||
160922512|NCT00877383|581109781|FG001|Overall Study|Administrative problems|0|||
160922513|NCT00877383|581109780|FG000|Overall Study|Protocol deviation|2|||
160922514|NCT00877383|581109781|FG001|Overall Study|Protocol deviation|6|||
160922515|NCT00877383|581109780|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
160922516|NCT00877383|581109781|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160922517|NCT00877383|581109780|FG000|Overall Study|Death|1|||
160922518|NCT00877383|581109781|FG001|Overall Study|Death|2|||
160922519|NCT00459108|581109782|FG000|Overall Study|Withdrawal by Subject|5|||
160922520|NCT00459108|581109782|FG000|Overall Study|Adverse Event|3|||
160922521|NCT00459108|581109782|FG000|Overall Study|Death|2|||
160922522|NCT00459108|581109782|FG000|Overall Study|Progression|1|||
160922523|NCT00391274|581109794|FG000|Overall Study|Death Due to Study Disease|55|||
160922524|NCT00391274|581109795|FG001|Overall Study|Death Due to Study Disease|45|||
160922525|NCT00391274|581109794|FG000|Overall Study|Lost to Follow-up|0|||
160922526|NCT00391274|581109795|FG001|Overall Study|Lost to Follow-up|3|||
160922527|NCT00391274|581109794|FG000|Overall Study|Physician Decision|4|||
160922528|NCT00391274|581109795|FG001|Overall Study|Physician Decision|2|||
160922529|NCT00391274|581109794|FG000|Overall Study|Withdrawal by Subject|0|||
160922530|NCT00391274|581109795|FG001|Overall Study|Withdrawal by Subject|3|||
160922531|NCT00391274|581109794|FG000|Overall Study|Death Due to Adverse Event|1|||
160922532|NCT00391274|581109795|FG001|Overall Study|Death Due to Adverse Event|3|||
160922533|NCT00391274|581109794|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
160922534|NCT00391274|581109795|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
160922535|NCT00391274|581109794|FG000|Overall Study|Death Not Study Related|0|||
160922536|NCT00391274|581109795|FG001|Overall Study|Death Not Study Related|1|||
160922537|NCT04501666|581109796|FG000|Overall Study|Physician Decision|0|||
160922538|NCT04501666|581109797|FG001|Overall Study|Physician Decision|1|||
160922539|NCT04501666|581109796|FG000|Overall Study|Adverse Event|12|||
160922540|NCT04501666|581109797|FG001|Overall Study|Adverse Event|4|||
160922541|NCT04501666|581109796|FG000|Overall Study|Subject's request|10|||
160922542|NCT04501666|581109797|FG001|Overall Study|Subject's request|6|||
160922543|NCT04501666|581109796|FG000|Overall Study|Protocol Deviation|2|||
160922544|NCT04501666|581109797|FG001|Overall Study|Protocol Deviation|1|||
160922545|NCT04501666|581109796|FG000|Overall Study|Other-- site permanently closing|0|||
160922546|NCT04501666|581109797|FG001|Overall Study|Other-- site permanently closing|1|||
160922547|NCT00642941|581109798|FG000|Overall Study|Physician Decision|3|||
161341283|NCT05493111|582637470|FG000|Overall Study|Non-compliance|1|||
160922548|NCT00642941|581109799|FG001|Overall Study|Physician Decision|1|||
160922549|NCT00642941|581109800|FG002|Overall Study|Physician Decision|0|||
160922550|NCT00642941|581109801|FG003|Overall Study|Physician Decision|0|||
160922551|NCT00642941|581109802|FG004|Overall Study|Physician Decision|0|||
160922552|NCT00642941|581109803|FG005|Overall Study|Physician Decision|0|||
160922553|NCT00642941|581109804|FG006|Overall Study|Physician Decision|1|||
160922554|NCT00642941|581109805|FG007|Overall Study|Physician Decision|0|||
160922555|NCT00642941|581109806|FG008|Overall Study|Physician Decision|0|||
160922556|NCT00642941|581109807|FG009|Overall Study|Physician Decision|1|||
160922557|NCT00642941|581109808|FG010|Overall Study|Physician Decision|0|||
160997828|NCT00414648|581376647|FG000|Overall Study|Death|0|||
160997829|NCT00414648|581376648|FG001|Overall Study|Death|1|||
161341284|NCT05493111|582637471|FG001|Overall Study|Non-compliance|1|||
160922558|NCT00642941|581109809|FG011|Overall Study|Physician Decision|1|||
160922559|NCT00642941|581109798|FG000|Overall Study|Death|4|||
160922560|NCT00642941|581109799|FG001|Overall Study|Death|0|||
160922561|NCT00642941|581109800|FG002|Overall Study|Death|1|||
160922562|NCT00642941|581109801|FG003|Overall Study|Death|1|||
160922563|NCT00642941|581109802|FG004|Overall Study|Death|2|||
160922564|NCT00642941|581109803|FG005|Overall Study|Death|1|||
160922565|NCT00642941|581109804|FG006|Overall Study|Death|0|||
160922566|NCT00642941|581109805|FG007|Overall Study|Death|0|||
160922567|NCT00642941|581109806|FG008|Overall Study|Death|0|||
160922568|NCT00642941|581109807|FG009|Overall Study|Death|0|||
160922569|NCT00642941|581109808|FG010|Overall Study|Death|0|||
160922570|NCT00642941|581109809|FG011|Overall Study|Death|1|||
160922571|NCT00642941|581109798|FG000|Overall Study|Study closed by Sponsor|0|||
160922572|NCT00642941|581109799|FG001|Overall Study|Study closed by Sponsor|1|||
160922573|NCT00642941|581109800|FG002|Overall Study|Study closed by Sponsor|0|||
160922574|NCT00642941|581109801|FG003|Overall Study|Study closed by Sponsor|0|||
160922575|NCT00642941|581109802|FG004|Overall Study|Study closed by Sponsor|0|||
160922576|NCT00642941|581109803|FG005|Overall Study|Study closed by Sponsor|0|||
160922577|NCT00642941|581109804|FG006|Overall Study|Study closed by Sponsor|0|||
160922578|NCT00642941|581109805|FG007|Overall Study|Study closed by Sponsor|0|||
160922579|NCT00642941|581109806|FG008|Overall Study|Study closed by Sponsor|0|||
160922580|NCT00642941|581109807|FG009|Overall Study|Study closed by Sponsor|0|||
160922581|NCT00642941|581109808|FG010|Overall Study|Study closed by Sponsor|0|||
160922582|NCT00642941|581109809|FG011|Overall Study|Study closed by Sponsor|0|||
160922583|NCT00642941|581109798|FG000|Overall Study|Withdrawal by Subject|1|||
160922584|NCT00642941|581109799|FG001|Overall Study|Withdrawal by Subject|0|||
160922585|NCT00642941|581109800|FG002|Overall Study|Withdrawal by Subject|0|||
160922586|NCT00642941|581109801|FG003|Overall Study|Withdrawal by Subject|2|||
160922587|NCT00642941|581109802|FG004|Overall Study|Withdrawal by Subject|0|||
160922588|NCT00642941|581109803|FG005|Overall Study|Withdrawal by Subject|0|||
160922589|NCT00642941|581109804|FG006|Overall Study|Withdrawal by Subject|2|||
160922590|NCT00642941|581109805|FG007|Overall Study|Withdrawal by Subject|0|||
160922591|NCT00642941|581109806|FG008|Overall Study|Withdrawal by Subject|1|||
160922592|NCT00642941|581109807|FG009|Overall Study|Withdrawal by Subject|0|||
160922593|NCT00642941|581109808|FG010|Overall Study|Withdrawal by Subject|0|||
160922594|NCT00642941|581109809|FG011|Overall Study|Withdrawal by Subject|1|||
160922595|NCT00642941|581109798|FG000|Overall Study|Protocol Violation|0|||
160922596|NCT00642941|581109799|FG001|Overall Study|Protocol Violation|0|||
160922597|NCT00642941|581109800|FG002|Overall Study|Protocol Violation|0|||
160922598|NCT00642941|581109801|FG003|Overall Study|Protocol Violation|0|||
160922599|NCT00642941|581109802|FG004|Overall Study|Protocol Violation|0|||
160922600|NCT00642941|581109803|FG005|Overall Study|Protocol Violation|0|||
160922601|NCT00642941|581109804|FG006|Overall Study|Protocol Violation|1|||
160922602|NCT00642941|581109805|FG007|Overall Study|Protocol Violation|0|||
160922603|NCT00642941|581109806|FG008|Overall Study|Protocol Violation|0|||
160922604|NCT00642941|581109807|FG009|Overall Study|Protocol Violation|0|||
160922605|NCT00642941|581109808|FG010|Overall Study|Protocol Violation|0|||
160922606|NCT00642941|581109809|FG011|Overall Study|Protocol Violation|0|||
160922607|NCT00642941|581109798|FG000|Overall Study|Adverse Event|1|||
160922608|NCT00642941|581109799|FG001|Overall Study|Adverse Event|1|||
160922609|NCT00642941|581109800|FG002|Overall Study|Adverse Event|0|||
160922610|NCT00642941|581109801|FG003|Overall Study|Adverse Event|0|||
160922611|NCT00642941|581109802|FG004|Overall Study|Adverse Event|0|||
160922612|NCT00642941|581109803|FG005|Overall Study|Adverse Event|0|||
160922613|NCT00642941|581109804|FG006|Overall Study|Adverse Event|1|||
160922614|NCT00642941|581109805|FG007|Overall Study|Adverse Event|1|||
160922615|NCT00642941|581109806|FG008|Overall Study|Adverse Event|0|||
160922616|NCT00642941|581109807|FG009|Overall Study|Adverse Event|1|||
160922617|NCT00642941|581109808|FG010|Overall Study|Adverse Event|0|||
160922618|NCT00642941|581109809|FG011|Overall Study|Adverse Event|0|||
160922619|NCT00642941|581109798|FG000|Overall Study|Other|1|||
161341285|NCT05493111|582637470|FG000|Overall Study|Lost to Follow-up|8|||
160922620|NCT00642941|581109799|FG001|Overall Study|Other|1|||
160922621|NCT00642941|581109800|FG002|Overall Study|Other|1|||
160922622|NCT00642941|581109801|FG003|Overall Study|Other|1|||
160922623|NCT00642941|581109802|FG004|Overall Study|Other|0|||
160922624|NCT00642941|581109803|FG005|Overall Study|Other|1|||
160997830|NCT00414648|581376647|FG000|Overall Study|Lack of Efficacy|0|||
160922625|NCT00642941|581109804|FG006|Overall Study|Other|0|||
160922626|NCT00642941|581109805|FG007|Overall Study|Other|1|||
160922627|NCT00642941|581109806|FG008|Overall Study|Other|0|||
160922628|NCT00642941|581109807|FG009|Overall Study|Other|0|||
160922629|NCT00642941|581109808|FG010|Overall Study|Other|0|||
160922630|NCT00642941|581109809|FG011|Overall Study|Other|1|||
160922631|NCT00642941|581109798|FG000|Overall Study|Disease progression|60|||
160922632|NCT00642941|581109799|FG001|Overall Study|Disease progression|50|||
160922633|NCT00642941|581109800|FG002|Overall Study|Disease progression|5|||
160922634|NCT00642941|581109801|FG003|Overall Study|Disease progression|36|||
160922635|NCT00642941|581109802|FG004|Overall Study|Disease progression|23|||
160922636|NCT00642941|581109803|FG005|Overall Study|Disease progression|39|||
160997831|NCT00414648|581376648|FG001|Overall Study|Lack of Efficacy|2|||
160997832|NCT00414648|581376647|FG000|Overall Study|Withdrawal by Subject|0|||
160997833|NCT00414648|581376648|FG001|Overall Study|Withdrawal by Subject|1|||
160997834|NCT01157182|581376649|FG000|Washout of 28 Days|Adverse Event|2|||
160997835|NCT01157182|581376650|FG001|Washout of 28 Days|Adverse Event|0|||
160997836|NCT00878722|581376651|FG000|Overall Study|Progressive disease|3|||
160997837|NCT00878722|581376652|FG001|Overall Study|Progressive disease|3|||
160997838|NCT00878722|581376653|FG002|Overall Study|Progressive disease|3|||
160997839|NCT00878722|581376654|FG003|Overall Study|Progressive disease|7|||
160997840|NCT00878722|581376655|FG004|Overall Study|Progressive disease|7|||
160997841|NCT00878722|581376656|FG005|Overall Study|Progressive disease|1|||
160997842|NCT00878722|581376657|FG006|Overall Study|Progressive disease|4|||
160997843|NCT00878722|581376658|FG007|Overall Study|Progressive disease|3|||
160997844|NCT00878722|581376651|FG000|Overall Study|Death|0|||
160997845|NCT00878722|581376652|FG001|Overall Study|Death|0|||
160997846|NCT00878722|581376653|FG002|Overall Study|Death|0|||
160997847|NCT00878722|581376654|FG003|Overall Study|Death|1|||
160997848|NCT00878722|581376655|FG004|Overall Study|Death|0|||
160997849|NCT00878722|581376656|FG005|Overall Study|Death|1|||
160997850|NCT00878722|581376657|FG006|Overall Study|Death|0|||
160997851|NCT00878722|581376658|FG007|Overall Study|Death|2|||
161341286|NCT05493111|582637471|FG001|Overall Study|Lost to Follow-up|1|||
160922637|NCT00642941|581109804|FG006|Overall Study|Disease progression|18|||
160922638|NCT00642941|581109805|FG007|Overall Study|Disease progression|12|||
160922639|NCT00642941|581109806|FG008|Overall Study|Disease progression|10|||
160922640|NCT00642941|581109807|FG009|Overall Study|Disease progression|7|||
160922641|NCT00642941|581109808|FG010|Overall Study|Disease progression|12|||
160922642|NCT00642941|581109809|FG011|Overall Study|Disease progression|7|||
160922643|NCT03051607|581109810|FG000|Overall Study|Adverse Event|66|||
160922644|NCT01505868|581109811|FG000|Overall Study|Withdrawal by Subject|1|||
160922645|NCT01505868|581109812|FG001|Overall Study|Withdrawal by Subject|0|||
160922646|NCT01505868|581109813|FG002|Overall Study|Withdrawal by Subject|0|||
160922647|NCT01505868|581109814|FG003|Overall Study|Withdrawal by Subject|0|||
160922648|NCT01505868|581109815|FG004|Overall Study|Withdrawal by Subject|0|||
160922649|NCT00894322|581109816|FG000|Overall Study|Withdrawal by Subject|1|||
160922650|NCT00894322|581109817|FG001|Overall Study|Withdrawal by Subject|0|||
160922651|NCT00894322|581109818|FG002|Overall Study|Withdrawal by Subject|0|||
160922652|NCT00553150|581109819|FG000|Overall Study|Withdrawal by Subject|0|||
160922653|NCT00553150|581109820|FG001|Overall Study|Withdrawal by Subject|0|||
160922654|NCT00553150|581109821|FG002|Overall Study|Withdrawal by Subject|0|||
160922655|NCT00553150|581109822|FG003|Overall Study|Withdrawal by Subject|2|||
160922656|NCT00553150|581109819|FG000|Overall Study|Protocol Violation|0|||
160922657|NCT00553150|581109820|FG001|Overall Study|Protocol Violation|0|||
160922658|NCT00553150|581109821|FG002|Overall Study|Protocol Violation|0|||
160922659|NCT00553150|581109822|FG003|Overall Study|Protocol Violation|1|||
160922660|NCT00553150|581109819|FG000|Overall Study|Ineligible|0|||
160922661|NCT00553150|581109820|FG001|Overall Study|Ineligible|0|||
160922662|NCT00553150|581109821|FG002|Overall Study|Ineligible|0|||
160922663|NCT00553150|581109822|FG003|Overall Study|Ineligible|1|||
160922664|NCT03251079|581109824|FG000|Overall Study|Withdrawal by Subject|1|||
160922665|NCT01387347|581109825|FG000|Overall Study|Lost to Follow-up|2|||
160922666|NCT01387347|581109826|FG001|Overall Study|Lost to Follow-up|1|||
160922667|NCT03605303|581109827|FG000|Period 1|Study Terminated|2|||
160922668|NCT03605303|581109828|FG001|Period 1|Study Terminated|1|||
160922669|NCT00399360|581109833|FG000|Overall Study|Lost to Follow-up|2|||
160922670|NCT00399360|581109834|FG001|Overall Study|Lost to Follow-up|1|||
160997852|NCT00878722|581376651|FG000|Overall Study|Adverse Event|0|||
160997853|NCT00878722|581376652|FG001|Overall Study|Adverse Event|0|||
160997854|NCT00878722|581376653|FG002|Overall Study|Adverse Event|0|||
160997855|NCT00878722|581376654|FG003|Overall Study|Adverse Event|0|||
160997856|NCT00878722|581376655|FG004|Overall Study|Adverse Event|0|||
160997857|NCT00878722|581376656|FG005|Overall Study|Adverse Event|0|||
160997858|NCT00878722|581376657|FG006|Overall Study|Adverse Event|2|||
160997859|NCT00878722|581376658|FG007|Overall Study|Adverse Event|0|||
160997860|NCT00878722|581376651|FG000|Overall Study|Withdrawal by Subject|0|||
160997861|NCT00878722|581376652|FG001|Overall Study|Withdrawal by Subject|0|||
160922671|NCT00399360|581109835|FG002|Overall Study|Lost to Follow-up|2|||
160922672|NCT00399360|581109836|FG003|Overall Study|Lost to Follow-up|4|||
160922673|NCT00399360|581109833|FG000|Overall Study|Adverse Event|0|||
160922674|NCT00399360|581109834|FG001|Overall Study|Adverse Event|0|||
160922675|NCT00399360|581109835|FG002|Overall Study|Adverse Event|1|||
160922676|NCT00399360|581109836|FG003|Overall Study|Adverse Event|0|||
160922677|NCT00399360|581109833|FG000|Overall Study|Withdrawal by Subject|0|||
160997862|NCT00878722|581376653|FG002|Overall Study|Withdrawal by Subject|0|||
160997863|NCT00878722|581376654|FG003|Overall Study|Withdrawal by Subject|0|||
160997864|NCT00878722|581376655|FG004|Overall Study|Withdrawal by Subject|0|||
160997865|NCT00878722|581376656|FG005|Overall Study|Withdrawal by Subject|0|||
160997866|NCT00878722|581376657|FG006|Overall Study|Withdrawal by Subject|0|||
160997867|NCT00878722|581376658|FG007|Overall Study|Withdrawal by Subject|2|||
160997868|NCT00878722|581376651|FG000|Overall Study|Relapse|0|||
160997869|NCT00878722|581376652|FG001|Overall Study|Relapse|0|||
160922678|NCT00399360|581109834|FG001|Overall Study|Withdrawal by Subject|2|||
160922679|NCT00399360|581109835|FG002|Overall Study|Withdrawal by Subject|0|||
161262054|NCT01206816|582339459|FG006|Overall Study|other than stated above|1|||
161262055|NCT02528123|582339461|FG000|Overall Study|Lost to Follow-up|1|||
161262056|NCT01939496|582339462|FG000|Overall Study|Adverse Event|2|||
161262057|NCT01939496|582339463|FG001|Overall Study|Adverse Event|0|||
161262058|NCT01939496|582339464|FG002|Overall Study|Adverse Event|0|||
161262059|NCT01939496|582339462|FG000|Overall Study|Lost to Follow-up|1|||
161262060|NCT01939496|582339463|FG001|Overall Study|Lost to Follow-up|1|||
160922680|NCT00399360|581109836|FG003|Overall Study|Withdrawal by Subject|2|||
160922681|NCT02626520|581109838|FG000|Overall Study|Physician Decision|1|||
160922682|NCT02626520|581109839|FG001|Overall Study|Physician Decision|1|||
160922683|NCT02626520|581109838|FG000|Overall Study|Adverse Event|0|||
160922684|NCT02626520|581109839|FG001|Overall Study|Adverse Event|4|||
160922685|NCT02626520|581109838|FG000|Overall Study|Lack of Efficacy|0|||
160922686|NCT02626520|581109839|FG001|Overall Study|Lack of Efficacy|2|||
160922687|NCT02626520|581109838|FG000|Overall Study|Did not start protocol therapy|0|||
160922688|NCT02626520|581109839|FG001|Overall Study|Did not start protocol therapy|2|||
160922689|NCT02626520|581109838|FG000|Overall Study|Study terminated|0|||
160922690|NCT02626520|581109839|FG001|Overall Study|Study terminated|1|||
160922691|NCT00492115|581109840|FG000|Overall Study|Withdrawal by Subject|3|||
160922692|NCT00492115|581109841|FG001|Overall Study|Withdrawal by Subject|4|||
160922693|NCT01288287|581109842|FG000|Overall Study|Lost to Follow-up|8|||
160922694|NCT01288287|581109842|FG000|Overall Study|Withdrawal by Subject|4|||
160922695|NCT01288287|581109842|FG000|Overall Study|Lack of Efficacy|13|||
160922696|NCT01288287|581109842|FG000|Overall Study|Other Reason|13|||
160922697|NCT01288287|581109842|FG000|Overall Study|Unknown Reason|1|||
160922698|NCT01288287|581109842|FG000|Overall Study|Unknown Status|7|||
160922699|NCT02472795|581109847|FG000|Overall Study|Adverse Event|0|||
160922700|NCT02472795|581109848|FG001|Overall Study|Adverse Event|1|||
160922701|NCT02472795|581109849|FG002|Overall Study|Adverse Event|0|||
160922702|NCT02472795|581109850|FG003|Overall Study|Adverse Event|0|||
160922703|NCT02472795|581109851|FG004|Overall Study|Adverse Event|2|||
160922704|NCT02472795|581109847|FG000|Overall Study|Withdrawal by Subject|0|||
160922705|NCT02472795|581109848|FG001|Overall Study|Withdrawal by Subject|0|||
160922706|NCT02472795|581109849|FG002|Overall Study|Withdrawal by Subject|0|||
160922707|NCT02472795|581109850|FG003|Overall Study|Withdrawal by Subject|0|||
160922708|NCT02472795|581109851|FG004|Overall Study|Withdrawal by Subject|1|||
160922709|NCT04734652|581111990|FG000|Overall Study|Withdrawal by Subject|2|||
160922710|NCT04734652|581111991|FG001|Overall Study|Withdrawal by Subject|0|||
160922711|NCT04734652|581111990|FG000|Overall Study|Death|0|||
160922712|NCT04734652|581111991|FG001|Overall Study|Death|1|||
160922713|NCT04729127|581111993|FG000|Overall Study|Suspended/Terminated EI Services|4|||
160922714|NCT04729127|581111994|FG001|Overall Study|Suspended/Terminated EI Services|0|||
160922715|NCT04729127|581111995|FG002|Overall Study|Suspended/Terminated EI Services|4|||
160922716|NCT04729127|581111996|FG003|Overall Study|Suspended/Terminated EI Services|6|||
160922717|NCT04729127|581111997|FG004|Overall Study|Suspended/Terminated EI Services|0|||
160922718|NCT04729127|581111998|FG005|Overall Study|Suspended/Terminated EI Services|6|||
160922719|NCT04729127|581111999|FG006|Overall Study|Suspended/Terminated EI Services|2|||
160922720|NCT04729127|581112000|FG007|Overall Study|Suspended/Terminated EI Services|0|||
160922721|NCT04729127|581112001|FG008|Overall Study|Suspended/Terminated EI Services|2|||
160922722|NCT04729127|581111993|FG000|Overall Study|Withdrawal by Subject|1|||
160922723|NCT04729127|581111994|FG001|Overall Study|Withdrawal by Subject|0|||
160922724|NCT04729127|581111995|FG002|Overall Study|Withdrawal by Subject|1|||
160922725|NCT04729127|581111996|FG003|Overall Study|Withdrawal by Subject|0|||
160922726|NCT04729127|581111997|FG004|Overall Study|Withdrawal by Subject|0|||
160922727|NCT04729127|581111998|FG005|Overall Study|Withdrawal by Subject|0|||
160922728|NCT04729127|581111999|FG006|Overall Study|Withdrawal by Subject|0|||
160922729|NCT04729127|581112000|FG007|Overall Study|Withdrawal by Subject|0|||
160922730|NCT04729127|581112001|FG008|Overall Study|Withdrawal by Subject|0|||
160922731|NCT04729127|581111993|FG000|Overall Study|Switched Agency/Setting|1|||
160922732|NCT04729127|581111994|FG001|Overall Study|Switched Agency/Setting|0|||
160922733|NCT04729127|581111995|FG002|Overall Study|Switched Agency/Setting|1|||
161262061|NCT01939496|582339464|FG002|Overall Study|Lost to Follow-up|0|||
160922734|NCT04729127|581111996|FG003|Overall Study|Switched Agency/Setting|1|||
160922735|NCT04729127|581111997|FG004|Overall Study|Switched Agency/Setting|0|||
160922736|NCT04729127|581111998|FG005|Overall Study|Switched Agency/Setting|1|||
160922737|NCT04729127|581111999|FG006|Overall Study|Switched Agency/Setting|1|||
160922738|NCT04729127|581112000|FG007|Overall Study|Switched Agency/Setting|0|||
160922739|NCT04729127|581112001|FG008|Overall Study|Switched Agency/Setting|1|||
160922740|NCT01912287|581112002|FG000|Overall Study|Ineligible|1|||
160922741|NCT01912287|581112003|FG001|Overall Study|Ineligible|0|||
160922742|NCT01912287|581112004|FG002|Overall Study|Ineligible|1|||
161262062|NCT01939496|582339462|FG000|Overall Study|Physician Decision|1|||
160922743|NCT01912287|581112002|FG000|Overall Study|No-show|0|||
160922744|NCT01912287|581112003|FG001|Overall Study|No-show|0|||
160922745|NCT01912287|581112004|FG002|Overall Study|No-show|1|||
160997870|NCT00878722|581376653|FG002|Overall Study|Relapse|0|||
160997871|NCT00878722|581376654|FG003|Overall Study|Relapse|1|||
160922746|NCT01912287|581112002|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
160922747|NCT01912287|581112003|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
160922748|NCT01912287|581112004|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
160922749|NCT01912287|581112002|FG000|Overall Study|Felt treatment no longer needed|0|||
160922750|NCT01912287|581112003|FG001|Overall Study|Felt treatment no longer needed|1|||
160922751|NCT01912287|581112004|FG002|Overall Study|Felt treatment no longer needed|0|||
160997872|NCT00878722|581376655|FG004|Overall Study|Relapse|0|||
160997873|NCT00878722|581376656|FG005|Overall Study|Relapse|0|||
160922752|NCT01912287|581112002|FG000|Overall Study|Life circumstances|4|||
160922753|NCT01912287|581112003|FG001|Overall Study|Life circumstances|2|||
160922754|NCT01912287|581112004|FG002|Overall Study|Life circumstances|0|||
160922755|NCT01912287|581112002|FG000|Overall Study|Lost Interest|1|||
160922756|NCT01912287|581112003|FG001|Overall Study|Lost Interest|0|||
160922757|NCT01912287|581112004|FG002|Overall Study|Lost Interest|0|||
160922758|NCT01912287|581112002|FG000|Overall Study|Uknown reason - subject drop out|5|||
160922759|NCT01912287|581112003|FG001|Overall Study|Uknown reason - subject drop out|7|||
160922760|NCT01912287|581112004|FG002|Overall Study|Uknown reason - subject drop out|3|||
160922761|NCT01912287|581112002|FG000|Overall Study|Missed Assesment|1|||
160922762|NCT01912287|581112003|FG001|Overall Study|Missed Assesment|1|||
160922763|NCT01912287|581112004|FG002|Overall Study|Missed Assesment|1|||
160922764|NCT01912287|581112002|FG000|Overall Study|Scheduling/change in availability|17|||
160922765|NCT01912287|581112003|FG001|Overall Study|Scheduling/change in availability|10|||
160922766|NCT01912287|581112004|FG002|Overall Study|Scheduling/change in availability|8|||
160922767|NCT02631850|581112005|FG000|Treatment Period|Lost to Follow-up|0|||
160922768|NCT02631850|581112006|FG001|Treatment Period|Lost to Follow-up|1|||
160922769|NCT02631850|581112007|FG002|Treatment Period|Lost to Follow-up|0|||
160922770|NCT02631850|581112008|FG003|Treatment Period|Lost to Follow-up|0|||
160922771|NCT02631850|581112005|FG000|Treatment Period|Protocol Violation|1|||
160922772|NCT02631850|581112006|FG001|Treatment Period|Protocol Violation|0|||
160922773|NCT02631850|581112007|FG002|Treatment Period|Protocol Violation|0|||
160922774|NCT02631850|581112008|FG003|Treatment Period|Protocol Violation|0|||
160922775|NCT02631850|581112005|FG000|Treatment Period|Withdrawal by Subject|0|||
160922776|NCT02631850|581112006|FG001|Treatment Period|Withdrawal by Subject|5|||
160922777|NCT02631850|581112007|FG002|Treatment Period|Withdrawal by Subject|2|||
160922778|NCT02631850|581112008|FG003|Treatment Period|Withdrawal by Subject|2|||
160922779|NCT02631850|581112005|FG000|Treatment Period|Adverse Event|1|||
160922780|NCT02631850|581112006|FG001|Treatment Period|Adverse Event|0|||
160922781|NCT02631850|581112007|FG002|Treatment Period|Adverse Event|2|||
160922782|NCT02631850|581112008|FG003|Treatment Period|Adverse Event|3|||
160922783|NCT02631850|581112005|FG000|Treatment Period|Family medical issue|1|||
160922784|NCT02631850|581112006|FG001|Treatment Period|Family medical issue|0|||
160922785|NCT02631850|581112007|FG002|Treatment Period|Family medical issue|0|||
160922786|NCT02631850|581112008|FG003|Treatment Period|Family medical issue|0|||
160922787|NCT02631850|581112005|FG000|6 Month Follow up|Lost to Follow-up|5|||
160922788|NCT02631850|581112006|FG001|6 Month Follow up|Lost to Follow-up|8|||
160922789|NCT02631850|581112007|FG002|6 Month Follow up|Lost to Follow-up|3|||
160922790|NCT02631850|581112008|FG003|6 Month Follow up|Lost to Follow-up|5|||
160922791|NCT02631850|581112005|FG000|6 Month Follow up|Withdrawal by Subject|1|||
160922792|NCT02631850|581112006|FG001|6 Month Follow up|Withdrawal by Subject|0|||
160922793|NCT02631850|581112007|FG002|6 Month Follow up|Withdrawal by Subject|0|||
160922794|NCT02631850|581112008|FG003|6 Month Follow up|Withdrawal by Subject|2|||
160922795|NCT02631850|581112005|FG000|6 Month Follow up|Adverse Event|1|||
160922796|NCT02631850|581112006|FG001|6 Month Follow up|Adverse Event|4|||
160922797|NCT02631850|581112007|FG002|6 Month Follow up|Adverse Event|1|||
160922798|NCT02631850|581112008|FG003|6 Month Follow up|Adverse Event|3|||
160922799|NCT02631850|581112005|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
160997874|NCT00878722|581376657|FG006|Overall Study|Relapse|0|||
160997875|NCT00878722|581376658|FG007|Overall Study|Relapse|0|||
160997876|NCT00554801|581376668|FG000|Overall Study|left area before completion|5|||
160997877|NCT00554801|581376669|FG001|Overall Study|left area before completion|0|||
160922800|NCT02631850|581112006|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
160922801|NCT02631850|581112007|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
160922802|NCT02631850|581112008|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
160922803|NCT00326950|581112010|FG000|Overall Study|Progressive Disease|1|||
160922804|NCT01514760|581112011|FG000|Overall Study|Lost to Follow-up|2|||
160922805|NCT00619801|581112032|FG000|Overall Study|Lack of Efficacy|0|||
160922806|NCT00619801|581112033|FG001|Overall Study|Lack of Efficacy|1|||
160922807|NCT00619801|581112032|FG000|Overall Study|Withdrawal by Subject|1|||
160922808|NCT00619801|581112033|FG001|Overall Study|Withdrawal by Subject|1|||
160922809|NCT00619801|581112032|FG000|Overall Study|Loss of efficacy|0|||
160922810|NCT00619801|581112033|FG001|Overall Study|Loss of efficacy|1|||
160997878|NCT00554801|581376668|FG000|Overall Study|Withdrawal by Subject|14|||
160997879|NCT00554801|581376669|FG001|Overall Study|Withdrawal by Subject|0|||
160922811|NCT04340362|581112041|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
160922812|NCT02375113|581112045|FG000|Overall Study|Undisclosed Reason(s).|1|||
160922813|NCT02375113|581112046|FG001|Overall Study|Undisclosed Reason(s).|1|||
160922814|NCT02375113|581112045|FG000|Overall Study|Poor adherence (<70%).|1|||
160922815|NCT02375113|581112046|FG001|Overall Study|Poor adherence (<70%).|0|||
160922816|NCT02375113|581112045|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
160922817|NCT02375113|581112046|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
160922818|NCT01214629|581112047|FG000|Overall Study|Progressive Disease|1|||
160922819|NCT01214629|581112048|FG001|Overall Study|Progressive Disease|1|||
160922820|NCT01214629|581112049|FG002|Overall Study|Progressive Disease|0|||
160922821|NCT01214629|581112050|FG003|Overall Study|Progressive Disease|1|||
160922822|NCT01214629|581112051|FG004|Overall Study|Progressive Disease|2|||
160922823|NCT01214629|581112052|FG005|Overall Study|Progressive Disease|3|||
160922824|NCT01214629|581112053|FG006|Overall Study|Progressive Disease|1|||
160922825|NCT01214629|581112054|FG007|Overall Study|Progressive Disease|1|||
160922826|NCT01214629|581112055|FG008|Overall Study|Progressive Disease|1|||
160922827|NCT01214629|581112056|FG009|Overall Study|Progressive Disease|5|||
160922828|NCT01214629|581112057|FG010|Overall Study|Progressive Disease|1|||
160922829|NCT01214629|581112047|FG000|Overall Study|Adverse Event|0|||
160922830|NCT01214629|581112048|FG001|Overall Study|Adverse Event|0|||
160922831|NCT01214629|581112049|FG002|Overall Study|Adverse Event|0|||
160922832|NCT01214629|581112050|FG003|Overall Study|Adverse Event|1|||
160922833|NCT01214629|581112051|FG004|Overall Study|Adverse Event|0|||
160922834|NCT01214629|581112052|FG005|Overall Study|Adverse Event|1|||
160922835|NCT01214629|581112053|FG006|Overall Study|Adverse Event|0|||
160922836|NCT01214629|581112054|FG007|Overall Study|Adverse Event|0|||
160922837|NCT01214629|581112055|FG008|Overall Study|Adverse Event|0|||
160922838|NCT01214629|581112056|FG009|Overall Study|Adverse Event|1|||
160922839|NCT01214629|581112057|FG010|Overall Study|Adverse Event|0|||
160922840|NCT01214629|581112047|FG000|Overall Study|Physician Decision|0|||
160922841|NCT01214629|581112048|FG001|Overall Study|Physician Decision|0|||
160922842|NCT01214629|581112049|FG002|Overall Study|Physician Decision|0|||
160922843|NCT01214629|581112050|FG003|Overall Study|Physician Decision|0|||
160922844|NCT01214629|581112051|FG004|Overall Study|Physician Decision|0|||
160922845|NCT01214629|581112052|FG005|Overall Study|Physician Decision|0|||
160922846|NCT01214629|581112053|FG006|Overall Study|Physician Decision|0|||
160922847|NCT01214629|581112054|FG007|Overall Study|Physician Decision|0|||
160922848|NCT01214629|581112055|FG008|Overall Study|Physician Decision|0|||
160922849|NCT01214629|581112056|FG009|Overall Study|Physician Decision|0|||
160922850|NCT01214629|581112057|FG010|Overall Study|Physician Decision|1|||
160922851|NCT01214629|581112047|FG000|Overall Study|Withdrawal by Subject|0|||
160922852|NCT01214629|581112048|FG001|Overall Study|Withdrawal by Subject|0|||
160922853|NCT01214629|581112049|FG002|Overall Study|Withdrawal by Subject|0|||
160922854|NCT01214629|581112050|FG003|Overall Study|Withdrawal by Subject|0|||
160922855|NCT01214629|581112051|FG004|Overall Study|Withdrawal by Subject|0|||
160922856|NCT01214629|581112052|FG005|Overall Study|Withdrawal by Subject|0|||
160922857|NCT01214629|581112053|FG006|Overall Study|Withdrawal by Subject|0|||
160922858|NCT01214629|581112054|FG007|Overall Study|Withdrawal by Subject|0|||
160922859|NCT01214629|581112055|FG008|Overall Study|Withdrawal by Subject|0|||
160922860|NCT01214629|581112056|FG009|Overall Study|Withdrawal by Subject|1|||
160922861|NCT01214629|581112057|FG010|Overall Study|Withdrawal by Subject|0|||
160922862|NCT04387435|581112059|FG000|Overall Study|Physician Decision|1|||
160922863|NCT03338855|581112062|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
160922864|NCT03338855|581112063|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
160922865|NCT00975481|581112071|FG000|Second Intervention Period|Adverse Event|2|||
160922866|NCT00975481|581112072|FG001|Second Intervention Period|Adverse Event|1|||
160922867|NCT00975481|581112073|FG002|Second Intervention Period|Adverse Event|0|||
160922868|NCT00975481|581112074|FG003|Second Intervention Period|Adverse Event|0|||
160922869|NCT00975481|581112075|FG004|Second Intervention Period|Adverse Event|0|||
160922870|NCT00975481|581112076|FG005|Second Intervention Period|Adverse Event|0|||
160922871|NCT00975481|581112071|FG000|Second Intervention Period|Withdrawal by Subject|0|||
160922872|NCT00975481|581112072|FG001|Second Intervention Period|Withdrawal by Subject|0|||
160922873|NCT00975481|581112073|FG002|Second Intervention Period|Withdrawal by Subject|1|||
160922874|NCT00975481|581112074|FG003|Second Intervention Period|Withdrawal by Subject|0|||
160922875|NCT00975481|581112075|FG004|Second Intervention Period|Withdrawal by Subject|0|||
161143413|NCT02111369|581907594|FG000|Overall Study|Withdrawal by Subject|1|||
160922876|NCT00975481|581112076|FG005|Second Intervention Period|Withdrawal by Subject|0|||
160922877|NCT00975481|581112071|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
160922878|NCT00975481|581112072|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
160922879|NCT00975481|581112073|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
160922880|NCT00975481|581112074|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
160922881|NCT00975481|581112075|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
161143414|NCT00144300|581907597|FG000|Overall Study|Adverse Event|18|||
160922882|NCT00975481|581112076|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
160922883|NCT00975481|581112071|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
160922884|NCT00975481|581112072|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
160922885|NCT00975481|581112073|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
160922886|NCT00975481|581112074|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
160922887|NCT00975481|581112075|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
160922888|NCT00975481|581112076|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
160922889|NCT02738450|581112079|FG000|Overall Study|Withdrawal by Subject|0|||
160922890|NCT02738450|581112080|FG001|Overall Study|Withdrawal by Subject|2|||
160922891|NCT02738450|581112081|FG002|Overall Study|Withdrawal by Subject|0|||
160922892|NCT03559257|581112082|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
160922893|NCT03559257|581112083|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
160922894|NCT03559257|581112082|FG000|Double Blind Treatment Period|Protocol Violation|1|||
160922895|NCT03559257|581112083|FG001|Double Blind Treatment Period|Protocol Violation|4|||
160922896|NCT03559257|581112082|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
160922897|NCT03559257|581112083|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
160922898|NCT03559257|581112082|FG000|Double Blind Treatment Period|Adverse Event|0|||
160922899|NCT03559257|581112083|FG001|Double Blind Treatment Period|Adverse Event|1|||
160922900|NCT03559257|581112082|FG000|Double Blind Treatment Period|Screen Failure|0|||
160922901|NCT03559257|581112083|FG001|Double Blind Treatment Period|Screen Failure|1|||
160922902|NCT03559257|581112082|FG000|Open-label Treatment Period|Adverse Event|1|||
160922903|NCT03559257|581112083|FG001|Open-label Treatment Period|Adverse Event|4|||
160922904|NCT03559257|581112082|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
160922905|NCT03559257|581112083|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
160922906|NCT03559257|581112082|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
160922907|NCT03559257|581112083|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
160922908|NCT03559257|581112082|FG000|Open-label Treatment Period|Protocol Violation|2|||
160922909|NCT03559257|581112083|FG001|Open-label Treatment Period|Protocol Violation|0|||
160922910|NCT03559257|581112082|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
160922911|NCT03559257|581112083|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
160922912|NCT03559257|581112082|FG000|Open-label Treatment Period|Physician Decision|0|||
160922913|NCT03559257|581112083|FG001|Open-label Treatment Period|Physician Decision|1|||
160922914|NCT03630120|581112084|FG000|Overall Study|Disease progression|0|||
160922915|NCT03630120|581112085|FG001|Overall Study|Disease progression|1|||
160922916|NCT03630120|581112086|FG002|Overall Study|Disease progression|1|||
160922917|NCT03630120|581112087|FG003|Overall Study|Disease progression|1|||
160922918|NCT01519960|581112088|FG000|Overall Study|Withdrawal from the study|26|||
160922919|NCT01519960|581112089|FG001|Overall Study|Withdrawal from the study|22|||
160922920|NCT01519960|581112090|FG002|Overall Study|Withdrawal from the study|5|||
160922921|NCT03204305|581112099|FG000|Overall Study|Lost to Follow-up|6|||
160922922|NCT03204305|581112100|FG001|Overall Study|Lost to Follow-up|4|||
160922923|NCT03204305|581112101|FG002|Overall Study|Lost to Follow-up|0|||
160922924|NCT03204305|581112102|FG003|Overall Study|Lost to Follow-up|0|||
160922925|NCT03204305|581112099|FG000|Overall Study|Physician Decision|1|||
160922926|NCT03204305|581112100|FG001|Overall Study|Physician Decision|0|||
160922927|NCT03204305|581112101|FG002|Overall Study|Physician Decision|0|||
160922928|NCT03204305|581112102|FG003|Overall Study|Physician Decision|0|||
160922929|NCT03204305|581112099|FG000|Overall Study|failure to place arterial line|2|||
160922930|NCT03204305|581112100|FG001|Overall Study|failure to place arterial line|1|||
160922931|NCT03204305|581112101|FG002|Overall Study|failure to place arterial line|0|||
160922932|NCT03204305|581112102|FG003|Overall Study|failure to place arterial line|0|||
160922933|NCT03204305|581112099|FG000|Overall Study|Withdrawal by Subject|2|||
160922934|NCT03204305|581112100|FG001|Overall Study|Withdrawal by Subject|0|||
160922935|NCT03204305|581112101|FG002|Overall Study|Withdrawal by Subject|0|||
160922936|NCT03204305|581112102|FG003|Overall Study|Withdrawal by Subject|0|||
160922937|NCT00535223|581112109|FG000|Overall Study|Withdrawal by Subject|4|||
160922938|NCT00535223|581112110|FG001|Overall Study|Withdrawal by Subject|1|||
160922939|NCT00238121|581112116|FG000|Overall Study|Withdrawal by Subject|1|||
160922940|NCT00238121|581112117|FG001|Overall Study|Withdrawal by Subject|1|||
160922941|NCT00238121|581112116|FG000|Overall Study|Adverse Event|2|||
160922942|NCT00238121|581112117|FG001|Overall Study|Adverse Event|1|||
160922943|NCT03255382|581112118|FG000|Overall Study|Adverse Event|3|||
160922944|NCT03255382|581112119|FG001|Overall Study|Adverse Event|0|||
160922945|NCT03255382|581112118|FG000|Overall Study|Lost to Follow-up|2|||
160922946|NCT03255382|581112119|FG001|Overall Study|Lost to Follow-up|0|||
160922947|NCT03255382|581112118|FG000|Overall Study|Withdrawal by Subject|2|||
160922948|NCT03255382|581112119|FG001|Overall Study|Withdrawal by Subject|0|||
160922949|NCT03255382|581112118|FG000|Overall Study|Other|6|||
160922950|NCT03255382|581112119|FG001|Overall Study|Other|0|||
160922951|NCT01166178|581112120|FG000|Overall Study|Withdrawal by Subject|1|||
160922952|NCT01166178|581112121|FG001|Overall Study|Withdrawal by Subject|0|||
160922953|NCT01166178|581112120|FG000|Overall Study|Study was terminated|20|||
160922954|NCT01166178|581112121|FG001|Overall Study|Study was terminated|8|||
160922955|NCT04948450|581112122|FG000|Overall Study|Return home|1|||
160922956|NCT04948450|581112123|FG001|Overall Study|Return home|3|||
160922957|NCT00101907|581112126|FG000|Overall Study|Adverse Event|1|||
160922958|NCT00101907|581112127|FG001|Overall Study|Adverse Event|0|||
160922959|NCT00101907|581112128|FG002|Overall Study|Adverse Event|0|||
161262063|NCT01939496|582339463|FG001|Overall Study|Physician Decision|0|||
160922960|NCT00101907|581112129|FG003|Overall Study|Adverse Event|0|||
160922961|NCT00101907|581112130|FG004|Overall Study|Adverse Event|0|||
160922962|NCT00101907|581112131|FG005|Overall Study|Adverse Event|0|||
160922963|NCT00101907|581112126|FG000|Overall Study|Death|0|||
160922964|NCT00101907|581112127|FG001|Overall Study|Death|1|||
160922965|NCT00101907|581112128|FG002|Overall Study|Death|0|||
160922966|NCT00101907|581112129|FG003|Overall Study|Death|0|||
160922967|NCT00101907|581112130|FG004|Overall Study|Death|3|||
160922968|NCT00101907|581112131|FG005|Overall Study|Death|0|||
161262064|NCT01939496|582339464|FG002|Overall Study|Physician Decision|0|||
161262065|NCT01939496|582339462|FG000|Overall Study|Protocol Violation|3|||
161262066|NCT01939496|582339463|FG001|Overall Study|Protocol Violation|0|||
161262067|NCT01939496|582339464|FG002|Overall Study|Protocol Violation|0|||
161262068|NCT01939496|582339462|FG000|Overall Study|Withdrawal by Subject|0|||
161262069|NCT01939496|582339463|FG001|Overall Study|Withdrawal by Subject|1|||
161262070|NCT01939496|582339464|FG002|Overall Study|Withdrawal by Subject|1|||
161262071|NCT01939496|582339462|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
161262072|NCT01939496|582339463|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
160922969|NCT00101907|581112126|FG000|Overall Study|Physician Decision|0|||
160922970|NCT00101907|581112127|FG001|Overall Study|Physician Decision|0|||
160922971|NCT00101907|581112128|FG002|Overall Study|Physician Decision|0|||
160922972|NCT00101907|581112129|FG003|Overall Study|Physician Decision|1|||
160922973|NCT00101907|581112130|FG004|Overall Study|Physician Decision|1|||
160922974|NCT00101907|581112131|FG005|Overall Study|Physician Decision|0|||
160922975|NCT00101907|581112126|FG000|Overall Study|Withdrawal by Subject|1|||
160922976|NCT00101907|581112127|FG001|Overall Study|Withdrawal by Subject|0|||
160922977|NCT00101907|581112128|FG002|Overall Study|Withdrawal by Subject|1|||
160922978|NCT00101907|581112129|FG003|Overall Study|Withdrawal by Subject|0|||
160922979|NCT00101907|581112130|FG004|Overall Study|Withdrawal by Subject|1|||
160922980|NCT00101907|581112131|FG005|Overall Study|Withdrawal by Subject|0|||
160922981|NCT00624052|581112132|FG000|Overall Study|Adverse Event|7|||
160922982|NCT00624052|581112133|FG001|Overall Study|Adverse Event|6|||
160922983|NCT00624052|581112134|FG002|Overall Study|Adverse Event|0|||
160922984|NCT00624052|581112135|FG003|Overall Study|Adverse Event|3|||
160922985|NCT00624052|581112132|FG000|Overall Study|Lack of Efficacy|1|||
160922986|NCT00624052|581112133|FG001|Overall Study|Lack of Efficacy|1|||
160922987|NCT00624052|581112134|FG002|Overall Study|Lack of Efficacy|0|||
160922988|NCT00624052|581112135|FG003|Overall Study|Lack of Efficacy|0|||
160922989|NCT00624052|581112132|FG000|Overall Study|Lost to Follow-up|2|||
160922990|NCT00624052|581112133|FG001|Overall Study|Lost to Follow-up|3|||
160922991|NCT00624052|581112134|FG002|Overall Study|Lost to Follow-up|1|||
160922992|NCT00624052|581112135|FG003|Overall Study|Lost to Follow-up|0|||
160922993|NCT00624052|581112132|FG000|Overall Study|Non compliant with the protocol|2|||
160922994|NCT00624052|581112133|FG001|Overall Study|Non compliant with the protocol|1|||
160922995|NCT00624052|581112134|FG002|Overall Study|Non compliant with the protocol|1|||
160922996|NCT00624052|581112135|FG003|Overall Study|Non compliant with the protocol|1|||
160922997|NCT00624052|581112132|FG000|Overall Study|Consent withdrawn|3|||
160922998|NCT00624052|581112133|FG001|Overall Study|Consent withdrawn|1|||
160922999|NCT00624052|581112134|FG002|Overall Study|Consent withdrawn|1|||
160923000|NCT00624052|581112135|FG003|Overall Study|Consent withdrawn|0|||
160923001|NCT00624052|581112132|FG000|Overall Study|Changed job/ran out if meds|0|||
160923002|NCT00624052|581112133|FG001|Overall Study|Changed job/ran out if meds|2|||
160923003|NCT00624052|581112134|FG002|Overall Study|Changed job/ran out if meds|0|||
160923004|NCT00624052|581112135|FG003|Overall Study|Changed job/ran out if meds|0|||
160923005|NCT01474876|581112141|FG000|Overall Study|Adverse Event|11|||
160923006|NCT01474876|581112142|FG001|Overall Study|Adverse Event|5|||
160923007|NCT01474876|581112143|FG002|Overall Study|Adverse Event|0|||
160923008|NCT01474876|581112141|FG000|Overall Study|Serious Adverse Event|2|||
161262073|NCT01939496|582339464|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
161262074|NCT01939496|582339462|FG000|Overall Study|Other|2|||
161262075|NCT01939496|582339463|FG001|Overall Study|Other|0|||
161262076|NCT01939496|582339464|FG002|Overall Study|Other|1|||
161262077|NCT00506129|582339467|FG000|Overall Study|Disease Progression/Relapse|15|||
161262078|NCT00506129|582339467|FG000|Overall Study|Death|7|||
160923009|NCT01474876|581112142|FG001|Overall Study|Serious Adverse Event|3|||
160923010|NCT01474876|581112143|FG002|Overall Study|Serious Adverse Event|0|||
160923011|NCT01474876|581112141|FG000|Overall Study|Lost to Follow-up|5|||
160923012|NCT01474876|581112142|FG001|Overall Study|Lost to Follow-up|4|||
160923013|NCT01474876|581112143|FG002|Overall Study|Lost to Follow-up|0|||
161262079|NCT01642914|582339468|FG000|Overall Study|Adverse Event|11|||
161262080|NCT01642914|582339469|FG001|Overall Study|Adverse Event|7|||
161262081|NCT01642914|582339470|FG002|Overall Study|Adverse Event|15|||
160923014|NCT01474876|581112141|FG000|Overall Study|Investigator's decision|28|||
160923015|NCT01474876|581112142|FG001|Overall Study|Investigator's decision|6|||
160923016|NCT01474876|581112143|FG002|Overall Study|Investigator's decision|0|||
160923017|NCT01474876|581112141|FG000|Overall Study|Patient's request|19|||
160923018|NCT01474876|581112142|FG001|Overall Study|Patient's request|5|||
160923019|NCT01474876|581112143|FG002|Overall Study|Patient's request|0|||
160923020|NCT01474876|581112141|FG000|Overall Study|Investigator's decision and pt request|1|||
160923021|NCT01474876|581112142|FG001|Overall Study|Investigator's decision and pt request|0|||
160923022|NCT01474876|581112143|FG002|Overall Study|Investigator's decision and pt request|0|||
160923023|NCT02291055|581112144|FG000|Overall Study|Death|2|||
160923024|NCT02291055|581112145|FG001|Overall Study|Death|2|||
160923025|NCT02291055|581112146|FG002|Overall Study|Death|5|||
160923026|NCT02291055|581112147|FG003|Overall Study|Death|8|||
160923027|NCT02291055|581112148|FG004|Overall Study|Death|12|||
160923028|NCT02291055|581112144|FG000|Overall Study|Lost to Follow-up|0|||
160923029|NCT02291055|581112145|FG001|Overall Study|Lost to Follow-up|0|||
160923030|NCT02291055|581112146|FG002|Overall Study|Lost to Follow-up|0|||
160923031|NCT02291055|581112147|FG003|Overall Study|Lost to Follow-up|1|||
160923032|NCT02291055|581112148|FG004|Overall Study|Lost to Follow-up|2|||
160923033|NCT02291055|581112144|FG000|Overall Study|Withdrawal by Subject|3|||
160923034|NCT02291055|581112145|FG001|Overall Study|Withdrawal by Subject|1|||
160923035|NCT02291055|581112146|FG002|Overall Study|Withdrawal by Subject|1|||
160923036|NCT02291055|581112147|FG003|Overall Study|Withdrawal by Subject|5|||
160923037|NCT02291055|581112148|FG004|Overall Study|Withdrawal by Subject|10|||
160923038|NCT02291055|581112144|FG000|Overall Study|Progressive Disease|0|||
160923039|NCT02291055|581112145|FG001|Overall Study|Progressive Disease|0|||
160923040|NCT02291055|581112146|FG002|Overall Study|Progressive Disease|1|||
160923041|NCT02291055|581112147|FG003|Overall Study|Progressive Disease|4|||
160923042|NCT02291055|581112148|FG004|Overall Study|Progressive Disease|2|||
160923043|NCT02291055|581112144|FG000|Overall Study|Study Terminated by Sponsor|0|||
160923044|NCT02291055|581112145|FG001|Overall Study|Study Terminated by Sponsor|0|||
160923045|NCT02291055|581112146|FG002|Overall Study|Study Terminated by Sponsor|0|||
161262082|NCT01642914|582339468|FG000|Overall Study|Lack of Efficacy|9|||
161262083|NCT01642914|582339469|FG001|Overall Study|Lack of Efficacy|4|||
161262084|NCT01642914|582339470|FG002|Overall Study|Lack of Efficacy|2|||
160923046|NCT02291055|581112147|FG003|Overall Study|Study Terminated by Sponsor|5|||
160923047|NCT02291055|581112148|FG004|Overall Study|Study Terminated by Sponsor|1|||
160923048|NCT02291055|581112144|FG000|Overall Study|Other|0|||
160923049|NCT02291055|581112145|FG001|Overall Study|Other|2|||
160923050|NCT02291055|581112146|FG002|Overall Study|Other|1|||
160923051|NCT02291055|581112147|FG003|Overall Study|Other|4|||
160923052|NCT02291055|581112148|FG004|Overall Study|Other|0|||
160923053|NCT01523886|581112152|FG000|Overall Study|surgery cancelled|0|||
160923054|NCT01523886|581112153|FG001|Overall Study|surgery cancelled|1|||
160923055|NCT03839212|581112157|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
160923056|NCT00679263|581112158|FG000|Visit 2/Dose 1|Adverse Event|1|||
160923057|NCT00679263|581112159|FG001|Visit 2/Dose 1|Adverse Event|0|||
160923058|NCT00679263|581112160|FG002|Visit 2/Dose 1|Adverse Event|0|||
160923059|NCT00679263|581112158|FG000|Visit 2/Dose 1|subject not compliance|1|||
160923060|NCT00679263|581112159|FG001|Visit 2/Dose 1|subject not compliance|1|||
160923061|NCT00679263|581112160|FG002|Visit 2/Dose 1|subject not compliance|0|||
160923062|NCT00733746|581112161|FG000|Overall Study|Ineligible|5|||
160923063|NCT01173718|581112164|FG000|Overall Study|Death|17|||
160923064|NCT01173718|581112164|FG000|Overall Study|Abandonment of study graft|27|||
160923065|NCT02113956|581112165|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
160923066|NCT02113956|581112166|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
160923067|NCT02113956|581112165|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
160923068|NCT02113956|581112166|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
160923069|NCT02113956|581112165|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
160923070|NCT02113956|581112166|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
160923071|NCT01499563|581112169|FG000|Overall Study|Withdrawal by Subject|10|||
160923072|NCT01499563|581112170|FG001|Overall Study|Withdrawal by Subject|11|||
160923073|NCT01499563|581112171|FG002|Overall Study|Withdrawal by Subject|7|||
160923074|NCT01499563|581112172|FG003|Overall Study|Withdrawal by Subject|8|||
160997880|NCT02104765|581376670|FG000|Overall Study|Lost to Follow-up|0|||
160997881|NCT02104765|581376671|FG001|Overall Study|Lost to Follow-up|0|||
161262085|NCT01642914|582339468|FG000|Overall Study|Protocol Violation|15|||
161262086|NCT01642914|582339469|FG001|Overall Study|Protocol Violation|13|||
161262087|NCT01642914|582339470|FG002|Overall Study|Protocol Violation|6|||
161262088|NCT01642914|582339468|FG000|Overall Study|Withdrawal by Subject|5|||
161262089|NCT01642914|582339469|FG001|Overall Study|Withdrawal by Subject|5|||
160923075|NCT01499563|581112169|FG000|Overall Study|Physician Decision|2|||
160997882|NCT02104765|581376672|FG002|Overall Study|Lost to Follow-up|1|||
160923076|NCT01499563|581112170|FG001|Overall Study|Physician Decision|1|||
160923077|NCT01499563|581112171|FG002|Overall Study|Physician Decision|3|||
160923078|NCT01499563|581112172|FG003|Overall Study|Physician Decision|0|||
160923079|NCT01499563|581112169|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
160997883|NCT02104765|581376673|FG003|Overall Study|Lost to Follow-up|0|||
161143415|NCT00144300|581907598|FG001|Overall Study|Adverse Event|16|||
161262090|NCT01642914|582339470|FG002|Overall Study|Withdrawal by Subject|10|||
161262091|NCT01642914|582339468|FG000|Overall Study|Lost to Follow-up|5|||
160923080|NCT01499563|581112170|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
160997884|NCT02104765|581376674|FG004|Overall Study|Lost to Follow-up|0|||
160923081|NCT01499563|581112171|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
160923082|NCT01499563|581112172|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
160923083|NCT01499563|581112169|FG000|Overall Study|Adverse Event|2|||
160923084|NCT01499563|581112170|FG001|Overall Study|Adverse Event|0|||
160923085|NCT01499563|581112171|FG002|Overall Study|Adverse Event|1|||
160923086|NCT01499563|581112172|FG003|Overall Study|Adverse Event|3|||
160923087|NCT01499563|581112169|FG000|Overall Study|Lack of Efficacy|0|||
160923088|NCT01499563|581112170|FG001|Overall Study|Lack of Efficacy|1|||
160923089|NCT01499563|581112171|FG002|Overall Study|Lack of Efficacy|6|||
160923090|NCT01499563|581112172|FG003|Overall Study|Lack of Efficacy|3|||
160923091|NCT01499563|581112169|FG000|Overall Study|Other|8|||
160923092|NCT01499563|581112170|FG001|Overall Study|Other|6|||
160923093|NCT01499563|581112171|FG002|Overall Study|Other|6|||
160923094|NCT01499563|581112172|FG003|Overall Study|Other|4|||
160923095|NCT03658538|581112173|FG000|Overall Study|Death|2|||
160923096|NCT03658538|581112174|FG001|Overall Study|Death|1|||
160923097|NCT03658538|581112173|FG000|Overall Study|Cancer diagnosis|1|||
160923098|NCT03658538|581112174|FG001|Overall Study|Cancer diagnosis|0|||
160923099|NCT03658538|581112173|FG000|Overall Study|Change residence|1|||
160923100|NCT03658538|581112174|FG001|Overall Study|Change residence|2|||
160923101|NCT03658538|581112173|FG000|Overall Study|Lost to Follow-up|3|||
160923102|NCT03658538|581112174|FG001|Overall Study|Lost to Follow-up|3|||
160923103|NCT03658538|581112173|FG000|Overall Study|Unblinded|2|||
160923104|NCT03658538|581112174|FG001|Overall Study|Unblinded|3|||
160923105|NCT03658538|581112173|FG000|Overall Study|Physician Decision|0|||
160923106|NCT03658538|581112174|FG001|Overall Study|Physician Decision|1|||
160923107|NCT03658538|581112173|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
160923108|NCT03658538|581112174|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
160923109|NCT03658538|581112173|FG000|Overall Study|Evicted from home|1|||
160923110|NCT03658538|581112174|FG001|Overall Study|Evicted from home|0|||
160923111|NCT02738151|581112176|FG000|Overall Study|Randomized but not treated|4|||
160923112|NCT02738151|581112177|FG001|Overall Study|Randomized but not treated|1|||
160923113|NCT02738151|581112176|FG000|Overall Study|Adverse Event|4|||
160923114|NCT02738151|581112177|FG001|Overall Study|Adverse Event|5|||
160923115|NCT02738151|581112176|FG000|Overall Study|Hypoglycemia|0|||
160923116|NCT02738151|581112177|FG001|Overall Study|Hypoglycemia|1|||
160923117|NCT02738151|581112176|FG000|Overall Study|Poor Compliance to Protocol|4|||
160923118|NCT02738151|581112177|FG001|Overall Study|Poor Compliance to Protocol|3|||
160923119|NCT02738151|581112176|FG000|Overall Study|Other than specified above|11|||
160923120|NCT02738151|581112177|FG001|Overall Study|Other than specified above|21|||
160923121|NCT03333044|581112181|FG000|Overall Study|Pregnancy|1|||
160923122|NCT03333044|581112182|FG001|Overall Study|Pregnancy|0|||
160923123|NCT03333044|581112183|FG002|Overall Study|Pregnancy|0|||
160923124|NCT03333044|581112181|FG000|Overall Study|Lost to Follow-up|0|||
160923125|NCT03333044|581112182|FG001|Overall Study|Lost to Follow-up|14|||
160923126|NCT03333044|581112183|FG002|Overall Study|Lost to Follow-up|6|||
160923127|NCT04537234|581112187|FG000|Overall Study|Withdrawal by Subject|2|||
160923128|NCT04537234|581112188|FG001|Overall Study|Withdrawal by Subject|0|||
160923129|NCT04318080|581115329|FG000|Overall Study|Study closed by sponsor|10|||
160923130|NCT04318080|581115330|FG001|Overall Study|Study closed by sponsor|22|||
160923131|NCT04318080|581115329|FG000|Overall Study|Death|3|||
160923132|NCT04318080|581115330|FG001|Overall Study|Death|9|||
160923133|NCT04318080|581115329|FG000|Overall Study|Withdrawal by Subject|1|||
160923134|NCT04318080|581115330|FG001|Overall Study|Withdrawal by Subject|0|||
160923135|NCT04318080|581115329|FG000|Overall Study|Protocol Deviation|1|||
160923136|NCT04318080|581115330|FG001|Overall Study|Protocol Deviation|0|||
160923137|NCT06308822|581115331|FG000|Overall Study|Mutation Status Not Confirmed|17|||
160923138|NCT06308822|581115331|FG000|Overall Study|Adverse Event|1|||
160923139|NCT06308822|581115331|FG000|Overall Study|Death|5|||
160923140|NCT06308822|581115331|FG000|Overall Study|Disease progression|8|||
160923141|NCT06308822|581115331|FG000|Overall Study|Withdrawal by Subject|1|||
160923142|NCT06308822|581115331|FG000|Overall Study|Physician Decision|3|||
161262092|NCT01642914|582339469|FG001|Overall Study|Lost to Follow-up|3|||
160923143|NCT01536379|581115332|FG000|Overall Study|Adverse Event|1|||
160923144|NCT01536379|581115333|FG001|Overall Study|Adverse Event|2|||
160923145|NCT01536379|581115332|FG000|Overall Study|Withdrawal by Subject|1|||
160923146|NCT01536379|581115333|FG001|Overall Study|Withdrawal by Subject|1|||
160923147|NCT00939809|581115341|FG000|Overall Study|Adverse Event|2|||
160923148|NCT00939809|581115341|FG000|Overall Study|Death|1|||
160923149|NCT01921179|581115342|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
160923150|NCT01921179|581115343|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
160923151|NCT01921179|581115342|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
160923152|NCT01921179|581115343|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
160923153|NCT02603809|581115344|FG000|Overall Study|Withdrawal by Subject|4|||
160923154|NCT02603809|581115345|FG001|Overall Study|Withdrawal by Subject|1|||
160923155|NCT02603809|581115346|FG002|Overall Study|Withdrawal by Subject|2|||
161262093|NCT01642914|582339470|FG002|Overall Study|Lost to Follow-up|7|||
160923156|NCT02603809|581115347|FG003|Overall Study|Withdrawal by Subject|3|||
161262094|NCT01642914|582339468|FG000|Overall Study|Other Reason|1|||
161262095|NCT01642914|582339469|FG001|Overall Study|Other Reason|0|||
161262096|NCT01642914|582339470|FG002|Overall Study|Other Reason|0|||
161262097|NCT02923674|582339471|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
161262098|NCT02923674|582339472|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
161262099|NCT02923674|582339473|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
161262100|NCT02923674|582339471|FG000|Overall Study|Lost to Follow-up|7|||
161262101|NCT02923674|582339472|FG001|Overall Study|Lost to Follow-up|12|||
161262102|NCT02923674|582339473|FG002|Overall Study|Lost to Follow-up|7|||
161341287|NCT05493111|582637470|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
161341288|NCT05493111|582637471|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
161341289|NCT05493111|582637470|FG000|Overall Study|Withdrawal by Subject|1|||
161341290|NCT05493111|582637471|FG001|Overall Study|Withdrawal by Subject|1|||
161341291|NCT00375752|582637472|FG000|Overall Study|Lack of Efficacy|4|||
161341292|NCT00375752|582637473|FG001|Overall Study|Lack of Efficacy|4|||
161341293|NCT00375752|582637472|FG000|Overall Study|Adverse Event|1|||
161341294|NCT00375752|582637473|FG001|Overall Study|Adverse Event|6|||
161341295|NCT00375752|582637472|FG000|Overall Study|Withdrawal by Subject|6|||
161341296|NCT00375752|582637473|FG001|Overall Study|Withdrawal by Subject|1|||
161341297|NCT00375752|582637472|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161341298|NCT00375752|582637473|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
160923157|NCT02603809|581115348|FG004|Overall Study|Withdrawal by Subject|3|||
160923158|NCT02603809|581115349|FG005|Overall Study|Withdrawal by Subject|4|||
160923159|NCT02603809|581115344|FG000|Overall Study|Lost to Follow-up|2|||
160923160|NCT02603809|581115345|FG001|Overall Study|Lost to Follow-up|3|||
160923161|NCT02603809|581115346|FG002|Overall Study|Lost to Follow-up|1|||
160923162|NCT02603809|581115347|FG003|Overall Study|Lost to Follow-up|4|||
160923163|NCT02603809|581115348|FG004|Overall Study|Lost to Follow-up|2|||
160923164|NCT02603809|581115349|FG005|Overall Study|Lost to Follow-up|2|||
160923165|NCT02603809|581115344|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
160923166|NCT02603809|581115345|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
160923167|NCT02603809|581115346|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
160923168|NCT02603809|581115347|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
160923169|NCT02603809|581115348|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
160923170|NCT02603809|581115349|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
160923171|NCT02603809|581115344|FG000|Overall Study|Physician Decision|0|||
160923172|NCT02603809|581115345|FG001|Overall Study|Physician Decision|0|||
160923173|NCT02603809|581115346|FG002|Overall Study|Physician Decision|0|||
160923174|NCT02603809|581115347|FG003|Overall Study|Physician Decision|1|||
160923175|NCT02603809|581115348|FG004|Overall Study|Physician Decision|2|||
160923176|NCT02603809|581115349|FG005|Overall Study|Physician Decision|1|||
160923177|NCT02603809|581115344|FG000|Overall Study|Adverse Event|3|||
160923178|NCT02603809|581115345|FG001|Overall Study|Adverse Event|0|||
160923179|NCT02603809|581115346|FG002|Overall Study|Adverse Event|2|||
160923180|NCT02603809|581115347|FG003|Overall Study|Adverse Event|2|||
160923181|NCT02603809|581115348|FG004|Overall Study|Adverse Event|1|||
160923182|NCT02603809|581115349|FG005|Overall Study|Adverse Event|1|||
160923183|NCT02603809|581115344|FG000|Overall Study|Lack of Efficacy|0|||
160923184|NCT02603809|581115345|FG001|Overall Study|Lack of Efficacy|1|||
160923185|NCT02603809|581115346|FG002|Overall Study|Lack of Efficacy|0|||
160923186|NCT02603809|581115347|FG003|Overall Study|Lack of Efficacy|0|||
160923187|NCT02603809|581115348|FG004|Overall Study|Lack of Efficacy|0|||
160923188|NCT02603809|581115349|FG005|Overall Study|Lack of Efficacy|1|||
160923189|NCT00380978|581115350|FG000|Overall Study|Refused allocated intervention|0|||
160923190|NCT00380978|581115351|FG001|Overall Study|Refused allocated intervention|6|||
160923191|NCT00380978|581115350|FG000|Overall Study|Wrong study envelope|0|||
160923192|NCT00380978|581115351|FG001|Overall Study|Wrong study envelope|2|||
160923193|NCT00380978|581115350|FG000|Overall Study|Allocation prior to analgesia request|1|||
160923194|NCT00380978|581115351|FG001|Overall Study|Allocation prior to analgesia request|2|||
160923195|NCT00380978|581115350|FG000|Overall Study|Parous patient|1|||
160923196|NCT00380978|581115351|FG001|Overall Study|Parous patient|0|||
160923197|NCT04146545|581115352|FG000|Overall Study|deemed ineligible after randomization|1|||
160923198|NCT04146545|581115353|FG001|Overall Study|deemed ineligible after randomization|0|||
160923199|NCT02750592|581115354|FG000|Overall Study|Adverse Event|3|||
161262103|NCT02923674|582339471|FG000|Overall Study|Problem with intervention|2|||
161262104|NCT02923674|582339472|FG001|Overall Study|Problem with intervention|2|||
160923200|NCT02750592|581115354|FG000|Overall Study|Lack of Efficacy|2|||
160923201|NCT02981342|581115355|FG000|Overall Study|Adverse Event|0|||
160923202|NCT02981342|581115356|FG001|Overall Study|Adverse Event|0|||
160923203|NCT02981342|581115357|FG002|Overall Study|Adverse Event|0|||
160923204|NCT02981342|581115358|FG003|Overall Study|Adverse Event|1|||
160923205|NCT02981342|581115355|FG000|Overall Study|Death|0|||
161341299|NCT00375752|582637472|FG000|Overall Study|Protocol Violation|0|||
160923206|NCT02981342|581115356|FG001|Overall Study|Death|9|||
161262105|NCT02923674|582339473|FG002|Overall Study|Problem with intervention|1|||
161341300|NCT00375752|582637473|FG001|Overall Study|Protocol Violation|2|||
161341301|NCT00375752|582637472|FG000|Overall Study|Administrative Problems|0|||
160923207|NCT02981342|581115357|FG002|Overall Study|Death|9|||
160923208|NCT02981342|581115358|FG003|Overall Study|Death|4|||
160923209|NCT02981342|581115355|FG000|Overall Study|Withdrawal by Subject|0|||
160923210|NCT02981342|581115356|FG001|Overall Study|Withdrawal by Subject|0|||
160923211|NCT02981342|581115357|FG002|Overall Study|Withdrawal by Subject|3|||
160923212|NCT02981342|581115358|FG003|Overall Study|Withdrawal by Subject|1|||
160923213|NCT02981342|581115355|FG000|Overall Study|Study closed by sponsor|0|||
160923214|NCT02981342|581115356|FG001|Overall Study|Study closed by sponsor|0|||
160923215|NCT02981342|581115357|FG002|Overall Study|Study closed by sponsor|1|||
160923216|NCT02981342|581115358|FG003|Overall Study|Study closed by sponsor|1|||
160923217|NCT02981342|581115355|FG000|Overall Study|Randomized, Never Treated|0|||
160923218|NCT02981342|581115356|FG001|Overall Study|Randomized, Never Treated|1|||
160923219|NCT02981342|581115357|FG002|Overall Study|Randomized, Never Treated|0|||
160923220|NCT02981342|581115358|FG003|Overall Study|Randomized, Never Treated|7|||
160923221|NCT02981342|581115355|FG000|Overall Study|Lost to Follow-up|0|||
160923222|NCT02981342|581115356|FG001|Overall Study|Lost to Follow-up|1|||
160923223|NCT02981342|581115357|FG002|Overall Study|Lost to Follow-up|0|||
160923224|NCT02981342|581115358|FG003|Overall Study|Lost to Follow-up|0|||
161262106|NCT02923674|582339471|FG000|Overall Study|Adverse Event|3|||
161262107|NCT02923674|582339472|FG001|Overall Study|Adverse Event|1|||
161262108|NCT02923674|582339473|FG002|Overall Study|Adverse Event|1|||
161262109|NCT02923674|582339471|FG000|Overall Study|Withdrawal by Subject|2|||
161262110|NCT02923674|582339472|FG001|Overall Study|Withdrawal by Subject|2|||
161262111|NCT02923674|582339473|FG002|Overall Study|Withdrawal by Subject|2|||
161262112|NCT02712333|582339477|FG000|First Period|Withdrawal by Subject|3|||
160923225|NCT01277523|581115361|FG000|Overall Study|Adverse Event|1|||
160923226|NCT01277523|581115362|FG001|Overall Study|Adverse Event|0|||
161262113|NCT02712333|582339478|FG001|First Period|Withdrawal by Subject|2|||
161262114|NCT03463993|582339479|FG000|Overall Study|Lost to Follow-up|7|||
161262115|NCT03463993|582339480|FG001|Overall Study|Lost to Follow-up|8|||
161262116|NCT03463993|582339479|FG000|Overall Study|Withdrawal by Subject|2|||
161262117|NCT03463993|582339480|FG001|Overall Study|Withdrawal by Subject|0|||
161262118|NCT03463993|582339479|FG000|Overall Study|Protocol Violation|4|||
161262119|NCT03463993|582339480|FG001|Overall Study|Protocol Violation|1|||
161262120|NCT03463993|582339479|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
161262121|NCT03463993|582339480|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
161262122|NCT03463993|582339479|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
161262123|NCT03463993|582339480|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
161262124|NCT01231373|582339485|FG000|Overall Study|Withdrew consent prior to randomization|2|||
161262125|NCT01231373|582339486|FG001|Overall Study|Withdrew consent prior to randomization|1|||
161262126|NCT01231373|582339487|FG002|Overall Study|Withdrew consent prior to randomization|0|||
161262127|NCT01231373|582339488|FG003|Overall Study|Withdrew consent prior to randomization|0|||
161262128|NCT01231373|582339485|FG000|Overall Study|Lost to Follow-up|0|||
161262129|NCT01231373|582339486|FG001|Overall Study|Lost to Follow-up|0|||
161262130|NCT01231373|582339487|FG002|Overall Study|Lost to Follow-up|0|||
161262131|NCT01231373|582339488|FG003|Overall Study|Lost to Follow-up|1|||
161262132|NCT01231373|582339485|FG000|Overall Study|Withdrew Consent|1|||
161262133|NCT01231373|582339486|FG001|Overall Study|Withdrew Consent|0|||
161262134|NCT01231373|582339487|FG002|Overall Study|Withdrew Consent|0|||
161262135|NCT01231373|582339488|FG003|Overall Study|Withdrew Consent|0|||
161262136|NCT01621191|582339493|FG000|Overall Study|Adverse Event|9|||
161262137|NCT01621191|582339493|FG000|Overall Study|Withdrawal by Subject|8|||
161262138|NCT01621191|582339493|FG000|Overall Study|Lack of Efficacy|6|||
161262139|NCT01621191|582339493|FG000|Overall Study|Lost to Follow-up|1|||
161262140|NCT01621191|582339493|FG000|Overall Study|Site Removed From Study|1|||
161262141|NCT04355663|582339495|FG000|Overall Study|Physician Decision|2|||
161262142|NCT04355663|582339496|FG001|Overall Study|Physician Decision|7|||
161262143|NCT04355663|582339497|FG002|Overall Study|Physician Decision|0|||
161262144|NCT04355663|582339495|FG000|Overall Study|Adverse Event|0|||
161262145|NCT04355663|582339496|FG001|Overall Study|Adverse Event|0|||
161262146|NCT04355663|582339497|FG002|Overall Study|Adverse Event|1|||
161262147|NCT04355663|582339495|FG000|Overall Study|Withdrawal by Subject|0|||
161262148|NCT04355663|582339496|FG001|Overall Study|Withdrawal by Subject|8|||
161262149|NCT04355663|582339497|FG002|Overall Study|Withdrawal by Subject|3|||
161262150|NCT02787408|582339503|FG000|Overall Study|Death|16|||
161262151|NCT02787408|582339503|FG000|Overall Study|Withdrawal by Subject|1|||
161262152|NCT02787408|582339503|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
161262153|NCT05444543|582339506|FG000|Overall Study|Withdrawal by Subject|1|||
161262154|NCT05444543|582339507|FG001|Overall Study|Withdrawal by Subject|0|||
161262155|NCT05444543|582339506|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
161341302|NCT00375752|582637473|FG001|Overall Study|Administrative Problems|1|||
160923227|NCT01277523|581115363|FG002|Overall Study|Adverse Event|0|||
160923228|NCT01277523|581115361|FG000|Overall Study|Protocol Violation|2|||
160923229|NCT01277523|581115362|FG001|Overall Study|Protocol Violation|0|||
160923230|NCT01277523|581115363|FG002|Overall Study|Protocol Violation|0|||
161341303|NCT01140906|582637478|FG000|Overall Study|Adverse Event|7|||
161341304|NCT01140906|582637479|FG001|Overall Study|Adverse Event|10|||
161341305|NCT01140906|582637480|FG002|Overall Study|Adverse Event|17|||
161341306|NCT01140906|582637481|FG003|Overall Study|Adverse Event|7|||
161341307|NCT01140906|582637478|FG000|Overall Study|Lack of Efficacy|6|||
161341308|NCT01140906|582637479|FG001|Overall Study|Lack of Efficacy|8|||
161341309|NCT01140906|582637480|FG002|Overall Study|Lack of Efficacy|2|||
161341310|NCT01140906|582637481|FG003|Overall Study|Lack of Efficacy|1|||
161341311|NCT01140906|582637478|FG000|Overall Study|Non-compliance|0|||
161341312|NCT01140906|582637479|FG001|Overall Study|Non-compliance|1|||
161341313|NCT01140906|582637480|FG002|Overall Study|Non-compliance|0|||
161341314|NCT01140906|582637481|FG003|Overall Study|Non-compliance|1|||
161341315|NCT01140906|582637478|FG000|Overall Study|Protocol Violation|5|||
161341316|NCT01140906|582637479|FG001|Overall Study|Protocol Violation|3|||
161341317|NCT01140906|582637480|FG002|Overall Study|Protocol Violation|2|||
161341318|NCT01140906|582637481|FG003|Overall Study|Protocol Violation|1|||
161341319|NCT01140906|582637478|FG000|Overall Study|Withdrawal of consent|6|||
161341320|NCT01140906|582637479|FG001|Overall Study|Withdrawal of consent|6|||
161341321|NCT01140906|582637480|FG002|Overall Study|Withdrawal of consent|2|||
161341322|NCT01140906|582637481|FG003|Overall Study|Withdrawal of consent|2|||
161341323|NCT01140906|582637478|FG000|Overall Study|Lost to Follow-up|1|||
161341324|NCT01140906|582637479|FG001|Overall Study|Lost to Follow-up|1|||
161341325|NCT01140906|582637480|FG002|Overall Study|Lost to Follow-up|0|||
161341326|NCT01140906|582637481|FG003|Overall Study|Lost to Follow-up|2|||
161341327|NCT01140906|582637478|FG000|Overall Study|Administrative or other reason|0|||
161341328|NCT01140906|582637479|FG001|Overall Study|Administrative or other reason|5|||
161341329|NCT01140906|582637480|FG002|Overall Study|Administrative or other reason|3|||
161341330|NCT01140906|582637481|FG003|Overall Study|Administrative or other reason|2|||
161341331|NCT01649765|582637482|FG000|Overall Study|Adverse Event|5|||
161341332|NCT01649765|582637483|FG001|Overall Study|Adverse Event|3|||
161341333|NCT01649765|582637482|FG000|Overall Study|Lack of Efficacy|1|||
161341334|NCT01649765|582637483|FG001|Overall Study|Lack of Efficacy|1|||
161341335|NCT01649765|582637482|FG000|Overall Study|Physician Decision|0|||
161341336|NCT01649765|582637483|FG001|Overall Study|Physician Decision|3|||
161341337|NCT01649765|582637482|FG000|Overall Study|Protocol Violation|1|||
161341338|NCT01649765|582637483|FG001|Overall Study|Protocol Violation|0|||
161341339|NCT01649765|582637482|FG000|Overall Study|Withdrawal by Subject|2|||
161341340|NCT01649765|582637483|FG001|Overall Study|Withdrawal by Subject|1|||
161341341|NCT02469233|582637484|FG000|Overall Study|Death|1|||
161341342|NCT02469233|582637485|FG001|Overall Study|Death|1|||
161341343|NCT02469233|582637484|FG000|Overall Study|Lost to post or 6 month follow up|7|||
161341344|NCT02469233|582637485|FG001|Overall Study|Lost to post or 6 month follow up|2|||
161341345|NCT01648764|582637486|FG000|Overall Study|Progressive Disease|0|||
161341346|NCT01648764|582637487|FG001|Overall Study|Progressive Disease|1|||
161341347|NCT01648764|582637488|FG002|Overall Study|Progressive Disease|0|||
161341348|NCT01648764|582637489|FG003|Overall Study|Progressive Disease|0|||
161341349|NCT01648764|582637490|FG004|Overall Study|Progressive Disease|0|||
161341350|NCT01648764|582637491|FG005|Overall Study|Progressive Disease|1|||
161341351|NCT01648764|582637492|FG006|Overall Study|Progressive Disease|1|||
161341352|NCT01648764|582637493|FG007|Overall Study|Progressive Disease|0|||
161341353|NCT01648764|582637494|FG008|Overall Study|Progressive Disease|0|||
161341354|NCT01648764|582637495|FG009|Overall Study|Progressive Disease|2|||
161341355|NCT01648764|582637496|FG010|Overall Study|Progressive Disease|0|||
161341356|NCT01648764|582637497|FG011|Overall Study|Progressive Disease|1|||
161341357|NCT01648764|582637498|FG012|Overall Study|Progressive Disease|2|||
161341358|NCT01648764|582637499|FG013|Overall Study|Progressive Disease|1|||
161341359|NCT01648764|582637486|FG000|Overall Study|Adverse Event|0|||
161341360|NCT01648764|582637487|FG001|Overall Study|Adverse Event|0|||
161341361|NCT01648764|582637488|FG002|Overall Study|Adverse Event|0|||
161341362|NCT01648764|582637489|FG003|Overall Study|Adverse Event|0|||
161341363|NCT01648764|582637490|FG004|Overall Study|Adverse Event|0|||
161341364|NCT01648764|582637491|FG005|Overall Study|Adverse Event|1|||
161341365|NCT01648764|582637492|FG006|Overall Study|Adverse Event|0|||
161341366|NCT01648764|582637493|FG007|Overall Study|Adverse Event|0|||
161341367|NCT01648764|582637494|FG008|Overall Study|Adverse Event|0|||
161341368|NCT01648764|582637495|FG009|Overall Study|Adverse Event|1|||
161341369|NCT01648764|582637496|FG010|Overall Study|Adverse Event|0|||
161341370|NCT01648764|582637497|FG011|Overall Study|Adverse Event|3|||
161341371|NCT01648764|582637498|FG012|Overall Study|Adverse Event|1|||
161341372|NCT01648764|582637499|FG013|Overall Study|Adverse Event|1|||
161341373|NCT01648764|582637486|FG000|Overall Study|Death|0|||
161341374|NCT01648764|582637487|FG001|Overall Study|Death|0|||
161341375|NCT01648764|582637488|FG002|Overall Study|Death|0|||
161341376|NCT01648764|582637489|FG003|Overall Study|Death|0|||
161341377|NCT01648764|582637490|FG004|Overall Study|Death|0|||
161341378|NCT01648764|582637491|FG005|Overall Study|Death|0|||
161341379|NCT01648764|582637492|FG006|Overall Study|Death|1|||
161341380|NCT01648764|582637493|FG007|Overall Study|Death|0|||
161341381|NCT01648764|582637494|FG008|Overall Study|Death|0|||
161341382|NCT01648764|582637495|FG009|Overall Study|Death|0|||
161341383|NCT01648764|582637496|FG010|Overall Study|Death|0|||
160923231|NCT01277523|581115361|FG000|Overall Study|Other Reason not Defined|0|||
160923232|NCT01277523|581115362|FG001|Overall Study|Other Reason not Defined|1|||
160923233|NCT01277523|581115363|FG002|Overall Study|Other Reason not Defined|0|||
160923234|NCT00112502|581115366|FG000|Overall Study|Withdrawal by Subject|0|||
160923235|NCT00112502|581115367|FG001|Overall Study|Withdrawal by Subject|1|||
160923236|NCT00112502|581115368|FG002|Overall Study|Withdrawal by Subject|1|||
161262156|NCT05444543|582339507|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
161262157|NCT05444543|582339506|FG000|Overall Study|Adverse Event|0|||
161262158|NCT05444543|582339507|FG001|Overall Study|Adverse Event|1|||
161262159|NCT05444543|582339506|FG000|Overall Study|Family relocating at a distance from study site|0|||
161262160|NCT05444543|582339507|FG001|Overall Study|Family relocating at a distance from study site|1|||
161262161|NCT02408120|582339510|FG000|Overall Study|Withdrawal by Subject|0|||
161262162|NCT02408120|582339511|FG001|Overall Study|Withdrawal by Subject|1|||
161262163|NCT02408120|582339510|FG000|Overall Study|Treatment Refusal|1|||
161262164|NCT02408120|582339511|FG001|Overall Study|Treatment Refusal|0|||
161262165|NCT02408120|582339510|FG000|Overall Study|Received Steroids|1|||
161262166|NCT02408120|582339511|FG001|Overall Study|Received Steroids|1|||
161262167|NCT02408120|582339510|FG000|Overall Study|Discharged same day|1|||
161262168|NCT02408120|582339511|FG001|Overall Study|Discharged same day|1|||
161262169|NCT02408120|582339510|FG000|Overall Study|Did not receive insulin|1|||
161262170|NCT02408120|582339511|FG001|Overall Study|Did not receive insulin|2|||
161262171|NCT00720226|582339512|FG000|Overall Study|Withdrawal by Subject|7|||
161262172|NCT00720226|582339513|FG001|Overall Study|Withdrawal by Subject|4|||
161262173|NCT00958126|582339514|FG000|Overall Study|Serious Adverse Event|0|||
161262174|NCT00958126|582339515|FG001|Overall Study|Serious Adverse Event|2|||
161262175|NCT00958126|582339516|FG002|Overall Study|Serious Adverse Event|0|||
161262176|NCT00958126|582339517|FG003|Overall Study|Serious Adverse Event|0|||
161262177|NCT00958126|582339518|FG004|Overall Study|Serious Adverse Event|0|||
161262178|NCT00958126|582339519|FG005|Overall Study|Serious Adverse Event|0|||
161262179|NCT00958126|582339520|FG006|Overall Study|Serious Adverse Event|1|||
161262180|NCT00958126|582339521|FG007|Overall Study|Serious Adverse Event|0|||
161262181|NCT00958126|582339514|FG000|Overall Study|Withdrawal by Subject|0|||
161262182|NCT00958126|582339515|FG001|Overall Study|Withdrawal by Subject|2|||
161262183|NCT00958126|582339516|FG002|Overall Study|Withdrawal by Subject|0|||
161262184|NCT00958126|582339517|FG003|Overall Study|Withdrawal by Subject|0|||
161262185|NCT00958126|582339518|FG004|Overall Study|Withdrawal by Subject|0|||
160997885|NCT02104765|581376675|FG005|Overall Study|Lost to Follow-up|0|||
160997886|NCT02104765|581376676|FG006|Overall Study|Lost to Follow-up|0|||
160997887|NCT02104765|581376670|FG000|Overall Study|Withdrawal by Subject|0|||
160997888|NCT02104765|581376671|FG001|Overall Study|Withdrawal by Subject|0|||
160997889|NCT02104765|581376672|FG002|Overall Study|Withdrawal by Subject|0|||
160997890|NCT02104765|581376673|FG003|Overall Study|Withdrawal by Subject|1|||
160997891|NCT02104765|581376674|FG004|Overall Study|Withdrawal by Subject|1|||
160997892|NCT02104765|581376675|FG005|Overall Study|Withdrawal by Subject|0|||
160997893|NCT02104765|581376676|FG006|Overall Study|Withdrawal by Subject|1|||
160997894|NCT00604721|581376677|FG000|Overall Study|Physician Decision|1|||
160997895|NCT00604721|581376677|FG000|Overall Study|Withdrawal by Subject|1|||
160997896|NCT04776213|581376680|FG000|Overall Study|Other|1|||
160997897|NCT04776213|581376680|FG000|Overall Study|Withdrawal by Subject|7|||
160997898|NCT04776213|581376680|FG000|Overall Study|Protocol Violation|1|||
160997899|NCT04776213|581376680|FG000|Overall Study|Lost to Follow-up|2|||
160997900|NCT01838551|581376682|FG000|Overall Study|Adverse Event|16|||
160997901|NCT01838551|581376682|FG000|Overall Study|Death|1|||
160997902|NCT01838551|581376682|FG000|Overall Study|Lack of Efficacy|10|||
160997903|NCT01838551|581376682|FG000|Overall Study|Physician Decision|4|||
160997904|NCT01838551|581376682|FG000|Overall Study|Withdrawal by Subject|10|||
160997905|NCT01838551|581376682|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
160997906|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
160997907|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
160997908|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Progressive disease|6|||
160997909|NCT00906282|581376683|FG000|Preoperative Chemotherapy|Toxicity|1|||
160923237|NCT00112502|581115369|FG003|Overall Study|Withdrawal by Subject|4|||
160997910|NCT00038103|581376684|FG000|Overall Study|Adverse Event|5|||
160997911|NCT00038103|581376685|FG001|Overall Study|Adverse Event|6|||
161262186|NCT00958126|582339519|FG005|Overall Study|Withdrawal by Subject|0|||
161262187|NCT00958126|582339520|FG006|Overall Study|Withdrawal by Subject|0|||
161262188|NCT00958126|582339521|FG007|Overall Study|Withdrawal by Subject|0|||
161262189|NCT00958126|582339514|FG000|Overall Study|Moved away from study area|0|||
161262190|NCT00958126|582339515|FG001|Overall Study|Moved away from study area|0|||
161262191|NCT00958126|582339516|FG002|Overall Study|Moved away from study area|1|||
160923238|NCT00112502|581115370|FG004|Overall Study|Withdrawal by Subject|2|||
160923239|NCT00112502|581115371|FG005|Overall Study|Withdrawal by Subject|5|||
160997912|NCT00038103|581376684|FG000|Overall Study|Lack of Efficacy|48|||
160997913|NCT00038103|581376685|FG001|Overall Study|Lack of Efficacy|41|||
160997914|NCT00038103|581376684|FG000|Overall Study|Withdrawal by Subject|0|||
161262192|NCT00958126|582339517|FG003|Overall Study|Moved away from study area|1|||
161262193|NCT00958126|582339518|FG004|Overall Study|Moved away from study area|0|||
161262194|NCT00958126|582339519|FG005|Overall Study|Moved away from study area|0|||
161262195|NCT00958126|582339520|FG006|Overall Study|Moved away from study area|0|||
160923240|NCT00112502|581115372|FG006|Overall Study|Withdrawal by Subject|3|||
160923241|NCT00112502|581115373|FG007|Overall Study|Withdrawal by Subject|7|||
160923242|NCT02608268|581115374|FG000|Overall Study|Adverse Event|0|||
160923243|NCT02608268|581115375|FG001|Overall Study|Adverse Event|0|||
160923244|NCT02608268|581115376|FG002|Overall Study|Adverse Event|1|||
160923245|NCT02608268|581115377|FG003|Overall Study|Adverse Event|0|||
160923246|NCT02608268|581115378|FG004|Overall Study|Adverse Event|0|||
160923247|NCT02608268|581115379|FG005|Overall Study|Adverse Event|0|||
160923248|NCT02608268|581115380|FG006|Overall Study|Adverse Event|0|||
160923249|NCT02608268|581115381|FG007|Overall Study|Adverse Event|0|||
160923250|NCT02608268|581115382|FG008|Overall Study|Adverse Event|0|||
160923251|NCT02608268|581115383|FG009|Overall Study|Adverse Event|0|||
160923252|NCT02608268|581115384|FG010|Overall Study|Adverse Event|0|||
160923253|NCT02608268|581115385|FG011|Overall Study|Adverse Event|0|||
160923254|NCT02608268|581115386|FG012|Overall Study|Adverse Event|2|||
160923255|NCT02608268|581115387|FG013|Overall Study|Adverse Event|0|||
160923256|NCT02608268|581115388|FG014|Overall Study|Adverse Event|0|||
160923257|NCT02608268|581115389|FG015|Overall Study|Adverse Event|0|||
160923258|NCT02608268|581115390|FG016|Overall Study|Adverse Event|0|||
160923259|NCT02608268|581115391|FG017|Overall Study|Adverse Event|0|||
160923260|NCT02608268|581115392|FG018|Overall Study|Adverse Event|0|||
160923261|NCT02608268|581115393|FG019|Overall Study|Adverse Event|0|||
160923262|NCT02608268|581115394|FG020|Overall Study|Adverse Event|1|||
160923263|NCT02608268|581115395|FG021|Overall Study|Adverse Event|1|||
160923264|NCT02608268|581115396|FG022|Overall Study|Adverse Event|0|||
160923265|NCT02608268|581115397|FG023|Overall Study|Adverse Event|0|||
160923266|NCT02608268|581115398|FG024|Overall Study|Adverse Event|1|||
160923267|NCT02608268|581115399|FG025|Overall Study|Adverse Event|0|||
160923268|NCT02608268|581115400|FG026|Overall Study|Adverse Event|0|||
160923269|NCT02608268|581115401|FG027|Overall Study|Adverse Event|0|||
160923270|NCT02608268|581115402|FG028|Overall Study|Adverse Event|1|||
160923271|NCT02608268|581115403|FG029|Overall Study|Adverse Event|0|||
160923272|NCT02608268|581115374|FG000|Overall Study|Death|1|||
160923273|NCT02608268|581115375|FG001|Overall Study|Death|0|||
160923274|NCT02608268|581115376|FG002|Overall Study|Death|0|||
160923275|NCT02608268|581115377|FG003|Overall Study|Death|0|||
160923276|NCT02608268|581115378|FG004|Overall Study|Death|0|||
160923277|NCT02608268|581115379|FG005|Overall Study|Death|0|||
160923278|NCT02608268|581115380|FG006|Overall Study|Death|0|||
160923279|NCT02608268|581115381|FG007|Overall Study|Death|0|||
160923280|NCT02608268|581115382|FG008|Overall Study|Death|1|||
160923281|NCT02608268|581115383|FG009|Overall Study|Death|1|||
160923282|NCT02608268|581115384|FG010|Overall Study|Death|0|||
160923283|NCT02608268|581115385|FG011|Overall Study|Death|0|||
160923284|NCT02608268|581115386|FG012|Overall Study|Death|0|||
160923285|NCT02608268|581115387|FG013|Overall Study|Death|0|||
160923286|NCT02608268|581115388|FG014|Overall Study|Death|0|||
160923287|NCT02608268|581115389|FG015|Overall Study|Death|1|||
160923288|NCT02608268|581115390|FG016|Overall Study|Death|0|||
160923289|NCT02608268|581115391|FG017|Overall Study|Death|1|||
160923290|NCT02608268|581115392|FG018|Overall Study|Death|0|||
160923291|NCT02608268|581115393|FG019|Overall Study|Death|1|||
160923292|NCT02608268|581115394|FG020|Overall Study|Death|1|||
160923293|NCT02608268|581115395|FG021|Overall Study|Death|0|||
160923294|NCT02608268|581115396|FG022|Overall Study|Death|0|||
160923295|NCT02608268|581115397|FG023|Overall Study|Death|0|||
160923296|NCT02608268|581115398|FG024|Overall Study|Death|1|||
160997915|NCT00038103|581376685|FG001|Overall Study|Withdrawal by Subject|3|||
160997916|NCT00038103|581376684|FG000|Overall Study|Lost to Follow-up|0|||
160923297|NCT02608268|581115399|FG025|Overall Study|Death|2|||
160923298|NCT02608268|581115400|FG026|Overall Study|Death|0|||
160923299|NCT02608268|581115401|FG027|Overall Study|Death|1|||
161262196|NCT00958126|582339521|FG007|Overall Study|Moved away from study area|0|||
160923300|NCT02608268|581115402|FG028|Overall Study|Death|4|||
160997917|NCT00038103|581376685|FG001|Overall Study|Lost to Follow-up|3|||
160997918|NCT00038103|581376684|FG000|Overall Study|Protocol Violation|0|||
160923301|NCT02608268|581115403|FG029|Overall Study|Death|0|||
160923302|NCT02608268|581115374|FG000|Overall Study|Physician Decision|0|||
160923303|NCT02608268|581115375|FG001|Overall Study|Physician Decision|0|||
160923304|NCT02608268|581115376|FG002|Overall Study|Physician Decision|0|||
160923305|NCT02608268|581115377|FG003|Overall Study|Physician Decision|0|||
160923306|NCT02608268|581115378|FG004|Overall Study|Physician Decision|0|||
160923307|NCT02608268|581115379|FG005|Overall Study|Physician Decision|0|||
160923308|NCT02608268|581115380|FG006|Overall Study|Physician Decision|0|||
160923309|NCT02608268|581115381|FG007|Overall Study|Physician Decision|0|||
160923310|NCT02608268|581115382|FG008|Overall Study|Physician Decision|0|||
160923311|NCT02608268|581115383|FG009|Overall Study|Physician Decision|0|||
160923312|NCT02608268|581115384|FG010|Overall Study|Physician Decision|1|||
160997919|NCT00038103|581376685|FG001|Overall Study|Protocol Violation|2|||
160923313|NCT02608268|581115385|FG011|Overall Study|Physician Decision|0|||
160923314|NCT02608268|581115386|FG012|Overall Study|Physician Decision|0|||
160923315|NCT02608268|581115387|FG013|Overall Study|Physician Decision|1|||
160923316|NCT02608268|581115388|FG014|Overall Study|Physician Decision|0|||
160923317|NCT02608268|581115389|FG015|Overall Study|Physician Decision|0|||
160923318|NCT02608268|581115390|FG016|Overall Study|Physician Decision|0|||
160923319|NCT02608268|581115391|FG017|Overall Study|Physician Decision|0|||
160923320|NCT02608268|581115392|FG018|Overall Study|Physician Decision|0|||
160923321|NCT02608268|581115393|FG019|Overall Study|Physician Decision|0|||
160923322|NCT02608268|581115394|FG020|Overall Study|Physician Decision|0|||
160923323|NCT02608268|581115395|FG021|Overall Study|Physician Decision|0|||
160923324|NCT02608268|581115396|FG022|Overall Study|Physician Decision|1|||
160923325|NCT02608268|581115397|FG023|Overall Study|Physician Decision|1|||
161262197|NCT00958126|582339514|FG000|Overall Study|Lost to Follow-up|1|||
160923326|NCT02608268|581115398|FG024|Overall Study|Physician Decision|1|||
160923327|NCT02608268|581115399|FG025|Overall Study|Physician Decision|0|||
160923328|NCT02608268|581115400|FG026|Overall Study|Physician Decision|0|||
160923329|NCT02608268|581115401|FG027|Overall Study|Physician Decision|2|||
160923330|NCT02608268|581115402|FG028|Overall Study|Physician Decision|1|||
160923331|NCT02608268|581115403|FG029|Overall Study|Physician Decision|1|||
160923332|NCT02608268|581115374|FG000|Overall Study|Progressive disease|12|||
160923333|NCT02608268|581115375|FG001|Overall Study|Progressive disease|8|||
160923334|NCT02608268|581115376|FG002|Overall Study|Progressive disease|13|||
160923335|NCT02608268|581115377|FG003|Overall Study|Progressive disease|5|||
160923336|NCT02608268|581115378|FG004|Overall Study|Progressive disease|2|||
160923337|NCT02608268|581115379|FG005|Overall Study|Progressive disease|4|||
160923338|NCT02608268|581115380|FG006|Overall Study|Progressive disease|6|||
160923339|NCT02608268|581115381|FG007|Overall Study|Progressive disease|2|||
160923340|NCT02608268|581115382|FG008|Overall Study|Progressive disease|5|||
160923341|NCT02608268|581115383|FG009|Overall Study|Progressive disease|6|||
160923342|NCT02608268|581115384|FG010|Overall Study|Progressive disease|5|||
160923343|NCT02608268|581115385|FG011|Overall Study|Progressive disease|5|||
160923344|NCT02608268|581115386|FG012|Overall Study|Progressive disease|4|||
160923345|NCT02608268|581115387|FG013|Overall Study|Progressive disease|11|||
160923346|NCT02608268|581115388|FG014|Overall Study|Progressive disease|6|||
161262198|NCT00958126|582339515|FG001|Overall Study|Lost to Follow-up|5|||
161262199|NCT00958126|582339516|FG002|Overall Study|Lost to Follow-up|9|||
161262200|NCT00958126|582339517|FG003|Overall Study|Lost to Follow-up|8|||
161262201|NCT00958126|582339518|FG004|Overall Study|Lost to Follow-up|0|||
161262202|NCT00958126|582339519|FG005|Overall Study|Lost to Follow-up|0|||
161262203|NCT00958126|582339520|FG006|Overall Study|Lost to Follow-up|0|||
161262204|NCT00958126|582339521|FG007|Overall Study|Lost to Follow-up|0|||
161262205|NCT00958126|582339514|FG000|Overall Study|Sponsor/Investigator decision|0|||
161262206|NCT00958126|582339515|FG001|Overall Study|Sponsor/Investigator decision|0|||
161262207|NCT00958126|582339516|FG002|Overall Study|Sponsor/Investigator decision|0|||
161262208|NCT00958126|582339517|FG003|Overall Study|Sponsor/Investigator decision|1|||
161262209|NCT00958126|582339518|FG004|Overall Study|Sponsor/Investigator decision|0|||
161262210|NCT00958126|582339519|FG005|Overall Study|Sponsor/Investigator decision|0|||
161262211|NCT00958126|582339520|FG006|Overall Study|Sponsor/Investigator decision|0|||
161262212|NCT00958126|582339521|FG007|Overall Study|Sponsor/Investigator decision|0|||
161262213|NCT00958126|582339514|FG000|Overall Study|Other Reason|0|||
161262214|NCT00958126|582339515|FG001|Overall Study|Other Reason|0|||
161262215|NCT00958126|582339516|FG002|Overall Study|Other Reason|0|||
161262216|NCT00958126|582339517|FG003|Overall Study|Other Reason|1|||
161262217|NCT00958126|582339518|FG004|Overall Study|Other Reason|0|||
161341384|NCT01648764|582637497|FG011|Overall Study|Death|0|||
161341385|NCT01648764|582637498|FG012|Overall Study|Death|0|||
161341386|NCT01648764|582637499|FG013|Overall Study|Death|1|||
161341387|NCT01648764|582637486|FG000|Overall Study|Withdrawal by Subject|0|||
160923347|NCT02608268|581115389|FG015|Overall Study|Progressive disease|3|||
160923348|NCT02608268|581115390|FG016|Overall Study|Progressive disease|5|||
160923349|NCT02608268|581115391|FG017|Overall Study|Progressive disease|5|||
160923350|NCT02608268|581115392|FG018|Overall Study|Progressive disease|5|||
160923351|NCT02608268|581115393|FG019|Overall Study|Progressive disease|2|||
160923352|NCT02608268|581115394|FG020|Overall Study|Progressive disease|10|||
160923353|NCT02608268|581115395|FG021|Overall Study|Progressive disease|4|||
160997920|NCT00038103|581376684|FG000|Overall Study|Sponsor Decision|0|||
161262218|NCT00958126|582339519|FG005|Overall Study|Other Reason|1|||
161262219|NCT00958126|582339520|FG006|Overall Study|Other Reason|0|||
161262220|NCT00958126|582339521|FG007|Overall Study|Other Reason|0|||
161262221|NCT00733369|582339522|FG000|Overall Study|Lost to Follow-up|2|||
161262222|NCT00733369|582339523|FG001|Overall Study|Lost to Follow-up|1|||
160923354|NCT02608268|581115396|FG022|Overall Study|Progressive disease|5|||
160923355|NCT02608268|581115397|FG023|Overall Study|Progressive disease|5|||
160923356|NCT02608268|581115398|FG024|Overall Study|Progressive disease|3|||
160923357|NCT02608268|581115399|FG025|Overall Study|Progressive disease|11|||
160923358|NCT02608268|581115400|FG026|Overall Study|Progressive disease|16|||
161341388|NCT01648764|582637487|FG001|Overall Study|Withdrawal by Subject|0|||
160923359|NCT02608268|581115401|FG027|Overall Study|Progressive disease|11|||
160923360|NCT02608268|581115402|FG028|Overall Study|Progressive disease|10|||
160923361|NCT02608268|581115403|FG029|Overall Study|Progressive disease|15|||
160923362|NCT02608268|581115374|FG000|Overall Study|Subject/guardian decision|1|||
161262223|NCT00733369|582339522|FG000|Overall Study|Adverse Event|4|||
161262224|NCT00733369|582339523|FG001|Overall Study|Adverse Event|4|||
161262225|NCT00733369|582339522|FG000|Overall Study|Protocol Violation|4|||
161262226|NCT00733369|582339523|FG001|Overall Study|Protocol Violation|4|||
161262227|NCT03401073|582339526|FG000|Overall Study|Lost to Follow-up|1|||
161262228|NCT03401073|582339527|FG001|Overall Study|Lost to Follow-up|2|||
160923363|NCT02608268|581115375|FG001|Overall Study|Subject/guardian decision|1|||
160923364|NCT02608268|581115376|FG002|Overall Study|Subject/guardian decision|2|||
160923365|NCT02608268|581115377|FG003|Overall Study|Subject/guardian decision|0|||
160923366|NCT02608268|581115378|FG004|Overall Study|Subject/guardian decision|0|||
160923367|NCT02608268|581115379|FG005|Overall Study|Subject/guardian decision|0|||
160923368|NCT02608268|581115380|FG006|Overall Study|Subject/guardian decision|0|||
160923369|NCT02608268|581115381|FG007|Overall Study|Subject/guardian decision|0|||
160923370|NCT02608268|581115382|FG008|Overall Study|Subject/guardian decision|2|||
160923371|NCT02608268|581115383|FG009|Overall Study|Subject/guardian decision|2|||
160923372|NCT02608268|581115384|FG010|Overall Study|Subject/guardian decision|0|||
160923373|NCT02608268|581115385|FG011|Overall Study|Subject/guardian decision|1|||
160923374|NCT02608268|581115386|FG012|Overall Study|Subject/guardian decision|0|||
160923375|NCT02608268|581115387|FG013|Overall Study|Subject/guardian decision|1|||
160923376|NCT02608268|581115388|FG014|Overall Study|Subject/guardian decision|0|||
160923377|NCT02608268|581115389|FG015|Overall Study|Subject/guardian decision|1|||
160923378|NCT02608268|581115390|FG016|Overall Study|Subject/guardian decision|0|||
160923379|NCT02608268|581115391|FG017|Overall Study|Subject/guardian decision|0|||
160923380|NCT02608268|581115392|FG018|Overall Study|Subject/guardian decision|1|||
160923381|NCT02608268|581115393|FG019|Overall Study|Subject/guardian decision|0|||
160923382|NCT02608268|581115394|FG020|Overall Study|Subject/guardian decision|0|||
160923383|NCT02608268|581115395|FG021|Overall Study|Subject/guardian decision|0|||
160923384|NCT02608268|581115396|FG022|Overall Study|Subject/guardian decision|1|||
160923385|NCT02608268|581115397|FG023|Overall Study|Subject/guardian decision|0|||
160923386|NCT02608268|581115398|FG024|Overall Study|Subject/guardian decision|0|||
160923387|NCT02608268|581115399|FG025|Overall Study|Subject/guardian decision|1|||
160923388|NCT02608268|581115400|FG026|Overall Study|Subject/guardian decision|1|||
160923389|NCT02608268|581115401|FG027|Overall Study|Subject/guardian decision|1|||
160923390|NCT02608268|581115402|FG028|Overall Study|Subject/guardian decision|1|||
160923391|NCT02608268|581115403|FG029|Overall Study|Subject/guardian decision|0|||
160923392|NCT00265343|581115404|FG000|Overall Study|Adverse Event|10|||
160923393|NCT00265343|581115405|FG001|Overall Study|Adverse Event|7|||
160923394|NCT00265343|581115404|FG000|Overall Study|Withdrawal by Subject|3|||
160923395|NCT00265343|581115405|FG001|Overall Study|Withdrawal by Subject|9|||
160923396|NCT00265343|581115404|FG000|Overall Study|Other|8|||
160923397|NCT00265343|581115405|FG001|Overall Study|Other|3|||
160923398|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
160923399|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923400|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923401|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923402|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923403|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923404|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923405|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923406|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
160923407|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923408|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
160923409|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923410|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923411|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923412|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923413|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923414|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923415|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
160923416|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
160923417|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
160923418|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
160923419|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
160923420|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
160923421|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
160923422|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
161262229|NCT01470612|582339528|FG000|Overall Study|Adverse Event|20|||
161262230|NCT01470612|582339529|FG001|Overall Study|Adverse Event|80|||
161262231|NCT01470612|582339528|FG000|Overall Study|Death|0|||
161262232|NCT01470612|582339529|FG001|Overall Study|Death|1|||
161262233|NCT01470612|582339528|FG000|Overall Study|Lack of Efficacy|20|||
160923423|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
160923424|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
160923425|NCT03662542|581115409|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
160923426|NCT03662542|581115410|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923427|NCT03662542|581115411|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923428|NCT03662542|581115412|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923429|NCT03662542|581115413|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
161262234|NCT01470612|582339529|FG001|Overall Study|Lack of Efficacy|326|||
161262235|NCT01470612|582339528|FG000|Overall Study|Lost to Follow-up|2|||
160923430|NCT03662542|581115414|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923431|NCT03662542|581115415|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923432|NCT03662542|581115416|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923433|NCT03662542|581115417|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
160923434|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923435|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923436|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923437|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923438|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923439|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
160923440|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923441|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923442|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
160923443|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923444|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923445|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923446|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
160923447|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
160923448|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923449|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923450|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923451|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
160923452|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923453|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923454|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923455|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
160923456|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
160923457|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
160923458|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923459|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923460|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
160923461|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923462|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923463|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923464|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923465|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
160923466|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
160923467|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923468|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923469|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
160923470|NCT03662542|581115409|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923471|NCT03662542|581115410|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923472|NCT03662542|581115411|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923473|NCT03662542|581115412|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923474|NCT03662542|581115413|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
161262236|NCT01470612|582339529|FG001|Overall Study|Lost to Follow-up|5|||
161262237|NCT01470612|582339528|FG000|Overall Study|Did not meet entrance criteria|0|||
161262238|NCT01470612|582339529|FG001|Overall Study|Did not meet entrance criteria|1|||
160923475|NCT03662542|581115414|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
160923476|NCT03662542|581115415|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923477|NCT03662542|581115416|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923478|NCT03662542|581115417|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
160923479|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923480|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923481|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923482|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923483|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923484|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923485|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923486|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
161262239|NCT01470612|582339528|FG000|Overall Study|Pregnancy|2|||
161262240|NCT01470612|582339529|FG001|Overall Study|Pregnancy|10|||
160923487|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
160923488|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923489|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923490|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923491|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923492|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923493|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923494|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
160923495|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
160923496|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
160923497|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923498|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923499|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923500|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923501|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923502|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923503|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
160923504|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
160923505|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
160923506|NCT03662542|581115409|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923507|NCT03662542|581115410|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
161262241|NCT01470612|582339528|FG000|Overall Study|Protocol Violation|2|||
161262242|NCT01470612|582339529|FG001|Overall Study|Protocol Violation|7|||
161262243|NCT01470612|582339528|FG000|Overall Study|Withdrawal by Subject|24|||
161262244|NCT01470612|582339529|FG001|Overall Study|Withdrawal by Subject|79|||
161262245|NCT01470612|582339528|FG000|Overall Study|Other|14|||
161262246|NCT01470612|582339529|FG001|Overall Study|Other|156|||
161262247|NCT02039414|582339530|FG000|Overall Study|Delivered|1|||
161262248|NCT02039414|582339531|FG001|Overall Study|Delivered|1|||
161262249|NCT02039414|582339530|FG000|Overall Study|Lost to Follow-up|2|||
161262250|NCT02039414|582339531|FG001|Overall Study|Lost to Follow-up|0|||
161262251|NCT02039414|582339530|FG000|Overall Study|Protocol Violation|3|||
161262252|NCT02039414|582339531|FG001|Overall Study|Protocol Violation|1|||
161262253|NCT03977701|582339532|FG000|Overall Study|COVID-19 pandemic|0|||
161262254|NCT03977701|582339533|FG001|Overall Study|COVID-19 pandemic|0|||
161262255|NCT03977701|582339534|FG002|Overall Study|COVID-19 pandemic|0|||
161262256|NCT03977701|582339535|FG003|Overall Study|COVID-19 pandemic|0|||
161262257|NCT03977701|582339536|FG004|Overall Study|COVID-19 pandemic|0|||
161262258|NCT03977701|582339537|FG005|Overall Study|COVID-19 pandemic|1|||
161262259|NCT03977701|582339538|FG006|Overall Study|COVID-19 pandemic|0|||
161262260|NCT03977701|582339539|FG007|Overall Study|COVID-19 pandemic|1|||
161262261|NCT03977701|582339540|FG008|Overall Study|COVID-19 pandemic|0|||
161262262|NCT03977701|582339541|FG009|Overall Study|COVID-19 pandemic|0|||
161262263|NCT00430950|582339543|FG000|Overall Study|Adverse Event|7|||
161262264|NCT00430950|582339544|FG001|Overall Study|Adverse Event|6|||
161262265|NCT00430950|582339543|FG000|Overall Study|Withdrawal by Subject|1|||
161262266|NCT00430950|582339544|FG001|Overall Study|Withdrawal by Subject|0|||
161262267|NCT00430950|582339543|FG000|Overall Study|concomitant medication,etc.|5|||
161262268|NCT00430950|582339544|FG001|Overall Study|concomitant medication,etc.|7|||
161262269|NCT02429934|582339545|FG000|Overall Study|Withdrawal by Subject|0|||
161262270|NCT02429934|582339546|FG001|Overall Study|Withdrawal by Subject|2|||
161262271|NCT02429934|582339545|FG000|Overall Study|Adverse Event|2|||
161262272|NCT02429934|582339546|FG001|Overall Study|Adverse Event|0|||
161262273|NCT02429934|582339545|FG000|Overall Study|Lost to Follow-up|1|||
161262274|NCT02429934|582339546|FG001|Overall Study|Lost to Follow-up|1|||
161262275|NCT02429934|582339545|FG000|Overall Study|Physician Decision|1|||
161262276|NCT02429934|582339546|FG001|Overall Study|Physician Decision|0|||
161262277|NCT00869024|582339547|FG000|Overall Study|Death|2|||
161262278|NCT00869024|582339548|FG001|Overall Study|Death|3|||
161262279|NCT00869024|582339547|FG000|Overall Study|Lost to Follow-up|0|||
160923508|NCT03662542|581115411|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923509|NCT03662542|581115412|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923510|NCT03662542|581115413|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923511|NCT03662542|581115414|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
160923512|NCT03662542|581115415|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
161262280|NCT00869024|582339548|FG001|Overall Study|Lost to Follow-up|1|||
161262281|NCT00869024|582339547|FG000|Overall Study|Protocol Violation|0|||
161262282|NCT00869024|582339548|FG001|Overall Study|Protocol Violation|1|||
161262283|NCT00293202|582339549|FG000|Overall Study|Withdrawal by Subject|1|||
161262284|NCT00293202|582339550|FG001|Overall Study|Withdrawal by Subject|2|||
161262285|NCT00293202|582339549|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
161262286|NCT00293202|582339550|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
161262287|NCT00293202|582339549|FG000|Overall Study|on-hold due to fistula maturation time|1|||
161262288|NCT00293202|582339550|FG001|Overall Study|on-hold due to fistula maturation time|0|||
161262289|NCT01564459|582339551|FG000|Run-In|Adverse Event|7|||
160923513|NCT03662542|581115416|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
160923514|NCT03662542|581115417|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
160923515|NCT01217060|581115418|FG000|Overall Study|Withdrawal by Subject|1|||
160923516|NCT04762680|581115427|FG000|Phase 2|Adverse Event|0|||
160923517|NCT04762680|581115428|FG001|Phase 2|Adverse Event|1|||
160923518|NCT04762680|581115429|FG002|Phase 2|Adverse Event|0|||
160923519|NCT04762680|581115430|FG003|Phase 2|Adverse Event|0|||
160923520|NCT04762680|581115431|FG004|Phase 2|Adverse Event|0|||
160923521|NCT04762680|581115432|FG005|Phase 2|Adverse Event|0|||
160923522|NCT04762680|581115433|FG006|Phase 2|Adverse Event|0|||
160923523|NCT04762680|581115434|FG007|Phase 2|Adverse Event|0|||
160923524|NCT04762680|581115435|FG008|Phase 2|Adverse Event|0|||
160923525|NCT04762680|581115436|FG009|Phase 2|Adverse Event|0|||
160923526|NCT04762680|581115437|FG010|Phase 2|Adverse Event|0|||
160923527|NCT04762680|581115438|FG011|Phase 2|Adverse Event|0|||
160923528|NCT04762680|581115439|FG012|Phase 2|Adverse Event|0|||
160923529|NCT04762680|581115440|FG013|Phase 2|Adverse Event|0|||
160923530|NCT04762680|581115441|FG014|Phase 2|Adverse Event|0|||
160923531|NCT04762680|581115442|FG015|Phase 2|Adverse Event|0|||
160923532|NCT04762680|581115443|FG016|Phase 2|Adverse Event|0|||
160923533|NCT04762680|581115444|FG017|Phase 2|Adverse Event|0|||
160923534|NCT04762680|581115445|FG018|Phase 2|Adverse Event|0|||
160923535|NCT04762680|581115446|FG019|Phase 2|Adverse Event|0|||
160923536|NCT04762680|581115447|FG020|Phase 2|Adverse Event|0|||
160923537|NCT04762680|581115448|FG021|Phase 2|Adverse Event|0|||
160923538|NCT04762680|581115427|FG000|Phase 2|Protocol Violation|5|||
160923539|NCT04762680|581115428|FG001|Phase 2|Protocol Violation|5|||
160923540|NCT04762680|581115429|FG002|Phase 2|Protocol Violation|1|||
160923541|NCT04762680|581115430|FG003|Phase 2|Protocol Violation|0|||
160923542|NCT04762680|581115431|FG004|Phase 2|Protocol Violation|0|||
160923543|NCT04762680|581115432|FG005|Phase 2|Protocol Violation|0|||
160923544|NCT04762680|581115433|FG006|Phase 2|Protocol Violation|0|||
160923545|NCT04762680|581115434|FG007|Phase 2|Protocol Violation|0|||
160923546|NCT04762680|581115435|FG008|Phase 2|Protocol Violation|0|||
160923547|NCT04762680|581115436|FG009|Phase 2|Protocol Violation|0|||
160923548|NCT04762680|581115437|FG010|Phase 2|Protocol Violation|0|||
160923549|NCT04762680|581115438|FG011|Phase 2|Protocol Violation|0|||
161262290|NCT01564459|582339552|FG001|Run-In|Adverse Event|0|||
161262291|NCT01564459|582339553|FG002|Run-In|Adverse Event|0|||
161262292|NCT01564459|582339551|FG000|Run-In|Lost to Follow-up|1|||
161262293|NCT01564459|582339552|FG001|Run-In|Lost to Follow-up|0|||
161262294|NCT01564459|582339553|FG002|Run-In|Lost to Follow-up|0|||
161262295|NCT01564459|582339551|FG000|Run-In|Non-compliance with study drug|2|||
161262296|NCT01564459|582339552|FG001|Run-In|Non-compliance with study drug|0|||
161262297|NCT01564459|582339553|FG002|Run-In|Non-compliance with study drug|0|||
161262298|NCT01564459|582339551|FG000|Run-In|Protocol Violation|1|||
161262299|NCT01564459|582339552|FG001|Run-In|Protocol Violation|0|||
161262300|NCT01564459|582339553|FG002|Run-In|Protocol Violation|0|||
161262301|NCT01564459|582339551|FG000|Run-In|Withdrawal by Subject|1|||
161262302|NCT01564459|582339552|FG001|Run-In|Withdrawal by Subject|0|||
161262303|NCT01564459|582339553|FG002|Run-In|Withdrawal by Subject|0|||
161262304|NCT01564459|582339551|FG000|Double-blind Treatment|Adverse Event|0|||
161262305|NCT01564459|582339552|FG001|Double-blind Treatment|Adverse Event|0|||
161262306|NCT01564459|582339553|FG002|Double-blind Treatment|Adverse Event|1|||
161262307|NCT00653991|582339559|FG000|3 Month Follow-up|Participant would not respond|150|||
161262308|NCT00653991|582339560|FG001|3 Month Follow-up|Participant would not respond|157|||
161262309|NCT00653991|582339559|FG000|6 Month Follow-up|Participant would not respond|133|||
161262310|NCT00653991|582339560|FG001|6 Month Follow-up|Participant would not respond|141|||
161262311|NCT00518622|582339561|FG000|Overall Study|Lost to Follow-up|0|||
161262312|NCT00518622|582339562|FG001|Overall Study|Lost to Follow-up|0|||
161262313|NCT00518622|582339563|FG002|Overall Study|Lost to Follow-up|1|||
161262314|NCT00518622|582339564|FG003|Overall Study|Lost to Follow-up|0|||
160923550|NCT04762680|581115439|FG012|Phase 2|Protocol Violation|0|||
160923551|NCT04762680|581115440|FG013|Phase 2|Protocol Violation|0|||
160923552|NCT04762680|581115441|FG014|Phase 2|Protocol Violation|0|||
160923553|NCT04762680|581115442|FG015|Phase 2|Protocol Violation|0|||
160923554|NCT04762680|581115443|FG016|Phase 2|Protocol Violation|0|||
160923555|NCT04762680|581115444|FG017|Phase 2|Protocol Violation|0|||
160923556|NCT04762680|581115445|FG018|Phase 2|Protocol Violation|0|||
160923557|NCT04762680|581115446|FG019|Phase 2|Protocol Violation|0|||
161341389|NCT01648764|582637488|FG002|Overall Study|Withdrawal by Subject|0|||
160923558|NCT04762680|581115447|FG020|Phase 2|Protocol Violation|0|||
160923559|NCT04762680|581115448|FG021|Phase 2|Protocol Violation|0|||
160923560|NCT04762680|581115427|FG000|Phase 2|Withdrawal by Subject|23|||
160923561|NCT04762680|581115428|FG001|Phase 2|Withdrawal by Subject|21|||
160923562|NCT04762680|581115429|FG002|Phase 2|Withdrawal by Subject|28|||
160923563|NCT04762680|581115430|FG003|Phase 2|Withdrawal by Subject|0|||
160923564|NCT04762680|581115431|FG004|Phase 2|Withdrawal by Subject|0|||
161262315|NCT00518622|582339565|FG004|Overall Study|Lost to Follow-up|0|||
161262316|NCT00518622|582339566|FG005|Overall Study|Lost to Follow-up|0|||
161262317|NCT00518622|582339567|FG006|Overall Study|Lost to Follow-up|0|||
161262318|NCT00518622|582339568|FG007|Overall Study|Lost to Follow-up|0|||
160923565|NCT04762680|581115432|FG005|Phase 2|Withdrawal by Subject|0|||
160923566|NCT04762680|581115433|FG006|Phase 2|Withdrawal by Subject|0|||
160923567|NCT04762680|581115434|FG007|Phase 2|Withdrawal by Subject|0|||
160923568|NCT04762680|581115435|FG008|Phase 2|Withdrawal by Subject|0|||
160923569|NCT04762680|581115436|FG009|Phase 2|Withdrawal by Subject|0|||
160923570|NCT04762680|581115437|FG010|Phase 2|Withdrawal by Subject|0|||
160923571|NCT04762680|581115438|FG011|Phase 2|Withdrawal by Subject|0|||
160923572|NCT04762680|581115439|FG012|Phase 2|Withdrawal by Subject|0|||
160923573|NCT04762680|581115440|FG013|Phase 2|Withdrawal by Subject|0|||
160923574|NCT04762680|581115441|FG014|Phase 2|Withdrawal by Subject|0|||
160923575|NCT04762680|581115442|FG015|Phase 2|Withdrawal by Subject|0|||
160923576|NCT04762680|581115443|FG016|Phase 2|Withdrawal by Subject|0|||
160923577|NCT04762680|581115444|FG017|Phase 2|Withdrawal by Subject|0|||
160923578|NCT04762680|581115445|FG018|Phase 2|Withdrawal by Subject|0|||
160923579|NCT04762680|581115446|FG019|Phase 2|Withdrawal by Subject|0|||
160923580|NCT04762680|581115447|FG020|Phase 2|Withdrawal by Subject|0|||
160923581|NCT04762680|581115448|FG021|Phase 2|Withdrawal by Subject|0|||
160923582|NCT04762680|581115427|FG000|Phase 2|Lost to Follow-up|14|||
160923583|NCT04762680|581115428|FG001|Phase 2|Lost to Follow-up|8|||
160923584|NCT04762680|581115429|FG002|Phase 2|Lost to Follow-up|9|||
160923585|NCT04762680|581115430|FG003|Phase 2|Lost to Follow-up|0|||
160923586|NCT04762680|581115431|FG004|Phase 2|Lost to Follow-up|0|||
161143416|NCT00144300|581907597|FG000|Overall Study|Protocol Violation|1|||
161262319|NCT00518622|582339561|FG000|Overall Study|Study medication taken incorrectly|0|||
160923587|NCT04762680|581115432|FG005|Phase 2|Lost to Follow-up|0|||
160923588|NCT04762680|581115433|FG006|Phase 2|Lost to Follow-up|0|||
160923589|NCT04762680|581115434|FG007|Phase 2|Lost to Follow-up|0|||
160923590|NCT04762680|581115435|FG008|Phase 2|Lost to Follow-up|0|||
160923591|NCT04762680|581115436|FG009|Phase 2|Lost to Follow-up|0|||
160923592|NCT04762680|581115437|FG010|Phase 2|Lost to Follow-up|0|||
160923593|NCT04762680|581115438|FG011|Phase 2|Lost to Follow-up|0|||
161262320|NCT00518622|582339562|FG001|Overall Study|Study medication taken incorrectly|1|||
161262321|NCT00518622|582339563|FG002|Overall Study|Study medication taken incorrectly|0|||
161262322|NCT00518622|582339564|FG003|Overall Study|Study medication taken incorrectly|0|||
161262323|NCT00518622|582339565|FG004|Overall Study|Study medication taken incorrectly|0|||
161262324|NCT00518622|582339566|FG005|Overall Study|Study medication taken incorrectly|0|||
161262325|NCT00518622|582339567|FG006|Overall Study|Study medication taken incorrectly|0|||
161262326|NCT00518622|582339568|FG007|Overall Study|Study medication taken incorrectly|0|||
161262327|NCT03499119|582339569|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
161262328|NCT03499119|582339570|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
161262329|NCT03499119|582339571|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
161262330|NCT03499119|582339572|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
161262331|NCT03499119|582339569|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
161262332|NCT03499119|582339570|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
161262333|NCT03499119|582339571|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
161262334|NCT03499119|582339572|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
161262335|NCT03499119|582339569|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
161262336|NCT03499119|582339570|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
161262337|NCT03499119|582339571|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
161262338|NCT03499119|582339572|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
161262339|NCT03499119|582339569|FG000|Optional Extension Phase|Lost to Follow-up|0|||
161262340|NCT03499119|582339570|FG001|Optional Extension Phase|Lost to Follow-up|0|||
161341390|NCT01648764|582637489|FG003|Overall Study|Withdrawal by Subject|0|||
161341391|NCT01648764|582637490|FG004|Overall Study|Withdrawal by Subject|0|||
161341392|NCT01648764|582637491|FG005|Overall Study|Withdrawal by Subject|0|||
161341393|NCT01648764|582637492|FG006|Overall Study|Withdrawal by Subject|2|||
161341394|NCT01648764|582637493|FG007|Overall Study|Withdrawal by Subject|0|||
161341395|NCT01648764|582637494|FG008|Overall Study|Withdrawal by Subject|0|||
161341396|NCT01648764|582637495|FG009|Overall Study|Withdrawal by Subject|0|||
160923594|NCT04762680|581115439|FG012|Phase 2|Lost to Follow-up|0|||
160923595|NCT04762680|581115440|FG013|Phase 2|Lost to Follow-up|0|||
160923596|NCT04762680|581115441|FG014|Phase 2|Lost to Follow-up|0|||
160923597|NCT04762680|581115442|FG015|Phase 2|Lost to Follow-up|0|||
160923598|NCT04762680|581115443|FG016|Phase 2|Lost to Follow-up|0|||
160923599|NCT04762680|581115444|FG017|Phase 2|Lost to Follow-up|0|||
160923600|NCT04762680|581115445|FG018|Phase 2|Lost to Follow-up|0|||
160923601|NCT04762680|581115446|FG019|Phase 2|Lost to Follow-up|0|||
160923602|NCT04762680|581115447|FG020|Phase 2|Lost to Follow-up|0|||
160923603|NCT04762680|581115448|FG021|Phase 2|Lost to Follow-up|0|||
160923604|NCT04762680|581115427|FG000|Phase 3|Adverse Event|0|||
160923605|NCT04762680|581115428|FG001|Phase 3|Adverse Event|0|||
160923606|NCT04762680|581115429|FG002|Phase 3|Adverse Event|0|||
160923607|NCT04762680|581115430|FG003|Phase 3|Adverse Event|1|||
160923608|NCT04762680|581115431|FG004|Phase 3|Adverse Event|0|||
160923609|NCT04762680|581115432|FG005|Phase 3|Adverse Event|0|||
160923610|NCT04762680|581115433|FG006|Phase 3|Adverse Event|0|||
160923611|NCT04762680|581115434|FG007|Phase 3|Adverse Event|0|||
160923612|NCT04762680|581115435|FG008|Phase 3|Adverse Event|0|||
161262341|NCT03499119|582339571|FG002|Optional Extension Phase|Lost to Follow-up|0|||
160923613|NCT04762680|581115436|FG009|Phase 3|Adverse Event|0|||
160923614|NCT04762680|581115437|FG010|Phase 3|Adverse Event|0|||
160923615|NCT04762680|581115438|FG011|Phase 3|Adverse Event|0|||
160923616|NCT04762680|581115439|FG012|Phase 3|Adverse Event|0|||
160923617|NCT04762680|581115440|FG013|Phase 3|Adverse Event|0|||
160923618|NCT04762680|581115441|FG014|Phase 3|Adverse Event|0|||
160923619|NCT04762680|581115442|FG015|Phase 3|Adverse Event|0|||
160923620|NCT04762680|581115443|FG016|Phase 3|Adverse Event|0|||
160923621|NCT04762680|581115444|FG017|Phase 3|Adverse Event|3|||
160923622|NCT04762680|581115445|FG018|Phase 3|Adverse Event|0|||
160923623|NCT04762680|581115446|FG019|Phase 3|Adverse Event|0|||
160923624|NCT04762680|581115447|FG020|Phase 3|Adverse Event|0|||
160923625|NCT04762680|581115448|FG021|Phase 3|Adverse Event|0|||
160923626|NCT04762680|581115427|FG000|Phase 3|Protocol Violation|0|||
160923627|NCT04762680|581115428|FG001|Phase 3|Protocol Violation|0|||
160923628|NCT04762680|581115429|FG002|Phase 3|Protocol Violation|0|||
160923629|NCT04762680|581115430|FG003|Phase 3|Protocol Violation|4|||
160923630|NCT04762680|581115431|FG004|Phase 3|Protocol Violation|1|||
160923631|NCT04762680|581115432|FG005|Phase 3|Protocol Violation|5|||
160923632|NCT04762680|581115433|FG006|Phase 3|Protocol Violation|1|||
160923633|NCT04762680|581115434|FG007|Phase 3|Protocol Violation|0|||
160923634|NCT04762680|581115435|FG008|Phase 3|Protocol Violation|0|||
160923635|NCT04762680|581115436|FG009|Phase 3|Protocol Violation|0|||
160923636|NCT04762680|581115437|FG010|Phase 3|Protocol Violation|0|||
160923637|NCT04762680|581115438|FG011|Phase 3|Protocol Violation|2|||
160923638|NCT04762680|581115439|FG012|Phase 3|Protocol Violation|3|||
160923639|NCT04762680|581115440|FG013|Phase 3|Protocol Violation|0|||
160923640|NCT04762680|581115441|FG014|Phase 3|Protocol Violation|0|||
160923641|NCT04762680|581115442|FG015|Phase 3|Protocol Violation|1|||
161262342|NCT03499119|582339572|FG003|Optional Extension Phase|Lost to Follow-up|1|||
161262343|NCT03499119|582339569|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
161262344|NCT03499119|582339570|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
161262345|NCT03499119|582339571|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
161262346|NCT03499119|582339572|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
161262347|NCT03499119|582339569|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
161262348|NCT03499119|582339570|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
161262349|NCT03499119|582339571|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
161262350|NCT03499119|582339572|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
161262351|NCT01558297|582339573|FG000|Overall Study|Withdrawal by Subject|2|||
161262352|NCT01558297|582339574|FG001|Overall Study|Withdrawal by Subject|2|||
161262353|NCT01558297|582339575|FG002|Overall Study|Withdrawal by Subject|1|||
161262354|NCT02655016|582339578|FG000|Overall Study|Disease progression|6|||
161262355|NCT02655016|582339579|FG001|Overall Study|Disease progression|4|||
161262356|NCT02655016|582339578|FG000|Overall Study|Site closed|0|||
161262357|NCT02655016|582339579|FG001|Overall Study|Site closed|1|||
161262358|NCT02655016|582339578|FG000|Overall Study|Death|30|||
161262359|NCT02655016|582339579|FG001|Overall Study|Death|48|||
161262360|NCT02655016|582339578|FG000|Overall Study|Lost to Follow-up|1|||
161262361|NCT02655016|582339579|FG001|Overall Study|Lost to Follow-up|1|||
161262362|NCT02655016|582339578|FG000|Overall Study|Withdrawal by Subject|18|||
161262363|NCT02655016|582339579|FG001|Overall Study|Withdrawal by Subject|36|||
161262364|NCT03959527|582341241|FG000|Overall Study|Withdrawal by Subject|8|||
161262365|NCT03959527|582341242|FG001|Overall Study|Withdrawal by Subject|3|||
161262366|NCT03959527|582341241|FG000|Overall Study|Lost to Follow-up|31|||
161262367|NCT03959527|582341242|FG001|Overall Study|Lost to Follow-up|15|||
161262368|NCT03959527|582341241|FG000|Overall Study|Did not meet eligibility criteria|1|||
161262369|NCT03959527|582341242|FG001|Overall Study|Did not meet eligibility criteria|1|||
161262370|NCT03959527|582341241|FG000|Overall Study|Protocol Violation|10|||
161262371|NCT03959527|582341242|FG001|Overall Study|Protocol Violation|5|||
161262372|NCT06029959|582341243|FG000|Overall Study|Physician Decision|6|||
161262373|NCT02960893|582341248|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
161262374|NCT02960893|582341249|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
161262375|NCT02960893|582341250|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
161262376|NCT02960893|582341251|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
161262377|NCT02960893|582341248|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
161262378|NCT02960893|582341249|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
161262379|NCT02960893|582341250|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
161262380|NCT02960893|582341251|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
161262381|NCT02960893|582341248|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161262382|NCT02960893|582341249|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
161262383|NCT02960893|582341250|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
161262384|NCT02960893|582341251|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
160923642|NCT04762680|581115443|FG016|Phase 3|Protocol Violation|0|||
160923643|NCT04762680|581115444|FG017|Phase 3|Protocol Violation|10|||
160923644|NCT04762680|581115445|FG018|Phase 3|Protocol Violation|0|||
160923645|NCT04762680|581115446|FG019|Phase 3|Protocol Violation|0|||
161262385|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
160923646|NCT04762680|581115447|FG020|Phase 3|Protocol Violation|0|||
160923647|NCT04762680|581115448|FG021|Phase 3|Protocol Violation|0|||
160923648|NCT04762680|581115427|FG000|Phase 3|Withdrawal by Subject|0|||
160923649|NCT04762680|581115428|FG001|Phase 3|Withdrawal by Subject|0|||
160923650|NCT04762680|581115429|FG002|Phase 3|Withdrawal by Subject|0|||
160923651|NCT04762680|581115430|FG003|Phase 3|Withdrawal by Subject|13|||
160923652|NCT04762680|581115431|FG004|Phase 3|Withdrawal by Subject|17|||
160923653|NCT04762680|581115432|FG005|Phase 3|Withdrawal by Subject|12|||
160923654|NCT04762680|581115433|FG006|Phase 3|Withdrawal by Subject|8|||
160923655|NCT04762680|581115434|FG007|Phase 3|Withdrawal by Subject|3|||
160923656|NCT04762680|581115435|FG008|Phase 3|Withdrawal by Subject|2|||
160923657|NCT04762680|581115436|FG009|Phase 3|Withdrawal by Subject|4|||
160923658|NCT04762680|581115437|FG010|Phase 3|Withdrawal by Subject|3|||
160923659|NCT04762680|581115438|FG011|Phase 3|Withdrawal by Subject|1|||
160923660|NCT04762680|581115439|FG012|Phase 3|Withdrawal by Subject|3|||
160923661|NCT04762680|581115440|FG013|Phase 3|Withdrawal by Subject|2|||
160923662|NCT04762680|581115441|FG014|Phase 3|Withdrawal by Subject|1|||
160923663|NCT04762680|581115442|FG015|Phase 3|Withdrawal by Subject|4|||
160923664|NCT04762680|581115443|FG016|Phase 3|Withdrawal by Subject|6|||
160923665|NCT04762680|581115444|FG017|Phase 3|Withdrawal by Subject|32|||
160923666|NCT04762680|581115445|FG018|Phase 3|Withdrawal by Subject|0|||
160923667|NCT04762680|581115446|FG019|Phase 3|Withdrawal by Subject|0|||
160923668|NCT04762680|581115447|FG020|Phase 3|Withdrawal by Subject|0|||
160923669|NCT04762680|581115448|FG021|Phase 3|Withdrawal by Subject|0|||
160923670|NCT04762680|581115427|FG000|Phase 3|Lost to Follow-up|0|||
160923671|NCT04762680|581115428|FG001|Phase 3|Lost to Follow-up|0|||
160923672|NCT04762680|581115429|FG002|Phase 3|Lost to Follow-up|0|||
160923673|NCT04762680|581115430|FG003|Phase 3|Lost to Follow-up|9|||
160923674|NCT04762680|581115431|FG004|Phase 3|Lost to Follow-up|22|||
160923675|NCT04762680|581115432|FG005|Phase 3|Lost to Follow-up|24|||
160923676|NCT04762680|581115433|FG006|Phase 3|Lost to Follow-up|2|||
160923677|NCT04762680|581115434|FG007|Phase 3|Lost to Follow-up|4|||
160923678|NCT04762680|581115435|FG008|Phase 3|Lost to Follow-up|6|||
161262386|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
161262387|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
161262388|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
161262389|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
161262390|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
161262391|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
161262392|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
161262393|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
161262394|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
161262395|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
161262396|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
161262397|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
161262398|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
161262399|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
161262400|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
161262401|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
161262402|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
161262403|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
161262404|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
161262405|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
161262406|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
161262407|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
161262408|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
161262409|NCT02960893|582341248|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
161262410|NCT02960893|582341249|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
161262411|NCT02960893|582341250|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
161262412|NCT02960893|582341251|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
161262413|NCT02631876|582341254|FG000|Overall Study|Death|96|||
161262414|NCT02631876|582341255|FG001|Overall Study|Death|50|||
161262415|NCT02631876|582341254|FG000|Overall Study|Investigator's discretion|1|||
161262416|NCT02631876|582341255|FG001|Overall Study|Investigator's discretion|0|||
161262417|NCT02631876|582341254|FG000|Overall Study|Lost to Follow-up|2|||
161262418|NCT02631876|582341255|FG001|Overall Study|Lost to Follow-up|0|||
161262419|NCT02631876|582341254|FG000|Overall Study|Withdrawal by Subject|16|||
160923679|NCT04762680|581115436|FG009|Phase 3|Lost to Follow-up|4|||
160923680|NCT04762680|581115437|FG010|Phase 3|Lost to Follow-up|3|||
160923681|NCT04762680|581115438|FG011|Phase 3|Lost to Follow-up|0|||
160923682|NCT04762680|581115439|FG012|Phase 3|Lost to Follow-up|5|||
160923683|NCT04762680|581115440|FG013|Phase 3|Lost to Follow-up|4|||
160923684|NCT04762680|581115441|FG014|Phase 3|Lost to Follow-up|6|||
160923685|NCT04762680|581115442|FG015|Phase 3|Lost to Follow-up|1|||
160923686|NCT04762680|581115443|FG016|Phase 3|Lost to Follow-up|1|||
160923687|NCT04762680|581115444|FG017|Phase 3|Lost to Follow-up|66|||
160923688|NCT04762680|581115445|FG018|Phase 3|Lost to Follow-up|0|||
160923689|NCT04762680|581115446|FG019|Phase 3|Lost to Follow-up|0|||
160923690|NCT04762680|581115447|FG020|Phase 3|Lost to Follow-up|0|||
160923691|NCT04762680|581115448|FG021|Phase 3|Lost to Follow-up|0|||
160923692|NCT04762680|581115427|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923693|NCT04762680|581115428|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923694|NCT04762680|581115429|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923695|NCT04762680|581115430|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923696|NCT04762680|581115431|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923697|NCT04762680|581115432|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923698|NCT04762680|581115433|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923699|NCT04762680|581115434|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923700|NCT04762680|581115435|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923701|NCT04762680|581115436|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923702|NCT04762680|581115437|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923703|NCT04762680|581115438|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923704|NCT04762680|581115439|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923705|NCT04762680|581115440|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923706|NCT04762680|581115441|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
161262420|NCT02631876|582341255|FG001|Overall Study|Withdrawal by Subject|9|||
161262421|NCT02631876|582341254|FG000|Overall Study|Other than specified|4|||
161262422|NCT02631876|582341255|FG001|Overall Study|Other than specified|4|||
161262423|NCT04285567|582341256|FG000|Overall Study|Death|3|||
161262424|NCT04285567|582341257|FG001|Overall Study|Death|3|||
160923707|NCT04762680|581115442|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923708|NCT04762680|581115443|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923709|NCT04762680|581115444|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923710|NCT04762680|581115445|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923711|NCT04762680|581115446|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923712|NCT04762680|581115447|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
160923713|NCT04762680|581115448|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
160923714|NCT04762680|581115427|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923715|NCT04762680|581115428|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923716|NCT04762680|581115429|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923717|NCT04762680|581115430|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923718|NCT04762680|581115431|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923719|NCT04762680|581115432|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
161262425|NCT04285567|582341256|FG000|Overall Study|Lost to Follow-up|1|||
160923720|NCT04762680|581115433|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923721|NCT04762680|581115434|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923722|NCT04762680|581115435|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923723|NCT04762680|581115436|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
161262426|NCT04285567|582341257|FG001|Overall Study|Lost to Follow-up|1|||
161262427|NCT04285567|582341256|FG000|Overall Study|Reason Not Specified|1|||
161262428|NCT04285567|582341257|FG001|Overall Study|Reason Not Specified|1|||
160997921|NCT00038103|581376685|FG001|Overall Study|Sponsor Decision|1|||
161262429|NCT04285567|582341256|FG000|Overall Study|Physician Decision|2|||
161262430|NCT04285567|582341257|FG001|Overall Study|Physician Decision|1|||
161262431|NCT04285567|582341256|FG000|Overall Study|Withdrawal by Subject|2|||
161262432|NCT04285567|582341257|FG001|Overall Study|Withdrawal by Subject|6|||
161262433|NCT04285567|582341256|FG000|Overall Study|Adverse Event|1|||
161262434|NCT04285567|582341257|FG001|Overall Study|Adverse Event|0|||
161262435|NCT04285567|582341256|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
161262436|NCT04285567|582341257|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
161262437|NCT00493779|582341258|FG000|Overall Study|Logistical issue at site|1|||
161262438|NCT02091141|582341260|FG000|Overall Study|Death|280|||
161262439|NCT02091141|582341261|FG001|Overall Study|Death|118|||
161262440|NCT02091141|582341262|FG002|Overall Study|Death|46|||
161262441|NCT02091141|582341263|FG003|Overall Study|Death|13|||
161262442|NCT02091141|582341264|FG004|Overall Study|Death|31|||
161262443|NCT02091141|582341265|FG005|Overall Study|Death|16|||
161262444|NCT02091141|582341266|FG006|Overall Study|Death|12|||
161262445|NCT02091141|582341260|FG000|Overall Study|Withdrawal by Subject|21|||
161262446|NCT02091141|582341261|FG001|Overall Study|Withdrawal by Subject|13|||
161262447|NCT02091141|582341262|FG002|Overall Study|Withdrawal by Subject|3|||
161262448|NCT02091141|582341263|FG003|Overall Study|Withdrawal by Subject|2|||
161262449|NCT02091141|582341264|FG004|Overall Study|Withdrawal by Subject|2|||
161262450|NCT02091141|582341265|FG005|Overall Study|Withdrawal by Subject|3|||
160923724|NCT04762680|581115437|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923725|NCT04762680|581115438|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923726|NCT04762680|581115439|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923727|NCT04762680|581115440|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923728|NCT04762680|581115441|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
161262451|NCT02091141|582341266|FG006|Overall Study|Withdrawal by Subject|0|||
161262452|NCT02091141|582341260|FG000|Overall Study|Lost to Follow-up|21|||
161262453|NCT02091141|582341261|FG001|Overall Study|Lost to Follow-up|5|||
160923729|NCT04762680|581115442|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923730|NCT04762680|581115443|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923731|NCT04762680|581115444|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923732|NCT04762680|581115445|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923733|NCT04762680|581115446|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
160923734|NCT04762680|581115447|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923735|NCT04762680|581115448|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
160923736|NCT03388138|581115449|FG000|Overall Study|Protocol Violation|1|||
160923737|NCT03388138|581115450|FG001|Overall Study|Protocol Violation|0|||
160923738|NCT01528072|581115451|FG000|Overall Study|Withdrawal by Subject|5|||
160923739|NCT01528072|581115451|FG000|Overall Study|Physician Decision|1|||
160923740|NCT01528072|581115451|FG000|Overall Study|Determined not eligible by AEAC|1|||
160923741|NCT01528072|581115451|FG000|Overall Study|Missed Visit|2|||
160923742|NCT01528072|581115451|FG000|Overall Study|Lost to Follow-up|5|||
160923743|NCT01528072|581115451|FG000|Overall Study|Explanted|2|||
160923744|NCT01528072|581115451|FG000|Overall Study|Site Closure|4|||
160923745|NCT01528072|581115451|FG000|Overall Study|Death|2|||
160923746|NCT01528072|581115451|FG000|Overall Study|Early Termination of Study|52|||
160923747|NCT02436759|581115458|FG000|Overall Study|Adverse Event|3|||
160923748|NCT02436759|581115459|FG001|Overall Study|Adverse Event|0|||
160923749|NCT02436759|581115458|FG000|Overall Study|Protocol Violation|1|||
160923750|NCT02436759|581115459|FG001|Overall Study|Protocol Violation|0|||
160923751|NCT02436759|581115458|FG000|Overall Study|Withdrawal by Subject|0|||
160923752|NCT02436759|581115459|FG001|Overall Study|Withdrawal by Subject|1|||
160923753|NCT04014075|581115460|FG000|Overall Study|Progressive Disease|53|||
160923754|NCT04014075|581115460|FG000|Overall Study|Adverse Event|15|||
160923755|NCT04014075|581115460|FG000|Overall Study|Clinical Progression|4|||
160923756|NCT04014075|581115460|FG000|Overall Study|Death|2|||
160923757|NCT04014075|581115460|FG000|Overall Study|Withdrawal by Subject|2|||
160923758|NCT04014075|581115460|FG000|Overall Study|Miscellaneous|2|||
160923759|NCT04014075|581115460|FG000|Overall Study|Physician Decision|1|||
160923760|NCT02584504|581115463|FG000|Double-blind Treatment|Participant withdrew consent|0|||
160923761|NCT02584504|581115464|FG001|Double-blind Treatment|Participant withdrew consent|0|||
160923762|NCT02584504|581115465|FG002|Double-blind Treatment|Participant withdrew consent|1|||
160923763|NCT02584504|581115463|FG000|Double-blind Treatment|Adverse Event|0|||
160923764|NCT02584504|581115464|FG001|Double-blind Treatment|Adverse Event|1|||
160923765|NCT02584504|581115465|FG002|Double-blind Treatment|Adverse Event|0|||
160923766|NCT02584504|581115463|FG000|Double-blind Treatment|Family Matter|0|||
160923767|NCT02584504|581115464|FG001|Double-blind Treatment|Family Matter|1|||
160923768|NCT02584504|581115465|FG002|Double-blind Treatment|Family Matter|0|||
160923769|NCT02584504|581115463|FG000|Open-label Treatment|Participant withdrew consent|0|||
160923770|NCT02584504|581115464|FG001|Open-label Treatment|Participant withdrew consent|0|||
160923771|NCT02584504|581115465|FG002|Open-label Treatment|Participant withdrew consent|4|||
160923772|NCT02584504|581115463|FG000|Open-label Treatment|Adverse Event|2|||
160923773|NCT02584504|581115464|FG001|Open-label Treatment|Adverse Event|2|||
161262454|NCT02091141|582341262|FG002|Overall Study|Lost to Follow-up|1|||
161262455|NCT02091141|582341263|FG003|Overall Study|Lost to Follow-up|0|||
161262456|NCT02091141|582341264|FG004|Overall Study|Lost to Follow-up|1|||
161262457|NCT02091141|582341265|FG005|Overall Study|Lost to Follow-up|2|||
161262458|NCT02091141|582341266|FG006|Overall Study|Lost to Follow-up|0|||
161262459|NCT02091141|582341260|FG000|Overall Study|Reason Not Specified|6|||
161262460|NCT02091141|582341261|FG001|Overall Study|Reason Not Specified|5|||
161262461|NCT02091141|582341262|FG002|Overall Study|Reason Not Specified|2|||
161262462|NCT02091141|582341263|FG003|Overall Study|Reason Not Specified|0|||
161262463|NCT02091141|582341264|FG004|Overall Study|Reason Not Specified|0|||
161262464|NCT02091141|582341265|FG005|Overall Study|Reason Not Specified|0|||
161262465|NCT02091141|582341266|FG006|Overall Study|Reason Not Specified|1|||
161262466|NCT02091141|582341260|FG000|Overall Study|Study Ended by Sponsor|1|||
161262467|NCT02091141|582341261|FG001|Overall Study|Study Ended by Sponsor|9|||
161262468|NCT02091141|582341262|FG002|Overall Study|Study Ended by Sponsor|0|||
161262469|NCT02091141|582341263|FG003|Overall Study|Study Ended by Sponsor|0|||
161262470|NCT02091141|582341264|FG004|Overall Study|Study Ended by Sponsor|0|||
161262471|NCT02091141|582341265|FG005|Overall Study|Study Ended by Sponsor|0|||
161262472|NCT02091141|582341266|FG006|Overall Study|Study Ended by Sponsor|0|||
161262473|NCT02091141|582341260|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
161262474|NCT02091141|582341261|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
160923774|NCT02584504|581115465|FG002|Open-label Treatment|Adverse Event|3|||
160923775|NCT02584504|581115463|FG000|Open-label Treatment|Physician Decision|0|||
160923776|NCT02584504|581115464|FG001|Open-label Treatment|Physician Decision|1|||
160923777|NCT02584504|581115465|FG002|Open-label Treatment|Physician Decision|0|||
160923778|NCT02584504|581115463|FG000|Open-label Treatment|Entered but not treated|0|||
160923779|NCT02584504|581115464|FG001|Open-label Treatment|Entered but not treated|1|||
160923780|NCT02584504|581115465|FG002|Open-label Treatment|Entered but not treated|1|||
160923781|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Death|3|||
160923782|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Death|2|||
160923783|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Death|4|||
160923784|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Death|3|||
160923785|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Death|0|||
160923786|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Death|0|||
160923787|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923788|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
160923789|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
160923790|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923791|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923792|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
160923793|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
160923794|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923795|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923796|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923797|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923798|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
160923799|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
160923800|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
160923801|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
160923802|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
160923803|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
160923804|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
160923805|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923806|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923807|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
160923808|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
160923809|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923810|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
160923811|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
160923812|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
160923813|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
160923814|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
160923815|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
160923816|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
160923817|NCT02432846|581115466|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923818|NCT02432846|581115467|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923819|NCT02432846|581115468|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
160923820|NCT02432846|581115469|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923821|NCT02432846|581115470|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923822|NCT02432846|581115471|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
160923823|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
160923824|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
160923825|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
160923826|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
160923827|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
160923828|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
160923829|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
161262475|NCT02091141|582341262|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
161262476|NCT02091141|582341263|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
160923830|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160923831|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160923832|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
160923833|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
160923834|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
160923835|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923836|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923837|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923838|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923839|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
160923840|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
160923841|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923842|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923843|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923844|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
160923845|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
160923846|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
160923847|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923848|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923849|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923850|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
160923851|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
160923852|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
160923853|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923854|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923855|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923856|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
160923857|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
160923858|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
160923859|NCT02432846|581115466|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923860|NCT02432846|581115467|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923861|NCT02432846|581115468|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923862|NCT02432846|581115469|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923863|NCT02432846|581115470|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
160923864|NCT02432846|581115471|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
160923865|NCT00413192|581115472|FG000|Overall Study|Disease progression|26|||
160923866|NCT00413192|581115473|FG001|Overall Study|Disease progression|31|||
160923867|NCT00413192|581115474|FG002|Overall Study|Disease progression|16|||
160923868|NCT00413192|581115475|FG003|Overall Study|Disease progression|25|||
160923869|NCT00413192|581115472|FG000|Overall Study|Toxicity|3|||
160923870|NCT00413192|581115473|FG001|Overall Study|Toxicity|2|||
160923871|NCT00413192|581115474|FG002|Overall Study|Toxicity|2|||
160923872|NCT00413192|581115475|FG003|Overall Study|Toxicity|2|||
160923873|NCT00413192|581115472|FG000|Overall Study|Withdrawal by Subject|3|||
160923874|NCT00413192|581115473|FG001|Overall Study|Withdrawal by Subject|5|||
160923875|NCT00413192|581115474|FG002|Overall Study|Withdrawal by Subject|0|||
160923876|NCT00413192|581115475|FG003|Overall Study|Withdrawal by Subject|1|||
160923877|NCT00413192|581115472|FG000|Overall Study|Intercurrent illness|0|||
160923878|NCT00413192|581115473|FG001|Overall Study|Intercurrent illness|0|||
160923879|NCT00413192|581115474|FG002|Overall Study|Intercurrent illness|0|||
160923880|NCT00413192|581115475|FG003|Overall Study|Intercurrent illness|1|||
160923881|NCT00413192|581115472|FG000|Overall Study|Intercurrent death|0|||
160923882|NCT00413192|581115473|FG001|Overall Study|Intercurrent death|1|||
160923883|NCT00413192|581115474|FG002|Overall Study|Intercurrent death|0|||
160923884|NCT00413192|581115475|FG003|Overall Study|Intercurrent death|0|||
160923885|NCT00413192|581115472|FG000|Overall Study|Other|5|||
160923886|NCT00413192|581115473|FG001|Overall Study|Other|1|||
160923887|NCT00413192|581115474|FG002|Overall Study|Other|1|||
160923888|NCT00413192|581115475|FG003|Overall Study|Other|2|||
160923889|NCT00413192|581115472|FG000|Overall Study|Not treated|0|||
160923890|NCT00413192|581115473|FG001|Overall Study|Not treated|0|||
160923891|NCT00413192|581115474|FG002|Overall Study|Not treated|0|||
160923892|NCT00413192|581115475|FG003|Overall Study|Not treated|1|||
160923893|NCT01998633|581115476|FG000|Overall Study|Death|1|||
160923894|NCT03814746|581115477|FG000|Overall Study|Participant decision|9|||
160923895|NCT03814746|581115478|FG001|Overall Study|Participant decision|6|||
160923896|NCT03814746|581115479|FG002|Overall Study|Participant decision|15|||
160923897|NCT03814746|581115477|FG000|Overall Study|Physician Decision|2|||
160923898|NCT03814746|581115478|FG001|Overall Study|Physician Decision|2|||
160923899|NCT03814746|581115479|FG002|Overall Study|Physician Decision|4|||
160923900|NCT03814746|581115477|FG000|Overall Study|Death|2|||
160923901|NCT03814746|581115478|FG001|Overall Study|Death|2|||
160923902|NCT03814746|581115479|FG002|Overall Study|Death|2|||
160923903|NCT03814746|581115477|FG000|Overall Study|Adverse Event|2|||
160923904|NCT03814746|581115478|FG001|Overall Study|Adverse Event|2|||
160923905|NCT03814746|581115479|FG002|Overall Study|Adverse Event|1|||
160923906|NCT03814746|581115477|FG000|Overall Study|Lost to Follow-up|2|||
160923907|NCT03814746|581115478|FG001|Overall Study|Lost to Follow-up|1|||
160923908|NCT03814746|581115479|FG002|Overall Study|Lost to Follow-up|2|||
160923909|NCT03814746|581115477|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
160923910|NCT03814746|581115478|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
160923911|NCT03814746|581115479|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
160923912|NCT03814746|581115477|FG000|Overall Study|Pregnancy|0|||
160923913|NCT03814746|581115478|FG001|Overall Study|Pregnancy|1|||
160923914|NCT03814746|581115479|FG002|Overall Study|Pregnancy|1|||
160923915|NCT03814746|581115477|FG000|Overall Study|Protocol Violation|1|||
160923916|NCT03814746|581115478|FG001|Overall Study|Protocol Violation|0|||
160923917|NCT03814746|581115479|FG002|Overall Study|Protocol Violation|0|||
160923918|NCT03992781|581115480|FG000|Overall Study|Lost to Follow-up|5|||
160923919|NCT03992781|581115480|FG000|Overall Study|Adverse Event|1|||
160923920|NCT03992781|581115480|FG000|Overall Study|Lack of Efficacy|5|||
160923921|NCT01996826|581115481|FG000|Overall Study|Lost to Follow-up|6|||
160923922|NCT01996826|581115482|FG001|Overall Study|Lost to Follow-up|2|||
160923923|NCT01996826|581115481|FG000|Overall Study|Physician Decision|1|||
160923924|NCT01996826|581115482|FG001|Overall Study|Physician Decision|1|||
160923925|NCT00695396|581115483|FG000|Overall Study|Study Closed Prematurely|5|||
160923926|NCT00695396|581115484|FG001|Overall Study|Study Closed Prematurely|6|||
160923927|NCT00695396|581115485|FG002|Overall Study|Study Closed Prematurely|8|||
160923928|NCT00695396|581115483|FG000|Overall Study|Withdrawal by Subject|2|||
160923929|NCT00695396|581115484|FG001|Overall Study|Withdrawal by Subject|2|||
160923930|NCT00695396|581115485|FG002|Overall Study|Withdrawal by Subject|0|||
160923931|NCT00518323|581115487|FG000|Overall Study|Lack of Efficacy|14|||
160923932|NCT00518323|581115488|FG001|Overall Study|Lack of Efficacy|2|||
160923933|NCT00518323|581115489|FG002|Overall Study|Lack of Efficacy|4|||
160923934|NCT00518323|581115490|FG003|Overall Study|Lack of Efficacy|20|||
160923935|NCT00518323|581115487|FG000|Overall Study|Withdrawal by Subject|1|||
160923936|NCT00518323|581115488|FG001|Overall Study|Withdrawal by Subject|2|||
160923937|NCT00518323|581115489|FG002|Overall Study|Withdrawal by Subject|4|||
160923938|NCT00518323|581115490|FG003|Overall Study|Withdrawal by Subject|2|||
160923939|NCT00518323|581115487|FG000|Overall Study|Lost to Follow-up|0|||
160923940|NCT00518323|581115488|FG001|Overall Study|Lost to Follow-up|2|||
160923941|NCT00518323|581115489|FG002|Overall Study|Lost to Follow-up|1|||
160923942|NCT00518323|581115490|FG003|Overall Study|Lost to Follow-up|3|||
160923943|NCT00518323|581115487|FG000|Overall Study|Adverse Event|1|||
160923944|NCT00518323|581115488|FG001|Overall Study|Adverse Event|1|||
160923945|NCT00518323|581115489|FG002|Overall Study|Adverse Event|1|||
160923946|NCT00518323|581115490|FG003|Overall Study|Adverse Event|0|||
160923947|NCT00518323|581115487|FG000|Overall Study|Prohibited medication and others|3|||
160923948|NCT00518323|581115488|FG001|Overall Study|Prohibited medication and others|1|||
160923949|NCT00518323|581115489|FG002|Overall Study|Prohibited medication and others|1|||
160923950|NCT00518323|581115490|FG003|Overall Study|Prohibited medication and others|0|||
160923951|NCT03164928|581115492|FG000|Overall Study|Lost to Follow-up|1|||
160923952|NCT03164928|581115493|FG001|Overall Study|Lost to Follow-up|0|||
160923953|NCT01275833|581115496|FG000|Overall Study|Study terminated|1|||
160923954|NCT01275833|581115497|FG001|Overall Study|Study terminated|1|||
160923955|NCT02118012|581115499|FG000|Overall Study|Adverse Event|0|||
160923956|NCT02118012|581115500|FG001|Overall Study|Adverse Event|1|||
160923957|NCT02118012|581115499|FG000|Overall Study|Physician Decision|0|||
160923958|NCT02118012|581115500|FG001|Overall Study|Physician Decision|1|||
160923959|NCT00536107|581115501|FG000|Overall Study|Death|5|||
160923960|NCT00536107|581115502|FG001|Overall Study|Death|1|||
160923961|NCT00536107|581115501|FG000|Overall Study|Incorrect enrolment|1|||
160923962|NCT00536107|581115502|FG001|Overall Study|Incorrect enrolment|0|||
160923963|NCT00536107|581115501|FG000|Overall Study|Withdrawal by Subject|0|||
160923964|NCT00536107|581115502|FG001|Overall Study|Withdrawal by Subject|1|||
160923965|NCT00536107|581115501|FG000|Overall Study|Study Termination|2|||
160923966|NCT00536107|581115502|FG001|Overall Study|Study Termination|4|||
160923967|NCT03329690|581115503|FG000|Overall Study|Progressive disease per RECIST|85|||
160923968|NCT03329690|581115504|FG001|Overall Study|Progressive disease per RECIST|44|||
160923969|NCT03329690|581115505|FG002|Overall Study|Progressive disease per RECIST|6|||
160923970|NCT03329690|581115506|FG003|Overall Study|Progressive disease per RECIST|16|||
160923971|NCT03329690|581115507|FG004|Overall Study|Progressive disease per RECIST|20|||
160923972|NCT03329690|581115503|FG000|Overall Study|Clinical progression|7|||
160923973|NCT03329690|581115504|FG001|Overall Study|Clinical progression|4|||
160923974|NCT03329690|581115505|FG002|Overall Study|Clinical progression|1|||
160923975|NCT03329690|581115506|FG003|Overall Study|Clinical progression|1|||
160923976|NCT03329690|581115507|FG004|Overall Study|Clinical progression|1|||
160923977|NCT03329690|581115503|FG000|Overall Study|Adverse Event|22|||
160923978|NCT03329690|581115504|FG001|Overall Study|Adverse Event|4|||
160923979|NCT03329690|581115505|FG002|Overall Study|Adverse Event|0|||
160923980|NCT03329690|581115506|FG003|Overall Study|Adverse Event|1|||
160923981|NCT03329690|581115507|FG004|Overall Study|Adverse Event|2|||
160923982|NCT03329690|581115503|FG000|Overall Study|Death|2|||
160923983|NCT03329690|581115504|FG001|Overall Study|Death|0|||
160923984|NCT03329690|581115505|FG002|Overall Study|Death|0|||
160923985|NCT03329690|581115506|FG003|Overall Study|Death|1|||
160997922|NCT00038103|581376684|FG000|Overall Study|Randomized/never treated|2|||
160923986|NCT03329690|581115507|FG004|Overall Study|Death|0|||
160923987|NCT03329690|581115503|FG000|Overall Study|Withdrawal by Subject|2|||
160923988|NCT03329690|581115504|FG001|Overall Study|Withdrawal by Subject|3|||
160923989|NCT03329690|581115505|FG002|Overall Study|Withdrawal by Subject|0|||
160923990|NCT03329690|581115506|FG003|Overall Study|Withdrawal by Subject|1|||
160923991|NCT03329690|581115507|FG004|Overall Study|Withdrawal by Subject|0|||
160923992|NCT03329690|581115503|FG000|Overall Study|Physician Decision|1|||
160923993|NCT03329690|581115504|FG001|Overall Study|Physician Decision|0|||
160923994|NCT03329690|581115505|FG002|Overall Study|Physician Decision|0|||
160923995|NCT03329690|581115506|FG003|Overall Study|Physician Decision|0|||
160923996|NCT03329690|581115507|FG004|Overall Study|Physician Decision|1|||
160923997|NCT03329690|581115503|FG000|Overall Study|Miscellaneous|6|||
160923998|NCT03329690|581115504|FG001|Overall Study|Miscellaneous|0|||
160923999|NCT03329690|581115505|FG002|Overall Study|Miscellaneous|0|||
160924000|NCT03329690|581115506|FG003|Overall Study|Miscellaneous|0|||
160924001|NCT03329690|581115507|FG004|Overall Study|Miscellaneous|0|||
160924002|NCT03329690|581115503|FG000|Overall Study|Did not receive treatment|1|||
160924003|NCT03329690|581115504|FG001|Overall Study|Did not receive treatment|0|||
160924004|NCT03329690|581115505|FG002|Overall Study|Did not receive treatment|0|||
160924005|NCT03329690|581115506|FG003|Overall Study|Did not receive treatment|1|||
160924006|NCT03329690|581115507|FG004|Overall Study|Did not receive treatment|0|||
160924007|NCT00099437|581115510|FG000|Overall Study|Lost to Follow-up|30|||
160924008|NCT00099437|581115511|FG001|Overall Study|Lost to Follow-up|33|||
160924009|NCT00099437|581115510|FG000|Overall Study|Death|293|||
160924010|NCT00099437|581115511|FG001|Overall Study|Death|261|||
160924011|NCT00099437|581115510|FG000|Overall Study|Withdrawal by Subject|6|||
160924012|NCT00099437|581115511|FG001|Overall Study|Withdrawal by Subject|10|||
160924013|NCT00099437|581115510|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
160924014|NCT00099437|581115511|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
160924015|NCT00450333|581115512|FG000|Overall Study|Study terminated|47|||
160924016|NCT00450333|581115513|FG001|Overall Study|Study terminated|54|||
160924017|NCT00450333|581115514|FG002|Overall Study|Study terminated|16|||
160924018|NCT00450333|581115515|FG003|Overall Study|Study terminated|21|||
160924019|NCT00450333|581115512|FG000|Overall Study|Adverse Event|1|||
160924020|NCT00450333|581115513|FG001|Overall Study|Adverse Event|7|||
160924021|NCT00450333|581115514|FG002|Overall Study|Adverse Event|2|||
160924022|NCT00450333|581115515|FG003|Overall Study|Adverse Event|2|||
160924023|NCT00450333|581115512|FG000|Overall Study|Protocol Violation|1|||
160924024|NCT00450333|581115513|FG001|Overall Study|Protocol Violation|0|||
160924025|NCT00450333|581115514|FG002|Overall Study|Protocol Violation|1|||
160924026|NCT00450333|581115515|FG003|Overall Study|Protocol Violation|0|||
160924027|NCT00450333|581115512|FG000|Overall Study|Withdrawal by Subject|1|||
160924028|NCT00450333|581115513|FG001|Overall Study|Withdrawal by Subject|0|||
160924029|NCT00450333|581115514|FG002|Overall Study|Withdrawal by Subject|3|||
160924030|NCT00450333|581115515|FG003|Overall Study|Withdrawal by Subject|0|||
160924031|NCT00450333|581115512|FG000|Overall Study|Kidney transplant|1|||
160924032|NCT00450333|581115513|FG001|Overall Study|Kidney transplant|0|||
160924033|NCT00450333|581115514|FG002|Overall Study|Kidney transplant|1|||
160924034|NCT00450333|581115515|FG003|Overall Study|Kidney transplant|3|||
160924035|NCT00450333|581115512|FG000|Overall Study|Death|3|||
160924036|NCT00450333|581115513|FG001|Overall Study|Death|2|||
160924037|NCT00450333|581115514|FG002|Overall Study|Death|2|||
160924038|NCT00450333|581115515|FG003|Overall Study|Death|2|||
160924039|NCT03855280|581115522|FG000|Treatment Phase|Adverse Event|1|||
160924040|NCT03855280|581115522|FG000|Treatment Phase|Withdrawal by Subject|1|||
160924041|NCT03855280|581115522|FG000|Continuation Phase|Protocol Violation|1|||
160924042|NCT03855280|581115522|FG000|Continuation Phase|Adverse Event|1|||
160924043|NCT03855280|581115522|FG000|Continuation Phase|Sponsor Concluded Study|1|||
160924044|NCT01165554|581115524|FG000|Overall Study|Withdrawal by Subject|23|||
160924045|NCT02951156|581115525|FG000|Overall Study|Death|3|||
160924046|NCT02951156|581115526|FG001|Overall Study|Death|8|||
160924047|NCT02951156|581115527|FG002|Overall Study|Death|5|||
160924048|NCT02951156|581115525|FG000|Overall Study|Progressive disease|1|||
160924049|NCT02951156|581115526|FG001|Overall Study|Progressive disease|0|||
160924050|NCT02951156|581115527|FG002|Overall Study|Progressive disease|1|||
160924051|NCT02951156|581115525|FG000|Overall Study|Withdrawal by Subject|0|||
160924052|NCT02951156|581115526|FG001|Overall Study|Withdrawal by Subject|0|||
160924053|NCT02951156|581115527|FG002|Overall Study|Withdrawal by Subject|1|||
160924054|NCT02951156|581115525|FG000|Overall Study|Study terminated by sponsor|0|||
160924055|NCT02951156|581115526|FG001|Overall Study|Study terminated by sponsor|0|||
160924056|NCT02951156|581115527|FG002|Overall Study|Study terminated by sponsor|1|||
160924057|NCT02951156|581115525|FG000|Overall Study|Other|5|||
160924058|NCT02951156|581115526|FG001|Overall Study|Other|1|||
160924059|NCT02951156|581115527|FG002|Overall Study|Other|2|||
160924060|NCT01603459|581115528|FG000|Overall Study|Adverse Event|5|||
160924061|NCT01603459|581115528|FG000|Overall Study|Withdrawal by Subject|5|||
160924062|NCT01603459|581115528|FG000|Overall Study|Lost to Follow-up|3|||
160997923|NCT00038103|581376685|FG001|Overall Study|Randomized/never treated|0|||
160997924|NCT01144182|581376686|FG000|Overall Study|Death|5|||
161262477|NCT02091141|582341264|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
160924063|NCT01603459|581115528|FG000|Overall Study|Predefined discontinuation criteria|3|||
160924064|NCT01603459|581115528|FG000|Overall Study|Non-compliance|1|||
160924065|NCT01603459|581115528|FG000|Overall Study|Administrative reason|1|||
160924066|NCT02953314|581115532|FG000|Overall Study|Adverse Event|0|||
160924067|NCT02953314|581115533|FG001|Overall Study|Adverse Event|1|||
160924068|NCT02953314|581115532|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
160924069|NCT02953314|581115533|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
160924070|NCT02515045|581115539|FG000|Overall Study|Adverse Event|0|||
160924071|NCT02515045|581115540|FG001|Overall Study|Adverse Event|3|||
160924072|NCT02515045|581115541|FG002|Overall Study|Adverse Event|3|||
160924073|NCT02515045|581115539|FG000|Overall Study|Lost to Follow-up|0|||
160924074|NCT02515045|581115540|FG001|Overall Study|Lost to Follow-up|1|||
160924075|NCT02515045|581115541|FG002|Overall Study|Lost to Follow-up|1|||
160924076|NCT02221284|581115542|FG000|Overall Study|Case Report Forms Uncollected|56|||
160924077|NCT02221284|581115542|FG000|Overall Study|Protocol Deviation|5|||
160924078|NCT01239368|581116946|FG000|Overall Study|Principal investigator discretion|1|||
160924079|NCT01239368|581116947|FG001|Overall Study|Principal investigator discretion|0|||
160924080|NCT01239368|581116948|FG002|Overall Study|Principal investigator discretion|0|||
160924081|NCT01239368|581116949|FG003|Overall Study|Principal investigator discretion|0|||
160924082|NCT01239368|581116950|FG004|Overall Study|Principal investigator discretion|1|||
160924083|NCT01239368|581116951|FG005|Overall Study|Principal investigator discretion|2|||
160924084|NCT01239368|581116952|FG006|Overall Study|Principal investigator discretion|0|||
160924085|NCT01239368|581116953|FG007|Overall Study|Principal investigator discretion|0|||
160924086|NCT01239368|581116954|FG008|Overall Study|Principal investigator discretion|0|||
160924087|NCT01239368|581116955|FG009|Overall Study|Principal investigator discretion|1|||
160924088|NCT01239368|581116946|FG000|Overall Study|Disease progression on study|1|||
160924089|NCT01239368|581116947|FG001|Overall Study|Disease progression on study|1|||
160924090|NCT01239368|581116948|FG002|Overall Study|Disease progression on study|1|||
160924091|NCT01239368|581116949|FG003|Overall Study|Disease progression on study|1|||
160924092|NCT01239368|581116950|FG004|Overall Study|Disease progression on study|4|||
160924093|NCT01239368|581116951|FG005|Overall Study|Disease progression on study|2|||
160924094|NCT01239368|581116952|FG006|Overall Study|Disease progression on study|5|||
160924095|NCT01239368|581116953|FG007|Overall Study|Disease progression on study|0|||
160924096|NCT01239368|581116954|FG008|Overall Study|Disease progression on study|0|||
160924097|NCT01239368|581116955|FG009|Overall Study|Disease progression on study|2|||
160924098|NCT01239368|581116946|FG000|Overall Study|Refused further treatment|0|||
160924099|NCT01239368|581116947|FG001|Overall Study|Refused further treatment|0|||
160924100|NCT01239368|581116948|FG002|Overall Study|Refused further treatment|0|||
160924101|NCT01239368|581116949|FG003|Overall Study|Refused further treatment|0|||
160924102|NCT01239368|581116950|FG004|Overall Study|Refused further treatment|0|||
160924103|NCT01239368|581116951|FG005|Overall Study|Refused further treatment|0|||
160924104|NCT01239368|581116952|FG006|Overall Study|Refused further treatment|0|||
160924105|NCT01239368|581116953|FG007|Overall Study|Refused further treatment|0|||
160924106|NCT01239368|581116954|FG008|Overall Study|Refused further treatment|0|||
160924107|NCT01239368|581116955|FG009|Overall Study|Refused further treatment|1|||
160924108|NCT01239368|581116946|FG000|Overall Study|Death|0|||
160924109|NCT01239368|581116947|FG001|Overall Study|Death|0|||
160924110|NCT01239368|581116948|FG002|Overall Study|Death|0|||
160924111|NCT01239368|581116949|FG003|Overall Study|Death|0|||
160924112|NCT01239368|581116950|FG004|Overall Study|Death|0|||
160924113|NCT01239368|581116951|FG005|Overall Study|Death|0|||
160924114|NCT01239368|581116952|FG006|Overall Study|Death|1|||
160924115|NCT01239368|581116953|FG007|Overall Study|Death|0|||
160924116|NCT01239368|581116954|FG008|Overall Study|Death|0|||
160924117|NCT01239368|581116955|FG009|Overall Study|Death|0|||
161262478|NCT02091141|582341265|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
161262479|NCT02091141|582341266|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
160924118|NCT04709575|581116956|FG000|Overall Study|Withdrawal by Subject|6|||
160924119|NCT04709575|581116957|FG001|Overall Study|Withdrawal by Subject|2|||
160924120|NCT04709575|581116956|FG000|Overall Study|Lost to Follow-up|2|||
160924121|NCT04709575|581116957|FG001|Overall Study|Lost to Follow-up|2|||
160924122|NCT04709575|581116956|FG000|Overall Study|Adverse Event|1|||
160924123|NCT04709575|581116957|FG001|Overall Study|Adverse Event|0|||
160924124|NCT04709575|581116956|FG000|Overall Study|Protocol Violation|1|||
160924125|NCT04709575|581116957|FG001|Overall Study|Protocol Violation|1|||
160924126|NCT03181399|581116959|FG000|6 Months on Treatment|Protocol non-compliance|7|||
160924127|NCT03181399|581116959|FG000|6 Months on Treatment|Adverse Event|4|||
160924128|NCT03181399|581116959|FG000|6 Months on Treatment|Tried alternative treatment|2|||
160924129|NCT03181399|581116959|FG000|6 Months on Treatment|Lost to Follow-up|2|||
160924130|NCT03181399|581116959|FG000|6 Months on Treatment|Personal reasons|1|||
160924131|NCT03181399|581116959|FG000|3 Months Off-treatment|Parent unable to travel|1|||
161262480|NCT02246439|582341267|FG000|Overall Study|Adverse Event|3|||
161262481|NCT02246439|582341268|FG001|Overall Study|Adverse Event|0|||
161262482|NCT02246439|582341267|FG000|Overall Study|Lost to Follow-up|7|||
161262483|NCT02246439|582341268|FG001|Overall Study|Lost to Follow-up|5|||
160924132|NCT02926924|581116960|FG000|Overall Study|withdrawal - reason unknown|0|||
161262484|NCT02246439|582341267|FG000|Overall Study|Protocol Violation|0|||
161262485|NCT02246439|582341268|FG001|Overall Study|Protocol Violation|2|||
160924133|NCT02926924|581116961|FG001|Overall Study|withdrawal - reason unknown|1|||
160924134|NCT01254227|581116965|FG000|Overall Study|Withdrawal by Subject|6|||
160924135|NCT01254227|581116965|FG000|Overall Study|Lost to Follow-up|6|||
160924136|NCT01254227|581116965|FG000|Overall Study|Adverse Event|5|||
160924137|NCT01254227|581116965|FG000|Overall Study|Abnormal test procedure result|5|||
160924138|NCT01254227|581116965|FG000|Overall Study|Administrative problems|2|||
160924139|NCT01254227|581116965|FG000|Overall Study|Death|1|||
160924140|NCT01254227|581116965|FG000|Overall Study|Protocol deviation|1|||
160924141|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
160997925|NCT01144182|581376687|FG001|Overall Study|Death|6|||
160924142|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
160924143|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
160924144|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
160924145|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
160924146|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
160924147|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
160924148|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
160924149|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
160924150|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
160924151|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
160924152|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
160924153|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
160924154|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
160924155|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
160924156|NCT03970733|581116966|FG000|Main Study Phase (18 Months)|Other|1|||
160924157|NCT03970733|581116967|FG001|Main Study Phase (18 Months)|Other|1|||
160924158|NCT03970733|581116968|FG002|Main Study Phase (18 Months)|Other|0|||
160924159|NCT03970733|581116969|FG003|Main Study Phase (18 Months)|Other|0|||
160924160|NCT03970733|581116970|FG004|Main Study Phase (18 Months)|Other|0|||
160924161|NCT03970733|581116966|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924162|NCT03970733|581116967|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924163|NCT03970733|581116968|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924164|NCT03970733|581116969|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
160924165|NCT03970733|581116970|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
160924166|NCT02082210|581116974|FG000|Overall Study|Death|0|||
160924167|NCT02082210|581116975|FG001|Overall Study|Death|0|||
160924168|NCT02082210|581116976|FG002|Overall Study|Death|1|||
160924169|NCT02082210|581116977|FG003|Overall Study|Death|1|||
160924170|NCT02082210|581116978|FG004|Overall Study|Death|1|||
160924171|NCT02082210|581116979|FG005|Overall Study|Death|0|||
160924172|NCT02082210|581116974|FG000|Overall Study|Withdrawal by Subject|0|||
160924173|NCT02082210|581116975|FG001|Overall Study|Withdrawal by Subject|0|||
160924174|NCT02082210|581116976|FG002|Overall Study|Withdrawal by Subject|0|||
160924175|NCT02082210|581116977|FG003|Overall Study|Withdrawal by Subject|1|||
160924176|NCT02082210|581116978|FG004|Overall Study|Withdrawal by Subject|2|||
160924177|NCT02082210|581116979|FG005|Overall Study|Withdrawal by Subject|2|||
160924178|NCT02082210|581116974|FG000|Overall Study|Clinical Progression|0|||
160924179|NCT02082210|581116975|FG001|Overall Study|Clinical Progression|0|||
160924180|NCT02082210|581116976|FG002|Overall Study|Clinical Progression|0|||
160924181|NCT02082210|581116977|FG003|Overall Study|Clinical Progression|1|||
160924182|NCT02082210|581116978|FG004|Overall Study|Clinical Progression|0|||
160924183|NCT02082210|581116979|FG005|Overall Study|Clinical Progression|0|||
160924184|NCT02082210|581116974|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924185|NCT02082210|581116975|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924186|NCT02082210|581116976|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
160924187|NCT02082210|581116977|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
160924188|NCT02082210|581116978|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924189|NCT02082210|581116979|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
160924190|NCT02082210|581116974|FG000|Overall Study|Physician Decision|0|||
160924191|NCT02082210|581116975|FG001|Overall Study|Physician Decision|0|||
160924192|NCT02082210|581116976|FG002|Overall Study|Physician Decision|1|||
160924193|NCT02082210|581116977|FG003|Overall Study|Physician Decision|1|||
161262486|NCT02246439|582341267|FG000|Overall Study|Physician Decision|0|||
161262487|NCT02246439|582341268|FG001|Overall Study|Physician Decision|1|||
161262488|NCT02246439|582341267|FG000|Overall Study|Unkonwn|1|||
161262489|NCT02246439|582341268|FG001|Overall Study|Unkonwn|3|||
161262490|NCT02246439|582341267|FG000|Overall Study|Withdrawal by Subject|1|||
161262491|NCT02246439|582341268|FG001|Overall Study|Withdrawal by Subject|0|||
161262492|NCT03439852|582341269|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
161262493|NCT03439852|582341270|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
161262494|NCT03439852|582341269|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
161262495|NCT03439852|582341270|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
161262496|NCT03439852|582341269|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
161262497|NCT03439852|582341270|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
161262498|NCT04551911|582341273|FG000|Overall Study|Lost to Follow-up|2|||
161262499|NCT04551911|582341274|FG001|Overall Study|Lost to Follow-up|1|||
161262500|NCT04551911|582341273|FG000|Overall Study|Withdrawal by Subject|10|||
161262501|NCT04551911|582341274|FG001|Overall Study|Withdrawal by Subject|10|||
160924194|NCT02082210|581116978|FG004|Overall Study|Physician Decision|0|||
160924195|NCT02082210|581116979|FG005|Overall Study|Physician Decision|0|||
160924196|NCT01859494|581116988|FG000|Overall Study|Adverse Event|1|||
160924197|NCT01290666|581116994|FG000|Overall Study|Lost to Follow-up|11|||
160924198|NCT01290666|581116994|FG000|Overall Study|Withdrawal by Subject|23|||
160924199|NCT01290666|581116994|FG000|Overall Study|Early Termination of Study|4|||
160924200|NCT05089682|581116997|FG000|Overall Study|Withdrawal by Subject|2|||
160924201|NCT00483379|581116999|FG000|Treatment Period|Adverse Event|1|||
160924202|NCT00483379|581117000|FG001|Treatment Period|Adverse Event|0|||
160924203|NCT00483379|581116999|FG000|Treatment Period|Withdrawal by Subject|1|||
160924204|NCT00483379|581117000|FG001|Treatment Period|Withdrawal by Subject|0|||
160924205|NCT00371254|581117002|FG000|Overall Study|Disease progression|13|||
160924206|NCT00371254|581117003|FG001|Overall Study|Disease progression|13|||
160924207|NCT00371254|581117002|FG000|Overall Study|Study drug toxicity|3|||
160924208|NCT00371254|581117003|FG001|Overall Study|Study drug toxicity|5|||
160924209|NCT00371254|581117002|FG000|Overall Study|Subject request|5|||
160924210|NCT00371254|581117003|FG001|Overall Study|Subject request|0|||
160924211|NCT00371254|581117002|FG000|Overall Study|Investigator Decision|2|||
160924212|NCT00371254|581117003|FG001|Overall Study|Investigator Decision|0|||
160924213|NCT00371254|581117002|FG000|Overall Study|Adverse event unrelated to study drug|0|||
160924214|NCT00371254|581117003|FG001|Overall Study|Adverse event unrelated to study drug|1|||
160924215|NCT00371254|581117002|FG000|Overall Study|Lost to Follow-up|0|||
160924216|NCT00371254|581117003|FG001|Overall Study|Lost to Follow-up|1|||
160924217|NCT00371254|581117002|FG000|Overall Study|Withdrawal by Subject|0|||
160924218|NCT00371254|581117003|FG001|Overall Study|Withdrawal by Subject|1|||
161262502|NCT04551911|582341273|FG000|Overall Study|Did not receive the study drug|3|||
161262503|NCT04551911|582341274|FG001|Overall Study|Did not receive the study drug|4|||
160924219|NCT01817725|581117004|FG000|Overall Study|Withdrawal by Subject|1|||
160924220|NCT02418468|581117006|FG000|Overall Study|Adverse Event|1|||
160924221|NCT02418468|581117007|FG001|Overall Study|Adverse Event|0|||
160924222|NCT02418468|581117006|FG000|Overall Study|Withdrawal of informed consent|1|||
160924223|NCT02418468|581117007|FG001|Overall Study|Withdrawal of informed consent|1|||
160924224|NCT02337907|581117008|FG000|Overall Study|Other than listed|1|||
160924225|NCT02337907|581117009|FG001|Overall Study|Other than listed|0|||
160924226|NCT02337907|581117010|FG002|Overall Study|Other than listed|0|||
160924227|NCT02337907|581117011|FG003|Overall Study|Other than listed|1|||
160924228|NCT02337907|581117012|FG004|Overall Study|Other than listed|1|||
160924229|NCT02337907|581117013|FG005|Overall Study|Other than listed|0|||
160924230|NCT02337907|581117008|FG000|Overall Study|Withdrawal by Subject|2|||
161262504|NCT00866658|582341285|FG000|Overall Study|Adverse Event|5|||
161262505|NCT00866658|582341286|FG001|Overall Study|Adverse Event|14|||
161262506|NCT00866658|582341285|FG000|Overall Study|Lack of Efficacy|2|||
161262507|NCT00866658|582341286|FG001|Overall Study|Lack of Efficacy|1|||
160924231|NCT02337907|581117009|FG001|Overall Study|Withdrawal by Subject|3|||
160924232|NCT02337907|581117010|FG002|Overall Study|Withdrawal by Subject|0|||
160924233|NCT02337907|581117011|FG003|Overall Study|Withdrawal by Subject|2|||
160924234|NCT02337907|581117012|FG004|Overall Study|Withdrawal by Subject|5|||
160924235|NCT02337907|581117013|FG005|Overall Study|Withdrawal by Subject|0|||
160924236|NCT02337907|581117008|FG000|Overall Study|Lost to Follow-up|0|||
160924237|NCT02337907|581117009|FG001|Overall Study|Lost to Follow-up|0|||
160924238|NCT02337907|581117010|FG002|Overall Study|Lost to Follow-up|0|||
160924239|NCT02337907|581117011|FG003|Overall Study|Lost to Follow-up|0|||
160924240|NCT02337907|581117012|FG004|Overall Study|Lost to Follow-up|0|||
160924241|NCT02337907|581117013|FG005|Overall Study|Lost to Follow-up|1|||
160924242|NCT02337907|581117008|FG000|Overall Study|Adverse Event|1|||
160924243|NCT02337907|581117009|FG001|Overall Study|Adverse Event|1|||
160924244|NCT02337907|581117010|FG002|Overall Study|Adverse Event|1|||
160924245|NCT02337907|581117011|FG003|Overall Study|Adverse Event|1|||
160924246|NCT02337907|581117012|FG004|Overall Study|Adverse Event|4|||
160924247|NCT02337907|581117013|FG005|Overall Study|Adverse Event|0|||
160924248|NCT00909779|581117014|FG000|Overall Study|Adverse Event|53|||
160924249|NCT00909779|581117015|FG001|Overall Study|Adverse Event|55|||
160924250|NCT00909779|581117014|FG000|Overall Study|Lack of Efficacy|7|||
160924251|NCT00909779|581117015|FG001|Overall Study|Lack of Efficacy|4|||
160924252|NCT00909779|581117014|FG000|Overall Study|Lost to Follow-up|19|||
160924253|NCT00909779|581117015|FG001|Overall Study|Lost to Follow-up|15|||
160924254|NCT00909779|581117014|FG000|Overall Study|Physician Decision|8|||
160924255|NCT00909779|581117015|FG001|Overall Study|Physician Decision|2|||
160924256|NCT00909779|581117014|FG000|Overall Study|Protocol Violation|2|||
161143417|NCT00144300|581907598|FG001|Overall Study|Protocol Violation|3|||
160924257|NCT00909779|581117015|FG001|Overall Study|Protocol Violation|5|||
160924258|NCT00909779|581117014|FG000|Overall Study|Withdrawal by Subject|116|||
160924259|NCT00909779|581117015|FG001|Overall Study|Withdrawal by Subject|80|||
160924260|NCT00909779|581117014|FG000|Overall Study|Site Ceasing Operation|2|||
160924261|NCT00909779|581117015|FG001|Overall Study|Site Ceasing Operation|2|||
160924262|NCT00909779|581117014|FG000|Overall Study|Medical Monitor Decision|1|||
161143418|NCT00144300|581907597|FG000|Overall Study|Lost to Follow-up|3|||
160924263|NCT00909779|581117015|FG001|Overall Study|Medical Monitor Decision|0|||
161143419|NCT00144300|581907598|FG001|Overall Study|Lost to Follow-up|0|||
161262508|NCT00866658|582341285|FG000|Overall Study|Withdrawal by Subject|1|||
160924264|NCT00909779|581117014|FG000|Overall Study|Noncompliance|1|||
160924265|NCT00909779|581117015|FG001|Overall Study|Noncompliance|1|||
160924266|NCT00909779|581117014|FG000|Overall Study|Randomized in error|1|||
161262509|NCT00866658|582341286|FG001|Overall Study|Withdrawal by Subject|0|||
161262510|NCT00866658|582341285|FG000|Overall Study|Protocol Violation|1|||
161262511|NCT00866658|582341286|FG001|Overall Study|Protocol Violation|1|||
160924267|NCT00909779|581117015|FG001|Overall Study|Randomized in error|1|||
160924268|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
160924269|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
160924270|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
160924271|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
160924272|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
160924273|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
160924274|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
160924275|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
160924276|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
160924277|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
160924278|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
160924279|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
160924280|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
160924281|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
160924282|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
160924283|NCT00561080|581117021|FG000|Vaccination Period (up to Month 4)|Other|0|||
160924284|NCT00561080|581117022|FG001|Vaccination Period (up to Month 4)|Other|2|||
160924285|NCT00561080|581117023|FG002|Vaccination Period (up to Month 4)|Other|1|||
160924286|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
160924287|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
160924288|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
160924289|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
160924290|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
160924291|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
160924292|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
160924293|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
160924294|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
160924295|NCT00561080|581117021|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
160924296|NCT00561080|581117022|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
160924297|NCT00561080|581117023|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
160924298|NCT00423150|581117024|FG000|Overall Study|Adverse Event|11|||
160924299|NCT00423150|581117024|FG000|Overall Study|Progression of disease being studied|69|||
160924300|NCT00423150|581117024|FG000|Overall Study|Withdrawal by Subject|1|||
160924301|NCT00423150|581117024|FG000|Overall Study|Non-compliance with protocol|1|||
160924302|NCT00423150|581117024|FG000|Overall Study|Administrative|4|||
160924303|NCT01092182|581117025|FG000|Overall Study|Death|0|||
160924304|NCT01092182|581117026|FG001|Overall Study|Death|5|||
160924305|NCT01092182|581117027|FG002|Overall Study|Death|3|||
160924306|NCT01092182|581117025|FG000|Overall Study|participant safety|1|||
160924307|NCT01092182|581117026|FG001|Overall Study|participant safety|2|||
160924308|NCT01092182|581117027|FG002|Overall Study|participant safety|0|||
160924309|NCT01092182|581117025|FG000|Overall Study|Physician Decision|0|||
160924310|NCT01092182|581117026|FG001|Overall Study|Physician Decision|6|||
160924311|NCT01092182|581117027|FG002|Overall Study|Physician Decision|0|||
160924312|NCT01092182|581117025|FG000|Overall Study|Did not meet criteria|0|||
160924313|NCT01092182|581117026|FG001|Overall Study|Did not meet criteria|0|||
160924314|NCT01092182|581117027|FG002|Overall Study|Did not meet criteria|25|||
160924315|NCT01092182|581117025|FG000|Overall Study|Non-compliance|0|||
160924316|NCT01092182|581117026|FG001|Overall Study|Non-compliance|3|||
160924317|NCT01092182|581117027|FG002|Overall Study|Non-compliance|0|||
160924318|NCT01092182|581117025|FG000|Overall Study|Participant refused follow-up|0|||
160924319|NCT01092182|581117026|FG001|Overall Study|Participant refused follow-up|2|||
160924320|NCT01092182|581117027|FG002|Overall Study|Participant refused follow-up|0|||
160924321|NCT01641692|581117028|FG000|Treatment Period 1|Adverse Event|1|||
161262512|NCT00866658|582341285|FG000|Overall Study|Familial and Personal Reasons|4|||
161262513|NCT00866658|582341286|FG001|Overall Study|Familial and Personal Reasons|5|||
161262514|NCT00430495|582341288|FG000|Overall Study|Adverse Event|2|||
160924322|NCT01641692|581117029|FG001|Treatment Period 1|Adverse Event|0|||
160924323|NCT01641692|581117030|FG002|Treatment Period 1|Adverse Event|0|||
160924324|NCT01641692|581117031|FG003|Treatment Period 1|Adverse Event|0|||
160924325|NCT01641692|581117032|FG004|Treatment Period 1|Adverse Event|0|||
160924326|NCT01641692|581117033|FG005|Treatment Period 1|Adverse Event|0|||
160924327|NCT01641692|581117034|FG006|Treatment Period 1|Adverse Event|0|||
160924328|NCT01641692|581117035|FG007|Treatment Period 1|Adverse Event|0|||
160924329|NCT01641692|581117028|FG000|Treatment Period 1|Lack of Efficacy|0|||
160924330|NCT01641692|581117029|FG001|Treatment Period 1|Lack of Efficacy|0|||
160924331|NCT01641692|581117030|FG002|Treatment Period 1|Lack of Efficacy|0|||
160924332|NCT01641692|581117031|FG003|Treatment Period 1|Lack of Efficacy|0|||
160924333|NCT01641692|581117032|FG004|Treatment Period 1|Lack of Efficacy|0|||
160924334|NCT01641692|581117033|FG005|Treatment Period 1|Lack of Efficacy|0|||
160924335|NCT01641692|581117034|FG006|Treatment Period 1|Lack of Efficacy|0|||
160924336|NCT01641692|581117035|FG007|Treatment Period 1|Lack of Efficacy|1|||
160924337|NCT01641692|581117028|FG000|Treatment Period 1|Protocol Violation|1|||
160924338|NCT01641692|581117029|FG001|Treatment Period 1|Protocol Violation|0|||
160924339|NCT01641692|581117030|FG002|Treatment Period 1|Protocol Violation|0|||
160924340|NCT01641692|581117031|FG003|Treatment Period 1|Protocol Violation|0|||
160924341|NCT01641692|581117032|FG004|Treatment Period 1|Protocol Violation|2|||
160924342|NCT01641692|581117033|FG005|Treatment Period 1|Protocol Violation|0|||
160924343|NCT01641692|581117034|FG006|Treatment Period 1|Protocol Violation|0|||
160924344|NCT01641692|581117035|FG007|Treatment Period 1|Protocol Violation|0|||
160924345|NCT01641692|581117028|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924346|NCT01641692|581117029|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924347|NCT01641692|581117030|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924348|NCT01641692|581117031|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924349|NCT01641692|581117032|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
160924350|NCT01641692|581117033|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924351|NCT01641692|581117034|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
160924352|NCT01641692|581117035|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
160924353|NCT01641692|581117028|FG000|Treatment Period 1|Lost to Follow-up|0|||
160924354|NCT01641692|581117029|FG001|Treatment Period 1|Lost to Follow-up|0|||
160924355|NCT01641692|581117030|FG002|Treatment Period 1|Lost to Follow-up|1|||
160924356|NCT01641692|581117031|FG003|Treatment Period 1|Lost to Follow-up|0|||
160924357|NCT01641692|581117032|FG004|Treatment Period 1|Lost to Follow-up|0|||
160924358|NCT01641692|581117033|FG005|Treatment Period 1|Lost to Follow-up|0|||
160924359|NCT01641692|581117034|FG006|Treatment Period 1|Lost to Follow-up|0|||
160924360|NCT01641692|581117035|FG007|Treatment Period 1|Lost to Follow-up|0|||
160924361|NCT01641692|581117028|FG000|Treatment Period 1|Physician Decision|0|||
160924362|NCT01641692|581117029|FG001|Treatment Period 1|Physician Decision|0|||
160924363|NCT01641692|581117030|FG002|Treatment Period 1|Physician Decision|0|||
160924364|NCT01641692|581117031|FG003|Treatment Period 1|Physician Decision|0|||
160997926|NCT01144182|581376686|FG000|Overall Study|Withdrawal by Subject|3|||
160997927|NCT01144182|581376687|FG001|Overall Study|Withdrawal by Subject|6|||
161262515|NCT00430495|582341289|FG001|Overall Study|Adverse Event|3|||
161262516|NCT00430495|582341290|FG002|Overall Study|Adverse Event|2|||
161262517|NCT00430495|582341291|FG003|Overall Study|Adverse Event|0|||
161262518|NCT00430495|582341288|FG000|Overall Study|Death|0|||
161262519|NCT00430495|582341289|FG001|Overall Study|Death|0|||
161262520|NCT00430495|582341290|FG002|Overall Study|Death|1|||
161262521|NCT00430495|582341291|FG003|Overall Study|Death|0|||
161262522|NCT00430495|582341288|FG000|Overall Study|Lost to Follow-up|0|||
161262523|NCT00430495|582341289|FG001|Overall Study|Lost to Follow-up|1|||
161262524|NCT00430495|582341290|FG002|Overall Study|Lost to Follow-up|4|||
161262525|NCT00430495|582341291|FG003|Overall Study|Lost to Follow-up|0|||
161262526|NCT00430495|582341288|FG000|Overall Study|Protocol Violation|1|||
161262527|NCT00430495|582341289|FG001|Overall Study|Protocol Violation|0|||
161262528|NCT00430495|582341290|FG002|Overall Study|Protocol Violation|1|||
161262529|NCT00430495|582341291|FG003|Overall Study|Protocol Violation|0|||
161262530|NCT00430495|582341288|FG000|Overall Study|Disease Progression|1|||
161262531|NCT00430495|582341289|FG001|Overall Study|Disease Progression|1|||
161262532|NCT00430495|582341290|FG002|Overall Study|Disease Progression|0|||
161262533|NCT00430495|582341291|FG003|Overall Study|Disease Progression|0|||
161262534|NCT00430495|582341288|FG000|Overall Study|Other|8|||
161262535|NCT00430495|582341289|FG001|Overall Study|Other|2|||
161262536|NCT00430495|582341290|FG002|Overall Study|Other|5|||
161262537|NCT00430495|582341291|FG003|Overall Study|Other|4|||
161262538|NCT00430495|582341288|FG000|Overall Study|Randomized but not Treated|2|||
161262539|NCT00430495|582341289|FG001|Overall Study|Randomized but not Treated|0|||
161262540|NCT00430495|582341290|FG002|Overall Study|Randomized but not Treated|0|||
161262541|NCT00430495|582341291|FG003|Overall Study|Randomized but not Treated|0|||
161262542|NCT00158756|582341292|FG000|Overall Study|Withdrawal by Subject|5|||
161262543|NCT00158756|582341293|FG001|Overall Study|Withdrawal by Subject|0|||
161262544|NCT00158756|582341294|FG002|Overall Study|Withdrawal by Subject|6|||
161262545|NCT00158756|582341295|FG003|Overall Study|Withdrawal by Subject|1|||
161262546|NCT00158756|582341296|FG004|Overall Study|Withdrawal by Subject|3|||
161262547|NCT00158756|582341292|FG000|Overall Study|Adverse Event|0|||
161262548|NCT00158756|582341293|FG001|Overall Study|Adverse Event|0|||
161262549|NCT00158756|582341294|FG002|Overall Study|Adverse Event|1|||
161262550|NCT00158756|582341295|FG003|Overall Study|Adverse Event|0|||
161262551|NCT00158756|582341296|FG004|Overall Study|Adverse Event|0|||
161262552|NCT00158756|582341292|FG000|Overall Study|Serious adverse event|0|||
161262553|NCT00158756|582341293|FG001|Overall Study|Serious adverse event|0|||
161262554|NCT00158756|582341294|FG002|Overall Study|Serious adverse event|1|||
161262555|NCT00158756|582341295|FG003|Overall Study|Serious adverse event|0|||
161262556|NCT00158756|582341296|FG004|Overall Study|Serious adverse event|0|||
161262557|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
160924365|NCT01641692|581117032|FG004|Treatment Period 1|Physician Decision|1|||
160924366|NCT01641692|581117033|FG005|Treatment Period 1|Physician Decision|0|||
160924367|NCT01641692|581117034|FG006|Treatment Period 1|Physician Decision|0|||
160924368|NCT01641692|581117035|FG007|Treatment Period 1|Physician Decision|0|||
160924369|NCT01641692|581117028|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160924370|NCT01641692|581117029|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160924371|NCT01641692|581117030|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160924372|NCT01641692|581117031|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160924373|NCT01641692|581117032|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160924374|NCT01641692|581117033|FG005|Treatment Period 1|Withdrawal by Subject|2|||
160924375|NCT01641692|581117034|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160924376|NCT01641692|581117035|FG007|Treatment Period 1|Withdrawal by Subject|1|||
160924377|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
160924378|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924379|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924380|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924381|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924382|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924383|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924384|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
160924385|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924386|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924387|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924388|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924389|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924390|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924391|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
160924392|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160924393|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924394|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924395|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
160924396|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924397|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
160924398|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924399|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924400|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924401|NCT01641692|581117028|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924402|NCT01641692|581117029|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924403|NCT01641692|581117030|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160924404|NCT01641692|581117031|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924405|NCT01641692|581117032|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924406|NCT01641692|581117033|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160924407|NCT01641692|581117034|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160924408|NCT01641692|581117035|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160924409|NCT01641692|581117028|FG000|Treatment Period 2|Lack of Efficacy|1|||
160924410|NCT01641692|581117029|FG001|Treatment Period 2|Lack of Efficacy|0|||
160924411|NCT01641692|581117030|FG002|Treatment Period 2|Lack of Efficacy|0|||
160924412|NCT01641692|581117031|FG003|Treatment Period 2|Lack of Efficacy|0|||
160924413|NCT01641692|581117032|FG004|Treatment Period 2|Lack of Efficacy|0|||
160924414|NCT01641692|581117033|FG005|Treatment Period 2|Lack of Efficacy|0|||
160924415|NCT01641692|581117034|FG006|Treatment Period 2|Lack of Efficacy|0|||
160924416|NCT01641692|581117035|FG007|Treatment Period 2|Lack of Efficacy|0|||
160924417|NCT01641692|581117028|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
160924418|NCT01641692|581117029|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924419|NCT01641692|581117030|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924420|NCT01641692|581117031|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924421|NCT01641692|581117032|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924422|NCT01641692|581117033|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
161262558|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
161262559|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
161262560|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
161262561|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
161262562|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
161262563|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
161262564|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
161262565|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
161341397|NCT01648764|582637496|FG010|Overall Study|Withdrawal by Subject|0|||
160924423|NCT01641692|581117034|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924424|NCT01641692|581117035|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
160924425|NCT01641692|581117028|FG000|Treatment Period 2|Lost to Follow-up|0|||
160924426|NCT01641692|581117029|FG001|Treatment Period 2|Lost to Follow-up|0|||
160924427|NCT01641692|581117030|FG002|Treatment Period 2|Lost to Follow-up|0|||
160924428|NCT01641692|581117031|FG003|Treatment Period 2|Lost to Follow-up|0|||
160924429|NCT01641692|581117032|FG004|Treatment Period 2|Lost to Follow-up|0|||
160924430|NCT01641692|581117033|FG005|Treatment Period 2|Lost to Follow-up|1|||
160924431|NCT01641692|581117034|FG006|Treatment Period 2|Lost to Follow-up|0|||
160924432|NCT01641692|581117035|FG007|Treatment Period 2|Lost to Follow-up|0|||
160924433|NCT01641692|581117028|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160924434|NCT01641692|581117029|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160924435|NCT01641692|581117030|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160924436|NCT01641692|581117031|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160924437|NCT01641692|581117032|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160924438|NCT01641692|581117033|FG005|Treatment Period 2|Withdrawal by Subject|1|||
160924439|NCT01641692|581117034|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160924440|NCT01641692|581117035|FG007|Treatment Period 2|Withdrawal by Subject|1|||
160924441|NCT01641692|581117028|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924442|NCT01641692|581117029|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924443|NCT01641692|581117030|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924444|NCT01641692|581117031|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924445|NCT01641692|581117032|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
160924446|NCT01641692|581117033|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924447|NCT01641692|581117034|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
160924448|NCT01641692|581117035|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
160924449|NCT01641692|581117028|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924450|NCT01641692|581117029|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924451|NCT01641692|581117030|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160924452|NCT01641692|581117031|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924453|NCT01641692|581117032|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924454|NCT01641692|581117033|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160924455|NCT01641692|581117034|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160924456|NCT01641692|581117035|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160924457|NCT01641692|581117028|FG000|Treatment Period 3|Adverse Event|0|||
160924458|NCT01641692|581117029|FG001|Treatment Period 3|Adverse Event|0|||
160924459|NCT01641692|581117030|FG002|Treatment Period 3|Adverse Event|0|||
161262566|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
161262567|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
161262568|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
161262569|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
161262570|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
161262571|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
161262572|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
161262573|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
161262574|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
161262575|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
161262576|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
161262577|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
161262578|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
161262579|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
161262580|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
161262581|NCT01421342|582341297|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
161262582|NCT01421342|582341298|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
161262583|NCT01421342|582341299|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
161262584|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
161262585|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
161262586|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
161262587|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
161262588|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
161262589|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
161262590|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
161262591|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
161262592|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
161262593|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
161262594|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
160924460|NCT01641692|581117031|FG003|Treatment Period 3|Adverse Event|0|||
160924461|NCT01641692|581117032|FG004|Treatment Period 3|Adverse Event|0|||
160924462|NCT01641692|581117033|FG005|Treatment Period 3|Adverse Event|0|||
160924463|NCT01641692|581117034|FG006|Treatment Period 3|Adverse Event|1|||
160924464|NCT01641692|581117035|FG007|Treatment Period 3|Adverse Event|0|||
160924465|NCT01641692|581117028|FG000|Treatment Period 3|Protocol Violation|0|||
160924466|NCT01641692|581117029|FG001|Treatment Period 3|Protocol Violation|0|||
160924467|NCT01641692|581117030|FG002|Treatment Period 3|Protocol Violation|1|||
160924468|NCT01641692|581117031|FG003|Treatment Period 3|Protocol Violation|0|||
160924469|NCT01641692|581117032|FG004|Treatment Period 3|Protocol Violation|0|||
160924470|NCT01641692|581117033|FG005|Treatment Period 3|Protocol Violation|0|||
160924471|NCT01641692|581117034|FG006|Treatment Period 3|Protocol Violation|0|||
160924472|NCT01641692|581117035|FG007|Treatment Period 3|Protocol Violation|0|||
160924473|NCT01641692|581117028|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924474|NCT01641692|581117029|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924475|NCT01641692|581117030|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924476|NCT01641692|581117031|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924477|NCT01641692|581117032|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924478|NCT01641692|581117033|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924479|NCT01641692|581117034|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
160924480|NCT01641692|581117035|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
160924481|NCT01641692|581117028|FG000|Treatment Period 3|Lost to Follow-up|0|||
160924482|NCT01641692|581117029|FG001|Treatment Period 3|Lost to Follow-up|1|||
160924483|NCT01641692|581117030|FG002|Treatment Period 3|Lost to Follow-up|0|||
160924484|NCT01641692|581117031|FG003|Treatment Period 3|Lost to Follow-up|0|||
160924485|NCT01641692|581117032|FG004|Treatment Period 3|Lost to Follow-up|0|||
160924486|NCT01641692|581117033|FG005|Treatment Period 3|Lost to Follow-up|0|||
160924487|NCT01641692|581117034|FG006|Treatment Period 3|Lost to Follow-up|0|||
160924488|NCT01641692|581117035|FG007|Treatment Period 3|Lost to Follow-up|0|||
160924489|NCT01641692|581117028|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924490|NCT01641692|581117029|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924491|NCT01641692|581117030|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924492|NCT01641692|581117031|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924493|NCT01641692|581117032|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924494|NCT01641692|581117033|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
160924495|NCT01641692|581117034|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924496|NCT01641692|581117035|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
160924497|NCT01641692|581117028|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924498|NCT01641692|581117029|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
160924499|NCT01641692|581117030|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924500|NCT01641692|581117031|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924501|NCT01641692|581117032|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
160924502|NCT01641692|581117033|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924503|NCT01641692|581117034|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
160924504|NCT01641692|581117035|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
160924505|NCT02295995|581117037|FG000|Overall Study|Lost to Follow-up|5|||
160924506|NCT02295995|581117038|FG001|Overall Study|Lost to Follow-up|1|||
160924507|NCT03649711|581117039|FG000|Overall Study|Adverse Event|0|||
160924508|NCT03649711|581117040|FG001|Overall Study|Adverse Event|1|||
160924509|NCT03649711|581117041|FG002|Overall Study|Adverse Event|0|||
160924510|NCT03649711|581117039|FG000|Overall Study|Kidney Transplant|1|||
161262595|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
161262596|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
161262597|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
161262598|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
161262599|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
161262600|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
161262601|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
161262602|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
161262603|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
161262604|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
161262605|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
161262606|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
161262607|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
161262608|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
161262609|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
161262610|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
161262611|NCT01421342|582341297|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
161262612|NCT01421342|582341298|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
161262613|NCT01421342|582341299|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
161262614|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
161341398|NCT01648764|582637497|FG011|Overall Study|Withdrawal by Subject|0|||
160924511|NCT03649711|581117040|FG001|Overall Study|Kidney Transplant|0|||
160924512|NCT03649711|581117041|FG002|Overall Study|Kidney Transplant|0|||
160924513|NCT04007094|581117046|FG000|Overall Study|Lost to Follow-up|1|||
160924514|NCT04007094|581117047|FG001|Overall Study|Lost to Follow-up|1|||
160924515|NCT02921776|581117052|FG000|Overall Study|patient deterioration, fatigue|2|||
160924516|NCT02921776|581117053|FG001|Overall Study|patient deterioration, fatigue|6|||
160924517|NCT02921776|581117054|FG002|Overall Study|patient deterioration, fatigue|0|||
160924518|NCT02921776|581117055|FG003|Overall Study|patient deterioration, fatigue|0|||
160924519|NCT02921776|581117056|FG004|Overall Study|patient deterioration, fatigue|0|||
160924520|NCT02921776|581117057|FG005|Overall Study|patient deterioration, fatigue|0|||
160924521|NCT02921776|581117058|FG006|Overall Study|patient deterioration, fatigue|0|||
160924522|NCT02921776|581117059|FG007|Overall Study|patient deterioration, fatigue|0|||
160924523|NCT02921776|581117052|FG000|Overall Study|Withdrawal by Subject|0|||
160924524|NCT02921776|581117053|FG001|Overall Study|Withdrawal by Subject|2|||
160924525|NCT02921776|581117054|FG002|Overall Study|Withdrawal by Subject|0|||
160924526|NCT02921776|581117055|FG003|Overall Study|Withdrawal by Subject|1|||
160924527|NCT02921776|581117056|FG004|Overall Study|Withdrawal by Subject|1|||
160924528|NCT02921776|581117057|FG005|Overall Study|Withdrawal by Subject|0|||
160924529|NCT02921776|581117058|FG006|Overall Study|Withdrawal by Subject|8|||
160924530|NCT02921776|581117059|FG007|Overall Study|Withdrawal by Subject|1|||
160924531|NCT02921776|581117052|FG000|Overall Study|Death|0|||
160924532|NCT02921776|581117053|FG001|Overall Study|Death|0|||
160924533|NCT02921776|581117054|FG002|Overall Study|Death|0|||
160924534|NCT02921776|581117055|FG003|Overall Study|Death|2|||
160924535|NCT02921776|581117056|FG004|Overall Study|Death|0|||
160924536|NCT02921776|581117057|FG005|Overall Study|Death|0|||
160924537|NCT02921776|581117058|FG006|Overall Study|Death|0|||
160924538|NCT02921776|581117059|FG007|Overall Study|Death|0|||
160924539|NCT02921776|581117052|FG000|Overall Study|extubation or early discharge|0|||
160924540|NCT02921776|581117053|FG001|Overall Study|extubation or early discharge|0|||
160924541|NCT02921776|581117054|FG002|Overall Study|extubation or early discharge|0|||
160924542|NCT02921776|581117055|FG003|Overall Study|extubation or early discharge|5|||
160924543|NCT02921776|581117056|FG004|Overall Study|extubation or early discharge|5|||
160924544|NCT02921776|581117057|FG005|Overall Study|extubation or early discharge|0|||
160924545|NCT02921776|581117058|FG006|Overall Study|extubation or early discharge|0|||
160924546|NCT02921776|581117059|FG007|Overall Study|extubation or early discharge|0|||
160924547|NCT02921776|581117052|FG000|Overall Study|Lost to Follow-up|0|||
160924548|NCT02921776|581117053|FG001|Overall Study|Lost to Follow-up|0|||
160924549|NCT02921776|581117054|FG002|Overall Study|Lost to Follow-up|0|||
160924550|NCT02921776|581117055|FG003|Overall Study|Lost to Follow-up|0|||
160924551|NCT02921776|581117056|FG004|Overall Study|Lost to Follow-up|0|||
160924552|NCT02921776|581117057|FG005|Overall Study|Lost to Follow-up|2|||
160924553|NCT02921776|581117058|FG006|Overall Study|Lost to Follow-up|3|||
160924554|NCT02921776|581117059|FG007|Overall Study|Lost to Follow-up|6|||
160924555|NCT04350788|581117068|FG000|Overall Study|Lost to Follow-up|6|||
160924556|NCT04350788|581117069|FG001|Overall Study|Lost to Follow-up|2|||
160924557|NCT04350788|581117068|FG000|Overall Study|Withdrawal by Subject|2|||
160924558|NCT04350788|581117069|FG001|Overall Study|Withdrawal by Subject|4|||
160924559|NCT04350788|581117068|FG000|Overall Study|Protocol Violation|4|||
160924560|NCT04350788|581117069|FG001|Overall Study|Protocol Violation|0|||
160924561|NCT01581307|581117070|FG000|Overall Study|Withdrawal by Subject|1|||
160924562|NCT00378209|581117071|FG000|Overall Study|Progressive disease|11|||
160924563|NCT00378209|581117071|FG000|Overall Study|Adverse Event|3|||
160924564|NCT00378209|581117071|FG000|Overall Study|Initiation of non-protocol therapy|3|||
160924565|NCT00378209|581117071|FG000|Overall Study|Physician Decision|3|||
160924566|NCT00378209|581117071|FG000|Overall Study|Death|1|||
160924567|NCT00378209|581117071|FG000|Overall Study|Treatment delay|1|||
160924568|NCT02070744|581117072|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924569|NCT02070744|581117073|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924570|NCT02070744|581117074|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924571|NCT02070744|581117075|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
160924572|NCT02070744|581117076|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
160924573|NCT02070744|581117072|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160924574|NCT02070744|581117073|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160924575|NCT02070744|581117074|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160997928|NCT01144182|581376686|FG000|Overall Study|Lost to Follow-up|9|||
161262615|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
161262616|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
161262617|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
161262618|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
161262619|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
161262620|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
161262621|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
161262622|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
160997929|NCT01144182|581376687|FG001|Overall Study|Lost to Follow-up|9|||
160924576|NCT02070744|581117075|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
160924577|NCT02070744|581117076|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
160924578|NCT02070744|581117072|FG000|OLE Phase (48 Weeks)|Other|0|||
160924579|NCT02070744|581117073|FG001|OLE Phase (48 Weeks)|Other|0|||
160924580|NCT02070744|581117074|FG002|OLE Phase (48 Weeks)|Other|0|||
160924581|NCT02070744|581117075|FG003|OLE Phase (48 Weeks)|Other|0|||
160924582|NCT02070744|581117076|FG004|OLE Phase (48 Weeks)|Other|1|||
160924583|NCT07114198|581117080|FG000|Overall Study|Protocol Violation|1|||
160924584|NCT07114198|581117081|FG001|Overall Study|Protocol Violation|1|||
160924585|NCT04439253|581118998|FG000|Overall Study|Adverse Event|1|||
160924586|NCT04439253|581118998|FG000|Overall Study|Disease progression|2|||
160924587|NCT04439253|581118998|FG000|Overall Study|Complicating disease|1|||
160924588|NCT00858442|581118999|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
160924589|NCT00858442|581119000|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
160924590|NCT02155738|581119003|FG000|Overall Study|Missing critical information|1|||
160924591|NCT02155738|581119004|FG001|Overall Study|Missing critical information|0|||
160924592|NCT02155738|581119005|FG002|Overall Study|Missing critical information|0|||
160924593|NCT02155738|581119006|FG003|Overall Study|Missing critical information|1|||
160924594|NCT02016625|581119007|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
160924595|NCT02016625|581119008|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
160924596|NCT02016625|581119007|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
160924597|NCT02016625|581119008|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
160924598|NCT02016625|581119007|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
160924599|NCT02016625|581119008|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
160924600|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
160924601|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
160924602|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
160924603|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
160924604|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
160924605|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
160924606|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
160924607|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
160924608|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
160924609|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
160924610|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
160924611|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
160924612|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
160924613|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
160924614|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
160924615|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
160924616|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
160924617|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
160924618|NCT00887354|581119011|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
160924619|NCT00887354|581119012|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
160924620|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
160924621|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
160924622|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
160924623|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
160924624|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
160924625|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
160924626|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
160924627|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
160924628|NCT00887354|581119011|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
160924629|NCT00887354|581119012|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
160924630|NCT01466348|581119013|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
160924631|NCT01466348|581119014|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
160924632|NCT02189473|581119019|FG000|Overall Study|Death|22|||
160924633|NCT02189473|581119020|FG001|Overall Study|Death|23|||
160924634|NCT02189473|581119019|FG000|Overall Study|Lost to Follow-up|1|||
160924635|NCT02189473|581119020|FG001|Overall Study|Lost to Follow-up|2|||
160924636|NCT02784821|581119021|FG000|Overall Study|Death|0|||
160924637|NCT02784821|581119022|FG001|Overall Study|Death|5|||
160924638|NCT02784821|581119023|FG002|Overall Study|Death|4|||
160924639|NCT02784821|581119024|FG003|Overall Study|Death|5|||
160924640|NCT01139450|581119025|FG000|Overall Study|Withdrawal by Subject|7|||
160924641|NCT01139450|581119026|FG001|Overall Study|Withdrawal by Subject|10|||
160924642|NCT01139450|581119027|FG002|Overall Study|Withdrawal by Subject|13|||
160924643|NCT01139450|581119025|FG000|Overall Study|Lack of Efficacy|3|||
160924644|NCT01139450|581119026|FG001|Overall Study|Lack of Efficacy|1|||
160924645|NCT01139450|581119027|FG002|Overall Study|Lack of Efficacy|8|||
160924646|NCT01139450|581119025|FG000|Overall Study|Protocol Violation|6|||
160924647|NCT01139450|581119026|FG001|Overall Study|Protocol Violation|5|||
160924648|NCT01139450|581119027|FG002|Overall Study|Protocol Violation|2|||
160924649|NCT01139450|581119025|FG000|Overall Study|Lost to Follow-up|9|||
160924650|NCT01139450|581119026|FG001|Overall Study|Lost to Follow-up|7|||
160924651|NCT01139450|581119027|FG002|Overall Study|Lost to Follow-up|11|||
160924652|NCT01139450|581119025|FG000|Overall Study|Administrative|0|||
160924653|NCT01139450|581119026|FG001|Overall Study|Administrative|0|||
160924654|NCT01139450|581119027|FG002|Overall Study|Administrative|1|||
160924655|NCT01139450|581119025|FG000|Overall Study|Adverse Event|2|||
160924656|NCT01139450|581119026|FG001|Overall Study|Adverse Event|2|||
160924657|NCT01139450|581119027|FG002|Overall Study|Adverse Event|3|||
160924658|NCT02794103|581119028|FG000|Overall Study|Loss to follow up due to high sedation|3|||
160924659|NCT02535741|581119033|FG000|Overall Study|Adverse Event|3|||
160924660|NCT02535741|581119033|FG000|Overall Study|Withdrawal by Subject|9|||
160924661|NCT02535741|581119033|FG000|Overall Study|Lost to Follow-up|10|||
160924662|NCT02535741|581119033|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
160924663|NCT02535741|581119033|FG000|Overall Study|Missing data|6|||
160924664|NCT01652664|581119039|FG000|Overall Study|Treatment Failure|5|||
160924665|NCT01652664|581119040|FG001|Overall Study|Treatment Failure|1|||
160924666|NCT01652664|581119039|FG000|Overall Study|Inadequate IOP control|1|||
161262623|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
160924667|NCT01652664|581119040|FG001|Overall Study|Inadequate IOP control|0|||
160924668|NCT00297037|581119041|FG000|Overall Study|Withdrawal by Subject|2|||
160924669|NCT00297037|581119042|FG001|Overall Study|Withdrawal by Subject|0|||
160924670|NCT00491387|581119047|FG000|Overall Study|study terminated|20|||
160924671|NCT00949325|581119054|FG000|Overall Study|Adverse Event|0|||
160924672|NCT00949325|581119055|FG001|Overall Study|Adverse Event|2|||
160924673|NCT00949325|581119056|FG002|Overall Study|Adverse Event|0|||
160924674|NCT02809677|581119057|FG000|Overall Study|Withdrawal by Subject|8|||
160924675|NCT05172544|581119062|FG000|Overall Study|Withdrawal by Subject|1|||
160924676|NCT05172544|581119063|FG001|Overall Study|Withdrawal by Subject|0|||
160924677|NCT05172544|581119064|FG002|Overall Study|Withdrawal by Subject|0|||
160924678|NCT05172544|581119062|FG000|Overall Study|Physician Decision|0|||
160924679|NCT05172544|581119063|FG001|Overall Study|Physician Decision|0|||
160924680|NCT05172544|581119064|FG002|Overall Study|Physician Decision|1|||
160924681|NCT03311659|581119069|FG000|Overall Study|Protocol Violation|1|||
160924682|NCT04327388|581119072|FG000|Overall Study|Adverse Event|17|||
160924683|NCT04327388|581119073|FG001|Overall Study|Adverse Event|18|||
160924684|NCT04327388|581119074|FG002|Overall Study|Adverse Event|9|||
160924685|NCT04327388|581119072|FG000|Overall Study|Other|1|||
160924686|NCT04327388|581119073|FG001|Overall Study|Other|2|||
160924687|NCT04327388|581119074|FG002|Overall Study|Other|0|||
160924688|NCT04327388|581119072|FG000|Overall Study|Randomized and not treated|2|||
160924689|NCT04327388|581119073|FG001|Overall Study|Randomized and not treated|0|||
160924690|NCT04327388|581119074|FG002|Overall Study|Randomized and not treated|2|||
160924691|NCT04829318|581119075|FG000|Overall Study|Adverse Event|6|||
160924692|NCT04829318|581119075|FG000|Overall Study|Death|1|||
160924693|NCT04829318|581119075|FG000|Overall Study|Lost to Follow-up|1|||
161262624|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
161262625|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
161262626|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
161262627|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
161262628|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
161262629|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
161262630|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
161262631|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
161262632|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
161262633|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
161262634|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
161262635|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161262636|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161262637|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
161262638|NCT01421342|582341297|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
161262639|NCT01421342|582341298|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
161262640|NCT01421342|582341299|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
161262641|NCT04505293|582341300|FG000|Overall Study|Lost to Follow-up|2|||
161262642|NCT04505293|582341300|FG000|Overall Study|Withdrawal by Subject|6|||
161262643|NCT04505293|582341300|FG000|Overall Study|CT scan unreadable|277|||
161262644|NCT04295135|582341301|FG000|Overall Study|Withdrawal by Subject|2|||
161262645|NCT04295135|582341302|FG001|Overall Study|Withdrawal by Subject|1|||
161262646|NCT04295135|582341301|FG000|Overall Study|Subject left organization|8|||
161262647|NCT04295135|582341302|FG001|Overall Study|Subject left organization|4|||
160924694|NCT04829318|581119075|FG000|Overall Study|Physician Decision|1|||
160924695|NCT04829318|581119075|FG000|Overall Study|Withdrawal by Subject|19|||
160924696|NCT04829318|581119075|FG000|Overall Study|Site terminated by sponsor|1|||
160924697|NCT04829318|581119075|FG000|Overall Study|Sponsor decision|5|||
160924698|NCT04829318|581119075|FG000|Overall Study|Other|1|||
160924699|NCT00728130|581119076|FG000|Overall Study|Withdrawal by Subject|1|||
160924700|NCT00728130|581119076|FG000|Overall Study|Paperwork not completed in time|1|||
160924701|NCT00728130|581119076|FG000|Overall Study|Physician Decision|1|||
160924702|NCT04053023|581119079|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
160924703|NCT04053023|581119080|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
160924704|NCT03447990|581119081|FG000|Overall Study|Withdrawal by Subject|0|||
161262648|NCT01300052|582341305|FG000|Overall Study|Adverse Event|3|||
161262649|NCT01300052|582341306|FG001|Overall Study|Adverse Event|0|||
161262650|NCT01300052|582341305|FG000|Overall Study|Withdrawal by Subject|2|||
161262651|NCT01300052|582341306|FG001|Overall Study|Withdrawal by Subject|2|||
160924705|NCT03447990|581119082|FG001|Overall Study|Withdrawal by Subject|0|||
160924706|NCT03447990|581119083|FG002|Overall Study|Withdrawal by Subject|0|||
160924707|NCT03447990|581119084|FG003|Overall Study|Withdrawal by Subject|0|||
160924708|NCT03447990|581119085|FG004|Overall Study|Withdrawal by Subject|0|||
160924709|NCT03447990|581119086|FG005|Overall Study|Withdrawal by Subject|0|||
161262652|NCT01300052|582341305|FG000|Overall Study|Protocol Violation|1|||
161262653|NCT01300052|582341306|FG001|Overall Study|Protocol Violation|1|||
161262654|NCT01782482|582341307|FG000|Overall Study|Adverse Event|2|||
161262655|NCT01782482|582341308|FG001|Overall Study|Adverse Event|1|||
161262656|NCT01782482|582341307|FG000|Overall Study|Lost to Follow-up|2|||
161262657|NCT01782482|582341308|FG001|Overall Study|Lost to Follow-up|3|||
161262658|NCT01782482|582341307|FG000|Overall Study|Physician Decision|1|||
161262659|NCT01782482|582341308|FG001|Overall Study|Physician Decision|0|||
161262660|NCT01782482|582341307|FG000|Overall Study|Protocol Violation|1|||
161262661|NCT01782482|582341308|FG001|Overall Study|Protocol Violation|0|||
161262662|NCT01782482|582341307|FG000|Overall Study|Withdrawal by Subject|2|||
161262663|NCT01782482|582341308|FG001|Overall Study|Withdrawal by Subject|3|||
161262664|NCT01782482|582341307|FG000|Overall Study|Randomized in Error|2|||
161262665|NCT01782482|582341308|FG001|Overall Study|Randomized in Error|2|||
161262666|NCT01782482|582341307|FG000|Overall Study|Habitually wearing toric lens OS|0|||
161262667|NCT01782482|582341308|FG001|Overall Study|Habitually wearing toric lens OS|1|||
161262668|NCT00767520|582341309|FG000|Overall Study|Participants still on treatment|11|||
161262669|NCT00767520|582341310|FG001|Overall Study|Participants still on treatment|15|||
161262670|NCT00767520|582341309|FG000|Overall Study|Randomized in error and Never treated|0|||
161262671|NCT00767520|582341310|FG001|Overall Study|Randomized in error and Never treated|2|||
161262672|NCT01901874|582341320|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
161262673|NCT01901874|582341320|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
161262674|NCT01901874|582341320|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
161262675|NCT01901874|582341320|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
161262676|NCT01901874|582341320|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
161262677|NCT01901874|582341320|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
161262678|NCT03078582|582341321|FG000|Overall Study|Adverse Event|0|||
161262679|NCT03078582|582341322|FG001|Overall Study|Adverse Event|8|||
161262680|NCT01491035|582341336|FG000|Overall Study|Lost to Follow-up|0|||
161262681|NCT01491035|582341337|FG001|Overall Study|Lost to Follow-up|0|||
161262682|NCT01491035|582341338|FG002|Overall Study|Lost to Follow-up|0|||
161262683|NCT01491035|582341339|FG003|Overall Study|Lost to Follow-up|0|||
161262684|NCT01491035|582341340|FG004|Overall Study|Lost to Follow-up|1|||
161262685|NCT01491035|582341341|FG005|Overall Study|Lost to Follow-up|0|||
161262686|NCT01491035|582341342|FG006|Overall Study|Lost to Follow-up|0|||
161262687|NCT01491035|582341343|FG007|Overall Study|Lost to Follow-up|0|||
161262688|NCT02025751|582341344|FG000|Overall Study|Lost to Follow-up|1|||
161262689|NCT02025751|582341345|FG001|Overall Study|Lost to Follow-up|0|||
161262690|NCT02025751|582341344|FG000|Overall Study|Adverse Event|0|||
161262691|NCT02025751|582341345|FG001|Overall Study|Adverse Event|1|||
161262692|NCT02025751|582341344|FG000|Overall Study|Physician Decision|0|||
161262693|NCT02025751|582341345|FG001|Overall Study|Physician Decision|1|||
161262694|NCT02025751|582341344|FG000|Overall Study|Withdrawal by Subject|0|||
161262695|NCT02025751|582341345|FG001|Overall Study|Withdrawal by Subject|1|||
161262696|NCT02687360|582341348|FG000|Overall Study|Withdrawal by Subject|3|||
161262697|NCT02687360|582341349|FG001|Overall Study|Withdrawal by Subject|0|||
161262698|NCT02181296|582341351|FG000|Overall Study|Lost to Follow-up|7|||
161262699|NCT02181296|582341352|FG001|Overall Study|Lost to Follow-up|6|||
161262700|NCT01568866|582341353|FG000|Overall Study|Disease Progression|208|||
161262701|NCT01568866|582341354|FG001|Overall Study|Disease Progression|183|||
161262702|NCT01568866|582341353|FG000|Overall Study|Adverse Event|94|||
161262703|NCT01568866|582341354|FG001|Overall Study|Adverse Event|96|||
161262704|NCT01568866|582341353|FG000|Overall Study|Patient Request|55|||
161262705|NCT01568866|582341354|FG001|Overall Study|Patient Request|71|||
161262706|NCT01568866|582341353|FG000|Overall Study|Physician Decision|40|||
161262707|NCT01568866|582341354|FG001|Overall Study|Physician Decision|32|||
161262708|NCT01568866|582341353|FG000|Overall Study|Withdrawal by Subject|19|||
161262709|NCT01568866|582341354|FG001|Overall Study|Withdrawal by Subject|11|||
161262710|NCT01568866|582341353|FG000|Overall Study|Death|10|||
160924710|NCT03447990|581119087|FG006|Overall Study|Withdrawal by Subject|1|||
160924711|NCT03755414|581119089|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
160924712|NCT03755414|581119090|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
160924713|NCT03755414|581119091|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
160924714|NCT03755414|581119089|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
160924715|NCT03755414|581119090|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
160924716|NCT03755414|581119091|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
160924717|NCT03755414|581119089|FG000|Overall Study|Non-compliance|0|||
160924718|NCT03755414|581119090|FG001|Overall Study|Non-compliance|1|||
160924719|NCT03755414|581119091|FG002|Overall Study|Non-compliance|0|||
160924720|NCT02153112|581119092|FG000|Overall Study|Adverse Event|0|||
160924721|NCT02153112|581119093|FG001|Overall Study|Adverse Event|0|||
160924722|NCT02153112|581119094|FG002|Overall Study|Adverse Event|1|||
160924723|NCT02153112|581119095|FG003|Overall Study|Adverse Event|0|||
160924724|NCT02153112|581119096|FG004|Overall Study|Adverse Event|0|||
160924725|NCT02153112|581119097|FG005|Overall Study|Adverse Event|0|||
160924726|NCT02153112|581119098|FG006|Overall Study|Adverse Event|0|||
160924727|NCT02153112|581119099|FG007|Overall Study|Adverse Event|0|||
160924728|NCT02153112|581119100|FG008|Overall Study|Adverse Event|0|||
161341399|NCT01648764|582637498|FG012|Overall Study|Withdrawal by Subject|1|||
161341400|NCT01648764|582637499|FG013|Overall Study|Withdrawal by Subject|0|||
161341401|NCT01648764|582637486|FG000|Overall Study|Investigator Decision|0|||
161341402|NCT01648764|582637487|FG001|Overall Study|Investigator Decision|0|||
161341403|NCT01648764|582637488|FG002|Overall Study|Investigator Decision|0|||
161341404|NCT01648764|582637489|FG003|Overall Study|Investigator Decision|0|||
161341405|NCT01648764|582637490|FG004|Overall Study|Investigator Decision|0|||
161341406|NCT01648764|582637491|FG005|Overall Study|Investigator Decision|0|||
161341407|NCT01648764|582637492|FG006|Overall Study|Investigator Decision|1|||
161341408|NCT01648764|582637493|FG007|Overall Study|Investigator Decision|0|||
160924729|NCT02153112|581119101|FG009|Overall Study|Adverse Event|0|||
160924730|NCT02153112|581119092|FG000|Overall Study|Lost to Follow-up|1|||
160924731|NCT02153112|581119093|FG001|Overall Study|Lost to Follow-up|1|||
160924732|NCT02153112|581119094|FG002|Overall Study|Lost to Follow-up|0|||
160924733|NCT02153112|581119095|FG003|Overall Study|Lost to Follow-up|0|||
160924734|NCT02153112|581119096|FG004|Overall Study|Lost to Follow-up|2|||
160924735|NCT02153112|581119097|FG005|Overall Study|Lost to Follow-up|1|||
160924736|NCT02153112|581119098|FG006|Overall Study|Lost to Follow-up|1|||
160924737|NCT02153112|581119099|FG007|Overall Study|Lost to Follow-up|0|||
160924738|NCT02153112|581119100|FG008|Overall Study|Lost to Follow-up|1|||
160924739|NCT02153112|581119101|FG009|Overall Study|Lost to Follow-up|1|||
160924740|NCT02153112|581119092|FG000|Overall Study|Withdrawal by Subject|3|||
160997930|NCT03254394|581376697|FG000|Overall Study|Withdrawal by Subject|0|||
160997931|NCT03254394|581376698|FG001|Overall Study|Withdrawal by Subject|2|||
161262711|NCT01568866|582341354|FG001|Overall Study|Death|18|||
161262712|NCT01568866|582341353|FG000|Overall Study|Protocol Non-compliance|2|||
161262713|NCT01568866|582341354|FG001|Overall Study|Protocol Non-compliance|4|||
161262714|NCT01568866|582341353|FG000|Overall Study|Lost to Follow-up|1|||
161262715|NCT01568866|582341354|FG001|Overall Study|Lost to Follow-up|0|||
161262716|NCT01568866|582341353|FG000|Overall Study|Randomized but Not Dosed|9|||
161262717|NCT01568866|582341354|FG001|Overall Study|Randomized but Not Dosed|1|||
161262718|NCT03864042|582341355|FG000|DDI Phase|Adverse Event|2|||
161262719|NCT03864042|582341356|FG001|DDI Phase|Adverse Event|0|||
161262720|NCT03864042|582341357|FG002|DDI Phase|Adverse Event|0|||
161262721|NCT03864042|582341355|FG000|DDI Phase|Physician Decision|1|||
161262722|NCT03864042|582341356|FG001|DDI Phase|Physician Decision|0|||
161262723|NCT03864042|582341357|FG002|DDI Phase|Physician Decision|0|||
161262724|NCT03864042|582341355|FG000|DDI Phase|Progressive Disease|1|||
161262725|NCT03864042|582341356|FG001|DDI Phase|Progressive Disease|0|||
161262726|NCT03864042|582341357|FG002|DDI Phase|Progressive Disease|0|||
161262727|NCT03864042|582341355|FG000|Post-DDI Phase|Adverse Event|5|||
161262728|NCT03864042|582341356|FG001|Post-DDI Phase|Adverse Event|3|||
160924741|NCT02153112|581119093|FG001|Overall Study|Withdrawal by Subject|1|||
160924742|NCT02153112|581119094|FG002|Overall Study|Withdrawal by Subject|2|||
160924743|NCT02153112|581119095|FG003|Overall Study|Withdrawal by Subject|2|||
160924744|NCT02153112|581119096|FG004|Overall Study|Withdrawal by Subject|1|||
160997932|NCT02163915|581376699|FG000|Overall Study|Withdrawal by Subject|2|||
161262729|NCT03864042|582341357|FG002|Post-DDI Phase|Adverse Event|2|||
161262730|NCT03864042|582341355|FG000|Post-DDI Phase|Progressive Disease|11|||
161262731|NCT03864042|582341356|FG001|Post-DDI Phase|Progressive Disease|6|||
161262732|NCT03864042|582341357|FG002|Post-DDI Phase|Progressive Disease|13|||
160997933|NCT02163915|581376700|FG001|Overall Study|Withdrawal by Subject|0|||
160997934|NCT02163915|581376701|FG002|Overall Study|Withdrawal by Subject|2|||
161341409|NCT01648764|582637494|FG008|Overall Study|Investigator Decision|0|||
161341410|NCT01648764|582637495|FG009|Overall Study|Investigator Decision|0|||
161262733|NCT03864042|582341355|FG000|Post-DDI Phase|Discretion of investigator|1|||
161341411|NCT01648764|582637496|FG010|Overall Study|Investigator Decision|0|||
161341412|NCT01648764|582637497|FG011|Overall Study|Investigator Decision|1|||
161341413|NCT01648764|582637498|FG012|Overall Study|Investigator Decision|0|||
161341414|NCT01648764|582637499|FG013|Overall Study|Investigator Decision|0|||
161341415|NCT04889040|582637500|FG000|Overall Study|Withdrawal by Subject|3|||
161341416|NCT04889040|582637501|FG001|Overall Study|Withdrawal by Subject|3|||
161341417|NCT04889040|582637500|FG000|Overall Study|Lost to Follow-up|0|||
161341418|NCT04889040|582637501|FG001|Overall Study|Lost to Follow-up|1|||
161341419|NCT04889040|582637500|FG000|Overall Study|Adverse Event|2|||
161341420|NCT04889040|582637501|FG001|Overall Study|Adverse Event|1|||
161341421|NCT03801252|582637504|FG000|Overall Study|Protocol Violation|1|||
161341422|NCT03801252|582637505|FG001|Overall Study|Protocol Violation|2|||
161341423|NCT00855582|582637508|FG000|Overall Study|Adverse Event|2|||
161341424|NCT00855582|582637509|FG001|Overall Study|Adverse Event|6|||
161341425|NCT00855582|582637510|FG002|Overall Study|Adverse Event|3|||
161341426|NCT00855582|582637508|FG000|Overall Study|Death|1|||
161341427|NCT00855582|582637509|FG001|Overall Study|Death|0|||
161341428|NCT00855582|582637510|FG002|Overall Study|Death|0|||
161341429|NCT00855582|582637508|FG000|Overall Study|Lack of Efficacy|1|||
161341430|NCT00855582|582637509|FG001|Overall Study|Lack of Efficacy|3|||
161341431|NCT00855582|582637510|FG002|Overall Study|Lack of Efficacy|8|||
161341432|NCT00855582|582637508|FG000|Overall Study|Lost to Follow-up|1|||
161341433|NCT00855582|582637509|FG001|Overall Study|Lost to Follow-up|3|||
161341434|NCT00855582|582637510|FG002|Overall Study|Lost to Follow-up|1|||
161341435|NCT00855582|582637508|FG000|Overall Study|Physician Decision|0|||
161341436|NCT00855582|582637509|FG001|Overall Study|Physician Decision|0|||
161341437|NCT00855582|582637510|FG002|Overall Study|Physician Decision|1|||
161341438|NCT00855582|582637508|FG000|Overall Study|Protocol Violation|6|||
161341439|NCT00855582|582637509|FG001|Overall Study|Protocol Violation|2|||
161341440|NCT00855582|582637510|FG002|Overall Study|Protocol Violation|6|||
161341441|NCT00855582|582637508|FG000|Overall Study|Entry Criteria Not Met|8|||
161341442|NCT00855582|582637509|FG001|Overall Study|Entry Criteria Not Met|6|||
161341443|NCT00855582|582637510|FG002|Overall Study|Entry Criteria Not Met|3|||
161341444|NCT00855582|582637508|FG000|Overall Study|Withdrawal by Subject|7|||
161341445|NCT00855582|582637509|FG001|Overall Study|Withdrawal by Subject|4|||
161341446|NCT00855582|582637510|FG002|Overall Study|Withdrawal by Subject|8|||
161341447|NCT02832037|582637514|FG000|Overall Study|Administrative reasons|0|||
161341448|NCT02832037|582637515|FG001|Overall Study|Administrative reasons|0|||
161341449|NCT02832037|582637516|FG002|Overall Study|Administrative reasons|1|||
161341450|NCT02832037|582637517|FG003|Overall Study|Administrative reasons|0|||
161341451|NCT02832037|582637518|FG004|Overall Study|Administrative reasons|0|||
161341452|NCT02832037|582637514|FG000|Overall Study|Protocol Violation|3|||
161341453|NCT02832037|582637515|FG001|Overall Study|Protocol Violation|0|||
161341454|NCT02832037|582637516|FG002|Overall Study|Protocol Violation|4|||
161341455|NCT02832037|582637517|FG003|Overall Study|Protocol Violation|1|||
161341456|NCT02832037|582637518|FG004|Overall Study|Protocol Violation|2|||
161341457|NCT02832037|582637514|FG000|Overall Study|Lost to Follow-up|2|||
161341458|NCT02832037|582637515|FG001|Overall Study|Lost to Follow-up|0|||
161341459|NCT02832037|582637516|FG002|Overall Study|Lost to Follow-up|3|||
161341460|NCT02832037|582637517|FG003|Overall Study|Lost to Follow-up|0|||
161341461|NCT02832037|582637518|FG004|Overall Study|Lost to Follow-up|5|||
161341462|NCT02832037|582637514|FG000|Overall Study|Withdrawal by Subject|9|||
161341463|NCT02832037|582637515|FG001|Overall Study|Withdrawal by Subject|8|||
161341464|NCT02832037|582637516|FG002|Overall Study|Withdrawal by Subject|0|||
161341465|NCT02832037|582637517|FG003|Overall Study|Withdrawal by Subject|4|||
161341466|NCT02832037|582637518|FG004|Overall Study|Withdrawal by Subject|8|||
161341467|NCT02832037|582637514|FG000|Overall Study|Adverse Event|5|||
161341468|NCT02832037|582637515|FG001|Overall Study|Adverse Event|4|||
160997935|NCT02163915|581376702|FG003|Overall Study|Withdrawal by Subject|2|||
160997936|NCT02163915|581376703|FG004|Overall Study|Withdrawal by Subject|2|||
160997937|NCT02163915|581376699|FG000|Overall Study|Study termination|1|||
161341469|NCT02832037|582637516|FG002|Overall Study|Adverse Event|0|||
161341470|NCT02832037|582637517|FG003|Overall Study|Adverse Event|2|||
161341471|NCT02832037|582637518|FG004|Overall Study|Adverse Event|4|||
161341472|NCT02378181|582637525|FG000|Overall Study|Lost to Follow-up|2|||
160997938|NCT02163915|581376700|FG001|Overall Study|Study termination|0|||
161341473|NCT02378181|582637526|FG001|Overall Study|Lost to Follow-up|5|||
161341474|NCT02378181|582637525|FG000|Overall Study|Withdrawal by Subject|1|||
161341475|NCT02378181|582637526|FG001|Overall Study|Withdrawal by Subject|1|||
161341476|NCT02378181|582637525|FG000|Overall Study|Incarcerated|0|||
161341477|NCT02378181|582637526|FG001|Overall Study|Incarcerated|1|||
161341478|NCT01180777|582637527|FG000|Overall Study|Protocol Violation|6|||
161341479|NCT01180777|582637527|FG000|Overall Study|Poor lens fit|4|||
161341480|NCT01180777|582637527|FG000|Overall Study|Lost to Follow-up|1|||
161341481|NCT01180777|582637527|FG000|Overall Study|Adverse Event|1|||
161341482|NCT02765165|582637528|FG000|Treatment Period|Progressive disease|3|||
161341483|NCT02765165|582637529|FG001|Treatment Period|Progressive disease|2|||
161341484|NCT02765165|582637530|FG002|Treatment Period|Progressive disease|3|||
160997939|NCT02163915|581376701|FG002|Overall Study|Study termination|0|||
161341485|NCT02765165|582637531|FG003|Treatment Period|Progressive disease|3|||
160924745|NCT02153112|581119097|FG005|Overall Study|Withdrawal by Subject|1|||
160924746|NCT02153112|581119098|FG006|Overall Study|Withdrawal by Subject|7|||
160924747|NCT02153112|581119099|FG007|Overall Study|Withdrawal by Subject|2|||
160924748|NCT02153112|581119100|FG008|Overall Study|Withdrawal by Subject|13|||
160924749|NCT02153112|581119101|FG009|Overall Study|Withdrawal by Subject|12|||
160924750|NCT02153112|581119092|FG000|Overall Study|Reason not Specified|0|||
160924751|NCT02153112|581119093|FG001|Overall Study|Reason not Specified|0|||
160924752|NCT02153112|581119094|FG002|Overall Study|Reason not Specified|0|||
160924753|NCT02153112|581119095|FG003|Overall Study|Reason not Specified|0|||
160924754|NCT02153112|581119096|FG004|Overall Study|Reason not Specified|0|||
160924755|NCT02153112|581119097|FG005|Overall Study|Reason not Specified|0|||
160924756|NCT02153112|581119098|FG006|Overall Study|Reason not Specified|0|||
160924757|NCT02153112|581119099|FG007|Overall Study|Reason not Specified|0|||
160924758|NCT02153112|581119100|FG008|Overall Study|Reason not Specified|1|||
160924759|NCT02153112|581119101|FG009|Overall Study|Reason not Specified|1|||
160924760|NCT05104567|581119102|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924761|NCT05104567|581119103|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
160924762|NCT05104567|581119104|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924763|NCT05104567|581119105|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924764|NCT05104567|581119106|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924765|NCT05104567|581119107|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924766|NCT05104567|581119108|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
160924767|NCT05104567|581119102|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
160924768|NCT05104567|581119103|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
160924769|NCT05104567|581119104|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
160924770|NCT05104567|581119105|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
160924771|NCT05104567|581119106|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
160924772|NCT05104567|581119107|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
160997940|NCT02163915|581376702|FG003|Overall Study|Study termination|0|||
160997941|NCT02163915|581376703|FG004|Overall Study|Study termination|2|||
160997942|NCT02163915|581376699|FG000|Overall Study|Physician Decision|0|||
160997943|NCT02163915|581376700|FG001|Overall Study|Physician Decision|0|||
160997944|NCT02163915|581376701|FG002|Overall Study|Physician Decision|0|||
160997945|NCT02163915|581376702|FG003|Overall Study|Physician Decision|1|||
160997946|NCT02163915|581376703|FG004|Overall Study|Physician Decision|0|||
160997947|NCT02013037|581376707|FG000|Overall Study|Death|6|||
160997948|NCT02013037|581376707|FG000|Overall Study|Withdrawal by Subject|1|||
160997949|NCT02013037|581376707|FG000|Overall Study|Awaiting Transplantation|7|||
161262734|NCT03864042|582341356|FG001|Post-DDI Phase|Discretion of investigator|1|||
161262735|NCT03864042|582341357|FG002|Post-DDI Phase|Discretion of investigator|0|||
161262736|NCT03864042|582341355|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
161262737|NCT03864042|582341356|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
161262738|NCT03864042|582341357|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
161262739|NCT03864042|582341355|FG000|Post-DDI Phase|Withdrawal of consent|1|||
161262740|NCT03864042|582341356|FG001|Post-DDI Phase|Withdrawal of consent|2|||
161262741|NCT03864042|582341357|FG002|Post-DDI Phase|Withdrawal of consent|0|||
161262742|NCT01698775|582341358|FG000|Phase A|Adverse Event|2|||
161262743|NCT01698775|582341359|FG001|Phase A|Adverse Event|1|||
161262744|NCT01698775|582341358|FG000|Phase A|Death|1|||
161262745|NCT01698775|582341359|FG001|Phase A|Death|1|||
161262746|NCT01698775|582341358|FG000|Phase A|Lack of Efficacy|1|||
161262747|NCT01698775|582341359|FG001|Phase A|Lack of Efficacy|0|||
161262748|NCT01698775|582341358|FG000|Phase A|Lost to Follow-up|1|||
161262749|NCT01698775|582341359|FG001|Phase A|Lost to Follow-up|2|||
161262750|NCT01698775|582341358|FG000|Phase A|Protocol Violation|1|||
161262751|NCT01698775|582341359|FG001|Phase A|Protocol Violation|0|||
161262752|NCT01698775|582341358|FG000|Phase A|Withdrawal by Subject|3|||
161262753|NCT01698775|582341359|FG001|Phase A|Withdrawal by Subject|4|||
161262754|NCT01698775|582341358|FG000|Phase A|Kidney [transplant]|0|||
161341486|NCT02765165|582637532|FG004|Treatment Period|Progressive disease|4|||
161341487|NCT02765165|582637533|FG005|Treatment Period|Progressive disease|2|||
160924773|NCT05104567|581119108|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
160924774|NCT05104567|581119102|FG000|Overall Study|Progressive disease|3|||
160924775|NCT05104567|581119103|FG001|Overall Study|Progressive disease|13|||
160924776|NCT05104567|581119104|FG002|Overall Study|Progressive disease|13|||
160924777|NCT05104567|581119105|FG003|Overall Study|Progressive disease|17|||
160997950|NCT02013037|581376707|FG000|Overall Study|Transplanted without DSA|2|||
161262755|NCT01698775|582341359|FG001|Phase A|Kidney [transplant]|1|||
161262756|NCT01698775|582341358|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
160997951|NCT00798265|581376708|FG000|Overall Study|Lost to Follow-up|1|||
160997952|NCT00798265|581376709|FG001|Overall Study|Lost to Follow-up|10|||
161262757|NCT01698775|582341359|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
161262758|NCT01698775|582341358|FG000|Phase B|Adverse Event|6|||
161262759|NCT01698775|582341359|FG001|Phase B|Adverse Event|3|||
161262760|NCT01698775|582341358|FG000|Phase B|Death|0|||
161262761|NCT01698775|582341359|FG001|Phase B|Death|1|||
161262762|NCT01698775|582341358|FG000|Phase B|Lack of Efficacy|0|||
161262763|NCT01698775|582341359|FG001|Phase B|Lack of Efficacy|1|||
161262764|NCT01698775|582341358|FG000|Phase B|Lost to Follow-up|0|||
161262765|NCT01698775|582341359|FG001|Phase B|Lost to Follow-up|1|||
161262766|NCT01698775|582341358|FG000|Phase B|Physician Decision|1|||
161262767|NCT01698775|582341359|FG001|Phase B|Physician Decision|1|||
160924778|NCT05104567|581119106|FG004|Overall Study|Progressive disease|17|||
160924779|NCT05104567|581119107|FG005|Overall Study|Progressive disease|28|||
160924780|NCT05104567|581119108|FG006|Overall Study|Progressive disease|24|||
160924781|NCT05104567|581119102|FG000|Overall Study|Withdrawal by Subject|1|||
160924782|NCT05104567|581119103|FG001|Overall Study|Withdrawal by Subject|1|||
161262768|NCT01698775|582341358|FG000|Phase B|Protocol Violation|1|||
161262769|NCT01698775|582341359|FG001|Phase B|Protocol Violation|1|||
161262770|NCT01698775|582341358|FG000|Phase B|Withdrawal by Subject|6|||
161262771|NCT01698775|582341359|FG001|Phase B|Withdrawal by Subject|2|||
161262772|NCT00766831|582341364|FG000|Overall Study|Withdrawal by Subject|4|||
161262773|NCT00766831|582341364|FG000|Overall Study|Lost to Follow-up|3|||
161262774|NCT00766831|582341364|FG000|Overall Study|Adverse Event|20|||
161262775|NCT00766831|582341364|FG000|Overall Study|Protocol Violation|15|||
161262776|NCT00766831|582341364|FG000|Overall Study|Physician Decision|5|||
161262777|NCT00766831|582341364|FG000|Overall Study|Withdrawal of consent|26|||
161262778|NCT00766831|582341364|FG000|Overall Study|Non cooperation by participants|14|||
161262779|NCT00766831|582341364|FG000|Overall Study|Other|28|||
161262780|NCT00515034|582341369|FG000|Overall Study|Adverse Event|2|||
161262781|NCT00515034|582341370|FG001|Overall Study|Adverse Event|0|||
161262782|NCT00515034|582341371|FG002|Overall Study|Adverse Event|1|||
161262783|NCT00515034|582341372|FG003|Overall Study|Adverse Event|0|||
161262784|NCT00515034|582341369|FG000|Overall Study|Death|4|||
161262785|NCT00515034|582341370|FG001|Overall Study|Death|2|||
161262786|NCT00515034|582341371|FG002|Overall Study|Death|1|||
161262787|NCT00515034|582341372|FG003|Overall Study|Death|3|||
161262788|NCT00515034|582341369|FG000|Overall Study|Withdrawal by Subject|1|||
161262789|NCT00515034|582341370|FG001|Overall Study|Withdrawal by Subject|0|||
161262790|NCT00515034|582341371|FG002|Overall Study|Withdrawal by Subject|3|||
161262791|NCT00515034|582341372|FG003|Overall Study|Withdrawal by Subject|0|||
161262792|NCT00515034|582341369|FG000|Overall Study|Physician Decision|0|||
161262793|NCT00515034|582341370|FG001|Overall Study|Physician Decision|0|||
161262794|NCT00515034|582341371|FG002|Overall Study|Physician Decision|1|||
161262795|NCT00515034|582341372|FG003|Overall Study|Physician Decision|1|||
161262796|NCT00515034|582341369|FG000|Overall Study|Other|1|||
161262797|NCT00515034|582341370|FG001|Overall Study|Other|0|||
161262798|NCT00515034|582341371|FG002|Overall Study|Other|2|||
161262799|NCT00515034|582341372|FG003|Overall Study|Other|1|||
161262800|NCT02340221|582341375|FG000|Overall Study|Death|100|||
161262801|NCT02340221|582341376|FG001|Overall Study|Death|197|||
161262802|NCT02340221|582341375|FG000|Overall Study|Withdrawal by Participant|24|||
161262803|NCT02340221|582341376|FG001|Overall Study|Withdrawal by Participant|37|||
161262804|NCT02340221|582341375|FG000|Overall Study|Lost to Follow-up|4|||
161262805|NCT02340221|582341376|FG001|Overall Study|Lost to Follow-up|15|||
161262806|NCT02340221|582341375|FG000|Overall Study|Reason Not Specified|85|||
160924783|NCT05104567|581119104|FG002|Overall Study|Withdrawal by Subject|2|||
160924784|NCT05104567|581119105|FG003|Overall Study|Withdrawal by Subject|0|||
160924785|NCT05104567|581119106|FG004|Overall Study|Withdrawal by Subject|0|||
160924786|NCT05104567|581119107|FG005|Overall Study|Withdrawal by Subject|0|||
160924787|NCT05104567|581119108|FG006|Overall Study|Withdrawal by Subject|0|||
160924788|NCT05104567|581119102|FG000|Overall Study|Other|1|||
160924789|NCT05104567|581119103|FG001|Overall Study|Other|1|||
160924790|NCT05104567|581119104|FG002|Overall Study|Other|1|||
160924791|NCT05104567|581119105|FG003|Overall Study|Other|0|||
160924792|NCT05104567|581119106|FG004|Overall Study|Other|0|||
160924793|NCT05104567|581119107|FG005|Overall Study|Other|0|||
160924794|NCT05104567|581119108|FG006|Overall Study|Other|0|||
160924795|NCT01464346|581119109|FG000|Overall Study|Withdrawal by Subject|0|||
161262807|NCT02340221|582341376|FG001|Overall Study|Reason Not Specified|165|||
161262808|NCT02340221|582341375|FG000|Overall Study|Study Terminated by Sponsor|1|||
161262809|NCT02340221|582341376|FG001|Overall Study|Study Terminated by Sponsor|3|||
161262810|NCT00952276|582341379|FG000|Overall Study|Withdrawal by Subject|1|||
161262811|NCT00952276|582341380|FG001|Overall Study|Withdrawal by Subject|0|||
161262812|NCT00952276|582341381|FG002|Overall Study|Withdrawal by Subject|0|||
161262813|NCT00952276|582341382|FG003|Overall Study|Withdrawal by Subject|1|||
161262814|NCT00952276|582341383|FG004|Overall Study|Withdrawal by Subject|0|||
161262815|NCT02427984|582341384|FG000|Overall Study|Lost to Follow-up|13|||
161262816|NCT02427984|582341385|FG001|Overall Study|Lost to Follow-up|5|||
161262817|NCT02427984|582341386|FG002|Overall Study|Lost to Follow-up|18|||
160924796|NCT01464346|581119110|FG001|Overall Study|Withdrawal by Subject|0|||
160924797|NCT01464346|581119111|FG002|Overall Study|Withdrawal by Subject|1|||
161262818|NCT04189445|582343471|FG000|Overall Study|Withdrawal of consent|8|||
161262819|NCT04189445|582343472|FG001|Overall Study|Withdrawal of consent|1|||
161262820|NCT04189445|582343473|FG002|Overall Study|Withdrawal of consent|0|||
160924798|NCT03999892|581119112|FG000|Overall Study|Lost to Follow-up|1|||
160924799|NCT01848756|581119113|FG000|Overall Study|Adverse Event|1|||
160924800|NCT01848756|581119113|FG000|Overall Study|Withdrawal by Subject|1|||
160924801|NCT01848756|581119113|FG000|Overall Study|Enrolled in Error|1|||
160924802|NCT01286012|581119114|FG000|Overall Study|Adverse Event|3|||
160924803|NCT01286012|581119115|FG001|Overall Study|Adverse Event|3|||
160924804|NCT01286012|581119114|FG000|Overall Study|Death|2|||
160924805|NCT01286012|581119115|FG001|Overall Study|Death|3|||
160924806|NCT01286012|581119114|FG000|Overall Study|Protocol Violation|1|||
160924807|NCT01286012|581119115|FG001|Overall Study|Protocol Violation|1|||
160924808|NCT01286012|581119114|FG000|Overall Study|Withdrawal by Subject|4|||
160924809|NCT01286012|581119115|FG001|Overall Study|Withdrawal by Subject|4|||
160924810|NCT01286012|581119114|FG000|Overall Study|Physician Decision|2|||
160924811|NCT01286012|581119115|FG001|Overall Study|Physician Decision|0|||
160924812|NCT01286012|581119114|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
160924813|NCT01286012|581119115|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
160924814|NCT04056195|581119119|FG000|Overall Study|Adverse Event|1|||
160924815|NCT04056195|581119120|FG001|Overall Study|Adverse Event|0|||
160924816|NCT04056195|581119121|FG002|Overall Study|Adverse Event|0|||
160924817|NCT04056195|581119119|FG000|Overall Study|Withdrawal by Subject|0|||
160924818|NCT04056195|581119120|FG001|Overall Study|Withdrawal by Subject|1|||
160924819|NCT04056195|581119121|FG002|Overall Study|Withdrawal by Subject|1|||
160924820|NCT04056195|581119119|FG000|Overall Study|Physician Decision|1|||
160924821|NCT04056195|581119120|FG001|Overall Study|Physician Decision|1|||
160924822|NCT04056195|581119121|FG002|Overall Study|Physician Decision|1|||
160924823|NCT01498458|581119122|FG000|Overall Study|Adverse Event|4|||
160924824|NCT01498458|581119122|FG000|Overall Study|Physician Decision|3|||
160924825|NCT02406651|581119123|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
160924826|NCT02226003|581119127|FG000|Overall Study|Lost to Follow-up|2|||
160924827|NCT02226003|581119128|FG001|Overall Study|Lost to Follow-up|1|||
160924828|NCT02226003|581119129|FG002|Overall Study|Lost to Follow-up|3|||
160924829|NCT02226003|581119127|FG000|Overall Study|Withdrawal by Subject|0|||
160924830|NCT02226003|581119128|FG001|Overall Study|Withdrawal by Subject|0|||
160924831|NCT02226003|581119129|FG002|Overall Study|Withdrawal by Subject|3|||
160924832|NCT00718328|581119130|FG000|Overall Study|Lost to Follow-up|1|||
160924833|NCT00718328|581119131|FG001|Overall Study|Lost to Follow-up|0|||
160924834|NCT02865915|581119132|FG000|Overall Study|Pregnancy|1|||
160924835|NCT02865915|581119133|FG001|Overall Study|Pregnancy|0|||
160924836|NCT02865915|581119132|FG000|Overall Study|Withdrawal by Subject|1|||
160924837|NCT02865915|581119133|FG001|Overall Study|Withdrawal by Subject|1|||
160924838|NCT02865915|581119132|FG000|Overall Study|Adverse Event|0|||
160924839|NCT02865915|581119133|FG001|Overall Study|Adverse Event|4|||
160924840|NCT02865915|581119132|FG000|Overall Study|Lost to Follow-up|0|||
160924841|NCT02865915|581119133|FG001|Overall Study|Lost to Follow-up|1|||
160924842|NCT02865915|581119132|FG000|Overall Study|Protocol Violation|0|||
160924843|NCT02865915|581119133|FG001|Overall Study|Protocol Violation|1|||
160924844|NCT02865915|581119132|FG000|Overall Study|Study terminated by sponsor|23|||
160924845|NCT02865915|581119133|FG001|Overall Study|Study terminated by sponsor|18|||
160924846|NCT02865915|581119132|FG000|Overall Study|Dosing group discontinued|0|||
160924847|NCT02865915|581119133|FG001|Overall Study|Dosing group discontinued|5|||
160924848|NCT00663052|581119136|FG000|Overall Study|Adverse Event|6|||
160924849|NCT00663052|581119137|FG001|Overall Study|Adverse Event|3|||
160924850|NCT00663052|581119136|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
160924851|NCT00663052|581119137|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
160924852|NCT00663052|581119136|FG000|Overall Study|Protocol Violation|1|||
160924853|NCT00663052|581119137|FG001|Overall Study|Protocol Violation|0|||
160924854|NCT00663052|581119136|FG000|Overall Study|Withdrawal by Subject|2|||
160924855|NCT00663052|581119137|FG001|Overall Study|Withdrawal by Subject|5|||
160924856|NCT00663052|581119136|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
160924857|NCT00663052|581119137|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
160924858|NCT00663052|581119136|FG000|Overall Study|Other|0|||
160924859|NCT00663052|581119137|FG001|Overall Study|Other|1|||
160924860|NCT05760300|581119146|FG000|Overall Study|Adverse Event|0|||
160924861|NCT05760300|581119147|FG001|Overall Study|Adverse Event|0|||
160924862|NCT05760300|581119148|FG002|Overall Study|Adverse Event|1|||
160924863|NCT05760300|581119149|FG003|Overall Study|Adverse Event|0|||
160924864|NCT05760300|581119146|FG000|Overall Study|Participant Decision|1|||
160924865|NCT05760300|581119147|FG001|Overall Study|Participant Decision|0|||
160924866|NCT05760300|581119148|FG002|Overall Study|Participant Decision|0|||
160924867|NCT05760300|581119149|FG003|Overall Study|Participant Decision|0|||
160924868|NCT03279692|581119150|FG000|Overall Study|Withdrawal by Subject|1|||
160924869|NCT02446990|581119153|FG000|Overall Study|Death|485|||
160924870|NCT02446990|581119154|FG001|Overall Study|Death|458|||
160924871|NCT02446990|581119153|FG000|Overall Study|Lost to Follow-up|3|||
160924872|NCT02446990|581119154|FG001|Overall Study|Lost to Follow-up|1|||
160924873|NCT02446990|581119153|FG000|Overall Study|Physician Decision|1|||
160924874|NCT02446990|581119154|FG001|Overall Study|Physician Decision|0|||
160924875|NCT02446990|581119153|FG000|Overall Study|Withdrawal by Subject|231|||
161262821|NCT04189445|582343471|FG000|Overall Study|Study Terminated by Sponsor|25|||
161262822|NCT04189445|582343472|FG001|Overall Study|Study Terminated by Sponsor|3|||
161262823|NCT04189445|582343473|FG002|Overall Study|Study Terminated by Sponsor|0|||
161262824|NCT04189445|582343471|FG000|Overall Study|Death|54|||
161262825|NCT04189445|582343472|FG001|Overall Study|Death|24|||
160924876|NCT02446990|581119154|FG001|Overall Study|Withdrawal by Subject|199|||
160924877|NCT01064401|581119155|FG000|Overall Study|Adverse Event|47|||
160924878|NCT01064401|581119156|FG001|Overall Study|Adverse Event|56|||
160924879|NCT01064401|581119155|FG000|Overall Study|Lack of Efficacy|46|||
160924880|NCT01064401|581119156|FG001|Overall Study|Lack of Efficacy|23|||
160924881|NCT01064401|581119155|FG000|Overall Study|Lost to Follow-up|12|||
160924882|NCT01064401|581119156|FG001|Overall Study|Lost to Follow-up|9|||
160924883|NCT01064401|581119155|FG000|Overall Study|Consent Withdrawn|98|||
160924884|NCT01064401|581119156|FG001|Overall Study|Consent Withdrawn|80|||
160924885|NCT01064401|581119155|FG000|Overall Study|Investigator Decision|4|||
160924886|NCT01064401|581119156|FG001|Overall Study|Investigator Decision|6|||
160924887|NCT01064401|581119155|FG000|Overall Study|Death|4|||
160924888|NCT01064401|581119156|FG001|Overall Study|Death|0|||
160924889|NCT01064401|581119155|FG000|Overall Study|Pregnancy|4|||
160924890|NCT01064401|581119156|FG001|Overall Study|Pregnancy|7|||
160924891|NCT01064401|581119155|FG000|Overall Study|Noncompliance|7|||
160924892|NCT01064401|581119156|FG001|Overall Study|Noncompliance|8|||
160924893|NCT01064401|581119155|FG000|Overall Study|Site Closure|4|||
160924894|NCT01064401|581119156|FG001|Overall Study|Site Closure|5|||
161262826|NCT04189445|582343473|FG002|Overall Study|Death|0|||
161262827|NCT00003138|582343474|FG000|Step 1|Reasons off treatment not documented|60|||
161262828|NCT00003138|582343475|FG001|Step 1|Reasons off treatment not documented|57|||
161262829|NCT00003138|582343474|FG000|Step 1|Never started treatment|1|||
161262830|NCT00003138|582343475|FG001|Step 1|Never started treatment|0|||
161262831|NCT00003138|582343474|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
160924895|NCT01064401|581119155|FG000|Overall Study|Other|2|||
160924896|NCT01064401|581119156|FG001|Overall Study|Other|1|||
160924897|NCT03158051|581119157|FG000|Overall Study|Lost to Follow-up|41|||
160924898|NCT03158051|581119158|FG001|Overall Study|Lost to Follow-up|47|||
160924899|NCT03158051|581119157|FG000|Overall Study|Physician Decision|6|||
160924900|NCT03158051|581119158|FG001|Overall Study|Physician Decision|7|||
160924901|NCT03158051|581119157|FG000|Overall Study|Withdrawal by Subject|24|||
160924902|NCT03158051|581119158|FG001|Overall Study|Withdrawal by Subject|15|||
161262832|NCT00003138|582343475|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
161262833|NCT00003138|582343474|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
161262834|NCT00003138|582343475|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
161262835|NCT00003138|582343474|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
161262836|NCT00003138|582343475|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
161262837|NCT00003138|582343474|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
161262838|NCT00003138|582343475|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
161262839|NCT02522403|582343476|FG000|Overall Study|Lost to Follow-up|2|||
161262840|NCT02522403|582343477|FG001|Overall Study|Lost to Follow-up|2|||
161262841|NCT02522403|582343476|FG000|Overall Study|Withdrawal by Subject|2|||
161262842|NCT02522403|582343477|FG001|Overall Study|Withdrawal by Subject|4|||
161262843|NCT05142566|582343478|FG000|Overall Study|Protocol Violation|1|||
161262844|NCT04556552|582343479|FG000|Overall Study|Lost to Follow-up|1|||
161262845|NCT04556552|582343480|FG001|Overall Study|Lost to Follow-up|0|||
161262846|NCT04556552|582343479|FG000|Overall Study|Claustrophobia|0|||
161262847|NCT04556552|582343480|FG001|Overall Study|Claustrophobia|1|||
161262848|NCT04556552|582343479|FG000|Overall Study|Inability to continue|0|||
161262849|NCT04556552|582343480|FG001|Overall Study|Inability to continue|1|||
161262850|NCT01553279|582343481|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
161262851|NCT01553279|582343482|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
161262852|NCT01553279|582343481|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
161262853|NCT01553279|582343482|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
161262854|NCT01553279|582343481|FG000|Interim Period|Withdrawal by Subject|2|||
161262855|NCT01553279|582343482|FG001|Interim Period|Withdrawal by Subject|2|||
161262856|NCT01553279|582343481|FG000|Interim Period|Lost to Follow-up|1|||
161262857|NCT01553279|582343482|FG001|Interim Period|Lost to Follow-up|0|||
161341488|NCT02765165|582637534|FG006|Treatment Period|Progressive disease|2|||
160924903|NCT03158051|581119157|FG000|Overall Study|Death|0|||
161262858|NCT01553279|582343481|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
161262859|NCT01553279|582343482|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
161262860|NCT01553279|582343481|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
161262861|NCT01553279|582343482|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
161341489|NCT02765165|582637528|FG000|Treatment Period|Physician Decision|0|||
160924904|NCT03158051|581119158|FG001|Overall Study|Death|1|||
160924905|NCT02005250|581119159|FG000|Overall Study|Lost to Follow-up|15|||
160924906|NCT02005250|581119160|FG001|Overall Study|Lost to Follow-up|5|||
160924907|NCT02588833|581119161|FG000|Part 1|Withdrawal by Subject|1|||
160924908|NCT02588833|581119162|FG001|Part 1|Withdrawal by Subject|0|||
161262862|NCT00605865|582343483|FG000|Overall Study|Protocol Violation|115|||
161262863|NCT02856880|582343489|FG000|Overall Study|Withdrawal of consent|1|||
161262864|NCT00094458|582343490|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
161262865|NCT00094458|582343491|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
161262866|NCT00094458|582343492|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
160924909|NCT02588833|581119161|FG000|Part 2A|Physician Decision|0|||
160924910|NCT02588833|581119162|FG001|Part 2A|Physician Decision|1|||
160924911|NCT02588833|581119161|FG000|Part 2A|Withdrawal by Subject|0|||
160924912|NCT02588833|581119162|FG001|Part 2A|Withdrawal by Subject|1|||
160924913|NCT02588833|581119161|FG000|Part 2B|Adverse Event|0|||
160924914|NCT02588833|581119162|FG001|Part 2B|Adverse Event|1|||
160924915|NCT02588833|581119161|FG000|Part 2C|Adverse Event|0|||
160924916|NCT02588833|581119162|FG001|Part 2C|Adverse Event|1|||
160924917|NCT02588833|581119161|FG000|Part 2C|Withdrawal by Subject|0|||
160924918|NCT02588833|581119162|FG001|Part 2C|Withdrawal by Subject|1|||
160924919|NCT02588833|581119161|FG000|Part 3 (Safety Follow-up)|Other|0|||
160924920|NCT02588833|581119162|FG001|Part 3 (Safety Follow-up)|Other|2|||
160924921|NCT02967692|581121043|FG000|Overall Study|Progressive disease|3|||
160924922|NCT02967692|581121044|FG001|Overall Study|Progressive disease|15|||
160924923|NCT02967692|581121045|FG002|Overall Study|Progressive disease|114|||
160924924|NCT02967692|581121046|FG003|Overall Study|Progressive disease|151|||
160924925|NCT02967692|581121043|FG000|Overall Study|Subject/guardian decision|1|||
160924926|NCT02967692|581121044|FG001|Overall Study|Subject/guardian decision|1|||
160924927|NCT02967692|581121045|FG002|Overall Study|Subject/guardian decision|14|||
160924928|NCT02967692|581121046|FG003|Overall Study|Subject/guardian decision|22|||
160924929|NCT02967692|581121043|FG000|Overall Study|Death|0|||
160924930|NCT02967692|581121044|FG001|Overall Study|Death|1|||
160924931|NCT02967692|581121045|FG002|Overall Study|Death|13|||
160924932|NCT02967692|581121046|FG003|Overall Study|Death|13|||
160924933|NCT02967692|581121043|FG000|Overall Study|Protocol deviation|1|||
160924934|NCT02967692|581121044|FG001|Overall Study|Protocol deviation|0|||
160924935|NCT02967692|581121045|FG002|Overall Study|Protocol deviation|1|||
160924936|NCT02967692|581121046|FG003|Overall Study|Protocol deviation|1|||
160924937|NCT02967692|581121043|FG000|Overall Study|Lost to Follow-up|0|||
160924938|NCT02967692|581121044|FG001|Overall Study|Lost to Follow-up|0|||
160924939|NCT02967692|581121045|FG002|Overall Study|Lost to Follow-up|1|||
160924940|NCT02967692|581121046|FG003|Overall Study|Lost to Follow-up|0|||
160924941|NCT02967692|581121043|FG000|Overall Study|Physician Decision|0|||
160924942|NCT02967692|581121044|FG001|Overall Study|Physician Decision|0|||
160924943|NCT02967692|581121045|FG002|Overall Study|Physician Decision|22|||
160924944|NCT02967692|581121046|FG003|Overall Study|Physician Decision|13|||
160924945|NCT02967692|581121043|FG000|Overall Study|Adverse Event|2|||
160924946|NCT02967692|581121044|FG001|Overall Study|Adverse Event|9|||
160924947|NCT02967692|581121045|FG002|Overall Study|Adverse Event|60|||
160924948|NCT02967692|581121046|FG003|Overall Study|Adverse Event|28|||
160924949|NCT02967692|581121043|FG000|Overall Study|Study terminated by sponsor|2|||
160924950|NCT02967692|581121044|FG001|Overall Study|Study terminated by sponsor|1|||
160924951|NCT02967692|581121045|FG002|Overall Study|Study terminated by sponsor|42|||
160924952|NCT02967692|581121046|FG003|Overall Study|Study terminated by sponsor|37|||
161262867|NCT00094458|582343493|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
161262868|NCT00094458|582343494|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
161262869|NCT00094458|582343495|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
161262870|NCT00094458|582343490|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
161262871|NCT00094458|582343491|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
160924953|NCT04447417|581121047|FG000|Overall Study|Withdrawal by Subject|1|||
160924954|NCT04447417|581121048|FG001|Overall Study|Withdrawal by Subject|0|||
160924955|NCT04447417|581121047|FG000|Overall Study|Failure to meet inclusion criteria|1|||
161262872|NCT00094458|582343492|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
161262873|NCT00094458|582343493|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
161262874|NCT00094458|582343494|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
161262875|NCT00094458|582343495|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
161262876|NCT00094458|582343490|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
161262877|NCT00094458|582343491|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
160924956|NCT04447417|581121048|FG001|Overall Study|Failure to meet inclusion criteria|0|||
160924957|NCT04447417|581121047|FG000|Overall Study|Lost to Follow-up|1|||
160924958|NCT04447417|581121048|FG001|Overall Study|Lost to Follow-up|0|||
160924959|NCT00702403|581121049|FG000|From Consent to Engraftment|Progressive leukemia|6|||
160924960|NCT00702403|581121049|FG000|From Consent to Engraftment|Critically ill|2|||
160924961|NCT00702403|581121049|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
160924962|NCT00702403|581121049|FG000|From Consent to Engraftment|Myocardial infarction|1|||
160924963|NCT00702403|581121049|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
160924964|NCT00702403|581121049|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
161262878|NCT00094458|582343492|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
161262879|NCT00094458|582343493|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
160924965|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
160924966|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
160924967|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Non-compliance|2|||
160924968|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
160924969|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
160924970|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Suicide|1|||
160924971|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
160924972|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
160924973|NCT00702403|581121049|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
160924974|NCT00066066|581121053|FG000|Overall Study|Lost to Follow-up|6|||
160924975|NCT00066066|581121054|FG001|Overall Study|Lost to Follow-up|4|||
160924976|NCT00066066|581121055|FG002|Overall Study|Lost to Follow-up|7|||
160924977|NCT00066066|581121056|FG003|Overall Study|Lost to Follow-up|4|||
160924978|NCT00066066|581121057|FG004|Overall Study|Lost to Follow-up|3|||
160924979|NCT00066066|581121058|FG005|Overall Study|Lost to Follow-up|5|||
160924980|NCT00192504|581121067|FG000|Overall Study|Lost to Follow-up|1|||
160924981|NCT00192504|581121068|FG001|Overall Study|Lost to Follow-up|0|||
160924982|NCT00192504|581121069|FG002|Overall Study|Lost to Follow-up|0|||
160924983|NCT00192504|581121070|FG003|Overall Study|Lost to Follow-up|0|||
160924984|NCT00192504|581121067|FG000|Overall Study|Dosing window missed|0|||
160924985|NCT00192504|581121068|FG001|Overall Study|Dosing window missed|0|||
160924986|NCT00192504|581121069|FG002|Overall Study|Dosing window missed|1|||
160924987|NCT00192504|581121070|FG003|Overall Study|Dosing window missed|0|||
160924988|NCT03989440|581121071|FG000|Overall Study|COVID-19 travel restrictions|0|||
160924989|NCT03989440|581121072|FG001|Overall Study|COVID-19 travel restrictions|0|||
160997953|NCT00798265|581376708|FG000|Overall Study|Study closing|7|||
161262880|NCT00094458|582343494|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
161262881|NCT00094458|582343495|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
161262882|NCT00094458|582343490|FG000|Main Study: Through Week 30|Adverse Event|38|||
161262883|NCT00094458|582343491|FG001|Main Study: Through Week 30|Adverse Event|20|||
161262884|NCT00094458|582343492|FG002|Main Study: Through Week 30|Adverse Event|28|||
161262885|NCT00094458|582343493|FG003|Main Study: Through Week 30|Adverse Event|0|||
161262886|NCT00094458|582343494|FG004|Main Study: Through Week 30|Adverse Event|0|||
161262887|NCT00094458|582343495|FG005|Main Study: Through Week 30|Adverse Event|0|||
161262888|NCT00094458|582343490|FG000|Main Study: Through Week 30|Death|1|||
161262889|NCT00094458|582343491|FG001|Main Study: Through Week 30|Death|0|||
161262890|NCT00094458|582343492|FG002|Main Study: Through Week 30|Death|0|||
161262891|NCT00094458|582343493|FG003|Main Study: Through Week 30|Death|0|||
161262892|NCT00094458|582343494|FG004|Main Study: Through Week 30|Death|0|||
161262893|NCT00094458|582343495|FG005|Main Study: Through Week 30|Death|0|||
161262894|NCT00094458|582343490|FG000|Main Study: Through Week 30|Other|19|||
161262895|NCT00094458|582343491|FG001|Main Study: Through Week 30|Other|16|||
161262896|NCT00094458|582343492|FG002|Main Study: Through Week 30|Other|9|||
161262897|NCT00094458|582343493|FG003|Main Study: Through Week 30|Other|0|||
161262898|NCT00094458|582343494|FG004|Main Study: Through Week 30|Other|0|||
161262899|NCT00094458|582343495|FG005|Main Study: Through Week 30|Other|0|||
161262900|NCT00094458|582343490|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
161262901|NCT00094458|582343491|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
161262902|NCT00094458|582343492|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
161262903|NCT00094458|582343493|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161262904|NCT00094458|582343494|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161262905|NCT00094458|582343495|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
161262906|NCT00094458|582343490|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
161262907|NCT00094458|582343491|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161262908|NCT00094458|582343492|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
161262909|NCT00094458|582343493|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161262910|NCT00094458|582343494|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161262911|NCT00094458|582343495|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
161262912|NCT00094458|582343490|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
161262913|NCT00094458|582343491|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
161262914|NCT00094458|582343492|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
161262915|NCT00094458|582343493|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
160997954|NCT00798265|581376709|FG001|Overall Study|Study closing|6|||
160997955|NCT00798265|581376708|FG000|Overall Study|Withdrawal by Subject|0|||
160997956|NCT00798265|581376709|FG001|Overall Study|Withdrawal by Subject|1|||
160997957|NCT00798265|581376708|FG000|Overall Study|Screen failure|0|||
160997958|NCT00798265|581376709|FG001|Overall Study|Screen failure|1|||
161262916|NCT00094458|582343494|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161262917|NCT00094458|582343495|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
161341490|NCT02765165|582637529|FG001|Treatment Period|Physician Decision|1|||
161262918|NCT00094458|582343490|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
161262919|NCT00094458|582343491|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
161262920|NCT00094458|582343492|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
161262921|NCT00094458|582343493|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
160924990|NCT03989440|581121073|FG002|Overall Study|COVID-19 travel restrictions|1|||
160924991|NCT03989440|581121074|FG003|Overall Study|COVID-19 travel restrictions|0|||
160924992|NCT03989440|581121075|FG004|Overall Study|COVID-19 travel restrictions|0|||
160924993|NCT03989440|581121076|FG005|Overall Study|COVID-19 travel restrictions|0|||
160924994|NCT03989440|581121071|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
160924995|NCT03989440|581121072|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
160924996|NCT03989440|581121073|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
160924997|NCT03989440|581121074|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
160924998|NCT03989440|581121075|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
160924999|NCT03989440|581121076|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
160925000|NCT01955161|581121077|FG000|Overall Study|Withdrawal before treatment|2|||
160925001|NCT01955161|581121078|FG001|Overall Study|Withdrawal before treatment|0|||
160925002|NCT01955161|581121079|FG002|Overall Study|Withdrawal before treatment|1|||
160925003|NCT01955161|581121077|FG000|Overall Study|Adverse Event|10|||
160925004|NCT01955161|581121078|FG001|Overall Study|Adverse Event|14|||
160925005|NCT01955161|581121079|FG002|Overall Study|Adverse Event|15|||
160925006|NCT01955161|581121077|FG000|Overall Study|Death|1|||
160925007|NCT01955161|581121078|FG001|Overall Study|Death|1|||
160925008|NCT01955161|581121079|FG002|Overall Study|Death|3|||
160925009|NCT01955161|581121077|FG000|Overall Study|Withdrawal by Subject|9|||
160925010|NCT01955161|581121078|FG001|Overall Study|Withdrawal by Subject|8|||
160925011|NCT01955161|581121079|FG002|Overall Study|Withdrawal by Subject|12|||
160925012|NCT01955161|581121077|FG000|Overall Study|Protocol Violation|2|||
160925013|NCT01955161|581121078|FG001|Overall Study|Protocol Violation|0|||
160925014|NCT01955161|581121079|FG002|Overall Study|Protocol Violation|0|||
160925015|NCT01955161|581121077|FG000|Overall Study|Other reason: physician decision|0|||
161262922|NCT00094458|582343494|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
160925016|NCT01955161|581121078|FG001|Overall Study|Other reason: physician decision|1|||
160925017|NCT01955161|581121079|FG002|Overall Study|Other reason: physician decision|1|||
160925018|NCT01955161|581121077|FG000|Overall Study|Other reason: disallowed medication|1|||
160925019|NCT01955161|581121078|FG001|Overall Study|Other reason: disallowed medication|0|||
160925020|NCT01955161|581121079|FG002|Overall Study|Other reason: disallowed medication|1|||
160925021|NCT01955161|581121077|FG000|Overall Study|Other reason: caregiver unavailable|1|||
160925022|NCT01955161|581121078|FG001|Overall Study|Other reason: caregiver unavailable|0|||
160925023|NCT01955161|581121079|FG002|Overall Study|Other reason: caregiver unavailable|0|||
160925024|NCT01955161|581121077|FG000|Overall Study|Other reason: moved to nursing home|0|||
160925025|NCT01955161|581121078|FG001|Overall Study|Other reason: moved to nursing home|1|||
160925026|NCT01955161|581121079|FG002|Overall Study|Other reason: moved to nursing home|0|||
160925027|NCT01955161|581121077|FG000|Overall Study|Other reason: insufficient compliance|0|||
160925028|NCT01955161|581121078|FG001|Overall Study|Other reason: insufficient compliance|0|||
160925029|NCT01955161|581121079|FG002|Overall Study|Other reason: insufficient compliance|1|||
160925030|NCT01955161|581121077|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
160925031|NCT01955161|581121078|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
161262923|NCT00094458|582343495|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
161262924|NCT00094458|582343490|FG000|OLE: Open-Label Extension|Adverse Event|0|||
161262925|NCT00094458|582343491|FG001|OLE: Open-Label Extension|Adverse Event|0|||
161262926|NCT00094458|582343492|FG002|OLE: Open-Label Extension|Adverse Event|0|||
161262927|NCT00094458|582343493|FG003|OLE: Open-Label Extension|Adverse Event|0|||
161262928|NCT00094458|582343494|FG004|OLE: Open-Label Extension|Adverse Event|3|||
161262929|NCT00094458|582343495|FG005|OLE: Open-Label Extension|Adverse Event|4|||
161262930|NCT00094458|582343490|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161262931|NCT00094458|582343491|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161262932|NCT00094458|582343492|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161262933|NCT00094458|582343493|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
161262934|NCT00094458|582343494|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
161262935|NCT00094458|582343495|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
161262936|NCT00094458|582343490|FG000|OLE: Open-Label Extension|Patient decision|0|||
161262937|NCT00094458|582343491|FG001|OLE: Open-Label Extension|Patient decision|0|||
161262938|NCT00094458|582343492|FG002|OLE: Open-Label Extension|Patient decision|0|||
161262939|NCT00094458|582343493|FG003|OLE: Open-Label Extension|Patient decision|0|||
161262940|NCT00094458|582343494|FG004|OLE: Open-Label Extension|Patient decision|1|||
161262941|NCT00094458|582343495|FG005|OLE: Open-Label Extension|Patient decision|0|||
161262942|NCT03247517|582343496|FG000|Overall Study|Adverse Event|0|||
160925032|NCT01955161|581121079|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
160925033|NCT01955161|581121077|FG000|Overall Study|Other reason: patient's will|0|||
160997959|NCT00589667|581378495|FG000|Overall Study|Adverse Event|2|||
161262943|NCT03247517|582343497|FG001|Overall Study|Adverse Event|4|||
161262944|NCT03247517|582343498|FG002|Overall Study|Adverse Event|2|||
161341491|NCT02765165|582637530|FG002|Treatment Period|Physician Decision|0|||
161262945|NCT03247517|582343496|FG000|Overall Study|Lost to Follow-up|2|||
161341492|NCT02765165|582637531|FG003|Treatment Period|Physician Decision|0|||
161341493|NCT02765165|582637532|FG004|Treatment Period|Physician Decision|0|||
161341494|NCT02765165|582637533|FG005|Treatment Period|Physician Decision|0|||
161341495|NCT02765165|582637534|FG006|Treatment Period|Physician Decision|0|||
161341496|NCT02765165|582637528|FG000|Treatment Period|Adverse Event|0|||
161341497|NCT02765165|582637529|FG001|Treatment Period|Adverse Event|1|||
161341498|NCT02765165|582637530|FG002|Treatment Period|Adverse Event|0|||
161341499|NCT02765165|582637531|FG003|Treatment Period|Adverse Event|0|||
161341500|NCT02765165|582637532|FG004|Treatment Period|Adverse Event|0|||
161341501|NCT02765165|582637533|FG005|Treatment Period|Adverse Event|0|||
161341502|NCT02765165|582637534|FG006|Treatment Period|Adverse Event|0|||
161341503|NCT02765165|582637528|FG000|Treatment Period|Withdrawal by Subject|0|||
161341504|NCT02765165|582637529|FG001|Treatment Period|Withdrawal by Subject|0|||
161341505|NCT02765165|582637530|FG002|Treatment Period|Withdrawal by Subject|0|||
161341506|NCT02765165|582637531|FG003|Treatment Period|Withdrawal by Subject|0|||
161341507|NCT02765165|582637532|FG004|Treatment Period|Withdrawal by Subject|2|||
161341508|NCT02765165|582637533|FG005|Treatment Period|Withdrawal by Subject|0|||
161341509|NCT02765165|582637534|FG006|Treatment Period|Withdrawal by Subject|0|||
161341510|NCT02765165|582637528|FG000|Treatment Period|Study terminated|0|||
161341511|NCT02765165|582637529|FG001|Treatment Period|Study terminated|0|||
161341512|NCT02765165|582637530|FG002|Treatment Period|Study terminated|0|||
161341513|NCT02765165|582637531|FG003|Treatment Period|Study terminated|0|||
161341514|NCT02765165|582637532|FG004|Treatment Period|Study terminated|0|||
161341515|NCT02765165|582637533|FG005|Treatment Period|Study terminated|1|||
161341516|NCT02765165|582637534|FG006|Treatment Period|Study terminated|2|||
161341517|NCT02765165|582637528|FG000|Post-treatment Follow-up|Death|1|||
161341518|NCT02765165|582637529|FG001|Post-treatment Follow-up|Death|2|||
161341519|NCT02765165|582637530|FG002|Post-treatment Follow-up|Death|1|||
161341520|NCT02765165|582637531|FG003|Post-treatment Follow-up|Death|1|||
161341521|NCT02765165|582637532|FG004|Post-treatment Follow-up|Death|1|||
161341522|NCT02765165|582637533|FG005|Post-treatment Follow-up|Death|1|||
161341523|NCT02765165|582637534|FG006|Post-treatment Follow-up|Death|0|||
161341524|NCT02765165|582637528|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
161341525|NCT02765165|582637529|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
161341526|NCT02765165|582637530|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
161341527|NCT02765165|582637531|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
161341528|NCT02765165|582637532|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
161341529|NCT02765165|582637533|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
161341530|NCT02765165|582637534|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
161341531|NCT02765165|582637528|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
161341532|NCT02765165|582637529|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
161341533|NCT02765165|582637530|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
161341534|NCT02765165|582637531|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
161341535|NCT02765165|582637532|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
161341536|NCT02765165|582637533|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
161341537|NCT02765165|582637534|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
161341538|NCT02765165|582637528|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161341539|NCT02765165|582637529|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161341540|NCT02765165|582637530|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
161341541|NCT02765165|582637531|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
161262946|NCT03247517|582343497|FG001|Overall Study|Lost to Follow-up|6|||
161262947|NCT03247517|582343498|FG002|Overall Study|Lost to Follow-up|4|||
161262948|NCT03247517|582343496|FG000|Overall Study|Consent withdrawn by caregiver|1|||
161262949|NCT03247517|582343497|FG001|Overall Study|Consent withdrawn by caregiver|4|||
161262950|NCT03247517|582343498|FG002|Overall Study|Consent withdrawn by caregiver|7|||
161262951|NCT03247517|582343496|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
161262952|NCT03247517|582343497|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
161262953|NCT03247517|582343498|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
161262954|NCT03247517|582343496|FG000|Overall Study|Protocol Violation|0|||
161262955|NCT03247517|582343497|FG001|Overall Study|Protocol Violation|2|||
161262956|NCT03247517|582343498|FG002|Overall Study|Protocol Violation|0|||
161262957|NCT03247517|582343496|FG000|Overall Study|Multiple reasons|3|||
161341542|NCT02765165|582637532|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161262958|NCT03247517|582343497|FG001|Overall Study|Multiple reasons|1|||
161262959|NCT03247517|582343498|FG002|Overall Study|Multiple reasons|0|||
161341543|NCT02765165|582637533|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161341544|NCT02765165|582637534|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
161341545|NCT02765165|582637528|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
161341546|NCT02765165|582637529|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
161341547|NCT02765165|582637530|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
161341548|NCT02765165|582637531|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
161341549|NCT02765165|582637532|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
161262960|NCT03310411|582343499|FG000|Period 1|Adverse Event|0|||
161341550|NCT02765165|582637533|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
161341551|NCT02765165|582637534|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
161341552|NCT02765165|582637528|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161341553|NCT02765165|582637529|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161341554|NCT02765165|582637530|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161341555|NCT02765165|582637531|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
161341556|NCT02765165|582637532|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
161341557|NCT02765165|582637533|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
161341558|NCT02765165|582637534|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
161341559|NCT00142415|582637535|FG000|Overall Study|Physician Decision|0|||
161341560|NCT00142415|582637536|FG001|Overall Study|Physician Decision|0|||
161341561|NCT00142415|582637537|FG002|Overall Study|Physician Decision|0|||
161341562|NCT00142415|582637538|FG003|Overall Study|Physician Decision|0|||
161341563|NCT00142415|582637539|FG004|Overall Study|Physician Decision|1|||
161341564|NCT00142415|582637540|FG005|Overall Study|Physician Decision|2|||
161341565|NCT01189266|582637545|FG000|Overall Study|Adverse Event|1|||
161341566|NCT01189266|582637546|FG001|Overall Study|Adverse Event|0|||
161341567|NCT01189266|582637547|FG002|Overall Study|Adverse Event|5|||
161341568|NCT01189266|582637545|FG000|Overall Study|Death|0|||
161341569|NCT01189266|582637546|FG001|Overall Study|Death|0|||
161341570|NCT01189266|582637547|FG002|Overall Study|Death|5|||
161341571|NCT01189266|582637545|FG000|Overall Study|Lack of Efficacy|4|||
161341572|NCT01189266|582637546|FG001|Overall Study|Lack of Efficacy|5|||
161341573|NCT01189266|582637547|FG002|Overall Study|Lack of Efficacy|44|||
161341574|NCT01189266|582637545|FG000|Overall Study|Physician Decision|0|||
161341575|NCT01189266|582637546|FG001|Overall Study|Physician Decision|0|||
161341576|NCT01189266|582637547|FG002|Overall Study|Physician Decision|1|||
161341577|NCT01189266|582637545|FG000|Overall Study|Protocol Violation|0|||
161341578|NCT01189266|582637546|FG001|Overall Study|Protocol Violation|1|||
161341579|NCT01189266|582637547|FG002|Overall Study|Protocol Violation|1|||
161341580|NCT01189266|582637545|FG000|Overall Study|Withdrawal by Subject|0|||
161341581|NCT01189266|582637546|FG001|Overall Study|Withdrawal by Subject|0|||
161341582|NCT01189266|582637547|FG002|Overall Study|Withdrawal by Subject|1|||
161341583|NCT01189266|582637545|FG000|Overall Study|Patient refuses further therapy|1|||
161341584|NCT01189266|582637546|FG001|Overall Study|Patient refuses further therapy|0|||
161341585|NCT01189266|582637547|FG002|Overall Study|Patient refuses further therapy|7|||
161341586|NCT01189266|582637545|FG000|Overall Study|No treatment|0|||
161341587|NCT01189266|582637546|FG001|Overall Study|No treatment|0|||
161341588|NCT01189266|582637547|FG002|Overall Study|No treatment|1|||
161341589|NCT03530696|582637548|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
161341590|NCT03530696|582637549|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
161341591|NCT01129128|582637550|FG000|Overall Study|Lost to Follow-up|2|||
161341592|NCT01129128|582637551|FG001|Overall Study|Lost to Follow-up|2|||
161341593|NCT01129128|582637552|FG002|Overall Study|Lost to Follow-up|1|||
161341594|NCT01129128|582637550|FG000|Overall Study|Protocol Violation|0|||
161341595|NCT01129128|582637551|FG001|Overall Study|Protocol Violation|1|||
161341596|NCT01129128|582637552|FG002|Overall Study|Protocol Violation|0|||
161341597|NCT01129128|582637550|FG000|Overall Study|Withdrawal by Subject|0|||
161341598|NCT01129128|582637551|FG001|Overall Study|Withdrawal by Subject|1|||
161341599|NCT01129128|582637552|FG002|Overall Study|Withdrawal by Subject|3|||
161341600|NCT01129128|582637550|FG000|Overall Study|Physician Decision|1|||
161341601|NCT01129128|582637551|FG001|Overall Study|Physician Decision|0|||
161341602|NCT01129128|582637552|FG002|Overall Study|Physician Decision|0|||
161341603|NCT01311661|582637555|FG000|Overall Study|Adverse Event|2|||
161341604|NCT01311661|582637555|FG000|Overall Study|Protocol Violation|3|||
161341605|NCT01311661|582637555|FG000|Overall Study|Withdrawal by Subject|2|||
161341606|NCT01900314|582637556|FG000|Overall Study|Lost to Follow-up|1|||
161341607|NCT01900314|582637557|FG001|Overall Study|Lost to Follow-up|0|||
161341608|NCT01900314|582637556|FG000|Overall Study|Protocol Violation|0|||
161341609|NCT01900314|582637557|FG001|Overall Study|Protocol Violation|1|||
161341610|NCT01900314|582637556|FG000|Overall Study|Withdrawal by Subject|3|||
161341611|NCT01900314|582637557|FG001|Overall Study|Withdrawal by Subject|3|||
161341612|NCT03197129|582637562|FG000|Overall Study|did not answer the VPT: shyness|4|||
161341613|NCT03197129|582637563|FG001|Overall Study|did not answer the VPT: shyness|5|||
161341614|NCT05219162|582637566|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
161341615|NCT05219162|582637566|FG000|Overall Study|Withdrawal by Subject|23|||
161341616|NCT05516758|582637570|FG000|Overall Study|Adverse Event|5|||
161341617|NCT05516758|582637571|FG001|Overall Study|Adverse Event|1|||
161341618|NCT05516758|582637572|FG002|Overall Study|Adverse Event|3|||
161341619|NCT05516758|582637573|FG003|Overall Study|Adverse Event|0|||
161341620|NCT05516758|582637574|FG004|Overall Study|Adverse Event|1|||
161341621|NCT05516758|582637575|FG005|Overall Study|Adverse Event|3|||
161341622|NCT05516758|582637576|FG006|Overall Study|Adverse Event|5|||
161341623|NCT05516758|582637570|FG000|Overall Study|Assigned treatment by mistake|1|||
161341624|NCT05516758|582637571|FG001|Overall Study|Assigned treatment by mistake|0|||
161341625|NCT05516758|582637572|FG002|Overall Study|Assigned treatment by mistake|0|||
161262961|NCT03310411|582343500|FG001|Period 1|Adverse Event|0|||
160925034|NCT01955161|581121078|FG001|Overall Study|Other reason: patient's will|0|||
160925035|NCT01955161|581121079|FG002|Overall Study|Other reason: patient's will|1|||
160925036|NCT04608500|581121080|FG000|Overall Study|Adverse Event|2|||
160925037|NCT04608500|581121081|FG001|Overall Study|Adverse Event|0|||
160925038|NCT04608500|581121080|FG000|Overall Study|Lost to Follow-up|15|||
160925039|NCT04608500|581121081|FG001|Overall Study|Lost to Follow-up|9|||
160925040|NCT04608500|581121080|FG000|Overall Study|Participant request|11|||
160925041|NCT04608500|581121081|FG001|Overall Study|Participant request|7|||
160925042|NCT04608500|581121080|FG000|Overall Study|Protocol Violation|1|||
160925043|NCT04608500|581121081|FG001|Overall Study|Protocol Violation|0|||
160925044|NCT04608500|581121080|FG000|Overall Study|Other|6|||
161262962|NCT03310411|582343501|FG002|Period 1|Adverse Event|0|||
161262963|NCT03310411|582343502|FG003|Period 1|Adverse Event|1|||
161262964|NCT00619112|582343503|FG000|Overall Study|Adverse Event|1|||
161262965|NCT00619112|582343504|FG001|Overall Study|Adverse Event|2|||
161262966|NCT00729248|582343505|FG000|Overall Study|Physician Decision|2|||
161262967|NCT03573505|582343506|FG000|Overall Study|Adverse Event|1|||
161262968|NCT03573505|582343507|FG001|Overall Study|Adverse Event|1|||
161262969|NCT03573505|582343506|FG000|Overall Study|Consent withdrawn|0|||
161262970|NCT03573505|582343507|FG001|Overall Study|Consent withdrawn|1|||
161262971|NCT03573505|582343506|FG000|Overall Study|Disease progression|0|||
161262972|NCT03573505|582343507|FG001|Overall Study|Disease progression|1|||
161262973|NCT03573505|582343506|FG000|Overall Study|Site Terminated by Sponsor|1|||
161262974|NCT03573505|582343507|FG001|Overall Study|Site Terminated by Sponsor|1|||
161262975|NCT03573505|582343506|FG000|Overall Study|Study terminated by sponsor|50|||
161262976|NCT03573505|582343507|FG001|Overall Study|Study terminated by sponsor|45|||
161262977|NCT03573505|582343506|FG000|Overall Study|Reason not specified|0|||
161262978|NCT03573505|582343507|FG001|Overall Study|Reason not specified|1|||
161262979|NCT03573505|582343506|FG000|Overall Study|Death|0|||
161262980|NCT03573505|582343507|FG001|Overall Study|Death|4|||
161262981|NCT00515541|582343508|FG000|Overall Study|Physician Decision|0|||
161262982|NCT00515541|582343509|FG001|Overall Study|Physician Decision|2|||
161262983|NCT00515541|582343510|FG002|Overall Study|Physician Decision|0|||
161262984|NCT00515541|582343511|FG003|Overall Study|Physician Decision|1|||
161262985|NCT00515541|582343508|FG000|Overall Study|No show for appointments|0|||
161262986|NCT00515541|582343509|FG001|Overall Study|No show for appointments|1|||
161262987|NCT00515541|582343510|FG002|Overall Study|No show for appointments|0|||
161262988|NCT00515541|582343511|FG003|Overall Study|No show for appointments|2|||
161262989|NCT00515541|582343508|FG000|Overall Study|Withdrawal by Subject|0|||
161262990|NCT00515541|582343509|FG001|Overall Study|Withdrawal by Subject|2|||
161262991|NCT00515541|582343510|FG002|Overall Study|Withdrawal by Subject|0|||
161262992|NCT00515541|582343511|FG003|Overall Study|Withdrawal by Subject|2|||
161262993|NCT02145026|582343512|FG000|Overall Study|Adverse Event|2|||
161262994|NCT02145026|582343512|FG000|Overall Study|Death|4|||
160925045|NCT04608500|581121081|FG001|Overall Study|Other|2|||
160925046|NCT00542919|581121082|FG000|Overall Study|Adverse Event|1|||
160925047|NCT00542919|581121083|FG001|Overall Study|Adverse Event|5|||
160925048|NCT00542919|581121084|FG002|Overall Study|Adverse Event|1|||
160925049|NCT00542919|581121082|FG000|Overall Study|Withdrawal by Subject|1|||
160925050|NCT00542919|581121083|FG001|Overall Study|Withdrawal by Subject|0|||
160925051|NCT00542919|581121084|FG002|Overall Study|Withdrawal by Subject|3|||
160925052|NCT00542919|581121082|FG000|Overall Study|Physician Decision|2|||
160925053|NCT00542919|581121083|FG001|Overall Study|Physician Decision|2|||
160925054|NCT00542919|581121084|FG002|Overall Study|Physician Decision|1|||
161262995|NCT02145026|582343512|FG000|Overall Study|Withdrawal by Subject|2|||
161262996|NCT02145026|582343512|FG000|Overall Study|Physician Decision|4|||
161262997|NCT03052322|582343513|FG000|Overall Study|Other un-specified|1|||
161262998|NCT03052322|582343514|FG001|Overall Study|Other un-specified|2|||
161262999|NCT03052322|582343513|FG000|Overall Study|Withdrawal by Subject|10|||
161263000|NCT03052322|582343514|FG001|Overall Study|Withdrawal by Subject|9|||
161263001|NCT03052322|582343513|FG000|Overall Study|Death|0|||
161263002|NCT03052322|582343514|FG001|Overall Study|Death|2|||
161263003|NCT03052322|582343513|FG000|Overall Study|Lack of Efficacy|1|||
161263004|NCT03052322|582343514|FG001|Overall Study|Lack of Efficacy|2|||
161263005|NCT03052322|582343513|FG000|Overall Study|Protocol Violation|1|||
161263006|NCT03052322|582343514|FG001|Overall Study|Protocol Violation|0|||
161263007|NCT03052322|582343513|FG000|Overall Study|Lost to Follow-up|2|||
161263008|NCT03052322|582343514|FG001|Overall Study|Lost to Follow-up|4|||
161263009|NCT03052322|582343513|FG000|Overall Study|Adverse Event|6|||
161263010|NCT03052322|582343514|FG001|Overall Study|Adverse Event|13|||
161263011|NCT05065983|582343515|FG000|Overall Study|Lost to Follow-up|2|||
161263012|NCT00003875|582343518|FG000|Overall Study|Screen Failed|1|||
161263013|NCT01546649|582343519|FG000|Overall Study|Adverse Event|4|||
161263014|NCT01546649|582343520|FG001|Overall Study|Adverse Event|5|||
161263015|NCT01546649|582343519|FG000|Overall Study|Protocol Violation|1|||
160925055|NCT00542919|581121082|FG000|Overall Study|Sponsor Decision|1|||
160925056|NCT00542919|581121083|FG001|Overall Study|Sponsor Decision|0|||
160925057|NCT00542919|581121084|FG002|Overall Study|Sponsor Decision|0|||
160925058|NCT00542919|581121082|FG000|Overall Study|Lost to Follow-up|2|||
161263016|NCT01546649|582343520|FG001|Overall Study|Protocol Violation|0|||
161263017|NCT01546649|582343519|FG000|Overall Study|Lack of Efficacy|1|||
161263018|NCT01546649|582343520|FG001|Overall Study|Lack of Efficacy|0|||
161263019|NCT01546649|582343519|FG000|Overall Study|Recurrence|1|||
161263020|NCT01546649|582343520|FG001|Overall Study|Recurrence|1|||
161263021|NCT01546649|582343519|FG000|Overall Study|Discovery of secondary cancer|0|||
161263022|NCT01546649|582343520|FG001|Overall Study|Discovery of secondary cancer|1|||
161263023|NCT01546649|582343519|FG000|Overall Study|Withdrawal by Subject|1|||
161263024|NCT01546649|582343520|FG001|Overall Study|Withdrawal by Subject|2|||
161263025|NCT01550744|582343521|FG000|Open-Label|Lost to Follow-up|7|||
161263026|NCT01550744|582343522|FG001|Open-Label|Lost to Follow-up|0|||
161263027|NCT01550744|582343523|FG002|Open-Label|Lost to Follow-up|0|||
161263028|NCT01550744|582343521|FG000|Open-Label|Withdrawal by Subject|13|||
161263029|NCT01550744|582343522|FG001|Open-Label|Withdrawal by Subject|0|||
161341626|NCT05516758|582637573|FG003|Overall Study|Assigned treatment by mistake|0|||
161263030|NCT01550744|582343523|FG002|Open-Label|Withdrawal by Subject|0|||
161263031|NCT01550744|582343521|FG000|Open-Label|Adverse Event|11|||
161341627|NCT05516758|582637574|FG004|Overall Study|Assigned treatment by mistake|1|||
161341628|NCT05516758|582637575|FG005|Overall Study|Assigned treatment by mistake|0|||
161341629|NCT05516758|582637576|FG006|Overall Study|Assigned treatment by mistake|0|||
161341630|NCT05516758|582637570|FG000|Overall Study|Lack of Efficacy|6|||
161341631|NCT05516758|582637571|FG001|Overall Study|Lack of Efficacy|0|||
161341632|NCT05516758|582637572|FG002|Overall Study|Lack of Efficacy|2|||
161341633|NCT05516758|582637573|FG003|Overall Study|Lack of Efficacy|0|||
161341634|NCT05516758|582637574|FG004|Overall Study|Lack of Efficacy|3|||
161341635|NCT05516758|582637575|FG005|Overall Study|Lack of Efficacy|6|||
161341636|NCT05516758|582637576|FG006|Overall Study|Lack of Efficacy|3|||
161341637|NCT05516758|582637570|FG000|Overall Study|Lost to Follow-up|2|||
161341638|NCT05516758|582637571|FG001|Overall Study|Lost to Follow-up|0|||
161341639|NCT05516758|582637572|FG002|Overall Study|Lost to Follow-up|2|||
161341640|NCT05516758|582637573|FG003|Overall Study|Lost to Follow-up|0|||
161341641|NCT05516758|582637574|FG004|Overall Study|Lost to Follow-up|3|||
161341642|NCT05516758|582637575|FG005|Overall Study|Lost to Follow-up|2|||
161341643|NCT05516758|582637576|FG006|Overall Study|Lost to Follow-up|1|||
161341644|NCT05516758|582637570|FG000|Overall Study|Other- As reported by the site|2|||
161341645|NCT05516758|582637571|FG001|Overall Study|Other- As reported by the site|1|||
161341646|NCT05516758|582637572|FG002|Overall Study|Other- As reported by the site|8|||
161341647|NCT05516758|582637573|FG003|Overall Study|Other- As reported by the site|1|||
161341648|NCT05516758|582637574|FG004|Overall Study|Other- As reported by the site|2|||
161341649|NCT05516758|582637575|FG005|Overall Study|Other- As reported by the site|3|||
161341650|NCT05516758|582637576|FG006|Overall Study|Other- As reported by the site|8|||
161341651|NCT05516758|582637570|FG000|Overall Study|Physician Decision|1|||
161341652|NCT05516758|582637571|FG001|Overall Study|Physician Decision|0|||
161341653|NCT05516758|582637572|FG002|Overall Study|Physician Decision|7|||
161341654|NCT05516758|582637573|FG003|Overall Study|Physician Decision|0|||
161341655|NCT05516758|582637574|FG004|Overall Study|Physician Decision|1|||
161341656|NCT05516758|582637575|FG005|Overall Study|Physician Decision|1|||
161341657|NCT05516758|582637576|FG006|Overall Study|Physician Decision|2|||
161341658|NCT05516758|582637570|FG000|Overall Study|Protocol Deviation|1|||
161341659|NCT05516758|582637571|FG001|Overall Study|Protocol Deviation|0|||
161341660|NCT05516758|582637572|FG002|Overall Study|Protocol Deviation|0|||
161341661|NCT05516758|582637573|FG003|Overall Study|Protocol Deviation|0|||
161341662|NCT05516758|582637574|FG004|Overall Study|Protocol Deviation|0|||
161341663|NCT05516758|582637575|FG005|Overall Study|Protocol Deviation|1|||
161341664|NCT05516758|582637576|FG006|Overall Study|Protocol Deviation|5|||
161341665|NCT05516758|582637570|FG000|Overall Study|Withdrawal by Subject|11|||
161341666|NCT05516758|582637571|FG001|Overall Study|Withdrawal by Subject|1|||
161341667|NCT05516758|582637572|FG002|Overall Study|Withdrawal by Subject|15|||
161341668|NCT05516758|582637573|FG003|Overall Study|Withdrawal by Subject|2|||
161341669|NCT05516758|582637574|FG004|Overall Study|Withdrawal by Subject|7|||
161341670|NCT05516758|582637575|FG005|Overall Study|Withdrawal by Subject|7|||
161341671|NCT05516758|582637576|FG006|Overall Study|Withdrawal by Subject|6|||
161341672|NCT05516758|582637570|FG000|Overall Study|Death|1|||
161341673|NCT05516758|582637571|FG001|Overall Study|Death|0|||
161341674|NCT05516758|582637572|FG002|Overall Study|Death|0|||
161341675|NCT05516758|582637573|FG003|Overall Study|Death|0|||
161341676|NCT05516758|582637574|FG004|Overall Study|Death|0|||
161341677|NCT05516758|582637575|FG005|Overall Study|Death|0|||
161341678|NCT05516758|582637576|FG006|Overall Study|Death|0|||
161341679|NCT05516758|582637570|FG000|Overall Study|Non-compliance With Study Drug|0|||
161341680|NCT05516758|582637571|FG001|Overall Study|Non-compliance With Study Drug|0|||
161341681|NCT05516758|582637572|FG002|Overall Study|Non-compliance With Study Drug|1|||
161263032|NCT01550744|582343522|FG001|Open-Label|Adverse Event|0|||
161263033|NCT01550744|582343523|FG002|Open-Label|Adverse Event|0|||
161341682|NCT05516758|582637573|FG003|Overall Study|Non-compliance With Study Drug|0|||
161263034|NCT01550744|582343521|FG000|Open-Label|Lack of Efficacy|4|||
161263035|NCT01550744|582343522|FG001|Open-Label|Lack of Efficacy|0|||
161263036|NCT01550744|582343523|FG002|Open-Label|Lack of Efficacy|0|||
161341683|NCT05516758|582637574|FG004|Overall Study|Non-compliance With Study Drug|0|||
161341684|NCT05516758|582637575|FG005|Overall Study|Non-compliance With Study Drug|0|||
161341685|NCT05516758|582637576|FG006|Overall Study|Non-compliance With Study Drug|0|||
161341686|NCT05516758|582637570|FG000|Overall Study|Site Terminated by Sponsor|2|||
161341687|NCT05516758|582637571|FG001|Overall Study|Site Terminated by Sponsor|0|||
161341688|NCT05516758|582637572|FG002|Overall Study|Site Terminated by Sponsor|0|||
161341689|NCT05516758|582637573|FG003|Overall Study|Site Terminated by Sponsor|0|||
161341690|NCT05516758|582637574|FG004|Overall Study|Site Terminated by Sponsor|0|||
161341691|NCT05516758|582637575|FG005|Overall Study|Site Terminated by Sponsor|0|||
161341692|NCT05516758|582637576|FG006|Overall Study|Site Terminated by Sponsor|0|||
161341693|NCT05516758|582637570|FG000|Overall Study|Study Terminated by Sponsor|4|||
161341694|NCT05516758|582637571|FG001|Overall Study|Study Terminated by Sponsor|0|||
161341695|NCT05516758|582637572|FG002|Overall Study|Study Terminated by Sponsor|3|||
161341696|NCT05516758|582637573|FG003|Overall Study|Study Terminated by Sponsor|0|||
161341697|NCT05516758|582637574|FG004|Overall Study|Study Terminated by Sponsor|2|||
161341698|NCT05516758|582637575|FG005|Overall Study|Study Terminated by Sponsor|3|||
161341699|NCT05516758|582637576|FG006|Overall Study|Study Terminated by Sponsor|0|||
161341700|NCT05516758|582637570|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
161341701|NCT05516758|582637571|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
161341702|NCT05516758|582637572|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
161341703|NCT05516758|582637573|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
161341704|NCT05516758|582637574|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
161341705|NCT05516758|582637575|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
161341706|NCT05516758|582637576|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
161341707|NCT05516758|582637570|FG000|Overall Study|Other|0|||
161341708|NCT05516758|582637571|FG001|Overall Study|Other|0|||
161341709|NCT05516758|582637572|FG002|Overall Study|Other|0|||
161341710|NCT05516758|582637573|FG003|Overall Study|Other|0|||
161341711|NCT05516758|582637574|FG004|Overall Study|Other|0|||
161341712|NCT05516758|582637575|FG005|Overall Study|Other|0|||
160925059|NCT00542919|581121083|FG001|Overall Study|Lost to Follow-up|0|||
160925060|NCT00542919|581121084|FG002|Overall Study|Lost to Follow-up|1|||
160925061|NCT05123222|581121096|FG000|Overall Study|Lost to Follow-up|2|||
160925062|NCT05123222|581121097|FG001|Overall Study|Lost to Follow-up|0|||
161263037|NCT01550744|582343521|FG000|Open-Label|Protocol Violation|4|||
161263038|NCT01550744|582343522|FG001|Open-Label|Protocol Violation|0|||
161263039|NCT01550744|582343523|FG002|Open-Label|Protocol Violation|0|||
161263040|NCT01550744|582343521|FG000|Open-Label|Not all 3 study drug injections received|2|||
161263041|NCT01550744|582343522|FG001|Open-Label|Not all 3 study drug injections received|0|||
161263042|NCT01550744|582343523|FG002|Open-Label|Not all 3 study drug injections received|0|||
161263043|NCT01550744|582343521|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
161263044|NCT01550744|582343522|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
161263045|NCT01550744|582343523|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
161263046|NCT01550744|582343521|FG000|Open-Label|Other|1|||
161263047|NCT01550744|582343522|FG001|Open-Label|Other|0|||
161263048|NCT01550744|582343523|FG002|Open-Label|Other|0|||
161263049|NCT01550744|582343521|FG000|Double-Blind|Lost to Follow-up|0|||
161263050|NCT01550744|582343522|FG001|Double-Blind|Lost to Follow-up|6|||
161263051|NCT01550744|582343523|FG002|Double-Blind|Lost to Follow-up|12|||
161263052|NCT01550744|582343521|FG000|Double-Blind|Withdrawal by Subject|0|||
161263053|NCT01550744|582343522|FG001|Double-Blind|Withdrawal by Subject|2|||
161263054|NCT01550744|582343523|FG002|Double-Blind|Withdrawal by Subject|15|||
161263055|NCT01550744|582343521|FG000|Double-Blind|Adverse Event|0|||
161263056|NCT01550744|582343522|FG001|Double-Blind|Adverse Event|4|||
161263057|NCT01550744|582343523|FG002|Double-Blind|Adverse Event|15|||
161263058|NCT01550744|582343521|FG000|Double-Blind|Death|0|||
161263059|NCT01550744|582343522|FG001|Double-Blind|Death|1|||
161263060|NCT01550744|582343523|FG002|Double-Blind|Death|0|||
161341713|NCT05516758|582637576|FG006|Overall Study|Other|1|||
161341714|NCT02792504|582637577|FG000|Overall Study|Lost to Follow-up|24|||
161341715|NCT02792504|582637577|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
161341716|NCT01114724|582637578|FG000|Overall Study|Death|8|||
161341717|NCT01114724|582637578|FG000|Overall Study|Lost to Follow-up|1|||
161341718|NCT01114724|582637578|FG000|Overall Study|Withdrawal by Subject|1|||
161341719|NCT02485860|582637579|FG000|Overall Study|Lost to Follow-up|4|||
161341720|NCT02485860|582637580|FG001|Overall Study|Lost to Follow-up|1|||
161341721|NCT02485860|582637579|FG000|Overall Study|Physician Decision|1|||
161341722|NCT02485860|582637580|FG001|Overall Study|Physician Decision|2|||
161341723|NCT02485860|582637579|FG000|Overall Study|Health context (COVID-19)|1|||
161341724|NCT02485860|582637580|FG001|Overall Study|Health context (COVID-19)|0|||
161263061|NCT01550744|582343521|FG000|Double-Blind|Lack of Efficacy|0|||
161263062|NCT01550744|582343522|FG001|Double-Blind|Lack of Efficacy|2|||
161263063|NCT01550744|582343523|FG002|Double-Blind|Lack of Efficacy|8|||
161263064|NCT01550744|582343521|FG000|Double-Blind|Protocol Violation|0|||
161263065|NCT01550744|582343522|FG001|Double-Blind|Protocol Violation|0|||
161263066|NCT01550744|582343523|FG002|Double-Blind|Protocol Violation|4|||
161263067|NCT01550744|582343521|FG000|Double-Blind|Pregnancy|0|||
161263068|NCT01550744|582343522|FG001|Double-Blind|Pregnancy|0|||
161263069|NCT01550744|582343523|FG002|Double-Blind|Pregnancy|3|||
161263070|NCT01550744|582343521|FG000|Double-Blind|Other|0|||
161263071|NCT01550744|582343522|FG001|Double-Blind|Other|2|||
161263072|NCT01550744|582343523|FG002|Double-Blind|Other|10|||
161263073|NCT00706381|582343526|FG000|Overall Study|Lost to Follow-up|0|||
161263074|NCT00706381|582343527|FG001|Overall Study|Lost to Follow-up|1|||
161263075|NCT00706381|582343528|FG002|Overall Study|Lost to Follow-up|1|||
161263076|NCT00706381|582343529|FG003|Overall Study|Lost to Follow-up|0|||
161263077|NCT05420012|582343530|FG000|Overall Study|Lost to Follow-up|0|||
161263078|NCT05420012|582343531|FG001|Overall Study|Lost to Follow-up|1|||
161263079|NCT00038649|582343535|FG000|Overall Study|Adverse Event|9|||
161263080|NCT03395639|582343536|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
161263081|NCT03395639|582343537|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
161263082|NCT03395639|582343538|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
161263083|NCT03395639|582343536|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
161263084|NCT03395639|582343537|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
161263085|NCT03395639|582343538|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
161263086|NCT03395639|582343536|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
161263087|NCT03395639|582343537|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
161263088|NCT03395639|582343538|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
161263089|NCT03395639|582343536|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
161263090|NCT03395639|582343537|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
161263091|NCT03395639|582343538|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
161263092|NCT03395639|582343536|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
161263093|NCT03395639|582343537|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
161263094|NCT03395639|582343538|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
161263095|NCT00942331|582343539|FG000|Overall Study|Did not start treatment|15|||
161263096|NCT00942331|582343540|FG001|Overall Study|Did not start treatment|22|||
161263097|NCT00700817|582343548|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
161263098|NCT00700817|582343549|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
161263099|NCT00700817|582343550|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
161263100|NCT00700817|582343551|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
161263101|NCT00700817|582343552|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
161263102|NCT00700817|582343548|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
161263103|NCT00700817|582343549|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161263104|NCT00700817|582343550|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
161263105|NCT00700817|582343551|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161263106|NCT00700817|582343552|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
161263107|NCT00700817|582343548|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
161263108|NCT00700817|582343549|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
161263109|NCT00700817|582343550|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
161263110|NCT00700817|582343551|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
161263111|NCT00700817|582343552|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
161263112|NCT00700817|582343548|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
161263113|NCT00700817|582343549|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
161263114|NCT00700817|582343550|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
161263115|NCT00700817|582343551|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
161263116|NCT00700817|582343552|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
161263117|NCT00700817|582343548|FG000|Week 0-26 (Main Period)|Unclassified|14|||
161263118|NCT00700817|582343549|FG001|Week 0-26 (Main Period)|Unclassified|4|||
161263119|NCT00700817|582343550|FG002|Week 0-26 (Main Period)|Unclassified|8|||
161263120|NCT00700817|582343551|FG003|Week 0-26 (Main Period)|Unclassified|0|||
161263121|NCT00700817|582343552|FG004|Week 0-26 (Main Period)|Unclassified|0|||
161263122|NCT00700817|582343548|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
161263123|NCT00700817|582343549|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
161263124|NCT00700817|582343550|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
161263125|NCT00700817|582343551|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
161263126|NCT00700817|582343552|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
161263127|NCT00700817|582343548|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
161263128|NCT00700817|582343549|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
161263129|NCT00700817|582343550|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
161263130|NCT00700817|582343551|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
161263131|NCT00700817|582343552|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
161263132|NCT00700817|582343548|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
161263133|NCT00700817|582343549|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
161263134|NCT00700817|582343550|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
161263135|NCT00700817|582343551|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
161263136|NCT00700817|582343552|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
161263137|NCT00700817|582343548|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
160925063|NCT05123222|581121098|FG002|Overall Study|Lost to Follow-up|0|||
160925064|NCT05123222|581121099|FG003|Overall Study|Lost to Follow-up|0|||
160925065|NCT05123222|581121096|FG000|Overall Study|Protocol Violation|0|||
160925066|NCT05123222|581121097|FG001|Overall Study|Protocol Violation|0|||
160925067|NCT05123222|581121098|FG002|Overall Study|Protocol Violation|1|||
160925068|NCT05123222|581121099|FG003|Overall Study|Protocol Violation|0|||
160925069|NCT02385266|581121100|FG000|Overall Study|Withdrawal by Subject|1|||
160925070|NCT02385266|581121101|FG001|Overall Study|Withdrawal by Subject|3|||
160925071|NCT00914810|581121102|FG000|Overall Study|Withdrawal by Subject|1|||
160925072|NCT00914810|581121103|FG001|Overall Study|Withdrawal by Subject|0|||
160925073|NCT00914810|581121102|FG000|Overall Study|Relocated out of state|1|||
160925074|NCT00914810|581121103|FG001|Overall Study|Relocated out of state|0|||
160925075|NCT00914810|581121102|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
160925076|NCT00914810|581121103|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
160925077|NCT03020823|581121106|FG000|Overall Study|Physician Decision|4|||
160925078|NCT03020823|581121106|FG000|Overall Study|Lack of Efficacy|4|||
160925079|NCT03020823|581121106|FG000|Overall Study|Adverse Event|2|||
160925080|NCT03739112|581121107|FG000|Overall Study|Adverse Event|2|||
160925081|NCT03739112|581121108|FG001|Overall Study|Adverse Event|2|||
160925082|NCT03739112|581121107|FG000|Overall Study|Withdrawal by Subject|38|||
160925083|NCT03739112|581121108|FG001|Overall Study|Withdrawal by Subject|19|||
160925084|NCT03739112|581121107|FG000|Overall Study|Lost to Follow-up|31|||
160925085|NCT03739112|581121108|FG001|Overall Study|Lost to Follow-up|33|||
160925086|NCT03739112|581121107|FG000|Overall Study|Protocol Deviation|12|||
160925087|NCT03739112|581121108|FG001|Overall Study|Protocol Deviation|9|||
160925088|NCT03739112|581121107|FG000|Overall Study|Physician Decision|1|||
160925089|NCT03739112|581121108|FG001|Overall Study|Physician Decision|0|||
160925090|NCT03739112|581121107|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
160925091|NCT03739112|581121108|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
160925092|NCT03739112|581121107|FG000|Overall Study|Site went on hold|65|||
160925093|NCT03739112|581121108|FG001|Overall Study|Site went on hold|67|||
160925094|NCT03739112|581121107|FG000|Overall Study|Other than specified|8|||
160925095|NCT03739112|581121108|FG001|Overall Study|Other than specified|5|||
160925096|NCT03739112|581121107|FG000|Overall Study|Randomized but not vaccinated|31|||
160925097|NCT03739112|581121108|FG001|Overall Study|Randomized but not vaccinated|25|||
160925098|NCT00588822|581121110|FG000|Overall Study|progression of disease|8|||
160925099|NCT01727141|581121112|FG000|Overall Study|Physician Decision|0|||
160925100|NCT01727141|581121113|FG001|Overall Study|Physician Decision|1|||
160925101|NCT01727141|581121114|FG002|Overall Study|Physician Decision|0|||
160925102|NCT01727141|581121115|FG003|Overall Study|Physician Decision|2|||
160925103|NCT01727141|581121112|FG000|Overall Study|Lost to Follow-up|0|||
160925104|NCT01727141|581121113|FG001|Overall Study|Lost to Follow-up|2|||
160925105|NCT01727141|581121114|FG002|Overall Study|Lost to Follow-up|0|||
160925106|NCT01727141|581121115|FG003|Overall Study|Lost to Follow-up|0|||
160925107|NCT01727141|581121112|FG000|Overall Study|Death|0|||
160925108|NCT01727141|581121113|FG001|Overall Study|Death|1|||
160925109|NCT01727141|581121114|FG002|Overall Study|Death|1|||
160925110|NCT01727141|581121115|FG003|Overall Study|Death|1|||
160925111|NCT01727141|581121112|FG000|Overall Study|Protocol deviation|1|||
160925112|NCT01727141|581121113|FG001|Overall Study|Protocol deviation|1|||
160925113|NCT01727141|581121114|FG002|Overall Study|Protocol deviation|0|||
160925114|NCT01727141|581121115|FG003|Overall Study|Protocol deviation|1|||
160925115|NCT01727141|581121112|FG000|Overall Study|Withdrawal by Subject|4|||
160925116|NCT01727141|581121113|FG001|Overall Study|Withdrawal by Subject|4|||
160925117|NCT01727141|581121114|FG002|Overall Study|Withdrawal by Subject|2|||
160925118|NCT01727141|581121115|FG003|Overall Study|Withdrawal by Subject|11|||
160925119|NCT02529137|581121118|FG000|Overall Study|Discontinuation for different reasons|8|||
160925120|NCT02731729|581121121|FG000|Overall Study|Death|2|||
160925121|NCT02731729|581121122|FG001|Overall Study|Death|2|||
160925122|NCT02731729|581121121|FG000|Overall Study|Study terminated by Sponsor|6|||
160925123|NCT02731729|581121122|FG001|Overall Study|Study terminated by Sponsor|6|||
160925124|NCT02731729|581121121|FG000|Overall Study|Withdrawal by Subject|1|||
160925125|NCT02731729|581121122|FG001|Overall Study|Withdrawal by Subject|0|||
160925126|NCT01344447|581121123|FG000|Overall Study|Adverse Event|1|||
160925127|NCT01344447|581121123|FG000|Overall Study|Protocol Violation|1|||
160925128|NCT01344447|581121123|FG000|Overall Study|Withdrawal by Subject|1|||
160925129|NCT01344447|581121123|FG000|Overall Study|The contrast was not seen|1|||
160997960|NCT00589667|581378495|FG000|Overall Study|Withdrawal by Subject|1|||
160925130|NCT01344447|581121123|FG000|Overall Study|Physician Decision|1|||
160925131|NCT01344447|581121123|FG000|Overall Study|MRA unsuccessful|1|||
160925132|NCT01344447|581121123|FG000|Overall Study|Bolus tracking failed|1|||
160925133|NCT01344447|581121123|FG000|Overall Study|Error of power injector|1|||
160925134|NCT01660711|581121124|FG000|Overall Study|Adverse Event|7|||
160925135|NCT01660711|581121124|FG000|Overall Study|Withdrawal by Subject|1|||
160925136|NCT00952341|581121126|FG000|Cycle 1|Adverse Event|4|||
160925137|NCT00952341|581121127|FG001|Cycle 1|Adverse Event|1|||
160925138|NCT00952341|581121126|FG000|Cycle 1|Withdrawal by Subject|3|||
160925139|NCT00952341|581121127|FG001|Cycle 1|Withdrawal by Subject|8|||
160925140|NCT00952341|581121126|FG000|Cycle 1|Protocol Violation|2|||
160925141|NCT00952341|581121127|FG001|Cycle 1|Protocol Violation|1|||
160925142|NCT00952341|581121126|FG000|Cycle 1|Lost to Follow-up|11|||
160925143|NCT00952341|581121127|FG001|Cycle 1|Lost to Follow-up|2|||
160925144|NCT00952341|581121126|FG000|Cycle 1|Physician Decision|0|||
160925145|NCT00952341|581121127|FG001|Cycle 1|Physician Decision|1|||
160925146|NCT00952341|581121126|FG000|Cycle 2|Withdrawal by Subject|1|||
160925147|NCT00952341|581121127|FG001|Cycle 2|Withdrawal by Subject|1|||
160925148|NCT00952341|581121126|FG000|Cycle 2|Protocol Violation|1|||
160925149|NCT00952341|581121127|FG001|Cycle 2|Protocol Violation|0|||
160925150|NCT00952341|581121126|FG000|Cycle 2|Lost to Follow-up|6|||
160925151|NCT00952341|581121127|FG001|Cycle 2|Lost to Follow-up|9|||
160925152|NCT00952341|581121126|FG000|Cycle 2|Physician Decision|1|||
160925153|NCT00952341|581121127|FG001|Cycle 2|Physician Decision|1|||
160925154|NCT00952341|581121126|FG000|Cycle 2|Progressive Disease|0|||
160925155|NCT00952341|581121127|FG001|Cycle 2|Progressive Disease|1|||
160925156|NCT02066467|581121132|FG000|Overall Study|Did not undergo implant procedure|24|||
160925157|NCT02066467|581121132|FG000|Overall Study|Attempted to implant withoput success|43|||
160925158|NCT02066467|581121132|FG000|Overall Study|Consent ineligible|1|||
160925159|NCT02066467|581121132|FG000|Overall Study|Death|54|||
160925160|NCT02066467|581121132|FG000|Overall Study|Lost to Follow-up|51|||
160925161|NCT02066467|581121132|FG000|Overall Study|Adverse Event|20|||
160925162|NCT02066467|581121132|FG000|Overall Study|Withdrawal by Subject|16|||
160925163|NCT02066467|581121132|FG000|Overall Study|Physician Decision|2|||
160925164|NCT02066467|581121132|FG000|Overall Study|Not defined|4|||
161263138|NCT00700817|582343549|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
161263139|NCT00700817|582343550|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
161263140|NCT00700817|582343551|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
161263141|NCT00700817|582343552|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
161263142|NCT00700817|582343548|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
161263143|NCT00700817|582343549|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
161263144|NCT00700817|582343550|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
161263145|NCT00700817|582343551|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
161263146|NCT00700817|582343552|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
161263147|NCT00700817|582343548|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161263148|NCT00700817|582343549|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
161263149|NCT00700817|582343550|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161263150|NCT00700817|582343551|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
161263151|NCT00700817|582343552|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
161263152|NCT00700817|582343548|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
160925165|NCT02914769|581121133|FG000|Overall Study|Protocol Violation|3|||
160925166|NCT02914769|581121134|FG001|Overall Study|Protocol Violation|2|||
160925167|NCT02914769|581121133|FG000|Overall Study|Withdrawal by Subject|0|||
161263153|NCT00700817|582343549|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
161263154|NCT00700817|582343550|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
161263155|NCT00700817|582343551|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161263156|NCT00700817|582343552|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
161263157|NCT00700817|582343548|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
160925168|NCT02914769|581121134|FG001|Overall Study|Withdrawal by Subject|1|||
160925169|NCT01592344|581121135|FG000|Overall Study|Adverse Event|1|||
160925170|NCT01592344|581121136|FG001|Overall Study|Adverse Event|1|||
160925171|NCT01592344|581121135|FG000|Overall Study|Lack of Efficacy|1|||
160925172|NCT01592344|581121136|FG001|Overall Study|Lack of Efficacy|0|||
160925173|NCT01592344|581121135|FG000|Overall Study|not available at primary outcome visit|2|||
160925174|NCT01592344|581121136|FG001|Overall Study|not available at primary outcome visit|4|||
160925175|NCT02738333|581121137|FG000|Overall Study|Death|1|||
160925176|NCT02738333|581121138|FG001|Overall Study|Death|0|||
160925177|NCT02738333|581121139|FG002|Overall Study|Death|0|||
160925178|NCT02738333|581121137|FG000|Overall Study|Lost to Follow-up|1|||
160925179|NCT02738333|581121138|FG001|Overall Study|Lost to Follow-up|0|||
161263158|NCT00700817|582343549|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
161263159|NCT00700817|582343550|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161263160|NCT00700817|582343551|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
161263161|NCT00700817|582343552|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
160925180|NCT02738333|581121139|FG002|Overall Study|Lost to Follow-up|0|||
160925181|NCT04519645|581121140|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
160925182|NCT04519645|581121141|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
160925183|NCT04519645|581121142|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
160925184|NCT04519645|581121140|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
160925185|NCT04519645|581121141|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
160925186|NCT04519645|581121142|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
160925187|NCT04519645|581121140|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
160925188|NCT04519645|581121141|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
160925189|NCT04519645|581121142|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
160925190|NCT04519645|581121140|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
160925191|NCT04519645|581121141|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
160925192|NCT04519645|581121142|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
160925193|NCT01679002|581121143|FG000|Overall Study|Adverse Event|1|||
160925194|NCT01679002|581121144|FG001|Overall Study|Adverse Event|1|||
160925195|NCT01679002|581121145|FG002|Overall Study|Adverse Event|0|||
160925196|NCT00730912|581121148|FG000|Overall Study|Discontinued|0|||
160925197|NCT00730912|581121149|FG001|Overall Study|Discontinued|0|||
160925198|NCT00730912|581121150|FG002|Overall Study|Discontinued|1|||
160925199|NCT02205333|581121154|FG000|Overall Study|Death|5|||
160925200|NCT02205333|581121155|FG001|Overall Study|Death|6|||
160925201|NCT02205333|581121156|FG002|Overall Study|Death|2|||
160925202|NCT02205333|581121157|FG003|Overall Study|Death|6|||
160925203|NCT02205333|581121158|FG004|Overall Study|Death|5|||
160925204|NCT02205333|581121159|FG005|Overall Study|Death|3|||
160925205|NCT02205333|581121160|FG006|Overall Study|Death|3|||
160925206|NCT02205333|581121161|FG007|Overall Study|Death|2|||
160925207|NCT02205333|581121162|FG008|Overall Study|Death|0|||
160925208|NCT02205333|581121154|FG000|Overall Study|Withdrawal by Subject|1|||
160925209|NCT02205333|581121155|FG001|Overall Study|Withdrawal by Subject|0|||
160925210|NCT02205333|581121156|FG002|Overall Study|Withdrawal by Subject|0|||
160925211|NCT02205333|581121157|FG003|Overall Study|Withdrawal by Subject|1|||
161263162|NCT00700817|582343548|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
161263163|NCT00700817|582343549|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
161263164|NCT00700817|582343550|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
161263165|NCT00700817|582343551|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
161263166|NCT00700817|582343552|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
160925212|NCT02205333|581121158|FG004|Overall Study|Withdrawal by Subject|0|||
160925213|NCT02205333|581121159|FG005|Overall Study|Withdrawal by Subject|0|||
160925214|NCT02205333|581121160|FG006|Overall Study|Withdrawal by Subject|2|||
160925215|NCT02205333|581121161|FG007|Overall Study|Withdrawal by Subject|0|||
160925216|NCT02205333|581121162|FG008|Overall Study|Withdrawal by Subject|0|||
160925217|NCT01176266|581121163|FG000|Overall Study|Death|6|||
160925218|NCT01176266|581121163|FG000|Overall Study|Withdrawal by Subject|3|||
160925219|NCT01179477|581121164|FG000|Overall Study|Death|542|||
160925220|NCT01179477|581121164|FG000|Overall Study|Unsuccessful implant|80|||
160925221|NCT01179477|581121164|FG000|Overall Study|Non-death withdrawal|438|||
161263167|NCT00700817|582343548|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
161341725|NCT02273167|582637588|FG000|Overall Study|Adverse Event|1|||
161341726|NCT02273167|582637589|FG001|Overall Study|Adverse Event|0|||
160925222|NCT01179477|581121164|FG000|Overall Study|Did not complete final visit|27|||
160925223|NCT00455429|581121166|FG000|Overall Study|Study Terminated by Sponsor|0|||
160925224|NCT00455429|581121167|FG001|Overall Study|Study Terminated by Sponsor|0|||
161263168|NCT00700817|582343549|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
161341727|NCT02273167|582637590|FG002|Overall Study|Adverse Event|0|||
161263169|NCT00700817|582343550|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
161263170|NCT00700817|582343551|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
161341728|NCT02273167|582637588|FG000|Overall Study|Protocol Violation|3|||
161263171|NCT00700817|582343552|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
161263172|NCT01194973|582343553|FG000|Screening Period|Screen Failure|3|||
161263173|NCT01194973|582343553|FG000|26 Week Treatment Period|Adverse Event|1|||
161263174|NCT01194973|582343553|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
161263175|NCT01194973|582343553|FG000|26 Week Treatment Period|Pregnancy|1|||
161263176|NCT01338987|582343556|FG000|Overall Study|enrolled on new protocol|0|||
161263177|NCT01338987|582343557|FG001|Overall Study|enrolled on new protocol|0|||
161263178|NCT01338987|582343558|FG002|Overall Study|enrolled on new protocol|1|||
161263179|NCT01338987|582343559|FG003|Overall Study|enrolled on new protocol|0|||
161263180|NCT01338987|582343560|FG004|Overall Study|enrolled on new protocol|0|||
161341729|NCT02273167|582637589|FG001|Overall Study|Protocol Violation|1|||
161341730|NCT02273167|582637590|FG002|Overall Study|Protocol Violation|1|||
161341731|NCT02273167|582637588|FG000|Overall Study|Lost to Follow-up|0|||
161341732|NCT02273167|582637589|FG001|Overall Study|Lost to Follow-up|1|||
161341733|NCT02273167|582637590|FG002|Overall Study|Lost to Follow-up|1|||
161341734|NCT02273167|582637588|FG000|Overall Study|Withdrawal by Subject|10|||
161341735|NCT02273167|582637589|FG001|Overall Study|Withdrawal by Subject|12|||
160925225|NCT00455429|581121168|FG002|Overall Study|Study Terminated by Sponsor|0|||
160925226|NCT00455429|581121169|FG003|Overall Study|Study Terminated by Sponsor|3|||
160925227|NCT00455429|581121166|FG000|Overall Study|Lost to Follow-up|1|||
161263181|NCT01338987|582343556|FG000|Overall Study|Disease progression on study|2|||
161341736|NCT02273167|582637590|FG002|Overall Study|Withdrawal by Subject|11|||
161341737|NCT02273167|582637588|FG000|Overall Study|Various|10|||
160925228|NCT00455429|581121167|FG001|Overall Study|Lost to Follow-up|0|||
160925229|NCT00455429|581121168|FG002|Overall Study|Lost to Follow-up|0|||
160925230|NCT00455429|581121169|FG003|Overall Study|Lost to Follow-up|3|||
160925231|NCT00455429|581121166|FG000|Overall Study|Withdrawal by Subject|0|||
160925232|NCT00455429|581121167|FG001|Overall Study|Withdrawal by Subject|1|||
161341738|NCT02273167|582637589|FG001|Overall Study|Various|9|||
161341739|NCT02273167|582637590|FG002|Overall Study|Various|8|||
161341740|NCT03082729|582637591|FG000|Overall Study|Lost to Follow-up|7|||
161341741|NCT03082729|582637591|FG000|Overall Study|Physician Decision|2|||
161341742|NCT03082729|582637591|FG000|Overall Study|Withdrawal by Subject|1|||
161341743|NCT03082729|582637591|FG000|Overall Study|Lack of Efficacy|9|||
161341744|NCT03082729|582637591|FG000|Overall Study|Adverse Event|4|||
161341745|NCT03082729|582637591|FG000|Overall Study|Protocol Violation|6|||
161341746|NCT03082729|582637591|FG000|Overall Study|Fear of study procedure|1|||
161341747|NCT03082729|582637591|FG000|Overall Study|Scheduling conflict|1|||
161341748|NCT01963611|582639020|FG000|Overall Study|Adverse Event|1|||
161341749|NCT01963611|582639021|FG001|Overall Study|Adverse Event|1|||
160925233|NCT00455429|581121168|FG002|Overall Study|Withdrawal by Subject|1|||
160925234|NCT00455429|581121169|FG003|Overall Study|Withdrawal by Subject|0|||
160925235|NCT00455429|581121166|FG000|Overall Study|Lack of Efficacy|0|||
160925236|NCT00455429|581121167|FG001|Overall Study|Lack of Efficacy|1|||
160925237|NCT00455429|581121168|FG002|Overall Study|Lack of Efficacy|0|||
160925238|NCT00455429|581121169|FG003|Overall Study|Lack of Efficacy|1|||
161341750|NCT01963611|582639022|FG002|Overall Study|Adverse Event|3|||
161341751|NCT01963611|582639023|FG003|Overall Study|Adverse Event|4|||
161341752|NCT01963611|582639024|FG004|Overall Study|Adverse Event|3|||
161341753|NCT01963611|582639020|FG000|Overall Study|Protocol Violation|0|||
161341754|NCT01963611|582639021|FG001|Overall Study|Protocol Violation|0|||
161341755|NCT01963611|582639022|FG002|Overall Study|Protocol Violation|0|||
161341756|NCT01963611|582639023|FG003|Overall Study|Protocol Violation|1|||
161341757|NCT01963611|582639024|FG004|Overall Study|Protocol Violation|0|||
161341758|NCT01963611|582639020|FG000|Overall Study|Lack of Efficacy|0|||
161341759|NCT01963611|582639021|FG001|Overall Study|Lack of Efficacy|0|||
160925239|NCT00455429|581121166|FG000|Overall Study|Adverse Event|0|||
160925240|NCT00455429|581121167|FG001|Overall Study|Adverse Event|1|||
160925241|NCT00455429|581121168|FG002|Overall Study|Adverse Event|0|||
160925242|NCT00455429|581121169|FG003|Overall Study|Adverse Event|3|||
160925243|NCT00455429|581121166|FG000|Overall Study|Randomly assigned but not treated|0|||
160925244|NCT00455429|581121167|FG001|Overall Study|Randomly assigned but not treated|0|||
160925245|NCT00455429|581121168|FG002|Overall Study|Randomly assigned but not treated|0|||
160925246|NCT00455429|581121169|FG003|Overall Study|Randomly assigned but not treated|2|||
160925247|NCT00455429|581121166|FG000|Overall Study|Personal Reason|1|||
160925248|NCT00455429|581121167|FG001|Overall Study|Personal Reason|0|||
160925249|NCT00455429|581121168|FG002|Overall Study|Personal Reason|0|||
160925250|NCT00455429|581121169|FG003|Overall Study|Personal Reason|0|||
160925251|NCT00455429|581121166|FG000|Overall Study|Non-compliance|0|||
160925252|NCT00455429|581121167|FG001|Overall Study|Non-compliance|0|||
160925253|NCT00455429|581121168|FG002|Overall Study|Non-compliance|0|||
160925254|NCT00455429|581121169|FG003|Overall Study|Non-compliance|1|||
160925255|NCT00455429|581121166|FG000|Overall Study|Other|0|||
160925256|NCT00455429|581121167|FG001|Overall Study|Other|2|||
160925257|NCT00455429|581121168|FG002|Overall Study|Other|0|||
160925258|NCT00455429|581121169|FG003|Overall Study|Other|1|||
160925259|NCT04351087|581121170|FG000|Overall Study|Lost to Follow-up|7|||
160925260|NCT04351087|581121171|FG001|Overall Study|Lost to Follow-up|3|||
160925261|NCT04351087|581121170|FG000|Overall Study|Withdrawal by Subject|3|||
160925262|NCT04351087|581121171|FG001|Overall Study|Withdrawal by Subject|4|||
160925263|NCT04351087|581121170|FG000|Overall Study|Lack of Efficacy|3|||
160925264|NCT04351087|581121171|FG001|Overall Study|Lack of Efficacy|2|||
160925265|NCT03519347|581121172|FG000|Interventional Crossover Period 1|Death|0|||
160925266|NCT03519347|581121173|FG001|Interventional Crossover Period 1|Death|0|||
161341760|NCT01963611|582639022|FG002|Overall Study|Lack of Efficacy|0|||
161341761|NCT01963611|582639023|FG003|Overall Study|Lack of Efficacy|1|||
161341762|NCT01963611|582639024|FG004|Overall Study|Lack of Efficacy|0|||
161341763|NCT01963611|582639020|FG000|Overall Study|Withdrawal by Subject|3|||
161341764|NCT01963611|582639021|FG001|Overall Study|Withdrawal by Subject|2|||
161341765|NCT01963611|582639022|FG002|Overall Study|Withdrawal by Subject|1|||
161341766|NCT01963611|582639023|FG003|Overall Study|Withdrawal by Subject|1|||
161341767|NCT01963611|582639024|FG004|Overall Study|Withdrawal by Subject|3|||
160925267|NCT03519347|581121174|FG002|Interventional Crossover Period 1|Death|0|||
161341768|NCT01963611|582639020|FG000|Overall Study|Other|47|||
161341769|NCT01963611|582639021|FG001|Overall Study|Other|46|||
161341770|NCT01963611|582639022|FG002|Overall Study|Other|48|||
161341771|NCT01963611|582639023|FG003|Overall Study|Other|45|||
161341772|NCT01963611|582639024|FG004|Overall Study|Other|45|||
160925268|NCT03519347|581121175|FG003|Interventional Crossover Period 1|Death|1|||
160925269|NCT01412021|581121176|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
160925270|NCT01412021|581121176|FG000|Overall Study|Treatment Prior to Approval|3|||
160925271|NCT01412021|581121176|FG000|Overall Study|Transferred to Other Hospital|9|||
160925272|NCT00484939|581121179|FG000|Overall Study|Death|9|||
160925273|NCT00484939|581121180|FG001|Overall Study|Death|13|||
160925274|NCT00484939|581121179|FG000|Overall Study|Adverse Event|22|||
160925275|NCT00484939|581121180|FG001|Overall Study|Adverse Event|12|||
161341773|NCT01126424|582639026|FG000|Overall Study|Adverse Event|0|||
160925276|NCT00484939|581121179|FG000|Overall Study|Patient Withdrew Consent|19|||
160925277|NCT00484939|581121180|FG001|Overall Study|Patient Withdrew Consent|10|||
160925278|NCT00484939|581121179|FG000|Overall Study|Protocol Violation|3|||
160925279|NCT00484939|581121180|FG001|Overall Study|Protocol Violation|3|||
160925280|NCT00484939|581121179|FG000|Overall Study|Lost to Follow-up|0|||
160925281|NCT00484939|581121180|FG001|Overall Study|Lost to Follow-up|3|||
160925282|NCT00484939|581121179|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
160925283|NCT00484939|581121180|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
160925284|NCT00484939|581121179|FG000|Overall Study|Disease progression|67|||
160925285|NCT00484939|581121180|FG001|Overall Study|Disease progression|88|||
160925286|NCT00484939|581121179|FG000|Overall Study|Screen Failure|2|||
160925287|NCT00484939|581121180|FG001|Overall Study|Screen Failure|2|||
160925288|NCT00484939|581121179|FG000|Overall Study|Reason Not Specified|11|||
160925289|NCT00484939|581121180|FG001|Overall Study|Reason Not Specified|6|||
160925290|NCT01522365|581121181|FG000|Overall Study|Withdrawal by Subject|1|||
160925291|NCT01522365|581121182|FG001|Overall Study|Withdrawal by Subject|1|||
160925292|NCT01522365|581121181|FG000|Overall Study|Lost to Follow-up|1|||
160925293|NCT01522365|581121182|FG001|Overall Study|Lost to Follow-up|1|||
160925294|NCT02466555|581121185|FG000|Overall Study|Lost to Follow-up|2|||
160925295|NCT01120756|581121186|FG000|Overall Study|Withdrawal by Subject|1|||
160925296|NCT01120756|581121187|FG001|Overall Study|Withdrawal by Subject|1|||
160925297|NCT00698581|581121188|FG000|Overall Study|Lack of Efficacy|23|||
160925298|NCT00698581|581121189|FG001|Overall Study|Lack of Efficacy|11|||
160925299|NCT00698581|581121188|FG000|Overall Study|Withdrawal by Subject|6|||
160925300|NCT00698581|581121189|FG001|Overall Study|Withdrawal by Subject|0|||
160925301|NCT00698581|581121188|FG000|Overall Study|Other reason|9|||
160925302|NCT00698581|581121189|FG001|Overall Study|Other reason|1|||
160925303|NCT00698581|581121188|FG000|Overall Study|SAE, non-fatal|1|||
160925304|NCT00698581|581121189|FG001|Overall Study|SAE, non-fatal|0|||
160925305|NCT00698581|581121188|FG000|Overall Study|AE, non-serious non-fatal|4|||
160925306|NCT00698581|581121189|FG001|Overall Study|AE, non-serious non-fatal|0|||
160925307|NCT00698581|581121188|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160925308|NCT00698581|581121189|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160925309|NCT00698581|581121188|FG000|Overall Study|AE of unknown type|1|||
160925310|NCT00698581|581121189|FG001|Overall Study|AE of unknown type|0|||
160925311|NCT03760146|581121190|FG000|Overall Study|Adverse Event|11|||
160925312|NCT03760146|581121191|FG001|Overall Study|Adverse Event|8|||
160925313|NCT03760146|581121192|FG002|Overall Study|Adverse Event|0|||
160925314|NCT03760146|581121193|FG003|Overall Study|Adverse Event|0|||
160925315|NCT03760146|581121194|FG004|Overall Study|Adverse Event|0|||
160925316|NCT03760146|581121195|FG005|Overall Study|Adverse Event|0|||
160925317|NCT03760146|581121190|FG000|Overall Study|Death|1|||
160925318|NCT03760146|581121191|FG001|Overall Study|Death|0|||
160925319|NCT03760146|581121192|FG002|Overall Study|Death|0|||
160925320|NCT03760146|581121193|FG003|Overall Study|Death|0|||
160925321|NCT03760146|581121194|FG004|Overall Study|Death|0|||
160925322|NCT03760146|581121195|FG005|Overall Study|Death|0|||
160925323|NCT03760146|581121190|FG000|Overall Study|Lost to Follow-up|41|||
160925324|NCT03760146|581121191|FG001|Overall Study|Lost to Follow-up|28|||
160925325|NCT03760146|581121192|FG002|Overall Study|Lost to Follow-up|9|||
160925326|NCT03760146|581121193|FG003|Overall Study|Lost to Follow-up|2|||
160925327|NCT03760146|581121194|FG004|Overall Study|Lost to Follow-up|14|||
160925328|NCT03760146|581121195|FG005|Overall Study|Lost to Follow-up|8|||
160925329|NCT03760146|581121190|FG000|Overall Study|No longer met eligibility criteria|3|||
160925330|NCT03760146|581121191|FG001|Overall Study|No longer met eligibility criteria|9|||
160925331|NCT03760146|581121192|FG002|Overall Study|No longer met eligibility criteria|0|||
160925332|NCT03760146|581121193|FG003|Overall Study|No longer met eligibility criteria|0|||
160925333|NCT03760146|581121194|FG004|Overall Study|No longer met eligibility criteria|1|||
160925334|NCT03760146|581121195|FG005|Overall Study|No longer met eligibility criteria|0|||
160925335|NCT03760146|581121190|FG000|Overall Study|Protocol Violation|21|||
160925336|NCT03760146|581121191|FG001|Overall Study|Protocol Violation|13|||
160925337|NCT03760146|581121192|FG002|Overall Study|Protocol Violation|1|||
160925338|NCT03760146|581121193|FG003|Overall Study|Protocol Violation|0|||
161263182|NCT01338987|582343557|FG001|Overall Study|Disease progression on study|1|||
160925339|NCT03760146|581121194|FG004|Overall Study|Protocol Violation|1|||
160925340|NCT03760146|581121195|FG005|Overall Study|Protocol Violation|0|||
160925341|NCT03760146|581121190|FG000|Overall Study|Withdrawal by Subject|19|||
160925342|NCT03760146|581121191|FG001|Overall Study|Withdrawal by Subject|20|||
160925343|NCT03760146|581121192|FG002|Overall Study|Withdrawal by Subject|1|||
160925344|NCT03760146|581121193|FG003|Overall Study|Withdrawal by Subject|0|||
160925345|NCT03760146|581121194|FG004|Overall Study|Withdrawal by Subject|1|||
160925346|NCT03760146|581121195|FG005|Overall Study|Withdrawal by Subject|0|||
160925347|NCT00449644|581121196|FG000|Overall Study|Adverse Event|0|||
160925348|NCT00449644|581121197|FG001|Overall Study|Adverse Event|0|||
160925349|NCT00449644|581121198|FG002|Overall Study|Adverse Event|3|||
160925350|NCT00449644|581121199|FG003|Overall Study|Adverse Event|5|||
160925351|NCT00449644|581121196|FG000|Overall Study|Death|1|||
160925352|NCT00449644|581121197|FG001|Overall Study|Death|0|||
161143420|NCT00144300|581907597|FG000|Overall Study|Withdrawal by Subject|6|||
161143421|NCT00144300|581907598|FG001|Overall Study|Withdrawal by Subject|6|||
161143422|NCT00144300|581907597|FG000|Overall Study|Other reason (not specified)|1|||
161143423|NCT00144300|581907598|FG001|Overall Study|Other reason (not specified)|3|||
161143424|NCT01877655|581907599|FG000|Overall Study|Death|57|||
161143425|NCT01877655|581907600|FG001|Overall Study|Death|52|||
161143426|NCT01877655|581907599|FG000|Overall Study|Withdrawal by Subject|18|||
161143427|NCT01877655|581907600|FG001|Overall Study|Withdrawal by Subject|26|||
161143428|NCT01877655|581907599|FG000|Overall Study|Physician Decision|11|||
161143429|NCT01877655|581907600|FG001|Overall Study|Physician Decision|10|||
161143430|NCT01877655|581907599|FG000|Overall Study|Miscellaneous|4|||
161143431|NCT01877655|581907600|FG001|Overall Study|Miscellaneous|4|||
161143432|NCT01877655|581907599|FG000|Overall Study|Randomized but Never Received Drug|8|||
160925353|NCT00449644|581121198|FG002|Overall Study|Death|6|||
161263183|NCT01338987|582343558|FG002|Overall Study|Disease progression on study|1|||
161263184|NCT01338987|582343559|FG003|Overall Study|Disease progression on study|0|||
161263185|NCT01338987|582343560|FG004|Overall Study|Disease progression on study|0|||
161263186|NCT00757848|582343561|FG000|Overall Study|Voluntary discontinuation|1|||
160925354|NCT00449644|581121199|FG003|Overall Study|Death|1|||
160925355|NCT00449644|581121196|FG000|Overall Study|Lost to Follow-up|1|||
160925356|NCT00449644|581121197|FG001|Overall Study|Lost to Follow-up|1|||
160925357|NCT00449644|581121198|FG002|Overall Study|Lost to Follow-up|5|||
160925358|NCT00449644|581121199|FG003|Overall Study|Lost to Follow-up|3|||
160925359|NCT00449644|581121196|FG000|Overall Study|Pregnancy|0|||
160925360|NCT00449644|581121197|FG001|Overall Study|Pregnancy|0|||
160925361|NCT00449644|581121198|FG002|Overall Study|Pregnancy|3|||
160925362|NCT00449644|581121199|FG003|Overall Study|Pregnancy|2|||
160925363|NCT00449644|581121196|FG000|Overall Study|Protocol Violation|4|||
160925364|NCT00449644|581121197|FG001|Overall Study|Protocol Violation|4|||
160925365|NCT00449644|581121198|FG002|Overall Study|Protocol Violation|3|||
160925366|NCT00449644|581121199|FG003|Overall Study|Protocol Violation|7|||
160925367|NCT00449644|581121196|FG000|Overall Study|Withdrawal by Subject|3|||
160925368|NCT00449644|581121197|FG001|Overall Study|Withdrawal by Subject|4|||
160925369|NCT00449644|581121198|FG002|Overall Study|Withdrawal by Subject|6|||
160925370|NCT00449644|581121199|FG003|Overall Study|Withdrawal by Subject|7|||
160925371|NCT00449644|581121196|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
160925372|NCT00449644|581121197|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
160925373|NCT00449644|581121198|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
160925374|NCT00449644|581121199|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
160925375|NCT00449644|581121196|FG000|Overall Study|Other|1|||
160925376|NCT00449644|581121197|FG001|Overall Study|Other|4|||
160925377|NCT00449644|581121198|FG002|Overall Study|Other|1|||
160925378|NCT00449644|581121199|FG003|Overall Study|Other|0|||
160925379|NCT00449644|581121196|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
160925380|NCT00449644|581121197|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
160925381|NCT00449644|581121198|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
160925382|NCT00449644|581121199|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
160925383|NCT00529542|581121200|FG000|Overall Study|Withdrawal by Subject|1|||
160925384|NCT00529542|581121201|FG001|Overall Study|Withdrawal by Subject|0|||
160925385|NCT00529542|581121200|FG000|Overall Study|Lost to Follow-up|0|||
160925386|NCT00529542|581121201|FG001|Overall Study|Lost to Follow-up|1|||
160925387|NCT01721330|581121212|FG000|Overall Study|Withdrawal by Subject|0|||
160925388|NCT01721330|581121213|FG001|Overall Study|Withdrawal by Subject|1|||
160925389|NCT00581776|581122836|FG000|Overall Study|Disease progression or no response|3|||
160925390|NCT02357901|581122837|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
160925391|NCT02357901|581122838|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
160925392|NCT02357901|581122839|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
160925393|NCT02357901|581122840|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
160925394|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
160925395|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
160997961|NCT03538041|581378498|FG000|12-Week Treatment Period|Adverse Event|1|||
161143433|NCT01877655|581907600|FG001|Overall Study|Randomized but Never Received Drug|5|||
161143434|NCT00095121|581907601|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
161143435|NCT00095121|581907602|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
161263187|NCT00757848|582343562|FG001|Overall Study|Voluntary discontinuation|0|||
161263188|NCT00757848|582343561|FG000|Overall Study|Adverse Event|1|||
161263189|NCT00757848|582343562|FG001|Overall Study|Adverse Event|2|||
160925396|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
160925397|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
160925398|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
160925399|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
160925400|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
160925401|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
160925402|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
161263190|NCT00757848|582343561|FG000|Overall Study|Incorrect enrolment|1|||
161263191|NCT00757848|582343562|FG001|Overall Study|Incorrect enrolment|0|||
161263192|NCT00058214|582343565|FG000|Overall Study|Adverse Event|1|||
160925403|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
160925404|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
160925405|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
160925406|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
160925407|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
160925408|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
160925409|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
160925410|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
160925411|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
160925412|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
160925413|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
160925414|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
160925415|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
160925416|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
160925417|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
160925418|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
160925419|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
160925420|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
160925421|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
160925422|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
160925423|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
160925424|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
160925425|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
160925426|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
160925427|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
160925428|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
160925429|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
160925430|NCT02357901|581122837|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
160925431|NCT02357901|581122838|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
160925432|NCT02357901|581122839|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
160925433|NCT02357901|581122840|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
160925434|NCT02759120|581122843|FG000|Overall Study|Death|34|||
160925435|NCT02759120|581122844|FG001|Overall Study|Death|36|||
160925436|NCT02759120|581122843|FG000|Overall Study|Lost to Follow-up|4|||
160925437|NCT02759120|581122844|FG001|Overall Study|Lost to Follow-up|7|||
160925438|NCT02759120|581122843|FG000|Overall Study|Physician Decision|3|||
160925439|NCT02759120|581122844|FG001|Overall Study|Physician Decision|0|||
160925440|NCT02759120|581122843|FG000|Overall Study|Withdrawal by Subject|28|||
160925441|NCT02759120|581122844|FG001|Overall Study|Withdrawal by Subject|15|||
160925442|NCT02759120|581122843|FG000|Overall Study|Moved out of area|3|||
160925443|NCT02759120|581122844|FG001|Overall Study|Moved out of area|4|||
160925444|NCT02759120|581122843|FG000|Overall Study|Lung transplant|3|||
160925445|NCT02759120|581122844|FG001|Overall Study|Lung transplant|5|||
160925446|NCT02759120|581122843|FG000|Overall Study|Other reason not completed|10|||
160925447|NCT02759120|581122844|FG001|Overall Study|Other reason not completed|12|||
160925448|NCT04461015|581122848|FG000|Overall Study|IV access lost during the study|0|||
160925449|NCT04461015|581122849|FG001|Overall Study|IV access lost during the study|1|||
160925450|NCT04461015|581122848|FG000|Overall Study|Withdrawal by Subject|0|||
160925451|NCT04461015|581122849|FG001|Overall Study|Withdrawal by Subject|1|||
160925452|NCT02063854|581122857|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
160925453|NCT02063854|581122858|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
160925454|NCT02063854|581122859|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
160925455|NCT02063854|581122860|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
160925456|NCT02063854|581122861|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
160925457|NCT02063854|581122862|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
160925458|NCT02063854|581122863|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
160925459|NCT02063854|581122857|FG000|Overall Study|Major Protocol Deviation|0|||
160925460|NCT02063854|581122858|FG001|Overall Study|Major Protocol Deviation|0|||
160925461|NCT02063854|581122859|FG002|Overall Study|Major Protocol Deviation|3|||
160925462|NCT02063854|581122860|FG003|Overall Study|Major Protocol Deviation|0|||
160925463|NCT02063854|581122861|FG004|Overall Study|Major Protocol Deviation|0|||
161263193|NCT03856593|582343568|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
161341774|NCT01126424|582639027|FG001|Overall Study|Adverse Event|0|||
160925464|NCT02063854|581122862|FG005|Overall Study|Major Protocol Deviation|0|||
160925465|NCT02063854|581122863|FG006|Overall Study|Major Protocol Deviation|0|||
160925466|NCT02063854|581122857|FG000|Overall Study|Voluntary Withdrawal|2|||
160925467|NCT02063854|581122858|FG001|Overall Study|Voluntary Withdrawal|0|||
160925468|NCT02063854|581122859|FG002|Overall Study|Voluntary Withdrawal|8|||
160925469|NCT02063854|581122860|FG003|Overall Study|Voluntary Withdrawal|1|||
160925470|NCT02063854|581122861|FG004|Overall Study|Voluntary Withdrawal|3|||
160925471|NCT02063854|581122862|FG005|Overall Study|Voluntary Withdrawal|6|||
160925472|NCT02063854|581122863|FG006|Overall Study|Voluntary Withdrawal|1|||
160925473|NCT02063854|581122857|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
160925474|NCT02063854|581122858|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
160925475|NCT02063854|581122859|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
160925476|NCT02063854|581122860|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
160925477|NCT02063854|581122861|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
160925478|NCT02063854|581122862|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
160925479|NCT02063854|581122863|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
160925480|NCT02063854|581122857|FG000|Overall Study|Reason Not Specified|1|||
160925481|NCT02063854|581122858|FG001|Overall Study|Reason Not Specified|0|||
160925482|NCT02063854|581122859|FG002|Overall Study|Reason Not Specified|0|||
160925483|NCT02063854|581122860|FG003|Overall Study|Reason Not Specified|0|||
161143436|NCT00095121|581907601|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
160925484|NCT02063854|581122861|FG004|Overall Study|Reason Not Specified|0|||
160925485|NCT02063854|581122862|FG005|Overall Study|Reason Not Specified|0|||
160925486|NCT02063854|581122863|FG006|Overall Study|Reason Not Specified|0|||
160925487|NCT02063854|581122857|FG000|Overall Study|Did Not Receive Study Drug|0|||
160925488|NCT02063854|581122858|FG001|Overall Study|Did Not Receive Study Drug|0|||
160925489|NCT02063854|581122859|FG002|Overall Study|Did Not Receive Study Drug|0|||
160925490|NCT02063854|581122860|FG003|Overall Study|Did Not Receive Study Drug|0|||
160925491|NCT02063854|581122861|FG004|Overall Study|Did Not Receive Study Drug|0|||
160925492|NCT02063854|581122862|FG005|Overall Study|Did Not Receive Study Drug|1|||
160925493|NCT02063854|581122863|FG006|Overall Study|Did Not Receive Study Drug|0|||
160925494|NCT01413360|581122868|FG000|Overall Study|Lost to Follow-up|2|||
160925495|NCT01413360|581122868|FG000|Overall Study|Adverse Event|1|||
160925496|NCT02246673|581122872|FG000|Overall Study|Sponsor Decision|1|||
160925497|NCT02246673|581122873|FG001|Overall Study|Sponsor Decision|0|||
160925498|NCT02246673|581122874|FG002|Overall Study|Sponsor Decision|0|||
160925499|NCT02246673|581122875|FG003|Overall Study|Sponsor Decision|0|||
160925500|NCT02246673|581122876|FG004|Overall Study|Sponsor Decision|0|||
160925501|NCT02246673|581122872|FG000|Overall Study|Withdrawal by Subject|0|||
160925502|NCT02246673|581122873|FG001|Overall Study|Withdrawal by Subject|0|||
160925503|NCT02246673|581122874|FG002|Overall Study|Withdrawal by Subject|0|||
160925504|NCT02246673|581122875|FG003|Overall Study|Withdrawal by Subject|0|||
160925505|NCT02246673|581122876|FG004|Overall Study|Withdrawal by Subject|1|||
160925506|NCT02246673|581122872|FG000|Overall Study|Lost to Follow-up|0|||
160925507|NCT02246673|581122873|FG001|Overall Study|Lost to Follow-up|0|||
161143437|NCT00095121|581907602|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
160925508|NCT02246673|581122874|FG002|Overall Study|Lost to Follow-up|0|||
160925509|NCT02246673|581122875|FG003|Overall Study|Lost to Follow-up|1|||
160925510|NCT02246673|581122876|FG004|Overall Study|Lost to Follow-up|0|||
160925511|NCT02246673|581122872|FG000|Overall Study|Protocol Violation|0|||
160925512|NCT02246673|581122873|FG001|Overall Study|Protocol Violation|0|||
160925513|NCT02246673|581122874|FG002|Overall Study|Protocol Violation|0|||
160925514|NCT02246673|581122875|FG003|Overall Study|Protocol Violation|1|||
160925515|NCT02246673|581122876|FG004|Overall Study|Protocol Violation|0|||
160925516|NCT05413369|581122877|FG000|Overall Study|Adverse Event|1|||
161143438|NCT03705494|581909361|FG000|Overall Study|Lost to Follow-up|2|||
161143439|NCT03705494|581909362|FG001|Overall Study|Lost to Follow-up|1|||
161143440|NCT03705494|581909361|FG000|Overall Study|Withdrawal by Subject|5|||
161263194|NCT03856593|582343569|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
161263195|NCT03407118|582343570|FG000|Period 2|Withdrawal by Subject|1|||
161263196|NCT03407118|582343571|FG001|Period 2|Withdrawal by Subject|0|||
161263197|NCT01347866|582343588|FG000|Overall Study|Death|0|||
161263198|NCT01347866|582343589|FG001|Overall Study|Death|0|||
161263199|NCT01347866|582343590|FG002|Overall Study|Death|0|||
160925517|NCT05413369|581122878|FG001|Overall Study|Adverse Event|1|||
160925518|NCT05413369|581122877|FG000|Overall Study|Withdrawal by Subject|13|||
160925519|NCT05413369|581122878|FG001|Overall Study|Withdrawal by Subject|4|||
160925520|NCT05413369|581122877|FG000|Overall Study|Non-compliance with study schedule|2|||
161143441|NCT03705494|581909362|FG001|Overall Study|Withdrawal by Subject|2|||
161143442|NCT03937986|581909363|FG000|Overall Study|COVID-19 Pandemic|1|||
161143443|NCT02839746|581909364|FG000|Overall Study|Not met selection criteria|12|||
160925521|NCT05413369|581122878|FG001|Overall Study|Non-compliance with study schedule|1|||
160925522|NCT05413369|581122877|FG000|Overall Study|Other|1|||
160925523|NCT05413369|581122878|FG001|Overall Study|Other|1|||
160925524|NCT05517382|581122891|FG000|Overall Study|Lost to Follow-up|0|||
160925525|NCT05517382|581122892|FG001|Overall Study|Lost to Follow-up|1|||
160925526|NCT00271947|581122895|FG000|Overall Study|Lost to Follow-up|1|||
160925527|NCT00651755|581122896|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
161263200|NCT01347866|582343591|FG003|Overall Study|Death|1|||
160925528|NCT00651755|581122897|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
160925529|NCT00651755|581122896|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
160925530|NCT00651755|581122897|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
160925531|NCT03642717|581122898|FG000|Overall Study|Lost to Follow-up|2|||
160925532|NCT03642717|581122898|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
160925533|NCT03642717|581122898|FG000|Overall Study|Taken study drug prior to contract date|3|||
160925534|NCT00946712|581122901|FG000|Overall Study|Adverse Event|118|||
160925535|NCT00946712|581122902|FG001|Overall Study|Adverse Event|124|||
160925536|NCT00946712|581122901|FG000|Overall Study|Disease progression|308|||
160925537|NCT00946712|581122902|FG001|Overall Study|Disease progression|404|||
160925538|NCT00946712|581122901|FG000|Overall Study|Death|21|||
160925539|NCT00946712|581122902|FG001|Overall Study|Death|22|||
160925540|NCT00946712|581122901|FG000|Overall Study|No treatment given|25|||
160925541|NCT00946712|581122902|FG001|Overall Study|No treatment given|29|||
160925542|NCT00946712|581122901|FG000|Overall Study|Other reasons|61|||
160925543|NCT00946712|581122902|FG001|Overall Study|Other reasons|73|||
160925544|NCT00946712|581122901|FG000|Overall Study|On Treatment|0|||
160925545|NCT00946712|581122902|FG001|Overall Study|On Treatment|4|||
160925546|NCT00946712|581122901|FG000|Overall Study|Ineligible|14|||
160925547|NCT00946712|581122902|FG001|Overall Study|Ineligible|6|||
160925548|NCT00302458|581122903|FG000|Overall Study|Lost to Follow-up|1|||
160925549|NCT00302458|581122903|FG000|Overall Study|Ineligible after screening|1|||
160925550|NCT00302458|581122903|FG000|Overall Study|Withdrawal by Subject|1|||
160925551|NCT00853723|581122905|FG000|Overall Study|Adverse Event|3|||
160925552|NCT00853723|581122906|FG001|Overall Study|Adverse Event|4|||
160925553|NCT00853723|581122907|FG002|Overall Study|Adverse Event|1|||
160925554|NCT00853723|581122905|FG000|Overall Study|Withdrawal by Subject|2|||
160925555|NCT00853723|581122906|FG001|Overall Study|Withdrawal by Subject|1|||
160925556|NCT00853723|581122907|FG002|Overall Study|Withdrawal by Subject|0|||
160925557|NCT00853723|581122905|FG000|Overall Study|Protocol Violation|1|||
160925558|NCT00853723|581122906|FG001|Overall Study|Protocol Violation|2|||
160925559|NCT00853723|581122907|FG002|Overall Study|Protocol Violation|1|||
160925560|NCT04248933|581122908|FG000|Overall Study|Lost to Follow-up|9|||
160925561|NCT04248933|581122908|FG000|Overall Study|Withdrawal by Subject|2|||
160925562|NCT02642432|581122911|FG000|Overall Study|Adverse Event|2|||
160925563|NCT02642432|581122911|FG000|Overall Study|Withdrew Consent|1|||
160925564|NCT02642432|581122911|FG000|Overall Study|Lost to Follow-up|2|||
161263201|NCT01347866|582343592|FG004|Overall Study|Death|2|||
161263202|NCT01347866|582343593|FG005|Overall Study|Death|2|||
161263203|NCT01347866|582343594|FG006|Overall Study|Death|1|||
160925565|NCT02642432|581122911|FG000|Overall Study|Other|3|||
160925566|NCT02447081|581122912|FG000|Overall Study|Death|161|||
160925567|NCT02447081|581122912|FG000|Overall Study|Lost to Follow-up|36|||
160925568|NCT02447081|581122912|FG000|Overall Study|Visit not completed|17|||
160925569|NCT02447081|581122912|FG000|Overall Study|unsuccessful implant procedure|10|||
160925570|NCT05778786|581122913|FG000|Period 1|COVID-19 Related|3|||
160925571|NCT05778786|581122914|FG001|Period 1|COVID-19 Related|3|||
160925572|NCT05778786|581122913|FG000|Period 1|Withdrew Consent during Study|1|||
160925573|NCT05778786|581122914|FG001|Period 1|Withdrew Consent during Study|0|||
160925574|NCT05778786|581122913|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
160925575|NCT05778786|581122914|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
160925576|NCT05778786|581122913|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
160925577|NCT05778786|581122914|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
160925578|NCT02075658|581122917|FG000|Overall Study|Physician Decision|2|||
160925579|NCT02075658|581122918|FG001|Overall Study|Physician Decision|2|||
161143444|NCT02089737|581909365|FG000|Overall Study|Survey form not completed|5|||
161143445|NCT02089737|581909365|FG000|Overall Study|Not treated|1|||
161143446|NCT00744055|581909366|FG000|Overall Study|Withdrawal by Subject|6|||
161143447|NCT00744055|581909367|FG001|Overall Study|Withdrawal by Subject|9|||
161143448|NCT00744055|581909366|FG000|Overall Study|Lack of Efficacy|0|||
161143449|NCT00744055|581909367|FG001|Overall Study|Lack of Efficacy|1|||
161263204|NCT01347866|582343595|FG007|Overall Study|Death|0|||
161143450|NCT00744055|581909366|FG000|Overall Study|Physician Decision|0|||
161143451|NCT00744055|581909367|FG001|Overall Study|Physician Decision|2|||
161143452|NCT00744055|581909366|FG000|Overall Study|Protocol Violation|1|||
161143453|NCT00744055|581909367|FG001|Overall Study|Protocol Violation|1|||
161143454|NCT00744055|581909366|FG000|Overall Study|Lost to Follow-up|0|||
161143455|NCT00744055|581909367|FG001|Overall Study|Lost to Follow-up|1|||
161143456|NCT04426630|581909368|FG000|Overall Study|Death|4|||
160925588|NCT05198843|581122922|FG000|Overall Study|Lack of Efficacy|1|||
160925589|NCT03188094|581122923|FG000|Overall Study|Screen failure|1|||
160925590|NCT03188094|581122924|FG001|Overall Study|Screen failure|0|||
160925591|NCT03188094|581122925|FG002|Overall Study|Screen failure|0|||
160925592|NCT03188094|581122923|FG000|Overall Study|Pregnancy|3|||
160925593|NCT03188094|581122924|FG001|Overall Study|Pregnancy|0|||
160925594|NCT03188094|581122925|FG002|Overall Study|Pregnancy|0|||
160925595|NCT03188094|581122923|FG000|Overall Study|Ineligible|1|||
160925596|NCT03188094|581122924|FG001|Overall Study|Ineligible|0|||
161143457|NCT04426630|581909368|FG000|Overall Study|Lost to Follow-up|2|||
161263205|NCT01347866|582343596|FG008|Overall Study|Death|4|||
160925597|NCT03188094|581122925|FG002|Overall Study|Ineligible|0|||
160925598|NCT03188094|581122923|FG000|Overall Study|Lost to Follow-up|0|||
160925599|NCT03188094|581122924|FG001|Overall Study|Lost to Follow-up|0|||
160925600|NCT03188094|581122925|FG002|Overall Study|Lost to Follow-up|17|||
160925601|NCT02946047|581122926|FG000|Overall Study|Adverse Event|1|||
160925602|NCT02946047|581122927|FG001|Overall Study|Adverse Event|0|||
160925603|NCT02946047|581122928|FG002|Overall Study|Adverse Event|0|||
160925604|NCT02946047|581122929|FG003|Overall Study|Adverse Event|0|||
160925605|NCT03615105|581122930|FG000|Overall Study|Protocol Violation|1|||
160925606|NCT03615105|581122931|FG001|Overall Study|Protocol Violation|0|||
160925607|NCT03615105|581122932|FG002|Overall Study|Protocol Violation|0|||
160925608|NCT03615105|581122930|FG000|Overall Study|Death|0|||
160925609|NCT03615105|581122931|FG001|Overall Study|Death|2|||
160925610|NCT03615105|581122932|FG002|Overall Study|Death|0|||
160925611|NCT01894581|581122933|FG000|Overall Study|Withdrawal by Subject|2|||
160925612|NCT01894581|581122934|FG001|Overall Study|Withdrawal by Subject|3|||
160925613|NCT01894581|581122933|FG000|Overall Study|Screen Failure|3|||
160925614|NCT01894581|581122934|FG001|Overall Study|Screen Failure|4|||
160925615|NCT03795298|581122935|FG000|Overall Study|Death|34|||
160925616|NCT03795298|581122936|FG001|Overall Study|Death|29|||
160925617|NCT03795298|581122935|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
160925618|NCT03795298|581122936|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
160925619|NCT03795298|581122935|FG000|Overall Study|Lost to Follow-up|28|||
160925620|NCT03795298|581122936|FG001|Overall Study|Lost to Follow-up|17|||
160925621|NCT03795298|581122935|FG000|Overall Study|Physician Decision|5|||
160925622|NCT03795298|581122936|FG001|Overall Study|Physician Decision|4|||
160925623|NCT03795298|581122935|FG000|Overall Study|Withdrawal by Subject|43|||
160925624|NCT03795298|581122936|FG001|Overall Study|Withdrawal by Subject|28|||
160925625|NCT03795298|581122935|FG000|Overall Study|Reason not reported|7|||
160925626|NCT03795298|581122936|FG001|Overall Study|Reason not reported|9|||
160925627|NCT01252940|581122937|FG000|Main Study Phase|Randomized but not treated|4|||
160925628|NCT01252940|581122938|FG001|Main Study Phase|Randomized but not treated|2|||
160925629|NCT01252940|581122937|FG000|Main Study Phase|Adverse Event|3|||
160925630|NCT01252940|581122938|FG001|Main Study Phase|Adverse Event|1|||
160925631|NCT01252940|581122937|FG000|Main Study Phase|Lack of Efficacy|1|||
160925632|NCT01252940|581122938|FG001|Main Study Phase|Lack of Efficacy|0|||
160925633|NCT01252940|581122937|FG000|Main Study Phase|Lost to Follow-up|6|||
160925634|NCT01252940|581122938|FG001|Main Study Phase|Lost to Follow-up|1|||
160925635|NCT01252940|581122937|FG000|Main Study Phase|Physician Decision|1|||
161263206|NCT01347866|582343597|FG009|Overall Study|Death|1|||
161263207|NCT01347866|582343598|FG010|Overall Study|Death|3|||
161263208|NCT01347866|582343599|FG011|Overall Study|Death|1|||
161263209|NCT01347866|582343600|FG012|Overall Study|Death|2|||
161263210|NCT01347866|582343601|FG013|Overall Study|Death|0|||
161263211|NCT01347866|582343602|FG014|Overall Study|Death|0|||
161263212|NCT01347866|582343603|FG015|Overall Study|Death|1|||
161263213|NCT01347866|582343604|FG016|Overall Study|Death|0|||
161263214|NCT01347866|582343588|FG000|Overall Study|Lost to Follow-up|0|||
161263215|NCT01347866|582343589|FG001|Overall Study|Lost to Follow-up|0|||
161263216|NCT01347866|582343590|FG002|Overall Study|Lost to Follow-up|0|||
161263217|NCT01347866|582343591|FG003|Overall Study|Lost to Follow-up|0|||
161263218|NCT01347866|582343592|FG004|Overall Study|Lost to Follow-up|0|||
161263219|NCT01347866|582343593|FG005|Overall Study|Lost to Follow-up|0|||
161263220|NCT01347866|582343594|FG006|Overall Study|Lost to Follow-up|0|||
161263221|NCT01347866|582343595|FG007|Overall Study|Lost to Follow-up|1|||
161263222|NCT01347866|582343596|FG008|Overall Study|Lost to Follow-up|1|||
161263223|NCT01347866|582343597|FG009|Overall Study|Lost to Follow-up|0|||
161263224|NCT01347866|582343598|FG010|Overall Study|Lost to Follow-up|0|||
161263225|NCT01347866|582343599|FG011|Overall Study|Lost to Follow-up|0|||
161263226|NCT01347866|582343600|FG012|Overall Study|Lost to Follow-up|0|||
161263227|NCT01347866|582343601|FG013|Overall Study|Lost to Follow-up|0|||
161263228|NCT01347866|582343602|FG014|Overall Study|Lost to Follow-up|0|||
161263229|NCT01347866|582343603|FG015|Overall Study|Lost to Follow-up|0|||
161263230|NCT01347866|582343604|FG016|Overall Study|Lost to Follow-up|0|||
161263231|NCT01347866|582343588|FG000|Overall Study|Other|3|||
161263232|NCT01347866|582343589|FG001|Overall Study|Other|1|||
161263233|NCT01347866|582343590|FG002|Overall Study|Other|1|||
160925636|NCT01252940|581122938|FG001|Main Study Phase|Physician Decision|0|||
160925637|NCT01252940|581122937|FG000|Main Study Phase|Protocol Violation|4|||
160925638|NCT01252940|581122938|FG001|Main Study Phase|Protocol Violation|2|||
160925639|NCT01252940|581122937|FG000|Main Study Phase|Withdrawal by Subject|6|||
160925640|NCT01252940|581122938|FG001|Main Study Phase|Withdrawal by Subject|5|||
160925641|NCT01252940|581122937|FG000|Main Study Phase|Subject Non-compliance|1|||
160925642|NCT01252940|581122938|FG001|Main Study Phase|Subject Non-compliance|1|||
160925643|NCT01252940|581122937|FG000|Extension Phase|Adverse Event|2|||
160925644|NCT01252940|581122938|FG001|Extension Phase|Adverse Event|1|||
160925645|NCT01252940|581122937|FG000|Extension Phase|Lack of Efficacy|1|||
161263234|NCT01347866|582343591|FG003|Overall Study|Other|4|||
161263235|NCT01347866|582343592|FG004|Overall Study|Other|5|||
161263236|NCT01347866|582343593|FG005|Overall Study|Other|0|||
161263237|NCT01347866|582343594|FG006|Overall Study|Other|5|||
161263238|NCT01347866|582343595|FG007|Overall Study|Other|3|||
161263239|NCT01347866|582343596|FG008|Overall Study|Other|22|||
161263240|NCT01347866|582343597|FG009|Overall Study|Other|5|||
161263241|NCT01347866|582343598|FG010|Overall Study|Other|0|||
161263242|NCT01347866|582343599|FG011|Overall Study|Other|3|||
161263243|NCT01347866|582343600|FG012|Overall Study|Other|4|||
161263244|NCT01347866|582343601|FG013|Overall Study|Other|4|||
161263245|NCT01347866|582343602|FG014|Overall Study|Other|2|||
161263246|NCT01347866|582343603|FG015|Overall Study|Other|3|||
161263247|NCT01347866|582343604|FG016|Overall Study|Other|0|||
161263248|NCT01347866|582343588|FG000|Overall Study|Subject refused further follow-up|2|||
161341775|NCT01126424|582639028|FG002|Overall Study|Adverse Event|0|||
160925646|NCT01252940|581122938|FG001|Extension Phase|Lack of Efficacy|0|||
160925647|NCT01252940|581122937|FG000|Extension Phase|Lost to Follow-up|5|||
160925648|NCT01252940|581122938|FG001|Extension Phase|Lost to Follow-up|0|||
160925649|NCT01252940|581122937|FG000|Extension Phase|Physician Decision|0|||
161341776|NCT01126424|582639029|FG003|Overall Study|Adverse Event|0|||
161341777|NCT01126424|582639030|FG004|Overall Study|Adverse Event|1|||
161341778|NCT01126424|582639031|FG005|Overall Study|Adverse Event|0|||
161341779|NCT01126424|582639026|FG000|Overall Study|Withdrawal by Subject|0|||
161341780|NCT01126424|582639027|FG001|Overall Study|Withdrawal by Subject|0|||
161341781|NCT01126424|582639028|FG002|Overall Study|Withdrawal by Subject|1|||
161341782|NCT01126424|582639029|FG003|Overall Study|Withdrawal by Subject|3|||
161341783|NCT01126424|582639030|FG004|Overall Study|Withdrawal by Subject|1|||
161341784|NCT01126424|582639031|FG005|Overall Study|Withdrawal by Subject|0|||
161341785|NCT02127671|582639032|FG000|Overall Study|Death|2|||
161341786|NCT02127671|582639033|FG001|Overall Study|Death|2|||
161341787|NCT02127671|582639032|FG000|Overall Study|Lost to Follow-up|4|||
161341788|NCT02127671|582639033|FG001|Overall Study|Lost to Follow-up|2|||
161341789|NCT02127671|582639032|FG000|Overall Study|Physician Decision|1|||
161341790|NCT02127671|582639033|FG001|Overall Study|Physician Decision|0|||
161341791|NCT02127671|582639032|FG000|Overall Study|incarceration|0|||
161341792|NCT02127671|582639033|FG001|Overall Study|incarceration|1|||
161341793|NCT02127671|582639032|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
161341794|NCT02127671|582639033|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
161341795|NCT02394275|582639034|FG000|Overall Study|Adverse Event|22|||
161341796|NCT02394275|582639034|FG000|Overall Study|Lost to Follow-up|7|||
161341797|NCT00782067|582639036|FG000|Overall Study|Adverse Event|35|||
161341798|NCT00782067|582639036|FG000|Overall Study|Subject withdrew consent|11|||
161341799|NCT00782067|582639036|FG000|Overall Study|Lost to Follow-up|2|||
161341800|NCT00782067|582639036|FG000|Overall Study|Administrative problems|14|||
161341801|NCT00782067|582639036|FG000|Overall Study|Death|9|||
161341802|NCT00782067|582639036|FG000|Overall Study|Disease progression|43|||
161341803|NCT00782067|582639036|FG000|Overall Study|Protocol deviation|2|||
160925650|NCT01252940|581122938|FG001|Extension Phase|Physician Decision|1|||
160925651|NCT01252940|581122937|FG000|Extension Phase|Subject Non-compliance|1|||
160925652|NCT01252940|581122938|FG001|Extension Phase|Subject Non-compliance|0|||
160925653|NCT01252940|581122937|FG000|Extension Phase|Withdrawal by Subject|1|||
160925654|NCT01252940|581122938|FG001|Extension Phase|Withdrawal by Subject|1|||
160925655|NCT04199117|581122939|FG000|Overall Study|Withdrawal by Subject|3|||
160925656|NCT04199117|581122940|FG001|Overall Study|Withdrawal by Subject|0|||
160925657|NCT04199117|581122941|FG002|Overall Study|Withdrawal by Subject|0|||
160925658|NCT04199117|581122942|FG003|Overall Study|Withdrawal by Subject|1|||
160925659|NCT04199117|581122943|FG004|Overall Study|Withdrawal by Subject|1|||
160925660|NCT04199117|581122944|FG005|Overall Study|Withdrawal by Subject|0|||
160925661|NCT04199117|581122945|FG006|Overall Study|Withdrawal by Subject|0|||
161341804|NCT02471183|582639037|FG000|Main Treatment Period|Adverse Event|1|||
161341805|NCT02471183|582639037|FG000|Main Treatment Period|Withdrawal by Subject|1|||
161341806|NCT02471183|582639037|FG000|Extended Treatment Period|Lack of Efficacy|1|||
161341807|NCT00614393|582639039|FG000|Overall Study|Adverse Event|20|||
161263249|NCT01347866|582343589|FG001|Overall Study|Subject refused further follow-up|0|||
161263250|NCT01347866|582343590|FG002|Overall Study|Subject refused further follow-up|0|||
161263251|NCT01347866|582343591|FG003|Overall Study|Subject refused further follow-up|2|||
161341808|NCT00614393|582639040|FG001|Overall Study|Adverse Event|2|||
161341809|NCT00614393|582639041|FG002|Overall Study|Adverse Event|3|||
161341810|NCT00614393|582639042|FG003|Overall Study|Adverse Event|13|||
161341811|NCT00614393|582639043|FG004|Overall Study|Adverse Event|21|||
161341812|NCT00614393|582639039|FG000|Overall Study|Lost to Follow-up|0|||
161341813|NCT00614393|582639040|FG001|Overall Study|Lost to Follow-up|0|||
160925662|NCT04199117|581122946|FG007|Overall Study|Withdrawal by Subject|2|||
160925663|NCT04199117|581122947|FG008|Overall Study|Withdrawal by Subject|0|||
160925664|NCT04199117|581122948|FG009|Overall Study|Withdrawal by Subject|0|||
160925665|NCT04199117|581122949|FG010|Overall Study|Withdrawal by Subject|1|||
160925666|NCT04199117|581122950|FG011|Overall Study|Withdrawal by Subject|1|||
161263252|NCT01347866|582343592|FG004|Overall Study|Subject refused further follow-up|0|||
161263253|NCT01347866|582343593|FG005|Overall Study|Subject refused further follow-up|1|||
161341814|NCT00614393|582639041|FG002|Overall Study|Lost to Follow-up|0|||
161341815|NCT00614393|582639042|FG003|Overall Study|Lost to Follow-up|1|||
160925667|NCT04199117|581122951|FG012|Overall Study|Withdrawal by Subject|2|||
160925668|NCT04199117|581122952|FG013|Overall Study|Withdrawal by Subject|1|||
160925669|NCT04199117|581122953|FG014|Overall Study|Withdrawal by Subject|1|||
160925670|NCT04199117|581122954|FG015|Overall Study|Withdrawal by Subject|1|||
160925671|NCT04199117|581122939|FG000|Overall Study|Death|1|||
160925672|NCT04199117|581122940|FG001|Overall Study|Death|1|||
160925673|NCT04199117|581122941|FG002|Overall Study|Death|0|||
160925674|NCT04199117|581122942|FG003|Overall Study|Death|0|||
160925675|NCT04199117|581122943|FG004|Overall Study|Death|0|||
160925676|NCT04199117|581122944|FG005|Overall Study|Death|0|||
160925677|NCT04199117|581122945|FG006|Overall Study|Death|0|||
160925678|NCT04199117|581122946|FG007|Overall Study|Death|0|||
160925679|NCT04199117|581122947|FG008|Overall Study|Death|0|||
161263254|NCT01347866|582343594|FG006|Overall Study|Subject refused further follow-up|0|||
161263255|NCT01347866|582343595|FG007|Overall Study|Subject refused further follow-up|0|||
161263256|NCT01347866|582343596|FG008|Overall Study|Subject refused further follow-up|4|||
161263257|NCT01347866|582343597|FG009|Overall Study|Subject refused further follow-up|1|||
161263258|NCT01347866|582343598|FG010|Overall Study|Subject refused further follow-up|0|||
161263259|NCT01347866|582343599|FG011|Overall Study|Subject refused further follow-up|0|||
161263260|NCT01347866|582343600|FG012|Overall Study|Subject refused further follow-up|1|||
161263261|NCT01347866|582343601|FG013|Overall Study|Subject refused further follow-up|3|||
161263262|NCT01347866|582343602|FG014|Overall Study|Subject refused further follow-up|1|||
161263263|NCT01347866|582343603|FG015|Overall Study|Subject refused further follow-up|0|||
161263264|NCT01347866|582343604|FG016|Overall Study|Subject refused further follow-up|2|||
161263265|NCT02939014|582343605|FG000|Overall Study|Lost to Follow-up|1|||
161263266|NCT02939014|582343606|FG001|Overall Study|Lost to Follow-up|0|||
161263267|NCT02939014|582343605|FG000|Overall Study|Death|4|||
161263268|NCT02939014|582343606|FG001|Overall Study|Death|3|||
161263269|NCT02143583|582343609|FG000|Overall Study|Withdrawal by Subject|1|||
161263270|NCT02143583|582343610|FG001|Overall Study|Withdrawal by Subject|0|||
161263271|NCT02143583|582343611|FG002|Overall Study|Withdrawal by Subject|1|||
161263272|NCT02143583|582343609|FG000|Overall Study|husband illness|0|||
161263273|NCT02143583|582343610|FG001|Overall Study|husband illness|0|||
161263274|NCT02143583|582343611|FG002|Overall Study|husband illness|1|||
161263275|NCT02333487|582343612|FG000|Overall Study|Adverse Event|0|||
161263276|NCT02333487|582343613|FG001|Overall Study|Adverse Event|2|||
161263277|NCT02333487|582343614|FG002|Overall Study|Adverse Event|0|||
161263278|NCT03303625|582345195|FG000|Overall Study|Withdrawal by Subject|2|||
161263279|NCT03303625|582345196|FG001|Overall Study|Withdrawal by Subject|0|||
161263280|NCT03303625|582345197|FG002|Overall Study|Withdrawal by Subject|0|||
161263281|NCT03303625|582345198|FG003|Overall Study|Withdrawal by Subject|0|||
161263282|NCT02588950|582345202|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
161263283|NCT02588950|582345203|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
161263284|NCT02588950|582345204|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
161263285|NCT02588950|582345205|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
161263286|NCT02588950|582345202|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
161263287|NCT02588950|582345203|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
161263288|NCT02588950|582345204|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
161263289|NCT02588950|582345205|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
161263290|NCT00652028|582345208|FG000|Overall Study|Adverse Event|1|||
161263291|NCT00652028|582345209|FG001|Overall Study|Adverse Event|0|||
161263292|NCT00652028|582345210|FG002|Overall Study|Adverse Event|0|||
161263293|NCT00652028|582345211|FG003|Overall Study|Adverse Event|0|||
161263294|NCT00652028|582345208|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
161263295|NCT00652028|582345209|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
161263296|NCT00652028|582345210|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
161263297|NCT00652028|582345211|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
161263298|NCT00652028|582345208|FG000|Overall Study|Physician Decision|0|||
161263299|NCT00652028|582345209|FG001|Overall Study|Physician Decision|0|||
161263300|NCT00652028|582345210|FG002|Overall Study|Physician Decision|1|||
161263301|NCT00652028|582345211|FG003|Overall Study|Physician Decision|0|||
161263302|NCT02072824|582345213|FG000|Overall Study|Insufficient clinical response|1|||
161263303|NCT02072824|582345214|FG001|Overall Study|Insufficient clinical response|0|||
161263304|NCT02072824|582345215|FG002|Overall Study|Insufficient clinical response|1|||
161263305|NCT02072824|582345213|FG000|Overall Study|No longer willing to participate|1|||
161263306|NCT02072824|582345214|FG001|Overall Study|No longer willing to participate|0|||
161263307|NCT02072824|582345215|FG002|Overall Study|No longer willing to participate|1|||
161263308|NCT02072824|582345213|FG000|Overall Study|Medication error|0|||
161263309|NCT02072824|582345214|FG001|Overall Study|Medication error|1|||
161263310|NCT02072824|582345215|FG002|Overall Study|Medication error|0|||
161263311|NCT02072824|582345213|FG000|Overall Study|Adverse Event|0|||
160925680|NCT04199117|581122948|FG009|Overall Study|Death|0|||
160925681|NCT04199117|581122949|FG010|Overall Study|Death|0|||
160925682|NCT04199117|581122950|FG011|Overall Study|Death|1|||
160925683|NCT04199117|581122951|FG012|Overall Study|Death|0|||
161263312|NCT02072824|582345214|FG001|Overall Study|Adverse Event|0|||
161263313|NCT02072824|582345215|FG002|Overall Study|Adverse Event|1|||
161263314|NCT01859130|582345216|FG000|Overall Study|Death|4|||
161341816|NCT00614393|582639043|FG004|Overall Study|Lost to Follow-up|2|||
161341817|NCT00614393|582639039|FG000|Overall Study|Physician Decision|17|||
161341818|NCT00614393|582639040|FG001|Overall Study|Physician Decision|0|||
161341819|NCT00614393|582639041|FG002|Overall Study|Physician Decision|1|||
161341820|NCT00614393|582639042|FG003|Overall Study|Physician Decision|8|||
161341821|NCT00614393|582639043|FG004|Overall Study|Physician Decision|9|||
161341822|NCT00614393|582639039|FG000|Overall Study|Progressive Disease|118|||
161341823|NCT00614393|582639040|FG001|Overall Study|Progressive Disease|5|||
161341824|NCT00614393|582639041|FG002|Overall Study|Progressive Disease|5|||
161341825|NCT00614393|582639042|FG003|Overall Study|Progressive Disease|138|||
161341826|NCT00614393|582639043|FG004|Overall Study|Progressive Disease|130|||
161341827|NCT00614393|582639039|FG000|Overall Study|Protocol Violation|1|||
161341828|NCT00614393|582639040|FG001|Overall Study|Protocol Violation|0|||
161341829|NCT00614393|582639041|FG002|Overall Study|Protocol Violation|0|||
161341830|NCT00614393|582639042|FG003|Overall Study|Protocol Violation|0|||
161341831|NCT00614393|582639043|FG004|Overall Study|Protocol Violation|0|||
161341832|NCT00614393|582639039|FG000|Overall Study|Terminated by Sponsor|0|||
161341833|NCT00614393|582639040|FG001|Overall Study|Terminated by Sponsor|0|||
160997962|NCT03538041|581378499|FG001|12-Week Treatment Period|Adverse Event|1|||
160997963|NCT03538041|581378498|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
160997964|NCT03538041|581378499|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
160997965|NCT03538041|581378498|FG000|Treatment Extension Period|Adverse Event|4|||
160997966|NCT03538041|581378499|FG001|Treatment Extension Period|Adverse Event|1|||
160997967|NCT03538041|581378498|FG000|Treatment Extension Period|Physician Decision|1|||
160997968|NCT03538041|581378499|FG001|Treatment Extension Period|Physician Decision|1|||
160997969|NCT03538041|581378498|FG000|Treatment Extension Period|Lack of Efficacy|1|||
160997970|NCT03538041|581378499|FG001|Treatment Extension Period|Lack of Efficacy|4|||
160997971|NCT03538041|581378498|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
160997972|NCT03538041|581378499|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
160997973|NCT03538041|581378498|FG000|Treatment Extension Period|Death|0|||
160997974|NCT03538041|581378499|FG001|Treatment Extension Period|Death|1|||
160997975|NCT01049503|581378500|FG000|Overall Study|Lost to Follow-up|11|||
160997976|NCT01049503|581378501|FG001|Overall Study|Lost to Follow-up|12|||
160997977|NCT01049503|581378502|FG002|Overall Study|Lost to Follow-up|24|||
160997978|NCT01049503|581378503|FG003|Overall Study|Lost to Follow-up|26|||
160997979|NCT01049503|581378504|FG004|Overall Study|Lost to Follow-up|27|||
160997980|NCT01049503|581378505|FG005|Overall Study|Lost to Follow-up|8|||
160997981|NCT00970307|581378506|FG000|Overall Study|Serious Adverse Event|1|||
160997982|NCT00970307|581378507|FG001|Overall Study|Serious Adverse Event|0|||
160997983|NCT00970307|581378508|FG002|Overall Study|Serious Adverse Event|0|||
160997984|NCT00970307|581378506|FG000|Overall Study|Withdrawal by Subject|2|||
160997985|NCT00970307|581378507|FG001|Overall Study|Withdrawal by Subject|3|||
160997986|NCT00970307|581378508|FG002|Overall Study|Withdrawal by Subject|2|||
160997987|NCT05174013|581378517|FG000|Overall Study|Lost to Follow-up|0|||
160997988|NCT05174013|581378518|FG001|Overall Study|Lost to Follow-up|0|||
160997989|NCT05174013|581378519|FG002|Overall Study|Lost to Follow-up|0|||
160997990|NCT05174013|581378520|FG003|Overall Study|Lost to Follow-up|1|||
160997991|NCT05174013|581378521|FG004|Overall Study|Lost to Follow-up|0|||
160997992|NCT05174013|581378522|FG005|Overall Study|Lost to Follow-up|0|||
160997993|NCT05174013|581378517|FG000|Overall Study|Withdrawal by Subject|0|||
160997994|NCT05174013|581378518|FG001|Overall Study|Withdrawal by Subject|0|||
160997995|NCT05174013|581378519|FG002|Overall Study|Withdrawal by Subject|1|||
160997996|NCT05174013|581378520|FG003|Overall Study|Withdrawal by Subject|0|||
160997997|NCT05174013|581378521|FG004|Overall Study|Withdrawal by Subject|0|||
160997998|NCT05174013|581378522|FG005|Overall Study|Withdrawal by Subject|0|||
160997999|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
160998000|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
160998001|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
160998002|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
160998003|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
160998004|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
160998005|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
160998006|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
160998007|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
160998008|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
160998009|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
160998010|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
161341834|NCT00614393|582639041|FG002|Overall Study|Terminated by Sponsor|0|||
160998011|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
160998012|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
160998013|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
161341835|NCT00614393|582639042|FG003|Overall Study|Terminated by Sponsor|0|||
161341836|NCT00614393|582639043|FG004|Overall Study|Terminated by Sponsor|1|||
161341837|NCT00614393|582639039|FG000|Overall Study|Withdrawal by Subject|20|||
161341838|NCT00614393|582639040|FG001|Overall Study|Withdrawal by Subject|1|||
160925684|NCT04199117|581122952|FG013|Overall Study|Death|1|||
160925685|NCT04199117|581122953|FG014|Overall Study|Death|0|||
160925686|NCT04199117|581122954|FG015|Overall Study|Death|0|||
160925687|NCT04199117|581122939|FG000|Overall Study|Withdrawal by PI|0|||
160925688|NCT04199117|581122940|FG001|Overall Study|Withdrawal by PI|0|||
160925689|NCT04199117|581122941|FG002|Overall Study|Withdrawal by PI|0|||
160925690|NCT04199117|581122942|FG003|Overall Study|Withdrawal by PI|0|||
160925691|NCT04199117|581122943|FG004|Overall Study|Withdrawal by PI|0|||
160925692|NCT04199117|581122944|FG005|Overall Study|Withdrawal by PI|0|||
160925693|NCT04199117|581122945|FG006|Overall Study|Withdrawal by PI|0|||
160925694|NCT04199117|581122946|FG007|Overall Study|Withdrawal by PI|0|||
160925695|NCT04199117|581122947|FG008|Overall Study|Withdrawal by PI|0|||
160925696|NCT04199117|581122948|FG009|Overall Study|Withdrawal by PI|0|||
160925697|NCT04199117|581122949|FG010|Overall Study|Withdrawal by PI|0|||
160925698|NCT04199117|581122950|FG011|Overall Study|Withdrawal by PI|0|||
160925699|NCT04199117|581122951|FG012|Overall Study|Withdrawal by PI|1|||
160925700|NCT04199117|581122952|FG013|Overall Study|Withdrawal by PI|0|||
160925701|NCT04199117|581122953|FG014|Overall Study|Withdrawal by PI|0|||
160925702|NCT04199117|581122954|FG015|Overall Study|Withdrawal by PI|0|||
160925703|NCT04383743|581122955|FG000|Overall Study|Withdrawal by Subject|1|||
160925704|NCT04383743|581122955|FG000|Overall Study|Adverse Event|1|||
160925705|NCT04814433|581122958|FG000|Overall Study|Survey not returned|4|||
160925706|NCT04814433|581122959|FG001|Overall Study|Survey not returned|8|||
160925707|NCT04814433|581122960|FG002|Overall Study|Survey not returned|4|||
160925708|NCT04814433|581122961|FG003|Overall Study|Survey not returned|5|||
160925709|NCT03482791|581122966|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
160925710|NCT03482791|581122967|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
160925711|NCT00296374|581122969|FG000|Overall Study|Adverse Event|14|||
160925712|NCT00296374|581122970|FG001|Overall Study|Adverse Event|10|||
160925713|NCT00296374|581122971|FG002|Overall Study|Adverse Event|7|||
160925714|NCT00296374|581122969|FG000|Overall Study|Withdrawal by Subject|3|||
160925715|NCT00296374|581122970|FG001|Overall Study|Withdrawal by Subject|5|||
160925716|NCT00296374|581122971|FG002|Overall Study|Withdrawal by Subject|11|||
160925717|NCT00296374|581122969|FG000|Overall Study|Incorrect enrollment|3|||
160925718|NCT00296374|581122970|FG001|Overall Study|Incorrect enrollment|3|||
160925719|NCT00296374|581122971|FG002|Overall Study|Incorrect enrollment|4|||
160925720|NCT00296374|581122969|FG000|Overall Study|Protocol Violation|1|||
160925721|NCT00296374|581122970|FG001|Overall Study|Protocol Violation|2|||
160925722|NCT00296374|581122971|FG002|Overall Study|Protocol Violation|3|||
160925723|NCT00296374|581122969|FG000|Overall Study|Lost to Follow-up|3|||
160925724|NCT00296374|581122970|FG001|Overall Study|Lost to Follow-up|1|||
160925725|NCT00296374|581122971|FG002|Overall Study|Lost to Follow-up|1|||
160925726|NCT00296374|581122969|FG000|Overall Study|Relocated to another state|1|||
160925727|NCT00296374|581122970|FG001|Overall Study|Relocated to another state|0|||
160925728|NCT00296374|581122971|FG002|Overall Study|Relocated to another state|0|||
160925729|NCT00296374|581122969|FG000|Overall Study|Stopped drug before end of study visit|0|||
160925730|NCT00296374|581122970|FG001|Overall Study|Stopped drug before end of study visit|1|||
160925731|NCT00296374|581122971|FG002|Overall Study|Stopped drug before end of study visit|0|||
160925732|NCT00296374|581122969|FG000|Overall Study|Nephrologist introduced ACE|0|||
160925733|NCT00296374|581122970|FG001|Overall Study|Nephrologist introduced ACE|1|||
160925734|NCT00296374|581122971|FG002|Overall Study|Nephrologist introduced ACE|0|||
160925735|NCT00296374|581122969|FG000|Overall Study|Pregnancy|0|||
160925736|NCT00296374|581122970|FG001|Overall Study|Pregnancy|0|||
160925737|NCT00296374|581122971|FG002|Overall Study|Pregnancy|2|||
160925738|NCT00296374|581122969|FG000|Overall Study|Other|0|||
160925739|NCT00296374|581122970|FG001|Overall Study|Other|0|||
160925740|NCT00296374|581122971|FG002|Overall Study|Other|1|||
160925741|NCT01816893|581122972|FG000|Washout Period|Withdrawal by Subject|2|||
160925742|NCT01816893|581122973|FG001|Washout Period|Withdrawal by Subject|0|||
161263315|NCT01859130|582345216|FG000|Overall Study|Lost to Follow-up|16|||
160925743|NCT04782856|581124501|FG000|Overall Study|Withdrawal by Subject|0|||
160925744|NCT04782856|581124502|FG001|Overall Study|Withdrawal by Subject|1|||
160925745|NCT01030523|581124503|FG000|Initial Study (5 Years)|Death|1|||
160925746|NCT01030523|581124504|FG001|Initial Study (5 Years)|Death|0|||
161263316|NCT01859130|582345216|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
161263317|NCT01859130|582345216|FG000|Overall Study|Physician Decision|6|||
161263318|NCT01859130|582345216|FG000|Overall Study|Withdrawal by Subject|17|||
161263319|NCT01859130|582345216|FG000|Overall Study|Adverse Event|11|||
161263320|NCT00127036|582345220|FG000|Overall Study|Insufficient Data for Analysis|6|||
160925747|NCT01030523|581124503|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
160925748|NCT01030523|581124504|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
160925749|NCT01030523|581124503|FG000|Initial Study (5 Years)|Implant failure|1|||
160925750|NCT01030523|581124504|FG001|Initial Study (5 Years)|Implant failure|0|||
160925751|NCT01030523|581124503|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
160925752|NCT01030523|581124504|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
160925753|NCT01030523|581124503|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
160925754|NCT01030523|581124504|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
160925755|NCT01030523|581124503|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
160925756|NCT01030523|581124504|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
160925757|NCT00798369|581124507|FG000|Overall Study|Subject withdrew consent|0|||
160925758|NCT00798369|581124508|FG001|Overall Study|Subject withdrew consent|0|||
160925759|NCT00798369|581124509|FG002|Overall Study|Subject withdrew consent|1|||
160925760|NCT00798369|581124510|FG003|Overall Study|Subject withdrew consent|1|||
160925761|NCT00798369|581124511|FG004|Overall Study|Subject withdrew consent|0|||
160925762|NCT00798369|581124512|FG005|Overall Study|Subject withdrew consent|2|||
160925763|NCT00798369|581124507|FG000|Overall Study|Lost to Follow-up|1|||
160925764|NCT00798369|581124508|FG001|Overall Study|Lost to Follow-up|1|||
160925765|NCT00798369|581124509|FG002|Overall Study|Lost to Follow-up|1|||
160925766|NCT00798369|581124510|FG003|Overall Study|Lost to Follow-up|0|||
160925767|NCT00798369|581124511|FG004|Overall Study|Lost to Follow-up|1|||
160925768|NCT00798369|581124512|FG005|Overall Study|Lost to Follow-up|0|||
160925769|NCT00798369|581124507|FG000|Overall Study|Adminstrative problems|0|||
160925770|NCT00798369|581124508|FG001|Overall Study|Adminstrative problems|0|||
160925771|NCT00798369|581124509|FG002|Overall Study|Adminstrative problems|0|||
160925772|NCT00798369|581124510|FG003|Overall Study|Adminstrative problems|0|||
160925773|NCT00798369|581124511|FG004|Overall Study|Adminstrative problems|0|||
160925774|NCT00798369|581124512|FG005|Overall Study|Adminstrative problems|1|||
160925775|NCT04475588|581124513|FG000|Overall Study|Adverse Event|2|||
160925776|NCT04475588|581124514|FG001|Overall Study|Adverse Event|0|||
160925777|NCT01327300|581124515|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
160925778|NCT01327300|581124516|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
160925779|NCT01063764|581124517|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
160925780|NCT01063764|581124517|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
160925781|NCT01063764|581124517|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
160925782|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
160925783|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
160925784|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
160925785|NCT01063764|581124517|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
160925786|NCT00697515|581124518|FG000|Dose Optimization Period|Adverse Event|4|||
160925787|NCT00697515|581124519|FG001|Dose Optimization Period|Adverse Event|0|||
160925788|NCT00697515|581124518|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
160925789|NCT00697515|581124519|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
160925790|NCT00697515|581124518|FG000|Dose Optimization Period|Lost to Follow-up|2|||
160925791|NCT00697515|581124519|FG001|Dose Optimization Period|Lost to Follow-up|0|||
160925792|NCT00697515|581124518|FG000|Dose Optimization Period|sponsor request|2|||
160925793|NCT00697515|581124519|FG001|Dose Optimization Period|sponsor request|0|||
160925794|NCT00697515|581124518|FG000|Dose Optimization Period|called to active duty|1|||
160925795|NCT00697515|581124519|FG001|Dose Optimization Period|called to active duty|0|||
160925796|NCT00697515|581124518|FG000|Dose Optimization Period|elevated QTc|1|||
161143458|NCT01123889|581909369|FG000|Overall Study|Lost to Follow-up|3|||
161143459|NCT01123889|581909370|FG001|Overall Study|Lost to Follow-up|1|||
161143460|NCT02333331|581909371|FG000|Overall Study|Adverse Event|1|||
161143461|NCT02333331|581909372|FG001|Overall Study|Adverse Event|0|||
161143462|NCT02333331|581909373|FG002|Overall Study|Adverse Event|4|||
161143463|NCT02333331|581909374|FG003|Overall Study|Adverse Event|1|||
161143464|NCT02333331|581909371|FG000|Overall Study|Death|0|||
160925797|NCT00697515|581124519|FG001|Dose Optimization Period|elevated QTc|0|||
160925798|NCT00697515|581124518|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
160925799|NCT00697515|581124519|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
160925800|NCT00697515|581124518|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
160925801|NCT00697515|581124519|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
160925802|NCT00697515|581124518|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
160925803|NCT00697515|581124519|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
160925804|NCT00697515|581124518|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
160925805|NCT00697515|581124519|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
160925806|NCT02603432|581124520|FG000|Overall Study|Adverse Event|1|||
160925807|NCT02603432|581124521|FG001|Overall Study|Adverse Event|0|||
160925808|NCT02603432|581124520|FG000|Overall Study|Death|221|||
160925809|NCT02603432|581124521|FG001|Overall Study|Death|242|||
160925810|NCT02603432|581124520|FG000|Overall Study|Lost to Follow-up|3|||
160925811|NCT02603432|581124521|FG001|Overall Study|Lost to Follow-up|9|||
160925812|NCT02603432|581124520|FG000|Overall Study|Progressive Disease|7|||
160925813|NCT02603432|581124521|FG001|Overall Study|Progressive Disease|5|||
160925814|NCT02603432|581124520|FG000|Overall Study|Withdrawal by Subject|12|||
160925815|NCT02603432|581124521|FG001|Overall Study|Withdrawal by Subject|18|||
160925816|NCT02603432|581124520|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
160925817|NCT02603432|581124521|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
160925818|NCT02603432|581124520|FG000|Overall Study|Study terminated by sponsor|74|||
161143465|NCT02333331|581909372|FG001|Overall Study|Death|0|||
161143466|NCT02333331|581909373|FG002|Overall Study|Death|2|||
161143467|NCT02333331|581909374|FG003|Overall Study|Death|0|||
160998014|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
160998015|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
160998016|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
160998017|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
160925819|NCT02603432|581124521|FG001|Overall Study|Study terminated by sponsor|75|||
160925820|NCT02603432|581124520|FG000|Overall Study|Other|13|||
160925821|NCT02603432|581124521|FG001|Overall Study|Other|0|||
160925822|NCT00666757|581124522|FG000|Overall Study|Lost to Follow-up|39|||
160925823|NCT00666757|581124523|FG001|Overall Study|Lost to Follow-up|35|||
160925824|NCT00666757|581124522|FG000|Overall Study|Protocol Violation|23|||
160925825|NCT00666757|581124523|FG001|Overall Study|Protocol Violation|24|||
160925826|NCT00666757|581124522|FG000|Overall Study|Adverse Event|22|||
160925827|NCT00666757|581124523|FG001|Overall Study|Adverse Event|12|||
160925828|NCT00666757|581124522|FG000|Overall Study|Withdrawal by Subject|13|||
160925829|NCT00666757|581124523|FG001|Overall Study|Withdrawal by Subject|17|||
160925830|NCT00666757|581124522|FG000|Overall Study|Lack of Efficacy|3|||
160925831|NCT00666757|581124523|FG001|Overall Study|Lack of Efficacy|6|||
160925832|NCT00666757|581124522|FG000|Overall Study|Physician Decision|0|||
160925833|NCT00666757|581124523|FG001|Overall Study|Physician Decision|2|||
160925834|NCT00666757|581124522|FG000|Overall Study|Sponsor decision|0|||
160925835|NCT00666757|581124523|FG001|Overall Study|Sponsor decision|1|||
160925836|NCT05954052|581124524|FG000|Overall Study|Adverse Event|1|||
160925837|NCT01957462|581124525|FG000|Test Period 1|Withdrawal by Subject|1|||
160925838|NCT01957462|581124526|FG001|Test Period 1|Withdrawal by Subject|0|||
160925839|NCT01957462|581124525|FG000|Test Period 1|Adverse Event|1|||
160925840|NCT01957462|581124526|FG001|Test Period 1|Adverse Event|0|||
160925841|NCT03102918|581124527|FG000|Overall Study|Protocol Violation|1|||
160925842|NCT03102918|581124528|FG001|Overall Study|Protocol Violation|0|||
160925843|NCT04765358|581124531|FG000|Overall Study|Withdrawal by Subject|1|||
160925844|NCT03446040|581124532|FG000|Overall Study|Disease progression|3|||
160925845|NCT03446040|581124533|FG001|Overall Study|Disease progression|3|||
160925846|NCT03446040|581124534|FG002|Overall Study|Disease progression|3|||
160925847|NCT03446040|581124535|FG003|Overall Study|Disease progression|4|||
160925848|NCT03446040|581124536|FG004|Overall Study|Disease progression|4|||
160925849|NCT03446040|581124537|FG005|Overall Study|Disease progression|6|||
160925850|NCT03446040|581124538|FG006|Overall Study|Disease progression|3|||
160925851|NCT03446040|581124539|FG007|Overall Study|Disease progression|4|||
160925852|NCT03446040|581124540|FG008|Overall Study|Disease progression|2|||
160925853|NCT03446040|581124541|FG009|Overall Study|Disease progression|4|||
160925854|NCT03446040|581124542|FG010|Overall Study|Disease progression|9|||
160925855|NCT03446040|581124543|FG011|Overall Study|Disease progression|3|||
160925856|NCT03446040|581124544|FG012|Overall Study|Disease progression|7|||
160925857|NCT03446040|581124545|FG013|Overall Study|Disease progression|7|||
160925858|NCT03446040|581124532|FG000|Overall Study|Study drug toxicity|0|||
160925859|NCT03446040|581124533|FG001|Overall Study|Study drug toxicity|0|||
160925860|NCT03446040|581124534|FG002|Overall Study|Study drug toxicity|0|||
160925861|NCT03446040|581124535|FG003|Overall Study|Study drug toxicity|0|||
160925862|NCT03446040|581124536|FG004|Overall Study|Study drug toxicity|0|||
160925863|NCT03446040|581124537|FG005|Overall Study|Study drug toxicity|0|||
160925864|NCT03446040|581124538|FG006|Overall Study|Study drug toxicity|0|||
160925865|NCT03446040|581124539|FG007|Overall Study|Study drug toxicity|0|||
160925866|NCT03446040|581124540|FG008|Overall Study|Study drug toxicity|1|||
160925867|NCT03446040|581124541|FG009|Overall Study|Study drug toxicity|0|||
160998018|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
160998019|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
160998020|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
160998021|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
160998022|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
161143468|NCT02333331|581909371|FG000|Overall Study|Lost to Follow-up|0|||
161263321|NCT00127036|582345221|FG001|Overall Study|Insufficient Data for Analysis|11|||
161263322|NCT00127036|582345220|FG000|Overall Study|Screen Failure|2|||
161263323|NCT00127036|582345221|FG001|Overall Study|Screen Failure|0|||
160998023|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
160998024|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
160998025|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
161263324|NCT03921151|582345224|FG000|Overall Study|Withdrawal by Subject|11|||
160925868|NCT03446040|581124542|FG010|Overall Study|Study drug toxicity|0|||
160925869|NCT03446040|581124543|FG011|Overall Study|Study drug toxicity|0|||
160925870|NCT03446040|581124544|FG012|Overall Study|Study drug toxicity|0|||
160925871|NCT03446040|581124545|FG013|Overall Study|Study drug toxicity|0|||
160925872|NCT03446040|581124532|FG000|Overall Study|Adverse Event|0|||
160925873|NCT03446040|581124533|FG001|Overall Study|Adverse Event|0|||
161143469|NCT02333331|581909372|FG001|Overall Study|Lost to Follow-up|0|||
160925874|NCT03446040|581124534|FG002|Overall Study|Adverse Event|0|||
160925875|NCT03446040|581124535|FG003|Overall Study|Adverse Event|0|||
160925876|NCT03446040|581124536|FG004|Overall Study|Adverse Event|0|||
160925877|NCT03446040|581124537|FG005|Overall Study|Adverse Event|2|||
160925878|NCT03446040|581124538|FG006|Overall Study|Adverse Event|0|||
160925879|NCT03446040|581124539|FG007|Overall Study|Adverse Event|0|||
160925880|NCT03446040|581124540|FG008|Overall Study|Adverse Event|1|||
160925881|NCT03446040|581124541|FG009|Overall Study|Adverse Event|0|||
160925882|NCT03446040|581124542|FG010|Overall Study|Adverse Event|0|||
160925883|NCT03446040|581124543|FG011|Overall Study|Adverse Event|0|||
160925884|NCT03446040|581124544|FG012|Overall Study|Adverse Event|0|||
160925885|NCT03446040|581124545|FG013|Overall Study|Adverse Event|0|||
160925886|NCT03446040|581124532|FG000|Overall Study|Death|0|||
160925887|NCT03446040|581124533|FG001|Overall Study|Death|0|||
160925888|NCT03446040|581124534|FG002|Overall Study|Death|0|||
160925889|NCT03446040|581124535|FG003|Overall Study|Death|0|||
160925890|NCT03446040|581124536|FG004|Overall Study|Death|0|||
160925891|NCT03446040|581124537|FG005|Overall Study|Death|0|||
160925892|NCT03446040|581124538|FG006|Overall Study|Death|0|||
160925893|NCT03446040|581124539|FG007|Overall Study|Death|0|||
160925894|NCT03446040|581124540|FG008|Overall Study|Death|0|||
160925895|NCT03446040|581124541|FG009|Overall Study|Death|0|||
160925896|NCT03446040|581124542|FG010|Overall Study|Death|1|||
160925897|NCT03446040|581124543|FG011|Overall Study|Death|0|||
160925898|NCT03446040|581124544|FG012|Overall Study|Death|0|||
160925899|NCT03446040|581124545|FG013|Overall Study|Death|2|||
160925900|NCT03446040|581124532|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
160925901|NCT03446040|581124533|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
160925902|NCT03446040|581124534|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
160925903|NCT03446040|581124535|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
160925904|NCT03446040|581124536|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
160925905|NCT03446040|581124537|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
160925906|NCT03446040|581124538|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
160925907|NCT03446040|581124539|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
160925908|NCT03446040|581124540|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
160925909|NCT03446040|581124541|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
160925910|NCT03446040|581124542|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
160925911|NCT03446040|581124543|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
160925912|NCT03446040|581124544|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
160925913|NCT03446040|581124545|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
160925914|NCT03446040|581124532|FG000|Overall Study|Participant withdrew consent|0|||
160925915|NCT03446040|581124533|FG001|Overall Study|Participant withdrew consent|0|||
160925916|NCT03446040|581124534|FG002|Overall Study|Participant withdrew consent|0|||
160925917|NCT03446040|581124535|FG003|Overall Study|Participant withdrew consent|0|||
160925918|NCT03446040|581124536|FG004|Overall Study|Participant withdrew consent|0|||
160925919|NCT03446040|581124537|FG005|Overall Study|Participant withdrew consent|1|||
160925920|NCT03446040|581124538|FG006|Overall Study|Participant withdrew consent|0|||
160925921|NCT03446040|581124539|FG007|Overall Study|Participant withdrew consent|1|||
160925922|NCT03446040|581124540|FG008|Overall Study|Participant withdrew consent|0|||
160925923|NCT03446040|581124541|FG009|Overall Study|Participant withdrew consent|0|||
160925924|NCT03446040|581124542|FG010|Overall Study|Participant withdrew consent|0|||
160925925|NCT03446040|581124543|FG011|Overall Study|Participant withdrew consent|0|||
160925926|NCT03446040|581124544|FG012|Overall Study|Participant withdrew consent|0|||
160925927|NCT03446040|581124545|FG013|Overall Study|Participant withdrew consent|0|||
160925928|NCT03446040|581124532|FG000|Overall Study|Not reported|0|||
160925929|NCT03446040|581124533|FG001|Overall Study|Not reported|0|||
160925930|NCT03446040|581124534|FG002|Overall Study|Not reported|1|||
160925931|NCT03446040|581124535|FG003|Overall Study|Not reported|0|||
160925932|NCT03446040|581124536|FG004|Overall Study|Not reported|0|||
160925933|NCT03446040|581124537|FG005|Overall Study|Not reported|0|||
160925934|NCT03446040|581124538|FG006|Overall Study|Not reported|0|||
160925935|NCT03446040|581124539|FG007|Overall Study|Not reported|0|||
160925936|NCT03446040|581124540|FG008|Overall Study|Not reported|0|||
160925937|NCT03446040|581124541|FG009|Overall Study|Not reported|0|||
160925938|NCT03446040|581124542|FG010|Overall Study|Not reported|0|||
160925939|NCT03446040|581124543|FG011|Overall Study|Not reported|0|||
160925940|NCT03446040|581124544|FG012|Overall Study|Not reported|0|||
160925941|NCT03446040|581124545|FG013|Overall Study|Not reported|0|||
160925942|NCT00605475|581124546|FG000|Overall Study|Abnormal Laboratory Values|0|||
160925943|NCT00605475|581124547|FG001|Overall Study|Abnormal Laboratory Values|0|||
160925944|NCT00605475|581124548|FG002|Overall Study|Abnormal Laboratory Values|0|||
160925945|NCT00605475|581124549|FG003|Overall Study|Abnormal Laboratory Values|0|||
160925946|NCT00605475|581124550|FG004|Overall Study|Abnormal Laboratory Values|0|||
160925947|NCT00605475|581124551|FG005|Overall Study|Abnormal Laboratory Values|0|||
160925948|NCT00605475|581124552|FG006|Overall Study|Abnormal Laboratory Values|0|||
160925949|NCT00605475|581124553|FG007|Overall Study|Abnormal Laboratory Values|0|||
160925950|NCT00605475|581124554|FG008|Overall Study|Abnormal Laboratory Values|1|||
160925951|NCT00605475|581124555|FG009|Overall Study|Abnormal Laboratory Values|0|||
160925952|NCT00605475|581124546|FG000|Overall Study|Administrative problems|0|||
160925953|NCT00605475|581124547|FG001|Overall Study|Administrative problems|0|||
160925954|NCT00605475|581124548|FG002|Overall Study|Administrative problems|0|||
160925955|NCT00605475|581124549|FG003|Overall Study|Administrative problems|0|||
160925956|NCT00605475|581124550|FG004|Overall Study|Administrative problems|0|||
160925957|NCT00605475|581124551|FG005|Overall Study|Administrative problems|0|||
160925958|NCT00605475|581124552|FG006|Overall Study|Administrative problems|1|||
160925959|NCT00605475|581124553|FG007|Overall Study|Administrative problems|0|||
160925960|NCT00605475|581124554|FG008|Overall Study|Administrative problems|0|||
160925961|NCT00605475|581124555|FG009|Overall Study|Administrative problems|0|||
160925962|NCT00605475|581124546|FG000|Overall Study|Lost to Follow-up|0|||
160925963|NCT00605475|581124547|FG001|Overall Study|Lost to Follow-up|0|||
160925964|NCT00605475|581124548|FG002|Overall Study|Lost to Follow-up|0|||
160925965|NCT00605475|581124549|FG003|Overall Study|Lost to Follow-up|0|||
160925966|NCT00605475|581124550|FG004|Overall Study|Lost to Follow-up|0|||
160925967|NCT00605475|581124551|FG005|Overall Study|Lost to Follow-up|0|||
160925968|NCT00605475|581124552|FG006|Overall Study|Lost to Follow-up|0|||
160925969|NCT00605475|581124553|FG007|Overall Study|Lost to Follow-up|0|||
160925970|NCT00605475|581124554|FG008|Overall Study|Lost to Follow-up|1|||
160925971|NCT00605475|581124555|FG009|Overall Study|Lost to Follow-up|1|||
160925972|NCT00605475|581124546|FG000|Overall Study|Protocol Violation|0|||
160925973|NCT00605475|581124547|FG001|Overall Study|Protocol Violation|0|||
160925974|NCT00605475|581124548|FG002|Overall Study|Protocol Violation|0|||
160925975|NCT00605475|581124549|FG003|Overall Study|Protocol Violation|0|||
160925976|NCT00605475|581124550|FG004|Overall Study|Protocol Violation|1|||
160925977|NCT00605475|581124551|FG005|Overall Study|Protocol Violation|0|||
160925978|NCT00605475|581124552|FG006|Overall Study|Protocol Violation|0|||
160925979|NCT00605475|581124553|FG007|Overall Study|Protocol Violation|0|||
160925980|NCT00605475|581124554|FG008|Overall Study|Protocol Violation|0|||
160925981|NCT00605475|581124555|FG009|Overall Study|Protocol Violation|0|||
160925982|NCT00605475|581124546|FG000|Overall Study|Withdrawal by Subject|0|||
160925983|NCT00605475|581124547|FG001|Overall Study|Withdrawal by Subject|0|||
160925984|NCT00605475|581124548|FG002|Overall Study|Withdrawal by Subject|0|||
160925985|NCT00605475|581124549|FG003|Overall Study|Withdrawal by Subject|0|||
160925986|NCT00605475|581124550|FG004|Overall Study|Withdrawal by Subject|0|||
160925987|NCT00605475|581124551|FG005|Overall Study|Withdrawal by Subject|2|||
160925988|NCT00605475|581124552|FG006|Overall Study|Withdrawal by Subject|0|||
160925989|NCT00605475|581124553|FG007|Overall Study|Withdrawal by Subject|0|||
160925990|NCT00605475|581124554|FG008|Overall Study|Withdrawal by Subject|0|||
160925991|NCT00605475|581124555|FG009|Overall Study|Withdrawal by Subject|1|||
160925992|NCT00464568|581124556|FG000|Overall Study|Adverse Event|2|||
160925993|NCT03538158|581124558|FG000|Overall Study|Lost to Follow-up|13|||
160925994|NCT03538158|581124559|FG001|Overall Study|Lost to Follow-up|7|||
160925995|NCT03538158|581124558|FG000|Overall Study|Withdrawal by Subject|2|||
160925996|NCT03538158|581124559|FG001|Overall Study|Withdrawal by Subject|1|||
160925997|NCT02419742|581124562|FG000|Overall Study|Adverse Event|2|||
160925998|NCT02419742|581124563|FG001|Overall Study|Adverse Event|0|||
160925999|NCT02419742|581124562|FG000|Overall Study|Disease Progression|0|||
160926000|NCT02419742|581124563|FG001|Overall Study|Disease Progression|1|||
160926001|NCT02419742|581124562|FG000|Overall Study|Withdrew Consent|2|||
160926002|NCT02419742|581124563|FG001|Overall Study|Withdrew Consent|1|||
160926003|NCT02419742|581124562|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
160926004|NCT02419742|581124563|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
160926005|NCT04649164|581124566|FG000|Overall Study|Withdrawal by Subject|1|||
160926006|NCT04649164|581124567|FG001|Overall Study|Withdrawal by Subject|1|||
160926007|NCT04649164|581124568|FG002|Overall Study|Withdrawal by Subject|2|||
160926008|NCT04649164|581124566|FG000|Overall Study|Participant's care recipient expired|0|||
160926009|NCT04649164|581124567|FG001|Overall Study|Participant's care recipient expired|0|||
160926010|NCT04649164|581124568|FG002|Overall Study|Participant's care recipient expired|2|||
160926011|NCT04356963|581124575|FG000|First Session|Withdrawal by Subject|1|||
160926012|NCT04356963|581124575|FG000|Second Session|Withdrawal by Subject|3|||
160926013|NCT04356963|581124575|FG000|Second Session|Lost to Follow-up|1|||
161263325|NCT03921151|582345225|FG001|Overall Study|Withdrawal by Subject|16|||
161263326|NCT03001219|582345233|FG000|Proof of Concept|Study Termination by Sponsor|0|||
161263327|NCT03001219|582345234|FG001|Proof of Concept|Study Termination by Sponsor|1|||
161263328|NCT03001219|582345233|FG000|Proof of Concept|Withdrawal by Subject|0|||
160926014|NCT04356963|581124575|FG000|Third Session|Lost to Follow-up|6|||
160926015|NCT04356963|581124575|FG000|Third Session|Withdrawal by Subject|1|||
160926016|NCT02410954|581124580|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
160926017|NCT02410954|581124581|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
160926018|NCT02410954|581124580|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
160926019|NCT02410954|581124581|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
160926020|NCT00791518|581124583|FG000|Overall Study|Protocol Violation|93|||
160926021|NCT02488681|581124584|FG000|Overall Study|Implant unsuccessful|7|||
160926022|NCT00720057|581124585|FG000|Overall Study|Lost to Follow-up|0|||
160926023|NCT00720057|581124586|FG001|Overall Study|Lost to Follow-up|2|||
160926024|NCT00720057|581124585|FG000|Overall Study|Protocol Violation|1|||
160926025|NCT00720057|581124586|FG001|Overall Study|Protocol Violation|0|||
160926026|NCT00720057|581124585|FG000|Overall Study|Withdrawal by Subject|0|||
160926027|NCT00720057|581124586|FG001|Overall Study|Withdrawal by Subject|1|||
160926028|NCT00271609|581124598|FG000|Overall Study|Adverse Event|11|||
160926029|NCT00271609|581124599|FG001|Overall Study|Adverse Event|3|||
160926030|NCT00271609|581124598|FG000|Overall Study|Withdrawal by Subject|2|||
160926031|NCT00271609|581124599|FG001|Overall Study|Withdrawal by Subject|0|||
160926032|NCT03341533|581124600|FG000|Overall Study|Withdrawal by Subject|1|||
160926033|NCT03341533|581124601|FG001|Overall Study|Withdrawal by Subject|1|||
160926034|NCT03341533|581124600|FG000|Overall Study|Not eligible after randomization|2|||
160926035|NCT03341533|581124601|FG001|Overall Study|Not eligible after randomization|1|||
160926036|NCT00643682|581124602|FG000|Overall Study|did not keep appointment|522|||
160926037|NCT00643682|581124603|FG001|Overall Study|did not keep appointment|509|||
160926038|NCT03886220|581124607|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
160926039|NCT03886220|581124608|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
160926040|NCT03886220|581124607|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
160926041|NCT03886220|581124608|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
160926042|NCT03886220|581124607|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
160926043|NCT03886220|581124608|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
160926044|NCT01675128|581124613|FG000|Overall Study|Disease progression on study|1|||
160926045|NCT01675128|581124614|FG001|Overall Study|Disease progression on study|1|||
160926046|NCT01675128|581124615|FG002|Overall Study|Disease progression on study|1|||
160926047|NCT01675128|581124613|FG000|Overall Study|Refused further treatment|1|||
160926048|NCT01675128|581124614|FG001|Overall Study|Refused further treatment|0|||
160926049|NCT01675128|581124615|FG002|Overall Study|Refused further treatment|0|||
160926050|NCT01675128|581124613|FG000|Overall Study|Pulmonary complication; off study|0|||
160926051|NCT01675128|581124614|FG001|Overall Study|Pulmonary complication; off study|1|||
160926052|NCT01675128|581124615|FG002|Overall Study|Pulmonary complication; off study|0|||
160926053|NCT03526458|581124619|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
160926054|NCT03526458|581124620|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
160926055|NCT03526458|581124619|FG000|Overall Study|Stone passed, surgery cancelled|2|||
160926056|NCT03526458|581124620|FG001|Overall Study|Stone passed, surgery cancelled|1|||
160926057|NCT03526458|581124619|FG000|Overall Study|Withdrawal by Subject|1|||
160926058|NCT03526458|581124620|FG001|Overall Study|Withdrawal by Subject|0|||
160926059|NCT03526458|581124619|FG000|Overall Study|Physician Decision|2|||
160926060|NCT03526458|581124620|FG001|Overall Study|Physician Decision|1|||
160926061|NCT03526458|581124619|FG000|Overall Study|Lack of equipment|1|||
160926062|NCT03526458|581124620|FG001|Overall Study|Lack of equipment|1|||
160926063|NCT01782664|581124621|FG000|Overall Study|Adverse Event|2|||
160926064|NCT01782664|581124622|FG001|Overall Study|Adverse Event|2|||
160926065|NCT01782664|581124623|FG002|Overall Study|Adverse Event|2|||
160926066|NCT01782664|581124624|FG003|Overall Study|Adverse Event|2|||
160926067|NCT01782664|581124625|FG004|Overall Study|Adverse Event|0|||
160926068|NCT01782664|581124626|FG005|Overall Study|Adverse Event|0|||
160926069|NCT01782664|581124621|FG000|Overall Study|Lack of Efficacy|2|||
160926070|NCT01782664|581124622|FG001|Overall Study|Lack of Efficacy|0|||
160926071|NCT01782664|581124623|FG002|Overall Study|Lack of Efficacy|2|||
160926072|NCT01782664|581124624|FG003|Overall Study|Lack of Efficacy|2|||
160926073|NCT01782664|581124625|FG004|Overall Study|Lack of Efficacy|0|||
160926074|NCT01782664|581124626|FG005|Overall Study|Lack of Efficacy|0|||
160926075|NCT01782664|581124621|FG000|Overall Study|Protocol Violation|0|||
160926076|NCT01782664|581124622|FG001|Overall Study|Protocol Violation|1|||
160926077|NCT01782664|581124623|FG002|Overall Study|Protocol Violation|0|||
160926078|NCT01782664|581124624|FG003|Overall Study|Protocol Violation|1|||
160926079|NCT01782664|581124625|FG004|Overall Study|Protocol Violation|0|||
160926080|NCT01782664|581124626|FG005|Overall Study|Protocol Violation|0|||
160926081|NCT01782664|581124621|FG000|Overall Study|Withdrawal by Subject|2|||
160926082|NCT01782664|581124622|FG001|Overall Study|Withdrawal by Subject|2|||
160926083|NCT01782664|581124623|FG002|Overall Study|Withdrawal by Subject|0|||
160926084|NCT01782664|581124624|FG003|Overall Study|Withdrawal by Subject|0|||
160926085|NCT01782664|581124625|FG004|Overall Study|Withdrawal by Subject|0|||
161341839|NCT00614393|582639041|FG002|Overall Study|Withdrawal by Subject|1|||
160926086|NCT01782664|581124626|FG005|Overall Study|Withdrawal by Subject|0|||
160926087|NCT04404855|581124627|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
160926088|NCT04404855|581124628|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
160926089|NCT00735878|581124629|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
160926090|NCT00735878|581124630|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
160926091|NCT00735878|581124631|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
160926092|NCT04170348|581124634|FG000|Overall Study|Lost to Follow-up|2|||
161341840|NCT00614393|582639042|FG003|Overall Study|Withdrawal by Subject|16|||
160926093|NCT04170348|581124635|FG001|Overall Study|Lost to Follow-up|2|||
161341841|NCT00614393|582639043|FG004|Overall Study|Withdrawal by Subject|13|||
161143470|NCT02333331|581909373|FG002|Overall Study|Lost to Follow-up|1|||
161143471|NCT02333331|581909374|FG003|Overall Study|Lost to Follow-up|0|||
161143472|NCT02333331|581909371|FG000|Overall Study|Physician Decision|0|||
161143473|NCT02333331|581909372|FG001|Overall Study|Physician Decision|1|||
160926094|NCT04170348|581124634|FG000|Overall Study|Withdrawal by Subject|1|||
160926095|NCT04170348|581124635|FG001|Overall Study|Withdrawal by Subject|5|||
160926096|NCT04170348|581124634|FG000|Overall Study|Non-adherence|1|||
160926097|NCT04170348|581124635|FG001|Overall Study|Non-adherence|1|||
160926098|NCT04170348|581124634|FG000|Overall Study|Adverse Event|1|||
160926099|NCT04170348|581124635|FG001|Overall Study|Adverse Event|0|||
160926100|NCT01082965|581124641|FG000|Overall Study|Protocol Violation|0|||
160926101|NCT01082965|581124642|FG001|Overall Study|Protocol Violation|1|||
160926102|NCT01082965|581124641|FG000|Overall Study|Other|1|||
160926103|NCT01082965|581124642|FG001|Overall Study|Other|1|||
160926104|NCT02587065|581124643|FG000|Overall Study|Adverse Event|14|||
160926105|NCT02587065|581124643|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
160926106|NCT02587065|581124643|FG000|Overall Study|Non-adherence to the Protocol|3|||
160926107|NCT02587065|581124643|FG000|Overall Study|Discontinuation of Study Medication|2|||
160926108|NCT02587065|581124643|FG000|Overall Study|Reason not Specified|3|||
160926109|NCT01559012|581124644|FG000|Overall Study|Withdrawal by Subject|0|||
160926110|NCT01559012|581124645|FG001|Overall Study|Withdrawal by Subject|1|||
160926111|NCT00445965|581124646|FG000|Overall Study|Adverse Event|2|||
160926112|NCT00445965|581124646|FG000|Overall Study|Physician Decision|1|||
160926113|NCT00445965|581124646|FG000|Overall Study|Enrolled but not treated|1|||
160926114|NCT00445965|581124646|FG000|Overall Study|Removed due to progressive disease|29|||
160926115|NCT02867709|581124647|FG000|Treatment Period|Adverse Event|1|||
160926116|NCT02867709|581124648|FG001|Treatment Period|Adverse Event|1|||
160926117|NCT02867709|581124649|FG002|Treatment Period|Adverse Event|2|||
160926118|NCT02867709|581124647|FG000|Treatment Period|Withdrawal of Consent|7|||
160926119|NCT02867709|581124648|FG001|Treatment Period|Withdrawal of Consent|9|||
160926120|NCT02867709|581124649|FG002|Treatment Period|Withdrawal of Consent|8|||
160926121|NCT02867709|581124647|FG000|Treatment Period|Lost to Follow-up|17|||
160926122|NCT02867709|581124648|FG001|Treatment Period|Lost to Follow-up|20|||
160926123|NCT02867709|581124649|FG002|Treatment Period|Lost to Follow-up|20|||
160926124|NCT02867709|581124647|FG000|Treatment Period|Lack of Qualifying Event|42|||
160926125|NCT02867709|581124648|FG001|Treatment Period|Lack of Qualifying Event|55|||
160926126|NCT02867709|581124649|FG002|Treatment Period|Lack of Qualifying Event|42|||
160926127|NCT02867709|581124647|FG000|Treatment Period|Protocol Violation|3|||
160926128|NCT02867709|581124648|FG001|Treatment Period|Protocol Violation|2|||
160926129|NCT02867709|581124649|FG002|Treatment Period|Protocol Violation|3|||
160926130|NCT02867709|581124647|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
160926131|NCT02867709|581124648|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
160926132|NCT02867709|581124649|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
160926133|NCT02867709|581124647|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
160926134|NCT02867709|581124648|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
160926135|NCT02867709|581124649|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
160926136|NCT02867709|581124647|FG000|Safety Follow-up Period|Pregnancy|0|||
160926137|NCT02867709|581124648|FG001|Safety Follow-up Period|Pregnancy|1|||
160926138|NCT02867709|581124649|FG002|Safety Follow-up Period|Pregnancy|0|||
160926139|NCT02867709|581124647|FG000|Safety Follow-up Period|Protocol Violation|0|||
160926140|NCT02867709|581124648|FG001|Safety Follow-up Period|Protocol Violation|1|||
160926141|NCT02867709|581124649|FG002|Safety Follow-up Period|Protocol Violation|1|||
160926142|NCT05041322|581124652|FG000|Baseline|Withdrawal by Subject|1|||
160926143|NCT05041322|581124653|FG001|Baseline|Withdrawal by Subject|0|||
160926144|NCT05041322|581124652|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
160926145|NCT05041322|581124653|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
160926146|NCT05041322|581124652|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
161143474|NCT02333331|581909373|FG002|Overall Study|Physician Decision|0|||
161263329|NCT03001219|582345234|FG001|Proof of Concept|Withdrawal by Subject|4|||
160926147|NCT05041322|581124653|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
160926148|NCT03313804|581124654|FG000|Treatment|Death|5|||
160926149|NCT03313804|581124654|FG000|Treatment|still on treatment|2|||
160926150|NCT03313804|581124654|FG000|Follow Up|still on follow up|3|||
161263330|NCT03001219|582345233|FG000|Proof of Concept|Protocol Deviation|0|||
161263331|NCT03001219|582345234|FG001|Proof of Concept|Protocol Deviation|1|||
160926151|NCT01502423|581124655|FG000|Overall Study|Withdrawal by Subject|0|||
160926152|NCT01502423|581124656|FG001|Overall Study|Withdrawal by Subject|1|||
160926153|NCT00699972|581126385|FG000|Overall Study|Adverse Event|7|||
160926154|NCT00699972|581126386|FG001|Overall Study|Adverse Event|9|||
160926155|NCT00699972|581126387|FG002|Overall Study|Adverse Event|24|||
160926156|NCT00699972|581126385|FG000|Overall Study|Lost to Follow-up|0|||
160926157|NCT00699972|581126386|FG001|Overall Study|Lost to Follow-up|2|||
160926158|NCT00699972|581126387|FG002|Overall Study|Lost to Follow-up|0|||
161143475|NCT02333331|581909374|FG003|Overall Study|Physician Decision|0|||
160926159|NCT00699972|581126385|FG000|Overall Study|Withdrawal by Subject|3|||
160926160|NCT00699972|581126386|FG001|Overall Study|Withdrawal by Subject|7|||
160926161|NCT00699972|581126387|FG002|Overall Study|Withdrawal by Subject|4|||
161341842|NCT00614393|582639039|FG000|Overall Study|Other|4|||
160926162|NCT00699972|581126385|FG000|Overall Study|Lack of Efficacy|2|||
160926163|NCT00699972|581126386|FG001|Overall Study|Lack of Efficacy|0|||
160926164|NCT00699972|581126387|FG002|Overall Study|Lack of Efficacy|2|||
160926165|NCT00699972|581126385|FG000|Overall Study|Administrative/Other|3|||
160926166|NCT00699972|581126386|FG001|Overall Study|Administrative/Other|1|||
160926167|NCT00699972|581126387|FG002|Overall Study|Administrative/Other|4|||
160926168|NCT00699972|581126385|FG000|Overall Study|Randomized, Not Treated|1|||
160926169|NCT00699972|581126386|FG001|Overall Study|Randomized, Not Treated|0|||
160926170|NCT00699972|581126387|FG002|Overall Study|Randomized, Not Treated|1|||
160926171|NCT01545817|581126388|FG000|Pazopanib|Disease progression|51|||
160926172|NCT01545817|581126389|FG001|Pazopanib|Disease progression|0|||
160926173|NCT01545817|581126388|FG000|Pazopanib|Adverse Event|19|||
160926174|NCT01545817|581126389|FG001|Pazopanib|Adverse Event|0|||
160926175|NCT01545817|581126388|FG000|Pazopanib|Other reason|4|||
160926176|NCT01545817|581126389|FG001|Pazopanib|Other reason|0|||
160926177|NCT01545817|581126388|FG000|Everolimus|Other reason|0|||
160926178|NCT01545817|581126389|FG001|Everolimus|Other reason|7|||
160926179|NCT01545817|581126388|FG000|Everolimus|Disease progression|0|||
160926180|NCT01545817|581126389|FG001|Everolimus|Disease progression|25|||
160926181|NCT01545817|581126388|FG000|Everolimus|Adverse Event|0|||
160926182|NCT01545817|581126389|FG001|Everolimus|Adverse Event|6|||
160926183|NCT03971695|581126393|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926184|NCT03971695|581126394|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926185|NCT03971695|581126395|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926186|NCT03971695|581126396|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
160926187|NCT03971695|581126397|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
160926188|NCT03971695|581126398|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926189|NCT03971695|581126399|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926190|NCT03971695|581126400|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926191|NCT03971695|581126401|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
160926192|NCT03971695|581126402|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
160926193|NCT03971695|581126403|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
160926194|NCT03971695|581126404|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
160926195|NCT03971695|581126405|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
160926196|NCT00156533|581126406|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
160926197|NCT00156533|581126407|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
160926198|NCT00156533|581126408|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
160926199|NCT00156533|581126409|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
160926200|NCT00156533|581126406|FG000|Overall Study|Withdrawal by Subject|1|||
160926201|NCT00156533|581126407|FG001|Overall Study|Withdrawal by Subject|0|||
160926202|NCT00156533|581126408|FG002|Overall Study|Withdrawal by Subject|0|||
160926203|NCT00156533|581126409|FG003|Overall Study|Withdrawal by Subject|1|||
160926204|NCT00156533|581126406|FG000|Overall Study|Failed Screening|1|||
160926205|NCT00156533|581126407|FG001|Overall Study|Failed Screening|0|||
160926206|NCT00156533|581126408|FG002|Overall Study|Failed Screening|1|||
160926207|NCT00156533|581126409|FG003|Overall Study|Failed Screening|1|||
160926208|NCT01881230|581126410|FG000|Overall Study|Death|2|||
160926209|NCT01881230|581126411|FG001|Overall Study|Death|0|||
160926210|NCT01881230|581126412|FG002|Overall Study|Death|1|||
160926211|NCT01881230|581126410|FG000|Overall Study|Adverse Event|9|||
160926212|NCT01881230|581126411|FG001|Overall Study|Adverse Event|13|||
160926213|NCT01881230|581126412|FG002|Overall Study|Adverse Event|12|||
160926214|NCT01881230|581126410|FG000|Overall Study|Progressive Disease|31|||
160926215|NCT01881230|581126411|FG001|Overall Study|Progressive Disease|35|||
161143476|NCT02333331|581909371|FG000|Overall Study|Protocol Deviation|0|||
161143477|NCT02333331|581909372|FG001|Overall Study|Protocol Deviation|3|||
161143478|NCT02333331|581909373|FG002|Overall Study|Protocol Deviation|2|||
161143479|NCT02333331|581909374|FG003|Overall Study|Protocol Deviation|1|||
161143480|NCT02333331|581909371|FG000|Overall Study|Patient/Guardian Decision|1|||
161143481|NCT02333331|581909372|FG001|Overall Study|Patient/Guardian Decision|2|||
161143482|NCT02333331|581909373|FG002|Overall Study|Patient/Guardian Decision|9|||
161341843|NCT00614393|582639040|FG001|Overall Study|Other|0|||
161341844|NCT00614393|582639041|FG002|Overall Study|Other|0|||
161143483|NCT02333331|581909374|FG003|Overall Study|Patient/Guardian Decision|1|||
161341845|NCT00614393|582639042|FG003|Overall Study|Other|4|||
160926216|NCT01881230|581126412|FG002|Overall Study|Progressive Disease|36|||
160926217|NCT01881230|581126410|FG000|Overall Study|Symptomatic Deterioration|3|||
160926218|NCT01881230|581126411|FG001|Overall Study|Symptomatic Deterioration|3|||
160926219|NCT01881230|581126412|FG002|Overall Study|Symptomatic Deterioration|1|||
160926220|NCT01881230|581126410|FG000|Overall Study|Withdrawal by Subject|6|||
160926221|NCT01881230|581126411|FG001|Overall Study|Withdrawal by Subject|4|||
161143484|NCT00685178|581909378|FG000|Overall Study|Adverse Event|1|||
161341846|NCT00614393|582639043|FG004|Overall Study|Other|2|||
160926222|NCT01881230|581126412|FG002|Overall Study|Withdrawal by Subject|6|||
160926223|NCT01881230|581126410|FG000|Overall Study|Physician Decision|4|||
160926224|NCT01881230|581126411|FG001|Overall Study|Physician Decision|3|||
160926225|NCT01881230|581126412|FG002|Overall Study|Physician Decision|6|||
160926226|NCT01881230|581126410|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160926227|NCT01881230|581126411|FG001|Overall Study|Non-Compliance with Study Drug|2|||
160926228|NCT01881230|581126412|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160926229|NCT01881230|581126410|FG000|Overall Study|Given Commercially Available Drug|0|||
160926230|NCT01881230|581126411|FG001|Overall Study|Given Commercially Available Drug|0|||
160926231|NCT01881230|581126412|FG002|Overall Study|Given Commercially Available Drug|2|||
160926232|NCT01881230|581126410|FG000|Overall Study|Protocol Violation|1|||
160926233|NCT01881230|581126411|FG001|Overall Study|Protocol Violation|1|||
160926234|NCT01881230|581126412|FG002|Overall Study|Protocol Violation|0|||
160926235|NCT01881230|581126410|FG000|Overall Study|Miscellaneous|3|||
160926236|NCT01881230|581126411|FG001|Overall Study|Miscellaneous|3|||
160926237|NCT01881230|581126412|FG002|Overall Study|Miscellaneous|0|||
160926238|NCT01881230|581126410|FG000|Overall Study|Untreated: Other|0|||
160926239|NCT01881230|581126411|FG001|Overall Study|Untreated: Other|0|||
160926240|NCT01881230|581126412|FG002|Overall Study|Untreated: Other|1|||
160926241|NCT01881230|581126410|FG000|Overall Study|Untreated: Death|0|||
160926242|NCT01881230|581126411|FG001|Overall Study|Untreated: Death|0|||
160926243|NCT01881230|581126412|FG002|Overall Study|Untreated: Death|1|||
160926244|NCT01881230|581126410|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
160926245|NCT01881230|581126411|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
160926246|NCT01881230|581126412|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
160926247|NCT02747420|581126413|FG000|Overall Study|Lost to Follow-up|4|||
160926248|NCT02747420|581126414|FG001|Overall Study|Lost to Follow-up|2|||
160926249|NCT02747420|581126413|FG000|Overall Study|Withdrawal by Subject|3|||
160926250|NCT02747420|581126414|FG001|Overall Study|Withdrawal by Subject|2|||
160926251|NCT05129488|581126415|FG000|Overall Study|Protocol Violation|3|||
160926252|NCT00706641|581126420|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
160926253|NCT00706641|581126420|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
160926254|NCT00706641|581126420|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
160926255|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
160926256|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
160926257|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
160926258|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
160926259|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
160926260|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
160926261|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
160926262|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
160926263|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
160926264|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
160926265|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
160926266|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
160926267|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
160926268|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
160926269|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
160926270|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
160926271|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
160926272|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
160926273|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
160926274|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
160926275|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
160926276|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
160926277|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
160998026|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
160998027|NCT00241644|581378523|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
160998028|NCT00241644|581378524|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
161143485|NCT00685178|581909379|FG001|Overall Study|Adverse Event|5|||
161263332|NCT03001219|582345233|FG000|Proof of Concept|Adverse Event|1|||
160926278|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
160926279|NCT00277212|581126421|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
160926280|NCT00277212|581126422|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
160926281|NCT00277212|581126423|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
160926282|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
160926283|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
160926284|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
160926285|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
160926286|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
161263333|NCT03001219|582345234|FG001|Proof of Concept|Adverse Event|1|||
160926287|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
160926288|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
160926289|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
160926290|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
160926291|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
160926292|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
160926293|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
160926294|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
160926295|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
160926296|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
160926297|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
160926298|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
160926299|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
160926300|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
160926301|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
160926302|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
160926303|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
160926304|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
160926305|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
160926306|NCT00277212|581126421|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
160926307|NCT00277212|581126422|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
160926308|NCT00277212|581126423|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
160926309|NCT00922766|581126426|FG000|Overall Study|Death|3|||
160926310|NCT00922766|581126426|FG000|Overall Study|Withdrawal by Subject|2|||
160926311|NCT00922766|581126426|FG000|Overall Study|Other|1|||
160926312|NCT00922766|581126426|FG000|Overall Study|Adverse Event|1|||
160926313|NCT01231581|581126430|FG000|Overall Study|Lost to Follow-up|2|||
160926314|NCT01231581|581126431|FG001|Overall Study|Lost to Follow-up|2|||
160926315|NCT01231581|581126430|FG000|Overall Study|Withdrawal by Subject|6|||
160926316|NCT01231581|581126431|FG001|Overall Study|Withdrawal by Subject|9|||
160926317|NCT01231581|581126430|FG000|Overall Study|Study Closed/Terminated|6|||
160926318|NCT01231581|581126431|FG001|Overall Study|Study Closed/Terminated|5|||
160926319|NCT01231581|581126430|FG000|Overall Study|Death|65|||
160926320|NCT01231581|581126431|FG001|Overall Study|Death|64|||
160926321|NCT01231581|581126430|FG000|Overall Study|Ongoing|1|||
160926322|NCT01231581|581126431|FG001|Overall Study|Ongoing|0|||
160926323|NCT01723163|581126434|FG000|Treatment Phase|Withdrawal by Subject|14|||
160926324|NCT01723163|581126435|FG001|Treatment Phase|Withdrawal by Subject|6|||
160926325|NCT01723163|581126434|FG000|Treatment Phase|Withdrawal by PI|5|||
160926326|NCT01723163|581126435|FG001|Treatment Phase|Withdrawal by PI|1|||
160926327|NCT01723163|581126434|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
160926328|NCT01723163|581126435|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
160926329|NCT01723163|581126434|FG000|3-Month Follow-up|Unable to Contact|12|||
160926330|NCT01723163|581126435|FG001|3-Month Follow-up|Unable to Contact|19|||
160926331|NCT01723163|581126434|FG000|6-Month Follow-up|Death|1|||
160926332|NCT01723163|581126435|FG001|6-Month Follow-up|Death|0|||
160926333|NCT01723163|581126434|FG000|6-Month Follow-up|Unable to Contact|17|||
160926334|NCT01723163|581126435|FG001|6-Month Follow-up|Unable to Contact|15|||
160926335|NCT01723163|581126434|FG000|12-Month Follow-up|Death|1|||
160926336|NCT01723163|581126435|FG001|12-Month Follow-up|Death|0|||
160926337|NCT01723163|581126434|FG000|12-Month Follow-up|Unable to Contact|23|||
161263334|NCT03001219|582345233|FG000|Proof of Concept|Physician Decision|1|||
161263335|NCT03001219|582345234|FG001|Proof of Concept|Physician Decision|0|||
161263336|NCT03001219|582345233|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
161263337|NCT03001219|582345234|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
161263338|NCT03001219|582345233|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
161263339|NCT03001219|582345234|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
161263340|NCT03001219|582345233|FG000|Extension Period Analysis|Physician Decision|0|||
161263341|NCT03001219|582345234|FG001|Extension Period Analysis|Physician Decision|1|||
161263342|NCT03001219|582345233|FG000|Extension Period Analysis|Adverse Event|1|||
161263343|NCT03001219|582345234|FG001|Extension Period Analysis|Adverse Event|1|||
161263344|NCT03001219|582345233|FG000|Extension Period Analysis|Protocol Deviation|0|||
160926338|NCT01723163|581126435|FG001|12-Month Follow-up|Unable to Contact|28|||
160926339|NCT02510794|581126436|FG000|Overall Study|Adverse Event|0|||
160926340|NCT02510794|581126437|FG001|Overall Study|Adverse Event|1|||
160926341|NCT02510794|581126438|FG002|Overall Study|Adverse Event|0|||
160926342|NCT02510794|581126439|FG003|Overall Study|Adverse Event|0|||
160926343|NCT02510794|581126436|FG000|Overall Study|Death|1|||
160926344|NCT02510794|581126437|FG001|Overall Study|Death|2|||
160926345|NCT02510794|581126438|FG002|Overall Study|Death|1|||
160926346|NCT02510794|581126439|FG003|Overall Study|Death|1|||
160926347|NCT02510794|581126436|FG000|Overall Study|Lack of Efficacy|3|||
160926348|NCT02510794|581126437|FG001|Overall Study|Lack of Efficacy|1|||
160926349|NCT02510794|581126438|FG002|Overall Study|Lack of Efficacy|1|||
161263345|NCT03001219|582345234|FG001|Extension Period Analysis|Protocol Deviation|1|||
161263346|NCT03001219|582345233|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
161263347|NCT03001219|582345234|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
161263348|NCT01797835|582345235|FG000|Overall Study|Lost to Follow-up|31|||
161263349|NCT01797835|582345236|FG001|Overall Study|Lost to Follow-up|27|||
161263350|NCT01403064|582345237|FG000|Overall Study|Death|0|||
161263351|NCT01403064|582345238|FG001|Overall Study|Death|0|||
161263352|NCT01403064|582345239|FG002|Overall Study|Death|1|||
161263353|NCT01403064|582345240|FG003|Overall Study|Death|1|||
161263354|NCT01403064|582345237|FG000|Overall Study|Withdrawal by Subject|0|||
161263355|NCT01403064|582345238|FG001|Overall Study|Withdrawal by Subject|0|||
160926350|NCT02510794|581126439|FG003|Overall Study|Lack of Efficacy|0|||
160926351|NCT02510794|581126436|FG000|Overall Study|Participant moved out of the area|0|||
160926352|NCT02510794|581126437|FG001|Overall Study|Participant moved out of the area|0|||
160926353|NCT02510794|581126438|FG002|Overall Study|Participant moved out of the area|0|||
160926354|NCT02510794|581126439|FG003|Overall Study|Participant moved out of the area|1|||
160926355|NCT02510794|581126436|FG000|Overall Study|Physician Decision|3|||
160926356|NCT02510794|581126437|FG001|Overall Study|Physician Decision|0|||
160926357|NCT02510794|581126438|FG002|Overall Study|Physician Decision|0|||
160926358|NCT02510794|581126439|FG003|Overall Study|Physician Decision|0|||
160926359|NCT02510794|581126436|FG000|Overall Study|Protocol Violation|0|||
160926360|NCT02510794|581126437|FG001|Overall Study|Protocol Violation|0|||
160926361|NCT02510794|581126438|FG002|Overall Study|Protocol Violation|1|||
160926362|NCT02510794|581126439|FG003|Overall Study|Protocol Violation|0|||
160926363|NCT02510794|581126436|FG000|Overall Study|Withdrawal by Subject|1|||
160926364|NCT02510794|581126437|FG001|Overall Study|Withdrawal by Subject|2|||
160926365|NCT02510794|581126438|FG002|Overall Study|Withdrawal by Subject|4|||
160926366|NCT02510794|581126439|FG003|Overall Study|Withdrawal by Subject|3|||
160926367|NCT01649375|581126440|FG000|Up to Week 16|Adverse Event|2|||
160926368|NCT01649375|581126441|FG001|Up to Week 16|Adverse Event|5|||
160926369|NCT01649375|581126442|FG002|Up to Week 16|Adverse Event|4|||
160926370|NCT01649375|581126443|FG003|Up to Week 16|Adverse Event|0|||
160926371|NCT01649375|581126444|FG004|Up to Week 16|Adverse Event|0|||
160926372|NCT01649375|581126440|FG000|Up to Week 16|Lack of Efficacy|0|||
160926373|NCT01649375|581126441|FG001|Up to Week 16|Lack of Efficacy|0|||
160926374|NCT01649375|581126442|FG002|Up to Week 16|Lack of Efficacy|1|||
160926375|NCT01649375|581126443|FG003|Up to Week 16|Lack of Efficacy|0|||
160926376|NCT01649375|581126444|FG004|Up to Week 16|Lack of Efficacy|0|||
160926377|NCT01649375|581126440|FG000|Up to Week 16|Physician Decision|0|||
160926378|NCT01649375|581126441|FG001|Up to Week 16|Physician Decision|0|||
160926379|NCT01649375|581126442|FG002|Up to Week 16|Physician Decision|1|||
161143486|NCT00685178|581909380|FG002|Overall Study|Adverse Event|2|||
161143487|NCT00685178|581909381|FG003|Overall Study|Adverse Event|4|||
161143488|NCT00685178|581909378|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
160926380|NCT01649375|581126443|FG003|Up to Week 16|Physician Decision|0|||
160926381|NCT01649375|581126444|FG004|Up to Week 16|Physician Decision|0|||
160926382|NCT01649375|581126440|FG000|Up to Week 16|Withdrawal by Subject|2|||
160926383|NCT01649375|581126441|FG001|Up to Week 16|Withdrawal by Subject|1|||
160926384|NCT01649375|581126442|FG002|Up to Week 16|Withdrawal by Subject|2|||
160926385|NCT01649375|581126443|FG003|Up to Week 16|Withdrawal by Subject|0|||
160926386|NCT01649375|581126444|FG004|Up to Week 16|Withdrawal by Subject|0|||
160926387|NCT01649375|581126440|FG000|Up to Week 16|Death|1|||
160926388|NCT01649375|581126441|FG001|Up to Week 16|Death|0|||
160926389|NCT01649375|581126442|FG002|Up to Week 16|Death|0|||
160926390|NCT01649375|581126443|FG003|Up to Week 16|Death|0|||
160926391|NCT01649375|581126444|FG004|Up to Week 16|Death|0|||
161143489|NCT00685178|581909379|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
161143490|NCT00685178|581909380|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
160926392|NCT01649375|581126440|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
161143491|NCT00685178|581909381|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
161143492|NCT00685178|581909378|FG000|Overall Study|voluntary study discharge|4|||
161143493|NCT00685178|581909379|FG001|Overall Study|voluntary study discharge|5|||
160926393|NCT01649375|581126441|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
160926394|NCT01649375|581126442|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
160926395|NCT01649375|581126443|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
160926396|NCT01649375|581126444|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
161143494|NCT00685178|581909380|FG002|Overall Study|voluntary study discharge|1|||
160926397|NCT01649375|581126440|FG000|Week 16 up to Week 260|Non-compliance|0|||
160926398|NCT01649375|581126441|FG001|Week 16 up to Week 260|Non-compliance|1|||
160926399|NCT01649375|581126442|FG002|Week 16 up to Week 260|Non-compliance|0|||
160926400|NCT01649375|581126443|FG003|Week 16 up to Week 260|Non-compliance|1|||
160926401|NCT01649375|581126444|FG004|Week 16 up to Week 260|Non-compliance|0|||
160926402|NCT01649375|581126440|FG000|Week 16 up to Week 260|Physician Decision|0|||
160926403|NCT01649375|581126441|FG001|Week 16 up to Week 260|Physician Decision|2|||
160926404|NCT01649375|581126442|FG002|Week 16 up to Week 260|Physician Decision|0|||
161143495|NCT00685178|581909381|FG003|Overall Study|voluntary study discharge|1|||
161143496|NCT00685178|581909378|FG000|Overall Study|incarcerated|1|||
161263356|NCT01403064|582345239|FG002|Overall Study|Withdrawal by Subject|1|||
160926405|NCT01649375|581126443|FG003|Week 16 up to Week 260|Physician Decision|0|||
160926406|NCT01649375|581126444|FG004|Week 16 up to Week 260|Physician Decision|0|||
160926407|NCT01649375|581126440|FG000|Week 16 up to Week 260|Technical issues|0|||
160926408|NCT01649375|581126441|FG001|Week 16 up to Week 260|Technical issues|1|||
160926409|NCT01649375|581126442|FG002|Week 16 up to Week 260|Technical issues|0|||
160926410|NCT01649375|581126443|FG003|Week 16 up to Week 260|Technical issues|1|||
160926411|NCT01649375|581126444|FG004|Week 16 up to Week 260|Technical issues|0|||
160926412|NCT01649375|581126440|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
160926413|NCT01649375|581126441|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
160926414|NCT01649375|581126442|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
160926415|NCT01649375|581126443|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
160926416|NCT01649375|581126444|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
160926417|NCT01649375|581126440|FG000|Week 16 up to Week 260|Death|1|||
160926418|NCT01649375|581126441|FG001|Week 16 up to Week 260|Death|1|||
160926419|NCT01649375|581126442|FG002|Week 16 up to Week 260|Death|0|||
160926420|NCT01649375|581126443|FG003|Week 16 up to Week 260|Death|0|||
160926421|NCT01649375|581126444|FG004|Week 16 up to Week 260|Death|0|||
160926422|NCT01649375|581126440|FG000|Week 16 up to Week 260|Adverse Event|5|||
160926423|NCT01649375|581126441|FG001|Week 16 up to Week 260|Adverse Event|2|||
160926424|NCT01649375|581126442|FG002|Week 16 up to Week 260|Adverse Event|0|||
160926425|NCT01649375|581126443|FG003|Week 16 up to Week 260|Adverse Event|3|||
160926426|NCT01649375|581126444|FG004|Week 16 up to Week 260|Adverse Event|2|||
160926427|NCT01856790|581126445|FG000|Closed Loop Control|Withdrawal by Subject|2|||
160926428|NCT01856790|581126445|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
160926429|NCT04091646|581126448|FG000|Overall Study|Adverse Event|2|||
160926430|NCT04091646|581126449|FG001|Overall Study|Adverse Event|1|||
160926431|NCT04091646|581126448|FG000|Overall Study|Lost to Follow-up|6|||
160926432|NCT04091646|581126449|FG001|Overall Study|Lost to Follow-up|2|||
160926433|NCT04091646|581126448|FG000|Overall Study|Protocol Violation|0|||
160926434|NCT04091646|581126449|FG001|Overall Study|Protocol Violation|1|||
160926435|NCT04091646|581126448|FG000|Overall Study|Withdrawal by Subject|4|||
160926436|NCT04091646|581126449|FG001|Overall Study|Withdrawal by Subject|1|||
160926437|NCT04091646|581126448|FG000|Overall Study|Participant Incarcerated|1|||
160926438|NCT04091646|581126449|FG001|Overall Study|Participant Incarcerated|0|||
160926439|NCT01921829|581126450|FG000|Overall Study|Withdrawal by Subject|0|||
160926440|NCT01921829|581126451|FG001|Overall Study|Withdrawal by Subject|1|||
160926441|NCT01316276|581126454|FG000|Overall Study|Death|1|||
160926442|NCT01316276|581126454|FG000|Overall Study|Adverse Event|19|||
160926443|NCT01316276|581126454|FG000|Overall Study|Withdrawal of consent|24|||
160926444|NCT01316276|581126454|FG000|Overall Study|Lost to Follow-up|1|||
160926445|NCT01316276|581126454|FG000|Overall Study|Other|22|||
160926446|NCT02255981|581126459|FG000|Overall Study|Lost to Follow-up|3|||
160926447|NCT02255981|581126459|FG000|Overall Study|Withdrawal by Subject|1|||
160926448|NCT01454570|581126470|FG000|Overall Study|Withdrawal by Subject|2|||
160926449|NCT01454570|581126470|FG000|Overall Study|Screen Failure|7|||
160926450|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
160926451|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
160926452|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
160926453|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
160926454|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
160926455|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
160926456|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
160926457|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
160926458|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
160926459|NCT00885755|581126471|FG000|Part I: Trastuzumab+Taxane|Death|0|||
160926460|NCT00885755|581126472|FG001|Part I: Trastuzumab+Taxane|Death|0|||
160926461|NCT00885755|581126473|FG002|Part I: Trastuzumab+Taxane|Death|1|||
160926462|NCT00885755|581126471|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
160926463|NCT00885755|581126472|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
160926464|NCT00885755|581126473|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
160926465|NCT00325754|581126474|FG000|Overall Study|Adverse Event|4|||
160926466|NCT00325754|581126475|FG001|Overall Study|Adverse Event|1|||
160926467|NCT01852812|581126479|FG000|Overall Study|Adverse Event|0|||
160926468|NCT01852812|581126480|FG001|Overall Study|Adverse Event|0|||
160926469|NCT01852812|581126481|FG002|Overall Study|Adverse Event|1|||
160926470|NCT01852812|581126479|FG000|Overall Study|Non-compliance With Study Drug|0|||
160926471|NCT01852812|581126480|FG001|Overall Study|Non-compliance With Study Drug|1|||
160926472|NCT01852812|581126481|FG002|Overall Study|Non-compliance With Study Drug|0|||
160926473|NCT02625090|581126486|FG000|Overall Study|Participant wants to be pregnant|2|||
160926474|NCT02625090|581126486|FG000|Overall Study|For the Promoter|1|||
160926475|NCT02625090|581126486|FG000|Overall Study|Sponsor's Decision|9|||
160926476|NCT02625090|581126486|FG000|Overall Study|Somnolence|1|||
160926477|NCT02625090|581126486|FG000|Overall Study|Study terminated by Sponsor|7|||
160926478|NCT02625090|581126486|FG000|Overall Study|Negative Benefit/Risk|1|||
160926479|NCT02625090|581126486|FG000|Overall Study|Protocol Deviation|2|||
160926480|NCT02625090|581126486|FG000|Overall Study|Lack of Efficacy|16|||
161341847|NCT00614393|582639039|FG000|Overall Study|Not Treated|0|||
161341848|NCT00614393|582639040|FG001|Overall Study|Not Treated|0|||
160926481|NCT02625090|581126486|FG000|Overall Study|Adverse Event|3|||
160926482|NCT03168464|581126487|FG000|Overall Study|Death|9|||
160926483|NCT03168464|581126487|FG000|Overall Study|Progression of disease|6|||
160926484|NCT02250443|581126488|FG000|Overall Study|Administrative problems|7|||
160926485|NCT02250443|581126488|FG000|Overall Study|Adverse Event|3|||
160926486|NCT01549964|581126489|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
160926487|NCT01549964|581126490|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
160926488|NCT01549964|581126491|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
160926489|NCT01549964|581126492|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
160926490|NCT01549964|581126489|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
160926491|NCT01549964|581126490|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
160926492|NCT01549964|581126491|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
160926493|NCT01549964|581126492|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
160926494|NCT01549964|581126489|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
160926495|NCT01549964|581126490|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
160926496|NCT01549964|581126491|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
160926497|NCT01549964|581126492|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
160926498|NCT01549964|581126489|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
160926499|NCT01549964|581126490|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
160926500|NCT01549964|581126491|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
160926501|NCT01549964|581126492|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
160926502|NCT01549964|581126489|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
160926503|NCT01549964|581126490|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
160926504|NCT01549964|581126491|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
160926505|NCT01549964|581126492|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
160926506|NCT01549964|581126489|FG000|24-Week Treatment Period|Other|1|||
160926507|NCT01549964|581126490|FG001|24-Week Treatment Period|Other|0|||
160926508|NCT01549964|581126491|FG002|24-Week Treatment Period|Other|1|||
160926509|NCT01549964|581126492|FG003|24-Week Treatment Period|Other|0|||
160926510|NCT01549964|581126489|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
160926511|NCT01549964|581126490|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
160926512|NCT01549964|581126491|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
160926513|NCT01549964|581126492|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
160926514|NCT01549964|581126489|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
160926515|NCT01549964|581126490|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
160926516|NCT01549964|581126491|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
160926517|NCT01549964|581126492|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
160926518|NCT01549964|581126489|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
160926519|NCT01549964|581126490|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
160926520|NCT01549964|581126491|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
160926521|NCT01549964|581126492|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
160926522|NCT01549964|581126489|FG000|80-Week Extension Period|Pregnancy|0|||
160926523|NCT01549964|581126490|FG001|80-Week Extension Period|Pregnancy|0|||
160926524|NCT01549964|581126491|FG002|80-Week Extension Period|Pregnancy|1|||
160926525|NCT01549964|581126492|FG003|80-Week Extension Period|Pregnancy|0|||
160926526|NCT01549964|581126489|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
160926527|NCT01549964|581126490|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
160926528|NCT01549964|581126491|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
160926529|NCT01549964|581126492|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
160926530|NCT01549964|581126489|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
160926531|NCT01549964|581126490|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
160926532|NCT01549964|581126491|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
160926533|NCT01549964|581126492|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
160926534|NCT01549964|581126489|FG000|80-Week Extension Period|Lost to Follow-up|1|||
160926535|NCT01549964|581126490|FG001|80-Week Extension Period|Lost to Follow-up|0|||
160926536|NCT01549964|581126491|FG002|80-Week Extension Period|Lost to Follow-up|2|||
160926537|NCT01549964|581126492|FG003|80-Week Extension Period|Lost to Follow-up|1|||
160926538|NCT01549964|581126489|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
160926539|NCT01549964|581126490|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
161341849|NCT00614393|582639041|FG002|Overall Study|Not Treated|0|||
160926540|NCT01549964|581126491|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
161341850|NCT00614393|582639042|FG003|Overall Study|Not Treated|0|||
161341851|NCT00614393|582639043|FG004|Overall Study|Not Treated|2|||
161341852|NCT02328105|582639044|FG000|Overall Study|Death|6|||
160926541|NCT01549964|581126492|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
160926542|NCT00634088|581126495|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
160926543|NCT00634088|581126496|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
161341853|NCT02328105|582639044|FG000|Overall Study|Withdrawal by Subject|1|||
161341854|NCT02328105|582639044|FG000|Overall Study|Still On Study in Follow-Up|4|||
160926544|NCT00634088|581126497|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
160926545|NCT00634088|581126498|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
160926546|NCT00634088|581126495|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
160926547|NCT00634088|581126496|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
160926548|NCT00634088|581126497|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
160926549|NCT00634088|581126498|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
160926550|NCT00634088|581126495|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
160926551|NCT00634088|581126496|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
160926552|NCT00634088|581126497|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
160926553|NCT00634088|581126498|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
160926554|NCT00634088|581126495|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
160926555|NCT00634088|581126496|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
160926556|NCT00634088|581126497|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
160926557|NCT00634088|581126498|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
160926558|NCT00634088|581126495|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
160926559|NCT00634088|581126496|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
160926560|NCT00634088|581126497|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
160926561|NCT00634088|581126498|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
160926562|NCT00634088|581126495|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
160926563|NCT00634088|581126496|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
160926564|NCT00634088|581126497|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
160926565|NCT00634088|581126498|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
160926566|NCT02290821|581126499|FG000|Overall Study|Withdrawal by Subject|1|||
160926567|NCT02290821|581126500|FG001|Overall Study|Withdrawal by Subject|1|||
160926568|NCT02290821|581126499|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
160926569|NCT02290821|581126500|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
160926570|NCT02290821|581126499|FG000|Overall Study|Lost to Follow-up|3|||
160926571|NCT02290821|581126500|FG001|Overall Study|Lost to Follow-up|2|||
160926572|NCT02438722|581126505|FG000|Overall Study|Adverse Event|12|||
160926573|NCT02438722|581126506|FG001|Overall Study|Adverse Event|9|||
160926574|NCT02438722|581126505|FG000|Overall Study|Refusal unrelated to AE|2|||
160926575|NCT02438722|581126506|FG001|Overall Study|Refusal unrelated to AE|5|||
160926576|NCT02438722|581126505|FG000|Overall Study|Disease progression/relapse|46|||
160926577|NCT02438722|581126506|FG001|Overall Study|Disease progression/relapse|51|||
160926578|NCT02438722|581126505|FG000|Overall Study|Death|0|||
160926579|NCT02438722|581126506|FG001|Overall Study|Death|3|||
160926580|NCT02438722|581126505|FG000|Overall Study|Physician Decision|2|||
160926581|NCT02438722|581126506|FG001|Overall Study|Physician Decision|2|||
160926582|NCT02438722|581126505|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
160926583|NCT02438722|581126506|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
160926584|NCT02438722|581126505|FG000|Overall Study|Withdrawal by Subject|0|||
160926585|NCT02438722|581126506|FG001|Overall Study|Withdrawal by Subject|1|||
160926586|NCT02438722|581126505|FG000|Overall Study|On protocol treatment|15|||
160926587|NCT02438722|581126506|FG001|Overall Study|On protocol treatment|14|||
160926588|NCT02438722|581126505|FG000|Overall Study|Did not receive protocol treatment|5|||
160926589|NCT02438722|581126506|FG001|Overall Study|Did not receive protocol treatment|0|||
160926590|NCT03343483|581126507|FG000|Overall Study|Death|0|||
160926591|NCT03343483|581126508|FG001|Overall Study|Death|3|||
160926592|NCT03343483|581126507|FG000|Overall Study|Lost to Follow-up|9|||
160926593|NCT03343483|581126508|FG001|Overall Study|Lost to Follow-up|13|||
160926594|NCT03343483|581126507|FG000|Overall Study|Withdrawal by Subject|8|||
160926595|NCT03343483|581126508|FG001|Overall Study|Withdrawal by Subject|17|||
160926596|NCT01488097|581126511|FG000|Overall Study|Lost to Follow-up|1|||
160926597|NCT01577758|581126512|FG000|Dose Escalation Phase|Adverse Event|0|||
160926598|NCT01577758|581126513|FG001|Dose Escalation Phase|Adverse Event|0|||
160926599|NCT01577758|581126514|FG002|Dose Escalation Phase|Adverse Event|0|||
160926600|NCT01577758|581126515|FG003|Dose Escalation Phase|Adverse Event|0|||
160926601|NCT01577758|581126516|FG004|Dose Escalation Phase|Adverse Event|0|||
160926602|NCT01577758|581126517|FG005|Dose Escalation Phase|Adverse Event|2|||
160926603|NCT01577758|581126518|FG006|Dose Escalation Phase|Adverse Event|1|||
160926604|NCT01577758|581126519|FG007|Dose Escalation Phase|Adverse Event|0|||
160926605|NCT01577758|581126512|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926606|NCT01577758|581126513|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926607|NCT01577758|581126514|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
161341855|NCT03286504|582639051|FG000|Overall Study|Lost to Follow-up|19|||
161341856|NCT03286504|582639052|FG001|Overall Study|Lost to Follow-up|16|||
160926608|NCT01577758|581126515|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926609|NCT01577758|581126516|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
160926610|NCT01577758|581126517|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
160926611|NCT01577758|581126518|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926612|NCT01577758|581126519|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
160926613|NCT01577758|581126512|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161143497|NCT00685178|581909379|FG001|Overall Study|incarcerated|3|||
161341857|NCT00141921|582639055|FG000|Overall Study|Remain on Study|28|||
160926614|NCT01577758|581126513|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
160926615|NCT01577758|581126514|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
160926616|NCT01577758|581126515|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
160926617|NCT01577758|581126516|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
160926618|NCT01577758|581126517|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
160926619|NCT01577758|581126518|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
160926620|NCT01577758|581126519|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
160926621|NCT01577758|581126512|FG000|Dose Escalation Phase|Progression Disease|2|||
160926622|NCT01577758|581126513|FG001|Dose Escalation Phase|Progression Disease|2|||
160926623|NCT01577758|581126514|FG002|Dose Escalation Phase|Progression Disease|1|||
160926624|NCT01577758|581126515|FG003|Dose Escalation Phase|Progression Disease|2|||
160926625|NCT01577758|581126516|FG004|Dose Escalation Phase|Progression Disease|5|||
160926626|NCT01577758|581126517|FG005|Dose Escalation Phase|Progression Disease|0|||
160926627|NCT01577758|581126518|FG006|Dose Escalation Phase|Progression Disease|0|||
160926628|NCT01577758|581126519|FG007|Dose Escalation Phase|Progression Disease|0|||
160926629|NCT01577758|581126512|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926630|NCT01577758|581126513|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926631|NCT01577758|581126514|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926632|NCT01577758|581126515|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926633|NCT01577758|581126516|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926634|NCT01577758|581126517|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926635|NCT01577758|581126518|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
160926636|NCT01577758|581126519|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
160926637|NCT01577758|581126512|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926638|NCT01577758|581126513|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926639|NCT01577758|581126514|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926640|NCT01577758|581126515|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926641|NCT01577758|581126516|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926642|NCT01577758|581126517|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926643|NCT01577758|581126518|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
160926644|NCT01577758|581126519|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
160926645|NCT01577758|581126512|FG000|mCRC Expansion Phase|Progression Disease|0|||
160926646|NCT01577758|581126513|FG001|mCRC Expansion Phase|Progression Disease|0|||
160926647|NCT01577758|581126514|FG002|mCRC Expansion Phase|Progression Disease|0|||
160926648|NCT01577758|581126515|FG003|mCRC Expansion Phase|Progression Disease|0|||
160926649|NCT01577758|581126516|FG004|mCRC Expansion Phase|Progression Disease|0|||
160926650|NCT01577758|581126517|FG005|mCRC Expansion Phase|Progression Disease|0|||
160926651|NCT01577758|581126518|FG006|mCRC Expansion Phase|Progression Disease|0|||
160926652|NCT01577758|581126519|FG007|mCRC Expansion Phase|Progression Disease|19|||
160926653|NCT04969224|581126524|FG000|Overall Study|Adverse Event|1|||
160926654|NCT04969224|581126524|FG000|Overall Study|Enrolled but never dosed|1|||
160926655|NCT03165110|581126528|FG000|Overall Study|Anroid phone software incompatibility|1|||
160926656|NCT05533632|581126529|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
160926657|NCT05533632|581126529|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
160926658|NCT05533632|581126529|FG000|Overall Study|Lost to Follow-up|1|||
160926659|NCT05533632|581126529|FG000|Overall Study|Withdrawal by Subject|4|||
160926660|NCT05533632|581126529|FG000|Overall Study|Adverse Event|4|||
160926661|NCT02726074|581126530|FG000|Overall Study|Withdrawal by Subject|4|||
160926662|NCT02726074|581126530|FG000|Overall Study|Adverse Event|14|||
160926663|NCT02726074|581126530|FG000|Overall Study|Protocol Violation|3|||
160926664|NCT02726074|581126530|FG000|Overall Study|Lost to Follow-up|2|||
160926665|NCT02726074|581126530|FG000|Overall Study|Others|3|||
160926666|NCT00579826|581126531|FG000|Overall Study|Withdrawal by Subject|5|||
160926667|NCT00579826|581126532|FG001|Overall Study|Withdrawal by Subject|3|||
160926668|NCT04191382|581126533|FG000|Overall Study|Withdrawal by Subject|1|||
160926669|NCT04191382|581126534|FG001|Overall Study|Withdrawal by Subject|0|||
160926670|NCT04191382|581126535|FG002|Overall Study|Withdrawal by Subject|0|||
160926671|NCT00454987|581126538|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
160926672|NCT00454987|581126539|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
160926673|NCT00454987|581126540|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
160926674|NCT00454987|581126538|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
160926675|NCT00454987|581126539|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
160926676|NCT00454987|581126540|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
160926677|NCT00454987|581126538|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
160926678|NCT00454987|581126539|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
160926679|NCT00454987|581126540|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
160926680|NCT03054870|581126542|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
160998029|NCT00241644|581378525|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
160998030|NCT00241644|581378526|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
160998031|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
160998032|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
161143498|NCT00685178|581909380|FG002|Overall Study|incarcerated|7|||
161263357|NCT01403064|582345240|FG003|Overall Study|Withdrawal by Subject|1|||
160926681|NCT03054870|581126542|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
160926682|NCT02009046|581126543|FG000|Overall Study|Lost to Follow-up|256|||
160926683|NCT02009046|581126544|FG001|Overall Study|Lost to Follow-up|206|||
160926684|NCT00973479|581126548|FG000|Overall Study|Lost to Follow-up|0|||
160926685|NCT00973479|581126549|FG001|Overall Study|Lost to Follow-up|3|||
160926686|NCT00973479|581126548|FG000|Overall Study|Death|2|||
160926687|NCT00973479|581126549|FG001|Overall Study|Death|2|||
160926688|NCT00973479|581126548|FG000|Overall Study|Withdrawal by Subject|15|||
160926689|NCT00973479|581126549|FG001|Overall Study|Withdrawal by Subject|16|||
161263358|NCT01403064|582345237|FG000|Overall Study|Other|1|||
161263359|NCT01403064|582345238|FG001|Overall Study|Other|0|||
160926690|NCT00973479|581126548|FG000|Overall Study|Lack of Efficacy|5|||
161263360|NCT01403064|582345239|FG002|Overall Study|Other|2|||
161263361|NCT01403064|582345240|FG003|Overall Study|Other|1|||
161263362|NCT00973765|582345241|FG000|Overall Study|Lost to Follow-up|8|||
161263363|NCT00973765|582345242|FG001|Overall Study|Lost to Follow-up|14|||
161263364|NCT02669940|582345243|FG000|Overall Study|Failure to return|0|||
161263365|NCT02669940|582345244|FG001|Overall Study|Failure to return|3|||
161263366|NCT02669940|582345243|FG000|Overall Study|Insufficient follow-up data|1|||
161263367|NCT02669940|582345244|FG001|Overall Study|Insufficient follow-up data|0|||
161263368|NCT01892657|582345245|FG000|Overall Study|Withdrawal by Subject|6|||
161263369|NCT01892657|582345245|FG000|Overall Study|Protocol Violation|12|||
161263370|NCT00986180|582345246|FG000|Overall Study|Adverse Event|21|||
161263371|NCT00986180|582345247|FG001|Overall Study|Adverse Event|23|||
161263372|NCT00986180|582345246|FG000|Overall Study|Lack of Efficacy|4|||
161263373|NCT00986180|582345247|FG001|Overall Study|Lack of Efficacy|3|||
161263374|NCT00986180|582345246|FG000|Overall Study|Lost to Follow-up|5|||
161263375|NCT00986180|582345247|FG001|Overall Study|Lost to Follow-up|7|||
161263376|NCT00986180|582345246|FG000|Overall Study|Physician Decision|1|||
161263377|NCT00986180|582345247|FG001|Overall Study|Physician Decision|3|||
161263378|NCT00986180|582345246|FG000|Overall Study|Protocol Violation|2|||
161263379|NCT00986180|582345247|FG001|Overall Study|Protocol Violation|0|||
161263380|NCT00986180|582345246|FG000|Overall Study|Withdrawal by Subject|1|||
161263381|NCT00986180|582345247|FG001|Overall Study|Withdrawal by Subject|9|||
161263382|NCT00986180|582345246|FG000|Overall Study|Miscellanies|10|||
161263383|NCT00986180|582345247|FG001|Overall Study|Miscellanies|11|||
161263384|NCT01070771|582345250|FG000|Overall Study|Adverse Event|2|||
161263385|NCT01070771|582345250|FG000|Overall Study|Protocol Violation|1|||
161263386|NCT03835325|582345251|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
161263387|NCT03835325|582345251|FG000|Overall Study|Selection failure|1|||
161263388|NCT01370213|582345254|FG000|Overall Study|Early Death|1|||
161263389|NCT01370213|582345255|FG001|Overall Study|Early Death|0|||
161263390|NCT01370213|582345256|FG002|Overall Study|Early Death|0|||
161263391|NCT01370213|582345254|FG000|Overall Study|Not evaluable|0|||
161263392|NCT01370213|582345255|FG001|Overall Study|Not evaluable|2|||
161263393|NCT01370213|582345256|FG002|Overall Study|Not evaluable|0|||
161263394|NCT00567476|582345262|FG000|Overall Study|Adverse Event|2|||
161263395|NCT00567476|582345263|FG001|Overall Study|Adverse Event|0|||
161263396|NCT00567476|582345262|FG000|Overall Study|Pregnancy|1|||
161263397|NCT00567476|582345263|FG001|Overall Study|Pregnancy|0|||
161263398|NCT00567476|582345262|FG000|Overall Study|Protocol Violation|4|||
161263399|NCT00567476|582345263|FG001|Overall Study|Protocol Violation|1|||
161263400|NCT00567476|582345262|FG000|Overall Study|Lost to Follow-up|0|||
161263401|NCT00567476|582345263|FG001|Overall Study|Lost to Follow-up|1|||
161263402|NCT00567476|582345262|FG000|Overall Study|Administrative issues|1|||
161263403|NCT00567476|582345263|FG001|Overall Study|Administrative issues|0|||
161263404|NCT00567476|582345262|FG000|Overall Study|Medical Decision|0|||
161263405|NCT00567476|582345263|FG001|Overall Study|Medical Decision|1|||
161263406|NCT00567476|582345262|FG000|Overall Study|Non-adherence to protocol|0|||
161263407|NCT00567476|582345263|FG001|Overall Study|Non-adherence to protocol|1|||
161263408|NCT00995085|582345264|FG000|Overall Study|Withdrawal by Subject|5|||
161263409|NCT02595008|582345265|FG000|Overall Study|Enrolled In Error|1|||
161263410|NCT02595008|582345266|FG001|Overall Study|Enrolled In Error|0|||
161263411|NCT02999477|582345267|FG000|Overall Study|found ineligible after first dose|0|||
161263412|NCT02999477|582345268|FG001|Overall Study|found ineligible after first dose|1|||
161263413|NCT02999477|582345267|FG000|Overall Study|Withdrawal by Subject|1|||
161263414|NCT02999477|582345268|FG001|Overall Study|Withdrawal by Subject|1|||
161263415|NCT01846273|582345271|FG000|Overall Study|Adverse Event|9|||
161263416|NCT01846273|582345272|FG001|Overall Study|Adverse Event|7|||
161263417|NCT01846273|582345273|FG002|Overall Study|Adverse Event|0|||
161263418|NCT01846273|582345271|FG000|Overall Study|Subject withdrew consent|5|||
161263419|NCT01846273|582345272|FG001|Overall Study|Subject withdrew consent|8|||
161263420|NCT01846273|582345273|FG002|Overall Study|Subject withdrew consent|0|||
161263421|NCT01846273|582345271|FG000|Overall Study|Lost to Follow-up|2|||
161263422|NCT01846273|582345272|FG001|Overall Study|Lost to Follow-up|1|||
161263423|NCT01846273|582345273|FG002|Overall Study|Lost to Follow-up|0|||
161263424|NCT01846273|582345271|FG000|Overall Study|Administrative problems|1|||
161263425|NCT01846273|582345272|FG001|Overall Study|Administrative problems|0|||
161263426|NCT01846273|582345273|FG002|Overall Study|Administrative problems|0|||
161263427|NCT01846273|582345271|FG000|Overall Study|Death|2|||
161341858|NCT00141921|582639055|FG000|Overall Study|Withdrawal by Subject|42|||
161341859|NCT00141921|582639055|FG000|Overall Study|Lost to Follow-up|19|||
161341860|NCT00141921|582639055|FG000|Overall Study|Noncompliance|17|||
161263428|NCT01846273|582345272|FG001|Overall Study|Death|1|||
161341861|NCT00141921|582639055|FG000|Overall Study|Disease Progression|7|||
161341862|NCT00141921|582639055|FG000|Overall Study|Protocol Deviation|7|||
161341863|NCT00141921|582639055|FG000|Overall Study|Adverse Event|5|||
161341864|NCT00141921|582639055|FG000|Overall Study|Administrative Decision|2|||
161341865|NCT00141921|582639055|FG000|Overall Study|Pregnancy|4|||
161341866|NCT00141921|582639055|FG000|Overall Study|Ineligibility Determined|2|||
161341867|NCT00141921|582639055|FG000|Overall Study|Other|8|||
161341868|NCT03320369|582639056|FG000|Overall Study|Adverse Event|1|||
161341869|NCT03320369|582639056|FG000|Overall Study|Withdrawal by Subject|2|||
161341870|NCT03813654|582639057|FG000|Overall Study|Protocol Violation|0|||
161341871|NCT03813654|582639058|FG001|Overall Study|Protocol Violation|1|||
161341872|NCT03813654|582639059|FG002|Overall Study|Protocol Violation|2|||
161341873|NCT03813654|582639057|FG000|Overall Study|Withdrawal by Subject|1|||
161341874|NCT03813654|582639058|FG001|Overall Study|Withdrawal by Subject|0|||
161341875|NCT03813654|582639059|FG002|Overall Study|Withdrawal by Subject|0|||
161341876|NCT04727749|582639080|FG000|Overall Study|Lost to Follow-up|10|||
161341877|NCT04727749|582639081|FG001|Overall Study|Lost to Follow-up|3|||
161341878|NCT00297167|582639083|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
161341879|NCT00297167|582639084|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
161341880|NCT00297167|582639085|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
161341881|NCT00297167|582639083|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
161341882|NCT00297167|582639084|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
161341883|NCT00297167|582639085|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
161341884|NCT04167462|582639086|FG000|Overall Study|Other reasons|3|||
161341885|NCT04167462|582639087|FG001|Overall Study|Other reasons|2|||
161341886|NCT04167462|582639086|FG000|Overall Study|Withdrawal by Subject|6|||
161341887|NCT04167462|582639087|FG001|Overall Study|Withdrawal by Subject|7|||
161341888|NCT04167462|582639086|FG000|Overall Study|Adverse Event|4|||
161341889|NCT04167462|582639087|FG001|Overall Study|Adverse Event|0|||
160998033|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
161263429|NCT01846273|582345273|FG002|Overall Study|Death|0|||
161263430|NCT01846273|582345271|FG000|Overall Study|Disease Progression|0|||
161263431|NCT01846273|582345272|FG001|Overall Study|Disease Progression|4|||
161263432|NCT01846273|582345273|FG002|Overall Study|Disease Progression|0|||
161263433|NCT01846273|582345271|FG000|Overall Study|Protocol Deviation|2|||
161263434|NCT01846273|582345272|FG001|Overall Study|Protocol Deviation|3|||
161263435|NCT01846273|582345273|FG002|Overall Study|Protocol Deviation|0|||
161263436|NCT01846273|582345271|FG000|Overall Study|Physician Decision|1|||
161263437|NCT01846273|582345272|FG001|Overall Study|Physician Decision|2|||
161263438|NCT01846273|582345273|FG002|Overall Study|Physician Decision|0|||
161263439|NCT00891839|582345274|FG000|Overall Study|Adverse Event|2|||
161263440|NCT00891839|582345274|FG000|Overall Study|Withdrawal by Subject|2|||
161263441|NCT00891839|582345274|FG000|Overall Study|Disease progression|3|||
161263442|NCT00851643|582345275|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
161263443|NCT00851643|582345276|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161263444|NCT00851643|582345277|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161263445|NCT00851643|582345278|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161263446|NCT00851643|582345279|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161263447|NCT00851643|582345280|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
161263448|NCT00851643|582345275|FG000|Base Study (Up to 12 Months)|Other|0|||
161263449|NCT00851643|582345276|FG001|Base Study (Up to 12 Months)|Other|0|||
161263450|NCT00851643|582345277|FG002|Base Study (Up to 12 Months)|Other|0|||
161263451|NCT00851643|582345278|FG003|Base Study (Up to 12 Months)|Other|0|||
161263452|NCT00851643|582345279|FG004|Base Study (Up to 12 Months)|Other|0|||
161263453|NCT00851643|582345280|FG005|Base Study (Up to 12 Months)|Other|1|||
161263454|NCT00851643|582345275|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
161263455|NCT00851643|582345276|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
161263456|NCT00851643|582345277|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
161263457|NCT00851643|582345278|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
161263458|NCT00851643|582345279|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
161263459|NCT00851643|582345280|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
161263460|NCT00851643|582345275|FG000|Extension Study (Up to 36 Months)|Moved|0|||
161263461|NCT00851643|582345276|FG001|Extension Study (Up to 36 Months)|Moved|2|||
161263462|NCT00851643|582345277|FG002|Extension Study (Up to 36 Months)|Moved|1|||
161263463|NCT00851643|582345278|FG003|Extension Study (Up to 36 Months)|Moved|1|||
161263464|NCT00851643|582345279|FG004|Extension Study (Up to 36 Months)|Moved|0|||
161341890|NCT04167462|582639086|FG000|Overall Study|Pregnancy|1|||
161341891|NCT04167462|582639087|FG001|Overall Study|Pregnancy|0|||
161341892|NCT04167462|582639086|FG000|Overall Study|Lack of Efficacy|0|||
161341893|NCT04167462|582639087|FG001|Overall Study|Lack of Efficacy|1|||
161143499|NCT00685178|581909381|FG003|Overall Study|incarcerated|0|||
161143500|NCT00685178|581909378|FG000|Overall Study|administrative (disciplinary) discharge|0|||
161143501|NCT00685178|581909379|FG001|Overall Study|administrative (disciplinary) discharge|1|||
161263465|NCT00851643|582345280|FG005|Extension Study (Up to 36 Months)|Moved|1|||
161263466|NCT00359788|582345281|FG000|Overall Study|Adverse Event|11|||
161263467|NCT00359788|582345282|FG001|Overall Study|Adverse Event|10|||
161263468|NCT00359788|582345281|FG000|Overall Study|Lack of Efficacy|1|||
161263469|NCT00359788|582345282|FG001|Overall Study|Lack of Efficacy|2|||
161263470|NCT00359788|582345281|FG000|Overall Study|Lost to Follow-up|3|||
161263471|NCT00359788|582345282|FG001|Overall Study|Lost to Follow-up|2|||
161263472|NCT00359788|582345281|FG000|Overall Study|Withdrawal by Subject|4|||
161263473|NCT00359788|582345282|FG001|Overall Study|Withdrawal by Subject|1|||
161263474|NCT00359788|582345281|FG000|Overall Study|Protocol Violation|4|||
161263475|NCT00359788|582345282|FG001|Overall Study|Protocol Violation|2|||
161263476|NCT01641133|582345283|FG000|Overall Study|Protocol Violation|0|||
161263477|NCT01641133|582345284|FG001|Overall Study|Protocol Violation|1|||
161263478|NCT01641133|582345285|FG002|Overall Study|Protocol Violation|1|||
161263479|NCT01641133|582345283|FG000|Overall Study|Migrated/moved from study area|5|||
161263480|NCT01641133|582345284|FG001|Overall Study|Migrated/moved from study area|3|||
161263481|NCT01641133|582345285|FG002|Overall Study|Migrated/moved from study area|1|||
161263482|NCT01641133|582345283|FG000|Overall Study|Adverse Event|0|||
161263483|NCT01641133|582345284|FG001|Overall Study|Adverse Event|0|||
161263484|NCT01641133|582345285|FG002|Overall Study|Adverse Event|1|||
161263485|NCT01641133|582345283|FG000|Overall Study|Withdrawal by Subject|5|||
161263486|NCT01641133|582345284|FG001|Overall Study|Withdrawal by Subject|3|||
161263487|NCT01641133|582345285|FG002|Overall Study|Withdrawal by Subject|3|||
161263488|NCT01641133|582345283|FG000|Overall Study|Lost to Follow-up|0|||
161263489|NCT01641133|582345284|FG001|Overall Study|Lost to Follow-up|2|||
161263490|NCT01641133|582345285|FG002|Overall Study|Lost to Follow-up|2|||
161263491|NCT02220725|582345286|FG000|Overall Study|Lost to Follow-up|0|||
161263492|NCT02220725|582345287|FG001|Overall Study|Lost to Follow-up|0|||
161263493|NCT02220725|582345288|FG002|Overall Study|Lost to Follow-up|0|||
161263494|NCT02220725|582345289|FG003|Overall Study|Lost to Follow-up|1|||
161263495|NCT02220725|582345286|FG000|Overall Study|Withdrawal by Subject|0|||
161263496|NCT02220725|582345287|FG001|Overall Study|Withdrawal by Subject|0|||
161263497|NCT02220725|582345288|FG002|Overall Study|Withdrawal by Subject|0|||
161263498|NCT02220725|582345289|FG003|Overall Study|Withdrawal by Subject|1|||
161263499|NCT03351231|582345292|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
161263500|NCT03351231|582345292|FG000|Combination Therapy Period|Disease progression|2|||
161263501|NCT03351231|582345292|FG000|Combination Therapy Period|Study drug toxicity|1|||
161263502|NCT03351231|582345292|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
161263503|NCT03351231|582345292|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
161263504|NCT03351231|582345292|FG000|Safety Follow-Up Period|Other reason|2|||
161263505|NCT00103402|582345293|FG000|Overall Study|Adverse Event|3|||
161263506|NCT00103402|582345294|FG001|Overall Study|Adverse Event|4|||
161263507|NCT00103402|582345293|FG000|Overall Study|Lost to Follow-up|8|||
161263508|NCT00103402|582345294|FG001|Overall Study|Lost to Follow-up|7|||
161263509|NCT00103402|582345293|FG000|Overall Study|Dissatisfied/No longer interested|6|||
161263510|NCT00103402|582345294|FG001|Overall Study|Dissatisfied/No longer interested|6|||
161263511|NCT00103402|582345293|FG000|Overall Study|Personal constraints/Other|5|||
161263512|NCT00103402|582345294|FG001|Overall Study|Personal constraints/Other|0|||
161263513|NCT01673698|582345295|FG000|Overall Study|Lost to Follow-up|51|||
161263514|NCT01673698|582345296|FG001|Overall Study|Lost to Follow-up|13|||
161263515|NCT01297322|582345297|FG000|Overall Study|Lost to Follow-up|1|||
161263516|NCT01297322|582345298|FG001|Overall Study|Lost to Follow-up|0|||
161263517|NCT01297322|582345297|FG000|Overall Study|Withdrawal by Subject|0|||
161263518|NCT01297322|582345298|FG001|Overall Study|Withdrawal by Subject|1|||
161263519|NCT01297322|582345297|FG000|Overall Study|Protocol Violation|0|||
161263520|NCT01297322|582345298|FG001|Overall Study|Protocol Violation|3|||
161263521|NCT01111019|582345299|FG000|Overall Study|Withdrew Prematurely|2|||
161143502|NCT00685178|581909380|FG002|Overall Study|administrative (disciplinary) discharge|0|||
161263522|NCT01111019|582345299|FG000|Overall Study|Other|1|||
161263523|NCT01583218|582345300|FG000|Overall Study|Withdrawal by Subject|43|||
161263524|NCT01583218|582345301|FG001|Overall Study|Withdrawal by Subject|29|||
161263525|NCT01583218|582345300|FG000|Overall Study|Death|206|||
161263526|NCT01583218|582345301|FG001|Overall Study|Death|211|||
161263527|NCT01583218|582345300|FG000|Overall Study|Lost to Follow-up|11|||
161263528|NCT01583218|582345301|FG001|Overall Study|Lost to Follow-up|17|||
161263529|NCT01583218|582345300|FG000|Overall Study|Adverse event or serious adverse event|3|||
161263530|NCT01583218|582345301|FG001|Overall Study|Adverse event or serious adverse event|3|||
161263531|NCT01583218|582345300|FG000|Overall Study|Patient /Family decision|3|||
161263532|NCT01583218|582345301|FG001|Overall Study|Patient /Family decision|0|||
161263533|NCT01583218|582345300|FG000|Overall Study|Cannot contact patient directly|1|||
161263534|NCT01583218|582345301|FG001|Overall Study|Cannot contact patient directly|2|||
161263535|NCT01583218|582345300|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
161263536|NCT01583218|582345301|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
161341894|NCT02320396|582639088|FG000|Overall Study|Adverse Event|2|||
161341895|NCT02320396|582639089|FG001|Overall Study|Adverse Event|2|||
161341896|NCT02320396|582639088|FG000|Overall Study|Pregnancy|0|||
161341897|NCT02320396|582639089|FG001|Overall Study|Pregnancy|1|||
161341898|NCT02320396|582639088|FG000|Overall Study|Protocol Violation|0|||
161341899|NCT02320396|582639089|FG001|Overall Study|Protocol Violation|1|||
161341900|NCT02320396|582639088|FG000|Overall Study|Withdrawal by Subject|2|||
161341901|NCT02320396|582639089|FG001|Overall Study|Withdrawal by Subject|0|||
161341902|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
161341903|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
161341904|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
161341905|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
161341906|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
161341907|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
161341908|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
161341909|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
161341910|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
161341911|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
161341912|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
161341913|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
161341914|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
161341915|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
161341916|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
161341917|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
161341918|NCT00410163|582639090|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
161341919|NCT00410163|582639091|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
161341920|NCT00410163|582639090|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
161341921|NCT00410163|582639091|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
161341922|NCT00410163|582639090|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
161341923|NCT00410163|582639091|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
161341924|NCT00410163|582639090|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
161341925|NCT00410163|582639091|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
161341926|NCT00410163|582639090|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
161341927|NCT00410163|582639091|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
161341928|NCT00410163|582639090|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
161341929|NCT00410163|582639091|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
161341930|NCT01572792|582639094|FG000|Lead-in Study|Lost to Follow-up|5|||
161341931|NCT01572792|582639095|FG001|Lead-in Study|Lost to Follow-up|9|||
161341932|NCT01572792|582639096|FG002|Lead-in Study|Lost to Follow-up|4|||
161341933|NCT01572792|582639097|FG003|Lead-in Study|Lost to Follow-up|2|||
161341934|NCT01572792|582639098|FG004|Lead-in Study|Lost to Follow-up|4|||
161341935|NCT01572792|582639094|FG000|Lead-in Study|Withdrawal by Subject|22|||
161341936|NCT01572792|582639095|FG001|Lead-in Study|Withdrawal by Subject|11|||
161341937|NCT01572792|582639096|FG002|Lead-in Study|Withdrawal by Subject|12|||
161341938|NCT01572792|582639097|FG003|Lead-in Study|Withdrawal by Subject|24|||
161341939|NCT01572792|582639098|FG004|Lead-in Study|Withdrawal by Subject|11|||
161341940|NCT01572792|582639094|FG000|Lead-in Study|Protocol Violation|19|||
161341941|NCT01572792|582639095|FG001|Lead-in Study|Protocol Violation|10|||
161341942|NCT01572792|582639096|FG002|Lead-in Study|Protocol Violation|12|||
161341943|NCT01572792|582639097|FG003|Lead-in Study|Protocol Violation|13|||
161341944|NCT01572792|582639098|FG004|Lead-in Study|Protocol Violation|21|||
161341945|NCT01572792|582639094|FG000|Lead-in Study|Lack of Efficacy|20|||
161341946|NCT01572792|582639095|FG001|Lead-in Study|Lack of Efficacy|5|||
161341947|NCT01572792|582639096|FG002|Lead-in Study|Lack of Efficacy|4|||
161341948|NCT01572792|582639097|FG003|Lead-in Study|Lack of Efficacy|8|||
161341949|NCT01572792|582639098|FG004|Lead-in Study|Lack of Efficacy|10|||
161341950|NCT01572792|582639094|FG000|Lead-in Study|Adverse Event|21|||
161341951|NCT01572792|582639095|FG001|Lead-in Study|Adverse Event|21|||
161341952|NCT01572792|582639096|FG002|Lead-in Study|Adverse Event|22|||
161341953|NCT01572792|582639097|FG003|Lead-in Study|Adverse Event|16|||
161341954|NCT01572792|582639098|FG004|Lead-in Study|Adverse Event|14|||
161341955|NCT01572792|582639094|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
161341956|NCT01572792|582639095|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
161341957|NCT01572792|582639096|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
161341958|NCT01572792|582639097|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
161341959|NCT01572792|582639098|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
161341960|NCT01572792|582639094|FG000|Extension Study|Lost to Follow-up|6|||
161341961|NCT01572792|582639095|FG001|Extension Study|Lost to Follow-up|2|||
161341962|NCT01572792|582639096|FG002|Extension Study|Lost to Follow-up|0|||
161341963|NCT01572792|582639097|FG003|Extension Study|Lost to Follow-up|3|||
161341964|NCT01572792|582639098|FG004|Extension Study|Lost to Follow-up|3|||
161263537|NCT01583218|582345300|FG000|Overall Study|Patient did not wish to attend visits|0|||
161263538|NCT01583218|582345301|FG001|Overall Study|Patient did not wish to attend visits|1|||
161263539|NCT01583218|582345300|FG000|Overall Study|Patient randomized but not dosed|17|||
161263540|NCT01583218|582345301|FG001|Overall Study|Patient randomized but not dosed|16|||
161263541|NCT01583218|582345300|FG000|Overall Study|Patient was assessed via phone in person|1|||
161263542|NCT01583218|582345301|FG001|Overall Study|Patient was assessed via phone in person|0|||
161263543|NCT01583218|582345300|FG000|Overall Study|Patient deemed ineligible after random|2|||
161263544|NCT01583218|582345301|FG001|Overall Study|Patient deemed ineligible after random|0|||
161263545|NCT01583218|582345300|FG000|Overall Study|Patient was early terminated from study|0|||
161263546|NCT01583218|582345301|FG001|Overall Study|Patient was early terminated from study|1|||
161263547|NCT01583218|582345300|FG000|Overall Study|Patient was randomized due to mistake|1|||
161263548|NCT01583218|582345301|FG001|Overall Study|Patient was randomized due to mistake|0|||
161263549|NCT01583218|582345300|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
161263550|NCT01583218|582345301|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
161263551|NCT01583218|582345300|FG000|Overall Study|Withdraw of consent on day of random|1|||
161263552|NCT01583218|582345301|FG001|Overall Study|Withdraw of consent on day of random|0|||
161263553|NCT02013375|582345304|FG000|Overall Study|Did not engraft|1|||
161263554|NCT02013375|582345304|FG000|Overall Study|Did not engraft|1|||
161263555|NCT00712985|582345305|FG000|Overall Study|1 withdrew prior to start of drug|1|||
161263556|NCT00712985|582345305|FG000|Overall Study|1 patient moved out of state|1|||
161263557|NCT00712985|582345305|FG000|Overall Study|Lack of Efficacy|3|||
161263558|NCT02674061|582345306|FG000|Overall Study|Death|229|||
161263559|NCT02674061|582345307|FG001|Overall Study|Death|77|||
161263560|NCT02674061|582345306|FG000|Overall Study|Lost to Follow-up|3|||
161263561|NCT02674061|582345307|FG001|Overall Study|Lost to Follow-up|3|||
161263562|NCT02674061|582345306|FG000|Overall Study|Withdrawal by Subject|9|||
161263563|NCT02674061|582345307|FG001|Overall Study|Withdrawal by Subject|1|||
161263564|NCT02674061|582345306|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
161263565|NCT02674061|582345307|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
161263566|NCT03334721|582345310|FG000|Overall Study|Withdrawal by Subject|1|||
161263567|NCT03334721|582345311|FG001|Overall Study|Withdrawal by Subject|0|||
161263568|NCT03334721|582345310|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
161263569|NCT03334721|582345311|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
161263570|NCT01663727|582345313|FG000|Overall Study|Death|161|||
161263571|NCT01663727|582345314|FG001|Overall Study|Death|155|||
161263572|NCT01663727|582345313|FG000|Overall Study|Lost to Follow-up|10|||
161263573|NCT01663727|582345314|FG001|Overall Study|Lost to Follow-up|8|||
161263574|NCT01663727|582345313|FG000|Overall Study|Withdrawal by Subject|18|||
161263575|NCT01663727|582345314|FG001|Overall Study|Withdrawal by Subject|25|||
161263576|NCT01663727|582345313|FG000|Overall Study|Study Terminated|51|||
161263577|NCT01663727|582345314|FG001|Overall Study|Study Terminated|50|||
161263578|NCT01663727|582345313|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
161263579|NCT01663727|582345314|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
161263580|NCT01663727|582345313|FG000|Overall Study|Withdrawal prior to dosing.|1|||
161263581|NCT01663727|582345314|FG001|Overall Study|Withdrawal prior to dosing.|0|||
161263582|NCT01902628|582345315|FG000|Overall Study|Withdrawal of participant's consent|7|||
161263583|NCT01902628|582345315|FG000|Overall Study|Adverse Event|41|||
161263584|NCT01902628|582345315|FG000|Overall Study|Lost to Follow-up|35|||
161263585|NCT01232491|582345316|FG000|Overall Study|Adverse Event|13|||
161263586|NCT01232491|582345317|FG001|Overall Study|Adverse Event|8|||
161263587|NCT01232491|582345316|FG000|Overall Study|Lack of Efficacy|1|||
161263588|NCT01232491|582345317|FG001|Overall Study|Lack of Efficacy|5|||
161263589|NCT01232491|582345316|FG000|Overall Study|Protocol Violation|13|||
161263590|NCT01232491|582345317|FG001|Overall Study|Protocol Violation|11|||
161263591|NCT01232491|582345316|FG000|Overall Study|Withdrawal Criteria|12|||
161263592|NCT01232491|582345317|FG001|Overall Study|Withdrawal Criteria|21|||
161263593|NCT01232491|582345316|FG000|Overall Study|Other|21|||
161263594|NCT01232491|582345317|FG001|Overall Study|Other|18|||
161263595|NCT02932228|582345318|FG000|Overall Study|Death|8|||
161263596|NCT02932228|582345319|FG001|Overall Study|Death|23|||
161263597|NCT02932228|582345318|FG000|Overall Study|not eligible upon chart review|2|||
161263598|NCT02932228|582345319|FG001|Overall Study|not eligible upon chart review|5|||
161263599|NCT04062448|582347064|FG000|Overall Study|Lost to Follow-up|1|||
161263600|NCT04062448|582347064|FG000|Overall Study|Withdrawal by Subject|2|||
161263601|NCT04385277|582347065|FG000|Overall Study|Physician Decision|2|||
161263602|NCT04385277|582347065|FG000|Overall Study|Ineligible|1|||
161263603|NCT04385277|582347065|FG000|Overall Study|Patient/Parent Refusal|2|||
161263604|NCT04905290|582347066|FG000|Overall Study|Adverse Event|4|||
161263605|NCT04905290|582347066|FG000|Overall Study|Death|2|||
161263606|NCT04905290|582347066|FG000|Overall Study|Withdrawal by Subject|4|||
161263607|NCT04905290|582347066|FG000|Overall Study|Physician Decision|2|||
161263608|NCT04905290|582347066|FG000|Overall Study|Lost to Follow-up|2|||
161263609|NCT04905290|582347066|FG000|Overall Study|Screen Failure|2|||
161263610|NCT04905290|582347066|FG000|Overall Study|Unsuccessful Procedure|2|||
161263611|NCT01045421|582347070|FG000|Phase 1|Progressive Disease|0|||
161341965|NCT01572792|582639094|FG000|Extension Study|Withdrawal by Subject|7|||
161341966|NCT01572792|582639095|FG001|Extension Study|Withdrawal by Subject|6|||
161341967|NCT01572792|582639096|FG002|Extension Study|Withdrawal by Subject|11|||
161341968|NCT01572792|582639097|FG003|Extension Study|Withdrawal by Subject|8|||
161341969|NCT01572792|582639098|FG004|Extension Study|Withdrawal by Subject|14|||
161341970|NCT01572792|582639094|FG000|Extension Study|Protocol Violation|0|||
161341971|NCT01572792|582639095|FG001|Extension Study|Protocol Violation|4|||
161341972|NCT01572792|582639096|FG002|Extension Study|Protocol Violation|3|||
161341973|NCT01572792|582639097|FG003|Extension Study|Protocol Violation|4|||
161341974|NCT01572792|582639098|FG004|Extension Study|Protocol Violation|3|||
161341975|NCT01572792|582639094|FG000|Extension Study|Lack of Efficacy|2|||
161341976|NCT01572792|582639095|FG001|Extension Study|Lack of Efficacy|3|||
161341977|NCT01572792|582639096|FG002|Extension Study|Lack of Efficacy|3|||
161341978|NCT01572792|582639097|FG003|Extension Study|Lack of Efficacy|2|||
161341979|NCT01572792|582639098|FG004|Extension Study|Lack of Efficacy|2|||
161341980|NCT01572792|582639094|FG000|Extension Study|Adverse Event|7|||
161341981|NCT01572792|582639095|FG001|Extension Study|Adverse Event|6|||
161341982|NCT01572792|582639096|FG002|Extension Study|Adverse Event|5|||
161341983|NCT01572792|582639097|FG003|Extension Study|Adverse Event|6|||
161263612|NCT01045421|582347071|FG001|Phase 1|Progressive Disease|0|||
161263613|NCT01045421|582347072|FG002|Phase 1|Progressive Disease|0|||
161263614|NCT01045421|582347073|FG003|Phase 1|Progressive Disease|0|||
161263615|NCT01045421|582347074|FG004|Phase 1|Progressive Disease|1|||
161263616|NCT01045421|582347075|FG005|Phase 1|Progressive Disease|0|||
161263617|NCT01045421|582347076|FG006|Phase 1|Progressive Disease|0|||
161341984|NCT01572792|582639098|FG004|Extension Study|Adverse Event|4|||
161341985|NCT01572792|582639094|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
161341986|NCT01572792|582639095|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
161341987|NCT01572792|582639096|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
161341988|NCT01572792|582639097|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
161341989|NCT01572792|582639098|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
161341990|NCT03692949|582639104|FG000|Overall Study|Lost to Follow-up|0|||
161341991|NCT03692949|582639105|FG001|Overall Study|Lost to Follow-up|0|||
161341992|NCT03692949|582639106|FG002|Overall Study|Lost to Follow-up|0|||
161341993|NCT03692949|582639107|FG003|Overall Study|Lost to Follow-up|0|||
161341994|NCT03692949|582639108|FG004|Overall Study|Lost to Follow-up|0|||
161341995|NCT03692949|582639109|FG005|Overall Study|Lost to Follow-up|0|||
161341996|NCT03692949|582639110|FG006|Overall Study|Lost to Follow-up|0|||
161341997|NCT03692949|582639111|FG007|Overall Study|Lost to Follow-up|1|||
161341998|NCT04848480|582639113|FG000|Main Phase (26 Weeks)|Death|1|||
161341999|NCT04848480|582639114|FG001|Main Phase (26 Weeks)|Death|0|||
161342000|NCT04848480|582639113|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
161342001|NCT04848480|582639114|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
161342002|NCT04848480|582639113|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
161342003|NCT04848480|582639114|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
161342004|NCT04848480|582639113|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
161342005|NCT04848480|582639114|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
161342006|NCT04848480|582639113|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
161342007|NCT04848480|582639114|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
161342008|NCT04848480|582639113|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
161342009|NCT04848480|582639114|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
161342010|NCT04428151|582639115|FG000|Overall Study|Death|100|||
161342011|NCT04428151|582639116|FG001|Overall Study|Death|86|||
161342012|NCT04428151|582639117|FG002|Overall Study|Death|57|||
161342013|NCT04428151|582639115|FG000|Overall Study|Lost to Follow-up|1|||
161342014|NCT04428151|582639116|FG001|Overall Study|Lost to Follow-up|1|||
161342015|NCT04428151|582639117|FG002|Overall Study|Lost to Follow-up|0|||
161342016|NCT04428151|582639115|FG000|Overall Study|Withdrawal by Subject|2|||
161342017|NCT04428151|582639116|FG001|Overall Study|Withdrawal by Subject|2|||
161342018|NCT04428151|582639117|FG002|Overall Study|Withdrawal by Subject|3|||
161342019|NCT04428151|582639115|FG000|Overall Study|Participant Ongoing in Study|41|||
161342020|NCT04428151|582639116|FG001|Overall Study|Participant Ongoing in Study|53|||
161342021|NCT04428151|582639117|FG002|Overall Study|Participant Ongoing in Study|28|||
161342022|NCT02783690|582639120|FG000|Overall Study|Withdrawal by Subject|3|||
161263618|NCT01045421|582347077|FG007|Phase 1|Progressive Disease|0|||
161342023|NCT02783690|582639121|FG001|Overall Study|Withdrawal by Subject|3|||
161342024|NCT04585893|582639122|FG000|Overall Study|Death|1|||
161342025|NCT04585893|582639123|FG001|Overall Study|Death|0|||
161342026|NCT06178991|582639126|FG000|Overall Study|Withdrawal by Subject|2|||
161342027|NCT06178991|582639127|FG001|Overall Study|Withdrawal by Subject|6|||
161342028|NCT06178991|582639128|FG002|Overall Study|Withdrawal by Subject|44|||
161263619|NCT01045421|582347078|FG008|Phase 1|Progressive Disease|0|||
161342029|NCT06178991|582639129|FG003|Overall Study|Withdrawal by Subject|23|||
161342030|NCT06178991|582639130|FG004|Overall Study|Withdrawal by Subject|7|||
161342031|NCT06178991|582639131|FG005|Overall Study|Withdrawal by Subject|7|||
161342032|NCT06178991|582639132|FG006|Overall Study|Withdrawal by Subject|7|||
161263620|NCT01045421|582347079|FG009|Phase 1|Progressive Disease|0|||
161263621|NCT01045421|582347080|FG010|Phase 1|Progressive Disease|0|||
161263622|NCT01045421|582347070|FG000|Phase 1|Withdrawal by Subject|0|||
161263623|NCT01045421|582347071|FG001|Phase 1|Withdrawal by Subject|0|||
161263624|NCT01045421|582347072|FG002|Phase 1|Withdrawal by Subject|0|||
161263625|NCT01045421|582347073|FG003|Phase 1|Withdrawal by Subject|1|||
161263626|NCT01045421|582347074|FG004|Phase 1|Withdrawal by Subject|0|||
161263627|NCT01045421|582347075|FG005|Phase 1|Withdrawal by Subject|0|||
161263628|NCT01045421|582347076|FG006|Phase 1|Withdrawal by Subject|0|||
161263629|NCT01045421|582347077|FG007|Phase 1|Withdrawal by Subject|0|||
161263630|NCT01045421|582347078|FG008|Phase 1|Withdrawal by Subject|0|||
161263631|NCT01045421|582347079|FG009|Phase 1|Withdrawal by Subject|0|||
161263632|NCT01045421|582347080|FG010|Phase 1|Withdrawal by Subject|0|||
161263633|NCT01045421|582347070|FG000|Phase 2|Progressive Disease|0|||
161263634|NCT01045421|582347071|FG001|Phase 2|Progressive Disease|0|||
161263635|NCT01045421|582347072|FG002|Phase 2|Progressive Disease|0|||
161263636|NCT01045421|582347073|FG003|Phase 2|Progressive Disease|0|||
161263637|NCT01045421|582347074|FG004|Phase 2|Progressive Disease|0|||
161263638|NCT01045421|582347075|FG005|Phase 2|Progressive Disease|0|||
161263639|NCT01045421|582347076|FG006|Phase 2|Progressive Disease|0|||
161263640|NCT01045421|582347077|FG007|Phase 2|Progressive Disease|1|||
161263641|NCT01045421|582347078|FG008|Phase 2|Progressive Disease|1|||
161263642|NCT01045421|582347079|FG009|Phase 2|Progressive Disease|1|||
161263643|NCT01045421|582347080|FG010|Phase 2|Progressive Disease|1|||
161263644|NCT01045421|582347070|FG000|Phase 2|Death|0|||
161263645|NCT01045421|582347071|FG001|Phase 2|Death|0|||
161263646|NCT01045421|582347072|FG002|Phase 2|Death|0|||
161263647|NCT01045421|582347073|FG003|Phase 2|Death|0|||
161263648|NCT01045421|582347074|FG004|Phase 2|Death|0|||
161263649|NCT01045421|582347075|FG005|Phase 2|Death|0|||
161263650|NCT01045421|582347076|FG006|Phase 2|Death|0|||
161263651|NCT01045421|582347077|FG007|Phase 2|Death|1|||
161263652|NCT01045421|582347078|FG008|Phase 2|Death|1|||
161263653|NCT01045421|582347079|FG009|Phase 2|Death|2|||
161263654|NCT01045421|582347080|FG010|Phase 2|Death|0|||
161263655|NCT01045421|582347070|FG000|Phase 2|Other|0|||
161263656|NCT01045421|582347071|FG001|Phase 2|Other|0|||
161263657|NCT01045421|582347072|FG002|Phase 2|Other|0|||
161263658|NCT01045421|582347073|FG003|Phase 2|Other|0|||
161263659|NCT01045421|582347074|FG004|Phase 2|Other|0|||
161263660|NCT01045421|582347075|FG005|Phase 2|Other|0|||
161263661|NCT01045421|582347076|FG006|Phase 2|Other|0|||
161263662|NCT01045421|582347077|FG007|Phase 2|Other|3|||
161263663|NCT01045421|582347078|FG008|Phase 2|Other|0|||
161263664|NCT01045421|582347079|FG009|Phase 2|Other|0|||
161263665|NCT01045421|582347080|FG010|Phase 2|Other|1|||
161263666|NCT03340064|582347081|FG000|First Period|Adverse Event, non-fatal|2|||
161263667|NCT03340064|582347082|FG001|First Period|Adverse Event, non-fatal|0|||
161263668|NCT03340064|582347081|FG000|First Period|Lack of Efficacy|3|||
161263669|NCT03340064|582347082|FG001|First Period|Lack of Efficacy|0|||
161263670|NCT03340064|582347081|FG000|Second Period|Adverse Event, non-fatal|1|||
161263671|NCT03340064|582347082|FG001|Second Period|Adverse Event, non-fatal|1|||
161263672|NCT03340064|582347081|FG000|Second Period|Lack of Efficacy|11|||
161263673|NCT03340064|582347082|FG001|Second Period|Lack of Efficacy|0|||
161263674|NCT03340064|582347081|FG000|Second Period|Physician Decision|3|||
161263675|NCT03340064|582347082|FG001|Second Period|Physician Decision|0|||
161263676|NCT03340064|582347081|FG000|Second Period|Withdrawal by Subject|2|||
161263677|NCT03340064|582347082|FG001|Second Period|Withdrawal by Subject|1|||
161263678|NCT03340064|582347081|FG000|Second Period|Approved Drug Available For Indication|1|||
161263679|NCT03340064|582347082|FG001|Second Period|Approved Drug Available For Indication|0|||
161263680|NCT03340064|582347081|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
161263681|NCT03340064|582347082|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
161263682|NCT00856973|582347083|FG000|Overall Study|Adverse Event|5|||
161263683|NCT00856973|582347084|FG001|Overall Study|Adverse Event|5|||
161263684|NCT00856973|582347085|FG002|Overall Study|Adverse Event|3|||
161263685|NCT00856973|582347083|FG000|Overall Study|Lost to Follow-up|6|||
161263686|NCT00856973|582347084|FG001|Overall Study|Lost to Follow-up|3|||
161263687|NCT00856973|582347085|FG002|Overall Study|Lost to Follow-up|5|||
161263688|NCT00856973|582347083|FG000|Overall Study|Physician Decision|0|||
161263689|NCT00856973|582347084|FG001|Overall Study|Physician Decision|3|||
161263690|NCT00856973|582347085|FG002|Overall Study|Physician Decision|1|||
161263691|NCT00856973|582347083|FG000|Overall Study|Protocol Violation|1|||
161263692|NCT00856973|582347084|FG001|Overall Study|Protocol Violation|2|||
161263693|NCT00856973|582347085|FG002|Overall Study|Protocol Violation|1|||
161263694|NCT00856973|582347083|FG000|Overall Study|Withdrawal by Subject|13|||
161263695|NCT00856973|582347084|FG001|Overall Study|Withdrawal by Subject|16|||
161263696|NCT00856973|582347085|FG002|Overall Study|Withdrawal by Subject|15|||
161263697|NCT00856973|582347083|FG000|Overall Study|Other|11|||
161263698|NCT00856973|582347084|FG001|Overall Study|Other|12|||
161263699|NCT00856973|582347085|FG002|Overall Study|Other|13|||
161263700|NCT03955471|582347087|FG000|Overall Study|Death|22|||
161263701|NCT03955471|582347087|FG000|Overall Study|Lost to Follow-up|1|||
161263702|NCT03955471|582347087|FG000|Overall Study|Withdrawal by Subject|6|||
161263703|NCT03955471|582347087|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
161342033|NCT06178991|582639133|FG007|Overall Study|Withdrawal by Subject|5|||
161342034|NCT06178991|582639126|FG000|Overall Study|Lost to Follow-up|2|||
161263704|NCT01030341|582347088|FG000|Overall Study|Withdrawal by Subject|1|||
161263705|NCT01030341|582347088|FG000|Overall Study|Lost to Follow-up|2|||
161263706|NCT01884311|582347089|FG000|Overall Study|Withdrawal by Subject|3|||
161263707|NCT01884311|582347089|FG000|Overall Study|withdrew consent due to AEs|1|||
161342035|NCT06178991|582639127|FG001|Overall Study|Lost to Follow-up|4|||
161342036|NCT06178991|582639128|FG002|Overall Study|Lost to Follow-up|133|||
161342037|NCT06178991|582639129|FG003|Overall Study|Lost to Follow-up|65|||
161342038|NCT06178991|582639130|FG004|Overall Study|Lost to Follow-up|68|||
161342039|NCT06178991|582639131|FG005|Overall Study|Lost to Follow-up|57|||
161342040|NCT06178991|582639132|FG006|Overall Study|Lost to Follow-up|25|||
161342041|NCT06178991|582639133|FG007|Overall Study|Lost to Follow-up|18|||
161342042|NCT06178991|582639126|FG000|Overall Study|Death|1|||
161342043|NCT06178991|582639127|FG001|Overall Study|Death|0|||
161342044|NCT06178991|582639128|FG002|Overall Study|Death|2|||
161342045|NCT06178991|582639129|FG003|Overall Study|Death|1|||
161342046|NCT06178991|582639130|FG004|Overall Study|Death|1|||
161342047|NCT06178991|582639131|FG005|Overall Study|Death|0|||
161342048|NCT06178991|582639132|FG006|Overall Study|Death|1|||
161342049|NCT06178991|582639133|FG007|Overall Study|Death|1|||
161342050|NCT06178991|582639126|FG000|Overall Study|Randomized but not Vaccinated|4|||
161342051|NCT06178991|582639127|FG001|Overall Study|Randomized but not Vaccinated|1|||
161342052|NCT06178991|582639128|FG002|Overall Study|Randomized but not Vaccinated|15|||
161342053|NCT06178991|582639129|FG003|Overall Study|Randomized but not Vaccinated|9|||
161342054|NCT06178991|582639130|FG004|Overall Study|Randomized but not Vaccinated|8|||
161342055|NCT06178991|582639131|FG005|Overall Study|Randomized but not Vaccinated|4|||
161342056|NCT06178991|582639132|FG006|Overall Study|Randomized but not Vaccinated|2|||
161342057|NCT06178991|582639133|FG007|Overall Study|Randomized but not Vaccinated|2|||
161342058|NCT06178991|582639126|FG000|Overall Study|Other: Unspecified|0|||
161342059|NCT06178991|582639127|FG001|Overall Study|Other: Unspecified|1|||
161342060|NCT06178991|582639128|FG002|Overall Study|Other: Unspecified|7|||
161342061|NCT06178991|582639129|FG003|Overall Study|Other: Unspecified|6|||
161342062|NCT06178991|582639130|FG004|Overall Study|Other: Unspecified|1|||
161342063|NCT06178991|582639131|FG005|Overall Study|Other: Unspecified|1|||
161342064|NCT06178991|582639132|FG006|Overall Study|Other: Unspecified|1|||
161342065|NCT06178991|582639133|FG007|Overall Study|Other: Unspecified|0|||
161342066|NCT06178991|582639126|FG000|Overall Study|Physician Decision|0|||
161342067|NCT06178991|582639127|FG001|Overall Study|Physician Decision|0|||
161342068|NCT06178991|582639128|FG002|Overall Study|Physician Decision|2|||
161342069|NCT06178991|582639129|FG003|Overall Study|Physician Decision|0|||
161342070|NCT06178991|582639130|FG004|Overall Study|Physician Decision|2|||
161342071|NCT06178991|582639131|FG005|Overall Study|Physician Decision|1|||
161342072|NCT06178991|582639132|FG006|Overall Study|Physician Decision|0|||
161342073|NCT06178991|582639133|FG007|Overall Study|Physician Decision|0|||
161342074|NCT06178991|582639126|FG000|Overall Study|Protocol Violation|0|||
161342075|NCT06178991|582639127|FG001|Overall Study|Protocol Violation|0|||
161342076|NCT06178991|582639128|FG002|Overall Study|Protocol Violation|1|||
161342077|NCT06178991|582639129|FG003|Overall Study|Protocol Violation|0|||
161342078|NCT06178991|582639130|FG004|Overall Study|Protocol Violation|0|||
161342079|NCT06178991|582639131|FG005|Overall Study|Protocol Violation|0|||
161342080|NCT06178991|582639132|FG006|Overall Study|Protocol Violation|0|||
161342081|NCT06178991|582639133|FG007|Overall Study|Protocol Violation|0|||
161342082|NCT01366092|582639137|FG000|Overall Study|Progressive cGVHD|2|||
161342083|NCT01366092|582639137|FG000|Overall Study|Physician Decision|1|||
161342084|NCT01366092|582639137|FG000|Overall Study|Withdrawal by Subject|1|||
161342085|NCT03353220|582639142|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
161342086|NCT03353220|582639143|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
161342087|NCT03586479|582639144|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
161342088|NCT03586479|582639145|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
161342089|NCT03586479|582639146|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
161342090|NCT03586479|582639144|FG000|Overall Study|Protocol Violation|2|||
161263708|NCT01884311|582347089|FG000|Overall Study|Precautionary measure|1|||
161263709|NCT02858492|582347090|FG000|Overall Study|Withdrawal by Subject|0|||
161263710|NCT02858492|582347091|FG001|Overall Study|Withdrawal by Subject|1|||
161342091|NCT03586479|582639145|FG001|Overall Study|Protocol Violation|0|||
161342092|NCT03586479|582639146|FG002|Overall Study|Protocol Violation|0|||
161263711|NCT02858492|582347092|FG002|Overall Study|Withdrawal by Subject|0|||
161342093|NCT03586479|582639144|FG000|Overall Study|Lost to Follow-up|1|||
161342094|NCT03586479|582639145|FG001|Overall Study|Lost to Follow-up|1|||
161342095|NCT03586479|582639146|FG002|Overall Study|Lost to Follow-up|2|||
161342096|NCT03586479|582639144|FG000|Overall Study|Behavioral Issues|1|||
161342097|NCT03586479|582639145|FG001|Overall Study|Behavioral Issues|0|||
161342098|NCT03586479|582639146|FG002|Overall Study|Behavioral Issues|0|||
161342099|NCT00661388|582639148|FG000|Overall Study|Adverse Event|14|||
161342100|NCT00661388|582639148|FG000|Overall Study|Protocol Violation|7|||
161342101|NCT00661388|582639148|FG000|Overall Study|Renal transplantation|1|||
161342102|NCT00661388|582639148|FG000|Overall Study|Dialysis initiation|1|||
161263712|NCT02858492|582347093|FG003|Overall Study|Withdrawal by Subject|1|||
161263713|NCT02858492|582347090|FG000|Overall Study|Adverse Event|0|||
161263714|NCT02858492|582347091|FG001|Overall Study|Adverse Event|0|||
161263715|NCT02858492|582347092|FG002|Overall Study|Adverse Event|0|||
161263716|NCT02858492|582347093|FG003|Overall Study|Adverse Event|3|||
161263717|NCT02858492|582347090|FG000|Overall Study|Lack of Efficacy|0|||
161263718|NCT02858492|582347091|FG001|Overall Study|Lack of Efficacy|0|||
161263719|NCT02858492|582347092|FG002|Overall Study|Lack of Efficacy|0|||
161263720|NCT02858492|582347093|FG003|Overall Study|Lack of Efficacy|1|||
161263721|NCT02858492|582347090|FG000|Overall Study|Protocol defined stopping criteria|0|||
161263722|NCT02858492|582347091|FG001|Overall Study|Protocol defined stopping criteria|0|||
161263723|NCT02858492|582347092|FG002|Overall Study|Protocol defined stopping criteria|0|||
161263724|NCT02858492|582347093|FG003|Overall Study|Protocol defined stopping criteria|1|||
161263725|NCT02944383|582347094|FG000|Overall Study|Lost to Follow-up|0|||
161263726|NCT02944383|582347095|FG001|Overall Study|Lost to Follow-up|0|||
161263727|NCT02944383|582347096|FG002|Overall Study|Lost to Follow-up|1|||
161263728|NCT02944383|582347094|FG000|Overall Study|Withdrawal by Subject|1|||
161263729|NCT02944383|582347095|FG001|Overall Study|Withdrawal by Subject|0|||
161263730|NCT02944383|582347096|FG002|Overall Study|Withdrawal by Subject|0|||
161263731|NCT01995266|582347098|FG000|Overall Study|Death|1|||
161263732|NCT01995266|582347098|FG000|Overall Study|Lack of Efficacy|6|||
161263733|NCT01995266|582347098|FG000|Overall Study|Adverse Event|2|||
161263734|NCT03853148|582347099|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
161263735|NCT03853148|582347100|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
161263736|NCT03853148|582347101|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
161263737|NCT03853148|582347102|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
161263738|NCT00090610|582347103|FG000|Overall Study|Withdrawal by Subject|1|||
161263739|NCT00090610|582347104|FG001|Overall Study|Withdrawal by Subject|1|||
161263740|NCT03623386|582347107|FG000|Overall Study|Protocol Violation|3|||
161263741|NCT03623386|582347108|FG001|Overall Study|Protocol Violation|2|||
161263742|NCT03623386|582347109|FG002|Overall Study|Protocol Violation|0|||
161263743|NCT03623386|582347107|FG000|Overall Study|Physician Decision|1|||
161263744|NCT03623386|582347108|FG001|Overall Study|Physician Decision|1|||
161263745|NCT03623386|582347109|FG002|Overall Study|Physician Decision|0|||
161263746|NCT03623386|582347107|FG000|Overall Study|Lost to Follow-up|0|||
161263747|NCT03623386|582347108|FG001|Overall Study|Lost to Follow-up|2|||
161263748|NCT03623386|582347109|FG002|Overall Study|Lost to Follow-up|0|||
161263749|NCT03623386|582347107|FG000|Overall Study|COVID-19|0|||
161263750|NCT03623386|582347108|FG001|Overall Study|COVID-19|1|||
161263751|NCT03623386|582347109|FG002|Overall Study|COVID-19|0|||
161263752|NCT00599521|582347112|FG000|Overall Study|Lack of Efficacy|4|||
161263753|NCT00599521|582347113|FG001|Overall Study|Lack of Efficacy|8|||
161263754|NCT00599521|582347112|FG000|Overall Study|Adverse Event|4|||
161263755|NCT00599521|582347113|FG001|Overall Study|Adverse Event|1|||
161263756|NCT00599521|582347112|FG000|Overall Study|Withdrawal by Subject|28|||
161263757|NCT00599521|582347113|FG001|Overall Study|Withdrawal by Subject|34|||
161263758|NCT00599521|582347112|FG000|Overall Study|Protocol Violation|1|||
161263759|NCT00599521|582347113|FG001|Overall Study|Protocol Violation|1|||
161263760|NCT00599521|582347112|FG000|Overall Study|Lost to Follow-up|23|||
161263761|NCT00599521|582347113|FG001|Overall Study|Lost to Follow-up|23|||
161263762|NCT00599521|582347112|FG000|Overall Study|Pregnancy|0|||
161263763|NCT00599521|582347113|FG001|Overall Study|Pregnancy|2|||
161263764|NCT05855616|582347114|FG000|Overall Study|Lost to Follow-up|1|||
161263765|NCT05855616|582347115|FG001|Overall Study|Lost to Follow-up|2|||
161263766|NCT01388166|582347116|FG000|Overall Study|Adverse Event|16|||
161263767|NCT01388166|582347116|FG000|Overall Study|Lost to Follow-up|30|||
161263768|NCT01388166|582347116|FG000|Overall Study|Others than specified above|13|||
161263769|NCT02751359|582347122|FG000|Overall Study|Lost to Follow-up|1|||
161263770|NCT02667288|582347123|FG000|Overall Study|Protocol Violation|5|||
161263771|NCT02667288|582347123|FG000|Overall Study|Lost to Follow-up|3|||
161263772|NCT02667288|582347123|FG000|Overall Study|Withdrawal by Subject|5|||
161263773|NCT01196078|582347124|FG000|Overall Study|Withdrawal by Subject|3|||
161263774|NCT01196078|582347125|FG001|Overall Study|Withdrawal by Subject|5|||
161263775|NCT01196078|582347124|FG000|Overall Study|Adverse Event|4|||
161263776|NCT01196078|582347125|FG001|Overall Study|Adverse Event|4|||
161263777|NCT01196078|582347124|FG000|Overall Study|Protocol Violation|2|||
161263778|NCT01196078|582347125|FG001|Overall Study|Protocol Violation|1|||
161263779|NCT01196078|582347124|FG000|Overall Study|Lack of Efficacy|17|||
161263780|NCT01196078|582347125|FG001|Overall Study|Lack of Efficacy|23|||
161263781|NCT01196078|582347124|FG000|Overall Study|Lost to Follow-up|1|||
161263782|NCT01196078|582347125|FG001|Overall Study|Lost to Follow-up|0|||
161263783|NCT01196078|582347124|FG000|Overall Study|Death|6|||
161263784|NCT01196078|582347125|FG001|Overall Study|Death|4|||
161263785|NCT02400671|582347126|FG000|Overall Study|Death|5|||
161263786|NCT02400671|582347127|FG001|Overall Study|Death|3|||
161263787|NCT02400671|582347128|FG002|Overall Study|Death|4|||
161263788|NCT02400671|582347126|FG000|Overall Study|Lost to Follow-up|20|||
161263789|NCT02400671|582347127|FG001|Overall Study|Lost to Follow-up|27|||
160998034|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
161263790|NCT02400671|582347128|FG002|Overall Study|Lost to Follow-up|24|||
161263791|NCT02400671|582347126|FG000|Overall Study|Withdrawal by Subject|2|||
161263792|NCT02400671|582347127|FG001|Overall Study|Withdrawal by Subject|2|||
161263793|NCT02400671|582347128|FG002|Overall Study|Withdrawal by Subject|0|||
161263794|NCT01429051|582347129|FG000|Titration Phase|Death|1|||
161263795|NCT01429051|582347129|FG000|Titration Phase|Withdrawal by Subject|7|||
161263796|NCT01429051|582347129|FG000|Titration Phase|Physician Decision|1|||
161263797|NCT01429051|582347129|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
161263798|NCT01429051|582347129|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
161263799|NCT01429051|582347129|FG000|Efficacy Phase|Adverse Event|1|||
161263800|NCT01429051|582347129|FG000|Efficacy Phase|Death|1|||
161263801|NCT01429051|582347129|FG000|Tolerability Phase|Death|5|||
161263802|NCT01429051|582347129|FG000|Tolerability Phase|Adverse Event|2|||
161263803|NCT01429051|582347129|FG000|Tolerability Phase|Withdrawal by Subject|5|||
161263804|NCT01429051|582347129|FG000|Tolerability Phase|Physician Decision|1|||
161263805|NCT01429051|582347129|FG000|Tolerability Phase|Other|2|||
161263806|NCT00857792|582347131|FG000|Overall Study|inadequate image quality for analysis|12|||
161263807|NCT03760250|582347132|FG000|Overall Study|Withdrawal by Subject|1|||
161263808|NCT03760250|582347132|FG000|Overall Study|Physician Decision|1|||
161263809|NCT03733210|582347134|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
161263810|NCT03733210|582347135|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
161263811|NCT04421586|582347136|FG000|Overall Study|Death|0|||
161263812|NCT04421586|582347137|FG001|Overall Study|Death|1|||
161263813|NCT04421586|582347136|FG000|Overall Study|Lost to Follow-up|2|||
161263814|NCT04421586|582347137|FG001|Overall Study|Lost to Follow-up|2|||
161263815|NCT04421586|582347136|FG000|Overall Study|Withdrawn by PI|1|||
161263816|NCT04421586|582347137|FG001|Overall Study|Withdrawn by PI|0|||
161263817|NCT04421586|582347136|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
161263818|NCT04421586|582347137|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
161263819|NCT02963441|582347138|FG000|Overall Study|Protocol violation or withdrawn|8|||
161263820|NCT02963441|582347138|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
161263821|NCT02963441|582347138|FG000|Overall Study|IDx-DR insufficient quality|33|||
161263822|NCT04920916|582347139|FG000|Phase IIa 60 Day Study|Death|2|||
161263823|NCT04920916|582347140|FG001|Phase IIa 60 Day Study|Death|5|||
161263824|NCT04920916|582347139|FG000|1 Year Follow up (Phone Call)|Death|1|||
161263825|NCT04920916|582347140|FG001|1 Year Follow up (Phone Call)|Death|3|||
161263826|NCT04920916|582347139|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
161263827|NCT04920916|582347140|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
161263828|NCT02011113|582347141|FG000|Overall Study|Adverse Event|4|||
161263829|NCT02011113|582347141|FG000|Overall Study|Disease Progression (DP)|16|||
161263830|NCT02011113|582347141|FG000|Overall Study|Death|1|||
161263831|NCT02011113|582347141|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
161263832|NCT02011113|582347141|FG000|Overall Study|Investigator's judgement- DP|3|||
161263833|NCT02011113|582347141|FG000|Overall Study|Study terminated by sponsor|11|||
161263834|NCT04688931|582347144|FG000|Overall Study|Adverse Event|4|||
161263835|NCT04688931|582347145|FG001|Overall Study|Adverse Event|1|||
161263836|NCT04688931|582347144|FG000|Overall Study|Withdrawal by Subject|5|||
161263837|NCT04688931|582347145|FG001|Overall Study|Withdrawal by Subject|16|||
161263838|NCT04688931|582347144|FG000|Overall Study|Physician Decision|3|||
161263839|NCT04688931|582347145|FG001|Overall Study|Physician Decision|5|||
161263840|NCT04688931|582347144|FG000|Overall Study|Noncompliance|0|||
161263841|NCT04688931|582347145|FG001|Overall Study|Noncompliance|1|||
161263842|NCT04688931|582347144|FG000|Overall Study|Lost to Follow-up|1|||
161263843|NCT04688931|582347145|FG001|Overall Study|Lost to Follow-up|3|||
161263844|NCT04688931|582347144|FG000|Overall Study|Randomization Error|3|||
161263845|NCT04688931|582347145|FG001|Overall Study|Randomization Error|0|||
161263846|NCT04688931|582347144|FG000|Overall Study|Not Eligible|1|||
161263847|NCT04688931|582347145|FG001|Overall Study|Not Eligible|3|||
161263848|NCT04688931|582347144|FG000|Overall Study|Disease Progression|0|||
161263849|NCT04688931|582347145|FG001|Overall Study|Disease Progression|2|||
161263850|NCT04688931|582347144|FG000|Overall Study|Sponsor Requirement|1|||
161263851|NCT04688931|582347145|FG001|Overall Study|Sponsor Requirement|1|||
161263852|NCT04688931|582347144|FG000|Overall Study|Other Reason|1|||
161263853|NCT04688931|582347145|FG001|Overall Study|Other Reason|2|||
161263854|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Adverse Event|9|||
161263855|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Adverse Event|4|||
161263856|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Adverse Event|5|||
161263857|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Adverse Event|9|||
161263858|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Adverse Event|8|||
161263859|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Adverse Event|0|||
161263860|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Adverse Event|0|||
161263861|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
161263862|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
161263863|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
161263864|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
161342103|NCT00661388|582639148|FG000|Overall Study|Administrative reasons|1|||
161342104|NCT03836053|582640116|FG000|Overall Study|Protocol-specified criteria|0|||
161342105|NCT03836053|582640117|FG001|Overall Study|Protocol-specified criteria|2|||
161342106|NCT03836053|582640118|FG002|Overall Study|Protocol-specified criteria|1|||
161342107|NCT03836053|582640116|FG000|Overall Study|Death|1|||
161342108|NCT03836053|582640117|FG001|Overall Study|Death|6|||
161342109|NCT03836053|582640118|FG002|Overall Study|Death|4|||
161342110|NCT03836053|582640116|FG000|Overall Study|Withdrawal of consent from study|0|||
161342111|NCT03836053|582640117|FG001|Overall Study|Withdrawal of consent from study|0|||
161342112|NCT03836053|582640118|FG002|Overall Study|Withdrawal of consent from study|1|||
161342113|NCT03836053|582640116|FG000|Overall Study|Decision by sponsor|0|||
161342114|NCT03836053|582640117|FG001|Overall Study|Decision by sponsor|2|||
161342115|NCT03836053|582640118|FG002|Overall Study|Decision by sponsor|4|||
161342116|NCT03846479|582640119|FG000|Overall Study|Death|8|||
161342117|NCT03846479|582640119|FG000|Overall Study|Lost to Follow-up|1|||
161342118|NCT02332707|582640120|FG000|Overall Study|Adverse Event|0|||
161342119|NCT02332707|582640121|FG001|Overall Study|Adverse Event|0|||
161342120|NCT02332707|582640122|FG002|Overall Study|Adverse Event|0|||
161342121|NCT02332707|582640123|FG003|Overall Study|Adverse Event|0|||
161342122|NCT02332707|582640124|FG004|Overall Study|Adverse Event|0|||
161342123|NCT02332707|582640125|FG005|Overall Study|Adverse Event|0|||
161342124|NCT02332707|582640126|FG006|Overall Study|Adverse Event|0|||
161342125|NCT02332707|582640127|FG007|Overall Study|Adverse Event|0|||
161342126|NCT02332707|582640128|FG008|Overall Study|Adverse Event|0|||
161342127|NCT02332707|582640129|FG009|Overall Study|Adverse Event|0|||
161342128|NCT02332707|582640130|FG010|Overall Study|Adverse Event|0|||
161342129|NCT02332707|582640131|FG011|Overall Study|Adverse Event|0|||
161342130|NCT02332707|582640132|FG012|Overall Study|Adverse Event|1|||
161342131|NCT02332707|582640133|FG013|Overall Study|Adverse Event|0|||
161342132|NCT02332707|582640134|FG014|Overall Study|Adverse Event|0|||
161342133|NCT02332707|582640135|FG015|Overall Study|Adverse Event|0|||
161342134|NCT02332707|582640136|FG016|Overall Study|Adverse Event|0|||
161342135|NCT02332707|582640137|FG017|Overall Study|Adverse Event|0|||
161342136|NCT02332707|582640120|FG000|Overall Study|Lost to Follow-up|0|||
161342137|NCT02332707|582640121|FG001|Overall Study|Lost to Follow-up|0|||
161342138|NCT02332707|582640122|FG002|Overall Study|Lost to Follow-up|0|||
161342139|NCT02332707|582640123|FG003|Overall Study|Lost to Follow-up|0|||
161342140|NCT02332707|582640124|FG004|Overall Study|Lost to Follow-up|0|||
161342141|NCT02332707|582640125|FG005|Overall Study|Lost to Follow-up|1|||
161342142|NCT02332707|582640126|FG006|Overall Study|Lost to Follow-up|0|||
161342143|NCT02332707|582640127|FG007|Overall Study|Lost to Follow-up|0|||
161342144|NCT02332707|582640128|FG008|Overall Study|Lost to Follow-up|0|||
161342145|NCT02332707|582640129|FG009|Overall Study|Lost to Follow-up|0|||
161342146|NCT02332707|582640130|FG010|Overall Study|Lost to Follow-up|2|||
161342147|NCT02332707|582640131|FG011|Overall Study|Lost to Follow-up|0|||
161342148|NCT02332707|582640132|FG012|Overall Study|Lost to Follow-up|3|||
161342149|NCT02332707|582640133|FG013|Overall Study|Lost to Follow-up|0|||
161342150|NCT02332707|582640134|FG014|Overall Study|Lost to Follow-up|0|||
161342151|NCT02332707|582640135|FG015|Overall Study|Lost to Follow-up|0|||
161342152|NCT02332707|582640136|FG016|Overall Study|Lost to Follow-up|0|||
161342153|NCT02332707|582640137|FG017|Overall Study|Lost to Follow-up|0|||
161342154|NCT02332707|582640120|FG000|Overall Study|Physician Decision|0|||
161342155|NCT02332707|582640121|FG001|Overall Study|Physician Decision|0|||
161342156|NCT02332707|582640122|FG002|Overall Study|Physician Decision|0|||
161342157|NCT02332707|582640123|FG003|Overall Study|Physician Decision|1|||
161342158|NCT02332707|582640124|FG004|Overall Study|Physician Decision|0|||
161342159|NCT02332707|582640125|FG005|Overall Study|Physician Decision|0|||
161342160|NCT02332707|582640126|FG006|Overall Study|Physician Decision|0|||
161342161|NCT02332707|582640127|FG007|Overall Study|Physician Decision|0|||
161342162|NCT02332707|582640128|FG008|Overall Study|Physician Decision|0|||
161342163|NCT02332707|582640129|FG009|Overall Study|Physician Decision|0|||
161342164|NCT02332707|582640130|FG010|Overall Study|Physician Decision|0|||
161342165|NCT02332707|582640131|FG011|Overall Study|Physician Decision|0|||
161342166|NCT02332707|582640132|FG012|Overall Study|Physician Decision|1|||
161342167|NCT02332707|582640133|FG013|Overall Study|Physician Decision|0|||
161342168|NCT02332707|582640134|FG014|Overall Study|Physician Decision|0|||
161342169|NCT02332707|582640135|FG015|Overall Study|Physician Decision|0|||
161342170|NCT02332707|582640136|FG016|Overall Study|Physician Decision|0|||
161342171|NCT02332707|582640137|FG017|Overall Study|Physician Decision|0|||
161342172|NCT02332707|582640120|FG000|Overall Study|Withdrawal by Subject|0|||
161342173|NCT02332707|582640121|FG001|Overall Study|Withdrawal by Subject|0|||
161342174|NCT02332707|582640122|FG002|Overall Study|Withdrawal by Subject|1|||
161342175|NCT02332707|582640123|FG003|Overall Study|Withdrawal by Subject|0|||
161342176|NCT02332707|582640124|FG004|Overall Study|Withdrawal by Subject|0|||
161342177|NCT02332707|582640125|FG005|Overall Study|Withdrawal by Subject|0|||
161342178|NCT02332707|582640126|FG006|Overall Study|Withdrawal by Subject|0|||
161342179|NCT02332707|582640127|FG007|Overall Study|Withdrawal by Subject|0|||
161342180|NCT02332707|582640128|FG008|Overall Study|Withdrawal by Subject|0|||
161342181|NCT02332707|582640129|FG009|Overall Study|Withdrawal by Subject|3|||
161342182|NCT02332707|582640130|FG010|Overall Study|Withdrawal by Subject|0|||
161143503|NCT00685178|581909381|FG003|Overall Study|administrative (disciplinary) discharge|2|||
161143504|NCT00685178|581909378|FG000|Overall Study|Pregnancy|0|||
161143505|NCT00685178|581909379|FG001|Overall Study|Pregnancy|0|||
161143506|NCT00685178|581909380|FG002|Overall Study|Pregnancy|0|||
161143507|NCT00685178|581909381|FG003|Overall Study|Pregnancy|1|||
161143508|NCT05299892|581909393|FG000|Overall Study|Withdrawal by Subject|2|||
161143509|NCT00149214|581909394|FG000|Overall Study|Adverse Event|12|||
161143510|NCT00149214|581909395|FG001|Overall Study|Adverse Event|9|||
161143511|NCT00149214|581909394|FG000|Overall Study|Withdrawal by Subject|4|||
161143512|NCT00149214|581909395|FG001|Overall Study|Withdrawal by Subject|1|||
161143513|NCT00149214|581909394|FG000|Overall Study|Physician Decision|3|||
161143514|NCT00149214|581909395|FG001|Overall Study|Physician Decision|3|||
161143515|NCT00149214|581909394|FG000|Overall Study|Sponsor Decision|0|||
161143516|NCT00149214|581909395|FG001|Overall Study|Sponsor Decision|1|||
161143517|NCT00149214|581909394|FG000|Overall Study|Progressive Disease|7|||
161143518|NCT00149214|581909395|FG001|Overall Study|Progressive Disease|3|||
161143519|NCT01272180|581909396|FG000|Overall Study|Adverse Event|0|||
161143520|NCT01272180|581909397|FG001|Overall Study|Adverse Event|0|||
161143521|NCT01272180|581909398|FG002|Overall Study|Adverse Event|1|||
161263865|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
161263866|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
161263867|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
161263868|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Death|1|||
161263869|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Death|1|||
161263870|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Death|1|||
161263871|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Death|1|||
161263872|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Death|0|||
161263873|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Death|0|||
161263874|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Death|0|||
161263875|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
161263876|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161263877|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161263878|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
161263879|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
161263880|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
161263881|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
161263882|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161263883|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161263884|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
161263885|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161263886|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161263887|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161263888|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
161263889|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
161263890|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
161263891|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
161263892|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
161263893|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
161263894|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
161263895|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
161263896|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Other|2|||
161263897|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Other|9|||
161263898|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Other|9|||
161263899|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Other|3|||
161263900|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Other|2|||
161263901|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Other|0|||
161263902|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Other|0|||
161263903|NCT00361335|582347148|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
161263904|NCT00361335|582347149|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
161263905|NCT00361335|582347150|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
161263906|NCT00361335|582347151|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
161263907|NCT00361335|582347152|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
161263908|NCT00361335|582347153|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
161263909|NCT00361335|582347154|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
161263910|NCT00361335|582347148|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
161263911|NCT00361335|582347149|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
161263912|NCT00361335|582347150|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
161263913|NCT00361335|582347151|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
160998035|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
161143522|NCT01272180|581909399|FG003|Overall Study|Adverse Event|0|||
161143523|NCT01272180|581909396|FG000|Overall Study|Withdrawal by Subject|2|||
161143524|NCT01272180|581909397|FG001|Overall Study|Withdrawal by Subject|6|||
161143525|NCT01272180|581909398|FG002|Overall Study|Withdrawal by Subject|3|||
161143526|NCT01272180|581909399|FG003|Overall Study|Withdrawal by Subject|2|||
161143527|NCT01272180|581909396|FG000|Overall Study|Lost to Follow-up|15|||
161143528|NCT01272180|581909397|FG001|Overall Study|Lost to Follow-up|14|||
161342183|NCT02332707|582640131|FG011|Overall Study|Withdrawal by Subject|0|||
161342184|NCT02332707|582640132|FG012|Overall Study|Withdrawal by Subject|0|||
161342185|NCT02332707|582640133|FG013|Overall Study|Withdrawal by Subject|0|||
161342186|NCT02332707|582640134|FG014|Overall Study|Withdrawal by Subject|0|||
161342187|NCT02332707|582640135|FG015|Overall Study|Withdrawal by Subject|0|||
161342188|NCT02332707|582640136|FG016|Overall Study|Withdrawal by Subject|0|||
161342189|NCT02332707|582640137|FG017|Overall Study|Withdrawal by Subject|0|||
161342190|NCT01473134|582640138|FG000|Overall Study|Lost to Follow-up|21|||
161342191|NCT01473134|582640139|FG001|Overall Study|Lost to Follow-up|13|||
161342192|NCT01473134|582640138|FG000|Overall Study|Protocol Violation|32|||
161342193|NCT01473134|582640139|FG001|Overall Study|Protocol Violation|19|||
161342194|NCT01473134|582640138|FG000|Overall Study|Withdrawal by Subject|1|||
161342195|NCT01473134|582640139|FG001|Overall Study|Withdrawal by Subject|2|||
161342196|NCT01473134|582640138|FG000|Overall Study|Death|0|||
161342197|NCT01473134|582640139|FG001|Overall Study|Death|1|||
161342198|NCT01473134|582640138|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
161342199|NCT01473134|582640139|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
161342200|NCT04761822|582640142|FG000|Overall Study|Adverse Event|3|||
161342201|NCT04761822|582640143|FG001|Overall Study|Adverse Event|1|||
161342202|NCT04761822|582640144|FG002|Overall Study|Adverse Event|1|||
161342203|NCT04761822|582640145|FG003|Overall Study|Adverse Event|3|||
161342204|NCT04761822|582640142|FG000|Overall Study|Lost to Follow-up|1|||
161342205|NCT04761822|582640143|FG001|Overall Study|Lost to Follow-up|0|||
161342206|NCT04761822|582640144|FG002|Overall Study|Lost to Follow-up|2|||
161342207|NCT04761822|582640145|FG003|Overall Study|Lost to Follow-up|3|||
161342208|NCT04761822|582640142|FG000|Overall Study|Physician Decision|0|||
161342209|NCT04761822|582640143|FG001|Overall Study|Physician Decision|1|||
161342210|NCT04761822|582640144|FG002|Overall Study|Physician Decision|0|||
161342211|NCT04761822|582640145|FG003|Overall Study|Physician Decision|0|||
161342212|NCT04761822|582640142|FG000|Overall Study|Withdrawal by Subject|3|||
161342213|NCT04761822|582640143|FG001|Overall Study|Withdrawal by Subject|8|||
161342214|NCT04761822|582640144|FG002|Overall Study|Withdrawal by Subject|1|||
161342215|NCT04761822|582640145|FG003|Overall Study|Withdrawal by Subject|11|||
161342216|NCT04761822|582640142|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
161342217|NCT04761822|582640143|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161342218|NCT04761822|582640144|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161342219|NCT04761822|582640145|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
161342220|NCT04761822|582640142|FG000|Overall Study|Participant requested unblinding|0|||
161342221|NCT04761822|582640143|FG001|Overall Study|Participant requested unblinding|0|||
161342222|NCT04761822|582640144|FG002|Overall Study|Participant requested unblinding|0|||
161342223|NCT04761822|582640145|FG003|Overall Study|Participant requested unblinding|1|||
161342224|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
161342225|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
161342226|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Death|1|||
161342227|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Death|3|||
161342228|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
161342229|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
161342230|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
161342231|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
161143529|NCT01272180|581909398|FG002|Overall Study|Lost to Follow-up|8|||
161143530|NCT01272180|581909399|FG003|Overall Study|Lost to Follow-up|10|||
161143531|NCT01272180|581909396|FG000|Overall Study|Inappropriate enrollment|0|||
161143532|NCT01272180|581909397|FG001|Overall Study|Inappropriate enrollment|0|||
160862055|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
161143533|NCT01272180|581909398|FG002|Overall Study|Inappropriate enrollment|1|||
161143534|NCT01272180|581909399|FG003|Overall Study|Inappropriate enrollment|1|||
161143535|NCT01272180|581909396|FG000|Overall Study|Protocol Violation|0|||
161143536|NCT01272180|581909397|FG001|Overall Study|Protocol Violation|1|||
161143537|NCT01272180|581909398|FG002|Overall Study|Protocol Violation|0|||
161143538|NCT01272180|581909399|FG003|Overall Study|Protocol Violation|1|||
161143539|NCT03056287|581909400|FG000|Overall Study|Withdrawal by Subject|0|||
161143540|NCT03056287|581909401|FG001|Overall Study|Withdrawal by Subject|1|||
161342232|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
161342233|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
161342234|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
161342235|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
161342236|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
161342237|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
161342238|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
161342239|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
161342240|NCT00362232|582640146|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
161143541|NCT03056287|581909402|FG002|Overall Study|Withdrawal by Subject|0|||
161342241|NCT00362232|582640147|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
161342242|NCT00362232|582640146|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
161342243|NCT00362232|582640147|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
161342244|NCT00362232|582640146|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
161342245|NCT00362232|582640147|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
161342246|NCT00362232|582640146|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
161342247|NCT00362232|582640147|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
161342248|NCT00362232|582640146|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
161342249|NCT00362232|582640147|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
161342250|NCT02233413|582640152|FG000|Overall Study|Lost to Follow-up|7|||
161342251|NCT02233413|582640153|FG001|Overall Study|Lost to Follow-up|9|||
161342252|NCT02233413|582640152|FG000|Overall Study|Withdrawal by Subject|4|||
161342253|NCT02233413|582640153|FG001|Overall Study|Withdrawal by Subject|5|||
161342254|NCT01799889|582640154|FG000|Overall Study|Adverse Event|4|||
161342255|NCT01799889|582640155|FG001|Overall Study|Adverse Event|4|||
161342256|NCT01799889|582640156|FG002|Overall Study|Adverse Event|5|||
161342257|NCT01799889|582640157|FG003|Overall Study|Adverse Event|1|||
161342258|NCT01799889|582640158|FG004|Overall Study|Adverse Event|11|||
161342259|NCT01799889|582640159|FG005|Overall Study|Adverse Event|1|||
161342260|NCT01799889|582640160|FG006|Overall Study|Adverse Event|5|||
161342261|NCT01799889|582640161|FG007|Overall Study|Adverse Event|2|||
161342262|NCT01799889|582640162|FG008|Overall Study|Adverse Event|3|||
161342263|NCT01799889|582640163|FG009|Overall Study|Adverse Event|1|||
161342264|NCT01799889|582640164|FG010|Overall Study|Adverse Event|1|||
161342265|NCT01799889|582640165|FG011|Overall Study|Adverse Event|0|||
161342266|NCT01799889|582640154|FG000|Overall Study|Death|1|||
161342267|NCT01799889|582640155|FG001|Overall Study|Death|0|||
161342268|NCT01799889|582640156|FG002|Overall Study|Death|5|||
161342269|NCT01799889|582640157|FG003|Overall Study|Death|3|||
161342270|NCT01799889|582640158|FG004|Overall Study|Death|1|||
161342271|NCT01799889|582640159|FG005|Overall Study|Death|0|||
161342272|NCT01799889|582640160|FG006|Overall Study|Death|0|||
161342273|NCT01799889|582640161|FG007|Overall Study|Death|0|||
161342274|NCT01799889|582640162|FG008|Overall Study|Death|1|||
161342275|NCT01799889|582640163|FG009|Overall Study|Death|0|||
161342276|NCT01799889|582640164|FG010|Overall Study|Death|1|||
161342277|NCT01799889|582640165|FG011|Overall Study|Death|0|||
161342278|NCT01799889|582640154|FG000|Overall Study|Lack of Efficacy|1|||
161342279|NCT01799889|582640155|FG001|Overall Study|Lack of Efficacy|1|||
161342280|NCT01799889|582640156|FG002|Overall Study|Lack of Efficacy|0|||
161342281|NCT01799889|582640157|FG003|Overall Study|Lack of Efficacy|1|||
161342282|NCT01799889|582640158|FG004|Overall Study|Lack of Efficacy|2|||
161342283|NCT01799889|582640159|FG005|Overall Study|Lack of Efficacy|2|||
161342284|NCT01799889|582640160|FG006|Overall Study|Lack of Efficacy|0|||
161342285|NCT01799889|582640161|FG007|Overall Study|Lack of Efficacy|0|||
161342286|NCT01799889|582640162|FG008|Overall Study|Lack of Efficacy|2|||
161342287|NCT01799889|582640163|FG009|Overall Study|Lack of Efficacy|0|||
161342288|NCT01799889|582640164|FG010|Overall Study|Lack of Efficacy|1|||
161342289|NCT01799889|582640165|FG011|Overall Study|Lack of Efficacy|0|||
161342290|NCT01799889|582640154|FG000|Overall Study|Lost to Follow-up|0|||
161342291|NCT01799889|582640155|FG001|Overall Study|Lost to Follow-up|1|||
161342292|NCT01799889|582640156|FG002|Overall Study|Lost to Follow-up|0|||
161342293|NCT01799889|582640157|FG003|Overall Study|Lost to Follow-up|0|||
161342294|NCT01799889|582640158|FG004|Overall Study|Lost to Follow-up|0|||
161342295|NCT01799889|582640159|FG005|Overall Study|Lost to Follow-up|0|||
161342296|NCT01799889|582640160|FG006|Overall Study|Lost to Follow-up|0|||
161342297|NCT01799889|582640161|FG007|Overall Study|Lost to Follow-up|0|||
161342298|NCT01799889|582640162|FG008|Overall Study|Lost to Follow-up|0|||
161342299|NCT01799889|582640163|FG009|Overall Study|Lost to Follow-up|0|||
161342300|NCT01799889|582640164|FG010|Overall Study|Lost to Follow-up|0|||
161342301|NCT01799889|582640165|FG011|Overall Study|Lost to Follow-up|0|||
161342302|NCT01799889|582640154|FG000|Overall Study|Physician Decision|3|||
161342303|NCT01799889|582640155|FG001|Overall Study|Physician Decision|2|||
161342304|NCT01799889|582640156|FG002|Overall Study|Physician Decision|4|||
161342305|NCT01799889|582640157|FG003|Overall Study|Physician Decision|4|||
161342306|NCT01799889|582640158|FG004|Overall Study|Physician Decision|5|||
161342307|NCT01799889|582640159|FG005|Overall Study|Physician Decision|5|||
161342308|NCT01799889|582640160|FG006|Overall Study|Physician Decision|5|||
161342309|NCT01799889|582640161|FG007|Overall Study|Physician Decision|2|||
161342310|NCT01799889|582640162|FG008|Overall Study|Physician Decision|6|||
161342311|NCT01799889|582640163|FG009|Overall Study|Physician Decision|0|||
161342312|NCT01799889|582640164|FG010|Overall Study|Physician Decision|0|||
161342313|NCT01799889|582640165|FG011|Overall Study|Physician Decision|1|||
161342314|NCT01799889|582640154|FG000|Overall Study|Progressive Disease|30|||
161342315|NCT01799889|582640155|FG001|Overall Study|Progressive Disease|26|||
161342316|NCT01799889|582640156|FG002|Overall Study|Progressive Disease|25|||
161342317|NCT01799889|582640157|FG003|Overall Study|Progressive Disease|30|||
161342318|NCT01799889|582640158|FG004|Overall Study|Progressive Disease|23|||
161342319|NCT01799889|582640159|FG005|Overall Study|Progressive Disease|9|||
161342320|NCT01799889|582640160|FG006|Overall Study|Progressive Disease|8|||
161342321|NCT01799889|582640161|FG007|Overall Study|Progressive Disease|13|||
161342322|NCT01799889|582640162|FG008|Overall Study|Progressive Disease|18|||
161342323|NCT01799889|582640163|FG009|Overall Study|Progressive Disease|5|||
161342324|NCT01799889|582640164|FG010|Overall Study|Progressive Disease|3|||
161342325|NCT01799889|582640165|FG011|Overall Study|Progressive Disease|1|||
161342326|NCT01799889|582640154|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
161342327|NCT01799889|582640155|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
161342328|NCT01799889|582640156|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
161342329|NCT01799889|582640157|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
161342330|NCT01799889|582640158|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
161342331|NCT01799889|582640159|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
161342332|NCT01799889|582640160|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
161342333|NCT01799889|582640161|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
161342334|NCT01799889|582640162|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
161342335|NCT01799889|582640163|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
161342336|NCT01799889|582640164|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
161342337|NCT01799889|582640165|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
161342338|NCT01799889|582640154|FG000|Overall Study|Study Terminated By Sponsor|1|||
161342339|NCT01799889|582640155|FG001|Overall Study|Study Terminated By Sponsor|0|||
161342340|NCT01799889|582640156|FG002|Overall Study|Study Terminated By Sponsor|0|||
161342341|NCT01799889|582640157|FG003|Overall Study|Study Terminated By Sponsor|0|||
161342342|NCT01799889|582640158|FG004|Overall Study|Study Terminated By Sponsor|2|||
161342343|NCT01799889|582640159|FG005|Overall Study|Study Terminated By Sponsor|1|||
161342344|NCT01799889|582640160|FG006|Overall Study|Study Terminated By Sponsor|0|||
161342345|NCT01799889|582640161|FG007|Overall Study|Study Terminated By Sponsor|2|||
161342346|NCT01799889|582640162|FG008|Overall Study|Study Terminated By Sponsor|1|||
161342347|NCT01799889|582640163|FG009|Overall Study|Study Terminated By Sponsor|1|||
161342348|NCT01799889|582640164|FG010|Overall Study|Study Terminated By Sponsor|0|||
161342349|NCT01799889|582640165|FG011|Overall Study|Study Terminated By Sponsor|0|||
161342350|NCT01799889|582640154|FG000|Overall Study|Withdrawal by Subject|1|||
161342351|NCT01799889|582640155|FG001|Overall Study|Withdrawal by Subject|6|||
161342352|NCT01799889|582640156|FG002|Overall Study|Withdrawal by Subject|4|||
161342353|NCT01799889|582640157|FG003|Overall Study|Withdrawal by Subject|0|||
161342354|NCT01799889|582640158|FG004|Overall Study|Withdrawal by Subject|5|||
161342355|NCT01799889|582640159|FG005|Overall Study|Withdrawal by Subject|1|||
161342356|NCT01799889|582640160|FG006|Overall Study|Withdrawal by Subject|3|||
161342357|NCT01799889|582640161|FG007|Overall Study|Withdrawal by Subject|1|||
161342358|NCT01799889|582640162|FG008|Overall Study|Withdrawal by Subject|2|||
161342359|NCT01799889|582640163|FG009|Overall Study|Withdrawal by Subject|1|||
161342360|NCT01799889|582640164|FG010|Overall Study|Withdrawal by Subject|1|||
161342361|NCT01799889|582640165|FG011|Overall Study|Withdrawal by Subject|1|||
161342362|NCT01799889|582640154|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161342363|NCT01799889|582640155|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161342364|NCT01799889|582640156|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160926691|NCT00973479|581126549|FG001|Overall Study|Lack of Efficacy|7|||
160926692|NCT00973479|581126548|FG000|Overall Study|Adverse Event|12|||
160926693|NCT00973479|581126549|FG001|Overall Study|Adverse Event|32|||
160926694|NCT00973479|581126548|FG000|Overall Study|Protocol Violation|2|||
160926695|NCT00973479|581126549|FG001|Overall Study|Protocol Violation|2|||
160926696|NCT00973479|581126548|FG000|Overall Study|Other|1|||
160926697|NCT00973479|581126549|FG001|Overall Study|Other|7|||
160926698|NCT05075850|581126550|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
160926699|NCT04256785|581126551|FG000|Overall Study|Adverse Event|8|||
160926700|NCT04256785|581126552|FG001|Overall Study|Adverse Event|6|||
160926701|NCT04256785|581126551|FG000|Overall Study|Lack of Efficacy|3|||
160926702|NCT04256785|581126552|FG001|Overall Study|Lack of Efficacy|4|||
160926703|NCT04256785|581126551|FG000|Overall Study|Lost to Follow-up|7|||
160926704|NCT04256785|581126552|FG001|Overall Study|Lost to Follow-up|7|||
160926705|NCT04256785|581126551|FG000|Overall Study|Protocol Violation|1|||
160926706|NCT04256785|581126552|FG001|Overall Study|Protocol Violation|0|||
160926707|NCT04256785|581126551|FG000|Overall Study|Withdrawal by Subject|4|||
160926708|NCT04256785|581126552|FG001|Overall Study|Withdrawal by Subject|1|||
160926709|NCT04256785|581126551|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
160998036|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
161342365|NCT01799889|582640157|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161342366|NCT01799889|582640158|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161342367|NCT01799889|582640159|FG005|Overall Study|Non-Compliance With Study Drug|1|||
161342368|NCT01799889|582640160|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161342369|NCT01799889|582640161|FG007|Overall Study|Non-Compliance With Study Drug|0|||
161342370|NCT01799889|582640162|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161342371|NCT01799889|582640163|FG009|Overall Study|Non-Compliance With Study Drug|0|||
161342372|NCT01799889|582640164|FG010|Overall Study|Non-Compliance With Study Drug|0|||
160926710|NCT04256785|581126552|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
160926711|NCT00362115|581126553|FG000|Overall Study|Adverse Event|0|||
160926712|NCT00362115|581126554|FG001|Overall Study|Adverse Event|1|||
160926713|NCT00362115|581126555|FG002|Overall Study|Adverse Event|1|||
160926714|NCT00362115|581126556|FG003|Overall Study|Adverse Event|1|||
160926715|NCT00362115|581126557|FG004|Overall Study|Adverse Event|2|||
160926716|NCT00362115|581126558|FG005|Overall Study|Adverse Event|2|||
160926717|NCT00362115|581126559|FG006|Overall Study|Adverse Event|1|||
160926718|NCT00362115|581126553|FG000|Overall Study|Protocol Violation|0|||
160926719|NCT00362115|581126554|FG001|Overall Study|Protocol Violation|0|||
160926720|NCT00362115|581126555|FG002|Overall Study|Protocol Violation|0|||
160926721|NCT00362115|581126556|FG003|Overall Study|Protocol Violation|0|||
160926722|NCT00362115|581126557|FG004|Overall Study|Protocol Violation|0|||
160926723|NCT00362115|581126558|FG005|Overall Study|Protocol Violation|1|||
160926724|NCT00362115|581126559|FG006|Overall Study|Protocol Violation|0|||
160926725|NCT00362115|581126553|FG000|Overall Study|Lost to Follow-up|0|||
160926726|NCT00362115|581126554|FG001|Overall Study|Lost to Follow-up|1|||
160926727|NCT00362115|581126555|FG002|Overall Study|Lost to Follow-up|0|||
160926728|NCT00362115|581126556|FG003|Overall Study|Lost to Follow-up|0|||
160926729|NCT00362115|581126557|FG004|Overall Study|Lost to Follow-up|2|||
160926730|NCT00362115|581126558|FG005|Overall Study|Lost to Follow-up|0|||
160926731|NCT00362115|581126559|FG006|Overall Study|Lost to Follow-up|1|||
160926732|NCT00362115|581126553|FG000|Overall Study|Withdrawal by Subject|1|||
160926733|NCT00362115|581126554|FG001|Overall Study|Withdrawal by Subject|3|||
160926734|NCT00362115|581126555|FG002|Overall Study|Withdrawal by Subject|1|||
160926735|NCT00362115|581126556|FG003|Overall Study|Withdrawal by Subject|0|||
160926736|NCT00362115|581126557|FG004|Overall Study|Withdrawal by Subject|1|||
160926737|NCT00362115|581126558|FG005|Overall Study|Withdrawal by Subject|3|||
160926738|NCT00362115|581126559|FG006|Overall Study|Withdrawal by Subject|4|||
160926739|NCT00362115|581126553|FG000|Overall Study|Lack of Efficacy|1|||
160926740|NCT00362115|581126554|FG001|Overall Study|Lack of Efficacy|0|||
160926741|NCT00362115|581126555|FG002|Overall Study|Lack of Efficacy|5|||
160926742|NCT00362115|581126556|FG003|Overall Study|Lack of Efficacy|2|||
160926743|NCT00362115|581126557|FG004|Overall Study|Lack of Efficacy|2|||
160926744|NCT00362115|581126558|FG005|Overall Study|Lack of Efficacy|0|||
160926745|NCT00362115|581126559|FG006|Overall Study|Lack of Efficacy|3|||
160926746|NCT00362115|581126553|FG000|Overall Study|Physician Decision|0|||
160926747|NCT00362115|581126554|FG001|Overall Study|Physician Decision|0|||
160926748|NCT00362115|581126555|FG002|Overall Study|Physician Decision|0|||
160926749|NCT00362115|581126556|FG003|Overall Study|Physician Decision|0|||
160926750|NCT00362115|581126557|FG004|Overall Study|Physician Decision|0|||
160926751|NCT00362115|581126558|FG005|Overall Study|Physician Decision|0|||
160926752|NCT00362115|581126559|FG006|Overall Study|Physician Decision|3|||
160926753|NCT00362115|581126553|FG000|Overall Study|Other|0|||
160926754|NCT00362115|581126554|FG001|Overall Study|Other|1|||
160926755|NCT00362115|581126555|FG002|Overall Study|Other|0|||
160926756|NCT00362115|581126556|FG003|Overall Study|Other|1|||
160926757|NCT00362115|581126557|FG004|Overall Study|Other|0|||
160926758|NCT00362115|581126558|FG005|Overall Study|Other|1|||
160926759|NCT00362115|581126559|FG006|Overall Study|Other|0|||
160926760|NCT01170091|581126560|FG000|Overall Study|Missing efficacy evaluation|3|||
160926761|NCT01170091|581126560|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
160926762|NCT02188589|581126561|FG000|Overall Study|Withdrawal by Subject|5|||
160926763|NCT00003641|581126562|FG000|Overall Study|Withdrawal by Subject|0|||
160926764|NCT00003641|581126563|FG001|Overall Study|Withdrawal by Subject|100|||
160926765|NCT00003641|581126562|FG000|Overall Study|Adverse Event|0|||
160926766|NCT00003641|581126563|FG001|Overall Study|Adverse Event|38|||
160926767|NCT00003641|581126562|FG000|Overall Study|Disease progression|0|||
160926768|NCT00003641|581126563|FG001|Overall Study|Disease progression|2|||
160926769|NCT00003641|581126562|FG000|Overall Study|Unknown/missing|0|||
160926770|NCT00003641|581126563|FG001|Overall Study|Unknown/missing|22|||
160926771|NCT00003641|581126562|FG000|Overall Study|Should not receive interferon therapy|2|||
160926772|NCT00003641|581126563|FG001|Overall Study|Should not receive interferon therapy|0|||
160926773|NCT00003641|581126562|FG000|Overall Study|Never started interferon|567|||
160926774|NCT00003641|581126563|FG001|Overall Study|Never started interferon|12|||
160926775|NCT00741039|581126567|FG000|Overall Study|Patient non-compliance|2|||
160926776|NCT00741039|581126568|FG001|Overall Study|Patient non-compliance|0|||
160926777|NCT00878709|581126569|FG000|Overall Study|Withdrawal by Subject|197|||
160926778|NCT00878709|581126570|FG001|Overall Study|Withdrawal by Subject|120|||
161263914|NCT00361335|582347152|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
160926779|NCT00878709|581126569|FG000|Overall Study|Lost to Follow-up|35|||
160926780|NCT00878709|581126570|FG001|Overall Study|Lost to Follow-up|33|||
160926781|NCT00878709|581126569|FG000|Overall Study|Other Reasons|93|||
160926782|NCT00878709|581126570|FG001|Overall Study|Other Reasons|84|||
160926783|NCT00768300|581126571|FG000|Overall Study|Randomized but not treated|1|||
160926784|NCT00768300|581126572|FG001|Overall Study|Randomized but not treated|1|||
160926785|NCT00768300|581126571|FG000|Overall Study|Adverse Event|10|||
160926786|NCT00768300|581126572|FG001|Overall Study|Adverse Event|2|||
160926787|NCT00768300|581126571|FG000|Overall Study|Protocol Violation|6|||
160926788|NCT00768300|581126572|FG001|Overall Study|Protocol Violation|1|||
160926789|NCT00768300|581126571|FG000|Overall Study|Withdrawal by Subject|13|||
161263915|NCT00361335|582347153|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
161263916|NCT00361335|582347154|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
161263917|NCT00361335|582347148|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
161263918|NCT00361335|582347149|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161263919|NCT00361335|582347150|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
160926790|NCT00768300|581126572|FG001|Overall Study|Withdrawal by Subject|7|||
160926791|NCT00768300|581126571|FG000|Overall Study|Physician Decision|2|||
160926792|NCT00768300|581126572|FG001|Overall Study|Physician Decision|3|||
160926793|NCT00768300|581126571|FG000|Overall Study|Study discontinued by Sponsor|271|||
160926794|NCT00768300|581126572|FG001|Overall Study|Study discontinued by Sponsor|140|||
160926795|NCT00768300|581126571|FG000|Overall Study|Death|21|||
160926796|NCT00768300|581126572|FG001|Overall Study|Death|5|||
160926797|NCT00768300|581126571|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
160926798|NCT00768300|581126572|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
160926799|NCT00768300|581126571|FG000|Overall Study|Screen failure following randomization|1|||
160926800|NCT00768300|581126572|FG001|Overall Study|Screen failure following randomization|0|||
160926801|NCT00768300|581126571|FG000|Overall Study|Received lung transplant|1|||
160926802|NCT00768300|581126572|FG001|Overall Study|Received lung transplant|1|||
160926803|NCT00768300|581126571|FG000|Overall Study|Lost to Follow-up|0|||
160926804|NCT00768300|581126572|FG001|Overall Study|Lost to Follow-up|1|||
160926805|NCT00768300|581126571|FG000|Overall Study|Began prohibited concomitant medication|0|||
160926806|NCT00768300|581126572|FG001|Overall Study|Began prohibited concomitant medication|1|||
160926807|NCT00768300|581126571|FG000|Overall Study|Treated but never dosed with Study drug|1|||
160926808|NCT00768300|581126572|FG001|Overall Study|Treated but never dosed with Study drug|0|||
160926809|NCT00768300|581126571|FG000|Overall Study|Missing data|1|||
160926810|NCT00768300|581126572|FG001|Overall Study|Missing data|0|||
160926811|NCT02068222|581126573|FG000|Overall Study|Lost to Follow-up|1|||
160926812|NCT01374087|581126576|FG000|Overall Study|Adverse Event|1|||
160926813|NCT01374087|581126577|FG001|Overall Study|Adverse Event|0|||
160926814|NCT01374087|581126576|FG000|Overall Study|Disease progression|2|||
160926815|NCT01374087|581126577|FG001|Overall Study|Disease progression|2|||
160926816|NCT01374087|581126576|FG000|Overall Study|Study discontinued|13|||
160926817|NCT01374087|581126577|FG001|Overall Study|Study discontinued|13|||
160926818|NCT03011307|581126578|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
160926819|NCT03011307|581126579|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
160926820|NCT03011307|581126578|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
160926821|NCT03011307|581126579|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
160926822|NCT03011307|581126578|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
160926823|NCT03011307|581126579|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
160926824|NCT04307446|581128137|FG000|Overall Study|Lost to Follow-up|2|||
160926825|NCT04307446|581128138|FG001|Overall Study|Lost to Follow-up|0|||
160926826|NCT02515942|581128139|FG000|Overall Study|Adverse Event|5|||
160926827|NCT02515942|581128140|FG001|Overall Study|Adverse Event|0|||
160926828|NCT02515942|581128141|FG002|Overall Study|Adverse Event|0|||
160926829|NCT02515942|581128139|FG000|Overall Study|Death|0|||
160926830|NCT02515942|581128140|FG001|Overall Study|Death|0|||
160926831|NCT02515942|581128141|FG002|Overall Study|Death|1|||
160926832|NCT02515942|581128139|FG000|Overall Study|Lack of Efficacy|0|||
160926833|NCT02515942|581128140|FG001|Overall Study|Lack of Efficacy|0|||
160926834|NCT02515942|581128141|FG002|Overall Study|Lack of Efficacy|1|||
160926835|NCT02515942|581128139|FG000|Overall Study|Lost to Follow-up|2|||
160926836|NCT02515942|581128140|FG001|Overall Study|Lost to Follow-up|0|||
160926837|NCT02515942|581128141|FG002|Overall Study|Lost to Follow-up|0|||
160926838|NCT02515942|581128139|FG000|Overall Study|Withdrawal by Subject|0|||
160926839|NCT02515942|581128140|FG001|Overall Study|Withdrawal by Subject|3|||
160926840|NCT02515942|581128141|FG002|Overall Study|Withdrawal by Subject|2|||
161263920|NCT00361335|582347151|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161263921|NCT00361335|582347152|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161342373|NCT01799889|582640165|FG011|Overall Study|Non-Compliance With Study Drug|0|||
161342374|NCT06217380|582640166|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
161342375|NCT06217380|582640166|FG000|Overall Study|Physician Decision|1|||
161342376|NCT06217380|582640166|FG000|Overall Study|Withdrawal by Subject|2|||
161342377|NCT06633965|582640167|FG000|Overall Study|Withdrawal by Subject|0|||
161342378|NCT06633965|582640168|FG001|Overall Study|Withdrawal by Subject|1|||
161342379|NCT00300053|582640171|FG000|Overall Study|Patient/Caregiver Preference|2|||
161342380|NCT00300053|582640172|FG001|Overall Study|Patient/Caregiver Preference|2|||
161342381|NCT00300053|582640173|FG002|Overall Study|Patient/Caregiver Preference|3|||
161342382|NCT00300053|582640171|FG000|Overall Study|Death|0|||
161342383|NCT00300053|582640172|FG001|Overall Study|Death|0|||
160926841|NCT00902564|581128142|FG000|Overall Study|Withdrawal by Subject|2|||
160926842|NCT05620576|581128143|FG000|Overall Study|Adverse Event|1|||
161263922|NCT00361335|582347153|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
161263923|NCT00361335|582347154|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
160926843|NCT05620576|581128144|FG001|Overall Study|Adverse Event|1|||
160926844|NCT05620576|581128143|FG000|Overall Study|Lost to Follow-up|3|||
160926845|NCT05620576|581128144|FG001|Overall Study|Lost to Follow-up|1|||
160926846|NCT05620576|581128143|FG000|Overall Study|Physician Decision|0|||
160926847|NCT05620576|581128144|FG001|Overall Study|Physician Decision|1|||
160926848|NCT05620576|581128143|FG000|Overall Study|Protocol Deviation|1|||
160926849|NCT05620576|581128144|FG001|Overall Study|Protocol Deviation|1|||
160926850|NCT05620576|581128143|FG000|Overall Study|Withdrawal by Subject|2|||
160926851|NCT05620576|581128144|FG001|Overall Study|Withdrawal by Subject|3|||
160926852|NCT03336216|581128145|FG000|Randomization|Not reported|2|||
160926853|NCT03336216|581128146|FG001|Randomization|Not reported|0|||
160926854|NCT03336216|581128147|FG002|Randomization|Not reported|1|||
160926855|NCT03336216|581128148|FG003|Randomization|Not reported|0|||
160926856|NCT03336216|581128145|FG000|Randomization|Other reasons|1|||
160926857|NCT03336216|581128146|FG001|Randomization|Other reasons|1|||
160926858|NCT03336216|581128147|FG002|Randomization|Other reasons|1|||
160926859|NCT03336216|581128148|FG003|Randomization|Other reasons|0|||
160926860|NCT03336216|581128145|FG000|Randomization|Participant no longer meets study criteria|0|||
160926861|NCT03336216|581128146|FG001|Randomization|Participant no longer meets study criteria|2|||
160926862|NCT03336216|581128147|FG002|Randomization|Participant no longer meets study criteria|4|||
160926863|NCT03336216|581128148|FG003|Randomization|Participant no longer meets study criteria|1|||
160926864|NCT03336216|581128145|FG000|Randomization|Lost to Follow-up|1|||
160926865|NCT03336216|581128146|FG001|Randomization|Lost to Follow-up|0|||
160926866|NCT03336216|581128147|FG002|Randomization|Lost to Follow-up|0|||
160926867|NCT03336216|581128148|FG003|Randomization|Lost to Follow-up|0|||
160926868|NCT03336216|581128145|FG000|Randomization|Participant withdrew consent|9|||
160926869|NCT03336216|581128146|FG001|Randomization|Participant withdrew consent|1|||
160926870|NCT03336216|581128147|FG002|Randomization|Participant withdrew consent|0|||
160926871|NCT03336216|581128148|FG003|Randomization|Participant withdrew consent|0|||
160926872|NCT03336216|581128145|FG000|Randomization|Adverse Event|1|||
160926873|NCT03336216|581128146|FG001|Randomization|Adverse Event|1|||
160926874|NCT03336216|581128147|FG002|Randomization|Adverse Event|0|||
160926875|NCT03336216|581128148|FG003|Randomization|Adverse Event|0|||
160926876|NCT03336216|581128145|FG000|Treatment|Adverse Event|2|||
160926877|NCT03336216|581128146|FG001|Treatment|Adverse Event|3|||
160926878|NCT03336216|581128147|FG002|Treatment|Adverse Event|4|||
160926879|NCT03336216|581128148|FG003|Treatment|Adverse Event|4|||
160926880|NCT03336216|581128145|FG000|Treatment|Participant request to discontinue treatment|2|||
160926881|NCT03336216|581128146|FG001|Treatment|Participant request to discontinue treatment|1|||
160926882|NCT03336216|581128147|FG002|Treatment|Participant request to discontinue treatment|2|||
160926883|NCT03336216|581128148|FG003|Treatment|Participant request to discontinue treatment|2|||
160926884|NCT03336216|581128145|FG000|Treatment|Participant withdrew consent|7|||
160926885|NCT03336216|581128146|FG001|Treatment|Participant withdrew consent|2|||
160998037|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
160998038|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
160998039|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
160998040|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
160998041|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
160926886|NCT03336216|581128147|FG002|Treatment|Participant withdrew consent|3|||
160926887|NCT03336216|581128148|FG003|Treatment|Participant withdrew consent|2|||
160926888|NCT03336216|581128145|FG000|Treatment|Death|2|||
160926889|NCT03336216|581128146|FG001|Treatment|Death|3|||
160926890|NCT03336216|581128147|FG002|Treatment|Death|3|||
160926891|NCT03336216|581128148|FG003|Treatment|Death|4|||
160926892|NCT03336216|581128145|FG000|Treatment|Participant no longer meets study criteria|0|||
160926893|NCT03336216|581128146|FG001|Treatment|Participant no longer meets study criteria|1|||
160926894|NCT03336216|581128147|FG002|Treatment|Participant no longer meets study criteria|0|||
160926895|NCT03336216|581128148|FG003|Treatment|Participant no longer meets study criteria|0|||
160998042|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
160926896|NCT03336216|581128145|FG000|Treatment|Other reasons|2|||
160926897|NCT03336216|581128146|FG001|Treatment|Other reasons|0|||
160926898|NCT03336216|581128147|FG002|Treatment|Other reasons|0|||
160926899|NCT03336216|581128148|FG003|Treatment|Other reasons|3|||
160926900|NCT03336216|581128145|FG000|Treatment|Disease progression|23|||
160926901|NCT03336216|581128146|FG001|Treatment|Disease progression|34|||
160926902|NCT03336216|581128147|FG002|Treatment|Disease progression|33|||
160926903|NCT03336216|581128148|FG003|Treatment|Disease progression|26|||
160926904|NCT03336216|581128145|FG000|Treatment|Study drug toxicity|0|||
160926905|NCT03336216|581128146|FG001|Treatment|Study drug toxicity|3|||
160926906|NCT03336216|581128147|FG002|Treatment|Study drug toxicity|2|||
160926907|NCT03336216|581128148|FG003|Treatment|Study drug toxicity|0|||
160926908|NCT03336216|581128145|FG000|Treatment|Adverse Event unrelated to study drug|1|||
160926909|NCT03336216|581128146|FG001|Treatment|Adverse Event unrelated to study drug|1|||
160926910|NCT03336216|581128147|FG002|Treatment|Adverse Event unrelated to study drug|1|||
160926911|NCT03336216|581128148|FG003|Treatment|Adverse Event unrelated to study drug|0|||
160926912|NCT03336216|581128145|FG000|Treatment|Disease Recurrence|1|||
160998043|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
160998044|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
160998045|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
160998046|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
160998047|NCT00241644|581378523|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
160998048|NCT00241644|581378524|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
160998049|NCT00241644|581378525|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
160998050|NCT00241644|581378526|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
160998051|NCT00864682|581378528|FG000|Overall Study|Protocol Violation|2|||
160998052|NCT00864682|581378529|FG001|Overall Study|Protocol Violation|1|||
160998053|NCT00864682|581378530|FG002|Overall Study|Protocol Violation|2|||
161263924|NCT00361335|582347148|FG000|SC Period: Week E0 to Week E24|Death|0|||
161263925|NCT00361335|582347149|FG001|SC Period: Week E0 to Week E24|Death|0|||
161263926|NCT00361335|582347150|FG002|SC Period: Week E0 to Week E24|Death|0|||
161263927|NCT00361335|582347151|FG003|SC Period: Week E0 to Week E24|Death|0|||
161263928|NCT00361335|582347152|FG004|SC Period: Week E0 to Week E24|Death|0|||
161263929|NCT00361335|582347153|FG005|SC Period: Week E0 to Week E24|Death|0|||
161263930|NCT00361335|582347154|FG006|SC Period: Week E0 to Week E24|Death|1|||
161263931|NCT00361335|582347148|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161263932|NCT00361335|582347149|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161263933|NCT00361335|582347150|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161263934|NCT00361335|582347151|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
161263935|NCT00361335|582347152|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161263936|NCT00361335|582347153|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
160926913|NCT03336216|581128146|FG001|Treatment|Disease Recurrence|0|||
160926914|NCT03336216|581128147|FG002|Treatment|Disease Recurrence|0|||
160926915|NCT03336216|581128148|FG003|Treatment|Disease Recurrence|0|||
160926916|NCT02622828|581128149|FG000|Overall Study|participant withdrew|3|||
160926917|NCT03616912|581128150|FG000|Overall Study|Adverse Event|17|||
160926918|NCT03616912|581128151|FG001|Overall Study|Adverse Event|21|||
160926919|NCT03616912|581128152|FG002|Overall Study|Adverse Event|9|||
160926920|NCT03616912|581128153|FG003|Overall Study|Adverse Event|0|||
160926921|NCT03616912|581128154|FG004|Overall Study|Adverse Event|0|||
160926922|NCT03616912|581128155|FG005|Overall Study|Adverse Event|0|||
160926923|NCT03616912|581128150|FG000|Overall Study|Death|1|||
160926924|NCT03616912|581128151|FG001|Overall Study|Death|1|||
160926925|NCT03616912|581128152|FG002|Overall Study|Death|0|||
160926926|NCT03616912|581128153|FG003|Overall Study|Death|0|||
160926927|NCT03616912|581128154|FG004|Overall Study|Death|0|||
160926928|NCT03616912|581128155|FG005|Overall Study|Death|0|||
160926929|NCT03616912|581128150|FG000|Overall Study|Lack of Efficacy|13|||
160926930|NCT03616912|581128151|FG001|Overall Study|Lack of Efficacy|6|||
160926931|NCT03616912|581128152|FG002|Overall Study|Lack of Efficacy|8|||
160926932|NCT03616912|581128153|FG003|Overall Study|Lack of Efficacy|4|||
160926933|NCT03616912|581128154|FG004|Overall Study|Lack of Efficacy|5|||
160926934|NCT03616912|581128155|FG005|Overall Study|Lack of Efficacy|1|||
160926935|NCT03616912|581128150|FG000|Overall Study|Lost to Follow-up|1|||
160926936|NCT03616912|581128151|FG001|Overall Study|Lost to Follow-up|2|||
160926937|NCT03616912|581128152|FG002|Overall Study|Lost to Follow-up|3|||
160926938|NCT03616912|581128153|FG003|Overall Study|Lost to Follow-up|0|||
160926939|NCT03616912|581128154|FG004|Overall Study|Lost to Follow-up|0|||
160926940|NCT03616912|581128155|FG005|Overall Study|Lost to Follow-up|0|||
160926941|NCT03616912|581128150|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
160926942|NCT03616912|581128151|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
160926943|NCT03616912|581128152|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
160926944|NCT03616912|581128153|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
160926945|NCT03616912|581128154|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
160926946|NCT03616912|581128155|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
160926947|NCT03616912|581128150|FG000|Overall Study|Withdrawal by Subject|12|||
160926948|NCT03616912|581128151|FG001|Overall Study|Withdrawal by Subject|12|||
161263937|NCT00361335|582347154|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
161263938|NCT00361335|582347148|FG000|SC Period: Week E0 to Week E24|Other|1|||
160926949|NCT03616912|581128152|FG002|Overall Study|Withdrawal by Subject|15|||
160926950|NCT03616912|581128153|FG003|Overall Study|Withdrawal by Subject|2|||
160926951|NCT03616912|581128154|FG004|Overall Study|Withdrawal by Subject|0|||
160998054|NCT00094809|581378534|FG000|Overall Study|Protocol deviation|2|||
160998055|NCT00094809|581378535|FG001|Overall Study|Protocol deviation|2|||
160998056|NCT00094809|581378534|FG000|Overall Study|Noncompliance|1|||
161263939|NCT00361335|582347149|FG001|SC Period: Week E0 to Week E24|Other|0|||
160926952|NCT03616912|581128155|FG005|Overall Study|Withdrawal by Subject|2|||
160926953|NCT03616912|581128150|FG000|Overall Study|Study Terminated by Sponsor|0|||
160926954|NCT03616912|581128151|FG001|Overall Study|Study Terminated by Sponsor|0|||
160926955|NCT03616912|581128152|FG002|Overall Study|Study Terminated by Sponsor|0|||
160926956|NCT03616912|581128153|FG003|Overall Study|Study Terminated by Sponsor|10|||
160926957|NCT03616912|581128154|FG004|Overall Study|Study Terminated by Sponsor|9|||
161263940|NCT00361335|582347150|FG002|SC Period: Week E0 to Week E24|Other|0|||
160926958|NCT03616912|581128155|FG005|Overall Study|Study Terminated by Sponsor|11|||
160926959|NCT03616912|581128150|FG000|Overall Study|Protocol Deviation|1|||
160926960|NCT03616912|581128151|FG001|Overall Study|Protocol Deviation|1|||
160926961|NCT03616912|581128152|FG002|Overall Study|Protocol Deviation|0|||
160926962|NCT03616912|581128153|FG003|Overall Study|Protocol Deviation|0|||
160926963|NCT03616912|581128154|FG004|Overall Study|Protocol Deviation|0|||
160926964|NCT03616912|581128155|FG005|Overall Study|Protocol Deviation|0|||
160926965|NCT03616912|581128150|FG000|Overall Study|Pregnancy|1|||
160926966|NCT03616912|581128151|FG001|Overall Study|Pregnancy|0|||
160926967|NCT03616912|581128152|FG002|Overall Study|Pregnancy|4|||
160926968|NCT03616912|581128153|FG003|Overall Study|Pregnancy|0|||
160926969|NCT03616912|581128154|FG004|Overall Study|Pregnancy|0|||
160926970|NCT03616912|581128155|FG005|Overall Study|Pregnancy|0|||
160926971|NCT03616912|581128150|FG000|Overall Study|Protocol Violation|1|||
160926972|NCT03616912|581128151|FG001|Overall Study|Protocol Violation|0|||
160926973|NCT03616912|581128152|FG002|Overall Study|Protocol Violation|2|||
160926974|NCT03616912|581128153|FG003|Overall Study|Protocol Violation|0|||
160926975|NCT03616912|581128154|FG004|Overall Study|Protocol Violation|0|||
160926976|NCT03616912|581128155|FG005|Overall Study|Protocol Violation|0|||
160926977|NCT03616912|581128150|FG000|Overall Study|Physician Decision|2|||
160926978|NCT03616912|581128151|FG001|Overall Study|Physician Decision|0|||
160926979|NCT03616912|581128152|FG002|Overall Study|Physician Decision|0|||
160926980|NCT03616912|581128153|FG003|Overall Study|Physician Decision|0|||
160926981|NCT03616912|581128154|FG004|Overall Study|Physician Decision|1|||
160926982|NCT03616912|581128155|FG005|Overall Study|Physician Decision|0|||
160926983|NCT03616912|581128150|FG000|Overall Study|Randomized But Never Treated|0|||
160926984|NCT03616912|581128151|FG001|Overall Study|Randomized But Never Treated|2|||
160926985|NCT03616912|581128152|FG002|Overall Study|Randomized But Never Treated|0|||
160926986|NCT03616912|581128153|FG003|Overall Study|Randomized But Never Treated|0|||
160926987|NCT03616912|581128154|FG004|Overall Study|Randomized But Never Treated|0|||
160926988|NCT03616912|581128155|FG005|Overall Study|Randomized But Never Treated|0|||
160926989|NCT01124604|581128156|FG000|Overall Study|Adverse Event|10|||
160926990|NCT01124604|581128157|FG001|Overall Study|Adverse Event|1|||
160926991|NCT01124604|581128156|FG000|Overall Study|Lack of Efficacy|1|||
160926992|NCT01124604|581128157|FG001|Overall Study|Lack of Efficacy|0|||
160926993|NCT01124604|581128156|FG000|Overall Study|Withdrawal by Subject|4|||
160926994|NCT01124604|581128157|FG001|Overall Study|Withdrawal by Subject|0|||
160926995|NCT01124604|581128156|FG000|Overall Study|Disease Progression|0|||
160926996|NCT01124604|581128157|FG001|Overall Study|Disease Progression|1|||
160926997|NCT01859507|581128158|FG000|Overall Study|left the country|4|||
160926998|NCT01762943|581128159|FG000|Overall Study|Physician Decision|1|||
160926999|NCT01762943|581128160|FG001|Overall Study|Physician Decision|1|||
160927000|NCT01762943|581128159|FG000|Overall Study|Protocol Violation|1|||
160927001|NCT01762943|581128160|FG001|Overall Study|Protocol Violation|0|||
160927002|NCT01762943|581128159|FG000|Overall Study|Withdrawal by Subject|2|||
160927003|NCT01762943|581128160|FG001|Overall Study|Withdrawal by Subject|1|||
160927004|NCT00539838|581128161|FG000|Overall Study|Fail to return|2|||
160927005|NCT00539838|581128162|FG001|Overall Study|Fail to return|0|||
160927006|NCT00539838|581128163|FG002|Overall Study|Fail to return|0|||
160927007|NCT00539838|581128161|FG000|Overall Study|Withdrawal by Subject|0|||
160927008|NCT00539838|581128162|FG001|Overall Study|Withdrawal by Subject|4|||
160927009|NCT00539838|581128163|FG002|Overall Study|Withdrawal by Subject|0|||
160927010|NCT00539838|581128161|FG000|Overall Study|Death|0|||
160927011|NCT00539838|581128162|FG001|Overall Study|Death|2|||
160927012|NCT00539838|581128163|FG002|Overall Study|Death|0|||
160927013|NCT00539838|581128161|FG000|Overall Study|Did not cooperate|1|||
160927014|NCT00539838|581128162|FG001|Overall Study|Did not cooperate|0|||
160927015|NCT00539838|581128163|FG002|Overall Study|Did not cooperate|1|||
160927016|NCT00539838|581128161|FG000|Overall Study|Administrative|4|||
160927017|NCT00539838|581128162|FG001|Overall Study|Administrative|0|||
160927018|NCT00539838|581128163|FG002|Overall Study|Administrative|8|||
160927019|NCT02474199|581128167|FG000|Overall Study|Lost to Follow-up|1|||
160927020|NCT02474199|581128168|FG001|Overall Study|Lost to Follow-up|0|||
160927021|NCT02474199|581128169|FG002|Overall Study|Lost to Follow-up|0|||
160927022|NCT02474199|581128170|FG003|Overall Study|Lost to Follow-up|0|||
160927023|NCT02474199|581128167|FG000|Overall Study|Withdrawal by Subject|1|||
160927024|NCT02474199|581128168|FG001|Overall Study|Withdrawal by Subject|2|||
160927025|NCT02474199|581128169|FG002|Overall Study|Withdrawal by Subject|0|||
160927026|NCT02474199|581128170|FG003|Overall Study|Withdrawal by Subject|1|||
160927027|NCT02474199|581128167|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
160927028|NCT02474199|581128168|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
160927029|NCT02474199|581128169|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
160927030|NCT02474199|581128170|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
160927031|NCT02474199|581128167|FG000|Overall Study|Did not meet eligibility criteria|0|||
160927032|NCT02474199|581128168|FG001|Overall Study|Did not meet eligibility criteria|0|||
160927033|NCT02474199|581128169|FG002|Overall Study|Did not meet eligibility criteria|2|||
160927034|NCT02474199|581128170|FG003|Overall Study|Did not meet eligibility criteria|2|||
160927035|NCT03090100|581128171|FG000|Overall Study|Adverse Event|9|||
161263941|NCT00361335|582347151|FG003|SC Period: Week E0 to Week E24|Other|1|||
161263942|NCT00361335|582347152|FG004|SC Period: Week E0 to Week E24|Other|0|||
161263943|NCT00361335|582347153|FG005|SC Period: Week E0 to Week E24|Other|1|||
161263944|NCT00361335|582347154|FG006|SC Period: Week E0 to Week E24|Other|2|||
161263945|NCT00361335|582347148|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161263946|NCT00361335|582347149|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161263947|NCT00361335|582347150|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
161263948|NCT00361335|582347151|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161263949|NCT00361335|582347152|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161263950|NCT00361335|582347153|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
161263951|NCT00361335|582347154|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
161263952|NCT01765582|582347163|FG000|Overall Study|Other|3|||
161263953|NCT01765582|582347164|FG001|Overall Study|Other|6|||
161263954|NCT01765582|582347165|FG002|Overall Study|Other|9|||
161263955|NCT01765582|582347163|FG000|Overall Study|Lost to Follow-up|2|||
161263956|NCT01765582|582347164|FG001|Overall Study|Lost to Follow-up|2|||
160927036|NCT03090100|581128172|FG001|Overall Study|Adverse Event|11|||
160927037|NCT03090100|581128171|FG000|Overall Study|Pregnancy|1|||
160927038|NCT03090100|581128172|FG001|Overall Study|Pregnancy|1|||
160927039|NCT03090100|581128171|FG000|Overall Study|Lack of Efficacy|2|||
160927040|NCT03090100|581128172|FG001|Overall Study|Lack of Efficacy|7|||
160927041|NCT03090100|581128171|FG000|Overall Study|Lost to Follow-up|2|||
160927042|NCT03090100|581128172|FG001|Overall Study|Lost to Follow-up|2|||
160927043|NCT03090100|581128171|FG000|Overall Study|Withdrawal by Subject|7|||
160927044|NCT03090100|581128172|FG001|Overall Study|Withdrawal by Subject|19|||
160927045|NCT03090100|581128171|FG000|Overall Study|Protocol Violation|2|||
160927046|NCT03090100|581128172|FG001|Overall Study|Protocol Violation|6|||
160927047|NCT03090100|581128171|FG000|Overall Study|Non-compliance|2|||
160927048|NCT03090100|581128172|FG001|Overall Study|Non-compliance|0|||
160927049|NCT03090100|581128171|FG000|Overall Study|Other|2|||
160927050|NCT03090100|581128172|FG001|Overall Study|Other|2|||
160927051|NCT00159588|581128175|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
160927052|NCT00159588|581128176|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
160927053|NCT00159588|581128177|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
160927054|NCT00456521|581128178|FG000|Overall Study|Adverse Event|150|||
160927055|NCT00456521|581128179|FG001|Overall Study|Adverse Event|25|||
160927056|NCT00456521|581128178|FG000|Overall Study|Withdrawal by Subject|43|||
160927057|NCT00456521|581128179|FG001|Overall Study|Withdrawal by Subject|24|||
160927058|NCT00456521|581128178|FG000|Overall Study|Lost to Follow-up|22|||
160927059|NCT00456521|581128179|FG001|Overall Study|Lost to Follow-up|17|||
160927060|NCT00456521|581128178|FG000|Overall Study|Lack of Efficacy|3|||
160927061|NCT00456521|581128179|FG001|Overall Study|Lack of Efficacy|6|||
160927062|NCT00456521|581128178|FG000|Overall Study|Protocol Violation|4|||
160927063|NCT00456521|581128179|FG001|Overall Study|Protocol Violation|0|||
160927064|NCT00456521|581128178|FG000|Overall Study|Pregnancy|1|||
160927065|NCT00456521|581128179|FG001|Overall Study|Pregnancy|1|||
160927066|NCT00456521|581128178|FG000|Overall Study|Drug non-compliance, moved, other|26|||
160927067|NCT00456521|581128179|FG001|Overall Study|Drug non-compliance, moved, other|11|||
160927068|NCT02596854|581128180|FG000|Overall Study|Withdrawn|8|||
160927069|NCT03406858|581128183|FG000|Overall Study|Failure to receive treatment drug.|1|||
160927070|NCT03406858|581128183|FG000|Overall Study|ineligible|1|||
160927071|NCT00405587|581128184|FG000|Overall Study|Death|0|||
160927072|NCT00405587|581128185|FG001|Overall Study|Death|0|||
160927073|NCT00405587|581128186|FG002|Overall Study|Death|0|||
160927074|NCT00405587|581128187|FG003|Overall Study|Death|1|||
160927075|NCT00405587|581128184|FG000|Overall Study|Disease Progression|22|||
160927076|NCT00405587|581128185|FG001|Overall Study|Disease Progression|23|||
160927077|NCT00405587|581128186|FG002|Overall Study|Disease Progression|21|||
160927078|NCT00405587|581128187|FG003|Overall Study|Disease Progression|17|||
160927079|NCT00405587|581128184|FG000|Overall Study|Physician Decision|3|||
160927080|NCT00405587|581128185|FG001|Overall Study|Physician Decision|2|||
160927081|NCT00405587|581128186|FG002|Overall Study|Physician Decision|0|||
160927082|NCT00405587|581128187|FG003|Overall Study|Physician Decision|0|||
160927083|NCT00405587|581128184|FG000|Overall Study|Adverse Event|1|||
160927084|NCT00405587|581128185|FG001|Overall Study|Adverse Event|0|||
160927085|NCT00405587|581128186|FG002|Overall Study|Adverse Event|0|||
160927086|NCT00405587|581128187|FG003|Overall Study|Adverse Event|0|||
160927087|NCT00405587|581128184|FG000|Overall Study|Lost to Follow-up|0|||
160927088|NCT00405587|581128185|FG001|Overall Study|Lost to Follow-up|1|||
160927089|NCT00405587|581128186|FG002|Overall Study|Lost to Follow-up|1|||
160927090|NCT00405587|581128187|FG003|Overall Study|Lost to Follow-up|0|||
160927091|NCT00405587|581128184|FG000|Overall Study|Radiation induced necrosis|0|||
160998057|NCT00094809|581378535|FG001|Overall Study|Noncompliance|0|||
161263957|NCT01765582|582347165|FG002|Overall Study|Lost to Follow-up|1|||
161263958|NCT01765582|582347163|FG000|Overall Study|Death|31|||
161263959|NCT01765582|582347164|FG001|Overall Study|Death|36|||
161263960|NCT01765582|582347165|FG002|Overall Study|Death|33|||
161263961|NCT01765582|582347163|FG000|Overall Study|Sponsor Decision|46|||
161263962|NCT01765582|582347164|FG001|Overall Study|Sponsor Decision|42|||
161263963|NCT01765582|582347165|FG002|Overall Study|Sponsor Decision|42|||
160927092|NCT00405587|581128185|FG001|Overall Study|Radiation induced necrosis|1|||
160927093|NCT00405587|581128186|FG002|Overall Study|Radiation induced necrosis|0|||
160927094|NCT00405587|581128187|FG003|Overall Study|Radiation induced necrosis|0|||
160927095|NCT00405587|581128184|FG000|Overall Study|Withdrawal by Subject|0|||
160927096|NCT00405587|581128185|FG001|Overall Study|Withdrawal by Subject|0|||
160927097|NCT00405587|581128186|FG002|Overall Study|Withdrawal by Subject|0|||
160927098|NCT00405587|581128187|FG003|Overall Study|Withdrawal by Subject|2|||
160927099|NCT00405587|581128184|FG000|Overall Study|Participant not dosed|0|||
160927100|NCT00405587|581128185|FG001|Overall Study|Participant not dosed|1|||
160927101|NCT00405587|581128186|FG002|Overall Study|Participant not dosed|0|||
160927102|NCT00405587|581128187|FG003|Overall Study|Participant not dosed|0|||
160927103|NCT06027866|581128188|FG000|Overall Study|Withdrawal by Subject|2|||
160927104|NCT00507442|581128191|FG000|Overall Study|Adverse Event|8|||
160927105|NCT00507442|581128192|FG001|Overall Study|Adverse Event|11|||
160927106|NCT00507442|581128193|FG002|Overall Study|Adverse Event|4|||
160927107|NCT00507442|581128194|FG003|Overall Study|Adverse Event|1|||
160927108|NCT00507442|581128191|FG000|Overall Study|Protocol Violation|0|||
160927109|NCT00507442|581128192|FG001|Overall Study|Protocol Violation|1|||
160927110|NCT00507442|581128193|FG002|Overall Study|Protocol Violation|0|||
160927111|NCT00507442|581128194|FG003|Overall Study|Protocol Violation|0|||
160927112|NCT00507442|581128191|FG000|Overall Study|Lost to Follow-up|0|||
160927113|NCT00507442|581128192|FG001|Overall Study|Lost to Follow-up|0|||
160927114|NCT00507442|581128193|FG002|Overall Study|Lost to Follow-up|1|||
160927115|NCT00507442|581128194|FG003|Overall Study|Lost to Follow-up|0|||
160927116|NCT00507442|581128191|FG000|Overall Study|Physician Decision|0|||
160927117|NCT00507442|581128192|FG001|Overall Study|Physician Decision|2|||
160927118|NCT00507442|581128193|FG002|Overall Study|Physician Decision|4|||
160927119|NCT00507442|581128194|FG003|Overall Study|Physician Decision|1|||
160927120|NCT00507442|581128191|FG000|Overall Study|Progressive Disease|2|||
160927121|NCT00507442|581128192|FG001|Overall Study|Progressive Disease|4|||
160927122|NCT00507442|581128193|FG002|Overall Study|Progressive Disease|2|||
160927123|NCT00507442|581128194|FG003|Overall Study|Progressive Disease|0|||
160927124|NCT00507442|581128191|FG000|Overall Study|Withdrawal by Subject|4|||
160927125|NCT00507442|581128192|FG001|Overall Study|Withdrawal by Subject|4|||
160927126|NCT00507442|581128193|FG002|Overall Study|Withdrawal by Subject|2|||
160927127|NCT00507442|581128194|FG003|Overall Study|Withdrawal by Subject|1|||
160927128|NCT00507442|581128191|FG000|Overall Study|Other|2|||
160927129|NCT00507442|581128192|FG001|Overall Study|Other|5|||
160927130|NCT00507442|581128193|FG002|Overall Study|Other|2|||
160927131|NCT00507442|581128194|FG003|Overall Study|Other|2|||
160927132|NCT02672423|581128196|FG000|Period 1|Adverse Event|0|||
160927133|NCT02672423|581128197|FG001|Period 1|Adverse Event|0|||
160927134|NCT02672423|581128198|FG002|Period 1|Adverse Event|0|||
160927135|NCT02672423|581128199|FG003|Period 1|Adverse Event|0|||
160927136|NCT02672423|581128200|FG004|Period 1|Adverse Event|1|||
161263964|NCT01765582|582347163|FG000|Overall Study|Withdrawal of Consent|11|||
161263965|NCT01765582|582347164|FG001|Overall Study|Withdrawal of Consent|6|||
161263966|NCT01765582|582347165|FG002|Overall Study|Withdrawal of Consent|10|||
161263967|NCT03251963|582347168|FG000|Overall Study|inappropriate Xa level timing|6|||
161263968|NCT03251963|582347169|FG001|Overall Study|inappropriate Xa level timing|3|||
161263969|NCT03251963|582347168|FG000|Overall Study|no peak Xa level drawn|2|||
161263970|NCT03251963|582347169|FG001|Overall Study|no peak Xa level drawn|0|||
161263971|NCT03251963|582347168|FG000|Overall Study|bled prior to Xa level|1|||
161263972|NCT03251963|582347169|FG001|Overall Study|bled prior to Xa level|2|||
161263973|NCT00714493|582347177|FG000|Overall Study|Adverse Event|11|||
160927137|NCT02672423|581128201|FG005|Period 1|Adverse Event|0|||
160927138|NCT02672423|581128202|FG006|Period 1|Adverse Event|0|||
160927139|NCT02672423|581128203|FG007|Period 1|Adverse Event|0|||
160998058|NCT00094809|581378534|FG000|Overall Study|Adverse Event|3|||
160998059|NCT00094809|581378535|FG001|Overall Study|Adverse Event|1|||
160998060|NCT00094809|581378534|FG000|Overall Study|Withdrawal by Subject|8|||
160998061|NCT00094809|581378535|FG001|Overall Study|Withdrawal by Subject|9|||
161263974|NCT00714493|582347177|FG000|Overall Study|Death|3|||
161263975|NCT00714493|582347177|FG000|Overall Study|Lack of Efficacy|10|||
161263976|NCT00714493|582347177|FG000|Overall Study|Lost to Follow-up|3|||
161263977|NCT00714493|582347177|FG000|Overall Study|Protocol Violation|12|||
160927140|NCT02672423|581128204|FG008|Period 1|Adverse Event|0|||
160927141|NCT02672423|581128205|FG009|Period 1|Adverse Event|0|||
160927142|NCT02672423|581128196|FG000|Period 2|Withdrawal by Subject|0|||
160927143|NCT02672423|581128197|FG001|Period 2|Withdrawal by Subject|0|||
160927144|NCT02672423|581128198|FG002|Period 2|Withdrawal by Subject|1|||
160927145|NCT02672423|581128199|FG003|Period 2|Withdrawal by Subject|0|||
160927146|NCT02672423|581128200|FG004|Period 2|Withdrawal by Subject|0|||
160927147|NCT02672423|581128201|FG005|Period 2|Withdrawal by Subject|0|||
160927148|NCT02672423|581128202|FG006|Period 2|Withdrawal by Subject|0|||
160927149|NCT02672423|581128203|FG007|Period 2|Withdrawal by Subject|0|||
160927150|NCT02672423|581128204|FG008|Period 2|Withdrawal by Subject|0|||
161263978|NCT00714493|582347177|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
161263979|NCT00714493|582347177|FG000|Overall Study|OTHER|2|||
161263980|NCT00354341|582347180|FG000|Overall Study|Adverse Event|1|||
160927151|NCT02672423|581128205|FG009|Period 2|Withdrawal by Subject|0|||
160927152|NCT02672423|581128196|FG000|Period 3|Withdrawal by Subject|0|||
160927153|NCT02672423|581128197|FG001|Period 3|Withdrawal by Subject|0|||
160927154|NCT02672423|581128198|FG002|Period 3|Withdrawal by Subject|0|||
160927155|NCT02672423|581128199|FG003|Period 3|Withdrawal by Subject|0|||
160927156|NCT02672423|581128200|FG004|Period 3|Withdrawal by Subject|0|||
160927157|NCT02672423|581128201|FG005|Period 3|Withdrawal by Subject|0|||
160927158|NCT02672423|581128202|FG006|Period 3|Withdrawal by Subject|0|||
160927159|NCT02672423|581128203|FG007|Period 3|Withdrawal by Subject|1|||
160927160|NCT02672423|581128204|FG008|Period 3|Withdrawal by Subject|0|||
160927161|NCT02672423|581128205|FG009|Period 3|Withdrawal by Subject|0|||
160927162|NCT02672423|581128196|FG000|Period 3|Physician Decision|0|||
160927163|NCT02672423|581128197|FG001|Period 3|Physician Decision|0|||
160927164|NCT02672423|581128198|FG002|Period 3|Physician Decision|0|||
160927165|NCT02672423|581128199|FG003|Period 3|Physician Decision|0|||
160927166|NCT02672423|581128200|FG004|Period 3|Physician Decision|0|||
160927167|NCT02672423|581128201|FG005|Period 3|Physician Decision|1|||
160927168|NCT02672423|581128202|FG006|Period 3|Physician Decision|0|||
160927169|NCT02672423|581128203|FG007|Period 3|Physician Decision|0|||
160927170|NCT02672423|581128204|FG008|Period 3|Physician Decision|0|||
160927171|NCT02672423|581128205|FG009|Period 3|Physician Decision|0|||
160927172|NCT01046682|581128212|FG000|Overall Study|Adverse Event|2|||
160927173|NCT01046682|581128213|FG001|Overall Study|Adverse Event|0|||
160927174|NCT05071183|581128214|FG000|Overall Study|Death|1|||
160927175|NCT05071183|581128215|FG001|Overall Study|Death|2|||
160927176|NCT05071183|581128216|FG002|Overall Study|Death|0|||
160927177|NCT05071183|581128214|FG000|Overall Study|Other Reasons|1|||
160927178|NCT05071183|581128215|FG001|Overall Study|Other Reasons|3|||
160927179|NCT05071183|581128216|FG002|Overall Study|Other Reasons|2|||
161342384|NCT00300053|582640173|FG002|Overall Study|Death|3|||
160927180|NCT02046148|581128217|FG000|Overall Study|Lost to Follow-up|1|||
160927181|NCT02046148|581128218|FG001|Overall Study|Lost to Follow-up|1|||
160927182|NCT02046148|581128217|FG000|Overall Study|Withdrawal by Subject|0|||
160927183|NCT02046148|581128218|FG001|Overall Study|Withdrawal by Subject|2|||
160927184|NCT03506373|581128220|FG000|Overall Study|Adverse Event|6|||
160927185|NCT03506373|581128220|FG000|Overall Study|Withdrawal by Subject|2|||
160927186|NCT03506373|581128220|FG000|Overall Study|Disease progression|5|||
160927187|NCT03506373|581128220|FG000|Overall Study|Other|3|||
160927188|NCT01293240|581128227|FG000|Overall Study|Noncompliance|2|||
160927189|NCT01520363|581128228|FG000|Overall Study|Withdrawal by Subject|2|||
160927190|NCT01520363|581128229|FG001|Overall Study|Withdrawal by Subject|0|||
160927191|NCT01498952|581128233|FG000|Overall Study|Death|2|||
160927192|NCT01498952|581128234|FG001|Overall Study|Death|2|||
160927193|NCT01498952|581128235|FG002|Overall Study|Death|0|||
160927194|NCT01498952|581128236|FG003|Overall Study|Death|0|||
160927195|NCT01498952|581128237|FG004|Overall Study|Death|0|||
160927196|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|5|||
160927197|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927198|NCT00304356|581128238|FG000|Nitazoxanide|number is 0|1|||
160927199|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927200|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927201|NCT00304356|581128238|FG000|Nitazoxanide|Physician Decision|1|||
160927202|NCT01154218|581128241|FG000|Third Intervention Period|Adverse Event|0|||
160927203|NCT01154218|581128242|FG001|Third Intervention Period|Adverse Event|1|||
160927204|NCT01154218|581128243|FG002|Third Intervention Period|Adverse Event|0|||
160927205|NCT01154218|581128244|FG003|Third Intervention Period|Adverse Event|0|||
161342385|NCT00300053|582640171|FG000|Overall Study|Lost to Follow-up|0|||
161342386|NCT00300053|582640172|FG001|Overall Study|Lost to Follow-up|1|||
161342387|NCT00300053|582640173|FG002|Overall Study|Lost to Follow-up|0|||
160927206|NCT01154218|581128241|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160927207|NCT01154218|581128242|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160927208|NCT01154218|581128243|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
160927209|NCT01154218|581128244|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
160927210|NCT01154218|581128241|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
160927211|NCT01154218|581128242|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
160927212|NCT01154218|581128243|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
161342388|NCT03095287|582640177|FG000|Overall Study|Treatment Failure|1|||
161342389|NCT03095287|582640177|FG000|Overall Study|Adverse Event|1|||
160927213|NCT01154218|581128244|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
160927214|NCT01265849|581128245|FG000|Overall Study|Randomized//Treatment not initiated|1|||
160927215|NCT01265849|581128246|FG001|Overall Study|Randomized//Treatment not initiated|4|||
160927216|NCT01265849|581128247|FG002|Overall Study|Randomized//Treatment not initiated|0|||
160927217|NCT01265849|581128245|FG000|Overall Study|Physician Decision|1|||
160927218|NCT01265849|581128246|FG001|Overall Study|Physician Decision|2|||
161342390|NCT01294514|582640180|FG000|Overall Study|Excluded due to Arrhythmia|1|||
160927219|NCT01265849|581128247|FG002|Overall Study|Physician Decision|0|||
160927220|NCT01265849|581128245|FG000|Overall Study|Lost to Follow-up|18|||
160927221|NCT01265849|581128246|FG001|Overall Study|Lost to Follow-up|15|||
160927222|NCT01265849|581128247|FG002|Overall Study|Lost to Follow-up|5|||
160927223|NCT01265849|581128245|FG000|Overall Study|Not otherwise specified|1|||
160927224|NCT01265849|581128246|FG001|Overall Study|Not otherwise specified|6|||
160927225|NCT01265849|581128247|FG002|Overall Study|Not otherwise specified|1|||
160927226|NCT01265849|581128245|FG000|Overall Study|Withdrawal by Subject|25|||
160927227|NCT01265849|581128246|FG001|Overall Study|Withdrawal by Subject|34|||
160927228|NCT01265849|581128247|FG002|Overall Study|Withdrawal by Subject|13|||
161342391|NCT05350423|582640181|FG000|Overall Study|Lost to Follow-up|3|||
161342392|NCT05350423|582640182|FG001|Overall Study|Lost to Follow-up|3|||
161342393|NCT05350423|582640181|FG000|Overall Study|screen failure|5|||
161342394|NCT05350423|582640182|FG001|Overall Study|screen failure|6|||
161342395|NCT02097277|582640183|FG000|Overall Study|Subject no longer meets study criteria|0|||
161342396|NCT02097277|582640184|FG001|Overall Study|Subject no longer meets study criteria|1|||
161342397|NCT02097277|582640185|FG002|Overall Study|Subject no longer meets study criteria|0|||
161342398|NCT02097277|582640186|FG003|Overall Study|Subject no longer meets study criteria|1|||
161342399|NCT02097277|582640187|FG004|Overall Study|Subject no longer meets study criteria|0|||
161342400|NCT02097277|582640183|FG000|Overall Study|Subject request to discontinue treatment|0|||
161342401|NCT02097277|582640184|FG001|Overall Study|Subject request to discontinue treatment|0|||
160927229|NCT03194321|581128248|FG000|Overall Study|Withdrawal by Subject|1|||
160927230|NCT03194321|581128248|FG000|Overall Study|Lost to Follow-up|1|||
160927231|NCT03194321|581128248|FG000|Overall Study|Travel for Follow-up|1|||
160927232|NCT00567892|581128259|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927233|NCT00567892|581128260|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927234|NCT00567892|581128261|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
160927235|NCT00567892|581128262|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
160927236|NCT00567892|581128259|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927237|NCT00567892|581128260|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927238|NCT00567892|581128261|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
160927239|NCT00567892|581128262|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
160927240|NCT04690751|581128264|FG000|Overall Study|Protocol Violation|0|||
160927241|NCT04690751|581128265|FG001|Overall Study|Protocol Violation|1|||
160927242|NCT04690751|581128266|FG002|Overall Study|Protocol Violation|0|||
160927243|NCT04690751|581128267|FG003|Overall Study|Protocol Violation|1|||
160927244|NCT04690751|581128268|FG004|Overall Study|Protocol Violation|2|||
160927245|NCT04690751|581128269|FG005|Overall Study|Protocol Violation|0|||
160927246|NCT04690751|581128264|FG000|Overall Study|Adverse Event|0|||
160927247|NCT04690751|581128265|FG001|Overall Study|Adverse Event|0|||
160927248|NCT04690751|581128266|FG002|Overall Study|Adverse Event|1|||
160927249|NCT04690751|581128267|FG003|Overall Study|Adverse Event|0|||
160927250|NCT04690751|581128268|FG004|Overall Study|Adverse Event|0|||
160927251|NCT04690751|581128269|FG005|Overall Study|Adverse Event|0|||
160927252|NCT04690751|581128264|FG000|Overall Study|Positive urine drug screen test|0|||
160927253|NCT04690751|581128265|FG001|Overall Study|Positive urine drug screen test|0|||
160927254|NCT04690751|581128266|FG002|Overall Study|Positive urine drug screen test|0|||
160927255|NCT04690751|581128267|FG003|Overall Study|Positive urine drug screen test|0|||
160927256|NCT04690751|581128268|FG004|Overall Study|Positive urine drug screen test|1|||
160927257|NCT04690751|581128269|FG005|Overall Study|Positive urine drug screen test|0|||
160927258|NCT04364620|581128270|FG000|Overall Study|Disease Progression|20|||
161263981|NCT00354341|582347181|FG001|Overall Study|Adverse Event|0|||
161263982|NCT00354341|582347180|FG000|Overall Study|Death|0|||
161263983|NCT00354341|582347181|FG001|Overall Study|Death|2|||
161263984|NCT00354341|582347180|FG000|Overall Study|Refused treatment|1|||
161263985|NCT00354341|582347181|FG001|Overall Study|Refused treatment|2|||
161263986|NCT00354341|582347180|FG000|Overall Study|Failure to return|0|||
161263987|NCT00354341|582347181|FG001|Overall Study|Failure to return|1|||
161263988|NCT00354341|582347180|FG000|Overall Study|Other|1|||
161263989|NCT00354341|582347181|FG001|Overall Study|Other|2|||
161263990|NCT00251719|582347182|FG000|Overall Study|Adverse Event|14|||
160927259|NCT04364620|581128270|FG000|Overall Study|Adverse Event|5|||
160927260|NCT04364620|581128270|FG000|Overall Study|Physician Decision|4|||
160927261|NCT04364620|581128270|FG000|Overall Study|Death|3|||
160927262|NCT04364620|581128270|FG000|Overall Study|Other|2|||
161263991|NCT00251719|582347183|FG001|Overall Study|Adverse Event|8|||
161263992|NCT00251719|582347184|FG002|Overall Study|Adverse Event|7|||
161263993|NCT00251719|582347182|FG000|Overall Study|Protocol Violation|1|||
161263994|NCT00251719|582347183|FG001|Overall Study|Protocol Violation|1|||
161263995|NCT00251719|582347184|FG002|Overall Study|Protocol Violation|1|||
161263996|NCT00251719|582347182|FG000|Overall Study|Lost to Follow-up|5|||
161342402|NCT02097277|582640185|FG002|Overall Study|Subject request to discontinue treatment|0|||
161342403|NCT02097277|582640186|FG003|Overall Study|Subject request to discontinue treatment|0|||
160927263|NCT04364620|581128270|FG000|Overall Study|Withdrawal by Subject|1|||
160927264|NCT01365507|581129952|FG000|Overall Study|Withdrawal Criteria|8|||
160927265|NCT01365507|581129953|FG001|Overall Study|Withdrawal Criteria|5|||
160927266|NCT01365507|581129952|FG000|Overall Study|Unclassified|1|||
160927267|NCT01365507|581129953|FG001|Overall Study|Unclassified|4|||
160927268|NCT04254978|581129956|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
161263997|NCT00251719|582347183|FG001|Overall Study|Lost to Follow-up|11|||
161143542|NCT03056287|581909403|FG003|Overall Study|Withdrawal by Subject|0|||
161263998|NCT00251719|582347184|FG002|Overall Study|Lost to Follow-up|8|||
161263999|NCT00251719|582347182|FG000|Overall Study|Withdrawal by Subject|14|||
161264000|NCT00251719|582347183|FG001|Overall Study|Withdrawal by Subject|12|||
161264001|NCT00251719|582347184|FG002|Overall Study|Withdrawal by Subject|11|||
161264002|NCT00251719|582347182|FG000|Overall Study|Lack of Efficacy|2|||
160927269|NCT04254978|581129956|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
160927270|NCT04254978|581129956|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
160927271|NCT04254978|581129956|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
160927272|NCT04254978|581129956|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
160927273|NCT04254978|581129956|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
160927274|NCT03257631|581129957|FG000|Overall Study|Death|1|||
160927275|NCT03257631|581129958|FG001|Overall Study|Death|0|||
160927276|NCT03257631|581129959|FG002|Overall Study|Death|1|||
160927277|NCT03257631|581129960|FG003|Overall Study|Death|1|||
160927278|NCT03257631|581129957|FG000|Overall Study|Progressive Disease|10|||
160927279|NCT03257631|581129958|FG001|Overall Study|Progressive Disease|9|||
160927280|NCT03257631|581129959|FG002|Overall Study|Progressive Disease|17|||
160927281|NCT03257631|581129960|FG003|Overall Study|Progressive Disease|8|||
160927282|NCT03257631|581129957|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160927283|NCT03257631|581129958|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160927284|NCT03257631|581129959|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
160927285|NCT03257631|581129960|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
160927286|NCT03257631|581129957|FG000|Overall Study|Adverse Event|0|||
160927287|NCT03257631|581129958|FG001|Overall Study|Adverse Event|0|||
160927288|NCT03257631|581129959|FG002|Overall Study|Adverse Event|2|||
160927289|NCT03257631|581129960|FG003|Overall Study|Adverse Event|0|||
160927290|NCT03509675|581129962|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
160927291|NCT03509675|581129963|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
160927292|NCT03509675|581129962|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
160927293|NCT03509675|581129963|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
160927294|NCT03509675|581129962|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
160927295|NCT03509675|581129963|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
160927296|NCT03509675|581129962|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
160927297|NCT03509675|581129963|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
160927298|NCT02658890|581129971|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927299|NCT02658890|581129972|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927300|NCT02658890|581129973|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927301|NCT02658890|581129974|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927302|NCT02658890|581129975|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927303|NCT02658890|581129976|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927304|NCT02658890|581129977|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927305|NCT02658890|581129978|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927306|NCT02658890|581129979|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927307|NCT02658890|581129980|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927308|NCT02658890|581129981|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927309|NCT02658890|581129982|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927310|NCT02658890|581129983|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927311|NCT02658890|581129984|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927312|NCT02658890|581129985|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927313|NCT02658890|581129986|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927314|NCT02658890|581129987|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927315|NCT02658890|581129988|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927316|NCT02658890|581129989|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927317|NCT02658890|581129990|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927318|NCT02658890|581129991|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927319|NCT02658890|581129992|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927320|NCT02658890|581129993|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927321|NCT02658890|581129994|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927322|NCT02658890|581129995|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927323|NCT02658890|581129996|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927324|NCT02658890|581129997|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927325|NCT02658890|581129971|FG000|Treatment Phase|Adverse Event|0|||
161143543|NCT03056287|581909400|FG000|Overall Study|move out of area|0|||
161264003|NCT00251719|582347183|FG001|Overall Study|Lack of Efficacy|1|||
161143544|NCT03056287|581909401|FG001|Overall Study|move out of area|0|||
161143545|NCT03056287|581909402|FG002|Overall Study|move out of area|1|||
161264004|NCT00251719|582347184|FG002|Overall Study|Lack of Efficacy|0|||
161264005|NCT00251719|582347182|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
161143546|NCT03056287|581909403|FG003|Overall Study|move out of area|1|||
161143547|NCT00550238|581909409|FG000|Overall Study|Adverse Event|88|||
161143548|NCT00550238|581909409|FG000|Overall Study|Death|34|||
161264006|NCT00251719|582347183|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
161264007|NCT00251719|582347184|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
161264008|NCT00251719|582347182|FG000|Overall Study|Investigator decision|1|||
160927326|NCT02658890|581129972|FG001|Treatment Phase|Adverse Event|1|||
160927327|NCT02658890|581129973|FG002|Treatment Phase|Adverse Event|2|||
160927328|NCT02658890|581129974|FG003|Treatment Phase|Adverse Event|2|||
160927329|NCT02658890|581129975|FG004|Treatment Phase|Adverse Event|1|||
160927330|NCT02658890|581129976|FG005|Treatment Phase|Adverse Event|0|||
160927331|NCT02658890|581129977|FG006|Treatment Phase|Adverse Event|0|||
160927332|NCT02658890|581129978|FG007|Treatment Phase|Adverse Event|2|||
160927333|NCT02658890|581129979|FG008|Treatment Phase|Adverse Event|1|||
160927334|NCT02658890|581129980|FG009|Treatment Phase|Adverse Event|2|||
160927335|NCT02658890|581129981|FG010|Treatment Phase|Adverse Event|3|||
160927336|NCT02658890|581129982|FG011|Treatment Phase|Adverse Event|0|||
160927337|NCT02658890|581129983|FG012|Treatment Phase|Adverse Event|1|||
160927338|NCT02658890|581129984|FG013|Treatment Phase|Adverse Event|4|||
160927339|NCT02658890|581129985|FG014|Treatment Phase|Adverse Event|0|||
160927340|NCT02658890|581129986|FG015|Treatment Phase|Adverse Event|0|||
160927341|NCT02658890|581129987|FG016|Treatment Phase|Adverse Event|0|||
160927342|NCT02658890|581129988|FG017|Treatment Phase|Adverse Event|0|||
160927343|NCT02658890|581129989|FG018|Treatment Phase|Adverse Event|5|||
160927344|NCT02658890|581129990|FG019|Treatment Phase|Adverse Event|1|||
160927345|NCT02658890|581129991|FG020|Treatment Phase|Adverse Event|3|||
160927346|NCT02658890|581129992|FG021|Treatment Phase|Adverse Event|0|||
160927347|NCT02658890|581129993|FG022|Treatment Phase|Adverse Event|5|||
160927348|NCT02658890|581129994|FG023|Treatment Phase|Adverse Event|0|||
160927349|NCT02658890|581129995|FG024|Treatment Phase|Adverse Event|0|||
160927350|NCT02658890|581129996|FG025|Treatment Phase|Adverse Event|2|||
160927351|NCT02658890|581129997|FG026|Treatment Phase|Adverse Event|1|||
160927352|NCT02658890|581129971|FG000|Treatment Phase|Death|0|||
160927353|NCT02658890|581129972|FG001|Treatment Phase|Death|0|||
160927354|NCT02658890|581129973|FG002|Treatment Phase|Death|0|||
160927355|NCT02658890|581129974|FG003|Treatment Phase|Death|0|||
160927356|NCT02658890|581129975|FG004|Treatment Phase|Death|0|||
160927357|NCT02658890|581129976|FG005|Treatment Phase|Death|0|||
160927358|NCT02658890|581129977|FG006|Treatment Phase|Death|0|||
160927359|NCT02658890|581129978|FG007|Treatment Phase|Death|0|||
160927360|NCT02658890|581129979|FG008|Treatment Phase|Death|0|||
160927361|NCT02658890|581129980|FG009|Treatment Phase|Death|0|||
160927362|NCT02658890|581129981|FG010|Treatment Phase|Death|0|||
160927363|NCT02658890|581129982|FG011|Treatment Phase|Death|0|||
160927364|NCT02658890|581129983|FG012|Treatment Phase|Death|0|||
160927365|NCT02658890|581129984|FG013|Treatment Phase|Death|0|||
161143549|NCT00550238|581909409|FG000|Overall Study|Disease progression|46|||
161143550|NCT00550238|581909409|FG000|Overall Study|Withdrawal by Subject|167|||
161143551|NCT00550238|581909409|FG000|Overall Study|Physician Decision|31|||
160927366|NCT02658890|581129985|FG014|Treatment Phase|Death|0|||
160927367|NCT02658890|581129986|FG015|Treatment Phase|Death|0|||
160927368|NCT02658890|581129987|FG016|Treatment Phase|Death|0|||
160927369|NCT02658890|581129988|FG017|Treatment Phase|Death|0|||
160927370|NCT02658890|581129989|FG018|Treatment Phase|Death|1|||
160927371|NCT02658890|581129990|FG019|Treatment Phase|Death|0|||
160927372|NCT02658890|581129991|FG020|Treatment Phase|Death|0|||
160927373|NCT02658890|581129992|FG021|Treatment Phase|Death|0|||
160927374|NCT02658890|581129993|FG022|Treatment Phase|Death|0|||
160927375|NCT02658890|581129994|FG023|Treatment Phase|Death|0|||
160927376|NCT02658890|581129995|FG024|Treatment Phase|Death|0|||
160927377|NCT02658890|581129996|FG025|Treatment Phase|Death|0|||
160927378|NCT02658890|581129997|FG026|Treatment Phase|Death|0|||
160927379|NCT02658890|581129971|FG000|Treatment Phase|Lost to Follow-up|0|||
160927380|NCT02658890|581129972|FG001|Treatment Phase|Lost to Follow-up|0|||
160927381|NCT02658890|581129973|FG002|Treatment Phase|Lost to Follow-up|0|||
160927382|NCT02658890|581129974|FG003|Treatment Phase|Lost to Follow-up|0|||
160927383|NCT02658890|581129975|FG004|Treatment Phase|Lost to Follow-up|0|||
160927384|NCT02658890|581129976|FG005|Treatment Phase|Lost to Follow-up|0|||
160927385|NCT02658890|581129977|FG006|Treatment Phase|Lost to Follow-up|1|||
160927386|NCT02658890|581129978|FG007|Treatment Phase|Lost to Follow-up|0|||
160927387|NCT02658890|581129979|FG008|Treatment Phase|Lost to Follow-up|0|||
160927388|NCT02658890|581129980|FG009|Treatment Phase|Lost to Follow-up|0|||
160927389|NCT02658890|581129981|FG010|Treatment Phase|Lost to Follow-up|0|||
161143552|NCT00550238|581909409|FG000|Overall Study|Patient noncompliance|25|||
160927390|NCT02658890|581129982|FG011|Treatment Phase|Lost to Follow-up|0|||
160927391|NCT02658890|581129983|FG012|Treatment Phase|Lost to Follow-up|0|||
160927392|NCT02658890|581129984|FG013|Treatment Phase|Lost to Follow-up|0|||
160927393|NCT02658890|581129985|FG014|Treatment Phase|Lost to Follow-up|0|||
160927394|NCT02658890|581129986|FG015|Treatment Phase|Lost to Follow-up|0|||
160927395|NCT02658890|581129987|FG016|Treatment Phase|Lost to Follow-up|0|||
160927396|NCT02658890|581129988|FG017|Treatment Phase|Lost to Follow-up|0|||
161143553|NCT00550238|581909409|FG000|Overall Study|Lost to Follow-up|13|||
161143554|NCT00550238|581909409|FG000|Overall Study|Sponsor decision|55|||
160927397|NCT02658890|581129989|FG018|Treatment Phase|Lost to Follow-up|0|||
160927398|NCT02658890|581129990|FG019|Treatment Phase|Lost to Follow-up|0|||
160927399|NCT02658890|581129991|FG020|Treatment Phase|Lost to Follow-up|0|||
160927400|NCT02658890|581129992|FG021|Treatment Phase|Lost to Follow-up|0|||
160927401|NCT02658890|581129993|FG022|Treatment Phase|Lost to Follow-up|0|||
160927402|NCT02658890|581129994|FG023|Treatment Phase|Lost to Follow-up|0|||
160927403|NCT02658890|581129995|FG024|Treatment Phase|Lost to Follow-up|0|||
160927404|NCT02658890|581129996|FG025|Treatment Phase|Lost to Follow-up|0|||
160927405|NCT02658890|581129997|FG026|Treatment Phase|Lost to Follow-up|0|||
160927406|NCT02658890|581129971|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
160927407|NCT02658890|581129972|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
160927408|NCT02658890|581129973|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
160927409|NCT02658890|581129974|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
160927410|NCT02658890|581129975|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
160927411|NCT02658890|581129976|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
160927412|NCT02658890|581129977|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
160927413|NCT02658890|581129978|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
160927414|NCT02658890|581129979|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
160927415|NCT02658890|581129980|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
160927416|NCT02658890|581129981|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
160927417|NCT02658890|581129982|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
160927418|NCT02658890|581129983|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
160927419|NCT02658890|581129984|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
160927420|NCT02658890|581129985|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
160927421|NCT02658890|581129986|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
160927422|NCT02658890|581129987|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
160998062|NCT00094809|581378534|FG000|Overall Study|Disease progression|3|||
160927423|NCT02658890|581129988|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
160927424|NCT02658890|581129989|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
160927425|NCT02658890|581129990|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
160927426|NCT02658890|581129991|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
160927427|NCT02658890|581129992|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
160927428|NCT02658890|581129993|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
160927429|NCT02658890|581129994|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
160927430|NCT02658890|581129995|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
160927431|NCT02658890|581129996|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
160927432|NCT02658890|581129997|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
160927433|NCT02658890|581129971|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
160927434|NCT02658890|581129972|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
160927435|NCT02658890|581129973|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
160927436|NCT02658890|581129974|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
160927437|NCT02658890|581129975|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
160927438|NCT02658890|581129976|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
160927439|NCT02658890|581129977|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
160927440|NCT02658890|581129978|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
160927441|NCT02658890|581129979|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
160927442|NCT02658890|581129980|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
160927443|NCT02658890|581129981|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
160927444|NCT02658890|581129982|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
160927445|NCT02658890|581129983|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
160927446|NCT02658890|581129984|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
160927447|NCT02658890|581129985|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
160927448|NCT02658890|581129986|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
160927449|NCT02658890|581129987|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
160927450|NCT02658890|581129988|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
160927451|NCT02658890|581129989|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
160927452|NCT02658890|581129990|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
160927453|NCT02658890|581129991|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
160927454|NCT02658890|581129992|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
160927455|NCT02658890|581129993|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
160927456|NCT02658890|581129994|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
160927457|NCT02658890|581129995|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
160927458|NCT02658890|581129996|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
160998063|NCT00094809|581378535|FG001|Overall Study|Disease progression|3|||
160998064|NCT00094809|581378534|FG000|Overall Study|Physician Decision|3|||
160998065|NCT00094809|581378535|FG001|Overall Study|Physician Decision|5|||
160998066|NCT00094809|581378534|FG000|Overall Study|Lost to Follow-up|6|||
160927459|NCT02658890|581129997|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
160927460|NCT02658890|581129971|FG000|Treatment Phase|Other Reasons|0|||
160927461|NCT02658890|581129972|FG001|Treatment Phase|Other Reasons|0|||
160927462|NCT02658890|581129973|FG002|Treatment Phase|Other Reasons|0|||
160927463|NCT02658890|581129974|FG003|Treatment Phase|Other Reasons|0|||
160927464|NCT02658890|581129975|FG004|Treatment Phase|Other Reasons|0|||
160998067|NCT00094809|581378535|FG001|Overall Study|Lost to Follow-up|6|||
160927465|NCT02658890|581129976|FG005|Treatment Phase|Other Reasons|0|||
160927466|NCT02658890|581129977|FG006|Treatment Phase|Other Reasons|1|||
160927467|NCT02658890|581129978|FG007|Treatment Phase|Other Reasons|0|||
160927468|NCT02658890|581129979|FG008|Treatment Phase|Other Reasons|1|||
160927469|NCT02658890|581129980|FG009|Treatment Phase|Other Reasons|0|||
160927470|NCT02658890|581129981|FG010|Treatment Phase|Other Reasons|0|||
160927471|NCT02658890|581129982|FG011|Treatment Phase|Other Reasons|0|||
160927472|NCT02658890|581129983|FG012|Treatment Phase|Other Reasons|0|||
160927473|NCT02658890|581129984|FG013|Treatment Phase|Other Reasons|2|||
160927474|NCT02658890|581129985|FG014|Treatment Phase|Other Reasons|0|||
160927475|NCT02658890|581129986|FG015|Treatment Phase|Other Reasons|0|||
160927476|NCT02658890|581129987|FG016|Treatment Phase|Other Reasons|0|||
160927477|NCT02658890|581129988|FG017|Treatment Phase|Other Reasons|0|||
160927478|NCT02658890|581129989|FG018|Treatment Phase|Other Reasons|1|||
160927479|NCT02658890|581129990|FG019|Treatment Phase|Other Reasons|0|||
160927480|NCT02658890|581129991|FG020|Treatment Phase|Other Reasons|0|||
160927481|NCT02658890|581129992|FG021|Treatment Phase|Other Reasons|0|||
160927482|NCT02658890|581129993|FG022|Treatment Phase|Other Reasons|0|||
160927483|NCT02658890|581129994|FG023|Treatment Phase|Other Reasons|0|||
160927484|NCT02658890|581129995|FG024|Treatment Phase|Other Reasons|1|||
160927485|NCT02658890|581129996|FG025|Treatment Phase|Other Reasons|0|||
160927486|NCT02658890|581129997|FG026|Treatment Phase|Other Reasons|1|||
160927487|NCT02658890|581129971|FG000|Treatment Phase|Progressive Disease|6|||
160927488|NCT02658890|581129972|FG001|Treatment Phase|Progressive Disease|7|||
160927489|NCT02658890|581129973|FG002|Treatment Phase|Progressive Disease|6|||
160927490|NCT02658890|581129974|FG003|Treatment Phase|Progressive Disease|12|||
160927491|NCT02658890|581129975|FG004|Treatment Phase|Progressive Disease|6|||
160927492|NCT02658890|581129976|FG005|Treatment Phase|Progressive Disease|18|||
160927493|NCT02658890|581129977|FG006|Treatment Phase|Progressive Disease|12|||
160927494|NCT02658890|581129978|FG007|Treatment Phase|Progressive Disease|19|||
160927495|NCT02658890|581129979|FG008|Treatment Phase|Progressive Disease|26|||
160927496|NCT02658890|581129980|FG009|Treatment Phase|Progressive Disease|8|||
160927497|NCT02658890|581129981|FG010|Treatment Phase|Progressive Disease|7|||
160927498|NCT02658890|581129982|FG011|Treatment Phase|Progressive Disease|9|||
160927499|NCT02658890|581129983|FG012|Treatment Phase|Progressive Disease|8|||
160927500|NCT02658890|581129984|FG013|Treatment Phase|Progressive Disease|29|||
160927501|NCT02658890|581129985|FG014|Treatment Phase|Progressive Disease|6|||
160927502|NCT02658890|581129986|FG015|Treatment Phase|Progressive Disease|2|||
160927503|NCT02658890|581129987|FG016|Treatment Phase|Progressive Disease|32|||
160927504|NCT02658890|581129988|FG017|Treatment Phase|Progressive Disease|14|||
160927505|NCT02658890|581129989|FG018|Treatment Phase|Progressive Disease|40|||
160927506|NCT02658890|581129990|FG019|Treatment Phase|Progressive Disease|32|||
160927507|NCT02658890|581129991|FG020|Treatment Phase|Progressive Disease|19|||
160927508|NCT02658890|581129992|FG021|Treatment Phase|Progressive Disease|30|||
160927509|NCT02658890|581129993|FG022|Treatment Phase|Progressive Disease|15|||
160927510|NCT02658890|581129994|FG023|Treatment Phase|Progressive Disease|0|||
160927511|NCT02658890|581129995|FG024|Treatment Phase|Progressive Disease|0|||
160927512|NCT02658890|581129996|FG025|Treatment Phase|Progressive Disease|14|||
160927513|NCT02658890|581129997|FG026|Treatment Phase|Progressive Disease|11|||
160927514|NCT02658890|581129971|FG000|Treatment Phase|Study Drug Toxicity|0|||
160927515|NCT02658890|581129972|FG001|Treatment Phase|Study Drug Toxicity|0|||
160927516|NCT02658890|581129973|FG002|Treatment Phase|Study Drug Toxicity|2|||
160927517|NCT02658890|581129974|FG003|Treatment Phase|Study Drug Toxicity|0|||
160927518|NCT02658890|581129975|FG004|Treatment Phase|Study Drug Toxicity|0|||
160927519|NCT02658890|581129976|FG005|Treatment Phase|Study Drug Toxicity|0|||
160927520|NCT02658890|581129977|FG006|Treatment Phase|Study Drug Toxicity|0|||
160927521|NCT02658890|581129978|FG007|Treatment Phase|Study Drug Toxicity|0|||
160927522|NCT02658890|581129979|FG008|Treatment Phase|Study Drug Toxicity|3|||
160927523|NCT02658890|581129980|FG009|Treatment Phase|Study Drug Toxicity|0|||
161143555|NCT01486238|581909415|FG000|Overall Study|Death|0|||
161143556|NCT01486238|581909416|FG001|Overall Study|Death|2|||
160927524|NCT02658890|581129981|FG010|Treatment Phase|Study Drug Toxicity|1|||
160927525|NCT02658890|581129982|FG011|Treatment Phase|Study Drug Toxicity|1|||
160927526|NCT02658890|581129983|FG012|Treatment Phase|Study Drug Toxicity|2|||
160927527|NCT02658890|581129984|FG013|Treatment Phase|Study Drug Toxicity|9|||
160927528|NCT02658890|581129985|FG014|Treatment Phase|Study Drug Toxicity|0|||
160927529|NCT02658890|581129986|FG015|Treatment Phase|Study Drug Toxicity|1|||
160927530|NCT02658890|581129987|FG016|Treatment Phase|Study Drug Toxicity|1|||
160927531|NCT02658890|581129988|FG017|Treatment Phase|Study Drug Toxicity|0|||
160927532|NCT02658890|581129989|FG018|Treatment Phase|Study Drug Toxicity|8|||
160927533|NCT02658890|581129990|FG019|Treatment Phase|Study Drug Toxicity|3|||
160927534|NCT02658890|581129991|FG020|Treatment Phase|Study Drug Toxicity|2|||
160927535|NCT02658890|581129992|FG021|Treatment Phase|Study Drug Toxicity|0|||
160927536|NCT02658890|581129993|FG022|Treatment Phase|Study Drug Toxicity|8|||
160927537|NCT02658890|581129994|FG023|Treatment Phase|Study Drug Toxicity|0|||
161143557|NCT01486238|581909415|FG000|Overall Study|Withdrawal by Subject|2|||
160927538|NCT02658890|581129995|FG024|Treatment Phase|Study Drug Toxicity|0|||
160927539|NCT02658890|581129996|FG025|Treatment Phase|Study Drug Toxicity|2|||
160927540|NCT02658890|581129997|FG026|Treatment Phase|Study Drug Toxicity|0|||
160927541|NCT02658890|581129971|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927542|NCT02658890|581129972|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927543|NCT02658890|581129973|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927544|NCT02658890|581129974|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927545|NCT02658890|581129975|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927546|NCT02658890|581129976|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927547|NCT02658890|581129977|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927548|NCT02658890|581129978|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927549|NCT02658890|581129979|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927550|NCT02658890|581129980|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
161264009|NCT00251719|582347183|FG001|Overall Study|Investigator decision|1|||
161264010|NCT00251719|582347184|FG002|Overall Study|Investigator decision|0|||
161264011|NCT00251719|582347182|FG000|Overall Study|Noncompliance|2|||
161264012|NCT00251719|582347183|FG001|Overall Study|Noncompliance|3|||
161264013|NCT00251719|582347184|FG002|Overall Study|Noncompliance|1|||
161264014|NCT00251719|582347182|FG000|Overall Study|Barrett's esophagus|2|||
161264015|NCT00251719|582347183|FG001|Overall Study|Barrett's esophagus|2|||
161264016|NCT00251719|582347184|FG002|Overall Study|Barrett's esophagus|0|||
161264017|NCT01449279|582347185|FG000|Overall Study|Lack of Efficacy|5|||
161264018|NCT01449279|582347185|FG000|Overall Study|Toxicity|2|||
161264019|NCT01732874|582347187|FG000|Overall Study|Withdrawal by Subject|5|||
161264020|NCT01732874|582347188|FG001|Overall Study|Withdrawal by Subject|1|||
161264021|NCT01732874|582347187|FG000|Overall Study|Death of Infant|3|||
161264022|NCT01732874|582347188|FG001|Overall Study|Death of Infant|2|||
161264023|NCT02792959|582347189|FG000|Overall Study|Protocol Violation|1|||
161264024|NCT03579966|582347190|FG000|Overall Study|Adverse Event|6|||
160927551|NCT02658890|581129981|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927552|NCT02658890|581129982|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927553|NCT02658890|581129983|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927554|NCT02658890|581129984|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927555|NCT02658890|581129985|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927556|NCT02658890|581129986|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927557|NCT02658890|581129987|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927558|NCT02658890|581129988|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927559|NCT02658890|581129989|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927560|NCT02658890|581129990|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927561|NCT02658890|581129991|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927562|NCT02658890|581129992|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927563|NCT02658890|581129993|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
160927564|NCT02658890|581129994|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927565|NCT02658890|581129995|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927566|NCT02658890|581129996|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927567|NCT02658890|581129997|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
160927568|NCT02658890|581129971|FG000|Treatment Phase|Withdrawal by Subject|0|||
160927569|NCT02658890|581129972|FG001|Treatment Phase|Withdrawal by Subject|1|||
160927570|NCT02658890|581129973|FG002|Treatment Phase|Withdrawal by Subject|0|||
160927571|NCT02658890|581129974|FG003|Treatment Phase|Withdrawal by Subject|0|||
160927572|NCT02658890|581129975|FG004|Treatment Phase|Withdrawal by Subject|0|||
160927573|NCT02658890|581129976|FG005|Treatment Phase|Withdrawal by Subject|0|||
160927574|NCT02658890|581129977|FG006|Treatment Phase|Withdrawal by Subject|1|||
160927575|NCT02658890|581129978|FG007|Treatment Phase|Withdrawal by Subject|0|||
160927576|NCT02658890|581129979|FG008|Treatment Phase|Withdrawal by Subject|0|||
160927577|NCT02658890|581129980|FG009|Treatment Phase|Withdrawal by Subject|1|||
160927578|NCT02658890|581129981|FG010|Treatment Phase|Withdrawal by Subject|0|||
160927579|NCT02658890|581129982|FG011|Treatment Phase|Withdrawal by Subject|0|||
160927580|NCT02658890|581129983|FG012|Treatment Phase|Withdrawal by Subject|1|||
160927581|NCT02658890|581129984|FG013|Treatment Phase|Withdrawal by Subject|3|||
160927582|NCT02658890|581129985|FG014|Treatment Phase|Withdrawal by Subject|0|||
161264025|NCT03579966|582347190|FG000|Overall Study|Lost to Follow-up|4|||
160927583|NCT02658890|581129986|FG015|Treatment Phase|Withdrawal by Subject|0|||
161342404|NCT02097277|582640187|FG004|Overall Study|Subject request to discontinue treatment|1|||
160927584|NCT02658890|581129987|FG016|Treatment Phase|Withdrawal by Subject|1|||
160927585|NCT02658890|581129988|FG017|Treatment Phase|Withdrawal by Subject|0|||
160927586|NCT02658890|581129989|FG018|Treatment Phase|Withdrawal by Subject|4|||
160927587|NCT02658890|581129990|FG019|Treatment Phase|Withdrawal by Subject|3|||
160927588|NCT02658890|581129991|FG020|Treatment Phase|Withdrawal by Subject|0|||
160927589|NCT02658890|581129992|FG021|Treatment Phase|Withdrawal by Subject|4|||
160998068|NCT00094809|581378534|FG000|Overall Study|Death|19|||
161264026|NCT03579966|582347190|FG000|Overall Study|Physician Decision|10|||
160927590|NCT02658890|581129993|FG022|Treatment Phase|Withdrawal by Subject|1|||
160927591|NCT02658890|581129994|FG023|Treatment Phase|Withdrawal by Subject|1|||
160927592|NCT02658890|581129995|FG024|Treatment Phase|Withdrawal by Subject|0|||
160927593|NCT02658890|581129996|FG025|Treatment Phase|Withdrawal by Subject|0|||
160927594|NCT02658890|581129997|FG026|Treatment Phase|Withdrawal by Subject|0|||
160927595|NCT02404311|581129998|FG000|Part A: Month 0-18|Death|2|||
160927596|NCT02404311|581129999|FG001|Part A: Month 0-18|Death|0|||
160927597|NCT02404311|581130000|FG002|Part A: Month 0-18|Death|0|||
160927598|NCT02404311|581130001|FG003|Part A: Month 0-18|Death|0|||
160927599|NCT02404311|581130002|FG004|Part A: Month 0-18|Death|0|||
160927600|NCT02404311|581129998|FG000|Part A: Month 0-18|Physician Decision|1|||
160927601|NCT02404311|581129999|FG001|Part A: Month 0-18|Physician Decision|0|||
160927602|NCT02404311|581130000|FG002|Part A: Month 0-18|Physician Decision|0|||
160927603|NCT02404311|581130001|FG003|Part A: Month 0-18|Physician Decision|0|||
160927604|NCT02404311|581130002|FG004|Part A: Month 0-18|Physician Decision|0|||
160927605|NCT02404311|581129998|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
160927606|NCT02404311|581129999|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
160927607|NCT02404311|581130000|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
160927608|NCT02404311|581130001|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
160927609|NCT02404311|581130002|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
160927610|NCT02404311|581129998|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
160927611|NCT02404311|581129999|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
160927612|NCT02404311|581130000|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
160927613|NCT02404311|581130001|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
160927614|NCT02404311|581130002|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
160927615|NCT02404311|581129998|FG000|Part A: Month 0-18|HIV Infection|6|||
160927616|NCT02404311|581129999|FG001|Part A: Month 0-18|HIV Infection|2|||
160927617|NCT02404311|581130000|FG002|Part A: Month 0-18|HIV Infection|0|||
160927618|NCT02404311|581130001|FG003|Part A: Month 0-18|HIV Infection|0|||
160927619|NCT02404311|581130002|FG004|Part A: Month 0-18|HIV Infection|0|||
160927620|NCT02404311|581129998|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
160927621|NCT02404311|581129999|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
160927622|NCT02404311|581130000|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
160927623|NCT02404311|581130001|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
160927624|NCT02404311|581130002|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
160927625|NCT00076011|581130007|FG000|Overall Study|Death|1|||
160927626|NCT00076011|581130007|FG000|Overall Study|Adverse Event|10|||
160927627|NCT00076011|581130007|FG000|Overall Study|Lack of Efficacy|25|||
160927628|NCT00076011|581130007|FG000|Overall Study|Withdrawal by Subject|1|||
160927629|NCT00076011|581130007|FG000|Overall Study|Study terminated by sponsor|3|||
160927630|NCT00076011|581130007|FG000|Overall Study|Other|11|||
160927631|NCT00076011|581130007|FG000|Overall Study|Ongoing|1|||
160927632|NCT03314584|581130011|FG000|Overall Study|Withdrawal by Subject|3|||
160927633|NCT03314584|581130012|FG001|Overall Study|Withdrawal by Subject|3|||
160927634|NCT03314584|581130011|FG000|Overall Study|Lost to Follow-up|4|||
160927635|NCT03314584|581130012|FG001|Overall Study|Lost to Follow-up|0|||
160927636|NCT06134817|581130013|FG000|Overall Study|Physician Departure - termination of study|1|||
160927637|NCT00930579|581130020|FG000|Overall Study|Withdrawal by Subject|1|||
160927638|NCT00930579|581130020|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
160927639|NCT02864251|581130025|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
160927640|NCT02864251|581130026|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
160927641|NCT02864251|581130027|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
160927642|NCT02864251|581130025|FG000|Pre-Treatment|Withdrawal by Participant|0|||
160927643|NCT02864251|581130026|FG001|Pre-Treatment|Withdrawal by Participant|0|||
160927644|NCT02864251|581130027|FG002|Pre-Treatment|Withdrawal by Participant|4|||
160927645|NCT02864251|581130025|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
161264027|NCT03579966|582347190|FG000|Overall Study|Pregnancy|1|||
161264028|NCT03579966|582347190|FG000|Overall Study|Withdrawal by Subject|16|||
161264029|NCT03579966|582347190|FG000|Overall Study|Study terminated by Sponsor|22|||
160927646|NCT02864251|581130026|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
160927647|NCT02864251|581130027|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
160927648|NCT02864251|581130025|FG000|Pre-Treatment|Other Reasons|0|||
160927649|NCT02864251|581130026|FG001|Pre-Treatment|Other Reasons|1|||
161264030|NCT03579966|582347190|FG000|Overall Study|Protocol Violation|1|||
161143558|NCT01486238|581909416|FG001|Overall Study|Withdrawal by Subject|1|||
161143559|NCT01486238|581909415|FG000|Overall Study|Lost to Follow-up|0|||
161143560|NCT01486238|581909416|FG001|Overall Study|Lost to Follow-up|3|||
160927650|NCT02864251|581130027|FG002|Pre-Treatment|Other Reasons|1|||
160927651|NCT02864251|581130025|FG000|Treatment|Disease Progression|109|||
160927652|NCT02864251|581130026|FG001|Treatment|Disease Progression|52|||
160927653|NCT02864251|581130027|FG002|Treatment|Disease Progression|101|||
160927654|NCT02864251|581130025|FG000|Treatment|Study Drug Toxicity|9|||
160927655|NCT02864251|581130026|FG001|Treatment|Study Drug Toxicity|4|||
161143561|NCT01050062|581909417|FG000|Overall Study|Adverse Event|75|||
161264031|NCT01249365|582347191|FG000|Overall Study|Lost to Follow-up|1|||
161264032|NCT02408068|582347192|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
161143562|NCT01050062|581909418|FG001|Overall Study|Adverse Event|22|||
161143563|NCT01050062|581909417|FG000|Overall Study|Lost to Follow-up|83|||
161143564|NCT01050062|581909418|FG001|Overall Study|Lost to Follow-up|35|||
161143565|NCT01050062|581909417|FG000|Overall Study|Lack of Efficacy|22|||
161143566|NCT01050062|581909418|FG001|Overall Study|Lack of Efficacy|35|||
161143567|NCT01050062|581909417|FG000|Overall Study|Physician Decision|74|||
161143568|NCT01050062|581909418|FG001|Overall Study|Physician Decision|9|||
161143569|NCT01050062|581909417|FG000|Overall Study|Others|17|||
161143570|NCT01050062|581909418|FG001|Overall Study|Others|11|||
161143571|NCT03894540|581909419|FG000|Overall Study|Adverse Event|0|||
161143572|NCT03894540|581909420|FG001|Overall Study|Adverse Event|0|||
161143573|NCT03894540|581909421|FG002|Overall Study|Adverse Event|0|||
161143574|NCT03894540|581909422|FG003|Overall Study|Adverse Event|0|||
161143575|NCT03894540|581909423|FG004|Overall Study|Adverse Event|1|||
161143576|NCT03894540|581909424|FG005|Overall Study|Adverse Event|0|||
161143577|NCT03894540|581909419|FG000|Overall Study|Withdrawal by Subject|0|||
161143578|NCT03894540|581909420|FG001|Overall Study|Withdrawal by Subject|0|||
161143579|NCT03894540|581909421|FG002|Overall Study|Withdrawal by Subject|0|||
161143580|NCT03894540|581909422|FG003|Overall Study|Withdrawal by Subject|0|||
161143581|NCT03894540|581909423|FG004|Overall Study|Withdrawal by Subject|1|||
161143582|NCT03894540|581909424|FG005|Overall Study|Withdrawal by Subject|0|||
161143583|NCT03894540|581909419|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
161143584|NCT03894540|581909420|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
161143585|NCT03894540|581909421|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
161143586|NCT03894540|581909422|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
161143587|NCT03894540|581909423|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
160927656|NCT02864251|581130027|FG002|Treatment|Study Drug Toxicity|10|||
160927657|NCT02864251|581130025|FG000|Treatment|Death|0|||
160927658|NCT02864251|581130026|FG001|Treatment|Death|2|||
160927659|NCT02864251|581130027|FG002|Treatment|Death|3|||
160927660|NCT02864251|581130025|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
160927661|NCT02864251|581130026|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
160927662|NCT02864251|581130027|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
160927663|NCT02864251|581130025|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
160927664|NCT02864251|581130026|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
160927665|NCT02864251|581130027|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
160927666|NCT02864251|581130025|FG000|Treatment|Withdrawal by Participant|8|||
160927667|NCT02864251|581130026|FG001|Treatment|Withdrawal by Participant|5|||
160927668|NCT02864251|581130027|FG002|Treatment|Withdrawal by Participant|13|||
160927669|NCT02864251|581130025|FG000|Treatment|Maximum Clinical Benefit|1|||
160927670|NCT02864251|581130026|FG001|Treatment|Maximum Clinical Benefit|0|||
160927671|NCT02864251|581130027|FG002|Treatment|Maximum Clinical Benefit|1|||
160927672|NCT02864251|581130025|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
160927673|NCT02864251|581130026|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
160927674|NCT02864251|581130027|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
160927675|NCT02864251|581130025|FG000|Treatment|Other Reasons|1|||
160927676|NCT02864251|581130026|FG001|Treatment|Other Reasons|1|||
160927677|NCT02864251|581130027|FG002|Treatment|Other Reasons|4|||
160927678|NCT02864251|581130025|FG000|Treatment|Administrative Reason by Sponsor|1|||
160927679|NCT02864251|581130026|FG001|Treatment|Administrative Reason by Sponsor|0|||
160927680|NCT02864251|581130027|FG002|Treatment|Administrative Reason by Sponsor|0|||
161143588|NCT03894540|581909424|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
161143589|NCT03894540|581909419|FG000|Overall Study|Progressive Disease Clinical|1|||
161143590|NCT03894540|581909420|FG001|Overall Study|Progressive Disease Clinical|1|||
161143591|NCT03894540|581909421|FG002|Overall Study|Progressive Disease Clinical|0|||
161143592|NCT03894540|581909422|FG003|Overall Study|Progressive Disease Clinical|1|||
161143593|NCT03894540|581909423|FG004|Overall Study|Progressive Disease Clinical|5|||
161143594|NCT03894540|581909424|FG005|Overall Study|Progressive Disease Clinical|1|||
161143595|NCT03894540|581909419|FG000|Overall Study|Study termination by sponsor|0|||
161143596|NCT03894540|581909420|FG001|Overall Study|Study termination by sponsor|0|||
161143597|NCT03894540|581909421|FG002|Overall Study|Study termination by sponsor|0|||
160927681|NCT04343521|581130028|FG000|Overall Study|Adverse Event|0|||
160927682|NCT04343521|581130029|FG001|Overall Study|Adverse Event|2|||
160927683|NCT04343521|581130028|FG000|Overall Study|Death|1|||
160927684|NCT04343521|581130029|FG001|Overall Study|Death|2|||
160927685|NCT04343521|581130028|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
160927686|NCT04343521|581130029|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
161143598|NCT03894540|581909422|FG003|Overall Study|Study termination by sponsor|0|||
161143599|NCT03894540|581909423|FG004|Overall Study|Study termination by sponsor|2|||
161143600|NCT03894540|581909424|FG005|Overall Study|Study termination by sponsor|0|||
161143601|NCT03000452|581909425|FG000|Treatment Period|Death|1|||
161143602|NCT03000452|581909425|FG000|Treatment Period|Progressive Disease (PD)|14|||
161264033|NCT02408068|582347193|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
161264034|NCT02408068|582347194|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
161264035|NCT02408068|582347195|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
161264036|NCT02408068|582347196|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
161264037|NCT02408068|582347197|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
161264038|NCT03484117|582347198|FG000|Overall Study|Lost to Follow-up|1|||
160927687|NCT04343521|581130028|FG000|Overall Study|Withdrawal by Subject|70|||
160927688|NCT04343521|581130029|FG001|Overall Study|Withdrawal by Subject|95|||
160927689|NCT04343521|581130028|FG000|Overall Study|Withdrawal by study team|6|||
160927690|NCT04343521|581130029|FG001|Overall Study|Withdrawal by study team|12|||
160927691|NCT00107198|581130030|FG000|Overall Study|Lack of Efficacy|28|||
160927692|NCT00107198|581130030|FG000|Overall Study|Lost to Follow-up|12|||
160927693|NCT00107198|581130030|FG000|Overall Study|Protocol Violation|1|||
160927694|NCT00107198|581130030|FG000|Overall Study|Withdrawal by Subject|6|||
160927695|NCT00107198|581130030|FG000|Overall Study|Ineligible|5|||
160927696|NCT02939560|581130036|FG000|Overall Study|Withdrawal by Subject|2|||
160927697|NCT02939560|581130036|FG000|Overall Study|Protocol Violation|1|||
160927698|NCT03340025|581130039|FG000|Overall Study|Lost to Follow-up|2|||
160927699|NCT03340025|581130040|FG001|Overall Study|Lost to Follow-up|2|||
160927700|NCT02420691|581130043|FG000|Overall Study|Adverse Event|3|||
160927701|NCT02420691|581130043|FG000|Overall Study|Withdrawal by Subject|3|||
160927702|NCT03897179|581130044|FG000|Overall Study|Withdrawal by Subject|1|||
160927703|NCT01480076|581130045|FG000|Overall Study|Run-in Failure|52|||
160927704|NCT01480076|581130045|FG000|Overall Study|Adverse Event|39|||
160927705|NCT01480076|581130045|FG000|Overall Study|Death|2|||
160927706|NCT01480076|581130045|FG000|Overall Study|Disease Progression|5|||
160927707|NCT01480076|581130045|FG000|Overall Study|Non-compliance With Study Protocol|15|||
160927708|NCT01480076|581130045|FG000|Overall Study|Withdrawal by Subject|105|||
160927709|NCT01480076|581130045|FG000|Overall Study|Lost to Follow-up|7|||
160927710|NCT01480076|581130045|FG000|Overall Study|Investigator Decision|13|||
160927711|NCT01480076|581130045|FG000|Overall Study|Other|52|||
160927712|NCT02503332|581130046|FG000|Overall Study|Adverse Event|17|||
160927713|NCT02503332|581130047|FG001|Overall Study|Adverse Event|5|||
160927714|NCT02503332|581130048|FG002|Overall Study|Adverse Event|3|||
160927715|NCT02503332|581130049|FG003|Overall Study|Adverse Event|1|||
160927716|NCT02503332|581130046|FG000|Overall Study|Investigator's Decision|5|||
160927717|NCT02503332|581130047|FG001|Overall Study|Investigator's Decision|1|||
160927718|NCT02503332|581130048|FG002|Overall Study|Investigator's Decision|0|||
160927719|NCT02503332|581130049|FG003|Overall Study|Investigator's Decision|0|||
160927720|NCT02503332|581130046|FG000|Overall Study|Sponsor's Decision|1|||
160927721|NCT02503332|581130047|FG001|Overall Study|Sponsor's Decision|0|||
160927722|NCT02503332|581130048|FG002|Overall Study|Sponsor's Decision|0|||
160927723|NCT02503332|581130049|FG003|Overall Study|Sponsor's Decision|1|||
160927724|NCT02503332|581130046|FG000|Overall Study|Subject Request|6|||
160927725|NCT02503332|581130047|FG001|Overall Study|Subject Request|5|||
160927726|NCT02503332|581130048|FG002|Overall Study|Subject Request|2|||
160927727|NCT02503332|581130049|FG003|Overall Study|Subject Request|1|||
160927728|NCT02503332|581130046|FG000|Overall Study|Death|0|||
160927729|NCT02503332|581130047|FG001|Overall Study|Death|2|||
160927730|NCT02503332|581130048|FG002|Overall Study|Death|2|||
160927731|NCT02503332|581130049|FG003|Overall Study|Death|0|||
160927732|NCT02503332|581130046|FG000|Overall Study|Other|5|||
160927733|NCT02503332|581130047|FG001|Overall Study|Other|6|||
160927734|NCT02503332|581130048|FG002|Overall Study|Other|1|||
160927735|NCT02503332|581130049|FG003|Overall Study|Other|1|||
160927736|NCT05694546|581130051|FG000|Overall Study|Lost to Follow-up|11|||
160927737|NCT02120950|581130052|FG000|Overall Study|Adverse Event|5|||
160927738|NCT02120950|581130053|FG001|Overall Study|Adverse Event|4|||
161264039|NCT03484117|582347199|FG001|Overall Study|Lost to Follow-up|3|||
160927739|NCT02120950|581130054|FG002|Overall Study|Adverse Event|3|||
160927740|NCT02120950|581130052|FG000|Overall Study|Death|3|||
160927741|NCT02120950|581130053|FG001|Overall Study|Death|0|||
160927742|NCT02120950|581130054|FG002|Overall Study|Death|1|||
160927743|NCT02120950|581130052|FG000|Overall Study|Withdrawal by Subject|6|||
160927744|NCT02120950|581130053|FG001|Overall Study|Withdrawal by Subject|3|||
160927745|NCT02120950|581130054|FG002|Overall Study|Withdrawal by Subject|2|||
160927746|NCT02120950|581130052|FG000|Overall Study|Protocol Violation|1|||
160927747|NCT02120950|581130053|FG001|Overall Study|Protocol Violation|1|||
160927748|NCT02120950|581130054|FG002|Overall Study|Protocol Violation|7|||
160927749|NCT02120950|581130052|FG000|Overall Study|Other reasons|5|||
161264040|NCT03484117|582347198|FG000|Overall Study|Declined participation in exit assess|1|||
160998069|NCT00094809|581378535|FG001|Overall Study|Death|25|||
161264041|NCT03484117|582347199|FG001|Overall Study|Declined participation in exit assess|1|||
161264042|NCT03551496|582347203|FG000|Overall Study|Death|11|||
160927750|NCT02120950|581130053|FG001|Overall Study|Other reasons|4|||
160927751|NCT02120950|581130054|FG002|Overall Study|Other reasons|1|||
160927752|NCT02120950|581130052|FG000|Overall Study|Lost to Follow-up|0|||
160927753|NCT02120950|581130053|FG001|Overall Study|Lost to Follow-up|2|||
160927754|NCT02120950|581130054|FG002|Overall Study|Lost to Follow-up|1|||
160927755|NCT02424383|581130055|FG000|Overall Study|Withdrawal by Subject|32|||
160927756|NCT02424383|581130055|FG000|Overall Study|Death|170|||
160927757|NCT02424383|581130055|FG000|Overall Study|Sponsor's decision|3|||
161264043|NCT03551496|582347204|FG001|Overall Study|Death|7|||
161264044|NCT03551496|582347203|FG000|Overall Study|Withdrawal by Subject|4|||
161264045|NCT03551496|582347204|FG001|Overall Study|Withdrawal by Subject|3|||
161264046|NCT03551496|582347203|FG000|Overall Study|Other Reasons|1|||
161264047|NCT03551496|582347204|FG001|Overall Study|Other Reasons|0|||
161264048|NCT02303041|582347207|FG000|Overall Study|Adverse Event|1|||
161264049|NCT02303041|582347208|FG001|Overall Study|Adverse Event|2|||
160927758|NCT02424383|581130055|FG000|Overall Study|Investigator's decision|44|||
160927759|NCT02424383|581130055|FG000|Overall Study|Lost to Follow-up|81|||
160927760|NCT02424383|581130055|FG000|Overall Study|Other|7|||
160927761|NCT02424383|581130055|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
160927762|NCT02439320|581130061|FG000|Overall Study|Adverse Event|0|||
160927763|NCT02439320|581130062|FG001|Overall Study|Adverse Event|2|||
160927764|NCT02439320|581130063|FG002|Overall Study|Adverse Event|0|||
160927765|NCT02439320|581130061|FG000|Overall Study|Lost to Follow-up|37|||
160927766|NCT02439320|581130062|FG001|Overall Study|Lost to Follow-up|34|||
160927767|NCT02439320|581130063|FG002|Overall Study|Lost to Follow-up|42|||
160927768|NCT02439320|581130061|FG000|Overall Study|Death|0|||
160927769|NCT02439320|581130062|FG001|Overall Study|Death|1|||
160927770|NCT02439320|581130063|FG002|Overall Study|Death|0|||
160927771|NCT02439320|581130061|FG000|Overall Study|Noncompliance with Protocol|10|||
160927772|NCT02439320|581130062|FG001|Overall Study|Noncompliance with Protocol|11|||
160927773|NCT02439320|581130063|FG002|Overall Study|Noncompliance with Protocol|7|||
160927774|NCT02439320|581130061|FG000|Overall Study|Pregnancy|0|||
160927775|NCT02439320|581130062|FG001|Overall Study|Pregnancy|1|||
160927776|NCT02439320|581130063|FG002|Overall Study|Pregnancy|1|||
160927777|NCT02439320|581130061|FG000|Overall Study|Withdrawal by Subject|12|||
160927778|NCT02439320|581130062|FG001|Overall Study|Withdrawal by Subject|16|||
160927779|NCT02439320|581130063|FG002|Overall Study|Withdrawal by Subject|14|||
160927780|NCT02439320|581130061|FG000|Overall Study|Physician Decision|2|||
160927781|NCT02439320|581130062|FG001|Overall Study|Physician Decision|1|||
160927782|NCT02439320|581130063|FG002|Overall Study|Physician Decision|0|||
160927783|NCT02439320|581130061|FG000|Overall Study|Sponsor Request|0|||
160927784|NCT02439320|581130062|FG001|Overall Study|Sponsor Request|2|||
160927785|NCT02439320|581130063|FG002|Overall Study|Sponsor Request|1|||
161264050|NCT00886288|582347209|FG000|Overall Study|no respect of the 12 weeks period|657|||
160927786|NCT02439320|581130061|FG000|Overall Study|Randomization Failure|35|||
160927787|NCT02439320|581130062|FG001|Overall Study|Randomization Failure|46|||
160927788|NCT02439320|581130063|FG002|Overall Study|Randomization Failure|34|||
160927789|NCT01251380|581130066|FG000|Overall Study|Other (Not otherwise specified)|12|||
160927790|NCT01251380|581130066|FG000|Overall Study|Withdrawal by Subject|6|||
160927791|NCT01251380|581130066|FG000|Overall Study|Lack of Efficacy|1|||
160927792|NCT01251380|581130066|FG000|Overall Study|Adverse Event|1|||
160927793|NCT01251380|581130066|FG000|Overall Study|Lost to Follow-up|2|||
160927794|NCT02404350|581130070|FG000|Overall Study|Adverse Event|2|||
160927795|NCT02404350|581130071|FG001|Overall Study|Adverse Event|2|||
160927796|NCT02404350|581130072|FG002|Overall Study|Adverse Event|3|||
160927797|NCT02404350|581130073|FG003|Overall Study|Adverse Event|9|||
160927798|NCT02404350|581130070|FG000|Overall Study|Lack of Efficacy|3|||
160927799|NCT02404350|581130071|FG001|Overall Study|Lack of Efficacy|1|||
160927800|NCT02404350|581130072|FG002|Overall Study|Lack of Efficacy|0|||
160927801|NCT02404350|581130073|FG003|Overall Study|Lack of Efficacy|3|||
160927802|NCT02404350|581130070|FG000|Overall Study|Lost to Follow-up|2|||
160927803|NCT02404350|581130071|FG001|Overall Study|Lost to Follow-up|0|||
160927804|NCT02404350|581130072|FG002|Overall Study|Lost to Follow-up|0|||
160927805|NCT02404350|581130073|FG003|Overall Study|Lost to Follow-up|1|||
160927806|NCT02404350|581130070|FG000|Overall Study|Physician Decision|1|||
160998070|NCT00094809|581378534|FG000|Overall Study|Protocol-specified criteria|1|||
160998071|NCT00094809|581378535|FG001|Overall Study|Protocol-specified criteria|1|||
160998072|NCT00094809|581378534|FG000|Overall Study|Other|2|||
160998073|NCT00094809|581378535|FG001|Overall Study|Other|4|||
161264051|NCT00886288|582347210|FG001|Overall Study|no respect of the 12 weeks period|227|||
161264052|NCT00886288|582347209|FG000|Overall Study|Lost to Follow-up|86|||
160927807|NCT02404350|581130071|FG001|Overall Study|Physician Decision|0|||
160927808|NCT02404350|581130072|FG002|Overall Study|Physician Decision|0|||
160927809|NCT02404350|581130073|FG003|Overall Study|Physician Decision|2|||
160927810|NCT02404350|581130070|FG000|Overall Study|Pregnancy|0|||
160927811|NCT02404350|581130071|FG001|Overall Study|Pregnancy|0|||
160927812|NCT02404350|581130072|FG002|Overall Study|Pregnancy|0|||
160927813|NCT02404350|581130073|FG003|Overall Study|Pregnancy|1|||
160927814|NCT02404350|581130070|FG000|Overall Study|Withdrawal by Subject|7|||
160927815|NCT02404350|581130071|FG001|Overall Study|Withdrawal by Subject|3|||
160927816|NCT02404350|581130072|FG002|Overall Study|Withdrawal by Subject|3|||
160927817|NCT02404350|581130073|FG003|Overall Study|Withdrawal by Subject|19|||
160927818|NCT02404350|581130070|FG000|Overall Study|Due to Non-compliance with treatment|0|||
160927819|NCT02404350|581130071|FG001|Overall Study|Due to Non-compliance with treatment|0|||
160927820|NCT02404350|581130072|FG002|Overall Study|Due to Non-compliance with treatment|0|||
160927821|NCT02404350|581130073|FG003|Overall Study|Due to Non-compliance with treatment|1|||
160927822|NCT02404350|581130070|FG000|Overall Study|Due to Technical problems|0|||
160927823|NCT02404350|581130071|FG001|Overall Study|Due to Technical problems|0|||
160927824|NCT02404350|581130072|FG002|Overall Study|Due to Technical problems|0|||
160927825|NCT02404350|581130073|FG003|Overall Study|Due to Technical problems|1|||
160927826|NCT05389657|581130074|FG000|Overall Study|Lost to Follow-up|7|||
160927827|NCT05389657|581130075|FG001|Overall Study|Lost to Follow-up|8|||
160927828|NCT05237206|581130077|FG000|Overall Study|screen failure-did not receive treatment|8|||
160927829|NCT05237206|581130077|FG000|Overall Study|did not receive treatment|3|||
160927830|NCT03261947|581130078|FG000|Overall Study|Death|10|||
160927831|NCT03261947|581130079|FG001|Overall Study|Death|13|||
160927832|NCT03261947|581130080|FG002|Overall Study|Death|17|||
160927833|NCT03261947|581130081|FG003|Overall Study|Death|12|||
160927834|NCT03261947|581130082|FG004|Overall Study|Death|8|||
160927835|NCT03261947|581130078|FG000|Overall Study|Lost to Follow-up|0|||
160927836|NCT03261947|581130079|FG001|Overall Study|Lost to Follow-up|0|||
160927837|NCT03261947|581130080|FG002|Overall Study|Lost to Follow-up|2|||
160927838|NCT03261947|581130081|FG003|Overall Study|Lost to Follow-up|1|||
160927839|NCT03261947|581130082|FG004|Overall Study|Lost to Follow-up|0|||
160927840|NCT03261947|581130078|FG000|Overall Study|Withdrawal by Subject|0|||
160927841|NCT03261947|581130079|FG001|Overall Study|Withdrawal by Subject|0|||
160927842|NCT03261947|581130080|FG002|Overall Study|Withdrawal by Subject|3|||
160927843|NCT03261947|581130081|FG003|Overall Study|Withdrawal by Subject|0|||
160927844|NCT03261947|581130082|FG004|Overall Study|Withdrawal by Subject|1|||
160927845|NCT03261947|581130078|FG000|Overall Study|Site Terminated by Sponsor|0|||
160927846|NCT03261947|581130079|FG001|Overall Study|Site Terminated by Sponsor|0|||
160927847|NCT03261947|581130080|FG002|Overall Study|Site Terminated by Sponsor|4|||
160927848|NCT03261947|581130081|FG003|Overall Study|Site Terminated by Sponsor|7|||
160927849|NCT03261947|581130082|FG004|Overall Study|Site Terminated by Sponsor|5|||
160927850|NCT03261947|581130078|FG000|Overall Study|Reason not Specified|2|||
160927851|NCT03261947|581130079|FG001|Overall Study|Reason not Specified|0|||
160927852|NCT03261947|581130080|FG002|Overall Study|Reason not Specified|4|||
160927853|NCT03261947|581130081|FG003|Overall Study|Reason not Specified|1|||
160927854|NCT03261947|581130082|FG004|Overall Study|Reason not Specified|3|||
160927855|NCT03969992|581130083|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
160927856|NCT03969992|581130084|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
160927857|NCT03969992|581130085|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
160927858|NCT03969992|581130083|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
160927859|NCT03969992|581130084|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
160927860|NCT03969992|581130085|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
160927861|NCT03969992|581130083|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
160927862|NCT03969992|581130084|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
160927863|NCT03969992|581130085|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
160927864|NCT03969992|581130083|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
160927865|NCT03969992|581130084|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
160927866|NCT03969992|581130085|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
160927867|NCT03969992|581130083|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
160927868|NCT03969992|581130084|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
160927869|NCT03969992|581130085|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
160927870|NCT04120974|581130086|FG000|Overall Study|Death|1|||
160927871|NCT04120974|581130086|FG000|Overall Study|Physician Decision|1|||
160927872|NCT04120974|581130086|FG000|Overall Study|Lost to Follow-up|6|||
160927873|NCT02154581|581130090|FG000|Overall Study|Lost to Follow-up|7|||
160927874|NCT02154581|581130091|FG001|Overall Study|Lost to Follow-up|8|||
160927875|NCT03082599|581130096|FG000|Overall Study|Lost to Follow-up|1|||
160927876|NCT03082599|581130097|FG001|Overall Study|Lost to Follow-up|0|||
160927877|NCT00832585|581130101|FG000|Overall Study|Withdrawal by Subject|1|||
160927878|NCT00832585|581130101|FG000|Overall Study|Lost to Follow-up|1|||
161143603|NCT03000452|581909425|FG000|Treatment Period|Physician Decision|1|||
161143604|NCT03000452|581909425|FG000|Treatment Period|Miscellaneous|2|||
160927879|NCT01344161|581130102|FG000|Overall Study|Lost to Follow-up|4|||
160927880|NCT01344161|581130103|FG001|Overall Study|Lost to Follow-up|1|||
160927881|NCT01344161|581130102|FG000|Overall Study|Pregnancy|0|||
160927882|NCT01344161|581130103|FG001|Overall Study|Pregnancy|1|||
160927883|NCT01344161|581130102|FG000|Overall Study|Protocol Violation|1|||
160927884|NCT01344161|581130103|FG001|Overall Study|Protocol Violation|1|||
160927885|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
160927886|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
160927887|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
160927888|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
160927889|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
160927890|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
160927891|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
161143605|NCT03000452|581909425|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
160927892|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
160927893|NCT01541969|581131652|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
160927894|NCT01541969|581131653|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
160927895|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
160927896|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
160927897|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
160927898|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
160927899|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
160927900|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
160927901|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
160927902|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
160927903|NCT01541969|581131652|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
160927904|NCT01541969|581131653|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
160927905|NCT01614990|581131654|FG000|Overall Study|Protocol Violation|1|||
160927906|NCT01614990|581131655|FG001|Overall Study|Protocol Violation|1|||
160927907|NCT02255500|581131660|FG000|Overall Study|Withdrawal by Subject|1|||
160927908|NCT02255500|581131661|FG001|Overall Study|Withdrawal by Subject|0|||
160927909|NCT02449239|581131664|FG000|Induction Phase|Lack of Efficacy|64|||
160927910|NCT02449239|581131664|FG000|Induction Phase|Adverse Event|1|||
160927911|NCT02449239|581131664|FG000|Induction Phase|Lost to Follow-up|1|||
160927912|NCT02449239|581131664|FG000|Induction Phase|Protocol Violation|1|||
160927913|NCT02449239|581131664|FG000|Induction Phase|Physician Decision|1|||
160927914|NCT02449239|581131664|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
160927915|NCT02449239|581131664|FG000|Induction Phase|Withdrawal by Subject|1|||
160927916|NCT02449239|581131664|FG000|Maintenance Month 3|Lack of Efficacy|14|||
160927917|NCT02449239|581131664|FG000|Maintenance Month 6|Lack of Efficacy|10|||
160927918|NCT02449239|581131664|FG000|Maintenance Month 6|Adverse Event|2|||
160927919|NCT02449239|581131664|FG000|Maintenance Month 6|Physician Decision|1|||
160927920|NCT02449239|581131664|FG000|Maintenance Month 9|Lack of Efficacy|2|||
160927921|NCT02449239|581131664|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
160927922|NCT02449239|581131664|FG000|Maintenance Month 12|Lack of Efficacy|5|||
160927923|NCT02449239|581131664|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
160927924|NCT02449239|581131664|FG000|Maintenance Month 12|Subject moved from area|1|||
160927925|NCT02449239|581131664|FG000|Maintenance Month 15|Lack of Efficacy|1|||
160927926|NCT02449239|581131664|FG000|Maintenance Month 21|Lack of Efficacy|1|||
160927927|NCT02449239|581131664|FG000|Maintenance Month 21|Sponsor decision|1|||
160927928|NCT03239470|581131667|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
160927929|NCT03239470|581131668|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
160927930|NCT01023581|581131669|FG000|Overall Study|Adverse Event|4|||
160927931|NCT01023581|581131670|FG001|Overall Study|Adverse Event|4|||
160927932|NCT01023581|581131671|FG002|Overall Study|Adverse Event|7|||
160927933|NCT01023581|581131672|FG003|Overall Study|Adverse Event|3|||
160927934|NCT01023581|581131673|FG004|Overall Study|Adverse Event|2|||
160927935|NCT01023581|581131674|FG005|Overall Study|Adverse Event|5|||
160927936|NCT01023581|581131675|FG006|Overall Study|Adverse Event|11|||
160927937|NCT01023581|581131669|FG000|Overall Study|Major protocol deviation|2|||
160927938|NCT01023581|581131670|FG001|Overall Study|Major protocol deviation|0|||
160927939|NCT01023581|581131671|FG002|Overall Study|Major protocol deviation|3|||
160927940|NCT01023581|581131672|FG003|Overall Study|Major protocol deviation|0|||
160927941|NCT01023581|581131673|FG004|Overall Study|Major protocol deviation|0|||
160927942|NCT01023581|581131674|FG005|Overall Study|Major protocol deviation|0|||
160927943|NCT01023581|581131675|FG006|Overall Study|Major protocol deviation|0|||
160927944|NCT01023581|581131669|FG000|Overall Study|Lost to Follow-up|4|||
160927945|NCT01023581|581131670|FG001|Overall Study|Lost to Follow-up|8|||
160927946|NCT01023581|581131671|FG002|Overall Study|Lost to Follow-up|7|||
160927947|NCT01023581|581131672|FG003|Overall Study|Lost to Follow-up|2|||
160927948|NCT01023581|581131673|FG004|Overall Study|Lost to Follow-up|5|||
160927949|NCT01023581|581131674|FG005|Overall Study|Lost to Follow-up|2|||
160927950|NCT01023581|581131675|FG006|Overall Study|Lost to Follow-up|2|||
160927951|NCT01023581|581131669|FG000|Overall Study|Withdrawal by Subject|13|||
160927952|NCT01023581|581131670|FG001|Overall Study|Withdrawal by Subject|8|||
160927953|NCT01023581|581131671|FG002|Overall Study|Withdrawal by Subject|16|||
160927954|NCT01023581|581131672|FG003|Overall Study|Withdrawal by Subject|10|||
160927955|NCT01023581|581131673|FG004|Overall Study|Withdrawal by Subject|6|||
160927956|NCT01023581|581131674|FG005|Overall Study|Withdrawal by Subject|8|||
160927957|NCT01023581|581131675|FG006|Overall Study|Withdrawal by Subject|5|||
160927958|NCT01023581|581131669|FG000|Overall Study|Pregnancy|0|||
160927959|NCT01023581|581131670|FG001|Overall Study|Pregnancy|0|||
160927960|NCT01023581|581131671|FG002|Overall Study|Pregnancy|0|||
160927961|NCT01023581|581131672|FG003|Overall Study|Pregnancy|2|||
160927962|NCT01023581|581131673|FG004|Overall Study|Pregnancy|0|||
160927963|NCT01023581|581131674|FG005|Overall Study|Pregnancy|1|||
160927964|NCT01023581|581131675|FG006|Overall Study|Pregnancy|0|||
160927965|NCT01023581|581131669|FG000|Overall Study|Lack of Efficacy|9|||
160927966|NCT01023581|581131670|FG001|Overall Study|Lack of Efficacy|3|||
160927967|NCT01023581|581131671|FG002|Overall Study|Lack of Efficacy|6|||
160927968|NCT01023581|581131672|FG003|Overall Study|Lack of Efficacy|2|||
160927969|NCT01023581|581131673|FG004|Overall Study|Lack of Efficacy|1|||
160927970|NCT01023581|581131674|FG005|Overall Study|Lack of Efficacy|2|||
160927971|NCT01023581|581131675|FG006|Overall Study|Lack of Efficacy|1|||
160927972|NCT01023581|581131669|FG000|Overall Study|Physician Decision|2|||
160927973|NCT01023581|581131670|FG001|Overall Study|Physician Decision|0|||
160927974|NCT01023581|581131671|FG002|Overall Study|Physician Decision|2|||
160927975|NCT01023581|581131672|FG003|Overall Study|Physician Decision|1|||
160927976|NCT01023581|581131673|FG004|Overall Study|Physician Decision|1|||
160927977|NCT01023581|581131674|FG005|Overall Study|Physician Decision|1|||
160927978|NCT01023581|581131675|FG006|Overall Study|Physician Decision|1|||
160927979|NCT01023581|581131669|FG000|Overall Study|Other|1|||
160927980|NCT01023581|581131670|FG001|Overall Study|Other|0|||
160927981|NCT01023581|581131671|FG002|Overall Study|Other|1|||
160927982|NCT01023581|581131672|FG003|Overall Study|Other|0|||
160927983|NCT01023581|581131673|FG004|Overall Study|Other|1|||
160927984|NCT01023581|581131674|FG005|Overall Study|Other|0|||
160927985|NCT01023581|581131675|FG006|Overall Study|Other|0|||
160927986|NCT02532647|581131684|FG000|Overall Study|Did not receive trial medication|1|||
160927987|NCT02532647|581131685|FG001|Overall Study|Did not receive trial medication|0|||
160927988|NCT02532647|581131686|FG002|Overall Study|Did not receive trial medication|1|||
160927989|NCT03412084|581131690|FG000|Overall Study|Withdrawal by Subject|2|||
160927990|NCT03412084|581131691|FG001|Overall Study|Withdrawal by Subject|0|||
160927991|NCT03412084|581131690|FG000|Overall Study|Participant moved|1|||
160927992|NCT03412084|581131691|FG001|Overall Study|Participant moved|0|||
160927993|NCT03412084|581131690|FG000|Overall Study|Lost to Follow-up|1|||
160927994|NCT03412084|581131691|FG001|Overall Study|Lost to Follow-up|1|||
160927995|NCT01928862|581131696|FG000|Overall Study|Lost to Follow-up|1|||
160927996|NCT01928862|581131697|FG001|Overall Study|Lost to Follow-up|0|||
160927997|NCT01928862|581131698|FG002|Overall Study|Lost to Follow-up|0|||
160927998|NCT01928862|581131699|FG003|Overall Study|Lost to Follow-up|0|||
160927999|NCT01928862|581131700|FG004|Overall Study|Lost to Follow-up|1|||
160928000|NCT01752855|581131701|FG000|Overall Study|Adverse Event|1|||
160928001|NCT01752855|581131702|FG001|Overall Study|Adverse Event|0|||
160928002|NCT01752855|581131701|FG000|Overall Study|Withdrew Consent|0|||
160928003|NCT01752855|581131702|FG001|Overall Study|Withdrew Consent|2|||
160928004|NCT01752855|581131701|FG000|Overall Study|Lack of Efficacy|0|||
160928005|NCT01752855|581131702|FG001|Overall Study|Lack of Efficacy|2|||
160928006|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
160928007|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
160928008|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
160928009|NCT01478321|581131703|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
160928010|NCT01478321|581131703|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
160928011|NCT01478321|581131703|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
160928012|NCT01478321|581131703|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
160928013|NCT01478321|581131703|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
160928014|NCT02053753|581131705|FG000|Overall Study|Withdrawal by Subject|2|||
161143606|NCT03000452|581909425|FG000|Follow-Up Period|Death|3|||
161143607|NCT03000452|581909425|FG000|Follow-Up Period|Withdrawal by Subject|3|||
161143608|NCT00593112|581909426|FG000|Overall Study|Scan Anxiety|3|||
161143609|NCT00593112|581909427|FG001|Overall Study|Scan Anxiety|0|||
160928015|NCT02053753|581131706|FG001|Overall Study|Withdrawal by Subject|4|||
160928016|NCT02053753|581131705|FG000|Overall Study|Decision by Sponsor|1|||
160928017|NCT02053753|581131706|FG001|Overall Study|Decision by Sponsor|1|||
161143610|NCT00593112|581909426|FG000|Overall Study|Abnormal Scan|1|||
161143611|NCT00593112|581909427|FG001|Overall Study|Abnormal Scan|0|||
161143612|NCT00593112|581909426|FG000|Overall Study|Unreadable Scan|1|||
161143613|NCT00593112|581909427|FG001|Overall Study|Unreadable Scan|0|||
161143614|NCT00593112|581909426|FG000|Overall Study|Withdrawal by Subject|5|||
161143615|NCT00593112|581909427|FG001|Overall Study|Withdrawal by Subject|0|||
161342405|NCT02097277|582640183|FG000|Overall Study|Lost to Follow-up|0|||
161342406|NCT02097277|582640184|FG001|Overall Study|Lost to Follow-up|1|||
161342407|NCT02097277|582640185|FG002|Overall Study|Lost to Follow-up|1|||
161342408|NCT02097277|582640186|FG003|Overall Study|Lost to Follow-up|0|||
161342409|NCT02097277|582640187|FG004|Overall Study|Lost to Follow-up|0|||
160928018|NCT02053753|581131705|FG000|Overall Study|Lost to Follow-up|4|||
160928019|NCT02053753|581131706|FG001|Overall Study|Lost to Follow-up|3|||
160928020|NCT01505608|581131707|FG000|Phase I|Lack of Efficacy|0|||
160928021|NCT01505608|581131708|FG001|Phase I|Lack of Efficacy|4|||
160928022|NCT01505608|581131707|FG000|Phase I|Adverse Event|0|||
160928023|NCT01505608|581131708|FG001|Phase I|Adverse Event|1|||
161143616|NCT03043365|581909428|FG000|Weeks 0 to Week 8|Adverse Event|1|||
160928024|NCT01505608|581131707|FG000|Phase I|Withdrawal by Subject|0|||
160928025|NCT01505608|581131708|FG001|Phase I|Withdrawal by Subject|1|||
160928026|NCT01505608|581131707|FG000|Phase II|Lack of Efficacy|2|||
161143617|NCT03043365|581909429|FG001|Weeks 0 to Week 8|Adverse Event|3|||
161143618|NCT03043365|581909428|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
161342410|NCT02097277|582640183|FG000|Overall Study|Withdrawal by Subject|2|||
161264053|NCT00886288|582347210|FG001|Overall Study|Lost to Follow-up|0|||
161264054|NCT04319718|582349083|FG000|Overall Study|Adverse Event|0|||
161264055|NCT04319718|582349084|FG001|Overall Study|Adverse Event|2|||
161264056|NCT04319718|582349083|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
161264057|NCT04319718|582349084|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
161264058|NCT02221037|582349085|FG000|Overall Study|Physician Decision|0|||
161264059|NCT02221037|582349086|FG001|Overall Study|Physician Decision|0|||
161264060|NCT02221037|582349087|FG002|Overall Study|Physician Decision|1|||
161342411|NCT02097277|582640184|FG001|Overall Study|Withdrawal by Subject|1|||
161342412|NCT02097277|582640185|FG002|Overall Study|Withdrawal by Subject|0|||
161342413|NCT02097277|582640186|FG003|Overall Study|Withdrawal by Subject|1|||
161342414|NCT02097277|582640187|FG004|Overall Study|Withdrawal by Subject|0|||
161342415|NCT02097277|582640183|FG000|Overall Study|Adverse Event|0|||
160928027|NCT01505608|581131708|FG001|Phase II|Lack of Efficacy|1|||
160928028|NCT01505608|581131707|FG000|Phase II|Protocol Violation|0|||
160928029|NCT01505608|581131708|FG001|Phase II|Protocol Violation|1|||
160928030|NCT02932904|581131709|FG000|Overall Study|Reason not Specified|1|||
160928031|NCT02932904|581131710|FG001|Overall Study|Reason not Specified|0|||
160928032|NCT02932904|581131711|FG002|Overall Study|Reason not Specified|2|||
160928033|NCT02932904|581131712|FG003|Overall Study|Reason not Specified|2|||
160928034|NCT02932904|581131709|FG000|Overall Study|Noncompliance with Study Drug|2|||
160928035|NCT02932904|581131710|FG001|Overall Study|Noncompliance with Study Drug|3|||
160928036|NCT02932904|581131711|FG002|Overall Study|Noncompliance with Study Drug|3|||
160928037|NCT02932904|581131712|FG003|Overall Study|Noncompliance with Study Drug|4|||
160928038|NCT02932904|581131709|FG000|Overall Study|Pregnancy|0|||
160928039|NCT02932904|581131710|FG001|Overall Study|Pregnancy|1|||
160928040|NCT02932904|581131711|FG002|Overall Study|Pregnancy|1|||
160928041|NCT02932904|581131712|FG003|Overall Study|Pregnancy|0|||
160928042|NCT02932904|581131709|FG000|Overall Study|Study Termination|0|||
160928043|NCT02932904|581131710|FG001|Overall Study|Study Termination|1|||
160928044|NCT02932904|581131711|FG002|Overall Study|Study Termination|0|||
160928045|NCT02932904|581131712|FG003|Overall Study|Study Termination|0|||
160928046|NCT02932904|581131709|FG000|Overall Study|Voluntary Withdrawal|2|||
160928047|NCT02932904|581131710|FG001|Overall Study|Voluntary Withdrawal|1|||
160928048|NCT02932904|581131711|FG002|Overall Study|Voluntary Withdrawal|4|||
160928049|NCT02932904|581131712|FG003|Overall Study|Voluntary Withdrawal|2|||
160928050|NCT02932904|581131709|FG000|Overall Study|Lost to Follow-up|5|||
160928051|NCT02932904|581131710|FG001|Overall Study|Lost to Follow-up|3|||
160928052|NCT02932904|581131711|FG002|Overall Study|Lost to Follow-up|6|||
160928053|NCT02932904|581131712|FG003|Overall Study|Lost to Follow-up|0|||
160928054|NCT02932904|581131709|FG000|Overall Study|Significant Protocol Deviation|2|||
160928055|NCT02932904|581131710|FG001|Overall Study|Significant Protocol Deviation|3|||
160928056|NCT02932904|581131711|FG002|Overall Study|Significant Protocol Deviation|6|||
160928057|NCT02932904|581131712|FG003|Overall Study|Significant Protocol Deviation|1|||
160928058|NCT02932904|581131709|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160928059|NCT02932904|581131710|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
160928060|NCT02932904|581131711|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
160928061|NCT02932904|581131712|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
160928062|NCT02932904|581131709|FG000|Overall Study|Randomized But Not Treated|1|||
160928063|NCT02932904|581131710|FG001|Overall Study|Randomized But Not Treated|1|||
160928064|NCT02932904|581131711|FG002|Overall Study|Randomized But Not Treated|0|||
160928065|NCT02932904|581131712|FG003|Overall Study|Randomized But Not Treated|2|||
160928066|NCT00751348|581131718|FG000|Overall Study|Withdrawal by Subject|5|||
160928067|NCT00751348|581131719|FG001|Overall Study|Withdrawal by Subject|2|||
160928068|NCT00751348|581131718|FG000|Overall Study|Migration from study area|1|||
160928069|NCT00751348|581131719|FG001|Overall Study|Migration from study area|0|||
160928070|NCT01476696|581131725|FG000|Overall Study|Sponsor decision|2|||
160928071|NCT01476696|581131726|FG001|Overall Study|Sponsor decision|1|||
160928072|NCT01476696|581131727|FG002|Overall Study|Sponsor decision|0|||
161264061|NCT02221037|582349088|FG003|Overall Study|Physician Decision|0|||
160928073|NCT01476696|581131725|FG000|Overall Study|Withdrawal by Subject|1|||
160928074|NCT01476696|581131726|FG001|Overall Study|Withdrawal by Subject|0|||
160928075|NCT01476696|581131727|FG002|Overall Study|Withdrawal by Subject|0|||
160928076|NCT02063737|581131728|FG000|Overall Study|Lost to Follow-up|11|||
160928077|NCT02063737|581131729|FG001|Overall Study|Lost to Follow-up|4|||
160928078|NCT00129129|581131733|FG000|Primary Phase|Adverse Event|2|||
160928079|NCT00129129|581131734|FG001|Primary Phase|Adverse Event|1|||
161264062|NCT01293539|582349091|FG000|Overall Study|Physician Decision|1|||
161264063|NCT00609518|582349093|FG000|Overall Study|Death from Study Disease|32|||
161264064|NCT00609518|582349094|FG001|Overall Study|Death from Study Disease|32|||
161342416|NCT02097277|582640184|FG001|Overall Study|Adverse Event|0|||
160928080|NCT00129129|581131735|FG002|Primary Phase|Adverse Event|0|||
160998074|NCT00094809|581378534|FG000|Overall Study|Informed consent signed after treatment|1|||
161342417|NCT02097277|582640185|FG002|Overall Study|Adverse Event|1|||
160928081|NCT00129129|581131736|FG003|Primary Phase|Adverse Event|0|||
160928082|NCT00129129|581131737|FG004|Primary Phase|Adverse Event|0|||
160928083|NCT00129129|581131733|FG000|Primary Phase|Withdrawal by Subject|12|||
161264065|NCT00609518|582349093|FG000|Overall Study|Withdrawal by Subject|5|||
161264066|NCT00609518|582349094|FG001|Overall Study|Withdrawal by Subject|3|||
161264067|NCT00609518|582349093|FG000|Overall Study|Lost to Follow-up|3|||
161264068|NCT00609518|582349094|FG001|Overall Study|Lost to Follow-up|0|||
161264069|NCT00609518|582349093|FG000|Overall Study|Physician Decision|1|||
161264070|NCT00609518|582349094|FG001|Overall Study|Physician Decision|3|||
161264071|NCT00609518|582349093|FG000|Overall Study|Death from Adverse Event|2|||
161264072|NCT00609518|582349094|FG001|Overall Study|Death from Adverse Event|2|||
161264073|NCT04032158|582349095|FG000|Overall Study|Study Termination|2|||
161264074|NCT04032158|582349096|FG001|Overall Study|Study Termination|1|||
161264075|NCT00059787|582349097|FG000|Overall Study|Adverse Event|13|||
161264076|NCT00059787|582349097|FG000|Overall Study|disease progression|2|||
161264077|NCT00059787|582349097|FG000|Overall Study|ineligible|1|||
161264078|NCT00059787|582349097|FG000|Overall Study|Other|4|||
160928084|NCT00129129|581131734|FG001|Primary Phase|Withdrawal by Subject|10|||
160928085|NCT00129129|581131735|FG002|Primary Phase|Withdrawal by Subject|0|||
160928086|NCT00129129|581131736|FG003|Primary Phase|Withdrawal by Subject|0|||
160928087|NCT00129129|581131737|FG004|Primary Phase|Withdrawal by Subject|0|||
160928088|NCT00129129|581131733|FG000|Primary Phase|Migration from study area|1|||
160928089|NCT00129129|581131734|FG001|Primary Phase|Migration from study area|3|||
160928090|NCT00129129|581131735|FG002|Primary Phase|Migration from study area|0|||
160928091|NCT00129129|581131736|FG003|Primary Phase|Migration from study area|0|||
160928092|NCT00129129|581131737|FG004|Primary Phase|Migration from study area|0|||
160928093|NCT00129129|581131733|FG000|Primary Phase|Lost to Follow-up|8|||
160928094|NCT00129129|581131734|FG001|Primary Phase|Lost to Follow-up|6|||
160928095|NCT00129129|581131735|FG002|Primary Phase|Lost to Follow-up|0|||
160928096|NCT00129129|581131736|FG003|Primary Phase|Lost to Follow-up|0|||
160928097|NCT00129129|581131737|FG004|Primary Phase|Lost to Follow-up|0|||
160928098|NCT00129129|581131733|FG000|Primary Phase|Other|2|||
160928099|NCT00129129|581131734|FG001|Primary Phase|Other|5|||
160928100|NCT00129129|581131735|FG002|Primary Phase|Other|0|||
160928101|NCT00129129|581131736|FG003|Primary Phase|Other|0|||
160928102|NCT00129129|581131737|FG004|Primary Phase|Other|0|||
160928103|NCT00129129|581131733|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
160928104|NCT00129129|581131734|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
160928105|NCT00129129|581131735|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
160928106|NCT00129129|581131736|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
160928107|NCT00129129|581131737|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
160928108|NCT00129129|581131733|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
160928109|NCT00129129|581131734|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
160928110|NCT00129129|581131735|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
160928111|NCT00129129|581131736|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
160928112|NCT00129129|581131737|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
160928113|NCT00129129|581131733|FG000|Fourth Dose Phase|Migration from study area|0|||
160928114|NCT00129129|581131734|FG001|Fourth Dose Phase|Migration from study area|0|||
160928115|NCT00129129|581131735|FG002|Fourth Dose Phase|Migration from study area|0|||
160928116|NCT00129129|581131736|FG003|Fourth Dose Phase|Migration from study area|0|||
160928117|NCT00129129|581131737|FG004|Fourth Dose Phase|Migration from study area|2|||
160928118|NCT00129129|581131733|FG000|Fourth Dose Phase|Other|0|||
160928119|NCT00129129|581131734|FG001|Fourth Dose Phase|Other|0|||
160928120|NCT00129129|581131735|FG002|Fourth Dose Phase|Other|0|||
160928121|NCT00129129|581131736|FG003|Fourth Dose Phase|Other|1|||
160928122|NCT00129129|581131737|FG004|Fourth Dose Phase|Other|1|||
160928123|NCT00129129|581131733|FG000|Fourth Dose Phase|Protocol Violation|0|||
160928124|NCT00129129|581131734|FG001|Fourth Dose Phase|Protocol Violation|0|||
160928125|NCT00129129|581131735|FG002|Fourth Dose Phase|Protocol Violation|0|||
160928126|NCT00129129|581131736|FG003|Fourth Dose Phase|Protocol Violation|1|||
160928127|NCT00129129|581131737|FG004|Fourth Dose Phase|Protocol Violation|0|||
160998075|NCT00094809|581378535|FG001|Overall Study|Informed consent signed after treatment|0|||
161264079|NCT01248013|582349100|FG000|Overall Study|Withdrawal by Subject|14|||
161264080|NCT04325204|582349103|FG000|Overall Study|Death|0|||
161264081|NCT04325204|582349104|FG001|Overall Study|Death|1|||
161264082|NCT04325204|582349103|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
161264083|NCT04325204|582349104|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
161264084|NCT04325204|582349103|FG000|Overall Study|Lost to Follow-up|8|||
160928128|NCT03089606|581131740|FG000|Overall Study|Progression after Cycle 1|1|||
160928129|NCT03965962|581131741|FG000|Overall Study|Adverse Event|1|||
160928130|NCT03965962|581131742|FG001|Overall Study|Adverse Event|0|||
160928131|NCT03965962|581131743|FG002|Overall Study|Adverse Event|0|||
160928132|NCT03965962|581131744|FG003|Overall Study|Adverse Event|0|||
160928133|NCT03965962|581131741|FG000|Overall Study|Protocol Violation|21|||
160928134|NCT03965962|581131742|FG001|Overall Study|Protocol Violation|4|||
160928135|NCT03965962|581131743|FG002|Overall Study|Protocol Violation|10|||
160928136|NCT03965962|581131744|FG003|Overall Study|Protocol Violation|5|||
160928137|NCT03965962|581131741|FG000|Overall Study|Lost to Follow-up|0|||
160928138|NCT03965962|581131742|FG001|Overall Study|Lost to Follow-up|1|||
160928139|NCT03965962|581131743|FG002|Overall Study|Lost to Follow-up|0|||
160928140|NCT03965962|581131744|FG003|Overall Study|Lost to Follow-up|0|||
160928141|NCT03965962|581131741|FG000|Overall Study|Withdrawal by Subject|3|||
160928142|NCT03965962|581131742|FG001|Overall Study|Withdrawal by Subject|0|||
160928143|NCT03965962|581131743|FG002|Overall Study|Withdrawal by Subject|0|||
160928144|NCT03965962|581131744|FG003|Overall Study|Withdrawal by Subject|1|||
160928145|NCT01358357|581131748|FG000|Open Label Phase|Adverse Event|0|||
160928146|NCT01358357|581131749|FG001|Open Label Phase|Adverse Event|0|||
160928147|NCT01358357|581131750|FG002|Open Label Phase|Adverse Event|59|||
160928148|NCT01358357|581131748|FG000|Open Label Phase|Lack of Efficacy|0|||
160928149|NCT01358357|581131749|FG001|Open Label Phase|Lack of Efficacy|0|||
160928150|NCT01358357|581131750|FG002|Open Label Phase|Lack of Efficacy|107|||
160928151|NCT01358357|581131748|FG000|Open Label Phase|Lost to Follow-up|0|||
160928152|NCT01358357|581131749|FG001|Open Label Phase|Lost to Follow-up|0|||
160928153|NCT01358357|581131750|FG002|Open Label Phase|Lost to Follow-up|76|||
160928154|NCT01358357|581131748|FG000|Open Label Phase|Protocol Violation|0|||
160928155|NCT01358357|581131749|FG001|Open Label Phase|Protocol Violation|0|||
160928156|NCT01358357|581131750|FG002|Open Label Phase|Protocol Violation|45|||
160928157|NCT01358357|581131748|FG000|Open Label Phase|Withdrawal by Subject|0|||
160928158|NCT01358357|581131749|FG001|Open Label Phase|Withdrawal by Subject|0|||
160928159|NCT01358357|581131750|FG002|Open Label Phase|Withdrawal by Subject|112|||
160928160|NCT01358357|581131748|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
160928161|NCT01358357|581131749|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
160928162|NCT01358357|581131750|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
160928163|NCT01358357|581131748|FG000|Open Label Phase|Terminated at study completion|0|||
160928164|NCT01358357|581131749|FG001|Open Label Phase|Terminated at study completion|0|||
160928165|NCT01358357|581131750|FG002|Open Label Phase|Terminated at study completion|5|||
160928166|NCT01358357|581131748|FG000|Open Label Phase|Mood episode|0|||
160928167|NCT01358357|581131749|FG001|Open Label Phase|Mood episode|0|||
160928168|NCT01358357|581131750|FG002|Open Label Phase|Mood episode|42|||
160928169|NCT01358357|581131748|FG000|Double-Blind Phase|Adverse Event|8|||
160928170|NCT01358357|581131749|FG001|Double-Blind Phase|Adverse Event|5|||
160928171|NCT01358357|581131750|FG002|Double-Blind Phase|Adverse Event|0|||
160928172|NCT01358357|581131748|FG000|Double-Blind Phase|Lost to Follow-up|5|||
160928173|NCT01358357|581131749|FG001|Double-Blind Phase|Lost to Follow-up|7|||
160928174|NCT01358357|581131750|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160928175|NCT01358357|581131748|FG000|Double-Blind Phase|Protocol Violation|1|||
160928176|NCT01358357|581131749|FG001|Double-Blind Phase|Protocol Violation|11|||
160928177|NCT01358357|581131750|FG002|Double-Blind Phase|Protocol Violation|0|||
160928178|NCT01358357|581131748|FG000|Double-Blind Phase|Protocol Violation|16|||
160928179|NCT01358357|581131749|FG001|Double-Blind Phase|Protocol Violation|12|||
160928180|NCT01358357|581131750|FG002|Double-Blind Phase|Protocol Violation|0|||
161264085|NCT04325204|582349104|FG001|Overall Study|Lost to Follow-up|8|||
160928181|NCT01358357|581131748|FG000|Double-Blind Phase|Terminated at study completion|2|||
160928182|NCT01358357|581131749|FG001|Double-Blind Phase|Terminated at study completion|0|||
160928183|NCT01358357|581131750|FG002|Double-Blind Phase|Terminated at study completion|0|||
160928184|NCT01358357|581131748|FG000|Double-Blind Phase|Recurrence of mood event|48|||
160928185|NCT01358357|581131749|FG001|Double-Blind Phase|Recurrence of mood event|64|||
161264086|NCT04325204|582349103|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
161264087|NCT04325204|582349104|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
161264088|NCT00841906|582349105|FG000|Overall Study|Withdrawal by Subject|2|||
161264089|NCT00841906|582349106|FG001|Overall Study|Withdrawal by Subject|0|||
161264090|NCT04710979|582349109|FG000|Overall Study|Lost to Follow-up|2|||
161264091|NCT04710979|582349110|FG001|Overall Study|Lost to Follow-up|4|||
161264092|NCT04710979|582349109|FG000|Overall Study|Withdrawal by Subject|1|||
161264093|NCT04710979|582349110|FG001|Overall Study|Withdrawal by Subject|0|||
161264094|NCT04397445|582349118|FG000|Overall Study|Withdrawal by Subject|1|||
161264095|NCT04397445|582349119|FG001|Overall Study|Withdrawal by Subject|0|||
161264096|NCT04397445|582349120|FG002|Overall Study|Withdrawal by Subject|0|||
161264097|NCT04397445|582349121|FG003|Overall Study|Withdrawal by Subject|0|||
161264098|NCT00891371|582349122|FG000|Pre-assignment|Inclusion/exclusion|5|||
161264099|NCT00891371|582349122|FG000|Pre-assignment|Consent withdrawal|1|||
161264100|NCT00891371|582349122|FG000|Treatment|Lack of Efficacy|5|||
160928186|NCT01358357|581131750|FG002|Double-Blind Phase|Recurrence of mood event|0|||
160928187|NCT01358357|581131748|FG000|Double-Blind Phase|Administrative|0|||
160928188|NCT01358357|581131749|FG001|Double-Blind Phase|Administrative|1|||
160928189|NCT01358357|581131750|FG002|Double-Blind Phase|Administrative|0|||
160928190|NCT02590939|581131751|FG000|Overall Study|Withdrawal by Subject|3|||
160928191|NCT02590939|581131752|FG001|Overall Study|Withdrawal by Subject|1|||
160928192|NCT02590939|581131751|FG000|Overall Study|Failed the nociceptive test|2|||
160928193|NCT02590939|581131752|FG001|Overall Study|Failed the nociceptive test|1|||
160928194|NCT00768144|581131757|FG000|Overall Study|Adverse Event|13|||
160928195|NCT00768144|581131757|FG000|Overall Study|Progressive Disease|21|||
160928196|NCT00768144|581131757|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
161264101|NCT00891371|582349122|FG000|Treatment|Adverse Event|2|||
161264102|NCT00891371|582349122|FG000|Treatment|Death|1|||
161264103|NCT00891371|582349122|FG000|Treatment|Lost to Follow-up|1|||
160928197|NCT00768144|581131757|FG000|Overall Study|Pt Withdrew Consent|1|||
160928198|NCT02225743|581131758|FG000|Overall Study|Withdrawal by Subject|18|||
160928199|NCT02171260|581131759|FG000|Overall Study|Death|0|||
160928200|NCT02171260|581131760|FG001|Overall Study|Death|0|||
160928201|NCT02171260|581131761|FG002|Overall Study|Death|0|||
160928202|NCT02171260|581131762|FG003|Overall Study|Death|1|||
160928203|NCT02171260|581131759|FG000|Overall Study|Physician Decision|1|||
160928204|NCT02171260|581131760|FG001|Overall Study|Physician Decision|0|||
160928205|NCT02171260|581131761|FG002|Overall Study|Physician Decision|1|||
160928206|NCT02171260|581131762|FG003|Overall Study|Physician Decision|0|||
160928207|NCT02171260|581131759|FG000|Overall Study|Withdrawal by Subject|1|||
160928208|NCT02171260|581131760|FG001|Overall Study|Withdrawal by Subject|0|||
160928209|NCT02171260|581131761|FG002|Overall Study|Withdrawal by Subject|0|||
160928210|NCT02171260|581131762|FG003|Overall Study|Withdrawal by Subject|0|||
160928211|NCT02171260|581131759|FG000|Overall Study|Evidence of progressive disease|4|||
160928212|NCT02171260|581131760|FG001|Overall Study|Evidence of progressive disease|6|||
160928213|NCT02171260|581131761|FG002|Overall Study|Evidence of progressive disease|4|||
160928214|NCT02171260|581131762|FG003|Overall Study|Evidence of progressive disease|4|||
160928215|NCT00322842|581131765|FG000|Overall Study|Withdrawal by Subject|0|||
160928216|NCT00322842|581131766|FG001|Overall Study|Withdrawal by Subject|1|||
160928217|NCT00322842|581131765|FG000|Overall Study|Lost to Follow-up|0|||
160928218|NCT00322842|581131766|FG001|Overall Study|Lost to Follow-up|1|||
160928219|NCT00322842|581131765|FG000|Overall Study|Refused transplant|1|||
160928220|NCT00322842|581131766|FG001|Overall Study|Refused transplant|0|||
160928221|NCT00322842|581131765|FG000|Overall Study|Death|1|||
160928222|NCT00322842|581131766|FG001|Overall Study|Death|0|||
160928223|NCT00323492|581131767|FG000|Study Phase 1|Adverse Event|2|||
160928224|NCT00323492|581131768|FG001|Study Phase 1|Adverse Event|0|||
160928225|NCT00323492|581131769|FG002|Study Phase 1|Adverse Event|0|||
160928226|NCT00323492|581131767|FG000|Study Phase 2|Adverse Event|1|||
160928227|NCT00323492|581131768|FG001|Study Phase 2|Adverse Event|0|||
160928228|NCT00323492|581131769|FG002|Study Phase 2|Adverse Event|0|||
160928229|NCT00323492|581131767|FG000|Study Phase 2|Physician Decision|1|||
160928230|NCT00323492|581131768|FG001|Study Phase 2|Physician Decision|0|||
160928231|NCT00323492|581131769|FG002|Study Phase 2|Physician Decision|0|||
160928232|NCT00323492|581131767|FG000|Study Phase 2|Lost to Follow-up|1|||
160928233|NCT00323492|581131768|FG001|Study Phase 2|Lost to Follow-up|0|||
160928234|NCT00323492|581131769|FG002|Study Phase 2|Lost to Follow-up|0|||
160928235|NCT00323492|581131767|FG000|Study Phase 2|Withdrawal by Subject|0|||
160928236|NCT00323492|581131768|FG001|Study Phase 2|Withdrawal by Subject|1|||
160928237|NCT00323492|581131769|FG002|Study Phase 2|Withdrawal by Subject|0|||
160928238|NCT00323492|581131767|FG000|Study Phase 2|Noncompliance with study schedule|0|||
160928239|NCT00323492|581131768|FG001|Study Phase 2|Noncompliance with study schedule|0|||
160928240|NCT00323492|581131769|FG002|Study Phase 2|Noncompliance with study schedule|1|||
160928241|NCT00323492|581131767|FG000|Study Phase 2|Protocol Violation|1|||
160928242|NCT00323492|581131768|FG001|Study Phase 2|Protocol Violation|0|||
160928243|NCT00323492|581131769|FG002|Study Phase 2|Protocol Violation|0|||
160928244|NCT02486042|581131770|FG000|Overall Study|Physician Decision|1|||
160928245|NCT02486042|581131771|FG001|Overall Study|Physician Decision|7|||
160928246|NCT02486042|581131770|FG000|Overall Study|Hospital transfer|2|||
160928247|NCT02486042|581131771|FG001|Overall Study|Hospital transfer|2|||
160928248|NCT02486042|581131770|FG000|Overall Study|Withdrawal by Subject|0|||
160928249|NCT02486042|581131771|FG001|Overall Study|Withdrawal by Subject|2|||
160928250|NCT00673179|581131783|FG000|Overall Study|Toxicity/Complications|3|||
160928251|NCT00673179|581131784|FG001|Overall Study|Toxicity/Complications|0|||
161264104|NCT00307034|582349129|FG000|Overall Study|Adverse Event|1|||
161264105|NCT00307034|582349130|FG001|Overall Study|Adverse Event|2|||
161264106|NCT00307034|582349129|FG000|Overall Study|Withdrawal by Subject|1|||
161264107|NCT00307034|582349130|FG001|Overall Study|Withdrawal by Subject|2|||
160928252|NCT00352846|581131785|FG000|Overall Study|Disease progression|0|||
160928253|NCT00352846|581131786|FG001|Overall Study|Disease progression|2|||
160928254|NCT00352846|581131785|FG000|Overall Study|Withdrawal by Subject|3|||
160928255|NCT00352846|581131786|FG001|Overall Study|Withdrawal by Subject|8|||
160928256|NCT00352846|581131785|FG000|Overall Study|Ineligible|3|||
160928257|NCT00352846|581131786|FG001|Overall Study|Ineligible|2|||
160928258|NCT00352846|581131785|FG000|Overall Study|Non-compliance|2|||
160928259|NCT00352846|581131786|FG001|Overall Study|Non-compliance|0|||
160928260|NCT00352846|581131785|FG000|Overall Study|Death|0|||
160928261|NCT00352846|581131786|FG001|Overall Study|Death|1|||
160928262|NCT00281684|581131787|FG000|Overall Study|Lost to Follow-up|0|||
160928263|NCT00281684|581131788|FG001|Overall Study|Lost to Follow-up|0|||
160928264|NCT00281684|581131789|FG002|Overall Study|Lost to Follow-up|1|||
161264108|NCT00307034|582349129|FG000|Overall Study|Lost to Follow-up|0|||
161264109|NCT00307034|582349130|FG001|Overall Study|Lost to Follow-up|3|||
160928265|NCT00281684|581131790|FG003|Overall Study|Lost to Follow-up|0|||
160928266|NCT00281684|581131787|FG000|Overall Study|Withdrawal by Subject|1|||
161264110|NCT02034058|582349133|FG000|Overall Study|Death|3|||
161264111|NCT00616941|582349134|FG000|Overall Study|Progressive Disease|1|||
161264112|NCT00616941|582349135|FG001|Overall Study|Progressive Disease|2|||
161264113|NCT00616941|582349136|FG002|Overall Study|Progressive Disease|1|||
161264114|NCT00616941|582349134|FG000|Overall Study|Adverse Event|0|||
161264115|NCT00616941|582349135|FG001|Overall Study|Adverse Event|1|||
161264116|NCT00616941|582349136|FG002|Overall Study|Adverse Event|1|||
161264117|NCT00616941|582349134|FG000|Overall Study|Subject Non-compliance|0|||
161264118|NCT00616941|582349135|FG001|Overall Study|Subject Non-compliance|0|||
161264119|NCT00616941|582349136|FG002|Overall Study|Subject Non-compliance|1|||
161264120|NCT00616941|582349134|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
161264121|NCT00616941|582349135|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
161264122|NCT00616941|582349136|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
161264123|NCT00616941|582349134|FG000|Overall Study|Vaccination Suspended|0|||
161264124|NCT00616941|582349135|FG001|Overall Study|Vaccination Suspended|0|||
161264125|NCT00616941|582349136|FG002|Overall Study|Vaccination Suspended|3|||
161264126|NCT00076804|582349147|FG000|Overall Study|Death|9|||
161264127|NCT00076804|582349148|FG001|Overall Study|Death|20|||
161264128|NCT00076804|582349147|FG000|Overall Study|Lost to Follow-up|9|||
161264129|NCT00076804|582349148|FG001|Overall Study|Lost to Follow-up|9|||
161264130|NCT00076804|582349147|FG000|Overall Study|Withdrawal by Subject|10|||
161264131|NCT00076804|582349148|FG001|Overall Study|Withdrawal by Subject|8|||
161264132|NCT00076804|582349147|FG000|Overall Study|Early study Closure|32|||
161264133|NCT00076804|582349148|FG001|Overall Study|Early study Closure|32|||
161264134|NCT03709823|582349149|FG000|Overall Study|Adverse Event|0|||
161264135|NCT03709823|582349150|FG001|Overall Study|Adverse Event|0|||
161264136|NCT03709823|582349151|FG002|Overall Study|Adverse Event|1|||
160928267|NCT00281684|581131788|FG001|Overall Study|Withdrawal by Subject|0|||
160928268|NCT00281684|581131789|FG002|Overall Study|Withdrawal by Subject|0|||
160928269|NCT00281684|581131790|FG003|Overall Study|Withdrawal by Subject|0|||
160928270|NCT01527682|581131791|FG000|Overall Study|Protocol Violation|8|||
160928271|NCT04668950|581131793|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
160928272|NCT04668950|581131794|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
160928273|NCT04668950|581131793|FG000|Overall Study|Could not confirm started study medication|15|||
160928274|NCT04668950|581131794|FG001|Overall Study|Could not confirm started study medication|15|||
160928275|NCT04668950|581131793|FG000|Overall Study|Could not confirm baseline status|6|||
160928276|NCT04668950|581131794|FG001|Overall Study|Could not confirm baseline status|2|||
160928277|NCT04668950|581131793|FG000|Overall Study|Drop out and did not start medication|15|||
160928278|NCT04668950|581131794|FG001|Overall Study|Drop out and did not start medication|17|||
160928279|NCT04668950|581131793|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
160928280|NCT04668950|581131794|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
160928281|NCT04668950|581131793|FG000|Overall Study|Other|2|||
160928282|NCT04668950|581131794|FG001|Overall Study|Other|4|||
160928283|NCT03979638|581131795|FG000|Period 1|Physician Decision|1|||
160928284|NCT03979638|581131796|FG001|Period 1|Physician Decision|1|||
160928285|NCT03979638|581131795|FG000|Period 1|Withdrawal by Subject|4|||
160928286|NCT03979638|581131796|FG001|Period 1|Withdrawal by Subject|3|||
160928287|NCT03979638|581131795|FG000|Period 1|Study terminated by Sponsor|1|||
160928288|NCT03979638|581131796|FG001|Period 1|Study terminated by Sponsor|3|||
160928289|NCT03979638|581131795|FG000|Period 1|Protocol Violation|1|||
160928290|NCT03979638|581131796|FG001|Period 1|Protocol Violation|0|||
160928291|NCT03979638|581131795|FG000|Period 2|Study terminated by Sponsor|1|||
160928292|NCT03979638|581131796|FG001|Period 2|Study terminated by Sponsor|1|||
160928293|NCT01531387|581131799|FG000|Overall Study|Early termination of study|11|||
160928294|NCT01531387|581131800|FG001|Overall Study|Early termination of study|11|||
160928295|NCT00578942|581131801|FG000|Overall Study|Lost to Follow-up|1|||
160928296|NCT01124643|581131804|FG000|Overall Study|Death|1|||
160928297|NCT04220411|581131805|FG000|Overall Study|Adverse Event|0|||
160928298|NCT04220411|581131806|FG001|Overall Study|Adverse Event|0|||
160928299|NCT04220411|581131807|FG002|Overall Study|Adverse Event|0|||
160928300|NCT04220411|581131808|FG003|Overall Study|Adverse Event|1|||
161264137|NCT03709823|582349152|FG003|Overall Study|Adverse Event|0|||
161264138|NCT03709823|582349153|FG004|Overall Study|Adverse Event|0|||
160928301|NCT02678676|581131809|FG000|Overall Study|Death|619|||
160928302|NCT02678676|581131810|FG001|Overall Study|Death|649|||
160928303|NCT02678676|581131809|FG000|Overall Study|Withdrawal by Subject|13|||
160928304|NCT02678676|581131810|FG001|Overall Study|Withdrawal by Subject|5|||
160928305|NCT02678676|581131809|FG000|Overall Study|Lost to Follow-up|171|||
161264139|NCT03709823|582349154|FG005|Overall Study|Adverse Event|0|||
161264140|NCT03709823|582349149|FG000|Overall Study|Lost to Follow-up|2|||
160928306|NCT02678676|581131810|FG001|Overall Study|Lost to Follow-up|151|||
161264141|NCT03709823|582349150|FG001|Overall Study|Lost to Follow-up|2|||
161264142|NCT03709823|582349151|FG002|Overall Study|Lost to Follow-up|2|||
160928307|NCT02678676|581131809|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
160998076|NCT00094809|581378534|FG000|Overall Study|Study drug not received|2|||
161264143|NCT03709823|582349152|FG003|Overall Study|Lost to Follow-up|1|||
161264144|NCT03709823|582349153|FG004|Overall Study|Lost to Follow-up|1|||
161264145|NCT03709823|582349154|FG005|Overall Study|Lost to Follow-up|0|||
160928308|NCT02678676|581131810|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
160928309|NCT01400516|581131814|FG000|Primary Trial|Withdrawal by Subject|0|||
160928310|NCT01400516|581131815|FG001|Primary Trial|Withdrawal by Subject|2|||
160928311|NCT00549562|581131818|FG000|Overall Study|Adverse Event|1|||
160928312|NCT00549562|581131818|FG000|Overall Study|Lack of Efficacy|1|||
160928313|NCT00403273|581133320|FG000|Overall Study|Lost to Follow-up|3|||
160928314|NCT00403273|581133321|FG001|Overall Study|Lost to Follow-up|2|||
160928315|NCT00403273|581133320|FG000|Overall Study|Physician Decision|0|||
160928316|NCT00403273|581133321|FG001|Overall Study|Physician Decision|1|||
160928317|NCT00403273|581133320|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
160928318|NCT00403273|581133321|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
160928319|NCT00502697|581133327|FG000|Overall Study|Withdrawal by Subject|3|||
160928320|NCT00502697|581133328|FG001|Overall Study|Withdrawal by Subject|1|||
160928321|NCT00502697|581133327|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
160928322|NCT00502697|581133328|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
160928323|NCT00502697|581133327|FG000|Overall Study|found not to meet eligibility criteria|3|||
160928324|NCT00502697|581133328|FG001|Overall Study|found not to meet eligibility criteria|4|||
160928325|NCT00502697|581133327|FG000|Overall Study|did not meet assignment criteria|4|||
160928326|NCT00502697|581133328|FG001|Overall Study|did not meet assignment criteria|2|||
160928327|NCT03256552|581133332|FG000|Overall Study|Protocol Violation|1|||
160928328|NCT03256552|581133332|FG000|Overall Study|Physician Decision|1|||
160928329|NCT03256552|581133332|FG000|Overall Study|Adverse Event|1|||
160928330|NCT03256552|581133332|FG000|Overall Study|Withdrawal by Subject|2|||
160928331|NCT03265249|581133341|FG000|Overall Study|Withdrawal by Subject|0|||
160928332|NCT03265249|581133342|FG001|Overall Study|Withdrawal by Subject|1|||
160928333|NCT01012622|581133343|FG000|Overall Study|Withdrawal by Subject|6|||
160928334|NCT01012622|581133343|FG000|Overall Study|Lost to Follow-up|5|||
161264146|NCT03709823|582349149|FG000|Overall Study|Withdrawal by Subject|1|||
161264147|NCT03709823|582349150|FG001|Overall Study|Withdrawal by Subject|3|||
161264148|NCT03709823|582349151|FG002|Overall Study|Withdrawal by Subject|0|||
161264149|NCT03709823|582349152|FG003|Overall Study|Withdrawal by Subject|0|||
161264150|NCT03709823|582349153|FG004|Overall Study|Withdrawal by Subject|0|||
161264151|NCT03709823|582349154|FG005|Overall Study|Withdrawal by Subject|0|||
161264152|NCT03709823|582349149|FG000|Overall Study|Other, Not Specified|0|||
161264153|NCT03709823|582349150|FG001|Overall Study|Other, Not Specified|0|||
161264154|NCT03709823|582349151|FG002|Overall Study|Other, Not Specified|0|||
161264155|NCT03709823|582349152|FG003|Overall Study|Other, Not Specified|1|||
161264156|NCT03709823|582349153|FG004|Overall Study|Other, Not Specified|0|||
161264157|NCT03709823|582349154|FG005|Overall Study|Other, Not Specified|0|||
161264158|NCT00557076|582349155|FG000|Overall Study|Unblinding|0|||
161264159|NCT00557076|582349156|FG001|Overall Study|Unblinding|1|||
161264160|NCT00688376|582349157|FG000|Double-Blind Phase|Adverse Event|4|||
161264161|NCT00688376|582349158|FG001|Double-Blind Phase|Adverse Event|4|||
161264162|NCT00688376|582349157|FG000|Double-Blind Phase|Protocol Violation|1|||
161264163|NCT00688376|582349158|FG001|Double-Blind Phase|Protocol Violation|2|||
161264164|NCT00688376|582349157|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
161264165|NCT00688376|582349158|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
161264166|NCT00688376|582349157|FG000|Double-Blind Phase|Not treated|0|||
161264167|NCT00688376|582349158|FG001|Double-Blind Phase|Not treated|1|||
161264168|NCT00688376|582349157|FG000|Blinded Extension Phase|Adverse Event|3|||
161264169|NCT00688376|582349158|FG001|Blinded Extension Phase|Adverse Event|4|||
160928335|NCT01012622|581133343|FG000|Overall Study|Adverse Event|7|||
160928336|NCT01012622|581133343|FG000|Overall Study|non-compliance with the drug|9|||
160928337|NCT01012622|581133343|FG000|Overall Study|Other|1|||
160928338|NCT01012622|581133343|FG000|Overall Study|screening failure|1|||
160928339|NCT01012622|581133343|FG000|Overall Study|withdrawal of consent by a parent|2|||
160928340|NCT05664490|581133344|FG000|Overall Study|Withdrawal by Subject|0|||
160928341|NCT05664490|581133345|FG001|Overall Study|Withdrawal by Subject|1|||
160928342|NCT05664490|581133344|FG000|Overall Study|Lost to Follow-up|14|||
160928343|NCT05664490|581133345|FG001|Overall Study|Lost to Follow-up|22|||
160928344|NCT00704535|581133346|FG000|Overall Study|Adverse Event|2|||
160928345|NCT00704535|581133346|FG000|Overall Study|Death|2|||
160928346|NCT00704535|581133346|FG000|Overall Study|Lost to Follow-up|8|||
160928347|NCT00704535|581133346|FG000|Overall Study|Protocol Violation|10|||
161264170|NCT00688376|582349157|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
161264171|NCT00688376|582349158|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
160928348|NCT00704535|581133346|FG000|Overall Study|Completed status not on Case Report Form|124|||
160928349|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
161264172|NCT00688376|582349157|FG000|Blinded Extension Phase|Physician Decision|1|||
161264173|NCT00688376|582349158|FG001|Blinded Extension Phase|Physician Decision|0|||
161264174|NCT00688376|582349157|FG000|Blinded Extension Phase|Other|1|||
160928350|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
160928351|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
160928352|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
160928353|NCT01589445|581133347|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
160928354|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
160928355|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
160928356|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
160928357|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
160928358|NCT01589445|581133347|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
160928359|NCT00314574|581133351|FG000|Overall Study|Death|3|||
160928360|NCT00314574|581133352|FG001|Overall Study|Death|0|||
160928361|NCT00314574|581133351|FG000|Overall Study|Adverse Event|11|||
160928362|NCT00314574|581133352|FG001|Overall Study|Adverse Event|16|||
160928363|NCT00314574|581133351|FG000|Overall Study|Lost to Follow-up|19|||
160928364|NCT00314574|581133352|FG001|Overall Study|Lost to Follow-up|25|||
160928365|NCT00314574|581133351|FG000|Overall Study|Withdrawal by Subject|33|||
160928366|NCT00314574|581133352|FG001|Overall Study|Withdrawal by Subject|22|||
160928367|NCT00314574|581133351|FG000|Overall Study|Physician Decision|22|||
160928368|NCT00314574|581133352|FG001|Overall Study|Physician Decision|15|||
160928369|NCT00314574|581133351|FG000|Overall Study|Pregnancy|6|||
160928370|NCT00314574|581133352|FG001|Overall Study|Pregnancy|4|||
160928371|NCT00314574|581133351|FG000|Overall Study|Data unknown at database lock|0|||
160928372|NCT00314574|581133352|FG001|Overall Study|Data unknown at database lock|1|||
160928373|NCT03144180|581133357|FG000|Overall Study|STAT Delivery|1|||
160928374|NCT03144180|581133358|FG001|Overall Study|STAT Delivery|1|||
160928375|NCT03144180|581133357|FG000|Overall Study|Provider forgot to fill out forms|1|||
160928376|NCT03144180|581133358|FG001|Overall Study|Provider forgot to fill out forms|3|||
160928377|NCT03144180|581133357|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
160928378|NCT03144180|581133358|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
160928379|NCT03144180|581133357|FG000|Overall Study|Scrub tech removed tube cap|0|||
160928380|NCT03144180|581133358|FG001|Overall Study|Scrub tech removed tube cap|1|||
160928381|NCT00743652|581133363|FG000|Overall Study|Parent/Legal Guardian Request|3|||
160928382|NCT00743652|581133364|FG001|Overall Study|Parent/Legal Guardian Request|2|||
160928383|NCT00743652|581133365|FG002|Overall Study|Parent/Legal Guardian Request|2|||
160928384|NCT00743652|581133366|FG003|Overall Study|Parent/Legal Guardian Request|2|||
160928385|NCT00743652|581133367|FG004|Overall Study|Parent/Legal Guardian Request|0|||
160928386|NCT00743652|581133363|FG000|Overall Study|Adverse Event|3|||
160928387|NCT00743652|581133364|FG001|Overall Study|Adverse Event|0|||
160928388|NCT00743652|581133365|FG002|Overall Study|Adverse Event|0|||
160928389|NCT00743652|581133366|FG003|Overall Study|Adverse Event|0|||
160928390|NCT00743652|581133367|FG004|Overall Study|Adverse Event|0|||
160928391|NCT00743652|581133363|FG000|Overall Study|Death|2|||
160928392|NCT00743652|581133364|FG001|Overall Study|Death|0|||
160928393|NCT00743652|581133365|FG002|Overall Study|Death|0|||
160928394|NCT00743652|581133366|FG003|Overall Study|Death|0|||
160928395|NCT00743652|581133367|FG004|Overall Study|Death|0|||
160928396|NCT00743652|581133363|FG000|Overall Study|Investigator Request|0|||
160928397|NCT00743652|581133364|FG001|Overall Study|Investigator Request|0|||
160928398|NCT00743652|581133365|FG002|Overall Study|Investigator Request|0|||
160928399|NCT00743652|581133366|FG003|Overall Study|Investigator Request|2|||
160928400|NCT00743652|581133367|FG004|Overall Study|Investigator Request|0|||
160928401|NCT00743652|581133363|FG000|Overall Study|Other|1|||
160928402|NCT00743652|581133364|FG001|Overall Study|Other|1|||
160928403|NCT00743652|581133365|FG002|Overall Study|Other|0|||
160928404|NCT00743652|581133366|FG003|Overall Study|Other|0|||
160928405|NCT00743652|581133367|FG004|Overall Study|Other|0|||
160928406|NCT00743652|581133363|FG000|Overall Study|Lost to Follow-up|1|||
160928407|NCT00743652|581133364|FG001|Overall Study|Lost to Follow-up|0|||
160928408|NCT00743652|581133365|FG002|Overall Study|Lost to Follow-up|0|||
160928409|NCT00743652|581133366|FG003|Overall Study|Lost to Follow-up|0|||
160928410|NCT00743652|581133367|FG004|Overall Study|Lost to Follow-up|0|||
160928411|NCT00228917|581133368|FG000|Overall Study|Migrated/moved from study area|0|||
160928412|NCT00228917|581133369|FG001|Overall Study|Migrated/moved from study area|0|||
160928413|NCT00228917|581133370|FG002|Overall Study|Migrated/moved from study area|0|||
160928414|NCT00228917|581133371|FG003|Overall Study|Migrated/moved from study area|0|||
160928415|NCT00228917|581133372|FG004|Overall Study|Migrated/moved from study area|0|||
160928416|NCT00228917|581133373|FG005|Overall Study|Migrated/moved from study area|2|||
160928417|NCT00228917|581133374|FG006|Overall Study|Migrated/moved from study area|0|||
160928418|NCT00228917|581133375|FG007|Overall Study|Migrated/moved from study area|0|||
160928419|NCT04372602|581133378|FG000|Overall Study|Withdrawal by Subject|1|||
160928420|NCT04372602|581133379|FG001|Overall Study|Withdrawal by Subject|1|||
160928421|NCT04372602|581133378|FG000|Overall Study|Adverse Event|0|||
160928422|NCT04372602|581133379|FG001|Overall Study|Adverse Event|1|||
160928423|NCT04372602|581133378|FG000|Overall Study|Transitioned to comfort care|0|||
160928424|NCT04372602|581133379|FG001|Overall Study|Transitioned to comfort care|1|||
160928425|NCT01085097|581133380|FG000|Overall Study|Adverse Event|0|||
160928426|NCT01085097|581133381|FG001|Overall Study|Adverse Event|0|||
160928427|NCT01085097|581133382|FG002|Overall Study|Adverse Event|2|||
160928428|NCT01085097|581133380|FG000|Overall Study|Treatment failure|2|||
160928429|NCT01085097|581133381|FG001|Overall Study|Treatment failure|0|||
160928430|NCT01085097|581133382|FG002|Overall Study|Treatment failure|0|||
160928431|NCT01498640|581133383|FG000|Overall Study|Lost to Follow-up|1|||
160928432|NCT01498640|581133383|FG000|Overall Study|Death|1|||
160928433|NCT01498640|581133383|FG000|Overall Study|Other|3|||
160928434|NCT06049043|581133384|FG000|Overall Study|Lost to Follow-up|11|||
160928435|NCT06049043|581133385|FG001|Overall Study|Lost to Follow-up|9|||
160928436|NCT00335972|581133386|FG000|Overall Study|not given treatments|0|||
160928437|NCT00335972|581133387|FG001|Overall Study|not given treatments|3|||
160928438|NCT03190889|581133391|FG000|Overall Study|Lost to Follow-up|7|||
160928439|NCT03190889|581133392|FG001|Overall Study|Lost to Follow-up|7|||
160928440|NCT03190889|581133393|FG002|Overall Study|Lost to Follow-up|3|||
160928441|NCT03190889|581133391|FG000|Overall Study|Withdrawal by Subject|1|||
160928442|NCT03190889|581133392|FG001|Overall Study|Withdrawal by Subject|1|||
160928443|NCT03190889|581133393|FG002|Overall Study|Withdrawal by Subject|2|||
160928444|NCT03190889|581133391|FG000|Overall Study|Did not complete protocol|4|||
160928445|NCT03190889|581133392|FG001|Overall Study|Did not complete protocol|9|||
160928446|NCT03190889|581133393|FG002|Overall Study|Did not complete protocol|0|||
160928447|NCT03190889|581133391|FG000|Overall Study|COVID-19|1|||
160928448|NCT03190889|581133392|FG001|Overall Study|COVID-19|0|||
160928449|NCT03190889|581133393|FG002|Overall Study|COVID-19|2|||
160928450|NCT02140567|581133394|FG000|Overall Study|Problems with recording equipment|6|||
160928451|NCT02882854|581133397|FG000|Overall Study|Lost to Follow-up|1|||
160928452|NCT02882854|581133398|FG001|Overall Study|Lost to Follow-up|2|||
160928453|NCT02882854|581133397|FG000|Overall Study|Physician Decision|0|||
160928454|NCT02882854|581133398|FG001|Overall Study|Physician Decision|1|||
160928455|NCT02039674|581133399|FG000|Overall Study|Adverse Event|0|||
160928456|NCT02039674|581133400|FG001|Overall Study|Adverse Event|0|||
160928457|NCT02039674|581133401|FG002|Overall Study|Adverse Event|0|||
160928458|NCT02039674|581133402|FG003|Overall Study|Adverse Event|1|||
160928459|NCT02039674|581133403|FG004|Overall Study|Adverse Event|0|||
160928460|NCT02039674|581133404|FG005|Overall Study|Adverse Event|0|||
160928461|NCT02039674|581133405|FG006|Overall Study|Adverse Event|0|||
160928462|NCT02039674|581133406|FG007|Overall Study|Adverse Event|0|||
160928463|NCT02039674|581133407|FG008|Overall Study|Adverse Event|2|||
160928464|NCT02039674|581133408|FG009|Overall Study|Adverse Event|1|||
160928465|NCT02039674|581133409|FG010|Overall Study|Adverse Event|0|||
160928466|NCT02039674|581133410|FG011|Overall Study|Adverse Event|2|||
160928467|NCT02039674|581133411|FG012|Overall Study|Adverse Event|3|||
160928468|NCT02039674|581133412|FG013|Overall Study|Adverse Event|1|||
160928469|NCT02039674|581133399|FG000|Overall Study|Death|2|||
160928470|NCT02039674|581133400|FG001|Overall Study|Death|0|||
160928471|NCT02039674|581133401|FG002|Overall Study|Death|2|||
160928472|NCT02039674|581133402|FG003|Overall Study|Death|3|||
160928473|NCT02039674|581133403|FG004|Overall Study|Death|0|||
160928474|NCT02039674|581133404|FG005|Overall Study|Death|0|||
160928475|NCT02039674|581133405|FG006|Overall Study|Death|1|||
160928476|NCT02039674|581133406|FG007|Overall Study|Death|0|||
160928477|NCT02039674|581133407|FG008|Overall Study|Death|2|||
160928478|NCT02039674|581133408|FG009|Overall Study|Death|0|||
160928479|NCT02039674|581133409|FG010|Overall Study|Death|1|||
160928480|NCT02039674|581133410|FG011|Overall Study|Death|3|||
160928481|NCT02039674|581133411|FG012|Overall Study|Death|2|||
160928482|NCT02039674|581133412|FG013|Overall Study|Death|8|||
160998077|NCT00094809|581378535|FG001|Overall Study|Study drug not received|8|||
160998078|NCT00094809|581378534|FG000|Overall Study|Other|1|||
160998079|NCT00094809|581378535|FG001|Overall Study|Other|1|||
160998080|NCT04889664|581378536|FG000|Screen|Lost to Follow-up|1|||
160998081|NCT04889664|581378536|FG000|Screen|Failed to meet screening criteria|1|||
160998082|NCT04889664|581378536|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
160998083|NCT02469064|581378542|FG000|Overall Study|Request not to receive intervention.|1|||
160998084|NCT02469064|581378543|FG001|Overall Study|Request not to receive intervention.|3|||
160998085|NCT02506257|581378556|FG000|Overall Study|Adverse Event|0|||
161264175|NCT00688376|582349158|FG001|Blinded Extension Phase|Other|0|||
160928483|NCT02039674|581133399|FG000|Overall Study|Excluded Medication|1|||
160928484|NCT02039674|581133400|FG001|Overall Study|Excluded Medication|1|||
160928485|NCT02039674|581133401|FG002|Overall Study|Excluded Medication|0|||
160928486|NCT02039674|581133402|FG003|Overall Study|Excluded Medication|1|||
160928487|NCT02039674|581133403|FG004|Overall Study|Excluded Medication|0|||
160928488|NCT02039674|581133404|FG005|Overall Study|Excluded Medication|1|||
160928489|NCT02039674|581133405|FG006|Overall Study|Excluded Medication|0|||
161264176|NCT00846521|582349159|FG000|Overall Study|Withdrawal by Subject|5|||
161264177|NCT00846521|582349159|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
160928490|NCT02039674|581133406|FG007|Overall Study|Excluded Medication|0|||
160928491|NCT02039674|581133407|FG008|Overall Study|Excluded Medication|2|||
160928492|NCT02039674|581133408|FG009|Overall Study|Excluded Medication|3|||
160928493|NCT02039674|581133409|FG010|Overall Study|Excluded Medication|5|||
160928494|NCT02039674|581133410|FG011|Overall Study|Excluded Medication|6|||
160928495|NCT02039674|581133411|FG012|Overall Study|Excluded Medication|8|||
161143619|NCT03043365|581909429|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
161264178|NCT00846521|582349159|FG000|Overall Study|Protocol Violation|1|||
160928496|NCT02039674|581133412|FG013|Overall Study|Excluded Medication|3|||
160928497|NCT02039674|581133399|FG000|Overall Study|Lost to Follow-up|0|||
160998086|NCT02506257|581378557|FG001|Overall Study|Adverse Event|2|||
160998087|NCT02506257|581378558|FG002|Overall Study|Adverse Event|3|||
160998088|NCT02506257|581378559|FG003|Overall Study|Adverse Event|0|||
160998089|NCT02506257|581378556|FG000|Overall Study|Protocol Violation|0|||
160998090|NCT02506257|581378557|FG001|Overall Study|Protocol Violation|0|||
160998091|NCT02506257|581378558|FG002|Overall Study|Protocol Violation|1|||
160998092|NCT02506257|581378559|FG003|Overall Study|Protocol Violation|0|||
160928498|NCT02039674|581133400|FG001|Overall Study|Lost to Follow-up|0|||
160928499|NCT02039674|581133401|FG002|Overall Study|Lost to Follow-up|0|||
160928500|NCT02039674|581133402|FG003|Overall Study|Lost to Follow-up|0|||
160928501|NCT02039674|581133403|FG004|Overall Study|Lost to Follow-up|1|||
160928502|NCT02039674|581133404|FG005|Overall Study|Lost to Follow-up|1|||
160928503|NCT02039674|581133405|FG006|Overall Study|Lost to Follow-up|0|||
160928504|NCT02039674|581133406|FG007|Overall Study|Lost to Follow-up|0|||
160928505|NCT02039674|581133407|FG008|Overall Study|Lost to Follow-up|0|||
160928506|NCT02039674|581133408|FG009|Overall Study|Lost to Follow-up|0|||
160928507|NCT02039674|581133409|FG010|Overall Study|Lost to Follow-up|0|||
160928508|NCT02039674|581133410|FG011|Overall Study|Lost to Follow-up|2|||
160928509|NCT02039674|581133411|FG012|Overall Study|Lost to Follow-up|2|||
160928510|NCT02039674|581133412|FG013|Overall Study|Lost to Follow-up|1|||
160928511|NCT02039674|581133399|FG000|Overall Study|Physician Decision|0|||
160928512|NCT02039674|581133400|FG001|Overall Study|Physician Decision|0|||
160928513|NCT02039674|581133401|FG002|Overall Study|Physician Decision|0|||
161264179|NCT03201250|582349161|FG000|Overall Study|screen failures|3|||
161264180|NCT03201250|582349162|FG001|Overall Study|screen failures|0|||
161264181|NCT03201250|582349163|FG002|Overall Study|screen failures|0|||
161264182|NCT02575911|582349166|FG000|Overall Study|Lost to Follow-up|1|||
161264183|NCT02335983|582349167|FG000|Overall Study|Sponsor Decision|0|||
161264184|NCT02335983|582349168|FG001|Overall Study|Sponsor Decision|0|||
161264185|NCT02335983|582349169|FG002|Overall Study|Sponsor Decision|1|||
161264186|NCT02335983|582349170|FG003|Overall Study|Sponsor Decision|1|||
161264187|NCT02335983|582349171|FG004|Overall Study|Sponsor Decision|0|||
161264188|NCT02335983|582349172|FG005|Overall Study|Sponsor Decision|1|||
161264189|NCT02335983|582349167|FG000|Overall Study|Withdrawal by Subject|3|||
161264190|NCT02335983|582349168|FG001|Overall Study|Withdrawal by Subject|2|||
161264191|NCT02335983|582349169|FG002|Overall Study|Withdrawal by Subject|2|||
161264192|NCT02335983|582349170|FG003|Overall Study|Withdrawal by Subject|1|||
161264193|NCT02335983|582349171|FG004|Overall Study|Withdrawal by Subject|3|||
161264194|NCT02335983|582349172|FG005|Overall Study|Withdrawal by Subject|9|||
161264195|NCT02335983|582349167|FG000|Overall Study|Death|0|||
160928514|NCT02039674|581133402|FG003|Overall Study|Physician Decision|0|||
160928515|NCT02039674|581133403|FG004|Overall Study|Physician Decision|0|||
160928516|NCT02039674|581133404|FG005|Overall Study|Physician Decision|0|||
160928517|NCT02039674|581133405|FG006|Overall Study|Physician Decision|0|||
160928518|NCT02039674|581133406|FG007|Overall Study|Physician Decision|0|||
160928519|NCT02039674|581133407|FG008|Overall Study|Physician Decision|0|||
160928520|NCT02039674|581133408|FG009|Overall Study|Physician Decision|0|||
160928521|NCT02039674|581133409|FG010|Overall Study|Physician Decision|0|||
160928522|NCT02039674|581133410|FG011|Overall Study|Physician Decision|1|||
160928523|NCT02039674|581133411|FG012|Overall Study|Physician Decision|1|||
160928524|NCT02039674|581133412|FG013|Overall Study|Physician Decision|0|||
160928525|NCT02039674|581133399|FG000|Overall Study|Progressive Disease|8|||
160928526|NCT02039674|581133400|FG001|Overall Study|Progressive Disease|8|||
160928527|NCT02039674|581133401|FG002|Overall Study|Progressive Disease|6|||
160928528|NCT02039674|581133402|FG003|Overall Study|Progressive Disease|7|||
160998093|NCT00964366|581378560|FG000|Overall Study|Did not qualify at Day 1|1|||
160998094|NCT00964366|581378561|FG001|Overall Study|Did not qualify at Day 1|0|||
160998095|NCT00964366|581378560|FG000|Overall Study|Withdrawal by Subject|0|||
161264196|NCT02335983|582349168|FG001|Overall Study|Death|0|||
161264197|NCT02335983|582349169|FG002|Overall Study|Death|2|||
160928529|NCT02039674|581133403|FG004|Overall Study|Progressive Disease|9|||
160928530|NCT02039674|581133404|FG005|Overall Study|Progressive Disease|10|||
160928531|NCT02039674|581133405|FG006|Overall Study|Progressive Disease|1|||
160928532|NCT02039674|581133406|FG007|Overall Study|Progressive Disease|3|||
160928533|NCT02039674|581133407|FG008|Overall Study|Progressive Disease|6|||
160928534|NCT02039674|581133408|FG009|Overall Study|Progressive Disease|4|||
160928535|NCT02039674|581133409|FG010|Overall Study|Progressive Disease|0|||
160928536|NCT02039674|581133410|FG011|Overall Study|Progressive Disease|34|||
160928537|NCT02039674|581133411|FG012|Overall Study|Progressive Disease|34|||
160928538|NCT02039674|581133412|FG013|Overall Study|Progressive Disease|18|||
160928539|NCT02039674|581133399|FG000|Overall Study|Withdrawal by Subject|1|||
160928540|NCT02039674|581133400|FG001|Overall Study|Withdrawal by Subject|2|||
160998096|NCT00964366|581378561|FG001|Overall Study|Withdrawal by Subject|1|||
160998097|NCT02046616|581378563|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
161264198|NCT02335983|582349170|FG003|Overall Study|Death|0|||
160928541|NCT02039674|581133401|FG002|Overall Study|Withdrawal by Subject|3|||
160928542|NCT02039674|581133402|FG003|Overall Study|Withdrawal by Subject|0|||
160928543|NCT02039674|581133403|FG004|Overall Study|Withdrawal by Subject|1|||
161264199|NCT02335983|582349171|FG004|Overall Study|Death|0|||
161264200|NCT02335983|582349172|FG005|Overall Study|Death|0|||
160928544|NCT02039674|581133404|FG005|Overall Study|Withdrawal by Subject|0|||
160928545|NCT02039674|581133405|FG006|Overall Study|Withdrawal by Subject|0|||
160928546|NCT02039674|581133406|FG007|Overall Study|Withdrawal by Subject|0|||
160928547|NCT02039674|581133407|FG008|Overall Study|Withdrawal by Subject|0|||
160928548|NCT02039674|581133408|FG009|Overall Study|Withdrawal by Subject|1|||
160928549|NCT02039674|581133409|FG010|Overall Study|Withdrawal by Subject|1|||
160928550|NCT02039674|581133410|FG011|Overall Study|Withdrawal by Subject|4|||
160928551|NCT02039674|581133411|FG012|Overall Study|Withdrawal by Subject|6|||
160928552|NCT02039674|581133412|FG013|Overall Study|Withdrawal by Subject|2|||
160928553|NCT02039674|581133399|FG000|Overall Study|Clinical Progression|0|||
160928554|NCT02039674|581133400|FG001|Overall Study|Clinical Progression|0|||
160928555|NCT02039674|581133401|FG002|Overall Study|Clinical Progression|0|||
160928556|NCT02039674|581133402|FG003|Overall Study|Clinical Progression|0|||
160928557|NCT02039674|581133403|FG004|Overall Study|Clinical Progression|0|||
160928558|NCT02039674|581133404|FG005|Overall Study|Clinical Progression|0|||
160928559|NCT02039674|581133405|FG006|Overall Study|Clinical Progression|1|||
160928560|NCT02039674|581133406|FG007|Overall Study|Clinical Progression|0|||
160928561|NCT02039674|581133407|FG008|Overall Study|Clinical Progression|0|||
160928562|NCT02039674|581133408|FG009|Overall Study|Clinical Progression|0|||
160928563|NCT02039674|581133409|FG010|Overall Study|Clinical Progression|0|||
160928564|NCT02039674|581133410|FG011|Overall Study|Clinical Progression|0|||
160928565|NCT02039674|581133411|FG012|Overall Study|Clinical Progression|1|||
160928566|NCT02039674|581133412|FG013|Overall Study|Clinical Progression|0|||
160928567|NCT02039674|581133399|FG000|Overall Study|Sponsor Decision|1|||
160928568|NCT02039674|581133400|FG001|Overall Study|Sponsor Decision|1|||
160928569|NCT02039674|581133401|FG002|Overall Study|Sponsor Decision|1|||
160928570|NCT02039674|581133402|FG003|Overall Study|Sponsor Decision|1|||
160928571|NCT02039674|581133403|FG004|Overall Study|Sponsor Decision|1|||
160928572|NCT02039674|581133404|FG005|Overall Study|Sponsor Decision|0|||
160928573|NCT02039674|581133405|FG006|Overall Study|Sponsor Decision|0|||
160928574|NCT02039674|581133406|FG007|Overall Study|Sponsor Decision|0|||
160928575|NCT02039674|581133407|FG008|Overall Study|Sponsor Decision|0|||
160928576|NCT02039674|581133408|FG009|Overall Study|Sponsor Decision|3|||
160928577|NCT02039674|581133409|FG010|Overall Study|Sponsor Decision|0|||
160928578|NCT02039674|581133410|FG011|Overall Study|Sponsor Decision|8|||
160928579|NCT02039674|581133411|FG012|Overall Study|Sponsor Decision|5|||
160928580|NCT02039674|581133412|FG013|Overall Study|Sponsor Decision|0|||
160928581|NCT02039674|581133399|FG000|Overall Study|Other|0|||
160928582|NCT02039674|581133400|FG001|Overall Study|Other|0|||
160928583|NCT02039674|581133401|FG002|Overall Study|Other|0|||
160928584|NCT02039674|581133402|FG003|Overall Study|Other|0|||
160928585|NCT02039674|581133403|FG004|Overall Study|Other|0|||
160928586|NCT02039674|581133404|FG005|Overall Study|Other|0|||
160928587|NCT02039674|581133405|FG006|Overall Study|Other|0|||
160928588|NCT02039674|581133406|FG007|Overall Study|Other|0|||
160928589|NCT02039674|581133407|FG008|Overall Study|Other|0|||
160928590|NCT02039674|581133408|FG009|Overall Study|Other|0|||
160928591|NCT02039674|581133409|FG010|Overall Study|Other|0|||
160928592|NCT02039674|581133410|FG011|Overall Study|Other|0|||
160928593|NCT02039674|581133411|FG012|Overall Study|Other|1|||
160928594|NCT02039674|581133412|FG013|Overall Study|Other|0|||
160928595|NCT03774433|581133413|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
160928596|NCT00108160|581133414|FG000|Overall Study|Lost to Follow-up|25|||
160928597|NCT00108160|581133415|FG001|Overall Study|Lost to Follow-up|12|||
160928598|NCT00108160|581133414|FG000|Overall Study|Death|1|||
160928599|NCT00108160|581133415|FG001|Overall Study|Death|2|||
160928600|NCT00108160|581133414|FG000|Overall Study|Withdrawal by Subject|4|||
160928601|NCT00108160|581133415|FG001|Overall Study|Withdrawal by Subject|2|||
160928602|NCT00108160|581133414|FG000|Overall Study|Protocol Violation|9|||
160928603|NCT00108160|581133415|FG001|Overall Study|Protocol Violation|5|||
160998098|NCT02046616|581378563|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
160998099|NCT02046616|581378563|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
160928604|NCT02081079|581133416|FG000|Overall Study|Lack of Efficacy|3|||
160928605|NCT02081079|581133417|FG001|Overall Study|Lack of Efficacy|2|||
160998100|NCT02046616|581378563|FG000|24-Week Treatment Period|Physician Decision|3|||
160928606|NCT02081079|581133416|FG000|Overall Study|Lost to Follow-up|1|||
160928607|NCT02081079|581133417|FG001|Overall Study|Lost to Follow-up|0|||
160928608|NCT01712854|581133418|FG000|Overall Study|Physician Decision|1|||
160998101|NCT02046616|581378563|FG000|24-Week Treatment Period|Other|1|||
160928609|NCT01150123|581133419|FG000|Overall Study|Withdrawal by Subject|1|||
160928610|NCT01150123|581133420|FG001|Overall Study|Withdrawal by Subject|1|||
160928611|NCT01150123|581133421|FG002|Overall Study|Withdrawal by Subject|2|||
160928612|NCT01150123|581133422|FG003|Overall Study|Withdrawal by Subject|1|||
160928613|NCT01150123|581133423|FG004|Overall Study|Withdrawal by Subject|1|||
160998102|NCT02046616|581378563|FG000|8-Week FU Period|Lost to Follow-up|1|||
160998103|NCT02957539|581378566|FG000|Baseline to Week 16|Lost to Follow-up|8|||
160928614|NCT01150123|581133424|FG005|Overall Study|Withdrawal by Subject|1|||
160928615|NCT01150123|581133425|FG006|Overall Study|Withdrawal by Subject|0|||
160928616|NCT01150123|581133426|FG007|Overall Study|Withdrawal by Subject|3|||
160928617|NCT01150123|581133427|FG008|Overall Study|Withdrawal by Subject|2|||
160928618|NCT01150123|581133428|FG009|Overall Study|Withdrawal by Subject|0|||
160928619|NCT01150123|581133429|FG010|Overall Study|Withdrawal by Subject|1|||
160928620|NCT01150123|581133430|FG011|Overall Study|Withdrawal by Subject|0|||
160928621|NCT01150123|581133431|FG012|Overall Study|Withdrawal by Subject|1|||
160928622|NCT01150123|581133432|FG013|Overall Study|Withdrawal by Subject|0|||
160928623|NCT01150123|581133433|FG014|Overall Study|Withdrawal by Subject|0|||
160928624|NCT01150123|581133434|FG015|Overall Study|Withdrawal by Subject|1|||
160928625|NCT01150123|581133435|FG016|Overall Study|Withdrawal by Subject|0|||
160928626|NCT01150123|581133436|FG017|Overall Study|Withdrawal by Subject|1|||
160928627|NCT01150123|581133419|FG000|Overall Study|Lost to Follow-up|2|||
160928628|NCT01150123|581133420|FG001|Overall Study|Lost to Follow-up|1|||
160928629|NCT01150123|581133421|FG002|Overall Study|Lost to Follow-up|2|||
160928630|NCT01150123|581133422|FG003|Overall Study|Lost to Follow-up|2|||
160928631|NCT01150123|581133423|FG004|Overall Study|Lost to Follow-up|2|||
160928632|NCT01150123|581133424|FG005|Overall Study|Lost to Follow-up|5|||
160928633|NCT01150123|581133425|FG006|Overall Study|Lost to Follow-up|0|||
160928634|NCT01150123|581133426|FG007|Overall Study|Lost to Follow-up|0|||
160928635|NCT01150123|581133427|FG008|Overall Study|Lost to Follow-up|3|||
160928636|NCT01150123|581133428|FG009|Overall Study|Lost to Follow-up|1|||
160928637|NCT01150123|581133429|FG010|Overall Study|Lost to Follow-up|1|||
160928638|NCT01150123|581133430|FG011|Overall Study|Lost to Follow-up|1|||
160928639|NCT01150123|581133431|FG012|Overall Study|Lost to Follow-up|2|||
160928640|NCT01150123|581133432|FG013|Overall Study|Lost to Follow-up|0|||
160928641|NCT01150123|581133433|FG014|Overall Study|Lost to Follow-up|0|||
160928642|NCT01150123|581133434|FG015|Overall Study|Lost to Follow-up|0|||
160928643|NCT01150123|581133435|FG016|Overall Study|Lost to Follow-up|0|||
160928644|NCT01150123|581133436|FG017|Overall Study|Lost to Follow-up|0|||
160928645|NCT01466387|581133437|FG000|Overall Study|Adverse Event|0|||
160928646|NCT01466387|581133438|FG001|Overall Study|Adverse Event|0|||
160928647|NCT01466387|581133439|FG002|Overall Study|Adverse Event|1|||
160928648|NCT01466387|581133440|FG003|Overall Study|Adverse Event|1|||
160928649|NCT01466387|581133441|FG004|Overall Study|Adverse Event|0|||
160928650|NCT01466387|581133442|FG005|Overall Study|Adverse Event|0|||
160928651|NCT01466387|581133437|FG000|Overall Study|Lost to Follow-up|0|||
160928652|NCT01466387|581133438|FG001|Overall Study|Lost to Follow-up|0|||
160928653|NCT01466387|581133439|FG002|Overall Study|Lost to Follow-up|0|||
160928654|NCT01466387|581133440|FG003|Overall Study|Lost to Follow-up|0|||
160928655|NCT01466387|581133441|FG004|Overall Study|Lost to Follow-up|0|||
160928656|NCT01466387|581133442|FG005|Overall Study|Lost to Follow-up|1|||
160928657|NCT01466387|581133437|FG000|Overall Study|Protocol Violation|1|||
160928658|NCT01466387|581133438|FG001|Overall Study|Protocol Violation|0|||
160928659|NCT01466387|581133439|FG002|Overall Study|Protocol Violation|0|||
160928660|NCT01466387|581133440|FG003|Overall Study|Protocol Violation|1|||
160928661|NCT01466387|581133441|FG004|Overall Study|Protocol Violation|0|||
160928662|NCT01466387|581133442|FG005|Overall Study|Protocol Violation|0|||
160928663|NCT01319877|581133443|FG000|Overall Study|Lost to Follow-up|100|||
160928664|NCT01319877|581133444|FG001|Overall Study|Lost to Follow-up|37|||
160928665|NCT01319877|581133443|FG000|Overall Study|Physician Decision|2|||
160928666|NCT01319877|581133444|FG001|Overall Study|Physician Decision|0|||
160928667|NCT01319877|581133443|FG000|Overall Study|Disease Progression|2|||
160928668|NCT01319877|581133444|FG001|Overall Study|Disease Progression|2|||
160928669|NCT01319877|581133443|FG000|Overall Study|Withdrawal by Subject|0|||
160928670|NCT01319877|581133444|FG001|Overall Study|Withdrawal by Subject|1|||
160928671|NCT01319877|581133443|FG000|Overall Study|Reason Not Specified|4|||
160928672|NCT01319877|581133444|FG001|Overall Study|Reason Not Specified|5|||
160928673|NCT02347189|581133447|FG000|Overall Study|No implant attempted of study device|9|||
160928674|NCT02347189|581133447|FG000|Overall Study|No primary outcome data available|2|||
160928675|NCT02677987|581133448|FG000|Overall Study|Withdrawal by Subject|3|||
160928676|NCT02677987|581133449|FG001|Overall Study|Withdrawal by Subject|0|||
160928677|NCT02677987|581133448|FG000|Overall Study|Lost to Follow-up|1|||
160928678|NCT02677987|581133449|FG001|Overall Study|Lost to Follow-up|0|||
161342418|NCT02097277|582640186|FG003|Overall Study|Adverse Event|2|||
160928679|NCT03320564|581133450|FG000|Overall Study|Protocol Violation|1|||
160928680|NCT00600938|581133451|FG000|Core Study|Abnormal test procedure result(s)|3|||
160928681|NCT00600938|581133452|FG001|Core Study|Abnormal test procedure result(s)|2|||
160928682|NCT00600938|581133453|FG002|Core Study|Abnormal test procedure result(s)|0|||
160928683|NCT00600938|581133454|FG003|Core Study|Abnormal test procedure result(s)|0|||
160928684|NCT00600938|581133451|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
160928685|NCT00600938|581133452|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
160928686|NCT00600938|581133453|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
160928687|NCT00600938|581133454|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
160928688|NCT00600938|581133451|FG000|Core Study|Patient withdrew consent|7|||
160928689|NCT00600938|581133452|FG001|Core Study|Patient withdrew consent|12|||
160928690|NCT00600938|581133453|FG002|Core Study|Patient withdrew consent|0|||
161342419|NCT02097277|582640187|FG004|Overall Study|Adverse Event|0|||
160928691|NCT00600938|581133454|FG003|Core Study|Patient withdrew consent|0|||
160928692|NCT00600938|581133451|FG000|Core Study|Lost to Follow-up|3|||
160928693|NCT00600938|581133452|FG001|Core Study|Lost to Follow-up|2|||
160928694|NCT00600938|581133453|FG002|Core Study|Lost to Follow-up|0|||
160928695|NCT00600938|581133454|FG003|Core Study|Lost to Follow-up|0|||
160928696|NCT00600938|581133451|FG000|Core Study|Death|1|||
160928697|NCT00600938|581133452|FG001|Core Study|Death|1|||
160928698|NCT00600938|581133453|FG002|Core Study|Death|0|||
160928699|NCT00600938|581133454|FG003|Core Study|Death|0|||
160928700|NCT00600938|581133451|FG000|Core Study|Protocol Violation|1|||
160928701|NCT00600938|581133452|FG001|Core Study|Protocol Violation|2|||
160928702|NCT00600938|581133453|FG002|Core Study|Protocol Violation|0|||
160928703|NCT00600938|581133454|FG003|Core Study|Protocol Violation|0|||
160928704|NCT00600938|581133451|FG000|Extension Study|Adverse Event|1|||
160928705|NCT00600938|581133452|FG001|Extension Study|Adverse Event|0|||
160928706|NCT00600938|581133453|FG002|Extension Study|Adverse Event|2|||
160928707|NCT00600938|581133454|FG003|Extension Study|Adverse Event|0|||
160928708|NCT00600938|581133451|FG000|Extension Study|Abnormal test procedure results|0|||
160928709|NCT00600938|581133452|FG001|Extension Study|Abnormal test procedure results|1|||
160928710|NCT00600938|581133453|FG002|Extension Study|Abnormal test procedure results|1|||
160928711|NCT00600938|581133454|FG003|Extension Study|Abnormal test procedure results|1|||
160928712|NCT00600938|581133451|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
160928713|NCT00600938|581133452|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
160928714|NCT00600938|581133453|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
160928715|NCT00600938|581133454|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
160928716|NCT00600938|581133451|FG000|Extension Study|Withdrawal by Subject|2|||
160928717|NCT00600938|581133452|FG001|Extension Study|Withdrawal by Subject|2|||
160928718|NCT00600938|581133453|FG002|Extension Study|Withdrawal by Subject|3|||
160928719|NCT00600938|581133454|FG003|Extension Study|Withdrawal by Subject|0|||
160928720|NCT00600938|581133451|FG000|Extension Study|Lost to Follow-up|1|||
160928721|NCT00600938|581133452|FG001|Extension Study|Lost to Follow-up|1|||
160928722|NCT00600938|581133453|FG002|Extension Study|Lost to Follow-up|2|||
160928723|NCT00600938|581133454|FG003|Extension Study|Lost to Follow-up|0|||
160928724|NCT00600938|581133451|FG000|Extension Study|Death|1|||
160928725|NCT00600938|581133452|FG001|Extension Study|Death|0|||
160928726|NCT00600938|581133453|FG002|Extension Study|Death|0|||
160928727|NCT00600938|581133454|FG003|Extension Study|Death|0|||
160928728|NCT02680639|581133455|FG000|Screening Period|Screen Failure|7|||
160928729|NCT02680639|581133456|FG001|Screening Period|Screen Failure|0|||
160928730|NCT02680639|581133457|FG002|Screening Period|Screen Failure|0|||
160928731|NCT03200899|581133458|FG000|Overall Study|Lost to Follow-up|10|||
160928732|NCT03200899|581133459|FG001|Overall Study|Lost to Follow-up|23|||
160928733|NCT01342510|581133471|FG000|Overall Study|Protocol Violation|12|||
160928734|NCT01342510|581133472|FG001|Overall Study|Protocol Violation|6|||
160928735|NCT01342510|581133473|FG002|Overall Study|Protocol Violation|13|||
160928736|NCT01342510|581133474|FG003|Overall Study|Protocol Violation|11|||
160928737|NCT00323115|581133479|FG000|Vaccine Administration|Adverse Event|1|||
160928738|NCT00323115|581133479|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
160928739|NCT04837131|581133480|FG000|Overall Study|Death|1|||
160928740|NCT04837131|581133480|FG000|Overall Study|Withdrawal by Subject|1|||
160928741|NCT04837131|581133480|FG000|Overall Study|Adverse Event|1|||
160928742|NCT04837131|581133480|FG000|Overall Study|Protocol Violation|1|||
160928743|NCT02496533|581133481|FG000|Overall Study|Lack of data on outcome|3|||
160928744|NCT02496533|581133482|FG001|Overall Study|Lack of data on outcome|0|||
160928745|NCT02496533|581133481|FG000|Overall Study|Patient did not complete all measures|0|||
160928746|NCT02496533|581133482|FG001|Overall Study|Patient did not complete all measures|4|||
160928747|NCT02496533|581133481|FG000|Overall Study|Late for radiologic testing|0|||
160928748|NCT02496533|581133482|FG001|Overall Study|Late for radiologic testing|2|||
160928749|NCT05756790|581133483|FG000|Overall Study|Withdrawal by Subject|1|||
160928750|NCT05756790|581133484|FG001|Overall Study|Withdrawal by Subject|1|||
160928751|NCT05756790|581133485|FG002|Overall Study|Withdrawal by Subject|1|||
160928752|NCT05756790|581133486|FG003|Overall Study|Withdrawal by Subject|1|||
160928753|NCT05756790|581133487|FG004|Overall Study|Withdrawal by Subject|0|||
160928754|NCT05756790|581133488|FG005|Overall Study|Withdrawal by Subject|0|||
160998104|NCT02957539|581378567|FG001|Baseline to Week 16|Lost to Follow-up|10|||
160998105|NCT02957539|581378568|FG002|Baseline to Week 16|Lost to Follow-up|16|||
160998106|NCT02957539|581378566|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
160928755|NCT05756790|581133483|FG000|Overall Study|Protocol Violation|0|||
160928756|NCT05756790|581133484|FG001|Overall Study|Protocol Violation|0|||
160928757|NCT05756790|581133485|FG002|Overall Study|Protocol Violation|1|||
160928758|NCT05756790|581133486|FG003|Overall Study|Protocol Violation|1|||
160928759|NCT05756790|581133487|FG004|Overall Study|Protocol Violation|0|||
160928760|NCT05756790|581133488|FG005|Overall Study|Protocol Violation|0|||
160928761|NCT05756790|581133483|FG000|Overall Study|Ineligible|0|||
161342420|NCT01461551|582640190|FG000|Overall Study|Physician Decision|2|||
160928762|NCT05756790|581133484|FG001|Overall Study|Ineligible|0|||
160928763|NCT05756790|581133485|FG002|Overall Study|Ineligible|0|||
160998107|NCT02957539|581378567|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
160928764|NCT05756790|581133486|FG003|Overall Study|Ineligible|0|||
160928765|NCT05756790|581133487|FG004|Overall Study|Ineligible|2|||
160928766|NCT05756790|581133488|FG005|Overall Study|Ineligible|2|||
160928767|NCT02268409|581134855|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
160928768|NCT02268409|581134855|FG000|Overall Study|Death|1|||
160928769|NCT02268409|581134855|FG000|Overall Study|Lost to Follow-up|1|||
160928770|NCT02268409|581134855|FG000|Overall Study|Protocol Violation|3|||
160928771|NCT02268409|581134855|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
160928772|NCT02268409|581134855|FG000|Overall Study|Withdrawal by Subject|5|||
160928773|NCT00489853|581134856|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
160928774|NCT00489853|581134857|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
160928775|NCT00489853|581134858|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
160928776|NCT00489853|581134856|FG000|Wash-out Period 1|Adverse Event|0|||
160928777|NCT00489853|581134857|FG001|Wash-out Period 1|Adverse Event|1|||
160928778|NCT00489853|581134858|FG002|Wash-out Period 1|Adverse Event|1|||
160928779|NCT00489853|581134856|FG000|Wash-out Period 1|Protocol Violation|0|||
160928780|NCT00489853|581134857|FG001|Wash-out Period 1|Protocol Violation|1|||
160928781|NCT00489853|581134858|FG002|Wash-out Period 1|Protocol Violation|1|||
160928782|NCT00489853|581134856|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
160928783|NCT00489853|581134857|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
160928784|NCT00489853|581134858|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
160928785|NCT00489853|581134856|FG000|Wash-out Period 2|Adverse Event|1|||
160928786|NCT00489853|581134857|FG001|Wash-out Period 2|Adverse Event|1|||
160928787|NCT00489853|581134858|FG002|Wash-out Period 2|Adverse Event|0|||
160928788|NCT00489853|581134856|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
160928789|NCT00489853|581134857|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
160928790|NCT00489853|581134858|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
160928791|NCT00489853|581134856|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
160928792|NCT00489853|581134857|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
160928793|NCT00489853|581134858|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
160928794|NCT01176292|581134862|FG000|Overall Study|Lost to Follow-up|2|||
160928795|NCT01176292|581134863|FG001|Overall Study|Lost to Follow-up|4|||
160928796|NCT01176292|581134862|FG000|Overall Study|Adverse Event|1|||
160928797|NCT01176292|581134863|FG001|Overall Study|Adverse Event|1|||
160928798|NCT01176292|581134862|FG000|Overall Study|Physician Decision|0|||
160928799|NCT01176292|581134863|FG001|Overall Study|Physician Decision|2|||
160928800|NCT01176292|581134862|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
160928801|NCT01176292|581134863|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
160928802|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
160928803|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
160928804|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
160928805|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
160928806|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
160928807|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
160928808|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
160928809|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
160928810|NCT00380393|581134864|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
160928811|NCT00380393|581134865|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
160928812|NCT00380393|581134864|FG000|Month 14|Withdrawal by Subject|9|||
160928813|NCT00380393|581134865|FG001|Month 14|Withdrawal by Subject|7|||
160928814|NCT00380393|581134864|FG000|Month 14|Death|1|||
160928815|NCT00380393|581134865|FG001|Month 14|Death|0|||
160928816|NCT00380393|581134864|FG000|Month 14|Lost to Follow-up|0|||
160928817|NCT00380393|581134865|FG001|Month 14|Lost to Follow-up|1|||
160928818|NCT00380393|581134864|FG000|Month 14|Migrated/moved from study area|39|||
160928819|NCT00380393|581134865|FG001|Month 14|Migrated/moved from study area|42|||
160928820|NCT00380393|581134864|FG000|Month 14|Protocol Violation|2|||
160928821|NCT00380393|581134865|FG001|Month 14|Protocol Violation|0|||
160928822|NCT00380393|581134864|FG000|Month 14|Others|6|||
160928823|NCT00380393|581134865|FG001|Month 14|Others|6|||
160928824|NCT00278954|581134876|FG000|Overall Study|Adverse Event|3|||
160928825|NCT00278954|581134876|FG000|Overall Study|Lost to Follow-up|1|||
160928826|NCT00278954|581134876|FG000|Overall Study|Withdrawal by Subject|1|||
160928827|NCT02211131|581134880|FG000|Overall Study|Death|26|||
160928828|NCT02211131|581134881|FG001|Overall Study|Death|16|||
160928829|NCT02211131|581134880|FG000|Overall Study|Lost to Follow-up|4|||
160928830|NCT02211131|581134881|FG001|Overall Study|Lost to Follow-up|3|||
160928831|NCT02211131|581134880|FG000|Overall Study|Decision by Sponsor|1|||
160928832|NCT02211131|581134881|FG001|Overall Study|Decision by Sponsor|1|||
161342421|NCT01461551|582640191|FG001|Overall Study|Physician Decision|1|||
160928833|NCT02211131|581134880|FG000|Overall Study|Withdrawal by Subject|3|||
160928834|NCT02211131|581134881|FG001|Overall Study|Withdrawal by Subject|8|||
160928835|NCT04064294|581134892|FG000|Overall Study|Adverse Event|1|||
160928836|NCT04064294|581134893|FG001|Overall Study|Adverse Event|0|||
160928837|NCT04064294|581134894|FG002|Overall Study|Adverse Event|0|||
160928838|NCT00481195|581134895|FG000|Overall Study|Adverse Event|16|||
160928839|NCT00481195|581134896|FG001|Overall Study|Adverse Event|11|||
160928840|NCT00481195|581134895|FG000|Overall Study|Lack of Efficacy|1|||
160928841|NCT00481195|581134896|FG001|Overall Study|Lack of Efficacy|3|||
160928842|NCT00481195|581134895|FG000|Overall Study|Lost to Follow-up|4|||
160928843|NCT00481195|581134896|FG001|Overall Study|Lost to Follow-up|6|||
160928844|NCT00481195|581134895|FG000|Overall Study|Physician Decision|3|||
160928845|NCT00481195|581134896|FG001|Overall Study|Physician Decision|1|||
160928846|NCT00481195|581134895|FG000|Overall Study|Protocol Violation|10|||
160928847|NCT00481195|581134896|FG001|Overall Study|Protocol Violation|7|||
160928848|NCT00481195|581134895|FG000|Overall Study|Withdrawal by Subject|3|||
160928849|NCT00481195|581134896|FG001|Overall Study|Withdrawal by Subject|9|||
160928850|NCT00481195|581134895|FG000|Overall Study|Miscellaneous|2|||
160928851|NCT00481195|581134896|FG001|Overall Study|Miscellaneous|2|||
160928852|NCT01289847|581134897|FG000|Overall Study|Patient could not comply with visits|1|||
160928853|NCT00006478|581134908|FG000|Overall Study|Vaccine could not be produced|1|||
160928854|NCT00006478|581134908|FG000|Overall Study|Physician Decision|6|||
160928855|NCT04753164|581134909|FG000|Overall Study|Adverse Event|0|||
160928856|NCT04753164|581134910|FG001|Overall Study|Adverse Event|2|||
160928857|NCT04753164|581134909|FG000|Overall Study|Withdrawal by Subject|9|||
160928858|NCT04753164|581134910|FG001|Overall Study|Withdrawal by Subject|7|||
160928859|NCT04753164|581134909|FG000|Overall Study|Lost to Follow-up|6|||
160928860|NCT04753164|581134910|FG001|Overall Study|Lost to Follow-up|6|||
160928861|NCT04753164|581134909|FG000|Overall Study|Other|12|||
160928862|NCT04753164|581134910|FG001|Overall Study|Other|5|||
160928863|NCT00694369|581134911|FG000|Overall Study|Adverse Event|0|||
160928864|NCT00694369|581134912|FG001|Overall Study|Adverse Event|1|||
160928865|NCT00694369|581134913|FG002|Overall Study|Adverse Event|0|||
160928866|NCT00694369|581134914|FG003|Overall Study|Adverse Event|1|||
160928867|NCT00694369|581134915|FG004|Overall Study|Adverse Event|3|||
160928868|NCT00694369|581134911|FG000|Overall Study|Lost to Follow-up|0|||
160928869|NCT00694369|581134912|FG001|Overall Study|Lost to Follow-up|0|||
160928870|NCT00694369|581134913|FG002|Overall Study|Lost to Follow-up|1|||
160928871|NCT00694369|581134914|FG003|Overall Study|Lost to Follow-up|1|||
160928872|NCT00694369|581134915|FG004|Overall Study|Lost to Follow-up|0|||
160928873|NCT00694369|581134911|FG000|Overall Study|Physician Decision|0|||
160928874|NCT00694369|581134912|FG001|Overall Study|Physician Decision|0|||
160928875|NCT00694369|581134913|FG002|Overall Study|Physician Decision|0|||
160928876|NCT00694369|581134914|FG003|Overall Study|Physician Decision|0|||
160928877|NCT00694369|581134915|FG004|Overall Study|Physician Decision|1|||
160928878|NCT00694369|581134911|FG000|Overall Study|Protocol Violation|0|||
160928879|NCT00694369|581134912|FG001|Overall Study|Protocol Violation|1|||
160928880|NCT00694369|581134913|FG002|Overall Study|Protocol Violation|0|||
160928881|NCT00694369|581134914|FG003|Overall Study|Protocol Violation|0|||
160928882|NCT00694369|581134915|FG004|Overall Study|Protocol Violation|0|||
160928883|NCT00694369|581134911|FG000|Overall Study|Withdrawal by Subject|1|||
160928884|NCT00694369|581134912|FG001|Overall Study|Withdrawal by Subject|1|||
160928885|NCT00694369|581134913|FG002|Overall Study|Withdrawal by Subject|1|||
160928886|NCT00694369|581134914|FG003|Overall Study|Withdrawal by Subject|1|||
160928887|NCT00694369|581134915|FG004|Overall Study|Withdrawal by Subject|2|||
160928888|NCT00439556|581134916|FG000|Overall Study|Patient was taken off study for non-comp|0|||
160928889|NCT00439556|581134917|FG001|Overall Study|Patient was taken off study for non-comp|1|||
160928890|NCT00439556|581134918|FG002|Overall Study|Patient was taken off study for non-comp|0|||
160928891|NCT02871739|581134919|FG000|Overall Study|Lost to Follow-up|3|||
160928892|NCT02871739|581134920|FG001|Overall Study|Lost to Follow-up|2|||
160928893|NCT02871739|581134921|FG002|Overall Study|Lost to Follow-up|0|||
160928894|NCT02871739|581134922|FG003|Overall Study|Lost to Follow-up|2|||
161264201|NCT02335983|582349167|FG000|Overall Study|Lost to Follow-up|0|||
160928895|NCT01324388|581134925|FG000|Part 1 of Study|Adverse Event|2|||
161264202|NCT02335983|582349168|FG001|Overall Study|Lost to Follow-up|0|||
160928896|NCT01324388|581134926|FG001|Part 1 of Study|Adverse Event|0|||
160928897|NCT01324388|581134927|FG002|Part 1 of Study|Adverse Event|0|||
160928898|NCT01324388|581134928|FG003|Part 1 of Study|Adverse Event|0|||
160928899|NCT01324388|581134925|FG000|Part 1 of Study|Protocol Violation|1|||
160928900|NCT01324388|581134926|FG001|Part 1 of Study|Protocol Violation|2|||
160998108|NCT02957539|581378568|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
161264203|NCT02335983|582349169|FG002|Overall Study|Lost to Follow-up|0|||
160928901|NCT01324388|581134927|FG002|Part 1 of Study|Protocol Violation|0|||
161264204|NCT02335983|582349170|FG003|Overall Study|Lost to Follow-up|0|||
160928902|NCT01324388|581134928|FG003|Part 1 of Study|Protocol Violation|0|||
160928903|NCT01324388|581134925|FG000|Part 1 of Study|Physician Decision|1|||
160928904|NCT01324388|581134926|FG001|Part 1 of Study|Physician Decision|0|||
160928905|NCT01324388|581134927|FG002|Part 1 of Study|Physician Decision|0|||
160928906|NCT01324388|581134928|FG003|Part 1 of Study|Physician Decision|0|||
160928907|NCT01324388|581134925|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
160928908|NCT01324388|581134926|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
160928909|NCT01324388|581134927|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
160928910|NCT01324388|581134928|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
160998109|NCT02957539|581378566|FG000|Week 16 to 32|Withdrawal by Subject|3|||
161264205|NCT02335983|582349171|FG004|Overall Study|Lost to Follow-up|0|||
160928911|NCT01324388|581134925|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
160928912|NCT01324388|581134926|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
160928913|NCT01324388|581134927|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
160928914|NCT01324388|581134928|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
160928915|NCT01405963|581134929|FG000|Overall Study|Moved Away|2|||
160928916|NCT01405963|581134930|FG001|Overall Study|Moved Away|0|||
160928917|NCT01405963|581134929|FG000|Overall Study|Adverse Event|0|||
160928918|NCT01405963|581134930|FG001|Overall Study|Adverse Event|1|||
160928919|NCT01405963|581134929|FG000|Overall Study|Lost to Follow-up|0|||
160928920|NCT01405963|581134930|FG001|Overall Study|Lost to Follow-up|1|||
160928921|NCT00850395|581134937|FG000|Overall Study|Death|1|||
160928922|NCT00850395|581134937|FG000|Overall Study|Adverse Event|1|||
160928923|NCT00850395|581134937|FG000|Overall Study|Insufficient clinical response|3|||
160928924|NCT00850395|581134937|FG000|Overall Study|Other|5|||
160928925|NCT01737047|581134938|FG000|Overall Study|Death|10|||
160928926|NCT01737047|581134939|FG001|Overall Study|Death|0|||
160928927|NCT01737047|581134940|FG002|Overall Study|Death|1|||
160928928|NCT01737047|581134938|FG000|Overall Study|Withdrawal by Subject|17|||
160928929|NCT01737047|581134939|FG001|Overall Study|Withdrawal by Subject|11|||
160928930|NCT01737047|581134940|FG002|Overall Study|Withdrawal by Subject|4|||
160928931|NCT02802592|581134941|FG000|Overall Study|Study terminated due to loss of funding|4|||
160928932|NCT04007523|581134942|FG000|Overall Study|Withdrawal by Subject|0|||
160928933|NCT04007523|581134943|FG001|Overall Study|Withdrawal by Subject|1|||
160928934|NCT04007523|581134944|FG002|Overall Study|Withdrawal by Subject|1|||
160928935|NCT04007523|581134945|FG003|Overall Study|Withdrawal by Subject|0|||
160928936|NCT04007523|581134942|FG000|Overall Study|ICU Transfer|0|||
160928937|NCT04007523|581134943|FG001|Overall Study|ICU Transfer|1|||
160928938|NCT04007523|581134944|FG002|Overall Study|ICU Transfer|0|||
160928939|NCT04007523|581134945|FG003|Overall Study|ICU Transfer|0|||
160928940|NCT04007523|581134942|FG000|Overall Study|COVID hospital closure|0|||
160928941|NCT04007523|581134943|FG001|Overall Study|COVID hospital closure|0|||
160928942|NCT04007523|581134944|FG002|Overall Study|COVID hospital closure|1|||
160928943|NCT04007523|581134945|FG003|Overall Study|COVID hospital closure|2|||
160928944|NCT04007523|581134942|FG000|Overall Study|Surgery cancelled|0|||
160928945|NCT04007523|581134943|FG001|Overall Study|Surgery cancelled|0|||
160928946|NCT04007523|581134944|FG002|Overall Study|Surgery cancelled|1|||
160928947|NCT04007523|581134945|FG003|Overall Study|Surgery cancelled|1|||
160928948|NCT01826487|581134946|FG000|Overall Study|Adverse Event|1|||
160928949|NCT01826487|581134947|FG001|Overall Study|Adverse Event|1|||
160928950|NCT01826487|581134946|FG000|Overall Study|Lost to Follow-up|1|||
160928951|NCT01826487|581134947|FG001|Overall Study|Lost to Follow-up|0|||
160928952|NCT01826487|581134946|FG000|Overall Study|Withdrawal by Subject|1|||
160928953|NCT01826487|581134947|FG001|Overall Study|Withdrawal by Subject|3|||
160928954|NCT01826487|581134946|FG000|Overall Study|Protocol Violation|1|||
160928955|NCT01826487|581134947|FG001|Overall Study|Protocol Violation|1|||
160928956|NCT01408030|581134948|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
160928957|NCT01408030|581134949|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
160928958|NCT01408030|581134950|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
160928959|NCT01408030|581134951|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
160928960|NCT01408030|581134948|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
160928961|NCT01408030|581134949|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
160928962|NCT01408030|581134950|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
160928963|NCT01408030|581134951|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
160928964|NCT01408030|581134948|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
160928965|NCT01408030|581134949|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
160928966|NCT01408030|581134950|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
160928967|NCT01408030|581134951|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
160928968|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
160928969|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
160928970|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
160928971|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
160928972|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
160928973|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
160928974|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
160928975|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
160928976|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
160928977|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
160928978|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
160928979|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
160928980|NCT01408030|581134948|FG000|Observation Phase (Off Drug)|Other|1|||
160928981|NCT01408030|581134949|FG001|Observation Phase (Off Drug)|Other|1|||
160928982|NCT01408030|581134950|FG002|Observation Phase (Off Drug)|Other|1|||
160928983|NCT01408030|581134951|FG003|Observation Phase (Off Drug)|Other|1|||
161264206|NCT02335983|582349172|FG005|Overall Study|Lost to Follow-up|1|||
161342422|NCT01461551|582640192|FG002|Overall Study|Physician Decision|2|||
160928984|NCT02965703|581134952|FG000|Overall Study|Withdrawal by Subject|6|||
160928985|NCT02965703|581134953|FG001|Overall Study|Withdrawal by Subject|3|||
160928986|NCT02965703|581134954|FG002|Overall Study|Withdrawal by Subject|1|||
160928987|NCT02965703|581134952|FG000|Overall Study|Protocol Violation|1|||
160928988|NCT02965703|581134953|FG001|Overall Study|Protocol Violation|0|||
160928989|NCT02965703|581134954|FG002|Overall Study|Protocol Violation|0|||
160928990|NCT02965703|581134952|FG000|Overall Study|Adverse Event|1|||
160928991|NCT02965703|581134953|FG001|Overall Study|Adverse Event|1|||
160928992|NCT02965703|581134954|FG002|Overall Study|Adverse Event|0|||
160928993|NCT02965703|581134952|FG000|Overall Study|Lost to Follow-up|2|||
160928994|NCT02965703|581134953|FG001|Overall Study|Lost to Follow-up|1|||
160928995|NCT02965703|581134954|FG002|Overall Study|Lost to Follow-up|1|||
160928996|NCT00788827|581134960|FG000|Overall Study|Lack of Efficacy|2|||
160928997|NCT03608774|581134961|FG000|Overall Study|Lost to Follow-up|5|||
160928998|NCT03608774|581134962|FG001|Overall Study|Lost to Follow-up|5|||
160928999|NCT03608774|581134961|FG000|Overall Study|Withdrawal by Subject|1|||
160929000|NCT03608774|581134962|FG001|Overall Study|Withdrawal by Subject|0|||
160929001|NCT03608774|581134961|FG000|Overall Study|Protocol Violation|1|||
160929002|NCT03608774|581134962|FG001|Overall Study|Protocol Violation|0|||
160929003|NCT03608774|581134961|FG000|Overall Study|Not eligible at enrollment|0|||
160929004|NCT03608774|581134962|FG001|Overall Study|Not eligible at enrollment|1|||
160929005|NCT03608774|581134961|FG000|Overall Study|Health related event|0|||
160929006|NCT03608774|581134962|FG001|Overall Study|Health related event|1|||
160929007|NCT01586819|581134963|FG000|Overall Study|Withdrawal by Subject|1|||
160929008|NCT01586819|581134964|FG001|Overall Study|Withdrawal by Subject|0|||
160929009|NCT01359254|581134965|FG000|Overall Study|Death|1|||
160929010|NCT01359254|581134966|FG001|Overall Study|Death|0|||
160929011|NCT02028988|581134972|FG000|Overall Study|Withdrawal by Subject|2|||
160929012|NCT00851799|581134975|FG000|Overall Study|Death|1|||
160929013|NCT00851799|581134976|FG001|Overall Study|Death|0|||
160929014|NCT00851799|581134977|FG002|Overall Study|Death|1|||
160929015|NCT00851799|581134975|FG000|Overall Study|Lost to Follow-up|5|||
160929016|NCT00851799|581134976|FG001|Overall Study|Lost to Follow-up|3|||
160929017|NCT00851799|581134977|FG002|Overall Study|Lost to Follow-up|10|||
160929018|NCT00851799|581134975|FG000|Overall Study|Not able to get to clinic|8|||
160929019|NCT00851799|581134976|FG001|Overall Study|Not able to get to clinic|5|||
160929020|NCT00851799|581134977|FG002|Overall Study|Not able to get to clinic|9|||
160929021|NCT00851799|581134975|FG000|Overall Study|Not willing to adhere to requirements|1|||
160929022|NCT00851799|581134976|FG001|Overall Study|Not willing to adhere to requirements|2|||
160929023|NCT00851799|581134977|FG002|Overall Study|Not willing to adhere to requirements|2|||
160929024|NCT00851799|581134975|FG000|Overall Study|Withdrew consent prior study completion|1|||
160929025|NCT00851799|581134976|FG001|Overall Study|Withdrew consent prior study completion|2|||
160929026|NCT00851799|581134977|FG002|Overall Study|Withdrew consent prior study completion|1|||
160929027|NCT00851799|581134975|FG000|Overall Study|Severe Debilitation|0|||
160929028|NCT00851799|581134976|FG001|Overall Study|Severe Debilitation|1|||
160929029|NCT00851799|581134977|FG002|Overall Study|Severe Debilitation|0|||
160929030|NCT00851799|581134975|FG000|Overall Study|Completed protocol due to pregnancy|0|||
160929031|NCT00851799|581134976|FG001|Overall Study|Completed protocol due to pregnancy|0|||
160929032|NCT00851799|581134977|FG002|Overall Study|Completed protocol due to pregnancy|1|||
160929033|NCT04365556|581134980|FG000|Overall Study|No longer eligible due to treatment plan|1|||
160929034|NCT04365556|581134981|FG001|Overall Study|No longer eligible due to treatment plan|0|||
160929035|NCT04365556|581134980|FG000|Overall Study|Lost to Follow-up|3|||
160929036|NCT04365556|581134981|FG001|Overall Study|Lost to Follow-up|2|||
160929037|NCT04439318|581134982|FG000|Overall Study|Ineligible|1|||
160929038|NCT04439318|581134982|FG000|Overall Study|Never Started Treatment|3|||
160929039|NCT04439318|581134982|FG000|Overall Study|Adverse Event|10|||
160929040|NCT04439318|581134982|FG000|Overall Study|Death|2|||
160929041|NCT04439318|581134982|FG000|Overall Study|Disease Progression|25|||
160929042|NCT04439318|581134982|FG000|Overall Study|Other Complicating Disease|2|||
160929043|NCT04439318|581134982|FG000|Overall Study|Withdrawal by Subject|4|||
161342423|NCT00303186|582640193|FG000|Overall Study|Other|52|||
160929044|NCT04439318|581134982|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
160929045|NCT04439318|581134982|FG000|Overall Study|Non-Compliance|1|||
160929046|NCT04439318|581134982|FG000|Overall Study|Still on Treatment|1|||
160929047|NCT00589108|581136725|FG000|Overall Study|Lost to Follow-up|1|||
160929048|NCT00589108|581136726|FG001|Overall Study|Lost to Follow-up|1|||
160929049|NCT00589108|581136727|FG002|Overall Study|Lost to Follow-up|1|||
160929050|NCT00589108|581136725|FG000|Overall Study|Death|3|||
160929051|NCT00589108|581136726|FG001|Overall Study|Death|3|||
160929052|NCT00589108|581136727|FG002|Overall Study|Death|4|||
160929053|NCT03026257|581136731|FG000|Overall Study|Adverse Event|3|||
160929054|NCT03026257|581136732|FG001|Overall Study|Adverse Event|0|||
160929055|NCT03026257|581136733|FG002|Overall Study|Adverse Event|0|||
160929056|NCT03026257|581136734|FG003|Overall Study|Adverse Event|0|||
160929057|NCT03026257|581136735|FG004|Overall Study|Adverse Event|0|||
160929058|NCT03026257|581136736|FG005|Overall Study|Adverse Event|0|||
160929059|NCT03026257|581136731|FG000|Overall Study|Lost to Follow-up|1|||
160929060|NCT03026257|581136732|FG001|Overall Study|Lost to Follow-up|0|||
160929061|NCT03026257|581136733|FG002|Overall Study|Lost to Follow-up|0|||
160929062|NCT03026257|581136734|FG003|Overall Study|Lost to Follow-up|0|||
160929063|NCT03026257|581136735|FG004|Overall Study|Lost to Follow-up|0|||
160929064|NCT03026257|581136736|FG005|Overall Study|Lost to Follow-up|0|||
160929065|NCT03026257|581136731|FG000|Overall Study|Protocol Violation|1|||
160929066|NCT03026257|581136732|FG001|Overall Study|Protocol Violation|0|||
160929067|NCT03026257|581136733|FG002|Overall Study|Protocol Violation|0|||
160929068|NCT03026257|581136734|FG003|Overall Study|Protocol Violation|1|||
160929069|NCT03026257|581136735|FG004|Overall Study|Protocol Violation|1|||
160929070|NCT03026257|581136736|FG005|Overall Study|Protocol Violation|0|||
160929071|NCT03026257|581136731|FG000|Overall Study|Withdrawal by Subject|1|||
160929072|NCT03026257|581136732|FG001|Overall Study|Withdrawal by Subject|1|||
160929073|NCT03026257|581136733|FG002|Overall Study|Withdrawal by Subject|0|||
160929074|NCT03026257|581136734|FG003|Overall Study|Withdrawal by Subject|0|||
160929075|NCT03026257|581136735|FG004|Overall Study|Withdrawal by Subject|0|||
160929076|NCT03026257|581136736|FG005|Overall Study|Withdrawal by Subject|0|||
160929077|NCT02181556|581136737|FG000|Overall Study|Withdrawal by Subject|1|||
160929078|NCT00427635|581136738|FG000|Treatment Phase|Withdrawal by Subject|1|||
160929079|NCT00427635|581136739|FG001|Treatment Phase|Withdrawal by Subject|0|||
160929080|NCT00427635|581136738|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
160929081|NCT00427635|581136739|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
160929082|NCT00838201|581136742|FG000|Overall Study|Investigator decision, or other reasons|2|||
160929083|NCT00838201|581136743|FG001|Overall Study|Investigator decision, or other reasons|3|||
160929084|NCT00838201|581136742|FG000|Overall Study|Noncompliance|0|||
160929085|NCT00838201|581136743|FG001|Overall Study|Noncompliance|1|||
160929086|NCT00838201|581136742|FG000|Overall Study|Administrative decision|1|||
160929087|NCT00838201|581136743|FG001|Overall Study|Administrative decision|2|||
160929088|NCT00838201|581136742|FG000|Overall Study|Disease progression|3|||
160929089|NCT00838201|581136743|FG001|Overall Study|Disease progression|3|||
160929090|NCT00838201|581136742|FG000|Overall Study|Consent withdrawn|16|||
160929091|NCT00838201|581136743|FG001|Overall Study|Consent withdrawn|19|||
160929092|NCT00838201|581136742|FG000|Overall Study|Lost to Follow-up|4|||
160929093|NCT00838201|581136743|FG001|Overall Study|Lost to Follow-up|3|||
160929094|NCT00838201|581136742|FG000|Overall Study|Adverse Event|5|||
160929095|NCT00838201|581136743|FG001|Overall Study|Adverse Event|9|||
160929096|NCT00838201|581136742|FG000|Overall Study|Death|11|||
160929097|NCT00838201|581136743|FG001|Overall Study|Death|13|||
160929098|NCT03873987|581136744|FG000|Overall Study|Adverse Event|1|||
160929099|NCT03873987|581136745|FG001|Overall Study|Adverse Event|0|||
160929100|NCT03873987|581136744|FG000|Overall Study|staff was unable to start a new IV line|1|||
160929101|NCT03873987|581136745|FG001|Overall Study|staff was unable to start a new IV line|0|||
160929102|NCT03873987|581136744|FG000|Overall Study|Lost to Follow-up|0|||
160929103|NCT03873987|581136745|FG001|Overall Study|Lost to Follow-up|1|||
160929104|NCT01465022|581136746|FG000|Overall Study|Lost to Follow-up|15|||
160929105|NCT01465022|581136747|FG001|Overall Study|Lost to Follow-up|14|||
160929106|NCT01465022|581136748|FG002|Overall Study|Lost to Follow-up|0|||
160929107|NCT01465022|581136746|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
160929108|NCT01465022|581136747|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
160929109|NCT01465022|581136748|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
160929110|NCT01465022|581136746|FG000|Overall Study|Not Randomized|0|||
160929111|NCT01465022|581136747|FG001|Overall Study|Not Randomized|0|||
160929112|NCT01465022|581136748|FG002|Overall Study|Not Randomized|70|||
160929113|NCT00004888|581136749|FG000|Overall Study|Adverse Event|5|||
160929114|NCT00004888|581136750|FG001|Overall Study|Adverse Event|10|||
160929115|NCT00004888|581136749|FG000|Overall Study|Withdrawal by Subject|0|||
160929116|NCT00004888|581136750|FG001|Overall Study|Withdrawal by Subject|3|||
160929117|NCT00004888|581136749|FG000|Overall Study|Physician Decision|1|||
160929118|NCT00004888|581136750|FG001|Overall Study|Physician Decision|1|||
160929119|NCT00004888|581136749|FG000|Overall Study|Progressive Disease|4|||
160929120|NCT00004888|581136750|FG001|Overall Study|Progressive Disease|9|||
160929121|NCT00004888|581136749|FG000|Overall Study|Death without progressive disease|0|||
160929122|NCT00004888|581136750|FG001|Overall Study|Death without progressive disease|1|||
160929123|NCT00004888|581136749|FG000|Overall Study|Toxic death|1|||
160929124|NCT00004888|581136750|FG001|Overall Study|Toxic death|0|||
160929125|NCT00136084|581136751|FG000|Overall Study|Death|12|||
160929126|NCT00136084|581136752|FG001|Overall Study|Death|5|||
160998110|NCT02957539|581378567|FG001|Week 16 to 32|Withdrawal by Subject|3|||
161264207|NCT02335983|582349167|FG000|Overall Study|Protocol Specified Criteria|5|||
161264208|NCT02335983|582349168|FG001|Overall Study|Protocol Specified Criteria|7|||
160929127|NCT00136084|581136751|FG000|Overall Study|Unacceptable toxicity|8|||
160929128|NCT00136084|581136752|FG001|Overall Study|Unacceptable toxicity|11|||
160929129|NCT00136084|581136751|FG000|Overall Study|Relapse|20|||
160929130|NCT00136084|581136752|FG001|Overall Study|Relapse|23|||
160929131|NCT00136084|581136751|FG000|Overall Study|Lost to Follow-up|2|||
160929132|NCT00136084|581136752|FG001|Overall Study|Lost to Follow-up|0|||
160929133|NCT00136084|581136751|FG000|Overall Study|No Response|1|||
160929134|NCT00136084|581136752|FG001|Overall Study|No Response|2|||
160929135|NCT00136084|581136751|FG000|Overall Study|Withdrawal by Subject|5|||
160929136|NCT00136084|581136752|FG001|Overall Study|Withdrawal by Subject|1|||
160929137|NCT02579265|581136753|FG000|Overall Study|Weaned off earlier than 28 days|44|||
160929138|NCT02579265|581136754|FG001|Overall Study|Weaned off earlier than 28 days|43|||
160929139|NCT02579265|581136753|FG000|Overall Study|Adverse Event|2|||
160929140|NCT02579265|581136754|FG001|Overall Study|Adverse Event|0|||
160929141|NCT02579265|581136753|FG000|Overall Study|Any other reason not specified|0|||
160929142|NCT02579265|581136754|FG001|Overall Study|Any other reason not specified|2|||
160929143|NCT02579265|581136753|FG000|Overall Study|Withdrawal by Subject|2|||
160929144|NCT02579265|581136754|FG001|Overall Study|Withdrawal by Subject|0|||
160929145|NCT02579265|581136753|FG000|Overall Study|Physician Decision|1|||
160929146|NCT02579265|581136754|FG001|Overall Study|Physician Decision|0|||
160929147|NCT02579265|581136753|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
160929148|NCT02579265|581136754|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
160929149|NCT02174848|581136755|FG000|Overall Study|Adverse Event|2|||
160929150|NCT02174848|581136756|FG001|Overall Study|Adverse Event|1|||
160929151|NCT02174848|581136755|FG000|Overall Study|Withdrawal by Subject|3|||
160929152|NCT02174848|581136756|FG001|Overall Study|Withdrawal by Subject|3|||
160929153|NCT02174848|581136755|FG000|Overall Study|Lost to Follow-up|0|||
160929154|NCT02174848|581136756|FG001|Overall Study|Lost to Follow-up|1|||
160929155|NCT02174848|581136755|FG000|Overall Study|Worsening of disease|1|||
160929156|NCT02174848|581136756|FG001|Overall Study|Worsening of disease|1|||
160929157|NCT02174848|581136755|FG000|Overall Study|Unable to comply with study requirements|1|||
160929158|NCT02174848|581136756|FG001|Overall Study|Unable to comply with study requirements|0|||
160929159|NCT02520011|581136758|FG000|Overall Study|Adverse Event|0|||
160929160|NCT02520011|581136759|FG001|Overall Study|Adverse Event|1|||
160929161|NCT02520011|581136760|FG002|Overall Study|Adverse Event|2|||
160929162|NCT02520011|581136758|FG000|Overall Study|Death|0|||
160929163|NCT02520011|581136759|FG001|Overall Study|Death|8|||
160929164|NCT02520011|581136760|FG002|Overall Study|Death|1|||
160929165|NCT02520011|581136758|FG000|Overall Study|Lack of Efficacy|4|||
160929166|NCT02520011|581136759|FG001|Overall Study|Lack of Efficacy|26|||
160929167|NCT02520011|581136760|FG002|Overall Study|Lack of Efficacy|4|||
160929168|NCT02520011|581136758|FG000|Overall Study|Physician Decision|0|||
160929169|NCT02520011|581136759|FG001|Overall Study|Physician Decision|2|||
160929170|NCT02520011|581136760|FG002|Overall Study|Physician Decision|0|||
160929171|NCT02520011|581136758|FG000|Overall Study|Withdrawal by Subject|1|||
160929172|NCT02520011|581136759|FG001|Overall Study|Withdrawal by Subject|3|||
160929173|NCT02520011|581136760|FG002|Overall Study|Withdrawal by Subject|0|||
160929174|NCT02520011|581136758|FG000|Overall Study|Protocol Deviation|0|||
160929175|NCT02520011|581136759|FG001|Overall Study|Protocol Deviation|1|||
160929176|NCT02520011|581136760|FG002|Overall Study|Protocol Deviation|0|||
160929177|NCT02520011|581136758|FG000|Overall Study|Patient went to hospice|0|||
160929178|NCT02520011|581136759|FG001|Overall Study|Patient went to hospice|1|||
160929179|NCT02520011|581136760|FG002|Overall Study|Patient went to hospice|0|||
160929180|NCT02520011|581136758|FG000|Overall Study|Progressive disease following response|0|||
160929181|NCT02520011|581136759|FG001|Overall Study|Progressive disease following response|4|||
160929182|NCT02520011|581136760|FG002|Overall Study|Progressive disease following response|2|||
160929183|NCT00644969|581136761|FG000|Treatment Phase|Randomized, not treated|1|||
160929184|NCT00644969|581136762|FG001|Treatment Phase|Randomized, not treated|0|||
160929185|NCT00644969|581136761|FG000|Treatment Phase|Adverse Event|3|||
160929186|NCT00644969|581136762|FG001|Treatment Phase|Adverse Event|0|||
160929187|NCT00644969|581136761|FG000|Treatment Phase|Withdrawal by Subject|4|||
160929188|NCT00644969|581136762|FG001|Treatment Phase|Withdrawal by Subject|0|||
160929189|NCT00644969|581136761|FG000|Treatment Phase|Lost to Follow-up|2|||
160929190|NCT00644969|581136762|FG001|Treatment Phase|Lost to Follow-up|2|||
160929191|NCT00644969|581136761|FG000|Treatment Phase|Other|4|||
160929192|NCT00644969|581136762|FG001|Treatment Phase|Other|1|||
160929193|NCT00644969|581136761|FG000|Post Treatment Phase|Death|1|||
160929194|NCT00644969|581136762|FG001|Post Treatment Phase|Death|0|||
160929195|NCT00644969|581136761|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
160929196|NCT00644969|581136762|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
160929197|NCT00644969|581136761|FG000|Post Treatment Phase|Lost to Follow-up|4|||
160929198|NCT00644969|581136762|FG001|Post Treatment Phase|Lost to Follow-up|1|||
160929199|NCT00644969|581136761|FG000|Post Treatment Phase|Other|1|||
160929200|NCT00644969|581136762|FG001|Post Treatment Phase|Other|0|||
160998111|NCT02957539|581378568|FG002|Week 16 to 32|Withdrawal by Subject|1|||
160998112|NCT02957539|581378566|FG000|Week 16 to 32|Lost to Follow-up|8|||
160998113|NCT02957539|581378567|FG001|Week 16 to 32|Lost to Follow-up|7|||
160998114|NCT02957539|581378568|FG002|Week 16 to 32|Lost to Follow-up|5|||
160929201|NCT00997503|581136768|FG000|Overall Study|Death|53|||
160929202|NCT00997503|581136768|FG000|Overall Study|Withdrawal by Subject|76|||
160929203|NCT00997503|581136768|FG000|Overall Study|Lost to Follow-up|33|||
160929204|NCT00997503|581136768|FG000|Overall Study|Adverse Event|3|||
160929205|NCT00997503|581136768|FG000|Overall Study|Physician Decision|10|||
160929206|NCT00997503|581136768|FG000|Overall Study|Missed 12-month follow-up|85|||
160929207|NCT00997503|581136768|FG000|Overall Study|Other reason|13|||
160998115|NCT02957539|581378566|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
160929208|NCT01933048|581136772|FG000|Overall Study|Lost to Follow-up|15|||
160929209|NCT01933048|581136773|FG001|Overall Study|Lost to Follow-up|18|||
160929210|NCT01933048|581136772|FG000|Overall Study|personal reasons|1|||
160929211|NCT01933048|581136773|FG001|Overall Study|personal reasons|1|||
160929212|NCT01933048|581136772|FG000|Overall Study|Protocol Violation|7|||
160929213|NCT01933048|581136773|FG001|Overall Study|Protocol Violation|8|||
160929214|NCT01933048|581136772|FG000|Overall Study|Physician Decision|1|||
160929215|NCT01933048|581136773|FG001|Overall Study|Physician Decision|0|||
160929216|NCT01933048|581136772|FG000|Overall Study|unknown reasons|1|||
160929217|NCT01933048|581136773|FG001|Overall Study|unknown reasons|1|||
160929218|NCT02780804|581136774|FG000|Overall Study|Death|1|||
160929219|NCT02780804|581136775|FG001|Overall Study|Death|0|||
160929220|NCT02780804|581136776|FG002|Overall Study|Death|0|||
160929221|NCT02780804|581136774|FG000|Overall Study|Lack of Efficacy|5|||
160929222|NCT02780804|581136775|FG001|Overall Study|Lack of Efficacy|8|||
160929223|NCT02780804|581136776|FG002|Overall Study|Lack of Efficacy|4|||
160929224|NCT02780804|581136774|FG000|Overall Study|Physician Decision|0|||
160929225|NCT02780804|581136775|FG001|Overall Study|Physician Decision|0|||
160929226|NCT02780804|581136776|FG002|Overall Study|Physician Decision|2|||
160929227|NCT02780804|581136774|FG000|Overall Study|Withdrawal by Subject|0|||
160929228|NCT02780804|581136775|FG001|Overall Study|Withdrawal by Subject|1|||
160929229|NCT02780804|581136776|FG002|Overall Study|Withdrawal by Subject|0|||
160929230|NCT02476968|581136777|FG000|Overall Study|Other|0|||
160929231|NCT02476968|581136778|FG001|Overall Study|Other|2|||
160929232|NCT02476968|581136779|FG002|Overall Study|Other|0|||
160929233|NCT02476968|581136777|FG000|Overall Study|Lost to Follow-up|10|||
160929234|NCT02476968|581136778|FG001|Overall Study|Lost to Follow-up|0|||
160929235|NCT02476968|581136779|FG002|Overall Study|Lost to Follow-up|1|||
160929236|NCT02476968|581136777|FG000|Overall Study|Death|48|||
160929237|NCT02476968|581136778|FG001|Overall Study|Death|8|||
160929238|NCT02476968|581136779|FG002|Overall Study|Death|1|||
160929239|NCT02476968|581136777|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160929240|NCT02476968|581136778|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160929241|NCT02476968|581136779|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
160929242|NCT02476968|581136777|FG000|Overall Study|Patient decision|37|||
160929243|NCT02476968|581136778|FG001|Overall Study|Patient decision|8|||
160929244|NCT02476968|581136779|FG002|Overall Study|Patient decision|0|||
160929245|NCT04171414|581136789|FG000|Overall Study|Death|1|||
160929246|NCT04171414|581136789|FG000|Overall Study|Withdrawal by Subject|1|||
160929247|NCT01714310|581136790|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
160929248|NCT01714310|581136791|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
160929249|NCT01714310|581136792|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
160929250|NCT01714310|581136790|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
160929251|NCT01714310|581136791|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
160929252|NCT01714310|581136792|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
160929253|NCT01714310|581136790|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
160929254|NCT01714310|581136791|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
160929255|NCT01714310|581136792|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
160929256|NCT01714310|581136790|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
160929257|NCT01714310|581136791|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
160929258|NCT01714310|581136792|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
160929259|NCT02487394|581136793|FG000|Phase 1|Withdrawal by Subject|0|||
160929260|NCT02487394|581136794|FG001|Phase 1|Withdrawal by Subject|1|||
160929261|NCT01641367|581136795|FG000|Cohorts|Death|18|||
160929262|NCT01641367|581136796|FG001|Cohorts|Death|1|||
160929263|NCT01641367|581136797|FG002|Cohorts|Death|2|||
160929264|NCT01641367|581136798|FG003|Cohorts|Death|0|||
160929265|NCT01641367|581136799|FG004|Cohorts|Death|1|||
160929266|NCT01641367|581136800|FG005|Cohorts|Death|1|||
160929267|NCT01641367|581136801|FG006|Cohorts|Death|0|||
160929268|NCT01641367|581136802|FG007|Cohorts|Death|0|||
160929269|NCT01641367|581136795|FG000|Cohorts|Lost to Follow-up|16|||
160929270|NCT01641367|581136796|FG001|Cohorts|Lost to Follow-up|0|||
161342424|NCT02326883|582640194|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
160929271|NCT01641367|581136797|FG002|Cohorts|Lost to Follow-up|2|||
160929272|NCT01641367|581136798|FG003|Cohorts|Lost to Follow-up|0|||
160929273|NCT01641367|581136799|FG004|Cohorts|Lost to Follow-up|2|||
160929274|NCT01641367|581136800|FG005|Cohorts|Lost to Follow-up|0|||
160929275|NCT01641367|581136801|FG006|Cohorts|Lost to Follow-up|0|||
160929276|NCT01641367|581136802|FG007|Cohorts|Lost to Follow-up|0|||
160929277|NCT01641367|581136795|FG000|Randomized Adherence Intervention|Death|0|||
160929278|NCT01641367|581136796|FG001|Randomized Adherence Intervention|Death|0|||
160929279|NCT01641367|581136797|FG002|Randomized Adherence Intervention|Death|0|||
160929280|NCT01641367|581136798|FG003|Randomized Adherence Intervention|Death|0|||
160929281|NCT01641367|581136799|FG004|Randomized Adherence Intervention|Death|0|||
160929282|NCT01641367|581136800|FG005|Randomized Adherence Intervention|Death|0|||
160929283|NCT01641367|581136801|FG006|Randomized Adherence Intervention|Death|11|||
160929284|NCT01641367|581136802|FG007|Randomized Adherence Intervention|Death|12|||
160929285|NCT01641367|581136795|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929286|NCT01641367|581136796|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929287|NCT01641367|581136797|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929288|NCT01641367|581136798|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929289|NCT01641367|581136799|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929290|NCT01641367|581136800|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
160929291|NCT01641367|581136801|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
160929292|NCT01641367|581136802|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
160929293|NCT04920123|581136805|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
160929294|NCT04920123|581136806|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
160929295|NCT04920123|581136807|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
160929296|NCT00218296|581136813|FG000|Overall Study|Lost to Follow-up|9|||
160929297|NCT00218296|581136814|FG001|Overall Study|Lost to Follow-up|7|||
160929298|NCT00218296|581136813|FG000|Overall Study|Withdrawal by Subject|36|||
160929299|NCT00218296|581136814|FG001|Overall Study|Withdrawal by Subject|47|||
160929300|NCT00218296|581136813|FG000|Overall Study|Randomized but did not enter treatment|66|||
160929301|NCT00218296|581136814|FG001|Overall Study|Randomized but did not enter treatment|67|||
160929302|NCT02586493|581136818|FG000|Overall Study|Adverse Event|4|||
160929303|NCT02586493|581136818|FG000|Overall Study|Protocol Violation|6|||
160929304|NCT02586493|581136818|FG000|Overall Study|Lost to Follow-up|1|||
160929305|NCT02586493|581136818|FG000|Overall Study|Withdrawal by Subject|1|||
160929306|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
160929307|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
160929308|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
160929309|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
160929310|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
160929311|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
160929312|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
160929313|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
160929314|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
160929315|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
160929316|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
160929317|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
160929318|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
160929319|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
160929320|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
160929321|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Death|5|||
160929322|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Death|0|||
160929323|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Death|2|||
160929324|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Death|0|||
160929325|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Death|4|||
160929326|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
160929327|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
160929328|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
160929329|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
160929330|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
160929331|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
160929332|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
160929333|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
160929334|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
160929335|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
160929336|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
160929337|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
160929338|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
160929339|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
160929340|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
160929341|NCT01604343|581136832|FG000|Prior to W52 Administration(Through W52)|Other|15|||
160929342|NCT01604343|581136833|FG001|Prior to W52 Administration(Through W52)|Other|0|||
160929343|NCT01604343|581136834|FG002|Prior to W52 Administration(Through W52)|Other|10|||
160929344|NCT01604343|581136835|FG003|Prior to W52 Administration(Through W52)|Other|0|||
160929345|NCT01604343|581136836|FG004|Prior to W52 Administration(Through W52)|Other|6|||
160929346|NCT01604343|581136832|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
160929347|NCT01604343|581136833|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
160929348|NCT01604343|581136834|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
160929349|NCT01604343|581136835|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
161342425|NCT02326883|582640195|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
160929350|NCT01604343|581136836|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
160929351|NCT01604343|581136832|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
160929352|NCT01604343|581136833|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
160929353|NCT01604343|581136834|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
160929354|NCT01604343|581136835|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
160929355|NCT01604343|581136836|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
160929356|NCT01604343|581136832|FG000|Week 52 to Week 104|Adverse Event|0|||
160929357|NCT01604343|581136833|FG001|Week 52 to Week 104|Adverse Event|12|||
160929358|NCT01604343|581136834|FG002|Week 52 to Week 104|Adverse Event|26|||
160929359|NCT01604343|581136835|FG003|Week 52 to Week 104|Adverse Event|21|||
160929360|NCT01604343|581136836|FG004|Week 52 to Week 104|Adverse Event|27|||
160929361|NCT01604343|581136832|FG000|Week 52 to Week 104|Death|0|||
160929362|NCT01604343|581136833|FG001|Week 52 to Week 104|Death|4|||
160929363|NCT01604343|581136834|FG002|Week 52 to Week 104|Death|2|||
160929364|NCT01604343|581136835|FG003|Week 52 to Week 104|Death|5|||
160929365|NCT01604343|581136836|FG004|Week 52 to Week 104|Death|0|||
160929366|NCT01604343|581136832|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
160929367|NCT01604343|581136833|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
160929368|NCT01604343|581136834|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
160929369|NCT01604343|581136835|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
160929370|NCT01604343|581136836|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
160929371|NCT01604343|581136832|FG000|Week 52 to Week 104|Physician Decision|0|||
160929372|NCT01604343|581136833|FG001|Week 52 to Week 104|Physician Decision|1|||
160929373|NCT01604343|581136834|FG002|Week 52 to Week 104|Physician Decision|0|||
160929374|NCT01604343|581136835|FG003|Week 52 to Week 104|Physician Decision|0|||
160929375|NCT01604343|581136836|FG004|Week 52 to Week 104|Physician Decision|2|||
160929376|NCT01604343|581136832|FG000|Week 52 to Week 104|Pregnancy|0|||
160929377|NCT01604343|581136833|FG001|Week 52 to Week 104|Pregnancy|0|||
160929378|NCT01604343|581136834|FG002|Week 52 to Week 104|Pregnancy|1|||
160929379|NCT01604343|581136835|FG003|Week 52 to Week 104|Pregnancy|2|||
160929380|NCT01604343|581136836|FG004|Week 52 to Week 104|Pregnancy|1|||
160929381|NCT01604343|581136832|FG000|Week 52 to Week 104|Other|0|||
160929382|NCT01604343|581136833|FG001|Week 52 to Week 104|Other|11|||
160929383|NCT01604343|581136834|FG002|Week 52 to Week 104|Other|11|||
160929384|NCT01604343|581136835|FG003|Week 52 to Week 104|Other|6|||
160929385|NCT01604343|581136836|FG004|Week 52 to Week 104|Other|3|||
160929386|NCT01604343|581136832|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
160929387|NCT01604343|581136833|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
160929388|NCT01604343|581136834|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
160929389|NCT01604343|581136835|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
160929390|NCT01604343|581136836|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
160929391|NCT01604343|581136832|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
160929392|NCT01604343|581136833|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
160929393|NCT01604343|581136834|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
160929394|NCT01604343|581136835|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
160929395|NCT01604343|581136836|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
160929396|NCT01604343|581136832|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
160929397|NCT01604343|581136833|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
160929398|NCT01604343|581136834|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
160929399|NCT01604343|581136835|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
160929400|NCT01604343|581136836|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
160929401|NCT02711800|581136838|FG000|Overall Study|Lost to Follow-up|1|||
160929402|NCT02711800|581136838|FG000|Overall Study|Withdrawal by Subject|1|||
160929403|NCT01990495|581136848|FG000|Overall Study|Physician Decision|5|||
160929404|NCT01990495|581136849|FG001|Overall Study|Physician Decision|4|||
160929405|NCT00449956|581136850|FG000|Overall Study|Adverse Event|7|||
160929406|NCT00449956|581136851|FG001|Overall Study|Adverse Event|1|||
160929407|NCT00449956|581136852|FG002|Overall Study|Adverse Event|6|||
160929408|NCT00449956|581136850|FG000|Overall Study|Lack of Efficacy|0|||
160929409|NCT00449956|581136851|FG001|Overall Study|Lack of Efficacy|0|||
160929410|NCT00449956|581136852|FG002|Overall Study|Lack of Efficacy|1|||
160929411|NCT00449956|581136850|FG000|Overall Study|Protocol Violation|1|||
160929412|NCT00449956|581136851|FG001|Overall Study|Protocol Violation|1|||
160929413|NCT00449956|581136852|FG002|Overall Study|Protocol Violation|1|||
160998116|NCT02957539|581378567|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
160998117|NCT02957539|581378568|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
160929414|NCT00449956|581136850|FG000|Overall Study|Withdrawal by Subject|0|||
160929415|NCT00449956|581136851|FG001|Overall Study|Withdrawal by Subject|1|||
160929416|NCT00449956|581136852|FG002|Overall Study|Withdrawal by Subject|0|||
160929417|NCT00449956|581136850|FG000|Overall Study|Physician Decision|2|||
160929418|NCT00449956|581136851|FG001|Overall Study|Physician Decision|1|||
160929419|NCT00449956|581136852|FG002|Overall Study|Physician Decision|1|||
160929420|NCT01988571|581136857|FG000|Overall Study|Death|3|||
160929421|NCT01988571|581136858|FG001|Overall Study|Death|1|||
160929422|NCT01988571|581136857|FG000|Overall Study|Physician Decision|2|||
160929423|NCT01988571|581136858|FG001|Overall Study|Physician Decision|1|||
160929424|NCT01988571|581136857|FG000|Overall Study|Lost to Follow-up|3|||
160929425|NCT01988571|581136858|FG001|Overall Study|Lost to Follow-up|0|||
160929426|NCT01988571|581136857|FG000|Overall Study|Withdrawal by Subject|31|||
160929427|NCT01988571|581136858|FG001|Overall Study|Withdrawal by Subject|33|||
160929428|NCT00337103|581136860|FG000|Overall Study|Progressive Disease|414|||
160929429|NCT00337103|581136861|FG001|Overall Study|Progressive Disease|410|||
160929430|NCT00337103|581136860|FG000|Overall Study|Adverse Event|45|||
160929431|NCT00337103|581136861|FG001|Overall Study|Adverse Event|59|||
160929432|NCT00337103|581136860|FG000|Overall Study|Subject Choice|34|||
160929433|NCT00337103|581136861|FG001|Overall Study|Subject Choice|27|||
160929434|NCT00337103|581136860|FG000|Overall Study|Clinical Progression|27|||
160929435|NCT00337103|581136861|FG001|Overall Study|Clinical Progression|24|||
160929436|NCT00337103|581136860|FG000|Overall Study|Physician Decision|15|||
160929437|NCT00337103|581136861|FG001|Overall Study|Physician Decision|14|||
160929438|NCT00337103|581136860|FG000|Overall Study|Withdrawal by Subject|8|||
160929439|NCT00337103|581136861|FG001|Overall Study|Withdrawal by Subject|5|||
160929440|NCT00337103|581136860|FG000|Overall Study|Other|5|||
160929441|NCT00337103|581136861|FG001|Overall Study|Other|6|||
160929442|NCT00337103|581136860|FG000|Overall Study|Entry Criteria Not Met|4|||
160929443|NCT00337103|581136861|FG001|Overall Study|Entry Criteria Not Met|1|||
160929444|NCT00337103|581136860|FG000|Overall Study|Lost to Follow-up|1|||
160929445|NCT00337103|581136861|FG001|Overall Study|Lost to Follow-up|2|||
160929446|NCT00337103|581136860|FG000|Overall Study|Death|1|||
160929447|NCT00337103|581136861|FG001|Overall Study|Death|0|||
160929448|NCT03161483|581136866|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
160929449|NCT03161483|581136867|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
160929450|NCT03161483|581136868|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
160929451|NCT03161483|581136869|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
160929452|NCT03161483|581136866|FG000|Treatment Period|Death|1|||
160929453|NCT03161483|581136867|FG001|Treatment Period|Death|0|||
160929454|NCT03161483|581136868|FG002|Treatment Period|Death|0|||
160929455|NCT03161483|581136869|FG003|Treatment Period|Death|0|||
160929456|NCT03161483|581136866|FG000|Treatment Period|Adverse Event|5|||
160929457|NCT03161483|581136867|FG001|Treatment Period|Adverse Event|2|||
160929458|NCT03161483|581136868|FG002|Treatment Period|Adverse Event|1|||
160929459|NCT03161483|581136869|FG003|Treatment Period|Adverse Event|11|||
160929460|NCT03161483|581136866|FG000|Treatment Period|Pregnancy|1|||
160929461|NCT03161483|581136867|FG001|Treatment Period|Pregnancy|0|||
160929462|NCT03161483|581136868|FG002|Treatment Period|Pregnancy|0|||
160929463|NCT03161483|581136869|FG003|Treatment Period|Pregnancy|0|||
160929464|NCT03161483|581136866|FG000|Treatment Period|Lack of Efficacy|0|||
160929465|NCT03161483|581136867|FG001|Treatment Period|Lack of Efficacy|0|||
160929466|NCT03161483|581136868|FG002|Treatment Period|Lack of Efficacy|0|||
160929467|NCT03161483|581136869|FG003|Treatment Period|Lack of Efficacy|1|||
160929468|NCT03161483|581136866|FG000|Treatment Period|Withdrawal by Subject|2|||
160929469|NCT03161483|581136867|FG001|Treatment Period|Withdrawal by Subject|5|||
160929470|NCT03161483|581136868|FG002|Treatment Period|Withdrawal by Subject|2|||
160929471|NCT03161483|581136869|FG003|Treatment Period|Withdrawal by Subject|6|||
160929472|NCT03161483|581136866|FG000|Treatment Period|Lost to Follow-up|0|||
160929473|NCT03161483|581136867|FG001|Treatment Period|Lost to Follow-up|0|||
160929474|NCT03161483|581136868|FG002|Treatment Period|Lost to Follow-up|0|||
160929475|NCT03161483|581136869|FG003|Treatment Period|Lost to Follow-up|1|||
160929476|NCT03161483|581136866|FG000|Treatment Period|Protocol Violation|0|||
160929477|NCT03161483|581136867|FG001|Treatment Period|Protocol Violation|0|||
160929478|NCT03161483|581136868|FG002|Treatment Period|Protocol Violation|0|||
160929479|NCT03161483|581136869|FG003|Treatment Period|Protocol Violation|1|||
160929480|NCT03161483|581136866|FG000|Treatment Period|Other reasons|1|||
160929481|NCT03161483|581136867|FG001|Treatment Period|Other reasons|1|||
160929482|NCT03161483|581136868|FG002|Treatment Period|Other reasons|0|||
160929483|NCT03161483|581136869|FG003|Treatment Period|Other reasons|0|||
160929484|NCT00600756|581136875|FG000|Analysis After 6 Months|Adverse Event|43|||
160929485|NCT00600756|581136876|FG001|Analysis After 6 Months|Adverse Event|33|||
160929486|NCT00600756|581136875|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
160929487|NCT00600756|581136876|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
160929488|NCT00600756|581136875|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
160929489|NCT00600756|581136876|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
160929490|NCT00600756|581136875|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
160929491|NCT00600756|581136876|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
160929492|NCT00600756|581136875|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
160929493|NCT00600756|581136876|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
160929494|NCT00600756|581136875|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
160929495|NCT00600756|581136876|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
160929496|NCT00600756|581136875|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
160929497|NCT00600756|581136876|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
160929498|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
160929499|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
160929500|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
160929501|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
160929502|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
160929503|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
160929504|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
160929505|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
160929506|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
160929507|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
160929508|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
160929509|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
160929510|NCT00600756|581136875|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
160929511|NCT00600756|581136876|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
160929512|NCT03818516|581136877|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
160929513|NCT03742141|581136883|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
160929514|NCT01524692|581136886|FG000|Overall Study|Withdrawal by Subject|3|||
160929515|NCT01709695|581136888|FG000|Overall Study|Withdrawal by Subject|1|||
160929516|NCT01709695|581136889|FG001|Overall Study|Withdrawal by Subject|1|||
160929517|NCT03065244|581136893|FG000|Overall Study|Lost to Follow-up|1|||
160929518|NCT03065244|581136894|FG001|Overall Study|Lost to Follow-up|1|||
160929519|NCT03065244|581136893|FG000|Overall Study|Diagnosed with a different disease|1|||
160929520|NCT03065244|581136894|FG001|Overall Study|Diagnosed with a different disease|1|||
160929521|NCT03065244|581136893|FG000|Overall Study|Protocol Violation|0|||
160929522|NCT03065244|581136894|FG001|Overall Study|Protocol Violation|1|||
160929523|NCT03065244|581136893|FG000|Overall Study|Withdrawal by Subject|1|||
160929524|NCT03065244|581136894|FG001|Overall Study|Withdrawal by Subject|1|||
160929525|NCT03717480|581136895|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
160929526|NCT01894152|581136896|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
160929527|NCT01774786|581136898|FG000|Overall Study|Death|300|||
160929528|NCT01774786|581136899|FG001|Overall Study|Death|319|||
160929529|NCT01774786|581136898|FG000|Overall Study|Lost to Follow-up|6|||
160929530|NCT01774786|581136899|FG001|Overall Study|Lost to Follow-up|7|||
160929531|NCT01774786|581136898|FG000|Overall Study|Withdrawal by Subject|18|||
160929532|NCT01774786|581136899|FG001|Overall Study|Withdrawal by Subject|14|||
160929533|NCT01774786|581136898|FG000|Overall Study|Physician Decision|2|||
160929534|NCT01774786|581136899|FG001|Overall Study|Physician Decision|0|||
160929535|NCT01774786|581136898|FG000|Overall Study|Non-compliance|0|||
160929536|NCT01774786|581136899|FG001|Overall Study|Non-compliance|1|||
160929537|NCT01774786|581136898|FG000|Overall Study|Reason Not Specified|2|||
160929538|NCT01774786|581136899|FG001|Overall Study|Reason Not Specified|5|||
160929539|NCT04544293|581136900|FG000|Double-blind|Adverse Event|2|||
160929540|NCT04544293|581136901|FG001|Double-blind|Adverse Event|1|||
160929541|NCT04544293|581136900|FG000|Double-blind|Pregnancy|0|||
160929542|NCT04544293|581136901|FG001|Double-blind|Pregnancy|1|||
160929543|NCT04544293|581136900|FG000|Double-blind|Lost to Follow-up|0|||
160929544|NCT04544293|581136901|FG001|Double-blind|Lost to Follow-up|1|||
160929545|NCT04544293|581136900|FG000|Open-Label Extension|Study ongoing|79|||
160929546|NCT04544293|581136901|FG001|Open-Label Extension|Study ongoing|81|||
160929547|NCT01062555|581136906|FG000|Phase 1|Death|10|||
160929548|NCT01062555|581136907|FG001|Phase 1|Death|17|||
160929549|NCT01062555|581136908|FG002|Phase 1|Death|0|||
160929550|NCT01062555|581136909|FG003|Phase 1|Death|0|||
160929551|NCT01062555|581136906|FG000|Phase 1|Graft Failure|12|||
160929552|NCT01062555|581136907|FG001|Phase 1|Graft Failure|8|||
160929553|NCT01062555|581136908|FG002|Phase 1|Graft Failure|0|||
160929554|NCT01062555|581136909|FG003|Phase 1|Graft Failure|0|||
160929555|NCT01062555|581136906|FG000|Phase 1|Withdrawal by Subject|1|||
160929556|NCT01062555|581136907|FG001|Phase 1|Withdrawal by Subject|1|||
160929557|NCT01062555|581136908|FG002|Phase 1|Withdrawal by Subject|0|||
160929558|NCT01062555|581136909|FG003|Phase 1|Withdrawal by Subject|0|||
160929559|NCT01062555|581136906|FG000|Phase 2|Death|0|||
160929560|NCT01062555|581136907|FG001|Phase 2|Death|0|||
160929561|NCT01062555|581136908|FG002|Phase 2|Death|8|||
160929562|NCT01062555|581136909|FG003|Phase 2|Death|3|||
160929563|NCT01062555|581136906|FG000|Phase 2|Graft failure|0|||
160998118|NCT02957539|581378566|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
160998119|NCT02957539|581378567|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
160929564|NCT01062555|581136907|FG001|Phase 2|Graft failure|0|||
160929565|NCT01062555|581136908|FG002|Phase 2|Graft failure|7|||
160929566|NCT01062555|581136909|FG003|Phase 2|Graft failure|4|||
160929567|NCT01062555|581136906|FG000|Phase 2|Withdrawal by Subject|0|||
160929568|NCT01062555|581136907|FG001|Phase 2|Withdrawal by Subject|0|||
160929569|NCT01062555|581136908|FG002|Phase 2|Withdrawal by Subject|0|||
160929570|NCT01062555|581136909|FG003|Phase 2|Withdrawal by Subject|7|||
160929571|NCT01062555|581136906|FG000|Phase 2|Protocol Violation|0|||
160929572|NCT01062555|581136907|FG001|Phase 2|Protocol Violation|0|||
160929573|NCT01062555|581136908|FG002|Phase 2|Protocol Violation|0|||
160929574|NCT01062555|581136909|FG003|Phase 2|Protocol Violation|3|||
160929575|NCT01062555|581136906|FG000|Phase 2|Physician Decision|0|||
160929576|NCT01062555|581136907|FG001|Phase 2|Physician Decision|0|||
160929577|NCT01062555|581136908|FG002|Phase 2|Physician Decision|0|||
160929578|NCT01062555|581136909|FG003|Phase 2|Physician Decision|17|||
160929579|NCT00826267|581138460|FG000|Overall Study|Other Adverse Event|1|||
160929580|NCT00826267|581138461|FG001|Overall Study|Other Adverse Event|0|||
160929581|NCT00826267|581138462|FG002|Overall Study|Other Adverse Event|0|||
160929582|NCT05442554|581138463|FG000|Overall Study|Adverse Event|1|||
160929583|NCT01828034|581138464|FG000|Overall Study|Withdrawal by Subject|0|||
160929584|NCT01828034|581138465|FG001|Overall Study|Withdrawal by Subject|0|||
160929585|NCT01828034|581138466|FG002|Overall Study|Withdrawal by Subject|0|||
160929586|NCT01828034|581138467|FG003|Overall Study|Withdrawal by Subject|1|||
160929587|NCT00409617|581138474|FG000|Overall Study|Adverse Event|57|||
160929588|NCT00409617|581138474|FG000|Overall Study|Lack of Efficacy|54|||
160929589|NCT00409617|581138474|FG000|Overall Study|Lost to Follow-up|2|||
160929590|NCT00409617|581138474|FG000|Overall Study|Protocol Violation|24|||
160929591|NCT00409617|581138474|FG000|Overall Study|Withdrawal by Subject|8|||
160929592|NCT00409617|581138474|FG000|Overall Study|Administrative reasons|1|||
160929593|NCT00409617|581138474|FG000|Overall Study|Not described|14|||
160929594|NCT00149747|581138485|FG000|Overall Study|Death|1|||
160929595|NCT00149747|581138486|FG001|Overall Study|Death|0|||
160929596|NCT00149747|581138485|FG000|Overall Study|Withdrawal by Subject|3|||
160929597|NCT00149747|581138486|FG001|Overall Study|Withdrawal by Subject|3|||
160929598|NCT02689258|581138487|FG000|Overall Study|Subject Non-Compliance|0|||
160929599|NCT02689258|581138488|FG001|Overall Study|Subject Non-Compliance|1|||
160929600|NCT02689258|581138489|FG002|Overall Study|Subject Non-Compliance|0|||
160929601|NCT02689258|581138490|FG003|Overall Study|Subject Non-Compliance|0|||
160929602|NCT02689258|581138491|FG004|Overall Study|Subject Non-Compliance|0|||
160929603|NCT02689258|581138492|FG005|Overall Study|Subject Non-Compliance|0|||
160929604|NCT02689258|581138493|FG006|Overall Study|Subject Non-Compliance|0|||
160929605|NCT02689258|581138494|FG007|Overall Study|Subject Non-Compliance|0|||
160929606|NCT02689258|581138495|FG008|Overall Study|Subject Non-Compliance|0|||
160929607|NCT02689258|581138496|FG009|Overall Study|Subject Non-Compliance|0|||
160929608|NCT02689258|581138497|FG010|Overall Study|Subject Non-Compliance|0|||
160929609|NCT02689258|581138498|FG011|Overall Study|Subject Non-Compliance|0|||
160929610|NCT02689258|581138487|FG000|Overall Study|Subject Refusal to Continue|0|||
160929611|NCT02689258|581138488|FG001|Overall Study|Subject Refusal to Continue|1|||
160929612|NCT02689258|581138489|FG002|Overall Study|Subject Refusal to Continue|0|||
160929613|NCT02689258|581138490|FG003|Overall Study|Subject Refusal to Continue|0|||
160929614|NCT02689258|581138491|FG004|Overall Study|Subject Refusal to Continue|0|||
160929615|NCT02689258|581138492|FG005|Overall Study|Subject Refusal to Continue|0|||
160929616|NCT02689258|581138493|FG006|Overall Study|Subject Refusal to Continue|0|||
160929617|NCT02689258|581138494|FG007|Overall Study|Subject Refusal to Continue|0|||
160929618|NCT02689258|581138495|FG008|Overall Study|Subject Refusal to Continue|1|||
160929619|NCT02689258|581138496|FG009|Overall Study|Subject Refusal to Continue|0|||
160929620|NCT02689258|581138497|FG010|Overall Study|Subject Refusal to Continue|0|||
160929621|NCT02689258|581138498|FG011|Overall Study|Subject Refusal to Continue|1|||
160929622|NCT02689258|581138487|FG000|Overall Study|Other|0|||
160929623|NCT02689258|581138488|FG001|Overall Study|Other|2|||
160929624|NCT02689258|581138489|FG002|Overall Study|Other|0|||
160929625|NCT02689258|581138490|FG003|Overall Study|Other|0|||
160929626|NCT02689258|581138491|FG004|Overall Study|Other|1|||
160929627|NCT02689258|581138492|FG005|Overall Study|Other|0|||
160929628|NCT02689258|581138493|FG006|Overall Study|Other|0|||
160929629|NCT02689258|581138494|FG007|Overall Study|Other|0|||
160929630|NCT02689258|581138495|FG008|Overall Study|Other|1|||
160929631|NCT02689258|581138496|FG009|Overall Study|Other|0|||
160929632|NCT02689258|581138497|FG010|Overall Study|Other|0|||
160929633|NCT02689258|581138498|FG011|Overall Study|Other|0|||
160929634|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
160929635|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
160929636|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
160929637|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
160929638|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
160929639|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
160929640|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
160929641|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160929642|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160929643|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
160929644|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
160929645|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
160929646|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
160929647|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
160929648|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
160929649|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
160929650|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929651|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929652|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929653|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
160929654|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
160929655|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
160929656|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
160929657|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
160929658|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
160929659|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929660|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
160929661|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929662|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929663|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
160929664|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929665|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929666|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929667|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
160929668|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
160929669|NCT03373383|581138499|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
160929670|NCT03373383|581138500|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
160929671|NCT03373383|581138501|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
160929672|NCT03373383|581138502|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
160929673|NCT03373383|581138503|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
160929674|NCT03373383|581138499|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
160929675|NCT03373383|581138500|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929676|NCT03373383|581138501|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929677|NCT03373383|581138502|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929678|NCT03373383|581138503|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
160929679|NCT02159521|581138505|FG000|Overall Study|Enrolled but not treated|3|||
160929680|NCT02159521|581138505|FG000|Overall Study|Withdrawal by Subject|7|||
160929681|NCT02159521|581138505|FG000|Overall Study|Lost to Follow-up|6|||
160929682|NCT02159521|581138505|FG000|Overall Study|Death|1|||
160929683|NCT02159521|581138505|FG000|Overall Study|Other than specified|1|||
160929684|NCT00907374|581138508|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
160929685|NCT00907374|581138509|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
160929686|NCT00594464|581138510|FG000|Overall Study|Withdrawal by Subject|1|||
160929687|NCT00594464|581138510|FG000|Overall Study|Delay in operation|2|||
160929688|NCT00785486|581138511|FG000|Midazolam Alone|Withdrawal by Subject|1|||
160929689|NCT03131440|581138516|FG000|Overall Study|Withdrawal by Subject|1|||
160929690|NCT03131440|581138517|FG001|Overall Study|Withdrawal by Subject|3|||
160929691|NCT03131440|581138518|FG002|Overall Study|Withdrawal by Subject|0|||
160929692|NCT03131440|581138519|FG003|Overall Study|Withdrawal by Subject|0|||
160929693|NCT03131440|581138520|FG004|Overall Study|Withdrawal by Subject|1|||
160929694|NCT03131440|581138521|FG005|Overall Study|Withdrawal by Subject|0|||
160929695|NCT03131440|581138522|FG006|Overall Study|Withdrawal by Subject|0|||
160929696|NCT03131440|581138523|FG007|Overall Study|Withdrawal by Subject|1|||
160929697|NCT03131440|581138524|FG008|Overall Study|Withdrawal by Subject|1|||
160929698|NCT03131440|581138525|FG009|Overall Study|Withdrawal by Subject|1|||
160929699|NCT03131440|581138526|FG010|Overall Study|Withdrawal by Subject|0|||
160929700|NCT03131440|581138527|FG011|Overall Study|Withdrawal by Subject|1|||
160929701|NCT03131440|581138528|FG012|Overall Study|Withdrawal by Subject|1|||
160929702|NCT03131440|581138529|FG013|Overall Study|Withdrawal by Subject|0|||
160929703|NCT03131440|581138530|FG014|Overall Study|Withdrawal by Subject|1|||
160929704|NCT03131440|581138531|FG015|Overall Study|Withdrawal by Subject|0|||
160929705|NCT03131440|581138532|FG016|Overall Study|Withdrawal by Subject|0|||
160929706|NCT03131440|581138533|FG017|Overall Study|Withdrawal by Subject|0|||
160929707|NCT03131440|581138534|FG018|Overall Study|Withdrawal by Subject|1|||
160929708|NCT03131440|581138535|FG019|Overall Study|Withdrawal by Subject|0|||
160929709|NCT03131440|581138536|FG020|Overall Study|Withdrawal by Subject|1|||
160929710|NCT03131440|581138537|FG021|Overall Study|Withdrawal by Subject|1|||
160929711|NCT03131440|581138538|FG022|Overall Study|Withdrawal by Subject|1|||
160929712|NCT03131440|581138539|FG023|Overall Study|Withdrawal by Subject|0|||
160929713|NCT03131440|581138540|FG024|Overall Study|Withdrawal by Subject|0|||
161143620|NCT03043365|581909428|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
160929714|NCT03131440|581138541|FG025|Overall Study|Withdrawal by Subject|0|||
160929715|NCT03131440|581138542|FG026|Overall Study|Withdrawal by Subject|0|||
160929716|NCT03131440|581138543|FG027|Overall Study|Withdrawal by Subject|0|||
160929717|NCT03131440|581138544|FG028|Overall Study|Withdrawal by Subject|0|||
160929718|NCT03131440|581138545|FG029|Overall Study|Withdrawal by Subject|0|||
160929719|NCT03131440|581138546|FG030|Overall Study|Withdrawal by Subject|1|||
160929720|NCT03131440|581138547|FG031|Overall Study|Withdrawal by Subject|0|||
160929721|NCT03131440|581138516|FG000|Overall Study|Lost to Follow-up|0|||
160998120|NCT02957539|581378568|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
160929722|NCT03131440|581138517|FG001|Overall Study|Lost to Follow-up|0|||
160929723|NCT03131440|581138518|FG002|Overall Study|Lost to Follow-up|0|||
160929724|NCT03131440|581138519|FG003|Overall Study|Lost to Follow-up|0|||
160929725|NCT03131440|581138520|FG004|Overall Study|Lost to Follow-up|0|||
160929726|NCT03131440|581138521|FG005|Overall Study|Lost to Follow-up|1|||
160929727|NCT03131440|581138522|FG006|Overall Study|Lost to Follow-up|0|||
160929728|NCT03131440|581138523|FG007|Overall Study|Lost to Follow-up|0|||
160929729|NCT03131440|581138524|FG008|Overall Study|Lost to Follow-up|0|||
160929730|NCT03131440|581138525|FG009|Overall Study|Lost to Follow-up|0|||
160929731|NCT03131440|581138526|FG010|Overall Study|Lost to Follow-up|0|||
160929732|NCT03131440|581138527|FG011|Overall Study|Lost to Follow-up|0|||
160929733|NCT03131440|581138528|FG012|Overall Study|Lost to Follow-up|0|||
160929734|NCT03131440|581138529|FG013|Overall Study|Lost to Follow-up|0|||
160929735|NCT03131440|581138530|FG014|Overall Study|Lost to Follow-up|0|||
160929736|NCT03131440|581138531|FG015|Overall Study|Lost to Follow-up|0|||
160929737|NCT03131440|581138532|FG016|Overall Study|Lost to Follow-up|0|||
160929738|NCT03131440|581138533|FG017|Overall Study|Lost to Follow-up|0|||
160929739|NCT03131440|581138534|FG018|Overall Study|Lost to Follow-up|0|||
160929740|NCT03131440|581138535|FG019|Overall Study|Lost to Follow-up|2|||
160929741|NCT03131440|581138536|FG020|Overall Study|Lost to Follow-up|1|||
160929742|NCT03131440|581138537|FG021|Overall Study|Lost to Follow-up|0|||
160929743|NCT03131440|581138538|FG022|Overall Study|Lost to Follow-up|1|||
160929744|NCT03131440|581138539|FG023|Overall Study|Lost to Follow-up|0|||
160929745|NCT03131440|581138540|FG024|Overall Study|Lost to Follow-up|1|||
160929746|NCT03131440|581138541|FG025|Overall Study|Lost to Follow-up|0|||
160929747|NCT03131440|581138542|FG026|Overall Study|Lost to Follow-up|0|||
160929748|NCT03131440|581138543|FG027|Overall Study|Lost to Follow-up|2|||
160929749|NCT03131440|581138544|FG028|Overall Study|Lost to Follow-up|0|||
160929750|NCT03131440|581138545|FG029|Overall Study|Lost to Follow-up|2|||
160929751|NCT03131440|581138546|FG030|Overall Study|Lost to Follow-up|0|||
160929752|NCT03131440|581138547|FG031|Overall Study|Lost to Follow-up|0|||
160929753|NCT03131440|581138516|FG000|Overall Study|Death|0|||
160929754|NCT03131440|581138517|FG001|Overall Study|Death|0|||
160929755|NCT03131440|581138518|FG002|Overall Study|Death|0|||
160929756|NCT03131440|581138519|FG003|Overall Study|Death|0|||
160929757|NCT03131440|581138520|FG004|Overall Study|Death|0|||
160929758|NCT03131440|581138521|FG005|Overall Study|Death|0|||
160929759|NCT03131440|581138522|FG006|Overall Study|Death|0|||
160929760|NCT03131440|581138523|FG007|Overall Study|Death|0|||
160929761|NCT03131440|581138524|FG008|Overall Study|Death|0|||
160929762|NCT03131440|581138525|FG009|Overall Study|Death|0|||
160929763|NCT03131440|581138526|FG010|Overall Study|Death|0|||
160929764|NCT03131440|581138527|FG011|Overall Study|Death|0|||
160929765|NCT03131440|581138528|FG012|Overall Study|Death|0|||
160929766|NCT03131440|581138529|FG013|Overall Study|Death|0|||
160929767|NCT03131440|581138530|FG014|Overall Study|Death|0|||
160929768|NCT03131440|581138531|FG015|Overall Study|Death|0|||
160929769|NCT03131440|581138532|FG016|Overall Study|Death|0|||
160929770|NCT03131440|581138533|FG017|Overall Study|Death|0|||
160929771|NCT03131440|581138534|FG018|Overall Study|Death|0|||
160929772|NCT03131440|581138535|FG019|Overall Study|Death|0|||
160929773|NCT03131440|581138536|FG020|Overall Study|Death|0|||
160929774|NCT03131440|581138537|FG021|Overall Study|Death|0|||
160929775|NCT03131440|581138538|FG022|Overall Study|Death|0|||
160929776|NCT03131440|581138539|FG023|Overall Study|Death|0|||
160929777|NCT03131440|581138540|FG024|Overall Study|Death|0|||
160929778|NCT03131440|581138541|FG025|Overall Study|Death|1|||
160929779|NCT03131440|581138542|FG026|Overall Study|Death|0|||
160929780|NCT03131440|581138543|FG027|Overall Study|Death|0|||
160929781|NCT03131440|581138544|FG028|Overall Study|Death|0|||
160929782|NCT03131440|581138545|FG029|Overall Study|Death|0|||
160929783|NCT03131440|581138546|FG030|Overall Study|Death|0|||
160929784|NCT03131440|581138547|FG031|Overall Study|Death|0|||
161264209|NCT02335983|582349169|FG002|Overall Study|Protocol Specified Criteria|27|||
160929785|NCT00746941|581138550|FG000|Overall Study|Death|2|||
160929786|NCT00746941|581138551|FG001|Overall Study|Death|0|||
160929787|NCT00746941|581138552|FG002|Overall Study|Death|0|||
160929788|NCT00746941|581138553|FG003|Overall Study|Death|6|||
160929789|NCT00746941|581138550|FG000|Overall Study|Physician Decision|0|||
160929790|NCT00746941|581138551|FG001|Overall Study|Physician Decision|0|||
160929791|NCT00746941|581138552|FG002|Overall Study|Physician Decision|2|||
160929792|NCT00746941|581138553|FG003|Overall Study|Physician Decision|0|||
160929793|NCT00746941|581138550|FG000|Overall Study|Withdrawal by Subject|3|||
160929794|NCT00746941|581138551|FG001|Overall Study|Withdrawal by Subject|0|||
160929795|NCT00746941|581138552|FG002|Overall Study|Withdrawal by Subject|0|||
161264210|NCT02335983|582349170|FG003|Overall Study|Protocol Specified Criteria|7|||
161264211|NCT02335983|582349171|FG004|Overall Study|Protocol Specified Criteria|5|||
160929796|NCT00746941|581138553|FG003|Overall Study|Withdrawal by Subject|2|||
160929797|NCT00746941|581138550|FG000|Overall Study|Other, reason not provided|2|||
160929798|NCT00746941|581138551|FG001|Overall Study|Other, reason not provided|4|||
160929799|NCT00746941|581138552|FG002|Overall Study|Other, reason not provided|0|||
160929800|NCT00746941|581138553|FG003|Overall Study|Other, reason not provided|4|||
160929801|NCT00746941|581138550|FG000|Overall Study|Adverse Event|0|||
160929802|NCT00746941|581138551|FG001|Overall Study|Adverse Event|0|||
160929803|NCT00746941|581138552|FG002|Overall Study|Adverse Event|0|||
160929804|NCT00746941|581138553|FG003|Overall Study|Adverse Event|1|||
160929805|NCT02741700|581138558|FG000|Overall Study|Lost to Follow-up|17|||
160929806|NCT02741700|581138559|FG001|Overall Study|Lost to Follow-up|8|||
160929807|NCT02741700|581138558|FG000|Overall Study|Withdrawal by Subject|2|||
160929808|NCT02741700|581138559|FG001|Overall Study|Withdrawal by Subject|5|||
160929809|NCT02741700|581138558|FG000|Overall Study|Physician Decision|3|||
160929810|NCT02741700|581138559|FG001|Overall Study|Physician Decision|0|||
160929811|NCT02741700|581138558|FG000|Overall Study|Moved out of State|0|||
160929812|NCT02741700|581138559|FG001|Overall Study|Moved out of State|1|||
160929813|NCT02741700|581138558|FG000|Overall Study|Death|4|||
160929814|NCT02741700|581138559|FG001|Overall Study|Death|5|||
160929815|NCT00075582|581138560|FG000|Overall Study|Adverse Event|3|||
160929816|NCT00075582|581138561|FG001|Overall Study|Adverse Event|1|||
160929817|NCT00075582|581138560|FG000|Overall Study|Lack of Efficacy|4|||
160929818|NCT00075582|581138561|FG001|Overall Study|Lack of Efficacy|8|||
160929819|NCT00075582|581138560|FG000|Overall Study|Physician Decision|5|||
160929820|NCT00075582|581138561|FG001|Overall Study|Physician Decision|8|||
160929821|NCT00075582|581138560|FG000|Overall Study|Withdrawal by Subject|2|||
160929822|NCT00075582|581138561|FG001|Overall Study|Withdrawal by Subject|2|||
160929823|NCT00075582|581138560|FG000|Overall Study|Ineligible for study|36|||
160929824|NCT00075582|581138561|FG001|Overall Study|Ineligible for study|16|||
160929825|NCT05045144|581138562|FG000|Overall Study|Lost to Follow-up|3|||
160929826|NCT05045144|581138563|FG001|Overall Study|Lost to Follow-up|2|||
160929827|NCT05045144|581138564|FG002|Overall Study|Lost to Follow-up|3|||
160929828|NCT05045144|581138565|FG003|Overall Study|Lost to Follow-up|5|||
160929829|NCT05045144|581138566|FG004|Overall Study|Lost to Follow-up|13|||
160929830|NCT05045144|581138562|FG000|Overall Study|Withdrawal by Subject|0|||
160929831|NCT05045144|581138563|FG001|Overall Study|Withdrawal by Subject|1|||
160929832|NCT05045144|581138564|FG002|Overall Study|Withdrawal by Subject|0|||
160929833|NCT05045144|581138565|FG003|Overall Study|Withdrawal by Subject|0|||
160929834|NCT05045144|581138566|FG004|Overall Study|Withdrawal by Subject|0|||
160929835|NCT05045144|581138562|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929836|NCT05045144|581138563|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929837|NCT05045144|581138564|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160929838|NCT05045144|581138565|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929839|NCT05045144|581138566|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
160929840|NCT02385084|581138567|FG000|Period 2|Protocol Violation|0|||
160929841|NCT02385084|581138568|FG001|Period 2|Protocol Violation|0|||
160929842|NCT02385084|581138569|FG002|Period 2|Protocol Violation|1|||
160929843|NCT02385084|581138570|FG003|Period 2|Protocol Violation|0|||
160929844|NCT02385084|581138571|FG004|Period 2|Protocol Violation|0|||
160929845|NCT02385084|581138572|FG005|Period 2|Protocol Violation|0|||
160929846|NCT02268786|581138573|FG000|Overall Study|No Euploid Embryos available|42|||
160929847|NCT02268786|581138574|FG001|Overall Study|No Euploid Embryos available|0|||
160929848|NCT02268786|581138573|FG000|Overall Study|Withdrawal by Subject|7|||
160929849|NCT02268786|581138574|FG001|Overall Study|Withdrawal by Subject|14|||
160929850|NCT02268786|581138573|FG000|Overall Study|Thaw Failure|6|||
160929851|NCT02268786|581138574|FG001|Overall Study|Thaw Failure|4|||
160929852|NCT02268786|581138573|FG000|Overall Study|Protocol Violation|1|||
160929853|NCT02268786|581138574|FG001|Overall Study|Protocol Violation|0|||
160929854|NCT00744627|581138575|FG000|Overall Study|Adverse Event|6|||
160929855|NCT00744627|581138576|FG001|Overall Study|Adverse Event|9|||
160929856|NCT00744627|581138575|FG000|Overall Study|Lack of Efficacy|7|||
160929857|NCT00744627|581138576|FG001|Overall Study|Lack of Efficacy|3|||
160929858|NCT00744627|581138575|FG000|Overall Study|Noncompliance|0|||
160929859|NCT00744627|581138576|FG001|Overall Study|Noncompliance|1|||
160929860|NCT00744627|581138575|FG000|Overall Study|Protocol Deviations|0|||
160929861|NCT00744627|581138576|FG001|Overall Study|Protocol Deviations|2|||
160929862|NCT00744627|581138575|FG000|Overall Study|Voluntary Withdrawal|9|||
160929863|NCT00744627|581138576|FG001|Overall Study|Voluntary Withdrawal|6|||
160929864|NCT00744627|581138575|FG000|Overall Study|Lost to Follow-up|2|||
160929865|NCT00744627|581138576|FG001|Overall Study|Lost to Follow-up|1|||
160929866|NCT00744627|581138575|FG000|Overall Study|Other|1|||
160929867|NCT00744627|581138576|FG001|Overall Study|Other|0|||
160929868|NCT04809220|581138579|FG000|Overall Study|Adverse Event|4|||
160929869|NCT04809220|581138580|FG001|Overall Study|Adverse Event|0|||
160929870|NCT04809220|581138579|FG000|Overall Study|Death|1|||
160929871|NCT04809220|581138580|FG001|Overall Study|Death|0|||
160929872|NCT04809220|581138579|FG000|Overall Study|Lost to Follow-up|3|||
160929873|NCT04809220|581138580|FG001|Overall Study|Lost to Follow-up|0|||
160929874|NCT04809220|581138579|FG000|Overall Study|Physician Decision|0|||
160929875|NCT04809220|581138580|FG001|Overall Study|Physician Decision|1|||
160929876|NCT04809220|581138579|FG000|Overall Study|Withdrawal by Subject|9|||
160929877|NCT04809220|581138580|FG001|Overall Study|Withdrawal by Subject|5|||
160929878|NCT04809220|581138579|FG000|Overall Study|Due to long-term overseas business trips|1|||
160929879|NCT04809220|581138580|FG001|Overall Study|Due to long-term overseas business trips|0|||
160929880|NCT03560531|581138585|FG000|Overall Study|Death|4|||
160929881|NCT03560531|581138586|FG001|Overall Study|Death|1|||
160929882|NCT03560531|581138587|FG002|Overall Study|Death|1|||
160929883|NCT03560531|581138588|FG003|Overall Study|Death|2|||
160929884|NCT03560531|581138589|FG004|Overall Study|Death|6|||
160929885|NCT03560531|581138590|FG005|Overall Study|Death|1|||
160929886|NCT03560531|581138591|FG006|Overall Study|Death|4|||
160929887|NCT03560531|581138592|FG007|Overall Study|Death|8|||
160929888|NCT03560531|581138593|FG008|Overall Study|Death|1|||
160929889|NCT03560531|581138594|FG009|Overall Study|Death|3|||
160929890|NCT03560531|581138595|FG010|Overall Study|Death|2|||
160929891|NCT03560531|581138596|FG011|Overall Study|Death|0|||
160929892|NCT03560531|581138597|FG012|Overall Study|Death|4|||
160929893|NCT03560531|581138598|FG013|Overall Study|Death|1|||
160929894|NCT03560531|581138585|FG000|Overall Study|Lost to Follow-up|1|||
160929895|NCT03560531|581138586|FG001|Overall Study|Lost to Follow-up|1|||
160929896|NCT03560531|581138587|FG002|Overall Study|Lost to Follow-up|0|||
160929897|NCT03560531|581138588|FG003|Overall Study|Lost to Follow-up|0|||
160929898|NCT03560531|581138589|FG004|Overall Study|Lost to Follow-up|0|||
160929899|NCT03560531|581138590|FG005|Overall Study|Lost to Follow-up|0|||
160929900|NCT03560531|581138591|FG006|Overall Study|Lost to Follow-up|1|||
160929901|NCT03560531|581138592|FG007|Overall Study|Lost to Follow-up|0|||
160929902|NCT03560531|581138593|FG008|Overall Study|Lost to Follow-up|0|||
160929903|NCT03560531|581138594|FG009|Overall Study|Lost to Follow-up|0|||
160929904|NCT03560531|581138595|FG010|Overall Study|Lost to Follow-up|0|||
160929905|NCT03560531|581138596|FG011|Overall Study|Lost to Follow-up|0|||
160929906|NCT03560531|581138597|FG012|Overall Study|Lost to Follow-up|0|||
160929907|NCT03560531|581138598|FG013|Overall Study|Lost to Follow-up|0|||
160929908|NCT03560531|581138585|FG000|Overall Study|Withdrawal by Subject|1|||
160929909|NCT03560531|581138586|FG001|Overall Study|Withdrawal by Subject|0|||
160929910|NCT03560531|581138587|FG002|Overall Study|Withdrawal by Subject|0|||
160929911|NCT03560531|581138588|FG003|Overall Study|Withdrawal by Subject|0|||
160929912|NCT03560531|581138589|FG004|Overall Study|Withdrawal by Subject|0|||
160929913|NCT03560531|581138590|FG005|Overall Study|Withdrawal by Subject|0|||
160929914|NCT03560531|581138591|FG006|Overall Study|Withdrawal by Subject|0|||
160929915|NCT03560531|581138592|FG007|Overall Study|Withdrawal by Subject|3|||
160929916|NCT03560531|581138593|FG008|Overall Study|Withdrawal by Subject|2|||
160929917|NCT03560531|581138594|FG009|Overall Study|Withdrawal by Subject|0|||
160929918|NCT03560531|581138595|FG010|Overall Study|Withdrawal by Subject|0|||
160929919|NCT03560531|581138596|FG011|Overall Study|Withdrawal by Subject|0|||
160929920|NCT03560531|581138597|FG012|Overall Study|Withdrawal by Subject|2|||
160929921|NCT03560531|581138598|FG013|Overall Study|Withdrawal by Subject|0|||
160929922|NCT03560531|581138585|FG000|Overall Study|Study end per-protocol|1|||
160929923|NCT03560531|581138586|FG001|Overall Study|Study end per-protocol|1|||
160929924|NCT03560531|581138587|FG002|Overall Study|Study end per-protocol|2|||
160929925|NCT03560531|581138588|FG003|Overall Study|Study end per-protocol|0|||
160929926|NCT03560531|581138589|FG004|Overall Study|Study end per-protocol|1|||
160929927|NCT03560531|581138590|FG005|Overall Study|Study end per-protocol|0|||
160929928|NCT03560531|581138591|FG006|Overall Study|Study end per-protocol|0|||
160929929|NCT03560531|581138592|FG007|Overall Study|Study end per-protocol|0|||
160929930|NCT03560531|581138593|FG008|Overall Study|Study end per-protocol|0|||
160929931|NCT03560531|581138594|FG009|Overall Study|Study end per-protocol|0|||
160929932|NCT03560531|581138595|FG010|Overall Study|Study end per-protocol|0|||
160929933|NCT03560531|581138596|FG011|Overall Study|Study end per-protocol|0|||
160929934|NCT03560531|581138597|FG012|Overall Study|Study end per-protocol|0|||
160929935|NCT03560531|581138598|FG013|Overall Study|Study end per-protocol|0|||
160929936|NCT03560531|581138585|FG000|Overall Study|Early study termination by sponsor|9|||
160929937|NCT03560531|581138586|FG001|Overall Study|Early study termination by sponsor|0|||
160929938|NCT03560531|581138587|FG002|Overall Study|Early study termination by sponsor|0|||
160929939|NCT03560531|581138588|FG003|Overall Study|Early study termination by sponsor|4|||
160929940|NCT03560531|581138589|FG004|Overall Study|Early study termination by sponsor|8|||
160929941|NCT03560531|581138590|FG005|Overall Study|Early study termination by sponsor|2|||
160929942|NCT03560531|581138591|FG006|Overall Study|Early study termination by sponsor|5|||
160929943|NCT03560531|581138592|FG007|Overall Study|Early study termination by sponsor|64|||
160929944|NCT03560531|581138593|FG008|Overall Study|Early study termination by sponsor|7|||
160929945|NCT03560531|581138594|FG009|Overall Study|Early study termination by sponsor|2|||
160929946|NCT03560531|581138595|FG010|Overall Study|Early study termination by sponsor|16|||
160929947|NCT03560531|581138596|FG011|Overall Study|Early study termination by sponsor|2|||
160929948|NCT03560531|581138597|FG012|Overall Study|Early study termination by sponsor|6|||
160929949|NCT03560531|581138598|FG013|Overall Study|Early study termination by sponsor|2|||
160929950|NCT02968979|581138599|FG000|Overall Study|Protocol Violation|7|||
160929951|NCT02968979|581138599|FG000|Overall Study|Withdrawal by Subject|1|||
160929952|NCT01471379|581138600|FG000|Overall Study|Adverse Event|1|||
160929953|NCT01471379|581138601|FG001|Overall Study|Adverse Event|0|||
160929954|NCT01471379|581138602|FG002|Overall Study|Adverse Event|0|||
160929955|NCT01471379|581138600|FG000|Overall Study|Study terminated|0|||
160929956|NCT01471379|581138601|FG001|Overall Study|Study terminated|1|||
160929957|NCT01471379|581138602|FG002|Overall Study|Study terminated|0|||
160929958|NCT00729183|581138603|FG000|Overall Study|Adverse Event|11|||
160929959|NCT00729183|581138604|FG001|Overall Study|Adverse Event|5|||
160929960|NCT00729183|581138603|FG000|Overall Study|Lack of Efficacy|0|||
160929961|NCT00729183|581138604|FG001|Overall Study|Lack of Efficacy|1|||
160929962|NCT00729183|581138603|FG000|Overall Study|Lost to Follow-up|3|||
160929963|NCT00729183|581138604|FG001|Overall Study|Lost to Follow-up|1|||
160929964|NCT00729183|581138603|FG000|Overall Study|Physician Decision|1|||
160929965|NCT00729183|581138604|FG001|Overall Study|Physician Decision|1|||
160929966|NCT00729183|581138603|FG000|Overall Study|Protocol Violation|1|||
160929967|NCT00729183|581138604|FG001|Overall Study|Protocol Violation|0|||
160929968|NCT00729183|581138603|FG000|Overall Study|Withdrawal by Subject|9|||
160929969|NCT00729183|581138604|FG001|Overall Study|Withdrawal by Subject|7|||
160929970|NCT01200797|581138613|FG000|Overall Study|symptomatic deterioration|2|||
160929971|NCT01200797|581138613|FG000|Overall Study|Adverse Event|4|||
160929972|NCT01200797|581138613|FG000|Overall Study|Disease Progression|13|||
160929973|NCT03745144|581138616|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
160929974|NCT03745144|581138617|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
160929975|NCT03745144|581138618|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
160929976|NCT03745144|581138616|FG000|Period 1|Other|0|||
160929977|NCT03745144|581138617|FG001|Period 1|Other|0|||
160929978|NCT03745144|581138618|FG002|Period 1|Other|1|||
160929979|NCT00642668|581138623|FG000|Overall Study|Lost to Follow-up|1|||
160929980|NCT00642668|581138623|FG000|Overall Study|Adverse Event|2|||
160929981|NCT00642668|581138623|FG000|Overall Study|Death|2|||
160929982|NCT00642668|581138623|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160929983|NCT00642668|581138623|FG000|Overall Study|Failure to Return|1|||
160929984|NCT00642668|581138623|FG000|Overall Study|Dialysis Initiation|5|||
160929985|NCT00642668|581138623|FG000|Overall Study|Blood Transfusion|2|||
160929986|NCT00896337|581138624|FG000|Overall Study|Death|7|||
160929987|NCT00896337|581138624|FG000|Overall Study|Withdrawal by Subject|7|||
160929988|NCT00896337|581138624|FG000|Overall Study|Lost to Follow-up|11|||
160929989|NCT02818777|581138631|FG000|Overall Study|Adverse Event|3|||
160929990|NCT00747435|581138632|FG000|Overall Study|Lost to Follow-up|2|||
160929991|NCT00747435|581138632|FG000|Overall Study|Withdrawal by Subject|3|||
160929992|NCT00747435|581138632|FG000|Overall Study|Still undergoing follow up|1|||
160929993|NCT01324349|581138633|FG000|Overall Study|Death|1|||
160929994|NCT01324349|581138634|FG001|Overall Study|Death|1|||
160929995|NCT01324349|581138633|FG000|Overall Study|Withdrawal by Subject|0|||
160929996|NCT01324349|581138634|FG001|Overall Study|Withdrawal by Subject|1|||
160929997|NCT04151290|581138639|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
160929998|NCT02276612|581138640|FG000|Overall Study|Death|1|||
160929999|NCT02276612|581138641|FG001|Overall Study|Death|0|||
160930000|NCT02276612|581138640|FG000|Overall Study|Pregnancy|1|||
160930001|NCT02276612|581138641|FG001|Overall Study|Pregnancy|0|||
160930002|NCT02276612|581138640|FG000|Overall Study|Withdrew Consent|1|||
160930003|NCT02276612|581138641|FG001|Overall Study|Withdrew Consent|0|||
160930004|NCT02276612|581138640|FG000|Overall Study|Lost to Follow-up|1|||
160930005|NCT02276612|581138641|FG001|Overall Study|Lost to Follow-up|0|||
160930006|NCT04380857|581140217|FG000|Overall Study|Lost to Follow-up|3|||
160930007|NCT04380857|581140218|FG001|Overall Study|Lost to Follow-up|3|||
160930008|NCT02558790|581140219|FG000|Overall Study|Lost to Follow-up|2|||
160930009|NCT02558790|581140219|FG000|Overall Study|Physician Decision|1|||
160930010|NCT02558790|581140219|FG000|Overall Study|Withdrawal by Subject|1|||
160930011|NCT02558790|581140219|FG000|Overall Study|Screen Fail|3|||
160930012|NCT05083442|581140220|FG000|Overall Study|Lost to Follow-up|1|||
160930013|NCT05083442|581140221|FG001|Overall Study|Lost to Follow-up|0|||
160930014|NCT05083442|581140220|FG000|Overall Study|Lack of Efficacy|0|||
160930015|NCT05083442|581140221|FG001|Overall Study|Lack of Efficacy|1|||
160930016|NCT05083442|581140220|FG000|Overall Study|Withdrawal by Subject|1|||
160930017|NCT05083442|581140221|FG001|Overall Study|Withdrawal by Subject|3|||
160930018|NCT05083442|581140220|FG000|Overall Study|scheduling difficulties|1|||
160930019|NCT05083442|581140221|FG001|Overall Study|scheduling difficulties|2|||
160930020|NCT04865354|581140229|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
160930021|NCT04865354|581140230|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
160930022|NCT04865354|581140229|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
160930023|NCT04865354|581140230|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
160930024|NCT04865354|581140229|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
160930025|NCT04865354|581140230|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
160930026|NCT01886833|581140231|FG000|Overall Study|IgA not available from both periods|204|||
160930027|NCT01454726|581140232|FG000|Overall Study|Withdrawal by Subject|0|||
160930028|NCT01454726|581140233|FG001|Overall Study|Withdrawal by Subject|1|||
160930029|NCT04476030|581140236|FG000|Overall Study|Withdrawal by Subject|20|||
160930030|NCT04476030|581140237|FG001|Overall Study|Withdrawal by Subject|16|||
160930031|NCT04476030|581140236|FG000|Overall Study|Adverse Event|10|||
160930032|NCT04476030|581140237|FG001|Overall Study|Adverse Event|11|||
160930033|NCT04476030|581140236|FG000|Overall Study|Lost to Follow-up|7|||
160930034|NCT04476030|581140237|FG001|Overall Study|Lost to Follow-up|4|||
160930035|NCT04476030|581140236|FG000|Overall Study|Physician Decision|1|||
160930036|NCT04476030|581140237|FG001|Overall Study|Physician Decision|1|||
160930037|NCT04476030|581140236|FG000|Overall Study|Protocol Deviation|2|||
160930038|NCT04476030|581140237|FG001|Overall Study|Protocol Deviation|0|||
160930039|NCT04476030|581140236|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
160930040|NCT04476030|581140237|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
160930041|NCT04476030|581140236|FG000|Overall Study|Randomized but not Dosed|2|||
160930042|NCT04476030|581140237|FG001|Overall Study|Randomized but not Dosed|8|||
160930043|NCT02342704|581140238|FG000|Overall Study|Physician Decision|0|||
160930044|NCT02342704|581140239|FG001|Overall Study|Physician Decision|3|||
160930045|NCT02342704|581140238|FG000|Overall Study|Sponsor Termination|49|||
160930046|NCT02342704|581140239|FG001|Overall Study|Sponsor Termination|43|||
160930047|NCT02342704|581140238|FG000|Overall Study|Other|0|||
160930048|NCT02342704|581140239|FG001|Overall Study|Other|1|||
160930049|NCT02342704|581140238|FG000|Overall Study|Withdrawal by Subject|1|||
160930050|NCT02342704|581140239|FG001|Overall Study|Withdrawal by Subject|0|||
160930051|NCT02342704|581140238|FG000|Overall Study|Lost to Follow-up|2|||
160930052|NCT02342704|581140239|FG001|Overall Study|Lost to Follow-up|1|||
160930053|NCT02342704|581140238|FG000|Overall Study|Adverse Event|1|||
160930054|NCT02342704|581140239|FG001|Overall Study|Adverse Event|3|||
160930055|NCT00302003|581140241|FG000|Overall Study|Lack of Efficacy|62|||
160930056|NCT00302003|581140241|FG000|Overall Study|Lost to Follow-up|1|||
160930057|NCT00302003|581140241|FG000|Overall Study|Physician Decision|2|||
161143621|NCT03043365|581909429|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
161143622|NCT02723630|581909430|FG000|Intervention Period 1|Adverse Event|1|||
161143623|NCT02723630|581909431|FG001|Intervention Period 1|Adverse Event|0|||
161143624|NCT02723630|581909432|FG002|Intervention Period 1|Adverse Event|0|||
161143625|NCT02723630|581909433|FG003|Intervention Period 1|Adverse Event|0|||
161143626|NCT02723630|581909434|FG004|Intervention Period 1|Adverse Event|0|||
161143627|NCT02723630|581909435|FG005|Intervention Period 1|Adverse Event|0|||
161143628|NCT02723630|581909430|FG000|Intervention Period 3|consumption of restricted item|0|||
161143629|NCT02723630|581909431|FG001|Intervention Period 3|consumption of restricted item|1|||
161143630|NCT02723630|581909432|FG002|Intervention Period 3|consumption of restricted item|0|||
161143631|NCT02723630|581909433|FG003|Intervention Period 3|consumption of restricted item|0|||
161143632|NCT02723630|581909434|FG004|Intervention Period 3|consumption of restricted item|0|||
161143633|NCT02723630|581909435|FG005|Intervention Period 3|consumption of restricted item|0|||
161143634|NCT00852930|581909436|FG000|Overall Study|Withdrawal by Subject|1|||
161143635|NCT00852930|581909437|FG001|Overall Study|Withdrawal by Subject|1|||
161143636|NCT00852930|581909438|FG002|Overall Study|Withdrawal by Subject|1|||
161143637|NCT00852930|581909436|FG000|Overall Study|Physician Decision|0|||
161143638|NCT00852930|581909437|FG001|Overall Study|Physician Decision|0|||
161143639|NCT00852930|581909438|FG002|Overall Study|Physician Decision|1|||
161143640|NCT00537745|581909441|FG000|Overall Study|Did not meet eligibility criteria|2|||
161143641|NCT00537745|581909441|FG000|Overall Study|Withdrawal by Subject|2|||
161143642|NCT00537745|581909441|FG000|Overall Study|Subject unable to provide Interlock info|1|||
161143643|NCT03700892|581909445|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
161143644|NCT03700892|581909446|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
161143645|NCT03700892|581909447|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
161143646|NCT00849212|581909448|FG000|Overall Study|Lack of Efficacy|1|||
161143647|NCT00849212|581909448|FG000|Overall Study|Withdrawal by Subject|3|||
160930058|NCT00302003|581140241|FG000|Overall Study|Withdrawal by Subject|5|||
160930059|NCT00302003|581140241|FG000|Overall Study|Ineligible|9|||
160930060|NCT00302003|581140241|FG000|Overall Study|Protocol Violation|1|||
160930061|NCT02042924|581140242|FG000|Overall Study|Early Death|1|||
160930062|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
160930063|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
160930064|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
160930065|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
160930066|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
160930067|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
161143648|NCT00849212|581909448|FG000|Overall Study|Adverse Event|2|||
161143649|NCT00849212|581909448|FG000|Overall Study|Miscellaneous|1|||
161143650|NCT02117050|581909459|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
161143651|NCT02460822|581909462|FG000|Overall Study|Withdrawal by Subject|1|||
161143652|NCT00754390|581909463|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
161264212|NCT02335983|582349172|FG005|Overall Study|Protocol Specified Criteria|21|||
161264213|NCT00629265|582349177|FG000|Overall Study|Lost to Follow-up|4|||
161264214|NCT00629265|582349178|FG001|Overall Study|Lost to Follow-up|5|||
160930068|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
160998121|NCT01563354|581378570|FG000|Core Phase|Adverse Event|5|||
161143653|NCT00754390|581909463|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
161143654|NCT00754390|581909463|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
161143655|NCT00754390|581909463|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
161143656|NCT00847613|581909464|FG000|Overall Study|Ongoing at cut-off date|250|||
160930069|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
160930070|NCT04033003|581140243|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
160930071|NCT04033003|581140244|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
160930072|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
160930073|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
160930074|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
160930075|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
160930076|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
160930077|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
160930078|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
160930079|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
160930080|NCT04033003|581140243|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
160930081|NCT04033003|581140244|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
160930082|NCT04033003|581140243|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
160930083|NCT04033003|581140244|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
160930084|NCT04033003|581140243|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
160930085|NCT04033003|581140244|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
160930086|NCT04033003|581140243|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
160930087|NCT04033003|581140244|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
160930088|NCT02919670|581140245|FG000|Overall Study|Only 17 participants met compliance|43|||
160930089|NCT02919670|581140246|FG001|Overall Study|Only 17 participants met compliance|39|||
160930090|NCT02256891|581140247|FG000|Overall Study|Death|0|||
160930091|NCT02256891|581140248|FG001|Overall Study|Death|2|||
160930092|NCT02256891|581140247|FG000|Overall Study|Lost to Follow-up|0|||
160930093|NCT02256891|581140248|FG001|Overall Study|Lost to Follow-up|3|||
160930094|NCT02256891|581140247|FG000|Overall Study|Physician Decision|7|||
160930095|NCT02256891|581140248|FG001|Overall Study|Physician Decision|3|||
160930096|NCT02256891|581140247|FG000|Overall Study|Screen Fail|5|||
160930097|NCT02256891|581140248|FG001|Overall Study|Screen Fail|4|||
160930098|NCT02256891|581140247|FG000|Overall Study|Equipment Malfunction|0|||
160930099|NCT02256891|581140248|FG001|Overall Study|Equipment Malfunction|1|||
160930100|NCT01675882|581140251|FG000|Overall Study|Adverse Event|0|||
160930101|NCT01675882|581140252|FG001|Overall Study|Adverse Event|2|||
160930102|NCT01675882|581140253|FG002|Overall Study|Adverse Event|1|||
160930103|NCT01675882|581140254|FG003|Overall Study|Adverse Event|0|||
160930104|NCT01675882|581140251|FG000|Overall Study|Participant unwilling to continue|2|||
160930105|NCT01675882|581140252|FG001|Overall Study|Participant unwilling to continue|4|||
160930106|NCT01675882|581140253|FG002|Overall Study|Participant unwilling to continue|2|||
160930107|NCT01675882|581140254|FG003|Overall Study|Participant unwilling to continue|1|||
160930108|NCT01675882|581140251|FG000|Overall Study|Lost to Follow-up|0|||
160930109|NCT01675882|581140252|FG001|Overall Study|Lost to Follow-up|1|||
160930110|NCT01675882|581140253|FG002|Overall Study|Lost to Follow-up|0|||
160930111|NCT01675882|581140254|FG003|Overall Study|Lost to Follow-up|0|||
160930112|NCT01675882|581140251|FG000|Overall Study|Non-compliance|0|||
160930113|NCT01675882|581140252|FG001|Overall Study|Non-compliance|0|||
160930114|NCT01675882|581140253|FG002|Overall Study|Non-compliance|0|||
160930115|NCT01675882|581140254|FG003|Overall Study|Non-compliance|1|||
160930116|NCT00735371|581140255|FG000|Overall Study|Adverse Event|3|||
160930117|NCT00735371|581140256|FG001|Overall Study|Adverse Event|3|||
160930118|NCT00735371|581140257|FG002|Overall Study|Adverse Event|4|||
160930119|NCT00735371|581140258|FG003|Overall Study|Adverse Event|1|||
160930120|NCT00735371|581140255|FG000|Overall Study|Protocol Violation|2|||
160930121|NCT00735371|581140256|FG001|Overall Study|Protocol Violation|2|||
160930122|NCT00735371|581140257|FG002|Overall Study|Protocol Violation|0|||
160930123|NCT00735371|581140258|FG003|Overall Study|Protocol Violation|3|||
160930124|NCT00735371|581140255|FG000|Overall Study|Withdrawal by Subject|0|||
160930125|NCT00735371|581140256|FG001|Overall Study|Withdrawal by Subject|2|||
160930126|NCT00735371|581140257|FG002|Overall Study|Withdrawal by Subject|2|||
160930127|NCT00735371|581140258|FG003|Overall Study|Withdrawal by Subject|0|||
160930128|NCT00735371|581140255|FG000|Overall Study|Lost to Follow-up|1|||
160930129|NCT00735371|581140256|FG001|Overall Study|Lost to Follow-up|1|||
160930130|NCT00735371|581140257|FG002|Overall Study|Lost to Follow-up|3|||
160930131|NCT00735371|581140258|FG003|Overall Study|Lost to Follow-up|1|||
160930132|NCT00735371|581140255|FG000|Overall Study|Lack of Efficacy|4|||
160930133|NCT00735371|581140256|FG001|Overall Study|Lack of Efficacy|2|||
160930134|NCT00735371|581140257|FG002|Overall Study|Lack of Efficacy|0|||
160930135|NCT00735371|581140258|FG003|Overall Study|Lack of Efficacy|4|||
160930136|NCT00735371|581140255|FG000|Overall Study|Sponsor Decision|3|||
160930137|NCT00735371|581140256|FG001|Overall Study|Sponsor Decision|1|||
160930138|NCT00735371|581140257|FG002|Overall Study|Sponsor Decision|0|||
160930139|NCT00735371|581140258|FG003|Overall Study|Sponsor Decision|1|||
160930140|NCT00735371|581140255|FG000|Overall Study|Protocol Violation|0|||
160930141|NCT00735371|581140256|FG001|Overall Study|Protocol Violation|1|||
160930142|NCT00735371|581140257|FG002|Overall Study|Protocol Violation|2|||
160930143|NCT00735371|581140258|FG003|Overall Study|Protocol Violation|0|||
160930144|NCT00735371|581140255|FG000|Overall Study|Prior Vyvanse Exposure|1|||
160930145|NCT00735371|581140256|FG001|Overall Study|Prior Vyvanse Exposure|1|||
160930146|NCT00735371|581140257|FG002|Overall Study|Prior Vyvanse Exposure|0|||
160930147|NCT00735371|581140258|FG003|Overall Study|Prior Vyvanse Exposure|0|||
160930148|NCT00735371|581140255|FG000|Overall Study|Exclusion criteria|1|||
160930149|NCT00735371|581140256|FG001|Overall Study|Exclusion criteria|0|||
160930150|NCT00735371|581140257|FG002|Overall Study|Exclusion criteria|0|||
160930151|NCT00735371|581140258|FG003|Overall Study|Exclusion criteria|0|||
160930152|NCT00436748|581140261|FG000|Overall Study|Ineligibility Determined|1|||
160930153|NCT00436748|581140262|FG001|Overall Study|Ineligibility Determined|1|||
160930154|NCT00436748|581140261|FG000|Overall Study|Adverse Event|0|||
160930155|NCT00436748|581140262|FG001|Overall Study|Adverse Event|2|||
160930156|NCT00436748|581140261|FG000|Overall Study|Consent Withdrawn|1|||
160930157|NCT00436748|581140262|FG001|Overall Study|Consent Withdrawn|4|||
160930158|NCT00436748|581140261|FG000|Overall Study|Administrative Decision|1|||
161264215|NCT00629265|582349177|FG000|Overall Study|Withdrawal by Subject|11|||
161264216|NCT00629265|582349178|FG001|Overall Study|Withdrawal by Subject|8|||
161264217|NCT00629265|582349177|FG000|Overall Study|Death|1|||
161264218|NCT00629265|582349178|FG001|Overall Study|Death|0|||
161264219|NCT00629265|582349177|FG000|Overall Study|Adverse Event|2|||
160930159|NCT00436748|581140262|FG001|Overall Study|Administrative Decision|0|||
160930160|NCT00436748|581140261|FG000|Overall Study|Lost to Follow-up|0|||
160930161|NCT00436748|581140262|FG001|Overall Study|Lost to Follow-up|1|||
160930162|NCT00436748|581140261|FG000|Overall Study|Protocol-specified Criteria|5|||
160930163|NCT00436748|581140262|FG001|Overall Study|Protocol-specified Criteria|4|||
160930164|NCT00436748|581140261|FG000|Overall Study|Other|3|||
160930165|NCT00436748|581140262|FG001|Overall Study|Other|0|||
160930166|NCT00850200|581140263|FG000|Overall Study|Physician Decision|2|||
160930167|NCT00850200|581140263|FG000|Overall Study|Did not recieve treatment|2|||
160930168|NCT00850200|581140263|FG000|Overall Study|Withdrawal by Subject|1|||
160930169|NCT00097721|581140273|FG000|Overall Study|Adverse Event|8|||
160930170|NCT00097721|581140274|FG001|Overall Study|Adverse Event|1|||
160930171|NCT00097721|581140273|FG000|Overall Study|Withdrawal by Subject|6|||
160930172|NCT00097721|581140274|FG001|Overall Study|Withdrawal by Subject|1|||
160930173|NCT00097721|581140273|FG000|Overall Study|Progressive Disease|55|||
160930174|NCT00097721|581140274|FG001|Overall Study|Progressive Disease|27|||
160930175|NCT00097721|581140273|FG000|Overall Study|Physician Decision|1|||
160930176|NCT00097721|581140274|FG001|Overall Study|Physician Decision|3|||
160930177|NCT00097721|581140273|FG000|Overall Study|Reason not given|1|||
160930178|NCT00097721|581140274|FG001|Overall Study|Reason not given|1|||
160930179|NCT02126969|581140280|FG000|Overall Study|Withdrawal by Subject|1|||
160930180|NCT02126969|581140281|FG001|Overall Study|Withdrawal by Subject|2|||
160930181|NCT02972632|581140282|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160930182|NCT02972632|581140282|FG000|Overall Study|Lost to Follow-up|4|||
160930183|NCT02972632|581140282|FG000|Overall Study|Voluntary Withdrawal|10|||
160930184|NCT01533246|581140283|FG000|Overall Study|Adverse Event|1|||
160930185|NCT01533246|581140283|FG000|Overall Study|Withdrawal by Subject|1|||
160930186|NCT00354172|581140284|FG000|Overall Study|Did not receive transplant|1|||
160930187|NCT01446965|581140285|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
160930188|NCT01446965|581140286|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
160930189|NCT01446965|581140285|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
160930190|NCT01446965|581140286|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
160930191|NCT02023151|581140287|FG000|Overall Study|Lost to Follow-up|4|||
160930192|NCT03450707|581140288|FG000|Overall Study|Outside enrollment window|4|||
160930193|NCT03450707|581140289|FG001|Overall Study|Outside enrollment window|1|||
160930194|NCT03450707|581140288|FG000|Overall Study|Death|1|||
160930195|NCT03450707|581140289|FG001|Overall Study|Death|0|||
160930196|NCT03450707|581140288|FG000|Overall Study|Indication for thiamine|1|||
160930197|NCT03450707|581140289|FG001|Overall Study|Indication for thiamine|1|||
160930198|NCT03450707|581140288|FG000|Overall Study|Evidence of traumatic brain injury|1|||
160930199|NCT03450707|581140289|FG001|Overall Study|Evidence of traumatic brain injury|0|||
160930200|NCT03450707|581140288|FG000|Overall Study|Following commands|0|||
160930201|NCT03450707|581140289|FG001|Overall Study|Following commands|3|||
160930202|NCT03450707|581140288|FG000|Overall Study|Lactate < 3.5|0|||
161264220|NCT00629265|582349178|FG001|Overall Study|Adverse Event|0|||
161264221|NCT00629265|582349177|FG000|Overall Study|HNC Recurrence|4|||
160930203|NCT03450707|581140289|FG001|Overall Study|Lactate < 3.5|2|||
161264222|NCT00629265|582349178|FG001|Overall Study|HNC Recurrence|0|||
160930204|NCT03450707|581140288|FG000|Overall Study|Rearrest with ECMO|0|||
160930205|NCT03450707|581140289|FG001|Overall Study|Rearrest with ECMO|1|||
161264223|NCT00629265|582349177|FG000|Overall Study|Other CA Requiring Treatment|1|||
160930206|NCT03450707|581140288|FG000|Overall Study|Indication for thiamine + head CT results|0|||
160930207|NCT03450707|581140289|FG001|Overall Study|Indication for thiamine + head CT results|1|||
160930208|NCT03450707|581140288|FG000|Overall Study|Family/patient goals of care|0|||
160930209|NCT03450707|581140289|FG001|Overall Study|Family/patient goals of care|1|||
160930210|NCT02871375|581140290|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
160930211|NCT02871375|581140291|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
161264224|NCT00629265|582349178|FG001|Overall Study|Other CA Requiring Treatment|3|||
160930212|NCT00004412|581140294|FG000|Randomized Period|Moved to Crossover Period|3|||
160930213|NCT00004412|581140295|FG001|Randomized Period|Moved to Crossover Period|0|||
160930214|NCT00004412|581140296|FG002|Randomized Period|Moved to Crossover Period|0|||
160930215|NCT02016482|581140306|FG000|Period A|Adverse Event|3|||
160930216|NCT02016482|581140307|FG001|Period A|Adverse Event|5|||
160930217|NCT02016482|581140306|FG000|Period A|Withdrawal by Subject|3|||
160930218|NCT02016482|581140307|FG001|Period A|Withdrawal by Subject|4|||
160930219|NCT02016482|581140306|FG000|Period A|Lost to Follow-up|3|||
160930220|NCT02016482|581140307|FG001|Period A|Lost to Follow-up|3|||
160930221|NCT02016482|581140306|FG000|Period A|Lack of Efficacy|2|||
160930222|NCT02016482|581140307|FG001|Period A|Lack of Efficacy|1|||
160930223|NCT02016482|581140306|FG000|Period A|Other|3|||
160930224|NCT02016482|581140307|FG001|Period A|Other|0|||
160930225|NCT02016482|581140306|FG000|Period A|Protocol Violation|0|||
160930226|NCT02016482|581140307|FG001|Period A|Protocol Violation|1|||
160930227|NCT02016482|581140306|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
160930228|NCT02016482|581140307|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
160930229|NCT02016482|581140306|FG000|Period B|Withdrawal by Subject|1|||
160930230|NCT02016482|581140307|FG001|Period B|Withdrawal by Subject|1|||
160930231|NCT02016482|581140306|FG000|Period B|Lost to Follow-up|2|||
160930232|NCT02016482|581140307|FG001|Period B|Lost to Follow-up|0|||
160930233|NCT02016482|581140306|FG000|Period B|Lack of Efficacy|6|||
160930234|NCT02016482|581140307|FG001|Period B|Lack of Efficacy|4|||
160930235|NCT02016482|581140306|FG000|Period B|Other|4|||
160930236|NCT02016482|581140307|FG001|Period B|Other|0|||
161264225|NCT00629265|582349177|FG000|Overall Study|Needed Esophageal Dilation|4|||
161264226|NCT00629265|582349178|FG001|Overall Study|Needed Esophageal Dilation|1|||
161264227|NCT00629265|582349177|FG000|Overall Study|Unrelated Medical Complications|3|||
160930237|NCT02016482|581140306|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
160930238|NCT02016482|581140307|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
160930239|NCT03387813|581140308|FG000|Overall Study|Death|40|||
160930240|NCT03387813|581140309|FG001|Overall Study|Death|37|||
160930241|NCT03387813|581140310|FG002|Overall Study|Death|190|||
160930242|NCT03387813|581140308|FG000|Overall Study|Withdrawal by Subject|9|||
160930243|NCT03387813|581140309|FG001|Overall Study|Withdrawal by Subject|19|||
160930244|NCT03387813|581140310|FG002|Overall Study|Withdrawal by Subject|32|||
160930245|NCT03387813|581140308|FG000|Overall Study|Lost to Follow-up|3|||
160930246|NCT03387813|581140309|FG001|Overall Study|Lost to Follow-up|9|||
160930247|NCT03387813|581140310|FG002|Overall Study|Lost to Follow-up|15|||
160930248|NCT03387813|581140308|FG000|Overall Study|Non-Compliance|6|||
160930249|NCT03387813|581140309|FG001|Overall Study|Non-Compliance|6|||
160930250|NCT03387813|581140310|FG002|Overall Study|Non-Compliance|31|||
160930251|NCT03387813|581140308|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
160930252|NCT03387813|581140309|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
160930253|NCT03387813|581140310|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
160930254|NCT00606892|581140311|FG000|First Intervention|Protocol Violation|1|||
160930255|NCT00606892|581140312|FG001|First Intervention|Protocol Violation|4|||
160930256|NCT00855309|581140314|FG000|Overall Study|patient never recieved drug|1|||
160930257|NCT00855309|581140315|FG001|Overall Study|patient never recieved drug|0|||
160930258|NCT00829296|581140316|FG000|Overall Study|Adverse Event|5|||
160930259|NCT00829296|581140317|FG001|Overall Study|Adverse Event|4|||
160930260|NCT04960228|581140323|FG000|Overall Study|Withdrawal by Subject|216|||
160930261|NCT04960228|581140324|FG001|Overall Study|Withdrawal by Subject|35|||
160930262|NCT04960228|581140323|FG000|Overall Study|Failed attention check|69|||
160930263|NCT04960228|581140324|FG001|Overall Study|Failed attention check|148|||
160930264|NCT04960228|581140323|FG000|Overall Study|Flagged for response quality by Dynata|3|||
160930265|NCT04960228|581140324|FG001|Overall Study|Flagged for response quality by Dynata|3|||
160930266|NCT01987427|581140325|FG000|Overall Study|Adverse Event|4|||
160930267|NCT01987427|581140326|FG001|Overall Study|Adverse Event|2|||
160930268|NCT01987427|581140327|FG002|Overall Study|Adverse Event|8|||
161264228|NCT00629265|582349178|FG001|Overall Study|Unrelated Medical Complications|1|||
161264229|NCT00629265|582349177|FG000|Overall Study|Unknown Reason|2|||
160930269|NCT01987427|581140325|FG000|Overall Study|Lost to Follow-up|6|||
160930270|NCT01987427|581140326|FG001|Overall Study|Lost to Follow-up|6|||
161264230|NCT00629265|582349178|FG001|Overall Study|Unknown Reason|2|||
161264231|NCT04465630|582349179|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
160930271|NCT01987427|581140327|FG002|Overall Study|Lost to Follow-up|9|||
160930272|NCT01987427|581140325|FG000|Overall Study|Withdrawal by Subject|2|||
160930273|NCT01987427|581140326|FG001|Overall Study|Withdrawal by Subject|1|||
160930274|NCT01987427|581140327|FG002|Overall Study|Withdrawal by Subject|3|||
160930275|NCT01987427|581140325|FG000|Overall Study|Lack of Efficacy|1|||
160930276|NCT01987427|581140326|FG001|Overall Study|Lack of Efficacy|0|||
160930277|NCT01987427|581140327|FG002|Overall Study|Lack of Efficacy|0|||
160930278|NCT01987427|581140325|FG000|Overall Study|Other|1|||
160930279|NCT01987427|581140326|FG001|Overall Study|Other|1|||
160930280|NCT01987427|581140327|FG002|Overall Study|Other|0|||
160930281|NCT02547129|581140332|FG000|Overall Study|Difficulty with ongoing infection|1|||
160930282|NCT02547129|581140333|FG001|Overall Study|Difficulty with ongoing infection|0|||
160930283|NCT00794196|581140335|FG000|Overall Study|Lost to Follow-up|5|||
160930284|NCT00794196|581140336|FG001|Overall Study|Lost to Follow-up|23|||
160930285|NCT02129803|581140337|FG000|Overall Study|Protocol Violation|4|||
160930286|NCT02129803|581140338|FG001|Overall Study|Protocol Violation|0|||
160930287|NCT02129803|581140337|FG000|Overall Study|Physician Decision|0|||
160930288|NCT02129803|581140338|FG001|Overall Study|Physician Decision|1|||
160930289|NCT02129803|581140337|FG000|Overall Study|Difficulty sleeping|1|||
160930290|NCT02129803|581140338|FG001|Overall Study|Difficulty sleeping|0|||
160930291|NCT02129803|581140337|FG000|Overall Study|Morning headache|0|||
160930292|NCT02129803|581140338|FG001|Overall Study|Morning headache|1|||
160930293|NCT02129803|581140337|FG000|Overall Study|Withdrawal by Subject|1|||
160930294|NCT02129803|581140338|FG001|Overall Study|Withdrawal by Subject|1|||
160930295|NCT02319031|581140339|FG000|Treatment Period|Death|1|||
160930296|NCT02319031|581140340|FG001|Treatment Period|Death|0|||
160930297|NCT02907359|581140345|FG000|Overall Study|Death|234|||
160930298|NCT02907359|581140346|FG001|Overall Study|Death|117|||
160930299|NCT02907359|581140345|FG000|Overall Study|Withdrawal by Subject|6|||
160930300|NCT02907359|581140346|FG001|Overall Study|Withdrawal by Subject|11|||
160930301|NCT02907359|581140345|FG000|Overall Study|Lost to Follow-up|1|||
160930302|NCT02907359|581140346|FG001|Overall Study|Lost to Follow-up|0|||
160930303|NCT01354496|581140350|FG000|Period 1|Adverse Event|0|||
160930304|NCT01354496|581140351|FG001|Period 1|Adverse Event|0|||
160930305|NCT01354496|581140352|FG002|Period 1|Adverse Event|1|||
160930306|NCT01354496|581140353|FG003|Period 1|Adverse Event|0|||
160930307|NCT01354496|581140354|FG004|Period 1|Adverse Event|0|||
160930308|NCT01354496|581140355|FG005|Period 1|Adverse Event|0|||
160930309|NCT01354496|581140350|FG000|Period 1|Physician Decision|0|||
160930310|NCT01354496|581140351|FG001|Period 1|Physician Decision|0|||
160930311|NCT01354496|581140352|FG002|Period 1|Physician Decision|1|||
160930312|NCT01354496|581140353|FG003|Period 1|Physician Decision|0|||
160930313|NCT01354496|581140354|FG004|Period 1|Physician Decision|0|||
160930314|NCT01354496|581140355|FG005|Period 1|Physician Decision|0|||
160930315|NCT01354496|581140350|FG000|Period 2|Adverse Event|0|||
160930316|NCT01354496|581140351|FG001|Period 2|Adverse Event|0|||
160930317|NCT01354496|581140352|FG002|Period 2|Adverse Event|0|||
160930318|NCT01354496|581140353|FG003|Period 2|Adverse Event|1|||
160930319|NCT01354496|581140354|FG004|Period 2|Adverse Event|0|||
160930320|NCT01354496|581140355|FG005|Period 2|Adverse Event|0|||
160930321|NCT01354496|581140350|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930322|NCT01354496|581140351|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
160930323|NCT01354496|581140352|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930324|NCT01354496|581140353|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
160930325|NCT01354496|581140354|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930326|NCT01354496|581140355|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
160930327|NCT00500292|581140357|FG000|Overall Study|Adverse Event|3|||
160930328|NCT00500292|581140358|FG001|Overall Study|Adverse Event|6|||
160930329|NCT00500292|581140359|FG002|Overall Study|Adverse Event|4|||
160930330|NCT00500292|581140357|FG000|Overall Study|Condition under investigation worsened|21|||
160930331|NCT00500292|581140358|FG001|Overall Study|Condition under investigation worsened|23|||
160930332|NCT00500292|581140359|FG002|Overall Study|Condition under investigation worsened|19|||
160930333|NCT00500292|581140357|FG000|Overall Study|Withdrawal by Subject|0|||
160930334|NCT00500292|581140358|FG001|Overall Study|Withdrawal by Subject|1|||
160930335|NCT00500292|581140359|FG002|Overall Study|Withdrawal by Subject|0|||
160930336|NCT00500292|581140357|FG000|Overall Study|Other|1|||
160930337|NCT00500292|581140358|FG001|Overall Study|Other|1|||
160930338|NCT00500292|581140359|FG002|Overall Study|Other|4|||
160930339|NCT01332149|581141997|FG000|Overall Study|Adverse Event|11|||
160930340|NCT01332149|581141998|FG001|Overall Study|Adverse Event|9|||
160930341|NCT01332149|581141997|FG000|Overall Study|Other unspecified|5|||
160930342|NCT01332149|581141998|FG001|Overall Study|Other unspecified|7|||
160930343|NCT01332149|581141997|FG000|Overall Study|Protocol Violation|1|||
160930344|NCT01332149|581141998|FG001|Overall Study|Protocol Violation|3|||
160930345|NCT01332149|581141997|FG000|Overall Study|Withdrawal by Subject|4|||
160930346|NCT01332149|581141998|FG001|Overall Study|Withdrawal by Subject|5|||
160930347|NCT01332149|581141997|FG000|Overall Study|Lost to Follow-up|1|||
160930348|NCT01332149|581141998|FG001|Overall Study|Lost to Follow-up|1|||
160930349|NCT01332149|581141997|FG000|Overall Study|Insufficient clinical response|4|||
160930350|NCT01332149|581141998|FG001|Overall Study|Insufficient clinical response|7|||
160930351|NCT01332149|581141997|FG000|Overall Study|Did not meet entrance criteria|3|||
160930352|NCT01332149|581141998|FG001|Overall Study|Did not meet entrance criteria|4|||
160930353|NCT01332149|581141997|FG000|Overall Study|Randomized but not treated|1|||
160930354|NCT01332149|581141998|FG001|Overall Study|Randomized but not treated|2|||
160930355|NCT03711162|581142002|FG000|Overall Study|Adverse Event|5|||
160930356|NCT03711162|581142003|FG001|Overall Study|Adverse Event|2|||
160930357|NCT03711162|581142004|FG002|Overall Study|Adverse Event|4|||
160930358|NCT03711162|581142002|FG000|Overall Study|Death|11|||
160930359|NCT03711162|581142003|FG001|Overall Study|Death|7|||
160930360|NCT03711162|581142004|FG002|Overall Study|Death|8|||
160930361|NCT03711162|581142002|FG000|Overall Study|Lost to Follow-up|1|||
160930362|NCT03711162|581142003|FG001|Overall Study|Lost to Follow-up|0|||
160930363|NCT03711162|581142004|FG002|Overall Study|Lost to Follow-up|1|||
160930364|NCT03711162|581142002|FG000|Overall Study|Study Terminated by Sponsor|139|||
160930365|NCT03711162|581142003|FG001|Overall Study|Study Terminated by Sponsor|152|||
160930366|NCT03711162|581142004|FG002|Overall Study|Study Terminated by Sponsor|146|||
160930367|NCT03711162|581142002|FG000|Overall Study|Withdrawal by Subject|17|||
160930368|NCT03711162|581142003|FG001|Overall Study|Withdrawal by Subject|10|||
160930369|NCT03711162|581142004|FG002|Overall Study|Withdrawal by Subject|10|||
160930370|NCT03711162|581142002|FG000|Overall Study|Miscellaneous|1|||
160930371|NCT03711162|581142003|FG001|Overall Study|Miscellaneous|2|||
160930372|NCT03711162|581142004|FG002|Overall Study|Miscellaneous|2|||
160930373|NCT03711162|581142002|FG000|Overall Study|Not Treated|1|||
160930374|NCT03711162|581142003|FG001|Overall Study|Not Treated|0|||
160930375|NCT03711162|581142004|FG002|Overall Study|Not Treated|1|||
160930376|NCT03711162|581142002|FG000|Overall Study|Physician Decision|0|||
160930377|NCT03711162|581142003|FG001|Overall Study|Physician Decision|2|||
160930378|NCT03711162|581142004|FG002|Overall Study|Physician Decision|0|||
160930379|NCT03711162|581142002|FG000|Overall Study|Lack of Efficacy|0|||
160930380|NCT03711162|581142003|FG001|Overall Study|Lack of Efficacy|0|||
160930381|NCT03711162|581142004|FG002|Overall Study|Lack of Efficacy|2|||
160930382|NCT03711162|581142002|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
160930383|NCT03711162|581142003|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
160930384|NCT03711162|581142004|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
160930385|NCT01275066|581142007|FG000|Overall Study|Withdrawal by Subject|0|||
160930386|NCT01275066|581142008|FG001|Overall Study|Withdrawal by Subject|0|||
160930387|NCT01275066|581142009|FG002|Overall Study|Withdrawal by Subject|1|||
160930388|NCT01275066|581142007|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
160930389|NCT01275066|581142008|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
160930390|NCT01275066|581142009|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
160930391|NCT03240133|581142010|FG000|Overall Study|Withdrawal by Subject|0|||
160930392|NCT03240133|581142011|FG001|Overall Study|Withdrawal by Subject|1|||
160930393|NCT03240133|581142012|FG002|Overall Study|Withdrawal by Subject|0|||
160930394|NCT03240133|581142010|FG000|Overall Study|Adverse Event|1|||
160930395|NCT03240133|581142011|FG001|Overall Study|Adverse Event|1|||
160930396|NCT03240133|581142012|FG002|Overall Study|Adverse Event|0|||
160930397|NCT03240133|581142010|FG000|Overall Study|Rash|1|||
160930398|NCT03240133|581142011|FG001|Overall Study|Rash|0|||
160930399|NCT03240133|581142012|FG002|Overall Study|Rash|0|||
160930400|NCT03240133|581142010|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
160930401|NCT03240133|581142011|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
160930402|NCT03240133|581142012|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
160930403|NCT03240133|581142010|FG000|Overall Study|Intercurrent illness.|0|||
160930404|NCT03240133|581142011|FG001|Overall Study|Intercurrent illness.|1|||
160930405|NCT03240133|581142012|FG002|Overall Study|Intercurrent illness.|0|||
160930406|NCT03240133|581142010|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
160930407|NCT03240133|581142011|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
160930408|NCT03240133|581142012|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
160930409|NCT00749463|581142013|FG000|Overall Study|Adverse Event|0|||
160930410|NCT00749463|581142014|FG001|Overall Study|Adverse Event|4|||
160930411|NCT00749463|581142015|FG002|Overall Study|Adverse Event|1|||
160930412|NCT00749463|581142013|FG000|Overall Study|Withdrawal by Subject|1|||
160930413|NCT00749463|581142014|FG001|Overall Study|Withdrawal by Subject|0|||
160930414|NCT00749463|581142015|FG002|Overall Study|Withdrawal by Subject|0|||
160930415|NCT00116831|581142016|FG000|Overall Study|Adverse Event|14|||
160930416|NCT00116831|581142017|FG001|Overall Study|Adverse Event|16|||
160930417|NCT00116831|581142016|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
160930418|NCT00116831|581142017|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
160930419|NCT00116831|581142016|FG000|Overall Study|Lost to Follow-up|8|||
160930420|NCT00116831|581142017|FG001|Overall Study|Lost to Follow-up|6|||
160930421|NCT00116831|581142016|FG000|Overall Study|Protocol Violation|3|||
160930422|NCT00116831|581142017|FG001|Overall Study|Protocol Violation|6|||
160930423|NCT00116831|581142016|FG000|Overall Study|Hypoglycaemic events|1|||
160930424|NCT00116831|581142017|FG001|Overall Study|Hypoglycaemic events|0|||
160930425|NCT00116831|581142016|FG000|Overall Study|Low haemoglobin on screening|1|||
160930426|NCT00116831|581142017|FG001|Overall Study|Low haemoglobin on screening|0|||
160930427|NCT00116831|581142016|FG000|Overall Study|Withdrawn investigational product|1|||
160930428|NCT00116831|581142017|FG001|Overall Study|Withdrawn investigational product|0|||
160930429|NCT00116831|581142016|FG000|Overall Study|Withdrawal by Subject|32|||
160930430|NCT00116831|581142017|FG001|Overall Study|Withdrawal by Subject|32|||
160930431|NCT00116831|581142016|FG000|Overall Study|Insufficient therapeutic effect|0|||
160930432|NCT00116831|581142017|FG001|Overall Study|Insufficient therapeutic effect|1|||
160930433|NCT00116831|581142016|FG000|Overall Study|Missing data for participant|1|||
160930434|NCT00116831|581142017|FG001|Overall Study|Missing data for participant|0|||
160930435|NCT04904185|581142018|FG000|Overall Study|Expansion failure|1|||
161264232|NCT04465630|582349179|FG000|Overall Study|Screen failure|8|||
160930436|NCT04904185|581142019|FG001|Overall Study|Expansion failure|0|||
160930437|NCT04904185|581142018|FG000|Overall Study|Late response on prior treatment|1|||
160930438|NCT04904185|581142019|FG001|Overall Study|Late response on prior treatment|0|||
160930439|NCT02945410|581142020|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930440|NCT02945410|581142021|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
160930441|NCT02945410|581142022|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930442|NCT02945410|581142023|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930443|NCT02945410|581142024|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930444|NCT02945410|581142025|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160930445|NCT02945410|581142020|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
160930446|NCT02945410|581142021|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
160930447|NCT02945410|581142022|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
160930448|NCT02945410|581142023|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
160930449|NCT02945410|581142024|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
160930450|NCT02945410|581142025|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
160930451|NCT02945410|581142020|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930452|NCT02945410|581142021|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930453|NCT02945410|581142022|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
160930454|NCT02945410|581142023|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930455|NCT02945410|581142024|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
160930456|NCT02945410|581142025|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
160930457|NCT01344369|581142028|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
160930458|NCT01344369|581142029|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
160930459|NCT01344369|581142028|FG000|Washout of 28 Days|Physician Decision|0|||
160930460|NCT01344369|581142029|FG001|Washout of 28 Days|Physician Decision|1|||
160930461|NCT01344369|581142028|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
160930462|NCT01344369|581142029|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
160930463|NCT00110812|581142030|FG000|Main Study|Death|0|||
160930464|NCT00110812|581142031|FG001|Main Study|Death|0|||
160930465|NCT00110812|581142032|FG002|Main Study|Death|2|||
160930466|NCT00110812|581142030|FG000|Main Study|Withdrawal by Subject|0|||
160930467|NCT00110812|581142031|FG001|Main Study|Withdrawal by Subject|0|||
160930468|NCT00110812|581142032|FG002|Main Study|Withdrawal by Subject|1|||
160930469|NCT00110812|581142030|FG000|Main Study|Lost to Follow-up|8|||
160930470|NCT00110812|581142031|FG001|Main Study|Lost to Follow-up|11|||
160930471|NCT00110812|581142032|FG002|Main Study|Lost to Follow-up|10|||
160930472|NCT00110812|581142030|FG000|Extended Follow-up|Death|1|||
160930473|NCT00110812|581142031|FG001|Extended Follow-up|Death|0|||
160930474|NCT00110812|581142032|FG002|Extended Follow-up|Death|3|||
160930475|NCT00110812|581142030|FG000|Extended Follow-up|Withdrawal by Subject|0|||
160930476|NCT00110812|581142031|FG001|Extended Follow-up|Withdrawal by Subject|1|||
160930477|NCT00110812|581142032|FG002|Extended Follow-up|Withdrawal by Subject|0|||
160930478|NCT00110812|581142030|FG000|Extended Follow-up|Lost to Follow-up|1|||
160930479|NCT00110812|581142031|FG001|Extended Follow-up|Lost to Follow-up|3|||
160930480|NCT00110812|581142032|FG002|Extended Follow-up|Lost to Follow-up|1|||
160930481|NCT04200248|581142035|FG000|Overall Study|Personal reasons|0|||
160930482|NCT04200248|581142036|FG001|Overall Study|Personal reasons|0|||
160930483|NCT04200248|581142037|FG002|Overall Study|Personal reasons|1|||
160930484|NCT04200248|581142035|FG000|Overall Study|Discontinued prior to treatment|3|||
160930485|NCT04200248|581142036|FG001|Overall Study|Discontinued prior to treatment|3|||
160930486|NCT04200248|581142037|FG002|Overall Study|Discontinued prior to treatment|2|||
160930487|NCT01465464|581142062|FG000|Overall Study|Adverse Event|96|||
160930488|NCT01465464|581142063|FG001|Overall Study|Adverse Event|49|||
160930489|NCT01465464|581142062|FG000|Overall Study|Lack of Efficacy|139|||
160930490|NCT01465464|581142063|FG001|Overall Study|Lack of Efficacy|190|||
160930491|NCT01465464|581142062|FG000|Overall Study|Physician Decision|13|||
160930492|NCT01465464|581142063|FG001|Overall Study|Physician Decision|5|||
160930493|NCT01465464|581142062|FG000|Overall Study|Protocol Violation|1|||
160930494|NCT01465464|581142063|FG001|Overall Study|Protocol Violation|1|||
160930495|NCT01465464|581142062|FG000|Overall Study|Withdrawal by Subject|46|||
160930496|NCT01465464|581142063|FG001|Overall Study|Withdrawal by Subject|30|||
160930497|NCT01465464|581142062|FG000|Overall Study|Other|9|||
160930498|NCT01465464|581142063|FG001|Overall Study|Other|3|||
160998122|NCT01563354|581378571|FG001|Core Phase|Adverse Event|15|||
160930499|NCT01465464|581142062|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
160998123|NCT01563354|581378572|FG002|Core Phase|Adverse Event|13|||
160998124|NCT01563354|581378570|FG000|Core Phase|Withdrawal by Subject|1|||
160930500|NCT01465464|581142063|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
160930501|NCT01183975|581142066|FG000|Overall Study|Lost to Follow-up|73|||
160930502|NCT01640366|581142072|FG000|Overall Study|Withdrawal by Subject|1|||
160930503|NCT01640366|581142072|FG000|Overall Study|Protocol Violation|16|||
160930504|NCT01640366|581142072|FG000|Overall Study|Lost to Follow-up|5|||
161264233|NCT04465630|582349179|FG000|Overall Study|Baseline failure|16|||
160930505|NCT02739269|581142075|FG000|Overall Study|Protocol Violation|5|||
160930506|NCT02739269|581142076|FG001|Overall Study|Protocol Violation|0|||
160930507|NCT02739269|581142075|FG000|Overall Study|Cycle cancellation|2|||
160930508|NCT02739269|581142076|FG001|Overall Study|Cycle cancellation|2|||
160998125|NCT01563354|581378571|FG001|Core Phase|Withdrawal by Subject|0|||
160930509|NCT02739269|581142075|FG000|Overall Study|Withdrawal by Subject|0|||
160930510|NCT02739269|581142076|FG001|Overall Study|Withdrawal by Subject|2|||
160930511|NCT02244580|581142077|FG000|Overall Study|No cancer tissues available|241|||
160930512|NCT02136576|581142079|FG000|Overall Study|Lost to Follow-up|2|||
160930513|NCT02136576|581142080|FG001|Overall Study|Lost to Follow-up|0|||
160930514|NCT02136576|581142081|FG002|Overall Study|Lost to Follow-up|0|||
160930515|NCT02197806|581142082|FG000|Overall Study|Adverse Event|0|||
160930516|NCT02197806|581142083|FG001|Overall Study|Adverse Event|1|||
160930517|NCT02197806|581142084|FG002|Overall Study|Adverse Event|0|||
160930518|NCT02197806|581142085|FG003|Overall Study|Adverse Event|1|||
160930519|NCT00680901|581142086|FG000|Overall Study|Ongoing: On Study Treatment|1|||
160930520|NCT00680901|581142087|FG001|Overall Study|Ongoing: On Study Treatment|0|||
160930521|NCT00680901|581142086|FG000|Overall Study|Ongoing: In Follow Up|1|||
160930522|NCT00680901|581142087|FG001|Overall Study|Ongoing: In Follow Up|0|||
160930523|NCT00680901|581142086|FG000|Overall Study|Adverse Event|1|||
160930524|NCT00680901|581142087|FG001|Overall Study|Adverse Event|1|||
160930525|NCT00680901|581142086|FG000|Overall Study|Lost to Follow-up|3|||
160930526|NCT00680901|581142087|FG001|Overall Study|Lost to Follow-up|5|||
160930527|NCT00680901|581142086|FG000|Overall Study|Subject decided to withdraw from the study|4|||
160930528|NCT00680901|581142087|FG001|Overall Study|Subject decided to withdraw from the study|15|||
160930529|NCT00680901|581142086|FG000|Overall Study|Sponsor decision|1|||
160930530|NCT00680901|581142087|FG001|Overall Study|Sponsor decision|0|||
160930531|NCT00680901|581142086|FG000|Overall Study|Physician Decision|0|||
160930532|NCT00680901|581142087|FG001|Overall Study|Physician Decision|2|||
160930533|NCT00680901|581142086|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
160930534|NCT00680901|581142087|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
160930535|NCT00680901|581142086|FG000|Overall Study|Other protocol defined stopping criteria|17|||
160930536|NCT00680901|581142087|FG001|Overall Study|Other protocol defined stopping criteria|17|||
160930537|NCT00537381|581142088|FG000|Overall Study|Adverse Event|13|||
160930538|NCT00537381|581142089|FG001|Overall Study|Adverse Event|9|||
160930539|NCT00537381|581142088|FG000|Overall Study|Death|3|||
160930540|NCT00537381|581142089|FG001|Overall Study|Death|3|||
160930541|NCT00537381|581142088|FG000|Overall Study|Withdrawal by Subject|5|||
160930542|NCT00537381|581142089|FG001|Overall Study|Withdrawal by Subject|14|||
160930543|NCT00537381|581142088|FG000|Overall Study|Physician Decision|7|||
160930544|NCT00537381|581142089|FG001|Overall Study|Physician Decision|6|||
160930545|NCT00537381|581142088|FG000|Overall Study|Disease Progression|9|||
160930546|NCT00537381|581142089|FG001|Overall Study|Disease Progression|18|||
160930547|NCT00537381|581142088|FG000|Overall Study|Sponsor decision|14|||
160930548|NCT00537381|581142089|FG001|Overall Study|Sponsor decision|9|||
160930549|NCT00537381|581142088|FG000|Overall Study|Other|5|||
160930550|NCT00537381|581142089|FG001|Overall Study|Other|3|||
160930551|NCT01708174|581142090|FG000|Treatment Period|Withdrawal by Subject|1|||
160930552|NCT01708174|581142091|FG001|Treatment Period|Withdrawal by Subject|0|||
160930553|NCT01708174|581142092|FG002|Treatment Period|Withdrawal by Subject|0|||
160930554|NCT01708174|581142090|FG000|Treatment Period|Progressive disease|0|||
160930555|NCT01708174|581142091|FG001|Treatment Period|Progressive disease|1|||
160930556|NCT01708174|581142092|FG002|Treatment Period|Progressive disease|0|||
160930557|NCT01708174|581142090|FG000|Treatment Period|Death|0|||
160930558|NCT01708174|581142091|FG001|Treatment Period|Death|0|||
160930559|NCT01708174|581142092|FG002|Treatment Period|Death|1|||
160930560|NCT01708174|581142090|FG000|Treatment Period|Adverse Event|0|||
160930561|NCT01708174|581142091|FG001|Treatment Period|Adverse Event|1|||
160930562|NCT01708174|581142092|FG002|Treatment Period|Adverse Event|0|||
160930563|NCT00923559|581142093|FG000|Overall Study|Lost to Follow-up|2|||
160930564|NCT00923559|581142094|FG001|Overall Study|Lost to Follow-up|3|||
160930565|NCT02268812|581142095|FG000|Overall Study|Adverse Event|8|||
160930566|NCT02268812|581142096|FG001|Overall Study|Adverse Event|26|||
160930567|NCT02268812|581142097|FG002|Overall Study|Adverse Event|7|||
160930568|NCT02268812|581142098|FG003|Overall Study|Adverse Event|10|||
160930569|NCT02268812|581142095|FG000|Overall Study|Protocol deviation|0|||
160930570|NCT02268812|581142096|FG001|Overall Study|Protocol deviation|0|||
160930571|NCT02268812|581142097|FG002|Overall Study|Protocol deviation|1|||
160930572|NCT02268812|581142098|FG003|Overall Study|Protocol deviation|0|||
160930573|NCT02268812|581142095|FG000|Overall Study|Withdrawal by Subject|0|||
160930574|NCT02268812|581142096|FG001|Overall Study|Withdrawal by Subject|1|||
160930575|NCT02268812|581142097|FG002|Overall Study|Withdrawal by Subject|0|||
160930576|NCT02268812|581142098|FG003|Overall Study|Withdrawal by Subject|0|||
160930577|NCT02268812|581142095|FG000|Overall Study|Physician Decision|3|||
160930578|NCT02268812|581142096|FG001|Overall Study|Physician Decision|1|||
160930579|NCT02268812|581142097|FG002|Overall Study|Physician Decision|0|||
160930580|NCT02268812|581142098|FG003|Overall Study|Physician Decision|1|||
160930581|NCT02268812|581142095|FG000|Overall Study|Other|5|||
160930582|NCT02268812|581142096|FG001|Overall Study|Other|4|||
160930583|NCT02268812|581142097|FG002|Overall Study|Other|1|||
160930584|NCT02268812|581142098|FG003|Overall Study|Other|3|||
160930585|NCT01951157|581142100|FG000|Overall Study|Progressive Disease|12|||
160930586|NCT01951157|581142101|FG001|Overall Study|Progressive Disease|13|||
160930587|NCT01951157|581142102|FG002|Overall Study|Progressive Disease|10|||
160930588|NCT01951157|581142100|FG000|Overall Study|Treatment-unrelated AE|1|||
160930589|NCT01951157|581142101|FG001|Overall Study|Treatment-unrelated AE|0|||
160930590|NCT01951157|581142102|FG002|Overall Study|Treatment-unrelated AE|3|||
160930591|NCT01951157|581142100|FG000|Overall Study|Study Termination|0|||
160930592|NCT01951157|581142101|FG001|Overall Study|Study Termination|0|||
160930593|NCT01951157|581142102|FG002|Overall Study|Study Termination|1|||
160930594|NCT01951157|581142100|FG000|Overall Study|Physician Decision|5|||
160930595|NCT01951157|581142101|FG001|Overall Study|Physician Decision|3|||
160930596|NCT01951157|581142102|FG002|Overall Study|Physician Decision|2|||
160930597|NCT01951157|581142100|FG000|Overall Study|Non-treatmentrelated death|2|||
160930598|NCT01951157|581142101|FG001|Overall Study|Non-treatmentrelated death|2|||
160930599|NCT01951157|581142102|FG002|Overall Study|Non-treatmentrelated death|2|||
160930600|NCT01951157|581142100|FG000|Overall Study|No treated|0|||
160930601|NCT01951157|581142101|FG001|Overall Study|No treated|1|||
160930602|NCT01951157|581142102|FG002|Overall Study|No treated|0|||
160930603|NCT01951157|581142100|FG000|Overall Study|Treatment-related AE|2|||
160930604|NCT01951157|581142101|FG001|Overall Study|Treatment-related AE|0|||
160930605|NCT01951157|581142102|FG002|Overall Study|Treatment-related AE|4|||
160930606|NCT01951157|581142100|FG000|Overall Study|Consent withdrawn by subject|0|||
160930607|NCT01951157|581142101|FG001|Overall Study|Consent withdrawn by subject|1|||
160930608|NCT01951157|581142102|FG002|Overall Study|Consent withdrawn by subject|3|||
160930609|NCT01951157|581142100|FG000|Overall Study|Treatment-related death|0|||
160930610|NCT01951157|581142101|FG001|Overall Study|Treatment-related death|2|||
160930611|NCT01951157|581142102|FG002|Overall Study|Treatment-related death|0|||
160930612|NCT04964128|581142107|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
160930613|NCT04964128|581142107|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
160930614|NCT00994240|581142109|FG000|Overall Study|Lost to Follow-up|3|||
160930615|NCT00994240|581142110|FG001|Overall Study|Lost to Follow-up|2|||
160930616|NCT00994240|581142109|FG000|Overall Study|Withdrawal by Subject|1|||
160930617|NCT00994240|581142110|FG001|Overall Study|Withdrawal by Subject|0|||
160930618|NCT00994240|581142109|FG000|Overall Study|study termination|2|||
160930619|NCT00994240|581142110|FG001|Overall Study|study termination|3|||
160930620|NCT01177540|581142111|FG000|Overall Study|Adverse Event|1|||
160930621|NCT01177540|581142112|FG001|Overall Study|Adverse Event|0|||
160930622|NCT01070316|581142132|FG000|Extension Phase|Lack of Efficacy|3|||
160930623|NCT01070316|581142132|FG000|Extension Phase|Withdrawal by Subject|1|||
160930624|NCT00748215|581142133|FG000|Overall Study|Withdrawal by Subject|7|||
160930625|NCT00748215|581142134|FG001|Overall Study|Withdrawal by Subject|7|||
160930626|NCT00748215|581142133|FG000|Overall Study|Treatment change|2|||
160930627|NCT00748215|581142134|FG001|Overall Study|Treatment change|1|||
160930628|NCT00748215|581142133|FG000|Overall Study|Change in patient condition|0|||
160930629|NCT00748215|581142134|FG001|Overall Study|Change in patient condition|3|||
160930630|NCT00748215|581142133|FG000|Overall Study|Non-compliant|0|||
160930631|NCT00748215|581142134|FG001|Overall Study|Non-compliant|2|||
160930632|NCT00748215|581142133|FG000|Overall Study|Adverse Event|0|||
160930633|NCT00748215|581142134|FG001|Overall Study|Adverse Event|5|||
160930634|NCT02013167|581142135|FG000|Overall Study|Withdrawal by Subject|15|||
160930635|NCT02013167|581142136|FG001|Overall Study|Withdrawal by Subject|14|||
160930636|NCT02013167|581142135|FG000|Overall Study|Sponsor Decision|1|||
160930637|NCT02013167|581142136|FG001|Overall Study|Sponsor Decision|3|||
160930638|NCT02013167|581142135|FG000|Overall Study|Lost to Follow-up|0|||
160930639|NCT02013167|581142136|FG001|Overall Study|Lost to Follow-up|1|||
160930640|NCT02013167|581142135|FG000|Overall Study|Death|85|||
160930641|NCT02013167|581142136|FG001|Overall Study|Death|160|||
160930642|NCT01113879|581142141|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
160930643|NCT01113879|581142142|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
160930644|NCT00082433|581142146|FG000|Overall Study|Adverse Event|12|||
160930645|NCT00082433|581142147|FG001|Overall Study|Adverse Event|17|||
160930646|NCT00082433|581142146|FG000|Overall Study|Death|8|||
160930647|NCT00082433|581142147|FG001|Overall Study|Death|18|||
161143657|NCT00847613|581909465|FG001|Overall Study|Ongoing at cut-off date|265|||
160930648|NCT00082433|581142146|FG000|Overall Study|Disease Progression/Relapse|270|||
160930649|NCT00082433|581142147|FG001|Overall Study|Disease Progression/Relapse|388|||
160930650|NCT00082433|581142146|FG000|Overall Study|Physician Decision|50|||
161143658|NCT00847613|581909466|FG002|Overall Study|Ongoing at cut-off date|64|||
161143659|NCT00847613|581909467|FG003|Overall Study|Ongoing at cut-off date|64|||
160930651|NCT00082433|581142147|FG001|Overall Study|Physician Decision|61|||
160930652|NCT00082433|581142146|FG000|Overall Study|Lost to Follow-up|1|||
160930653|NCT00082433|581142147|FG001|Overall Study|Lost to Follow-up|2|||
160930654|NCT00082433|581142146|FG000|Overall Study|Study Drug Toxicity|179|||
161143660|NCT00847613|581909464|FG000|Overall Study|Death|1|||
160930655|NCT00082433|581142147|FG001|Overall Study|Study Drug Toxicity|66|||
160930656|NCT00082433|581142146|FG000|Overall Study|Withdrawal by Subject|55|||
160930657|NCT00082433|581142147|FG001|Overall Study|Withdrawal by Subject|30|||
160930658|NCT00082433|581142146|FG000|Overall Study|Still On Treatment|2|||
160930659|NCT00082433|581142147|FG001|Overall Study|Still On Treatment|1|||
160930660|NCT00082433|581142146|FG000|Overall Study|Not Treated|12|||
161143661|NCT00847613|581909465|FG001|Overall Study|Death|1|||
160930661|NCT00082433|581142147|FG001|Overall Study|Not Treated|11|||
160930662|NCT00082433|581142146|FG000|Overall Study|Ineligible|2|||
160930663|NCT00082433|581142147|FG001|Overall Study|Ineligible|1|||
160930664|NCT00082433|581142146|FG000|Overall Study|Noncompliance|2|||
160930665|NCT00082433|581142147|FG001|Overall Study|Noncompliance|1|||
160930666|NCT00082433|581142146|FG000|Overall Study|New primary cancer|1|||
160930667|NCT00082433|581142147|FG001|Overall Study|New primary cancer|0|||
160930668|NCT00082433|581142146|FG000|Overall Study|Impending surgery|0|||
160930669|NCT00082433|581142147|FG001|Overall Study|Impending surgery|1|||
160930670|NCT01796197|581142150|FG000|Overall Study|Lost to Follow-up|1|||
160930671|NCT01796197|581142150|FG000|Overall Study|Lack of Efficacy|1|||
160930672|NCT04097821|581142151|FG000|Overall Study|Subject Decision|0|||
160930673|NCT04097821|581142152|FG001|Overall Study|Subject Decision|0|||
160930674|NCT04097821|581142153|FG002|Overall Study|Subject Decision|0|||
160930675|NCT04097821|581142154|FG003|Overall Study|Subject Decision|1|||
160930676|NCT04097821|581142155|FG004|Overall Study|Subject Decision|2|||
160930677|NCT04097821|581142156|FG005|Overall Study|Subject Decision|2|||
160930678|NCT04097821|581142157|FG006|Overall Study|Subject Decision|0|||
160930679|NCT04097821|581142158|FG007|Overall Study|Subject Decision|1|||
160930680|NCT04097821|581142151|FG000|Overall Study|Death|0|||
160930681|NCT04097821|581142152|FG001|Overall Study|Death|0|||
160930682|NCT04097821|581142153|FG002|Overall Study|Death|3|||
160930683|NCT04097821|581142154|FG003|Overall Study|Death|1|||
160930684|NCT04097821|581142155|FG004|Overall Study|Death|0|||
160930685|NCT04097821|581142156|FG005|Overall Study|Death|0|||
160930686|NCT04097821|581142157|FG006|Overall Study|Death|0|||
160930687|NCT04097821|581142158|FG007|Overall Study|Death|0|||
160930688|NCT04097821|581142151|FG000|Overall Study|Physician Decision|1|||
160930689|NCT04097821|581142152|FG001|Overall Study|Physician Decision|2|||
160930690|NCT04097821|581142153|FG002|Overall Study|Physician Decision|0|||
160930691|NCT04097821|581142154|FG003|Overall Study|Physician Decision|0|||
160930692|NCT04097821|581142155|FG004|Overall Study|Physician Decision|0|||
160930693|NCT04097821|581142156|FG005|Overall Study|Physician Decision|0|||
160930694|NCT04097821|581142157|FG006|Overall Study|Physician Decision|0|||
160930695|NCT04097821|581142158|FG007|Overall Study|Physician Decision|0|||
160930696|NCT04097821|581142151|FG000|Overall Study|Adverse Event|0|||
160930697|NCT04097821|581142152|FG001|Overall Study|Adverse Event|0|||
160930698|NCT04097821|581142153|FG002|Overall Study|Adverse Event|1|||
160930699|NCT04097821|581142154|FG003|Overall Study|Adverse Event|1|||
160930700|NCT04097821|581142155|FG004|Overall Study|Adverse Event|0|||
160930701|NCT04097821|581142156|FG005|Overall Study|Adverse Event|0|||
160930702|NCT04097821|581142157|FG006|Overall Study|Adverse Event|0|||
160930703|NCT04097821|581142158|FG007|Overall Study|Adverse Event|0|||
160930704|NCT04097821|581142151|FG000|Overall Study|New Therapy For Study Indication|0|||
161143662|NCT00847613|581909466|FG002|Overall Study|Death|0|||
161342426|NCT02326883|582640196|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
161342427|NCT01385176|582640197|FG000|Randomization Phase|Death|1|||
161342428|NCT01385176|582640198|FG001|Randomization Phase|Death|2|||
161342429|NCT01385176|582640197|FG000|6-18 Month All VNS Active|Death|1|||
161342430|NCT01385176|582640198|FG001|6-18 Month All VNS Active|Death|2|||
161342431|NCT01385176|582640197|FG000|6-18 Month All VNS Active|Physician Decision|0|||
161342432|NCT01385176|582640198|FG001|6-18 Month All VNS Active|Physician Decision|1|||
161342433|NCT01385176|582640197|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
161342434|NCT01385176|582640198|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
161342435|NCT01385176|582640197|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
161342436|NCT01385176|582640198|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
161342437|NCT00284856|582640199|FG000|Overall Study|Adverse Event|3|||
161342438|NCT00284856|582640200|FG001|Overall Study|Adverse Event|3|||
161342439|NCT00284856|582640201|FG002|Overall Study|Adverse Event|3|||
160930705|NCT04097821|581142152|FG001|Overall Study|New Therapy For Study Indication|0|||
160930706|NCT04097821|581142153|FG002|Overall Study|New Therapy For Study Indication|0|||
160930707|NCT04097821|581142154|FG003|Overall Study|New Therapy For Study Indication|0|||
161143663|NCT00847613|581909467|FG003|Overall Study|Death|0|||
161342440|NCT00284856|582640199|FG000|Overall Study|Lack of Efficacy|2|||
161342441|NCT00284856|582640200|FG001|Overall Study|Lack of Efficacy|1|||
160930708|NCT04097821|581142155|FG004|Overall Study|New Therapy For Study Indication|0|||
160930709|NCT04097821|581142156|FG005|Overall Study|New Therapy For Study Indication|0|||
160930710|NCT04097821|581142157|FG006|Overall Study|New Therapy For Study Indication|1|||
160930711|NCT04097821|581142158|FG007|Overall Study|New Therapy For Study Indication|0|||
160930712|NCT00244712|581142162|FG000|Overall Study|Adverse Event|20|||
160930713|NCT00244712|581142163|FG001|Overall Study|Adverse Event|21|||
161143664|NCT00847613|581909464|FG000|Overall Study|Adverse Event|36|||
160930714|NCT00244712|581142162|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
160930715|NCT00244712|581142163|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
160930716|NCT00244712|581142162|FG000|Overall Study|Lack of Compliance|10|||
160930717|NCT00244712|581142163|FG001|Overall Study|Lack of Compliance|11|||
161342442|NCT00284856|582640201|FG002|Overall Study|Lack of Efficacy|8|||
161342443|NCT00284856|582640199|FG000|Overall Study|Lost to Follow-up|25|||
161342444|NCT00284856|582640200|FG001|Overall Study|Lost to Follow-up|21|||
160930718|NCT00244712|581142162|FG000|Overall Study|Lost to Follow-up|45|||
160930719|NCT00244712|581142163|FG001|Overall Study|Lost to Follow-up|52|||
160930720|NCT00244712|581142162|FG000|Overall Study|Withdrawal by Subject|13|||
160930721|NCT00244712|581142163|FG001|Overall Study|Withdrawal by Subject|23|||
160930722|NCT00244712|581142162|FG000|Overall Study|Protocol Violation, disease progression|13|||
160930723|NCT00244712|581142163|FG001|Overall Study|Protocol Violation, disease progression|11|||
160930724|NCT01077804|581142166|FG000|Overall Study|Unreachable|102|||
160930725|NCT01077804|581142166|FG000|Overall Study|Refused to continue|79|||
160930726|NCT01077804|581142166|FG000|Overall Study|Other|18|||
160930727|NCT02776917|581142167|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
160930728|NCT02620046|581142169|FG000|Overall Study|Adverse Event|22|||
160930729|NCT02620046|581142170|FG001|Overall Study|Adverse Event|42|||
160930730|NCT02620046|581142169|FG000|Overall Study|Lost to Follow-up|4|||
160930731|NCT02620046|581142170|FG001|Overall Study|Lost to Follow-up|10|||
160930732|NCT02620046|581142169|FG000|Overall Study|Withdrawal by Subject|36|||
160930733|NCT02620046|581142170|FG001|Overall Study|Withdrawal by Subject|66|||
160930734|NCT02620046|581142169|FG000|Overall Study|Site Termination|3|||
160930735|NCT02620046|581142170|FG001|Overall Study|Site Termination|3|||
160930736|NCT02620046|581142169|FG000|Overall Study|Pregnancy|3|||
160930737|NCT02620046|581142170|FG001|Overall Study|Pregnancy|7|||
160930738|NCT02620046|581142169|FG000|Overall Study|Lack of Efficacy|81|||
160930739|NCT02620046|581142170|FG001|Overall Study|Lack of Efficacy|146|||
160930740|NCT02620046|581142169|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
160930741|NCT02620046|581142170|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
160930742|NCT02620046|581142169|FG000|Overall Study|Reason Not Specified|13|||
160930743|NCT02620046|581142170|FG001|Overall Study|Reason Not Specified|21|||
160930744|NCT02620046|581142169|FG000|Overall Study|Significant Protocol Deviation|0|||
160930745|NCT02620046|581142170|FG001|Overall Study|Significant Protocol Deviation|1|||
160930746|NCT00560950|581142175|FG000|Overall Study|Lost to Follow-up|1|||
160930747|NCT00560950|581142176|FG001|Overall Study|Lost to Follow-up|0|||
160930748|NCT00574405|581144001|FG000|Overall Study|Withdrawal by Subject|3|||
160930749|NCT00574405|581144002|FG001|Overall Study|Withdrawal by Subject|2|||
160930750|NCT01336738|581144003|FG000|Overall Study|Adverse Event|0|||
160930751|NCT01336738|581144004|FG001|Overall Study|Adverse Event|3|||
160930752|NCT01336738|581144005|FG002|Overall Study|Adverse Event|2|||
160930753|NCT01336738|581144006|FG003|Overall Study|Adverse Event|1|||
160930754|NCT01336738|581144007|FG004|Overall Study|Adverse Event|3|||
160930755|NCT01336738|581144003|FG000|Overall Study|Lost to Follow-up|2|||
160930756|NCT01336738|581144004|FG001|Overall Study|Lost to Follow-up|1|||
160930757|NCT01336738|581144005|FG002|Overall Study|Lost to Follow-up|2|||
160930758|NCT01336738|581144006|FG003|Overall Study|Lost to Follow-up|2|||
160930759|NCT01336738|581144007|FG004|Overall Study|Lost to Follow-up|2|||
160930760|NCT01336738|581144003|FG000|Overall Study|Did not meet entrance criteria|0|||
160930761|NCT01336738|581144004|FG001|Overall Study|Did not meet entrance criteria|1|||
160930762|NCT01336738|581144005|FG002|Overall Study|Did not meet entrance criteria|0|||
160930763|NCT01336738|581144006|FG003|Overall Study|Did not meet entrance criteria|0|||
160930764|NCT01336738|581144007|FG004|Overall Study|Did not meet entrance criteria|0|||
160930765|NCT01336738|581144003|FG000|Overall Study|Protocol Violation|0|||
160930766|NCT01336738|581144004|FG001|Overall Study|Protocol Violation|1|||
160930767|NCT01336738|581144005|FG002|Overall Study|Protocol Violation|0|||
160930768|NCT01336738|581144006|FG003|Overall Study|Protocol Violation|0|||
160930769|NCT01336738|581144007|FG004|Overall Study|Protocol Violation|0|||
160930770|NCT01336738|581144003|FG000|Overall Study|Withdrawal by Subject|2|||
160930771|NCT01336738|581144004|FG001|Overall Study|Withdrawal by Subject|0|||
160930772|NCT01336738|581144005|FG002|Overall Study|Withdrawal by Subject|2|||
160930773|NCT01336738|581144006|FG003|Overall Study|Withdrawal by Subject|1|||
160930774|NCT01336738|581144007|FG004|Overall Study|Withdrawal by Subject|1|||
160930775|NCT01336738|581144003|FG000|Overall Study|Other|3|||
161143665|NCT00847613|581909465|FG001|Overall Study|Adverse Event|26|||
161143666|NCT00847613|581909466|FG002|Overall Study|Adverse Event|5|||
161143667|NCT00847613|581909467|FG003|Overall Study|Adverse Event|6|||
161143668|NCT00847613|581909464|FG000|Overall Study|Lack of Efficacy|7|||
160930776|NCT01336738|581144004|FG001|Overall Study|Other|3|||
160930777|NCT01336738|581144005|FG002|Overall Study|Other|2|||
160930778|NCT01336738|581144006|FG003|Overall Study|Other|3|||
160930779|NCT01336738|581144007|FG004|Overall Study|Other|4|||
160930780|NCT01083433|581144008|FG000|Overall Study|Lost to Follow-up|2|||
161143669|NCT00847613|581909465|FG001|Overall Study|Lack of Efficacy|3|||
160930781|NCT01083433|581144009|FG001|Overall Study|Lost to Follow-up|1|||
160930782|NCT01083433|581144010|FG002|Overall Study|Lost to Follow-up|1|||
160930783|NCT01083433|581144008|FG000|Overall Study|Withdrawal by Subject|0|||
160930784|NCT01083433|581144009|FG001|Overall Study|Withdrawal by Subject|5|||
160930785|NCT01083433|581144010|FG002|Overall Study|Withdrawal by Subject|3|||
160930786|NCT01083433|581144008|FG000|Overall Study|Pregnancy|0|||
160930787|NCT01083433|581144009|FG001|Overall Study|Pregnancy|0|||
160930788|NCT01083433|581144010|FG002|Overall Study|Pregnancy|1|||
160930789|NCT02970968|581144012|FG000|Overall Study|Withdrawal by Subject|3|||
160930790|NCT02970968|581144013|FG001|Overall Study|Withdrawal by Subject|3|||
160930791|NCT02970968|581144012|FG000|Overall Study|Adverse Event|1|||
160930792|NCT02970968|581144013|FG001|Overall Study|Adverse Event|2|||
160930793|NCT02970968|581144012|FG000|Overall Study|Lost to Follow-up|1|||
160930794|NCT02970968|581144013|FG001|Overall Study|Lost to Follow-up|1|||
160930795|NCT02970968|581144012|FG000|Overall Study|Non-Compliance|0|||
160930796|NCT02970968|581144013|FG001|Overall Study|Non-Compliance|1|||
160930797|NCT03003520|581144014|FG000|Overall Study|Adverse Event|9|||
160930798|NCT03003520|581144015|FG001|Overall Study|Adverse Event|0|||
160930799|NCT03003520|581144014|FG000|Overall Study|Death|1|||
160930800|NCT03003520|581144015|FG001|Overall Study|Death|0|||
160930801|NCT03003520|581144014|FG000|Overall Study|Other reasons|4|||
160930802|NCT03003520|581144015|FG001|Overall Study|Other reasons|0|||
160930803|NCT03003520|581144014|FG000|Overall Study|Withdrawal by Subject|6|||
160930804|NCT03003520|581144015|FG001|Overall Study|Withdrawal by Subject|0|||
160930805|NCT03003520|581144014|FG000|Overall Study|Progressive disease|9|||
160930806|NCT03003520|581144015|FG001|Overall Study|Progressive disease|1|||
160930807|NCT04982029|581144016|FG000|Overall Study|Lost to Follow-up|2|||
160930808|NCT04982029|581144017|FG001|Overall Study|Lost to Follow-up|3|||
160930809|NCT03264404|581144018|FG000|Overall Study|Death|2|||
160930810|NCT03264404|581144018|FG000|Overall Study|Physician Decision|1|||
160930811|NCT03264404|581144018|FG000|Overall Study|Disease Progression|28|||
160930812|NCT03264404|581144018|FG000|Overall Study|Adverse Event|1|||
160930813|NCT03264404|581144018|FG000|Overall Study|Off study prior to treatment|2|||
160930814|NCT02565381|581144019|FG000|Overall Study|Lost to Follow-up|1|||
160930815|NCT02565381|581144020|FG001|Overall Study|Lost to Follow-up|0|||
160930816|NCT02565381|581144021|FG002|Overall Study|Lost to Follow-up|1|||
160930817|NCT04615949|581144024|FG000|Overall Study|Withdrawal by Subject|2|||
160930818|NCT04615949|581144025|FG001|Overall Study|Withdrawal by Subject|4|||
160930819|NCT04615949|581144024|FG000|Overall Study|Lost to Follow-up|2|||
160930820|NCT04615949|581144025|FG001|Overall Study|Lost to Follow-up|2|||
160930821|NCT04615949|581144024|FG000|Overall Study|Death|0|||
160930822|NCT04615949|581144025|FG001|Overall Study|Death|2|||
160930823|NCT03036566|581144026|FG000|Overall Study|Lost to Follow-up|3|||
160930824|NCT05458856|581144027|FG000|Overall Study|Withdrawal by Subject|5|||
160930825|NCT05458856|581144027|FG000|Overall Study|Death|4|||
160930826|NCT05458856|581144027|FG000|Overall Study|Protocol Deviation|3|||
160930827|NCT05458856|581144027|FG000|Overall Study|Physician Decision|1|||
160930828|NCT01852292|581144031|FG000|Overall Study|Untreated - did not receive study drug|3|||
160930829|NCT01852292|581144032|FG001|Overall Study|Untreated - did not receive study drug|1|||
160930830|NCT01852292|581144031|FG000|Overall Study|Death|9|||
160930831|NCT01852292|581144032|FG001|Overall Study|Death|8|||
160930832|NCT01852292|581144031|FG000|Overall Study|Patient/guardian decision|8|||
160930833|NCT01852292|581144032|FG001|Overall Study|Patient/guardian decision|4|||
160930834|NCT01852292|581144031|FG000|Overall Study|Adverse Event|8|||
160930835|NCT01852292|581144032|FG001|Overall Study|Adverse Event|11|||
160930836|NCT01852292|581144031|FG000|Overall Study|Physician Decision|6|||
160930837|NCT01852292|581144032|FG001|Overall Study|Physician Decision|2|||
160930838|NCT01852292|581144031|FG000|Overall Study|Protocol Violation|2|||
160930839|NCT01852292|581144032|FG001|Overall Study|Protocol Violation|0|||
160930840|NCT01852292|581144031|FG000|Overall Study|Non-compliance with study treatment|1|||
160930841|NCT01852292|581144032|FG001|Overall Study|Non-compliance with study treatment|0|||
160930842|NCT01852292|581144031|FG000|Overall Study|Study terminated by Sponsor|0|||
160930843|NCT01852292|581144032|FG001|Overall Study|Study terminated by Sponsor|1|||
160930844|NCT01852292|581144031|FG000|Overall Study|Progressive disease|42|||
160930845|NCT01852292|581144032|FG001|Overall Study|Progressive disease|52|||
160930846|NCT01914666|581144033|FG000|Treatment Period|Lack of Efficacy|0|||
160930847|NCT01914666|581144034|FG001|Treatment Period|Lack of Efficacy|0|||
160930848|NCT01914666|581144035|FG002|Treatment Period|Lack of Efficacy|2|||
160930849|NCT01914666|581144033|FG000|Treatment Period|Adverse Event|10|||
160930850|NCT01914666|581144034|FG001|Treatment Period|Adverse Event|4|||
160930851|NCT01914666|581144035|FG002|Treatment Period|Adverse Event|2|||
160930852|NCT01914666|581144033|FG000|Treatment Period|Withdrawal by Subject|3|||
160930853|NCT01914666|581144034|FG001|Treatment Period|Withdrawal by Subject|2|||
160930854|NCT01914666|581144035|FG002|Treatment Period|Withdrawal by Subject|2|||
161143670|NCT00847613|581909466|FG002|Overall Study|Lack of Efficacy|3|||
161143671|NCT00847613|581909467|FG003|Overall Study|Lack of Efficacy|1|||
161143672|NCT00847613|581909464|FG000|Overall Study|Study terminated by Sponsor|1|||
160930855|NCT01914666|581144033|FG000|Treatment Period|Physician Decision|0|||
160930856|NCT01914666|581144034|FG001|Treatment Period|Physician Decision|0|||
160930857|NCT01914666|581144035|FG002|Treatment Period|Physician Decision|2|||
160930858|NCT02388737|581144036|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
160930859|NCT02388737|581144037|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
160930860|NCT02388737|581144038|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
160930861|NCT02388737|581144036|FG000|Overall Study|Major Protocol Deviation|18|||
160930862|NCT02388737|581144037|FG001|Overall Study|Major Protocol Deviation|25|||
160930863|NCT02388737|581144038|FG002|Overall Study|Major Protocol Deviation|22|||
160930864|NCT02388737|581144036|FG000|Overall Study|Lost to Follow-up|5|||
160930865|NCT02388737|581144037|FG001|Overall Study|Lost to Follow-up|1|||
160930866|NCT02388737|581144038|FG002|Overall Study|Lost to Follow-up|4|||
160930867|NCT02388737|581144036|FG000|Overall Study|Voluntary Withdrawal|10|||
160930868|NCT02388737|581144037|FG001|Overall Study|Voluntary Withdrawal|18|||
160930869|NCT02388737|581144038|FG002|Overall Study|Voluntary Withdrawal|17|||
160930870|NCT02388737|581144036|FG000|Overall Study|Lack of Efficacy|3|||
160930871|NCT02388737|581144037|FG001|Overall Study|Lack of Efficacy|0|||
160930872|NCT02388737|581144038|FG002|Overall Study|Lack of Efficacy|3|||
160930873|NCT02388737|581144036|FG000|Overall Study|Reason Not Specified|5|||
160930874|NCT02388737|581144037|FG001|Overall Study|Reason Not Specified|5|||
160930875|NCT02388737|581144038|FG002|Overall Study|Reason Not Specified|4|||
160930876|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
160930877|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
160930878|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
160930879|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
160930880|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
160930881|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
160930882|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
160930883|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
160930884|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
160930885|NCT03252522|581144039|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
160930886|NCT03252522|581144040|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
160930887|NCT03252522|581144041|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
160930888|NCT03252522|581144039|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
160930889|NCT03252522|581144040|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
160930890|NCT03252522|581144041|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
160930891|NCT03252522|581144039|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
160930892|NCT03252522|581144040|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
160930893|NCT03252522|581144041|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
160930894|NCT03252522|581144039|FG000|Phase 2: Open Label|Adverse Event|0|||
160930895|NCT03252522|581144040|FG001|Phase 2: Open Label|Adverse Event|0|||
160930896|NCT03252522|581144041|FG002|Phase 2: Open Label|Adverse Event|2|||
160930897|NCT03252522|581144039|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
160930898|NCT03252522|581144040|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
160930899|NCT03252522|581144041|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
160930900|NCT03299842|581144043|FG000|Overall Study|Caregiver withdrew consent|2|||
160930901|NCT03299842|581144043|FG000|Overall Study|Child would not keep the watch on|3|||
160930902|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Adverse Event|2|||
160930903|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Adverse Event|3|||
160930904|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Adverse Event|4|||
160930905|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Adverse Event|4|||
160930906|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
160930907|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
160930908|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
160930909|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
160930910|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
160930911|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
160930912|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
160930913|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
160930914|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
160930915|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
160930916|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
160930917|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
160930918|NCT00071812|581144044|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
160930919|NCT00071812|581144045|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
160930920|NCT00071812|581144046|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
160930921|NCT00071812|581144047|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
160930922|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
160930923|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
160998126|NCT01563354|581378572|FG002|Core Phase|Withdrawal by Subject|3|||
160998127|NCT01563354|581378570|FG000|Core Phase|Lost to Follow-up|1|||
161264234|NCT01732484|582349183|FG000|Overall Study|Death|7|||
161264235|NCT01732484|582349183|FG000|Overall Study|Lost to Follow-up|14|||
161264236|NCT01732484|582349183|FG000|Overall Study|chronical illness|5|||
161264237|NCT00289874|582349184|FG000|Overall Study|Adverse Event|1|||
161264238|NCT00289874|582349185|FG001|Overall Study|Adverse Event|5|||
160930924|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
160930925|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
160930926|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160930927|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160930928|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160998128|NCT01563354|581378571|FG001|Core Phase|Lost to Follow-up|0|||
160998129|NCT01563354|581378572|FG002|Core Phase|Lost to Follow-up|0|||
161264239|NCT00289874|582349184|FG000|Overall Study|Lost to Follow-up|1|||
160930929|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
160930930|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160930931|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160930932|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160930933|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
160930934|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160930935|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160930936|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160930937|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
160930938|NCT00071812|581144044|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160930939|NCT00071812|581144045|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160930940|NCT00071812|581144046|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
160930941|NCT00071812|581144047|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
160930942|NCT01940120|581144050|FG000|Overall Study|Death|40|||
160930943|NCT01940120|581144050|FG000|Overall Study|Withdrawal by Subject|8|||
160930944|NCT01572038|581144052|FG000|Overall Study|Death|648|||
160930945|NCT01572038|581144052|FG000|Overall Study|Withdrawal by Subject|204|||
160930946|NCT01572038|581144052|FG000|Overall Study|Lost to Follow-up|81|||
160930947|NCT01572038|581144052|FG000|Overall Study|Physician Decision|20|||
160930948|NCT01572038|581144052|FG000|Overall Study|Patient Decision|14|||
160930949|NCT01572038|581144052|FG000|Overall Study|Progressive Disease|8|||
160930950|NCT01572038|581144052|FG000|Overall Study|Site Closed Before Completing Form|6|||
160930951|NCT01572038|581144052|FG000|Overall Study|Enrolled into Another Trial|3|||
160930952|NCT01572038|581144052|FG000|Overall Study|Participated in Another Trial|3|||
160930953|NCT01572038|581144052|FG000|Overall Study|Termination by Sponsor|2|||
160930954|NCT01572038|581144052|FG000|Overall Study|Patient Deterioration|1|||
160930955|NCT01572038|581144052|FG000|Overall Study|Sponsor Decision|1|||
160930956|NCT04152447|581144053|FG000|Overall Study|Lost to Follow-up|1|||
160930957|NCT04152447|581144054|FG001|Overall Study|Lost to Follow-up|0|||
160930958|NCT04152447|581144053|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
160930959|NCT04152447|581144054|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
160930960|NCT04152447|581144053|FG000|Overall Study|Withdrawal by Subject|0|||
160930961|NCT04152447|581144054|FG001|Overall Study|Withdrawal by Subject|1|||
160930962|NCT04152447|581144053|FG000|Overall Study|Found ineligible after enrolling|1|||
160930963|NCT04152447|581144054|FG001|Overall Study|Found ineligible after enrolling|1|||
160930964|NCT04152447|581144053|FG000|Overall Study|Did not receive VR headset in time.|0|||
160930965|NCT04152447|581144054|FG001|Overall Study|Did not receive VR headset in time.|2|||
160930966|NCT03240575|581144055|FG000|Overall Study|Adverse Event|0|||
160930967|NCT03240575|581144056|FG001|Overall Study|Adverse Event|2|||
160930968|NCT03240575|581144057|FG002|Overall Study|Adverse Event|0|||
160930969|NCT03240575|581144058|FG003|Overall Study|Adverse Event|1|||
160930970|NCT03240575|581144055|FG000|Overall Study|Withdrawal by Subject|2|||
160930971|NCT03240575|581144056|FG001|Overall Study|Withdrawal by Subject|11|||
160930972|NCT03240575|581144057|FG002|Overall Study|Withdrawal by Subject|0|||
160930973|NCT03240575|581144058|FG003|Overall Study|Withdrawal by Subject|1|||
160930974|NCT03240575|581144055|FG000|Overall Study|Other|0|||
160930975|NCT03240575|581144056|FG001|Overall Study|Other|1|||
160930976|NCT03240575|581144057|FG002|Overall Study|Other|0|||
160930977|NCT03240575|581144058|FG003|Overall Study|Other|0|||
160930978|NCT04482179|581144059|FG000|Overall Study|Death|1|||
160930979|NCT04482179|581144060|FG001|Overall Study|Death|0|||
160930980|NCT04482179|581144059|FG000|Overall Study|Withdrawal by Subject|1|||
160930981|NCT04482179|581144060|FG001|Overall Study|Withdrawal by Subject|0|||
160930982|NCT03034954|581144063|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
160930983|NCT03034954|581144064|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
160930984|NCT03568942|581144067|FG000|Overall Study|Family emergency|1|||
160930985|NCT03568942|581144067|FG000|Overall Study|Lost to Follow-up|1|||
160930986|NCT04145895|581144073|FG000|Overall Study|Physician Decision|2|||
160930987|NCT04145895|581144074|FG001|Overall Study|Physician Decision|0|||
160930988|NCT04145895|581144073|FG000|Overall Study|Withdrawal by Subject|0|||
161264240|NCT00289874|582349185|FG001|Overall Study|Lost to Follow-up|1|||
161264241|NCT00289874|582349184|FG000|Overall Study|Protocol Violation|3|||
161264242|NCT00289874|582349185|FG001|Overall Study|Protocol Violation|2|||
160930989|NCT04145895|581144074|FG001|Overall Study|Withdrawal by Subject|2|||
160930990|NCT00913744|581144075|FG000|Overall Study|Adverse Event|2|||
160930991|NCT00913744|581144076|FG001|Overall Study|Adverse Event|0|||
160930992|NCT00913744|581144075|FG000|Overall Study|Withdrawal by Subject|2|||
160930993|NCT00913744|581144076|FG001|Overall Study|Withdrawal by Subject|1|||
160930994|NCT00913744|581144075|FG000|Overall Study|Death|1|||
160930995|NCT00913744|581144076|FG001|Overall Study|Death|0|||
160930996|NCT00805935|581144077|FG000|Overall Study|Stimulation Failure|1|||
160930997|NCT00805935|581144078|FG001|Overall Study|Stimulation Failure|5|||
160930998|NCT00805935|581144079|FG002|Overall Study|Stimulation Failure|2|||
160930999|NCT00805935|581144080|FG003|Overall Study|Stimulation Failure|2|||
160931000|NCT00805935|581144077|FG000|Overall Study|Cycle cancelled|0|||
160931001|NCT00805935|581144078|FG001|Overall Study|Cycle cancelled|0|||
160931002|NCT00805935|581144079|FG002|Overall Study|Cycle cancelled|2|||
160931003|NCT00805935|581144080|FG003|Overall Study|Cycle cancelled|0|||
160931004|NCT00805935|581144077|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
160931005|NCT00805935|581144078|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
160931006|NCT00805935|581144079|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
160931007|NCT00805935|581144080|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
160931008|NCT00805935|581144077|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
160931009|NCT00805935|581144078|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
160931010|NCT00805935|581144079|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
160931011|NCT00805935|581144080|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
160931012|NCT00805935|581144077|FG000|Overall Study|Lost to Follow-up|1|||
160931013|NCT00805935|581144078|FG001|Overall Study|Lost to Follow-up|0|||
160931014|NCT00805935|581144079|FG002|Overall Study|Lost to Follow-up|0|||
160931015|NCT00805935|581144080|FG003|Overall Study|Lost to Follow-up|0|||
160931016|NCT00805935|581144077|FG000|Overall Study|No positive serum pregnancy|8|||
160931017|NCT00805935|581144078|FG001|Overall Study|No positive serum pregnancy|7|||
160931018|NCT00805935|581144079|FG002|Overall Study|No positive serum pregnancy|6|||
160931019|NCT00805935|581144080|FG003|Overall Study|No positive serum pregnancy|5|||
160931020|NCT00805935|581144077|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160931021|NCT00805935|581144078|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160931022|NCT00805935|581144079|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
160931023|NCT00805935|581144080|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
160931024|NCT00805935|581144077|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
160931025|NCT00805935|581144078|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
160931026|NCT00805935|581144079|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
160931027|NCT00805935|581144080|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
160931028|NCT00805935|581144077|FG000|Overall Study|Biochemical pregnancy|0|||
160931029|NCT00805935|581144078|FG001|Overall Study|Biochemical pregnancy|1|||
160931030|NCT00805935|581144079|FG002|Overall Study|Biochemical pregnancy|0|||
160931031|NCT00805935|581144080|FG003|Overall Study|Biochemical pregnancy|0|||
160931032|NCT00805935|581144077|FG000|Overall Study|Chemical pregnancy|0|||
160931033|NCT00805935|581144078|FG001|Overall Study|Chemical pregnancy|5|||
160931034|NCT00805935|581144079|FG002|Overall Study|Chemical pregnancy|3|||
160931035|NCT00805935|581144080|FG003|Overall Study|Chemical pregnancy|2|||
160931036|NCT00805935|581144077|FG000|Overall Study|Ectopic pregnancy|0|||
160931037|NCT00805935|581144078|FG001|Overall Study|Ectopic pregnancy|0|||
160931038|NCT00805935|581144079|FG002|Overall Study|Ectopic pregnancy|1|||
160931039|NCT00805935|581144080|FG003|Overall Study|Ectopic pregnancy|0|||
160931040|NCT00805935|581144077|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
160931041|NCT00805935|581144078|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
160931042|NCT00805935|581144079|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
160931043|NCT00805935|581144080|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
160931044|NCT00283439|581144081|FG000|Overall Study|Adverse Event|0|||
160931045|NCT00283439|581144082|FG001|Overall Study|Adverse Event|0|||
160931046|NCT00283439|581144083|FG002|Overall Study|Adverse Event|0|||
160931047|NCT00283439|581144084|FG003|Overall Study|Adverse Event|1|||
160931048|NCT00283439|581144081|FG000|Overall Study|Death|0|||
161143673|NCT00847613|581909465|FG001|Overall Study|Study terminated by Sponsor|0|||
161143674|NCT00847613|581909466|FG002|Overall Study|Study terminated by Sponsor|2|||
161143675|NCT00847613|581909467|FG003|Overall Study|Study terminated by Sponsor|1|||
161143676|NCT00847613|581909464|FG000|Overall Study|Lost to Follow-up|5|||
161143677|NCT00847613|581909465|FG001|Overall Study|Lost to Follow-up|0|||
161143678|NCT00847613|581909466|FG002|Overall Study|Lost to Follow-up|0|||
161143679|NCT00847613|581909467|FG003|Overall Study|Lost to Follow-up|3|||
161143680|NCT00847613|581909464|FG000|Overall Study|Protocol Violation|6|||
161143681|NCT00847613|581909465|FG001|Overall Study|Protocol Violation|6|||
161143682|NCT00847613|581909466|FG002|Overall Study|Protocol Violation|3|||
161143683|NCT00847613|581909467|FG003|Overall Study|Protocol Violation|1|||
161143684|NCT00847613|581909464|FG000|Overall Study|Pregnancy|1|||
161143685|NCT00847613|581909465|FG001|Overall Study|Pregnancy|1|||
161143686|NCT00847613|581909466|FG002|Overall Study|Pregnancy|0|||
161143687|NCT00847613|581909467|FG003|Overall Study|Pregnancy|0|||
161143688|NCT00847613|581909464|FG000|Overall Study|Site closure|1|||
160931049|NCT00283439|581144082|FG001|Overall Study|Death|0|||
160931050|NCT00283439|581144083|FG002|Overall Study|Death|1|||
160931051|NCT00283439|581144084|FG003|Overall Study|Death|0|||
160931052|NCT00283439|581144081|FG000|Overall Study|Disease progression|0|||
160931053|NCT00283439|581144082|FG001|Overall Study|Disease progression|1|||
160931054|NCT00283439|581144083|FG002|Overall Study|Disease progression|0|||
160931055|NCT00283439|581144084|FG003|Overall Study|Disease progression|0|||
160931056|NCT00283439|581144081|FG000|Overall Study|Requirement for alternative therapy|1|||
161143689|NCT00847613|581909465|FG001|Overall Study|Site closure|0|||
161143690|NCT00847613|581909466|FG002|Overall Study|Site closure|0|||
161143691|NCT00847613|581909467|FG003|Overall Study|Site closure|1|||
161143692|NCT00847613|581909464|FG000|Overall Study|Withdrawal by Subject|8|||
161143693|NCT00847613|581909465|FG001|Overall Study|Withdrawal by Subject|11|||
160931057|NCT00283439|581144082|FG001|Overall Study|Requirement for alternative therapy|2|||
160931058|NCT00283439|581144083|FG002|Overall Study|Requirement for alternative therapy|5|||
160931059|NCT00283439|581144084|FG003|Overall Study|Requirement for alternative therapy|2|||
160931060|NCT00283439|581144081|FG000|Overall Study|Stem cell transplant|6|||
160931061|NCT00283439|581144082|FG001|Overall Study|Stem cell transplant|6|||
160931062|NCT00283439|581144083|FG002|Overall Study|Stem cell transplant|4|||
160931063|NCT00283439|581144084|FG003|Overall Study|Stem cell transplant|3|||
160931064|NCT00283439|581144081|FG000|Overall Study|Treatment discontinued|0|||
160931065|NCT00283439|581144082|FG001|Overall Study|Treatment discontinued|2|||
160931066|NCT00283439|581144083|FG002|Overall Study|Treatment discontinued|1|||
160931067|NCT00283439|581144084|FG003|Overall Study|Treatment discontinued|3|||
160931068|NCT00283439|581144081|FG000|Overall Study|Other|1|||
160931069|NCT00283439|581144082|FG001|Overall Study|Other|0|||
160931070|NCT00283439|581144083|FG002|Overall Study|Other|0|||
160931071|NCT00283439|581144084|FG003|Overall Study|Other|0|||
160931072|NCT01539226|581144085|FG000|Overall Study|Withdrawal by Subject|24|||
160931073|NCT01539226|581144086|FG001|Overall Study|Withdrawal by Subject|54|||
160931074|NCT01539226|581144085|FG000|Overall Study|Lost to Follow-up|20|||
160931075|NCT01539226|581144086|FG001|Overall Study|Lost to Follow-up|54|||
160931076|NCT01539226|581144085|FG000|Overall Study|Death|1|||
160931077|NCT01539226|581144086|FG001|Overall Study|Death|2|||
160931078|NCT01539226|581144085|FG000|Overall Study|Adverse Event|2|||
160931079|NCT01539226|581144086|FG001|Overall Study|Adverse Event|0|||
160931080|NCT01539226|581144085|FG000|Overall Study|Pregnancy|13|||
160931081|NCT01539226|581144086|FG001|Overall Study|Pregnancy|29|||
160931082|NCT01539226|581144085|FG000|Overall Study|inappropriate enrollment|0|||
160931083|NCT01539226|581144086|FG001|Overall Study|inappropriate enrollment|1|||
160931084|NCT01539226|581144085|FG000|Overall Study|Multiple Reasons|3|||
160931085|NCT01539226|581144086|FG001|Overall Study|Multiple Reasons|1|||
160931086|NCT01539226|581144085|FG000|Overall Study|not HIV seroconversion-related|93|||
160931087|NCT01539226|581144086|FG001|Overall Study|not HIV seroconversion-related|176|||
160931088|NCT01539226|581144085|FG000|Overall Study|HIV seroconversion-related|55|||
160931089|NCT01539226|581144086|FG001|Overall Study|HIV seroconversion-related|80|||
160931090|NCT01539226|581144085|FG000|Overall Study|Non-compliance|6|||
160931091|NCT01539226|581144086|FG001|Overall Study|Non-compliance|8|||
160931092|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
160931093|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
160931094|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
160931095|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
160931096|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
160931097|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
160931098|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
160931099|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
160931100|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
160931101|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
160931102|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
161264243|NCT00289874|582349184|FG000|Overall Study|Did not meet eligibility|1|||
161264244|NCT00289874|582349185|FG001|Overall Study|Did not meet eligibility|0|||
161264245|NCT01087489|582349186|FG000|Overall Study|enrolled in another VA study|0|||
160931103|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
160931104|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
160931105|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
160931106|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
160931107|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
160998130|NCT01563354|581378570|FG000|Core Phase|Death|1|||
160998131|NCT01563354|581378571|FG001|Core Phase|Death|5|||
160998132|NCT01563354|581378572|FG002|Core Phase|Death|2|||
160998133|NCT01563354|581378570|FG000|Core Phase|Diseasse progression|18|||
161143694|NCT00847613|581909466|FG002|Overall Study|Withdrawal by Subject|2|||
161264246|NCT01087489|582349187|FG001|Overall Study|enrolled in another VA study|1|||
161143695|NCT00847613|581909467|FG003|Overall Study|Withdrawal by Subject|2|||
161143696|NCT00847613|581909464|FG000|Overall Study|Participant moved|4|||
161264247|NCT01087489|582349186|FG000|Overall Study|Death|0|||
161264248|NCT01087489|582349187|FG001|Overall Study|Death|1|||
161342445|NCT00284856|582640201|FG002|Overall Study|Lost to Follow-up|22|||
160931108|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
160931109|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
160931110|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
160931111|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
160931112|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
160931113|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
160998134|NCT01563354|581378571|FG001|Core Phase|Diseasse progression|7|||
160998135|NCT01563354|581378572|FG002|Core Phase|Diseasse progression|8|||
160931114|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
160931115|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
160931116|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
160931117|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
160931118|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
160931119|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
160931120|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
160931121|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
160931122|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
160931123|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
160931124|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
160931125|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
160931126|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
160931127|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
160931128|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
160931129|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
160931130|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
160931131|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
160931132|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
160931133|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
160931134|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
160931135|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
160931136|NCT01218516|581144087|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
160931137|NCT01218516|581144088|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
160931138|NCT01218516|581144089|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
160931139|NCT01218516|581144090|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
160931140|NCT01632891|581144091|FG000|Overall Study|Lost to Follow-up|0|||
160931141|NCT01632891|581144092|FG001|Overall Study|Lost to Follow-up|1|||
160931142|NCT01632891|581144091|FG000|Overall Study|Withdrawal by Subject|1|||
160931143|NCT01632891|581144092|FG001|Overall Study|Withdrawal by Subject|0|||
160931144|NCT00333229|581144093|FG000|Overall Study|Lack of Efficacy|0|||
160931145|NCT00333229|581144094|FG001|Overall Study|Lack of Efficacy|1|||
160931146|NCT00240071|581144096|FG000|Overall Study|Withdrawal by Subject|3|||
160931147|NCT02821962|581144097|FG000|Overall Study|Lost to Follow-up|2|||
160931148|NCT02821962|581144098|FG001|Overall Study|Lost to Follow-up|0|||
160931149|NCT04206293|581144111|FG000|Overall Study|Consent withdrawal|1|||
160931150|NCT01610791|581144120|FG000|Overall Study|Lost to Follow-up|7|||
160931151|NCT01610791|581144120|FG000|Overall Study|Adverse Event|6|||
160931152|NCT01610791|581144120|FG000|Overall Study|Physician Decision|1|||
160931153|NCT01610791|581144120|FG000|Overall Study|Adverse event and Investigator decision|1|||
160931154|NCT01610791|581144120|FG000|Overall Study|Death|1|||
160931155|NCT01610791|581144120|FG000|Overall Study|Not determined|5|||
160931156|NCT05358821|581144121|FG000|Overall Study|Withdrawal by Subject|0|||
160931157|NCT05358821|581144122|FG001|Overall Study|Withdrawal by Subject|1|||
160931158|NCT05358821|581144123|FG002|Overall Study|Withdrawal by Subject|0|||
160931159|NCT05358821|581144121|FG000|Overall Study|Withdrawal of Consent|0|||
160931160|NCT05358821|581144122|FG001|Overall Study|Withdrawal of Consent|0|||
160931161|NCT05358821|581144123|FG002|Overall Study|Withdrawal of Consent|1|||
161264249|NCT01087489|582349186|FG000|Overall Study|unable to survey by telephone|0|||
161264250|NCT01087489|582349187|FG001|Overall Study|unable to survey by telephone|1|||
161264251|NCT05070546|582349195|FG000|Overall Study|Death|0|||
161264252|NCT05070546|582349196|FG001|Overall Study|Death|0|||
160931162|NCT04627064|581144124|FG000|Overall Study|Progressive disease|8|||
160931163|NCT04627064|581144125|FG001|Overall Study|Progressive disease|0|||
160931164|NCT04627064|581144124|FG000|Overall Study|Withdrawal by Subject|2|||
160931165|NCT04627064|581144125|FG001|Overall Study|Withdrawal by Subject|0|||
161143697|NCT00847613|581909465|FG001|Overall Study|Participant moved|1|||
161143698|NCT00847613|581909466|FG002|Overall Study|Participant moved|0|||
161264253|NCT05070546|582349197|FG002|Overall Study|Death|0|||
161264254|NCT05070546|582349198|FG003|Overall Study|Death|0|||
161264255|NCT05070546|582349199|FG004|Overall Study|Death|0|||
161264256|NCT05070546|582349200|FG005|Overall Study|Death|1|||
161264257|NCT05070546|582349195|FG000|Overall Study|Lost to Follow-up|8|||
160931166|NCT04627064|581144124|FG000|Overall Study|Physician Decision|1|||
160931167|NCT04627064|581144125|FG001|Overall Study|Physician Decision|0|||
160931168|NCT02272413|581144129|FG000|Randomized Through Treatment Start|Not treated|3|||
160931169|NCT02272413|581144130|FG001|Randomized Through Treatment Start|Not treated|5|||
160931170|NCT02272413|581144129|FG000|Pre-switch Period|Adverse Event|38|||
160931171|NCT02272413|581144130|FG001|Pre-switch Period|Adverse Event|37|||
160931172|NCT02272413|581144129|FG000|Pre-switch Period|Death|26|||
161264258|NCT05070546|582349196|FG001|Overall Study|Lost to Follow-up|2|||
160931173|NCT02272413|581144130|FG001|Pre-switch Period|Death|26|||
160931174|NCT02272413|581144129|FG000|Pre-switch Period|Withdrawal by Subject|27|||
160931175|NCT02272413|581144130|FG001|Pre-switch Period|Withdrawal by Subject|15|||
160931176|NCT02272413|581144129|FG000|Pre-switch Period|Physician Decision|6|||
160931177|NCT02272413|581144130|FG001|Pre-switch Period|Physician Decision|18|||
160931178|NCT02272413|581144129|FG000|Pre-switch Period|Progressive disease|185|||
160931179|NCT02272413|581144130|FG001|Pre-switch Period|Progressive disease|173|||
160931180|NCT02272413|581144129|FG000|Pre-switch Period|Lost to Follow-up|0|||
160931181|NCT02272413|581144130|FG001|Pre-switch Period|Lost to Follow-up|2|||
160931182|NCT02272413|581144129|FG000|Pre-switch Period|Protocol Violation|1|||
160931183|NCT02272413|581144130|FG001|Pre-switch Period|Protocol Violation|0|||
160931184|NCT02272413|581144129|FG000|Pre-switch Period|Other than listed|10|||
160931185|NCT02272413|581144130|FG001|Pre-switch Period|Other than listed|11|||
160931186|NCT02272413|581144129|FG000|Post-switch Period|Adverse Event|4|||
160931187|NCT02272413|581144130|FG001|Post-switch Period|Adverse Event|4|||
160931188|NCT02272413|581144129|FG000|Post-switch Period|Death|3|||
160931189|NCT02272413|581144130|FG001|Post-switch Period|Death|2|||
160931190|NCT02272413|581144129|FG000|Post-switch Period|Withdrawal by Subject|1|||
160931191|NCT02272413|581144130|FG001|Post-switch Period|Withdrawal by Subject|2|||
160931192|NCT02272413|581144129|FG000|Post-switch Period|Physician Decision|1|||
160931193|NCT02272413|581144130|FG001|Post-switch Period|Physician Decision|1|||
160931194|NCT02272413|581144129|FG000|Post-switch Period|Progressive disease|21|||
160931195|NCT02272413|581144130|FG001|Post-switch Period|Progressive disease|21|||
160931196|NCT02272413|581144129|FG000|Post-switch Period|Study terminated by sponsor|8|||
160931197|NCT02272413|581144130|FG001|Post-switch Period|Study terminated by sponsor|11|||
160931198|NCT02272413|581144129|FG000|Post-switch Period|Other than listed|4|||
160931199|NCT02272413|581144130|FG001|Post-switch Period|Other than listed|5|||
160931200|NCT02286193|581144133|FG000|Overall Study|Referred: CRS unable to make contact|62|||
160931201|NCT02286193|581144133|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
160931202|NCT02286193|581144133|FG000|Overall Study|Referred: Declined service|38|||
160931203|NCT00423891|581144134|FG000|Enrolled|Withdrawal by Subject|0|||
160931204|NCT00423891|581144135|FG001|Enrolled|Withdrawal by Subject|0|||
160931205|NCT00423891|581144136|FG002|Enrolled|Withdrawal by Subject|1|||
160931206|NCT00423891|581144134|FG000|Enrolled|Lost to Follow-up|0|||
160931207|NCT00423891|581144135|FG001|Enrolled|Lost to Follow-up|0|||
160931208|NCT00423891|581144136|FG002|Enrolled|Lost to Follow-up|1|||
160931209|NCT00423891|581144134|FG000|Enrolled|No longer met criteria|11|||
160931210|NCT00423891|581144135|FG001|Enrolled|No longer met criteria|2|||
160931211|NCT00423891|581144136|FG002|Enrolled|No longer met criteria|1|||
160931212|NCT00423891|581144134|FG000|Treatment|Withdrawal by Subject|1|||
160931213|NCT00423891|581144135|FG001|Treatment|Withdrawal by Subject|0|||
160931214|NCT00423891|581144136|FG002|Treatment|Withdrawal by Subject|0|||
160931215|NCT00423891|581144134|FG000|Treatment|Lost to Follow-up|1|||
160931216|NCT00423891|581144135|FG001|Treatment|Lost to Follow-up|0|||
160931217|NCT00423891|581144136|FG002|Treatment|Lost to Follow-up|0|||
160931218|NCT00423891|581144134|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
160931219|NCT00423891|581144135|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
160931220|NCT00423891|581144136|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
160931221|NCT00423891|581144134|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
160998136|NCT01563354|581378570|FG000|Core Phase|Protocol deviation|2|||
160998137|NCT01563354|581378571|FG001|Core Phase|Protocol deviation|0|||
160998138|NCT01563354|581378572|FG002|Core Phase|Protocol deviation|0|||
160998139|NCT01563354|581378570|FG000|Core Phase|PI decision - did not enter extension|0|||
160998140|NCT01563354|581378571|FG001|Core Phase|PI decision - did not enter extension|1|||
160998141|NCT01563354|581378572|FG002|Core Phase|PI decision - did not enter extension|0|||
160998142|NCT01563354|581378570|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
160998143|NCT01563354|581378571|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
160998144|NCT01563354|581378572|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
160998145|NCT01563354|581378570|FG000|Extension Phase|Adverse Event|0|||
160998146|NCT01563354|581378571|FG001|Extension Phase|Adverse Event|3|||
160998147|NCT01563354|581378572|FG002|Extension Phase|Adverse Event|2|||
161143699|NCT00847613|581909467|FG003|Overall Study|Participant moved|0|||
160998148|NCT01563354|581378570|FG000|Extension Phase|Withdrawal by Subject|0|||
160998149|NCT01563354|581378571|FG001|Extension Phase|Withdrawal by Subject|1|||
160931222|NCT00423891|581144135|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
160931223|NCT00423891|581144136|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
160931224|NCT04327999|581144139|FG000|Overall Study|Protocol Violation|1|||
160931225|NCT02872116|581144144|FG000|Pre-Treatment|Disease Progression|0|||
160931226|NCT02872116|581144145|FG001|Pre-Treatment|Disease Progression|1|||
160931227|NCT02872116|581144146|FG002|Pre-Treatment|Disease Progression|0|||
160931228|NCT02872116|581144144|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
160931229|NCT02872116|581144145|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
160931230|NCT02872116|581144146|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
160931231|NCT02872116|581144144|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
160931232|NCT02872116|581144145|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
160931233|NCT02872116|581144146|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
160931234|NCT02872116|581144144|FG000|Pre-Treatment|Participant withdrew consent|2|||
160931235|NCT02872116|581144145|FG001|Pre-Treatment|Participant withdrew consent|20|||
160931236|NCT02872116|581144146|FG002|Pre-Treatment|Participant withdrew consent|3|||
160931237|NCT02872116|581144144|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
160931238|NCT02872116|581144145|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
160931239|NCT02872116|581144146|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
160931240|NCT02872116|581144144|FG000|Pre-Treatment|Other reasons|1|||
160931241|NCT02872116|581144145|FG001|Pre-Treatment|Other reasons|2|||
160931242|NCT02872116|581144146|FG002|Pre-Treatment|Other reasons|2|||
160931243|NCT02872116|581144144|FG000|Treatment|Death|121|||
160931244|NCT02872116|581144145|FG001|Treatment|Death|94|||
160931245|NCT02872116|581144146|FG002|Treatment|Death|68|||
160931246|NCT02872116|581144144|FG000|Treatment|Lost to Follow-up|5|||
160931247|NCT02872116|581144145|FG001|Treatment|Lost to Follow-up|7|||
160931248|NCT02872116|581144146|FG002|Treatment|Lost to Follow-up|3|||
160931249|NCT02872116|581144144|FG000|Treatment|Participant withdrew consent|20|||
160931250|NCT02872116|581144145|FG001|Treatment|Participant withdrew consent|40|||
160931251|NCT02872116|581144146|FG002|Treatment|Participant withdrew consent|8|||
160931252|NCT02872116|581144144|FG000|Treatment|Other reasons|13|||
160931253|NCT02872116|581144145|FG001|Treatment|Other reasons|12|||
160931254|NCT02872116|581144146|FG002|Treatment|Other reasons|5|||
160931255|NCT01073865|581144150|FG000|Overall Study|Reasons other than below|19|||
160931256|NCT01073865|581144151|FG001|Overall Study|Reasons other than below|31|||
160931257|NCT01073865|581144150|FG000|Overall Study|Lost to Follow-up|1|||
160931258|NCT01073865|581144151|FG001|Overall Study|Lost to Follow-up|1|||
160931259|NCT01073865|581144150|FG000|Overall Study|Death|3|||
160931260|NCT01073865|581144151|FG001|Overall Study|Death|2|||
160931261|NCT01073865|581144150|FG000|Overall Study|Withdrawal by Subject|5|||
160931262|NCT01073865|581144151|FG001|Overall Study|Withdrawal by Subject|5|||
160931263|NCT00696137|581144152|FG000|Overall Study|Withdrawal by Subject|2|||
160931264|NCT04371380|581144156|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
160931265|NCT04371380|581144157|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
160931266|NCT04371380|581144158|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
160931267|NCT02376166|581144159|FG000|Overall Study|Adverse Event|1|||
160931268|NCT02376166|581144159|FG000|Overall Study|Discontinued metformin early|2|||
160931269|NCT01816139|581145626|FG000|Overall Study|Adverse Event|6|||
160931270|NCT01816139|581145627|FG001|Overall Study|Adverse Event|8|||
160931271|NCT01816139|581145626|FG000|Overall Study|Lack of Efficacy|1|||
160931272|NCT01816139|581145627|FG001|Overall Study|Lack of Efficacy|2|||
160931273|NCT01816139|581145626|FG000|Overall Study|Lost to Follow-up|5|||
160931274|NCT01816139|581145627|FG001|Overall Study|Lost to Follow-up|3|||
160931275|NCT01816139|581145626|FG000|Overall Study|Withdrew Consent|6|||
160931276|NCT01816139|581145627|FG001|Overall Study|Withdrew Consent|4|||
160931277|NCT01816139|581145626|FG000|Overall Study|Protocol Violation|6|||
160931278|NCT01816139|581145627|FG001|Overall Study|Protocol Violation|3|||
160931279|NCT01816139|581145626|FG000|Overall Study|Reason not Specified|4|||
160931280|NCT01816139|581145627|FG001|Overall Study|Reason not Specified|2|||
160931281|NCT02554656|581145628|FG000|Overall Study|Protocol Violation|3|||
160931282|NCT04304001|581145632|FG000|Overall Study|Lost to Follow-up|13|||
160931283|NCT04304001|581145633|FG001|Overall Study|Lost to Follow-up|9|||
161264259|NCT05070546|582349197|FG002|Overall Study|Lost to Follow-up|7|||
160931284|NCT04164901|581145634|FG000|Overall Study|Withdrawal by Subject|4|||
160931285|NCT04164901|581145635|FG001|Overall Study|Withdrawal by Subject|4|||
160931286|NCT02465528|581145636|FG000|Overall Study|Progressive disease|0|||
160931287|NCT02465528|581145637|FG001|Overall Study|Progressive disease|2|||
160931288|NCT02465528|581145638|FG002|Overall Study|Progressive disease|9|||
160931289|NCT02465528|581145639|FG003|Overall Study|Progressive disease|4|||
160931290|NCT02465528|581145636|FG000|Overall Study|Study terminated by sponsor|1|||
160931291|NCT02465528|581145637|FG001|Overall Study|Study terminated by sponsor|2|||
160931292|NCT02465528|581145638|FG002|Overall Study|Study terminated by sponsor|0|||
160931293|NCT02465528|581145639|FG003|Overall Study|Study terminated by sponsor|0|||
160931294|NCT02465528|581145636|FG000|Overall Study|Withdrawal by Subject|0|||
160931295|NCT02465528|581145637|FG001|Overall Study|Withdrawal by Subject|0|||
161264260|NCT05070546|582349198|FG003|Overall Study|Lost to Follow-up|1|||
160931296|NCT02465528|581145638|FG002|Overall Study|Withdrawal by Subject|2|||
160931297|NCT02465528|581145639|FG003|Overall Study|Withdrawal by Subject|0|||
161264261|NCT05070546|582349199|FG004|Overall Study|Lost to Follow-up|2|||
161264262|NCT05070546|582349200|FG005|Overall Study|Lost to Follow-up|0|||
160931298|NCT02465528|581145636|FG000|Overall Study|Adverse Event|0|||
160931299|NCT02465528|581145637|FG001|Overall Study|Adverse Event|0|||
160931300|NCT02465528|581145638|FG002|Overall Study|Adverse Event|0|||
160931301|NCT02465528|581145639|FG003|Overall Study|Adverse Event|1|||
160931302|NCT02465528|581145636|FG000|Overall Study|Physician Decision|0|||
160931303|NCT02465528|581145637|FG001|Overall Study|Physician Decision|0|||
160931304|NCT02465528|581145638|FG002|Overall Study|Physician Decision|1|||
160931305|NCT02465528|581145639|FG003|Overall Study|Physician Decision|0|||
161264263|NCT05070546|582349195|FG000|Overall Study|Withdrawal by Subject|1|||
160931306|NCT05040152|581145642|FG000|Overall Study|Withdrawal by Subject|5|||
160931307|NCT05040152|581145643|FG001|Overall Study|Withdrawal by Subject|0|||
160931308|NCT05040152|581145642|FG000|Overall Study|Lost to Follow-up|0|||
160931309|NCT05040152|581145643|FG001|Overall Study|Lost to Follow-up|2|||
160931310|NCT02704364|581145646|FG000|Overall Study|Adverse Event|1|||
160931311|NCT02704364|581145647|FG001|Overall Study|Adverse Event|1|||
160931312|NCT02704364|581145648|FG002|Overall Study|Adverse Event|0|||
160931313|NCT02704364|581145646|FG000|Overall Study|Noncompliance with study drug|1|||
160931314|NCT02704364|581145647|FG001|Overall Study|Noncompliance with study drug|1|||
160931315|NCT02704364|581145648|FG002|Overall Study|Noncompliance with study drug|0|||
160931316|NCT02704364|581145646|FG000|Overall Study|Other|0|||
160931317|NCT02704364|581145647|FG001|Overall Study|Other|1|||
160931318|NCT02704364|581145648|FG002|Overall Study|Other|1|||
160931319|NCT02086110|581145655|FG000|Overall Study|Withdrawal by Subject|1|||
160931320|NCT02086110|581145656|FG001|Overall Study|Withdrawal by Subject|1|||
160931321|NCT01869192|581145657|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
160931322|NCT01869192|581145658|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
160931323|NCT01869192|581145657|FG000|Postoperative Chemotherapy|Physician Decision|0|||
160931324|NCT01869192|581145658|FG001|Postoperative Chemotherapy|Physician Decision|2|||
160931325|NCT03792672|581145667|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
160931326|NCT03792672|581145668|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931327|NCT03792672|581145669|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931328|NCT03792672|581145670|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
160931329|NCT03792672|581145671|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931330|NCT03792672|581145672|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
160931331|NCT03792672|581145667|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
160931332|NCT03792672|581145668|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
160931333|NCT03792672|581145669|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
160931334|NCT03792672|581145670|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
160931335|NCT03792672|581145671|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
160931336|NCT03792672|581145672|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
160931337|NCT03792672|581145667|FG000|Treatment Period 4 (2 Days)|Other|1|||
160931338|NCT03792672|581145668|FG001|Treatment Period 4 (2 Days)|Other|0|||
160931339|NCT03792672|581145669|FG002|Treatment Period 4 (2 Days)|Other|0|||
160931340|NCT03792672|581145670|FG003|Treatment Period 4 (2 Days)|Other|0|||
160931341|NCT03792672|581145671|FG004|Treatment Period 4 (2 Days)|Other|0|||
160931342|NCT03792672|581145672|FG005|Treatment Period 4 (2 Days)|Other|0|||
160931343|NCT00453999|581145673|FG000|Overall Study|Adverse Event|1|||
160931344|NCT00453999|581145674|FG001|Overall Study|Adverse Event|2|||
160931345|NCT00453999|581145675|FG002|Overall Study|Adverse Event|1|||
160931346|NCT00453999|581145673|FG000|Overall Study|Lost to Follow-up|0|||
160931347|NCT00453999|581145674|FG001|Overall Study|Lost to Follow-up|1|||
160931348|NCT00453999|581145675|FG002|Overall Study|Lost to Follow-up|1|||
160931349|NCT00453999|581145673|FG000|Overall Study|Withdrawal by Subject|2|||
160931350|NCT00453999|581145674|FG001|Overall Study|Withdrawal by Subject|1|||
160931351|NCT00453999|581145675|FG002|Overall Study|Withdrawal by Subject|1|||
160931352|NCT00453999|581145673|FG000|Overall Study|Subject Request|2|||
160931353|NCT00453999|581145674|FG001|Overall Study|Subject Request|1|||
160931354|NCT00453999|581145675|FG002|Overall Study|Subject Request|0|||
160931355|NCT04238728|581145686|FG000|Overall Study|Withdrawal by Subject|1|||
160931356|NCT04238728|581145686|FG000|Overall Study|Lost to Follow-up|2|||
160931357|NCT04225923|581145693|FG000|Overall Study|Protocol Violation|1|||
160931358|NCT04225923|581145694|FG001|Overall Study|Protocol Violation|0|||
160931359|NCT04225923|581145695|FG002|Overall Study|Protocol Violation|1|||
160931360|NCT04225923|581145693|FG000|Overall Study|Withdrawal by Subject|4|||
160931361|NCT04225923|581145694|FG001|Overall Study|Withdrawal by Subject|1|||
160931362|NCT04225923|581145695|FG002|Overall Study|Withdrawal by Subject|3|||
160931363|NCT04225923|581145693|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
160931364|NCT04225923|581145694|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
160931365|NCT04225923|581145695|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
160931366|NCT01907828|581145701|FG000|Overall Study|Exclusion criteria not met|0|||
160998150|NCT01563354|581378572|FG002|Extension Phase|Withdrawal by Subject|0|||
160998151|NCT01563354|581378570|FG000|Extension Phase|Administration problems|3|||
160998152|NCT01563354|581378571|FG001|Extension Phase|Administration problems|2|||
160931367|NCT01907828|581145702|FG001|Overall Study|Exclusion criteria not met|1|||
160931368|NCT01907828|581145701|FG000|Overall Study|Withdrawal by Subject|3|||
160931369|NCT01907828|581145702|FG001|Overall Study|Withdrawal by Subject|4|||
160931370|NCT01907828|581145701|FG000|Overall Study|Lost to Follow-up|3|||
160931371|NCT01907828|581145702|FG001|Overall Study|Lost to Follow-up|0|||
160931372|NCT01907828|581145701|FG000|Overall Study|Participant refused 24-month follow-up|1|||
160931373|NCT01907828|581145702|FG001|Overall Study|Participant refused 24-month follow-up|0|||
160931374|NCT01907828|581145701|FG000|Overall Study|Participant met exclusion criteria|0|||
160931375|NCT01907828|581145702|FG001|Overall Study|Participant met exclusion criteria|1|||
160931376|NCT01585766|581145703|FG000|Overall Study|Withdrawal by Subject|0|||
160931377|NCT01585766|581145704|FG001|Overall Study|Withdrawal by Subject|1|||
160931378|NCT01585766|581145705|FG002|Overall Study|Withdrawal by Subject|1|||
160931379|NCT01585766|581145706|FG003|Overall Study|Withdrawal by Subject|0|||
160931380|NCT01585766|581145707|FG004|Overall Study|Withdrawal by Subject|0|||
160931381|NCT01585766|581145708|FG005|Overall Study|Withdrawal by Subject|0|||
160931382|NCT01585766|581145703|FG000|Overall Study|Death|0|||
160931383|NCT01585766|581145704|FG001|Overall Study|Death|1|||
160931384|NCT01585766|581145705|FG002|Overall Study|Death|0|||
160931385|NCT01585766|581145706|FG003|Overall Study|Death|0|||
160931386|NCT01585766|581145707|FG004|Overall Study|Death|0|||
160931387|NCT01585766|581145708|FG005|Overall Study|Death|0|||
160931388|NCT01585766|581145703|FG000|Overall Study|Physician Decision|0|||
160931389|NCT01585766|581145704|FG001|Overall Study|Physician Decision|0|||
160931390|NCT01585766|581145705|FG002|Overall Study|Physician Decision|1|||
160931391|NCT01585766|581145706|FG003|Overall Study|Physician Decision|0|||
160931392|NCT01585766|581145707|FG004|Overall Study|Physician Decision|0|||
160931393|NCT01585766|581145708|FG005|Overall Study|Physician Decision|0|||
160931394|NCT01364428|581145709|FG000|Overall Study|Adverse Event|1|||
160931395|NCT01364428|581145710|FG001|Overall Study|Adverse Event|2|||
160931396|NCT01364428|581145709|FG000|Overall Study|Protocol Violation|2|||
160931397|NCT01364428|581145710|FG001|Overall Study|Protocol Violation|0|||
160931398|NCT01364428|581145709|FG000|Overall Study|Withdrawal Criteria|14|||
160931399|NCT01364428|581145710|FG001|Overall Study|Withdrawal Criteria|10|||
160931400|NCT01364428|581145709|FG000|Overall Study|Other|3|||
160931401|NCT01364428|581145710|FG001|Overall Study|Other|3|||
160931402|NCT03925324|581145711|FG000|Overall Study|Death|1|||
160931403|NCT03925324|581145712|FG001|Overall Study|Death|1|||
160931404|NCT04414553|581145713|FG000|Overall Study|Lost to Follow-up|20|||
160931405|NCT00775437|581145729|FG000|Overall Study|Loss of efficacy|2|||
160931406|NCT00775437|581145729|FG000|Overall Study|Withdrawal by Subject|3|||
160931407|NCT00775437|581145729|FG000|Overall Study|Lost to Follow-up|1|||
160931408|NCT04180020|581145734|FG000|Overall Study|missed visit|18|||
160931409|NCT04180020|581145735|FG001|Overall Study|missed visit|16|||
160931410|NCT04180020|581145734|FG000|Overall Study|Death|2|||
160931411|NCT04180020|581145735|FG001|Overall Study|Death|3|||
160931412|NCT04180020|581145734|FG000|Overall Study|Withdrawal by Subject|1|||
160931413|NCT04180020|581145735|FG001|Overall Study|Withdrawal by Subject|5|||
160931414|NCT04180020|581145734|FG000|Overall Study|incarcerated|1|||
160931415|NCT04180020|581145735|FG001|Overall Study|incarcerated|1|||
160931416|NCT04180020|581145734|FG000|Overall Study|Physician Decision|0|||
160931417|NCT04180020|581145735|FG001|Overall Study|Physician Decision|2|||
160931418|NCT03554291|581145736|FG000|Overall Study|Death|2|||
160931419|NCT03554291|581145737|FG001|Overall Study|Death|1|||
160931420|NCT03554291|581145736|FG000|Overall Study|Lost to Follow-up|1|||
160931421|NCT03554291|581145737|FG001|Overall Study|Lost to Follow-up|0|||
160931422|NCT03554291|581145736|FG000|Overall Study|Withdrawal by Subject|1|||
160931423|NCT03554291|581145737|FG001|Overall Study|Withdrawal by Subject|0|||
160931424|NCT03554291|581145736|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
160931425|NCT03554291|581145737|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
160931426|NCT04251221|581145743|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
160931427|NCT04251221|581145744|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
160931428|NCT02120794|581145745|FG000|Overall Study|Withdrawal by Subject|43|||
160931429|NCT02120794|581145745|FG000|Overall Study|Adverse Event|10|||
160931430|NCT02120794|581145745|FG000|Overall Study|Physician Decision|4|||
160931431|NCT02120794|581145745|FG000|Overall Study|Due to insurance coverage|1|||
160931432|NCT01148511|581145747|FG000|Exposed to Study Drug|Protocol Violation|2|||
160931433|NCT01148511|581145748|FG001|Exposed to Study Drug|Protocol Violation|0|||
160931434|NCT01148511|581145749|FG002|Exposed to Study Drug|Protocol Violation|0|||
160931435|NCT01148511|581145747|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
160931436|NCT01148511|581145748|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
160931437|NCT01148511|581145749|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
160931438|NCT01148511|581145747|FG000|Randomized|Adverse Event|0|||
160931439|NCT01148511|581145748|FG001|Randomized|Adverse Event|1|||
160931440|NCT01148511|581145749|FG002|Randomized|Adverse Event|0|||
160931441|NCT01148511|581145747|FG000|Randomized|Protocol Violation|0|||
160931442|NCT01148511|581145748|FG001|Randomized|Protocol Violation|2|||
160931443|NCT01148511|581145749|FG002|Randomized|Protocol Violation|1|||
160931444|NCT01148511|581145747|FG000|Randomized|Lost to Follow-up|0|||
160931445|NCT01148511|581145748|FG001|Randomized|Lost to Follow-up|1|||
160931446|NCT01148511|581145749|FG002|Randomized|Lost to Follow-up|1|||
160931447|NCT01148511|581145747|FG000|Randomized|Consent withdrawal|0|||
160931448|NCT01148511|581145748|FG001|Randomized|Consent withdrawal|5|||
160931449|NCT01148511|581145749|FG002|Randomized|Consent withdrawal|3|||
160931450|NCT01148511|581145747|FG000|Randomized|Other|0|||
161143700|NCT00847613|581909464|FG000|Overall Study|Sponsor request|0|||
160931451|NCT01148511|581145748|FG001|Randomized|Other|1|||
160931452|NCT01148511|581145749|FG002|Randomized|Other|1|||
160931453|NCT04258605|581145751|FG000|Overall Study|Death|1|||
160931454|NCT04258605|581145752|FG001|Overall Study|Death|0|||
160931455|NCT04258605|581145751|FG000|Overall Study|Early study termination|21|||
160931456|NCT04258605|581145752|FG001|Overall Study|Early study termination|2|||
160931457|NCT00842348|581145758|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
160931458|NCT00842348|581145759|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
160931459|NCT00842348|581145758|FG000|Study 729|Disease progression/death|19|||
160931460|NCT00842348|581145759|FG001|Study 729|Disease progression/death|30|||
160931461|NCT00842348|581145758|FG000|Study 729|Adverse Event|1|||
160931462|NCT00842348|581145759|FG001|Study 729|Adverse Event|1|||
160931463|NCT00842348|581145758|FG000|Study 729|Protocol Violation|1|||
160931464|NCT00842348|581145759|FG001|Study 729|Protocol Violation|1|||
160931465|NCT00842348|581145758|FG000|Study 729|Withdrawal by Subject|2|||
160931466|NCT00842348|581145759|FG001|Study 729|Withdrawal by Subject|4|||
160931467|NCT00842348|581145758|FG000|Study 729|Due to Sponsor stopping the study|1|||
160931468|NCT00842348|581145759|FG001|Study 729|Due to Sponsor stopping the study|1|||
160931469|NCT00842348|581145758|FG000|Study 729|Due to non-availability of IP|0|||
160931470|NCT00842348|581145759|FG001|Study 729|Due to non-availability of IP|1|||
160931471|NCT00842348|581145758|FG000|Study 729|Sponsor's decision|1|||
160931472|NCT00842348|581145759|FG001|Study 729|Sponsor's decision|0|||
160931473|NCT00842348|581145758|FG000|Study 729|Surgical resection|1|||
160931474|NCT00842348|581145759|FG001|Study 729|Surgical resection|0|||
160931475|NCT00026793|581145764|FG000|Overall Study|Death on study due to underlying disease|4|||
160931476|NCT00026793|581145764|FG000|Overall Study|Physician Decision|2|||
160931477|NCT00026793|581145764|FG000|Overall Study|Off study|2|||
160931478|NCT01449526|581145765|FG000|Overall Study|Lost to Follow-up|1|||
160931479|NCT01449526|581145766|FG001|Overall Study|Lost to Follow-up|2|||
160931480|NCT01449526|581145765|FG000|Overall Study|Withdrawal by Subject|1|||
160931481|NCT01449526|581145766|FG001|Overall Study|Withdrawal by Subject|1|||
160931482|NCT01449526|581145765|FG000|Overall Study|Symptoms/complaints|0|||
160931483|NCT01449526|581145766|FG001|Overall Study|Symptoms/complaints|1|||
160931484|NCT01449526|581145765|FG000|Overall Study|Lack of Motivation|0|||
160931485|NCT01449526|581145766|FG001|Overall Study|Lack of Motivation|1|||
160931486|NCT01449526|581145765|FG000|Overall Study|Cannot maintain visits|0|||
160931487|NCT01449526|581145766|FG001|Overall Study|Cannot maintain visits|1|||
160931488|NCT01132495|581145767|FG000|Overall Study|Various reasons|40|||
160931489|NCT01132495|581145768|FG001|Overall Study|Various reasons|38|||
160931490|NCT01132495|581145769|FG002|Overall Study|Various reasons|20|||
160931491|NCT01132495|581145770|FG003|Overall Study|Various reasons|12|||
160931492|NCT03913091|581145771|FG000|Overall Study|Lost to Follow-up|18|||
160931493|NCT03913091|581145772|FG001|Overall Study|Lost to Follow-up|11|||
160931494|NCT03913091|581145771|FG000|Overall Study|Required additional meds/surgery|1|||
160931495|NCT03913091|581145772|FG001|Overall Study|Required additional meds/surgery|2|||
160931496|NCT03913091|581145771|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
160931497|NCT03913091|581145772|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
160931498|NCT00969553|581145773|FG000|Overall Study|Progressive disease (PD)|2|||
160931499|NCT00969553|581145774|FG001|Overall Study|Progressive disease (PD)|2|||
160931500|NCT00969553|581145775|FG002|Overall Study|Progressive disease (PD)|6|||
160931501|NCT00969553|581145776|FG003|Overall Study|Progressive disease (PD)|9|||
160931502|NCT00969553|581145777|FG004|Overall Study|Progressive disease (PD)|2|||
160931503|NCT00969553|581145778|FG005|Overall Study|Progressive disease (PD)|4|||
160931504|NCT00969553|581145779|FG006|Overall Study|Progressive disease (PD)|2|||
160931505|NCT00969553|581145780|FG007|Overall Study|Progressive disease (PD)|12|||
160931506|NCT00969553|581145781|FG008|Overall Study|Progressive disease (PD)|3|||
160931507|NCT00969553|581145773|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931508|NCT00969553|581145774|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931509|NCT00969553|581145775|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931510|NCT00969553|581145776|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931511|NCT00969553|581145777|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
160931512|NCT00969553|581145778|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931513|NCT00969553|581145779|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931514|NCT00969553|581145780|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931515|NCT00969553|581145781|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
160931516|NCT00969553|581145773|FG000|Overall Study|Other Adverse Event|0|||
160931517|NCT00969553|581145774|FG001|Overall Study|Other Adverse Event|0|||
160931518|NCT00969553|581145775|FG002|Overall Study|Other Adverse Event|0|||
161264264|NCT05070546|582349196|FG001|Overall Study|Withdrawal by Subject|1|||
161264265|NCT05070546|582349197|FG002|Overall Study|Withdrawal by Subject|3|||
160931519|NCT00969553|581145776|FG003|Overall Study|Other Adverse Event|1|||
160931520|NCT00969553|581145777|FG004|Overall Study|Other Adverse Event|0|||
160931521|NCT00969553|581145778|FG005|Overall Study|Other Adverse Event|0|||
160931522|NCT00969553|581145779|FG006|Overall Study|Other Adverse Event|1|||
160931523|NCT00969553|581145780|FG007|Overall Study|Other Adverse Event|0|||
160931524|NCT00969553|581145781|FG008|Overall Study|Other Adverse Event|0|||
160931525|NCT00969553|581145773|FG000|Overall Study|Refused cont. medication|1|||
160931526|NCT00969553|581145774|FG001|Overall Study|Refused cont. medication|1|||
161264266|NCT05070546|582349198|FG003|Overall Study|Withdrawal by Subject|0|||
160931527|NCT00969553|581145775|FG002|Overall Study|Refused cont. medication|0|||
160931528|NCT00969553|581145776|FG003|Overall Study|Refused cont. medication|2|||
160931529|NCT00969553|581145777|FG004|Overall Study|Refused cont. medication|0|||
160931530|NCT00969553|581145778|FG005|Overall Study|Refused cont. medication|0|||
160931531|NCT00969553|581145779|FG006|Overall Study|Refused cont. medication|0|||
160931532|NCT00969553|581145780|FG007|Overall Study|Refused cont. medication|1|||
160931533|NCT00969553|581145781|FG008|Overall Study|Refused cont. medication|0|||
160931534|NCT00969553|581145773|FG000|Overall Study|Not specified above|0|||
160931535|NCT00969553|581145774|FG001|Overall Study|Not specified above|0|||
160931536|NCT00969553|581145775|FG002|Overall Study|Not specified above|0|||
160931537|NCT00969553|581145776|FG003|Overall Study|Not specified above|4|||
160931538|NCT00969553|581145777|FG004|Overall Study|Not specified above|0|||
160931539|NCT00969553|581145778|FG005|Overall Study|Not specified above|0|||
160931540|NCT00969553|581145779|FG006|Overall Study|Not specified above|1|||
160931541|NCT00969553|581145780|FG007|Overall Study|Not specified above|1|||
160931542|NCT00969553|581145781|FG008|Overall Study|Not specified above|0|||
160931543|NCT04243538|581145782|FG000|Overall Study|Withdrawal by Subject|0|||
160931544|NCT04243538|581145783|FG001|Overall Study|Withdrawal by Subject|2|||
160931545|NCT04243538|581145782|FG000|Overall Study|Lost to Follow-up|0|||
160931546|NCT04243538|581145783|FG001|Overall Study|Lost to Follow-up|3|||
160931547|NCT00655564|581145784|FG000|Overall Study|Adverse Event|1|||
160931548|NCT00655564|581145784|FG000|Overall Study|Lost to Follow-up|1|||
160931549|NCT00655564|581145784|FG000|Overall Study|Desired Alternate Therapy|1|||
161264267|NCT05070546|582349199|FG004|Overall Study|Withdrawal by Subject|0|||
161264268|NCT05070546|582349200|FG005|Overall Study|Withdrawal by Subject|0|||
161264269|NCT05070546|582349195|FG000|Overall Study|Other|0|||
161264270|NCT05070546|582349196|FG001|Overall Study|Other|0|||
160931550|NCT04536727|581145785|FG000|Overall Study|Lost to Follow-up|1|||
160931551|NCT04536727|581145786|FG001|Overall Study|Lost to Follow-up|1|||
160931552|NCT04536727|581145785|FG000|Overall Study|Death|0|||
160931553|NCT04536727|581145786|FG001|Overall Study|Death|1|||
160931554|NCT00500370|581145787|FG000|Overall Study|Adverse Event|9|||
160931555|NCT00500370|581145788|FG001|Overall Study|Adverse Event|3|||
160931556|NCT00500370|581145787|FG000|Overall Study|Lost to Follow-up|10|||
160931557|NCT00500370|581145788|FG001|Overall Study|Lost to Follow-up|10|||
160931558|NCT00500370|581145787|FG000|Overall Study|Protocol Violation|2|||
160931559|NCT00500370|581145788|FG001|Overall Study|Protocol Violation|4|||
160931560|NCT00500370|581145787|FG000|Overall Study|Sponsor Decision|2|||
160931561|NCT00500370|581145788|FG001|Overall Study|Sponsor Decision|0|||
160931562|NCT00500370|581145787|FG000|Overall Study|Subject Decision|10|||
160931563|NCT00500370|581145788|FG001|Overall Study|Subject Decision|17|||
160931564|NCT05308901|581147753|FG000|Overall Study|Death|6|||
160931565|NCT02586012|581147754|FG000|Overall Study|Withdrawal by Subject|1|||
160931566|NCT02586012|581147755|FG001|Overall Study|Withdrawal by Subject|1|||
160931567|NCT02586012|581147756|FG002|Overall Study|Withdrawal by Subject|0|||
160931568|NCT02586012|581147757|FG003|Overall Study|Withdrawal by Subject|1|||
160931569|NCT02586012|581147758|FG004|Overall Study|Withdrawal by Subject|0|||
160931570|NCT02586012|581147759|FG005|Overall Study|Withdrawal by Subject|2|||
160931571|NCT02586012|581147754|FG000|Overall Study|Protocol Violation|0|||
160931572|NCT02586012|581147755|FG001|Overall Study|Protocol Violation|0|||
160931573|NCT02586012|581147756|FG002|Overall Study|Protocol Violation|0|||
160931574|NCT02586012|581147757|FG003|Overall Study|Protocol Violation|0|||
160931575|NCT02586012|581147758|FG004|Overall Study|Protocol Violation|0|||
160931576|NCT02586012|581147759|FG005|Overall Study|Protocol Violation|1|||
160931577|NCT02586012|581147754|FG000|Overall Study|study terminated|0|||
160931578|NCT02586012|581147755|FG001|Overall Study|study terminated|2|||
160931579|NCT02586012|581147756|FG002|Overall Study|study terminated|1|||
160931580|NCT02586012|581147757|FG003|Overall Study|study terminated|1|||
160931581|NCT02586012|581147758|FG004|Overall Study|study terminated|1|||
160931582|NCT02586012|581147759|FG005|Overall Study|study terminated|0|||
160931583|NCT01888497|581147760|FG000|Washout Period 1|Withdrawal by Subject|0|||
161264271|NCT05070546|582349197|FG002|Overall Study|Other|0|||
161264272|NCT05070546|582349198|FG003|Overall Study|Other|0|||
160931584|NCT01888497|581147761|FG001|Washout Period 1|Withdrawal by Subject|0|||
160931585|NCT01888497|581147762|FG002|Washout Period 1|Withdrawal by Subject|1|||
160931586|NCT01888497|581147763|FG003|Washout Period 1|Withdrawal by Subject|1|||
160931587|NCT01888497|581147760|FG000|Washout Period 2|Adverse Event|0|||
160931588|NCT01888497|581147761|FG001|Washout Period 2|Adverse Event|0|||
160931589|NCT01888497|581147762|FG002|Washout Period 2|Adverse Event|0|||
160931590|NCT01888497|581147763|FG003|Washout Period 2|Adverse Event|1|||
160931591|NCT01888497|581147760|FG000|Washout Period 2|Withdrawal by Subject|0|||
160931592|NCT01888497|581147761|FG001|Washout Period 2|Withdrawal by Subject|0|||
160931593|NCT01888497|581147762|FG002|Washout Period 2|Withdrawal by Subject|0|||
160931594|NCT01888497|581147763|FG003|Washout Period 2|Withdrawal by Subject|1|||
160931595|NCT01140477|581147766|FG000|Overall Study|Lost to Follow-up|4|||
161264273|NCT05070546|582349199|FG004|Overall Study|Other|3|||
160931596|NCT01140477|581147767|FG001|Overall Study|Lost to Follow-up|0|||
160931597|NCT01140477|581147766|FG000|Overall Study|Withdrawal by Subject|1|||
160931598|NCT01140477|581147767|FG001|Overall Study|Withdrawal by Subject|4|||
160931599|NCT01140477|581147766|FG000|Overall Study|Surgical complication preventing implant|2|||
160931600|NCT01140477|581147767|FG001|Overall Study|Surgical complication preventing implant|0|||
160931601|NCT01140477|581147766|FG000|Overall Study|Death|1|||
160931602|NCT01140477|581147767|FG001|Overall Study|Death|1|||
160931603|NCT01140477|581147766|FG000|Overall Study|Subject explanted|0|||
160931604|NCT01140477|581147767|FG001|Overall Study|Subject explanted|1|||
160931605|NCT04013191|581147768|FG000|Overall Study|Adverse Event|1|||
160931606|NCT04013191|581147769|FG001|Overall Study|Adverse Event|0|||
160931607|NCT04127786|581147782|FG000|Primary Series|Adverse Event|1|||
160931608|NCT04127786|581147783|FG001|Primary Series|Adverse Event|0|||
160931609|NCT04127786|581147784|FG002|Primary Series|Adverse Event|0|||
160931610|NCT04127786|581147785|FG003|Primary Series|Adverse Event|1|||
160931611|NCT04127786|581147786|FG004|Primary Series|Adverse Event|0|||
160931612|NCT04127786|581147787|FG005|Primary Series|Adverse Event|1|||
160931613|NCT04127786|581147782|FG000|Primary Series|Protocol Violation|5|||
160931614|NCT04127786|581147783|FG001|Primary Series|Protocol Violation|3|||
160931615|NCT04127786|581147784|FG002|Primary Series|Protocol Violation|4|||
160931616|NCT04127786|581147785|FG003|Primary Series|Protocol Violation|3|||
160931617|NCT04127786|581147786|FG004|Primary Series|Protocol Violation|2|||
160931618|NCT04127786|581147787|FG005|Primary Series|Protocol Violation|0|||
160931619|NCT04127786|581147782|FG000|Primary Series|Withdrawal by Subject|0|||
160931620|NCT04127786|581147783|FG001|Primary Series|Withdrawal by Subject|0|||
160931621|NCT04127786|581147784|FG002|Primary Series|Withdrawal by Subject|0|||
160931622|NCT04127786|581147785|FG003|Primary Series|Withdrawal by Subject|1|||
160931623|NCT04127786|581147786|FG004|Primary Series|Withdrawal by Subject|0|||
160931624|NCT04127786|581147787|FG005|Primary Series|Withdrawal by Subject|0|||
160931625|NCT04127786|581147782|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
160931626|NCT04127786|581147783|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
160931627|NCT04127786|581147784|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
160931628|NCT04127786|581147785|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
160931629|NCT04127786|581147786|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
160931630|NCT04127786|581147787|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
160931631|NCT04127786|581147782|FG000|Booster Phase|Withdrawal by Subject|2|||
160931632|NCT04127786|581147783|FG001|Booster Phase|Withdrawal by Subject|0|||
160931633|NCT04127786|581147784|FG002|Booster Phase|Withdrawal by Subject|0|||
160931634|NCT04127786|581147785|FG003|Booster Phase|Withdrawal by Subject|0|||
160931635|NCT04127786|581147786|FG004|Booster Phase|Withdrawal by Subject|0|||
160931636|NCT04127786|581147787|FG005|Booster Phase|Withdrawal by Subject|0|||
160931637|NCT01904604|581147788|FG000|Overall Study|Withdrew before receiving dosing|0|||
160931638|NCT01904604|581147789|FG001|Overall Study|Withdrew before receiving dosing|1|||
160931639|NCT01904604|581147790|FG002|Overall Study|Withdrew before receiving dosing|0|||
160931640|NCT01904604|581147788|FG000|Overall Study|Non-compliance|1|||
160931641|NCT01904604|581147789|FG001|Overall Study|Non-compliance|0|||
160931642|NCT01904604|581147790|FG002|Overall Study|Non-compliance|0|||
160931643|NCT01904604|581147788|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
160931644|NCT01904604|581147789|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
160931645|NCT01904604|581147790|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
160931646|NCT01904604|581147788|FG000|Overall Study|Patch site reactions|1|||
160931647|NCT01904604|581147789|FG001|Overall Study|Patch site reactions|1|||
160931648|NCT01904604|581147790|FG002|Overall Study|Patch site reactions|0|||
160931649|NCT01904604|581147788|FG000|Overall Study|Increased syncope|0|||
160931650|NCT01904604|581147789|FG001|Overall Study|Increased syncope|1|||
160931651|NCT01904604|581147790|FG002|Overall Study|Increased syncope|0|||
160931652|NCT01904604|581147788|FG000|Overall Study|Unrelated illness|0|||
160931653|NCT01904604|581147789|FG001|Overall Study|Unrelated illness|1|||
160931654|NCT01904604|581147790|FG002|Overall Study|Unrelated illness|0|||
160931655|NCT01904604|581147788|FG000|Overall Study|Passed Week 52 OFC|1|||
160931656|NCT01904604|581147789|FG001|Overall Study|Passed Week 52 OFC|0|||
160931657|NCT01904604|581147790|FG002|Overall Study|Passed Week 52 OFC|0|||
160931658|NCT01904604|581147788|FG000|Overall Study|Withdrawal by Subject|1|||
160998153|NCT01563354|581378572|FG002|Extension Phase|Administration problems|3|||
160931659|NCT01904604|581147789|FG001|Overall Study|Withdrawal by Subject|2|||
160931660|NCT01904604|581147790|FG002|Overall Study|Withdrawal by Subject|0|||
160931661|NCT01904604|581147788|FG000|Overall Study|Participant Relocated|1|||
160931662|NCT01904604|581147789|FG001|Overall Study|Participant Relocated|1|||
160931663|NCT01904604|581147790|FG002|Overall Study|Participant Relocated|1|||
160998154|NCT01563354|581378570|FG000|Extension Phase|Disease progression|9|||
160998155|NCT01563354|581378571|FG001|Extension Phase|Disease progression|8|||
160998156|NCT01563354|581378572|FG002|Extension Phase|Disease progression|10|||
160998157|NCT01050569|581378586|FG000|Overall Study|Lost to Follow-up|20|||
161143701|NCT00847613|581909465|FG001|Overall Study|Sponsor request|1|||
160931664|NCT01904604|581147788|FG000|Overall Study|Lost to Follow-up|0|||
160931665|NCT01904604|581147789|FG001|Overall Study|Lost to Follow-up|0|||
160931666|NCT01904604|581147790|FG002|Overall Study|Lost to Follow-up|1|||
160931667|NCT00394212|581147796|FG000|Overall Study|Lost to Follow-up|3|||
160931668|NCT00394212|581147797|FG001|Overall Study|Lost to Follow-up|0|||
160931669|NCT00394212|581147796|FG000|Overall Study|Withdrawal by Subject|4|||
160931670|NCT00394212|581147797|FG001|Overall Study|Withdrawal by Subject|1|||
160931671|NCT00588445|581147798|FG000|Overall Study|Protocol Violation|1|||
160931672|NCT00588445|581147798|FG000|Overall Study|Withdrawal by Subject|3|||
160931673|NCT00588445|581147798|FG000|Overall Study|Disease Progression|1|||
160931674|NCT00588445|581147798|FG000|Overall Study|Not Treated|10|||
160931675|NCT00358527|581147799|FG000|Overall Study|Adverse Event|4|||
160931676|NCT00358527|581147800|FG001|Overall Study|Adverse Event|0|||
160931677|NCT00358527|581147799|FG000|Overall Study|Withdrawal by Subject|1|||
160931678|NCT00358527|581147800|FG001|Overall Study|Withdrawal by Subject|1|||
160931679|NCT00358527|581147799|FG000|Overall Study|Non-compliance with protocol|6|||
160931680|NCT00358527|581147800|FG001|Overall Study|Non-compliance with protocol|1|||
160931681|NCT00358527|581147799|FG000|Overall Study|Administrative|2|||
160998158|NCT01050569|581378587|FG001|Overall Study|Lost to Follow-up|14|||
160998159|NCT01050569|581378588|FG002|Overall Study|Lost to Follow-up|16|||
160998160|NCT01050569|581378586|FG000|Overall Study|Withdrawal by Subject|9|||
160998161|NCT01050569|581378587|FG001|Overall Study|Withdrawal by Subject|3|||
160998162|NCT01050569|581378588|FG002|Overall Study|Withdrawal by Subject|11|||
160998163|NCT01050569|581378586|FG000|Overall Study|Lack of Efficacy|5|||
160998164|NCT01050569|581378587|FG001|Overall Study|Lack of Efficacy|4|||
160998165|NCT01050569|581378588|FG002|Overall Study|Lack of Efficacy|3|||
160998166|NCT01050569|581378586|FG000|Overall Study|Adverse Event|1|||
160998167|NCT01050569|581378587|FG001|Overall Study|Adverse Event|0|||
160998168|NCT01050569|581378588|FG002|Overall Study|Adverse Event|0|||
160998169|NCT01050569|581378586|FG000|Overall Study|Physician Decision|3|||
160998170|NCT01050569|581378587|FG001|Overall Study|Physician Decision|3|||
160998171|NCT01050569|581378588|FG002|Overall Study|Physician Decision|3|||
160998172|NCT03525119|581378589|FG000|Overall Study|Adverse Event|0|||
160998173|NCT03525119|581378590|FG001|Overall Study|Adverse Event|1|||
160998174|NCT03525119|581378591|FG002|Overall Study|Adverse Event|0|||
160998175|NCT03525119|581378589|FG000|Overall Study|Lost to Follow-up|32|||
160998176|NCT03525119|581378590|FG001|Overall Study|Lost to Follow-up|33|||
160998177|NCT03525119|581378591|FG002|Overall Study|Lost to Follow-up|37|||
160998178|NCT03525119|581378589|FG000|Overall Study|Withdrawal by Subject|5|||
160998179|NCT03525119|581378590|FG001|Overall Study|Withdrawal by Subject|4|||
160998180|NCT03525119|581378591|FG002|Overall Study|Withdrawal by Subject|2|||
160998181|NCT03525119|581378589|FG000|Overall Study|Reason not Specified|2|||
160998182|NCT03525119|581378590|FG001|Overall Study|Reason not Specified|1|||
160998183|NCT03525119|581378591|FG002|Overall Study|Reason not Specified|2|||
160998184|NCT03525119|581378589|FG000|Overall Study|Randomized but not Vaccinated|1|||
160998185|NCT03525119|581378590|FG001|Overall Study|Randomized but not Vaccinated|0|||
160998186|NCT03525119|581378591|FG002|Overall Study|Randomized but not Vaccinated|2|||
160998187|NCT03781336|581378592|FG000|Overall Study|Withdrawal by Subject|2|||
160998188|NCT03781336|581378593|FG001|Overall Study|Withdrawal by Subject|2|||
160998189|NCT01490580|581378594|FG000|Overall Study|Parents withdrew consent|0|||
160998190|NCT01490580|581378595|FG001|Overall Study|Parents withdrew consent|2|||
160998191|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
160998192|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
160998193|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
160998194|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
160998195|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
160998196|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
160998197|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
160998198|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
160998199|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
160998200|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
160998201|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
160998202|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
160998203|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Death|7|||
160998204|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Death|4|||
160998205|NCT00410124|581378596|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
161264274|NCT05070546|582349200|FG005|Overall Study|Other|0|||
161264275|NCT05070546|582349195|FG000|Overall Study|Randomized but not vaccinated|1|||
161264276|NCT05070546|582349196|FG001|Overall Study|Randomized but not vaccinated|0|||
161264277|NCT05070546|582349197|FG002|Overall Study|Randomized but not vaccinated|1|||
160931682|NCT00358527|581147800|FG001|Overall Study|Administrative|1|||
160998206|NCT00410124|581378597|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
160998207|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
160998208|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
160998209|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
160998210|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
160998211|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
160998212|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
161264278|NCT05070546|582349198|FG003|Overall Study|Randomized but not vaccinated|1|||
161264279|NCT05070546|582349199|FG004|Overall Study|Randomized but not vaccinated|3|||
160931683|NCT04144166|581147803|FG000|Overall Study|Discharged before study start|1|||
161342446|NCT00284856|582640199|FG000|Overall Study|Protocol Violation|5|||
161342447|NCT00284856|582640200|FG001|Overall Study|Protocol Violation|4|||
161342448|NCT00284856|582640201|FG002|Overall Study|Protocol Violation|5|||
160931684|NCT04144166|581147803|FG000|Overall Study|Pregnancy|1|||
160931685|NCT04144166|581147803|FG000|Overall Study|Nail polish could not be removed from finger|1|||
160931686|NCT00697346|581147804|FG000|Overall Study|Adverse Event|4|||
160931687|NCT00697346|581147805|FG001|Overall Study|Adverse Event|5|||
160931688|NCT00697346|581147806|FG002|Overall Study|Adverse Event|0|||
160931689|NCT00697346|581147804|FG000|Overall Study|Progressive Disease|19|||
160931690|NCT00697346|581147805|FG001|Overall Study|Progressive Disease|18|||
160931691|NCT00697346|581147806|FG002|Overall Study|Progressive Disease|0|||
160931692|NCT00697346|581147804|FG000|Overall Study|Symptomatic Deterioration|0|||
160931693|NCT00697346|581147805|FG001|Overall Study|Symptomatic Deterioration|1|||
160931694|NCT00697346|581147806|FG002|Overall Study|Symptomatic Deterioration|0|||
160931695|NCT00697346|581147804|FG000|Overall Study|Withdrawal by Subject|2|||
160931696|NCT00697346|581147805|FG001|Overall Study|Withdrawal by Subject|2|||
160931697|NCT00697346|581147806|FG002|Overall Study|Withdrawal by Subject|0|||
160931698|NCT00697346|581147804|FG000|Overall Study|Reason not Specified|3|||
160931699|NCT00697346|581147805|FG001|Overall Study|Reason not Specified|0|||
160931700|NCT00697346|581147806|FG002|Overall Study|Reason not Specified|1|||
160931701|NCT03569371|581147807|FG000|Overall Study|Lack of Efficacy|1|||
160931702|NCT03569371|581147807|FG000|Overall Study|Lost to Follow-up|1|||
160931703|NCT03569371|581147807|FG000|Overall Study|Adverse Event|1|||
160931704|NCT03643562|581147808|FG000|Overall Study|Adverse Event|1|||
160931705|NCT03643562|581147809|FG001|Overall Study|Adverse Event|0|||
160931706|NCT03643562|581147808|FG000|Overall Study|Lack of Efficacy|0|||
160931707|NCT03643562|581147809|FG001|Overall Study|Lack of Efficacy|1|||
160931708|NCT03643562|581147808|FG000|Overall Study|Physician Decision|0|||
160931709|NCT03643562|581147809|FG001|Overall Study|Physician Decision|1|||
160931710|NCT03643562|581147808|FG000|Overall Study|Study Terminated by Sponsor|2|||
160931711|NCT03643562|581147809|FG001|Overall Study|Study Terminated by Sponsor|10|||
160931712|NCT03643562|581147808|FG000|Overall Study|Withdrawal by Subject|2|||
160931713|NCT03643562|581147809|FG001|Overall Study|Withdrawal by Subject|2|||
160931714|NCT03643562|581147808|FG000|Overall Study|Other than specified|3|||
160931715|NCT03643562|581147809|FG001|Overall Study|Other than specified|2|||
160931716|NCT01236755|581147811|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
160931717|NCT01236755|581147811|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
160931718|NCT01236755|581147811|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
160931719|NCT01236755|581147811|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
160931720|NCT01481116|581147812|FG000|Overall Study|Adverse Event|26|||
160931721|NCT01481116|581147813|FG001|Overall Study|Adverse Event|26|||
160931722|NCT01481116|581147814|FG002|Overall Study|Adverse Event|42|||
160931723|NCT01481116|581147812|FG000|Overall Study|Major Protocol Deviation|3|||
160931724|NCT01481116|581147813|FG001|Overall Study|Major Protocol Deviation|7|||
160931725|NCT01481116|581147814|FG002|Overall Study|Major Protocol Deviation|1|||
160931726|NCT01481116|581147812|FG000|Overall Study|Lost to Follow-up|8|||
160931727|NCT01481116|581147813|FG001|Overall Study|Lost to Follow-up|12|||
160931728|NCT01481116|581147814|FG002|Overall Study|Lost to Follow-up|11|||
160931729|NCT01481116|581147812|FG000|Overall Study|Withdrawal by Subject|37|||
160931730|NCT01481116|581147813|FG001|Overall Study|Withdrawal by Subject|33|||
160931731|NCT01481116|581147814|FG002|Overall Study|Withdrawal by Subject|37|||
160931732|NCT01481116|581147812|FG000|Overall Study|Study Termination|730|||
160931733|NCT01481116|581147813|FG001|Overall Study|Study Termination|729|||
160931734|NCT01481116|581147814|FG002|Overall Study|Study Termination|713|||
160931735|NCT01481116|581147812|FG000|Overall Study|Pregnancy|0|||
160931736|NCT01481116|581147813|FG001|Overall Study|Pregnancy|0|||
160931737|NCT01481116|581147814|FG002|Overall Study|Pregnancy|1|||
160931738|NCT01481116|581147812|FG000|Overall Study|Lack of Efficacy|3|||
160931739|NCT01481116|581147813|FG001|Overall Study|Lack of Efficacy|3|||
160931740|NCT01481116|581147814|FG002|Overall Study|Lack of Efficacy|1|||
160931741|NCT01481116|581147812|FG000|Overall Study|Contraindications|1|||
160931742|NCT01481116|581147813|FG001|Overall Study|Contraindications|1|||
160998213|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
161342449|NCT00284856|582640199|FG000|Overall Study|Withdrawal by Subject|12|||
160931743|NCT01481116|581147814|FG002|Overall Study|Contraindications|0|||
160931744|NCT01481116|581147812|FG000|Overall Study|Other|1|||
160931745|NCT01481116|581147813|FG001|Overall Study|Other|1|||
160931746|NCT01481116|581147814|FG002|Overall Study|Other|0|||
160931747|NCT01481116|581147812|FG000|Overall Study|Participant Started Taking Glipizide|1|||
160931748|NCT01481116|581147813|FG001|Overall Study|Participant Started Taking Glipizide|0|||
160931749|NCT01481116|581147814|FG002|Overall Study|Participant Started Taking Glipizide|0|||
161143702|NCT00847613|581909466|FG002|Overall Study|Sponsor request|0|||
160931750|NCT01481116|581147812|FG000|Overall Study|Participant Moved Out of Area|2|||
160931751|NCT01481116|581147813|FG001|Overall Study|Participant Moved Out of Area|0|||
160931752|NCT01481116|581147814|FG002|Overall Study|Participant Moved Out of Area|1|||
160931753|NCT01481116|581147812|FG000|Overall Study|Participant Moved Out of Country|1|||
161342450|NCT00284856|582640200|FG001|Overall Study|Withdrawal by Subject|16|||
160931754|NCT01481116|581147813|FG001|Overall Study|Participant Moved Out of Country|0|||
160931755|NCT01481116|581147814|FG002|Overall Study|Participant Moved Out of Country|1|||
160931756|NCT01481116|581147812|FG000|Overall Study|Investigator Decision|3|||
160931757|NCT01481116|581147813|FG001|Overall Study|Investigator Decision|2|||
160931758|NCT01481116|581147814|FG002|Overall Study|Investigator Decision|1|||
160931759|NCT01481116|581147812|FG000|Overall Study|Sponsor Decision|0|||
160931760|NCT01481116|581147813|FG001|Overall Study|Sponsor Decision|1|||
160931761|NCT01481116|581147814|FG002|Overall Study|Sponsor Decision|3|||
160931762|NCT01481116|581147812|FG000|Overall Study|Non-Compliant With Study Drug|0|||
160931763|NCT01481116|581147813|FG001|Overall Study|Non-Compliant With Study Drug|1|||
160931764|NCT01481116|581147814|FG002|Overall Study|Non-Compliant With Study Drug|1|||
160931765|NCT01481116|581147812|FG000|Overall Study|Investigator's Discretion|2|||
160931766|NCT01481116|581147813|FG001|Overall Study|Investigator's Discretion|0|||
160931767|NCT01481116|581147814|FG002|Overall Study|Investigator's Discretion|0|||
160931768|NCT01481116|581147812|FG000|Overall Study|Death|2|||
160931769|NCT01481116|581147813|FG001|Overall Study|Death|1|||
160931770|NCT01481116|581147814|FG002|Overall Study|Death|0|||
160931771|NCT01481116|581147812|FG000|Overall Study|Hypoglycemic Event|4|||
160931772|NCT01481116|581147813|FG001|Overall Study|Hypoglycemic Event|0|||
160931773|NCT01481116|581147814|FG002|Overall Study|Hypoglycemic Event|0|||
160931774|NCT03848845|581147815|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
160931775|NCT03848845|581147816|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
160931776|NCT03848845|581147817|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
161264280|NCT05070546|582349200|FG005|Overall Study|Randomized but not vaccinated|0|||
160931777|NCT03848845|581147818|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
160931778|NCT03848845|581147815|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
160931779|NCT03848845|581147816|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
160931780|NCT03848845|581147817|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
160931781|NCT03848845|581147818|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
160931782|NCT03848845|581147815|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
160931783|NCT03848845|581147816|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
160931784|NCT03848845|581147817|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
160931785|NCT03848845|581147818|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
160931786|NCT03848845|581147815|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
160931787|NCT03848845|581147816|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
160931788|NCT03848845|581147817|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
160931789|NCT03848845|581147818|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
160931790|NCT02433834|581147820|FG000|Overall Study|Protocol-specified criteria|7|||
160931791|NCT02433834|581147820|FG000|Overall Study|Protocol Violation|3|||
160931792|NCT02433834|581147820|FG000|Overall Study|Lost to Follow-up|6|||
160931793|NCT02433834|581147820|FG000|Overall Study|Withdrawal by Subject|14|||
160931794|NCT02433834|581147820|FG000|Overall Study|Adverse Event|6|||
160931795|NCT02433834|581147820|FG000|Overall Study|Physician Decision|1|||
160931796|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
160931797|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
160931798|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
160931799|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
160931800|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
160931801|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
160931802|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
160931803|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
160931804|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
160931805|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
160931806|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
160931807|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
160998214|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
160998215|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
161264281|NCT00988065|582349216|FG000|Overall Study|Adverse Event|4|||
161264282|NCT00988065|582349217|FG001|Overall Study|Adverse Event|10|||
161264283|NCT00988065|582349218|FG002|Overall Study|Adverse Event|2|||
161264284|NCT00988065|582349216|FG000|Overall Study|Lost to Follow-up|1|||
161264285|NCT00988065|582349217|FG001|Overall Study|Lost to Follow-up|2|||
160931808|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
160931809|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
160931810|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
160931811|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
160931812|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
160931813|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
160931814|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
161264286|NCT00988065|582349218|FG002|Overall Study|Lost to Follow-up|2|||
161264287|NCT00988065|582349216|FG000|Overall Study|Subject withdrew consent|3|||
160931815|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
160931816|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
160931817|NCT00934544|581147821|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
160931818|NCT00934544|581147822|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
160931819|NCT00934544|581147823|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
160931820|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
161264288|NCT00988065|582349217|FG001|Overall Study|Subject withdrew consent|5|||
161264289|NCT00988065|582349218|FG002|Overall Study|Subject withdrew consent|2|||
161264290|NCT00988065|582349216|FG000|Overall Study|Noncompliance with protocol|5|||
161264291|NCT00988065|582349217|FG001|Overall Study|Noncompliance with protocol|6|||
161264292|NCT00988065|582349218|FG002|Overall Study|Noncompliance with protocol|9|||
161264293|NCT03096847|582349224|FG000|Overall Study|Other|2|||
161264294|NCT03096847|582349225|FG001|Overall Study|Other|1|||
161264295|NCT03096847|582349226|FG002|Overall Study|Other|2|||
161264296|NCT03096847|582349224|FG000|Overall Study|Lost to Follow-up|1|||
161264297|NCT03096847|582349225|FG001|Overall Study|Lost to Follow-up|0|||
161264298|NCT03096847|582349226|FG002|Overall Study|Lost to Follow-up|1|||
161264299|NCT03096847|582349224|FG000|Overall Study|Death|6|||
161264300|NCT03096847|582349225|FG001|Overall Study|Death|0|||
161264301|NCT03096847|582349226|FG002|Overall Study|Death|2|||
161264302|NCT03096847|582349224|FG000|Overall Study|Protocol Violation|3|||
161264303|NCT03096847|582349225|FG001|Overall Study|Protocol Violation|0|||
161264304|NCT03096847|582349226|FG002|Overall Study|Protocol Violation|6|||
161264305|NCT03096847|582349224|FG000|Overall Study|Physician Decision|12|||
161264306|NCT03096847|582349225|FG001|Overall Study|Physician Decision|2|||
161264307|NCT03096847|582349226|FG002|Overall Study|Physician Decision|8|||
161264308|NCT03096847|582349224|FG000|Overall Study|Withdrawal by Subject|24|||
161264309|NCT03096847|582349225|FG001|Overall Study|Withdrawal by Subject|1|||
161264310|NCT03096847|582349226|FG002|Overall Study|Withdrawal by Subject|12|||
161264311|NCT03096847|582349224|FG000|Overall Study|Adverse Event|72|||
161264312|NCT03096847|582349225|FG001|Overall Study|Adverse Event|6|||
161264313|NCT03096847|582349226|FG002|Overall Study|Adverse Event|28|||
161264314|NCT03096847|582349224|FG000|Overall Study|Progressive disease|97|||
161264315|NCT03096847|582349225|FG001|Overall Study|Progressive disease|10|||
161264316|NCT03096847|582349226|FG002|Overall Study|Progressive disease|78|||
161264317|NCT03096847|582349224|FG000|Overall Study|Non-compliance with study medication|1|||
161264318|NCT03096847|582349225|FG001|Overall Study|Non-compliance with study medication|0|||
161264319|NCT03096847|582349226|FG002|Overall Study|Non-compliance with study medication|0|||
161264320|NCT03096847|582349224|FG000|Overall Study|New therapy for study indication|1|||
161264321|NCT03096847|582349225|FG001|Overall Study|New therapy for study indication|0|||
161264322|NCT03096847|582349226|FG002|Overall Study|New therapy for study indication|1|||
161264323|NCT00359632|582349230|FG000|Overall Study|Death|2|||
161264324|NCT00359632|582349231|FG001|Overall Study|Death|0|||
161264325|NCT00359632|582349230|FG000|Overall Study|Adverse Event|1|||
161264326|NCT00359632|582349231|FG001|Overall Study|Adverse Event|0|||
161342451|NCT00284856|582640201|FG002|Overall Study|Withdrawal by Subject|18|||
161342452|NCT00284856|582640199|FG000|Overall Study|Other|4|||
160931821|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
160998216|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
160998217|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
160998218|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
160998219|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
160998220|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
160998221|NCT00410124|581378596|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
160998222|NCT00410124|581378597|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
160998223|NCT00319436|581378598|FG000|Overall Study|Withdrawal by Subject|6|||
160998224|NCT00319436|581378599|FG001|Overall Study|Withdrawal by Subject|7|||
160998225|NCT01104415|581378603|FG000|Core Phase|Consent withdrawn by subjects|1|||
160998226|NCT01104415|581378604|FG001|Core Phase|Consent withdrawn by subjects|0|||
160998227|NCT01104415|581378603|FG000|Extension Period|Progressive disease|0|||
160998228|NCT01104415|581378604|FG001|Extension Period|Progressive disease|4|||
161143703|NCT00847613|581909467|FG003|Overall Study|Sponsor request|0|||
161143704|NCT00847613|581909464|FG000|Overall Study|Randomized, but not treated|0|||
161143705|NCT00847613|581909465|FG001|Overall Study|Randomized, but not treated|3|||
160998229|NCT01104415|581378603|FG000|Extension Period|Death|0|||
160998230|NCT01104415|581378604|FG001|Extension Period|Death|1|||
161143706|NCT00847613|581909466|FG002|Overall Study|Randomized, but not treated|0|||
161264327|NCT00359632|582349230|FG000|Overall Study|Non-compliance with visit schedule|1|||
161264328|NCT00359632|582349231|FG001|Overall Study|Non-compliance with visit schedule|0|||
161264329|NCT03978091|582349232|FG000|Overall Study|Lost to Follow-up|0|||
161264330|NCT03978091|582349233|FG001|Overall Study|Lost to Follow-up|0|||
161264331|NCT03978091|582349234|FG002|Overall Study|Lost to Follow-up|1|||
161264332|NCT03978091|582349235|FG003|Overall Study|Lost to Follow-up|0|||
160998231|NCT01104415|581378603|FG000|Extension Period|Physician Decision|0|||
160998232|NCT01104415|581378604|FG001|Extension Period|Physician Decision|1|||
160998233|NCT01104415|581378603|FG000|Extension Period|Transition to Study LX1606.302|0|||
160998234|NCT01104415|581378604|FG001|Extension Period|Transition to Study LX1606.302|4|||
160998235|NCT01104415|581378603|FG000|Extension Period|Heart surgery/feeling miserable|0|||
160998236|NCT01104415|581378604|FG001|Extension Period|Heart surgery/feeling miserable|1|||
160998237|NCT01839877|581378608|FG000|Overall Study|Protocol Violation|1|||
160998238|NCT00597519|581378609|FG000|Overall Study|Death|1|||
160998239|NCT03098030|581378610|FG000|Overall Study|Death|10|||
160998240|NCT03098030|581378611|FG001|Overall Study|Death|156|||
160998241|NCT03098030|581378612|FG002|Overall Study|Death|156|||
160998242|NCT03098030|581378613|FG003|Overall Study|Death|82|||
160998243|NCT03098030|581378610|FG000|Overall Study|Withdrawal by Subject|0|||
161264333|NCT03978091|582349236|FG004|Overall Study|Lost to Follow-up|0|||
161264334|NCT03978091|582349237|FG005|Overall Study|Lost to Follow-up|0|||
161264335|NCT03978091|582349232|FG000|Overall Study|Withdrawal by Subject|0|||
161264336|NCT03978091|582349233|FG001|Overall Study|Withdrawal by Subject|0|||
161264337|NCT03978091|582349234|FG002|Overall Study|Withdrawal by Subject|0|||
161264338|NCT03978091|582349235|FG003|Overall Study|Withdrawal by Subject|1|||
161264339|NCT03978091|582349236|FG004|Overall Study|Withdrawal by Subject|1|||
161264340|NCT03978091|582349237|FG005|Overall Study|Withdrawal by Subject|0|||
161264341|NCT02093221|582349243|FG000|Overall Study|Adverse Event|1|||
160931822|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
160931823|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
160931824|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
160931825|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
160931826|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
160931827|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
160931828|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
160931829|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
160931830|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
160931831|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
160931832|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
160931833|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
160931834|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
160931835|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
160931836|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
160931837|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
160931838|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
160931839|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
160931840|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
160931841|NCT00934544|581147821|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
160931842|NCT00934544|581147822|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
160931843|NCT00934544|581147823|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
160931844|NCT02643251|581147824|FG000|Overall Study|Adverse Event|3|||
160931845|NCT02643251|581147825|FG001|Overall Study|Adverse Event|1|||
160931846|NCT02643251|581147824|FG000|Overall Study|Withdrawal by Subject|2|||
160931847|NCT02643251|581147825|FG001|Overall Study|Withdrawal by Subject|0|||
160931848|NCT02643251|581147824|FG000|Overall Study|Lost to Follow-up|4|||
160931849|NCT02643251|581147825|FG001|Overall Study|Lost to Follow-up|1|||
160931850|NCT02643251|581147824|FG000|Overall Study|Protocol Violation|1|||
160998244|NCT03098030|581378611|FG001|Overall Study|Withdrawal by Subject|7|||
160998245|NCT03098030|581378612|FG002|Overall Study|Withdrawal by Subject|8|||
160998246|NCT03098030|581378613|FG003|Overall Study|Withdrawal by Subject|2|||
160998247|NCT03098030|581378610|FG000|Overall Study|Lost to Follow-up|0|||
160998248|NCT03098030|581378611|FG001|Overall Study|Lost to Follow-up|0|||
161264342|NCT02093221|582349244|FG001|Overall Study|Adverse Event|0|||
161264343|NCT02093221|582349245|FG002|Overall Study|Adverse Event|0|||
161264344|NCT02093221|582349246|FG003|Overall Study|Adverse Event|0|||
161264345|NCT02093221|582349247|FG004|Overall Study|Adverse Event|0|||
161264346|NCT02093221|582349243|FG000|Overall Study|Withdrawal by Subject|1|||
161264347|NCT02093221|582349244|FG001|Overall Study|Withdrawal by Subject|1|||
161264348|NCT02093221|582349245|FG002|Overall Study|Withdrawal by Subject|4|||
161342453|NCT00284856|582640200|FG001|Overall Study|Other|5|||
160998249|NCT03098030|581378612|FG002|Overall Study|Lost to Follow-up|2|||
161264349|NCT02093221|582349246|FG003|Overall Study|Withdrawal by Subject|1|||
161264350|NCT02093221|582349247|FG004|Overall Study|Withdrawal by Subject|1|||
161264351|NCT02093221|582349243|FG000|Overall Study|Lost to Follow-up|2|||
160931851|NCT02643251|581147825|FG001|Overall Study|Protocol Violation|0|||
160931852|NCT02643251|581147824|FG000|Overall Study|PI Decision to terminate patient|1|||
160998250|NCT03098030|581378613|FG003|Overall Study|Lost to Follow-up|1|||
161342454|NCT00284856|582640201|FG002|Overall Study|Other|4|||
160931853|NCT02643251|581147825|FG001|Overall Study|PI Decision to terminate patient|0|||
160931854|NCT00348556|581147826|FG000|Overall Study|Adverse Event|1|||
160931855|NCT01956110|581147833|FG000|Overall Study|Protocol Violation|25|||
160931856|NCT01956110|581147834|FG001|Overall Study|Protocol Violation|11|||
160931857|NCT01956110|581147833|FG000|Overall Study|Adverse Event|9|||
160931858|NCT01956110|581147834|FG001|Overall Study|Adverse Event|10|||
160931859|NCT01956110|581147833|FG000|Overall Study|Personal reasons|1|||
160931860|NCT01956110|581147834|FG001|Overall Study|Personal reasons|1|||
160931861|NCT00430092|581147835|FG000|Overall Study|Adverse Event|0|||
160931862|NCT00430092|581147836|FG001|Overall Study|Adverse Event|0|||
160931863|NCT00430092|581147837|FG002|Overall Study|Adverse Event|1|||
160931864|NCT00430092|581147835|FG000|Overall Study|Lack of Efficacy|5|||
160931865|NCT00430092|581147836|FG001|Overall Study|Lack of Efficacy|2|||
160931866|NCT00430092|581147837|FG002|Overall Study|Lack of Efficacy|54|||
160931867|NCT00430092|581147835|FG000|Overall Study|Lost to Follow-up|1|||
160931868|NCT00430092|581147836|FG001|Overall Study|Lost to Follow-up|0|||
160931869|NCT00430092|581147837|FG002|Overall Study|Lost to Follow-up|0|||
160931870|NCT00430092|581147835|FG000|Overall Study|Protocol Violation|0|||
160931871|NCT00430092|581147836|FG001|Overall Study|Protocol Violation|1|||
160931872|NCT00430092|581147837|FG002|Overall Study|Protocol Violation|1|||
160931873|NCT00430092|581147835|FG000|Overall Study|Withdrawal by Subject|0|||
160931874|NCT00430092|581147836|FG001|Overall Study|Withdrawal by Subject|1|||
160931875|NCT00430092|581147837|FG002|Overall Study|Withdrawal by Subject|1|||
160931876|NCT02118428|581147840|FG000|Overall Study|Physician Decision|0|||
160931877|NCT02118428|581147841|FG001|Overall Study|Physician Decision|1|||
160931878|NCT02118428|581147842|FG002|Overall Study|Physician Decision|0|||
160931879|NCT02118428|581147840|FG000|Overall Study|Withdrawal by Subject|2|||
160931880|NCT02118428|581147841|FG001|Overall Study|Withdrawal by Subject|2|||
160931881|NCT02118428|581147842|FG002|Overall Study|Withdrawal by Subject|0|||
160931882|NCT02118428|581147840|FG000|Overall Study|Death|7|||
160931883|NCT02118428|581147841|FG001|Overall Study|Death|5|||
160931884|NCT02118428|581147842|FG002|Overall Study|Death|0|||
160931885|NCT02118428|581147840|FG000|Overall Study|Lost to Follow-up|3|||
160931886|NCT02118428|581147841|FG001|Overall Study|Lost to Follow-up|1|||
160931887|NCT02118428|581147842|FG002|Overall Study|Lost to Follow-up|0|||
160931888|NCT02118428|581147840|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
160931889|NCT02118428|581147841|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
160931890|NCT02118428|581147842|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
160931891|NCT03325166|581147843|FG000|Overall Study|Adverse Event|1|||
160931892|NCT01633944|581147844|FG000|Open-label Titration Phase|Adverse Event|109|||
160998251|NCT03368001|581378617|FG000|Allocation|Lost to Pretest|16|||
160998252|NCT03368001|581378618|FG001|Allocation|Lost to Pretest|25|||
161264352|NCT02093221|582349244|FG001|Overall Study|Lost to Follow-up|0|||
161264353|NCT02093221|582349245|FG002|Overall Study|Lost to Follow-up|1|||
161264354|NCT02093221|582349246|FG003|Overall Study|Lost to Follow-up|1|||
161264355|NCT02093221|582349247|FG004|Overall Study|Lost to Follow-up|0|||
161264356|NCT02093221|582349243|FG000|Overall Study|Death|0|||
161264357|NCT02093221|582349244|FG001|Overall Study|Death|1|||
161264358|NCT02093221|582349245|FG002|Overall Study|Death|0|||
161264359|NCT02093221|582349246|FG003|Overall Study|Death|0|||
161264360|NCT02093221|582349247|FG004|Overall Study|Death|0|||
160931893|NCT01633944|581147845|FG001|Open-label Titration Phase|Adverse Event|0|||
160998253|NCT03368001|581378617|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
160998254|NCT03368001|581378618|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
160998255|NCT03368001|581378617|FG000|Posttest|Lost to Posttest|7|||
160998256|NCT03368001|581378618|FG001|Posttest|Lost to Posttest|11|||
160998257|NCT03368001|581378617|FG000|Posttest|Discontinued Intervention|6|||
160998258|NCT03368001|581378618|FG001|Posttest|Discontinued Intervention|19|||
160998259|NCT03368001|581378617|FG000|Follow-up|Lost to Follow-up|6|||
160998260|NCT03368001|581378618|FG001|Follow-up|Lost to Follow-up|3|||
160998261|NCT03612804|581378619|FG000|Overall Study|Death|0|||
160998262|NCT03612804|581378620|FG001|Overall Study|Death|7|||
161264361|NCT02093221|582349243|FG000|Overall Study|Protocol Violation|0|||
160998263|NCT03612804|581378621|FG002|Overall Study|Death|0|||
160998264|NCT03612804|581378622|FG003|Overall Study|Death|8|||
160998265|NCT03612804|581378619|FG000|Overall Study|Medication copay coverage issues|0|||
161264362|NCT02093221|582349244|FG001|Overall Study|Protocol Violation|1|||
160931894|NCT01633944|581147846|FG002|Open-label Titration Phase|Adverse Event|0|||
160931895|NCT01633944|581147844|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
160931896|NCT01633944|581147845|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
160931897|NCT01633944|581147846|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
160931898|NCT01633944|581147844|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
160931899|NCT01633944|581147845|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
160931900|NCT01633944|581147846|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
160931901|NCT01633944|581147844|FG000|Open-label Titration Phase|Protocol Violation|24|||
160998266|NCT03612804|581378620|FG001|Overall Study|Medication copay coverage issues|0|||
160998267|NCT03612804|581378621|FG002|Overall Study|Medication copay coverage issues|0|||
161264363|NCT02093221|582349245|FG002|Overall Study|Protocol Violation|0|||
161264364|NCT02093221|582349246|FG003|Overall Study|Protocol Violation|0|||
160931902|NCT01633944|581147845|FG001|Open-label Titration Phase|Protocol Violation|0|||
160931903|NCT01633944|581147846|FG002|Open-label Titration Phase|Protocol Violation|0|||
160931904|NCT01633944|581147844|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
160931905|NCT01633944|581147845|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
160931906|NCT01633944|581147846|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
160931907|NCT01633944|581147844|FG000|Open-label Titration Phase|Other|68|||
160931908|NCT01633944|581147845|FG001|Open-label Titration Phase|Other|0|||
160931909|NCT01633944|581147846|FG002|Open-label Titration Phase|Other|0|||
160931910|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Adverse Event|0|||
160931911|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Adverse Event|13|||
160931912|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Adverse Event|7|||
160931913|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
160931914|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
160931915|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
160931916|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
160931917|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
160931918|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
160931919|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
160931920|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
160931921|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
160931922|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
160931923|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
160931924|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
160931925|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
160931926|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
160931927|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
160931928|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
160931929|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
160931930|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
160931931|NCT01633944|581147844|FG000|Double-blind Treatment Phase|Other|0|||
160931932|NCT01633944|581147845|FG001|Double-blind Treatment Phase|Other|7|||
160931933|NCT01633944|581147846|FG002|Double-blind Treatment Phase|Other|0|||
160931934|NCT03354429|581147847|FG000|Overall Study|Withdrawal by Subject|8|||
160931935|NCT03354429|581147848|FG001|Overall Study|Withdrawal by Subject|7|||
160931936|NCT03354429|581147847|FG000|Overall Study|Lost to Follow-up|1|||
160931937|NCT03354429|581147848|FG001|Overall Study|Lost to Follow-up|0|||
160931938|NCT00782210|581147850|FG000|Overall Study|Adverse Event|21|||
160931939|NCT00782210|581147851|FG001|Overall Study|Adverse Event|17|||
160931940|NCT00782210|581147852|FG002|Overall Study|Adverse Event|16|||
160931941|NCT00782210|581147850|FG000|Overall Study|Lost to Follow-up|2|||
160931942|NCT00782210|581147851|FG001|Overall Study|Lost to Follow-up|1|||
160931943|NCT00782210|581147852|FG002|Overall Study|Lost to Follow-up|2|||
160931944|NCT00782210|581147850|FG000|Overall Study|Withdrawal by Subject|11|||
160931945|NCT00782210|581147851|FG001|Overall Study|Withdrawal by Subject|8|||
160931946|NCT00782210|581147852|FG002|Overall Study|Withdrawal by Subject|11|||
160931947|NCT00782210|581147850|FG000|Overall Study|Non compliance with protocol|0|||
160931948|NCT00782210|581147851|FG001|Overall Study|Non compliance with protocol|3|||
160931949|NCT00782210|581147852|FG002|Overall Study|Non compliance with protocol|2|||
160931950|NCT00782210|581147850|FG000|Overall Study|Lack of Efficacy|13|||
160931951|NCT00782210|581147851|FG001|Overall Study|Lack of Efficacy|4|||
160931952|NCT00782210|581147852|FG002|Overall Study|Lack of Efficacy|1|||
160931953|NCT00782210|581147850|FG000|Overall Study|Other reason not described above|3|||
160931954|NCT00782210|581147851|FG001|Overall Study|Other reason not described above|2|||
160931955|NCT00782210|581147852|FG002|Overall Study|Other reason not described above|3|||
160931956|NCT03100825|581147853|FG000|Overall Study|Participant/Guardian Decision|7|||
160931957|NCT03100825|581147853|FG000|Overall Study|Physician Decision|1|||
160931958|NCT00994448|581147855|FG000|Overall Study|Adverse Event|1|||
160931959|NCT00994448|581147856|FG001|Overall Study|Adverse Event|0|||
160931960|NCT00994448|581147855|FG000|Overall Study|Lost to Follow-up|5|||
160931961|NCT00994448|581147856|FG001|Overall Study|Lost to Follow-up|1|||
160931962|NCT00994448|581147855|FG000|Overall Study|Withdrawal by Subject|1|||
160931963|NCT00994448|581147856|FG001|Overall Study|Withdrawal by Subject|1|||
160931964|NCT00994448|581147855|FG000|Overall Study|Physician Decision|1|||
160931965|NCT00994448|581147856|FG001|Overall Study|Physician Decision|0|||
160931966|NCT05923229|581147862|FG000|Overall Study|Withdrawal by Subject|3|||
160931967|NCT05923229|581147863|FG001|Overall Study|Withdrawal by Subject|0|||
160931968|NCT05923229|581147862|FG000|Overall Study|Health related|2|||
160931969|NCT05923229|581147863|FG001|Overall Study|Health related|1|||
160931970|NCT04098458|581147864|FG000|Overall Study|Death|1|||
160931971|NCT04098458|581147864|FG000|Overall Study|did not meet study inclusion criteria|3|||
160931972|NCT00006489|581147865|FG000|Overall Study|Adverse Event|3|||
160998268|NCT03612804|581378622|FG003|Overall Study|Medication copay coverage issues|17|||
161342455|NCT01056536|582640202|FG000|Overall Study|Lost to Follow-up|202|||
160931973|NCT00006489|581147866|FG001|Overall Study|Adverse Event|2|||
160931974|NCT00006489|581147867|FG002|Overall Study|Adverse Event|4|||
160931975|NCT00006489|581147868|FG003|Overall Study|Adverse Event|3|||
160931976|NCT00006489|581147865|FG000|Overall Study|Withdrawal by Subject|10|||
160931977|NCT00006489|581147866|FG001|Overall Study|Withdrawal by Subject|9|||
160931978|NCT00006489|581147867|FG002|Overall Study|Withdrawal by Subject|9|||
160931979|NCT00006489|581147868|FG003|Overall Study|Withdrawal by Subject|6|||
160931980|NCT00006489|581147865|FG000|Overall Study|Scheduling Conflict|0|||
160931981|NCT00006489|581147866|FG001|Overall Study|Scheduling Conflict|3|||
160931982|NCT00006489|581147867|FG002|Overall Study|Scheduling Conflict|2|||
160931983|NCT00006489|581147868|FG003|Overall Study|Scheduling Conflict|1|||
160931984|NCT00006489|581147865|FG000|Overall Study|Death|0|||
160931985|NCT00006489|581147866|FG001|Overall Study|Death|0|||
160931986|NCT00006489|581147867|FG002|Overall Study|Death|0|||
160931987|NCT00006489|581147868|FG003|Overall Study|Death|1|||
160931988|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
160931989|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931990|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931991|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931992|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931993|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931994|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160931995|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
160931996|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160931997|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160931998|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160931999|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160932000|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160932001|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160932002|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
160932003|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932004|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932005|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932006|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932007|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932008|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160932009|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
160932010|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932011|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932012|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932013|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932014|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932015|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160932016|NCT01479621|581147869|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
160932017|NCT01479621|581147870|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932018|NCT01479621|581147871|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932019|NCT01479621|581147872|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932020|NCT01479621|581147873|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932021|NCT01479621|581147874|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932022|NCT01479621|581147875|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160932023|NCT01479621|581147869|FG000|Treatment Period|Adverse Event|0|||
160932024|NCT01479621|581147870|FG001|Treatment Period|Adverse Event|0|||
160932025|NCT01479621|581147871|FG002|Treatment Period|Adverse Event|0|||
160932026|NCT01479621|581147872|FG003|Treatment Period|Adverse Event|0|||
160932027|NCT01479621|581147873|FG004|Treatment Period|Adverse Event|1|||
160932028|NCT01479621|581147874|FG005|Treatment Period|Adverse Event|2|||
160932029|NCT01479621|581147875|FG006|Treatment Period|Adverse Event|2|||
160932030|NCT01479621|581147869|FG000|Treatment Period|Withdrawal by Subject|0|||
160932031|NCT01479621|581147870|FG001|Treatment Period|Withdrawal by Subject|4|||
160932032|NCT01479621|581147871|FG002|Treatment Period|Withdrawal by Subject|2|||
160932033|NCT01479621|581147872|FG003|Treatment Period|Withdrawal by Subject|2|||
160932034|NCT01479621|581147873|FG004|Treatment Period|Withdrawal by Subject|5|||
160932035|NCT01479621|581147874|FG005|Treatment Period|Withdrawal by Subject|5|||
160932036|NCT01479621|581147875|FG006|Treatment Period|Withdrawal by Subject|1|||
160932037|NCT01479621|581147869|FG000|Treatment Period|Physician Decision|0|||
160932038|NCT01479621|581147870|FG001|Treatment Period|Physician Decision|0|||
160932039|NCT01479621|581147871|FG002|Treatment Period|Physician Decision|0|||
160932040|NCT01479621|581147872|FG003|Treatment Period|Physician Decision|0|||
161342456|NCT01056536|582640203|FG001|Overall Study|Lost to Follow-up|116|||
161342457|NCT01056536|582640204|FG002|Overall Study|Lost to Follow-up|248|||
160998269|NCT03612804|581378619|FG000|Overall Study|Not current smoker at time of screening|0|||
160998270|NCT03612804|581378620|FG001|Overall Study|Not current smoker at time of screening|1|||
160998271|NCT03612804|581378621|FG002|Overall Study|Not current smoker at time of screening|0|||
160998272|NCT03612804|581378622|FG003|Overall Study|Not current smoker at time of screening|3|||
160998273|NCT03612804|581378619|FG000|Overall Study|Non-veteran status|0|||
160998274|NCT03612804|581378620|FG001|Overall Study|Non-veteran status|1|||
160998275|NCT03612804|581378621|FG002|Overall Study|Non-veteran status|0|||
160998276|NCT03612804|581378622|FG003|Overall Study|Non-veteran status|0|||
160998277|NCT03612804|581378619|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
160932041|NCT01479621|581147873|FG004|Treatment Period|Physician Decision|1|||
160932042|NCT01479621|581147874|FG005|Treatment Period|Physician Decision|1|||
160932043|NCT01479621|581147875|FG006|Treatment Period|Physician Decision|0|||
160932044|NCT01479621|581147869|FG000|Treatment Period|Non-compliance to study drug|0|||
160932045|NCT01479621|581147870|FG001|Treatment Period|Non-compliance to study drug|1|||
160932046|NCT01479621|581147871|FG002|Treatment Period|Non-compliance to study drug|0|||
160932047|NCT01479621|581147872|FG003|Treatment Period|Non-compliance to study drug|0|||
160932048|NCT01479621|581147873|FG004|Treatment Period|Non-compliance to study drug|0|||
160932049|NCT01479621|581147874|FG005|Treatment Period|Non-compliance to study drug|0|||
160932050|NCT01479621|581147875|FG006|Treatment Period|Non-compliance to study drug|1|||
160932051|NCT01479621|581147869|FG000|Treatment Period|Protocol Violation|0|||
160932052|NCT01479621|581147870|FG001|Treatment Period|Protocol Violation|9|||
160932053|NCT01479621|581147871|FG002|Treatment Period|Protocol Violation|6|||
160932054|NCT01479621|581147872|FG003|Treatment Period|Protocol Violation|5|||
160932055|NCT01479621|581147873|FG004|Treatment Period|Protocol Violation|2|||
160932056|NCT01479621|581147874|FG005|Treatment Period|Protocol Violation|10|||
160932057|NCT01479621|581147875|FG006|Treatment Period|Protocol Violation|6|||
160932058|NCT01479621|581147869|FG000|Treatment Period|Pregnancy|0|||
160932059|NCT01479621|581147870|FG001|Treatment Period|Pregnancy|0|||
160932060|NCT01479621|581147871|FG002|Treatment Period|Pregnancy|2|||
160932061|NCT01479621|581147872|FG003|Treatment Period|Pregnancy|0|||
160932062|NCT01479621|581147873|FG004|Treatment Period|Pregnancy|0|||
160932063|NCT01479621|581147874|FG005|Treatment Period|Pregnancy|0|||
160932064|NCT01479621|581147875|FG006|Treatment Period|Pregnancy|0|||
160932065|NCT01479621|581147869|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
160932066|NCT01479621|581147870|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
160932067|NCT01479621|581147871|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
160932068|NCT01479621|581147872|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
160932069|NCT01479621|581147873|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
160932070|NCT01479621|581147874|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
160932071|NCT01479621|581147875|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
160932072|NCT01479621|581147869|FG000|Treatment Period|Lost to Follow-up|0|||
160932073|NCT01479621|581147870|FG001|Treatment Period|Lost to Follow-up|0|||
160932074|NCT01479621|581147871|FG002|Treatment Period|Lost to Follow-up|1|||
160932075|NCT01479621|581147872|FG003|Treatment Period|Lost to Follow-up|0|||
160932076|NCT01479621|581147873|FG004|Treatment Period|Lost to Follow-up|2|||
160932077|NCT01479621|581147874|FG005|Treatment Period|Lost to Follow-up|2|||
160932078|NCT01479621|581147875|FG006|Treatment Period|Lost to Follow-up|1|||
160932079|NCT01479621|581147869|FG000|Treatment Period|Met stopping criteria|0|||
160932080|NCT01479621|581147870|FG001|Treatment Period|Met stopping criteria|8|||
160932081|NCT01479621|581147871|FG002|Treatment Period|Met stopping criteria|7|||
160932082|NCT01479621|581147872|FG003|Treatment Period|Met stopping criteria|4|||
160932083|NCT01479621|581147873|FG004|Treatment Period|Met stopping criteria|9|||
160932084|NCT01479621|581147874|FG005|Treatment Period|Met stopping criteria|20|||
160932085|NCT01479621|581147875|FG006|Treatment Period|Met stopping criteria|6|||
160932086|NCT02308735|581147876|FG000|Overall Study|Physician Decision|2|||
160932087|NCT02308735|581147877|FG001|Overall Study|Physician Decision|0|||
160932088|NCT02308735|581147878|FG002|Overall Study|Physician Decision|0|||
160932089|NCT02308735|581147879|FG003|Overall Study|Physician Decision|2|||
160932090|NCT01417481|581147880|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
160998278|NCT03612804|581378620|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
160932091|NCT01417481|581147881|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160932092|NCT03029624|581147884|FG000|Overall Study|Adverse Event|1|||
160932093|NCT03029624|581147884|FG000|Overall Study|Withdrawal by Subject|1|||
160932094|NCT03029624|581147884|FG000|Overall Study|Lack of Efficacy|1|||
160932095|NCT03029624|581147884|FG000|Overall Study|MRI need|2|||
160932096|NCT00974571|581147886|FG000|Overall Study|Adverse Event|31|||
160932097|NCT00974571|581147887|FG001|Overall Study|Adverse Event|4|||
160998279|NCT03612804|581378621|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
160998280|NCT03612804|581378622|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
160998281|NCT03612804|581378619|FG000|Overall Study|Provider retired from VA|0|||
160998282|NCT03612804|581378620|FG001|Overall Study|Provider retired from VA|0|||
161264365|NCT02093221|582349247|FG004|Overall Study|Protocol Violation|0|||
161264366|NCT02093221|582349243|FG000|Overall Study|Study termination|6|||
161264367|NCT02093221|582349244|FG001|Overall Study|Study termination|5|||
160932098|NCT00974571|581147888|FG002|Overall Study|Adverse Event|27|||
160932099|NCT00974571|581147886|FG000|Overall Study|Lack of Efficacy|3|||
160932100|NCT00974571|581147887|FG001|Overall Study|Lack of Efficacy|2|||
160932101|NCT00974571|581147888|FG002|Overall Study|Lack of Efficacy|9|||
160932102|NCT00974571|581147886|FG000|Overall Study|Lost to Follow-up|2|||
160932103|NCT00974571|581147887|FG001|Overall Study|Lost to Follow-up|1|||
160932104|NCT00974571|581147888|FG002|Overall Study|Lost to Follow-up|2|||
160932105|NCT00974571|581147886|FG000|Overall Study|Protocol Violation|13|||
160932106|NCT00974571|581147887|FG001|Overall Study|Protocol Violation|4|||
160932107|NCT00974571|581147888|FG002|Overall Study|Protocol Violation|18|||
160932108|NCT00974571|581147886|FG000|Overall Study|Withdrawal by Subject|14|||
160932109|NCT00974571|581147887|FG001|Overall Study|Withdrawal by Subject|5|||
160932110|NCT00974571|581147888|FG002|Overall Study|Withdrawal by Subject|16|||
160932111|NCT00974571|581147886|FG000|Overall Study|Patient Moved|1|||
160932112|NCT00974571|581147887|FG001|Overall Study|Patient Moved|0|||
160932113|NCT00974571|581147888|FG002|Overall Study|Patient Moved|1|||
160932114|NCT00974571|581147886|FG000|Overall Study|Other|4|||
160932115|NCT00974571|581147887|FG001|Overall Study|Other|0|||
160932116|NCT00974571|581147888|FG002|Overall Study|Other|10|||
160932117|NCT01371656|581147889|FG000|Overall Study|Death|7|||
160932118|NCT01371656|581147890|FG001|Overall Study|Death|4|||
160932119|NCT01371656|581147889|FG000|Overall Study|Physician Decision|46|||
160932120|NCT01371656|581147890|FG001|Overall Study|Physician Decision|7|||
160932121|NCT01371656|581147889|FG000|Overall Study|Withdrawal by Subject|7|||
160932122|NCT01371656|581147890|FG001|Overall Study|Withdrawal by Subject|0|||
160932123|NCT01371656|581147889|FG000|Overall Study|Ineligible|4|||
160932124|NCT01371656|581147890|FG001|Overall Study|Ineligible|3|||
160932125|NCT04334460|581147897|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
160932126|NCT04334460|581147898|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
160932127|NCT04334460|581147897|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
160932128|NCT04334460|581147898|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
160932129|NCT03778931|581147899|FG000|Overall Study|Withdrawal by Subject|12|||
160932130|NCT03778931|581147900|FG001|Overall Study|Withdrawal by Subject|25|||
160932131|NCT03778931|581147899|FG000|Overall Study|Physician Decision|1|||
160932132|NCT03778931|581147900|FG001|Overall Study|Physician Decision|3|||
160932133|NCT03778931|581147899|FG000|Overall Study|Participant Noncompliance|1|||
160932134|NCT03778931|581147900|FG001|Overall Study|Participant Noncompliance|1|||
160932135|NCT03778931|581147899|FG000|Overall Study|Lost to Follow-up|4|||
160932136|NCT03778931|581147900|FG001|Overall Study|Lost to Follow-up|1|||
160932137|NCT03778931|581147899|FG000|Overall Study|Death|69|||
160932138|NCT03778931|581147900|FG001|Overall Study|Death|79|||
160932139|NCT03216850|581147907|FG000|Overall Study|Pre-analytical error|6|||
160932140|NCT01228747|581147910|FG000|Overall Study|Adverse Event|8|||
160932141|NCT01228747|581147911|FG001|Overall Study|Adverse Event|4|||
160932142|NCT01228747|581147910|FG000|Overall Study|Lack of Efficacy|40|||
160932143|NCT01228747|581147911|FG001|Overall Study|Lack of Efficacy|27|||
160932144|NCT01228747|581147910|FG000|Overall Study|Protocol Violation|6|||
160932145|NCT01228747|581147911|FG001|Overall Study|Protocol Violation|5|||
160932146|NCT01228747|581147910|FG000|Overall Study|Lost to Follow-up|4|||
160932147|NCT01228747|581147911|FG001|Overall Study|Lost to Follow-up|3|||
160932148|NCT01228747|581147910|FG000|Overall Study|Withdrawal by Subject|5|||
160932149|NCT01228747|581147911|FG001|Overall Study|Withdrawal by Subject|1|||
160998283|NCT03612804|581378621|FG002|Overall Study|Provider retired from VA|2|||
160998284|NCT03612804|581378622|FG003|Overall Study|Provider retired from VA|0|||
160998285|NCT03612804|581378619|FG000|Overall Study|Withdrawal by Subject|0|||
160998286|NCT03612804|581378620|FG001|Overall Study|Withdrawal by Subject|0|||
160998287|NCT03612804|581378621|FG002|Overall Study|Withdrawal by Subject|7|||
160998288|NCT03612804|581378622|FG003|Overall Study|Withdrawal by Subject|0|||
160998289|NCT03612804|581378619|FG000|Overall Study|Provider involved with study activities|1|||
160998290|NCT03612804|581378620|FG001|Overall Study|Provider involved with study activities|0|||
160998291|NCT03612804|581378621|FG002|Overall Study|Provider involved with study activities|0|||
160998292|NCT03612804|581378622|FG003|Overall Study|Provider involved with study activities|0|||
160932150|NCT01228747|581147910|FG000|Overall Study|Other Reason|2|||
160932151|NCT01228747|581147911|FG001|Overall Study|Other Reason|5|||
161264368|NCT02093221|582349245|FG002|Overall Study|Study termination|4|||
161264369|NCT02093221|582349246|FG003|Overall Study|Study termination|6|||
161264370|NCT02093221|582349247|FG004|Overall Study|Study termination|7|||
160932152|NCT02910167|581147912|FG000|Overall Study|Adverse Event|1|||
160932153|NCT02910167|581147912|FG000|Overall Study|Lost to Follow-up|18|||
160998293|NCT05484726|581378623|FG000|Overall Study|Protocol Violation|3|||
161264371|NCT00725621|582349248|FG000|Overall Study|Adverse Event|25|||
161264372|NCT00725621|582349248|FG000|Overall Study|Lack of Efficacy|46|||
160932154|NCT01398956|581147913|FG000|Overall Study|Withdrawal by Subject|4|||
160932155|NCT01398956|581147913|FG000|Overall Study|AE, non-serious non-fatal|4|||
160932156|NCT01398956|581147913|FG000|Overall Study|Withdrawal Criteria No.3|1|||
160932157|NCT01398956|581147913|FG000|Overall Study|Subject moved a long distance|1|||
160932158|NCT01623596|581147916|FG000|Overall Study|Abnormal laboratory values|2|||
160932159|NCT01623596|581147917|FG001|Overall Study|Abnormal laboratory values|0|||
160932160|NCT01623596|581147916|FG000|Overall Study|Administrative problems|9|||
160932161|NCT01623596|581147917|FG001|Overall Study|Administrative problems|13|||
160932162|NCT01623596|581147916|FG000|Overall Study|Adverse Event|20|||
160932163|NCT01623596|581147917|FG001|Overall Study|Adverse Event|29|||
160932164|NCT01623596|581147916|FG000|Overall Study|Death|0|||
160932165|NCT01623596|581147917|FG001|Overall Study|Death|2|||
160932166|NCT01623596|581147916|FG000|Overall Study|Lost to Follow-up|12|||
160932167|NCT01623596|581147917|FG001|Overall Study|Lost to Follow-up|16|||
160932168|NCT01623596|581147916|FG000|Overall Study|Withdrawal by Subject|13|||
160932169|NCT01623596|581147917|FG001|Overall Study|Withdrawal by Subject|31|||
160932170|NCT01623596|581147916|FG000|Overall Study|Patient no longer requires study drug|1|||
160932171|NCT01623596|581147917|FG001|Overall Study|Patient no longer requires study drug|0|||
160932172|NCT01623596|581147916|FG000|Overall Study|Protocol Violation|0|||
160932173|NCT01623596|581147917|FG001|Overall Study|Protocol Violation|6|||
160932174|NCT01623596|581147916|FG000|Overall Study|Lack of Efficacy|5|||
160932175|NCT01623596|581147917|FG001|Overall Study|Lack of Efficacy|3|||
160932176|NCT03274986|581147920|FG000|Overall Study|Withdrawal by Subject|0|||
160932177|NCT03274986|581147921|FG001|Overall Study|Withdrawal by Subject|1|||
160932178|NCT03274986|581147920|FG000|Overall Study|Lost to Follow-up|0|||
160932179|NCT03274986|581147921|FG001|Overall Study|Lost to Follow-up|1|||
160932180|NCT00603746|581147922|FG000|Overall Study|Adverse Event|2|||
160932181|NCT00603746|581147923|FG001|Overall Study|Adverse Event|3|||
160932182|NCT00603746|581147924|FG002|Overall Study|Adverse Event|0|||
160932183|NCT00603746|581147925|FG003|Overall Study|Adverse Event|1|||
160932184|NCT00603746|581147926|FG004|Overall Study|Adverse Event|0|||
160932185|NCT00603746|581147927|FG005|Overall Study|Adverse Event|4|||
160932186|NCT00603746|581147922|FG000|Overall Study|Lack of Efficacy|34|||
160932187|NCT00603746|581147923|FG001|Overall Study|Lack of Efficacy|11|||
160932188|NCT00603746|581147924|FG002|Overall Study|Lack of Efficacy|6|||
160932189|NCT00603746|581147925|FG003|Overall Study|Lack of Efficacy|11|||
160932190|NCT00603746|581147926|FG004|Overall Study|Lack of Efficacy|12|||
160932191|NCT00603746|581147927|FG005|Overall Study|Lack of Efficacy|8|||
160932192|NCT00603746|581147922|FG000|Overall Study|Protocol Violation|0|||
160932193|NCT00603746|581147923|FG001|Overall Study|Protocol Violation|3|||
160932194|NCT00603746|581147924|FG002|Overall Study|Protocol Violation|1|||
160932195|NCT00603746|581147925|FG003|Overall Study|Protocol Violation|0|||
160932196|NCT00603746|581147926|FG004|Overall Study|Protocol Violation|1|||
160932197|NCT00603746|581147927|FG005|Overall Study|Protocol Violation|0|||
160932198|NCT00603746|581147922|FG000|Overall Study|Lost to Follow-up|0|||
160932199|NCT00603746|581147923|FG001|Overall Study|Lost to Follow-up|1|||
160932200|NCT00603746|581147924|FG002|Overall Study|Lost to Follow-up|1|||
160932201|NCT00603746|581147925|FG003|Overall Study|Lost to Follow-up|0|||
160932202|NCT00603746|581147926|FG004|Overall Study|Lost to Follow-up|0|||
160932203|NCT00603746|581147927|FG005|Overall Study|Lost to Follow-up|0|||
160932204|NCT00603746|581147922|FG000|Overall Study|Physician Decision|1|||
160932205|NCT00603746|581147923|FG001|Overall Study|Physician Decision|0|||
160932206|NCT00603746|581147924|FG002|Overall Study|Physician Decision|0|||
160932207|NCT00603746|581147925|FG003|Overall Study|Physician Decision|0|||
160932208|NCT00603746|581147926|FG004|Overall Study|Physician Decision|1|||
160932209|NCT00603746|581147927|FG005|Overall Study|Physician Decision|0|||
160932210|NCT00603746|581147922|FG000|Overall Study|Withdrawal by Subject|1|||
160932211|NCT00603746|581147923|FG001|Overall Study|Withdrawal by Subject|0|||
160932212|NCT00603746|581147924|FG002|Overall Study|Withdrawal by Subject|0|||
160932213|NCT00603746|581147925|FG003|Overall Study|Withdrawal by Subject|1|||
160932214|NCT00603746|581147926|FG004|Overall Study|Withdrawal by Subject|3|||
160932215|NCT00603746|581147927|FG005|Overall Study|Withdrawal by Subject|1|||
160932216|NCT01524627|581147928|FG000|Overall Study|Physician Decision|0|||
160932217|NCT01524627|581147929|FG001|Overall Study|Physician Decision|1|||
160932218|NCT01524627|581147928|FG000|Overall Study|Lost to Follow-up|1|||
160932219|NCT01524627|581147929|FG001|Overall Study|Lost to Follow-up|1|||
160932220|NCT03323658|581147930|FG000|Overall Study|Adverse Event|0|||
160932221|NCT03323658|581147931|FG001|Overall Study|Adverse Event|1|||
160998294|NCT05484726|581378624|FG001|Overall Study|Protocol Violation|3|||
160998295|NCT05484726|581378623|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
160998296|NCT05484726|581378624|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
161342458|NCT05853120|582640205|FG000|Overall Study|Lost to Follow-up|4|||
160932222|NCT03323658|581147932|FG002|Overall Study|Adverse Event|0|||
160932223|NCT05627518|581147933|FG000|Treatment Period 1|Adverse Event|0|||
160932224|NCT05627518|581147934|FG001|Treatment Period 1|Adverse Event|0|||
160932225|NCT05627518|581147935|FG002|Treatment Period 1|Adverse Event|1|||
160932226|NCT05627518|581147936|FG003|Treatment Period 1|Adverse Event|0|||
160932227|NCT05627518|581147937|FG004|Treatment Period 1|Adverse Event|0|||
160932228|NCT05627518|581147938|FG005|Treatment Period 1|Adverse Event|0|||
160932229|NCT05627518|581147939|FG006|Treatment Period 1|Adverse Event|0|||
160932230|NCT05627518|581147940|FG007|Treatment Period 1|Adverse Event|1|||
160932231|NCT05627518|581147933|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160932232|NCT05627518|581147934|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160932233|NCT05627518|581147935|FG002|Treatment Period 1|Withdrawal by Subject|1|||
160932234|NCT05627518|581147936|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160932235|NCT05627518|581147937|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160932236|NCT05627518|581147938|FG005|Treatment Period 1|Withdrawal by Subject|1|||
160932237|NCT05627518|581147939|FG006|Treatment Period 1|Withdrawal by Subject|0|||
160932238|NCT05627518|581147940|FG007|Treatment Period 1|Withdrawal by Subject|0|||
160932239|NCT05627518|581147933|FG000|Treatment Period 1|Protocol Violation|0|||
160932240|NCT05627518|581147934|FG001|Treatment Period 1|Protocol Violation|0|||
160932241|NCT05627518|581147935|FG002|Treatment Period 1|Protocol Violation|0|||
160932242|NCT05627518|581147936|FG003|Treatment Period 1|Protocol Violation|0|||
160932243|NCT05627518|581147937|FG004|Treatment Period 1|Protocol Violation|0|||
160932244|NCT05627518|581147938|FG005|Treatment Period 1|Protocol Violation|0|||
160932245|NCT05627518|581147939|FG006|Treatment Period 1|Protocol Violation|6|||
160932246|NCT05627518|581147940|FG007|Treatment Period 1|Protocol Violation|6|||
160932247|NCT05627518|581147933|FG000|Treatment Period 2|Adverse Event|1|||
160932248|NCT05627518|581147934|FG001|Treatment Period 2|Adverse Event|0|||
160932249|NCT05627518|581147935|FG002|Treatment Period 2|Adverse Event|0|||
160932250|NCT05627518|581147936|FG003|Treatment Period 2|Adverse Event|0|||
160932251|NCT05627518|581147937|FG004|Treatment Period 2|Adverse Event|0|||
160932252|NCT05627518|581147938|FG005|Treatment Period 2|Adverse Event|0|||
160932253|NCT05627518|581147939|FG006|Treatment Period 2|Adverse Event|0|||
160932254|NCT05627518|581147940|FG007|Treatment Period 2|Adverse Event|0|||
160932255|NCT05627518|581147933|FG000|Treatment Period 2|Withdrawal by Subject|1|||
160932256|NCT05627518|581147934|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160932257|NCT05627518|581147935|FG002|Treatment Period 2|Withdrawal by Subject|0|||
160932258|NCT05627518|581147936|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160932259|NCT05627518|581147937|FG004|Treatment Period 2|Withdrawal by Subject|0|||
160932260|NCT05627518|581147938|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160932261|NCT05627518|581147939|FG006|Treatment Period 2|Withdrawal by Subject|0|||
160932262|NCT05627518|581147940|FG007|Treatment Period 2|Withdrawal by Subject|0|||
160932263|NCT02223767|581150572|FG000|Overall Study|Withdrawal by Subject|4|||
160932264|NCT02223767|581150573|FG001|Overall Study|Withdrawal by Subject|4|||
160932265|NCT00192075|581150574|FG000|Overall Study|Disease Progression|23|||
160932266|NCT00192075|581150575|FG001|Overall Study|Disease Progression|6|||
160932267|NCT00192075|581150574|FG000|Overall Study|Adverse Event|1|||
160932268|NCT00192075|581150575|FG001|Overall Study|Adverse Event|3|||
160932269|NCT00192075|581150574|FG000|Overall Study|Death|0|||
160932270|NCT00192075|581150575|FG001|Overall Study|Death|1|||
160932271|NCT00192075|581150574|FG000|Overall Study|Lack of Efficacy|0|||
160932272|NCT00192075|581150575|FG001|Overall Study|Lack of Efficacy|0|||
160932273|NCT00192075|581150574|FG000|Overall Study|Physician Decision|3|||
160932274|NCT00192075|581150575|FG001|Overall Study|Physician Decision|0|||
160932275|NCT00192075|581150574|FG000|Overall Study|Withdrawal by Subject|5|||
160932276|NCT00192075|581150575|FG001|Overall Study|Withdrawal by Subject|5|||
160932277|NCT00192075|581150574|FG000|Overall Study|Patient Non-Compliance|0|||
160932278|NCT00192075|581150575|FG001|Overall Study|Patient Non-Compliance|1|||
160932279|NCT00192075|581150574|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
160932280|NCT00192075|581150575|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
160932281|NCT00192075|581150574|FG000|Overall Study|Other|5|||
160932282|NCT00192075|581150575|FG001|Overall Study|Other|2|||
160932283|NCT00779675|581150576|FG000|Treatment Period|Adverse Event|87|||
160932284|NCT00779675|581150576|FG000|Treatment Period|Treatment Failure|80|||
160932285|NCT00779675|581150576|FG000|Treatment Period|Transferred to Another Study|38|||
160932286|NCT00779675|581150576|FG000|Treatment Period|Lost to Follow-up|23|||
160932287|NCT00779675|581150576|FG000|Treatment Period|Withdrawal by Subject|46|||
160932288|NCT00779675|581150576|FG000|Treatment Period|Protocol Violation|54|||
160932289|NCT00779675|581150576|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
160932290|NCT00779675|581150576|FG000|Treatment Period|Administrative|3|||
160932291|NCT00779675|581150576|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
160932292|NCT00779675|581150576|FG000|Extended Treatment Period|Protocol Violation|13|||
160932293|NCT00779675|581150576|FG000|Extended Treatment Period|Adverse Event|6|||
161342459|NCT05853120|582640206|FG001|Overall Study|Lost to Follow-up|4|||
160932294|NCT00779675|581150576|FG000|Extended Treatment Period|Treatment Failure|11|||
160932295|NCT00779675|581150576|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
160932296|NCT00779675|581150576|FG000|Extended Treatment Period|Lost to Follow-up|6|||
160932297|NCT01944059|581150577|FG000|Overall Study|Lost to Follow-up|1|||
160932298|NCT01944059|581150577|FG000|Overall Study|Physician Decision|3|||
160932299|NCT01944059|581150577|FG000|Overall Study|Withdrawal by Subject|1|||
160932300|NCT01944059|581150577|FG000|Overall Study|Adverse Event|2|||
160932301|NCT00463060|581150583|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
160932302|NCT00463060|581150583|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
160932303|NCT01400841|581150584|FG000|Initial Study Phase (6 Months)|Death|1|||
160932304|NCT01400841|581150584|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
160932305|NCT00701129|581150585|FG000|Overall Study|Death|2|||
161342460|NCT05853120|582640205|FG000|Overall Study|Physician Decision|3|||
161342461|NCT05853120|582640206|FG001|Overall Study|Physician Decision|0|||
160932306|NCT00910715|581150586|FG000|Overall Study|Lost to Follow-up|22|||
160932307|NCT00910715|581150587|FG001|Overall Study|Lost to Follow-up|26|||
160932308|NCT00910715|581150588|FG002|Overall Study|Lost to Follow-up|0|||
160932309|NCT02412631|581150591|FG000|Overall Study|Adverse Event|1|||
160932310|NCT02412631|581150592|FG001|Overall Study|Adverse Event|2|||
160932311|NCT02412631|581150591|FG000|Overall Study|Lost to Follow-up|5|||
160932312|NCT02412631|581150592|FG001|Overall Study|Lost to Follow-up|9|||
160932313|NCT02412631|581150591|FG000|Overall Study|Withdrawal by Subject|9|||
160932314|NCT02412631|581150592|FG001|Overall Study|Withdrawal by Subject|3|||
160932315|NCT02412631|581150591|FG000|Overall Study|Early stop by FDA|5|||
160932316|NCT02412631|581150592|FG001|Overall Study|Early stop by FDA|2|||
160932317|NCT02412631|581150591|FG000|Overall Study|Unspecified reason|6|||
160932318|NCT02412631|581150592|FG001|Overall Study|Unspecified reason|8|||
160932319|NCT00770120|581150593|FG000|Overall Study|Progression|31|||
160932320|NCT00770120|581150593|FG000|Overall Study|Adverse Event|11|||
160932321|NCT00770120|581150593|FG000|Overall Study|Not Protocol Specified|11|||
160932322|NCT00770120|581150593|FG000|Overall Study|Death|3|||
160932323|NCT00770120|581150593|FG000|Overall Study|Withdrawal by Subject|2|||
160932324|NCT00770120|581150593|FG000|Overall Study|Ineligible|1|||
160932325|NCT00770120|581150593|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
160932326|NCT00770120|581150593|FG000|Overall Study|Reason under Review|1|||
160932327|NCT00706966|581150594|FG000|Overall Study|Adverse Event|1|||
160932328|NCT02884089|581150599|FG000|Period 1|Dosing error|2|||
160932329|NCT02884089|581150600|FG001|Period 1|Dosing error|2|||
160932330|NCT02884089|581150601|FG002|Period 1|Dosing error|0|||
160932331|NCT02884089|581150602|FG003|Period 1|Dosing error|0|||
160932332|NCT02884089|581150599|FG000|Washout Period 1|Lost to Follow-up|0|||
160932333|NCT02884089|581150600|FG001|Washout Period 1|Lost to Follow-up|1|||
160932334|NCT02884089|581150601|FG002|Washout Period 1|Lost to Follow-up|0|||
160932335|NCT02884089|581150602|FG003|Washout Period 1|Lost to Follow-up|1|||
160932336|NCT02884089|581150599|FG000|Washout Period 1|Withdrawal by Subject|0|||
160932337|NCT02884089|581150600|FG001|Washout Period 1|Withdrawal by Subject|1|||
160932338|NCT02884089|581150601|FG002|Washout Period 1|Withdrawal by Subject|0|||
160932339|NCT02884089|581150602|FG003|Washout Period 1|Withdrawal by Subject|0|||
160932340|NCT02884089|581150599|FG000|Period 2|Adverse Event|1|||
160932341|NCT02884089|581150600|FG001|Period 2|Adverse Event|0|||
160932342|NCT02884089|581150601|FG002|Period 2|Adverse Event|0|||
160932343|NCT02884089|581150602|FG003|Period 2|Adverse Event|0|||
160932344|NCT02884089|581150599|FG000|Period 3|Withdrawal by Subject|0|||
160932345|NCT02884089|581150600|FG001|Period 3|Withdrawal by Subject|0|||
160932346|NCT02884089|581150601|FG002|Period 3|Withdrawal by Subject|1|||
160932347|NCT02884089|581150602|FG003|Period 3|Withdrawal by Subject|0|||
160932348|NCT02884089|581150599|FG000|Washout Period 3|Withdrawal by Subject|0|||
160932349|NCT02884089|581150600|FG001|Washout Period 3|Withdrawal by Subject|0|||
160932350|NCT02884089|581150601|FG002|Washout Period 3|Withdrawal by Subject|1|||
160932351|NCT02884089|581150602|FG003|Washout Period 3|Withdrawal by Subject|0|||
160932352|NCT02884089|581150599|FG000|Washout Period 3|Lost to Follow-up|0|||
160932353|NCT02884089|581150600|FG001|Washout Period 3|Lost to Follow-up|0|||
160932354|NCT02884089|581150601|FG002|Washout Period 3|Lost to Follow-up|0|||
160932355|NCT02884089|581150602|FG003|Washout Period 3|Lost to Follow-up|1|||
160932356|NCT02884089|581150599|FG000|Period 4|Withdrawal by Subject|0|||
160932357|NCT02884089|581150600|FG001|Period 4|Withdrawal by Subject|1|||
160932358|NCT02884089|581150601|FG002|Period 4|Withdrawal by Subject|0|||
160932359|NCT02884089|581150602|FG003|Period 4|Withdrawal by Subject|0|||
160932360|NCT02884089|581150599|FG000|Period 4|Lost to Follow-up|1|||
160932361|NCT02884089|581150600|FG001|Period 4|Lost to Follow-up|0|||
160932362|NCT02884089|581150601|FG002|Period 4|Lost to Follow-up|0|||
160932363|NCT02884089|581150602|FG003|Period 4|Lost to Follow-up|0|||
160932364|NCT02884089|581150599|FG000|Follow-up Visit|Withdrawal by Subject|1|||
160932365|NCT02884089|581150600|FG001|Follow-up Visit|Withdrawal by Subject|0|||
160998297|NCT05484726|581378623|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
160998298|NCT05484726|581378624|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
160998299|NCT05484726|581378623|FG000|Overall Study|continued need of mechanical ventilation|2|||
161342462|NCT05853120|582640205|FG000|Overall Study|Withdrawal by Subject|5|||
160932366|NCT02884089|581150601|FG002|Follow-up Visit|Withdrawal by Subject|0|||
160932367|NCT02884089|581150602|FG003|Follow-up Visit|Withdrawal by Subject|1|||
160932368|NCT01631474|581150603|FG000|Overall Study|Lost to Follow-up|8|||
160932369|NCT01631474|581150604|FG001|Overall Study|Lost to Follow-up|5|||
160932370|NCT01631474|581150605|FG002|Overall Study|Lost to Follow-up|7|||
160932371|NCT01631474|581150606|FG003|Overall Study|Lost to Follow-up|5|||
160932372|NCT01631474|581150607|FG004|Overall Study|Lost to Follow-up|5|||
160932373|NCT01631474|581150603|FG000|Overall Study|Withdrawal by Subject|4|||
160932374|NCT01631474|581150604|FG001|Overall Study|Withdrawal by Subject|4|||
161342463|NCT05853120|582640206|FG001|Overall Study|Withdrawal by Subject|2|||
160932375|NCT01631474|581150605|FG002|Overall Study|Withdrawal by Subject|2|||
160932376|NCT01631474|581150606|FG003|Overall Study|Withdrawal by Subject|6|||
160932377|NCT01631474|581150607|FG004|Overall Study|Withdrawal by Subject|5|||
160932378|NCT01631474|581150603|FG000|Overall Study|Lack of Efficacy|2|||
160932379|NCT01631474|581150604|FG001|Overall Study|Lack of Efficacy|2|||
160932380|NCT01631474|581150605|FG002|Overall Study|Lack of Efficacy|0|||
160932381|NCT01631474|581150606|FG003|Overall Study|Lack of Efficacy|0|||
160932382|NCT01631474|581150607|FG004|Overall Study|Lack of Efficacy|2|||
160932383|NCT01631474|581150603|FG000|Overall Study|Noncompliance with Study Drug|0|||
160932384|NCT01631474|581150604|FG001|Overall Study|Noncompliance with Study Drug|0|||
160932385|NCT01631474|581150605|FG002|Overall Study|Noncompliance with Study Drug|0|||
160932386|NCT01631474|581150606|FG003|Overall Study|Noncompliance with Study Drug|0|||
160932387|NCT01631474|581150607|FG004|Overall Study|Noncompliance with Study Drug|1|||
160932388|NCT01631474|581150603|FG000|Overall Study|Adverse Event|0|||
160932389|NCT01631474|581150604|FG001|Overall Study|Adverse Event|1|||
160932390|NCT01631474|581150605|FG002|Overall Study|Adverse Event|0|||
160932391|NCT01631474|581150606|FG003|Overall Study|Adverse Event|0|||
160932392|NCT01631474|581150607|FG004|Overall Study|Adverse Event|0|||
160932393|NCT01467076|581150608|FG000|Overall Study|Lost to Follow-up|1|||
160932394|NCT01467076|581150609|FG001|Overall Study|Lost to Follow-up|0|||
160932395|NCT01467076|581150610|FG002|Overall Study|Lost to Follow-up|0|||
160932396|NCT00654381|581150615|FG000|1st Stage|Adverse Event|3|||
160932397|NCT00654381|581150616|FG001|1st Stage|Adverse Event|3|||
160932398|NCT00654381|581150617|FG002|1st Stage|Adverse Event|3|||
160932399|NCT00654381|581150618|FG003|1st Stage|Adverse Event|3|||
160932400|NCT00654381|581150619|FG004|1st Stage|Adverse Event|2|||
160932401|NCT00654381|581150620|FG005|1st Stage|Adverse Event|1|||
160932402|NCT00654381|581150615|FG000|1st Stage|Withdrawal by Subject|0|||
160932403|NCT00654381|581150616|FG001|1st Stage|Withdrawal by Subject|0|||
160932404|NCT00654381|581150617|FG002|1st Stage|Withdrawal by Subject|0|||
160932405|NCT00654381|581150618|FG003|1st Stage|Withdrawal by Subject|1|||
160932406|NCT00654381|581150619|FG004|1st Stage|Withdrawal by Subject|0|||
160932407|NCT00654381|581150620|FG005|1st Stage|Withdrawal by Subject|1|||
160932408|NCT00654381|581150615|FG000|1st Stage|Investigator's decision|0|||
160932409|NCT00654381|581150616|FG001|1st Stage|Investigator's decision|0|||
160932410|NCT00654381|581150617|FG002|1st Stage|Investigator's decision|0|||
160932411|NCT00654381|581150618|FG003|1st Stage|Investigator's decision|1|||
160932412|NCT00654381|581150619|FG004|1st Stage|Investigator's decision|0|||
160932413|NCT00654381|581150620|FG005|1st Stage|Investigator's decision|0|||
160932414|NCT00654381|581150615|FG000|2nd Stage|Adverse Event|2|||
160998300|NCT05484726|581378624|FG001|Overall Study|continued need of mechanical ventilation|3|||
160998301|NCT05484726|581378623|FG000|Overall Study|Withdrawal by Subject|2|||
160998302|NCT05484726|581378624|FG001|Overall Study|Withdrawal by Subject|3|||
160998303|NCT05484726|581378623|FG000|Overall Study|IVH (G III & IV)|2|||
160998304|NCT05484726|581378624|FG001|Overall Study|IVH (G III & IV)|1|||
160998305|NCT05484726|581378623|FG000|Overall Study|NEC (stage II & III)|2|||
160998306|NCT05484726|581378624|FG001|Overall Study|NEC (stage II & III)|3|||
160998307|NCT04550039|581378632|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
160998308|NCT04550039|581378633|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
160998309|NCT04550039|581378632|FG000|Overall Study|patient self-withdrew from study|0|||
160998310|NCT04550039|581378633|FG001|Overall Study|patient self-withdrew from study|1|||
160998311|NCT04391309|581378634|FG000|Overall Study|Death|1|||
160998312|NCT04391309|581378635|FG001|Overall Study|Death|1|||
160998313|NCT04391309|581378634|FG000|Overall Study|Lost to Follow-up|3|||
160998314|NCT04391309|581378635|FG001|Overall Study|Lost to Follow-up|2|||
160998315|NCT04391309|581378634|FG000|Overall Study|Withdrawal by Subject|2|||
161264373|NCT00725621|582349248|FG000|Overall Study|Withdrawal by Subject|57|||
161264374|NCT00725621|582349248|FG000|Overall Study|Physician Decision|19|||
161264375|NCT00725621|582349248|FG000|Overall Study|Lost to Follow-up|52|||
161264376|NCT00725621|582349248|FG000|Overall Study|Non-compliance|8|||
161264377|NCT00725621|582349248|FG000|Overall Study|Continued treatment by other physician|6|||
160932415|NCT00654381|581150616|FG001|2nd Stage|Adverse Event|0|||
160932416|NCT00654381|581150617|FG002|2nd Stage|Adverse Event|2|||
160932417|NCT00654381|581150618|FG003|2nd Stage|Adverse Event|3|||
160932418|NCT00654381|581150619|FG004|2nd Stage|Adverse Event|7|||
160932419|NCT00654381|581150620|FG005|2nd Stage|Adverse Event|2|||
160932420|NCT00654381|581150615|FG000|2nd Stage|Withdrawal by Subject|0|||
160932421|NCT00654381|581150616|FG001|2nd Stage|Withdrawal by Subject|0|||
161264378|NCT00725621|582349248|FG000|Overall Study|Switched to other study|1|||
161264379|NCT00725621|582349248|FG000|Overall Study|Switched to other drug|1|||
161264380|NCT00725621|582349248|FG000|Overall Study|Prepared for elective surgery|1|||
160932422|NCT00654381|581150617|FG002|2nd Stage|Withdrawal by Subject|0|||
160932423|NCT00654381|581150618|FG003|2nd Stage|Withdrawal by Subject|0|||
160998316|NCT04391309|581378635|FG001|Overall Study|Withdrawal by Subject|2|||
160998317|NCT02781584|581378636|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
160998318|NCT02781584|581378637|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
160998319|NCT02781584|581378638|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
161264381|NCT00725621|582349248|FG000|Overall Study|Reason not specified|55|||
160932424|NCT00654381|581150619|FG004|2nd Stage|Withdrawal by Subject|1|||
160932425|NCT00654381|581150620|FG005|2nd Stage|Withdrawal by Subject|1|||
160932426|NCT00654381|581150615|FG000|2nd Stage|Investigator's decision|0|||
160998320|NCT02781584|581378639|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
160998321|NCT02781584|581378640|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
160932427|NCT00654381|581150616|FG001|2nd Stage|Investigator's decision|0|||
160932428|NCT00654381|581150617|FG002|2nd Stage|Investigator's decision|1|||
160932429|NCT00654381|581150618|FG003|2nd Stage|Investigator's decision|1|||
160932430|NCT00654381|581150619|FG004|2nd Stage|Investigator's decision|0|||
160932431|NCT00654381|581150620|FG005|2nd Stage|Investigator's decision|0|||
160932432|NCT00654381|581150615|FG000|Extension Stage|Adverse Event|1|||
160932433|NCT00654381|581150616|FG001|Extension Stage|Adverse Event|2|||
160932434|NCT00654381|581150617|FG002|Extension Stage|Adverse Event|9|||
160932435|NCT00654381|581150618|FG003|Extension Stage|Adverse Event|7|||
160932436|NCT00654381|581150619|FG004|Extension Stage|Adverse Event|1|||
160932437|NCT00654381|581150620|FG005|Extension Stage|Adverse Event|1|||
160932438|NCT00654381|581150615|FG000|Extension Stage|Protocol Violation|0|||
160932439|NCT00654381|581150616|FG001|Extension Stage|Protocol Violation|0|||
160932440|NCT00654381|581150617|FG002|Extension Stage|Protocol Violation|0|||
160932441|NCT00654381|581150618|FG003|Extension Stage|Protocol Violation|1|||
160932442|NCT00654381|581150619|FG004|Extension Stage|Protocol Violation|0|||
160932443|NCT00654381|581150620|FG005|Extension Stage|Protocol Violation|0|||
160932444|NCT00654381|581150615|FG000|Extension Stage|Lack of Efficacy|0|||
160932445|NCT00654381|581150616|FG001|Extension Stage|Lack of Efficacy|0|||
160932446|NCT00654381|581150617|FG002|Extension Stage|Lack of Efficacy|1|||
160932447|NCT00654381|581150618|FG003|Extension Stage|Lack of Efficacy|0|||
160932448|NCT00654381|581150619|FG004|Extension Stage|Lack of Efficacy|0|||
160932449|NCT00654381|581150620|FG005|Extension Stage|Lack of Efficacy|0|||
160932450|NCT00654381|581150615|FG000|Extension Stage|Withdrawal by Subject|0|||
160932451|NCT00654381|581150616|FG001|Extension Stage|Withdrawal by Subject|0|||
160932452|NCT00654381|581150617|FG002|Extension Stage|Withdrawal by Subject|1|||
160932453|NCT00654381|581150618|FG003|Extension Stage|Withdrawal by Subject|1|||
160932454|NCT00654381|581150619|FG004|Extension Stage|Withdrawal by Subject|1|||
160932455|NCT00654381|581150620|FG005|Extension Stage|Withdrawal by Subject|1|||
160932456|NCT00654381|581150615|FG000|Extension Stage|Closure of the trial site|0|||
160932457|NCT00654381|581150616|FG001|Extension Stage|Closure of the trial site|0|||
160932458|NCT00654381|581150617|FG002|Extension Stage|Closure of the trial site|0|||
160932459|NCT00654381|581150618|FG003|Extension Stage|Closure of the trial site|0|||
160932460|NCT00654381|581150619|FG004|Extension Stage|Closure of the trial site|1|||
160932461|NCT00654381|581150620|FG005|Extension Stage|Closure of the trial site|1|||
160932462|NCT05288556|581150621|FG000|Overall Study|Protocol Violation|1|||
160932463|NCT05288556|581150621|FG000|Overall Study|Withdrawal by Subject|1|||
160932464|NCT00578175|581150622|FG000|Overall Study|Adverse Event|0|||
160932465|NCT00578175|581150623|FG001|Overall Study|Adverse Event|1|||
160932466|NCT00578175|581150624|FG002|Overall Study|Adverse Event|1|||
160932467|NCT00578175|581150622|FG000|Overall Study|Other reasons|70|||
160932468|NCT00578175|581150623|FG001|Overall Study|Other reasons|42|||
160932469|NCT00578175|581150624|FG002|Overall Study|Other reasons|23|||
160932470|NCT01232296|581150630|FG000|Overall Study|Adverse Event|24|||
160932471|NCT01232296|581150631|FG001|Overall Study|Adverse Event|12|||
160932472|NCT01232296|581150630|FG000|Overall Study|Physician Decision|1|||
160932473|NCT01232296|581150631|FG001|Overall Study|Physician Decision|1|||
160932474|NCT01232296|581150630|FG000|Overall Study|Progressive disease|43|||
160932475|NCT01232296|581150631|FG001|Overall Study|Progressive disease|61|||
160932476|NCT01232296|581150630|FG000|Overall Study|Study terminated by sponsor|0|||
161264382|NCT01189500|582349249|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
161264383|NCT01189500|582349249|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
161264384|NCT00062751|582349250|FG000|Overall Study|Disease progression|24|||
161264385|NCT00062751|582349251|FG001|Overall Study|Disease progression|17|||
161264386|NCT00062751|582349252|FG002|Overall Study|Disease progression|24|||
161264387|NCT00062751|582349253|FG003|Overall Study|Disease progression|2|||
161264388|NCT00062751|582349254|FG004|Overall Study|Disease progression|2|||
161264389|NCT00062751|582349250|FG000|Overall Study|Adverse Event|4|||
161264390|NCT00062751|582349251|FG001|Overall Study|Adverse Event|7|||
161264391|NCT00062751|582349252|FG002|Overall Study|Adverse Event|2|||
161264392|NCT00062751|582349253|FG003|Overall Study|Adverse Event|2|||
161264393|NCT00062751|582349254|FG004|Overall Study|Adverse Event|2|||
161264394|NCT00062751|582349250|FG000|Overall Study|Other|2|||
161264395|NCT00062751|582349251|FG001|Overall Study|Other|3|||
161342464|NCT00671788|582640207|FG000|Overall Study|Adverse Event|8|||
161342465|NCT00671788|582640207|FG000|Overall Study|Refused further treatment|3|||
161264396|NCT00062751|582349252|FG002|Overall Study|Other|1|||
161264397|NCT00062751|582349253|FG003|Overall Study|Other|0|||
161264398|NCT00062751|582349254|FG004|Overall Study|Other|1|||
161264399|NCT00062751|582349250|FG000|Overall Study|Withdrawal by Subject|1|||
161264400|NCT00062751|582349251|FG001|Overall Study|Withdrawal by Subject|2|||
161264401|NCT00062751|582349252|FG002|Overall Study|Withdrawal by Subject|2|||
161264402|NCT00062751|582349253|FG003|Overall Study|Withdrawal by Subject|1|||
160932477|NCT01232296|581150631|FG001|Overall Study|Study terminated by sponsor|1|||
160932478|NCT01232296|581150630|FG000|Overall Study|Technical problems|3|||
160932479|NCT01232296|581150631|FG001|Overall Study|Technical problems|0|||
160932480|NCT01232296|581150630|FG000|Overall Study|Subject/guardian decision|10|||
160932481|NCT01232296|581150631|FG001|Overall Study|Subject/guardian decision|2|||
161342466|NCT00671788|582640207|FG000|Overall Study|Ineligible|1|||
160932482|NCT01232296|581150630|FG000|Overall Study|Death|1|||
160932483|NCT01232296|581150631|FG001|Overall Study|Death|6|||
160932484|NCT01461096|581150633|FG000|Overall Study|Death|3|||
160932485|NCT01461096|581150634|FG001|Overall Study|Death|6|||
160932486|NCT01461096|581150633|FG000|Overall Study|Severe debilitation, unable to continue|1|||
160932487|NCT01461096|581150634|FG001|Overall Study|Severe debilitation, unable to continue|1|||
160932488|NCT01461096|581150633|FG000|Overall Study|Subj not able to get to clinic|15|||
160932489|NCT01461096|581150634|FG001|Overall Study|Subj not able to get to clinic|13|||
160932490|NCT01461096|581150633|FG000|Overall Study|Site is closing|27|||
160932491|NCT01461096|581150634|FG001|Overall Study|Site is closing|30|||
160932492|NCT01461096|581150633|FG000|Overall Study|Withdrawal by Subject|5|||
160932493|NCT01461096|581150634|FG001|Overall Study|Withdrawal by Subject|3|||
160932494|NCT01461096|581150633|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
160932495|NCT01461096|581150634|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
160932496|NCT01461096|581150633|FG000|Overall Study|Lost to Follow-up|8|||
160932497|NCT01461096|581150634|FG001|Overall Study|Lost to Follow-up|4|||
160932498|NCT04889625|581150636|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
160932499|NCT04889625|581150637|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
160932500|NCT04889625|581150636|FG000|Period 1|Subject out of window|0|||
160932501|NCT04889625|581150637|FG001|Period 1|Subject out of window|1|||
160932502|NCT04889625|581150636|FG000|Period 1|Wrong add power dispensed|0|||
160932503|NCT04889625|581150637|FG001|Period 1|Wrong add power dispensed|1|||
160932504|NCT04889625|581150636|FG000|Period 1|Discontinued due to fitting guide error|1|||
160932505|NCT04889625|581150637|FG001|Period 1|Discontinued due to fitting guide error|1|||
160932506|NCT04889625|581150636|FG000|Period 2|Test article no longer available|1|||
160932507|NCT04889625|581150637|FG001|Period 2|Test article no longer available|0|||
160932508|NCT04889625|581150636|FG000|Period 2|Incorrect lens dispensed|1|||
160932509|NCT04889625|581150637|FG001|Period 2|Incorrect lens dispensed|0|||
160932510|NCT04889625|581150636|FG000|Period 2|Wrong add power dispensed|0|||
160932511|NCT04889625|581150637|FG001|Period 2|Wrong add power dispensed|1|||
160932512|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
160932513|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
160932514|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
160932515|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
160932516|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
160932517|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
160932518|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
160932519|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
161264403|NCT00062751|582349254|FG004|Overall Study|Withdrawal by Subject|0|||
161264404|NCT00062751|582349250|FG000|Overall Study|Symptomatic deterioration|1|||
161264405|NCT00062751|582349251|FG001|Overall Study|Symptomatic deterioration|1|||
161264406|NCT00062751|582349252|FG002|Overall Study|Symptomatic deterioration|0|||
161264407|NCT00062751|582349253|FG003|Overall Study|Symptomatic deterioration|0|||
161264408|NCT00062751|582349254|FG004|Overall Study|Symptomatic deterioration|1|||
161264409|NCT00062751|582349250|FG000|Overall Study|Death|1|||
161264410|NCT00062751|582349251|FG001|Overall Study|Death|0|||
161264411|NCT00062751|582349252|FG002|Overall Study|Death|1|||
161264412|NCT00062751|582349253|FG003|Overall Study|Death|0|||
161264413|NCT00062751|582349254|FG004|Overall Study|Death|0|||
161264414|NCT03097588|582349261|FG000|Overall Study|Adverse Event|1|||
161264415|NCT01144364|582349262|FG000|Induction Phase|Disease progression|14|||
161264416|NCT01144364|582349263|FG001|Induction Phase|Disease progression|0|||
161264417|NCT01144364|582349264|FG002|Induction Phase|Disease progression|0|||
161264418|NCT01144364|582349262|FG000|Induction Phase|Adverse Event|9|||
161264419|NCT01144364|582349263|FG001|Induction Phase|Adverse Event|0|||
161264420|NCT01144364|582349264|FG002|Induction Phase|Adverse Event|0|||
161264421|NCT01144364|582349262|FG000|Induction Phase|Death|1|||
160932520|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
161264422|NCT01144364|582349263|FG001|Induction Phase|Death|0|||
161264423|NCT01144364|582349264|FG002|Induction Phase|Death|0|||
161264424|NCT01144364|582349262|FG000|Induction Phase|Withdrawal by Subject|1|||
161264425|NCT01144364|582349263|FG001|Induction Phase|Withdrawal by Subject|0|||
161264426|NCT01144364|582349264|FG002|Induction Phase|Withdrawal by Subject|0|||
161264427|NCT01144364|582349262|FG000|Induction Phase|Lost to Follow-up|2|||
161264428|NCT01144364|582349263|FG001|Induction Phase|Lost to Follow-up|0|||
161264429|NCT01144364|582349264|FG002|Induction Phase|Lost to Follow-up|0|||
161264430|NCT01144364|582349262|FG000|Induction Phase|Physician Decision|1|||
161264431|NCT01144364|582349263|FG001|Induction Phase|Physician Decision|0|||
161264432|NCT01144364|582349264|FG002|Induction Phase|Physician Decision|0|||
161264433|NCT01144364|582349262|FG000|Induction Phase|Stable disease|2|||
161264434|NCT01144364|582349263|FG001|Induction Phase|Stable disease|0|||
160932521|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
160932522|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
160932523|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
160932524|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
161264435|NCT01144364|582349264|FG002|Induction Phase|Stable disease|0|||
160932525|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
160932526|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
160932527|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
160932528|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
160932529|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
160932530|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Death|0|||
160932531|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Death|0|||
160932532|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Death|1|||
160932533|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Death|0|||
160932534|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Death|0|||
160932535|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Death|0|||
160932536|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Death|0|||
160932537|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Death|0|||
160932538|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Death|0|||
160932539|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
160932540|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
160932541|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
160932542|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932543|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932544|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932545|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932546|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932547|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
160932548|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
160932549|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
160932550|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
160932551|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932552|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932553|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932554|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932555|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932556|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
160932557|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
160932558|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
160932559|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
160932560|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
160932561|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
160932562|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
160932563|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
160932564|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
160932565|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
160932566|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
160932567|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
160932568|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
160932569|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
160932570|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
160932571|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
160932572|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
160932573|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
160932574|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
160932575|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
160932576|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
160932577|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
160932578|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932579|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
161143707|NCT00847613|581909467|FG003|Overall Study|Randomized, but not treated|0|||
161143708|NCT00847613|581909464|FG000|Overall Study|Other|1|||
161264436|NCT01144364|582349262|FG000|Induction Phase|Secondary neoplasia|1|||
161264437|NCT01144364|582349263|FG001|Induction Phase|Secondary neoplasia|0|||
161264438|NCT01144364|582349264|FG002|Induction Phase|Secondary neoplasia|0|||
161264439|NCT01144364|582349262|FG000|Induction Phase|Protocol Violation|1|||
161264440|NCT01144364|582349263|FG001|Induction Phase|Protocol Violation|0|||
161264441|NCT01144364|582349264|FG002|Induction Phase|Protocol Violation|0|||
161143709|NCT00847613|581909465|FG001|Overall Study|Other|1|||
161264442|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
161264443|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
161264444|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
161264445|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
161143710|NCT00847613|581909466|FG002|Overall Study|Other|2|||
161264446|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
161264447|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
160932580|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932581|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932582|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932583|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
160932584|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932585|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
160932586|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932587|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932588|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932589|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932590|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932591|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932592|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
160932593|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
160932594|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
160932595|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
160932596|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
160932597|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
160932598|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
160932599|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
160932600|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
160932601|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
160932602|NCT00404352|581150640|FG000|Double Blind (up to 24 Month)|Other|0|||
160932603|NCT00404352|581150641|FG001|Double Blind (up to 24 Month)|Other|1|||
160932604|NCT00404352|581150642|FG002|Double Blind (up to 24 Month)|Other|0|||
160932605|NCT00404352|581150643|FG003|Double Blind (up to 24 Month)|Other|0|||
160932606|NCT00404352|581150644|FG004|Double Blind (up to 24 Month)|Other|0|||
160932607|NCT00404352|581150645|FG005|Double Blind (up to 24 Month)|Other|0|||
160932608|NCT00404352|581150646|FG006|Double Blind (up to 24 Month)|Other|0|||
160932609|NCT00404352|581150647|FG007|Double Blind (up to 24 Month)|Other|0|||
160932610|NCT00404352|581150648|FG008|Double Blind (up to 24 Month)|Other|0|||
160932611|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
161143711|NCT00847613|581909467|FG003|Overall Study|Other|0|||
160932612|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
160932613|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
160932614|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
160932615|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
160932616|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
160932617|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
160932618|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
160932619|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
160932620|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
160932621|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
160932622|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
160932623|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
160932624|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
160932625|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
160932626|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
160932627|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
160932628|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
160932629|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932630|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932631|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932632|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932633|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
160932634|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932635|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932636|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932637|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
160932638|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932639|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932640|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932641|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
161143712|NCT02859415|581909468|FG000|Overall Study|Physician Decision|1|||
161143713|NCT02859415|581909469|FG001|Overall Study|Physician Decision|0|||
161143714|NCT02859415|581909468|FG000|Overall Study|Off treatment due to cardiac event|0|||
161143715|NCT02859415|581909469|FG001|Overall Study|Off treatment due to cardiac event|1|||
161143716|NCT01396525|581909470|FG000|Overall Study|Withdrawal by Subject|8|||
161143717|NCT01396525|581909470|FG000|Overall Study|Death|14|||
161143718|NCT01396525|581909470|FG000|Overall Study|Lost to Follow-up|4|||
161143719|NCT03114969|581909471|FG000|Overall Study|Lost to Follow-up|0|||
161143720|NCT03114969|581909472|FG001|Overall Study|Lost to Follow-up|0|||
160932642|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932643|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
160932644|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932645|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932646|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
160932647|NCT00404352|581150640|FG000|Open Label (up to 24 Month)|Disease progression|0|||
160932648|NCT00404352|581150641|FG001|Open Label (up to 24 Month)|Disease progression|0|||
160932649|NCT00404352|581150642|FG002|Open Label (up to 24 Month)|Disease progression|0|||
160932650|NCT00404352|581150643|FG003|Open Label (up to 24 Month)|Disease progression|1|||
160932651|NCT00404352|581150644|FG004|Open Label (up to 24 Month)|Disease progression|0|||
160932652|NCT00404352|581150645|FG005|Open Label (up to 24 Month)|Disease progression|0|||
160932653|NCT00404352|581150646|FG006|Open Label (up to 24 Month)|Disease progression|0|||
160932654|NCT00404352|581150647|FG007|Open Label (up to 24 Month)|Disease progression|0|||
160932655|NCT00404352|581150648|FG008|Open Label (up to 24 Month)|Disease progression|0|||
160932656|NCT00404352|581150640|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932657|NCT00404352|581150641|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932658|NCT00404352|581150642|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932659|NCT00404352|581150643|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932660|NCT00404352|581150644|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932661|NCT00404352|581150645|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932662|NCT00404352|581150646|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
160932663|NCT00404352|581150647|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
160932664|NCT00404352|581150648|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
160932665|NCT00404352|581150640|FG000|Open Label Extension (up to 36 Months)|Other|0|||
160932666|NCT00404352|581150641|FG001|Open Label Extension (up to 36 Months)|Other|0|||
160932667|NCT00404352|581150642|FG002|Open Label Extension (up to 36 Months)|Other|0|||
160932668|NCT00404352|581150643|FG003|Open Label Extension (up to 36 Months)|Other|0|||
160932669|NCT00404352|581150644|FG004|Open Label Extension (up to 36 Months)|Other|0|||
160932670|NCT00404352|581150645|FG005|Open Label Extension (up to 36 Months)|Other|0|||
160932671|NCT00404352|581150646|FG006|Open Label Extension (up to 36 Months)|Other|0|||
160932672|NCT00404352|581150647|FG007|Open Label Extension (up to 36 Months)|Other|0|||
160932673|NCT00404352|581150648|FG008|Open Label Extension (up to 36 Months)|Other|2|||
160932674|NCT02346136|581150649|FG000|Overall Study|Withdrawal by Subject|7|||
160932675|NCT02346136|581150650|FG001|Overall Study|Withdrawal by Subject|5|||
160932676|NCT02346136|581150649|FG000|Overall Study|Death|1|||
160932677|NCT02346136|581150650|FG001|Overall Study|Death|0|||
160932678|NCT02346136|581150649|FG000|Overall Study|Study termination|14|||
160932679|NCT02346136|581150650|FG001|Overall Study|Study termination|18|||
160932680|NCT00582933|581150654|FG000|Overall Study|Physician Decision|3|||
160932681|NCT03316885|581150657|FG000|Overall Study|Adverse Event|1|||
160932682|NCT03316885|581150657|FG000|Overall Study|Death|10|||
160932683|NCT03316885|581150657|FG000|Overall Study|Lost to Follow-up|4|||
160932684|NCT03316885|581150657|FG000|Overall Study|Withdrawal by Subject|9|||
160932685|NCT03316885|581150657|FG000|Overall Study|COVID related|8|||
161264448|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Death|0|||
161264449|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Death|2|||
161264450|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Death|0|||
161264451|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
161264452|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
161264453|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
161264454|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
161264455|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
161264456|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
161264457|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
161264458|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
161264459|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
161264460|NCT01144364|582349262|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
161264461|NCT01144364|582349263|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
161264462|NCT01144364|582349264|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
161264463|NCT04932941|582349265|FG000|Overall Study|Lost to Follow-up|3|||
161264464|NCT04932941|582349266|FG001|Overall Study|Lost to Follow-up|1|||
161264465|NCT04932941|582349265|FG000|Overall Study|Withdrawal by Subject|7|||
160932686|NCT01736696|581150665|FG000|Overall Study|Withdrawal by Subject|0|||
160932687|NCT01736696|581150666|FG001|Overall Study|Withdrawal by Subject|0|||
160932688|NCT01736696|581150667|FG002|Overall Study|Withdrawal by Subject|1|||
160932689|NCT01736696|581150668|FG003|Overall Study|Withdrawal by Subject|0|||
160932690|NCT01736696|581150669|FG004|Overall Study|Withdrawal by Subject|0|||
160932691|NCT01736696|581150670|FG005|Overall Study|Withdrawal by Subject|0|||
161264466|NCT04932941|582349266|FG001|Overall Study|Withdrawal by Subject|4|||
161264467|NCT04932941|582349265|FG000|Overall Study|Other|4|||
161264468|NCT04932941|582349266|FG001|Overall Study|Other|2|||
161264469|NCT03510182|582349269|FG000|Overall Study|Withdrawal by Subject|2|||
161264470|NCT00375492|582349270|FG000|Overall Study|Adverse Event|4|||
160932692|NCT01736696|581150671|FG006|Overall Study|Withdrawal by Subject|0|||
160932693|NCT01116232|581150672|FG000|Overall Study|Progressive diease|4|||
160932694|NCT00405548|581150673|FG000|Overall Study|Cognitive Memory problems on study day|1|||
160932695|NCT00405548|581150674|FG001|Overall Study|Cognitive Memory problems on study day|0|||
160932696|NCT00405548|581150673|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
160932697|NCT00405548|581150674|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
160932698|NCT00405548|581150673|FG000|Overall Study|Unable to self-administer shots|1|||
160932699|NCT00405548|581150674|FG001|Overall Study|Unable to self-administer shots|0|||
160932700|NCT00405548|581150673|FG000|Overall Study|Venous access failed during study day|1|||
160932701|NCT00405548|581150674|FG001|Overall Study|Venous access failed during study day|0|||
160932702|NCT00405548|581150673|FG000|Overall Study|Withdrawal by Subject|1|||
160932703|NCT00405548|581150674|FG001|Overall Study|Withdrawal by Subject|0|||
160932704|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Death|3|||
160932705|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Death|2|||
160932706|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Death|0|||
160932707|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Death|0|||
160932708|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Death|0|||
160932709|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Death|0|||
160932710|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Death|0|||
160932711|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Death|0|||
160932712|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
160932713|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932714|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932715|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932716|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932717|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932718|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932719|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
160932720|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932721|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
160932722|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160998322|NCT02781584|581378641|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
160998323|NCT02781584|581378642|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
160998324|NCT02781584|581378643|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
160998325|NCT02781584|581378644|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
160998326|NCT02781584|581378645|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
160998327|NCT02781584|581378646|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
160998328|NCT02781584|581378647|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
160998329|NCT02781584|581378648|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
160998330|NCT02781584|581378636|FG000|Pre-treatment Phase|Adverse Event|0|||
160998331|NCT02781584|581378637|FG001|Pre-treatment Phase|Adverse Event|0|||
160998332|NCT02781584|581378638|FG002|Pre-treatment Phase|Adverse Event|0|||
160998333|NCT02781584|581378639|FG003|Pre-treatment Phase|Adverse Event|0|||
160998334|NCT02781584|581378640|FG004|Pre-treatment Phase|Adverse Event|0|||
160998335|NCT02781584|581378641|FG005|Pre-treatment Phase|Adverse Event|0|||
160998336|NCT02781584|581378642|FG006|Pre-treatment Phase|Adverse Event|0|||
160998337|NCT02781584|581378643|FG007|Pre-treatment Phase|Adverse Event|0|||
160998338|NCT02781584|581378644|FG008|Pre-treatment Phase|Adverse Event|0|||
160998339|NCT02781584|581378645|FG009|Pre-treatment Phase|Adverse Event|0|||
160998340|NCT02781584|581378646|FG010|Pre-treatment Phase|Adverse Event|0|||
160998341|NCT02781584|581378647|FG011|Pre-treatment Phase|Adverse Event|1|||
160998342|NCT02781584|581378648|FG012|Pre-treatment Phase|Adverse Event|0|||
160998343|NCT02781584|581378636|FG000|Treatment Phase|Withdrew Consent|0|||
160998344|NCT02781584|581378637|FG001|Treatment Phase|Withdrew Consent|0|||
160998345|NCT02781584|581378638|FG002|Treatment Phase|Withdrew Consent|0|||
160998346|NCT02781584|581378639|FG003|Treatment Phase|Withdrew Consent|0|||
160998347|NCT02781584|581378640|FG004|Treatment Phase|Withdrew Consent|0|||
160998348|NCT02781584|581378641|FG005|Treatment Phase|Withdrew Consent|1|||
161264471|NCT00375492|582349271|FG001|Overall Study|Adverse Event|5|||
161264472|NCT00375492|582349270|FG000|Overall Study|Entry Criteria Not Met|0|||
160998349|NCT02781584|581378642|FG006|Treatment Phase|Withdrew Consent|0|||
160998350|NCT02781584|581378643|FG007|Treatment Phase|Withdrew Consent|0|||
161264473|NCT00375492|582349271|FG001|Overall Study|Entry Criteria Not Met|1|||
160932723|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160998351|NCT02781584|581378644|FG008|Treatment Phase|Withdrew Consent|0|||
160998352|NCT02781584|581378645|FG009|Treatment Phase|Withdrew Consent|0|||
160998353|NCT02781584|581378646|FG010|Treatment Phase|Withdrew Consent|1|||
160998354|NCT02781584|581378647|FG011|Treatment Phase|Withdrew Consent|2|||
160998355|NCT02781584|581378648|FG012|Treatment Phase|Withdrew Consent|0|||
160998356|NCT02781584|581378636|FG000|Treatment Phase|Adverse Event|0|||
160998357|NCT02781584|581378637|FG001|Treatment Phase|Adverse Event|0|||
160998358|NCT02781584|581378638|FG002|Treatment Phase|Adverse Event|0|||
160998359|NCT02781584|581378639|FG003|Treatment Phase|Adverse Event|0|||
161264474|NCT00375492|582349270|FG000|Overall Study|Loss of Glucose Control|0|||
160932724|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932725|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932726|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932727|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
160932728|NCT02036502|581150675|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
160932729|NCT02036502|581150676|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
160932730|NCT02036502|581150677|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
160932731|NCT02036502|581150678|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
160932732|NCT02036502|581150679|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
160932733|NCT02036502|581150680|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
160932734|NCT02036502|581150681|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
160932735|NCT02036502|581150682|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
160932736|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932737|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932738|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
160932739|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
160932740|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
160932741|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932742|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932743|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
160932744|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932745|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932746|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
160932747|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932748|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932749|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932750|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932751|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
160932752|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Death|0|||
160932753|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Death|0|||
160932754|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Death|1|||
160932755|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Death|0|||
160932756|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Death|0|||
160932757|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Death|0|||
160932758|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Death|0|||
160932759|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Death|0|||
160932760|NCT02036502|581150675|FG000|Part 2:Dose Confirmation|Not treated|0|||
160932761|NCT02036502|581150676|FG001|Part 2:Dose Confirmation|Not treated|0|||
160932762|NCT02036502|581150677|FG002|Part 2:Dose Confirmation|Not treated|0|||
160932763|NCT02036502|581150678|FG003|Part 2:Dose Confirmation|Not treated|1|||
160932764|NCT02036502|581150679|FG004|Part 2:Dose Confirmation|Not treated|0|||
160932765|NCT02036502|581150680|FG005|Part 2:Dose Confirmation|Not treated|0|||
160932766|NCT02036502|581150681|FG006|Part 2:Dose Confirmation|Not treated|0|||
160932767|NCT02036502|581150682|FG007|Part 2:Dose Confirmation|Not treated|0|||
160932768|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Adverse Event|0|||
160932769|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Adverse Event|0|||
160932770|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Adverse Event|0|||
160932771|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Adverse Event|0|||
160932772|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Adverse Event|0|||
160932773|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Adverse Event|4|||
160932774|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Adverse Event|0|||
160932775|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Adverse Event|2|||
160932776|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Death|0|||
160932777|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Death|0|||
160932778|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Death|0|||
160932779|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Death|0|||
160932780|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Death|0|||
160932781|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Death|24|||
160932782|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Death|0|||
160932783|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Death|3|||
160932784|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932785|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932786|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932787|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932788|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932789|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932790|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
160932791|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
160932792|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Physician Decision|0|||
160932793|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Physician Decision|0|||
160998360|NCT02781584|581378640|FG004|Treatment Phase|Adverse Event|0|||
160998361|NCT02781584|581378641|FG005|Treatment Phase|Adverse Event|0|||
161264475|NCT00375492|582349271|FG001|Overall Study|Loss of Glucose Control|1|||
160932794|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Physician Decision|0|||
160932795|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Physician Decision|0|||
160932796|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Physician Decision|0|||
160932797|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Physician Decision|1|||
160932798|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Physician Decision|0|||
160932799|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Physician Decision|0|||
160932800|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
160932801|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
160932802|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
160932803|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
160932804|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
160932805|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
160932806|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
160932807|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
160932808|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932809|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932810|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932811|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932812|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932813|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
160932814|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
160932815|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
160932816|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932817|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932818|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932819|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932820|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
160932821|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
160932822|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
160932823|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
160932824|NCT02036502|581150675|FG000|Part 3:Dose Expansion|Not Treated|0|||
160932825|NCT02036502|581150676|FG001|Part 3:Dose Expansion|Not Treated|0|||
160932826|NCT02036502|581150677|FG002|Part 3:Dose Expansion|Not Treated|0|||
160932827|NCT02036502|581150678|FG003|Part 3:Dose Expansion|Not Treated|0|||
160998362|NCT02781584|581378642|FG006|Treatment Phase|Adverse Event|0|||
160998363|NCT02781584|581378643|FG007|Treatment Phase|Adverse Event|1|||
160998364|NCT02781584|581378644|FG008|Treatment Phase|Adverse Event|0|||
160998365|NCT02781584|581378645|FG009|Treatment Phase|Adverse Event|0|||
160998366|NCT02781584|581378646|FG010|Treatment Phase|Adverse Event|0|||
160998367|NCT02781584|581378647|FG011|Treatment Phase|Adverse Event|0|||
160998368|NCT02781584|581378648|FG012|Treatment Phase|Adverse Event|0|||
160998369|NCT05826431|581378649|FG000|Overall Study|Withdrawal by Subject|1|||
160998370|NCT04771273|581378654|FG000|Dose Escalation Period|Not treated with trial medication|0|||
160998371|NCT04771273|581378655|FG001|Dose Escalation Period|Not treated with trial medication|1|||
161264476|NCT00375492|582349270|FG000|Overall Study|Lost to Follow-up|10|||
161264477|NCT00375492|582349271|FG001|Overall Study|Lost to Follow-up|5|||
161264478|NCT00375492|582349270|FG000|Overall Study|Physician Decision|0|||
160932828|NCT02036502|581150679|FG004|Part 3:Dose Expansion|Not Treated|0|||
160932829|NCT02036502|581150680|FG005|Part 3:Dose Expansion|Not Treated|2|||
160932830|NCT02036502|581150681|FG006|Part 3:Dose Expansion|Not Treated|0|||
160932831|NCT02036502|581150682|FG007|Part 3:Dose Expansion|Not Treated|0|||
160932832|NCT00811577|581150688|FG000|Overall Study|Lost to Follow-up|7|||
160932833|NCT00811577|581150689|FG001|Overall Study|Lost to Follow-up|1|||
160932834|NCT00811577|581150688|FG000|Overall Study|Withdrawal by Subject|3|||
160932835|NCT00811577|581150689|FG001|Overall Study|Withdrawal by Subject|0|||
160998372|NCT04771273|581378656|FG002|Dose Escalation Period|Not treated with trial medication|1|||
160998373|NCT04771273|581378657|FG003|Dose Escalation Period|Not treated with trial medication|0|||
160998374|NCT04771273|581378654|FG000|Dose Escalation Period|Other reasons than listed|2|||
160998375|NCT04771273|581378655|FG001|Dose Escalation Period|Other reasons than listed|0|||
160998376|NCT04771273|581378656|FG002|Dose Escalation Period|Other reasons than listed|2|||
160998377|NCT04771273|581378657|FG003|Dose Escalation Period|Other reasons than listed|1|||
161264479|NCT00375492|582349271|FG001|Overall Study|Physician Decision|4|||
160998378|NCT04771273|581378654|FG000|Dose Escalation Period|Protocol Violation|0|||
160998379|NCT04771273|581378655|FG001|Dose Escalation Period|Protocol Violation|0|||
160998380|NCT04771273|581378656|FG002|Dose Escalation Period|Protocol Violation|3|||
160998381|NCT04771273|581378657|FG003|Dose Escalation Period|Protocol Violation|1|||
160998382|NCT04771273|581378654|FG000|Dose Escalation Period|Burden of study procedures|1|||
161264480|NCT00375492|582349270|FG000|Overall Study|Protocol Violation|6|||
161264481|NCT00375492|582349271|FG001|Overall Study|Protocol Violation|3|||
160932836|NCT04011410|581150690|FG000|Overall Study|Withdrawal by Subject|1|||
160932837|NCT01068509|581150691|FG000|Overall Study|Death|0|||
160998383|NCT04771273|581378655|FG001|Dose Escalation Period|Burden of study procedures|0|||
161264482|NCT00375492|582349270|FG000|Overall Study|Sponsor Decision|0|||
160932838|NCT01068509|581150692|FG001|Overall Study|Death|0|||
160932839|NCT01068509|581150693|FG002|Overall Study|Death|1|||
160932840|NCT01068509|581150691|FG000|Overall Study|Disease Progression|5|||
160932841|NCT01068509|581150692|FG001|Overall Study|Disease Progression|20|||
160932842|NCT01068509|581150693|FG002|Overall Study|Disease Progression|18|||
160932843|NCT01068509|581150691|FG000|Overall Study|Lost to Follow-up|1|||
160932844|NCT01068509|581150692|FG001|Overall Study|Lost to Follow-up|0|||
160932845|NCT01068509|581150693|FG002|Overall Study|Lost to Follow-up|0|||
160932846|NCT01068509|581150691|FG000|Overall Study|Withdrew Consent|0|||
160932847|NCT01068509|581150692|FG001|Overall Study|Withdrew Consent|1|||
160932848|NCT01068509|581150693|FG002|Overall Study|Withdrew Consent|2|||
160932849|NCT01068509|581150691|FG000|Overall Study|Reason Not Specified|0|||
160932850|NCT01068509|581150692|FG001|Overall Study|Reason Not Specified|1|||
160932851|NCT01068509|581150693|FG002|Overall Study|Reason Not Specified|0|||
160932852|NCT02357940|581150694|FG000|Overall Study|Adverse Event|0|||
160932853|NCT02357940|581150695|FG001|Overall Study|Adverse Event|1|||
160932854|NCT02357940|581150694|FG000|Overall Study|Investigator's judgement|0|||
160932855|NCT02357940|581150695|FG001|Overall Study|Investigator's judgement|1|||
160932856|NCT02442778|581150696|FG000|Overall Study|Adverse Event|2|||
160932857|NCT02442778|581150697|FG001|Overall Study|Adverse Event|6|||
160932858|NCT02442778|581150698|FG002|Overall Study|Adverse Event|6|||
160932859|NCT02442778|581150696|FG000|Overall Study|Death|0|||
160932860|NCT02442778|581150697|FG001|Overall Study|Death|2|||
160932861|NCT02442778|581150698|FG002|Overall Study|Death|0|||
160932862|NCT02442778|581150696|FG000|Overall Study|Lack of Efficacy|1|||
160932863|NCT02442778|581150697|FG001|Overall Study|Lack of Efficacy|0|||
160932864|NCT02442778|581150698|FG002|Overall Study|Lack of Efficacy|0|||
160932865|NCT02442778|581150696|FG000|Overall Study|Lost to Follow-up|1|||
160932866|NCT02442778|581150697|FG001|Overall Study|Lost to Follow-up|1|||
160932867|NCT02442778|581150698|FG002|Overall Study|Lost to Follow-up|1|||
160932868|NCT02442778|581150696|FG000|Overall Study|Non-compliance with study drug|2|||
160932869|NCT02442778|581150697|FG001|Overall Study|Non-compliance with study drug|0|||
160932870|NCT02442778|581150698|FG002|Overall Study|Non-compliance with study drug|1|||
160932871|NCT02442778|581150696|FG000|Overall Study|Physician Decision|1|||
160932872|NCT02442778|581150697|FG001|Overall Study|Physician Decision|1|||
160932873|NCT02442778|581150698|FG002|Overall Study|Physician Decision|1|||
160932874|NCT02442778|581150696|FG000|Overall Study|Protocol Deviation|3|||
160932875|NCT02442778|581150697|FG001|Overall Study|Protocol Deviation|0|||
160932876|NCT02442778|581150698|FG002|Overall Study|Protocol Deviation|1|||
160932877|NCT02442778|581150696|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
160932878|NCT02442778|581150697|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
160932879|NCT02442778|581150698|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
160932880|NCT02442778|581150696|FG000|Overall Study|Withdrawal by Subject|4|||
160932881|NCT02442778|581150697|FG001|Overall Study|Withdrawal by Subject|4|||
160932882|NCT02442778|581150698|FG002|Overall Study|Withdrawal by Subject|3|||
160932883|NCT02442778|581150696|FG000|Overall Study|Reason not specified|1|||
160932884|NCT02442778|581150697|FG001|Overall Study|Reason not specified|4|||
160932885|NCT02442778|581150698|FG002|Overall Study|Reason not specified|0|||
160932886|NCT01165138|581150701|FG000|Overall Study|Adverse Event|0|||
160932887|NCT01165138|581150702|FG001|Overall Study|Adverse Event|1|||
160932888|NCT01165138|581150703|FG002|Overall Study|Adverse Event|0|||
160932889|NCT01165138|581150704|FG003|Overall Study|Adverse Event|2|||
160932890|NCT01165138|581150701|FG000|Overall Study|Lack of Efficacy|0|||
160932891|NCT01165138|581150702|FG001|Overall Study|Lack of Efficacy|32|||
160932892|NCT01165138|581150703|FG002|Overall Study|Lack of Efficacy|6|||
160932893|NCT01165138|581150704|FG003|Overall Study|Lack of Efficacy|7|||
160932894|NCT01165138|581150701|FG000|Overall Study|Protocol Violation|0|||
160932895|NCT01165138|581150702|FG001|Overall Study|Protocol Violation|7|||
160932896|NCT01165138|581150703|FG002|Overall Study|Protocol Violation|0|||
160932897|NCT01165138|581150704|FG003|Overall Study|Protocol Violation|2|||
161264483|NCT00375492|582349271|FG001|Overall Study|Sponsor Decision|1|||
161264484|NCT00375492|582349270|FG000|Overall Study|Withdrawal by Subject|6|||
161264485|NCT00375492|582349271|FG001|Overall Study|Withdrawal by Subject|6|||
161264486|NCT03295318|582350631|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
161264487|NCT03295318|582350632|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
160932898|NCT01165138|581150701|FG000|Overall Study|Lost to Follow-up|0|||
161264488|NCT03295318|582350633|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
160932899|NCT01165138|581150702|FG001|Overall Study|Lost to Follow-up|0|||
160932900|NCT01165138|581150703|FG002|Overall Study|Lost to Follow-up|1|||
160932901|NCT01165138|581150704|FG003|Overall Study|Lost to Follow-up|2|||
160932902|NCT01165138|581150701|FG000|Overall Study|Physician Decision|0|||
160932903|NCT01165138|581150702|FG001|Overall Study|Physician Decision|6|||
160932904|NCT01165138|581150703|FG002|Overall Study|Physician Decision|7|||
160932905|NCT01165138|581150704|FG003|Overall Study|Physician Decision|6|||
160932906|NCT01165138|581150701|FG000|Overall Study|Withdrawal by Subject|0|||
160932907|NCT01165138|581150702|FG001|Overall Study|Withdrawal by Subject|6|||
160932908|NCT01165138|581150703|FG002|Overall Study|Withdrawal by Subject|6|||
160932909|NCT01165138|581150704|FG003|Overall Study|Withdrawal by Subject|3|||
160932910|NCT02641379|581150705|FG000|Overall Study|Exclusion criterion during screening|1|||
160932911|NCT02641379|581150706|FG001|Overall Study|Exclusion criterion during screening|0|||
160932912|NCT02641379|581150707|FG002|Overall Study|Exclusion criterion during screening|0|||
160932913|NCT02641379|581150708|FG003|Overall Study|Exclusion criterion during screening|1|||
160932914|NCT02641379|581150709|FG004|Overall Study|Exclusion criterion during screening|2|||
160932915|NCT02641379|581150710|FG005|Overall Study|Exclusion criterion during screening|0|||
160932916|NCT02641379|581150711|FG006|Overall Study|Exclusion criterion during screening|0|||
160932917|NCT02641379|581150712|FG007|Overall Study|Exclusion criterion during screening|0|||
160932918|NCT02641379|581150713|FG008|Overall Study|Exclusion criterion during screening|0|||
160932919|NCT02641379|581150714|FG009|Overall Study|Exclusion criterion during screening|0|||
160932920|NCT02641379|581150715|FG010|Overall Study|Exclusion criterion during screening|0|||
160932921|NCT02641379|581150705|FG000|Overall Study|Withdrawal of informed consent|0|||
160932922|NCT02641379|581150706|FG001|Overall Study|Withdrawal of informed consent|1|||
160932923|NCT02641379|581150707|FG002|Overall Study|Withdrawal of informed consent|0|||
160932924|NCT02641379|581150708|FG003|Overall Study|Withdrawal of informed consent|0|||
160932925|NCT02641379|581150709|FG004|Overall Study|Withdrawal of informed consent|0|||
160932926|NCT02641379|581150710|FG005|Overall Study|Withdrawal of informed consent|0|||
160932927|NCT02641379|581150711|FG006|Overall Study|Withdrawal of informed consent|0|||
160932928|NCT02641379|581150712|FG007|Overall Study|Withdrawal of informed consent|1|||
160932929|NCT02641379|581150713|FG008|Overall Study|Withdrawal of informed consent|0|||
160932930|NCT02641379|581150714|FG009|Overall Study|Withdrawal of informed consent|0|||
160932931|NCT02641379|581150715|FG010|Overall Study|Withdrawal of informed consent|0|||
160932932|NCT02641379|581150705|FG000|Overall Study|Adverse Event|7|||
160932933|NCT02641379|581150706|FG001|Overall Study|Adverse Event|8|||
160932934|NCT02641379|581150707|FG002|Overall Study|Adverse Event|2|||
160932935|NCT02641379|581150708|FG003|Overall Study|Adverse Event|2|||
160932936|NCT02641379|581150709|FG004|Overall Study|Adverse Event|5|||
160932937|NCT02641379|581150710|FG005|Overall Study|Adverse Event|1|||
160932938|NCT02641379|581150711|FG006|Overall Study|Adverse Event|5|||
160932939|NCT02641379|581150712|FG007|Overall Study|Adverse Event|0|||
160932940|NCT02641379|581150713|FG008|Overall Study|Adverse Event|1|||
160932941|NCT02641379|581150714|FG009|Overall Study|Adverse Event|1|||
160932942|NCT02641379|581150715|FG010|Overall Study|Adverse Event|5|||
160932943|NCT02641379|581150705|FG000|Overall Study|Lack of Efficacy|0|||
160932944|NCT02641379|581150706|FG001|Overall Study|Lack of Efficacy|0|||
160932945|NCT02641379|581150707|FG002|Overall Study|Lack of Efficacy|2|||
160932946|NCT02641379|581150708|FG003|Overall Study|Lack of Efficacy|0|||
160932947|NCT02641379|581150709|FG004|Overall Study|Lack of Efficacy|0|||
160932948|NCT02641379|581150710|FG005|Overall Study|Lack of Efficacy|2|||
160932949|NCT02641379|581150711|FG006|Overall Study|Lack of Efficacy|0|||
160932950|NCT02641379|581150712|FG007|Overall Study|Lack of Efficacy|5|||
160932951|NCT02641379|581150713|FG008|Overall Study|Lack of Efficacy|0|||
160932952|NCT02641379|581150714|FG009|Overall Study|Lack of Efficacy|0|||
160932953|NCT02641379|581150715|FG010|Overall Study|Lack of Efficacy|0|||
160932954|NCT02641379|581150705|FG000|Overall Study|Participant unable to attend study visit|4|||
160932955|NCT02641379|581150706|FG001|Overall Study|Participant unable to attend study visit|10|||
160932956|NCT02641379|581150707|FG002|Overall Study|Participant unable to attend study visit|1|||
160932957|NCT02641379|581150708|FG003|Overall Study|Participant unable to attend study visit|2|||
160932958|NCT02641379|581150709|FG004|Overall Study|Participant unable to attend study visit|5|||
160932959|NCT02641379|581150710|FG005|Overall Study|Participant unable to attend study visit|1|||
160932960|NCT02641379|581150711|FG006|Overall Study|Participant unable to attend study visit|1|||
160932961|NCT02641379|581150712|FG007|Overall Study|Participant unable to attend study visit|1|||
160932962|NCT02641379|581150713|FG008|Overall Study|Participant unable to attend study visit|0|||
160932963|NCT02641379|581150714|FG009|Overall Study|Participant unable to attend study visit|2|||
160932964|NCT02641379|581150715|FG010|Overall Study|Participant unable to attend study visit|0|||
160932965|NCT02641379|581150705|FG000|Overall Study|Participant's compliance|0|||
160932966|NCT02641379|581150706|FG001|Overall Study|Participant's compliance|1|||
160932967|NCT02641379|581150707|FG002|Overall Study|Participant's compliance|0|||
160932968|NCT02641379|581150708|FG003|Overall Study|Participant's compliance|1|||
160932969|NCT02641379|581150709|FG004|Overall Study|Participant's compliance|0|||
160932970|NCT02641379|581150710|FG005|Overall Study|Participant's compliance|2|||
160932971|NCT02641379|581150711|FG006|Overall Study|Participant's compliance|0|||
160932972|NCT02641379|581150712|FG007|Overall Study|Participant's compliance|0|||
160932973|NCT02641379|581150713|FG008|Overall Study|Participant's compliance|1|||
160932974|NCT02641379|581150714|FG009|Overall Study|Participant's compliance|1|||
160932975|NCT02641379|581150715|FG010|Overall Study|Participant's compliance|1|||
160932976|NCT02641379|581150705|FG000|Overall Study|Participant cannot be reached|4|||
160932977|NCT02641379|581150706|FG001|Overall Study|Participant cannot be reached|4|||
160932978|NCT02641379|581150707|FG002|Overall Study|Participant cannot be reached|0|||
160932979|NCT02641379|581150708|FG003|Overall Study|Participant cannot be reached|8|||
160932980|NCT02641379|581150709|FG004|Overall Study|Participant cannot be reached|2|||
160932981|NCT02641379|581150710|FG005|Overall Study|Participant cannot be reached|1|||
160932982|NCT02641379|581150711|FG006|Overall Study|Participant cannot be reached|0|||
160932983|NCT02641379|581150712|FG007|Overall Study|Participant cannot be reached|1|||
160932984|NCT02641379|581150713|FG008|Overall Study|Participant cannot be reached|0|||
160932985|NCT02641379|581150714|FG009|Overall Study|Participant cannot be reached|2|||
160932986|NCT02641379|581150715|FG010|Overall Study|Participant cannot be reached|1|||
160932987|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 24|15|||
160932988|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 24|21|||
160932989|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 24|62|||
160932990|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 24|0|||
160932991|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 24|0|||
160932992|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 24|6|||
160932993|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 24|3|||
160932994|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 24|8|||
160932995|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 24|0|||
160932996|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 24|1|||
160932997|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 24|0|||
160932998|NCT02641379|581150705|FG000|Overall Study|PCR positive at follow up 2|1|||
160932999|NCT02641379|581150706|FG001|Overall Study|PCR positive at follow up 2|0|||
160933000|NCT02641379|581150707|FG002|Overall Study|PCR positive at follow up 2|0|||
160933001|NCT02641379|581150708|FG003|Overall Study|PCR positive at follow up 2|0|||
160933002|NCT02641379|581150709|FG004|Overall Study|PCR positive at follow up 2|0|||
160933003|NCT02641379|581150710|FG005|Overall Study|PCR positive at follow up 2|0|||
160933004|NCT02641379|581150711|FG006|Overall Study|PCR positive at follow up 2|0|||
160933005|NCT02641379|581150712|FG007|Overall Study|PCR positive at follow up 2|0|||
160933006|NCT02641379|581150713|FG008|Overall Study|PCR positive at follow up 2|0|||
160933007|NCT02641379|581150714|FG009|Overall Study|PCR positive at follow up 2|0|||
160933008|NCT02641379|581150715|FG010|Overall Study|PCR positive at follow up 2|0|||
160933009|NCT02641379|581150705|FG000|Overall Study|Participant showed relapse|1|||
160933010|NCT02641379|581150706|FG001|Overall Study|Participant showed relapse|0|||
160933011|NCT02641379|581150707|FG002|Overall Study|Participant showed relapse|0|||
160933012|NCT02641379|581150708|FG003|Overall Study|Participant showed relapse|0|||
160933013|NCT02641379|581150709|FG004|Overall Study|Participant showed relapse|0|||
160933014|NCT02641379|581150710|FG005|Overall Study|Participant showed relapse|0|||
160933015|NCT02641379|581150711|FG006|Overall Study|Participant showed relapse|1|||
160933016|NCT02641379|581150712|FG007|Overall Study|Participant showed relapse|0|||
160933017|NCT02641379|581150713|FG008|Overall Study|Participant showed relapse|0|||
160933018|NCT02641379|581150714|FG009|Overall Study|Participant showed relapse|0|||
160933019|NCT02641379|581150715|FG010|Overall Study|Participant showed relapse|0|||
160933020|NCT02641379|581150705|FG000|Overall Study|Participant stopped study/treatment|1|||
160933021|NCT02641379|581150706|FG001|Overall Study|Participant stopped study/treatment|3|||
160933022|NCT02641379|581150707|FG002|Overall Study|Participant stopped study/treatment|1|||
160933023|NCT02641379|581150708|FG003|Overall Study|Participant stopped study/treatment|0|||
160933024|NCT02641379|581150709|FG004|Overall Study|Participant stopped study/treatment|0|||
160933025|NCT02641379|581150710|FG005|Overall Study|Participant stopped study/treatment|1|||
160933026|NCT02641379|581150711|FG006|Overall Study|Participant stopped study/treatment|2|||
160933027|NCT02641379|581150712|FG007|Overall Study|Participant stopped study/treatment|0|||
160933028|NCT02641379|581150713|FG008|Overall Study|Participant stopped study/treatment|1|||
160933029|NCT02641379|581150714|FG009|Overall Study|Participant stopped study/treatment|0|||
160933030|NCT02641379|581150715|FG010|Overall Study|Participant stopped study/treatment|0|||
160933031|NCT02641379|581150705|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
160933032|NCT02641379|581150706|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
160933033|NCT02641379|581150707|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
160933034|NCT02641379|581150708|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
160933035|NCT02641379|581150709|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
160933036|NCT02641379|581150710|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
160933037|NCT02641379|581150711|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
160933038|NCT02641379|581150712|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
160933039|NCT02641379|581150713|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
160933040|NCT02641379|581150714|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
160933041|NCT02641379|581150715|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
160933042|NCT02641379|581150705|FG000|Overall Study|Financial problems|0|||
160933043|NCT02641379|581150706|FG001|Overall Study|Financial problems|1|||
161264489|NCT03295318|582350631|FG000|Overall Study|Death|1|||
161264490|NCT03295318|582350632|FG001|Overall Study|Death|1|||
161264491|NCT03295318|582350633|FG002|Overall Study|Death|1|||
161264492|NCT03295318|582350631|FG000|Overall Study|Protocol Violation|4|||
160933044|NCT02641379|581150707|FG002|Overall Study|Financial problems|0|||
160933045|NCT02641379|581150708|FG003|Overall Study|Financial problems|0|||
160933046|NCT02641379|581150709|FG004|Overall Study|Financial problems|0|||
160933047|NCT02641379|581150710|FG005|Overall Study|Financial problems|0|||
160933048|NCT02641379|581150711|FG006|Overall Study|Financial problems|0|||
160933049|NCT02641379|581150712|FG007|Overall Study|Financial problems|0|||
161264493|NCT03295318|582350632|FG001|Overall Study|Protocol Violation|3|||
161264494|NCT03295318|582350633|FG002|Overall Study|Protocol Violation|3|||
161264495|NCT03295318|582350631|FG000|Overall Study|Withdrawal by Subject|0|||
161143721|NCT03114969|581909473|FG002|Overall Study|Lost to Follow-up|3|||
161143722|NCT03114969|581909474|FG003|Overall Study|Lost to Follow-up|2|||
161143723|NCT03114969|581909475|FG004|Overall Study|Lost to Follow-up|0|||
161143724|NCT03114969|581909476|FG005|Overall Study|Lost to Follow-up|0|||
161143725|NCT03114969|581909477|FG006|Overall Study|Lost to Follow-up|0|||
161143726|NCT03114969|581909478|FG007|Overall Study|Lost to Follow-up|0|||
161143727|NCT03114969|581909479|FG008|Overall Study|Lost to Follow-up|0|||
161143728|NCT03114969|581909471|FG000|Overall Study|Adverse Event|0|||
161143729|NCT03114969|581909472|FG001|Overall Study|Adverse Event|0|||
161143730|NCT03114969|581909473|FG002|Overall Study|Adverse Event|1|||
161143731|NCT03114969|581909474|FG003|Overall Study|Adverse Event|0|||
161143732|NCT03114969|581909475|FG004|Overall Study|Adverse Event|0|||
161143733|NCT03114969|581909476|FG005|Overall Study|Adverse Event|1|||
161143734|NCT03114969|581909477|FG006|Overall Study|Adverse Event|1|||
161143735|NCT03114969|581909478|FG007|Overall Study|Adverse Event|0|||
161143736|NCT03114969|581909479|FG008|Overall Study|Adverse Event|2|||
161143737|NCT00971321|581909480|FG000|Up to Month 7|Withdrawal by Subject|1|||
161143738|NCT00971321|581909481|FG001|Up to Month 7|Withdrawal by Subject|0|||
161143739|NCT00971321|581909480|FG000|Up to Month 7|Migrated/moved from study area|3|||
161143740|NCT00971321|581909481|FG001|Up to Month 7|Migrated/moved from study area|2|||
161264496|NCT03295318|582350632|FG001|Overall Study|Withdrawal by Subject|0|||
161264497|NCT03295318|582350633|FG002|Overall Study|Withdrawal by Subject|1|||
161264498|NCT03295318|582350631|FG000|Overall Study|Subject discontinued due to travel|0|||
161143741|NCT00971321|581909480|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
161143742|NCT00971321|581909481|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
161143743|NCT00971321|581909480|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
161143744|NCT00971321|581909481|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
161143745|NCT00971321|581909480|FG000|Up to Month 11-12|Lost to Follow-up|1|||
161143746|NCT00971321|581909481|FG001|Up to Month 11-12|Lost to Follow-up|0|||
161143747|NCT01591330|581909484|FG000|Period 1|Adverse Event|1|||
161143748|NCT01591330|581909485|FG001|Period 1|Adverse Event|0|||
161264499|NCT03295318|582350632|FG001|Overall Study|Subject discontinued due to travel|1|||
160933050|NCT02641379|581150713|FG008|Overall Study|Financial problems|0|||
160933051|NCT02641379|581150714|FG009|Overall Study|Financial problems|0|||
160933052|NCT02641379|581150715|FG010|Overall Study|Financial problems|0|||
160933053|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 68|0|||
160933054|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 68|1|||
160933055|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 68|0|||
160933056|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 68|0|||
160933057|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 68|0|||
160933058|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 68|0|||
160933059|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 68|0|||
160933060|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 68|0|||
160933061|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 68|0|||
160933062|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 68|0|||
160933063|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 68|0|||
160933064|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 48|0|||
160933065|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 48|1|||
160933066|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 48|0|||
160933067|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 48|0|||
160933068|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 48|0|||
160933069|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 48|0|||
160933070|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 48|0|||
160933071|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 48|0|||
160933072|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 48|0|||
161264500|NCT03295318|582350633|FG002|Overall Study|Subject discontinued due to travel|0|||
160933073|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 48|0|||
161143749|NCT01591330|581909486|FG002|Period 1|Adverse Event|0|||
161143750|NCT01591330|581909487|FG003|Period 1|Adverse Event|0|||
161143751|NCT01591330|581909484|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
161143752|NCT01591330|581909485|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161143753|NCT01591330|581909486|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161264501|NCT03747601|582350634|FG000|Overall Study|COVID halt to visits|4|||
160933074|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 48|0|||
160933075|NCT02641379|581150705|FG000|Overall Study|PCR not performed at Week 12|0|||
160933076|NCT02641379|581150706|FG001|Overall Study|PCR not performed at Week 12|0|||
160933077|NCT02641379|581150707|FG002|Overall Study|PCR not performed at Week 12|1|||
160933078|NCT02641379|581150708|FG003|Overall Study|PCR not performed at Week 12|0|||
160933079|NCT02641379|581150709|FG004|Overall Study|PCR not performed at Week 12|0|||
161143754|NCT01591330|581909487|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
161143755|NCT01591330|581909484|FG000|Period 2|Adverse Event|1|||
161143756|NCT01591330|581909485|FG001|Period 2|Adverse Event|0|||
161143757|NCT01591330|581909486|FG002|Period 2|Adverse Event|0|||
161264502|NCT02307266|582350637|FG000|Overall Study|Adverse Event|3|||
161143758|NCT01591330|581909487|FG003|Period 2|Adverse Event|0|||
161143759|NCT02782715|581909488|FG000|Overall Study|Withdrawal by Subject|1|||
161143760|NCT01662999|581909491|FG000|Period 3|Withdrawal by Subject|0|||
161342467|NCT00671788|582640207|FG000|Overall Study|MD Decision|1|||
160933080|NCT02641379|581150710|FG005|Overall Study|PCR not performed at Week 12|0|||
160933081|NCT02641379|581150711|FG006|Overall Study|PCR not performed at Week 12|0|||
160933082|NCT02641379|581150712|FG007|Overall Study|PCR not performed at Week 12|0|||
160933083|NCT02641379|581150713|FG008|Overall Study|PCR not performed at Week 12|0|||
160933084|NCT02641379|581150714|FG009|Overall Study|PCR not performed at Week 12|0|||
160933085|NCT02641379|581150715|FG010|Overall Study|PCR not performed at Week 12|0|||
160933086|NCT02641379|581150705|FG000|Overall Study|No PCR at baseline|0|||
160933087|NCT02641379|581150706|FG001|Overall Study|No PCR at baseline|0|||
160933088|NCT02641379|581150707|FG002|Overall Study|No PCR at baseline|1|||
160933089|NCT02641379|581150708|FG003|Overall Study|No PCR at baseline|0|||
160933090|NCT02641379|581150709|FG004|Overall Study|No PCR at baseline|0|||
160933091|NCT02641379|581150710|FG005|Overall Study|No PCR at baseline|0|||
160933092|NCT02641379|581150711|FG006|Overall Study|No PCR at baseline|0|||
160933093|NCT02641379|581150712|FG007|Overall Study|No PCR at baseline|0|||
160933094|NCT02641379|581150713|FG008|Overall Study|No PCR at baseline|0|||
160933095|NCT02641379|581150714|FG009|Overall Study|No PCR at baseline|0|||
160933096|NCT02641379|581150715|FG010|Overall Study|No PCR at baseline|0|||
160933097|NCT02641379|581150705|FG000|Overall Study|PCR positive at Week 28|0|||
160933098|NCT02641379|581150706|FG001|Overall Study|PCR positive at Week 28|0|||
160933099|NCT02641379|581150707|FG002|Overall Study|PCR positive at Week 28|1|||
160933100|NCT02641379|581150708|FG003|Overall Study|PCR positive at Week 28|0|||
160933101|NCT02641379|581150709|FG004|Overall Study|PCR positive at Week 28|0|||
160933102|NCT02641379|581150710|FG005|Overall Study|PCR positive at Week 28|0|||
160933103|NCT02641379|581150711|FG006|Overall Study|PCR positive at Week 28|0|||
160933104|NCT02641379|581150712|FG007|Overall Study|PCR positive at Week 28|0|||
160933105|NCT02641379|581150713|FG008|Overall Study|PCR positive at Week 28|0|||
160933106|NCT02641379|581150714|FG009|Overall Study|PCR positive at Week 28|0|||
160933107|NCT02641379|581150715|FG010|Overall Study|PCR positive at Week 28|0|||
160933108|NCT02641379|581150705|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
160933109|NCT02641379|581150706|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
160933110|NCT02641379|581150707|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
160933111|NCT02641379|581150708|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
160933112|NCT02641379|581150709|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
160933113|NCT02641379|581150710|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
160933114|NCT02641379|581150711|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
160933115|NCT02641379|581150712|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
160933116|NCT02641379|581150713|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
160933117|NCT02641379|581150714|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
160933118|NCT02641379|581150715|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
160933119|NCT02641379|581150705|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
160933120|NCT02641379|581150706|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
160933121|NCT02641379|581150707|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
160933122|NCT02641379|581150708|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
160933123|NCT02641379|581150709|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
160933124|NCT02641379|581150710|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
160933125|NCT02641379|581150711|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
160933126|NCT02641379|581150712|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
160933127|NCT02641379|581150713|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
160933128|NCT02641379|581150714|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
160933129|NCT02641379|581150715|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
160933130|NCT02641379|581150705|FG000|Overall Study|Baseline viral load unavailable|0|||
160933131|NCT02641379|581150706|FG001|Overall Study|Baseline viral load unavailable|0|||
160933132|NCT02641379|581150707|FG002|Overall Study|Baseline viral load unavailable|0|||
160933133|NCT02641379|581150708|FG003|Overall Study|Baseline viral load unavailable|1|||
160933134|NCT02641379|581150709|FG004|Overall Study|Baseline viral load unavailable|0|||
160933135|NCT02641379|581150710|FG005|Overall Study|Baseline viral load unavailable|0|||
160933136|NCT02641379|581150711|FG006|Overall Study|Baseline viral load unavailable|0|||
160998384|NCT04771273|581378656|FG002|Dose Escalation Period|Burden of study procedures|0|||
160998385|NCT04771273|581378657|FG003|Dose Escalation Period|Burden of study procedures|0|||
161143761|NCT01662999|581909492|FG001|Period 3|Withdrawal by Subject|1|||
161143762|NCT01662999|581909493|FG002|Period 3|Withdrawal by Subject|0|||
161143763|NCT01662999|581909494|FG003|Period 3|Withdrawal by Subject|0|||
160933137|NCT02641379|581150712|FG007|Overall Study|Baseline viral load unavailable|0|||
160933138|NCT02641379|581150713|FG008|Overall Study|Baseline viral load unavailable|0|||
160933139|NCT02641379|581150714|FG009|Overall Study|Baseline viral load unavailable|0|||
160933140|NCT02641379|581150715|FG010|Overall Study|Baseline viral load unavailable|0|||
160933141|NCT02641379|581150705|FG000|Overall Study|Blood could not be drawn|0|||
160933142|NCT02641379|581150706|FG001|Overall Study|Blood could not be drawn|0|||
160933143|NCT02641379|581150707|FG002|Overall Study|Blood could not be drawn|0|||
160998386|NCT04771273|581378654|FG000|Dose Escalation Period|Change of residence|0|||
160998387|NCT04771273|581378655|FG001|Dose Escalation Period|Change of residence|0|||
161143764|NCT01662999|581909495|FG004|Period 3|Withdrawal by Subject|0|||
160933144|NCT02641379|581150708|FG003|Overall Study|Blood could not be drawn|0|||
160933145|NCT02641379|581150709|FG004|Overall Study|Blood could not be drawn|1|||
160933146|NCT02641379|581150710|FG005|Overall Study|Blood could not be drawn|0|||
160933147|NCT02641379|581150711|FG006|Overall Study|Blood could not be drawn|0|||
160933148|NCT02641379|581150712|FG007|Overall Study|Blood could not be drawn|0|||
160933149|NCT02641379|581150713|FG008|Overall Study|Blood could not be drawn|0|||
160933150|NCT02641379|581150714|FG009|Overall Study|Blood could not be drawn|0|||
160933151|NCT02641379|581150715|FG010|Overall Study|Blood could not be drawn|0|||
160933152|NCT02641379|581150705|FG000|Overall Study|Protocol Violation|0|||
160933153|NCT02641379|581150706|FG001|Overall Study|Protocol Violation|0|||
161342468|NCT00671788|582640207|FG000|Overall Study|Other|1|||
161342469|NCT04739800|582640208|FG000|Overall Study|Adverse Event|2|||
161342470|NCT04739800|582640209|FG001|Overall Study|Adverse Event|1|||
161342471|NCT04739800|582640210|FG002|Overall Study|Adverse Event|4|||
161342472|NCT04739800|582640211|FG003|Overall Study|Adverse Event|5|||
161342473|NCT04739800|582640208|FG000|Overall Study|Never Treated|2|||
161342474|NCT04739800|582640209|FG001|Overall Study|Never Treated|0|||
161342475|NCT04739800|582640210|FG002|Overall Study|Never Treated|1|||
161342476|NCT04739800|582640211|FG003|Overall Study|Never Treated|1|||
161342477|NCT04739800|582640208|FG000|Overall Study|On Treatment|5|||
161342478|NCT04739800|582640209|FG001|Overall Study|On Treatment|9|||
160933154|NCT02641379|581150707|FG002|Overall Study|Protocol Violation|0|||
160933155|NCT02641379|581150708|FG003|Overall Study|Protocol Violation|0|||
160933156|NCT02641379|581150709|FG004|Overall Study|Protocol Violation|2|||
160933157|NCT02641379|581150710|FG005|Overall Study|Protocol Violation|0|||
160933158|NCT02641379|581150711|FG006|Overall Study|Protocol Violation|0|||
160933159|NCT02641379|581150712|FG007|Overall Study|Protocol Violation|0|||
160933160|NCT02641379|581150713|FG008|Overall Study|Protocol Violation|1|||
160933161|NCT02641379|581150714|FG009|Overall Study|Protocol Violation|0|||
160933162|NCT02641379|581150715|FG010|Overall Study|Protocol Violation|0|||
160933163|NCT02641379|581150705|FG000|Overall Study|Participation in sili rescue study|0|||
160933164|NCT02641379|581150706|FG001|Overall Study|Participation in sili rescue study|0|||
160933165|NCT02641379|581150707|FG002|Overall Study|Participation in sili rescue study|0|||
160933166|NCT02641379|581150708|FG003|Overall Study|Participation in sili rescue study|0|||
160933167|NCT02641379|581150709|FG004|Overall Study|Participation in sili rescue study|0|||
160933168|NCT02641379|581150710|FG005|Overall Study|Participation in sili rescue study|1|||
160933169|NCT02641379|581150711|FG006|Overall Study|Participation in sili rescue study|0|||
160933170|NCT02641379|581150712|FG007|Overall Study|Participation in sili rescue study|0|||
160933171|NCT02641379|581150713|FG008|Overall Study|Participation in sili rescue study|0|||
160933172|NCT02641379|581150714|FG009|Overall Study|Participation in sili rescue study|0|||
160933173|NCT02641379|581150715|FG010|Overall Study|Participation in sili rescue study|0|||
160933174|NCT02641379|581150705|FG000|Overall Study|Lost to Follow-up|0|||
160933175|NCT02641379|581150706|FG001|Overall Study|Lost to Follow-up|0|||
160933176|NCT02641379|581150707|FG002|Overall Study|Lost to Follow-up|0|||
160933177|NCT02641379|581150708|FG003|Overall Study|Lost to Follow-up|0|||
160933178|NCT02641379|581150709|FG004|Overall Study|Lost to Follow-up|0|||
160933179|NCT02641379|581150710|FG005|Overall Study|Lost to Follow-up|0|||
160933180|NCT02641379|581150711|FG006|Overall Study|Lost to Follow-up|0|||
160933181|NCT02641379|581150712|FG007|Overall Study|Lost to Follow-up|0|||
160933182|NCT02641379|581150713|FG008|Overall Study|Lost to Follow-up|1|||
160933183|NCT02641379|581150714|FG009|Overall Study|Lost to Follow-up|0|||
160933184|NCT02641379|581150715|FG010|Overall Study|Lost to Follow-up|0|||
160933185|NCT02641379|581150705|FG000|Overall Study|Source data not found|0|||
160933186|NCT02641379|581150706|FG001|Overall Study|Source data not found|0|||
160933187|NCT02641379|581150707|FG002|Overall Study|Source data not found|0|||
160933188|NCT02641379|581150708|FG003|Overall Study|Source data not found|0|||
160933189|NCT02641379|581150709|FG004|Overall Study|Source data not found|0|||
160933190|NCT02641379|581150710|FG005|Overall Study|Source data not found|1|||
161342479|NCT04739800|582640210|FG002|Overall Study|On Treatment|9|||
161342480|NCT04739800|582640211|FG003|Overall Study|On Treatment|9|||
161342481|NCT04739800|582640208|FG000|Overall Study|Symptomatic Deterioration|1|||
160933191|NCT02641379|581150711|FG006|Overall Study|Source data not found|0|||
160933192|NCT02641379|581150712|FG007|Overall Study|Source data not found|0|||
160933193|NCT02641379|581150713|FG008|Overall Study|Source data not found|0|||
160998388|NCT04771273|581378656|FG002|Dose Escalation Period|Change of residence|0|||
161342482|NCT04739800|582640209|FG001|Overall Study|Symptomatic Deterioration|1|||
160933194|NCT02641379|581150714|FG009|Overall Study|Source data not found|0|||
160933195|NCT02641379|581150715|FG010|Overall Study|Source data not found|0|||
160933196|NCT02641379|581150705|FG000|Overall Study|Participant showed weight reduction|0|||
160933197|NCT02641379|581150706|FG001|Overall Study|Participant showed weight reduction|0|||
161342483|NCT04739800|582640210|FG002|Overall Study|Symptomatic Deterioration|3|||
161143765|NCT01662999|581909496|FG005|Period 3|Withdrawal by Subject|0|||
161342484|NCT04739800|582640211|FG003|Overall Study|Symptomatic Deterioration|0|||
160933198|NCT02641379|581150707|FG002|Overall Study|Participant showed weight reduction|0|||
160933199|NCT02641379|581150708|FG003|Overall Study|Participant showed weight reduction|0|||
160933200|NCT02641379|581150709|FG004|Overall Study|Participant showed weight reduction|0|||
161342485|NCT04739800|582640208|FG000|Overall Study|Withdrawal by Subject|1|||
160933201|NCT02641379|581150710|FG005|Overall Study|Participant showed weight reduction|0|||
160933202|NCT02641379|581150711|FG006|Overall Study|Participant showed weight reduction|0|||
160933203|NCT02641379|581150712|FG007|Overall Study|Participant showed weight reduction|1|||
160933204|NCT02641379|581150713|FG008|Overall Study|Participant showed weight reduction|0|||
160933205|NCT02641379|581150714|FG009|Overall Study|Participant showed weight reduction|0|||
160933206|NCT02641379|581150715|FG010|Overall Study|Participant showed weight reduction|0|||
160933207|NCT02641379|581150705|FG000|Overall Study|Non-response Week 12|0|||
160933208|NCT02641379|581150706|FG001|Overall Study|Non-response Week 12|0|||
160933209|NCT02641379|581150707|FG002|Overall Study|Non-response Week 12|0|||
160933210|NCT02641379|581150708|FG003|Overall Study|Non-response Week 12|0|||
160933211|NCT02641379|581150709|FG004|Overall Study|Non-response Week 12|0|||
160933212|NCT02641379|581150710|FG005|Overall Study|Non-response Week 12|0|||
160933213|NCT02641379|581150711|FG006|Overall Study|Non-response Week 12|0|||
160933214|NCT02641379|581150712|FG007|Overall Study|Non-response Week 12|1|||
160933215|NCT02641379|581150713|FG008|Overall Study|Non-response Week 12|0|||
160933216|NCT02641379|581150714|FG009|Overall Study|Non-response Week 12|0|||
160933217|NCT02641379|581150715|FG010|Overall Study|Non-response Week 12|0|||
160933218|NCT02641379|581150705|FG000|Overall Study|No 2 Log drop at Week 12|0|||
160933219|NCT02641379|581150706|FG001|Overall Study|No 2 Log drop at Week 12|0|||
160933220|NCT02641379|581150707|FG002|Overall Study|No 2 Log drop at Week 12|0|||
160933221|NCT02641379|581150708|FG003|Overall Study|No 2 Log drop at Week 12|0|||
160933222|NCT02641379|581150709|FG004|Overall Study|No 2 Log drop at Week 12|0|||
160933223|NCT02641379|581150710|FG005|Overall Study|No 2 Log drop at Week 12|0|||
160933224|NCT02641379|581150711|FG006|Overall Study|No 2 Log drop at Week 12|0|||
160933225|NCT02641379|581150712|FG007|Overall Study|No 2 Log drop at Week 12|0|||
160933226|NCT02641379|581150713|FG008|Overall Study|No 2 Log drop at Week 12|0|||
160933227|NCT02641379|581150714|FG009|Overall Study|No 2 Log drop at Week 12|0|||
160933228|NCT02641379|581150715|FG010|Overall Study|No 2 Log drop at Week 12|1|||
160933229|NCT02641379|581150705|FG000|Overall Study|Negative PCR result|0|||
160933230|NCT02641379|581150706|FG001|Overall Study|Negative PCR result|0|||
160933231|NCT02641379|581150707|FG002|Overall Study|Negative PCR result|0|||
160933232|NCT02641379|581150708|FG003|Overall Study|Negative PCR result|0|||
160933233|NCT02641379|581150709|FG004|Overall Study|Negative PCR result|0|||
160933234|NCT02641379|581150710|FG005|Overall Study|Negative PCR result|0|||
160933235|NCT02641379|581150711|FG006|Overall Study|Negative PCR result|0|||
160933236|NCT02641379|581150712|FG007|Overall Study|Negative PCR result|0|||
160933237|NCT02641379|581150713|FG008|Overall Study|Negative PCR result|0|||
160933238|NCT02641379|581150714|FG009|Overall Study|Negative PCR result|1|||
160933239|NCT02641379|581150715|FG010|Overall Study|Negative PCR result|0|||
160933240|NCT02641379|581150705|FG000|Overall Study|Participant's PCR high|0|||
160933241|NCT02641379|581150706|FG001|Overall Study|Participant's PCR high|0|||
160933242|NCT02641379|581150707|FG002|Overall Study|Participant's PCR high|0|||
160933243|NCT02641379|581150708|FG003|Overall Study|Participant's PCR high|0|||
160933244|NCT02641379|581150709|FG004|Overall Study|Participant's PCR high|0|||
160933245|NCT02641379|581150710|FG005|Overall Study|Participant's PCR high|0|||
160933246|NCT02641379|581150711|FG006|Overall Study|Participant's PCR high|0|||
160933247|NCT02641379|581150712|FG007|Overall Study|Participant's PCR high|1|||
160933248|NCT02641379|581150713|FG008|Overall Study|Participant's PCR high|0|||
160933249|NCT02641379|581150714|FG009|Overall Study|Participant's PCR high|0|||
160933250|NCT02641379|581150715|FG010|Overall Study|Participant's PCR high|0|||
160933251|NCT02641379|581150705|FG000|Overall Study|Participant treated after Week 24|0|||
160933252|NCT02641379|581150706|FG001|Overall Study|Participant treated after Week 24|0|||
160933253|NCT02641379|581150707|FG002|Overall Study|Participant treated after Week 24|0|||
160933254|NCT02641379|581150708|FG003|Overall Study|Participant treated after Week 24|0|||
160933255|NCT02641379|581150709|FG004|Overall Study|Participant treated after Week 24|0|||
160933256|NCT02641379|581150710|FG005|Overall Study|Participant treated after Week 24|0|||
160933257|NCT02641379|581150711|FG006|Overall Study|Participant treated after Week 24|0|||
160933258|NCT02641379|581150712|FG007|Overall Study|Participant treated after Week 24|0|||
160933259|NCT02641379|581150713|FG008|Overall Study|Participant treated after Week 24|1|||
160933260|NCT02641379|581150714|FG009|Overall Study|Participant treated after Week 24|0|||
161264503|NCT02307266|582350638|FG001|Overall Study|Adverse Event|1|||
161264504|NCT02307266|582350639|FG002|Overall Study|Adverse Event|5|||
160933261|NCT02641379|581150715|FG010|Overall Study|Participant treated after Week 24|0|||
160933262|NCT02641379|581150705|FG000|Overall Study|Missing PCR result at Week 8|0|||
160933263|NCT02641379|581150706|FG001|Overall Study|Missing PCR result at Week 8|0|||
160933264|NCT02641379|581150707|FG002|Overall Study|Missing PCR result at Week 8|0|||
160933265|NCT02641379|581150708|FG003|Overall Study|Missing PCR result at Week 8|0|||
161264505|NCT02307266|582350637|FG000|Overall Study|Withdrawal by Subject|2|||
161264506|NCT02307266|582350638|FG001|Overall Study|Withdrawal by Subject|0|||
160933266|NCT02641379|581150709|FG004|Overall Study|Missing PCR result at Week 8|0|||
160933267|NCT02641379|581150710|FG005|Overall Study|Missing PCR result at Week 8|0|||
160933268|NCT02641379|581150711|FG006|Overall Study|Missing PCR result at Week 8|0|||
160933269|NCT02641379|581150712|FG007|Overall Study|Missing PCR result at Week 8|0|||
160933270|NCT02641379|581150713|FG008|Overall Study|Missing PCR result at Week 8|0|||
160933271|NCT02641379|581150714|FG009|Overall Study|Missing PCR result at Week 8|1|||
160933272|NCT02641379|581150715|FG010|Overall Study|Missing PCR result at Week 8|0|||
160933273|NCT02641379|581150705|FG000|Overall Study|PCR positive|0|||
160933274|NCT02641379|581150706|FG001|Overall Study|PCR positive|0|||
160933275|NCT02641379|581150707|FG002|Overall Study|PCR positive|0|||
160933276|NCT02641379|581150708|FG003|Overall Study|PCR positive|0|||
160933277|NCT02641379|581150709|FG004|Overall Study|PCR positive|0|||
160933278|NCT02641379|581150710|FG005|Overall Study|PCR positive|0|||
160933279|NCT02641379|581150711|FG006|Overall Study|PCR positive|1|||
160933280|NCT02641379|581150712|FG007|Overall Study|PCR positive|0|||
160933281|NCT02641379|581150713|FG008|Overall Study|PCR positive|0|||
160933282|NCT02641379|581150714|FG009|Overall Study|PCR positive|0|||
160933283|NCT02641379|581150715|FG010|Overall Study|PCR positive|0|||
160933284|NCT01644175|581150718|FG000|Overall Study|Randomized But Not Treated|0|||
160933285|NCT01644175|581150719|FG001|Overall Study|Randomized But Not Treated|2|||
160933286|NCT01644175|581150718|FG000|Overall Study|Adverse Event|8|||
160933287|NCT01644175|581150719|FG001|Overall Study|Adverse Event|13|||
160933288|NCT01644175|581150718|FG000|Overall Study|Death|1|||
160933289|NCT01644175|581150719|FG001|Overall Study|Death|2|||
160933290|NCT01644175|581150718|FG000|Overall Study|Poor compliance to protocol|9|||
160933291|NCT01644175|581150719|FG001|Overall Study|Poor compliance to protocol|10|||
160933292|NCT01644175|581150718|FG000|Overall Study|Physician Decision|1|||
160933293|NCT01644175|581150719|FG001|Overall Study|Physician Decision|2|||
160933294|NCT01644175|581150718|FG000|Overall Study|Participant Moved|1|||
160933295|NCT01644175|581150719|FG001|Overall Study|Participant Moved|2|||
160933296|NCT01644175|581150718|FG000|Overall Study|Consent withdrawn by participant|3|||
160933297|NCT01644175|581150719|FG001|Overall Study|Consent withdrawn by participant|4|||
160933298|NCT01644175|581150718|FG000|Overall Study|Related to Autoinjector Administration|2|||
160933299|NCT01644175|581150719|FG001|Overall Study|Related to Autoinjector Administration|1|||
160933300|NCT01644175|581150718|FG000|Overall Study|Last visit outside protocol visit window|4|||
160933301|NCT01644175|581150719|FG001|Overall Study|Last visit outside protocol visit window|11|||
160933302|NCT01644175|581150718|FG000|Overall Study|Selection criteria finally not met|0|||
160933303|NCT01644175|581150719|FG001|Overall Study|Selection criteria finally not met|1|||
160933304|NCT01644175|581150718|FG000|Overall Study|Site closure|2|||
160933305|NCT01644175|581150719|FG001|Overall Study|Site closure|2|||
160933306|NCT01644175|581150718|FG000|Overall Study|Lost to Follow-up|1|||
160933307|NCT01644175|581150719|FG001|Overall Study|Lost to Follow-up|0|||
160933308|NCT01644175|581150718|FG000|Overall Study|Other than specified above|0|||
160933309|NCT01644175|581150719|FG001|Overall Study|Other than specified above|3|||
160933310|NCT01418937|581150723|FG000|Overall Study|Lost to Follow-up|5|||
160933311|NCT01418937|581150723|FG000|Overall Study|Protocol Violation|1|||
160933312|NCT01418937|581150723|FG000|Overall Study|Pregnancy|1|||
160933313|NCT01418937|581150723|FG000|Overall Study|Withdrawal by Subject|1|||
160933314|NCT00856908|581150744|FG000|Overall Study|Lost to Follow-up|1|||
160933315|NCT00856908|581150745|FG001|Overall Study|Lost to Follow-up|0|||
160933316|NCT01063595|581150746|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
160933317|NCT01063595|581150747|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
160933318|NCT01063595|581150746|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
160933319|NCT01063595|581150747|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
160933320|NCT01063595|581150746|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
160933321|NCT01063595|581150747|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
160933322|NCT01063595|581150746|FG000|First Intervention|Adverse Event|1|||
160933323|NCT01063595|581150747|FG001|First Intervention|Adverse Event|4|||
161143766|NCT02190591|581909497|FG000|Overall Study|Withdrawal by Subject|1|||
161143767|NCT02190591|581909498|FG001|Overall Study|Withdrawal by Subject|8|||
161143768|NCT02190591|581909497|FG000|Overall Study|Protocol Violation|1|||
161143769|NCT02190591|581909498|FG001|Overall Study|Protocol Violation|0|||
161342486|NCT04739800|582640209|FG001|Overall Study|Withdrawal by Subject|2|||
160933324|NCT01063595|581150746|FG000|First Intervention|Withdrawal by Subject|1|||
160933325|NCT01063595|581150747|FG001|First Intervention|Withdrawal by Subject|0|||
160933326|NCT01063595|581150746|FG000|First Intervention|Reason not Specified|0|||
160933327|NCT01063595|581150747|FG001|First Intervention|Reason not Specified|1|||
160933328|NCT04059146|581150753|FG000|Overall Study|Withdrawal by Subject|0|||
160933329|NCT04059146|581150754|FG001|Overall Study|Withdrawal by Subject|1|||
160933330|NCT00451035|581150755|FG000|Overall Study|Disease progression|11|||
160933331|NCT00451035|581150755|FG000|Overall Study|Death|3|||
160933332|NCT00451035|581150755|FG000|Overall Study|New anti-neoplastic therapy|3|||
160933333|NCT01712256|581150758|FG000|Overall Study|Lost to Follow-up|1|||
160933334|NCT00962104|581150759|FG000|Overall Study|Adverse Event|10|||
160933335|NCT00962104|581150760|FG001|Overall Study|Adverse Event|3|||
160933336|NCT00962104|581150759|FG000|Overall Study|Entry Criteria Not Met|1|||
160933337|NCT00962104|581150760|FG001|Overall Study|Entry Criteria Not Met|2|||
160933338|NCT00962104|581150759|FG000|Overall Study|Lack of Efficacy|0|||
160933339|NCT00962104|581150760|FG001|Overall Study|Lack of Efficacy|1|||
160933340|NCT00962104|581150759|FG000|Overall Study|Lost to Follow-up|10|||
160933341|NCT00962104|581150760|FG001|Overall Study|Lost to Follow-up|4|||
161342487|NCT04739800|582640210|FG002|Overall Study|Withdrawal by Subject|1|||
160933342|NCT00962104|581150759|FG000|Overall Study|Physician Decision|1|||
160933343|NCT00962104|581150760|FG001|Overall Study|Physician Decision|0|||
160933344|NCT00962104|581150759|FG000|Overall Study|Protocol Violation|6|||
161342488|NCT04739800|582640211|FG003|Overall Study|Withdrawal by Subject|3|||
160933345|NCT00962104|581150760|FG001|Overall Study|Protocol Violation|8|||
160933346|NCT00962104|581150759|FG000|Overall Study|Sponsor Decision|0|||
160933347|NCT00962104|581150760|FG001|Overall Study|Sponsor Decision|1|||
160933348|NCT00962104|581150759|FG000|Overall Study|Withdrawal by Subject|10|||
160933349|NCT00962104|581150760|FG001|Overall Study|Withdrawal by Subject|6|||
160933350|NCT00962104|581150759|FG000|Overall Study|Other|2|||
160933351|NCT00962104|581150760|FG001|Overall Study|Other|0|||
160933352|NCT00615056|581150762|FG000|Overall Study|Death|31|||
160933353|NCT00615056|581150763|FG001|Overall Study|Death|31|||
160933354|NCT00615056|581150764|FG002|Overall Study|Death|21|||
160933355|NCT00615056|581150765|FG003|Overall Study|Death|23|||
160933356|NCT00615056|581150762|FG000|Overall Study|Lost to Follow-up|1|||
160933357|NCT00615056|581150763|FG001|Overall Study|Lost to Follow-up|2|||
160933358|NCT00615056|581150764|FG002|Overall Study|Lost to Follow-up|4|||
160933359|NCT00615056|581150765|FG003|Overall Study|Lost to Follow-up|5|||
160933360|NCT00615056|581150762|FG000|Overall Study|Other|13|||
160933361|NCT00615056|581150763|FG001|Overall Study|Other|15|||
160933362|NCT00615056|581150764|FG002|Overall Study|Other|10|||
160933363|NCT00615056|581150765|FG003|Overall Study|Other|7|||
160933364|NCT00615056|581150762|FG000|Overall Study|Objective progression or relapse|0|||
160933365|NCT00615056|581150763|FG001|Overall Study|Objective progression or relapse|2|||
160933366|NCT00615056|581150764|FG002|Overall Study|Objective progression or relapse|0|||
160933367|NCT00615056|581150765|FG003|Overall Study|Objective progression or relapse|0|||
160933368|NCT00615056|581150762|FG000|Overall Study|Withdrawal by Subject|0|||
160933369|NCT00615056|581150763|FG001|Overall Study|Withdrawal by Subject|1|||
160933370|NCT00615056|581150764|FG002|Overall Study|Withdrawal by Subject|1|||
160933371|NCT00615056|581150765|FG003|Overall Study|Withdrawal by Subject|0|||
160933372|NCT00615056|581150762|FG000|Overall Study|Discontinued by Sponsor|1|||
160933373|NCT00615056|581150763|FG001|Overall Study|Discontinued by Sponsor|0|||
160933374|NCT00615056|581150764|FG002|Overall Study|Discontinued by Sponsor|0|||
160933375|NCT00615056|581150765|FG003|Overall Study|Discontinued by Sponsor|0|||
160933376|NCT00615056|581150762|FG000|Overall Study|Randomized but not treated|3|||
160933377|NCT00615056|581150763|FG001|Overall Study|Randomized but not treated|0|||
160933378|NCT00615056|581150764|FG002|Overall Study|Randomized but not treated|0|||
160933379|NCT00615056|581150765|FG003|Overall Study|Randomized but not treated|0|||
160933380|NCT00717769|581150766|FG000|Overall Study|Adverse Event|9|||
160933381|NCT00717769|581150767|FG001|Overall Study|Adverse Event|6|||
160933382|NCT00717769|581150768|FG002|Overall Study|Adverse Event|1|||
160933383|NCT00717769|581150766|FG000|Overall Study|Lack of compliance|0|||
160933384|NCT00717769|581150767|FG001|Overall Study|Lack of compliance|2|||
160933385|NCT00717769|581150768|FG002|Overall Study|Lack of compliance|0|||
160933386|NCT00717769|581150766|FG000|Overall Study|Lost to Follow-up|3|||
160933387|NCT00717769|581150767|FG001|Overall Study|Lost to Follow-up|4|||
160933388|NCT00717769|581150768|FG002|Overall Study|Lost to Follow-up|0|||
160933389|NCT00717769|581150766|FG000|Overall Study|Lack of Efficacy|1|||
160933390|NCT00717769|581150767|FG001|Overall Study|Lack of Efficacy|2|||
160933391|NCT00717769|581150768|FG002|Overall Study|Lack of Efficacy|0|||
160933392|NCT00717769|581150766|FG000|Overall Study|Protocol Violation|0|||
160933393|NCT00717769|581150767|FG001|Overall Study|Protocol Violation|2|||
160933394|NCT00717769|581150768|FG002|Overall Study|Protocol Violation|0|||
160998389|NCT04771273|581378657|FG003|Dose Escalation Period|Change of residence|1|||
161342489|NCT04739800|582640208|FG000|Overall Study|Other Reason|1|||
161342490|NCT04739800|582640209|FG001|Overall Study|Other Reason|3|||
160933395|NCT00717769|581150766|FG000|Overall Study|Sponsor decision|1|||
160933396|NCT00717769|581150767|FG001|Overall Study|Sponsor decision|0|||
160933397|NCT00717769|581150768|FG002|Overall Study|Sponsor decision|10|||
160933398|NCT00717769|581150766|FG000|Overall Study|Withdrew consent|2|||
160933399|NCT00717769|581150767|FG001|Overall Study|Withdrew consent|2|||
160933400|NCT00717769|581150768|FG002|Overall Study|Withdrew consent|0|||
160933401|NCT02196324|581150772|FG000|Overall Study|Withdrawal by Subject|8|||
160933402|NCT02196324|581150773|FG001|Overall Study|Withdrawal by Subject|4|||
160933403|NCT02196324|581150772|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
160933404|NCT02196324|581150773|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
160933405|NCT02196324|581150772|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
160998390|NCT04771273|581378654|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
160998391|NCT04771273|581378655|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
160933406|NCT02196324|581150773|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
160933407|NCT02196324|581150772|FG000|Overall Study|Other|1|||
160933408|NCT02196324|581150773|FG001|Overall Study|Other|0|||
160933409|NCT01380184|581150774|FG000|Part 1 (19 Days)|Adverse Event|1|||
160933410|NCT01380184|581150774|FG000|Part 2|Adverse Event|5|||
160933411|NCT01380184|581150774|FG000|Part 2|Disease Progression|8|||
161342491|NCT04739800|582640210|FG002|Overall Study|Other Reason|5|||
160933412|NCT01380184|581150774|FG000|Part 2|Lost to Follow-up|1|||
160933413|NCT04327986|581150778|FG000|Overall Study|Physician Decision|2|||
160933414|NCT04327986|581150779|FG001|Overall Study|Physician Decision|0|||
160933415|NCT04327986|581150780|FG002|Overall Study|Physician Decision|0|||
160933416|NCT04327986|581150778|FG000|Overall Study|Death|1|||
160933417|NCT04327986|581150779|FG001|Overall Study|Death|0|||
160933418|NCT04327986|581150780|FG002|Overall Study|Death|0|||
160933419|NCT03350503|581150782|FG000|Overall Study|Adverse Event|5|||
160933420|NCT03350503|581150782|FG000|Overall Study|Withdrawal by Subject|5|||
160933421|NCT03350503|581150782|FG000|Overall Study|Continuation impossible due to move|4|||
160933422|NCT03350503|581150782|FG000|Overall Study|Physician Decision|3|||
160933423|NCT00262067|581150785|FG000|Overall Study|Death|190|||
160933424|NCT00262067|581150786|FG001|Overall Study|Death|89|||
160933425|NCT00262067|581150787|FG002|Overall Study|Death|186|||
160933426|NCT00262067|581150788|FG003|Overall Study|Death|99|||
160933427|NCT00262067|581150785|FG000|Overall Study|Lost to Follow-up|5|||
160933428|NCT00262067|581150786|FG001|Overall Study|Lost to Follow-up|4|||
160933429|NCT00262067|581150787|FG002|Overall Study|Lost to Follow-up|7|||
160933430|NCT00262067|581150788|FG003|Overall Study|Lost to Follow-up|5|||
160933431|NCT00262067|581150785|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
160933432|NCT00262067|581150786|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
160933433|NCT00262067|581150787|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
160933434|NCT00262067|581150788|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
160933435|NCT00262067|581150785|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
160933436|NCT00262067|581150786|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
160933437|NCT00262067|581150787|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
160933438|NCT00262067|581150788|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
160933439|NCT03829046|581150789|FG000|Overall Study|Withdrawal by Subject|1|||
160933440|NCT03829046|581150790|FG001|Overall Study|Withdrawal by Subject|0|||
160933441|NCT01581593|581152698|FG000|Overall Study|Withdrawal by Subject|1|||
160933442|NCT01101841|581152699|FG000|Overall Study|Adverse Event|15|||
160933443|NCT01101841|581152700|FG001|Overall Study|Adverse Event|15|||
160933444|NCT01101841|581152699|FG000|Overall Study|Lost to Follow-up|9|||
160933445|NCT01101841|581152700|FG001|Overall Study|Lost to Follow-up|3|||
160933446|NCT01101841|581152699|FG000|Overall Study|Withdrawal by Subject|21|||
160933447|NCT01101841|581152700|FG001|Overall Study|Withdrawal by Subject|40|||
160933448|NCT01101841|581152699|FG000|Overall Study|Protocol Violation|1|||
160933449|NCT01101841|581152700|FG001|Overall Study|Protocol Violation|1|||
160933450|NCT01101841|581152699|FG000|Overall Study|Physician Decision|0|||
160933451|NCT01101841|581152700|FG001|Overall Study|Physician Decision|2|||
160933452|NCT01101841|581152699|FG000|Overall Study|Lack of Efficacy|0|||
160933453|NCT01101841|581152700|FG001|Overall Study|Lack of Efficacy|2|||
160933454|NCT01101841|581152699|FG000|Overall Study|Other|0|||
160933455|NCT01101841|581152700|FG001|Overall Study|Other|1|||
160933456|NCT01101841|581152699|FG000|Overall Study|Suicidality Tracking Scale|3|||
160933457|NCT01101841|581152700|FG001|Overall Study|Suicidality Tracking Scale|1|||
160933458|NCT01101841|581152699|FG000|Overall Study|Eligibility Criteria|1|||
160933459|NCT01101841|581152700|FG001|Overall Study|Eligibility Criteria|2|||
160933460|NCT00653224|581152703|FG000|Overall Study|Adverse Event|2|||
160933461|NCT00653224|581152704|FG001|Overall Study|Adverse Event|1|||
160933462|NCT00653224|581152703|FG000|Overall Study|Lack of Efficacy|1|||
160933463|NCT00653224|581152704|FG001|Overall Study|Lack of Efficacy|2|||
160933464|NCT00653224|581152703|FG000|Overall Study|Loss of efficacy|1|||
160933465|NCT00653224|581152704|FG001|Overall Study|Loss of efficacy|0|||
160933466|NCT00653224|581152703|FG000|Overall Study|Lost to Follow-up|1|||
160933467|NCT00653224|581152704|FG001|Overall Study|Lost to Follow-up|0|||
160933468|NCT00653224|581152703|FG000|Overall Study|Other|2|||
160933469|NCT00653224|581152704|FG001|Overall Study|Other|4|||
160933470|NCT03756558|581152705|FG000|Overall Study|Death|1|||
160998392|NCT04771273|581378656|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
160933471|NCT03756558|581152705|FG000|Overall Study|Lost to Follow-up|2|||
160933472|NCT03756558|581152705|FG000|Overall Study|Withdrawal by Subject|2|||
160933473|NCT02896400|581152707|FG000|1 Month Follow-up|Lost to Follow-up|7|||
160933474|NCT02896400|581152708|FG001|1 Month Follow-up|Lost to Follow-up|7|||
160933475|NCT02896400|581152709|FG002|1 Month Follow-up|Lost to Follow-up|5|||
160933476|NCT02896400|581152710|FG003|1 Month Follow-up|Lost to Follow-up|8|||
160933477|NCT02896400|581152711|FG004|1 Month Follow-up|Lost to Follow-up|9|||
160933478|NCT02896400|581152712|FG005|1 Month Follow-up|Lost to Follow-up|6|||
160998393|NCT04771273|581378657|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
161342492|NCT04739800|582640211|FG003|Overall Study|Other Reason|4|||
160933479|NCT02896400|581152713|FG006|1 Month Follow-up|Lost to Follow-up|5|||
160933480|NCT02896400|581152714|FG007|1 Month Follow-up|Lost to Follow-up|6|||
160933481|NCT02896400|581152715|FG008|1 Month Follow-up|Lost to Follow-up|4|||
160933482|NCT02896400|581152716|FG009|1 Month Follow-up|Lost to Follow-up|7|||
160933483|NCT02896400|581152717|FG010|1 Month Follow-up|Lost to Follow-up|5|||
160933484|NCT02896400|581152718|FG011|1 Month Follow-up|Lost to Follow-up|5|||
160933485|NCT02896400|581152719|FG012|1 Month Follow-up|Lost to Follow-up|3|||
160933486|NCT02896400|581152720|FG013|1 Month Follow-up|Lost to Follow-up|4|||
160933487|NCT02896400|581152721|FG014|1 Month Follow-up|Lost to Follow-up|1|||
160933488|NCT02896400|581152722|FG015|1 Month Follow-up|Lost to Follow-up|2|||
160933489|NCT02896400|581152707|FG000|1 Month Follow-up|Death|0|||
160933490|NCT02896400|581152708|FG001|1 Month Follow-up|Death|0|||
160933491|NCT02896400|581152709|FG002|1 Month Follow-up|Death|0|||
160933492|NCT02896400|581152710|FG003|1 Month Follow-up|Death|0|||
160933493|NCT02896400|581152711|FG004|1 Month Follow-up|Death|0|||
160933494|NCT02896400|581152712|FG005|1 Month Follow-up|Death|0|||
160933495|NCT02896400|581152713|FG006|1 Month Follow-up|Death|0|||
160933496|NCT02896400|581152714|FG007|1 Month Follow-up|Death|0|||
160933497|NCT02896400|581152715|FG008|1 Month Follow-up|Death|0|||
160933498|NCT02896400|581152716|FG009|1 Month Follow-up|Death|0|||
160933499|NCT02896400|581152717|FG010|1 Month Follow-up|Death|0|||
160933500|NCT02896400|581152718|FG011|1 Month Follow-up|Death|0|||
160933501|NCT02896400|581152719|FG012|1 Month Follow-up|Death|0|||
160933502|NCT02896400|581152720|FG013|1 Month Follow-up|Death|0|||
160933503|NCT02896400|581152721|FG014|1 Month Follow-up|Death|0|||
160933504|NCT02896400|581152722|FG015|1 Month Follow-up|Death|1|||
160933505|NCT02896400|581152707|FG000|3 Month Follow-up|Lost to Follow-up|6|||
160933506|NCT02896400|581152708|FG001|3 Month Follow-up|Lost to Follow-up|3|||
160933507|NCT02896400|581152709|FG002|3 Month Follow-up|Lost to Follow-up|6|||
160933508|NCT02896400|581152710|FG003|3 Month Follow-up|Lost to Follow-up|11|||
160933509|NCT02896400|581152711|FG004|3 Month Follow-up|Lost to Follow-up|12|||
160933510|NCT02896400|581152712|FG005|3 Month Follow-up|Lost to Follow-up|6|||
160933511|NCT02896400|581152713|FG006|3 Month Follow-up|Lost to Follow-up|4|||
160933512|NCT02896400|581152714|FG007|3 Month Follow-up|Lost to Follow-up|3|||
160933513|NCT02896400|581152715|FG008|3 Month Follow-up|Lost to Follow-up|6|||
160933514|NCT02896400|581152716|FG009|3 Month Follow-up|Lost to Follow-up|5|||
160933515|NCT02896400|581152717|FG010|3 Month Follow-up|Lost to Follow-up|6|||
160933516|NCT02896400|581152718|FG011|3 Month Follow-up|Lost to Follow-up|6|||
160933517|NCT02896400|581152719|FG012|3 Month Follow-up|Lost to Follow-up|3|||
160933518|NCT02896400|581152720|FG013|3 Month Follow-up|Lost to Follow-up|5|||
160933519|NCT02896400|581152721|FG014|3 Month Follow-up|Lost to Follow-up|3|||
160933520|NCT02896400|581152722|FG015|3 Month Follow-up|Lost to Follow-up|2|||
160933521|NCT02896400|581152707|FG000|3 Month Follow-up|Death|0|||
160933522|NCT02896400|581152708|FG001|3 Month Follow-up|Death|0|||
160933523|NCT02896400|581152709|FG002|3 Month Follow-up|Death|0|||
160933524|NCT02896400|581152710|FG003|3 Month Follow-up|Death|0|||
160933525|NCT02896400|581152711|FG004|3 Month Follow-up|Death|0|||
160933526|NCT02896400|581152712|FG005|3 Month Follow-up|Death|0|||
160933527|NCT02896400|581152713|FG006|3 Month Follow-up|Death|0|||
160933528|NCT02896400|581152714|FG007|3 Month Follow-up|Death|0|||
160933529|NCT02896400|581152715|FG008|3 Month Follow-up|Death|0|||
160933530|NCT02896400|581152716|FG009|3 Month Follow-up|Death|0|||
160933531|NCT02896400|581152717|FG010|3 Month Follow-up|Death|0|||
160933532|NCT02896400|581152718|FG011|3 Month Follow-up|Death|0|||
160933533|NCT02896400|581152719|FG012|3 Month Follow-up|Death|0|||
160933534|NCT02896400|581152720|FG013|3 Month Follow-up|Death|1|||
160933535|NCT02896400|581152721|FG014|3 Month Follow-up|Death|1|||
160933536|NCT02896400|581152722|FG015|3 Month Follow-up|Death|0|||
160933537|NCT02896400|581152707|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933538|NCT02896400|581152708|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933539|NCT02896400|581152709|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933540|NCT02896400|581152710|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933541|NCT02896400|581152711|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933542|NCT02896400|581152712|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933543|NCT02896400|581152713|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
160933544|NCT02896400|581152714|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
160933545|NCT02896400|581152715|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933546|NCT02896400|581152716|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933547|NCT02896400|581152717|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933548|NCT02896400|581152718|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933549|NCT02896400|581152719|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
161264507|NCT02307266|582350639|FG002|Overall Study|Withdrawal by Subject|1|||
161264508|NCT02307266|582350637|FG000|Overall Study|Lost to Follow-up|3|||
161264509|NCT02307266|582350638|FG001|Overall Study|Lost to Follow-up|0|||
161264510|NCT02307266|582350639|FG002|Overall Study|Lost to Follow-up|0|||
161264511|NCT00793780|582350640|FG000|Overall Study|Withdrawal by Subject|2|||
160933550|NCT02896400|581152720|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
160933551|NCT02896400|581152721|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
160933552|NCT02896400|581152722|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
160933553|NCT02896400|581152707|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
160933554|NCT02896400|581152708|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160933555|NCT02896400|581152709|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
160933556|NCT02896400|581152710|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
160933557|NCT02896400|581152711|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
160933558|NCT02896400|581152712|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
161264512|NCT00793780|582350641|FG001|Overall Study|Withdrawal by Subject|1|||
160933559|NCT02896400|581152713|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160933560|NCT02896400|581152714|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
160933561|NCT02896400|581152715|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
160933562|NCT02896400|581152716|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
160933563|NCT02896400|581152717|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
160933564|NCT02896400|581152718|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
160933565|NCT02896400|581152719|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
160933566|NCT02896400|581152720|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
160933567|NCT02896400|581152721|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
160933568|NCT02896400|581152722|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
160933569|NCT02984020|581152723|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
160933570|NCT02984020|581152723|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
160933571|NCT02984020|581152723|FG000|Overall Study|Other significant protocol violation|2|||
160933572|NCT01700179|581152724|FG000|Overall Study|Physician Decision|2|||
160933573|NCT01896895|581152725|FG000|Double-blind MP|Physician Decision|0|||
160933574|NCT01896895|581152726|FG001|Double-blind MP|Physician Decision|0|||
160933575|NCT01896895|581152727|FG002|Double-blind MP|Physician Decision|1|||
160933576|NCT01896895|581152728|FG003|Double-blind MP|Physician Decision|0|||
160933577|NCT01896895|581152725|FG000|Double-blind MP|Withdrawal by Subject|0|||
160933578|NCT01896895|581152726|FG001|Double-blind MP|Withdrawal by Subject|2|||
160933579|NCT01896895|581152727|FG002|Double-blind MP|Withdrawal by Subject|1|||
160933580|NCT01896895|581152728|FG003|Double-blind MP|Withdrawal by Subject|0|||
160933581|NCT01896895|581152725|FG000|Double-blind MP|Lost to Follow-up|1|||
160933582|NCT01896895|581152726|FG001|Double-blind MP|Lost to Follow-up|0|||
160933583|NCT01896895|581152727|FG002|Double-blind MP|Lost to Follow-up|1|||
160933584|NCT01896895|581152728|FG003|Double-blind MP|Lost to Follow-up|0|||
160933585|NCT03277846|581152729|FG000|Overall Study|Inpatient stay too brief|12|||
160933586|NCT03277846|581152730|FG001|Overall Study|Inpatient stay too brief|11|||
160933587|NCT01207778|581152731|FG000|Overall Study|Lost to Follow-up|0|||
160933588|NCT01207778|581152732|FG001|Overall Study|Lost to Follow-up|3|||
160933589|NCT01207778|581152733|FG002|Overall Study|Lost to Follow-up|3|||
160933590|NCT01589822|581152736|FG000|Overall Study|Withdrawal by Subject|1|||
160933591|NCT01589822|581152737|FG001|Overall Study|Withdrawal by Subject|2|||
160933592|NCT01589822|581152738|FG002|Overall Study|Withdrawal by Subject|0|||
160933593|NCT01589822|581152736|FG000|Overall Study|Death|1|||
160933594|NCT01589822|581152737|FG001|Overall Study|Death|0|||
160933595|NCT01589822|581152738|FG002|Overall Study|Death|0|||
160933596|NCT01589822|581152736|FG000|Overall Study|Missed 90 day visit|2|||
160933597|NCT01589822|581152737|FG001|Overall Study|Missed 90 day visit|1|||
160933598|NCT01589822|581152738|FG002|Overall Study|Missed 90 day visit|1|||
160933599|NCT05168475|581152739|FG000|Period 1|Protocol Violation|1|||
160933600|NCT05168475|581152739|FG000|Period 1|IMP shortage|2|||
160933601|NCT05168475|581152739|FG000|Period 1|Not randomised|2|||
160933602|NCT05168475|581152739|FG000|Period 2|IMP shortage|1|||
160933603|NCT00646204|581152740|FG000|Overall Study|Adverse Event|3|||
160933604|NCT00646204|581152741|FG001|Overall Study|Adverse Event|0|||
160933605|NCT00646204|581152740|FG000|Overall Study|Withdrawal by Subject|1|||
160933606|NCT00646204|581152741|FG001|Overall Study|Withdrawal by Subject|0|||
160933607|NCT00773175|581152745|FG000|Overall Study|Adverse Event|2|||
160933608|NCT00773175|581152746|FG001|Overall Study|Adverse Event|0|||
160933609|NCT00773175|581152745|FG000|Overall Study|Consent Withdrawn|0|||
160933610|NCT00773175|581152746|FG001|Overall Study|Consent Withdrawn|2|||
160933611|NCT00503841|581152747|FG000|Overall Study|All screen failures|44|||
160933612|NCT01302964|581152748|FG000|Overall Study|Adverse Event|1|||
160933613|NCT01302964|581152749|FG001|Overall Study|Adverse Event|0|||
160933614|NCT01945489|581152750|FG000|Cycle 1|Adverse Event|2|||
160933615|NCT01945489|581152751|FG001|Cycle 1|Adverse Event|0|||
160933616|NCT01945489|581152750|FG000|Cycle 1|Lost to Follow-up|4|||
160998394|NCT04771273|581378654|FG000|Dose Escalation Period|Adverse Event|8|||
161264513|NCT00573157|582350642|FG000|Overall Study|Adverse Event|3|||
161264514|NCT00573157|582350643|FG001|Overall Study|Adverse Event|1|||
161264515|NCT00573157|582350642|FG000|Overall Study|Other|1|||
161264516|NCT00573157|582350643|FG001|Overall Study|Other|1|||
161264517|NCT00858143|582350644|FG000|Overall Study|Adverse Event|16|||
160933617|NCT01945489|581152751|FG001|Cycle 1|Lost to Follow-up|0|||
160998395|NCT04771273|581378655|FG001|Dose Escalation Period|Adverse Event|9|||
160933618|NCT01945489|581152750|FG000|Cycle 1|Personal Reasons|4|||
160933619|NCT01945489|581152751|FG001|Cycle 1|Personal Reasons|2|||
160933620|NCT01945489|581152750|FG000|Cycle 1|Protocol Violation|0|||
160933621|NCT01945489|581152751|FG001|Cycle 1|Protocol Violation|1|||
160933622|NCT01945489|581152750|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
160933623|NCT01945489|581152751|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
160933624|NCT01945489|581152750|FG000|Cycle 2|Adverse Event|1|||
160933625|NCT01945489|581152751|FG001|Cycle 2|Adverse Event|0|||
161264518|NCT00858143|582350644|FG000|Overall Study|Lack of Efficacy|4|||
160998396|NCT04771273|581378656|FG002|Dose Escalation Period|Adverse Event|12|||
160998397|NCT04771273|581378657|FG003|Dose Escalation Period|Adverse Event|2|||
160998398|NCT04771273|581378654|FG000|Maintenance Period|Other than listed|4|||
160998399|NCT04771273|581378655|FG001|Maintenance Period|Other than listed|2|||
160998400|NCT04771273|581378656|FG002|Maintenance Period|Other than listed|0|||
160998401|NCT04771273|581378657|FG003|Maintenance Period|Other than listed|3|||
160998402|NCT04771273|581378654|FG000|Maintenance Period|Burden of study procedures|1|||
160998403|NCT04771273|581378655|FG001|Maintenance Period|Burden of study procedures|0|||
160998404|NCT04771273|581378656|FG002|Maintenance Period|Burden of study procedures|0|||
160998405|NCT04771273|581378657|FG003|Maintenance Period|Burden of study procedures|0|||
160998406|NCT04771273|581378654|FG000|Maintenance Period|Change of residence|0|||
160998407|NCT04771273|581378655|FG001|Maintenance Period|Change of residence|1|||
160998408|NCT04771273|581378656|FG002|Maintenance Period|Change of residence|3|||
160998409|NCT04771273|581378657|FG003|Maintenance Period|Change of residence|0|||
160998410|NCT04771273|581378654|FG000|Maintenance Period|Perceived lack of efficacy|0|||
160998411|NCT04771273|581378655|FG001|Maintenance Period|Perceived lack of efficacy|0|||
160998412|NCT04771273|581378656|FG002|Maintenance Period|Perceived lack of efficacy|0|||
160998413|NCT04771273|581378657|FG003|Maintenance Period|Perceived lack of efficacy|1|||
160933626|NCT01945489|581152750|FG000|Cycle 2|Lost to Follow-up|0|||
160933627|NCT01945489|581152751|FG001|Cycle 2|Lost to Follow-up|1|||
160933628|NCT00145509|581152752|FG000|Overall Study|Adverse Event|10|||
160933629|NCT00145509|581152753|FG001|Overall Study|Adverse Event|3|||
160933630|NCT00145509|581152752|FG000|Overall Study|Lack of Efficacy|3|||
160933631|NCT00145509|581152753|FG001|Overall Study|Lack of Efficacy|1|||
160933632|NCT00145509|581152752|FG000|Overall Study|Lost to Follow-up|5|||
160933633|NCT00145509|581152753|FG001|Overall Study|Lost to Follow-up|9|||
160933634|NCT00145509|581152752|FG000|Overall Study|Withdrew Consent|2|||
160933635|NCT00145509|581152753|FG001|Overall Study|Withdrew Consent|7|||
160933636|NCT00145509|581152752|FG000|Overall Study|Reason not provided|2|||
160933637|NCT00145509|581152753|FG001|Overall Study|Reason not provided|1|||
160933638|NCT01982253|581152761|FG000|Overall Study|Withdrawal by Subject|1|||
160933639|NCT01982253|581152762|FG001|Overall Study|Withdrawal by Subject|0|||
160933640|NCT01982253|581152763|FG002|Overall Study|Withdrawal by Subject|0|||
160933641|NCT01982253|581152761|FG000|Overall Study|Study terminated by sponsor|1|||
160933642|NCT01982253|581152762|FG001|Overall Study|Study terminated by sponsor|4|||
160933643|NCT01982253|581152763|FG002|Overall Study|Study terminated by sponsor|4|||
160933644|NCT02789176|581152767|FG000|Overall Study|Death|0|||
160933645|NCT02789176|581152768|FG001|Overall Study|Death|0|||
160933646|NCT02789176|581152769|FG002|Overall Study|Death|3|||
160933647|NCT02789176|581152770|FG003|Overall Study|Death|0|||
160933648|NCT02789176|581152767|FG000|Overall Study|Withdrawal by Subject|0|||
160933649|NCT02789176|581152768|FG001|Overall Study|Withdrawal by Subject|0|||
160933650|NCT02789176|581152769|FG002|Overall Study|Withdrawal by Subject|1|||
160933651|NCT02789176|581152770|FG003|Overall Study|Withdrawal by Subject|0|||
160933652|NCT02789176|581152767|FG000|Overall Study|Lost to Follow-up|8|||
160933653|NCT02789176|581152768|FG001|Overall Study|Lost to Follow-up|2|||
160933654|NCT02789176|581152769|FG002|Overall Study|Lost to Follow-up|6|||
160933655|NCT02789176|581152770|FG003|Overall Study|Lost to Follow-up|1|||
160933656|NCT00596011|581152773|FG000|Overall Study|Withdrawal by Subject|2|||
160933657|NCT00596011|581152774|FG001|Overall Study|Withdrawal by Subject|3|||
160933658|NCT00596011|581152773|FG000|Overall Study|Adverse Event|11|||
160933659|NCT00596011|581152774|FG001|Overall Study|Adverse Event|7|||
160933660|NCT02347527|581152775|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
160933661|NCT02347527|581152776|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
160933662|NCT02347527|581152777|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
160933663|NCT02347527|581152778|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
160933664|NCT02347527|581152775|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
160933665|NCT02347527|581152776|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
160933666|NCT02347527|581152777|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
160933667|NCT02347527|581152778|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
160998414|NCT04771273|581378654|FG000|Maintenance Period|Adverse Event|4|||
160998415|NCT04771273|581378655|FG001|Maintenance Period|Adverse Event|5|||
160998416|NCT04771273|581378656|FG002|Maintenance Period|Adverse Event|5|||
160998417|NCT04771273|581378657|FG003|Maintenance Period|Adverse Event|0|||
160933668|NCT02347527|581152775|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
160933669|NCT02347527|581152776|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
160933670|NCT02347527|581152777|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
160933671|NCT02347527|581152778|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
160933672|NCT02347527|581152775|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
160933673|NCT02347527|581152776|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
160933674|NCT02347527|581152777|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
160998418|NCT05196737|581378658|FG000|Non-intervention Week|Lost to Follow-up|2|||
160933675|NCT02347527|581152778|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
160933676|NCT02347527|581152775|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
160933677|NCT02347527|581152776|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
160933678|NCT02347527|581152777|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
160933679|NCT02347527|581152778|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
160933680|NCT01466270|581152783|FG000|Overall Study|Withdrawal by Subject|4|||
160933681|NCT01466270|581152784|FG001|Overall Study|Withdrawal by Subject|1|||
160933682|NCT01466270|581152783|FG000|Overall Study|Physician Decision|1|||
160933683|NCT01466270|581152784|FG001|Overall Study|Physician Decision|0|||
160933684|NCT01466270|581152783|FG000|Overall Study|Lost to Follow-up|1|||
160933685|NCT01466270|581152784|FG001|Overall Study|Lost to Follow-up|3|||
160933686|NCT01466270|581152783|FG000|Overall Study|Progression|1|||
160933687|NCT01466270|581152784|FG001|Overall Study|Progression|0|||
160933688|NCT01466270|581152783|FG000|Overall Study|Toxicity|4|||
160933689|NCT01466270|581152784|FG001|Overall Study|Toxicity|1|||
160933690|NCT01466270|581152783|FG000|Overall Study|Multiple|1|||
160933691|NCT01466270|581152784|FG001|Overall Study|Multiple|1|||
160933692|NCT00749775|581152793|FG000|Overall Study|Protocol Violation|24|||
160933693|NCT00749775|581152793|FG000|Overall Study|Lost to Follow-up|36|||
160933694|NCT00749775|581152793|FG000|Overall Study|No visit after first day of treatment|44|||
160933695|NCT00749775|581152793|FG000|Overall Study|No drug administration|3|||
160933696|NCT03364049|581152801|FG000|Overall Study|Death|6|||
160933697|NCT03364049|581152802|FG001|Overall Study|Death|4|||
160933698|NCT03364049|581152803|FG002|Overall Study|Death|5|||
160933699|NCT03364049|581152804|FG003|Overall Study|Death|14|||
160933700|NCT03364049|581152801|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
160933701|NCT03364049|581152802|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
160933702|NCT03364049|581152803|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
160933703|NCT03364049|581152804|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
160933704|NCT03364049|581152801|FG000|Overall Study|Withdrawal by Subject|0|||
160933705|NCT03364049|581152802|FG001|Overall Study|Withdrawal by Subject|1|||
160933706|NCT03364049|581152803|FG002|Overall Study|Withdrawal by Subject|1|||
160933707|NCT03364049|581152804|FG003|Overall Study|Withdrawal by Subject|1|||
160933708|NCT01340976|581152805|FG000|Overall Study|Physician Decision|2|||
160933709|NCT01340976|581152806|FG001|Overall Study|Physician Decision|0|||
160933710|NCT01340976|581152807|FG002|Overall Study|Physician Decision|1|||
160933711|NCT01340976|581152808|FG003|Overall Study|Physician Decision|1|||
160933712|NCT01340976|581152809|FG004|Overall Study|Physician Decision|1|||
160933713|NCT01340976|581152810|FG005|Overall Study|Physician Decision|0|||
160933714|NCT01340976|581152805|FG000|Overall Study|Death|0|||
160933715|NCT01340976|581152806|FG001|Overall Study|Death|1|||
160933716|NCT01340976|581152807|FG002|Overall Study|Death|0|||
160933717|NCT01340976|581152808|FG003|Overall Study|Death|0|||
160933718|NCT01340976|581152809|FG004|Overall Study|Death|0|||
160933719|NCT01340976|581152810|FG005|Overall Study|Death|0|||
160933720|NCT01340976|581152805|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
160933721|NCT01340976|581152806|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933722|NCT01340976|581152807|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933723|NCT01340976|581152808|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933724|NCT01340976|581152809|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933725|NCT01340976|581152810|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
160933726|NCT01340976|581152805|FG000|Overall Study|Withdrawal by Subject|0|||
160933727|NCT01340976|581152806|FG001|Overall Study|Withdrawal by Subject|0|||
160933728|NCT01340976|581152807|FG002|Overall Study|Withdrawal by Subject|0|||
160933729|NCT01340976|581152808|FG003|Overall Study|Withdrawal by Subject|1|||
160933730|NCT01340976|581152809|FG004|Overall Study|Withdrawal by Subject|1|||
161264519|NCT00858143|582350644|FG000|Overall Study|Death|7|||
161264520|NCT00858143|582350644|FG000|Overall Study|Other|23|||
161264521|NCT02621034|582350649|FG000|Overall Study|Lost to Follow-up|3|||
161264522|NCT02621034|582350650|FG001|Overall Study|Lost to Follow-up|2|||
161264523|NCT02621034|582350651|FG002|Overall Study|Lost to Follow-up|5|||
161264524|NCT00974974|582350660|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
161264525|NCT00974974|582350661|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
161264526|NCT00974974|582350660|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
160933731|NCT01340976|581152810|FG005|Overall Study|Withdrawal by Subject|0|||
160933732|NCT01340976|581152805|FG000|Overall Study|Other anemia treatment|1|||
160933733|NCT01340976|581152806|FG001|Overall Study|Other anemia treatment|0|||
160933734|NCT01340976|581152807|FG002|Overall Study|Other anemia treatment|2|||
160933735|NCT01340976|581152808|FG003|Overall Study|Other anemia treatment|1|||
160933736|NCT01340976|581152809|FG004|Overall Study|Other anemia treatment|0|||
160933737|NCT01340976|581152810|FG005|Overall Study|Other anemia treatment|1|||
160933738|NCT01340976|581152805|FG000|Overall Study|Adverse Event|0|||
161264527|NCT00974974|582350661|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
160933739|NCT01340976|581152806|FG001|Overall Study|Adverse Event|1|||
160933740|NCT01340976|581152807|FG002|Overall Study|Adverse Event|0|||
160933741|NCT01340976|581152808|FG003|Overall Study|Adverse Event|0|||
160933742|NCT01340976|581152809|FG004|Overall Study|Adverse Event|0|||
160933743|NCT01340976|581152810|FG005|Overall Study|Adverse Event|0|||
160933744|NCT02953821|581152811|FG000|Overall Study|Adverse Event|0|||
160933745|NCT02953821|581152812|FG001|Overall Study|Adverse Event|4|||
160933746|NCT02953821|581152811|FG000|Overall Study|Death|1|||
160933747|NCT02953821|581152812|FG001|Overall Study|Death|0|||
160933748|NCT02953821|581152811|FG000|Overall Study|Progressive Disease|5|||
160933749|NCT02953821|581152812|FG001|Overall Study|Progressive Disease|1|||
160933750|NCT02953821|581152811|FG000|Overall Study|Lost to Follow-up|2|||
160933751|NCT02953821|581152812|FG001|Overall Study|Lost to Follow-up|0|||
160933752|NCT02953821|581152811|FG000|Overall Study|Physician Decision|1|||
160933753|NCT02953821|581152812|FG001|Overall Study|Physician Decision|1|||
160933754|NCT02953821|581152811|FG000|Overall Study|Withdrawal by Subject|3|||
160933755|NCT02953821|581152812|FG001|Overall Study|Withdrawal by Subject|3|||
160933756|NCT02953821|581152811|FG000|Overall Study|Change of address|0|||
160933757|NCT02953821|581152812|FG001|Overall Study|Change of address|1|||
160933758|NCT02953821|581152811|FG000|Overall Study|Lack of Efficacy|1|||
160933759|NCT02953821|581152812|FG001|Overall Study|Lack of Efficacy|0|||
160933760|NCT02953821|581152811|FG000|Overall Study|Out of state for indeterminate time|0|||
160933761|NCT02953821|581152812|FG001|Overall Study|Out of state for indeterminate time|1|||
160933762|NCT02953821|581152811|FG000|Overall Study|No improvement|0|||
160933763|NCT02953821|581152812|FG001|Overall Study|No improvement|1|||
160933764|NCT02953821|581152811|FG000|Overall Study|Refused follow-up visit|2|||
160933765|NCT02953821|581152812|FG001|Overall Study|Refused follow-up visit|1|||
160933766|NCT01067352|581152813|FG000|Overall Study|Withdrawal by Subject|1|||
160933767|NCT01067352|581152814|FG001|Overall Study|Withdrawal by Subject|2|||
160933768|NCT01067352|581152815|FG002|Overall Study|Withdrawal by Subject|1|||
160933769|NCT01067352|581152813|FG000|Overall Study|Physician Decision|0|||
160933770|NCT01067352|581152814|FG001|Overall Study|Physician Decision|1|||
160933771|NCT01067352|581152815|FG002|Overall Study|Physician Decision|0|||
160933772|NCT00976898|581152816|FG000|Overall Study|Protocol Violation|1|||
160933773|NCT00976898|581152816|FG000|Overall Study|Adverse Event|1|||
160933774|NCT00976898|581152816|FG000|Overall Study|Physician Decision|1|||
160933775|NCT00976898|581152816|FG000|Overall Study|Liver Transplant|1|||
160933776|NCT00976898|581152816|FG000|Overall Study|Progressive Disease|1|||
160933777|NCT03064126|581152817|FG000|Overall Study|Death|40|||
160933778|NCT03064126|581152818|FG001|Overall Study|Death|16|||
160933779|NCT03064126|581152819|FG002|Overall Study|Death|4|||
160933780|NCT03064126|581152820|FG003|Overall Study|Death|2|||
160933781|NCT03064126|581152817|FG000|Overall Study|Withdrawal by Subject|17|||
160933782|NCT03064126|581152818|FG001|Overall Study|Withdrawal by Subject|9|||
160933783|NCT03064126|581152819|FG002|Overall Study|Withdrawal by Subject|0|||
160933784|NCT03064126|581152820|FG003|Overall Study|Withdrawal by Subject|2|||
160933785|NCT03064126|581152817|FG000|Overall Study|Lost to Follow-up|7|||
160933786|NCT03064126|581152818|FG001|Overall Study|Lost to Follow-up|3|||
160933787|NCT03064126|581152819|FG002|Overall Study|Lost to Follow-up|0|||
160933788|NCT03064126|581152820|FG003|Overall Study|Lost to Follow-up|0|||
160933789|NCT03064126|581152817|FG000|Overall Study|Adverse Event|2|||
160933790|NCT03064126|581152818|FG001|Overall Study|Adverse Event|0|||
160933791|NCT03064126|581152819|FG002|Overall Study|Adverse Event|0|||
160933792|NCT03064126|581152820|FG003|Overall Study|Adverse Event|0|||
160933793|NCT03064126|581152817|FG000|Overall Study|Physician Decision|3|||
160933794|NCT03064126|581152818|FG001|Overall Study|Physician Decision|0|||
160933795|NCT03064126|581152819|FG002|Overall Study|Physician Decision|0|||
160933796|NCT03064126|581152820|FG003|Overall Study|Physician Decision|0|||
160933797|NCT03064126|581152817|FG000|Overall Study|Other reason for early termination|3|||
160933798|NCT03064126|581152818|FG001|Overall Study|Other reason for early termination|2|||
160933799|NCT03064126|581152819|FG002|Overall Study|Other reason for early termination|0|||
160933800|NCT03064126|581152820|FG003|Overall Study|Other reason for early termination|0|||
160933801|NCT03064126|581152817|FG000|Overall Study|Missed Visit|3|||
160933802|NCT03064126|581152818|FG001|Overall Study|Missed Visit|1|||
160933803|NCT03064126|581152819|FG002|Overall Study|Missed Visit|0|||
160933804|NCT03064126|581152820|FG003|Overall Study|Missed Visit|0|||
160933805|NCT04649151|581152821|FG000|Overall Study|Pregnancy|0|||
160933806|NCT04649151|581152822|FG001|Overall Study|Pregnancy|0|||
160933807|NCT04649151|581152823|FG002|Overall Study|Pregnancy|0|||
160933808|NCT04649151|581152824|FG003|Overall Study|Pregnancy|0|||
161264528|NCT00974974|582350660|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
160933809|NCT04649151|581152825|FG004|Overall Study|Pregnancy|3|||
160933810|NCT04649151|581152821|FG000|Overall Study|Physician Decision|10|||
160933811|NCT04649151|581152822|FG001|Overall Study|Physician Decision|0|||
160933812|NCT04649151|581152823|FG002|Overall Study|Physician Decision|0|||
160933813|NCT04649151|581152824|FG003|Overall Study|Physician Decision|1|||
160933814|NCT04649151|581152825|FG004|Overall Study|Physician Decision|1|||
160933815|NCT04649151|581152821|FG000|Overall Study|Protocol Deviation|25|||
160933816|NCT04649151|581152822|FG001|Overall Study|Protocol Deviation|3|||
160933817|NCT04649151|581152823|FG002|Overall Study|Protocol Deviation|0|||
160933818|NCT04649151|581152824|FG003|Overall Study|Protocol Deviation|0|||
160933819|NCT04649151|581152825|FG004|Overall Study|Protocol Deviation|0|||
160933820|NCT04649151|581152821|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
160933821|NCT04649151|581152822|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
160933822|NCT04649151|581152823|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
160933823|NCT04649151|581152824|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
160933824|NCT04649151|581152825|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
160933825|NCT04649151|581152821|FG000|Overall Study|Withdrawal by Subject|370|||
160933826|NCT04649151|581152822|FG001|Overall Study|Withdrawal by Subject|113|||
160933827|NCT04649151|581152823|FG002|Overall Study|Withdrawal by Subject|2|||
160933828|NCT04649151|581152824|FG003|Overall Study|Withdrawal by Subject|7|||
160933829|NCT04649151|581152825|FG004|Overall Study|Withdrawal by Subject|15|||
160933830|NCT04649151|581152821|FG000|Overall Study|Adverse Event|1|||
160933831|NCT04649151|581152822|FG001|Overall Study|Adverse Event|0|||
160933832|NCT04649151|581152823|FG002|Overall Study|Adverse Event|0|||
160933833|NCT04649151|581152824|FG003|Overall Study|Adverse Event|0|||
160933834|NCT04649151|581152825|FG004|Overall Study|Adverse Event|0|||
160933835|NCT04649151|581152821|FG000|Overall Study|Lost to Follow-up|256|||
160933836|NCT04649151|581152822|FG001|Overall Study|Lost to Follow-up|29|||
160933837|NCT04649151|581152823|FG002|Overall Study|Lost to Follow-up|10|||
160933838|NCT04649151|581152824|FG003|Overall Study|Lost to Follow-up|3|||
160933839|NCT04649151|581152825|FG004|Overall Study|Lost to Follow-up|6|||
160933840|NCT04649151|581152821|FG000|Overall Study|Other than specified|59|||
160933841|NCT04649151|581152822|FG001|Overall Study|Other than specified|294|||
160933842|NCT04649151|581152823|FG002|Overall Study|Other than specified|0|||
160933843|NCT04649151|581152824|FG003|Overall Study|Other than specified|0|||
160933844|NCT04649151|581152825|FG004|Overall Study|Other than specified|4|||
160933845|NCT04649151|581152821|FG000|Overall Study|Death|0|||
160933846|NCT04649151|581152822|FG001|Overall Study|Death|0|||
160933847|NCT04649151|581152823|FG002|Overall Study|Death|0|||
160933848|NCT04649151|581152824|FG003|Overall Study|Death|0|||
160933849|NCT04649151|581152825|FG004|Overall Study|Death|1|||
160933850|NCT03752619|581152826|FG000|Overall Study|Lost to Follow-up|2|||
160933851|NCT03752619|581152827|FG001|Overall Study|Lost to Follow-up|1|||
160933852|NCT03752619|581152826|FG000|Overall Study|Withdrawal by Subject|1|||
160933853|NCT03752619|581152827|FG001|Overall Study|Withdrawal by Subject|1|||
160933854|NCT03752619|581152826|FG000|Overall Study|Adverse Event|0|||
160933855|NCT03752619|581152827|FG001|Overall Study|Adverse Event|1|||
160933856|NCT03907683|581152833|FG000|Overall Study|Pregnancy|1|||
160933857|NCT03907683|581152833|FG000|Overall Study|Withdrawal by Subject|1|||
160933858|NCT03400332|581152834|FG000|Pre-Treatment|Other reasons|0|||
160933859|NCT03400332|581152835|FG001|Pre-Treatment|Other reasons|0|||
160933860|NCT03400332|581152836|FG002|Pre-Treatment|Other reasons|0|||
160933861|NCT03400332|581152837|FG003|Pre-Treatment|Other reasons|0|||
160933862|NCT03400332|581152838|FG004|Pre-Treatment|Other reasons|0|||
160933863|NCT03400332|581152839|FG005|Pre-Treatment|Other reasons|0|||
160933864|NCT03400332|581152840|FG006|Pre-Treatment|Other reasons|0|||
160933865|NCT03400332|581152841|FG007|Pre-Treatment|Other reasons|0|||
160933866|NCT03400332|581152842|FG008|Pre-Treatment|Other reasons|1|||
161264529|NCT00974974|582350661|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
161264530|NCT00974974|582350660|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
161264531|NCT00974974|582350661|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
161264532|NCT00974974|582350660|FG000|IR CD-LD Dose Adjustment|Various|0|||
161264533|NCT00974974|582350661|FG001|IR CD-LD Dose Adjustment|Various|9|||
160933867|NCT03400332|581152834|FG000|Pre-Treatment|No longer met study criteria|0|||
160933868|NCT03400332|581152835|FG001|Pre-Treatment|No longer met study criteria|0|||
160933869|NCT03400332|581152836|FG002|Pre-Treatment|No longer met study criteria|0|||
160933870|NCT03400332|581152837|FG003|Pre-Treatment|No longer met study criteria|0|||
160933871|NCT03400332|581152838|FG004|Pre-Treatment|No longer met study criteria|0|||
160933872|NCT03400332|581152839|FG005|Pre-Treatment|No longer met study criteria|0|||
161264534|NCT00974974|582350660|FG000|IPX066 Dose Conversion|Adverse Event|23|||
161264535|NCT00974974|582350661|FG001|IPX066 Dose Conversion|Adverse Event|0|||
161264536|NCT00974974|582350660|FG000|IPX066 Dose Conversion|Death|2|||
160933873|NCT03400332|581152840|FG006|Pre-Treatment|No longer met study criteria|0|||
160933874|NCT03400332|581152841|FG007|Pre-Treatment|No longer met study criteria|0|||
160933875|NCT03400332|581152842|FG008|Pre-Treatment|No longer met study criteria|1|||
160933876|NCT03400332|581152834|FG000|Pre-Treatment|Withdrawal by Subject|0|||
160933877|NCT03400332|581152835|FG001|Pre-Treatment|Withdrawal by Subject|0|||
160933878|NCT03400332|581152836|FG002|Pre-Treatment|Withdrawal by Subject|0|||
160933879|NCT03400332|581152837|FG003|Pre-Treatment|Withdrawal by Subject|0|||
161143770|NCT02190591|581909497|FG000|Overall Study|did not use peanut ball as instructed|0|||
160933880|NCT03400332|581152838|FG004|Pre-Treatment|Withdrawal by Subject|0|||
160933881|NCT03400332|581152839|FG005|Pre-Treatment|Withdrawal by Subject|0|||
160933882|NCT03400332|581152840|FG006|Pre-Treatment|Withdrawal by Subject|0|||
160933883|NCT03400332|581152841|FG007|Pre-Treatment|Withdrawal by Subject|0|||
160933884|NCT03400332|581152842|FG008|Pre-Treatment|Withdrawal by Subject|1|||
160933885|NCT03400332|581152834|FG000|Treatment|Participant withdrew consent|2|||
160933886|NCT03400332|581152835|FG001|Treatment|Participant withdrew consent|2|||
160933887|NCT03400332|581152836|FG002|Treatment|Participant withdrew consent|0|||
160933888|NCT03400332|581152837|FG003|Treatment|Participant withdrew consent|0|||
160933889|NCT03400332|581152838|FG004|Treatment|Participant withdrew consent|3|||
160933890|NCT03400332|581152839|FG005|Treatment|Participant withdrew consent|3|||
160933891|NCT03400332|581152840|FG006|Treatment|Participant withdrew consent|1|||
160933892|NCT03400332|581152841|FG007|Treatment|Participant withdrew consent|1|||
160933893|NCT03400332|581152842|FG008|Treatment|Participant withdrew consent|1|||
160933894|NCT03400332|581152834|FG000|Treatment|Other reasons|0|||
160933895|NCT03400332|581152835|FG001|Treatment|Other reasons|1|||
160933896|NCT03400332|581152836|FG002|Treatment|Other reasons|1|||
160933897|NCT03400332|581152837|FG003|Treatment|Other reasons|0|||
160933898|NCT03400332|581152838|FG004|Treatment|Other reasons|3|||
160933899|NCT03400332|581152839|FG005|Treatment|Other reasons|1|||
160933900|NCT03400332|581152840|FG006|Treatment|Other reasons|2|||
160933901|NCT03400332|581152841|FG007|Treatment|Other reasons|0|||
160933902|NCT03400332|581152842|FG008|Treatment|Other reasons|1|||
160933903|NCT03400332|581152834|FG000|Treatment|Lost to Follow-up|0|||
160933904|NCT03400332|581152835|FG001|Treatment|Lost to Follow-up|1|||
160933905|NCT03400332|581152836|FG002|Treatment|Lost to Follow-up|0|||
160933906|NCT03400332|581152837|FG003|Treatment|Lost to Follow-up|0|||
160933907|NCT03400332|581152838|FG004|Treatment|Lost to Follow-up|0|||
160933908|NCT03400332|581152839|FG005|Treatment|Lost to Follow-up|0|||
160933909|NCT03400332|581152840|FG006|Treatment|Lost to Follow-up|0|||
160933910|NCT03400332|581152841|FG007|Treatment|Lost to Follow-up|0|||
160933911|NCT03400332|581152842|FG008|Treatment|Lost to Follow-up|0|||
160933912|NCT03400332|581152834|FG000|Treatment|Death|3|||
160933913|NCT03400332|581152835|FG001|Treatment|Death|1|||
160933914|NCT03400332|581152836|FG002|Treatment|Death|2|||
160933915|NCT03400332|581152837|FG003|Treatment|Death|3|||
160933916|NCT03400332|581152838|FG004|Treatment|Death|6|||
160933917|NCT03400332|581152839|FG005|Treatment|Death|2|||
160933918|NCT03400332|581152840|FG006|Treatment|Death|1|||
160933919|NCT03400332|581152841|FG007|Treatment|Death|3|||
160933920|NCT03400332|581152842|FG008|Treatment|Death|6|||
160933921|NCT00048542|581152843|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160933922|NCT00048542|581152844|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
160933923|NCT00048542|581152845|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
160933924|NCT00048542|581152846|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160933925|NCT00048542|581152847|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160933926|NCT00048542|581152848|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
160933927|NCT00048542|581152849|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
160933928|NCT00048542|581152850|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
160933929|NCT00048542|581152843|FG000|Double-Blind Phase|Protocol Violation|0|||
160933930|NCT00048542|581152844|FG001|Double-Blind Phase|Protocol Violation|0|||
160933931|NCT00048542|581152845|FG002|Double-Blind Phase|Protocol Violation|1|||
160933932|NCT00048542|581152846|FG003|Double-Blind Phase|Protocol Violation|0|||
160933933|NCT00048542|581152847|FG004|Double-Blind Phase|Protocol Violation|0|||
160933934|NCT00048542|581152848|FG005|Double-Blind Phase|Protocol Violation|0|||
160933935|NCT00048542|581152849|FG006|Double-Blind Phase|Protocol Violation|0|||
160933936|NCT00048542|581152850|FG007|Double-Blind Phase|Protocol Violation|0|||
160933937|NCT00048542|581152843|FG000|Double-Blind Phase|Sponsor request or decision|2|||
160933938|NCT00048542|581152844|FG001|Double-Blind Phase|Sponsor request or decision|0|||
160933939|NCT00048542|581152845|FG002|Double-Blind Phase|Sponsor request or decision|0|||
160933940|NCT00048542|581152846|FG003|Double-Blind Phase|Sponsor request or decision|0|||
160933941|NCT00048542|581152847|FG004|Double-Blind Phase|Sponsor request or decision|0|||
160933942|NCT00048542|581152848|FG005|Double-Blind Phase|Sponsor request or decision|0|||
160933943|NCT00048542|581152849|FG006|Double-Blind Phase|Sponsor request or decision|0|||
160933944|NCT00048542|581152850|FG007|Double-Blind Phase|Sponsor request or decision|0|||
160933945|NCT00048542|581152843|FG000|Double-Blind Phase|Randomized in error|1|||
160933946|NCT00048542|581152844|FG001|Double-Blind Phase|Randomized in error|0|||
160933947|NCT00048542|581152845|FG002|Double-Blind Phase|Randomized in error|0|||
160933948|NCT00048542|581152846|FG003|Double-Blind Phase|Randomized in error|0|||
160933949|NCT00048542|581152847|FG004|Double-Blind Phase|Randomized in error|0|||
160933950|NCT00048542|581152848|FG005|Double-Blind Phase|Randomized in error|0|||
160933951|NCT00048542|581152849|FG006|Double-Blind Phase|Randomized in error|0|||
160933952|NCT00048542|581152850|FG007|Double-Blind Phase|Randomized in error|0|||
160933953|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933954|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933955|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933956|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933957|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
160933958|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
160933959|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933960|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
160933961|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933962|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933963|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933964|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933965|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933966|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
160933967|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933968|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
160933969|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933970|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933971|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933972|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933973|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
160933974|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
160933975|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933976|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
160933977|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
160933978|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
160933979|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
160933980|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
160933981|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
160933982|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
160933983|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
160933984|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
160933985|NCT00048542|581152843|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933986|NCT00048542|581152844|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933987|NCT00048542|581152845|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933988|NCT00048542|581152846|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933989|NCT00048542|581152847|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
160933990|NCT00048542|581152848|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
160933991|NCT00048542|581152849|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933992|NCT00048542|581152850|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
160933993|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933994|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933995|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933996|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933997|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933998|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
160933999|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
160934000|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
160934001|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934002|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934003|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934004|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934005|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934006|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
160934007|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
160934008|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
160934009|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934010|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934011|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934012|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934013|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
160934014|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
161143771|NCT02190591|581909498|FG001|Overall Study|did not use peanut ball as instructed|2|||
161143772|NCT02190591|581909497|FG000|Overall Study|face presentation so she was ineligible|0|||
160934015|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
160934016|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
160934017|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934018|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934019|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161143773|NCT02190591|581909498|FG001|Overall Study|face presentation so she was ineligible|1|||
160934020|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934021|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
160934022|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
161143774|NCT00072189|581909501|FG000|Overall Study|Withdrawal by Subject|1|||
161143775|NCT01933672|581909502|FG000|Metformin Run-in Period|Adverse Event|1|||
160934023|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
160934024|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
160934025|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934026|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934027|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934028|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934029|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934030|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
160934031|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
160934032|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
160934033|NCT00048542|581152843|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934034|NCT00048542|581152844|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934035|NCT00048542|581152845|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934036|NCT00048542|581152846|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934037|NCT00048542|581152847|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934038|NCT00048542|581152848|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
160934039|NCT00048542|581152849|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
160934040|NCT00048542|581152850|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
160934041|NCT01455012|581152854|FG000|Overall Study|Adverse Event|0|||
160934042|NCT01455012|581152855|FG001|Overall Study|Adverse Event|2|||
160934043|NCT01455012|581152854|FG000|Overall Study|Lack of Efficacy|6|||
160934044|NCT01455012|581152855|FG001|Overall Study|Lack of Efficacy|1|||
160934045|NCT01455012|581152854|FG000|Overall Study|Withdrawal by Subject|3|||
160934046|NCT01455012|581152855|FG001|Overall Study|Withdrawal by Subject|1|||
160934047|NCT01455012|581152854|FG000|Overall Study|Unknown reason|2|||
160934048|NCT01455012|581152855|FG001|Overall Study|Unknown reason|0|||
160934049|NCT00692770|581152859|FG000|Overall Study|Protocol Violation|2|||
160934050|NCT00692770|581152860|FG001|Overall Study|Protocol Violation|7|||
160934051|NCT00692770|581152859|FG000|Overall Study|Withdrawal by Subject|97|||
160934052|NCT00692770|581152860|FG001|Overall Study|Withdrawal by Subject|36|||
160934053|NCT00692770|581152859|FG000|Overall Study|Adverse Event|136|||
160934054|NCT00692770|581152860|FG001|Overall Study|Adverse Event|41|||
160934055|NCT00692770|581152859|FG000|Overall Study|Death|10|||
160934056|NCT00692770|581152860|FG001|Overall Study|Death|5|||
160934057|NCT00692770|581152859|FG000|Overall Study|Lost to Follow-up|7|||
160934058|NCT00692770|581152860|FG001|Overall Study|Lost to Follow-up|3|||
160934059|NCT00692770|581152859|FG000|Overall Study|Non-compliant with study medication|11|||
160934060|NCT00692770|581152860|FG001|Overall Study|Non-compliant with study medication|5|||
160934061|NCT00692770|581152859|FG000|Overall Study|Progression by clinical judgment|2|||
160934062|NCT00692770|581152860|FG001|Overall Study|Progression by clinical judgment|3|||
160934063|NCT00692770|581152859|FG000|Overall Study|Physician decision not protocol driven|10|||
160934064|NCT00692770|581152860|FG001|Overall Study|Physician decision not protocol driven|14|||
160934065|NCT00692770|581152859|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
160934066|NCT00692770|581152860|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
160934067|NCT00692770|581152859|FG000|Overall Study|Protocol driven decision point|3|||
160934068|NCT00692770|581152860|FG001|Overall Study|Protocol driven decision point|7|||
160934069|NCT00692770|581152859|FG000|Overall Study|Completed all planned assessments|79|||
160934070|NCT00692770|581152860|FG001|Overall Study|Completed all planned assessments|101|||
160934071|NCT00692770|581152859|FG000|Overall Study|Radiological and clinical progression|8|||
160934072|NCT00692770|581152860|FG001|Overall Study|Radiological and clinical progression|8|||
160934073|NCT00692770|581152859|FG000|Overall Study|Clinical endpoint reached|16|||
160934074|NCT00692770|581152860|FG001|Overall Study|Clinical endpoint reached|43|||
160934075|NCT00692770|581152859|FG000|Overall Study|Study terminated by sponsor|2|||
160934076|NCT00692770|581152860|FG001|Overall Study|Study terminated by sponsor|2|||
160934077|NCT00692770|581152859|FG000|Overall Study|Randomized but not treated|3|||
160934078|NCT00692770|581152860|FG001|Overall Study|Randomized but not treated|4|||
160934079|NCT04248816|581152861|FG000|Overall Study|Ineligible post-randomization|7|||
160934080|NCT04248816|581152862|FG001|Overall Study|Ineligible post-randomization|21|||
160934081|NCT04248816|581152863|FG002|Overall Study|Ineligible post-randomization|25|||
160934082|NCT01399593|581152869|FG000|Overall Study|Physician Decision|1|||
160934083|NCT01399593|581152870|FG001|Overall Study|Physician Decision|0|||
160934084|NCT01399593|581152869|FG000|Overall Study|Adverse Event|1|||
160934085|NCT01399593|581152870|FG001|Overall Study|Adverse Event|0|||
160934086|NCT01399593|581152869|FG000|Overall Study|Death|1|||
160934087|NCT01399593|581152870|FG001|Overall Study|Death|1|||
160934088|NCT01399593|581152869|FG000|Overall Study|Transplantectomy|0|||
160934089|NCT01399593|581152870|FG001|Overall Study|Transplantectomy|1|||
160934090|NCT00344773|581152872|FG000|Overall Study|Adverse Event|2|||
160934091|NCT00344773|581152872|FG000|Overall Study|Objective Disease Progression|16|||
160934092|NCT00344773|581152872|FG000|Overall Study|Withdrawal by Subject|1|||
160934093|NCT00344773|581152872|FG000|Overall Study|Not Eligible for the study|2|||
160934094|NCT02849548|581152880|FG000|Overall Study|Lost to Follow-up|1|||
160934095|NCT02849548|581152881|FG001|Overall Study|Lost to Follow-up|2|||
160998419|NCT05196737|581378658|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
160998420|NCT00462943|581378659|FG000|Overall Study|Failure to achieve a response|5|||
160998421|NCT00462943|581378660|FG001|Overall Study|Failure to achieve a response|5|||
160998422|NCT00462943|581378661|FG002|Overall Study|Failure to achieve a response|1|||
160998423|NCT00462943|581378659|FG000|Overall Study|Adverse Event|6|||
160998424|NCT00462943|581378660|FG001|Overall Study|Adverse Event|4|||
160998425|NCT00462943|581378661|FG002|Overall Study|Adverse Event|1|||
160998426|NCT00462943|581378659|FG000|Overall Study|Protocol Violation|1|||
160934096|NCT02849548|581152880|FG000|Overall Study|Protocol Violation|1|||
160934097|NCT02849548|581152881|FG001|Overall Study|Protocol Violation|0|||
160934098|NCT00714259|581152882|FG000|Overall Study|Death|2|||
160934099|NCT04804813|581152884|FG000|Overall Study|Protocol Violation|2|||
160934100|NCT04804813|581152885|FG001|Overall Study|Protocol Violation|0|||
160934101|NCT04804813|581152884|FG000|Overall Study|Withdrawal by Subject|1|||
160934102|NCT04804813|581152885|FG001|Overall Study|Withdrawal by Subject|0|||
160934103|NCT02357147|581152886|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
160934104|NCT02357147|581152887|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
160934105|NCT02357147|581152886|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
160934106|NCT02357147|581152887|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
160934107|NCT02357147|581152886|FG000|Combination Treatment Phase|Investigator Discretion|1|||
160934108|NCT02357147|581152887|FG001|Combination Treatment Phase|Investigator Discretion|1|||
160934109|NCT02357147|581152886|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
160934110|NCT02357147|581152887|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
160934111|NCT02357147|581152886|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
160934112|NCT02357147|581152887|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
160934113|NCT02357147|581152886|FG000|Combination Treatment Phase|Adverse Event|12|||
160934114|NCT02357147|581152887|FG001|Combination Treatment Phase|Adverse Event|4|||
160934115|NCT02357147|581152886|FG000|Combination Treatment Phase|Death|1|||
160934116|NCT02357147|581152887|FG001|Combination Treatment Phase|Death|1|||
160934117|NCT02357147|581152886|FG000|Combination Treatment Phase|Sponsor Decision|0|||
160934118|NCT02357147|581152887|FG001|Combination Treatment Phase|Sponsor Decision|12|||
160934119|NCT02357147|581152886|FG000|Combination Treatment Phase|Other|1|||
160934120|NCT02357147|581152887|FG001|Combination Treatment Phase|Other|0|||
160934121|NCT02357147|581152886|FG000|Combination Treatment Phase|Not treated|0|||
160934122|NCT02357147|581152887|FG001|Combination Treatment Phase|Not treated|2|||
160934123|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
160934124|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
160934125|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160934126|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
160934127|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
160934128|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
160934129|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Adverse Event|0|||
160934130|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Adverse Event|3|||
160934131|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
160934132|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
160934133|NCT02357147|581152886|FG000|Maintenance Treatment Phase|Not Treated|1|||
160934134|NCT02357147|581152887|FG001|Maintenance Treatment Phase|Not Treated|0|||
160934135|NCT02103478|581154964|FG000|Overall Study|Adverse Event|0|||
160934136|NCT02103478|581154965|FG001|Overall Study|Adverse Event|0|||
160934137|NCT02103478|581154966|FG002|Overall Study|Adverse Event|1|||
160934138|NCT02103478|581154967|FG003|Overall Study|Adverse Event|1|||
160934139|NCT02103478|581154968|FG004|Overall Study|Adverse Event|2|||
160934140|NCT02103478|581154969|FG005|Overall Study|Adverse Event|1|||
160934141|NCT02103478|581154970|FG006|Overall Study|Adverse Event|0|||
160934142|NCT02103478|581154971|FG007|Overall Study|Adverse Event|0|||
160934143|NCT02103478|581154972|FG008|Overall Study|Adverse Event|0|||
160934144|NCT02103478|581154964|FG000|Overall Study|Death|2|||
160934145|NCT02103478|581154965|FG001|Overall Study|Death|2|||
160934146|NCT02103478|581154966|FG002|Overall Study|Death|1|||
160934147|NCT02103478|581154967|FG003|Overall Study|Death|1|||
160934148|NCT02103478|581154968|FG004|Overall Study|Death|5|||
160934149|NCT02103478|581154969|FG005|Overall Study|Death|15|||
160934150|NCT02103478|581154970|FG006|Overall Study|Death|14|||
160998427|NCT00462943|581378660|FG001|Overall Study|Protocol Violation|0|||
160998428|NCT00462943|581378661|FG002|Overall Study|Protocol Violation|0|||
160998429|NCT00462943|581378659|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
160998430|NCT00462943|581378660|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
160934151|NCT02103478|581154971|FG007|Overall Study|Death|10|||
160934152|NCT02103478|581154972|FG008|Overall Study|Death|11|||
160934153|NCT02103478|581154964|FG000|Overall Study|Progressive Disease|2|||
160934154|NCT02103478|581154965|FG001|Overall Study|Progressive Disease|1|||
160934155|NCT02103478|581154966|FG002|Overall Study|Progressive Disease|2|||
160934156|NCT02103478|581154967|FG003|Overall Study|Progressive Disease|0|||
160998431|NCT00462943|581378661|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
160934157|NCT02103478|581154968|FG004|Overall Study|Progressive Disease|9|||
160934158|NCT02103478|581154969|FG005|Overall Study|Progressive Disease|1|||
160934159|NCT02103478|581154970|FG006|Overall Study|Progressive Disease|2|||
160934160|NCT02103478|581154971|FG007|Overall Study|Progressive Disease|0|||
160934161|NCT02103478|581154972|FG008|Overall Study|Progressive Disease|1|||
160934162|NCT02103478|581154964|FG000|Overall Study|Withdrawal by Subject|2|||
160934163|NCT02103478|581154965|FG001|Overall Study|Withdrawal by Subject|0|||
160934164|NCT02103478|581154966|FG002|Overall Study|Withdrawal by Subject|0|||
160934165|NCT02103478|581154967|FG003|Overall Study|Withdrawal by Subject|4|||
160934166|NCT02103478|581154968|FG004|Overall Study|Withdrawal by Subject|0|||
160934167|NCT02103478|581154969|FG005|Overall Study|Withdrawal by Subject|0|||
160934168|NCT02103478|581154970|FG006|Overall Study|Withdrawal by Subject|1|||
160934169|NCT02103478|581154971|FG007|Overall Study|Withdrawal by Subject|1|||
160934170|NCT02103478|581154972|FG008|Overall Study|Withdrawal by Subject|0|||
160934171|NCT02103478|581154964|FG000|Overall Study|Lost to Follow-up|0|||
160934172|NCT02103478|581154965|FG001|Overall Study|Lost to Follow-up|0|||
160934173|NCT02103478|581154966|FG002|Overall Study|Lost to Follow-up|0|||
160934174|NCT02103478|581154967|FG003|Overall Study|Lost to Follow-up|0|||
160934175|NCT02103478|581154968|FG004|Overall Study|Lost to Follow-up|0|||
160934176|NCT02103478|581154969|FG005|Overall Study|Lost to Follow-up|0|||
160934177|NCT02103478|581154970|FG006|Overall Study|Lost to Follow-up|0|||
160934178|NCT02103478|581154971|FG007|Overall Study|Lost to Follow-up|1|||
160934179|NCT02103478|581154972|FG008|Overall Study|Lost to Follow-up|0|||
160934180|NCT02103478|581154964|FG000|Overall Study|Other|1|||
160934181|NCT02103478|581154965|FG001|Overall Study|Other|3|||
160934182|NCT02103478|581154966|FG002|Overall Study|Other|2|||
160934183|NCT02103478|581154967|FG003|Overall Study|Other|0|||
160934184|NCT02103478|581154968|FG004|Overall Study|Other|3|||
160934185|NCT02103478|581154969|FG005|Overall Study|Other|8|||
160934186|NCT02103478|581154970|FG006|Overall Study|Other|8|||
160934187|NCT02103478|581154971|FG007|Overall Study|Other|4|||
160934188|NCT02103478|581154972|FG008|Overall Study|Other|2|||
160934189|NCT03219333|581154973|FG000|Overall Study|Withdrawal by Subject|9|||
160934190|NCT03219333|581154974|FG001|Overall Study|Withdrawal by Subject|4|||
160934191|NCT03219333|581154973|FG000|Overall Study|Lost to Follow-up|1|||
160934192|NCT03219333|581154974|FG001|Overall Study|Lost to Follow-up|1|||
160934193|NCT03219333|581154973|FG000|Overall Study|Death|104|||
160934194|NCT03219333|581154974|FG001|Overall Study|Death|72|||
160934195|NCT03219333|581154973|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
160934196|NCT03219333|581154974|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
160934197|NCT03219333|581154973|FG000|Overall Study|Other|2|||
160934198|NCT03219333|581154974|FG001|Overall Study|Other|2|||
160934199|NCT00723606|581154975|FG000|Overall Study|Adverse Event|2|||
160934200|NCT00723606|581154976|FG001|Overall Study|Adverse Event|5|||
160934201|NCT00723606|581154975|FG000|Overall Study|Other|2|||
160934202|NCT00723606|581154976|FG001|Overall Study|Other|0|||
160934203|NCT00723606|581154975|FG000|Overall Study|Withdrawal by Subject|0|||
161264537|NCT00974974|582350661|FG001|IPX066 Dose Conversion|Death|0|||
161264538|NCT00974974|582350660|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
161264539|NCT00974974|582350661|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
161264540|NCT00974974|582350660|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
160934204|NCT00723606|581154976|FG001|Overall Study|Withdrawal by Subject|2|||
160934205|NCT02566759|581154977|FG000|All Parts|Withdrawal by Subject|0|||
160934206|NCT02566759|581154978|FG001|All Parts|Withdrawal by Subject|1|||
160934207|NCT02566759|581154979|FG002|All Parts|Withdrawal by Subject|0|||
160934208|NCT02566759|581154980|FG003|All Parts|Withdrawal by Subject|0|||
160934209|NCT02566759|581154981|FG004|All Parts|Withdrawal by Subject|0|||
160934210|NCT02566759|581154982|FG005|All Parts|Withdrawal by Subject|0|||
160934211|NCT02566759|581154983|FG006|All Parts|Withdrawal by Subject|0|||
160934212|NCT02566759|581154984|FG007|All Parts|Withdrawal by Subject|0|||
160934213|NCT02566759|581154985|FG008|All Parts|Withdrawal by Subject|0|||
161264541|NCT00974974|582350661|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
160934214|NCT02566759|581154986|FG009|All Parts|Withdrawal by Subject|0|||
161264542|NCT00974974|582350660|FG000|IPX066 Dose Conversion|Various|3|||
161264543|NCT00974974|582350661|FG001|IPX066 Dose Conversion|Various|0|||
160934215|NCT02566759|581154987|FG010|All Parts|Withdrawal by Subject|0|||
160934216|NCT02566759|581154988|FG011|All Parts|Withdrawal by Subject|0|||
160934217|NCT02566759|581154989|FG012|All Parts|Withdrawal by Subject|0|||
160934218|NCT02566759|581154990|FG013|All Parts|Withdrawal by Subject|0|||
160934219|NCT02566759|581154991|FG014|All Parts|Withdrawal by Subject|0|||
160934220|NCT02566759|581154992|FG015|All Parts|Withdrawal by Subject|0|||
160934221|NCT02566759|581154993|FG016|All Parts|Withdrawal by Subject|0|||
160934222|NCT02566759|581154977|FG000|All Parts|Adverse Event|0|||
160934223|NCT02566759|581154978|FG001|All Parts|Adverse Event|0|||
160934224|NCT02566759|581154979|FG002|All Parts|Adverse Event|0|||
160934225|NCT02566759|581154980|FG003|All Parts|Adverse Event|0|||
160934226|NCT02566759|581154981|FG004|All Parts|Adverse Event|0|||
160934227|NCT02566759|581154982|FG005|All Parts|Adverse Event|0|||
160934228|NCT02566759|581154983|FG006|All Parts|Adverse Event|0|||
160934229|NCT02566759|581154984|FG007|All Parts|Adverse Event|0|||
160934230|NCT02566759|581154985|FG008|All Parts|Adverse Event|0|||
160934231|NCT02566759|581154986|FG009|All Parts|Adverse Event|0|||
160934232|NCT02566759|581154987|FG010|All Parts|Adverse Event|0|||
160934233|NCT02566759|581154988|FG011|All Parts|Adverse Event|0|||
160934234|NCT02566759|581154989|FG012|All Parts|Adverse Event|1|||
160934235|NCT02566759|581154990|FG013|All Parts|Adverse Event|3|||
160934236|NCT02566759|581154991|FG014|All Parts|Adverse Event|0|||
160934237|NCT02566759|581154992|FG015|All Parts|Adverse Event|0|||
160934238|NCT02566759|581154993|FG016|All Parts|Adverse Event|0|||
160934239|NCT02566759|581154977|FG000|All Parts|Other|0|||
160934240|NCT02566759|581154978|FG001|All Parts|Other|0|||
160934241|NCT02566759|581154979|FG002|All Parts|Other|0|||
160934242|NCT02566759|581154980|FG003|All Parts|Other|0|||
160934243|NCT02566759|581154981|FG004|All Parts|Other|0|||
160934244|NCT02566759|581154982|FG005|All Parts|Other|0|||
160934245|NCT02566759|581154983|FG006|All Parts|Other|0|||
160934246|NCT02566759|581154984|FG007|All Parts|Other|0|||
160934247|NCT02566759|581154985|FG008|All Parts|Other|0|||
160934248|NCT02566759|581154986|FG009|All Parts|Other|0|||
160934249|NCT02566759|581154987|FG010|All Parts|Other|0|||
160934250|NCT02566759|581154988|FG011|All Parts|Other|0|||
160934251|NCT02566759|581154989|FG012|All Parts|Other|0|||
160934252|NCT02566759|581154990|FG013|All Parts|Other|2|||
160934253|NCT02566759|581154991|FG014|All Parts|Other|0|||
160934254|NCT02566759|581154992|FG015|All Parts|Other|0|||
160934255|NCT02566759|581154993|FG016|All Parts|Other|0|||
160934256|NCT02566759|581154977|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934257|NCT02566759|581154978|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934258|NCT02566759|581154979|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934259|NCT02566759|581154980|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934260|NCT02566759|581154981|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934261|NCT02566759|581154982|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934262|NCT02566759|581154983|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934263|NCT02566759|581154984|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934264|NCT02566759|581154985|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934265|NCT02566759|581154986|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934266|NCT02566759|581154987|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934267|NCT02566759|581154988|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934268|NCT02566759|581154989|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934269|NCT02566759|581154990|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934270|NCT02566759|581154991|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934271|NCT02566759|581154992|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
160934272|NCT02566759|581154993|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
160934273|NCT01096784|581154994|FG000|Overall Study|Withdrawal by Subject|2|||
160934274|NCT01096784|581154995|FG001|Overall Study|Withdrawal by Subject|1|||
160934275|NCT01096784|581154994|FG000|Overall Study|Adverse Event|11|||
160934276|NCT01096784|581154995|FG001|Overall Study|Adverse Event|9|||
160934277|NCT01096784|581154994|FG000|Overall Study|Protocol Deviation|2|||
160934278|NCT01096784|581154995|FG001|Overall Study|Protocol Deviation|2|||
160934279|NCT01096784|581154994|FG000|Overall Study|Administrative Decision|0|||
160934280|NCT01096784|581154995|FG001|Overall Study|Administrative Decision|1|||
160934281|NCT01096784|581154994|FG000|Overall Study|Other Unspecified|0|||
160934282|NCT01096784|581154995|FG001|Overall Study|Other Unspecified|1|||
160934283|NCT05107128|581154996|FG000|Overall Study|Adverse Event|2|||
160934284|NCT05107128|581154997|FG001|Overall Study|Adverse Event|0|||
160934285|NCT05107128|581154996|FG000|Overall Study|Withdrawal by Subject|3|||
160934286|NCT05107128|581154997|FG001|Overall Study|Withdrawal by Subject|3|||
160934287|NCT05107128|581154996|FG000|Overall Study|Withdrawal of Consent|0|||
160934288|NCT05107128|581154997|FG001|Overall Study|Withdrawal of Consent|1|||
160934289|NCT05107128|581154996|FG000|Overall Study|Reason Not Specified|2|||
160934290|NCT05107128|581154997|FG001|Overall Study|Reason Not Specified|0|||
160934291|NCT03761628|581154998|FG000|Overall Study|Withdrawal by Subject|3|||
160934292|NCT03761628|581154998|FG000|Overall Study|Physician Decision|1|||
160934293|NCT03761628|581154998|FG000|Overall Study|Pregnancy|1|||
160934294|NCT03761628|581154998|FG000|Overall Study|Lost to Follow-up|1|||
160934295|NCT01470469|581155001|FG000|Overall Study|Withdrawal by Subject|4|||
160934296|NCT01470469|581155002|FG001|Overall Study|Withdrawal by Subject|6|||
160934297|NCT01470469|581155001|FG000|Overall Study|Lack of Efficacy|1|||
160934298|NCT01470469|581155002|FG001|Overall Study|Lack of Efficacy|7|||
160934299|NCT01470469|581155001|FG000|Overall Study|Adverse Event|0|||
160934300|NCT01470469|581155002|FG001|Overall Study|Adverse Event|7|||
160934301|NCT01470469|581155001|FG000|Overall Study|Lost to Follow-up|2|||
160934302|NCT01470469|581155002|FG001|Overall Study|Lost to Follow-up|2|||
160934303|NCT01470469|581155001|FG000|Overall Study|Protocol Violation|1|||
160934304|NCT01470469|581155002|FG001|Overall Study|Protocol Violation|1|||
160934305|NCT01470469|581155001|FG000|Overall Study|Other|2|||
160934306|NCT01470469|581155002|FG001|Overall Study|Other|1|||
160934307|NCT05459129|581155003|FG000|Overall Study|Death|1|||
160934308|NCT05459129|581155004|FG001|Overall Study|Death|0|||
160934309|NCT05459129|581155003|FG000|Overall Study|Study Terminated By Sponsor|5|||
160934310|NCT05459129|581155004|FG001|Overall Study|Study Terminated By Sponsor|6|||
160934311|NCT04476017|581155012|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
160934312|NCT04476017|581155013|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
160934313|NCT03362502|581155014|FG000|Overall Study|Death|0|||
160934314|NCT03362502|581155015|FG001|Overall Study|Death|0|||
160934315|NCT03362502|581155016|FG002|Overall Study|Death|1|||
160934316|NCT03795610|581155020|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
160934317|NCT03795610|581155020|FG000|Overall Study|Withdrawal by Subject|1|||
160934318|NCT03795610|581155020|FG000|Overall Study|Screen Failure (Unknown)|1|||
160934319|NCT02775344|581155021|FG000|Overall Study|No ovarian cyst identified|3|||
160934320|NCT02775344|581155022|FG001|Overall Study|No ovarian cyst identified|2|||
160934321|NCT03909165|581155033|FG000|Overall Study|Physician Decision|0|||
160934322|NCT03909165|581155034|FG001|Overall Study|Physician Decision|1|||
160934323|NCT03909165|581155035|FG002|Overall Study|Physician Decision|0|||
160934324|NCT03909165|581155036|FG003|Overall Study|Physician Decision|0|||
160934325|NCT03909165|581155037|FG004|Overall Study|Physician Decision|0|||
160934326|NCT03909165|581155033|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934327|NCT03909165|581155034|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934328|NCT03909165|581155035|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934329|NCT03909165|581155036|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
160934330|NCT03909165|581155037|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
160934331|NCT03909165|581155033|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160934332|NCT03909165|581155034|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
160934333|NCT03909165|581155035|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
160934334|NCT03909165|581155036|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
160934335|NCT03909165|581155037|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
160934336|NCT03909165|581155033|FG000|Overall Study|Previous Drug Exposure|0|||
160934337|NCT03909165|581155034|FG001|Overall Study|Previous Drug Exposure|0|||
160934338|NCT03909165|581155035|FG002|Overall Study|Previous Drug Exposure|1|||
160934339|NCT03909165|581155036|FG003|Overall Study|Previous Drug Exposure|0|||
160934340|NCT03909165|581155037|FG004|Overall Study|Previous Drug Exposure|0|||
160934341|NCT03909165|581155033|FG000|Overall Study|Early Discharge|1|||
160934342|NCT03909165|581155034|FG001|Overall Study|Early Discharge|0|||
160934343|NCT03909165|581155035|FG002|Overall Study|Early Discharge|0|||
160934344|NCT03909165|581155036|FG003|Overall Study|Early Discharge|0|||
160934345|NCT03909165|581155037|FG004|Overall Study|Early Discharge|0|||
160934346|NCT06034496|581155038|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
160934347|NCT06034496|581155039|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
160934348|NCT06034496|581155038|FG000|Overall Study|Withdrawal by Subject|5|||
160934349|NCT06034496|581155039|FG001|Overall Study|Withdrawal by Subject|4|||
160934350|NCT02018458|581155040|FG000|Overall Study|Death|4|||
160934351|NCT04033159|581155041|FG000|Washout Period|Physician Decision|0|||
160934352|NCT04033159|581155042|FG001|Washout Period|Physician Decision|1|||
160934353|NCT04033159|581155043|FG002|Washout Period|Physician Decision|0|||
160934354|NCT04033159|581155041|FG000|Washout Period|Study terminated by Sponsor|0|||
160934355|NCT04033159|581155042|FG001|Washout Period|Study terminated by Sponsor|7|||
160934356|NCT04033159|581155043|FG002|Washout Period|Study terminated by Sponsor|0|||
160934357|NCT04033159|581155041|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
160934358|NCT04033159|581155042|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
160934359|NCT04033159|581155043|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
160934360|NCT03277261|581155050|FG000|Overall Study|Adverse Event|17|||
160934361|NCT03277261|581155051|FG001|Overall Study|Adverse Event|1|||
160934362|NCT03277261|581155050|FG000|Overall Study|Participant Withdrawal of Consent|6|||
160934363|NCT03277261|581155051|FG001|Overall Study|Participant Withdrawal of Consent|15|||
160934364|NCT03277261|581155050|FG000|Overall Study|Investigator / Sponsor Decision|4|||
160934365|NCT03277261|581155051|FG001|Overall Study|Investigator / Sponsor Decision|2|||
160934366|NCT03277261|581155050|FG000|Overall Study|Pregnancy|2|||
160934367|NCT03277261|581155051|FG001|Overall Study|Pregnancy|0|||
161264544|NCT00974974|582350660|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
161264545|NCT00974974|582350661|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
160934368|NCT03277261|581155050|FG000|Overall Study|Lost to Follow-up|2|||
160934369|NCT03277261|581155051|FG001|Overall Study|Lost to Follow-up|2|||
160934370|NCT03277261|581155050|FG000|Overall Study|Lack of Efficacy|2|||
160934371|NCT03277261|581155051|FG001|Overall Study|Lack of Efficacy|2|||
160934372|NCT03277261|581155050|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
160934373|NCT03277261|581155051|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
160934374|NCT03762083|581155052|FG000|Overall Study|Withdrawal by Subject|2|||
161264546|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
161264547|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
161264548|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
160934375|NCT03762083|581155052|FG000|Overall Study|Physician Decision|1|||
160934376|NCT01203072|581155053|FG000|Overall Study|Adverse Event|5|||
160934377|NCT01203072|581155054|FG001|Overall Study|Adverse Event|3|||
160934378|NCT01203072|581155055|FG002|Overall Study|Adverse Event|2|||
160934379|NCT01203072|581155056|FG003|Overall Study|Adverse Event|4|||
160934380|NCT01203072|581155057|FG004|Overall Study|Adverse Event|2|||
160934381|NCT01203072|581155053|FG000|Overall Study|Lack of Efficacy|1|||
160934382|NCT01203072|581155054|FG001|Overall Study|Lack of Efficacy|0|||
160934383|NCT01203072|581155055|FG002|Overall Study|Lack of Efficacy|0|||
160934384|NCT01203072|581155056|FG003|Overall Study|Lack of Efficacy|0|||
160934385|NCT01203072|581155057|FG004|Overall Study|Lack of Efficacy|0|||
160934386|NCT01203072|581155053|FG000|Overall Study|Lost to Follow-up|0|||
160934387|NCT01203072|581155054|FG001|Overall Study|Lost to Follow-up|1|||
160934388|NCT01203072|581155055|FG002|Overall Study|Lost to Follow-up|0|||
160934389|NCT01203072|581155056|FG003|Overall Study|Lost to Follow-up|0|||
161264549|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
161264550|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
160934390|NCT01203072|581155057|FG004|Overall Study|Lost to Follow-up|0|||
160934391|NCT01203072|581155053|FG000|Overall Study|Protocol Violation|2|||
160934392|NCT01203072|581155054|FG001|Overall Study|Protocol Violation|0|||
160934393|NCT01203072|581155055|FG002|Overall Study|Protocol Violation|0|||
160934394|NCT01203072|581155056|FG003|Overall Study|Protocol Violation|0|||
160934395|NCT01203072|581155057|FG004|Overall Study|Protocol Violation|1|||
160934396|NCT01203072|581155053|FG000|Overall Study|Withdrawal by Subject|2|||
160934397|NCT01203072|581155054|FG001|Overall Study|Withdrawal by Subject|2|||
160934398|NCT01203072|581155055|FG002|Overall Study|Withdrawal by Subject|1|||
160934399|NCT01203072|581155056|FG003|Overall Study|Withdrawal by Subject|2|||
160934400|NCT01203072|581155057|FG004|Overall Study|Withdrawal by Subject|3|||
160934401|NCT00235872|581155058|FG000|Overall Study|Adverse Event|34|||
160934402|NCT00235872|581155058|FG000|Overall Study|Death|1|||
160934403|NCT00235872|581155058|FG000|Overall Study|Lost to Follow-up|1|||
160934404|NCT00235872|581155058|FG000|Overall Study|Withdrawal by Subject|50|||
160934405|NCT00235872|581155058|FG000|Overall Study|Administrative reason|61|||
160934406|NCT00116558|581155059|FG000|Overall Study|Death|11|||
160934407|NCT00116558|581155060|FG001|Overall Study|Death|5|||
160934408|NCT00116558|581155061|FG002|Overall Study|Death|3|||
160934409|NCT00116558|581155059|FG000|Overall Study|Withdrawal by Subject|17|||
160934410|NCT00116558|581155060|FG001|Overall Study|Withdrawal by Subject|3|||
160934411|NCT00116558|581155061|FG002|Overall Study|Withdrawal by Subject|12|||
160934412|NCT00116558|581155059|FG000|Overall Study|disease progression|3|||
160934413|NCT00116558|581155060|FG001|Overall Study|disease progression|7|||
160934414|NCT00116558|581155061|FG002|Overall Study|disease progression|18|||
160934415|NCT02027844|581155062|FG000|Overall Study|Withdrawal by Subject|3|||
160934416|NCT02027844|581155063|FG001|Overall Study|Withdrawal by Subject|2|||
160934417|NCT02027844|581155064|FG002|Overall Study|Withdrawal by Subject|1|||
160934418|NCT02027844|581155062|FG000|Overall Study|Lost to Follow-up|0|||
160934419|NCT02027844|581155063|FG001|Overall Study|Lost to Follow-up|2|||
160934420|NCT02027844|581155064|FG002|Overall Study|Lost to Follow-up|1|||
160934421|NCT02027844|581155062|FG000|Overall Study|Protocol Violation|0|||
160934422|NCT02027844|581155063|FG001|Overall Study|Protocol Violation|2|||
160934423|NCT02027844|581155064|FG002|Overall Study|Protocol Violation|0|||
160934424|NCT02027844|581155062|FG000|Overall Study|Incomlete data|2|||
160934425|NCT02027844|581155063|FG001|Overall Study|Incomlete data|0|||
160934426|NCT02027844|581155064|FG002|Overall Study|Incomlete data|0|||
160934427|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
160934428|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
160934429|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Graft loss|1|||
160934430|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Graft loss|2|||
160934431|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Death|5|||
161264551|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
161264552|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
161264553|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
161264554|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
161264555|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
160934432|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Death|3|||
160934433|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
160934434|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
160934435|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
160934436|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
160934437|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
160934438|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
160934439|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
160934440|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
160934441|NCT00378014|581155065|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
160934442|NCT00378014|581155066|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
160934443|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
160934444|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
160934445|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Death|1|||
160934446|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Death|2|||
160934447|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
160934448|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
160934449|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
160934450|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
160934451|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
160934452|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
160934453|NCT00378014|581155065|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
160934454|NCT00378014|581155066|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
160934455|NCT00414661|581155070|FG000|Overall Study|Death|2|||
160934456|NCT00414661|581155071|FG001|Overall Study|Death|5|||
160934457|NCT00414661|581155072|FG002|Overall Study|Death|0|||
160934458|NCT00414661|581155073|FG003|Overall Study|Death|0|||
160934459|NCT00414661|581155070|FG000|Overall Study|Lost to Follow-up|1|||
160934460|NCT00414661|581155071|FG001|Overall Study|Lost to Follow-up|4|||
160934461|NCT00414661|581155072|FG002|Overall Study|Lost to Follow-up|0|||
160934462|NCT00414661|581155073|FG003|Overall Study|Lost to Follow-up|1|||
160934463|NCT00414661|581155070|FG000|Overall Study|Withdrawal by Subject|5|||
160934464|NCT00414661|581155071|FG001|Overall Study|Withdrawal by Subject|2|||
161143776|NCT01933672|581909503|FG001|Metformin Run-in Period|Adverse Event|0|||
161143777|NCT01933672|581909504|FG002|Metformin Run-in Period|Adverse Event|0|||
161143778|NCT01933672|581909505|FG003|Metformin Run-in Period|Adverse Event|0|||
161143779|NCT01933672|581909506|FG004|Metformin Run-in Period|Adverse Event|0|||
161143780|NCT01933672|581909507|FG005|Metformin Run-in Period|Adverse Event|0|||
161143781|NCT01933672|581909508|FG006|Metformin Run-in Period|Adverse Event|0|||
161143782|NCT01933672|581909502|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
161143783|NCT01933672|581909503|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161143784|NCT01933672|581909504|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161143785|NCT01933672|581909505|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161143786|NCT01933672|581909506|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161143787|NCT01933672|581909507|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161143788|NCT01933672|581909508|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
161143789|NCT01933672|581909502|FG000|Metformin Run-in Period|Other|5|||
161143790|NCT01933672|581909503|FG001|Metformin Run-in Period|Other|0|||
161143791|NCT01933672|581909504|FG002|Metformin Run-in Period|Other|0|||
161143792|NCT01933672|581909505|FG003|Metformin Run-in Period|Other|0|||
161143793|NCT01933672|581909506|FG004|Metformin Run-in Period|Other|0|||
161143794|NCT01933672|581909507|FG005|Metformin Run-in Period|Other|0|||
161143795|NCT01933672|581909508|FG006|Metformin Run-in Period|Other|0|||
161143796|NCT01933672|581909502|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143797|NCT01933672|581909503|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143798|NCT01933672|581909504|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143799|NCT01933672|581909505|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143800|NCT01933672|581909506|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
161143801|NCT01933672|581909507|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143802|NCT01933672|581909508|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143803|NCT01933672|581909502|FG000|First Intervention Period (12-16 Days)|Other|0|||
161143804|NCT01933672|581909503|FG001|First Intervention Period (12-16 Days)|Other|0|||
161143805|NCT01933672|581909504|FG002|First Intervention Period (12-16 Days)|Other|1|||
161143806|NCT01933672|581909505|FG003|First Intervention Period (12-16 Days)|Other|0|||
161143807|NCT01933672|581909506|FG004|First Intervention Period (12-16 Days)|Other|0|||
161143808|NCT01933672|581909507|FG005|First Intervention Period (12-16 Days)|Other|1|||
161143809|NCT01933672|581909508|FG006|First Intervention Period (12-16 Days)|Other|0|||
161143810|NCT01933672|581909502|FG000|Second Intervention Period (12-16 Days)|Other|0|||
161143811|NCT01933672|581909503|FG001|Second Intervention Period (12-16 Days)|Other|1|||
161143812|NCT01933672|581909504|FG002|Second Intervention Period (12-16 Days)|Other|1|||
161143813|NCT01933672|581909505|FG003|Second Intervention Period (12-16 Days)|Other|0|||
161143814|NCT01933672|581909506|FG004|Second Intervention Period (12-16 Days)|Other|0|||
161143815|NCT01933672|581909507|FG005|Second Intervention Period (12-16 Days)|Other|0|||
161143816|NCT01933672|581909508|FG006|Second Intervention Period (12-16 Days)|Other|0|||
161143817|NCT01933672|581909502|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143818|NCT01933672|581909503|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143819|NCT01933672|581909504|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
160934465|NCT00414661|581155072|FG002|Overall Study|Withdrawal by Subject|2|||
160934466|NCT00414661|581155073|FG003|Overall Study|Withdrawal by Subject|2|||
160934467|NCT00414661|581155070|FG000|Overall Study|Other|6|||
160934468|NCT00414661|581155071|FG001|Overall Study|Other|3|||
160934469|NCT00414661|581155072|FG002|Overall Study|Other|0|||
160934470|NCT00414661|581155073|FG003|Overall Study|Other|0|||
161143820|NCT01933672|581909505|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
161143821|NCT01933672|581909506|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161342493|NCT03415178|582640213|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
160934471|NCT02852265|581155074|FG000|3-month Follow-up|Lost to Follow-up|1|||
160934472|NCT02852265|581155075|FG001|3-month Follow-up|Lost to Follow-up|1|||
160934473|NCT01143090|581155076|FG000|Overall Study|Lack of Efficacy|2|||
160934474|NCT01143090|581155076|FG000|Overall Study|Adverse Event|17|||
160934475|NCT01143090|581155076|FG000|Overall Study|Lost to Follow-up|9|||
160934476|NCT01143090|581155076|FG000|Overall Study|Protocol Violation|2|||
160934477|NCT01143090|581155076|FG000|Overall Study|Withdrawal by Subject|18|||
160934478|NCT01143090|581155076|FG000|Overall Study|Non-compliance with study drug|1|||
160934479|NCT01143090|581155076|FG000|Overall Study|Failure to meet eligibility criteria|1|||
160934480|NCT01143090|581155076|FG000|Overall Study|Administrative|1|||
160934481|NCT01800916|581155079|FG000|Test Period 1 (1 Week)|Convex product user|0|||
160934482|NCT01800916|581155080|FG001|Test Period 1 (1 Week)|Convex product user|0|||
160934483|NCT01800916|581155081|FG002|Test Period 1 (1 Week)|Convex product user|0|||
160934484|NCT01800916|581155082|FG003|Test Period 1 (1 Week)|Convex product user|1|||
160934485|NCT01800916|581155083|FG004|Test Period 1 (1 Week)|Convex product user|0|||
160934486|NCT01800916|581155084|FG005|Test Period 1 (1 Week)|Convex product user|0|||
160934487|NCT01800916|581155085|FG006|Test Period 1 (1 Week)|Convex product user|0|||
160934488|NCT01800916|581155086|FG007|Test Period 1 (1 Week)|Convex product user|0|||
160934489|NCT01800916|581155087|FG008|Test Period 1 (1 Week)|Convex product user|0|||
160934490|NCT01800916|581155079|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
160934491|NCT01800916|581155080|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
160934492|NCT01800916|581155081|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
160934493|NCT01800916|581155082|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
160934494|NCT01800916|581155083|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
160934495|NCT01800916|581155084|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
160934496|NCT01800916|581155085|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
160934497|NCT01800916|581155086|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
160934498|NCT01800916|581155087|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
160934499|NCT00559962|581155102|FG000|Overall Study|Adverse Event|1|||
160934500|NCT00559962|581155103|FG001|Overall Study|Adverse Event|7|||
160934501|NCT00559962|581155104|FG002|Overall Study|Adverse Event|8|||
160934502|NCT00559962|581155105|FG003|Overall Study|Adverse Event|5|||
160934503|NCT00559962|581155106|FG004|Overall Study|Adverse Event|11|||
160934504|NCT00559962|581155107|FG005|Overall Study|Adverse Event|4|||
160934505|NCT00559962|581155108|FG006|Overall Study|Adverse Event|4|||
160934506|NCT00559962|581155109|FG007|Overall Study|Adverse Event|2|||
160934507|NCT00559962|581155102|FG000|Overall Study|Lost to Follow-up|0|||
160934508|NCT00559962|581155103|FG001|Overall Study|Lost to Follow-up|1|||
160934509|NCT00559962|581155104|FG002|Overall Study|Lost to Follow-up|0|||
160934510|NCT00559962|581155105|FG003|Overall Study|Lost to Follow-up|0|||
160934511|NCT00559962|581155106|FG004|Overall Study|Lost to Follow-up|0|||
160934512|NCT00559962|581155107|FG005|Overall Study|Lost to Follow-up|0|||
160934513|NCT00559962|581155108|FG006|Overall Study|Lost to Follow-up|0|||
160934514|NCT00559962|581155109|FG007|Overall Study|Lost to Follow-up|0|||
160934515|NCT00559962|581155102|FG000|Overall Study|Withdrawal by Subject|1|||
160934516|NCT00559962|581155103|FG001|Overall Study|Withdrawal by Subject|1|||
160934517|NCT00559962|581155104|FG002|Overall Study|Withdrawal by Subject|2|||
160934518|NCT00559962|581155105|FG003|Overall Study|Withdrawal by Subject|0|||
160934519|NCT00559962|581155106|FG004|Overall Study|Withdrawal by Subject|3|||
160934520|NCT00559962|581155107|FG005|Overall Study|Withdrawal by Subject|1|||
160934521|NCT00559962|581155108|FG006|Overall Study|Withdrawal by Subject|0|||
160934522|NCT00559962|581155109|FG007|Overall Study|Withdrawal by Subject|2|||
160934523|NCT00559962|581155102|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
160934524|NCT00559962|581155103|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
160934525|NCT00559962|581155104|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
160934526|NCT00559962|581155105|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
160934527|NCT00559962|581155106|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
160934528|NCT00559962|581155107|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
160934529|NCT00559962|581155108|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
160934530|NCT00559962|581155109|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
161342494|NCT03415178|582640214|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
160934531|NCT01639040|581155119|FG000|Overall Study|Adverse Event|1|||
160934532|NCT01639040|581155120|FG001|Overall Study|Adverse Event|0|||
161342495|NCT03415178|582640213|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
161342496|NCT03415178|582640214|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
161342497|NCT04880850|582640215|FG000|Overall Study|Death|2|||
160934533|NCT04370691|581155121|FG000|Overall Study|Pending visit|48|||
160934534|NCT04370691|581155121|FG000|Overall Study|Have Not Reached Lower Window|15|||
160934535|NCT04370691|581155121|FG000|Overall Study|Termination|14|||
160934536|NCT04370691|581155121|FG000|Overall Study|Missed or Overdue|10|||
160934537|NCT00486265|581155125|FG000|Overall Study|Adverse Event|1|||
160934538|NCT00486265|581155125|FG000|Overall Study|Lack of Efficacy|8|||
160934539|NCT01452412|581155126|FG000|Overall Study|Withdrawal by Subject|15|||
161342498|NCT04880850|582640216|FG001|Overall Study|Death|1|||
160934540|NCT01452412|581155127|FG001|Overall Study|Withdrawal by Subject|11|||
160934541|NCT01452412|581155126|FG000|Overall Study|Adverse Event|4|||
160934542|NCT01452412|581155127|FG001|Overall Study|Adverse Event|3|||
160934543|NCT01452412|581155126|FG000|Overall Study|Lost to Follow-up|5|||
160934544|NCT01452412|581155127|FG001|Overall Study|Lost to Follow-up|3|||
160934545|NCT01452412|581155126|FG000|Overall Study|Death|1|||
160934546|NCT01452412|581155127|FG001|Overall Study|Death|0|||
160934547|NCT01452412|581155126|FG000|Overall Study|Initiated dialysis|1|||
160934548|NCT01452412|581155127|FG001|Overall Study|Initiated dialysis|0|||
160934549|NCT01452412|581155126|FG000|Overall Study|Other|2|||
160934550|NCT01452412|581155127|FG001|Overall Study|Other|0|||
160934551|NCT03047135|581155128|FG000|Overall Study|Still being treated|3|||
160934552|NCT03013543|581155129|FG000|Overall Study|Withdrawal by Subject|0|||
160934553|NCT03013543|581155130|FG001|Overall Study|Withdrawal by Subject|2|||
160934554|NCT03013543|581155131|FG002|Overall Study|Withdrawal by Subject|0|||
160934555|NCT03013543|581155132|FG003|Overall Study|Withdrawal by Subject|5|||
160934556|NCT03013543|581155133|FG004|Overall Study|Withdrawal by Subject|6|||
160934557|NCT03013543|581155134|FG005|Overall Study|Withdrawal by Subject|2|||
160934558|NCT03013543|581155135|FG006|Overall Study|Withdrawal by Subject|3|||
160934559|NCT03013543|581155136|FG007|Overall Study|Withdrawal by Subject|1|||
160934560|NCT03013543|581155137|FG008|Overall Study|Withdrawal by Subject|0|||
160934561|NCT03013543|581155138|FG009|Overall Study|Withdrawal by Subject|4|||
160934562|NCT03013543|581155129|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
160934563|NCT03013543|581155130|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
160934564|NCT03013543|581155131|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
160934565|NCT03013543|581155132|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
160934566|NCT03013543|581155133|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
160934567|NCT03013543|581155134|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
160934568|NCT03013543|581155135|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
160934569|NCT03013543|581155136|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
160934570|NCT03013543|581155137|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
160934571|NCT03013543|581155138|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
160934572|NCT03013543|581155129|FG000|Overall Study|Other|0|||
160934573|NCT03013543|581155130|FG001|Overall Study|Other|0|||
160934574|NCT03013543|581155131|FG002|Overall Study|Other|2|||
160934575|NCT03013543|581155132|FG003|Overall Study|Other|0|||
160934576|NCT03013543|581155133|FG004|Overall Study|Other|2|||
160934577|NCT03013543|581155134|FG005|Overall Study|Other|0|||
160934578|NCT03013543|581155135|FG006|Overall Study|Other|0|||
160934579|NCT03013543|581155136|FG007|Overall Study|Other|0|||
160934580|NCT03013543|581155137|FG008|Overall Study|Other|1|||
160934581|NCT03013543|581155138|FG009|Overall Study|Other|0|||
160934582|NCT03013543|581155129|FG000|Overall Study|Adverse Event|0|||
160934583|NCT03013543|581155130|FG001|Overall Study|Adverse Event|0|||
160934584|NCT03013543|581155131|FG002|Overall Study|Adverse Event|0|||
160934585|NCT03013543|581155132|FG003|Overall Study|Adverse Event|3|||
160934586|NCT03013543|581155133|FG004|Overall Study|Adverse Event|2|||
160934587|NCT03013543|581155134|FG005|Overall Study|Adverse Event|1|||
160934588|NCT03013543|581155135|FG006|Overall Study|Adverse Event|3|||
160934589|NCT03013543|581155136|FG007|Overall Study|Adverse Event|8|||
160934590|NCT03013543|581155137|FG008|Overall Study|Adverse Event|0|||
161143822|NCT01933672|581909507|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161143823|NCT01933672|581909508|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
161264556|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
161264557|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
161264558|NCT00974974|582350660|FG000|Maintenance - Double Blind Treatment|Various|4|||
161264559|NCT00974974|582350661|FG001|Maintenance - Double Blind Treatment|Various|0|||
161264560|NCT01959035|582350662|FG000|Overall Study|Adverse Event|5|||
161264561|NCT01959035|582350662|FG000|Overall Study|Withdrawal by Subject|4|||
161264562|NCT01959035|582350662|FG000|Overall Study|Lost to Follow-up|1|||
161264563|NCT01959035|582350662|FG000|Overall Study|Other (no primary reason given)|1|||
161264564|NCT03254602|582350663|FG000|Overall Study|Lost to Follow-up|4|||
161264565|NCT01691820|582350666|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
161264566|NCT01691820|582350667|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
160934591|NCT03013543|581155138|FG009|Overall Study|Adverse Event|2|||
160934592|NCT03013543|581155129|FG000|Overall Study|Death|0|||
160934593|NCT03013543|581155130|FG001|Overall Study|Death|0|||
160934594|NCT03013543|581155131|FG002|Overall Study|Death|0|||
160934595|NCT03013543|581155132|FG003|Overall Study|Death|1|||
160934596|NCT03013543|581155133|FG004|Overall Study|Death|0|||
160934597|NCT03013543|581155134|FG005|Overall Study|Death|0|||
160934598|NCT03013543|581155135|FG006|Overall Study|Death|0|||
160934599|NCT03013543|581155136|FG007|Overall Study|Death|0|||
160934600|NCT03013543|581155137|FG008|Overall Study|Death|0|||
160934601|NCT03013543|581155138|FG009|Overall Study|Death|0|||
160934602|NCT03013543|581155129|FG000|Overall Study|Lack of Efficacy|0|||
160934603|NCT03013543|581155130|FG001|Overall Study|Lack of Efficacy|0|||
160934604|NCT03013543|581155131|FG002|Overall Study|Lack of Efficacy|0|||
160934605|NCT03013543|581155132|FG003|Overall Study|Lack of Efficacy|1|||
160934606|NCT03013543|581155133|FG004|Overall Study|Lack of Efficacy|0|||
160934607|NCT03013543|581155134|FG005|Overall Study|Lack of Efficacy|0|||
160934608|NCT03013543|581155135|FG006|Overall Study|Lack of Efficacy|0|||
160934609|NCT03013543|581155136|FG007|Overall Study|Lack of Efficacy|0|||
160934610|NCT03013543|581155137|FG008|Overall Study|Lack of Efficacy|0|||
160934611|NCT03013543|581155138|FG009|Overall Study|Lack of Efficacy|0|||
160934612|NCT03013543|581155129|FG000|Overall Study|Lost to Follow-up|0|||
160934613|NCT03013543|581155130|FG001|Overall Study|Lost to Follow-up|0|||
160934614|NCT03013543|581155131|FG002|Overall Study|Lost to Follow-up|0|||
160934615|NCT03013543|581155132|FG003|Overall Study|Lost to Follow-up|1|||
160934616|NCT03013543|581155133|FG004|Overall Study|Lost to Follow-up|0|||
160934617|NCT03013543|581155134|FG005|Overall Study|Lost to Follow-up|0|||
160934618|NCT03013543|581155135|FG006|Overall Study|Lost to Follow-up|1|||
160934619|NCT03013543|581155136|FG007|Overall Study|Lost to Follow-up|0|||
160934620|NCT03013543|581155137|FG008|Overall Study|Lost to Follow-up|0|||
160934621|NCT03013543|581155138|FG009|Overall Study|Lost to Follow-up|2|||
160934622|NCT03013543|581155129|FG000|Overall Study|Non-Compliance With Study Drug|0|||
160934623|NCT03013543|581155130|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160934624|NCT03013543|581155131|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160934625|NCT03013543|581155132|FG003|Overall Study|Non-Compliance With Study Drug|0|||
160934626|NCT03013543|581155133|FG004|Overall Study|Non-Compliance With Study Drug|0|||
160934627|NCT03013543|581155134|FG005|Overall Study|Non-Compliance With Study Drug|0|||
160934628|NCT03013543|581155135|FG006|Overall Study|Non-Compliance With Study Drug|0|||
160934629|NCT03013543|581155136|FG007|Overall Study|Non-Compliance With Study Drug|0|||
160934630|NCT03013543|581155137|FG008|Overall Study|Non-Compliance With Study Drug|1|||
160934631|NCT03013543|581155138|FG009|Overall Study|Non-Compliance With Study Drug|0|||
160934632|NCT03013543|581155129|FG000|Overall Study|Physician Decision|0|||
160934633|NCT03013543|581155130|FG001|Overall Study|Physician Decision|0|||
160934634|NCT03013543|581155131|FG002|Overall Study|Physician Decision|0|||
160934635|NCT03013543|581155132|FG003|Overall Study|Physician Decision|0|||
160934636|NCT03013543|581155133|FG004|Overall Study|Physician Decision|1|||
160934637|NCT03013543|581155134|FG005|Overall Study|Physician Decision|0|||
160934638|NCT03013543|581155135|FG006|Overall Study|Physician Decision|0|||
160934639|NCT03013543|581155136|FG007|Overall Study|Physician Decision|0|||
160934640|NCT03013543|581155137|FG008|Overall Study|Physician Decision|0|||
160934641|NCT03013543|581155138|FG009|Overall Study|Physician Decision|0|||
160934642|NCT03013543|581155129|FG000|Overall Study|Protocol Violation|0|||
160934643|NCT03013543|581155130|FG001|Overall Study|Protocol Violation|0|||
160934644|NCT03013543|581155131|FG002|Overall Study|Protocol Violation|0|||
160934645|NCT03013543|581155132|FG003|Overall Study|Protocol Violation|0|||
160934646|NCT03013543|581155133|FG004|Overall Study|Protocol Violation|0|||
160934647|NCT03013543|581155134|FG005|Overall Study|Protocol Violation|0|||
160934648|NCT03013543|581155135|FG006|Overall Study|Protocol Violation|0|||
160934649|NCT03013543|581155136|FG007|Overall Study|Protocol Violation|0|||
160934650|NCT03013543|581155137|FG008|Overall Study|Protocol Violation|0|||
160934651|NCT03013543|581155138|FG009|Overall Study|Protocol Violation|1|||
160934652|NCT00323414|581155139|FG000|Overall Study|Withdrawal by Subject|0|||
160934653|NCT00323414|581155140|FG001|Overall Study|Withdrawal by Subject|1|||
160934654|NCT02552316|581155142|FG000|Overall Study|Withdrawal by Subject|1|||
160934655|NCT02552316|581155142|FG000|Overall Study|Withdrawal due to non-compliance|1|||
160934656|NCT04382911|581155143|FG000|Overall Study|unable to be imaged prior to surgery|2|||
161143824|NCT01933672|581909502|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161143825|NCT01933672|581909503|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
161264567|NCT01691820|582350666|FG000|Overall Study|Migrated/moved from study area|7|||
161264568|NCT01691820|582350667|FG001|Overall Study|Migrated/moved from study area|4|||
161264569|NCT01691820|582350666|FG000|Overall Study|Lost to Follow-up|6|||
161264570|NCT01691820|582350667|FG001|Overall Study|Lost to Follow-up|17|||
161264571|NCT01691820|582350666|FG000|Overall Study|Other (unspecified)|4|||
161264572|NCT01691820|582350667|FG001|Overall Study|Other (unspecified)|1|||
161264573|NCT01968694|582350668|FG000|Washout (1 Month)|Lost to Follow-up|0|||
161264574|NCT01968694|582350669|FG001|Washout (1 Month)|Lost to Follow-up|1|||
160934657|NCT04116710|581155147|FG000|Overall Study|Death|4|||
160934658|NCT04116710|581155148|FG001|Overall Study|Death|6|||
160934659|NCT04116710|581155149|FG002|Overall Study|Death|3|||
160934660|NCT04116710|581155150|FG003|Overall Study|Death|1|||
160934661|NCT04116710|581155147|FG000|Overall Study|Withdrawal by Subject|0|||
160934662|NCT04116710|581155148|FG001|Overall Study|Withdrawal by Subject|0|||
160934663|NCT04116710|581155149|FG002|Overall Study|Withdrawal by Subject|0|||
160934664|NCT04116710|581155150|FG003|Overall Study|Withdrawal by Subject|1|||
160934665|NCT01256593|581155151|FG000|Overall Study|Protocol Violation|26|||
160934666|NCT01256593|581155151|FG000|Overall Study|No Drug Administration Information|2|||
160934667|NCT01256593|581155151|FG000|Overall Study|No Visit After Treatment|186|||
160934668|NCT05619692|581155158|FG000|Overall Study|Adverse Event|2|||
160934669|NCT05619692|581155159|FG001|Overall Study|Adverse Event|2|||
160934670|NCT05619692|581155158|FG000|Overall Study|Withdrawal by Participant|3|||
160934671|NCT05619692|581155159|FG001|Overall Study|Withdrawal by Participant|4|||
160934672|NCT05619692|581155158|FG000|Overall Study|Lost to Follow-up|2|||
160934673|NCT05619692|581155159|FG001|Overall Study|Lost to Follow-up|1|||
160934674|NCT05619692|581155158|FG000|Overall Study|Randomized but not treated|1|||
160934675|NCT05619692|581155159|FG001|Overall Study|Randomized but not treated|3|||
160934676|NCT02457598|581155160|FG000|Overall Study|Progressive Disease|2|||
160934677|NCT02457598|581155161|FG001|Overall Study|Progressive Disease|2|||
160934678|NCT02457598|581155162|FG002|Overall Study|Progressive Disease|1|||
160934679|NCT02457598|581155163|FG003|Overall Study|Progressive Disease|11|||
160934680|NCT02457598|581155164|FG004|Overall Study|Progressive Disease|7|||
160934681|NCT02457598|581155165|FG005|Overall Study|Progressive Disease|3|||
160934682|NCT02457598|581155166|FG006|Overall Study|Progressive Disease|2|||
160934683|NCT02457598|581155167|FG007|Overall Study|Progressive Disease|1|||
160934684|NCT02457598|581155168|FG008|Overall Study|Progressive Disease|1|||
160934685|NCT02457598|581155169|FG009|Overall Study|Progressive Disease|2|||
160934686|NCT02457598|581155170|FG010|Overall Study|Progressive Disease|45|||
160934687|NCT02457598|581155171|FG011|Overall Study|Progressive Disease|6|||
160934688|NCT02457598|581155172|FG012|Overall Study|Progressive Disease|2|||
160934689|NCT02457598|581155173|FG013|Overall Study|Progressive Disease|2|||
160934690|NCT02457598|581155174|FG014|Overall Study|Progressive Disease|10|||
160934691|NCT02457598|581155175|FG015|Overall Study|Progressive Disease|1|||
160934692|NCT02457598|581155176|FG016|Overall Study|Progressive Disease|1|||
160934693|NCT02457598|581155160|FG000|Overall Study|Investigator's Discretion|0|||
160934694|NCT02457598|581155161|FG001|Overall Study|Investigator's Discretion|2|||
160934695|NCT02457598|581155162|FG002|Overall Study|Investigator's Discretion|2|||
160934696|NCT02457598|581155163|FG003|Overall Study|Investigator's Discretion|2|||
160934697|NCT02457598|581155164|FG004|Overall Study|Investigator's Discretion|0|||
160934698|NCT02457598|581155165|FG005|Overall Study|Investigator's Discretion|0|||
160934699|NCT02457598|581155166|FG006|Overall Study|Investigator's Discretion|0|||
160934700|NCT02457598|581155167|FG007|Overall Study|Investigator's Discretion|1|||
160934701|NCT02457598|581155168|FG008|Overall Study|Investigator's Discretion|2|||
160934702|NCT02457598|581155169|FG009|Overall Study|Investigator's Discretion|0|||
160934703|NCT02457598|581155170|FG010|Overall Study|Investigator's Discretion|10|||
160934704|NCT02457598|581155171|FG011|Overall Study|Investigator's Discretion|2|||
160934705|NCT02457598|581155172|FG012|Overall Study|Investigator's Discretion|2|||
160934706|NCT02457598|581155173|FG013|Overall Study|Investigator's Discretion|1|||
160934707|NCT02457598|581155174|FG014|Overall Study|Investigator's Discretion|5|||
160934708|NCT02457598|581155175|FG015|Overall Study|Investigator's Discretion|0|||
160934709|NCT02457598|581155176|FG016|Overall Study|Investigator's Discretion|0|||
160934710|NCT02457598|581155160|FG000|Overall Study|Study Terminated by Sponsor|0|||
160934711|NCT02457598|581155161|FG001|Overall Study|Study Terminated by Sponsor|1|||
160934712|NCT02457598|581155162|FG002|Overall Study|Study Terminated by Sponsor|0|||
160934713|NCT02457598|581155163|FG003|Overall Study|Study Terminated by Sponsor|4|||
160934714|NCT02457598|581155164|FG004|Overall Study|Study Terminated by Sponsor|1|||
160934715|NCT02457598|581155165|FG005|Overall Study|Study Terminated by Sponsor|0|||
160934716|NCT02457598|581155166|FG006|Overall Study|Study Terminated by Sponsor|1|||
160934717|NCT02457598|581155167|FG007|Overall Study|Study Terminated by Sponsor|0|||
160934718|NCT02457598|581155168|FG008|Overall Study|Study Terminated by Sponsor|0|||
160934719|NCT02457598|581155169|FG009|Overall Study|Study Terminated by Sponsor|0|||
160934720|NCT02457598|581155170|FG010|Overall Study|Study Terminated by Sponsor|4|||
160934721|NCT02457598|581155171|FG011|Overall Study|Study Terminated by Sponsor|0|||
160934722|NCT02457598|581155172|FG012|Overall Study|Study Terminated by Sponsor|1|||
160934723|NCT02457598|581155173|FG013|Overall Study|Study Terminated by Sponsor|0|||
160934724|NCT02457598|581155174|FG014|Overall Study|Study Terminated by Sponsor|8|||
160934725|NCT02457598|581155175|FG015|Overall Study|Study Terminated by Sponsor|1|||
160934726|NCT02457598|581155176|FG016|Overall Study|Study Terminated by Sponsor|0|||
160934727|NCT02457598|581155160|FG000|Overall Study|Adverse Event|0|||
160934728|NCT02457598|581155161|FG001|Overall Study|Adverse Event|1|||
160934729|NCT02457598|581155162|FG002|Overall Study|Adverse Event|1|||
160934730|NCT02457598|581155163|FG003|Overall Study|Adverse Event|4|||
160934731|NCT02457598|581155164|FG004|Overall Study|Adverse Event|1|||
160934732|NCT02457598|581155165|FG005|Overall Study|Adverse Event|0|||
160934733|NCT02457598|581155166|FG006|Overall Study|Adverse Event|0|||
160934734|NCT02457598|581155167|FG007|Overall Study|Adverse Event|1|||
160934735|NCT02457598|581155168|FG008|Overall Study|Adverse Event|0|||
160934736|NCT02457598|581155169|FG009|Overall Study|Adverse Event|1|||
160934737|NCT02457598|581155170|FG010|Overall Study|Adverse Event|6|||
160934738|NCT02457598|581155171|FG011|Overall Study|Adverse Event|0|||
160934739|NCT02457598|581155172|FG012|Overall Study|Adverse Event|0|||
160934740|NCT02457598|581155173|FG013|Overall Study|Adverse Event|1|||
160934741|NCT02457598|581155174|FG014|Overall Study|Adverse Event|2|||
160934742|NCT02457598|581155175|FG015|Overall Study|Adverse Event|0|||
160934743|NCT02457598|581155176|FG016|Overall Study|Adverse Event|0|||
160934744|NCT02457598|581155160|FG000|Overall Study|Death|0|||
160934745|NCT02457598|581155161|FG001|Overall Study|Death|0|||
161264575|NCT02836496|582350670|FG000|Overall Study|Adverse Event|2|||
160934746|NCT02457598|581155162|FG002|Overall Study|Death|0|||
160934747|NCT02457598|581155163|FG003|Overall Study|Death|3|||
160934748|NCT02457598|581155164|FG004|Overall Study|Death|0|||
160934749|NCT02457598|581155165|FG005|Overall Study|Death|1|||
161264576|NCT02836496|582350671|FG001|Overall Study|Adverse Event|1|||
161264577|NCT02836496|582350670|FG000|Overall Study|Withdrawal by Subject|0|||
161264578|NCT02836496|582350671|FG001|Overall Study|Withdrawal by Subject|1|||
161264579|NCT01400919|582350672|FG000|Overall Study|Withdrawal by Subject|4|||
160934750|NCT02457598|581155166|FG006|Overall Study|Death|0|||
160998432|NCT00462943|581378659|FG000|Overall Study|Disease Progression|15|||
160998433|NCT00462943|581378660|FG001|Overall Study|Disease Progression|15|||
160998434|NCT00462943|581378661|FG002|Overall Study|Disease Progression|9|||
160998435|NCT00462943|581378659|FG000|Overall Study|Death|5|||
160998436|NCT00462943|581378660|FG001|Overall Study|Death|2|||
160998437|NCT00462943|581378661|FG002|Overall Study|Death|7|||
160998438|NCT00462943|581378659|FG000|Overall Study|Stem Cell Transplant|1|||
160998439|NCT00462943|581378660|FG001|Overall Study|Stem Cell Transplant|1|||
160998440|NCT00462943|581378661|FG002|Overall Study|Stem Cell Transplant|0|||
160998441|NCT00462943|581378659|FG000|Overall Study|Bone Marrow Transplant|1|||
160998442|NCT00462943|581378660|FG001|Overall Study|Bone Marrow Transplant|0|||
160998443|NCT00462943|581378661|FG002|Overall Study|Bone Marrow Transplant|0|||
160998444|NCT00462943|581378659|FG000|Overall Study|Required Lymphocyte Infusion|1|||
160998445|NCT00462943|581378660|FG001|Overall Study|Required Lymphocyte Infusion|0|||
160998446|NCT00462943|581378661|FG002|Overall Study|Required Lymphocyte Infusion|0|||
160998447|NCT00462943|581378659|FG000|Overall Study|Transplant - not specified|1|||
160998448|NCT00462943|581378660|FG001|Overall Study|Transplant - not specified|0|||
160998449|NCT00462943|581378661|FG002|Overall Study|Transplant - not specified|1|||
160998450|NCT00462943|581378659|FG000|Overall Study|Physician Decision|1|||
160998451|NCT00462943|581378660|FG001|Overall Study|Physician Decision|0|||
160998452|NCT00462943|581378661|FG002|Overall Study|Physician Decision|0|||
160998453|NCT00462943|581378659|FG000|Overall Study|Withdrawal by Subject|0|||
160998454|NCT00462943|581378660|FG001|Overall Study|Withdrawal by Subject|1|||
160998455|NCT00462943|581378661|FG002|Overall Study|Withdrawal by Subject|0|||
160998456|NCT00995709|581378662|FG000|Overall Study|Adverse Event|4|||
160998457|NCT00995709|581378663|FG001|Overall Study|Adverse Event|2|||
160998458|NCT00995709|581378664|FG002|Overall Study|Adverse Event|0|||
160998459|NCT00995709|581378662|FG000|Overall Study|Lack of Efficacy|0|||
160998460|NCT00995709|581378663|FG001|Overall Study|Lack of Efficacy|1|||
160998461|NCT00995709|581378664|FG002|Overall Study|Lack of Efficacy|4|||
160934751|NCT02457598|581155167|FG007|Overall Study|Death|0|||
160934752|NCT02457598|581155168|FG008|Overall Study|Death|0|||
160934753|NCT02457598|581155169|FG009|Overall Study|Death|0|||
160934754|NCT02457598|581155170|FG010|Overall Study|Death|3|||
160934755|NCT02457598|581155171|FG011|Overall Study|Death|0|||
160934756|NCT02457598|581155172|FG012|Overall Study|Death|0|||
160934757|NCT02457598|581155173|FG013|Overall Study|Death|1|||
160934758|NCT02457598|581155174|FG014|Overall Study|Death|2|||
160934759|NCT02457598|581155175|FG015|Overall Study|Death|0|||
160934760|NCT02457598|581155176|FG016|Overall Study|Death|1|||
160934761|NCT02457598|581155160|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934762|NCT02457598|581155161|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
160934763|NCT02457598|581155162|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934764|NCT02457598|581155163|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934765|NCT02457598|581155164|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934766|NCT02457598|581155165|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934767|NCT02457598|581155166|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934768|NCT02457598|581155167|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934769|NCT02457598|581155168|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934770|NCT02457598|581155169|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934771|NCT02457598|581155170|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
160934772|NCT02457598|581155171|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934773|NCT02457598|581155172|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934774|NCT02457598|581155173|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
160934775|NCT02457598|581155174|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934776|NCT02457598|581155175|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
160998462|NCT00995709|581378662|FG000|Overall Study|Withdrawal by Subject|0|||
160998463|NCT00995709|581378663|FG001|Overall Study|Withdrawal by Subject|4|||
161264580|NCT01400919|582350672|FG000|Overall Study|Lost to Follow-up|2|||
160998464|NCT00995709|581378664|FG002|Overall Study|Withdrawal by Subject|1|||
161143826|NCT01933672|581909504|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161264581|NCT01400919|582350672|FG000|Overall Study|Missed visit|2|||
160934777|NCT02457598|581155176|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
160934778|NCT02457598|581155160|FG000|Overall Study|Withdrew Consent|0|||
160934779|NCT02457598|581155161|FG001|Overall Study|Withdrew Consent|0|||
160934780|NCT02457598|581155162|FG002|Overall Study|Withdrew Consent|0|||
160998465|NCT00995709|581378662|FG000|Overall Study|Lost to Follow-up|1|||
160998466|NCT00995709|581378663|FG001|Overall Study|Lost to Follow-up|0|||
160998467|NCT00995709|581378664|FG002|Overall Study|Lost to Follow-up|0|||
160998468|NCT00995709|581378662|FG000|Overall Study|Death|0|||
161264582|NCT01246011|582350673|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
160934781|NCT02457598|581155163|FG003|Overall Study|Withdrew Consent|0|||
160934782|NCT02457598|581155164|FG004|Overall Study|Withdrew Consent|0|||
160934783|NCT02457598|581155165|FG005|Overall Study|Withdrew Consent|0|||
160934784|NCT02457598|581155166|FG006|Overall Study|Withdrew Consent|0|||
160934785|NCT02457598|581155167|FG007|Overall Study|Withdrew Consent|2|||
160934786|NCT02457598|581155168|FG008|Overall Study|Withdrew Consent|0|||
160934787|NCT02457598|581155169|FG009|Overall Study|Withdrew Consent|0|||
160934788|NCT02457598|581155170|FG010|Overall Study|Withdrew Consent|3|||
160934789|NCT02457598|581155171|FG011|Overall Study|Withdrew Consent|0|||
160934790|NCT02457598|581155172|FG012|Overall Study|Withdrew Consent|0|||
160934791|NCT02457598|581155173|FG013|Overall Study|Withdrew Consent|1|||
160934792|NCT02457598|581155174|FG014|Overall Study|Withdrew Consent|0|||
160934793|NCT02457598|581155175|FG015|Overall Study|Withdrew Consent|0|||
160934794|NCT02457598|581155176|FG016|Overall Study|Withdrew Consent|0|||
160934795|NCT02457598|581155160|FG000|Overall Study|Unacceptable Toxicity|0|||
160934796|NCT02457598|581155161|FG001|Overall Study|Unacceptable Toxicity|0|||
160934797|NCT02457598|581155162|FG002|Overall Study|Unacceptable Toxicity|0|||
160934798|NCT02457598|581155163|FG003|Overall Study|Unacceptable Toxicity|0|||
160934799|NCT02457598|581155164|FG004|Overall Study|Unacceptable Toxicity|0|||
160998469|NCT00995709|581378663|FG001|Overall Study|Death|1|||
160998470|NCT00995709|581378664|FG002|Overall Study|Death|0|||
160934800|NCT02457598|581155165|FG005|Overall Study|Unacceptable Toxicity|0|||
160934801|NCT02457598|581155166|FG006|Overall Study|Unacceptable Toxicity|0|||
160934802|NCT02457598|581155167|FG007|Overall Study|Unacceptable Toxicity|0|||
160934803|NCT02457598|581155168|FG008|Overall Study|Unacceptable Toxicity|0|||
160934804|NCT02457598|581155169|FG009|Overall Study|Unacceptable Toxicity|0|||
160934805|NCT02457598|581155170|FG010|Overall Study|Unacceptable Toxicity|1|||
160934806|NCT02457598|581155171|FG011|Overall Study|Unacceptable Toxicity|0|||
160934807|NCT02457598|581155172|FG012|Overall Study|Unacceptable Toxicity|1|||
160934808|NCT02457598|581155173|FG013|Overall Study|Unacceptable Toxicity|1|||
160934809|NCT02457598|581155174|FG014|Overall Study|Unacceptable Toxicity|1|||
160934810|NCT02457598|581155175|FG015|Overall Study|Unacceptable Toxicity|0|||
160934811|NCT02457598|581155176|FG016|Overall Study|Unacceptable Toxicity|0|||
160934812|NCT02457598|581155160|FG000|Overall Study|Intercurrent Illness|0|||
160934813|NCT02457598|581155161|FG001|Overall Study|Intercurrent Illness|0|||
160934814|NCT02457598|581155162|FG002|Overall Study|Intercurrent Illness|0|||
160934815|NCT02457598|581155163|FG003|Overall Study|Intercurrent Illness|0|||
160934816|NCT02457598|581155164|FG004|Overall Study|Intercurrent Illness|0|||
160934817|NCT02457598|581155165|FG005|Overall Study|Intercurrent Illness|0|||
160934818|NCT02457598|581155166|FG006|Overall Study|Intercurrent Illness|0|||
160934819|NCT02457598|581155167|FG007|Overall Study|Intercurrent Illness|0|||
160934820|NCT02457598|581155168|FG008|Overall Study|Intercurrent Illness|0|||
160934821|NCT02457598|581155169|FG009|Overall Study|Intercurrent Illness|0|||
160934822|NCT02457598|581155170|FG010|Overall Study|Intercurrent Illness|1|||
160934823|NCT02457598|581155171|FG011|Overall Study|Intercurrent Illness|0|||
160934824|NCT02457598|581155172|FG012|Overall Study|Intercurrent Illness|0|||
160934825|NCT02457598|581155173|FG013|Overall Study|Intercurrent Illness|0|||
160934826|NCT02457598|581155174|FG014|Overall Study|Intercurrent Illness|0|||
160934827|NCT02457598|581155175|FG015|Overall Study|Intercurrent Illness|0|||
160934828|NCT02457598|581155176|FG016|Overall Study|Intercurrent Illness|0|||
160934829|NCT02457598|581155160|FG000|Overall Study|Protocol Violation|0|||
160934830|NCT02457598|581155161|FG001|Overall Study|Protocol Violation|0|||
160934831|NCT02457598|581155162|FG002|Overall Study|Protocol Violation|0|||
160934832|NCT02457598|581155163|FG003|Overall Study|Protocol Violation|0|||
160934833|NCT02457598|581155164|FG004|Overall Study|Protocol Violation|0|||
160934834|NCT02457598|581155165|FG005|Overall Study|Protocol Violation|0|||
160934835|NCT02457598|581155166|FG006|Overall Study|Protocol Violation|0|||
160998471|NCT00995709|581378662|FG000|Overall Study|Protocol Violation|2|||
160998472|NCT00995709|581378663|FG001|Overall Study|Protocol Violation|1|||
160998473|NCT00995709|581378664|FG002|Overall Study|Protocol Violation|0|||
160998474|NCT02698241|581378665|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
160998475|NCT02698241|581378665|FG000|Overall Study|Screening not met|7|||
160998476|NCT02698241|581378665|FG000|Overall Study|Withdrawal by Subject|7|||
160998477|NCT02698241|581378665|FG000|Overall Study|Physician Decision|2|||
160998478|NCT02698241|581378665|FG000|Overall Study|Subject underwent system modification|2|||
160934836|NCT02457598|581155167|FG007|Overall Study|Protocol Violation|0|||
160934837|NCT02457598|581155168|FG008|Overall Study|Protocol Violation|0|||
160934838|NCT02457598|581155169|FG009|Overall Study|Protocol Violation|0|||
160934839|NCT02457598|581155170|FG010|Overall Study|Protocol Violation|1|||
160934840|NCT02457598|581155171|FG011|Overall Study|Protocol Violation|0|||
160998479|NCT02698241|581378665|FG000|Overall Study|Lost to Follow-up|3|||
160934841|NCT02457598|581155172|FG012|Overall Study|Protocol Violation|0|||
160934842|NCT02457598|581155173|FG013|Overall Study|Protocol Violation|0|||
160934843|NCT02457598|581155174|FG014|Overall Study|Protocol Violation|0|||
160934844|NCT02457598|581155175|FG015|Overall Study|Protocol Violation|0|||
160934845|NCT02457598|581155176|FG016|Overall Study|Protocol Violation|0|||
160934846|NCT02703636|581155178|FG000|Overall Study|Adverse Event|14|||
160998480|NCT02698241|581378665|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
160998481|NCT02698241|581378665|FG000|Overall Study|geographic and licensing issue|1|||
160998482|NCT02698241|581378665|FG000|Overall Study|Death|2|||
160998483|NCT01543685|581378668|FG000|Overall Study|Lack of Efficacy|1|||
160998484|NCT01543685|581378669|FG001|Overall Study|Lack of Efficacy|2|||
160934847|NCT02703636|581155178|FG000|Overall Study|Study stopped by sponsor|1|||
160934848|NCT02703636|581155178|FG000|Overall Study|Withdrawal by Subject|1|||
160934849|NCT01110915|581155188|FG000|Overall Study|Death|2|||
160934850|NCT01110915|581155189|FG001|Overall Study|Death|1|||
160934851|NCT01110915|581155188|FG000|Overall Study|Lost to Follow-up|1|||
160934852|NCT01110915|581155189|FG001|Overall Study|Lost to Follow-up|0|||
160934853|NCT01110915|581155188|FG000|Overall Study|Withdrawal by Subject|7|||
160934854|NCT01110915|581155189|FG001|Overall Study|Withdrawal by Subject|1|||
160934855|NCT01215227|581155193|FG000|Overall Study|Adverse Event|11|||
160934856|NCT01215227|581155194|FG001|Overall Study|Adverse Event|11|||
160934857|NCT01215227|581155195|FG002|Overall Study|Adverse Event|4|||
160934858|NCT01215227|581155196|FG003|Overall Study|Adverse Event|8|||
160934859|NCT01215227|581155197|FG004|Overall Study|Adverse Event|7|||
160934860|NCT01215227|581155198|FG005|Overall Study|Adverse Event|6|||
160934861|NCT01215227|581155193|FG000|Overall Study|Treatment Failure|8|||
160934862|NCT01215227|581155194|FG001|Overall Study|Treatment Failure|4|||
160934863|NCT01215227|581155195|FG002|Overall Study|Treatment Failure|1|||
160934864|NCT01215227|581155196|FG003|Overall Study|Treatment Failure|5|||
160934865|NCT01215227|581155197|FG004|Overall Study|Treatment Failure|1|||
160934866|NCT01215227|581155198|FG005|Overall Study|Treatment Failure|1|||
160934867|NCT01215227|581155193|FG000|Overall Study|Lost to Follow-up|1|||
160934868|NCT01215227|581155194|FG001|Overall Study|Lost to Follow-up|4|||
160934869|NCT01215227|581155195|FG002|Overall Study|Lost to Follow-up|1|||
160934870|NCT01215227|581155196|FG003|Overall Study|Lost to Follow-up|1|||
160934871|NCT01215227|581155197|FG004|Overall Study|Lost to Follow-up|1|||
160934872|NCT01215227|581155198|FG005|Overall Study|Lost to Follow-up|2|||
160934873|NCT01215227|581155193|FG000|Overall Study|Subject Withdrew Consent|16|||
160934874|NCT01215227|581155194|FG001|Overall Study|Subject Withdrew Consent|20|||
160934875|NCT01215227|581155195|FG002|Overall Study|Subject Withdrew Consent|7|||
160934876|NCT01215227|581155196|FG003|Overall Study|Subject Withdrew Consent|10|||
160934877|NCT01215227|581155197|FG004|Overall Study|Subject Withdrew Consent|11|||
160934878|NCT01215227|581155198|FG005|Overall Study|Subject Withdrew Consent|8|||
160934879|NCT01215227|581155193|FG000|Overall Study|Non-Compliance With Protocol|2|||
160934880|NCT01215227|581155194|FG001|Overall Study|Non-Compliance With Protocol|6|||
160934881|NCT01215227|581155195|FG002|Overall Study|Non-Compliance With Protocol|1|||
160934882|NCT01215227|581155196|FG003|Overall Study|Non-Compliance With Protocol|0|||
160934883|NCT01215227|581155197|FG004|Overall Study|Non-Compliance With Protocol|0|||
160934884|NCT01215227|581155198|FG005|Overall Study|Non-Compliance With Protocol|0|||
160934885|NCT01215227|581155193|FG000|Overall Study|Administrative|83|||
160934886|NCT01215227|581155194|FG001|Overall Study|Administrative|73|||
160934887|NCT01215227|581155195|FG002|Overall Study|Administrative|42|||
160934888|NCT01215227|581155196|FG003|Overall Study|Administrative|24|||
160934889|NCT01215227|581155197|FG004|Overall Study|Administrative|28|||
160934890|NCT01215227|581155198|FG005|Overall Study|Administrative|40|||
160934891|NCT01215227|581155193|FG000|Overall Study|Missing Status|0|||
160934892|NCT01215227|581155194|FG001|Overall Study|Missing Status|1|||
160934893|NCT01215227|581155195|FG002|Overall Study|Missing Status|0|||
160934894|NCT01215227|581155196|FG003|Overall Study|Missing Status|0|||
160934895|NCT01215227|581155197|FG004|Overall Study|Missing Status|0|||
160934896|NCT01215227|581155198|FG005|Overall Study|Missing Status|0|||
160934897|NCT01215227|581155193|FG000|Overall Study|Randomized but not treated|0|||
160934898|NCT01215227|581155194|FG001|Overall Study|Randomized but not treated|0|||
160934899|NCT01215227|581155195|FG002|Overall Study|Randomized but not treated|1|||
160934900|NCT01215227|581155196|FG003|Overall Study|Randomized but not treated|1|||
160934901|NCT01215227|581155197|FG004|Overall Study|Randomized but not treated|0|||
160934902|NCT01215227|581155198|FG005|Overall Study|Randomized but not treated|1|||
160934903|NCT00293384|581156809|FG000|Overall Study|Non-compliance|2|||
160934904|NCT00293384|581156809|FG000|Overall Study|Missed dosage/study drug|1|||
160934905|NCT00293384|581156809|FG000|Overall Study|Ineligible|2|||
160934906|NCT05723770|581156810|FG000|Overall Study|Lost to Follow-up|4|||
160934907|NCT05723770|581156810|FG000|Overall Study|Withdrawal by Subject|2|||
160934908|NCT01359592|581156811|FG000|Initial Registration|Adverse Event|1|||
160934909|NCT01359592|581156812|FG001|Initial Registration|Adverse Event|0|||
160934910|NCT01359592|581156813|FG002|Initial Registration|Adverse Event|0|||
160934911|NCT01359592|581156814|FG003|Initial Registration|Adverse Event|0|||
160934912|NCT01359592|581156811|FG000|Initial Registration|Death|1|||
160934913|NCT01359592|581156812|FG001|Initial Registration|Death|0|||
160934914|NCT01359592|581156813|FG002|Initial Registration|Death|0|||
160998485|NCT01543685|581378670|FG002|Overall Study|Lack of Efficacy|2|||
160934915|NCT01359592|581156814|FG003|Initial Registration|Death|0|||
160934916|NCT01359592|581156811|FG000|Initial Registration|Other reason not protocol specified|1|||
160934917|NCT01359592|581156812|FG001|Initial Registration|Other reason not protocol specified|0|||
160934918|NCT01359592|581156813|FG002|Initial Registration|Other reason not protocol specified|0|||
160934919|NCT01359592|581156814|FG003|Initial Registration|Other reason not protocol specified|0|||
160934920|NCT01359592|581156811|FG000|Initial Registration|Ineligible|26|||
160934921|NCT01359592|581156812|FG001|Initial Registration|Ineligible|0|||
160934922|NCT01359592|581156813|FG002|Initial Registration|Ineligible|0|||
160934923|NCT01359592|581156814|FG003|Initial Registration|Ineligible|0|||
160934924|NCT01359592|581156811|FG000|PET-Directed Therapy|Adverse Event|0|||
160934925|NCT01359592|581156812|FG001|PET-Directed Therapy|Adverse Event|0|||
160934926|NCT01359592|581156813|FG002|PET-Directed Therapy|Adverse Event|1|||
160934927|NCT01359592|581156814|FG003|PET-Directed Therapy|Adverse Event|0|||
160934928|NCT01359592|581156811|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
160934929|NCT01359592|581156812|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
160934930|NCT01359592|581156813|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
160934931|NCT01359592|581156814|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
160934932|NCT01359592|581156811|FG000|PET-Directed Therapy|Ineligible|0|||
160934933|NCT01359592|581156812|FG001|PET-Directed Therapy|Ineligible|0|||
160934934|NCT01359592|581156813|FG002|PET-Directed Therapy|Ineligible|24|||
160934935|NCT01359592|581156814|FG003|PET-Directed Therapy|Ineligible|0|||
160934936|NCT00326612|581156817|FG000|Overall Study|They did not have a seizure requiring tx|129|||
160934937|NCT00326612|581156818|FG001|Overall Study|They did not have a seizure requiring tx|137|||
160934938|NCT00419562|581156819|FG000|Overall Study|Lost to Follow-up|12|||
160934939|NCT00419562|581156820|FG001|Overall Study|Lost to Follow-up|13|||
160934940|NCT00419562|581156819|FG000|Overall Study|Withdrawal by Subject|20|||
160934941|NCT00419562|581156820|FG001|Overall Study|Withdrawal by Subject|18|||
160934942|NCT00419562|581156819|FG000|Overall Study|Participant Institutionalized|1|||
160934943|NCT00419562|581156820|FG001|Overall Study|Participant Institutionalized|0|||
160934944|NCT02365636|581156821|FG000|Overall Study|Adverse Event|3|||
160934945|NCT02365636|581156822|FG001|Overall Study|Adverse Event|3|||
160934946|NCT02365636|581156823|FG002|Overall Study|Adverse Event|2|||
160934947|NCT02365636|581156821|FG000|Overall Study|Protocol Violation|1|||
160934948|NCT02365636|581156822|FG001|Overall Study|Protocol Violation|4|||
160934949|NCT02365636|581156823|FG002|Overall Study|Protocol Violation|0|||
160934950|NCT02365636|581156821|FG000|Overall Study|Lost to Follow-up|0|||
160934951|NCT02365636|581156822|FG001|Overall Study|Lost to Follow-up|0|||
160934952|NCT02365636|581156823|FG002|Overall Study|Lost to Follow-up|1|||
160934953|NCT02365636|581156821|FG000|Overall Study|Other|2|||
160934954|NCT02365636|581156822|FG001|Overall Study|Other|0|||
160934955|NCT02365636|581156823|FG002|Overall Study|Other|0|||
160934956|NCT00355238|581156824|FG000|Overall Study|Adverse event unrelated to study drug|2|||
160934957|NCT00355238|581156825|FG001|Overall Study|Adverse event unrelated to study drug|2|||
160934958|NCT00355238|581156826|FG002|Overall Study|Adverse event unrelated to study drug|0|||
160934959|NCT00355238|581156827|FG003|Overall Study|Adverse event unrelated to study drug|1|||
160934960|NCT00355238|581156824|FG000|Overall Study|Death|1|||
160934961|NCT00355238|581156825|FG001|Overall Study|Death|0|||
160934962|NCT00355238|581156826|FG002|Overall Study|Death|0|||
160934963|NCT00355238|581156827|FG003|Overall Study|Death|0|||
160934964|NCT00355238|581156824|FG000|Overall Study|Disease progression|37|||
160934965|NCT00355238|581156825|FG001|Overall Study|Disease progression|36|||
160934966|NCT00355238|581156826|FG002|Overall Study|Disease progression|16|||
160934967|NCT00355238|581156827|FG003|Overall Study|Disease progression|11|||
160934968|NCT00355238|581156824|FG000|Overall Study|Study drug toxicity|11|||
160934969|NCT00355238|581156825|FG001|Overall Study|Study drug toxicity|7|||
160934970|NCT00355238|581156826|FG002|Overall Study|Study drug toxicity|5|||
160934971|NCT00355238|581156827|FG003|Overall Study|Study drug toxicity|2|||
160934972|NCT00355238|581156824|FG000|Overall Study|Participant withdrew consent|3|||
160934973|NCT00355238|581156825|FG001|Overall Study|Participant withdrew consent|1|||
160934974|NCT00355238|581156826|FG002|Overall Study|Participant withdrew consent|0|||
160934975|NCT00355238|581156827|FG003|Overall Study|Participant withdrew consent|0|||
160934976|NCT00355238|581156824|FG000|Overall Study|Participant request to discontinue study treatment|1|||
160934977|NCT00355238|581156825|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160934978|NCT00355238|581156826|FG002|Overall Study|Participant request to discontinue study treatment|1|||
160934979|NCT00355238|581156827|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160934980|NCT01454934|581156828|FG000|Overall Study|Clinical progression|28|||
160934981|NCT01454934|581156829|FG001|Overall Study|Clinical progression|25|||
160934982|NCT01454934|581156828|FG000|Overall Study|Other|6|||
160934983|NCT01454934|581156829|FG001|Overall Study|Other|17|||
160934984|NCT01454934|581156828|FG000|Overall Study|Adverse Event|28|||
160934985|NCT01454934|581156829|FG001|Overall Study|Adverse Event|24|||
160934986|NCT01454934|581156828|FG000|Overall Study|Withdrawn consent|2|||
160934987|NCT01454934|581156829|FG001|Overall Study|Withdrawn consent|5|||
160934988|NCT01454934|581156828|FG000|Overall Study|Withdrawal by Subject|11|||
160934989|NCT01454934|581156829|FG001|Overall Study|Withdrawal by Subject|15|||
160934990|NCT01454934|581156828|FG000|Overall Study|Disease progression|194|||
160934991|NCT01454934|581156829|FG001|Overall Study|Disease progression|181|||
160934992|NCT01454934|581156828|FG000|Overall Study|Lost to Follow-up|0|||
160934993|NCT01454934|581156829|FG001|Overall Study|Lost to Follow-up|1|||
160934994|NCT01454934|581156828|FG000|Overall Study|Not treated|1|||
160934995|NCT01454934|581156829|FG001|Overall Study|Not treated|2|||
160934996|NCT00480636|581156830|FG000|Overall Study|Death|12|||
160934997|NCT00480636|581156830|FG000|Overall Study|Lost to Follow-up|4|||
160934998|NCT00480636|581156830|FG000|Overall Study|Other|2|||
160934999|NCT00480636|581156830|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
160935000|NCT03912233|581156831|FG000|Overall Study|Adverse Event|1|||
160935001|NCT03912233|581156832|FG001|Overall Study|Adverse Event|0|||
160935002|NCT03912233|581156833|FG002|Overall Study|Adverse Event|0|||
160935003|NCT03912233|581156834|FG003|Overall Study|Adverse Event|0|||
160935004|NCT03912233|581156835|FG004|Overall Study|Adverse Event|0|||
160935005|NCT03912233|581156836|FG005|Overall Study|Adverse Event|0|||
160935006|NCT03912233|581156831|FG000|Overall Study|Physician Decision|1|||
160935007|NCT03912233|581156832|FG001|Overall Study|Physician Decision|0|||
160935008|NCT03912233|581156833|FG002|Overall Study|Physician Decision|0|||
160935009|NCT03912233|581156834|FG003|Overall Study|Physician Decision|0|||
160935010|NCT03912233|581156835|FG004|Overall Study|Physician Decision|0|||
160935011|NCT03912233|581156836|FG005|Overall Study|Physician Decision|0|||
160935012|NCT03912233|581156831|FG000|Overall Study|Other|0|||
160935013|NCT03912233|581156832|FG001|Overall Study|Other|0|||
160935014|NCT03912233|581156833|FG002|Overall Study|Other|0|||
160935015|NCT03912233|581156834|FG003|Overall Study|Other|0|||
160935016|NCT03912233|581156835|FG004|Overall Study|Other|7|||
160935017|NCT03912233|581156836|FG005|Overall Study|Other|12|||
160935018|NCT02583256|581156837|FG000|Overall Study|Withdrawal by Subject|0|||
160935019|NCT02583256|581156838|FG001|Overall Study|Withdrawal by Subject|1|||
160935020|NCT02583256|581156839|FG002|Overall Study|Withdrawal by Subject|1|||
160935021|NCT02583256|581156840|FG003|Overall Study|Withdrawal by Subject|0|||
160935022|NCT02583256|581156837|FG000|Overall Study|Lost to Follow-up|1|||
160935023|NCT02583256|581156838|FG001|Overall Study|Lost to Follow-up|1|||
160935024|NCT02583256|581156839|FG002|Overall Study|Lost to Follow-up|0|||
160935025|NCT02583256|581156840|FG003|Overall Study|Lost to Follow-up|1|||
160935026|NCT02583256|581156837|FG000|Overall Study|Administrative/Other|2|||
160935027|NCT02583256|581156838|FG001|Overall Study|Administrative/Other|0|||
160935028|NCT02583256|581156839|FG002|Overall Study|Administrative/Other|1|||
160935029|NCT02583256|581156840|FG003|Overall Study|Administrative/Other|2|||
160935030|NCT02177266|581156848|FG000|Overall Study|Adverse Event|0|||
160935031|NCT02177266|581156849|FG001|Overall Study|Adverse Event|1|||
160935032|NCT02177266|581156848|FG000|Overall Study|Withdrawal by Subject|1|||
160935033|NCT02177266|581156849|FG001|Overall Study|Withdrawal by Subject|0|||
160935034|NCT01023659|581156850|FG000|Overall Study|Lost to Follow-up|73|||
160935035|NCT01023659|581156851|FG001|Overall Study|Lost to Follow-up|228|||
160935036|NCT01023659|581156852|FG002|Overall Study|Lost to Follow-up|99|||
160935037|NCT04537806|581156855|FG000|Overall Study|Randomized but not treated|1|||
160935038|NCT04537806|581156856|FG001|Overall Study|Randomized but not treated|0|||
160935039|NCT04537806|581156855|FG000|Overall Study|Adverse Event|1|||
160935040|NCT04537806|581156856|FG001|Overall Study|Adverse Event|1|||
160935041|NCT03019627|581156857|FG000|Overall Study|Adverse Event|8|||
160935042|NCT03019627|581156858|FG001|Overall Study|Adverse Event|0|||
160935043|NCT03019627|581156857|FG000|Overall Study|Unrelated to adverse event|1|||
160935044|NCT03019627|581156858|FG001|Overall Study|Unrelated to adverse event|3|||
160935045|NCT03019627|581156857|FG000|Overall Study|Lost to Follow-up|2|||
160935046|NCT03019627|581156858|FG001|Overall Study|Lost to Follow-up|1|||
160935047|NCT03019627|581156857|FG000|Overall Study|not compliance|2|||
160935048|NCT03019627|581156858|FG001|Overall Study|not compliance|2|||
160935049|NCT03019627|581156857|FG000|Overall Study|Other|2|||
160935050|NCT03019627|581156858|FG001|Overall Study|Other|2|||
160935051|NCT01802775|581156861|FG000|Overall Study|Death|0|||
160935052|NCT01802775|581156862|FG001|Overall Study|Death|3|||
160935053|NCT01802775|581156861|FG000|Overall Study|Reason not provided|0|||
160935054|NCT01802775|581156862|FG001|Overall Study|Reason not provided|1|||
160935055|NCT01802775|581156861|FG000|Overall Study|Physician Decision|1|||
160935056|NCT01802775|581156862|FG001|Overall Study|Physician Decision|0|||
160935057|NCT01802775|581156861|FG000|Overall Study|Adverse Event|1|||
160935058|NCT01802775|581156862|FG001|Overall Study|Adverse Event|1|||
160935059|NCT01802775|581156861|FG000|Overall Study|Withdrawal by Subject|3|||
160935060|NCT01802775|581156862|FG001|Overall Study|Withdrawal by Subject|5|||
160935061|NCT01802775|581156861|FG000|Overall Study|Lost to Follow-up|1|||
160935062|NCT01802775|581156862|FG001|Overall Study|Lost to Follow-up|2|||
160935063|NCT00519649|581156863|FG000|Overall Study|Withdrawal by Subject|1|||
160935064|NCT01465802|581156864|FG000|Overall Study|Study terminated by sponsor|1|||
160935065|NCT01465802|581156865|FG001|Overall Study|Study terminated by sponsor|0|||
160935066|NCT01465802|581156866|FG002|Overall Study|Study terminated by sponsor|0|||
161264583|NCT01246011|582350674|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
160935067|NCT01465802|581156867|FG003|Overall Study|Study terminated by sponsor|1|||
160935068|NCT01465802|581156868|FG004|Overall Study|Study terminated by sponsor|7|||
160935069|NCT01465802|581156864|FG000|Overall Study|Withdrawal by Subject|7|||
160935070|NCT01465802|581156865|FG001|Overall Study|Withdrawal by Subject|7|||
160935071|NCT01465802|581156866|FG002|Overall Study|Withdrawal by Subject|0|||
160935072|NCT01465802|581156867|FG003|Overall Study|Withdrawal by Subject|8|||
160935073|NCT01465802|581156868|FG004|Overall Study|Withdrawal by Subject|1|||
160935074|NCT01465802|581156864|FG000|Overall Study|Lost to Follow-up|1|||
160998486|NCT01543685|581378671|FG003|Overall Study|Lack of Efficacy|0|||
160998487|NCT01543685|581378672|FG004|Overall Study|Lack of Efficacy|2|||
160998488|NCT01543685|581378668|FG000|Overall Study|Adverse Event|2|||
160998489|NCT01543685|581378669|FG001|Overall Study|Adverse Event|1|||
160998490|NCT01543685|581378670|FG002|Overall Study|Adverse Event|0|||
160998491|NCT01543685|581378671|FG003|Overall Study|Adverse Event|0|||
160998492|NCT01543685|581378672|FG004|Overall Study|Adverse Event|2|||
160998493|NCT02465359|581378674|FG000|Overall Study|Lack of Efficacy|1|||
160998494|NCT02465359|581378674|FG000|Overall Study|Withdrawal by Subject|1|||
160998495|NCT02465359|581378674|FG000|Overall Study|Adverse Event|1|||
160935075|NCT01465802|581156865|FG001|Overall Study|Lost to Follow-up|1|||
160935076|NCT01465802|581156866|FG002|Overall Study|Lost to Follow-up|0|||
160935077|NCT01465802|581156867|FG003|Overall Study|Lost to Follow-up|0|||
160935078|NCT01465802|581156868|FG004|Overall Study|Lost to Follow-up|0|||
160935079|NCT01465802|581156864|FG000|Overall Study|Reason not specified|9|||
160935080|NCT01465802|581156865|FG001|Overall Study|Reason not specified|4|||
160935081|NCT01465802|581156866|FG002|Overall Study|Reason not specified|0|||
160935082|NCT01465802|581156867|FG003|Overall Study|Reason not specified|10|||
160935083|NCT01465802|581156868|FG004|Overall Study|Reason not specified|2|||
160935084|NCT01465802|581156864|FG000|Overall Study|Death|15|||
160935085|NCT01465802|581156865|FG001|Overall Study|Death|12|||
160935086|NCT01465802|581156866|FG002|Overall Study|Death|0|||
160935087|NCT01465802|581156867|FG003|Overall Study|Death|10|||
160935088|NCT01465802|581156868|FG004|Overall Study|Death|2|||
160935089|NCT00727714|581156869|FG000|Overall Study|Lost to Follow-up|2|||
160935090|NCT00325234|581156872|FG000|Overall Study|Adverse Event|10|||
160935091|NCT00325234|581156873|FG001|Overall Study|Adverse Event|7|||
160935092|NCT00325234|581156872|FG000|Overall Study|Death due to Study Disease|1|||
160935093|NCT00325234|581156873|FG001|Overall Study|Death due to Study Disease|0|||
160935094|NCT00325234|581156872|FG000|Overall Study|Entry Criteria Not Met|1|||
160935095|NCT00325234|581156873|FG001|Overall Study|Entry Criteria Not Met|2|||
160935096|NCT00325234|581156872|FG000|Overall Study|Subject Decision|6|||
160935097|NCT00325234|581156873|FG001|Overall Study|Subject Decision|8|||
160935098|NCT00325234|581156872|FG000|Overall Study|Physician Decision|17|||
160935099|NCT00325234|581156873|FG001|Overall Study|Physician Decision|12|||
160935100|NCT00325234|581156872|FG000|Overall Study|Progressive Disease|34|||
160935101|NCT00325234|581156873|FG001|Overall Study|Progressive Disease|37|||
160935102|NCT01234467|581156874|FG000|Overall Study|Adverse Event|3|||
160935103|NCT01234467|581156874|FG000|Overall Study|Death|2|||
160935104|NCT01234467|581156874|FG000|Overall Study|Withdrawal by Subject|2|||
160935105|NCT01234467|581156874|FG000|Overall Study|Disease Progression|2|||
160935106|NCT01234467|581156874|FG000|Overall Study|Clinical deterioration|1|||
160935107|NCT01234467|581156874|FG000|Overall Study|Physician Decision|1|||
160935108|NCT01234467|581156874|FG000|Overall Study|Other complicating disease (stroke)|1|||
160935109|NCT01120210|581156877|FG000|MAIN INFUSION|Adverse Event|1|||
160935110|NCT01120210|581156878|FG001|MAIN INFUSION|Adverse Event|0|||
160935111|NCT01120210|581156877|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
160935112|NCT01120210|581156878|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
160935113|NCT04049760|581156886|FG000|Overall Study|Withdrawal by Subject|1|||
160935114|NCT03995953|581156889|FG000|Overall Study|Death|3|||
160935115|NCT03995953|581156890|FG001|Overall Study|Death|0|||
160935116|NCT03995953|581156891|FG002|Overall Study|Death|3|||
160935117|NCT03995953|581156892|FG003|Overall Study|Death|0|||
160935118|NCT03995953|581156893|FG004|Overall Study|Death|3|||
160935119|NCT03995953|581156894|FG005|Overall Study|Death|0|||
160935120|NCT03995953|581156895|FG006|Overall Study|Death|0|||
160935121|NCT03995953|581156896|FG007|Overall Study|Death|0|||
160935122|NCT03995953|581156897|FG008|Overall Study|Death|1|||
160935123|NCT03995953|581156898|FG009|Overall Study|Death|0|||
160935124|NCT03995953|581156899|FG010|Overall Study|Death|0|||
160998496|NCT02812966|581378677|FG000|Overall Study|Death|1|||
161264584|NCT01246011|582350675|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
161264585|NCT01246011|582350673|FG000|Overall Study|Withdrawal by Subject|0|||
160935125|NCT03995953|581156900|FG011|Overall Study|Death|0|||
160935126|NCT03995953|581156889|FG000|Overall Study|Lost to Follow-up|6|||
160935127|NCT03995953|581156890|FG001|Overall Study|Lost to Follow-up|54|||
160935128|NCT03995953|581156891|FG002|Overall Study|Lost to Follow-up|3|||
160935129|NCT03995953|581156892|FG003|Overall Study|Lost to Follow-up|32|||
160935130|NCT03995953|581156893|FG004|Overall Study|Lost to Follow-up|5|||
160998497|NCT02812966|581378678|FG001|Overall Study|Death|0|||
160998498|NCT01066923|581378679|FG000|Overall Study|Withdrawal by Subject|3|||
161264586|NCT01246011|582350674|FG001|Overall Study|Withdrawal by Subject|0|||
161264587|NCT01246011|582350675|FG002|Overall Study|Withdrawal by Subject|1|||
160935131|NCT03995953|581156894|FG005|Overall Study|Lost to Follow-up|44|||
160935132|NCT03995953|581156895|FG006|Overall Study|Lost to Follow-up|0|||
160935133|NCT03995953|581156896|FG007|Overall Study|Lost to Follow-up|31|||
160935134|NCT03995953|581156897|FG008|Overall Study|Lost to Follow-up|8|||
160935135|NCT03995953|581156898|FG009|Overall Study|Lost to Follow-up|36|||
160935136|NCT03995953|581156899|FG010|Overall Study|Lost to Follow-up|5|||
160998499|NCT01066923|581378680|FG001|Overall Study|Withdrawal by Subject|3|||
160998500|NCT01066923|581378681|FG002|Overall Study|Withdrawal by Subject|8|||
160935137|NCT03995953|581156900|FG011|Overall Study|Lost to Follow-up|41|||
160935138|NCT03995953|581156889|FG000|Overall Study|Withdrawal by Subject|4|||
160935139|NCT03995953|581156890|FG001|Overall Study|Withdrawal by Subject|0|||
160935140|NCT03995953|581156891|FG002|Overall Study|Withdrawal by Subject|1|||
160935141|NCT03995953|581156892|FG003|Overall Study|Withdrawal by Subject|0|||
160935142|NCT03995953|581156893|FG004|Overall Study|Withdrawal by Subject|1|||
160935143|NCT03995953|581156894|FG005|Overall Study|Withdrawal by Subject|0|||
160935144|NCT03995953|581156895|FG006|Overall Study|Withdrawal by Subject|1|||
160935145|NCT03995953|581156896|FG007|Overall Study|Withdrawal by Subject|0|||
160935146|NCT03995953|581156897|FG008|Overall Study|Withdrawal by Subject|3|||
160935147|NCT03995953|581156898|FG009|Overall Study|Withdrawal by Subject|0|||
160935148|NCT03995953|581156899|FG010|Overall Study|Withdrawal by Subject|3|||
160935149|NCT03995953|581156900|FG011|Overall Study|Withdrawal by Subject|0|||
160935150|NCT03995953|581156889|FG000|Overall Study|Health Issues|0|||
160935151|NCT03995953|581156890|FG001|Overall Study|Health Issues|0|||
160935152|NCT03995953|581156891|FG002|Overall Study|Health Issues|0|||
160935153|NCT03995953|581156892|FG003|Overall Study|Health Issues|0|||
160935154|NCT03995953|581156893|FG004|Overall Study|Health Issues|1|||
160935155|NCT03995953|581156894|FG005|Overall Study|Health Issues|0|||
160935156|NCT03995953|581156895|FG006|Overall Study|Health Issues|0|||
160935157|NCT03995953|581156896|FG007|Overall Study|Health Issues|0|||
160935158|NCT03995953|581156897|FG008|Overall Study|Health Issues|4|||
160935159|NCT03995953|581156898|FG009|Overall Study|Health Issues|0|||
160935160|NCT03995953|581156899|FG010|Overall Study|Health Issues|0|||
160935161|NCT03995953|581156900|FG011|Overall Study|Health Issues|0|||
160935162|NCT03995953|581156889|FG000|Overall Study|Relocated|11|||
160935163|NCT03995953|581156890|FG001|Overall Study|Relocated|0|||
160935164|NCT03995953|581156891|FG002|Overall Study|Relocated|16|||
160935165|NCT03995953|581156892|FG003|Overall Study|Relocated|0|||
160935166|NCT03995953|581156893|FG004|Overall Study|Relocated|14|||
160935167|NCT03995953|581156894|FG005|Overall Study|Relocated|0|||
160935168|NCT03995953|581156895|FG006|Overall Study|Relocated|16|||
160935169|NCT03995953|581156896|FG007|Overall Study|Relocated|0|||
160935170|NCT03995953|581156897|FG008|Overall Study|Relocated|14|||
160935171|NCT03995953|581156898|FG009|Overall Study|Relocated|0|||
160935172|NCT03995953|581156899|FG010|Overall Study|Relocated|15|||
160935173|NCT03995953|581156900|FG011|Overall Study|Relocated|0|||
160935174|NCT02388997|581156901|FG000|Overall Study|Adverse Event|1|||
160935175|NCT02388997|581156902|FG001|Overall Study|Adverse Event|2|||
160935176|NCT02388997|581156901|FG000|Overall Study|Withdrawal by Subject|2|||
160935177|NCT02388997|581156902|FG001|Overall Study|Withdrawal by Subject|1|||
160935178|NCT02388997|581156901|FG000|Overall Study|Lung function exclusion criteria|0|||
160935179|NCT02388997|581156902|FG001|Overall Study|Lung function exclusion criteria|2|||
160935180|NCT02388997|581156901|FG000|Overall Study|Tested positive for virus during run-in|0|||
160935181|NCT02388997|581156902|FG001|Overall Study|Tested positive for virus during run-in|1|||
160935182|NCT02130765|581156903|FG000|Overall Study|Did not receive treatment|4|||
160935183|NCT02130765|581156904|FG001|Overall Study|Did not receive treatment|0|||
160935184|NCT02130765|581156905|FG002|Overall Study|Did not receive treatment|0|||
160935185|NCT02130765|581156906|FG003|Overall Study|Did not receive treatment|0|||
161143827|NCT01933672|581909505|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160935186|NCT00006184|581156909|FG000|Overall Study|Death|1|||
160935187|NCT00006184|581156910|FG001|Overall Study|Death|0|||
161143828|NCT01933672|581909506|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
161143829|NCT01933672|581909507|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160935188|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
160935189|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
160935190|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
160935191|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
160935192|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
160935193|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
160935194|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
160935195|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
160935196|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
160935197|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
160935198|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
160935199|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
160935200|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
160935201|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
161143830|NCT01933672|581909508|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
160935202|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
160935203|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
160935204|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
160935205|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
160935206|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
160935207|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
160935208|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
160935209|NCT02161718|581156911|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
160935210|NCT02161718|581156912|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
160935211|NCT02161718|581156913|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
160935212|NCT02161718|581156911|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
160935213|NCT02161718|581156912|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
161143831|NCT03478683|581909511|FG000|Overall Study|Adverse Event|5|||
161143832|NCT03478683|581909512|FG001|Overall Study|Adverse Event|3|||
161143833|NCT03478683|581909511|FG000|Overall Study|Lost to Follow-up|0|||
161143834|NCT03478683|581909512|FG001|Overall Study|Lost to Follow-up|5|||
160935214|NCT02161718|581156913|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
160935215|NCT02161718|581156911|FG000|Post- Randomization Period|Lost to Follow-up|0|||
160935216|NCT02161718|581156912|FG001|Post- Randomization Period|Lost to Follow-up|9|||
160935217|NCT02161718|581156913|FG002|Post- Randomization Period|Lost to Follow-up|15|||
160935218|NCT02161718|581156911|FG000|Post- Randomization Period|Adverse Event|0|||
160935219|NCT02161718|581156912|FG001|Post- Randomization Period|Adverse Event|9|||
160935220|NCT02161718|581156913|FG002|Post- Randomization Period|Adverse Event|10|||
160935221|NCT02161718|581156911|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
160935222|NCT02161718|581156912|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
161143835|NCT03478683|581909511|FG000|Overall Study|Physician Decision|1|||
161143836|NCT03478683|581909512|FG001|Overall Study|Physician Decision|3|||
161143837|NCT03478683|581909511|FG000|Overall Study|Withdrawal by Subject|7|||
161143838|NCT03478683|581909512|FG001|Overall Study|Withdrawal by Subject|7|||
161143839|NCT00524303|581909513|FG000|Overall Study|Lost to Follow-up|6|||
161143840|NCT00524303|581909514|FG001|Overall Study|Lost to Follow-up|0|||
161143841|NCT00524303|581909515|FG002|Overall Study|Lost to Follow-up|3|||
161143842|NCT00524303|581909513|FG000|Overall Study|Protocol Violation|0|||
161143843|NCT00524303|581909514|FG001|Overall Study|Protocol Violation|1|||
161143844|NCT00524303|581909515|FG002|Overall Study|Protocol Violation|1|||
161143845|NCT00524303|581909513|FG000|Overall Study|Withdrawal by Subject|3|||
161143846|NCT00524303|581909514|FG001|Overall Study|Withdrawal by Subject|0|||
161143847|NCT00524303|581909515|FG002|Overall Study|Withdrawal by Subject|4|||
161143848|NCT00524303|581909513|FG000|Overall Study|Death|0|||
161143849|NCT00524303|581909514|FG001|Overall Study|Death|2|||
161143850|NCT00524303|581909515|FG002|Overall Study|Death|3|||
161143851|NCT00524303|581909513|FG000|Overall Study|Adverse Event|1|||
161143852|NCT00524303|581909514|FG001|Overall Study|Adverse Event|2|||
161143853|NCT00524303|581909515|FG002|Overall Study|Adverse Event|3|||
161143854|NCT00524303|581909513|FG000|Overall Study|Did not Complete Study Dosing|1|||
161143855|NCT00524303|581909514|FG001|Overall Study|Did not Complete Study Dosing|0|||
161143856|NCT00524303|581909515|FG002|Overall Study|Did not Complete Study Dosing|0|||
161143857|NCT00524303|581909513|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
161143858|NCT00524303|581909514|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
161143859|NCT00524303|581909515|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
161143860|NCT00524303|581909513|FG000|Overall Study|Disease Progression|0|||
161143861|NCT00524303|581909514|FG001|Overall Study|Disease Progression|4|||
160935223|NCT02161718|581156913|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
160935224|NCT02161718|581156911|FG000|Post- Randomization Period|Physician Decision|0|||
160935225|NCT02161718|581156912|FG001|Post- Randomization Period|Physician Decision|2|||
160935226|NCT02161718|581156913|FG002|Post- Randomization Period|Physician Decision|4|||
160935227|NCT02161718|581156911|FG000|Post- Randomization Period|Protocol Violation|0|||
160935228|NCT02161718|581156912|FG001|Post- Randomization Period|Protocol Violation|2|||
160935229|NCT02161718|581156913|FG002|Post- Randomization Period|Protocol Violation|3|||
160935230|NCT02161718|581156911|FG000|Post- Randomization Period|Lack of Efficacy|0|||
160935231|NCT02161718|581156912|FG001|Post- Randomization Period|Lack of Efficacy|0|||
160935232|NCT02161718|581156913|FG002|Post- Randomization Period|Lack of Efficacy|1|||
161143862|NCT00524303|581909515|FG002|Overall Study|Disease Progression|1|||
160935233|NCT02161718|581156911|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
161143863|NCT00524303|581909513|FG000|Overall Study|Disease Recurrence|0|||
161143864|NCT00524303|581909514|FG001|Overall Study|Disease Recurrence|1|||
161143865|NCT00524303|581909515|FG002|Overall Study|Disease Recurrence|0|||
161143866|NCT00524303|581909513|FG000|Overall Study|Sponsor Request|0|||
161143867|NCT00524303|581909514|FG001|Overall Study|Sponsor Request|0|||
161143868|NCT00524303|581909515|FG002|Overall Study|Sponsor Request|1|||
161143869|NCT00524303|581909513|FG000|Overall Study|Physician Decision|0|||
161143870|NCT00524303|581909514|FG001|Overall Study|Physician Decision|0|||
161143871|NCT00524303|581909515|FG002|Overall Study|Physician Decision|1|||
161143872|NCT00524303|581909513|FG000|Overall Study|Completed 5 years|0|||
161143873|NCT00524303|581909514|FG001|Overall Study|Completed 5 years|0|||
161143874|NCT00524303|581909515|FG002|Overall Study|Completed 5 years|1|||
161143875|NCT01676116|581909524|FG000|Overall Study|Withdrawal criteria|2|||
161143876|NCT01676116|581909525|FG001|Overall Study|Withdrawal criteria|14|||
161143877|NCT01676116|581909524|FG000|Overall Study|Adverse Event|1|||
161143878|NCT01676116|581909525|FG001|Overall Study|Adverse Event|2|||
161143879|NCT01676116|581909524|FG000|Overall Study|Unclassified|4|||
160935234|NCT02161718|581156912|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
160935235|NCT02161718|581156913|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
160935236|NCT02161718|581156911|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
160935237|NCT02161718|581156912|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
160935238|NCT02161718|581156913|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
160935239|NCT02161718|581156911|FG000|Post- Randomization Period|Relocation|0|||
160935240|NCT02161718|581156912|FG001|Post- Randomization Period|Relocation|3|||
160935241|NCT02161718|581156913|FG002|Post- Randomization Period|Relocation|0|||
160935242|NCT02948842|581156915|FG000|Overall Study|Withdrawal by Subject|4|||
160935243|NCT01537783|581156916|FG000|Overall Study|Lost to Follow-up|11|||
160935244|NCT01537783|581156917|FG001|Overall Study|Lost to Follow-up|2|||
160935245|NCT02350309|581156919|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935246|NCT02350309|581156920|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935247|NCT02350309|581156921|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
160935248|NCT02350309|581156922|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935249|NCT02350309|581156923|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935250|NCT02350309|581156924|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
160935251|NCT02350309|581156919|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935252|NCT02350309|581156920|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935253|NCT02350309|581156921|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935254|NCT02350309|581156922|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935255|NCT02350309|581156923|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
160935256|NCT02350309|581156924|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
160935257|NCT00207142|581156925|FG000|Induction Phase|Adverse Event|9|||
160935258|NCT00207142|581156926|FG001|Induction Phase|Adverse Event|0|||
160935259|NCT00207142|581156927|FG002|Induction Phase|Adverse Event|0|||
160935260|NCT00207142|581156928|FG003|Induction Phase|Adverse Event|0|||
160935261|NCT00207142|581156925|FG000|Induction Phase|Death|1|||
160935262|NCT00207142|581156926|FG001|Induction Phase|Death|0|||
160935263|NCT00207142|581156927|FG002|Induction Phase|Death|0|||
160935264|NCT00207142|581156928|FG003|Induction Phase|Death|0|||
160935265|NCT00207142|581156925|FG000|Induction Phase|Lack of Efficacy|1|||
160935266|NCT00207142|581156926|FG001|Induction Phase|Lack of Efficacy|0|||
160935267|NCT00207142|581156927|FG002|Induction Phase|Lack of Efficacy|0|||
160935268|NCT00207142|581156928|FG003|Induction Phase|Lack of Efficacy|0|||
160935269|NCT00207142|581156925|FG000|Induction Phase|Lost to Follow-up|5|||
160935270|NCT00207142|581156926|FG001|Induction Phase|Lost to Follow-up|0|||
160935271|NCT00207142|581156927|FG002|Induction Phase|Lost to Follow-up|0|||
160935272|NCT00207142|581156928|FG003|Induction Phase|Lost to Follow-up|0|||
160935273|NCT00207142|581156925|FG000|Induction Phase|Physician Decision|2|||
160935274|NCT00207142|581156926|FG001|Induction Phase|Physician Decision|0|||
160935275|NCT00207142|581156927|FG002|Induction Phase|Physician Decision|0|||
160935276|NCT00207142|581156928|FG003|Induction Phase|Physician Decision|0|||
160935277|NCT00207142|581156925|FG000|Induction Phase|Poor/noncompliance|2|||
160935278|NCT00207142|581156926|FG001|Induction Phase|Poor/noncompliance|0|||
160935279|NCT00207142|581156927|FG002|Induction Phase|Poor/noncompliance|0|||
160935280|NCT00207142|581156928|FG003|Induction Phase|Poor/noncompliance|0|||
160935281|NCT00207142|581156925|FG000|Induction Phase|Pregnancy|1|||
160935282|NCT00207142|581156926|FG001|Induction Phase|Pregnancy|0|||
160935283|NCT00207142|581156927|FG002|Induction Phase|Pregnancy|0|||
160935284|NCT00207142|581156928|FG003|Induction Phase|Pregnancy|0|||
160935285|NCT00207142|581156925|FG000|Induction Phase|Subject no longer meets study criteria|3|||
160935286|NCT00207142|581156926|FG001|Induction Phase|Subject no longer meets study criteria|0|||
160935287|NCT00207142|581156927|FG002|Induction Phase|Subject no longer meets study criteria|0|||
160935288|NCT00207142|581156928|FG003|Induction Phase|Subject no longer meets study criteria|0|||
160935289|NCT00207142|581156925|FG000|Induction Phase|Withdrawal by Subject|4|||
160935290|NCT00207142|581156926|FG001|Induction Phase|Withdrawal by Subject|0|||
160935291|NCT00207142|581156927|FG002|Induction Phase|Withdrawal by Subject|0|||
160935292|NCT00207142|581156928|FG003|Induction Phase|Withdrawal by Subject|0|||
160935293|NCT00207142|581156925|FG000|Induction Phase|Incarceration|1|||
160935294|NCT00207142|581156926|FG001|Induction Phase|Incarceration|0|||
160935295|NCT00207142|581156927|FG002|Induction Phase|Incarceration|0|||
160935296|NCT00207142|581156928|FG003|Induction Phase|Incarceration|0|||
160935297|NCT00207142|581156925|FG000|Induction Phase|Missing lab data|1|||
160935298|NCT00207142|581156926|FG001|Induction Phase|Missing lab data|0|||
160998501|NCT01066923|581378682|FG003|Overall Study|Withdrawal by Subject|8|||
160998502|NCT02577523|581380529|FG000|Overall Study|Adverse Event|1|||
160935299|NCT00207142|581156927|FG002|Induction Phase|Missing lab data|0|||
160935300|NCT00207142|581156928|FG003|Induction Phase|Missing lab data|0|||
160998503|NCT02577523|581380530|FG001|Overall Study|Adverse Event|1|||
160998504|NCT02577523|581380529|FG000|Overall Study|Lack of Efficacy|1|||
160998505|NCT02577523|581380530|FG001|Overall Study|Lack of Efficacy|1|||
160998506|NCT02577523|581380529|FG000|Overall Study|Withdrawal by Subject|1|||
160935301|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
160935302|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
160998507|NCT02577523|581380530|FG001|Overall Study|Withdrawal by Subject|0|||
160998508|NCT00487578|581380533|FG000|Overall Study|Adverse Event|1|||
160935303|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
160935304|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
160935305|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
160935306|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
160935307|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
160935308|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
160935309|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
160935310|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
160935311|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
160935312|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
160935313|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
160935314|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
160935315|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
160935316|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
160935317|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
160935318|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
160935319|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
160935320|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
160935321|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
160935322|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
160935323|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
160935324|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
160935325|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
160935326|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
160935327|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
160935328|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
160935329|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Death|0|||
160935330|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Death|0|||
160935331|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Death|0|||
160935332|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Death|1|||
160935333|NCT00207142|581156925|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
160935334|NCT00207142|581156926|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
160935335|NCT00207142|581156927|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
160935336|NCT00207142|581156928|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
160935337|NCT01554618|581156929|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
160935338|NCT01554618|581156930|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
160935339|NCT01554618|581156929|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
160935340|NCT01554618|581156930|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
160935341|NCT01554618|581156929|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
160935342|NCT01554618|581156930|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
160935343|NCT01554618|581156929|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
160935344|NCT01554618|581156930|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
160935345|NCT01554618|581156929|FG000|Open-Label Extension Period|Physician Decision|0|||
160935346|NCT01554618|581156930|FG001|Open-Label Extension Period|Physician Decision|1|||
160935347|NCT01554618|581156929|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
160935348|NCT01554618|581156930|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
160935349|NCT01857063|581156931|FG000|Period 1 (7 Days)|Adverse Event|0|||
160935350|NCT01857063|581156932|FG001|Period 1 (7 Days)|Adverse Event|1|||
160935351|NCT01857063|581156931|FG000|Period 1 (7 Days)|Physician Decision|1|||
160935352|NCT01857063|581156932|FG001|Period 1 (7 Days)|Physician Decision|0|||
160935353|NCT01857063|581156931|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
160935354|NCT01857063|581156932|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
160935355|NCT01857063|581156931|FG000|Period 2 (7 Days)|Adverse Event|2|||
160935356|NCT01857063|581156932|FG001|Period 2 (7 Days)|Adverse Event|1|||
160935357|NCT01857063|581156931|FG000|Period 2 (7 Days)|Physician Decision|1|||
160935358|NCT01857063|581156932|FG001|Period 2 (7 Days)|Physician Decision|1|||
160935359|NCT01857063|581156931|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
160935360|NCT01857063|581156932|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
160935361|NCT01256710|581156933|FG000|Overall Study|Death|449|||
160935362|NCT01256710|581156933|FG000|Overall Study|System Explant|67|||
160935363|NCT01256710|581156933|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
160998509|NCT00487578|581380534|FG001|Overall Study|Adverse Event|2|||
160998510|NCT00487578|581380533|FG000|Overall Study|Lack of Efficacy|0|||
160998511|NCT00487578|581380534|FG001|Overall Study|Lack of Efficacy|1|||
160998512|NCT00487578|581380533|FG000|Overall Study|Lost to Follow-up|0|||
160998513|NCT00487578|581380534|FG001|Overall Study|Lost to Follow-up|1|||
160935364|NCT01256710|581156933|FG000|Overall Study|Lost to Follow-up|67|||
160935365|NCT01256710|581156933|FG000|Overall Study|Withdrawal by Subject|29|||
160935366|NCT01256710|581156933|FG000|Overall Study|Physician Decision|9|||
161143880|NCT01676116|581909525|FG001|Overall Study|Unclassified|10|||
161143881|NCT01676116|581909524|FG000|Overall Study|Protocol Violation|9|||
160935367|NCT01256710|581156933|FG000|Overall Study|Subject Noncompliance|2|||
160935368|NCT01256710|581156933|FG000|Overall Study|Study Terminated by Sponsor|273|||
160935369|NCT00058825|581156934|FG000|Overall Study|Relapse|9|||
160935370|NCT00058825|581156934|FG000|Overall Study|Progressive Disease|5|||
160935371|NCT00058825|581156934|FG000|Overall Study|Graft Failure|5|||
160935372|NCT00058825|581156934|FG000|Overall Study|Death|3|||
160935373|NCT01205165|581156935|FG000|Overall Study|Lost to Follow-up|2|||
160935374|NCT00329407|581156943|FG000|Overall Study|Withdrawal by Subject|1|||
160935375|NCT00978068|581156944|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
160935376|NCT00978068|581156945|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
160935377|NCT00978068|581156944|FG000|Overall Study|Death|1|||
160935378|NCT00978068|581156945|FG001|Overall Study|Death|2|||
160935379|NCT00978068|581156944|FG000|Overall Study|Lost to Follow-up|1|||
160935380|NCT00978068|581156945|FG001|Overall Study|Lost to Follow-up|2|||
160935381|NCT00978068|581156944|FG000|Overall Study|Physician Decision|0|||
160935382|NCT00978068|581156945|FG001|Overall Study|Physician Decision|1|||
160935383|NCT00978068|581156944|FG000|Overall Study|Unable to Comply with Study|0|||
160935384|NCT00978068|581156945|FG001|Overall Study|Unable to Comply with Study|2|||
160935385|NCT02275481|581156946|FG000|Overall Study|Death|2|||
160935386|NCT02275481|581156947|FG001|Overall Study|Death|1|||
160935387|NCT02275481|581156946|FG000|Overall Study|Lost to Follow-up|2|||
160935388|NCT02275481|581156947|FG001|Overall Study|Lost to Follow-up|0|||
160935389|NCT02275481|581156946|FG000|Overall Study|Withdrawal by Subject|3|||
160935390|NCT02275481|581156947|FG001|Overall Study|Withdrawal by Subject|0|||
160935391|NCT02275481|581156946|FG000|Overall Study|all other reasons combined|2|||
160935392|NCT02275481|581156947|FG001|Overall Study|all other reasons combined|1|||
160935393|NCT02275481|581156946|FG000|Overall Study|Physician Decision|0|||
160935394|NCT02275481|581156947|FG001|Overall Study|Physician Decision|1|||
160935395|NCT01393405|581156948|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
160935396|NCT01393405|581156949|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
160935397|NCT01393405|581156950|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
160935398|NCT01393405|581156948|FG000|Induction Period (week1-16)|Adverse Event|16|||
160935399|NCT01393405|581156949|FG001|Induction Period (week1-16)|Adverse Event|0|||
160935400|NCT01393405|581156950|FG002|Induction Period (week1-16)|Adverse Event|0|||
160935401|NCT01393405|581156948|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
160935402|NCT01393405|581156949|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
160935403|NCT01393405|581156950|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
160935404|NCT01393405|581156948|FG000|Maintenance Period Week|Lack of Efficacy|0|||
160935405|NCT01393405|581156949|FG001|Maintenance Period Week|Lack of Efficacy|22|||
160935406|NCT01393405|581156950|FG002|Maintenance Period Week|Lack of Efficacy|22|||
160935407|NCT01393405|581156948|FG000|Maintenance Period Week|Adverse Event|0|||
160935408|NCT01393405|581156949|FG001|Maintenance Period Week|Adverse Event|5|||
160935409|NCT01393405|581156950|FG002|Maintenance Period Week|Adverse Event|2|||
160935410|NCT01393405|581156948|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
160935411|NCT01393405|581156949|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
160935412|NCT01393405|581156950|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
160935413|NCT01393405|581156948|FG000|Maintenance Period Week|Lost to Follow-up|0|||
160935414|NCT01393405|581156949|FG001|Maintenance Period Week|Lost to Follow-up|1|||
160935415|NCT01393405|581156950|FG002|Maintenance Period Week|Lost to Follow-up|0|||
160935416|NCT01434290|581156951|FG000|Overall Study|Protocol Violation|6|||
160935417|NCT01434290|581156952|FG001|Overall Study|Protocol Violation|3|||
160935418|NCT01434290|581156951|FG000|Overall Study|No protocol treatment|2|||
160935419|NCT01434290|581156952|FG001|Overall Study|No protocol treatment|4|||
160935420|NCT02281552|581156953|FG000|Overall Study|Medication error|1|||
160935421|NCT02281552|581156954|FG001|Overall Study|Medication error|0|||
160935422|NCT02281552|581156953|FG000|Overall Study|Insufficient clinical response|0|||
160935423|NCT02281552|581156954|FG001|Overall Study|Insufficient clinical response|1|||
160935424|NCT02281552|581156953|FG000|Overall Study|Adverse Event|3|||
160935425|NCT02281552|581156954|FG001|Overall Study|Adverse Event|9|||
160935426|NCT01224639|581156955|FG000|Overall Study|Withdrawal by Subject|0|||
160935427|NCT01224639|581156956|FG001|Overall Study|Withdrawal by Subject|0|||
160935428|NCT01224639|581156957|FG002|Overall Study|Withdrawal by Subject|0|||
160935429|NCT01224639|581156958|FG003|Overall Study|Withdrawal by Subject|0|||
160935430|NCT01224639|581156959|FG004|Overall Study|Withdrawal by Subject|2|||
160935431|NCT01224639|581156960|FG005|Overall Study|Withdrawal by Subject|0|||
160935432|NCT01224639|581156961|FG006|Overall Study|Withdrawal by Subject|1|||
160935433|NCT01224639|581156962|FG007|Overall Study|Withdrawal by Subject|1|||
160935434|NCT01224639|581156955|FG000|Overall Study|Adverse Event|0|||
160935435|NCT01224639|581156956|FG001|Overall Study|Adverse Event|0|||
160935436|NCT01224639|581156957|FG002|Overall Study|Adverse Event|0|||
160935437|NCT01224639|581156958|FG003|Overall Study|Adverse Event|0|||
160935438|NCT01224639|581156959|FG004|Overall Study|Adverse Event|0|||
160935439|NCT01224639|581156960|FG005|Overall Study|Adverse Event|0|||
160935440|NCT01224639|581156961|FG006|Overall Study|Adverse Event|0|||
160935441|NCT01224639|581156962|FG007|Overall Study|Adverse Event|1|||
160935442|NCT04656132|581156963|FG000|Overall Study|Lost to Follow-up|4|||
160935443|NCT04656132|581156963|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
160935444|NCT04365699|581156964|FG000|Overall Study|Death|2|||
160935445|NCT04365699|581156965|FG001|Overall Study|Death|5|||
160935446|NCT04365699|581156966|FG002|Overall Study|Death|15|||
160935447|NCT03925727|581156968|FG000|Overall Study|Adverse Event|4|||
160935448|NCT03925727|581156969|FG001|Overall Study|Adverse Event|0|||
160935449|NCT03925727|581156970|FG002|Overall Study|Adverse Event|3|||
160935450|NCT03925727|581156968|FG000|Overall Study|Protocol Violation|1|||
160935451|NCT03925727|581156969|FG001|Overall Study|Protocol Violation|2|||
160935452|NCT03925727|581156970|FG002|Overall Study|Protocol Violation|2|||
160935453|NCT03925727|581156968|FG000|Overall Study|Withdrawal by Subject|3|||
160935454|NCT03925727|581156969|FG001|Overall Study|Withdrawal by Subject|2|||
160935455|NCT03925727|581156970|FG002|Overall Study|Withdrawal by Subject|4|||
160935456|NCT03925727|581156968|FG000|Overall Study|Administrative Reasons|3|||
160935457|NCT03925727|581156969|FG001|Overall Study|Administrative Reasons|1|||
160935458|NCT03925727|581156970|FG002|Overall Study|Administrative Reasons|2|||
160935459|NCT03925727|581156968|FG000|Overall Study|Randomized in error or Disqualified|8|||
160935460|NCT03925727|581156969|FG001|Overall Study|Randomized in error or Disqualified|1|||
160935461|NCT03925727|581156970|FG002|Overall Study|Randomized in error or Disqualified|7|||
160935462|NCT03044197|581156983|FG000|Overall Study|Withdrawal by Subject|3|||
160935463|NCT03044197|581156984|FG001|Overall Study|Withdrawal by Subject|1|||
160935464|NCT00834912|581156985|FG000|Treatment Period 1|Adverse Event|0|||
160935465|NCT00834912|581156986|FG001|Treatment Period 1|Adverse Event|1|||
160935466|NCT00834912|581156987|FG002|Treatment Period 1|Adverse Event|0|||
160935467|NCT00834912|581156988|FG003|Treatment Period 1|Adverse Event|1|||
160935468|NCT00834912|581156989|FG004|Treatment Period 1|Adverse Event|0|||
160935469|NCT00834912|581156990|FG005|Treatment Period 1|Adverse Event|0|||
160935470|NCT00834912|581156985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160935471|NCT00834912|581156986|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160935472|NCT00834912|581156987|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160935473|NCT00834912|581156988|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160935474|NCT00834912|581156989|FG004|Treatment Period 2|Withdrawal by Subject|1|||
160935475|NCT00834912|581156990|FG005|Treatment Period 2|Withdrawal by Subject|0|||
160935476|NCT01574352|581156993|FG000|Overall Study|Withdrawal by Subject|6|||
160935477|NCT01574352|581156994|FG001|Overall Study|Withdrawal by Subject|13|||
160935478|NCT01574352|581156993|FG000|Overall Study|Injury in non-camp related sport|1|||
160935479|NCT01574352|581156994|FG001|Overall Study|Injury in non-camp related sport|0|||
160935480|NCT00256698|581156995|FG000|Overall Study|Withdrawal by Subject|7|||
160935481|NCT00256698|581156996|FG001|Overall Study|Withdrawal by Subject|7|||
160935482|NCT00256698|581156995|FG000|Overall Study|Adverse Event|13|||
160935483|NCT00256698|581156996|FG001|Overall Study|Adverse Event|6|||
160935484|NCT00256698|581156995|FG000|Overall Study|Protocol Violation|6|||
160935485|NCT00256698|581156996|FG001|Overall Study|Protocol Violation|5|||
160935486|NCT00256698|581156995|FG000|Overall Study|Lost to Follow-up|1|||
160935487|NCT00256698|581156996|FG001|Overall Study|Lost to Follow-up|3|||
160935488|NCT00256698|581156995|FG000|Overall Study|disease progression|97|||
160935489|NCT00256698|581156996|FG001|Overall Study|disease progression|105|||
160935490|NCT00256698|581156995|FG000|Overall Study|still ongoing at data cut-off|41|||
160935491|NCT00256698|581156996|FG001|Overall Study|still ongoing at data cut-off|46|||
160935492|NCT00256698|581156995|FG000|Overall Study|withdrawn due to osteoporosis|1|||
160935493|NCT00256698|581156996|FG001|Overall Study|withdrawn due to osteoporosis|0|||
160935494|NCT00256698|581156995|FG000|Overall Study|Prematurely Discontinued|1|||
160935495|NCT00256698|581156996|FG001|Overall Study|Prematurely Discontinued|0|||
160935496|NCT03962543|581156997|FG000|Treatment Phase|Death|0|||
160935497|NCT03962543|581156998|FG001|Treatment Phase|Death|1|||
160935498|NCT03962543|581156997|FG000|Treatment Phase|Withdrawal by Subject|3|||
160935499|NCT03962543|581156998|FG001|Treatment Phase|Withdrawal by Subject|0|||
160935500|NCT03962543|581156997|FG000|Treatment Phase|Adverse Event|3|||
161264588|NCT04392583|582350676|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
161264589|NCT01340768|582350679|FG000|Overall Study|Lost to Follow-up|10|||
161264590|NCT01340768|582350680|FG001|Overall Study|Lost to Follow-up|4|||
161264591|NCT01340768|582350679|FG000|Overall Study|Withdrawal by Subject|5|||
161264592|NCT01340768|582350680|FG001|Overall Study|Withdrawal by Subject|1|||
161264593|NCT01340768|582350679|FG000|Overall Study|Other|2|||
161264594|NCT01340768|582350680|FG001|Overall Study|Other|0|||
161342499|NCT04880850|582640215|FG000|Overall Study|Lost to Follow-up|3|||
160935501|NCT03962543|581156998|FG001|Treatment Phase|Adverse Event|12|||
160935502|NCT03962543|581156997|FG000|Treatment Phase|Lost to Follow-up|1|||
160935503|NCT03962543|581156998|FG001|Treatment Phase|Lost to Follow-up|2|||
160935504|NCT03962543|581156997|FG000|Treatment Phase|Radiographic PD|9|||
160935505|NCT03962543|581156998|FG001|Treatment Phase|Radiographic PD|3|||
160935506|NCT03962543|581156997|FG000|Treatment Phase|Participant Decision|3|||
160935507|NCT03962543|581156998|FG001|Treatment Phase|Participant Decision|8|||
160935508|NCT03962543|581156997|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
160935509|NCT03962543|581156998|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
160935510|NCT03962543|581156997|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
160935511|NCT03962543|581156998|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
161264595|NCT03052959|582350683|FG000|Overall Study|Lost to Follow-up|4|||
160935512|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
160935513|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
160935514|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
160935515|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
160935516|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
160935517|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
160935518|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
160935519|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
160935520|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
160935521|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
160935522|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
160935523|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
160935524|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
160935525|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
160935526|NCT03962543|581156997|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
160935527|NCT03962543|581156998|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
160935528|NCT03548584|581158769|FG000|Overall Study|Lost to Follow-up|0|||
160935529|NCT03548584|581158770|FG001|Overall Study|Lost to Follow-up|0|||
160935530|NCT03548584|581158771|FG002|Overall Study|Lost to Follow-up|1|||
160935531|NCT03548584|581158769|FG000|Overall Study|Adverse Event|1|||
160935532|NCT03548584|581158770|FG001|Overall Study|Adverse Event|11|||
160935533|NCT03548584|581158771|FG002|Overall Study|Adverse Event|5|||
160935534|NCT03548584|581158769|FG000|Overall Study|Site Terminated by Sponsor|1|||
160935535|NCT03548584|581158770|FG001|Overall Study|Site Terminated by Sponsor|3|||
160935536|NCT03548584|581158771|FG002|Overall Study|Site Terminated by Sponsor|2|||
160935537|NCT03548584|581158769|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
160935538|NCT03548584|581158770|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
160935539|NCT03548584|581158771|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
160935540|NCT03548584|581158769|FG000|Overall Study|Lack of Efficacy|0|||
160935541|NCT03548584|581158770|FG001|Overall Study|Lack of Efficacy|1|||
160935542|NCT03548584|581158771|FG002|Overall Study|Lack of Efficacy|0|||
160935543|NCT03548584|581158769|FG000|Overall Study|Non-compliance with Study Drug|0|||
160935544|NCT03548584|581158770|FG001|Overall Study|Non-compliance with Study Drug|1|||
160935545|NCT03548584|581158771|FG002|Overall Study|Non-compliance with Study Drug|0|||
160935546|NCT03548584|581158769|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
160935547|NCT03548584|581158770|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
160935548|NCT03548584|581158771|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
160935549|NCT01677195|581158773|FG000|Overall Study|Lost to Follow-up|14|||
160935550|NCT01677195|581158774|FG001|Overall Study|Lost to Follow-up|22|||
160935551|NCT01677195|581158775|FG002|Overall Study|Lost to Follow-up|22|||
160935552|NCT01677195|581158773|FG000|Overall Study|Withdrawal by Subject|1|||
160935553|NCT01677195|581158774|FG001|Overall Study|Withdrawal by Subject|0|||
160935554|NCT01677195|581158775|FG002|Overall Study|Withdrawal by Subject|1|||
160935555|NCT01677195|581158773|FG000|Overall Study|Adverse Event|6|||
160935556|NCT01677195|581158774|FG001|Overall Study|Adverse Event|4|||
160935557|NCT01677195|581158775|FG002|Overall Study|Adverse Event|1|||
160935558|NCT01677195|581158773|FG000|Overall Study|Physician Decision|1|||
160935559|NCT01677195|581158774|FG001|Overall Study|Physician Decision|2|||
160935560|NCT01677195|581158775|FG002|Overall Study|Physician Decision|2|||
160935561|NCT01677195|581158773|FG000|Overall Study|Pregnancy|0|||
160935562|NCT01677195|581158774|FG001|Overall Study|Pregnancy|1|||
160935563|NCT01677195|581158775|FG002|Overall Study|Pregnancy|0|||
160935564|NCT01677195|581158773|FG000|Overall Study|Protocol Violation|7|||
160935565|NCT01677195|581158774|FG001|Overall Study|Protocol Violation|3|||
160935566|NCT01677195|581158775|FG002|Overall Study|Protocol Violation|4|||
160935567|NCT03633396|581158778|FG000|Overall Study|Withdrawal by Subject|4|||
160935568|NCT03633396|581158779|FG001|Overall Study|Withdrawal by Subject|4|||
160935569|NCT03633396|581158778|FG000|Overall Study|Adverse Event|1|||
160935570|NCT03633396|581158779|FG001|Overall Study|Adverse Event|1|||
160935571|NCT03633396|581158778|FG000|Overall Study|Lack of Efficacy|1|||
160935572|NCT03633396|581158779|FG001|Overall Study|Lack of Efficacy|0|||
160935573|NCT03633396|581158778|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
160935574|NCT03633396|581158779|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
161143882|NCT01676116|581909525|FG001|Overall Study|Protocol Violation|3|||
161264596|NCT03052959|582350684|FG001|Overall Study|Lost to Follow-up|5|||
161264597|NCT02397408|582350685|FG000|Overall Study|Physician Decision|4|||
161264598|NCT02397408|582350685|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
160935575|NCT01012817|581158780|FG000|Overall Study|Withdrawal by Subject|0|||
160935576|NCT01012817|581158781|FG001|Overall Study|Withdrawal by Subject|0|||
160935577|NCT01012817|581158782|FG002|Overall Study|Withdrawal by Subject|0|||
160935578|NCT01012817|581158783|FG003|Overall Study|Withdrawal by Subject|1|||
160935579|NCT01012817|581158784|FG004|Overall Study|Withdrawal by Subject|0|||
160935580|NCT01012817|581158785|FG005|Overall Study|Withdrawal by Subject|0|||
161143883|NCT01821677|581909526|FG000|Overall Study|Adverse Event|4|||
160935581|NCT01012817|581158786|FG006|Overall Study|Withdrawal by Subject|0|||
160935582|NCT01012817|581158787|FG007|Overall Study|Withdrawal by Subject|1|||
160935583|NCT01012817|581158788|FG008|Overall Study|Withdrawal by Subject|0|||
160998514|NCT02525796|581380535|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
160998515|NCT02525796|581380536|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
160998516|NCT02525796|581380537|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
160998517|NCT02525796|581380535|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
160998518|NCT02525796|581380536|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
160935584|NCT01012817|581158789|FG009|Overall Study|Withdrawal by Subject|0|||
160935585|NCT01012817|581158790|FG010|Overall Study|Withdrawal by Subject|1|||
160935586|NCT01012817|581158791|FG011|Overall Study|Withdrawal by Subject|1|||
160935587|NCT01012817|581158792|FG012|Overall Study|Withdrawal by Subject|0|||
160935588|NCT01012817|581158793|FG013|Overall Study|Withdrawal by Subject|1|||
160935589|NCT01012817|581158780|FG000|Overall Study|Adverse Event|0|||
160935590|NCT01012817|581158781|FG001|Overall Study|Adverse Event|0|||
160935591|NCT01012817|581158782|FG002|Overall Study|Adverse Event|0|||
160935592|NCT01012817|581158783|FG003|Overall Study|Adverse Event|0|||
160935593|NCT01012817|581158784|FG004|Overall Study|Adverse Event|0|||
160935594|NCT01012817|581158785|FG005|Overall Study|Adverse Event|1|||
160935595|NCT01012817|581158786|FG006|Overall Study|Adverse Event|0|||
160935596|NCT01012817|581158787|FG007|Overall Study|Adverse Event|0|||
160935597|NCT01012817|581158788|FG008|Overall Study|Adverse Event|0|||
160935598|NCT01012817|581158789|FG009|Overall Study|Adverse Event|0|||
160935599|NCT01012817|581158790|FG010|Overall Study|Adverse Event|1|||
160935600|NCT01012817|581158791|FG011|Overall Study|Adverse Event|0|||
160935601|NCT01012817|581158792|FG012|Overall Study|Adverse Event|0|||
160935602|NCT01012817|581158793|FG013|Overall Study|Adverse Event|1|||
160935603|NCT00023673|581158794|FG000|Overall Study|Ineligible / no protocol treatment|0|||
160935604|NCT00023673|581158795|FG001|Overall Study|Ineligible / no protocol treatment|0|||
160935605|NCT00023673|581158796|FG002|Overall Study|Ineligible / no protocol treatment|0|||
160935606|NCT00023673|581158797|FG003|Overall Study|Ineligible / no protocol treatment|1|||
160935607|NCT00023673|581158794|FG000|Overall Study|Patient withdrew consent|0|||
160935608|NCT00023673|581158795|FG001|Overall Study|Patient withdrew consent|0|||
160935609|NCT00023673|581158796|FG002|Overall Study|Patient withdrew consent|0|||
160935610|NCT00023673|581158797|FG003|Overall Study|Patient withdrew consent|1|||
160935611|NCT00110266|581158798|FG000|Overall Study|Adverse Event|27|||
160935612|NCT00110266|581158798|FG000|Overall Study|Abnormal laboratory value|15|||
160935613|NCT00110266|581158798|FG000|Overall Study|Withdrawal by Subject|16|||
160935614|NCT00110266|581158798|FG000|Overall Study|Death|17|||
160935615|NCT00110266|581158798|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160935616|NCT00110266|581158798|FG000|Overall Study|Participant condition no longer requires study drug|1|||
160935617|NCT00634647|581158803|FG000|Overall Study|death on study|3|||
160935618|NCT00634647|581158803|FG000|Overall Study|refused further treatment|3|||
160935619|NCT00634647|581158803|FG000|Overall Study|declined to participate before treatment|1|||
160935620|NCT03852316|581158804|FG000|Overall Study|Protocol Violation|1|||
160935621|NCT03852316|581158804|FG000|Overall Study|Withdrawal by Subject|2|||
160935622|NCT03852316|581158804|FG000|Overall Study|Enrolled but Device not Utilized|1|||
160935623|NCT01018264|581158805|FG000|Overall Study|Withdrawal by Subject|1|||
160935624|NCT01018264|581158806|FG001|Overall Study|Withdrawal by Subject|0|||
160935625|NCT01018264|581158805|FG000|Overall Study|Lost to Follow-up|0|||
160935626|NCT01018264|581158806|FG001|Overall Study|Lost to Follow-up|1|||
160935627|NCT02075840|581158807|FG000|Overall Study|Withdrawal by Subject|13|||
160935628|NCT02075840|581158808|FG001|Overall Study|Withdrawal by Subject|22|||
160935629|NCT02075840|581158807|FG000|Overall Study|Reason not specified|1|||
160935630|NCT02075840|581158808|FG001|Overall Study|Reason not specified|0|||
160935631|NCT02075840|581158807|FG000|Overall Study|Adverse Event|0|||
160935632|NCT02075840|581158808|FG001|Overall Study|Adverse Event|2|||
160935633|NCT02075840|581158807|FG000|Overall Study|Death|35|||
160935634|NCT02075840|581158808|FG001|Overall Study|Death|40|||
160998519|NCT02525796|581380537|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
160998520|NCT02525796|581380535|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
160998521|NCT02525796|581380536|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
160998522|NCT02525796|581380537|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
160935635|NCT02075840|581158807|FG000|Overall Study|Lost to Follow-up|3|||
160935636|NCT02075840|581158808|FG001|Overall Study|Lost to Follow-up|2|||
160935637|NCT02075840|581158807|FG000|Overall Study|Physician Decision|1|||
160935638|NCT02075840|581158808|FG001|Overall Study|Physician Decision|3|||
160935639|NCT02075840|581158807|FG000|Overall Study|Ongoing at CCOD|99|||
160935640|NCT02075840|581158808|FG001|Overall Study|Ongoing at CCOD|82|||
160935641|NCT02644967|581158811|FG000|Overall Study|Death|26|||
160935642|NCT02644967|581158811|FG000|Overall Study|Physician Decision|1|||
160935643|NCT02644967|581158811|FG000|Overall Study|Withdrawal by Subject|2|||
160935644|NCT02644967|581158811|FG000|Overall Study|Protocol Violation|1|||
160935645|NCT02644967|581158811|FG000|Overall Study|Progressive Disease|1|||
160935646|NCT02644967|581158811|FG000|Overall Study|Study Terminated by Sponsor|4|||
160935647|NCT02287896|581158812|FG000|Second Injection Visit|Withdrawal by Subject|0|||
160935648|NCT02287896|581158813|FG001|Second Injection Visit|Withdrawal by Subject|1|||
160935649|NCT05179421|581158814|FG000|First Infusion Day|Adverse Event|1|||
160935650|NCT05179421|581158815|FG001|First Infusion Day|Adverse Event|0|||
160935651|NCT03746522|581158817|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
160935652|NCT03746522|581158818|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
160935653|NCT03746522|581158819|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
160935654|NCT03746522|581158817|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
160935655|NCT03746522|581158818|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
160935656|NCT03746522|581158819|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
160935657|NCT03746522|581158817|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
160935658|NCT03746522|581158818|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
160935659|NCT03746522|581158819|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
160935660|NCT03746522|581158817|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
160935661|NCT03746522|581158818|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
160935662|NCT03746522|581158819|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
160935663|NCT03746522|581158817|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
160935664|NCT03746522|581158818|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
160935665|NCT03746522|581158819|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
160935666|NCT03323099|581158820|FG000|Overall Study|Withdrawal by Subject|6|||
160935667|NCT03323099|581158821|FG001|Overall Study|Withdrawal by Subject|12|||
160935668|NCT03323099|581158820|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
160935669|NCT03323099|581158821|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
160935670|NCT00767676|581158824|FG000|Overall Study|Investigator error|54|||
160935671|NCT05132127|581158828|FG000|Overall Study|Adverse Event|1|||
160935672|NCT05220397|581158829|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935673|NCT05220397|581158830|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935674|NCT05220397|581158831|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
160935675|NCT05220397|581158832|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935676|NCT05220397|581158833|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
160935677|NCT02659020|581158834|FG000|Overall Study|Adverse Event|0|||
160935678|NCT02659020|581158835|FG001|Overall Study|Adverse Event|0|||
160935679|NCT02659020|581158836|FG002|Overall Study|Adverse Event|0|||
160935680|NCT02659020|581158837|FG003|Overall Study|Adverse Event|2|||
160935681|NCT02659020|581158838|FG004|Overall Study|Adverse Event|0|||
160935682|NCT02659020|581158839|FG005|Overall Study|Adverse Event|0|||
160935683|NCT02659020|581158840|FG006|Overall Study|Adverse Event|2|||
160935684|NCT02659020|581158834|FG000|Overall Study|Lost to Follow-up|1|||
160935685|NCT02659020|581158835|FG001|Overall Study|Lost to Follow-up|2|||
160935686|NCT02659020|581158836|FG002|Overall Study|Lost to Follow-up|1|||
160935687|NCT02659020|581158837|FG003|Overall Study|Lost to Follow-up|6|||
160935688|NCT02659020|581158838|FG004|Overall Study|Lost to Follow-up|1|||
160935689|NCT02659020|581158839|FG005|Overall Study|Lost to Follow-up|5|||
160935690|NCT02659020|581158840|FG006|Overall Study|Lost to Follow-up|0|||
160935691|NCT02659020|581158834|FG000|Overall Study|Physician Decision|0|||
160935692|NCT02659020|581158835|FG001|Overall Study|Physician Decision|0|||
160935693|NCT02659020|581158836|FG002|Overall Study|Physician Decision|0|||
160935694|NCT02659020|581158837|FG003|Overall Study|Physician Decision|1|||
160935695|NCT02659020|581158838|FG004|Overall Study|Physician Decision|1|||
160935696|NCT02659020|581158839|FG005|Overall Study|Physician Decision|0|||
161264599|NCT01646138|582350686|FG000|Overall Study|Lost to Follow-up|0|||
161264600|NCT01646138|582350687|FG001|Overall Study|Lost to Follow-up|0|||
161264601|NCT01646138|582350688|FG002|Overall Study|Lost to Follow-up|0|||
160935697|NCT02659020|581158840|FG006|Overall Study|Physician Decision|1|||
160935698|NCT02659020|581158834|FG000|Overall Study|Withdrawal by Subject|2|||
160935699|NCT02659020|581158835|FG001|Overall Study|Withdrawal by Subject|1|||
160935700|NCT02659020|581158836|FG002|Overall Study|Withdrawal by Subject|0|||
160935701|NCT02659020|581158837|FG003|Overall Study|Withdrawal by Subject|3|||
160935702|NCT02659020|581158838|FG004|Overall Study|Withdrawal by Subject|3|||
160935703|NCT02659020|581158839|FG005|Overall Study|Withdrawal by Subject|6|||
160935704|NCT02659020|581158840|FG006|Overall Study|Withdrawal by Subject|3|||
160935705|NCT02659020|581158834|FG000|Overall Study|Progressive Disease|0|||
160935706|NCT02659020|581158835|FG001|Overall Study|Progressive Disease|0|||
160935707|NCT02659020|581158836|FG002|Overall Study|Progressive Disease|0|||
160935708|NCT02659020|581158837|FG003|Overall Study|Progressive Disease|4|||
160935709|NCT02659020|581158838|FG004|Overall Study|Progressive Disease|1|||
160935710|NCT02659020|581158839|FG005|Overall Study|Progressive Disease|0|||
160935711|NCT02659020|581158840|FG006|Overall Study|Progressive Disease|2|||
160935712|NCT02052739|581158841|FG000|Overall Study|Withdrew due to Adverse Event|3|||
160935713|NCT02052739|581158842|FG001|Overall Study|Withdrew due to Adverse Event|0|||
160935714|NCT02052739|581158841|FG000|Overall Study|Participant Died|2|||
160935715|NCT02052739|581158842|FG001|Overall Study|Participant Died|1|||
160935716|NCT02043015|581158843|FG000|Overall Study|Lost to Follow-up|4|||
160935717|NCT02043015|581158843|FG000|Overall Study|Withdrawal by Subject|4|||
160935718|NCT02043015|581158843|FG000|Overall Study|Removed once target enrollment reached|15|||
160935719|NCT02043015|581158843|FG000|Overall Study|Participant moved away from study city|4|||
160935720|NCT02043015|581158843|FG000|Overall Study|Incarceration|1|||
160935721|NCT01077960|581158844|FG000|Overall Study|Adverse Event|6|||
160935722|NCT01077960|581158844|FG000|Overall Study|Protocol Violation|3|||
160935723|NCT01077960|581158844|FG000|Overall Study|Lost to Follow-up|5|||
160935724|NCT01077960|581158844|FG000|Overall Study|Subject decision|1|||
160935725|NCT01077960|581158844|FG000|Overall Study|Reason unspecified|1|||
160935726|NCT03837899|581158845|FG000|Overall Study|Death|6|||
160935727|NCT03837899|581158846|FG001|Overall Study|Death|8|||
160935728|NCT03837899|581158847|FG002|Overall Study|Death|3|||
160935729|NCT03837899|581158848|FG003|Overall Study|Death|7|||
160935730|NCT03837899|581158849|FG004|Overall Study|Death|8|||
160935731|NCT03837899|581158850|FG005|Overall Study|Death|7|||
160935732|NCT03837899|581158845|FG000|Overall Study|Moved to post-trial access program|0|||
160935733|NCT03837899|581158846|FG001|Overall Study|Moved to post-trial access program|1|||
160935734|NCT03837899|581158847|FG002|Overall Study|Moved to post-trial access program|0|||
160935735|NCT03837899|581158848|FG003|Overall Study|Moved to post-trial access program|0|||
160935736|NCT03837899|581158849|FG004|Overall Study|Moved to post-trial access program|0|||
160935737|NCT03837899|581158850|FG005|Overall Study|Moved to post-trial access program|0|||
160935738|NCT03837899|581158845|FG000|Overall Study|Other|0|||
160935739|NCT03837899|581158846|FG001|Overall Study|Other|0|||
160935740|NCT03837899|581158847|FG002|Overall Study|Other|0|||
160935741|NCT03837899|581158848|FG003|Overall Study|Other|0|||
160935742|NCT03837899|581158849|FG004|Overall Study|Other|0|||
160935743|NCT03837899|581158850|FG005|Overall Study|Other|2|||
160935744|NCT03837899|581158845|FG000|Overall Study|Lost to Follow-up|0|||
160935745|NCT03837899|581158846|FG001|Overall Study|Lost to Follow-up|1|||
160935746|NCT03837899|581158847|FG002|Overall Study|Lost to Follow-up|0|||
160935747|NCT03837899|581158848|FG003|Overall Study|Lost to Follow-up|0|||
160935748|NCT03837899|581158849|FG004|Overall Study|Lost to Follow-up|0|||
160935749|NCT03837899|581158850|FG005|Overall Study|Lost to Follow-up|0|||
160935750|NCT03837899|581158845|FG000|Overall Study|Withdrawal by Subject|0|||
160935751|NCT03837899|581158846|FG001|Overall Study|Withdrawal by Subject|0|||
160935752|NCT03837899|581158847|FG002|Overall Study|Withdrawal by Subject|0|||
160935753|NCT03837899|581158848|FG003|Overall Study|Withdrawal by Subject|1|||
160935754|NCT03837899|581158849|FG004|Overall Study|Withdrawal by Subject|0|||
160935755|NCT03837899|581158850|FG005|Overall Study|Withdrawal by Subject|0|||
160935756|NCT03837899|581158845|FG000|Overall Study|Study specific discontinuation criteria|0|||
160935757|NCT03837899|581158846|FG001|Overall Study|Study specific discontinuation criteria|1|||
160935758|NCT03837899|581158847|FG002|Overall Study|Study specific discontinuation criteria|0|||
160935759|NCT03837899|581158848|FG003|Overall Study|Study specific discontinuation criteria|0|||
160935760|NCT03837899|581158849|FG004|Overall Study|Study specific discontinuation criteria|3|||
160935761|NCT03837899|581158850|FG005|Overall Study|Study specific discontinuation criteria|1|||
160935762|NCT01403974|581158851|FG000|Overall Study|Progressive disease according to RECIST|3|||
160935763|NCT01403974|581158852|FG001|Overall Study|Progressive disease according to RECIST|3|||
160935764|NCT01403974|581158853|FG002|Overall Study|Progressive disease according to RECIST|2|||
160935765|NCT01403974|581158854|FG003|Overall Study|Progressive disease according to RECIST|3|||
160935766|NCT01403974|581158855|FG004|Overall Study|Progressive disease according to RECIST|3|||
160935767|NCT01403974|581158856|FG005|Overall Study|Progressive disease according to RECIST|2|||
160935768|NCT01403974|581158857|FG006|Overall Study|Progressive disease according to RECIST|3|||
160935769|NCT01403974|581158858|FG007|Overall Study|Progressive disease according to RECIST|2|||
160935770|NCT01403974|581158859|FG008|Overall Study|Progressive disease according to RECIST|6|||
160935771|NCT01403974|581158860|FG009|Overall Study|Progressive disease according to RECIST|2|||
160935772|NCT01403974|581158861|FG010|Overall Study|Progressive disease according to RECIST|3|||
160935773|NCT01403974|581158862|FG011|Overall Study|Progressive disease according to RECIST|2|||
160935774|NCT01403974|581158863|FG012|Overall Study|Progressive disease according to RECIST|2|||
160935775|NCT01403974|581158864|FG013|Overall Study|Progressive disease according to RECIST|3|||
160935776|NCT01403974|581158865|FG014|Overall Study|Progressive disease according to RECIST|1|||
160935777|NCT01403974|581158866|FG015|Overall Study|Progressive disease according to RECIST|8|||
160935778|NCT01403974|581158851|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
160935779|NCT01403974|581158852|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
160935780|NCT01403974|581158853|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
160935781|NCT01403974|581158854|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
160935782|NCT01403974|581158855|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
160935783|NCT01403974|581158856|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
160935784|NCT01403974|581158857|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
160935785|NCT01403974|581158858|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
160935786|NCT01403974|581158859|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
160935787|NCT01403974|581158860|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
160935788|NCT01403974|581158861|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
160935789|NCT01403974|581158862|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
160935790|NCT01403974|581158863|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
160935791|NCT01403974|581158864|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
160935792|NCT01403974|581158865|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
160935793|NCT01403974|581158866|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
160935794|NCT01403974|581158851|FG000|Overall Study|Refused to continue study medication|0|||
160935795|NCT01403974|581158852|FG001|Overall Study|Refused to continue study medication|0|||
160935796|NCT01403974|581158853|FG002|Overall Study|Refused to continue study medication|0|||
160935797|NCT01403974|581158854|FG003|Overall Study|Refused to continue study medication|0|||
160935798|NCT01403974|581158855|FG004|Overall Study|Refused to continue study medication|0|||
160935799|NCT01403974|581158856|FG005|Overall Study|Refused to continue study medication|1|||
160935800|NCT01403974|581158857|FG006|Overall Study|Refused to continue study medication|0|||
160935801|NCT01403974|581158858|FG007|Overall Study|Refused to continue study medication|0|||
160935802|NCT01403974|581158859|FG008|Overall Study|Refused to continue study medication|1|||
160935803|NCT01403974|581158860|FG009|Overall Study|Refused to continue study medication|0|||
160935804|NCT01403974|581158861|FG010|Overall Study|Refused to continue study medication|1|||
160935805|NCT01403974|581158862|FG011|Overall Study|Refused to continue study medication|0|||
160935806|NCT01403974|581158863|FG012|Overall Study|Refused to continue study medication|0|||
160935807|NCT01403974|581158864|FG013|Overall Study|Refused to continue study medication|0|||
160935808|NCT01403974|581158865|FG014|Overall Study|Refused to continue study medication|0|||
160935809|NCT01403974|581158866|FG015|Overall Study|Refused to continue study medication|4|||
160935810|NCT01403974|581158851|FG000|Overall Study|Adverse Event|0|||
160935811|NCT01403974|581158852|FG001|Overall Study|Adverse Event|0|||
160935812|NCT01403974|581158853|FG002|Overall Study|Adverse Event|1|||
160935813|NCT01403974|581158854|FG003|Overall Study|Adverse Event|0|||
160935814|NCT01403974|581158855|FG004|Overall Study|Adverse Event|0|||
160935815|NCT01403974|581158856|FG005|Overall Study|Adverse Event|0|||
160935816|NCT01403974|581158857|FG006|Overall Study|Adverse Event|0|||
160935817|NCT01403974|581158858|FG007|Overall Study|Adverse Event|1|||
160935818|NCT01403974|581158859|FG008|Overall Study|Adverse Event|0|||
160935819|NCT01403974|581158860|FG009|Overall Study|Adverse Event|0|||
160935820|NCT01403974|581158861|FG010|Overall Study|Adverse Event|0|||
160935821|NCT01403974|581158862|FG011|Overall Study|Adverse Event|0|||
160935822|NCT01403974|581158863|FG012|Overall Study|Adverse Event|1|||
160935823|NCT01403974|581158864|FG013|Overall Study|Adverse Event|0|||
160935824|NCT01403974|581158865|FG014|Overall Study|Adverse Event|0|||
160935825|NCT01403974|581158866|FG015|Overall Study|Adverse Event|0|||
160935826|NCT01403974|581158851|FG000|Overall Study|Other than specified|0|||
160935827|NCT01403974|581158852|FG001|Overall Study|Other than specified|0|||
160935828|NCT01403974|581158853|FG002|Overall Study|Other than specified|0|||
160935829|NCT01403974|581158854|FG003|Overall Study|Other than specified|0|||
160935830|NCT01403974|581158855|FG004|Overall Study|Other than specified|0|||
160935831|NCT01403974|581158856|FG005|Overall Study|Other than specified|0|||
160935832|NCT01403974|581158857|FG006|Overall Study|Other than specified|0|||
160935833|NCT01403974|581158858|FG007|Overall Study|Other than specified|0|||
160935834|NCT01403974|581158859|FG008|Overall Study|Other than specified|0|||
160935835|NCT01403974|581158860|FG009|Overall Study|Other than specified|1|||
160935836|NCT01403974|581158861|FG010|Overall Study|Other than specified|0|||
160935837|NCT01403974|581158862|FG011|Overall Study|Other than specified|1|||
160935838|NCT01403974|581158863|FG012|Overall Study|Other than specified|0|||
160935839|NCT01403974|581158864|FG013|Overall Study|Other than specified|0|||
160935840|NCT01403974|581158865|FG014|Overall Study|Other than specified|0|||
160935841|NCT01403974|581158866|FG015|Overall Study|Other than specified|0|||
160935842|NCT01526889|581158867|FG000|Treatment Period|Adverse Event|2|||
160935843|NCT01526889|581158868|FG001|Treatment Period|Adverse Event|0|||
160935844|NCT01526889|581158867|FG000|Treatment Extension Period|Administrative problems|1|||
160935845|NCT01526889|581158868|FG001|Treatment Extension Period|Administrative problems|0|||
160935846|NCT00393939|581158874|FG000|Overall Study|Protocol Violation|1|||
160935847|NCT00393939|581158875|FG001|Overall Study|Protocol Violation|1|||
160935848|NCT00393939|581158874|FG000|Overall Study|Lost to Follow-up|2|||
160935849|NCT00393939|581158875|FG001|Overall Study|Lost to Follow-up|4|||
160935850|NCT00393939|581158874|FG000|Overall Study|Death|10|||
160935851|NCT00393939|581158875|FG001|Overall Study|Death|4|||
160935852|NCT00393939|581158874|FG000|Overall Study|Sponsor|5|||
160935853|NCT00393939|581158875|FG001|Overall Study|Sponsor|13|||
160935854|NCT00393939|581158874|FG000|Overall Study|Objective progression or relapse|239|||
160935855|NCT00393939|581158875|FG001|Overall Study|Objective progression or relapse|223|||
160935856|NCT00393939|581158874|FG000|Overall Study|Withdrawal by Subject|2|||
160935857|NCT00393939|581158875|FG001|Overall Study|Withdrawal by Subject|7|||
160935858|NCT00393939|581158874|FG000|Overall Study|Other|37|||
160935859|NCT00393939|581158875|FG001|Overall Study|Other|45|||
160935860|NCT01494610|581158876|FG000|Period 1|Withdrawal by Subject|1|||
160935861|NCT01494610|581158877|FG001|Period 1|Withdrawal by Subject|1|||
160935862|NCT01494610|581158876|FG000|Period 3|Adverse Event|1|||
160935863|NCT01494610|581158877|FG001|Period 3|Adverse Event|0|||
160935864|NCT01494610|581158876|FG000|Period 3|Withdrawal by Subject|1|||
160935865|NCT01494610|581158877|FG001|Period 3|Withdrawal by Subject|0|||
160935866|NCT01494610|581158876|FG000|Period 4|Protocol Violation|1|||
160935867|NCT01494610|581158877|FG001|Period 4|Protocol Violation|0|||
160935868|NCT02385799|581158878|FG000|Overall Study|Lost to Follow-up|1|||
160935869|NCT02385799|581158879|FG001|Overall Study|Lost to Follow-up|2|||
160935870|NCT02385799|581158878|FG000|Overall Study|Adverse Event|4|||
160935871|NCT02385799|581158879|FG001|Overall Study|Adverse Event|2|||
160935872|NCT02385799|581158878|FG000|Overall Study|Withdrawal by Subject|0|||
160935873|NCT02385799|581158879|FG001|Overall Study|Withdrawal by Subject|4|||
160935874|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935875|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
160935876|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
160935877|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
160935878|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935879|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935880|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935881|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935882|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935883|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935884|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935885|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935886|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935887|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935888|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935889|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935890|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935891|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935892|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935893|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935894|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935895|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935896|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935897|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
160935898|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935899|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
160935900|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935901|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935902|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935903|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935904|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935905|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935906|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935907|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935908|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935909|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935910|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935911|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935912|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935913|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935914|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935915|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935916|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935917|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935918|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935919|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160998523|NCT02525796|581380535|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
160935920|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935921|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
160935922|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935923|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
160935924|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935925|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935926|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935927|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935928|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935929|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935930|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935931|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160998524|NCT02525796|581380536|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
160998525|NCT02525796|581380537|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
160998526|NCT02525796|581380535|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
160935932|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935933|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935934|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935935|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935936|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935937|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935938|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935939|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935940|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935941|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935942|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935943|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935944|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160935945|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
160998527|NCT02525796|581380536|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
160935946|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
160935947|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
160935948|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
160935949|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
160935950|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935951|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935952|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935953|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935954|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935955|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935956|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935957|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935958|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935959|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935960|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935961|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935962|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935963|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935964|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935965|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935966|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935967|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935968|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935969|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
160935970|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
160935971|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
160935972|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
160935973|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
160935974|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935975|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935976|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935977|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935978|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935979|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935980|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935981|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935982|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935983|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935984|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935985|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935986|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161264602|NCT01646138|582350689|FG003|Overall Study|Lost to Follow-up|0|||
161264603|NCT01646138|582350690|FG004|Overall Study|Lost to Follow-up|2|||
161264604|NCT01683838|582350691|FG000|Overall Study|Adverse Event|12|||
160935987|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935988|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
161264605|NCT01683838|582350692|FG001|Overall Study|Adverse Event|2|||
160935989|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935990|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935991|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935992|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935993|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
160935994|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160935995|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
160935996|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160935997|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
160935998|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160935999|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936000|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936001|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936002|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936003|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936004|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936005|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936006|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936007|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936008|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936009|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936010|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936011|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936012|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936013|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936014|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936015|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936016|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160998528|NCT02525796|581380537|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
160936017|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
160936018|NCT02346240|581158880|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936019|NCT02346240|581158881|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936020|NCT02346240|581158882|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
160936021|NCT02346240|581158883|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936022|NCT02346240|581158884|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936023|NCT02346240|581158885|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936024|NCT02346240|581158886|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936025|NCT02346240|581158887|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936026|NCT02346240|581158888|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936027|NCT02346240|581158889|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936028|NCT02346240|581158890|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936029|NCT02346240|581158891|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936030|NCT02346240|581158892|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936031|NCT02346240|581158893|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936032|NCT02346240|581158894|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936033|NCT02346240|581158895|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936034|NCT02346240|581158896|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936035|NCT02346240|581158897|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936036|NCT02346240|581158898|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936037|NCT02346240|581158899|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936038|NCT02346240|581158900|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936039|NCT02346240|581158901|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160998529|NCT00726999|581380538|FG000|Overall Study|Physician Decision|0|||
160998530|NCT00726999|581380539|FG001|Overall Study|Physician Decision|1|||
160998531|NCT00726999|581380538|FG000|Overall Study|Withdrawal by Subject|2|||
160998532|NCT00726999|581380539|FG001|Overall Study|Withdrawal by Subject|0|||
161342500|NCT04880850|582640216|FG001|Overall Study|Lost to Follow-up|6|||
160936040|NCT02346240|581158902|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936041|NCT02346240|581158903|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
160936042|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936043|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936044|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936045|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160998533|NCT00726999|581380538|FG000|Overall Study|Protocol Violation|1|||
160998534|NCT00726999|581380539|FG001|Overall Study|Protocol Violation|0|||
160936046|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936047|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936048|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936049|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160936050|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
160936051|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936052|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936053|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936054|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936055|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160936056|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
160936057|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
160936058|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
160936059|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936060|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160998535|NCT01198275|581380540|FG000|Overall Study|Adverse Event|2|||
160998536|NCT01198275|581380541|FG001|Overall Study|Adverse Event|3|||
160998537|NCT01198275|581380540|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
160936061|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936062|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936063|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936064|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936065|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
160936066|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936067|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936068|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936069|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936070|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936071|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936072|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936073|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936074|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936075|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936076|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936077|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936078|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936079|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
160936080|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936081|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
160936082|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936083|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936084|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936085|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936086|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936087|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936088|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936089|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
160936090|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936091|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936092|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936093|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936094|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936095|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936096|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936097|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936098|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936099|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160998538|NCT01198275|581380541|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
160998539|NCT02810080|581380545|FG000|Overall Study|Adverse Event|3|||
160936100|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936101|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936102|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936103|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936104|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
160936105|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936106|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936107|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936108|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936109|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936110|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936111|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936112|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936113|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
160936114|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936115|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936116|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936117|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936118|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936119|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936120|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936121|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936122|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936123|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936124|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936125|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
160936126|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936127|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
160936128|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
160936129|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
160936130|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
160936131|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936132|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936133|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936134|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936135|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936136|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936137|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
160936138|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936139|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936140|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936141|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936142|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936143|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936144|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936145|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936146|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936147|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936148|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936149|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936150|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936151|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
160936152|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
160936153|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
160936154|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
160936155|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936156|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936157|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936158|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936159|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936160|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936161|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
160936162|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936163|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936164|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936165|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936166|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936167|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160998540|NCT02810080|581380546|FG001|Overall Study|Adverse Event|0|||
160936168|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
160936169|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936170|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936171|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936172|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936173|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936174|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936175|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936176|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936177|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936178|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936179|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936180|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936181|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936182|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936183|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936184|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936185|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
160936186|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936187|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936188|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936189|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936190|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936191|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936192|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936193|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936194|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936195|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936196|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936197|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936198|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936199|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936200|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
160936201|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936202|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936203|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936204|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936205|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936206|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936207|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936208|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936209|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
160936210|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936211|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936212|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936213|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936214|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936215|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936216|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936217|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936218|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936219|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
160936220|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
161264606|NCT01683838|582350691|FG000|Overall Study|Protocol Violation|3|||
161264607|NCT01683838|582350692|FG001|Overall Study|Protocol Violation|1|||
160998541|NCT02810080|581380545|FG000|Overall Study|Death|0|||
161264608|NCT01683838|582350691|FG000|Overall Study|Withdrawal by Subject|6|||
161264609|NCT01683838|582350692|FG001|Overall Study|Withdrawal by Subject|5|||
161264610|NCT01683838|582350691|FG000|Overall Study|Lost to Follow-up|1|||
160936221|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936222|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936223|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936224|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936225|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936226|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936227|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936228|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936229|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936230|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936231|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936232|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936233|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
160936234|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936235|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936236|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936237|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936238|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936239|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936240|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936241|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936242|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936243|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936244|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
160936245|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936246|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936247|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936248|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936249|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936250|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936251|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936252|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936253|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936254|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936255|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936256|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936257|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
160936258|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936259|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936260|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936261|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936262|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936263|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936264|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936265|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936266|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936267|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936268|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936269|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936270|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936271|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936272|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
160936273|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936274|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936275|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936276|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936277|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160998542|NCT02810080|581380546|FG001|Overall Study|Death|2|||
160936278|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936279|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936280|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936281|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
160936282|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936283|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936284|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936285|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936286|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
161143884|NCT01821677|581909527|FG001|Overall Study|Adverse Event|6|||
161143885|NCT01821677|581909528|FG002|Overall Study|Adverse Event|5|||
161143886|NCT01821677|581909526|FG000|Overall Study|Physician Decision|1|||
161143887|NCT01821677|581909527|FG001|Overall Study|Physician Decision|4|||
161143888|NCT01821677|581909528|FG002|Overall Study|Physician Decision|1|||
161143889|NCT01821677|581909526|FG000|Overall Study|Non-compliance|0|||
161143890|NCT01821677|581909527|FG001|Overall Study|Non-compliance|1|||
161143891|NCT01821677|581909528|FG002|Overall Study|Non-compliance|2|||
161143892|NCT01821677|581909526|FG000|Overall Study|Lost to Follow-up|2|||
161143893|NCT01821677|581909527|FG001|Overall Study|Lost to Follow-up|1|||
161143894|NCT01821677|581909528|FG002|Overall Study|Lost to Follow-up|3|||
161143895|NCT01821677|581909526|FG000|Overall Study|Protocol Violation|0|||
161342501|NCT04880850|582640215|FG000|Overall Study|Physician Decision|2|||
161342502|NCT04880850|582640216|FG001|Overall Study|Physician Decision|1|||
160998543|NCT02810080|581380545|FG000|Overall Study|Physician Decision|4|||
160998544|NCT02810080|581380546|FG001|Overall Study|Physician Decision|0|||
160936287|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936288|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936289|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936290|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936291|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936292|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936293|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936294|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936295|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936296|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
160936297|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936298|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936299|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936300|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936301|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936302|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936303|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936304|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936305|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
160936306|NCT02346240|581158880|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936307|NCT02346240|581158881|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936308|NCT02346240|581158882|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936309|NCT02346240|581158883|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936310|NCT02346240|581158884|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936311|NCT02346240|581158885|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936312|NCT02346240|581158886|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936313|NCT02346240|581158887|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160998545|NCT02810080|581380545|FG000|Overall Study|Withdrawal by Subject|0|||
160998546|NCT02810080|581380546|FG001|Overall Study|Withdrawal by Subject|2|||
160998547|NCT02034916|581380549|FG000|Overall Study|Death|39|||
160998548|NCT02034916|581380550|FG001|Overall Study|Death|28|||
160998549|NCT02034916|581380549|FG000|Overall Study|Withdrawal by Subject|2|||
160998550|NCT02034916|581380550|FG001|Overall Study|Withdrawal by Subject|1|||
160998551|NCT02034916|581380549|FG000|Overall Study|Lost to Follow-up|4|||
160998552|NCT02034916|581380550|FG001|Overall Study|Lost to Follow-up|1|||
160998553|NCT02034916|581380549|FG000|Overall Study|Study terminated by sponsor|4|||
161143896|NCT01821677|581909527|FG001|Overall Study|Protocol Violation|0|||
160998554|NCT02034916|581380550|FG001|Overall Study|Study terminated by sponsor|5|||
161143897|NCT01821677|581909528|FG002|Overall Study|Protocol Violation|2|||
161143898|NCT01821677|581909526|FG000|Overall Study|Withdrawal by Subject|7|||
161143899|NCT01821677|581909527|FG001|Overall Study|Withdrawal by Subject|3|||
161143900|NCT01821677|581909528|FG002|Overall Study|Withdrawal by Subject|2|||
160998555|NCT01591616|581380555|FG000|Overall Study|Withdrawal by Subject|1|||
160936314|NCT02346240|581158888|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936315|NCT02346240|581158889|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936316|NCT02346240|581158890|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936317|NCT02346240|581158891|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936318|NCT02346240|581158892|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936319|NCT02346240|581158893|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936320|NCT02346240|581158894|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
160936321|NCT02346240|581158895|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936322|NCT02346240|581158896|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936323|NCT02346240|581158897|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936324|NCT02346240|581158898|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936325|NCT02346240|581158899|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936326|NCT02346240|581158900|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936327|NCT02346240|581158901|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936328|NCT02346240|581158902|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936329|NCT02346240|581158903|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
160936330|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936331|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936332|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936333|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936334|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936335|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936336|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936337|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936338|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936339|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936340|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936341|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936342|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936343|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936344|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936345|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936346|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
160936347|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
160936348|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
160936349|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
160936350|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
160936351|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
160936352|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
160936353|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
160936354|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936355|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936356|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936357|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936358|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936359|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936360|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936361|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
160998556|NCT00758602|581380556|FG000|Overall Study|Adverse Event|11|||
160998557|NCT00758602|581380557|FG001|Overall Study|Adverse Event|10|||
160998558|NCT00758602|581380556|FG000|Overall Study|Lost to Follow-up|4|||
160936362|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936363|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936364|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936365|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936366|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936367|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936368|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936369|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936370|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
160998559|NCT00758602|581380557|FG001|Overall Study|Lost to Follow-up|3|||
160936371|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936372|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
160998560|NCT00758602|581380556|FG000|Overall Study|Withdrawal by Subject|1|||
160936373|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
160936374|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936375|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
160936376|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936377|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
160936378|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936379|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936380|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936381|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936382|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936383|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936384|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936385|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936386|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936387|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936388|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936389|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936390|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936391|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936392|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936393|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936394|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936395|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936396|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160936397|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936398|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936399|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
160936400|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936401|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
160936402|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936403|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936404|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936405|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936406|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936407|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936408|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936409|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936410|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936411|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936412|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936413|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936414|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936415|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936416|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161143901|NCT01821677|581909526|FG000|Overall Study|Other|9|||
161143902|NCT01821677|581909527|FG001|Overall Study|Other|0|||
160936417|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936418|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936419|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936420|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936421|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936422|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936423|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
160936424|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
161143903|NCT01821677|581909528|FG002|Overall Study|Other|0|||
161143904|NCT00538733|581909529|FG000|Overall Study|Adverse Event|8|||
161264611|NCT01683838|582350692|FG001|Overall Study|Lost to Follow-up|1|||
161264612|NCT01683838|582350691|FG000|Overall Study|Other|4|||
161264613|NCT01683838|582350692|FG001|Overall Study|Other|3|||
161264614|NCT04049617|582350693|FG000|Overall Study|Adverse Event|0|||
161264615|NCT04049617|582350694|FG001|Overall Study|Adverse Event|0|||
160936425|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
160936426|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936427|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936428|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936429|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936430|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936431|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936432|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936433|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936434|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936435|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936436|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936437|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936438|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936439|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936440|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936441|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936442|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936443|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
160936444|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
160936445|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
160936446|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
160936447|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160936448|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160936449|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
160936450|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936451|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936452|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936453|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936454|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936455|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936456|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936457|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936458|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936459|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936460|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936461|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936462|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936463|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936464|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936465|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936466|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936467|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936468|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
160936469|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160936470|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
160936471|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
160936472|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160936473|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
160936474|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936475|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936476|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936477|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936478|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936479|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936480|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936481|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936482|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936483|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936484|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936485|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936486|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936487|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936488|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
161264616|NCT04049617|582350695|FG002|Overall Study|Adverse Event|0|||
161264617|NCT04049617|582350696|FG003|Overall Study|Adverse Event|1|||
161264618|NCT04049617|582350697|FG004|Overall Study|Adverse Event|0|||
161264619|NCT04049617|582350698|FG005|Overall Study|Adverse Event|0|||
161264620|NCT04049617|582350693|FG000|Overall Study|Death|0|||
160936489|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936490|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936491|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936492|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
160936493|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936494|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
160936495|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
160936496|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
160936497|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
160936498|NCT02346240|581158880|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936499|NCT02346240|581158881|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936500|NCT02346240|581158882|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936501|NCT02346240|581158883|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936502|NCT02346240|581158884|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936503|NCT02346240|581158885|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936504|NCT02346240|581158886|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936505|NCT02346240|581158887|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936506|NCT02346240|581158888|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936507|NCT02346240|581158889|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936508|NCT02346240|581158890|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936509|NCT02346240|581158891|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936510|NCT02346240|581158892|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936511|NCT02346240|581158893|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936512|NCT02346240|581158894|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936513|NCT02346240|581158895|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936514|NCT02346240|581158896|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936515|NCT02346240|581158897|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936516|NCT02346240|581158898|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
160936517|NCT02346240|581158899|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936518|NCT02346240|581158900|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936519|NCT02346240|581158901|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936520|NCT02346240|581158902|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936521|NCT02346240|581158903|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
160936522|NCT02942017|581158904|FG000|Overall Study|Adverse Event|0|||
160936523|NCT02942017|581158905|FG001|Overall Study|Adverse Event|1|||
160936524|NCT02942017|581158904|FG000|Overall Study|Withdrawal by Subject|0|||
160936525|NCT02942017|581158905|FG001|Overall Study|Withdrawal by Subject|1|||
160998561|NCT00758602|581380557|FG001|Overall Study|Withdrawal by Subject|3|||
160998562|NCT00758602|581380556|FG000|Overall Study|Protocol Violation|0|||
160936526|NCT02942017|581158904|FG000|Overall Study|Lost to Follow-up|1|||
160936527|NCT02942017|581158905|FG001|Overall Study|Lost to Follow-up|1|||
160936528|NCT02942017|581158904|FG000|Overall Study|Randomized but not dosed|1|||
160936529|NCT02942017|581158905|FG001|Overall Study|Randomized but not dosed|3|||
160936530|NCT00477672|581158906|FG000|Overall Study|Adverse Event|3|||
160936531|NCT00477672|581158907|FG001|Overall Study|Adverse Event|5|||
160936532|NCT00477672|581158908|FG002|Overall Study|Adverse Event|6|||
160998563|NCT00758602|581380557|FG001|Overall Study|Protocol Violation|2|||
160998564|NCT00758602|581380556|FG000|Overall Study|Death|0|||
160998565|NCT00758602|581380557|FG001|Overall Study|Death|1|||
160998566|NCT00758602|581380556|FG000|Overall Study|Reason not specified|3|||
160998567|NCT00758602|581380557|FG001|Overall Study|Reason not specified|3|||
160936533|NCT00477672|581158906|FG000|Overall Study|Death|0|||
160936534|NCT00477672|581158907|FG001|Overall Study|Death|1|||
160936535|NCT00477672|581158908|FG002|Overall Study|Death|0|||
160998568|NCT05046132|581380558|FG000|Overall Study|Adverse Event|4|||
160998569|NCT05046132|581380559|FG001|Overall Study|Adverse Event|0|||
160936536|NCT00477672|581158906|FG000|Overall Study|Disease progression|0|||
160936537|NCT00477672|581158907|FG001|Overall Study|Disease progression|1|||
160936538|NCT00477672|581158908|FG002|Overall Study|Disease progression|0|||
160936539|NCT00477672|581158906|FG000|Overall Study|Physician Decision|1|||
160936540|NCT00477672|581158907|FG001|Overall Study|Physician Decision|0|||
160936541|NCT00477672|581158908|FG002|Overall Study|Physician Decision|0|||
160936542|NCT00477672|581158906|FG000|Overall Study|Protocol noncompliance|0|||
160998570|NCT05046132|581380560|FG002|Overall Study|Adverse Event|0|||
160998571|NCT05046132|581380558|FG000|Overall Study|Withdrawal by Subject|3|||
160998572|NCT05046132|581380559|FG001|Overall Study|Withdrawal by Subject|0|||
160936543|NCT00477672|581158907|FG001|Overall Study|Protocol noncompliance|2|||
160998573|NCT05046132|581380560|FG002|Overall Study|Withdrawal by Subject|0|||
160936544|NCT00477672|581158908|FG002|Overall Study|Protocol noncompliance|0|||
160936545|NCT00477672|581158906|FG000|Overall Study|Consent withdrawn|2|||
160936546|NCT00477672|581158907|FG001|Overall Study|Consent withdrawn|5|||
160936547|NCT00477672|581158908|FG002|Overall Study|Consent withdrawn|10|||
160936548|NCT00477672|581158906|FG000|Overall Study|Discretion of Sponsor|1|||
160936549|NCT00477672|581158907|FG001|Overall Study|Discretion of Sponsor|2|||
160936550|NCT00477672|581158908|FG002|Overall Study|Discretion of Sponsor|0|||
160936551|NCT00838565|581158909|FG000|Overall Study|Withdrawal by Subject|0|||
160936552|NCT00838565|581158910|FG001|Overall Study|Withdrawal by Subject|0|||
160936553|NCT00838565|581158911|FG002|Overall Study|Withdrawal by Subject|1|||
160936554|NCT00838565|581158912|FG003|Overall Study|Withdrawal by Subject|0|||
160936555|NCT00838565|581158913|FG004|Overall Study|Withdrawal by Subject|0|||
160936556|NCT00838565|581158914|FG005|Overall Study|Withdrawal by Subject|2|||
160936557|NCT00838565|581158909|FG000|Overall Study|Other|0|||
160936558|NCT00838565|581158910|FG001|Overall Study|Other|2|||
160936559|NCT00838565|581158911|FG002|Overall Study|Other|0|||
160936560|NCT00838565|581158912|FG003|Overall Study|Other|0|||
160936561|NCT00838565|581158913|FG004|Overall Study|Other|0|||
160936562|NCT00838565|581158914|FG005|Overall Study|Other|0|||
160936563|NCT00838565|581158909|FG000|Overall Study|Randomized but not Treated|0|||
160936564|NCT00838565|581158910|FG001|Overall Study|Randomized but not Treated|1|||
160936565|NCT00838565|581158911|FG002|Overall Study|Randomized but not Treated|0|||
160936566|NCT00838565|581158912|FG003|Overall Study|Randomized but not Treated|0|||
160936567|NCT00838565|581158913|FG004|Overall Study|Randomized but not Treated|0|||
160936568|NCT00838565|581158914|FG005|Overall Study|Randomized but not Treated|0|||
161264621|NCT04049617|582350694|FG001|Overall Study|Death|0|||
161264622|NCT04049617|582350695|FG002|Overall Study|Death|0|||
161264623|NCT04049617|582350696|FG003|Overall Study|Death|0|||
161264624|NCT04049617|582350697|FG004|Overall Study|Death|0|||
161264625|NCT04049617|582350698|FG005|Overall Study|Death|1|||
160936569|NCT00458484|581158915|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
160936570|NCT00458484|581158916|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
160936571|NCT00458484|581158917|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
160936572|NCT00458484|581158918|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
160936573|NCT00458484|581158919|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
160936574|NCT00458484|581158920|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
160936575|NCT00458484|581158921|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
160936576|NCT04907032|581158922|FG000|Overall Study|Withdrawal by Subject|7|||
160936577|NCT04907032|581158923|FG001|Overall Study|Withdrawal by Subject|1|||
160936578|NCT01838642|581158924|FG000|Overall Study|Died on study|1|||
160936579|NCT02253810|581158925|FG000|Overall Study|Withdrawal by Subject|2|||
160936580|NCT02253810|581158926|FG001|Overall Study|Withdrawal by Subject|1|||
160936581|NCT02253810|581158925|FG000|Overall Study|Unknown concomitant procedure|3|||
160936582|NCT02253810|581158926|FG001|Overall Study|Unknown concomitant procedure|2|||
160936583|NCT00291668|581158928|FG000|Overall Study|Lack of Efficacy|1|||
160936584|NCT00291668|581158929|FG001|Overall Study|Lack of Efficacy|0|||
160936585|NCT00291668|581158930|FG002|Overall Study|Lack of Efficacy|0|||
160936586|NCT00291668|581158928|FG000|Overall Study|SAE, non-fatal|1|||
160936587|NCT00291668|581158929|FG001|Overall Study|SAE, non-fatal|1|||
160998574|NCT05046132|581380558|FG000|Overall Study|Positive Covid19 Result.|0|||
160998575|NCT05046132|581380559|FG001|Overall Study|Positive Covid19 Result.|1|||
160998576|NCT05046132|581380560|FG002|Overall Study|Positive Covid19 Result.|0|||
160998577|NCT01186848|581380566|FG000|Overall Study|Lost to Follow-up|4|||
160936588|NCT00291668|581158930|FG002|Overall Study|SAE, non-fatal|1|||
160936589|NCT00291668|581158928|FG000|Overall Study|AE, non-serious non-fatal|1|||
160936590|NCT00291668|581158929|FG001|Overall Study|AE, non-serious non-fatal|0|||
160936591|NCT00291668|581158930|FG002|Overall Study|AE, non-serious non-fatal|0|||
160936592|NCT00291668|581158928|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
160936593|NCT00291668|581158929|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160936594|NCT00291668|581158930|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
160936595|NCT01557400|581158931|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
160936596|NCT01557400|581158931|FG000|Overall Study|Adverse Event|3|||
160936597|NCT01557400|581158931|FG000|Overall Study|Lost to Follow-up|5|||
160936598|NCT01557400|581158931|FG000|Overall Study|Withdrawal by Subject|9|||
160936599|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
160936600|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
160936601|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
160998578|NCT01186848|581380566|FG000|Overall Study|Withdrawal by Subject|2|||
160936602|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160936603|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160936604|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160936605|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936606|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160998579|NCT01186848|581380566|FG000|Overall Study|Adverse Event|2|||
160936607|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
160936608|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936609|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936610|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
160936611|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
160936612|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
160936613|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
160936614|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160936615|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160936616|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160936617|NCT04019041|581158934|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936618|NCT04019041|581158935|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936619|NCT04019041|581158936|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
160936620|NCT04019041|581158937|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936621|NCT04019041|581158938|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936622|NCT04019041|581158939|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
160936623|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160936624|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160936625|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160936626|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
160936627|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
160936628|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
160936629|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936630|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936631|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936632|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
160936633|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936634|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
160936635|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936636|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936637|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936638|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936639|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
160936640|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
160936641|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160936642|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160936643|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160936644|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
160936645|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
160936646|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
160936647|NCT04019041|581158934|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936648|NCT04019041|581158935|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936649|NCT04019041|581158936|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936650|NCT04019041|581158937|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160936651|NCT04019041|581158938|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
160936652|NCT04019041|581158939|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
160936653|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
160936654|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
160936655|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
160936656|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
160936657|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
160998580|NCT00770965|581380583|FG000|Safety Set|Withdrawal by Subject|0|||
160998581|NCT00770965|581380584|FG001|Safety Set|Withdrawal by Subject|0|||
160998582|NCT00770965|581380585|FG002|Safety Set|Withdrawal by Subject|0|||
160998583|NCT00770965|581380586|FG003|Safety Set|Withdrawal by Subject|1|||
160998584|NCT00770965|581380583|FG000|Safety Set|Protocol deviation|0|||
160998585|NCT00770965|581380584|FG001|Safety Set|Protocol deviation|0|||
160936658|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
160936659|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
160936660|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
160936661|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
160936662|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
160998586|NCT00770965|581380585|FG002|Safety Set|Protocol deviation|1|||
160936663|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
160936664|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
160936665|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
160936666|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
160936667|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
160936668|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
160936669|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
160936670|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
160936671|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
160936672|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
160936673|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Other|3|||
160936674|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Other|0|||
160936675|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Other|2|||
160936676|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Other|2|||
160936677|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Other|7|||
160936678|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936679|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936680|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936681|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
160936682|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936683|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936684|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936685|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936686|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936687|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
160936688|NCT00213148|581158940|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
160936689|NCT00213148|581158941|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
160936690|NCT00213148|581158942|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
160936691|NCT00213148|581158943|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
160936692|NCT00213148|581158944|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
160936693|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
160936694|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
160936695|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
160936696|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
160936697|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
160936698|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
160936699|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
160936700|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
160936701|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
160936702|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
160936703|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Other|2|||
160936704|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Other|1|||
160936705|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Other|2|||
160936706|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Other|8|||
160936707|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Other|7|||
160936708|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936709|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
160936710|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936711|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936712|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
160936713|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
160936714|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936715|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936716|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936717|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
160936718|NCT00213148|581158940|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
160936719|NCT00213148|581158941|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
160998587|NCT00770965|581380586|FG003|Safety Set|Protocol deviation|0|||
160936720|NCT00213148|581158942|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
160936721|NCT00213148|581158943|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
160936722|NCT00213148|581158944|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
160936723|NCT00213148|581158940|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
160936724|NCT00213148|581158941|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
160998588|NCT00770965|581380583|FG000|Excluded Set|Administrative problems|14|||
161264626|NCT04049617|582350693|FG000|Overall Study|Lost to Follow-up|0|||
160936725|NCT00213148|581158942|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
160936726|NCT00213148|581158943|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
160998589|NCT00770965|581380584|FG001|Excluded Set|Administrative problems|12|||
161264627|NCT04049617|582350694|FG001|Overall Study|Lost to Follow-up|0|||
160936727|NCT00213148|581158944|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
160936728|NCT00213148|581158940|FG000|Cycle 3 (1 Month)|Other|0|||
160936729|NCT00213148|581158941|FG001|Cycle 3 (1 Month)|Other|0|||
160936730|NCT00213148|581158942|FG002|Cycle 3 (1 Month)|Other|1|||
160936731|NCT00213148|581158943|FG003|Cycle 3 (1 Month)|Other|1|||
160936732|NCT00213148|581158944|FG004|Cycle 3 (1 Month)|Other|0|||
160936733|NCT02321462|581158945|FG000|Overall Study|Withdrawal by Subject|5|||
160936734|NCT02321462|581158946|FG001|Overall Study|Withdrawal by Subject|2|||
160936735|NCT02321462|581158945|FG000|Overall Study|Subject withdrawn before any treatment|1|||
160936736|NCT02321462|581158946|FG001|Overall Study|Subject withdrawn before any treatment|1|||
160998590|NCT00770965|581380585|FG002|Excluded Set|Administrative problems|12|||
160936737|NCT00660348|581158948|FG000|Overall Study|Withdrawal by Subject|1|||
160936738|NCT00660348|581158949|FG001|Overall Study|Withdrawal by Subject|0|||
160936739|NCT02741115|581158950|FG000|Overall Study|Adverse Event|1|||
160936740|NCT02741115|581158951|FG001|Overall Study|Adverse Event|0|||
160936741|NCT02741115|581158950|FG000|Overall Study|Lost to Follow-up|7|||
160936742|NCT02741115|581158951|FG001|Overall Study|Lost to Follow-up|4|||
160936743|NCT02741115|581158950|FG000|Overall Study|Withdrawal by Subject|4|||
160936744|NCT02741115|581158951|FG001|Overall Study|Withdrawal by Subject|2|||
160936745|NCT03945981|581158952|FG000|Overall Study|Lost to Follow-up|12|||
160936746|NCT03945981|581158952|FG000|Overall Study|Physician Decision|4|||
160936747|NCT03945981|581158952|FG000|Overall Study|Withdrawal by Subject|6|||
160936748|NCT03945981|581158952|FG000|Overall Study|Protocol Violation|1|||
160936749|NCT02917031|581158956|FG000|Overall Study|Reason not specified|7|||
160936750|NCT02917031|581158957|FG001|Overall Study|Reason not specified|5|||
160936751|NCT02917031|581158958|FG002|Overall Study|Reason not specified|6|||
160936752|NCT02917031|581158956|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
160936753|NCT02917031|581158957|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
160936754|NCT02917031|581158958|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
160936755|NCT02917031|581158956|FG000|Overall Study|Withdrawal by Subject|3|||
160936756|NCT02917031|581158957|FG001|Overall Study|Withdrawal by Subject|3|||
160936757|NCT02917031|581158958|FG002|Overall Study|Withdrawal by Subject|0|||
160936758|NCT02917031|581158956|FG000|Overall Study|Physician Decision|1|||
160936759|NCT02917031|581158957|FG001|Overall Study|Physician Decision|0|||
160936760|NCT02917031|581158958|FG002|Overall Study|Physician Decision|0|||
160936761|NCT02917031|581158956|FG000|Overall Study|Adverse Event|4|||
160936762|NCT02917031|581158957|FG001|Overall Study|Adverse Event|1|||
160936763|NCT02917031|581158958|FG002|Overall Study|Adverse Event|5|||
160936764|NCT02917031|581158956|FG000|Overall Study|Death|2|||
160936765|NCT02917031|581158957|FG001|Overall Study|Death|3|||
160936766|NCT02917031|581158958|FG002|Overall Study|Death|4|||
160936767|NCT04346615|581160290|FG000|Overall Study|Lost to Follow-up|0|||
160936768|NCT04346615|581160291|FG001|Overall Study|Lost to Follow-up|2|||
160936769|NCT04346615|581160290|FG000|Overall Study|Withdrawal by Subject|1|||
160936770|NCT04346615|581160291|FG001|Overall Study|Withdrawal by Subject|0|||
160936771|NCT04346615|581160290|FG000|Overall Study|Death|5|||
160936772|NCT04346615|581160291|FG001|Overall Study|Death|1|||
160936773|NCT04346615|581160290|FG000|Overall Study|Other|0|||
160936774|NCT04346615|581160291|FG001|Overall Study|Other|2|||
160936775|NCT04346615|581160290|FG000|Overall Study|Randomized not treated|1|||
160936776|NCT04346615|581160291|FG001|Overall Study|Randomized not treated|0|||
160936777|NCT02096835|581160297|FG000|Overall Study|Withdrawal by Subject|1|||
160936778|NCT02096835|581160298|FG001|Overall Study|Withdrawal by Subject|0|||
160936779|NCT02096835|581160299|FG002|Overall Study|Withdrawal by Subject|0|||
160936780|NCT02096835|581160297|FG000|Overall Study|converted to open procedures|1|||
160936781|NCT02096835|581160298|FG001|Overall Study|converted to open procedures|0|||
160936782|NCT02096835|581160299|FG002|Overall Study|converted to open procedures|0|||
160936783|NCT02096835|581160297|FG000|Overall Study|Lost to Follow-up|1|||
160936784|NCT02096835|581160298|FG001|Overall Study|Lost to Follow-up|0|||
160936785|NCT02096835|581160299|FG002|Overall Study|Lost to Follow-up|1|||
160936786|NCT04368429|581160300|FG000|Overall Study|Adverse Event|1|||
160936787|NCT04368429|581160301|FG001|Overall Study|Adverse Event|0|||
160936788|NCT00667342|581160302|FG000|Overall Study|Protocol Violation|1|||
160936789|NCT00667342|581160303|FG001|Overall Study|Protocol Violation|0|||
160936790|NCT00667342|581160304|FG002|Overall Study|Protocol Violation|0|||
160936791|NCT00667342|581160302|FG000|Overall Study|Withdrawal by Subject|1|||
160936792|NCT00667342|581160303|FG001|Overall Study|Withdrawal by Subject|0|||
160936793|NCT00667342|581160304|FG002|Overall Study|Withdrawal by Subject|0|||
160936794|NCT00667342|581160302|FG000|Overall Study|Physician Decision|3|||
160936795|NCT00667342|581160303|FG001|Overall Study|Physician Decision|0|||
160936796|NCT00667342|581160304|FG002|Overall Study|Physician Decision|0|||
160936797|NCT00667342|581160302|FG000|Overall Study|Relapse or tumor progression|9|||
160936798|NCT00667342|581160303|FG001|Overall Study|Relapse or tumor progression|0|||
160936799|NCT00667342|581160304|FG002|Overall Study|Relapse or tumor progression|7|||
160936800|NCT00667342|581160302|FG000|Overall Study|Adverse Event|0|||
160936801|NCT00667342|581160303|FG001|Overall Study|Adverse Event|0|||
160936802|NCT00667342|581160304|FG002|Overall Study|Adverse Event|1|||
160936803|NCT00667342|581160302|FG000|Overall Study|Ineligible|0|||
161264628|NCT04049617|582350695|FG002|Overall Study|Lost to Follow-up|0|||
161264629|NCT04049617|582350696|FG003|Overall Study|Lost to Follow-up|1|||
161264630|NCT04049617|582350697|FG004|Overall Study|Lost to Follow-up|0|||
160936804|NCT00667342|581160303|FG001|Overall Study|Ineligible|0|||
161264631|NCT04049617|582350698|FG005|Overall Study|Lost to Follow-up|0|||
161264632|NCT04049617|582350693|FG000|Overall Study|Withdrew consent|0|||
161264633|NCT04049617|582350694|FG001|Overall Study|Withdrew consent|0|||
160936805|NCT00667342|581160304|FG002|Overall Study|Ineligible|1|||
160936806|NCT01433263|581160305|FG000|Overall Study|Adverse Event|3|||
160936807|NCT01433263|581160306|FG001|Overall Study|Adverse Event|1|||
160936808|NCT01433263|581160305|FG000|Overall Study|Death|5|||
160936809|NCT01433263|581160306|FG001|Overall Study|Death|3|||
160936810|NCT01433263|581160305|FG000|Overall Study|Lost to Follow-up|0|||
160936811|NCT01433263|581160306|FG001|Overall Study|Lost to Follow-up|1|||
160936812|NCT01433263|581160305|FG000|Overall Study|Protocol Deviation|1|||
160936813|NCT01433263|581160306|FG001|Overall Study|Protocol Deviation|0|||
160936814|NCT01433263|581160305|FG000|Overall Study|Withdrawal by Subject|10|||
160936815|NCT01433263|581160306|FG001|Overall Study|Withdrawal by Subject|7|||
160936816|NCT04709237|581160308|FG000|Overall Study|Lost to Follow-up|1|||
160936817|NCT04709237|581160309|FG001|Overall Study|Lost to Follow-up|0|||
160936818|NCT04709237|581160310|FG002|Overall Study|Lost to Follow-up|0|||
160936819|NCT02610192|581160311|FG000|Overall Study|Received other treatment|8|||
160936820|NCT02610192|581160311|FG000|Overall Study|Physician Decision|1|||
160936821|NCT00640510|581160320|FG000|Overall Study|Lack of Efficacy|0|||
160936822|NCT00640510|581160321|FG001|Overall Study|Lack of Efficacy|1|||
160936823|NCT00640510|581160320|FG000|Overall Study|Protocol Violation|1|||
160936824|NCT00640510|581160321|FG001|Overall Study|Protocol Violation|0|||
160936825|NCT00640510|581160320|FG000|Overall Study|Physician Decision|0|||
160936826|NCT00640510|581160321|FG001|Overall Study|Physician Decision|1|||
160936827|NCT01440322|581160322|FG000|Overall Study|Discomfort|2|||
160936828|NCT01440322|581160323|FG001|Overall Study|Discomfort|0|||
160936829|NCT01440322|581160322|FG000|Overall Study|Biomicroscopy|1|||
160936830|NCT01440322|581160323|FG001|Overall Study|Biomicroscopy|0|||
160936831|NCT01440322|581160322|FG000|Overall Study|Symptoms and Problems|1|||
160936832|NCT01440322|581160323|FG001|Overall Study|Symptoms and Problems|0|||
160936833|NCT01440322|581160322|FG000|Overall Study|Unacceptable Subjective Vision|1|||
160936834|NCT01440322|581160323|FG001|Overall Study|Unacceptable Subjective Vision|0|||
160936835|NCT01440322|581160322|FG000|Overall Study|Other Product Related|1|||
160936836|NCT01440322|581160323|FG001|Overall Study|Other Product Related|0|||
160936837|NCT01440322|581160322|FG000|Overall Study|Unrelated Medical Problem|0|||
160936838|NCT01440322|581160323|FG001|Overall Study|Unrelated Medical Problem|1|||
160936839|NCT01440322|581160322|FG000|Overall Study|Other Non-Product Related|1|||
160936840|NCT01440322|581160323|FG001|Overall Study|Other Non-Product Related|0|||
160936841|NCT04300296|581160327|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
160936842|NCT04300296|581160328|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936843|NCT04300296|581160329|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936844|NCT04300296|581160330|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936845|NCT04300296|581160331|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936846|NCT04300296|581160332|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
160936847|NCT04300296|581160327|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936848|NCT04300296|581160328|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936849|NCT04300296|581160329|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936850|NCT04300296|581160330|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936851|NCT04300296|581160331|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
160936852|NCT04300296|581160332|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
160936853|NCT04300296|581160327|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
160936854|NCT04300296|581160328|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
160936855|NCT04300296|581160329|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
160936856|NCT04300296|581160330|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
160936857|NCT04300296|581160331|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
160936858|NCT04300296|581160332|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
160936859|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
160936860|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
160936861|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
160936862|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
160936863|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
160936864|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
160936865|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
160936866|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
160936867|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
160936868|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
160936869|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
160936870|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
160936871|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936872|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
160936873|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936874|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936875|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
161264634|NCT04049617|582350695|FG002|Overall Study|Withdrew consent|1|||
161264635|NCT04049617|582350696|FG003|Overall Study|Withdrew consent|0|||
160936876|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
160936877|NCT04300296|581160327|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
160936878|NCT04300296|581160328|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
160936879|NCT04300296|581160329|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
160936880|NCT04300296|581160330|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
160936881|NCT04300296|581160331|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
160936882|NCT04300296|581160332|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
160936883|NCT05044234|581160333|FG000|Overall Study|Lost to Follow-up|2|||
160936884|NCT05044234|581160334|FG001|Overall Study|Lost to Follow-up|1|||
160936885|NCT05044234|581160335|FG002|Overall Study|Lost to Follow-up|1|||
160936886|NCT05044234|581160336|FG003|Overall Study|Lost to Follow-up|2|||
160936887|NCT05044234|581160333|FG000|Overall Study|Withdrawal by Subject|6|||
160936888|NCT05044234|581160334|FG001|Overall Study|Withdrawal by Subject|4|||
160936889|NCT05044234|581160335|FG002|Overall Study|Withdrawal by Subject|5|||
160936890|NCT05044234|581160336|FG003|Overall Study|Withdrawal by Subject|8|||
160936891|NCT05044234|581160333|FG000|Overall Study|Study terminated by Sponsor|21|||
160936892|NCT05044234|581160334|FG001|Overall Study|Study terminated by Sponsor|21|||
160936893|NCT05044234|581160335|FG002|Overall Study|Study terminated by Sponsor|20|||
160936894|NCT05044234|581160336|FG003|Overall Study|Study terminated by Sponsor|14|||
160936895|NCT05044234|581160333|FG000|Overall Study|Other, not specified|0|||
160936896|NCT05044234|581160334|FG001|Overall Study|Other, not specified|0|||
160936897|NCT05044234|581160335|FG002|Overall Study|Other, not specified|1|||
160936898|NCT05044234|581160336|FG003|Overall Study|Other, not specified|2|||
160936899|NCT05044234|581160333|FG000|Overall Study|Delayed data entry|0|||
160936900|NCT05044234|581160334|FG001|Overall Study|Delayed data entry|0|||
160936901|NCT05044234|581160335|FG002|Overall Study|Delayed data entry|0|||
160936902|NCT05044234|581160336|FG003|Overall Study|Delayed data entry|1|||
160936903|NCT00279708|581160342|FG000|Overall Study|Withdrawal by Subject|2|||
160936904|NCT00279708|581160343|FG001|Overall Study|Withdrawal by Subject|3|||
160936905|NCT00279708|581160342|FG000|Overall Study|Adverse Event|1|||
160936906|NCT00279708|581160343|FG001|Overall Study|Adverse Event|1|||
160936907|NCT02624284|581160344|FG000|Overall Study|Withdrawal by Subject|3|||
160936908|NCT02624284|581160345|FG001|Overall Study|Withdrawal by Subject|6|||
160936909|NCT02624284|581160346|FG002|Overall Study|Withdrawal by Subject|3|||
160936910|NCT02624284|581160344|FG000|Overall Study|Protocol Violation|9|||
160936911|NCT02624284|581160345|FG001|Overall Study|Protocol Violation|10|||
160936912|NCT02624284|581160346|FG002|Overall Study|Protocol Violation|7|||
160936913|NCT02624284|581160344|FG000|Overall Study|Revealed exclusionary condition|2|||
160936914|NCT02624284|581160345|FG001|Overall Study|Revealed exclusionary condition|2|||
160936915|NCT02624284|581160346|FG002|Overall Study|Revealed exclusionary condition|0|||
160936916|NCT02624284|581160344|FG000|Overall Study|Adverse Event|0|||
160936917|NCT02624284|581160345|FG001|Overall Study|Adverse Event|0|||
160936918|NCT02624284|581160346|FG002|Overall Study|Adverse Event|1|||
160936919|NCT01782313|581160347|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
160936920|NCT01782313|581160347|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
160936921|NCT01782313|581160347|FG000|Treated Cycle 3|Progressive Disease|21|||
160936922|NCT01782313|581160347|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
160936923|NCT01782313|581160347|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
160936924|NCT01782313|581160347|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
160936925|NCT01782313|581160347|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
160936926|NCT01782313|581160347|FG000|Survival Follow up|Lost to Follow-up|1|||
160936927|NCT02940691|581160348|FG000|Overall Study|Lost to Follow-up|5|||
160936928|NCT02940691|581160348|FG000|Overall Study|Incarceration|1|||
160936929|NCT00546715|581160349|FG000|Overall Study|Withdrawal by Subject|0|||
160936930|NCT00546715|581160350|FG001|Overall Study|Withdrawal by Subject|1|||
160936931|NCT00546715|581160351|FG002|Overall Study|Withdrawal by Subject|0|||
160936932|NCT00546715|581160352|FG003|Overall Study|Withdrawal by Subject|0|||
160936933|NCT00418691|581160353|FG000|Overall Study|Lost to Follow-up|1|||
160936934|NCT00418691|581160354|FG001|Overall Study|Lost to Follow-up|2|||
160936935|NCT00418691|581160355|FG002|Overall Study|Lost to Follow-up|3|||
160936936|NCT00418691|581160353|FG000|Overall Study|Started new medication voiding entry|0|||
160936937|NCT00418691|581160354|FG001|Overall Study|Started new medication voiding entry|0|||
160936938|NCT00418691|581160355|FG002|Overall Study|Started new medication voiding entry|1|||
160936939|NCT00418691|581160353|FG000|Overall Study|Progressive Disease|1|||
160936940|NCT00418691|581160354|FG001|Overall Study|Progressive Disease|0|||
160936941|NCT00418691|581160355|FG002|Overall Study|Progressive Disease|1|||
160936942|NCT02477020|581160358|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
160936943|NCT02477020|581160359|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
160936944|NCT02477020|581160358|FG000|Overall Study|Voluntary Withdrawal|7|||
160936945|NCT02477020|581160359|FG001|Overall Study|Voluntary Withdrawal|16|||
160936946|NCT02477020|581160358|FG000|Overall Study|Reason not Specified|3|||
160936947|NCT02477020|581160359|FG001|Overall Study|Reason not Specified|1|||
160936948|NCT02477020|581160358|FG000|Overall Study|Lack of Efficacy|14|||
160936949|NCT02477020|581160359|FG001|Overall Study|Lack of Efficacy|5|||
160936950|NCT01049919|581160360|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
160936951|NCT01049919|581160361|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
160936952|NCT01049919|581160360|FG000|Overall Study|Withdrawal by Subject|5|||
160936953|NCT01049919|581160361|FG001|Overall Study|Withdrawal by Subject|0|||
160936954|NCT01049919|581160360|FG000|Overall Study|Lost to Follow-up|6|||
160936955|NCT01049919|581160361|FG001|Overall Study|Lost to Follow-up|1|||
160936956|NCT01049919|581160360|FG000|Overall Study|Physician Decision|2|||
160936957|NCT01049919|581160361|FG001|Overall Study|Physician Decision|0|||
160936958|NCT01049919|581160360|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
160936959|NCT01049919|581160361|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
160936960|NCT01049919|581160360|FG000|Overall Study|Early study termination by sponsor.|2|||
160936961|NCT01049919|581160361|FG001|Overall Study|Early study termination by sponsor.|0|||
160936962|NCT02975934|581160362|FG000|Treatment Phase|Never initiated study drug|0|||
160936963|NCT02975934|581160363|FG001|Treatment Phase|Never initiated study drug|5|||
160936964|NCT02975934|581160364|FG002|Treatment Phase|Never initiated study drug|0|||
160936965|NCT03491150|581160368|FG000|Overall Study|Adverse Event|1|||
160936966|NCT03491150|581160369|FG001|Overall Study|Adverse Event|0|||
160936967|NCT03491150|581160368|FG000|Overall Study|Study Terminated by Sponsor|74|||
160936968|NCT03491150|581160369|FG001|Overall Study|Study Terminated by Sponsor|70|||
160936969|NCT03491150|581160368|FG000|Overall Study|Other|0|||
160936970|NCT03491150|581160369|FG001|Overall Study|Other|1|||
160936971|NCT03491150|581160368|FG000|Overall Study|Withdrawal by Subject|1|||
160936972|NCT03491150|581160369|FG001|Overall Study|Withdrawal by Subject|2|||
160936973|NCT00499603|581160370|FG000|Overall Study|Adverse Event|0|||
160936974|NCT00499603|581160371|FG001|Overall Study|Adverse Event|1|||
160936975|NCT00937547|581160372|FG000|Overall Study|misdiagnosis|1|||
160936976|NCT00937547|581160373|FG001|Overall Study|misdiagnosis|6|||
160936977|NCT00937547|581160374|FG002|Overall Study|misdiagnosis|7|||
160936978|NCT04439240|581160375|FG000|Overall Study|Ineligible|2|||
160936979|NCT04439240|581160375|FG000|Overall Study|Never started treatment|2|||
160936980|NCT04439240|581160375|FG000|Overall Study|Adverse Event|12|||
160936981|NCT04439240|581160375|FG000|Overall Study|Death|2|||
160936982|NCT04439240|581160375|FG000|Overall Study|Disease progression|25|||
160936983|NCT04439240|581160375|FG000|Overall Study|Other diseases|2|||
160936984|NCT04439240|581160375|FG000|Overall Study|Withdrawal by Subject|3|||
160936985|NCT04439240|581160375|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
160936986|NCT04439240|581160375|FG000|Overall Study|Symptomatic decline|1|||
160936987|NCT04439240|581160375|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
160936988|NCT04439240|581160375|FG000|Overall Study|Clinical progression|1|||
160936989|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
160936990|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
160936991|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
160936992|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
160936993|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
160936994|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
160936995|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
160936996|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
160936997|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
160936998|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
160936999|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
160937000|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
161264636|NCT04049617|582350697|FG004|Overall Study|Withdrew consent|0|||
160937001|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
160937002|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
160937003|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
160937004|NCT00280566|581160377|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
160937005|NCT00280566|581160378|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
160937006|NCT00280566|581160379|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
160937007|NCT00280566|581160377|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
160937008|NCT00280566|581160378|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
160937009|NCT00280566|581160379|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
160937010|NCT00280566|581160377|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
160937011|NCT00280566|581160378|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
160937012|NCT00280566|581160379|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
160937013|NCT00280566|581160377|FG000|Period 2 Double Blind|Adverse Event|0|||
160937014|NCT00280566|581160378|FG001|Period 2 Double Blind|Adverse Event|11|||
160937015|NCT00280566|581160379|FG002|Period 2 Double Blind|Adverse Event|15|||
160937016|NCT00280566|581160377|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
160937017|NCT00280566|581160378|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
160937018|NCT00280566|581160379|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
160937019|NCT00280566|581160377|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
160937020|NCT00280566|581160378|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
160937021|NCT00280566|581160379|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
160937022|NCT00280566|581160377|FG000|Period 2 Double Blind|miscellaneous|0|||
160937023|NCT00280566|581160378|FG001|Period 2 Double Blind|miscellaneous|10|||
160937024|NCT00280566|581160379|FG002|Period 2 Double Blind|miscellaneous|5|||
160937025|NCT01502644|581160380|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
160937026|NCT01502644|581160381|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
160937027|NCT01502644|581160382|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
160937028|NCT01502644|581160383|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
160937029|NCT01502644|581160380|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
160937030|NCT01502644|581160381|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
160937031|NCT01502644|581160382|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
160937032|NCT01502644|581160383|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
160937033|NCT01502644|581160380|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
160937034|NCT01502644|581160381|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
160937035|NCT01502644|581160382|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
160937036|NCT01502644|581160383|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
160937037|NCT01502644|581160380|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
160937038|NCT01502644|581160381|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
160937039|NCT01502644|581160382|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
160937040|NCT01502644|581160383|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
160937041|NCT01502644|581160380|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
160937042|NCT01502644|581160381|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
160937043|NCT01502644|581160382|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
160937044|NCT01502644|581160383|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
160937045|NCT04958109|581160389|FG000|Overall Study|Withdrawal by Subject|0|||
160937046|NCT04958109|581160390|FG001|Overall Study|Withdrawal by Subject|1|||
160937047|NCT04958109|581160389|FG000|Overall Study|Lost to Follow-up|0|||
160937048|NCT04958109|581160390|FG001|Overall Study|Lost to Follow-up|1|||
160937049|NCT00715793|581160391|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
160937050|NCT00715793|581160392|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
160937051|NCT00715793|581160391|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
160937052|NCT00715793|581160392|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
160937053|NCT02681302|581160393|FG000|Overall Study|Withdrawal by Subject|1|||
160937054|NCT02681302|581160394|FG001|Overall Study|Withdrawal by Subject|1|||
160937055|NCT02681302|581160395|FG002|Overall Study|Withdrawal by Subject|0|||
160937056|NCT02681302|581160396|FG003|Overall Study|Withdrawal by Subject|0|||
160937057|NCT02681302|581160397|FG004|Overall Study|Withdrawal by Subject|1|||
160937058|NCT02681302|581160398|FG005|Overall Study|Withdrawal by Subject|0|||
160937059|NCT02681302|581160393|FG000|Overall Study|Screen Failure|2|||
160937060|NCT02681302|581160394|FG001|Overall Study|Screen Failure|4|||
160937061|NCT02681302|581160395|FG002|Overall Study|Screen Failure|2|||
160937062|NCT02681302|581160396|FG003|Overall Study|Screen Failure|0|||
160937063|NCT02681302|581160397|FG004|Overall Study|Screen Failure|1|||
160937064|NCT02681302|581160398|FG005|Overall Study|Screen Failure|1|||
160937065|NCT02681302|581160393|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937066|NCT02681302|581160394|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937067|NCT02681302|581160395|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937068|NCT02681302|581160396|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937069|NCT02681302|581160397|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
160937070|NCT02681302|581160398|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
160937071|NCT04399161|581160399|FG000|Overall Study|Withdrawal by Subject|1|||
160937072|NCT04399161|581160400|FG001|Overall Study|Withdrawal by Subject|0|||
160937073|NCT04399161|581160401|FG002|Overall Study|Withdrawal by Subject|2|||
160937074|NCT04399161|581160399|FG000|Overall Study|Protocol Violation|1|||
160937075|NCT04399161|581160400|FG001|Overall Study|Protocol Violation|2|||
160937076|NCT04399161|581160401|FG002|Overall Study|Protocol Violation|0|||
160937077|NCT03417141|581160402|FG000|Overall Study|Withdrawal by Subject|1|||
160937078|NCT03417141|581160402|FG000|Overall Study|Protocol Violation|3|||
160937079|NCT03571516|581160403|FG000|Overall Study|Severe diarrhea|1|||
160937080|NCT03571516|581160404|FG001|Overall Study|Severe diarrhea|0|||
160937081|NCT03571516|581160403|FG000|Overall Study|Withdrawal by Subject|0|||
160937082|NCT03571516|581160404|FG001|Overall Study|Withdrawal by Subject|1|||
160937083|NCT00613509|581160408|FG000|Cycle 1|Adverse Event|2|||
160937084|NCT00613509|581160409|FG001|Cycle 1|Adverse Event|1|||
160937085|NCT00613509|581160408|FG000|Cycle 1|Disease Progression|2|||
160937086|NCT00613509|581160409|FG001|Cycle 1|Disease Progression|6|||
160937087|NCT00613509|581160408|FG000|Cycle 1|Unacceptable Toxicity|1|||
161264637|NCT04049617|582350698|FG005|Overall Study|Withdrew consent|0|||
161264638|NCT01524679|582350699|FG000|Overall Study|Lost to Follow-up|1|||
161264639|NCT01524679|582350700|FG001|Overall Study|Lost to Follow-up|4|||
161264640|NCT01524679|582350699|FG000|Overall Study|Withdrawal by Subject|4|||
160937088|NCT00613509|581160409|FG001|Cycle 1|Unacceptable Toxicity|0|||
161143905|NCT00538733|581909529|FG000|Overall Study|Death|1|||
160937089|NCT00613509|581160408|FG000|Cycle 1|Other administrative reason|0|||
160937090|NCT00613509|581160409|FG001|Cycle 1|Other administrative reason|1|||
160937091|NCT03465878|581160416|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
160937092|NCT03465878|581160417|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
160937093|NCT03465878|581160418|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
160937094|NCT03465878|581160419|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
160937095|NCT03465878|581160416|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
160937096|NCT03465878|581160417|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
160937097|NCT03465878|581160418|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
160937098|NCT03465878|581160419|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
160937099|NCT03465878|581160416|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
160937100|NCT03465878|581160417|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
160937101|NCT03465878|581160418|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
160937102|NCT03465878|581160419|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
160937103|NCT02540954|581160420|FG000|Overall Study|Physician Decision|3|||
160937104|NCT02540954|581160421|FG001|Overall Study|Physician Decision|1|||
160937105|NCT02540954|581160420|FG000|Overall Study|Withdrawal by Subject|6|||
160937106|NCT02540954|581160421|FG001|Overall Study|Withdrawal by Subject|5|||
160937107|NCT02540954|581160420|FG000|Overall Study|Lost to Follow-up|1|||
160937108|NCT02540954|581160421|FG001|Overall Study|Lost to Follow-up|1|||
160937109|NCT02540954|581160420|FG000|Overall Study|Adverse Event|4|||
160937110|NCT02540954|581160421|FG001|Overall Study|Adverse Event|2|||
160937111|NCT02540954|581160420|FG000|Overall Study|Death|0|||
160937112|NCT02540954|581160421|FG001|Overall Study|Death|3|||
160937113|NCT02540954|581160420|FG000|Overall Study|Treatment failure|1|||
160937114|NCT02540954|581160421|FG001|Overall Study|Treatment failure|0|||
160937115|NCT02540954|581160420|FG000|Overall Study|Other reason|4|||
160937116|NCT02540954|581160421|FG001|Overall Study|Other reason|2|||
160937117|NCT01723228|581160425|FG000|Overall Study|Adverse Event|2|||
160937118|NCT01723228|581160426|FG001|Overall Study|Adverse Event|6|||
160937119|NCT01723228|581160425|FG000|Overall Study|Withdrawal by Subject|2|||
160937120|NCT01723228|581160426|FG001|Overall Study|Withdrawal by Subject|1|||
160937121|NCT01723228|581160425|FG000|Overall Study|Protocol Violation|0|||
160937122|NCT01723228|581160426|FG001|Overall Study|Protocol Violation|2|||
160937123|NCT01723228|581160425|FG000|Overall Study|Lost to Follow-up|2|||
160937124|NCT01723228|581160426|FG001|Overall Study|Lost to Follow-up|1|||
160937125|NCT01723228|581160425|FG000|Overall Study|Other|2|||
160937126|NCT01723228|581160426|FG001|Overall Study|Other|1|||
160937127|NCT01282216|581160427|FG000|Overall Study|Graft failure|0|||
160937128|NCT01282216|581160428|FG001|Overall Study|Graft failure|0|||
160937129|NCT01282216|581160429|FG002|Overall Study|Graft failure|3|||
160937130|NCT01282216|581160430|FG003|Overall Study|Graft failure|2|||
160937131|NCT01282216|581160427|FG000|Overall Study|Physician Decision|0|||
160937132|NCT01282216|581160428|FG001|Overall Study|Physician Decision|0|||
160937133|NCT01282216|581160429|FG002|Overall Study|Physician Decision|11|||
160937134|NCT01282216|581160430|FG003|Overall Study|Physician Decision|0|||
160937135|NCT01282216|581160427|FG000|Overall Study|Relapse|0|||
160937136|NCT01282216|581160428|FG001|Overall Study|Relapse|0|||
160937137|NCT01282216|581160429|FG002|Overall Study|Relapse|17|||
160937138|NCT01282216|581160430|FG003|Overall Study|Relapse|6|||
160937139|NCT01282216|581160427|FG000|Overall Study|Death|0|||
160937140|NCT01282216|581160428|FG001|Overall Study|Death|0|||
160937141|NCT01282216|581160429|FG002|Overall Study|Death|2|||
160937142|NCT01282216|581160430|FG003|Overall Study|Death|0|||
160937143|NCT01806896|581160431|FG000|Overall Study|Adverse Event|2|||
160937144|NCT01806896|581160432|FG001|Overall Study|Adverse Event|0|||
160937145|NCT01806896|581160431|FG000|Overall Study|Other|1|||
160937146|NCT01806896|581160432|FG001|Overall Study|Other|0|||
160937147|NCT01864291|581160433|FG000|Overall Study|need for revision surgery|2|||
160937148|NCT02448875|581160434|FG000|Overall Study|Adverse Event|2|||
160937149|NCT02448875|581160435|FG001|Overall Study|Adverse Event|1|||
160937150|NCT02448875|581160436|FG002|Overall Study|Adverse Event|0|||
160937151|NCT02448875|581160434|FG000|Overall Study|Lost to Follow-up|1|||
160937152|NCT02448875|581160435|FG001|Overall Study|Lost to Follow-up|0|||
160937153|NCT02448875|581160436|FG002|Overall Study|Lost to Follow-up|0|||
160937154|NCT02448875|581160434|FG000|Overall Study|Investigator Decision|3|||
160937155|NCT02448875|581160435|FG001|Overall Study|Investigator Decision|0|||
160937156|NCT02448875|581160436|FG002|Overall Study|Investigator Decision|1|||
160937157|NCT02448875|581160434|FG000|Overall Study|Withdrawal by Subject|1|||
160937158|NCT02448875|581160435|FG001|Overall Study|Withdrawal by Subject|0|||
160937159|NCT02448875|581160436|FG002|Overall Study|Withdrawal by Subject|0|||
160937160|NCT02434770|581160438|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
160937161|NCT02434770|581160439|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
160937162|NCT02434770|581160440|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
160937163|NCT02434770|581160438|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
160937164|NCT02434770|581160439|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
160937165|NCT02434770|581160440|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
160937166|NCT02434770|581160438|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
160937167|NCT02434770|581160439|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
160937168|NCT02434770|581160440|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
160937169|NCT02434770|581160438|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
160937170|NCT02434770|581160439|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
160937171|NCT02434770|581160440|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
160937172|NCT02434770|581160438|FG000|Week 1 to Week 18|Death|1|||
160937173|NCT02434770|581160439|FG001|Week 1 to Week 18|Death|0|||
160937174|NCT02434770|581160440|FG002|Week 1 to Week 18|Death|0|||
160937175|NCT02434770|581160438|FG000|Week 18 to Week|Lost to Follow-up|2|||
160937176|NCT02434770|581160439|FG001|Week 18 to Week|Lost to Follow-up|2|||
160937177|NCT02434770|581160440|FG002|Week 18 to Week|Lost to Follow-up|1|||
160937178|NCT02434770|581160438|FG000|Week 18 to Week|Withdrawal by Subject|0|||
160937179|NCT02434770|581160439|FG001|Week 18 to Week|Withdrawal by Subject|0|||
160937180|NCT02434770|581160440|FG002|Week 18 to Week|Withdrawal by Subject|2|||
160937181|NCT02434770|581160438|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
160937182|NCT02434770|581160439|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
160937183|NCT02434770|581160440|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
160937184|NCT00245765|581160441|FG000|Overall Study|Adverse Event|1|||
160937185|NCT00245765|581160442|FG001|Overall Study|Adverse Event|1|||
160937186|NCT00245765|581160443|FG002|Overall Study|Adverse Event|0|||
160937187|NCT00245765|581160441|FG000|Overall Study|Lack of Efficacy|14|||
160937188|NCT00245765|581160442|FG001|Overall Study|Lack of Efficacy|7|||
160937189|NCT00245765|581160443|FG002|Overall Study|Lack of Efficacy|0|||
160937190|NCT00245765|581160441|FG000|Overall Study|Lost to Follow-up|1|||
160937191|NCT00245765|581160442|FG001|Overall Study|Lost to Follow-up|2|||
160937192|NCT00245765|581160443|FG002|Overall Study|Lost to Follow-up|0|||
160937193|NCT00245765|581160441|FG000|Overall Study|Withdrawal by Subject|1|||
160937194|NCT00245765|581160442|FG001|Overall Study|Withdrawal by Subject|0|||
160937195|NCT00245765|581160443|FG002|Overall Study|Withdrawal by Subject|3|||
160937196|NCT00245765|581160441|FG000|Overall Study|Other reason|2|||
160937197|NCT00245765|581160442|FG001|Overall Study|Other reason|0|||
160937198|NCT00245765|581160443|FG002|Overall Study|Other reason|1|||
160937199|NCT00245765|581160441|FG000|Overall Study|Other|13|||
160937200|NCT00245765|581160442|FG001|Overall Study|Other|4|||
160937201|NCT00245765|581160443|FG002|Overall Study|Other|4|||
160937202|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
160937203|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
160937204|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
160937205|NCT01282424|581160449|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
160937206|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
160937207|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
160937208|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
160937209|NCT01282424|581160449|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
160937210|NCT06425458|581160450|FG000|Overall Study|Removed by study team|2|||
160937211|NCT06425458|581160450|FG000|Overall Study|Lost to Follow-up|5|||
160937212|NCT02777125|581160454|FG000|Overall Study|Consent form violation|14|||
160937213|NCT02777125|581160455|FG001|Overall Study|Consent form violation|12|||
160937214|NCT02777125|581160454|FG000|Overall Study|Assent form violation|21|||
160937215|NCT02777125|581160455|FG001|Overall Study|Assent form violation|23|||
160937216|NCT02777125|581160454|FG000|Overall Study|Protocol Violation|8|||
160937217|NCT02777125|581160455|FG001|Overall Study|Protocol Violation|12|||
160937218|NCT02742103|581161765|FG000|Overall Study|Protocol Violation|1|||
160937219|NCT02742103|581161766|FG001|Overall Study|Protocol Violation|0|||
160937220|NCT02742103|581161765|FG000|Overall Study|Death|2|||
160937221|NCT02742103|581161766|FG001|Overall Study|Death|2|||
160937222|NCT02742103|581161765|FG000|Overall Study|Adverse Event|1|||
160937223|NCT02742103|581161766|FG001|Overall Study|Adverse Event|0|||
160937224|NCT02742103|581161765|FG000|Overall Study|Moved to another town|0|||
161264641|NCT01524679|582350700|FG001|Overall Study|Withdrawal by Subject|4|||
160937225|NCT02742103|581161766|FG001|Overall Study|Moved to another town|1|||
160937226|NCT02742103|581161765|FG000|Overall Study|Withdrawal by Subject|5|||
160937227|NCT02742103|581161766|FG001|Overall Study|Withdrawal by Subject|2|||
160937228|NCT00533949|581161771|FG000|Overall Study|Protocol Violation|12|||
160937229|NCT00533949|581161772|FG001|Overall Study|Protocol Violation|12|||
160937230|NCT00533949|581161773|FG002|Overall Study|Protocol Violation|9|||
160937231|NCT00533949|581161774|FG003|Overall Study|Protocol Violation|9|||
160937232|NCT00533949|581161771|FG000|Overall Study|Withdrawal by Subject|3|||
160937233|NCT00533949|581161772|FG001|Overall Study|Withdrawal by Subject|2|||
160937234|NCT00533949|581161773|FG002|Overall Study|Withdrawal by Subject|1|||
161264642|NCT01524679|582350699|FG000|Overall Study|Adverse Event|9|||
160937235|NCT00533949|581161774|FG003|Overall Study|Withdrawal by Subject|1|||
160937236|NCT00727194|581161775|FG000|Screening Period|Low QMG scores|0|||
160937237|NCT00727194|581161776|FG001|Screening Period|Low QMG scores|0|||
160937238|NCT00727194|581161777|FG002|Screening Period|Low QMG scores|6|||
160937239|NCT00727194|581161775|FG000|Screening Period|Lacked AChR antibodies|0|||
160937240|NCT00727194|581161776|FG001|Screening Period|Lacked AChR antibodies|0|||
160937241|NCT00727194|581161777|FG002|Screening Period|Lacked AChR antibodies|5|||
160937242|NCT00727194|581161775|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
160937243|NCT00727194|581161776|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
160937244|NCT00727194|581161777|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
160937245|NCT00727194|581161775|FG000|Screening Period|Severe infections|0|||
160937246|NCT00727194|581161776|FG001|Screening Period|Severe infections|0|||
160937247|NCT00727194|581161777|FG002|Screening Period|Severe infections|2|||
160937248|NCT00727194|581161775|FG000|Screening Period|History of thymoma|0|||
160937249|NCT00727194|581161776|FG001|Screening Period|History of thymoma|0|||
160937250|NCT00727194|581161777|FG002|Screening Period|History of thymoma|1|||
160937251|NCT00727194|581161775|FG000|Treatment Period 2|Lack of Efficacy|0|||
160937252|NCT00727194|581161776|FG001|Treatment Period 2|Lack of Efficacy|1|||
160937253|NCT00727194|581161777|FG002|Treatment Period 2|Lack of Efficacy|0|||
160937254|NCT02649972|581161784|FG000|Overall Study|Not treated|1|||
160937255|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Adverse Event|9|||
160937256|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Adverse Event|2|||
160937257|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
160937258|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
160937259|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
160937260|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
160937261|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Physician Decision|1|||
160937262|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Physician Decision|1|||
160937263|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Pregnancy|2|||
160937264|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Pregnancy|0|||
160937265|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
160937266|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
160937267|NCT02896127|581161787|FG000|COMPLETED WEEK 52|Technical problems|1|||
160937268|NCT02896127|581161788|FG001|COMPLETED WEEK 52|Technical problems|0|||
160937269|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
160937270|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
160937271|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
160937272|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
160937273|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
160937274|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
160937275|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
160937276|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
160937277|NCT02896127|581161787|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
160937278|NCT02896127|581161788|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
160937279|NCT00958776|581161789|FG000|Overall Study|Adverse Event|0|||
160937280|NCT00958776|581161790|FG001|Overall Study|Adverse Event|1|||
160937281|NCT00958776|581161789|FG000|Overall Study|Physician Decision|1|||
160937282|NCT00958776|581161790|FG001|Overall Study|Physician Decision|0|||
160937283|NCT00958776|581161789|FG000|Overall Study|Lost to Follow-up|2|||
160937284|NCT00958776|581161790|FG001|Overall Study|Lost to Follow-up|6|||
160937285|NCT00958776|581161789|FG000|Overall Study|Withdrawal by Subject|7|||
160937286|NCT00958776|581161790|FG001|Overall Study|Withdrawal by Subject|16|||
160937287|NCT00958776|581161789|FG000|Overall Study|Protocol Violation|1|||
160937288|NCT00958776|581161790|FG001|Overall Study|Protocol Violation|1|||
160937289|NCT00958776|581161789|FG000|Overall Study|Death|2|||
160937290|NCT00958776|581161790|FG001|Overall Study|Death|1|||
160937291|NCT00958776|581161789|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
160937292|NCT00958776|581161790|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
160937293|NCT00958776|581161789|FG000|Overall Study|Missing|1|||
160937294|NCT00958776|581161790|FG001|Overall Study|Missing|1|||
160937295|NCT02506816|581161797|FG000|Overall Study|Adverse Event|3|||
160937296|NCT00501540|581161804|FG000|Overall Study|Death|5|||
160937297|NCT02331446|581161805|FG000|Overall Study|Lost to Follow-up|2|||
160937298|NCT02331446|581161806|FG001|Overall Study|Lost to Follow-up|1|||
160937299|NCT02331446|581161807|FG002|Overall Study|Lost to Follow-up|0|||
160937300|NCT02331446|581161808|FG003|Overall Study|Lost to Follow-up|1|||
160937301|NCT02331446|581161805|FG000|Overall Study|Personal Problem|2|||
160937302|NCT02331446|581161806|FG001|Overall Study|Personal Problem|0|||
160937303|NCT02331446|581161807|FG002|Overall Study|Personal Problem|0|||
160937304|NCT02331446|581161808|FG003|Overall Study|Personal Problem|0|||
160937305|NCT02331446|581161805|FG000|Overall Study|Disease|0|||
160937306|NCT02331446|581161806|FG001|Overall Study|Disease|2|||
160937307|NCT02331446|581161807|FG002|Overall Study|Disease|2|||
160937308|NCT02331446|581161808|FG003|Overall Study|Disease|1|||
160937309|NCT02331446|581161805|FG000|Overall Study|Physician Decision|0|||
160937310|NCT02331446|581161806|FG001|Overall Study|Physician Decision|1|||
160998591|NCT00770965|581380586|FG003|Excluded Set|Administrative problems|10|||
160937311|NCT02331446|581161807|FG002|Overall Study|Physician Decision|0|||
160937312|NCT02331446|581161808|FG003|Overall Study|Physician Decision|1|||
160937313|NCT02331446|581161805|FG000|Overall Study|Lost before baseline analysis|0|||
160937314|NCT02331446|581161806|FG001|Overall Study|Lost before baseline analysis|1|||
160937315|NCT02331446|581161807|FG002|Overall Study|Lost before baseline analysis|1|||
160998592|NCT00770965|581380583|FG000|Excluded Set|Withdrawal by Subject|1|||
160998593|NCT00770965|581380584|FG001|Excluded Set|Withdrawal by Subject|1|||
160998594|NCT00770965|581380585|FG002|Excluded Set|Withdrawal by Subject|2|||
160998595|NCT00770965|581380586|FG003|Excluded Set|Withdrawal by Subject|3|||
160998596|NCT02371746|581380587|FG000|Overall Study|Consent withdrawn|0|||
160998597|NCT02371746|581380588|FG001|Overall Study|Consent withdrawn|0|||
160998598|NCT02371746|581380589|FG002|Overall Study|Consent withdrawn|0|||
160998599|NCT02371746|581380590|FG003|Overall Study|Consent withdrawn|0|||
160998600|NCT02371746|581380591|FG004|Overall Study|Consent withdrawn|0|||
160937316|NCT02331446|581161808|FG003|Overall Study|Lost before baseline analysis|0|||
161264643|NCT01524679|582350700|FG001|Overall Study|Adverse Event|0|||
160937317|NCT02984995|581161809|FG000|Overall Study|Required stem cell transplant|13|||
160937318|NCT02984995|581161810|FG001|Overall Study|Required stem cell transplant|2|||
160937319|NCT02984995|581161809|FG000|Overall Study|Progressive disease|11|||
160937320|NCT02984995|581161810|FG001|Overall Study|Progressive disease|1|||
160937321|NCT02984995|581161809|FG000|Overall Study|Adverse Event|1|||
160937322|NCT02984995|581161810|FG001|Overall Study|Adverse Event|0|||
160937323|NCT04354831|581161811|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
160937324|NCT04354831|581161812|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
160937325|NCT00812929|581161813|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
160937326|NCT00812929|581161814|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
160937327|NCT00812929|581161815|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
160937328|NCT00812929|581161816|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
160937329|NCT00812929|581161817|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
160937330|NCT00812929|581161818|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
160937331|NCT00812929|581161819|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
160937332|NCT00812929|581161820|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
160937333|NCT00812929|581161821|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
160937334|NCT00812929|581161822|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
160937335|NCT00812929|581161813|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
160937336|NCT00812929|581161814|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
160937337|NCT00812929|581161815|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
160937338|NCT00812929|581161816|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
160937339|NCT00812929|581161817|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
160937340|NCT00812929|581161818|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
160937341|NCT00812929|581161819|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
160937342|NCT00812929|581161820|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
160937343|NCT00812929|581161821|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
160937344|NCT00812929|581161822|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
160937345|NCT00812929|581161813|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
160937346|NCT00812929|581161814|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
160937347|NCT00812929|581161815|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
160937348|NCT00812929|581161816|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
160937349|NCT00812929|581161817|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
160937350|NCT00812929|581161818|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
160937351|NCT00812929|581161819|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
160937352|NCT00812929|581161820|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
160937353|NCT00812929|581161821|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
160937354|NCT00812929|581161822|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
160937355|NCT02504372|581161824|FG000|Overall Study|Death|136|||
160998601|NCT02371746|581380592|FG005|Overall Study|Consent withdrawn|0|||
160998602|NCT02371746|581380593|FG006|Overall Study|Consent withdrawn|1|||
160998603|NCT00612586|581380594|FG000|Overall Study|Adverse Event|6|||
161264644|NCT01524679|582350699|FG000|Overall Study|Protocol Violation|1|||
161264645|NCT01524679|582350700|FG001|Overall Study|Protocol Violation|0|||
161264646|NCT01524679|582350699|FG000|Overall Study|Lack of Efficacy|2|||
161264647|NCT01524679|582350700|FG001|Overall Study|Lack of Efficacy|0|||
161264648|NCT01524679|582350699|FG000|Overall Study|e.g.wish for children, relocation|6|||
160937356|NCT02504372|581161825|FG001|Overall Study|Death|154|||
160937357|NCT02504372|581161824|FG000|Overall Study|Lost to Follow-up|0|||
160937358|NCT02504372|581161825|FG001|Overall Study|Lost to Follow-up|2|||
160937359|NCT02504372|581161824|FG000|Overall Study|Withdrawal of consent|25|||
160937360|NCT02504372|581161825|FG001|Overall Study|Withdrawal of consent|16|||
160937361|NCT02504372|581161824|FG000|Overall Study|Participants ongoing|429|||
160937362|NCT02504372|581161825|FG001|Overall Study|Participants ongoing|415|||
160998604|NCT00612586|581380595|FG001|Overall Study|Adverse Event|2|||
160998605|NCT00612586|581380594|FG000|Overall Study|Death|1|||
160998606|NCT00612586|581380595|FG001|Overall Study|Death|0|||
160998607|NCT00612586|581380594|FG000|Overall Study|Entry Criteria Not Met|0|||
160998608|NCT00612586|581380595|FG001|Overall Study|Entry Criteria Not Met|2|||
161264649|NCT01524679|582350700|FG001|Overall Study|e.g.wish for children, relocation|1|||
161264650|NCT00801099|582350701|FG000|Overall Study|Lost to Follow-up|101|||
161264651|NCT01780987|582350702|FG000|Overall Study|Adverse Event|0|||
161264652|NCT01780987|582350703|FG001|Overall Study|Adverse Event|4|||
161264653|NCT01780987|582350702|FG000|Overall Study|Withdrawal by Subject|2|||
160937363|NCT00433654|581161826|FG000|Overall Study|Death|4|||
160937364|NCT00433654|581161827|FG001|Overall Study|Death|0|||
160937365|NCT00433654|581161826|FG000|Overall Study|Missed visit|6|||
160937366|NCT00433654|581161827|FG001|Overall Study|Missed visit|3|||
160937367|NCT00433654|581161826|FG000|Overall Study|Subject not yet due for visit|4|||
160937368|NCT00433654|581161827|FG001|Overall Study|Subject not yet due for visit|0|||
160937369|NCT00433654|581161826|FG000|Overall Study|Withdrawal by Subject|1|||
160937370|NCT00433654|581161827|FG001|Overall Study|Withdrawal by Subject|2|||
160937371|NCT01428193|581161851|FG000|Overall Study|Physician Decision|1|||
160937372|NCT01428193|581161851|FG000|Overall Study|Elevated screening liver enzymes|1|||
160937373|NCT00357370|581161854|FG000|Cohort 2|Lack of Efficacy|0|||
160937374|NCT00357370|581161855|FG001|Cohort 2|Lack of Efficacy|2|||
160937375|NCT00357370|581161856|FG002|Cohort 2|Lack of Efficacy|1|||
160937376|NCT00357370|581161854|FG000|Cohort 2|Adverse Event|1|||
160937377|NCT00357370|581161855|FG001|Cohort 2|Adverse Event|1|||
160937378|NCT00357370|581161856|FG002|Cohort 2|Adverse Event|1|||
160937379|NCT00357370|581161854|FG000|Cohort 2|Lost to Follow-up|0|||
160937380|NCT00357370|581161855|FG001|Cohort 2|Lost to Follow-up|1|||
160937381|NCT00357370|581161856|FG002|Cohort 2|Lost to Follow-up|0|||
160937382|NCT00357370|581161854|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
160937383|NCT00357370|581161855|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
160937384|NCT00357370|581161856|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
160937385|NCT00357370|581161854|FG000|Cohort 2|Withdrawal by Subject|0|||
160937386|NCT00357370|581161855|FG001|Cohort 2|Withdrawal by Subject|2|||
160937387|NCT00357370|581161856|FG002|Cohort 2|Withdrawal by Subject|0|||
160937388|NCT00079274|581161857|FG000|Overall Study|Withdrawal by Subject|111|||
160937389|NCT00079274|581161858|FG001|Overall Study|Withdrawal by Subject|10|||
160937390|NCT00079274|581161859|FG002|Overall Study|Withdrawal by Subject|12|||
160937391|NCT00079274|581161860|FG003|Overall Study|Withdrawal by Subject|163|||
160937392|NCT00079274|581161861|FG004|Overall Study|Withdrawal by Subject|7|||
160937393|NCT00079274|581161862|FG005|Overall Study|Withdrawal by Subject|8|||
160937394|NCT00079274|581161863|FG006|Overall Study|Withdrawal by Subject|0|||
160937395|NCT00079274|581161857|FG000|Overall Study|Adverse Event|130|||
160937396|NCT00079274|581161858|FG001|Overall Study|Adverse Event|8|||
160937397|NCT00079274|581161859|FG002|Overall Study|Adverse Event|8|||
160937398|NCT00079274|581161860|FG003|Overall Study|Adverse Event|184|||
160937399|NCT00079274|581161861|FG004|Overall Study|Adverse Event|7|||
160937400|NCT00079274|581161862|FG005|Overall Study|Adverse Event|8|||
160937401|NCT00079274|581161863|FG006|Overall Study|Adverse Event|0|||
160937402|NCT00079274|581161857|FG000|Overall Study|Recurrence|21|||
160937403|NCT00079274|581161858|FG001|Overall Study|Recurrence|0|||
160937404|NCT00079274|581161859|FG002|Overall Study|Recurrence|1|||
160937405|NCT00079274|581161860|FG003|Overall Study|Recurrence|15|||
160937406|NCT00079274|581161861|FG004|Overall Study|Recurrence|0|||
160937407|NCT00079274|581161862|FG005|Overall Study|Recurrence|2|||
160937408|NCT00079274|581161863|FG006|Overall Study|Recurrence|0|||
160937409|NCT00079274|581161857|FG000|Overall Study|Alternate Treatment|6|||
160937410|NCT00079274|581161858|FG001|Overall Study|Alternate Treatment|1|||
160937411|NCT00079274|581161859|FG002|Overall Study|Alternate Treatment|0|||
160937412|NCT00079274|581161860|FG003|Overall Study|Alternate Treatment|3|||
160937413|NCT00079274|581161861|FG004|Overall Study|Alternate Treatment|0|||
160937414|NCT00079274|581161862|FG005|Overall Study|Alternate Treatment|0|||
160937415|NCT00079274|581161863|FG006|Overall Study|Alternate Treatment|0|||
160937416|NCT00079274|581161857|FG000|Overall Study|Other Medical Problems|6|||
160937417|NCT00079274|581161858|FG001|Overall Study|Other Medical Problems|1|||
160937418|NCT00079274|581161859|FG002|Overall Study|Other Medical Problems|0|||
160937419|NCT00079274|581161860|FG003|Overall Study|Other Medical Problems|7|||
160937420|NCT00079274|581161861|FG004|Overall Study|Other Medical Problems|0|||
160937421|NCT00079274|581161862|FG005|Overall Study|Other Medical Problems|0|||
160937422|NCT00079274|581161863|FG006|Overall Study|Other Medical Problems|0|||
160937423|NCT00079274|581161857|FG000|Overall Study|Death|4|||
160937424|NCT00079274|581161858|FG001|Overall Study|Death|0|||
160937425|NCT00079274|581161859|FG002|Overall Study|Death|1|||
160937426|NCT00079274|581161860|FG003|Overall Study|Death|15|||
160937427|NCT00079274|581161861|FG004|Overall Study|Death|0|||
160937428|NCT00079274|581161862|FG005|Overall Study|Death|0|||
160937429|NCT00079274|581161863|FG006|Overall Study|Death|0|||
160937430|NCT00079274|581161857|FG000|Overall Study|Cytogenetic resistance|0|||
160937431|NCT00079274|581161858|FG001|Overall Study|Cytogenetic resistance|0|||
160937432|NCT00079274|581161859|FG002|Overall Study|Cytogenetic resistance|0|||
160937433|NCT00079274|581161860|FG003|Overall Study|Cytogenetic resistance|2|||
160937434|NCT00079274|581161861|FG004|Overall Study|Cytogenetic resistance|0|||
160937435|NCT00079274|581161862|FG005|Overall Study|Cytogenetic resistance|0|||
160937436|NCT00079274|581161863|FG006|Overall Study|Cytogenetic resistance|0|||
160937437|NCT00079274|581161857|FG000|Overall Study|Other|43|||
160937438|NCT00079274|581161858|FG001|Overall Study|Other|7|||
160937439|NCT00079274|581161859|FG002|Overall Study|Other|5|||
160937440|NCT00079274|581161860|FG003|Overall Study|Other|55|||
160937441|NCT00079274|581161861|FG004|Overall Study|Other|1|||
160937442|NCT00079274|581161862|FG005|Overall Study|Other|2|||
160937443|NCT00079274|581161863|FG006|Overall Study|Other|0|||
160937444|NCT01302392|581161864|FG000|Overall Study|Lost to Follow-up|1|||
160937445|NCT01302392|581161865|FG001|Overall Study|Lost to Follow-up|0|||
160937446|NCT01302392|581161864|FG000|Overall Study|Withdrawal by Subject|6|||
160937447|NCT01302392|581161865|FG001|Overall Study|Withdrawal by Subject|1|||
160937448|NCT00670228|581161866|FG000|Overall Study|Adverse Event|1|||
160937449|NCT00670228|581161867|FG001|Overall Study|Adverse Event|0|||
160937450|NCT00670228|581161866|FG000|Overall Study|Death or MACE|0|||
160937451|NCT00670228|581161867|FG001|Overall Study|Death or MACE|1|||
160937452|NCT00670228|581161866|FG000|Overall Study|Not treated|2|||
160937453|NCT00670228|581161867|FG001|Overall Study|Not treated|2|||
160937454|NCT00670228|581161866|FG000|Overall Study|Not meeting the selection criteria|2|||
160937455|NCT00670228|581161867|FG001|Overall Study|Not meeting the selection criteria|0|||
160937456|NCT03604692|581161871|FG000|Overall Study|Investigator's Decision|0|||
160937457|NCT03604692|581161872|FG001|Overall Study|Investigator's Decision|0|||
160937458|NCT03604692|581161873|FG002|Overall Study|Investigator's Decision|0|||
160937459|NCT03604692|581161874|FG003|Overall Study|Investigator's Decision|1|||
160937460|NCT03604692|581161875|FG004|Overall Study|Investigator's Decision|0|||
160937461|NCT03604692|581161876|FG005|Overall Study|Investigator's Decision|7|||
160937462|NCT03604692|581161871|FG000|Overall Study|Withdrawal by Subject|0|||
160937463|NCT03604692|581161872|FG001|Overall Study|Withdrawal by Subject|0|||
160937464|NCT03604692|581161873|FG002|Overall Study|Withdrawal by Subject|0|||
160937465|NCT03604692|581161874|FG003|Overall Study|Withdrawal by Subject|0|||
160937466|NCT03604692|581161875|FG004|Overall Study|Withdrawal by Subject|0|||
160937467|NCT03604692|581161876|FG005|Overall Study|Withdrawal by Subject|2|||
160937468|NCT03604692|581161871|FG000|Overall Study|Progressive Disease|1|||
161342503|NCT04880850|582640215|FG000|Overall Study|Withdrawal by Subject|9|||
161342504|NCT04880850|582640216|FG001|Overall Study|Withdrawal by Subject|10|||
161342505|NCT03907488|582640217|FG000|Overall Study|Adverse Event|20|||
161342506|NCT03907488|582640218|FG001|Overall Study|Adverse Event|20|||
160937469|NCT03604692|581161872|FG001|Overall Study|Progressive Disease|0|||
160937470|NCT03604692|581161873|FG002|Overall Study|Progressive Disease|1|||
160937471|NCT03604692|581161874|FG003|Overall Study|Progressive Disease|0|||
160937472|NCT03604692|581161875|FG004|Overall Study|Progressive Disease|3|||
160937473|NCT03604692|581161876|FG005|Overall Study|Progressive Disease|4|||
160937474|NCT03604692|581161871|FG000|Overall Study|Difficulty Coming into Site|0|||
160937475|NCT03604692|581161872|FG001|Overall Study|Difficulty Coming into Site|0|||
160937476|NCT03604692|581161873|FG002|Overall Study|Difficulty Coming into Site|0|||
160937477|NCT03604692|581161874|FG003|Overall Study|Difficulty Coming into Site|0|||
160937478|NCT03604692|581161875|FG004|Overall Study|Difficulty Coming into Site|0|||
160937479|NCT03604692|581161876|FG005|Overall Study|Difficulty Coming into Site|1|||
160937480|NCT03604692|581161871|FG000|Overall Study|Death|0|||
160937481|NCT03604692|581161872|FG001|Overall Study|Death|0|||
160937482|NCT03604692|581161873|FG002|Overall Study|Death|1|||
160937483|NCT03604692|581161874|FG003|Overall Study|Death|0|||
161143906|NCT00538733|581909529|FG000|Overall Study|declined to participate|2|||
161143907|NCT00538733|581909529|FG000|Overall Study|still on therapy|1|||
161143908|NCT04513158|581909532|FG000|Overall Study|Screen Failure|1|||
161143909|NCT05278104|581909533|FG000|Overall Study|Not treated|1|||
161143910|NCT05278104|581909534|FG001|Overall Study|Not treated|0|||
161143911|NCT05278104|581909533|FG000|Overall Study|Adverse Event|2|||
161143912|NCT05278104|581909534|FG001|Overall Study|Adverse Event|1|||
161143913|NCT05278104|581909533|FG000|Overall Study|Exclusion criteria not met|1|||
160937484|NCT03604692|581161875|FG004|Overall Study|Death|0|||
161143914|NCT05278104|581909534|FG001|Overall Study|Exclusion criteria not met|0|||
161342507|NCT03907488|582640217|FG000|Overall Study|Withdrawal by Subject|9|||
161342508|NCT03907488|582640218|FG001|Overall Study|Withdrawal by Subject|13|||
161342509|NCT03907488|582640217|FG000|Overall Study|Lack of Efficacy|0|||
160937485|NCT03604692|581161876|FG005|Overall Study|Death|0|||
160937486|NCT03604692|581161871|FG000|Overall Study|Drug Intolerance|0|||
161342510|NCT03907488|582640218|FG001|Overall Study|Lack of Efficacy|9|||
161342511|NCT03907488|582640217|FG000|Overall Study|Death|3|||
161342512|NCT03907488|582640218|FG001|Overall Study|Death|8|||
161342513|NCT03907488|582640217|FG000|Overall Study|not protocol specified|5|||
161342514|NCT03907488|582640218|FG001|Overall Study|not protocol specified|8|||
161342515|NCT03907488|582640217|FG000|Overall Study|Ineligible|9|||
161342516|NCT03907488|582640218|FG001|Overall Study|Ineligible|15|||
160937487|NCT03604692|581161872|FG001|Overall Study|Drug Intolerance|0|||
160937488|NCT03604692|581161873|FG002|Overall Study|Drug Intolerance|0|||
160937489|NCT03604692|581161874|FG003|Overall Study|Drug Intolerance|1|||
160998609|NCT00612586|581380594|FG000|Overall Study|Withdrawal by Subject|7|||
160998610|NCT00612586|581380595|FG001|Overall Study|Withdrawal by Subject|9|||
160937490|NCT03604692|581161875|FG004|Overall Study|Drug Intolerance|0|||
161143915|NCT00001259|581911782|FG000|Study 2|Adverse Event|0|||
160937491|NCT03604692|581161876|FG005|Overall Study|Drug Intolerance|0|||
160937492|NCT03604692|581161871|FG000|Overall Study|Noncompliance with follow-up visit|0|||
161143916|NCT00001259|581911783|FG001|Study 2|Adverse Event|0|||
161143917|NCT00001259|581911784|FG002|Study 2|Adverse Event|0|||
161143918|NCT00001259|581911785|FG003|Study 2|Adverse Event|0|||
161342517|NCT01093846|582640220|FG000|Overall Study|Adverse Event|0|||
161342518|NCT01093846|582640221|FG001|Overall Study|Adverse Event|0|||
161143919|NCT00001259|581911786|FG004|Study 2|Adverse Event|2|||
161143920|NCT00001259|581911787|FG005|Study 2|Adverse Event|0|||
161143921|NCT00001259|581911788|FG006|Study 2|Adverse Event|0|||
161143922|NCT01582282|581911789|FG000|Overall Study|Adverse Event|1|||
161143923|NCT01582282|581911790|FG001|Overall Study|Adverse Event|1|||
161143924|NCT01582282|581911791|FG002|Overall Study|Adverse Event|0|||
161143925|NCT01582282|581911789|FG000|Overall Study|Lost to Follow-up|1|||
161143926|NCT01582282|581911790|FG001|Overall Study|Lost to Follow-up|0|||
161143927|NCT01582282|581911791|FG002|Overall Study|Lost to Follow-up|0|||
161143928|NCT01582282|581911789|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
161143929|NCT01582282|581911790|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
160937493|NCT03604692|581161872|FG001|Overall Study|Noncompliance with follow-up visit|0|||
160937494|NCT03604692|581161873|FG002|Overall Study|Noncompliance with follow-up visit|0|||
160937495|NCT03604692|581161874|FG003|Overall Study|Noncompliance with follow-up visit|1|||
160937496|NCT03604692|581161875|FG004|Overall Study|Noncompliance with follow-up visit|0|||
160937497|NCT03604692|581161876|FG005|Overall Study|Noncompliance with follow-up visit|0|||
160937498|NCT03604692|581161871|FG000|Overall Study|Not Treated|0|||
160937499|NCT03604692|581161872|FG001|Overall Study|Not Treated|0|||
160937500|NCT03604692|581161873|FG002|Overall Study|Not Treated|0|||
160937501|NCT03604692|581161874|FG003|Overall Study|Not Treated|0|||
160937502|NCT03604692|581161875|FG004|Overall Study|Not Treated|1|||
160937503|NCT03604692|581161876|FG005|Overall Study|Not Treated|0|||
160937504|NCT00637195|581161877|FG000|Overall Study|Lost to Follow-up|1|||
160937505|NCT00637195|581161878|FG001|Overall Study|Lost to Follow-up|0|||
160937506|NCT00637195|581161877|FG000|Overall Study|Other|2|||
160937507|NCT00637195|581161878|FG001|Overall Study|Other|0|||
160937508|NCT00637195|581161877|FG000|Overall Study|Withdrawal by Subject|0|||
160937509|NCT00637195|581161878|FG001|Overall Study|Withdrawal by Subject|1|||
160937510|NCT00547703|581161881|FG000|Overall Study|Lost to Follow-up|1|||
160937511|NCT00547703|581161882|FG001|Overall Study|Lost to Follow-up|0|||
160937512|NCT01193556|581161885|FG000|Overall Study|Study termination|26|||
160937513|NCT01193556|581161886|FG001|Overall Study|Study termination|25|||
160937514|NCT01696032|581161887|FG000|Overall Study|Withdrawal by Subject|0|||
160937515|NCT01696032|581161888|FG001|Overall Study|Withdrawal by Subject|0|||
160937516|NCT01696032|581161889|FG002|Overall Study|Withdrawal by Subject|1|||
160937517|NCT01696032|581161890|FG003|Overall Study|Withdrawal by Subject|2|||
160937518|NCT01696032|581161887|FG000|Overall Study|Death|14|||
160937519|NCT01696032|581161888|FG001|Overall Study|Death|4|||
160937520|NCT01696032|581161889|FG002|Overall Study|Death|43|||
160937521|NCT01696032|581161890|FG003|Overall Study|Death|18|||
160937522|NCT01696032|581161887|FG000|Overall Study|Lost to Follow-up|0|||
160937523|NCT01696032|581161888|FG001|Overall Study|Lost to Follow-up|1|||
160937524|NCT01696032|581161889|FG002|Overall Study|Lost to Follow-up|0|||
160937525|NCT01696032|581161890|FG003|Overall Study|Lost to Follow-up|0|||
160937526|NCT01696032|581161887|FG000|Overall Study|Database lock|0|||
160937527|NCT01696032|581161888|FG001|Overall Study|Database lock|1|||
160937528|NCT01696032|581161889|FG002|Overall Study|Database lock|7|||
160937529|NCT01696032|581161890|FG003|Overall Study|Database lock|2|||
160937530|NCT00376168|581161891|FG000|Overall Study|Adverse Event|1|||
160937531|NCT00376168|581161892|FG001|Overall Study|Adverse Event|1|||
160937532|NCT00376168|581161891|FG000|Overall Study|Pregnancy|1|||
160937533|NCT00376168|581161892|FG001|Overall Study|Pregnancy|0|||
160937534|NCT01020019|581161893|FG000|Overall Study|Lost to Follow-up|21|||
160937535|NCT01020019|581161894|FG001|Overall Study|Lost to Follow-up|18|||
160937536|NCT01020019|581161893|FG000|Overall Study|Adverse Event|1|||
160937537|NCT01020019|581161894|FG001|Overall Study|Adverse Event|5|||
160937538|NCT01020019|581161893|FG000|Overall Study|not interested in treatment|4|||
160937539|NCT01020019|581161894|FG001|Overall Study|not interested in treatment|4|||
160937540|NCT01020019|581161893|FG000|Overall Study|moving|0|||
160937541|NCT01020019|581161894|FG001|Overall Study|moving|2|||
160937542|NCT05091528|581161895|FG000|Overall Study|Study Termination by Sponsor|0|||
160937543|NCT05091528|581161896|FG001|Overall Study|Study Termination by Sponsor|1|||
160937544|NCT05091528|581161897|FG002|Overall Study|Study Termination by Sponsor|0|||
160937545|NCT05091528|581161898|FG003|Overall Study|Study Termination by Sponsor|1|||
160937546|NCT03316872|581161899|FG000|Overall Study|Death|1|||
160937547|NCT02239536|581161900|FG000|Overall Study|Non-neoplastic polyp|23|||
160937548|NCT02239536|581161901|FG001|Overall Study|Non-neoplastic polyp|17|||
160937549|NCT04074317|581161902|FG000|Third Period|Withdrawal by Subject|0|||
160937550|NCT04074317|581161903|FG001|Third Period|Withdrawal by Subject|0|||
160937551|NCT04074317|581161904|FG002|Third Period|Withdrawal by Subject|0|||
160937552|NCT04074317|581161905|FG003|Third Period|Withdrawal by Subject|1|||
161143930|NCT01582282|581911791|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
160937553|NCT04074317|581161906|FG004|Third Period|Withdrawal by Subject|0|||
160937554|NCT04074317|581161907|FG005|Third Period|Withdrawal by Subject|0|||
160937555|NCT01038778|581161908|FG000|Overall Study|Withdrawal by Subject|0|||
160937556|NCT01038778|581161909|FG001|Overall Study|Withdrawal by Subject|2|||
161143931|NCT02413255|581911795|FG000|Overall Study|Voluntary Withdrawal|0|||
161143932|NCT02413255|581911796|FG001|Overall Study|Voluntary Withdrawal|0|||
161143933|NCT02413255|581911797|FG002|Overall Study|Voluntary Withdrawal|0|||
160998611|NCT00612586|581380594|FG000|Overall Study|Physician Decision|1|||
160998612|NCT00612586|581380595|FG001|Overall Study|Physician Decision|2|||
160998613|NCT00612586|581380594|FG000|Overall Study|Sponsor Decision|1|||
160998614|NCT00612586|581380595|FG001|Overall Study|Sponsor Decision|1|||
160998615|NCT00612586|581380594|FG000|Overall Study|Progressive Disease|26|||
160937557|NCT01038778|581161910|FG002|Overall Study|Withdrawal by Subject|3|||
160937558|NCT02283788|581161912|FG000|Overall Study|Adverse Event|1|||
160937559|NCT02283788|581161913|FG001|Overall Study|Adverse Event|3|||
160937560|NCT02283788|581161914|FG002|Overall Study|Adverse Event|5|||
160937561|NCT02283788|581161915|FG003|Overall Study|Adverse Event|1|||
160937562|NCT02283788|581161912|FG000|Overall Study|Withdrawal by Subject|0|||
160937563|NCT02283788|581161913|FG001|Overall Study|Withdrawal by Subject|1|||
160937564|NCT02283788|581161914|FG002|Overall Study|Withdrawal by Subject|0|||
160998616|NCT00612586|581380595|FG001|Overall Study|Progressive Disease|24|||
160937565|NCT02283788|581161915|FG003|Overall Study|Withdrawal by Subject|1|||
160937566|NCT04269161|581163424|FG000|Overall Study|Change of modality and no longer eligible|3|||
160937567|NCT04269161|581163425|FG001|Overall Study|Change of modality and no longer eligible|3|||
160937568|NCT04269161|581163424|FG000|Overall Study|Required procedure outside of NICU|1|||
160937569|NCT04269161|581163425|FG001|Overall Study|Required procedure outside of NICU|0|||
160937570|NCT04269161|581163424|FG000|Overall Study|Equipment issue|1|||
160937571|NCT04269161|581163425|FG001|Overall Study|Equipment issue|1|||
160937572|NCT02472756|581163426|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
160937573|NCT02472756|581163426|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
160937574|NCT02472756|581163426|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
160937575|NCT02472756|581163426|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
160937576|NCT02472756|581163426|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
160937577|NCT00326911|581163429|FG000|Overall Study|Hospitalization prior to treatment|0|||
160937578|NCT00326911|581163430|FG001|Overall Study|Hospitalization prior to treatment|1|||
160937579|NCT00326911|581163429|FG000|Overall Study|Physician decision prior to treatment|1|||
160937580|NCT00326911|581163430|FG001|Overall Study|Physician decision prior to treatment|0|||
160937581|NCT00326911|581163429|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
160937582|NCT00326911|581163430|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
160937583|NCT04182100|581163431|FG000|Overall Study|Adverse Event|1|||
160937584|NCT04182100|581163431|FG000|Overall Study|Withdrawal by Subject|1|||
160937585|NCT01632800|581163438|FG000|Overall Study|Subject did not fit in apparatus|1|||
160937586|NCT00813124|581163439|FG000|Overall Study|Death|2|||
160937587|NCT00813124|581163439|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
160937588|NCT00813124|581163439|FG000|Overall Study|Withdrawal by Subject|1|||
160937589|NCT01147653|581163446|FG000|Year 2|Withdrawal by Subject|2|||
160937590|NCT01147653|581163447|FG001|Year 2|Withdrawal by Subject|3|||
160937591|NCT02214121|581163452|FG000|Part A|Patient decision|2|||
160937592|NCT02214121|581163453|FG001|Part A|Patient decision|0|||
160937593|NCT02214121|581163454|FG002|Part A|Patient decision|0|||
160937594|NCT02214121|581163452|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
160937595|NCT02214121|581163453|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
160937596|NCT02214121|581163454|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
160937597|NCT02214121|581163452|FG000|Part A|Other|1|||
160937598|NCT02214121|581163453|FG001|Part A|Other|0|||
160937599|NCT02214121|581163454|FG002|Part A|Other|0|||
160937600|NCT02214121|581163452|FG000|Part B|Patient decision|0|||
160937601|NCT02214121|581163453|FG001|Part B|Patient decision|1|||
160937602|NCT02214121|581163454|FG002|Part B|Patient decision|0|||
160937603|NCT02214121|581163452|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
160937604|NCT02214121|581163453|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
160937605|NCT02214121|581163454|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
160937606|NCT02214121|581163452|FG000|Part B|Lost to Follow-up|0|||
160937607|NCT02214121|581163453|FG001|Part B|Lost to Follow-up|0|||
160937608|NCT02214121|581163454|FG002|Part B|Lost to Follow-up|1|||
160998617|NCT00612586|581380594|FG000|Overall Study|Randomized and Not Treated|1|||
160998618|NCT00612586|581380595|FG001|Overall Study|Randomized and Not Treated|1|||
160998619|NCT02613364|581380596|FG000|Overall Study|Other|19|||
160998620|NCT02613364|581380597|FG001|Overall Study|Other|29|||
161143934|NCT02413255|581911798|FG003|Overall Study|Voluntary Withdrawal|0|||
160937609|NCT02375672|581163455|FG000|Overall Study|remain on follow up|20|||
160937610|NCT02203591|581163456|FG000|Overall Study|Did not meet treatment day baseline|147|||
160937611|NCT02203591|581163457|FG001|Overall Study|Did not meet treatment day baseline|141|||
160937612|NCT02203591|581163458|FG002|Overall Study|Did not meet treatment day baseline|150|||
160937613|NCT02203591|581163459|FG003|Overall Study|Did not meet treatment day baseline|45|||
160998621|NCT02613364|581380598|FG002|Overall Study|Other|17|||
160998622|NCT02613364|581380596|FG000|Overall Study|Too time consuming|21|||
161143935|NCT02413255|581911799|FG004|Overall Study|Voluntary Withdrawal|0|||
161143936|NCT02413255|581911800|FG005|Overall Study|Voluntary Withdrawal|0|||
160937614|NCT02203591|581163460|FG004|Overall Study|Did not meet treatment day baseline|33|||
160937615|NCT02203591|581163461|FG005|Overall Study|Did not meet treatment day baseline|35|||
160937616|NCT02203591|581163462|FG006|Overall Study|Did not meet treatment day baseline|29|||
160937617|NCT02203591|581163463|FG007|Overall Study|Did not meet treatment day baseline|12|||
160937618|NCT02203591|581163456|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
160937619|NCT02203591|581163457|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
160937620|NCT02203591|581163458|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
160937621|NCT02203591|581163459|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
160937622|NCT02203591|581163460|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
160937623|NCT02203591|581163461|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
160937624|NCT02203591|581163462|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
160937625|NCT02203591|581163463|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
160937626|NCT04115358|581163464|FG000|Overall Study|exfoliation|0|||
160937627|NCT04115358|581163465|FG001|Overall Study|exfoliation|0|||
160937628|NCT04115358|581163466|FG002|Overall Study|exfoliation|1|||
160937629|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937630|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937631|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
160937632|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937633|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937634|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
160937635|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
160937636|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
160937637|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
160937638|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
160937639|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
160937640|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
160937641|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
160937642|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
160937643|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
160937644|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937645|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937646|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937647|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937648|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160998623|NCT02613364|581380597|FG001|Overall Study|Too time consuming|26|||
160998624|NCT02613364|581380598|FG002|Overall Study|Too time consuming|26|||
160998625|NCT02613364|581380596|FG000|Overall Study|Withdrawal by Subject|13|||
160998626|NCT02613364|581380597|FG001|Overall Study|Withdrawal by Subject|18|||
160937649|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
160937650|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160937651|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937652|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
160937653|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937654|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937655|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
160937656|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
160937657|NCT01573624|581163469|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
160937658|NCT01573624|581163470|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
160937659|NCT01573624|581163471|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937660|NCT01573624|581163472|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937661|NCT01573624|581163473|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
160937662|NCT01573624|581163474|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937663|NCT01573624|581163475|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
160937664|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937665|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937666|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937667|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937668|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937669|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
160937670|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
160937671|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160998627|NCT02613364|581380598|FG002|Overall Study|Withdrawal by Subject|17|||
160937672|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
160937673|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160998628|NCT02613364|581380596|FG000|Overall Study|Medical|12|||
160998629|NCT02613364|581380597|FG001|Overall Study|Medical|13|||
160998630|NCT02613364|581380598|FG002|Overall Study|Medical|9|||
160998631|NCT02613364|581380596|FG000|Overall Study|Disliked Study Procedure|1|||
160937674|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
160937675|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160937676|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
160937677|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
160937678|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
160937679|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937680|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
160937681|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
160937682|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937683|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937684|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
160937685|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937686|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937687|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937688|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937689|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937690|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
160937691|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
160937692|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937693|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937694|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937695|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
160937696|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937697|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
160937698|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
160937699|NCT01573624|581163469|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937700|NCT01573624|581163470|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937701|NCT01573624|581163471|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937702|NCT01573624|581163472|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937703|NCT01573624|581163473|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937704|NCT01573624|581163474|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937705|NCT01573624|581163475|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937706|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
160937707|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
160937708|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
160937709|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
160937710|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
160937711|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
160937712|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
160937713|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937714|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
160937715|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937716|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937717|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937718|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
160937719|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
160937720|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
160937721|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937722|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937723|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937724|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937725|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937726|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
160937727|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937728|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160937729|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160937730|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937731|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937732|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
160937733|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
160937734|NCT01573624|581163469|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
160937735|NCT01573624|581163470|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937736|NCT01573624|581163471|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937737|NCT01573624|581163472|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937738|NCT01573624|581163473|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937739|NCT01573624|581163474|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937740|NCT01573624|581163475|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
160937741|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
160937742|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937743|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937744|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937745|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937746|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
160937747|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
160937748|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
160937749|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937750|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937751|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937752|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937753|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
160937754|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
160937755|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937756|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
160937757|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937758|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937759|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937760|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937761|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
160937762|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937763|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
160937764|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937765|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937766|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937767|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937768|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
160937769|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937770|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937771|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937772|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937773|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
160937774|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160937775|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
160937776|NCT01573624|581163469|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937777|NCT01573624|581163470|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937778|NCT01573624|581163471|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937779|NCT01573624|581163472|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937780|NCT01573624|581163473|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937781|NCT01573624|581163474|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
160937782|NCT01573624|581163475|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
160937783|NCT01573624|581163469|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
160937784|NCT01573624|581163470|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160937785|NCT01573624|581163471|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160937786|NCT01573624|581163472|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
160937787|NCT01573624|581163473|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
161143937|NCT02413255|581911801|FG006|Overall Study|Voluntary Withdrawal|0|||
161143938|NCT02413255|581911802|FG007|Overall Study|Voluntary Withdrawal|0|||
161143939|NCT02413255|581911803|FG008|Overall Study|Voluntary Withdrawal|0|||
160937788|NCT01573624|581163474|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
160937789|NCT01573624|581163475|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
160937790|NCT01573624|581163469|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
161143940|NCT02413255|581911804|FG009|Overall Study|Voluntary Withdrawal|0|||
161143941|NCT02413255|581911805|FG010|Overall Study|Voluntary Withdrawal|0|||
161264654|NCT01780987|582350703|FG001|Overall Study|Withdrawal by Subject|0|||
161143942|NCT02413255|581911806|FG011|Overall Study|Voluntary Withdrawal|0|||
161143943|NCT02413255|581911807|FG012|Overall Study|Voluntary Withdrawal|0|||
161143944|NCT02413255|581911808|FG013|Overall Study|Voluntary Withdrawal|0|||
161143945|NCT02413255|581911809|FG014|Overall Study|Voluntary Withdrawal|1|||
161143946|NCT02413255|581911810|FG015|Overall Study|Voluntary Withdrawal|0|||
161143947|NCT02413255|581911811|FG016|Overall Study|Voluntary Withdrawal|0|||
161143948|NCT00077623|581911812|FG000|Overall Study|Adverse Event|1|||
161143949|NCT00077623|581911813|FG001|Overall Study|Adverse Event|0|||
161143950|NCT00077623|581911814|FG002|Overall Study|Adverse Event|1|||
161143951|NCT00077623|581911812|FG000|Overall Study|Withdrawal by Subject|2|||
161143952|NCT00077623|581911813|FG001|Overall Study|Withdrawal by Subject|10|||
161143953|NCT00077623|581911814|FG002|Overall Study|Withdrawal by Subject|1|||
161143954|NCT00077623|581911812|FG000|Overall Study|Other-Non safety reason|18|||
160937791|NCT01573624|581163470|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
160937792|NCT01573624|581163471|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937793|NCT01573624|581163472|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937794|NCT01573624|581163473|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937795|NCT01573624|581163474|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
160937796|NCT01573624|581163475|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
160937797|NCT01573624|581163469|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
160937798|NCT01573624|581163470|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937799|NCT01573624|581163471|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937800|NCT01573624|581163472|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937801|NCT01573624|581163473|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937802|NCT01573624|581163474|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937803|NCT01573624|581163475|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
160937804|NCT01573624|581163469|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937805|NCT01573624|581163470|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937806|NCT01573624|581163471|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937807|NCT01573624|581163472|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
161143955|NCT00077623|581911813|FG001|Overall Study|Other-Non safety reason|15|||
160937808|NCT01573624|581163473|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
160937809|NCT01573624|581163474|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
160937810|NCT01573624|581163475|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
160937811|NCT01573624|581163469|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
160937812|NCT01573624|581163470|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937813|NCT01573624|581163471|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937814|NCT01573624|581163472|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937815|NCT01573624|581163473|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937816|NCT01573624|581163474|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937817|NCT01573624|581163475|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
160937818|NCT03306264|581163478|FG000|Overall Study|Death|33|||
160937819|NCT03306264|581163479|FG001|Overall Study|Death|25|||
160937820|NCT03306264|581163480|FG002|Overall Study|Death|34|||
160937821|NCT03306264|581163481|FG003|Overall Study|Death|34|||
160937822|NCT03306264|581163478|FG000|Overall Study|Complete Consent Withdrawal|4|||
160937823|NCT03306264|581163479|FG001|Overall Study|Complete Consent Withdrawal|4|||
160937824|NCT03306264|581163480|FG002|Overall Study|Complete Consent Withdrawal|1|||
160937825|NCT03306264|581163481|FG003|Overall Study|Complete Consent Withdrawal|8|||
160937826|NCT03306264|581163478|FG000|Overall Study|Lost to Follow-up|1|||
160937827|NCT03306264|581163479|FG001|Overall Study|Lost to Follow-up|0|||
160937828|NCT03306264|581163480|FG002|Overall Study|Lost to Follow-up|1|||
160937829|NCT03306264|581163481|FG003|Overall Study|Lost to Follow-up|0|||
160937830|NCT03306264|581163478|FG000|Overall Study|Rollover to ASTX727-06|10|||
160937831|NCT03306264|581163479|FG001|Overall Study|Rollover to ASTX727-06|18|||
160937832|NCT03306264|581163480|FG002|Overall Study|Rollover to ASTX727-06|4|||
160937833|NCT03306264|581163481|FG003|Overall Study|Rollover to ASTX727-06|2|||
160937834|NCT03306264|581163478|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
160937835|NCT03306264|581163479|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
160937836|NCT03306264|581163480|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
160937837|NCT03306264|581163481|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
160937838|NCT02722928|581163485|FG000|Overall Study|Standard CT was not as required per prot|5|||
160937839|NCT02722928|581163486|FG001|Overall Study|Standard CT was not as required per prot|13|||
160937840|NCT02722928|581163485|FG000|Overall Study|Required Intraoperative MRI|5|||
160937841|NCT02722928|581163486|FG001|Overall Study|Required Intraoperative MRI|7|||
160937842|NCT00094653|581163489|FG000|Overall Study|Death|306|||
161264655|NCT01780987|582350702|FG000|Overall Study|Request of Changing Hospital|0|||
161342519|NCT01093846|582640222|FG002|Overall Study|Adverse Event|1|||
160937843|NCT00094653|581163490|FG001|Overall Study|Death|100|||
160937844|NCT00094653|581163491|FG002|Overall Study|Death|119|||
161143956|NCT00077623|581911814|FG002|Overall Study|Other-Non safety reason|19|||
161143957|NCT00077623|581911812|FG000|Overall Study|Insufficient therapeutic response|2|||
161143958|NCT00077623|581911813|FG001|Overall Study|Insufficient therapeutic response|0|||
161143959|NCT00077623|581911814|FG002|Overall Study|Insufficient therapeutic response|0|||
161143960|NCT00077623|581911812|FG000|Overall Study|Death|12|||
161143961|NCT00077623|581911813|FG001|Overall Study|Death|18|||
161143962|NCT00077623|581911814|FG002|Overall Study|Death|11|||
161143963|NCT00077623|581911812|FG000|Overall Study|Failure to return|1|||
161143964|NCT00077623|581911813|FG001|Overall Study|Failure to return|0|||
161143965|NCT00077623|581911814|FG002|Overall Study|Failure to return|0|||
161143966|NCT01334125|581911815|FG000|Overall Study|Lost to Follow-up|3|||
161143967|NCT01334125|581911816|FG001|Overall Study|Lost to Follow-up|3|||
161143968|NCT00882713|581911819|FG000|Overall Study|Adverse Event|2|||
161143969|NCT00882713|581911819|FG000|Overall Study|Death|3|||
161143970|NCT00882713|581911819|FG000|Overall Study|Administrative reasons|4|||
161143971|NCT00882713|581911819|FG000|Overall Study|refused treatment/withdrew consent|4|||
161143972|NCT00882713|581911819|FG000|Overall Study|Blood transfusion|2|||
161143973|NCT00882713|581911819|FG000|Overall Study|Insufficient therapeutic response|3|||
161143974|NCT00882713|581911819|FG000|Overall Study|Failure to return|2|||
161143975|NCT00882713|581911819|FG000|Overall Study|Other - Reasons|2|||
161143976|NCT00401973|581911822|FG000|Overall Study|Adverse Event|2|||
161143977|NCT00401973|581911823|FG001|Overall Study|Adverse Event|8|||
161143978|NCT00401973|581911824|FG002|Overall Study|Adverse Event|4|||
161143979|NCT00401973|581911822|FG000|Overall Study|Clinical Relapse|0|||
161143980|NCT00401973|581911823|FG001|Overall Study|Clinical Relapse|1|||
161143981|NCT00401973|581911824|FG002|Overall Study|Clinical Relapse|1|||
161143982|NCT00401973|581911822|FG000|Overall Study|Lack of Efficacy|0|||
161143983|NCT00401973|581911823|FG001|Overall Study|Lack of Efficacy|0|||
161143984|NCT00401973|581911824|FG002|Overall Study|Lack of Efficacy|3|||
161143985|NCT00401973|581911822|FG000|Overall Study|Lost to Follow-up|2|||
161143986|NCT00401973|581911823|FG001|Overall Study|Lost to Follow-up|2|||
161143987|NCT00401973|581911824|FG002|Overall Study|Lost to Follow-up|2|||
161143988|NCT00401973|581911822|FG000|Overall Study|Physician Decision|2|||
161143989|NCT00401973|581911823|FG001|Overall Study|Physician Decision|0|||
161143990|NCT00401973|581911824|FG002|Overall Study|Physician Decision|1|||
161143991|NCT00401973|581911822|FG000|Overall Study|Protocol Violation|1|||
161143992|NCT00401973|581911823|FG001|Overall Study|Protocol Violation|2|||
161143993|NCT00401973|581911824|FG002|Overall Study|Protocol Violation|3|||
161143994|NCT00401973|581911822|FG000|Overall Study|Sponsor Decision|0|||
161143995|NCT00401973|581911823|FG001|Overall Study|Sponsor Decision|1|||
161143996|NCT00401973|581911824|FG002|Overall Study|Sponsor Decision|0|||
161143997|NCT00401973|581911822|FG000|Overall Study|Withdrawal by Subject|4|||
161143998|NCT00401973|581911823|FG001|Overall Study|Withdrawal by Subject|12|||
161143999|NCT00401973|581911824|FG002|Overall Study|Withdrawal by Subject|9|||
161144000|NCT02760602|581911825|FG000|Overall Study|Withdrawal by Subject|1|||
161144001|NCT02760602|581911826|FG001|Overall Study|Withdrawal by Subject|0|||
161144002|NCT02760602|581911825|FG000|Overall Study|Terminated by sponsor|12|||
161144003|NCT02760602|581911826|FG001|Overall Study|Terminated by sponsor|13|||
161144004|NCT01335971|581911833|FG000|Overall Study|Withdrawal by Subject|1|||
161144005|NCT01335971|581911834|FG001|Overall Study|Withdrawal by Subject|0|||
161144006|NCT01335971|581911835|FG002|Overall Study|Withdrawal by Subject|0|||
161144007|NCT01335971|581911833|FG000|Overall Study|Did not complete bronchoscopy|1|||
161144008|NCT01335971|581911834|FG001|Overall Study|Did not complete bronchoscopy|1|||
161144009|NCT01335971|581911835|FG002|Overall Study|Did not complete bronchoscopy|1|||
161144010|NCT01260181|581911836|FG000|Overall Study|Decision of Investigator|1|||
161144011|NCT03351244|581911837|FG000|Overall Study|Adverse Event|7|||
161144012|NCT03351244|581911838|FG001|Overall Study|Adverse Event|11|||
161144013|NCT03351244|581911839|FG002|Overall Study|Adverse Event|12|||
161144014|NCT03351244|581911837|FG000|Overall Study|Investigator's decision|0|||
161144015|NCT03351244|581911838|FG001|Overall Study|Investigator's decision|0|||
161144016|NCT03351244|581911839|FG002|Overall Study|Investigator's decision|2|||
161144017|NCT03351244|581911837|FG000|Overall Study|System error|0|||
161264656|NCT01780987|582350703|FG001|Overall Study|Request of Changing Hospital|1|||
161264657|NCT01780987|582350702|FG000|Overall Study|Changing Residence|1|||
161264658|NCT01780987|582350703|FG001|Overall Study|Changing Residence|0|||
161264659|NCT01780987|582350702|FG000|Overall Study|Not Receiving any Study Medication|0|||
161144018|NCT03351244|581911838|FG001|Overall Study|System error|0|||
161144019|NCT03351244|581911839|FG002|Overall Study|System error|2|||
161144020|NCT03351244|581911837|FG000|Overall Study|COVID-19 restrictions|3|||
161144021|NCT03351244|581911838|FG001|Overall Study|COVID-19 restrictions|0|||
161144022|NCT03351244|581911839|FG002|Overall Study|COVID-19 restrictions|1|||
161144023|NCT03351244|581911837|FG000|Overall Study|Non-compliance|2|||
161144024|NCT03351244|581911838|FG001|Overall Study|Non-compliance|5|||
161144025|NCT03351244|581911839|FG002|Overall Study|Non-compliance|0|||
161144026|NCT03351244|581911837|FG000|Overall Study|Withdrawal by Subject|11|||
161144027|NCT03351244|581911838|FG001|Overall Study|Withdrawal by Subject|16|||
161144028|NCT03351244|581911839|FG002|Overall Study|Withdrawal by Subject|13|||
161144029|NCT03351244|581911837|FG000|Overall Study|Lost to Follow-up|2|||
161144030|NCT03351244|581911838|FG001|Overall Study|Lost to Follow-up|6|||
161144031|NCT03351244|581911839|FG002|Overall Study|Lost to Follow-up|4|||
160937845|NCT00094653|581163489|FG000|Overall Study|Subject Withdrew Consent|10|||
160937846|NCT00094653|581163490|FG001|Overall Study|Subject Withdrew Consent|2|||
160937847|NCT00094653|581163491|FG002|Overall Study|Subject Withdrew Consent|3|||
160937848|NCT00094653|581163489|FG000|Overall Study|Other|2|||
160937849|NCT00094653|581163490|FG001|Overall Study|Other|2|||
160937850|NCT00094653|581163491|FG002|Overall Study|Other|2|||
160937851|NCT00094653|581163489|FG000|Overall Study|Lost to Follow-up|3|||
160937852|NCT00094653|581163490|FG001|Overall Study|Lost to Follow-up|2|||
160937853|NCT00094653|581163491|FG002|Overall Study|Lost to Follow-up|1|||
160937854|NCT00094653|581163489|FG000|Overall Study|Protocol Violation|0|||
160937855|NCT00094653|581163490|FG001|Overall Study|Protocol Violation|0|||
160937856|NCT00094653|581163491|FG002|Overall Study|Protocol Violation|1|||
160937857|NCT03921411|581163492|FG000|Overall Study|Withdrawal by Subject|1|||
160937858|NCT03921411|581163492|FG000|Overall Study|Protocol Deviation|2|||
160937859|NCT03921411|581163492|FG000|Overall Study|Enrolled, but never treated|2|||
160937860|NCT02114879|581163493|FG000|Overall Study|Withdrawal by Subject|9|||
160937861|NCT02114879|581163494|FG001|Overall Study|Withdrawal by Subject|5|||
160937862|NCT02114879|581163493|FG000|Overall Study|Death|6|||
160937863|NCT02114879|581163494|FG001|Overall Study|Death|11|||
160937864|NCT02114879|581163493|FG000|Overall Study|Lost to Follow-up|4|||
160937865|NCT02114879|581163494|FG001|Overall Study|Lost to Follow-up|6|||
160937866|NCT02114879|581163493|FG000|Overall Study|Physician Decision|0|||
160937867|NCT02114879|581163494|FG001|Overall Study|Physician Decision|2|||
160937868|NCT03120013|581163497|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
160937869|NCT03120013|581163498|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
160937870|NCT05059600|581163500|FG000|Overall Study|Enrolled but not Treated|10|||
160937871|NCT02152995|581163501|FG000|Overall Study|Withdrawal by Subject|1|||
160937872|NCT02152995|581163502|FG001|Overall Study|Withdrawal by Subject|0|||
160937873|NCT02098109|581163503|FG000|Overall Study|Protocol Violation|3|||
160937874|NCT02098109|581163504|FG001|Overall Study|Protocol Violation|0|||
160937875|NCT01565291|581163506|FG000|Overall Study|Withdrawal by Subject|1|||
160937876|NCT01565291|581163507|FG001|Overall Study|Withdrawal by Subject|0|||
160937877|NCT04552587|581163513|FG000|Overall Study|Lost to Follow-up|4|||
160937878|NCT01822132|581163514|FG000|Overall Study|Lost to Follow-up|4|||
160937879|NCT01822132|581163515|FG001|Overall Study|Lost to Follow-up|2|||
160937880|NCT00313612|581163516|FG000|Overall Study|Patient never received treatment|0|||
160937881|NCT00313612|581163517|FG001|Overall Study|Patient never received treatment|1|||
160937882|NCT04847674|581163518|FG000|Overall Study|Withdrawal by Subject|0|||
160937883|NCT04847674|581163519|FG001|Overall Study|Withdrawal by Subject|1|||
160937884|NCT04847674|581163520|FG002|Overall Study|Withdrawal by Subject|0|||
160937885|NCT04847674|581163518|FG000|Overall Study|Lost to Follow-up|0|||
160937886|NCT04847674|581163519|FG001|Overall Study|Lost to Follow-up|0|||
160937887|NCT04847674|581163520|FG002|Overall Study|Lost to Follow-up|2|||
160937888|NCT04847674|581163518|FG000|Overall Study|Other than specified|21|||
160937889|NCT04847674|581163519|FG001|Overall Study|Other than specified|20|||
160937890|NCT04847674|581163520|FG002|Overall Study|Other than specified|20|||
160937891|NCT00677807|581163523|FG000|Overall Study|Adverse Event|4|||
160937892|NCT00677807|581163524|FG001|Overall Study|Adverse Event|1|||
160937893|NCT00677807|581163525|FG002|Overall Study|Adverse Event|6|||
160937894|NCT00677807|581163523|FG000|Overall Study|Lack of Efficacy|0|||
160937895|NCT00677807|581163524|FG001|Overall Study|Lack of Efficacy|0|||
161144032|NCT03351244|581911837|FG000|Overall Study|Protocol Violation|2|||
161144033|NCT03351244|581911838|FG001|Overall Study|Protocol Violation|2|||
161144034|NCT03351244|581911839|FG002|Overall Study|Protocol Violation|0|||
161144035|NCT00474253|581911842|FG000|Overall Study|Withdrew consent|2|||
161342520|NCT01093846|582640220|FG000|Overall Study|Lack of Efficacy|0|||
161342521|NCT01093846|582640221|FG001|Overall Study|Lack of Efficacy|0|||
161342522|NCT01093846|582640222|FG002|Overall Study|Lack of Efficacy|4|||
160937896|NCT00677807|581163525|FG002|Overall Study|Lack of Efficacy|2|||
160937897|NCT00677807|581163523|FG000|Overall Study|Participant no longer needs study drug|0|||
160937898|NCT00677807|581163524|FG001|Overall Study|Participant no longer needs study drug|0|||
160937899|NCT00677807|581163525|FG002|Overall Study|Participant no longer needs study drug|1|||
160937900|NCT00677807|581163523|FG000|Overall Study|Withdrawal by Subject|10|||
160937901|NCT00677807|581163524|FG001|Overall Study|Withdrawal by Subject|3|||
160937902|NCT00677807|581163525|FG002|Overall Study|Withdrawal by Subject|6|||
160937903|NCT00677807|581163523|FG000|Overall Study|Lost to Follow-up|2|||
160937904|NCT00677807|581163524|FG001|Overall Study|Lost to Follow-up|2|||
160937905|NCT00677807|581163525|FG002|Overall Study|Lost to Follow-up|2|||
160937906|NCT00677807|581163523|FG000|Overall Study|Administrative problems|1|||
160937907|NCT00677807|581163524|FG001|Overall Study|Administrative problems|1|||
160937908|NCT00677807|581163525|FG002|Overall Study|Administrative problems|2|||
160937909|NCT00677807|581163523|FG000|Overall Study|Death|0|||
160937910|NCT00677807|581163524|FG001|Overall Study|Death|1|||
160937911|NCT00677807|581163525|FG002|Overall Study|Death|1|||
160937912|NCT00677807|581163523|FG000|Overall Study|Protocol Deviation|1|||
160937913|NCT00677807|581163524|FG001|Overall Study|Protocol Deviation|3|||
160937914|NCT00677807|581163525|FG002|Overall Study|Protocol Deviation|0|||
160937915|NCT01393743|581163526|FG000|Core Study|Adverse Event|5|||
160998632|NCT02613364|581380597|FG001|Overall Study|Disliked Study Procedure|1|||
160998633|NCT02613364|581380598|FG002|Overall Study|Disliked Study Procedure|4|||
160998634|NCT02613364|581380596|FG000|Overall Study|Disliked Intervention|0|||
160937916|NCT01393743|581163527|FG001|Core Study|Adverse Event|9|||
160937917|NCT01393743|581163528|FG002|Core Study|Adverse Event|0|||
160937918|NCT01393743|581163526|FG000|Core Study|Lost to Follow-up|1|||
160937919|NCT01393743|581163527|FG001|Core Study|Lost to Follow-up|1|||
160937920|NCT01393743|581163528|FG002|Core Study|Lost to Follow-up|0|||
160937921|NCT01393743|581163526|FG000|Core Study|Participant's Choice|2|||
160937922|NCT01393743|581163527|FG001|Core Study|Participant's Choice|3|||
160937923|NCT01393743|581163528|FG002|Core Study|Participant's Choice|0|||
160937924|NCT01393743|581163526|FG000|Core Study|Inadequate therapeutic effect|2|||
160937925|NCT01393743|581163527|FG001|Core Study|Inadequate therapeutic effect|0|||
160937926|NCT01393743|581163528|FG002|Core Study|Inadequate therapeutic effect|0|||
160937927|NCT01393743|581163526|FG000|Extension Phase|Adverse Event|0|||
160937928|NCT01393743|581163527|FG001|Extension Phase|Adverse Event|0|||
160937929|NCT01393743|581163528|FG002|Extension Phase|Adverse Event|12|||
160937930|NCT01393743|581163526|FG000|Extension Phase|Lost to Follow-up|0|||
160937931|NCT01393743|581163527|FG001|Extension Phase|Lost to Follow-up|0|||
160937932|NCT01393743|581163528|FG002|Extension Phase|Lost to Follow-up|2|||
160937933|NCT01393743|581163526|FG000|Extension Phase|Participant choice|0|||
160937934|NCT01393743|581163527|FG001|Extension Phase|Participant choice|0|||
160937935|NCT01393743|581163528|FG002|Extension Phase|Participant choice|16|||
160937936|NCT01393743|581163526|FG000|Extension Phase|Inadequate therapeutic effect|0|||
160937937|NCT01393743|581163527|FG001|Extension Phase|Inadequate therapeutic effect|0|||
160937938|NCT01393743|581163528|FG002|Extension Phase|Inadequate therapeutic effect|7|||
160937939|NCT01393743|581163526|FG000|Extension Phase|Withdrawal by Subject|0|||
160937940|NCT01393743|581163527|FG001|Extension Phase|Withdrawal by Subject|0|||
160937941|NCT01393743|581163528|FG002|Extension Phase|Withdrawal by Subject|8|||
160937942|NCT01393743|581163526|FG000|Extension Phase|Pregnancy|0|||
160937943|NCT01393743|581163527|FG001|Extension Phase|Pregnancy|0|||
160937944|NCT01393743|581163528|FG002|Extension Phase|Pregnancy|1|||
160937945|NCT01393743|581163526|FG000|Extension Phase|Other|0|||
160937946|NCT01393743|581163527|FG001|Extension Phase|Other|0|||
160998635|NCT02613364|581380597|FG001|Overall Study|Disliked Intervention|3|||
160998636|NCT02613364|581380598|FG002|Overall Study|Disliked Intervention|3|||
160998637|NCT01909336|581380599|FG000|Overall Study|Lost to Follow-up|4|||
160998638|NCT01909336|581380600|FG001|Overall Study|Lost to Follow-up|2|||
160998639|NCT01909336|581380601|FG002|Overall Study|Lost to Follow-up|2|||
160998640|NCT01909336|581380599|FG000|Overall Study|Physician Decision|0|||
160998641|NCT01909336|581380600|FG001|Overall Study|Physician Decision|1|||
161342523|NCT01093846|582640220|FG000|Overall Study|Condition no longer required study drug|1|||
161342524|NCT01093846|582640221|FG001|Overall Study|Condition no longer required study drug|1|||
161342525|NCT01093846|582640222|FG002|Overall Study|Condition no longer required study drug|1|||
161342526|NCT01093846|582640220|FG000|Overall Study|Administrative Problems|18|||
161342527|NCT01093846|582640221|FG001|Overall Study|Administrative Problems|17|||
161342528|NCT01093846|582640222|FG002|Overall Study|Administrative Problems|15|||
161342529|NCT02781324|582640223|FG000|Overall Study|Withdrawal by Subject|1|||
161342530|NCT02781324|582640224|FG001|Overall Study|Withdrawal by Subject|0|||
161342531|NCT02781324|582640223|FG000|Overall Study|Physician Decision|1|||
161342532|NCT02781324|582640224|FG001|Overall Study|Physician Decision|2|||
161342533|NCT03074500|582640225|FG000|Overall Study|Lost to Follow-up|1|||
161342534|NCT03074500|582640226|FG001|Overall Study|Lost to Follow-up|0|||
161342535|NCT03074500|582640227|FG002|Overall Study|Lost to Follow-up|0|||
161342536|NCT03074500|582640225|FG000|Overall Study|Lack of Efficacy|0|||
161342537|NCT03074500|582640226|FG001|Overall Study|Lack of Efficacy|1|||
161342538|NCT03074500|582640227|FG002|Overall Study|Lack of Efficacy|0|||
161342539|NCT03074500|582640225|FG000|Overall Study|Adverse Event|0|||
161342540|NCT03074500|582640226|FG001|Overall Study|Adverse Event|0|||
161342541|NCT03074500|582640227|FG002|Overall Study|Adverse Event|1|||
161342542|NCT03321721|582640228|FG000|Overall Study|Lost to Follow-up|4|||
161342543|NCT03321721|582640229|FG001|Overall Study|Lost to Follow-up|8|||
161342544|NCT03321721|582640230|FG002|Overall Study|Lost to Follow-up|11|||
161342545|NCT05020015|582642175|FG000|Overall Study|Ongoing on study|1|||
160937947|NCT01393743|581163528|FG002|Extension Phase|Other|14|||
160937948|NCT01524770|581163534|FG000|First Intervention|Withdrawal by Subject|1|||
160937949|NCT01524770|581163535|FG001|First Intervention|Withdrawal by Subject|0|||
160937950|NCT01524770|581163534|FG000|First Intervention|Adverse Event|1|||
160937951|NCT01524770|581163535|FG001|First Intervention|Adverse Event|1|||
160937952|NCT01524770|581163534|FG000|First Intervention|Protocol Violation|1|||
160937953|NCT01524770|581163535|FG001|First Intervention|Protocol Violation|0|||
160937954|NCT03080961|581163537|FG000|Overall Study|Withdrawal by Subject|3|||
160937955|NCT04602624|581163540|FG000|Overall Study|Protocol Deviation|1|||
160937956|NCT04602624|581163540|FG000|Overall Study|Withdrawal by Participant|1|||
160937957|NCT00316199|581163541|FG000|Overall Study|Adverse Event|2|||
160937958|NCT00316199|581163541|FG000|Overall Study|Death|8|||
160937959|NCT00316199|581163541|FG000|Overall Study|Lost to Follow-up|2|||
160937960|NCT04477304|581163542|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
160937961|NCT04477304|581163543|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
160937962|NCT05645432|581163544|FG000|Overall Study|Withdrawal by Subject|1|||
160937963|NCT02349711|581164879|FG000|Overall Study|Withdrawal by Subject|2|||
160937964|NCT02349711|581164880|FG001|Overall Study|Withdrawal by Subject|1|||
160937965|NCT02349711|581164879|FG000|Overall Study|Lost to Follow-up|1|||
160937966|NCT02349711|581164880|FG001|Overall Study|Lost to Follow-up|1|||
160937967|NCT01610700|581164884|FG000|Overall Study|Adverse Event|3|||
160937968|NCT01610700|581164885|FG001|Overall Study|Adverse Event|1|||
160937969|NCT01610700|581164884|FG000|Overall Study|Withdrawal by Subject|0|||
160937970|NCT01610700|581164885|FG001|Overall Study|Withdrawal by Subject|1|||
160937971|NCT01610700|581164884|FG000|Overall Study|subject took one dose of street cannabis|0|||
160937972|NCT01610700|581164885|FG001|Overall Study|subject took one dose of street cannabis|1|||
160937973|NCT02143414|581164887|FG000|Induction|Adverse Event|1|||
160937974|NCT02143414|581164888|FG001|Induction|Adverse Event|2|||
160937975|NCT02143414|581164887|FG000|Induction|Death|1|||
160937976|NCT02143414|581164888|FG001|Induction|Death|2|||
160937977|NCT02143414|581164887|FG000|Induction|Patient refusal|1|||
160937978|NCT02143414|581164888|FG001|Induction|Patient refusal|1|||
160937979|NCT02143414|581164887|FG000|Induction|Refractory|1|||
160937980|NCT02143414|581164888|FG001|Induction|Refractory|0|||
160937981|NCT02143414|581164887|FG000|Induction|Began alternative treatment|1|||
160937982|NCT02143414|581164888|FG001|Induction|Began alternative treatment|0|||
160937983|NCT02143414|581164887|FG000|Induction|Ineligible for postremission|5|||
160937984|NCT02143414|581164888|FG001|Induction|Ineligible for postremission|1|||
160937985|NCT02143414|581164887|FG000|Post-remission|Adverse Event|0|||
160937986|NCT02143414|581164888|FG001|Post-remission|Adverse Event|2|||
160937987|NCT02143414|581164887|FG000|Post-remission|Disease progression/relapse|5|||
160937988|NCT02143414|581164888|FG001|Post-remission|Disease progression/relapse|0|||
160937989|NCT02143414|581164887|FG000|Maintenance|Adverse Event|4|||
160937990|NCT02143414|581164888|FG001|Maintenance|Adverse Event|6|||
160937991|NCT02143414|581164887|FG000|Maintenance|Disease progression/relapse|3|||
160937992|NCT02143414|581164888|FG001|Maintenance|Disease progression/relapse|2|||
160998642|NCT01909336|581380601|FG002|Overall Study|Physician Decision|1|||
160998643|NCT01235949|581380602|FG000|Primary Phase|Migrated/moved from study area|1|||
160998644|NCT01235949|581380603|FG001|Primary Phase|Migrated/moved from study area|1|||
160998645|NCT01235949|581380604|FG002|Primary Phase|Migrated/moved from study area|0|||
160998646|NCT01235949|581380605|FG003|Primary Phase|Migrated/moved from study area|0|||
160998647|NCT01235949|581380606|FG004|Primary Phase|Migrated/moved from study area|1|||
160998648|NCT01235949|581380607|FG005|Primary Phase|Migrated/moved from study area|2|||
160998649|NCT01235949|581380608|FG006|Primary Phase|Migrated/moved from study area|0|||
160998650|NCT01235949|581380609|FG007|Primary Phase|Migrated/moved from study area|0|||
160998651|NCT01235949|581380610|FG008|Primary Phase|Migrated/moved from study area|0|||
160998652|NCT01235949|581380611|FG009|Primary Phase|Migrated/moved from study area|0|||
160998653|NCT01235949|581380612|FG010|Primary Phase|Migrated/moved from study area|0|||
160998654|NCT01235949|581380613|FG011|Primary Phase|Migrated/moved from study area|0|||
160998655|NCT01235949|581380614|FG012|Primary Phase|Migrated/moved from study area|0|||
160998656|NCT01235949|581380615|FG013|Primary Phase|Migrated/moved from study area|0|||
160998657|NCT01235949|581380616|FG014|Primary Phase|Migrated/moved from study area|0|||
160998658|NCT01235949|581380617|FG015|Primary Phase|Migrated/moved from study area|0|||
160998659|NCT01235949|581380618|FG016|Primary Phase|Migrated/moved from study area|0|||
160998660|NCT01235949|581380619|FG017|Primary Phase|Migrated/moved from study area|0|||
160998661|NCT01235949|581380602|FG000|Primary Phase|Adverse Event|0|||
160998662|NCT01235949|581380603|FG001|Primary Phase|Adverse Event|0|||
160998663|NCT01235949|581380604|FG002|Primary Phase|Adverse Event|0|||
160998664|NCT01235949|581380605|FG003|Primary Phase|Adverse Event|1|||
160998665|NCT01235949|581380606|FG004|Primary Phase|Adverse Event|0|||
160998666|NCT01235949|581380607|FG005|Primary Phase|Adverse Event|0|||
161342546|NCT05020015|582642176|FG001|Overall Study|Ongoing on study|3|||
161342547|NCT05020015|582642177|FG002|Overall Study|Ongoing on study|4|||
161342548|NCT05020015|582642178|FG003|Overall Study|Ongoing on study|7|||
160937993|NCT02143414|581164887|FG000|Maintenance|Patient refusal|2|||
160937994|NCT02143414|581164888|FG001|Maintenance|Patient refusal|1|||
160937995|NCT02143414|581164887|FG000|Maintenance|Physician Decision|1|||
160937996|NCT02143414|581164888|FG001|Maintenance|Physician Decision|0|||
160937997|NCT02143414|581164887|FG000|Maintenance|Death|0|||
160937998|NCT02143414|581164888|FG001|Maintenance|Death|1|||
160937999|NCT02143414|581164887|FG000|Maintenance|On protocol treatment|0|||
160938000|NCT02143414|581164888|FG001|Maintenance|On protocol treatment|6|||
160938001|NCT00978731|581164892|FG000|Overall Study|Death|4|||
160938002|NCT00978731|581164893|FG001|Overall Study|Death|1|||
160938003|NCT00978731|581164894|FG002|Overall Study|Death|1|||
160938004|NCT00978731|581164895|FG003|Overall Study|Death|0|||
160938005|NCT00978731|581164892|FG000|Overall Study|Lost to Follow-up|0|||
160938006|NCT00978731|581164893|FG001|Overall Study|Lost to Follow-up|0|||
160938007|NCT00978731|581164894|FG002|Overall Study|Lost to Follow-up|0|||
160938008|NCT00978731|581164895|FG003|Overall Study|Lost to Follow-up|1|||
160938009|NCT00978731|581164892|FG000|Overall Study|Adverse Event|5|||
160938010|NCT00978731|581164893|FG001|Overall Study|Adverse Event|2|||
160938011|NCT00978731|581164894|FG002|Overall Study|Adverse Event|0|||
160938012|NCT00978731|581164895|FG003|Overall Study|Adverse Event|0|||
160938013|NCT00978731|581164892|FG000|Overall Study|Participant's request|1|||
160938014|NCT00978731|581164893|FG001|Overall Study|Participant's request|0|||
160938015|NCT00978731|581164894|FG002|Overall Study|Participant's request|0|||
160938016|NCT00978731|581164895|FG003|Overall Study|Participant's request|0|||
160938017|NCT00978731|581164892|FG000|Overall Study|Administrative reason|3|||
161264660|NCT01780987|582350703|FG001|Overall Study|Not Receiving any Study Medication|1|||
161264661|NCT03321630|582350704|FG000|Overall Study|Adverse Event|1|||
161264662|NCT03321630|582350704|FG000|Overall Study|Investigator Discretion|2|||
161264663|NCT03321630|582350704|FG000|Overall Study|Withdrawal by Subject|1|||
161264664|NCT04168190|582350705|FG000|Overall Study|Lost to Follow-up|0|||
161264665|NCT04168190|582350706|FG001|Overall Study|Lost to Follow-up|1|||
161264666|NCT04168190|582350707|FG002|Overall Study|Lost to Follow-up|0|||
161264667|NCT04168190|582350708|FG003|Overall Study|Lost to Follow-up|7|||
161264668|NCT04168190|582350709|FG004|Overall Study|Lost to Follow-up|5|||
161264669|NCT04168190|582350705|FG000|Overall Study|Withdrawal by Subject|1|||
161264670|NCT04168190|582350706|FG001|Overall Study|Withdrawal by Subject|0|||
161264671|NCT04168190|582350707|FG002|Overall Study|Withdrawal by Subject|0|||
160938018|NCT00978731|581164893|FG001|Overall Study|Administrative reason|3|||
160938019|NCT00978731|581164894|FG002|Overall Study|Administrative reason|1|||
160938020|NCT00978731|581164895|FG003|Overall Study|Administrative reason|0|||
160938021|NCT00978731|581164892|FG000|Overall Study|Deterioration without progression|0|||
160938022|NCT00978731|581164893|FG001|Overall Study|Deterioration without progression|1|||
160938023|NCT00978731|581164894|FG002|Overall Study|Deterioration without progression|0|||
160938024|NCT00978731|581164895|FG003|Overall Study|Deterioration without progression|0|||
160938025|NCT00978731|581164892|FG000|Overall Study|Disease progression/relapse|5|||
160938026|NCT00978731|581164893|FG001|Overall Study|Disease progression/relapse|4|||
160938027|NCT00978731|581164894|FG002|Overall Study|Disease progression/relapse|2|||
160938028|NCT00978731|581164895|FG003|Overall Study|Disease progression/relapse|2|||
160938029|NCT00978731|581164892|FG000|Overall Study|Study closure|3|||
160938030|NCT00978731|581164893|FG001|Overall Study|Study closure|4|||
160938031|NCT00978731|581164894|FG002|Overall Study|Study closure|1|||
160938032|NCT00978731|581164895|FG003|Overall Study|Study closure|1|||
160938033|NCT00978731|581164892|FG000|Overall Study|No response|1|||
160938034|NCT00978731|581164893|FG001|Overall Study|No response|0|||
160938035|NCT00978731|581164894|FG002|Overall Study|No response|0|||
160938036|NCT00978731|581164895|FG003|Overall Study|No response|0|||
160938037|NCT03107988|581164898|FG000|Overall Study|Adverse Event|0|||
160938038|NCT03107988|581164899|FG001|Overall Study|Adverse Event|0|||
160938039|NCT03107988|581164900|FG002|Overall Study|Adverse Event|0|||
161264672|NCT04168190|582350708|FG003|Overall Study|Withdrawal by Subject|2|||
160938040|NCT03107988|581164901|FG003|Overall Study|Adverse Event|1|||
160938041|NCT03107988|581164902|FG004|Overall Study|Adverse Event|0|||
160938042|NCT03107988|581164903|FG005|Overall Study|Adverse Event|1|||
160938043|NCT03107988|581164904|FG006|Overall Study|Adverse Event|0|||
160998667|NCT01235949|581380608|FG006|Primary Phase|Adverse Event|0|||
160998668|NCT01235949|581380609|FG007|Primary Phase|Adverse Event|0|||
161264673|NCT04168190|582350709|FG004|Overall Study|Withdrawal by Subject|4|||
161264674|NCT04168190|582350705|FG000|Overall Study|Death|0|||
161264675|NCT04168190|582350706|FG001|Overall Study|Death|0|||
160998669|NCT01235949|581380610|FG008|Primary Phase|Adverse Event|0|||
160998670|NCT01235949|581380611|FG009|Primary Phase|Adverse Event|0|||
160998671|NCT01235949|581380612|FG010|Primary Phase|Adverse Event|0|||
160998672|NCT01235949|581380613|FG011|Primary Phase|Adverse Event|0|||
160998673|NCT01235949|581380614|FG012|Primary Phase|Adverse Event|0|||
160998674|NCT01235949|581380615|FG013|Primary Phase|Adverse Event|0|||
160998675|NCT01235949|581380616|FG014|Primary Phase|Adverse Event|0|||
160998676|NCT01235949|581380617|FG015|Primary Phase|Adverse Event|0|||
160998677|NCT01235949|581380618|FG016|Primary Phase|Adverse Event|0|||
160998678|NCT01235949|581380619|FG017|Primary Phase|Adverse Event|0|||
160998679|NCT01235949|581380602|FG000|Primary Phase|Withdrawal by Subject|3|||
160998680|NCT01235949|581380603|FG001|Primary Phase|Withdrawal by Subject|2|||
160998681|NCT01235949|581380604|FG002|Primary Phase|Withdrawal by Subject|2|||
160998682|NCT01235949|581380605|FG003|Primary Phase|Withdrawal by Subject|0|||
161144036|NCT00474253|581911843|FG001|Overall Study|Withdrew consent|0|||
161264676|NCT04168190|582350707|FG002|Overall Study|Death|0|||
160938044|NCT03107988|581164905|FG007|Overall Study|Adverse Event|1|||
160938045|NCT03107988|581164906|FG008|Overall Study|Adverse Event|0|||
160998683|NCT01235949|581380606|FG004|Primary Phase|Withdrawal by Subject|0|||
160998684|NCT01235949|581380607|FG005|Primary Phase|Withdrawal by Subject|3|||
161264677|NCT04168190|582350708|FG003|Overall Study|Death|1|||
161264678|NCT04168190|582350709|FG004|Overall Study|Death|0|||
161264679|NCT02325518|582350710|FG000|Overall Study|Adverse Event|4|||
160938046|NCT03107988|581164907|FG009|Overall Study|Adverse Event|0|||
160938047|NCT03107988|581164908|FG010|Overall Study|Adverse Event|0|||
160938048|NCT03107988|581164909|FG011|Overall Study|Adverse Event|0|||
160938049|NCT03107988|581164910|FG012|Overall Study|Adverse Event|0|||
160938050|NCT03107988|581164898|FG000|Overall Study|Disease Progression or Relapse|1|||
160938051|NCT03107988|581164899|FG001|Overall Study|Disease Progression or Relapse|2|||
160938052|NCT03107988|581164900|FG002|Overall Study|Disease Progression or Relapse|2|||
160938053|NCT03107988|581164901|FG003|Overall Study|Disease Progression or Relapse|5|||
160938054|NCT03107988|581164902|FG004|Overall Study|Disease Progression or Relapse|1|||
160938055|NCT03107988|581164903|FG005|Overall Study|Disease Progression or Relapse|1|||
160938056|NCT03107988|581164904|FG006|Overall Study|Disease Progression or Relapse|0|||
160938057|NCT03107988|581164905|FG007|Overall Study|Disease Progression or Relapse|0|||
160938058|NCT03107988|581164906|FG008|Overall Study|Disease Progression or Relapse|0|||
160938059|NCT03107988|581164907|FG009|Overall Study|Disease Progression or Relapse|1|||
160938060|NCT03107988|581164908|FG010|Overall Study|Disease Progression or Relapse|4|||
160938061|NCT03107988|581164909|FG011|Overall Study|Disease Progression or Relapse|0|||
160938062|NCT03107988|581164910|FG012|Overall Study|Disease Progression or Relapse|0|||
160938063|NCT03107988|581164898|FG000|Overall Study|Ineligible|0|||
160938064|NCT03107988|581164899|FG001|Overall Study|Ineligible|0|||
160938065|NCT03107988|581164900|FG002|Overall Study|Ineligible|0|||
160938066|NCT03107988|581164901|FG003|Overall Study|Ineligible|0|||
160998685|NCT01235949|581380608|FG006|Primary Phase|Withdrawal by Subject|0|||
160998686|NCT01235949|581380609|FG007|Primary Phase|Withdrawal by Subject|0|||
160998687|NCT01235949|581380610|FG008|Primary Phase|Withdrawal by Subject|0|||
160998688|NCT01235949|581380611|FG009|Primary Phase|Withdrawal by Subject|0|||
160998689|NCT01235949|581380612|FG010|Primary Phase|Withdrawal by Subject|0|||
160998690|NCT01235949|581380613|FG011|Primary Phase|Withdrawal by Subject|0|||
160998691|NCT01235949|581380614|FG012|Primary Phase|Withdrawal by Subject|0|||
160998692|NCT01235949|581380615|FG013|Primary Phase|Withdrawal by Subject|0|||
160998693|NCT01235949|581380616|FG014|Primary Phase|Withdrawal by Subject|0|||
160998694|NCT01235949|581380617|FG015|Primary Phase|Withdrawal by Subject|0|||
160998695|NCT01235949|581380618|FG016|Primary Phase|Withdrawal by Subject|0|||
160998696|NCT01235949|581380619|FG017|Primary Phase|Withdrawal by Subject|0|||
160998697|NCT01235949|581380602|FG000|Primary Phase|Lost to Follow-up|0|||
160998698|NCT01235949|581380603|FG001|Primary Phase|Lost to Follow-up|0|||
160998699|NCT01235949|581380604|FG002|Primary Phase|Lost to Follow-up|1|||
160998700|NCT01235949|581380605|FG003|Primary Phase|Lost to Follow-up|1|||
160998701|NCT01235949|581380606|FG004|Primary Phase|Lost to Follow-up|0|||
160998702|NCT01235949|581380607|FG005|Primary Phase|Lost to Follow-up|2|||
160998703|NCT01235949|581380608|FG006|Primary Phase|Lost to Follow-up|0|||
160998704|NCT01235949|581380609|FG007|Primary Phase|Lost to Follow-up|0|||
160998705|NCT01235949|581380610|FG008|Primary Phase|Lost to Follow-up|0|||
160998706|NCT01235949|581380611|FG009|Primary Phase|Lost to Follow-up|0|||
160998707|NCT01235949|581380612|FG010|Primary Phase|Lost to Follow-up|0|||
160998708|NCT01235949|581380613|FG011|Primary Phase|Lost to Follow-up|0|||
160998709|NCT01235949|581380614|FG012|Primary Phase|Lost to Follow-up|0|||
160998710|NCT01235949|581380615|FG013|Primary Phase|Lost to Follow-up|0|||
160998711|NCT01235949|581380616|FG014|Primary Phase|Lost to Follow-up|0|||
160998712|NCT01235949|581380617|FG015|Primary Phase|Lost to Follow-up|0|||
160998713|NCT01235949|581380618|FG016|Primary Phase|Lost to Follow-up|0|||
160998714|NCT01235949|581380619|FG017|Primary Phase|Lost to Follow-up|0|||
160998715|NCT01235949|581380602|FG000|Booster Phase|Migrated/moved from study area|0|||
160998716|NCT01235949|581380603|FG001|Booster Phase|Migrated/moved from study area|0|||
160998717|NCT01235949|581380604|FG002|Booster Phase|Migrated/moved from study area|0|||
160998718|NCT01235949|581380605|FG003|Booster Phase|Migrated/moved from study area|0|||
160998719|NCT01235949|581380606|FG004|Booster Phase|Migrated/moved from study area|0|||
160998720|NCT01235949|581380607|FG005|Booster Phase|Migrated/moved from study area|0|||
160938067|NCT03107988|581164902|FG004|Overall Study|Ineligible|0|||
160938068|NCT03107988|581164903|FG005|Overall Study|Ineligible|0|||
160938069|NCT03107988|581164904|FG006|Overall Study|Ineligible|0|||
160938070|NCT03107988|581164905|FG007|Overall Study|Ineligible|0|||
160938071|NCT03107988|581164906|FG008|Overall Study|Ineligible|1|||
160938072|NCT03107988|581164907|FG009|Overall Study|Ineligible|0|||
160938073|NCT03107988|581164908|FG010|Overall Study|Ineligible|0|||
160938074|NCT03107988|581164909|FG011|Overall Study|Ineligible|0|||
160938075|NCT03107988|581164910|FG012|Overall Study|Ineligible|0|||
160938076|NCT01344057|581164911|FG000|Overall Study|Premature Withdrawal|1|||
160938077|NCT00548808|581164912|FG000|Overall Study|Lost to Follow-up|9|||
160938078|NCT00548808|581164913|FG001|Overall Study|Lost to Follow-up|3|||
160938079|NCT00548808|581164912|FG000|Overall Study|Protocol Violation|8|||
160938080|NCT00548808|581164913|FG001|Overall Study|Protocol Violation|8|||
160998721|NCT01235949|581380608|FG006|Booster Phase|Migrated/moved from study area|0|||
160998722|NCT01235949|581380609|FG007|Booster Phase|Migrated/moved from study area|0|||
160998723|NCT01235949|581380610|FG008|Booster Phase|Migrated/moved from study area|0|||
160938081|NCT00548808|581164912|FG000|Overall Study|Withdrawal by Subject|8|||
160938082|NCT00548808|581164913|FG001|Overall Study|Withdrawal by Subject|4|||
160938083|NCT00548808|581164912|FG000|Overall Study|Physician Decision|6|||
160998724|NCT01235949|581380611|FG009|Booster Phase|Migrated/moved from study area|0|||
160998725|NCT01235949|581380612|FG010|Booster Phase|Migrated/moved from study area|0|||
160998726|NCT01235949|581380613|FG011|Booster Phase|Migrated/moved from study area|1|||
160938084|NCT00548808|581164913|FG001|Overall Study|Physician Decision|3|||
160938085|NCT00548808|581164912|FG000|Overall Study|Adverse Event|4|||
161144037|NCT00474253|581911842|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
161144038|NCT00474253|581911843|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
161144039|NCT00474253|581911842|FG000|Overall Study|Lost to Follow-up|1|||
161144040|NCT00474253|581911843|FG001|Overall Study|Lost to Follow-up|0|||
161144041|NCT00474253|581911842|FG000|Overall Study|Discharged prior to study completion|0|||
161144042|NCT00474253|581911843|FG001|Overall Study|Discharged prior to study completion|1|||
161144043|NCT01165229|581911844|FG000|Overall Study|Serious Adverse Event|456|||
161144044|NCT01165229|581911845|FG001|Overall Study|Serious Adverse Event|487|||
161144045|NCT01165229|581911844|FG000|Overall Study|Non-Serious Adverse Event|47|||
161144046|NCT01165229|581911845|FG001|Overall Study|Non-Serious Adverse Event|15|||
161144047|NCT01165229|581911844|FG000|Overall Study|Protocol Violation|6|||
161144048|NCT01165229|581911845|FG001|Overall Study|Protocol Violation|8|||
161144049|NCT01165229|581911844|FG000|Overall Study|Withdrawal by Subject|387|||
161144050|NCT01165229|581911845|FG001|Overall Study|Withdrawal by Subject|396|||
161144051|NCT01165229|581911844|FG000|Overall Study|Migrated/moved from study area|51|||
161144052|NCT01165229|581911845|FG001|Overall Study|Migrated/moved from study area|46|||
161144053|NCT01165229|581911844|FG000|Overall Study|Lost to Follow-up|123|||
161144054|NCT01165229|581911845|FG001|Overall Study|Lost to Follow-up|133|||
161144055|NCT01165229|581911844|FG000|Overall Study|Suspected HZ Episode|2|||
161144056|NCT01165229|581911845|FG001|Overall Study|Suspected HZ Episode|2|||
161144057|NCT01165229|581911844|FG000|Overall Study|No reason from the subject|108|||
161144058|NCT01165229|581911845|FG001|Overall Study|No reason from the subject|102|||
161144059|NCT01165229|581911844|FG000|Overall Study|Unknown completion status|0|||
161144060|NCT01165229|581911845|FG001|Overall Study|Unknown completion status|1|||
161144061|NCT01357239|581911846|FG000|Stratum: All Patients|Adverse Event|0|||
161144062|NCT01357239|581911847|FG001|Stratum: All Patients|Adverse Event|0|||
161144063|NCT01357239|581911848|FG002|Stratum: All Patients|Adverse Event|1|||
161144064|NCT01357239|581911849|FG003|Stratum: All Patients|Adverse Event|1|||
161144065|NCT01357239|581911846|FG000|Stratum: All Patients|Subject withdrew consent|0|||
161144066|NCT01357239|581911847|FG001|Stratum: All Patients|Subject withdrew consent|0|||
161144067|NCT01357239|581911848|FG002|Stratum: All Patients|Subject withdrew consent|1|||
161144068|NCT01357239|581911849|FG003|Stratum: All Patients|Subject withdrew consent|1|||
161144069|NCT01357239|581911846|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
161144070|NCT01357239|581911847|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
161144071|NCT01357239|581911848|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
161144072|NCT01357239|581911849|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
161144073|NCT01357239|581911846|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
161144074|NCT01357239|581911847|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
161144075|NCT01357239|581911848|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
161144076|NCT01357239|581911849|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
161144077|NCT01357239|581911846|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
161144078|NCT01357239|581911847|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
161144079|NCT01357239|581911848|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
161144080|NCT01357239|581911849|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
161144081|NCT03133481|581911852|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
161144082|NCT03133481|581911853|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
161144083|NCT00637728|581911857|FG000|Double-blind Phase|Adverse Event|1|||
161144084|NCT00637728|581911858|FG001|Double-blind Phase|Adverse Event|0|||
161144085|NCT00637728|581911859|FG002|Double-blind Phase|Adverse Event|0|||
161144086|NCT00637728|581911857|FG000|Double-blind Phase|Non-compliance|2|||
161144087|NCT00637728|581911858|FG001|Double-blind Phase|Non-compliance|0|||
161144088|NCT00637728|581911859|FG002|Double-blind Phase|Non-compliance|0|||
161144089|NCT00637728|581911857|FG000|Double-blind Phase|Study Discontinued|1|||
161144090|NCT00637728|581911858|FG001|Double-blind Phase|Study Discontinued|1|||
161144091|NCT00637728|581911859|FG002|Double-blind Phase|Study Discontinued|0|||
161144092|NCT01873950|581911862|FG000|Period 5|Withdrawal by Subject|0|||
161144093|NCT01873950|581911863|FG001|Period 5|Withdrawal by Subject|0|||
161144094|NCT01873950|581911864|FG002|Period 5|Withdrawal by Subject|0|||
161144095|NCT01873950|581911865|FG003|Period 5|Withdrawal by Subject|1|||
161264680|NCT02325518|582350711|FG001|Overall Study|Adverse Event|1|||
160938086|NCT00548808|581164913|FG001|Overall Study|Adverse Event|5|||
160938087|NCT00548808|581164912|FG000|Overall Study|Death|2|||
161144096|NCT01873950|581911866|FG004|Period 5|Withdrawal by Subject|0|||
161144097|NCT01512368|581911868|FG000|Overall Study|Protocol Violation|3|||
161144098|NCT00328198|581911869|FG000|Treatment|Adverse Event|21|||
161144099|NCT00328198|581911869|FG000|Treatment|Death|1|||
161144100|NCT00328198|581911869|FG000|Treatment|Physician Decision|5|||
161264681|NCT02325518|582350710|FG000|Overall Study|Physician Decision|0|||
161264682|NCT02325518|582350711|FG001|Overall Study|Physician Decision|1|||
160938088|NCT00548808|581164913|FG001|Overall Study|Death|0|||
161144101|NCT00328198|581911869|FG000|Treatment|Withdrawal by Subject|5|||
161144102|NCT00328198|581911869|FG000|Treatment|Evidence of disease progression|2|||
161144103|NCT00328198|581911869|FG000|Treatment|Non-compliance|1|||
161144104|NCT00328198|581911869|FG000|Treatment|Confirmed complete response, MRD -|3|||
161144105|NCT00328198|581911869|FG000|Follow-up|Lost to Follow-up|4|||
161144106|NCT00328198|581911869|FG000|Follow-up|Death|31|||
160938089|NCT00548808|581164912|FG000|Overall Study|Entry Criteria Not Met|2|||
160938090|NCT00548808|581164913|FG001|Overall Study|Entry Criteria Not Met|2|||
160938091|NCT00548808|581164912|FG000|Overall Study|Lack of Efficacy|2|||
160938092|NCT00548808|581164913|FG001|Overall Study|Lack of Efficacy|0|||
160938093|NCT00548808|581164912|FG000|Overall Study|Sponsor Decision|1|||
160938094|NCT00548808|581164913|FG001|Overall Study|Sponsor Decision|1|||
160938095|NCT00529386|581164914|FG000|Overall Study|Lost to Follow-up|1|||
160938096|NCT03592641|581164915|FG000|Overall Study|Withdrawal by Subject|1|||
160938097|NCT04027686|581164916|FG000|Overall Study|Lost to Follow-up|2|||
160938098|NCT04027686|581164917|FG001|Overall Study|Lost to Follow-up|0|||
160938099|NCT04027686|581164916|FG000|Overall Study|Withdrawal by Subject|0|||
160938100|NCT04027686|581164917|FG001|Overall Study|Withdrawal by Subject|1|||
160938101|NCT04456699|581164923|FG000|Overall Study|Death|48|||
160938102|NCT04456699|581164924|FG001|Overall Study|Death|50|||
160938103|NCT04456699|581164925|FG002|Overall Study|Death|52|||
160938104|NCT04456699|581164923|FG000|Overall Study|Physician Decision|0|||
160938105|NCT04456699|581164924|FG001|Overall Study|Physician Decision|0|||
160938106|NCT04456699|581164925|FG002|Overall Study|Physician Decision|2|||
160938107|NCT04456699|581164923|FG000|Overall Study|Sponsor Decision|55|||
160938108|NCT04456699|581164924|FG001|Overall Study|Sponsor Decision|61|||
160938109|NCT04456699|581164925|FG002|Overall Study|Sponsor Decision|50|||
160938110|NCT04456699|581164923|FG000|Overall Study|Withdrawal by Subject|8|||
160938111|NCT04456699|581164924|FG001|Overall Study|Withdrawal by Subject|4|||
160938112|NCT04456699|581164925|FG002|Overall Study|Withdrawal by Subject|5|||
160938113|NCT02075437|581164930|FG000|Overall Study|Withdrawal by Subject|5|||
160938114|NCT02075437|581164930|FG000|Overall Study|Lost to Follow-up|1|||
160938115|NCT01541826|581164933|FG000|Overall Study|Lost to Follow-up|2|||
160938116|NCT01541826|581164934|FG001|Overall Study|Lost to Follow-up|3|||
160938117|NCT01541826|581164935|FG002|Overall Study|Lost to Follow-up|0|||
160938118|NCT01541826|581164933|FG000|Overall Study|Withdrawal by Subject|2|||
160938119|NCT01541826|581164934|FG001|Overall Study|Withdrawal by Subject|0|||
160938120|NCT01541826|581164935|FG002|Overall Study|Withdrawal by Subject|0|||
160938121|NCT01365273|581164938|FG000|Overall Study|Lost to Follow-up|1|||
160938122|NCT01365273|581164939|FG001|Overall Study|Lost to Follow-up|0|||
160938123|NCT01365273|581164938|FG000|Overall Study|Protocol Violation|0|||
160938124|NCT01365273|581164939|FG001|Overall Study|Protocol Violation|1|||
160938125|NCT01365273|581164938|FG000|Overall Study|Physician Decision|1|||
160938126|NCT01365273|581164939|FG001|Overall Study|Physician Decision|0|||
160938127|NCT00854581|581164944|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
160938128|NCT00854581|581164944|FG000|Induction (Up to Day 21)|Death|1|||
160938129|NCT00854581|581164944|FG000|Induction (Up to Day 21)|Physician Decision|1|||
160938130|NCT00854581|581164944|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
160938131|NCT02705820|581164947|FG000|Overall Study|Death|2|||
160938132|NCT02705820|581164947|FG000|Overall Study|Disease Progression|34|||
160938133|NCT02705820|581164947|FG000|Overall Study|Clinical Deterioration|3|||
160938134|NCT02702401|581164948|FG000|Overall Study|Death|242|||
160938135|NCT02702401|581164949|FG001|Overall Study|Death|125|||
160938136|NCT02702401|581164948|FG000|Overall Study|Withdrawal by Subject|15|||
160938137|NCT02702401|581164949|FG001|Overall Study|Withdrawal by Subject|5|||
160938138|NCT02702401|581164948|FG000|Overall Study|Sponsor Decision|19|||
160938139|NCT02702401|581164949|FG001|Overall Study|Sponsor Decision|3|||
160938140|NCT02702401|581164948|FG000|Overall Study|Physician Decision|1|||
160938141|NCT02702401|581164949|FG001|Overall Study|Physician Decision|2|||
160998727|NCT01235949|581380614|FG012|Booster Phase|Migrated/moved from study area|1|||
160998728|NCT01235949|581380615|FG013|Booster Phase|Migrated/moved from study area|0|||
161264683|NCT02325518|582350710|FG000|Overall Study|Withdrawal by Subject|0|||
161264684|NCT02325518|582350711|FG001|Overall Study|Withdrawal by Subject|1|||
160938142|NCT02702401|581164948|FG000|Overall Study|Lost to Follow-up|1|||
160938143|NCT02702401|581164949|FG001|Overall Study|Lost to Follow-up|0|||
160938144|NCT00989833|581164957|FG000|Overall Study|Lost to Follow-up|0|||
160938145|NCT00989833|581164958|FG001|Overall Study|Lost to Follow-up|1|||
160938146|NCT00989833|581164959|FG002|Overall Study|Lost to Follow-up|0|||
160938147|NCT00989833|581164957|FG000|Overall Study|Protocol Violation|1|||
160938148|NCT00989833|581164958|FG001|Overall Study|Protocol Violation|2|||
160938149|NCT00989833|581164959|FG002|Overall Study|Protocol Violation|1|||
160938150|NCT00989833|581164957|FG000|Overall Study|Withdrawal by Subject|0|||
160938151|NCT00989833|581164958|FG001|Overall Study|Withdrawal by Subject|0|||
160938152|NCT00989833|581164959|FG002|Overall Study|Withdrawal by Subject|1|||
160938153|NCT00989833|581164957|FG000|Overall Study|Incorrectly randomized|1|||
160938154|NCT00989833|581164958|FG001|Overall Study|Incorrectly randomized|0|||
160938155|NCT00989833|581164959|FG002|Overall Study|Incorrectly randomized|0|||
160938156|NCT01420081|581164960|FG000|Overall Study|Death|1|||
160938157|NCT01420081|581164961|FG001|Overall Study|Death|0|||
160938158|NCT01420081|581164962|FG002|Overall Study|Death|8|||
160938159|NCT01420081|581164963|FG003|Overall Study|Death|0|||
160938160|NCT01420081|581164964|FG004|Overall Study|Death|7|||
160938161|NCT01420081|581164965|FG005|Overall Study|Death|12|||
160938162|NCT01420081|581164966|FG006|Overall Study|Death|0|||
160938163|NCT01420081|581164967|FG007|Overall Study|Death|1|||
160938164|NCT01420081|581164968|FG008|Overall Study|Death|1|||
160938165|NCT01420081|581164960|FG000|Overall Study|Lost to Follow-up|0|||
160938166|NCT01420081|581164961|FG001|Overall Study|Lost to Follow-up|0|||
160938167|NCT01420081|581164962|FG002|Overall Study|Lost to Follow-up|0|||
160938168|NCT01420081|581164963|FG003|Overall Study|Lost to Follow-up|0|||
160938169|NCT01420081|581164964|FG004|Overall Study|Lost to Follow-up|1|||
160938170|NCT01420081|581164965|FG005|Overall Study|Lost to Follow-up|1|||
160938171|NCT01420081|581164966|FG006|Overall Study|Lost to Follow-up|0|||
160938172|NCT01420081|581164967|FG007|Overall Study|Lost to Follow-up|0|||
160938173|NCT01420081|581164968|FG008|Overall Study|Lost to Follow-up|0|||
160938174|NCT01420081|581164960|FG000|Overall Study|Study Terminated by Sponsor|2|||
160938175|NCT01420081|581164961|FG001|Overall Study|Study Terminated by Sponsor|1|||
160938176|NCT01420081|581164962|FG002|Overall Study|Study Terminated by Sponsor|1|||
160938177|NCT01420081|581164963|FG003|Overall Study|Study Terminated by Sponsor|3|||
160938178|NCT01420081|581164964|FG004|Overall Study|Study Terminated by Sponsor|11|||
160938179|NCT01420081|581164965|FG005|Overall Study|Study Terminated by Sponsor|7|||
160938180|NCT01420081|581164966|FG006|Overall Study|Study Terminated by Sponsor|3|||
160938181|NCT01420081|581164967|FG007|Overall Study|Study Terminated by Sponsor|2|||
160938182|NCT01420081|581164968|FG008|Overall Study|Study Terminated by Sponsor|2|||
160938183|NCT01420081|581164960|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
160938184|NCT01420081|581164961|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
160938185|NCT01420081|581164962|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
160938186|NCT01420081|581164963|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
160938187|NCT01420081|581164964|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
160938188|NCT01420081|581164965|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
160938189|NCT01420081|581164966|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
160938190|NCT01420081|581164967|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
160938191|NCT01420081|581164968|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
160938192|NCT01420081|581164960|FG000|Overall Study|Other Reasons|0|||
160938193|NCT01420081|581164961|FG001|Overall Study|Other Reasons|0|||
160938194|NCT01420081|581164962|FG002|Overall Study|Other Reasons|1|||
160938195|NCT01420081|581164963|FG003|Overall Study|Other Reasons|0|||
160938196|NCT01420081|581164964|FG004|Overall Study|Other Reasons|0|||
160938197|NCT01420081|581164965|FG005|Overall Study|Other Reasons|0|||
160938198|NCT01420081|581164966|FG006|Overall Study|Other Reasons|0|||
160938199|NCT01420081|581164967|FG007|Overall Study|Other Reasons|0|||
160938200|NCT01420081|581164968|FG008|Overall Study|Other Reasons|0|||
160938201|NCT00678561|581164970|FG000|Overall Study|Adverse Event|0|||
160938202|NCT00678561|581164971|FG001|Overall Study|Adverse Event|1|||
160938203|NCT00678561|581164972|FG002|Overall Study|Adverse Event|1|||
160998729|NCT01235949|581380616|FG014|Booster Phase|Migrated/moved from study area|0|||
160998730|NCT01235949|581380617|FG015|Booster Phase|Migrated/moved from study area|0|||
161144107|NCT01570491|581911870|FG000|Overall Study|Lost to Follow-up|3|||
161264685|NCT03246126|582350712|FG000|Overall Study|Withdrawal by Subject|0|||
160938204|NCT00678561|581164973|FG003|Overall Study|Adverse Event|0|||
160938205|NCT00678561|581164974|FG004|Overall Study|Adverse Event|1|||
160938206|NCT00678561|581164975|FG005|Overall Study|Adverse Event|0|||
160938207|NCT00678561|581164976|FG006|Overall Study|Adverse Event|0|||
160938208|NCT00678561|581164977|FG007|Overall Study|Adverse Event|0|||
160938209|NCT00678561|581164970|FG000|Overall Study|Protocol Violation|0|||
160938210|NCT00678561|581164971|FG001|Overall Study|Protocol Violation|0|||
160938211|NCT00678561|581164972|FG002|Overall Study|Protocol Violation|0|||
160938212|NCT00678561|581164973|FG003|Overall Study|Protocol Violation|0|||
160938213|NCT00678561|581164974|FG004|Overall Study|Protocol Violation|1|||
160938214|NCT00678561|581164975|FG005|Overall Study|Protocol Violation|1|||
160938215|NCT00678561|581164976|FG006|Overall Study|Protocol Violation|0|||
160938216|NCT00678561|581164977|FG007|Overall Study|Protocol Violation|0|||
160938217|NCT00678561|581164970|FG000|Overall Study|Withdrawal by Subject|0|||
160938218|NCT00678561|581164971|FG001|Overall Study|Withdrawal by Subject|0|||
160938219|NCT00678561|581164972|FG002|Overall Study|Withdrawal by Subject|0|||
160938220|NCT00678561|581164973|FG003|Overall Study|Withdrawal by Subject|0|||
160938221|NCT00678561|581164974|FG004|Overall Study|Withdrawal by Subject|0|||
160938222|NCT00678561|581164975|FG005|Overall Study|Withdrawal by Subject|0|||
160938223|NCT00678561|581164976|FG006|Overall Study|Withdrawal by Subject|0|||
160938224|NCT00678561|581164977|FG007|Overall Study|Withdrawal by Subject|1|||
160938225|NCT00689481|581164978|FG000|Overall Study|Adverse Event|7|||
160938226|NCT00689481|581164979|FG001|Overall Study|Adverse Event|1|||
160938227|NCT00689481|581164978|FG000|Overall Study|Lost to Follow-up|4|||
160938228|NCT00689481|581164979|FG001|Overall Study|Lost to Follow-up|3|||
160938229|NCT00689481|581164978|FG000|Overall Study|Lack of Efficacy|4|||
160938230|NCT00689481|581164979|FG001|Overall Study|Lack of Efficacy|3|||
160938231|NCT00689481|581164978|FG000|Overall Study|Non-compliance with study treatment|1|||
160938232|NCT00689481|581164979|FG001|Overall Study|Non-compliance with study treatment|1|||
160938233|NCT00689481|581164978|FG000|Overall Study|Withdrawal by Subject|8|||
160938234|NCT00689481|581164979|FG001|Overall Study|Withdrawal by Subject|4|||
160938235|NCT00689481|581164978|FG000|Overall Study|Excluded medication started during study|0|||
160938236|NCT00689481|581164979|FG001|Overall Study|Excluded medication started during study|1|||
160938237|NCT00689481|581164978|FG000|Overall Study|Subject early term, left on vacation|0|||
160938238|NCT00689481|581164979|FG001|Overall Study|Subject early term, left on vacation|1|||
160938239|NCT03337724|581164982|FG000|Overall Study|Reason not Specified|12|||
160938240|NCT03337724|581164983|FG001|Overall Study|Reason not Specified|21|||
160938241|NCT03337724|581164984|FG002|Overall Study|Reason not Specified|9|||
160938242|NCT03337724|581164985|FG003|Overall Study|Reason not Specified|9|||
160938243|NCT03337724|581164986|FG004|Overall Study|Reason not Specified|29|||
160938244|NCT03337724|581164982|FG000|Overall Study|Withdrawal by Subject|13|||
160938245|NCT03337724|581164983|FG001|Overall Study|Withdrawal by Subject|15|||
160938246|NCT03337724|581164984|FG002|Overall Study|Withdrawal by Subject|4|||
160938247|NCT03337724|581164985|FG003|Overall Study|Withdrawal by Subject|15|||
160938248|NCT03337724|581164986|FG004|Overall Study|Withdrawal by Subject|6|||
160938249|NCT03337724|581164982|FG000|Overall Study|Protocol Deviation|0|||
160938250|NCT03337724|581164983|FG001|Overall Study|Protocol Deviation|1|||
160938251|NCT03337724|581164984|FG002|Overall Study|Protocol Deviation|1|||
160938252|NCT03337724|581164985|FG003|Overall Study|Protocol Deviation|1|||
160938253|NCT03337724|581164986|FG004|Overall Study|Protocol Deviation|0|||
160938254|NCT03337724|581164982|FG000|Overall Study|Adverse Event|1|||
160938255|NCT03337724|581164983|FG001|Overall Study|Adverse Event|1|||
160938256|NCT03337724|581164984|FG002|Overall Study|Adverse Event|0|||
160938257|NCT03337724|581164985|FG003|Overall Study|Adverse Event|1|||
160938258|NCT03337724|581164986|FG004|Overall Study|Adverse Event|0|||
160938259|NCT03337724|581164982|FG000|Overall Study|Death|40|||
160938260|NCT03337724|581164983|FG001|Overall Study|Death|89|||
160938261|NCT03337724|581164984|FG002|Overall Study|Death|43|||
160938262|NCT03337724|581164985|FG003|Overall Study|Death|76|||
160938263|NCT03337724|581164986|FG004|Overall Study|Death|50|||
160938264|NCT03337724|581164982|FG000|Overall Study|Lost to Follow-up|5|||
160938265|NCT03337724|581164983|FG001|Overall Study|Lost to Follow-up|5|||
160938266|NCT03337724|581164984|FG002|Overall Study|Lost to Follow-up|4|||
160938267|NCT03337724|581164985|FG003|Overall Study|Lost to Follow-up|7|||
160938268|NCT03337724|581164986|FG004|Overall Study|Lost to Follow-up|4|||
160938269|NCT03337724|581164982|FG000|Overall Study|Physician Decision|16|||
160938270|NCT03337724|581164983|FG001|Overall Study|Physician Decision|34|||
160938271|NCT03337724|581164984|FG002|Overall Study|Physician Decision|14|||
160938272|NCT03337724|581164985|FG003|Overall Study|Physician Decision|34|||
160938273|NCT03337724|581164986|FG004|Overall Study|Physician Decision|13|||
160938274|NCT03337724|581164982|FG000|Overall Study|Progressive Disease|0|||
160938275|NCT03337724|581164983|FG001|Overall Study|Progressive Disease|2|||
160938276|NCT03337724|581164984|FG002|Overall Study|Progressive Disease|1|||
160938277|NCT03337724|581164985|FG003|Overall Study|Progressive Disease|2|||
160938278|NCT03337724|581164986|FG004|Overall Study|Progressive Disease|0|||
160938279|NCT03337724|581164982|FG000|Overall Study|Symptomatic Deterioration|0|||
160938280|NCT03337724|581164983|FG001|Overall Study|Symptomatic Deterioration|0|||
160938281|NCT03337724|581164984|FG002|Overall Study|Symptomatic Deterioration|0|||
160938282|NCT03337724|581164985|FG003|Overall Study|Symptomatic Deterioration|1|||
160938283|NCT03337724|581164986|FG004|Overall Study|Symptomatic Deterioration|0|||
160938284|NCT00528528|581164987|FG000|Overall Study|Lost to Follow-up|0|||
160938285|NCT00528528|581164988|FG001|Overall Study|Lost to Follow-up|0|||
160938286|NCT00528528|581164989|FG002|Overall Study|Lost to Follow-up|1|||
160938287|NCT00528528|581164990|FG003|Overall Study|Lost to Follow-up|1|||
160938288|NCT00528528|581164987|FG000|Overall Study|Ineligible to continue the trial|0|||
160938289|NCT00528528|581164988|FG001|Overall Study|Ineligible to continue the trial|0|||
160938290|NCT00528528|581164989|FG002|Overall Study|Ineligible to continue the trial|0|||
160938291|NCT00528528|581164990|FG003|Overall Study|Ineligible to continue the trial|1|||
160938292|NCT00528528|581164987|FG000|Overall Study|Other|0|||
160938293|NCT00528528|581164988|FG001|Overall Study|Other|1|||
160938294|NCT00528528|581164989|FG002|Overall Study|Other|0|||
160938295|NCT00528528|581164990|FG003|Overall Study|Other|0|||
160938296|NCT00528528|581164987|FG000|Overall Study|Withdrawal by Subject|3|||
160938297|NCT00528528|581164988|FG001|Overall Study|Withdrawal by Subject|2|||
160938298|NCT00528528|581164989|FG002|Overall Study|Withdrawal by Subject|1|||
160938299|NCT00528528|581164990|FG003|Overall Study|Withdrawal by Subject|1|||
160938300|NCT00528528|581164987|FG000|Overall Study|Ongoing participant|0|||
160938301|NCT00528528|581164988|FG001|Overall Study|Ongoing participant|0|||
160938302|NCT00528528|581164989|FG002|Overall Study|Ongoing participant|1|||
160938303|NCT00528528|581164990|FG003|Overall Study|Ongoing participant|0|||
160938304|NCT00773097|581164991|FG000|Overall Study|Withdrawal by Subject|1|||
160938305|NCT00773097|581164991|FG000|Overall Study|Physician Decision|6|||
160938306|NCT04084769|581164996|FG000|Overall Study|Protocol Violation|1|||
160938307|NCT04084769|581164997|FG001|Overall Study|Protocol Violation|3|||
160938308|NCT04084769|581164998|FG002|Overall Study|Protocol Violation|0|||
160938309|NCT04084769|581164999|FG003|Overall Study|Protocol Violation|1|||
160938310|NCT04084769|581164996|FG000|Overall Study|Withdrawal by Subject|0|||
160938311|NCT04084769|581164997|FG001|Overall Study|Withdrawal by Subject|1|||
160938312|NCT04084769|581164998|FG002|Overall Study|Withdrawal by Subject|0|||
160938313|NCT04084769|581164999|FG003|Overall Study|Withdrawal by Subject|0|||
160938314|NCT04084769|581164996|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160938315|NCT04084769|581164997|FG001|Overall Study|Withdrawal by parent/guardian|0|||
160938316|NCT04084769|581164998|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160938317|NCT04084769|581164999|FG003|Overall Study|Withdrawal by parent/guardian|1|||
160938318|NCT04084769|581164996|FG000|Overall Study|Lost to Follow-up|2|||
160938319|NCT04084769|581164997|FG001|Overall Study|Lost to Follow-up|0|||
160938320|NCT04084769|581164998|FG002|Overall Study|Lost to Follow-up|0|||
160938321|NCT04084769|581164999|FG003|Overall Study|Lost to Follow-up|0|||
160938322|NCT03508219|581165000|FG000|Overall Study|Death|2|||
160938323|NCT03508219|581165000|FG000|Overall Study|Withdrawal by Subject|1|||
160938324|NCT03508219|581165000|FG000|Overall Study|Lost to Follow-up|4|||
160938325|NCT03508219|581165000|FG000|Overall Study|Missed visit|2|||
160938326|NCT04466891|581165001|FG000|Overall Study|Death|60|||
160938327|NCT04466891|581165002|FG001|Overall Study|Death|6|||
160938328|NCT04466891|581165001|FG000|Overall Study|Withdrawal by Subject|8|||
160938329|NCT04466891|581165002|FG001|Overall Study|Withdrawal by Subject|1|||
160938330|NCT04466891|581165001|FG000|Overall Study|Study terminated by sponsor|5|||
160938331|NCT04466891|581165002|FG001|Overall Study|Study terminated by sponsor|0|||
160938332|NCT04466891|581165001|FG000|Overall Study|Lost to Follow-up|2|||
160938333|NCT04466891|581165002|FG001|Overall Study|Lost to Follow-up|0|||
160938334|NCT04466891|581165001|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
160938335|NCT04466891|581165002|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
160938336|NCT00445328|581165003|FG000|Overall Study|Death|0|||
160938337|NCT00445328|581165004|FG001|Overall Study|Death|1|||
160938338|NCT00445328|581165003|FG000|Overall Study|Adverse Event|0|||
160938339|NCT00445328|581165004|FG001|Overall Study|Adverse Event|3|||
160938340|NCT00445328|581165003|FG000|Overall Study|Other|0|||
160938341|NCT00445328|581165004|FG001|Overall Study|Other|2|||
160938342|NCT00445328|581165003|FG000|Overall Study|Withdrawal by Subject|2|||
160938343|NCT00445328|581165004|FG001|Overall Study|Withdrawal by Subject|0|||
160938344|NCT00445328|581165003|FG000|Overall Study|Protocol Violation|1|||
160938345|NCT00445328|581165004|FG001|Overall Study|Protocol Violation|0|||
160938346|NCT00590954|581165007|FG000|Overall Study|Inevaluable|2|||
160938347|NCT06023394|581165014|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
160938348|NCT06023394|581165015|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
160938349|NCT06023394|581165014|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
160938350|NCT06023394|581165015|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
160938351|NCT06023394|581165014|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
160938352|NCT06023394|581165015|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
160938353|NCT06023394|581165014|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
160938354|NCT06023394|581165015|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
160938355|NCT00941733|581166301|FG000|Overall Study|Death|24|||
160938356|NCT00941733|581166302|FG001|Overall Study|Death|10|||
160938357|NCT00941733|581166301|FG000|Overall Study|Withdrawal by Subject|14|||
160938358|NCT00941733|581166302|FG001|Overall Study|Withdrawal by Subject|6|||
160938359|NCT00941733|581166301|FG000|Overall Study|Adverse Event|20|||
160938360|NCT00941733|581166302|FG001|Overall Study|Adverse Event|4|||
160938361|NCT00941733|581166301|FG000|Overall Study|Lost to Follow-up|1|||
160938362|NCT00941733|581166302|FG001|Overall Study|Lost to Follow-up|2|||
160938363|NCT00941733|581166301|FG000|Overall Study|Protocol Violation|15|||
160938364|NCT00941733|581166302|FG001|Overall Study|Protocol Violation|6|||
160938365|NCT01105533|581166303|FG000|Overall Study|Death|0|||
160938366|NCT01105533|581166304|FG001|Overall Study|Death|0|||
160938367|NCT01105533|581166305|FG002|Overall Study|Death|0|||
160938368|NCT01105533|581166306|FG003|Overall Study|Death|0|||
160938369|NCT01105533|581166307|FG004|Overall Study|Death|1|||
160938370|NCT01105533|581166308|FG005|Overall Study|Death|0|||
160938371|NCT01105533|581166309|FG006|Overall Study|Death|0|||
160938372|NCT01105533|581166310|FG007|Overall Study|Death|0|||
160938373|NCT01105533|581166311|FG008|Overall Study|Death|0|||
160938374|NCT01105533|581166303|FG000|Overall Study|Lack of Efficacy|1|||
160938375|NCT01105533|581166304|FG001|Overall Study|Lack of Efficacy|1|||
160938376|NCT01105533|581166305|FG002|Overall Study|Lack of Efficacy|3|||
160938377|NCT01105533|581166306|FG003|Overall Study|Lack of Efficacy|3|||
160938378|NCT01105533|581166307|FG004|Overall Study|Lack of Efficacy|4|||
160938379|NCT01105533|581166308|FG005|Overall Study|Lack of Efficacy|5|||
160938380|NCT01105533|581166309|FG006|Overall Study|Lack of Efficacy|3|||
160938381|NCT01105533|581166310|FG007|Overall Study|Lack of Efficacy|2|||
160938382|NCT01105533|581166311|FG008|Overall Study|Lack of Efficacy|9|||
160938383|NCT01105533|581166303|FG000|Overall Study|Adverse Event|0|||
160938384|NCT01105533|581166304|FG001|Overall Study|Adverse Event|0|||
160938385|NCT01105533|581166305|FG002|Overall Study|Adverse Event|0|||
160938386|NCT01105533|581166306|FG003|Overall Study|Adverse Event|0|||
160938387|NCT01105533|581166307|FG004|Overall Study|Adverse Event|1|||
160938388|NCT01105533|581166308|FG005|Overall Study|Adverse Event|2|||
160938389|NCT01105533|581166309|FG006|Overall Study|Adverse Event|2|||
160938390|NCT01105533|581166310|FG007|Overall Study|Adverse Event|0|||
160938391|NCT01105533|581166311|FG008|Overall Study|Adverse Event|1|||
160938392|NCT01105533|581166303|FG000|Overall Study|Other|0|||
160938393|NCT01105533|581166304|FG001|Overall Study|Other|0|||
160938394|NCT01105533|581166305|FG002|Overall Study|Other|0|||
160938395|NCT01105533|581166306|FG003|Overall Study|Other|0|||
160938396|NCT01105533|581166307|FG004|Overall Study|Other|1|||
160938397|NCT01105533|581166308|FG005|Overall Study|Other|0|||
160938398|NCT01105533|581166309|FG006|Overall Study|Other|3|||
160938399|NCT01105533|581166310|FG007|Overall Study|Other|1|||
160938400|NCT01105533|581166311|FG008|Overall Study|Other|2|||
160938401|NCT01105533|581166303|FG000|Overall Study|Physician Decision|0|||
160938402|NCT01105533|581166304|FG001|Overall Study|Physician Decision|0|||
160938403|NCT01105533|581166305|FG002|Overall Study|Physician Decision|0|||
160938404|NCT01105533|581166306|FG003|Overall Study|Physician Decision|0|||
160938405|NCT01105533|581166307|FG004|Overall Study|Physician Decision|0|||
160938406|NCT01105533|581166308|FG005|Overall Study|Physician Decision|0|||
160938407|NCT01105533|581166309|FG006|Overall Study|Physician Decision|0|||
160938408|NCT01105533|581166310|FG007|Overall Study|Physician Decision|1|||
160938409|NCT01105533|581166311|FG008|Overall Study|Physician Decision|0|||
160938410|NCT03892889|581166312|FG000|Overall Study|Adverse Event|17|||
160938411|NCT03892889|581166312|FG000|Overall Study|Lack of Efficacy|1|||
160938412|NCT03892889|581166312|FG000|Overall Study|Lost to Follow-up|46|||
160938413|NCT03892889|581166312|FG000|Overall Study|Non-compliance with study drug|22|||
160938414|NCT03892889|581166312|FG000|Overall Study|Pregnancy|1|||
160938415|NCT03892889|581166312|FG000|Overall Study|Protocol Deviation|3|||
160938416|NCT03892889|581166312|FG000|Overall Study|Withdrawal by Subject|50|||
160938417|NCT03892889|581166312|FG000|Overall Study|Withdrawal by Caregiver|1|||
160938418|NCT03892889|581166312|FG000|Overall Study|Study Terminated by Sponsor|50|||
160938419|NCT03892889|581166312|FG000|Overall Study|Physician Decision|8|||
160938420|NCT03892889|581166312|FG000|Overall Study|Reason not Specified|5|||
160938421|NCT01639001|581166316|FG000|Overall Study|Refused further follow-up|9|||
160938422|NCT01639001|581166317|FG001|Overall Study|Refused further follow-up|12|||
160938423|NCT01639001|581166316|FG000|Overall Study|Lost to Follow-up|3|||
160938424|NCT01639001|581166317|FG001|Overall Study|Lost to Follow-up|0|||
160938425|NCT01639001|581166316|FG000|Overall Study|Death|62|||
160938426|NCT01639001|581166317|FG001|Overall Study|Death|61|||
160938427|NCT01639001|581166316|FG000|Overall Study|Randomized but not treated|0|||
160938428|NCT01639001|581166317|FG001|Overall Study|Randomized but not treated|2|||
160938429|NCT01639001|581166316|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
160938430|NCT01639001|581166317|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
160938431|NCT02453594|581166318|FG000|Overall Study|Protocol Violation|0|||
160938432|NCT02453594|581166319|FG001|Overall Study|Protocol Violation|0|||
160938433|NCT02453594|581166320|FG002|Overall Study|Protocol Violation|1|||
160938434|NCT02453594|581166318|FG000|Overall Study|Cohort Was Closed|17|||
160938435|NCT02453594|581166319|FG001|Overall Study|Cohort Was Closed|21|||
160938436|NCT02453594|581166320|FG002|Overall Study|Cohort Was Closed|14|||
160938437|NCT02453594|581166318|FG000|Overall Study|Death|20|||
160938438|NCT02453594|581166319|FG001|Overall Study|Death|24|||
160938439|NCT02453594|581166320|FG002|Overall Study|Death|16|||
160938440|NCT02453594|581166318|FG000|Overall Study|Lost to Follow-up|6|||
160938441|NCT02453594|581166319|FG001|Overall Study|Lost to Follow-up|14|||
160938442|NCT02453594|581166320|FG002|Overall Study|Lost to Follow-up|2|||
160938443|NCT02453594|581166318|FG000|Overall Study|Physician Decision|2|||
160938444|NCT02453594|581166319|FG001|Overall Study|Physician Decision|4|||
160998731|NCT01235949|581380618|FG016|Booster Phase|Migrated/moved from study area|0|||
160998732|NCT01235949|581380619|FG017|Booster Phase|Migrated/moved from study area|1|||
161144108|NCT01570491|581911871|FG001|Overall Study|Lost to Follow-up|1|||
160938445|NCT02453594|581166320|FG002|Overall Study|Physician Decision|0|||
160938446|NCT02453594|581166318|FG000|Overall Study|Site Terminated by Sponsor|1|||
160938447|NCT02453594|581166319|FG001|Overall Study|Site Terminated by Sponsor|0|||
160938448|NCT02453594|581166320|FG002|Overall Study|Site Terminated by Sponsor|1|||
160938449|NCT02453594|581166318|FG000|Overall Study|Transitioned to Extension Study|16|||
160938450|NCT02453594|581166319|FG001|Overall Study|Transitioned to Extension Study|9|||
160938451|NCT02453594|581166320|FG002|Overall Study|Transitioned to Extension Study|16|||
160938452|NCT02453594|581166318|FG000|Overall Study|Withdrawal by Subject|7|||
160938453|NCT02453594|581166319|FG001|Overall Study|Withdrawal by Subject|9|||
160938454|NCT02453594|581166320|FG002|Overall Study|Withdrawal by Subject|11|||
160938455|NCT02097134|581166321|FG000|Overall Study|Physician Decision|4|||
160938456|NCT02097134|581166321|FG000|Overall Study|Non-Protocol Therapy|1|||
160938457|NCT02097134|581166321|FG000|Overall Study|Progressive Disease|3|||
160938458|NCT02097134|581166321|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
160938459|NCT00679341|581166323|FG000|Overall Study|Disease progression|42|||
160938460|NCT00679341|581166324|FG001|Overall Study|Disease progression|36|||
160938461|NCT00679341|581166323|FG000|Overall Study|Adverse Event|5|||
160938462|NCT00679341|581166324|FG001|Overall Study|Adverse Event|6|||
160938463|NCT00679341|581166323|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
160938464|NCT00679341|581166324|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
160938465|NCT00679341|581166323|FG000|Overall Study|Death|1|||
160938466|NCT00679341|581166324|FG001|Overall Study|Death|1|||
160938467|NCT00679341|581166323|FG000|Overall Study|Other|1|||
160938468|NCT00679341|581166324|FG001|Overall Study|Other|0|||
160938469|NCT00679341|581166323|FG000|Overall Study|Physician Decision|1|||
160938470|NCT00679341|581166324|FG001|Overall Study|Physician Decision|0|||
160938471|NCT00679341|581166323|FG000|Overall Study|Not treated|0|||
160938472|NCT00679341|581166324|FG001|Overall Study|Not treated|2|||
160938473|NCT00679341|581166323|FG000|Overall Study|Physician/patient decision to withdraw|0|||
160938474|NCT00679341|581166324|FG001|Overall Study|Physician/patient decision to withdraw|6|||
160938475|NCT02660359|581166333|FG000|Overall Study|Protocol Deviation|0|||
160938476|NCT02660359|581166334|FG001|Overall Study|Protocol Deviation|0|||
160938477|NCT02660359|581166335|FG002|Overall Study|Protocol Deviation|1|||
160938478|NCT02660359|581166333|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
160938479|NCT02660359|581166334|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
160938480|NCT02660359|581166335|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
160938481|NCT02660359|581166333|FG000|Overall Study|Lack of Efficacy|1|||
160938482|NCT02660359|581166334|FG001|Overall Study|Lack of Efficacy|1|||
160938483|NCT02660359|581166335|FG002|Overall Study|Lack of Efficacy|1|||
160938484|NCT02660359|581166333|FG000|Overall Study|Adverse Event|0|||
160938485|NCT02660359|581166334|FG001|Overall Study|Adverse Event|1|||
160938486|NCT02660359|581166335|FG002|Overall Study|Adverse Event|0|||
160938487|NCT02660359|581166333|FG000|Overall Study|Other|2|||
160938488|NCT02660359|581166334|FG001|Overall Study|Other|1|||
160938489|NCT02660359|581166335|FG002|Overall Study|Other|3|||
160938490|NCT02660359|581166333|FG000|Overall Study|Withdrawal by Subject|7|||
160938491|NCT02660359|581166334|FG001|Overall Study|Withdrawal by Subject|5|||
160938492|NCT02660359|581166335|FG002|Overall Study|Withdrawal by Subject|8|||
160938493|NCT02660359|581166333|FG000|Overall Study|Lost to Follow-up|3|||
160938494|NCT02660359|581166334|FG001|Overall Study|Lost to Follow-up|3|||
160938495|NCT02660359|581166335|FG002|Overall Study|Lost to Follow-up|0|||
160938496|NCT04879745|581166342|FG000|Overall Study|Lost to Follow-up|4|||
160938497|NCT04879745|581166343|FG001|Overall Study|Lost to Follow-up|1|||
160938498|NCT00120042|581166344|FG000|Overall Study|all completed protocl|0|||
160938499|NCT00120042|581166345|FG001|Overall Study|all completed protocl|0|||
160938500|NCT00120042|581166346|FG002|Overall Study|all completed protocl|0|||
160938501|NCT04532112|581166349|FG000|Overall Study|Adverse Event|3|||
160938502|NCT04532112|581166350|FG001|Overall Study|Adverse Event|0|||
160938503|NCT01126541|581166352|FG000|Overall Study|Adverse Event|0|||
160938504|NCT01126541|581166353|FG001|Overall Study|Adverse Event|2|||
160938505|NCT01126541|581166354|FG002|Overall Study|Adverse Event|4|||
160938506|NCT01126541|581166352|FG000|Overall Study|Death|0|||
160938507|NCT01126541|581166353|FG001|Overall Study|Death|1|||
160938508|NCT01126541|581166354|FG002|Overall Study|Death|0|||
160938509|NCT01126541|581166352|FG000|Overall Study|Lack of Efficacy|6|||
160938510|NCT01126541|581166353|FG001|Overall Study|Lack of Efficacy|1|||
160938511|NCT01126541|581166354|FG002|Overall Study|Lack of Efficacy|11|||
160938512|NCT01126541|581166352|FG000|Overall Study|Lost to Follow-up|1|||
160938513|NCT01126541|581166353|FG001|Overall Study|Lost to Follow-up|2|||
160938514|NCT01126541|581166354|FG002|Overall Study|Lost to Follow-up|2|||
160938515|NCT01126541|581166352|FG000|Overall Study|Withdrawal by Subject|2|||
160938516|NCT01126541|581166353|FG001|Overall Study|Withdrawal by Subject|5|||
160938517|NCT01126541|581166354|FG002|Overall Study|Withdrawal by Subject|6|||
160938518|NCT01126541|581166352|FG000|Overall Study|Protocol Violation|0|||
160938519|NCT01126541|581166353|FG001|Overall Study|Protocol Violation|0|||
160938520|NCT01126541|581166354|FG002|Overall Study|Protocol Violation|1|||
160938521|NCT01126541|581166352|FG000|Overall Study|Administrative reason or other|1|||
160938522|NCT01126541|581166353|FG001|Overall Study|Administrative reason or other|1|||
160938523|NCT01126541|581166354|FG002|Overall Study|Administrative reason or other|2|||
160938524|NCT02939404|581166356|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
160938525|NCT02939404|581166357|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
160938526|NCT02939404|581166356|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
160938527|NCT02939404|581166357|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
160938528|NCT02664038|581166358|FG000|13 Week|Lost to Follow-up|7|||
160938529|NCT02664038|581166359|FG001|13 Week|Lost to Follow-up|14|||
160938530|NCT02664038|581166358|FG000|13 Week|Withdrawal by Subject|1|||
160938531|NCT02664038|581166359|FG001|13 Week|Withdrawal by Subject|0|||
160938532|NCT02664038|581166358|FG000|26 Week|Lost to Follow-up|5|||
160938533|NCT02664038|581166359|FG001|26 Week|Lost to Follow-up|4|||
160938534|NCT06640829|581166364|FG000|Overall Study|Withdrawal by Subject|1|||
160938535|NCT06640829|581166364|FG000|Overall Study|Lost to Follow-up|1|||
160938536|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Adverse Event|41|||
160938537|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Adverse Event|24|||
160938538|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
160938539|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
160938540|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
160938541|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
160938542|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Physician Decision|0|||
160938543|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Physician Decision|6|||
160938544|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
160938545|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
160938546|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
160938547|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
160938548|NCT00673452|581166366|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
160938549|NCT00673452|581166367|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
160938550|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
160938551|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
160938552|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
160938553|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
160938554|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
160938555|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
160938556|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
160938557|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
160938558|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
160938559|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
160938560|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
160938561|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
160938562|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
160938563|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
160938564|NCT00673452|581166366|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
160938565|NCT00673452|581166367|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
160938566|NCT03025828|581166368|FG000|Overall Study|Lost to Follow-up|1|||
160938567|NCT00480779|581166369|FG000|Overall Study|Other|2|||
160938568|NCT00480779|581166370|FG001|Overall Study|Other|0|||
160938569|NCT00480779|581166369|FG000|Overall Study|Job and Health-related|0|||
160938570|NCT00480779|581166370|FG001|Overall Study|Job and Health-related|3|||
160938571|NCT02519712|581166373|FG000|Overall Study|Disease Relapse|1|||
160938572|NCT02519712|581166373|FG000|Overall Study|Disease Progression|1|||
160938573|NCT02519712|581166373|FG000|Overall Study|Accruals are donors|2|||
160938574|NCT02908529|581166384|FG000|Overall Study|Lost to Follow-up|0|||
160938575|NCT02908529|581166385|FG001|Overall Study|Lost to Follow-up|2|||
160938576|NCT04497987|581166386|FG000|Overall Study|Adverse Event|1|||
160938577|NCT04497987|581166387|FG001|Overall Study|Adverse Event|0|||
160938578|NCT04497987|581166386|FG000|Overall Study|Death|21|||
160938579|NCT04497987|581166387|FG001|Overall Study|Death|13|||
160938580|NCT04497987|581166386|FG000|Overall Study|Lost to Follow-up|19|||
160938581|NCT04497987|581166387|FG001|Overall Study|Lost to Follow-up|17|||
160938582|NCT04497987|581166386|FG000|Overall Study|Other - as reported by the investigator|22|||
160938583|NCT04497987|581166387|FG001|Overall Study|Other - as reported by the investigator|16|||
160938584|NCT04497987|581166386|FG000|Overall Study|Physician Decision|1|||
160938585|NCT04497987|581166387|FG001|Overall Study|Physician Decision|0|||
160938586|NCT04497987|581166386|FG000|Overall Study|Withdrawal by Subject|35|||
160938587|NCT04497987|581166387|FG001|Overall Study|Withdrawal by Subject|21|||
160938588|NCT02553421|581166392|FG000|Overall Study|Lost to Follow-up|21|||
160938589|NCT02553421|581166393|FG001|Overall Study|Lost to Follow-up|1|||
160938590|NCT02553421|581166392|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
160938591|NCT02553421|581166393|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
160938592|NCT02553421|581166392|FG000|Overall Study|Improper Device Placement|3|||
160938593|NCT02553421|581166393|FG001|Overall Study|Improper Device Placement|0|||
160938594|NCT04579679|581166400|FG000|Overall Study|New Antitumor Therapy|6|||
161144109|NCT01570491|581911870|FG000|Overall Study|treatment: not given or discontinued|2|||
161144110|NCT01570491|581911871|FG001|Overall Study|treatment: not given or discontinued|0|||
160938595|NCT04579679|581166401|FG001|Overall Study|New Antitumor Therapy|4|||
160938596|NCT04579679|581166402|FG002|Overall Study|New Antitumor Therapy|7|||
160938597|NCT04579679|581166403|FG003|Overall Study|New Antitumor Therapy|0|||
160938598|NCT04579679|581166400|FG000|Overall Study|Withdrawal of Consent|1|||
160938599|NCT04579679|581166401|FG001|Overall Study|Withdrawal of Consent|1|||
160938600|NCT04579679|581166402|FG002|Overall Study|Withdrawal of Consent|2|||
161144111|NCT02532543|581911873|FG000|Overall Study|Lost to Follow-up|0|||
160938601|NCT04579679|581166403|FG003|Overall Study|Withdrawal of Consent|4|||
160938602|NCT04579679|581166400|FG000|Overall Study|Death|2|||
160938603|NCT04579679|581166401|FG001|Overall Study|Death|2|||
160938604|NCT04579679|581166402|FG002|Overall Study|Death|2|||
160938605|NCT04579679|581166403|FG003|Overall Study|Death|0|||
160938606|NCT04579679|581166400|FG000|Overall Study|Adverse Event|0|||
160938607|NCT04579679|581166401|FG001|Overall Study|Adverse Event|4|||
160938608|NCT04579679|581166402|FG002|Overall Study|Adverse Event|0|||
160938609|NCT04579679|581166403|FG003|Overall Study|Adverse Event|0|||
160938610|NCT04579679|581166400|FG000|Overall Study|Disease Progression|9|||
160938611|NCT04579679|581166401|FG001|Overall Study|Disease Progression|13|||
160938612|NCT04579679|581166402|FG002|Overall Study|Disease Progression|7|||
160938613|NCT04579679|581166403|FG003|Overall Study|Disease Progression|0|||
160938614|NCT04579679|581166400|FG000|Overall Study|Physician Decision|0|||
160938615|NCT04579679|581166401|FG001|Overall Study|Physician Decision|0|||
160938616|NCT04579679|581166402|FG002|Overall Study|Physician Decision|1|||
160938617|NCT04579679|581166403|FG003|Overall Study|Physician Decision|0|||
160938618|NCT04579679|581166400|FG000|Overall Study|Study Terminated by Sponsor|2|||
160938619|NCT04579679|581166401|FG001|Overall Study|Study Terminated by Sponsor|7|||
160938620|NCT04579679|581166402|FG002|Overall Study|Study Terminated by Sponsor|1|||
160938621|NCT04579679|581166403|FG003|Overall Study|Study Terminated by Sponsor|0|||
160938622|NCT02782949|581166404|FG000|Overall Study|Protocol Violation|1|||
160938623|NCT02782949|581166405|FG001|Overall Study|Protocol Violation|0|||
160938624|NCT02782949|581166404|FG000|Overall Study|Withdrawal by Subject|0|||
160938625|NCT02782949|581166405|FG001|Overall Study|Withdrawal by Subject|1|||
160938626|NCT03238911|581166406|FG000|Overall Study|Withdrawal by Subject|1|||
160938627|NCT03238911|581166407|FG001|Overall Study|Withdrawal by Subject|2|||
160938628|NCT03238911|581166406|FG000|Overall Study|Lost to Follow-up|2|||
160938629|NCT03238911|581166407|FG001|Overall Study|Lost to Follow-up|1|||
160938630|NCT03091192|581166411|FG000|Overall Study|Study terminated by sponsor|21|||
160938631|NCT03091192|581166412|FG001|Overall Study|Study terminated by sponsor|14|||
160938632|NCT03091192|581166411|FG000|Overall Study|Death|9|||
160938633|NCT03091192|581166412|FG001|Overall Study|Death|13|||
160938634|NCT03091192|581166411|FG000|Overall Study|Withdrawal by Subject|2|||
160938635|NCT03091192|581166412|FG001|Overall Study|Withdrawal by Subject|0|||
160938636|NCT03091192|581166411|FG000|Overall Study|Lost to Follow-up|1|||
160938637|NCT03091192|581166412|FG001|Overall Study|Lost to Follow-up|0|||
160938638|NCT03195478|581166413|FG000|Overall Study|Disease Progression|5|||
160938639|NCT03195478|581166414|FG001|Overall Study|Disease Progression|4|||
160938640|NCT03195478|581166415|FG002|Overall Study|Disease Progression|6|||
160938641|NCT03195478|581166416|FG003|Overall Study|Disease Progression|1|||
160938642|NCT03195478|581166413|FG000|Overall Study|Study Drug Toxicity|2|||
160938643|NCT03195478|581166414|FG001|Overall Study|Study Drug Toxicity|0|||
160938644|NCT03195478|581166415|FG002|Overall Study|Study Drug Toxicity|0|||
160938645|NCT03195478|581166416|FG003|Overall Study|Study Drug Toxicity|1|||
160938646|NCT03195478|581166413|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
160938647|NCT03195478|581166414|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
160938648|NCT03195478|581166415|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
160938649|NCT03195478|581166416|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
160938650|NCT03195478|581166413|FG000|Overall Study|Participant Withdrew Consent|1|||
160938651|NCT03195478|581166414|FG001|Overall Study|Participant Withdrew Consent|0|||
160938652|NCT03195478|581166415|FG002|Overall Study|Participant Withdrew Consent|0|||
160938653|NCT03195478|581166416|FG003|Overall Study|Participant Withdrew Consent|0|||
160938654|NCT03195478|581166413|FG000|Overall Study|Maximum Clinical benefit|0|||
160938655|NCT03195478|581166414|FG001|Overall Study|Maximum Clinical benefit|0|||
160938656|NCT03195478|581166415|FG002|Overall Study|Maximum Clinical benefit|1|||
160938657|NCT03195478|581166416|FG003|Overall Study|Maximum Clinical benefit|0|||
160938658|NCT03195478|581166413|FG000|Overall Study|Other Reasons|0|||
160938659|NCT03195478|581166414|FG001|Overall Study|Other Reasons|0|||
160938660|NCT03195478|581166415|FG002|Overall Study|Other Reasons|1|||
160938661|NCT03195478|581166416|FG003|Overall Study|Other Reasons|0|||
160938662|NCT03370341|581168665|FG000|Overall Study|Lost to Follow-up|0|||
160938663|NCT03370341|581168666|FG001|Overall Study|Lost to Follow-up|1|||
160938664|NCT01707004|581168669|FG000|Overall Study|Physician Decision|3|||
160938665|NCT02573324|581168673|FG000|Overall Study|Withdrawal by Subject|26|||
160938666|NCT02573324|581168674|FG001|Overall Study|Withdrawal by Subject|23|||
160938667|NCT02573324|581168675|FG002|Overall Study|Withdrawal by Subject|3|||
160938668|NCT02573324|581168673|FG000|Overall Study|Lost to Follow-up|4|||
160938669|NCT02573324|581168674|FG001|Overall Study|Lost to Follow-up|5|||
160938670|NCT02573324|581168675|FG002|Overall Study|Lost to Follow-up|0|||
160998733|NCT01235949|581380602|FG000|Booster Phase|Adverse Event|0|||
160998734|NCT01235949|581380603|FG001|Booster Phase|Adverse Event|0|||
161264686|NCT03246126|582350713|FG001|Overall Study|Withdrawal by Subject|1|||
160938671|NCT02573324|581168673|FG000|Overall Study|Study Terminated by Sponsor|107|||
160938672|NCT02573324|581168674|FG001|Overall Study|Study Terminated by Sponsor|89|||
160938673|NCT02573324|581168675|FG002|Overall Study|Study Terminated by Sponsor|2|||
160938674|NCT02573324|581168673|FG000|Overall Study|Death|182|||
160938675|NCT02573324|581168674|FG001|Overall Study|Death|200|||
160938676|NCT02573324|581168675|FG002|Overall Study|Death|1|||
160938677|NCT02573324|581168673|FG000|Overall Study|Other, Not Specified|20|||
160938678|NCT02573324|581168674|FG001|Overall Study|Other, Not Specified|27|||
160938679|NCT02573324|581168675|FG002|Overall Study|Other, Not Specified|0|||
160938680|NCT02573324|581168673|FG000|Overall Study|Unknown Reason|2|||
160938681|NCT02573324|581168674|FG001|Overall Study|Unknown Reason|0|||
160938682|NCT02573324|581168675|FG002|Overall Study|Unknown Reason|0|||
160938683|NCT01607905|581168676|FG000|Overall Study|Withdrawal by participant|7|||
160938684|NCT01607905|581168677|FG001|Overall Study|Withdrawal by participant|2|||
160938685|NCT01607905|581168678|FG002|Overall Study|Withdrawal by participant|4|||
160938686|NCT01607905|581168679|FG003|Overall Study|Withdrawal by participant|6|||
160938687|NCT01607905|581168680|FG004|Overall Study|Withdrawal by participant|0|||
160938688|NCT01607905|581168681|FG005|Overall Study|Withdrawal by participant|4|||
160938689|NCT01607905|581168682|FG006|Overall Study|Withdrawal by participant|12|||
160938690|NCT01607905|581168676|FG000|Overall Study|Incidence or severity of AEs|5|||
160998735|NCT01235949|581380604|FG002|Booster Phase|Adverse Event|0|||
161264687|NCT01006135|582350716|FG000|Overall Study|Adverse Event|22|||
160938691|NCT01607905|581168677|FG001|Overall Study|Incidence or severity of AEs|1|||
160938692|NCT01607905|581168678|FG002|Overall Study|Incidence or severity of AEs|1|||
160938693|NCT01607905|581168679|FG003|Overall Study|Incidence or severity of AEs|3|||
160938694|NCT01607905|581168680|FG004|Overall Study|Incidence or severity of AEs|0|||
160938695|NCT01607905|581168681|FG005|Overall Study|Incidence or severity of AEs|2|||
160938696|NCT01607905|581168682|FG006|Overall Study|Incidence or severity of AEs|8|||
160938697|NCT01607905|581168676|FG000|Overall Study|Disease progression|44|||
160938698|NCT01607905|581168677|FG001|Overall Study|Disease progression|16|||
160938699|NCT01607905|581168678|FG002|Overall Study|Disease progression|15|||
160938700|NCT01607905|581168679|FG003|Overall Study|Disease progression|11|||
160938701|NCT01607905|581168680|FG004|Overall Study|Disease progression|6|||
160938702|NCT01607905|581168681|FG005|Overall Study|Disease progression|7|||
160938703|NCT01607905|581168682|FG006|Overall Study|Disease progression|21|||
160938704|NCT01607905|581168676|FG000|Overall Study|Non-compliance with study procedures|0|||
160938705|NCT01607905|581168677|FG001|Overall Study|Non-compliance with study procedures|0|||
160938706|NCT01607905|581168678|FG002|Overall Study|Non-compliance with study procedures|0|||
160938707|NCT01607905|581168679|FG003|Overall Study|Non-compliance with study procedures|0|||
160938708|NCT01607905|581168680|FG004|Overall Study|Non-compliance with study procedures|0|||
160938709|NCT01607905|581168681|FG005|Overall Study|Non-compliance with study procedures|0|||
160938710|NCT01607905|581168682|FG006|Overall Study|Non-compliance with study procedures|1|||
160938711|NCT01607905|581168676|FG000|Overall Study|Death|1|||
160938712|NCT01607905|581168677|FG001|Overall Study|Death|1|||
160938713|NCT01607905|581168678|FG002|Overall Study|Death|1|||
160938714|NCT01607905|581168679|FG003|Overall Study|Death|1|||
160938715|NCT01607905|581168680|FG004|Overall Study|Death|0|||
160938716|NCT01607905|581168681|FG005|Overall Study|Death|0|||
160938717|NCT01607905|581168682|FG006|Overall Study|Death|3|||
160938718|NCT01607905|581168676|FG000|Overall Study|Other treatments become available|1|||
160938719|NCT01607905|581168677|FG001|Overall Study|Other treatments become available|0|||
160938720|NCT01607905|581168678|FG002|Overall Study|Other treatments become available|0|||
160938721|NCT01607905|581168679|FG003|Overall Study|Other treatments become available|0|||
160938722|NCT01607905|581168680|FG004|Overall Study|Other treatments become available|0|||
160938723|NCT01607905|581168681|FG005|Overall Study|Other treatments become available|0|||
160938724|NCT01607905|581168682|FG006|Overall Study|Other treatments become available|1|||
160938725|NCT01607905|581168676|FG000|Overall Study|Investigator discretion|0|||
160938726|NCT01607905|581168677|FG001|Overall Study|Investigator discretion|0|||
160938727|NCT01607905|581168678|FG002|Overall Study|Investigator discretion|0|||
160938728|NCT01607905|581168679|FG003|Overall Study|Investigator discretion|0|||
160938729|NCT01607905|581168680|FG004|Overall Study|Investigator discretion|0|||
160938730|NCT01607905|581168681|FG005|Overall Study|Investigator discretion|1|||
160938731|NCT01607905|581168682|FG006|Overall Study|Investigator discretion|0|||
160938732|NCT01607905|581168676|FG000|Overall Study|Other|1|||
160938733|NCT01607905|581168677|FG001|Overall Study|Other|0|||
160938734|NCT01607905|581168678|FG002|Overall Study|Other|0|||
160938735|NCT01607905|581168679|FG003|Overall Study|Other|0|||
160938736|NCT01607905|581168680|FG004|Overall Study|Other|0|||
160938737|NCT01607905|581168681|FG005|Overall Study|Other|0|||
160938738|NCT01607905|581168682|FG006|Overall Study|Other|1|||
160938739|NCT01607905|581168676|FG000|Overall Study|Randomized but not treated|1|||
160938740|NCT01607905|581168677|FG001|Overall Study|Randomized but not treated|0|||
160938741|NCT01607905|581168678|FG002|Overall Study|Randomized but not treated|0|||
160938742|NCT01607905|581168679|FG003|Overall Study|Randomized but not treated|0|||
160938743|NCT01607905|581168680|FG004|Overall Study|Randomized but not treated|1|||
160938744|NCT01607905|581168681|FG005|Overall Study|Randomized but not treated|1|||
160938745|NCT01607905|581168682|FG006|Overall Study|Randomized but not treated|0|||
160938746|NCT00194012|581168683|FG000|Randomized Phase|Lack of Efficacy|8|||
160938747|NCT00194012|581168684|FG001|Randomized Phase|Lack of Efficacy|18|||
160938748|NCT00194012|581168683|FG000|Randomized Phase|Study nonadherence|2|||
160938749|NCT00194012|581168684|FG001|Randomized Phase|Study nonadherence|1|||
160938750|NCT00194012|581168683|FG000|Randomized Phase|Withdrawal by Subject|3|||
160938751|NCT00194012|581168684|FG001|Randomized Phase|Withdrawal by Subject|3|||
160938752|NCT00194012|581168683|FG000|Randomized Phase|Adverse Event|2|||
161264688|NCT01006135|582350716|FG000|Overall Study|Protocol Violation|14|||
161264689|NCT01006135|582350716|FG000|Overall Study|Lost to Follow-up|32|||
161264690|NCT01006135|582350716|FG000|Overall Study|Other|72|||
161264691|NCT05297578|582350717|FG000|Overall Study|Lost to Follow-up|1|||
161264692|NCT05297578|582350718|FG001|Overall Study|Lost to Follow-up|1|||
161264693|NCT05297578|582350719|FG002|Overall Study|Lost to Follow-up|2|||
160938753|NCT00194012|581168684|FG001|Randomized Phase|Adverse Event|1|||
160938754|NCT00194012|581168683|FG000|Randomized Phase|Participant reported having a rash|1|||
160938755|NCT00194012|581168684|FG001|Randomized Phase|Participant reported having a rash|0|||
160938756|NCT00194012|581168683|FG000|Randomized Phase|Emesis and enuresis|0|||
160938757|NCT00194012|581168684|FG001|Randomized Phase|Emesis and enuresis|1|||
160938758|NCT00194012|581168683|FG000|Randomized Phase|Oral/nasal twitching|0|||
160938759|NCT00194012|581168684|FG001|Randomized Phase|Oral/nasal twitching|1|||
160938760|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Weight Gain|1|||
161144112|NCT02532543|581911874|FG001|Overall Study|Lost to Follow-up|0|||
161144113|NCT02532543|581911875|FG002|Overall Study|Lost to Follow-up|1|||
160938761|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Weight Gain|0|||
160938762|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
160938763|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
160938764|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
160938765|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
160938766|NCT00194012|581168683|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
160938767|NCT00194012|581168684|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
160938768|NCT00298896|581168690|FG000|Overall Study|Death|3|||
160938769|NCT00298896|581168690|FG000|Overall Study|Physician Decision|2|||
160938770|NCT00298896|581168690|FG000|Overall Study|Intercurrent Illness|1|||
160938771|NCT00298896|581168690|FG000|Overall Study|Disease Progression|41|||
160938772|NCT00298896|581168690|FG000|Overall Study|Withdrawal by Subject|2|||
160938773|NCT00298896|581168690|FG000|Overall Study|Assigned to treatment in error|1|||
160938774|NCT02880371|581168691|FG000|Phase 1b|Lost to Follow-up|1|||
160938775|NCT02880371|581168692|FG001|Phase 1b|Lost to Follow-up|0|||
160938776|NCT02880371|581168693|FG002|Phase 1b|Lost to Follow-up|0|||
160938777|NCT02880371|581168694|FG003|Phase 1b|Lost to Follow-up|0|||
160938778|NCT02880371|581168695|FG004|Phase 1b|Lost to Follow-up|0|||
160938779|NCT02880371|581168696|FG005|Phase 1b|Lost to Follow-up|0|||
160938780|NCT02880371|581168697|FG006|Phase 1b|Lost to Follow-up|0|||
160938781|NCT02880371|581168698|FG007|Phase 1b|Lost to Follow-up|0|||
160938782|NCT02880371|581168691|FG000|Phase 1b|Participants terminated by Sponsor|1|||
160938783|NCT02880371|581168692|FG001|Phase 1b|Participants terminated by Sponsor|0|||
160938784|NCT02880371|581168693|FG002|Phase 1b|Participants terminated by Sponsor|0|||
160938785|NCT02880371|581168694|FG003|Phase 1b|Participants terminated by Sponsor|0|||
160938786|NCT02880371|581168695|FG004|Phase 1b|Participants terminated by Sponsor|0|||
160938787|NCT02880371|581168696|FG005|Phase 1b|Participants terminated by Sponsor|0|||
160938788|NCT02880371|581168697|FG006|Phase 1b|Participants terminated by Sponsor|0|||
160938789|NCT02880371|581168698|FG007|Phase 1b|Participants terminated by Sponsor|0|||
160938790|NCT02880371|581168691|FG000|Phase 1b|Withdrawal by Subject|0|||
160938791|NCT02880371|581168692|FG001|Phase 1b|Withdrawal by Subject|0|||
160938792|NCT02880371|581168693|FG002|Phase 1b|Withdrawal by Subject|1|||
160938793|NCT02880371|581168694|FG003|Phase 1b|Withdrawal by Subject|0|||
160938794|NCT02880371|581168695|FG004|Phase 1b|Withdrawal by Subject|0|||
160938795|NCT02880371|581168696|FG005|Phase 1b|Withdrawal by Subject|0|||
160938796|NCT02880371|581168697|FG006|Phase 1b|Withdrawal by Subject|0|||
160938797|NCT02880371|581168698|FG007|Phase 1b|Withdrawal by Subject|0|||
160938798|NCT02880371|581168691|FG000|Phase 1b|Death|4|||
160938799|NCT02880371|581168692|FG001|Phase 1b|Death|6|||
160938800|NCT02880371|581168693|FG002|Phase 1b|Death|5|||
160938801|NCT02880371|581168694|FG003|Phase 1b|Death|1|||
160938802|NCT02880371|581168695|FG004|Phase 1b|Death|0|||
160938803|NCT02880371|581168696|FG005|Phase 1b|Death|0|||
160938804|NCT02880371|581168697|FG006|Phase 1b|Death|0|||
160938805|NCT02880371|581168698|FG007|Phase 1b|Death|0|||
160938806|NCT02880371|581168691|FG000|Phase 1b|Enrolled but not Treated|0|||
160938807|NCT02880371|581168692|FG001|Phase 1b|Enrolled but not Treated|1|||
160938808|NCT02880371|581168693|FG002|Phase 1b|Enrolled but not Treated|0|||
160938809|NCT02880371|581168694|FG003|Phase 1b|Enrolled but not Treated|0|||
160938810|NCT02880371|581168695|FG004|Phase 1b|Enrolled but not Treated|0|||
160998736|NCT01235949|581380605|FG003|Booster Phase|Adverse Event|0|||
161144114|NCT02532543|581911876|FG003|Overall Study|Lost to Follow-up|0|||
161144115|NCT02640612|581911877|FG000|Overall Study|Adverse Event|6|||
161144116|NCT02640612|581911878|FG001|Overall Study|Adverse Event|7|||
161144117|NCT02640612|581911879|FG002|Overall Study|Adverse Event|2|||
161144118|NCT02640612|581911877|FG000|Overall Study|Death|1|||
161144119|NCT02640612|581911878|FG001|Overall Study|Death|0|||
161144120|NCT02640612|581911879|FG002|Overall Study|Death|0|||
161342549|NCT05020015|582642175|FG000|Overall Study|Death|2|||
161342550|NCT05020015|582642176|FG001|Overall Study|Death|3|||
160938811|NCT02880371|581168696|FG005|Phase 1b|Enrolled but not Treated|0|||
160938812|NCT02880371|581168697|FG006|Phase 1b|Enrolled but not Treated|0|||
160998737|NCT01235949|581380606|FG004|Booster Phase|Adverse Event|0|||
161144121|NCT02640612|581911877|FG000|Overall Study|Withdrawal by Subject|10|||
161144122|NCT02640612|581911878|FG001|Overall Study|Withdrawal by Subject|3|||
161144123|NCT02640612|581911879|FG002|Overall Study|Withdrawal by Subject|3|||
161342551|NCT05020015|582642177|FG002|Overall Study|Death|4|||
160938813|NCT02880371|581168698|FG007|Phase 1b|Enrolled but not Treated|0|||
160938814|NCT02880371|581168691|FG000|Phase 2|Enrolled but not Treated|0|||
160938815|NCT02880371|581168692|FG001|Phase 2|Enrolled but not Treated|0|||
160938816|NCT02880371|581168693|FG002|Phase 2|Enrolled but not Treated|0|||
160938817|NCT02880371|581168694|FG003|Phase 2|Enrolled but not Treated|0|||
160938818|NCT02880371|581168695|FG004|Phase 2|Enrolled but not Treated|0|||
160938819|NCT02880371|581168696|FG005|Phase 2|Enrolled but not Treated|1|||
160938820|NCT02880371|581168697|FG006|Phase 2|Enrolled but not Treated|1|||
161144124|NCT02640612|581911877|FG000|Overall Study|Lost to Follow-up|4|||
160938821|NCT02880371|581168698|FG007|Phase 2|Enrolled but not Treated|0|||
160938822|NCT02880371|581168691|FG000|Phase 2|Other|0|||
160938823|NCT02880371|581168692|FG001|Phase 2|Other|0|||
160938824|NCT02880371|581168693|FG002|Phase 2|Other|0|||
160938825|NCT02880371|581168694|FG003|Phase 2|Other|0|||
160938826|NCT02880371|581168695|FG004|Phase 2|Other|0|||
160938827|NCT02880371|581168696|FG005|Phase 2|Other|1|||
160938828|NCT02880371|581168697|FG006|Phase 2|Other|2|||
160938829|NCT02880371|581168698|FG007|Phase 2|Other|1|||
160938830|NCT02880371|581168691|FG000|Phase 2|Participants terminated by Sponsor|0|||
160938831|NCT02880371|581168692|FG001|Phase 2|Participants terminated by Sponsor|0|||
160938832|NCT02880371|581168693|FG002|Phase 2|Participants terminated by Sponsor|0|||
160938833|NCT02880371|581168694|FG003|Phase 2|Participants terminated by Sponsor|0|||
160938834|NCT02880371|581168695|FG004|Phase 2|Participants terminated by Sponsor|1|||
160938835|NCT02880371|581168696|FG005|Phase 2|Participants terminated by Sponsor|6|||
160938836|NCT02880371|581168697|FG006|Phase 2|Participants terminated by Sponsor|1|||
160938837|NCT02880371|581168698|FG007|Phase 2|Participants terminated by Sponsor|5|||
160938838|NCT02880371|581168691|FG000|Phase 2|Death|0|||
160938839|NCT02880371|581168692|FG001|Phase 2|Death|0|||
160938840|NCT02880371|581168693|FG002|Phase 2|Death|0|||
160938841|NCT02880371|581168694|FG003|Phase 2|Death|0|||
160938842|NCT02880371|581168695|FG004|Phase 2|Death|1|||
160938843|NCT02880371|581168696|FG005|Phase 2|Death|10|||
160938844|NCT02880371|581168697|FG006|Phase 2|Death|20|||
160938845|NCT02880371|581168698|FG007|Phase 2|Death|5|||
160938846|NCT02880371|581168691|FG000|Phase 2|Lost to Follow-up|0|||
160938847|NCT02880371|581168692|FG001|Phase 2|Lost to Follow-up|0|||
160938848|NCT02880371|581168693|FG002|Phase 2|Lost to Follow-up|0|||
160938849|NCT02880371|581168694|FG003|Phase 2|Lost to Follow-up|0|||
160938850|NCT02880371|581168695|FG004|Phase 2|Lost to Follow-up|0|||
160938851|NCT02880371|581168696|FG005|Phase 2|Lost to Follow-up|0|||
160938852|NCT02880371|581168697|FG006|Phase 2|Lost to Follow-up|3|||
160938853|NCT02880371|581168698|FG007|Phase 2|Lost to Follow-up|0|||
160938854|NCT02880371|581168691|FG000|Phase 2|Withdrawal by Subject|0|||
160938855|NCT02880371|581168692|FG001|Phase 2|Withdrawal by Subject|0|||
160938856|NCT02880371|581168693|FG002|Phase 2|Withdrawal by Subject|0|||
160938857|NCT02880371|581168694|FG003|Phase 2|Withdrawal by Subject|0|||
160938858|NCT02880371|581168695|FG004|Phase 2|Withdrawal by Subject|0|||
160938859|NCT02880371|581168696|FG005|Phase 2|Withdrawal by Subject|1|||
160938860|NCT02880371|581168697|FG006|Phase 2|Withdrawal by Subject|1|||
160938861|NCT02880371|581168698|FG007|Phase 2|Withdrawal by Subject|0|||
160938862|NCT02880371|581168691|FG000|Phase 2|End of Study page not completed by error|0|||
160938863|NCT02880371|581168692|FG001|Phase 2|End of Study page not completed by error|0|||
160938864|NCT02880371|581168693|FG002|Phase 2|End of Study page not completed by error|0|||
160938865|NCT02880371|581168694|FG003|Phase 2|End of Study page not completed by error|0|||
160938866|NCT02880371|581168695|FG004|Phase 2|End of Study page not completed by error|0|||
160938867|NCT02880371|581168696|FG005|Phase 2|End of Study page not completed by error|1|||
160938868|NCT02880371|581168697|FG006|Phase 2|End of Study page not completed by error|0|||
160938869|NCT02880371|581168698|FG007|Phase 2|End of Study page not completed by error|0|||
160938870|NCT03285646|581168703|FG000|Overall Study|Adverse Event|1|||
160938871|NCT03285646|581168704|FG001|Overall Study|Adverse Event|0|||
160938872|NCT03285646|581168703|FG000|Overall Study|Withdrawal by Subject|10|||
160938873|NCT03285646|581168704|FG001|Overall Study|Withdrawal by Subject|2|||
160938874|NCT03285646|581168703|FG000|Overall Study|Lost to Follow-up|2|||
160938875|NCT03285646|581168704|FG001|Overall Study|Lost to Follow-up|1|||
160938876|NCT03285646|581168703|FG000|Overall Study|Investigator/Sponsor Decision|0|||
160938877|NCT03285646|581168704|FG001|Overall Study|Investigator/Sponsor Decision|1|||
160938878|NCT01694706|581168708|FG000|Overall Study|Adverse Event|0|||
160938879|NCT01694706|581168709|FG001|Overall Study|Adverse Event|1|||
160938880|NCT01694706|581168710|FG002|Overall Study|Adverse Event|0|||
160938881|NCT01694706|581168708|FG000|Overall Study|other reason not defined above|1|||
160938882|NCT01694706|581168709|FG001|Overall Study|other reason not defined above|0|||
160938883|NCT01694706|581168710|FG002|Overall Study|other reason not defined above|0|||
160938884|NCT01923181|581168711|FG000|Overall Study|Protocol Violation|2|||
160938885|NCT01923181|581168712|FG001|Overall Study|Protocol Violation|2|||
160938886|NCT01923181|581168713|FG002|Overall Study|Protocol Violation|0|||
160938887|NCT01923181|581168714|FG003|Overall Study|Protocol Violation|2|||
160938888|NCT01923181|581168715|FG004|Overall Study|Protocol Violation|2|||
160938889|NCT01923181|581168716|FG005|Overall Study|Protocol Violation|1|||
160998738|NCT01235949|581380607|FG005|Booster Phase|Adverse Event|0|||
160938890|NCT01923181|581168717|FG006|Overall Study|Protocol Violation|1|||
160938891|NCT01923181|581168718|FG007|Overall Study|Protocol Violation|2|||
160938892|NCT01923181|581168719|FG008|Overall Study|Protocol Violation|1|||
160938893|NCT01923181|581168711|FG000|Overall Study|Withdrawal by Subject|0|||
160938894|NCT01923181|581168712|FG001|Overall Study|Withdrawal by Subject|1|||
160938895|NCT01923181|581168713|FG002|Overall Study|Withdrawal by Subject|0|||
160938896|NCT01923181|581168714|FG003|Overall Study|Withdrawal by Subject|1|||
160938897|NCT01923181|581168715|FG004|Overall Study|Withdrawal by Subject|4|||
160938898|NCT01923181|581168716|FG005|Overall Study|Withdrawal by Subject|2|||
160938899|NCT01923181|581168717|FG006|Overall Study|Withdrawal by Subject|4|||
160938900|NCT01923181|581168718|FG007|Overall Study|Withdrawal by Subject|3|||
160938901|NCT01923181|581168719|FG008|Overall Study|Withdrawal by Subject|1|||
160938902|NCT01923181|581168711|FG000|Overall Study|Other|1|||
160938903|NCT01923181|581168712|FG001|Overall Study|Other|0|||
160938904|NCT01923181|581168713|FG002|Overall Study|Other|0|||
160938905|NCT01923181|581168714|FG003|Overall Study|Other|1|||
160938906|NCT01923181|581168715|FG004|Overall Study|Other|0|||
160938907|NCT01923181|581168716|FG005|Overall Study|Other|0|||
160938908|NCT01923181|581168717|FG006|Overall Study|Other|0|||
160938909|NCT01923181|581168718|FG007|Overall Study|Other|0|||
160938910|NCT01923181|581168719|FG008|Overall Study|Other|0|||
160938911|NCT01923181|581168711|FG000|Overall Study|Lost to Follow-up|0|||
160938912|NCT01923181|581168712|FG001|Overall Study|Lost to Follow-up|3|||
160938913|NCT01923181|581168713|FG002|Overall Study|Lost to Follow-up|2|||
160938914|NCT01923181|581168714|FG003|Overall Study|Lost to Follow-up|1|||
160938915|NCT01923181|581168715|FG004|Overall Study|Lost to Follow-up|2|||
160938916|NCT01923181|581168716|FG005|Overall Study|Lost to Follow-up|1|||
160938917|NCT01923181|581168717|FG006|Overall Study|Lost to Follow-up|3|||
160938918|NCT01923181|581168718|FG007|Overall Study|Lost to Follow-up|3|||
160938919|NCT01923181|581168719|FG008|Overall Study|Lost to Follow-up|1|||
160938920|NCT04101526|581168720|FG000|Overall Study|Did not complete all sleep diary entries|0|||
160938921|NCT04101526|581168721|FG001|Overall Study|Did not complete all sleep diary entries|1|||
160938922|NCT02944578|581168722|FG000|Overall Study|Physician Decision|1|||
160938923|NCT02944578|581168723|FG001|Overall Study|Physician Decision|0|||
160938924|NCT00424372|581168725|FG000|Overall Study|Death|1|||
160938925|NCT00424372|581168725|FG000|Overall Study|Adverse Event|18|||
160938926|NCT00424372|581168725|FG000|Overall Study|Lack of Efficacy|6|||
160938927|NCT00424372|581168725|FG000|Overall Study|Withdrawal by Subject|4|||
160938928|NCT00424372|581168725|FG000|Overall Study|Protocol Violation|1|||
160938929|NCT00424372|581168725|FG000|Overall Study|Health deterioration|1|||
160938930|NCT00654628|581168726|FG000|6-week Active Treatment Period|Adverse Event|9|||
160938931|NCT00654628|581168726|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
160938932|NCT00654628|581168726|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
160938933|NCT00654628|581168726|FG000|6-week Active Treatment Period|Out of window period|1|||
160938934|NCT00654628|581168726|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
160938935|NCT00654628|581168726|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
160938936|NCT00912405|581168729|FG000|Overall Study|Lost to Follow-up|5|||
160938937|NCT00953329|581168730|FG000|Overall Study|Lack of Efficacy|1|||
160938938|NCT01434823|581168733|FG000|Overall Study|Incomplete data in medical record|4|||
160938939|NCT01434823|581168734|FG001|Overall Study|Incomplete data in medical record|7|||
160938940|NCT00451282|581168739|FG000|Overall Study|Lost to Follow-up|6|||
160938941|NCT00451282|581168740|FG001|Overall Study|Lost to Follow-up|5|||
160938942|NCT01797536|581168741|FG000|Overall Study|Adverse Event|0|||
160938943|NCT01797536|581168742|FG001|Overall Study|Adverse Event|1|||
160938944|NCT01797536|581168743|FG002|Overall Study|Adverse Event|0|||
160938945|NCT01797536|581168744|FG003|Overall Study|Adverse Event|0|||
160938946|NCT00098839|581168745|FG000|Overall Study|Adverse Event|5|||
160938947|NCT00098839|581168746|FG001|Overall Study|Adverse Event|2|||
160938948|NCT00098839|581168745|FG000|Overall Study|Death|1|||
160938949|NCT00098839|581168746|FG001|Overall Study|Death|2|||
160938950|NCT00098839|581168745|FG000|Overall Study|Physician Decision|4|||
160938951|NCT00098839|581168746|FG001|Overall Study|Physician Decision|14|||
160938952|NCT00098839|581168745|FG000|Overall Study|Withdrawal by Subject|1|||
160938953|NCT00098839|581168746|FG001|Overall Study|Withdrawal by Subject|0|||
160938954|NCT00098839|581168745|FG000|Overall Study|Refusal of further protocol therapy|3|||
160938955|NCT00098839|581168746|FG001|Overall Study|Refusal of further protocol therapy|1|||
160938956|NCT00098839|581168745|FG000|Overall Study|Relapse|6|||
160938957|NCT00098839|581168746|FG001|Overall Study|Relapse|3|||
160938958|NCT00098839|581168745|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
160938959|NCT00098839|581168746|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
160938960|NCT00098839|581168745|FG000|Overall Study|Ineligible|2|||
160938961|NCT00098839|581168746|FG001|Overall Study|Ineligible|0|||
160938962|NCT00617240|581168747|FG000|Overall Study|Lack of Efficacy|1|||
160938963|NCT00617240|581168748|FG001|Overall Study|Lack of Efficacy|0|||
160938964|NCT01611259|581168749|FG000|Overall Study|Physician Decision|1|||
160938965|NCT01611259|581168749|FG000|Overall Study|Lack of Efficacy|2|||
160938966|NCT01611259|581168749|FG000|Overall Study|Adverse Event|4|||
160998739|NCT01235949|581380608|FG006|Booster Phase|Adverse Event|0|||
160938967|NCT01611259|581168749|FG000|Overall Study|Withdrawal by Subject|7|||
160998740|NCT01235949|581380609|FG007|Booster Phase|Adverse Event|0|||
160938968|NCT04936685|581168750|FG000|Overall Study|Protocol Violation|1|||
160938969|NCT04936685|581168751|FG001|Overall Study|Protocol Violation|0|||
160938970|NCT02410811|581168755|FG000|Overall Study|Withdrawal by Subject|0|||
160938971|NCT02410811|581168756|FG001|Overall Study|Withdrawal by Subject|0|||
160998741|NCT01235949|581380610|FG008|Booster Phase|Adverse Event|0|||
160938972|NCT02410811|581168757|FG002|Overall Study|Withdrawal by Subject|1|||
160938973|NCT02410811|581168758|FG003|Overall Study|Withdrawal by Subject|0|||
160938974|NCT00353366|581168759|FG000|Overall Study|Adverse Event|8|||
160938975|NCT00353366|581168759|FG000|Overall Study|Protocol Violation|12|||
160938976|NCT00353366|581168759|FG000|Overall Study|Withdrawal by Subject|12|||
160938977|NCT00353366|581168759|FG000|Overall Study|Lost to Follow-up|92|||
161342552|NCT05020015|582642178|FG003|Overall Study|Death|0|||
160938978|NCT00353366|581168759|FG000|Overall Study|Other|19|||
160938979|NCT00259857|581168760|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
160938980|NCT00259857|581168761|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
160938981|NCT00259857|581168760|FG000|24 Months Treatment|Lost to Follow-up|0|||
160938982|NCT00259857|581168761|FG001|24 Months Treatment|Lost to Follow-up|3|||
160938983|NCT05267054|581168762|FG000|Overall Study|Death|13|||
160938984|NCT05267054|581168763|FG001|Overall Study|Death|14|||
160938985|NCT05267054|581168762|FG000|Overall Study|Study Ended by Sponsor|9|||
160938986|NCT05267054|581168763|FG001|Overall Study|Study Ended by Sponsor|13|||
160938987|NCT05267054|581168762|FG000|Overall Study|Lost to Follow-up|1|||
160938988|NCT05267054|581168763|FG001|Overall Study|Lost to Follow-up|1|||
160938989|NCT05267054|581168762|FG000|Overall Study|Withdrawal by Subject|1|||
160938990|NCT05267054|581168763|FG001|Overall Study|Withdrawal by Subject|1|||
160938991|NCT01552226|581168766|FG000|Overall Study|Withdrawal by Subject|4|||
160938992|NCT01552226|581168767|FG001|Overall Study|Withdrawal by Subject|4|||
160938993|NCT01469065|581168771|FG000|Overall Study|Lack of Efficacy|0|||
160938994|NCT01469065|581168772|FG001|Overall Study|Lack of Efficacy|0|||
160938995|NCT01469065|581168773|FG002|Overall Study|Lack of Efficacy|0|||
160938996|NCT01469065|581168774|FG003|Overall Study|Lack of Efficacy|0|||
160938997|NCT01469065|581168775|FG004|Overall Study|Lack of Efficacy|1|||
160938998|NCT01469065|581168771|FG000|Overall Study|Other|0|||
160938999|NCT01469065|581168772|FG001|Overall Study|Other|1|||
160939000|NCT01469065|581168773|FG002|Overall Study|Other|0|||
160939001|NCT01469065|581168774|FG003|Overall Study|Other|0|||
160939002|NCT01469065|581168775|FG004|Overall Study|Other|0|||
160939003|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
160939004|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
160939005|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
160939006|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
160939007|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
160939008|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
160939009|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
160939010|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
160939011|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
160939012|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
160939013|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
160939014|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
160939015|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
160939016|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
160939017|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
160939018|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
160939019|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
160939020|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
160939021|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
160939022|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
160939023|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
160939024|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
160939025|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
160939026|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
160939027|NCT04542070|581168776|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
160939028|NCT04542070|581168777|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
160939029|NCT04542070|581168778|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
160939030|NCT04542070|581168779|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
160939031|NCT04542070|581168776|FG000|Maintenance + Extension Period|Adverse Event|10|||
160998742|NCT01235949|581380611|FG009|Booster Phase|Adverse Event|0|||
160998743|NCT01235949|581380612|FG010|Booster Phase|Adverse Event|0|||
160998744|NCT01235949|581380613|FG011|Booster Phase|Adverse Event|0|||
161342553|NCT05020015|582642175|FG000|Overall Study|Withdrawal by Subject|0|||
161342554|NCT05020015|582642176|FG001|Overall Study|Withdrawal by Subject|0|||
161342555|NCT05020015|582642177|FG002|Overall Study|Withdrawal by Subject|1|||
160939032|NCT04542070|581168777|FG001|Maintenance + Extension Period|Adverse Event|2|||
160939033|NCT04542070|581168778|FG002|Maintenance + Extension Period|Adverse Event|0|||
160939034|NCT04542070|581168779|FG003|Maintenance + Extension Period|Adverse Event|0|||
160939035|NCT04542070|581168776|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
160939036|NCT04542070|581168777|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
160939037|NCT04542070|581168778|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
160939038|NCT04542070|581168779|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
160939039|NCT04542070|581168776|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
161342556|NCT05020015|582642178|FG003|Overall Study|Withdrawal by Subject|0|||
161342557|NCT05020015|582642175|FG000|Overall Study|Reason Not Specified|0|||
160939040|NCT04542070|581168777|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
160939041|NCT04542070|581168778|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
160939042|NCT04542070|581168779|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
160939043|NCT04542070|581168776|FG000|Maintenance + Extension Period|Physician Decision|1|||
161144125|NCT02640612|581911878|FG001|Overall Study|Lost to Follow-up|1|||
161144126|NCT02640612|581911879|FG002|Overall Study|Lost to Follow-up|1|||
161144127|NCT02640612|581911877|FG000|Overall Study|Protocol Violation|0|||
161144128|NCT02640612|581911878|FG001|Overall Study|Protocol Violation|2|||
161144129|NCT02640612|581911879|FG002|Overall Study|Protocol Violation|0|||
161144130|NCT02640612|581911877|FG000|Overall Study|Lack of Efficacy|1|||
161144131|NCT02640612|581911878|FG001|Overall Study|Lack of Efficacy|1|||
161144132|NCT02640612|581911879|FG002|Overall Study|Lack of Efficacy|0|||
161144133|NCT04407507|581911882|FG000|Overall Study|Withdrawal by Subject|0|||
161144134|NCT04407507|581911883|FG001|Overall Study|Withdrawal by Subject|1|||
161144135|NCT01499576|581911885|FG000|Overall Study|Physician Decision|12|||
161144136|NCT01499576|581911885|FG000|Overall Study|Withdrawal by Subject|9|||
161144137|NCT03396471|581911890|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
161144138|NCT03396471|581911890|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
161144139|NCT03396471|581911890|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
161144140|NCT03396471|581911890|FG000|Study Treatment - Up to 22 Months|Death|2|||
161144141|NCT03396471|581911890|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
161144142|NCT03396471|581911890|FG000|Follow up - Up to 2 Years|Death|9|||
161144143|NCT03396471|581911890|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
161144144|NCT03396471|581911890|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
161144145|NCT03396471|581911890|FG000|Follow up - Up to 2 Years|study terminated|1|||
161144146|NCT03396471|581911890|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
161144147|NCT03396471|581911890|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
161144148|NCT01319929|581911891|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
161144149|NCT01319929|581911892|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
161144150|NCT01319929|581911891|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
161144151|NCT01319929|581911892|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
161144152|NCT01319929|581911891|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
161144153|NCT01319929|581911892|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
161144154|NCT01319929|581911891|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
161144155|NCT01319929|581911892|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
161144156|NCT01319929|581911891|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
161144157|NCT01319929|581911892|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
161144158|NCT03237845|581911893|FG000|Overall Study|Adverse Event|0|||
161144159|NCT03237845|581911894|FG001|Overall Study|Adverse Event|1|||
161144160|NCT03237845|581911893|FG000|Overall Study|Lost to Follow-up|13|||
161144161|NCT03237845|581911894|FG001|Overall Study|Lost to Follow-up|10|||
161144162|NCT03237845|581911893|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
161144163|NCT03237845|581911894|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
161144164|NCT03237845|581911893|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
161144165|NCT03237845|581911894|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
161144166|NCT03237845|581911893|FG000|Overall Study|Physician Decision|1|||
161144167|NCT03237845|581911894|FG001|Overall Study|Physician Decision|2|||
161144168|NCT03237845|581911893|FG000|Overall Study|Pregnancy|1|||
161144169|NCT03237845|581911894|FG001|Overall Study|Pregnancy|0|||
161144170|NCT03237845|581911893|FG000|Overall Study|Protocol Deviation|0|||
161144171|NCT03237845|581911894|FG001|Overall Study|Protocol Deviation|1|||
161144172|NCT03237845|581911893|FG000|Overall Study|Technical Problems|8|||
161144173|NCT03237845|581911894|FG001|Overall Study|Technical Problems|1|||
161144174|NCT03237845|581911893|FG000|Overall Study|Withdrawal by Subject|3|||
161144175|NCT03237845|581911894|FG001|Overall Study|Withdrawal by Subject|3|||
161144176|NCT03237845|581911893|FG000|Overall Study|Other Reasons|4|||
161144177|NCT03237845|581911894|FG001|Overall Study|Other Reasons|0|||
161144178|NCT01221233|581911895|FG000|Overall Study|Withdrawal by Subject|3|||
161144179|NCT01221233|581911896|FG001|Overall Study|Withdrawal by Subject|1|||
161144180|NCT03865407|581911898|FG000|Overall Study|Adverse Event|1|||
161144181|NCT03865407|581911899|FG001|Overall Study|Adverse Event|0|||
161144182|NCT03865407|581911898|FG000|Overall Study|Withdrawal by Subject|1|||
161144183|NCT03865407|581911899|FG001|Overall Study|Withdrawal by Subject|0|||
161144184|NCT03865407|581911898|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
161144185|NCT03865407|581911899|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
161144186|NCT01645280|581911900|FG000|Overall Study|Death|0|||
161144187|NCT01645280|581911901|FG001|Overall Study|Death|1|||
161144188|NCT01645280|581911902|FG002|Overall Study|Death|0|||
161144189|NCT01645280|581911903|FG003|Overall Study|Death|0|||
161144190|NCT01645280|581911904|FG004|Overall Study|Death|0|||
161144191|NCT01645280|581911900|FG000|Overall Study|Withdrawal by Subject|4|||
160939044|NCT04542070|581168777|FG001|Maintenance + Extension Period|Physician Decision|1|||
160939045|NCT04542070|581168778|FG002|Maintenance + Extension Period|Physician Decision|0|||
161144192|NCT01645280|581911901|FG001|Overall Study|Withdrawal by Subject|0|||
161144193|NCT01645280|581911902|FG002|Overall Study|Withdrawal by Subject|2|||
161144194|NCT01645280|581911903|FG003|Overall Study|Withdrawal by Subject|4|||
161144195|NCT01645280|581911904|FG004|Overall Study|Withdrawal by Subject|5|||
161144196|NCT01645280|581911900|FG000|Overall Study|Lost to Follow-up|0|||
161144197|NCT01645280|581911901|FG001|Overall Study|Lost to Follow-up|0|||
161144198|NCT01645280|581911902|FG002|Overall Study|Lost to Follow-up|0|||
161144199|NCT01645280|581911903|FG003|Overall Study|Lost to Follow-up|2|||
161144200|NCT01645280|581911904|FG004|Overall Study|Lost to Follow-up|1|||
161144201|NCT01645280|581911900|FG000|Overall Study|Other|1|||
161144202|NCT01645280|581911901|FG001|Overall Study|Other|1|||
161144203|NCT01645280|581911902|FG002|Overall Study|Other|2|||
161144204|NCT01645280|581911903|FG003|Overall Study|Other|0|||
161144205|NCT01645280|581911904|FG004|Overall Study|Other|0|||
161144206|NCT01645280|581911900|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
161144207|NCT01645280|581911901|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
161144208|NCT01645280|581911902|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
161144209|NCT01645280|581911903|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
161144210|NCT01645280|581911904|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
161144211|NCT03233048|581911911|FG000|Overall Study|Withdrawal by Subject|1|||
161144212|NCT00491530|581911912|FG000|Overall Study|Adverse Event|6|||
161144213|NCT00491530|581911913|FG001|Overall Study|Adverse Event|1|||
161144214|NCT00491530|581911914|FG002|Overall Study|Adverse Event|2|||
161144215|NCT00491530|581911912|FG000|Overall Study|Withdrawal by Subject|3|||
161144216|NCT00491530|581911913|FG001|Overall Study|Withdrawal by Subject|0|||
161144217|NCT00491530|581911914|FG002|Overall Study|Withdrawal by Subject|0|||
160939046|NCT04542070|581168779|FG003|Maintenance + Extension Period|Physician Decision|0|||
160939047|NCT04542070|581168776|FG000|Maintenance + Extension Period|Protocol Violation|2|||
160939048|NCT04542070|581168777|FG001|Maintenance + Extension Period|Protocol Violation|5|||
160939049|NCT04542070|581168778|FG002|Maintenance + Extension Period|Protocol Violation|0|||
160939050|NCT04542070|581168779|FG003|Maintenance + Extension Period|Protocol Violation|0|||
160939051|NCT04542070|581168776|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
160939052|NCT04542070|581168777|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
160939053|NCT04542070|581168778|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
160939054|NCT04542070|581168779|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
160939055|NCT04542070|581168776|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
160939056|NCT04542070|581168777|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
160939057|NCT04542070|581168778|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
160939058|NCT04542070|581168779|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
160939059|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
160939060|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
160939061|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
160939062|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
160939063|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
160939064|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
160939065|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
160939066|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
160939067|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
160939068|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
160939069|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
160939070|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
160939071|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
160939072|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
160939073|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
160939074|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
160939075|NCT04542070|581168776|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
161144218|NCT00491530|581911912|FG000|Overall Study|Lost to Follow-up|3|||
161144219|NCT00491530|581911913|FG001|Overall Study|Lost to Follow-up|2|||
161144220|NCT00491530|581911914|FG002|Overall Study|Lost to Follow-up|2|||
161144221|NCT00491530|581911912|FG000|Overall Study|Lack of Efficacy|0|||
161144222|NCT00491530|581911913|FG001|Overall Study|Lack of Efficacy|1|||
161144223|NCT00491530|581911914|FG002|Overall Study|Lack of Efficacy|0|||
160939076|NCT04542070|581168777|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
160939077|NCT04542070|581168778|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
160939078|NCT04542070|581168779|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
160939079|NCT03511560|581168782|FG000|Overall Study|Death|0|||
161144224|NCT00491530|581911912|FG000|Overall Study|Investigator Discretion|0|||
161144225|NCT00491530|581911913|FG001|Overall Study|Investigator Discretion|1|||
161144226|NCT00491530|581911914|FG002|Overall Study|Investigator Discretion|0|||
161144227|NCT00491530|581911912|FG000|Overall Study|Patient Request|0|||
161144228|NCT00491530|581911913|FG001|Overall Study|Patient Request|1|||
160998745|NCT01235949|581380614|FG012|Booster Phase|Adverse Event|0|||
160939080|NCT03511560|581168783|FG001|Overall Study|Death|1|||
160939081|NCT03511560|581168782|FG000|Overall Study|Adverse Event|0|||
160939082|NCT03511560|581168783|FG001|Overall Study|Adverse Event|2|||
160939083|NCT03511560|581168782|FG000|Overall Study|Transplant cancelled|0|||
160939084|NCT03511560|581168783|FG001|Overall Study|Transplant cancelled|1|||
160939085|NCT03511560|581168782|FG000|Overall Study|Patient switched to another drug|1|||
160939086|NCT03511560|581168783|FG001|Overall Study|Patient switched to another drug|0|||
160939087|NCT01813019|581168789|FG000|Overall Study|Adverse Event|0|||
160939088|NCT01813019|581168790|FG001|Overall Study|Adverse Event|3|||
160939089|NCT01813019|581168789|FG000|Overall Study|Withdrawal by Subject|3|||
160939090|NCT01813019|581168790|FG001|Overall Study|Withdrawal by Subject|2|||
160939091|NCT01813019|581168789|FG000|Overall Study|administrative problems|2|||
160939092|NCT01813019|581168790|FG001|Overall Study|administrative problems|0|||
160939093|NCT01813019|581168789|FG000|Overall Study|Protocol Deviation|2|||
160939094|NCT01813019|581168790|FG001|Overall Study|Protocol Deviation|1|||
160939095|NCT03075644|581168791|FG000|Overall Study|Withdrawal by Subject|1|||
160939096|NCT03075644|581168792|FG001|Overall Study|Withdrawal by Subject|1|||
160939097|NCT01458171|581168796|FG000|Overall Study|Adverse Event|1|||
160939098|NCT00578565|581168801|FG000|Overall Study|Adverse Event|3|||
160939099|NCT01192152|581168802|FG000|Period 1|left prematurely (while on treatment B)|0|||
160939100|NCT01192152|581168803|FG001|Period 1|left prematurely (while on treatment B)|1|||
160939101|NCT01192152|581168802|FG000|Period 3|family emergency|1|||
160939102|NCT01192152|581168803|FG001|Period 3|family emergency|0|||
160939103|NCT02143843|581168805|FG000|Overall Study|Adverse Event|8|||
160939104|NCT02143843|581168805|FG000|Overall Study|Lack of Efficacy|2|||
160939105|NCT02143843|581168805|FG000|Overall Study|Withdrawal by Subject|2|||
160939106|NCT01462357|581168807|FG000|Overall Study|Death|0|||
160939107|NCT01462357|581168808|FG001|Overall Study|Death|0|||
160939108|NCT01462357|581168809|FG002|Overall Study|Death|1|||
160939109|NCT01462357|581168807|FG000|Overall Study|Withdrawal by Subject|3|||
160939110|NCT01462357|581168808|FG001|Overall Study|Withdrawal by Subject|11|||
160939111|NCT01462357|581168809|FG002|Overall Study|Withdrawal by Subject|3|||
160939112|NCT01462357|581168807|FG000|Overall Study|Migrated/moved from study area|2|||
160939113|NCT01462357|581168808|FG001|Overall Study|Migrated/moved from study area|3|||
160939114|NCT01462357|581168809|FG002|Overall Study|Migrated/moved from study area|1|||
160939115|NCT01462357|581168807|FG000|Overall Study|Lost to Follow-up|3|||
160939116|NCT01462357|581168808|FG001|Overall Study|Lost to Follow-up|5|||
160939117|NCT01462357|581168809|FG002|Overall Study|Lost to Follow-up|7|||
160939118|NCT01527292|581168815|FG000|Overall Study|Physician Decision|0|||
160939119|NCT01527292|581168816|FG001|Overall Study|Physician Decision|3|||
160939120|NCT00314366|581168817|FG000|Overall Study|not treated due to patient medical condi|1|||
160939121|NCT00314366|581168818|FG001|Overall Study|not treated due to patient medical condi|0|||
160939122|NCT02469610|581168819|FG000|Overall Study|Death|1|||
160939123|NCT02469610|581168820|FG001|Overall Study|Death|0|||
160939124|NCT02469610|581168819|FG000|Overall Study|Lost to Follow-up|1|||
160939125|NCT02469610|581168820|FG001|Overall Study|Lost to Follow-up|0|||
160939126|NCT02469610|581168819|FG000|Overall Study|exclusion criteria|2|||
160939127|NCT02469610|581168820|FG001|Overall Study|exclusion criteria|1|||
160939128|NCT01451424|581168823|FG000|Overall Study|Withdrawal by Subject|1|||
160939129|NCT01451424|581168824|FG001|Overall Study|Withdrawal by Subject|1|||
160939130|NCT01451424|581168825|FG002|Overall Study|Withdrawal by Subject|0|||
160939131|NCT01451424|581168826|FG003|Overall Study|Withdrawal by Subject|2|||
160939132|NCT01451424|581168823|FG000|Overall Study|Lost to Follow-up|0|||
160998746|NCT01235949|581380615|FG013|Booster Phase|Adverse Event|0|||
160998747|NCT01235949|581380616|FG014|Booster Phase|Adverse Event|0|||
160998748|NCT01235949|581380617|FG015|Booster Phase|Adverse Event|1|||
161342558|NCT05020015|582642176|FG001|Overall Study|Reason Not Specified|0|||
160939133|NCT01451424|581168824|FG001|Overall Study|Lost to Follow-up|1|||
160939134|NCT01451424|581168825|FG002|Overall Study|Lost to Follow-up|0|||
160939135|NCT01451424|581168826|FG003|Overall Study|Lost to Follow-up|1|||
160939136|NCT01451424|581168823|FG000|Overall Study|Physician Decision|0|||
160939137|NCT01451424|581168824|FG001|Overall Study|Physician Decision|0|||
160939138|NCT01451424|581168825|FG002|Overall Study|Physician Decision|1|||
160939139|NCT01451424|581168826|FG003|Overall Study|Physician Decision|1|||
160939140|NCT01451424|581168823|FG000|Overall Study|Adverse Event|0|||
160939141|NCT01451424|581168824|FG001|Overall Study|Adverse Event|0|||
160939142|NCT01451424|581168825|FG002|Overall Study|Adverse Event|0|||
160939143|NCT01451424|581168826|FG003|Overall Study|Adverse Event|1|||
160939144|NCT02920983|581168827|FG000|Dispense 1|Unacceptable Lens Fit|0|||
160939145|NCT02920983|581168828|FG001|Dispense 1|Unacceptable Lens Fit|0|||
160939146|NCT02920983|581168829|FG002|Dispense 1|Unacceptable Lens Fit|0|||
160998749|NCT01235949|581380618|FG016|Booster Phase|Adverse Event|0|||
160998750|NCT01235949|581380619|FG017|Booster Phase|Adverse Event|0|||
160939147|NCT02920983|581168830|FG003|Dispense 1|Unacceptable Lens Fit|0|||
160939148|NCT02920983|581168831|FG004|Dispense 1|Unacceptable Lens Fit|1|||
160939149|NCT02920983|581168832|FG005|Dispense 1|Unacceptable Lens Fit|0|||
160939150|NCT02920983|581168827|FG000|Dispense 2|Unscceptable lens fit|1|||
161342559|NCT05020015|582642177|FG002|Overall Study|Reason Not Specified|2|||
161264694|NCT05297578|582350720|FG003|Overall Study|Lost to Follow-up|1|||
161264695|NCT05297578|582350717|FG000|Overall Study|Death|0|||
161264696|NCT05297578|582350718|FG001|Overall Study|Death|1|||
161264697|NCT05297578|582350719|FG002|Overall Study|Death|0|||
161264698|NCT05297578|582350720|FG003|Overall Study|Death|0|||
161264699|NCT05297578|582350717|FG000|Overall Study|Withdrawal by Subject|0|||
161264700|NCT05297578|582350718|FG001|Overall Study|Withdrawal by Subject|0|||
161264701|NCT05297578|582350719|FG002|Overall Study|Withdrawal by Subject|1|||
161264702|NCT05297578|582350720|FG003|Overall Study|Withdrawal by Subject|0|||
161264703|NCT03127644|582350721|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161264704|NCT03127644|582350722|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161264705|NCT03127644|582350723|FG002|Overall Study|Study-specific withdrawal criteria|2|||
161264706|NCT02032706|582350724|FG000|Overall Study|Did not qualify|5|||
161264707|NCT02032706|582350724|FG000|Overall Study|Protocol Violation|1|||
161264708|NCT01156142|582350727|FG000|Overall Study|Withdrawal by Subject|8|||
161264709|NCT01156142|582350728|FG001|Overall Study|Withdrawal by Subject|6|||
161264710|NCT01156142|582350727|FG000|Overall Study|Ineligible|0|||
161264711|NCT01156142|582350728|FG001|Overall Study|Ineligible|1|||
161264712|NCT00893737|582350729|FG000|Overall Study|Adverse Event|4|||
161264713|NCT00893737|582350729|FG000|Overall Study|Withdrawal by Subject|2|||
161264714|NCT00893737|582350729|FG000|Overall Study|Lost to Follow-up|6|||
161264715|NCT00928707|582350730|FG000|Overall Study|Protocol Violation|1|||
161264716|NCT00928707|582350731|FG001|Overall Study|Protocol Violation|0|||
161264717|NCT00132028|582350732|FG000|Overall Study|Adverse Event|7|||
161264718|NCT00132028|582350732|FG000|Overall Study|Death|2|||
161264719|NCT00132028|582350732|FG000|Overall Study|Lack of Efficacy|11|||
161264720|NCT00132028|582350732|FG000|Overall Study|Withdrawal by Subject|2|||
161264721|NCT00132028|582350732|FG000|Overall Study|not eligible|2|||
160939151|NCT02920983|581168828|FG001|Dispense 2|Unscceptable lens fit|0|||
160939152|NCT02920983|581168829|FG002|Dispense 2|Unscceptable lens fit|0|||
160939153|NCT02920983|581168830|FG003|Dispense 2|Unscceptable lens fit|0|||
160939154|NCT02920983|581168831|FG004|Dispense 2|Unscceptable lens fit|1|||
160939155|NCT02920983|581168832|FG005|Dispense 2|Unscceptable lens fit|0|||
160939156|NCT02920983|581168827|FG000|Dispense 3|Unacceptable Lens Fit|1|||
160939157|NCT02920983|581168828|FG001|Dispense 3|Unacceptable Lens Fit|1|||
160939158|NCT02920983|581168829|FG002|Dispense 3|Unacceptable Lens Fit|0|||
160939159|NCT02920983|581168830|FG003|Dispense 3|Unacceptable Lens Fit|0|||
160939160|NCT02920983|581168831|FG004|Dispense 3|Unacceptable Lens Fit|1|||
160939161|NCT02920983|581168832|FG005|Dispense 3|Unacceptable Lens Fit|0|||
160939162|NCT01387607|581168838|FG000|Overall Study|Adverse Event|23|||
160939163|NCT01387607|581168839|FG001|Overall Study|Adverse Event|11|||
160939164|NCT01387607|581168838|FG000|Overall Study|Lack of Efficacy|8|||
160939165|NCT01387607|581168839|FG001|Overall Study|Lack of Efficacy|6|||
160939166|NCT01387607|581168838|FG000|Overall Study|Lost to Follow-up|2|||
160939167|NCT01387607|581168839|FG001|Overall Study|Lost to Follow-up|1|||
160939168|NCT01387607|581168838|FG000|Overall Study|No longer meets eligibility criteria|0|||
160939169|NCT01387607|581168839|FG001|Overall Study|No longer meets eligibility criteria|1|||
160939170|NCT01387607|581168838|FG000|Overall Study|Protocol Violation|1|||
160939171|NCT01387607|581168839|FG001|Overall Study|Protocol Violation|5|||
161264722|NCT00132028|582350732|FG000|Overall Study|Physician Decision|3|||
161264723|NCT02140411|582350733|FG000|Overall Study|Adverse Event|1|||
161264724|NCT03981419|582350736|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
161264725|NCT03981419|582350737|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
161264726|NCT01330459|582350742|FG000|Overall Study|Physician Decision|0|||
161264727|NCT01330459|582350743|FG001|Overall Study|Physician Decision|2|||
161264728|NCT02272634|582350747|FG000|Overall Study|Adverse Event|1|||
161264729|NCT02272634|582350748|FG001|Overall Study|Adverse Event|0|||
161264730|NCT02272634|582350749|FG002|Overall Study|Adverse Event|0|||
161264731|NCT02272634|582350747|FG000|Overall Study|Protocol Violation|0|||
161264732|NCT02272634|582350748|FG001|Overall Study|Protocol Violation|0|||
161264733|NCT02272634|582350749|FG002|Overall Study|Protocol Violation|1|||
161264734|NCT02272634|582350747|FG000|Overall Study|Withdrawal by Subject|0|||
160939172|NCT01387607|581168838|FG000|Overall Study|Withdrawal by Subject|13|||
160939173|NCT01387607|581168839|FG001|Overall Study|Withdrawal by Subject|14|||
160939174|NCT01387607|581168838|FG000|Overall Study|Other|1|||
160939175|NCT01387607|581168839|FG001|Overall Study|Other|1|||
160939176|NCT01387607|581168838|FG000|Overall Study|Randomized, not treated|3|||
160939177|NCT01387607|581168839|FG001|Overall Study|Randomized, not treated|6|||
160939178|NCT02556710|581170914|FG000|Overall Study|Surgical treatment|3|||
160939179|NCT02556710|581170915|FG001|Overall Study|Surgical treatment|0|||
160939180|NCT02556710|581170914|FG000|Overall Study|Required proscribed pain medication|2|||
160939181|NCT02556710|581170915|FG001|Overall Study|Required proscribed pain medication|1|||
160939182|NCT02556710|581170914|FG000|Overall Study|Lack of Efficacy|1|||
160939183|NCT02556710|581170915|FG001|Overall Study|Lack of Efficacy|0|||
160939184|NCT02556710|581170914|FG000|Overall Study|Worsening osteoarthritis|1|||
160939185|NCT02556710|581170915|FG001|Overall Study|Worsening osteoarthritis|0|||
160939186|NCT02556710|581170914|FG000|Overall Study|Moved out of state|1|||
160939187|NCT02556710|581170915|FG001|Overall Study|Moved out of state|0|||
160939188|NCT02556710|581170914|FG000|Overall Study|Missing reason|3|||
160939189|NCT02556710|581170915|FG001|Overall Study|Missing reason|1|||
160939190|NCT02556710|581170914|FG000|Overall Study|Pain as lack of efficacy|0|||
160939191|NCT02556710|581170915|FG001|Overall Study|Pain as lack of efficacy|4|||
160939192|NCT04524403|581170918|FG000|Overall Study|Withdrawal by Subject|10|||
160939193|NCT04524403|581170919|FG001|Overall Study|Withdrawal by Subject|3|||
160939194|NCT04524403|581170920|FG002|Overall Study|Withdrawal by Subject|8|||
160939195|NCT04524403|581170918|FG000|Overall Study|Lost to Follow-up|3|||
160939196|NCT04524403|581170919|FG001|Overall Study|Lost to Follow-up|4|||
160939197|NCT04524403|581170920|FG002|Overall Study|Lost to Follow-up|3|||
160939198|NCT04524403|581170918|FG000|Overall Study|Adverse Event|3|||
160939199|NCT04524403|581170919|FG001|Overall Study|Adverse Event|1|||
160939200|NCT04524403|581170920|FG002|Overall Study|Adverse Event|4|||
160939201|NCT04524403|581170918|FG000|Overall Study|Non-compliant with study drug|1|||
160939202|NCT04524403|581170919|FG001|Overall Study|Non-compliant with study drug|2|||
160939203|NCT04524403|581170920|FG002|Overall Study|Non-compliant with study drug|3|||
160939204|NCT04524403|581170918|FG000|Overall Study|Moved|0|||
160939205|NCT04524403|581170919|FG001|Overall Study|Moved|1|||
160939206|NCT04524403|581170920|FG002|Overall Study|Moved|0|||
160939207|NCT00991302|581170921|FG000|Overall Study|Death|0|||
160939208|NCT00991302|581170922|FG001|Overall Study|Death|1|||
160939209|NCT00991302|581170921|FG000|Overall Study|Lost to Follow-up|14|||
160939210|NCT00991302|581170922|FG001|Overall Study|Lost to Follow-up|12|||
160939211|NCT01709318|581170923|FG000|Overall Study|Adverse Event|3|||
160939212|NCT01709318|581170924|FG001|Overall Study|Adverse Event|4|||
160939213|NCT01709318|581170925|FG002|Overall Study|Adverse Event|2|||
160939214|NCT01709318|581170926|FG003|Overall Study|Adverse Event|2|||
160939215|NCT01709318|581170927|FG004|Overall Study|Adverse Event|0|||
160939216|NCT01709318|581170928|FG005|Overall Study|Adverse Event|1|||
160939217|NCT01709318|581170929|FG006|Overall Study|Adverse Event|2|||
160939218|NCT01709318|581170923|FG000|Overall Study|Lost to Follow-up|2|||
160939219|NCT01709318|581170924|FG001|Overall Study|Lost to Follow-up|0|||
160939220|NCT01709318|581170925|FG002|Overall Study|Lost to Follow-up|0|||
160939221|NCT01709318|581170926|FG003|Overall Study|Lost to Follow-up|0|||
160939222|NCT01709318|581170927|FG004|Overall Study|Lost to Follow-up|1|||
160939223|NCT01709318|581170928|FG005|Overall Study|Lost to Follow-up|1|||
160939224|NCT01709318|581170929|FG006|Overall Study|Lost to Follow-up|1|||
160939225|NCT01709318|581170923|FG000|Overall Study|Non-compliance with Study Drug|0|||
160939226|NCT01709318|581170924|FG001|Overall Study|Non-compliance with Study Drug|2|||
160939227|NCT01709318|581170925|FG002|Overall Study|Non-compliance with Study Drug|1|||
160939228|NCT01709318|581170926|FG003|Overall Study|Non-compliance with Study Drug|1|||
160939229|NCT01709318|581170927|FG004|Overall Study|Non-compliance with Study Drug|0|||
160939230|NCT01709318|581170928|FG005|Overall Study|Non-compliance with Study Drug|0|||
160939231|NCT01709318|581170929|FG006|Overall Study|Non-compliance with Study Drug|2|||
160939232|NCT01709318|581170923|FG000|Overall Study|Physician Decision|0|||
160939233|NCT01709318|581170924|FG001|Overall Study|Physician Decision|0|||
160939234|NCT01709318|581170925|FG002|Overall Study|Physician Decision|0|||
160939235|NCT01709318|581170926|FG003|Overall Study|Physician Decision|0|||
160939236|NCT01709318|581170927|FG004|Overall Study|Physician Decision|0|||
160939237|NCT01709318|581170928|FG005|Overall Study|Physician Decision|0|||
160939238|NCT01709318|581170929|FG006|Overall Study|Physician Decision|1|||
160939239|NCT01709318|581170923|FG000|Overall Study|Pregnancy|0|||
160939240|NCT01709318|581170924|FG001|Overall Study|Pregnancy|0|||
160939241|NCT01709318|581170925|FG002|Overall Study|Pregnancy|0|||
160939242|NCT01709318|581170926|FG003|Overall Study|Pregnancy|0|||
160998751|NCT01235949|581380602|FG000|Booster Phase|Withdrawal by Subject|0|||
161264735|NCT02272634|582350748|FG001|Overall Study|Withdrawal by Subject|1|||
161264736|NCT02272634|582350749|FG002|Overall Study|Withdrawal by Subject|0|||
161264737|NCT01437943|582350750|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
161264738|NCT01437943|582350751|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
161264739|NCT01437943|582350750|FG000|Overall Study|Subject expressed pregnancy plans|1|||
160939243|NCT01709318|581170927|FG004|Overall Study|Pregnancy|1|||
160939244|NCT01709318|581170928|FG005|Overall Study|Pregnancy|0|||
160939245|NCT01709318|581170929|FG006|Overall Study|Pregnancy|0|||
160939246|NCT01709318|581170923|FG000|Overall Study|Protocol Violation|0|||
160939247|NCT01709318|581170924|FG001|Overall Study|Protocol Violation|0|||
160939248|NCT01709318|581170925|FG002|Overall Study|Protocol Violation|0|||
160939249|NCT01709318|581170926|FG003|Overall Study|Protocol Violation|0|||
161264740|NCT01437943|582350751|FG001|Overall Study|Subject expressed pregnancy plans|0|||
160939250|NCT01709318|581170927|FG004|Overall Study|Protocol Violation|2|||
160939251|NCT01709318|581170928|FG005|Overall Study|Protocol Violation|0|||
160939252|NCT01709318|581170929|FG006|Overall Study|Protocol Violation|1|||
160939253|NCT01709318|581170923|FG000|Overall Study|Technical Problems|1|||
160939254|NCT01709318|581170924|FG001|Overall Study|Technical Problems|0|||
160939255|NCT01709318|581170925|FG002|Overall Study|Technical Problems|0|||
160939256|NCT01709318|581170926|FG003|Overall Study|Technical Problems|0|||
160939257|NCT01709318|581170927|FG004|Overall Study|Technical Problems|0|||
160939258|NCT01709318|581170928|FG005|Overall Study|Technical Problems|0|||
160939259|NCT01709318|581170929|FG006|Overall Study|Technical Problems|0|||
160939260|NCT01709318|581170923|FG000|Overall Study|Withdrawal by Subject|3|||
160939261|NCT01709318|581170924|FG001|Overall Study|Withdrawal by Subject|0|||
160939262|NCT01709318|581170925|FG002|Overall Study|Withdrawal by Subject|3|||
160939263|NCT01709318|581170926|FG003|Overall Study|Withdrawal by Subject|3|||
160939264|NCT01709318|581170927|FG004|Overall Study|Withdrawal by Subject|0|||
160939265|NCT01709318|581170928|FG005|Overall Study|Withdrawal by Subject|2|||
160939266|NCT01709318|581170929|FG006|Overall Study|Withdrawal by Subject|4|||
160939267|NCT01709318|581170923|FG000|Overall Study|Other Protocol Specified Criteria|0|||
160939268|NCT01709318|581170924|FG001|Overall Study|Other Protocol Specified Criteria|1|||
161264741|NCT01437943|582350750|FG000|Overall Study|Adverse Event|2|||
161264742|NCT01437943|582350751|FG001|Overall Study|Adverse Event|0|||
161264743|NCT04647721|582350752|FG000|Overall Study|Withdrawal by Subject|0|||
160939269|NCT01709318|581170925|FG002|Overall Study|Other Protocol Specified Criteria|0|||
160939270|NCT01709318|581170926|FG003|Overall Study|Other Protocol Specified Criteria|0|||
160939271|NCT01709318|581170927|FG004|Overall Study|Other Protocol Specified Criteria|0|||
160939272|NCT01709318|581170928|FG005|Overall Study|Other Protocol Specified Criteria|0|||
160939273|NCT01709318|581170929|FG006|Overall Study|Other Protocol Specified Criteria|0|||
160939274|NCT00646958|581170934|FG000|Overall Study|Lack of Efficacy|1|||
160939275|NCT00646958|581170935|FG001|Overall Study|Lack of Efficacy|0|||
160939276|NCT00646958|581170936|FG002|Overall Study|Lack of Efficacy|0|||
160939277|NCT00646958|581170934|FG000|Overall Study|Adverse Event|4|||
160939278|NCT00646958|581170935|FG001|Overall Study|Adverse Event|0|||
160939279|NCT00646958|581170936|FG002|Overall Study|Adverse Event|0|||
160939280|NCT00646958|581170934|FG000|Overall Study|Lost to Follow-up|1|||
160939281|NCT00646958|581170935|FG001|Overall Study|Lost to Follow-up|5|||
160939282|NCT00646958|581170936|FG002|Overall Study|Lost to Follow-up|7|||
160939283|NCT00646958|581170934|FG000|Overall Study|Protocol Violation|1|||
160939284|NCT00646958|581170935|FG001|Overall Study|Protocol Violation|1|||
160939285|NCT00646958|581170936|FG002|Overall Study|Protocol Violation|0|||
160939286|NCT00646958|581170934|FG000|Overall Study|Abnormal screening lab tests|1|||
160939287|NCT00646958|581170935|FG001|Overall Study|Abnormal screening lab tests|1|||
160939288|NCT00646958|581170936|FG002|Overall Study|Abnormal screening lab tests|0|||
160939289|NCT00646958|581170934|FG000|Overall Study|Withdrawal by Subject|1|||
160939290|NCT00646958|581170935|FG001|Overall Study|Withdrawal by Subject|2|||
160939291|NCT00646958|581170936|FG002|Overall Study|Withdrawal by Subject|0|||
160939292|NCT00646958|581170934|FG000|Overall Study|Did not receive study drug|2|||
160939293|NCT00646958|581170935|FG001|Overall Study|Did not receive study drug|0|||
160939294|NCT00646958|581170936|FG002|Overall Study|Did not receive study drug|2|||
160939295|NCT00827372|581170937|FG000|Overall Study|Adverse Event|5|||
160939296|NCT00827372|581170937|FG000|Overall Study|Lack of Efficacy|3|||
160939297|NCT03085927|581170938|FG000|Overall Study|Withdrawal by Subject|1|||
160939298|NCT03085927|581170939|FG001|Overall Study|Withdrawal by Subject|4|||
160939299|NCT03085927|581170938|FG000|Overall Study|Lost to Follow-up|3|||
160939300|NCT03085927|581170939|FG001|Overall Study|Lost to Follow-up|1|||
160939301|NCT03085927|581170938|FG000|Overall Study|Death|1|||
160939302|NCT03085927|581170939|FG001|Overall Study|Death|0|||
160939303|NCT03085927|581170938|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
160939304|NCT03085927|581170939|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
160939305|NCT03085927|581170938|FG000|Overall Study|Dyad Became Ineligible|0|||
160939306|NCT03085927|581170939|FG001|Overall Study|Dyad Became Ineligible|1|||
160939307|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
160939308|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939309|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939310|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161264744|NCT04647721|582350753|FG001|Overall Study|Withdrawal by Subject|2|||
161264745|NCT04647721|582350752|FG000|Overall Study|Lost to Follow-up|2|||
161264746|NCT04647721|582350753|FG001|Overall Study|Lost to Follow-up|0|||
161264747|NCT02643355|582350754|FG000|Overall Study|Withdrawal by Subject|1|||
161264748|NCT02643355|582350755|FG001|Overall Study|Withdrawal by Subject|3|||
160939311|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939312|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
160939313|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
160939314|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939315|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939316|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939317|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939318|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
160939319|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
160939320|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160998752|NCT01235949|581380603|FG001|Booster Phase|Withdrawal by Subject|0|||
161264749|NCT02643355|582350754|FG000|Overall Study|Protocol Violation|0|||
161264750|NCT02643355|582350755|FG001|Overall Study|Protocol Violation|2|||
161264751|NCT00136318|582350758|FG000|Overall Study|Adverse Event|5|||
161264752|NCT00136318|582350759|FG001|Overall Study|Adverse Event|5|||
160939321|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939322|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939323|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939324|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
160939325|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
160939326|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939327|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939328|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939329|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939330|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
160939331|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
160939332|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939333|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939334|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939335|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939336|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
160939337|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
160939338|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939339|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939340|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939341|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939342|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
160939343|NCT02139644|581170940|FG000|Run-In Period (Pre-assignment)|Other|6|||
160939344|NCT02139644|581170941|FG001|Run-In Period (Pre-assignment)|Other|0|||
160939345|NCT02139644|581170942|FG002|Run-In Period (Pre-assignment)|Other|0|||
160939346|NCT02139644|581170943|FG003|Run-In Period (Pre-assignment)|Other|0|||
160939347|NCT02139644|581170944|FG004|Run-In Period (Pre-assignment)|Other|0|||
160939348|NCT02139644|581170945|FG005|Run-In Period (Pre-assignment)|Other|0|||
160939349|NCT02139644|581170940|FG000|Treatment Period|Adverse Event|0|||
160939350|NCT02139644|581170941|FG001|Treatment Period|Adverse Event|0|||
160939351|NCT02139644|581170942|FG002|Treatment Period|Adverse Event|3|||
160939352|NCT02139644|581170943|FG003|Treatment Period|Adverse Event|2|||
160939353|NCT02139644|581170944|FG004|Treatment Period|Adverse Event|1|||
160939354|NCT02139644|581170945|FG005|Treatment Period|Adverse Event|6|||
160939355|NCT02139644|581170940|FG000|Treatment Period|Withdrawal by Subject|0|||
160939356|NCT02139644|581170941|FG001|Treatment Period|Withdrawal by Subject|0|||
160998753|NCT01235949|581380604|FG002|Booster Phase|Withdrawal by Subject|0|||
160998754|NCT01235949|581380605|FG003|Booster Phase|Withdrawal by Subject|0|||
160998755|NCT01235949|581380606|FG004|Booster Phase|Withdrawal by Subject|0|||
160998756|NCT01235949|581380607|FG005|Booster Phase|Withdrawal by Subject|0|||
160998757|NCT01235949|581380608|FG006|Booster Phase|Withdrawal by Subject|0|||
160998758|NCT01235949|581380609|FG007|Booster Phase|Withdrawal by Subject|1|||
160998759|NCT01235949|581380610|FG008|Booster Phase|Withdrawal by Subject|1|||
160998760|NCT01235949|581380611|FG009|Booster Phase|Withdrawal by Subject|0|||
160998761|NCT01235949|581380612|FG010|Booster Phase|Withdrawal by Subject|1|||
160998762|NCT01235949|581380613|FG011|Booster Phase|Withdrawal by Subject|1|||
160998763|NCT01235949|581380614|FG012|Booster Phase|Withdrawal by Subject|2|||
160998764|NCT01235949|581380615|FG013|Booster Phase|Withdrawal by Subject|0|||
160998765|NCT01235949|581380616|FG014|Booster Phase|Withdrawal by Subject|2|||
160998766|NCT01235949|581380617|FG015|Booster Phase|Withdrawal by Subject|0|||
160998767|NCT01235949|581380618|FG016|Booster Phase|Withdrawal by Subject|0|||
160998768|NCT01235949|581380619|FG017|Booster Phase|Withdrawal by Subject|0|||
160939357|NCT02139644|581170942|FG002|Treatment Period|Withdrawal by Subject|2|||
160939358|NCT02139644|581170943|FG003|Treatment Period|Withdrawal by Subject|2|||
160939359|NCT02139644|581170944|FG004|Treatment Period|Withdrawal by Subject|3|||
160939360|NCT02139644|581170945|FG005|Treatment Period|Withdrawal by Subject|2|||
160939361|NCT02139644|581170940|FG000|Treatment Period|Non-compliance|0|||
160939362|NCT02139644|581170941|FG001|Treatment Period|Non-compliance|0|||
160939363|NCT02139644|581170942|FG002|Treatment Period|Non-compliance|0|||
160939364|NCT02139644|581170943|FG003|Treatment Period|Non-compliance|1|||
160998769|NCT01235949|581380602|FG000|Booster Phase|Lost to Follow-up|0|||
160998770|NCT01235949|581380603|FG001|Booster Phase|Lost to Follow-up|0|||
160998771|NCT01235949|581380604|FG002|Booster Phase|Lost to Follow-up|0|||
160939365|NCT02139644|581170944|FG004|Treatment Period|Non-compliance|0|||
160939366|NCT02139644|581170945|FG005|Treatment Period|Non-compliance|0|||
160939367|NCT02139644|581170940|FG000|Treatment Period|Protocol Violation|0|||
160939368|NCT02139644|581170941|FG001|Treatment Period|Protocol Violation|0|||
160939369|NCT02139644|581170942|FG002|Treatment Period|Protocol Violation|0|||
160939370|NCT02139644|581170943|FG003|Treatment Period|Protocol Violation|1|||
160998772|NCT01235949|581380605|FG003|Booster Phase|Lost to Follow-up|0|||
160998773|NCT01235949|581380606|FG004|Booster Phase|Lost to Follow-up|0|||
160998774|NCT01235949|581380607|FG005|Booster Phase|Lost to Follow-up|0|||
160998775|NCT01235949|581380608|FG006|Booster Phase|Lost to Follow-up|0|||
160998776|NCT01235949|581380609|FG007|Booster Phase|Lost to Follow-up|0|||
160939371|NCT02139644|581170944|FG004|Treatment Period|Protocol Violation|1|||
160939372|NCT02139644|581170945|FG005|Treatment Period|Protocol Violation|1|||
160939373|NCT02139644|581170940|FG000|Treatment Period|Disease progression|0|||
160939374|NCT02139644|581170941|FG001|Treatment Period|Disease progression|0|||
160939375|NCT02139644|581170942|FG002|Treatment Period|Disease progression|0|||
160939376|NCT02139644|581170943|FG003|Treatment Period|Disease progression|1|||
160939377|NCT02139644|581170944|FG004|Treatment Period|Disease progression|1|||
160939378|NCT02139644|581170945|FG005|Treatment Period|Disease progression|2|||
160939379|NCT02139644|581170940|FG000|Treatment Period|Lost to Follow-up|0|||
160939380|NCT02139644|581170941|FG001|Treatment Period|Lost to Follow-up|0|||
160939381|NCT02139644|581170942|FG002|Treatment Period|Lost to Follow-up|1|||
160939382|NCT02139644|581170943|FG003|Treatment Period|Lost to Follow-up|1|||
160939383|NCT02139644|581170944|FG004|Treatment Period|Lost to Follow-up|1|||
160939384|NCT02139644|581170945|FG005|Treatment Period|Lost to Follow-up|1|||
160939385|NCT02139644|581170940|FG000|Treatment Period|Lack of Efficacy|0|||
160939386|NCT02139644|581170941|FG001|Treatment Period|Lack of Efficacy|0|||
160939387|NCT02139644|581170942|FG002|Treatment Period|Lack of Efficacy|1|||
160939388|NCT02139644|581170943|FG003|Treatment Period|Lack of Efficacy|0|||
160939389|NCT02139644|581170944|FG004|Treatment Period|Lack of Efficacy|1|||
160939390|NCT02139644|581170945|FG005|Treatment Period|Lack of Efficacy|4|||
160939391|NCT02139644|581170940|FG000|Treatment Period|Other|0|||
160939392|NCT02139644|581170941|FG001|Treatment Period|Other|3|||
160939393|NCT02139644|581170942|FG002|Treatment Period|Other|1|||
160939394|NCT02139644|581170943|FG003|Treatment Period|Other|1|||
160939395|NCT02139644|581170944|FG004|Treatment Period|Other|0|||
160939396|NCT02139644|581170945|FG005|Treatment Period|Other|1|||
160939397|NCT00630877|581170948|FG000|Overall Study|Adverse Event|11|||
160939398|NCT00630877|581170949|FG001|Overall Study|Adverse Event|8|||
160939399|NCT00630877|581170950|FG002|Overall Study|Adverse Event|7|||
160939400|NCT00630877|581170948|FG000|Overall Study|Withdrawal by Subject|3|||
160939401|NCT00630877|581170949|FG001|Overall Study|Withdrawal by Subject|4|||
160939402|NCT00630877|581170950|FG002|Overall Study|Withdrawal by Subject|0|||
160939403|NCT00630877|581170948|FG000|Overall Study|Lost to Follow-up|2|||
160939404|NCT00630877|581170949|FG001|Overall Study|Lost to Follow-up|0|||
160939405|NCT00630877|581170950|FG002|Overall Study|Lost to Follow-up|0|||
160939406|NCT00630877|581170948|FG000|Overall Study|Noncompliance|2|||
160939407|NCT00630877|581170949|FG001|Overall Study|Noncompliance|3|||
160939408|NCT00630877|581170950|FG002|Overall Study|Noncompliance|1|||
160939409|NCT00630877|581170948|FG000|Overall Study|Protocol violation|1|||
160939410|NCT00630877|581170949|FG001|Overall Study|Protocol violation|0|||
160939411|NCT00630877|581170950|FG002|Overall Study|Protocol violation|1|||
160939412|NCT00630877|581170948|FG000|Overall Study|Personal reasons|0|||
160939413|NCT00630877|581170949|FG001|Overall Study|Personal reasons|0|||
160939414|NCT00630877|581170950|FG002|Overall Study|Personal reasons|1|||
160939415|NCT01312909|581170951|FG000|Overall Study|Randomized but not treated|1|||
160939416|NCT01312909|581170952|FG001|Overall Study|Randomized but not treated|3|||
160939417|NCT01312909|581170953|FG002|Overall Study|Randomized but not treated|1|||
160939418|NCT01312909|581170951|FG000|Overall Study|Adverse Event|1|||
160939419|NCT01312909|581170952|FG001|Overall Study|Adverse Event|0|||
160939420|NCT01312909|581170953|FG002|Overall Study|Adverse Event|3|||
160939421|NCT01312909|581170951|FG000|Overall Study|Protocol Violation|2|||
160939422|NCT01312909|581170952|FG001|Overall Study|Protocol Violation|0|||
160939423|NCT01312909|581170953|FG002|Overall Study|Protocol Violation|2|||
160939424|NCT01312909|581170951|FG000|Overall Study|Other|9|||
160939425|NCT01312909|581170952|FG001|Overall Study|Other|6|||
160939426|NCT01312909|581170953|FG002|Overall Study|Other|11|||
160939427|NCT01312909|581170951|FG000|Overall Study|Withdrawal by Subject|8|||
160939428|NCT01312909|581170952|FG001|Overall Study|Withdrawal by Subject|10|||
160939429|NCT01312909|581170953|FG002|Overall Study|Withdrawal by Subject|7|||
160939430|NCT01312909|581170951|FG000|Overall Study|Lost to Follow-up|21|||
160939431|NCT01312909|581170952|FG001|Overall Study|Lost to Follow-up|17|||
160939432|NCT01312909|581170953|FG002|Overall Study|Lost to Follow-up|20|||
160939433|NCT01312909|581170951|FG000|Overall Study|Insufficient clinical response|0|||
160939434|NCT01312909|581170952|FG001|Overall Study|Insufficient clinical response|0|||
160939435|NCT01312909|581170953|FG002|Overall Study|Insufficient clinical response|1|||
160939436|NCT01312909|581170951|FG000|Overall Study|Entrance criteria not met|0|||
160939437|NCT01312909|581170952|FG001|Overall Study|Entrance criteria not met|0|||
160939438|NCT01312909|581170953|FG002|Overall Study|Entrance criteria not met|2|||
160939439|NCT02200042|581170954|FG000|Overall Study|Withdrawal by Subject|0|||
160939440|NCT02200042|581170955|FG001|Overall Study|Withdrawal by Subject|1|||
160939441|NCT00306592|581170958|FG000|Overall Study|Adverse Event|8|||
160939442|NCT00306592|581170959|FG001|Overall Study|Adverse Event|15|||
160939443|NCT00306592|581170958|FG000|Overall Study|Lost to Follow-up|1|||
160939444|NCT00306592|581170959|FG001|Overall Study|Lost to Follow-up|0|||
160939445|NCT00306592|581170958|FG000|Overall Study|Noncompliance|0|||
160939446|NCT00306592|581170959|FG001|Overall Study|Noncompliance|2|||
160939447|NCT00306592|581170958|FG000|Overall Study|Persistent Antibodies|6|||
160939448|NCT00306592|581170959|FG001|Overall Study|Persistent Antibodies|3|||
160939449|NCT00306592|581170958|FG000|Overall Study|Voluntary|10|||
160939450|NCT00306592|581170959|FG001|Overall Study|Voluntary|6|||
160939451|NCT00306592|581170958|FG000|Overall Study|Other|5|||
160939452|NCT00306592|581170959|FG001|Overall Study|Other|10|||
160939453|NCT00306592|581170958|FG000|Overall Study|Other|1|||
160939454|NCT00306592|581170959|FG001|Overall Study|Other|2|||
160939455|NCT00306592|581170958|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
160939456|NCT00306592|581170959|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
160939457|NCT00456092|581170961|FG000|Extension Phase|Grade 2 or Greater AE|2|||
160939458|NCT00456092|581170962|FG001|Extension Phase|Grade 2 or Greater AE|2|||
160939459|NCT00456092|581170963|FG002|Extension Phase|Grade 2 or Greater AE|0|||
160939460|NCT00456092|581170964|FG003|Extension Phase|Grade 2 or Greater AE|0|||
160939461|NCT00456092|581170965|FG004|Extension Phase|Grade 2 or Greater AE|2|||
160939462|NCT00456092|581170961|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
160939463|NCT00456092|581170962|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
160939464|NCT00456092|581170963|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
160939465|NCT00456092|581170964|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
160939466|NCT00456092|581170965|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
160939467|NCT00456092|581170961|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
160939468|NCT00456092|581170962|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
160939469|NCT00456092|581170963|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
160939470|NCT00456092|581170964|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
160939471|NCT00456092|581170965|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
160939472|NCT00456092|581170961|FG000|Extension Phase|Withdrew Consent|2|||
160939473|NCT00456092|581170962|FG001|Extension Phase|Withdrew Consent|0|||
160939474|NCT00456092|581170963|FG002|Extension Phase|Withdrew Consent|0|||
160939475|NCT00456092|581170964|FG003|Extension Phase|Withdrew Consent|0|||
160939476|NCT00456092|581170965|FG004|Extension Phase|Withdrew Consent|0|||
160939477|NCT00456092|581170961|FG000|Extension Phase|Lost to Follow-up|1|||
160939478|NCT00456092|581170962|FG001|Extension Phase|Lost to Follow-up|1|||
160939479|NCT00456092|581170963|FG002|Extension Phase|Lost to Follow-up|0|||
160939480|NCT00456092|581170964|FG003|Extension Phase|Lost to Follow-up|0|||
160939481|NCT00456092|581170965|FG004|Extension Phase|Lost to Follow-up|1|||
160939482|NCT00456092|581170961|FG000|Extension Phase|Other|2|||
160939483|NCT00456092|581170962|FG001|Extension Phase|Other|0|||
160939484|NCT00456092|581170963|FG002|Extension Phase|Other|0|||
160939485|NCT00456092|581170964|FG003|Extension Phase|Other|1|||
160939486|NCT00456092|581170965|FG004|Extension Phase|Other|1|||
160939487|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
160939488|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
160939489|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
160939490|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
160939491|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
160939492|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
160939493|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
160939494|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
160939495|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
160939496|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
160939497|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
160939498|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939499|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939500|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939501|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
160939502|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
160939503|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
160939504|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
160939505|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
160939506|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
160939507|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
160939508|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
160939509|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
160939510|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
160939511|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
160939512|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
160939513|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
160939514|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
160998777|NCT01235949|581380610|FG008|Booster Phase|Lost to Follow-up|1|||
160998778|NCT01235949|581380611|FG009|Booster Phase|Lost to Follow-up|1|||
160998779|NCT01235949|581380612|FG010|Booster Phase|Lost to Follow-up|1|||
160939515|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
160998780|NCT01235949|581380613|FG011|Booster Phase|Lost to Follow-up|1|||
160998781|NCT01235949|581380614|FG012|Booster Phase|Lost to Follow-up|0|||
161264753|NCT00136318|582350758|FG000|Overall Study|Withdrawal by Subject|2|||
160939516|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
160939517|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
160939518|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
160939519|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
160939520|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
160939521|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
160939522|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160939523|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160939524|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
160939525|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160939526|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
160939527|NCT00456092|581170961|FG000|Treatment Phase (12 Weeks)|Other|1|||
160939528|NCT00456092|581170962|FG001|Treatment Phase (12 Weeks)|Other|0|||
160939529|NCT00456092|581170963|FG002|Treatment Phase (12 Weeks)|Other|1|||
160939530|NCT00456092|581170964|FG003|Treatment Phase (12 Weeks)|Other|0|||
160939531|NCT00456092|581170965|FG004|Treatment Phase (12 Weeks)|Other|0|||
160939532|NCT01252290|581170970|FG000|Overall Study|Withdrawal by Subject|1|||
160939533|NCT02247349|581170971|FG000|Overall Study|Disease Progression|7|||
160939534|NCT02247349|581170972|FG001|Overall Study|Disease Progression|4|||
160939535|NCT02247349|581170973|FG002|Overall Study|Disease Progression|26|||
160939536|NCT02247349|581170974|FG003|Overall Study|Disease Progression|31|||
160939537|NCT02247349|581170975|FG004|Overall Study|Disease Progression|16|||
160939538|NCT02247349|581170976|FG005|Overall Study|Disease Progression|6|||
160939539|NCT02247349|581170971|FG000|Overall Study|Study drug toxicity|0|||
160939540|NCT02247349|581170972|FG001|Overall Study|Study drug toxicity|1|||
160939541|NCT02247349|581170973|FG002|Overall Study|Study drug toxicity|1|||
161264754|NCT00136318|582350759|FG001|Overall Study|Withdrawal by Subject|2|||
161264755|NCT02005887|582350760|FG000|Overall Study|Protocol Violation|0|||
161264756|NCT02005887|582350761|FG001|Overall Study|Protocol Violation|2|||
161264757|NCT01615263|582350762|FG000|Overall Study|Post-randomization exclusion|0|||
161264758|NCT01615263|582350763|FG001|Overall Study|Post-randomization exclusion|2|||
161264759|NCT00160641|582350766|FG000|Overall Study|Adverse Event|102|||
160939542|NCT02247349|581170974|FG003|Overall Study|Study drug toxicity|1|||
160939543|NCT02247349|581170975|FG004|Overall Study|Study drug toxicity|2|||
160939544|NCT02247349|581170976|FG005|Overall Study|Study drug toxicity|2|||
160939545|NCT02247349|581170971|FG000|Overall Study|Death|0|||
160939546|NCT02247349|581170972|FG001|Overall Study|Death|0|||
160939547|NCT02247349|581170973|FG002|Overall Study|Death|0|||
160939548|NCT02247349|581170974|FG003|Overall Study|Death|1|||
160939549|NCT02247349|581170975|FG004|Overall Study|Death|0|||
160939550|NCT02247349|581170976|FG005|Overall Study|Death|0|||
160939551|NCT02247349|581170971|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
160939552|NCT02247349|581170972|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
160939553|NCT02247349|581170973|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
160939554|NCT02247349|581170974|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
160939555|NCT02247349|581170975|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
160939556|NCT02247349|581170976|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
160939557|NCT02247349|581170971|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160939558|NCT02247349|581170972|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160939559|NCT02247349|581170973|FG002|Overall Study|Participant request to discontinue study treatment|1|||
160939560|NCT02247349|581170974|FG003|Overall Study|Participant request to discontinue study treatment|2|||
160939561|NCT02247349|581170975|FG004|Overall Study|Participant request to discontinue study treatment|1|||
160939562|NCT02247349|581170976|FG005|Overall Study|Participant request to discontinue study treatment|0|||
160939563|NCT02247349|581170971|FG000|Overall Study|Withdrawal by Subject|0|||
160939564|NCT02247349|581170972|FG001|Overall Study|Withdrawal by Subject|1|||
160939565|NCT02247349|581170973|FG002|Overall Study|Withdrawal by Subject|0|||
160939566|NCT02247349|581170974|FG003|Overall Study|Withdrawal by Subject|0|||
160939567|NCT02247349|581170975|FG004|Overall Study|Withdrawal by Subject|0|||
160939568|NCT02247349|581170976|FG005|Overall Study|Withdrawal by Subject|0|||
160939569|NCT02247349|581170971|FG000|Overall Study|Administrative reason by sponsor|0|||
160939570|NCT02247349|581170972|FG001|Overall Study|Administrative reason by sponsor|0|||
160939571|NCT02247349|581170973|FG002|Overall Study|Administrative reason by sponsor|0|||
160939572|NCT02247349|581170974|FG003|Overall Study|Administrative reason by sponsor|0|||
160939573|NCT02247349|581170975|FG004|Overall Study|Administrative reason by sponsor|1|||
160939574|NCT02247349|581170976|FG005|Overall Study|Administrative reason by sponsor|0|||
160939575|NCT02247349|581170971|FG000|Overall Study|Other reasons|0|||
160939576|NCT02247349|581170972|FG001|Overall Study|Other reasons|0|||
160939577|NCT02247349|581170973|FG002|Overall Study|Other reasons|1|||
160939578|NCT02247349|581170974|FG003|Overall Study|Other reasons|0|||
160939579|NCT02247349|581170975|FG004|Overall Study|Other reasons|0|||
160939580|NCT02247349|581170976|FG005|Overall Study|Other reasons|0|||
160939581|NCT03049813|581170977|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
160939582|NCT03049813|581170978|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
160939583|NCT03049813|581170979|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
160939584|NCT03049813|581170980|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
160939585|NCT03049813|581170977|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
160939586|NCT03049813|581170978|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
160939587|NCT03049813|581170979|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
160939588|NCT03049813|581170980|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
160939589|NCT03049813|581170977|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
160939590|NCT03049813|581170978|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
160939591|NCT03049813|581170979|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
160939592|NCT03049813|581170980|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
160939593|NCT03049813|581170977|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
160939594|NCT03049813|581170978|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
160939595|NCT03049813|581170979|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
160939596|NCT03049813|581170980|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
160939597|NCT00382733|581170981|FG000|Overall Study|Withdrawal by Subject|0|||
160939598|NCT00382733|581170982|FG001|Overall Study|Withdrawal by Subject|1|||
160939599|NCT00382733|581170983|FG002|Overall Study|Withdrawal by Subject|0|||
160939600|NCT00382733|581170984|FG003|Overall Study|Withdrawal by Subject|0|||
160939601|NCT00382733|581170985|FG004|Overall Study|Withdrawal by Subject|0|||
160939602|NCT00179413|581170986|FG000|Overall Study|Adverse Event|38|||
160939603|NCT00179413|581170987|FG001|Overall Study|Adverse Event|20|||
160939604|NCT00179413|581170986|FG000|Overall Study|Withdrawal by Subject|87|||
160939605|NCT00179413|581170987|FG001|Overall Study|Withdrawal by Subject|95|||
160939606|NCT00439140|581170990|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
160939607|NCT00439140|581170991|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
160939608|NCT00439140|581170992|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
160939609|NCT00439140|581170990|FG000|Treatment Cycle 1|Personal reasons|0|||
160939610|NCT00439140|581170991|FG001|Treatment Cycle 1|Personal reasons|2|||
160939611|NCT00439140|581170992|FG002|Treatment Cycle 1|Personal reasons|0|||
160939612|NCT00439140|581170990|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
160939613|NCT00439140|581170991|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
160939614|NCT00439140|581170992|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
160939615|NCT00439140|581170990|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
160939616|NCT00439140|581170991|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
160939617|NCT00439140|581170992|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
160939618|NCT00439140|581170990|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
160939619|NCT00439140|581170991|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
160939620|NCT00439140|581170992|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
160939621|NCT01339390|581170995|FG000|Overall Study|Death|32|||
160939622|NCT01339390|581170996|FG001|Overall Study|Death|29|||
160939623|NCT01339390|581170995|FG000|Overall Study|Lost to Follow-up|125|||
160939624|NCT01339390|581170996|FG001|Overall Study|Lost to Follow-up|127|||
160939625|NCT00378703|581170997|FG000|Overall Study|Disease progression|59|||
160939626|NCT00378703|581170998|FG001|Overall Study|Disease progression|43|||
160939627|NCT00378703|581170999|FG002|Overall Study|Disease progression|48|||
160939628|NCT00378703|581171000|FG003|Overall Study|Disease progression|49|||
160939629|NCT00378703|581170997|FG000|Overall Study|Adverse Event|11|||
160939630|NCT00378703|581170998|FG001|Overall Study|Adverse Event|17|||
160939631|NCT00378703|581170999|FG002|Overall Study|Adverse Event|20|||
160939632|NCT00378703|581171000|FG003|Overall Study|Adverse Event|18|||
160939633|NCT00378703|581170997|FG000|Overall Study|Death|2|||
160939634|NCT00378703|581170998|FG001|Overall Study|Death|2|||
160939635|NCT00378703|581170999|FG002|Overall Study|Death|4|||
160939636|NCT00378703|581171000|FG003|Overall Study|Death|3|||
160939637|NCT00378703|581170997|FG000|Overall Study|Withdrawal by Subject|4|||
160939638|NCT00378703|581170998|FG001|Overall Study|Withdrawal by Subject|8|||
160939639|NCT00378703|581170999|FG002|Overall Study|Withdrawal by Subject|5|||
160939640|NCT00378703|581171000|FG003|Overall Study|Withdrawal by Subject|7|||
160939641|NCT00378703|581170997|FG000|Overall Study|Physician Decision|1|||
161264760|NCT00160641|582350766|FG000|Overall Study|Withdrawal by Subject|87|||
160939642|NCT00378703|581170998|FG001|Overall Study|Physician Decision|4|||
160939643|NCT00378703|581170999|FG002|Overall Study|Physician Decision|1|||
160939644|NCT00378703|581171000|FG003|Overall Study|Physician Decision|0|||
160939645|NCT00378703|581170997|FG000|Overall Study|Alternative therapy|4|||
160939646|NCT00378703|581170998|FG001|Overall Study|Alternative therapy|2|||
160939647|NCT00378703|581170999|FG002|Overall Study|Alternative therapy|0|||
160939648|NCT00378703|581171000|FG003|Overall Study|Alternative therapy|0|||
160939649|NCT00378703|581170997|FG000|Overall Study|Other complicated disease|0|||
160939650|NCT00378703|581170998|FG001|Overall Study|Other complicated disease|2|||
160939651|NCT00378703|581170999|FG002|Overall Study|Other complicated disease|2|||
160939652|NCT00378703|581171000|FG003|Overall Study|Other complicated disease|0|||
161264761|NCT00160641|582350766|FG000|Overall Study|Lost to Follow-up|8|||
160939653|NCT00378703|581170997|FG000|Overall Study|Symptomatic deterioration|0|||
160939654|NCT00378703|581170998|FG001|Overall Study|Symptomatic deterioration|1|||
161264762|NCT00160641|582350766|FG000|Overall Study|Lack of Efficacy|12|||
161144229|NCT00491530|581911914|FG002|Overall Study|Patient Request|0|||
161144230|NCT00491530|581911912|FG000|Overall Study|Use of Prohibited Medication|0|||
161144231|NCT00491530|581911913|FG001|Overall Study|Use of Prohibited Medication|0|||
161144232|NCT00491530|581911914|FG002|Overall Study|Use of Prohibited Medication|1|||
161144233|NCT01856673|581911915|FG000|Overall Study|Withdrawal by Subject|44|||
161144234|NCT01856673|581911916|FG001|Overall Study|Withdrawal by Subject|50|||
161144235|NCT01856673|581911917|FG002|Overall Study|Withdrawal by Subject|33|||
161144236|NCT01856673|581911915|FG000|Overall Study|Lost to Follow-up|31|||
161144237|NCT01856673|581911916|FG001|Overall Study|Lost to Follow-up|34|||
160939655|NCT00378703|581170999|FG002|Overall Study|Symptomatic deterioration|0|||
160939656|NCT00378703|581171000|FG003|Overall Study|Symptomatic deterioration|2|||
160939657|NCT00378703|581170997|FG000|Overall Study|Surgery|1|||
160939658|NCT00378703|581170998|FG001|Overall Study|Surgery|0|||
160939659|NCT00378703|581170999|FG002|Overall Study|Surgery|0|||
160939660|NCT00378703|581171000|FG003|Overall Study|Surgery|1|||
160939661|NCT00378703|581170997|FG000|Overall Study|Joint decision of physician and patient|1|||
160939662|NCT00378703|581170998|FG001|Overall Study|Joint decision of physician and patient|0|||
160939663|NCT00378703|581170999|FG002|Overall Study|Joint decision of physician and patient|0|||
160939664|NCT00378703|581171000|FG003|Overall Study|Joint decision of physician and patient|0|||
160939665|NCT00378703|581170997|FG000|Overall Study|Adverse events and progressive disease|0|||
160939666|NCT00378703|581170998|FG001|Overall Study|Adverse events and progressive disease|0|||
160939667|NCT00378703|581170999|FG002|Overall Study|Adverse events and progressive disease|0|||
160939668|NCT00378703|581171000|FG003|Overall Study|Adverse events and progressive disease|1|||
160939669|NCT00378703|581170997|FG000|Overall Study|Relocation|0|||
160939670|NCT00378703|581170998|FG001|Overall Study|Relocation|0|||
160939671|NCT00378703|581170999|FG002|Overall Study|Relocation|1|||
160939672|NCT00378703|581171000|FG003|Overall Study|Relocation|0|||
160939673|NCT00378703|581170997|FG000|Overall Study|Ineligible|4|||
160939674|NCT00378703|581170998|FG001|Overall Study|Ineligible|7|||
160939675|NCT00378703|581170999|FG002|Overall Study|Ineligible|7|||
160939676|NCT00378703|581171000|FG003|Overall Study|Ineligible|7|||
160939677|NCT00378703|581170997|FG000|Overall Study|Never started treatment|1|||
160939678|NCT00378703|581170998|FG001|Overall Study|Never started treatment|4|||
160939679|NCT00378703|581170999|FG002|Overall Study|Never started treatment|0|||
160939680|NCT00378703|581171000|FG003|Overall Study|Never started treatment|0|||
160939681|NCT00378703|581170997|FG000|Overall Study|Other|1|||
160939682|NCT00378703|581170998|FG001|Overall Study|Other|1|||
160939683|NCT00378703|581170999|FG002|Overall Study|Other|2|||
160939684|NCT00378703|581171000|FG003|Overall Study|Other|3|||
160939685|NCT03181542|581171003|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
160939686|NCT03181542|581171004|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
160939687|NCT04292730|581171012|FG000|Overall Study|Lost to Follow-up|8|||
160939688|NCT04292730|581171013|FG001|Overall Study|Lost to Follow-up|12|||
160939689|NCT04292730|581171014|FG002|Overall Study|Lost to Follow-up|12|||
160939690|NCT04292730|581171015|FG003|Overall Study|Lost to Follow-up|48|||
160939691|NCT04292730|581171012|FG000|Overall Study|Death|2|||
160939692|NCT04292730|581171013|FG001|Overall Study|Death|2|||
160939693|NCT04292730|581171014|FG002|Overall Study|Death|4|||
160939694|NCT04292730|581171015|FG003|Overall Study|Death|12|||
160939695|NCT04292730|581171012|FG000|Overall Study|Withdrew Consent|2|||
160939696|NCT04292730|581171013|FG001|Overall Study|Withdrew Consent|2|||
161144238|NCT01856673|581911917|FG002|Overall Study|Lost to Follow-up|0|||
161144239|NCT01856673|581911915|FG000|Overall Study|Unknown reasons|9|||
161144240|NCT01856673|581911916|FG001|Overall Study|Unknown reasons|0|||
161144241|NCT01856673|581911917|FG002|Overall Study|Unknown reasons|0|||
160939697|NCT04292730|581171014|FG002|Overall Study|Withdrew Consent|5|||
160939698|NCT04292730|581171015|FG003|Overall Study|Withdrew Consent|6|||
160939699|NCT04292730|581171012|FG000|Overall Study|Non-Compliance with Study Drug|0|||
160939700|NCT04292730|581171013|FG001|Overall Study|Non-Compliance with Study Drug|1|||
160939701|NCT04292730|581171014|FG002|Overall Study|Non-Compliance with Study Drug|0|||
160939702|NCT04292730|581171015|FG003|Overall Study|Non-Compliance with Study Drug|0|||
160939703|NCT04292730|581171012|FG000|Overall Study|Protocol Violation|0|||
160939704|NCT04292730|581171013|FG001|Overall Study|Protocol Violation|0|||
160939705|NCT04292730|581171014|FG002|Overall Study|Protocol Violation|1|||
160939706|NCT04292730|581171015|FG003|Overall Study|Protocol Violation|0|||
160939707|NCT04292730|581171012|FG000|Overall Study|Randomized but not Treated|8|||
160939708|NCT04292730|581171013|FG001|Overall Study|Randomized but not Treated|4|||
160939709|NCT04292730|581171014|FG002|Overall Study|Randomized but not Treated|0|||
160939710|NCT04292730|581171015|FG003|Overall Study|Randomized but not Treated|14|||
160939711|NCT01482767|581171019|FG000|Overall Study|Death|1|||
161144242|NCT01856673|581911915|FG000|Overall Study|Psychologist decision|1|||
161144243|NCT01856673|581911916|FG001|Overall Study|Psychologist decision|0|||
161264763|NCT00160641|582350766|FG000|Overall Study|Protocol Violation|3|||
160939712|NCT01482767|581171020|FG001|Overall Study|Death|1|||
160939713|NCT01482767|581171019|FG000|Overall Study|Withdrawal by Subject|7|||
160939714|NCT01482767|581171020|FG001|Overall Study|Withdrawal by Subject|5|||
161144244|NCT01856673|581911917|FG002|Overall Study|Psychologist decision|0|||
160939715|NCT01482767|581171019|FG000|Overall Study|Lost to Follow-up|12|||
160939716|NCT01482767|581171020|FG001|Overall Study|Lost to Follow-up|6|||
160939717|NCT01482767|581171019|FG000|Overall Study|Adverse Event|0|||
160939718|NCT01482767|581171020|FG001|Overall Study|Adverse Event|3|||
160939719|NCT01482767|581171019|FG000|Overall Study|Site closure|22|||
160939720|NCT01482767|581171020|FG001|Overall Study|Site closure|14|||
160939721|NCT01482767|581171019|FG000|Overall Study|Non-adherence to study requirements|4|||
160939722|NCT01482767|581171020|FG001|Overall Study|Non-adherence to study requirements|7|||
160939723|NCT01482767|581171019|FG000|Overall Study|Alternate HCV treatment|7|||
160939724|NCT01482767|581171020|FG001|Overall Study|Alternate HCV treatment|8|||
160939725|NCT01482767|581171019|FG000|Overall Study|Ineligible|0|||
160939726|NCT01482767|581171020|FG001|Overall Study|Ineligible|5|||
160939727|NCT01482767|581171019|FG000|Overall Study|Nurse error|1|||
160939728|NCT01482767|581171020|FG001|Overall Study|Nurse error|0|||
160939729|NCT03400033|581171030|FG000|Overall Study|Withdrawal by Subject|1|||
160939730|NCT03400033|581171031|FG001|Overall Study|Withdrawal by Subject|2|||
160939731|NCT00806546|581171034|FG000|Overall Study|Enrolled, not treated|35|||
160939732|NCT00806546|581171034|FG000|Overall Study|Lost to Follow-up|32|||
160939733|NCT00806546|581171034|FG000|Overall Study|Adverse Event|74|||
160939734|NCT00806546|581171034|FG000|Overall Study|Withdrawal by Subject|75|||
160939735|NCT00806546|581171034|FG000|Overall Study|Protocol Violation|49|||
160939736|NCT00806546|581171034|FG000|Overall Study|Various|42|||
160939737|NCT01247090|581171035|FG000|Overall Study|Physician Decision|1|||
160939738|NCT01247090|581171036|FG001|Overall Study|Physician Decision|0|||
160939739|NCT01247090|581171037|FG002|Overall Study|Physician Decision|0|||
160939740|NCT01247090|581171035|FG000|Overall Study|Withdrawal by Subject|0|||
160939741|NCT01247090|581171036|FG001|Overall Study|Withdrawal by Subject|1|||
160939742|NCT01247090|581171037|FG002|Overall Study|Withdrawal by Subject|0|||
160939743|NCT00006916|581171039|FG000|Overall Study|Device not inserted|4|||
160939744|NCT00006916|581171039|FG000|Overall Study|Complication of device insertion|1|||
160939745|NCT00558103|581171040|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
160939746|NCT00558103|581171041|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
160939747|NCT00558103|581171042|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
160939748|NCT00558103|581171043|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
160939749|NCT00558103|581171044|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
160939750|NCT00558103|581171045|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
160939751|NCT00558103|581171040|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
160939752|NCT00558103|581171041|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
160939753|NCT00558103|581171042|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
160939754|NCT00558103|581171043|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
160939755|NCT00558103|581171044|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
160939756|NCT00558103|581171045|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
160939757|NCT00558103|581171040|FG000|Randomized Treatment Phase|Disease Progression|1|||
160939758|NCT00558103|581171041|FG001|Randomized Treatment Phase|Disease Progression|0|||
160939759|NCT00558103|581171042|FG002|Randomized Treatment Phase|Disease Progression|1|||
160939760|NCT00558103|581171043|FG003|Randomized Treatment Phase|Disease Progression|0|||
160939761|NCT00558103|581171044|FG004|Randomized Treatment Phase|Disease Progression|0|||
160939762|NCT00558103|581171045|FG005|Randomized Treatment Phase|Disease Progression|0|||
160939763|NCT00558103|581171040|FG000|Randomized Treatment Phase|Adverse Event|0|||
160939764|NCT00558103|581171041|FG001|Randomized Treatment Phase|Adverse Event|0|||
160939765|NCT00558103|581171042|FG002|Randomized Treatment Phase|Adverse Event|0|||
160939766|NCT00558103|581171043|FG003|Randomized Treatment Phase|Adverse Event|1|||
160939767|NCT00558103|581171044|FG004|Randomized Treatment Phase|Adverse Event|1|||
161144245|NCT01856673|581911915|FG000|Overall Study|Paperwork errors|8|||
161144246|NCT01856673|581911916|FG001|Overall Study|Paperwork errors|0|||
161144247|NCT01856673|581911917|FG002|Overall Study|Paperwork errors|0|||
161144248|NCT01856673|581911915|FG000|Overall Study|Death|1|||
160939768|NCT00558103|581171045|FG005|Randomized Treatment Phase|Adverse Event|0|||
160939769|NCT00558103|581171040|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
160939770|NCT00558103|581171041|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
160939771|NCT00558103|581171042|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
160939772|NCT00558103|581171043|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
160939773|NCT00558103|581171044|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
160939774|NCT00558103|581171045|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
160939775|NCT00558103|581171040|FG000|Monotherapy Extension Phase|Disease Progression|0|||
160939776|NCT00558103|581171041|FG001|Monotherapy Extension Phase|Disease Progression|0|||
160939777|NCT00558103|581171042|FG002|Monotherapy Extension Phase|Disease Progression|0|||
160939778|NCT00558103|581171043|FG003|Monotherapy Extension Phase|Disease Progression|0|||
160939779|NCT00558103|581171044|FG004|Monotherapy Extension Phase|Disease Progression|0|||
160939780|NCT00558103|581171045|FG005|Monotherapy Extension Phase|Disease Progression|8|||
160939781|NCT02457325|581171056|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
160939782|NCT02457325|581171057|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
160939783|NCT01541930|581171058|FG000|Overall Study|Withdrawal by Subject|1|||
160939784|NCT03385239|581171059|FG000|Overall Study|Voluntary Withdrawal|2|||
161144249|NCT01856673|581911916|FG001|Overall Study|Death|1|||
160939785|NCT03385239|581171060|FG001|Overall Study|Voluntary Withdrawal|3|||
160939786|NCT03385239|581171061|FG002|Overall Study|Voluntary Withdrawal|2|||
160939787|NCT03385239|581171062|FG003|Overall Study|Voluntary Withdrawal|3|||
160939788|NCT03385239|581171063|FG004|Overall Study|Voluntary Withdrawal|0|||
160939789|NCT03385239|581171059|FG000|Overall Study|Adverse Event|0|||
160939790|NCT03385239|581171060|FG001|Overall Study|Adverse Event|0|||
160939791|NCT03385239|581171061|FG002|Overall Study|Adverse Event|1|||
160939792|NCT03385239|581171062|FG003|Overall Study|Adverse Event|0|||
160939793|NCT03385239|581171063|FG004|Overall Study|Adverse Event|0|||
160939794|NCT03385239|581171059|FG000|Overall Study|Other|0|||
160939795|NCT03385239|581171060|FG001|Overall Study|Other|0|||
161144250|NCT01856673|581911917|FG002|Overall Study|Death|0|||
161144251|NCT01856673|581911915|FG000|Overall Study|Protocol Violation|1|||
161144252|NCT01856673|581911916|FG001|Overall Study|Protocol Violation|0|||
161144253|NCT01856673|581911917|FG002|Overall Study|Protocol Violation|1|||
161144254|NCT00196937|581911926|FG000|Overall Study|Serious Adverse Event|1|||
161144255|NCT00196937|581911927|FG001|Overall Study|Serious Adverse Event|0|||
161144256|NCT00196937|581911928|FG002|Overall Study|Serious Adverse Event|0|||
160939796|NCT03385239|581171061|FG002|Overall Study|Other|0|||
160939797|NCT03385239|581171062|FG003|Overall Study|Other|1|||
160939798|NCT03385239|581171063|FG004|Overall Study|Other|0|||
160939799|NCT01574703|581171064|FG000|Overall Study|Adverse Event|0|||
160939800|NCT01574703|581171065|FG001|Overall Study|Adverse Event|2|||
160939801|NCT01574703|581171066|FG002|Overall Study|Adverse Event|1|||
160939802|NCT01574703|581171067|FG003|Overall Study|Adverse Event|1|||
160939803|NCT01574703|581171064|FG000|Overall Study|Protocol Violation|0|||
160939804|NCT01574703|581171065|FG001|Overall Study|Protocol Violation|0|||
160939805|NCT01574703|581171066|FG002|Overall Study|Protocol Violation|0|||
161144257|NCT00196937|581911926|FG000|Overall Study|Non-serious adverse event|1|||
161144258|NCT00196937|581911927|FG001|Overall Study|Non-serious adverse event|1|||
161144259|NCT00196937|581911928|FG002|Overall Study|Non-serious adverse event|1|||
161144260|NCT00196937|581911926|FG000|Overall Study|Withdrawal by Subject|0|||
161144261|NCT00196937|581911927|FG001|Overall Study|Withdrawal by Subject|0|||
161144262|NCT00196937|581911928|FG002|Overall Study|Withdrawal by Subject|2|||
161144263|NCT00196937|581911926|FG000|Overall Study|Lost to Follow-up|4|||
161144264|NCT00196937|581911927|FG001|Overall Study|Lost to Follow-up|3|||
161144265|NCT00196937|581911928|FG002|Overall Study|Lost to Follow-up|3|||
161144266|NCT00196937|581911926|FG000|Overall Study|Other|3|||
161144267|NCT00196937|581911927|FG001|Overall Study|Other|1|||
161144268|NCT00196937|581911928|FG002|Overall Study|Other|1|||
161144269|NCT03368404|581911935|FG000|Overall Study|Adverse Event|2|||
161144270|NCT03368404|581911936|FG001|Overall Study|Adverse Event|1|||
161144271|NCT03368404|581911935|FG000|Overall Study|Withdrawal by Subject|1|||
161144272|NCT03368404|581911936|FG001|Overall Study|Withdrawal by Subject|1|||
161144273|NCT04725682|581911937|FG000|Overall Study|Withdrawal by Subject|7|||
161144274|NCT04725682|581911938|FG001|Overall Study|Withdrawal by Subject|5|||
161144275|NCT04725682|581911937|FG000|Overall Study|Failed to comply with the requirements|2|||
161144276|NCT04725682|581911938|FG001|Overall Study|Failed to comply with the requirements|1|||
161144277|NCT04725682|581911937|FG000|Overall Study|Adverse Event|1|||
161144278|NCT04725682|581911938|FG001|Overall Study|Adverse Event|1|||
161144279|NCT04725682|581911937|FG000|Overall Study|Death|0|||
161144280|NCT04725682|581911938|FG001|Overall Study|Death|1|||
161144281|NCT00964795|581911939|FG000|Overall Study|Withdrawal by Subject|79|||
161144282|NCT00964795|581911939|FG000|Overall Study|Adverse Event|12|||
161144283|NCT00964795|581911939|FG000|Overall Study|Death|14|||
161144284|NCT00964795|581911939|FG000|Overall Study|Lost to Follow-up|7|||
161144285|NCT00964795|581911939|FG000|Overall Study|Termination of Study by Sponsor|169|||
161144286|NCT00964795|581911939|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
160939806|NCT01574703|581171067|FG003|Overall Study|Protocol Violation|1|||
160939807|NCT01574703|581171064|FG000|Overall Study|Unspecified Reason|27|||
160939808|NCT01574703|581171065|FG001|Overall Study|Unspecified Reason|15|||
160939809|NCT01574703|581171066|FG002|Overall Study|Unspecified Reason|20|||
160939810|NCT01574703|581171067|FG003|Overall Study|Unspecified Reason|16|||
161264764|NCT00160641|582350766|FG000|Overall Study|Other|9|||
161264765|NCT00985712|582350768|FG000|Overall Study|Adverse Event|0|||
161264766|NCT00985712|582350769|FG001|Overall Study|Adverse Event|1|||
160939811|NCT01574703|581171064|FG000|Overall Study|Withdrawal by Subject|53|||
160939812|NCT01574703|581171065|FG001|Overall Study|Withdrawal by Subject|52|||
161264767|NCT00985712|582350768|FG000|Overall Study|Lost to Follow-up|2|||
160939813|NCT01574703|581171066|FG002|Overall Study|Withdrawal by Subject|36|||
160939814|NCT01574703|581171067|FG003|Overall Study|Withdrawal by Subject|61|||
160939815|NCT01574703|581171064|FG000|Overall Study|Met Withdrawal Criteria|0|||
160939816|NCT01574703|581171065|FG001|Overall Study|Met Withdrawal Criteria|1|||
161144287|NCT00964795|581911939|FG000|Overall Study|Other|23|||
161144288|NCT02453841|581911947|FG000|Overall Study|Protocol Violation|1|||
161144289|NCT02453841|581911947|FG000|Overall Study|Unable to obtain blood samples|2|||
161144290|NCT00586690|581911948|FG000|Overall Study|Death|2|||
161144291|NCT00586690|581911949|FG001|Overall Study|Death|0|||
161144292|NCT00586690|581911948|FG000|Overall Study|Disease Progression|10|||
161264768|NCT00985712|582350769|FG001|Overall Study|Lost to Follow-up|2|||
160939817|NCT01574703|581171066|FG002|Overall Study|Met Withdrawal Criteria|1|||
160939818|NCT01574703|581171067|FG003|Overall Study|Met Withdrawal Criteria|0|||
160939819|NCT01574703|581171064|FG000|Overall Study|Lost to Follow-up|43|||
160939820|NCT01574703|581171065|FG001|Overall Study|Lost to Follow-up|41|||
160939821|NCT01574703|581171066|FG002|Overall Study|Lost to Follow-up|46|||
160939822|NCT01574703|581171067|FG003|Overall Study|Lost to Follow-up|35|||
160939823|NCT01574703|581171064|FG000|Overall Study|Death|2|||
160939824|NCT01574703|581171065|FG001|Overall Study|Death|1|||
160939825|NCT01574703|581171066|FG002|Overall Study|Death|1|||
160939826|NCT01574703|581171067|FG003|Overall Study|Death|0|||
160939827|NCT02751983|581171073|FG000|Treatment|Stopped ACT, but Remained in study|2|||
160939828|NCT02751983|581171074|FG001|Treatment|Stopped ACT, but Remained in study|0|||
160939829|NCT02751983|581171073|FG000|Treatment|Discharged prior to beginning ACT|2|||
160939830|NCT02751983|581171074|FG001|Treatment|Discharged prior to beginning ACT|0|||
160939831|NCT02751983|581171073|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
160939832|NCT02751983|581171074|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
160939833|NCT02751983|581171073|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
160939834|NCT02751983|581171074|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
160939835|NCT02751983|581171073|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
160939836|NCT02751983|581171074|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
160939837|NCT00308711|581171075|FG000|Overall Study|Withdrawal by Subject|1|||
160939838|NCT00308711|581171076|FG001|Overall Study|Withdrawal by Subject|0|||
160939839|NCT00308711|581171077|FG002|Overall Study|Withdrawal by Subject|1|||
160939840|NCT00308711|581171075|FG000|Overall Study|Protocol Violation|0|||
160939841|NCT00308711|581171076|FG001|Overall Study|Protocol Violation|1|||
160939842|NCT00308711|581171077|FG002|Overall Study|Protocol Violation|1|||
160939843|NCT00308711|581171075|FG000|Overall Study|Lost to Follow-up|0|||
160939844|NCT00308711|581171076|FG001|Overall Study|Lost to Follow-up|1|||
160939845|NCT00308711|581171077|FG002|Overall Study|Lost to Follow-up|0|||
160939846|NCT00308711|581171075|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
160939847|NCT00308711|581171076|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
160939848|NCT00308711|581171077|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
160939849|NCT00308711|581171075|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
160939850|NCT00308711|581171076|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
160939851|NCT00308711|581171077|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
160939852|NCT02167256|581171080|FG000|Overall Study|Adverse Event|13|||
160939853|NCT02167256|581171081|FG001|Overall Study|Adverse Event|6|||
160939854|NCT02167256|581171080|FG000|Overall Study|Withdrawal by Subject|4|||
160939855|NCT02167256|581171081|FG001|Overall Study|Withdrawal by Subject|4|||
160939856|NCT02167256|581171080|FG000|Overall Study|non-compliance|3|||
160939857|NCT02167256|581171081|FG001|Overall Study|non-compliance|0|||
160939858|NCT02167256|581171080|FG000|Overall Study|Study partner unable to participate|1|||
160939859|NCT02167256|581171081|FG001|Overall Study|Study partner unable to participate|0|||
160939860|NCT03139916|581171082|FG000|Overall Study|Withdrawal by Subject|2|||
160939861|NCT03139916|581171082|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
160939862|NCT01957475|581171083|FG000|Test Period 1|Withdrawal by Subject|1|||
160939863|NCT01957475|581171084|FG001|Test Period 1|Withdrawal by Subject|0|||
160939864|NCT01957475|581171083|FG000|Test Period 1|Other|1|||
160939865|NCT01957475|581171084|FG001|Test Period 1|Other|0|||
160939866|NCT01957475|581171083|FG000|Test Period 1|Lack of Efficacy|0|||
160939867|NCT01957475|581171084|FG001|Test Period 1|Lack of Efficacy|1|||
160939868|NCT01957475|581171083|FG000|Test Period 2|Adverse Event|1|||
160939869|NCT01957475|581171084|FG001|Test Period 2|Adverse Event|0|||
160939870|NCT00414388|581171085|FG000|Overall Study|Adverse Event|1|||
160939871|NCT03467425|581171086|FG000|Overall Study|Adverse Event|9|||
160939872|NCT03467425|581171087|FG001|Overall Study|Adverse Event|9|||
160939873|NCT03467425|581171086|FG000|Overall Study|Lack of Efficacy|3|||
160939874|NCT03467425|581171087|FG001|Overall Study|Lack of Efficacy|1|||
160939875|NCT03467425|581171086|FG000|Overall Study|Protocol Violation|0|||
160939876|NCT03467425|581171087|FG001|Overall Study|Protocol Violation|1|||
160939877|NCT03467425|581171086|FG000|Overall Study|Lost to Follow-up|18|||
160939878|NCT03467425|581171087|FG001|Overall Study|Lost to Follow-up|25|||
160939879|NCT03467425|581171086|FG000|Overall Study|Physician Decision|2|||
160939880|NCT03467425|581171087|FG001|Overall Study|Physician Decision|1|||
160939881|NCT03467425|581171086|FG000|Overall Study|Withdrawal by Subject|15|||
160939882|NCT03467425|581171087|FG001|Overall Study|Withdrawal by Subject|17|||
160939883|NCT02318693|581171088|FG000|Overall Study|Protocol Violation|0|||
160939884|NCT02318693|581171089|FG001|Overall Study|Protocol Violation|1|||
160939885|NCT00025883|581171092|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
160939886|NCT00025883|581171092|FG000|Overall Study|no baseline data|1|||
160939887|NCT00025883|581171092|FG000|Overall Study|Death|1|||
160939888|NCT00025883|581171092|FG000|Overall Study|Adverse Event|1|||
160939889|NCT00025883|581171092|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
160939890|NCT03591575|581171093|FG000|Overall Study|Adverse Event|2|||
160939891|NCT03591575|581171094|FG001|Overall Study|Adverse Event|0|||
160939892|NCT03591575|581171093|FG000|Overall Study|Withdrawal by Subject|4|||
161144293|NCT00586690|581911949|FG001|Overall Study|Disease Progression|0|||
161144294|NCT00586690|581911948|FG000|Overall Study|Adverse Event|1|||
161144295|NCT00586690|581911949|FG001|Overall Study|Adverse Event|0|||
161144296|NCT00586690|581911948|FG000|Overall Study|Lack of Efficacy|2|||
161144297|NCT00586690|581911949|FG001|Overall Study|Lack of Efficacy|0|||
161144298|NCT00586690|581911948|FG000|Overall Study|Lab can't accommodate|1|||
161144299|NCT00586690|581911949|FG001|Overall Study|Lab can't accommodate|0|||
161144300|NCT01751646|581911950|FG000|Overall Study|Lost to Follow-up|5|||
161144301|NCT01751646|581911951|FG001|Overall Study|Lost to Follow-up|1|||
161144302|NCT01751646|581911950|FG000|Overall Study|Withdrawal by Subject|0|||
161144303|NCT01751646|581911951|FG001|Overall Study|Withdrawal by Subject|4|||
161144304|NCT01751646|581911950|FG000|Overall Study|Starting hormone therapy|1|||
161144305|NCT01751646|581911951|FG001|Overall Study|Starting hormone therapy|0|||
161144306|NCT01751646|581911950|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
161144307|NCT01751646|581911951|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
161144308|NCT01751646|581911950|FG000|Overall Study|Inadvertent enrollment|1|||
161144309|NCT01751646|581911951|FG001|Overall Study|Inadvertent enrollment|1|||
161144310|NCT01751646|581911950|FG000|Overall Study|Moved out of the area|1|||
161144311|NCT01751646|581911951|FG001|Overall Study|Moved out of the area|5|||
161144312|NCT01751646|581911950|FG000|Overall Study|Inability to attend required visits|0|||
161144313|NCT01751646|581911951|FG001|Overall Study|Inability to attend required visits|1|||
161144314|NCT01751646|581911950|FG000|Overall Study|Off study due to multiple obligations|0|||
161144315|NCT01751646|581911951|FG001|Overall Study|Off study due to multiple obligations|1|||
161144316|NCT01751646|581911950|FG000|Overall Study|Fails to comply with study requirements|0|||
161144317|NCT01751646|581911951|FG001|Overall Study|Fails to comply with study requirements|1|||
161144318|NCT01751646|581911950|FG000|Overall Study|Childcare issues|1|||
161144319|NCT01751646|581911951|FG001|Overall Study|Childcare issues|1|||
161144320|NCT01151137|581911952|FG000|Overall Study|Death|15|||
161144321|NCT01151137|581911953|FG001|Overall Study|Death|27|||
161144322|NCT01151137|581911952|FG000|Overall Study|Lost to Follow-up|1|||
161144323|NCT01151137|581911953|FG001|Overall Study|Lost to Follow-up|1|||
161144324|NCT02973815|581911954|FG000|Post Intervention|Death|1|||
161264769|NCT00985712|582350768|FG000|Overall Study|Protocol Violation|0|||
161264770|NCT00985712|582350769|FG001|Overall Study|Protocol Violation|1|||
161264771|NCT00985712|582350768|FG000|Overall Study|Withdrawal by Subject|4|||
161264772|NCT00985712|582350769|FG001|Overall Study|Withdrawal by Subject|1|||
161264773|NCT00985712|582350768|FG000|Overall Study|Sponsor decision|0|||
161264774|NCT00985712|582350769|FG001|Overall Study|Sponsor decision|2|||
161264775|NCT04700280|582350770|FG000|Overall Study|Adverse Event|4|||
161264776|NCT04700280|582350771|FG001|Overall Study|Adverse Event|0|||
161264777|NCT04700280|582350770|FG000|Overall Study|Lack of Efficacy|1|||
161264778|NCT04700280|582350771|FG001|Overall Study|Lack of Efficacy|0|||
161264779|NCT04700280|582350770|FG000|Overall Study|Study terminated by sponsor|5|||
160939893|NCT03591575|581171094|FG001|Overall Study|Withdrawal by Subject|1|||
160939894|NCT00813358|581171095|FG000|Overall Study|Death|32|||
160939895|NCT00813358|581171095|FG000|Overall Study|Lost to Follow-up|12|||
160939896|NCT00813358|581171095|FG000|Overall Study|other endpoints|5|||
160939897|NCT00813358|581171095|FG000|Overall Study|Withdrawal by Subject|20|||
160939898|NCT00218543|581171096|FG000|Overall Study|Lost to Follow-up|8|||
160939899|NCT00218543|581171096|FG000|Overall Study|relocated|1|||
160939900|NCT00218543|581171096|FG000|Overall Study|Withdrawal by Subject|1|||
160939901|NCT00218543|581171096|FG000|Overall Study|Physician Decision|3|||
160939902|NCT00218543|581171096|FG000|Overall Study|Adverse Event|2|||
160939903|NCT03665038|581171097|FG000|Overall Study|Lost to Follow-up|0|||
160939904|NCT03665038|581171098|FG001|Overall Study|Lost to Follow-up|0|||
160939905|NCT03665038|581171099|FG002|Overall Study|Lost to Follow-up|1|||
160939906|NCT03013491|581171100|FG000|Main Study|Death|2|||
160939907|NCT03013491|581171101|FG001|Main Study|Death|2|||
160939908|NCT03013491|581171102|FG002|Main Study|Death|5|||
160939909|NCT03013491|581171103|FG003|Main Study|Death|3|||
161264780|NCT04700280|582350771|FG001|Overall Study|Study terminated by sponsor|3|||
161264781|NCT04700280|582350770|FG000|Overall Study|Other than specified|1|||
161264782|NCT04700280|582350771|FG001|Overall Study|Other than specified|0|||
160939910|NCT03013491|581171104|FG004|Main Study|Death|9|||
160939911|NCT03013491|581171105|FG005|Main Study|Death|12|||
160939912|NCT03013491|581171106|FG006|Main Study|Death|3|||
161264783|NCT00257920|582350772|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
160939913|NCT03013491|581171107|FG007|Main Study|Death|5|||
160939914|NCT03013491|581171108|FG008|Main Study|Death|1|||
161144325|NCT02973815|581911955|FG001|Post Intervention|Death|0|||
161144326|NCT02973815|581911954|FG000|Post Intervention|Lost to Follow-up|7|||
161144327|NCT02973815|581911955|FG001|Post Intervention|Lost to Follow-up|24|||
161144328|NCT02973815|581911954|FG000|Follow-up|Lost to Follow-up|2|||
161144329|NCT02973815|581911955|FG001|Follow-up|Lost to Follow-up|0|||
161144330|NCT00970294|581911962|FG000|Overall Study|Physician Decision|4|||
161144331|NCT00970294|581911962|FG000|Overall Study|Withdrawal by Subject|1|||
160939915|NCT03013491|581171109|FG009|Main Study|Death|2|||
160939916|NCT03013491|581171110|FG010|Main Study|Death|4|||
161144332|NCT01607892|581911963|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
161342560|NCT05020015|582642178|FG003|Overall Study|Reason Not Specified|0|||
160939917|NCT03013491|581171111|FG011|Main Study|Death|1|||
160939918|NCT03013491|581171112|FG012|Main Study|Death|1|||
160939919|NCT03013491|581171113|FG013|Main Study|Death|4|||
160939920|NCT03013491|581171114|FG014|Main Study|Death|0|||
160939921|NCT03013491|581171115|FG015|Main Study|Death|3|||
160939922|NCT03013491|581171116|FG016|Main Study|Death|5|||
160939923|NCT03013491|581171117|FG017|Main Study|Death|1|||
160939924|NCT03013491|581171118|FG018|Main Study|Death|47|||
160939925|NCT03013491|581171100|FG000|Main Study|Lost to Follow-up|0|||
160939926|NCT03013491|581171101|FG001|Main Study|Lost to Follow-up|0|||
160939927|NCT03013491|581171102|FG002|Main Study|Lost to Follow-up|1|||
160939928|NCT03013491|581171103|FG003|Main Study|Lost to Follow-up|0|||
160939929|NCT03013491|581171104|FG004|Main Study|Lost to Follow-up|1|||
160939930|NCT03013491|581171105|FG005|Main Study|Lost to Follow-up|0|||
160939931|NCT03013491|581171106|FG006|Main Study|Lost to Follow-up|0|||
160939932|NCT03013491|581171107|FG007|Main Study|Lost to Follow-up|0|||
160939933|NCT03013491|581171108|FG008|Main Study|Lost to Follow-up|0|||
160939934|NCT03013491|581171109|FG009|Main Study|Lost to Follow-up|0|||
160939935|NCT03013491|581171110|FG010|Main Study|Lost to Follow-up|0|||
160939936|NCT03013491|581171111|FG011|Main Study|Lost to Follow-up|0|||
160939937|NCT03013491|581171112|FG012|Main Study|Lost to Follow-up|0|||
160939938|NCT03013491|581171113|FG013|Main Study|Lost to Follow-up|0|||
160939939|NCT03013491|581171114|FG014|Main Study|Lost to Follow-up|0|||
160939940|NCT03013491|581171115|FG015|Main Study|Lost to Follow-up|0|||
160939941|NCT03013491|581171116|FG016|Main Study|Lost to Follow-up|0|||
160939942|NCT03013491|581171117|FG017|Main Study|Lost to Follow-up|0|||
160939943|NCT03013491|581171118|FG018|Main Study|Lost to Follow-up|3|||
160939944|NCT03013491|581171100|FG000|Main Study|Termination of the study by Sponsor|0|||
160939945|NCT03013491|581171101|FG001|Main Study|Termination of the study by Sponsor|0|||
160939946|NCT03013491|581171102|FG002|Main Study|Termination of the study by Sponsor|2|||
160939947|NCT03013491|581171103|FG003|Main Study|Termination of the study by Sponsor|0|||
160939948|NCT03013491|581171104|FG004|Main Study|Termination of the study by Sponsor|1|||
160939949|NCT03013491|581171105|FG005|Main Study|Termination of the study by Sponsor|2|||
160939950|NCT03013491|581171106|FG006|Main Study|Termination of the study by Sponsor|0|||
160939951|NCT03013491|581171107|FG007|Main Study|Termination of the study by Sponsor|0|||
160939952|NCT03013491|581171108|FG008|Main Study|Termination of the study by Sponsor|1|||
160939953|NCT03013491|581171109|FG009|Main Study|Termination of the study by Sponsor|1|||
160939954|NCT03013491|581171110|FG010|Main Study|Termination of the study by Sponsor|1|||
160939955|NCT03013491|581171111|FG011|Main Study|Termination of the study by Sponsor|2|||
160939956|NCT03013491|581171112|FG012|Main Study|Termination of the study by Sponsor|0|||
160939957|NCT03013491|581171113|FG013|Main Study|Termination of the study by Sponsor|0|||
160939958|NCT03013491|581171114|FG014|Main Study|Termination of the study by Sponsor|0|||
160939959|NCT03013491|581171115|FG015|Main Study|Termination of the study by Sponsor|0|||
160939960|NCT03013491|581171116|FG016|Main Study|Termination of the study by Sponsor|0|||
160939961|NCT03013491|581171117|FG017|Main Study|Termination of the study by Sponsor|1|||
160939962|NCT03013491|581171118|FG018|Main Study|Termination of the study by Sponsor|13|||
160939963|NCT03013491|581171100|FG000|Main Study|Withdrawal by Subject|0|||
160939964|NCT03013491|581171101|FG001|Main Study|Withdrawal by Subject|0|||
160939965|NCT03013491|581171102|FG002|Main Study|Withdrawal by Subject|0|||
160939966|NCT03013491|581171103|FG003|Main Study|Withdrawal by Subject|4|||
160939967|NCT03013491|581171104|FG004|Main Study|Withdrawal by Subject|2|||
161342561|NCT00947544|582642181|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
160939968|NCT03013491|581171105|FG005|Main Study|Withdrawal by Subject|1|||
161342562|NCT00947544|582642182|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
161342563|NCT02472405|582642184|FG000|Overall Study|Lost to Follow-up|9|||
161342564|NCT02472405|582642184|FG000|Overall Study|Adverse Event|1|||
160939969|NCT03013491|581171106|FG006|Main Study|Withdrawal by Subject|0|||
160939970|NCT03013491|581171107|FG007|Main Study|Withdrawal by Subject|0|||
160939971|NCT03013491|581171108|FG008|Main Study|Withdrawal by Subject|0|||
160939972|NCT03013491|581171109|FG009|Main Study|Withdrawal by Subject|0|||
160939973|NCT03013491|581171110|FG010|Main Study|Withdrawal by Subject|1|||
160939974|NCT03013491|581171111|FG011|Main Study|Withdrawal by Subject|2|||
160939975|NCT03013491|581171112|FG012|Main Study|Withdrawal by Subject|0|||
160939976|NCT03013491|581171113|FG013|Main Study|Withdrawal by Subject|2|||
160939977|NCT03013491|581171114|FG014|Main Study|Withdrawal by Subject|0|||
160939978|NCT03013491|581171115|FG015|Main Study|Withdrawal by Subject|0|||
160939979|NCT03013491|581171116|FG016|Main Study|Withdrawal by Subject|0|||
160939980|NCT03013491|581171117|FG017|Main Study|Withdrawal by Subject|0|||
160939981|NCT03013491|581171118|FG018|Main Study|Withdrawal by Subject|18|||
160939982|NCT03013491|581171100|FG000|Main Study|Disease progression|0|||
161342565|NCT01431976|582642185|FG000|Overall Study|Adverse Event|6|||
161342566|NCT01431976|582642185|FG000|Overall Study|Lack of Efficacy|2|||
160939983|NCT03013491|581171101|FG001|Main Study|Disease progression|0|||
161342567|NCT01431976|582642185|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
160939984|NCT03013491|581171102|FG002|Main Study|Disease progression|0|||
160939985|NCT03013491|581171103|FG003|Main Study|Disease progression|1|||
160939986|NCT03013491|581171104|FG004|Main Study|Disease progression|0|||
160939987|NCT03013491|581171105|FG005|Main Study|Disease progression|0|||
160939988|NCT03013491|581171106|FG006|Main Study|Disease progression|0|||
160939989|NCT03013491|581171107|FG007|Main Study|Disease progression|0|||
160939990|NCT03013491|581171108|FG008|Main Study|Disease progression|1|||
160939991|NCT03013491|581171109|FG009|Main Study|Disease progression|0|||
161144333|NCT01607892|581911964|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
161144334|NCT01607892|581911965|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
161144335|NCT01607892|581911966|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
160939992|NCT03013491|581171110|FG010|Main Study|Disease progression|1|||
160939993|NCT03013491|581171111|FG011|Main Study|Disease progression|0|||
160939994|NCT03013491|581171112|FG012|Main Study|Disease progression|0|||
160939995|NCT03013491|581171113|FG013|Main Study|Disease progression|0|||
160939996|NCT03013491|581171114|FG014|Main Study|Disease progression|0|||
160939997|NCT03013491|581171115|FG015|Main Study|Disease progression|0|||
160939998|NCT03013491|581171116|FG016|Main Study|Disease progression|0|||
160939999|NCT03013491|581171117|FG017|Main Study|Disease progression|0|||
160940000|NCT03013491|581171118|FG018|Main Study|Disease progression|4|||
160940001|NCT03013491|581171100|FG000|Main Study|Symptomatic deterioration|0|||
160940002|NCT03013491|581171101|FG001|Main Study|Symptomatic deterioration|0|||
160940003|NCT03013491|581171102|FG002|Main Study|Symptomatic deterioration|0|||
160940004|NCT03013491|581171103|FG003|Main Study|Symptomatic deterioration|0|||
160940005|NCT03013491|581171104|FG004|Main Study|Symptomatic deterioration|0|||
160940006|NCT03013491|581171105|FG005|Main Study|Symptomatic deterioration|1|||
160940007|NCT03013491|581171106|FG006|Main Study|Symptomatic deterioration|0|||
160940008|NCT03013491|581171107|FG007|Main Study|Symptomatic deterioration|0|||
160940009|NCT03013491|581171108|FG008|Main Study|Symptomatic deterioration|0|||
160940010|NCT03013491|581171109|FG009|Main Study|Symptomatic deterioration|0|||
160940011|NCT03013491|581171110|FG010|Main Study|Symptomatic deterioration|0|||
160940012|NCT03013491|581171111|FG011|Main Study|Symptomatic deterioration|0|||
160940013|NCT03013491|581171112|FG012|Main Study|Symptomatic deterioration|0|||
160940014|NCT03013491|581171113|FG013|Main Study|Symptomatic deterioration|0|||
160940015|NCT03013491|581171114|FG014|Main Study|Symptomatic deterioration|0|||
160940016|NCT03013491|581171115|FG015|Main Study|Symptomatic deterioration|0|||
160940017|NCT03013491|581171116|FG016|Main Study|Symptomatic deterioration|0|||
160940018|NCT03013491|581171117|FG017|Main Study|Symptomatic deterioration|0|||
160940019|NCT03013491|581171118|FG018|Main Study|Symptomatic deterioration|0|||
160940020|NCT03013491|581171100|FG000|Main Study|Protocol version 8.0 approval|0|||
160940021|NCT03013491|581171101|FG001|Main Study|Protocol version 8.0 approval|0|||
160940022|NCT03013491|581171102|FG002|Main Study|Protocol version 8.0 approval|0|||
160940023|NCT03013491|581171103|FG003|Main Study|Protocol version 8.0 approval|0|||
160940024|NCT03013491|581171104|FG004|Main Study|Protocol version 8.0 approval|0|||
160940025|NCT03013491|581171105|FG005|Main Study|Protocol version 8.0 approval|0|||
160940026|NCT03013491|581171106|FG006|Main Study|Protocol version 8.0 approval|0|||
160940027|NCT03013491|581171107|FG007|Main Study|Protocol version 8.0 approval|0|||
160940028|NCT03013491|581171108|FG008|Main Study|Protocol version 8.0 approval|0|||
160940029|NCT03013491|581171109|FG009|Main Study|Protocol version 8.0 approval|0|||
160940030|NCT03013491|581171110|FG010|Main Study|Protocol version 8.0 approval|1|||
160940031|NCT03013491|581171111|FG011|Main Study|Protocol version 8.0 approval|0|||
160940032|NCT03013491|581171112|FG012|Main Study|Protocol version 8.0 approval|0|||
160940033|NCT03013491|581171113|FG013|Main Study|Protocol version 8.0 approval|0|||
160940034|NCT03013491|581171114|FG014|Main Study|Protocol version 8.0 approval|0|||
160940035|NCT03013491|581171115|FG015|Main Study|Protocol version 8.0 approval|0|||
160940036|NCT03013491|581171116|FG016|Main Study|Protocol version 8.0 approval|0|||
160940037|NCT03013491|581171117|FG017|Main Study|Protocol version 8.0 approval|0|||
160940038|NCT03013491|581171118|FG018|Main Study|Protocol version 8.0 approval|0|||
160940039|NCT03013491|581171100|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
160940040|NCT03013491|581171101|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
160940041|NCT03013491|581171102|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
160940042|NCT03013491|581171103|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
160940043|NCT03013491|581171104|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
160940044|NCT03013491|581171105|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
160940045|NCT03013491|581171106|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
160940046|NCT03013491|581171107|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
160940047|NCT03013491|581171108|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
160940048|NCT03013491|581171109|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
160940049|NCT03013491|581171110|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
160940050|NCT03013491|581171111|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
160940051|NCT03013491|581171112|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
160940052|NCT03013491|581171113|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
160940053|NCT03013491|581171114|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
160940054|NCT03013491|581171115|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
160940055|NCT03013491|581171116|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
161144336|NCT01607892|581911967|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
161264784|NCT00257920|582350773|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
161264785|NCT00257920|582350772|FG000|Period: Second Intervention|Other|2|||
161264786|NCT00257920|582350773|FG001|Period: Second Intervention|Other|1|||
161264787|NCT00770692|582350774|FG000|Overall Study|Withdrawal by Subject|7|||
161264788|NCT00770692|582350775|FG001|Overall Study|Withdrawal by Subject|9|||
161264789|NCT00770692|582350776|FG002|Overall Study|Withdrawal by Subject|9|||
160940056|NCT03013491|581171117|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
160940057|NCT03013491|581171118|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
160940058|NCT03013491|581171100|FG000|Main Study|Start of new anticancer therapy|0|||
160940059|NCT03013491|581171101|FG001|Main Study|Start of new anticancer therapy|0|||
160940060|NCT03013491|581171102|FG002|Main Study|Start of new anticancer therapy|0|||
160940061|NCT03013491|581171103|FG003|Main Study|Start of new anticancer therapy|0|||
160940062|NCT03013491|581171104|FG004|Main Study|Start of new anticancer therapy|0|||
160940063|NCT03013491|581171105|FG005|Main Study|Start of new anticancer therapy|0|||
160940064|NCT03013491|581171106|FG006|Main Study|Start of new anticancer therapy|0|||
160940065|NCT03013491|581171107|FG007|Main Study|Start of new anticancer therapy|0|||
160940066|NCT03013491|581171108|FG008|Main Study|Start of new anticancer therapy|0|||
160940067|NCT03013491|581171109|FG009|Main Study|Start of new anticancer therapy|0|||
160940068|NCT03013491|581171110|FG010|Main Study|Start of new anticancer therapy|0|||
160940069|NCT03013491|581171111|FG011|Main Study|Start of new anticancer therapy|0|||
160940070|NCT03013491|581171112|FG012|Main Study|Start of new anticancer therapy|0|||
160940071|NCT03013491|581171113|FG013|Main Study|Start of new anticancer therapy|0|||
160940072|NCT03013491|581171114|FG014|Main Study|Start of new anticancer therapy|0|||
160940073|NCT03013491|581171115|FG015|Main Study|Start of new anticancer therapy|0|||
160940074|NCT03013491|581171116|FG016|Main Study|Start of new anticancer therapy|0|||
160940075|NCT03013491|581171117|FG017|Main Study|Start of new anticancer therapy|0|||
160940076|NCT03013491|581171118|FG018|Main Study|Start of new anticancer therapy|2|||
160940077|NCT03013491|581171100|FG000|Long-term Extension|Disease progression|0|||
160940078|NCT03013491|581171101|FG001|Long-term Extension|Disease progression|0|||
160940079|NCT03013491|581171102|FG002|Long-term Extension|Disease progression|0|||
160940080|NCT03013491|581171103|FG003|Long-term Extension|Disease progression|1|||
160940081|NCT03013491|581171104|FG004|Long-term Extension|Disease progression|0|||
160940082|NCT03013491|581171105|FG005|Long-term Extension|Disease progression|0|||
160940083|NCT03013491|581171106|FG006|Long-term Extension|Disease progression|0|||
160940084|NCT03013491|581171107|FG007|Long-term Extension|Disease progression|0|||
160940085|NCT03013491|581171108|FG008|Long-term Extension|Disease progression|0|||
160940086|NCT03013491|581171109|FG009|Long-term Extension|Disease progression|0|||
160940087|NCT03013491|581171110|FG010|Long-term Extension|Disease progression|0|||
160940088|NCT03013491|581171111|FG011|Long-term Extension|Disease progression|0|||
160940089|NCT03013491|581171112|FG012|Long-term Extension|Disease progression|0|||
160940090|NCT03013491|581171113|FG013|Long-term Extension|Disease progression|0|||
160940091|NCT03013491|581171114|FG014|Long-term Extension|Disease progression|0|||
160998782|NCT01235949|581380615|FG013|Booster Phase|Lost to Follow-up|0|||
160998783|NCT01235949|581380616|FG014|Booster Phase|Lost to Follow-up|0|||
160998784|NCT01235949|581380617|FG015|Booster Phase|Lost to Follow-up|0|||
160998785|NCT01235949|581380618|FG016|Booster Phase|Lost to Follow-up|0|||
160998786|NCT01235949|581380619|FG017|Booster Phase|Lost to Follow-up|1|||
160998787|NCT00754936|581380620|FG000|Overall Study|Lost to Follow-up|3|||
160998788|NCT00754936|581380620|FG000|Overall Study|Physician Decision|1|||
160998789|NCT00754936|581380620|FG000|Overall Study|Withdrawal by Subject|2|||
160998790|NCT00754936|581380620|FG000|Overall Study|Side Effects|3|||
160998791|NCT00754936|581380620|FG000|Overall Study|Inter-current medical events|3|||
160998792|NCT00436644|581380621|FG000|Overall Study|Adverse Event|2|||
160998793|NCT00436644|581380621|FG000|Overall Study|Death|1|||
160998794|NCT00619645|581380622|FG000|Overall Study|Adverse Event|1|||
160998795|NCT04364269|581380627|FG000|Overall Study|Adverse Event|1|||
160998796|NCT04364269|581380628|FG001|Overall Study|Adverse Event|0|||
160998797|NCT04364269|581380629|FG002|Overall Study|Adverse Event|0|||
160998798|NCT04364269|581380627|FG000|Overall Study|Withdrawal by Subject|0|||
160998799|NCT04364269|581380628|FG001|Overall Study|Withdrawal by Subject|1|||
160998800|NCT04364269|581380629|FG002|Overall Study|Withdrawal by Subject|0|||
161264790|NCT00770692|582350777|FG003|Overall Study|Withdrawal by Subject|6|||
160940092|NCT03013491|581171115|FG015|Long-term Extension|Disease progression|0|||
160940093|NCT03013491|581171116|FG016|Long-term Extension|Disease progression|0|||
160940094|NCT03013491|581171117|FG017|Long-term Extension|Disease progression|0|||
160940095|NCT03013491|581171118|FG018|Long-term Extension|Disease progression|1|||
160940096|NCT03013491|581171100|FG000|Long-term Extension|Withdrawal by Subject|0|||
160998801|NCT02026258|581380632|FG000|Randomized|Did not start treatment|2|||
160998802|NCT02026258|581380633|FG001|Randomized|Did not start treatment|1|||
160998803|NCT02026258|581380632|FG000|Randomized|Change in treatment plan|1|||
160998804|NCT02026258|581380633|FG001|Randomized|Change in treatment plan|0|||
161264791|NCT00770692|582350774|FG000|Overall Study|Adverse Event|3|||
161264792|NCT00770692|582350775|FG001|Overall Study|Adverse Event|0|||
161264793|NCT00770692|582350776|FG002|Overall Study|Adverse Event|4|||
160940097|NCT03013491|581171101|FG001|Long-term Extension|Withdrawal by Subject|0|||
160940098|NCT03013491|581171102|FG002|Long-term Extension|Withdrawal by Subject|0|||
160940099|NCT03013491|581171103|FG003|Long-term Extension|Withdrawal by Subject|0|||
160940100|NCT03013491|581171104|FG004|Long-term Extension|Withdrawal by Subject|0|||
160940101|NCT03013491|581171105|FG005|Long-term Extension|Withdrawal by Subject|0|||
160940102|NCT03013491|581171106|FG006|Long-term Extension|Withdrawal by Subject|0|||
160940103|NCT03013491|581171107|FG007|Long-term Extension|Withdrawal by Subject|1|||
160940104|NCT03013491|581171108|FG008|Long-term Extension|Withdrawal by Subject|0|||
160940105|NCT03013491|581171109|FG009|Long-term Extension|Withdrawal by Subject|0|||
160940106|NCT03013491|581171110|FG010|Long-term Extension|Withdrawal by Subject|0|||
160940107|NCT03013491|581171111|FG011|Long-term Extension|Withdrawal by Subject|0|||
160940108|NCT03013491|581171112|FG012|Long-term Extension|Withdrawal by Subject|0|||
160940109|NCT03013491|581171113|FG013|Long-term Extension|Withdrawal by Subject|0|||
160940110|NCT03013491|581171114|FG014|Long-term Extension|Withdrawal by Subject|0|||
160940111|NCT03013491|581171115|FG015|Long-term Extension|Withdrawal by Subject|0|||
160940112|NCT03013491|581171116|FG016|Long-term Extension|Withdrawal by Subject|0|||
160940113|NCT03013491|581171117|FG017|Long-term Extension|Withdrawal by Subject|0|||
160940114|NCT03013491|581171118|FG018|Long-term Extension|Withdrawal by Subject|0|||
160940115|NCT03013491|581171100|FG000|Long-term Extension|Adverse Event|0|||
160940116|NCT03013491|581171101|FG001|Long-term Extension|Adverse Event|0|||
160940117|NCT03013491|581171102|FG002|Long-term Extension|Adverse Event|0|||
160940118|NCT03013491|581171103|FG003|Long-term Extension|Adverse Event|0|||
160940119|NCT03013491|581171104|FG004|Long-term Extension|Adverse Event|0|||
161144337|NCT01607892|581911963|FG000|Overall Study|Death|4|||
161144338|NCT01607892|581911964|FG001|Overall Study|Death|2|||
160940120|NCT03013491|581171105|FG005|Long-term Extension|Adverse Event|0|||
160940121|NCT03013491|581171106|FG006|Long-term Extension|Adverse Event|0|||
160940122|NCT03013491|581171107|FG007|Long-term Extension|Adverse Event|0|||
160940123|NCT03013491|581171108|FG008|Long-term Extension|Adverse Event|0|||
160940124|NCT03013491|581171109|FG009|Long-term Extension|Adverse Event|0|||
160940125|NCT03013491|581171110|FG010|Long-term Extension|Adverse Event|0|||
160940126|NCT03013491|581171111|FG011|Long-term Extension|Adverse Event|0|||
160940127|NCT03013491|581171112|FG012|Long-term Extension|Adverse Event|0|||
160940128|NCT03013491|581171113|FG013|Long-term Extension|Adverse Event|0|||
160940129|NCT03013491|581171114|FG014|Long-term Extension|Adverse Event|0|||
160940130|NCT03013491|581171115|FG015|Long-term Extension|Adverse Event|0|||
160940131|NCT03013491|581171116|FG016|Long-term Extension|Adverse Event|0|||
160940132|NCT03013491|581171117|FG017|Long-term Extension|Adverse Event|0|||
160940133|NCT03013491|581171118|FG018|Long-term Extension|Adverse Event|1|||
160940134|NCT03013491|581171100|FG000|Long-term Extension|Death|0|||
160940135|NCT03013491|581171101|FG001|Long-term Extension|Death|0|||
160940136|NCT03013491|581171102|FG002|Long-term Extension|Death|0|||
160940137|NCT03013491|581171103|FG003|Long-term Extension|Death|0|||
160940138|NCT03013491|581171104|FG004|Long-term Extension|Death|0|||
160940139|NCT03013491|581171105|FG005|Long-term Extension|Death|0|||
160940140|NCT03013491|581171106|FG006|Long-term Extension|Death|0|||
160940141|NCT03013491|581171107|FG007|Long-term Extension|Death|0|||
160940142|NCT03013491|581171108|FG008|Long-term Extension|Death|0|||
160940143|NCT03013491|581171109|FG009|Long-term Extension|Death|0|||
160940144|NCT03013491|581171110|FG010|Long-term Extension|Death|0|||
160940145|NCT03013491|581171111|FG011|Long-term Extension|Death|0|||
160940146|NCT03013491|581171112|FG012|Long-term Extension|Death|0|||
160940147|NCT03013491|581171113|FG013|Long-term Extension|Death|0|||
160940148|NCT03013491|581171114|FG014|Long-term Extension|Death|0|||
160940149|NCT03013491|581171115|FG015|Long-term Extension|Death|0|||
160940150|NCT03013491|581171116|FG016|Long-term Extension|Death|0|||
160940151|NCT03013491|581171117|FG017|Long-term Extension|Death|0|||
160940152|NCT03013491|581171118|FG018|Long-term Extension|Death|1|||
161144339|NCT01607892|581911965|FG002|Overall Study|Death|8|||
161144340|NCT01607892|581911966|FG003|Overall Study|Death|10|||
161144341|NCT01607892|581911967|FG004|Overall Study|Death|3|||
161144342|NCT01607892|581911963|FG000|Overall Study|Investigator discretion|2|||
161144343|NCT01607892|581911964|FG001|Overall Study|Investigator discretion|4|||
160940153|NCT04740034|581171121|FG000|Overall Study|Death|0|||
160940154|NCT04740034|581171122|FG001|Overall Study|Death|1|||
160940155|NCT04740034|581171123|FG002|Overall Study|Death|2|||
160940156|NCT04740034|581171124|FG003|Overall Study|Death|3|||
160940157|NCT04740034|581171125|FG004|Overall Study|Death|4|||
160940158|NCT04740034|581171126|FG005|Overall Study|Death|4|||
160940159|NCT04740034|581171127|FG006|Overall Study|Death|2|||
160940160|NCT04740034|581171128|FG007|Overall Study|Death|2|||
160940161|NCT04740034|581171129|FG008|Overall Study|Death|2|||
160940162|NCT04740034|581171130|FG009|Overall Study|Death|4|||
160940163|NCT04740034|581171131|FG010|Overall Study|Death|0|||
160940164|NCT04740034|581171121|FG000|Overall Study|Lost to Follow-up|0|||
160940165|NCT04740034|581171122|FG001|Overall Study|Lost to Follow-up|0|||
161144344|NCT01607892|581911965|FG002|Overall Study|Investigator discretion|4|||
160940166|NCT04740034|581171123|FG002|Overall Study|Lost to Follow-up|0|||
160940167|NCT04740034|581171124|FG003|Overall Study|Lost to Follow-up|1|||
160940168|NCT04740034|581171125|FG004|Overall Study|Lost to Follow-up|2|||
160940169|NCT04740034|581171126|FG005|Overall Study|Lost to Follow-up|2|||
160940170|NCT04740034|581171127|FG006|Overall Study|Lost to Follow-up|0|||
160940171|NCT04740034|581171128|FG007|Overall Study|Lost to Follow-up|0|||
160940172|NCT04740034|581171129|FG008|Overall Study|Lost to Follow-up|0|||
160940173|NCT04740034|581171130|FG009|Overall Study|Lost to Follow-up|1|||
160940174|NCT04740034|581171131|FG010|Overall Study|Lost to Follow-up|0|||
160940175|NCT04740034|581171121|FG000|Overall Study|Withdrawal by Subject|1|||
160940176|NCT04740034|581171122|FG001|Overall Study|Withdrawal by Subject|0|||
160940177|NCT04740034|581171123|FG002|Overall Study|Withdrawal by Subject|0|||
160940178|NCT04740034|581171124|FG003|Overall Study|Withdrawal by Subject|0|||
160940179|NCT04740034|581171125|FG004|Overall Study|Withdrawal by Subject|0|||
160940180|NCT04740034|581171126|FG005|Overall Study|Withdrawal by Subject|0|||
160940181|NCT04740034|581171127|FG006|Overall Study|Withdrawal by Subject|0|||
160940182|NCT04740034|581171128|FG007|Overall Study|Withdrawal by Subject|1|||
160940183|NCT04740034|581171129|FG008|Overall Study|Withdrawal by Subject|0|||
160940184|NCT04740034|581171130|FG009|Overall Study|Withdrawal by Subject|1|||
160940185|NCT04740034|581171131|FG010|Overall Study|Withdrawal by Subject|0|||
160940186|NCT04740034|581171121|FG000|Overall Study|Decision by sponsor|0|||
160940187|NCT04740034|581171122|FG001|Overall Study|Decision by sponsor|0|||
160940188|NCT04740034|581171123|FG002|Overall Study|Decision by sponsor|1|||
160940189|NCT04740034|581171124|FG003|Overall Study|Decision by sponsor|0|||
160940190|NCT04740034|581171125|FG004|Overall Study|Decision by sponsor|0|||
160940191|NCT04740034|581171126|FG005|Overall Study|Decision by sponsor|0|||
160940192|NCT04740034|581171127|FG006|Overall Study|Decision by sponsor|1|||
160940193|NCT04740034|581171128|FG007|Overall Study|Decision by sponsor|2|||
160940194|NCT04740034|581171129|FG008|Overall Study|Decision by sponsor|1|||
160940195|NCT04740034|581171130|FG009|Overall Study|Decision by sponsor|1|||
160940196|NCT04740034|581171131|FG010|Overall Study|Decision by sponsor|2|||
160940197|NCT03890367|581171133|FG000|Overall Study|Withdrawal by parent/guardian|1|||
160940198|NCT03890367|581171134|FG001|Overall Study|Withdrawal by parent/guardian|3|||
160940199|NCT03890367|581171135|FG002|Overall Study|Withdrawal by parent/guardian|0|||
160940200|NCT03890367|581171133|FG000|Overall Study|Protocol deviation|2|||
160940201|NCT03890367|581171134|FG001|Overall Study|Protocol deviation|2|||
160940202|NCT03890367|581171135|FG002|Overall Study|Protocol deviation|1|||
160940203|NCT03890367|581171133|FG000|Overall Study|Lost to Follow-up|1|||
160940204|NCT03890367|581171134|FG001|Overall Study|Lost to Follow-up|1|||
160940205|NCT03890367|581171135|FG002|Overall Study|Lost to Follow-up|0|||
160940206|NCT02383758|581173045|FG000|Overall Study|Withdrawal by Subject|0|||
160940207|NCT02383758|581173046|FG001|Overall Study|Withdrawal by Subject|2|||
160940208|NCT02564471|581173047|FG000|Overall Study|Adverse Event|1|||
161264794|NCT00770692|582350777|FG003|Overall Study|Adverse Event|4|||
161264795|NCT00770692|582350774|FG000|Overall Study|Investigator judgment|2|||
161264796|NCT00770692|582350775|FG001|Overall Study|Investigator judgment|0|||
161264797|NCT00770692|582350776|FG002|Overall Study|Investigator judgment|1|||
161264798|NCT00770692|582350777|FG003|Overall Study|Investigator judgment|1|||
161264799|NCT01230892|582350778|FG000|Overall Study|Withdrawal by Subject|1|||
160940209|NCT02564471|581173048|FG001|Overall Study|Adverse Event|0|||
160940210|NCT02564471|581173049|FG002|Overall Study|Adverse Event|0|||
160940211|NCT02564471|581173050|FG003|Overall Study|Adverse Event|0|||
160940212|NCT02564471|581173047|FG000|Overall Study|Withdrawal by Subject|2|||
160940213|NCT02564471|581173048|FG001|Overall Study|Withdrawal by Subject|1|||
160940214|NCT02564471|581173049|FG002|Overall Study|Withdrawal by Subject|3|||
160940215|NCT02564471|581173050|FG003|Overall Study|Withdrawal by Subject|0|||
160940216|NCT02564471|581173047|FG000|Overall Study|Lost to Follow-up|0|||
160940217|NCT02564471|581173048|FG001|Overall Study|Lost to Follow-up|2|||
160940218|NCT02564471|581173049|FG002|Overall Study|Lost to Follow-up|0|||
160940219|NCT02564471|581173050|FG003|Overall Study|Lost to Follow-up|0|||
160940220|NCT01643473|581173053|FG000|Overall Study|Lost to Follow-up|1|||
160940221|NCT01643473|581173054|FG001|Overall Study|Lost to Follow-up|0|||
160940222|NCT01519518|581173055|FG000|Overall Study|Consent not available|7|||
160998805|NCT02026258|581380632|FG000|Randomized|Presence of periodontal disease|1|||
160998806|NCT02026258|581380633|FG001|Randomized|Presence of periodontal disease|1|||
160998807|NCT02026258|581380632|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
160998808|NCT02026258|581380633|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
161264800|NCT01230892|582350779|FG001|Overall Study|Withdrawal by Subject|1|||
161264801|NCT01230892|582350778|FG000|Overall Study|Lost to Follow-up|2|||
161342568|NCT01431976|582642185|FG000|Overall Study|Physician Decision|1|||
161264802|NCT01230892|582350779|FG001|Overall Study|Lost to Follow-up|0|||
161264803|NCT02037165|582350780|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161264804|NCT02037165|582350781|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161342569|NCT01431976|582642185|FG000|Overall Study|Withdrawal by Subject|1|||
161342570|NCT01013753|582642192|FG000|Overall Study|Adverse Event|8|||
161342571|NCT01013753|582642192|FG000|Overall Study|Protocol Violation|3|||
160940223|NCT01519518|581173056|FG001|Overall Study|Consent not available|10|||
160940224|NCT02033889|581173057|FG000|Overall Study|Adverse Event|3|||
160940225|NCT02033889|581173058|FG001|Overall Study|Adverse Event|1|||
160940226|NCT02033889|581173059|FG002|Overall Study|Adverse Event|3|||
160940227|NCT02033889|581173057|FG000|Overall Study|Death|3|||
160940228|NCT02033889|581173058|FG001|Overall Study|Death|1|||
160940229|NCT02033889|581173059|FG002|Overall Study|Death|2|||
160940230|NCT02033889|581173057|FG000|Overall Study|Excluded Medication|1|||
160940231|NCT02033889|581173058|FG001|Overall Study|Excluded Medication|1|||
160940232|NCT02033889|581173059|FG002|Overall Study|Excluded Medication|0|||
160940233|NCT02033889|581173057|FG000|Overall Study|Lost to Follow-up|8|||
160940234|NCT02033889|581173058|FG001|Overall Study|Lost to Follow-up|5|||
160940235|NCT02033889|581173059|FG002|Overall Study|Lost to Follow-up|6|||
160940236|NCT02033889|581173057|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161264805|NCT02037165|582350782|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161264806|NCT02037165|582350783|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
161264807|NCT02037165|582350784|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
161264808|NCT00673933|582350785|FG000|Overall Study|Withdrawal by Subject|2|||
161264809|NCT00673933|582350785|FG000|Overall Study|Lost to Follow-up|1|||
160940237|NCT02033889|581173058|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160940238|NCT02033889|581173059|FG002|Overall Study|Non-Compliance With Study Drug|0|||
160940239|NCT02033889|581173057|FG000|Overall Study|Physician Decision|0|||
160940240|NCT02033889|581173058|FG001|Overall Study|Physician Decision|1|||
160940241|NCT02033889|581173059|FG002|Overall Study|Physician Decision|1|||
160940242|NCT02033889|581173057|FG000|Overall Study|Participant moved|0|||
160940243|NCT02033889|581173058|FG001|Overall Study|Participant moved|1|||
160940244|NCT02033889|581173059|FG002|Overall Study|Participant moved|0|||
160940245|NCT02033889|581173057|FG000|Overall Study|Withdrawal by Subject|18|||
160940246|NCT02033889|581173058|FG001|Overall Study|Withdrawal by Subject|10|||
160940247|NCT02033889|581173059|FG002|Overall Study|Withdrawal by Subject|13|||
160940248|NCT00182689|581173065|FG000|Overall Study|Adverse Event|8|||
160940249|NCT00182689|581173066|FG001|Overall Study|Adverse Event|11|||
160940250|NCT00182689|581173065|FG000|Overall Study|Withdrawal by Subject|2|||
160940251|NCT00182689|581173066|FG001|Overall Study|Withdrawal by Subject|2|||
160940252|NCT00182689|581173065|FG000|Overall Study|Progression|27|||
160940253|NCT00182689|581173066|FG001|Overall Study|Progression|29|||
160940254|NCT00182689|581173065|FG000|Overall Study|Death|1|||
160940255|NCT00182689|581173066|FG001|Overall Study|Death|0|||
160940256|NCT00182689|581173065|FG000|Overall Study|not protocol specified|0|||
160940257|NCT00182689|581173066|FG001|Overall Study|not protocol specified|3|||
160940258|NCT00182689|581173065|FG000|Overall Study|Ineligible|1|||
160940259|NCT00182689|581173066|FG001|Overall Study|Ineligible|4|||
160940260|NCT00182689|581173065|FG000|Overall Study|Never received treatment|1|||
160940261|NCT00182689|581173066|FG001|Overall Study|Never received treatment|0|||
160940262|NCT01640301|581173067|FG000|Overall Study|Death|0|||
160940263|NCT01640301|581173068|FG001|Overall Study|Death|8|||
160940264|NCT01969838|581173074|FG000|Double-blind Phase|Adverse Event|10|||
160940265|NCT01969838|581173075|FG001|Double-blind Phase|Adverse Event|4|||
160940266|NCT01969838|581173076|FG002|Double-blind Phase|Adverse Event|0|||
160940267|NCT01969838|581173077|FG003|Double-blind Phase|Adverse Event|0|||
160940268|NCT01969838|581173074|FG000|Double-blind Phase|Death|5|||
160940269|NCT01969838|581173075|FG001|Double-blind Phase|Death|2|||
160940270|NCT01969838|581173076|FG002|Double-blind Phase|Death|0|||
160940271|NCT01969838|581173077|FG003|Double-blind Phase|Death|0|||
160940272|NCT01969838|581173074|FG000|Double-blind Phase|Physician Decision|5|||
160940273|NCT01969838|581173075|FG001|Double-blind Phase|Physician Decision|1|||
160940274|NCT01969838|581173076|FG002|Double-blind Phase|Physician Decision|0|||
160940275|NCT01969838|581173077|FG003|Double-blind Phase|Physician Decision|0|||
160940276|NCT01969838|581173074|FG000|Double-blind Phase|Subject Decision|4|||
160940277|NCT01969838|581173075|FG001|Double-blind Phase|Subject Decision|2|||
160940278|NCT01969838|581173076|FG002|Double-blind Phase|Subject Decision|0|||
160940279|NCT01969838|581173077|FG003|Double-blind Phase|Subject Decision|0|||
160940280|NCT01969838|581173074|FG000|Double-blind Phase|Disease Progression|2|||
160940281|NCT01969838|581173075|FG001|Double-blind Phase|Disease Progression|0|||
161264810|NCT02206620|582350786|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161264811|NCT02206620|582350787|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161264812|NCT02206620|582350786|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
161264813|NCT02206620|582350787|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
161264814|NCT05816200|582350788|FG000|Overall Study|Lost to Follow-up|2|||
161264815|NCT05816200|582350789|FG001|Overall Study|Lost to Follow-up|1|||
161264816|NCT02394730|582350790|FG000|Overall Study|Lost to Follow-up|1|||
161264817|NCT02394730|582350791|FG001|Overall Study|Lost to Follow-up|0|||
161264818|NCT02394730|582350790|FG000|Overall Study|Withdrawal by Subject|0|||
161264819|NCT02394730|582350791|FG001|Overall Study|Withdrawal by Subject|1|||
161264820|NCT00588640|582350792|FG000|Overall Study|Physician Decision|1|||
160940282|NCT01969838|581173076|FG002|Double-blind Phase|Disease Progression|0|||
160940283|NCT01969838|581173077|FG003|Double-blind Phase|Disease Progression|0|||
160940284|NCT01969838|581173074|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
160940285|NCT01969838|581173075|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
160940286|NCT01969838|581173076|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
160940287|NCT01969838|581173077|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
160940288|NCT01969838|581173074|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
160940289|NCT01969838|581173075|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
160940290|NCT01969838|581173076|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
161144345|NCT01607892|581911966|FG003|Overall Study|Investigator discretion|8|||
160940291|NCT01969838|581173077|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
160940292|NCT01969838|581173074|FG000|Open-label Phase|Adverse Event|0|||
160940293|NCT01969838|581173075|FG001|Open-label Phase|Adverse Event|0|||
160940294|NCT01969838|581173076|FG002|Open-label Phase|Adverse Event|37|||
160940295|NCT01969838|581173077|FG003|Open-label Phase|Adverse Event|49|||
160940296|NCT01969838|581173074|FG000|Open-label Phase|Disease Progression|0|||
160940297|NCT01969838|581173075|FG001|Open-label Phase|Disease Progression|0|||
160940298|NCT01969838|581173076|FG002|Open-label Phase|Disease Progression|26|||
160940299|NCT01969838|581173077|FG003|Open-label Phase|Disease Progression|27|||
160940300|NCT01969838|581173074|FG000|Open-label Phase|Lack of Efficacy|0|||
160940301|NCT01969838|581173075|FG001|Open-label Phase|Lack of Efficacy|0|||
160940302|NCT01969838|581173076|FG002|Open-label Phase|Lack of Efficacy|17|||
160940303|NCT01969838|581173077|FG003|Open-label Phase|Lack of Efficacy|19|||
160940304|NCT01969838|581173074|FG000|Open-label Phase|Subject Decision|0|||
160940305|NCT01969838|581173075|FG001|Open-label Phase|Subject Decision|0|||
160940306|NCT01969838|581173076|FG002|Open-label Phase|Subject Decision|14|||
160940307|NCT01969838|581173077|FG003|Open-label Phase|Subject Decision|15|||
160940308|NCT01969838|581173074|FG000|Open-label Phase|Death|0|||
160940309|NCT01969838|581173075|FG001|Open-label Phase|Death|0|||
160940310|NCT01969838|581173076|FG002|Open-label Phase|Death|13|||
160940311|NCT01969838|581173077|FG003|Open-label Phase|Death|11|||
160940312|NCT01969838|581173074|FG000|Open-label Phase|Physician Decision|0|||
160940313|NCT01969838|581173075|FG001|Open-label Phase|Physician Decision|0|||
160940314|NCT01969838|581173076|FG002|Open-label Phase|Physician Decision|9|||
160940315|NCT01969838|581173077|FG003|Open-label Phase|Physician Decision|14|||
160940316|NCT01969838|581173074|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
160940317|NCT01969838|581173075|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
160940318|NCT01969838|581173076|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
160940319|NCT01969838|581173077|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
160940320|NCT00408993|581173078|FG000|Overall Study|Adverse Event|15|||
160940321|NCT00408993|581173079|FG001|Overall Study|Adverse Event|4|||
160940322|NCT00408993|581173078|FG000|Overall Study|Protocol Violation|1|||
160940323|NCT00408993|581173079|FG001|Overall Study|Protocol Violation|6|||
160940324|NCT00408993|581173078|FG000|Overall Study|Lack of Efficacy|1|||
160940325|NCT00408993|581173079|FG001|Overall Study|Lack of Efficacy|4|||
160940326|NCT00408993|581173078|FG000|Overall Study|Withdrawal by Subject|2|||
160940327|NCT00408993|581173079|FG001|Overall Study|Withdrawal by Subject|3|||
160940328|NCT04193202|581173084|FG000|Overall Study|Adverse Event|2|||
160940329|NCT04193202|581173085|FG001|Overall Study|Adverse Event|1|||
160940330|NCT04193202|581173084|FG000|Overall Study|Death|0|||
160940331|NCT04193202|581173085|FG001|Overall Study|Death|1|||
160940332|NCT04193202|581173084|FG000|Overall Study|Physician Decision|1|||
160940333|NCT04193202|581173085|FG001|Overall Study|Physician Decision|1|||
160940334|NCT04193202|581173084|FG000|Overall Study|Protocol Violation|2|||
160940335|NCT04193202|581173085|FG001|Overall Study|Protocol Violation|2|||
160940336|NCT04193202|581173084|FG000|Overall Study|Withdrawal by Subject|11|||
160940337|NCT04193202|581173085|FG001|Overall Study|Withdrawal by Subject|5|||
160940338|NCT01777997|581173086|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
160940339|NCT01777997|581173086|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
160940340|NCT01777997|581173086|FG000|Weeks 48 to 72/96 on ART|Death|1|||
160940341|NCT01777997|581173086|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
160940342|NCT02488629|581173088|FG000|Overall Study|Lack of Efficacy|3|||
160940343|NCT02488629|581173089|FG001|Overall Study|Lack of Efficacy|1|||
160940344|NCT02488629|581173090|FG002|Overall Study|Lack of Efficacy|0|||
160940345|NCT02488629|581173091|FG003|Overall Study|Lack of Efficacy|0|||
160940346|NCT02488629|581173088|FG000|Overall Study|Withdrawal by Subject|0|||
160940347|NCT02488629|581173089|FG001|Overall Study|Withdrawal by Subject|1|||
160940348|NCT02488629|581173090|FG002|Overall Study|Withdrawal by Subject|0|||
160940349|NCT02488629|581173091|FG003|Overall Study|Withdrawal by Subject|0|||
160940350|NCT02932891|581173092|FG000|Overall Study|Lost to Follow-up|2|||
160940351|NCT02932891|581173092|FG000|Overall Study|HPA Suppress|2|||
160940352|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940353|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
160940354|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940355|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940356|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940357|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
160940358|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
160940359|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
160940360|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
160940361|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160940362|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160940363|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
160940364|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
160940365|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940366|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940367|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940368|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940369|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
160940370|NCT04622254|581173093|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940371|NCT04622254|581173094|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
160940372|NCT04622254|581173095|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
160940373|NCT04622254|581173096|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940374|NCT04622254|581173097|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940375|NCT04622254|581173098|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
160940376|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940377|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940378|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940379|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
160940380|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940381|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
160940382|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940383|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940384|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940385|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
160940386|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
160940387|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
160940388|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940389|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940390|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940391|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
160940392|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940393|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
160940394|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940395|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940396|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940397|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
160940398|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940399|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
160940400|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160940401|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160940402|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
160940403|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
160940404|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
160940405|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
160940406|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160940407|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160940408|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
160940409|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
160940410|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
160940411|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
160940412|NCT04622254|581173093|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
160940413|NCT04622254|581173094|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
160940414|NCT04622254|581173095|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
160940415|NCT04622254|581173096|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
160940416|NCT04622254|581173097|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
160940417|NCT04622254|581173098|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
160940418|NCT02652624|581173099|FG000|Randomized Phase|Pregnancy|3|||
160940419|NCT02652624|581173100|FG001|Randomized Phase|Pregnancy|1|||
160940420|NCT02652624|581173099|FG000|Randomized Phase|Investigator's Discretion|0|||
160940421|NCT02652624|581173100|FG001|Randomized Phase|Investigator's Discretion|2|||
160940422|NCT02652624|581173099|FG000|Randomized Phase|Death|0|||
160940423|NCT02652624|581173100|FG001|Randomized Phase|Death|1|||
160940424|NCT02652624|581173099|FG000|Randomized Phase|Lost to Follow-up|0|||
160940425|NCT02652624|581173100|FG001|Randomized Phase|Lost to Follow-up|1|||
160940426|NCT02652624|581173099|FG000|Extension Phase|Lost to Follow-up|3|||
160940427|NCT02652624|581173100|FG001|Extension Phase|Lost to Follow-up|1|||
160940428|NCT02652624|581173099|FG000|Extension Phase|Pregnancy|1|||
160940429|NCT02652624|581173100|FG001|Extension Phase|Pregnancy|1|||
160940430|NCT02652624|581173099|FG000|Extension Phase|Adverse Event|0|||
160940431|NCT02652624|581173100|FG001|Extension Phase|Adverse Event|1|||
160940432|NCT02652624|581173099|FG000|Extension Phase|Withdrew Consent|0|||
160940433|NCT02652624|581173100|FG001|Extension Phase|Withdrew Consent|1|||
160940434|NCT00577122|581173101|FG000|Overall Study|Adverse Event|0|||
160940435|NCT00577122|581173102|FG001|Overall Study|Adverse Event|2|||
160940436|NCT00577122|581173101|FG000|Overall Study|Progression, relapse during active trt|6|||
161264821|NCT00588640|582350792|FG000|Overall Study|Ineligible Patient|1|||
160940437|NCT00577122|581173102|FG001|Overall Study|Progression, relapse during active trt|8|||
160940438|NCT00577122|581173101|FG000|Overall Study|Prog, refract disease during active trt|8|||
160940439|NCT00577122|581173102|FG001|Overall Study|Prog, refract disease during active trt|5|||
160940440|NCT00577122|581173101|FG000|Overall Study|Alternative Therapy|0|||
160940441|NCT00577122|581173102|FG001|Overall Study|Alternative Therapy|1|||
160940442|NCT03228680|581173103|FG000|Overall Study|Adverse Event|13|||
160940443|NCT03228680|581173104|FG001|Overall Study|Adverse Event|18|||
160940444|NCT03228680|581173103|FG000|Overall Study|Randomization failure|0|||
160940445|NCT03228680|581173104|FG001|Overall Study|Randomization failure|1|||
160940446|NCT03228680|581173103|FG000|Overall Study|Withdrawal by Subject|1|||
160940447|NCT03228680|581173104|FG001|Overall Study|Withdrawal by Subject|0|||
160940448|NCT03228680|581173103|FG000|Overall Study|Other|9|||
160940449|NCT03228680|581173104|FG001|Overall Study|Other|16|||
160940450|NCT00796861|581173105|FG000|Overall Study|Withdrawal by Subject|2|||
160940451|NCT00796861|581173105|FG000|Overall Study|Death|2|||
160940452|NCT00844545|581173116|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
160940453|NCT00844545|581173116|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
160940454|NCT00844545|581173116|FG000|Extension Treatment Period|Adverse Event|2|||
160940455|NCT00844545|581173116|FG000|Post Treatment Period|Withdrawal by Subject|1|||
160940456|NCT00403455|581173117|FG000|Overall Study|Withdrawal by Subject|1|||
160940457|NCT01358981|581173118|FG000|Period 1|Withdrawal by Subject|0|||
160940458|NCT01358981|581173119|FG001|Period 1|Withdrawal by Subject|0|||
160940459|NCT01358981|581173120|FG002|Period 1|Withdrawal by Subject|0|||
160940460|NCT01358981|581173121|FG003|Period 1|Withdrawal by Subject|1|||
160940461|NCT01358981|581173122|FG004|Period 1|Withdrawal by Subject|0|||
160940462|NCT01358981|581173123|FG005|Period 1|Withdrawal by Subject|0|||
160940463|NCT01358981|581173124|FG006|Period 1|Withdrawal by Subject|0|||
160940464|NCT04574362|581173125|FG000|Overall Study|Other|0|||
160940465|NCT04574362|581173126|FG001|Overall Study|Other|5|||
160940466|NCT04574362|581173125|FG000|Overall Study|COVID-19|0|||
160940467|NCT04574362|581173126|FG001|Overall Study|COVID-19|1|||
160940468|NCT04574362|581173125|FG000|Overall Study|Adverse Event|1|||
160940469|NCT04574362|581173126|FG001|Overall Study|Adverse Event|1|||
160940470|NCT04574362|581173125|FG000|Overall Study|Withdrawal by Subject|2|||
160940471|NCT04574362|581173126|FG001|Overall Study|Withdrawal by Subject|4|||
160940472|NCT04574362|581173125|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
160940473|NCT04574362|581173126|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
160940474|NCT04574362|581173125|FG000|Overall Study|Participant refused to come to the hospital|1|||
160940475|NCT04574362|581173126|FG001|Overall Study|Participant refused to come to the hospital|0|||
160940476|NCT04574362|581173125|FG000|Overall Study|Participant refused the visit|1|||
160940477|NCT04574362|581173126|FG001|Overall Study|Participant refused the visit|0|||
160940478|NCT04574362|581173125|FG000|Overall Study|Participant quit early because of business trip|1|||
160940479|NCT04574362|581173126|FG001|Overall Study|Participant quit early because of business trip|0|||
160940480|NCT01785524|581173127|FG000|Overall Study|Withdrawal by Subject|2|||
160940481|NCT01785524|581173128|FG001|Overall Study|Withdrawal by Subject|2|||
160940482|NCT01060384|581173129|FG000|Overall Study|Withdrawal by Subject|0|||
160940483|NCT01060384|581173130|FG001|Overall Study|Withdrawal by Subject|1|||
160940484|NCT01060384|581173131|FG002|Overall Study|Withdrawal by Subject|0|||
160940485|NCT01060384|581173132|FG003|Overall Study|Withdrawal by Subject|0|||
160940486|NCT01060384|581173133|FG004|Overall Study|Withdrawal by Subject|0|||
160940487|NCT01060384|581173129|FG000|Overall Study|Death|0|||
160940488|NCT01060384|581173130|FG001|Overall Study|Death|0|||
160940489|NCT01060384|581173131|FG002|Overall Study|Death|0|||
160940490|NCT01060384|581173132|FG003|Overall Study|Death|0|||
160940491|NCT01060384|581173133|FG004|Overall Study|Death|1|||
160940492|NCT01060384|581173129|FG000|Overall Study|Intercurrent illness|0|||
160940493|NCT01060384|581173130|FG001|Overall Study|Intercurrent illness|0|||
160940494|NCT01060384|581173131|FG002|Overall Study|Intercurrent illness|0|||
160940495|NCT01060384|581173132|FG003|Overall Study|Intercurrent illness|0|||
160940496|NCT01060384|581173133|FG004|Overall Study|Intercurrent illness|1|||
160940497|NCT01332305|581173134|FG000|Overall Study|Adverse Event|1|||
160940498|NCT01332305|581173135|FG001|Overall Study|Adverse Event|4|||
160940499|NCT01332305|581173136|FG002|Overall Study|Adverse Event|6|||
160940500|NCT01332305|581173137|FG003|Overall Study|Adverse Event|3|||
160940501|NCT01332305|581173138|FG004|Overall Study|Adverse Event|5|||
160940502|NCT01332305|581173134|FG000|Overall Study|Withdrawal by Subject|6|||
160940503|NCT01332305|581173135|FG001|Overall Study|Withdrawal by Subject|5|||
160940504|NCT01332305|581173136|FG002|Overall Study|Withdrawal by Subject|4|||
160940505|NCT01332305|581173137|FG003|Overall Study|Withdrawal by Subject|1|||
160940506|NCT01332305|581173138|FG004|Overall Study|Withdrawal by Subject|0|||
160940507|NCT01332305|581173134|FG000|Overall Study|Lost to Follow-up|0|||
160940508|NCT01332305|581173135|FG001|Overall Study|Lost to Follow-up|2|||
160940509|NCT01332305|581173136|FG002|Overall Study|Lost to Follow-up|3|||
160940510|NCT01332305|581173137|FG003|Overall Study|Lost to Follow-up|2|||
160940511|NCT01332305|581173138|FG004|Overall Study|Lost to Follow-up|3|||
160940512|NCT01332305|581173134|FG000|Overall Study|Protocol Violation|1|||
160940513|NCT01332305|581173135|FG001|Overall Study|Protocol Violation|2|||
161264822|NCT01393730|582350793|FG000|Overall Study|Withdrawal by Subject|3|||
161264823|NCT01393730|582350793|FG000|Overall Study|Other|2|||
160940514|NCT01332305|581173136|FG002|Overall Study|Protocol Violation|1|||
160940515|NCT01332305|581173137|FG003|Overall Study|Protocol Violation|0|||
160940516|NCT01332305|581173138|FG004|Overall Study|Protocol Violation|3|||
161264824|NCT01393730|582350793|FG000|Overall Study|Adverse Event|1|||
161319318|NCT03488563|582555265|FG000|Overall Study|Subject returned for ET visit|0|||
161319319|NCT03488563|582555266|FG001|Overall Study|Subject returned for ET visit|1|||
161319320|NCT03488563|582555267|FG002|Overall Study|Subject returned for ET visit|0|||
161319321|NCT03488563|582555265|FG000|Overall Study|Sponsor's decision|0|||
161319322|NCT03488563|582555266|FG001|Overall Study|Sponsor's decision|0|||
161319323|NCT03488563|582555267|FG002|Overall Study|Sponsor's decision|1|||
161319324|NCT02626000|582555268|FG000|Overall Study|Decision by Sponsor|1|||
161319325|NCT02626000|582555268|FG000|Overall Study|Death|29|||
161319326|NCT01411319|582555273|FG000|Overall Study|Lost to Follow-up|1|||
161319327|NCT01796301|582555279|FG000|Overall Study|Withdrawal by Subject|15|||
161319328|NCT01796301|582555280|FG001|Overall Study|Withdrawal by Subject|15|||
161319329|NCT01796301|582555279|FG000|Overall Study|Lost to Follow-up|3|||
161319330|NCT01796301|582555280|FG001|Overall Study|Lost to Follow-up|3|||
161319331|NCT01796301|582555279|FG000|Overall Study|Death|0|||
161319332|NCT01796301|582555280|FG001|Overall Study|Death|1|||
161319333|NCT01796301|582555279|FG000|Overall Study|Decision by Sponsor|0|||
161319334|NCT01796301|582555280|FG001|Overall Study|Decision by Sponsor|1|||
161319335|NCT01597492|582555281|FG000|Overall Study|Withdrawal by Subject|1|||
161319336|NCT01597492|582555282|FG001|Overall Study|Withdrawal by Subject|2|||
161319337|NCT01597492|582555281|FG000|Overall Study|Adverse Event|3|||
161319338|NCT01597492|582555282|FG001|Overall Study|Adverse Event|0|||
161319339|NCT01597492|582555281|FG000|Overall Study|Lost to Follow-up|0|||
161319340|NCT01597492|582555282|FG001|Overall Study|Lost to Follow-up|2|||
161319341|NCT01597492|582555281|FG000|Overall Study|Other Reason|2|||
161319342|NCT01597492|582555282|FG001|Overall Study|Other Reason|0|||
161319343|NCT02570750|582555283|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
161319344|NCT02570750|582555284|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
161319345|NCT02570750|582555283|FG000|Overall Study|Protocol deviation|4|||
161319346|NCT02570750|582555284|FG001|Overall Study|Protocol deviation|2|||
160940517|NCT01332305|581173134|FG000|Overall Study|Withdrawal by Sponsor|1|||
160940518|NCT01332305|581173135|FG001|Overall Study|Withdrawal by Sponsor|0|||
160940519|NCT01332305|581173136|FG002|Overall Study|Withdrawal by Sponsor|0|||
160940520|NCT01332305|581173137|FG003|Overall Study|Withdrawal by Sponsor|1|||
160940521|NCT01332305|581173138|FG004|Overall Study|Withdrawal by Sponsor|1|||
160940522|NCT01332305|581173134|FG000|Overall Study|Treatment Failure|1|||
160940523|NCT01332305|581173135|FG001|Overall Study|Treatment Failure|1|||
160940524|NCT01332305|581173136|FG002|Overall Study|Treatment Failure|0|||
160940525|NCT01332305|581173137|FG003|Overall Study|Treatment Failure|0|||
160940526|NCT01332305|581173138|FG004|Overall Study|Treatment Failure|0|||
161144346|NCT01607892|581911967|FG004|Overall Study|Investigator discretion|0|||
161144347|NCT01607892|581911963|FG000|Overall Study|Other treatments became available|1|||
161144348|NCT01607892|581911964|FG001|Overall Study|Other treatments became available|1|||
161144349|NCT01607892|581911965|FG002|Overall Study|Other treatments became available|0|||
161144350|NCT01607892|581911966|FG003|Overall Study|Other treatments became available|0|||
160940527|NCT01332305|581173134|FG000|Overall Study|Physician Decision|0|||
160940528|NCT01332305|581173135|FG001|Overall Study|Physician Decision|0|||
160940529|NCT01332305|581173136|FG002|Overall Study|Physician Decision|0|||
160940530|NCT01332305|581173137|FG003|Overall Study|Physician Decision|1|||
160940531|NCT01332305|581173138|FG004|Overall Study|Physician Decision|0|||
160940532|NCT01600040|581173139|FG000|Overall Study|Withdrawal by Subject|1|||
160940533|NCT01401530|581173145|FG000|Overall Study|Disease Progression|1|||
160940534|NCT01401530|581173146|FG001|Overall Study|Disease Progression|2|||
160940535|NCT01401530|581173147|FG002|Overall Study|Disease Progression|1|||
160940536|NCT01401530|581173145|FG000|Overall Study|Adverse Event|1|||
161144351|NCT01607892|581911967|FG004|Overall Study|Other treatments became available|2|||
161319347|NCT02570750|582555283|FG000|Overall Study|Withdrawal by Subject|5|||
161319348|NCT02570750|582555284|FG001|Overall Study|Withdrawal by Subject|0|||
161319349|NCT02570750|582555283|FG000|Overall Study|Lost to Follow-up|2|||
161319350|NCT02570750|582555284|FG001|Overall Study|Lost to Follow-up|2|||
160940537|NCT01401530|581173146|FG001|Overall Study|Adverse Event|1|||
160940538|NCT01401530|581173147|FG002|Overall Study|Adverse Event|1|||
160940539|NCT01401530|581173145|FG000|Overall Study|Participant Choice|1|||
160940540|NCT01401530|581173146|FG001|Overall Study|Participant Choice|2|||
161144352|NCT01607892|581911963|FG000|Overall Study|Intercurrent illness|1|||
161319351|NCT02570750|582555283|FG000|Overall Study|Adverse Event|2|||
161319352|NCT02570750|582555284|FG001|Overall Study|Adverse Event|1|||
161319353|NCT01884545|582555285|FG000|Overall Study|Lost to Follow-up|6|||
161319354|NCT01884545|582555286|FG001|Overall Study|Lost to Follow-up|4|||
161319355|NCT01884545|582555287|FG002|Overall Study|Lost to Follow-up|9|||
161319356|NCT01884545|582555288|FG003|Overall Study|Lost to Follow-up|4|||
161319357|NCT01884545|582555285|FG000|Overall Study|Patient withdrawn|7|||
160940541|NCT01401530|581173147|FG002|Overall Study|Participant Choice|1|||
161319358|NCT01884545|582555286|FG001|Overall Study|Patient withdrawn|12|||
161264825|NCT00321828|582352276|FG000|Overall Study|Ineligible|3|||
161264826|NCT00321828|582352276|FG000|Overall Study|No follow up data|1|||
161264827|NCT01032018|582352279|FG000|Overall Study|Lost to Follow-up|6|||
161264828|NCT01032018|582352280|FG001|Overall Study|Lost to Follow-up|5|||
161264829|NCT01032018|582352279|FG000|Overall Study|Death|0|||
161264830|NCT01032018|582352280|FG001|Overall Study|Death|1|||
161264831|NCT00678041|582352290|FG000|Overall Study|Physician Decision|5|||
161264832|NCT00678041|582352291|FG001|Overall Study|Physician Decision|5|||
161264833|NCT00577395|582352294|FG000|Overall Study|Study was terminated early by Sponsor|7|||
161264834|NCT00577395|582352295|FG001|Overall Study|Study was terminated early by Sponsor|6|||
161264835|NCT03084367|582352298|FG000|Overall Study|Lost to Follow-up|32|||
161264836|NCT03084367|582352298|FG000|Overall Study|Withdrawal by Subject|4|||
161264837|NCT03084367|582352298|FG000|Overall Study|Other|1|||
160940542|NCT01401530|581173145|FG000|Overall Study|Physician Decision|0|||
160940543|NCT01401530|581173146|FG001|Overall Study|Physician Decision|1|||
160940544|NCT01401530|581173147|FG002|Overall Study|Physician Decision|0|||
160940545|NCT03670810|581173148|FG000|Main Study|Adverse Event|37|||
160940546|NCT03670810|581173149|FG001|Main Study|Adverse Event|38|||
160940547|NCT03670810|581173150|FG002|Main Study|Adverse Event|3|||
160940548|NCT03670810|581173151|FG003|Main Study|Adverse Event|4|||
160940549|NCT03670810|581173152|FG004|Main Study|Adverse Event|4|||
160940550|NCT03670810|581173153|FG005|Main Study|Adverse Event|5|||
160940551|NCT03670810|581173154|FG006|Main Study|Adverse Event|0|||
160940552|NCT03670810|581173155|FG007|Main Study|Adverse Event|0|||
160940553|NCT03670810|581173156|FG008|Main Study|Adverse Event|0|||
160940554|NCT03670810|581173148|FG000|Main Study|Lack of Efficacy|8|||
160940555|NCT03670810|581173149|FG001|Main Study|Lack of Efficacy|9|||
160940556|NCT03670810|581173150|FG002|Main Study|Lack of Efficacy|3|||
160940557|NCT03670810|581173151|FG003|Main Study|Lack of Efficacy|4|||
160940558|NCT03670810|581173152|FG004|Main Study|Lack of Efficacy|0|||
160940559|NCT03670810|581173153|FG005|Main Study|Lack of Efficacy|0|||
160940560|NCT03670810|581173154|FG006|Main Study|Lack of Efficacy|0|||
160940561|NCT03670810|581173155|FG007|Main Study|Lack of Efficacy|0|||
160940562|NCT03670810|581173156|FG008|Main Study|Lack of Efficacy|0|||
160940563|NCT03670810|581173148|FG000|Main Study|Lost to Follow-up|9|||
160940564|NCT03670810|581173149|FG001|Main Study|Lost to Follow-up|7|||
160940565|NCT03670810|581173150|FG002|Main Study|Lost to Follow-up|4|||
160940566|NCT03670810|581173151|FG003|Main Study|Lost to Follow-up|6|||
160940567|NCT03670810|581173152|FG004|Main Study|Lost to Follow-up|1|||
160940568|NCT03670810|581173153|FG005|Main Study|Lost to Follow-up|0|||
160940569|NCT03670810|581173154|FG006|Main Study|Lost to Follow-up|0|||
160940570|NCT03670810|581173155|FG007|Main Study|Lost to Follow-up|0|||
160940571|NCT03670810|581173156|FG008|Main Study|Lost to Follow-up|0|||
160940572|NCT03670810|581173148|FG000|Main Study|Non-compliance with Study Drug|0|||
160940573|NCT03670810|581173149|FG001|Main Study|Non-compliance with Study Drug|2|||
160940574|NCT03670810|581173150|FG002|Main Study|Non-compliance with Study Drug|3|||
160940575|NCT03670810|581173151|FG003|Main Study|Non-compliance with Study Drug|0|||
161264838|NCT01206101|582352299|FG000|Overall Study|Adverse Event|1|||
161264839|NCT01206101|582352300|FG001|Overall Study|Adverse Event|0|||
161264840|NCT01206101|582352299|FG000|Overall Study|Physician Decision|0|||
161264841|NCT01206101|582352300|FG001|Overall Study|Physician Decision|1|||
160940576|NCT03670810|581173152|FG004|Main Study|Non-compliance with Study Drug|0|||
160940577|NCT03670810|581173153|FG005|Main Study|Non-compliance with Study Drug|0|||
160940578|NCT03670810|581173154|FG006|Main Study|Non-compliance with Study Drug|0|||
160940579|NCT03670810|581173155|FG007|Main Study|Non-compliance with Study Drug|1|||
160940580|NCT03670810|581173156|FG008|Main Study|Non-compliance with Study Drug|0|||
160940581|NCT03670810|581173148|FG000|Main Study|Physician Decision|3|||
160940582|NCT03670810|581173149|FG001|Main Study|Physician Decision|0|||
160940583|NCT03670810|581173150|FG002|Main Study|Physician Decision|1|||
160940584|NCT03670810|581173151|FG003|Main Study|Physician Decision|0|||
160940585|NCT03670810|581173152|FG004|Main Study|Physician Decision|0|||
160940586|NCT03670810|581173153|FG005|Main Study|Physician Decision|0|||
160940587|NCT03670810|581173154|FG006|Main Study|Physician Decision|1|||
160940588|NCT03670810|581173155|FG007|Main Study|Physician Decision|1|||
160940589|NCT03670810|581173156|FG008|Main Study|Physician Decision|0|||
160940590|NCT03670810|581173148|FG000|Main Study|Pregnancy|1|||
160940591|NCT03670810|581173149|FG001|Main Study|Pregnancy|2|||
160940592|NCT03670810|581173150|FG002|Main Study|Pregnancy|0|||
160940593|NCT03670810|581173151|FG003|Main Study|Pregnancy|0|||
160940594|NCT03670810|581173152|FG004|Main Study|Pregnancy|0|||
160940595|NCT03670810|581173153|FG005|Main Study|Pregnancy|0|||
160940596|NCT03670810|581173154|FG006|Main Study|Pregnancy|0|||
161264842|NCT01206101|582352299|FG000|Overall Study|Unclassified|1|||
161264843|NCT01206101|582352300|FG001|Overall Study|Unclassified|0|||
161264844|NCT00368979|582352306|FG000|Overall Study|Adverse Event|9|||
160940597|NCT03670810|581173155|FG007|Main Study|Pregnancy|0|||
160940598|NCT03670810|581173156|FG008|Main Study|Pregnancy|0|||
160940599|NCT03670810|581173148|FG000|Main Study|Protocol Deviation|2|||
160940600|NCT03670810|581173149|FG001|Main Study|Protocol Deviation|12|||
160940601|NCT03670810|581173150|FG002|Main Study|Protocol Deviation|8|||
160940602|NCT03670810|581173151|FG003|Main Study|Protocol Deviation|4|||
161264845|NCT00368979|582352307|FG001|Overall Study|Adverse Event|16|||
160940603|NCT03670810|581173152|FG004|Main Study|Protocol Deviation|0|||
160940604|NCT03670810|581173153|FG005|Main Study|Protocol Deviation|0|||
160940605|NCT03670810|581173154|FG006|Main Study|Protocol Deviation|0|||
160940606|NCT03670810|581173155|FG007|Main Study|Protocol Deviation|0|||
160940607|NCT03670810|581173156|FG008|Main Study|Protocol Deviation|0|||
160940608|NCT03670810|581173148|FG000|Main Study|Withdrawal by Subject|21|||
160940609|NCT03670810|581173149|FG001|Main Study|Withdrawal by Subject|21|||
160940610|NCT03670810|581173150|FG002|Main Study|Withdrawal by Subject|8|||
160940611|NCT03670810|581173151|FG003|Main Study|Withdrawal by Subject|9|||
160940612|NCT03670810|581173152|FG004|Main Study|Withdrawal by Subject|5|||
160940613|NCT03670810|581173153|FG005|Main Study|Withdrawal by Subject|2|||
160940614|NCT03670810|581173154|FG006|Main Study|Withdrawal by Subject|1|||
160940615|NCT03670810|581173155|FG007|Main Study|Withdrawal by Subject|1|||
160940616|NCT03670810|581173156|FG008|Main Study|Withdrawal by Subject|0|||
160940617|NCT03670810|581173148|FG000|Main Study|Participant did not want to take the three other treatments|1|||
160940618|NCT03670810|581173149|FG001|Main Study|Participant did not want to take the three other treatments|0|||
160940619|NCT03670810|581173150|FG002|Main Study|Participant did not want to take the three other treatments|0|||
160940620|NCT03670810|581173151|FG003|Main Study|Participant did not want to take the three other treatments|0|||
160940621|NCT03670810|581173152|FG004|Main Study|Participant did not want to take the three other treatments|0|||
160940622|NCT03670810|581173153|FG005|Main Study|Participant did not want to take the three other treatments|0|||
160940623|NCT03670810|581173154|FG006|Main Study|Participant did not want to take the three other treatments|0|||
160940624|NCT03670810|581173155|FG007|Main Study|Participant did not want to take the three other treatments|0|||
160940625|NCT03670810|581173156|FG008|Main Study|Participant did not want to take the three other treatments|0|||
160940626|NCT03670810|581173148|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940627|NCT03670810|581173149|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
160940628|NCT03670810|581173150|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940629|NCT03670810|581173151|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940630|NCT03670810|581173152|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940631|NCT03670810|581173153|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940632|NCT03670810|581173154|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940633|NCT03670810|581173155|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940634|NCT03670810|581173156|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
160940635|NCT03670810|581173148|FG000|Main Study|Travel and Coronavirus issues|0|||
160940636|NCT03670810|581173149|FG001|Main Study|Travel and Coronavirus issues|0|||
160940637|NCT03670810|581173150|FG002|Main Study|Travel and Coronavirus issues|0|||
160940638|NCT03670810|581173151|FG003|Main Study|Travel and Coronavirus issues|1|||
160940639|NCT03670810|581173152|FG004|Main Study|Travel and Coronavirus issues|0|||
160940640|NCT03670810|581173153|FG005|Main Study|Travel and Coronavirus issues|0|||
160940641|NCT03670810|581173154|FG006|Main Study|Travel and Coronavirus issues|0|||
160940642|NCT03670810|581173155|FG007|Main Study|Travel and Coronavirus issues|0|||
160940643|NCT03670810|581173156|FG008|Main Study|Travel and Coronavirus issues|0|||
160940644|NCT03670810|581173148|FG000|Open Label Extension|Protocol Deviation|0|||
160940645|NCT03670810|581173149|FG001|Open Label Extension|Protocol Deviation|0|||
160940646|NCT03670810|581173150|FG002|Open Label Extension|Protocol Deviation|0|||
160940647|NCT03670810|581173151|FG003|Open Label Extension|Protocol Deviation|0|||
160940648|NCT03670810|581173152|FG004|Open Label Extension|Protocol Deviation|0|||
160940649|NCT03670810|581173153|FG005|Open Label Extension|Protocol Deviation|0|||
160940650|NCT03670810|581173154|FG006|Open Label Extension|Protocol Deviation|0|||
160940651|NCT03670810|581173155|FG007|Open Label Extension|Protocol Deviation|0|||
160940652|NCT03670810|581173156|FG008|Open Label Extension|Protocol Deviation|5|||
160940653|NCT03670810|581173148|FG000|Open Label Extension|Death|0|||
160940654|NCT03670810|581173149|FG001|Open Label Extension|Death|0|||
160940655|NCT03670810|581173150|FG002|Open Label Extension|Death|0|||
161264846|NCT00368979|582352306|FG000|Overall Study|Lack of Efficacy|5|||
161264847|NCT00368979|582352307|FG001|Overall Study|Lack of Efficacy|3|||
161264848|NCT00368979|582352306|FG000|Overall Study|Other|3|||
161264849|NCT00368979|582352307|FG001|Overall Study|Other|1|||
161264850|NCT00368979|582352306|FG000|Overall Study|Lost to Follow-up|1|||
161264851|NCT00368979|582352307|FG001|Overall Study|Lost to Follow-up|0|||
161264852|NCT00368979|582352306|FG000|Overall Study|Protocol Violation|2|||
161264853|NCT00368979|582352307|FG001|Overall Study|Protocol Violation|1|||
161264854|NCT00368979|582352306|FG000|Overall Study|Withdrawal by Subject|5|||
161264855|NCT00368979|582352307|FG001|Overall Study|Withdrawal by Subject|9|||
161264856|NCT00103311|582352308|FG000|Overall Study|Lost to Follow-up|1|||
161264857|NCT00103311|582352309|FG001|Overall Study|Lost to Follow-up|0|||
160940656|NCT03670810|581173151|FG003|Open Label Extension|Death|0|||
160940657|NCT03670810|581173152|FG004|Open Label Extension|Death|0|||
160940658|NCT03670810|581173153|FG005|Open Label Extension|Death|0|||
161144353|NCT01607892|581911964|FG001|Overall Study|Intercurrent illness|0|||
161264858|NCT00103311|582352308|FG000|Overall Study|Withdrawal by Subject|2|||
161264859|NCT00103311|582352309|FG001|Overall Study|Withdrawal by Subject|1|||
161264860|NCT00103311|582352308|FG000|Overall Study|Adverse Event|1|||
161144354|NCT01607892|581911965|FG002|Overall Study|Intercurrent illness|0|||
161144355|NCT01607892|581911966|FG003|Overall Study|Intercurrent illness|3|||
161144356|NCT01607892|581911967|FG004|Overall Study|Intercurrent illness|0|||
161144357|NCT01607892|581911963|FG000|Overall Study|Non-Compliance with study procedures|0|||
161144358|NCT01607892|581911964|FG001|Overall Study|Non-Compliance with study procedures|0|||
161144359|NCT01607892|581911965|FG002|Overall Study|Non-Compliance with study procedures|1|||
161144360|NCT01607892|581911966|FG003|Overall Study|Non-Compliance with study procedures|0|||
161144361|NCT01607892|581911967|FG004|Overall Study|Non-Compliance with study procedures|0|||
160940659|NCT03670810|581173154|FG006|Open Label Extension|Death|0|||
160940660|NCT03670810|581173155|FG007|Open Label Extension|Death|0|||
160940661|NCT03670810|581173156|FG008|Open Label Extension|Death|1|||
160940662|NCT03670810|581173148|FG000|Open Label Extension|COVID-19|0|||
160940663|NCT03670810|581173149|FG001|Open Label Extension|COVID-19|0|||
160940664|NCT03670810|581173150|FG002|Open Label Extension|COVID-19|0|||
160940665|NCT03670810|581173151|FG003|Open Label Extension|COVID-19|0|||
160940666|NCT03670810|581173152|FG004|Open Label Extension|COVID-19|0|||
160940667|NCT03670810|581173153|FG005|Open Label Extension|COVID-19|0|||
160940668|NCT03670810|581173154|FG006|Open Label Extension|COVID-19|0|||
160940669|NCT03670810|581173155|FG007|Open Label Extension|COVID-19|0|||
160940670|NCT03670810|581173156|FG008|Open Label Extension|COVID-19|1|||
160940671|NCT03670810|581173148|FG000|Open Label Extension|Lack of Efficacy|0|||
160940672|NCT03670810|581173149|FG001|Open Label Extension|Lack of Efficacy|0|||
160940673|NCT03670810|581173150|FG002|Open Label Extension|Lack of Efficacy|0|||
160940674|NCT03670810|581173151|FG003|Open Label Extension|Lack of Efficacy|0|||
160940675|NCT03670810|581173152|FG004|Open Label Extension|Lack of Efficacy|0|||
160940676|NCT03670810|581173153|FG005|Open Label Extension|Lack of Efficacy|0|||
160940677|NCT03670810|581173154|FG006|Open Label Extension|Lack of Efficacy|0|||
160940678|NCT03670810|581173155|FG007|Open Label Extension|Lack of Efficacy|0|||
160940679|NCT03670810|581173156|FG008|Open Label Extension|Lack of Efficacy|39|||
160940680|NCT03670810|581173148|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
160940681|NCT03670810|581173149|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
160940682|NCT03670810|581173150|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
160940683|NCT03670810|581173151|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
160940684|NCT03670810|581173152|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
160940685|NCT03670810|581173153|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
160940686|NCT03670810|581173154|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
160940687|NCT03670810|581173155|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
160940688|NCT03670810|581173156|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
160940689|NCT03670810|581173148|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940690|NCT03670810|581173149|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940691|NCT03670810|581173150|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940692|NCT03670810|581173151|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940693|NCT03670810|581173152|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940694|NCT03670810|581173153|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940695|NCT03670810|581173154|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940696|NCT03670810|581173155|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
160940697|NCT03670810|581173156|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
160940698|NCT03670810|581173148|FG000|Open Label Extension|Withdrawal by Subject|0|||
160940699|NCT03670810|581173149|FG001|Open Label Extension|Withdrawal by Subject|0|||
160940700|NCT03670810|581173150|FG002|Open Label Extension|Withdrawal by Subject|0|||
160940701|NCT03670810|581173151|FG003|Open Label Extension|Withdrawal by Subject|0|||
160940702|NCT03670810|581173152|FG004|Open Label Extension|Withdrawal by Subject|0|||
160940703|NCT03670810|581173153|FG005|Open Label Extension|Withdrawal by Subject|0|||
160940704|NCT03670810|581173154|FG006|Open Label Extension|Withdrawal by Subject|0|||
160940705|NCT03670810|581173155|FG007|Open Label Extension|Withdrawal by Subject|0|||
160940706|NCT03670810|581173156|FG008|Open Label Extension|Withdrawal by Subject|46|||
160940707|NCT03670810|581173148|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940708|NCT03670810|581173149|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940709|NCT03670810|581173150|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940710|NCT03670810|581173151|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940711|NCT03670810|581173152|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
161144362|NCT01607892|581911963|FG000|Overall Study|Consent withdrawn by participant|9|||
161144363|NCT01607892|581911964|FG001|Overall Study|Consent withdrawn by participant|4|||
161144364|NCT01607892|581911965|FG002|Overall Study|Consent withdrawn by participant|24|||
161144365|NCT01607892|581911966|FG003|Overall Study|Consent withdrawn by participant|14|||
161264861|NCT00103311|582352309|FG001|Overall Study|Adverse Event|0|||
161264862|NCT00912093|582352310|FG000|The Controlled Phase|Death|0|||
161144366|NCT01607892|581911967|FG004|Overall Study|Consent withdrawn by participant|4|||
160940712|NCT03670810|581173153|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940713|NCT03670810|581173154|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940714|NCT03670810|581173155|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
160940715|NCT03670810|581173156|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
160940716|NCT03670810|581173148|FG000|Open Label Extension|Physician Decision|0|||
160940717|NCT03670810|581173149|FG001|Open Label Extension|Physician Decision|0|||
160940718|NCT03670810|581173150|FG002|Open Label Extension|Physician Decision|0|||
160940719|NCT03670810|581173151|FG003|Open Label Extension|Physician Decision|0|||
160940720|NCT03670810|581173152|FG004|Open Label Extension|Physician Decision|0|||
160940721|NCT03670810|581173153|FG005|Open Label Extension|Physician Decision|0|||
160940722|NCT03670810|581173154|FG006|Open Label Extension|Physician Decision|0|||
160940723|NCT03670810|581173155|FG007|Open Label Extension|Physician Decision|0|||
160940724|NCT03670810|581173156|FG008|Open Label Extension|Physician Decision|2|||
160940725|NCT03670810|581173148|FG000|Open Label Extension|Non-compliance with study drug|0|||
160940726|NCT03670810|581173149|FG001|Open Label Extension|Non-compliance with study drug|0|||
160940727|NCT03670810|581173150|FG002|Open Label Extension|Non-compliance with study drug|0|||
160940728|NCT03670810|581173151|FG003|Open Label Extension|Non-compliance with study drug|0|||
160940729|NCT03670810|581173152|FG004|Open Label Extension|Non-compliance with study drug|0|||
160940730|NCT03670810|581173153|FG005|Open Label Extension|Non-compliance with study drug|0|||
160940731|NCT03670810|581173154|FG006|Open Label Extension|Non-compliance with study drug|0|||
160940732|NCT03670810|581173155|FG007|Open Label Extension|Non-compliance with study drug|0|||
160940733|NCT03670810|581173156|FG008|Open Label Extension|Non-compliance with study drug|5|||
160940734|NCT03670810|581173148|FG000|Open Label Extension|Pregnancy|0|||
160940735|NCT03670810|581173149|FG001|Open Label Extension|Pregnancy|0|||
160940736|NCT03670810|581173150|FG002|Open Label Extension|Pregnancy|0|||
160940737|NCT03670810|581173151|FG003|Open Label Extension|Pregnancy|0|||
160940738|NCT03670810|581173152|FG004|Open Label Extension|Pregnancy|0|||
160940739|NCT03670810|581173153|FG005|Open Label Extension|Pregnancy|0|||
160940740|NCT03670810|581173154|FG006|Open Label Extension|Pregnancy|0|||
160940741|NCT03670810|581173155|FG007|Open Label Extension|Pregnancy|0|||
160940742|NCT03670810|581173156|FG008|Open Label Extension|Pregnancy|3|||
160940743|NCT03670810|581173148|FG000|Open Label Extension|Adverse Event|0|||
160940744|NCT03670810|581173149|FG001|Open Label Extension|Adverse Event|0|||
160940745|NCT03670810|581173150|FG002|Open Label Extension|Adverse Event|0|||
160940746|NCT03670810|581173151|FG003|Open Label Extension|Adverse Event|0|||
160940747|NCT03670810|581173152|FG004|Open Label Extension|Adverse Event|0|||
160940748|NCT03670810|581173153|FG005|Open Label Extension|Adverse Event|0|||
160940749|NCT03670810|581173154|FG006|Open Label Extension|Adverse Event|0|||
160940750|NCT03670810|581173155|FG007|Open Label Extension|Adverse Event|0|||
160940751|NCT03670810|581173156|FG008|Open Label Extension|Adverse Event|24|||
160940752|NCT03670810|581173148|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
160940753|NCT03670810|581173149|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
160940754|NCT03670810|581173150|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
160940755|NCT03670810|581173151|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
160940756|NCT03670810|581173152|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
160940757|NCT03670810|581173153|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
160940758|NCT03670810|581173154|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
160940759|NCT03670810|581173155|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
160940760|NCT03670810|581173156|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
160940761|NCT03670810|581173148|FG000|Open Label Extension|Lost to Follow-up|0|||
160940762|NCT03670810|581173149|FG001|Open Label Extension|Lost to Follow-up|0|||
160940763|NCT03670810|581173150|FG002|Open Label Extension|Lost to Follow-up|0|||
160940764|NCT03670810|581173151|FG003|Open Label Extension|Lost to Follow-up|0|||
160940765|NCT03670810|581173152|FG004|Open Label Extension|Lost to Follow-up|0|||
160940766|NCT03670810|581173153|FG005|Open Label Extension|Lost to Follow-up|0|||
160940767|NCT03670810|581173154|FG006|Open Label Extension|Lost to Follow-up|0|||
160940768|NCT03670810|581173155|FG007|Open Label Extension|Lost to Follow-up|0|||
160940769|NCT03670810|581173156|FG008|Open Label Extension|Lost to Follow-up|23|||
160940770|NCT00678691|581173157|FG000|Overall Study|Adverse Event|6|||
160940771|NCT00678691|581173158|FG001|Overall Study|Adverse Event|4|||
160940772|NCT03192150|581173165|FG000|Overall Study|Adverse Event|14|||
160940773|NCT03192150|581173166|FG001|Overall Study|Adverse Event|12|||
160940774|NCT03192150|581173165|FG000|Overall Study|Lack of Efficacy|23|||
160940775|NCT03192150|581173166|FG001|Overall Study|Lack of Efficacy|30|||
160940776|NCT03192150|581173165|FG000|Overall Study|Lost to Follow-up|1|||
160940777|NCT03192150|581173166|FG001|Overall Study|Lost to Follow-up|1|||
160940778|NCT03192150|581173165|FG000|Overall Study|Withdrawal by Subject|4|||
160940779|NCT03192150|581173166|FG001|Overall Study|Withdrawal by Subject|2|||
160940780|NCT03192150|581173165|FG000|Overall Study|Protocol Violation|5|||
160940781|NCT03192150|581173166|FG001|Overall Study|Protocol Violation|2|||
160940782|NCT03192150|581173165|FG000|Overall Study|Surgery Canceled|6|||
160940783|NCT03192150|581173166|FG001|Overall Study|Surgery Canceled|2|||
161264863|NCT00912093|582352311|FG001|The Controlled Phase|Death|1|||
160940784|NCT03192150|581173165|FG000|Overall Study|Other-Various Administrative Reasons|2|||
160940785|NCT03192150|581173166|FG001|Overall Study|Other-Various Administrative Reasons|5|||
160940786|NCT00779766|581173167|FG000|Month 24|Serious Adverse Event|2|||
160940787|NCT00779766|581173168|FG001|Month 24|Serious Adverse Event|3|||
160940788|NCT00779766|581173167|FG000|Month 24|Adverse Event|3|||
160940789|NCT00779766|581173168|FG001|Month 24|Adverse Event|3|||
160940790|NCT00779766|581173167|FG000|Month 24|Protocol Violation|3|||
160940791|NCT00779766|581173168|FG001|Month 24|Protocol Violation|1|||
160940792|NCT00779766|581173167|FG000|Month 24|Withdrawal by Subject|159|||
160940793|NCT00779766|581173168|FG001|Month 24|Withdrawal by Subject|127|||
161264864|NCT00912093|582352312|FG002|The Controlled Phase|Death|0|||
161264865|NCT00912093|582352313|FG003|The Controlled Phase|Death|0|||
161264866|NCT00912093|582352314|FG004|The Controlled Phase|Death|0|||
161264867|NCT00912093|582352310|FG000|The Controlled Phase|Medical Condition|0|||
160940794|NCT00779766|581173167|FG000|Month 24|Migrated/moved from study area|138|||
161264868|NCT00912093|582352311|FG001|The Controlled Phase|Medical Condition|1|||
161264869|NCT00912093|582352312|FG002|The Controlled Phase|Medical Condition|0|||
161264870|NCT00912093|582352313|FG003|The Controlled Phase|Medical Condition|0|||
161264871|NCT00912093|582352314|FG004|The Controlled Phase|Medical Condition|0|||
161264872|NCT00912093|582352310|FG000|The Controlled Phase|Lost to Follow-up|0|||
161264873|NCT00912093|582352311|FG001|The Controlled Phase|Lost to Follow-up|0|||
161264874|NCT00912093|582352312|FG002|The Controlled Phase|Lost to Follow-up|0|||
161264875|NCT00912093|582352313|FG003|The Controlled Phase|Lost to Follow-up|0|||
161264876|NCT00912093|582352314|FG004|The Controlled Phase|Lost to Follow-up|1|||
161264877|NCT00394524|582352315|FG000|Overall Study|Protocol Violation|2|||
161264878|NCT00394524|582352316|FG001|Overall Study|Protocol Violation|3|||
161264879|NCT00394524|582352315|FG000|Overall Study|Death|1|||
161264880|NCT00394524|582352316|FG001|Overall Study|Death|0|||
161264881|NCT00394524|582352315|FG000|Overall Study|Withdrawal by Subject|0|||
161264882|NCT00394524|582352316|FG001|Overall Study|Withdrawal by Subject|1|||
161264883|NCT01462318|582352319|FG000|Main Study / TP-DI Study|Other|2|||
161264884|NCT01462318|582352320|FG001|Main Study / TP-DI Study|Other|0|||
161264885|NCT01462318|582352321|FG002|Main Study / TP-DI Study|Other|0|||
161264886|NCT01462318|582352319|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
161264887|NCT01462318|582352320|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
161264888|NCT01462318|582352321|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
161264889|NCT01462318|582352319|FG000|Main Study / TP-DI Study|Adverse Event|4|||
161264890|NCT01462318|582352320|FG001|Main Study / TP-DI Study|Adverse Event|0|||
161264891|NCT01462318|582352321|FG002|Main Study / TP-DI Study|Adverse Event|0|||
161264892|NCT01462318|582352319|FG000|Extension Phase|Lost to Follow-up|0|||
161264893|NCT01462318|582352320|FG001|Extension Phase|Lost to Follow-up|0|||
161264894|NCT01462318|582352321|FG002|Extension Phase|Lost to Follow-up|1|||
161264895|NCT01462318|582352319|FG000|Extension Phase|Other|0|||
161264896|NCT01462318|582352320|FG001|Extension Phase|Other|0|||
161264897|NCT01462318|582352321|FG002|Extension Phase|Other|1|||
161264898|NCT01462318|582352319|FG000|Extension Phase|Disease Progression|0|||
161264899|NCT01462318|582352320|FG001|Extension Phase|Disease Progression|0|||
161264900|NCT01462318|582352321|FG002|Extension Phase|Disease Progression|1|||
160940795|NCT00779766|581173168|FG001|Month 24|Migrated/moved from study area|162|||
160940796|NCT00779766|581173167|FG000|Month 24|Lost to Follow-up|9|||
160940797|NCT00779766|581173168|FG001|Month 24|Lost to Follow-up|9|||
160940798|NCT00779766|581173167|FG000|Month 24|Other|18|||
160940799|NCT00779766|581173168|FG001|Month 24|Other|27|||
160940800|NCT00779766|581173167|FG000|Month 48|Withdrawal by Subject|68|||
160940801|NCT00779766|581173168|FG001|Month 48|Withdrawal by Subject|63|||
160940802|NCT00779766|581173167|FG000|Month 48|Migrated/moved from study area|76|||
160940803|NCT00779766|581173168|FG001|Month 48|Migrated/moved from study area|75|||
160940804|NCT00779766|581173167|FG000|Month 48|Lost to Follow-up|29|||
160940805|NCT00779766|581173168|FG001|Month 48|Lost to Follow-up|30|||
160940806|NCT00779766|581173167|FG000|Month 48|Other|1|||
160940807|NCT00779766|581173168|FG001|Month 48|Other|0|||
160940808|NCT00779766|581173167|FG000|Month 72|Withdrawal by Subject|55|||
161264901|NCT01462318|582352319|FG000|Extension Phase|Withdrawal by Subject|0|||
161264902|NCT01462318|582352320|FG001|Extension Phase|Withdrawal by Subject|0|||
161264903|NCT01462318|582352321|FG002|Extension Phase|Withdrawal by Subject|15|||
160940809|NCT00779766|581173168|FG001|Month 72|Withdrawal by Subject|71|||
160940810|NCT00779766|581173167|FG000|Month 72|Migrated/moved from study area|124|||
161264904|NCT01462318|582352319|FG000|Extension Phase|Investigator Decision|0|||
161264905|NCT01462318|582352320|FG001|Extension Phase|Investigator Decision|0|||
161264906|NCT01462318|582352321|FG002|Extension Phase|Investigator Decision|5|||
160940811|NCT00779766|581173168|FG001|Month 72|Migrated/moved from study area|109|||
160940812|NCT00779766|581173167|FG000|Month 72|Lost to Follow-up|6|||
160940813|NCT00779766|581173168|FG001|Month 72|Lost to Follow-up|8|||
160940814|NCT00779766|581173167|FG000|Month 72|Other|0|||
160940815|NCT00779766|581173168|FG001|Month 72|Other|1|||
161264907|NCT01462318|582352319|FG000|Extension Phase|Adverse Event|0|||
161264908|NCT01462318|582352320|FG001|Extension Phase|Adverse Event|0|||
161264909|NCT01462318|582352321|FG002|Extension Phase|Adverse Event|22|||
160940816|NCT01412424|581173169|FG000|Core Treatment Period|Treatment Failure|24|||
160940817|NCT01412424|581173169|FG000|Core Treatment Period|Adverse Event|21|||
160940818|NCT01412424|581173169|FG000|Core Treatment Period|Patient Request|5|||
160940819|NCT01412424|581173169|FG000|Core Treatment Period|Lost to Follow-up|2|||
160940820|NCT01412424|581173169|FG000|Core Treatment Period|Sponsor Request|1|||
160940821|NCT01412424|581173169|FG000|Extension Treatment Period|Adverse Event|2|||
160940822|NCT01412424|581173169|FG000|Extension Treatment Period|Treatment Failure|2|||
160940823|NCT01412424|581173169|FG000|Extension Treatment Period|Patient Request|2|||
160940824|NCT01274637|581173170|FG000|Overall Study|Withdrawal by Subject|0|||
160940825|NCT01274637|581173171|FG001|Overall Study|Withdrawal by Subject|1|||
160940826|NCT01274637|581173170|FG000|Overall Study|Lost to Follow-up|0|||
160940827|NCT01274637|581173171|FG001|Overall Study|Lost to Follow-up|1|||
160940828|NCT01824303|581173185|FG000|Randomized Study|Withdrawal by Subject|1|||
160940829|NCT01824303|581173186|FG001|Randomized Study|Withdrawal by Subject|1|||
160940830|NCT01824303|581173185|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
160940831|NCT01824303|581173186|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
160940832|NCT02606136|581173194|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
160940833|NCT02606136|581173194|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
160940834|NCT02606136|581173194|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
160940835|NCT02606136|581173194|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
160940836|NCT03296696|581173195|FG000|Overall Study|Started Other Antitumor Therapy|1|||
160940837|NCT03296696|581173196|FG001|Overall Study|Started Other Antitumor Therapy|2|||
160940838|NCT03296696|581173197|FG002|Overall Study|Started Other Antitumor Therapy|1|||
160940839|NCT03296696|581173198|FG003|Overall Study|Started Other Antitumor Therapy|2|||
160940840|NCT03296696|581173199|FG004|Overall Study|Started Other Antitumor Therapy|1|||
160940841|NCT03296696|581173200|FG005|Overall Study|Started Other Antitumor Therapy|1|||
160940842|NCT03296696|581173201|FG006|Overall Study|Started Other Antitumor Therapy|2|||
160940843|NCT03296696|581173202|FG007|Overall Study|Started Other Antitumor Therapy|3|||
160940844|NCT03296696|581173203|FG008|Overall Study|Started Other Antitumor Therapy|1|||
160940845|NCT03296696|581173204|FG009|Overall Study|Started Other Antitumor Therapy|0|||
160940846|NCT03296696|581173195|FG000|Overall Study|Death|0|||
160940847|NCT03296696|581173196|FG001|Overall Study|Death|1|||
160940848|NCT03296696|581173197|FG002|Overall Study|Death|1|||
160940849|NCT03296696|581173198|FG003|Overall Study|Death|2|||
160940850|NCT03296696|581173199|FG004|Overall Study|Death|2|||
160940851|NCT03296696|581173200|FG005|Overall Study|Death|3|||
160940852|NCT03296696|581173201|FG006|Overall Study|Death|1|||
160940853|NCT03296696|581173202|FG007|Overall Study|Death|2|||
160940854|NCT03296696|581173203|FG008|Overall Study|Death|0|||
160940855|NCT03296696|581173204|FG009|Overall Study|Death|0|||
160940856|NCT03296696|581173195|FG000|Overall Study|Withdrawal by Subject|0|||
160940857|NCT03296696|581173196|FG001|Overall Study|Withdrawal by Subject|0|||
160940858|NCT03296696|581173197|FG002|Overall Study|Withdrawal by Subject|1|||
160940859|NCT03296696|581173198|FG003|Overall Study|Withdrawal by Subject|0|||
160940860|NCT03296696|581173199|FG004|Overall Study|Withdrawal by Subject|1|||
160940861|NCT03296696|581173200|FG005|Overall Study|Withdrawal by Subject|0|||
160940862|NCT03296696|581173201|FG006|Overall Study|Withdrawal by Subject|0|||
160940863|NCT03296696|581173202|FG007|Overall Study|Withdrawal by Subject|0|||
160940864|NCT03296696|581173203|FG008|Overall Study|Withdrawal by Subject|0|||
160940865|NCT03296696|581173204|FG009|Overall Study|Withdrawal by Subject|1|||
160940866|NCT04694131|581173207|FG000|Overall Study|Withdrawal by Subject|7|||
160940867|NCT04694131|581173207|FG000|Overall Study|Screen Failure|1|||
160940868|NCT04694131|581173207|FG000|Overall Study|High stimulation threshold|3|||
160940869|NCT01350128|581173208|FG000|Overall Study|Withdrawal by Subject|3|||
160940870|NCT01350128|581173208|FG000|Overall Study|Protocol discontinuation criteria|8|||
160940871|NCT01350128|581173208|FG000|Overall Study|Physician Decision|1|||
160940872|NCT01350128|581173208|FG000|Overall Study|Lost to Follow-up|2|||
160940873|NCT02399085|581173212|FG000|Overall Study|Adverse Event|16|||
160940874|NCT02399085|581173212|FG000|Overall Study|Death|2|||
160940875|NCT02399085|581173212|FG000|Overall Study|Withdrawal by Subject|8|||
160940876|NCT02399085|581173212|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
160940877|NCT02399085|581173212|FG000|Overall Study|Physician Decision|5|||
160940878|NCT02170727|581173213|FG000|Overall Study|Lost to Follow-up|1|||
160940879|NCT02170727|581173214|FG001|Overall Study|Lost to Follow-up|0|||
160940880|NCT02170727|581173213|FG000|Overall Study|Withdrawal by Subject|2|||
160940881|NCT02170727|581173214|FG001|Overall Study|Withdrawal by Subject|0|||
160940882|NCT01959581|581173219|FG000|Overall Study|Lost to Follow-up|5|||
160940883|NCT00700011|581173222|FG000|Overall Study|Death|0|||
160940884|NCT00700011|581173223|FG001|Overall Study|Death|1|||
160940885|NCT00004031|581173224|FG000|Overall Study|Adverse Event|5|||
160940886|NCT00004031|581173225|FG001|Overall Study|Adverse Event|0|||
160940887|NCT00004031|581173224|FG000|Overall Study|Refusal unrelated to adverse events|2|||
160940888|NCT00004031|581173225|FG001|Overall Study|Refusal unrelated to adverse events|11|||
160940889|NCT00004031|581173224|FG000|Overall Study|Progression/relapse|9|||
160940890|NCT00004031|581173225|FG001|Overall Study|Progression/relapse|4|||
160940891|NCT00004031|581173224|FG000|Overall Study|Death|3|||
160940892|NCT00004031|581173225|FG001|Overall Study|Death|1|||
160940893|NCT00004031|581173224|FG000|Overall Study|Other- not protocol specified|3|||
160940894|NCT00004031|581173225|FG001|Overall Study|Other- not protocol specified|3|||
160940895|NCT00004031|581173224|FG000|Overall Study|Reason under review|3|||
160940896|NCT00004031|581173225|FG001|Overall Study|Reason under review|2|||
160940897|NCT00600821|581174800|FG000|Overall Study|Death|45|||
160940898|NCT00600821|581174801|FG001|Overall Study|Death|46|||
160940899|NCT00600821|581174800|FG000|Overall Study|Lost to Follow-up|2|||
160940900|NCT00600821|581174801|FG001|Overall Study|Lost to Follow-up|2|||
160940901|NCT00600821|581174800|FG000|Overall Study|Withdrawal by Subject|1|||
160940902|NCT00600821|581174801|FG001|Overall Study|Withdrawal by Subject|1|||
160940903|NCT00600821|581174800|FG000|Overall Study|Terminated by sponsor|8|||
160940904|NCT00600821|581174801|FG001|Overall Study|Terminated by sponsor|6|||
160940905|NCT00600821|581174800|FG000|Overall Study|Objective progression or relapse|0|||
160940906|NCT00600821|581174801|FG001|Overall Study|Objective progression or relapse|1|||
160940907|NCT00600821|581174800|FG000|Overall Study|Randomized but not treated|0|||
160940908|NCT00600821|581174801|FG001|Overall Study|Randomized but not treated|1|||
160940909|NCT00600821|581174800|FG000|Overall Study|Other|2|||
160940910|NCT00600821|581174801|FG001|Overall Study|Other|3|||
160940911|NCT02602288|581174802|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
160940912|NCT02602288|581174803|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
160940913|NCT02602288|581174802|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
160940914|NCT02602288|581174803|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
160940915|NCT02602288|581174802|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
160940916|NCT02602288|581174803|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
160940917|NCT02602288|581174802|FG000|12 Month Follow-up|Lost to Follow-up|0|||
160940918|NCT02602288|581174803|FG001|12 Month Follow-up|Lost to Follow-up|4|||
160940919|NCT02602288|581174802|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
160940920|NCT02602288|581174803|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
160940921|NCT01310413|581174804|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
160940922|NCT01310413|581174805|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
160940923|NCT01310413|581174806|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
160940924|NCT01310413|581174807|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
160940925|NCT01310413|581174808|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
160940926|NCT01310413|581174809|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
160940927|NCT01310413|581174810|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
160940928|NCT01310413|581174804|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
160940929|NCT01310413|581174805|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
160940930|NCT01310413|581174806|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
160940931|NCT01310413|581174807|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
160940932|NCT01310413|581174808|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
160940933|NCT01310413|581174809|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
160940934|NCT01310413|581174810|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
160940935|NCT01310413|581174804|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
160940936|NCT01310413|581174805|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
160940937|NCT01310413|581174806|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
160940938|NCT01310413|581174807|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
160940939|NCT01310413|581174808|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
160940940|NCT01310413|581174809|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
160940941|NCT01310413|581174810|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
160940942|NCT01310413|581174804|FG000|Day 0 to Day 385|Other|1|||
160940943|NCT01310413|581174805|FG001|Day 0 to Day 385|Other|0|||
160940944|NCT01310413|581174806|FG002|Day 0 to Day 385|Other|3|||
160940945|NCT01310413|581174807|FG003|Day 0 to Day 385|Other|0|||
160940946|NCT01310413|581174808|FG004|Day 0 to Day 385|Other|0|||
160940947|NCT01310413|581174809|FG005|Day 0 to Day 385|Other|0|||
160940948|NCT01310413|581174810|FG006|Day 0 to Day 385|Other|0|||
160940949|NCT01310413|581174804|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940950|NCT01310413|581174805|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940951|NCT01310413|581174806|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940952|NCT01310413|581174807|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940953|NCT01310413|581174808|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940954|NCT01310413|581174809|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
160940955|NCT01310413|581174810|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
160940956|NCT01310413|581174804|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
160940957|NCT01310413|581174805|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
160940958|NCT01310413|581174806|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
160940959|NCT01310413|581174807|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
161264910|NCT03827564|582352322|FG000|Overall Study|Discontinued due to Study Termination|1|||
161264911|NCT03827564|582352323|FG001|Overall Study|Discontinued due to Study Termination|0|||
161264912|NCT02238626|582352324|FG000|Overall Study|Adverse Event|3|||
160940960|NCT01310413|581174808|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
160940961|NCT01310413|581174809|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
160940962|NCT01310413|581174810|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
160940963|NCT02066298|581174812|FG000|Overall Study|Lost to Follow-up|3|||
161264913|NCT02238626|582352325|FG001|Overall Study|Adverse Event|5|||
160940964|NCT02066298|581174813|FG001|Overall Study|Lost to Follow-up|2|||
160940965|NCT02066298|581174814|FG002|Overall Study|Lost to Follow-up|3|||
160940966|NCT02066298|581174815|FG003|Overall Study|Lost to Follow-up|2|||
160940967|NCT02066298|581174816|FG004|Overall Study|Lost to Follow-up|3|||
160940968|NCT02066298|581174817|FG005|Overall Study|Lost to Follow-up|4|||
160940969|NCT02066298|581174812|FG000|Overall Study|Withdrawal by Subject|6|||
160940970|NCT02066298|581174813|FG001|Overall Study|Withdrawal by Subject|6|||
160940971|NCT02066298|581174814|FG002|Overall Study|Withdrawal by Subject|6|||
160940972|NCT02066298|581174815|FG003|Overall Study|Withdrawal by Subject|4|||
160940973|NCT02066298|581174816|FG004|Overall Study|Withdrawal by Subject|5|||
160940974|NCT02066298|581174817|FG005|Overall Study|Withdrawal by Subject|8|||
160940975|NCT02066298|581174812|FG000|Overall Study|Physician Decision|0|||
160940976|NCT02066298|581174813|FG001|Overall Study|Physician Decision|0|||
160940977|NCT02066298|581174814|FG002|Overall Study|Physician Decision|1|||
160940978|NCT02066298|581174815|FG003|Overall Study|Physician Decision|0|||
160940979|NCT02066298|581174816|FG004|Overall Study|Physician Decision|1|||
160940980|NCT02066298|581174817|FG005|Overall Study|Physician Decision|0|||
160940981|NCT04260191|581174818|FG000|Overall Study|Decision by Sponsor|0|||
160940982|NCT04260191|581174819|FG001|Overall Study|Decision by Sponsor|1|||
160940983|NCT04260191|581174820|FG002|Overall Study|Decision by Sponsor|0|||
160940984|NCT04260191|581174818|FG000|Overall Study|Withdrawal by Subject|1|||
160940985|NCT04260191|581174819|FG001|Overall Study|Withdrawal by Subject|0|||
160940986|NCT04260191|581174820|FG002|Overall Study|Withdrawal by Subject|3|||
160940987|NCT04260191|581174818|FG000|Overall Study|Death|4|||
160940988|NCT04260191|581174819|FG001|Overall Study|Death|3|||
160940989|NCT04260191|581174820|FG002|Overall Study|Death|2|||
160940990|NCT01513317|581174822|FG000|Overall Study|Withdrawal by Subject|15|||
160940991|NCT01513317|581174823|FG001|Overall Study|Withdrawal by Subject|4|||
160940992|NCT01513317|581174822|FG000|Overall Study|Death|1|||
160940993|NCT01513317|581174823|FG001|Overall Study|Death|1|||
160940994|NCT01513317|581174822|FG000|Overall Study|Study terminated by sponsor|18|||
160940995|NCT01513317|581174823|FG001|Overall Study|Study terminated by sponsor|18|||
160940996|NCT01513317|581174822|FG000|Overall Study|Other|0|||
160940997|NCT01513317|581174823|FG001|Overall Study|Other|1|||
160940998|NCT01265953|581174824|FG000|Overall Study|Non compliance|5|||
160940999|NCT01265953|581174825|FG001|Overall Study|Non compliance|3|||
160941000|NCT02564198|581174826|FG000|Overall Study|Withdrawal by Subject|2|||
160941001|NCT02564198|581174827|FG001|Overall Study|Withdrawal by Subject|4|||
160941002|NCT02564198|581174828|FG002|Overall Study|Withdrawal by Subject|0|||
160941003|NCT02564198|581174826|FG000|Overall Study|Adverse Event|0|||
160941004|NCT02564198|581174827|FG001|Overall Study|Adverse Event|1|||
160941005|NCT02564198|581174828|FG002|Overall Study|Adverse Event|0|||
160941006|NCT00659646|581174829|FG000|Overall Study|Protocol Violation|12|||
160941007|NCT00659646|581174830|FG001|Overall Study|Protocol Violation|8|||
160941008|NCT00659646|581174829|FG000|Overall Study|Adverse Event|1|||
160941009|NCT00659646|581174830|FG001|Overall Study|Adverse Event|0|||
160941010|NCT00659646|581174829|FG000|Overall Study|Lost to Follow-up|1|||
160941011|NCT00659646|581174830|FG001|Overall Study|Lost to Follow-up|0|||
160941012|NCT00659646|581174829|FG000|Overall Study|protocol noncompliance after randomized|1|||
160941013|NCT00659646|581174830|FG001|Overall Study|protocol noncompliance after randomized|0|||
160941014|NCT02391948|581174831|FG000|6-month Assessment|Death|0|||
160941015|NCT02391948|581174832|FG001|6-month Assessment|Death|0|||
160941016|NCT02391948|581174833|FG002|6-month Assessment|Death|0|||
160941017|NCT02391948|581174834|FG003|6-month Assessment|Death|0|||
160941018|NCT02391948|581174835|FG004|6-month Assessment|Death|1|||
160941019|NCT02391948|581174831|FG000|6-month Assessment|Withdrawal by Subject|0|||
160941020|NCT02391948|581174832|FG001|6-month Assessment|Withdrawal by Subject|0|||
161264914|NCT02238626|582352326|FG002|Overall Study|Adverse Event|0|||
160941021|NCT02391948|581174833|FG002|6-month Assessment|Withdrawal by Subject|1|||
160941022|NCT02391948|581174834|FG003|6-month Assessment|Withdrawal by Subject|2|||
160941023|NCT02391948|581174835|FG004|6-month Assessment|Withdrawal by Subject|0|||
160941024|NCT02391948|581174831|FG000|6-month Assessment|Lost to Follow-up|4|||
160941025|NCT02391948|581174832|FG001|6-month Assessment|Lost to Follow-up|5|||
160941026|NCT02391948|581174833|FG002|6-month Assessment|Lost to Follow-up|2|||
160941027|NCT02391948|581174834|FG003|6-month Assessment|Lost to Follow-up|3|||
160941028|NCT02391948|581174835|FG004|6-month Assessment|Lost to Follow-up|1|||
160941029|NCT02391948|581174831|FG000|6-month Assessment|Medical issue/illness|1|||
161264915|NCT02238626|582352327|FG003|Overall Study|Adverse Event|3|||
161264916|NCT02238626|582352324|FG000|Overall Study|Lost to Follow-up|2|||
160941030|NCT02391948|581174832|FG001|6-month Assessment|Medical issue/illness|1|||
160941031|NCT02391948|581174833|FG002|6-month Assessment|Medical issue/illness|0|||
160941032|NCT02391948|581174834|FG003|6-month Assessment|Medical issue/illness|0|||
160941033|NCT02391948|581174835|FG004|6-month Assessment|Medical issue/illness|0|||
160941034|NCT02391948|581174831|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
160941035|NCT02391948|581174832|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
160941036|NCT02391948|581174833|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
161144367|NCT01607892|581911963|FG000|Overall Study|Disease progression|38|||
160941037|NCT02391948|581174834|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
160941038|NCT02391948|581174835|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
160941039|NCT02391948|581174831|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
160941040|NCT02391948|581174832|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
160941041|NCT02391948|581174833|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
160941042|NCT02391948|581174834|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
160941043|NCT02391948|581174835|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
160941044|NCT02391948|581174831|FG000|12-month Assessment|Death|0|||
160941045|NCT02391948|581174832|FG001|12-month Assessment|Death|0|||
160941046|NCT02391948|581174833|FG002|12-month Assessment|Death|0|||
160941047|NCT02391948|581174834|FG003|12-month Assessment|Death|1|||
160941048|NCT02391948|581174835|FG004|12-month Assessment|Death|0|||
160941049|NCT02391948|581174831|FG000|12-month Assessment|Withdrawal by Subject|1|||
160941050|NCT02391948|581174832|FG001|12-month Assessment|Withdrawal by Subject|0|||
160941051|NCT02391948|581174833|FG002|12-month Assessment|Withdrawal by Subject|0|||
160941052|NCT02391948|581174834|FG003|12-month Assessment|Withdrawal by Subject|1|||
160941053|NCT02391948|581174835|FG004|12-month Assessment|Withdrawal by Subject|0|||
160941054|NCT02391948|581174831|FG000|12-month Assessment|Lost to Follow-up|5|||
160941055|NCT02391948|581174832|FG001|12-month Assessment|Lost to Follow-up|4|||
160941056|NCT02391948|581174833|FG002|12-month Assessment|Lost to Follow-up|4|||
160941057|NCT02391948|581174834|FG003|12-month Assessment|Lost to Follow-up|4|||
160941058|NCT02391948|581174835|FG004|12-month Assessment|Lost to Follow-up|5|||
160941059|NCT02391948|581174831|FG000|12-month Assessment|Medical issue/illness|0|||
160941060|NCT02391948|581174832|FG001|12-month Assessment|Medical issue/illness|1|||
160941061|NCT02391948|581174833|FG002|12-month Assessment|Medical issue/illness|0|||
160941062|NCT02391948|581174834|FG003|12-month Assessment|Medical issue/illness|1|||
161144368|NCT01607892|581911964|FG001|Overall Study|Disease progression|13|||
161144369|NCT01607892|581911965|FG002|Overall Study|Disease progression|37|||
161144370|NCT01607892|581911966|FG003|Overall Study|Disease progression|57|||
161144371|NCT01607892|581911967|FG004|Overall Study|Disease progression|9|||
161144372|NCT01607892|581911963|FG000|Overall Study|Incidence or severity of Adverse events|3|||
161144373|NCT01607892|581911964|FG001|Overall Study|Incidence or severity of Adverse events|3|||
161144374|NCT01607892|581911965|FG002|Overall Study|Incidence or severity of Adverse events|7|||
161144375|NCT01607892|581911966|FG003|Overall Study|Incidence or severity of Adverse events|2|||
161144376|NCT01607892|581911967|FG004|Overall Study|Incidence or severity of Adverse events|6|||
161144377|NCT02273973|581911970|FG000|Overall Study|Adverse Event|4|||
161144378|NCT02273973|581911971|FG001|Overall Study|Adverse Event|0|||
161144379|NCT02273973|581911970|FG000|Overall Study|Withdrawal by Subject|2|||
161144380|NCT02273973|581911971|FG001|Overall Study|Withdrawal by Subject|3|||
161144381|NCT02273973|581911970|FG000|Overall Study|Death|1|||
161144382|NCT02273973|581911971|FG001|Overall Study|Death|0|||
161144383|NCT02273973|581911970|FG000|Overall Study|Non-compliance|1|||
161144384|NCT02273973|581911971|FG001|Overall Study|Non-compliance|0|||
161144385|NCT02273973|581911970|FG000|Overall Study|Protocol Violation|1|||
161144386|NCT02273973|581911971|FG001|Overall Study|Protocol Violation|0|||
161144387|NCT02273973|581911970|FG000|Overall Study|Progression of disease|0|||
161144388|NCT02273973|581911971|FG001|Overall Study|Progression of disease|2|||
161264917|NCT02238626|582352325|FG001|Overall Study|Lost to Follow-up|4|||
161264918|NCT02238626|582352326|FG002|Overall Study|Lost to Follow-up|2|||
160941063|NCT02391948|581174835|FG004|12-month Assessment|Medical issue/illness|0|||
160941064|NCT02391948|581174831|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
160941065|NCT02391948|581174832|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
160941066|NCT02391948|581174833|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
160941067|NCT02391948|581174834|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
160941068|NCT02391948|581174835|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
160941069|NCT02391948|581174831|FG000|18-month Assessment|Death|0|||
161144389|NCT02273973|581911970|FG000|Overall Study|Lost to Follow-up|0|||
161144390|NCT02273973|581911971|FG001|Overall Study|Lost to Follow-up|1|||
161144391|NCT02273973|581911970|FG000|Overall Study|Physician Decision|0|||
161144392|NCT02273973|581911971|FG001|Overall Study|Physician Decision|1|||
161144393|NCT02273973|581911970|FG000|Overall Study|Reason not specified|0|||
161144394|NCT02273973|581911971|FG001|Overall Study|Reason not specified|1|||
161264919|NCT02238626|582352327|FG003|Overall Study|Lost to Follow-up|2|||
161264920|NCT02238626|582352324|FG000|Overall Study|Withdrawal by Subject|0|||
161144395|NCT03022422|581911972|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
161144396|NCT03022422|581911973|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
161144397|NCT03022422|581911974|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
161144398|NCT03022422|581911975|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
161144399|NCT03022422|581911976|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
161264921|NCT02238626|582352325|FG001|Overall Study|Withdrawal by Subject|3|||
161264922|NCT02238626|582352326|FG002|Overall Study|Withdrawal by Subject|0|||
160941070|NCT02391948|581174832|FG001|18-month Assessment|Death|0|||
160941071|NCT02391948|581174833|FG002|18-month Assessment|Death|0|||
160941072|NCT02391948|581174834|FG003|18-month Assessment|Death|1|||
160941073|NCT02391948|581174835|FG004|18-month Assessment|Death|1|||
161264923|NCT02238626|582352327|FG003|Overall Study|Withdrawal by Subject|1|||
161264924|NCT02238626|582352324|FG000|Overall Study|Death|0|||
161264925|NCT02238626|582352325|FG001|Overall Study|Death|0|||
161264926|NCT02238626|582352326|FG002|Overall Study|Death|1|||
161264927|NCT02238626|582352327|FG003|Overall Study|Death|1|||
161264928|NCT02238626|582352324|FG000|Overall Study|Other|0|||
161264929|NCT02238626|582352325|FG001|Overall Study|Other|2|||
161264930|NCT02238626|582352326|FG002|Overall Study|Other|0|||
161264931|NCT02238626|582352327|FG003|Overall Study|Other|0|||
161264932|NCT00270257|582352328|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
161264933|NCT00270257|582352329|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
161264934|NCT01195103|582352332|FG000|Overall Study|Withdrawal by Subject|1|||
161264935|NCT01195103|582352333|FG001|Overall Study|Withdrawal by Subject|0|||
160941074|NCT02391948|581174831|FG000|18-month Assessment|Withdrawal by Subject|1|||
160941075|NCT02391948|581174832|FG001|18-month Assessment|Withdrawal by Subject|0|||
160941076|NCT02391948|581174833|FG002|18-month Assessment|Withdrawal by Subject|0|||
160941077|NCT02391948|581174834|FG003|18-month Assessment|Withdrawal by Subject|1|||
160941078|NCT02391948|581174835|FG004|18-month Assessment|Withdrawal by Subject|0|||
160941079|NCT02391948|581174831|FG000|18-month Assessment|Lost to Follow-up|2|||
160941080|NCT02391948|581174832|FG001|18-month Assessment|Lost to Follow-up|6|||
160941081|NCT02391948|581174833|FG002|18-month Assessment|Lost to Follow-up|2|||
160941082|NCT02391948|581174834|FG003|18-month Assessment|Lost to Follow-up|2|||
160941083|NCT02391948|581174835|FG004|18-month Assessment|Lost to Follow-up|3|||
160941084|NCT02391948|581174831|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
160941085|NCT02391948|581174832|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
160941086|NCT02391948|581174833|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
160941087|NCT02391948|581174834|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
160941088|NCT02391948|581174835|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
160941089|NCT02391948|581174831|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
160941090|NCT02391948|581174832|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
160941091|NCT02391948|581174833|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
160941092|NCT02391948|581174834|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
160941093|NCT02391948|581174835|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
160941094|NCT02391948|581174831|FG000|24-month Assessment|Death|0|||
160941095|NCT02391948|581174832|FG001|24-month Assessment|Death|0|||
160941096|NCT02391948|581174833|FG002|24-month Assessment|Death|0|||
160941097|NCT02391948|581174834|FG003|24-month Assessment|Death|0|||
160941098|NCT02391948|581174835|FG004|24-month Assessment|Death|1|||
160941099|NCT02391948|581174831|FG000|24-month Assessment|Withdrawal by Subject|1|||
160941100|NCT02391948|581174832|FG001|24-month Assessment|Withdrawal by Subject|1|||
160941101|NCT02391948|581174833|FG002|24-month Assessment|Withdrawal by Subject|0|||
160941102|NCT02391948|581174834|FG003|24-month Assessment|Withdrawal by Subject|0|||
160941103|NCT02391948|581174835|FG004|24-month Assessment|Withdrawal by Subject|1|||
160941104|NCT02391948|581174831|FG000|24-month Assessment|Lost to Follow-up|5|||
160941105|NCT02391948|581174832|FG001|24-month Assessment|Lost to Follow-up|4|||
160941106|NCT02391948|581174833|FG002|24-month Assessment|Lost to Follow-up|0|||
160941107|NCT02391948|581174834|FG003|24-month Assessment|Lost to Follow-up|0|||
160941108|NCT02391948|581174835|FG004|24-month Assessment|Lost to Follow-up|0|||
161264936|NCT01195103|582352334|FG002|Overall Study|Withdrawal by Subject|0|||
161264937|NCT00450619|582352341|FG000|Overall Study|refused treatment after randomization|2|||
161264938|NCT00450619|582352342|FG001|Overall Study|refused treatment after randomization|0|||
161264939|NCT00450619|582352341|FG000|Overall Study|did not progress; refused further trmt|1|||
161264940|NCT00450619|582352342|FG001|Overall Study|did not progress; refused further trmt|1|||
161264941|NCT00450619|582352341|FG000|Overall Study|Adverse Event|1|||
161264942|NCT00450619|582352342|FG001|Overall Study|Adverse Event|0|||
161264943|NCT02963311|582352343|FG000|Overall Study|Withdrawal by Subject|1|||
161264944|NCT02963311|582352343|FG000|Overall Study|Screen Failure|4|||
161264945|NCT04442490|582352346|FG000|Overall Study|Withdrawal by Subject|18|||
160941109|NCT02391948|581174831|FG000|24-month Assessment|Medical issue/illness|0|||
160941110|NCT02391948|581174832|FG001|24-month Assessment|Medical issue/illness|0|||
160941111|NCT02391948|581174833|FG002|24-month Assessment|Medical issue/illness|1|||
160941112|NCT02391948|581174834|FG003|24-month Assessment|Medical issue/illness|0|||
160941113|NCT02391948|581174835|FG004|24-month Assessment|Medical issue/illness|0|||
160941114|NCT02391948|581174831|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
160941115|NCT02391948|581174832|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
160941116|NCT02391948|581174833|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
160941117|NCT02391948|581174834|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
160941118|NCT02391948|581174835|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
161264946|NCT04442490|582352347|FG001|Overall Study|Withdrawal by Subject|10|||
161264947|NCT04442490|582352346|FG000|Overall Study|Lost to Follow-up|7|||
161264948|NCT04442490|582352347|FG001|Overall Study|Lost to Follow-up|7|||
161264949|NCT04442490|582352346|FG000|Overall Study|Adverse Event|2|||
161264950|NCT04442490|582352347|FG001|Overall Study|Adverse Event|6|||
160941119|NCT02348489|581174836|FG000|Overall Study|Death|336|||
160941120|NCT02348489|581174837|FG001|Overall Study|Death|335|||
160941121|NCT02348489|581174836|FG000|Overall Study|Withdrawal by Subject|14|||
160998809|NCT02026258|581380632|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
160998810|NCT02026258|581380633|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
160998811|NCT02534350|581380634|FG000|Overall Study|Randomized But Not Treated|1|||
160998812|NCT02534350|581380635|FG001|Overall Study|Randomized But Not Treated|0|||
160998813|NCT02534350|581380634|FG000|Overall Study|Protocol Violation|1|||
160998814|NCT02534350|581380635|FG001|Overall Study|Protocol Violation|0|||
160998815|NCT02534350|581380634|FG000|Overall Study|Withdrew Consent|2|||
160998816|NCT02534350|581380635|FG001|Overall Study|Withdrew Consent|0|||
160998817|NCT00972504|581380636|FG000|Overall Study|Adverse Event|2|||
160998818|NCT00972504|581380636|FG000|Overall Study|Investigator discretion|1|||
160998819|NCT00716144|581380637|FG000|Overall Study|Withdrawal by Subject|4|||
160998820|NCT00716144|581380638|FG001|Overall Study|Withdrawal by Subject|2|||
160998821|NCT00716144|581380639|FG002|Overall Study|Withdrawal by Subject|6|||
160998822|NCT00716144|581380640|FG003|Overall Study|Withdrawal by Subject|6|||
160998823|NCT00716144|581380637|FG000|Overall Study|Lost to Follow-up|2|||
160998824|NCT00716144|581380638|FG001|Overall Study|Lost to Follow-up|2|||
160998825|NCT00716144|581380639|FG002|Overall Study|Lost to Follow-up|1|||
160998826|NCT00716144|581380640|FG003|Overall Study|Lost to Follow-up|2|||
160998827|NCT00716144|581380637|FG000|Overall Study|Adverse Event|0|||
160998828|NCT00716144|581380638|FG001|Overall Study|Adverse Event|0|||
160998829|NCT00716144|581380639|FG002|Overall Study|Adverse Event|0|||
160998830|NCT00716144|581380640|FG003|Overall Study|Adverse Event|2|||
160998831|NCT00716144|581380637|FG000|Overall Study|Non-compliance|1|||
160998832|NCT00716144|581380638|FG001|Overall Study|Non-compliance|0|||
160998833|NCT00716144|581380639|FG002|Overall Study|Non-compliance|0|||
160998834|NCT00716144|581380640|FG003|Overall Study|Non-compliance|0|||
160998835|NCT00716144|581380637|FG000|Overall Study|Protocol Violation|2|||
160998836|NCT00716144|581380638|FG001|Overall Study|Protocol Violation|0|||
160998837|NCT00716144|581380639|FG002|Overall Study|Protocol Violation|1|||
160998838|NCT00716144|581380640|FG003|Overall Study|Protocol Violation|0|||
160998839|NCT00716144|581380637|FG000|Overall Study|Physician Decision|0|||
160998840|NCT00716144|581380638|FG001|Overall Study|Physician Decision|1|||
160998841|NCT00716144|581380639|FG002|Overall Study|Physician Decision|2|||
160998842|NCT00716144|581380640|FG003|Overall Study|Physician Decision|2|||
160998843|NCT00716144|581380637|FG000|Overall Study|Intercurrent illness|0|||
160998844|NCT00716144|581380638|FG001|Overall Study|Intercurrent illness|0|||
160998845|NCT00716144|581380639|FG002|Overall Study|Intercurrent illness|1|||
160998846|NCT00716144|581380640|FG003|Overall Study|Intercurrent illness|0|||
161144400|NCT03022422|581911977|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
161144401|NCT02104180|581911978|FG000|Overall Study|Protocol Violation|1|||
161144402|NCT02104180|581911979|FG001|Overall Study|Protocol Violation|0|||
161144403|NCT00793585|581911980|FG000|Overall Study|Adverse Event|1|||
161144404|NCT00793585|581911981|FG001|Overall Study|Adverse Event|1|||
161144405|NCT00793585|581911980|FG000|Overall Study|Protocol Violation|1|||
161144406|NCT00793585|581911981|FG001|Overall Study|Protocol Violation|2|||
161144407|NCT01769404|581911982|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
161144408|NCT01769404|581911983|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
160941122|NCT02348489|581174837|FG001|Overall Study|Withdrawal by Subject|27|||
160941123|NCT02348489|581174836|FG000|Overall Study|Lost to Follow-up|3|||
160941124|NCT02348489|581174837|FG001|Overall Study|Lost to Follow-up|5|||
160941125|NCT00201006|581174838|FG000|Overall Study|Withdrawal by Subject|7|||
160941126|NCT00201006|581174839|FG001|Overall Study|Withdrawal by Subject|2|||
160941127|NCT00201006|581174840|FG002|Overall Study|Withdrawal by Subject|3|||
160941128|NCT00201006|581174838|FG000|Overall Study|Adverse Event|1|||
160941129|NCT00201006|581174839|FG001|Overall Study|Adverse Event|0|||
160941130|NCT00201006|581174840|FG002|Overall Study|Adverse Event|1|||
160941131|NCT02167035|581174843|FG000|Overall Study|Adverse Event|2|||
160941132|NCT02167035|581174844|FG001|Overall Study|Adverse Event|2|||
160941133|NCT02167035|581174843|FG000|Overall Study|Lost to Follow-up|3|||
160941134|NCT02167035|581174844|FG001|Overall Study|Lost to Follow-up|3|||
160941135|NCT02167035|581174843|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
160941136|NCT02167035|581174844|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
160998847|NCT00716144|581380637|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
160998848|NCT00716144|581380638|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
160998849|NCT00716144|581380639|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
160998850|NCT00716144|581380640|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
161144409|NCT01769404|581911982|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161144410|NCT01769404|581911983|FG001|Treatment Period 1|Withdrawal by Subject|0|||
160941137|NCT02252081|581174845|FG000|Overall Study|Withdrawal by Subject|2|||
160941138|NCT02252081|581174846|FG001|Overall Study|Withdrawal by Subject|1|||
160998851|NCT00716144|581380637|FG000|Overall Study|Adverse event: left foot pain|0|||
160998852|NCT00716144|581380638|FG001|Overall Study|Adverse event: left foot pain|1|||
160998853|NCT00716144|581380639|FG002|Overall Study|Adverse event: left foot pain|0|||
160941139|NCT02252081|581174845|FG000|Overall Study|Adverse Event|4|||
160941140|NCT02252081|581174846|FG001|Overall Study|Adverse Event|1|||
160941141|NCT02252081|581174845|FG000|Overall Study|non compliance & others|0|||
160941142|NCT02252081|581174846|FG001|Overall Study|non compliance & others|2|||
160941143|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
160941144|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
160941145|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
160941146|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
160941147|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
160941148|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
160941149|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
160941150|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
160941151|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
160941152|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
160941153|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
160941154|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
160941155|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
160941156|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
160941157|NCT03732638|581174853|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
160941158|NCT03732638|581174854|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
160941159|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
160941160|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
160941161|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
160941162|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
160941163|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
160941164|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
160941165|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
160941166|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
160941167|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
160941168|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
160941169|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
160941170|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
160941171|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
160941172|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
160941173|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
160941174|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
160941175|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
160941176|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
160941177|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
160941178|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
160941179|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
160941180|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
160941181|NCT03732638|581174853|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
160941182|NCT03732638|581174854|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
160941183|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
161342572|NCT01013753|582642192|FG000|Overall Study|Lost to Follow-up|1|||
161342573|NCT01013753|582642192|FG000|Overall Study|Withdrawal by Subject|2|||
161342574|NCT01013753|582642192|FG000|Overall Study|Other|2|||
161342575|NCT00984867|582642194|FG000|Overall Study|Adverse Event|3|||
161342576|NCT00984867|582642195|FG001|Overall Study|Adverse Event|7|||
161342577|NCT00984867|582642194|FG000|Overall Study|Death|1|||
161342578|NCT00984867|582642195|FG001|Overall Study|Death|0|||
161342579|NCT00984867|582642194|FG000|Overall Study|Withdrawal by Subject|13|||
161342580|NCT00984867|582642195|FG001|Overall Study|Withdrawal by Subject|4|||
161342581|NCT00984867|582642194|FG000|Overall Study|Lost to Follow-up|3|||
160998854|NCT00716144|581380640|FG003|Overall Study|Adverse event: left foot pain|0|||
160998855|NCT00716144|581380637|FG000|Overall Study|Clinical Depression|0|||
161342582|NCT00984867|582642195|FG001|Overall Study|Lost to Follow-up|4|||
161342583|NCT00984867|582642194|FG000|Overall Study|Poor/non-compliance|0|||
161342584|NCT00984867|582642195|FG001|Overall Study|Poor/non-compliance|1|||
161342585|NCT00984867|582642194|FG000|Overall Study|Subject no longer meets study criteria|1|||
161342586|NCT00984867|582642195|FG001|Overall Study|Subject no longer meets study criteria|1|||
161342587|NCT00984867|582642194|FG000|Overall Study|site closing|1|||
161342588|NCT00984867|582642195|FG001|Overall Study|site closing|0|||
160941184|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
160941185|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
160941186|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
160941187|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
160941188|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
160941189|NCT03732638|581174853|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
160941190|NCT03732638|581174854|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
161342589|NCT00984867|582642194|FG000|Overall Study|lack of efficacy and subject compliance|1|||
160941191|NCT02370888|581174855|FG000|Overall Study|disease progression|2|||
160941192|NCT02370888|581174855|FG000|Overall Study|did not meet chimerism criteria|6|||
160941193|NCT00642304|581174858|FG000|Overall Study|Adverse Event|1|||
160941194|NCT00642304|581174858|FG000|Overall Study|Death|1|||
160941195|NCT00642304|581174858|FG000|Overall Study|Blood transfusion|2|||
160941196|NCT00642304|581174858|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
160941197|NCT00642304|581174858|FG000|Overall Study|Transplantation|1|||
160941198|NCT00482391|581174859|FG000|Overall Study|Withdrawal by Subject|1|||
160941199|NCT00482391|581174859|FG000|Overall Study|Adverse Event|1|||
160941200|NCT00482391|581174859|FG000|Overall Study|Death|1|||
160941201|NCT01859715|581174864|FG000|Overall Study|No 2nd VAS|16|||
160941202|NCT01859715|581174865|FG001|Overall Study|No 2nd VAS|8|||
160941203|NCT01859715|581174866|FG002|Overall Study|No 2nd VAS|23|||
160941204|NCT00086580|581174870|FG000|Treatment Period|Disease progression|9|||
160941205|NCT00086580|581174871|FG001|Treatment Period|Disease progression|8|||
160941206|NCT00086580|581174870|FG000|Treatment Period|Unable to comply with protocol|3|||
160941207|NCT00086580|581174871|FG001|Treatment Period|Unable to comply with protocol|1|||
160941208|NCT00086580|581174870|FG000|Treatment Period|Withdrawal by Subject|7|||
160941209|NCT00086580|581174871|FG001|Treatment Period|Withdrawal by Subject|8|||
160941210|NCT00086580|581174870|FG000|Treatment Period|Physician Decision|13|||
160941211|NCT00086580|581174871|FG001|Treatment Period|Physician Decision|7|||
160941212|NCT00086580|581174870|FG000|Treatment Period|AE - not treatment related|7|||
160941213|NCT00086580|581174871|FG001|Treatment Period|AE - not treatment related|7|||
160941214|NCT00086580|581174870|FG000|Treatment Period|Toxicity - treatment related|15|||
160941215|NCT00086580|581174871|FG001|Treatment Period|Toxicity - treatment related|15|||
160941216|NCT00086580|581174870|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
160941217|NCT00086580|581174871|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
160941218|NCT00086580|581174870|FG000|Treatment Period|Death|5|||
160941219|NCT00086580|581174871|FG001|Treatment Period|Death|7|||
160941220|NCT00086580|581174870|FG000|Treatment Period|Other|5|||
160941221|NCT00086580|581174871|FG001|Treatment Period|Other|3|||
160941222|NCT00086580|581174870|FG000|Follow-up Period|Disease progression|72|||
160941223|NCT00086580|581174871|FG001|Follow-up Period|Disease progression|99|||
160941224|NCT00086580|581174870|FG000|Follow-up Period|Unable to comply with protocol|5|||
160941225|NCT00086580|581174871|FG001|Follow-up Period|Unable to comply with protocol|0|||
160941226|NCT00086580|581174870|FG000|Follow-up Period|Withdrawal by Subject|6|||
160941227|NCT00086580|581174871|FG001|Follow-up Period|Withdrawal by Subject|6|||
160941228|NCT00086580|581174870|FG000|Follow-up Period|Physician Decision|0|||
160941229|NCT00086580|581174871|FG001|Follow-up Period|Physician Decision|1|||
160941230|NCT00086580|581174870|FG000|Follow-up Period|AE - not related|1|||
160941231|NCT00086580|581174871|FG001|Follow-up Period|AE - not related|0|||
160941232|NCT00086580|581174870|FG000|Follow-up Period|Death|13|||
160941233|NCT00086580|581174871|FG001|Follow-up Period|Death|7|||
160941234|NCT00086580|581174870|FG000|Follow-up Period|Other|7|||
160941235|NCT00086580|581174871|FG001|Follow-up Period|Other|6|||
160941236|NCT00086580|581174870|FG000|Observation Period|Unable to comply with protocol|1|||
160941237|NCT00086580|581174871|FG001|Observation Period|Unable to comply with protocol|1|||
160941238|NCT00086580|581174870|FG000|Observation Period|Withdrawal by Subject|4|||
160941239|NCT00086580|581174871|FG001|Observation Period|Withdrawal by Subject|2|||
160941240|NCT00086580|581174870|FG000|Observation Period|Death|33|||
160941241|NCT00086580|581174871|FG001|Observation Period|Death|55|||
160941242|NCT00086580|581174870|FG000|Observation Period|Other|8|||
160941243|NCT00086580|581174871|FG001|Observation Period|Other|7|||
160941244|NCT03235024|581174873|FG000|Overall Study|Adverse Event|2|||
160941245|NCT03235024|581174874|FG001|Overall Study|Adverse Event|2|||
160941246|NCT03235024|581174873|FG000|Overall Study|Death|1|||
160941247|NCT03235024|581174874|FG001|Overall Study|Death|0|||
160998856|NCT00716144|581380638|FG001|Overall Study|Clinical Depression|1|||
160998857|NCT00716144|581380639|FG002|Overall Study|Clinical Depression|0|||
160998858|NCT00716144|581380640|FG003|Overall Study|Clinical Depression|0|||
160941248|NCT03235024|581174873|FG000|Overall Study|Lost to Follow-up|2|||
160941249|NCT03235024|581174874|FG001|Overall Study|Lost to Follow-up|5|||
160941250|NCT03235024|581174873|FG000|Overall Study|Protocol Violation|1|||
160941251|NCT03235024|581174874|FG001|Overall Study|Protocol Violation|0|||
160941252|NCT03235024|581174873|FG000|Overall Study|Withdrawal by Subject|0|||
160941253|NCT03235024|581174874|FG001|Overall Study|Withdrawal by Subject|3|||
160941254|NCT02357576|581174875|FG000|Treatment Period|Withdrawal by Subject|0|||
160941255|NCT02357576|581174876|FG001|Treatment Period|Withdrawal by Subject|1|||
160941256|NCT02357576|581174875|FG000|Treatment Period|Physician Decision|0|||
160941257|NCT02357576|581174876|FG001|Treatment Period|Physician Decision|1|||
160941258|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
160941259|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
160941260|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
160941261|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
161144411|NCT01769404|581911982|FG000|Treatment Period 1|Sponsor decision|1|||
160941262|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
160941263|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
160941264|NCT02357576|581174875|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
160941265|NCT02357576|581174876|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
160941266|NCT00261716|581174877|FG000|Overall Study|Withdrawal by Subject|6|||
160941267|NCT00261716|581174878|FG001|Overall Study|Withdrawal by Subject|8|||
160941268|NCT00261716|581174877|FG000|Overall Study|Lost to Follow-up|0|||
160941269|NCT00261716|581174878|FG001|Overall Study|Lost to Follow-up|2|||
160941270|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
160941271|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
160941272|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
160941273|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
160941274|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
160941275|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
160941276|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
160941277|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
160941278|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
160941279|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
160941280|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
160941281|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
160998859|NCT00880048|581380641|FG000|Overall Study|Adverse Event|2|||
160998860|NCT00880048|581380642|FG001|Overall Study|Adverse Event|3|||
160998861|NCT00880048|581380643|FG002|Overall Study|Adverse Event|5|||
160998862|NCT00880048|581380641|FG000|Overall Study|Lack of Efficacy|1|||
160998863|NCT00880048|581380642|FG001|Overall Study|Lack of Efficacy|2|||
160998864|NCT00880048|581380643|FG002|Overall Study|Lack of Efficacy|2|||
160998865|NCT00880048|581380641|FG000|Overall Study|Protocol Violation|4|||
160998866|NCT00880048|581380642|FG001|Overall Study|Protocol Violation|6|||
160998867|NCT00880048|581380643|FG002|Overall Study|Protocol Violation|5|||
160998868|NCT00880048|581380641|FG000|Overall Study|Lost to Follow-up|6|||
160998869|NCT00880048|581380642|FG001|Overall Study|Lost to Follow-up|6|||
160998870|NCT00880048|581380643|FG002|Overall Study|Lost to Follow-up|5|||
160998871|NCT00880048|581380641|FG000|Overall Study|Physician Decision|1|||
160998872|NCT00880048|581380642|FG001|Overall Study|Physician Decision|1|||
160998873|NCT00880048|581380643|FG002|Overall Study|Physician Decision|7|||
160998874|NCT00880048|581380641|FG000|Overall Study|Withdrawal by Subject|5|||
160998875|NCT00880048|581380642|FG001|Overall Study|Withdrawal by Subject|8|||
160998876|NCT00880048|581380643|FG002|Overall Study|Withdrawal by Subject|5|||
160998877|NCT00880048|581380641|FG000|Overall Study|Study closed/terminated|9|||
160998878|NCT00880048|581380642|FG001|Overall Study|Study closed/terminated|7|||
160998879|NCT00880048|581380643|FG002|Overall Study|Study closed/terminated|6|||
160998880|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
160998881|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
160998882|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
160998883|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
160998884|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
160998885|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
160998886|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
160998887|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
160998888|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
160998889|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
160998890|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
160998891|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
160998892|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
160998893|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
160998894|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
160998895|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
160998896|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
160998897|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
161342590|NCT00984867|582642195|FG001|Overall Study|lack of efficacy and subject compliance|0|||
160941282|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
160941283|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
160998898|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998899|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998900|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998901|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
160998902|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
160998903|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
160998904|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
161144412|NCT01769404|581911983|FG001|Treatment Period 1|Sponsor decision|0|||
160998905|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
160998906|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
160998907|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
160998908|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
160941284|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
160941285|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
160941286|NCT02047110|581174881|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
160941287|NCT02047110|581174882|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
160941288|NCT02047110|581174883|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
160941289|NCT02047110|581174884|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
160941290|NCT02047110|581174881|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
160941291|NCT02047110|581174882|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
160941292|NCT02047110|581174883|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
160941293|NCT02047110|581174884|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
160941294|NCT02047110|581174881|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
160941295|NCT02047110|581174882|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
160941296|NCT02047110|581174883|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
160941297|NCT02047110|581174884|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
160941298|NCT02047110|581174881|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
160941299|NCT02047110|581174882|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
160941300|NCT02047110|581174883|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
160941301|NCT02047110|581174884|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
160941302|NCT02047110|581174881|FG000|Escape Treatment Period|Adverse Event|1|||
160941303|NCT02047110|581174882|FG001|Escape Treatment Period|Adverse Event|2|||
160941304|NCT02047110|581174883|FG002|Escape Treatment Period|Adverse Event|2|||
160941305|NCT02047110|581174884|FG003|Escape Treatment Period|Adverse Event|0|||
160941306|NCT02047110|581174881|FG000|Escape Treatment Period|Other than specified|1|||
160941307|NCT02047110|581174882|FG001|Escape Treatment Period|Other than specified|2|||
160941308|NCT02047110|581174883|FG002|Escape Treatment Period|Other than specified|0|||
160941309|NCT02047110|581174884|FG003|Escape Treatment Period|Other than specified|1|||
160941310|NCT02047110|581174881|FG000|OLE Treatment Period|Other than specified|0|||
160941311|NCT02047110|581174882|FG001|OLE Treatment Period|Other than specified|0|||
160941312|NCT02047110|581174883|FG002|OLE Treatment Period|Other than specified|1|||
160941313|NCT02047110|581174884|FG003|OLE Treatment Period|Other than specified|0|||
160941314|NCT00699699|581174885|FG000|Overall Study|Adverse Event|36|||
160941315|NCT00699699|581174885|FG000|Overall Study|Individual different reasons|21|||
160941316|NCT00705575|581174886|FG000|Overall Study|Abnormal laboratory value(s)|0|||
160941317|NCT00705575|581174887|FG001|Overall Study|Abnormal laboratory value(s)|3|||
160941318|NCT00705575|581174886|FG000|Overall Study|Abnormal test procedure result(s)|2|||
160941319|NCT00705575|581174887|FG001|Overall Study|Abnormal test procedure result(s)|12|||
160941320|NCT00705575|581174886|FG000|Overall Study|Adverse Event|11|||
160941321|NCT00705575|581174887|FG001|Overall Study|Adverse Event|15|||
160941322|NCT00705575|581174886|FG000|Overall Study|Lost to Follow-up|3|||
160941323|NCT00705575|581174887|FG001|Overall Study|Lost to Follow-up|4|||
160941324|NCT00705575|581174886|FG000|Overall Study|Protocol Violation|2|||
160941325|NCT00705575|581174887|FG001|Overall Study|Protocol Violation|2|||
160941326|NCT00705575|581174886|FG000|Overall Study|Withdrawal by Subject|5|||
160941327|NCT00705575|581174887|FG001|Overall Study|Withdrawal by Subject|10|||
160941328|NCT01000051|581174891|FG000|Overall Study|Withdrawal by Subject|1|||
160941329|NCT01000051|581174892|FG001|Overall Study|Withdrawal by Subject|1|||
160941330|NCT01000051|581174891|FG000|Overall Study|Disease Progression|1|||
160941331|NCT01000051|581174892|FG001|Overall Study|Disease Progression|0|||
160941332|NCT01000051|581174891|FG000|Overall Study|Serious noncompliance|1|||
160941333|NCT01000051|581174892|FG001|Overall Study|Serious noncompliance|0|||
160941334|NCT02802345|581174894|FG000|Overall Study|Not Treated|0|||
160941335|NCT02802345|581174895|FG001|Overall Study|Not Treated|1|||
160941336|NCT02802345|581174894|FG000|Overall Study|Adverse Event|28|||
160941337|NCT02802345|581174895|FG001|Overall Study|Adverse Event|20|||
160941338|NCT02802345|581174894|FG000|Overall Study|Withdrawal by Subject|3|||
160941339|NCT02802345|581174895|FG001|Overall Study|Withdrawal by Subject|3|||
160941340|NCT02802345|581174894|FG000|Overall Study|Protocol Violation|0|||
160941341|NCT02802345|581174895|FG001|Overall Study|Protocol Violation|1|||
160941342|NCT02802345|581174894|FG000|Overall Study|Other than listed|1|||
160941343|NCT02802345|581174895|FG001|Overall Study|Other than listed|5|||
160941344|NCT03969212|581174896|FG000|Overall Study|Adverse Event|1|||
160941345|NCT03969212|581174897|FG001|Overall Study|Adverse Event|0|||
160941346|NCT03969212|581174898|FG002|Overall Study|Adverse Event|0|||
160941347|NCT03969212|581174899|FG003|Overall Study|Adverse Event|0|||
160941348|NCT03969212|581174896|FG000|Overall Study|Lost to Follow-up|2|||
160941349|NCT03969212|581174897|FG001|Overall Study|Lost to Follow-up|2|||
160941350|NCT03969212|581174898|FG002|Overall Study|Lost to Follow-up|2|||
160941351|NCT03969212|581174899|FG003|Overall Study|Lost to Follow-up|2|||
160941352|NCT03969212|581174896|FG000|Overall Study|Protocol Violation|0|||
160941353|NCT03969212|581174897|FG001|Overall Study|Protocol Violation|0|||
160941354|NCT03969212|581174898|FG002|Overall Study|Protocol Violation|0|||
160941355|NCT03969212|581174899|FG003|Overall Study|Protocol Violation|1|||
160941356|NCT03969212|581174896|FG000|Overall Study|Withdrawal by Subject|7|||
160941357|NCT03969212|581174897|FG001|Overall Study|Withdrawal by Subject|13|||
160941358|NCT03969212|581174898|FG002|Overall Study|Withdrawal by Subject|5|||
161264951|NCT04442490|582352346|FG000|Overall Study|Noncompliance|3|||
161264952|NCT04442490|582352347|FG001|Overall Study|Noncompliance|1|||
161264953|NCT04442490|582352346|FG000|Overall Study|Physician Decision|2|||
161264954|NCT04442490|582352347|FG001|Overall Study|Physician Decision|1|||
161264955|NCT04442490|582352346|FG000|Overall Study|Reason not Specified|2|||
161264956|NCT04442490|582352347|FG001|Overall Study|Reason not Specified|1|||
161264957|NCT04442490|582352346|FG000|Overall Study|Randomized but not Treated|3|||
161264958|NCT04442490|582352347|FG001|Overall Study|Randomized but not Treated|3|||
161264959|NCT00415194|582352352|FG000|Overall Study|Adverse Event|37|||
161264960|NCT00415194|582352353|FG001|Overall Study|Adverse Event|32|||
161264961|NCT00415194|582352352|FG000|Overall Study|Entry Criteria Not Met|4|||
161264962|NCT00415194|582352353|FG001|Overall Study|Entry Criteria Not Met|8|||
161264963|NCT00415194|582352352|FG000|Overall Study|Lost to Follow-up|1|||
161264964|NCT00415194|582352353|FG001|Overall Study|Lost to Follow-up|0|||
161264965|NCT00415194|582352352|FG000|Overall Study|Physician Decision|10|||
161264966|NCT00415194|582352353|FG001|Overall Study|Physician Decision|16|||
161264967|NCT00415194|582352352|FG000|Overall Study|Progressive Disease|180|||
161264968|NCT00415194|582352353|FG001|Overall Study|Progressive Disease|217|||
161264969|NCT00415194|582352352|FG000|Overall Study|Protocol Violation|4|||
161264970|NCT00415194|582352353|FG001|Overall Study|Protocol Violation|2|||
161264971|NCT00415194|582352352|FG000|Overall Study|Withdrawal by Subject|28|||
161264972|NCT00415194|582352353|FG001|Overall Study|Withdrawal by Subject|21|||
161264973|NCT00415194|582352352|FG000|Overall Study|Death Due to Study Disease|26|||
161264974|NCT00415194|582352353|FG001|Overall Study|Death Due to Study Disease|29|||
161264975|NCT00415194|582352352|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
161264976|NCT00415194|582352353|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
160941359|NCT03969212|581174899|FG003|Overall Study|Withdrawal by Subject|11|||
160941360|NCT03969212|581174896|FG000|Overall Study|Physician Decision|0|||
160941361|NCT03969212|581174897|FG001|Overall Study|Physician Decision|0|||
160941362|NCT03969212|581174898|FG002|Overall Study|Physician Decision|1|||
160941363|NCT03969212|581174899|FG003|Overall Study|Physician Decision|0|||
161264977|NCT00415194|582352352|FG000|Overall Study|Death Due to Procedural Related AE|0|||
161264978|NCT00415194|582352353|FG001|Overall Study|Death Due to Procedural Related AE|1|||
161264979|NCT00415194|582352352|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
161264980|NCT00415194|582352353|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
161264981|NCT01297465|582352354|FG000|Overall Study|Lack of Ovarian Response|1|||
161264982|NCT01297465|582352355|FG001|Overall Study|Lack of Ovarian Response|1|||
161264983|NCT01297465|582352354|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
161264984|NCT01297465|582352355|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161264985|NCT01297465|582352354|FG000|Overall Study|No Oocytes Retrieved|1|||
161264986|NCT01297465|582352355|FG001|Overall Study|No Oocytes Retrieved|1|||
161264987|NCT01297465|582352354|FG000|Overall Study|Poor oocyte quality|0|||
161264988|NCT01297465|582352355|FG001|Overall Study|Poor oocyte quality|1|||
161264989|NCT01297465|582352354|FG000|Overall Study|No Fertilization|6|||
161264990|NCT01297465|582352355|FG001|Overall Study|No Fertilization|4|||
161264991|NCT01297465|582352354|FG000|Overall Study|All Embryos Discarded|0|||
161264992|NCT01297465|582352355|FG001|Overall Study|All Embryos Discarded|1|||
161264993|NCT01297465|582352354|FG000|Overall Study|Intention to Freeze all Embryos|0|||
160941364|NCT03969212|581174896|FG000|Overall Study|Reason not Specified|22|||
161264994|NCT01297465|582352355|FG001|Overall Study|Intention to Freeze all Embryos|1|||
161264995|NCT00969540|582352356|FG000|Overall Study|Lost to Follow-up|1|||
161342591|NCT00671060|582642196|FG000|Overall Study|Protocol Violation|1|||
161342592|NCT00671060|582642197|FG001|Overall Study|Protocol Violation|0|||
161342593|NCT00671060|582642196|FG000|Overall Study|Physician Decision|0|||
161342594|NCT00671060|582642197|FG001|Overall Study|Physician Decision|1|||
160941365|NCT03969212|581174897|FG001|Overall Study|Reason not Specified|23|||
160941366|NCT03969212|581174898|FG002|Overall Study|Reason not Specified|28|||
160941367|NCT03969212|581174899|FG003|Overall Study|Reason not Specified|26|||
160941368|NCT02075320|581174901|FG000|Overall Study|Withdrawal by Subject|2|||
160941369|NCT03773757|581174902|FG000|Overall Study|Withdrawal by Subject|2|||
160941370|NCT03773757|581174903|FG001|Overall Study|Withdrawal by Subject|4|||
160941371|NCT00057746|581174904|FG000|Overall Study|Withdrawal by Subject|0|||
160941372|NCT00057746|581174905|FG001|Overall Study|Withdrawal by Subject|0|||
160941373|NCT00057746|581174906|FG002|Overall Study|Withdrawal by Subject|1|||
160941374|NCT02985736|581174909|FG000|Overall Study|Lost to Follow-up|3|||
160941375|NCT00550836|581174910|FG000|Overall Study|Withdrawal by Subject|3|||
161264996|NCT00969540|582352357|FG001|Overall Study|Lost to Follow-up|1|||
161264997|NCT04078126|582352360|FG000|Washout|Study put on hold due to COVID-19|0|||
161264998|NCT04078126|582352361|FG001|Washout|Study put on hold due to COVID-19|2|||
161264999|NCT04078126|582352360|FG000|Period 2|Study put on hold due to COVID-19|1|||
161265000|NCT04078126|582352361|FG001|Period 2|Study put on hold due to COVID-19|1|||
161265001|NCT00140426|582352364|FG000|Overall Study|Withdrawal by Subject|0|||
161265002|NCT00140426|582352365|FG001|Overall Study|Withdrawal by Subject|3|||
161265003|NCT02149108|582352366|FG000|Overall Study|Not treated|1|||
161265004|NCT02149108|582352367|FG001|Overall Study|Not treated|2|||
161342595|NCT00626639|582642205|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
160941376|NCT00550836|581174911|FG001|Overall Study|Withdrawal by Subject|9|||
160941377|NCT01552772|581174912|FG000|Overall Study|Lost to Follow-up|2|||
160941378|NCT01552772|581174912|FG000|Overall Study|Adverse Event|1|||
160941379|NCT01552772|581174912|FG000|Overall Study|Protocol Deviation|1|||
160941380|NCT01848990|581174913|FG000|Overall Study|Adverse Event|6|||
160941381|NCT01848990|581174914|FG001|Overall Study|Adverse Event|2|||
160941382|NCT01848990|581174915|FG002|Overall Study|Adverse Event|0|||
160941383|NCT01848990|581174913|FG000|Overall Study|Lost to Follow-up|6|||
160941384|NCT01848990|581174914|FG001|Overall Study|Lost to Follow-up|2|||
160941385|NCT01848990|581174915|FG002|Overall Study|Lost to Follow-up|2|||
160941386|NCT01848990|581174913|FG000|Overall Study|Protocol Violation|1|||
160941387|NCT01848990|581174914|FG001|Overall Study|Protocol Violation|1|||
160941388|NCT01848990|581174915|FG002|Overall Study|Protocol Violation|0|||
160941389|NCT01848990|581174913|FG000|Overall Study|Withdrawal by Subject|29|||
160941390|NCT01848990|581174914|FG001|Overall Study|Withdrawal by Subject|10|||
160941391|NCT01848990|581174915|FG002|Overall Study|Withdrawal by Subject|11|||
160941392|NCT01848990|581174913|FG000|Overall Study|Physician Decision|1|||
160941393|NCT01848990|581174914|FG001|Overall Study|Physician Decision|1|||
160941394|NCT01848990|581174915|FG002|Overall Study|Physician Decision|0|||
160941395|NCT01848990|581174913|FG000|Overall Study|Non Compliance|1|||
160941396|NCT01848990|581174914|FG001|Overall Study|Non Compliance|0|||
160941397|NCT01848990|581174915|FG002|Overall Study|Non Compliance|0|||
160941398|NCT01848990|581174913|FG000|Overall Study|Death|1|||
160941399|NCT01848990|581174914|FG001|Overall Study|Death|0|||
160941400|NCT01848990|581174915|FG002|Overall Study|Death|1|||
160941401|NCT01848990|581174913|FG000|Overall Study|Other|1|||
160941402|NCT01848990|581174914|FG001|Overall Study|Other|4|||
160941403|NCT01848990|581174915|FG002|Overall Study|Other|2|||
160941404|NCT00512096|581174924|FG000|Overall Study|Adverse Event|2|||
160941405|NCT00512096|581174924|FG000|Overall Study|Withdrawal by Subject|2|||
160941406|NCT00512096|581174924|FG000|Overall Study|Lack of Efficacy|3|||
160941407|NCT00298038|581174928|FG000|Overall Study|Lost to Follow-up|0|||
160941408|NCT00298038|581174929|FG001|Overall Study|Lost to Follow-up|1|||
160941409|NCT00298038|581174928|FG000|Overall Study|Liver Transplant|0|||
160941410|NCT00298038|581174929|FG001|Overall Study|Liver Transplant|1|||
160941411|NCT00298038|581174928|FG000|Overall Study|Protocol Violation|1|||
160941412|NCT00298038|581174929|FG001|Overall Study|Protocol Violation|3|||
160941413|NCT00298038|581174928|FG000|Overall Study|Death|6|||
160941414|NCT00298038|581174929|FG001|Overall Study|Death|3|||
160941415|NCT00298038|581174928|FG000|Overall Study|Withdrawal by Subject|6|||
160941416|NCT00298038|581174929|FG001|Overall Study|Withdrawal by Subject|9|||
160941417|NCT00298038|581174928|FG000|Overall Study|Adverse Event|8|||
160941418|NCT00298038|581174929|FG001|Overall Study|Adverse Event|7|||
160941419|NCT00298038|581174928|FG000|Overall Study|Breakthrough overt HE episode|28|||
160941420|NCT00298038|581174929|FG001|Overall Study|Breakthrough overt HE episode|69|||
160941421|NCT00298038|581174928|FG000|Overall Study|Noncompliance|1|||
160941422|NCT00298038|581174929|FG001|Overall Study|Noncompliance|0|||
160941423|NCT00298038|581174928|FG000|Overall Study|Cocaine Abuse|1|||
160941424|NCT00298038|581174929|FG001|Overall Study|Cocaine Abuse|0|||
160941425|NCT00298038|581174928|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
160941426|NCT00298038|581174929|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
160941427|NCT02696096|581174930|FG000|Overall Study|ruled out at screening|1|||
160941428|NCT02696096|581174930|FG000|Overall Study|did not attend second fMRI|1|||
160941429|NCT01940705|581174934|FG000|Overall Study|Lost to Follow-up|1|||
160941430|NCT01940705|581174935|FG001|Overall Study|Lost to Follow-up|3|||
160941431|NCT01940705|581174936|FG002|Overall Study|Lost to Follow-up|2|||
160941432|NCT01940705|581174937|FG003|Overall Study|Lost to Follow-up|2|||
160941433|NCT01940705|581174934|FG000|Overall Study|Withdrawal by Subject|2|||
160941434|NCT01940705|581174935|FG001|Overall Study|Withdrawal by Subject|2|||
160941435|NCT01940705|581174936|FG002|Overall Study|Withdrawal by Subject|3|||
160941436|NCT01940705|581174937|FG003|Overall Study|Withdrawal by Subject|2|||
160941437|NCT01940705|581174934|FG000|Overall Study|Intervention not given|0|||
160941438|NCT01940705|581174935|FG001|Overall Study|Intervention not given|3|||
161265005|NCT02149108|582352366|FG000|Overall Study|Progressive Disease (PD)|324|||
161265006|NCT02149108|582352367|FG001|Overall Study|Progressive Disease (PD)|318|||
161265007|NCT02149108|582352366|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
160941439|NCT01940705|581174936|FG002|Overall Study|Intervention not given|3|||
160941440|NCT01940705|581174937|FG003|Overall Study|Intervention not given|0|||
160941441|NCT01940705|581174934|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
160941442|NCT01940705|581174935|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
160941443|NCT01940705|581174936|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
160941444|NCT01940705|581174937|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
160941445|NCT02447991|581174938|FG000|Overall Study|Withdrawn by subject - no data|0|||
160941446|NCT02447991|581174939|FG001|Overall Study|Withdrawn by subject - no data|2|||
160941447|NCT02447991|581174938|FG000|Overall Study|Withdrawn by Subject - with data|4|||
160941448|NCT02447991|581174939|FG001|Overall Study|Withdrawn by Subject - with data|4|||
160941449|NCT02447991|581174938|FG000|Overall Study|Lost to Follow-up - no data|3|||
161265008|NCT02149108|582352367|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
160941450|NCT02447991|581174939|FG001|Overall Study|Lost to Follow-up - no data|6|||
160941451|NCT02447991|581174938|FG000|Overall Study|Lost to follow-up - with data|0|||
161265009|NCT02149108|582352366|FG000|Overall Study|Other Adverse Event (AE)|8|||
161265010|NCT02149108|582352367|FG001|Overall Study|Other Adverse Event (AE)|18|||
161265011|NCT02149108|582352366|FG000|Overall Study|Other not defined above|0|||
160941452|NCT02447991|581174939|FG001|Overall Study|Lost to follow-up - with data|3|||
160941453|NCT02447991|581174938|FG000|Overall Study|End of study - no treatment results|3|||
160941454|NCT02447991|581174939|FG001|Overall Study|End of study - no treatment results|6|||
160941455|NCT02447991|581174938|FG000|Overall Study|End of study - partial treatment results|0|||
160941456|NCT02447991|581174939|FG001|Overall Study|End of study - partial treatment results|9|||
160941457|NCT00829621|581174940|FG000|Overall Study|Death|1|||
160941458|NCT00829621|581174941|FG001|Overall Study|Death|0|||
160941459|NCT00829621|581174940|FG000|Overall Study|Lost to Follow-up|3|||
160941460|NCT00829621|581174941|FG001|Overall Study|Lost to Follow-up|4|||
160941461|NCT03551210|581174944|FG000|Overall Study|Adverse Event|5|||
160941462|NCT03551210|581174945|FG001|Overall Study|Adverse Event|6|||
160941463|NCT03551210|581174944|FG000|Overall Study|Withdrawal by Subject|1|||
160941464|NCT03551210|581174945|FG001|Overall Study|Withdrawal by Subject|7|||
160941465|NCT03551210|581174944|FG000|Overall Study|Needed in other antibiotic treatment|2|||
160941466|NCT03551210|581174945|FG001|Overall Study|Needed in other antibiotic treatment|5|||
160941467|NCT03551210|581174944|FG000|Overall Study|Lost to Follow-up|1|||
160941468|NCT03551210|581174945|FG001|Overall Study|Lost to Follow-up|1|||
160941469|NCT03551210|581174944|FG000|Overall Study|Absence of visit 4 and 5|1|||
160941470|NCT03551210|581174945|FG001|Overall Study|Absence of visit 4 and 5|0|||
160941471|NCT03551210|581174944|FG000|Overall Study|No drug for dispensing|0|||
160941472|NCT03551210|581174945|FG001|Overall Study|No drug for dispensing|1|||
160941473|NCT03265119|581174946|FG000|Overall Study|Adverse Event|2|||
160941474|NCT03265119|581174947|FG001|Overall Study|Adverse Event|1|||
160941475|NCT03265119|581174946|FG000|Overall Study|Lack of Efficacy|3|||
160941476|NCT03265119|581174947|FG001|Overall Study|Lack of Efficacy|0|||
160941477|NCT03265119|581174946|FG000|Overall Study|Protocol Violation|1|||
160941478|NCT03265119|581174947|FG001|Overall Study|Protocol Violation|2|||
160941479|NCT03265119|581174946|FG000|Overall Study|Withdrawal by Subject|2|||
160941480|NCT03265119|581174947|FG001|Overall Study|Withdrawal by Subject|4|||
160941481|NCT03265119|581174946|FG000|Overall Study|Lost to Follow-up|1|||
160941482|NCT03265119|581174947|FG001|Overall Study|Lost to Follow-up|0|||
160941483|NCT03265119|581174946|FG000|Overall Study|Lack of Compliance|1|||
160941484|NCT03265119|581174947|FG001|Overall Study|Lack of Compliance|0|||
160941485|NCT01076400|581176665|FG000|Overall Study|Adverse Event|2|||
160941486|NCT01076400|581176666|FG001|Overall Study|Adverse Event|0|||
160941487|NCT01076400|581176667|FG002|Overall Study|Adverse Event|0|||
160941488|NCT01076400|581176665|FG000|Overall Study|Progressive Disease|5|||
160941489|NCT01076400|581176666|FG001|Overall Study|Progressive Disease|0|||
160941490|NCT01076400|581176667|FG002|Overall Study|Progressive Disease|0|||
160941491|NCT02766608|581176670|FG000|Overall Study|Adverse Event|27|||
160941492|NCT02766608|581176671|FG001|Overall Study|Adverse Event|22|||
160941493|NCT02766608|581176672|FG002|Overall Study|Adverse Event|17|||
160941494|NCT02766608|581176673|FG003|Overall Study|Adverse Event|13|||
160941495|NCT02766608|581176674|FG004|Overall Study|Adverse Event|12|||
160941496|NCT02766608|581176670|FG000|Overall Study|Withdrawal by Subject|21|||
160941497|NCT02766608|581176671|FG001|Overall Study|Withdrawal by Subject|20|||
160941498|NCT02766608|581176672|FG002|Overall Study|Withdrawal by Subject|24|||
160941499|NCT02766608|581176673|FG003|Overall Study|Withdrawal by Subject|13|||
160941500|NCT02766608|581176674|FG004|Overall Study|Withdrawal by Subject|10|||
160941501|NCT02766608|581176670|FG000|Overall Study|Lack of Efficacy|16|||
160941502|NCT02766608|581176671|FG001|Overall Study|Lack of Efficacy|15|||
160941503|NCT02766608|581176672|FG002|Overall Study|Lack of Efficacy|32|||
160941504|NCT02766608|581176673|FG003|Overall Study|Lack of Efficacy|8|||
160941505|NCT02766608|581176674|FG004|Overall Study|Lack of Efficacy|2|||
160941506|NCT02766608|581176670|FG000|Overall Study|Lost to Follow-up|6|||
160941507|NCT02766608|581176671|FG001|Overall Study|Lost to Follow-up|3|||
160941508|NCT02766608|581176672|FG002|Overall Study|Lost to Follow-up|5|||
160941509|NCT02766608|581176673|FG003|Overall Study|Lost to Follow-up|2|||
161265012|NCT02149108|582352367|FG001|Overall Study|Other not defined above|2|||
161265013|NCT02149108|582352366|FG000|Overall Study|Refusal to continue trial medication|15|||
160941510|NCT02766608|581176674|FG004|Overall Study|Lost to Follow-up|2|||
160941511|NCT02766608|581176670|FG000|Overall Study|Physician Decision|3|||
160941512|NCT02766608|581176671|FG001|Overall Study|Physician Decision|2|||
160941513|NCT02766608|581176672|FG002|Overall Study|Physician Decision|3|||
160941514|NCT02766608|581176673|FG003|Overall Study|Physician Decision|1|||
161265014|NCT02149108|582352367|FG001|Overall Study|Refusal to continue trial medication|11|||
160941515|NCT02766608|581176674|FG004|Overall Study|Physician Decision|2|||
160941516|NCT02766608|581176670|FG000|Overall Study|Protocol disc criteria|3|||
160941517|NCT02766608|581176671|FG001|Overall Study|Protocol disc criteria|3|||
160941518|NCT02766608|581176672|FG002|Overall Study|Protocol disc criteria|4|||
161265015|NCT02149108|582352366|FG000|Overall Study|Lost to Follow-up|1|||
161265016|NCT02149108|582352367|FG001|Overall Study|Lost to Follow-up|0|||
161265017|NCT00950963|582352368|FG000|Overall Study|Lost to Follow-up|29|||
160941519|NCT02766608|581176673|FG003|Overall Study|Protocol disc criteria|0|||
160941520|NCT02766608|581176674|FG004|Overall Study|Protocol disc criteria|0|||
160941521|NCT02766608|581176670|FG000|Overall Study|Protocol Violation|0|||
160941522|NCT02766608|581176671|FG001|Overall Study|Protocol Violation|4|||
160941523|NCT02766608|581176672|FG002|Overall Study|Protocol Violation|4|||
160941524|NCT02766608|581176673|FG003|Overall Study|Protocol Violation|0|||
160941525|NCT02766608|581176674|FG004|Overall Study|Protocol Violation|1|||
160941526|NCT02766608|581176670|FG000|Overall Study|Administrative Reasons|3|||
160941527|NCT02766608|581176671|FG001|Overall Study|Administrative Reasons|1|||
160941528|NCT02766608|581176672|FG002|Overall Study|Administrative Reasons|1|||
160941529|NCT02766608|581176673|FG003|Overall Study|Administrative Reasons|0|||
160941530|NCT02766608|581176674|FG004|Overall Study|Administrative Reasons|0|||
160941531|NCT02343458|581176675|FG000|Overall Study|Adverse Event|15|||
160941532|NCT02343458|581176676|FG001|Overall Study|Adverse Event|14|||
160941533|NCT02343458|581176677|FG002|Overall Study|Adverse Event|15|||
160941534|NCT02343458|581176678|FG003|Overall Study|Adverse Event|3|||
160941535|NCT02343458|581176675|FG000|Overall Study|Lack of Efficacy|3|||
160941536|NCT02343458|581176676|FG001|Overall Study|Lack of Efficacy|8|||
160941537|NCT02343458|581176677|FG002|Overall Study|Lack of Efficacy|4|||
160941538|NCT02343458|581176678|FG003|Overall Study|Lack of Efficacy|8|||
160941539|NCT02343458|581176675|FG000|Overall Study|Withdrawal by Subject|18|||
160941540|NCT02343458|581176676|FG001|Overall Study|Withdrawal by Subject|17|||
160941541|NCT02343458|581176677|FG002|Overall Study|Withdrawal by Subject|23|||
160941542|NCT02343458|581176678|FG003|Overall Study|Withdrawal by Subject|14|||
160941543|NCT02343458|581176675|FG000|Overall Study|Physician Decision|1|||
160941544|NCT02343458|581176676|FG001|Overall Study|Physician Decision|4|||
160941545|NCT02343458|581176677|FG002|Overall Study|Physician Decision|2|||
160941546|NCT02343458|581176678|FG003|Overall Study|Physician Decision|2|||
160941547|NCT02343458|581176675|FG000|Overall Study|Lost to Follow-up|5|||
160941548|NCT02343458|581176676|FG001|Overall Study|Lost to Follow-up|5|||
160941549|NCT02343458|581176677|FG002|Overall Study|Lost to Follow-up|3|||
160941550|NCT02343458|581176678|FG003|Overall Study|Lost to Follow-up|1|||
160941551|NCT02343458|581176675|FG000|Overall Study|Protocol Violation|2|||
161144413|NCT01769404|581911982|FG000|Treatment Period 2|Sponsor decision|7|||
161144414|NCT01769404|581911983|FG001|Treatment Period 2|Sponsor decision|0|||
160941552|NCT02343458|581176676|FG001|Overall Study|Protocol Violation|5|||
160941553|NCT02343458|581176677|FG002|Overall Study|Protocol Violation|2|||
160941554|NCT02343458|581176678|FG003|Overall Study|Protocol Violation|2|||
160941555|NCT02343458|581176675|FG000|Overall Study|Protocol Specified Criteria|17|||
160941556|NCT02343458|581176676|FG001|Overall Study|Protocol Specified Criteria|13|||
160941557|NCT02343458|581176677|FG002|Overall Study|Protocol Specified Criteria|14|||
160941558|NCT02343458|581176678|FG003|Overall Study|Protocol Specified Criteria|8|||
160941559|NCT01913041|581176679|FG000|Overall Study|Protocol Violation|35|||
160941560|NCT01913041|581176679|FG000|Overall Study|Withdrawal by Subject|3|||
160941561|NCT01913041|581176679|FG000|Overall Study|Physician Decision|1|||
160941562|NCT02866682|581176682|FG000|Overall Study|Death|0|||
160941563|NCT02866682|581176683|FG001|Overall Study|Death|1|||
160941564|NCT02866682|581176682|FG000|Overall Study|Lost to Follow-up|0|||
160941565|NCT02866682|581176683|FG001|Overall Study|Lost to Follow-up|4|||
160941566|NCT02866682|581176682|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
160941567|NCT02866682|581176683|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
160941568|NCT02866682|581176682|FG000|Overall Study|Other|0|||
160941569|NCT02866682|581176683|FG001|Overall Study|Other|1|||
160941570|NCT01750268|581176684|FG000|Overall Study|Lost to Follow-up|0|||
160941571|NCT01750268|581176685|FG001|Overall Study|Lost to Follow-up|2|||
160941572|NCT01750268|581176684|FG000|Overall Study|Physician Decision|0|||
160941573|NCT01750268|581176685|FG001|Overall Study|Physician Decision|3|||
160941574|NCT01750268|581176684|FG000|Overall Study|Withdrawal by Subject|2|||
160941575|NCT01750268|581176685|FG001|Overall Study|Withdrawal by Subject|0|||
160941576|NCT02086591|581176688|FG000|Overall Study|Adverse Event|1|||
160941577|NCT02086591|581176688|FG000|Overall Study|Withdrawal by Subject|1|||
160941578|NCT02086591|581176688|FG000|Overall Study|protocol terminated|3|||
160941579|NCT01529645|581176689|FG000|Overall Study|Lost to Follow-up|0|||
160941580|NCT01529645|581176690|FG001|Overall Study|Lost to Follow-up|1|||
160941581|NCT01529645|581176691|FG002|Overall Study|Lost to Follow-up|1|||
160941582|NCT01529645|581176692|FG003|Overall Study|Lost to Follow-up|1|||
160941583|NCT01529645|581176693|FG004|Overall Study|Lost to Follow-up|1|||
160941584|NCT01529645|581176694|FG005|Overall Study|Lost to Follow-up|0|||
160941585|NCT01529645|581176695|FG006|Overall Study|Lost to Follow-up|2|||
161144415|NCT02277444|581911995|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
160941586|NCT01529645|581176696|FG007|Overall Study|Lost to Follow-up|0|||
160941587|NCT01529645|581176697|FG008|Overall Study|Lost to Follow-up|1|||
160941588|NCT01529645|581176698|FG009|Overall Study|Lost to Follow-up|0|||
160941589|NCT01529645|581176689|FG000|Overall Study|SAE - Premature contractions|0|||
160941590|NCT01529645|581176690|FG001|Overall Study|SAE - Premature contractions|0|||
160941591|NCT01529645|581176691|FG002|Overall Study|SAE - Premature contractions|1|||
160941592|NCT01529645|581176692|FG003|Overall Study|SAE - Premature contractions|0|||
160941593|NCT01529645|581176693|FG004|Overall Study|SAE - Premature contractions|0|||
160941594|NCT01529645|581176694|FG005|Overall Study|SAE - Premature contractions|0|||
160941595|NCT01529645|581176695|FG006|Overall Study|SAE - Premature contractions|0|||
160941596|NCT01529645|581176696|FG007|Overall Study|SAE - Premature contractions|0|||
160941597|NCT01529645|581176697|FG008|Overall Study|SAE - Premature contractions|0|||
160941598|NCT01529645|581176698|FG009|Overall Study|SAE - Premature contractions|0|||
160941599|NCT01529645|581176689|FG000|Overall Study|Withdrawal by Subject|2|||
160941600|NCT01529645|581176690|FG001|Overall Study|Withdrawal by Subject|0|||
160941601|NCT01529645|581176691|FG002|Overall Study|Withdrawal by Subject|0|||
160941602|NCT01529645|581176692|FG003|Overall Study|Withdrawal by Subject|1|||
160941603|NCT01529645|581176693|FG004|Overall Study|Withdrawal by Subject|1|||
160941604|NCT01529645|581176694|FG005|Overall Study|Withdrawal by Subject|1|||
160941605|NCT01529645|581176695|FG006|Overall Study|Withdrawal by Subject|0|||
160941606|NCT01529645|581176696|FG007|Overall Study|Withdrawal by Subject|0|||
160941607|NCT01529645|581176697|FG008|Overall Study|Withdrawal by Subject|0|||
160941608|NCT01529645|581176698|FG009|Overall Study|Withdrawal by Subject|0|||
160941609|NCT00274716|581176699|FG000|Phase A|Other non-reported reason|4|||
160941610|NCT00274716|581176700|FG001|Phase A|Other non-reported reason|2|||
160941611|NCT00274716|581176701|FG002|Phase A|Other non-reported reason|1|||
160941612|NCT00274716|581176702|FG003|Phase A|Other non-reported reason|2|||
160941613|NCT00274716|581176703|FG004|Phase A|Other non-reported reason|0|||
160941614|NCT00274716|581176704|FG005|Phase A|Other non-reported reason|1|||
160941615|NCT00274716|581176699|FG000|Phase A|Participant moved|0|||
160941616|NCT00274716|581176700|FG001|Phase A|Participant moved|0|||
160941617|NCT00274716|581176701|FG002|Phase A|Participant moved|1|||
160941618|NCT00274716|581176702|FG003|Phase A|Participant moved|0|||
160941619|NCT00274716|581176703|FG004|Phase A|Participant moved|0|||
160941620|NCT00274716|581176704|FG005|Phase A|Participant moved|1|||
160941621|NCT00274716|581176699|FG000|Phase A|Site Terminated|0|||
160941622|NCT00274716|581176700|FG001|Phase A|Site Terminated|0|||
160941623|NCT00274716|581176701|FG002|Phase A|Site Terminated|0|||
160941624|NCT00274716|581176702|FG003|Phase A|Site Terminated|1|||
160941625|NCT00274716|581176703|FG004|Phase A|Site Terminated|0|||
160941626|NCT00274716|581176704|FG005|Phase A|Site Terminated|0|||
160941627|NCT00274716|581176699|FG000|Phase A|Protocol Violation|1|||
160941628|NCT00274716|581176700|FG001|Phase A|Protocol Violation|0|||
160941629|NCT00274716|581176701|FG002|Phase A|Protocol Violation|0|||
160941630|NCT00274716|581176702|FG003|Phase A|Protocol Violation|1|||
160941631|NCT00274716|581176703|FG004|Phase A|Protocol Violation|0|||
160941632|NCT00274716|581176704|FG005|Phase A|Protocol Violation|0|||
160941633|NCT00274716|581176699|FG000|Phase A|Met criteria for discontinuation|1|||
161144416|NCT02277444|581911995|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
160941634|NCT00274716|581176700|FG001|Phase A|Met criteria for discontinuation|1|||
160941635|NCT00274716|581176701|FG002|Phase A|Met criteria for discontinuation|0|||
160941636|NCT00274716|581176702|FG003|Phase A|Met criteria for discontinuation|0|||
160941637|NCT00274716|581176703|FG004|Phase A|Met criteria for discontinuation|0|||
160941638|NCT00274716|581176704|FG005|Phase A|Met criteria for discontinuation|0|||
160941639|NCT00274716|581176699|FG000|Phase A|Withdrawal by Subject|2|||
160941640|NCT00274716|581176700|FG001|Phase A|Withdrawal by Subject|2|||
160941641|NCT00274716|581176701|FG002|Phase A|Withdrawal by Subject|1|||
160941642|NCT00274716|581176702|FG003|Phase A|Withdrawal by Subject|3|||
160941643|NCT00274716|581176703|FG004|Phase A|Withdrawal by Subject|0|||
160941644|NCT00274716|581176704|FG005|Phase A|Withdrawal by Subject|1|||
160941645|NCT00274716|581176699|FG000|Phase A|Adverse Event|2|||
160941646|NCT00274716|581176700|FG001|Phase A|Adverse Event|3|||
160941647|NCT00274716|581176701|FG002|Phase A|Adverse Event|3|||
160941648|NCT00274716|581176702|FG003|Phase A|Adverse Event|0|||
160941649|NCT00274716|581176703|FG004|Phase A|Adverse Event|2|||
160941650|NCT00274716|581176704|FG005|Phase A|Adverse Event|0|||
160941651|NCT00274716|581176699|FG000|Phase A|Completed but did not enter Phase B|1|||
160941652|NCT00274716|581176700|FG001|Phase A|Completed but did not enter Phase B|2|||
160941653|NCT00274716|581176701|FG002|Phase A|Completed but did not enter Phase B|2|||
160941654|NCT00274716|581176702|FG003|Phase A|Completed but did not enter Phase B|2|||
160941655|NCT00274716|581176703|FG004|Phase A|Completed but did not enter Phase B|1|||
160941656|NCT00274716|581176704|FG005|Phase A|Completed but did not enter Phase B|1|||
161144417|NCT02277444|581911995|FG000|Treatment Period (Week 0-52)|Other|1|||
161342596|NCT00626639|582642206|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
160941657|NCT00274716|581176699|FG000|Phase B|Adverse Event|0|||
160941658|NCT00274716|581176700|FG001|Phase B|Adverse Event|0|||
160941659|NCT00274716|581176701|FG002|Phase B|Adverse Event|2|||
160941660|NCT00274716|581176702|FG003|Phase B|Adverse Event|0|||
160941661|NCT00274716|581176703|FG004|Phase B|Adverse Event|0|||
160941662|NCT00274716|581176704|FG005|Phase B|Adverse Event|1|||
160941663|NCT00274716|581176699|FG000|Phase B|Protocol Violation|0|||
160941664|NCT00274716|581176700|FG001|Phase B|Protocol Violation|2|||
160941665|NCT00274716|581176701|FG002|Phase B|Protocol Violation|0|||
160941666|NCT00274716|581176702|FG003|Phase B|Protocol Violation|0|||
160941667|NCT00274716|581176703|FG004|Phase B|Protocol Violation|0|||
160941668|NCT00274716|581176704|FG005|Phase B|Protocol Violation|0|||
160941669|NCT00274716|581176699|FG000|Phase B|Withdrawal by Subject|0|||
160941670|NCT00274716|581176700|FG001|Phase B|Withdrawal by Subject|1|||
160941671|NCT00274716|581176701|FG002|Phase B|Withdrawal by Subject|0|||
160941672|NCT00274716|581176702|FG003|Phase B|Withdrawal by Subject|0|||
160941673|NCT00274716|581176703|FG004|Phase B|Withdrawal by Subject|0|||
160941674|NCT00274716|581176704|FG005|Phase B|Withdrawal by Subject|0|||
160941675|NCT00274716|581176699|FG000|Phase B|Participant moved|1|||
160941676|NCT00274716|581176700|FG001|Phase B|Participant moved|0|||
160941677|NCT00274716|581176701|FG002|Phase B|Participant moved|0|||
160941678|NCT00274716|581176702|FG003|Phase B|Participant moved|0|||
160941679|NCT00274716|581176703|FG004|Phase B|Participant moved|0|||
160941680|NCT00274716|581176704|FG005|Phase B|Participant moved|0|||
160941681|NCT00274716|581176699|FG000|Phase B|Other non-reported reason|0|||
160941682|NCT00274716|581176700|FG001|Phase B|Other non-reported reason|0|||
160941683|NCT00274716|581176701|FG002|Phase B|Other non-reported reason|1|||
160941684|NCT00274716|581176702|FG003|Phase B|Other non-reported reason|1|||
160941685|NCT00274716|581176703|FG004|Phase B|Other non-reported reason|0|||
160941686|NCT00274716|581176704|FG005|Phase B|Other non-reported reason|0|||
160941687|NCT00274716|581176699|FG000|Phase B|Lost to Follow-up|0|||
160941688|NCT00274716|581176700|FG001|Phase B|Lost to Follow-up|1|||
160941689|NCT00274716|581176701|FG002|Phase B|Lost to Follow-up|0|||
160941690|NCT00274716|581176702|FG003|Phase B|Lost to Follow-up|0|||
160941691|NCT00274716|581176703|FG004|Phase B|Lost to Follow-up|0|||
160941692|NCT00274716|581176704|FG005|Phase B|Lost to Follow-up|0|||
160941693|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
160941694|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
160941695|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
160941696|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
160941697|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
160941698|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
160941699|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
160941700|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
160941701|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
160941702|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160941703|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
160941704|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
160941705|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
160941706|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
160941707|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
160941708|NCT01257204|581176705|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
160941709|NCT01257204|581176706|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
160941710|NCT01257204|581176707|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
160941711|NCT01257204|581176705|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
160941712|NCT01257204|581176706|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
160941713|NCT01257204|581176707|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
160941714|NCT01257204|581176705|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
160941715|NCT01257204|581176706|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
160941716|NCT01257204|581176707|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
160941717|NCT01257204|581176705|FG000|Follow-up Period (up to Week 48)|Other|0|||
160941718|NCT01257204|581176706|FG001|Follow-up Period (up to Week 48)|Other|0|||
160941719|NCT01257204|581176707|FG002|Follow-up Period (up to Week 48)|Other|5|||
160941720|NCT03394391|581176708|FG000|Overall Study|Lost to Follow-up|1|||
160941721|NCT03394391|581176709|FG001|Overall Study|Lost to Follow-up|2|||
160941722|NCT00723801|581176712|FG000|Overall Study|Lost to Follow-up|1|||
160941723|NCT00723801|581176713|FG001|Overall Study|Lost to Follow-up|2|||
160941724|NCT00723801|581176712|FG000|Overall Study|Protocol Violation|2|||
160941725|NCT00723801|581176713|FG001|Overall Study|Protocol Violation|1|||
160941726|NCT02148003|581176714|FG000|Overall Study|Failed inclusion criteria|1|||
160941727|NCT02148003|581176715|FG001|Overall Study|Failed inclusion criteria|0|||
160941728|NCT02148003|581176714|FG000|Overall Study|Met exclusion criteria|0|||
160941729|NCT02148003|581176715|FG001|Overall Study|Met exclusion criteria|1|||
160941730|NCT02148003|581176714|FG000|Overall Study|Withdrawal by Subject|0|||
160941731|NCT02148003|581176715|FG001|Overall Study|Withdrawal by Subject|1|||
160941732|NCT02489981|581176716|FG000|Overall Study|Adverse Event|21|||
160941733|NCT02489981|581176716|FG000|Overall Study|Insufficient effectiveness|16|||
160941734|NCT02489981|581176716|FG000|Overall Study|Improved|31|||
160941735|NCT02489981|581176716|FG000|Overall Study|Lost to Follow-up|31|||
160941736|NCT02489981|581176716|FG000|Overall Study|Other than listed|28|||
160941737|NCT01565993|581176724|FG000|Overall Study|Physician Decision|0|||
160941738|NCT01565993|581176725|FG001|Overall Study|Physician Decision|3|||
160941739|NCT02039427|581176727|FG000|Overall Study|Duration of surgery > 3h|1|||
160941740|NCT02039427|581176728|FG001|Overall Study|Duration of surgery > 3h|1|||
160941741|NCT02039427|581176729|FG002|Overall Study|Duration of surgery > 3h|0|||
160941742|NCT02039427|581176730|FG003|Overall Study|Duration of surgery > 3h|0|||
160941743|NCT02039427|581176727|FG000|Overall Study|Withdrawal on concent|0|||
160941744|NCT02039427|581176728|FG001|Overall Study|Withdrawal on concent|0|||
160941745|NCT02039427|581176729|FG002|Overall Study|Withdrawal on concent|0|||
160941746|NCT02039427|581176730|FG003|Overall Study|Withdrawal on concent|1|||
160941747|NCT02039427|581176727|FG000|Overall Study|Cancellation of surgery|0|||
160941748|NCT02039427|581176728|FG001|Overall Study|Cancellation of surgery|0|||
160941749|NCT02039427|581176729|FG002|Overall Study|Cancellation of surgery|1|||
160941750|NCT02039427|581176730|FG003|Overall Study|Cancellation of surgery|0|||
160941751|NCT02039427|581176727|FG000|Overall Study|Loss of follow - up|1|||
160941752|NCT02039427|581176728|FG001|Overall Study|Loss of follow - up|0|||
160941753|NCT02039427|581176729|FG002|Overall Study|Loss of follow - up|2|||
160941754|NCT02039427|581176730|FG003|Overall Study|Loss of follow - up|4|||
160941755|NCT02039427|581176727|FG000|Overall Study|Steroid Use|1|||
160941756|NCT02039427|581176728|FG001|Overall Study|Steroid Use|0|||
160941757|NCT02039427|581176729|FG002|Overall Study|Steroid Use|0|||
160941758|NCT02039427|581176730|FG003|Overall Study|Steroid Use|0|||
160941759|NCT01532687|581176735|FG000|Overall Study|Death|2|||
160941760|NCT01532687|581176736|FG001|Overall Study|Death|0|||
160941761|NCT01532687|581176735|FG000|Overall Study|Adverse Event|6|||
160941762|NCT01532687|581176736|FG001|Overall Study|Adverse Event|1|||
160941763|NCT01532687|581176735|FG000|Overall Study|Withdrawal by Subject|1|||
160941764|NCT01532687|581176736|FG001|Overall Study|Withdrawal by Subject|0|||
160941765|NCT01532687|581176735|FG000|Overall Study|Physician Decision|2|||
160941766|NCT01532687|581176736|FG001|Overall Study|Physician Decision|1|||
160941767|NCT01532687|581176735|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
160941768|NCT01532687|581176736|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
160941769|NCT03160703|581176737|FG000|Overall Study|Withdrawal by Subject|0|||
160941770|NCT03160703|581176738|FG001|Overall Study|Withdrawal by Subject|0|||
160941771|NCT03160703|581176739|FG002|Overall Study|Withdrawal by Subject|0|||
160941772|NCT03160703|581176740|FG003|Overall Study|Withdrawal by Subject|1|||
160941773|NCT00087568|581176741|FG000|Overall Study|Adverse Event|4|||
160941774|NCT00087568|581176742|FG001|Overall Study|Adverse Event|0|||
160941775|NCT00087568|581176741|FG000|Overall Study|Withdrawal by Subject|1|||
160941776|NCT00087568|581176742|FG001|Overall Study|Withdrawal by Subject|1|||
160941777|NCT00087568|581176741|FG000|Overall Study|Lost to Follow-up|1|||
160941778|NCT00087568|581176742|FG001|Overall Study|Lost to Follow-up|0|||
160941779|NCT00087568|581176741|FG000|Overall Study|Lack of Efficacy|24|||
160941780|NCT00087568|581176742|FG001|Overall Study|Lack of Efficacy|1|||
160941781|NCT01513291|581176743|FG000|Treatment Period|Adverse Event|8|||
160941782|NCT01513291|581176744|FG001|Treatment Period|Adverse Event|4|||
160941783|NCT01513291|581176745|FG002|Treatment Period|Adverse Event|0|||
160941784|NCT01513291|581176746|FG003|Treatment Period|Adverse Event|0|||
160941785|NCT01513291|581176747|FG004|Treatment Period|Adverse Event|0|||
160941786|NCT01513291|581176743|FG000|Treatment Period|Lack of Efficacy|3|||
160941787|NCT01513291|581176744|FG001|Treatment Period|Lack of Efficacy|0|||
160941788|NCT01513291|581176745|FG002|Treatment Period|Lack of Efficacy|0|||
160941789|NCT01513291|581176746|FG003|Treatment Period|Lack of Efficacy|0|||
160941790|NCT01513291|581176747|FG004|Treatment Period|Lack of Efficacy|0|||
160941791|NCT01513291|581176743|FG000|Treatment Period|Lost to Follow-up|2|||
160941792|NCT01513291|581176744|FG001|Treatment Period|Lost to Follow-up|3|||
160941793|NCT01513291|581176745|FG002|Treatment Period|Lost to Follow-up|0|||
160941794|NCT01513291|581176746|FG003|Treatment Period|Lost to Follow-up|0|||
160941795|NCT01513291|581176747|FG004|Treatment Period|Lost to Follow-up|0|||
160941796|NCT01513291|581176743|FG000|Treatment Period|Physician Decision|1|||
160941797|NCT01513291|581176744|FG001|Treatment Period|Physician Decision|0|||
160941798|NCT01513291|581176745|FG002|Treatment Period|Physician Decision|0|||
160941799|NCT01513291|581176746|FG003|Treatment Period|Physician Decision|0|||
160941800|NCT01513291|581176747|FG004|Treatment Period|Physician Decision|0|||
160941801|NCT01513291|581176743|FG000|Treatment Period|Protocol Violation|1|||
160941802|NCT01513291|581176744|FG001|Treatment Period|Protocol Violation|2|||
160941803|NCT01513291|581176745|FG002|Treatment Period|Protocol Violation|0|||
160941804|NCT01513291|581176746|FG003|Treatment Period|Protocol Violation|0|||
160941805|NCT01513291|581176747|FG004|Treatment Period|Protocol Violation|0|||
160941806|NCT01513291|581176743|FG000|Treatment Period|Withdrawal by Subject|8|||
160941807|NCT01513291|581176744|FG001|Treatment Period|Withdrawal by Subject|5|||
161265018|NCT00950963|582352369|FG001|Overall Study|Lost to Follow-up|24|||
161265019|NCT01675661|582352370|FG000|Overall Study|Lost to Follow-up|22|||
160941808|NCT01513291|581176745|FG002|Treatment Period|Withdrawal by Subject|0|||
160941809|NCT01513291|581176746|FG003|Treatment Period|Withdrawal by Subject|0|||
160941810|NCT01513291|581176747|FG004|Treatment Period|Withdrawal by Subject|0|||
160941811|NCT01513291|581176743|FG000|Treatment Period|Randomized not treated|0|||
160941812|NCT01513291|581176744|FG001|Treatment Period|Randomized not treated|2|||
160941813|NCT01513291|581176745|FG002|Treatment Period|Randomized not treated|0|||
160941814|NCT01513291|581176746|FG003|Treatment Period|Randomized not treated|0|||
160941815|NCT01513291|581176747|FG004|Treatment Period|Randomized not treated|0|||
161144418|NCT02277444|581911995|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
161265020|NCT01675661|582352371|FG001|Overall Study|Lost to Follow-up|23|||
161265021|NCT01675661|582352370|FG000|Overall Study|Practical problems|9|||
160941816|NCT01513291|581176743|FG000|Run-out Period|Lost to Follow-up|0|||
160941817|NCT01513291|581176744|FG001|Run-out Period|Lost to Follow-up|0|||
160941818|NCT01513291|581176745|FG002|Run-out Period|Lost to Follow-up|0|||
160941819|NCT01513291|581176746|FG003|Run-out Period|Lost to Follow-up|1|||
160941820|NCT01513291|581176747|FG004|Run-out Period|Lost to Follow-up|0|||
160941821|NCT01513291|581176743|FG000|Run-out Period|Withdrawal by Subject|0|||
160941822|NCT01513291|581176744|FG001|Run-out Period|Withdrawal by Subject|0|||
160941823|NCT01513291|581176745|FG002|Run-out Period|Withdrawal by Subject|0|||
160941824|NCT01513291|581176746|FG003|Run-out Period|Withdrawal by Subject|1|||
160941825|NCT01513291|581176747|FG004|Run-out Period|Withdrawal by Subject|0|||
160941826|NCT03728582|581176752|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
160941827|NCT03728582|581176753|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
160941828|NCT03728582|581176752|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
160941829|NCT03728582|581176753|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
160941830|NCT02732847|581176754|FG000|Overall Study|some filled early|42|||
160941831|NCT02732847|581176755|FG001|Overall Study|some filled early|42|||
160941832|NCT02992899|581176756|FG000|Overall Study|Withdrawal by Subject|1|||
160941833|NCT02992899|581176757|FG001|Overall Study|Withdrawal by Subject|0|||
160941834|NCT02992899|581176756|FG000|Overall Study|Lost to Follow-up|1|||
160941835|NCT02992899|581176757|FG001|Overall Study|Lost to Follow-up|3|||
160941836|NCT02738775|581176758|FG000|Overall Study|Withdrawal by Subject|0|||
160941837|NCT02738775|581176759|FG001|Overall Study|Withdrawal by Subject|1|||
160941838|NCT02738775|581176760|FG002|Overall Study|Withdrawal by Subject|0|||
160941839|NCT02738775|581176761|FG003|Overall Study|Withdrawal by Subject|0|||
160941840|NCT02738775|581176762|FG004|Overall Study|Withdrawal by Subject|0|||
160941841|NCT02738775|581176763|FG005|Overall Study|Withdrawal by Subject|0|||
160941842|NCT02738775|581176758|FG000|Overall Study|Adverse Event|0|||
160941843|NCT02738775|581176759|FG001|Overall Study|Adverse Event|0|||
160941844|NCT02738775|581176760|FG002|Overall Study|Adverse Event|0|||
160941845|NCT02738775|581176761|FG003|Overall Study|Adverse Event|1|||
160941846|NCT02738775|581176762|FG004|Overall Study|Adverse Event|0|||
160941847|NCT02738775|581176763|FG005|Overall Study|Adverse Event|0|||
160941848|NCT02738775|581176758|FG000|Overall Study|Pregnancy|0|||
160941849|NCT02738775|581176759|FG001|Overall Study|Pregnancy|1|||
160941850|NCT02738775|581176760|FG002|Overall Study|Pregnancy|0|||
160941851|NCT02738775|581176761|FG003|Overall Study|Pregnancy|0|||
160941852|NCT02738775|581176762|FG004|Overall Study|Pregnancy|0|||
160941853|NCT02738775|581176763|FG005|Overall Study|Pregnancy|0|||
160941854|NCT02738775|581176758|FG000|Overall Study|Missing|0|||
160941855|NCT02738775|581176759|FG001|Overall Study|Missing|0|||
160941856|NCT02738775|581176760|FG002|Overall Study|Missing|0|||
160941857|NCT02738775|581176761|FG003|Overall Study|Missing|0|||
160941858|NCT02738775|581176762|FG004|Overall Study|Missing|0|||
160941859|NCT02738775|581176763|FG005|Overall Study|Missing|1|||
160941860|NCT01034397|581176764|FG000|Overall Study|Lack of compliance|0|||
160941861|NCT01034397|581176765|FG001|Overall Study|Lack of compliance|1|||
160941862|NCT01034397|581176764|FG000|Overall Study|Lack of Efficacy|3|||
160941863|NCT01034397|581176765|FG001|Overall Study|Lack of Efficacy|0|||
160941864|NCT01034397|581176764|FG000|Overall Study|Adverse Event|4|||
160941865|NCT01034397|581176765|FG001|Overall Study|Adverse Event|0|||
160941866|NCT01034397|581176764|FG000|Overall Study|Other|0|||
160941867|NCT01034397|581176765|FG001|Overall Study|Other|1|||
160941868|NCT01263873|581176768|FG000|Overall Study|One provider unable to complete numbers|1|||
160941869|NCT01263873|581176769|FG001|Overall Study|One provider unable to complete numbers|1|||
160941870|NCT00047463|581176770|FG000|Overall Study|Withdrawal by Subject|0|||
160998909|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
160998910|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
160998911|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
160998912|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
160998913|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160941871|NCT00047463|581176771|FG001|Overall Study|Withdrawal by Subject|3|||
160941872|NCT03217136|581176772|FG000|Overall Study|Lost to Follow-up|2|||
160941873|NCT03217136|581176773|FG001|Overall Study|Lost to Follow-up|1|||
160998914|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
161144419|NCT02277444|581911995|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
160941874|NCT03217136|581176772|FG000|Overall Study|Site Randomized Participant in Error|0|||
160941875|NCT03217136|581176773|FG001|Overall Study|Site Randomized Participant in Error|1|||
160941876|NCT03217136|581176772|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
160941877|NCT03217136|581176773|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
161144420|NCT02277444|581911995|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
160941878|NCT03217136|581176772|FG000|Overall Study|Dispensing Error|1|||
160941879|NCT03217136|581176773|FG001|Overall Study|Dispensing Error|0|||
160941880|NCT03217136|581176772|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160941881|NCT03217136|581176773|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
160941882|NCT00720876|581176786|FG000|Overall Study|found to be ineligible after starting tx|2|||
160941883|NCT03495908|581176788|FG000|Overall Study|Withdrawal by Subject|3|||
160941884|NCT03495908|581176789|FG001|Overall Study|Withdrawal by Subject|1|||
160941885|NCT03495908|581176788|FG000|Overall Study|Lost to Follow-up|1|||
160998915|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
161342597|NCT01155141|582642207|FG000|Overall Study|Withdrawal by Subject|1|||
160941886|NCT03495908|581176789|FG001|Overall Study|Lost to Follow-up|4|||
160941887|NCT03495908|581176788|FG000|Overall Study|Adverse Event|0|||
160941888|NCT03495908|581176789|FG001|Overall Study|Adverse Event|2|||
161342598|NCT01155141|582642207|FG000|Overall Study|Screen Failure|1|||
161342599|NCT03473197|582642208|FG000|Overall Study|Adverse Event|4|||
161342600|NCT03473197|582642208|FG000|Overall Study|Lost to Follow-up|1|||
161342601|NCT03473197|582642208|FG000|Overall Study|Withdrawal by Subject|5|||
161342602|NCT02107898|582642211|FG000|Overall Study|Adverse Event|4|||
161342603|NCT02107898|582642212|FG001|Overall Study|Adverse Event|7|||
161342604|NCT02107898|582642211|FG000|Overall Study|Poor compliance to protocol|0|||
161342605|NCT02107898|582642212|FG001|Overall Study|Poor compliance to protocol|1|||
161342606|NCT02107898|582642211|FG000|Overall Study|Participant moved|0|||
161342607|NCT02107898|582642212|FG001|Overall Study|Participant moved|2|||
161342608|NCT02107898|582642211|FG000|Overall Study|Consent withdrawn by participant|2|||
161342609|NCT02107898|582642212|FG001|Overall Study|Consent withdrawn by participant|1|||
161342610|NCT02107898|582642211|FG000|Overall Study|Randomized but not treated|0|||
160941889|NCT03495908|581176788|FG000|Overall Study|Death|1|||
160941890|NCT03495908|581176789|FG001|Overall Study|Death|0|||
160941891|NCT03495908|581176788|FG000|Overall Study|Physician Decision|5|||
160941892|NCT03495908|581176789|FG001|Overall Study|Physician Decision|4|||
160941893|NCT03495908|581176788|FG000|Overall Study|No documented reason|0|||
160941894|NCT03495908|581176789|FG001|Overall Study|No documented reason|2|||
160941895|NCT03304379|581176790|FG000|Overall Study|Protocol Violation|8|||
160941896|NCT03304379|581176791|FG001|Overall Study|Protocol Violation|10|||
160941897|NCT03304379|581176792|FG002|Overall Study|Protocol Violation|5|||
160941898|NCT03304379|581176793|FG003|Overall Study|Protocol Violation|0|||
160941899|NCT03304379|581176794|FG004|Overall Study|Protocol Violation|2|||
160941900|NCT03304379|581176790|FG000|Overall Study|Adverse Event|4|||
160941901|NCT03304379|581176791|FG001|Overall Study|Adverse Event|20|||
160941902|NCT03304379|581176792|FG002|Overall Study|Adverse Event|17|||
160941903|NCT03304379|581176793|FG003|Overall Study|Adverse Event|1|||
160941904|NCT03304379|581176794|FG004|Overall Study|Adverse Event|0|||
160941905|NCT03304379|581176790|FG000|Overall Study|Lack of Efficacy|17|||
160941906|NCT03304379|581176791|FG001|Overall Study|Lack of Efficacy|16|||
160998916|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
160998917|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998918|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998919|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998920|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998921|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998922|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
161144421|NCT02277444|581911995|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
161144422|NCT02277444|581911995|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
161144423|NCT02277444|581911995|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
161144424|NCT02031146|581913888|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161265022|NCT01675661|582352371|FG001|Overall Study|Practical problems|5|||
161265023|NCT01675661|582352370|FG000|Overall Study|Moved away|5|||
161265024|NCT01675661|582352371|FG001|Overall Study|Moved away|6|||
161265025|NCT01675661|582352370|FG000|Overall Study|Withdrawal by Subject|3|||
161265026|NCT01675661|582352371|FG001|Overall Study|Withdrawal by Subject|7|||
161265027|NCT01675661|582352370|FG000|Overall Study|Physician Decision|0|||
161265028|NCT01675661|582352371|FG001|Overall Study|Physician Decision|2|||
161265029|NCT01675661|582352370|FG000|Overall Study|Death|0|||
161265030|NCT01675661|582352371|FG001|Overall Study|Death|1|||
161265031|NCT01675661|582352370|FG000|Overall Study|Other reason|1|||
161342611|NCT02107898|582642212|FG001|Overall Study|Randomized but not treated|1|||
161342612|NCT03483103|582642213|FG000|Pre-Treatment Phase|Other reasons|1|||
161342613|NCT03483103|582642213|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
161342614|NCT03483103|582642213|FG000|Pre-Treatment Phase|Disease-related complications|1|||
161342615|NCT03483103|582642213|FG000|Pre-Treatment Phase|Death|5|||
161342616|NCT03483103|582642213|FG000|Treatment Phase|Withdrawal by Subject|7|||
160941907|NCT03304379|581176792|FG002|Overall Study|Lack of Efficacy|20|||
160941908|NCT03304379|581176793|FG003|Overall Study|Lack of Efficacy|0|||
160941909|NCT03304379|581176794|FG004|Overall Study|Lack of Efficacy|0|||
160998923|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
160998924|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
161265032|NCT01675661|582352371|FG001|Overall Study|Other reason|2|||
161265033|NCT04765384|582352372|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
160941910|NCT03304379|581176790|FG000|Overall Study|Physician Decision|6|||
160941911|NCT03304379|581176791|FG001|Overall Study|Physician Decision|10|||
160941912|NCT03304379|581176792|FG002|Overall Study|Physician Decision|6|||
160941913|NCT03304379|581176793|FG003|Overall Study|Physician Decision|9|||
161265034|NCT04765384|582352373|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
161265035|NCT04765384|582352374|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
161342617|NCT03483103|582642213|FG000|Treatment Phase|Other reasons|1|||
161342618|NCT03483103|582642213|FG000|Treatment Phase|Death|23|||
161265036|NCT04765384|582352375|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
161265037|NCT04765384|582352376|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
161265038|NCT04765384|582352377|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
161265039|NCT04765384|582352372|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
161265040|NCT04765384|582352373|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
161265041|NCT04765384|582352374|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
161265042|NCT04765384|582352375|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
161265043|NCT04765384|582352376|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
161265044|NCT04765384|582352377|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
161265045|NCT04765384|582352372|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161265046|NCT04765384|582352373|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161265047|NCT04765384|582352374|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161265048|NCT04765384|582352375|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161265049|NCT04765384|582352376|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
161265050|NCT04765384|582352377|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
161265051|NCT04765384|582352372|FG000|Post-natal: Neonates and Infants|Death|0|||
161265052|NCT04765384|582352373|FG001|Post-natal: Neonates and Infants|Death|0|||
161265053|NCT04765384|582352374|FG002|Post-natal: Neonates and Infants|Death|0|||
161265054|NCT04765384|582352375|FG003|Post-natal: Neonates and Infants|Death|1|||
161265055|NCT04765384|582352376|FG004|Post-natal: Neonates and Infants|Death|0|||
161265056|NCT04765384|582352377|FG005|Post-natal: Neonates and Infants|Death|0|||
160941914|NCT03304379|581176794|FG004|Overall Study|Physician Decision|10|||
160941915|NCT03304379|581176790|FG000|Overall Study|Withdrawal by Subject|26|||
160941916|NCT03304379|581176791|FG001|Overall Study|Withdrawal by Subject|58|||
160941917|NCT03304379|581176792|FG002|Overall Study|Withdrawal by Subject|66|||
160941918|NCT03304379|581176793|FG003|Overall Study|Withdrawal by Subject|3|||
160941919|NCT03304379|581176794|FG004|Overall Study|Withdrawal by Subject|5|||
160941920|NCT03304379|581176790|FG000|Overall Study|Lost to Follow-up|8|||
160941921|NCT03304379|581176791|FG001|Overall Study|Lost to Follow-up|24|||
161265057|NCT04765384|582352372|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161265058|NCT04765384|582352373|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161265059|NCT04765384|582352374|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161265060|NCT04765384|582352375|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161265061|NCT04765384|582352376|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
161265062|NCT04765384|582352377|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
161265063|NCT00987389|582352378|FG000|Overall Study|Ineligible|0|||
161265064|NCT00987389|582352379|FG001|Overall Study|Ineligible|3|||
161265065|NCT00987389|582352380|FG002|Overall Study|Ineligible|0|||
161265066|NCT00987389|582352381|FG003|Overall Study|Ineligible|0|||
161265067|NCT00987389|582352378|FG000|Overall Study|Lost to Follow-up|4|||
161265068|NCT00987389|582352379|FG001|Overall Study|Lost to Follow-up|1|||
161265069|NCT00987389|582352380|FG002|Overall Study|Lost to Follow-up|3|||
161265070|NCT00987389|582352381|FG003|Overall Study|Lost to Follow-up|1|||
161265071|NCT00987389|582352378|FG000|Overall Study|Withdrawal by Subject|4|||
161265072|NCT00987389|582352379|FG001|Overall Study|Withdrawal by Subject|3|||
160941922|NCT03304379|581176792|FG002|Overall Study|Lost to Follow-up|35|||
160941923|NCT03304379|581176793|FG003|Overall Study|Lost to Follow-up|4|||
160998925|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998926|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998927|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998928|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
160998929|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998930|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998931|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998932|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998933|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998934|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
160998935|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
160998936|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998937|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998938|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998939|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998940|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
161265073|NCT00987389|582352380|FG002|Overall Study|Withdrawal by Subject|2|||
161265074|NCT00987389|582352381|FG003|Overall Study|Withdrawal by Subject|1|||
161265075|NCT00987389|582352378|FG000|Overall Study|Withdrawn from Treatment|0|||
161265076|NCT00987389|582352379|FG001|Overall Study|Withdrawn from Treatment|1|||
161265077|NCT00987389|582352380|FG002|Overall Study|Withdrawn from Treatment|0|||
161265078|NCT00987389|582352381|FG003|Overall Study|Withdrawn from Treatment|0|||
160941924|NCT03304379|581176794|FG004|Overall Study|Lost to Follow-up|0|||
160941925|NCT03304379|581176790|FG000|Overall Study|Death|1|||
160941926|NCT03304379|581176791|FG001|Overall Study|Death|2|||
160941927|NCT03304379|581176792|FG002|Overall Study|Death|0|||
160941928|NCT03304379|581176793|FG003|Overall Study|Death|0|||
160941929|NCT03304379|581176794|FG004|Overall Study|Death|0|||
160941930|NCT03304379|581176790|FG000|Overall Study|Other|0|||
160941931|NCT03304379|581176791|FG001|Overall Study|Other|1|||
160941932|NCT03304379|581176792|FG002|Overall Study|Other|0|||
160941933|NCT03304379|581176793|FG003|Overall Study|Other|0|||
160941934|NCT03304379|581176794|FG004|Overall Study|Other|0|||
160941935|NCT01109316|581176801|FG000|Study Period 1|Adverse Event|0|||
160941936|NCT01109316|581176802|FG001|Study Period 1|Adverse Event|0|||
160941937|NCT01109316|581176803|FG002|Study Period 1|Adverse Event|1|||
160941938|NCT01109316|581176804|FG003|Study Period 1|Adverse Event|0|||
160941939|NCT01109316|581176805|FG004|Study Period 1|Adverse Event|0|||
160941940|NCT01109316|581176806|FG005|Study Period 1|Adverse Event|0|||
160941941|NCT01109316|581176801|FG000|Study Period 1|Lost to Follow-up|0|||
160941942|NCT01109316|581176802|FG001|Study Period 1|Lost to Follow-up|0|||
160941943|NCT01109316|581176803|FG002|Study Period 1|Lost to Follow-up|1|||
160941944|NCT01109316|581176804|FG003|Study Period 1|Lost to Follow-up|1|||
160941945|NCT01109316|581176805|FG004|Study Period 1|Lost to Follow-up|0|||
160941946|NCT01109316|581176806|FG005|Study Period 1|Lost to Follow-up|0|||
160941947|NCT01109316|581176801|FG000|Study Period 1|Withdrawal by Subject|0|||
160941948|NCT01109316|581176802|FG001|Study Period 1|Withdrawal by Subject|0|||
160941949|NCT01109316|581176803|FG002|Study Period 1|Withdrawal by Subject|1|||
160941950|NCT01109316|581176804|FG003|Study Period 1|Withdrawal by Subject|0|||
160941951|NCT01109316|581176805|FG004|Study Period 1|Withdrawal by Subject|2|||
160941952|NCT01109316|581176806|FG005|Study Period 1|Withdrawal by Subject|0|||
160941953|NCT01109316|581176801|FG000|Study Period 1|Sponsor Decision|0|||
160941954|NCT01109316|581176802|FG001|Study Period 1|Sponsor Decision|0|||
160941955|NCT01109316|581176803|FG002|Study Period 1|Sponsor Decision|0|||
160941956|NCT01109316|581176804|FG003|Study Period 1|Sponsor Decision|0|||
160941957|NCT01109316|581176805|FG004|Study Period 1|Sponsor Decision|0|||
160941958|NCT01109316|581176806|FG005|Study Period 1|Sponsor Decision|2|||
160941959|NCT01109316|581176801|FG000|Study Period 2|Entry Criteria Not Met|0|||
161265079|NCT00987389|582352378|FG000|Overall Study|Multiple different reasons|1|||
161265080|NCT00987389|582352379|FG001|Overall Study|Multiple different reasons|0|||
161265081|NCT00987389|582352380|FG002|Overall Study|Multiple different reasons|3|||
161265082|NCT00987389|582352381|FG003|Overall Study|Multiple different reasons|1|||
161265083|NCT02992418|582352384|FG000|Overall Study|Withdrawal by Subject|11|||
161265084|NCT02992418|582352385|FG001|Overall Study|Withdrawal by Subject|12|||
161265085|NCT02992418|582352384|FG000|Overall Study|Non-compliance with the protocol|308|||
161265086|NCT02992418|582352385|FG001|Overall Study|Non-compliance with the protocol|308|||
161265087|NCT02992418|582352384|FG000|Overall Study|Lost to Follow-up|27|||
161265088|NCT02992418|582352385|FG001|Overall Study|Lost to Follow-up|22|||
161265089|NCT00289536|582352386|FG000|Period 3|Lost to Follow-up|0|||
161265090|NCT00289536|582352387|FG001|Period 3|Lost to Follow-up|0|||
161265091|NCT00289536|582352388|FG002|Period 3|Lost to Follow-up|1|||
161265092|NCT01974440|582352389|FG000|Overall Study|Lost to Follow-up|7|||
161265093|NCT01974440|582352390|FG001|Overall Study|Lost to Follow-up|7|||
161265094|NCT01974440|582352389|FG000|Overall Study|Withdrawal by Subject|24|||
161265095|NCT01974440|582352390|FG001|Overall Study|Withdrawal by Subject|20|||
161265096|NCT01974440|582352389|FG000|Overall Study|Sponsor decision|109|||
161265097|NCT01974440|582352390|FG001|Overall Study|Sponsor decision|110|||
161265098|NCT01843348|582352395|FG000|Overall Study|Withdrawal by Subject|4|||
161265099|NCT01843348|582352396|FG001|Overall Study|Withdrawal by Subject|16|||
161265100|NCT01843348|582352397|FG002|Overall Study|Withdrawal by Subject|18|||
161265101|NCT01843348|582352395|FG000|Overall Study|Lost to Follow-up|5|||
161265102|NCT01843348|582352396|FG001|Overall Study|Lost to Follow-up|4|||
161265103|NCT01843348|582352397|FG002|Overall Study|Lost to Follow-up|2|||
161265104|NCT01843348|582352395|FG000|Overall Study|Death|5|||
161265105|NCT01843348|582352396|FG001|Overall Study|Death|3|||
160941960|NCT01109316|581176802|FG001|Study Period 2|Entry Criteria Not Met|1|||
160941961|NCT01109316|581176803|FG002|Study Period 2|Entry Criteria Not Met|0|||
160941962|NCT01109316|581176804|FG003|Study Period 2|Entry Criteria Not Met|0|||
160941963|NCT01109316|581176805|FG004|Study Period 2|Entry Criteria Not Met|0|||
160941964|NCT01109316|581176806|FG005|Study Period 2|Entry Criteria Not Met|0|||
160941965|NCT01109316|581176801|FG000|Study Period 2|Physician Decision|0|||
160941966|NCT01109316|581176802|FG001|Study Period 2|Physician Decision|0|||
160941967|NCT01109316|581176803|FG002|Study Period 2|Physician Decision|0|||
160941968|NCT01109316|581176804|FG003|Study Period 2|Physician Decision|1|||
161265106|NCT01843348|582352397|FG002|Overall Study|Death|4|||
161265107|NCT01843348|582352395|FG000|Overall Study|Graft loss/retransplantation|5|||
161265108|NCT01843348|582352396|FG001|Overall Study|Graft loss/retransplantation|8|||
161265109|NCT01843348|582352397|FG002|Overall Study|Graft loss/retransplantation|11|||
161265110|NCT01843348|582352395|FG000|Overall Study|Various reasons|4|||
161265111|NCT01843348|582352396|FG001|Overall Study|Various reasons|9|||
160941969|NCT01109316|581176805|FG004|Study Period 2|Physician Decision|0|||
160941970|NCT01109316|581176806|FG005|Study Period 2|Physician Decision|0|||
160941971|NCT01109316|581176801|FG000|Study Period 2|Protocol Violation|1|||
160941972|NCT01109316|581176802|FG001|Study Period 2|Protocol Violation|0|||
161265112|NCT01843348|582352397|FG002|Overall Study|Various reasons|6|||
161265113|NCT00251641|582352398|FG000|Overall Study|Adverse Event|80|||
161265114|NCT00251641|582352399|FG001|Overall Study|Adverse Event|8|||
161265115|NCT00251641|582352398|FG000|Overall Study|Lack of Efficacy|2|||
161265116|NCT00251641|582352399|FG001|Overall Study|Lack of Efficacy|1|||
161265117|NCT00251641|582352398|FG000|Overall Study|Progression of Disease|0|||
161265118|NCT00251641|582352399|FG001|Overall Study|Progression of Disease|2|||
161265119|NCT00251641|582352398|FG000|Overall Study|Lost to Follow-up|3|||
161265120|NCT00251641|582352399|FG001|Overall Study|Lost to Follow-up|3|||
161265121|NCT00251641|582352398|FG000|Overall Study|Withdrawal by Subject|6|||
161265122|NCT00251641|582352399|FG001|Overall Study|Withdrawal by Subject|8|||
161265123|NCT00251641|582352398|FG000|Overall Study|Protocol Violation|10|||
161265124|NCT00251641|582352399|FG001|Overall Study|Protocol Violation|2|||
161265125|NCT00251641|582352398|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
161265126|NCT00251641|582352399|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
161265127|NCT00251641|582352398|FG000|Overall Study|Switched Treatment|9|||
161265128|NCT00251641|582352399|FG001|Overall Study|Switched Treatment|63|||
161265129|NCT00876018|582352400|FG000|Overall Study|Lost to Follow-up|0|||
161265130|NCT00876018|582352401|FG001|Overall Study|Lost to Follow-up|1|||
161265131|NCT00876018|582352402|FG002|Overall Study|Lost to Follow-up|1|||
161265132|NCT00876018|582352400|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
161265133|NCT00876018|582352401|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
161265134|NCT00876018|582352402|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
161265135|NCT03828448|582352404|FG000|Overall Study|Sponsor's Discretion|34|||
161265136|NCT02192164|582352410|FG000|Overall Study|Other|8|||
161265137|NCT02192164|582352410|FG000|Overall Study|Withdrawal by Subject|1|||
161265138|NCT02192164|582352410|FG000|Overall Study|Physician Decision|4|||
161265139|NCT02192164|582352410|FG000|Overall Study|Did not meet the exclusion criteria|1|||
161265140|NCT03123861|582352411|FG000|Overall Study|Protocol Violation|1|||
161265141|NCT03123861|582352412|FG001|Overall Study|Protocol Violation|1|||
161265142|NCT03123861|582352411|FG000|Overall Study|Withdrawal by Subject|2|||
161265143|NCT03123861|582352412|FG001|Overall Study|Withdrawal by Subject|2|||
161265144|NCT05069155|582352413|FG000|Overall Study|Withdrawal by Subject|1|||
161265145|NCT05069155|582352414|FG001|Overall Study|Withdrawal by Subject|3|||
161265146|NCT01929031|582352415|FG000|Overall Study|Adverse Event|3|||
161265147|NCT01929031|582352416|FG001|Overall Study|Adverse Event|1|||
160941973|NCT01109316|581176803|FG002|Study Period 2|Protocol Violation|0|||
160941974|NCT01109316|581176804|FG003|Study Period 2|Protocol Violation|0|||
160941975|NCT01109316|581176805|FG004|Study Period 2|Protocol Violation|0|||
160941976|NCT01109316|581176806|FG005|Study Period 2|Protocol Violation|0|||
160941977|NCT01109316|581176801|FG000|Study Period 2|Withdrawal by Subject|0|||
160941978|NCT01109316|581176802|FG001|Study Period 2|Withdrawal by Subject|0|||
160941979|NCT01109316|581176803|FG002|Study Period 2|Withdrawal by Subject|1|||
160941980|NCT01109316|581176804|FG003|Study Period 2|Withdrawal by Subject|0|||
160941981|NCT01109316|581176805|FG004|Study Period 2|Withdrawal by Subject|0|||
160941982|NCT01109316|581176806|FG005|Study Period 2|Withdrawal by Subject|1|||
160941983|NCT01109316|581176801|FG000|Study Period 3|Lost to Follow-up|0|||
160941984|NCT01109316|581176802|FG001|Study Period 3|Lost to Follow-up|0|||
160941985|NCT01109316|581176803|FG002|Study Period 3|Lost to Follow-up|0|||
160941986|NCT01109316|581176804|FG003|Study Period 3|Lost to Follow-up|0|||
160941987|NCT01109316|581176805|FG004|Study Period 3|Lost to Follow-up|1|||
160941988|NCT01109316|581176806|FG005|Study Period 3|Lost to Follow-up|0|||
160941989|NCT01109316|581176801|FG000|Study Period 3|Withdrawal by Subject|1|||
160941990|NCT01109316|581176802|FG001|Study Period 3|Withdrawal by Subject|0|||
160941991|NCT01109316|581176803|FG002|Study Period 3|Withdrawal by Subject|0|||
160941992|NCT01109316|581176804|FG003|Study Period 3|Withdrawal by Subject|0|||
160941993|NCT01109316|581176805|FG004|Study Period 3|Withdrawal by Subject|1|||
160941994|NCT01109316|581176806|FG005|Study Period 3|Withdrawal by Subject|0|||
160941995|NCT01559311|581176811|FG000|Overall Study|Protocol Violation|0|||
160941996|NCT01559311|581176812|FG001|Overall Study|Protocol Violation|0|||
160941997|NCT01559311|581176813|FG002|Overall Study|Protocol Violation|2|||
161265148|NCT01929031|582352417|FG002|Overall Study|Adverse Event|1|||
161265149|NCT01929031|582352418|FG003|Overall Study|Adverse Event|0|||
161265150|NCT01929031|582352419|FG004|Overall Study|Adverse Event|0|||
161265151|NCT01929031|582352420|FG005|Overall Study|Adverse Event|0|||
161265152|NCT01929031|582352415|FG000|Overall Study|Protocol Violation|1|||
160941998|NCT01559311|581176811|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
160941999|NCT01559311|581176812|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
160942000|NCT01559311|581176813|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
160942001|NCT01559311|581176811|FG000|Overall Study|Withdrawal by Subject|2|||
160942002|NCT01559311|581176812|FG001|Overall Study|Withdrawal by Subject|1|||
160942003|NCT01559311|581176813|FG002|Overall Study|Withdrawal by Subject|0|||
160942004|NCT01559311|581176811|FG000|Overall Study|Death|0|||
161265153|NCT01929031|582352416|FG001|Overall Study|Protocol Violation|0|||
161265154|NCT01929031|582352417|FG002|Overall Study|Protocol Violation|0|||
161265155|NCT01929031|582352418|FG003|Overall Study|Protocol Violation|0|||
161265156|NCT01929031|582352419|FG004|Overall Study|Protocol Violation|0|||
161265157|NCT01929031|582352420|FG005|Overall Study|Protocol Violation|1|||
161265158|NCT01929031|582352415|FG000|Overall Study|Reason other than specified above|0|||
161265159|NCT01929031|582352416|FG001|Overall Study|Reason other than specified above|1|||
161265160|NCT01929031|582352417|FG002|Overall Study|Reason other than specified above|0|||
161265161|NCT01929031|582352418|FG003|Overall Study|Reason other than specified above|0|||
161265162|NCT01929031|582352419|FG004|Overall Study|Reason other than specified above|1|||
161265163|NCT01929031|582352420|FG005|Overall Study|Reason other than specified above|0|||
161265164|NCT01366443|582352421|FG000|Overall Study|Lost to Follow-up|2|||
161265165|NCT01366443|582352421|FG000|Overall Study|Under 18 yo|1|||
161265166|NCT00731549|582352422|FG000|Overall Study|Lost to Follow-up|19|||
161265167|NCT00731549|582352422|FG000|Overall Study|Met withdrawal criteria|24|||
161265168|NCT00731549|582352422|FG000|Overall Study|Physician Decision|16|||
161265169|NCT00731549|582352422|FG000|Overall Study|Withdrawal by Subject|89|||
161265170|NCT00731549|582352422|FG000|Overall Study|Protocol deviation|1|||
161265171|NCT00731549|582352422|FG000|Overall Study|Adverse Event|31|||
161265172|NCT00731549|582352422|FG000|Overall Study|Lack of efficacy with AE|37|||
161265173|NCT00731549|582352422|FG000|Overall Study|Lack of efficacy without AE|6|||
161265174|NCT00448136|582352425|FG000|Overall Study|Death|3|||
161265175|NCT00448136|582352426|FG001|Overall Study|Death|8|||
161265176|NCT00448136|582352425|FG000|Overall Study|Investigator's decision (progression)|1|||
161265177|NCT00448136|582352426|FG001|Overall Study|Investigator's decision (progression)|0|||
161265178|NCT00609466|582352427|FG000|Overall Study|Withdrawal by Subject|0|||
161265179|NCT00609466|582352428|FG001|Overall Study|Withdrawal by Subject|1|||
161265180|NCT00609466|582352429|FG002|Overall Study|Withdrawal by Subject|1|||
161265181|NCT00609466|582352427|FG000|Overall Study|Adverse Event|2|||
161265182|NCT00609466|582352428|FG001|Overall Study|Adverse Event|3|||
161265183|NCT00609466|582352429|FG002|Overall Study|Adverse Event|1|||
161265184|NCT00609466|582352427|FG000|Overall Study|Lack of Efficacy|0|||
161265185|NCT00609466|582352428|FG001|Overall Study|Lack of Efficacy|2|||
161265186|NCT00609466|582352429|FG002|Overall Study|Lack of Efficacy|2|||
161265187|NCT03407430|582352430|FG000|Washout|Protocol Violation|1|||
161265188|NCT03407430|582352431|FG001|Washout|Protocol Violation|0|||
161265189|NCT00922987|582352433|FG000|Overall Study|Insufficient clinical response|1|||
160942005|NCT01559311|581176812|FG001|Overall Study|Death|2|||
160942006|NCT01559311|581176813|FG002|Overall Study|Death|3|||
160942007|NCT01559311|581176811|FG000|Overall Study|Lost to Follow-up|0|||
160942008|NCT01559311|581176812|FG001|Overall Study|Lost to Follow-up|3|||
160942009|NCT01559311|581176813|FG002|Overall Study|Lost to Follow-up|2|||
160942010|NCT01559311|581176811|FG000|Overall Study|Adverse Event|0|||
160942011|NCT01559311|581176812|FG001|Overall Study|Adverse Event|0|||
160942012|NCT01559311|581176813|FG002|Overall Study|Adverse Event|1|||
160942013|NCT03027466|581176816|FG000|Overall Study|Opting out of the app|1869|||
160942014|NCT03027466|581176817|FG001|Overall Study|Opting out of the app|1819|||
160942015|NCT03027466|581176818|FG002|Overall Study|Opting out of the app|1743|||
160942016|NCT03027466|581176819|FG003|Overall Study|Opting out of the app|1821|||
160942017|NCT03286140|581176820|FG000|Overall Study|Withdrawal by Subject|10|||
160942018|NCT03286140|581176821|FG001|Overall Study|Withdrawal by Subject|5|||
160942019|NCT03286140|581176820|FG000|Overall Study|Lost to Follow-up|5|||
160942020|NCT03286140|581176821|FG001|Overall Study|Lost to Follow-up|10|||
160942021|NCT03286140|581176820|FG000|Overall Study|Failure to comply|0|||
160942022|NCT03286140|581176821|FG001|Overall Study|Failure to comply|1|||
160942023|NCT01826825|581176826|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
160942024|NCT01826825|581176827|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
160942025|NCT01858194|581176828|FG000|Overall Study|Total Artificial Heart Implant|0|||
160942026|NCT01858194|581176829|FG001|Overall Study|Total Artificial Heart Implant|1|||
160942027|NCT01858194|581176828|FG000|Overall Study|Lost to Follow-up|0|||
160942028|NCT01858194|581176829|FG001|Overall Study|Lost to Follow-up|1|||
160942029|NCT02158039|581176830|FG000|Overall Study|Withdrawal by Subject|1|||
160942030|NCT02158039|581176830|FG000|Overall Study|Screen Failure|9|||
160942031|NCT02563028|581176838|FG000|Overall Study|Lack of equipment|1|||
160942032|NCT02563028|581176838|FG000|Overall Study|Unable to elicit VEP post induction|1|||
160942033|NCT01856543|581176839|FG000|Overall Study|Treatment discontinued|6|||
160942034|NCT01856543|581176840|FG001|Overall Study|Treatment discontinued|3|||
160942035|NCT01856543|581176839|FG000|Overall Study|Withdrawn before start|7|||
160942036|NCT01856543|581176840|FG001|Overall Study|Withdrawn before start|3|||
160942037|NCT02188485|581176845|FG000|Overall Study|Withdrawal by Subject|2|||
160942038|NCT02188485|581176846|FG001|Overall Study|Withdrawal by Subject|1|||
160942039|NCT02188485|581176845|FG000|Overall Study|PI withdrew, lack of capacity|0|||
160942040|NCT02188485|581176846|FG001|Overall Study|PI withdrew, lack of capacity|2|||
160942041|NCT00799617|581176847|FG000|Main Testosterone Trial|Randomized in error|1|||
160942042|NCT00799617|581176848|FG001|Main Testosterone Trial|Randomized in error|1|||
161265190|NCT00922987|582352433|FG000|Overall Study|Protocol Violation|2|||
161265191|NCT00922987|582352433|FG000|Overall Study|Adverse Event|1|||
161265192|NCT01334710|582352440|FG000|Overall Study|Trial was terminated|3|||
161265193|NCT05011123|582354009|FG000|Overall Study|Withdrawal by Subject|4|||
161265194|NCT05011123|582354010|FG001|Overall Study|Withdrawal by Subject|2|||
161265195|NCT05011123|582354009|FG000|Overall Study|Lost to Follow-up|7|||
161265196|NCT05011123|582354010|FG001|Overall Study|Lost to Follow-up|6|||
161265197|NCT05011123|582354009|FG000|Overall Study|Ongoing at the time of DBL date|36|||
161265198|NCT05011123|582354010|FG001|Overall Study|Ongoing at the time of DBL date|10|||
161265199|NCT05011123|582354009|FG000|Overall Study|Randomized but did not receive vaccination|1|||
161265200|NCT05011123|582354010|FG001|Overall Study|Randomized but did not receive vaccination|0|||
161265201|NCT04221789|582354011|FG000|Overall Study|deviation from protoco|22|||
161265202|NCT04221789|582354012|FG001|Overall Study|deviation from protoco|8|||
161265203|NCT02068092|582354015|FG000|Overall Study|Physician Decision|2|||
161265204|NCT02068092|582354015|FG000|Overall Study|Adverse Event|2|||
161265205|NCT02068092|582354015|FG000|Overall Study|Lost to Follow-up|4|||
161265206|NCT02068092|582354015|FG000|Overall Study|Withdrawal by Subject|2|||
161265207|NCT03502707|582354016|FG000|Overall Study|Adverse Event|0|||
161265208|NCT03502707|582354017|FG001|Overall Study|Adverse Event|0|||
161265209|NCT03502707|582354018|FG002|Overall Study|Adverse Event|0|||
161265210|NCT03502707|582354019|FG003|Overall Study|Adverse Event|0|||
161265211|NCT03502707|582354020|FG004|Overall Study|Adverse Event|0|||
161265212|NCT03502707|582354021|FG005|Overall Study|Adverse Event|0|||
161265213|NCT03502707|582354022|FG006|Overall Study|Adverse Event|0|||
161265214|NCT03502707|582354023|FG007|Overall Study|Adverse Event|0|||
161265215|NCT03502707|582354024|FG008|Overall Study|Adverse Event|0|||
161265216|NCT03502707|582354025|FG009|Overall Study|Adverse Event|0|||
161265217|NCT03502707|582354026|FG010|Overall Study|Adverse Event|0|||
161265218|NCT03502707|582354027|FG011|Overall Study|Adverse Event|0|||
161265219|NCT03502707|582354028|FG012|Overall Study|Adverse Event|0|||
161265220|NCT03502707|582354029|FG013|Overall Study|Adverse Event|0|||
161265221|NCT03502707|582354030|FG014|Overall Study|Adverse Event|0|||
161265222|NCT03502707|582354031|FG015|Overall Study|Adverse Event|1|||
161265223|NCT03502707|582354032|FG016|Overall Study|Adverse Event|5|||
161265224|NCT03502707|582354033|FG017|Overall Study|Adverse Event|0|||
161265225|NCT03502707|582354016|FG000|Overall Study|Death|0|||
161265226|NCT03502707|582354017|FG001|Overall Study|Death|0|||
161265227|NCT03502707|582354018|FG002|Overall Study|Death|0|||
161265228|NCT03502707|582354019|FG003|Overall Study|Death|1|||
161265229|NCT03502707|582354020|FG004|Overall Study|Death|0|||
161342619|NCT03483103|582642213|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
160942043|NCT00799617|581176847|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
160998941|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998942|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998943|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998944|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998945|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
160998946|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
160998947|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
160998948|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
160998949|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
161265230|NCT03502707|582354021|FG005|Overall Study|Death|0|||
161265231|NCT03502707|582354022|FG006|Overall Study|Death|0|||
161265232|NCT03502707|582354023|FG007|Overall Study|Death|0|||
161265233|NCT03502707|582354024|FG008|Overall Study|Death|1|||
161265234|NCT03502707|582354025|FG009|Overall Study|Death|1|||
160942044|NCT00799617|581176848|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
160942045|NCT00799617|581176847|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
160942046|NCT00799617|581176848|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
160942047|NCT00799617|581176847|FG000|Sexual Funtion Trial|No Baseline Data|4|||
160942048|NCT00799617|581176848|FG001|Sexual Funtion Trial|No Baseline Data|7|||
160942049|NCT00799617|581176847|FG000|Physical Function Trial|Lost to Follow-up|6|||
160942050|NCT00799617|581176848|FG001|Physical Function Trial|Lost to Follow-up|11|||
160942051|NCT00799617|581176847|FG000|Vitality Trial|Lost to Follow-up|7|||
160942052|NCT00799617|581176848|FG001|Vitality Trial|Lost to Follow-up|22|||
160942053|NCT00799617|581176847|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
160942054|NCT00799617|581176848|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
160942055|NCT00799617|581176847|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
160942056|NCT00799617|581176848|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
160942057|NCT00799617|581176847|FG000|Bone Trial|Month 12 scan not available|6|||
160998950|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
160998951|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
161265235|NCT03502707|582354026|FG010|Overall Study|Death|0|||
161265236|NCT03502707|582354027|FG011|Overall Study|Death|0|||
161265237|NCT03502707|582354028|FG012|Overall Study|Death|1|||
161265238|NCT03502707|582354029|FG013|Overall Study|Death|0|||
161265239|NCT03502707|582354030|FG014|Overall Study|Death|0|||
161265240|NCT03502707|582354031|FG015|Overall Study|Death|1|||
161265241|NCT03502707|582354032|FG016|Overall Study|Death|0|||
161265242|NCT03502707|582354033|FG017|Overall Study|Death|0|||
161265243|NCT03502707|582354016|FG000|Overall Study|Lost to Follow-up|0|||
160942058|NCT00799617|581176848|FG001|Bone Trial|Month 12 scan not available|16|||
160942059|NCT00799617|581176847|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
160942060|NCT00799617|581176848|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
160942061|NCT00799617|581176847|FG000|Anemia Trial|Withdrawal by Subject|3|||
160942062|NCT00799617|581176848|FG001|Anemia Trial|Withdrawal by Subject|3|||
160942063|NCT04545515|581176849|FG000|Overall Study|Adverse Event|1|||
160942064|NCT04545515|581176849|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
160942065|NCT04545515|581176849|FG000|Overall Study|Commercial drug is available for participant|7|||
160942066|NCT02052466|581176850|FG000|Overall Study|Withdrawal by Subject|1|||
160942067|NCT02052466|581176850|FG000|Overall Study|Acromial fracture|1|||
160942068|NCT03851016|581176852|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
160942069|NCT03851016|581176853|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
160942070|NCT01660412|581176854|FG000|Overall Study|Protocol Violation|0|||
160942071|NCT01660412|581176855|FG001|Overall Study|Protocol Violation|3|||
161265244|NCT03502707|582354017|FG001|Overall Study|Lost to Follow-up|0|||
161265245|NCT03502707|582354018|FG002|Overall Study|Lost to Follow-up|0|||
161265246|NCT03502707|582354019|FG003|Overall Study|Lost to Follow-up|0|||
161265247|NCT03502707|582354020|FG004|Overall Study|Lost to Follow-up|0|||
161265248|NCT03502707|582354021|FG005|Overall Study|Lost to Follow-up|0|||
161265249|NCT03502707|582354022|FG006|Overall Study|Lost to Follow-up|0|||
161265250|NCT03502707|582354023|FG007|Overall Study|Lost to Follow-up|5|||
161265251|NCT03502707|582354024|FG008|Overall Study|Lost to Follow-up|0|||
161265252|NCT03502707|582354025|FG009|Overall Study|Lost to Follow-up|2|||
161265253|NCT03502707|582354026|FG010|Overall Study|Lost to Follow-up|1|||
161265254|NCT03502707|582354027|FG011|Overall Study|Lost to Follow-up|2|||
161265255|NCT03502707|582354028|FG012|Overall Study|Lost to Follow-up|1|||
161265256|NCT03502707|582354029|FG013|Overall Study|Lost to Follow-up|1|||
161265257|NCT03502707|582354030|FG014|Overall Study|Lost to Follow-up|0|||
161265258|NCT03502707|582354031|FG015|Overall Study|Lost to Follow-up|4|||
161265259|NCT03502707|582354032|FG016|Overall Study|Lost to Follow-up|9|||
161265260|NCT03502707|582354033|FG017|Overall Study|Lost to Follow-up|2|||
161265261|NCT03502707|582354016|FG000|Overall Study|Physician Decision|0|||
161265262|NCT03502707|582354017|FG001|Overall Study|Physician Decision|0|||
161265263|NCT03502707|582354018|FG002|Overall Study|Physician Decision|0|||
161265264|NCT03502707|582354019|FG003|Overall Study|Physician Decision|0|||
161265265|NCT03502707|582354020|FG004|Overall Study|Physician Decision|0|||
161265266|NCT03502707|582354021|FG005|Overall Study|Physician Decision|0|||
161265267|NCT03502707|582354022|FG006|Overall Study|Physician Decision|0|||
161265268|NCT03502707|582354023|FG007|Overall Study|Physician Decision|0|||
161265269|NCT03502707|582354024|FG008|Overall Study|Physician Decision|2|||
161265270|NCT03502707|582354025|FG009|Overall Study|Physician Decision|1|||
161265271|NCT03502707|582354026|FG010|Overall Study|Physician Decision|0|||
161265272|NCT03502707|582354027|FG011|Overall Study|Physician Decision|0|||
161265273|NCT03502707|582354028|FG012|Overall Study|Physician Decision|0|||
161265274|NCT03502707|582354029|FG013|Overall Study|Physician Decision|0|||
161265275|NCT03502707|582354030|FG014|Overall Study|Physician Decision|1|||
161265276|NCT03502707|582354031|FG015|Overall Study|Physician Decision|3|||
161265277|NCT03502707|582354032|FG016|Overall Study|Physician Decision|0|||
161265278|NCT03502707|582354033|FG017|Overall Study|Physician Decision|0|||
161265279|NCT03502707|582354016|FG000|Overall Study|Protocol Violation|0|||
160942072|NCT02080091|581178416|FG000|Overall Study|Study Terminated|22|||
160942073|NCT02080091|581178416|FG000|Overall Study|Death|1|||
160942074|NCT02080091|581178416|FG000|Overall Study|Withdrawal by Subject|1|||
160942075|NCT02080091|581178416|FG000|Overall Study|Other|1|||
160942076|NCT03019536|581178417|FG000|Overall Study|Withdrawal by Subject|1|||
160942077|NCT03019536|581178418|FG001|Overall Study|Withdrawal by Subject|1|||
160942078|NCT03019536|581178419|FG002|Overall Study|Withdrawal by Subject|0|||
160942079|NCT03019536|581178417|FG000|Overall Study|Adverse Event|0|||
160942080|NCT03019536|581178418|FG001|Overall Study|Adverse Event|0|||
160942081|NCT03019536|581178419|FG002|Overall Study|Adverse Event|2|||
160942082|NCT03143829|581178423|FG000|Overall Study|Withdrawal by Subject|2|||
160942083|NCT03143829|581178424|FG001|Overall Study|Withdrawal by Subject|5|||
160942084|NCT03143829|581178423|FG000|Overall Study|Lost to Follow-up|0|||
160942085|NCT03143829|581178424|FG001|Overall Study|Lost to Follow-up|2|||
160942086|NCT03143829|581178423|FG000|Overall Study|Death|1|||
160942087|NCT03143829|581178424|FG001|Overall Study|Death|1|||
160942088|NCT03143829|581178423|FG000|Overall Study|changed treatment, no longer eligible|2|||
160942089|NCT03143829|581178424|FG001|Overall Study|changed treatment, no longer eligible|2|||
160942090|NCT02212730|581178426|FG000|Overall Study|Tumor not of the required cell histology|1|||
160942091|NCT02212730|581178427|FG001|Overall Study|Tumor not of the required cell histology|0|||
160942092|NCT02212730|581178426|FG000|Overall Study|Withdrawal by Subject|1|||
160942093|NCT02212730|581178427|FG001|Overall Study|Withdrawal by Subject|0|||
160942094|NCT02212730|581178426|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
160942095|NCT02212730|581178427|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
160942096|NCT02057757|581178428|FG000|Overall Study|Withdrawal by Subject|3|||
160942097|NCT02057757|581178429|FG001|Overall Study|Withdrawal by Subject|5|||
160942098|NCT02057757|581178428|FG000|Overall Study|Death|2|||
160942099|NCT02057757|581178429|FG001|Overall Study|Death|0|||
160942100|NCT02057757|581178428|FG000|Overall Study|Lost to Follow-up|8|||
160942101|NCT02057757|581178429|FG001|Overall Study|Lost to Follow-up|3|||
160942102|NCT02057757|581178428|FG000|Overall Study|Non-compliance|1|||
160942103|NCT02057757|581178429|FG001|Overall Study|Non-compliance|0|||
160942104|NCT00440271|581178430|FG000|Overall Study|Protocol Violation|1|||
160942105|NCT00440271|581178431|FG001|Overall Study|Protocol Violation|1|||
160942106|NCT00440271|581178430|FG000|Overall Study|Adverse Event|0|||
160998952|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
160998953|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
160998954|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
160998955|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
160998956|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
160998957|NCT02914522|581380650|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998958|NCT02914522|581380651|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
161265280|NCT03502707|582354017|FG001|Overall Study|Protocol Violation|0|||
161265281|NCT03502707|582354018|FG002|Overall Study|Protocol Violation|0|||
161265282|NCT03502707|582354019|FG003|Overall Study|Protocol Violation|0|||
161265283|NCT03502707|582354020|FG004|Overall Study|Protocol Violation|0|||
161265284|NCT03502707|582354021|FG005|Overall Study|Protocol Violation|0|||
161265285|NCT03502707|582354022|FG006|Overall Study|Protocol Violation|0|||
161265286|NCT03502707|582354023|FG007|Overall Study|Protocol Violation|0|||
161265287|NCT03502707|582354024|FG008|Overall Study|Protocol Violation|0|||
161265288|NCT03502707|582354025|FG009|Overall Study|Protocol Violation|0|||
161265289|NCT03502707|582354026|FG010|Overall Study|Protocol Violation|0|||
161265290|NCT03502707|582354027|FG011|Overall Study|Protocol Violation|0|||
161265291|NCT03502707|582354028|FG012|Overall Study|Protocol Violation|0|||
161265292|NCT03502707|582354029|FG013|Overall Study|Protocol Violation|0|||
161265293|NCT03502707|582354030|FG014|Overall Study|Protocol Violation|0|||
161265294|NCT03502707|582354031|FG015|Overall Study|Protocol Violation|1|||
161265295|NCT03502707|582354032|FG016|Overall Study|Protocol Violation|0|||
161265296|NCT03502707|582354033|FG017|Overall Study|Protocol Violation|0|||
161265297|NCT03502707|582354016|FG000|Overall Study|Withdrawal by Subject|1|||
161265298|NCT03502707|582354017|FG001|Overall Study|Withdrawal by Subject|1|||
161265299|NCT03502707|582354018|FG002|Overall Study|Withdrawal by Subject|0|||
161265300|NCT03502707|582354019|FG003|Overall Study|Withdrawal by Subject|0|||
161265301|NCT03502707|582354020|FG004|Overall Study|Withdrawal by Subject|0|||
161265302|NCT03502707|582354021|FG005|Overall Study|Withdrawal by Subject|2|||
161265303|NCT03502707|582354022|FG006|Overall Study|Withdrawal by Subject|0|||
161265304|NCT03502707|582354023|FG007|Overall Study|Withdrawal by Subject|3|||
161265305|NCT03502707|582354024|FG008|Overall Study|Withdrawal by Subject|1|||
161265306|NCT03502707|582354025|FG009|Overall Study|Withdrawal by Subject|2|||
161265307|NCT03502707|582354026|FG010|Overall Study|Withdrawal by Subject|12|||
161265308|NCT03502707|582354027|FG011|Overall Study|Withdrawal by Subject|23|||
160942107|NCT00440271|581178431|FG001|Overall Study|Adverse Event|1|||
160942108|NCT00440271|581178430|FG000|Overall Study|Lost to Follow-up|1|||
160942109|NCT00440271|581178431|FG001|Overall Study|Lost to Follow-up|0|||
160942110|NCT00440271|581178430|FG000|Overall Study|Withdrawal by Subject|0|||
160942111|NCT00440271|581178431|FG001|Overall Study|Withdrawal by Subject|2|||
160942112|NCT00440271|581178430|FG000|Overall Study|Lack of Efficacy|0|||
160942113|NCT00440271|581178431|FG001|Overall Study|Lack of Efficacy|1|||
160942114|NCT00440271|581178430|FG000|Overall Study|Due to closure of trial|8|||
160942115|NCT00440271|581178431|FG001|Overall Study|Due to closure of trial|10|||
160942116|NCT00440271|581178430|FG000|Overall Study|Other|2|||
160942117|NCT00440271|581178431|FG001|Overall Study|Other|0|||
160998959|NCT02914522|581380652|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998960|NCT02914522|581380653|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998961|NCT02914522|581380654|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
160998962|NCT02914522|581380655|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
160998963|NCT02914522|581380656|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998964|NCT02914522|581380657|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998965|NCT02914522|581380658|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998966|NCT02914522|581380659|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998967|NCT02914522|581380660|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
160998968|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161265309|NCT03502707|582354028|FG012|Overall Study|Withdrawal by Subject|5|||
160942118|NCT04086472|581178443|FG000|Overall Study|Lost to Follow-up|1|||
160942119|NCT04086472|581178444|FG001|Overall Study|Lost to Follow-up|0|||
160942120|NCT04086472|581178445|FG002|Overall Study|Lost to Follow-up|0|||
161265310|NCT03502707|582354029|FG013|Overall Study|Withdrawal by Subject|3|||
161265311|NCT03502707|582354030|FG014|Overall Study|Withdrawal by Subject|3|||
161265312|NCT03502707|582354031|FG015|Overall Study|Withdrawal by Subject|43|||
161265313|NCT03502707|582354032|FG016|Overall Study|Withdrawal by Subject|44|||
161265314|NCT03502707|582354033|FG017|Overall Study|Withdrawal by Subject|18|||
160942121|NCT04086472|581178446|FG003|Overall Study|Lost to Follow-up|0|||
160998969|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160942122|NCT04086472|581178447|FG004|Overall Study|Lost to Follow-up|1|||
160942123|NCT04086472|581178443|FG000|Overall Study|Physician Decision|0|||
160942124|NCT04086472|581178444|FG001|Overall Study|Physician Decision|1|||
160942125|NCT04086472|581178445|FG002|Overall Study|Physician Decision|1|||
160942126|NCT04086472|581178446|FG003|Overall Study|Physician Decision|0|||
160942127|NCT04086472|581178447|FG004|Overall Study|Physician Decision|0|||
160942128|NCT04086472|581178443|FG000|Overall Study|Withdrawal by Subject|1|||
160942129|NCT04086472|581178444|FG001|Overall Study|Withdrawal by Subject|1|||
160942130|NCT04086472|581178445|FG002|Overall Study|Withdrawal by Subject|1|||
160942131|NCT04086472|581178446|FG003|Overall Study|Withdrawal by Subject|0|||
160942132|NCT04086472|581178447|FG004|Overall Study|Withdrawal by Subject|0|||
160942133|NCT04086472|581178443|FG000|Overall Study|Various reasons|2|||
160942134|NCT04086472|581178444|FG001|Overall Study|Various reasons|0|||
160942135|NCT04086472|581178445|FG002|Overall Study|Various reasons|0|||
160942136|NCT04086472|581178446|FG003|Overall Study|Various reasons|3|||
160942137|NCT04086472|581178447|FG004|Overall Study|Various reasons|1|||
160942138|NCT03348904|581178448|FG000|Overall Study|Administrative reason by the sponsor|0|||
160942139|NCT03348904|581178449|FG001|Overall Study|Administrative reason by the sponsor|1|||
160942140|NCT03348904|581178450|FG002|Overall Study|Administrative reason by the sponsor|0|||
160942141|NCT00436280|581178456|FG000|Period 1: Induction|Adverse Event|8|||
160942142|NCT00436280|581178456|FG000|Period 1: Induction|Progressive Disease|12|||
160942143|NCT00436280|581178456|FG000|Period 1: Induction|Stable Disease|6|||
160942144|NCT00436280|581178456|FG000|Period 1: Induction|Withdrawal by Subject|1|||
160942145|NCT00436280|581178456|FG000|Period 1: Induction|Death|1|||
160942146|NCT00436280|581178456|FG000|Period 2: Consolidation|Adverse Event|1|||
160942147|NCT00436280|581178456|FG000|Period 2: Consolidation|Progressive Disease|10|||
160942148|NCT00436280|581178456|FG000|Period 2: Consolidation|Stable Disease|1|||
160942149|NCT00436280|581178456|FG000|Period 2: Consolidation|Physician Decision|2|||
160942150|NCT00436280|581178456|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
160942151|NCT00436280|581178456|FG000|Period 2: Consolidation|Death|1|||
160942152|NCT00436280|581178456|FG000|Period 3: Maintenance|Adverse Event|6|||
160942153|NCT00436280|581178456|FG000|Period 3: Maintenance|Progressive Disease|12|||
160942154|NCT00048724|581178457|FG000|Overall Study|Adverse Event|53|||
160942155|NCT00048724|581178458|FG001|Overall Study|Adverse Event|12|||
160942156|NCT00048724|581178457|FG000|Overall Study|Withdrawal by Subject|34|||
160942157|NCT00048724|581178458|FG001|Overall Study|Withdrawal by Subject|54|||
160942158|NCT00048724|581178457|FG000|Overall Study|Lost to Follow-up|5|||
160942159|NCT00048724|581178458|FG001|Overall Study|Lost to Follow-up|5|||
160942160|NCT00048724|581178457|FG000|Overall Study|Protocol-defined Clinical Event|17|||
160942161|NCT00048724|581178458|FG001|Overall Study|Protocol-defined Clinical Event|32|||
160942162|NCT00048724|581178457|FG000|Overall Study|Noncompliance With Protocol|4|||
160942163|NCT00048724|581178458|FG001|Overall Study|Noncompliance With Protocol|12|||
160942164|NCT00048724|581178457|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
160942165|NCT00048724|581178458|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
160942166|NCT00048724|581178457|FG000|Overall Study|Administrative|1|||
160942167|NCT00048724|581178458|FG001|Overall Study|Administrative|1|||
160942168|NCT03586869|581178459|FG000|Overall Study|Progressive Disease|3|||
160942169|NCT04116229|581178460|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
160942170|NCT04116229|581178461|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
160942171|NCT04116229|581178460|FG000|Overall Study|Scheduling not possible.|0|||
160942172|NCT04116229|581178461|FG001|Overall Study|Scheduling not possible.|1|||
160942173|NCT02809976|581178464|FG000|Overall Study|Lost to Follow-up|1|||
160942174|NCT02809976|581178464|FG000|Overall Study|Withdrawal by Subject|1|||
160942175|NCT00226941|581178465|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
160942176|NCT00226941|581178466|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
160942177|NCT00226941|581178467|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
160942178|NCT00226941|581178468|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
160998970|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160998971|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
161265315|NCT03502707|582354016|FG000|Overall Study|Sponsor's Decision|1|||
160942179|NCT00226941|581178465|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
160942180|NCT00226941|581178466|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
160942181|NCT00226941|581178467|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
160942182|NCT00226941|581178468|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
160942183|NCT01163682|581178470|FG000|Overall Study|Lost to Follow-up|6|||
160942184|NCT01163682|581178471|FG001|Overall Study|Lost to Follow-up|9|||
160942185|NCT00211081|581178473|FG000|Overall Study|Withdrawal by Subject|2|||
160942186|NCT01931839|581178474|FG000|Overall Study|Death|0|||
160942187|NCT01931839|581178475|FG001|Overall Study|Death|1|||
160942188|NCT01931839|581178476|FG002|Overall Study|Death|2|||
160942189|NCT01931839|581178477|FG003|Overall Study|Death|0|||
160942190|NCT01931839|581178478|FG004|Overall Study|Death|0|||
160942191|NCT01931839|581178479|FG005|Overall Study|Death|0|||
160942192|NCT01931839|581178480|FG006|Overall Study|Death|0|||
160942193|NCT01931839|581178474|FG000|Overall Study|Physician Decision|1|||
160998972|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160998973|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
160998974|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
160998975|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
160998976|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
160998977|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
160998978|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
160998979|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998980|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998981|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998982|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998983|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
161144425|NCT02031146|581913889|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
161144426|NCT02031146|581913890|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
160998984|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
160998985|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
160998986|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
160998987|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
160998988|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
160998989|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
160998990|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998991|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998992|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998993|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998994|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160998995|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
161265316|NCT03502707|582354017|FG001|Overall Study|Sponsor's Decision|0|||
161265317|NCT03502707|582354018|FG002|Overall Study|Sponsor's Decision|0|||
161265318|NCT03502707|582354019|FG003|Overall Study|Sponsor's Decision|0|||
161265319|NCT03502707|582354020|FG004|Overall Study|Sponsor's Decision|0|||
161265320|NCT03502707|582354021|FG005|Overall Study|Sponsor's Decision|0|||
161265321|NCT03502707|582354022|FG006|Overall Study|Sponsor's Decision|0|||
161265322|NCT03502707|582354023|FG007|Overall Study|Sponsor's Decision|0|||
161265323|NCT03502707|582354024|FG008|Overall Study|Sponsor's Decision|0|||
161265324|NCT03502707|582354025|FG009|Overall Study|Sponsor's Decision|1|||
161265325|NCT03502707|582354026|FG010|Overall Study|Sponsor's Decision|0|||
161265326|NCT03502707|582354027|FG011|Overall Study|Sponsor's Decision|0|||
161265327|NCT03502707|582354028|FG012|Overall Study|Sponsor's Decision|0|||
161265328|NCT03502707|582354029|FG013|Overall Study|Sponsor's Decision|0|||
161265329|NCT03502707|582354030|FG014|Overall Study|Sponsor's Decision|0|||
161265330|NCT03502707|582354031|FG015|Overall Study|Sponsor's Decision|2|||
161265331|NCT03502707|582354032|FG016|Overall Study|Sponsor's Decision|1|||
161265332|NCT03502707|582354033|FG017|Overall Study|Sponsor's Decision|0|||
161265333|NCT03502707|582354016|FG000|Overall Study|Initiated Prohibited Medication|0|||
161265334|NCT03502707|582354017|FG001|Overall Study|Initiated Prohibited Medication|0|||
161265335|NCT03502707|582354018|FG002|Overall Study|Initiated Prohibited Medication|0|||
161265336|NCT03502707|582354019|FG003|Overall Study|Initiated Prohibited Medication|0|||
161265337|NCT03502707|582354020|FG004|Overall Study|Initiated Prohibited Medication|0|||
161265338|NCT03502707|582354021|FG005|Overall Study|Initiated Prohibited Medication|0|||
161265339|NCT03502707|582354022|FG006|Overall Study|Initiated Prohibited Medication|0|||
161265340|NCT03502707|582354023|FG007|Overall Study|Initiated Prohibited Medication|0|||
161265341|NCT03502707|582354024|FG008|Overall Study|Initiated Prohibited Medication|0|||
161265342|NCT03502707|582354025|FG009|Overall Study|Initiated Prohibited Medication|0|||
161265343|NCT03502707|582354026|FG010|Overall Study|Initiated Prohibited Medication|0|||
160998996|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
161144427|NCT02031146|581913891|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
161144428|NCT02031146|581913892|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
161144429|NCT02031146|581913893|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
161144430|NCT02031146|581913894|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
161144431|NCT02629393|581913898|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
161144432|NCT02629393|581913898|FG000|Overall Study|Physician Decision|1|||
161265344|NCT03502707|582354027|FG011|Overall Study|Initiated Prohibited Medication|0|||
161265345|NCT03502707|582354028|FG012|Overall Study|Initiated Prohibited Medication|0|||
161265346|NCT03502707|582354029|FG013|Overall Study|Initiated Prohibited Medication|0|||
161265347|NCT03502707|582354030|FG014|Overall Study|Initiated Prohibited Medication|0|||
161144433|NCT00151411|581913899|FG000|Overall Study|Lost to Follow-up|15|||
161144434|NCT00151411|581913900|FG001|Overall Study|Lost to Follow-up|19|||
161144435|NCT00151411|581913899|FG000|Overall Study|Withdrawal by Subject|12|||
160942194|NCT01931839|581178475|FG001|Overall Study|Physician Decision|0|||
160942195|NCT01931839|581178476|FG002|Overall Study|Physician Decision|1|||
160942196|NCT01931839|581178477|FG003|Overall Study|Physician Decision|0|||
160942197|NCT01931839|581178478|FG004|Overall Study|Physician Decision|0|||
160942198|NCT01931839|581178479|FG005|Overall Study|Physician Decision|0|||
160942199|NCT01931839|581178480|FG006|Overall Study|Physician Decision|1|||
160942200|NCT01931839|581178474|FG000|Overall Study|Withdrawal of consent|0|||
160942201|NCT01931839|581178475|FG001|Overall Study|Withdrawal of consent|0|||
160998997|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
160998998|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
160998999|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
160999000|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
160999001|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999002|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999003|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999004|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999005|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999006|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
160999007|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
160999008|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
160999009|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
160999010|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
160999011|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
160999012|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
160999013|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
160999014|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
160999015|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
160999016|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
160999017|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
160999018|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
160999019|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
160999020|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
160999021|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
160999022|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
160999023|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999024|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999025|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999026|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999027|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999028|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999029|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999030|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
160999031|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
160999032|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999033|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
160999034|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999035|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999036|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999037|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999038|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999039|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999040|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999041|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999042|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
160999043|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
160999044|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
160999045|NCT02914522|581380650|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999046|NCT02914522|581380651|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999047|NCT02914522|581380652|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161144436|NCT00151411|581913900|FG001|Overall Study|Withdrawal by Subject|20|||
161265348|NCT03502707|582354031|FG015|Overall Study|Initiated Prohibited Medication|0|||
161265349|NCT03502707|582354032|FG016|Overall Study|Initiated Prohibited Medication|1|||
160999048|NCT02914522|581380653|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999049|NCT02914522|581380654|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
161144437|NCT00151411|581913899|FG000|Overall Study|Adverse Event|6|||
161319359|NCT01884545|582555287|FG002|Overall Study|Patient withdrawn|5|||
160942202|NCT01931839|581178476|FG002|Overall Study|Withdrawal of consent|0|||
160942203|NCT01931839|581178477|FG003|Overall Study|Withdrawal of consent|0|||
160942204|NCT01931839|581178478|FG004|Overall Study|Withdrawal of consent|1|||
160942205|NCT01931839|581178479|FG005|Overall Study|Withdrawal of consent|0|||
160942206|NCT01931839|581178480|FG006|Overall Study|Withdrawal of consent|0|||
160942207|NCT01931839|581178474|FG000|Overall Study|Adverse Event|9|||
160942208|NCT01931839|581178475|FG001|Overall Study|Adverse Event|4|||
160942209|NCT01931839|581178476|FG002|Overall Study|Adverse Event|1|||
160942210|NCT01931839|581178477|FG003|Overall Study|Adverse Event|3|||
160942211|NCT01931839|581178478|FG004|Overall Study|Adverse Event|0|||
160942212|NCT01931839|581178479|FG005|Overall Study|Adverse Event|0|||
160942213|NCT01931839|581178480|FG006|Overall Study|Adverse Event|1|||
160942214|NCT01931839|581178474|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
160942215|NCT01931839|581178475|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
160942216|NCT01931839|581178476|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
160942217|NCT01931839|581178477|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
160942218|NCT01931839|581178478|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
160942219|NCT01931839|581178479|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
160942220|NCT01931839|581178480|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
160942221|NCT01931839|581178474|FG000|Overall Study|Other non-compliance|15|||
160942222|NCT01931839|581178475|FG001|Overall Study|Other non-compliance|9|||
161265350|NCT03502707|582354033|FG017|Overall Study|Initiated Prohibited Medication|0|||
161265351|NCT03502707|582354016|FG000|Overall Study|Other|0|||
161265352|NCT03502707|582354017|FG001|Overall Study|Other|0|||
161265353|NCT03502707|582354018|FG002|Overall Study|Other|0|||
161265354|NCT03502707|582354019|FG003|Overall Study|Other|0|||
161265355|NCT03502707|582354020|FG004|Overall Study|Other|0|||
161265356|NCT03502707|582354021|FG005|Overall Study|Other|0|||
161265357|NCT03502707|582354022|FG006|Overall Study|Other|0|||
161265358|NCT03502707|582354023|FG007|Overall Study|Other|0|||
161265359|NCT03502707|582354024|FG008|Overall Study|Other|1|||
161265360|NCT03502707|582354025|FG009|Overall Study|Other|1|||
161265361|NCT03502707|582354026|FG010|Overall Study|Other|2|||
161265362|NCT03502707|582354027|FG011|Overall Study|Other|0|||
161265363|NCT03502707|582354028|FG012|Overall Study|Other|0|||
161265364|NCT03502707|582354029|FG013|Overall Study|Other|0|||
161265365|NCT03502707|582354030|FG014|Overall Study|Other|0|||
161265366|NCT03502707|582354031|FG015|Overall Study|Other|4|||
161265367|NCT03502707|582354032|FG016|Overall Study|Other|1|||
161265368|NCT03502707|582354033|FG017|Overall Study|Other|0|||
161265369|NCT03502707|582354016|FG000|Overall Study|Randomized but not vaccinated|0|||
161265370|NCT03502707|582354017|FG001|Overall Study|Randomized but not vaccinated|0|||
161265371|NCT03502707|582354018|FG002|Overall Study|Randomized but not vaccinated|0|||
161265372|NCT03502707|582354019|FG003|Overall Study|Randomized but not vaccinated|0|||
161265373|NCT03502707|582354020|FG004|Overall Study|Randomized but not vaccinated|0|||
161265374|NCT03502707|582354021|FG005|Overall Study|Randomized but not vaccinated|0|||
161265375|NCT03502707|582354022|FG006|Overall Study|Randomized but not vaccinated|0|||
161265376|NCT03502707|582354023|FG007|Overall Study|Randomized but not vaccinated|0|||
161265377|NCT03502707|582354024|FG008|Overall Study|Randomized but not vaccinated|0|||
161265378|NCT03502707|582354025|FG009|Overall Study|Randomized but not vaccinated|0|||
161265379|NCT03502707|582354026|FG010|Overall Study|Randomized but not vaccinated|0|||
161265380|NCT03502707|582354027|FG011|Overall Study|Randomized but not vaccinated|1|||
161265381|NCT03502707|582354028|FG012|Overall Study|Randomized but not vaccinated|0|||
161265382|NCT03502707|582354029|FG013|Overall Study|Randomized but not vaccinated|0|||
161265383|NCT03502707|582354030|FG014|Overall Study|Randomized but not vaccinated|0|||
161265384|NCT03502707|582354031|FG015|Overall Study|Randomized but not vaccinated|0|||
161265385|NCT03502707|582354032|FG016|Overall Study|Randomized but not vaccinated|0|||
161265386|NCT03502707|582354033|FG017|Overall Study|Randomized but not vaccinated|1|||
161265387|NCT00461253|582354034|FG000|Overall Study|Death|985|||
161265388|NCT00461253|582354035|FG001|Overall Study|Death|0|||
161265389|NCT00461253|582354034|FG000|Overall Study|Protocol Violation|613|||
161265390|NCT00461253|582354035|FG001|Overall Study|Protocol Violation|236|||
160942223|NCT01931839|581178476|FG002|Overall Study|Other non-compliance|12|||
160942224|NCT01931839|581178477|FG003|Overall Study|Other non-compliance|3|||
161265391|NCT00461253|582354034|FG000|Overall Study|no response|2609|||
161265392|NCT00461253|582354035|FG001|Overall Study|no response|11789|||
161265393|NCT00461253|582354034|FG000|Overall Study|administrative|773|||
161265394|NCT00461253|582354035|FG001|Overall Study|administrative|7773|||
161265395|NCT01933113|582354036|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
161265396|NCT02297438|582354037|FG000|Overall Study|Death|79|||
161265397|NCT02297438|582354038|FG001|Overall Study|Death|86|||
161265398|NCT02297438|582354037|FG000|Overall Study|Lost to Follow-up|9|||
161265399|NCT02297438|582354038|FG001|Overall Study|Lost to Follow-up|7|||
161091125|NCT02581631|581723819|FG001|Overall Study|AE unrelated to study drug|1|||
161265400|NCT02297438|582354037|FG000|Overall Study|Withdrawal by Subject|7|||
161265401|NCT02297438|582354038|FG001|Overall Study|Withdrawal by Subject|0|||
161342620|NCT03483103|582642213|FG000|Treatment Phase|Received nonconforming product|1|||
160942225|NCT01931839|581178478|FG004|Overall Study|Other non-compliance|0|||
160942226|NCT01931839|581178479|FG005|Overall Study|Other non-compliance|3|||
161342621|NCT00790036|582642219|FG000|Overall Study|Abnormal lab values|3|||
161342622|NCT00790036|582642220|FG001|Overall Study|Abnormal lab values|2|||
161342623|NCT00790036|582642219|FG000|Overall Study|Administrative problems|5|||
161342624|NCT00790036|582642220|FG001|Overall Study|Administrative problems|9|||
161342625|NCT00790036|582642219|FG000|Overall Study|Adverse Event|113|||
161342626|NCT00790036|582642220|FG001|Overall Study|Adverse Event|44|||
161342627|NCT00790036|582642219|FG000|Overall Study|Death|1|||
160999050|NCT02914522|581380655|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999051|NCT02914522|581380656|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999052|NCT02914522|581380657|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999053|NCT02914522|581380658|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999054|NCT02914522|581380659|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
160999055|NCT02914522|581380660|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
160999056|NCT00639002|581380661|FG000|Overall Study|Death|1|||
160999057|NCT00639002|581380661|FG000|Overall Study|Adverse Event|1|||
160999058|NCT00639002|581380661|FG000|Overall Study|Protocol Violation|1|||
160999059|NCT00639002|581380661|FG000|Overall Study|Disease progression|3|||
160999060|NCT00639002|581380661|FG000|Overall Study|Physician Decision|6|||
160999061|NCT00639002|581380661|FG000|Overall Study|Lack of Efficacy|1|||
161265402|NCT02297438|582354037|FG000|Overall Study|Other|9|||
161265403|NCT02297438|582354038|FG001|Overall Study|Other|5|||
161265404|NCT02297438|582354037|FG000|Overall Study|Ongoing|65|||
161265405|NCT02297438|582354038|FG001|Overall Study|Ongoing|73|||
161265406|NCT02358343|582354041|FG000|Screening Intervention|Death|0|||
161265407|NCT02358343|582354042|FG001|Screening Intervention|Death|2|||
161265408|NCT02358343|582354043|FG002|Screening Intervention|Death|0|||
161265409|NCT02358343|582354044|FG003|Screening Intervention|Death|0|||
161265410|NCT02358343|582354045|FG004|Screening Intervention|Death|0|||
161265411|NCT02358343|582354041|FG000|Screening Intervention|Withdrawal by Subject|1|||
161265412|NCT02358343|582354042|FG001|Screening Intervention|Withdrawal by Subject|0|||
161265413|NCT02358343|582354043|FG002|Screening Intervention|Withdrawal by Subject|0|||
161265414|NCT02358343|582354044|FG003|Screening Intervention|Withdrawal by Subject|0|||
161265415|NCT02358343|582354045|FG004|Screening Intervention|Withdrawal by Subject|0|||
161265416|NCT02358343|582354041|FG000|Screening Intervention|Determined Ineligible|5|||
161265417|NCT02358343|582354042|FG001|Screening Intervention|Determined Ineligible|6|||
161265418|NCT02358343|582354043|FG002|Screening Intervention|Determined Ineligible|0|||
161265419|NCT02358343|582354044|FG003|Screening Intervention|Determined Ineligible|0|||
161265420|NCT02358343|582354045|FG004|Screening Intervention|Determined Ineligible|0|||
161265421|NCT02358343|582354041|FG000|Comparative Efficacy Trial / Observation|Death|0|||
161265422|NCT02358343|582354042|FG001|Comparative Efficacy Trial / Observation|Death|0|||
161265423|NCT02358343|582354043|FG002|Comparative Efficacy Trial / Observation|Death|2|||
161265424|NCT02358343|582354044|FG003|Comparative Efficacy Trial / Observation|Death|0|||
161265425|NCT02358343|582354045|FG004|Comparative Efficacy Trial / Observation|Death|0|||
161265426|NCT02358343|582354041|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
161265427|NCT02358343|582354042|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
161265428|NCT02358343|582354043|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161265429|NCT02358343|582354044|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161265430|NCT02358343|582354045|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
161265431|NCT02358343|582354041|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161265432|NCT02358343|582354042|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161265433|NCT02358343|582354043|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
161342628|NCT00790036|582642220|FG001|Overall Study|Death|0|||
161342629|NCT00790036|582642219|FG000|Overall Study|Disease progression|24|||
161342630|NCT00790036|582642220|FG001|Overall Study|Disease progression|48|||
160999062|NCT00768651|581380664|FG000|Overall Study|Withdrawal by Subject|1|||
160999063|NCT02357784|581380665|FG000|Overall Study|Withdrawal by Subject|1|||
160999064|NCT01697319|581380667|FG000|Primary Phase|Withdrawal by Subject|1|||
160999065|NCT01697319|581380667|FG000|Extension Phase|Terminated by Sponsor|15|||
161265434|NCT02358343|582354044|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
161265435|NCT02358343|582354045|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
160999066|NCT04222959|581380670|FG000|Overall Study|Lost to Follow-up|76|||
161265436|NCT01951885|582354047|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
161265437|NCT01951885|582354048|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
161265438|NCT01951885|582354047|FG000|Overall Study|Adverse Event|1|||
161265439|NCT01951885|582354048|FG001|Overall Study|Adverse Event|0|||
161265440|NCT01951885|582354047|FG000|Overall Study|Withdrawal by Subject|0|||
161265441|NCT01951885|582354048|FG001|Overall Study|Withdrawal by Subject|1|||
161265442|NCT01951885|582354047|FG000|Overall Study|ineligible due to a change in donor|0|||
161342631|NCT00790036|582642219|FG000|Overall Study|Lost to Follow-up|1|||
160999067|NCT04222959|581380671|FG001|Overall Study|Lost to Follow-up|28|||
160999068|NCT04248829|581380675|FG000|Overall Study|Disease progression|44|||
160999069|NCT04248829|581380676|FG001|Overall Study|Disease progression|109|||
160942227|NCT01931839|581178480|FG006|Overall Study|Other non-compliance|0|||
160942228|NCT01931839|581178474|FG000|Overall Study|Lost to Follow-up|1|||
160942229|NCT01931839|581178475|FG001|Overall Study|Lost to Follow-up|2|||
160942230|NCT01931839|581178476|FG002|Overall Study|Lost to Follow-up|4|||
160942231|NCT01931839|581178477|FG003|Overall Study|Lost to Follow-up|5|||
160942232|NCT01931839|581178478|FG004|Overall Study|Lost to Follow-up|0|||
160942233|NCT01931839|581178479|FG005|Overall Study|Lost to Follow-up|0|||
160942234|NCT01931839|581178480|FG006|Overall Study|Lost to Follow-up|0|||
160942235|NCT01931839|581178474|FG000|Overall Study|Other|4|||
160942236|NCT01931839|581178475|FG001|Overall Study|Other|2|||
160942237|NCT01931839|581178476|FG002|Overall Study|Other|6|||
160942238|NCT01931839|581178477|FG003|Overall Study|Other|0|||
160942239|NCT01931839|581178478|FG004|Overall Study|Other|0|||
160942240|NCT01931839|581178479|FG005|Overall Study|Other|0|||
160942241|NCT01931839|581178480|FG006|Overall Study|Other|0|||
160942242|NCT00113516|581178481|FG000|Part 1|Adverse Event|6|||
160942243|NCT00113516|581178482|FG001|Part 1|Adverse Event|0|||
160942244|NCT00113516|581178481|FG000|Part 1|Death|3|||
160942245|NCT00113516|581178482|FG001|Part 1|Death|0|||
160942246|NCT00113516|581178481|FG000|Part 1|Other|3|||
160942247|NCT00113516|581178482|FG001|Part 1|Other|0|||
160942248|NCT00113516|581178481|FG000|Part 1|Withdrawal by Subject|2|||
160942249|NCT00113516|581178482|FG001|Part 1|Withdrawal by Subject|0|||
160942250|NCT00113516|581178481|FG000|Part 1|Lack of Efficacy|2|||
160942251|NCT00113516|581178482|FG001|Part 1|Lack of Efficacy|0|||
160942252|NCT00113516|581178481|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
160942253|NCT00113516|581178482|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
160942254|NCT00113516|581178481|FG000|Part 1|Laboratory Abnormality|1|||
160942255|NCT00113516|581178482|FG001|Part 1|Laboratory Abnormality|0|||
160942256|NCT00113516|581178481|FG000|Part 1|Ongoing|1|||
160942257|NCT00113516|581178482|FG001|Part 1|Ongoing|0|||
160942258|NCT00113516|581178481|FG000|Part 1|Missing|65|||
160942259|NCT00113516|581178482|FG001|Part 1|Missing|0|||
160942260|NCT00113516|581178481|FG000|Part 2|Adverse Event|0|||
160942261|NCT00113516|581178482|FG001|Part 2|Adverse Event|16|||
160942262|NCT00113516|581178481|FG000|Part 2|Death|0|||
160942263|NCT00113516|581178482|FG001|Part 2|Death|5|||
160942264|NCT00113516|581178481|FG000|Part 2|Lack of Efficacy|0|||
160942265|NCT00113516|581178482|FG001|Part 2|Lack of Efficacy|37|||
160942266|NCT00113516|581178481|FG000|Part 2|Withdrawal by Subject|0|||
160942267|NCT00113516|581178482|FG001|Part 2|Withdrawal by Subject|3|||
160942268|NCT00113516|581178481|FG000|Part 2|Other|0|||
160942269|NCT00113516|581178482|FG001|Part 2|Other|3|||
160942270|NCT00113516|581178481|FG000|Part 2|Laboratory Abnormality|0|||
160942271|NCT00113516|581178482|FG001|Part 2|Laboratory Abnormality|1|||
160942272|NCT00113516|581178481|FG000|Part 2|Ongoing|0|||
160942273|NCT00113516|581178482|FG001|Part 2|Ongoing|1|||
160942274|NCT03755765|581178491|FG000|Overall Study|Withdrawal by Subject|2|||
160942275|NCT03755765|581178492|FG001|Overall Study|Withdrawal by Subject|4|||
160942276|NCT03755765|581178493|FG002|Overall Study|Withdrawal by Subject|4|||
160942277|NCT02104557|581178494|FG000|Overall Study|Adverse Event|24|||
160942278|NCT02104557|581178494|FG000|Overall Study|Lost to Follow-up|34|||
160942279|NCT02104557|581178494|FG000|Overall Study|Violated the usage and dosage|14|||
160942280|NCT02104557|581178494|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
160942281|NCT02104557|581178494|FG000|Overall Study|Administered Sayana prior to the contract|1|||
160942282|NCT02104557|581178494|FG000|Overall Study|Other|17|||
160942283|NCT02104557|581178494|FG000|Overall Study|Change to other contraception methods|5|||
160942284|NCT02104557|581178494|FG000|Overall Study|Discontinuation due to no pain|1|||
160942285|NCT02104557|581178494|FG000|Overall Study|Withdrawal consent|2|||
160942286|NCT02104557|581178494|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
160942287|NCT02104557|581178494|FG000|Overall Study|Discontinuation of contraception|9|||
160942288|NCT01158222|581178498|FG000|Overall Study|Not eligible for intermediate phase|17|||
160942289|NCT00111228|581178501|FG000|Overall Study|Withdrawal by Subject|5|||
160942290|NCT00111228|581178502|FG001|Overall Study|Withdrawal by Subject|1|||
160942291|NCT00111228|581178503|FG002|Overall Study|Withdrawal by Subject|0|||
160942292|NCT02579616|581178504|FG000|Overall Study|Participants did not receive treatment|3|||
160942293|NCT01430585|581178505|FG000|Overall Study|Death|1|||
160942294|NCT01430585|581178505|FG000|Overall Study|Objective Progression or Relapse|3|||
160942295|NCT01430585|581178505|FG000|Overall Study|Study Terminated by Sponsor|3|||
160942296|NCT01430585|581178505|FG000|Overall Study|Other|7|||
160942297|NCT01448850|581178506|FG000|Overall Study|Death|3|||
160942298|NCT01448850|581178507|FG001|Overall Study|Death|6|||
160942299|NCT01448850|581178506|FG000|Overall Study|Withdrawal by Subject|13|||
161342632|NCT00790036|582642220|FG001|Overall Study|Lost to Follow-up|2|||
160942300|NCT01448850|581178507|FG001|Overall Study|Withdrawal by Subject|21|||
160942301|NCT01448850|581178506|FG000|Overall Study|Lost to Follow-up|3|||
160942302|NCT01448850|581178507|FG001|Overall Study|Lost to Follow-up|1|||
160942303|NCT01448850|581178506|FG000|Overall Study|Other|15|||
160942304|NCT01448850|581178507|FG001|Overall Study|Other|12|||
160942305|NCT01490060|581178510|FG000|Cycle 1|Change of Treatment|0|||
160942306|NCT01490060|581178511|FG001|Cycle 1|Change of Treatment|1|||
160942307|NCT01490060|581178512|FG002|Cycle 1|Change of Treatment|1|||
160942308|NCT01490060|581178513|FG003|Cycle 1|Change of Treatment|1|||
160942309|NCT01490060|581178510|FG000|Cycle 1|Insurance Denied|0|||
160942310|NCT01490060|581178511|FG001|Cycle 1|Insurance Denied|0|||
160942311|NCT01490060|581178512|FG002|Cycle 1|Insurance Denied|2|||
160942312|NCT01490060|581178513|FG003|Cycle 1|Insurance Denied|0|||
160942313|NCT01490060|581178510|FG000|Cycle 1|Withdrawal by Subject|0|||
160942314|NCT01490060|581178511|FG001|Cycle 1|Withdrawal by Subject|0|||
160942315|NCT01490060|581178512|FG002|Cycle 1|Withdrawal by Subject|0|||
160942316|NCT01490060|581178513|FG003|Cycle 1|Withdrawal by Subject|1|||
160942317|NCT01490060|581178510|FG000|Cycle 1|Treatment at Another Facility|0|||
160942318|NCT01490060|581178511|FG001|Cycle 1|Treatment at Another Facility|0|||
160942319|NCT01490060|581178512|FG002|Cycle 1|Treatment at Another Facility|0|||
160942320|NCT01490060|581178513|FG003|Cycle 1|Treatment at Another Facility|1|||
160942321|NCT01490060|581178510|FG000|Cycle 2|Change of Treatment|1|||
160942322|NCT01490060|581178511|FG001|Cycle 2|Change of Treatment|1|||
160942323|NCT01490060|581178512|FG002|Cycle 2|Change of Treatment|0|||
160942324|NCT01490060|581178513|FG003|Cycle 2|Change of Treatment|0|||
160942325|NCT01490060|581178510|FG000|Cycle 2|Non-Compliance|0|||
160942326|NCT01490060|581178511|FG001|Cycle 2|Non-Compliance|0|||
160942327|NCT01490060|581178512|FG002|Cycle 2|Non-Compliance|1|||
160942328|NCT01490060|581178513|FG003|Cycle 2|Non-Compliance|0|||
160942329|NCT01490060|581178510|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
160942330|NCT01490060|581178511|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
160942331|NCT01490060|581178512|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
160942332|NCT01490060|581178513|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
160942333|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
160942334|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
160942335|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
160942336|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
160942337|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
160942338|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
161342633|NCT00790036|582642219|FG000|Overall Study|Protocol Violation|10|||
161342634|NCT00790036|582642220|FG001|Overall Study|Protocol Violation|2|||
160942339|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
160942340|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
160942341|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
160942342|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
160942343|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
160942344|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
160942345|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
160942346|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
160942347|NCT02464969|581178514|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
160942348|NCT02464969|581178515|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
160942349|NCT02464969|581178514|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
160942350|NCT02464969|581178515|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
160942351|NCT02464969|581178514|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
160942352|NCT02464969|581178515|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
160942353|NCT02464969|581178514|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
160942354|NCT02464969|581178515|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
160942355|NCT02863354|581178516|FG000|Year 1|Lost to Follow-up|1|||
160942356|NCT02863354|581178517|FG001|Year 1|Lost to Follow-up|1|||
160942357|NCT02863354|581178516|FG000|Year 1|Withdrawal by Subject|3|||
160942358|NCT02863354|581178517|FG001|Year 1|Withdrawal by Subject|0|||
160942359|NCT02863354|581178516|FG000|Year 1|Death|0|||
160942360|NCT02863354|581178517|FG001|Year 1|Death|1|||
160942361|NCT02863354|581178516|FG000|Year 2|Lost to Follow-up|2|||
160999070|NCT04248829|581380675|FG000|Overall Study|Adverse Event|19|||
160999071|NCT04248829|581380676|FG001|Overall Study|Adverse Event|18|||
161342635|NCT00790036|582642219|FG000|Overall Study|Withdrawal by Subject|18|||
161342636|NCT00790036|582642220|FG001|Overall Study|Withdrawal by Subject|7|||
161342637|NCT00790036|582642219|FG000|Overall Study|Subject/guardian decision|20|||
161342638|NCT00790036|582642220|FG001|Overall Study|Subject/guardian decision|7|||
160942362|NCT02863354|581178517|FG001|Year 2|Lost to Follow-up|2|||
160942363|NCT00724451|581178523|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
160942364|NCT00724451|581178523|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
160942365|NCT00724451|581178523|FG000|Overall Study|Not Eligible for Treatment|431|||
160942366|NCT00724451|581178523|FG000|Overall Study|Participant Refused Treatment|89|||
160942367|NCT00724451|581178523|FG000|Overall Study|Never Started Treatment|89|||
160942368|NCT00724451|581178523|FG000|Overall Study|Unknown; No Data Sources Available|9|||
160942369|NCT00724451|581178523|FG000|Overall Study|Physician Decision|116|||
160942370|NCT00724451|581178523|FG000|Overall Study|Withdrawal by Subject|45|||
160942371|NCT00724451|581178523|FG000|Overall Study|Investigator + Participant Decision|13|||
160942372|NCT00414050|581178525|FG000|Overall Study|Adverse Event|1|||
160942373|NCT00414050|581178526|FG001|Overall Study|Adverse Event|1|||
161144438|NCT00151411|581913900|FG001|Overall Study|Adverse Event|0|||
160942374|NCT00414050|581178527|FG002|Overall Study|Adverse Event|1|||
160942375|NCT00414050|581178528|FG003|Overall Study|Adverse Event|1|||
160942376|NCT00414050|581178525|FG000|Overall Study|Lost to Follow-up|2|||
160942377|NCT00414050|581178526|FG001|Overall Study|Lost to Follow-up|2|||
160942378|NCT00414050|581178527|FG002|Overall Study|Lost to Follow-up|1|||
160942379|NCT00414050|581178528|FG003|Overall Study|Lost to Follow-up|1|||
160942380|NCT00414050|581178525|FG000|Overall Study|Withdrawal by Subject|5|||
160942381|NCT00414050|581178526|FG001|Overall Study|Withdrawal by Subject|3|||
160942382|NCT00414050|581178527|FG002|Overall Study|Withdrawal by Subject|2|||
160942383|NCT00414050|581178528|FG003|Overall Study|Withdrawal by Subject|4|||
160942384|NCT00414050|581178525|FG000|Overall Study|Subject discontinued for other reason|1|||
160942385|NCT00414050|581178526|FG001|Overall Study|Subject discontinued for other reason|2|||
160942386|NCT00414050|581178527|FG002|Overall Study|Subject discontinued for other reason|2|||
160942387|NCT00414050|581178528|FG003|Overall Study|Subject discontinued for other reason|1|||
160942388|NCT00414050|581178525|FG000|Overall Study|Subject Moved|0|||
160942389|NCT00414050|581178526|FG001|Overall Study|Subject Moved|0|||
160942390|NCT00414050|581178527|FG002|Overall Study|Subject Moved|0|||
161144439|NCT00151411|581913899|FG000|Overall Study|Pregnancy|0|||
161144440|NCT00151411|581913900|FG001|Overall Study|Pregnancy|4|||
160942391|NCT00414050|581178528|FG003|Overall Study|Subject Moved|1|||
160942392|NCT02550652|581178535|FG000|Overall Study|Death|1|||
160942393|NCT02550652|581178536|FG001|Overall Study|Death|4|||
160942394|NCT02550652|581178535|FG000|Overall Study|Lack of Efficacy|1|||
160942395|NCT02550652|581178536|FG001|Overall Study|Lack of Efficacy|0|||
160942396|NCT02550652|581178535|FG000|Overall Study|Withdrawal by Subject|4|||
160942397|NCT02550652|581178536|FG001|Overall Study|Withdrawal by Subject|7|||
160942398|NCT02550652|581178535|FG000|Overall Study|Post Trial Access|1|||
160942399|NCT02550652|581178536|FG001|Overall Study|Post Trial Access|0|||
160942400|NCT02550652|581178535|FG000|Overall Study|Lost to Follow-up|1|||
160942401|NCT02550652|581178536|FG001|Overall Study|Lost to Follow-up|3|||
160942402|NCT02550652|581178535|FG000|Overall Study|Physician Decision|0|||
160942403|NCT02550652|581178536|FG001|Overall Study|Physician Decision|2|||
160942404|NCT02550652|581178535|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
160942405|NCT02550652|581178536|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
160942406|NCT01706250|581178537|FG000|Overall Study|Lost to Follow-up|2|||
160942407|NCT00515827|581178543|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
160942408|NCT00515827|581178544|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
160942409|NCT00515827|581178543|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
160942410|NCT00515827|581178544|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
160942411|NCT03254134|581178546|FG000|Overall Study|Not eligible patients|599|||
160942412|NCT03254134|581178547|FG001|Overall Study|Not eligible patients|3630|||
160942413|NCT00205712|581178548|FG000|Overall Study|Lost to Follow-up|0|||
160942414|NCT00205712|581178549|FG001|Overall Study|Lost to Follow-up|1|||
160942415|NCT01009099|581178550|FG000|Overall Study|Lost to Follow-up|1|||
160942416|NCT01009099|581178551|FG001|Overall Study|Lost to Follow-up|0|||
160942417|NCT01009099|581178550|FG000|Overall Study|Physician Decision|3|||
160942418|NCT01009099|581178551|FG001|Overall Study|Physician Decision|2|||
160942419|NCT01009099|581178550|FG000|Overall Study|Withdrawal by Subject|1|||
160942420|NCT01009099|581178551|FG001|Overall Study|Withdrawal by Subject|1|||
160942421|NCT01009099|581178550|FG000|Overall Study|Death|0|||
160942422|NCT01009099|581178551|FG001|Overall Study|Death|1|||
160942423|NCT01712984|581178552|FG000|Overall Study|Adverse Event|0|||
160942424|NCT01712984|581178553|FG001|Overall Study|Adverse Event|0|||
160942425|NCT01712984|581178554|FG002|Overall Study|Adverse Event|1|||
160942426|NCT01712984|581178552|FG000|Overall Study|Protocol Violation|2|||
160942427|NCT01712984|581178553|FG001|Overall Study|Protocol Violation|0|||
160942428|NCT01712984|581178554|FG002|Overall Study|Protocol Violation|1|||
160942429|NCT01712984|581178552|FG000|Overall Study|Lost to Follow-up|8|||
160942430|NCT01712984|581178553|FG001|Overall Study|Lost to Follow-up|10|||
160942431|NCT01712984|581178554|FG002|Overall Study|Lost to Follow-up|1|||
160942432|NCT01712984|581178552|FG000|Overall Study|Withdrawal by Subject|6|||
160942433|NCT01712984|581178553|FG001|Overall Study|Withdrawal by Subject|6|||
160942434|NCT01712984|581178554|FG002|Overall Study|Withdrawal by Subject|7|||
160942435|NCT00096044|581178557|FG000|Overall Study|Withdrawal by Subject|9|||
160942436|NCT00096044|581178557|FG000|Overall Study|Adverse Event|21|||
160942437|NCT00096044|581178557|FG000|Overall Study|Disease Progression|4|||
160942438|NCT03149237|581178558|FG000|Overall Study|Withdrawal by Subject|4|||
160942439|NCT03149237|581178559|FG001|Overall Study|Withdrawal by Subject|5|||
160942440|NCT02442830|581178560|FG000|Overall Study|Technical Failure|0|||
160942441|NCT02442830|581178561|FG001|Overall Study|Technical Failure|1|||
160942442|NCT04587193|581178562|FG000|Overall Study|Screen failure after consent|3|||
160942443|NCT04587193|581178563|FG001|Overall Study|Screen failure after consent|0|||
160942444|NCT04587193|581178562|FG000|Overall Study|Device broke during study|3|||
160942445|NCT04587193|581178563|FG001|Overall Study|Device broke during study|2|||
160942446|NCT00508742|581178564|FG000|Period 1: Infant Series|Adverse Event|5|||
161144441|NCT00417612|581913901|FG000|Overall Study|Errant diagnosis|0|||
161144442|NCT00417612|581913902|FG001|Overall Study|Errant diagnosis|1|||
160942447|NCT00508742|581178565|FG001|Period 1: Infant Series|Adverse Event|4|||
160942448|NCT00508742|581178564|FG000|Period 1: Infant Series|Protocol Violation|1|||
160942449|NCT00508742|581178565|FG001|Period 1: Infant Series|Protocol Violation|0|||
160942450|NCT00508742|581178564|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
160942451|NCT00508742|581178565|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
160942452|NCT00508742|581178564|FG000|Period 1: Infant Series|Physician Decision|1|||
160942453|NCT00508742|581178565|FG001|Period 1: Infant Series|Physician Decision|0|||
160942454|NCT00508742|581178564|FG000|Period 1: Infant Series|Other|4|||
160942455|NCT00508742|581178565|FG001|Period 1: Infant Series|Other|1|||
160942456|NCT00508742|581178564|FG000|Period 2: After Infant Series|Adverse Event|2|||
160942457|NCT00508742|581178565|FG001|Period 2: After Infant Series|Adverse Event|6|||
160942458|NCT00508742|581178564|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
160942459|NCT00508742|581178565|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
160942460|NCT00508742|581178564|FG000|Period 2: After Infant Series|Protocol Violation|1|||
160942461|NCT00508742|581178565|FG001|Period 2: After Infant Series|Protocol Violation|0|||
160942462|NCT00508742|581178564|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
160942463|NCT00508742|581178565|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
160942464|NCT00508742|581178564|FG000|Period 2: After Infant Series|Failed to Return|1|||
160942465|NCT00508742|581178565|FG001|Period 2: After Infant Series|Failed to Return|0|||
160942466|NCT00508742|581178564|FG000|Period 2: After Infant Series|Other|2|||
160942467|NCT00508742|581178565|FG001|Period 2: After Infant Series|Other|1|||
160942468|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Adverse Event|1|||
160942469|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Adverse Event|0|||
160942470|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
160942471|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
160942472|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
160942473|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
160942474|NCT00508742|581178564|FG000|Period 3: Toddler Dose|Other|5|||
160942475|NCT00508742|581178565|FG001|Period 3: Toddler Dose|Other|4|||
160942476|NCT02501096|581178566|FG000|Overall Study|Lost to Follow-up|0|||
160942477|NCT02501096|581178567|FG001|Overall Study|Lost to Follow-up|0|||
160942478|NCT02501096|581178568|FG002|Overall Study|Lost to Follow-up|0|||
160942479|NCT02501096|581178569|FG003|Overall Study|Lost to Follow-up|0|||
160942480|NCT02501096|581178570|FG004|Overall Study|Lost to Follow-up|1|||
160942481|NCT02501096|581178571|FG005|Overall Study|Lost to Follow-up|1|||
160942482|NCT02501096|581178572|FG006|Overall Study|Lost to Follow-up|3|||
160942483|NCT02501096|581178573|FG007|Overall Study|Lost to Follow-up|0|||
160942484|NCT02501096|581178574|FG008|Overall Study|Lost to Follow-up|0|||
160942485|NCT02501096|581178566|FG000|Overall Study|Withdrawal by Subject|1|||
160942486|NCT02501096|581178567|FG001|Overall Study|Withdrawal by Subject|0|||
160942487|NCT02501096|581178568|FG002|Overall Study|Withdrawal by Subject|7|||
160942488|NCT02501096|581178569|FG003|Overall Study|Withdrawal by Subject|13|||
160942489|NCT02501096|581178570|FG004|Overall Study|Withdrawal by Subject|2|||
160942490|NCT02501096|581178571|FG005|Overall Study|Withdrawal by Subject|2|||
160942491|NCT02501096|581178572|FG006|Overall Study|Withdrawal by Subject|2|||
160942492|NCT02501096|581178573|FG007|Overall Study|Withdrawal by Subject|3|||
160942493|NCT02501096|581178574|FG008|Overall Study|Withdrawal by Subject|0|||
160942494|NCT02501096|581178566|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
160942495|NCT02501096|581178567|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
160942496|NCT02501096|581178568|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
160942497|NCT02501096|581178569|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
160942498|NCT02501096|581178570|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
160942499|NCT02501096|581178571|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
160942500|NCT02501096|581178572|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
160942501|NCT02501096|581178573|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
160942502|NCT02501096|581178574|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
160942503|NCT02501096|581178566|FG000|Overall Study|Death|1|||
160942504|NCT02501096|581178567|FG001|Overall Study|Death|1|||
160942505|NCT02501096|581178568|FG002|Overall Study|Death|88|||
160942506|NCT02501096|581178569|FG003|Overall Study|Death|74|||
160942507|NCT02501096|581178570|FG004|Overall Study|Death|15|||
160942508|NCT02501096|581178571|FG005|Overall Study|Death|16|||
160942509|NCT02501096|581178572|FG006|Overall Study|Death|15|||
160942510|NCT02501096|581178573|FG007|Overall Study|Death|16|||
160942511|NCT02501096|581178574|FG008|Overall Study|Death|1|||
160942512|NCT00437034|581178575|FG000|Overall Study|Adverse Event|1|||
160942513|NCT00437034|581178575|FG000|Overall Study|Disease progression during treatment|5|||
160942514|NCT00595582|581178576|FG000|Overall Study|Pilot study that PI terminated|2|||
160942515|NCT00595582|581178576|FG000|Overall Study|Lost to Follow-up|1|||
160942516|NCT00595582|581178576|FG000|Overall Study|Adverse Event|2|||
160942517|NCT00595582|581178576|FG000|Overall Study|Physician Decision|5|||
160942518|NCT03878134|581178577|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
160942519|NCT00586469|581178578|FG000|Overall Study|Adverse Event|0|||
160942520|NCT00586469|581178579|FG001|Overall Study|Adverse Event|1|||
160942521|NCT04055116|581178580|FG000|First Intervention|Physician Decision|2|||
160942522|NCT04055116|581178581|FG001|First Intervention|Physician Decision|7|||
160942523|NCT01978184|581178582|FG000|Overall Study|Progressive disease|5|||
160942524|NCT01978184|581178583|FG001|Overall Study|Progressive disease|5|||
160942525|NCT01978184|581178582|FG000|Overall Study|Other than PDA|2|||
160942526|NCT01978184|581178583|FG001|Overall Study|Other than PDA|2|||
160942527|NCT01978184|581178582|FG000|Overall Study|Physician Decision|0|||
160942528|NCT01978184|581178583|FG001|Overall Study|Physician Decision|3|||
160942529|NCT01978184|581178582|FG000|Overall Study|Noncompliance|1|||
161265443|NCT01951885|582354048|FG001|Overall Study|ineligible due to a change in donor|1|||
161265444|NCT01951885|582354047|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
161265445|NCT01951885|582354048|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
161265446|NCT01687478|582354049|FG000|Overall Study|Adverse Event|3|||
161265447|NCT01687478|582354050|FG001|Overall Study|Adverse Event|10|||
161265448|NCT01687478|582354049|FG000|Overall Study|Lost to Follow-up|1|||
161265449|NCT01687478|582354050|FG001|Overall Study|Lost to Follow-up|3|||
161265450|NCT01687478|582354049|FG000|Overall Study|Protocol Violation|0|||
161265451|NCT01687478|582354050|FG001|Overall Study|Protocol Violation|2|||
161265452|NCT01687478|582354049|FG000|Overall Study|Withdrawal by Subject|21|||
161265453|NCT01687478|582354050|FG001|Overall Study|Withdrawal by Subject|19|||
161265454|NCT01687478|582354049|FG000|Overall Study|Physician Decision|1|||
161265455|NCT01687478|582354050|FG001|Overall Study|Physician Decision|3|||
161265456|NCT01687478|582354049|FG000|Overall Study|Entry Criteria Not Met|6|||
161265457|NCT01687478|582354050|FG001|Overall Study|Entry Criteria Not Met|2|||
161265458|NCT03188718|582354051|FG000|Overall Study|Participant noncompliance|4|||
161265459|NCT03188718|582354051|FG000|Overall Study|Withdrawal by Subject|1|||
161265460|NCT03188718|582354051|FG000|Overall Study|Device failure|3|||
161265461|NCT04322149|582354052|FG000|Overall Study|Adverse Event|1|||
161265462|NCT04322149|582354053|FG001|Overall Study|Adverse Event|1|||
161265463|NCT04322149|582354054|FG002|Overall Study|Adverse Event|0|||
161265464|NCT04322149|582354055|FG003|Overall Study|Adverse Event|0|||
161265465|NCT04322149|582354052|FG000|Overall Study|Withdrawal by Subject|0|||
161265466|NCT04322149|582354053|FG001|Overall Study|Withdrawal by Subject|0|||
161265467|NCT04322149|582354054|FG002|Overall Study|Withdrawal by Subject|0|||
161265468|NCT04322149|582354055|FG003|Overall Study|Withdrawal by Subject|2|||
161265469|NCT04322149|582354052|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161265470|NCT04322149|582354053|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
161265471|NCT04322149|582354054|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161265472|NCT04322149|582354055|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
161265473|NCT01700049|582354062|FG000|Overall Study|Withdrawal by Subject|1|||
161265474|NCT00792935|582354063|FG000|Overall Study|Adverse Event|2|||
161265475|NCT00792935|582354064|FG001|Overall Study|Adverse Event|1|||
161265476|NCT00792935|582354063|FG000|Overall Study|Lost to Follow-up|0|||
161265477|NCT00792935|582354064|FG001|Overall Study|Lost to Follow-up|1|||
161265478|NCT00792935|582354063|FG000|Overall Study|Protocol Violation|2|||
161265479|NCT00792935|582354064|FG001|Overall Study|Protocol Violation|0|||
161265480|NCT00792935|582354063|FG000|Overall Study|Withdrawal by Subject|0|||
161265481|NCT00792935|582354064|FG001|Overall Study|Withdrawal by Subject|1|||
161265482|NCT01155024|582354072|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
161265483|NCT01155024|582354073|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
161265484|NCT01155024|582354072|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
161265485|NCT01155024|582354073|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
161265486|NCT01155024|582354072|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
161265487|NCT01155024|582354073|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
161265488|NCT01593696|582354074|FG000|Dose Escalation|Progressive Disease|2|||
161265489|NCT01593696|582354075|FG001|Dose Escalation|Progressive Disease|0|||
161265490|NCT01593696|582354076|FG002|Dose Escalation|Progressive Disease|0|||
161265491|NCT01593696|582354077|FG003|Dose Escalation|Progressive Disease|0|||
161265492|NCT01593696|582354074|FG000|Dose Expansion|Fungal infection|0|||
161265493|NCT01593696|582354075|FG001|Dose Expansion|Fungal infection|0|||
160942530|NCT01978184|581178583|FG001|Overall Study|Noncompliance|2|||
160942531|NCT01978184|581178582|FG000|Overall Study|Death|1|||
160942532|NCT01978184|581178583|FG001|Overall Study|Death|0|||
161265494|NCT01593696|582354076|FG002|Dose Expansion|Fungal infection|1|||
161265495|NCT01593696|582354077|FG003|Dose Expansion|Fungal infection|0|||
161265496|NCT00369655|582354078|FG000|Overall Study|Refusal of further treatment|2|||
161265497|NCT03402750|582354079|FG000|Overall Study|Lost to Follow-up|2|||
161265498|NCT03402750|582354080|FG001|Overall Study|Lost to Follow-up|1|||
161265499|NCT02981303|582354081|FG000|Overall Study|Progressive Disease|17|||
161265500|NCT02981303|582354082|FG001|Overall Study|Progressive Disease|37|||
161265501|NCT02981303|582354081|FG000|Overall Study|Adverse Event|1|||
160942533|NCT01978184|581178582|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
160942534|NCT01978184|581178583|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
161265502|NCT02981303|582354082|FG001|Overall Study|Adverse Event|4|||
161265503|NCT02981303|582354081|FG000|Overall Study|Withdrawal by Subject|0|||
161265504|NCT02981303|582354082|FG001|Overall Study|Withdrawal by Subject|1|||
161265505|NCT00848107|582354083|FG000|Overall Study|Lost to Follow-up|2|||
161265506|NCT00848107|582354083|FG000|Overall Study|Withdrawal by Subject|8|||
161265507|NCT00848107|582354083|FG000|Overall Study|Adverse Event|9|||
161265508|NCT00848107|582354083|FG000|Overall Study|Death|1|||
161265509|NCT00848107|582354083|FG000|Overall Study|Pregnancy|1|||
161265510|NCT00762437|582354084|FG000|Overall Study|Lost to Follow-up|7|||
161265511|NCT00762437|582354084|FG000|Overall Study|Missed final study visit|11|||
161265512|NCT00762437|582354084|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
161265513|NCT00302081|582354088|FG000|Overall Study|Adverse Event|6|||
161265514|NCT00302081|582354089|FG001|Overall Study|Adverse Event|5|||
161265515|NCT00302081|582354090|FG002|Overall Study|Adverse Event|4|||
161265516|NCT00302081|582354088|FG000|Overall Study|Lost to Follow-up|21|||
161265517|NCT00302081|582354089|FG001|Overall Study|Lost to Follow-up|18|||
161265518|NCT00302081|582354090|FG002|Overall Study|Lost to Follow-up|28|||
161265519|NCT00302081|582354088|FG000|Overall Study|Withdrawal by Subject|8|||
161265520|NCT00302081|582354089|FG001|Overall Study|Withdrawal by Subject|12|||
161265521|NCT00302081|582354090|FG002|Overall Study|Withdrawal by Subject|8|||
161265522|NCT00302081|582354088|FG000|Overall Study|Protocol Violation|5|||
161265523|NCT00302081|582354089|FG001|Overall Study|Protocol Violation|1|||
161265524|NCT00302081|582354090|FG002|Overall Study|Protocol Violation|2|||
161265525|NCT00302081|582354088|FG000|Overall Study|Lack of Efficacy|1|||
161265526|NCT00302081|582354089|FG001|Overall Study|Lack of Efficacy|0|||
161265527|NCT00302081|582354090|FG002|Overall Study|Lack of Efficacy|5|||
161265528|NCT00302081|582354088|FG000|Overall Study|Death|2|||
161265529|NCT00302081|582354089|FG001|Overall Study|Death|1|||
161265530|NCT00302081|582354090|FG002|Overall Study|Death|0|||
161265531|NCT00302081|582354088|FG000|Overall Study|Other|13|||
161265532|NCT00302081|582354089|FG001|Overall Study|Other|6|||
161265533|NCT00302081|582354090|FG002|Overall Study|Other|5|||
161265534|NCT04771403|582354091|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
161265535|NCT04771403|582354092|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
161265536|NCT04771403|582354091|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
160942535|NCT02770391|581178584|FG000|Overall Study|Lost to Follow-up|2|||
160942536|NCT02770391|581178584|FG000|Overall Study|Withdrawal by Subject|1|||
160942537|NCT02770391|581178584|FG000|Overall Study|Surgery delayed unevaluable|2|||
160942538|NCT02770391|581178584|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
160942539|NCT01976845|581178587|FG000|Overall Study|Physician Decision|8|||
160942540|NCT01976845|581178588|FG001|Overall Study|Physician Decision|8|||
160942541|NCT01976845|581178589|FG002|Overall Study|Physician Decision|3|||
160942542|NCT04258839|581179846|FG000|Overall Study|Adverse Event|2|||
160942543|NCT04258839|581179847|FG001|Overall Study|Adverse Event|4|||
160942544|NCT04258839|581179846|FG000|Overall Study|Lack of Efficacy|0|||
160942545|NCT04258839|581179847|FG001|Overall Study|Lack of Efficacy|2|||
160942546|NCT04258839|581179846|FG000|Overall Study|Lost to Follow-up|2|||
160942547|NCT04258839|581179847|FG001|Overall Study|Lost to Follow-up|0|||
160942548|NCT04258839|581179846|FG000|Overall Study|Withdrawal by Subject|1|||
160942549|NCT04258839|581179847|FG001|Overall Study|Withdrawal by Subject|2|||
160942550|NCT04258839|581179846|FG000|Overall Study|Withdrawal by Caregiver|5|||
160942551|NCT04258839|581179847|FG001|Overall Study|Withdrawal by Caregiver|6|||
160942552|NCT04258839|581179846|FG000|Overall Study|Reason not Specified|0|||
160942553|NCT04258839|581179847|FG001|Overall Study|Reason not Specified|1|||
160942554|NCT02293005|581179848|FG000|Overall Study|Adverse Event|2|||
160942555|NCT02293005|581179848|FG000|Overall Study|Death|4|||
160942556|NCT02293005|581179848|FG000|Overall Study|Lost to Follow-up|1|||
160942557|NCT02293005|581179848|FG000|Overall Study|Withdrawal by Subject|2|||
160942558|NCT02293005|581179848|FG000|Overall Study|Progression|17|||
160999072|NCT04248829|581380675|FG000|Overall Study|Withdrawal by Subject|11|||
160942559|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Adverse Event|4|||
160942560|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Adverse Event|1|||
160999073|NCT04248829|581380676|FG001|Overall Study|Withdrawal by Subject|2|||
160942561|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Adverse Event|1|||
160942562|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
160999074|NCT04248829|581380675|FG000|Overall Study|Lost to Follow-up|0|||
160999075|NCT04248829|581380676|FG001|Overall Study|Lost to Follow-up|1|||
161265537|NCT04771403|582354092|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
161265538|NCT04771403|582354091|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
161265539|NCT04771403|582354092|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
160942563|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
160942564|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
160942565|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Pregnancy|3|||
160999076|NCT04248829|581380675|FG000|Overall Study|Death|12|||
160942566|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Pregnancy|0|||
160942567|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Pregnancy|0|||
160942568|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
160942569|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
160942570|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
160942571|NCT03328897|581179849|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
160942572|NCT03328897|581179850|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
160942573|NCT03328897|581179851|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
160942574|NCT03328897|581179849|FG000|Follow-up Epoch|Adverse Event|4|||
160942575|NCT03328897|581179850|FG001|Follow-up Epoch|Adverse Event|0|||
160942576|NCT03328897|581179851|FG002|Follow-up Epoch|Adverse Event|1|||
160942577|NCT03328897|581179849|FG000|Follow-up Epoch|Lack of Efficacy|1|||
160942578|NCT03328897|581179850|FG001|Follow-up Epoch|Lack of Efficacy|1|||
160942579|NCT03328897|581179851|FG002|Follow-up Epoch|Lack of Efficacy|1|||
160942580|NCT03328897|581179849|FG000|Follow-up Epoch|Lost to Follow-up|0|||
160942581|NCT03328897|581179850|FG001|Follow-up Epoch|Lost to Follow-up|1|||
160942582|NCT03328897|581179851|FG002|Follow-up Epoch|Lost to Follow-up|0|||
160942583|NCT03328897|581179849|FG000|Follow-up Epoch|Pregnancy|1|||
160942584|NCT03328897|581179850|FG001|Follow-up Epoch|Pregnancy|0|||
160942585|NCT03328897|581179851|FG002|Follow-up Epoch|Pregnancy|0|||
160942586|NCT03328897|581179849|FG000|Follow-up Epoch|Patient/guardian decision|2|||
160942587|NCT03328897|581179850|FG001|Follow-up Epoch|Patient/guardian decision|1|||
160942588|NCT03328897|581179851|FG002|Follow-up Epoch|Patient/guardian decision|0|||
160942589|NCT00608829|581179852|FG000|Overall Study|Death|6|||
160942590|NCT00608829|581179852|FG000|Overall Study|Withdrawal by Subject|4|||
160942591|NCT00608829|581179852|FG000|Overall Study|Subject refuses to follow up or return.|5|||
160942592|NCT02648698|581179860|FG000|Overall Study|Protocol Violation|1|||
160942593|NCT02648698|581179861|FG001|Overall Study|Protocol Violation|5|||
160942594|NCT00672477|581179864|FG000|Overall Study|Adverse Event|10|||
160942595|NCT00672477|581179865|FG001|Overall Study|Adverse Event|7|||
160942596|NCT00672477|581179864|FG000|Overall Study|Death|7|||
160942597|NCT00672477|581179865|FG001|Overall Study|Death|11|||
160942598|NCT00672477|581179864|FG000|Overall Study|Physician Decision|2|||
160942599|NCT00672477|581179865|FG001|Overall Study|Physician Decision|0|||
160942600|NCT00672477|581179864|FG000|Overall Study|Protocol Violation|1|||
160942601|NCT00672477|581179865|FG001|Overall Study|Protocol Violation|1|||
160942602|NCT00672477|581179864|FG000|Overall Study|Withdrawal by Subject|5|||
160942603|NCT00672477|581179865|FG001|Overall Study|Withdrawal by Subject|3|||
160942604|NCT00672477|581179864|FG000|Overall Study|Lack of Efficacy|1|||
160942605|NCT00672477|581179865|FG001|Overall Study|Lack of Efficacy|1|||
160942606|NCT00672477|581179864|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
160942607|NCT00672477|581179865|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
160942608|NCT00938431|581179868|FG000|Overall Study|Adverse Event|5|||
160942609|NCT00938431|581179869|FG001|Overall Study|Adverse Event|8|||
160999077|NCT04248829|581380676|FG001|Overall Study|Death|14|||
160999078|NCT04248829|581380675|FG000|Overall Study|Physician Decision|2|||
160999079|NCT04248829|581380676|FG001|Overall Study|Physician Decision|4|||
160999080|NCT04248829|581380675|FG000|Overall Study|Any reason not specifically recorded|0|||
161144443|NCT00417612|581913901|FG000|Overall Study|Adverse Event|2|||
161144444|NCT00417612|581913902|FG001|Overall Study|Adverse Event|0|||
161144445|NCT00417612|581913901|FG000|Overall Study|Protocol Violation|0|||
161144446|NCT00417612|581913902|FG001|Overall Study|Protocol Violation|2|||
161144447|NCT00417612|581913901|FG000|Overall Study|Lost to Follow-up|1|||
161144448|NCT00417612|581913902|FG001|Overall Study|Lost to Follow-up|0|||
161144449|NCT01283581|581913905|FG000|Overall Study|Lost to Follow-up|8|||
161144450|NCT01283581|581913906|FG001|Overall Study|Lost to Follow-up|6|||
161144451|NCT01283581|581913907|FG002|Overall Study|Lost to Follow-up|8|||
161144452|NCT01283581|581913905|FG000|Overall Study|Withdrawal by Subject|2|||
161144453|NCT01283581|581913906|FG001|Overall Study|Withdrawal by Subject|5|||
161144454|NCT01283581|581913907|FG002|Overall Study|Withdrawal by Subject|2|||
161144455|NCT01283581|581913905|FG000|Overall Study|Adverse Event|1|||
160942610|NCT00938431|581179870|FG002|Overall Study|Adverse Event|6|||
160942611|NCT00938431|581179868|FG000|Overall Study|Lack of Efficacy|0|||
160942612|NCT00938431|581179869|FG001|Overall Study|Lack of Efficacy|1|||
160942613|NCT00938431|581179870|FG002|Overall Study|Lack of Efficacy|0|||
160942614|NCT00938431|581179868|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
160942615|NCT00938431|581179869|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
160942616|NCT00938431|581179870|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
160942617|NCT00938431|581179868|FG000|Overall Study|Dosing compliance issue|0|||
160999081|NCT04248829|581380676|FG001|Overall Study|Any reason not specifically recorded|2|||
160942618|NCT00938431|581179869|FG001|Overall Study|Dosing compliance issue|0|||
160999082|NCT02299336|581380677|FG000|Overall Study|Withdrawal by Subject|11|||
161144456|NCT01283581|581913906|FG001|Overall Study|Adverse Event|1|||
161144457|NCT01283581|581913907|FG002|Overall Study|Adverse Event|4|||
161144458|NCT01283581|581913905|FG000|Overall Study|Physician Decision|0|||
161144459|NCT01283581|581913906|FG001|Overall Study|Physician Decision|1|||
161144460|NCT01283581|581913907|FG002|Overall Study|Physician Decision|2|||
161144461|NCT01283581|581913905|FG000|Overall Study|Protocol Violation|0|||
160942619|NCT00938431|581179870|FG002|Overall Study|Dosing compliance issue|1|||
160942620|NCT00938431|581179868|FG000|Overall Study|Reached maximum dose early|0|||
160942621|NCT00938431|581179869|FG001|Overall Study|Reached maximum dose early|0|||
160942622|NCT00938431|581179870|FG002|Overall Study|Reached maximum dose early|1|||
160942623|NCT03738865|581179875|FG000|Overall Study|Withdrawal by Subject|3|||
160942624|NCT03738865|581179876|FG001|Overall Study|Withdrawal by Subject|3|||
160942625|NCT03738865|581179875|FG000|Overall Study|Adverse Event|2|||
160942626|NCT03738865|581179876|FG001|Overall Study|Adverse Event|0|||
160942627|NCT03738865|581179875|FG000|Overall Study|Physician Decision|0|||
160942628|NCT03738865|581179876|FG001|Overall Study|Physician Decision|1|||
160942629|NCT01175824|581179877|FG000|Overall Study|Adverse Event|2|||
161144462|NCT01283581|581913906|FG001|Overall Study|Protocol Violation|1|||
161144463|NCT01283581|581913907|FG002|Overall Study|Protocol Violation|2|||
161144464|NCT01283581|581913905|FG000|Overall Study|Noncompliance|1|||
161144465|NCT01283581|581913906|FG001|Overall Study|Noncompliance|0|||
161144466|NCT01283581|581913907|FG002|Overall Study|Noncompliance|0|||
161144467|NCT01283581|581913905|FG000|Overall Study|Investigator unblinded|0|||
161144468|NCT01283581|581913906|FG001|Overall Study|Investigator unblinded|0|||
161144469|NCT01283581|581913907|FG002|Overall Study|Investigator unblinded|1|||
161144470|NCT01283581|581913905|FG000|Overall Study|"Early termination"|0|||
161144471|NCT01283581|581913906|FG001|Overall Study|"Early termination"|0|||
161144472|NCT01283581|581913907|FG002|Overall Study|"Early termination"|1|||
161144473|NCT01712438|581913908|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
161144474|NCT01712438|581913908|FG000|Overall Study|Ongoing ITI treatment|6|||
161144475|NCT01712438|581913908|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
161144476|NCT01712438|581913908|FG000|Overall Study|Prematurely Discontinued|25|||
161144477|NCT02786537|581913909|FG000|As Randomized|Adverse Event|0|||
161144478|NCT02786537|581913910|FG001|As Randomized|Adverse Event|11|||
161144479|NCT02786537|581913911|FG002|As Randomized|Adverse Event|0|||
161144480|NCT02786537|581913912|FG003|As Randomized|Adverse Event|4|||
161144481|NCT02786537|581913913|FG004|As Randomized|Adverse Event|6|||
161144482|NCT02786537|581913914|FG005|As Randomized|Adverse Event|2|||
161144483|NCT02786537|581913909|FG000|As Randomized|Lack of Efficacy|0|||
161144484|NCT02786537|581913910|FG001|As Randomized|Lack of Efficacy|0|||
161144485|NCT02786537|581913911|FG002|As Randomized|Lack of Efficacy|0|||
161144486|NCT02786537|581913912|FG003|As Randomized|Lack of Efficacy|1|||
161144487|NCT02786537|581913913|FG004|As Randomized|Lack of Efficacy|0|||
161144488|NCT02786537|581913914|FG005|As Randomized|Lack of Efficacy|0|||
161144489|NCT02786537|581913909|FG000|As Randomized|Withdrawal by Subject|1|||
161144490|NCT02786537|581913910|FG001|As Randomized|Withdrawal by Subject|2|||
161144491|NCT02786537|581913911|FG002|As Randomized|Withdrawal by Subject|0|||
161144492|NCT02786537|581913912|FG003|As Randomized|Withdrawal by Subject|1|||
161144493|NCT02786537|581913913|FG004|As Randomized|Withdrawal by Subject|1|||
161144494|NCT02786537|581913914|FG005|As Randomized|Withdrawal by Subject|0|||
161144495|NCT02786537|581913909|FG000|As Randomized|Death|0|||
161144496|NCT02786537|581913910|FG001|As Randomized|Death|2|||
161144497|NCT02786537|581913911|FG002|As Randomized|Death|0|||
161144498|NCT02786537|581913912|FG003|As Randomized|Death|3|||
161144499|NCT02786537|581913913|FG004|As Randomized|Death|1|||
161144500|NCT02786537|581913914|FG005|As Randomized|Death|0|||
161144501|NCT02786537|581913909|FG000|As Randomized|Non-compliance with study drug|1|||
161144502|NCT02786537|581913910|FG001|As Randomized|Non-compliance with study drug|11|||
161144503|NCT02786537|581913911|FG002|As Randomized|Non-compliance with study drug|0|||
161144504|NCT02786537|581913912|FG003|As Randomized|Non-compliance with study drug|1|||
161144505|NCT02786537|581913913|FG004|As Randomized|Non-compliance with study drug|0|||
161144506|NCT02786537|581913914|FG005|As Randomized|Non-compliance with study drug|1|||
161144507|NCT02786537|581913909|FG000|As Randomized|Lost to treatment follow-up|4|||
161144508|NCT02786537|581913910|FG001|As Randomized|Lost to treatment follow-up|32|||
161144509|NCT02786537|581913911|FG002|As Randomized|Lost to treatment follow-up|0|||
161265540|NCT04771403|582354091|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
161265541|NCT04771403|582354092|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
161265542|NCT04771403|582354091|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
161319360|NCT01884545|582555288|FG003|Overall Study|Patient withdrawn|5|||
160942630|NCT01175824|581179878|FG001|Overall Study|Adverse Event|1|||
161144510|NCT02786537|581913912|FG003|As Randomized|Lost to treatment follow-up|24|||
161144511|NCT02786537|581913913|FG004|As Randomized|Lost to treatment follow-up|4|||
161144512|NCT02786537|581913914|FG005|As Randomized|Lost to treatment follow-up|4|||
161144513|NCT02786537|581913909|FG000|As Randomized|Incarceration|0|||
161144514|NCT02786537|581913910|FG001|As Randomized|Incarceration|1|||
161144515|NCT02786537|581913911|FG002|As Randomized|Incarceration|0|||
161144516|NCT02786537|581913912|FG003|As Randomized|Incarceration|0|||
161144517|NCT02786537|581913913|FG004|As Randomized|Incarceration|0|||
161144518|NCT02786537|581913914|FG005|As Randomized|Incarceration|0|||
161144519|NCT02786537|581913909|FG000|As Randomized|Opiate Dependency Relapse|0|||
161144520|NCT02786537|581913910|FG001|As Randomized|Opiate Dependency Relapse|1|||
161144521|NCT02786537|581913911|FG002|As Randomized|Opiate Dependency Relapse|0|||
160942631|NCT01175824|581179877|FG000|Overall Study|Lack of Efficacy|2|||
161265543|NCT04771403|582354092|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
161265544|NCT04771403|582354091|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
161265545|NCT04771403|582354092|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
161265546|NCT04771403|582354091|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
161265547|NCT04771403|582354092|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
161265548|NCT04771403|582354091|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
161265549|NCT04771403|582354092|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
161265550|NCT00857259|582354093|FG000|Overall Study|Protocol Violation|1|||
161265551|NCT00857259|582354094|FG001|Overall Study|Protocol Violation|0|||
161265552|NCT00857259|582354095|FG002|Overall Study|Protocol Violation|1|||
161265553|NCT02701413|582354096|FG000|Overall Study|Withdrawal by Subject|7|||
161265554|NCT02701413|582354097|FG001|Overall Study|Withdrawal by Subject|11|||
161265555|NCT02138136|582354098|FG000|Overall Study|Protocol Violation|4|||
161265556|NCT02138136|582354098|FG000|Overall Study|Physician Decision|7|||
161265557|NCT02138136|582354098|FG000|Overall Study|Lack of Efficacy|35|||
161265558|NCT02138136|582354098|FG000|Overall Study|Pregnancy|2|||
161265559|NCT02138136|582354098|FG000|Overall Study|Adverse Event|18|||
161265560|NCT02138136|582354098|FG000|Overall Study|Withdrawal by Subject|36|||
161265561|NCT02138136|582354098|FG000|Overall Study|Lost to Follow-up|32|||
161265562|NCT02138136|582354098|FG000|Overall Study|Withdrawn by Sponsor|5|||
161265563|NCT01359644|582354103|FG000|Treatment Period|Lack of Efficacy|0|||
161265564|NCT01359644|582354104|FG001|Treatment Period|Lack of Efficacy|1|||
161265565|NCT01359644|582354105|FG002|Treatment Period|Lack of Efficacy|0|||
161265566|NCT01359644|582354106|FG003|Treatment Period|Lack of Efficacy|0|||
161265567|NCT01359644|582354107|FG004|Treatment Period|Lack of Efficacy|0|||
161265568|NCT01359644|582354108|FG005|Treatment Period|Lack of Efficacy|0|||
161265569|NCT01359644|582354109|FG006|Treatment Period|Lack of Efficacy|0|||
161265570|NCT01359644|582354110|FG007|Treatment Period|Lack of Efficacy|0|||
161265571|NCT01359644|582354111|FG008|Treatment Period|Lack of Efficacy|0|||
161265572|NCT01359644|582354112|FG009|Treatment Period|Lack of Efficacy|0|||
161265573|NCT01359644|582354103|FG000|Treatment Period|Adverse Event|0|||
161265574|NCT01359644|582354104|FG001|Treatment Period|Adverse Event|0|||
161265575|NCT01359644|582354105|FG002|Treatment Period|Adverse Event|1|||
161265576|NCT01359644|582354106|FG003|Treatment Period|Adverse Event|0|||
161265577|NCT01359644|582354107|FG004|Treatment Period|Adverse Event|0|||
161265578|NCT01359644|582354108|FG005|Treatment Period|Adverse Event|1|||
161265579|NCT01359644|582354109|FG006|Treatment Period|Adverse Event|0|||
161265580|NCT01359644|582354110|FG007|Treatment Period|Adverse Event|0|||
161265581|NCT01359644|582354111|FG008|Treatment Period|Adverse Event|0|||
161265582|NCT01359644|582354112|FG009|Treatment Period|Adverse Event|0|||
161265583|NCT01359644|582354103|FG000|Treatment Period|Lost to Follow-up|0|||
161265584|NCT01359644|582354104|FG001|Treatment Period|Lost to Follow-up|0|||
161265585|NCT01359644|582354105|FG002|Treatment Period|Lost to Follow-up|0|||
161265586|NCT01359644|582354106|FG003|Treatment Period|Lost to Follow-up|0|||
161265587|NCT01359644|582354107|FG004|Treatment Period|Lost to Follow-up|0|||
161265588|NCT01359644|582354108|FG005|Treatment Period|Lost to Follow-up|1|||
161265589|NCT01359644|582354109|FG006|Treatment Period|Lost to Follow-up|0|||
161265590|NCT01359644|582354110|FG007|Treatment Period|Lost to Follow-up|0|||
161265591|NCT01359644|582354111|FG008|Treatment Period|Lost to Follow-up|0|||
161265592|NCT01359644|582354112|FG009|Treatment Period|Lost to Follow-up|0|||
161265593|NCT01359644|582354103|FG000|Follow-up Period|Withdrawal by Subject|0|||
161265594|NCT01359644|582354104|FG001|Follow-up Period|Withdrawal by Subject|0|||
161265595|NCT01359644|582354105|FG002|Follow-up Period|Withdrawal by Subject|0|||
161265596|NCT01359644|582354106|FG003|Follow-up Period|Withdrawal by Subject|0|||
161265597|NCT01359644|582354107|FG004|Follow-up Period|Withdrawal by Subject|0|||
161265598|NCT01359644|582354108|FG005|Follow-up Period|Withdrawal by Subject|1|||
161265599|NCT01359644|582354109|FG006|Follow-up Period|Withdrawal by Subject|0|||
161265600|NCT01359644|582354110|FG007|Follow-up Period|Withdrawal by Subject|0|||
160942632|NCT01175824|581179878|FG001|Overall Study|Lack of Efficacy|0|||
160942633|NCT01175824|581179877|FG000|Overall Study|Lost to Follow-up|0|||
160942634|NCT01175824|581179878|FG001|Overall Study|Lost to Follow-up|1|||
160942635|NCT01175824|581179877|FG000|Overall Study|Physician Decision|0|||
160942636|NCT01175824|581179878|FG001|Overall Study|Physician Decision|4|||
161265601|NCT01359644|582354111|FG008|Follow-up Period|Withdrawal by Subject|0|||
160942637|NCT01175824|581179877|FG000|Overall Study|Protocol Violation|2|||
160942638|NCT01175824|581179878|FG001|Overall Study|Protocol Violation|5|||
160942639|NCT01175824|581179877|FG000|Overall Study|Withdrawal by Subject|3|||
161265602|NCT01359644|582354112|FG009|Follow-up Period|Withdrawal by Subject|0|||
161265603|NCT01359644|582354103|FG000|Follow-up Period|Lost to Follow-up|0|||
161265604|NCT01359644|582354104|FG001|Follow-up Period|Lost to Follow-up|0|||
161265605|NCT01359644|582354105|FG002|Follow-up Period|Lost to Follow-up|0|||
161265606|NCT01359644|582354106|FG003|Follow-up Period|Lost to Follow-up|0|||
160942640|NCT01175824|581179878|FG001|Overall Study|Withdrawal by Subject|7|||
160942641|NCT01175824|581179877|FG000|Overall Study|Sponsor Decision|1|||
161144522|NCT02786537|581913912|FG003|As Randomized|Opiate Dependency Relapse|0|||
161144523|NCT02786537|581913913|FG004|As Randomized|Opiate Dependency Relapse|0|||
161144524|NCT02786537|581913914|FG005|As Randomized|Opiate Dependency Relapse|0|||
161144525|NCT02786537|581913909|FG000|As Randomized|HCV drugs stolen from pt|0|||
161144526|NCT02786537|581913910|FG001|As Randomized|HCV drugs stolen from pt|1|||
161144527|NCT02786537|581913911|FG002|As Randomized|HCV drugs stolen from pt|0|||
161144528|NCT02786537|581913912|FG003|As Randomized|HCV drugs stolen from pt|0|||
161144529|NCT02786537|581913913|FG004|As Randomized|HCV drugs stolen from pt|0|||
161144530|NCT02786537|581913914|FG005|As Randomized|HCV drugs stolen from pt|0|||
160942642|NCT01175824|581179878|FG001|Overall Study|Sponsor Decision|0|||
160942643|NCT01175824|581179877|FG000|Overall Study|Entry Criteria Not Met|6|||
160942644|NCT01175824|581179878|FG001|Overall Study|Entry Criteria Not Met|4|||
160942645|NCT03455855|581179879|FG000|Overall Study|Lost to Follow-up|4|||
160942646|NCT03455855|581179880|FG001|Overall Study|Lost to Follow-up|2|||
160942647|NCT01774903|581179881|FG000|Overall Study|Adverse Event|7|||
160942648|NCT01774903|581179881|FG000|Overall Study|Withdrawal by Subject|2|||
160942649|NCT01774903|581179881|FG000|Overall Study|Lack of Efficacy|1|||
160942650|NCT01774903|581179881|FG000|Overall Study|Ineligible to continue the trial|1|||
160942651|NCT00924950|581179882|FG000|Overall Study|Lost to Follow-up|2|||
160942652|NCT01602315|581179883|FG000|Overall Study|Protocol Violation|0|||
160942653|NCT01602315|581179884|FG001|Overall Study|Protocol Violation|0|||
161144531|NCT02786537|581913909|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
161144532|NCT02786537|581913910|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
161144533|NCT02786537|581913911|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
161144534|NCT02786537|581913912|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
161144535|NCT02786537|581913913|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
161144536|NCT02786537|581913914|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
161144537|NCT02786537|581913909|FG000|As Randomized|Subject lost insurance|0|||
161144538|NCT02786537|581913910|FG001|As Randomized|Subject lost insurance|0|||
161144539|NCT02786537|581913911|FG002|As Randomized|Subject lost insurance|0|||
161144540|NCT02786537|581913912|FG003|As Randomized|Subject lost insurance|1|||
161144541|NCT02786537|581913913|FG004|As Randomized|Subject lost insurance|0|||
161144542|NCT02786537|581913914|FG005|As Randomized|Subject lost insurance|0|||
161144543|NCT02786537|581913909|FG000|As Treated|Adverse Event|0|||
161144544|NCT02786537|581913910|FG001|As Treated|Adverse Event|11|||
161144545|NCT02786537|581913911|FG002|As Treated|Adverse Event|0|||
161144546|NCT02786537|581913912|FG003|As Treated|Adverse Event|4|||
161144547|NCT02786537|581913913|FG004|As Treated|Adverse Event|6|||
161144548|NCT02786537|581913914|FG005|As Treated|Adverse Event|2|||
161144549|NCT02786537|581913909|FG000|As Treated|Death|0|||
161144550|NCT02786537|581913910|FG001|As Treated|Death|2|||
161144551|NCT02786537|581913911|FG002|As Treated|Death|0|||
161144552|NCT02786537|581913912|FG003|As Treated|Death|3|||
161144553|NCT02786537|581913913|FG004|As Treated|Death|1|||
161144554|NCT02786537|581913914|FG005|As Treated|Death|0|||
161144555|NCT02786537|581913909|FG000|As Treated|Lack of Efficacy|0|||
161144556|NCT02786537|581913910|FG001|As Treated|Lack of Efficacy|0|||
161144557|NCT02786537|581913911|FG002|As Treated|Lack of Efficacy|0|||
161144558|NCT02786537|581913912|FG003|As Treated|Lack of Efficacy|1|||
161265607|NCT01359644|582354107|FG004|Follow-up Period|Lost to Follow-up|0|||
160942654|NCT01602315|581179885|FG002|Overall Study|Protocol Violation|0|||
160942655|NCT01602315|581179886|FG003|Overall Study|Protocol Violation|0|||
160942656|NCT01602315|581179887|FG004|Overall Study|Protocol Violation|0|||
160942657|NCT01602315|581179888|FG005|Overall Study|Protocol Violation|1|||
160942658|NCT01602315|581179889|FG006|Overall Study|Protocol Violation|0|||
160942659|NCT01602315|581179883|FG000|Overall Study|Physician Decision|2|||
160942660|NCT01602315|581179884|FG001|Overall Study|Physician Decision|0|||
160942661|NCT01602315|581179885|FG002|Overall Study|Physician Decision|0|||
160942662|NCT01602315|581179886|FG003|Overall Study|Physician Decision|0|||
160942663|NCT01602315|581179887|FG004|Overall Study|Physician Decision|2|||
160942664|NCT01602315|581179888|FG005|Overall Study|Physician Decision|1|||
160942665|NCT01602315|581179889|FG006|Overall Study|Physician Decision|1|||
160942666|NCT01602315|581179883|FG000|Overall Study|Disease progression|6|||
160942667|NCT01602315|581179884|FG001|Overall Study|Disease progression|3|||
160942668|NCT01602315|581179885|FG002|Overall Study|Disease progression|10|||
160942669|NCT01602315|581179886|FG003|Overall Study|Disease progression|1|||
160942670|NCT01602315|581179887|FG004|Overall Study|Disease progression|41|||
161144559|NCT02786537|581913913|FG004|As Treated|Lack of Efficacy|0|||
161144560|NCT02786537|581913914|FG005|As Treated|Lack of Efficacy|0|||
160942671|NCT01602315|581179888|FG005|Overall Study|Disease progression|12|||
160942672|NCT01602315|581179889|FG006|Overall Study|Disease progression|15|||
161144561|NCT02786537|581913909|FG000|As Treated|Lost to Follow-up|4|||
161144562|NCT02786537|581913910|FG001|As Treated|Lost to Follow-up|32|||
161144563|NCT02786537|581913911|FG002|As Treated|Lost to Follow-up|0|||
161144564|NCT02786537|581913912|FG003|As Treated|Lost to Follow-up|25|||
161144565|NCT02786537|581913913|FG004|As Treated|Lost to Follow-up|4|||
161144566|NCT02786537|581913914|FG005|As Treated|Lost to Follow-up|4|||
160999083|NCT02299336|581380677|FG000|Overall Study|Adverse Event|1|||
160999084|NCT02299336|581380677|FG000|Overall Study|Death|1|||
160999085|NCT02299336|581380677|FG000|Overall Study|Lost to Follow-up|1|||
160999086|NCT01867580|581380680|FG000|Overall Study|Withdrawal by Subject|2|||
160999087|NCT01867580|581380681|FG001|Overall Study|Withdrawal by Subject|3|||
161265608|NCT01359644|582354108|FG005|Follow-up Period|Lost to Follow-up|0|||
161265609|NCT01359644|582354109|FG006|Follow-up Period|Lost to Follow-up|1|||
161265610|NCT01359644|582354110|FG007|Follow-up Period|Lost to Follow-up|2|||
161265611|NCT01359644|582354111|FG008|Follow-up Period|Lost to Follow-up|0|||
161265612|NCT01359644|582354112|FG009|Follow-up Period|Lost to Follow-up|0|||
161265613|NCT01660334|582354114|FG000|Overall Study|Lost to Follow-up|1|||
161265614|NCT00311311|582354115|FG000|Overall Study|Adverse Event|3|||
161265615|NCT00311311|582354116|FG001|Overall Study|Adverse Event|2|||
161265616|NCT00311311|582354115|FG000|Overall Study|Withdrawal by Subject|1|||
161265617|NCT00311311|582354116|FG001|Overall Study|Withdrawal by Subject|1|||
161265618|NCT00311311|582354115|FG000|Overall Study|Noncompliance|0|||
161265619|NCT00311311|582354116|FG001|Overall Study|Noncompliance|1|||
161265620|NCT00311311|582354115|FG000|Overall Study|Study Termination by Sponsor|3|||
161265621|NCT00311311|582354116|FG001|Overall Study|Study Termination by Sponsor|4|||
161265622|NCT00311311|582354115|FG000|Overall Study|Death|1|||
161265623|NCT00311311|582354116|FG001|Overall Study|Death|0|||
161265624|NCT00311311|582354115|FG000|Overall Study|Lack of ancillary assistance|0|||
161265625|NCT00311311|582354116|FG001|Overall Study|Lack of ancillary assistance|1|||
160942673|NCT01602315|581179883|FG000|Overall Study|Death|1|||
160942674|NCT01602315|581179884|FG001|Overall Study|Death|1|||
160942675|NCT01602315|581179885|FG002|Overall Study|Death|1|||
160942676|NCT01602315|581179886|FG003|Overall Study|Death|1|||
160942677|NCT01602315|581179887|FG004|Overall Study|Death|7|||
160942678|NCT01602315|581179888|FG005|Overall Study|Death|2|||
160942679|NCT01602315|581179889|FG006|Overall Study|Death|2|||
160942680|NCT01602315|581179883|FG000|Overall Study|Withdrawal by Subject|2|||
160942681|NCT01602315|581179884|FG001|Overall Study|Withdrawal by Subject|0|||
160942682|NCT01602315|581179885|FG002|Overall Study|Withdrawal by Subject|2|||
160942683|NCT01602315|581179886|FG003|Overall Study|Withdrawal by Subject|0|||
160942684|NCT01602315|581179887|FG004|Overall Study|Withdrawal by Subject|6|||
160942685|NCT01602315|581179888|FG005|Overall Study|Withdrawal by Subject|0|||
160942686|NCT01602315|581179889|FG006|Overall Study|Withdrawal by Subject|1|||
160942687|NCT01602315|581179883|FG000|Overall Study|Adverse Event|5|||
160942688|NCT01602315|581179884|FG001|Overall Study|Adverse Event|1|||
160942689|NCT01602315|581179885|FG002|Overall Study|Adverse Event|5|||
160942690|NCT01602315|581179886|FG003|Overall Study|Adverse Event|4|||
160942691|NCT01602315|581179887|FG004|Overall Study|Adverse Event|15|||
160942692|NCT01602315|581179888|FG005|Overall Study|Adverse Event|3|||
160942693|NCT01602315|581179889|FG006|Overall Study|Adverse Event|9|||
160942694|NCT01602315|581179883|FG000|Overall Study|Subject/guardian decision|0|||
160942695|NCT01602315|581179884|FG001|Overall Study|Subject/guardian decision|0|||
160942696|NCT01602315|581179885|FG002|Overall Study|Subject/guardian decision|0|||
160942697|NCT01602315|581179886|FG003|Overall Study|Subject/guardian decision|0|||
160942698|NCT01602315|581179887|FG004|Overall Study|Subject/guardian decision|0|||
160942699|NCT01602315|581179888|FG005|Overall Study|Subject/guardian decision|0|||
160942700|NCT01602315|581179889|FG006|Overall Study|Subject/guardian decision|1|||
160942701|NCT01602315|581179883|FG000|Overall Study|Cross-over patients to combo treatment|0|||
160942702|NCT01602315|581179884|FG001|Overall Study|Cross-over patients to combo treatment|0|||
160942703|NCT01602315|581179885|FG002|Overall Study|Cross-over patients to combo treatment|0|||
160942704|NCT01602315|581179886|FG003|Overall Study|Cross-over patients to combo treatment|0|||
160942705|NCT01602315|581179887|FG004|Overall Study|Cross-over patients to combo treatment|0|||
160942706|NCT01602315|581179888|FG005|Overall Study|Cross-over patients to combo treatment|16|||
160942707|NCT01602315|581179889|FG006|Overall Study|Cross-over patients to combo treatment|0|||
160942708|NCT00982319|581179892|FG000|Overall Study|Surgery date change|1|||
160942709|NCT00982319|581179893|FG001|Overall Study|Surgery date change|0|||
160942710|NCT00982319|581179892|FG000|Overall Study|Preop values out of acceptable range|1|||
160942711|NCT00982319|581179893|FG001|Overall Study|Preop values out of acceptable range|1|||
160942712|NCT00982319|581179892|FG000|Overall Study|Pregnancy|0|||
160942713|NCT00982319|581179893|FG001|Overall Study|Pregnancy|1|||
160942714|NCT00961259|581179898|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
160942715|NCT00961259|581179899|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
160942716|NCT00961259|581179900|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
160942717|NCT01252251|581179901|FG000|Overall Study|Withdrawal by Subject|1|||
160942718|NCT02691455|581179904|FG000|Overall Study|Withdrawal by Subject|1|||
161265626|NCT00536263|582354117|FG000|Overall Study|Adverse Event|5|||
160942719|NCT02691455|581179905|FG001|Overall Study|Withdrawal by Subject|2|||
160942720|NCT02691455|581179904|FG000|Overall Study|Lost to Follow-up|15|||
161265627|NCT00536263|582354118|FG001|Overall Study|Adverse Event|5|||
161265628|NCT00536263|582354119|FG002|Overall Study|Adverse Event|7|||
160942721|NCT02691455|581179905|FG001|Overall Study|Lost to Follow-up|15|||
160999088|NCT01867580|581380680|FG000|Overall Study|Physician Decision|17|||
160942722|NCT01743092|581179906|FG000|Overall Study|Lost to Follow-up|14|||
160942723|NCT01743092|581179907|FG001|Overall Study|Lost to Follow-up|15|||
160942724|NCT03603964|581179908|FG000|Overall Study|Death|9|||
160942725|NCT03603964|581179908|FG000|Overall Study|Withdrawal by participant|7|||
160942726|NCT03603964|581179908|FG000|Overall Study|Study terminated by Sponsor|19|||
160942727|NCT00563797|581179909|FG000|Overall Study|Lost to Follow-up|7|||
160942728|NCT00563797|581179910|FG001|Overall Study|Lost to Follow-up|2|||
160942729|NCT00179647|581179914|FG000|Overall Study|Adverse Event|294|||
160942730|NCT00179647|581179914|FG000|Overall Study|Lack of Efficacy|478|||
160942731|NCT00179647|581179914|FG000|Overall Study|Withdrawal by Subject|83|||
160942732|NCT00179647|581179914|FG000|Overall Study|Lost to Follow-up|4|||
160942733|NCT00179647|581179914|FG000|Overall Study|Death|94|||
160942734|NCT00179647|581179914|FG000|Overall Study|Other|960|||
160942735|NCT00622635|581179915|FG000|Treatment Period 1|Adverse Event|0|||
160942736|NCT00622635|581179916|FG001|Treatment Period 1|Adverse Event|0|||
160942737|NCT00622635|581179917|FG002|Treatment Period 1|Adverse Event|1|||
160942738|NCT00622635|581179918|FG003|Treatment Period 1|Adverse Event|0|||
160942739|NCT00622635|581179919|FG004|Treatment Period 1|Adverse Event|0|||
160999089|NCT01867580|581380681|FG001|Overall Study|Physician Decision|12|||
160999090|NCT01867580|581380680|FG000|Overall Study|Lost to Follow-up|3|||
160999091|NCT01867580|581380681|FG001|Overall Study|Lost to Follow-up|5|||
160999092|NCT01867580|581380680|FG000|Overall Study|Sponsor terminated study|1|||
160999093|NCT01867580|581380681|FG001|Overall Study|Sponsor terminated study|0|||
160999094|NCT01867580|581380680|FG000|Overall Study|Missed follow-up assessment|2|||
160999095|NCT01867580|581380681|FG001|Overall Study|Missed follow-up assessment|1|||
160999096|NCT01867580|581380680|FG000|Overall Study|Interruption to therapy|3|||
160999097|NCT01867580|581380681|FG001|Overall Study|Interruption to therapy|0|||
160999098|NCT01867580|581380680|FG000|Overall Study|Osteomyelitis|0|||
160999099|NCT01867580|581380681|FG001|Overall Study|Osteomyelitis|1|||
160999100|NCT01867580|581380680|FG000|Overall Study|Continuation of therapy|0|||
160999101|NCT01867580|581380681|FG001|Overall Study|Continuation of therapy|1|||
160999102|NCT01867580|581380680|FG000|Overall Study|Wound recurrence|0|||
160999103|NCT01867580|581380681|FG001|Overall Study|Wound recurrence|1|||
160999104|NCT01304147|581380682|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
160999105|NCT01304147|581380683|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
160999106|NCT01278862|581380684|FG000|Overall Study|Lost to Follow-up|1|||
160999107|NCT01278862|581380685|FG001|Overall Study|Lost to Follow-up|1|||
161265629|NCT00536263|582354117|FG000|Overall Study|Lost to Follow-up|3|||
161265630|NCT00536263|582354118|FG001|Overall Study|Lost to Follow-up|4|||
161265631|NCT00536263|582354119|FG002|Overall Study|Lost to Follow-up|4|||
161265632|NCT00536263|582354117|FG000|Overall Study|Subject withdrew - not treatment related|2|||
161265633|NCT00536263|582354118|FG001|Overall Study|Subject withdrew - not treatment related|0|||
161265634|NCT00536263|582354119|FG002|Overall Study|Subject withdrew - not treatment related|5|||
161265635|NCT00536263|582354117|FG000|Overall Study|Subject withdrew - treatment related|0|||
161265636|NCT00536263|582354118|FG001|Overall Study|Subject withdrew - treatment related|3|||
161265637|NCT00536263|582354119|FG002|Overall Study|Subject withdrew - treatment related|2|||
161265638|NCT00536263|582354117|FG000|Overall Study|Noncompliance with protocol|0|||
161265639|NCT00536263|582354118|FG001|Overall Study|Noncompliance with protocol|0|||
161265640|NCT00536263|582354119|FG002|Overall Study|Noncompliance with protocol|1|||
161265641|NCT00536263|582354117|FG000|Overall Study|Did not meet protocol eligibility|1|||
161265642|NCT00536263|582354118|FG001|Overall Study|Did not meet protocol eligibility|2|||
161265643|NCT00536263|582354119|FG002|Overall Study|Did not meet protocol eligibility|2|||
161265644|NCT00826449|582354120|FG000|Overall Study|Disease Progression|4|||
161265645|NCT00826449|582354120|FG000|Overall Study|Withdrawal by Subject|1|||
161265646|NCT01640873|582354139|FG000|Overall Study|Protocol Violation|2|||
161265647|NCT01640873|582354140|FG001|Overall Study|Protocol Violation|1|||
161265648|NCT01875471|582354141|FG000|Overall Study|Adverse Event|0|||
161265649|NCT01875471|582354142|FG001|Overall Study|Adverse Event|1|||
161265650|NCT01875471|582354141|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
161265651|NCT01875471|582354142|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
160999108|NCT02952261|581380687|FG000|Overall Study|Withdrawal by Subject|4|||
160999109|NCT02952261|581380688|FG001|Overall Study|Withdrawal by Subject|5|||
161265652|NCT01321008|582354143|FG000|Overall Study|Early Study Termination|1|||
161265653|NCT02749292|582354144|FG000|Overall Study|Physician Decision|1|||
161265654|NCT02749292|582354145|FG001|Overall Study|Physician Decision|0|||
161265655|NCT02749292|582354144|FG000|Overall Study|Withdrawal by Subject|5|||
161265656|NCT02749292|582354145|FG001|Overall Study|Withdrawal by Subject|7|||
161265657|NCT02749292|582354144|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
161265658|NCT02749292|582354145|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
160999110|NCT02952261|581380687|FG000|Overall Study|Protocol Violation|1|||
161265659|NCT02749292|582354144|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
161319361|NCT01884545|582555285|FG000|Overall Study|Non-adherence|0|||
160942740|NCT00622635|581179920|FG005|Treatment Period 1|Adverse Event|0|||
160942741|NCT00622635|581179915|FG000|Treatment Period 1|Withdrawal by Subject|0|||
160942742|NCT00622635|581179916|FG001|Treatment Period 1|Withdrawal by Subject|1|||
160942743|NCT00622635|581179917|FG002|Treatment Period 1|Withdrawal by Subject|0|||
160999111|NCT02952261|581380688|FG001|Overall Study|Protocol Violation|0|||
160942744|NCT00622635|581179918|FG003|Treatment Period 1|Withdrawal by Subject|0|||
160942745|NCT00622635|581179919|FG004|Treatment Period 1|Withdrawal by Subject|0|||
160942746|NCT00622635|581179920|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161265660|NCT02749292|582354145|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
161265661|NCT02749292|582354144|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
161265662|NCT02749292|582354145|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
161265663|NCT02749292|582354144|FG000|Overall Study|Adverse Event|4|||
160942747|NCT00622635|581179915|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942748|NCT00622635|581179916|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942749|NCT00622635|581179917|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942750|NCT00622635|581179918|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942751|NCT00622635|581179919|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
160942752|NCT00622635|581179920|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
160942753|NCT00622635|581179915|FG000|Treatment Period 2|Adverse Event|1|||
160942754|NCT00622635|581179916|FG001|Treatment Period 2|Adverse Event|0|||
160942755|NCT00622635|581179917|FG002|Treatment Period 2|Adverse Event|0|||
160942756|NCT00622635|581179918|FG003|Treatment Period 2|Adverse Event|0|||
160942757|NCT00622635|581179919|FG004|Treatment Period 2|Adverse Event|0|||
160942758|NCT00622635|581179920|FG005|Treatment Period 2|Adverse Event|0|||
160942759|NCT00622635|581179915|FG000|Treatment Period 3|Adverse Event|0|||
160942760|NCT00622635|581179916|FG001|Treatment Period 3|Adverse Event|0|||
160942761|NCT00622635|581179917|FG002|Treatment Period 3|Adverse Event|0|||
160942762|NCT00622635|581179918|FG003|Treatment Period 3|Adverse Event|2|||
160942763|NCT00622635|581179919|FG004|Treatment Period 3|Adverse Event|0|||
160942764|NCT00622635|581179920|FG005|Treatment Period 3|Adverse Event|0|||
160942765|NCT00622635|581179915|FG000|Treatment Period 3|Withdrawal by Subject|0|||
160942766|NCT00622635|581179916|FG001|Treatment Period 3|Withdrawal by Subject|0|||
160942767|NCT00622635|581179917|FG002|Treatment Period 3|Withdrawal by Subject|0|||
160942768|NCT00622635|581179918|FG003|Treatment Period 3|Withdrawal by Subject|1|||
160942769|NCT00622635|581179919|FG004|Treatment Period 3|Withdrawal by Subject|0|||
160942770|NCT00622635|581179920|FG005|Treatment Period 3|Withdrawal by Subject|0|||
160942771|NCT05013905|581179923|FG000|Overall Study|Adverse Event|1|||
160942772|NCT05013905|581179923|FG000|Overall Study|Lack of Efficacy|1|||
160942773|NCT01849588|581179926|FG000|Overall Study|Lack of Efficacy|3|||
160942774|NCT02486406|581179934|FG000|Overall Study|Withdrew consent|1|||
160942775|NCT02486406|581179935|FG001|Overall Study|Withdrew consent|0|||
160942776|NCT02486406|581179936|FG002|Overall Study|Withdrew consent|0|||
160942777|NCT02486406|581179937|FG003|Overall Study|Withdrew consent|1|||
160942778|NCT02486406|581179934|FG000|Overall Study|Lost to Follow-up|1|||
160942779|NCT02486406|581179935|FG001|Overall Study|Lost to Follow-up|3|||
160942780|NCT02486406|581179936|FG002|Overall Study|Lost to Follow-up|1|||
160942781|NCT02486406|581179937|FG003|Overall Study|Lost to Follow-up|3|||
160942782|NCT02486406|581179934|FG000|Overall Study|Other, not specified|0|||
160942783|NCT02486406|581179935|FG001|Overall Study|Other, not specified|0|||
160942784|NCT02486406|581179936|FG002|Overall Study|Other, not specified|1|||
160942785|NCT02486406|581179937|FG003|Overall Study|Other, not specified|0|||
160942786|NCT03509948|581179949|FG000|Overall Study|Protocol Violation|0|||
160942787|NCT03509948|581179950|FG001|Overall Study|Protocol Violation|1|||
160942788|NCT01071512|581179961|FG000|Overall Study|Adverse Event|1|||
160942789|NCT01071512|581179961|FG000|Overall Study|Development of antibodies to drug|2|||
160942790|NCT01071512|581179961|FG000|Overall Study|positive anti-JC virus antibody test|2|||
160942791|NCT00183872|581179962|FG000|Overall Study|Death|3|||
160942792|NCT00183872|581179962|FG000|Overall Study|Adverse Event|9|||
160942793|NCT00183872|581179962|FG000|Overall Study|Withdrawal by Subject|2|||
160942794|NCT00183872|581179962|FG000|Overall Study|Drug delayed more than 28 days|2|||
160942795|NCT00853658|581179963|FG000|Overall Study|Death|713|||
161265664|NCT02749292|582354145|FG001|Overall Study|Adverse Event|1|||
160942796|NCT00853658|581179964|FG001|Overall Study|Death|768|||
160942797|NCT00853658|581179965|FG002|Overall Study|Death|753|||
160942798|NCT00853658|581179963|FG000|Overall Study|Lost to Follow-up|11|||
160942799|NCT00853658|581179964|FG001|Overall Study|Lost to Follow-up|6|||
161265665|NCT02749292|582354144|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
160942800|NCT00853658|581179965|FG002|Overall Study|Lost to Follow-up|11|||
160942801|NCT00853658|581179963|FG000|Overall Study|H.A. Request|26|||
160942802|NCT00853658|581179964|FG001|Overall Study|H.A. Request|23|||
160942803|NCT00853658|581179965|FG002|Overall Study|H.A. Request|19|||
160942804|NCT00853658|581179963|FG000|Overall Study|IRB request|0|||
160942805|NCT00853658|581179964|FG001|Overall Study|IRB request|0|||
160942806|NCT00853658|581179965|FG002|Overall Study|IRB request|2|||
160942807|NCT00853658|581179963|FG000|Overall Study|Vital Status known (alive) at study end|2|||
160942808|NCT00853658|581179964|FG001|Overall Study|Vital Status known (alive) at study end|3|||
160942809|NCT00853658|581179965|FG002|Overall Study|Vital Status known (alive) at study end|3|||
160942810|NCT00853658|581179963|FG000|Overall Study|Vital Status unknown at study end|1|||
160942811|NCT00853658|581179964|FG001|Overall Study|Vital Status unknown at study end|1|||
160942812|NCT00853658|581179965|FG002|Overall Study|Vital Status unknown at study end|0|||
161144567|NCT02786537|581913909|FG000|As Treated|Non-compliance with study drug|1|||
161265666|NCT02749292|582354145|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
161265667|NCT02749292|582354144|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
161265668|NCT02749292|582354145|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
161265669|NCT02749292|582354144|FG000|Overall Study|Requiring glucocorticoids|0|||
161265670|NCT02749292|582354145|FG001|Overall Study|Requiring glucocorticoids|3|||
161265671|NCT02749292|582354144|FG000|Overall Study|Cancer|1|||
161265672|NCT02749292|582354145|FG001|Overall Study|Cancer|0|||
161265673|NCT02458092|582354146|FG000|Overall Study|Withdrawal by Subject|1|||
161265674|NCT02458092|582354147|FG001|Overall Study|Withdrawal by Subject|0|||
161265675|NCT00679913|582354148|FG000|Overall Study|Protocol Violation|18|||
161265676|NCT00679913|582354149|FG001|Overall Study|Protocol Violation|13|||
161265677|NCT01000493|582354155|FG000|Overall Study|Adverse Event|3|||
161265678|NCT01000493|582354156|FG001|Overall Study|Adverse Event|6|||
161265679|NCT01000493|582354155|FG000|Overall Study|Lack of Efficacy|1|||
161265680|NCT01000493|582354156|FG001|Overall Study|Lack of Efficacy|1|||
161265681|NCT01000493|582354155|FG000|Overall Study|Protocol Violation|1|||
161265682|NCT01000493|582354156|FG001|Overall Study|Protocol Violation|8|||
161265683|NCT01000493|582354155|FG000|Overall Study|Study closed/terminated|25|||
161265684|NCT01000493|582354156|FG001|Overall Study|Study closed/terminated|23|||
161265685|NCT01000493|582354155|FG000|Overall Study|Lost to Follow-up|5|||
161265686|NCT01000493|582354156|FG001|Overall Study|Lost to Follow-up|9|||
161265687|NCT01000493|582354155|FG000|Overall Study|Physician Decision|1|||
161265688|NCT01000493|582354156|FG001|Overall Study|Physician Decision|1|||
161265689|NCT01000493|582354155|FG000|Overall Study|Withdrawal by Subject|3|||
161265690|NCT01000493|582354156|FG001|Overall Study|Withdrawal by Subject|7|||
161265691|NCT03629028|582354157|FG000|Overall Study|Lost to Follow-up|26|||
161265692|NCT03629028|582354158|FG001|Overall Study|Lost to Follow-up|23|||
160942813|NCT00853658|581179963|FG000|Overall Study|Vital Status at study end N/A|8|||
160942814|NCT00853658|581179964|FG001|Overall Study|Vital Status at study end N/A|10|||
160942815|NCT00853658|581179965|FG002|Overall Study|Vital Status at study end N/A|10|||
160942816|NCT00853658|581179963|FG000|Overall Study|Patient's request|21|||
160942817|NCT00853658|581179964|FG001|Overall Study|Patient's request|17|||
160942818|NCT00853658|581179965|FG002|Overall Study|Patient's request|11|||
160942819|NCT00853658|581179963|FG000|Overall Study|Missing study completion information|5|||
160942820|NCT00853658|581179964|FG001|Overall Study|Missing study completion information|4|||
160942821|NCT00853658|581179965|FG002|Overall Study|Missing study completion information|6|||
160942822|NCT02797262|581179966|FG000|Overall Study|Withdrawal by Subject|5|||
160942823|NCT02797262|581179967|FG001|Overall Study|Withdrawal by Subject|1|||
160942824|NCT02797262|581179966|FG000|Overall Study|Lost to Follow-up|10|||
160942825|NCT02797262|581179967|FG001|Overall Study|Lost to Follow-up|7|||
160942826|NCT02797262|581179966|FG000|Overall Study|Death|1|||
160942827|NCT02797262|581179967|FG001|Overall Study|Death|2|||
160942828|NCT02797262|581179966|FG000|Overall Study|Adverse Event|1|||
160942829|NCT02797262|581179967|FG001|Overall Study|Adverse Event|0|||
160942830|NCT02797262|581179966|FG000|Overall Study|COVID-19|2|||
160942831|NCT02797262|581179967|FG001|Overall Study|COVID-19|1|||
160942832|NCT02797262|581179966|FG000|Overall Study|Out-of-country|1|||
160942833|NCT02797262|581179967|FG001|Overall Study|Out-of-country|0|||
160942834|NCT01600586|581179968|FG000|Overall Study|Physician Decision|3|||
160942835|NCT01600586|581179969|FG001|Overall Study|Physician Decision|3|||
160942836|NCT01227512|581179971|FG000|Overall Study|Physician Decision|6|||
160942837|NCT01227512|581179972|FG001|Overall Study|Physician Decision|6|||
160942838|NCT01227512|581179971|FG000|Overall Study|Adverse Event|4|||
160942839|NCT01227512|581179972|FG001|Overall Study|Adverse Event|3|||
160942840|NCT01227512|581179971|FG000|Overall Study|Withdrawal by Subject|3|||
160942841|NCT01227512|581179972|FG001|Overall Study|Withdrawal by Subject|0|||
160942842|NCT01227512|581179971|FG000|Overall Study|Participant met withdrawal criteria|0|||
160942843|NCT01227512|581179972|FG001|Overall Study|Participant met withdrawal criteria|1|||
160942844|NCT01069289|581179974|FG000|Overall Study|Withdrawal by Subject|15|||
160942845|NCT01069289|581179975|FG001|Overall Study|Withdrawal by Subject|26|||
160942846|NCT01069289|581179974|FG000|Overall Study|Adverse Event|21|||
160942847|NCT01069289|581179975|FG001|Overall Study|Adverse Event|28|||
160942848|NCT01069289|581179974|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160942849|NCT01069289|581179975|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160942850|NCT01069289|581179974|FG000|Overall Study|Severe non-compliance to protocol|3|||
160942851|NCT01069289|581179975|FG001|Overall Study|Severe non-compliance to protocol|2|||
161265693|NCT03629028|582354157|FG000|Overall Study|Pregnancy|4|||
161265694|NCT03629028|582354158|FG001|Overall Study|Pregnancy|2|||
161265695|NCT03629028|582354157|FG000|Overall Study|intolerance to examination|2|||
161265696|NCT03629028|582354158|FG001|Overall Study|intolerance to examination|0|||
161265697|NCT00456495|582354164|FG000|Overall Study|Physician Decision|2|||
160942852|NCT01069289|581179974|FG000|Overall Study|Due to deteriorating health condition|1|||
160942853|NCT01069289|581179975|FG001|Overall Study|Due to deteriorating health condition|0|||
160942854|NCT01818336|581181296|FG000|Overall Study|Declined retest visit|0|||
160942855|NCT01818336|581181297|FG001|Overall Study|Declined retest visit|11|||
160942856|NCT01818336|581181296|FG000|Overall Study|Lost to Follow-up|0|||
160942857|NCT01818336|581181297|FG001|Overall Study|Lost to Follow-up|1|||
160942858|NCT03042312|581181300|FG000|Overall Study|Administrative Reason|1|||
160942859|NCT03042312|581181301|FG001|Overall Study|Administrative Reason|1|||
160942860|NCT03042312|581181300|FG000|Overall Study|Adverse Event|0|||
160942861|NCT03042312|581181301|FG001|Overall Study|Adverse Event|1|||
160942862|NCT03042312|581181300|FG000|Overall Study|Lost to Follow-up|1|||
160942863|NCT03042312|581181301|FG001|Overall Study|Lost to Follow-up|3|||
160942864|NCT03042312|581181300|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
160942865|NCT03042312|581181301|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
160942866|NCT03042312|581181300|FG000|Overall Study|Withdrawal by Subject|4|||
160942867|NCT03042312|581181301|FG001|Overall Study|Withdrawal by Subject|5|||
160942868|NCT03422003|581181312|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
160942869|NCT03422003|581181313|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
160942870|NCT03422003|581181312|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
160942871|NCT03422003|581181313|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
160942872|NCT00317772|581181314|FG000|Overall Study|Adverse Event|0|||
160942873|NCT00317772|581181315|FG001|Overall Study|Adverse Event|0|||
160942874|NCT00317772|581181316|FG002|Overall Study|Adverse Event|0|||
160942875|NCT00317772|581181317|FG003|Overall Study|Adverse Event|2|||
160942876|NCT00317772|581181314|FG000|Overall Study|Disease Progression|2|||
160942877|NCT00317772|581181315|FG001|Overall Study|Disease Progression|2|||
160942878|NCT00317772|581181316|FG002|Overall Study|Disease Progression|1|||
160942879|NCT00317772|581181317|FG003|Overall Study|Disease Progression|7|||
160942880|NCT00966940|581181318|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
160942881|NCT00966940|581181319|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
160942882|NCT00966940|581181318|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
160942883|NCT00966940|581181319|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
160942884|NCT01040871|581181322|FG000|Overall Study|Adverse Event|6|||
160942885|NCT01040871|581181323|FG001|Overall Study|Adverse Event|2|||
160942886|NCT01040871|581181322|FG000|Overall Study|Withdrawal by Subject|2|||
160942887|NCT01040871|581181323|FG001|Overall Study|Withdrawal by Subject|0|||
160942888|NCT01040871|581181322|FG000|Overall Study|Death|1|||
160942889|NCT01040871|581181323|FG001|Overall Study|Death|3|||
160942890|NCT01040871|581181322|FG000|Overall Study|Lack of Efficacy|1|||
160942891|NCT01040871|581181323|FG001|Overall Study|Lack of Efficacy|1|||
160942892|NCT01040871|581181322|FG000|Overall Study|drug supply issue|1|||
161265698|NCT01301508|582354165|FG000|Overall Study|Withdrawal by Subject|1|||
160942893|NCT01040871|581181323|FG001|Overall Study|drug supply issue|0|||
160942894|NCT01040871|581181322|FG000|Overall Study|Randomized and Not Treated|2|||
160942895|NCT01040871|581181323|FG001|Overall Study|Randomized and Not Treated|1|||
160942896|NCT02886572|581181324|FG000|Overall Study|Death|8|||
160942897|NCT03087591|581181326|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
160942898|NCT03087591|581181326|FG000|Overall Study|Withdrawal by Subject|1|||
160942899|NCT02621606|581181327|FG000|Overall Study|Withdrawal by Subject|0|||
160942900|NCT02621606|581181328|FG001|Overall Study|Withdrawal by Subject|1|||
160942901|NCT02621606|581181329|FG002|Overall Study|Withdrawal by Subject|0|||
160942902|NCT01933334|581181330|FG000|Overall Study|Adverse Event|5|||
160942903|NCT01933334|581181331|FG001|Overall Study|Adverse Event|1|||
160942904|NCT01933334|581181330|FG000|Overall Study|Withdrawal by Subject|0|||
160942905|NCT01933334|581181331|FG001|Overall Study|Withdrawal by Subject|1|||
160942906|NCT00767000|581181332|FG000|54-week Study|Adverse Event|4|||
160942907|NCT00767000|581181333|FG001|54-week Study|Adverse Event|6|||
160942908|NCT00767000|581181334|FG002|54-week Study|Adverse Event|6|||
160942909|NCT00767000|581181335|FG003|54-week Study|Adverse Event|8|||
160942910|NCT00767000|581181336|FG004|54-week Study|Adverse Event|4|||
160942911|NCT00767000|581181332|FG000|54-week Study|Creaninine/creatinine clearance|2|||
160942912|NCT00767000|581181333|FG001|54-week Study|Creaninine/creatinine clearance|1|||
160942913|NCT00767000|581181334|FG002|54-week Study|Creaninine/creatinine clearance|2|||
160942914|NCT00767000|581181335|FG003|54-week Study|Creaninine/creatinine clearance|2|||
160942915|NCT00767000|581181336|FG004|54-week Study|Creaninine/creatinine clearance|4|||
160942916|NCT00767000|581181332|FG000|54-week Study|Hyperglycemia|0|||
160942917|NCT00767000|581181333|FG001|54-week Study|Hyperglycemia|0|||
160942918|NCT00767000|581181334|FG002|54-week Study|Hyperglycemia|1|||
160942919|NCT00767000|581181335|FG003|54-week Study|Hyperglycemia|0|||
160942920|NCT00767000|581181336|FG004|54-week Study|Hyperglycemia|1|||
160942921|NCT00767000|581181332|FG000|54-week Study|Hypoglycemia|0|||
160942922|NCT00767000|581181333|FG001|54-week Study|Hypoglycemia|1|||
160942923|NCT00767000|581181334|FG002|54-week Study|Hypoglycemia|0|||
160942924|NCT00767000|581181335|FG003|54-week Study|Hypoglycemia|0|||
160942925|NCT00767000|581181336|FG004|54-week Study|Hypoglycemia|0|||
160942926|NCT00767000|581181332|FG000|54-week Study|Interruption of study medication|0|||
160942927|NCT00767000|581181333|FG001|54-week Study|Interruption of study medication|0|||
160942928|NCT00767000|581181334|FG002|54-week Study|Interruption of study medication|1|||
160942929|NCT00767000|581181335|FG003|54-week Study|Interruption of study medication|0|||
160942930|NCT00767000|581181336|FG004|54-week Study|Interruption of study medication|0|||
160942931|NCT00767000|581181332|FG000|54-week Study|Lack of Efficacy|2|||
160942932|NCT00767000|581181333|FG001|54-week Study|Lack of Efficacy|0|||
160942933|NCT00767000|581181334|FG002|54-week Study|Lack of Efficacy|1|||
160942934|NCT00767000|581181335|FG003|54-week Study|Lack of Efficacy|0|||
160942935|NCT00767000|581181336|FG004|54-week Study|Lack of Efficacy|5|||
160942936|NCT00767000|581181332|FG000|54-week Study|Lost to Follow-up|4|||
160942937|NCT00767000|581181333|FG001|54-week Study|Lost to Follow-up|0|||
160942938|NCT00767000|581181334|FG002|54-week Study|Lost to Follow-up|1|||
160942939|NCT00767000|581181335|FG003|54-week Study|Lost to Follow-up|4|||
160942940|NCT00767000|581181336|FG004|54-week Study|Lost to Follow-up|2|||
160942941|NCT00767000|581181332|FG000|54-week Study|Physician Decision|4|||
160942942|NCT00767000|581181333|FG001|54-week Study|Physician Decision|0|||
160942943|NCT00767000|581181334|FG002|54-week Study|Physician Decision|1|||
160942944|NCT00767000|581181335|FG003|54-week Study|Physician Decision|1|||
160942945|NCT00767000|581181336|FG004|54-week Study|Physician Decision|1|||
160942946|NCT00767000|581181332|FG000|54-week Study|Progressive disease|0|||
160942947|NCT00767000|581181333|FG001|54-week Study|Progressive disease|0|||
160942948|NCT00767000|581181334|FG002|54-week Study|Progressive disease|1|||
160942949|NCT00767000|581181335|FG003|54-week Study|Progressive disease|0|||
160942950|NCT00767000|581181336|FG004|54-week Study|Progressive disease|0|||
160942951|NCT00767000|581181332|FG000|54-week Study|Protocol Violation|0|||
160942952|NCT00767000|581181333|FG001|54-week Study|Protocol Violation|0|||
160942953|NCT00767000|581181334|FG002|54-week Study|Protocol Violation|1|||
160942954|NCT00767000|581181335|FG003|54-week Study|Protocol Violation|2|||
160942955|NCT00767000|581181336|FG004|54-week Study|Protocol Violation|0|||
160942956|NCT00767000|581181332|FG000|54-week Study|Withdrawal by Subject|2|||
160942957|NCT00767000|581181333|FG001|54-week Study|Withdrawal by Subject|3|||
160942958|NCT00767000|581181334|FG002|54-week Study|Withdrawal by Subject|5|||
160942959|NCT00767000|581181335|FG003|54-week Study|Withdrawal by Subject|11|||
160942960|NCT00767000|581181336|FG004|54-week Study|Withdrawal by Subject|13|||
160942961|NCT00767000|581181332|FG000|54-week Study|Study terminated by sponsor|90|||
160942962|NCT00767000|581181333|FG001|54-week Study|Study terminated by sponsor|102|||
160942963|NCT00767000|581181334|FG002|54-week Study|Study terminated by sponsor|89|||
160942964|NCT00767000|581181335|FG003|54-week Study|Study terminated by sponsor|196|||
160942965|NCT00767000|581181336|FG004|54-week Study|Study terminated by sponsor|194|||
160942966|NCT00767000|581181332|FG000|54-week Study|Reason not reported|0|||
160942967|NCT00767000|581181333|FG001|54-week Study|Reason not reported|0|||
160999112|NCT05233085|581380689|FG000|Overall Study|Adverse Event|1|||
160999113|NCT05233085|581380690|FG001|Overall Study|Adverse Event|0|||
160999114|NCT05233085|581380691|FG002|Overall Study|Adverse Event|0|||
160999115|NCT05233085|581380692|FG003|Overall Study|Adverse Event|0|||
160999116|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
160999117|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
160999118|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
160999119|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999120|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999121|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999122|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999123|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999124|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160999125|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
160999126|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
160999127|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
160999128|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161265699|NCT01301508|582354166|FG001|Overall Study|Withdrawal by Subject|2|||
161265700|NCT01301508|582354165|FG000|Overall Study|Lost to Follow-up|0|||
161265701|NCT01301508|582354166|FG001|Overall Study|Lost to Follow-up|1|||
161265702|NCT01300923|582354167|FG000|Overall Study|Physician Decision|0|||
161265703|NCT01300923|582354168|FG001|Overall Study|Physician Decision|2|||
161265704|NCT02707861|582354171|FG000|Overall Study|Went onto commercial drug|30|||
161265705|NCT02707861|582354172|FG001|Overall Study|Went onto commercial drug|23|||
161265706|NCT02707861|582354171|FG000|Overall Study|Adverse Event|2|||
161265707|NCT02707861|582354172|FG001|Overall Study|Adverse Event|3|||
160942968|NCT00767000|581181334|FG002|54-week Study|Reason not reported|0|||
160942969|NCT00767000|581181335|FG003|54-week Study|Reason not reported|1|||
160942970|NCT00767000|581181336|FG004|54-week Study|Reason not reported|0|||
160942971|NCT00767000|581181332|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
160942972|NCT00767000|581181333|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
160999129|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999130|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161144568|NCT02786537|581913910|FG001|As Treated|Non-compliance with study drug|11|||
161144569|NCT02786537|581913911|FG002|As Treated|Non-compliance with study drug|0|||
160942973|NCT00767000|581181334|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
160942974|NCT00767000|581181335|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
160942975|NCT00767000|581181336|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
160942976|NCT01324024|581181340|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
160942977|NCT01324024|581181341|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160942978|NCT00097591|581181343|FG000|Overall Study|Withdrawal of consent|342|||
160942979|NCT00097591|581181344|FG001|Overall Study|Withdrawal of consent|323|||
160942980|NCT00097591|581181343|FG000|Overall Study|Less than 6 months on study drug|9|||
160942981|NCT00097591|581181344|FG001|Overall Study|Less than 6 months on study drug|7|||
160942982|NCT00097591|581181343|FG000|Overall Study|Unable to attend termination visit|53|||
160942983|NCT00097591|581181344|FG001|Overall Study|Unable to attend termination visit|51|||
160942984|NCT00097591|581181343|FG000|Overall Study|Lost to follow up|6|||
160942985|NCT00097591|581181344|FG001|Overall Study|Lost to follow up|10|||
160942986|NCT00097591|581181343|FG000|Overall Study|Other|0|||
160942987|NCT00097591|581181344|FG001|Overall Study|Other|3|||
160942988|NCT00009737|581181351|FG000|Overall Study|Adverse Event|112|||
161144570|NCT02786537|581913912|FG003|As Treated|Non-compliance with study drug|1|||
160942989|NCT00009737|581181352|FG001|Overall Study|Adverse Event|75|||
161144571|NCT02786537|581913913|FG004|As Treated|Non-compliance with study drug|0|||
161265708|NCT02707861|582354171|FG000|Overall Study|Death|5|||
161265709|NCT02707861|582354172|FG001|Overall Study|Death|2|||
160942990|NCT00009737|581181351|FG000|Overall Study|Death|4|||
160942991|NCT00009737|581181352|FG001|Overall Study|Death|6|||
160942992|NCT00009737|581181351|FG000|Overall Study|Lack of Efficacy|17|||
160942993|NCT00009737|581181352|FG001|Overall Study|Lack of Efficacy|15|||
160942994|NCT00009737|581181351|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
160942995|NCT00009737|581181352|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
160942996|NCT00009737|581181351|FG000|Overall Study|Other Protocol Violation|1|||
160942997|NCT00009737|581181352|FG001|Overall Study|Other Protocol Violation|0|||
160942998|NCT00009737|581181351|FG000|Overall Study|Refused Treatment|15|||
160942999|NCT00009737|581181352|FG001|Overall Study|Refused Treatment|16|||
160943000|NCT00009737|581181351|FG000|Overall Study|Lost to Follow-up|1|||
160943001|NCT00009737|581181352|FG001|Overall Study|Lost to Follow-up|1|||
160943002|NCT00009737|581181351|FG000|Overall Study|Administrative/Other Reasons|7|||
160943003|NCT00009737|581181352|FG001|Overall Study|Administrative/Other Reasons|1|||
160943004|NCT00530023|581181353|FG000|Overall Study|Withdrawal by Subject|0|||
160943005|NCT00530023|581181354|FG001|Overall Study|Withdrawal by Subject|1|||
160943006|NCT00003498|581181355|FG000|Overall Study|Not evaluable.|4|||
160943007|NCT00812812|581181365|FG000|Overall Study|Adverse Event|2|||
160943008|NCT00812812|581181366|FG001|Overall Study|Adverse Event|1|||
160943009|NCT00812812|581181365|FG000|Overall Study|Lack of Efficacy|1|||
160943010|NCT00812812|581181366|FG001|Overall Study|Lack of Efficacy|0|||
160943011|NCT00812812|581181365|FG000|Overall Study|Lost to Follow-up|0|||
160943012|NCT00812812|581181366|FG001|Overall Study|Lost to Follow-up|1|||
160943013|NCT00812812|581181365|FG000|Overall Study|Withdrawal by Subject|0|||
160943014|NCT00812812|581181366|FG001|Overall Study|Withdrawal by Subject|2|||
160943015|NCT02114892|581181367|FG000|Overall Study|Lost to Follow-up|1|||
160943016|NCT02114892|581181368|FG001|Overall Study|Lost to Follow-up|2|||
160943017|NCT02013765|581181369|FG000|Overall Study|Trial was terminated by sponsor|1|||
160943018|NCT02178475|581181375|FG000|Overall Study|Withdrawal by Subject|7|||
160943019|NCT02178475|581181375|FG000|Overall Study|Lost to Follow-up|10|||
160943020|NCT02178475|581181375|FG000|Overall Study|Death|13|||
160943021|NCT02178475|581181375|FG000|Overall Study|Protocol-specified Criteria|99|||
160943022|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943023|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943024|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943025|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943026|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
160943027|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
160943028|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
160943029|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943030|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943031|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943032|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
160943033|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
160943034|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943035|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
160943036|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
160943037|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943038|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943039|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
160943040|NCT00718042|581181376|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943041|NCT00718042|581181377|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
160943042|NCT00718042|581181378|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943043|NCT00718042|581181379|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943044|NCT00718042|581181380|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943045|NCT00718042|581181381|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
160943046|NCT00718042|581181376|FG000|Donor Follow-up|Lost to Follow-up|13|||
160943047|NCT00718042|581181377|FG001|Donor Follow-up|Lost to Follow-up|0|||
160943048|NCT00718042|581181378|FG002|Donor Follow-up|Lost to Follow-up|0|||
160943049|NCT00718042|581181379|FG003|Donor Follow-up|Lost to Follow-up|0|||
160943050|NCT00718042|581181380|FG004|Donor Follow-up|Lost to Follow-up|19|||
160943051|NCT00718042|581181381|FG005|Donor Follow-up|Lost to Follow-up|0|||
160943052|NCT04327934|581181382|FG000|Overall Study|Did not qualify|7|||
160943053|NCT04327934|581181383|FG001|Overall Study|Did not qualify|4|||
160943054|NCT04327934|581181382|FG000|Overall Study|Physician Decision|0|||
160943055|NCT04327934|581181383|FG001|Overall Study|Physician Decision|1|||
160943056|NCT02443298|581181384|FG000|Overall Study|Adverse Event|3|||
160943057|NCT02443298|581181385|FG001|Overall Study|Adverse Event|3|||
160943058|NCT02443298|581181384|FG000|Overall Study|Withdrawal by Subject|1|||
160943059|NCT02443298|581181385|FG001|Overall Study|Withdrawal by Subject|2|||
160943060|NCT03095417|581181386|FG000|Overall Study|missed|1|||
160943061|NCT03095417|581181387|FG001|Overall Study|missed|2|||
160943062|NCT03095417|581181388|FG002|Overall Study|missed|0|||
160943063|NCT03095417|581181389|FG003|Overall Study|missed|1|||
160943064|NCT03095417|581181386|FG000|Overall Study|Lost to Follow-up|2|||
160943065|NCT03095417|581181387|FG001|Overall Study|Lost to Follow-up|2|||
160943066|NCT03095417|581181388|FG002|Overall Study|Lost to Follow-up|1|||
160943067|NCT03095417|581181389|FG003|Overall Study|Lost to Follow-up|0|||
160943068|NCT03095417|581181386|FG000|Overall Study|refusal|0|||
160943069|NCT03095417|581181387|FG001|Overall Study|refusal|1|||
160943070|NCT03095417|581181388|FG002|Overall Study|refusal|0|||
160943071|NCT03095417|581181389|FG003|Overall Study|refusal|1|||
160943072|NCT03095417|581181386|FG000|Overall Study|Withdrawal by Subject|8|||
160943073|NCT03095417|581181387|FG001|Overall Study|Withdrawal by Subject|2|||
160943074|NCT03095417|581181388|FG002|Overall Study|Withdrawal by Subject|5|||
160943075|NCT03095417|581181389|FG003|Overall Study|Withdrawal by Subject|4|||
160943076|NCT03095417|581181386|FG000|Overall Study|Physician Decision|1|||
160943077|NCT03095417|581181387|FG001|Overall Study|Physician Decision|2|||
160943078|NCT03095417|581181388|FG002|Overall Study|Physician Decision|2|||
160943079|NCT03095417|581181389|FG003|Overall Study|Physician Decision|2|||
160943080|NCT03095417|581181386|FG000|Overall Study|Death|1|||
160943081|NCT03095417|581181387|FG001|Overall Study|Death|2|||
160943082|NCT03095417|581181388|FG002|Overall Study|Death|1|||
160943083|NCT03095417|581181389|FG003|Overall Study|Death|3|||
160943084|NCT02571452|581181390|FG000|Overall Study Treatment|Protocol Violation|0|||
160943085|NCT02571452|581181391|FG001|Overall Study Treatment|Protocol Violation|1|||
160943086|NCT02571452|581181390|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
160943087|NCT02571452|581181391|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
160943088|NCT02571452|581181390|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
160943089|NCT02571452|581181391|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
160943090|NCT01877421|581181392|FG000|Phase 2|Lost to Follow-up|0|||
160943091|NCT01877421|581181393|FG001|Phase 2|Lost to Follow-up|0|||
160943092|NCT01877421|581181394|FG002|Phase 2|Lost to Follow-up|0|||
160943093|NCT01877421|581181395|FG003|Phase 2|Lost to Follow-up|0|||
160943094|NCT01877421|581181396|FG004|Phase 2|Lost to Follow-up|0|||
160943095|NCT01877421|581181397|FG005|Phase 2|Lost to Follow-up|0|||
160943096|NCT01877421|581181398|FG006|Phase 2|Lost to Follow-up|1|||
160943097|NCT01877421|581181399|FG007|Phase 2|Lost to Follow-up|0|||
160943098|NCT01877421|581181400|FG008|Phase 2|Lost to Follow-up|0|||
160943099|NCT01877421|581181401|FG009|Phase 2|Lost to Follow-up|0|||
160943100|NCT01877421|581181402|FG010|Phase 2|Lost to Follow-up|0|||
160943101|NCT01877421|581181403|FG011|Phase 2|Lost to Follow-up|0|||
160943102|NCT01877421|581181404|FG012|Phase 2|Lost to Follow-up|0|||
160943103|NCT01877421|581181405|FG013|Phase 2|Lost to Follow-up|0|||
160943104|NCT01877421|581181406|FG014|Phase 2|Lost to Follow-up|0|||
160943105|NCT01877421|581181407|FG015|Phase 2|Lost to Follow-up|0|||
160943106|NCT01877421|581181408|FG016|Phase 2|Lost to Follow-up|0|||
160943107|NCT01877421|581181409|FG017|Phase 2|Lost to Follow-up|0|||
160943108|NCT01877421|581181392|FG000|Phase 2|Withdrawal by Subject|0|||
160943109|NCT01877421|581181393|FG001|Phase 2|Withdrawal by Subject|0|||
160943110|NCT01877421|581181394|FG002|Phase 2|Withdrawal by Subject|0|||
160943111|NCT01877421|581181395|FG003|Phase 2|Withdrawal by Subject|0|||
160943112|NCT01877421|581181396|FG004|Phase 2|Withdrawal by Subject|0|||
160943113|NCT01877421|581181397|FG005|Phase 2|Withdrawal by Subject|0|||
160943114|NCT01877421|581181398|FG006|Phase 2|Withdrawal by Subject|0|||
160943115|NCT01877421|581181399|FG007|Phase 2|Withdrawal by Subject|0|||
160943116|NCT01877421|581181400|FG008|Phase 2|Withdrawal by Subject|1|||
160943117|NCT01877421|581181401|FG009|Phase 2|Withdrawal by Subject|0|||
160943118|NCT01877421|581181402|FG010|Phase 2|Withdrawal by Subject|1|||
160943119|NCT01877421|581181403|FG011|Phase 2|Withdrawal by Subject|0|||
160943120|NCT01877421|581181404|FG012|Phase 2|Withdrawal by Subject|1|||
160943121|NCT01877421|581181405|FG013|Phase 2|Withdrawal by Subject|0|||
160943122|NCT01877421|581181406|FG014|Phase 2|Withdrawal by Subject|0|||
160943123|NCT01877421|581181407|FG015|Phase 2|Withdrawal by Subject|1|||
160943124|NCT01877421|581181408|FG016|Phase 2|Withdrawal by Subject|0|||
160943125|NCT01877421|581181409|FG017|Phase 2|Withdrawal by Subject|0|||
160943126|NCT01877421|581181392|FG000|Phase 2|Protocol Violation|0|||
160943127|NCT01877421|581181393|FG001|Phase 2|Protocol Violation|0|||
160943128|NCT01877421|581181394|FG002|Phase 2|Protocol Violation|0|||
160943129|NCT01877421|581181395|FG003|Phase 2|Protocol Violation|0|||
160943130|NCT01877421|581181396|FG004|Phase 2|Protocol Violation|0|||
160943131|NCT01877421|581181397|FG005|Phase 2|Protocol Violation|0|||
160943132|NCT01877421|581181398|FG006|Phase 2|Protocol Violation|0|||
160943133|NCT01877421|581181399|FG007|Phase 2|Protocol Violation|0|||
160943134|NCT01877421|581181400|FG008|Phase 2|Protocol Violation|0|||
160943135|NCT01877421|581181401|FG009|Phase 2|Protocol Violation|0|||
160943136|NCT01877421|581181402|FG010|Phase 2|Protocol Violation|1|||
160943137|NCT01877421|581181403|FG011|Phase 2|Protocol Violation|0|||
160943138|NCT01877421|581181404|FG012|Phase 2|Protocol Violation|0|||
160943139|NCT01877421|581181405|FG013|Phase 2|Protocol Violation|0|||
160943140|NCT01877421|581181406|FG014|Phase 2|Protocol Violation|0|||
160943141|NCT01877421|581181407|FG015|Phase 2|Protocol Violation|0|||
160943142|NCT01877421|581181408|FG016|Phase 2|Protocol Violation|0|||
160943143|NCT01877421|581181409|FG017|Phase 2|Protocol Violation|0|||
160943144|NCT03698773|581181423|FG000|Overall Study|Lost to Follow-up|2|||
160943145|NCT03698773|581181424|FG001|Overall Study|Lost to Follow-up|1|||
160943146|NCT01158924|581181426|FG000|Overall Study|Withdrawal by Subject|1|||
160943147|NCT01158924|581181427|FG001|Overall Study|Withdrawal by Subject|2|||
160943148|NCT01158924|581181426|FG000|Overall Study|Lost to Follow-up|0|||
160943149|NCT01158924|581181427|FG001|Overall Study|Lost to Follow-up|1|||
160943150|NCT01260922|581181431|FG000|First Intervention|Withdrawal by Subject|0|||
160943151|NCT01260922|581181432|FG001|First Intervention|Withdrawal by Subject|1|||
160943152|NCT01260922|581181431|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
160943153|NCT01260922|581181432|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
160943154|NCT01260922|581181431|FG000|Second Intervention|Emesis|0|||
160943155|NCT01260922|581181432|FG001|Second Intervention|Emesis|2|||
160943156|NCT01599650|581181437|FG000|Overall Study|Administrative issue|1|||
160943157|NCT01599650|581181438|FG001|Overall Study|Administrative issue|0|||
160943158|NCT01599650|581181439|FG002|Overall Study|Administrative issue|1|||
160943159|NCT01599650|581181437|FG000|Overall Study|Physician Decision|2|||
160943160|NCT01599650|581181438|FG001|Overall Study|Physician Decision|0|||
160943161|NCT01599650|581181439|FG002|Overall Study|Physician Decision|7|||
160943162|NCT01599650|581181437|FG000|Overall Study|Protocol Violation|0|||
160943163|NCT01599650|581181438|FG001|Overall Study|Protocol Violation|3|||
160943164|NCT01599650|581181439|FG002|Overall Study|Protocol Violation|0|||
160943165|NCT01599650|581181437|FG000|Overall Study|Death|2|||
160943166|NCT01599650|581181438|FG001|Overall Study|Death|1|||
160943167|NCT01599650|581181439|FG002|Overall Study|Death|2|||
160943168|NCT01599650|581181437|FG000|Overall Study|Lost to Follow-up|3|||
160943169|NCT01599650|581181438|FG001|Overall Study|Lost to Follow-up|3|||
160943170|NCT01599650|581181439|FG002|Overall Study|Lost to Follow-up|3|||
160943171|NCT01599650|581181437|FG000|Overall Study|Withdrawal by Subject|11|||
160943172|NCT01599650|581181438|FG001|Overall Study|Withdrawal by Subject|11|||
160943173|NCT01599650|581181439|FG002|Overall Study|Withdrawal by Subject|10|||
160943174|NCT01599650|581181437|FG000|Overall Study|Adverse Event|3|||
160943175|NCT01599650|581181438|FG001|Overall Study|Adverse Event|8|||
160943176|NCT01599650|581181439|FG002|Overall Study|Adverse Event|4|||
160943177|NCT01731171|581181440|FG000|Overall Study|Withdrawal by Subject|4|||
160943178|NCT01731171|581181441|FG001|Overall Study|Withdrawal by Subject|1|||
160999131|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999132|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999133|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160999134|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
160999135|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
160943179|NCT01731171|581181440|FG000|Overall Study|Lost to Follow-up|3|||
160999136|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
160999137|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999138|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999139|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999140|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999141|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160943180|NCT01731171|581181441|FG001|Overall Study|Lost to Follow-up|2|||
160943181|NCT01731171|581181440|FG000|Overall Study|Moved out of Area|0|||
160943182|NCT01731171|581181441|FG001|Overall Study|Moved out of Area|2|||
160943183|NCT01731171|581181440|FG000|Overall Study|Terminated for Lack of Adherence|0|||
160943184|NCT01731171|581181441|FG001|Overall Study|Terminated for Lack of Adherence|1|||
160943185|NCT01731171|581181440|FG000|Overall Study|Terminated for Safety Reasons|0|||
160943186|NCT01731171|581181441|FG001|Overall Study|Terminated for Safety Reasons|1|||
160943187|NCT01410110|581181442|FG000|Overall Study|Withdrawal by Subject|4|||
160943188|NCT01410110|581181443|FG001|Overall Study|Withdrawal by Subject|2|||
160943189|NCT01416805|581181444|FG000|Overall Study|Lost to Follow-up|4|||
160943190|NCT01416805|581181445|FG001|Overall Study|Lost to Follow-up|4|||
160943191|NCT02604589|581181452|FG000|Overall Study|catheter dislodgement|0|||
160943192|NCT02604589|581181453|FG001|Overall Study|catheter dislodgement|0|||
160943193|NCT02604589|581181454|FG002|Overall Study|catheter dislodgement|1|||
160943194|NCT01700946|581181460|FG000|Overall Study|Lost to Follow-up|1|||
160943195|NCT01700946|581181461|FG001|Overall Study|Lost to Follow-up|0|||
160943196|NCT01700946|581181460|FG000|Overall Study|Physician Decision|7|||
160943197|NCT01700946|581181461|FG001|Overall Study|Physician Decision|12|||
160943198|NCT01700946|581181460|FG000|Overall Study|Withdrawal by Subject|0|||
160943199|NCT01700946|581181461|FG001|Overall Study|Withdrawal by Subject|2|||
160943200|NCT01700946|581181460|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
160943201|NCT01700946|581181461|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
160943202|NCT01700946|581181460|FG000|Overall Study|Relapse|2|||
160943203|NCT01700946|581181461|FG001|Overall Study|Relapse|1|||
160943204|NCT01700946|581181460|FG000|Overall Study|Unacceptable toxicity|1|||
160943205|NCT01700946|581181461|FG001|Overall Study|Unacceptable toxicity|0|||
160943206|NCT04632940|581181465|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
160943207|NCT04632940|581181466|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
160943208|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
160943209|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
160943210|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
160943211|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
160943212|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
160999142|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160999143|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
160999144|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999145|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
160999146|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999147|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999148|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999149|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999150|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999151|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
160999152|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160999153|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160999154|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
160999155|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999156|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999157|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999158|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999159|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999160|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160999161|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999162|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160999163|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160999164|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999165|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999166|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999167|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999168|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999169|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160999170|NCT01212757|581380693|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
160999171|NCT01212757|581380694|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
160999172|NCT01212757|581380695|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999173|NCT01212757|581380696|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999174|NCT01212757|581380697|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999175|NCT01212757|581380698|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999176|NCT01212757|581380699|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999177|NCT01212757|581380700|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999178|NCT01212757|581380701|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
160999179|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999180|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
160999181|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
160999182|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
160999183|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999184|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
160999185|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
161265710|NCT02707861|582354171|FG000|Overall Study|Lack of Efficacy|0|||
160943213|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
160943214|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
160943215|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
160943216|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
160943217|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
160943218|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Other than specified|0|||
160943219|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Other than specified|1|||
160943220|NCT04632940|581181465|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
160943221|NCT04632940|581181466|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
160943222|NCT00684424|581181467|FG000|Overall Study|Adverse Event|1|||
160943223|NCT00684424|581181467|FG000|Overall Study|Lost to Follow-up|2|||
160943224|NCT00684424|581181467|FG000|Overall Study|Other|2|||
160943225|NCT02520531|581181470|FG000|Overall Study|Revision of study device components|2|||
160943226|NCT02520531|581181471|FG001|Overall Study|Revision of study device components|2|||
160943227|NCT02520531|581181470|FG000|Overall Study|Death|1|||
160943228|NCT02520531|581181471|FG001|Overall Study|Death|2|||
160943229|NCT02520531|581181470|FG000|Overall Study|Lost to Follow-up|1|||
160943230|NCT02520531|581181471|FG001|Overall Study|Lost to Follow-up|1|||
160943231|NCT02520531|581181470|FG000|Overall Study|Meet exclusion criterion|0|||
160943232|NCT02520531|581181471|FG001|Overall Study|Meet exclusion criterion|1|||
160943233|NCT02520531|581181470|FG000|Overall Study|Withdrawal by Subject|1|||
160943234|NCT02520531|581181471|FG001|Overall Study|Withdrawal by Subject|0|||
160943235|NCT02520531|581181470|FG000|Overall Study|Not study device|1|||
160943236|NCT02520531|581181471|FG001|Overall Study|Not study device|0|||
160943237|NCT02805257|581183802|FG000|Overall Study|Lost to Follow-up|7|||
160943238|NCT02805257|581183803|FG001|Overall Study|Lost to Follow-up|6|||
160943239|NCT02805257|581183802|FG000|Overall Study|Death|0|||
160943240|NCT02805257|581183803|FG001|Overall Study|Death|1|||
160943241|NCT01043874|581183806|FG000|Overall Study|Adverse Event|3|||
160943242|NCT01043874|581183806|FG000|Overall Study|Withdrawal by Subject|1|||
160943243|NCT01043874|581183806|FG000|Overall Study|Lack of Efficacy|1|||
160943244|NCT01043874|581183806|FG000|Overall Study|Administrative Problems|1|||
160943245|NCT01404312|581183807|FG000|Overall Study|Death|21|||
160943246|NCT01404312|581183808|FG001|Overall Study|Death|27|||
160943247|NCT01404312|581183807|FG000|Overall Study|Withdrawal by Subject|15|||
160943248|NCT01404312|581183808|FG001|Overall Study|Withdrawal by Subject|18|||
160943249|NCT01404312|581183807|FG000|Overall Study|Participant Unable to get to clinic|93|||
160943250|NCT01404312|581183808|FG001|Overall Study|Participant Unable to get to clinic|103|||
160943251|NCT01404312|581183807|FG000|Overall Study|Lost to Follow-up|115|||
160943252|NCT01404312|581183808|FG001|Overall Study|Lost to Follow-up|111|||
160943253|NCT01404312|581183807|FG000|Overall Study|Site closed|22|||
160943254|NCT01404312|581183808|FG001|Overall Study|Site closed|21|||
160943255|NCT01404312|581183807|FG000|Overall Study|Participant not willing to adhere to req|31|||
160943256|NCT01404312|581183808|FG001|Overall Study|Participant not willing to adhere to req|29|||
160943257|NCT01404312|581183807|FG000|Overall Study|Severe debilitation, unable to continue|1|||
160943258|NCT01404312|581183808|FG001|Overall Study|Severe debilitation, unable to continue|2|||
160943259|NCT02696850|581183809|FG000|Overall Study|Withdrawal by Subject|3|||
160943260|NCT02696850|581183810|FG001|Overall Study|Withdrawal by Subject|3|||
160943261|NCT02696850|581183809|FG000|Overall Study|Lost to Follow-up|8|||
160943262|NCT02696850|581183810|FG001|Overall Study|Lost to Follow-up|5|||
160943263|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
160943264|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
160943265|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
160943266|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
160943267|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Death|235|||
160943268|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Death|167|||
160943269|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Death|1|||
160943270|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Death|0|||
160943271|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
160943272|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
160943273|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
160943274|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
160943275|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
160943276|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
160943277|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
160943278|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
160943279|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Other|1|||
160943280|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Other|2|||
160943281|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Other|0|||
160943282|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Other|0|||
160943283|NCT00673049|581183811|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
160943284|NCT00673049|581183812|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
160943285|NCT00673049|581183813|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
160943286|NCT00673049|581183814|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
160943287|NCT00673049|581183811|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
161342639|NCT01285518|582642221|FG000|Overall Study|Lost to Follow-up|0|||
161342640|NCT01285518|582642222|FG001|Overall Study|Lost to Follow-up|0|||
161342641|NCT01285518|582642223|FG002|Overall Study|Lost to Follow-up|0|||
161342642|NCT01285518|582642224|FG003|Overall Study|Lost to Follow-up|0|||
161342643|NCT01285518|582642225|FG004|Overall Study|Lost to Follow-up|0|||
161342644|NCT01285518|582642226|FG005|Overall Study|Lost to Follow-up|1|||
161342645|NCT01285518|582642227|FG006|Overall Study|Lost to Follow-up|0|||
161342646|NCT01285518|582642228|FG007|Overall Study|Lost to Follow-up|0|||
161342647|NCT00879658|582642231|FG000|Overall Study|Abnormal laboratory value(s)|3|||
161342648|NCT00879658|582642232|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161342649|NCT00879658|582642233|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161342650|NCT00879658|582642234|FG003|Overall Study|Abnormal laboratory value(s)|1|||
161342651|NCT00879658|582642235|FG004|Overall Study|Abnormal laboratory value(s)|0|||
161342652|NCT00879658|582642236|FG005|Overall Study|Abnormal laboratory value(s)|0|||
161342653|NCT00879658|582642237|FG006|Overall Study|Abnormal laboratory value(s)|0|||
161342654|NCT00879658|582642231|FG000|Overall Study|Administrative problems|2|||
161342655|NCT00879658|582642232|FG001|Overall Study|Administrative problems|1|||
161342656|NCT00879658|582642233|FG002|Overall Study|Administrative problems|0|||
161342657|NCT00879658|582642234|FG003|Overall Study|Administrative problems|1|||
161342658|NCT00879658|582642235|FG004|Overall Study|Administrative problems|0|||
161342659|NCT00879658|582642236|FG005|Overall Study|Administrative problems|0|||
160943288|NCT00673049|581183812|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
160943289|NCT00673049|581183813|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
160943290|NCT00673049|581183814|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
160943291|NCT00673049|581183811|FG000|After Progression on Erlotinib|Death|0|||
160943292|NCT00673049|581183812|FG001|After Progression on Erlotinib|Death|0|||
160943293|NCT00673049|581183813|FG002|After Progression on Erlotinib|Death|0|||
160943294|NCT00673049|581183814|FG003|After Progression on Erlotinib|Death|71|||
160943295|NCT00673049|581183811|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
160943296|NCT00673049|581183812|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
160943297|NCT00673049|581183813|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
160943298|NCT00673049|581183814|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
160943299|NCT00673049|581183811|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
160943300|NCT00673049|581183812|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
160943301|NCT00673049|581183813|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
160943302|NCT00673049|581183814|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
160943303|NCT00673049|581183811|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
160943304|NCT00673049|581183812|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
160943305|NCT00673049|581183813|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
160943306|NCT00673049|581183814|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
160943307|NCT04265755|581183815|FG000|Overall Study|Withdrawal by Subject|39|||
160943308|NCT04265755|581183815|FG000|Overall Study|Decision by sponsor|2|||
160943309|NCT04265755|581183815|FG000|Overall Study|Lost to Follow-up|11|||
160943310|NCT04265755|581183815|FG000|Overall Study|Death|1|||
160943311|NCT01863446|581183816|FG000|Overall Study|Withdrawal by Subject|1|||
160943312|NCT01863446|581183817|FG001|Overall Study|Withdrawal by Subject|0|||
160943313|NCT01863446|581183818|FG002|Overall Study|Withdrawal by Subject|1|||
160943314|NCT01863446|581183819|FG003|Overall Study|Withdrawal by Subject|2|||
160943315|NCT01863446|581183816|FG000|Overall Study|Physician Decision|0|||
160943316|NCT01863446|581183817|FG001|Overall Study|Physician Decision|0|||
160943317|NCT01863446|581183818|FG002|Overall Study|Physician Decision|1|||
160943318|NCT01863446|581183819|FG003|Overall Study|Physician Decision|0|||
160943319|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
160999186|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999187|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
160999188|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999189|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
160999190|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
160999191|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
160999192|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999193|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
161342660|NCT00879658|582642237|FG006|Overall Study|Administrative problems|0|||
161342661|NCT00879658|582642231|FG000|Overall Study|Adverse Event|6|||
161342662|NCT00879658|582642232|FG001|Overall Study|Adverse Event|4|||
161342663|NCT00879658|582642233|FG002|Overall Study|Adverse Event|3|||
161342664|NCT00879658|582642234|FG003|Overall Study|Adverse Event|1|||
161342665|NCT00879658|582642235|FG004|Overall Study|Adverse Event|2|||
161342666|NCT00879658|582642236|FG005|Overall Study|Adverse Event|0|||
161342667|NCT00879658|582642237|FG006|Overall Study|Adverse Event|0|||
161342668|NCT00879658|582642231|FG000|Overall Study|Protocol Violation|1|||
161342669|NCT00879658|582642232|FG001|Overall Study|Protocol Violation|0|||
160943320|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
160943321|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
160943322|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
160943323|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
160943324|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
160943325|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Death|1|||
160943326|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Death|0|||
160943327|NCT02554773|581183820|FG000|Original Dose Regimen (SAS 1)|Other|4|||
160943328|NCT02554773|581183821|FG001|Original Dose Regimen (SAS 1)|Other|0|||
160943329|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
160943330|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
160943331|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
160943332|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
160943333|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
160943334|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
160943335|NCT02554773|581183820|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
160943336|NCT02554773|581183821|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
160943337|NCT02956629|581183822|FG000|Overall Study|Adverse Event|0|||
160943338|NCT02956629|581183823|FG001|Overall Study|Adverse Event|0|||
160943339|NCT02956629|581183824|FG002|Overall Study|Adverse Event|1|||
160943340|NCT02956629|581183825|FG003|Overall Study|Adverse Event|0|||
160943341|NCT02956629|581183826|FG004|Overall Study|Adverse Event|0|||
160943342|NCT02956629|581183827|FG005|Overall Study|Adverse Event|0|||
160943343|NCT02956629|581183822|FG000|Overall Study|Lost to Follow-up|2|||
160943344|NCT02956629|581183823|FG001|Overall Study|Lost to Follow-up|5|||
160943345|NCT02956629|581183824|FG002|Overall Study|Lost to Follow-up|3|||
160943346|NCT02956629|581183825|FG003|Overall Study|Lost to Follow-up|1|||
160943347|NCT02956629|581183826|FG004|Overall Study|Lost to Follow-up|0|||
160943348|NCT02956629|581183827|FG005|Overall Study|Lost to Follow-up|1|||
160943349|NCT02956629|581183822|FG000|Overall Study|Withdrawal by Subject|3|||
160943350|NCT02956629|581183823|FG001|Overall Study|Withdrawal by Subject|1|||
160943351|NCT02956629|581183824|FG002|Overall Study|Withdrawal by Subject|0|||
160943352|NCT02956629|581183825|FG003|Overall Study|Withdrawal by Subject|0|||
160943353|NCT02956629|581183826|FG004|Overall Study|Withdrawal by Subject|0|||
160943354|NCT02956629|581183827|FG005|Overall Study|Withdrawal by Subject|0|||
160943355|NCT00406029|581183831|FG000|Overall Study|Adverse Event|12|||
160943356|NCT00406029|581183832|FG001|Overall Study|Adverse Event|2|||
160943357|NCT00406029|581183833|FG002|Overall Study|Adverse Event|5|||
160943358|NCT00406029|581183834|FG003|Overall Study|Adverse Event|10|||
160943359|NCT00406029|581183835|FG004|Overall Study|Adverse Event|7|||
160943360|NCT00406029|581183831|FG000|Overall Study|Withdrawal by Subject|3|||
160943361|NCT00406029|581183832|FG001|Overall Study|Withdrawal by Subject|4|||
160943362|NCT00406029|581183833|FG002|Overall Study|Withdrawal by Subject|2|||
160943363|NCT00406029|581183834|FG003|Overall Study|Withdrawal by Subject|2|||
160943364|NCT00406029|581183835|FG004|Overall Study|Withdrawal by Subject|0|||
160943365|NCT00406029|581183831|FG000|Overall Study|Protocol Violation|1|||
160943366|NCT00406029|581183832|FG001|Overall Study|Protocol Violation|2|||
160943367|NCT00406029|581183833|FG002|Overall Study|Protocol Violation|0|||
160943368|NCT00406029|581183834|FG003|Overall Study|Protocol Violation|2|||
160943369|NCT00406029|581183835|FG004|Overall Study|Protocol Violation|0|||
160943370|NCT00406029|581183831|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943371|NCT00406029|581183832|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943372|NCT00406029|581183833|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
160943373|NCT00406029|581183834|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943374|NCT00406029|581183835|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
160943375|NCT00406029|581183831|FG000|Overall Study|Randomized in Error|0|||
160943376|NCT00406029|581183832|FG001|Overall Study|Randomized in Error|0|||
160943377|NCT00406029|581183833|FG002|Overall Study|Randomized in Error|2|||
160943378|NCT00406029|581183834|FG003|Overall Study|Randomized in Error|3|||
160943379|NCT00406029|581183835|FG004|Overall Study|Randomized in Error|1|||
160943380|NCT02822794|581183836|FG000|Overall Study|Withdrew Consent|1|||
160943381|NCT02822794|581183837|FG001|Overall Study|Withdrew Consent|0|||
160943382|NCT04788147|581183838|FG000|Overall Study|Screen Failure|3|||
160999194|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999195|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999196|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
160999197|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999198|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160943383|NCT04788147|581183839|FG001|Overall Study|Screen Failure|10|||
160943384|NCT04788147|581183838|FG000|Overall Study|Incomplete RMRS image session|2|||
160943385|NCT04788147|581183839|FG001|Overall Study|Incomplete RMRS image session|0|||
160943386|NCT02266381|581183840|FG000|Overall Study|Physician Decision|3|||
160943387|NCT02266381|581183841|FG001|Overall Study|Physician Decision|5|||
160943388|NCT02266381|581183842|FG002|Overall Study|Physician Decision|4|||
160943389|NCT03732248|581183843|FG000|Overall Study|Withdrawal by Subject|1|||
160943390|NCT03732248|581183844|FG001|Overall Study|Withdrawal by Subject|0|||
160943391|NCT05101252|581183845|FG000|Overall Study|Unsatisfactory Test Article|1|||
160862056|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
160862057|NCT05138653|580887920|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862058|NCT05138653|580887921|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862059|NCT05138653|580887922|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862060|NCT05138653|580887923|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862061|NCT05138653|580887924|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862062|NCT05138653|580887925|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862063|NCT05138653|580887926|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
160862064|NCT05138653|580887927|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862065|NCT05138653|580887928|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862066|NCT05138653|580887929|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862067|NCT05138653|580887930|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862068|NCT05138653|580887931|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862069|NCT05138653|580887932|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862070|NCT05138653|580887933|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862071|NCT05138653|580887934|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862072|NCT05138653|580887935|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
160862073|NCT05138653|580887920|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862074|NCT05138653|580887921|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862075|NCT05138653|580887922|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862076|NCT05138653|580887923|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862077|NCT05138653|580887924|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862078|NCT05138653|580887925|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862079|NCT05138653|580887926|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862080|NCT05138653|580887927|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862081|NCT05138653|580887928|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862082|NCT05138653|580887929|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862083|NCT05138653|580887930|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
160862084|NCT05138653|580887931|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862085|NCT05138653|580887932|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
160862086|NCT05138653|580887933|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862087|NCT05138653|580887934|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
160862088|NCT05138653|580887935|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
160862089|NCT05138653|580887920|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862090|NCT05138653|580887921|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862091|NCT05138653|580887922|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862092|NCT05138653|580887923|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862093|NCT05138653|580887924|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862094|NCT05138653|580887925|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862095|NCT05138653|580887926|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862096|NCT05138653|580887927|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862097|NCT05138653|580887928|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862098|NCT05138653|580887929|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862099|NCT05138653|580887930|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862100|NCT05138653|580887931|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862101|NCT05138653|580887932|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862102|NCT05138653|580887933|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862103|NCT05138653|580887934|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
160862104|NCT05138653|580887935|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
160862105|NCT05138653|580887920|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862106|NCT05138653|580887921|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862107|NCT05138653|580887922|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862108|NCT05138653|580887923|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862109|NCT05138653|580887924|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862110|NCT05138653|580887925|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862111|NCT05138653|580887926|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862112|NCT05138653|580887927|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862113|NCT05138653|580887928|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862114|NCT05138653|580887929|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862115|NCT05138653|580887930|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862116|NCT05138653|580887931|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862117|NCT05138653|580887932|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160943392|NCT05101252|581183846|FG001|Overall Study|Unsatisfactory Test Article|0|||
160943393|NCT05101252|581183845|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160943394|NCT05101252|581183846|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
160943395|NCT05101252|581183845|FG000|Overall Study|Withdrew Consent during study|0|||
160943396|NCT05101252|581183846|FG001|Overall Study|Withdrew Consent during study|1|||
160943397|NCT05101252|581183845|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
160943398|NCT05101252|581183846|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
160943399|NCT01649856|581183853|FG000|Overall Study|Withdrawal by Subject|14|||
160943400|NCT01649856|581183854|FG001|Overall Study|Withdrawal by Subject|14|||
160943401|NCT01649856|581183853|FG000|Overall Study|Protocol Violation|4|||
160943402|NCT01649856|581183854|FG001|Overall Study|Protocol Violation|4|||
160943403|NCT01649856|581183853|FG000|Overall Study|Treatment Failure|1|||
160943404|NCT01649856|581183854|FG001|Overall Study|Treatment Failure|1|||
160943405|NCT01649856|581183853|FG000|Overall Study|Death|69|||
160943406|NCT01649856|581183854|FG001|Overall Study|Death|34|||
160943407|NCT01649856|581183853|FG000|Overall Study|Stable or Progressed Disease|5|||
160943408|NCT01649856|581183854|FG001|Overall Study|Stable or Progressed Disease|3|||
160943409|NCT01649856|581183853|FG000|Overall Study|Lost to Follow-up|20|||
160943410|NCT01649856|581183854|FG001|Overall Study|Lost to Follow-up|16|||
160943411|NCT01649856|581183853|FG000|Overall Study|Lack of Compliance|6|||
160943412|NCT01649856|581183854|FG001|Overall Study|Lack of Compliance|1|||
160943413|NCT01649856|581183853|FG000|Overall Study|Other|20|||
160943414|NCT01649856|581183854|FG001|Overall Study|Other|5|||
160943415|NCT00835406|581183855|FG000|Period: First Intervention|Adverse Event|0|||
160943416|NCT00835406|581183856|FG001|Period: First Intervention|Adverse Event|1|||
160943417|NCT00835406|581183855|FG000|Period: First Intervention|Withdrawal by Subject|2|||
160943418|NCT00835406|581183856|FG001|Period: First Intervention|Withdrawal by Subject|0|||
160943419|NCT00835406|581183855|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
160943420|NCT00835406|581183856|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
160943421|NCT00281840|581183857|FG000|Overall Study|Adverse Event|12|||
160943422|NCT00281840|581183857|FG000|Overall Study|Physician Decision|6|||
160943423|NCT00281840|581183857|FG000|Overall Study|Withdrawal by Subject|3|||
160943424|NCT00281840|581183857|FG000|Overall Study|Disease Progression|2|||
160943425|NCT00281840|581183857|FG000|Overall Study|exceed maximum delay in treatment|1|||
160943426|NCT00281840|581183857|FG000|Overall Study|Complicating Disease|1|||
160943427|NCT02138214|581183858|FG000|Overall Study|Withdrawal by Subject|0|||
160943428|NCT02138214|581183859|FG001|Overall Study|Withdrawal by Subject|1|||
160943429|NCT02138214|581183860|FG002|Overall Study|Withdrawal by Subject|0|||
160943430|NCT02138214|581183858|FG000|Overall Study|Lost to Follow-up|0|||
160943431|NCT02138214|581183859|FG001|Overall Study|Lost to Follow-up|2|||
160943432|NCT02138214|581183860|FG002|Overall Study|Lost to Follow-up|4|||
160943433|NCT02138214|581183858|FG000|Overall Study|Screen Failure|0|||
160943434|NCT02138214|581183859|FG001|Overall Study|Screen Failure|1|||
160943435|NCT02138214|581183860|FG002|Overall Study|Screen Failure|0|||
160943436|NCT02185768|581183861|FG000|Overall Study|Patients were not treated|2|||
160943437|NCT01079234|581183862|FG000|Main: Week 0 to 26|Adverse Event|5|||
160943438|NCT01079234|581183863|FG001|Main: Week 0 to 26|Adverse Event|4|||
160943439|NCT01079234|581183864|FG002|Main: Week 0 to 26|Adverse Event|1|||
160943440|NCT01079234|581183865|FG003|Main: Week 0 to 26|Adverse Event|0|||
160943441|NCT01079234|581183862|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
160943442|NCT01079234|581183863|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
160943443|NCT01079234|581183864|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
160943444|NCT01079234|581183865|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
160943445|NCT01079234|581183862|FG000|Main: Week 0 to 26|Protocol Violation|6|||
160943446|NCT01079234|581183863|FG001|Main: Week 0 to 26|Protocol Violation|2|||
160943447|NCT01079234|581183864|FG002|Main: Week 0 to 26|Protocol Violation|4|||
160943448|NCT01079234|581183865|FG003|Main: Week 0 to 26|Protocol Violation|0|||
160943449|NCT01079234|581183862|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
160943450|NCT01079234|581183863|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
160943451|NCT01079234|581183864|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
160943452|NCT01079234|581183865|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
160943453|NCT01079234|581183862|FG000|Main: Week 0 to 26|Unclassified|7|||
160943454|NCT01079234|581183863|FG001|Main: Week 0 to 26|Unclassified|13|||
160943455|NCT01079234|581183864|FG002|Main: Week 0 to 26|Unclassified|4|||
160943456|NCT01079234|581183865|FG003|Main: Week 0 to 26|Unclassified|0|||
160943457|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Adverse Event|0|||
160943458|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Adverse Event|0|||
160943459|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Adverse Event|1|||
160943460|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Adverse Event|0|||
160943461|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
160943462|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
160943463|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
160943464|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
160943465|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
160943466|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
160943467|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
160999199|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
160999200|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
161265711|NCT02707861|582354172|FG001|Overall Study|Lack of Efficacy|2|||
161265712|NCT02707861|582354171|FG000|Overall Study|Physician Decision|1|||
161265713|NCT02707861|582354172|FG001|Overall Study|Physician Decision|4|||
161265714|NCT02707861|582354171|FG000|Overall Study|Withdrawal by Subject|2|||
161265715|NCT02707861|582354172|FG001|Overall Study|Withdrawal by Subject|1|||
161265716|NCT02707861|582354171|FG000|Overall Study|Lost to Follow-up|1|||
161265717|NCT02707861|582354172|FG001|Overall Study|Lost to Follow-up|3|||
160943468|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
160943469|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
160943470|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
160943471|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
160943472|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
160943473|NCT01079234|581183862|FG000|Extension: Week 27 to 52|Unclassified|0|||
160943474|NCT01079234|581183863|FG001|Extension: Week 27 to 52|Unclassified|0|||
160943475|NCT01079234|581183864|FG002|Extension: Week 27 to 52|Unclassified|4|||
160943476|NCT01079234|581183865|FG003|Extension: Week 27 to 52|Unclassified|7|||
160943477|NCT03221257|581183866|FG000|Overall Study|Lost to Follow-up|0|||
160943478|NCT03221257|581183867|FG001|Overall Study|Lost to Follow-up|1|||
160943479|NCT03221257|581183866|FG000|Overall Study|Withdrawal by Subject|1|||
160943480|NCT03221257|581183867|FG001|Overall Study|Withdrawal by Subject|1|||
160943481|NCT01334866|581183870|FG000|Overall Study|Withdrawal by Subject|10|||
160943482|NCT01334866|581183870|FG000|Overall Study|Lost to Follow-up|3|||
160943483|NCT01334866|581183870|FG000|Overall Study|Physician Decision|3|||
160943484|NCT01334866|581183870|FG000|Overall Study|medically necessary prior to procedure|2|||
160943485|NCT01334866|581183870|FG000|Overall Study|medically necessary post-procedure|1|||
160943486|NCT02460224|581183873|FG000|Overall Study|Adverse Event|0|||
160943487|NCT02460224|581183874|FG001|Overall Study|Adverse Event|0|||
160943488|NCT02460224|581183875|FG002|Overall Study|Adverse Event|0|||
160943489|NCT02460224|581183876|FG003|Overall Study|Adverse Event|0|||
160943490|NCT02460224|581183877|FG004|Overall Study|Adverse Event|0|||
160943491|NCT02460224|581183878|FG005|Overall Study|Adverse Event|0|||
160943492|NCT02460224|581183879|FG006|Overall Study|Adverse Event|1|||
160943493|NCT02460224|581183880|FG007|Overall Study|Adverse Event|0|||
160943494|NCT02460224|581183881|FG008|Overall Study|Adverse Event|0|||
160943495|NCT02460224|581183882|FG009|Overall Study|Adverse Event|0|||
160943496|NCT02460224|581183883|FG010|Overall Study|Adverse Event|0|||
160943497|NCT02460224|581183884|FG011|Overall Study|Adverse Event|0|||
160943498|NCT02460224|581183885|FG012|Overall Study|Adverse Event|1|||
160943499|NCT02460224|581183886|FG013|Overall Study|Adverse Event|0|||
160943500|NCT02460224|581183887|FG014|Overall Study|Adverse Event|0|||
160943501|NCT02460224|581183888|FG015|Overall Study|Adverse Event|0|||
160943502|NCT02460224|581183889|FG016|Overall Study|Adverse Event|1|||
160943503|NCT02460224|581183890|FG017|Overall Study|Adverse Event|0|||
160943504|NCT02460224|581183891|FG018|Overall Study|Adverse Event|1|||
160943505|NCT02460224|581183892|FG019|Overall Study|Adverse Event|0|||
160943506|NCT02460224|581183893|FG020|Overall Study|Adverse Event|1|||
160943507|NCT02460224|581183894|FG021|Overall Study|Adverse Event|1|||
160943508|NCT02460224|581183895|FG022|Overall Study|Adverse Event|1|||
160943509|NCT02460224|581183896|FG023|Overall Study|Adverse Event|0|||
160943510|NCT02460224|581183897|FG024|Overall Study|Adverse Event|0|||
160943511|NCT02460224|581183898|FG025|Overall Study|Adverse Event|0|||
160943512|NCT02460224|581183899|FG026|Overall Study|Adverse Event|11|||
160943513|NCT02460224|581183900|FG027|Overall Study|Adverse Event|1|||
161265718|NCT01346774|582354175|FG000|Overall Study|Did not take a single dose|6|||
161265719|NCT01346774|582354176|FG001|Overall Study|Did not take a single dose|4|||
161265720|NCT01346774|582354175|FG000|Overall Study|Lost to Follow-up|3|||
161265721|NCT01346774|582354176|FG001|Overall Study|Lost to Follow-up|4|||
161265722|NCT01346774|582354175|FG000|Overall Study|Withdrawal by Subject|1|||
161265723|NCT01346774|582354176|FG001|Overall Study|Withdrawal by Subject|4|||
161265724|NCT01346774|582354175|FG000|Overall Study|Protocol Violation|2|||
160943514|NCT02460224|581183901|FG028|Overall Study|Adverse Event|6|||
160943515|NCT02460224|581183873|FG000|Overall Study|Death|0|||
161265725|NCT01346774|582354176|FG001|Overall Study|Protocol Violation|3|||
160943516|NCT02460224|581183874|FG001|Overall Study|Death|0|||
160943517|NCT02460224|581183875|FG002|Overall Study|Death|0|||
160943518|NCT02460224|581183876|FG003|Overall Study|Death|0|||
160943519|NCT02460224|581183877|FG004|Overall Study|Death|0|||
160943520|NCT02460224|581183878|FG005|Overall Study|Death|2|||
160943521|NCT02460224|581183879|FG006|Overall Study|Death|1|||
160943522|NCT02460224|581183880|FG007|Overall Study|Death|0|||
160943523|NCT02460224|581183881|FG008|Overall Study|Death|0|||
160943524|NCT02460224|581183882|FG009|Overall Study|Death|1|||
160943525|NCT02460224|581183883|FG010|Overall Study|Death|0|||
160943526|NCT02460224|581183884|FG011|Overall Study|Death|0|||
160943527|NCT02460224|581183885|FG012|Overall Study|Death|0|||
160943528|NCT02460224|581183886|FG013|Overall Study|Death|1|||
160943529|NCT02460224|581183887|FG014|Overall Study|Death|0|||
160943530|NCT02460224|581183888|FG015|Overall Study|Death|0|||
160943531|NCT02460224|581183889|FG016|Overall Study|Death|2|||
160943532|NCT02460224|581183890|FG017|Overall Study|Death|1|||
160943533|NCT02460224|581183891|FG018|Overall Study|Death|0|||
160943534|NCT02460224|581183892|FG019|Overall Study|Death|2|||
160943535|NCT02460224|581183893|FG020|Overall Study|Death|0|||
160943536|NCT02460224|581183894|FG021|Overall Study|Death|0|||
160943537|NCT02460224|581183895|FG022|Overall Study|Death|0|||
160943538|NCT02460224|581183896|FG023|Overall Study|Death|0|||
160943539|NCT02460224|581183897|FG024|Overall Study|Death|1|||
160943540|NCT02460224|581183898|FG025|Overall Study|Death|1|||
160943541|NCT02460224|581183899|FG026|Overall Study|Death|5|||
160943542|NCT02460224|581183900|FG027|Overall Study|Death|0|||
160943543|NCT02460224|581183901|FG028|Overall Study|Death|1|||
160943544|NCT02460224|581183873|FG000|Overall Study|Lost to Follow-up|0|||
160943545|NCT02460224|581183874|FG001|Overall Study|Lost to Follow-up|0|||
160943546|NCT02460224|581183875|FG002|Overall Study|Lost to Follow-up|0|||
160943547|NCT02460224|581183876|FG003|Overall Study|Lost to Follow-up|0|||
160943548|NCT02460224|581183877|FG004|Overall Study|Lost to Follow-up|0|||
160943549|NCT02460224|581183878|FG005|Overall Study|Lost to Follow-up|0|||
160943550|NCT02460224|581183879|FG006|Overall Study|Lost to Follow-up|0|||
160943551|NCT02460224|581183880|FG007|Overall Study|Lost to Follow-up|0|||
160999201|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999202|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999203|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999204|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999205|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
160999206|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160943552|NCT02460224|581183881|FG008|Overall Study|Lost to Follow-up|0|||
160943553|NCT02460224|581183882|FG009|Overall Study|Lost to Follow-up|0|||
160999207|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
160999208|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
160999209|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
160999210|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
160999211|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
160999212|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161265726|NCT01346774|582354175|FG000|Overall Study|Adverse Event|1|||
161265727|NCT01346774|582354176|FG001|Overall Study|Adverse Event|2|||
161265728|NCT00369382|582354184|FG000|Overall Study|Death|0|||
161265729|NCT00369382|582354185|FG001|Overall Study|Death|2|||
161265730|NCT00369382|582354184|FG000|Overall Study|Physician Decision|2|||
161265731|NCT00369382|582354185|FG001|Overall Study|Physician Decision|1|||
161265732|NCT00369382|582354184|FG000|Overall Study|Withdrawal by Subject|5|||
161265733|NCT00369382|582354185|FG001|Overall Study|Withdrawal by Subject|0|||
161265734|NCT00369382|582354184|FG000|Overall Study|Randomized, not treated|2|||
161265735|NCT00369382|582354185|FG001|Overall Study|Randomized, not treated|0|||
160999213|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160999214|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
160999215|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999216|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
160999217|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999218|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999219|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
160999220|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160999221|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161265736|NCT00369382|582354184|FG000|Overall Study|Other|1|||
161265737|NCT00369382|582354185|FG001|Overall Study|Other|0|||
161265738|NCT00507546|582354186|FG000|Overall Study|Withdrawal by Subject|1|||
161265739|NCT00507546|582354187|FG001|Overall Study|Withdrawal by Subject|0|||
161265740|NCT00507546|582354186|FG000|Overall Study|Protocol Violation|1|||
161265741|NCT00507546|582354187|FG001|Overall Study|Protocol Violation|0|||
161265742|NCT00507546|582354186|FG000|Overall Study|Physician Decision|0|||
160943554|NCT02460224|581183883|FG010|Overall Study|Lost to Follow-up|0|||
160943555|NCT02460224|581183884|FG011|Overall Study|Lost to Follow-up|0|||
160943556|NCT02460224|581183885|FG012|Overall Study|Lost to Follow-up|0|||
160943557|NCT02460224|581183886|FG013|Overall Study|Lost to Follow-up|0|||
160943558|NCT02460224|581183887|FG014|Overall Study|Lost to Follow-up|0|||
160943559|NCT02460224|581183888|FG015|Overall Study|Lost to Follow-up|0|||
160943560|NCT02460224|581183889|FG016|Overall Study|Lost to Follow-up|0|||
160943561|NCT02460224|581183890|FG017|Overall Study|Lost to Follow-up|0|||
160943562|NCT02460224|581183891|FG018|Overall Study|Lost to Follow-up|0|||
160943563|NCT02460224|581183892|FG019|Overall Study|Lost to Follow-up|0|||
160943564|NCT02460224|581183893|FG020|Overall Study|Lost to Follow-up|0|||
160943565|NCT02460224|581183894|FG021|Overall Study|Lost to Follow-up|0|||
160943566|NCT02460224|581183895|FG022|Overall Study|Lost to Follow-up|1|||
160943567|NCT02460224|581183896|FG023|Overall Study|Lost to Follow-up|0|||
160943568|NCT02460224|581183897|FG024|Overall Study|Lost to Follow-up|0|||
160943569|NCT02460224|581183898|FG025|Overall Study|Lost to Follow-up|0|||
160943570|NCT02460224|581183899|FG026|Overall Study|Lost to Follow-up|0|||
160943571|NCT02460224|581183900|FG027|Overall Study|Lost to Follow-up|0|||
160943572|NCT02460224|581183901|FG028|Overall Study|Lost to Follow-up|0|||
160943573|NCT02460224|581183873|FG000|Overall Study|Physician Decision|0|||
160943574|NCT02460224|581183874|FG001|Overall Study|Physician Decision|1|||
160943575|NCT02460224|581183875|FG002|Overall Study|Physician Decision|0|||
160943576|NCT02460224|581183876|FG003|Overall Study|Physician Decision|0|||
160943577|NCT02460224|581183877|FG004|Overall Study|Physician Decision|1|||
160943578|NCT02460224|581183878|FG005|Overall Study|Physician Decision|0|||
160943579|NCT02460224|581183879|FG006|Overall Study|Physician Decision|0|||
160943580|NCT02460224|581183880|FG007|Overall Study|Physician Decision|1|||
160943581|NCT02460224|581183881|FG008|Overall Study|Physician Decision|0|||
160943582|NCT02460224|581183882|FG009|Overall Study|Physician Decision|0|||
160943583|NCT02460224|581183883|FG010|Overall Study|Physician Decision|0|||
160943584|NCT02460224|581183884|FG011|Overall Study|Physician Decision|1|||
160943585|NCT02460224|581183885|FG012|Overall Study|Physician Decision|0|||
160943586|NCT02460224|581183886|FG013|Overall Study|Physician Decision|1|||
160943587|NCT02460224|581183887|FG014|Overall Study|Physician Decision|0|||
160943588|NCT02460224|581183888|FG015|Overall Study|Physician Decision|0|||
160943589|NCT02460224|581183889|FG016|Overall Study|Physician Decision|2|||
160943590|NCT02460224|581183890|FG017|Overall Study|Physician Decision|1|||
160943591|NCT02460224|581183891|FG018|Overall Study|Physician Decision|1|||
160943592|NCT02460224|581183892|FG019|Overall Study|Physician Decision|2|||
160943593|NCT02460224|581183893|FG020|Overall Study|Physician Decision|1|||
160943594|NCT02460224|581183894|FG021|Overall Study|Physician Decision|1|||
160943595|NCT02460224|581183895|FG022|Overall Study|Physician Decision|0|||
160943596|NCT02460224|581183896|FG023|Overall Study|Physician Decision|0|||
160943597|NCT02460224|581183897|FG024|Overall Study|Physician Decision|1|||
160943598|NCT02460224|581183898|FG025|Overall Study|Physician Decision|0|||
160943599|NCT02460224|581183899|FG026|Overall Study|Physician Decision|14|||
160943600|NCT02460224|581183900|FG027|Overall Study|Physician Decision|1|||
160943601|NCT02460224|581183901|FG028|Overall Study|Physician Decision|6|||
160943602|NCT02460224|581183873|FG000|Overall Study|Progressive disease|15|||
160943603|NCT02460224|581183874|FG001|Overall Study|Progressive disease|11|||
160943604|NCT02460224|581183875|FG002|Overall Study|Progressive disease|5|||
160943605|NCT02460224|581183876|FG003|Overall Study|Progressive disease|6|||
160943606|NCT02460224|581183877|FG004|Overall Study|Progressive disease|3|||
160943607|NCT02460224|581183878|FG005|Overall Study|Progressive disease|26|||
160943608|NCT02460224|581183879|FG006|Overall Study|Progressive disease|28|||
160943609|NCT02460224|581183880|FG007|Overall Study|Progressive disease|4|||
160943610|NCT02460224|581183881|FG008|Overall Study|Progressive disease|5|||
160943611|NCT02460224|581183882|FG009|Overall Study|Progressive disease|9|||
160943612|NCT02460224|581183883|FG010|Overall Study|Progressive disease|5|||
160943613|NCT02460224|581183884|FG011|Overall Study|Progressive disease|4|||
160943614|NCT02460224|581183885|FG012|Overall Study|Progressive disease|5|||
160943615|NCT02460224|581183886|FG013|Overall Study|Progressive disease|4|||
160943616|NCT02460224|581183887|FG014|Overall Study|Progressive disease|5|||
160943617|NCT02460224|581183888|FG015|Overall Study|Progressive disease|5|||
160943618|NCT02460224|581183889|FG016|Overall Study|Progressive disease|15|||
160943619|NCT02460224|581183890|FG017|Overall Study|Progressive disease|3|||
160943620|NCT02460224|581183891|FG018|Overall Study|Progressive disease|8|||
160943621|NCT02460224|581183892|FG019|Overall Study|Progressive disease|3|||
160943622|NCT02460224|581183893|FG020|Overall Study|Progressive disease|4|||
160943623|NCT02460224|581183894|FG021|Overall Study|Progressive disease|9|||
160943624|NCT02460224|581183895|FG022|Overall Study|Progressive disease|4|||
160943625|NCT02460224|581183896|FG023|Overall Study|Progressive disease|11|||
160943626|NCT02460224|581183897|FG024|Overall Study|Progressive disease|4|||
160943627|NCT02460224|581183898|FG025|Overall Study|Progressive disease|5|||
160943628|NCT02460224|581183899|FG026|Overall Study|Progressive disease|85|||
160943629|NCT02460224|581183900|FG027|Overall Study|Progressive disease|17|||
160943630|NCT02460224|581183901|FG028|Overall Study|Progressive disease|77|||
160999222|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160943631|NCT02460224|581183873|FG000|Overall Study|Subject/guardian decision|2|||
160943632|NCT02460224|581183874|FG001|Overall Study|Subject/guardian decision|0|||
160943633|NCT02460224|581183875|FG002|Overall Study|Subject/guardian decision|1|||
160943634|NCT02460224|581183876|FG003|Overall Study|Subject/guardian decision|0|||
160943635|NCT02460224|581183877|FG004|Overall Study|Subject/guardian decision|2|||
160943636|NCT02460224|581183878|FG005|Overall Study|Subject/guardian decision|2|||
160943637|NCT02460224|581183879|FG006|Overall Study|Subject/guardian decision|0|||
160943638|NCT02460224|581183880|FG007|Overall Study|Subject/guardian decision|0|||
160943639|NCT02460224|581183881|FG008|Overall Study|Subject/guardian decision|1|||
160943640|NCT02460224|581183882|FG009|Overall Study|Subject/guardian decision|1|||
160999223|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
160943641|NCT02460224|581183883|FG010|Overall Study|Subject/guardian decision|0|||
160943642|NCT02460224|581183884|FG011|Overall Study|Subject/guardian decision|1|||
160943643|NCT02460224|581183885|FG012|Overall Study|Subject/guardian decision|0|||
160943644|NCT02460224|581183886|FG013|Overall Study|Subject/guardian decision|0|||
160943645|NCT02460224|581183887|FG014|Overall Study|Subject/guardian decision|0|||
160943646|NCT02460224|581183888|FG015|Overall Study|Subject/guardian decision|1|||
160943647|NCT02460224|581183889|FG016|Overall Study|Subject/guardian decision|0|||
160943648|NCT02460224|581183890|FG017|Overall Study|Subject/guardian decision|1|||
160943649|NCT02460224|581183891|FG018|Overall Study|Subject/guardian decision|2|||
160943650|NCT02460224|581183892|FG019|Overall Study|Subject/guardian decision|0|||
160943651|NCT02460224|581183893|FG020|Overall Study|Subject/guardian decision|0|||
160943652|NCT02460224|581183894|FG021|Overall Study|Subject/guardian decision|1|||
160943653|NCT02460224|581183895|FG022|Overall Study|Subject/guardian decision|0|||
160943654|NCT02460224|581183896|FG023|Overall Study|Subject/guardian decision|0|||
160943655|NCT02460224|581183897|FG024|Overall Study|Subject/guardian decision|0|||
160943656|NCT02460224|581183898|FG025|Overall Study|Subject/guardian decision|0|||
160943657|NCT02460224|581183899|FG026|Overall Study|Subject/guardian decision|6|||
160943658|NCT02460224|581183900|FG027|Overall Study|Subject/guardian decision|2|||
160943659|NCT02460224|581183901|FG028|Overall Study|Subject/guardian decision|3|||
160943660|NCT02774681|581183910|FG000|Treatment on Study|Progressive Disease|7|||
160943661|NCT02774681|581183910|FG000|Follow-Up for 3 Years|Death|11|||
160943662|NCT02774681|581183910|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
160943663|NCT03146650|581183913|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
160943664|NCT03146650|581183913|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
160943665|NCT03146650|581183913|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
160943666|NCT03146650|581183913|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
160943667|NCT03146650|581183913|FG000|2 Year Follow-up|Death|11|||
160943668|NCT03146650|581183913|FG000|2 Year Follow-up|Still in follow-up|7|||
160943669|NCT03146650|581183913|FG000|2 Year Follow-up|Lost to Follow-up|1|||
160943670|NCT02460198|581183916|FG000|Overall Study|Adverse Event|1|||
160943671|NCT02460198|581183917|FG001|Overall Study|Adverse Event|3|||
160943672|NCT02460198|581183916|FG000|Overall Study|Death|36|||
160943673|NCT02460198|581183917|FG001|Overall Study|Death|28|||
160999224|NCT01212757|581380693|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999225|NCT01212757|581380694|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
160999226|NCT01212757|581380695|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
160999227|NCT01212757|581380696|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999228|NCT01212757|581380697|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999229|NCT01212757|581380698|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999230|NCT01212757|581380699|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999231|NCT01212757|581380700|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999232|NCT01212757|581380701|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
160999233|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999234|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999235|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999236|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999237|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999238|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999239|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999240|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
160999241|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
160999242|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999243|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
160999244|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
160999245|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999246|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999247|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999248|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
160999249|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
160999250|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
160999251|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999252|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
160999253|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
160999254|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999255|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999256|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999257|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160999258|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
160999259|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
160943674|NCT02460198|581183916|FG000|Overall Study|Lost to Follow-up|1|||
160943675|NCT02460198|581183917|FG001|Overall Study|Lost to Follow-up|1|||
160943676|NCT02460198|581183916|FG000|Overall Study|Transferred to Extension Study|15|||
160943677|NCT02460198|581183917|FG001|Overall Study|Transferred to Extension Study|15|||
160943678|NCT02460198|581183916|FG000|Overall Study|Withdrawal by Subject|2|||
160943679|NCT02460198|581183917|FG001|Overall Study|Withdrawal by Subject|4|||
160943680|NCT02460198|581183916|FG000|Overall Study|Site Terminated By Sponsor|0|||
160943681|NCT02460198|581183917|FG001|Overall Study|Site Terminated By Sponsor|1|||
160943682|NCT02460198|581183916|FG000|Overall Study|Did Not Continue on Extension Study|6|||
160943683|NCT02460198|581183917|FG001|Overall Study|Did Not Continue on Extension Study|11|||
160943684|NCT00931307|581183918|FG000|Overall Study|Lack of Efficacy|12|||
160943685|NCT00931307|581183918|FG000|Overall Study|Biomicroscopy|1|||
160943686|NCT00965848|581183921|FG000|Overall Study|Protocol Violation|3|||
160943687|NCT00965848|581183922|FG001|Overall Study|Protocol Violation|0|||
160943688|NCT00965848|581183923|FG002|Overall Study|Protocol Violation|1|||
160943689|NCT00965848|581183921|FG000|Overall Study|Death|11|||
160943690|NCT00965848|581183922|FG001|Overall Study|Death|1|||
160943691|NCT00965848|581183923|FG002|Overall Study|Death|5|||
160943692|NCT00965848|581183921|FG000|Overall Study|Lost to Follow-up|0|||
160943693|NCT00965848|581183922|FG001|Overall Study|Lost to Follow-up|0|||
160943694|NCT00965848|581183923|FG002|Overall Study|Lost to Follow-up|1|||
160943695|NCT00965848|581183921|FG000|Overall Study|Withdrawal by Subject|1|||
160943696|NCT00965848|581183922|FG001|Overall Study|Withdrawal by Subject|0|||
160943697|NCT00965848|581183923|FG002|Overall Study|Withdrawal by Subject|0|||
160943698|NCT00965848|581183921|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
160943699|NCT00965848|581183922|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
160943700|NCT00965848|581183923|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
160943701|NCT00965848|581183921|FG000|Overall Study|Not Clinically Evaluable|7|||
160943702|NCT00965848|581183922|FG001|Overall Study|Not Clinically Evaluable|1|||
160943703|NCT00965848|581183923|FG002|Overall Study|Not Clinically Evaluable|1|||
160943704|NCT00965848|581183921|FG000|Overall Study|Other|5|||
160943705|NCT00965848|581183922|FG001|Overall Study|Other|0|||
160943706|NCT00965848|581183923|FG002|Overall Study|Other|1|||
160943707|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
160943708|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
160943709|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
160943710|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
160943711|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
160943712|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
160943713|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
160943714|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
160943715|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
160943716|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
161265743|NCT00507546|582354187|FG001|Overall Study|Physician Decision|1|||
161265744|NCT03512262|582354191|FG000|Overall Study|Adverse Event|8|||
161265745|NCT03512262|582354192|FG001|Overall Study|Adverse Event|3|||
161265746|NCT03512262|582354191|FG000|Overall Study|Death (non-treatment emergent)|1|||
161265747|NCT03512262|582354192|FG001|Overall Study|Death (non-treatment emergent)|0|||
161265748|NCT03512262|582354191|FG000|Overall Study|Withdrawal by Subject|17|||
161265749|NCT03512262|582354192|FG001|Overall Study|Withdrawal by Subject|9|||
161265750|NCT03512262|582354191|FG000|Overall Study|Lost to Follow-up|7|||
161265751|NCT03512262|582354192|FG001|Overall Study|Lost to Follow-up|1|||
161265752|NCT03512262|582354191|FG000|Overall Study|Other than Specified|2|||
161265753|NCT03512262|582354192|FG001|Overall Study|Other than Specified|2|||
161265754|NCT01299805|582354195|FG000|Overall Study|Adverse Event|2|||
160943717|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
160943718|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
160943719|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
160943720|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
160943721|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
160943722|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
160943723|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
160943724|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
160943725|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
160943726|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
160943727|NCT00813761|581183924|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
160943728|NCT00813761|581183925|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
160943729|NCT00813761|581183926|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
160943730|NCT00813761|581183927|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
160943731|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
160943732|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
160943733|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
161265755|NCT01299805|582354196|FG001|Overall Study|Adverse Event|0|||
160943734|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
160943735|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
160943736|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
160943737|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
160999260|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
161265756|NCT04394351|582355766|FG000|Part A (16 Weeks)|Adverse Event|1|||
161265757|NCT04394351|582355767|FG001|Part A (16 Weeks)|Adverse Event|0|||
161265758|NCT04394351|582355768|FG002|Part A (16 Weeks)|Adverse Event|0|||
161265759|NCT04394351|582355769|FG003|Part A (16 Weeks)|Adverse Event|0|||
161265760|NCT04394351|582355770|FG004|Part A (16 Weeks)|Adverse Event|0|||
161265761|NCT04394351|582355771|FG005|Part A (16 Weeks)|Adverse Event|0|||
161265762|NCT04394351|582355772|FG006|Part A (16 Weeks)|Adverse Event|0|||
160943738|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
160943739|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
160943740|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
160943741|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
160943742|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
160943743|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
160943744|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
160943745|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
160943746|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
160943747|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
160943748|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
160943749|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
160943750|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
160943751|NCT00813761|581183924|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
160943752|NCT00813761|581183925|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
160943753|NCT00813761|581183926|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
160943754|NCT00813761|581183927|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
160943755|NCT00691210|581183928|FG000|Overall Study|Progression of Disease|0|||
160943756|NCT00691210|581183929|FG001|Overall Study|Progression of Disease|0|||
160943757|NCT00691210|581183930|FG002|Overall Study|Progression of Disease|0|||
160943758|NCT00691210|581183931|FG003|Overall Study|Progression of Disease|2|||
160943759|NCT00691210|581183932|FG004|Overall Study|Progression of Disease|0|||
160943760|NCT00691210|581183933|FG005|Overall Study|Progression of Disease|0|||
160943761|NCT00691210|581183934|FG006|Overall Study|Progression of Disease|0|||
160943762|NCT00691210|581183935|FG007|Overall Study|Progression of Disease|0|||
160943763|NCT00691210|581183928|FG000|Overall Study|Lack of Efficacy|0|||
160943764|NCT00691210|581183929|FG001|Overall Study|Lack of Efficacy|0|||
160943765|NCT00691210|581183930|FG002|Overall Study|Lack of Efficacy|0|||
160943766|NCT00691210|581183931|FG003|Overall Study|Lack of Efficacy|1|||
160943767|NCT00691210|581183932|FG004|Overall Study|Lack of Efficacy|0|||
160943768|NCT00691210|581183933|FG005|Overall Study|Lack of Efficacy|1|||
160943769|NCT00691210|581183934|FG006|Overall Study|Lack of Efficacy|0|||
160943770|NCT00691210|581183935|FG007|Overall Study|Lack of Efficacy|0|||
160943771|NCT02047604|581183938|FG000|Overall Study|Withdrawal by Subject|0|||
160943772|NCT02047604|581183939|FG001|Overall Study|Withdrawal by Subject|0|||
160943773|NCT02047604|581183940|FG002|Overall Study|Withdrawal by Subject|0|||
160943774|NCT02047604|581183941|FG003|Overall Study|Withdrawal by Subject|0|||
160943775|NCT02047604|581183942|FG004|Overall Study|Withdrawal by Subject|1|||
160943776|NCT02047604|581183943|FG005|Overall Study|Withdrawal by Subject|1|||
160943777|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
160943778|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
160943779|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
160943780|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
160943781|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
160943782|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
160943783|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
160943784|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
160943785|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
160943786|NCT00983814|581183944|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
160943787|NCT00983814|581183945|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
160943788|NCT00983814|581183946|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
160943789|NCT00983814|581183944|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
160943790|NCT00983814|581183945|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
160943791|NCT00983814|581183946|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
160943792|NCT01181895|581183947|FG000|Overall Study|Adverse Event|3|||
160943793|NCT01181895|581183948|FG001|Overall Study|Adverse Event|1|||
160943794|NCT01181895|581183949|FG002|Overall Study|Adverse Event|1|||
161265763|NCT04394351|582355773|FG007|Part A (16 Weeks)|Adverse Event|0|||
161265764|NCT04394351|582355766|FG000|Part A (16 Weeks)|Physician Decision|0|||
160943795|NCT01181895|581183947|FG000|Overall Study|Lack of Efficacy|8|||
160943796|NCT01181895|581183948|FG001|Overall Study|Lack of Efficacy|9|||
160943797|NCT01181895|581183949|FG002|Overall Study|Lack of Efficacy|9|||
160943798|NCT01181895|581183947|FG000|Overall Study|Protocol Violation|2|||
160943799|NCT01181895|581183948|FG001|Overall Study|Protocol Violation|1|||
161265765|NCT04394351|582355767|FG001|Part A (16 Weeks)|Physician Decision|1|||
160943800|NCT01181895|581183949|FG002|Overall Study|Protocol Violation|0|||
160943801|NCT01181895|581183947|FG000|Overall Study|Lost to Follow-up|0|||
160943802|NCT01181895|581183948|FG001|Overall Study|Lost to Follow-up|1|||
160943803|NCT01181895|581183949|FG002|Overall Study|Lost to Follow-up|2|||
160943804|NCT01181895|581183947|FG000|Overall Study|Investigator Discretion|1|||
161265766|NCT04394351|582355768|FG002|Part A (16 Weeks)|Physician Decision|0|||
161265767|NCT04394351|582355769|FG003|Part A (16 Weeks)|Physician Decision|0|||
160943805|NCT01181895|581183948|FG001|Overall Study|Investigator Discretion|2|||
160943806|NCT01181895|581183949|FG002|Overall Study|Investigator Discretion|1|||
160999261|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
160999262|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
160999263|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999264|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999265|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999266|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160999267|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
160999268|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
160999269|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999270|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999271|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
160999272|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999273|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999274|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999275|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999276|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999277|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
160999278|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999279|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
160999280|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
160999281|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999282|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999283|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999284|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999285|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
160999286|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
160999287|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999288|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
160943807|NCT01181895|581183947|FG000|Overall Study|Withdrawal by Subject|3|||
160943808|NCT01181895|581183948|FG001|Overall Study|Withdrawal by Subject|0|||
160943809|NCT01181895|581183949|FG002|Overall Study|Withdrawal by Subject|5|||
160943810|NCT00555438|581183950|FG000|10 Days Post-operative|Death|4|||
160943811|NCT00555438|581183950|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
160943812|NCT02707640|581183951|FG000|Overall Study|Adverse Event|4|||
160943813|NCT02707640|581183952|FG001|Overall Study|Adverse Event|2|||
160943814|NCT02707640|581183951|FG000|Overall Study|Death|1|||
160943815|NCT02707640|581183952|FG001|Overall Study|Death|2|||
160943816|NCT02707640|581183951|FG000|Overall Study|Physician Decision|2|||
160943817|NCT02707640|581183952|FG001|Overall Study|Physician Decision|0|||
160943818|NCT02707640|581183951|FG000|Overall Study|Withdrawal by Subject|0|||
160943819|NCT02707640|581183952|FG001|Overall Study|Withdrawal by Subject|1|||
160943820|NCT02707640|581183951|FG000|Overall Study|Participant's Personal Decision|1|||
160943821|NCT02707640|581183952|FG001|Overall Study|Participant's Personal Decision|2|||
160943822|NCT02707640|581183951|FG000|Overall Study|Sponsor Discretion|1|||
160943823|NCT02707640|581183952|FG001|Overall Study|Sponsor Discretion|0|||
160943824|NCT02517905|581183953|FG000|Overall Study|Lost to Follow-up|4|||
160943825|NCT02517905|581183954|FG001|Overall Study|Lost to Follow-up|0|||
160943826|NCT02517905|581183953|FG000|Overall Study|Withdrawal by Subject|4|||
160943827|NCT02517905|581183954|FG001|Overall Study|Withdrawal by Subject|0|||
160943828|NCT02517905|581183953|FG000|Overall Study|Screen failure|2|||
160943829|NCT02517905|581183954|FG001|Overall Study|Screen failure|2|||
160943830|NCT05789875|581183955|FG000|Overall Study|Lost to Follow-up|6|||
160943831|NCT00023452|581183956|FG000|Overall Study|Ineligible for Study|163|||
160943832|NCT00023452|581183957|FG001|Overall Study|Ineligible for Study|159|||
160943833|NCT00023452|581183956|FG000|Overall Study|Out of Window|129|||
160943834|NCT00023452|581183957|FG001|Overall Study|Out of Window|69|||
160943835|NCT00023452|581183956|FG000|Overall Study|Death|2|||
160943836|NCT00023452|581183957|FG001|Overall Study|Death|0|||
160999289|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
160999290|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999291|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160943837|NCT00023452|581183956|FG000|Overall Study|Withdrawal by Subject|66|||
160943838|NCT00023452|581183957|FG001|Overall Study|Withdrawal by Subject|54|||
160999292|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999293|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
160999294|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
160999295|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
161319362|NCT01884545|582555286|FG001|Overall Study|Non-adherence|2|||
160943839|NCT00023452|581183956|FG000|Overall Study|Adverse Event|139|||
160943840|NCT00023452|581183957|FG001|Overall Study|Adverse Event|196|||
160943841|NCT00023452|581183956|FG000|Overall Study|Lost to Follow-up|293|||
160943842|NCT00023452|581183957|FG001|Overall Study|Lost to Follow-up|60|||
160943843|NCT00023452|581183956|FG000|Overall Study|Physician Decision|49|||
160943844|NCT00023452|581183957|FG001|Overall Study|Physician Decision|21|||
160943845|NCT00023452|581183956|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
160943846|NCT00023452|581183957|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
160943847|NCT00023452|581183956|FG000|Overall Study|Pregnant|53|||
160943848|NCT00023452|581183957|FG001|Overall Study|Pregnant|20|||
160943849|NCT00023452|581183956|FG000|Overall Study|Other|204|||
160943850|NCT00023452|581183957|FG001|Overall Study|Other|69|||
160943851|NCT01994395|581183958|FG000|Overall Study|Withdrawal by Subject|1|||
160943852|NCT01994395|581183959|FG001|Overall Study|Withdrawal by Subject|2|||
160943853|NCT00459134|581183967|FG000|Overall Study|Physician Decision|1|||
160943854|NCT00459134|581183968|FG001|Overall Study|Physician Decision|1|||
160943855|NCT00459134|581183967|FG000|Overall Study|Withdrawal by Subject|8|||
160943856|NCT00459134|581183968|FG001|Overall Study|Withdrawal by Subject|7|||
160943857|NCT00459134|581183967|FG000|Overall Study|Lost to Follow-up|6|||
160943858|NCT00459134|581183968|FG001|Overall Study|Lost to Follow-up|7|||
160943859|NCT00459134|581183967|FG000|Overall Study|Surgery|1|||
160943860|NCT00459134|581183968|FG001|Overall Study|Surgery|2|||
160943861|NCT00459134|581183967|FG000|Overall Study|Toxicity|4|||
160943862|NCT00459134|581183968|FG001|Overall Study|Toxicity|5|||
160943863|NCT00459134|581183967|FG000|Overall Study|Progression|1|||
160943864|NCT00459134|581183968|FG001|Overall Study|Progression|0|||
160943865|NCT00459134|581183967|FG000|Overall Study|Multiple Reasons|2|||
160943866|NCT00459134|581183968|FG001|Overall Study|Multiple Reasons|3|||
160943867|NCT03333486|581183969|FG000|Overall Study|Withdrawal by Subject|1|||
160943868|NCT03333486|581183969|FG000|Overall Study|Lost to Follow-up|1|||
160943869|NCT01755416|581183973|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
160943870|NCT01755416|581183974|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
160943871|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
160943872|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
160943873|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
160943874|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
160943875|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
160943876|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
160943877|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
160943878|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
160943879|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
160943880|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
160943881|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
160943882|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
160943883|NCT03246529|581183982|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
160943884|NCT03246529|581183983|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
160943885|NCT03246529|581183984|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
160943886|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
160943887|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
160943888|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
160943889|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
160943890|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
160943891|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
160943892|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
160943893|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
160943894|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
160943895|NCT03246529|581183982|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
160943896|NCT03246529|581183983|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
160943897|NCT03246529|581183984|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
160943898|NCT00441337|581183985|FG000|Overall Study|Disease Progression|6|||
160943899|NCT00441337|581183986|FG001|Overall Study|Disease Progression|6|||
160943900|NCT00441337|581183987|FG002|Overall Study|Disease Progression|4|||
160943901|NCT00441337|581183988|FG003|Overall Study|Disease Progression|18|||
160943902|NCT00441337|581183985|FG000|Overall Study|Lost to Follow-up|0|||
160943903|NCT00441337|581183986|FG001|Overall Study|Lost to Follow-up|0|||
161265768|NCT04394351|582355770|FG004|Part A (16 Weeks)|Physician Decision|0|||
161265769|NCT04394351|582355771|FG005|Part A (16 Weeks)|Physician Decision|0|||
160943904|NCT00441337|581183987|FG002|Overall Study|Lost to Follow-up|0|||
160943905|NCT00441337|581183988|FG003|Overall Study|Lost to Follow-up|1|||
160943906|NCT00441337|581183985|FG000|Overall Study|Sponsor Decision|0|||
160943907|NCT00441337|581183986|FG001|Overall Study|Sponsor Decision|0|||
160943908|NCT00441337|581183987|FG002|Overall Study|Sponsor Decision|1|||
160943909|NCT00441337|581183988|FG003|Overall Study|Sponsor Decision|2|||
160943910|NCT00441337|581183985|FG000|Overall Study|Did not meet inclusion criteria|0|||
160943911|NCT00441337|581183986|FG001|Overall Study|Did not meet inclusion criteria|0|||
161265770|NCT04394351|582355772|FG006|Part A (16 Weeks)|Physician Decision|0|||
161265771|NCT04394351|582355773|FG007|Part A (16 Weeks)|Physician Decision|0|||
161265772|NCT04394351|582355766|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
161265773|NCT04394351|582355767|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
161265774|NCT04394351|582355768|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
161265775|NCT04394351|582355769|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
161265776|NCT04394351|582355770|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
160943912|NCT00441337|581183987|FG002|Overall Study|Did not meet inclusion criteria|1|||
160943913|NCT00441337|581183988|FG003|Overall Study|Did not meet inclusion criteria|0|||
160943914|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
160943915|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
160943916|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
160943917|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Death|1|||
160943918|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Death|0|||
160943919|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Death|0|||
160943920|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
160943921|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
160943922|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
160943923|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
160943924|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
160943925|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
160943926|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
160943927|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
160943928|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
160943929|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
160943930|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
160943931|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
160943932|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
160943933|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
160943934|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
160943935|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
160943936|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
160943937|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
160943938|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
160943939|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
160943940|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
160943941|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
160943942|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
160943943|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
160943944|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
160943945|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
160943946|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
160943947|NCT03655236|581183989|FG000|Subject Disposition in Part 1 Period|Other|0|||
160943948|NCT03655236|581183990|FG001|Subject Disposition in Part 1 Period|Other|2|||
160943949|NCT03655236|581183991|FG002|Subject Disposition in Part 1 Period|Other|2|||
160943950|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
160943951|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
160943952|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
160943953|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
160943954|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
160943955|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
160943956|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
160943957|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
160943958|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
160943959|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
160943960|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
160943961|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
160999296|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999297|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999298|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
161265777|NCT04394351|582355771|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
161265778|NCT04394351|582355772|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
161265779|NCT04394351|582355773|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
161265780|NCT04394351|582355766|FG000|Part B (36 Weeks)|Adverse Event|0|||
161265781|NCT04394351|582355767|FG001|Part B (36 Weeks)|Adverse Event|0|||
161342670|NCT00879658|582642233|FG002|Overall Study|Protocol Violation|0|||
161342671|NCT00879658|582642234|FG003|Overall Study|Protocol Violation|0|||
160943962|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
160943963|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
160943964|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
160943965|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
160943966|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
160943967|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
160943968|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
160943969|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
160943970|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
160943971|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
160943972|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
160943973|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
160943974|NCT03655236|581183989|FG000|Subject Disposition in Part 2 Period|Other|1|||
160943975|NCT03655236|581183990|FG001|Subject Disposition in Part 2 Period|Other|0|||
160943976|NCT03655236|581183991|FG002|Subject Disposition in Part 2 Period|Other|0|||
160943977|NCT06748040|581183992|FG000|Overall Study|Death|3|||
160943978|NCT06748040|581183993|FG001|Overall Study|Death|4|||
160943979|NCT06748040|581183992|FG000|Overall Study|Lost to Follow-up|134|||
160943980|NCT06748040|581183993|FG001|Overall Study|Lost to Follow-up|132|||
160943981|NCT06748040|581183992|FG000|Overall Study|Withdrawal by Subject|3|||
160943982|NCT06748040|581183993|FG001|Overall Study|Withdrawal by Subject|5|||
160943983|NCT03136068|581185759|FG000|Overall Study|Lost to Follow-up|1|||
160943984|NCT03136068|581185760|FG001|Overall Study|Lost to Follow-up|1|||
160943985|NCT03136068|581185759|FG000|Overall Study|Protocol Violation|1|||
160943986|NCT03136068|581185760|FG001|Overall Study|Protocol Violation|0|||
160943987|NCT00432380|581185764|FG000|Overall Study|Migrated/moved from study area|3|||
160943988|NCT00432380|581185765|FG001|Overall Study|Migrated/moved from study area|4|||
160943989|NCT00432380|581185766|FG002|Overall Study|Migrated/moved from study area|1|||
160943990|NCT00432380|581185764|FG000|Overall Study|Adverse Event|1|||
160943991|NCT00432380|581185765|FG001|Overall Study|Adverse Event|0|||
160943992|NCT00432380|581185766|FG002|Overall Study|Adverse Event|0|||
160943993|NCT01071395|581185767|FG000|Overall Study|Withdrawal by Subject|2|||
160943994|NCT01071395|581185768|FG001|Overall Study|Withdrawal by Subject|1|||
160943995|NCT01071395|581185767|FG000|Overall Study|Adverse Event|3|||
160943996|NCT01071395|581185768|FG001|Overall Study|Adverse Event|1|||
160943997|NCT00612066|581185769|FG000|Overall Study|Adverse Event|1|||
160943998|NCT01337089|581185770|FG000|Overall Study|Adverse Event|237|||
160943999|NCT01337089|581185770|FG000|Overall Study|Withdrawal by Subject|129|||
160944000|NCT01337089|581185770|FG000|Overall Study|Withdrawal by Investigator|33|||
160944001|NCT01337089|581185770|FG000|Overall Study|Met Withdrawal Criteria|3|||
160944002|NCT01337089|581185770|FG000|Overall Study|Lost to Follow-up|2|||
160944003|NCT04419493|581185771|FG000|Wash-out After Period 1|Adverse Event|1|||
160944004|NCT04419493|581185772|FG001|Wash-out After Period 1|Adverse Event|2|||
160944005|NCT04419493|581185773|FG002|Wash-out After Period 1|Adverse Event|1|||
160944006|NCT04419493|581185774|FG003|Wash-out After Period 1|Adverse Event|0|||
160944007|NCT00524134|581185775|FG000|Overall Study|Withdrawal by Subject|1|||
160944008|NCT00524134|581185775|FG000|Overall Study|Physician Decision|1|||
160944009|NCT03794089|581185776|FG000|Overall Study|Lost to Follow-up|4|||
160944010|NCT03794089|581185777|FG001|Overall Study|Lost to Follow-up|1|||
160944011|NCT03794089|581185776|FG000|Overall Study|Withdrawal by Subject|2|||
160944012|NCT03794089|581185777|FG001|Overall Study|Withdrawal by Subject|0|||
160944013|NCT03985423|581185778|FG000|Overall Study|Adverse Event|1|||
160944014|NCT03985423|581185778|FG000|Overall Study|Death|2|||
160944015|NCT03985423|581185778|FG000|Overall Study|Physician Decision|1|||
160944016|NCT03985423|581185778|FG000|Overall Study|Withdrawal by Subject|2|||
160944017|NCT03985423|581185778|FG000|Overall Study|Lack of insurance and citizenship|1|||
160944018|NCT01045447|581185789|FG000|Overall Study|Adverse Event|0|||
160944019|NCT01045447|581185790|FG001|Overall Study|Adverse Event|1|||
160944020|NCT01045447|581185789|FG000|Overall Study|Lack of Efficacy|3|||
160944021|NCT01045447|581185790|FG001|Overall Study|Lack of Efficacy|1|||
160944022|NCT01045447|581185789|FG000|Overall Study|Protocol Violation|6|||
160999299|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160944023|NCT01045447|581185790|FG001|Overall Study|Protocol Violation|3|||
160944024|NCT01045447|581185789|FG000|Overall Study|Withdrawal Criteria|10|||
160944025|NCT01045447|581185790|FG001|Overall Study|Withdrawal Criteria|10|||
160944026|NCT01045447|581185789|FG000|Overall Study|Unclassified|17|||
160944027|NCT01045447|581185790|FG001|Overall Study|Unclassified|13|||
161265782|NCT04394351|582355768|FG002|Part B (36 Weeks)|Adverse Event|0|||
160944028|NCT01782131|581185794|FG000|Overall Study|Death|93|||
160944029|NCT01782131|581185795|FG001|Overall Study|Death|96|||
160944030|NCT01782131|581185794|FG000|Overall Study|Lost to Follow-up|1|||
160944031|NCT01782131|581185795|FG001|Overall Study|Lost to Follow-up|3|||
160944032|NCT01782131|581185794|FG000|Overall Study|Withdrawal by Subject|10|||
160944033|NCT01782131|581185795|FG001|Overall Study|Withdrawal by Subject|10|||
160944034|NCT01782131|581185794|FG000|Overall Study|Randomized but not treated|5|||
160944035|NCT01782131|581185795|FG001|Overall Study|Randomized but not treated|5|||
160944036|NCT01782131|581185794|FG000|Overall Study|Reason not provided|0|||
160944037|NCT01782131|581185795|FG001|Overall Study|Reason not provided|1|||
160944038|NCT01627249|581185796|FG000|Overall Study|Death|3|||
160944039|NCT01627249|581185797|FG001|Overall Study|Death|5|||
160944040|NCT01627249|581185798|FG002|Overall Study|Death|3|||
160944041|NCT01627249|581185796|FG000|Overall Study|Withdrawal by Subject|12|||
160944042|NCT01627249|581185797|FG001|Overall Study|Withdrawal by Subject|6|||
160944043|NCT01627249|581185798|FG002|Overall Study|Withdrawal by Subject|9|||
160944044|NCT01627249|581185796|FG000|Overall Study|Missed Visit|1|||
160944045|NCT01627249|581185797|FG001|Overall Study|Missed Visit|1|||
160944046|NCT01627249|581185798|FG002|Overall Study|Missed Visit|0|||
160944047|NCT00796718|581185799|FG000|Overall Study|Adverse Event|2|||
160944048|NCT00796718|581185799|FG000|Overall Study|Exclusion Criteria|1|||
160944049|NCT00796718|581185799|FG000|Overall Study|Lost to Follow-up|5|||
160944050|NCT00796718|581185799|FG000|Overall Study|Withdrawal by Informed Consent|1|||
160944051|NCT03266588|581185800|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
160944052|NCT03266588|581185801|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
160944053|NCT03266588|581185802|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
160944054|NCT03266588|581185800|FG000|Observational Period|Withdrawal by Subject|44|||
160944055|NCT03266588|581185801|FG001|Observational Period|Withdrawal by Subject|22|||
160944056|NCT03266588|581185802|FG002|Observational Period|Withdrawal by Subject|13|||
160944057|NCT03266588|581185800|FG000|Observational Period|Non-compliance|18|||
160944058|NCT03266588|581185801|FG001|Observational Period|Non-compliance|12|||
160944059|NCT03266588|581185802|FG002|Observational Period|Non-compliance|10|||
160944060|NCT03266588|581185800|FG000|Observational Period|Lost to Follow-up|8|||
160944061|NCT03266588|581185801|FG001|Observational Period|Lost to Follow-up|12|||
160944062|NCT03266588|581185802|FG002|Observational Period|Lost to Follow-up|4|||
160944063|NCT03266588|581185800|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
160944064|NCT03266588|581185801|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
160944065|NCT03266588|581185802|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
160944066|NCT03266588|581185800|FG000|Observational Period|Protocol Deviation|1|||
160944067|NCT03266588|581185801|FG001|Observational Period|Protocol Deviation|0|||
160944068|NCT03266588|581185802|FG002|Observational Period|Protocol Deviation|0|||
160944069|NCT03266588|581185800|FG000|Observational Period|Other Reasons|3|||
160944070|NCT03266588|581185801|FG001|Observational Period|Other Reasons|0|||
160944071|NCT03266588|581185802|FG002|Observational Period|Other Reasons|1|||
160944072|NCT03266588|581185800|FG000|Long-term Treatment Period|Adverse Event|33|||
160944073|NCT03266588|581185801|FG001|Long-term Treatment Period|Adverse Event|17|||
160944074|NCT03266588|581185802|FG002|Long-term Treatment Period|Adverse Event|8|||
160944075|NCT03266588|581185800|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
160944076|NCT03266588|581185801|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
160944077|NCT03266588|581185802|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
160944078|NCT03266588|581185800|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
160944079|NCT03266588|581185801|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
160944080|NCT03266588|581185802|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
160944081|NCT03266588|581185800|FG000|Long-term Treatment Period|Non-Compliance|126|||
160944082|NCT03266588|581185801|FG001|Long-term Treatment Period|Non-Compliance|57|||
160944083|NCT03266588|581185802|FG002|Long-term Treatment Period|Non-Compliance|7|||
160944084|NCT03266588|581185800|FG000|Long-term Treatment Period|Pregnancy|11|||
160944085|NCT03266588|581185801|FG001|Long-term Treatment Period|Pregnancy|5|||
161265783|NCT04394351|582355769|FG003|Part B (36 Weeks)|Adverse Event|0|||
161265784|NCT04394351|582355770|FG004|Part B (36 Weeks)|Adverse Event|0|||
160944086|NCT03266588|581185802|FG002|Long-term Treatment Period|Pregnancy|0|||
160944087|NCT03266588|581185800|FG000|Long-term Treatment Period|Protocol Deviation|17|||
160944088|NCT03266588|581185801|FG001|Long-term Treatment Period|Protocol Deviation|10|||
160944089|NCT03266588|581185802|FG002|Long-term Treatment Period|Protocol Deviation|4|||
160944090|NCT03266588|581185800|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
160944091|NCT03266588|581185801|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
161265785|NCT04394351|582355771|FG005|Part B (36 Weeks)|Adverse Event|0|||
161265786|NCT04394351|582355772|FG006|Part B (36 Weeks)|Adverse Event|1|||
161265787|NCT04394351|582355773|FG007|Part B (36 Weeks)|Adverse Event|0|||
161265788|NCT04394351|582355766|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160944092|NCT03266588|581185802|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
160944093|NCT03266588|581185800|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
160944094|NCT03266588|581185801|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
160944095|NCT03266588|581185802|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
160944096|NCT03266588|581185800|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
160944097|NCT03266588|581185801|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
161265789|NCT04394351|582355767|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160944098|NCT03266588|581185802|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
160944099|NCT03266588|581185800|FG000|Long-term Treatment Period|Other Reasons|5|||
161319363|NCT01884545|582555287|FG002|Overall Study|Non-adherence|0|||
160944100|NCT03266588|581185801|FG001|Long-term Treatment Period|Other Reasons|0|||
160944101|NCT03266588|581185802|FG002|Long-term Treatment Period|Other Reasons|0|||
160944102|NCT03266588|581185800|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
160944103|NCT03266588|581185801|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
160944104|NCT03266588|581185802|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
160944105|NCT02627677|581185804|FG000|Overall Study|Adverse event (not progressive disease)|1|||
160944106|NCT02627677|581185805|FG001|Overall Study|Adverse event (not progressive disease)|4|||
160944107|NCT02627677|581185806|FG002|Overall Study|Adverse event (not progressive disease)|1|||
160944108|NCT02627677|581185804|FG000|Overall Study|Progressive disease|1|||
160944109|NCT02627677|581185805|FG001|Overall Study|Progressive disease|3|||
160944110|NCT02627677|581185806|FG002|Overall Study|Progressive disease|0|||
160944111|NCT02627677|581185804|FG000|Overall Study|Lack of Efficacy|1|||
160944112|NCT02627677|581185805|FG001|Overall Study|Lack of Efficacy|2|||
160944113|NCT02627677|581185806|FG002|Overall Study|Lack of Efficacy|0|||
160944114|NCT02627677|581185804|FG000|Overall Study|Lost to Follow-up|0|||
160944115|NCT02627677|581185805|FG001|Overall Study|Lost to Follow-up|0|||
160944116|NCT02627677|581185806|FG002|Overall Study|Lost to Follow-up|1|||
160944117|NCT02627677|581185804|FG000|Overall Study|Pregnancy|0|||
160944118|NCT02627677|581185805|FG001|Overall Study|Pregnancy|1|||
160944119|NCT02627677|581185806|FG002|Overall Study|Pregnancy|0|||
160944120|NCT02627677|581185804|FG000|Overall Study|Study Terminated by Sponsor|5|||
160944121|NCT02627677|581185805|FG001|Overall Study|Study Terminated by Sponsor|10|||
160944122|NCT02627677|581185806|FG002|Overall Study|Study Terminated by Sponsor|6|||
160944123|NCT02627677|581185804|FG000|Overall Study|Physician Decision|0|||
160944124|NCT02627677|581185805|FG001|Overall Study|Physician Decision|0|||
160944125|NCT02627677|581185806|FG002|Overall Study|Physician Decision|2|||
160944126|NCT02627677|581185804|FG000|Overall Study|Withdrawal by Subject|2|||
160944127|NCT02627677|581185805|FG001|Overall Study|Withdrawal by Subject|1|||
160944128|NCT02627677|581185806|FG002|Overall Study|Withdrawal by Subject|1|||
160944129|NCT02627677|581185804|FG000|Overall Study|Reason not Specified|0|||
160944130|NCT02627677|581185805|FG001|Overall Study|Reason not Specified|0|||
160944131|NCT02627677|581185806|FG002|Overall Study|Reason not Specified|1|||
160944132|NCT02627677|581185804|FG000|Overall Study|Randomized but not Treated|1|||
160944133|NCT02627677|581185805|FG001|Overall Study|Randomized but not Treated|0|||
160944134|NCT02627677|581185806|FG002|Overall Study|Randomized but not Treated|0|||
160944135|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Adverse Event|5|||
160944136|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Adverse Event|8|||
160944137|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Adverse Event|4|||
160944138|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Adverse Event|8|||
160944139|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
160944140|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
160944141|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
160944142|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
160944143|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
160944144|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
160944145|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
160944146|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
160944147|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Physician Decision|1|||
160944148|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Physician Decision|0|||
160944149|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Physician Decision|0|||
160944150|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Physician Decision|0|||
160944151|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
160944152|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
160944153|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
160944154|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
160944155|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Pregnancy|0|||
160944156|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Pregnancy|1|||
160944157|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Pregnancy|0|||
160944158|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Pregnancy|0|||
160944159|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
160944160|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
160944161|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
160944162|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
160944163|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Death|0|||
160999300|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160944164|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Death|1|||
160944165|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Death|0|||
160944166|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Death|0|||
160944167|NCT00071487|581185812|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
160944168|NCT00071487|581185813|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
160944169|NCT00071487|581185814|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
160944170|NCT00071487|581185815|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
160944171|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
160944172|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
161265790|NCT04394351|582355768|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161265791|NCT04394351|582355769|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160944173|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
160944174|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
160944175|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160944176|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160944177|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
160944178|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
160944179|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160944180|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160944181|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
160944182|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
160944183|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
160944184|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
160944185|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
160944186|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
160944187|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160944188|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160944189|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
160944190|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
160944191|NCT00071487|581185812|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160944192|NCT00071487|581185813|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160944193|NCT00071487|581185814|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
160944194|NCT00071487|581185815|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
160944195|NCT01073618|581185820|FG000|Overall Study|Death|208|||
160944196|NCT01073618|581185820|FG000|Overall Study|Adverse Event|19|||
160944197|NCT01073618|581185820|FG000|Overall Study|Other|80|||
160944198|NCT02044510|581185823|FG000|Overall Study|Adverse Event|1|||
160944199|NCT02044510|581185824|FG001|Overall Study|Adverse Event|2|||
160944200|NCT00975975|581185831|FG000|Overall Study|Death|6|||
160944201|NCT02496884|581185836|FG000|Overall Study|Counted twice as enrolled|2|||
160944202|NCT02496884|581185837|FG001|Overall Study|Counted twice as enrolled|0|||
160944203|NCT02496884|581185838|FG002|Overall Study|Counted twice as enrolled|0|||
160944204|NCT02496884|581185839|FG003|Overall Study|Counted twice as enrolled|0|||
160944205|NCT02496884|581185836|FG000|Overall Study|Withdrawal by Subject|0|||
160944206|NCT02496884|581185837|FG001|Overall Study|Withdrawal by Subject|3|||
160944207|NCT02496884|581185838|FG002|Overall Study|Withdrawal by Subject|0|||
160944208|NCT02496884|581185839|FG003|Overall Study|Withdrawal by Subject|0|||
160944209|NCT00807092|581185842|FG000|Overall Study|Adverse Event|0|||
160944210|NCT00807092|581185843|FG001|Overall Study|Adverse Event|1|||
160944211|NCT00807092|581185842|FG000|Overall Study|Protocol Violation|0|||
160944212|NCT00807092|581185843|FG001|Overall Study|Protocol Violation|2|||
160944213|NCT00807092|581185842|FG000|Overall Study|Withdrawal by Subject|1|||
160944214|NCT00807092|581185843|FG001|Overall Study|Withdrawal by Subject|0|||
160944215|NCT00807092|581185842|FG000|Overall Study|CGMS data collection failed|0|||
160944216|NCT00807092|581185843|FG001|Overall Study|CGMS data collection failed|1|||
160944217|NCT03224468|581185852|FG000|Overall Study|Did not obtain MM card|53|||
160944218|NCT03224468|581185853|FG001|Overall Study|Did not obtain MM card|0|||
160944219|NCT03224468|581185852|FG000|Overall Study|Lost to Follow-up|4|||
160944220|NCT03224468|581185853|FG001|Overall Study|Lost to Follow-up|11|||
160944221|NCT03224468|581185852|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
160944222|NCT03224468|581185853|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
160944223|NCT04713748|581185854|FG000|Overall Study|Not enough kits allocated|35|||
160944224|NCT04067141|581185855|FG000|First Intervention|Withdrawal by Subject|0|||
160944225|NCT04067141|581185856|FG001|First Intervention|Withdrawal by Subject|1|||
160944226|NCT04067141|581185855|FG000|Second Intervention|Adverse Event|0|||
160944227|NCT04067141|581185856|FG001|Second Intervention|Adverse Event|2|||
160944228|NCT01557946|581185857|FG000|Overall Study|Adverse Event|3|||
160944229|NCT01557946|581185858|FG001|Overall Study|Adverse Event|0|||
160944230|NCT05402995|581185861|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
160944231|NCT05402995|581185862|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
160944232|NCT05402995|581185863|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
160944233|NCT05402995|581185864|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
160944234|NCT00958880|581185876|FG000|Overall Study|Lost to Follow-up|2|||
160944235|NCT00958880|581185877|FG001|Overall Study|Lost to Follow-up|2|||
160944236|NCT01971346|581185878|FG000|Overall Study|Protocol Violation|3|||
160944237|NCT01971346|581185878|FG000|Overall Study|Lost to Follow-up|2|||
160944238|NCT01971346|581185878|FG000|Overall Study|Withdrawal by Subject|2|||
160944239|NCT01971346|581185878|FG000|Overall Study|Physician Decision|1|||
160944240|NCT04187196|581185879|FG000|Overall Study|Screen Failure|2|||
160944241|NCT04187196|581185880|FG001|Overall Study|Screen Failure|0|||
160944242|NCT01687166|581185881|FG000|Overall Study|Attempt subject|2|||
160944243|NCT01687166|581185882|FG001|Overall Study|Attempt subject|3|||
160944244|NCT01687166|581185883|FG002|Overall Study|Attempt subject|2|||
160944245|NCT01687166|581185884|FG003|Overall Study|Attempt subject|0|||
160944246|NCT01687166|581185881|FG000|Overall Study|Did not meet eligibility criteria|4|||
160944247|NCT01687166|581185882|FG001|Overall Study|Did not meet eligibility criteria|6|||
160944248|NCT01687166|581185883|FG002|Overall Study|Did not meet eligibility criteria|1|||
160944249|NCT01687166|581185884|FG003|Overall Study|Did not meet eligibility criteria|1|||
160944250|NCT01687166|581185881|FG000|Overall Study|Adverse Event|2|||
160944251|NCT01687166|581185882|FG001|Overall Study|Adverse Event|1|||
160944252|NCT01687166|581185883|FG002|Overall Study|Adverse Event|0|||
160944253|NCT01687166|581185884|FG003|Overall Study|Adverse Event|0|||
160944254|NCT01687166|581185881|FG000|Overall Study|Physician Decision|3|||
160944255|NCT01687166|581185882|FG001|Overall Study|Physician Decision|2|||
160944256|NCT01687166|581185883|FG002|Overall Study|Physician Decision|1|||
160944257|NCT01687166|581185884|FG003|Overall Study|Physician Decision|0|||
160944258|NCT01687166|581185881|FG000|Overall Study|Withdrawal by Subject|11|||
160944259|NCT01687166|581185882|FG001|Overall Study|Withdrawal by Subject|4|||
160944260|NCT01687166|581185883|FG002|Overall Study|Withdrawal by Subject|3|||
160944261|NCT01687166|581185884|FG003|Overall Study|Withdrawal by Subject|0|||
160944262|NCT01687166|581185881|FG000|Overall Study|Lost to Follow-up|2|||
160944263|NCT01687166|581185882|FG001|Overall Study|Lost to Follow-up|5|||
160944264|NCT01687166|581185883|FG002|Overall Study|Lost to Follow-up|1|||
160944265|NCT01687166|581185884|FG003|Overall Study|Lost to Follow-up|0|||
160944266|NCT01687166|581185881|FG000|Overall Study|Equipment/Device Availability|0|||
160944267|NCT01687166|581185882|FG001|Overall Study|Equipment/Device Availability|1|||
160944268|NCT01687166|581185883|FG002|Overall Study|Equipment/Device Availability|0|||
160944269|NCT01687166|581185884|FG003|Overall Study|Equipment/Device Availability|0|||
160944270|NCT01687166|581185881|FG000|Overall Study|Death|1|||
160944271|NCT01687166|581185882|FG001|Overall Study|Death|1|||
160944272|NCT01687166|581185883|FG002|Overall Study|Death|0|||
160944273|NCT01687166|581185884|FG003|Overall Study|Death|0|||
160944274|NCT01687166|581185881|FG000|Overall Study|Protocol Violation|1|||
160944275|NCT01687166|581185882|FG001|Overall Study|Protocol Violation|1|||
160944276|NCT01687166|581185883|FG002|Overall Study|Protocol Violation|1|||
160944277|NCT01687166|581185884|FG003|Overall Study|Protocol Violation|0|||
160944278|NCT01687166|581185881|FG000|Overall Study|Subject moved out of state|0|||
160944279|NCT01687166|581185882|FG001|Overall Study|Subject moved out of state|1|||
160944280|NCT01687166|581185883|FG002|Overall Study|Subject moved out of state|0|||
160944281|NCT01687166|581185884|FG003|Overall Study|Subject moved out of state|0|||
160944282|NCT01687166|581185881|FG000|Overall Study|Patient unable to be compliant|1|||
160944283|NCT01687166|581185882|FG001|Overall Study|Patient unable to be compliant|0|||
160944284|NCT01687166|581185883|FG002|Overall Study|Patient unable to be compliant|0|||
160944285|NCT01687166|581185884|FG003|Overall Study|Patient unable to be compliant|0|||
160944286|NCT01687166|581185881|FG000|Overall Study|Physician choice to use different device|1|||
160944287|NCT01687166|581185882|FG001|Overall Study|Physician choice to use different device|2|||
160944288|NCT01687166|581185883|FG002|Overall Study|Physician choice to use different device|4|||
160944289|NCT01687166|581185884|FG003|Overall Study|Physician choice to use different device|0|||
160944290|NCT01687166|581185881|FG000|Overall Study|Insurance|0|||
160944291|NCT01687166|581185882|FG001|Overall Study|Insurance|0|||
160944292|NCT01687166|581185883|FG002|Overall Study|Insurance|1|||
160944293|NCT01687166|581185884|FG003|Overall Study|Insurance|1|||
160944294|NCT02755831|581185885|FG000|Overall Study|Lost to Follow-up|3|||
160944295|NCT02755831|581185886|FG001|Overall Study|Lost to Follow-up|3|||
160944296|NCT02316717|581185887|FG000|Overall Study|Adverse Event|2|||
160944297|NCT02316717|581185888|FG001|Overall Study|Adverse Event|2|||
160944298|NCT02316717|581185889|FG002|Overall Study|Adverse Event|0|||
160944299|NCT02316717|581185887|FG000|Overall Study|Lost to Follow-up|1|||
160944300|NCT02316717|581185888|FG001|Overall Study|Lost to Follow-up|2|||
160944301|NCT02316717|581185889|FG002|Overall Study|Lost to Follow-up|1|||
160944302|NCT02316717|581185887|FG000|Overall Study|Non compliance|3|||
160944303|NCT02316717|581185888|FG001|Overall Study|Non compliance|1|||
160944304|NCT02316717|581185889|FG002|Overall Study|Non compliance|0|||
160944305|NCT02316717|581185887|FG000|Overall Study|Protocol Violation|2|||
160944306|NCT02316717|581185888|FG001|Overall Study|Protocol Violation|0|||
160944307|NCT02316717|581185889|FG002|Overall Study|Protocol Violation|0|||
160944308|NCT02316717|581185887|FG000|Overall Study|Withdrawal by Subject|2|||
160944309|NCT02316717|581185888|FG001|Overall Study|Withdrawal by Subject|1|||
160944310|NCT02316717|581185889|FG002|Overall Study|Withdrawal by Subject|1|||
160944311|NCT02316717|581185887|FG000|Overall Study|Death|0|||
160944312|NCT02316717|581185888|FG001|Overall Study|Death|0|||
160944313|NCT02316717|581185889|FG002|Overall Study|Death|1|||
160944314|NCT02316717|581185887|FG000|Overall Study|Physician Decision|0|||
160944315|NCT02316717|581185888|FG001|Overall Study|Physician Decision|1|||
160944316|NCT02316717|581185889|FG002|Overall Study|Physician Decision|0|||
160944317|NCT02316717|581185887|FG000|Overall Study|TBC|1|||
160944318|NCT02316717|581185888|FG001|Overall Study|TBC|0|||
160944319|NCT02316717|581185889|FG002|Overall Study|TBC|0|||
160944320|NCT02296112|581185890|FG000|Overall Study|Disease progression|7|||
160944321|NCT02296112|581185890|FG000|Overall Study|Toxicity|1|||
160944322|NCT02296112|581185890|FG000|Overall Study|Began an alternate therapy|1|||
160944323|NCT00298831|581185891|FG000|Overall Study|Adverse Event|1|||
160944324|NCT00298831|581185891|FG000|Overall Study|Lost to Follow-up|3|||
160944325|NCT00298831|581185891|FG000|Overall Study|Withdrawal by Subject|1|||
160944326|NCT00298831|581185891|FG000|Overall Study|Participants did not receive treatment|27|||
160944327|NCT01516879|581185892|FG000|Overall Study|Withdrawal by Subject|9|||
160944328|NCT01516879|581185893|FG001|Overall Study|Withdrawal by Subject|11|||
160944329|NCT01516879|581185892|FG000|Overall Study|Death|0|||
160944330|NCT01516879|581185893|FG001|Overall Study|Death|2|||
160944331|NCT01516879|581185892|FG000|Overall Study|Lost to Follow-up|2|||
160944332|NCT01516879|581185893|FG001|Overall Study|Lost to Follow-up|11|||
160944333|NCT01516879|581185892|FG000|Overall Study|Other|5|||
160944334|NCT01516879|581185893|FG001|Overall Study|Other|10|||
160944335|NCT04568122|581185894|FG000|Overall Study|Lost to Follow-up|48|||
160944336|NCT04568122|581185895|FG001|Overall Study|Lost to Follow-up|44|||
160944337|NCT04568122|581185896|FG002|Overall Study|Lost to Follow-up|4|||
160944338|NCT04568122|581185897|FG003|Overall Study|Lost to Follow-up|0|||
160944339|NCT04568122|581185898|FG004|Overall Study|Lost to Follow-up|0|||
160944340|NCT01916304|581185904|FG000|Overall Study|Screening failure|17|||
160944341|NCT04666441|581185905|FG000|Overall Study|Lost to Follow-up|1|||
160944342|NCT04666441|581185906|FG001|Overall Study|Lost to Follow-up|4|||
161265792|NCT04394351|582355770|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161265793|NCT04394351|582355771|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
160944343|NCT04666441|581185907|FG002|Overall Study|Lost to Follow-up|1|||
160944344|NCT04666441|581185908|FG003|Overall Study|Lost to Follow-up|3|||
160944345|NCT04666441|581185909|FG004|Overall Study|Lost to Follow-up|0|||
160944346|NCT04666441|581185910|FG005|Overall Study|Lost to Follow-up|2|||
160944347|NCT04666441|581185911|FG006|Overall Study|Lost to Follow-up|2|||
160944348|NCT04666441|581185912|FG007|Overall Study|Lost to Follow-up|2|||
160944349|NCT04666441|581185905|FG000|Overall Study|Subject Decision|1|||
160944350|NCT04666441|581185906|FG001|Overall Study|Subject Decision|1|||
160944351|NCT04666441|581185907|FG002|Overall Study|Subject Decision|3|||
160944352|NCT04666441|581185908|FG003|Overall Study|Subject Decision|1|||
160944353|NCT04666441|581185909|FG004|Overall Study|Subject Decision|0|||
160944354|NCT04666441|581185910|FG005|Overall Study|Subject Decision|1|||
160999301|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999302|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999303|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999304|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
160999305|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999306|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
160999307|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160999308|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999309|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999310|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999311|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160999312|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160999313|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160999314|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999315|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999316|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999317|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999318|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999319|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999320|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999321|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
160999322|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
160999323|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999324|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
160999325|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999326|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999327|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999328|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999329|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
161265794|NCT04394351|582355772|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
161265795|NCT04394351|582355773|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
161265796|NCT04394351|582355766|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160944355|NCT04666441|581185911|FG006|Overall Study|Subject Decision|3|||
160944356|NCT04666441|581185912|FG007|Overall Study|Subject Decision|2|||
160944357|NCT00766415|581185921|FG000|Overall Study|Withdrawal by Subject|0|||
160944358|NCT00766415|581185922|FG001|Overall Study|Withdrawal by Subject|1|||
160944359|NCT01114516|581185929|FG000|Overall Study|Lost to Follow-up|2|||
160944360|NCT01114516|581185930|FG001|Overall Study|Lost to Follow-up|1|||
160944361|NCT01431508|581185933|FG000|Overall Study|Lack of Efficacy|1|||
160944362|NCT01431508|581185933|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
160944363|NCT00132769|581185934|FG000|Overall Study|Withdrawal by Subject|1|||
160944364|NCT00132769|581185935|FG001|Overall Study|Withdrawal by Subject|3|||
160944365|NCT00132769|581185934|FG000|Overall Study|Lack of Efficacy|7|||
160944366|NCT00132769|581185935|FG001|Overall Study|Lack of Efficacy|6|||
160944367|NCT00132769|581185934|FG000|Overall Study|Adverse Event|2|||
160944368|NCT00132769|581185935|FG001|Overall Study|Adverse Event|1|||
160944369|NCT00132769|581185934|FG000|Overall Study|Protocol Violation|1|||
160944370|NCT00132769|581185935|FG001|Overall Study|Protocol Violation|1|||
160944371|NCT00129259|581185936|FG000|Overall Study|Lost to Follow-up|1|||
160944372|NCT00129259|581185937|FG001|Overall Study|Lost to Follow-up|1|||
160944373|NCT00129259|581185936|FG000|Overall Study|Withdrawal by Subject|2|||
160944374|NCT00129259|581185937|FG001|Overall Study|Withdrawal by Subject|1|||
160944375|NCT00129259|581185936|FG000|Overall Study|Only available minimal phone assessments|0|||
160944376|NCT00129259|581185937|FG001|Overall Study|Only available minimal phone assessments|1|||
160944377|NCT02758236|581185939|FG000|Overall Study|Investigator discretion|43|||
160944378|NCT01632579|581185942|FG000|Washout Period|Adverse Event|1|||
160944379|NCT01632579|581185943|FG001|Washout Period|Adverse Event|0|||
161144572|NCT02786537|581913914|FG005|As Treated|Non-compliance with study drug|1|||
161144573|NCT02786537|581913909|FG000|As Treated|Lost insurance|0|||
160944380|NCT01632579|581185944|FG002|Washout Period|Adverse Event|0|||
160944381|NCT01632579|581185945|FG003|Washout Period|Adverse Event|0|||
160944382|NCT01632579|581185946|FG004|Washout Period|Adverse Event|0|||
160944383|NCT01632579|581185947|FG005|Washout Period|Adverse Event|0|||
160944384|NCT01632579|581185948|FG006|Washout Period|Adverse Event|0|||
160944385|NCT01632579|581185949|FG007|Washout Period|Adverse Event|0|||
160944386|NCT01632579|581185950|FG008|Washout Period|Adverse Event|0|||
160944387|NCT01632579|581185942|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
160944388|NCT01632579|581185943|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
160944389|NCT01632579|581185944|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
160944390|NCT01632579|581185945|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
160944391|NCT01632579|581185946|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
160944392|NCT01632579|581185947|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
160944393|NCT01632579|581185948|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
160944394|NCT01632579|581185949|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
160944395|NCT01632579|581185950|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
160944396|NCT02039505|581188020|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
160944397|NCT02039505|581188021|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
160944398|NCT02039505|581188022|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
160944399|NCT02039505|581188023|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944400|NCT02039505|581188024|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944401|NCT02039505|581188025|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944402|NCT02039505|581188026|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
160944403|NCT02039505|581188020|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
160944404|NCT02039505|581188021|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
160944405|NCT02039505|581188022|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
160944406|NCT02039505|581188023|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944407|NCT02039505|581188024|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944408|NCT02039505|581188025|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944409|NCT02039505|581188026|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
160944410|NCT02039505|581188020|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
160944411|NCT02039505|581188021|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944412|NCT02039505|581188022|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944413|NCT02039505|581188023|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944414|NCT02039505|581188024|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944415|NCT02039505|581188025|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944416|NCT02039505|581188026|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
160944417|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944418|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944419|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944420|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
160944421|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
161144574|NCT02786537|581913910|FG001|As Treated|Lost insurance|0|||
161144575|NCT02786537|581913911|FG002|As Treated|Lost insurance|0|||
160944422|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
160944423|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
160944424|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944425|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944426|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944427|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
160944428|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
160944429|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
160944430|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
160944431|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944432|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944433|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944434|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
160944435|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
160944436|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
160944437|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
160944438|NCT02039505|581188020|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944439|NCT02039505|581188021|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944440|NCT02039505|581188022|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944441|NCT02039505|581188023|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
160944442|NCT02039505|581188024|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944443|NCT02039505|581188025|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944444|NCT02039505|581188026|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
160944445|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944446|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944447|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944448|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944449|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944450|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
160944451|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
160944452|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944453|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944454|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944455|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944456|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944457|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
160944458|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
160944459|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944460|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944461|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944462|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944463|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944464|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
160944465|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
160944466|NCT02039505|581188020|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944467|NCT02039505|581188021|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944468|NCT02039505|581188022|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944469|NCT02039505|581188023|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944470|NCT02039505|581188024|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944471|NCT02039505|581188025|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
160944472|NCT02039505|581188026|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
160944473|NCT00353704|581188033|FG000|Overall Study|Protocol Violation|3|||
160944474|NCT00353704|581188034|FG001|Overall Study|Protocol Violation|1|||
160944475|NCT01154166|581188035|FG000|Overall Study|Adverse Event|14|||
160944476|NCT01154166|581188036|FG001|Overall Study|Adverse Event|9|||
160944477|NCT01154166|581188035|FG000|Overall Study|Lost to Follow-up|1|||
160944478|NCT01154166|581188036|FG001|Overall Study|Lost to Follow-up|1|||
160944479|NCT01154166|581188035|FG000|Overall Study|Protocol Violation|4|||
160944480|NCT01154166|581188036|FG001|Overall Study|Protocol Violation|1|||
160944481|NCT01154166|581188035|FG000|Overall Study|Withdrawal by Subject|10|||
160944482|NCT01154166|581188036|FG001|Overall Study|Withdrawal by Subject|1|||
160944483|NCT01154166|581188035|FG000|Overall Study|Lack of Efficacy|3|||
160944484|NCT01154166|581188036|FG001|Overall Study|Lack of Efficacy|0|||
160944485|NCT01154166|581188035|FG000|Overall Study|Disease Progression|1|||
160944486|NCT01154166|581188036|FG001|Overall Study|Disease Progression|0|||
160944487|NCT01154166|581188035|FG000|Overall Study|Poor Compliance|1|||
160944488|NCT01154166|581188036|FG001|Overall Study|Poor Compliance|0|||
160944489|NCT01375049|581188037|FG000|Overall Study|Adverse Event|2|||
160944490|NCT01375049|581188037|FG000|Overall Study|Lost to Follow-up|1|||
160944491|NCT01375049|581188037|FG000|Overall Study|Withdrawal by Subject|2|||
160944492|NCT01375049|581188037|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
161265797|NCT04394351|582355767|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160944493|NCT03614793|581188038|FG000|Overall Study|Lost to Follow-up|1|||
160944494|NCT03614793|581188039|FG001|Overall Study|Lost to Follow-up|2|||
160944495|NCT03614793|581188038|FG000|Overall Study|Lack of Efficacy|0|||
160944496|NCT03614793|581188039|FG001|Overall Study|Lack of Efficacy|5|||
160944497|NCT03614793|581188038|FG000|Overall Study|Withdrawal by Subject|0|||
160944498|NCT03614793|581188039|FG001|Overall Study|Withdrawal by Subject|1|||
160944499|NCT03614793|581188038|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
160944500|NCT03614793|581188039|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
160944501|NCT02082522|581188040|FG000|Overall Study|Sponsor termination|5|||
160944502|NCT02082522|581188041|FG001|Overall Study|Sponsor termination|3|||
160944503|NCT02082522|581188040|FG000|Overall Study|Withdrawal by Subject|2|||
160944504|NCT02082522|581188041|FG001|Overall Study|Withdrawal by Subject|4|||
160944505|NCT02082522|581188040|FG000|Overall Study|Death|1|||
160944506|NCT02082522|581188041|FG001|Overall Study|Death|0|||
160944507|NCT02082522|581188040|FG000|Overall Study|Lost to Follow-up|1|||
160944508|NCT02082522|581188041|FG001|Overall Study|Lost to Follow-up|0|||
160944509|NCT02082522|581188040|FG000|Overall Study|Physician Decision|3|||
160944510|NCT02082522|581188041|FG001|Overall Study|Physician Decision|1|||
160944511|NCT02082522|581188040|FG000|Overall Study|Disease progression|2|||
160944512|NCT02082522|581188041|FG001|Overall Study|Disease progression|2|||
160944513|NCT02082522|581188040|FG000|Overall Study|Chemotherapy change|1|||
160944514|NCT02082522|581188041|FG001|Overall Study|Chemotherapy change|3|||
160944515|NCT00633984|581188042|FG000|Overall Study|Lost to Follow-up|0|||
160944516|NCT00633984|581188043|FG001|Overall Study|Lost to Follow-up|6|||
160944517|NCT00633984|581188042|FG000|Overall Study|Withdrawal by Subject|8|||
160944518|NCT00633984|581188043|FG001|Overall Study|Withdrawal by Subject|7|||
160944519|NCT00633984|581188042|FG000|Overall Study|Hospitalized|1|||
160944520|NCT00633984|581188043|FG001|Overall Study|Hospitalized|0|||
160944521|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
160944522|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
160944523|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
160944524|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Death|1|||
160944525|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
160944526|NCT02840877|581188044|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
160944527|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
160944528|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Treatment failure|1|||
160944529|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
160944530|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
160944531|NCT02840877|581188044|FG000|12 Weeks to 6 Months|Death|1|||
160944532|NCT02840877|581188044|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
160944533|NCT02840877|581188044|FG000|6 Months to 18 Months|Treatment failure|7|||
160944534|NCT02840877|581188044|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
160944535|NCT02840877|581188044|FG000|6 Months to 18 Months|Moved/transferred out|6|||
160944536|NCT02840877|581188044|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
160944537|NCT02840877|581188044|FG000|6 Months to 18 Months|Death|4|||
160944538|NCT02840877|581188044|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
160944539|NCT02840877|581188044|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
160944540|NCT02840877|581188044|FG000|6 Months to 18 Months|Still in study.|14|||
160944541|NCT01168999|581188045|FG000|Overall Study|Lost to Follow-up|2|||
160944542|NCT01168999|581188046|FG001|Overall Study|Lost to Follow-up|1|||
160944543|NCT01168999|581188047|FG002|Overall Study|Lost to Follow-up|0|||
160944544|NCT01168999|581188048|FG003|Overall Study|Lost to Follow-up|0|||
160944545|NCT04317586|581188049|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
160944546|NCT04317586|581188049|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
160944547|NCT01276327|581188050|FG000|Overall Study|Adverse Event|1|||
160944548|NCT01276327|581188051|FG001|Overall Study|Adverse Event|3|||
160944549|NCT01276327|581188050|FG000|Overall Study|Withdrawal by Subject|1|||
160944550|NCT01276327|581188051|FG001|Overall Study|Withdrawal by Subject|0|||
160944551|NCT01794949|581188052|FG000|Overall Study|Lost to Follow-up|1|||
160944552|NCT01794949|581188053|FG001|Overall Study|Lost to Follow-up|0|||
160944553|NCT03003676|581188054|FG000|Overall Study|Lack of Efficacy|5|||
160944554|NCT03003676|581188055|FG001|Overall Study|Lack of Efficacy|7|||
160944555|NCT03003676|581188054|FG000|Overall Study|Withdrawal by Subject|0|||
160944556|NCT03003676|581188055|FG001|Overall Study|Withdrawal by Subject|1|||
160944557|NCT03003676|581188054|FG000|Overall Study|Hepatitis B infection|1|||
160944558|NCT03003676|581188055|FG001|Overall Study|Hepatitis B infection|0|||
160944559|NCT03766646|581188057|FG000|Overall Study|Withdrawal by Subject|1|||
160944560|NCT03766646|581188058|FG001|Overall Study|Withdrawal by Subject|0|||
160944561|NCT03766646|581188057|FG000|Overall Study|Protocol Violation|0|||
160944562|NCT03766646|581188058|FG001|Overall Study|Protocol Violation|3|||
160944563|NCT02530619|581188068|FG000|Registered for Study|Withdrawal by Subject|2|||
160944564|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
160944565|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
160944566|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
160999330|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160944567|NCT02530619|581188068|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
160944568|NCT02530619|581188068|FG000|Follow-up Period (6 Months)|Death|4|||
160944569|NCT02530619|581188068|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
160944570|NCT02530619|581188068|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
160944571|NCT01854554|581188081|FG000|Overall Study|Denial of Insurance Coverage|12|||
160944572|NCT01854554|581188082|FG001|Overall Study|Denial of Insurance Coverage|0|||
160944573|NCT01854554|581188081|FG000|Overall Study|Decided to get treatment locally|1|||
160944574|NCT01854554|581188082|FG001|Overall Study|Decided to get treatment locally|5|||
160944575|NCT01854554|581188081|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
160944576|NCT01854554|581188082|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
160944577|NCT01854554|581188081|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160944578|NCT01854554|581188082|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
160944579|NCT01854554|581188081|FG000|Overall Study|Progression|0|||
160944580|NCT01854554|581188082|FG001|Overall Study|Progression|1|||
160944581|NCT01854554|581188081|FG000|Overall Study|Lost to Follow-up|0|||
160944582|NCT01854554|581188082|FG001|Overall Study|Lost to Follow-up|1|||
160944583|NCT02819726|581188085|FG000|Part A (All Participants)|Lost to Follow-up|0|||
160944584|NCT02819726|581188086|FG001|Part A (All Participants)|Lost to Follow-up|1|||
160944585|NCT02819726|581188087|FG002|Part A (All Participants)|Lost to Follow-up|0|||
160944586|NCT02819726|581188088|FG003|Part A (All Participants)|Lost to Follow-up|0|||
160944587|NCT02819726|581188085|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
160944588|NCT02819726|581188086|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
160944589|NCT02819726|581188087|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
160944590|NCT02819726|581188088|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
160944591|NCT02819726|581188085|FG000|Part A (All Participants)|Protocol non-compliance|3|||
160944592|NCT02819726|581188086|FG001|Part A (All Participants)|Protocol non-compliance|4|||
160944593|NCT02819726|581188087|FG002|Part A (All Participants)|Protocol non-compliance|5|||
160944594|NCT02819726|581188088|FG003|Part A (All Participants)|Protocol non-compliance|0|||
160944595|NCT02819726|581188085|FG000|Part B (All Participants)|Lost to Follow-up|1|||
160944596|NCT02819726|581188086|FG001|Part B (All Participants)|Lost to Follow-up|1|||
160944597|NCT02819726|581188087|FG002|Part B (All Participants)|Lost to Follow-up|2|||
160944598|NCT02819726|581188088|FG003|Part B (All Participants)|Lost to Follow-up|2|||
160944599|NCT02819726|581188085|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
160944600|NCT02819726|581188086|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
160944601|NCT02819726|581188087|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
160944602|NCT02819726|581188088|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
160944603|NCT02819726|581188085|FG000|Part B (All Participants)|Protocol non-compliance|0|||
160944604|NCT02819726|581188086|FG001|Part B (All Participants)|Protocol non-compliance|0|||
160944605|NCT02819726|581188087|FG002|Part B (All Participants)|Protocol non-compliance|1|||
160944606|NCT02819726|581188088|FG003|Part B (All Participants)|Protocol non-compliance|0|||
160944607|NCT00359762|581188089|FG000|Period II|Adverse Event|17|||
160944608|NCT00359762|581188090|FG001|Period II|Adverse Event|0|||
160944609|NCT00359762|581188091|FG002|Period II|Adverse Event|0|||
160944610|NCT00359762|581188092|FG003|Period II|Adverse Event|0|||
160944611|NCT00359762|581188093|FG004|Period II|Adverse Event|49|||
160944612|NCT00359762|581188089|FG000|Period II|Protocol Violation|18|||
160944613|NCT00359762|581188090|FG001|Period II|Protocol Violation|0|||
160944614|NCT00359762|581188091|FG002|Period II|Protocol Violation|0|||
160944615|NCT00359762|581188092|FG003|Period II|Protocol Violation|0|||
160944616|NCT00359762|581188093|FG004|Period II|Protocol Violation|11|||
160944617|NCT00359762|581188089|FG000|Period II|Physician Decision|17|||
160944618|NCT00359762|581188090|FG001|Period II|Physician Decision|0|||
160944619|NCT00359762|581188091|FG002|Period II|Physician Decision|0|||
160944620|NCT00359762|581188092|FG003|Period II|Physician Decision|0|||
160944621|NCT00359762|581188093|FG004|Period II|Physician Decision|23|||
160944622|NCT00359762|581188089|FG000|Period II|Death|2|||
160944623|NCT00359762|581188090|FG001|Period II|Death|0|||
160944624|NCT00359762|581188091|FG002|Period II|Death|0|||
160944625|NCT00359762|581188092|FG003|Period II|Death|0|||
160944626|NCT00359762|581188093|FG004|Period II|Death|4|||
160944627|NCT00359762|581188089|FG000|Period II|Lack of Efficacy|11|||
160944628|NCT00359762|581188090|FG001|Period II|Lack of Efficacy|0|||
160944629|NCT00359762|581188091|FG002|Period II|Lack of Efficacy|0|||
160944630|NCT00359762|581188092|FG003|Period II|Lack of Efficacy|0|||
160944631|NCT00359762|581188093|FG004|Period II|Lack of Efficacy|8|||
160944632|NCT00359762|581188089|FG000|Period II|Lost to follow up|5|||
160944633|NCT00359762|581188090|FG001|Period II|Lost to follow up|0|||
160944634|NCT00359762|581188091|FG002|Period II|Lost to follow up|0|||
160944635|NCT00359762|581188092|FG003|Period II|Lost to follow up|0|||
161342672|NCT00879658|582642235|FG004|Overall Study|Protocol Violation|0|||
160944636|NCT00359762|581188093|FG004|Period II|Lost to follow up|5|||
160944637|NCT00359762|581188089|FG000|Period II|Entry Criteria Not Met|8|||
160944638|NCT00359762|581188090|FG001|Period II|Entry Criteria Not Met|0|||
160944639|NCT00359762|581188091|FG002|Period II|Entry Criteria Not Met|0|||
160944640|NCT00359762|581188092|FG003|Period II|Entry Criteria Not Met|0|||
160944641|NCT00359762|581188093|FG004|Period II|Entry Criteria Not Met|4|||
160944642|NCT00359762|581188089|FG000|Period II|Subject Decision|50|||
160944643|NCT00359762|581188090|FG001|Period II|Subject Decision|0|||
160944644|NCT00359762|581188091|FG002|Period II|Subject Decision|0|||
160944645|NCT00359762|581188092|FG003|Period II|Subject Decision|0|||
160944646|NCT00359762|581188093|FG004|Period II|Subject Decision|70|||
160944647|NCT00359762|581188089|FG000|Period III|Protocol Violation|0|||
160944648|NCT00359762|581188090|FG001|Period III|Protocol Violation|5|||
160944649|NCT00359762|581188091|FG002|Period III|Protocol Violation|3|||
160944650|NCT00359762|581188092|FG003|Period III|Protocol Violation|8|||
160944651|NCT00359762|581188093|FG004|Period III|Protocol Violation|0|||
160944652|NCT00359762|581188089|FG000|Period III|Adverse Event|0|||
160944653|NCT00359762|581188090|FG001|Period III|Adverse Event|3|||
160944654|NCT00359762|581188091|FG002|Period III|Adverse Event|4|||
160944655|NCT00359762|581188092|FG003|Period III|Adverse Event|10|||
160944656|NCT00359762|581188093|FG004|Period III|Adverse Event|0|||
160944657|NCT00359762|581188089|FG000|Period III|Physician Decision|0|||
160944658|NCT00359762|581188090|FG001|Period III|Physician Decision|5|||
160944659|NCT00359762|581188091|FG002|Period III|Physician Decision|9|||
160944660|NCT00359762|581188092|FG003|Period III|Physician Decision|15|||
160944661|NCT00359762|581188093|FG004|Period III|Physician Decision|0|||
160944662|NCT00359762|581188089|FG000|Period III|Lack of Efficacy|0|||
160944663|NCT00359762|581188090|FG001|Period III|Lack of Efficacy|7|||
160944664|NCT00359762|581188091|FG002|Period III|Lack of Efficacy|5|||
160944665|NCT00359762|581188092|FG003|Period III|Lack of Efficacy|9|||
160944666|NCT00359762|581188093|FG004|Period III|Lack of Efficacy|0|||
160944667|NCT00359762|581188089|FG000|Period III|Lost to follow up|0|||
160944668|NCT00359762|581188090|FG001|Period III|Lost to follow up|1|||
160944669|NCT00359762|581188091|FG002|Period III|Lost to follow up|1|||
160944670|NCT00359762|581188092|FG003|Period III|Lost to follow up|2|||
160944671|NCT00359762|581188093|FG004|Period III|Lost to follow up|0|||
160999331|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
160999332|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999333|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999334|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
160999335|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999336|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999337|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999338|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999339|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
160999340|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
160999341|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999342|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
160999343|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999344|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999345|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999346|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999347|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999348|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
160999349|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
160999350|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999351|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
160999352|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
160999353|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999354|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999355|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999356|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
160999357|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
160999358|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
160999359|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160999360|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
160999361|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
160999362|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160999363|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160944672|NCT00359762|581188089|FG000|Period III|Entry Criteria Not Met|0|||
160944673|NCT00359762|581188090|FG001|Period III|Entry Criteria Not Met|1|||
160944674|NCT00359762|581188091|FG002|Period III|Entry Criteria Not Met|0|||
160944675|NCT00359762|581188092|FG003|Period III|Entry Criteria Not Met|1|||
160944676|NCT00359762|581188093|FG004|Period III|Entry Criteria Not Met|0|||
160944677|NCT00359762|581188089|FG000|Period III|Subject Decision|0|||
160944678|NCT00359762|581188090|FG001|Period III|Subject Decision|7|||
160944679|NCT00359762|581188091|FG002|Period III|Subject Decision|8|||
160944680|NCT00359762|581188092|FG003|Period III|Subject Decision|20|||
160999364|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160999365|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
160944681|NCT00359762|581188093|FG004|Period III|Subject Decision|0|||
160944682|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
160944683|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
160944684|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
160944685|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944686|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944687|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944688|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944689|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944690|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
160944691|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
160944692|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
160944693|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
160944694|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944695|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944696|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
161265798|NCT04394351|582355768|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
160944697|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944698|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944699|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
160944700|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944701|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
160944702|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
160944703|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944704|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944705|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944706|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944707|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944708|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
160944709|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
160944710|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
160944711|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
160944712|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944713|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944714|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944715|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
161265799|NCT04394351|582355769|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161265800|NCT04394351|582355770|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161265801|NCT04394351|582355771|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161319364|NCT01884545|582555288|FG003|Overall Study|Non-adherence|0|||
160944716|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944717|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
160944718|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944719|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
160944720|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944721|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944722|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944723|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944724|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944725|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944726|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
160944727|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
160944728|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944729|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944730|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944731|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944732|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944733|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944734|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944735|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
160944736|NCT01172938|581188096|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944737|NCT01172938|581188097|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
160944738|NCT01172938|581188098|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
160944739|NCT01172938|581188099|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944740|NCT01172938|581188100|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944741|NCT01172938|581188101|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944742|NCT01172938|581188102|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944743|NCT01172938|581188103|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944744|NCT01172938|581188104|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
160944745|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944746|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
160944747|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
160944748|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
160944749|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
160944750|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
160944751|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944752|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944753|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
160944754|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944755|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
160944756|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
160944757|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
160944758|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
160944759|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
160944760|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944761|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944762|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
160944763|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944764|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944765|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
160944766|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944767|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944768|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944769|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944770|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944771|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
160944772|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
160944773|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
160944774|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
160999366|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
160999367|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
160999368|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999369|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
160999370|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
160999371|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999372|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999373|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999374|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160999375|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
160999376|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
160999377|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
160999378|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
160999379|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
160999380|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
160999381|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
160999382|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
160999383|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
160999384|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
160999385|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
160999386|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999387|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999388|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999389|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999390|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999391|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999392|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999393|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
160999394|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
160999395|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160999396|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
160999397|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
161342673|NCT00879658|582642236|FG005|Overall Study|Protocol Violation|0|||
160944775|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
161265802|NCT04394351|582355772|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
161265803|NCT04394351|582355773|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
161265804|NCT04394351|582355766|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265805|NCT04394351|582355767|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265806|NCT04394351|582355768|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265807|NCT04394351|582355769|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265808|NCT04394351|582355770|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265809|NCT04394351|582355771|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265810|NCT04394351|582355772|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
161265811|NCT04394351|582355773|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
161265812|NCT04394351|582355766|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265813|NCT04394351|582355767|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265814|NCT04394351|582355768|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265815|NCT04394351|582355769|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265816|NCT04394351|582355770|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265817|NCT04394351|582355771|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265818|NCT04394351|582355772|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
161265819|NCT04394351|582355773|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
161265820|NCT03653507|582355774|FG000|Overall Study|Miscellaneous|28|||
161265821|NCT03653507|582355775|FG001|Overall Study|Miscellaneous|19|||
161265822|NCT03653507|582355774|FG000|Overall Study|Withdrawal by Subject|37|||
161265823|NCT03653507|582355775|FG001|Overall Study|Withdrawal by Subject|22|||
161265824|NCT03653507|582355774|FG000|Overall Study|Protocol Deviation|2|||
161265825|NCT03653507|582355775|FG001|Overall Study|Protocol Deviation|1|||
161265826|NCT03653507|582355774|FG000|Overall Study|Progressive disease|117|||
161265827|NCT03653507|582355775|FG001|Overall Study|Progressive disease|168|||
161265828|NCT03653507|582355774|FG000|Overall Study|Lost to Follow-up|1|||
161265829|NCT03653507|582355775|FG001|Overall Study|Lost to Follow-up|1|||
161265830|NCT03653507|582355774|FG000|Overall Study|Death|25|||
161265831|NCT03653507|582355775|FG001|Overall Study|Death|22|||
161265832|NCT03653507|582355774|FG000|Overall Study|Adverse Event|35|||
161265833|NCT03653507|582355775|FG001|Overall Study|Adverse Event|14|||
161265834|NCT01288053|582355782|FG000|Overall Study|Death|1|||
161265835|NCT03188666|582355783|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161265836|NCT03188666|582355784|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
161265837|NCT03188666|582355785|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161265838|NCT03188666|582355786|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
161265839|NCT03188666|582355783|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
161265840|NCT03188666|582355784|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
161265841|NCT03188666|582355785|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
161265842|NCT03188666|582355786|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
160944776|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
160944777|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
160944778|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
160944779|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
160944780|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
160944781|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944782|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
160944783|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
160944784|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
160944785|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944786|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944787|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944788|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944789|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
160944790|NCT01172938|581188096|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
161265843|NCT03188666|582355783|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
160944791|NCT01172938|581188097|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944792|NCT01172938|581188098|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944793|NCT01172938|581188099|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944794|NCT01172938|581188100|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944795|NCT01172938|581188101|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
161265844|NCT03188666|582355784|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161265845|NCT03188666|582355785|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
161265846|NCT03188666|582355786|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
161265847|NCT03188666|582355783|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
161265848|NCT03188666|582355784|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
161265849|NCT03188666|582355785|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
161265850|NCT03188666|582355786|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
161265851|NCT00144781|582355787|FG000|Overall Study|Adverse Event|0|||
160944796|NCT01172938|581188102|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
160944797|NCT01172938|581188103|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
161265852|NCT00144781|582355788|FG001|Overall Study|Adverse Event|1|||
161265853|NCT00144781|582355789|FG002|Overall Study|Adverse Event|0|||
161265854|NCT00144781|582355790|FG003|Overall Study|Adverse Event|0|||
160944798|NCT01172938|581188104|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
160944799|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944800|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
160944801|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
160944802|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944803|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944804|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944805|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
160944806|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
160944807|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
160944808|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944809|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
160944810|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
160944811|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944812|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944813|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944814|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944815|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
160944816|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
160944817|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944818|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944819|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
160944820|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944821|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
161265855|NCT00144781|582355787|FG000|Overall Study|Non-compliant|0|||
161265856|NCT00144781|582355788|FG001|Overall Study|Non-compliant|1|||
161265857|NCT00144781|582355789|FG002|Overall Study|Non-compliant|0|||
161265858|NCT00144781|582355790|FG003|Overall Study|Non-compliant|0|||
161265859|NCT03696953|582355791|FG000|Overall Study|Withdrawal by Subject|6|||
160944822|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944823|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944824|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944825|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
160944826|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944827|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
160944828|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
160944829|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944830|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944831|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944832|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
160944833|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
160944834|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
160944835|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944836|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944837|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
160944838|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944839|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160999398|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161265860|NCT03696953|582355792|FG001|Overall Study|Withdrawal by Subject|1|||
161265861|NCT03696953|582355791|FG000|Overall Study|missed GBS swabs|2|||
161265862|NCT03696953|582355792|FG001|Overall Study|missed GBS swabs|2|||
161265863|NCT03696953|582355791|FG000|Overall Study|lost study bottle containing capsules|2|||
161265864|NCT03696953|582355792|FG001|Overall Study|lost study bottle containing capsules|0|||
160944840|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944841|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944842|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944843|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
160944844|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
161265865|NCT03696953|582355791|FG000|Overall Study|Premature birth|1|||
161265866|NCT03696953|582355792|FG001|Overall Study|Premature birth|4|||
161265867|NCT03696953|582355791|FG000|Overall Study|Gestational hypertension|1|||
161265868|NCT03696953|582355792|FG001|Overall Study|Gestational hypertension|1|||
160944845|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
160944846|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
160944847|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944848|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944849|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944850|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944851|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
160944852|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
160944853|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944854|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
160944855|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944856|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944857|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944858|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944859|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944860|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
160944861|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
160944862|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944863|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
160944864|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944865|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944866|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944867|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944868|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944869|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944870|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
160944871|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944872|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944873|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944874|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944875|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944876|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944877|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944878|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
160944879|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
160944880|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944881|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
160944882|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
160944883|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944884|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944885|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944886|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
160944887|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
160944888|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
160944889|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944890|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
160944891|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
160944892|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944893|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944894|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944895|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
160944896|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
160944897|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
160944898|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944899|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944900|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944901|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
161144576|NCT02786537|581913912|FG003|As Treated|Lost insurance|1|||
161144577|NCT02786537|581913913|FG004|As Treated|Lost insurance|0|||
161144578|NCT02786537|581913914|FG005|As Treated|Lost insurance|0|||
161144579|NCT02786537|581913909|FG000|As Treated|Withdrawal by Subject|1|||
161144580|NCT02786537|581913910|FG001|As Treated|Withdrawal by Subject|2|||
160944902|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
161144581|NCT02786537|581913911|FG002|As Treated|Withdrawal by Subject|0|||
161144582|NCT02786537|581913912|FG003|As Treated|Withdrawal by Subject|0|||
161144583|NCT02786537|581913913|FG004|As Treated|Withdrawal by Subject|1|||
161144584|NCT02786537|581913914|FG005|As Treated|Withdrawal by Subject|0|||
161144585|NCT02786537|581913909|FG000|As Treated|Incarceration|0|||
160944903|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944904|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944905|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
160944906|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
160944907|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944908|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
160944909|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944910|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944911|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944912|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944913|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944914|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944915|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
160944916|NCT01172938|581188096|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944917|NCT01172938|581188097|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944918|NCT01172938|581188098|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
160944919|NCT01172938|581188099|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944920|NCT01172938|581188100|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944921|NCT01172938|581188101|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944922|NCT01172938|581188102|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944923|NCT01172938|581188103|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944924|NCT01172938|581188104|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
160944925|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944926|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
160944927|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
160944928|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944929|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944930|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944931|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944932|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
160944933|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
160944934|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944935|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
160944936|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
160944937|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944938|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944939|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944940|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
160944941|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
160944942|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
160944943|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944944|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
160944945|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
160944946|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944947|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944948|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944949|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
160944950|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
160944951|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
160944952|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944953|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944954|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
160944955|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944956|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944957|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944958|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944959|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
160944960|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
160944961|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944962|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944963|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944964|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160999399|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160999400|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161144586|NCT02786537|581913910|FG001|As Treated|Incarceration|1|||
161144587|NCT02786537|581913911|FG002|As Treated|Incarceration|0|||
160944965|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944966|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944967|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944968|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
160944969|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
160944970|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944971|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944972|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
160944973|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944974|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944975|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944976|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
160944977|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
160944978|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
160944979|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944980|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944981|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
160944982|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944983|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944984|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944985|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944986|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944987|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
160944988|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944989|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
160944990|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944991|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944992|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944993|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944994|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944995|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
160944996|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
160944997|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160944998|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
160944999|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
160945000|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945001|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945002|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945003|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945004|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
160945005|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
160945006|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945007|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945008|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
160945009|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945010|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945011|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945012|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945013|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945014|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
160945015|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945016|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945017|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
160945018|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
161144588|NCT02786537|581913912|FG003|As Treated|Incarceration|0|||
161265869|NCT03696953|582355791|FG000|Overall Study|Gestational diabetes|2|||
161265870|NCT03696953|582355792|FG001|Overall Study|Gestational diabetes|1|||
161265871|NCT03696953|582355791|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
161265872|NCT03696953|582355792|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
161265873|NCT03696953|582355791|FG000|Overall Study|Changed prenatal provider|1|||
161265874|NCT03696953|582355792|FG001|Overall Study|Changed prenatal provider|1|||
161265875|NCT04092894|582355793|FG000|Overall Study|Withdrawal by Subject|2|||
161265876|NCT04092894|582355794|FG001|Overall Study|Withdrawal by Subject|4|||
161265877|NCT04092894|582355793|FG000|Overall Study|Discontinued EEG after randomization|10|||
161265878|NCT04092894|582355794|FG001|Overall Study|Discontinued EEG after randomization|6|||
161319365|NCT01410240|582555289|FG000|Overall Study|Physician Decision|0|||
160945019|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945020|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945021|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945022|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945023|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
160945024|NCT01172938|581188096|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945025|NCT01172938|581188097|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945026|NCT01172938|581188098|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945027|NCT01172938|581188099|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945028|NCT01172938|581188100|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945029|NCT01172938|581188101|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945030|NCT01172938|581188102|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945031|NCT01172938|581188103|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
160945032|NCT01172938|581188104|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
160945033|NCT02613481|581188105|FG000|Overall Study|Lost to Follow-up|7|||
160945034|NCT02613481|581188105|FG000|Overall Study|Withdrawal by Subject|2|||
160945035|NCT01033747|581188106|FG000|Overall Study|Adverse Event|9|||
160945036|NCT01033747|581188107|FG001|Overall Study|Adverse Event|4|||
160945037|NCT01033747|581188106|FG000|Overall Study|Abnormal Laboratory Value|1|||
160945038|NCT01033747|581188107|FG001|Overall Study|Abnormal Laboratory Value|0|||
160945039|NCT01033747|581188106|FG000|Overall Study|Abnormal test procedure|0|||
160945040|NCT01033747|581188107|FG001|Overall Study|Abnormal test procedure|1|||
160945041|NCT01033747|581188106|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
160945042|NCT01033747|581188107|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
160945043|NCT01033747|581188106|FG000|Overall Study|Protocol Violation|1|||
160945044|NCT01033747|581188107|FG001|Overall Study|Protocol Violation|0|||
160945045|NCT01033747|581188106|FG000|Overall Study|Withdrawal by Subject|9|||
160945046|NCT01033747|581188107|FG001|Overall Study|Withdrawal by Subject|6|||
160945047|NCT01033747|581188106|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
160945048|NCT01033747|581188107|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
160945049|NCT01033747|581188106|FG000|Overall Study|Stopped at end of Extension 1|2|||
161144589|NCT02786537|581913913|FG004|As Treated|Incarceration|0|||
161144590|NCT02786537|581913914|FG005|As Treated|Incarceration|0|||
161144591|NCT02786537|581913909|FG000|As Treated|Opiate dependency relapse|0|||
161144592|NCT02786537|581913910|FG001|As Treated|Opiate dependency relapse|1|||
161144593|NCT02786537|581913911|FG002|As Treated|Opiate dependency relapse|0|||
161144594|NCT02786537|581913912|FG003|As Treated|Opiate dependency relapse|0|||
161144595|NCT02786537|581913913|FG004|As Treated|Opiate dependency relapse|0|||
161144596|NCT02786537|581913914|FG005|As Treated|Opiate dependency relapse|0|||
161144597|NCT02786537|581913909|FG000|As Treated|Drugs stolen from patient|0|||
161144598|NCT02786537|581913910|FG001|As Treated|Drugs stolen from patient|1|||
161144599|NCT02786537|581913911|FG002|As Treated|Drugs stolen from patient|0|||
161144600|NCT02786537|581913912|FG003|As Treated|Drugs stolen from patient|0|||
161144601|NCT02786537|581913913|FG004|As Treated|Drugs stolen from patient|0|||
161144602|NCT02786537|581913914|FG005|As Treated|Drugs stolen from patient|0|||
161144603|NCT02786537|581913909|FG000|As Treated|Advised to stop tx after loss of meds|0|||
161144604|NCT02786537|581913910|FG001|As Treated|Advised to stop tx after loss of meds|1|||
161144605|NCT02786537|581913911|FG002|As Treated|Advised to stop tx after loss of meds|0|||
161144606|NCT02786537|581913912|FG003|As Treated|Advised to stop tx after loss of meds|0|||
161144607|NCT02786537|581913913|FG004|As Treated|Advised to stop tx after loss of meds|0|||
161144608|NCT02786537|581913914|FG005|As Treated|Advised to stop tx after loss of meds|0|||
160945050|NCT01033747|581188107|FG001|Overall Study|Stopped at end of Extension 1|0|||
160945051|NCT02647658|581188112|FG000|Overall Study|Consent refusal|15|||
160945052|NCT02647658|581188113|FG001|Overall Study|Consent refusal|24|||
160945053|NCT00803023|581188114|FG000|Overall Study|Adverse Event|5|||
160945054|NCT00803023|581188115|FG001|Overall Study|Adverse Event|4|||
160945055|NCT00803023|581188116|FG002|Overall Study|Adverse Event|8|||
160945056|NCT00803023|581188117|FG003|Overall Study|Adverse Event|6|||
160945057|NCT00803023|581188114|FG000|Overall Study|Withdrawal by Subject|0|||
160945058|NCT00803023|581188115|FG001|Overall Study|Withdrawal by Subject|2|||
160945059|NCT00803023|581188116|FG002|Overall Study|Withdrawal by Subject|0|||
160945060|NCT00803023|581188117|FG003|Overall Study|Withdrawal by Subject|0|||
160945061|NCT00803023|581188114|FG000|Overall Study|Lost to Follow-up|0|||
160945062|NCT00803023|581188115|FG001|Overall Study|Lost to Follow-up|1|||
160945063|NCT00803023|581188116|FG002|Overall Study|Lost to Follow-up|2|||
160945064|NCT00803023|581188117|FG003|Overall Study|Lost to Follow-up|1|||
160945065|NCT00803023|581188114|FG000|Overall Study|Lack of Efficacy|0|||
161342674|NCT00879658|582642237|FG006|Overall Study|Protocol Violation|0|||
161342675|NCT00879658|582642231|FG000|Overall Study|Withdrawal by Subject|3|||
160945066|NCT00803023|581188115|FG001|Overall Study|Lack of Efficacy|1|||
160945067|NCT00803023|581188116|FG002|Overall Study|Lack of Efficacy|1|||
160945068|NCT00803023|581188117|FG003|Overall Study|Lack of Efficacy|1|||
160945069|NCT01542528|581188118|FG000|Overall Study|Lost to Follow-up|2|||
160945070|NCT01542528|581188119|FG001|Overall Study|Lost to Follow-up|1|||
160945071|NCT01542528|581188118|FG000|Overall Study|Physician Decision|1|||
160945072|NCT01542528|581188119|FG001|Overall Study|Physician Decision|0|||
160945073|NCT01542528|581188118|FG000|Overall Study|Withdrawal by Subject|9|||
160945074|NCT01542528|581188119|FG001|Overall Study|Withdrawal by Subject|6|||
160945075|NCT05282004|581188120|FG000|Overall Study|Adverse Event|2|||
160945076|NCT04808609|581188121|FG000|Overall Study|Lost to Follow-up|0|||
160945077|NCT04808609|581188122|FG001|Overall Study|Lost to Follow-up|2|||
160945078|NCT04808609|581188121|FG000|Overall Study|Administrative Withdrawal|0|||
160945079|NCT04808609|581188122|FG001|Overall Study|Administrative Withdrawal|1|||
160945080|NCT00562159|581188123|FG000|Overall Study|Adverse Event|11|||
160945081|NCT00562159|581188124|FG001|Overall Study|Adverse Event|8|||
160945082|NCT00562159|581188123|FG000|Overall Study|Lost to Follow-up|5|||
160945083|NCT00562159|581188124|FG001|Overall Study|Lost to Follow-up|4|||
160945084|NCT00562159|581188123|FG000|Overall Study|Withdrawal by Subject|9|||
160945085|NCT00562159|581188124|FG001|Overall Study|Withdrawal by Subject|8|||
160945086|NCT00562159|581188123|FG000|Overall Study|Protocol Violation|12|||
160945087|NCT00562159|581188124|FG001|Overall Study|Protocol Violation|12|||
160945088|NCT00562159|581188123|FG000|Overall Study|Did not meet protocol eligibility|1|||
160945089|NCT00562159|581188124|FG001|Overall Study|Did not meet protocol eligibility|1|||
160945090|NCT04382326|581188128|FG000|Overall Study|Adverse Event, not serious|1|||
160945091|NCT04382326|581188129|FG001|Overall Study|Adverse Event, not serious|2|||
160945092|NCT04382326|581188128|FG000|Overall Study|Other|1|||
160945093|NCT04382326|581188129|FG001|Overall Study|Other|0|||
160945094|NCT04382326|581188128|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
160945095|NCT04382326|581188129|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
160945096|NCT04382326|581188128|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
160945097|NCT04382326|581188129|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
160945098|NCT04382326|581188128|FG000|Overall Study|Protocol Violation|29|||
160945099|NCT04382326|581188129|FG001|Overall Study|Protocol Violation|23|||
160945100|NCT04382326|581188128|FG000|Overall Study|Physician Decision|0|||
160945101|NCT04382326|581188129|FG001|Overall Study|Physician Decision|1|||
160945102|NCT04382326|581188128|FG000|Overall Study|Lost to Follow-up|48|||
160945103|NCT04382326|581188129|FG001|Overall Study|Lost to Follow-up|63|||
160945104|NCT04382326|581188128|FG000|Overall Study|Adverse Event, non-fatal|1|||
160945105|NCT04382326|581188129|FG001|Overall Study|Adverse Event, non-fatal|1|||
160945106|NCT01181921|581188132|FG000|Overall Study|Lost to Follow-up|1|||
160945107|NCT02461589|581188138|FG000|Overall Study|Withdrawal by Subject|5|||
160945108|NCT02461589|581188139|FG001|Overall Study|Withdrawal by Subject|1|||
160945109|NCT02461589|581188140|FG002|Overall Study|Withdrawal by Subject|3|||
160945110|NCT02461589|581188141|FG003|Overall Study|Withdrawal by Subject|2|||
160945111|NCT02461589|581188142|FG004|Overall Study|Withdrawal by Subject|1|||
160945112|NCT02461589|581188143|FG005|Overall Study|Withdrawal by Subject|2|||
160945113|NCT02461589|581188144|FG006|Overall Study|Withdrawal by Subject|1|||
160945114|NCT02461589|581188145|FG007|Overall Study|Withdrawal by Subject|3|||
160945115|NCT02461589|581188146|FG008|Overall Study|Withdrawal by Subject|3|||
160945116|NCT02461589|581188147|FG009|Overall Study|Withdrawal by Subject|1|||
160945117|NCT02461589|581188138|FG000|Overall Study|Lost to Follow-up|0|||
160945118|NCT02461589|581188139|FG001|Overall Study|Lost to Follow-up|0|||
160945119|NCT02461589|581188140|FG002|Overall Study|Lost to Follow-up|2|||
160945120|NCT02461589|581188141|FG003|Overall Study|Lost to Follow-up|3|||
160945121|NCT02461589|581188142|FG004|Overall Study|Lost to Follow-up|1|||
160945122|NCT02461589|581188143|FG005|Overall Study|Lost to Follow-up|1|||
160945123|NCT02461589|581188144|FG006|Overall Study|Lost to Follow-up|3|||
160945124|NCT02461589|581188145|FG007|Overall Study|Lost to Follow-up|1|||
160999401|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
161265879|NCT01106014|582355795|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
161265880|NCT01106014|582355796|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
161265881|NCT01106014|582355795|FG000|Overall Study|Adverse Event|78|||
161265882|NCT01106014|582355796|FG001|Overall Study|Adverse Event|42|||
161265883|NCT01106014|582355795|FG000|Overall Study|Withdrawal by Subject|43|||
161265884|NCT01106014|582355796|FG001|Overall Study|Withdrawal by Subject|37|||
160945125|NCT02461589|581188146|FG008|Overall Study|Lost to Follow-up|3|||
160945126|NCT02461589|581188147|FG009|Overall Study|Lost to Follow-up|1|||
160945127|NCT02461589|581188138|FG000|Overall Study|Death|0|||
160999402|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161265885|NCT01106014|582355795|FG000|Overall Study|Administrative reason|7|||
160999403|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
161265886|NCT01106014|582355796|FG001|Overall Study|Administrative reason|6|||
161342676|NCT00879658|582642232|FG001|Overall Study|Withdrawal by Subject|0|||
160945128|NCT02461589|581188139|FG001|Overall Study|Death|0|||
160945129|NCT02461589|581188140|FG002|Overall Study|Death|0|||
160945130|NCT02461589|581188141|FG003|Overall Study|Death|0|||
160945131|NCT02461589|581188142|FG004|Overall Study|Death|0|||
160945132|NCT02461589|581188143|FG005|Overall Study|Death|0|||
160945133|NCT02461589|581188144|FG006|Overall Study|Death|0|||
160945134|NCT02461589|581188145|FG007|Overall Study|Death|1|||
160945135|NCT02461589|581188146|FG008|Overall Study|Death|0|||
160945136|NCT02461589|581188147|FG009|Overall Study|Death|0|||
160945137|NCT02461589|581188138|FG000|Overall Study|Unclassified|0|||
160945138|NCT02461589|581188139|FG001|Overall Study|Unclassified|0|||
160945139|NCT02461589|581188140|FG002|Overall Study|Unclassified|0|||
160945140|NCT02461589|581188141|FG003|Overall Study|Unclassified|0|||
160945141|NCT02461589|581188142|FG004|Overall Study|Unclassified|0|||
160945142|NCT02461589|581188143|FG005|Overall Study|Unclassified|0|||
160945143|NCT02461589|581188144|FG006|Overall Study|Unclassified|1|||
160945144|NCT02461589|581188145|FG007|Overall Study|Unclassified|0|||
160945145|NCT02461589|581188146|FG008|Overall Study|Unclassified|0|||
160945146|NCT02461589|581188147|FG009|Overall Study|Unclassified|2|||
160945147|NCT02461589|581188138|FG000|Overall Study|Missing follow-up information|1|||
160945148|NCT02461589|581188139|FG001|Overall Study|Missing follow-up information|1|||
160945149|NCT02461589|581188140|FG002|Overall Study|Missing follow-up information|0|||
160945150|NCT02461589|581188141|FG003|Overall Study|Missing follow-up information|0|||
160945151|NCT02461589|581188142|FG004|Overall Study|Missing follow-up information|0|||
160945152|NCT02461589|581188143|FG005|Overall Study|Missing follow-up information|0|||
160945153|NCT02461589|581188144|FG006|Overall Study|Missing follow-up information|1|||
160945154|NCT02461589|581188145|FG007|Overall Study|Missing follow-up information|0|||
160945155|NCT02461589|581188146|FG008|Overall Study|Missing follow-up information|0|||
160945156|NCT02461589|581188147|FG009|Overall Study|Missing follow-up information|0|||
160945157|NCT02461589|581188138|FG000|Overall Study|Withdrawal from trial before exposure|0|||
160945158|NCT02461589|581188139|FG001|Overall Study|Withdrawal from trial before exposure|0|||
160945159|NCT02461589|581188140|FG002|Overall Study|Withdrawal from trial before exposure|0|||
160945160|NCT02461589|581188141|FG003|Overall Study|Withdrawal from trial before exposure|0|||
160945161|NCT02461589|581188142|FG004|Overall Study|Withdrawal from trial before exposure|0|||
160945162|NCT02461589|581188143|FG005|Overall Study|Withdrawal from trial before exposure|0|||
160945163|NCT02461589|581188144|FG006|Overall Study|Withdrawal from trial before exposure|0|||
160945164|NCT02461589|581188145|FG007|Overall Study|Withdrawal from trial before exposure|0|||
160945165|NCT02461589|581188146|FG008|Overall Study|Withdrawal from trial before exposure|0|||
160945166|NCT02461589|581188147|FG009|Overall Study|Withdrawal from trial before exposure|1|||
160945167|NCT01978119|581188152|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
160945168|NCT01978119|581188153|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
160945169|NCT01978119|581188152|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
160945170|NCT01978119|581188153|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
160945171|NCT01978119|581188152|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
160945172|NCT01978119|581188153|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
160945173|NCT02519504|581188155|FG000|Overall Study|Protocol Violation|6|||
160945174|NCT02519504|581188156|FG001|Overall Study|Protocol Violation|5|||
160945175|NCT02519504|581188155|FG000|Overall Study|Ineligible for direct testing|12|||
160945176|NCT02519504|581188156|FG001|Overall Study|Ineligible for direct testing|12|||
160945177|NCT02519504|581188155|FG000|Overall Study|Did not participate in direct testing|95|||
160945178|NCT02519504|581188156|FG001|Overall Study|Did not participate in direct testing|86|||
160945179|NCT02548962|581188157|FG000|Overall Study|Withdrawal by Subject|1|||
160945180|NCT02548962|581188158|FG001|Overall Study|Withdrawal by Subject|0|||
160945181|NCT01958918|581188159|FG000|Overall Study|Death|1|||
160945182|NCT01958918|581188160|FG001|Overall Study|Death|3|||
160945183|NCT01958918|581188159|FG000|Overall Study|Lost to Follow-up|4|||
160945184|NCT01958918|581188160|FG001|Overall Study|Lost to Follow-up|7|||
160945185|NCT01958918|581188159|FG000|Overall Study|Withdrawal by Subject|13|||
160945186|NCT01958918|581188160|FG001|Overall Study|Withdrawal by Subject|8|||
160945187|NCT01958918|581188159|FG000|Overall Study|Lack of Efficacy|13|||
160945188|NCT01958918|581188160|FG001|Overall Study|Lack of Efficacy|10|||
160945189|NCT01958918|581188159|FG000|Overall Study|Adverse Event|12|||
160945190|NCT01958918|581188160|FG001|Overall Study|Adverse Event|12|||
160945191|NCT01958918|581188159|FG000|Overall Study|administrative problems|0|||
160945192|NCT01958918|581188160|FG001|Overall Study|administrative problems|2|||
160945193|NCT03653429|581188168|FG000|Overall Study|Physician Decision|4|||
160945194|NCT03653429|581188169|FG001|Overall Study|Physician Decision|10|||
160945195|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
160945196|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
160945197|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
160945198|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
160945199|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
161144609|NCT01330381|581913915|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
161144610|NCT01330381|581913916|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
160945200|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
160945201|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
160945202|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
161144611|NCT01330381|581913917|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
161144612|NCT01330381|581913915|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
161144613|NCT01330381|581913916|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
160945203|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
160945204|NCT00403546|581188170|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
160945205|NCT00403546|581188171|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
160945206|NCT00403546|581188172|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
160945207|NCT00403546|581188170|FG000|Screening Phase|Screening Failure|22|||
160945208|NCT00403546|581188171|FG001|Screening Phase|Screening Failure|0|||
160945209|NCT00403546|581188172|FG002|Screening Phase|Screening Failure|0|||
160945210|NCT00403546|581188170|FG000|Screening Phase|Adverse Event|1|||
160945211|NCT00403546|581188171|FG001|Screening Phase|Adverse Event|0|||
160945212|NCT00403546|581188172|FG002|Screening Phase|Adverse Event|0|||
160945213|NCT00403546|581188170|FG000|Screening Phase|Terminated Prior to Randomization|5|||
160945214|NCT00403546|581188171|FG001|Screening Phase|Terminated Prior to Randomization|0|||
160945215|NCT00403546|581188172|FG002|Screening Phase|Terminated Prior to Randomization|0|||
160945216|NCT00403546|581188170|FG000|Randomized Trial|Early Terminations|0|||
160945217|NCT00403546|581188171|FG001|Randomized Trial|Early Terminations|17|||
160945218|NCT00403546|581188172|FG002|Randomized Trial|Early Terminations|16|||
160945219|NCT00793910|581188173|FG000|Overall Study|discarded study pills|0|||
160945220|NCT00793910|581188174|FG001|Overall Study|discarded study pills|1|||
160945221|NCT00793910|581188173|FG000|Overall Study|did not pick up medications|1|||
160945222|NCT00793910|581188174|FG001|Overall Study|did not pick up medications|1|||
160945223|NCT00793910|581188173|FG000|Overall Study|ineligible based on entry criteria|2|||
160945224|NCT00793910|581188174|FG001|Overall Study|ineligible based on entry criteria|3|||
160945225|NCT00793910|581188173|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
160945226|NCT00793910|581188174|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
160945227|NCT00793910|581188173|FG000|Overall Study|Withdrawal by Subject|0|||
160945228|NCT00793910|581188174|FG001|Overall Study|Withdrawal by Subject|1|||
160945229|NCT03634579|581188177|FG000|Overall Study|study termination|9|||
160945230|NCT02480621|581188178|FG000|Randomization|Withdrawal by Subject|1|||
160945231|NCT02480621|581188179|FG001|Randomization|Withdrawal by Subject|0|||
160945232|NCT02480621|581188178|FG000|Randomization|Surgeon did not give intervention|0|||
160945233|NCT02480621|581188179|FG001|Randomization|Surgeon did not give intervention|1|||
160945234|NCT02480621|581188178|FG000|Follow Up|Lost to Follow-up|4|||
160945235|NCT02480621|581188179|FG001|Follow Up|Lost to Follow-up|2|||
160945236|NCT01723904|581188182|FG000|Overall Study|Noncompliant|3|||
160945237|NCT01723904|581188182|FG000|Overall Study|Adverse Event|5|||
160945238|NCT01723904|581188182|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
160945239|NCT02610140|581188193|FG000|Randomization and Treatment Period|Radiological progression|23|||
160945240|NCT02610140|581188194|FG001|Randomization and Treatment Period|Radiological progression|15|||
160945241|NCT02610140|581188193|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
160945242|NCT02610140|581188194|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
160945243|NCT02610140|581188193|FG000|Randomization and Treatment Period|Protocol Violation|1|||
160945244|NCT02610140|581188194|FG001|Randomization and Treatment Period|Protocol Violation|0|||
160945245|NCT02610140|581188193|FG000|Randomization and Treatment Period|Physician Decision|0|||
160945246|NCT02610140|581188194|FG001|Randomization and Treatment Period|Physician Decision|1|||
160945247|NCT02610140|581188193|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
160945248|NCT02610140|581188194|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
160945249|NCT02610140|581188193|FG000|Randomization and Treatment Period|Death|7|||
160945250|NCT02610140|581188194|FG001|Randomization and Treatment Period|Death|1|||
160945251|NCT02610140|581188193|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
160945252|NCT02610140|581188194|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
160945253|NCT02610140|581188193|FG000|Randomization and Treatment Period|Adverse Event|44|||
160945254|NCT02610140|581188194|FG001|Randomization and Treatment Period|Adverse Event|13|||
160945255|NCT02610140|581188193|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
160945256|NCT02610140|581188194|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
160945257|NCT02610140|581188193|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
160945258|NCT02610140|581188194|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
160945259|NCT02610140|581188193|FG000|Randomization and Treatment Period|Not treated|3|||
160945260|NCT02610140|581188194|FG001|Randomization and Treatment Period|Not treated|10|||
160945261|NCT02610140|581188193|FG000|Safety Follow-up|Other|0|||
160945262|NCT02610140|581188194|FG001|Safety Follow-up|Other|2|||
160945263|NCT02610140|581188193|FG000|Safety Follow-up|Lost to Follow-up|1|||
160945264|NCT02610140|581188194|FG001|Safety Follow-up|Lost to Follow-up|0|||
160945265|NCT02610140|581188193|FG000|Safety Follow-up|No follow-up|5|||
160945266|NCT02610140|581188194|FG001|Safety Follow-up|No follow-up|3|||
160945267|NCT02610140|581188193|FG000|Safety Follow-up|Death|12|||
160945268|NCT02610140|581188194|FG001|Safety Follow-up|Death|2|||
160945269|NCT02610140|581188193|FG000|Safety Follow-up|Deterioration of general conditions|15|||
160945270|NCT02610140|581188194|FG001|Safety Follow-up|Deterioration of general conditions|5|||
160945271|NCT02610140|581188193|FG000|Safety Follow-up|Withdrawal by Subject|12|||
160945272|NCT02610140|581188194|FG001|Safety Follow-up|Withdrawal by Subject|12|||
161265887|NCT01106014|582355795|FG000|Overall Study|Lost to Follow-up|2|||
161265888|NCT01106014|582355796|FG001|Overall Study|Lost to Follow-up|3|||
160945273|NCT02610140|581188193|FG000|Active Follow-up|Progressive disease - radiological|30|||
160945274|NCT02610140|581188194|FG001|Active Follow-up|Progressive disease - radiological|22|||
160945275|NCT02610140|581188193|FG000|Active Follow-up|Death|8|||
160945276|NCT02610140|581188194|FG001|Active Follow-up|Death|1|||
160945277|NCT02610140|581188193|FG000|Active Follow-up|Withdrawal by Subject|4|||
160945278|NCT02610140|581188194|FG001|Active Follow-up|Withdrawal by Subject|0|||
160945279|NCT02610140|581188193|FG000|Active Follow-up|Progressive disease - clinical|1|||
160945280|NCT02610140|581188194|FG001|Active Follow-up|Progressive disease - clinical|2|||
160945281|NCT02610140|581188193|FG000|Active Follow-up|Deterioration of general conditions|1|||
160945282|NCT02610140|581188194|FG001|Active Follow-up|Deterioration of general conditions|0|||
160945283|NCT02610140|581188193|FG000|Active Follow-up|Ongoing but not completed|4|||
160945284|NCT02610140|581188194|FG001|Active Follow-up|Ongoing but not completed|1|||
160945285|NCT02610140|581188193|FG000|Long-term Follow-up|Death|86|||
160945286|NCT02610140|581188194|FG001|Long-term Follow-up|Death|44|||
160945287|NCT02610140|581188193|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
160945288|NCT02610140|581188194|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
160945289|NCT02610140|581188193|FG000|Long-term Follow-up|Lost to Follow-up|1|||
160945290|NCT02610140|581188194|FG001|Long-term Follow-up|Lost to Follow-up|2|||
160945291|NCT02610140|581188193|FG000|Long-term Follow-up|Ongoing but not completed|30|||
160945292|NCT02610140|581188194|FG001|Long-term Follow-up|Ongoing but not completed|17|||
160945293|NCT00887341|581188195|FG000|Overall Study|Refused treatment|1|||
160945294|NCT00887341|581188196|FG001|Overall Study|Refused treatment|0|||
160945295|NCT00887341|581188195|FG000|Overall Study|Withdrawal by Subject|1|||
160945296|NCT00887341|581188196|FG001|Overall Study|Withdrawal by Subject|1|||
160945297|NCT00887341|581188195|FG000|Overall Study|Adverse Event|0|||
160945298|NCT00887341|581188196|FG001|Overall Study|Adverse Event|1|||
160945299|NCT00887341|581188195|FG000|Overall Study|Lost to Follow-up|0|||
160945300|NCT00887341|581188196|FG001|Overall Study|Lost to Follow-up|1|||
161265889|NCT02935686|582355797|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
161265890|NCT02935686|582355798|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161265891|NCT02935686|582355799|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161265892|NCT02935686|582355800|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
160945301|NCT02617589|581188197|FG000|Randomization|Request to Discontinue Study Treatment|1|||
160945302|NCT02617589|581188198|FG001|Randomization|Request to Discontinue Study Treatment|3|||
160945303|NCT02617589|581188197|FG000|Randomization|Participant Withdrew Consent|1|||
160945304|NCT02617589|581188198|FG001|Randomization|Participant Withdrew Consent|2|||
160945305|NCT02617589|581188197|FG000|Treatment|Other Reasons|3|||
160945306|NCT02617589|581188198|FG001|Treatment|Other Reasons|3|||
160945307|NCT02617589|581188197|FG000|Treatment|Poor/Non Compliance|1|||
160945308|NCT02617589|581188198|FG001|Treatment|Poor/Non Compliance|1|||
160945309|NCT02617589|581188197|FG000|Treatment|Maximum Clinical Benefit|0|||
160945310|NCT02617589|581188198|FG001|Treatment|Maximum Clinical Benefit|2|||
160945311|NCT02617589|581188197|FG000|Treatment|Participant Withdrew Consent|2|||
160945312|NCT02617589|581188198|FG001|Treatment|Participant Withdrew Consent|6|||
160945313|NCT02617589|581188197|FG000|Treatment|Participant Request to Discontinue|12|||
160945314|NCT02617589|581188198|FG001|Treatment|Participant Request to Discontinue|21|||
160945315|NCT02617589|581188197|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
160945316|NCT02617589|581188198|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
160945317|NCT02617589|581188197|FG000|Treatment|Death|1|||
160945318|NCT02617589|581188198|FG001|Treatment|Death|1|||
160945319|NCT02617589|581188197|FG000|Treatment|Study Drug Toxicity|27|||
160945320|NCT02617589|581188198|FG001|Treatment|Study Drug Toxicity|20|||
160945321|NCT02617589|581188197|FG000|Treatment|Disease Progression|216|||
160945322|NCT02617589|581188198|FG001|Treatment|Disease Progression|136|||
160945323|NCT01752933|581188201|FG000|Treatment|Disease Progression|3|||
160945324|NCT01752933|581188202|FG001|Treatment|Disease Progression|29|||
160945325|NCT01752933|581188201|FG000|Treatment|Withdrawal by Subject|0|||
160945326|NCT01752933|581188202|FG001|Treatment|Withdrawal by Subject|5|||
160945327|NCT01752933|581188201|FG000|Treatment|Adverse Event|1|||
160945328|NCT01752933|581188202|FG001|Treatment|Adverse Event|4|||
160945329|NCT01752933|581188201|FG000|Treatment|Physician Decision|0|||
161265893|NCT02935686|582355801|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
161265894|NCT02935686|582355797|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
161265895|NCT02935686|582355798|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
160945330|NCT01752933|581188202|FG001|Treatment|Physician Decision|3|||
160945331|NCT01752933|581188201|FG000|Treatment|Death|0|||
160945332|NCT01752933|581188202|FG001|Treatment|Death|2|||
161265896|NCT02935686|582355799|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
160945333|NCT01752933|581188201|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
160945334|NCT01752933|581188202|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
160945335|NCT01752933|581188201|FG000|Treatment|Patient noncompliant|0|||
160945336|NCT01752933|581188202|FG001|Treatment|Patient noncompliant|1|||
161265897|NCT02935686|582355800|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
160945337|NCT01752933|581188201|FG000|Treatment|Patient unable to travel to appointments|0|||
160945338|NCT01752933|581188202|FG001|Treatment|Patient unable to travel to appointments|1|||
160945339|NCT01752933|581188201|FG000|Overall Study and Follow-up|Death|4|||
161265898|NCT02935686|582355801|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
161265899|NCT02935686|582355797|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161265900|NCT02935686|582355798|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
161265901|NCT02935686|582355799|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161265902|NCT02935686|582355800|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161265903|NCT02935686|582355801|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
161265904|NCT02935686|582355797|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
161265905|NCT02935686|582355798|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
161265906|NCT02935686|582355799|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
160945340|NCT01752933|581188202|FG001|Overall Study and Follow-up|Death|34|||
160945341|NCT01752933|581188201|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
160945342|NCT01752933|581188202|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
160945343|NCT01752933|581188201|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
160945344|NCT01752933|581188202|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
160945345|NCT01752933|581188201|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
160945346|NCT01752933|581188202|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
160945347|NCT01591681|581188203|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
160945348|NCT01591681|581188203|FG000|Overall Study|Failed to use system during run-in|1|||
160945349|NCT03062891|581188204|FG000|Overall Study|Withdrawal by Subject|2|||
160945350|NCT03062891|581188205|FG001|Overall Study|Withdrawal by Subject|0|||
160945351|NCT03062891|581188204|FG000|Overall Study|Lost to Follow-up|50|||
160945352|NCT03062891|581188205|FG001|Overall Study|Lost to Follow-up|38|||
160945353|NCT01208233|581188211|FG000|Overall Study|Adverse Event|0|||
160945354|NCT01208233|581188212|FG001|Overall Study|Adverse Event|1|||
160945355|NCT01208233|581188213|FG002|Overall Study|Adverse Event|2|||
160945356|NCT01208233|581188214|FG003|Overall Study|Adverse Event|0|||
160945357|NCT01208233|581188215|FG004|Overall Study|Adverse Event|3|||
160945358|NCT01208233|581188216|FG005|Overall Study|Adverse Event|5|||
160945359|NCT01208233|581188211|FG000|Overall Study|Death|0|||
160945360|NCT01208233|581188212|FG001|Overall Study|Death|0|||
160945361|NCT01208233|581188213|FG002|Overall Study|Death|0|||
160945362|NCT01208233|581188214|FG003|Overall Study|Death|0|||
160945363|NCT01208233|581188215|FG004|Overall Study|Death|3|||
160945364|NCT01208233|581188216|FG005|Overall Study|Death|5|||
160945365|NCT01208233|581188211|FG000|Overall Study|Did not meet entrance criteria|2|||
160945366|NCT01208233|581188212|FG001|Overall Study|Did not meet entrance criteria|1|||
160945367|NCT01208233|581188213|FG002|Overall Study|Did not meet entrance criteria|1|||
160945368|NCT01208233|581188214|FG003|Overall Study|Did not meet entrance criteria|0|||
160945369|NCT01208233|581188215|FG004|Overall Study|Did not meet entrance criteria|1|||
160945370|NCT01208233|581188216|FG005|Overall Study|Did not meet entrance criteria|0|||
160945371|NCT01208233|581188211|FG000|Overall Study|Medication error without adverse event|0|||
160945372|NCT01208233|581188212|FG001|Overall Study|Medication error without adverse event|0|||
160945373|NCT01208233|581188213|FG002|Overall Study|Medication error without adverse event|0|||
160945374|NCT01208233|581188214|FG003|Overall Study|Medication error without adverse event|0|||
160945375|NCT01208233|581188215|FG004|Overall Study|Medication error without adverse event|0|||
160945376|NCT01208233|581188216|FG005|Overall Study|Medication error without adverse event|1|||
160945377|NCT01208233|581188211|FG000|Overall Study|Study terminated by sponsor|0|||
160945378|NCT01208233|581188212|FG001|Overall Study|Study terminated by sponsor|0|||
160945379|NCT01208233|581188213|FG002|Overall Study|Study terminated by sponsor|0|||
160945380|NCT01208233|581188214|FG003|Overall Study|Study terminated by sponsor|0|||
160945381|NCT01208233|581188215|FG004|Overall Study|Study terminated by sponsor|10|||
160945382|NCT01208233|581188216|FG005|Overall Study|Study terminated by sponsor|7|||
160945383|NCT01208233|581188211|FG000|Overall Study|Protocol Violation|0|||
160945384|NCT01208233|581188212|FG001|Overall Study|Protocol Violation|0|||
160945385|NCT01208233|581188213|FG002|Overall Study|Protocol Violation|0|||
160945386|NCT01208233|581188214|FG003|Overall Study|Protocol Violation|0|||
160945387|NCT01208233|581188215|FG004|Overall Study|Protocol Violation|3|||
160945388|NCT01208233|581188216|FG005|Overall Study|Protocol Violation|0|||
160945389|NCT01208233|581188211|FG000|Overall Study|Other|2|||
160945390|NCT01208233|581188212|FG001|Overall Study|Other|1|||
160945391|NCT01208233|581188213|FG002|Overall Study|Other|0|||
160945392|NCT01208233|581188214|FG003|Overall Study|Other|0|||
160945393|NCT01208233|581188215|FG004|Overall Study|Other|0|||
160945394|NCT01208233|581188216|FG005|Overall Study|Other|1|||
160945395|NCT01208233|581188211|FG000|Overall Study|Withdrawal by Subject|1|||
161265907|NCT02935686|582355800|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161265908|NCT02935686|582355801|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
161265909|NCT02935686|582355797|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
160945396|NCT01208233|581188212|FG001|Overall Study|Withdrawal by Subject|0|||
160945397|NCT01208233|581188213|FG002|Overall Study|Withdrawal by Subject|1|||
161265910|NCT02935686|582355798|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
160945398|NCT01208233|581188214|FG003|Overall Study|Withdrawal by Subject|1|||
160945399|NCT01208233|581188215|FG004|Overall Study|Withdrawal by Subject|4|||
160945400|NCT01208233|581188216|FG005|Overall Study|Withdrawal by Subject|2|||
161265911|NCT02935686|582355799|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
161265912|NCT02935686|582355800|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
161265913|NCT02935686|582355801|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
161265914|NCT02935686|582355797|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161265915|NCT02935686|582355798|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
161265916|NCT02935686|582355799|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161265917|NCT02935686|582355800|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161265918|NCT02935686|582355801|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
161265919|NCT02935686|582355797|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
161265920|NCT02935686|582355798|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
161265921|NCT02935686|582355799|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161265922|NCT02935686|582355800|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161265923|NCT02935686|582355801|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
161265924|NCT02935686|582355797|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161265925|NCT02935686|582355798|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
161265926|NCT02935686|582355799|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161265927|NCT02935686|582355800|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161265928|NCT02935686|582355801|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
161265929|NCT02935686|582355797|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161265930|NCT02935686|582355798|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
161265931|NCT02935686|582355799|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161265932|NCT02935686|582355800|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161265933|NCT02935686|582355801|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
161265934|NCT02935686|582355797|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161265935|NCT02935686|582355798|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161265936|NCT02935686|582355799|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161265937|NCT02935686|582355800|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
161265938|NCT02935686|582355801|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
161265939|NCT02935686|582355797|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161265940|NCT02935686|582355798|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161265941|NCT02935686|582355799|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
161265942|NCT02935686|582355800|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
161265943|NCT02935686|582355801|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
161265944|NCT00062010|582355804|FG000|Overall Study|Ineligible|3|||
161265945|NCT00852969|582355805|FG000|Overall Study|Adverse Event|0|||
161265946|NCT00852969|582355806|FG001|Overall Study|Adverse Event|1|||
161265947|NCT00852969|582355805|FG000|Overall Study|Lost to Follow-up|0|||
161265948|NCT00852969|582355806|FG001|Overall Study|Lost to Follow-up|1|||
161265949|NCT03986138|582355810|FG000|First MRI Examination|Physician Decision|0|||
161265950|NCT03986138|582355811|FG001|First MRI Examination|Physician Decision|1|||
161265951|NCT03986138|582355810|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
161265952|NCT03986138|582355811|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
161265953|NCT03986138|582355810|FG000|Washout|Withdrawal by Subject|4|||
161265954|NCT03986138|582355811|FG001|Washout|Withdrawal by Subject|5|||
161265955|NCT03986138|582355810|FG000|Washout|Lost to Follow-up|0|||
161265956|NCT03986138|582355811|FG001|Washout|Lost to Follow-up|2|||
161265957|NCT03986138|582355810|FG000|Washout|Adverse Event|1|||
161265958|NCT03986138|582355811|FG001|Washout|Adverse Event|1|||
161265959|NCT03986138|582355810|FG000|Washout|Other reason|5|||
161265960|NCT03986138|582355811|FG001|Washout|Other reason|5|||
161265961|NCT03986138|582355810|FG000|Second MRI Examination|Withdrawal by Subject|0|||
161265962|NCT03986138|582355811|FG001|Second MRI Examination|Withdrawal by Subject|2|||
161265963|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
161265964|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
161265965|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
161265966|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
161265967|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
161265968|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
161265969|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
161265970|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
161265971|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
161265972|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
161265973|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
161265974|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
161265975|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
161265976|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
161265977|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
161265978|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
161265979|NCT03182244|582355815|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
161319366|NCT01410240|582555290|FG001|Overall Study|Physician Decision|0|||
161144614|NCT01330381|581913917|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
161144615|NCT01330381|581913915|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161144616|NCT01330381|581913916|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161144617|NCT01330381|581913917|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
161144618|NCT01330381|581913915|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
161144619|NCT01330381|581913916|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
161144620|NCT01330381|581913917|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
161144621|NCT01330381|581913915|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
161144622|NCT01330381|581913916|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
161144623|NCT01330381|581913917|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
161144624|NCT01330381|581913915|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161144625|NCT01330381|581913916|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161144626|NCT01330381|581913917|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161144627|NCT01330381|581913915|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
161144628|NCT01330381|581913916|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
161144629|NCT01330381|581913917|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
161144630|NCT01330381|581913915|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
161144631|NCT01330381|581913916|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
161144632|NCT01330381|581913917|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
161144633|NCT01330381|581913915|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
161144634|NCT01330381|581913916|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
161265980|NCT03182244|582355816|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
161265981|NCT03182244|582355815|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
161265982|NCT03182244|582355816|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
160945401|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945402|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945403|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945404|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945405|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945406|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945407|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945408|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945409|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945410|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945411|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945412|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
160945413|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945414|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945415|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945416|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
160945417|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945418|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
160945419|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
160945420|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
160945421|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
160945422|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
160945423|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
160945424|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
160945425|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
160945426|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
160945427|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
160945428|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
160999404|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999405|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
160999406|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
160999407|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999408|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999409|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999410|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
160999411|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
160999412|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
161265983|NCT03182244|582355815|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
161265984|NCT03182244|582355816|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
160999413|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
161265985|NCT03182244|582355815|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
160945429|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945430|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945431|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945432|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
160945433|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945434|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945435|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160999414|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
160999415|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
160999416|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999417|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999418|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999419|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
160999420|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
160999421|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
160999422|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999423|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
160999424|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999425|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999426|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999427|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999428|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999429|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999430|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
160999431|NCT01212757|581380693|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999432|NCT01212757|581380694|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
160999433|NCT01212757|581380695|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
160999434|NCT01212757|581380696|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999435|NCT01212757|581380697|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999436|NCT01212757|581380698|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999437|NCT01212757|581380699|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999438|NCT01212757|581380700|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999439|NCT01212757|581380701|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
160999440|NCT03141788|581380702|FG000|Overall Study|Lost to Follow-up|1|||
160999441|NCT03141788|581380702|FG000|Overall Study|Protocol Violation|3|||
160999442|NCT03141788|581380702|FG000|Overall Study|Withdrawal by Subject|4|||
160945436|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945437|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945438|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
160999443|NCT03169244|581382715|FG000|Overall Study|Lost to Follow-up|1|||
160999444|NCT03169244|581382716|FG001|Overall Study|Lost to Follow-up|2|||
160999445|NCT03169244|581382715|FG000|Overall Study|Adverse Event|1|||
160999446|NCT03169244|581382716|FG001|Overall Study|Adverse Event|0|||
160999447|NCT03169244|581382715|FG000|Overall Study|Withdrawal by Subject|2|||
160999448|NCT03169244|581382716|FG001|Overall Study|Withdrawal by Subject|2|||
160999449|NCT03169244|581382715|FG000|Overall Study|Physician Decision|1|||
160999450|NCT03169244|581382716|FG001|Overall Study|Physician Decision|0|||
160999451|NCT02631148|581382717|FG000|Overall Study|8 were ineligible|8|||
160999452|NCT02631148|581382718|FG001|Overall Study|8 were ineligible|0|||
160999453|NCT02631148|581382717|FG000|Overall Study|Withdrawal by Subject|1|||
160999454|NCT02631148|581382718|FG001|Overall Study|Withdrawal by Subject|0|||
160999455|NCT02631148|581382717|FG000|Overall Study|PAH not available to study participant|1|||
160999456|NCT02631148|581382718|FG001|Overall Study|PAH not available to study participant|0|||
160999457|NCT00708032|581382722|FG000|Overall Study|Adverse Event|0|||
160999458|NCT00708032|581382723|FG001|Overall Study|Adverse Event|2|||
160999459|NCT00708032|581382722|FG000|Overall Study|Lost to Follow-up|1|||
160999460|NCT00708032|581382723|FG001|Overall Study|Lost to Follow-up|2|||
160999461|NCT00708032|581382722|FG000|Overall Study|Pregnancy|0|||
160999462|NCT00708032|581382723|FG001|Overall Study|Pregnancy|1|||
160999463|NCT00708032|581382722|FG000|Overall Study|Poor vision|0|||
160999464|NCT00708032|581382723|FG001|Overall Study|Poor vision|6|||
160999465|NCT00708032|581382722|FG000|Overall Study|Visit out of range at month 12|4|||
160999466|NCT00708032|581382723|FG001|Overall Study|Visit out of range at month 12|1|||
160999467|NCT00708032|581382722|FG000|Overall Study|Did not meet protocol criteria|1|||
160999468|NCT00708032|581382723|FG001|Overall Study|Did not meet protocol criteria|2|||
160999469|NCT00708032|581382722|FG000|Overall Study|Protocol Violation|4|||
160999470|NCT00708032|581382723|FG001|Overall Study|Protocol Violation|1|||
160999471|NCT00708032|581382722|FG000|Overall Study|Withdrawal by Subject|0|||
160999472|NCT00708032|581382723|FG001|Overall Study|Withdrawal by Subject|1|||
160999473|NCT00391846|581382724|FG000|Overall Study|Adverse Event|4|||
160999474|NCT00391846|581382725|FG001|Overall Study|Adverse Event|1|||
160999475|NCT00391846|581382724|FG000|Overall Study|Did not meet the required elig. crit|2|||
160945439|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
160945440|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945441|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945442|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
160945443|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
160945444|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
160945445|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945446|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945447|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945448|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
160945449|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945450|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945451|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945452|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945453|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945454|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
160945455|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945456|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945457|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945458|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945459|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945460|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
160945461|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945462|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
161265986|NCT03182244|582355816|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
161265987|NCT03182244|582355815|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
161265988|NCT03182244|582355816|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
161265989|NCT02049450|582355817|FG000|Overall Study|Adverse Event|2|||
161265990|NCT02049450|582355817|FG000|Overall Study|Withdrawal by Subject|1|||
161265991|NCT02049450|582355817|FG000|Overall Study|Patients/guardian decision|1|||
161265992|NCT03186781|582355818|FG000|Overall Study|Lost to Follow-up|0|||
161265993|NCT03186781|582355819|FG001|Overall Study|Lost to Follow-up|0|||
161265994|NCT03186781|582355820|FG002|Overall Study|Lost to Follow-up|1|||
161265995|NCT03186781|582355821|FG003|Overall Study|Lost to Follow-up|0|||
161265996|NCT03186781|582355822|FG004|Overall Study|Lost to Follow-up|1|||
161265997|NCT03186781|582355823|FG005|Overall Study|Lost to Follow-up|0|||
161265998|NCT03186781|582355818|FG000|Overall Study|Moved from Area|0|||
161265999|NCT03186781|582355819|FG001|Overall Study|Moved from Area|0|||
161266000|NCT03186781|582355820|FG002|Overall Study|Moved from Area|0|||
161266001|NCT03186781|582355821|FG003|Overall Study|Moved from Area|0|||
161266002|NCT03186781|582355822|FG004|Overall Study|Moved from Area|1|||
161266003|NCT03186781|582355823|FG005|Overall Study|Moved from Area|0|||
161266004|NCT03186781|582355818|FG000|Overall Study|Withdrawal by Subject|0|||
161266005|NCT03186781|582355819|FG001|Overall Study|Withdrawal by Subject|0|||
161266006|NCT03186781|582355820|FG002|Overall Study|Withdrawal by Subject|0|||
161266007|NCT03186781|582355821|FG003|Overall Study|Withdrawal by Subject|0|||
161266008|NCT03186781|582355822|FG004|Overall Study|Withdrawal by Subject|1|||
161266009|NCT03186781|582355823|FG005|Overall Study|Withdrawal by Subject|0|||
161266010|NCT04709835|582355824|FG000|Overall Study|Withdrawal by Subject|0|||
160945463|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945464|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
160945465|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945466|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945467|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945468|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945469|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945470|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
160945471|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945472|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945473|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945474|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945475|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945476|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161266011|NCT04709835|582355825|FG001|Overall Study|Withdrawal by Subject|1|||
161266012|NCT04709835|582355826|FG002|Overall Study|Withdrawal by Subject|0|||
160945477|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
161266013|NCT02372071|582355827|FG000|Overall Study|Protocol Violation|18|||
161266014|NCT03347422|582355831|FG000|Part A (26 Weeks)|Adverse Event|3|||
160945478|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945479|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945480|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
160945481|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945482|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945483|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945484|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945485|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945486|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945487|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945488|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945489|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
160945490|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945491|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945492|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945493|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945494|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945495|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945496|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
160945497|NCT01609556|581188221|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
160945498|NCT01609556|581188222|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945499|NCT01609556|581188223|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945500|NCT01609556|581188224|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945501|NCT01609556|581188225|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945502|NCT01609556|581188226|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
160945503|NCT01609556|581188227|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945504|NCT01609556|581188228|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945505|NCT01609556|581188229|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945506|NCT01609556|581188230|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945507|NCT01609556|581188231|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
160945508|NCT01609556|581188232|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945509|NCT01609556|581188233|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945510|NCT01609556|581188234|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945511|NCT01609556|581188235|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945512|NCT01609556|581188236|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
160945513|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945514|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945515|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945516|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945517|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945518|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945519|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945520|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945521|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945522|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945523|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945524|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
160945525|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
160945526|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
160945527|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
160945528|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
160945529|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945530|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945531|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945532|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945533|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945534|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945535|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945536|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945537|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945538|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945539|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945540|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
160945541|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
160945542|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
160945543|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
161144635|NCT01330381|581913917|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
161144636|NCT01330381|581913915|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
161144637|NCT01330381|581913916|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
161144638|NCT01330381|581913917|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
161144639|NCT02584634|581913918|FG000|Overall Study|Adverse Event|3|||
161144640|NCT02584634|581913919|FG001|Overall Study|Adverse Event|5|||
161144641|NCT02584634|581913918|FG000|Overall Study|Death|0|||
160945544|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
161144642|NCT02584634|581913919|FG001|Overall Study|Death|1|||
161144643|NCT02584634|581913918|FG000|Overall Study|Lost to Follow-up|0|||
161144644|NCT02584634|581913919|FG001|Overall Study|Lost to Follow-up|1|||
161144645|NCT02584634|581913918|FG000|Overall Study|Physician Decision|1|||
161144646|NCT02584634|581913919|FG001|Overall Study|Physician Decision|2|||
160945545|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945546|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945547|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945548|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945549|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945550|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945551|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945552|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945553|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945554|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945555|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945556|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
160945557|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
160945558|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
160945559|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
161144647|NCT02584634|581913918|FG000|Overall Study|Progressive disease|7|||
161144648|NCT02584634|581913919|FG001|Overall Study|Progressive disease|15|||
161144649|NCT02584634|581913918|FG000|Overall Study|Withdrawal by Subject|1|||
161144650|NCT02584634|581913919|FG001|Overall Study|Withdrawal by Subject|1|||
161144651|NCT02584634|581913918|FG000|Overall Study|Other|0|||
161144652|NCT02584634|581913919|FG001|Overall Study|Other|6|||
161144653|NCT05523362|581913920|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
161144654|NCT05523362|581913920|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
161144655|NCT05523362|581913920|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
161144656|NCT05523362|581913920|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
161144657|NCT04075604|581913922|FG000|Overall Study|Adverse Event|0|||
161144658|NCT04075604|581913923|FG001|Overall Study|Adverse Event|0|||
161144659|NCT04075604|581913924|FG002|Overall Study|Adverse Event|3|||
161144660|NCT04075604|581913922|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161144661|NCT04075604|581913923|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160999476|NCT00391846|581382725|FG001|Overall Study|Did not meet the required elig. crit|2|||
160999477|NCT00391846|581382724|FG000|Overall Study|Withdrawal by Subject|2|||
160999478|NCT00391846|581382725|FG001|Overall Study|Withdrawal by Subject|3|||
161144662|NCT04075604|581913924|FG002|Overall Study|Participant request to discontinue study treatment|1|||
161144663|NCT04075604|581913922|FG000|Overall Study|Participant withdrew consent|0|||
160945560|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
160945561|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945562|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945563|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945564|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945565|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945566|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945567|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945568|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945569|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945570|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945571|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945572|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160999479|NCT00391846|581382724|FG000|Overall Study|Developed study specific DC criteria|0|||
161144664|NCT04075604|581913923|FG001|Overall Study|Participant withdrew consent|0|||
161144665|NCT04075604|581913924|FG002|Overall Study|Participant withdrew consent|1|||
161144666|NCT04075604|581913922|FG000|Overall Study|Other reasons|1|||
161144667|NCT04075604|581913923|FG001|Overall Study|Other reasons|0|||
161144668|NCT04075604|581913924|FG002|Overall Study|Other reasons|0|||
161266015|NCT03347422|582355832|FG001|Part A (26 Weeks)|Adverse Event|0|||
161266016|NCT03347422|582355831|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
160945573|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
160945574|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945575|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945576|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
160945577|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945578|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945579|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945580|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945581|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945582|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945583|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945584|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945585|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945586|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945587|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945588|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
160945589|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
160945590|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
160945591|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
160945592|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
160945593|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945594|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945595|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945596|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945597|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945598|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945599|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945600|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945601|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945602|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945603|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945604|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945605|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945606|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945607|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
160945608|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
160945609|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945610|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945611|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945612|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945613|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945614|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945615|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945616|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945617|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945618|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945619|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945620|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945621|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
160945622|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
160945623|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
160945624|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
160945625|NCT01609556|581188221|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945626|NCT01609556|581188222|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945627|NCT01609556|581188223|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945628|NCT01609556|581188224|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945629|NCT01609556|581188225|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945630|NCT01609556|581188226|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945631|NCT01609556|581188227|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945632|NCT01609556|581188228|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945633|NCT01609556|581188229|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945634|NCT01609556|581188230|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945635|NCT01609556|581188231|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945636|NCT01609556|581188232|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945637|NCT01609556|581188233|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
160945638|NCT01609556|581188234|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
161266017|NCT03347422|582355832|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
161266018|NCT03347422|582355831|FG000|Part B (149 Weeks)|Adverse Event|0|||
160945639|NCT01609556|581188235|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945640|NCT01609556|581188236|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
160945641|NCT01539291|581189987|FG000|Study GS-US-312-0116|Adverse Event|9|||
160945642|NCT01539291|581189988|FG001|Study GS-US-312-0116|Adverse Event|0|||
160945643|NCT01539291|581189989|FG002|Study GS-US-312-0116|Adverse Event|0|||
160945644|NCT01539291|581189990|FG003|Study GS-US-312-0116|Adverse Event|0|||
160945645|NCT01539291|581189987|FG000|Study GS-US-312-0116|Physician Decision|1|||
160945646|NCT01539291|581189988|FG001|Study GS-US-312-0116|Physician Decision|0|||
160945647|NCT01539291|581189989|FG002|Study GS-US-312-0116|Physician Decision|0|||
160945648|NCT01539291|581189990|FG003|Study GS-US-312-0116|Physician Decision|0|||
160945649|NCT01539291|581189987|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
160945650|NCT01539291|581189988|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
160945651|NCT01539291|581189989|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
160945652|NCT01539291|581189990|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
160945653|NCT01539291|581189987|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
160945654|NCT01539291|581189988|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
160945655|NCT01539291|581189989|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
160945656|NCT01539291|581189990|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
160945657|NCT01539291|581189987|FG000|Study GS-US-312-0116|Other|1|||
160945658|NCT01539291|581189988|FG001|Study GS-US-312-0116|Other|0|||
160945659|NCT01539291|581189989|FG002|Study GS-US-312-0116|Other|0|||
160945660|NCT01539291|581189990|FG003|Study GS-US-312-0116|Other|0|||
160945661|NCT01539291|581189987|FG000|Study GS-US-312-0117|Adverse Event|22|||
160945662|NCT01539291|581189988|FG001|Study GS-US-312-0117|Adverse Event|1|||
160945663|NCT01539291|581189989|FG002|Study GS-US-312-0117|Adverse Event|9|||
160945664|NCT01539291|581189990|FG003|Study GS-US-312-0117|Adverse Event|12|||
160945665|NCT01539291|581189987|FG000|Study GS-US-312-0117|Physician Decision|9|||
160945666|NCT01539291|581189988|FG001|Study GS-US-312-0117|Physician Decision|0|||
160945667|NCT01539291|581189989|FG002|Study GS-US-312-0117|Physician Decision|6|||
160945668|NCT01539291|581189990|FG003|Study GS-US-312-0117|Physician Decision|4|||
160945669|NCT01539291|581189987|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
160945670|NCT01539291|581189988|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
160945671|NCT01539291|581189989|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
160945672|NCT01539291|581189990|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
160945673|NCT01539291|581189987|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
160945674|NCT01539291|581189988|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
160945675|NCT01539291|581189989|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
160945676|NCT01539291|581189990|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
160945677|NCT01539291|581189987|FG000|Study GS-US-312-0117|Other|2|||
160945678|NCT01539291|581189988|FG001|Study GS-US-312-0117|Other|1|||
160945679|NCT01539291|581189989|FG002|Study GS-US-312-0117|Other|1|||
160945680|NCT01539291|581189990|FG003|Study GS-US-312-0117|Other|1|||
160945681|NCT00129987|581189995|FG000|1st Educational Session|Withdrawal by Subject|141|||
160945682|NCT00129987|581189996|FG001|1st Educational Session|Withdrawal by Subject|109|||
160945683|NCT00129987|581189995|FG000|1 Year|Withdrawal by Subject|32|||
160945684|NCT00129987|581189996|FG001|1 Year|Withdrawal by Subject|21|||
160945685|NCT00581945|581189997|FG000|Overall Study|Adverse Event|4|||
160945686|NCT00581945|581189998|FG001|Overall Study|Adverse Event|4|||
160945687|NCT00581945|581189997|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160945688|NCT00581945|581189998|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
160945689|NCT00581945|581189997|FG000|Overall Study|Withdrawal by Subject|2|||
160945690|NCT00581945|581189998|FG001|Overall Study|Withdrawal by Subject|6|||
160945691|NCT00581945|581189997|FG000|Overall Study|Death|1|||
160945692|NCT00581945|581189998|FG001|Overall Study|Death|0|||
160945693|NCT02979535|581189999|FG000|Overall Study|Non compliance with the protocol|78|||
160945694|NCT02979535|581190000|FG001|Overall Study|Non compliance with the protocol|82|||
160945695|NCT02979535|581189999|FG000|Overall Study|Consent withdrawn by participant|11|||
160945696|NCT02979535|581190000|FG001|Overall Study|Consent withdrawn by participant|18|||
160945697|NCT02979535|581189999|FG000|Overall Study|Lost to Follow-up|6|||
160999480|NCT00391846|581382725|FG001|Overall Study|Developed study specific DC criteria|1|||
160999481|NCT00150176|581382726|FG000|Overall Study|Adverse Event|16|||
160999482|NCT00150176|581382727|FG001|Overall Study|Adverse Event|53|||
160999483|NCT00150176|581382726|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
161266019|NCT03347422|582355832|FG001|Part B (149 Weeks)|Adverse Event|1|||
160945698|NCT02979535|581190000|FG001|Overall Study|Lost to Follow-up|1|||
160945699|NCT02032901|581190004|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
161266020|NCT03347422|582355831|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
160945700|NCT02032901|581190005|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
160945701|NCT02032901|581190004|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
160945702|NCT02032901|581190005|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
160945703|NCT01722331|581190006|FG000|Part 1|Adverse Event|5|||
160945704|NCT01722331|581190007|FG001|Part 1|Adverse Event|0|||
160945705|NCT01722331|581190008|FG002|Part 1|Adverse Event|0|||
160945706|NCT01722331|581190009|FG003|Part 1|Adverse Event|0|||
160945707|NCT01722331|581190010|FG004|Part 1|Adverse Event|0|||
160945708|NCT01722331|581190011|FG005|Part 1|Adverse Event|0|||
160945709|NCT01722331|581190012|FG006|Part 1|Adverse Event|0|||
160945710|NCT01722331|581190006|FG000|Part 1|Lack of Efficacy|0|||
160945711|NCT01722331|581190007|FG001|Part 1|Lack of Efficacy|0|||
160945712|NCT01722331|581190008|FG002|Part 1|Lack of Efficacy|1|||
160945713|NCT01722331|581190009|FG003|Part 1|Lack of Efficacy|0|||
160945714|NCT01722331|581190010|FG004|Part 1|Lack of Efficacy|2|||
160945715|NCT01722331|581190011|FG005|Part 1|Lack of Efficacy|0|||
160945716|NCT01722331|581190012|FG006|Part 1|Lack of Efficacy|0|||
160945717|NCT01722331|581190006|FG000|Part 1|Lost to Follow-up|1|||
160945718|NCT01722331|581190007|FG001|Part 1|Lost to Follow-up|0|||
160945719|NCT01722331|581190008|FG002|Part 1|Lost to Follow-up|2|||
160945720|NCT01722331|581190009|FG003|Part 1|Lost to Follow-up|0|||
160945721|NCT01722331|581190010|FG004|Part 1|Lost to Follow-up|1|||
160945722|NCT01722331|581190011|FG005|Part 1|Lost to Follow-up|0|||
160945723|NCT01722331|581190012|FG006|Part 1|Lost to Follow-up|0|||
160945724|NCT01722331|581190006|FG000|Part 1|Physician Decision|0|||
160945725|NCT01722331|581190007|FG001|Part 1|Physician Decision|0|||
160945726|NCT01722331|581190008|FG002|Part 1|Physician Decision|3|||
160945727|NCT01722331|581190009|FG003|Part 1|Physician Decision|0|||
160945728|NCT01722331|581190010|FG004|Part 1|Physician Decision|1|||
160945729|NCT01722331|581190011|FG005|Part 1|Physician Decision|0|||
160945730|NCT01722331|581190012|FG006|Part 1|Physician Decision|0|||
160945731|NCT01722331|581190006|FG000|Part 1|Pregnancy|1|||
160945732|NCT01722331|581190007|FG001|Part 1|Pregnancy|0|||
160945733|NCT01722331|581190008|FG002|Part 1|Pregnancy|0|||
160945734|NCT01722331|581190009|FG003|Part 1|Pregnancy|0|||
160945735|NCT01722331|581190010|FG004|Part 1|Pregnancy|0|||
160945736|NCT01722331|581190011|FG005|Part 1|Pregnancy|0|||
160945737|NCT01722331|581190012|FG006|Part 1|Pregnancy|0|||
160945738|NCT01722331|581190006|FG000|Part 1|Progressive Disease|0|||
160945739|NCT01722331|581190007|FG001|Part 1|Progressive Disease|0|||
160945740|NCT01722331|581190008|FG002|Part 1|Progressive Disease|0|||
160945741|NCT01722331|581190009|FG003|Part 1|Progressive Disease|0|||
160945742|NCT01722331|581190010|FG004|Part 1|Progressive Disease|1|||
160945743|NCT01722331|581190011|FG005|Part 1|Progressive Disease|0|||
160945744|NCT01722331|581190012|FG006|Part 1|Progressive Disease|0|||
160945745|NCT01722331|581190006|FG000|Part 1|Protocol Violation|1|||
160945746|NCT01722331|581190007|FG001|Part 1|Protocol Violation|0|||
160945747|NCT01722331|581190008|FG002|Part 1|Protocol Violation|0|||
160945748|NCT01722331|581190009|FG003|Part 1|Protocol Violation|0|||
160945749|NCT01722331|581190010|FG004|Part 1|Protocol Violation|1|||
160945750|NCT01722331|581190011|FG005|Part 1|Protocol Violation|0|||
160945751|NCT01722331|581190012|FG006|Part 1|Protocol Violation|0|||
160945752|NCT01722331|581190006|FG000|Part 1|Withdrawal by Subject|2|||
161266021|NCT03347422|582355832|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
160945753|NCT01722331|581190007|FG001|Part 1|Withdrawal by Subject|0|||
160945754|NCT01722331|581190008|FG002|Part 1|Withdrawal by Subject|3|||
160945755|NCT01722331|581190009|FG003|Part 1|Withdrawal by Subject|0|||
160945756|NCT01722331|581190010|FG004|Part 1|Withdrawal by Subject|3|||
160945757|NCT01722331|581190011|FG005|Part 1|Withdrawal by Subject|0|||
160945758|NCT01722331|581190012|FG006|Part 1|Withdrawal by Subject|0|||
160945759|NCT01722331|581190006|FG000|Part 2|Adverse Event|3|||
160945760|NCT01722331|581190007|FG001|Part 2|Adverse Event|0|||
160945761|NCT01722331|581190008|FG002|Part 2|Adverse Event|0|||
160945762|NCT01722331|581190009|FG003|Part 2|Adverse Event|0|||
160999484|NCT00150176|581382727|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
160999485|NCT00150176|581382726|FG000|Overall Study|Withdrawal by Subject|19|||
161266022|NCT03347422|582355831|FG000|Part B (149 Weeks)|Other|1|||
161266023|NCT03347422|582355832|FG001|Part B (149 Weeks)|Other|0|||
160945763|NCT01722331|581190010|FG004|Part 2|Adverse Event|0|||
160945764|NCT01722331|581190011|FG005|Part 2|Adverse Event|1|||
160945765|NCT01722331|581190012|FG006|Part 2|Adverse Event|0|||
160945766|NCT01722331|581190006|FG000|Part 2|Lack of Efficacy|3|||
160945767|NCT01722331|581190007|FG001|Part 2|Lack of Efficacy|0|||
160945768|NCT01722331|581190008|FG002|Part 2|Lack of Efficacy|11|||
160945769|NCT01722331|581190009|FG003|Part 2|Lack of Efficacy|0|||
160945770|NCT01722331|581190010|FG004|Part 2|Lack of Efficacy|0|||
160945771|NCT01722331|581190011|FG005|Part 2|Lack of Efficacy|3|||
160945772|NCT01722331|581190012|FG006|Part 2|Lack of Efficacy|3|||
160945773|NCT01722331|581190006|FG000|Part 2|Lost to Follow-up|0|||
160945774|NCT01722331|581190007|FG001|Part 2|Lost to Follow-up|0|||
160999486|NCT00150176|581382727|FG001|Overall Study|Withdrawal by Subject|12|||
160945775|NCT01722331|581190008|FG002|Part 2|Lost to Follow-up|3|||
160945776|NCT01722331|581190009|FG003|Part 2|Lost to Follow-up|0|||
160945777|NCT01722331|581190010|FG004|Part 2|Lost to Follow-up|0|||
160945778|NCT01722331|581190011|FG005|Part 2|Lost to Follow-up|1|||
160945779|NCT01722331|581190012|FG006|Part 2|Lost to Follow-up|1|||
160945780|NCT01722331|581190006|FG000|Part 2|Non-Compliance with Study Drug|1|||
160945781|NCT01722331|581190007|FG001|Part 2|Non-Compliance with Study Drug|0|||
160945782|NCT01722331|581190008|FG002|Part 2|Non-Compliance with Study Drug|1|||
160945783|NCT01722331|581190009|FG003|Part 2|Non-Compliance with Study Drug|0|||
160945784|NCT01722331|581190010|FG004|Part 2|Non-Compliance with Study Drug|0|||
160945785|NCT01722331|581190011|FG005|Part 2|Non-Compliance with Study Drug|0|||
160945786|NCT01722331|581190012|FG006|Part 2|Non-Compliance with Study Drug|0|||
161266024|NCT00622466|582355837|FG000|Overall Study|Death|1|||
160945787|NCT01722331|581190006|FG000|Part 2|Physician Decision|0|||
160945788|NCT01722331|581190007|FG001|Part 2|Physician Decision|0|||
160945789|NCT01722331|581190008|FG002|Part 2|Physician Decision|2|||
160945790|NCT01722331|581190009|FG003|Part 2|Physician Decision|0|||
160945791|NCT01722331|581190010|FG004|Part 2|Physician Decision|0|||
160945792|NCT01722331|581190011|FG005|Part 2|Physician Decision|0|||
160945793|NCT01722331|581190012|FG006|Part 2|Physician Decision|0|||
160945794|NCT01722331|581190006|FG000|Part 2|Pregnancy|0|||
160945795|NCT01722331|581190007|FG001|Part 2|Pregnancy|0|||
160945796|NCT01722331|581190008|FG002|Part 2|Pregnancy|0|||
160945797|NCT01722331|581190009|FG003|Part 2|Pregnancy|0|||
160945798|NCT01722331|581190010|FG004|Part 2|Pregnancy|0|||
160945799|NCT01722331|581190011|FG005|Part 2|Pregnancy|1|||
160945800|NCT01722331|581190012|FG006|Part 2|Pregnancy|0|||
160945801|NCT01722331|581190006|FG000|Part 2|Progressive Disease|0|||
160945802|NCT01722331|581190007|FG001|Part 2|Progressive Disease|0|||
160945803|NCT01722331|581190008|FG002|Part 2|Progressive Disease|1|||
160945804|NCT01722331|581190009|FG003|Part 2|Progressive Disease|0|||
160945805|NCT01722331|581190010|FG004|Part 2|Progressive Disease|0|||
160945806|NCT01722331|581190011|FG005|Part 2|Progressive Disease|0|||
160945807|NCT01722331|581190012|FG006|Part 2|Progressive Disease|0|||
160945808|NCT01722331|581190006|FG000|Part 2|Protocol Violation|1|||
160945809|NCT01722331|581190007|FG001|Part 2|Protocol Violation|0|||
160945810|NCT01722331|581190008|FG002|Part 2|Protocol Violation|0|||
160945811|NCT01722331|581190009|FG003|Part 2|Protocol Violation|0|||
160945812|NCT01722331|581190010|FG004|Part 2|Protocol Violation|0|||
160945813|NCT01722331|581190011|FG005|Part 2|Protocol Violation|0|||
160945814|NCT01722331|581190012|FG006|Part 2|Protocol Violation|0|||
160945815|NCT01722331|581190006|FG000|Part 2|Withdrawal by Subject|5|||
160945816|NCT01722331|581190007|FG001|Part 2|Withdrawal by Subject|0|||
160945817|NCT01722331|581190008|FG002|Part 2|Withdrawal by Subject|3|||
160945818|NCT01722331|581190009|FG003|Part 2|Withdrawal by Subject|0|||
160945819|NCT01722331|581190010|FG004|Part 2|Withdrawal by Subject|0|||
160945820|NCT01722331|581190011|FG005|Part 2|Withdrawal by Subject|2|||
160945821|NCT01722331|581190012|FG006|Part 2|Withdrawal by Subject|2|||
160945822|NCT01722331|581190006|FG000|Part 2|Other Protocol Specified Criteria|6|||
160945823|NCT01722331|581190007|FG001|Part 2|Other Protocol Specified Criteria|0|||
160945824|NCT01722331|581190008|FG002|Part 2|Other Protocol Specified Criteria|10|||
160945825|NCT01722331|581190009|FG003|Part 2|Other Protocol Specified Criteria|0|||
160945826|NCT01722331|581190010|FG004|Part 2|Other Protocol Specified Criteria|0|||
160945827|NCT01722331|581190011|FG005|Part 2|Other Protocol Specified Criteria|2|||
160945828|NCT01722331|581190012|FG006|Part 2|Other Protocol Specified Criteria|1|||
160945829|NCT01722331|581190006|FG000|Part 3|Adverse Event|2|||
160945830|NCT01722331|581190007|FG001|Part 3|Adverse Event|2|||
160945831|NCT01722331|581190008|FG002|Part 3|Adverse Event|0|||
160945832|NCT01722331|581190009|FG003|Part 3|Adverse Event|1|||
160945833|NCT01722331|581190010|FG004|Part 3|Adverse Event|0|||
160945834|NCT01722331|581190011|FG005|Part 3|Adverse Event|0|||
160945835|NCT01722331|581190012|FG006|Part 3|Adverse Event|0|||
160945836|NCT01722331|581190006|FG000|Part 3|Death|1|||
160945837|NCT01722331|581190007|FG001|Part 3|Death|0|||
160945838|NCT01722331|581190008|FG002|Part 3|Death|0|||
160945839|NCT01722331|581190009|FG003|Part 3|Death|0|||
160945840|NCT01722331|581190010|FG004|Part 3|Death|0|||
160945841|NCT01722331|581190011|FG005|Part 3|Death|0|||
160945842|NCT01722331|581190012|FG006|Part 3|Death|0|||
160945843|NCT01722331|581190006|FG000|Part 3|Lack of Efficacy|1|||
160945844|NCT01722331|581190007|FG001|Part 3|Lack of Efficacy|0|||
160945845|NCT01722331|581190008|FG002|Part 3|Lack of Efficacy|0|||
160945846|NCT01722331|581190009|FG003|Part 3|Lack of Efficacy|0|||
160945847|NCT01722331|581190010|FG004|Part 3|Lack of Efficacy|0|||
160945848|NCT01722331|581190011|FG005|Part 3|Lack of Efficacy|0|||
160945849|NCT01722331|581190012|FG006|Part 3|Lack of Efficacy|0|||
160945850|NCT01722331|581190006|FG000|Part 3|Lost to Follow-up|3|||
160945851|NCT01722331|581190007|FG001|Part 3|Lost to Follow-up|4|||
160945852|NCT01722331|581190008|FG002|Part 3|Lost to Follow-up|0|||
161266025|NCT00622466|582355837|FG000|Overall Study|Adverse Event|1|||
160945853|NCT01722331|581190009|FG003|Part 3|Lost to Follow-up|0|||
160945854|NCT01722331|581190010|FG004|Part 3|Lost to Follow-up|0|||
160945855|NCT01722331|581190011|FG005|Part 3|Lost to Follow-up|1|||
160945856|NCT01722331|581190012|FG006|Part 3|Lost to Follow-up|0|||
160945857|NCT01722331|581190006|FG000|Part 3|Non-Compliance with Study Drug|0|||
160945858|NCT01722331|581190007|FG001|Part 3|Non-Compliance with Study Drug|1|||
160945859|NCT01722331|581190008|FG002|Part 3|Non-Compliance with Study Drug|0|||
160945860|NCT01722331|581190009|FG003|Part 3|Non-Compliance with Study Drug|0|||
160945861|NCT01722331|581190010|FG004|Part 3|Non-Compliance with Study Drug|0|||
160945862|NCT01722331|581190011|FG005|Part 3|Non-Compliance with Study Drug|0|||
160945863|NCT01722331|581190012|FG006|Part 3|Non-Compliance with Study Drug|0|||
160945864|NCT01722331|581190006|FG000|Part 3|Physician Decision|1|||
160945865|NCT01722331|581190007|FG001|Part 3|Physician Decision|1|||
160945866|NCT01722331|581190008|FG002|Part 3|Physician Decision|0|||
160945867|NCT01722331|581190009|FG003|Part 3|Physician Decision|0|||
160945868|NCT01722331|581190010|FG004|Part 3|Physician Decision|0|||
160945869|NCT01722331|581190011|FG005|Part 3|Physician Decision|0|||
160945870|NCT01722331|581190012|FG006|Part 3|Physician Decision|1|||
160945871|NCT01722331|581190006|FG000|Part 3|Protocol Violation|2|||
161266026|NCT00622466|582355837|FG000|Overall Study|Withdrawal by Subject|2|||
160945872|NCT01722331|581190007|FG001|Part 3|Protocol Violation|1|||
160945873|NCT01722331|581190008|FG002|Part 3|Protocol Violation|0|||
160945874|NCT01722331|581190009|FG003|Part 3|Protocol Violation|0|||
160945875|NCT01722331|581190010|FG004|Part 3|Protocol Violation|0|||
160945876|NCT01722331|581190011|FG005|Part 3|Protocol Violation|0|||
160945877|NCT01722331|581190012|FG006|Part 3|Protocol Violation|0|||
160945878|NCT01722331|581190006|FG000|Part 3|Withdrawal by Subject|4|||
160945879|NCT01722331|581190007|FG001|Part 3|Withdrawal by Subject|7|||
160945880|NCT01722331|581190008|FG002|Part 3|Withdrawal by Subject|0|||
160945881|NCT01722331|581190009|FG003|Part 3|Withdrawal by Subject|0|||
160945882|NCT01722331|581190010|FG004|Part 3|Withdrawal by Subject|0|||
160945883|NCT01722331|581190011|FG005|Part 3|Withdrawal by Subject|2|||
160945884|NCT01722331|581190012|FG006|Part 3|Withdrawal by Subject|1|||
160945885|NCT01722331|581190006|FG000|Part 3|Other Protocol Specified Criteria|1|||
160945886|NCT01722331|581190007|FG001|Part 3|Other Protocol Specified Criteria|1|||
160945887|NCT01722331|581190008|FG002|Part 3|Other Protocol Specified Criteria|0|||
160945888|NCT01722331|581190009|FG003|Part 3|Other Protocol Specified Criteria|0|||
160945889|NCT01722331|581190010|FG004|Part 3|Other Protocol Specified Criteria|0|||
160945890|NCT01722331|581190011|FG005|Part 3|Other Protocol Specified Criteria|0|||
160945891|NCT01722331|581190012|FG006|Part 3|Other Protocol Specified Criteria|0|||
160945892|NCT00086346|581190018|FG000|Randomization|Did not receive test article|4|||
160945893|NCT00086346|581190019|FG001|Randomization|Did not receive test article|4|||
160945894|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Adverse Event|94|||
160945895|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Adverse Event|11|||
160945896|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
160945897|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
160945898|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
160945899|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
160945900|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
160945901|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
160945902|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
160945903|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
160945904|NCT00086346|581190018|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
160945905|NCT00086346|581190019|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
160945906|NCT04495374|581190020|FG000|Overall Study|Protocol Violation|2|||
160945907|NCT04495374|581190021|FG001|Overall Study|Protocol Violation|1|||
160945908|NCT02807948|581190022|FG000|Overall Study|Physician Decision|1|||
160945909|NCT02807948|581190023|FG001|Overall Study|Physician Decision|0|||
160945910|NCT03727750|581190024|FG000|Overall Study|Death|45|||
160945911|NCT03727750|581190024|FG000|Overall Study|Withdrawal by Subject|2|||
160945912|NCT03727750|581190024|FG000|Overall Study|Lost to Follow-up|1|||
160945913|NCT03727750|581190024|FG000|Overall Study|Other|1|||
160945914|NCT01575561|581190025|FG000|Overall Study|Adverse Event|9|||
160945915|NCT01575561|581190025|FG000|Overall Study|Lack of Efficacy|8|||
160945916|NCT01575561|581190025|FG000|Overall Study|Lost to Follow-up|6|||
160945917|NCT01575561|581190025|FG000|Overall Study|Protocol Violation|4|||
160945918|NCT01575561|581190025|FG000|Overall Study|Withdrawal by Subject|11|||
160945919|NCT01575561|581190025|FG000|Overall Study|administration|1|||
160945920|NCT01038921|581190026|FG000|Overall Study|Withdrawal by Subject|1|||
160945921|NCT01038921|581190027|FG001|Overall Study|Withdrawal by Subject|0|||
160945922|NCT01038921|581190026|FG000|Overall Study|Physician Decision|1|||
160945923|NCT01038921|581190027|FG001|Overall Study|Physician Decision|0|||
160945924|NCT03295201|581190029|FG000|Overall Study|Lost to Follow-up|1|||
160945925|NCT03295201|581190030|FG001|Overall Study|Lost to Follow-up|1|||
160945926|NCT03295201|581190029|FG000|Overall Study|Hospital admission|0|||
160945927|NCT03295201|581190030|FG001|Overall Study|Hospital admission|1|||
160945928|NCT00572572|581190031|FG000|Overall Study|Withdrawal by Subject|3|||
160945929|NCT00572572|581190032|FG001|Overall Study|Withdrawal by Subject|6|||
160945930|NCT01831089|581190033|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
160945931|NCT01831089|581190034|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
160945932|NCT01831089|581190035|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
160945933|NCT01831089|581190036|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
160945934|NCT01831089|581190037|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
161266027|NCT01936623|582355849|FG000|Overall Study|Lost to Follow-up|0|||
161266028|NCT01936623|582355850|FG001|Overall Study|Lost to Follow-up|5|||
160945935|NCT01831089|581190038|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
160945936|NCT01831089|581190033|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
160945937|NCT01831089|581190034|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
160945938|NCT01831089|581190035|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
160945939|NCT01831089|581190036|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
160945940|NCT01831089|581190037|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
160945941|NCT01831089|581190038|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
161266029|NCT02534844|582355853|FG000|Part B|Withdrawal by Subject|0|||
160945942|NCT01831089|581190033|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160999487|NCT00150176|581382726|FG000|Overall Study|Lost to Follow-up|3|||
160945943|NCT01831089|581190034|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
160945944|NCT01831089|581190035|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945945|NCT01831089|581190036|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945946|NCT01831089|581190037|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945947|NCT01831089|581190038|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
160945948|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
160945949|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
160945950|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
160945951|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
160945952|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
160945953|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
160945954|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945955|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945956|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
160945957|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945958|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945959|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
160945960|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
160945961|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
160945962|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
160945963|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
160945964|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
160945965|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
160945966|NCT01831089|581190033|FG000|Cohort III: Dose Level 3|Global end of study|0|||
160945967|NCT01831089|581190034|FG001|Cohort III: Dose Level 3|Global end of study|0|||
160945968|NCT01831089|581190035|FG002|Cohort III: Dose Level 3|Global end of study|1|||
160945969|NCT01831089|581190036|FG003|Cohort III: Dose Level 3|Global end of study|0|||
160945970|NCT01831089|581190037|FG004|Cohort III: Dose Level 3|Global end of study|0|||
160945971|NCT01831089|581190038|FG005|Cohort III: Dose Level 3|Global end of study|0|||
160945972|NCT01831089|581190033|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
160945973|NCT01831089|581190034|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
160945974|NCT01831089|581190035|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
160945975|NCT01831089|581190036|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
160945976|NCT01831089|581190037|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
160945977|NCT01831089|581190038|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
160945978|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
160945979|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
160945980|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
160945981|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
160945982|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
160945983|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
160945984|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945985|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945986|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945987|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945988|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
160945989|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
160945990|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Death|0|||
160945991|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Death|0|||
160945992|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Death|0|||
160945993|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Death|0|||
160945994|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Death|1|||
160945995|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Death|0|||
160945996|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Global end of study|0|||
160945997|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Global end of study|0|||
160945998|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Global end of study|0|||
160945999|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Global end of study|0|||
160946000|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Global end of study|2|||
160946001|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Global end of study|0|||
160946002|NCT01831089|581190033|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946003|NCT01831089|581190034|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946004|NCT01831089|581190035|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946005|NCT01831089|581190036|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946006|NCT01831089|581190037|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
160946007|NCT01831089|581190038|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
160946008|NCT01831089|581190033|FG000|Cohort B: Arm B|Progressive disease|0|||
160946009|NCT01831089|581190034|FG001|Cohort B: Arm B|Progressive disease|0|||
160946010|NCT01831089|581190035|FG002|Cohort B: Arm B|Progressive disease|0|||
160946011|NCT01831089|581190036|FG003|Cohort B: Arm B|Progressive disease|0|||
160946012|NCT01831089|581190037|FG004|Cohort B: Arm B|Progressive disease|0|||
160946013|NCT01831089|581190038|FG005|Cohort B: Arm B|Progressive disease|8|||
160946014|NCT01831089|581190033|FG000|Cohort B: Arm B|Physician Decision|0|||
161144669|NCT04075604|581913922|FG000|Overall Study|Disease progression|0|||
161144670|NCT04075604|581913923|FG001|Overall Study|Disease progression|1|||
161144671|NCT04075604|581913924|FG002|Overall Study|Disease progression|0|||
161144672|NCT04075604|581913922|FG000|Overall Study|Study drug toxicity|0|||
161144673|NCT04075604|581913923|FG001|Overall Study|Study drug toxicity|5|||
161144674|NCT04075604|581913924|FG002|Overall Study|Study drug toxicity|1|||
161144675|NCT05372315|581913925|FG000|Overall Study|Withdrawal by Subject|1|||
161144676|NCT05372315|581913926|FG001|Overall Study|Withdrawal by Subject|0|||
160946015|NCT01831089|581190034|FG001|Cohort B: Arm B|Physician Decision|0|||
160946016|NCT01831089|581190035|FG002|Cohort B: Arm B|Physician Decision|0|||
160946017|NCT01831089|581190036|FG003|Cohort B: Arm B|Physician Decision|0|||
160946018|NCT01831089|581190037|FG004|Cohort B: Arm B|Physician Decision|0|||
160946019|NCT01831089|581190038|FG005|Cohort B: Arm B|Physician Decision|2|||
160946020|NCT01831089|581190033|FG000|Cohort B: Arm B|Never treated|0|||
160946021|NCT01831089|581190034|FG001|Cohort B: Arm B|Never treated|0|||
160946022|NCT01831089|581190035|FG002|Cohort B: Arm B|Never treated|0|||
160946023|NCT01831089|581190036|FG003|Cohort B: Arm B|Never treated|0|||
160946024|NCT01831089|581190037|FG004|Cohort B: Arm B|Never treated|0|||
160946025|NCT01831089|581190038|FG005|Cohort B: Arm B|Never treated|2|||
160946026|NCT01831089|581190033|FG000|Cohort B: Arm B|Adverse Event|0|||
160946027|NCT01831089|581190034|FG001|Cohort B: Arm B|Adverse Event|0|||
160946028|NCT01831089|581190035|FG002|Cohort B: Arm B|Adverse Event|0|||
160946029|NCT01831089|581190036|FG003|Cohort B: Arm B|Adverse Event|0|||
160946030|NCT01831089|581190037|FG004|Cohort B: Arm B|Adverse Event|0|||
160946031|NCT01831089|581190038|FG005|Cohort B: Arm B|Adverse Event|1|||
160946032|NCT01831089|581190033|FG000|Cohort B: Arm B|Global end of study|0|||
160946033|NCT01831089|581190034|FG001|Cohort B: Arm B|Global end of study|0|||
160946034|NCT01831089|581190035|FG002|Cohort B: Arm B|Global end of study|0|||
160946035|NCT01831089|581190036|FG003|Cohort B: Arm B|Global end of study|0|||
160946036|NCT01831089|581190037|FG004|Cohort B: Arm B|Global end of study|0|||
160946037|NCT01831089|581190038|FG005|Cohort B: Arm B|Global end of study|1|||
160946038|NCT00889421|581190042|FG000|Overall Study|Lack of Efficacy|3|||
160946039|NCT03551938|581190043|FG000|3-Month Follow Up|Lost to Follow-up|39|||
161144677|NCT00650585|581913931|FG000|Overall Study|Lost to Follow-up|505|||
161144678|NCT00650585|581913932|FG001|Overall Study|Lost to Follow-up|482|||
161144679|NCT00650585|581913931|FG000|Overall Study|No parental consent|935|||
161144680|NCT00650585|581913932|FG001|Overall Study|No parental consent|866|||
161144681|NCT00650585|581913931|FG000|Overall Study|Excluded/ruled ineligible|357|||
161144682|NCT00650585|581913932|FG001|Overall Study|Excluded/ruled ineligible|129|||
161144683|NCT01720667|581913933|FG000|Overall Study|Adverse Event|1|||
161144684|NCT01720667|581913934|FG001|Overall Study|Adverse Event|1|||
161144685|NCT01720667|581913933|FG000|Overall Study|Withdrawal by Subject|3|||
161144686|NCT01720667|581913934|FG001|Overall Study|Withdrawal by Subject|0|||
161144687|NCT03472534|581913935|FG000|Overall Study|Withdrawal by Subject|9|||
161144688|NCT03472534|581913935|FG000|Overall Study|Adverse Event|2|||
161144689|NCT02614794|581913936|FG000|Overall Study|Death|258|||
161144690|NCT02614794|581913937|FG001|Overall Study|Death|151|||
161144691|NCT02614794|581913936|FG000|Overall Study|Study closure by Sponsor|119|||
161144692|NCT02614794|581913937|FG001|Overall Study|Study closure by Sponsor|45|||
161144693|NCT02614794|581913936|FG000|Overall Study|Withdrawal by Subject|24|||
161144694|NCT02614794|581913937|FG001|Overall Study|Withdrawal by Subject|5|||
161144695|NCT02614794|581913936|FG000|Overall Study|Lost to Follow-up|7|||
161144696|NCT02614794|581913937|FG001|Overall Study|Lost to Follow-up|0|||
160946040|NCT03551938|581190044|FG001|3-Month Follow Up|Lost to Follow-up|38|||
160946041|NCT03551938|581190043|FG000|6-Month Follow Up|Lost to Follow-up|46|||
160946042|NCT03551938|581190044|FG001|6-Month Follow Up|Lost to Follow-up|42|||
160946043|NCT03551938|581190043|FG000|9-Month Follow Up|Lost to Follow-up|44|||
160946044|NCT03551938|581190044|FG001|9-Month Follow Up|Lost to Follow-up|43|||
160946045|NCT01114646|581190045|FG000|Overall Study|Withdrawal by Subject|3|||
160946046|NCT01114646|581190046|FG001|Overall Study|Withdrawal by Subject|2|||
160946047|NCT00659269|581190056|FG000|Overall Study|Physician Decision|1|||
160946048|NCT00659269|581190057|FG001|Overall Study|Physician Decision|1|||
160946049|NCT00908960|581190059|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
160946050|NCT00908960|581190060|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
160946051|NCT00908960|581190061|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
160946052|NCT00781326|581190062|FG000|Phase I|Adverse Event|1|||
160946053|NCT00781326|581190062|FG000|Phase I|Withdrawal by Subject|1|||
160946054|NCT00781326|581190062|FG000|Phase I|Physician Decision|2|||
161144697|NCT02614794|581913936|FG000|Overall Study|Physician Decision|1|||
161144698|NCT02614794|581913937|FG001|Overall Study|Physician Decision|1|||
160946055|NCT00096941|581190063|FG000|Overall Study|disease progression|3|||
160946056|NCT02401672|581190064|FG000|Overall Study|Withdrawal by Subject|1|||
160946057|NCT02401672|581190065|FG001|Overall Study|Withdrawal by Subject|3|||
160946058|NCT05061446|581190071|FG000|Overall Study|Adverse Event|2|||
161144699|NCT02614794|581913936|FG000|Overall Study|Hospital closure|1|||
161144700|NCT02614794|581913937|FG001|Overall Study|Hospital closure|0|||
161144701|NCT00234104|581913942|FG000|Overall Study|Adverse Event|4|||
161144702|NCT00234104|581913943|FG001|Overall Study|Adverse Event|0|||
160946059|NCT05061446|581190072|FG001|Overall Study|Adverse Event|0|||
160946060|NCT05061446|581190073|FG002|Overall Study|Adverse Event|0|||
160946061|NCT05061446|581190071|FG000|Overall Study|Participant no longer available due to personal reason|0|||
160946062|NCT05061446|581190072|FG001|Overall Study|Participant no longer available due to personal reason|1|||
160946063|NCT05061446|581190073|FG002|Overall Study|Participant no longer available due to personal reason|0|||
160946064|NCT04111497|581190074|FG000|Overall Study|relapse of primary disease|1|||
160946065|NCT04111497|581190074|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
160946066|NCT01993719|581190077|FG000|First Drug Administration|Not treated|1|||
160946067|NCT01993719|581190078|FG001|First Drug Administration|Not treated|0|||
160946068|NCT01993719|581190079|FG002|First Drug Administration|Not treated|0|||
160946069|NCT01993719|581190080|FG003|First Drug Administration|Not treated|0|||
160946070|NCT01993719|581190081|FG004|First Drug Administration|Not treated|0|||
160946071|NCT05857527|581190082|FG000|Overall Study|Withdrawal by Subject|0|||
160946072|NCT05857527|581190083|FG001|Overall Study|Withdrawal by Subject|1|||
160946073|NCT02799082|581190085|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
160946074|NCT02799082|581190086|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
160946075|NCT02799082|581190085|FG000|Overall Study|Protocol Violation|0|||
160946076|NCT02799082|581190086|FG001|Overall Study|Protocol Violation|1|||
160946077|NCT01592708|581190087|FG000|Overall Study|Protocol Violation|3|||
160946078|NCT01592708|581190088|FG001|Overall Study|Protocol Violation|0|||
160946079|NCT01748994|581190090|FG000|Overall Study|Lost to Follow-up|8|||
160946080|NCT01748994|581190091|FG001|Overall Study|Lost to Follow-up|6|||
160946081|NCT03105362|581190092|FG000|Overall Study|Withdrawal by Subject|1|||
160946082|NCT03105362|581190092|FG000|Overall Study|Lost to Follow-up|1|||
160946083|NCT00861341|581190094|FG000|Overall Study|Withdrawal by Subject|2|||
160946084|NCT01440946|581190095|FG000|Overall Study|Lost to Follow-up|1|||
160946085|NCT01440946|581190096|FG001|Overall Study|Lost to Follow-up|1|||
160946086|NCT01440946|581190095|FG000|Overall Study|Physician Decision|1|||
160946087|NCT01440946|581190096|FG001|Overall Study|Physician Decision|0|||
160946088|NCT01975389|581190097|FG000|Overall Study|Adverse Event|10|||
160946089|NCT01975389|581190098|FG001|Overall Study|Adverse Event|6|||
160946090|NCT01975389|581190097|FG000|Overall Study|Death|61|||
160946091|NCT01975389|581190098|FG001|Overall Study|Death|54|||
160946092|NCT01975389|581190097|FG000|Overall Study|Lost to Follow-up|81|||
160946093|NCT01975389|581190098|FG001|Overall Study|Lost to Follow-up|86|||
160946094|NCT01975389|581190097|FG000|Overall Study|Withdrawal by Subject|90|||
160946095|NCT01975389|581190098|FG001|Overall Study|Withdrawal by Subject|76|||
160946096|NCT01975389|581190097|FG000|Overall Study|Other|6|||
160946097|NCT01975389|581190098|FG001|Overall Study|Other|9|||
160946098|NCT01975389|581190097|FG000|Overall Study|Randomized, not treated|4|||
160946099|NCT01975389|581190098|FG001|Overall Study|Randomized, not treated|5|||
160946100|NCT01312961|581190099|FG000|Overall Study|Adverse Event|3|||
160946101|NCT01312961|581190100|FG001|Overall Study|Adverse Event|3|||
160946102|NCT01312961|581190099|FG000|Overall Study|Lack of Efficacy|11|||
160946103|NCT01312961|581190100|FG001|Overall Study|Lack of Efficacy|1|||
160946104|NCT01312961|581190099|FG000|Overall Study|Poor compliance to protocol|1|||
160946105|NCT01312961|581190100|FG001|Overall Study|Poor compliance to protocol|0|||
160946106|NCT01312961|581190099|FG000|Overall Study|Other than specified above|2|||
160946107|NCT01312961|581190100|FG001|Overall Study|Other than specified above|3|||
160946108|NCT01337297|581190106|FG000|Overall Study|They entered to single anodal tDCS|4|||
160946109|NCT01337297|581190107|FG001|Overall Study|They entered to single anodal tDCS|3|||
160946110|NCT01337297|581190106|FG000|Overall Study|Lost to Follow-up|1|||
160946111|NCT01337297|581190107|FG001|Overall Study|Lost to Follow-up|3|||
160946112|NCT01800903|581190108|FG000|Second Test Period|unable to catheterise|1|||
160946113|NCT01800903|581190109|FG001|Second Test Period|unable to catheterise|0|||
160946114|NCT01800903|581190110|FG002|Second Test Period|unable to catheterise|0|||
160946115|NCT01800903|581190111|FG003|Second Test Period|unable to catheterise|0|||
160946116|NCT01800903|581190112|FG004|Second Test Period|unable to catheterise|0|||
160946117|NCT01800903|581190113|FG005|Second Test Period|unable to catheterise|0|||
160946118|NCT02778204|581190114|FG000|Overall Study|Adverse Event|1|||
160946119|NCT02778204|581190115|FG001|Overall Study|Adverse Event|0|||
160946120|NCT02778204|581190116|FG002|Overall Study|Adverse Event|0|||
160946121|NCT02778204|581190117|FG003|Overall Study|Adverse Event|0|||
160946122|NCT02778204|581190114|FG000|Overall Study|Withdrawal by Subject|0|||
160946123|NCT02778204|581190115|FG001|Overall Study|Withdrawal by Subject|0|||
160946124|NCT02778204|581190116|FG002|Overall Study|Withdrawal by Subject|1|||
160946125|NCT02778204|581190117|FG003|Overall Study|Withdrawal by Subject|2|||
160946126|NCT02778204|581190114|FG000|Overall Study|Lost to Follow-up|1|||
160946127|NCT02778204|581190115|FG001|Overall Study|Lost to Follow-up|0|||
160946128|NCT02778204|581190116|FG002|Overall Study|Lost to Follow-up|2|||
160999488|NCT00150176|581382727|FG001|Overall Study|Lost to Follow-up|3|||
160946129|NCT02778204|581190117|FG003|Overall Study|Lost to Follow-up|1|||
160946130|NCT02778204|581190114|FG000|Overall Study|Protocol Violation|0|||
160946131|NCT02778204|581190115|FG001|Overall Study|Protocol Violation|0|||
160946132|NCT02778204|581190116|FG002|Overall Study|Protocol Violation|1|||
160946133|NCT02778204|581190117|FG003|Overall Study|Protocol Violation|0|||
160946134|NCT02778204|581190114|FG000|Overall Study|Eligibility Violation|0|||
160946135|NCT02778204|581190115|FG001|Overall Study|Eligibility Violation|0|||
160946136|NCT02778204|581190116|FG002|Overall Study|Eligibility Violation|0|||
160946137|NCT02778204|581190117|FG003|Overall Study|Eligibility Violation|1|||
160946138|NCT01720069|581190118|FG000|Overall Study|Could not use e-diary correctly|0|||
160946139|NCT01720069|581190119|FG001|Overall Study|Could not use e-diary correctly|1|||
160946140|NCT01720069|581190120|FG002|Overall Study|Could not use e-diary correctly|1|||
160946141|NCT01720069|581190118|FG000|Overall Study|Randomised without baseline values|0|||
160946142|NCT01720069|581190119|FG001|Overall Study|Randomised without baseline values|0|||
160946143|NCT01720069|581190120|FG002|Overall Study|Randomised without baseline values|1|||
160946144|NCT01720069|581190118|FG000|Overall Study|Adverse Event|0|||
160946145|NCT01720069|581190119|FG001|Overall Study|Adverse Event|0|||
160946146|NCT01720069|581190120|FG002|Overall Study|Adverse Event|1|||
160946147|NCT01720069|581190118|FG000|Overall Study|Lack of Efficacy|0|||
160946148|NCT01720069|581190119|FG001|Overall Study|Lack of Efficacy|4|||
160946149|NCT01720069|581190120|FG002|Overall Study|Lack of Efficacy|0|||
160946150|NCT01720069|581190118|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
160946151|NCT01720069|581190119|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
160946152|NCT01720069|581190120|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
160946153|NCT01720069|581190118|FG000|Overall Study|Withdrawal by Subject|0|||
160946154|NCT01720069|581190119|FG001|Overall Study|Withdrawal by Subject|2|||
160946155|NCT01720069|581190120|FG002|Overall Study|Withdrawal by Subject|1|||
160946156|NCT01720069|581190118|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
160946157|NCT01720069|581190119|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
160946158|NCT01720069|581190120|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
160946159|NCT01720069|581190118|FG000|Overall Study|Non-compliance on using e-diary|0|||
160946160|NCT01720069|581190119|FG001|Overall Study|Non-compliance on using e-diary|0|||
160946161|NCT01720069|581190120|FG002|Overall Study|Non-compliance on using e-diary|1|||
160946162|NCT01720069|581190118|FG000|Overall Study|Lost to Follow-up|0|||
160946163|NCT01720069|581190119|FG001|Overall Study|Lost to Follow-up|0|||
160946164|NCT01720069|581190120|FG002|Overall Study|Lost to Follow-up|1|||
160946165|NCT00360334|581190121|FG000|Overall Study|Adverse Event|7|||
160946166|NCT00360334|581190122|FG001|Overall Study|Adverse Event|4|||
160946167|NCT00360334|581190121|FG000|Overall Study|Protocol Violation|1|||
160946168|NCT00360334|581190122|FG001|Overall Study|Protocol Violation|1|||
160946169|NCT00360334|581190121|FG000|Overall Study|Physician Decision|2|||
160946170|NCT00360334|581190122|FG001|Overall Study|Physician Decision|3|||
160946171|NCT00360334|581190121|FG000|Overall Study|Lack of Efficacy|0|||
160946172|NCT00360334|581190122|FG001|Overall Study|Lack of Efficacy|1|||
160946173|NCT00360334|581190121|FG000|Overall Study|Entry criterion not met|1|||
160946174|NCT00360334|581190122|FG001|Overall Study|Entry criterion not met|2|||
160946175|NCT00360334|581190121|FG000|Overall Study|Subject decision|8|||
160946176|NCT00360334|581190122|FG001|Overall Study|Subject decision|2|||
160946177|NCT01898793|581190124|FG000|Overall Study|Death|2|||
160946178|NCT01898793|581190125|FG001|Overall Study|Death|1|||
160946179|NCT01898793|581190126|FG002|Overall Study|Death|4|||
160946180|NCT01898793|581190127|FG003|Overall Study|Death|0|||
160946181|NCT01898793|581190128|FG004|Overall Study|Death|0|||
160946182|NCT01898793|581190129|FG005|Overall Study|Death|0|||
160946183|NCT01898793|581190130|FG006|Overall Study|Death|0|||
160946184|NCT01306617|581190134|FG000|Overall Study|Adverse Event|1|||
160946185|NCT01306617|581190135|FG001|Overall Study|Adverse Event|0|||
160946186|NCT01306617|581190136|FG002|Overall Study|Adverse Event|0|||
160946187|NCT01306617|581190134|FG000|Overall Study|Virologic Failure|0|||
160946188|NCT01306617|581190135|FG001|Overall Study|Virologic Failure|0|||
160946189|NCT01306617|581190136|FG002|Overall Study|Virologic Failure|5|||
160946190|NCT01306617|581190134|FG000|Overall Study|Non-compliance|0|||
160946191|NCT01306617|581190135|FG001|Overall Study|Non-compliance|1|||
160946192|NCT01306617|581190136|FG002|Overall Study|Non-compliance|0|||
160946193|NCT04028388|581190137|FG000|Overall Study|Evaluations missing|3|||
160946194|NCT04028388|581190138|FG001|Overall Study|Evaluations missing|6|||
160946195|NCT04028388|581190137|FG000|Overall Study|Not started|2|||
160946196|NCT04028388|581190138|FG001|Overall Study|Not started|0|||
160946197|NCT00162136|581190139|FG000|Overall Study|Adverse Event|1|||
160946198|NCT00162136|581190139|FG000|Overall Study|Death|1|||
160946199|NCT00162136|581190139|FG000|Overall Study|Disease Progression/Relapse|23|||
160999489|NCT00150176|581382726|FG000|Overall Study|OTHER|11|||
160999490|NCT00150176|581382727|FG001|Overall Study|OTHER|13|||
161144703|NCT00234104|581913944|FG002|Overall Study|Adverse Event|3|||
160946200|NCT00162136|581190139|FG000|Overall Study|Investigator Request|5|||
160946201|NCT00162136|581190139|FG000|Overall Study|Study Drug Toxicity|4|||
160946202|NCT00162136|581190139|FG000|Overall Study|Withdrawal by Subject|1|||
160946203|NCT00836875|581190141|FG000|Overall Study|Death|3|||
160946204|NCT00836875|581190142|FG001|Overall Study|Death|2|||
160946205|NCT00836875|581190141|FG000|Overall Study|Withdrawal by Subject|0|||
160946206|NCT00836875|581190142|FG001|Overall Study|Withdrawal by Subject|1|||
160946207|NCT03964454|581190151|FG000|Overall Study|Lost to Follow-up|13|||
160946208|NCT03964454|581190152|FG001|Overall Study|Lost to Follow-up|7|||
160946209|NCT03964454|581190151|FG000|Overall Study|Withdrawal by Subject|4|||
161266030|NCT02534844|582355854|FG001|Part B|Withdrawal by Subject|0|||
161266031|NCT02534844|582355855|FG002|Part B|Withdrawal by Subject|0|||
161266032|NCT02534844|582355856|FG003|Part B|Withdrawal by Subject|0|||
161266033|NCT02534844|582355857|FG004|Part B|Withdrawal by Subject|2|||
161266034|NCT02534844|582355858|FG005|Part B|Withdrawal by Subject|1|||
161266035|NCT01971970|582355859|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
161266036|NCT01971970|582355860|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
161266037|NCT01971970|582355859|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
161266038|NCT01971970|582355860|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
161266039|NCT01971970|582355859|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
161266040|NCT01971970|582355860|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
161266041|NCT01971970|582355859|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
161266042|NCT01971970|582355860|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
161266043|NCT01971970|582355859|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
161266044|NCT01971970|582355860|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
161266045|NCT01971970|582355859|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
161266046|NCT01971970|582355860|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
160946210|NCT03964454|581190152|FG001|Overall Study|Withdrawal by Subject|11|||
160946211|NCT04450264|581191943|FG000|Overall Study|Incomplete survey|13|||
160946212|NCT04450264|581191944|FG001|Overall Study|Incomplete survey|19|||
160946213|NCT00116805|581191948|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
160946214|NCT00116805|581191949|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
160946215|NCT00116805|581191948|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
160946216|NCT00116805|581191949|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
160946217|NCT00116805|581191948|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
160946218|NCT00116805|581191949|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
160946219|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
160946220|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
160946221|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
160946222|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
160946223|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
160946224|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
160946225|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
160946226|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
160946227|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
160946228|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
160946229|NCT00116805|581191948|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
160946230|NCT00116805|581191949|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
160946231|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
160946232|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
160946233|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
160946234|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
160946235|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
160946236|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
160946237|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
160946238|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
160946239|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
160946240|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
160946241|NCT00116805|581191948|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
160946242|NCT00116805|581191949|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
160946243|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
160946244|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
160946245|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
160946246|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
160946247|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
160946248|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
160946249|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
160946250|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
160946251|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
160946252|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
160946253|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
160946254|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
160946255|NCT00116805|581191948|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
161266047|NCT01971970|582355859|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
161266048|NCT01971970|582355860|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
161266049|NCT01831765|582355861|FG000|Overall Study|Lack of Efficacy|1|||
161266050|NCT01831765|582355862|FG001|Overall Study|Lack of Efficacy|0|||
160999491|NCT04035668|581382732|FG000|Overall Study|Adverse Event|3|||
160999492|NCT04035668|581382733|FG001|Overall Study|Adverse Event|4|||
160999493|NCT04035668|581382734|FG002|Overall Study|Adverse Event|2|||
160999494|NCT04035668|581382732|FG000|Overall Study|Lost to Follow-up|0|||
160999495|NCT04035668|581382733|FG001|Overall Study|Lost to Follow-up|1|||
160999496|NCT04035668|581382734|FG002|Overall Study|Lost to Follow-up|0|||
160999497|NCT04035668|581382732|FG000|Overall Study|Physician Decision|2|||
160999498|NCT04035668|581382733|FG001|Overall Study|Physician Decision|1|||
160999499|NCT04035668|581382734|FG002|Overall Study|Physician Decision|1|||
161266051|NCT01831765|582355863|FG002|Overall Study|Lack of Efficacy|0|||
161266052|NCT01831765|582355861|FG000|Overall Study|Other, sponsor withdrew subject|0|||
161266053|NCT01831765|582355862|FG001|Overall Study|Other, sponsor withdrew subject|1|||
160946256|NCT00116805|581191949|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
160946257|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
160946258|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
160946259|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
160946260|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
160946261|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
160946262|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
160946263|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
160946264|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
160946265|NCT00116805|581191948|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
160946266|NCT00116805|581191949|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
160946267|NCT00116805|581191948|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
160946268|NCT00116805|581191949|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
160946269|NCT00116805|581191948|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
160946270|NCT00116805|581191949|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
160946271|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
160946272|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
160946273|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
160946274|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
160946275|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
160946276|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
160946277|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
160946278|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
160946279|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
160946280|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
160946281|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
160946282|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
160946283|NCT00116805|581191948|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
160946284|NCT00116805|581191949|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
160946285|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
160946286|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
160946287|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
160946288|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
160946289|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
160946290|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
160946291|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
160946292|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
160946293|NCT00116805|581191948|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
160946294|NCT00116805|581191949|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
160946295|NCT00116805|581191948|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
160946296|NCT00116805|581191949|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
160946297|NCT00116805|581191948|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
160946298|NCT00116805|581191949|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
161266054|NCT01831765|582355863|FG002|Overall Study|Other, sponsor withdrew subject|0|||
161266055|NCT01831765|582355861|FG000|Overall Study|Pregnancy|1|||
160946299|NCT00116805|581191948|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
160946300|NCT00116805|581191949|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
161266056|NCT01831765|582355862|FG001|Overall Study|Pregnancy|1|||
161266057|NCT01831765|582355863|FG002|Overall Study|Pregnancy|2|||
160999500|NCT04035668|581382732|FG000|Overall Study|Subject Decision|2|||
160946301|NCT00116805|581191948|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
160946302|NCT00116805|581191949|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
160999501|NCT04035668|581382733|FG001|Overall Study|Subject Decision|2|||
160999502|NCT04035668|581382734|FG002|Overall Study|Subject Decision|0|||
161266058|NCT01831765|582355861|FG000|Overall Study|Death|0|||
161266059|NCT01831765|582355862|FG001|Overall Study|Death|1|||
160946303|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
160946304|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
160946305|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
160946306|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
160946307|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Adverse Event|5|||
160946308|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Adverse Event|3|||
160946309|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Adverse Event|4|||
160946310|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Adverse Event|10|||
160946311|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
160946312|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
160946313|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
160946314|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
160946315|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
160946316|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
160946317|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
160946318|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
160946319|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Pregnancy|5|||
160946320|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Pregnancy|0|||
160946321|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Pregnancy|3|||
160946322|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Pregnancy|2|||
160946323|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Non-compliance|1|||
160946324|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Non-compliance|4|||
160946325|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Non-compliance|0|||
160946326|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Non-compliance|3|||
160946327|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Other|0|||
160946328|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Other|3|||
160946329|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Other|3|||
160946330|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Other|1|||
160946331|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
160946332|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
160946333|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
160946334|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
160946335|NCT01760954|581191950|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
160946336|NCT01760954|581191951|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
160946337|NCT01760954|581191952|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
160946338|NCT01760954|581191953|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
160946339|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
160946340|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
160946341|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
160946342|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
160946343|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
160946344|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
160946345|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
160946346|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
160946347|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
160946348|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
160946349|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
160946350|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
160946351|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
160946352|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
160946353|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
160946354|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
160946355|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
160946356|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
160946357|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
160946358|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
160946359|NCT01760954|581191950|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
160946360|NCT01760954|581191951|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
160946361|NCT01760954|581191952|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
160946362|NCT01760954|581191953|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
160946363|NCT01159938|581191954|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160946364|NCT01159938|581191955|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
161266060|NCT01831765|582355863|FG002|Overall Study|Death|1|||
160946365|NCT01159938|581191956|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
160999503|NCT02477670|581382735|FG000|Stage 1|Adverse Event|2|||
161266061|NCT01831765|582355861|FG000|Overall Study|Other, site closed|1|||
161266062|NCT01831765|582355862|FG001|Overall Study|Other, site closed|1|||
161266063|NCT01831765|582355863|FG002|Overall Study|Other, site closed|0|||
161266064|NCT01831765|582355861|FG000|Overall Study|Adverse Event|5|||
161266065|NCT01831765|582355862|FG001|Overall Study|Adverse Event|3|||
161266066|NCT01831765|582355863|FG002|Overall Study|Adverse Event|3|||
161266067|NCT01831765|582355861|FG000|Overall Study|Withdrawal by Subject|22|||
161266068|NCT01831765|582355862|FG001|Overall Study|Withdrawal by Subject|7|||
161266069|NCT01831765|582355863|FG002|Overall Study|Withdrawal by Subject|17|||
161266070|NCT01831765|582355861|FG000|Overall Study|Withdrawal criteria|12|||
160946366|NCT01159938|581191957|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160946367|NCT01159938|581191958|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
160946368|NCT02105116|581191960|FG000|Overall Study|not eligible for step 2 of trial|5|||
160946369|NCT02105116|581191960|FG000|Overall Study|Death|1|||
160946370|NCT02318329|581191962|FG000|Overall Study|Progressive Disease|2|||
160946371|NCT02318329|581191963|FG001|Overall Study|Progressive Disease|3|||
160946372|NCT02318329|581191964|FG002|Overall Study|Progressive Disease|2|||
160946373|NCT02318329|581191965|FG003|Overall Study|Progressive Disease|3|||
160946374|NCT02318329|581191966|FG004|Overall Study|Progressive Disease|3|||
160946375|NCT02318329|581191967|FG005|Overall Study|Progressive Disease|3|||
160946376|NCT02318329|581191968|FG006|Overall Study|Progressive Disease|1|||
160946377|NCT02318329|581191969|FG007|Overall Study|Progressive Disease|1|||
160946378|NCT02318329|581191970|FG008|Overall Study|Progressive Disease|5|||
160946379|NCT02318329|581191971|FG009|Overall Study|Progressive Disease|39|||
160946380|NCT02318329|581191962|FG000|Overall Study|Death|0|||
160946381|NCT02318329|581191963|FG001|Overall Study|Death|0|||
160946382|NCT02318329|581191964|FG002|Overall Study|Death|0|||
160946383|NCT02318329|581191965|FG003|Overall Study|Death|0|||
160946384|NCT02318329|581191966|FG004|Overall Study|Death|0|||
160946385|NCT02318329|581191967|FG005|Overall Study|Death|0|||
160946386|NCT02318329|581191968|FG006|Overall Study|Death|0|||
160946387|NCT02318329|581191969|FG007|Overall Study|Death|0|||
160946388|NCT02318329|581191970|FG008|Overall Study|Death|0|||
160946389|NCT02318329|581191971|FG009|Overall Study|Death|5|||
160946390|NCT02318329|581191962|FG000|Overall Study|Lost to Follow-up|0|||
160946391|NCT02318329|581191963|FG001|Overall Study|Lost to Follow-up|0|||
160946392|NCT02318329|581191964|FG002|Overall Study|Lost to Follow-up|0|||
160946393|NCT02318329|581191965|FG003|Overall Study|Lost to Follow-up|0|||
160946394|NCT02318329|581191966|FG004|Overall Study|Lost to Follow-up|0|||
160946395|NCT02318329|581191967|FG005|Overall Study|Lost to Follow-up|0|||
160946396|NCT02318329|581191968|FG006|Overall Study|Lost to Follow-up|0|||
160946397|NCT02318329|581191969|FG007|Overall Study|Lost to Follow-up|0|||
160946398|NCT02318329|581191970|FG008|Overall Study|Lost to Follow-up|0|||
160946399|NCT02318329|581191971|FG009|Overall Study|Lost to Follow-up|1|||
160999504|NCT02477670|581382736|FG001|Stage 1|Adverse Event|7|||
160999505|NCT02477670|581382737|FG002|Stage 1|Adverse Event|0|||
160999506|NCT02477670|581382738|FG003|Stage 1|Adverse Event|0|||
160999507|NCT02477670|581382739|FG004|Stage 1|Adverse Event|0|||
160999508|NCT02477670|581382740|FG005|Stage 1|Adverse Event|0|||
160999509|NCT02477670|581382741|FG006|Stage 1|Adverse Event|0|||
160999510|NCT02477670|581382735|FG000|Stage 1|Lost to Follow-up|0|||
160999511|NCT02477670|581382736|FG001|Stage 1|Lost to Follow-up|2|||
160999512|NCT02477670|581382737|FG002|Stage 1|Lost to Follow-up|0|||
160999513|NCT02477670|581382738|FG003|Stage 1|Lost to Follow-up|0|||
161266071|NCT01831765|582355862|FG001|Overall Study|Withdrawal criteria|10|||
161266072|NCT01831765|582355863|FG002|Overall Study|Withdrawal criteria|16|||
161266073|NCT01831765|582355861|FG000|Overall Study|Lost to Follow-up|2|||
161266074|NCT01831765|582355862|FG001|Overall Study|Lost to Follow-up|3|||
160946400|NCT02318329|581191962|FG000|Overall Study|Withdrawal by Subject|0|||
160946401|NCT02318329|581191963|FG001|Overall Study|Withdrawal by Subject|0|||
160946402|NCT02318329|581191964|FG002|Overall Study|Withdrawal by Subject|0|||
160946403|NCT02318329|581191965|FG003|Overall Study|Withdrawal by Subject|0|||
160946404|NCT02318329|581191966|FG004|Overall Study|Withdrawal by Subject|0|||
160946405|NCT02318329|581191967|FG005|Overall Study|Withdrawal by Subject|0|||
160946406|NCT02318329|581191968|FG006|Overall Study|Withdrawal by Subject|0|||
161266075|NCT01831765|582355863|FG002|Overall Study|Lost to Follow-up|3|||
160946407|NCT02318329|581191969|FG007|Overall Study|Withdrawal by Subject|0|||
160999514|NCT02477670|581382739|FG004|Stage 1|Lost to Follow-up|0|||
160999515|NCT02477670|581382740|FG005|Stage 1|Lost to Follow-up|0|||
160946408|NCT02318329|581191970|FG008|Overall Study|Withdrawal by Subject|0|||
160946409|NCT02318329|581191971|FG009|Overall Study|Withdrawal by Subject|6|||
160946410|NCT02318329|581191962|FG000|Overall Study|Other|1|||
160946411|NCT02318329|581191963|FG001|Overall Study|Other|1|||
160946412|NCT02318329|581191964|FG002|Overall Study|Other|1|||
160946413|NCT02318329|581191965|FG003|Overall Study|Other|0|||
160946414|NCT02318329|581191966|FG004|Overall Study|Other|0|||
160946415|NCT02318329|581191967|FG005|Overall Study|Other|0|||
160946416|NCT02318329|581191968|FG006|Overall Study|Other|0|||
160946417|NCT02318329|581191969|FG007|Overall Study|Other|0|||
160999516|NCT02477670|581382741|FG006|Stage 1|Lost to Follow-up|0|||
160999517|NCT02477670|581382735|FG000|Stage 1|Withdrawal by Subject|1|||
161266076|NCT00859586|582355864|FG000|Overall Study|Donors|4|||
161266077|NCT00080938|582355865|FG000|Overall Study|Adverse Event|3|||
160946418|NCT02318329|581191970|FG008|Overall Study|Other|1|||
160946419|NCT02318329|581191971|FG009|Overall Study|Other|1|||
160946420|NCT04837482|581191972|FG000|Period 2|Withdrawal by Subject|0|||
160946421|NCT04837482|581191973|FG001|Period 2|Withdrawal by Subject|1|||
160946422|NCT04820673|581191974|FG000|Overall Study|Adverse Event|6|||
160946423|NCT04820673|581191974|FG000|Overall Study|Due to Lack of Effectiveness|1|||
160946424|NCT04820673|581191974|FG000|Overall Study|Pregnancy|1|||
160946425|NCT04820673|581191974|FG000|Overall Study|Voluntary Withdrawal|20|||
160946426|NCT04820673|581191974|FG000|Overall Study|Lost to Follow-up|10|||
160946427|NCT00587587|581191977|FG000|Overall Study|Lost to Follow-up|6|||
160946428|NCT00587587|581191978|FG001|Overall Study|Lost to Follow-up|1|||
160946429|NCT00982020|581191981|FG000|Overall Study|Adverse Event|19|||
160946430|NCT00982020|581191982|FG001|Overall Study|Adverse Event|15|||
160946431|NCT00982020|581191981|FG000|Overall Study|Withdrawal by Subject|11|||
160946432|NCT00982020|581191982|FG001|Overall Study|Withdrawal by Subject|14|||
160946433|NCT00982020|581191981|FG000|Overall Study|Lost to Follow-up|5|||
160946434|NCT00982020|581191982|FG001|Overall Study|Lost to Follow-up|11|||
160946435|NCT00982020|581191981|FG000|Overall Study|Lack of Efficacy|10|||
160946436|NCT00982020|581191982|FG001|Overall Study|Lack of Efficacy|4|||
160946437|NCT00982020|581191981|FG000|Overall Study|Parent/Caregiver Decision|5|||
160946438|NCT00982020|581191982|FG001|Overall Study|Parent/Caregiver Decision|5|||
160946439|NCT00982020|581191981|FG000|Overall Study|Treatment Non-compliance|3|||
160946440|NCT00982020|581191982|FG001|Overall Study|Treatment Non-compliance|6|||
160946441|NCT00982020|581191981|FG000|Overall Study|Physician Decision|2|||
160946442|NCT00982020|581191982|FG001|Overall Study|Physician Decision|5|||
160946443|NCT00982020|581191981|FG000|Overall Study|Entry Criteria Not Met|2|||
160946444|NCT00982020|581191982|FG001|Overall Study|Entry Criteria Not Met|1|||
160946445|NCT00982020|581191981|FG000|Overall Study|Protocol Violation|0|||
160946446|NCT00982020|581191982|FG001|Overall Study|Protocol Violation|2|||
160946447|NCT00982020|581191981|FG000|Overall Study|Clinical Relapse|0|||
160946448|NCT00982020|581191982|FG001|Overall Study|Clinical Relapse|1|||
160946449|NCT00466193|581191983|FG000|Overall Study|Adverse Event|0|||
160946450|NCT00466193|581191984|FG001|Overall Study|Adverse Event|1|||
160946451|NCT00466193|581191983|FG000|Overall Study|Lost to Follow-up|2|||
160946452|NCT00466193|581191984|FG001|Overall Study|Lost to Follow-up|4|||
160946453|NCT00466193|581191983|FG000|Overall Study|Physician Decision|1|||
160946454|NCT00466193|581191984|FG001|Overall Study|Physician Decision|0|||
160946455|NCT00466193|581191983|FG000|Overall Study|Protocol Violation|1|||
160946456|NCT00466193|581191984|FG001|Overall Study|Protocol Violation|1|||
160946457|NCT00466193|581191983|FG000|Overall Study|Withdrawal by Subject|7|||
160946458|NCT00466193|581191984|FG001|Overall Study|Withdrawal by Subject|2|||
160946459|NCT00466193|581191983|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
160946460|NCT00466193|581191984|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
160946461|NCT02473614|581191988|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
160946462|NCT02473614|581191989|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
160946463|NCT02525133|581191990|FG000|Overall Study|Adverse Event|0|||
160946464|NCT02525133|581191991|FG001|Overall Study|Adverse Event|1|||
160946465|NCT02525133|581191990|FG000|Overall Study|Death|0|||
160946466|NCT02525133|581191991|FG001|Overall Study|Death|1|||
160946467|NCT02525133|581191990|FG000|Overall Study|did not meet randomization criteria|1|||
160946468|NCT02525133|581191991|FG001|Overall Study|did not meet randomization criteria|0|||
160946469|NCT02525133|581191990|FG000|Overall Study|Lost to Follow-up|5|||
160946470|NCT02525133|581191991|FG001|Overall Study|Lost to Follow-up|1|||
160946471|NCT02525133|581191990|FG000|Overall Study|randomized not enrolled|3|||
160946472|NCT02525133|581191991|FG001|Overall Study|randomized not enrolled|0|||
160946473|NCT02525133|581191990|FG000|Overall Study|Withdrawal by Subject|1|||
160946474|NCT02525133|581191991|FG001|Overall Study|Withdrawal by Subject|0|||
160946475|NCT01343082|581191992|FG000|The run-in Period|Not meeting criteria|3|||
160946476|NCT01343082|581191993|FG001|The run-in Period|Not meeting criteria|4|||
160946477|NCT01343082|581191994|FG002|The run-in Period|Not meeting criteria|5|||
160946478|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
160946479|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
160946480|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
160946481|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
160946482|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
160946483|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
160946484|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
161266078|NCT00080938|582355865|FG000|Overall Study|Withdrawal by Subject|6|||
160946485|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
160946486|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
160946487|NCT01343082|581191992|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
160946488|NCT01343082|581191993|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
160946489|NCT01343082|581191994|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
160946490|NCT01075074|581191995|FG000|Overall Study|Surgeon changed to open incisional case|1|||
160946491|NCT01075074|581191996|FG001|Overall Study|Surgeon changed to open incisional case|2|||
161266079|NCT00080938|582355865|FG000|Overall Study|Death|2|||
161266080|NCT00080938|582355865|FG000|Overall Study|Lack of Efficacy|7|||
161266081|NCT00080938|582355865|FG000|Overall Study|other disease|1|||
161266082|NCT00080938|582355865|FG000|Overall Study|Not started protocol therapy|1|||
161266083|NCT00080938|582355865|FG000|Overall Study|Ineligible|4|||
161266084|NCT00706511|582355868|FG000|Overall Study|Withdrawal by Subject|1|||
161266085|NCT00706511|582355869|FG001|Overall Study|Withdrawal by Subject|0|||
161266086|NCT00706511|582355870|FG002|Overall Study|Withdrawal by Subject|0|||
161266087|NCT00706511|582355871|FG003|Overall Study|Withdrawal by Subject|0|||
161266088|NCT02605993|582355872|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161266089|NCT02605993|582355873|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161266090|NCT02605993|582355874|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
161266091|NCT02605993|582355875|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
161266092|NCT02116608|582355883|FG000|Overall Study|Lost to Follow-up|0|||
161266093|NCT02116608|582355884|FG001|Overall Study|Lost to Follow-up|0|||
161266094|NCT02116608|582355885|FG002|Overall Study|Lost to Follow-up|1|||
161266095|NCT02116608|582355883|FG000|Overall Study|Physician Decision|0|||
161266096|NCT02116608|582355884|FG001|Overall Study|Physician Decision|1|||
161266097|NCT02116608|582355885|FG002|Overall Study|Physician Decision|0|||
161266098|NCT02116608|582355883|FG000|Overall Study|Death|0|||
161266099|NCT02116608|582355884|FG001|Overall Study|Death|1|||
161266100|NCT02116608|582355885|FG002|Overall Study|Death|0|||
161266101|NCT01169532|582355888|FG000|Overall Study|Withdrawal by Subject|1|||
161266102|NCT00117325|582355892|FG000|Overall Study|Adverse Event|3|||
161266103|NCT00117325|582355893|FG001|Overall Study|Adverse Event|3|||
161266104|NCT00117325|582355892|FG000|Overall Study|Lost to Follow-up|1|||
161266105|NCT00117325|582355893|FG001|Overall Study|Lost to Follow-up|1|||
161266106|NCT00117325|582355892|FG000|Overall Study|Protocol Violation|2|||
161266107|NCT00117325|582355893|FG001|Overall Study|Protocol Violation|3|||
161266108|NCT00117325|582355892|FG000|Overall Study|Withdrawal by Subject|3|||
161266109|NCT00117325|582355893|FG001|Overall Study|Withdrawal by Subject|2|||
161266110|NCT00117325|582355892|FG000|Overall Study|Lack of Efficacy|1|||
161266111|NCT00117325|582355893|FG001|Overall Study|Lack of Efficacy|0|||
161266112|NCT00117325|582355892|FG000|Overall Study|Use of prohibited medicine|1|||
161266113|NCT00117325|582355893|FG001|Overall Study|Use of prohibited medicine|2|||
161266114|NCT00117325|582355892|FG000|Overall Study|Early termination|1|||
161266115|NCT00117325|582355893|FG001|Overall Study|Early termination|1|||
161266116|NCT00117325|582355892|FG000|Overall Study|Admisnitrative|1|||
161266117|NCT00117325|582355893|FG001|Overall Study|Admisnitrative|0|||
161266118|NCT01468818|582355897|FG000|Overall Study|Death during treatment|2|||
161266119|NCT02266134|582355898|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
161266120|NCT02266134|582355899|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
161266121|NCT02266134|582355900|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
161266122|NCT02266134|582355901|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
161266123|NCT02266134|582355898|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
161266124|NCT02266134|582355899|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
161266125|NCT02266134|582355900|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
161266126|NCT02266134|582355901|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
161266127|NCT02266134|582355898|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
161266128|NCT02266134|582355899|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
161266129|NCT02266134|582355900|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
161266130|NCT02266134|582355901|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
161266131|NCT02266134|582355898|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
161266132|NCT02266134|582355899|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161266133|NCT02266134|582355900|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161266134|NCT02266134|582355901|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
161266135|NCT02266134|582355898|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
161266136|NCT02266134|582355899|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
161266137|NCT02266134|582355900|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
161266138|NCT02266134|582355901|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
161266139|NCT02266134|582355898|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
161266140|NCT02266134|582355899|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161266141|NCT02266134|582355900|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161266142|NCT02266134|582355901|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
161266143|NCT04620135|582355902|FG000|Study Completion|Adverse Event|2|||
161266144|NCT04620135|582355903|FG001|Study Completion|Adverse Event|3|||
161266145|NCT04620135|582355902|FG000|Study Completion|Withdrawal by Subject|2|||
161266146|NCT04620135|582355903|FG001|Study Completion|Withdrawal by Subject|0|||
161266147|NCT01442688|582355905|FG000|First Intervention|Withdrawal by Subject|1|||
161266148|NCT01442688|582355906|FG001|First Intervention|Withdrawal by Subject|0|||
161266149|NCT01442688|582355905|FG000|First Intervention|subject incarcerated|1|||
161266150|NCT01442688|582355906|FG001|First Intervention|subject incarcerated|0|||
160946492|NCT01075074|581191997|FG002|Overall Study|Surgeon changed to open incisional case|2|||
160946493|NCT00844194|581191999|FG000|Overall Study|Adverse Event|17|||
160946494|NCT00844194|581192000|FG001|Overall Study|Adverse Event|5|||
160946495|NCT00844194|581191999|FG000|Overall Study|Protocol Violation|1|||
160946496|NCT00844194|581192000|FG001|Overall Study|Protocol Violation|1|||
160946497|NCT00844194|581191999|FG000|Overall Study|Lost to Follow-up|1|||
160946498|NCT00844194|581192000|FG001|Overall Study|Lost to Follow-up|1|||
160946499|NCT00844194|581191999|FG000|Overall Study|Withdrawal by Subject|2|||
160946500|NCT00844194|581192000|FG001|Overall Study|Withdrawal by Subject|1|||
160946501|NCT00844194|581191999|FG000|Overall Study|Lack of Efficacy|3|||
160946502|NCT00844194|581192000|FG001|Overall Study|Lack of Efficacy|0|||
160946503|NCT00844194|581191999|FG000|Overall Study|Other reason (not specified)|1|||
160946504|NCT00844194|581192000|FG001|Overall Study|Other reason (not specified)|0|||
160946505|NCT02667912|581192001|FG000|Overall Study|Death|3|||
160946506|NCT02667912|581192002|FG001|Overall Study|Death|1|||
160946507|NCT02667912|581192001|FG000|Overall Study|Withdrawal by Subject|1|||
160946508|NCT02667912|581192002|FG001|Overall Study|Withdrawal by Subject|2|||
160946509|NCT02667912|581192001|FG000|Overall Study|Withdrawal by Subject|1|||
160946510|NCT02667912|581192002|FG001|Overall Study|Withdrawal by Subject|0|||
160946511|NCT04443218|581192003|FG000|Overall Study|Exited study for other reasons|9|||
160946512|NCT04443218|581192003|FG000|Overall Study|Withdrawal by Subject|1|||
160946513|NCT04443218|581192003|FG000|Overall Study|Lost to Follow-up|4|||
160946514|NCT04443218|581192003|FG000|Overall Study|Death|19|||
160946515|NCT01047683|581192004|FG000|Overall Study|Adverse Event|3|||
160946516|NCT01047683|581192005|FG001|Overall Study|Adverse Event|1|||
160946517|NCT01047683|581192006|FG002|Overall Study|Adverse Event|0|||
160946518|NCT01047683|581192004|FG000|Overall Study|Withdrew Consent|1|||
160946519|NCT01047683|581192005|FG001|Overall Study|Withdrew Consent|4|||
160946520|NCT01047683|581192006|FG002|Overall Study|Withdrew Consent|2|||
160946521|NCT01047683|581192004|FG000|Overall Study|Lost to Follow-up|0|||
160946522|NCT01047683|581192005|FG001|Overall Study|Lost to Follow-up|1|||
160946523|NCT01047683|581192006|FG002|Overall Study|Lost to Follow-up|0|||
160999518|NCT02477670|581382736|FG001|Stage 1|Withdrawal by Subject|2|||
160999519|NCT02477670|581382737|FG002|Stage 1|Withdrawal by Subject|0|||
160999520|NCT02477670|581382738|FG003|Stage 1|Withdrawal by Subject|0|||
160999521|NCT02477670|581382739|FG004|Stage 1|Withdrawal by Subject|0|||
160999522|NCT02477670|581382740|FG005|Stage 1|Withdrawal by Subject|0|||
160999523|NCT02477670|581382741|FG006|Stage 1|Withdrawal by Subject|0|||
160999524|NCT02477670|581382735|FG000|Stage 1|Non-compliance with Study Drug|1|||
160999525|NCT02477670|581382736|FG001|Stage 1|Non-compliance with Study Drug|2|||
160999526|NCT02477670|581382737|FG002|Stage 1|Non-compliance with Study Drug|0|||
160999527|NCT02477670|581382738|FG003|Stage 1|Non-compliance with Study Drug|0|||
160999528|NCT02477670|581382739|FG004|Stage 1|Non-compliance with Study Drug|0|||
160999529|NCT02477670|581382740|FG005|Stage 1|Non-compliance with Study Drug|0|||
160999530|NCT02477670|581382741|FG006|Stage 1|Non-compliance with Study Drug|0|||
161266151|NCT01442688|582355905|FG000|Second Intervention|Adverse Event|1|||
161266152|NCT01442688|582355906|FG001|Second Intervention|Adverse Event|0|||
161266153|NCT00546572|582355907|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
161266154|NCT00546572|582355908|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
161266155|NCT00546572|582355907|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
161266156|NCT00546572|582355908|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
161266157|NCT00546572|582355907|FG000|Vax 1 / Year 0|Protocol Violation|3|||
161266158|NCT00546572|582355908|FG001|Vax 1 / Year 0|Protocol Violation|4|||
161266159|NCT00546572|582355907|FG000|Vax 1 / Year 0|Death|2|||
161266160|NCT00546572|582355908|FG001|Vax 1 / Year 0|Death|2|||
161266161|NCT00546572|582355907|FG000|Vax 1 / Year 0|Adverse Event|0|||
161266162|NCT00546572|582355908|FG001|Vax 1 / Year 0|Adverse Event|1|||
161266163|NCT00546572|582355907|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
161266164|NCT00546572|582355908|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
161266165|NCT00546572|582355907|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
161266166|NCT00546572|582355908|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
161266167|NCT00546572|582355907|FG000|Vax 2 / Year 1|Other|1|||
161266168|NCT00546572|582355908|FG001|Vax 2 / Year 1|Other|1|||
161266169|NCT00546572|582355907|FG000|Vax 2 / Year 1|Adverse Event|1|||
161266170|NCT00546572|582355908|FG001|Vax 2 / Year 1|Adverse Event|0|||
161266171|NCT00546572|582355907|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
160946524|NCT01047683|581192004|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
160946525|NCT01047683|581192005|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
160946526|NCT01047683|581192006|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
160946527|NCT03447769|581192007|FG000|Overall Study|Progressive disease|138|||
160946528|NCT03447769|581192008|FG001|Overall Study|Progressive disease|148|||
160946529|NCT03447769|581192007|FG000|Overall Study|Study terminated by Sponsor|60|||
160946530|NCT03447769|581192008|FG001|Overall Study|Study terminated by Sponsor|44|||
160946531|NCT03447769|581192007|FG000|Overall Study|Adverse Event|34|||
160946532|NCT03447769|581192008|FG001|Overall Study|Adverse Event|31|||
160946533|NCT03447769|581192007|FG000|Overall Study|Patient decision|27|||
160946534|NCT03447769|581192008|FG001|Overall Study|Patient decision|27|||
160946535|NCT03447769|581192007|FG000|Overall Study|Protocol deviation|4|||
161266172|NCT00546572|582355908|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
161266173|NCT03979820|582355909|FG000|Overall Study|Protocol Violation|1|||
161266174|NCT03979820|582355910|FG001|Overall Study|Protocol Violation|0|||
161266175|NCT03979820|582355911|FG002|Overall Study|Protocol Violation|0|||
161266176|NCT03979820|582355912|FG003|Overall Study|Protocol Violation|0|||
161266177|NCT03979820|582355909|FG000|Overall Study|Withdrawal by Subject|0|||
161266178|NCT03979820|582355910|FG001|Overall Study|Withdrawal by Subject|0|||
161266179|NCT03979820|582355911|FG002|Overall Study|Withdrawal by Subject|1|||
160946536|NCT03447769|581192008|FG001|Overall Study|Protocol deviation|6|||
160946537|NCT03447769|581192007|FG000|Overall Study|Death|2|||
160946538|NCT03447769|581192008|FG001|Overall Study|Death|7|||
160946539|NCT03447769|581192007|FG000|Overall Study|Technical problems|1|||
160946540|NCT03447769|581192008|FG001|Overall Study|Technical problems|0|||
160946541|NCT03447769|581192007|FG000|Overall Study|Lost to Follow-up|0|||
160946542|NCT03447769|581192008|FG001|Overall Study|Lost to Follow-up|1|||
160946543|NCT03447769|581192007|FG000|Overall Study|Physician Decision|13|||
160946544|NCT03447769|581192008|FG001|Overall Study|Physician Decision|5|||
160946545|NCT01485861|581192011|FG000|Phase Ib|Death|1|||
160946546|NCT01485861|581192012|FG001|Phase Ib|Death|0|||
160946547|NCT01485861|581192013|FG002|Phase Ib|Death|0|||
160946548|NCT01485861|581192014|FG003|Phase Ib|Death|0|||
160946549|NCT01485861|581192015|FG004|Phase Ib|Death|0|||
160946550|NCT01485861|581192016|FG005|Phase Ib|Death|0|||
160946551|NCT01485861|581192011|FG000|Phase Ib|Physician Decision|1|||
160946552|NCT01485861|581192012|FG001|Phase Ib|Physician Decision|1|||
160946553|NCT01485861|581192013|FG002|Phase Ib|Physician Decision|0|||
160946554|NCT01485861|581192014|FG003|Phase Ib|Physician Decision|0|||
160946555|NCT01485861|581192015|FG004|Phase Ib|Physician Decision|0|||
160946556|NCT01485861|581192016|FG005|Phase Ib|Physician Decision|0|||
160946557|NCT01485861|581192011|FG000|Phase Ib|Adverse Event|0|||
160946558|NCT01485861|581192012|FG001|Phase Ib|Adverse Event|4|||
160946559|NCT01485861|581192013|FG002|Phase Ib|Adverse Event|0|||
160946560|NCT01485861|581192014|FG003|Phase Ib|Adverse Event|0|||
160946561|NCT01485861|581192015|FG004|Phase Ib|Adverse Event|0|||
160946562|NCT01485861|581192016|FG005|Phase Ib|Adverse Event|0|||
160946563|NCT01485861|581192011|FG000|Phase Ib|Progression of disease|5|||
160946564|NCT01485861|581192012|FG001|Phase Ib|Progression of disease|0|||
160946565|NCT01485861|581192013|FG002|Phase Ib|Progression of disease|0|||
160946566|NCT01485861|581192014|FG003|Phase Ib|Progression of disease|0|||
160946567|NCT01485861|581192015|FG004|Phase Ib|Progression of disease|0|||
160946568|NCT01485861|581192016|FG005|Phase Ib|Progression of disease|0|||
160946569|NCT01485861|581192011|FG000|Phase Ib|Other|3|||
160946570|NCT01485861|581192012|FG001|Phase Ib|Other|0|||
160946571|NCT01485861|581192013|FG002|Phase Ib|Other|0|||
160946572|NCT01485861|581192014|FG003|Phase Ib|Other|0|||
160946573|NCT01485861|581192015|FG004|Phase Ib|Other|0|||
160946574|NCT01485861|581192016|FG005|Phase Ib|Other|0|||
160946575|NCT01485861|581192011|FG000|Phase Ib|Withdrawal by Subject|4|||
160946576|NCT01485861|581192012|FG001|Phase Ib|Withdrawal by Subject|1|||
160946577|NCT01485861|581192013|FG002|Phase Ib|Withdrawal by Subject|0|||
160946578|NCT01485861|581192014|FG003|Phase Ib|Withdrawal by Subject|0|||
160946579|NCT01485861|581192015|FG004|Phase Ib|Withdrawal by Subject|0|||
160946580|NCT01485861|581192016|FG005|Phase Ib|Withdrawal by Subject|0|||
160946581|NCT01485861|581192011|FG000|Phase II|Death|0|||
160946582|NCT01485861|581192012|FG001|Phase II|Death|0|||
160946583|NCT01485861|581192013|FG002|Phase II|Death|67|||
160946584|NCT01485861|581192014|FG003|Phase II|Death|71|||
161266180|NCT03979820|582355912|FG003|Overall Study|Withdrawal by Subject|0|||
161266181|NCT03979820|582355909|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
161266182|NCT03979820|582355910|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
161266183|NCT03979820|582355911|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
161319367|NCT01410240|582555291|FG002|Overall Study|Physician Decision|1|||
160946585|NCT01485861|581192015|FG004|Phase II|Death|68|||
160946586|NCT01485861|581192016|FG005|Phase II|Death|0|||
160946587|NCT01485861|581192011|FG000|Phase II|Progression of Disease|0|||
160946588|NCT01485861|581192012|FG001|Phase II|Progression of Disease|0|||
160946589|NCT01485861|581192013|FG002|Phase II|Progression of Disease|1|||
160946590|NCT01485861|581192014|FG003|Phase II|Progression of Disease|0|||
160946591|NCT01485861|581192015|FG004|Phase II|Progression of Disease|0|||
160946592|NCT01485861|581192016|FG005|Phase II|Progression of Disease|0|||
160946593|NCT01485861|581192011|FG000|Phase II|Other|0|||
160946594|NCT01485861|581192012|FG001|Phase II|Other|0|||
160946595|NCT01485861|581192013|FG002|Phase II|Other|0|||
160946596|NCT01485861|581192014|FG003|Phase II|Other|1|||
160946597|NCT01485861|581192015|FG004|Phase II|Other|0|||
160946598|NCT01485861|581192016|FG005|Phase II|Other|0|||
160946599|NCT01485861|581192011|FG000|Phase II|Withdrawal by Subject|0|||
160946600|NCT01485861|581192012|FG001|Phase II|Withdrawal by Subject|0|||
160946601|NCT01485861|581192013|FG002|Phase II|Withdrawal by Subject|6|||
160946602|NCT01485861|581192014|FG003|Phase II|Withdrawal by Subject|3|||
160946603|NCT01485861|581192015|FG004|Phase II|Withdrawal by Subject|4|||
160946604|NCT01485861|581192016|FG005|Phase II|Withdrawal by Subject|0|||
160946605|NCT01485861|581192011|FG000|Phase II|Lost to Follow-up|0|||
160946606|NCT01485861|581192012|FG001|Phase II|Lost to Follow-up|0|||
161144704|NCT00234104|581913945|FG003|Overall Study|Adverse Event|5|||
161144705|NCT00234104|581913942|FG000|Overall Study|Protocol Violation|0|||
161144706|NCT00234104|581913943|FG001|Overall Study|Protocol Violation|0|||
161144707|NCT00234104|581913944|FG002|Overall Study|Protocol Violation|0|||
161144708|NCT00234104|581913945|FG003|Overall Study|Protocol Violation|1|||
161144709|NCT00234104|581913942|FG000|Overall Study|Physician Decision|0|||
161144710|NCT00234104|581913943|FG001|Overall Study|Physician Decision|1|||
161144711|NCT00234104|581913944|FG002|Overall Study|Physician Decision|2|||
161144712|NCT00234104|581913945|FG003|Overall Study|Physician Decision|2|||
161144713|NCT00546819|581913946|FG000|Overall Study|Adverse Event|2|||
161144714|NCT00546819|581913947|FG001|Overall Study|Adverse Event|3|||
161144715|NCT00546819|581913946|FG000|Overall Study|Lost to Follow-up|2|||
161144716|NCT00546819|581913947|FG001|Overall Study|Lost to Follow-up|1|||
161144717|NCT00546819|581913946|FG000|Overall Study|Withdrawal by Subject|4|||
161144718|NCT00546819|581913947|FG001|Overall Study|Withdrawal by Subject|2|||
161144719|NCT02052960|581913949|FG000|Overall Study|Adverse Event|19|||
161144720|NCT02052960|581913950|FG001|Overall Study|Adverse Event|17|||
161144721|NCT02052960|581913949|FG000|Overall Study|Protocol Violation|4|||
161144722|NCT02052960|581913950|FG001|Overall Study|Protocol Violation|3|||
161144723|NCT02052960|581913949|FG000|Overall Study|Withdrawal by Subject|6|||
161144724|NCT02052960|581913950|FG001|Overall Study|Withdrawal by Subject|11|||
161144725|NCT02052960|581913949|FG000|Overall Study|Other|25|||
161144726|NCT02052960|581913950|FG001|Overall Study|Other|15|||
161144727|NCT03849560|581913951|FG000|Overall Study|Withdrawal by Subject|1|||
161144728|NCT03849560|581913952|FG001|Overall Study|Withdrawal by Subject|0|||
161144729|NCT03849560|581913953|FG002|Overall Study|Withdrawal by Subject|0|||
161144730|NCT04045613|581913954|FG000|Overall Study|Adverse Event|2|||
161144731|NCT04045613|581913955|FG001|Overall Study|Adverse Event|2|||
161144732|NCT04045613|581913956|FG002|Overall Study|Adverse Event|1|||
161144733|NCT04045613|581913957|FG003|Overall Study|Adverse Event|1|||
161144734|NCT04045613|581913958|FG004|Overall Study|Adverse Event|0|||
161144735|NCT04045613|581913959|FG005|Overall Study|Adverse Event|0|||
161144736|NCT04045613|581913960|FG006|Overall Study|Adverse Event|1|||
161144737|NCT04045613|581913954|FG000|Overall Study|Withdrawal by Subject|0|||
161144738|NCT04045613|581913955|FG001|Overall Study|Withdrawal by Subject|5|||
161144739|NCT04045613|581913956|FG002|Overall Study|Withdrawal by Subject|0|||
161144740|NCT04045613|581913957|FG003|Overall Study|Withdrawal by Subject|0|||
161144741|NCT04045613|581913958|FG004|Overall Study|Withdrawal by Subject|0|||
161144742|NCT04045613|581913959|FG005|Overall Study|Withdrawal by Subject|1|||
161144743|NCT04045613|581913960|FG006|Overall Study|Withdrawal by Subject|0|||
161144744|NCT04045613|581913954|FG000|Overall Study|Physician Decision|2|||
161144745|NCT04045613|581913955|FG001|Overall Study|Physician Decision|0|||
161144746|NCT04045613|581913956|FG002|Overall Study|Physician Decision|0|||
161144747|NCT04045613|581913957|FG003|Overall Study|Physician Decision|0|||
161144748|NCT04045613|581913958|FG004|Overall Study|Physician Decision|1|||
161144749|NCT04045613|581913959|FG005|Overall Study|Physician Decision|0|||
161144750|NCT04045613|581913960|FG006|Overall Study|Physician Decision|0|||
161144751|NCT04045613|581913954|FG000|Overall Study|Death|3|||
161144752|NCT04045613|581913955|FG001|Overall Study|Death|0|||
161144753|NCT04045613|581913956|FG002|Overall Study|Death|0|||
161144754|NCT04045613|581913957|FG003|Overall Study|Death|0|||
161144755|NCT04045613|581913958|FG004|Overall Study|Death|0|||
161144756|NCT04045613|581913959|FG005|Overall Study|Death|0|||
161144757|NCT04045613|581913960|FG006|Overall Study|Death|1|||
161144758|NCT04045613|581913954|FG000|Overall Study|Other reasons|0|||
161144759|NCT04045613|581913955|FG001|Overall Study|Other reasons|1|||
161144760|NCT04045613|581913956|FG002|Overall Study|Other reasons|0|||
161144761|NCT04045613|581913957|FG003|Overall Study|Other reasons|0|||
161144762|NCT04045613|581913958|FG004|Overall Study|Other reasons|0|||
161144763|NCT04045613|581913959|FG005|Overall Study|Other reasons|0|||
160946607|NCT01485861|581192013|FG002|Phase II|Lost to Follow-up|2|||
161144764|NCT04045613|581913960|FG006|Overall Study|Other reasons|1|||
161144765|NCT04045613|581913954|FG000|Overall Study|Progressive disease: Clinical progression|1|||
161144766|NCT04045613|581913955|FG001|Overall Study|Progressive disease: Clinical progression|0|||
160946608|NCT01485861|581192014|FG003|Phase II|Lost to Follow-up|3|||
160946609|NCT01485861|581192015|FG004|Phase II|Lost to Follow-up|5|||
161144767|NCT04045613|581913956|FG002|Overall Study|Progressive disease: Clinical progression|3|||
161144768|NCT04045613|581913957|FG003|Overall Study|Progressive disease: Clinical progression|1|||
161144769|NCT04045613|581913958|FG004|Overall Study|Progressive disease: Clinical progression|1|||
161144770|NCT04045613|581913959|FG005|Overall Study|Progressive disease: Clinical progression|3|||
160946610|NCT01485861|581192016|FG005|Phase II|Lost to Follow-up|0|||
161144771|NCT04045613|581913960|FG006|Overall Study|Progressive disease: Clinical progression|3|||
161144772|NCT04045613|581913954|FG000|Overall Study|Progressive disease: Radiological progression|24|||
161144773|NCT04045613|581913955|FG001|Overall Study|Progressive disease: Radiological progression|6|||
161144774|NCT04045613|581913956|FG002|Overall Study|Progressive disease: Radiological progression|8|||
161144775|NCT04045613|581913957|FG003|Overall Study|Progressive disease: Radiological progression|0|||
161144776|NCT04045613|581913958|FG004|Overall Study|Progressive disease: Radiological progression|6|||
160946611|NCT01485861|581192011|FG000|Phase II|Study Ended|0|||
160946612|NCT01485861|581192012|FG001|Phase II|Study Ended|0|||
160946613|NCT01485861|581192013|FG002|Phase II|Study Ended|7|||
160946614|NCT01485861|581192014|FG003|Phase II|Study Ended|8|||
160946615|NCT01485861|581192015|FG004|Phase II|Study Ended|6|||
160946616|NCT01485861|581192016|FG005|Phase II|Study Ended|0|||
160946617|NCT01485861|581192011|FG000|Safety Phase|Death|0|||
160946618|NCT01485861|581192012|FG001|Safety Phase|Death|0|||
160946619|NCT01485861|581192013|FG002|Safety Phase|Death|0|||
160946620|NCT01485861|581192014|FG003|Safety Phase|Death|0|||
160999531|NCT02477670|581382735|FG000|Stage 2|Adverse Event|0|||
160999532|NCT02477670|581382736|FG001|Stage 2|Adverse Event|0|||
160999533|NCT02477670|581382737|FG002|Stage 2|Adverse Event|1|||
160999534|NCT02477670|581382738|FG003|Stage 2|Adverse Event|0|||
160999535|NCT02477670|581382739|FG004|Stage 2|Adverse Event|0|||
160999536|NCT02477670|581382740|FG005|Stage 2|Adverse Event|0|||
160999537|NCT02477670|581382741|FG006|Stage 2|Adverse Event|0|||
160999538|NCT02477670|581382735|FG000|Stage 2|Antipsychotic Medication Changed|0|||
160999539|NCT02477670|581382736|FG001|Stage 2|Antipsychotic Medication Changed|0|||
160999540|NCT02477670|581382737|FG002|Stage 2|Antipsychotic Medication Changed|1|||
160999541|NCT02477670|581382738|FG003|Stage 2|Antipsychotic Medication Changed|0|||
160999542|NCT02477670|581382739|FG004|Stage 2|Antipsychotic Medication Changed|0|||
160999543|NCT02477670|581382740|FG005|Stage 2|Antipsychotic Medication Changed|0|||
160999544|NCT02477670|581382741|FG006|Stage 2|Antipsychotic Medication Changed|0|||
160999545|NCT02477670|581382735|FG000|Stage 2|Withdrawal by Subject|0|||
160999546|NCT02477670|581382736|FG001|Stage 2|Withdrawal by Subject|0|||
160999547|NCT02477670|581382737|FG002|Stage 2|Withdrawal by Subject|0|||
160999548|NCT02477670|581382738|FG003|Stage 2|Withdrawal by Subject|1|||
160999549|NCT02477670|581382739|FG004|Stage 2|Withdrawal by Subject|0|||
160999550|NCT02477670|581382740|FG005|Stage 2|Withdrawal by Subject|0|||
160999551|NCT02477670|581382741|FG006|Stage 2|Withdrawal by Subject|0|||
160999552|NCT02937831|581382742|FG000|Overall Study|Protocol Violation|4|||
160999553|NCT01759264|581382743|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
160999554|NCT01759264|581382743|FG000|Overall Study|Adverse Event|1|||
160999555|NCT01759264|581382743|FG000|Overall Study|Other|2|||
160999556|NCT01759264|581382743|FG000|Overall Study|Lost to Follow-up|2|||
160999557|NCT01759264|581382743|FG000|Overall Study|Withdrawal by Subject|3|||
160999558|NCT01759264|581382743|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
160999559|NCT00114244|581382744|FG000|Overall Study|Adverse Event|2|||
160999560|NCT00114244|581382745|FG001|Overall Study|Adverse Event|5|||
160999561|NCT00114244|581382744|FG000|Overall Study|Withdrawal by Subject|0|||
160999562|NCT00114244|581382745|FG001|Overall Study|Withdrawal by Subject|2|||
160999563|NCT00753012|581382751|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
160999564|NCT00753012|581382752|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
160999565|NCT00753012|581382751|FG000|Overall Study|Adverse Event|2|||
160999566|NCT00753012|581382752|FG001|Overall Study|Adverse Event|0|||
160999567|NCT00753012|581382751|FG000|Overall Study|Withdrawal by Subject|0|||
160999568|NCT00753012|581382752|FG001|Overall Study|Withdrawal by Subject|1|||
160999569|NCT00753012|581382751|FG000|Overall Study|Lost to Follow-up|4|||
160999570|NCT00753012|581382752|FG001|Overall Study|Lost to Follow-up|0|||
160999571|NCT00753012|581382751|FG000|Overall Study|Confounded endpoint data|1|||
160999572|NCT00753012|581382752|FG001|Overall Study|Confounded endpoint data|0|||
160999573|NCT01930045|581382753|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999574|NCT01930045|581382754|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999575|NCT01930045|581382755|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999576|NCT01930045|581382756|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999577|NCT01930045|581382757|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
160999578|NCT01930045|581382758|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
160999579|NCT01930045|581382753|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
160999580|NCT01930045|581382754|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
161144777|NCT04045613|581913959|FG005|Overall Study|Progressive disease: Radiological progression|6|||
160946621|NCT01485861|581192015|FG004|Safety Phase|Death|0|||
160946622|NCT01485861|581192016|FG005|Safety Phase|Death|2|||
161144778|NCT04045613|581913960|FG006|Overall Study|Progressive disease: Radiological progression|11|||
161319368|NCT01410240|582555289|FG000|Overall Study|Missed week 6 assessments|1|||
160946623|NCT01485861|581192011|FG000|Safety Phase|Adverse Event|0|||
160946624|NCT01485861|581192012|FG001|Safety Phase|Adverse Event|0|||
160999581|NCT01930045|581382755|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
160999582|NCT01930045|581382756|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
160999583|NCT01930045|581382757|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
160999584|NCT01930045|581382758|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
160999585|NCT01370694|581382761|FG000|Overall Study|Switched to rituximab|4|||
160999586|NCT01370694|581382761|FG000|Overall Study|Progressive disease|2|||
160946625|NCT01485861|581192013|FG002|Safety Phase|Adverse Event|0|||
160946626|NCT01485861|581192014|FG003|Safety Phase|Adverse Event|0|||
160946627|NCT01485861|581192015|FG004|Safety Phase|Adverse Event|0|||
160946628|NCT01485861|581192016|FG005|Safety Phase|Adverse Event|1|||
160946629|NCT01485861|581192011|FG000|Safety Phase|Other|0|||
160946630|NCT01485861|581192012|FG001|Safety Phase|Other|0|||
161266184|NCT03979820|582355912|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
161266185|NCT01229735|582355913|FG000|Overall Study|Lack of Efficacy|8|||
160946631|NCT01485861|581192013|FG002|Safety Phase|Other|0|||
160946632|NCT01485861|581192014|FG003|Safety Phase|Other|0|||
160946633|NCT01485861|581192015|FG004|Safety Phase|Other|0|||
160946634|NCT01485861|581192016|FG005|Safety Phase|Other|5|||
160946635|NCT01485861|581192011|FG000|Safety Phase|Progression of Disease|0|||
160946636|NCT01485861|581192012|FG001|Safety Phase|Progression of Disease|0|||
160946637|NCT01485861|581192013|FG002|Safety Phase|Progression of Disease|0|||
160946638|NCT01485861|581192014|FG003|Safety Phase|Progression of Disease|0|||
160946639|NCT01485861|581192015|FG004|Safety Phase|Progression of Disease|0|||
161266186|NCT01229735|582355914|FG001|Overall Study|Lack of Efficacy|8|||
161266187|NCT01229735|582355913|FG000|Overall Study|Protocol Violation|13|||
161266188|NCT01229735|582355914|FG001|Overall Study|Protocol Violation|8|||
161266189|NCT01229735|582355913|FG000|Overall Study|Lost to Follow-up|0|||
161266190|NCT01229735|582355914|FG001|Overall Study|Lost to Follow-up|2|||
161266191|NCT01229735|582355913|FG000|Overall Study|Withdrawal by Subject|18|||
161266192|NCT01229735|582355914|FG001|Overall Study|Withdrawal by Subject|17|||
161266193|NCT01229735|582355913|FG000|Overall Study|Other Reason|13|||
161266194|NCT01229735|582355914|FG001|Overall Study|Other Reason|10|||
161266195|NCT01229735|582355913|FG000|Overall Study|SAE, non-fatal|0|||
161266196|NCT01229735|582355914|FG001|Overall Study|SAE, non-fatal|4|||
161266197|NCT01229735|582355913|FG000|Overall Study|AE, non-serious non-fatal|13|||
161266198|NCT01229735|582355914|FG001|Overall Study|AE, non-serious non-fatal|17|||
161266199|NCT01229735|582355913|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
161266200|NCT01229735|582355914|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
161266201|NCT02685202|582355915|FG000|Overall Study|Lost to Follow-up|9|||
161266202|NCT02130882|582355916|FG000|Overall Study|Withdrawal by Subject|0|||
161266203|NCT02130882|582355917|FG001|Overall Study|Withdrawal by Subject|1|||
161266204|NCT02331368|582355922|FG000|Overall Study|Withdrawal by Subject|3|||
161266205|NCT02302859|582355923|FG000|Overall Study|Lost Phone|1|||
161266206|NCT02302859|582355924|FG001|Overall Study|Lost Phone|1|||
161266207|NCT02302859|582355923|FG000|Overall Study|Withdrawal by Subject|0|||
161266208|NCT02302859|582355924|FG001|Overall Study|Withdrawal by Subject|1|||
161266209|NCT02384850|582355928|FG000|Overall Study|Withdrawal by Subject|2|||
161266210|NCT02384850|582355929|FG001|Overall Study|Withdrawal by Subject|2|||
161266211|NCT03548064|582358961|FG000|Overall Study|Withdrawal by Subject|0|||
161266212|NCT03548064|582358962|FG001|Overall Study|Withdrawal by Subject|0|||
161266213|NCT03548064|582358963|FG002|Overall Study|Withdrawal by Subject|0|||
161266214|NCT03548064|582358964|FG003|Overall Study|Withdrawal by Subject|1|||
161266215|NCT03548064|582358965|FG004|Overall Study|Withdrawal by Subject|0|||
161266216|NCT03548064|582358966|FG005|Overall Study|Withdrawal by Subject|0|||
161266217|NCT03548064|582358967|FG006|Overall Study|Withdrawal by Subject|0|||
160946640|NCT01485861|581192016|FG005|Safety Phase|Progression of Disease|9|||
160946641|NCT01485861|581192011|FG000|Safety Phase|Withdrawal by Subject|0|||
160946642|NCT01485861|581192012|FG001|Safety Phase|Withdrawal by Subject|0|||
160946643|NCT01485861|581192013|FG002|Safety Phase|Withdrawal by Subject|0|||
160946644|NCT01485861|581192014|FG003|Safety Phase|Withdrawal by Subject|0|||
160946645|NCT01485861|581192015|FG004|Safety Phase|Withdrawal by Subject|0|||
160946646|NCT01485861|581192016|FG005|Safety Phase|Withdrawal by Subject|6|||
160946647|NCT01485861|581192011|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946648|NCT01485861|581192012|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946649|NCT01485861|581192013|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946650|NCT01485861|581192014|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946651|NCT01485861|581192015|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
160946652|NCT01485861|581192016|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
160946653|NCT03795922|581192017|FG000|Overall Study|Adverse Event|2|||
160946654|NCT03795922|581192018|FG001|Overall Study|Adverse Event|1|||
160946655|NCT03795922|581192017|FG000|Overall Study|Withdrawal by Subject|5|||
160946656|NCT03795922|581192018|FG001|Overall Study|Withdrawal by Subject|13|||
160946657|NCT03795922|581192017|FG000|Overall Study|Lost to Follow-up|2|||
160946658|NCT03795922|581192018|FG001|Overall Study|Lost to Follow-up|3|||
160946659|NCT03795922|581192017|FG000|Overall Study|Pregnancy|0|||
160946660|NCT03795922|581192018|FG001|Overall Study|Pregnancy|1|||
160946661|NCT03795922|581192017|FG000|Overall Study|Physician Decision|1|||
160946662|NCT03795922|581192018|FG001|Overall Study|Physician Decision|2|||
160946663|NCT03795922|581192017|FG000|Overall Study|Protocol Violation|0|||
160946664|NCT03795922|581192018|FG001|Overall Study|Protocol Violation|1|||
160946665|NCT03795922|581192017|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
160946666|NCT03795922|581192018|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
160946667|NCT03056690|581192029|FG000|Overall Study|Adverse Event|3|||
160946668|NCT03056690|581192030|FG001|Overall Study|Adverse Event|2|||
160946669|NCT03056690|581192029|FG000|Overall Study|Lack of Efficacy|1|||
160946670|NCT03056690|581192030|FG001|Overall Study|Lack of Efficacy|2|||
160946671|NCT03056690|581192029|FG000|Overall Study|Lost to Follow-up|3|||
160946672|NCT03056690|581192030|FG001|Overall Study|Lost to Follow-up|2|||
160946673|NCT03056690|581192029|FG000|Overall Study|Protocol Violation|2|||
160946674|NCT03056690|581192030|FG001|Overall Study|Protocol Violation|2|||
160946675|NCT03056690|581192029|FG000|Overall Study|Withdrawal by Subject|3|||
160946676|NCT03056690|581192030|FG001|Overall Study|Withdrawal by Subject|6|||
160946677|NCT03056690|581192029|FG000|Overall Study|Non-compliance with Study Drug|1|||
160946678|NCT03056690|581192030|FG001|Overall Study|Non-compliance with Study Drug|0|||
160946679|NCT03056690|581192029|FG000|Overall Study|Miscellaneous|1|||
160946680|NCT03056690|581192030|FG001|Overall Study|Miscellaneous|2|||
160946681|NCT02328326|581192036|FG000|Overall Study|Withdrawal by Subject|10|||
160946682|NCT02328326|581192037|FG001|Overall Study|Withdrawal by Subject|3|||
160946683|NCT02328326|581192036|FG000|Overall Study|Death|2|||
160946684|NCT02328326|581192037|FG001|Overall Study|Death|1|||
160946685|NCT02328326|581192036|FG000|Overall Study|Lost to Follow-up|10|||
160946686|NCT02328326|581192037|FG001|Overall Study|Lost to Follow-up|4|||
160946687|NCT02543346|581192038|FG000|Second Priming Visit|Withdrawal by Subject|0|||
160946688|NCT02543346|581192039|FG001|Second Priming Visit|Withdrawal by Subject|2|||
160946689|NCT02543346|581192040|FG002|Second Priming Visit|Withdrawal by Subject|2|||
160946690|NCT02543346|581192041|FG003|Second Priming Visit|Withdrawal by Subject|2|||
160946691|NCT02543346|581192038|FG000|Second Priming Visit|Adverse Event|1|||
160946692|NCT02543346|581192039|FG001|Second Priming Visit|Adverse Event|0|||
160946693|NCT02543346|581192040|FG002|Second Priming Visit|Adverse Event|0|||
160946694|NCT02543346|581192041|FG003|Second Priming Visit|Adverse Event|0|||
160946695|NCT02209324|581192044|FG000|Overall Study|Adverse Event|2|||
160946696|NCT02209324|581192044|FG000|Overall Study|Lack of Efficacy|1|||
160946697|NCT02209324|581192044|FG000|Overall Study|Lost to Follow-up|1|||
160946698|NCT02209324|581192044|FG000|Overall Study|Physician Decision|3|||
160946699|NCT02209324|581192044|FG000|Overall Study|Protocol Violation|14|||
160946700|NCT02209324|581192044|FG000|Overall Study|Withdrawal by Subject|8|||
160946701|NCT02209324|581192044|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
160946702|NCT02209324|581192044|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
160946703|NCT02209324|581192044|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
160946704|NCT01985126|581192045|FG000|Overall Study|Death|15|||
160946705|NCT01985126|581192046|FG001|Overall Study|Death|69|||
160946706|NCT01985126|581192045|FG000|Overall Study|Lost to Follow-up|0|||
160946707|NCT01985126|581192046|FG001|Overall Study|Lost to Follow-up|8|||
160946708|NCT01985126|581192045|FG000|Overall Study|Study Terminated By Sponsor|1|||
160946709|NCT01985126|581192046|FG001|Overall Study|Study Terminated By Sponsor|22|||
160946710|NCT01985126|581192045|FG000|Overall Study|Withdrawal by Subject|2|||
160946711|NCT01985126|581192046|FG001|Overall Study|Withdrawal by Subject|7|||
160946712|NCT03433456|581192049|FG000|Overall Study|Death|1|||
160946713|NCT03433456|581192050|FG001|Overall Study|Death|1|||
160946714|NCT03433456|581192049|FG000|Overall Study|Lost to Follow-up|14|||
160946715|NCT03433456|581192050|FG001|Overall Study|Lost to Follow-up|11|||
160946716|NCT03433456|581192049|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
160946717|NCT03433456|581192050|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
160946718|NCT01198600|581192055|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
160946719|NCT01198600|581192056|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
160946720|NCT01198600|581192057|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
160946721|NCT01198600|581192058|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
160946722|NCT01198600|581192055|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
160946723|NCT01198600|581192056|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
160946724|NCT01198600|581192057|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
160946725|NCT01198600|581192058|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
160946726|NCT01198600|581192055|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
160946727|NCT01198600|581192056|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
160946728|NCT01198600|581192057|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
160999587|NCT04842604|581382766|FG000|Overall Study|Death|1|||
160946729|NCT01198600|581192058|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
160946730|NCT01198600|581192055|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
160946731|NCT01198600|581192056|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
160946732|NCT01198600|581192057|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
160946733|NCT01198600|581192058|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
160946734|NCT01198600|581192055|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
160946735|NCT01198600|581192056|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
160946736|NCT01198600|581192057|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
160946737|NCT01198600|581192058|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
160946738|NCT01198600|581192055|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
160946739|NCT01198600|581192056|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
160946740|NCT01198600|581192057|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
160946741|NCT01198600|581192058|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
160946742|NCT01198600|581192055|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
160946743|NCT01198600|581192056|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
161266218|NCT03548064|582358968|FG007|Overall Study|Withdrawal by Subject|0|||
161266219|NCT03548064|582358961|FG000|Overall Study|Lost to Follow-up|0|||
161266220|NCT03548064|582358962|FG001|Overall Study|Lost to Follow-up|0|||
161266221|NCT03548064|582358963|FG002|Overall Study|Lost to Follow-up|0|||
160946744|NCT01198600|581192057|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
160946745|NCT01198600|581192058|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
160946746|NCT01785602|581192059|FG000|Overall Study|Withdrawal by Subject|2|||
160946747|NCT01785602|581192060|FG001|Overall Study|Withdrawal by Subject|0|||
160946748|NCT01785602|581192059|FG000|Overall Study|Lost to Follow-up|1|||
160946749|NCT01785602|581192060|FG001|Overall Study|Lost to Follow-up|1|||
160946750|NCT01785602|581192059|FG000|Overall Study|Adverse Event|3|||
160946751|NCT01785602|581192060|FG001|Overall Study|Adverse Event|5|||
160946752|NCT01785602|581192059|FG000|Overall Study|Administrative problems|7|||
160946753|NCT01785602|581192060|FG001|Overall Study|Administrative problems|3|||
160946754|NCT02141516|581192063|FG000|Overall Study|Adverse Event|0|||
160946755|NCT02141516|581192064|FG001|Overall Study|Adverse Event|1|||
160946756|NCT02141516|581192065|FG002|Overall Study|Adverse Event|0|||
160946757|NCT02141516|581192063|FG000|Overall Study|Lost to Follow-up|0|||
160946758|NCT02141516|581192064|FG001|Overall Study|Lost to Follow-up|1|||
160946759|NCT02141516|581192065|FG002|Overall Study|Lost to Follow-up|0|||
160946760|NCT02141516|581192063|FG000|Overall Study|Other|0|||
160946761|NCT02141516|581192064|FG001|Overall Study|Other|3|||
160946762|NCT02141516|581192065|FG002|Overall Study|Other|0|||
160946763|NCT03251924|581192067|FG000|Overall Study|Disease Progression|6|||
160946764|NCT03251924|581192068|FG001|Overall Study|Disease Progression|6|||
160946765|NCT03251924|581192069|FG002|Overall Study|Disease Progression|7|||
160946766|NCT03251924|581192070|FG003|Overall Study|Disease Progression|8|||
160946767|NCT03251924|581192071|FG004|Overall Study|Disease Progression|8|||
160946768|NCT03251924|581192072|FG005|Overall Study|Disease Progression|7|||
160946769|NCT03251924|581192073|FG006|Overall Study|Disease Progression|6|||
160946770|NCT03251924|581192074|FG007|Overall Study|Disease Progression|10|||
160946771|NCT03251924|581192075|FG008|Overall Study|Disease Progression|6|||
160946772|NCT03251924|581192067|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
160946773|NCT03251924|581192068|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
160946774|NCT03251924|581192069|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
160946775|NCT03251924|581192070|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
160946776|NCT03251924|581192071|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
160946777|NCT03251924|581192072|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
160946778|NCT03251924|581192073|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
160946779|NCT03251924|581192074|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
160946780|NCT03251924|581192075|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
160946781|NCT03251924|581192067|FG000|Overall Study|Death|0|||
160946782|NCT03251924|581192068|FG001|Overall Study|Death|1|||
160946783|NCT03251924|581192069|FG002|Overall Study|Death|0|||
160946784|NCT03251924|581192070|FG003|Overall Study|Death|1|||
160946785|NCT03251924|581192071|FG004|Overall Study|Death|1|||
160946786|NCT03251924|581192072|FG005|Overall Study|Death|1|||
160946787|NCT03251924|581192073|FG006|Overall Study|Death|0|||
160946788|NCT03251924|581192074|FG007|Overall Study|Death|0|||
160946789|NCT03251924|581192075|FG008|Overall Study|Death|0|||
160946790|NCT03251924|581192067|FG000|Overall Study|Study Drug Toxicity|0|||
160946791|NCT03251924|581192068|FG001|Overall Study|Study Drug Toxicity|0|||
160946792|NCT03251924|581192069|FG002|Overall Study|Study Drug Toxicity|0|||
160946793|NCT03251924|581192070|FG003|Overall Study|Study Drug Toxicity|1|||
160946794|NCT03251924|581192071|FG004|Overall Study|Study Drug Toxicity|0|||
160946795|NCT03251924|581192072|FG005|Overall Study|Study Drug Toxicity|0|||
160946796|NCT03251924|581192073|FG006|Overall Study|Study Drug Toxicity|0|||
160946797|NCT03251924|581192074|FG007|Overall Study|Study Drug Toxicity|0|||
160946798|NCT03251924|581192075|FG008|Overall Study|Study Drug Toxicity|1|||
160946799|NCT03251924|581192067|FG000|Overall Study|Other Reasons|0|||
160946800|NCT03251924|581192068|FG001|Overall Study|Other Reasons|0|||
160946801|NCT03251924|581192069|FG002|Overall Study|Other Reasons|0|||
160946802|NCT03251924|581192070|FG003|Overall Study|Other Reasons|0|||
160946803|NCT03251924|581192071|FG004|Overall Study|Other Reasons|0|||
161144779|NCT01254344|581913970|FG000|Overall Study|Adverse Event|2|||
160946804|NCT03251924|581192072|FG005|Overall Study|Other Reasons|0|||
160946805|NCT03251924|581192073|FG006|Overall Study|Other Reasons|0|||
160999588|NCT04842604|581382767|FG001|Overall Study|Death|0|||
161144780|NCT01254344|581913971|FG001|Overall Study|Adverse Event|5|||
161266222|NCT03548064|582358964|FG003|Overall Study|Lost to Follow-up|0|||
161266223|NCT03548064|582358965|FG004|Overall Study|Lost to Follow-up|2|||
160946806|NCT03251924|581192074|FG007|Overall Study|Other Reasons|0|||
160946807|NCT03251924|581192075|FG008|Overall Study|Other Reasons|1|||
160946808|NCT03251924|581192067|FG000|Overall Study|Participant request to discontinue study treatment|0|||
160946809|NCT03251924|581192068|FG001|Overall Study|Participant request to discontinue study treatment|0|||
160946810|NCT03251924|581192069|FG002|Overall Study|Participant request to discontinue study treatment|0|||
160946811|NCT03251924|581192070|FG003|Overall Study|Participant request to discontinue study treatment|0|||
160999589|NCT04842604|581382766|FG000|Overall Study|Other|4|||
160946812|NCT03251924|581192071|FG004|Overall Study|Participant request to discontinue study treatment|0|||
160946813|NCT03251924|581192072|FG005|Overall Study|Participant request to discontinue study treatment|0|||
160946814|NCT03251924|581192073|FG006|Overall Study|Participant request to discontinue study treatment|0|||
160946815|NCT03251924|581192074|FG007|Overall Study|Participant request to discontinue study treatment|1|||
160946816|NCT03251924|581192075|FG008|Overall Study|Participant request to discontinue study treatment|0|||
160946817|NCT00784043|581192076|FG000|Overall Study|Withdrawal by Subject|8|||
160946818|NCT00784043|581192077|FG001|Overall Study|Withdrawal by Subject|5|||
160946819|NCT00784043|581192076|FG000|Overall Study|Protocol Terminated|23|||
160946820|NCT00784043|581192077|FG001|Overall Study|Protocol Terminated|1|||
160946821|NCT02127307|581192084|FG000|Overall Study|Protocol Violation|36|||
160946822|NCT02127307|581192084|FG000|Overall Study|Lost to Follow-up|2|||
160946823|NCT02127307|581192084|FG000|Overall Study|Death|101|||
160946824|NCT02127307|581192084|FG000|Overall Study|Other than specified above|169|||
160946825|NCT00235989|581192085|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946826|NCT00235989|581192086|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946827|NCT00235989|581192087|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946828|NCT00235989|581192088|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946829|NCT00235989|581192089|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
160946830|NCT00235989|581192090|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
160946831|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
160946832|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
160946833|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
160946834|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
160946835|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
160946836|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
160946837|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
160946838|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946839|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
160946840|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946841|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946842|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
160946843|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
160946844|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
160946845|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
160946846|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
160946847|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
160946848|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
160946849|NCT00235989|581192085|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
160946850|NCT00235989|581192086|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
160946851|NCT00235989|581192087|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
160946852|NCT00235989|581192088|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
160946853|NCT00235989|581192089|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
160946854|NCT00235989|581192090|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
160946855|NCT00983580|581192096|FG000|Overall Study|Cancel Prior to treatment|1|||
160946856|NCT00983580|581192097|FG001|Overall Study|Cancel Prior to treatment|3|||
160946857|NCT00983580|581192096|FG000|Overall Study|Protocol Violation|1|||
160946858|NCT00983580|581192097|FG001|Overall Study|Protocol Violation|1|||
160946859|NCT00983580|581192096|FG000|Overall Study|Ineligible|3|||
160946860|NCT00983580|581192097|FG001|Overall Study|Ineligible|0|||
160946861|NCT01992536|581193808|FG000|Overall Study|Administrative Reason|0|||
160946862|NCT01992536|581193809|FG001|Overall Study|Administrative Reason|0|||
160946863|NCT01992536|581193810|FG002|Overall Study|Administrative Reason|0|||
160946864|NCT01992536|581193811|FG003|Overall Study|Administrative Reason|0|||
160999590|NCT04842604|581382767|FG001|Overall Study|Other|4|||
160999591|NCT04842604|581382766|FG000|Overall Study|Randomized but not treated|1|||
160999592|NCT04842604|581382767|FG001|Overall Study|Randomized but not treated|0|||
160999593|NCT00344019|581382768|FG000|Overall Study|did not meet final inclusion criteria|0|||
160999594|NCT00344019|581382769|FG001|Overall Study|did not meet final inclusion criteria|0|||
160999595|NCT00344019|581382770|FG002|Overall Study|did not meet final inclusion criteria|74|||
160999596|NCT01193153|581382771|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
160999597|NCT01193153|581382772|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
160946865|NCT01992536|581193812|FG004|Overall Study|Administrative Reason|0|||
160946866|NCT01992536|581193813|FG005|Overall Study|Administrative Reason|0|||
160946867|NCT01992536|581193814|FG006|Overall Study|Administrative Reason|7|||
160946868|NCT01992536|581193815|FG007|Overall Study|Administrative Reason|0|||
160999598|NCT01193153|581382771|FG000|Open-label Lead in Period|Pregnancy|1|||
160946869|NCT01992536|581193816|FG008|Overall Study|Administrative Reason|0|||
160946870|NCT01992536|581193817|FG009|Overall Study|Administrative Reason|0|||
160946871|NCT01992536|581193808|FG000|Overall Study|Lost to Follow-up|4|||
160999599|NCT01193153|581382772|FG001|Open-label Lead in Period|Pregnancy|0|||
161266224|NCT03548064|582358966|FG005|Overall Study|Lost to Follow-up|0|||
161266225|NCT03548064|582358967|FG006|Overall Study|Lost to Follow-up|0|||
161266226|NCT03548064|582358968|FG007|Overall Study|Lost to Follow-up|0|||
161266227|NCT03548064|582358961|FG000|Overall Study|Covid-19 Pandemic|0|||
161266228|NCT03548064|582358962|FG001|Overall Study|Covid-19 Pandemic|0|||
161266229|NCT03548064|582358963|FG002|Overall Study|Covid-19 Pandemic|0|||
161266230|NCT03548064|582358964|FG003|Overall Study|Covid-19 Pandemic|0|||
161266231|NCT03548064|582358965|FG004|Overall Study|Covid-19 Pandemic|10|||
161266232|NCT03548064|582358966|FG005|Overall Study|Covid-19 Pandemic|3|||
161266233|NCT03548064|582358967|FG006|Overall Study|Covid-19 Pandemic|0|||
161266234|NCT03548064|582358968|FG007|Overall Study|Covid-19 Pandemic|0|||
160946872|NCT01992536|581193809|FG001|Overall Study|Lost to Follow-up|2|||
161266235|NCT02128217|582358973|FG000|Overall Study|Lost to Follow-up|0|||
161266236|NCT02128217|582358974|FG001|Overall Study|Lost to Follow-up|1|||
161266237|NCT05071313|582358975|FG000|Overall Study|Lost to Follow-up|17|||
161266238|NCT05071313|582358976|FG001|Overall Study|Lost to Follow-up|10|||
161266239|NCT05071313|582358975|FG000|Overall Study|Physician Decision|1|||
161266240|NCT05071313|582358976|FG001|Overall Study|Physician Decision|6|||
161266241|NCT05071313|582358975|FG000|Overall Study|Death|1|||
161266242|NCT05071313|582358976|FG001|Overall Study|Death|0|||
161266243|NCT05071313|582358975|FG000|Overall Study|Withdrawal by Subject|10|||
161266244|NCT05071313|582358976|FG001|Overall Study|Withdrawal by Subject|15|||
161266245|NCT05071313|582358975|FG000|Overall Study|Other|1|||
161266246|NCT05071313|582358976|FG001|Overall Study|Other|0|||
161266247|NCT05071313|582358975|FG000|Overall Study|Randomized but not vaccinated|4|||
161266248|NCT05071313|582358976|FG001|Overall Study|Randomized but not vaccinated|2|||
161266249|NCT00541970|582358977|FG000|Month 7|Protocol Violation|9|||
161266250|NCT00541970|582358978|FG001|Month 7|Protocol Violation|13|||
161266251|NCT00541970|582358979|FG002|Month 7|Protocol Violation|11|||
161266252|NCT00541970|582358980|FG003|Month 7|Protocol Violation|5|||
161266253|NCT00541970|582358977|FG000|Month 12|Adverse Event|0|||
161266254|NCT00541970|582358978|FG001|Month 12|Adverse Event|1|||
161266255|NCT00541970|582358979|FG002|Month 12|Adverse Event|1|||
161266256|NCT00541970|582358980|FG003|Month 12|Adverse Event|1|||
161266257|NCT00541970|582358977|FG000|Month 12|Protocol Violation|12|||
161266258|NCT00541970|582358978|FG001|Month 12|Protocol Violation|21|||
161266259|NCT00541970|582358979|FG002|Month 12|Protocol Violation|20|||
161266260|NCT00541970|582358980|FG003|Month 12|Protocol Violation|15|||
161266261|NCT00541970|582358977|FG000|Month 18|Adverse Event|0|||
161266262|NCT00541970|582358978|FG001|Month 18|Adverse Event|1|||
161266263|NCT00541970|582358979|FG002|Month 18|Adverse Event|1|||
161266264|NCT00541970|582358980|FG003|Month 18|Adverse Event|1|||
161266265|NCT00541970|582358977|FG000|Month 18|Protocol Violation|14|||
161266266|NCT00541970|582358978|FG001|Month 18|Protocol Violation|23|||
161266267|NCT00541970|582358979|FG002|Month 18|Protocol Violation|24|||
161266268|NCT00541970|582358980|FG003|Month 18|Protocol Violation|16|||
160946873|NCT01992536|581193810|FG002|Overall Study|Lost to Follow-up|1|||
160946874|NCT01992536|581193811|FG003|Overall Study|Lost to Follow-up|0|||
160946875|NCT01992536|581193812|FG004|Overall Study|Lost to Follow-up|0|||
160946876|NCT01992536|581193813|FG005|Overall Study|Lost to Follow-up|1|||
160946877|NCT01992536|581193814|FG006|Overall Study|Lost to Follow-up|0|||
160946878|NCT01992536|581193815|FG007|Overall Study|Lost to Follow-up|0|||
160946879|NCT01992536|581193816|FG008|Overall Study|Lost to Follow-up|1|||
160946880|NCT01992536|581193817|FG009|Overall Study|Lost to Follow-up|1|||
160946881|NCT01992536|581193808|FG000|Overall Study|Withdrawal by Subject|0|||
160946882|NCT01992536|581193809|FG001|Overall Study|Withdrawal by Subject|1|||
160946883|NCT01992536|581193810|FG002|Overall Study|Withdrawal by Subject|0|||
160946884|NCT01992536|581193811|FG003|Overall Study|Withdrawal by Subject|2|||
161266269|NCT00541970|582358977|FG000|Month 24|Adverse Event|0|||
161266270|NCT00541970|582358978|FG001|Month 24|Adverse Event|1|||
161266271|NCT00541970|582358979|FG002|Month 24|Adverse Event|1|||
161266272|NCT00541970|582358980|FG003|Month 24|Adverse Event|1|||
161266273|NCT00541970|582358977|FG000|Month 24|Protocol Violation|29|||
161266274|NCT00541970|582358978|FG001|Month 24|Protocol Violation|31|||
161266275|NCT00541970|582358979|FG002|Month 24|Protocol Violation|31|||
160946885|NCT01992536|581193812|FG004|Overall Study|Withdrawal by Subject|0|||
160946886|NCT01992536|581193813|FG005|Overall Study|Withdrawal by Subject|0|||
160946887|NCT01992536|581193814|FG006|Overall Study|Withdrawal by Subject|0|||
160946888|NCT01992536|581193815|FG007|Overall Study|Withdrawal by Subject|0|||
160946889|NCT01992536|581193816|FG008|Overall Study|Withdrawal by Subject|0|||
160946890|NCT01992536|581193817|FG009|Overall Study|Withdrawal by Subject|0|||
160946891|NCT01762761|581193818|FG000|Overall Study|Adverse Event|15|||
160946892|NCT01762761|581193819|FG001|Overall Study|Adverse Event|17|||
160946893|NCT01762761|581193818|FG000|Overall Study|Lack of Efficacy|9|||
160946894|NCT01762761|581193819|FG001|Overall Study|Lack of Efficacy|25|||
160946895|NCT01762761|581193818|FG000|Overall Study|Protocol Violation|1|||
160946896|NCT01762761|581193819|FG001|Overall Study|Protocol Violation|1|||
160946897|NCT01762761|581193818|FG000|Overall Study|Study closed/terminated|0|||
161266276|NCT00541970|582358980|FG003|Month 24|Protocol Violation|21|||
161266277|NCT00541970|582358977|FG000|Month 36|Protocol Violation|61|||
161266278|NCT00541970|582358978|FG001|Month 36|Protocol Violation|66|||
161266279|NCT00541970|582358979|FG002|Month 36|Protocol Violation|66|||
160946898|NCT01762761|581193819|FG001|Overall Study|Study closed/terminated|2|||
160946899|NCT01762761|581193818|FG000|Overall Study|Lost to Follow-up|3|||
160946900|NCT01762761|581193819|FG001|Overall Study|Lost to Follow-up|6|||
160946901|NCT01762761|581193818|FG000|Overall Study|Physician Decision|4|||
160946902|NCT01762761|581193819|FG001|Overall Study|Physician Decision|6|||
160946903|NCT01762761|581193818|FG000|Overall Study|Withdrawal by Subject|7|||
160946904|NCT01762761|581193819|FG001|Overall Study|Withdrawal by Subject|8|||
160946905|NCT02352493|581193822|FG000|Overall Study|Pregnancy|0|||
160946906|NCT02352493|581193823|FG001|Overall Study|Pregnancy|0|||
160946907|NCT02352493|581193824|FG002|Overall Study|Pregnancy|0|||
160946908|NCT02352493|581193825|FG003|Overall Study|Pregnancy|0|||
160946909|NCT02352493|581193826|FG004|Overall Study|Pregnancy|0|||
160946910|NCT02352493|581193827|FG005|Overall Study|Pregnancy|0|||
160946911|NCT02352493|581193828|FG006|Overall Study|Pregnancy|1|||
161266280|NCT00541970|582358980|FG003|Month 36|Protocol Violation|60|||
161266281|NCT00541970|582358977|FG000|Month 48|Withdrawal by Subject|2|||
161266282|NCT00541970|582358978|FG001|Month 48|Withdrawal by Subject|4|||
161266283|NCT00541970|582358979|FG002|Month 48|Withdrawal by Subject|4|||
161266284|NCT00541970|582358980|FG003|Month 48|Withdrawal by Subject|2|||
161266285|NCT00541970|582358977|FG000|Month 48|Other|3|||
161266286|NCT00541970|582358978|FG001|Month 48|Other|1|||
161266287|NCT00541970|582358979|FG002|Month 48|Other|1|||
161266288|NCT00541970|582358980|FG003|Month 48|Other|0|||
161266289|NCT00541970|582358977|FG000|Month 48|Lost to Follow-up|66|||
161266290|NCT00541970|582358978|FG001|Month 48|Lost to Follow-up|68|||
161266291|NCT00541970|582358979|FG002|Month 48|Lost to Follow-up|68|||
161266292|NCT00541970|582358980|FG003|Month 48|Lost to Follow-up|73|||
161266293|NCT00541970|582358977|FG000|Month 60|Protocol Violation|78|||
161266294|NCT00541970|582358978|FG001|Month 60|Protocol Violation|77|||
161266295|NCT00541970|582358979|FG002|Month 60|Protocol Violation|82|||
161266296|NCT00541970|582358980|FG003|Month 60|Protocol Violation|72|||
161266297|NCT03107026|582358981|FG000|Overall Study|Adverse Event|2|||
161266298|NCT03107026|582358982|FG001|Overall Study|Adverse Event|14|||
161266299|NCT03107026|582358983|FG002|Overall Study|Adverse Event|23|||
161266300|NCT03107026|582358981|FG000|Overall Study|Lost to Follow-up|12|||
161266301|NCT03107026|582358982|FG001|Overall Study|Lost to Follow-up|12|||
161266302|NCT03107026|582358983|FG002|Overall Study|Lost to Follow-up|13|||
161266303|NCT03107026|582358981|FG000|Overall Study|Protocol Violation|1|||
161266304|NCT03107026|582358982|FG001|Overall Study|Protocol Violation|2|||
161266305|NCT03107026|582358983|FG002|Overall Study|Protocol Violation|0|||
161266306|NCT03107026|582358981|FG000|Overall Study|Pregnancy|1|||
161266307|NCT03107026|582358982|FG001|Overall Study|Pregnancy|0|||
161266308|NCT03107026|582358983|FG002|Overall Study|Pregnancy|0|||
161266309|NCT03107026|582358981|FG000|Overall Study|Withdrawal by Subject|13|||
161266310|NCT03107026|582358982|FG001|Overall Study|Withdrawal by Subject|5|||
161266311|NCT03107026|582358983|FG002|Overall Study|Withdrawal by Subject|17|||
161266312|NCT03107026|582358981|FG000|Overall Study|non compliance with study visits|1|||
161266313|NCT03107026|582358982|FG001|Overall Study|non compliance with study visits|2|||
161266314|NCT03107026|582358983|FG002|Overall Study|non compliance with study visits|0|||
161266315|NCT03107026|582358981|FG000|Overall Study|non-compliance with study drug|2|||
160946912|NCT02352493|581193829|FG007|Overall Study|Pregnancy|0|||
160946913|NCT02352493|581193830|FG008|Overall Study|Pregnancy|1|||
160946914|NCT02352493|581193831|FG009|Overall Study|Pregnancy|0|||
160946915|NCT02352493|581193832|FG010|Overall Study|Pregnancy|0|||
160946916|NCT02352493|581193833|FG011|Overall Study|Pregnancy|0|||
160946917|NCT02352493|581193834|FG012|Overall Study|Pregnancy|0|||
160946918|NCT02352493|581193835|FG013|Overall Study|Pregnancy|0|||
160946919|NCT02352493|581193836|FG014|Overall Study|Pregnancy|0|||
160946920|NCT02352493|581193837|FG015|Overall Study|Pregnancy|0|||
160946921|NCT02352493|581193838|FG016|Overall Study|Pregnancy|0|||
160999600|NCT01193153|581382771|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
160999601|NCT01193153|581382772|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
161144781|NCT01254344|581913970|FG000|Overall Study|Physician Decision|7|||
160946922|NCT02352493|581193839|FG017|Overall Study|Pregnancy|0|||
160946923|NCT02352493|581193822|FG000|Overall Study|Withdrawal by Subject|0|||
160946924|NCT02352493|581193823|FG001|Overall Study|Withdrawal by Subject|0|||
160946925|NCT02352493|581193824|FG002|Overall Study|Withdrawal by Subject|0|||
161266316|NCT03107026|582358982|FG001|Overall Study|non-compliance with study drug|2|||
161266317|NCT03107026|582358983|FG002|Overall Study|non-compliance with study drug|3|||
160946926|NCT02352493|581193825|FG003|Overall Study|Withdrawal by Subject|0|||
160946927|NCT02352493|581193826|FG004|Overall Study|Withdrawal by Subject|0|||
160946928|NCT02352493|581193827|FG005|Overall Study|Withdrawal by Subject|0|||
161144782|NCT01254344|581913971|FG001|Overall Study|Physician Decision|4|||
160946929|NCT02352493|581193828|FG006|Overall Study|Withdrawal by Subject|0|||
160946930|NCT02352493|581193829|FG007|Overall Study|Withdrawal by Subject|0|||
160946931|NCT02352493|581193830|FG008|Overall Study|Withdrawal by Subject|1|||
160946932|NCT02352493|581193831|FG009|Overall Study|Withdrawal by Subject|0|||
161266318|NCT03107026|582358981|FG000|Overall Study|Physician Decision|0|||
161266319|NCT03107026|582358982|FG001|Overall Study|Physician Decision|1|||
161266320|NCT03107026|582358983|FG002|Overall Study|Physician Decision|0|||
161266321|NCT01183221|582358984|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
161144783|NCT01254344|581913970|FG000|Overall Study|Protocol Violation|1|||
161144784|NCT01254344|581913971|FG001|Overall Study|Protocol Violation|4|||
161144785|NCT01254344|581913970|FG000|Overall Study|Withdrawal by Subject|3|||
161144786|NCT01254344|581913971|FG001|Overall Study|Withdrawal by Subject|6|||
161144787|NCT00467649|581913972|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
161144788|NCT00467649|581913973|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
161144789|NCT00467649|581913974|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
161144790|NCT00467649|581913975|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
161144791|NCT00467649|581913976|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
161144792|NCT00467649|581913977|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
161144793|NCT00467649|581913972|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
161144794|NCT00467649|581913973|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
161144795|NCT00467649|581913974|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
161144796|NCT00467649|581913975|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
161144797|NCT00467649|581913976|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
161144798|NCT00467649|581913977|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
161144799|NCT00467649|581913972|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
161144800|NCT00467649|581913973|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
160946933|NCT02352493|581193832|FG010|Overall Study|Withdrawal by Subject|0|||
160946934|NCT02352493|581193833|FG011|Overall Study|Withdrawal by Subject|0|||
160946935|NCT02352493|581193834|FG012|Overall Study|Withdrawal by Subject|0|||
160946936|NCT02352493|581193835|FG013|Overall Study|Withdrawal by Subject|0|||
160946937|NCT02352493|581193836|FG014|Overall Study|Withdrawal by Subject|1|||
160946938|NCT02352493|581193837|FG015|Overall Study|Withdrawal by Subject|0|||
160946939|NCT02352493|581193838|FG016|Overall Study|Withdrawal by Subject|0|||
160946940|NCT02352493|581193839|FG017|Overall Study|Withdrawal by Subject|0|||
160946941|NCT02352493|581193822|FG000|Overall Study|Lost to Follow-up|0|||
160946942|NCT02352493|581193823|FG001|Overall Study|Lost to Follow-up|0|||
160946943|NCT02352493|581193824|FG002|Overall Study|Lost to Follow-up|0|||
160946944|NCT02352493|581193825|FG003|Overall Study|Lost to Follow-up|0|||
161144801|NCT00467649|581913974|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161144802|NCT00467649|581913975|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
160946945|NCT02352493|581193826|FG004|Overall Study|Lost to Follow-up|0|||
160946946|NCT02352493|581193827|FG005|Overall Study|Lost to Follow-up|0|||
160946947|NCT02352493|581193828|FG006|Overall Study|Lost to Follow-up|0|||
160946948|NCT02352493|581193829|FG007|Overall Study|Lost to Follow-up|0|||
160946949|NCT02352493|581193830|FG008|Overall Study|Lost to Follow-up|0|||
161144803|NCT00467649|581913976|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161144804|NCT00467649|581913977|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
161144805|NCT00467649|581913972|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
161144806|NCT00467649|581913973|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
161144807|NCT00467649|581913974|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161144808|NCT00467649|581913975|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161144809|NCT00467649|581913976|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161144810|NCT00467649|581913977|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
161144811|NCT00467649|581913972|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161144812|NCT00467649|581913973|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161144813|NCT00467649|581913974|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161144814|NCT00467649|581913975|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
161144815|NCT00467649|581913976|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161144816|NCT00467649|581913977|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
161144817|NCT00467649|581913972|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161144818|NCT00467649|581913973|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161144819|NCT00467649|581913974|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161144820|NCT00467649|581913975|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
161144821|NCT00467649|581913976|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161144822|NCT00467649|581913977|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
161144823|NCT00467649|581913972|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161144824|NCT00467649|581913973|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161144825|NCT00467649|581913974|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161144826|NCT00467649|581913975|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161144827|NCT00467649|581913976|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
161266322|NCT01183221|582358985|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
160946950|NCT02352493|581193831|FG009|Overall Study|Lost to Follow-up|1|||
160946951|NCT02352493|581193832|FG010|Overall Study|Lost to Follow-up|0|||
160946952|NCT02352493|581193833|FG011|Overall Study|Lost to Follow-up|0|||
160946953|NCT02352493|581193834|FG012|Overall Study|Lost to Follow-up|1|||
160946954|NCT02352493|581193835|FG013|Overall Study|Lost to Follow-up|2|||
160946955|NCT02352493|581193836|FG014|Overall Study|Lost to Follow-up|0|||
161144828|NCT00467649|581913977|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
161266323|NCT03596151|582358990|FG000|Overall Study|Withdrawal by Subject|1|||
160946956|NCT02352493|581193837|FG015|Overall Study|Lost to Follow-up|0|||
160946957|NCT02352493|581193838|FG016|Overall Study|Lost to Follow-up|0|||
160946958|NCT02352493|581193839|FG017|Overall Study|Lost to Follow-up|0|||
160946959|NCT02162810|581193840|FG000|Overall Study|Protocol Violation|1|||
160946960|NCT02162810|581193841|FG001|Overall Study|Protocol Violation|0|||
160946961|NCT02162810|581193840|FG000|Overall Study|patients did not report compliance|4|||
160946962|NCT02162810|581193841|FG001|Overall Study|patients did not report compliance|1|||
160946963|NCT00389324|581193842|FG000|Run-In Phase|Adverse Event|1|||
160946964|NCT00389324|581193842|FG000|Run-In Phase|Lost to Follow-up|1|||
160946965|NCT00389324|581193842|FG000|Run-In Phase|Withdrawal by Subject|1|||
160946966|NCT00389324|581193842|FG000|Subcutaneous Phase|Adverse Event|2|||
160946967|NCT00389324|581193842|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
161266324|NCT00807248|582358992|FG000|Overall Study|Adverse Event|1|||
161266325|NCT00807248|582358993|FG001|Overall Study|Adverse Event|2|||
161266326|NCT00807248|582358994|FG002|Overall Study|Adverse Event|2|||
161266327|NCT00807248|582358995|FG003|Overall Study|Adverse Event|6|||
161266328|NCT00807248|582358992|FG000|Overall Study|Lack of Efficacy|14|||
161266329|NCT00807248|582358993|FG001|Overall Study|Lack of Efficacy|4|||
161266330|NCT00807248|582358994|FG002|Overall Study|Lack of Efficacy|8|||
161266331|NCT00807248|582358995|FG003|Overall Study|Lack of Efficacy|3|||
161266332|NCT00807248|582358992|FG000|Overall Study|Protocol Violation|0|||
161266333|NCT00807248|582358993|FG001|Overall Study|Protocol Violation|1|||
161266334|NCT00807248|582358994|FG002|Overall Study|Protocol Violation|1|||
161266335|NCT00807248|582358995|FG003|Overall Study|Protocol Violation|0|||
160946968|NCT00389324|581193842|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
160946969|NCT00389324|581193842|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
160946970|NCT02317575|581193843|FG000|Period 1|Difficulty with venous cannulation|0|||
160946971|NCT02317575|581193844|FG001|Period 1|Difficulty with venous cannulation|1|||
160946972|NCT02317575|581193845|FG002|Period 1|Difficulty with venous cannulation|0|||
160946973|NCT02317575|581193846|FG003|Period 1|Difficulty with venous cannulation|0|||
160946974|NCT02317575|581193847|FG004|Period 1|Difficulty with venous cannulation|0|||
160946975|NCT02317575|581193843|FG000|Period 1|Withdrawal by Subject|1|||
160946976|NCT02317575|581193844|FG001|Period 1|Withdrawal by Subject|0|||
160946977|NCT02317575|581193845|FG002|Period 1|Withdrawal by Subject|0|||
160946978|NCT02317575|581193846|FG003|Period 1|Withdrawal by Subject|0|||
160946979|NCT02317575|581193847|FG004|Period 1|Withdrawal by Subject|0|||
160946980|NCT01465334|581193848|FG000|Overall Study|Disease Progression|1|||
160946981|NCT01465334|581193849|FG001|Overall Study|Disease Progression|0|||
160946982|NCT01465334|581193848|FG000|Overall Study|Adverse Event|1|||
160946983|NCT01465334|581193849|FG001|Overall Study|Adverse Event|0|||
160946984|NCT01465334|581193848|FG000|Overall Study|Richter's transformation|0|||
160946985|NCT01465334|581193849|FG001|Overall Study|Richter's transformation|3|||
160946986|NCT01465334|581193848|FG000|Overall Study|Refractory Disease|0|||
160946987|NCT01465334|581193849|FG001|Overall Study|Refractory Disease|3|||
160946988|NCT03936244|581193853|FG000|Overall Study|Lost to Follow-up|5|||
160946989|NCT03936244|581193854|FG001|Overall Study|Lost to Follow-up|1|||
160946990|NCT03936244|581193853|FG000|Overall Study|Physician Decision|7|||
160946991|NCT03936244|581193854|FG001|Overall Study|Physician Decision|3|||
160946992|NCT01925183|581193857|FG000|Overall Study|Adverse Event|1|||
160946993|NCT01925183|581193858|FG001|Overall Study|Adverse Event|0|||
160946994|NCT01046110|581193859|FG000|Overall Study|Adverse Event|9|||
160946995|NCT01046110|581193860|FG001|Overall Study|Adverse Event|2|||
160946996|NCT01046110|581193859|FG000|Overall Study|Lack of Efficacy|0|||
160946997|NCT01046110|581193860|FG001|Overall Study|Lack of Efficacy|1|||
160946998|NCT01046110|581193859|FG000|Overall Study|Protocol Violation|7|||
160946999|NCT01046110|581193860|FG001|Overall Study|Protocol Violation|12|||
160947000|NCT01046110|581193859|FG000|Overall Study|Withdrawal Criteria|3|||
160947001|NCT01046110|581193860|FG001|Overall Study|Withdrawal Criteria|5|||
160947002|NCT01046110|581193859|FG000|Overall Study|Unclassified|36|||
160947003|NCT01046110|581193860|FG001|Overall Study|Unclassified|35|||
161144829|NCT01633060|581913978|FG000|Randomization Phase|Protocol deviation|1|||
161266336|NCT00807248|582358992|FG000|Overall Study|Withdrawal of Consent|5|||
160947004|NCT01233817|581193863|FG000|Overall Study|Lost to Follow-up|1|||
160947005|NCT01233817|581193863|FG000|Overall Study|Withdrawal by Subject|2|||
160947006|NCT02159482|581193864|FG000|Overall Study|Withdrawal by Subject|2|||
160947007|NCT02159482|581193864|FG000|Overall Study|Physician Decision|3|||
160947008|NCT01248884|581193867|FG000|Overall Study|Withdrawal by Subject|1|||
160947009|NCT01248884|581193868|FG001|Overall Study|Withdrawal by Subject|3|||
160947010|NCT01248884|581193869|FG002|Overall Study|Withdrawal by Subject|1|||
160947011|NCT01248884|581193867|FG000|Overall Study|Adverse Event|1|||
160947012|NCT01248884|581193868|FG001|Overall Study|Adverse Event|0|||
160947013|NCT01248884|581193869|FG002|Overall Study|Adverse Event|0|||
160947014|NCT04479618|581193870|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
160947015|NCT04479618|581193871|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
161266337|NCT00807248|582358993|FG001|Overall Study|Withdrawal of Consent|5|||
161266338|NCT00807248|582358994|FG002|Overall Study|Withdrawal of Consent|5|||
161266339|NCT00807248|582358995|FG003|Overall Study|Withdrawal of Consent|5|||
161266340|NCT00807248|582358992|FG000|Overall Study|Lost to Follow-up|1|||
161266341|NCT00807248|582358993|FG001|Overall Study|Lost to Follow-up|0|||
161266342|NCT00807248|582358994|FG002|Overall Study|Lost to Follow-up|0|||
161266343|NCT00807248|582358995|FG003|Overall Study|Lost to Follow-up|0|||
161266344|NCT00807248|582358992|FG000|Overall Study|Other Reason|0|||
161266345|NCT00807248|582358993|FG001|Overall Study|Other Reason|0|||
161266346|NCT00807248|582358994|FG002|Overall Study|Other Reason|2|||
161266347|NCT00807248|582358995|FG003|Overall Study|Other Reason|0|||
161266348|NCT02444793|582358996|FG000|Overall Study|Lost to Follow-up|2|||
161266349|NCT02444793|582358997|FG001|Overall Study|Lost to Follow-up|2|||
161266350|NCT02444793|582358998|FG002|Overall Study|Lost to Follow-up|0|||
161266351|NCT02444793|582358999|FG003|Overall Study|Lost to Follow-up|0|||
161266352|NCT02444793|582358996|FG000|Overall Study|Death|0|||
161266353|NCT02444793|582358997|FG001|Overall Study|Death|3|||
161266354|NCT02444793|582358998|FG002|Overall Study|Death|0|||
161266355|NCT02444793|582358999|FG003|Overall Study|Death|0|||
161266356|NCT02444793|582358996|FG000|Overall Study|Other|0|||
161266357|NCT02444793|582358997|FG001|Overall Study|Other|0|||
161266358|NCT02444793|582358998|FG002|Overall Study|Other|2|||
161266359|NCT02444793|582358999|FG003|Overall Study|Other|0|||
161266360|NCT02444793|582358996|FG000|Overall Study|Objective progression or relapse|9|||
161266361|NCT02444793|582358997|FG001|Overall Study|Objective progression or relapse|1|||
161266362|NCT02444793|582358998|FG002|Overall Study|Objective progression or relapse|2|||
161266363|NCT02444793|582358999|FG003|Overall Study|Objective progression or relapse|3|||
161266364|NCT02504671|582359001|FG000|Overall Study|Withdrawal by Subject|1|||
161266365|NCT02504671|582359002|FG001|Overall Study|Withdrawal by Subject|5|||
161266366|NCT02504671|582359003|FG002|Overall Study|Withdrawal by Subject|4|||
161266367|NCT02504671|582359004|FG003|Overall Study|Withdrawal by Subject|4|||
161266368|NCT02504671|582359005|FG004|Overall Study|Withdrawal by Subject|5|||
161266369|NCT02504671|582359006|FG005|Overall Study|Withdrawal by Subject|3|||
161266370|NCT02504671|582359001|FG000|Overall Study|Lack of Efficacy|1|||
161266371|NCT02504671|582359002|FG001|Overall Study|Lack of Efficacy|3|||
161266372|NCT02504671|582359003|FG002|Overall Study|Lack of Efficacy|1|||
161266373|NCT02504671|582359004|FG003|Overall Study|Lack of Efficacy|0|||
161266374|NCT02504671|582359005|FG004|Overall Study|Lack of Efficacy|4|||
161266375|NCT02504671|582359006|FG005|Overall Study|Lack of Efficacy|4|||
161266376|NCT02504671|582359001|FG000|Overall Study|Adverse Event|1|||
161266377|NCT02504671|582359002|FG001|Overall Study|Adverse Event|1|||
161266378|NCT02504671|582359003|FG002|Overall Study|Adverse Event|0|||
161266379|NCT02504671|582359004|FG003|Overall Study|Adverse Event|1|||
161266380|NCT02504671|582359005|FG004|Overall Study|Adverse Event|0|||
161266381|NCT02504671|582359006|FG005|Overall Study|Adverse Event|2|||
161266382|NCT02504671|582359001|FG000|Overall Study|Protocol Violation|2|||
161266383|NCT02504671|582359002|FG001|Overall Study|Protocol Violation|1|||
161266384|NCT02504671|582359003|FG002|Overall Study|Protocol Violation|0|||
161266385|NCT02504671|582359004|FG003|Overall Study|Protocol Violation|0|||
161266386|NCT02504671|582359005|FG004|Overall Study|Protocol Violation|0|||
161266387|NCT02504671|582359006|FG005|Overall Study|Protocol Violation|1|||
161266388|NCT02504671|582359001|FG000|Overall Study|Lost to Follow-up|0|||
161266389|NCT02504671|582359002|FG001|Overall Study|Lost to Follow-up|0|||
161266390|NCT02504671|582359003|FG002|Overall Study|Lost to Follow-up|2|||
161266391|NCT02504671|582359004|FG003|Overall Study|Lost to Follow-up|0|||
161266392|NCT02504671|582359005|FG004|Overall Study|Lost to Follow-up|0|||
161266393|NCT02504671|582359006|FG005|Overall Study|Lost to Follow-up|1|||
161266394|NCT02504671|582359001|FG000|Overall Study|Protocol defined stopping criteria|7|||
161266395|NCT02504671|582359002|FG001|Overall Study|Protocol defined stopping criteria|4|||
160947016|NCT04479618|581193872|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
160947017|NCT04479618|581193870|FG000|Overall Study|Lack of Efficacy|1|||
160947018|NCT04479618|581193871|FG001|Overall Study|Lack of Efficacy|0|||
160947019|NCT04479618|581193872|FG002|Overall Study|Lack of Efficacy|0|||
161266396|NCT02504671|582359003|FG002|Overall Study|Protocol defined stopping criteria|3|||
161266397|NCT02504671|582359004|FG003|Overall Study|Protocol defined stopping criteria|5|||
161266398|NCT02504671|582359005|FG004|Overall Study|Protocol defined stopping criteria|3|||
161266399|NCT02504671|582359006|FG005|Overall Study|Protocol defined stopping criteria|3|||
161266400|NCT00210249|582359007|FG000|Overall Study|Lost to Follow-up|5|||
161266401|NCT00210249|582359007|FG000|Overall Study|Protocol Violation|11|||
161266402|NCT04280705|582359008|FG000|Overall Study|Enrolled but not treated|4|||
161266403|NCT04280705|582359009|FG001|Overall Study|Enrolled but not treated|10|||
161266404|NCT04280705|582359008|FG000|Overall Study|Physician Decision|1|||
160947020|NCT04479618|581193870|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
161266405|NCT04280705|582359009|FG001|Overall Study|Physician Decision|0|||
161266406|NCT04280705|582359008|FG000|Overall Study|Withdrawal by Subject|7|||
161266407|NCT04280705|582359009|FG001|Overall Study|Withdrawal by Subject|9|||
160947021|NCT04479618|581193871|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
160947022|NCT04479618|581193872|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
161266408|NCT04280705|582359008|FG000|Overall Study|Adverse Event|0|||
161266409|NCT04280705|582359009|FG001|Overall Study|Adverse Event|4|||
161266410|NCT04280705|582359008|FG000|Overall Study|Transferred to another hospital|1|||
160947023|NCT04479618|581193870|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
160947024|NCT04479618|581193871|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
160947025|NCT04479618|581193872|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
160947026|NCT04479618|581193870|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
160947027|NCT04479618|581193871|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
160947028|NCT04479618|581193872|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
160947029|NCT04479618|581193870|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
160947030|NCT04479618|581193871|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
160947031|NCT04479618|581193872|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
160947032|NCT01430130|581193873|FG000|Overall Study|Lost to Follow-up|1|||
160947033|NCT01430130|581193873|FG000|Overall Study|Infection on Control Side of Incision|1|||
160947034|NCT01243944|581193876|FG000|Overall Study|Adverse Event|15|||
160947035|NCT01243944|581193877|FG001|Overall Study|Adverse Event|13|||
160947036|NCT01243944|581193876|FG000|Overall Study|Lost to Follow-up|2|||
160947037|NCT01243944|581193877|FG001|Overall Study|Lost to Follow-up|1|||
160947038|NCT01243944|581193876|FG000|Overall Study|Physician Decision|2|||
160947039|NCT01243944|581193877|FG001|Overall Study|Physician Decision|7|||
160947040|NCT01243944|581193876|FG000|Overall Study|Disease progression|12|||
160947041|NCT01243944|581193877|FG001|Overall Study|Disease progression|11|||
160947042|NCT01243944|581193876|FG000|Overall Study|Protocol deviation|1|||
160947043|NCT01243944|581193877|FG001|Overall Study|Protocol deviation|1|||
160947044|NCT01243944|581193876|FG000|Overall Study|Participant decision|10|||
160947045|NCT01243944|581193877|FG001|Overall Study|Participant decision|15|||
160947046|NCT01243944|581193876|FG000|Overall Study|Death|2|||
160947047|NCT01243944|581193877|FG001|Overall Study|Death|3|||
160947048|NCT01243944|581193876|FG000|Overall Study|Non-compliance with study treatment|1|||
160947049|NCT01243944|581193877|FG001|Overall Study|Non-compliance with study treatment|0|||
160947050|NCT02673697|581193880|FG000|Overall Study|Adverse Event|2|||
160947051|NCT02673697|581193881|FG001|Overall Study|Adverse Event|0|||
160947052|NCT02673697|581193880|FG000|Overall Study|Death|32|||
160947053|NCT02673697|581193881|FG001|Overall Study|Death|24|||
160947054|NCT02673697|581193880|FG000|Overall Study|Lost to Follow-up|5|||
160947055|NCT02673697|581193881|FG001|Overall Study|Lost to Follow-up|2|||
160947056|NCT02673697|581193880|FG000|Overall Study|Physician Decision|2|||
160947057|NCT02673697|581193881|FG001|Overall Study|Physician Decision|1|||
160947058|NCT02673697|581193880|FG000|Overall Study|Withdrawal by Subject|10|||
160947059|NCT02673697|581193881|FG001|Overall Study|Withdrawal by Subject|7|||
160947060|NCT02673697|581193880|FG000|Overall Study|Change subj medical status|1|||
160947061|NCT02673697|581193881|FG001|Overall Study|Change subj medical status|2|||
160947062|NCT02673697|581193880|FG000|Overall Study|Explant|10|||
160947063|NCT02673697|581193881|FG001|Overall Study|Explant|5|||
160947064|NCT02673697|581193880|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
160947065|NCT02673697|581193881|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
160947066|NCT00437489|581193882|FG000|Overall Study|Study terminated by sponsor|23|||
160947067|NCT00437489|581193883|FG001|Overall Study|Study terminated by sponsor|21|||
160947068|NCT00437489|581193882|FG000|Overall Study|Lost to Follow-up|0|||
160947069|NCT00437489|581193883|FG001|Overall Study|Lost to Follow-up|1|||
160947070|NCT01525082|581193891|FG000|Overall Study|Death|1|||
160947071|NCT00022516|581193899|FG000|Overall Study|Adverse Event|0|||
160947072|NCT00022516|581193900|FG001|Overall Study|Adverse Event|59|||
160947073|NCT00022516|581193899|FG000|Overall Study|Lack of Efficacy|0|||
160947074|NCT00022516|581193900|FG001|Overall Study|Lack of Efficacy|27|||
160947075|NCT00022516|581193899|FG000|Overall Study|Physician Decision|0|||
160947076|NCT00022516|581193900|FG001|Overall Study|Physician Decision|1|||
160947077|NCT00022516|581193899|FG000|Overall Study|Protocol Violation|1|||
160947078|NCT00022516|581193900|FG001|Overall Study|Protocol Violation|3|||
160947079|NCT00022516|581193899|FG000|Overall Study|Withdrawal by Subject|2|||
160947080|NCT00022516|581193900|FG001|Overall Study|Withdrawal by Subject|113|||
160947081|NCT00022516|581193899|FG000|Overall Study|Incomplete documentation|0|||
160947082|NCT00022516|581193900|FG001|Overall Study|Incomplete documentation|27|||
160947083|NCT03321019|581193902|FG000|Overall Study|Withdrawal by Subject|0|||
160947084|NCT03321019|581193903|FG001|Overall Study|Withdrawal by Subject|6|||
160947085|NCT03321019|581193902|FG000|Overall Study|Lost to Follow-up|0|||
160947086|NCT03321019|581193903|FG001|Overall Study|Lost to Follow-up|22|||
160947087|NCT03880578|581193904|FG000|Overall Study|Withdrawal by Subject|0|||
160947088|NCT03880578|581193905|FG001|Overall Study|Withdrawal by Subject|3|||
160947089|NCT03880578|581193906|FG002|Overall Study|Withdrawal by Subject|1|||
160947090|NCT03880578|581193904|FG000|Overall Study|Death|0|||
161144830|NCT01633060|581913979|FG001|Randomization Phase|Protocol deviation|2|||
160947091|NCT03880578|581193905|FG001|Overall Study|Death|1|||
160947092|NCT03880578|581193906|FG002|Overall Study|Death|0|||
160947093|NCT01568047|581193908|FG000|Overall Study|Ineligibility|1|||
160947094|NCT01568047|581193909|FG001|Overall Study|Ineligibility|0|||
161266411|NCT04280705|582359009|FG001|Overall Study|Transferred to another hospital|1|||
161266412|NCT03222583|582359012|FG000|Overall Study|Withdrawal by Subject|3|||
161266413|NCT03222583|582359013|FG001|Overall Study|Withdrawal by Subject|3|||
161266414|NCT03222583|582359012|FG000|Overall Study|Lost to Follow-up|1|||
161266415|NCT03222583|582359013|FG001|Overall Study|Lost to Follow-up|0|||
161266416|NCT03222583|582359012|FG000|Overall Study|Other|1|||
161266417|NCT03222583|582359013|FG001|Overall Study|Other|3|||
161266418|NCT02518919|582359014|FG000|Overall Study|Protocol Violation|1|||
161266419|NCT02518919|582359015|FG001|Overall Study|Protocol Violation|1|||
161266420|NCT02518919|582359016|FG002|Overall Study|Protocol Violation|2|||
161266421|NCT04498403|582359017|FG000|Overall Study|Adverse Event|1|||
161266422|NCT04498403|582359018|FG001|Overall Study|Adverse Event|0|||
161266423|NCT04498403|582359017|FG000|Overall Study|Study Terminated By Sponsor|29|||
161266424|NCT04498403|582359018|FG001|Overall Study|Study Terminated By Sponsor|10|||
161266425|NCT02492880|582359019|FG000|Overall Study|Lost to Follow-up|1|||
161266426|NCT02492880|582359019|FG000|Overall Study|Protocol Violation|1|||
161266427|NCT01200992|582359020|FG000|Overall Study|Study terminated early|35|||
161266428|NCT01200992|582359021|FG001|Overall Study|Study terminated early|41|||
161266429|NCT01200992|582359020|FG000|Overall Study|Randomized but not treated|2|||
161266430|NCT01200992|582359021|FG001|Overall Study|Randomized but not treated|0|||
161266431|NCT00667810|582359022|FG000|Overall Study|Adverse Event|13|||
161266432|NCT00667810|582359023|FG001|Overall Study|Adverse Event|14|||
161266433|NCT00667810|582359024|FG002|Overall Study|Adverse Event|19|||
161266434|NCT00667810|582359025|FG003|Overall Study|Adverse Event|1|||
161266435|NCT00667810|582359022|FG000|Overall Study|Death|1|||
161266436|NCT00667810|582359023|FG001|Overall Study|Death|1|||
161266437|NCT00667810|582359024|FG002|Overall Study|Death|3|||
161266438|NCT00667810|582359025|FG003|Overall Study|Death|0|||
161266439|NCT00667810|582359022|FG000|Overall Study|Lack of Efficacy|1|||
161266440|NCT00667810|582359023|FG001|Overall Study|Lack of Efficacy|0|||
161266441|NCT00667810|582359024|FG002|Overall Study|Lack of Efficacy|2|||
161266442|NCT00667810|582359025|FG003|Overall Study|Lack of Efficacy|0|||
161266443|NCT00667810|582359022|FG000|Overall Study|Lost to Follow-up|1|||
161266444|NCT00667810|582359023|FG001|Overall Study|Lost to Follow-up|4|||
161266445|NCT00667810|582359024|FG002|Overall Study|Lost to Follow-up|2|||
161266446|NCT00667810|582359025|FG003|Overall Study|Lost to Follow-up|0|||
161266447|NCT00667810|582359022|FG000|Overall Study|Physician Decision|1|||
160947095|NCT01568047|581193910|FG002|Overall Study|Ineligibility|0|||
160947096|NCT01568047|581193911|FG003|Overall Study|Ineligibility|0|||
160947097|NCT01568047|581193908|FG000|Overall Study|Withdrawal by Subject|0|||
160947098|NCT01568047|581193909|FG001|Overall Study|Withdrawal by Subject|1|||
160947099|NCT01568047|581193910|FG002|Overall Study|Withdrawal by Subject|0|||
160947100|NCT01568047|581193911|FG003|Overall Study|Withdrawal by Subject|0|||
160947101|NCT01568047|581193908|FG000|Overall Study|Adverse Event|0|||
160947102|NCT01568047|581193909|FG001|Overall Study|Adverse Event|0|||
160947103|NCT01568047|581193910|FG002|Overall Study|Adverse Event|1|||
160947104|NCT01568047|581193911|FG003|Overall Study|Adverse Event|1|||
160947105|NCT03783923|581193912|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
160947106|NCT03783923|581193913|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
160947107|NCT03783923|581193912|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
160947108|NCT03783923|581193913|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
160947109|NCT03783923|581193912|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
160947110|NCT03783923|581193913|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
160947111|NCT03783923|581193912|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
160947112|NCT03783923|581193913|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
160947113|NCT03783923|581193912|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
160947114|NCT03783923|581193913|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
160947115|NCT01944046|581193921|FG000|Randomized to DB|Adverse Event|5|||
160947116|NCT01944046|581193922|FG001|Randomized to DB|Adverse Event|2|||
160947117|NCT01944046|581193921|FG000|Randomized to DB|Clinical Worsening|3|||
160947118|NCT01944046|581193922|FG001|Randomized to DB|Clinical Worsening|2|||
161266448|NCT00667810|582359023|FG001|Overall Study|Physician Decision|1|||
161266449|NCT00667810|582359024|FG002|Overall Study|Physician Decision|2|||
161266450|NCT00667810|582359025|FG003|Overall Study|Physician Decision|0|||
160947119|NCT01944046|581193921|FG000|Randomized to DB|Lost to Follow-up|3|||
160999602|NCT01193153|581382771|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
160999603|NCT01193153|581382772|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
160999604|NCT01193153|581382771|FG000|Open-label Lead in Period|Other|14|||
161266451|NCT00667810|582359022|FG000|Overall Study|Protocol Violation|0|||
160947120|NCT01944046|581193922|FG001|Randomized to DB|Lost to Follow-up|3|||
160999605|NCT01193153|581382772|FG001|Open-label Lead in Period|Other|0|||
161266452|NCT00667810|582359023|FG001|Overall Study|Protocol Violation|2|||
161266453|NCT00667810|582359024|FG002|Overall Study|Protocol Violation|0|||
161266454|NCT00667810|582359025|FG003|Overall Study|Protocol Violation|0|||
161266455|NCT00667810|582359022|FG000|Overall Study|Withdrawal by Subject|14|||
161266456|NCT00667810|582359023|FG001|Overall Study|Withdrawal by Subject|20|||
161266457|NCT00667810|582359024|FG002|Overall Study|Withdrawal by Subject|29|||
161266458|NCT00667810|582359025|FG003|Overall Study|Withdrawal by Subject|1|||
161266459|NCT00667810|582359022|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
161266460|NCT00667810|582359023|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
161266461|NCT00667810|582359024|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
161266462|NCT00667810|582359025|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161266463|NCT00667810|582359022|FG000|Overall Study|Failed to Return|0|||
161266464|NCT00667810|582359023|FG001|Overall Study|Failed to Return|0|||
161266465|NCT00667810|582359024|FG002|Overall Study|Failed to Return|2|||
161266466|NCT00667810|582359025|FG003|Overall Study|Failed to Return|0|||
161266467|NCT00667810|582359022|FG000|Overall Study|Loss of Caregiver|0|||
161266468|NCT00667810|582359023|FG001|Overall Study|Loss of Caregiver|1|||
161266469|NCT00667810|582359024|FG002|Overall Study|Loss of Caregiver|3|||
160947121|NCT01944046|581193921|FG000|Randomized to DB|Withdrawal by Subject|2|||
160947122|NCT01944046|581193922|FG001|Randomized to DB|Withdrawal by Subject|4|||
160947123|NCT01944046|581193921|FG000|Randomized to DB|Physician Decision|1|||
160947124|NCT01944046|581193922|FG001|Randomized to DB|Physician Decision|2|||
160947125|NCT01944046|581193921|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
160947126|NCT01944046|581193922|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
160947127|NCT01944046|581193921|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
160947128|NCT01944046|581193922|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
160947129|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
160947130|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
160947131|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Adverse Event|6|||
160947132|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Adverse Event|1|||
160947133|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
160947134|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
160947135|NCT01944046|581193921|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
160947136|NCT01944046|581193922|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
160947137|NCT02056301|581193925|FG000|Overall Study|Protocol Violation|1|||
160947138|NCT02056301|581193926|FG001|Overall Study|Protocol Violation|2|||
160947139|NCT02056301|581193925|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
160947140|NCT02056301|581193926|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
160947141|NCT02056301|581193925|FG000|Overall Study|Withdrawal by Subject|0|||
160947142|NCT02056301|581193926|FG001|Overall Study|Withdrawal by Subject|1|||
160947143|NCT02056301|581193925|FG000|Overall Study|Issues with epidural|0|||
160947144|NCT02056301|581193926|FG001|Overall Study|Issues with epidural|3|||
160947145|NCT02041429|581193928|FG000|Overall Study|Progressive Disease|2|||
160947146|NCT02041429|581193929|FG001|Overall Study|Progressive Disease|2|||
160947147|NCT02041429|581193930|FG002|Overall Study|Progressive Disease|3|||
160947148|NCT02041429|581193931|FG003|Overall Study|Progressive Disease|2|||
160947149|NCT02041429|581193928|FG000|Overall Study|Toxicity|0|||
160947150|NCT02041429|581193929|FG001|Overall Study|Toxicity|1|||
160947151|NCT02041429|581193930|FG002|Overall Study|Toxicity|4|||
160947152|NCT02041429|581193931|FG003|Overall Study|Toxicity|2|||
160947153|NCT02041429|581193928|FG000|Overall Study|Withdrawal by Subject|0|||
160947154|NCT02041429|581193929|FG001|Overall Study|Withdrawal by Subject|1|||
160947155|NCT02041429|581193930|FG002|Overall Study|Withdrawal by Subject|0|||
160947156|NCT02041429|581193931|FG003|Overall Study|Withdrawal by Subject|0|||
160947157|NCT02041429|581193928|FG000|Overall Study|On Maintenance Therapy|1|||
160947158|NCT02041429|581193929|FG001|Overall Study|On Maintenance Therapy|0|||
160947159|NCT02041429|581193930|FG002|Overall Study|On Maintenance Therapy|0|||
160947160|NCT02041429|581193931|FG003|Overall Study|On Maintenance Therapy|2|||
160947161|NCT00153101|581193932|FG000|Overall Study|Lost to Follow-up|14|||
160947162|NCT00153101|581193933|FG001|Overall Study|Lost to Follow-up|14|||
160999606|NCT01193153|581382771|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
160999607|NCT01193153|581382772|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
160999608|NCT01193153|581382771|FG000|Open-label Lead in Period|Adverse Event|41|||
160999609|NCT01193153|581382772|FG001|Open-label Lead in Period|Adverse Event|0|||
160999610|NCT01193153|581382771|FG000|Open-label Lead in Period|Death|1|||
160999611|NCT01193153|581382772|FG001|Open-label Lead in Period|Death|0|||
160999612|NCT01193153|581382771|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
160999613|NCT01193153|581382772|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
161144831|NCT01633060|581913978|FG000|Randomization Phase|Technical problem|0|||
161266470|NCT00667810|582359025|FG003|Overall Study|Loss of Caregiver|0|||
161266471|NCT00667810|582359022|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
161266472|NCT00667810|582359023|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
161266473|NCT00667810|582359024|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
161266474|NCT00667810|582359025|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
160947163|NCT00153101|581193934|FG002|Overall Study|Lost to Follow-up|12|||
160947164|NCT00153101|581193935|FG003|Overall Study|Lost to Follow-up|5|||
160947165|NCT00153101|581193936|FG004|Overall Study|Lost to Follow-up|5|||
160947166|NCT00153101|581193932|FG000|Overall Study|Withdrawal by Subject|3|||
160947167|NCT00153101|581193933|FG001|Overall Study|Withdrawal by Subject|4|||
161266475|NCT00667810|582359022|FG000|Overall Study|Other|6|||
160947168|NCT00153101|581193934|FG002|Overall Study|Withdrawal by Subject|3|||
160999614|NCT01193153|581382771|FG000|Open-label Stabilization Period|Adverse Event|9|||
160999615|NCT01193153|581382772|FG001|Open-label Stabilization Period|Adverse Event|0|||
160999616|NCT01193153|581382771|FG000|Open-label Stabilization Period|Death|2|||
160999617|NCT01193153|581382772|FG001|Open-label Stabilization Period|Death|0|||
160999618|NCT01193153|581382771|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
160999619|NCT01193153|581382772|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
160999620|NCT01193153|581382771|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
160999621|NCT01193153|581382772|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
160999622|NCT01193153|581382771|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
160999623|NCT01193153|581382772|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
160999624|NCT01193153|581382771|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
160999625|NCT01193153|581382772|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
160999626|NCT01193153|581382771|FG000|Open-label Stabilization Period|Other|8|||
160999627|NCT01193153|581382772|FG001|Open-label Stabilization Period|Other|0|||
160999628|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Other|2|||
160999629|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Other|3|||
160999630|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
160999631|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
160999632|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Death|2|||
160999633|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Death|0|||
160999634|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
160999635|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
160999636|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
160999637|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
160999638|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
160999639|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
160999640|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
160947169|NCT00153101|581193935|FG003|Overall Study|Withdrawal by Subject|3|||
160947170|NCT00153101|581193936|FG004|Overall Study|Withdrawal by Subject|5|||
160947171|NCT03169153|581193937|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160947172|NCT03169153|581193938|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
160947173|NCT03169153|581193937|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
160947174|NCT03169153|581193938|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
160947175|NCT03169153|581193937|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
160947176|NCT03169153|581193938|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
160947177|NCT03169153|581193937|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
160947178|NCT03169153|581193938|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
160947179|NCT00439777|581193939|FG000|Treatment Period|Death|29|||
160999641|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
160999642|NCT01193153|581382771|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
160999643|NCT01193153|581382772|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
160999644|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Death|1|||
160999645|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Death|1|||
161266476|NCT00667810|582359023|FG001|Overall Study|Other|6|||
161266477|NCT00667810|582359024|FG002|Overall Study|Other|5|||
161266478|NCT00667810|582359025|FG003|Overall Study|Other|0|||
161266479|NCT01570686|582359028|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161266480|NCT01570686|582359029|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161266481|NCT01570686|582359028|FG000|Overall Study|Administrative problems|0|||
161266482|NCT01570686|582359029|FG001|Overall Study|Administrative problems|1|||
161266483|NCT01570686|582359028|FG000|Overall Study|Adverse Event|8|||
161266484|NCT01570686|582359029|FG001|Overall Study|Adverse Event|6|||
161266485|NCT01570686|582359028|FG000|Overall Study|Lost to Follow-up|4|||
161266486|NCT01570686|582359029|FG001|Overall Study|Lost to Follow-up|3|||
161266487|NCT01570686|582359028|FG000|Overall Study|Protocol Deviation|3|||
161266488|NCT01570686|582359029|FG001|Overall Study|Protocol Deviation|0|||
161266489|NCT01570686|582359028|FG000|Overall Study|Withdrawal by Subject|4|||
161266490|NCT01570686|582359029|FG001|Overall Study|Withdrawal by Subject|4|||
161266491|NCT01570686|582359028|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161266492|NCT01570686|582359029|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161266493|NCT00754650|582359030|FG000|Overall Study|Disease Progression|2|||
161266494|NCT00158600|582359042|FG000|Overall Study|unable to commit time to study|0|||
161266495|NCT00158600|582359043|FG001|Overall Study|unable to commit time to study|1|||
161266496|NCT00158600|582359042|FG000|Overall Study|Adverse Event|2|||
160947180|NCT00439777|581193940|FG001|Treatment Period|Death|21|||
160947181|NCT00439777|581193939|FG000|Treatment Period|Study terminated by sponsor|125|||
160947182|NCT00439777|581193940|FG001|Treatment Period|Study terminated by sponsor|132|||
160947183|NCT00439777|581193939|FG000|Treatment Period|Site closed by investigator|0|||
160999646|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Death|0|||
161144832|NCT01633060|581913979|FG001|Randomization Phase|Technical problem|1|||
161266497|NCT00158600|582359043|FG001|Overall Study|Adverse Event|1|||
161266498|NCT00158600|582359042|FG000|Overall Study|Death|1|||
160947184|NCT00439777|581193940|FG001|Treatment Period|Site closed by investigator|1|||
160947185|NCT00439777|581193939|FG000|Treatment Period|Did not take study treatment|7|||
160947186|NCT00439777|581193940|FG001|Treatment Period|Did not take study treatment|8|||
160947187|NCT00439777|581193939|FG000|Treatment Period|Adverse Event|111|||
160947188|NCT00439777|581193940|FG001|Treatment Period|Adverse Event|92|||
160947189|NCT00439777|581193939|FG000|Treatment Period|Protocol Violation|23|||
160947190|NCT00439777|581193940|FG001|Treatment Period|Protocol Violation|30|||
160947191|NCT00439777|581193939|FG000|Treatment Period|Withdrawal by Subject|66|||
160947192|NCT00439777|581193940|FG001|Treatment Period|Withdrawal by Subject|118|||
160947193|NCT00439777|581193939|FG000|Treatment Period|Lack of Efficacy|1|||
160947194|NCT00439777|581193940|FG001|Treatment Period|Lack of Efficacy|4|||
160947195|NCT00439777|581193939|FG000|Treatment Period|Lost to Follow-up|8|||
160947196|NCT00439777|581193940|FG001|Treatment Period|Lost to Follow-up|10|||
160947197|NCT00439777|581193939|FG000|Treatment Period|Protocol driven decision point|1|||
160947198|NCT00439777|581193940|FG001|Treatment Period|Protocol driven decision point|3|||
160947199|NCT00439777|581193939|FG000|Treatment Period|Physician Decision|7|||
160947200|NCT00439777|581193940|FG001|Treatment Period|Physician Decision|18|||
160947201|NCT00439777|581193939|FG000|Treatment Period|Clinical endpoint reached|26|||
160947202|NCT00439777|581193940|FG001|Treatment Period|Clinical endpoint reached|13|||
160947203|NCT00439777|581193939|FG000|Treatment Period|Technical problems|3|||
160947204|NCT00439777|581193940|FG001|Treatment Period|Technical problems|1|||
160947205|NCT00439777|581193939|FG000|Treatment Period|Participant convenience|12|||
160947206|NCT00439777|581193940|FG001|Treatment Period|Participant convenience|8|||
160947207|NCT00439777|581193939|FG000|Observational Period|Protocol Violation|0|||
160947208|NCT00439777|581193940|FG001|Observational Period|Protocol Violation|2|||
160947209|NCT00439777|581193939|FG000|Observational Period|Withdrawal by Subject|9|||
160947210|NCT00439777|581193940|FG001|Observational Period|Withdrawal by Subject|5|||
160947211|NCT00439777|581193939|FG000|Observational Period|Lost to Follow-up|1|||
160947212|NCT00439777|581193940|FG001|Observational Period|Lost to Follow-up|11|||
160947213|NCT00439777|581193939|FG000|Observational Period|Death|27|||
160947214|NCT00439777|581193940|FG001|Observational Period|Death|20|||
160947215|NCT00439777|581193939|FG000|Observational Period|Study terminated by sponsor|3|||
160947216|NCT00439777|581193940|FG001|Observational Period|Study terminated by sponsor|1|||
160947217|NCT00439777|581193939|FG000|Observational Period|Protocol driven decision point|0|||
160947218|NCT00439777|581193940|FG001|Observational Period|Protocol driven decision point|1|||
160947219|NCT00439777|581193939|FG000|Observational Period|Lack of Efficacy|1|||
160947220|NCT00439777|581193940|FG001|Observational Period|Lack of Efficacy|0|||
160947221|NCT00439777|581193939|FG000|Observational Period|Technical problems|0|||
160947222|NCT00439777|581193940|FG001|Observational Period|Technical problems|1|||
160947223|NCT03791398|581193943|FG000|Overall Study|Progression of Disease Under Study|2|||
160947224|NCT03791398|581193944|FG001|Overall Study|Progression of Disease Under Study|0|||
160947225|NCT03791398|581193945|FG002|Overall Study|Progression of Disease Under Study|0|||
160947226|NCT00766376|581193946|FG000|Overall Study|Withdrawal by Subject|27|||
160947227|NCT01072201|581193947|FG000|Overall Study|Lost to Follow-up|0|||
160947228|NCT01072201|581193948|FG001|Overall Study|Lost to Follow-up|1|||
160947229|NCT04382612|581193949|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
160947230|NCT01328002|581193951|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
160947231|NCT01328002|581193952|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
160947232|NCT01328002|581193951|FG000|Open-Label Period|Adverse Event|8|||
160947233|NCT01328002|581193952|FG001|Open-Label Period|Adverse Event|0|||
160947234|NCT01328002|581193951|FG000|Open-Label Period|Lack of Efficacy|3|||
160947235|NCT01328002|581193952|FG001|Open-Label Period|Lack of Efficacy|0|||
160947236|NCT01328002|581193951|FG000|Open-Label Period|Protocol Violation|2|||
160947237|NCT01328002|581193952|FG001|Open-Label Period|Protocol Violation|0|||
160947238|NCT01328002|581193951|FG000|Open-Label Period|Withdrawal by Subject|9|||
160947239|NCT01328002|581193952|FG001|Open-Label Period|Withdrawal by Subject|0|||
160947240|NCT01328002|581193951|FG000|Open-Label Period|Lost to Follow-up|6|||
160947241|NCT01328002|581193952|FG001|Open-Label Period|Lost to Follow-up|0|||
160947242|NCT01328002|581193951|FG000|Open-Label Period|Other Reason|2|||
160947243|NCT01328002|581193952|FG001|Open-Label Period|Other Reason|0|||
160947244|NCT01328002|581193951|FG000|Double-Blind Period|Adverse Event|1|||
160947245|NCT01328002|581193952|FG001|Double-Blind Period|Adverse Event|0|||
160947246|NCT01328002|581193951|FG000|Double-Blind Period|Lack of Efficacy|1|||
160947247|NCT01328002|581193952|FG001|Double-Blind Period|Lack of Efficacy|0|||
160947248|NCT01578551|581193953|FG000|Overall Study|Adverse Event|1|||
160947249|NCT01578551|581193954|FG001|Overall Study|Adverse Event|0|||
160947250|NCT00061048|581193956|FG000|Overall Study|Adverse Event|2|||
160947251|NCT00061048|581193956|FG000|Overall Study|disease progression|20|||
160947252|NCT02752048|581193957|FG000|Overall Study|Withdrawal by Subject|0|||
160947253|NCT02752048|581193958|FG001|Overall Study|Withdrawal by Subject|0|||
160947254|NCT02752048|581193959|FG002|Overall Study|Withdrawal by Subject|3|||
161144833|NCT01633060|581913978|FG000|Treatment Phase|Adverse Event|24|||
160947255|NCT03779841|581193963|FG000|Randomized Population|Did Not Receive Treatment|3|||
160947256|NCT03779841|581193964|FG001|Randomized Population|Did Not Receive Treatment|1|||
160999647|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Death|0|||
161266499|NCT00158600|582359043|FG001|Overall Study|Death|0|||
161266500|NCT00158600|582359042|FG000|Overall Study|Withdrawal by Subject|2|||
160947257|NCT03779841|581193965|FG002|Randomized Population|Did Not Receive Treatment|0|||
160947258|NCT03779841|581193963|FG000|Treated (Safety) Population|Adverse Event|1|||
160947259|NCT03779841|581193964|FG001|Treated (Safety) Population|Adverse Event|1|||
160947260|NCT03779841|581193965|FG002|Treated (Safety) Population|Adverse Event|0|||
160947261|NCT03779841|581193963|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
160947262|NCT03779841|581193964|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
160947263|NCT03779841|581193965|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
160947264|NCT03779841|581193963|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
160947265|NCT03779841|581193964|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
160947266|NCT03779841|581193965|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
160947267|NCT03779841|581193963|FG000|Treated (Safety) Population|Death|1|||
160947268|NCT03779841|581193964|FG001|Treated (Safety) Population|Death|0|||
160947269|NCT03779841|581193965|FG002|Treated (Safety) Population|Death|2|||
160947270|NCT02788175|581193966|FG000|Overall Study|Protocol Violation|3|||
160947271|NCT02788175|581193966|FG000|Overall Study|Withdrawal by Subject|4|||
160947272|NCT02788175|581193966|FG000|Overall Study|Ineligible prior to study agent|6|||
160947273|NCT00818441|581193967|FG000|Overall Study|Death|69|||
160947274|NCT00818441|581193968|FG001|Overall Study|Death|26|||
160947275|NCT00818441|581193967|FG000|Overall Study|Other|5|||
160947276|NCT00818441|581193968|FG001|Overall Study|Other|0|||
160947277|NCT00818441|581193967|FG000|Overall Study|Lost to Follow-up|2|||
160947278|NCT00818441|581193968|FG001|Overall Study|Lost to Follow-up|1|||
160947279|NCT00818441|581193967|FG000|Overall Study|Withdrawal by Subject|2|||
160947280|NCT00818441|581193968|FG001|Overall Study|Withdrawal by Subject|0|||
160947281|NCT00818441|581193967|FG000|Overall Study|Adverse Event|0|||
160947282|NCT00818441|581193968|FG001|Overall Study|Adverse Event|1|||
160947283|NCT00818441|581193967|FG000|Overall Study|Study terminated by sponsor|11|||
160947284|NCT00818441|581193968|FG001|Overall Study|Study terminated by sponsor|2|||
160947285|NCT00898677|581193969|FG000|Overall Study|Adverse Event|0|||
160947286|NCT00898677|581193970|FG001|Overall Study|Adverse Event|0|||
160947287|NCT00898677|581193971|FG002|Overall Study|Adverse Event|1|||
160947288|NCT00898677|581193972|FG003|Overall Study|Adverse Event|0|||
160947289|NCT00898677|581193969|FG000|Overall Study|Lost to Follow-up|0|||
160947290|NCT00898677|581193970|FG001|Overall Study|Lost to Follow-up|0|||
160947291|NCT00898677|581193971|FG002|Overall Study|Lost to Follow-up|2|||
160947292|NCT00898677|581193972|FG003|Overall Study|Lost to Follow-up|0|||
160947293|NCT00898677|581193969|FG000|Overall Study|Protocol Violation|1|||
160947294|NCT00898677|581193970|FG001|Overall Study|Protocol Violation|1|||
160947295|NCT00898677|581193971|FG002|Overall Study|Protocol Violation|2|||
160947296|NCT00898677|581193972|FG003|Overall Study|Protocol Violation|0|||
160947297|NCT00898677|581193969|FG000|Overall Study|Withdrawal by Subject|0|||
160947298|NCT00898677|581193970|FG001|Overall Study|Withdrawal by Subject|0|||
160947299|NCT00898677|581193971|FG002|Overall Study|Withdrawal by Subject|0|||
160947300|NCT00898677|581193972|FG003|Overall Study|Withdrawal by Subject|1|||
160947301|NCT00898677|581193969|FG000|Overall Study|Not Treated: Adverse Event|0|||
160947302|NCT00898677|581193970|FG001|Overall Study|Not Treated: Adverse Event|2|||
160947303|NCT00898677|581193971|FG002|Overall Study|Not Treated: Adverse Event|1|||
160947304|NCT00898677|581193972|FG003|Overall Study|Not Treated: Adverse Event|0|||
160947305|NCT00898677|581193969|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
160947306|NCT00898677|581193970|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
160999648|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Death|0|||
160999649|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
160999650|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
160999651|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
160999652|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
160999653|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
161266501|NCT00158600|582359043|FG001|Overall Study|Withdrawal by Subject|2|||
161266502|NCT02570113|582359044|FG000|Overall Study|Withdrawal by Subject|3|||
161266503|NCT02038907|582359045|FG000|Overall Study|Protocol Violation|0|||
161266504|NCT02038907|582359046|FG001|Overall Study|Protocol Violation|0|||
161266505|NCT02038907|582359047|FG002|Overall Study|Protocol Violation|0|||
161266506|NCT02038907|582359048|FG003|Overall Study|Protocol Violation|0|||
161266507|NCT02038907|582359049|FG004|Overall Study|Protocol Violation|0|||
160947307|NCT00898677|581193971|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
160947308|NCT00898677|581193972|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
160947309|NCT00898677|581193969|FG000|Overall Study|Not Treated: Pregnancy|0|||
160947310|NCT00898677|581193970|FG001|Overall Study|Not Treated: Pregnancy|0|||
160947311|NCT00898677|581193971|FG002|Overall Study|Not Treated: Pregnancy|1|||
160947312|NCT00898677|581193972|FG003|Overall Study|Not Treated: Pregnancy|0|||
161266508|NCT02038907|582359050|FG005|Overall Study|Protocol Violation|0|||
161266509|NCT02038907|582359051|FG006|Overall Study|Protocol Violation|0|||
161266510|NCT02038907|582359052|FG007|Overall Study|Protocol Violation|0|||
160947313|NCT00898677|581193969|FG000|Overall Study|Not Treated: Protocol Violation|2|||
160947314|NCT00898677|581193970|FG001|Overall Study|Not Treated: Protocol Violation|0|||
160947315|NCT00898677|581193971|FG002|Overall Study|Not Treated: Protocol Violation|2|||
160947316|NCT00898677|581193972|FG003|Overall Study|Not Treated: Protocol Violation|0|||
160947317|NCT00898677|581193969|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
160947318|NCT00898677|581193970|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
160947319|NCT00898677|581193971|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
160947320|NCT00898677|581193972|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
160947321|NCT00898677|581193969|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
160947322|NCT00898677|581193970|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
160947323|NCT00898677|581193971|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
160947324|NCT00898677|581193972|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
160947325|NCT00898677|581193969|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
160947326|NCT00898677|581193970|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
160947327|NCT00898677|581193971|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
160947328|NCT00898677|581193972|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
160947329|NCT00898677|581193969|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
160947330|NCT00898677|581193970|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
160947331|NCT00898677|581193971|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
160947332|NCT00898677|581193972|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
160947333|NCT00898677|581193969|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
160947334|NCT00898677|581193970|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
160947335|NCT00898677|581193971|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
160947336|NCT00898677|581193972|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
160947337|NCT00898677|581193969|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
160947338|NCT00898677|581193970|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
160947339|NCT00898677|581193971|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
160947340|NCT00898677|581193972|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
160947341|NCT00898677|581193969|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
160947342|NCT00898677|581193970|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
160947343|NCT00898677|581193971|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
160947344|NCT00898677|581193972|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
160947345|NCT00852397|581193973|FG000|Overall Study|Adverse Event|4|||
160947346|NCT00852397|581193974|FG001|Overall Study|Adverse Event|6|||
160947347|NCT00852397|581193975|FG002|Overall Study|Adverse Event|4|||
160947348|NCT00852397|581193973|FG000|Overall Study|Death|0|||
160947349|NCT00852397|581193974|FG001|Overall Study|Death|0|||
160947350|NCT00852397|581193975|FG002|Overall Study|Death|1|||
160947351|NCT00852397|581193973|FG000|Overall Study|Withdrawal by Subject|4|||
160947352|NCT00852397|581193974|FG001|Overall Study|Withdrawal by Subject|1|||
160947353|NCT00852397|581193975|FG002|Overall Study|Withdrawal by Subject|2|||
160947354|NCT00852397|581193973|FG000|Overall Study|Study terminated by sponsor|2|||
160947355|NCT00852397|581193974|FG001|Overall Study|Study terminated by sponsor|1|||
160947356|NCT00852397|581193975|FG002|Overall Study|Study terminated by sponsor|6|||
160947357|NCT00852397|581193973|FG000|Overall Study|Difficulty in study site visit|1|||
160947358|NCT00852397|581193974|FG001|Overall Study|Difficulty in study site visit|0|||
160947359|NCT00852397|581193975|FG002|Overall Study|Difficulty in study site visit|0|||
161144834|NCT01633060|581913979|FG001|Treatment Phase|Adverse Event|3|||
161144835|NCT01633060|581913978|FG000|Treatment Phase|Lost to Follow-up|1|||
160947360|NCT00852397|581193973|FG000|Overall Study|Protocol Violation|0|||
160947361|NCT00852397|581193974|FG001|Overall Study|Protocol Violation|0|||
160947362|NCT00852397|581193975|FG002|Overall Study|Protocol Violation|1|||
160947363|NCT00774995|581193979|FG000|Overall Study|Protocol Violation|0|||
160947364|NCT00774995|581193980|FG001|Overall Study|Protocol Violation|0|||
160947365|NCT00774995|581193981|FG002|Overall Study|Protocol Violation|1|||
160947366|NCT00774995|581193982|FG003|Overall Study|Protocol Violation|0|||
160947367|NCT00074282|581195898|FG000|Step 1|Adverse Event|32|||
160947368|NCT00074282|581195899|FG001|Step 1|Adverse Event|0|||
160947369|NCT00074282|581195900|FG002|Step 1|Adverse Event|0|||
160947370|NCT00074282|581195898|FG000|Step 1|Death|6|||
160947371|NCT00074282|581195899|FG001|Step 1|Death|0|||
160947372|NCT00074282|581195900|FG002|Step 1|Death|0|||
160947373|NCT00074282|581195898|FG000|Step 1|Withdrawal by Subject|7|||
160947374|NCT00074282|581195899|FG001|Step 1|Withdrawal by Subject|0|||
160947375|NCT00074282|581195900|FG002|Step 1|Withdrawal by Subject|0|||
160947376|NCT00074282|581195898|FG000|Step 1|Disease progression|2|||
160947377|NCT00074282|581195899|FG001|Step 1|Disease progression|0|||
160947378|NCT00074282|581195900|FG002|Step 1|Disease progression|0|||
160947379|NCT00074282|581195898|FG000|Step 1|Alternative therapy|2|||
160947380|NCT00074282|581195899|FG001|Step 1|Alternative therapy|0|||
160947381|NCT00074282|581195900|FG002|Step 1|Alternative therapy|0|||
160947382|NCT00074282|581195898|FG000|Step 1|Other complicating disease|2|||
160947383|NCT00074282|581195899|FG001|Step 1|Other complicating disease|0|||
160947384|NCT00074282|581195900|FG002|Step 1|Other complicating disease|0|||
160947385|NCT00074282|581195898|FG000|Step 1|Physician Decision|1|||
160947386|NCT00074282|581195899|FG001|Step 1|Physician Decision|0|||
160947387|NCT00074282|581195900|FG002|Step 1|Physician Decision|0|||
160947388|NCT00074282|581195898|FG000|Step 1|Ineligible|4|||
161266511|NCT02038907|582359053|FG008|Overall Study|Protocol Violation|0|||
160947389|NCT00074282|581195899|FG001|Step 1|Ineligible|0|||
160947390|NCT00074282|581195900|FG002|Step 1|Ineligible|0|||
160947391|NCT00074282|581195898|FG000|Step 1|Never started treatment|2|||
160947392|NCT00074282|581195899|FG001|Step 1|Never started treatment|0|||
160947393|NCT00074282|581195900|FG002|Step 1|Never started treatment|0|||
160947394|NCT00074282|581195898|FG000|Step 2|Adverse Event|0|||
160947395|NCT00074282|581195899|FG001|Step 2|Adverse Event|2|||
160947396|NCT00074282|581195900|FG002|Step 2|Adverse Event|12|||
160947397|NCT00074282|581195898|FG000|Step 2|Disease progression|0|||
160947398|NCT00074282|581195899|FG001|Step 2|Disease progression|0|||
160947399|NCT00074282|581195900|FG002|Step 2|Disease progression|5|||
160947400|NCT00074282|581195898|FG000|Step 2|Death|0|||
160947401|NCT00074282|581195899|FG001|Step 2|Death|0|||
160947402|NCT00074282|581195900|FG002|Step 2|Death|3|||
160947403|NCT00074282|581195898|FG000|Step 2|Withdrawal by Subject|0|||
160947404|NCT00074282|581195899|FG001|Step 2|Withdrawal by Subject|0|||
161266512|NCT02038907|582359054|FG009|Overall Study|Protocol Violation|0|||
161266513|NCT02038907|582359055|FG010|Overall Study|Protocol Violation|1|||
161266514|NCT02038907|582359056|FG011|Overall Study|Protocol Violation|0|||
161266515|NCT02038907|582359057|FG012|Overall Study|Protocol Violation|0|||
161266516|NCT02038907|582359058|FG013|Overall Study|Protocol Violation|0|||
161266517|NCT02038907|582359045|FG000|Overall Study|Withdrawal by Subject|0|||
161266518|NCT02038907|582359046|FG001|Overall Study|Withdrawal by Subject|0|||
161266519|NCT02038907|582359047|FG002|Overall Study|Withdrawal by Subject|0|||
161266520|NCT02038907|582359048|FG003|Overall Study|Withdrawal by Subject|0|||
161266521|NCT02038907|582359049|FG004|Overall Study|Withdrawal by Subject|0|||
161266522|NCT02038907|582359050|FG005|Overall Study|Withdrawal by Subject|0|||
161266523|NCT02038907|582359051|FG006|Overall Study|Withdrawal by Subject|0|||
161266524|NCT02038907|582359052|FG007|Overall Study|Withdrawal by Subject|0|||
161266525|NCT02038907|582359053|FG008|Overall Study|Withdrawal by Subject|0|||
161266526|NCT02038907|582359054|FG009|Overall Study|Withdrawal by Subject|0|||
161266527|NCT02038907|582359055|FG010|Overall Study|Withdrawal by Subject|1|||
161266528|NCT02038907|582359056|FG011|Overall Study|Withdrawal by Subject|0|||
161266529|NCT02038907|582359057|FG012|Overall Study|Withdrawal by Subject|0|||
161266530|NCT02038907|582359058|FG013|Overall Study|Withdrawal by Subject|0|||
161266531|NCT02746471|582359059|FG000|Overall Study|Death|43|||
161266532|NCT02746471|582359059|FG000|Overall Study|Exited before 36 months|1119|||
161266533|NCT02564211|582359060|FG000|Overall Study|Adverse Event|4|||
161266534|NCT02618408|582359062|FG000|Overall Study|Withdrawal by Subject|1|||
161266535|NCT02618408|582359063|FG001|Overall Study|Withdrawal by Subject|0|||
161266536|NCT02618408|582359064|FG002|Overall Study|Withdrawal by Subject|4|||
161266537|NCT02618408|582359062|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
161266538|NCT02618408|582359063|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
161266539|NCT02618408|582359064|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
161266540|NCT02618408|582359062|FG000|Overall Study|Lost to Follow-up|4|||
161266541|NCT02618408|582359063|FG001|Overall Study|Lost to Follow-up|2|||
161266542|NCT02618408|582359064|FG002|Overall Study|Lost to Follow-up|6|||
161266543|NCT02618408|582359062|FG000|Overall Study|Adverse Event|4|||
161266544|NCT02618408|582359063|FG001|Overall Study|Adverse Event|0|||
161266545|NCT02618408|582359064|FG002|Overall Study|Adverse Event|10|||
161266546|NCT02618408|582359062|FG000|Overall Study|Physician Decision|1|||
161266547|NCT02618408|582359063|FG001|Overall Study|Physician Decision|1|||
161266548|NCT02618408|582359064|FG002|Overall Study|Physician Decision|2|||
161266549|NCT02618408|582359062|FG000|Overall Study|Protocol Violation|1|||
161266550|NCT02618408|582359063|FG001|Overall Study|Protocol Violation|1|||
161266551|NCT02618408|582359064|FG002|Overall Study|Protocol Violation|2|||
161266552|NCT02618408|582359062|FG000|Overall Study|Other, Multiple Categories|0|||
161266553|NCT02618408|582359063|FG001|Overall Study|Other, Multiple Categories|0|||
161266554|NCT02618408|582359064|FG002|Overall Study|Other, Multiple Categories|4|||
161266555|NCT03914950|582359069|FG000|Overall Study|Physician Decision|54|||
161266556|NCT01383135|582359075|FG000|Overall Study|Not Scanned / Imaged|1|||
161266557|NCT01383135|582359076|FG001|Overall Study|Not Scanned / Imaged|0|||
161266558|NCT01383135|582359077|FG002|Overall Study|Not Scanned / Imaged|1|||
161266559|NCT01383135|582359078|FG003|Overall Study|Not Scanned / Imaged|0|||
161266560|NCT03167723|582359081|FG000|Overall Study|Protocol Violation|4|||
161266561|NCT03167723|582359082|FG001|Overall Study|Protocol Violation|6|||
161266562|NCT03397771|582359083|FG000|Overall Study|2 erroneously randomized, never treated|3|||
161266563|NCT03397771|582359084|FG001|Overall Study|2 erroneously randomized, never treated|1|||
161266564|NCT03397771|582359083|FG000|Overall Study|Withdrawal by Subject|1|||
161266565|NCT03397771|582359084|FG001|Overall Study|Withdrawal by Subject|3|||
161266566|NCT03397771|582359083|FG000|Overall Study|Protocol Violation|2|||
161266567|NCT03397771|582359084|FG001|Overall Study|Protocol Violation|2|||
160947405|NCT00074282|581195900|FG002|Step 2|Withdrawal by Subject|2|||
160947406|NCT00074282|581195898|FG000|Step 2|Physician Decision|0|||
160947407|NCT00074282|581195899|FG001|Step 2|Physician Decision|0|||
160947408|NCT00074282|581195900|FG002|Step 2|Physician Decision|1|||
160947409|NCT00074282|581195898|FG000|Step 2|Ineligible|0|||
160947410|NCT00074282|581195899|FG001|Step 2|Ineligible|0|||
161266568|NCT03397771|582359083|FG000|Overall Study|Adverse Event|2|||
161266569|NCT03397771|582359084|FG001|Overall Study|Adverse Event|1|||
161266570|NCT02669758|582359087|FG000|Overall Study|Withdrawal by Subject|43|||
161266571|NCT02669758|582359087|FG000|Overall Study|Lost to Follow-up|19|||
161266572|NCT02669758|582359087|FG000|Overall Study|Adverse Event|16|||
161266573|NCT02669758|582359087|FG000|Overall Study|Non-Compliance with Study Drug|8|||
161266574|NCT02669758|582359087|FG000|Overall Study|Lack of Efficacy|5|||
161266575|NCT02669758|582359087|FG000|Overall Study|Pregnancy|1|||
161266576|NCT02669758|582359087|FG000|Overall Study|Study noncompliance|1|||
161266577|NCT02669758|582359087|FG000|Overall Study|Protocol Violation|1|||
161266578|NCT02455050|582359088|FG000|Treatment Period 1|Lost to Follow-up|1|||
161266579|NCT02455050|582359089|FG001|Treatment Period 1|Lost to Follow-up|1|||
161266580|NCT02455050|582359090|FG002|Treatment Period 1|Lost to Follow-up|1|||
161266581|NCT02455050|582359091|FG003|Treatment Period 1|Lost to Follow-up|2|||
161266582|NCT02455050|582359088|FG000|Treatment Period 2|Lost to Follow-up|1|||
161266583|NCT02455050|582359089|FG001|Treatment Period 2|Lost to Follow-up|0|||
161266584|NCT02455050|582359090|FG002|Treatment Period 2|Lost to Follow-up|2|||
161266585|NCT02455050|582359091|FG003|Treatment Period 2|Lost to Follow-up|1|||
161266586|NCT03393806|582359094|FG000|Overall Study|Physician Decision|1|||
161266587|NCT03393806|582359095|FG001|Overall Study|Physician Decision|0|||
161266588|NCT01259115|582359096|FG000|Period 1|Adverse Event|1|||
161266589|NCT01259115|582359097|FG001|Period 1|Adverse Event|0|||
161266590|NCT01259115|582359096|FG000|Period 1|Protocol Violation|2|||
161266591|NCT01259115|582359097|FG001|Period 1|Protocol Violation|0|||
161266592|NCT01259115|582359096|FG000|Period 1|Lost to Follow-up|0|||
161266593|NCT01259115|582359097|FG001|Period 1|Lost to Follow-up|1|||
161266594|NCT01259115|582359096|FG000|Period 2|Adverse Event|1|||
161266595|NCT01259115|582359097|FG001|Period 2|Adverse Event|0|||
161266596|NCT03493386|582359098|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161266597|NCT03493386|582359099|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161266598|NCT03493386|582359100|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161266599|NCT03493386|582359101|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161266600|NCT00988442|582359103|FG000|Overall Study|Death|1|||
161266601|NCT00988442|582359104|FG001|Overall Study|Death|2|||
161266602|NCT00988442|582359103|FG000|Overall Study|Lost to Follow-up|0|||
161266603|NCT00988442|582359104|FG001|Overall Study|Lost to Follow-up|1|||
161266604|NCT00988442|582359103|FG000|Overall Study|Early Study Closure|29|||
161266605|NCT00988442|582359104|FG001|Overall Study|Early Study Closure|25|||
161266606|NCT02731326|582359107|FG000|Overall Study|Withdrawal by Subject|4|||
161266607|NCT02731326|582359108|FG001|Overall Study|Withdrawal by Subject|1|||
161266608|NCT02731326|582359107|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
161266609|NCT02731326|582359108|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
161266610|NCT02731326|582359107|FG000|Overall Study|Discharged without AliveCor|10|||
161266611|NCT02731326|582359108|FG001|Overall Study|Discharged without AliveCor|0|||
161266612|NCT02731326|582359107|FG000|Overall Study|Duplicate Participant|1|||
161266613|NCT02731326|582359108|FG001|Overall Study|Duplicate Participant|1|||
161266614|NCT04480021|582359109|FG000|Overall Study|Lost to Follow-up|3|||
161266615|NCT04480021|582359110|FG001|Overall Study|Lost to Follow-up|4|||
161266616|NCT04453202|582359115|FG000|Overall Study|Adverse Event|0|||
161266617|NCT04453202|582359116|FG001|Overall Study|Adverse Event|0|||
161266618|NCT04453202|582359117|FG002|Overall Study|Adverse Event|0|||
161266619|NCT04453202|582359118|FG003|Overall Study|Adverse Event|0|||
161266620|NCT04453202|582359119|FG004|Overall Study|Adverse Event|0|||
161266621|NCT04453202|582359120|FG005|Overall Study|Adverse Event|0|||
161266622|NCT04453202|582359121|FG006|Overall Study|Adverse Event|1|||
161266623|NCT04453202|582359122|FG007|Overall Study|Adverse Event|0|||
160947411|NCT00074282|581195900|FG002|Step 2|Ineligible|1|||
160947412|NCT00464542|581195901|FG000|Pre-treatment|Withdrawal by Subject|2|||
160947413|NCT02055352|581195903|FG000|Overall Study|Adverse Event|0|||
160947414|NCT02055352|581195904|FG001|Overall Study|Adverse Event|1|||
160947415|NCT02055352|581195903|FG000|Overall Study|Non-eligible|0|||
160947416|NCT02055352|581195904|FG001|Overall Study|Non-eligible|1|||
160947417|NCT02055352|581195903|FG000|Overall Study|Poor compliance|1|||
160947418|NCT02055352|581195904|FG001|Overall Study|Poor compliance|1|||
160947419|NCT02055352|581195903|FG000|Overall Study|Death|1|||
160947420|NCT02055352|581195904|FG001|Overall Study|Death|2|||
160947421|NCT02055352|581195903|FG000|Overall Study|Patient decision|1|||
160947422|NCT02055352|581195904|FG001|Overall Study|Patient decision|1|||
161266624|NCT04453202|582359123|FG008|Overall Study|Adverse Event|0|||
161266625|NCT04453202|582359124|FG009|Overall Study|Adverse Event|0|||
161266626|NCT04453202|582359125|FG010|Overall Study|Adverse Event|0|||
161266627|NCT04453202|582359115|FG000|Overall Study|Death|0|||
161266628|NCT04453202|582359116|FG001|Overall Study|Death|0|||
161266629|NCT04453202|582359117|FG002|Overall Study|Death|0|||
161266630|NCT04453202|582359118|FG003|Overall Study|Death|0|||
161266631|NCT04453202|582359119|FG004|Overall Study|Death|0|||
160947423|NCT02055352|581195903|FG000|Overall Study|Use of prohibited treatment|0|||
160947424|NCT02055352|581195904|FG001|Overall Study|Use of prohibited treatment|3|||
161266632|NCT04453202|582359120|FG005|Overall Study|Death|0|||
161266633|NCT04453202|582359121|FG006|Overall Study|Death|0|||
161266634|NCT04453202|582359122|FG007|Overall Study|Death|0|||
160947425|NCT02055352|581195903|FG000|Overall Study|AE, study drug would be detrimental|1|||
160947426|NCT02055352|581195904|FG001|Overall Study|AE, study drug would be detrimental|3|||
160947427|NCT02055352|581195903|FG000|Overall Study|Withdrawal of informed consent|1|||
160947428|NCT02055352|581195904|FG001|Overall Study|Withdrawal of informed consent|0|||
160947429|NCT02055352|581195903|FG000|Overall Study|Reason unknown|1|||
160947430|NCT02055352|581195904|FG001|Overall Study|Reason unknown|5|||
160947431|NCT02246998|581195905|FG000|Overall Study|Adverse Event|0|||
160947432|NCT02246998|581195906|FG001|Overall Study|Adverse Event|1|||
160947433|NCT02246998|581195907|FG002|Overall Study|Adverse Event|1|||
160947434|NCT02246998|581195908|FG003|Overall Study|Adverse Event|0|||
160947435|NCT02246998|581195905|FG000|Overall Study|Lost to Follow-up|1|||
160947436|NCT02246998|581195906|FG001|Overall Study|Lost to Follow-up|0|||
160947437|NCT02246998|581195907|FG002|Overall Study|Lost to Follow-up|0|||
161266635|NCT04453202|582359123|FG008|Overall Study|Death|0|||
161266636|NCT04453202|582359124|FG009|Overall Study|Death|1|||
161266637|NCT04453202|582359125|FG010|Overall Study|Death|0|||
161266638|NCT04453202|582359115|FG000|Overall Study|Lost to Follow-up|0|||
161266639|NCT04453202|582359116|FG001|Overall Study|Lost to Follow-up|1|||
160947438|NCT02246998|581195908|FG003|Overall Study|Lost to Follow-up|1|||
160947439|NCT02246998|581195905|FG000|Overall Study|Randomized but Never Dosed|1|||
160947440|NCT02246998|581195906|FG001|Overall Study|Randomized but Never Dosed|2|||
160947441|NCT02246998|581195907|FG002|Overall Study|Randomized but Never Dosed|2|||
160947442|NCT02246998|581195908|FG003|Overall Study|Randomized but Never Dosed|1|||
160947443|NCT01303627|581195910|FG000|Overall Study|the failure while performing URS|0|||
160947444|NCT01303627|581195911|FG001|Overall Study|the failure while performing URS|1|||
160947445|NCT01709227|581195915|FG000|Overall Study|Physician Decision|1|||
160947446|NCT01709227|581195916|FG001|Overall Study|Physician Decision|0|||
160947447|NCT01709227|581195915|FG000|Overall Study|Pleural Peritoneal communication|0|||
160947448|NCT01709227|581195916|FG001|Overall Study|Pleural Peritoneal communication|9|||
160947449|NCT04831736|581195919|FG000|Overall Study|Withdrawal by Subject|0|||
160947450|NCT04831736|581195920|FG001|Overall Study|Withdrawal by Subject|1|||
160947451|NCT00795600|581195921|FG000|Overall Study|Adverse Event|1|||
160947452|NCT00795600|581195922|FG001|Overall Study|Adverse Event|1|||
160947453|NCT00795600|581195921|FG000|Overall Study|Protocol Violation|1|||
160947454|NCT00795600|581195922|FG001|Overall Study|Protocol Violation|2|||
160947455|NCT00795600|581195921|FG000|Overall Study|Withdrawal by Subject|1|||
160947456|NCT00795600|581195922|FG001|Overall Study|Withdrawal by Subject|0|||
160947457|NCT00795600|581195921|FG000|Overall Study|Unclassified|1|||
160947458|NCT00795600|581195922|FG001|Overall Study|Unclassified|1|||
160947459|NCT01659021|581195923|FG000|Main Study|Adverse Event|2|||
160947460|NCT01659021|581195924|FG001|Main Study|Adverse Event|3|||
160947461|NCT01659021|581195923|FG000|Main Study|Lost to Follow-up|1|||
160947462|NCT01659021|581195924|FG001|Main Study|Lost to Follow-up|0|||
160947463|NCT01659021|581195923|FG000|Main Study|Unknown Reasons|2|||
160947464|NCT01659021|581195924|FG001|Main Study|Unknown Reasons|1|||
160947465|NCT01659021|581195923|FG000|Main Study|Physician Decision|34|||
160947466|NCT01659021|581195924|FG001|Main Study|Physician Decision|16|||
160947467|NCT01659021|581195923|FG000|Main Study|Withdrawal by Subject|19|||
160947468|NCT01659021|581195924|FG001|Main Study|Withdrawal by Subject|16|||
160947469|NCT01659021|581195923|FG000|Main Study|Study Terminated by Sponsor|16|||
160947470|NCT01659021|581195924|FG001|Main Study|Study Terminated by Sponsor|1|||
160947471|NCT01659021|581195923|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
160947472|NCT01659021|581195924|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
160947473|NCT01659021|581195923|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
160947474|NCT01659021|581195924|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
160947475|NCT01202773|581195925|FG000|Overall Study|Adverse Event|4|||
160947476|NCT01202773|581195926|FG001|Overall Study|Adverse Event|5|||
160947477|NCT01202773|581195927|FG002|Overall Study|Adverse Event|5|||
160947478|NCT01202773|581195925|FG000|Overall Study|Lack of Efficacy|5|||
160947479|NCT01202773|581195926|FG001|Overall Study|Lack of Efficacy|4|||
161266640|NCT04453202|582359117|FG002|Overall Study|Lost to Follow-up|0|||
161266641|NCT04453202|582359118|FG003|Overall Study|Lost to Follow-up|1|||
161266642|NCT04453202|582359119|FG004|Overall Study|Lost to Follow-up|0|||
161266643|NCT04453202|582359120|FG005|Overall Study|Lost to Follow-up|0|||
160947480|NCT01202773|581195927|FG002|Overall Study|Lack of Efficacy|9|||
160947481|NCT01202773|581195925|FG000|Overall Study|Entry Criteria Not Met|2|||
160947482|NCT01202773|581195926|FG001|Overall Study|Entry Criteria Not Met|0|||
160947483|NCT01202773|581195927|FG002|Overall Study|Entry Criteria Not Met|1|||
160947484|NCT01202773|581195925|FG000|Overall Study|Lost to Follow-up|1|||
160947485|NCT01202773|581195926|FG001|Overall Study|Lost to Follow-up|2|||
160947486|NCT01202773|581195927|FG002|Overall Study|Lost to Follow-up|2|||
160947487|NCT01202773|581195925|FG000|Overall Study|Withdrawal by Subject|13|||
160947488|NCT01202773|581195926|FG001|Overall Study|Withdrawal by Subject|6|||
160947489|NCT01202773|581195927|FG002|Overall Study|Withdrawal by Subject|5|||
160947490|NCT01202773|581195925|FG000|Overall Study|Physician Decision|2|||
161266644|NCT04453202|582359121|FG006|Overall Study|Lost to Follow-up|0|||
161266645|NCT04453202|582359122|FG007|Overall Study|Lost to Follow-up|0|||
161266646|NCT04453202|582359123|FG008|Overall Study|Lost to Follow-up|0|||
161266647|NCT04453202|582359124|FG009|Overall Study|Lost to Follow-up|1|||
161266648|NCT04453202|582359125|FG010|Overall Study|Lost to Follow-up|1|||
161266649|NCT04453202|582359115|FG000|Overall Study|Withdrawal by Subject|1|||
161266650|NCT04453202|582359116|FG001|Overall Study|Withdrawal by Subject|2|||
161266651|NCT04453202|582359117|FG002|Overall Study|Withdrawal by Subject|1|||
161266652|NCT04453202|582359118|FG003|Overall Study|Withdrawal by Subject|2|||
161266653|NCT04453202|582359119|FG004|Overall Study|Withdrawal by Subject|1|||
161266654|NCT04453202|582359120|FG005|Overall Study|Withdrawal by Subject|1|||
161266655|NCT04453202|582359121|FG006|Overall Study|Withdrawal by Subject|0|||
161266656|NCT04453202|582359122|FG007|Overall Study|Withdrawal by Subject|0|||
161266657|NCT04453202|582359123|FG008|Overall Study|Withdrawal by Subject|0|||
161266658|NCT04453202|582359124|FG009|Overall Study|Withdrawal by Subject|1|||
161266659|NCT04453202|582359125|FG010|Overall Study|Withdrawal by Subject|0|||
161266660|NCT04453202|582359115|FG000|Overall Study|Adverse Event|0|||
161266661|NCT04453202|582359116|FG001|Overall Study|Adverse Event|0|||
161266662|NCT04453202|582359117|FG002|Overall Study|Adverse Event|0|||
161266663|NCT04453202|582359118|FG003|Overall Study|Adverse Event|0|||
161266664|NCT04453202|582359119|FG004|Overall Study|Adverse Event|0|||
161266665|NCT04453202|582359120|FG005|Overall Study|Adverse Event|1|||
161266666|NCT04453202|582359121|FG006|Overall Study|Adverse Event|0|||
161266667|NCT04453202|582359122|FG007|Overall Study|Adverse Event|0|||
161266668|NCT04453202|582359123|FG008|Overall Study|Adverse Event|0|||
161266669|NCT04453202|582359124|FG009|Overall Study|Adverse Event|0|||
161266670|NCT04453202|582359125|FG010|Overall Study|Adverse Event|0|||
161266671|NCT01355159|582359130|FG000|Overall Study|Withdrew consent|39|||
161266672|NCT01355159|582359131|FG001|Overall Study|Withdrew consent|47|||
161266673|NCT01355159|582359130|FG000|Overall Study|No primary outcome data|17|||
160947491|NCT01202773|581195926|FG001|Overall Study|Physician Decision|0|||
160947492|NCT01202773|581195927|FG002|Overall Study|Physician Decision|0|||
160947493|NCT01202773|581195925|FG000|Overall Study|Protocol Violation|11|||
160947494|NCT01202773|581195926|FG001|Overall Study|Protocol Violation|6|||
161144836|NCT01633060|581913979|FG001|Treatment Phase|Lost to Follow-up|0|||
161144837|NCT01633060|581913978|FG000|Treatment Phase|Physician Decision|16|||
161144838|NCT01633060|581913979|FG001|Treatment Phase|Physician Decision|7|||
161144839|NCT01633060|581913978|FG000|Treatment Phase|Progressive Disease|210|||
161144840|NCT01633060|581913979|FG001|Treatment Phase|Progressive Disease|120|||
161144841|NCT01633060|581913978|FG000|Treatment Phase|Protocol Deviation|1|||
161144842|NCT01633060|581913979|FG001|Treatment Phase|Protocol Deviation|0|||
161144843|NCT01633060|581913978|FG000|Treatment Phase|Study Terminated by sponsor|7|||
161144844|NCT01633060|581913979|FG001|Treatment Phase|Study Terminated by sponsor|3|||
160947495|NCT01202773|581195927|FG002|Overall Study|Protocol Violation|10|||
160947496|NCT01202773|581195925|FG000|Overall Study|Sponsor Decision|19|||
160947497|NCT01202773|581195926|FG001|Overall Study|Sponsor Decision|20|||
160947498|NCT01202773|581195927|FG002|Overall Study|Sponsor Decision|23|||
160947499|NCT00575588|581195930|FG000|Overall Study|Adverse Event|11|||
160947500|NCT00575588|581195931|FG001|Overall Study|Adverse Event|13|||
160947501|NCT00575588|581195930|FG000|Overall Study|Withdrawal by Subject|27|||
160947502|NCT00575588|581195931|FG001|Overall Study|Withdrawal by Subject|31|||
160947503|NCT00575588|581195930|FG000|Overall Study|Lost to Follow-up|1|||
161144845|NCT01633060|581913978|FG000|Treatment Phase|Subject/guardian decision|25|||
161144846|NCT01633060|581913979|FG001|Treatment Phase|Subject/guardian decision|4|||
161144847|NCT01633060|581913978|FG000|Treatment Phase|Death|4|||
161266674|NCT01355159|582359131|FG001|Overall Study|No primary outcome data|11|||
161266675|NCT01355159|582359130|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
161266676|NCT01355159|582359131|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
161266677|NCT01355159|582359130|FG000|Overall Study|Early intrauterine fetal death|6|||
161266678|NCT01355159|582359131|FG001|Overall Study|Early intrauterine fetal death|6|||
161266679|NCT03276221|582359132|FG000|Overall Study|Lost to Follow-up|6|||
161266680|NCT03276221|582359133|FG001|Overall Study|Lost to Follow-up|2|||
161266681|NCT03276221|582359134|FG002|Overall Study|Lost to Follow-up|0|||
160947504|NCT00575588|581195931|FG001|Overall Study|Lost to Follow-up|3|||
160947505|NCT00575588|581195930|FG000|Overall Study|Death|4|||
160947506|NCT00575588|581195931|FG001|Overall Study|Death|2|||
160947507|NCT00575588|581195930|FG000|Overall Study|Incorrect enrollment|8|||
160947508|NCT00575588|581195931|FG001|Overall Study|Incorrect enrollment|4|||
160947509|NCT00575588|581195930|FG000|Overall Study|Study specific discontinuation criteria|203|||
161266682|NCT03276221|582359132|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
161266683|NCT03276221|582359133|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
161266684|NCT03276221|582359134|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
161266685|NCT00424775|582359135|FG000|Overall Study|Adverse Event|2|||
161266686|NCT00424775|582359136|FG001|Overall Study|Adverse Event|0|||
161266687|NCT00424775|582359135|FG000|Overall Study|Lack of Efficacy|1|||
160947510|NCT00575588|581195931|FG001|Overall Study|Study specific discontinuation criteria|218|||
160947511|NCT00575588|581195930|FG000|Overall Study|Severe non-compliance to protocol|5|||
160947512|NCT00575588|581195931|FG001|Overall Study|Severe non-compliance to protocol|7|||
160947513|NCT00575588|581195930|FG000|Overall Study|Safety reasons|2|||
161266688|NCT00424775|582359136|FG001|Overall Study|Lack of Efficacy|0|||
161144848|NCT01633060|581913979|FG001|Treatment Phase|Death|3|||
161266689|NCT02615171|582359137|FG000|Overall Study|Lost to Follow-up|2|||
160947514|NCT00575588|581195931|FG001|Overall Study|Safety reasons|1|||
160947515|NCT00575588|581195930|FG000|Overall Study|Elevated triglyceride|1|||
160947516|NCT00575588|581195931|FG001|Overall Study|Elevated triglyceride|0|||
160947517|NCT00575588|581195930|FG000|Overall Study|Patient moved|1|||
160947518|NCT00575588|581195931|FG001|Overall Study|Patient moved|3|||
160947519|NCT00575588|581195930|FG000|Overall Study|Impossible to determine HbA1c|0|||
160947520|NCT00575588|581195931|FG001|Overall Study|Impossible to determine HbA1c|1|||
160947521|NCT00614939|581195933|FG000|Overall Study|Withdrawal by Subject|10|||
160947522|NCT00614939|581195934|FG001|Overall Study|Withdrawal by Subject|17|||
160947523|NCT00614939|581195933|FG000|Overall Study|Study specific discontinuation criteris|13|||
160947524|NCT00614939|581195934|FG001|Overall Study|Study specific discontinuation criteris|16|||
160947525|NCT00614939|581195933|FG000|Overall Study|Adverse Event|2|||
160947526|NCT00614939|581195934|FG001|Overall Study|Adverse Event|5|||
160947527|NCT00614939|581195933|FG000|Overall Study|Incorrect enrollment|1|||
160947528|NCT00614939|581195934|FG001|Overall Study|Incorrect enrollment|2|||
160947529|NCT00614939|581195933|FG000|Overall Study|Death|4|||
160947530|NCT00614939|581195934|FG001|Overall Study|Death|3|||
160947531|NCT00614939|581195933|FG000|Overall Study|Poor/non-compliance|4|||
160947532|NCT00614939|581195934|FG001|Overall Study|Poor/non-compliance|0|||
160947533|NCT00614939|581195933|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
160947534|NCT00614939|581195934|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
160947535|NCT00840970|581195935|FG000|Overall Study|Adverse Event|0|||
160947536|NCT00840970|581195936|FG001|Overall Study|Adverse Event|0|||
160947537|NCT00840970|581195937|FG002|Overall Study|Adverse Event|1|||
160947538|NCT03465540|581195938|FG000|Overall Study|Withdrawal by Subject|0|||
160947539|NCT03465540|581195939|FG001|Overall Study|Withdrawal by Subject|0|||
160947540|NCT03465540|581195940|FG002|Overall Study|Withdrawal by Subject|1|||
160947541|NCT03465540|581195941|FG003|Overall Study|Withdrawal by Subject|1|||
160947542|NCT03465540|581195942|FG004|Overall Study|Withdrawal by Subject|1|||
160947543|NCT03465540|581195943|FG005|Overall Study|Withdrawal by Subject|0|||
160947544|NCT03465540|581195938|FG000|Overall Study|Lost to Follow-up|0|||
160947545|NCT03465540|581195939|FG001|Overall Study|Lost to Follow-up|1|||
160947546|NCT03465540|581195940|FG002|Overall Study|Lost to Follow-up|0|||
160947547|NCT03465540|581195941|FG003|Overall Study|Lost to Follow-up|0|||
160947548|NCT03465540|581195942|FG004|Overall Study|Lost to Follow-up|1|||
160947549|NCT03465540|581195943|FG005|Overall Study|Lost to Follow-up|0|||
160947550|NCT03465540|581195938|FG000|Overall Study|Death|1|||
160947551|NCT03465540|581195939|FG001|Overall Study|Death|1|||
160947552|NCT03465540|581195940|FG002|Overall Study|Death|0|||
160947553|NCT03465540|581195941|FG003|Overall Study|Death|2|||
160947554|NCT03465540|581195942|FG004|Overall Study|Death|0|||
160947555|NCT03465540|581195943|FG005|Overall Study|Death|2|||
160947556|NCT03465540|581195938|FG000|Overall Study|Protocol specified criteria|0|||
161266690|NCT02615171|582359138|FG001|Overall Study|Lost to Follow-up|1|||
161266691|NCT00975286|582359143|FG000|Overall Study|Adverse Event|9|||
160947557|NCT03465540|581195939|FG001|Overall Study|Protocol specified criteria|2|||
160947558|NCT03465540|581195940|FG002|Overall Study|Protocol specified criteria|2|||
160947559|NCT03465540|581195941|FG003|Overall Study|Protocol specified criteria|0|||
160947560|NCT03465540|581195942|FG004|Overall Study|Protocol specified criteria|2|||
160947561|NCT03465540|581195943|FG005|Overall Study|Protocol specified criteria|0|||
160947562|NCT00504829|581195944|FG000|Overall Study|Protocol Violation|6|||
160947563|NCT00504829|581195945|FG001|Overall Study|Protocol Violation|4|||
160947564|NCT00504829|581195946|FG002|Overall Study|Protocol Violation|10|||
160947565|NCT01854827|581195947|FG000|Overall Study|Death|1|||
160947566|NCT00736996|581195948|FG000|Overall Study|Lost to Follow-up|1|||
160947567|NCT00736996|581195949|FG001|Overall Study|Lost to Follow-up|9|||
160947568|NCT00736996|581195950|FG002|Overall Study|Lost to Follow-up|2|||
160947569|NCT00462384|581195951|FG000|Overall Study|Adverse Event|2|||
160947570|NCT00462384|581195951|FG000|Overall Study|Death|2|||
160947571|NCT00462384|581195951|FG000|Overall Study|Withdrawal by Subject|1|||
161266692|NCT00975286|582359144|FG001|Overall Study|Adverse Event|19|||
161266693|NCT00975286|582359143|FG000|Overall Study|Protocol Violation|1|||
160947572|NCT00462384|581195951|FG000|Overall Study|Other|4|||
160947573|NCT04000165|581195952|FG000|Overall Study|Physician Decision|1|||
160947574|NCT04000165|581195952|FG000|Overall Study|Withdrawal by Subject|1|||
160947575|NCT01751568|581195957|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
160947576|NCT01751568|581195958|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
160947577|NCT01751568|581195959|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
160947578|NCT02660944|581195968|FG000|Overall Study|Adverse Event|3|||
160947579|NCT02660944|581195969|FG001|Overall Study|Adverse Event|4|||
160947580|NCT02660944|581195968|FG000|Overall Study|Physician Decision|3|||
160947581|NCT02660944|581195969|FG001|Overall Study|Physician Decision|1|||
160947582|NCT02660944|581195968|FG000|Overall Study|Withdrawal by Subject|5|||
160947583|NCT02660944|581195969|FG001|Overall Study|Withdrawal by Subject|3|||
160947584|NCT02660944|581195968|FG000|Overall Study|Lost to Follow-up|4|||
161266694|NCT00975286|582359144|FG001|Overall Study|Protocol Violation|2|||
160947585|NCT02660944|581195969|FG001|Overall Study|Lost to Follow-up|1|||
160947586|NCT02660944|581195968|FG000|Overall Study|Subject schedule|0|||
160947587|NCT02660944|581195969|FG001|Overall Study|Subject schedule|1|||
160947588|NCT02660944|581195968|FG000|Overall Study|Exclusion criteria met|2|||
160947589|NCT02660944|581195969|FG001|Overall Study|Exclusion criteria met|0|||
160947590|NCT02843568|581195970|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
160947591|NCT02843568|581195971|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
160947592|NCT02843568|581195970|FG000|Overall Study|Death|3|||
160947593|NCT02843568|581195971|FG001|Overall Study|Death|3|||
160947594|NCT02843568|581195970|FG000|Overall Study|Withdrawal by Subject|1|||
160947595|NCT02843568|581195971|FG001|Overall Study|Withdrawal by Subject|1|||
160947596|NCT02843568|581195970|FG000|Overall Study|Lost to Follow-up|2|||
160947597|NCT02843568|581195971|FG001|Overall Study|Lost to Follow-up|0|||
160947598|NCT03586999|581195972|FG000|Overall Study|Lack of Efficacy|2|||
160947599|NCT04096560|581195973|FG000|Overall Study|Reason not Specified|1|||
160947600|NCT04096560|581195974|FG001|Overall Study|Reason not Specified|0|||
160947601|NCT04096560|581195975|FG002|Overall Study|Reason not Specified|0|||
160947602|NCT04096560|581195976|FG003|Overall Study|Reason not Specified|0|||
160947603|NCT04096560|581195977|FG004|Overall Study|Reason not Specified|1|||
160947604|NCT04096560|581195978|FG005|Overall Study|Reason not Specified|1|||
160947605|NCT04096560|581195979|FG006|Overall Study|Reason not Specified|1|||
160947606|NCT04096560|581195980|FG007|Overall Study|Reason not Specified|0|||
160947607|NCT04096560|581195973|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947608|NCT04096560|581195974|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947609|NCT04096560|581195975|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947610|NCT04096560|581195976|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947611|NCT04096560|581195977|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947612|NCT04096560|581195978|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
160947613|NCT04096560|581195979|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
160947614|NCT04096560|581195980|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
160947615|NCT04096560|581195973|FG000|Overall Study|Study Terminated by Sponsor|0|||
160947616|NCT04096560|581195974|FG001|Overall Study|Study Terminated by Sponsor|0|||
160947617|NCT04096560|581195975|FG002|Overall Study|Study Terminated by Sponsor|0|||
160947618|NCT04096560|581195976|FG003|Overall Study|Study Terminated by Sponsor|5|||
160947619|NCT04096560|581195977|FG004|Overall Study|Study Terminated by Sponsor|6|||
160947620|NCT04096560|581195978|FG005|Overall Study|Study Terminated by Sponsor|4|||
160947621|NCT04096560|581195979|FG006|Overall Study|Study Terminated by Sponsor|6|||
160947622|NCT04096560|581195980|FG007|Overall Study|Study Terminated by Sponsor|1|||
160947623|NCT04096560|581195973|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947624|NCT04096560|581195974|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947625|NCT04096560|581195975|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947626|NCT04096560|581195976|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947627|NCT04096560|581195977|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947628|NCT04096560|581195978|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947629|NCT04096560|581195979|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
160947630|NCT04096560|581195980|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
160947631|NCT00534352|581195983|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
160947632|NCT00534352|581195983|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
160947633|NCT00534352|581195983|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
160947634|NCT00534352|581195983|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
160947635|NCT00534352|581195983|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
160947636|NCT00534352|581195983|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
160947637|NCT03264989|581195986|FG000|Overall Study|Lost to Follow-up|1|||
160947638|NCT03264989|581195987|FG001|Overall Study|Lost to Follow-up|0|||
160947639|NCT03264989|581195986|FG000|Overall Study|New Therapy for study Indication|1|||
160947640|NCT03264989|581195987|FG001|Overall Study|New Therapy for study Indication|0|||
160947641|NCT03264989|581195986|FG000|Overall Study|Protocol Violation|0|||
160947642|NCT03264989|581195987|FG001|Overall Study|Protocol Violation|1|||
160947643|NCT03264989|581195986|FG000|Overall Study|Patient decision|13|||
160947644|NCT03264989|581195987|FG001|Overall Study|Patient decision|0|||
160947645|NCT03264989|581195986|FG000|Overall Study|Physician Decision|6|||
161266695|NCT00975286|582359143|FG000|Overall Study|Withdrawal by Subject|0|||
161266696|NCT00975286|582359144|FG001|Overall Study|Withdrawal by Subject|2|||
161266697|NCT00975286|582359143|FG000|Overall Study|Familial and Personal Reasons|2|||
160947646|NCT03264989|581195987|FG001|Overall Study|Physician Decision|4|||
160947647|NCT03264989|581195986|FG000|Overall Study|Adverse Event|2|||
160947648|NCT03264989|581195987|FG001|Overall Study|Adverse Event|1|||
160947649|NCT03264989|581195986|FG000|Overall Study|Death|1|||
160947650|NCT03264989|581195987|FG001|Overall Study|Death|1|||
160947651|NCT03264989|581195986|FG000|Overall Study|Pregnancy|2|||
160947652|NCT03264989|581195987|FG001|Overall Study|Pregnancy|0|||
160947653|NCT03264989|581195986|FG000|Overall Study|End of Study|19|||
160947654|NCT03264989|581195987|FG001|Overall Study|End of Study|5|||
160947655|NCT00833924|581195993|FG000|Overall Study|Death|21|||
160947656|NCT00833924|581195993|FG000|Overall Study|Conversion|2|||
160947657|NCT00833924|581195993|FG000|Overall Study|Lost to Follow-up|2|||
160947658|NCT00833924|581195993|FG000|Overall Study|Withdrawal by Subject|13|||
160947659|NCT00833924|581195993|FG000|Overall Study|In study follow-up|71|||
160947660|NCT00797667|581195994|FG000|Overall Study|Lack of Efficacy|0|||
160947661|NCT00797667|581195995|FG001|Overall Study|Lack of Efficacy|1|||
160947662|NCT00797667|581195996|FG002|Overall Study|Lack of Efficacy|0|||
160947663|NCT00797667|581195994|FG000|Overall Study|Lost to Follow-up|8|||
160947664|NCT00797667|581195995|FG001|Overall Study|Lost to Follow-up|12|||
160947665|NCT00797667|581195996|FG002|Overall Study|Lost to Follow-up|2|||
160947666|NCT00797667|581195994|FG000|Overall Study|Physician Decision|3|||
160947667|NCT00797667|581195995|FG001|Overall Study|Physician Decision|1|||
160947668|NCT00797667|581195996|FG002|Overall Study|Physician Decision|0|||
160947669|NCT00797667|581195994|FG000|Overall Study|Pregnancy|2|||
160947670|NCT00797667|581195995|FG001|Overall Study|Pregnancy|0|||
160947671|NCT00797667|581195996|FG002|Overall Study|Pregnancy|0|||
160947672|NCT00797667|581195994|FG000|Overall Study|Protocol Violation|2|||
160947673|NCT00797667|581195995|FG001|Overall Study|Protocol Violation|7|||
160947674|NCT00797667|581195996|FG002|Overall Study|Protocol Violation|0|||
160947675|NCT00797667|581195994|FG000|Overall Study|Study Terminated by Sponsor|217|||
160947676|NCT00797667|581195995|FG001|Overall Study|Study Terminated by Sponsor|216|||
160947677|NCT00797667|581195996|FG002|Overall Study|Study Terminated by Sponsor|115|||
160947678|NCT00797667|581195994|FG000|Overall Study|Withdrawal by Subject|9|||
160947679|NCT00797667|581195995|FG001|Overall Study|Withdrawal by Subject|14|||
160947680|NCT00797667|581195996|FG002|Overall Study|Withdrawal by Subject|2|||
160947681|NCT00797667|581195994|FG000|Overall Study|Adverse Event|19|||
160947682|NCT00797667|581195995|FG001|Overall Study|Adverse Event|8|||
160947683|NCT00797667|581195996|FG002|Overall Study|Adverse Event|8|||
160947684|NCT01986829|581196001|FG000|Overall Study|Death|1|||
160947685|NCT02504866|581196002|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
160947686|NCT02504866|581196003|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
160947687|NCT02504866|581196004|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
160947688|NCT01229436|581196005|FG000|Overall Study|Withdrawal by Subject|2|||
161266698|NCT00975286|582359144|FG001|Overall Study|Familial and Personal Reasons|2|||
161266699|NCT00975286|582359143|FG000|Overall Study|Poor Compliance to Protocol|0|||
161266700|NCT00975286|582359144|FG001|Overall Study|Poor Compliance to Protocol|2|||
161266701|NCT00975286|582359143|FG000|Overall Study|Sponsor Decision|0|||
161266702|NCT00975286|582359144|FG001|Overall Study|Sponsor Decision|2|||
161266703|NCT02989168|582359149|FG000|Overall Study|Withdrawal by Subject|2|||
161266704|NCT02989168|582359150|FG001|Overall Study|Withdrawal by Subject|0|||
161266705|NCT02989168|582359149|FG000|Overall Study|Physician Decision|0|||
161266706|NCT02989168|582359150|FG001|Overall Study|Physician Decision|1|||
161266707|NCT02989168|582359149|FG000|Overall Study|Adverse Event|1|||
161144849|NCT01633060|581913978|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
161144850|NCT01633060|581913979|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161266708|NCT02989168|582359150|FG001|Overall Study|Adverse Event|2|||
161266709|NCT02989168|582359149|FG000|Overall Study|Sponsor stopped study.|1|||
160947689|NCT01229436|581196005|FG000|Overall Study|Lost to Follow-up|3|||
160947690|NCT01775137|581196010|FG000|Overall Study|Death|1|||
161266710|NCT02989168|582359150|FG001|Overall Study|Sponsor stopped study.|0|||
161144851|NCT01633060|581913978|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
161144852|NCT01633060|581913979|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
161144853|NCT01633060|581913978|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
161144854|NCT01633060|581913979|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
161144855|NCT01633060|581913978|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
161144856|NCT01633060|581913979|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
161144857|NCT01633060|581913978|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161144858|NCT01633060|581913979|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161144859|NCT01633060|581913978|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
161144860|NCT01633060|581913979|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
161144861|NCT00883753|581913980|FG000|Overall Study|Adverse Event|37|||
160947691|NCT01775137|581196010|FG000|Overall Study|Protocol deviation|2|||
160947692|NCT01775137|581196010|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160947693|NCT01775137|581196010|FG000|Overall Study|Adverse Event|1|||
160999654|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Physician Decision|0|||
161144862|NCT00883753|581913980|FG000|Overall Study|Death|2|||
161144863|NCT00883753|581913980|FG000|Overall Study|Insufficient therapeutic response|16|||
161266711|NCT03456960|582359151|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161266712|NCT03456960|582359152|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161266713|NCT03456960|582359153|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
160947694|NCT01775137|581196010|FG000|Overall Study|Withdrawal by participants|5|||
160947695|NCT04796610|581196011|FG000|Overall Study|Withdrawal by Subject|1|||
160947696|NCT04796610|581196012|FG001|Overall Study|Withdrawal by Subject|0|||
160947697|NCT04796610|581196013|FG002|Overall Study|Withdrawal by Subject|0|||
160947698|NCT04796610|581196014|FG003|Overall Study|Withdrawal by Subject|0|||
160947699|NCT04796610|581196011|FG000|Overall Study|Lost to Follow-up|2|||
160947700|NCT04796610|581196012|FG001|Overall Study|Lost to Follow-up|0|||
161144864|NCT00883753|581913980|FG000|Overall Study|Lost to Follow-up|4|||
161144865|NCT00883753|581913980|FG000|Overall Study|Violation of selection criteria at entry|7|||
161144866|NCT00883753|581913980|FG000|Overall Study|Protocol Violation|2|||
161144867|NCT00883753|581913980|FG000|Overall Study|Refused treatment|4|||
161144868|NCT00883753|581913980|FG000|Overall Study|Withdrew consent|10|||
161144869|NCT00883753|581913980|FG000|Overall Study|Investigator's decision|17|||
161144870|NCT00883753|581913980|FG000|Overall Study|Administrative/Other|8|||
161144871|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Adverse Event|12|||
161144872|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Adverse Event|3|||
161144873|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Adverse Event|4|||
161144874|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Adverse Event|2|||
161144875|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
161144876|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
161144877|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
161144878|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
161144879|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
161144880|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
161144881|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
161144882|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
161144883|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
161144884|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
161144885|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
161144886|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
161144887|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
161144888|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
161144889|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
161144890|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
161144891|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
161144892|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
161144893|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
161144894|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
161144895|NCT02436239|581913984|FG000|Open-Lable Treatment Period|Other Reason|1|||
161144896|NCT02436239|581913985|FG001|Open-Lable Treatment Period|Other Reason|1|||
161144897|NCT02436239|581913986|FG002|Open-Lable Treatment Period|Other Reason|0|||
161144898|NCT02436239|581913987|FG003|Open-Lable Treatment Period|Other Reason|0|||
161144899|NCT02436239|581913984|FG000|Down-Taper Period|Withdrawal by Subject|4|||
161144900|NCT02436239|581913985|FG001|Down-Taper Period|Withdrawal by Subject|4|||
161266714|NCT03456960|582359154|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
161266715|NCT03456960|582359155|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161266716|NCT03456960|582359156|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
161266717|NCT03456960|582359151|FG000|Period 2 (1 Day)|Adverse Event|1|||
161266718|NCT03456960|582359152|FG001|Period 2 (1 Day)|Adverse Event|0|||
161266719|NCT03456960|582359153|FG002|Period 2 (1 Day)|Adverse Event|0|||
161266720|NCT03456960|582359154|FG003|Period 2 (1 Day)|Adverse Event|1|||
161266721|NCT03456960|582359155|FG004|Period 2 (1 Day)|Adverse Event|0|||
161266722|NCT03456960|582359156|FG005|Period 2 (1 Day)|Adverse Event|0|||
161266723|NCT01940497|582359157|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
161266724|NCT01940497|582359158|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
161266725|NCT01940497|582359157|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
161266726|NCT01940497|582359158|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
161266727|NCT01940497|582359157|FG000|Overall Study|Violation of Entry Criteria|1|||
161266728|NCT01940497|582359158|FG001|Overall Study|Violation of Entry Criteria|1|||
161266729|NCT01940497|582359157|FG000|Overall Study|Refused Treatment|1|||
161266730|NCT01940497|582359158|FG001|Overall Study|Refused Treatment|3|||
161266731|NCT01940497|582359157|FG000|Overall Study|Withdrew Consent|6|||
161266732|NCT01940497|582359158|FG001|Overall Study|Withdrew Consent|2|||
160947701|NCT04796610|581196013|FG002|Overall Study|Lost to Follow-up|1|||
160947702|NCT04796610|581196014|FG003|Overall Study|Lost to Follow-up|1|||
161144901|NCT02436239|581913986|FG002|Down-Taper Period|Withdrawal by Subject|1|||
161144902|NCT02436239|581913987|FG003|Down-Taper Period|Withdrawal by Subject|2|||
161144903|NCT02168946|581913988|FG000|Overall Study|Adverse Event|8|||
161266733|NCT01940497|582359157|FG000|Overall Study|Administrative/Other|1|||
161266734|NCT01940497|582359158|FG001|Overall Study|Administrative/Other|1|||
161144904|NCT02168946|581913989|FG001|Overall Study|Adverse Event|5|||
161144905|NCT02168946|581913988|FG000|Overall Study|Lost to Follow-up|3|||
161144906|NCT02168946|581913989|FG001|Overall Study|Lost to Follow-up|0|||
161144907|NCT02168946|581913988|FG000|Overall Study|Subject unable to come back for visits|1|||
161144908|NCT02168946|581913989|FG001|Overall Study|Subject unable to come back for visits|0|||
161266735|NCT00502801|582359159|FG000|Treatment Period|Withdrawal by Subject|3|||
160947703|NCT01459796|581196015|FG000|Overall Study|Non compliance with protocol|2|||
161266736|NCT00502801|582359159|FG000|Treatment Period|Adverse Event|7|||
161266737|NCT00502801|582359159|FG000|Treatment Period|Death|14|||
161266738|NCT00502801|582359159|FG000|Treatment Period|OTHER|30|||
161266739|NCT00502801|582359159|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
161266740|NCT00502801|582359159|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
161266741|NCT00502801|582359159|FG000|End of Therapy to Test of Cure|Death|3|||
161266742|NCT00502801|582359159|FG000|End of Therapy to Test of Cure|OTHER|2|||
161266743|NCT03071094|582359163|FG000|Overall Study|Death|1|||
161266744|NCT03071094|582359164|FG001|Overall Study|Death|1|||
161266745|NCT03071094|582359163|FG000|Overall Study|Adverse Event|1|||
161266746|NCT03071094|582359164|FG001|Overall Study|Adverse Event|0|||
161266747|NCT02312063|582359165|FG000|Overall Study|Withdrawal by Subject|0|||
161266748|NCT02312063|582359166|FG001|Overall Study|Withdrawal by Subject|1|||
161266749|NCT01195272|582359170|FG000|Overall Study|Adverse Event|1|||
161266750|NCT01195272|582359170|FG000|Overall Study|Lack of Efficacy|3|||
161266751|NCT01769339|582359171|FG000|Overall Study|Lost to Follow-up|42|||
161266752|NCT01769339|582359171|FG000|Overall Study|Adverse Event|1|||
161266753|NCT04969861|582359174|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
161266754|NCT04969861|582359175|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
161266755|NCT06218823|582360944|FG000|Overall Study|Death|3|||
161266756|NCT06218823|582360945|FG001|Overall Study|Death|0|||
161266757|NCT06218823|582360944|FG000|Overall Study|Lost to Follow-up|0|||
161266758|NCT06218823|582360945|FG001|Overall Study|Lost to Follow-up|2|||
161266759|NCT06077487|582360946|FG000|Overall Study|Withdrawal by Subject|0|||
161266760|NCT06077487|582360947|FG001|Overall Study|Withdrawal by Subject|1|||
161266761|NCT05101486|582360948|FG000|Overall Study|Death|1|||
161266762|NCT05101486|582360949|FG001|Overall Study|Death|0|||
161266763|NCT05101486|582360950|FG002|Overall Study|Death|1|||
161266764|NCT05101486|582360948|FG000|Overall Study|Lost to Follow-up|12|||
161266765|NCT05101486|582360949|FG001|Overall Study|Lost to Follow-up|8|||
161266766|NCT05101486|582360950|FG002|Overall Study|Lost to Follow-up|17|||
161266767|NCT05101486|582360948|FG000|Overall Study|Physician Decision|1|||
160999655|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Physician Decision|0|||
160999656|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Physician Decision|0|||
160999657|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Physician Decision|0|||
160999658|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Physician Decision|1|||
160999659|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
160999660|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
160999661|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
160999662|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
160999663|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
160999664|NCT02503202|581382775|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
160999665|NCT02503202|581382776|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
160999666|NCT02503202|581382777|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
160999667|NCT02503202|581382778|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
160999668|NCT02503202|581382779|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
160999669|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
160999670|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
160999671|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
160999672|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
160999673|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
160999674|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Death|1|||
160999675|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Death|0|||
160999676|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Death|0|||
160999677|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Death|0|||
160999678|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Death|0|||
160999679|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
160999680|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
160999681|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
160999682|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
161266768|NCT05101486|582360949|FG001|Overall Study|Physician Decision|0|||
161266769|NCT05101486|582360950|FG002|Overall Study|Physician Decision|0|||
160999683|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
160999684|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Physician Decision|1|||
160999685|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Physician Decision|0|||
161266770|NCT05101486|582360948|FG000|Overall Study|Protocol Violation|0|||
161266771|NCT05101486|582360949|FG001|Overall Study|Protocol Violation|0|||
161266772|NCT05101486|582360950|FG002|Overall Study|Protocol Violation|1|||
161266773|NCT05101486|582360948|FG000|Overall Study|Withdrawal by Subject|5|||
161266774|NCT05101486|582360949|FG001|Overall Study|Withdrawal by Subject|2|||
160999686|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Physician Decision|1|||
160999687|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Physician Decision|3|||
161266775|NCT05101486|582360950|FG002|Overall Study|Withdrawal by Subject|4|||
161266776|NCT05101486|582360948|FG000|Overall Study|Randomized but not vaccinated|1|||
160999688|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Physician Decision|0|||
160999689|NCT02503202|581382775|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
160999690|NCT02503202|581382776|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
160999691|NCT02503202|581382777|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
160999692|NCT02503202|581382778|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
160999693|NCT02503202|581382779|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
160999694|NCT01119950|581382780|FG000|Overall Study|Adverse Event|25|||
160999695|NCT01119950|581382780|FG000|Overall Study|Withdrawal by Subject|9|||
160999696|NCT01119950|581382780|FG000|Overall Study|Protocol Violation|5|||
160999697|NCT01119950|581382780|FG000|Overall Study|Lost to Follow-up|4|||
160999698|NCT01119950|581382780|FG000|Overall Study|Administrative|2|||
160999699|NCT01119950|581382780|FG000|Overall Study|Abnormal lab value|1|||
160999700|NCT01119950|581382780|FG000|Overall Study|Death|1|||
161266777|NCT05101486|582360949|FG001|Overall Study|Randomized but not vaccinated|1|||
161266778|NCT05101486|582360950|FG002|Overall Study|Randomized but not vaccinated|1|||
161266779|NCT02788045|582360951|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
161266780|NCT02788045|582360952|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
161266781|NCT02788045|582360953|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
161266782|NCT02788045|582360951|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
161266783|NCT02788045|582360952|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
161266784|NCT02788045|582360953|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
161266785|NCT02788045|582360951|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
161266786|NCT02788045|582360952|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
161266787|NCT02788045|582360953|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
161266788|NCT02788045|582360951|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
161266789|NCT02788045|582360952|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
161266790|NCT02788045|582360953|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
161266791|NCT02788045|582360951|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
161266792|NCT02788045|582360952|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
161266793|NCT02788045|582360953|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
161266794|NCT02788045|582360951|FG000|Main Study (Up to Week 72)|Other|3|||
161266795|NCT02788045|582360952|FG001|Main Study (Up to Week 72)|Other|0|||
161266796|NCT02788045|582360953|FG002|Main Study (Up to Week 72)|Other|0|||
161266797|NCT02788045|582360951|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
161266798|NCT02788045|582360952|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
161266799|NCT02788045|582360953|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
161266800|NCT02788045|582360951|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
160947704|NCT01459796|581196016|FG001|Overall Study|Non compliance with protocol|4|||
160947705|NCT01459796|581196015|FG000|Overall Study|Adverse Event|5|||
160947706|NCT01459796|581196016|FG001|Overall Study|Adverse Event|5|||
160947707|NCT01459796|581196015|FG000|Overall Study|Withdrawal by Subject|6|||
160947708|NCT01459796|581196016|FG001|Overall Study|Withdrawal by Subject|3|||
160947709|NCT01459796|581196015|FG000|Overall Study|Lost to Follow-up|5|||
160947710|NCT01459796|581196016|FG001|Overall Study|Lost to Follow-up|4|||
160947711|NCT01459796|581196015|FG000|Overall Study|Reason unspecified|1|||
160947712|NCT01459796|581196016|FG001|Overall Study|Reason unspecified|2|||
160947713|NCT01459796|581196015|FG000|Overall Study|Decision by the sponsor|75|||
160947714|NCT01459796|581196016|FG001|Overall Study|Decision by the sponsor|108|||
160947715|NCT00733824|581196017|FG000|Phase I|Withdrawal by Subject|1|||
160947716|NCT00733824|581196018|FG001|Phase I|Withdrawal by Subject|0|||
160947717|NCT00733824|581196019|FG002|Phase I|Withdrawal by Subject|0|||
160947718|NCT00733824|581196020|FG003|Phase I|Withdrawal by Subject|0|||
160947719|NCT00733824|581196021|FG004|Phase I|Withdrawal by Subject|0|||
160947720|NCT00701051|581196022|FG000|Screening|Failed Screening|40|||
160947721|NCT00701051|581196023|FG001|Screening|Failed Screening|0|||
160947722|NCT00701051|581196024|FG002|Screening|Failed Screening|0|||
160947723|NCT00701051|581196022|FG000|Screening|Time conflicts|19|||
160947724|NCT00701051|581196023|FG001|Screening|Time conflicts|0|||
160947725|NCT00701051|581196024|FG002|Screening|Time conflicts|0|||
160947726|NCT00701051|581196022|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
160947727|NCT00701051|581196023|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
160947728|NCT00701051|581196024|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
160947729|NCT01343056|581196025|FG000|Overall Study|Lost to Follow-up|7|||
160947730|NCT01343056|581196026|FG001|Overall Study|Lost to Follow-up|5|||
160947731|NCT01343056|581196027|FG002|Overall Study|Lost to Follow-up|3|||
160947732|NCT01343056|581196028|FG003|Overall Study|Lost to Follow-up|9|||
160947733|NCT02059148|581196029|FG000|Treatment 1|Protocol Violation|0|||
160947734|NCT02059148|581196030|FG001|Treatment 1|Protocol Violation|0|||
160947735|NCT02059148|581196031|FG002|Treatment 1|Protocol Violation|0|||
160947736|NCT02059148|581196032|FG003|Treatment 1|Protocol Violation|0|||
160947737|NCT02059148|581196033|FG004|Treatment 1|Protocol Violation|0|||
160947738|NCT02059148|581196034|FG005|Treatment 1|Protocol Violation|1|||
160947739|NCT03231371|581196035|FG000|Overall Study|Withdrawal by Subject|1|||
160947740|NCT03231371|581196035|FG000|Overall Study|chose or were ineligible to have MRI|12|||
160999701|NCT01988233|581382781|FG000|Overall Study|Lost to Follow-up|64|||
160947741|NCT03029208|581196040|FG000|Overall Study|Withdrawal by Subject|2|||
160947742|NCT03029208|581196041|FG001|Overall Study|Withdrawal by Subject|3|||
160947743|NCT03029208|581196040|FG000|Overall Study|Lost to Follow-up|0|||
160947744|NCT03029208|581196041|FG001|Overall Study|Lost to Follow-up|1|||
160947745|NCT03893448|581196044|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
160947746|NCT03893448|581196045|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
160947747|NCT03893448|581196044|FG000|Overall Study|Physician Decision|8|||
160947748|NCT03893448|581196045|FG001|Overall Study|Physician Decision|14|||
160947749|NCT03893448|581196044|FG000|Overall Study|Lost to Follow-up|34|||
160947750|NCT03893448|581196045|FG001|Overall Study|Lost to Follow-up|27|||
161266801|NCT02788045|582360952|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
161266802|NCT02788045|582360953|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
161266803|NCT02788045|582360951|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
161266804|NCT02788045|582360952|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
161266805|NCT02788045|582360953|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
161266806|NCT00292188|582360965|FG000|Single-Blind|Adverse Event|14|||
161266807|NCT00292188|582360966|FG001|Single-Blind|Adverse Event|0|||
161266808|NCT00292188|582360967|FG002|Single-Blind|Adverse Event|0|||
161266809|NCT00292188|582360965|FG000|Single-Blind|Lack of Efficacy|2|||
161266810|NCT00292188|582360966|FG001|Single-Blind|Lack of Efficacy|0|||
161266811|NCT00292188|582360967|FG002|Single-Blind|Lack of Efficacy|0|||
161266812|NCT00292188|582360965|FG000|Single-Blind|Laboratory Abnormality|5|||
161266813|NCT00292188|582360966|FG001|Single-Blind|Laboratory Abnormality|0|||
161266814|NCT00292188|582360967|FG002|Single-Blind|Laboratory Abnormality|0|||
161266815|NCT00292188|582360965|FG000|Single-Blind|Lost to Follow-up|3|||
160947751|NCT03893448|581196044|FG000|Overall Study|Death|1|||
160947752|NCT03893448|581196045|FG001|Overall Study|Death|0|||
160947753|NCT03321981|581196046|FG000|Overall Study|Progressive Disease (PD)|15|||
160947754|NCT03321981|581196047|FG001|Overall Study|Progressive Disease (PD)|30|||
160947755|NCT03321981|581196048|FG002|Overall Study|Progressive Disease (PD)|47|||
160947756|NCT03321981|581196046|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
160947757|NCT03321981|581196047|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
160947758|NCT03321981|581196048|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
160947759|NCT03321981|581196046|FG000|Overall Study|Adverse Event|0|||
160947760|NCT03321981|581196047|FG001|Overall Study|Adverse Event|0|||
161266816|NCT00292188|582360966|FG001|Single-Blind|Lost to Follow-up|0|||
161266817|NCT00292188|582360967|FG002|Single-Blind|Lost to Follow-up|0|||
161266818|NCT00292188|582360965|FG000|Single-Blind|Other|77|||
161266819|NCT00292188|582360966|FG001|Single-Blind|Other|0|||
161266820|NCT00292188|582360967|FG002|Single-Blind|Other|0|||
161266821|NCT00292188|582360965|FG000|Single-Blind|Withdrawal by Subject|12|||
161266822|NCT00292188|582360966|FG001|Single-Blind|Withdrawal by Subject|0|||
161266823|NCT00292188|582360967|FG002|Single-Blind|Withdrawal by Subject|0|||
161266824|NCT00292188|582360965|FG000|Single-Blind|Did not receive treatment|1|||
161266825|NCT00292188|582360966|FG001|Single-Blind|Did not receive treatment|0|||
161266826|NCT00292188|582360967|FG002|Single-Blind|Did not receive treatment|0|||
161266827|NCT00292188|582360965|FG000|Double-Blind|Adverse Event|0|||
161266828|NCT00292188|582360966|FG001|Double-Blind|Adverse Event|25|||
161266829|NCT00292188|582360967|FG002|Double-Blind|Adverse Event|9|||
161266830|NCT00292188|582360965|FG000|Double-Blind|Lack of Efficacy|0|||
161266831|NCT00292188|582360966|FG001|Double-Blind|Lack of Efficacy|2|||
161266832|NCT00292188|582360967|FG002|Double-Blind|Lack of Efficacy|12|||
161266833|NCT00292188|582360965|FG000|Double-Blind|Lost to Follow-up|0|||
161266834|NCT00292188|582360966|FG001|Double-Blind|Lost to Follow-up|1|||
161266835|NCT00292188|582360967|FG002|Double-Blind|Lost to Follow-up|0|||
161266836|NCT00292188|582360965|FG000|Double-Blind|Other|0|||
161266837|NCT00292188|582360966|FG001|Double-Blind|Other|3|||
161266838|NCT00292188|582360967|FG002|Double-Blind|Other|4|||
161266839|NCT00292188|582360965|FG000|Double-Blind|Withdrawal by Subject|0|||
161266840|NCT00292188|582360966|FG001|Double-Blind|Withdrawal by Subject|0|||
161266841|NCT00292188|582360967|FG002|Double-Blind|Withdrawal by Subject|3|||
161266842|NCT00292188|582360965|FG000|Double-Blind|Laboratory Abnormality|0|||
161266843|NCT00292188|582360966|FG001|Double-Blind|Laboratory Abnormality|0|||
161266844|NCT00292188|582360967|FG002|Double-Blind|Laboratory Abnormality|1|||
161266845|NCT00824616|582360968|FG000|Overall Study|Adverse Event|2|||
160947761|NCT03321981|581196048|FG002|Overall Study|Adverse Event|2|||
160947762|NCT03321981|581196046|FG000|Overall Study|symptomatic deterioration|0|||
160947763|NCT03321981|581196047|FG001|Overall Study|symptomatic deterioration|1|||
160947764|NCT03321981|581196048|FG002|Overall Study|symptomatic deterioration|1|||
160947765|NCT03321981|581196046|FG000|Overall Study|Lack of compliance|0|||
160947766|NCT03321981|581196047|FG001|Overall Study|Lack of compliance|1|||
161266846|NCT00824616|582360969|FG001|Overall Study|Adverse Event|1|||
161266847|NCT00824616|582360968|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
161266848|NCT00824616|582360969|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
161266849|NCT00824616|582360968|FG000|Overall Study|Hyperglycemia|1|||
161266850|NCT00824616|582360969|FG001|Overall Study|Hyperglycemia|1|||
160947767|NCT03321981|581196048|FG002|Overall Study|Lack of compliance|0|||
160947768|NCT03321981|581196046|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
160947769|NCT03321981|581196047|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
160947770|NCT03321981|581196048|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
160947771|NCT03321981|581196046|FG000|Overall Study|Death|0|||
160947772|NCT03321981|581196047|FG001|Overall Study|Death|1|||
160947773|NCT03321981|581196048|FG002|Overall Study|Death|0|||
160947774|NCT03321981|581196046|FG000|Overall Study|Subject withdrawal of investigational product|0|||
160947775|NCT03321981|581196047|FG001|Overall Study|Subject withdrawal of investigational product|1|||
160947776|NCT03321981|581196048|FG002|Overall Study|Subject withdrawal of investigational product|0|||
160947777|NCT03321981|581196046|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
160947778|NCT03321981|581196047|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
160947779|NCT03321981|581196048|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
160947780|NCT03321981|581196046|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
160947781|NCT03321981|581196047|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
160947782|NCT03321981|581196048|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
160947783|NCT04934670|581196049|FG000|Overall Study|Death|4|||
160947784|NCT04934670|581196050|FG001|Overall Study|Death|0|||
160947785|NCT04934670|581196049|FG000|Overall Study|Lost to Follow-up|1|||
160947786|NCT04934670|581196050|FG001|Overall Study|Lost to Follow-up|4|||
160947787|NCT03067441|581196051|FG000|Overall Study|Withdrawal by Subject|16|||
160947788|NCT03067441|581196052|FG001|Overall Study|Withdrawal by Subject|34|||
160947789|NCT03067441|581196051|FG000|Overall Study|Lost to Follow-up|7|||
160947790|NCT03067441|581196052|FG001|Overall Study|Lost to Follow-up|5|||
160947791|NCT03067441|581196051|FG000|Overall Study|Adverse Event|7|||
160947792|NCT03067441|581196052|FG001|Overall Study|Adverse Event|14|||
160947793|NCT03067441|581196051|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
160947794|NCT03067441|581196052|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
160947795|NCT03067441|581196051|FG000|Overall Study|Physician Decision|1|||
160947796|NCT03067441|581196052|FG001|Overall Study|Physician Decision|3|||
160947797|NCT03067441|581196051|FG000|Overall Study|Other|1|||
160947798|NCT03067441|581196052|FG001|Overall Study|Other|1|||
160947799|NCT00856583|581196053|FG000|Overall Study|Lack of Efficacy|389|||
160947800|NCT00856583|581196054|FG001|Overall Study|Lack of Efficacy|377|||
160947801|NCT00856583|581196053|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
160947802|NCT00856583|581196054|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
160947803|NCT00856583|581196053|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
160947804|NCT00856583|581196054|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
160947805|NCT00856583|581196053|FG000|Overall Study|Non-compliance|305|||
160947806|NCT00856583|581196054|FG001|Overall Study|Non-compliance|262|||
160947807|NCT00856583|581196053|FG000|Overall Study|Withdrawal by Subject|1092|||
160947808|NCT00856583|581196054|FG001|Overall Study|Withdrawal by Subject|919|||
160947809|NCT00856583|581196053|FG000|Overall Study|Physician Decision|59|||
160947810|NCT00856583|581196054|FG001|Overall Study|Physician Decision|82|||
160947811|NCT00856583|581196053|FG000|Overall Study|Pregnancy|14|||
160947812|NCT00856583|581196054|FG001|Overall Study|Pregnancy|5|||
160947813|NCT00856583|581196053|FG000|Overall Study|Other|92|||
160947814|NCT00856583|581196054|FG001|Overall Study|Other|104|||
160947815|NCT00856583|581196053|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
160947816|NCT00856583|581196054|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
160947817|NCT04496258|581196062|FG000|Overall Study|Withdrawal by Subject|2|||
160947818|NCT04496258|581196063|FG001|Overall Study|Withdrawal by Subject|1|||
160947819|NCT01427712|581196064|FG000|Overall Study|Transfer to a different hospital|2|||
160947820|NCT01427712|581196064|FG000|Overall Study|Lost to Follow-up|1|||
160947821|NCT01427712|581196064|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
160947822|NCT01427712|581196064|FG000|Overall Study|Failure to visit|1|||
161144909|NCT00450866|581913997|FG000|Overall Study|Adverse Event|0|||
160947823|NCT00661492|581196065|FG000|Overall Study|Adverse Event|16|||
160947824|NCT00661492|581196066|FG001|Overall Study|Adverse Event|13|||
160947825|NCT00661492|581196065|FG000|Overall Study|Disease Progression|44|||
160947826|NCT00661492|581196066|FG001|Overall Study|Disease Progression|14|||
161144910|NCT00450866|581913998|FG001|Overall Study|Adverse Event|1|||
161144911|NCT00450866|581913997|FG000|Overall Study|Withdrawal by Subject|5|||
161144912|NCT00450866|581913998|FG001|Overall Study|Withdrawal by Subject|2|||
160947827|NCT00661492|581196065|FG000|Overall Study|Patient Request|6|||
160947828|NCT00661492|581196066|FG001|Overall Study|Patient Request|1|||
160947829|NCT00661492|581196065|FG000|Overall Study|Investigator Request|1|||
160947830|NCT00661492|581196066|FG001|Overall Study|Investigator Request|0|||
160947831|NCT00661492|581196065|FG000|Overall Study|Lost to Follow-up|0|||
160947832|NCT00661492|581196066|FG001|Overall Study|Lost to Follow-up|1|||
160947833|NCT00661492|581196065|FG000|Overall Study|Other|1|||
161144913|NCT00450866|581913997|FG000|Overall Study|Death|1|||
161144914|NCT00450866|581913998|FG001|Overall Study|Death|0|||
160947834|NCT00661492|581196066|FG001|Overall Study|Other|0|||
160947835|NCT00803634|581196067|FG000|Overall Study|Withdrew Consent|1|||
160947836|NCT00803634|581196068|FG001|Overall Study|Withdrew Consent|0|||
160947837|NCT00803634|581196067|FG000|Overall Study|Lost to Follow-up|2|||
160947838|NCT00803634|581196068|FG001|Overall Study|Lost to Follow-up|3|||
160947839|NCT00803634|581196067|FG000|Overall Study|Death|3|||
160947840|NCT00803634|581196068|FG001|Overall Study|Death|2|||
161266851|NCT00824616|582360968|FG000|Overall Study|Lack of Efficacy|2|||
161266852|NCT00824616|582360969|FG001|Overall Study|Lack of Efficacy|1|||
161266853|NCT00824616|582360968|FG000|Overall Study|Lost to Follow-up|0|||
161266854|NCT00824616|582360969|FG001|Overall Study|Lost to Follow-up|1|||
161266855|NCT00824616|582360968|FG000|Overall Study|Withdrawal by Subject|1|||
161266856|NCT00824616|582360969|FG001|Overall Study|Withdrawal by Subject|1|||
161266857|NCT00721630|582360970|FG000|Overall Study|Participant found to be ineligible|1|||
161266858|NCT04711902|582360974|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
161266859|NCT04711902|582360975|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
161266860|NCT04711902|582360976|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
161266861|NCT04711902|582360977|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
161266862|NCT04711902|582360978|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
161266863|NCT04711902|582360979|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
161266864|NCT03786718|582360980|FG000|Overall Study|Lost to Follow-up|3|||
161266865|NCT03786718|582360980|FG000|Overall Study|Withdrawal by Subject|1|||
161266866|NCT03786718|582360980|FG000|Overall Study|Did not use the intervention|2|||
161266867|NCT03786718|582360980|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
161266868|NCT00372411|582360987|FG000|Overall Study|Withdrawal by Subject|3|||
161266869|NCT00372411|582360988|FG001|Overall Study|Withdrawal by Subject|4|||
161266870|NCT00372411|582360989|FG002|Overall Study|Withdrawal by Subject|1|||
161266871|NCT00372411|582360987|FG000|Overall Study|Death|0|||
161266872|NCT00372411|582360988|FG001|Overall Study|Death|2|||
161266873|NCT00372411|582360989|FG002|Overall Study|Death|1|||
161266874|NCT00372411|582360987|FG000|Overall Study|Lost to Follow-up|1|||
161266875|NCT00372411|582360988|FG001|Overall Study|Lost to Follow-up|1|||
161266876|NCT00372411|582360989|FG002|Overall Study|Lost to Follow-up|1|||
161266877|NCT00372411|582360987|FG000|Overall Study|Adverse Event|1|||
161266878|NCT00372411|582360988|FG001|Overall Study|Adverse Event|1|||
161266879|NCT00372411|582360989|FG002|Overall Study|Adverse Event|0|||
161266880|NCT01398514|582360990|FG000|Overall Study|Adverse Event|1|||
161266881|NCT01398514|582360991|FG001|Overall Study|Adverse Event|0|||
161266882|NCT01398514|582360990|FG000|Overall Study|Non-compliance with study procedures|2|||
161266883|NCT01398514|582360991|FG001|Overall Study|Non-compliance with study procedures|0|||
161266884|NCT01398514|582360990|FG000|Overall Study|Physiologic non-responsiveness|1|||
161266885|NCT01398514|582360991|FG001|Overall Study|Physiologic non-responsiveness|3|||
161266886|NCT01398514|582360990|FG000|Overall Study|Failure to show a conditioned response|4|||
161266887|NCT01398514|582360991|FG001|Overall Study|Failure to show a conditioned response|3|||
161266888|NCT02227147|582361001|FG000|Controlled Treatment Period|Adverse Event|4|||
161266889|NCT02227147|582361002|FG001|Controlled Treatment Period|Adverse Event|3|||
161266890|NCT02227147|582361001|FG000|Controlled Treatment Period|Other|2|||
161266891|NCT02227147|582361002|FG001|Controlled Treatment Period|Other|0|||
161266892|NCT02227147|582361001|FG000|Follow-up Period|Other|3|||
161266893|NCT02227147|582361002|FG001|Follow-up Period|Other|5|||
161266894|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
161266895|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
161266896|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
161266897|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
161266898|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
161266899|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
161266900|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
161266901|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
161266902|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
161266903|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
161266904|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
160947841|NCT01652716|581196069|FG000|Overall Study|Loss of glucose control|1|||
161266905|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
161342677|NCT00879658|582642233|FG002|Overall Study|Withdrawal by Subject|2|||
160947842|NCT01652716|581196070|FG001|Overall Study|Loss of glucose control|0|||
160947843|NCT01652716|581196069|FG000|Overall Study|Administrative|0|||
160947844|NCT01652716|581196070|FG001|Overall Study|Administrative|2|||
160947845|NCT01652716|581196069|FG000|Overall Study|Investigator decision|1|||
161266906|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
161266907|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
161266908|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
161266909|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
161266910|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
161266911|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
160947846|NCT01652716|581196070|FG001|Overall Study|Investigator decision|4|||
160947847|NCT01652716|581196069|FG000|Overall Study|Lost to Follow-up|12|||
160947848|NCT01652716|581196070|FG001|Overall Study|Lost to Follow-up|11|||
160947849|NCT01652716|581196069|FG000|Overall Study|Protocol Violation|2|||
160947850|NCT01652716|581196070|FG001|Overall Study|Protocol Violation|1|||
160947851|NCT01652716|581196069|FG000|Overall Study|Adverse Event|7|||
160947852|NCT01652716|581196070|FG001|Overall Study|Adverse Event|10|||
160947853|NCT01652716|581196069|FG000|Overall Study|Withdrawal by Subject|33|||
160947854|NCT01652716|581196070|FG001|Overall Study|Withdrawal by Subject|18|||
160947855|NCT04745169|581198320|FG000|Overall Study|Kidney transplantation|1|||
160947856|NCT04745169|581198320|FG000|Overall Study|Participant health problems|3|||
160947857|NCT04745169|581198320|FG000|Overall Study|Physician Decision|2|||
160947858|NCT00993447|581198321|FG000|Overall Study|Withdrawal by Subject|23|||
160947859|NCT00993447|581198322|FG001|Overall Study|Withdrawal by Subject|8|||
160947860|NCT00993447|581198321|FG000|Overall Study|Protocol Violation|12|||
160947861|NCT00993447|581198322|FG001|Overall Study|Protocol Violation|8|||
160947862|NCT00993447|581198321|FG000|Overall Study|Lost to Follow-up|1|||
160947863|NCT00993447|581198322|FG001|Overall Study|Lost to Follow-up|3|||
160947864|NCT00993447|581198321|FG000|Overall Study|Adverse Event|1|||
160947865|NCT00993447|581198322|FG001|Overall Study|Adverse Event|0|||
160947866|NCT00970502|581198323|FG000|Overall Study|Withdrawal by Subject|1|||
160947867|NCT02707055|581198324|FG000|Phase 1|Withdrawal by Subject|1|||
161266912|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
160947868|NCT02707055|581198325|FG001|Phase 1|Withdrawal by Subject|2|||
160947869|NCT02707055|581198324|FG000|Phase 1|Physician Decision|0|||
160947870|NCT02707055|581198325|FG001|Phase 1|Physician Decision|1|||
160947871|NCT02707055|581198324|FG000|Phase 2|Adverse Event|1|||
160947872|NCT02707055|581198325|FG001|Phase 2|Adverse Event|2|||
160947873|NCT01880424|581198326|FG000|Overall Study|Adverse Event|7|||
160947874|NCT01880424|581198327|FG001|Overall Study|Adverse Event|6|||
160947875|NCT01880424|581198326|FG000|Overall Study|Lack of Efficacy|1|||
161266913|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
160947876|NCT01880424|581198327|FG001|Overall Study|Lack of Efficacy|4|||
160947877|NCT01880424|581198326|FG000|Overall Study|Lost to Follow-up|3|||
160947878|NCT01880424|581198327|FG001|Overall Study|Lost to Follow-up|2|||
160947879|NCT01880424|581198326|FG000|Overall Study|Protocol Violation|11|||
160947880|NCT01880424|581198327|FG001|Overall Study|Protocol Violation|13|||
160947881|NCT01880424|581198326|FG000|Overall Study|Withdrawal by Subject|10|||
160947882|NCT01880424|581198327|FG001|Overall Study|Withdrawal by Subject|30|||
161266914|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
161266915|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161266916|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161266917|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
161266918|NCT03514641|582361006|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161266919|NCT03514641|582361007|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
161266920|NCT03514641|582361008|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161266921|NCT03514641|582361009|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
161266922|NCT03514641|582361006|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
161266923|NCT03514641|582361007|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
161266924|NCT03514641|582361008|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
161266925|NCT03514641|582361009|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
161266926|NCT03514641|582361006|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
161266927|NCT03514641|582361007|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
161266928|NCT03514641|582361008|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
161266929|NCT03514641|582361009|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
161266930|NCT03514641|582361006|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
161266931|NCT03514641|582361007|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
161266932|NCT03514641|582361008|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
161266933|NCT03514641|582361009|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
160947883|NCT01880424|581198326|FG000|Overall Study|Other|1|||
160947884|NCT01880424|581198327|FG001|Overall Study|Other|0|||
160947885|NCT02280044|581198332|FG000|Overall Study|Planned alternate|0|||
160947886|NCT02280044|581198333|FG001|Overall Study|Planned alternate|2|||
160947887|NCT05706506|581198334|FG000|Overall Study|Adverse Event|1|||
160947888|NCT05706506|581198334|FG000|Overall Study|Withdrawal by Subject|4|||
160947889|NCT05706506|581198334|FG000|Overall Study|Lost to Follow-up|2|||
160947890|NCT05706506|581198334|FG000|Overall Study|Inadvertent Enrolment|12|||
160947891|NCT05706506|581198334|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
160947892|NCT05706506|581198334|FG000|Overall Study|Participant Moved Out of State|1|||
160947893|NCT01075321|581198338|FG000|Overall Study|Withdrawal by Subject|0|||
160947894|NCT01075321|581198339|FG001|Overall Study|Withdrawal by Subject|0|||
160947895|NCT01075321|581198340|FG002|Overall Study|Withdrawal by Subject|1|||
161266934|NCT03514641|582361006|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
161266935|NCT03514641|582361007|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
160947896|NCT01075321|581198341|FG003|Overall Study|Withdrawal by Subject|1|||
161266936|NCT03514641|582361008|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
161266937|NCT03514641|582361009|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
161266938|NCT03514641|582361006|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
161266939|NCT03514641|582361007|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
161266940|NCT03514641|582361008|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
161266941|NCT03514641|582361009|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
161266942|NCT01345175|582361010|FG000|Overall Study|Physician Decision|0|||
161266943|NCT01345175|582361011|FG001|Overall Study|Physician Decision|1|||
161266944|NCT01345175|582361010|FG000|Overall Study|Withdrawal by Subject|1|||
161266945|NCT01345175|582361011|FG001|Overall Study|Withdrawal by Subject|1|||
161266946|NCT01345175|582361010|FG000|Overall Study|Failed to complete BFI|3|||
161266947|NCT01345175|582361011|FG001|Overall Study|Failed to complete BFI|2|||
161266948|NCT01345175|582361010|FG000|Overall Study|Stopped taking medication|2|||
161266949|NCT01345175|582361011|FG001|Overall Study|Stopped taking medication|2|||
161266950|NCT04112173|582361013|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
161266951|NCT01561430|582361014|FG000|Overall Study|Adverse Event|0|||
161266952|NCT01561430|582361015|FG001|Overall Study|Adverse Event|0|||
161266953|NCT01561430|582361016|FG002|Overall Study|Adverse Event|3|||
161266954|NCT01561430|582361017|FG003|Overall Study|Adverse Event|1|||
161266955|NCT01561430|582361014|FG000|Overall Study|Withdrawal by Subject|0|||
161266956|NCT01561430|582361015|FG001|Overall Study|Withdrawal by Subject|0|||
161266957|NCT01561430|582361016|FG002|Overall Study|Withdrawal by Subject|1|||
161266958|NCT01561430|582361017|FG003|Overall Study|Withdrawal by Subject|0|||
161266959|NCT01561430|582361014|FG000|Overall Study|Physician Decision|0|||
160862118|NCT05138653|580887933|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
161266960|NCT01561430|582361015|FG001|Overall Study|Physician Decision|1|||
161266961|NCT01561430|582361016|FG002|Overall Study|Physician Decision|0|||
161266962|NCT01561430|582361017|FG003|Overall Study|Physician Decision|0|||
161266963|NCT01561430|582361014|FG000|Overall Study|Sponsor Decision|1|||
161266964|NCT01561430|582361015|FG001|Overall Study|Sponsor Decision|14|||
161266965|NCT01561430|582361016|FG002|Overall Study|Sponsor Decision|13|||
161266966|NCT01561430|582361017|FG003|Overall Study|Sponsor Decision|12|||
161266967|NCT04234984|582361018|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
161342678|NCT00879658|582642234|FG003|Overall Study|Withdrawal by Subject|0|||
161342679|NCT00879658|582642235|FG004|Overall Study|Withdrawal by Subject|0|||
160862119|NCT05138653|580887934|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862120|NCT05138653|580887935|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
160862121|NCT04272242|580887936|FG000|Overall Study|Withdrawal by Subject|3|||
160862122|NCT04272242|580887936|FG000|Overall Study|Lost to Follow-up|1|||
160862123|NCT04272242|580887936|FG000|Overall Study|Adverse Event|1|||
160862124|NCT03204188|580887944|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
160862125|NCT03204188|580887944|FG000|Immunotherapy Phase (1 Year)|Death|1|||
160862126|NCT03204188|580887944|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
160862127|NCT03204188|580887944|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
160862128|NCT01520506|580889654|FG000|Overall Study|Missed Visit|4|||
160862129|NCT01520506|580889654|FG000|Overall Study|Lost to Follow-up|1|||
160862130|NCT01520506|580889654|FG000|Overall Study|Withdrawal by Subject|1|||
160862131|NCT00906204|580889655|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
160862132|NCT00906204|580889656|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
160862133|NCT00906204|580889655|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
160862134|NCT00906204|580889656|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
160862135|NCT00906204|580889655|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
160862136|NCT00906204|580889656|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
160862137|NCT00906204|580889655|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
160862138|NCT00906204|580889656|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
160862139|NCT00906204|580889655|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
160862140|NCT00906204|580889656|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
160862141|NCT00696072|580889657|FG000|Overall Study|continuing active treatment|10|||
160862142|NCT00696072|580889658|FG001|Overall Study|continuing active treatment|13|||
160862143|NCT00696072|580889657|FG000|Overall Study|Adverse Event|10|||
160862144|NCT00696072|580889658|FG001|Overall Study|Adverse Event|6|||
160862145|NCT00696072|580889657|FG000|Overall Study|Patient Request|3|||
160862146|NCT00696072|580889658|FG001|Overall Study|Patient Request|7|||
160862147|NCT00696072|580889657|FG000|Overall Study|Investigator Request|1|||
160862148|NCT00696072|580889658|FG001|Overall Study|Investigator Request|4|||
160862149|NCT00696072|580889657|FG000|Overall Study|Sponsor Request|0|||
161266968|NCT04234984|582361018|FG000|Follow-up at the Second Time Point|Death|1|||
161266969|NCT04234984|582361018|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
161266970|NCT01055132|582361019|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
161266971|NCT01055132|582361020|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
161342680|NCT00879658|582642236|FG005|Overall Study|Withdrawal by Subject|1|||
160862150|NCT00696072|580889658|FG001|Overall Study|Sponsor Request|1|||
160862151|NCT00696072|580889657|FG000|Overall Study|Disease Progression|32|||
161266972|NCT01055132|582361019|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
161266973|NCT01055132|582361020|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
161266974|NCT00910091|582361021|FG000|Pre-assignment|Withdrawal by Subject|0|||
161266975|NCT00910091|582361022|FG001|Pre-assignment|Withdrawal by Subject|2|||
161266976|NCT00910091|582361021|FG000|Treatment and Survival|Withdrawal by Subject|3|||
161266977|NCT00910091|582361022|FG001|Treatment and Survival|Withdrawal by Subject|4|||
161266978|NCT00910091|582361021|FG000|Treatment and Survival|Adverse Event|1|||
161266979|NCT00910091|582361022|FG001|Treatment and Survival|Adverse Event|0|||
161266980|NCT01908816|582361025|FG000|Overall Study|Subject's no longer requires study drug|0|||
161266981|NCT01908816|582361026|FG001|Overall Study|Subject's no longer requires study drug|0|||
161266982|NCT01908816|582361027|FG002|Overall Study|Subject's no longer requires study drug|0|||
161266983|NCT01908816|582361028|FG003|Overall Study|Subject's no longer requires study drug|1|||
161266984|NCT01908816|582361025|FG000|Overall Study|Protocol deviation|1|||
161266985|NCT01908816|582361026|FG001|Overall Study|Protocol deviation|2|||
161266986|NCT01908816|582361027|FG002|Overall Study|Protocol deviation|1|||
161266987|NCT01908816|582361028|FG003|Overall Study|Protocol deviation|1|||
161266988|NCT01908816|582361025|FG000|Overall Study|Withdrawal by Subject|0|||
161266989|NCT01908816|582361026|FG001|Overall Study|Withdrawal by Subject|4|||
161266990|NCT01908816|582361027|FG002|Overall Study|Withdrawal by Subject|2|||
161266991|NCT01908816|582361028|FG003|Overall Study|Withdrawal by Subject|2|||
161266992|NCT01908816|582361025|FG000|Overall Study|Lost to Follow-up|3|||
161266993|NCT01908816|582361026|FG001|Overall Study|Lost to Follow-up|5|||
161266994|NCT01908816|582361027|FG002|Overall Study|Lost to Follow-up|4|||
161266995|NCT01908816|582361028|FG003|Overall Study|Lost to Follow-up|2|||
161266996|NCT01908816|582361025|FG000|Overall Study|Death|1|||
161266997|NCT01908816|582361026|FG001|Overall Study|Death|0|||
161266998|NCT01908816|582361027|FG002|Overall Study|Death|7|||
161266999|NCT01908816|582361028|FG003|Overall Study|Death|1|||
161267000|NCT01908816|582361025|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161267001|NCT01908816|582361026|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161267002|NCT01908816|582361027|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161267003|NCT01908816|582361028|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161267004|NCT01908816|582361025|FG000|Overall Study|Early termination|87|||
161267005|NCT01908816|582361026|FG001|Overall Study|Early termination|60|||
161267006|NCT01908816|582361027|FG002|Overall Study|Early termination|43|||
161267007|NCT01908816|582361028|FG003|Overall Study|Early termination|28|||
161267008|NCT05183217|582361029|FG000|Overall Study|Withdrawal by Subject|1|||
161267009|NCT05183217|582361030|FG001|Overall Study|Withdrawal by Subject|1|||
161267010|NCT00507130|582361031|FG000|Overall Study|Lost to Follow-up|0|||
161267011|NCT00507130|582361032|FG001|Overall Study|Lost to Follow-up|0|||
161267012|NCT00507130|582361033|FG002|Overall Study|Lost to Follow-up|1|||
161267013|NCT00507130|582361034|FG003|Overall Study|Lost to Follow-up|1|||
161267014|NCT00507130|582361031|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
161267015|NCT00507130|582361032|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161267016|NCT00507130|582361033|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161267017|NCT00507130|582361034|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
161267018|NCT02524730|582361035|FG000|Overall Study|Lost to Follow-up|5|||
161267019|NCT02524730|582361035|FG000|Overall Study|Withdrawal by Subject|18|||
161267020|NCT02524730|582361035|FG000|Overall Study|Death|10|||
161267021|NCT02524730|582361035|FG000|Overall Study|Adverse Event|8|||
161267022|NCT02524730|582361035|FG000|Overall Study|Protocol Violation|1|||
161267023|NCT02524730|582361035|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
161267024|NCT04480710|582361047|FG000|Overall Study|Adverse Event|0|||
161267025|NCT04480710|582361048|FG001|Overall Study|Adverse Event|2|||
161267026|NCT04480710|582361049|FG002|Overall Study|Adverse Event|0|||
161267027|NCT04480710|582361050|FG003|Overall Study|Adverse Event|0|||
161267028|NCT04480710|582361047|FG000|Overall Study|Withdrawal by Subject|0|||
161267029|NCT04480710|582361048|FG001|Overall Study|Withdrawal by Subject|1|||
161267030|NCT04480710|582361049|FG002|Overall Study|Withdrawal by Subject|0|||
161267031|NCT04480710|582361050|FG003|Overall Study|Withdrawal by Subject|0|||
161267032|NCT04480710|582361047|FG000|Overall Study|Physician Decision|0|||
161267033|NCT04480710|582361048|FG001|Overall Study|Physician Decision|0|||
161267034|NCT04480710|582361049|FG002|Overall Study|Physician Decision|1|||
161267035|NCT04480710|582361050|FG003|Overall Study|Physician Decision|0|||
160999702|NCT01988233|581382782|FG001|Overall Study|Lost to Follow-up|51|||
160999703|NCT02148133|581382783|FG000|Overall Study|Investigator discretion|1|||
160999704|NCT02148133|581382783|FG000|Overall Study|Lack of Efficacy|1|||
160999705|NCT02148133|581382783|FG000|Overall Study|Protocol deviation|1|||
161144915|NCT00450866|581913997|FG000|Overall Study|Physician Decision|1|||
161267036|NCT01103466|582361058|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
161267037|NCT01103466|582361059|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
161267038|NCT01103466|582361060|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
161267039|NCT01103466|582361058|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
161267040|NCT01103466|582361059|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
161267041|NCT01103466|582361060|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
160947897|NCT01075321|581198338|FG000|Overall Study|Protocol Violation|0|||
160947898|NCT01075321|581198339|FG001|Overall Study|Protocol Violation|0|||
160947899|NCT01075321|581198340|FG002|Overall Study|Protocol Violation|1|||
160947900|NCT01075321|581198341|FG003|Overall Study|Protocol Violation|0|||
160947901|NCT01075321|581198338|FG000|Overall Study|Treatment Incomplete due to progression|1|||
160947902|NCT01075321|581198339|FG001|Overall Study|Treatment Incomplete due to progression|0|||
160947903|NCT01075321|581198340|FG002|Overall Study|Treatment Incomplete due to progression|0|||
160947904|NCT01075321|581198341|FG003|Overall Study|Treatment Incomplete due to progression|0|||
160947905|NCT01075321|581198338|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
160947906|NCT01075321|581198339|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
160947907|NCT01075321|581198340|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
160947908|NCT01075321|581198341|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
160947909|NCT02646423|581198342|FG000|Overall Study|Adverse Event|5|||
160947910|NCT02646423|581198343|FG001|Overall Study|Adverse Event|7|||
160947911|NCT02646423|581198342|FG000|Overall Study|Ineligible|2|||
160947912|NCT02646423|581198343|FG001|Overall Study|Ineligible|1|||
160947913|NCT00003457|581198344|FG000|Overall Study|Not evaluable|9|||
160947914|NCT01054729|581198348|FG000|Overall Study|Randomized but Not Treated|0|||
160947915|NCT01054729|581198349|FG001|Overall Study|Randomized but Not Treated|1|||
160947916|NCT01054729|581198350|FG002|Overall Study|Randomized but Not Treated|0|||
160947917|NCT01054729|581198351|FG003|Overall Study|Randomized but Not Treated|0|||
160947918|NCT01054729|581198348|FG000|Overall Study|Adverse Event|1|||
160947919|NCT01054729|581198349|FG001|Overall Study|Adverse Event|1|||
160947920|NCT01054729|581198350|FG002|Overall Study|Adverse Event|2|||
160947921|NCT01054729|581198351|FG003|Overall Study|Adverse Event|1|||
160947922|NCT01054729|581198348|FG000|Overall Study|Withdrawal by Subject|1|||
160947923|NCT01054729|581198349|FG001|Overall Study|Withdrawal by Subject|0|||
160947924|NCT01054729|581198350|FG002|Overall Study|Withdrawal by Subject|1|||
160947925|NCT01054729|581198351|FG003|Overall Study|Withdrawal by Subject|0|||
160947926|NCT01054729|581198348|FG000|Overall Study|Lost to Follow-up|0|||
160947927|NCT01054729|581198349|FG001|Overall Study|Lost to Follow-up|1|||
160947928|NCT01054729|581198350|FG002|Overall Study|Lost to Follow-up|0|||
160947929|NCT01054729|581198351|FG003|Overall Study|Lost to Follow-up|0|||
160947930|NCT01054729|581198348|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
160947931|NCT01054729|581198349|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
160947932|NCT01054729|581198350|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
160947933|NCT01054729|581198351|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
160947934|NCT01054729|581198348|FG000|Overall Study|Non-responder|1|||
160947935|NCT01054729|581198349|FG001|Overall Study|Non-responder|0|||
160947936|NCT01054729|581198350|FG002|Overall Study|Non-responder|1|||
160947937|NCT01054729|581198351|FG003|Overall Study|Non-responder|1|||
160947938|NCT01054729|581198348|FG000|Overall Study|PEG/RBV Non-responder|1|||
160947939|NCT01054729|581198349|FG001|Overall Study|PEG/RBV Non-responder|0|||
160947940|NCT01054729|581198350|FG002|Overall Study|PEG/RBV Non-responder|1|||
160947941|NCT01054729|581198351|FG003|Overall Study|PEG/RBV Non-responder|0|||
160947942|NCT01054729|581198348|FG000|Overall Study|Personal/Obligations|0|||
160947943|NCT01054729|581198349|FG001|Overall Study|Personal/Obligations|1|||
160947944|NCT01054729|581198350|FG002|Overall Study|Personal/Obligations|0|||
160947945|NCT01054729|581198351|FG003|Overall Study|Personal/Obligations|0|||
160947946|NCT01054729|581198348|FG000|Overall Study|Subject moved|0|||
160947947|NCT01054729|581198349|FG001|Overall Study|Subject moved|0|||
160947948|NCT01054729|581198350|FG002|Overall Study|Subject moved|1|||
160947949|NCT01054729|581198351|FG003|Overall Study|Subject moved|0|||
160947950|NCT01054729|581198348|FG000|Overall Study|Lack of Efficacy|0|||
160947951|NCT01054729|581198349|FG001|Overall Study|Lack of Efficacy|0|||
160947952|NCT01054729|581198350|FG002|Overall Study|Lack of Efficacy|0|||
160947953|NCT01054729|581198351|FG003|Overall Study|Lack of Efficacy|1|||
160947954|NCT00321919|581198352|FG000|Overall Study|Adverse Event|17|||
160947955|NCT00321919|581198353|FG001|Overall Study|Adverse Event|10|||
160947956|NCT00321919|581198352|FG000|Overall Study|Death|21|||
160947957|NCT00321919|581198353|FG001|Overall Study|Death|17|||
160947958|NCT00321919|581198352|FG000|Overall Study|Insufficient Therapeutic Response|1|||
160947959|NCT00321919|581198353|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160947960|NCT00321919|581198352|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160947961|NCT00321919|581198353|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160947962|NCT00321919|581198352|FG000|Overall Study|Refused Treatment|23|||
160947963|NCT00321919|581198353|FG001|Overall Study|Refused Treatment|14|||
160947964|NCT00321919|581198352|FG000|Overall Study|Other Protocol Violation|2|||
160947965|NCT00321919|581198353|FG001|Overall Study|Other Protocol Violation|3|||
160947966|NCT00321919|581198352|FG000|Overall Study|Failure to Return|3|||
160947967|NCT00321919|581198353|FG001|Overall Study|Failure to Return|1|||
160947968|NCT00321919|581198352|FG000|Overall Study|Other withdrawal reason|7|||
160947969|NCT00321919|581198353|FG001|Overall Study|Other withdrawal reason|6|||
160947970|NCT02624804|581198354|FG000|Overall Study|Screen Failure|5|||
160947971|NCT02590354|581198355|FG000|Phase 1|Active hepatitis B or C infection|1|||
160947972|NCT02590354|581198355|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
160947973|NCT02590354|581198355|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
160947974|NCT02590354|581198355|FG000|Phase 1|Subject does not want to participate|20|||
160947975|NCT02590354|581198355|FG000|Phase 1|Lost to Follow-up|1|||
160947976|NCT02590354|581198355|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
160947977|NCT00996996|581198356|FG000|Overall Study|Progressive Disease|10|||
160947978|NCT00996996|581198356|FG000|Overall Study|Non-compliance|8|||
160947979|NCT00996996|581198356|FG000|Overall Study|Lost to Follow-up|9|||
160947980|NCT00996996|581198356|FG000|Overall Study|Death|5|||
160947981|NCT00996996|581198356|FG000|Overall Study|Did Not Receive Study Medications|1|||
160947982|NCT01227889|581198357|FG000|Randomized Phase (RP)|Adverse Event|13|||
160947983|NCT01227889|581198358|FG001|Randomized Phase (RP)|Adverse Event|0|||
160947984|NCT01227889|581198357|FG000|Randomized Phase (RP)|Physician Decision|13|||
160947985|NCT01227889|581198358|FG001|Randomized Phase (RP)|Physician Decision|5|||
160947986|NCT01227889|581198357|FG000|Randomized Phase (RP)|Progressive Disease|135|||
160947987|NCT01227889|581198358|FG001|Randomized Phase (RP)|Progressive Disease|52|||
160947988|NCT01227889|581198357|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
160947989|NCT01227889|581198358|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
161267042|NCT01103466|582361058|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161267043|NCT01103466|582361059|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161267044|NCT01103466|582361060|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161267045|NCT01103466|582361058|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
161267046|NCT01103466|582361059|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
161267047|NCT01103466|582361060|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
161267048|NCT01103466|582361058|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
161267049|NCT01103466|582361059|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161267050|NCT01103466|582361060|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
161267051|NCT01103466|582361058|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
161267052|NCT01103466|582361059|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
161267053|NCT01103466|582361060|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
161267054|NCT02994940|582361061|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
161267055|NCT02994940|582361062|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
161267056|NCT02994940|582361061|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
161267057|NCT02994940|582361062|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
161267058|NCT02994940|582361061|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
161267059|NCT02994940|582361062|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
161267060|NCT02987959|582361067|FG000|Overall Study|Grantor stopped supply of drugs|6|||
161267061|NCT04126213|582361070|FG000|Overall Study|Lost to Follow-up|9|||
161267062|NCT04126213|582361071|FG001|Overall Study|Lost to Follow-up|1|||
161267063|NCT04126213|582361072|FG002|Overall Study|Lost to Follow-up|5|||
161267064|NCT04126213|582361073|FG003|Overall Study|Lost to Follow-up|10|||
161267065|NCT04126213|582361074|FG004|Overall Study|Lost to Follow-up|4|||
161267066|NCT04126213|582361075|FG005|Overall Study|Lost to Follow-up|7|||
161267067|NCT04126213|582361070|FG000|Overall Study|Withdrawal by Subject|3|||
161267068|NCT04126213|582361071|FG001|Overall Study|Withdrawal by Subject|2|||
161267069|NCT04126213|582361072|FG002|Overall Study|Withdrawal by Subject|1|||
161267070|NCT04126213|582361073|FG003|Overall Study|Withdrawal by Subject|1|||
161267071|NCT04126213|582361074|FG004|Overall Study|Withdrawal by Subject|1|||
161267072|NCT04126213|582361075|FG005|Overall Study|Withdrawal by Subject|1|||
161267073|NCT04126213|582361070|FG000|Overall Study|Other|0|||
161267074|NCT04126213|582361071|FG001|Overall Study|Other|0|||
161267075|NCT04126213|582361072|FG002|Overall Study|Other|2|||
161267076|NCT04126213|582361073|FG003|Overall Study|Other|2|||
161267077|NCT04126213|582361074|FG004|Overall Study|Other|0|||
161267078|NCT04126213|582361075|FG005|Overall Study|Other|1|||
161267079|NCT04126213|582361070|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161267080|NCT04126213|582361071|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161267081|NCT04126213|582361072|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161267082|NCT04126213|582361073|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161267083|NCT04126213|582361074|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161267084|NCT04126213|582361075|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161267085|NCT02853370|582361076|FG000|Overall Study|Physician Decision|1|||
161267086|NCT02853370|582361076|FG000|Overall Study|Lack of Efficacy|2|||
161267087|NCT02853370|582361076|FG000|Overall Study|Death|1|||
161267088|NCT02853370|582361076|FG000|Overall Study|Adverse Event|4|||
161267089|NCT02853370|582361076|FG000|Overall Study|Withdrawal by Subject|3|||
161267090|NCT03283761|582361080|FG000|Study Treatment|Patient Non-Compliance|1|||
161267091|NCT03283761|582361080|FG000|Study Treatment|Alternative Cancer Therapy|7|||
160947990|NCT01227889|581198357|FG000|Randomized Phase (RP)|Missing|1|||
160947991|NCT01227889|581198358|FG001|Randomized Phase (RP)|Missing|3|||
160947992|NCT01227889|581198357|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
160947993|NCT01227889|581198358|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
160947994|NCT01227889|581198357|FG000|Crossover Phase|Adverse Event|0|||
160999706|NCT02148133|581382783|FG000|Overall Study|Protocol-defined stopping criteria|2|||
160999707|NCT03808883|581382784|FG000|Overall Study|Withdrawal by Subject|2|||
160999708|NCT03808883|581382785|FG001|Overall Study|Withdrawal by Subject|0|||
160999709|NCT03808883|581382784|FG000|Overall Study|Did not complete pre test or post test survey|4|||
160999710|NCT03808883|581382785|FG001|Overall Study|Did not complete pre test or post test survey|3|||
160999711|NCT00855465|581382787|FG000|Treatment Period|Adverse Event|4|||
160999712|NCT00855465|581382788|FG001|Treatment Period|Adverse Event|2|||
160999713|NCT00855465|581382787|FG000|Treatment Period|Death|2|||
160999714|NCT00855465|581382788|FG001|Treatment Period|Death|2|||
160999715|NCT00855465|581382787|FG000|Treatment Period|Lack of Efficacy|2|||
160999716|NCT00855465|581382788|FG001|Treatment Period|Lack of Efficacy|1|||
160999717|NCT00855465|581382787|FG000|Treatment Period|Non-compliance|1|||
160999718|NCT00855465|581382788|FG001|Treatment Period|Non-compliance|0|||
160999719|NCT00855465|581382787|FG000|Treatment Period|Protocol Violation|2|||
160999720|NCT00855465|581382788|FG001|Treatment Period|Protocol Violation|0|||
160999721|NCT00855465|581382787|FG000|Treatment Period|Withdrawal by Subject|2|||
161267092|NCT03283761|582361080|FG000|Study Treatment|Disease progression|21|||
161267093|NCT03283761|582361080|FG000|Study Treatment|Adverse Event|3|||
161267094|NCT03283761|582361080|FG000|Study Treatment|Withdrawal by Subject|4|||
161267095|NCT03283761|582361080|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
161267096|NCT03283761|582361080|FG000|Study Treatment|Symptomatic Deterioration|1|||
161267097|NCT03283761|582361080|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
161267098|NCT03283761|582361080|FG000|Follow up|Lost to Follow-up|1|||
161267099|NCT03283761|582361080|FG000|Follow up|Symptomatic Deterioration|1|||
161267100|NCT03283761|582361080|FG000|Follow up|Death|29|||
161267101|NCT03283761|582361080|FG000|Follow up|study terminated|4|||
161267102|NCT03283761|582361080|FG000|Follow up|Primary Investigator Withdrawal|1|||
161267103|NCT03283761|582361080|FG000|Follow up|Switched to alternative therapy|1|||
161267104|NCT03283761|582361080|FG000|Follow up|Subject is now in Hospice|1|||
161267105|NCT00741936|582361083|FG000|Overall Study|Lost to Follow-up|1|||
161267106|NCT00741936|582361084|FG001|Overall Study|Lost to Follow-up|1|||
161267107|NCT00741936|582361083|FG000|Overall Study|Adverse Event|3|||
161267108|NCT00741936|582361084|FG001|Overall Study|Adverse Event|4|||
161267109|NCT00741936|582361083|FG000|Overall Study|Pregnancy|0|||
161267110|NCT00741936|582361084|FG001|Overall Study|Pregnancy|1|||
161267111|NCT00741936|582361083|FG000|Overall Study|Protocol Violation|2|||
161267112|NCT00741936|582361084|FG001|Overall Study|Protocol Violation|0|||
161267113|NCT00741936|582361083|FG000|Overall Study|Lack of Efficacy|0|||
161267114|NCT00741936|582361084|FG001|Overall Study|Lack of Efficacy|2|||
161267115|NCT00741936|582361083|FG000|Overall Study|Low compliance|3|||
161267116|NCT00741936|582361084|FG001|Overall Study|Low compliance|0|||
161267117|NCT01941940|582361085|FG000|Overall Study|Adverse Event|11|||
161267118|NCT01941940|582361085|FG000|Overall Study|Lost to Follow-up|2|||
161267119|NCT01941940|582361085|FG000|Overall Study|Physician Decision|2|||
161267120|NCT01941940|582361085|FG000|Overall Study|Withdrawal by Subject|15|||
161267121|NCT01941940|582361085|FG000|Overall Study|Death|1|||
161267122|NCT01941940|582361085|FG000|Overall Study|Other|1|||
161267123|NCT01941940|582361085|FG000|Overall Study|Other|1|||
161267124|NCT00532935|582361086|FG000|Overall Study|Adverse Event|11|||
161267125|NCT00532935|582361087|FG001|Overall Study|Adverse Event|12|||
161267126|NCT00532935|582361086|FG000|Overall Study|Lack of Efficacy|0|||
161267127|NCT00532935|582361087|FG001|Overall Study|Lack of Efficacy|3|||
161267128|NCT00532935|582361086|FG000|Overall Study|Lost to Follow-up|10|||
161267129|NCT00532935|582361087|FG001|Overall Study|Lost to Follow-up|6|||
161267130|NCT00532935|582361086|FG000|Overall Study|Physician Decision|4|||
161267131|NCT00532935|582361087|FG001|Overall Study|Physician Decision|5|||
161267132|NCT00532935|582361086|FG000|Overall Study|Pregnancy|1|||
161267133|NCT00532935|582361087|FG001|Overall Study|Pregnancy|0|||
161267134|NCT00532935|582361086|FG000|Overall Study|Protocol Violation|4|||
161267135|NCT00532935|582361087|FG001|Overall Study|Protocol Violation|2|||
161267136|NCT00532935|582361086|FG000|Overall Study|Withdrawal by Subject|10|||
161267137|NCT00532935|582361087|FG001|Overall Study|Withdrawal by Subject|9|||
161342681|NCT00879658|582642237|FG006|Overall Study|Withdrawal by Subject|0|||
161342682|NCT00879658|582642231|FG000|Overall Study|Lack of Efficacy|0|||
161342683|NCT00879658|582642232|FG001|Overall Study|Lack of Efficacy|0|||
161267138|NCT00532935|582361086|FG000|Overall Study|Protocol Specific Criteria|11|||
161342684|NCT00879658|582642233|FG002|Overall Study|Lack of Efficacy|2|||
161342685|NCT00879658|582642234|FG003|Overall Study|Lack of Efficacy|0|||
161342686|NCT00879658|582642235|FG004|Overall Study|Lack of Efficacy|0|||
161342687|NCT00879658|582642236|FG005|Overall Study|Lack of Efficacy|0|||
160999722|NCT00855465|581382788|FG001|Treatment Period|Withdrawal by Subject|0|||
160999723|NCT00855465|581382787|FG000|Treatment Period|Not treated|1|||
161267139|NCT00532935|582361087|FG001|Overall Study|Protocol Specific Criteria|15|||
161267140|NCT03212521|582361090|FG000|Overall Study|Adverse Event|1|||
161267141|NCT03212521|582361090|FG000|Overall Study|Lost to Follow-up|4|||
161267142|NCT03212521|582361090|FG000|Overall Study|Withdrawal by Subject|1|||
161267143|NCT03212521|582361090|FG000|Overall Study|Other|1|||
161267144|NCT00914459|582361093|FG000|Overall Study|Protocol Violation|0|||
161342688|NCT00879658|582642237|FG006|Overall Study|Lack of Efficacy|0|||
160999724|NCT00855465|581382788|FG001|Treatment Period|Not treated|0|||
160999725|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Adverse Event|0|||
160999726|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Adverse Event|1|||
160999727|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Death|0|||
160999728|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Death|1|||
160999729|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
160999730|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
160999731|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
160999732|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
160999733|NCT00855465|581382787|FG000|Follow-up Period (FUP)|Missing|1|||
160999734|NCT00855465|581382788|FG001|Follow-up Period (FUP)|Missing|0|||
160999735|NCT04173572|581382799|FG000|Overall Study|Withdrawal by Subject|1|||
160999736|NCT04173572|581382800|FG001|Overall Study|Withdrawal by Subject|5|||
160999737|NCT04173572|581382799|FG000|Overall Study|Lost to Follow-up|3|||
160999738|NCT04173572|581382800|FG001|Overall Study|Lost to Follow-up|1|||
160999739|NCT00082810|581382802|FG000|Overall Study|Adverse Event|3|||
160999740|NCT00082810|581382802|FG000|Overall Study|Progressive disease|24|||
160999741|NCT00082810|581382802|FG000|Overall Study|Withdrawal by Subject|4|||
160999742|NCT02341625|581382803|FG000|Overall Study|Disease Progression|2|||
160999743|NCT02341625|581382804|FG001|Overall Study|Disease Progression|2|||
160999744|NCT02341625|581382805|FG002|Overall Study|Disease Progression|3|||
160999745|NCT02341625|581382806|FG003|Overall Study|Disease Progression|6|||
160999746|NCT02341625|581382807|FG004|Overall Study|Disease Progression|7|||
160999747|NCT02341625|581382808|FG005|Overall Study|Disease Progression|7|||
160999748|NCT02341625|581382809|FG006|Overall Study|Disease Progression|28|||
160999749|NCT02341625|581382810|FG007|Overall Study|Disease Progression|5|||
160999750|NCT02341625|581382811|FG008|Overall Study|Disease Progression|4|||
160999751|NCT02341625|581382812|FG009|Overall Study|Disease Progression|19|||
160999752|NCT02341625|581382803|FG000|Overall Study|Study Drug Toxicity|0|||
160999753|NCT02341625|581382804|FG001|Overall Study|Study Drug Toxicity|0|||
160999754|NCT02341625|581382805|FG002|Overall Study|Study Drug Toxicity|0|||
160999755|NCT02341625|581382806|FG003|Overall Study|Study Drug Toxicity|1|||
160999756|NCT02341625|581382807|FG004|Overall Study|Study Drug Toxicity|0|||
160999757|NCT02341625|581382808|FG005|Overall Study|Study Drug Toxicity|3|||
160999758|NCT02341625|581382809|FG006|Overall Study|Study Drug Toxicity|10|||
160999759|NCT02341625|581382810|FG007|Overall Study|Study Drug Toxicity|0|||
160999760|NCT02341625|581382811|FG008|Overall Study|Study Drug Toxicity|0|||
160999761|NCT02341625|581382812|FG009|Overall Study|Study Drug Toxicity|3|||
160999762|NCT02341625|581382803|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999763|NCT02341625|581382804|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999764|NCT02341625|581382805|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999765|NCT02341625|581382806|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999766|NCT02341625|581382807|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999767|NCT02341625|581382808|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999768|NCT02341625|581382809|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160999769|NCT02341625|581382810|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160999770|NCT02341625|581382811|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
160999771|NCT02341625|581382812|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160999772|NCT02341625|581382803|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999773|NCT02341625|581382804|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999774|NCT02341625|581382805|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999775|NCT02341625|581382806|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999776|NCT02341625|581382807|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999777|NCT02341625|581382808|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999778|NCT02341625|581382809|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
161144916|NCT00450866|581913998|FG001|Overall Study|Physician Decision|0|||
161144917|NCT01743027|581913999|FG000|Overall Study|Adverse Event|2|||
161144918|NCT01743027|581914000|FG001|Overall Study|Adverse Event|0|||
161144919|NCT01743027|581914001|FG002|Overall Study|Adverse Event|0|||
161144920|NCT01743027|581914002|FG003|Overall Study|Adverse Event|0|||
161144921|NCT01743027|581913999|FG000|Overall Study|Lost to Follow-up|0|||
161144922|NCT01743027|581914000|FG001|Overall Study|Lost to Follow-up|0|||
161144923|NCT01743027|581914001|FG002|Overall Study|Lost to Follow-up|2|||
161144924|NCT01743027|581914002|FG003|Overall Study|Lost to Follow-up|0|||
161144925|NCT01743027|581913999|FG000|Overall Study|Progressive Disease|1|||
161144926|NCT01743027|581914000|FG001|Overall Study|Progressive Disease|4|||
161144927|NCT01743027|581914001|FG002|Overall Study|Progressive Disease|3|||
161144928|NCT01743027|581914002|FG003|Overall Study|Progressive Disease|0|||
161144929|NCT01743027|581913999|FG000|Overall Study|Protocol Violation|1|||
161144930|NCT01743027|581914000|FG001|Overall Study|Protocol Violation|1|||
161144931|NCT01743027|581914001|FG002|Overall Study|Protocol Violation|1|||
160999779|NCT02341625|581382810|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
160999780|NCT02341625|581382811|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
160999781|NCT02341625|581382812|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
161144932|NCT01743027|581914002|FG003|Overall Study|Protocol Violation|0|||
161267145|NCT00914459|582361094|FG001|Overall Study|Protocol Violation|1|||
161267146|NCT00914459|582361093|FG000|Overall Study|Parent/Legal guardian request|1|||
161267147|NCT00914459|582361094|FG001|Overall Study|Parent/Legal guardian request|0|||
161267148|NCT03176459|582361095|FG000|Overall Study|Lost to Follow-up|5|||
161267149|NCT03176459|582361096|FG001|Overall Study|Lost to Follow-up|7|||
161267150|NCT01661179|582361097|FG000|Overall Study|Death|1|||
161267151|NCT01661179|582361097|FG000|Overall Study|Withdrawal by Subject|1|||
161267152|NCT01661179|582361097|FG000|Overall Study|Other Eligibility criteria|4|||
161267153|NCT01083810|582361098|FG000|Overall Study|Lost to Follow-up|23|||
161267154|NCT01083810|582361099|FG001|Overall Study|Lost to Follow-up|11|||
161267155|NCT01083810|582361100|FG002|Overall Study|Lost to Follow-up|4|||
161267156|NCT01083810|582361098|FG000|Overall Study|Adverse Event|15|||
161267157|NCT01083810|582361099|FG001|Overall Study|Adverse Event|11|||
161267158|NCT01083810|582361100|FG002|Overall Study|Adverse Event|4|||
161267159|NCT01083810|582361098|FG000|Overall Study|Withdrawal by Subject|7|||
161267160|NCT01083810|582361099|FG001|Overall Study|Withdrawal by Subject|2|||
161267161|NCT01083810|582361100|FG002|Overall Study|Withdrawal by Subject|4|||
161267162|NCT01083810|582361098|FG000|Overall Study|Reason not reported|6|||
161267163|NCT01083810|582361099|FG001|Overall Study|Reason not reported|1|||
161267164|NCT01083810|582361100|FG002|Overall Study|Reason not reported|1|||
161267165|NCT01083810|582361098|FG000|Overall Study|Non-compliance|4|||
161267166|NCT01083810|582361099|FG001|Overall Study|Non-compliance|7|||
161267167|NCT01083810|582361100|FG002|Overall Study|Non-compliance|2|||
161267168|NCT01083810|582361098|FG000|Overall Study|Simplification|4|||
161267169|NCT01083810|582361099|FG001|Overall Study|Simplification|1|||
161267170|NCT01083810|582361100|FG002|Overall Study|Simplification|0|||
161267171|NCT01083810|582361098|FG000|Overall Study|Death|2|||
161267172|NCT01083810|582361099|FG001|Overall Study|Death|2|||
161267173|NCT01083810|582361100|FG002|Overall Study|Death|3|||
161267174|NCT01083810|582361098|FG000|Overall Study|Co-morbidities|1|||
161267175|NCT01083810|582361099|FG001|Overall Study|Co-morbidities|0|||
161267176|NCT01083810|582361100|FG002|Overall Study|Co-morbidities|0|||
161267177|NCT01083810|582361098|FG000|Overall Study|Participation in study|1|||
161267178|NCT01083810|582361099|FG001|Overall Study|Participation in study|0|||
161267179|NCT01083810|582361100|FG002|Overall Study|Participation in study|0|||
161267180|NCT01083810|582361098|FG000|Overall Study|Therapy break|1|||
161267181|NCT01083810|582361099|FG001|Overall Study|Therapy break|2|||
161267182|NCT01083810|582361100|FG002|Overall Study|Therapy break|2|||
161267183|NCT01083810|582361098|FG000|Overall Study|Virologic failure|1|||
161267184|NCT01083810|582361099|FG001|Overall Study|Virologic failure|8|||
161267185|NCT01083810|582361100|FG002|Overall Study|Virologic failure|0|||
161267186|NCT01602965|582361101|FG000|Overall Study|Lost to Follow-up|4|||
161267187|NCT01602965|582361102|FG001|Overall Study|Lost to Follow-up|2|||
161267188|NCT00446199|582361105|FG000|Overall Study|Adverse Event|7|||
161267189|NCT00446199|582361106|FG001|Overall Study|Adverse Event|4|||
161267190|NCT00446199|582361107|FG002|Overall Study|Adverse Event|6|||
161267191|NCT00446199|582361108|FG003|Overall Study|Adverse Event|4|||
161267192|NCT00446199|582361105|FG000|Overall Study|Lost to Follow-up|4|||
161267193|NCT00446199|582361106|FG001|Overall Study|Lost to Follow-up|5|||
161267194|NCT00446199|582361107|FG002|Overall Study|Lost to Follow-up|2|||
161267195|NCT00446199|582361108|FG003|Overall Study|Lost to Follow-up|6|||
161267196|NCT00446199|582361105|FG000|Overall Study|Protocol Violation|1|||
161267197|NCT00446199|582361106|FG001|Overall Study|Protocol Violation|2|||
161267198|NCT00446199|582361107|FG002|Overall Study|Protocol Violation|1|||
161267199|NCT00446199|582361108|FG003|Overall Study|Protocol Violation|3|||
161267200|NCT00446199|582361105|FG000|Overall Study|Withdrawal by Subject|2|||
161267201|NCT00446199|582361106|FG001|Overall Study|Withdrawal by Subject|5|||
161267202|NCT00446199|582361107|FG002|Overall Study|Withdrawal by Subject|9|||
160947995|NCT01227889|581198358|FG001|Crossover Phase|Adverse Event|1|||
160947996|NCT01227889|581198357|FG000|Crossover Phase|Physician Decision|0|||
161267203|NCT00446199|582361108|FG003|Overall Study|Withdrawal by Subject|10|||
161267204|NCT00446199|582361105|FG000|Overall Study|Site termination|2|||
161267205|NCT00446199|582361106|FG001|Overall Study|Site termination|0|||
160947997|NCT01227889|581198358|FG001|Crossover Phase|Physician Decision|3|||
160947998|NCT01227889|581198357|FG000|Crossover Phase|Progressive Disease|0|||
160947999|NCT01227889|581198358|FG001|Crossover Phase|Progressive Disease|31|||
161267206|NCT00446199|582361107|FG002|Overall Study|Site termination|0|||
161267207|NCT00446199|582361108|FG003|Overall Study|Site termination|1|||
161267208|NCT00446199|582361105|FG000|Overall Study|Randomization in Error|2|||
161267209|NCT00446199|582361106|FG001|Overall Study|Randomization in Error|0|||
161267210|NCT00446199|582361107|FG002|Overall Study|Randomization in Error|1|||
161267211|NCT00446199|582361108|FG003|Overall Study|Randomization in Error|1|||
160948000|NCT01227889|581198357|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
161267212|NCT00446199|582361105|FG000|Overall Study|Lack of Efficacy|1|||
161267213|NCT00446199|582361106|FG001|Overall Study|Lack of Efficacy|0|||
161267214|NCT00446199|582361107|FG002|Overall Study|Lack of Efficacy|0|||
161267215|NCT00446199|582361108|FG003|Overall Study|Lack of Efficacy|1|||
161267216|NCT00446199|582361105|FG000|Overall Study|Non-compliant with study drug|1|||
161267217|NCT00446199|582361106|FG001|Overall Study|Non-compliant with study drug|0|||
160999782|NCT02341625|581382803|FG000|Overall Study|Participant Withdrew Consent|0|||
160999783|NCT02341625|581382804|FG001|Overall Study|Participant Withdrew Consent|0|||
160999784|NCT02341625|581382805|FG002|Overall Study|Participant Withdrew Consent|0|||
160999785|NCT02341625|581382806|FG003|Overall Study|Participant Withdrew Consent|1|||
160999786|NCT02341625|581382807|FG004|Overall Study|Participant Withdrew Consent|0|||
160999787|NCT02341625|581382808|FG005|Overall Study|Participant Withdrew Consent|0|||
160999788|NCT02341625|581382809|FG006|Overall Study|Participant Withdrew Consent|0|||
160999789|NCT02341625|581382810|FG007|Overall Study|Participant Withdrew Consent|0|||
160999790|NCT02341625|581382811|FG008|Overall Study|Participant Withdrew Consent|0|||
160999791|NCT02341625|581382812|FG009|Overall Study|Participant Withdrew Consent|0|||
161267218|NCT00446199|582361107|FG002|Overall Study|Non-compliant with study drug|5|||
161267219|NCT00446199|582361108|FG003|Overall Study|Non-compliant with study drug|0|||
161267220|NCT00446199|582361105|FG000|Overall Study|Non-compliant with visit schedule|1|||
161267221|NCT00446199|582361106|FG001|Overall Study|Non-compliant with visit schedule|1|||
161267222|NCT00446199|582361107|FG002|Overall Study|Non-compliant with visit schedule|1|||
161267223|NCT00446199|582361108|FG003|Overall Study|Non-compliant with visit schedule|2|||
161267224|NCT00446199|582361105|FG000|Overall Study|Hormone fear|0|||
161267225|NCT00446199|582361106|FG001|Overall Study|Hormone fear|0|||
161267226|NCT00446199|582361107|FG002|Overall Study|Hormone fear|0|||
161267227|NCT00446199|582361108|FG003|Overall Study|Hormone fear|1|||
161267228|NCT00446199|582361105|FG000|Overall Study|Lost interest in study participation|0|||
161267229|NCT00446199|582361106|FG001|Overall Study|Lost interest in study participation|1|||
161267230|NCT00446199|582361107|FG002|Overall Study|Lost interest in study participation|0|||
161267231|NCT00446199|582361108|FG003|Overall Study|Lost interest in study participation|0|||
161267232|NCT00446199|582361105|FG000|Overall Study|In-/Exclusion criterion violated|2|||
161267233|NCT00446199|582361106|FG001|Overall Study|In-/Exclusion criterion violated|1|||
161267234|NCT00446199|582361107|FG002|Overall Study|In-/Exclusion criterion violated|2|||
161267235|NCT00446199|582361108|FG003|Overall Study|In-/Exclusion criterion violated|1|||
161267236|NCT00446199|582361105|FG000|Overall Study|Move|0|||
161267237|NCT00446199|582361106|FG001|Overall Study|Move|1|||
161267238|NCT00446199|582361107|FG002|Overall Study|Move|0|||
161267239|NCT00446199|582361108|FG003|Overall Study|Move|0|||
161267240|NCT01079832|582361109|FG000|Overall Study|Withdrawal by Subject|1|||
161267241|NCT00290251|582361110|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161267242|NCT00290251|582361111|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161267243|NCT00290251|582361112|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161267244|NCT00290251|582361113|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161267245|NCT00290251|582361114|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
161267246|NCT00290251|582361115|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
161267247|NCT00290251|582361110|FG000|Treatment 1 (Months 2-4)|headache|0|||
161267248|NCT00290251|582361111|FG001|Treatment 1 (Months 2-4)|headache|0|||
161267249|NCT00290251|582361112|FG002|Treatment 1 (Months 2-4)|headache|0|||
161267250|NCT00290251|582361113|FG003|Treatment 1 (Months 2-4)|headache|0|||
161267251|NCT00290251|582361114|FG004|Treatment 1 (Months 2-4)|headache|1|||
161267252|NCT00290251|582361115|FG005|Treatment 1 (Months 2-4)|headache|0|||
161267253|NCT00290251|582361110|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
161267254|NCT00290251|582361111|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
161267255|NCT00290251|582361112|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
161267256|NCT00290251|582361113|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
161267257|NCT00290251|582361114|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
161267258|NCT00290251|582361115|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
161267259|NCT04941729|582363289|FG000|Overall Study|Death|0|||
161267260|NCT04941729|582363290|FG001|Overall Study|Death|1|||
161267261|NCT04941729|582363289|FG000|Overall Study|Study terminated by sponsor|11|||
161267262|NCT04941729|582363290|FG001|Overall Study|Study terminated by sponsor|10|||
161267263|NCT00006721|582363291|FG000|Overall Study|Adverse Event|0|||
160999792|NCT02341625|581382803|FG000|Overall Study|Completed Treatment as per Protocol|0|||
161267264|NCT00006721|582363292|FG001|Overall Study|Adverse Event|4|||
161267265|NCT00006721|582363293|FG002|Overall Study|Adverse Event|4|||
161267266|NCT00006721|582363291|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161267267|NCT00006721|582363292|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
161267268|NCT00006721|582363293|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
161267269|NCT00006721|582363291|FG000|Overall Study|Progression/Relapse|0|||
160999793|NCT02341625|581382804|FG001|Overall Study|Completed Treatment as per Protocol|0|||
160999794|NCT02341625|581382805|FG002|Overall Study|Completed Treatment as per Protocol|0|||
160999795|NCT02341625|581382806|FG003|Overall Study|Completed Treatment as per Protocol|0|||
160999796|NCT02341625|581382807|FG004|Overall Study|Completed Treatment as per Protocol|0|||
160999797|NCT02341625|581382808|FG005|Overall Study|Completed Treatment as per Protocol|0|||
161267270|NCT00006721|582363292|FG001|Overall Study|Progression/Relapse|1|||
161267271|NCT00006721|582363293|FG002|Overall Study|Progression/Relapse|2|||
161267272|NCT00006721|582363291|FG000|Overall Study|Death|0|||
161267273|NCT00006721|582363292|FG001|Overall Study|Death|1|||
161342689|NCT00879658|582642231|FG000|Overall Study|misrandomized (never received study med)|0|||
161342690|NCT00879658|582642232|FG001|Overall Study|misrandomized (never received study med)|0|||
160948001|NCT01227889|581198358|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
160948002|NCT01227889|581198357|FG000|Crossover Phase|Withdrawal by Subject|0|||
160948003|NCT01227889|581198358|FG001|Crossover Phase|Withdrawal by Subject|1|||
160948004|NCT01148810|581198361|FG000|Overall Study|Adverse Event|0|||
161144933|NCT01743027|581913999|FG000|Overall Study|Withdrawal by Subject|1|||
161144934|NCT01743027|581914000|FG001|Overall Study|Withdrawal by Subject|0|||
161144935|NCT01743027|581914001|FG002|Overall Study|Withdrawal by Subject|3|||
160948005|NCT01148810|581198362|FG001|Overall Study|Adverse Event|2|||
160948006|NCT01148810|581198361|FG000|Overall Study|Lack of Efficacy|0|||
160948007|NCT01148810|581198362|FG001|Overall Study|Lack of Efficacy|1|||
160948008|NCT01148810|581198361|FG000|Overall Study|Withdrawal by Subject|0|||
160948009|NCT01148810|581198362|FG001|Overall Study|Withdrawal by Subject|2|||
160948010|NCT01148810|581198361|FG000|Overall Study|Protocol Violation|1|||
160948011|NCT01148810|581198362|FG001|Overall Study|Protocol Violation|0|||
160948012|NCT02731131|581198369|FG000|Overall Study|Psychiatric Disorder|0|||
160948013|NCT02731131|581198370|FG001|Overall Study|Psychiatric Disorder|1|||
160948014|NCT02731131|581198369|FG000|Overall Study|Refused Therapy|0|||
160948015|NCT02731131|581198370|FG001|Overall Study|Refused Therapy|1|||
160948016|NCT02348216|581198376|FG000|Overall Study|Death|5|||
160948017|NCT02348216|581198377|FG001|Overall Study|Death|53|||
160948018|NCT02348216|581198378|FG002|Overall Study|Death|11|||
160948019|NCT02348216|581198379|FG003|Overall Study|Death|20|||
160948020|NCT02348216|581198380|FG004|Overall Study|Death|16|||
160948021|NCT02348216|581198381|FG005|Overall Study|Death|32|||
160948022|NCT02348216|581198382|FG006|Overall Study|Death|17|||
160948023|NCT02348216|581198376|FG000|Overall Study|Full consent withdrawal|0|||
160948024|NCT02348216|581198377|FG001|Overall Study|Full consent withdrawal|0|||
160948025|NCT02348216|581198378|FG002|Overall Study|Full consent withdrawal|0|||
160948026|NCT02348216|581198379|FG003|Overall Study|Full consent withdrawal|1|||
160948027|NCT02348216|581198380|FG004|Overall Study|Full consent withdrawal|3|||
160948028|NCT02348216|581198381|FG005|Overall Study|Full consent withdrawal|0|||
160948029|NCT02348216|581198382|FG006|Overall Study|Full consent withdrawal|3|||
160948030|NCT02348216|581198376|FG000|Overall Study|Lost to Follow-up|0|||
160948031|NCT02348216|581198377|FG001|Overall Study|Lost to Follow-up|5|||
160948032|NCT02348216|581198378|FG002|Overall Study|Lost to Follow-up|2|||
160948033|NCT02348216|581198379|FG003|Overall Study|Lost to Follow-up|0|||
160948034|NCT02348216|581198380|FG004|Overall Study|Lost to Follow-up|1|||
160948035|NCT02348216|581198381|FG005|Overall Study|Lost to Follow-up|1|||
160948036|NCT02348216|581198382|FG006|Overall Study|Lost to Follow-up|1|||
160948037|NCT02348216|581198376|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
160948038|NCT02348216|581198377|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
160948039|NCT02348216|581198378|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
160948040|NCT02348216|581198379|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
160948041|NCT02348216|581198380|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
160948042|NCT02348216|581198381|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
161144936|NCT01743027|581914002|FG003|Overall Study|Withdrawal by Subject|1|||
161144937|NCT00138151|581914003|FG000|Overall Study|Withdrawal by Subject|3|||
161144938|NCT00138151|581914003|FG000|Overall Study|Physician Decision|1|||
161144939|NCT04925570|581914006|FG000|Overall Study|Protocol Violation|24|||
161144940|NCT04925570|581914007|FG001|Overall Study|Protocol Violation|30|||
161144941|NCT04925570|581914006|FG000|Overall Study|Withdrawal by Subject|0|||
161144942|NCT04925570|581914007|FG001|Overall Study|Withdrawal by Subject|2|||
161144943|NCT02675517|581914008|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
161144944|NCT02675517|581914008|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
161144945|NCT01088412|581914009|FG000|Overall Study|Adverse Event|38|||
161144946|NCT01088412|581914010|FG001|Overall Study|Adverse Event|0|||
161267274|NCT00006721|582363293|FG002|Overall Study|Death|2|||
161267275|NCT00006721|582363291|FG000|Overall Study|Other - Not Protocol Specified|0|||
160948043|NCT02348216|581198382|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
160948044|NCT02348216|581198376|FG000|Overall Study|Reason not specified|2|||
160948045|NCT02348216|581198377|FG001|Overall Study|Reason not specified|19|||
160948046|NCT02348216|581198378|FG002|Overall Study|Reason not specified|11|||
160948047|NCT02348216|581198379|FG003|Overall Study|Reason not specified|17|||
160948048|NCT02348216|581198380|FG004|Overall Study|Reason not specified|21|||
161144947|NCT01088412|581914011|FG002|Overall Study|Adverse Event|0|||
161144948|NCT01088412|581914009|FG000|Overall Study|Death|42|||
161144949|NCT01088412|581914010|FG001|Overall Study|Death|6|||
161144950|NCT01088412|581914011|FG002|Overall Study|Death|0|||
161144951|NCT01088412|581914009|FG000|Overall Study|Other Reason per Case Report Form|2089|||
161267276|NCT00006721|582363292|FG001|Overall Study|Other - Not Protocol Specified|7|||
160948049|NCT02348216|581198381|FG005|Overall Study|Reason not specified|17|||
160948050|NCT02348216|581198382|FG006|Overall Study|Reason not specified|19|||
161144952|NCT01088412|581914010|FG001|Overall Study|Other Reason per Case Report Form|103|||
161144953|NCT01088412|581914011|FG002|Overall Study|Other Reason per Case Report Form|9|||
161144954|NCT01088412|581914009|FG000|Overall Study|Withdrawal by Subject|1761|||
161144955|NCT01088412|581914010|FG001|Overall Study|Withdrawal by Subject|25|||
161144956|NCT01088412|581914011|FG002|Overall Study|Withdrawal by Subject|1|||
161144957|NCT01088412|581914009|FG000|Overall Study|Received Another GH Product|79|||
161144958|NCT01088412|581914010|FG001|Overall Study|Received Another GH Product|0|||
161144959|NCT01088412|581914011|FG002|Overall Study|Received Another GH Product|0|||
161144960|NCT01088412|581914009|FG000|Overall Study|Participant Moved|601|||
161144961|NCT01088412|581914010|FG001|Overall Study|Participant Moved|21|||
161144962|NCT01088412|581914011|FG002|Overall Study|Participant Moved|2|||
161144963|NCT01088412|581914009|FG000|Overall Study|Physician Decision|1041|||
160948051|NCT01055639|581198383|FG000|Overall Study|Adverse Event|0|||
160948052|NCT01055639|581198384|FG001|Overall Study|Adverse Event|1|||
160948053|NCT01055639|581198383|FG000|Overall Study|Lack of Efficacy|0|||
160948054|NCT01055639|581198384|FG001|Overall Study|Lack of Efficacy|1|||
160948055|NCT01055639|581198383|FG000|Overall Study|Lost to Follow-up|8|||
160948056|NCT01055639|581198384|FG001|Overall Study|Lost to Follow-up|11|||
160948057|NCT01055639|581198383|FG000|Overall Study|Protocol Violation|5|||
160948058|NCT01055639|581198384|FG001|Overall Study|Protocol Violation|5|||
160948059|NCT01055639|581198383|FG000|Overall Study|Withdrawal by Subject|8|||
160948060|NCT01055639|581198384|FG001|Overall Study|Withdrawal by Subject|11|||
160948061|NCT00765245|581198385|FG000|Overall Study|disease progression|3|||
160948062|NCT00765245|581198386|FG001|Overall Study|disease progression|2|||
160948063|NCT00765245|581198385|FG000|Overall Study|Withdrawal by Subject|3|||
161144964|NCT01088412|581914010|FG001|Overall Study|Physician Decision|8|||
161144965|NCT01088412|581914011|FG002|Overall Study|Physician Decision|4|||
161144966|NCT01088412|581914009|FG000|Overall Study|Sponsor Decision|4467|||
161144967|NCT01088412|581914010|FG001|Overall Study|Sponsor Decision|79|||
161144968|NCT01088412|581914011|FG002|Overall Study|Sponsor Decision|23|||
161144969|NCT01088412|581914009|FG000|Overall Study|Third Party Required to Change Brand|487|||
160948064|NCT00765245|581198386|FG001|Overall Study|Withdrawal by Subject|0|||
160948065|NCT00765245|581198385|FG000|Overall Study|Adverse Event|5|||
160948066|NCT00765245|581198386|FG001|Overall Study|Adverse Event|0|||
160948067|NCT00765245|581198385|FG000|Overall Study|Physician Decision|1|||
160948068|NCT00765245|581198386|FG001|Overall Study|Physician Decision|0|||
160948069|NCT00765245|581198385|FG000|Overall Study|Death|1|||
160948070|NCT00765245|581198386|FG001|Overall Study|Death|0|||
160948071|NCT02079805|581198388|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
160948072|NCT02079805|581198389|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
160948073|NCT02079805|581198388|FG000|Overall Study|Voluntary Withdrawal|0|||
160948074|NCT02079805|581198389|FG001|Overall Study|Voluntary Withdrawal|1|||
160948075|NCT01753193|581198390|FG000|Overall Study|Withdrawal by Subject|23|||
160948076|NCT01753193|581198390|FG000|Overall Study|Lost to Follow-up|6|||
160948077|NCT01753193|581198390|FG000|Overall Study|Death|1|||
160948078|NCT01753193|581198390|FG000|Overall Study|Other|16|||
160948079|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
160948080|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
160948081|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
160948082|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
160948083|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
160948084|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
160948085|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
160948086|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
160948087|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
160948088|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
160948089|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
160948090|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
160948091|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
160948092|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
160948093|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161144970|NCT01088412|581914010|FG001|Overall Study|Third Party Required to Change Brand|0|||
160948094|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
160948095|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
160948096|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
160948097|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
160948098|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
160948099|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
160948100|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
161144971|NCT01088412|581914011|FG002|Overall Study|Third Party Required to Change Brand|0|||
161144972|NCT01088412|581914009|FG000|Overall Study|Lost to Follow-up|3052|||
161144973|NCT01088412|581914010|FG001|Overall Study|Lost to Follow-up|130|||
161144974|NCT01088412|581914011|FG002|Overall Study|Lost to Follow-up|11|||
161144975|NCT01088412|581914009|FG000|Overall Study|Study Summary Not Completed|4360|||
161144976|NCT01088412|581914010|FG001|Overall Study|Study Summary Not Completed|64|||
161144977|NCT01088412|581914011|FG002|Overall Study|Study Summary Not Completed|22|||
161267277|NCT00006721|582363293|FG002|Overall Study|Other - Not Protocol Specified|7|||
161267278|NCT00006721|582363291|FG000|Overall Study|Ineligible|2|||
161267279|NCT00006721|582363292|FG001|Overall Study|Ineligible|12|||
161267280|NCT00006721|582363293|FG002|Overall Study|Ineligible|10|||
161267281|NCT00006721|582363291|FG000|Overall Study|Eligible but no Treatment Received|1|||
161267282|NCT00006721|582363292|FG001|Overall Study|Eligible but no Treatment Received|0|||
161267283|NCT00006721|582363293|FG002|Overall Study|Eligible but no Treatment Received|0|||
161267284|NCT03845296|582363294|FG000|Overall Study|On Treatment|2|||
161267285|NCT03845296|582363295|FG001|Overall Study|On Treatment|1|||
161267286|NCT03845296|582363294|FG000|Overall Study|Adverse Event|4|||
161267287|NCT03845296|582363295|FG001|Overall Study|Adverse Event|11|||
161267288|NCT03845296|582363294|FG000|Overall Study|Refusal unrelated to adverse event|0|||
161267289|NCT03845296|582363295|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161267290|NCT03845296|582363294|FG000|Overall Study|Progression/relapse|14|||
161267291|NCT03845296|582363295|FG001|Overall Study|Progression/relapse|18|||
161267292|NCT03845296|582363294|FG000|Overall Study|Death|4|||
161267293|NCT03845296|582363295|FG001|Overall Study|Death|0|||
161267294|NCT03845296|582363294|FG000|Overall Study|Other - not protocol specified|1|||
161267295|NCT03845296|582363295|FG001|Overall Study|Other - not protocol specified|3|||
161267296|NCT05424042|582363296|FG000|Overall Study|Withdrawal by Subject|2|||
161267297|NCT05424042|582363297|FG001|Overall Study|Withdrawal by Subject|0|||
161267298|NCT05424042|582363298|FG002|Overall Study|Withdrawal by Subject|4|||
161267299|NCT05424042|582363296|FG000|Overall Study|Lost to Follow-up|0|||
161267300|NCT05424042|582363297|FG001|Overall Study|Lost to Follow-up|0|||
161267301|NCT05424042|582363298|FG002|Overall Study|Lost to Follow-up|1|||
161267302|NCT05091307|582363299|FG000|Overall Study|Death|0|||
161267303|NCT05091307|582363300|FG001|Overall Study|Death|0|||
161267304|NCT05091307|582363301|FG002|Overall Study|Death|1|||
160948101|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
160948102|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
160948103|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
160948104|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
160948105|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
160948106|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
160948107|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
160948108|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
160948109|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
160948110|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
160948111|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
160948112|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
160948113|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
160948114|NCT00383435|581198391|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
160948115|NCT00383435|581198392|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
160948116|NCT00383435|581198393|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
160948117|NCT00383435|581198394|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
160948118|NCT00383435|581198395|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
160948119|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
160948120|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
160948121|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
160948122|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
160948123|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
160948124|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160948125|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160948126|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
160948127|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161267305|NCT05091307|582363302|FG003|Overall Study|Death|0|||
160948128|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
160948129|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161267306|NCT05091307|582363299|FG000|Overall Study|Lost to Follow-up|33|||
161267307|NCT05091307|582363300|FG001|Overall Study|Lost to Follow-up|33|||
161342691|NCT00879658|582642233|FG002|Overall Study|misrandomized (never received study med)|0|||
160948130|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
160948131|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
160948132|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
160948133|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
160948134|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
160948135|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
161144978|NCT00793104|581914012|FG000|Overall Study|Lost to Follow-up|1|||
161267308|NCT05091307|582363301|FG002|Overall Study|Lost to Follow-up|2|||
161267309|NCT05091307|582363302|FG003|Overall Study|Lost to Follow-up|0|||
160948136|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
160948137|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
160948138|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
160948139|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160948140|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
160948141|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
160948142|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
160948143|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
160948144|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
160948145|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160948146|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160948147|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
160948148|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
160948149|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160948150|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160948151|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160948152|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
160948153|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
160948154|NCT00383435|581198391|FG000|26-Week Treatment Safety Extension|Administrative|1|||
160948155|NCT00383435|581198392|FG001|26-Week Treatment Safety Extension|Administrative|1|||
160948156|NCT00383435|581198393|FG002|26-Week Treatment Safety Extension|Administrative|0|||
160948157|NCT00383435|581198394|FG003|26-Week Treatment Safety Extension|Administrative|1|||
160948158|NCT00383435|581198395|FG004|26-Week Treatment Safety Extension|Administrative|0|||
160948159|NCT00583557|581198396|FG000|Overall Study|Withdrawal by Subject|18|||
160948160|NCT00583557|581198396|FG000|Overall Study|Adverse Event|9|||
160948161|NCT00583557|581198396|FG000|Overall Study|Lack of Efficacy|31|||
160948162|NCT00583557|581198396|FG000|Overall Study|Lack of Compliance|5|||
160948163|NCT00583557|581198396|FG000|Overall Study|Other|5|||
160948164|NCT00583557|581198396|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
160948165|NCT01131312|581198397|FG000|Overall Study|Lost to Follow-up|425|||
160948166|NCT01131312|581198398|FG001|Overall Study|Lost to Follow-up|229|||
160948167|NCT01131312|581198399|FG002|Overall Study|Lost to Follow-up|351|||
160948168|NCT02347761|581198400|FG000|All Collected|Death|1|||
160948169|NCT02347761|581198401|FG001|All Collected|Death|0|||
160948170|NCT02347761|581198402|FG002|All Collected|Death|0|||
160948171|NCT02347761|581198400|FG000|All Collected|Lost to Follow-up|3|||
160948172|NCT02347761|581198401|FG001|All Collected|Lost to Follow-up|2|||
160948173|NCT02347761|581198402|FG002|All Collected|Lost to Follow-up|3|||
160948174|NCT02347761|581198400|FG000|All Collected|Withdrawal by Subject|11|||
160948175|NCT02347761|581198401|FG001|All Collected|Withdrawal by Subject|11|||
160948176|NCT02347761|581198402|FG002|All Collected|Withdrawal by Subject|22|||
160948177|NCT02347761|581198400|FG000|All Collected|invetigator disretion|2|||
160948178|NCT02347761|581198401|FG001|All Collected|invetigator disretion|0|||
160948179|NCT02347761|581198402|FG002|All Collected|invetigator disretion|0|||
160948180|NCT02347761|581198400|FG000|All Collected|instillation site pain|0|||
160948181|NCT02347761|581198401|FG001|All Collected|instillation site pain|0|||
160948182|NCT02347761|581198402|FG002|All Collected|instillation site pain|1|||
160948183|NCT02347761|581198400|FG000|All Collected|exacerbation of COPD|0|||
160948184|NCT02347761|581198401|FG001|All Collected|exacerbation of COPD|0|||
160948185|NCT02347761|581198402|FG002|All Collected|exacerbation of COPD|1|||
160948186|NCT02347761|581198400|FG000|All Collected|moved/travel|0|||
160948187|NCT02347761|581198401|FG001|All Collected|moved/travel|1|||
160948188|NCT02347761|581198402|FG002|All Collected|moved/travel|0|||
160948189|NCT02347761|581198400|FG000|On Study Treatment|Lack of Efficacy|2|||
160948190|NCT02347761|581198401|FG001|On Study Treatment|Lack of Efficacy|3|||
160948191|NCT02347761|581198402|FG002|On Study Treatment|Lack of Efficacy|4|||
160948192|NCT02347761|581198400|FG000|On Study Treatment|non-compliance with study medication|0|||
160948193|NCT02347761|581198401|FG001|On Study Treatment|non-compliance with study medication|0|||
160948194|NCT02347761|581198402|FG002|On Study Treatment|non-compliance with study medication|2|||
160948195|NCT02347761|581198400|FG000|On Study Treatment|Withdrawal by Subject|7|||
160948196|NCT02347761|581198401|FG001|On Study Treatment|Withdrawal by Subject|3|||
160948197|NCT02347761|581198402|FG002|On Study Treatment|Withdrawal by Subject|5|||
160948198|NCT02347761|581198400|FG000|On Study Treatment|move/travel|2|||
160948199|NCT02347761|581198401|FG001|On Study Treatment|move/travel|6|||
160999798|NCT02341625|581382809|FG006|Overall Study|Completed Treatment as per Protocol|0|||
160948200|NCT02347761|581198402|FG002|On Study Treatment|move/travel|5|||
160948201|NCT02347761|581198400|FG000|On Study Treatment|dissastisfaction with device|2|||
160948202|NCT02347761|581198401|FG001|On Study Treatment|dissastisfaction with device|1|||
160948203|NCT02347761|581198402|FG002|On Study Treatment|dissastisfaction with device|4|||
160948204|NCT02347761|581198400|FG000|On Study Treatment|Lost to Follow-up|2|||
160948205|NCT02347761|581198401|FG001|On Study Treatment|Lost to Follow-up|1|||
160948206|NCT02347761|581198402|FG002|On Study Treatment|Lost to Follow-up|1|||
160948207|NCT02347761|581198400|FG000|On Study Treatment|investigator discretion|2|||
160948208|NCT02347761|581198401|FG001|On Study Treatment|investigator discretion|0|||
160948209|NCT02347761|581198402|FG002|On Study Treatment|investigator discretion|0|||
160948210|NCT02347761|581198400|FG000|On Study Treatment|durg not working|0|||
160948211|NCT02347761|581198401|FG001|On Study Treatment|durg not working|1|||
160948212|NCT02347761|581198402|FG002|On Study Treatment|durg not working|1|||
160948213|NCT02347761|581198400|FG000|On Study Treatment|Adverse Event|10|||
160948214|NCT02347761|581198401|FG001|On Study Treatment|Adverse Event|8|||
160948215|NCT02347761|581198402|FG002|On Study Treatment|Adverse Event|20|||
160999799|NCT02341625|581382810|FG007|Overall Study|Completed Treatment as per Protocol|0|||
161267310|NCT05091307|582363299|FG000|Overall Study|Physician Decision|1|||
161267311|NCT05091307|582363300|FG001|Overall Study|Physician Decision|0|||
161267312|NCT05091307|582363301|FG002|Overall Study|Physician Decision|0|||
161267313|NCT05091307|582363302|FG003|Overall Study|Physician Decision|0|||
161267314|NCT05091307|582363299|FG000|Overall Study|Protocol Violation|1|||
161267315|NCT05091307|582363300|FG001|Overall Study|Protocol Violation|0|||
161267316|NCT05091307|582363301|FG002|Overall Study|Protocol Violation|0|||
161267317|NCT05091307|582363302|FG003|Overall Study|Protocol Violation|0|||
161267318|NCT05091307|582363299|FG000|Overall Study|Withdrawal by Subject|16|||
161267319|NCT05091307|582363300|FG001|Overall Study|Withdrawal by Subject|16|||
161267320|NCT05091307|582363301|FG002|Overall Study|Withdrawal by Subject|0|||
161267321|NCT05091307|582363302|FG003|Overall Study|Withdrawal by Subject|1|||
161267322|NCT05091307|582363299|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
161267323|NCT05091307|582363300|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
161267324|NCT05091307|582363301|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
161267325|NCT05091307|582363302|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
161267326|NCT05091307|582363299|FG000|Overall Study|Initiated Prohibited Medication|1|||
161267327|NCT05091307|582363300|FG001|Overall Study|Initiated Prohibited Medication|0|||
161267328|NCT05091307|582363301|FG002|Overall Study|Initiated Prohibited Medication|0|||
161267329|NCT05091307|582363302|FG003|Overall Study|Initiated Prohibited Medication|0|||
161267330|NCT05091307|582363299|FG000|Overall Study|Other|4|||
161267331|NCT05091307|582363300|FG001|Overall Study|Other|4|||
161267332|NCT05091307|582363301|FG002|Overall Study|Other|0|||
161267333|NCT05091307|582363302|FG003|Overall Study|Other|0|||
161267334|NCT05091307|582363299|FG000|Overall Study|Randomized but not vaccinated|0|||
161267335|NCT05091307|582363300|FG001|Overall Study|Randomized but not vaccinated|2|||
161267336|NCT05091307|582363301|FG002|Overall Study|Randomized but not vaccinated|0|||
161267337|NCT05091307|582363302|FG003|Overall Study|Randomized but not vaccinated|0|||
161267338|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Death|89|||
161267339|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Death|193|||
161267340|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Death|198|||
161267341|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
161267342|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
161267343|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
161267344|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
161267345|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
161267346|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
161267347|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
161267348|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
161267349|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
161267350|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
161267351|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
161267352|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
161267353|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
161267354|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
161267355|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
161267356|NCT02031458|582363305|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
161267357|NCT02031458|582363306|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
161267358|NCT02031458|582363307|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
160948216|NCT02682264|581198403|FG000|Overall Study|Withdrawal by Subject|56|||
160948217|NCT02682264|581198404|FG001|Overall Study|Withdrawal by Subject|45|||
160948218|NCT02682264|581198403|FG000|Overall Study|Lost to Follow-up|49|||
160948219|NCT02682264|581198404|FG001|Overall Study|Lost to Follow-up|41|||
160948220|NCT02682264|581198403|FG000|Overall Study|Lack of Efficacy|14|||
160948221|NCT02682264|581198404|FG001|Overall Study|Lack of Efficacy|16|||
160948222|NCT02682264|581198403|FG000|Overall Study|Withdrawal by Parent|6|||
161267359|NCT02031458|582363305|FG000|Baseline to May 8, 2015|Death|36|||
161267360|NCT02031458|582363306|FG001|Baseline to May 8, 2015|Death|87|||
161342692|NCT00879658|582642234|FG003|Overall Study|misrandomized (never received study med)|1|||
160948223|NCT02682264|581198404|FG001|Overall Study|Withdrawal by Parent|7|||
161267361|NCT02031458|582363307|FG002|Baseline to May 8, 2015|Death|100|||
161267362|NCT02031458|582363305|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
161144979|NCT03494725|581914015|FG000|Overall Study|Withdrawal by Subject|0|||
161144980|NCT03494725|581914016|FG001|Overall Study|Withdrawal by Subject|2|||
161342693|NCT00879658|582642235|FG004|Overall Study|misrandomized (never received study med)|0|||
160948224|NCT02682264|581198403|FG000|Overall Study|Adverse Event|9|||
160948225|NCT02682264|581198404|FG001|Overall Study|Adverse Event|0|||
160948226|NCT02682264|581198403|FG000|Overall Study|Noncompliance with study drug|1|||
160948227|NCT02682264|581198404|FG001|Overall Study|Noncompliance with study drug|4|||
160948228|NCT02682264|581198403|FG000|Overall Study|Pregnancy|1|||
160948229|NCT02682264|581198404|FG001|Overall Study|Pregnancy|2|||
160948230|NCT02682264|581198403|FG000|Overall Study|Recovery|1|||
160948231|NCT02682264|581198404|FG001|Overall Study|Recovery|2|||
160948232|NCT02682264|581198403|FG000|Overall Study|Progressive Disease|1|||
160948233|NCT02682264|581198404|FG001|Overall Study|Progressive Disease|0|||
160948234|NCT02682264|581198403|FG000|Overall Study|Technical Problems|0|||
160948235|NCT02682264|581198404|FG001|Overall Study|Technical Problems|1|||
160948236|NCT02682264|581198403|FG000|Overall Study|Moved abroad and unable to continue|0|||
160948237|NCT02682264|581198404|FG001|Overall Study|Moved abroad and unable to continue|3|||
160948238|NCT02682264|581198403|FG000|Overall Study|Stopped test article application|0|||
160948239|NCT02682264|581198404|FG001|Overall Study|Stopped test article application|1|||
160948240|NCT01255358|581198405|FG000|Overall Study|Adverse Event|2|||
160948241|NCT01255358|581198405|FG000|Overall Study|Protocol Violation|2|||
160948242|NCT04079933|581198408|FG000|Overall Study|Withdrawal by Subject|3|||
160948243|NCT04079933|581198409|FG001|Overall Study|Withdrawal by Subject|4|||
160948244|NCT04079933|581198408|FG000|Overall Study|Lost to Follow-up|0|||
160948245|NCT04079933|581198409|FG001|Overall Study|Lost to Follow-up|1|||
160948246|NCT03207750|581198410|FG000|Overall Study|Adverse Event|3|||
160948247|NCT03207750|581198411|FG001|Overall Study|Adverse Event|2|||
160948248|NCT03207750|581198410|FG000|Overall Study|Lost to Follow-up|21|||
160948249|NCT03207750|581198411|FG001|Overall Study|Lost to Follow-up|29|||
160948250|NCT03207750|581198410|FG000|Overall Study|Protocol Violation|0|||
160948251|NCT03207750|581198411|FG001|Overall Study|Protocol Violation|1|||
160948252|NCT03207750|581198410|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
160948253|NCT03207750|581198411|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
160948254|NCT03207750|581198410|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
160948255|NCT03207750|581198411|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
160948256|NCT03207750|581198410|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
160948257|NCT03207750|581198411|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
160948258|NCT03207750|581198410|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
160948259|NCT03207750|581198411|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
160948260|NCT03207750|581198410|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
160948261|NCT03207750|581198411|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
160948262|NCT02493361|581198412|FG000|Overall Study|Withdrawal by Subject|3|||
160948263|NCT02937545|581198416|FG000|Overall Study|Withdrawal by Subject|1|||
160948264|NCT02937545|581198417|FG001|Overall Study|Withdrawal by Subject|2|||
160948265|NCT02937545|581198418|FG002|Overall Study|Withdrawal by Subject|6|||
160948266|NCT02937545|581198419|FG003|Overall Study|Withdrawal by Subject|7|||
160948267|NCT02937545|581198416|FG000|Overall Study|Lost to Follow-up|1|||
160948268|NCT02937545|581198417|FG001|Overall Study|Lost to Follow-up|0|||
160948269|NCT02937545|581198418|FG002|Overall Study|Lost to Follow-up|0|||
160948270|NCT02937545|581198419|FG003|Overall Study|Lost to Follow-up|0|||
160948271|NCT02504294|581198422|FG000|Overall Study|Adverse Event|15|||
160948272|NCT02504294|581198423|FG001|Overall Study|Adverse Event|12|||
160948273|NCT02504294|581198422|FG000|Overall Study|Withdrawal by Subject|7|||
160948274|NCT02504294|581198423|FG001|Overall Study|Withdrawal by Subject|1|||
160948275|NCT02504294|581198422|FG000|Overall Study|Protocol Violation|27|||
160948276|NCT02504294|581198423|FG001|Overall Study|Protocol Violation|26|||
160948277|NCT02504294|581198422|FG000|Overall Study|Physician Decision|1|||
160948278|NCT02504294|581198423|FG001|Overall Study|Physician Decision|2|||
160948279|NCT02504294|581198422|FG000|Overall Study|Lost to Follow-up|6|||
160948280|NCT02504294|581198423|FG001|Overall Study|Lost to Follow-up|7|||
160948281|NCT02252211|581198426|FG000|Overall Study|Adverse Event|0|||
160948282|NCT02252211|581198427|FG001|Overall Study|Adverse Event|1|||
160948283|NCT02252211|581198428|FG002|Overall Study|Adverse Event|0|||
160999800|NCT02341625|581382811|FG008|Overall Study|Completed Treatment as per Protocol|0|||
160948284|NCT02252211|581198426|FG000|Overall Study|Progressive disease|3|||
160948285|NCT02252211|581198427|FG001|Overall Study|Progressive disease|2|||
160948286|NCT02252211|581198428|FG002|Overall Study|Progressive disease|0|||
160948287|NCT02252211|581198426|FG000|Overall Study|Withdrawal by Subject|1|||
160948288|NCT02252211|581198427|FG001|Overall Study|Withdrawal by Subject|0|||
160948289|NCT02252211|581198428|FG002|Overall Study|Withdrawal by Subject|0|||
160948290|NCT02252211|581198426|FG000|Overall Study|Serious Adverse Event During Screening|1|||
160948291|NCT02252211|581198427|FG001|Overall Study|Serious Adverse Event During Screening|0|||
160948292|NCT02252211|581198428|FG002|Overall Study|Serious Adverse Event During Screening|1|||
160948293|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
160948294|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
160948295|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
160948296|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
160948297|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
160948298|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
160948299|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
160948300|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
160948301|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Other|0|||
160948302|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Other|1|||
160948303|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Other|0|||
160948304|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Other|0|||
160948305|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
160948306|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
160948307|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
160948308|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
160948309|NCT05799495|581198433|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
160948310|NCT05799495|581198434|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
160948311|NCT05799495|581198435|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
160948312|NCT05799495|581198436|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
160948313|NCT05799495|581198433|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160948314|NCT05799495|581198434|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160948315|NCT05799495|581198435|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
160948316|NCT05799495|581198436|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
160948317|NCT03694548|581198440|FG000|Part A Survey|Protocol Violation|3|||
160948318|NCT03694548|581198441|FG001|Part A Survey|Protocol Violation|3|||
160948319|NCT03694548|581198442|FG002|Part A Survey|Protocol Violation|0|||
160948320|NCT03694548|581198440|FG000|Part B Yoga Program|Protocol Violation|0|||
160948321|NCT03694548|581198441|FG001|Part B Yoga Program|Protocol Violation|0|||
160948322|NCT03694548|581198442|FG002|Part B Yoga Program|Protocol Violation|3|||
160948323|NCT03694548|581198440|FG000|Part B Yoga Program|Did not attend intervention|0|||
160948324|NCT03694548|581198441|FG001|Part B Yoga Program|Did not attend intervention|0|||
160948325|NCT03694548|581198442|FG002|Part B Yoga Program|Did not attend intervention|8|||
160948326|NCT04177108|581198443|FG000|Overall Study|Withdrawal by Subject|4|||
160948327|NCT04177108|581198444|FG001|Overall Study|Withdrawal by Subject|8|||
160948328|NCT04177108|581198445|FG002|Overall Study|Withdrawal by Subject|9|||
160948329|NCT04177108|581198446|FG003|Overall Study|Withdrawal by Subject|11|||
160948330|NCT04177108|581198447|FG004|Overall Study|Withdrawal by Subject|13|||
160948331|NCT04177108|581198443|FG000|Overall Study|Physician Decision|23|||
160948332|NCT04177108|581198444|FG001|Overall Study|Physician Decision|15|||
160948333|NCT04177108|581198445|FG002|Overall Study|Physician Decision|18|||
160948334|NCT04177108|581198446|FG003|Overall Study|Physician Decision|29|||
160948335|NCT04177108|581198447|FG004|Overall Study|Physician Decision|23|||
160948336|NCT04177108|581198443|FG000|Overall Study|Reason Not Specified|0|||
160948337|NCT04177108|581198444|FG001|Overall Study|Reason Not Specified|1|||
160948338|NCT04177108|581198445|FG002|Overall Study|Reason Not Specified|0|||
160948339|NCT04177108|581198446|FG003|Overall Study|Reason Not Specified|0|||
160948340|NCT04177108|581198447|FG004|Overall Study|Reason Not Specified|2|||
160948341|NCT04177108|581198443|FG000|Overall Study|Lost to Follow-up|0|||
160948342|NCT04177108|581198444|FG001|Overall Study|Lost to Follow-up|0|||
160948343|NCT04177108|581198445|FG002|Overall Study|Lost to Follow-up|1|||
160948344|NCT04177108|581198446|FG003|Overall Study|Lost to Follow-up|1|||
160948345|NCT04177108|581198447|FG004|Overall Study|Lost to Follow-up|1|||
160948346|NCT04177108|581198443|FG000|Overall Study|Death|16|||
160948347|NCT04177108|581198444|FG001|Overall Study|Death|19|||
160948348|NCT04177108|581198445|FG002|Overall Study|Death|13|||
160948349|NCT04177108|581198446|FG003|Overall Study|Death|17|||
160948350|NCT04177108|581198447|FG004|Overall Study|Death|18|||
160948351|NCT01143259|581198449|FG000|Overall Study|Withdrawal by Subject|3|||
160948352|NCT01143259|581198450|FG001|Overall Study|Withdrawal by Subject|2|||
160948353|NCT01143259|581198449|FG000|Overall Study|Protocol Violation|13|||
160948354|NCT01143259|581198450|FG001|Overall Study|Protocol Violation|9|||
160948355|NCT01143259|581198449|FG000|Overall Study|Screen Failure|7|||
160999801|NCT02341625|581382812|FG009|Overall Study|Completed Treatment as per Protocol|1|||
160999802|NCT02341625|581382803|FG000|Overall Study|Other Reasons|0|||
160999803|NCT02341625|581382804|FG001|Overall Study|Other Reasons|0|||
160999804|NCT02341625|581382805|FG002|Overall Study|Other Reasons|0|||
160948356|NCT01143259|581198450|FG001|Overall Study|Screen Failure|9|||
160948357|NCT00099983|581198451|FG000|Overall Study|Lost to Follow-up|2|||
160948358|NCT00099983|581198452|FG001|Overall Study|Lost to Follow-up|3|||
160948359|NCT00099983|581198451|FG000|Overall Study|Missing Source Documents|14|||
160948360|NCT00099983|581198452|FG001|Overall Study|Missing Source Documents|15|||
160948361|NCT00099983|581198451|FG000|Overall Study|Withdrawal by Subject|3|||
160948362|NCT00099983|581198452|FG001|Overall Study|Withdrawal by Subject|2|||
160948363|NCT00099983|581198451|FG000|Overall Study|Adverse Event|1|||
160948364|NCT00099983|581198452|FG001|Overall Study|Adverse Event|1|||
160948365|NCT00099983|581198451|FG000|Overall Study|Lack of Efficacy|0|||
160948366|NCT00099983|581198452|FG001|Overall Study|Lack of Efficacy|1|||
160948367|NCT00099983|581198451|FG000|Overall Study|Unable to return for appointments|1|||
160948368|NCT00099983|581198452|FG001|Overall Study|Unable to return for appointments|1|||
160948369|NCT00099983|581198451|FG000|Overall Study|Moved|1|||
160948370|NCT00099983|581198452|FG001|Overall Study|Moved|0|||
160948371|NCT00099983|581198451|FG000|Overall Study|Other psychiatric problem|1|||
160948372|NCT00099983|581198452|FG001|Overall Study|Other psychiatric problem|0|||
160948373|NCT00099983|581198451|FG000|Overall Study|Incarcerated|0|||
160948374|NCT00099983|581198452|FG001|Overall Study|Incarcerated|1|||
160948375|NCT00099983|581198451|FG000|Overall Study|Intolerant of burden of visits|0|||
160948376|NCT00099983|581198452|FG001|Overall Study|Intolerant of burden of visits|1|||
160948377|NCT00099983|581198451|FG000|Overall Study|Other issue|1|||
160948378|NCT00099983|581198452|FG001|Overall Study|Other issue|0|||
160948379|NCT02641080|581198453|FG000|Overall Study|Physician Decision|2|||
160948380|NCT02641080|581198454|FG001|Overall Study|Physician Decision|0|||
160948381|NCT02641080|581198453|FG000|Overall Study|Withdrawal by Subject|0|||
160948382|NCT02641080|581198454|FG001|Overall Study|Withdrawal by Subject|1|||
160948383|NCT02641080|581198453|FG000|Overall Study|Rehab Center denied use of pumps|0|||
160948384|NCT02641080|581198454|FG001|Overall Study|Rehab Center denied use of pumps|3|||
160948385|NCT02641080|581198453|FG000|Overall Study|Lost to Follow-up|0|||
160948386|NCT02641080|581198454|FG001|Overall Study|Lost to Follow-up|3|||
160948387|NCT06281548|581198455|FG000|Overall Study|Lost to Follow-up|3|||
160948388|NCT03835533|581198456|FG000|Overall Study|Death|5|||
160948389|NCT03835533|581198457|FG001|Overall Study|Death|10|||
160948390|NCT03835533|581198458|FG002|Overall Study|Death|9|||
160948391|NCT03835533|581198456|FG000|Overall Study|Withdrawal by Subject|2|||
160948392|NCT03835533|581198457|FG001|Overall Study|Withdrawal by Subject|2|||
160948393|NCT03835533|581198458|FG002|Overall Study|Withdrawal by Subject|2|||
160948394|NCT03835533|581198456|FG000|Overall Study|Lost to Follow-up|1|||
160948395|NCT03835533|581198457|FG001|Overall Study|Lost to Follow-up|0|||
160948396|NCT03835533|581198458|FG002|Overall Study|Lost to Follow-up|0|||
160948397|NCT01866709|581198459|FG000|Overall Study|Adverse Event|1|||
160948398|NCT01866709|581198460|FG001|Overall Study|Adverse Event|0|||
160948399|NCT00499889|581198461|FG000|Overall Study|Infection prior to treatment|1|||
160948400|NCT02207829|581198462|FG000|Overall Study|Adverse Event|10|||
160948401|NCT02207829|581198463|FG001|Overall Study|Adverse Event|9|||
160999805|NCT02341625|581382806|FG003|Overall Study|Other Reasons|0|||
160999806|NCT02341625|581382807|FG004|Overall Study|Other Reasons|1|||
160999807|NCT02341625|581382808|FG005|Overall Study|Other Reasons|0|||
160999808|NCT02341625|581382809|FG006|Overall Study|Other Reasons|5|||
161267363|NCT02031458|582363306|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
161267364|NCT02031458|582363307|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
161267365|NCT02031458|582363305|FG000|Baseline to May 8, 2015|Physician Decision|0|||
161267366|NCT02031458|582363306|FG001|Baseline to May 8, 2015|Physician Decision|1|||
161267367|NCT02031458|582363307|FG002|Baseline to May 8, 2015|Physician Decision|0|||
161342694|NCT00879658|582642236|FG005|Overall Study|misrandomized (never received study med)|0|||
161342695|NCT00879658|582642237|FG006|Overall Study|misrandomized (never received study med)|0|||
161342696|NCT00639509|582642242|FG000|Overall Study|Death|1|||
160999809|NCT02341625|581382810|FG007|Overall Study|Other Reasons|0|||
161267368|NCT02031458|582363305|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
161267369|NCT02031458|582363306|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
161267370|NCT02031458|582363307|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
161267371|NCT02031458|582363305|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
161267372|NCT02031458|582363306|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
161267373|NCT02031458|582363307|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
161267374|NCT02031458|582363305|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
161267375|NCT02031458|582363306|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
161267376|NCT02031458|582363307|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
161267377|NCT02031458|582363305|FG000|Baseline to May 8, 2015|On Treatment|43|||
161267378|NCT02031458|582363306|FG001|Baseline to May 8, 2015|On Treatment|81|||
161267379|NCT02031458|582363307|FG002|Baseline to May 8, 2015|On Treatment|73|||
161267380|NCT02031458|582363305|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
161342697|NCT02921256|582642243|FG000|Arm 1a v. Arm II|Adverse Event|6|||
161342698|NCT02921256|582642244|FG001|Arm 1a v. Arm II|Adverse Event|15|||
161342699|NCT02921256|582642245|FG002|Arm 1a v. Arm II|Adverse Event|0|||
161342700|NCT02921256|582642243|FG000|Arm 1a v. Arm II|Death|0|||
160948402|NCT02207829|581198462|FG000|Overall Study|Lack of Efficacy|7|||
161267381|NCT02031458|582363306|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
160948403|NCT02207829|581198463|FG001|Overall Study|Lack of Efficacy|5|||
160948404|NCT02207829|581198462|FG000|Overall Study|Lost to Follow-up|2|||
160948405|NCT02207829|581198463|FG001|Overall Study|Lost to Follow-up|2|||
160948406|NCT02207829|581198462|FG000|Overall Study|Protocol deviation|5|||
160948407|NCT02207829|581198463|FG001|Overall Study|Protocol deviation|4|||
160948408|NCT02207829|581198462|FG000|Overall Study|Withdrew consent|18|||
160948409|NCT02207829|581198463|FG001|Overall Study|Withdrew consent|14|||
160948410|NCT03299192|581198464|FG000|Overall Study|Fell before classes started|1|||
160948411|NCT03299192|581198465|FG001|Overall Study|Fell before classes started|0|||
160948412|NCT03299192|581198466|FG002|Overall Study|Fell before classes started|0|||
160948413|NCT03299192|581198464|FG000|Overall Study|Other|0|||
160948414|NCT03299192|581198465|FG001|Overall Study|Other|2|||
160948415|NCT03299192|581198466|FG002|Overall Study|Other|1|||
160948416|NCT01418209|581198472|FG000|Overall Study|Withdrawal by Subject|1|||
160948417|NCT01418209|581198473|FG001|Overall Study|Withdrawal by Subject|0|||
160948418|NCT01418209|581198474|FG002|Overall Study|Withdrawal by Subject|1|||
160948419|NCT01418209|581198472|FG000|Overall Study|Did not provide hot flash diary data|1|||
160948420|NCT01418209|581198473|FG001|Overall Study|Did not provide hot flash diary data|3|||
160948421|NCT01418209|581198474|FG002|Overall Study|Did not provide hot flash diary data|3|||
160948422|NCT00101101|581198475|FG000|Overall Study|never received vaccine|20|||
160948423|NCT01603875|581198476|FG000|Overall Study|Preexisting rabies antibody|3|||
160948424|NCT01603875|581198477|FG001|Overall Study|Preexisting rabies antibody|4|||
160948425|NCT01603875|581198478|FG002|Overall Study|Preexisting rabies antibody|3|||
160948426|NCT01603875|581198476|FG000|Overall Study|Lost to Follow-up|4|||
160948427|NCT01603875|581198477|FG001|Overall Study|Lost to Follow-up|3|||
160948428|NCT01603875|581198478|FG002|Overall Study|Lost to Follow-up|6|||
160948429|NCT01603875|581198476|FG000|Overall Study|Protocol Violation|0|||
160948430|NCT01603875|581198477|FG001|Overall Study|Protocol Violation|1|||
160948431|NCT01603875|581198478|FG002|Overall Study|Protocol Violation|0|||
160948432|NCT04122443|581198484|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
160948433|NCT04122443|581198485|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
160948434|NCT04122443|581198486|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
160948435|NCT04122443|581198484|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
160948436|NCT04122443|581198485|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
160948437|NCT04122443|581198486|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
160948438|NCT05204134|581198487|FG000|Overall Study|Withdrawal by Subject|3|||
160948439|NCT05204134|581198487|FG000|Overall Study|Physician Decision|1|||
160948440|NCT01312467|581198491|FG000|Overall Study|Adverse Event|4|||
160948441|NCT01312467|581198491|FG000|Overall Study|Lost to Follow-up|1|||
160948442|NCT01312467|581198491|FG000|Overall Study|Withdrawal by Subject|2|||
160948443|NCT01312467|581198491|FG000|Overall Study|Deported to country of origin|1|||
160948444|NCT01312467|581198491|FG000|Overall Study|Another medical condition|1|||
161267382|NCT02031458|582363307|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
161267383|NCT04305587|582363308|FG000|Overall Study|Withdrawal by Subject|0|||
161267384|NCT04305587|582363309|FG001|Overall Study|Withdrawal by Subject|0|||
161267385|NCT04305587|582363310|FG002|Overall Study|Withdrawal by Subject|0|||
161267386|NCT04305587|582363311|FG003|Overall Study|Withdrawal by Subject|1|||
161267387|NCT04305587|582363312|FG004|Overall Study|Withdrawal by Subject|0|||
161267388|NCT04305587|582363313|FG005|Overall Study|Withdrawal by Subject|0|||
161267389|NCT04305587|582363314|FG006|Overall Study|Withdrawal by Subject|0|||
161267390|NCT04305587|582363315|FG007|Overall Study|Withdrawal by Subject|0|||
161267391|NCT04305587|582363316|FG008|Overall Study|Withdrawal by Subject|0|||
161267392|NCT02752906|582363317|FG000|Overall Study|Protocol Violation|2|||
161267393|NCT02752906|582363318|FG001|Overall Study|Protocol Violation|1|||
161267394|NCT02752906|582363317|FG000|Overall Study|Withdrawal by Subject|2|||
161267395|NCT02752906|582363318|FG001|Overall Study|Withdrawal by Subject|2|||
161267396|NCT02752906|582363317|FG000|Overall Study|Lost to Follow-up|3|||
161267397|NCT02752906|582363318|FG001|Overall Study|Lost to Follow-up|2|||
161267398|NCT01007942|582363320|FG000|Overall Study|Adverse Event|29|||
161267399|NCT01007942|582363321|FG001|Overall Study|Adverse Event|14|||
161267400|NCT01007942|582363320|FG000|Overall Study|Abnormal test procedure|0|||
161267401|NCT01007942|582363321|FG001|Overall Study|Abnormal test procedure|1|||
161267402|NCT01007942|582363320|FG000|Overall Study|Disease progression|217|||
161267403|NCT01007942|582363321|FG001|Overall Study|Disease progression|242|||
161267404|NCT01007942|582363320|FG000|Overall Study|New cancer therapy|5|||
161267405|NCT01007942|582363321|FG001|Overall Study|New cancer therapy|1|||
161267406|NCT01007942|582363320|FG000|Overall Study|Protocol Violation|1|||
161267407|NCT01007942|582363321|FG001|Overall Study|Protocol Violation|1|||
161267408|NCT01007942|582363320|FG000|Overall Study|Withdrawal by Subject|19|||
161267409|NCT01007942|582363321|FG001|Overall Study|Withdrawal by Subject|14|||
161267410|NCT01007942|582363320|FG000|Overall Study|Lost to Follow-up|1|||
161267411|NCT01007942|582363321|FG001|Overall Study|Lost to Follow-up|0|||
161342701|NCT02921256|582642244|FG001|Arm 1a v. Arm II|Death|2|||
160948445|NCT01312467|581198491|FG000|Overall Study|Ineligible|4|||
160948446|NCT01059617|581198494|FG000|Overall Study|Other|7|||
161267412|NCT01007942|582363320|FG000|Overall Study|Administrative problems|2|||
161267413|NCT01007942|582363321|FG001|Overall Study|Administrative problems|0|||
161267414|NCT01007942|582363320|FG000|Overall Study|Death|3|||
161267415|NCT01007942|582363321|FG001|Overall Study|Death|2|||
161267416|NCT01007942|582363320|FG000|Overall Study|Patients untreated|4|||
160948447|NCT01059617|581198495|FG001|Overall Study|Other|1|||
160948448|NCT01059617|581198496|FG002|Overall Study|Other|8|||
160948449|NCT01059617|581198497|FG003|Overall Study|Other|6|||
160948450|NCT01968434|581198498|FG000|Overall Study|Lost to Follow-up|3|||
160948451|NCT01968434|581198499|FG001|Overall Study|Lost to Follow-up|6|||
160948452|NCT02199691|581198500|FG000|Overall Study|Protocol Violation|3|||
161267417|NCT01007942|582363321|FG001|Overall Study|Patients untreated|3|||
161342702|NCT02921256|582642245|FG002|Arm 1a v. Arm II|Death|0|||
160948453|NCT02199691|581198501|FG001|Overall Study|Protocol Violation|3|||
160948454|NCT02199691|581198502|FG002|Overall Study|Protocol Violation|6|||
160948455|NCT02199691|581198503|FG003|Overall Study|Protocol Violation|7|||
160948456|NCT02199691|581198500|FG000|Overall Study|Withdrawal by Subject|5|||
160948457|NCT02199691|581198501|FG001|Overall Study|Withdrawal by Subject|3|||
160948458|NCT02199691|581198502|FG002|Overall Study|Withdrawal by Subject|12|||
160948459|NCT02199691|581198503|FG003|Overall Study|Withdrawal by Subject|13|||
160948460|NCT02199691|581198500|FG000|Overall Study|Lost to Follow-up|2|||
160948461|NCT02199691|581198501|FG001|Overall Study|Lost to Follow-up|1|||
160948462|NCT02199691|581198502|FG002|Overall Study|Lost to Follow-up|9|||
160948463|NCT02199691|581198503|FG003|Overall Study|Lost to Follow-up|10|||
160948464|NCT00612313|581198506|FG000|Overall Study|Withdrawal by Subject|6|||
160948465|NCT00612313|581198507|FG001|Overall Study|Withdrawal by Subject|9|||
160948466|NCT00612313|581198506|FG000|Overall Study|Lost to Follow-up|11|||
160948467|NCT00612313|581198507|FG001|Overall Study|Lost to Follow-up|4|||
160948468|NCT00136955|581200429|FG000|Overall Study|Adverse Event|8|||
160948469|NCT00136955|581200429|FG000|Overall Study|Lost to Follow-up|1|||
160948470|NCT00136955|581200429|FG000|Overall Study|Withdrawal by Subject|2|||
160948471|NCT00136955|581200429|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
160948472|NCT02239510|581200430|FG000|Overall Study|Lost to Follow-up|2|||
160948473|NCT02239510|581200431|FG001|Overall Study|Lost to Follow-up|1|||
160948474|NCT01773226|581200432|FG000|Overall Study|Withdrawal by Subject|1|||
160948475|NCT05349617|581200438|FG000|Overall Study|Death|1|||
160948476|NCT05349617|581200439|FG001|Overall Study|Death|1|||
160948477|NCT05349617|581200438|FG000|Overall Study|Lost to Follow-up|3|||
160948478|NCT05349617|581200439|FG001|Overall Study|Lost to Follow-up|8|||
161144981|NCT03494725|581914015|FG000|Overall Study|Antibiotic use|1|||
161144982|NCT03494725|581914016|FG001|Overall Study|Antibiotic use|0|||
161144983|NCT02619253|581914017|FG000|Overall Study|Adverse Event|0|||
161144984|NCT02619253|581914018|FG001|Overall Study|Adverse Event|0|||
161144985|NCT02619253|581914019|FG002|Overall Study|Adverse Event|1|||
161144986|NCT02619253|581914020|FG003|Overall Study|Adverse Event|1|||
161144987|NCT02619253|581914021|FG004|Overall Study|Adverse Event|3|||
161144988|NCT02619253|581914017|FG000|Overall Study|Alternative Therapy|0|||
161144989|NCT02619253|581914018|FG001|Overall Study|Alternative Therapy|0|||
161144990|NCT02619253|581914019|FG002|Overall Study|Alternative Therapy|1|||
161144991|NCT02619253|581914020|FG003|Overall Study|Alternative Therapy|0|||
161144992|NCT02619253|581914021|FG004|Overall Study|Alternative Therapy|0|||
160948479|NCT05349617|581200438|FG000|Overall Study|Withdrawal by Subject|2|||
161144993|NCT02619253|581914017|FG000|Overall Study|Death|0|||
161144994|NCT02619253|581914018|FG001|Overall Study|Death|0|||
161144995|NCT02619253|581914019|FG002|Overall Study|Death|0|||
161144996|NCT02619253|581914020|FG003|Overall Study|Death|1|||
161144997|NCT02619253|581914021|FG004|Overall Study|Death|0|||
161144998|NCT02619253|581914017|FG000|Overall Study|Disease Progression|4|||
161144999|NCT02619253|581914018|FG001|Overall Study|Disease Progression|2|||
161145000|NCT02619253|581914019|FG002|Overall Study|Disease Progression|8|||
161145001|NCT02619253|581914020|FG003|Overall Study|Disease Progression|9|||
161145002|NCT02619253|581914021|FG004|Overall Study|Disease Progression|10|||
161145003|NCT02619253|581914017|FG000|Overall Study|Needed a disqualifying therapy|0|||
161145004|NCT02619253|581914018|FG001|Overall Study|Needed a disqualifying therapy|0|||
161145005|NCT02619253|581914019|FG002|Overall Study|Needed a disqualifying therapy|1|||
161145006|NCT02619253|581914020|FG003|Overall Study|Needed a disqualifying therapy|0|||
161145007|NCT02619253|581914021|FG004|Overall Study|Needed a disqualifying therapy|0|||
161145008|NCT02619253|581914017|FG000|Overall Study|Transferred to hospice|0|||
161145009|NCT02619253|581914018|FG001|Overall Study|Transferred to hospice|0|||
161145010|NCT02619253|581914019|FG002|Overall Study|Transferred to hospice|1|||
161145011|NCT02619253|581914020|FG003|Overall Study|Transferred to hospice|0|||
161145012|NCT02619253|581914021|FG004|Overall Study|Transferred to hospice|0|||
161145013|NCT02619253|581914017|FG000|Overall Study|Physician Decision|0|||
161145014|NCT02619253|581914018|FG001|Overall Study|Physician Decision|1|||
161267418|NCT03412396|582363322|FG000|Overall Study|Withdrawal by Subject|2|||
161267419|NCT03412396|582363322|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
160948480|NCT05349617|581200439|FG001|Overall Study|Withdrawal by Subject|10|||
160948481|NCT03811912|581200444|FG000|Overall Study|Withdrew Consent|4|||
160948482|NCT03811912|581200445|FG001|Overall Study|Withdrew Consent|2|||
160948483|NCT04401579|581200446|FG000|Overall Study|Death|23|||
160948484|NCT04401579|581200447|FG001|Overall Study|Death|36|||
160948485|NCT04401579|581200446|FG000|Overall Study|Lost to Follow-up|40|||
161145015|NCT02619253|581914019|FG002|Overall Study|Physician Decision|2|||
161145016|NCT02619253|581914020|FG003|Overall Study|Physician Decision|3|||
161145017|NCT02619253|581914021|FG004|Overall Study|Physician Decision|0|||
161145018|NCT02619253|581914017|FG000|Overall Study|Withdrawal by Subject|0|||
160948486|NCT04401579|581200447|FG001|Overall Study|Lost to Follow-up|41|||
160948487|NCT04401579|581200446|FG000|Overall Study|Withdrawal by Subject|8|||
160948488|NCT04401579|581200447|FG001|Overall Study|Withdrawal by Subject|16|||
160948489|NCT04401579|581200446|FG000|Overall Study|Physician Decision|1|||
161145019|NCT02619253|581914018|FG001|Overall Study|Withdrawal by Subject|1|||
161145020|NCT02619253|581914019|FG002|Overall Study|Withdrawal by Subject|0|||
161267420|NCT03412396|582363322|FG000|Overall Study|Did not undergo RP|2|||
161267421|NCT00655876|582363324|FG000|Overall Study|Protocol Violation|9|||
161267422|NCT00655876|582363325|FG001|Overall Study|Protocol Violation|7|||
161267423|NCT01460901|582363328|FG000|Overall Study|Withdrawal by Subject|2|||
161267424|NCT00470067|582363329|FG000|Overall Study|Death|1|||
161267425|NCT00470067|582363329|FG000|Overall Study|Disease Progression|6|||
161267426|NCT01059539|582363332|FG000|Overall Study|Adverse Event|66|||
161267427|NCT01059539|582363332|FG000|Overall Study|Insufficient Therapeutic Response|26|||
161267428|NCT01059539|582363332|FG000|Overall Study|Protocol Violation|55|||
161267429|NCT01059539|582363332|FG000|Overall Study|Withdrawal of Consent|80|||
161267430|NCT01059539|582363332|FG000|Overall Study|Lost to Follow-up|42|||
161267431|NCT01059539|582363332|FG000|Overall Study|Reason Not Specified|2|||
161267432|NCT04091659|582363336|FG000|Overall Study|Protocol Violation|3|||
161267433|NCT04091659|582363337|FG001|Overall Study|Protocol Violation|0|||
161267434|NCT04091659|582363336|FG000|Overall Study|Lost to Follow-up|0|||
161267435|NCT04091659|582363337|FG001|Overall Study|Lost to Follow-up|1|||
161267436|NCT00895947|582363338|FG000|Overall Study|Adverse Event|3|||
160948490|NCT04401579|581200447|FG001|Overall Study|Physician Decision|2|||
160948491|NCT04401579|581200446|FG000|Overall Study|Became ineligible after enrollment|1|||
160948492|NCT04401579|581200447|FG001|Overall Study|Became ineligible after enrollment|1|||
160948493|NCT04401579|581200446|FG000|Overall Study|Enrolled but treatment not administered|7|||
160948494|NCT04401579|581200447|FG001|Overall Study|Enrolled but treatment not administered|9|||
161267437|NCT00895947|582363339|FG001|Overall Study|Adverse Event|4|||
161267438|NCT00895947|582363338|FG000|Overall Study|Lost to Follow-up|3|||
161267439|NCT00895947|582363339|FG001|Overall Study|Lost to Follow-up|4|||
161267440|NCT00895947|582363338|FG000|Overall Study|Protocol Violation|4|||
161267441|NCT00895947|582363339|FG001|Overall Study|Protocol Violation|2|||
161267442|NCT00895947|582363338|FG000|Overall Study|Withdrawal by Subject|2|||
161267443|NCT00895947|582363339|FG001|Overall Study|Withdrawal by Subject|0|||
161342703|NCT02921256|582642243|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
161342704|NCT02921256|582642244|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
160948495|NCT04401579|581200446|FG000|Overall Study|Adverse Event|2|||
160948496|NCT04401579|581200447|FG001|Overall Study|Adverse Event|1|||
160948497|NCT04401579|581200446|FG000|Overall Study|Scheduling error|1|||
160948498|NCT04401579|581200447|FG001|Overall Study|Scheduling error|2|||
160948499|NCT04401579|581200446|FG000|Overall Study|Transferred to another hospital|1|||
160948500|NCT04401579|581200447|FG001|Overall Study|Transferred to another hospital|2|||
160948501|NCT00489970|581200448|FG000|Persistence Year 9|Lost to Follow-up|2|||
160948502|NCT00489970|581200449|FG001|Persistence Year 9|Lost to Follow-up|2|||
160948503|NCT00489970|581200450|FG002|Persistence Year 9|Lost to Follow-up|3|||
160948504|NCT00489970|581200448|FG000|Persistence Year 9|Other|1|||
160948505|NCT00489970|581200449|FG001|Persistence Year 9|Other|0|||
160948506|NCT00489970|581200450|FG002|Persistence Year 9|Other|2|||
160948507|NCT03320070|581200451|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
160948508|NCT03320070|581200452|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
160948509|NCT03320070|581200451|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
160948510|NCT03320070|581200452|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
160999810|NCT02341625|581382811|FG008|Overall Study|Other Reasons|0|||
160999811|NCT02341625|581382812|FG009|Overall Study|Other Reasons|2|||
160999812|NCT02341625|581382803|FG000|Overall Study|Not Reported|0|||
160999813|NCT02341625|581382804|FG001|Overall Study|Not Reported|0|||
160999814|NCT02341625|581382805|FG002|Overall Study|Not Reported|0|||
160999815|NCT02341625|581382806|FG003|Overall Study|Not Reported|0|||
160999816|NCT02341625|581382807|FG004|Overall Study|Not Reported|0|||
160999817|NCT02341625|581382808|FG005|Overall Study|Not Reported|0|||
160948511|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
160948512|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
160948513|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
160948514|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
160948515|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
160948516|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
160948517|NCT03320070|581200451|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
160948518|NCT03320070|581200452|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
160948519|NCT03586648|581200453|FG000|Period 1|Withdrawal by Subject|0|||
160999818|NCT02341625|581382809|FG006|Overall Study|Not Reported|0|||
160948520|NCT03586648|581200454|FG001|Period 1|Withdrawal by Subject|1|||
161342705|NCT02921256|582642245|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
160948521|NCT03586648|581200453|FG000|Period 1|Lost to Follow-up|1|||
160999819|NCT02341625|581382810|FG007|Overall Study|Not Reported|0|||
160999820|NCT02341625|581382811|FG008|Overall Study|Not Reported|0|||
161267444|NCT03678285|582363348|FG000|Overall Study|Adverse Event|2|||
161267445|NCT03678285|582363348|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
161267446|NCT03678285|582363348|FG000|Overall Study|Dehydrated prior to start of workout|1|||
161267447|NCT00123474|582363349|FG000|Randomized to Treatment|Randomized, never treated|1|||
161342706|NCT02921256|582642243|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
161267448|NCT00123474|582363350|FG001|Randomized to Treatment|Randomized, never treated|4|||
161267449|NCT00123474|582363351|FG002|Randomized to Treatment|Randomized, never treated|2|||
161267450|NCT00123474|582363352|FG003|Randomized to Treatment|Randomized, never treated|1|||
161267451|NCT00123474|582363349|FG000|As Treated at Study Closure|not reported when site closed|1|||
161267452|NCT00123474|582363350|FG001|As Treated at Study Closure|not reported when site closed|0|||
161267453|NCT00123474|582363351|FG002|As Treated at Study Closure|not reported when site closed|1|||
161267454|NCT00123474|582363352|FG003|As Treated at Study Closure|not reported when site closed|0|||
161267455|NCT00123474|582363349|FG000|As Treated at Study Closure|Adverse Event|10|||
161267456|NCT00123474|582363350|FG001|As Treated at Study Closure|Adverse Event|4|||
161267457|NCT00123474|582363351|FG002|As Treated at Study Closure|Adverse Event|10|||
161267458|NCT00123474|582363352|FG003|As Treated at Study Closure|Adverse Event|8|||
161267459|NCT00123474|582363349|FG000|As Treated at Study Closure|Disease Progression|35|||
161267460|NCT00123474|582363350|FG001|As Treated at Study Closure|Disease Progression|42|||
161267461|NCT00123474|582363351|FG002|As Treated at Study Closure|Disease Progression|29|||
161267462|NCT00123474|582363352|FG003|As Treated at Study Closure|Disease Progression|27|||
161267463|NCT00123474|582363349|FG000|As Treated at Study Closure|Investigator Request|12|||
161267464|NCT00123474|582363350|FG001|As Treated at Study Closure|Investigator Request|6|||
161267465|NCT00123474|582363351|FG002|As Treated at Study Closure|Investigator Request|7|||
161267466|NCT00123474|582363352|FG003|As Treated at Study Closure|Investigator Request|5|||
161267467|NCT00123474|582363349|FG000|As Treated at Study Closure|non-specified|54|||
161267468|NCT00123474|582363350|FG001|As Treated at Study Closure|non-specified|47|||
161267469|NCT00123474|582363351|FG002|As Treated at Study Closure|non-specified|57|||
161267470|NCT00123474|582363352|FG003|As Treated at Study Closure|non-specified|60|||
161267471|NCT00123474|582363349|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
161267472|NCT00123474|582363350|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
161267473|NCT00123474|582363351|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
161267474|NCT00123474|582363352|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
161267475|NCT00123474|582363349|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
161267476|NCT00123474|582363350|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
161267477|NCT00123474|582363351|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
161267478|NCT00123474|582363352|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
161267479|NCT00616629|582363353|FG000|Overall Study|Protocol Violation|1|||
161267480|NCT00616629|582363354|FG001|Overall Study|Protocol Violation|2|||
161267481|NCT00616629|582363355|FG002|Overall Study|Protocol Violation|1|||
160948522|NCT03586648|581200454|FG001|Period 1|Lost to Follow-up|1|||
160948523|NCT03586648|581200453|FG000|Period 1|Adverse Event|1|||
160948524|NCT03586648|581200454|FG001|Period 1|Adverse Event|0|||
160948525|NCT03586648|581200453|FG000|Period 1|Study related symptoms or complaints|2|||
160948526|NCT03586648|581200454|FG001|Period 1|Study related symptoms or complaints|1|||
160948527|NCT03586648|581200453|FG000|Period 1|Physician Decision|0|||
160948528|NCT03586648|581200454|FG001|Period 1|Physician Decision|1|||
160948529|NCT03586648|581200453|FG000|Period 2|Adverse Event|1|||
160948530|NCT03586648|581200454|FG001|Period 2|Adverse Event|0|||
160948531|NCT02367911|581200457|FG000|Overall Study|Withdrawal by Subject|3|||
160948532|NCT02367911|581200458|FG001|Overall Study|Withdrawal by Subject|2|||
160948533|NCT02367911|581200457|FG000|Overall Study|Lost to Follow-up|2|||
160948534|NCT02367911|581200458|FG001|Overall Study|Lost to Follow-up|2|||
160948535|NCT00263666|581200459|FG000|Overall Study|Adverse Event|6|||
160948536|NCT00263666|581200460|FG001|Overall Study|Adverse Event|8|||
160948537|NCT00263666|581200459|FG000|Overall Study|Lost to Follow-up|1|||
160948538|NCT00263666|581200460|FG001|Overall Study|Lost to Follow-up|2|||
160948539|NCT00263666|581200459|FG000|Overall Study|Withdrawal by Subject|0|||
160948540|NCT00263666|581200460|FG001|Overall Study|Withdrawal by Subject|1|||
160948541|NCT00896168|581200461|FG000|Overall Study|Adverse Event|4|||
160948542|NCT00896168|581200462|FG001|Overall Study|Adverse Event|7|||
160948543|NCT00896168|581200461|FG000|Overall Study|Treatment failure|8|||
160948544|NCT00896168|581200462|FG001|Overall Study|Treatment failure|10|||
160948545|NCT00896168|581200461|FG000|Overall Study|Lost to Follow-up|1|||
160948546|NCT00896168|581200462|FG001|Overall Study|Lost to Follow-up|1|||
160948547|NCT00896168|581200461|FG000|Overall Study|Other|1|||
160948548|NCT00896168|581200462|FG001|Overall Study|Other|1|||
160948549|NCT00902304|581200463|FG000|Overall Study|Adverse Event|4|||
160948550|NCT00902304|581200464|FG001|Overall Study|Adverse Event|10|||
160948551|NCT00902304|581200465|FG002|Overall Study|Adverse Event|25|||
160948552|NCT00902304|581200463|FG000|Overall Study|Investigator discretion|3|||
160948553|NCT00902304|581200464|FG001|Overall Study|Investigator discretion|5|||
160948554|NCT00902304|581200465|FG002|Overall Study|Investigator discretion|13|||
160948555|NCT00902304|581200463|FG000|Overall Study|Lost to Follow-up|7|||
160948556|NCT00902304|581200464|FG001|Overall Study|Lost to Follow-up|7|||
160948557|NCT00902304|581200465|FG002|Overall Study|Lost to Follow-up|7|||
161267482|NCT00616629|582363356|FG003|Overall Study|Protocol Violation|0|||
161267483|NCT00616629|582363357|FG004|Overall Study|Protocol Violation|0|||
160948558|NCT00902304|581200463|FG000|Overall Study|Protocol Violation|9|||
160948559|NCT00902304|581200464|FG001|Overall Study|Protocol Violation|18|||
160948560|NCT00902304|581200465|FG002|Overall Study|Protocol Violation|20|||
160948561|NCT00902304|581200463|FG000|Overall Study|Withdrawal by Subject|32|||
160948562|NCT00902304|581200464|FG001|Overall Study|Withdrawal by Subject|22|||
161267484|NCT00616629|582363353|FG000|Overall Study|AV-block|1|||
161267485|NCT00616629|582363354|FG001|Overall Study|AV-block|0|||
161267486|NCT00616629|582363355|FG002|Overall Study|AV-block|0|||
161342707|NCT02921256|582642244|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
161342708|NCT02921256|582642245|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
161342709|NCT02921256|582642243|FG000|Arm 1a v. Arm II|Physician Decision|1|||
161342710|NCT02921256|582642244|FG001|Arm 1a v. Arm II|Physician Decision|1|||
161342711|NCT02921256|582642245|FG002|Arm 1a v. Arm II|Physician Decision|0|||
161342712|NCT02921256|582642243|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
161342713|NCT02921256|582642244|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
161342714|NCT02921256|582642245|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
161342715|NCT02921256|582642243|FG000|Arm Ib v Arm III|Adverse Event|9|||
161342716|NCT02921256|582642244|FG001|Arm Ib v Arm III|Adverse Event|0|||
161342717|NCT02921256|582642245|FG002|Arm Ib v Arm III|Adverse Event|4|||
161342718|NCT02921256|582642243|FG000|Arm Ib v Arm III|Death|1|||
161342719|NCT02921256|582642244|FG001|Arm Ib v Arm III|Death|0|||
161342720|NCT02921256|582642245|FG002|Arm Ib v Arm III|Death|1|||
161342721|NCT02921256|582642243|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
161342722|NCT02921256|582642244|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
161342723|NCT02921256|582642245|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
161342724|NCT02921256|582642243|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
161342725|NCT02921256|582642244|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
161342726|NCT02921256|582642245|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
161342727|NCT02921256|582642243|FG000|Arm Ib v Arm III|Physician Decision|4|||
161267487|NCT00616629|582363356|FG003|Overall Study|AV-block|0|||
161267488|NCT00616629|582363357|FG004|Overall Study|AV-block|0|||
161267489|NCT01059344|582363358|FG000|Overall Study|Adverse Event|12|||
161267490|NCT01059344|582363359|FG001|Overall Study|Adverse Event|30|||
161267491|NCT01059344|582363358|FG000|Overall Study|Withdrawal by Subject|6|||
161267492|NCT01059344|582363359|FG001|Overall Study|Withdrawal by Subject|9|||
161267493|NCT01059344|582363358|FG000|Overall Study|Lost to Follow-up|1|||
161267494|NCT01059344|582363359|FG001|Overall Study|Lost to Follow-up|1|||
161267495|NCT01059344|582363358|FG000|Overall Study|Other|3|||
161267496|NCT01059344|582363359|FG001|Overall Study|Other|6|||
161267497|NCT01739348|582363360|FG000|Part I (Base Study)|Adverse Event|41|||
161267498|NCT01739348|582363361|FG001|Part I (Base Study)|Adverse Event|52|||
161267499|NCT01739348|582363362|FG002|Part I (Base Study)|Adverse Event|8|||
161267500|NCT01739348|582363363|FG003|Part I (Base Study)|Adverse Event|33|||
161267501|NCT01739348|582363360|FG000|Part I (Base Study)|Death|10|||
161267502|NCT01739348|582363361|FG001|Part I (Base Study)|Death|7|||
161267503|NCT01739348|582363362|FG002|Part I (Base Study)|Death|2|||
161267504|NCT01739348|582363363|FG003|Part I (Base Study)|Death|8|||
161267505|NCT01739348|582363360|FG000|Part I (Base Study)|Lack of Efficacy|3|||
161267506|NCT01739348|582363361|FG001|Part I (Base Study)|Lack of Efficacy|8|||
161267507|NCT01739348|582363362|FG002|Part I (Base Study)|Lack of Efficacy|0|||
161267508|NCT01739348|582363363|FG003|Part I (Base Study)|Lack of Efficacy|7|||
161267509|NCT01739348|582363360|FG000|Part I (Base Study)|Lost to Follow-up|4|||
161267510|NCT01739348|582363361|FG001|Part I (Base Study)|Lost to Follow-up|2|||
161267511|NCT01739348|582363362|FG002|Part I (Base Study)|Lost to Follow-up|4|||
161267512|NCT01739348|582363363|FG003|Part I (Base Study)|Lost to Follow-up|4|||
161267513|NCT01739348|582363360|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
161267514|NCT01739348|582363361|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
161267515|NCT01739348|582363362|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
161267516|NCT01739348|582363363|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
161267517|NCT01739348|582363360|FG000|Part I (Base Study)|Physician Decision|10|||
161267518|NCT01739348|582363361|FG001|Part I (Base Study)|Physician Decision|7|||
161267519|NCT01739348|582363362|FG002|Part I (Base Study)|Physician Decision|1|||
161267520|NCT01739348|582363363|FG003|Part I (Base Study)|Physician Decision|4|||
161267521|NCT01739348|582363360|FG000|Part I (Base Study)|Protocol Violation|2|||
161342728|NCT02921256|582642244|FG001|Arm Ib v Arm III|Physician Decision|0|||
161342729|NCT02921256|582642245|FG002|Arm Ib v Arm III|Physician Decision|1|||
161342730|NCT02921256|582642243|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
161342731|NCT02921256|582642244|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
161342732|NCT02921256|582642245|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
161342733|NCT03507790|582642246|FG000|Overall Study|Adverse Event|0|||
161342734|NCT03507790|582642247|FG001|Overall Study|Adverse Event|11|||
160948563|NCT00902304|581200465|FG002|Overall Study|Withdrawal by Subject|43|||
161267522|NCT01739348|582363361|FG001|Part I (Base Study)|Protocol Violation|0|||
161267523|NCT01739348|582363362|FG002|Part I (Base Study)|Protocol Violation|1|||
161267524|NCT01739348|582363363|FG003|Part I (Base Study)|Protocol Violation|2|||
161267525|NCT01739348|582363360|FG000|Part I (Base Study)|Screen Failure|2|||
161267526|NCT01739348|582363361|FG001|Part I (Base Study)|Screen Failure|0|||
161342735|NCT03507790|582642248|FG002|Overall Study|Adverse Event|3|||
161342736|NCT03507790|582642246|FG000|Overall Study|Withdrawal by Subject|2|||
161342737|NCT03507790|582642247|FG001|Overall Study|Withdrawal by Subject|0|||
161342738|NCT03507790|582642248|FG002|Overall Study|Withdrawal by Subject|0|||
161267527|NCT01739348|582363362|FG002|Part I (Base Study)|Screen Failure|0|||
161267528|NCT01739348|582363363|FG003|Part I (Base Study)|Screen Failure|0|||
161267529|NCT01739348|582363360|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
161267530|NCT01739348|582363361|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
161267531|NCT01739348|582363362|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
161267532|NCT01739348|582363363|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
161267533|NCT01739348|582363360|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
161267534|NCT01739348|582363361|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
160948564|NCT00902304|581200463|FG000|Overall Study|includes pregnancy|3|||
160948565|NCT00902304|581200464|FG001|Overall Study|includes pregnancy|9|||
160948566|NCT00902304|581200465|FG002|Overall Study|includes pregnancy|2|||
160948567|NCT02492100|581200466|FG000|Overall Study|Death|1|||
160948568|NCT03832010|581200467|FG000|Overall Study|Withdrawal by Subject|2|||
161267535|NCT01739348|582363362|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
161267536|NCT01739348|582363363|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
161267537|NCT01739348|582363360|FG000|Part I (Base Study)|Participant Moved|4|||
161267538|NCT01739348|582363361|FG001|Part I (Base Study)|Participant Moved|3|||
161267539|NCT01739348|582363362|FG002|Part I (Base Study)|Participant Moved|1|||
161267540|NCT01739348|582363363|FG003|Part I (Base Study)|Participant Moved|7|||
161267541|NCT01739348|582363360|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
161267542|NCT01739348|582363361|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
161267543|NCT01739348|582363362|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
161267544|NCT01739348|582363363|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
161267545|NCT01739348|582363360|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
161267546|NCT01739348|582363361|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
161267547|NCT01739348|582363362|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
161267548|NCT01739348|582363363|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
161267549|NCT01739348|582363360|FG000|Part II (Extension Study)|Adverse Event|10|||
161267550|NCT01739348|582363361|FG001|Part II (Extension Study)|Adverse Event|11|||
161267551|NCT01739348|582363362|FG002|Part II (Extension Study)|Adverse Event|7|||
161267552|NCT01739348|582363363|FG003|Part II (Extension Study)|Adverse Event|26|||
161267553|NCT01739348|582363360|FG000|Part II (Extension Study)|Death|3|||
161267554|NCT01739348|582363361|FG001|Part II (Extension Study)|Death|3|||
161267555|NCT01739348|582363362|FG002|Part II (Extension Study)|Death|2|||
161267556|NCT01739348|582363363|FG003|Part II (Extension Study)|Death|6|||
161267557|NCT01739348|582363360|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
161267558|NCT01739348|582363361|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
161267559|NCT01739348|582363362|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
161267560|NCT01739348|582363363|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
161267561|NCT01739348|582363360|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
161267562|NCT01739348|582363361|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
161267563|NCT01739348|582363362|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
161267564|NCT01739348|582363363|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
161267565|NCT01739348|582363360|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161267566|NCT01739348|582363361|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161267567|NCT01739348|582363362|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
161267568|NCT01739348|582363363|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
161267569|NCT01739348|582363360|FG000|Part II (Extension Study)|Physician Decision|7|||
161267570|NCT01739348|582363361|FG001|Part II (Extension Study)|Physician Decision|11|||
161267571|NCT01739348|582363362|FG002|Part II (Extension Study)|Physician Decision|6|||
161267572|NCT01739348|582363363|FG003|Part II (Extension Study)|Physician Decision|12|||
161267573|NCT01739348|582363360|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
161267574|NCT01739348|582363361|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
161267575|NCT01739348|582363362|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
161267576|NCT01739348|582363363|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
161267577|NCT01739348|582363360|FG000|Part II (Extension Study)|Participant Moved|3|||
161267578|NCT01739348|582363361|FG001|Part II (Extension Study)|Participant Moved|3|||
161267579|NCT01739348|582363362|FG002|Part II (Extension Study)|Participant Moved|0|||
161267580|NCT01739348|582363363|FG003|Part II (Extension Study)|Participant Moved|3|||
161267581|NCT01739348|582363360|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
161267582|NCT01739348|582363361|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
161267583|NCT01739348|582363362|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
161267584|NCT01739348|582363363|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
161267585|NCT01739348|582363360|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
160948569|NCT03832010|581200468|FG001|Overall Study|Withdrawal by Subject|1|||
160948570|NCT03832010|581200469|FG002|Overall Study|Withdrawal by Subject|0|||
160948571|NCT03832010|581200467|FG000|Overall Study|Lost to Follow-up|2|||
160948572|NCT03832010|581200468|FG001|Overall Study|Lost to Follow-up|1|||
161267586|NCT01739348|582363361|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
161267587|NCT01739348|582363362|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
161267588|NCT01739348|582363363|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
161267589|NCT01447420|582363370|FG000|Overall Study|Adverse Event|2|||
161267590|NCT01447420|582363371|FG001|Overall Study|Adverse Event|4|||
161145021|NCT02619253|581914020|FG003|Overall Study|Withdrawal by Subject|0|||
161267591|NCT01447420|582363372|FG002|Overall Study|Adverse Event|2|||
161267592|NCT01447420|582363370|FG000|Overall Study|Protocol Violation|3|||
161267593|NCT01447420|582363371|FG001|Overall Study|Protocol Violation|3|||
161267594|NCT01447420|582363372|FG002|Overall Study|Protocol Violation|0|||
161267595|NCT01447420|582363370|FG000|Overall Study|Withdrawal by Subject|4|||
161267596|NCT01447420|582363371|FG001|Overall Study|Withdrawal by Subject|1|||
161267597|NCT01447420|582363372|FG002|Overall Study|Withdrawal by Subject|0|||
161267598|NCT01447420|582363370|FG000|Overall Study|Lack of Efficacy|1|||
161267599|NCT01447420|582363371|FG001|Overall Study|Lack of Efficacy|19|||
161267600|NCT01447420|582363372|FG002|Overall Study|Lack of Efficacy|8|||
161267601|NCT01085201|582363379|FG000|Overall Study|Scheduling conflict|1|||
161267602|NCT01085201|582363380|FG001|Overall Study|Scheduling conflict|0|||
161267603|NCT01085201|582363381|FG002|Overall Study|Scheduling conflict|1|||
161267604|NCT01085201|582363382|FG003|Overall Study|Scheduling conflict|0|||
161267605|NCT01085201|582363383|FG004|Overall Study|Scheduling conflict|0|||
161267606|NCT01085201|582363379|FG000|Overall Study|Unknown- no study drug|2|||
161267607|NCT01085201|582363380|FG001|Overall Study|Unknown- no study drug|0|||
161267608|NCT01085201|582363381|FG002|Overall Study|Unknown- no study drug|0|||
161267609|NCT01085201|582363382|FG003|Overall Study|Unknown- no study drug|0|||
161267610|NCT01085201|582363383|FG004|Overall Study|Unknown- no study drug|0|||
161267611|NCT01085201|582363379|FG000|Overall Study|Fond ineligible after consent|0|||
161267612|NCT01085201|582363380|FG001|Overall Study|Fond ineligible after consent|1|||
161267613|NCT01085201|582363381|FG002|Overall Study|Fond ineligible after consent|1|||
161267614|NCT01085201|582363382|FG003|Overall Study|Fond ineligible after consent|0|||
161267615|NCT01085201|582363383|FG004|Overall Study|Fond ineligible after consent|0|||
161267616|NCT00528411|582363384|FG000|Overall Study|Adverse Event|4|||
161267617|NCT00528411|582363385|FG001|Overall Study|Adverse Event|0|||
161267618|NCT00528411|582363386|FG002|Overall Study|Adverse Event|1|||
161267619|NCT00528411|582363384|FG000|Overall Study|Incorrect Enrolment|1|||
161267620|NCT00528411|582363385|FG001|Overall Study|Incorrect Enrolment|1|||
161267621|NCT00528411|582363386|FG002|Overall Study|Incorrect Enrolment|0|||
161267622|NCT00528411|582363384|FG000|Overall Study|Severe non-compliance to protocol|0|||
161267623|NCT00528411|582363385|FG001|Overall Study|Severe non-compliance to protocol|1|||
161267624|NCT00528411|582363386|FG002|Overall Study|Severe non-compliance to protocol|0|||
161267625|NCT00528411|582363384|FG000|Overall Study|Prior commitment medication|0|||
161267626|NCT00528411|582363385|FG001|Overall Study|Prior commitment medication|1|||
161267627|NCT00528411|582363386|FG002|Overall Study|Prior commitment medication|0|||
161267628|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
161267629|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
161267630|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
161267631|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
161267632|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
161267633|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
161267634|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
161267635|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
161267636|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
161267637|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267638|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
161267639|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267640|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267641|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267642|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267643|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267644|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267645|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
161267646|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267647|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
161267648|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
160862152|NCT00696072|580889658|FG001|Overall Study|Disease Progression|30|||
160862153|NCT00696072|580889657|FG000|Overall Study|Non-specified|1|||
160862154|NCT00696072|580889658|FG001|Overall Study|Non-specified|2|||
160862155|NCT01597596|580889659|FG000|Overall Study|Study terminated by sponsor|1|||
160862156|NCT01597596|580889660|FG001|Overall Study|Study terminated by sponsor|0|||
160862157|NCT01597596|580889659|FG000|Overall Study|Physician Decision|0|||
160862158|NCT01597596|580889660|FG001|Overall Study|Physician Decision|1|||
160862159|NCT00124943|580889661|FG000|Phase II|Adverse Event|0|||
160862160|NCT00124943|580889662|FG001|Phase II|Adverse Event|2|||
160862161|NCT00124943|580889663|FG002|Phase II|Adverse Event|0|||
160862162|NCT00124943|580889664|FG003|Phase II|Adverse Event|1|||
160862163|NCT00124943|580889661|FG000|Phase II|Protocol Violation|0|||
160862164|NCT00124943|580889662|FG001|Phase II|Protocol Violation|0|||
161145022|NCT02619253|581914021|FG004|Overall Study|Withdrawal by Subject|2|||
161145023|NCT02111811|581914022|FG000|Treatment Phase|Lost to Follow-up|22|||
160948573|NCT03832010|581200469|FG002|Overall Study|Lost to Follow-up|1|||
160948574|NCT04969783|581200470|FG000|Overall Study|Lost to Follow-up|2|||
160948575|NCT04969783|581200471|FG001|Overall Study|Lost to Follow-up|0|||
160948576|NCT04969783|581200470|FG000|Overall Study|Withdrawal by Subject|4|||
160948577|NCT04969783|581200471|FG001|Overall Study|Withdrawal by Subject|0|||
160948578|NCT04969783|581200470|FG000|Overall Study|Physician Decision|6|||
160948579|NCT04969783|581200471|FG001|Overall Study|Physician Decision|0|||
160948580|NCT02489500|581200472|FG000|Overall Study|Death|1|||
160948581|NCT02489500|581200473|FG001|Overall Study|Death|1|||
160948582|NCT00987467|581200478|FG000|Overall Study|Lost to Follow-up|2|||
160948583|NCT02019719|581200481|FG000|Overall Study|Adverse Event|1|||
160948584|NCT02019719|581200482|FG001|Overall Study|Adverse Event|0|||
160948585|NCT02019719|581200483|FG002|Overall Study|Adverse Event|0|||
160948586|NCT02019719|581200484|FG003|Overall Study|Adverse Event|1|||
160948587|NCT02019719|581200485|FG004|Overall Study|Adverse Event|1|||
160948588|NCT02019719|581200481|FG000|Overall Study|Protocol Violation|1|||
160948589|NCT02019719|581200482|FG001|Overall Study|Protocol Violation|1|||
160948590|NCT02019719|581200483|FG002|Overall Study|Protocol Violation|0|||
160948591|NCT02019719|581200484|FG003|Overall Study|Protocol Violation|0|||
161145024|NCT02111811|581914023|FG001|Treatment Phase|Lost to Follow-up|18|||
161267649|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
161267650|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267651|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267652|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267653|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267654|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267655|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267656|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
161267657|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267658|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
161267659|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267660|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267661|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267662|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267663|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
161267664|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
161267665|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
161267666|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
161267667|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267668|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
161267669|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267670|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160948592|NCT02019719|581200485|FG004|Overall Study|Protocol Violation|0|||
160948593|NCT02019719|581200481|FG000|Overall Study|Protocol defined stopping criteria|2|||
160948594|NCT02019719|581200482|FG001|Overall Study|Protocol defined stopping criteria|0|||
161267671|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267672|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267673|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267674|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
161267675|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267676|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267677|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267678|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267679|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267680|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267681|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
161267682|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267683|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267684|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267685|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
160948595|NCT02019719|581200483|FG002|Overall Study|Protocol defined stopping criteria|0|||
160948596|NCT02019719|581200484|FG003|Overall Study|Protocol defined stopping criteria|1|||
161145025|NCT02111811|581914022|FG000|Treatment Phase|Death|2|||
160948597|NCT02019719|581200485|FG004|Overall Study|Protocol defined stopping criteria|1|||
161145026|NCT02111811|581914023|FG001|Treatment Phase|Death|0|||
160948598|NCT02019719|581200481|FG000|Overall Study|Physician Decision|2|||
160948599|NCT02019719|581200482|FG001|Overall Study|Physician Decision|0|||
160948600|NCT02019719|581200483|FG002|Overall Study|Physician Decision|0|||
160948601|NCT02019719|581200484|FG003|Overall Study|Physician Decision|0|||
160948602|NCT02019719|581200485|FG004|Overall Study|Physician Decision|0|||
160948603|NCT02417246|581200486|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
160948604|NCT02417246|581200487|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
160948605|NCT02417246|581200486|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
160948606|NCT02417246|581200487|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
161267686|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267687|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267688|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267689|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267690|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267691|NCT03893565|582363387|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161267692|NCT03893565|582363388|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
161267693|NCT03893565|582363389|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
161267694|NCT03893565|582363390|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
161267695|NCT03893565|582363391|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161267696|NCT03893565|582363392|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161267697|NCT03893565|582363393|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161267698|NCT03893565|582363394|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161267699|NCT03893565|582363395|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
161267700|NCT03893565|582363387|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
161267701|NCT03893565|582363388|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
161267702|NCT03893565|582363389|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
161267703|NCT03893565|582363390|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
161267704|NCT03893565|582363391|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
161267705|NCT03893565|582363392|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
161267706|NCT03893565|582363393|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
161267707|NCT03893565|582363394|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
161267708|NCT03893565|582363395|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
161267709|NCT03893565|582363387|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267710|NCT03893565|582363388|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267711|NCT03893565|582363389|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267712|NCT03893565|582363390|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267713|NCT03893565|582363391|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267714|NCT03893565|582363392|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161342739|NCT03507790|582642246|FG000|Overall Study|Subject moved to another location|1|||
160948607|NCT02417246|581200486|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
160948608|NCT02417246|581200487|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
160948609|NCT02417246|581200486|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
160948610|NCT02417246|581200487|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
160948611|NCT04408469|581200497|FG000|Overall Study|Lost to Follow-up|6|||
160948612|NCT04408469|581200498|FG001|Overall Study|Lost to Follow-up|9|||
160948613|NCT04408469|581200497|FG000|Overall Study|Withdrawal by Subject|6|||
160948614|NCT04408469|581200498|FG001|Overall Study|Withdrawal by Subject|1|||
160948615|NCT04408469|581200497|FG000|Overall Study|Dismissal due to ineligibility|0|||
160948616|NCT04408469|581200498|FG001|Overall Study|Dismissal due to ineligibility|1|||
160948617|NCT04321460|581200499|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
160948618|NCT04321460|581200500|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
160948619|NCT03669081|581200503|FG000|Overall Study|Data could not be validated|1|||
160948620|NCT03669081|581200504|FG001|Overall Study|Data could not be validated|1|||
160948621|NCT01308749|581200509|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
160948622|NCT01308749|581200510|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
160948623|NCT01308749|581200509|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
160948624|NCT01308749|581200510|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
160948625|NCT01308749|581200509|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
160948626|NCT01308749|581200510|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
160948627|NCT02546544|581200511|FG000|Overall Study|Disease Progression|14|||
160948628|NCT02546544|581200511|FG000|Overall Study|Adverse Event|1|||
160948629|NCT02546544|581200511|FG000|Overall Study|Withdrawal by Subject|1|||
160948630|NCT01921348|581200512|FG000|Overall Study|Withdrawal by Subject|1|||
160948631|NCT01921348|581200513|FG001|Overall Study|Withdrawal by Subject|0|||
160948632|NCT01921348|581200512|FG000|Overall Study|Lost to Follow-up|0|||
160948633|NCT01921348|581200513|FG001|Overall Study|Lost to Follow-up|2|||
160948634|NCT02223390|581200514|FG000|Overall Study|Lost to Follow-up|9|||
160948635|NCT02223390|581200515|FG001|Overall Study|Lost to Follow-up|4|||
160948636|NCT01197950|581200521|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
160948637|NCT01197950|581200522|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
160948638|NCT01197950|581200523|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
160948639|NCT02553330|581200524|FG000|Overall Study|Study Terminated by Sponsor|2|||
160948640|NCT02553330|581200525|FG001|Overall Study|Study Terminated by Sponsor|13|||
160948641|NCT02553330|581200526|FG002|Overall Study|Study Terminated by Sponsor|12|||
160948642|NCT02553330|581200524|FG000|Overall Study|Withdrawal by Subject|3|||
160948643|NCT02553330|581200525|FG001|Overall Study|Withdrawal by Subject|19|||
160948644|NCT02553330|581200526|FG002|Overall Study|Withdrawal by Subject|21|||
160948645|NCT02553330|581200524|FG000|Overall Study|Other|0|||
160948646|NCT02553330|581200525|FG001|Overall Study|Other|1|||
160948647|NCT02553330|581200526|FG002|Overall Study|Other|0|||
160948648|NCT02553330|581200524|FG000|Overall Study|Non compliance to study treatment|0|||
160948649|NCT02553330|581200525|FG001|Overall Study|Non compliance to study treatment|1|||
160948650|NCT02553330|581200526|FG002|Overall Study|Non compliance to study treatment|0|||
160948651|NCT02553330|581200524|FG000|Overall Study|Adverse Event|0|||
160948652|NCT02553330|581200525|FG001|Overall Study|Adverse Event|1|||
160948653|NCT02553330|581200526|FG002|Overall Study|Adverse Event|0|||
160948654|NCT02553330|581200524|FG000|Overall Study|Lost to Follow-up|0|||
160948655|NCT02553330|581200525|FG001|Overall Study|Lost to Follow-up|4|||
160948656|NCT02553330|581200526|FG002|Overall Study|Lost to Follow-up|4|||
160948657|NCT02896855|581200527|FG000|Overall Study|Death|50|||
160948658|NCT02896855|581200528|FG001|Overall Study|Death|40|||
160948659|NCT02896855|581200527|FG000|Overall Study|Lost to Follow-up|15|||
160948660|NCT02896855|581200528|FG001|Overall Study|Lost to Follow-up|9|||
160948661|NCT02896855|581200527|FG000|Overall Study|Withdrawal by Subject|7|||
160948662|NCT02896855|581200528|FG001|Overall Study|Withdrawal by Subject|4|||
160948663|NCT01205685|581200529|FG000|Overall Study|Disease Progression|10|||
160948664|NCT01205685|581200529|FG000|Overall Study|Withdrawal by Subject|1|||
160948665|NCT02169674|581200530|FG000|Overall Study|Withdrawal by Subject|2|||
160948666|NCT02169674|581200531|FG001|Overall Study|Withdrawal by Subject|1|||
160948667|NCT02169674|581200530|FG000|Overall Study|Seroprotected|30|||
160948668|NCT02169674|581200531|FG001|Overall Study|Seroprotected|76|||
160948669|NCT02169674|581200530|FG000|Overall Study|Lost to Follow-up|0|||
160948670|NCT02169674|581200531|FG001|Overall Study|Lost to Follow-up|1|||
160948671|NCT01666002|581200532|FG000|Overall Study|Lost to Follow-up|5|||
160948672|NCT01666002|581200533|FG001|Overall Study|Lost to Follow-up|0|||
160948673|NCT02511431|581200534|FG000|Treatment|Lost to Follow-up|0|||
160948674|NCT02511431|581200535|FG001|Treatment|Lost to Follow-up|0|||
160948675|NCT02511431|581200536|FG002|Treatment|Lost to Follow-up|1|||
161267715|NCT03893565|582363393|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
161267716|NCT03893565|582363394|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267717|NCT03893565|582363395|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
161267718|NCT03893565|582363387|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267719|NCT03893565|582363388|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267720|NCT03893565|582363389|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267721|NCT03893565|582363390|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267722|NCT03893565|582363391|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267723|NCT03893565|582363392|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
161267724|NCT03893565|582363393|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
161267725|NCT03893565|582363394|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267726|NCT03893565|582363395|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
161267727|NCT03893565|582363387|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
161267728|NCT03893565|582363388|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
161267729|NCT03893565|582363389|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
161267730|NCT03893565|582363390|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
161267731|NCT03893565|582363391|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
161267732|NCT03893565|582363392|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
161267733|NCT03893565|582363393|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
160948676|NCT02511431|581200537|FG003|Treatment|Lost to Follow-up|0|||
160948677|NCT02511431|581200538|FG004|Treatment|Lost to Follow-up|0|||
160948678|NCT02511431|581200539|FG005|Treatment|Lost to Follow-up|1|||
160948679|NCT03058679|581200547|FG000|Baseline to Week 6|Lost to Follow-up|3|||
160948680|NCT03058679|581200548|FG001|Baseline to Week 6|Lost to Follow-up|2|||
160948681|NCT03058679|581200547|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
160948682|NCT03058679|581200548|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
160948683|NCT03058679|581200547|FG000|Baseline to Week 6|Adverse Event|6|||
160948684|NCT03058679|581200548|FG001|Baseline to Week 6|Adverse Event|6|||
160948685|NCT03058679|581200547|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
160948686|NCT03058679|581200548|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
160948687|NCT03058679|581200547|FG000|Baseline to Week 6|Difficulty following the diet|0|||
160948688|NCT03058679|581200548|FG001|Baseline to Week 6|Difficulty following the diet|2|||
160948689|NCT03058679|581200547|FG000|Baseline to Week 6|Physician Decision|1|||
161267734|NCT03893565|582363394|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
161267735|NCT03893565|582363395|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
161267736|NCT03893565|582363387|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267737|NCT03893565|582363388|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267738|NCT03893565|582363389|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267739|NCT03893565|582363390|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267740|NCT03893565|582363391|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267741|NCT03893565|582363392|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267742|NCT03893565|582363393|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267743|NCT03893565|582363394|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
161267744|NCT03893565|582363395|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
161267745|NCT03893565|582363387|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267746|NCT03893565|582363388|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267747|NCT03893565|582363389|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267748|NCT03893565|582363390|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267749|NCT03893565|582363391|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160948690|NCT03058679|581200548|FG001|Baseline to Week 6|Physician Decision|0|||
160948691|NCT03058679|581200547|FG000|Week 6 to Week 12|Change in medication|5|||
160948692|NCT03058679|581200548|FG001|Week 6 to Week 12|Change in medication|7|||
160948693|NCT03058679|581200547|FG000|Week 6 to Week 12|Adverse Event|4|||
160948694|NCT03058679|581200548|FG001|Week 6 to Week 12|Adverse Event|3|||
160948695|NCT03058679|581200547|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
160948696|NCT03058679|581200548|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
160948697|NCT03058679|581200547|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
160948698|NCT03058679|581200548|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
160948699|NCT04137380|581200553|FG000|Overall Study|Physician Decision|0|||
160948700|NCT04137380|581200554|FG001|Overall Study|Physician Decision|0|||
160948701|NCT04137380|581200555|FG002|Overall Study|Physician Decision|0|||
160948702|NCT04137380|581200556|FG003|Overall Study|Physician Decision|1|||
160948703|NCT04137380|581200557|FG004|Overall Study|Physician Decision|0|||
160948704|NCT04137380|581200558|FG005|Overall Study|Physician Decision|0|||
160948705|NCT04137380|581200559|FG006|Overall Study|Physician Decision|0|||
160948706|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Adverse Event|3|||
160948707|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Adverse Event|2|||
160948708|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Adverse Event|0|||
160948709|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Adverse Event|0|||
160948710|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Adverse Event|0|||
160948711|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Adverse Event|0|||
160948712|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Adverse Event|0|||
160948713|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
160948714|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
160948715|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948716|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948717|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948718|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948719|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
160948720|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Physician Decision|1|||
160948721|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Physician Decision|0|||
160948722|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Physician Decision|0|||
160948723|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Physician Decision|0|||
160948724|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Physician Decision|0|||
160948725|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Physician Decision|0|||
160948726|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Physician Decision|0|||
160948727|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
160948728|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
160948729|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948730|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948731|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
161267750|NCT03893565|582363392|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267751|NCT03893565|582363393|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
160948732|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948733|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
160948734|NCT02265705|581200565|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
160999821|NCT02341625|581382812|FG009|Overall Study|Not Reported|3|||
160948735|NCT02265705|581200566|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
160948736|NCT02265705|581200567|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948737|NCT02265705|581200568|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948738|NCT02265705|581200569|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948739|NCT02265705|581200570|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
161267752|NCT03893565|582363394|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
161267753|NCT03893565|582363395|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
161267754|NCT03893565|582363387|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267755|NCT03893565|582363388|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267756|NCT03893565|582363389|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267757|NCT03893565|582363390|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267758|NCT03893565|582363391|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267759|NCT03893565|582363392|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267760|NCT03893565|582363393|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267761|NCT03893565|582363394|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
161267762|NCT03893565|582363395|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
161267763|NCT03893565|582363387|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267764|NCT03893565|582363388|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267765|NCT03893565|582363389|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
160948740|NCT02265705|581200571|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
160948741|NCT02265705|581200565|FG000|Rescue Period|Withdrawal by Subject|0|||
160948742|NCT02265705|581200566|FG001|Rescue Period|Withdrawal by Subject|0|||
160948743|NCT02265705|581200567|FG002|Rescue Period|Withdrawal by Subject|1|||
160948744|NCT02265705|581200568|FG003|Rescue Period|Withdrawal by Subject|0|||
160948745|NCT02265705|581200569|FG004|Rescue Period|Withdrawal by Subject|0|||
160948746|NCT02265705|581200570|FG005|Rescue Period|Withdrawal by Subject|0|||
160948747|NCT02265705|581200571|FG006|Rescue Period|Withdrawal by Subject|0|||
160948748|NCT02265705|581200565|FG000|Rescue Period|Death|0|||
160948749|NCT02265705|581200566|FG001|Rescue Period|Death|0|||
160948750|NCT02265705|581200567|FG002|Rescue Period|Death|1|||
160948751|NCT02265705|581200568|FG003|Rescue Period|Death|0|||
160948752|NCT02265705|581200569|FG004|Rescue Period|Death|0|||
160948753|NCT02265705|581200570|FG005|Rescue Period|Death|0|||
160948754|NCT02265705|581200571|FG006|Rescue Period|Death|0|||
160948755|NCT02265705|581200565|FG000|Rescue Period|Lack of Efficacy|0|||
160948756|NCT02265705|581200566|FG001|Rescue Period|Lack of Efficacy|0|||
160948757|NCT02265705|581200567|FG002|Rescue Period|Lack of Efficacy|1|||
160948758|NCT02265705|581200568|FG003|Rescue Period|Lack of Efficacy|0|||
160948759|NCT02265705|581200569|FG004|Rescue Period|Lack of Efficacy|0|||
160948760|NCT02265705|581200570|FG005|Rescue Period|Lack of Efficacy|0|||
160948761|NCT02265705|581200571|FG006|Rescue Period|Lack of Efficacy|0|||
160948762|NCT02265705|581200565|FG000|Open Label Period|Adverse Event|0|||
160948763|NCT02265705|581200566|FG001|Open Label Period|Adverse Event|0|||
160948764|NCT02265705|581200567|FG002|Open Label Period|Adverse Event|0|||
160948765|NCT02265705|581200568|FG003|Open Label Period|Adverse Event|2|||
160948766|NCT02265705|581200569|FG004|Open Label Period|Adverse Event|2|||
160948767|NCT02265705|581200570|FG005|Open Label Period|Adverse Event|0|||
160948768|NCT02265705|581200571|FG006|Open Label Period|Adverse Event|0|||
160948769|NCT02265705|581200565|FG000|Open Label Period|Physician Decision|0|||
160948770|NCT02265705|581200566|FG001|Open Label Period|Physician Decision|0|||
160948771|NCT02265705|581200567|FG002|Open Label Period|Physician Decision|0|||
160948772|NCT02265705|581200568|FG003|Open Label Period|Physician Decision|0|||
160948773|NCT02265705|581200569|FG004|Open Label Period|Physician Decision|1|||
160948774|NCT02265705|581200570|FG005|Open Label Period|Physician Decision|0|||
160948775|NCT02265705|581200571|FG006|Open Label Period|Physician Decision|0|||
160948776|NCT02265705|581200565|FG000|Open Label Period|Withdrawal by Subject|0|||
160948777|NCT02265705|581200566|FG001|Open Label Period|Withdrawal by Subject|0|||
160948778|NCT02265705|581200567|FG002|Open Label Period|Withdrawal by Subject|0|||
160948779|NCT02265705|581200568|FG003|Open Label Period|Withdrawal by Subject|0|||
160948780|NCT02265705|581200569|FG004|Open Label Period|Withdrawal by Subject|2|||
160948781|NCT02265705|581200570|FG005|Open Label Period|Withdrawal by Subject|0|||
160948782|NCT02265705|581200571|FG006|Open Label Period|Withdrawal by Subject|0|||
160948783|NCT02265705|581200565|FG000|Follow-up Period|Sponsor Decision|0|||
160948784|NCT02265705|581200566|FG001|Follow-up Period|Sponsor Decision|0|||
160948785|NCT02265705|581200567|FG002|Follow-up Period|Sponsor Decision|0|||
160948786|NCT02265705|581200568|FG003|Follow-up Period|Sponsor Decision|0|||
160948787|NCT02265705|581200569|FG004|Follow-up Period|Sponsor Decision|0|||
161342740|NCT03507790|582642247|FG001|Overall Study|Subject moved to another location|2|||
161342741|NCT03507790|582642248|FG002|Overall Study|Subject moved to another location|0|||
160948788|NCT02265705|581200570|FG005|Follow-up Period|Sponsor Decision|1|||
160948789|NCT02265705|581200571|FG006|Follow-up Period|Sponsor Decision|6|||
160948790|NCT02265705|581200565|FG000|Follow-up Period|Adverse Event|0|||
160948791|NCT02265705|581200566|FG001|Follow-up Period|Adverse Event|0|||
161145027|NCT02111811|581914022|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
160948792|NCT02265705|581200567|FG002|Follow-up Period|Adverse Event|0|||
160948793|NCT02265705|581200568|FG003|Follow-up Period|Adverse Event|0|||
160948794|NCT02265705|581200569|FG004|Follow-up Period|Adverse Event|0|||
160948795|NCT02265705|581200570|FG005|Follow-up Period|Adverse Event|0|||
160948796|NCT02265705|581200571|FG006|Follow-up Period|Adverse Event|3|||
160948797|NCT02265705|581200565|FG000|Follow-up Period|Physician Decision|0|||
161267766|NCT03893565|582363390|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267767|NCT03893565|582363391|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267768|NCT03893565|582363392|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267769|NCT03893565|582363393|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267770|NCT03893565|582363394|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
161267771|NCT03893565|582363395|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
161267772|NCT03870477|582363400|FG000|Overall Study|Early Study Termination|1|||
161267773|NCT02256436|582363409|FG000|Overall Study|Adverse Event|9|||
161267774|NCT02256436|582363410|FG001|Overall Study|Adverse Event|14|||
161267775|NCT02256436|582363409|FG000|Overall Study|Death|216|||
161267776|NCT02256436|582363410|FG001|Overall Study|Death|208|||
161267777|NCT02256436|582363409|FG000|Overall Study|Lost to Follow-up|1|||
161267778|NCT02256436|582363410|FG001|Overall Study|Lost to Follow-up|2|||
161267779|NCT02256436|582363409|FG000|Overall Study|Physician Decision|1|||
161267780|NCT02256436|582363410|FG001|Overall Study|Physician Decision|0|||
161267781|NCT02256436|582363409|FG000|Overall Study|Protocol Violation|0|||
161267782|NCT02256436|582363410|FG001|Overall Study|Protocol Violation|1|||
161267783|NCT02256436|582363409|FG000|Overall Study|Withdrawal by Subject|26|||
161267784|NCT02256436|582363410|FG001|Overall Study|Withdrawal by Subject|10|||
161267785|NCT02256436|582363409|FG000|Overall Study|Transferred to Extension Study|11|||
161267786|NCT02256436|582363410|FG001|Overall Study|Transferred to Extension Study|23|||
161267787|NCT02256436|582363409|FG000|Overall Study|Did Not Continue on Extension Study|8|||
161267788|NCT02256436|582363410|FG001|Overall Study|Did Not Continue on Extension Study|12|||
161267789|NCT05961215|582363411|FG000|Overall Study|Withdrawal by Subject|1|||
161267790|NCT01394952|582363412|FG000|Overall Study|Lost to Follow-up|0|||
161267791|NCT01394952|582363413|FG001|Overall Study|Lost to Follow-up|5|||
161267792|NCT01394952|582363412|FG000|Overall Study|Withdrawal by Subject|10|||
161267793|NCT01394952|582363413|FG001|Overall Study|Withdrawal by Subject|5|||
161267794|NCT01394952|582363412|FG000|Overall Study|Physician Decision|2|||
161267795|NCT01394952|582363413|FG001|Overall Study|Physician Decision|0|||
161267796|NCT01394952|582363412|FG000|Overall Study|Sponsor Decision|5|||
161267797|NCT01394952|582363413|FG001|Overall Study|Sponsor Decision|7|||
161267798|NCT01986010|582363414|FG000|Overall Study|Adverse Event|0|||
161267799|NCT01986010|582363415|FG001|Overall Study|Adverse Event|1|||
161267800|NCT01986010|582363416|FG002|Overall Study|Adverse Event|0|||
160862165|NCT00124943|580889663|FG002|Phase II|Protocol Violation|0|||
160862166|NCT00124943|580889664|FG003|Phase II|Protocol Violation|1|||
160862167|NCT00124943|580889661|FG000|Phase II|Lost to Follow-up|0|||
160862168|NCT00124943|580889662|FG001|Phase II|Lost to Follow-up|0|||
160862169|NCT00124943|580889663|FG002|Phase II|Lost to Follow-up|0|||
160862170|NCT00124943|580889664|FG003|Phase II|Lost to Follow-up|1|||
160862171|NCT00124943|580889661|FG000|Phase II|Withdrawal by Subject|0|||
160862172|NCT00124943|580889662|FG001|Phase II|Withdrawal by Subject|0|||
160862173|NCT00124943|580889663|FG002|Phase II|Withdrawal by Subject|0|||
160862174|NCT00124943|580889664|FG003|Phase II|Withdrawal by Subject|2|||
160862175|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
160862176|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
160862177|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
160862178|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
160862179|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
160862180|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
160862181|NCT03181932|580889665|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
160862182|NCT03181932|580889666|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
160862183|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
160862184|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
160862185|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
160862186|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
160862187|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
160862188|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
160862189|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
160862190|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
160862191|NCT03181932|580889665|FG000|Period 2 (Open-label Period)|Reason missing|2|||
160862192|NCT03181932|580889666|FG001|Period 2 (Open-label Period)|Reason missing|0|||
160862193|NCT00408317|580889673|FG000|First Intervention Period|Adverse Event|0|||
160862194|NCT00408317|580889674|FG001|First Intervention Period|Adverse Event|1|||
160862195|NCT00408317|580889673|FG000|Second Intervention Period|Adverse Event|2|||
160862196|NCT00408317|580889674|FG001|Second Intervention Period|Adverse Event|0|||
160862197|NCT00408317|580889673|FG000|Second Intervention Period|Protocol Violation|0|||
160862198|NCT00408317|580889674|FG001|Second Intervention Period|Protocol Violation|1|||
160862199|NCT00408317|580889673|FG000|Second Intervention Period|Withdrawal of consent|0|||
160862200|NCT00408317|580889674|FG001|Second Intervention Period|Withdrawal of consent|1|||
160862201|NCT00360230|580889681|FG000|Overall Study|Withdrawal by Subject|1|||
161267801|NCT01986010|582363417|FG003|Overall Study|Adverse Event|0|||
161267802|NCT01986010|582363418|FG004|Overall Study|Adverse Event|0|||
161267803|NCT01986010|582363419|FG005|Overall Study|Adverse Event|0|||
161267804|NCT01986010|582363420|FG006|Overall Study|Adverse Event|0|||
161267805|NCT01986010|582363421|FG007|Overall Study|Adverse Event|0|||
161267806|NCT01986010|582363422|FG008|Overall Study|Adverse Event|0|||
161267807|NCT01986010|582363423|FG009|Overall Study|Adverse Event|0|||
161267808|NCT01986010|582363424|FG010|Overall Study|Adverse Event|0|||
161267809|NCT01986010|582363425|FG011|Overall Study|Adverse Event|0|||
161267810|NCT01986010|582363426|FG012|Overall Study|Adverse Event|0|||
161267811|NCT01986010|582363427|FG013|Overall Study|Adverse Event|0|||
161267812|NCT01986010|582363428|FG014|Overall Study|Adverse Event|0|||
161267813|NCT01986010|582363429|FG015|Overall Study|Adverse Event|1|||
161267814|NCT01986010|582363430|FG016|Overall Study|Adverse Event|0|||
161267815|NCT01986010|582363414|FG000|Overall Study|Lost to Follow-up|2|||
161267816|NCT01986010|582363415|FG001|Overall Study|Lost to Follow-up|1|||
161267817|NCT01986010|582363416|FG002|Overall Study|Lost to Follow-up|2|||
161267818|NCT01986010|582363417|FG003|Overall Study|Lost to Follow-up|2|||
161267819|NCT01986010|582363418|FG004|Overall Study|Lost to Follow-up|2|||
161267820|NCT01986010|582363419|FG005|Overall Study|Lost to Follow-up|2|||
161267821|NCT01986010|582363420|FG006|Overall Study|Lost to Follow-up|0|||
161267822|NCT01986010|582363421|FG007|Overall Study|Lost to Follow-up|0|||
161267823|NCT01986010|582363422|FG008|Overall Study|Lost to Follow-up|4|||
161267824|NCT01986010|582363423|FG009|Overall Study|Lost to Follow-up|2|||
161267825|NCT01986010|582363424|FG010|Overall Study|Lost to Follow-up|0|||
161267826|NCT01986010|582363425|FG011|Overall Study|Lost to Follow-up|1|||
161267827|NCT01986010|582363426|FG012|Overall Study|Lost to Follow-up|1|||
161267828|NCT01986010|582363427|FG013|Overall Study|Lost to Follow-up|1|||
161267829|NCT01986010|582363428|FG014|Overall Study|Lost to Follow-up|2|||
161267830|NCT01986010|582363429|FG015|Overall Study|Lost to Follow-up|0|||
161267831|NCT01986010|582363430|FG016|Overall Study|Lost to Follow-up|0|||
161267832|NCT01986010|582363414|FG000|Overall Study|Physician Decision|0|||
161267833|NCT01986010|582363415|FG001|Overall Study|Physician Decision|0|||
161267834|NCT01986010|582363416|FG002|Overall Study|Physician Decision|0|||
161267835|NCT01986010|582363417|FG003|Overall Study|Physician Decision|0|||
161267836|NCT01986010|582363418|FG004|Overall Study|Physician Decision|0|||
161267837|NCT01986010|582363419|FG005|Overall Study|Physician Decision|0|||
161267838|NCT01986010|582363420|FG006|Overall Study|Physician Decision|0|||
161267839|NCT01986010|582363421|FG007|Overall Study|Physician Decision|0|||
161267840|NCT01986010|582363422|FG008|Overall Study|Physician Decision|0|||
161267841|NCT01986010|582363423|FG009|Overall Study|Physician Decision|0|||
161267842|NCT01986010|582363424|FG010|Overall Study|Physician Decision|0|||
161267843|NCT01986010|582363425|FG011|Overall Study|Physician Decision|0|||
161267844|NCT01986010|582363426|FG012|Overall Study|Physician Decision|0|||
161267845|NCT01986010|582363427|FG013|Overall Study|Physician Decision|0|||
161267846|NCT01986010|582363428|FG014|Overall Study|Physician Decision|1|||
161267847|NCT01986010|582363429|FG015|Overall Study|Physician Decision|0|||
161267848|NCT01986010|582363430|FG016|Overall Study|Physician Decision|0|||
161267849|NCT01986010|582363414|FG000|Overall Study|Withdrawal by Subject|2|||
161267850|NCT01986010|582363415|FG001|Overall Study|Withdrawal by Subject|2|||
161267851|NCT01986010|582363416|FG002|Overall Study|Withdrawal by Subject|3|||
161267852|NCT01986010|582363417|FG003|Overall Study|Withdrawal by Subject|0|||
161267853|NCT01986010|582363418|FG004|Overall Study|Withdrawal by Subject|2|||
161267854|NCT01986010|582363419|FG005|Overall Study|Withdrawal by Subject|4|||
161267855|NCT01986010|582363420|FG006|Overall Study|Withdrawal by Subject|0|||
161267856|NCT01986010|582363421|FG007|Overall Study|Withdrawal by Subject|0|||
160948798|NCT02265705|581200566|FG001|Follow-up Period|Physician Decision|0|||
160948799|NCT02265705|581200567|FG002|Follow-up Period|Physician Decision|0|||
160948800|NCT02265705|581200568|FG003|Follow-up Period|Physician Decision|0|||
160948801|NCT02265705|581200569|FG004|Follow-up Period|Physician Decision|0|||
160948802|NCT02265705|581200570|FG005|Follow-up Period|Physician Decision|0|||
161267857|NCT01986010|582363422|FG008|Overall Study|Withdrawal by Subject|0|||
161267858|NCT01986010|582363423|FG009|Overall Study|Withdrawal by Subject|0|||
161267859|NCT01986010|582363424|FG010|Overall Study|Withdrawal by Subject|0|||
161267860|NCT01986010|582363425|FG011|Overall Study|Withdrawal by Subject|2|||
161267861|NCT01986010|582363426|FG012|Overall Study|Withdrawal by Subject|0|||
161267862|NCT01986010|582363427|FG013|Overall Study|Withdrawal by Subject|1|||
161267863|NCT01986010|582363428|FG014|Overall Study|Withdrawal by Subject|2|||
161267864|NCT01986010|582363429|FG015|Overall Study|Withdrawal by Subject|0|||
161267865|NCT01986010|582363430|FG016|Overall Study|Withdrawal by Subject|0|||
161267866|NCT01986010|582363414|FG000|Overall Study|Status Not Recorded|2|||
161267867|NCT01986010|582363415|FG001|Overall Study|Status Not Recorded|4|||
160948803|NCT02265705|581200571|FG006|Follow-up Period|Physician Decision|1|||
161267868|NCT01986010|582363416|FG002|Overall Study|Status Not Recorded|2|||
161267869|NCT01986010|582363417|FG003|Overall Study|Status Not Recorded|0|||
160948804|NCT02265705|581200565|FG000|Follow-up Period|Withdrawal by Subject|0|||
160948805|NCT02265705|581200566|FG001|Follow-up Period|Withdrawal by Subject|0|||
161267870|NCT01986010|582363418|FG004|Overall Study|Status Not Recorded|1|||
161267871|NCT01986010|582363419|FG005|Overall Study|Status Not Recorded|2|||
161267872|NCT01986010|582363420|FG006|Overall Study|Status Not Recorded|0|||
160948806|NCT02265705|581200567|FG002|Follow-up Period|Withdrawal by Subject|0|||
160948807|NCT02265705|581200568|FG003|Follow-up Period|Withdrawal by Subject|0|||
160948808|NCT02265705|581200569|FG004|Follow-up Period|Withdrawal by Subject|0|||
160948809|NCT02265705|581200570|FG005|Follow-up Period|Withdrawal by Subject|0|||
160948810|NCT02265705|581200571|FG006|Follow-up Period|Withdrawal by Subject|1|||
160948811|NCT02828111|581200575|FG000|Overall Study|Withdrawal by Subject|0|||
160948812|NCT02828111|581200576|FG001|Overall Study|Withdrawal by Subject|0|||
160948813|NCT02828111|581200577|FG002|Overall Study|Withdrawal by Subject|2|||
160948814|NCT02828111|581200578|FG003|Overall Study|Withdrawal by Subject|0|||
160948815|NCT02828111|581200579|FG004|Overall Study|Withdrawal by Subject|0|||
160948816|NCT02828111|581200575|FG000|Overall Study|Lost to Follow-up|0|||
160948817|NCT02828111|581200576|FG001|Overall Study|Lost to Follow-up|0|||
160948818|NCT02828111|581200577|FG002|Overall Study|Lost to Follow-up|0|||
160948819|NCT02828111|581200578|FG003|Overall Study|Lost to Follow-up|1|||
160948820|NCT02828111|581200579|FG004|Overall Study|Lost to Follow-up|1|||
160948821|NCT03285477|581200588|FG000|Treatment and Response Assessment Period|Death|1|||
160948822|NCT03285477|581200589|FG001|Treatment and Response Assessment Period|Death|0|||
160948823|NCT03285477|581200588|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
160948824|NCT03285477|581200589|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
160948825|NCT03285477|581200588|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
160948826|NCT03285477|581200589|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
160948827|NCT03285477|581200588|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
160948828|NCT03285477|581200589|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
160948829|NCT03285477|581200588|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
160948830|NCT03285477|581200589|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
160948831|NCT00560833|581200602|FG000|Overall Study|Adverse Event|16|||
160948832|NCT00560833|581200603|FG001|Overall Study|Adverse Event|10|||
160948833|NCT00560833|581200604|FG002|Overall Study|Adverse Event|25|||
160948834|NCT00560833|581200605|FG003|Overall Study|Adverse Event|23|||
160999822|NCT00177216|581382813|FG000|Overall Study|Withdrawal by Subject|6|||
160999823|NCT00177216|581382814|FG001|Overall Study|Withdrawal by Subject|3|||
160999824|NCT00177216|581382815|FG002|Overall Study|Withdrawal by Subject|1|||
160999825|NCT00988637|581382818|FG000|Overall Study|Lost to Follow-up|2|||
160999826|NCT00988637|581382819|FG001|Overall Study|Lost to Follow-up|1|||
160999827|NCT00988637|581382818|FG000|Overall Study|Withdrawal by Subject|1|||
160999828|NCT00988637|581382819|FG001|Overall Study|Withdrawal by Subject|1|||
160999829|NCT00988637|581382818|FG000|Overall Study|non-compliance with study drug|0|||
160999830|NCT00988637|581382819|FG001|Overall Study|non-compliance with study drug|1|||
160999831|NCT01161498|581382820|FG000|Overall Study|Disease Progression|0|||
160999832|NCT01161498|581382821|FG001|Overall Study|Disease Progression|1|||
160999833|NCT03310983|581382827|FG000|Overall Study|Lost to Follow-up|15|||
160999834|NCT03310983|581382828|FG001|Overall Study|Lost to Follow-up|17|||
160999835|NCT01656304|581382829|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
160999836|NCT00823979|581382832|FG000|Overall Study|Lack of Efficacy|13|||
160999837|NCT00823979|581382833|FG001|Overall Study|Lack of Efficacy|16|||
160999838|NCT00823979|581382834|FG002|Overall Study|Lack of Efficacy|9|||
160999839|NCT00823979|581382832|FG000|Overall Study|Lost to Follow-up|2|||
160999840|NCT00823979|581382833|FG001|Overall Study|Lost to Follow-up|1|||
160999841|NCT00823979|581382834|FG002|Overall Study|Lost to Follow-up|0|||
160999842|NCT00823979|581382832|FG000|Overall Study|Withdrawal by Subject|2|||
160999843|NCT00823979|581382833|FG001|Overall Study|Withdrawal by Subject|3|||
160999844|NCT00823979|581382834|FG002|Overall Study|Withdrawal by Subject|2|||
160999845|NCT00823979|581382832|FG000|Overall Study|Protocol Violation|1|||
160999846|NCT00823979|581382833|FG001|Overall Study|Protocol Violation|1|||
160999847|NCT00823979|581382834|FG002|Overall Study|Protocol Violation|0|||
160999848|NCT00823979|581382832|FG000|Overall Study|Pregnancy|0|||
161267873|NCT01986010|582363421|FG007|Overall Study|Status Not Recorded|0|||
161267874|NCT01986010|582363422|FG008|Overall Study|Status Not Recorded|2|||
161267875|NCT01986010|582363423|FG009|Overall Study|Status Not Recorded|1|||
161267876|NCT01986010|582363424|FG010|Overall Study|Status Not Recorded|7|||
161267877|NCT01986010|582363425|FG011|Overall Study|Status Not Recorded|7|||
161267878|NCT01986010|582363426|FG012|Overall Study|Status Not Recorded|9|||
161267879|NCT01986010|582363427|FG013|Overall Study|Status Not Recorded|9|||
161267880|NCT01986010|582363428|FG014|Overall Study|Status Not Recorded|5|||
161267881|NCT01986010|582363429|FG015|Overall Study|Status Not Recorded|10|||
161267882|NCT01986010|582363430|FG016|Overall Study|Status Not Recorded|4|||
161267883|NCT01335997|582363431|FG000|Period I and II|Adverse Event|63|||
161267884|NCT01335997|582363432|FG001|Period I and II|Adverse Event|43|||
161267885|NCT01335997|582363431|FG000|Period I and II|Noncompliance with Study Drug|1|||
161267886|NCT01335997|582363432|FG001|Period I and II|Noncompliance with Study Drug|1|||
161267887|NCT01335997|582363431|FG000|Period I and II|Lost to Follow-up|3|||
161267888|NCT01335997|582363432|FG001|Period I and II|Lost to Follow-up|5|||
161267889|NCT01335997|582363431|FG000|Period I and II|Withdrawal by Subject|9|||
161267890|NCT01335997|582363432|FG001|Period I and II|Withdrawal by Subject|4|||
161267891|NCT01335997|582363431|FG000|Period I and II|Study Terminated by Sponsor|406|||
161267892|NCT01335997|582363432|FG001|Period I and II|Study Terminated by Sponsor|415|||
160948835|NCT00560833|581200606|FG004|Overall Study|Adverse Event|35|||
160948836|NCT00560833|581200602|FG000|Overall Study|Lost to Follow-up|0|||
160948837|NCT00560833|581200603|FG001|Overall Study|Lost to Follow-up|0|||
160948838|NCT00560833|581200604|FG002|Overall Study|Lost to Follow-up|1|||
160948839|NCT00560833|581200605|FG003|Overall Study|Lost to Follow-up|0|||
160948840|NCT00560833|581200606|FG004|Overall Study|Lost to Follow-up|0|||
160948841|NCT00560833|581200602|FG000|Overall Study|Lack of Efficacy|22|||
160948842|NCT00560833|581200603|FG001|Overall Study|Lack of Efficacy|9|||
160948843|NCT00560833|581200604|FG002|Overall Study|Lack of Efficacy|6|||
160948844|NCT00560833|581200605|FG003|Overall Study|Lack of Efficacy|4|||
160948845|NCT00560833|581200606|FG004|Overall Study|Lack of Efficacy|4|||
160948846|NCT00560833|581200602|FG000|Overall Study|Participant uncooperative|5|||
160948847|NCT00560833|581200603|FG001|Overall Study|Participant uncooperative|5|||
160948848|NCT00560833|581200604|FG002|Overall Study|Participant uncooperative|4|||
160948849|NCT00560833|581200605|FG003|Overall Study|Participant uncooperative|4|||
160948850|NCT00560833|581200606|FG004|Overall Study|Participant uncooperative|2|||
160948851|NCT00560833|581200602|FG000|Overall Study|Other|1|||
160948852|NCT00560833|581200603|FG001|Overall Study|Other|1|||
160948853|NCT00560833|581200604|FG002|Overall Study|Other|3|||
160948854|NCT00560833|581200605|FG003|Overall Study|Other|0|||
160948855|NCT00560833|581200606|FG004|Overall Study|Other|0|||
160948856|NCT00560833|581200602|FG000|Overall Study|Never received drug|0|||
160948857|NCT00560833|581200603|FG001|Overall Study|Never received drug|1|||
160948858|NCT00560833|581200604|FG002|Overall Study|Never received drug|0|||
160948859|NCT00560833|581200605|FG003|Overall Study|Never received drug|0|||
160948860|NCT00560833|581200606|FG004|Overall Study|Never received drug|1|||
160948861|NCT03283670|581200607|FG000|Placebo Gas|Withdrawal by Subject|2|||
160948862|NCT03283670|581200607|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
160948863|NCT03283670|581200607|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
160948864|NCT01307501|581200608|FG000|Overall Study|Treatment Failure|1|||
160948865|NCT01307501|581200608|FG000|Overall Study|Death|20|||
160948866|NCT01307501|581200608|FG000|Overall Study|Lost to Follow-up|1|||
160948867|NCT01307501|581200608|FG000|Overall Study|Starting Hospice|1|||
160948868|NCT01209624|581200611|FG000|Overall Study|Death|2|||
161267893|NCT01335997|582363431|FG000|Period I and II|Protocol Violation|9|||
161267894|NCT01335997|582363432|FG001|Period I and II|Protocol Violation|10|||
161267895|NCT01335997|582363431|FG000|Period I and II|Physician Decision|2|||
161267896|NCT01335997|582363432|FG001|Period I and II|Physician Decision|1|||
161267897|NCT01335997|582363431|FG000|Period III|Adverse Event|0|||
161267898|NCT01335997|582363432|FG001|Period III|Adverse Event|2|||
161267899|NCT01335997|582363431|FG000|Period III|Study Terminated by Sponsor|77|||
161267900|NCT01335997|582363432|FG001|Period III|Study Terminated by Sponsor|76|||
161267901|NCT01335997|582363431|FG000|Period III|Protocol Violation|0|||
161267902|NCT01335997|582363432|FG001|Period III|Protocol Violation|1|||
161267903|NCT01335997|582363431|FG000|Period III|Lost to Follow-up|1|||
161267904|NCT01335997|582363432|FG001|Period III|Lost to Follow-up|0|||
161267905|NCT00085423|582363435|FG000|Overall Study|Withdrawal by Subject|1|||
160862202|NCT00360230|580889682|FG001|Overall Study|Withdrawal by Subject|1|||
160862203|NCT00360230|580889683|FG002|Overall Study|Withdrawal by Subject|0|||
160862204|NCT00360230|580889684|FG003|Overall Study|Withdrawal by Subject|1|||
160862205|NCT00360230|580889685|FG004|Overall Study|Withdrawal by Subject|1|||
160862206|NCT00360230|580889686|FG005|Overall Study|Withdrawal by Subject|1|||
160862207|NCT00360230|580889687|FG006|Overall Study|Withdrawal by Subject|0|||
160862208|NCT00360230|580889681|FG000|Overall Study|Migrated|4|||
160862209|NCT00360230|580889682|FG001|Overall Study|Migrated|1|||
160862210|NCT00360230|580889683|FG002|Overall Study|Migrated|3|||
160862211|NCT00360230|580889684|FG003|Overall Study|Migrated|1|||
160862212|NCT00360230|580889685|FG004|Overall Study|Migrated|4|||
160862213|NCT00360230|580889686|FG005|Overall Study|Migrated|1|||
160862214|NCT00360230|580889687|FG006|Overall Study|Migrated|1|||
160862215|NCT00360230|580889681|FG000|Overall Study|Other|1|||
160862216|NCT00360230|580889682|FG001|Overall Study|Other|0|||
160862217|NCT00360230|580889683|FG002|Overall Study|Other|0|||
160862218|NCT00360230|580889684|FG003|Overall Study|Other|0|||
160862219|NCT00360230|580889685|FG004|Overall Study|Other|0|||
160862220|NCT00360230|580889686|FG005|Overall Study|Other|0|||
160862221|NCT00360230|580889687|FG006|Overall Study|Other|0|||
160862222|NCT00360230|580889681|FG000|Overall Study|Protocol Violation|0|||
160862223|NCT00360230|580889682|FG001|Overall Study|Protocol Violation|0|||
160862224|NCT00360230|580889683|FG002|Overall Study|Protocol Violation|0|||
160862225|NCT00360230|580889684|FG003|Overall Study|Protocol Violation|0|||
160862226|NCT00360230|580889685|FG004|Overall Study|Protocol Violation|0|||
160862227|NCT00360230|580889686|FG005|Overall Study|Protocol Violation|1|||
160948869|NCT01209624|581200611|FG000|Overall Study|Adverse Event|13|||
160948870|NCT01209624|581200611|FG000|Overall Study|Lack of Efficacy|17|||
160862228|NCT00360230|580889687|FG006|Overall Study|Protocol Violation|0|||
160862229|NCT00360230|580889681|FG000|Overall Study|Death|0|||
160862230|NCT00360230|580889682|FG001|Overall Study|Death|1|||
160862231|NCT00360230|580889683|FG002|Overall Study|Death|0|||
160862232|NCT00360230|580889684|FG003|Overall Study|Death|0|||
160862233|NCT00360230|580889685|FG004|Overall Study|Death|0|||
160862234|NCT00360230|580889686|FG005|Overall Study|Death|1|||
161267906|NCT00085423|582363435|FG000|Overall Study|screen failure|1|||
161267907|NCT04740814|582363436|FG000|Overall Study|Adverse Event|3|||
161267908|NCT04740814|582363436|FG000|Overall Study|Protocol Violation|2|||
161267909|NCT04740814|582363436|FG000|Overall Study|Lost to Follow-up|2|||
161267910|NCT04740814|582363436|FG000|Overall Study|Withdrawal by Subject|3|||
161267911|NCT02317614|582363442|FG000|Overall Study|Lost to Follow-up|1|||
161267912|NCT02317614|582363443|FG001|Overall Study|Lost to Follow-up|1|||
161267913|NCT02317614|582363442|FG000|Overall Study|Withdrawal by Subject|1|||
161267914|NCT02317614|582363443|FG001|Overall Study|Withdrawal by Subject|0|||
161267915|NCT02317614|582363442|FG000|Overall Study|Death|1|||
161267916|NCT02317614|582363443|FG001|Overall Study|Death|1|||
161267917|NCT03285308|582363444|FG000|Overall Study|Adverse Event|3|||
160948871|NCT01209624|581200611|FG000|Overall Study|Lost to Follow-up|290|||
160948872|NCT01209624|581200611|FG000|Overall Study|Other|4|||
160948873|NCT03564496|581200612|FG000|Overall Study|Withdrawal by Subject|1|||
160948874|NCT03564496|581200613|FG001|Overall Study|Withdrawal by Subject|1|||
160948875|NCT03564496|581200614|FG002|Overall Study|Withdrawal by Subject|0|||
160948876|NCT03564496|581200612|FG000|Overall Study|Screen failure|0|||
160948877|NCT03564496|581200613|FG001|Overall Study|Screen failure|3|||
160948878|NCT03564496|581200614|FG002|Overall Study|Screen failure|0|||
160948879|NCT00428610|581200615|FG000|Overall Study|Death Due to Adverse Event|3|||
160948880|NCT00428610|581200616|FG001|Overall Study|Death Due to Adverse Event|0|||
160948881|NCT00428610|581200617|FG002|Overall Study|Death Due to Adverse Event|5|||
160948882|NCT00428610|581200615|FG000|Overall Study|Death Due to Progressive Disease|0|||
160948883|NCT00428610|581200616|FG001|Overall Study|Death Due to Progressive Disease|0|||
160948884|NCT00428610|581200617|FG002|Overall Study|Death Due to Progressive Disease|2|||
160948885|NCT00428610|581200615|FG000|Overall Study|Adverse Event|2|||
160948886|NCT00428610|581200616|FG001|Overall Study|Adverse Event|3|||
160948887|NCT00428610|581200617|FG002|Overall Study|Adverse Event|2|||
160948888|NCT00428610|581200615|FG000|Overall Study|Investigator Decision|2|||
160948889|NCT00428610|581200616|FG001|Overall Study|Investigator Decision|1|||
160948890|NCT00428610|581200617|FG002|Overall Study|Investigator Decision|1|||
160948891|NCT00428610|581200615|FG000|Overall Study|Progressive Disease|42|||
160948892|NCT00428610|581200616|FG001|Overall Study|Progressive Disease|14|||
160948893|NCT00428610|581200617|FG002|Overall Study|Progressive Disease|22|||
160948894|NCT00428610|581200615|FG000|Overall Study|Withdrawal by Subject|4|||
160948895|NCT00428610|581200616|FG001|Overall Study|Withdrawal by Subject|0|||
160948896|NCT00428610|581200617|FG002|Overall Study|Withdrawal by Subject|0|||
160948897|NCT04827576|581202915|FG000|Overall Study|Death|5|||
160948898|NCT04827576|581202916|FG001|Overall Study|Death|17|||
160948899|NCT04827576|581202917|FG002|Overall Study|Death|17|||
161267918|NCT03285308|582363445|FG001|Overall Study|Adverse Event|7|||
161267919|NCT03285308|582363444|FG000|Overall Study|Withdrawal by Subject|8|||
161267920|NCT03285308|582363445|FG001|Overall Study|Withdrawal by Subject|9|||
161267921|NCT03285308|582363444|FG000|Overall Study|Lost to Follow-up|3|||
161267922|NCT03285308|582363445|FG001|Overall Study|Lost to Follow-up|1|||
161267923|NCT03285308|582363444|FG000|Overall Study|Protocol Deviation|6|||
161267924|NCT03285308|582363445|FG001|Overall Study|Protocol Deviation|5|||
161267925|NCT03285308|582363444|FG000|Overall Study|Reason not Specified|0|||
161267926|NCT03285308|582363445|FG001|Overall Study|Reason not Specified|1|||
161267927|NCT03734666|582363446|FG000|Overall Study|Other|7|||
161267928|NCT03734666|582363447|FG001|Overall Study|Other|4|||
160948900|NCT04827576|581202918|FG003|Overall Study|Death|32|||
160948901|NCT04827576|581202915|FG000|Overall Study|Study Terminated by Sponsor|2|||
160948902|NCT04827576|581202916|FG001|Overall Study|Study Terminated by Sponsor|9|||
161145028|NCT02111811|581914023|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
161145029|NCT02111811|581914022|FG000|Follow up Period (Aim 2)|Death|2|||
161267929|NCT03734666|582363446|FG000|Overall Study|Lost to Follow-up|12|||
161267930|NCT03734666|582363447|FG001|Overall Study|Lost to Follow-up|12|||
160948903|NCT04827576|581202917|FG002|Overall Study|Study Terminated by Sponsor|7|||
160948904|NCT04827576|581202918|FG003|Overall Study|Study Terminated by Sponsor|5|||
160948905|NCT04827576|581202915|FG000|Overall Study|Investigator's Discretion|1|||
160948906|NCT04827576|581202916|FG001|Overall Study|Investigator's Discretion|0|||
160948907|NCT04827576|581202917|FG002|Overall Study|Investigator's Discretion|2|||
161145030|NCT02111811|581914023|FG001|Follow up Period (Aim 2)|Death|0|||
161267931|NCT01910389|582363448|FG000|Overall Study|Withdrawal by Subject|2|||
161267932|NCT01910389|582363449|FG001|Overall Study|Withdrawal by Subject|0|||
161267933|NCT01910389|582363448|FG000|Overall Study|Study Closed|13|||
161267934|NCT01910389|582363449|FG001|Overall Study|Study Closed|8|||
161267935|NCT01898650|582363450|FG000|Overall Study|the subject would not lie still for imaging|1|||
160948908|NCT04827576|581202918|FG003|Overall Study|Investigator's Discretion|5|||
160948909|NCT04827576|581202915|FG000|Overall Study|Withdrew Consent|0|||
160948910|NCT04827576|581202916|FG001|Overall Study|Withdrew Consent|3|||
160948911|NCT04827576|581202917|FG002|Overall Study|Withdrew Consent|0|||
160948912|NCT04827576|581202918|FG003|Overall Study|Withdrew Consent|0|||
160999849|NCT00823979|581382833|FG001|Overall Study|Pregnancy|1|||
160948913|NCT04827576|581202915|FG000|Overall Study|Lost to Follow-up|1|||
161267936|NCT02912650|582363452|FG000|Overall Study|Withdrawal by Subject|1|||
161267937|NCT02912650|582363453|FG001|Overall Study|Withdrawal by Subject|0|||
160948914|NCT04827576|581202916|FG001|Overall Study|Lost to Follow-up|0|||
160948915|NCT04827576|581202917|FG002|Overall Study|Lost to Follow-up|0|||
160948916|NCT04827576|581202918|FG003|Overall Study|Lost to Follow-up|0|||
160948917|NCT04295564|581202919|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
160948918|NCT04295564|581202920|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
160948919|NCT03859323|581202921|FG000|Overall Study|Lost to Follow-up|0|||
160948920|NCT03859323|581202922|FG001|Overall Study|Lost to Follow-up|0|||
160948921|NCT03859323|581202923|FG002|Overall Study|Lost to Follow-up|0|||
160948922|NCT03859323|581202924|FG003|Overall Study|Lost to Follow-up|0|||
160948923|NCT03859323|581202925|FG004|Overall Study|Lost to Follow-up|0|||
160948924|NCT03859323|581202926|FG005|Overall Study|Lost to Follow-up|0|||
160948925|NCT03859323|581202927|FG006|Overall Study|Lost to Follow-up|1|||
160948926|NCT03859323|581202928|FG007|Overall Study|Lost to Follow-up|0|||
160948927|NCT03859323|581202929|FG008|Overall Study|Lost to Follow-up|0|||
160948928|NCT03859323|581202930|FG009|Overall Study|Lost to Follow-up|0|||
160948929|NCT03859323|581202931|FG010|Overall Study|Lost to Follow-up|0|||
160948930|NCT03859323|581202932|FG011|Overall Study|Lost to Follow-up|0|||
160948931|NCT03859323|581202933|FG012|Overall Study|Lost to Follow-up|0|||
160948932|NCT03859323|581202921|FG000|Overall Study|Withdrawal by Subject|0|||
160948933|NCT03859323|581202922|FG001|Overall Study|Withdrawal by Subject|0|||
160948934|NCT03859323|581202923|FG002|Overall Study|Withdrawal by Subject|1|||
160948935|NCT03859323|581202924|FG003|Overall Study|Withdrawal by Subject|0|||
160948936|NCT03859323|581202925|FG004|Overall Study|Withdrawal by Subject|0|||
160948937|NCT03859323|581202926|FG005|Overall Study|Withdrawal by Subject|1|||
160948938|NCT03859323|581202927|FG006|Overall Study|Withdrawal by Subject|0|||
160948939|NCT03859323|581202928|FG007|Overall Study|Withdrawal by Subject|0|||
160948940|NCT03859323|581202929|FG008|Overall Study|Withdrawal by Subject|0|||
160948941|NCT03859323|581202930|FG009|Overall Study|Withdrawal by Subject|1|||
160948942|NCT03859323|581202931|FG010|Overall Study|Withdrawal by Subject|1|||
160948943|NCT03859323|581202932|FG011|Overall Study|Withdrawal by Subject|2|||
160948944|NCT03859323|581202933|FG012|Overall Study|Withdrawal by Subject|1|||
160948945|NCT03859323|581202921|FG000|Overall Study|Pregnancy|0|||
160948946|NCT03859323|581202922|FG001|Overall Study|Pregnancy|0|||
160948947|NCT03859323|581202923|FG002|Overall Study|Pregnancy|0|||
160948948|NCT03859323|581202924|FG003|Overall Study|Pregnancy|0|||
160948949|NCT03859323|581202925|FG004|Overall Study|Pregnancy|0|||
160948950|NCT03859323|581202926|FG005|Overall Study|Pregnancy|0|||
160948951|NCT03859323|581202927|FG006|Overall Study|Pregnancy|0|||
160948952|NCT03859323|581202928|FG007|Overall Study|Pregnancy|0|||
160948953|NCT03859323|581202929|FG008|Overall Study|Pregnancy|0|||
160948954|NCT03859323|581202930|FG009|Overall Study|Pregnancy|1|||
160948955|NCT03859323|581202931|FG010|Overall Study|Pregnancy|0|||
160948956|NCT03859323|581202932|FG011|Overall Study|Pregnancy|0|||
160948957|NCT03859323|581202933|FG012|Overall Study|Pregnancy|0|||
160948958|NCT01682460|581202935|FG000|Overall Study|Withdrawal by Subject|2|||
160948959|NCT01682460|581202935|FG000|Overall Study|Did not meet inclusion criteria|2|||
160948960|NCT00724282|581202939|FG000|Overall Study|Withdrawal by Subject|3|||
160948961|NCT00724282|581202939|FG000|Overall Study|Physician Decision|1|||
160948962|NCT01438411|581202940|FG000|Overall Study|Adverse Event|8|||
160948963|NCT01438411|581202940|FG000|Overall Study|Lost to Follow-up|1|||
160948964|NCT01438411|581202940|FG000|Overall Study|Lack of Efficacy|1|||
160999850|NCT00823979|581382834|FG002|Overall Study|Pregnancy|0|||
160999851|NCT00823979|581382832|FG000|Overall Study|Adverse Event|0|||
160999852|NCT00823979|581382833|FG001|Overall Study|Adverse Event|2|||
160999853|NCT00823979|581382834|FG002|Overall Study|Adverse Event|4|||
160999854|NCT00823979|581382832|FG000|Overall Study|Other|2|||
160999855|NCT00823979|581382833|FG001|Overall Study|Other|0|||
160999856|NCT00823979|581382834|FG002|Overall Study|Other|1|||
160999857|NCT00823979|581382832|FG000|Overall Study|Randomized but not Treated|4|||
161145031|NCT03443024|581914026|FG000|Overall Study|Adverse Event|2|||
161145032|NCT03443024|581914027|FG001|Overall Study|Adverse Event|4|||
161145033|NCT03443024|581914028|FG002|Overall Study|Adverse Event|3|||
161267938|NCT02912650|582363454|FG002|Overall Study|Withdrawal by Subject|1|||
161267939|NCT02912650|582363455|FG003|Overall Study|Withdrawal by Subject|5|||
160948965|NCT01438411|581202940|FG000|Overall Study|Withdrawal by Subject|3|||
161145034|NCT03443024|581914029|FG003|Overall Study|Adverse Event|1|||
161267940|NCT02912650|582363452|FG000|Overall Study|Adverse Event|0|||
160948966|NCT01863680|581202941|FG000|Overall Study|Adverse Event|17|||
160948967|NCT01863680|581202941|FG000|Overall Study|Risk of OHSS|17|||
160948968|NCT01863680|581202941|FG000|Overall Study|Spontaneous pregnancy|2|||
160948969|NCT01863680|581202941|FG000|Overall Study|Withdrawal by Subject|1|||
160948970|NCT01863680|581202941|FG000|Overall Study|Did not undergo IVF/ET|14|||
160948971|NCT01863680|581202941|FG000|Overall Study|Other|6|||
160948972|NCT00618514|581202942|FG000|Overall Study|Lost to Follow-up|11|||
160948973|NCT00618514|581202943|FG001|Overall Study|Lost to Follow-up|12|||
160948974|NCT00618514|581202944|FG002|Overall Study|Lost to Follow-up|4|||
160999858|NCT00823979|581382833|FG001|Overall Study|Randomized but not Treated|3|||
160999859|NCT00823979|581382834|FG002|Overall Study|Randomized but not Treated|1|||
160999860|NCT00823979|581382832|FG000|Overall Study|Study Terminated by Sponsor|5|||
161342742|NCT03507790|582642246|FG000|Overall Study|Non-compliance with study drug|0|||
160948975|NCT00566228|581202951|FG000|Overall Study|Withdrawal by Subject|1|||
160948976|NCT00566228|581202952|FG001|Overall Study|Withdrawal by Subject|0|||
160948977|NCT00566228|581202951|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
160948978|NCT00566228|581202952|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
160948979|NCT00566228|581202951|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
160948980|NCT00566228|581202952|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
160948981|NCT00566228|581202951|FG000|Overall Study|progressed before infusion could occur|0|||
160948982|NCT00566228|581202952|FG001|Overall Study|progressed before infusion could occur|1|||
160948983|NCT02041195|581202955|FG000|Overall Study|Adverse Event|1|||
160948984|NCT02041195|581202956|FG001|Overall Study|Adverse Event|2|||
160948985|NCT02041195|581202957|FG002|Overall Study|Adverse Event|0|||
160948986|NCT02041195|581202958|FG003|Overall Study|Adverse Event|0|||
160948987|NCT02041195|581202959|FG004|Overall Study|Adverse Event|0|||
160948988|NCT02041195|581202960|FG005|Overall Study|Adverse Event|0|||
160948989|NCT02041195|581202961|FG006|Overall Study|Adverse Event|3|||
160948990|NCT02041195|581202962|FG007|Overall Study|Adverse Event|0|||
160948991|NCT02041195|581202955|FG000|Overall Study|Withdrawal by Subject|1|||
160948992|NCT02041195|581202956|FG001|Overall Study|Withdrawal by Subject|0|||
160948993|NCT02041195|581202957|FG002|Overall Study|Withdrawal by Subject|0|||
160948994|NCT02041195|581202958|FG003|Overall Study|Withdrawal by Subject|0|||
160948995|NCT02041195|581202959|FG004|Overall Study|Withdrawal by Subject|0|||
160948996|NCT02041195|581202960|FG005|Overall Study|Withdrawal by Subject|0|||
160948997|NCT02041195|581202961|FG006|Overall Study|Withdrawal by Subject|4|||
160948998|NCT02041195|581202962|FG007|Overall Study|Withdrawal by Subject|3|||
160948999|NCT02041195|581202955|FG000|Overall Study|Unable to comply with study visits|0|||
160949000|NCT02041195|581202956|FG001|Overall Study|Unable to comply with study visits|1|||
160949001|NCT02041195|581202957|FG002|Overall Study|Unable to comply with study visits|0|||
160949002|NCT02041195|581202958|FG003|Overall Study|Unable to comply with study visits|0|||
160949003|NCT02041195|581202959|FG004|Overall Study|Unable to comply with study visits|1|||
160949004|NCT02041195|581202960|FG005|Overall Study|Unable to comply with study visits|0|||
160949005|NCT02041195|581202961|FG006|Overall Study|Unable to comply with study visits|0|||
160949006|NCT02041195|581202962|FG007|Overall Study|Unable to comply with study visits|0|||
160949007|NCT00674986|581202963|FG000|Overall Study|Adverse Event|2|||
160949008|NCT00674986|581202964|FG001|Overall Study|Adverse Event|1|||
160949009|NCT00674986|581202963|FG000|Overall Study|Subject withdrew consent|12|||
160949010|NCT00674986|581202964|FG001|Overall Study|Subject withdrew consent|19|||
160949011|NCT00674986|581202963|FG000|Overall Study|Lost to Follow-up|25|||
160949012|NCT00674986|581202964|FG001|Overall Study|Lost to Follow-up|53|||
160949013|NCT00674986|581202963|FG000|Overall Study|Other reasons|4|||
160949014|NCT00674986|581202964|FG001|Overall Study|Other reasons|8|||
160949015|NCT00377234|581202965|FG000|Overall Study|Adverse Event|14|||
160949016|NCT00377234|581202966|FG001|Overall Study|Adverse Event|17|||
160949017|NCT00377234|581202965|FG000|Overall Study|Withdrawal by Subject|11|||
160949018|NCT00377234|581202966|FG001|Overall Study|Withdrawal by Subject|9|||
160949019|NCT00377234|581202965|FG000|Overall Study|Lost to Follow-up|4|||
160949020|NCT00377234|581202966|FG001|Overall Study|Lost to Follow-up|2|||
160949021|NCT00377234|581202965|FG000|Overall Study|Administrative|2|||
160949022|NCT00377234|581202966|FG001|Overall Study|Administrative|1|||
160949023|NCT00377234|581202965|FG000|Overall Study|Not assigned|3|||
160949024|NCT00377234|581202966|FG001|Overall Study|Not assigned|2|||
160949025|NCT02053350|581202973|FG000|Overall Study|Withdrawal by Subject|1|||
160949026|NCT02053350|581202973|FG000|Overall Study|Adverse Event|4|||
160949027|NCT01275625|581202974|FG000|Overall Study|Death|1|||
160949028|NCT01275625|581202974|FG000|Overall Study|Lack of Efficacy|2|||
160949029|NCT01275625|581202974|FG000|Overall Study|Lost to Follow-up|1|||
160949030|NCT01275625|581202974|FG000|Overall Study|Withdrawal by Subject|3|||
160949031|NCT01275625|581202974|FG000|Overall Study|Protocol Violation|1|||
160949032|NCT01275625|581202974|FG000|Overall Study|Adverse Event|4|||
160949033|NCT01275625|581202974|FG000|Overall Study|Other|1|||
161342743|NCT03507790|582642247|FG001|Overall Study|Non-compliance with study drug|0|||
160949034|NCT03521635|581202975|FG000|Overall Study|Adverse Event|1|||
160949035|NCT03521635|581202976|FG001|Overall Study|Adverse Event|1|||
160949036|NCT03521635|581202975|FG000|Overall Study|Refused to complete study visit|1|||
160949037|NCT03521635|581202976|FG001|Overall Study|Refused to complete study visit|0|||
160949038|NCT03521635|581202975|FG000|Overall Study|Refused to continue trial medication|2|||
160949039|NCT03521635|581202976|FG001|Overall Study|Refused to continue trial medication|2|||
160949040|NCT03521635|581202975|FG000|Overall Study|Lost to Follow-up|0|||
160949041|NCT03521635|581202976|FG001|Overall Study|Lost to Follow-up|1|||
160949042|NCT03521635|581202975|FG000|Overall Study|Meet exclusion criteria|0|||
160949043|NCT03521635|581202976|FG001|Overall Study|Meet exclusion criteria|1|||
160949044|NCT03521635|581202975|FG000|Overall Study|Patient not taken study medicine|0|||
160949045|NCT03521635|581202976|FG001|Overall Study|Patient not taken study medicine|1|||
160949046|NCT01747772|581202977|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
161342744|NCT03507790|582642248|FG002|Overall Study|Non-compliance with study drug|1|||
160949047|NCT02244944|581202978|FG000|Overall Study|Withdrawal by Subject|1|||
160949048|NCT02244944|581202978|FG000|Overall Study|Study Terminated|1|||
160949049|NCT00626522|581202981|FG000|Overall Study|Protocol Violation|0|||
160949050|NCT00626522|581202982|FG001|Overall Study|Protocol Violation|0|||
160949051|NCT00626522|581202983|FG002|Overall Study|Protocol Violation|0|||
160949052|NCT00626522|581202984|FG003|Overall Study|Protocol Violation|0|||
160949053|NCT00626522|581202985|FG004|Overall Study|Protocol Violation|1|||
160999861|NCT00823979|581382833|FG001|Overall Study|Study Terminated by Sponsor|5|||
160999862|NCT00823979|581382834|FG002|Overall Study|Study Terminated by Sponsor|7|||
160999863|NCT03396913|581382835|FG000|Overall Study|Lost to Follow-up|0|||
160999864|NCT03396913|581382836|FG001|Overall Study|Lost to Follow-up|6|||
160999865|NCT03523091|581382837|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
160999866|NCT03523091|581382838|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
160999867|NCT03523091|581382837|FG000|Overall Study|Withdrawal by Subject|0|||
160999868|NCT03523091|581382838|FG001|Overall Study|Withdrawal by Subject|3|||
160999869|NCT03523091|581382837|FG000|Overall Study|Increase Botox dose|0|||
160999870|NCT03523091|581382838|FG001|Overall Study|Increase Botox dose|1|||
160999871|NCT01093534|581382839|FG000|Overall Study|Adverse Event|2|||
160999872|NCT01093534|581382840|FG001|Overall Study|Adverse Event|5|||
160999873|NCT01093534|581382841|FG002|Overall Study|Adverse Event|2|||
160999874|NCT01093534|581382839|FG000|Overall Study|Lack of Efficacy|2|||
160999875|NCT01093534|581382840|FG001|Overall Study|Lack of Efficacy|1|||
160999876|NCT01093534|581382841|FG002|Overall Study|Lack of Efficacy|1|||
160999877|NCT01093534|581382839|FG000|Overall Study|Withdrawal by Subject|5|||
160999878|NCT01093534|581382840|FG001|Overall Study|Withdrawal by Subject|7|||
160999879|NCT01093534|581382841|FG002|Overall Study|Withdrawal by Subject|2|||
160999880|NCT01093534|581382839|FG000|Overall Study|Other|1|||
160999881|NCT01093534|581382840|FG001|Overall Study|Other|3|||
160999882|NCT01093534|581382841|FG002|Overall Study|Other|4|||
160999883|NCT04436120|581382845|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999884|NCT04436120|581382846|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999885|NCT04436120|581382847|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999886|NCT04436120|581382848|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
160999887|NCT04436120|581382849|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999888|NCT04436120|581382850|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
160999889|NCT04436120|581382851|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
160999890|NCT01981356|581382870|FG000|Overall Study|Lost to Follow-up|4|||
160999891|NCT01981356|581382871|FG001|Overall Study|Lost to Follow-up|1|||
160999892|NCT01981356|581382870|FG000|Overall Study|Withdrawal by Subject|1|||
160999893|NCT01981356|581382871|FG001|Overall Study|Withdrawal by Subject|1|||
160999894|NCT01981356|581382870|FG000|Overall Study|Protocol Violation|2|||
160999895|NCT01981356|581382871|FG001|Overall Study|Protocol Violation|0|||
160999896|NCT03284957|581384911|FG000|Overall Study|Adverse Event|0|||
160999897|NCT03284957|581384912|FG001|Overall Study|Adverse Event|0|||
160999898|NCT03284957|581384913|FG002|Overall Study|Adverse Event|0|||
160999899|NCT03284957|581384914|FG003|Overall Study|Adverse Event|0|||
160999900|NCT03284957|581384915|FG004|Overall Study|Adverse Event|0|||
160999901|NCT03284957|581384916|FG005|Overall Study|Adverse Event|1|||
160949054|NCT00626522|581202986|FG005|Overall Study|Protocol Violation|0|||
160999902|NCT03284957|581384917|FG006|Overall Study|Adverse Event|1|||
160999903|NCT03284957|581384918|FG007|Overall Study|Adverse Event|1|||
160999904|NCT03284957|581384919|FG008|Overall Study|Adverse Event|0|||
160999905|NCT03284957|581384920|FG009|Overall Study|Adverse Event|4|||
160999906|NCT03284957|581384921|FG010|Overall Study|Adverse Event|1|||
160999907|NCT03284957|581384922|FG011|Overall Study|Adverse Event|1|||
160999908|NCT03284957|581384923|FG012|Overall Study|Adverse Event|0|||
160999909|NCT03284957|581384924|FG013|Overall Study|Adverse Event|0|||
160999910|NCT03284957|581384925|FG014|Overall Study|Adverse Event|0|||
160999911|NCT03284957|581384926|FG015|Overall Study|Adverse Event|0|||
160999912|NCT03284957|581384911|FG000|Overall Study|Progressive Disease|3|||
160999913|NCT03284957|581384912|FG001|Overall Study|Progressive Disease|3|||
160999914|NCT03284957|581384913|FG002|Overall Study|Progressive Disease|4|||
160999915|NCT03284957|581384914|FG003|Overall Study|Progressive Disease|3|||
160999916|NCT03284957|581384915|FG004|Overall Study|Progressive Disease|3|||
160999917|NCT03284957|581384916|FG005|Overall Study|Progressive Disease|5|||
160999918|NCT03284957|581384917|FG006|Overall Study|Progressive Disease|45|||
160999919|NCT03284957|581384918|FG007|Overall Study|Progressive Disease|8|||
160999920|NCT03284957|581384919|FG008|Overall Study|Progressive Disease|5|||
160999921|NCT03284957|581384920|FG009|Overall Study|Progressive Disease|18|||
160999922|NCT03284957|581384921|FG010|Overall Study|Progressive Disease|7|||
160999923|NCT03284957|581384922|FG011|Overall Study|Progressive Disease|2|||
161145035|NCT03443024|581914026|FG000|Overall Study|Lost to Follow-up|9|||
161267941|NCT02912650|582363453|FG001|Overall Study|Adverse Event|0|||
160949055|NCT00626522|581202981|FG000|Overall Study|Adverse Event|2|||
160999924|NCT03284957|581384923|FG012|Overall Study|Progressive Disease|3|||
160999925|NCT03284957|581384924|FG013|Overall Study|Progressive Disease|1|||
160949056|NCT00626522|581202982|FG001|Overall Study|Adverse Event|1|||
160999926|NCT03284957|581384925|FG014|Overall Study|Progressive Disease|1|||
161145036|NCT03443024|581914027|FG001|Overall Study|Lost to Follow-up|9|||
161145037|NCT03443024|581914028|FG002|Overall Study|Lost to Follow-up|7|||
161145038|NCT03443024|581914029|FG003|Overall Study|Lost to Follow-up|5|||
161145039|NCT03443024|581914026|FG000|Overall Study|Withdrawal by Subject|8|||
161145040|NCT03443024|581914027|FG001|Overall Study|Withdrawal by Subject|15|||
161145041|NCT03443024|581914028|FG002|Overall Study|Withdrawal by Subject|9|||
161145042|NCT03443024|581914029|FG003|Overall Study|Withdrawal by Subject|23|||
161145043|NCT03443024|581914026|FG000|Overall Study|Physician Decision|1|||
161145044|NCT03443024|581914027|FG001|Overall Study|Physician Decision|2|||
161145045|NCT03443024|581914028|FG002|Overall Study|Physician Decision|0|||
161145046|NCT03443024|581914029|FG003|Overall Study|Physician Decision|1|||
161145047|NCT03443024|581914026|FG000|Overall Study|Sponsor Decision|1|||
161145048|NCT03443024|581914027|FG001|Overall Study|Sponsor Decision|1|||
161145049|NCT03443024|581914028|FG002|Overall Study|Sponsor Decision|0|||
161145050|NCT03443024|581914029|FG003|Overall Study|Sponsor Decision|0|||
160949057|NCT00626522|581202983|FG002|Overall Study|Adverse Event|2|||
160949058|NCT00626522|581202984|FG003|Overall Study|Adverse Event|0|||
160949059|NCT00626522|581202985|FG004|Overall Study|Adverse Event|1|||
160949060|NCT00626522|581202986|FG005|Overall Study|Adverse Event|1|||
160949061|NCT00626522|581202981|FG000|Overall Study|Withdrawal by Subject|2|||
160949062|NCT00626522|581202982|FG001|Overall Study|Withdrawal by Subject|5|||
160949063|NCT00626522|581202983|FG002|Overall Study|Withdrawal by Subject|5|||
160949064|NCT00626522|581202984|FG003|Overall Study|Withdrawal by Subject|0|||
160949065|NCT00626522|581202985|FG004|Overall Study|Withdrawal by Subject|4|||
160949066|NCT00626522|581202986|FG005|Overall Study|Withdrawal by Subject|1|||
160949067|NCT00626522|581202981|FG000|Overall Study|COPD exacerbation|0|||
160949068|NCT00626522|581202982|FG001|Overall Study|COPD exacerbation|0|||
160949069|NCT00626522|581202983|FG002|Overall Study|COPD exacerbation|0|||
160949070|NCT00626522|581202984|FG003|Overall Study|COPD exacerbation|1|||
160949071|NCT00626522|581202985|FG004|Overall Study|COPD exacerbation|1|||
160949072|NCT00626522|581202986|FG005|Overall Study|COPD exacerbation|0|||
160949073|NCT00626522|581202981|FG000|Overall Study|Lost to Follow-up|0|||
160949074|NCT00626522|581202982|FG001|Overall Study|Lost to Follow-up|1|||
160949075|NCT00626522|581202983|FG002|Overall Study|Lost to Follow-up|0|||
160949076|NCT00626522|581202984|FG003|Overall Study|Lost to Follow-up|0|||
160949077|NCT00626522|581202985|FG004|Overall Study|Lost to Follow-up|0|||
160949078|NCT00626522|581202986|FG005|Overall Study|Lost to Follow-up|0|||
160949079|NCT00626522|581202981|FG000|Overall Study|Inconsistent reason reported|1|||
160949080|NCT00626522|581202982|FG001|Overall Study|Inconsistent reason reported|0|||
160949081|NCT00626522|581202983|FG002|Overall Study|Inconsistent reason reported|0|||
160949082|NCT00626522|581202984|FG003|Overall Study|Inconsistent reason reported|0|||
160949083|NCT00626522|581202985|FG004|Overall Study|Inconsistent reason reported|0|||
160949084|NCT00626522|581202986|FG005|Overall Study|Inconsistent reason reported|0|||
160949085|NCT00626522|581202981|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
160949086|NCT00626522|581202982|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
160949087|NCT00626522|581202983|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
160949088|NCT00626522|581202984|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
160949089|NCT00626522|581202985|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
160949090|NCT00626522|581202986|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
160949091|NCT01928719|581202987|FG000|Overall Study|Lost to Follow-up|26|||
160949092|NCT01928719|581202988|FG001|Overall Study|Lost to Follow-up|11|||
160949093|NCT01928719|581202987|FG000|Overall Study|Withdrawal by Subject|22|||
160949094|NCT01928719|581202988|FG001|Overall Study|Withdrawal by Subject|7|||
160949095|NCT01928719|581202987|FG000|Overall Study|Protocol Violation|3|||
160949096|NCT01928719|581202988|FG001|Overall Study|Protocol Violation|1|||
160949097|NCT01928719|581202987|FG000|Overall Study|Adverse Event|1|||
160949098|NCT01928719|581202988|FG001|Overall Study|Adverse Event|0|||
160949099|NCT03725982|581202989|FG000|First Intervention|Withdrawal by Subject|0|||
160949100|NCT03725982|581202990|FG001|First Intervention|Withdrawal by Subject|1|||
160949101|NCT03725982|581202989|FG000|First Intervention|Physician Decision|1|||
160949102|NCT03725982|581202990|FG001|First Intervention|Physician Decision|1|||
160949103|NCT01003899|581202991|FG000|Overall Study|Other Adverse Event|8|||
160949104|NCT01003899|581202991|FG000|Overall Study|Not entered|4|||
160949105|NCT01003899|581202991|FG000|Overall Study|Not treated|1|||
160949106|NCT01003899|581202991|FG000|Overall Study|Progressive disease|34|||
160949107|NCT00512135|581202994|FG000|Overall Study|Not Treated|5|||
160949108|NCT00512135|581202994|FG000|Overall Study|Lack of Efficacy|2|||
160949109|NCT00512135|581202994|FG000|Overall Study|Adverse Event|6|||
160949110|NCT00512135|581202994|FG000|Overall Study|Withdrawal by Subject|22|||
160949111|NCT00512135|581202994|FG000|Overall Study|Lost to Follow-up|27|||
160949112|NCT00512135|581202994|FG000|Overall Study|Other|22|||
161145051|NCT03443024|581914026|FG000|Overall Study|Protocol Deviation|0|||
161145052|NCT03443024|581914027|FG001|Overall Study|Protocol Deviation|0|||
161145053|NCT03443024|581914028|FG002|Overall Study|Protocol Deviation|0|||
160949113|NCT00262834|581202995|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
161145054|NCT03443024|581914029|FG003|Overall Study|Protocol Deviation|2|||
161145055|NCT00301067|581914030|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
161267942|NCT02912650|582363454|FG002|Overall Study|Adverse Event|1|||
161267943|NCT02912650|582363455|FG003|Overall Study|Adverse Event|0|||
161267944|NCT02357342|582363456|FG000|First 6 Months|Death|2|||
161267945|NCT02357342|582363457|FG001|First 6 Months|Death|0|||
161267946|NCT01674647|582363458|FG000|Treatment Period|Death|4|||
161267947|NCT01674647|582363459|FG001|Treatment Period|Death|1|||
161267948|NCT01674647|582363458|FG000|Treatment Period|Efficacy outcome reached|0|||
161267949|NCT01674647|582363459|FG001|Treatment Period|Efficacy outcome reached|1|||
161267950|NCT01674647|582363458|FG000|Treatment Period|Physician Decision|3|||
161267951|NCT01674647|582363459|FG001|Treatment Period|Physician Decision|1|||
161267952|NCT01674647|582363458|FG000|Treatment Period|Adverse Event|60|||
161267953|NCT01674647|582363459|FG001|Treatment Period|Adverse Event|22|||
161267954|NCT01674647|582363458|FG000|Treatment Period|Non-compliance with study drug|3|||
161267955|NCT01674647|582363459|FG001|Treatment Period|Non-compliance with study drug|0|||
161267956|NCT01674647|582363458|FG000|Treatment Period|Lost to Follow-up|1|||
161267957|NCT01674647|582363459|FG001|Treatment Period|Lost to Follow-up|1|||
161267958|NCT01674647|582363458|FG000|Treatment Period|Withdrawal by Subject|19|||
161267959|NCT01674647|582363459|FG001|Treatment Period|Withdrawal by Subject|16|||
161267960|NCT01674647|582363458|FG000|Treatment Period|Switching to other therapy|5|||
161267961|NCT01674647|582363459|FG001|Treatment Period|Switching to other therapy|2|||
161267962|NCT01674647|582363458|FG000|Treatment Period|Logistical difficulties|5|||
161267963|NCT01674647|582363459|FG001|Treatment Period|Logistical difficulties|8|||
161267964|NCT01674647|582363458|FG000|Treatment Period|Treatment failure|0|||
161267965|NCT01674647|582363459|FG001|Treatment Period|Treatment failure|14|||
161267966|NCT01674647|582363458|FG000|Treatment Period|Protocol Violation|56|||
161267967|NCT01674647|582363459|FG001|Treatment Period|Protocol Violation|36|||
161267968|NCT01674647|582363458|FG000|30-day Safety Follow-up Period|Death|3|||
161267969|NCT01674647|582363459|FG001|30-day Safety Follow-up Period|Death|2|||
161267970|NCT01674647|582363458|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
161267971|NCT01674647|582363459|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
161267972|NCT01674647|582363458|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
161267973|NCT01674647|582363459|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
161267974|NCT01674647|582363458|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
161267975|NCT01674647|582363459|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
161267976|NCT01674647|582363458|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
161267977|NCT01674647|582363459|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
161267978|NCT01674647|582363458|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
161267979|NCT01674647|582363459|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
161267980|NCT01490866|582363460|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
161267981|NCT01490866|582363460|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
161267982|NCT01490866|582363460|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
161267983|NCT01490866|582363460|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
161267984|NCT01490866|582363460|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
161267985|NCT01490866|582363460|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
161267986|NCT01490866|582363460|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
161267987|NCT01490866|582363460|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
160949114|NCT00262834|581202996|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
160949115|NCT03422250|581202997|FG000|Intervention|Adverse Event|0|||
160949116|NCT03422250|581202998|FG001|Intervention|Adverse Event|1|||
160949117|NCT03422250|581202999|FG002|Intervention|Adverse Event|0|||
160949118|NCT03422250|581203000|FG003|Intervention|Adverse Event|1|||
160949119|NCT03422250|581202997|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
160949120|NCT03422250|581202998|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
160949121|NCT03422250|581202999|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
160949122|NCT03422250|581203000|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
160949123|NCT03422250|581202997|FG000|Follow-up|Withdrawal by Subject|0|||
160949124|NCT03422250|581202998|FG001|Follow-up|Withdrawal by Subject|0|||
160949125|NCT03422250|581202999|FG002|Follow-up|Withdrawal by Subject|0|||
160949126|NCT03422250|581203000|FG003|Follow-up|Withdrawal by Subject|1|||
161267988|NCT01490866|582363460|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
160949127|NCT03422250|581202997|FG000|Follow-up|Adverse Event|0|||
161267989|NCT01490866|582363460|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
161267990|NCT01490866|582363460|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
161342745|NCT03507790|582642246|FG000|Overall Study|COVID 19 Pandemic|0|||
160949128|NCT03422250|581202998|FG001|Follow-up|Adverse Event|0|||
160949129|NCT03422250|581202999|FG002|Follow-up|Adverse Event|0|||
160949130|NCT03422250|581203000|FG003|Follow-up|Adverse Event|1|||
160949131|NCT00377819|581203003|FG000|Overall Study|Adverse Event|2|||
161267991|NCT03923530|582363461|FG000|Overall Study|Withdrawal by Subject|1|||
161267992|NCT03923530|582363461|FG000|Overall Study|screen failure|3|||
161267993|NCT04135196|582363462|FG000|Overall Study|Lost to Follow-up|8|||
161267994|NCT04135196|582363463|FG001|Overall Study|Lost to Follow-up|7|||
161267995|NCT04135196|582363464|FG002|Overall Study|Lost to Follow-up|8|||
161267996|NCT04135196|582363465|FG003|Overall Study|Lost to Follow-up|9|||
160949132|NCT00377819|581203004|FG001|Overall Study|Adverse Event|3|||
160949133|NCT00377819|581203003|FG000|Overall Study|Withdrawal by Subject|10|||
160949134|NCT00377819|581203004|FG001|Overall Study|Withdrawal by Subject|4|||
160949135|NCT00377819|581203003|FG000|Overall Study|Death|0|||
160949136|NCT00377819|581203004|FG001|Overall Study|Death|1|||
160949137|NCT00377819|581203003|FG000|Overall Study|Lost to Follow-up|0|||
160949138|NCT00377819|581203004|FG001|Overall Study|Lost to Follow-up|1|||
160949139|NCT00377819|581203003|FG000|Overall Study|Protocol Violation|1|||
160949140|NCT00377819|581203004|FG001|Overall Study|Protocol Violation|1|||
160949141|NCT02416791|581203005|FG000|6 Months|Lost to Follow-up|0|||
160949142|NCT02416791|581203006|FG001|6 Months|Lost to Follow-up|0|||
160949143|NCT02416791|581203007|FG002|6 Months|Lost to Follow-up|1|||
160949144|NCT01054820|581203008|FG000|Overall Study|Withdrawal by Subject|2|||
160949145|NCT00467870|581203015|FG000|Overall Study|Adverse Event|13|||
160949146|NCT00467870|581203016|FG001|Overall Study|Adverse Event|9|||
160949147|NCT00467870|581203017|FG002|Overall Study|Adverse Event|1|||
160949148|NCT00467870|581203018|FG003|Overall Study|Adverse Event|15|||
160949149|NCT00467870|581203019|FG004|Overall Study|Adverse Event|15|||
160949150|NCT00467870|581203020|FG005|Overall Study|Adverse Event|1|||
160949151|NCT00467870|581203015|FG000|Overall Study|Protocol Violation|2|||
160949152|NCT00467870|581203016|FG001|Overall Study|Protocol Violation|1|||
160949153|NCT00467870|581203017|FG002|Overall Study|Protocol Violation|1|||
160949154|NCT00467870|581203018|FG003|Overall Study|Protocol Violation|2|||
160949155|NCT00467870|581203019|FG004|Overall Study|Protocol Violation|0|||
160949156|NCT00467870|581203020|FG005|Overall Study|Protocol Violation|0|||
160949157|NCT00467870|581203015|FG000|Overall Study|Withdrawal by Subject|14|||
160949158|NCT00467870|581203016|FG001|Overall Study|Withdrawal by Subject|21|||
160949159|NCT00467870|581203017|FG002|Overall Study|Withdrawal by Subject|0|||
160949160|NCT00467870|581203018|FG003|Overall Study|Withdrawal by Subject|9|||
160949161|NCT00467870|581203019|FG004|Overall Study|Withdrawal by Subject|10|||
160949162|NCT00467870|581203020|FG005|Overall Study|Withdrawal by Subject|1|||
160949163|NCT00467870|581203015|FG000|Overall Study|Lost to Follow-up|5|||
160949164|NCT00467870|581203016|FG001|Overall Study|Lost to Follow-up|3|||
160949165|NCT00467870|581203017|FG002|Overall Study|Lost to Follow-up|1|||
160949166|NCT00467870|581203018|FG003|Overall Study|Lost to Follow-up|1|||
161267997|NCT04135196|582363466|FG004|Overall Study|Lost to Follow-up|1|||
161267998|NCT04135196|582363462|FG000|Overall Study|Pregnancy|0|||
161267999|NCT04135196|582363463|FG001|Overall Study|Pregnancy|0|||
161268000|NCT04135196|582363464|FG002|Overall Study|Pregnancy|1|||
161268001|NCT04135196|582363465|FG003|Overall Study|Pregnancy|0|||
161268002|NCT04135196|582363466|FG004|Overall Study|Pregnancy|0|||
161268003|NCT04135196|582363462|FG000|Overall Study|Withdrawal by Subject|0|||
161268004|NCT04135196|582363463|FG001|Overall Study|Withdrawal by Subject|0|||
161268005|NCT04135196|582363464|FG002|Overall Study|Withdrawal by Subject|0|||
161268006|NCT04135196|582363465|FG003|Overall Study|Withdrawal by Subject|0|||
161268007|NCT04135196|582363466|FG004|Overall Study|Withdrawal by Subject|1|||
161268008|NCT00444457|582363468|FG000|Infant Series|Other|0|||
161268009|NCT00444457|582363469|FG001|Infant Series|Other|1|||
161268010|NCT00444457|582363470|FG002|Infant Series|Other|0|||
161268011|NCT00444457|582363471|FG003|Infant Series|Other|0|||
161268012|NCT00444457|582363468|FG000|Infant Series|Parent or legal guardian request|18|||
161268013|NCT00444457|582363469|FG001|Infant Series|Parent or legal guardian request|29|||
161268014|NCT00444457|582363470|FG002|Infant Series|Parent or legal guardian request|34|||
161268015|NCT00444457|582363471|FG003|Infant Series|Parent or legal guardian request|14|||
161268016|NCT00444457|582363468|FG000|Infant Series|Lost to Follow-up|10|||
160949167|NCT00467870|581203019|FG004|Overall Study|Lost to Follow-up|3|||
160949168|NCT00467870|581203020|FG005|Overall Study|Lost to Follow-up|0|||
160949169|NCT00467870|581203015|FG000|Overall Study|Subject Non-compliance|3|||
160949170|NCT00467870|581203016|FG001|Overall Study|Subject Non-compliance|4|||
160949171|NCT00467870|581203017|FG002|Overall Study|Subject Non-compliance|0|||
160949172|NCT00467870|581203018|FG003|Overall Study|Subject Non-compliance|1|||
160949173|NCT00467870|581203019|FG004|Overall Study|Subject Non-compliance|5|||
161268017|NCT00444457|582363469|FG001|Infant Series|Lost to Follow-up|11|||
160949174|NCT00467870|581203020|FG005|Overall Study|Subject Non-compliance|0|||
161145056|NCT00301067|581914031|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
161268018|NCT00444457|582363470|FG002|Infant Series|Lost to Follow-up|7|||
161342746|NCT03507790|582642247|FG001|Overall Study|COVID 19 Pandemic|1|||
160949175|NCT00467870|581203015|FG000|Overall Study|Other/Unknown|8|||
160949176|NCT00467870|581203016|FG001|Overall Study|Other/Unknown|5|||
160949177|NCT00467870|581203017|FG002|Overall Study|Other/Unknown|1|||
160949178|NCT00467870|581203018|FG003|Overall Study|Other/Unknown|5|||
160949179|NCT00467870|581203019|FG004|Overall Study|Other/Unknown|4|||
160949180|NCT00467870|581203020|FG005|Overall Study|Other/Unknown|0|||
160949181|NCT03489304|581203021|FG000|Overall Study|Lost to Follow-up|4|||
160949182|NCT02239679|581203022|FG000|Overall Study|Lost to Follow-up|1|||
160949183|NCT02239679|581203023|FG001|Overall Study|Lost to Follow-up|0|||
161268019|NCT00444457|582363471|FG003|Infant Series|Lost to Follow-up|6|||
161268020|NCT00444457|582363468|FG000|Infant Series|Protocol Violation|16|||
161268021|NCT00444457|582363469|FG001|Infant Series|Protocol Violation|8|||
161268022|NCT00444457|582363470|FG002|Infant Series|Protocol Violation|6|||
161268023|NCT00444457|582363471|FG003|Infant Series|Protocol Violation|3|||
161268024|NCT00444457|582363468|FG000|Infant Series|Failed to return|5|||
161268025|NCT00444457|582363469|FG001|Infant Series|Failed to return|4|||
161268026|NCT00444457|582363470|FG002|Infant Series|Failed to return|4|||
161268027|NCT00444457|582363471|FG003|Infant Series|Failed to return|2|||
161268028|NCT00444457|582363468|FG000|Infant Series|Investigator request|4|||
161268029|NCT00444457|582363469|FG001|Infant Series|Investigator request|3|||
161268030|NCT00444457|582363470|FG002|Infant Series|Investigator request|3|||
161268031|NCT00444457|582363471|FG003|Infant Series|Investigator request|2|||
161268032|NCT00444457|582363468|FG000|Infant Series|Other|0|||
161268033|NCT00444457|582363469|FG001|Infant Series|Other|2|||
161268034|NCT00444457|582363470|FG002|Infant Series|Other|4|||
161268035|NCT00444457|582363471|FG003|Infant Series|Other|0|||
161268036|NCT00444457|582363468|FG000|Infant Series|Adverse Event|1|||
161268037|NCT00444457|582363469|FG001|Infant Series|Adverse Event|2|||
161268038|NCT00444457|582363470|FG002|Infant Series|Adverse Event|2|||
161268039|NCT00444457|582363471|FG003|Infant Series|Adverse Event|0|||
161268040|NCT00444457|582363468|FG000|Infant Series|Death|0|||
161268041|NCT00444457|582363469|FG001|Infant Series|Death|1|||
161268042|NCT00444457|582363470|FG002|Infant Series|Death|1|||
161268043|NCT00444457|582363471|FG003|Infant Series|Death|1|||
161268044|NCT00444457|582363468|FG000|After Infant Series|Other|0|||
161268045|NCT00444457|582363469|FG001|After Infant Series|Other|1|||
161268046|NCT00444457|582363470|FG002|After Infant Series|Other|1|||
161268047|NCT00444457|582363471|FG003|After Infant Series|Other|1|||
161268048|NCT00444457|582363468|FG000|After Infant Series|Parent or legal guardian request|4|||
161268049|NCT00444457|582363469|FG001|After Infant Series|Parent or legal guardian request|11|||
161268050|NCT00444457|582363470|FG002|After Infant Series|Parent or legal guardian request|6|||
161268051|NCT00444457|582363471|FG003|After Infant Series|Parent or legal guardian request|3|||
161268052|NCT00444457|582363468|FG000|After Infant Series|Failed to return|7|||
160949184|NCT02239679|581203024|FG002|Overall Study|Lost to Follow-up|0|||
160949185|NCT02239679|581203022|FG000|Overall Study|Withdrawal by Subject|2|||
160949186|NCT02239679|581203023|FG001|Overall Study|Withdrawal by Subject|3|||
160949187|NCT02239679|581203024|FG002|Overall Study|Withdrawal by Subject|1|||
160949188|NCT01917526|581203025|FG000|Overall Study|Protocol Violation|1|||
160949189|NCT01917526|581203026|FG001|Overall Study|Protocol Violation|1|||
160949190|NCT00760929|581203030|FG000|Overall Study|Adverse Event|2|||
160949191|NCT00760929|581203031|FG001|Overall Study|Adverse Event|0|||
160949192|NCT00760929|581203032|FG002|Overall Study|Adverse Event|6|||
160949193|NCT00760929|581203033|FG003|Overall Study|Adverse Event|10|||
160949194|NCT00760929|581203030|FG000|Overall Study|Lack of Efficacy|0|||
160949195|NCT00760929|581203031|FG001|Overall Study|Lack of Efficacy|2|||
160949196|NCT00760929|581203032|FG002|Overall Study|Lack of Efficacy|1|||
160949197|NCT00760929|581203033|FG003|Overall Study|Lack of Efficacy|0|||
160949198|NCT00760929|581203030|FG000|Overall Study|Withdrawal by Subject|1|||
160949199|NCT00760929|581203031|FG001|Overall Study|Withdrawal by Subject|0|||
160949200|NCT00760929|581203032|FG002|Overall Study|Withdrawal by Subject|9|||
160949201|NCT00760929|581203033|FG003|Overall Study|Withdrawal by Subject|1|||
160949202|NCT00760929|581203030|FG000|Overall Study|Lost to Follow-up|0|||
160949203|NCT00760929|581203031|FG001|Overall Study|Lost to Follow-up|0|||
160949204|NCT00760929|581203032|FG002|Overall Study|Lost to Follow-up|1|||
161268053|NCT00444457|582363469|FG001|After Infant Series|Failed to return|6|||
161268054|NCT00444457|582363470|FG002|After Infant Series|Failed to return|5|||
161268055|NCT00444457|582363471|FG003|After Infant Series|Failed to return|1|||
161268056|NCT00444457|582363468|FG000|After Infant Series|Lost to Follow-up|5|||
161268057|NCT00444457|582363469|FG001|After Infant Series|Lost to Follow-up|5|||
161268058|NCT00444457|582363470|FG002|After Infant Series|Lost to Follow-up|5|||
161268059|NCT00444457|582363471|FG003|After Infant Series|Lost to Follow-up|2|||
161268060|NCT00444457|582363468|FG000|After Infant Series|Protocol Violation|2|||
160949205|NCT00760929|581203033|FG003|Overall Study|Lost to Follow-up|0|||
161268061|NCT00444457|582363469|FG001|After Infant Series|Protocol Violation|4|||
161268062|NCT00444457|582363470|FG002|After Infant Series|Protocol Violation|2|||
161268063|NCT00444457|582363471|FG003|After Infant Series|Protocol Violation|2|||
161268064|NCT00444457|582363468|FG000|After Infant Series|Adverse Event|2|||
161268065|NCT00444457|582363469|FG001|After Infant Series|Adverse Event|2|||
161268066|NCT00444457|582363470|FG002|After Infant Series|Adverse Event|0|||
161268067|NCT00444457|582363471|FG003|After Infant Series|Adverse Event|0|||
161268068|NCT00444457|582363468|FG000|After Infant Series|Investigator request|0|||
160949206|NCT00760929|581203030|FG000|Overall Study|Progression of Disease|21|||
160949207|NCT00760929|581203031|FG001|Overall Study|Progression of Disease|26|||
161268069|NCT00444457|582363469|FG001|After Infant Series|Investigator request|0|||
161268070|NCT00444457|582363470|FG002|After Infant Series|Investigator request|0|||
161268071|NCT00444457|582363471|FG003|After Infant Series|Investigator request|1|||
161268072|NCT00444457|582363468|FG000|After Infant Series|Other|0|||
161268073|NCT00444457|582363469|FG001|After Infant Series|Other|1|||
161268074|NCT00444457|582363470|FG002|After Infant Series|Other|0|||
161268075|NCT00444457|582363471|FG003|After Infant Series|Other|0|||
160949208|NCT00760929|581203032|FG002|Overall Study|Progression of Disease|38|||
161268076|NCT00444457|582363468|FG000|Toddler Dose|Lost to Follow-up|4|||
161268077|NCT00444457|582363469|FG001|Toddler Dose|Lost to Follow-up|1|||
161268078|NCT00444457|582363470|FG002|Toddler Dose|Lost to Follow-up|1|||
161268079|NCT00444457|582363471|FG003|Toddler Dose|Lost to Follow-up|3|||
161268080|NCT00444457|582363468|FG000|Toddler Dose|Failed to return|2|||
161268081|NCT00444457|582363469|FG001|Toddler Dose|Failed to return|2|||
161268082|NCT00444457|582363470|FG002|Toddler Dose|Failed to return|1|||
161268083|NCT00444457|582363471|FG003|Toddler Dose|Failed to return|3|||
161268084|NCT00444457|582363468|FG000|Toddler Dose|Parent or legal guardian request|0|||
160862235|NCT00360230|580889687|FG006|Overall Study|Death|1|||
160862236|NCT02703597|580889688|FG000|Assignment to Baseline|Lost to Follow-up|17|||
160862237|NCT02703597|580889689|FG001|Assignment to Baseline|Lost to Follow-up|16|||
160862238|NCT02703597|580889688|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
160862239|NCT02703597|580889689|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
160862240|NCT02703597|580889688|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
160862241|NCT02703597|580889689|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
160862242|NCT02703597|580889688|FG000|First Post-test to First Follow-up|Site drop out|0|||
160862243|NCT02703597|580889689|FG001|First Post-test to First Follow-up|Site drop out|58|||
160862244|NCT02703597|580889688|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
160862245|NCT02703597|580889689|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
160862246|NCT02703597|580889688|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
160862247|NCT02703597|580889689|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
160862248|NCT02703597|580889688|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
160862249|NCT02703597|580889689|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
160862250|NCT00581308|580889690|FG000|Pre Discharge|Lost to Follow-up|1|||
160862251|NCT00581308|580889690|FG000|Pre Discharge|Device Removed|1|||
160862252|NCT00581308|580889690|FG000|Month 1|Lost to Follow-up|3|||
160862253|NCT00581308|580889690|FG000|Month 1|Withdrawal by Subject|2|||
160862254|NCT00581308|580889690|FG000|Month 1|Device Removed|2|||
160862255|NCT00581308|580889690|FG000|Month 1|Uknown|1|||
160862256|NCT00581308|580889690|FG000|Month 6|Lost to Follow-up|1|||
160862257|NCT00581308|580889690|FG000|Month 6|Withdrawal by Subject|2|||
160862258|NCT00581308|580889690|FG000|Month 12|Death|1|||
160862259|NCT00581308|580889690|FG000|Month 12|Lost to Follow-up|14|||
160862260|NCT00581308|580889690|FG000|Month 12|Withdrawal by Subject|3|||
160862261|NCT00581308|580889690|FG000|Month 12|Device Removed|1|||
160862262|NCT00581308|580889690|FG000|Month 12|Other|1|||
160862263|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
160862264|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
160862265|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
160862266|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
160862267|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
160862268|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862269|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862270|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
160862271|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862272|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
160862273|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
160862274|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
160862275|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
160862276|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
160862277|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
160862278|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Other|1|||
160862279|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Other|5|||
160862280|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Other|0|||
160862281|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Other|2|||
160862282|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Other|3|||
160862283|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
160862284|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
160862285|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
160862286|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
160862287|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
160862288|NCT02006472|580889691|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
160862289|NCT02006472|580889692|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
160862290|NCT02006472|580889693|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
160862291|NCT02006472|580889694|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
160862292|NCT02006472|580889695|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
160862293|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
160862294|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
160862295|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
160862296|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
160862297|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
160862298|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
160862299|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
160862300|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
160949209|NCT00760929|581203033|FG003|Overall Study|Progression of Disease|42|||
160949210|NCT00760929|581203030|FG000|Overall Study|Other|2|||
160949211|NCT00760929|581203031|FG001|Overall Study|Other|0|||
160949212|NCT00760929|581203032|FG002|Overall Study|Other|2|||
160949213|NCT00760929|581203033|FG003|Overall Study|Other|1|||
160949214|NCT00760929|581203030|FG000|Overall Study|Death|0|||
160949215|NCT00760929|581203031|FG001|Overall Study|Death|0|||
160949216|NCT00760929|581203032|FG002|Overall Study|Death|1|||
160949217|NCT00760929|581203033|FG003|Overall Study|Death|0|||
160949218|NCT00760929|581203030|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
160949219|NCT00760929|581203031|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
160949220|NCT00760929|581203032|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
160949221|NCT00760929|581203033|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
160949222|NCT02099838|581203034|FG000|Overall Study|Death|1|||
160949223|NCT02099838|581203035|FG001|Overall Study|Death|0|||
160949224|NCT02099838|581203034|FG000|Overall Study|Lost to Follow-up|3|||
160949225|NCT02099838|581203035|FG001|Overall Study|Lost to Follow-up|1|||
160949226|NCT02099838|581203034|FG000|Overall Study|Withdrawal by Subject|0|||
160949227|NCT02099838|581203035|FG001|Overall Study|Withdrawal by Subject|1|||
160949228|NCT04121962|581203036|FG000|Overall Study|Lost to Follow-up|42|||
160949229|NCT04121962|581203037|FG001|Overall Study|Lost to Follow-up|39|||
160949230|NCT01175382|581203038|FG000|Overall Study|Lost to Follow-up|4|||
160949231|NCT01175382|581203039|FG001|Overall Study|Lost to Follow-up|3|||
160949232|NCT01175382|581203040|FG002|Overall Study|Lost to Follow-up|1|||
160949233|NCT01175382|581203038|FG000|Overall Study|Physician Decision|0|||
160949234|NCT01175382|581203039|FG001|Overall Study|Physician Decision|1|||
160949235|NCT01175382|581203040|FG002|Overall Study|Physician Decision|0|||
160949236|NCT01175382|581203038|FG000|Overall Study|Withdrawal by Subject|0|||
160949237|NCT01175382|581203039|FG001|Overall Study|Withdrawal by Subject|0|||
160949238|NCT01175382|581203040|FG002|Overall Study|Withdrawal by Subject|1|||
160949239|NCT01175382|581203038|FG000|Overall Study|No longer having problem|1|||
160949240|NCT01175382|581203039|FG001|Overall Study|No longer having problem|0|||
160949241|NCT01175382|581203040|FG002|Overall Study|No longer having problem|1|||
160949242|NCT01175382|581203038|FG000|Overall Study|Unable/unwilling to attend visits|3|||
160949243|NCT01175382|581203039|FG001|Overall Study|Unable/unwilling to attend visits|1|||
160949244|NCT01175382|581203040|FG002|Overall Study|Unable/unwilling to attend visits|2|||
160949245|NCT01175382|581203038|FG000|Overall Study|Unwilling to follow protocol|0|||
160949246|NCT01175382|581203039|FG001|Overall Study|Unwilling to follow protocol|1|||
160949247|NCT01175382|581203040|FG002|Overall Study|Unwilling to follow protocol|0|||
160949248|NCT01175382|581203038|FG000|Overall Study|Unable to tolerate study meds|0|||
160949249|NCT01175382|581203039|FG001|Overall Study|Unable to tolerate study meds|1|||
160949250|NCT01175382|581203040|FG002|Overall Study|Unable to tolerate study meds|1|||
160949251|NCT00774787|581203041|FG000|Overall Study|Lost to Follow-up|1|||
160949252|NCT04535037|581203042|FG000|Overall Study|Protocol Violation|1|||
160949253|NCT04535037|581203043|FG001|Overall Study|Protocol Violation|0|||
160949254|NCT04535037|581203042|FG000|Overall Study|Withdrawal by Subject|8|||
160949255|NCT04535037|581203043|FG001|Overall Study|Withdrawal by Subject|9|||
160949256|NCT04535037|581203042|FG000|Overall Study|Migrated / moved from the study area|1|||
160949257|NCT04535037|581203043|FG001|Overall Study|Migrated / moved from the study area|4|||
160949258|NCT04535037|581203042|FG000|Overall Study|Other|2|||
160949259|NCT04535037|581203043|FG001|Overall Study|Other|5|||
160949260|NCT02031276|581203044|FG000|Period 1 Double-blind IV|Adverse Event|6|||
160949261|NCT02031276|581203045|FG001|Period 1 Double-blind IV|Adverse Event|5|||
161145057|NCT00301067|581914032|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
161145058|NCT00301067|581914033|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
161145059|NCT00301067|581914030|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
161145060|NCT00301067|581914031|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
160949262|NCT02031276|581203046|FG002|Period 1 Double-blind IV|Adverse Event|1|||
160949263|NCT02031276|581203044|FG000|Period 1 Double-blind IV|Other|0|||
160949264|NCT02031276|581203045|FG001|Period 1 Double-blind IV|Other|1|||
160949265|NCT02031276|581203046|FG002|Period 1 Double-blind IV|Other|0|||
160949266|NCT02031276|581203044|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
160949267|NCT02031276|581203045|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
160949268|NCT02031276|581203046|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
160949269|NCT02031276|581203044|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
160949270|NCT02031276|581203045|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
160949271|NCT02031276|581203046|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
161145061|NCT00301067|581914032|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
160949272|NCT02031276|581203044|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
160949273|NCT02031276|581203045|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
160949274|NCT02031276|581203046|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
160949275|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
160949276|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
160949277|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
160949278|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
160949279|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
160949280|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
160949281|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
160949282|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
160949283|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
160949284|NCT02031276|581203044|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
160949285|NCT02031276|581203045|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
160949286|NCT02031276|581203046|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
160949287|NCT03525834|581203059|FG000|Overall Study|Progressive disease|1|||
160949288|NCT00346034|581203062|FG000|Overall Study|Adverse Event|34|||
160949289|NCT00346034|581203062|FG000|Overall Study|Lack of Efficacy|8|||
160949290|NCT00346034|581203062|FG000|Overall Study|Withdrawal by Subject|13|||
160949291|NCT00346034|581203062|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
160949292|NCT00346034|581203062|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
160949293|NCT00941603|581203063|FG000|Overall Study|Adverse Event|10|||
160949294|NCT00941603|581203064|FG001|Overall Study|Adverse Event|15|||
160949295|NCT00941603|581203065|FG002|Overall Study|Adverse Event|5|||
160949296|NCT00941603|581203066|FG003|Overall Study|Adverse Event|1|||
160949297|NCT00941603|581203067|FG004|Overall Study|Adverse Event|4|||
160949298|NCT00941603|581203068|FG005|Overall Study|Adverse Event|0|||
160949299|NCT00941603|581203063|FG000|Overall Study|Lost to Follow-up|0|||
160949300|NCT00941603|581203064|FG001|Overall Study|Lost to Follow-up|0|||
160949301|NCT00941603|581203065|FG002|Overall Study|Lost to Follow-up|0|||
160949302|NCT00941603|581203066|FG003|Overall Study|Lost to Follow-up|1|||
160949303|NCT00941603|581203067|FG004|Overall Study|Lost to Follow-up|0|||
160949304|NCT00941603|581203068|FG005|Overall Study|Lost to Follow-up|2|||
160949305|NCT00941603|581203063|FG000|Overall Study|Withdrawal by Subject|0|||
160949306|NCT00941603|581203064|FG001|Overall Study|Withdrawal by Subject|0|||
160949307|NCT00941603|581203065|FG002|Overall Study|Withdrawal by Subject|0|||
160949308|NCT00941603|581203066|FG003|Overall Study|Withdrawal by Subject|2|||
160949309|NCT00941603|581203067|FG004|Overall Study|Withdrawal by Subject|0|||
160949310|NCT00941603|581203068|FG005|Overall Study|Withdrawal by Subject|1|||
160949311|NCT00941603|581203063|FG000|Overall Study|Protocol Violation|0|||
160949312|NCT00941603|581203064|FG001|Overall Study|Protocol Violation|1|||
160949313|NCT00941603|581203065|FG002|Overall Study|Protocol Violation|0|||
160949314|NCT00941603|581203066|FG003|Overall Study|Protocol Violation|0|||
160949315|NCT00941603|581203067|FG004|Overall Study|Protocol Violation|0|||
160949316|NCT00941603|581203068|FG005|Overall Study|Protocol Violation|0|||
160949317|NCT00941603|581203063|FG000|Overall Study|Did not meet protocol eligibility|1|||
160949318|NCT00941603|581203064|FG001|Overall Study|Did not meet protocol eligibility|0|||
160949319|NCT00941603|581203065|FG002|Overall Study|Did not meet protocol eligibility|0|||
160949320|NCT00941603|581203066|FG003|Overall Study|Did not meet protocol eligibility|0|||
160949321|NCT00941603|581203067|FG004|Overall Study|Did not meet protocol eligibility|0|||
160949322|NCT00941603|581203068|FG005|Overall Study|Did not meet protocol eligibility|0|||
160949323|NCT03879798|581203071|FG000|Overall Study|Adverse Event|0|||
160949324|NCT03879798|581203072|FG001|Overall Study|Adverse Event|0|||
160949325|NCT03879798|581203073|FG002|Overall Study|Adverse Event|0|||
160949326|NCT03879798|581203074|FG003|Overall Study|Adverse Event|0|||
160949327|NCT03879798|581203075|FG004|Overall Study|Adverse Event|0|||
160949328|NCT03879798|581203076|FG005|Overall Study|Adverse Event|1|||
160949329|NCT03879798|581203071|FG000|Overall Study|Lack of Efficacy|0|||
160949330|NCT03879798|581203072|FG001|Overall Study|Lack of Efficacy|0|||
160949331|NCT03879798|581203073|FG002|Overall Study|Lack of Efficacy|0|||
161268085|NCT00444457|582363469|FG001|Toddler Dose|Parent or legal guardian request|3|||
161268086|NCT00444457|582363470|FG002|Toddler Dose|Parent or legal guardian request|2|||
161268087|NCT00444457|582363471|FG003|Toddler Dose|Parent or legal guardian request|1|||
161268088|NCT00444457|582363468|FG000|Toddler Dose|Protocol Violation|1|||
161268089|NCT00444457|582363469|FG001|Toddler Dose|Protocol Violation|0|||
160949332|NCT03879798|581203074|FG003|Overall Study|Lack of Efficacy|0|||
160949333|NCT03879798|581203075|FG004|Overall Study|Lack of Efficacy|0|||
160949334|NCT03879798|581203076|FG005|Overall Study|Lack of Efficacy|1|||
160949335|NCT03879798|581203071|FG000|Overall Study|Withdrawal by Subject|0|||
160949336|NCT03879798|581203072|FG001|Overall Study|Withdrawal by Subject|0|||
160949337|NCT03879798|581203073|FG002|Overall Study|Withdrawal by Subject|0|||
160949338|NCT03879798|581203074|FG003|Overall Study|Withdrawal by Subject|0|||
160949339|NCT03879798|581203075|FG004|Overall Study|Withdrawal by Subject|0|||
160949340|NCT03879798|581203076|FG005|Overall Study|Withdrawal by Subject|1|||
160949341|NCT01343407|581203077|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
160949342|NCT01343407|581203078|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
160949343|NCT01343407|581203079|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
160949344|NCT01343407|581203080|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
161268090|NCT00444457|582363470|FG002|Toddler Dose|Protocol Violation|0|||
160949345|NCT01343407|581203081|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
160949346|NCT01343407|581203082|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
160949347|NCT01343407|581203077|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949348|NCT01343407|581203078|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949349|NCT01343407|581203079|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
160949350|NCT01343407|581203080|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949351|NCT01343407|581203081|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949352|NCT01343407|581203082|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
160949353|NCT06027216|581203083|FG000|Overall Study|Did not qualify|8|||
160949354|NCT00345579|581203087|FG000|Overall Study|Adverse Event|9|||
160949355|NCT00345579|581203088|FG001|Overall Study|Adverse Event|6|||
160949356|NCT00345579|581203087|FG000|Overall Study|Protocol Violation|14|||
160949357|NCT00345579|581203088|FG001|Overall Study|Protocol Violation|5|||
160949358|NCT00345579|581203087|FG000|Overall Study|Withdrawal by Subject|50|||
160949359|NCT00345579|581203088|FG001|Overall Study|Withdrawal by Subject|17|||
160949360|NCT00345579|581203087|FG000|Overall Study|Lost to Follow-up|82|||
160949361|NCT00345579|581203088|FG001|Overall Study|Lost to Follow-up|36|||
160949362|NCT00345579|581203087|FG000|Overall Study|Other|9|||
160949363|NCT00345579|581203088|FG001|Overall Study|Other|1|||
160949364|NCT03646513|581203089|FG000|Overall Study|Premature study termination|4|||
160949365|NCT01732835|581203090|FG000|6-month Primary Endpoint|Did not receive device|19|||
160949366|NCT01732835|581203090|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
160949367|NCT01732835|581203090|FG000|6-month Primary Endpoint|Adverse Event|3|||
160949368|NCT01732835|581203090|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
160949369|NCT01732835|581203090|FG000|2-year Extended Follow-up|Adverse Event|3|||
160949370|NCT01732835|581203090|FG000|2-year Extended Follow-up|Death|1|||
160949371|NCT02043782|581203095|FG000|Period 1|Adverse Event|0|||
160949372|NCT02043782|581203096|FG001|Period 1|Adverse Event|0|||
160949373|NCT02043782|581203097|FG002|Period 1|Adverse Event|1|||
160949374|NCT02043782|581203098|FG003|Period 1|Adverse Event|0|||
160949375|NCT02043782|581203099|FG004|Period 1|Adverse Event|0|||
160949376|NCT02043782|581203100|FG005|Period 1|Adverse Event|0|||
160949377|NCT00874029|581203101|FG000|Overall Study|Withdrawal by Subject|10|||
160949378|NCT00874029|581203101|FG000|Overall Study|Pregnancy|4|||
160949379|NCT00874029|581203101|FG000|Overall Study|Physician Decision|1|||
160949380|NCT00874029|581203101|FG000|Overall Study|Adverse Event|1|||
160949381|NCT00874029|581203101|FG000|Overall Study|Lost to Follow-up|5|||
160949382|NCT02007577|581203102|FG000|Overall Study|Adverse Event|1|||
160949383|NCT02007577|581203103|FG001|Overall Study|Adverse Event|0|||
160949384|NCT02007577|581203102|FG000|Overall Study|Withdrawal by Subject|0|||
160949385|NCT02007577|581203103|FG001|Overall Study|Withdrawal by Subject|1|||
160949386|NCT01767116|581203104|FG000|Overall Study|Lost to Follow-up|2|||
160949387|NCT01767116|581203105|FG001|Overall Study|Lost to Follow-up|2|||
160949388|NCT00968669|581203106|FG000|Overall Study|Lost to Follow-up|5|||
160949389|NCT00968669|581203107|FG001|Overall Study|Lost to Follow-up|2|||
160949390|NCT00968669|581203108|FG002|Overall Study|Lost to Follow-up|1|||
160949391|NCT00968669|581203109|FG003|Overall Study|Lost to Follow-up|4|||
160949392|NCT00968669|581203106|FG000|Overall Study|Withdrawal by Subject|9|||
160949393|NCT00968669|581203107|FG001|Overall Study|Withdrawal by Subject|7|||
160949394|NCT00968669|581203108|FG002|Overall Study|Withdrawal by Subject|5|||
161268091|NCT00444457|582363471|FG003|Toddler Dose|Protocol Violation|1|||
160949395|NCT00968669|581203109|FG003|Overall Study|Withdrawal by Subject|3|||
160949396|NCT00968669|581203106|FG000|Overall Study|Pregnancy|0|||
160949397|NCT00968669|581203107|FG001|Overall Study|Pregnancy|0|||
160949398|NCT00968669|581203108|FG002|Overall Study|Pregnancy|2|||
160949399|NCT00968669|581203109|FG003|Overall Study|Pregnancy|0|||
161268092|NCT02435836|582363472|FG000|Overall Study|Lost to Follow-up|21|||
161268093|NCT02435836|582363472|FG000|Overall Study|Lack of Efficacy|1|||
161268094|NCT02435836|582363472|FG000|Overall Study|Withdrawal by Subject|236|||
161268095|NCT02435836|582363472|FG000|Overall Study|Insufficient Clinical Response|26|||
160949400|NCT00968669|581203106|FG000|Overall Study|AE|1|||
160949401|NCT00968669|581203107|FG001|Overall Study|AE|0|||
161268096|NCT02435836|582363472|FG000|Overall Study|Adverse Event|44|||
161268097|NCT02435836|582363472|FG000|Overall Study|Sponsor discontinued trial|167|||
160949402|NCT00968669|581203108|FG002|Overall Study|AE|0|||
160949403|NCT00968669|581203109|FG003|Overall Study|AE|0|||
160949404|NCT00968669|581203106|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
160949405|NCT00968669|581203107|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
160949406|NCT00968669|581203108|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
160949407|NCT00968669|581203109|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
160949408|NCT00968669|581203106|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
160949409|NCT00968669|581203107|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
160949410|NCT00968669|581203108|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
160949411|NCT00968669|581203109|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
160949412|NCT00968669|581203106|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
160949413|NCT00968669|581203107|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
161268098|NCT02435836|582363472|FG000|Overall Study|Noncompliance|27|||
160949414|NCT00968669|581203108|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
160949415|NCT00968669|581203109|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
160949416|NCT00968669|581203106|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
160949417|NCT00968669|581203107|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
160999927|NCT03284957|581384926|FG015|Overall Study|Progressive Disease|2|||
160949418|NCT00968669|581203108|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
160949419|NCT00968669|581203109|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
160949420|NCT00968669|581203106|FG000|Overall Study|EARLY WITHDRAWAL|0|||
160949421|NCT00968669|581203107|FG001|Overall Study|EARLY WITHDRAWAL|1|||
160949422|NCT00968669|581203108|FG002|Overall Study|EARLY WITHDRAWAL|0|||
160949423|NCT00968669|581203109|FG003|Overall Study|EARLY WITHDRAWAL|0|||
160949424|NCT00968669|581203106|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
160949425|NCT00968669|581203107|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
160949426|NCT00968669|581203108|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
160949427|NCT00968669|581203109|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
160949428|NCT00968669|581203106|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
160949429|NCT00968669|581203107|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
160949430|NCT00968669|581203108|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
160949431|NCT00968669|581203109|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
160949432|NCT00968669|581203106|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
160949433|NCT00968669|581203107|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
160949434|NCT00968669|581203108|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
160949435|NCT00968669|581203109|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
160949436|NCT00968669|581203106|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
160949437|NCT00968669|581203107|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
160949438|NCT00968669|581203108|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
160949439|NCT00968669|581203109|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
160949440|NCT00968669|581203106|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
160949441|NCT00968669|581203107|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
160949442|NCT00968669|581203108|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
160949443|NCT00968669|581203109|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
160949444|NCT00968669|581203106|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
160949445|NCT00968669|581203107|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
160949446|NCT00968669|581203108|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
160949447|NCT00968669|581203109|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
160949448|NCT00968669|581203106|FG000|Overall Study|SPONSOR DECISION|0|||
160949449|NCT00968669|581203107|FG001|Overall Study|SPONSOR DECISION|1|||
160949450|NCT00968669|581203108|FG002|Overall Study|SPONSOR DECISION|0|||
160949451|NCT00968669|581203109|FG003|Overall Study|SPONSOR DECISION|0|||
160949452|NCT00968669|581203106|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
160949453|NCT00968669|581203107|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
160949454|NCT00968669|581203108|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
160949455|NCT00968669|581203109|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
160949456|NCT00968669|581203106|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
160949457|NCT00968669|581203107|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
160949458|NCT00968669|581203108|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
160949459|NCT00968669|581203109|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
160949460|NCT00968669|581203106|FG000|Overall Study|SUBJECT INCARCERATED|0|||
160949461|NCT00968669|581203107|FG001|Overall Study|SUBJECT INCARCERATED|1|||
160949462|NCT00968669|581203108|FG002|Overall Study|SUBJECT INCARCERATED|0|||
160949463|NCT00968669|581203109|FG003|Overall Study|SUBJECT INCARCERATED|0|||
160949464|NCT00968669|581203106|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
160949465|NCT00968669|581203107|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
160949466|NCT00968669|581203108|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
160949467|NCT00968669|581203109|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
160949468|NCT00968669|581203106|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
160949469|NCT00968669|581203107|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
160949470|NCT00968669|581203108|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
160949471|NCT00968669|581203109|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
160949472|NCT02338362|581203112|FG000|Overall Study|Withdrawal by Subject|1|||
160949473|NCT02338362|581203113|FG001|Overall Study|Withdrawal by Subject|1|||
160949474|NCT01669343|581203114|FG000|Part A: All Patients|Withdrawal by Subject|7|||
160949475|NCT01669343|581203114|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
160949476|NCT01669343|581203114|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
160949477|NCT01669343|581203114|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
160949478|NCT01669343|581203114|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
160949479|NCT02371369|581203119|FG000|Part 1|Physician Decision|0|||
161268099|NCT02435836|582363472|FG000|Overall Study|Protocol Violation|6|||
161268100|NCT02435836|582363472|FG000|Overall Study|Met Withdrawal Criteria|7|||
161268101|NCT02435836|582363472|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
160949480|NCT02371369|581203120|FG001|Part 1|Physician Decision|3|||
160949481|NCT02371369|581203119|FG000|Part 1|Adverse Event|8|||
160949482|NCT02371369|581203120|FG001|Part 1|Adverse Event|0|||
160949483|NCT02371369|581203119|FG000|Part 1|Withdrawal by Subject|1|||
161268102|NCT01946191|582363473|FG000|Allocation|Did not complete orientation|1|||
160949484|NCT02371369|581203120|FG001|Part 1|Withdrawal by Subject|6|||
160949485|NCT02371369|581203119|FG000|Part 1|Disease progression|0|||
161145062|NCT00301067|581914033|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
161342747|NCT03507790|582642248|FG002|Overall Study|COVID 19 Pandemic|0|||
160862301|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
160862302|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
160862303|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
160862304|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
160862305|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
160862306|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
160862307|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
160862308|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Other|0|||
160862309|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Other|1|||
160862310|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Other|0|||
160862311|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Other|1|||
160862312|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Other|0|||
160862313|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Not treated|0|||
160862314|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Not treated|0|||
160862315|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Not treated|2|||
160862316|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Not treated|0|||
160862317|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Not treated|0|||
160862318|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
160862319|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
160862320|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
160862321|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
160862322|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
160862323|NCT02006472|580889691|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
160862324|NCT02006472|580889692|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
160862325|NCT02006472|580889693|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
160862326|NCT02006472|580889694|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
160862327|NCT02006472|580889695|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
160862328|NCT05966142|580889702|FG000|Overall Study|Death|3|||
160862329|NCT05966142|580889703|FG001|Overall Study|Death|3|||
160862330|NCT05966142|580889702|FG000|Overall Study|Lost to Follow-up|55|||
160862331|NCT05966142|580889703|FG001|Overall Study|Lost to Follow-up|52|||
160862332|NCT05966142|580889702|FG000|Overall Study|Physician Decision|1|||
160862333|NCT05966142|580889703|FG001|Overall Study|Physician Decision|0|||
160862334|NCT05966142|580889702|FG000|Overall Study|Withdrawal by Subject|9|||
160862335|NCT05966142|580889703|FG001|Overall Study|Withdrawal by Subject|8|||
160862336|NCT05966142|580889702|FG000|Overall Study|Duplicate Enrollment|1|||
160862337|NCT05966142|580889703|FG001|Overall Study|Duplicate Enrollment|0|||
160862338|NCT05966142|580889702|FG000|Overall Study|Study Logistical Reason|1|||
160862339|NCT05966142|580889703|FG001|Overall Study|Study Logistical Reason|0|||
160862340|NCT05966142|580889702|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
160862341|NCT05966142|580889703|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
160862342|NCT00894803|580889704|FG000|Overall Study|Death|20|||
160862343|NCT00894803|580889705|FG001|Overall Study|Death|4|||
160862344|NCT00894803|580889704|FG000|Overall Study|Lost to Follow-up|0|||
160862345|NCT00894803|580889705|FG001|Overall Study|Lost to Follow-up|1|||
160862346|NCT01710345|580889706|FG000|Overall Study|Adverse Event|0|||
160862347|NCT01710345|580889707|FG001|Overall Study|Adverse Event|2|||
160862348|NCT01710345|580889708|FG002|Overall Study|Adverse Event|0|||
160862349|NCT01710345|580889706|FG000|Overall Study|Lack of Efficacy|2|||
160862350|NCT01710345|580889707|FG001|Overall Study|Lack of Efficacy|3|||
160862351|NCT01710345|580889708|FG002|Overall Study|Lack of Efficacy|1|||
160862352|NCT01710345|580889706|FG000|Overall Study|Drug Dosing Error|1|||
160862353|NCT01710345|580889707|FG001|Overall Study|Drug Dosing Error|0|||
160862354|NCT01710345|580889708|FG002|Overall Study|Drug Dosing Error|0|||
160862355|NCT00627393|580889712|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
160862356|NCT00627393|580889713|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
160862357|NCT00627393|580889712|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
160862358|NCT00627393|580889713|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
160862359|NCT00627393|580889712|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
160862360|NCT00627393|580889713|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
160862361|NCT00627393|580889712|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
160862362|NCT00627393|580889713|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
160862363|NCT03337308|580889716|FG000|Overall Study|Adverse Event|2|||
160862364|NCT03337308|580889717|FG001|Overall Study|Adverse Event|3|||
160862365|NCT03337308|580889718|FG002|Overall Study|Adverse Event|3|||
160862366|NCT03337308|580889719|FG003|Overall Study|Adverse Event|1|||
160862367|NCT03337308|580889716|FG000|Overall Study|Lost to Follow-up|1|||
160862368|NCT03337308|580889717|FG001|Overall Study|Lost to Follow-up|2|||
160862369|NCT03337308|580889718|FG002|Overall Study|Lost to Follow-up|0|||
160862370|NCT03337308|580889719|FG003|Overall Study|Lost to Follow-up|0|||
160862371|NCT03337308|580889716|FG000|Overall Study|Withdrawal by Subject|2|||
160862372|NCT03337308|580889717|FG001|Overall Study|Withdrawal by Subject|1|||
160862373|NCT03337308|580889718|FG002|Overall Study|Withdrawal by Subject|2|||
160949486|NCT02371369|581203120|FG001|Part 1|Disease progression|1|||
160949487|NCT02371369|581203119|FG000|Part 1|Protocol Violation|0|||
160949488|NCT02371369|581203120|FG001|Part 1|Protocol Violation|1|||
160949489|NCT02371369|581203119|FG000|Part 2|Adverse Event|6|||
160949490|NCT02371369|581203120|FG001|Part 2|Adverse Event|5|||
160949491|NCT02371369|581203119|FG000|Part 2|Withdrawal by Subject|16|||
160949492|NCT02371369|581203120|FG001|Part 2|Withdrawal by Subject|6|||
160949493|NCT02371369|581203119|FG000|Part 2|Investigator decision|1|||
160949494|NCT02371369|581203120|FG001|Part 2|Investigator decision|2|||
160949495|NCT02371369|581203119|FG000|Part 2|Death|0|||
160949496|NCT02371369|581203120|FG001|Part 2|Death|1|||
160949497|NCT02371369|581203119|FG000|Part 2|Disease progression|1|||
160949498|NCT02371369|581203120|FG001|Part 2|Disease progression|0|||
160949499|NCT02371369|581203119|FG000|Part 2|Subject Noncompliance|1|||
160949500|NCT02371369|581203120|FG001|Part 2|Subject Noncompliance|0|||
160949501|NCT02371369|581203119|FG000|Part 2|Lost to Follow-up|1|||
160949502|NCT02371369|581203120|FG001|Part 2|Lost to Follow-up|1|||
160949503|NCT02371369|581203119|FG000|Part 2|Subject transitioned to commercial supply|6|||
160949504|NCT02371369|581203120|FG001|Part 2|Subject transitioned to commercial supply|4|||
160949505|NCT02371369|581203119|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
160949506|NCT02371369|581203120|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
160949507|NCT02371369|581203119|FG000|Part 2|Surgical resection of tumor|1|||
160949508|NCT02371369|581203120|FG001|Part 2|Surgical resection of tumor|1|||
160949509|NCT02371369|581203119|FG000|Part 2|Other|0|||
160949510|NCT02371369|581203120|FG001|Part 2|Other|1|||
160949511|NCT01024387|581203121|FG000|Overall Study|Radiographic Progression|29|||
160949512|NCT01024387|581203121|FG000|Overall Study|Symptomatic Progression|10|||
160949513|NCT01024387|581203121|FG000|Overall Study|Physician Decision|5|||
160949514|NCT01024387|581203121|FG000|Overall Study|Withdrawal by Subject|5|||
160949515|NCT01024387|581203121|FG000|Overall Study|Death|2|||
160999928|NCT03284957|581384911|FG000|Overall Study|Withdrawal by Subject|0|||
160999929|NCT03284957|581384912|FG001|Overall Study|Withdrawal by Subject|0|||
160999930|NCT03284957|581384913|FG002|Overall Study|Withdrawal by Subject|0|||
160999931|NCT03284957|581384914|FG003|Overall Study|Withdrawal by Subject|0|||
160999932|NCT03284957|581384915|FG004|Overall Study|Withdrawal by Subject|0|||
160999933|NCT03284957|581384916|FG005|Overall Study|Withdrawal by Subject|0|||
160999934|NCT03284957|581384917|FG006|Overall Study|Withdrawal by Subject|0|||
160999935|NCT03284957|581384918|FG007|Overall Study|Withdrawal by Subject|0|||
160999936|NCT03284957|581384919|FG008|Overall Study|Withdrawal by Subject|0|||
160999937|NCT03284957|581384920|FG009|Overall Study|Withdrawal by Subject|2|||
160999938|NCT03284957|581384921|FG010|Overall Study|Withdrawal by Subject|0|||
160999939|NCT03284957|581384922|FG011|Overall Study|Withdrawal by Subject|0|||
160999940|NCT03284957|581384923|FG012|Overall Study|Withdrawal by Subject|0|||
160999941|NCT03284957|581384924|FG013|Overall Study|Withdrawal by Subject|0|||
160999942|NCT03284957|581384925|FG014|Overall Study|Withdrawal by Subject|0|||
160999943|NCT03284957|581384926|FG015|Overall Study|Withdrawal by Subject|0|||
160999944|NCT03284957|581384911|FG000|Overall Study|Other|0|||
160999945|NCT03284957|581384912|FG001|Overall Study|Other|0|||
160999946|NCT03284957|581384913|FG002|Overall Study|Other|0|||
160999947|NCT03284957|581384914|FG003|Overall Study|Other|0|||
160999948|NCT03284957|581384915|FG004|Overall Study|Other|0|||
160999949|NCT03284957|581384916|FG005|Overall Study|Other|0|||
160999950|NCT03284957|581384917|FG006|Overall Study|Other|3|||
160999951|NCT03284957|581384918|FG007|Overall Study|Other|0|||
160999952|NCT03284957|581384919|FG008|Overall Study|Other|1|||
160999953|NCT03284957|581384920|FG009|Overall Study|Other|6|||
160999954|NCT03284957|581384921|FG010|Overall Study|Other|0|||
160999955|NCT03284957|581384922|FG011|Overall Study|Other|0|||
160999956|NCT03284957|581384923|FG012|Overall Study|Other|0|||
160999957|NCT03284957|581384924|FG013|Overall Study|Other|0|||
160999958|NCT03284957|581384925|FG014|Overall Study|Other|2|||
161145063|NCT00301067|581914030|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
161145064|NCT00301067|581914031|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
160949516|NCT01024387|581203121|FG000|Overall Study|Prolonged Treatment Delay|1|||
160949517|NCT01024387|581203121|FG000|Overall Study|Adverse Event|3|||
160949518|NCT01024387|581203121|FG000|Overall Study|Other|5|||
160949519|NCT03855189|581203122|FG000|Overall Study|Adverse Event|5|||
160999959|NCT03284957|581384926|FG015|Overall Study|Other|0|||
160999960|NCT03351075|581384927|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
160999961|NCT03351075|581384928|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
160999962|NCT03351075|581384927|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
160999963|NCT03351075|581384928|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
160999964|NCT03351075|581384927|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
160999965|NCT03351075|581384928|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
161145065|NCT00301067|581914032|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
161145066|NCT00301067|581914033|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
160949520|NCT03855189|581203123|FG001|Overall Study|Adverse Event|2|||
160949521|NCT03855189|581203124|FG002|Overall Study|Adverse Event|4|||
160949522|NCT03855189|581203122|FG000|Overall Study|Treatment Failure|1|||
160999966|NCT03351075|581384927|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
160999967|NCT03351075|581384928|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
160999968|NCT05219253|581384934|FG000|Overall Study|Withdrawal by Subject|1|||
160999969|NCT05219253|581384935|FG001|Overall Study|Withdrawal by Subject|2|||
160999970|NCT03086369|581384936|FG000|Overall Study|Lost to Follow-up|1|||
160999971|NCT03086369|581384937|FG001|Overall Study|Lost to Follow-up|0|||
160999972|NCT03086369|581384938|FG002|Overall Study|Lost to Follow-up|0|||
160999973|NCT03086369|581384939|FG003|Overall Study|Lost to Follow-up|2|||
160999974|NCT03086369|581384940|FG004|Overall Study|Lost to Follow-up|1|||
160999975|NCT03086369|581384936|FG000|Overall Study|Physician Decision|0|||
160999976|NCT03086369|581384937|FG001|Overall Study|Physician Decision|0|||
160999977|NCT03086369|581384938|FG002|Overall Study|Physician Decision|0|||
160999978|NCT03086369|581384939|FG003|Overall Study|Physician Decision|1|||
160999979|NCT03086369|581384940|FG004|Overall Study|Physician Decision|2|||
160999980|NCT03086369|581384936|FG000|Overall Study|Withdrawal by Subject|0|||
160999981|NCT03086369|581384937|FG001|Overall Study|Withdrawal by Subject|0|||
160999982|NCT03086369|581384938|FG002|Overall Study|Withdrawal by Subject|0|||
160999983|NCT03086369|581384939|FG003|Overall Study|Withdrawal by Subject|5|||
160999984|NCT03086369|581384940|FG004|Overall Study|Withdrawal by Subject|3|||
160999985|NCT03086369|581384936|FG000|Overall Study|Progressive Disease|0|||
160999986|NCT03086369|581384937|FG001|Overall Study|Progressive Disease|0|||
160999987|NCT03086369|581384938|FG002|Overall Study|Progressive Disease|0|||
160999988|NCT03086369|581384939|FG003|Overall Study|Progressive Disease|1|||
160999989|NCT03086369|581384940|FG004|Overall Study|Progressive Disease|1|||
160999990|NCT03544515|581384941|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
160999991|NCT03544515|581384942|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
160999992|NCT03544515|581384941|FG000|Overall Study|Lost to Follow-up|2|||
160999993|NCT03544515|581384942|FG001|Overall Study|Lost to Follow-up|0|||
160999994|NCT01070888|581384943|FG000|First Intervention (14 Days)|Adverse Event|0|||
160999995|NCT01070888|581384944|FG001|First Intervention (14 Days)|Adverse Event|1|||
160999996|NCT01070888|581384943|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
160999997|NCT01070888|581384944|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
160999998|NCT01070888|581384943|FG000|Washout (14 Days)|Physician Decision|1|||
160999999|NCT01070888|581384944|FG001|Washout (14 Days)|Physician Decision|0|||
161000000|NCT00178399|581384945|FG000|Overall Study|Physician Decision|4|||
161000001|NCT00178399|581384945|FG000|Overall Study|Withdrawal by Subject|8|||
161000002|NCT00178399|581384945|FG000|Overall Study|Lost to Follow-up|1|||
161000003|NCT00357396|581384946|FG000|Overall Study|Adverse Event|1|||
161000004|NCT00357396|581384947|FG001|Overall Study|Adverse Event|0|||
161000005|NCT00955825|581384948|FG000|Overall Study|Adverse Event|15|||
161000006|NCT00955825|581384949|FG001|Overall Study|Adverse Event|2|||
161000007|NCT00955825|581384948|FG000|Overall Study|Withdrawal by Subject|4|||
161000008|NCT00955825|581384949|FG001|Overall Study|Withdrawal by Subject|6|||
161000009|NCT00955825|581384948|FG000|Overall Study|Any other reason not above-mentioned|7|||
161000010|NCT00955825|581384949|FG001|Overall Study|Any other reason not above-mentioned|9|||
161000011|NCT02385669|581384950|FG000|Overall Study|Adverse Event|2|||
161000012|NCT00004124|581384951|FG000|Overall Study|Received no protocol therapy|12|||
161000013|NCT00004124|581384952|FG001|Overall Study|Received no protocol therapy|20|||
161000014|NCT00393848|581384957|FG000|Overall Study|Surgical schedule|0|||
161000015|NCT00393848|581384958|FG001|Overall Study|Surgical schedule|0|||
161000016|NCT00393848|581384959|FG002|Overall Study|Surgical schedule|0|||
161000017|NCT00393848|581384960|FG003|Overall Study|Surgical schedule|1|||
161000018|NCT00393848|581384957|FG000|Overall Study|Personal reasons|0|||
161000019|NCT00393848|581384958|FG001|Overall Study|Personal reasons|0|||
161000020|NCT00393848|581384959|FG002|Overall Study|Personal reasons|2|||
161000021|NCT00393848|581384960|FG003|Overall Study|Personal reasons|0|||
161000022|NCT03743246|581384963|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161000023|NCT03743246|581384964|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161000024|NCT03743246|581384965|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
161000025|NCT03743246|581384966|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
161268103|NCT01946191|582363474|FG001|Allocation|Did not complete orientation|1|||
161268104|NCT01946191|582363473|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
161000026|NCT03743246|581384963|FG000|Pre-Treatment Period|Death|0|||
161000027|NCT03743246|581384964|FG001|Pre-Treatment Period|Death|1|||
161000028|NCT03743246|581384965|FG002|Pre-Treatment Period|Death|0|||
161342748|NCT03507790|582642246|FG000|Overall Study|Lost to Follow-up|0|||
161000029|NCT03743246|581384966|FG003|Pre-Treatment Period|Death|1|||
161000030|NCT03743246|581384963|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
161000031|NCT03743246|581384964|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161000032|NCT03743246|581384965|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161000033|NCT03743246|581384966|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
161000034|NCT03743246|581384963|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
161000035|NCT03743246|581384964|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161000036|NCT03743246|581384965|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161000037|NCT03743246|581384966|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
161000038|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
161000039|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161268105|NCT01946191|582363474|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
161268106|NCT01946191|582363473|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
161268107|NCT01946191|582363474|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
161268108|NCT01946191|582363473|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
161268109|NCT01946191|582363474|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
161268110|NCT04732221|582366744|FG000|Base Period|Death|2|||
161268111|NCT04732221|582366745|FG001|Base Period|Death|0|||
161268112|NCT04732221|582366746|FG002|Base Period|Death|0|||
161268113|NCT04732221|582366747|FG003|Base Period|Death|0|||
161268114|NCT04732221|582366748|FG004|Base Period|Death|0|||
161268115|NCT04732221|582366749|FG005|Base Period|Death|0|||
161268116|NCT04732221|582366750|FG006|Base Period|Death|0|||
161268117|NCT04732221|582366744|FG000|Base Period|Withdrawal by Subject|0|||
161268118|NCT04732221|582366745|FG001|Base Period|Withdrawal by Subject|1|||
161268119|NCT04732221|582366746|FG002|Base Period|Withdrawal by Subject|1|||
161342749|NCT03507790|582642247|FG001|Overall Study|Lost to Follow-up|1|||
161342750|NCT03507790|582642248|FG002|Overall Study|Lost to Follow-up|0|||
160862374|NCT03337308|580889719|FG003|Overall Study|Withdrawal by Subject|1|||
160862375|NCT03337308|580889716|FG000|Overall Study|Protocol Violation|0|||
160862376|NCT03337308|580889717|FG001|Overall Study|Protocol Violation|1|||
160862377|NCT03337308|580889718|FG002|Overall Study|Protocol Violation|0|||
160862378|NCT03337308|580889719|FG003|Overall Study|Protocol Violation|0|||
160862379|NCT00283296|580889721|FG000|Overall Study|in-home trial not completed|5|||
160862380|NCT03558737|580889722|FG000|Overall Study|Death|1|||
160862381|NCT03558737|580889723|FG001|Overall Study|Death|1|||
160862382|NCT01294553|580889724|FG000|Overall Study|Duplicated Participants|1|||
160862383|NCT01294553|580889724|FG000|Overall Study|Protocol Violation|268|||
160862384|NCT00795535|580889725|FG000|Overall Study|incomplete data and technical problems|20|||
160862385|NCT01903460|580889726|FG000|Overall Study|Adverse Event|0|||
160862386|NCT01903460|580889727|FG001|Overall Study|Adverse Event|0|||
160862387|NCT01903460|580889728|FG002|Overall Study|Adverse Event|0|||
160862388|NCT01903460|580889729|FG003|Overall Study|Adverse Event|1|||
160862389|NCT03104868|580889730|FG000|6 Week Follow up|Lost to Follow-up|5|||
160862390|NCT03104868|580889731|FG001|6 Week Follow up|Lost to Follow-up|8|||
160862391|NCT03104868|580889730|FG000|6 Week Follow up|Death|1|||
160862392|NCT03104868|580889731|FG001|6 Week Follow up|Death|1|||
160862393|NCT03104868|580889730|FG000|6 Week Follow up|Withdrawal by Subject|7|||
160862394|NCT03104868|580889731|FG001|6 Week Follow up|Withdrawal by Subject|6|||
160862395|NCT03104868|580889730|FG000|6 Week Follow up|Completed Later Timepoint|24|||
160862396|NCT03104868|580889731|FG001|6 Week Follow up|Completed Later Timepoint|22|||
160862397|NCT03104868|580889730|FG000|6 Month Follow up|Lost to Follow-up|2|||
160862398|NCT03104868|580889731|FG001|6 Month Follow up|Lost to Follow-up|2|||
160862399|NCT03104868|580889730|FG000|6 Month Follow up|Death|0|||
160862400|NCT03104868|580889731|FG001|6 Month Follow up|Death|1|||
160862401|NCT03104868|580889730|FG000|6 Month Follow up|Completed Later Timepoint|22|||
160862402|NCT03104868|580889731|FG001|6 Month Follow up|Completed Later Timepoint|32|||
160862403|NCT03104868|580889730|FG000|12 Month Follow up|Lost to Follow-up|1|||
160862404|NCT03104868|580889731|FG001|12 Month Follow up|Lost to Follow-up|2|||
160862405|NCT03104868|580889730|FG000|12 Month Follow up|Death|0|||
160862406|NCT03104868|580889731|FG001|12 Month Follow up|Death|1|||
160862407|NCT03104868|580889730|FG000|12 Month Follow up|Withdrawal by Subject|0|||
160862408|NCT03104868|580889731|FG001|12 Month Follow up|Withdrawal by Subject|3|||
160862409|NCT03104868|580889730|FG000|12 Month Follow up|Completed Later Timepoint|32|||
160862410|NCT03104868|580889731|FG001|12 Month Follow up|Completed Later Timepoint|29|||
160862411|NCT03104868|580889730|FG000|18 Month Follow up|Lost to Follow-up|7|||
160862412|NCT03104868|580889731|FG001|18 Month Follow up|Lost to Follow-up|11|||
160862413|NCT03104868|580889730|FG000|18 Month Follow up|Death|2|||
160862414|NCT03104868|580889731|FG001|18 Month Follow up|Death|1|||
160862415|NCT03104868|580889730|FG000|18 Month Follow up|Withdrawal by Subject|1|||
160862416|NCT03104868|580889731|FG001|18 Month Follow up|Withdrawal by Subject|2|||
160862417|NCT03104868|580889730|FG000|18 Month Follow up|Graft Loss|1|||
160862418|NCT03104868|580889731|FG001|18 Month Follow up|Graft Loss|1|||
160862419|NCT03104868|580889730|FG000|18 Month Follow up|Completed Later Timepoint|19|||
160862420|NCT03104868|580889731|FG001|18 Month Follow up|Completed Later Timepoint|20|||
160862421|NCT03104868|580889730|FG000|24 Month Follow up|Lost to Follow-up|15|||
160862422|NCT03104868|580889731|FG001|24 Month Follow up|Lost to Follow-up|16|||
160862423|NCT03104868|580889730|FG000|24 Month Follow up|Death|3|||
160862424|NCT03104868|580889731|FG001|24 Month Follow up|Death|2|||
160862425|NCT03104868|580889730|FG000|24 Month Follow up|Withdrawal by Subject|1|||
160862426|NCT03104868|580889731|FG001|24 Month Follow up|Withdrawal by Subject|0|||
160862427|NCT03104868|580889730|FG000|24 Month Follow up|Graft Loss|2|||
160862428|NCT03104868|580889731|FG001|24 Month Follow up|Graft Loss|0|||
160862429|NCT00888173|580889735|FG000|Overall Study|Wrong Primary|1|||
160862430|NCT00888173|580889735|FG000|Overall Study|Ineligible: required test not done|1|||
160862431|NCT02059278|580889736|FG000|Overall Study|Adverse Event|1|||
160862432|NCT02059278|580889737|FG001|Overall Study|Adverse Event|1|||
161268120|NCT04732221|582366747|FG003|Base Period|Withdrawal by Subject|0|||
161145067|NCT00301067|581914030|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
161145068|NCT00301067|581914031|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
161145069|NCT00301067|581914032|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
161145070|NCT00301067|581914033|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
161145071|NCT00301067|581914030|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
161145072|NCT00301067|581914031|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
161145073|NCT00301067|581914032|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
161145074|NCT00301067|581914033|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
161145075|NCT00301067|581914030|FG000|Follow up Until Death|Alive at last data cut point|1|||
161145076|NCT00301067|581914031|FG001|Follow up Until Death|Alive at last data cut point|0|||
161145077|NCT00301067|581914032|FG002|Follow up Until Death|Alive at last data cut point|0|||
161145078|NCT00301067|581914033|FG003|Follow up Until Death|Alive at last data cut point|1|||
160949523|NCT03855189|581203123|FG001|Overall Study|Treatment Failure|1|||
160949524|NCT03855189|581203124|FG002|Overall Study|Treatment Failure|2|||
160949525|NCT03855189|581203122|FG000|Overall Study|Noncompliance with Protocol|0|||
160949526|NCT03855189|581203123|FG001|Overall Study|Noncompliance with Protocol|1|||
160949527|NCT03855189|581203124|FG002|Overall Study|Noncompliance with Protocol|0|||
160949528|NCT03855189|581203122|FG000|Overall Study|Did Not Return|4|||
161145079|NCT00149825|581914034|FG000|Overall Study|Intolerance to medication side effects|1|||
161145080|NCT00149825|581914035|FG001|Overall Study|Intolerance to medication side effects|2|||
161145081|NCT00149825|581914034|FG000|Overall Study|Time commitments|2|||
161145082|NCT00149825|581914035|FG001|Overall Study|Time commitments|1|||
161145083|NCT00149825|581914034|FG000|Overall Study|Not liking insomnia therapy|1|||
161145084|NCT00149825|581914035|FG001|Overall Study|Not liking insomnia therapy|0|||
161145085|NCT00149825|581914034|FG000|Overall Study|Other|1|||
161145086|NCT00149825|581914035|FG001|Overall Study|Other|0|||
161145087|NCT01359982|581914036|FG000|Overall Study|Adverse Event|2|||
161145088|NCT01359982|581914037|FG001|Overall Study|Adverse Event|0|||
161145089|NCT01359982|581914038|FG002|Overall Study|Adverse Event|0|||
161145090|NCT01359982|581914039|FG003|Overall Study|Adverse Event|1|||
161145091|NCT01359982|581914040|FG004|Overall Study|Adverse Event|0|||
161145092|NCT01359982|581914041|FG005|Overall Study|Adverse Event|0|||
161145093|NCT01359982|581914036|FG000|Overall Study|Death|1|||
161145094|NCT01359982|581914037|FG001|Overall Study|Death|0|||
161145095|NCT01359982|581914038|FG002|Overall Study|Death|0|||
161145096|NCT01359982|581914039|FG003|Overall Study|Death|0|||
161145097|NCT01359982|581914040|FG004|Overall Study|Death|0|||
161145098|NCT01359982|581914041|FG005|Overall Study|Death|0|||
161145099|NCT05593432|581914042|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
161145100|NCT05593432|581914043|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
161268121|NCT04732221|582366748|FG004|Base Period|Withdrawal by Subject|0|||
161268122|NCT04732221|582366749|FG005|Base Period|Withdrawal by Subject|0|||
161268123|NCT04732221|582366750|FG006|Base Period|Withdrawal by Subject|0|||
161268124|NCT04732221|582366744|FG000|Extension Period|Adverse Event|0|||
160949529|NCT03855189|581203123|FG001|Overall Study|Did Not Return|3|||
160949530|NCT03855189|581203124|FG002|Overall Study|Did Not Return|0|||
160949531|NCT04307186|581203125|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
160949532|NCT04307186|581203125|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
160949533|NCT04307186|581203125|FG000|Washout 3-14 Days|Progressive disease|1|||
160949534|NCT04307186|581203125|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
160949535|NCT04307186|581203125|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
160949536|NCT01618838|581203128|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
160949537|NCT01587651|581203129|FG000|Overall Study|Adverse Event|0|||
160949538|NCT01587651|581203130|FG001|Overall Study|Adverse Event|1|||
160949539|NCT01587651|581203131|FG002|Overall Study|Adverse Event|0|||
160949540|NCT01587651|581203129|FG000|Overall Study|Protocol Violation|0|||
160949541|NCT01587651|581203130|FG001|Overall Study|Protocol Violation|1|||
160949542|NCT01587651|581203131|FG002|Overall Study|Protocol Violation|1|||
160949543|NCT01587651|581203129|FG000|Overall Study|Withdrawal by Subject|0|||
160949544|NCT01587651|581203130|FG001|Overall Study|Withdrawal by Subject|1|||
161000040|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161145101|NCT05593432|581914044|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
161268125|NCT04732221|582366745|FG001|Extension Period|Adverse Event|0|||
160949545|NCT01587651|581203131|FG002|Overall Study|Withdrawal by Subject|0|||
161000041|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
161145102|NCT05593432|581914045|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
161145103|NCT05593432|581914042|FG000|16-Week OLE Period|Lack of Efficacy|0|||
161145104|NCT05593432|581914043|FG001|16-Week OLE Period|Lack of Efficacy|0|||
161145105|NCT05593432|581914044|FG002|16-Week OLE Period|Lack of Efficacy|0|||
161145106|NCT05593432|581914045|FG003|16-Week OLE Period|Lack of Efficacy|1|||
161145107|NCT05593432|581914042|FG000|16-Week OLE Period|Lost to Follow-up|0|||
161145108|NCT05593432|581914043|FG001|16-Week OLE Period|Lost to Follow-up|0|||
161268126|NCT04732221|582366746|FG002|Extension Period|Adverse Event|0|||
160949546|NCT03238001|581203132|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
160949547|NCT03238001|581203132|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
161268127|NCT04732221|582366747|FG003|Extension Period|Adverse Event|0|||
161268128|NCT04732221|582366748|FG004|Extension Period|Adverse Event|0|||
161268129|NCT04732221|582366749|FG005|Extension Period|Adverse Event|1|||
161268130|NCT04732221|582366750|FG006|Extension Period|Adverse Event|0|||
161268131|NCT04732221|582366744|FG000|Extension Period|Death|0|||
161268132|NCT04732221|582366745|FG001|Extension Period|Death|0|||
161268133|NCT04732221|582366746|FG002|Extension Period|Death|0|||
161268134|NCT04732221|582366747|FG003|Extension Period|Death|0|||
161268135|NCT04732221|582366748|FG004|Extension Period|Death|1|||
161268136|NCT04732221|582366749|FG005|Extension Period|Death|0|||
161268137|NCT04732221|582366750|FG006|Extension Period|Death|2|||
161268138|NCT04732221|582366744|FG000|Extension Period|Pregnancy|0|||
161268139|NCT04732221|582366745|FG001|Extension Period|Pregnancy|0|||
161268140|NCT04732221|582366746|FG002|Extension Period|Pregnancy|0|||
161268141|NCT04732221|582366747|FG003|Extension Period|Pregnancy|0|||
161268142|NCT04732221|582366748|FG004|Extension Period|Pregnancy|1|||
161268143|NCT04732221|582366749|FG005|Extension Period|Pregnancy|0|||
161268144|NCT04732221|582366750|FG006|Extension Period|Pregnancy|0|||
161268145|NCT04732221|582366744|FG000|Extension Period|Sponsors Decision|0|||
161268146|NCT04732221|582366745|FG001|Extension Period|Sponsors Decision|0|||
161268147|NCT04732221|582366746|FG002|Extension Period|Sponsors Decision|0|||
161268148|NCT04732221|582366747|FG003|Extension Period|Sponsors Decision|0|||
161268149|NCT04732221|582366748|FG004|Extension Period|Sponsors Decision|41|||
161268150|NCT04732221|582366749|FG005|Extension Period|Sponsors Decision|40|||
161268151|NCT04732221|582366750|FG006|Extension Period|Sponsors Decision|40|||
161268152|NCT04732221|582366744|FG000|Extension Period|Withdrawal by Subject|0|||
161268153|NCT04732221|582366745|FG001|Extension Period|Withdrawal by Subject|0|||
161268154|NCT04732221|582366746|FG002|Extension Period|Withdrawal by Subject|0|||
161268155|NCT04732221|582366747|FG003|Extension Period|Withdrawal by Subject|0|||
161268156|NCT04732221|582366748|FG004|Extension Period|Withdrawal by Subject|1|||
161268157|NCT04732221|582366749|FG005|Extension Period|Withdrawal by Subject|5|||
161268158|NCT04732221|582366750|FG006|Extension Period|Withdrawal by Subject|2|||
161268159|NCT03611543|582366751|FG000|Overall Study|Withdrawal by Subject|4|||
161268160|NCT03611543|582366752|FG001|Overall Study|Withdrawal by Subject|4|||
161268161|NCT03611543|582366751|FG000|Overall Study|Physician Decision|1|||
161268162|NCT03611543|582366752|FG001|Overall Study|Physician Decision|1|||
161268163|NCT03611543|582366751|FG000|Overall Study|Protocol Violation|2|||
161268164|NCT03611543|582366752|FG001|Overall Study|Protocol Violation|2|||
161268165|NCT03611543|582366751|FG000|Overall Study|Device failure|2|||
161268166|NCT03611543|582366752|FG001|Overall Study|Device failure|2|||
161268167|NCT03611543|582366751|FG000|Overall Study|Missing information|5|||
161268168|NCT03611543|582366752|FG001|Overall Study|Missing information|5|||
161268169|NCT00379340|582366757|FG000|Overall Study|Death|0|||
161268170|NCT00379340|582366758|FG001|Overall Study|Death|0|||
161268171|NCT00379340|582366759|FG002|Overall Study|Death|0|||
161268172|NCT00379340|582366760|FG003|Overall Study|Death|2|||
161268173|NCT00379340|582366761|FG004|Overall Study|Death|0|||
161268174|NCT00379340|582366757|FG000|Overall Study|Lack of Efficacy|6|||
161268175|NCT00379340|582366758|FG001|Overall Study|Lack of Efficacy|1|||
161268176|NCT00379340|582366759|FG002|Overall Study|Lack of Efficacy|0|||
161268177|NCT00379340|582366760|FG003|Overall Study|Lack of Efficacy|4|||
161268178|NCT00379340|582366761|FG004|Overall Study|Lack of Efficacy|3|||
161268179|NCT00379340|582366757|FG000|Overall Study|Physician Decision|6|||
161268180|NCT00379340|582366758|FG001|Overall Study|Physician Decision|2|||
161268181|NCT00379340|582366759|FG002|Overall Study|Physician Decision|1|||
161268182|NCT00379340|582366760|FG003|Overall Study|Physician Decision|2|||
161268183|NCT00379340|582366761|FG004|Overall Study|Physician Decision|3|||
161268184|NCT00379340|582366757|FG000|Overall Study|Withdrawal by Subject|0|||
161268185|NCT00379340|582366758|FG001|Overall Study|Withdrawal by Subject|0|||
161268186|NCT00379340|582366759|FG002|Overall Study|Withdrawal by Subject|0|||
161268187|NCT00379340|582366760|FG003|Overall Study|Withdrawal by Subject|1|||
161268188|NCT00379340|582366761|FG004|Overall Study|Withdrawal by Subject|0|||
160949548|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
161268189|NCT00379340|582366757|FG000|Overall Study|Refusal of further protocol therapy|1|||
161268190|NCT00379340|582366758|FG001|Overall Study|Refusal of further protocol therapy|0|||
161268191|NCT00379340|582366759|FG002|Overall Study|Refusal of further protocol therapy|1|||
161268192|NCT00379340|582366760|FG003|Overall Study|Refusal of further protocol therapy|1|||
161268193|NCT00379340|582366761|FG004|Overall Study|Refusal of further protocol therapy|7|||
161268194|NCT00379340|582366757|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
161268195|NCT00379340|582366758|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
161268196|NCT00379340|582366759|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
161268197|NCT00379340|582366760|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
161268198|NCT00379340|582366761|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
161268199|NCT00379340|582366757|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
161268200|NCT00379340|582366758|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
161268201|NCT00379340|582366759|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
161268202|NCT00379340|582366760|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
161268203|NCT00379340|582366761|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
161268204|NCT02799095|582366762|FG000|Part A|Adverse Event|1|||
161268205|NCT02799095|582366763|FG001|Part A|Adverse Event|0|||
161268206|NCT02799095|582366764|FG002|Part A|Adverse Event|1|||
161268207|NCT02799095|582366765|FG003|Part A|Adverse Event|4|||
161268208|NCT02799095|582366766|FG004|Part A|Adverse Event|1|||
161268209|NCT02799095|582366767|FG005|Part A|Adverse Event|0|||
161268210|NCT02799095|582366768|FG006|Part A|Adverse Event|0|||
161268211|NCT02799095|582366769|FG007|Part A|Adverse Event|0|||
161268212|NCT02799095|582366770|FG008|Part A|Adverse Event|0|||
161000042|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161000043|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
161000044|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161000045|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
161000046|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
161000047|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161000048|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161000049|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
161000050|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
161268213|NCT02799095|582366771|FG009|Part A|Adverse Event|0|||
161268214|NCT02799095|582366772|FG010|Part A|Adverse Event|0|||
161268215|NCT02799095|582366773|FG011|Part A|Adverse Event|0|||
161268216|NCT02799095|582366774|FG012|Part A|Adverse Event|0|||
161268217|NCT02799095|582366775|FG013|Part A|Adverse Event|0|||
161268218|NCT02799095|582366776|FG014|Part A|Adverse Event|0|||
161268219|NCT02799095|582366777|FG015|Part A|Adverse Event|0|||
161268220|NCT02799095|582366778|FG016|Part A|Adverse Event|0|||
161268221|NCT02799095|582366762|FG000|Part A|Death|0|||
161268222|NCT02799095|582366763|FG001|Part A|Death|0|||
161268223|NCT02799095|582366764|FG002|Part A|Death|0|||
161268224|NCT02799095|582366765|FG003|Part A|Death|0|||
161268225|NCT02799095|582366766|FG004|Part A|Death|0|||
161268226|NCT02799095|582366767|FG005|Part A|Death|0|||
161268227|NCT02799095|582366768|FG006|Part A|Death|3|||
161268228|NCT02799095|582366769|FG007|Part A|Death|0|||
161268229|NCT02799095|582366770|FG008|Part A|Death|0|||
161268230|NCT02799095|582366771|FG009|Part A|Death|0|||
161268231|NCT02799095|582366772|FG010|Part A|Death|0|||
161268232|NCT02799095|582366773|FG011|Part A|Death|0|||
161268233|NCT02799095|582366774|FG012|Part A|Death|0|||
161268234|NCT02799095|582366775|FG013|Part A|Death|0|||
161268235|NCT02799095|582366776|FG014|Part A|Death|0|||
161268236|NCT02799095|582366777|FG015|Part A|Death|0|||
161268237|NCT02799095|582366778|FG016|Part A|Death|0|||
161268238|NCT02799095|582366762|FG000|Part A|Lost to Follow-up|0|||
161268239|NCT02799095|582366763|FG001|Part A|Lost to Follow-up|1|||
161268240|NCT02799095|582366764|FG002|Part A|Lost to Follow-up|0|||
161268241|NCT02799095|582366765|FG003|Part A|Lost to Follow-up|0|||
161268242|NCT02799095|582366766|FG004|Part A|Lost to Follow-up|0|||
161268243|NCT02799095|582366767|FG005|Part A|Lost to Follow-up|0|||
161268244|NCT02799095|582366768|FG006|Part A|Lost to Follow-up|1|||
161268245|NCT02799095|582366769|FG007|Part A|Lost to Follow-up|0|||
160862433|NCT02059278|580889736|FG000|Overall Study|Lost to Follow-up|1|||
160862434|NCT02059278|580889737|FG001|Overall Study|Lost to Follow-up|0|||
160862435|NCT02059278|580889736|FG000|Overall Study|Withdrawal by Subject|0|||
160862436|NCT02059278|580889737|FG001|Overall Study|Withdrawal by Subject|3|||
160862437|NCT02059278|580889736|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
160862438|NCT02059278|580889737|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
160862439|NCT00829426|580889738|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
160862440|NCT00829426|580889739|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
160862441|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
160862442|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
160862443|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
160862444|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
160862445|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Adverse Event|2|||
160862446|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Adverse Event|5|||
160862447|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Adverse Event|1|||
160862448|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Adverse Event|2|||
160862449|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Death|13|||
160862450|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Death|17|||
160862451|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Death|1|||
160862452|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Death|0|||
160862453|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
160862454|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
160862455|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
160862456|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
160862457|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Disease Progression|2|||
160862458|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Disease Progression|0|||
160862459|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Disease Progression|0|||
161268246|NCT02799095|582366770|FG008|Part A|Lost to Follow-up|0|||
161268247|NCT02799095|582366771|FG009|Part A|Lost to Follow-up|0|||
161268248|NCT02799095|582366772|FG010|Part A|Lost to Follow-up|0|||
161268249|NCT02799095|582366773|FG011|Part A|Lost to Follow-up|0|||
161268250|NCT02799095|582366774|FG012|Part A|Lost to Follow-up|0|||
160949549|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
160949550|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
160949551|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
160949552|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
160949553|NCT03238001|581203132|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
160949554|NCT03149328|581203138|FG000|Overall Study|Withdrawal by Subject|30|||
160949555|NCT03149328|581203139|FG001|Overall Study|Withdrawal by Subject|26|||
160949556|NCT03149328|581203138|FG000|Overall Study|Changed Dialysis Modality|18|||
160949557|NCT03149328|581203139|FG001|Overall Study|Changed Dialysis Modality|1|||
160949558|NCT03149328|581203138|FG000|Overall Study|Transplant|9|||
160949559|NCT03149328|581203139|FG001|Overall Study|Transplant|1|||
160949560|NCT03149328|581203138|FG000|Overall Study|Lost to Follow-up|25|||
160949561|NCT03149328|581203139|FG001|Overall Study|Lost to Follow-up|16|||
160949562|NCT03149328|581203138|FG000|Overall Study|Left Study Site|1|||
160949563|NCT03149328|581203139|FG001|Overall Study|Left Study Site|2|||
160949564|NCT03149328|581203138|FG000|Overall Study|Language Barrier|1|||
160949565|NCT03149328|581203139|FG001|Overall Study|Language Barrier|0|||
160949566|NCT01110239|581203140|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
160949567|NCT01110239|581203141|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
160949568|NCT01110239|581203142|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
160949569|NCT01110239|581203143|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
160949570|NCT01110239|581203140|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
160949571|NCT01110239|581203141|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
160949572|NCT01110239|581203142|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
160949573|NCT01110239|581203143|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
160949574|NCT00080223|581203148|FG000|Overall Study|Adverse Event|23|||
160949575|NCT00080223|581203148|FG000|Overall Study|Death|21|||
160949576|NCT00080223|581203148|FG000|Overall Study|Withdrawal by Subject|13|||
160949577|NCT00080223|581203148|FG000|Overall Study|Lung Transplantation|9|||
160949578|NCT00080223|581203148|FG000|Overall Study|Non-compliance With Study Treatment|7|||
160949579|NCT00080223|581203148|FG000|Overall Study|Participant unwilling to continue|2|||
160949580|NCT00080223|581203148|FG000|Overall Study|Physician Decision|1|||
161000051|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
161000052|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
161000053|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
161000054|NCT03743246|581384963|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
161000055|NCT03743246|581384964|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161000056|NCT03743246|581384965|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161000057|NCT03743246|581384966|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
161000058|NCT00395018|581384967|FG000|On-Treatment|Death|4|||
161000059|NCT00395018|581384967|FG000|On-Treatment|Other Reason|2|||
161000060|NCT00395018|581384967|FG000|On-Treatment|Poor/non-compliance|2|||
161000061|NCT00395018|581384967|FG000|On-Treatment|Subject no longer meets study criteria|2|||
161000062|NCT00395018|581384967|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
161000063|NCT00395018|581384967|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
161000064|NCT00395018|581384967|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
161000065|NCT04439799|581384968|FG000|Overall Study|Lost to Follow-up|6|||
161000066|NCT04439799|581384969|FG001|Overall Study|Lost to Follow-up|6|||
161000067|NCT04439799|581384968|FG000|Overall Study|Withdrawal by Subject|2|||
161000068|NCT04439799|581384969|FG001|Overall Study|Withdrawal by Subject|6|||
161000069|NCT04439799|581384968|FG000|Overall Study|Adverse Event|2|||
161000070|NCT04439799|581384969|FG001|Overall Study|Adverse Event|5|||
161000071|NCT00371566|581384970|FG000|Treatment Phase|Withdrawal by Subject|0|||
161000072|NCT00371566|581384971|FG001|Treatment Phase|Withdrawal by Subject|1|||
161000073|NCT00371566|581384970|FG000|Treatment Phase|Adverse Event|0|||
161000074|NCT00371566|581384971|FG001|Treatment Phase|Adverse Event|1|||
161000075|NCT00371566|581384970|FG000|Treatment Phase|Protocol Violation|0|||
161000076|NCT00371566|581384971|FG001|Treatment Phase|Protocol Violation|1|||
161000077|NCT00371566|581384970|FG000|Chemoradiation Phase|Physician Decision|2|||
161000078|NCT00371566|581384971|FG001|Chemoradiation Phase|Physician Decision|0|||
161268251|NCT02799095|582366775|FG013|Part A|Lost to Follow-up|0|||
161268252|NCT02799095|582366776|FG014|Part A|Lost to Follow-up|0|||
161268253|NCT02799095|582366777|FG015|Part A|Lost to Follow-up|0|||
161268254|NCT02799095|582366778|FG016|Part A|Lost to Follow-up|0|||
161268255|NCT02799095|582366762|FG000|Part A|Progressive Disease|3|||
161268256|NCT02799095|582366763|FG001|Part A|Progressive Disease|3|||
161268257|NCT02799095|582366764|FG002|Part A|Progressive Disease|3|||
161268258|NCT02799095|582366765|FG003|Part A|Progressive Disease|2|||
161268259|NCT02799095|582366766|FG004|Part A|Progressive Disease|2|||
161268260|NCT02799095|582366767|FG005|Part A|Progressive Disease|0|||
161000079|NCT00371566|581384970|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
161000080|NCT00371566|581384971|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
161000081|NCT00371566|581384970|FG000|Chemoradiation Phase|Non compliant|0|||
161268261|NCT02799095|582366768|FG006|Part A|Progressive Disease|0|||
161268262|NCT02799095|582366769|FG007|Part A|Progressive Disease|0|||
161000082|NCT00371566|581384971|FG001|Chemoradiation Phase|Non compliant|1|||
161000083|NCT00371566|581384970|FG000|Chemoradiation Phase|Progressive Disease|1|||
161000084|NCT00371566|581384971|FG001|Chemoradiation Phase|Progressive Disease|1|||
161000085|NCT00371566|581384970|FG000|Chemoradiation Phase|Death|2|||
161000086|NCT00371566|581384971|FG001|Chemoradiation Phase|Death|0|||
161000087|NCT00371566|581384970|FG000|Follow Up Phase|Death|0|||
161268263|NCT02799095|582366770|FG008|Part A|Progressive Disease|0|||
161268264|NCT02799095|582366771|FG009|Part A|Progressive Disease|0|||
161268265|NCT02799095|582366772|FG010|Part A|Progressive Disease|0|||
161268266|NCT02799095|582366773|FG011|Part A|Progressive Disease|0|||
161268267|NCT02799095|582366774|FG012|Part A|Progressive Disease|0|||
161268268|NCT02799095|582366775|FG013|Part A|Progressive Disease|0|||
161268269|NCT02799095|582366776|FG014|Part A|Progressive Disease|0|||
161268270|NCT02799095|582366777|FG015|Part A|Progressive Disease|0|||
161268271|NCT02799095|582366778|FG016|Part A|Progressive Disease|0|||
161268272|NCT02799095|582366762|FG000|Part A|Clinical Progression|1|||
161268273|NCT02799095|582366763|FG001|Part A|Clinical Progression|0|||
161268274|NCT02799095|582366764|FG002|Part A|Clinical Progression|2|||
161268275|NCT02799095|582366765|FG003|Part A|Clinical Progression|1|||
161268276|NCT02799095|582366766|FG004|Part A|Clinical Progression|5|||
161268277|NCT02799095|582366767|FG005|Part A|Clinical Progression|0|||
161268278|NCT02799095|582366768|FG006|Part A|Clinical Progression|0|||
161268279|NCT02799095|582366769|FG007|Part A|Clinical Progression|0|||
161268280|NCT02799095|582366770|FG008|Part A|Clinical Progression|0|||
161268281|NCT02799095|582366771|FG009|Part A|Clinical Progression|0|||
161268282|NCT02799095|582366772|FG010|Part A|Clinical Progression|0|||
161268283|NCT02799095|582366773|FG011|Part A|Clinical Progression|0|||
161342751|NCT03507790|582642246|FG000|Overall Study|Discontinuation of the trial at the site|1|||
161342752|NCT03507790|582642247|FG001|Overall Study|Discontinuation of the trial at the site|1|||
161342753|NCT03507790|582642248|FG002|Overall Study|Discontinuation of the trial at the site|0|||
161145109|NCT05593432|581914044|FG002|16-Week OLE Period|Lost to Follow-up|1|||
161268284|NCT02799095|582366774|FG012|Part A|Clinical Progression|0|||
161268285|NCT02799095|582366775|FG013|Part A|Clinical Progression|0|||
161268286|NCT02799095|582366776|FG014|Part A|Clinical Progression|0|||
161268287|NCT02799095|582366777|FG015|Part A|Clinical Progression|0|||
161268288|NCT02799095|582366778|FG016|Part A|Clinical Progression|0|||
161268289|NCT02799095|582366762|FG000|Part A|Protocol Deviation|0|||
160862460|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Disease Progression|0|||
160862461|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
160862462|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
160862463|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
160862464|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
160862465|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
160862466|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
160862467|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
160862468|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
160862469|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
160862470|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
160862471|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
160862472|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
160862473|NCT03955146|580889740|FG000|DB Period (48 Weeks)|Participant Decision|9|||
160862474|NCT03955146|580889741|FG001|DB Period (48 Weeks)|Participant Decision|12|||
160862475|NCT03955146|580889742|FG002|DB Period (48 Weeks)|Participant Decision|1|||
160862476|NCT03955146|580889743|FG003|DB Period (48 Weeks)|Participant Decision|1|||
160862477|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
160862478|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
160862479|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
160862480|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
160862481|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
160862482|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
160862483|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
160862484|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
160862485|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
160862486|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
160862487|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
160862488|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
160862489|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
160862490|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
160862491|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
160862492|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
160862493|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
160862494|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
160862495|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
161268290|NCT02799095|582366763|FG001|Part A|Protocol Deviation|0|||
161268291|NCT02799095|582366764|FG002|Part A|Protocol Deviation|1|||
161268292|NCT02799095|582366765|FG003|Part A|Protocol Deviation|0|||
161268293|NCT02799095|582366766|FG004|Part A|Protocol Deviation|0|||
161268294|NCT02799095|582366767|FG005|Part A|Protocol Deviation|0|||
161268295|NCT02799095|582366768|FG006|Part A|Protocol Deviation|0|||
161268296|NCT02799095|582366769|FG007|Part A|Protocol Deviation|0|||
161268297|NCT02799095|582366770|FG008|Part A|Protocol Deviation|0|||
161268298|NCT02799095|582366771|FG009|Part A|Protocol Deviation|0|||
161268299|NCT02799095|582366772|FG010|Part A|Protocol Deviation|0|||
161268300|NCT02799095|582366773|FG011|Part A|Protocol Deviation|0|||
161268301|NCT02799095|582366774|FG012|Part A|Protocol Deviation|0|||
161268302|NCT02799095|582366775|FG013|Part A|Protocol Deviation|0|||
161268303|NCT02799095|582366776|FG014|Part A|Protocol Deviation|0|||
161268304|NCT02799095|582366777|FG015|Part A|Protocol Deviation|0|||
161268305|NCT02799095|582366778|FG016|Part A|Protocol Deviation|0|||
161268306|NCT02799095|582366762|FG000|Part A|Withdrawal by Subject|0|||
161268307|NCT02799095|582366763|FG001|Part A|Withdrawal by Subject|0|||
161268308|NCT02799095|582366764|FG002|Part A|Withdrawal by Subject|0|||
161268309|NCT02799095|582366765|FG003|Part A|Withdrawal by Subject|1|||
161268310|NCT02799095|582366766|FG004|Part A|Withdrawal by Subject|3|||
161268311|NCT02799095|582366767|FG005|Part A|Withdrawal by Subject|1|||
161268312|NCT02799095|582366768|FG006|Part A|Withdrawal by Subject|1|||
161268313|NCT02799095|582366769|FG007|Part A|Withdrawal by Subject|0|||
161268314|NCT02799095|582366770|FG008|Part A|Withdrawal by Subject|0|||
161268315|NCT02799095|582366771|FG009|Part A|Withdrawal by Subject|0|||
161268316|NCT02799095|582366772|FG010|Part A|Withdrawal by Subject|0|||
161268317|NCT02799095|582366773|FG011|Part A|Withdrawal by Subject|0|||
161268318|NCT02799095|582366774|FG012|Part A|Withdrawal by Subject|0|||
161268319|NCT02799095|582366775|FG013|Part A|Withdrawal by Subject|0|||
161268320|NCT02799095|582366776|FG014|Part A|Withdrawal by Subject|0|||
161268321|NCT02799095|582366777|FG015|Part A|Withdrawal by Subject|0|||
161268322|NCT02799095|582366778|FG016|Part A|Withdrawal by Subject|0|||
161268323|NCT02799095|582366762|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
161268324|NCT02799095|582366763|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
161268325|NCT02799095|582366764|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
161268326|NCT02799095|582366765|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
161268327|NCT02799095|582366766|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
161268328|NCT02799095|582366767|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
161268329|NCT02799095|582366768|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
161268330|NCT02799095|582366769|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
161268331|NCT02799095|582366770|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
161268332|NCT02799095|582366771|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
161268333|NCT02799095|582366772|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
161268334|NCT02799095|582366773|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
161268335|NCT02799095|582366774|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
161268336|NCT02799095|582366775|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
161268337|NCT02799095|582366776|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
161268338|NCT02799095|582366777|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
161268339|NCT02799095|582366778|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
161268340|NCT02799095|582366762|FG000|Part B|Death|0|||
161268341|NCT02799095|582366763|FG001|Part B|Death|0|||
161268342|NCT02799095|582366764|FG002|Part B|Death|0|||
161268343|NCT02799095|582366765|FG003|Part B|Death|0|||
161268344|NCT02799095|582366766|FG004|Part B|Death|0|||
161268345|NCT02799095|582366767|FG005|Part B|Death|0|||
161268346|NCT02799095|582366768|FG006|Part B|Death|0|||
161268347|NCT02799095|582366769|FG007|Part B|Death|7|||
161268348|NCT02799095|582366770|FG008|Part B|Death|7|||
161268349|NCT02799095|582366771|FG009|Part B|Death|0|||
161268350|NCT02799095|582366772|FG010|Part B|Death|0|||
161268351|NCT02799095|582366773|FG011|Part B|Death|0|||
161342754|NCT03507790|582642246|FG000|Overall Study|Randomized in error|0|||
161342755|NCT03507790|582642247|FG001|Overall Study|Randomized in error|0|||
161342756|NCT03507790|582642248|FG002|Overall Study|Randomized in error|1|||
161268352|NCT02799095|582366774|FG012|Part B|Death|0|||
161268353|NCT02799095|582366775|FG013|Part B|Death|0|||
161268354|NCT02799095|582366776|FG014|Part B|Death|0|||
161268355|NCT02799095|582366777|FG015|Part B|Death|0|||
161268356|NCT02799095|582366778|FG016|Part B|Death|0|||
161268357|NCT02799095|582366762|FG000|Part B|Progressive Disease|0|||
161268358|NCT02799095|582366763|FG001|Part B|Progressive Disease|0|||
161268359|NCT02799095|582366764|FG002|Part B|Progressive Disease|0|||
161268360|NCT02799095|582366765|FG003|Part B|Progressive Disease|0|||
161268361|NCT02799095|582366766|FG004|Part B|Progressive Disease|0|||
161268362|NCT02799095|582366767|FG005|Part B|Progressive Disease|0|||
161268363|NCT02799095|582366768|FG006|Part B|Progressive Disease|0|||
161268364|NCT02799095|582366769|FG007|Part B|Progressive Disease|1|||
160949581|NCT00791765|581204893|FG000|Weeks 1 to 12|Adverse Event|0|||
160949582|NCT00791765|581204894|FG001|Weeks 1 to 12|Adverse Event|1|||
160949583|NCT00791765|581204893|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
160949584|NCT00791765|581204894|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
160949585|NCT00791765|581204893|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
161268365|NCT02799095|582366770|FG008|Part B|Progressive Disease|0|||
161268366|NCT02799095|582366771|FG009|Part B|Progressive Disease|0|||
160949586|NCT00791765|581204894|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
160949587|NCT00791765|581204893|FG000|Weeks 1 to 12|Physician Decision|1|||
160949588|NCT00791765|581204894|FG001|Weeks 1 to 12|Physician Decision|0|||
160949589|NCT00791765|581204893|FG000|Weeks 1 to 12|Disease progression|3|||
160949590|NCT00791765|581204894|FG001|Weeks 1 to 12|Disease progression|0|||
160949591|NCT00791765|581204893|FG000|Weeks 1 to 12|Ineligibility determined|0|||
160949592|NCT00791765|581204894|FG001|Weeks 1 to 12|Ineligibility determined|3|||
160949593|NCT00791765|581204893|FG000|Weeks 13 to 24|Protocol deviation|2|||
160949594|NCT00791765|581204894|FG001|Weeks 13 to 24|Protocol deviation|0|||
160949595|NCT00791765|581204893|FG000|Weeks 13 to 24|Adverse Event|0|||
160949596|NCT00791765|581204894|FG001|Weeks 13 to 24|Adverse Event|3|||
160949597|NCT00791765|581204893|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
160949598|NCT00791765|581204894|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
160949599|NCT00791765|581204893|FG000|Weeks 13 to 24|Disease progression|0|||
160949600|NCT00791765|581204894|FG001|Weeks 13 to 24|Disease progression|1|||
160949601|NCT00791765|581204893|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
161268367|NCT02799095|582366772|FG010|Part B|Progressive Disease|0|||
160949602|NCT00791765|581204894|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
160949603|NCT00791765|581204893|FG000|Weeks 13 to 24|Other|0|||
160949604|NCT00791765|581204894|FG001|Weeks 13 to 24|Other|1|||
160949605|NCT04537923|581204895|FG000|Overall Study|Adverse Event|2|||
160949606|NCT04537923|581204896|FG001|Overall Study|Adverse Event|1|||
160949607|NCT04537923|581204897|FG002|Overall Study|Adverse Event|2|||
160949608|NCT04537923|581204898|FG003|Overall Study|Adverse Event|4|||
160949609|NCT04537923|581204895|FG000|Overall Study|Death|3|||
160949610|NCT04537923|581204896|FG001|Overall Study|Death|3|||
160949611|NCT04537923|581204897|FG002|Overall Study|Death|1|||
160949612|NCT04537923|581204898|FG003|Overall Study|Death|11|||
160949613|NCT04537923|581204895|FG000|Overall Study|Lost to Follow-up|1|||
160949614|NCT04537923|581204896|FG001|Overall Study|Lost to Follow-up|2|||
160949615|NCT04537923|581204897|FG002|Overall Study|Lost to Follow-up|1|||
160949616|NCT04537923|581204898|FG003|Overall Study|Lost to Follow-up|6|||
160949617|NCT04537923|581204895|FG000|Overall Study|Physician Decision|1|||
160949618|NCT04537923|581204896|FG001|Overall Study|Physician Decision|0|||
160949619|NCT04537923|581204897|FG002|Overall Study|Physician Decision|2|||
160949620|NCT04537923|581204898|FG003|Overall Study|Physician Decision|5|||
160949621|NCT04537923|581204895|FG000|Overall Study|Pregnancy|1|||
160949622|NCT04537923|581204896|FG001|Overall Study|Pregnancy|0|||
160949623|NCT04537923|581204897|FG002|Overall Study|Pregnancy|0|||
160949624|NCT04537923|581204898|FG003|Overall Study|Pregnancy|0|||
160949625|NCT04537923|581204895|FG000|Overall Study|Withdrawal by Subject|4|||
160949626|NCT04537923|581204896|FG001|Overall Study|Withdrawal by Subject|4|||
160949627|NCT04537923|581204897|FG002|Overall Study|Withdrawal by Subject|4|||
160949628|NCT04537923|581204898|FG003|Overall Study|Withdrawal by Subject|58|||
160949629|NCT04537923|581204895|FG000|Overall Study|Missed study visits|2|||
160949630|NCT04537923|581204896|FG001|Overall Study|Missed study visits|0|||
160949631|NCT04537923|581204897|FG002|Overall Study|Missed study visits|0|||
160949632|NCT04537923|581204898|FG003|Overall Study|Missed study visits|3|||
160949633|NCT04537923|581204895|FG000|Overall Study|Sponsor's decision|0|||
160949634|NCT04537923|581204896|FG001|Overall Study|Sponsor's decision|0|||
160949635|NCT04537923|581204897|FG002|Overall Study|Sponsor's decision|1|||
160949636|NCT04537923|581204898|FG003|Overall Study|Sponsor's decision|1|||
160949637|NCT04537923|581204895|FG000|Overall Study|Safety reasons|1|||
160949638|NCT04537923|581204896|FG001|Overall Study|Safety reasons|0|||
160949639|NCT04537923|581204897|FG002|Overall Study|Safety reasons|0|||
160949640|NCT04537923|581204898|FG003|Overall Study|Safety reasons|0|||
160949641|NCT01261611|581204899|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
160949642|NCT01261611|581204900|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
160949643|NCT01261611|581204901|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
160949644|NCT01261611|581204899|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
160949645|NCT01261611|581204900|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
160949646|NCT01261611|581204901|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
160949647|NCT01261611|581204899|FG000|Treatment Cycle 1|Adverse Event|0|||
160949648|NCT01261611|581204900|FG001|Treatment Cycle 1|Adverse Event|1|||
160949649|NCT01261611|581204901|FG002|Treatment Cycle 1|Adverse Event|0|||
160949650|NCT01261611|581204899|FG000|Treatment Cycle 1|Protocol Violation|0|||
160949651|NCT01261611|581204900|FG001|Treatment Cycle 1|Protocol Violation|0|||
161268368|NCT02799095|582366773|FG011|Part B|Progressive Disease|0|||
160949652|NCT01261611|581204901|FG002|Treatment Cycle 1|Protocol Violation|2|||
160949653|NCT01261611|581204899|FG000|Treatment Cycle 2|Completed study|4|||
160949654|NCT01261611|581204900|FG001|Treatment Cycle 2|Completed study|0|||
160949655|NCT01261611|581204901|FG002|Treatment Cycle 2|Completed study|0|||
160949656|NCT01261611|581204899|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
161268369|NCT02799095|582366774|FG012|Part B|Progressive Disease|0|||
160949657|NCT01261611|581204900|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
160949658|NCT01261611|581204901|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
160949659|NCT01261611|581204899|FG000|Treatment Cycle 2|Adverse Event|1|||
160949660|NCT01261611|581204900|FG001|Treatment Cycle 2|Adverse Event|0|||
160949661|NCT01261611|581204901|FG002|Treatment Cycle 2|Adverse Event|0|||
160949662|NCT01261611|581204899|FG000|Treatment Cycle 2|Protocol Violation|2|||
160949663|NCT01261611|581204900|FG001|Treatment Cycle 2|Protocol Violation|0|||
160949664|NCT01261611|581204901|FG002|Treatment Cycle 2|Protocol Violation|0|||
160949665|NCT01261611|581204899|FG000|Treatment Cycle 2|Not otherwise specified|2|||
160949666|NCT01261611|581204900|FG001|Treatment Cycle 2|Not otherwise specified|0|||
160949667|NCT01261611|581204901|FG002|Treatment Cycle 2|Not otherwise specified|0|||
160949668|NCT01261611|581204899|FG000|Treatment Cycle 3|Completed study|24|||
160949669|NCT01261611|581204900|FG001|Treatment Cycle 3|Completed study|0|||
160949670|NCT01261611|581204901|FG002|Treatment Cycle 3|Completed study|0|||
160949671|NCT01261611|581204899|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
160949672|NCT01261611|581204900|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
160949673|NCT01261611|581204901|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
161268370|NCT02799095|582366775|FG013|Part B|Progressive Disease|0|||
161268371|NCT02799095|582366776|FG014|Part B|Progressive Disease|0|||
161268372|NCT02799095|582366777|FG015|Part B|Progressive Disease|0|||
161268373|NCT02799095|582366778|FG016|Part B|Progressive Disease|0|||
161268374|NCT02799095|582366762|FG000|Part B|Withdrawal by Subject|0|||
161268375|NCT02799095|582366763|FG001|Part B|Withdrawal by Subject|0|||
161268376|NCT02799095|582366764|FG002|Part B|Withdrawal by Subject|0|||
161268377|NCT02799095|582366765|FG003|Part B|Withdrawal by Subject|0|||
161268378|NCT02799095|582366766|FG004|Part B|Withdrawal by Subject|0|||
161268379|NCT02799095|582366767|FG005|Part B|Withdrawal by Subject|0|||
160949674|NCT01261611|581204899|FG000|Treatment Cycle 3|Adverse Event|1|||
160949675|NCT01261611|581204900|FG001|Treatment Cycle 3|Adverse Event|0|||
160949676|NCT01261611|581204901|FG002|Treatment Cycle 3|Adverse Event|0|||
160949677|NCT01261611|581204899|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
160949678|NCT01261611|581204900|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
160949679|NCT01261611|581204901|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
160949680|NCT01261611|581204899|FG000|Treatment Cycle 4|Completed study|87|||
160949681|NCT01261611|581204900|FG001|Treatment Cycle 4|Completed study|0|||
160949682|NCT01261611|581204901|FG002|Treatment Cycle 4|Completed study|0|||
160949683|NCT01261611|581204899|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
160949684|NCT01261611|581204900|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
160949685|NCT01261611|581204901|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
160949686|NCT01261611|581204899|FG000|Treatment Cycle 4|Adverse Event|1|||
160949687|NCT01261611|581204900|FG001|Treatment Cycle 4|Adverse Event|0|||
160949688|NCT01261611|581204901|FG002|Treatment Cycle 4|Adverse Event|0|||
160949689|NCT01261611|581204899|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
160949690|NCT01261611|581204900|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
160949691|NCT01261611|581204901|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
160949692|NCT01261611|581204899|FG000|Treatment Cycle 4|Not otherwise specified|3|||
160949693|NCT01261611|581204900|FG001|Treatment Cycle 4|Not otherwise specified|0|||
160949694|NCT01261611|581204901|FG002|Treatment Cycle 4|Not otherwise specified|0|||
160949695|NCT01261611|581204899|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
160949696|NCT01261611|581204900|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
160949697|NCT01261611|581204901|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
160949698|NCT01261611|581204899|FG000|Treatment Cycle 5|Adverse Event|1|||
160949699|NCT01261611|581204900|FG001|Treatment Cycle 5|Adverse Event|0|||
160949700|NCT01261611|581204901|FG002|Treatment Cycle 5|Adverse Event|0|||
160949701|NCT01261611|581204899|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
160949702|NCT01261611|581204900|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
160949703|NCT01261611|581204901|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
160949704|NCT02527798|581204902|FG000|Overall Study|Physician Decision|1|||
160949705|NCT02527798|581204903|FG001|Overall Study|Physician Decision|0|||
160949706|NCT02527798|581204904|FG002|Overall Study|Physician Decision|1|||
160949707|NCT02527798|581204905|FG003|Overall Study|Physician Decision|1|||
160949708|NCT02527798|581204906|FG004|Overall Study|Physician Decision|0|||
160949709|NCT02527798|581204907|FG005|Overall Study|Physician Decision|0|||
160949710|NCT02527798|581204902|FG000|Overall Study|Death|0|||
160949711|NCT02527798|581204903|FG001|Overall Study|Death|0|||
160949712|NCT02527798|581204904|FG002|Overall Study|Death|1|||
160949713|NCT02527798|581204905|FG003|Overall Study|Death|0|||
161000088|NCT00371566|581384971|FG001|Follow Up Phase|Death|5|||
161000089|NCT00371566|581384970|FG000|Follow Up Phase|Disease progression|1|||
161268380|NCT02799095|582366768|FG006|Part B|Withdrawal by Subject|0|||
161268381|NCT02799095|582366769|FG007|Part B|Withdrawal by Subject|10|||
161268382|NCT02799095|582366770|FG008|Part B|Withdrawal by Subject|7|||
161268383|NCT02799095|582366771|FG009|Part B|Withdrawal by Subject|0|||
160949714|NCT02527798|581204906|FG004|Overall Study|Death|0|||
160949715|NCT02527798|581204907|FG005|Overall Study|Death|0|||
160949716|NCT02527798|581204902|FG000|Overall Study|Withdrawal by Subject|0|||
160949717|NCT02527798|581204903|FG001|Overall Study|Withdrawal by Subject|1|||
160949718|NCT02527798|581204904|FG002|Overall Study|Withdrawal by Subject|2|||
160949719|NCT02527798|581204905|FG003|Overall Study|Withdrawal by Subject|0|||
160949720|NCT02527798|581204906|FG004|Overall Study|Withdrawal by Subject|0|||
160949721|NCT02527798|581204907|FG005|Overall Study|Withdrawal by Subject|0|||
161268384|NCT02799095|582366772|FG010|Part B|Withdrawal by Subject|0|||
161268385|NCT02799095|582366773|FG011|Part B|Withdrawal by Subject|0|||
160949722|NCT02527798|581204902|FG000|Overall Study|Reason undisclosed|1|||
160949723|NCT02527798|581204903|FG001|Overall Study|Reason undisclosed|0|||
161145110|NCT05593432|581914045|FG003|16-Week OLE Period|Lost to Follow-up|2|||
161145111|NCT05593432|581914042|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
161145112|NCT05593432|581914043|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
161145113|NCT05593432|581914044|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
161145114|NCT05593432|581914045|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
161145115|NCT00857246|581914048|FG000|Induction Regimen|Adverse Event|1|||
161145116|NCT00857246|581914048|FG000|Induction Regimen|disease-related complications|1|||
161145117|NCT00857246|581914048|FG000|Induction Regimen|Withdrawal by Subject|1|||
161145118|NCT00857246|581914048|FG000|Surgery (Curative)|disease progression|6|||
161145119|NCT00857246|581914048|FG000|ChemoRT|Withdrawal by Subject|1|||
161145120|NCT00857246|581914048|FG000|ChemoRT|Adverse Event|2|||
161145121|NCT03851510|581914049|FG000|Overall Study|Screen Fail|1|||
161145122|NCT03851510|581914049|FG000|Overall Study|Adverse Event|1|||
161145123|NCT03851510|581914049|FG000|Overall Study|Withdrawal by Subject|1|||
161145124|NCT02426086|581914050|FG000|Overall Study|Death|33|||
161145125|NCT02426086|581914051|FG001|Overall Study|Death|36|||
161145126|NCT02426086|581914050|FG000|Overall Study|Lost to Follow-up|2|||
161145127|NCT02426086|581914051|FG001|Overall Study|Lost to Follow-up|0|||
161145128|NCT02426086|581914050|FG000|Overall Study|Study Terminated by Sponsor|5|||
161145129|NCT02426086|581914051|FG001|Overall Study|Study Terminated by Sponsor|14|||
161145130|NCT02426086|581914050|FG000|Overall Study|Withdrawal by Subject|8|||
161145131|NCT02426086|581914051|FG001|Overall Study|Withdrawal by Subject|9|||
161145132|NCT01287117|581914052|FG000|Overall Study|Adverse Event|2|||
161145133|NCT01287117|581914053|FG001|Overall Study|Adverse Event|1|||
161145134|NCT01287117|581914054|FG002|Overall Study|Adverse Event|1|||
161145135|NCT01287117|581914055|FG003|Overall Study|Adverse Event|1|||
161145136|NCT01287117|581914052|FG000|Overall Study|Lost to Follow-up|1|||
161145137|NCT01287117|581914053|FG001|Overall Study|Lost to Follow-up|1|||
161145138|NCT01287117|581914054|FG002|Overall Study|Lost to Follow-up|0|||
161145139|NCT01287117|581914055|FG003|Overall Study|Lost to Follow-up|0|||
161145140|NCT01287117|581914052|FG000|Overall Study|Physician Decision|0|||
161145141|NCT01287117|581914053|FG001|Overall Study|Physician Decision|1|||
161145142|NCT01287117|581914054|FG002|Overall Study|Physician Decision|1|||
161145143|NCT01287117|581914055|FG003|Overall Study|Physician Decision|1|||
161145144|NCT01287117|581914052|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
161145145|NCT01287117|581914053|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
161145146|NCT01287117|581914054|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
161145147|NCT01287117|581914055|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
161145148|NCT01287117|581914052|FG000|Overall Study|Disease Progression|10|||
161145149|NCT01287117|581914053|FG001|Overall Study|Disease Progression|5|||
161145150|NCT01287117|581914054|FG002|Overall Study|Disease Progression|6|||
161145151|NCT01287117|581914055|FG003|Overall Study|Disease Progression|5|||
161145152|NCT02606877|581914070|FG000|Overall Study|Adverse Event|3|||
161145153|NCT02606877|581914071|FG001|Overall Study|Adverse Event|0|||
161145154|NCT02606877|581914070|FG000|Overall Study|Non-compliance with protocol|0|||
161145155|NCT02606877|581914071|FG001|Overall Study|Non-compliance with protocol|1|||
161145156|NCT02606877|581914070|FG000|Overall Study|Other than listed above|1|||
161145157|NCT02606877|581914071|FG001|Overall Study|Other than listed above|0|||
161145158|NCT00778999|581914072|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
161145159|NCT00778999|581914073|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
161145160|NCT00778999|581914072|FG000|Overall Study|Did not receive recFSH|14|||
161145161|NCT00778999|581914073|FG001|Overall Study|Did not receive recFSH|20|||
161145162|NCT02032524|581914074|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
161145163|NCT02032524|581914075|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
161145164|NCT02032524|581914076|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
161268386|NCT02799095|582366774|FG012|Part B|Withdrawal by Subject|0|||
161268387|NCT02799095|582366775|FG013|Part B|Withdrawal by Subject|0|||
161268388|NCT02799095|582366776|FG014|Part B|Withdrawal by Subject|0|||
161268389|NCT02799095|582366777|FG015|Part B|Withdrawal by Subject|0|||
161145165|NCT02032524|581914077|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
161145166|NCT02032524|581914078|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
161145167|NCT02032524|581914079|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
161145168|NCT02032524|581914074|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161145169|NCT02032524|581914075|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161145170|NCT02032524|581914076|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161145171|NCT02032524|581914077|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
161145172|NCT02032524|581914078|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
161145173|NCT02032524|581914079|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
161145174|NCT02032524|581914074|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
161145175|NCT02032524|581914075|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
161145176|NCT02032524|581914076|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
161268390|NCT02799095|582366778|FG016|Part B|Withdrawal by Subject|0|||
161268391|NCT02799095|582366762|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
161145177|NCT02032524|581914077|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
161145178|NCT02032524|581914078|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
161268392|NCT02799095|582366763|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
161268393|NCT02799095|582366764|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
161000090|NCT00371566|581384971|FG001|Follow Up Phase|Disease progression|0|||
161000091|NCT00371566|581384970|FG000|Follow Up Phase|Withdrawal by Subject|0|||
161000092|NCT00371566|581384971|FG001|Follow Up Phase|Withdrawal by Subject|1|||
161000093|NCT00371566|581384970|FG000|Follow Up Phase|Physician Decision|1|||
161000094|NCT00371566|581384971|FG001|Follow Up Phase|Physician Decision|1|||
161000095|NCT00371566|581384970|FG000|Follow Up Phase|Lost to Follow-up|1|||
161000096|NCT00371566|581384971|FG001|Follow Up Phase|Lost to Follow-up|0|||
161000097|NCT00530842|581384976|FG000|Overall Study|Adverse Event|10|||
161000098|NCT00530842|581384977|FG001|Overall Study|Adverse Event|6|||
161000099|NCT00530842|581384976|FG000|Overall Study|Lack of Efficacy|2|||
161000100|NCT00530842|581384977|FG001|Overall Study|Lack of Efficacy|1|||
161000101|NCT00530842|581384976|FG000|Overall Study|Lost to Follow-up|0|||
161000102|NCT00530842|581384977|FG001|Overall Study|Lost to Follow-up|4|||
161000103|NCT00530842|581384976|FG000|Overall Study|Protocol Violation|3|||
161000104|NCT00530842|581384977|FG001|Overall Study|Protocol Violation|2|||
161000105|NCT00530842|581384976|FG000|Overall Study|Withdrawal by Subject|4|||
161000106|NCT00530842|581384977|FG001|Overall Study|Withdrawal by Subject|5|||
161000107|NCT00530842|581384976|FG000|Overall Study|Individual different reasons|4|||
161000108|NCT00530842|581384977|FG001|Overall Study|Individual different reasons|3|||
161000109|NCT00530842|581384976|FG000|Period 1|Adverse Event|7|||
161000110|NCT00530842|581384977|FG001|Period 1|Adverse Event|3|||
161000111|NCT00530842|581384976|FG000|Period 1|Lack of Efficacy|1|||
161000112|NCT00530842|581384977|FG001|Period 1|Lack of Efficacy|1|||
161000113|NCT00530842|581384976|FG000|Period 1|Protocol Violation|2|||
161000114|NCT00530842|581384977|FG001|Period 1|Protocol Violation|1|||
161000115|NCT00530842|581384976|FG000|Period 1|Withdrawal by Subject|2|||
161000116|NCT00530842|581384977|FG001|Period 1|Withdrawal by Subject|3|||
161000117|NCT00530842|581384976|FG000|Period 1|Individual different reasons|2|||
161000118|NCT00530842|581384977|FG001|Period 1|Individual different reasons|3|||
161000119|NCT00530842|581384976|FG000|Period 2|Adverse Event|3|||
161000120|NCT00530842|581384977|FG001|Period 2|Adverse Event|3|||
161000121|NCT00530842|581384976|FG000|Period 2|Lack of Efficacy|1|||
161000122|NCT00530842|581384977|FG001|Period 2|Lack of Efficacy|0|||
161000123|NCT00530842|581384976|FG000|Period 2|Lost to Follow-up|0|||
161000124|NCT00530842|581384977|FG001|Period 2|Lost to Follow-up|4|||
161000125|NCT00530842|581384976|FG000|Period 2|Protocol Violation|1|||
161000126|NCT00530842|581384977|FG001|Period 2|Protocol Violation|0|||
161000127|NCT00530842|581384976|FG000|Period 2|Withdrawal by Subject|1|||
161000128|NCT00530842|581384977|FG001|Period 2|Withdrawal by Subject|2|||
161000129|NCT00530842|581384976|FG000|Period 2|Individual different reasons|2|||
161000130|NCT00530842|581384977|FG001|Period 2|Individual different reasons|0|||
161000131|NCT03478696|581384993|FG000|Overall Study|Adverse Event|1|||
160949724|NCT02527798|581204904|FG002|Overall Study|Reason undisclosed|1|||
160949725|NCT02527798|581204905|FG003|Overall Study|Reason undisclosed|0|||
160949726|NCT02527798|581204906|FG004|Overall Study|Reason undisclosed|0|||
160949727|NCT02527798|581204907|FG005|Overall Study|Reason undisclosed|0|||
160949728|NCT02527798|581204902|FG000|Overall Study|Did not receive intervention|1|||
160949729|NCT02527798|581204903|FG001|Overall Study|Did not receive intervention|1|||
160949730|NCT02527798|581204904|FG002|Overall Study|Did not receive intervention|0|||
160949731|NCT02527798|581204905|FG003|Overall Study|Did not receive intervention|0|||
160949732|NCT02527798|581204906|FG004|Overall Study|Did not receive intervention|0|||
160949733|NCT02527798|581204907|FG005|Overall Study|Did not receive intervention|0|||
160949734|NCT01808690|581204909|FG000|Overall Study|Withdrawal by Subject|1|||
160949735|NCT01808690|581204910|FG001|Overall Study|Withdrawal by Subject|2|||
160949736|NCT02891187|581204911|FG000|Overall Study|Lost to Follow-up|1|||
160949737|NCT02891187|581204912|FG001|Overall Study|Lost to Follow-up|2|||
160949738|NCT01585103|581204914|FG000|Overall Study|Unable to swallow Cytosponge|6|||
160949739|NCT01349569|581204915|FG000|Overall Study|Lack of Efficacy|4|||
160949740|NCT03581305|581204916|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
160949741|NCT03581305|581204917|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
160949742|NCT03581305|581204916|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
161000132|NCT03478696|581384994|FG001|Overall Study|Adverse Event|5|||
161000133|NCT03478696|581384993|FG000|Overall Study|Lost to Follow-up|1|||
161000134|NCT03478696|581384994|FG001|Overall Study|Lost to Follow-up|0|||
161000135|NCT03478696|581384993|FG000|Overall Study|Physician Decision|6|||
160949743|NCT03581305|581204917|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
160949744|NCT03581305|581204916|FG000|Serotonergic Study|Withdrawal by Subject|5|||
160949745|NCT03581305|581204917|FG001|Serotonergic Study|Withdrawal by Subject|1|||
161000136|NCT03478696|581384994|FG001|Overall Study|Physician Decision|3|||
161000137|NCT03478696|581384993|FG000|Overall Study|Withdrawal by Subject|9|||
161000138|NCT03478696|581384994|FG001|Overall Study|Withdrawal by Subject|4|||
161000139|NCT00741988|581385003|FG000|Overall Study|Adverse Event|2|||
161000140|NCT00741988|581385004|FG001|Overall Study|Adverse Event|4|||
160949746|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
160949747|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
160949748|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
161000141|NCT00741988|581385003|FG000|Overall Study|Lack of Efficacy|2|||
161000142|NCT00741988|581385004|FG001|Overall Study|Lack of Efficacy|0|||
161000143|NCT03863834|581385014|FG000|Overall Study|Lost to Follow-up|3|||
161000144|NCT02685488|581385015|FG000|Overall Study|Withdrawal by Subject|0|||
161000145|NCT02685488|581385016|FG001|Overall Study|Withdrawal by Subject|1|||
161000146|NCT02020616|581385017|FG000|Overall Study|Adverse Event|0|||
161000147|NCT02020616|581385018|FG001|Overall Study|Adverse Event|0|||
161000148|NCT02020616|581385019|FG002|Overall Study|Adverse Event|0|||
161000149|NCT02020616|581385020|FG003|Overall Study|Adverse Event|0|||
161000150|NCT02020616|581385021|FG004|Overall Study|Adverse Event|0|||
161000151|NCT02020616|581385022|FG005|Overall Study|Adverse Event|1|||
161000152|NCT02020616|581385023|FG006|Overall Study|Adverse Event|1|||
161000153|NCT02020616|581385017|FG000|Overall Study|Physician Decision|0|||
161000154|NCT02020616|581385018|FG001|Overall Study|Physician Decision|0|||
161000155|NCT02020616|581385019|FG002|Overall Study|Physician Decision|0|||
161000156|NCT02020616|581385020|FG003|Overall Study|Physician Decision|0|||
161000157|NCT02020616|581385021|FG004|Overall Study|Physician Decision|0|||
161000158|NCT02020616|581385022|FG005|Overall Study|Physician Decision|1|||
161000159|NCT02020616|581385023|FG006|Overall Study|Physician Decision|2|||
161000160|NCT02020616|581385017|FG000|Overall Study|Withdrawal by Subject|0|||
161000161|NCT02020616|581385018|FG001|Overall Study|Withdrawal by Subject|0|||
161000162|NCT02020616|581385019|FG002|Overall Study|Withdrawal by Subject|1|||
161000163|NCT02020616|581385020|FG003|Overall Study|Withdrawal by Subject|0|||
161000164|NCT02020616|581385021|FG004|Overall Study|Withdrawal by Subject|0|||
161000165|NCT02020616|581385022|FG005|Overall Study|Withdrawal by Subject|1|||
161000166|NCT02020616|581385023|FG006|Overall Study|Withdrawal by Subject|1|||
161000167|NCT02020616|581385017|FG000|Overall Study|Lost to Follow-up|0|||
161000168|NCT02020616|581385018|FG001|Overall Study|Lost to Follow-up|1|||
161000169|NCT02020616|581385019|FG002|Overall Study|Lost to Follow-up|0|||
161000170|NCT02020616|581385020|FG003|Overall Study|Lost to Follow-up|1|||
161000171|NCT02020616|581385021|FG004|Overall Study|Lost to Follow-up|1|||
161000172|NCT02020616|581385022|FG005|Overall Study|Lost to Follow-up|1|||
161000173|NCT02020616|581385023|FG006|Overall Study|Lost to Follow-up|0|||
161000174|NCT02020616|581385017|FG000|Overall Study|Early Termination Criteria Met|0|||
161000175|NCT02020616|581385018|FG001|Overall Study|Early Termination Criteria Met|0|||
161000176|NCT02020616|581385019|FG002|Overall Study|Early Termination Criteria Met|1|||
161000177|NCT02020616|581385020|FG003|Overall Study|Early Termination Criteria Met|0|||
161000178|NCT02020616|581385021|FG004|Overall Study|Early Termination Criteria Met|0|||
161000179|NCT02020616|581385022|FG005|Overall Study|Early Termination Criteria Met|1|||
161000180|NCT02020616|581385023|FG006|Overall Study|Early Termination Criteria Met|0|||
161000181|NCT02020616|581385017|FG000|Overall Study|Randomized in Error|0|||
161000182|NCT02020616|581385018|FG001|Overall Study|Randomized in Error|0|||
161000183|NCT02020616|581385019|FG002|Overall Study|Randomized in Error|0|||
161000184|NCT02020616|581385020|FG003|Overall Study|Randomized in Error|1|||
161000185|NCT02020616|581385021|FG004|Overall Study|Randomized in Error|0|||
161000186|NCT02020616|581385022|FG005|Overall Study|Randomized in Error|0|||
161000187|NCT02020616|581385023|FG006|Overall Study|Randomized in Error|0|||
161000188|NCT02020616|581385017|FG000|Overall Study|Lack of Efficacy|0|||
161000189|NCT02020616|581385018|FG001|Overall Study|Lack of Efficacy|0|||
161000190|NCT02020616|581385019|FG002|Overall Study|Lack of Efficacy|0|||
161000191|NCT02020616|581385020|FG003|Overall Study|Lack of Efficacy|0|||
161000192|NCT02020616|581385021|FG004|Overall Study|Lack of Efficacy|1|||
161268394|NCT02799095|582366765|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
161268395|NCT02799095|582366766|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
161268396|NCT02799095|582366767|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
161268397|NCT02799095|582366768|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
161268398|NCT02799095|582366769|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
161000193|NCT02020616|581385022|FG005|Overall Study|Lack of Efficacy|0|||
161000194|NCT02020616|581385023|FG006|Overall Study|Lack of Efficacy|0|||
161000195|NCT05019729|581385024|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161268399|NCT02799095|582366770|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
161268400|NCT02799095|582366771|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
161268401|NCT02799095|582366772|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
161268402|NCT02799095|582366773|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
161000196|NCT05019729|581385025|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000197|NCT05019729|581385026|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000198|NCT05019729|581385027|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000199|NCT05019729|581385028|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
161000200|NCT05019729|581385029|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
161000201|NCT03008915|581385030|FG000|Treatment 1|Withdrawal by Subject|0|||
161000202|NCT03008915|581385031|FG001|Treatment 1|Withdrawal by Subject|1|||
161000203|NCT00712166|581385034|FG000|Overall Study|Noncompliance|0|||
161000204|NCT00712166|581385035|FG001|Overall Study|Noncompliance|1|||
161268403|NCT02799095|582366774|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
161268404|NCT02799095|582366775|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
161000205|NCT01773122|581385036|FG000|Overall Study|Due to amended age eligibility criteria|3|||
161000206|NCT01773122|581385037|FG001|Overall Study|Due to amended age eligibility criteria|1|||
161000207|NCT01773122|581385038|FG002|Overall Study|Due to amended age eligibility criteria|0|||
161000208|NCT01773122|581385039|FG003|Overall Study|Due to amended age eligibility criteria|1|||
161000209|NCT02289560|581385042|FG000|Overall Study|Lost to Follow-up|6|||
161000210|NCT02289560|581385042|FG000|Overall Study|Alternative Treatment|4|||
161000211|NCT02289560|581385042|FG000|Overall Study|Inadequate Treatment|2|||
160949749|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
160949750|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
160949751|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
160949752|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
160949753|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
160949754|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
160949755|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
160949756|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
161000212|NCT02289560|581385042|FG000|Overall Study|Withdrawal by Subject|23|||
161000213|NCT02540213|581385043|FG000|Overall Study|Death/adverse event|18|||
161000214|NCT02540213|581385043|FG000|Overall Study|Administrative reasons|3|||
161000215|NCT02540213|581385043|FG000|Overall Study|Kidney transplant|3|||
161000216|NCT02540213|581385043|FG000|Overall Study|Lack of Efficacy|6|||
161000217|NCT02540213|581385043|FG000|Overall Study|Consent withdrawn|7|||
161000218|NCT02540213|581385043|FG000|Overall Study|Enrolled but not treated|2|||
161000219|NCT01264718|581385044|FG000|Overall Study|Lost to Follow-up|3|||
161000220|NCT01264718|581385045|FG001|Overall Study|Lost to Follow-up|2|||
161000221|NCT01264718|581385044|FG000|Overall Study|Withdrawal by Subject|9|||
161000222|NCT01264718|581385045|FG001|Overall Study|Withdrawal by Subject|15|||
161000223|NCT01264718|581385044|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
161000224|NCT01264718|581385045|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
161000225|NCT02908464|581385046|FG000|Overall Study|Withdrawal by Subject|2|||
161000226|NCT02908464|581385047|FG001|Overall Study|Withdrawal by Subject|1|||
161000227|NCT02908464|581385046|FG000|Overall Study|Found ineligible after randomization|0|||
161000228|NCT02908464|581385047|FG001|Overall Study|Found ineligible after randomization|2|||
161000229|NCT01769391|581385050|FG000|Overall Study|Death|10|||
161000230|NCT01769391|581385051|FG001|Overall Study|Death|1|||
161000231|NCT01769391|581385050|FG000|Overall Study|Adverse Event|0|||
161000232|NCT01769391|581385051|FG001|Overall Study|Adverse Event|3|||
161000233|NCT01769391|581385050|FG000|Overall Study|Progressive Disease|1|||
161000234|NCT01769391|581385051|FG001|Overall Study|Progressive Disease|2|||
161000235|NCT01769391|581385050|FG000|Overall Study|Withdrawal by Subject|4|||
161000236|NCT01769391|581385051|FG001|Overall Study|Withdrawal by Subject|3|||
161000237|NCT01769391|581385050|FG000|Overall Study|Investigator Decision|2|||
161000238|NCT01769391|581385051|FG001|Overall Study|Investigator Decision|0|||
161000239|NCT03386929|581385052|FG000|Overall Study|Death|0|||
161000240|NCT03386929|581385053|FG001|Overall Study|Death|0|||
161000241|NCT03386929|581385054|FG002|Overall Study|Death|1|||
161000242|NCT03386929|581385052|FG000|Overall Study|Withdrawal by Subject|0|||
161000243|NCT03386929|581385053|FG001|Overall Study|Withdrawal by Subject|1|||
161000244|NCT03386929|581385054|FG002|Overall Study|Withdrawal by Subject|0|||
161000245|NCT03386929|581385052|FG000|Overall Study|Physician Decision|0|||
161000246|NCT03386929|581385053|FG001|Overall Study|Physician Decision|0|||
161000247|NCT03386929|581385054|FG002|Overall Study|Physician Decision|1|||
161000248|NCT03386929|581385052|FG000|Overall Study|Progression|4|||
161000249|NCT03386929|581385053|FG001|Overall Study|Progression|4|||
161000250|NCT03386929|581385054|FG002|Overall Study|Progression|0|||
161000251|NCT03386929|581385052|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161000252|NCT03386929|581385053|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161000253|NCT03386929|581385054|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
161000254|NCT03386929|581385052|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
161000255|NCT03386929|581385053|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
161000256|NCT03386929|581385054|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
161000257|NCT03538054|581385055|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
161000258|NCT03538054|581385055|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
161000259|NCT03538054|581385055|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
161000260|NCT02351180|581385058|FG000|Overall Study|Withdrawal by Subject|1|||
161000261|NCT02351180|581385059|FG001|Overall Study|Withdrawal by Subject|0|||
161000262|NCT00208767|581385060|FG000|Overall Study|Adverse Event|9|||
161000263|NCT00208767|581385061|FG001|Overall Study|Adverse Event|1|||
161268405|NCT02799095|582366776|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
160949757|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
161268406|NCT02799095|582366777|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
161000264|NCT00208767|581385060|FG000|Overall Study|Withdrawal by Subject|14|||
161000265|NCT00208767|581385061|FG001|Overall Study|Withdrawal by Subject|3|||
161000266|NCT00208767|581385060|FG000|Overall Study|Death|1|||
161000267|NCT00208767|581385061|FG001|Overall Study|Death|0|||
161000268|NCT00208767|581385060|FG000|Overall Study|Lost to Follow-up|3|||
160949758|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
160949759|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
160949760|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
160949761|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
160949762|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
160949763|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
160949764|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
160949765|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
160949766|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
160949767|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
161000269|NCT00208767|581385061|FG001|Overall Study|Lost to Follow-up|3|||
161000270|NCT02317016|581385062|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
161000271|NCT02317016|581385062|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
161000272|NCT02317016|581385062|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
161000273|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
161000274|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
161000275|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
161000276|NCT02317016|581385062|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
161000277|NCT00536380|581385063|FG000|Overall Study|Adverse Event|0|||
161000278|NCT00536380|581385064|FG001|Overall Study|Adverse Event|2|||
161000279|NCT00536380|581385065|FG002|Overall Study|Adverse Event|2|||
161000280|NCT00536380|581385063|FG000|Overall Study|Lost to Follow-up|0|||
161000281|NCT00536380|581385064|FG001|Overall Study|Lost to Follow-up|0|||
161000282|NCT00536380|581385065|FG002|Overall Study|Lost to Follow-up|1|||
161000283|NCT00536380|581385063|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
161000284|NCT00536380|581385064|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
161000285|NCT00536380|581385065|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
161000286|NCT00536380|581385063|FG000|Overall Study|Withdrawal related to study drug|7|||
161000287|NCT00536380|581385064|FG001|Overall Study|Withdrawal related to study drug|5|||
161000288|NCT00536380|581385065|FG002|Overall Study|Withdrawal related to study drug|2|||
161000289|NCT00536380|581385063|FG000|Overall Study|Noncompliance with protocol|3|||
161000290|NCT00536380|581385064|FG001|Overall Study|Noncompliance with protocol|2|||
161000291|NCT00536380|581385065|FG002|Overall Study|Noncompliance with protocol|2|||
161000292|NCT00536380|581385063|FG000|Overall Study|Did not meet protocol eligibility|0|||
161000293|NCT00536380|581385064|FG001|Overall Study|Did not meet protocol eligibility|0|||
161000294|NCT00536380|581385065|FG002|Overall Study|Did not meet protocol eligibility|1|||
161000295|NCT00536380|581385063|FG000|Overall Study|Administrative|0|||
161000296|NCT00536380|581385064|FG001|Overall Study|Administrative|0|||
161000297|NCT00536380|581385065|FG002|Overall Study|Administrative|1|||
161000298|NCT03545984|581385066|FG000|Overall Study|CSF cases not present during rotation|11|||
161000299|NCT03545984|581385067|FG001|Overall Study|CSF cases not present during rotation|9|||
161000300|NCT00387465|581385068|FG000|Overall Study|Withdrawal by Subject|0|||
161000301|NCT00387465|581385069|FG001|Overall Study|Withdrawal by Subject|1|||
161000302|NCT00387465|581385070|FG002|Overall Study|Withdrawal by Subject|0|||
161000303|NCT03418324|581385071|FG000|Overall Study|Death|0|||
161000304|NCT03418324|581385072|FG001|Overall Study|Death|1|||
161000305|NCT03418324|581385071|FG000|Overall Study|Physician Decision|1|||
161000306|NCT03418324|581385072|FG001|Overall Study|Physician Decision|1|||
161000307|NCT01768676|581385073|FG000|Overall Study|Adverse Event|3|||
161000308|NCT01768676|581385074|FG001|Overall Study|Adverse Event|3|||
161000309|NCT01768676|581385073|FG000|Overall Study|Lost to Follow-up|13|||
161145179|NCT02032524|581914079|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
161145180|NCT02032524|581914074|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161268407|NCT02799095|582366778|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
160862496|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
160862497|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
160862498|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
160862499|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
160862500|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
160862501|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
160862502|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
160862503|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
160862504|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
160862505|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
160862506|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
160862507|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
160862508|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
160949768|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
160862509|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
160949769|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
160949770|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160862510|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
160862511|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
160862512|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
160862513|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
160862514|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
160862515|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
160862516|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
160862517|NCT03955146|580889740|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
160862518|NCT03955146|580889741|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
160862519|NCT03955146|580889742|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
160862520|NCT03955146|580889743|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
160862521|NCT04408989|580889744|FG000|Overall Study|Lost to Follow-up|0|||
160862522|NCT04408989|580889745|FG001|Overall Study|Lost to Follow-up|0|||
160862523|NCT04408989|580889746|FG002|Overall Study|Lost to Follow-up|1|||
160862524|NCT04408989|580889744|FG000|Overall Study|Withdrawal by Subject|0|||
160862525|NCT04408989|580889745|FG001|Overall Study|Withdrawal by Subject|0|||
160862526|NCT04408989|580889746|FG002|Overall Study|Withdrawal by Subject|2|||
160862527|NCT04363320|580889749|FG000|Overall Study|Lost to Follow-up|43|||
160862528|NCT04363320|580889750|FG001|Overall Study|Lost to Follow-up|42|||
160862529|NCT04363320|580889751|FG002|Overall Study|Lost to Follow-up|24|||
160862530|NCT04363320|580889752|FG003|Overall Study|Lost to Follow-up|29|||
160862531|NCT04363320|580889749|FG000|Overall Study|Death|0|||
160862532|NCT04363320|580889750|FG001|Overall Study|Death|0|||
160862533|NCT04363320|580889751|FG002|Overall Study|Death|1|||
160862534|NCT04363320|580889752|FG003|Overall Study|Death|0|||
160862535|NCT00604565|580889756|FG000|Overall Study|Study terminated|0|||
160862536|NCT00604565|580889757|FG001|Overall Study|Study terminated|3|||
161000310|NCT01768676|581385074|FG001|Overall Study|Lost to Follow-up|16|||
161000311|NCT01768676|581385073|FG000|Overall Study|Protocol Violation|1|||
161000312|NCT01768676|581385074|FG001|Overall Study|Protocol Violation|1|||
161000313|NCT01768676|581385073|FG000|Overall Study|Physician Decision|4|||
161000314|NCT01768676|581385074|FG001|Overall Study|Physician Decision|1|||
161000315|NCT01768676|581385073|FG000|Overall Study|Withdrawal by Subject|3|||
161000316|NCT01768676|581385074|FG001|Overall Study|Withdrawal by Subject|10|||
161000317|NCT00605033|581385075|FG000|Overall Study|Adverse Event|2|||
161000318|NCT00605033|581385076|FG001|Overall Study|Adverse Event|2|||
161000319|NCT00605033|581385075|FG000|Overall Study|Lost to Follow-up|1|||
161000320|NCT00605033|581385076|FG001|Overall Study|Lost to Follow-up|1|||
161000321|NCT00605033|581385075|FG000|Overall Study|Withdrawal by Subject|3|||
161000322|NCT00605033|581385076|FG001|Overall Study|Withdrawal by Subject|4|||
161000323|NCT00605033|581385075|FG000|Overall Study|Protocol Violation|1|||
161000324|NCT00605033|581385076|FG001|Overall Study|Protocol Violation|1|||
161000325|NCT03121950|581385079|FG000|Overall Study|Withdrawal by Subject|11|||
161000326|NCT03121950|581385080|FG001|Overall Study|Withdrawal by Subject|2|||
160949771|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949772|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949773|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949774|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949775|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949776|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949777|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949778|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949779|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949780|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949781|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949782|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949783|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161000327|NCT02754479|581385084|FG000|Overall Study|Lost to Follow-up|1|||
161000328|NCT03183518|581385085|FG000|Overall Study|Other (Not specified)|2|||
161000329|NCT03183518|581385085|FG000|Overall Study|Other (Withdrawal of consent)|1|||
160949784|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
160949785|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
161000330|NCT02132702|581385086|FG000|Overall Study|Protocol Violation|2|||
161000331|NCT02132702|581385086|FG000|Overall Study|Adverse Event|3|||
160949786|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949787|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949788|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
161000332|NCT02132702|581385086|FG000|Overall Study|Withdrawal by Subject|3|||
161000333|NCT01244828|581385089|FG000|Overall Study|Adverse Event|37|||
161000334|NCT01244828|581385089|FG000|Overall Study|Withdrawal by Subject|31|||
161000335|NCT01244828|581385089|FG000|Overall Study|Lack of Efficacy|7|||
160862537|NCT02260934|580889767|FG000|Overall Study|Lost to Follow-up|2|||
160862538|NCT02260934|580889768|FG001|Overall Study|Lost to Follow-up|1|||
160862539|NCT02260934|580889767|FG000|Overall Study|Withdrawal by Subject|0|||
161000336|NCT01244828|581385089|FG000|Overall Study|Lost to Follow-up|2|||
160949789|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
160949790|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
160949791|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949792|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949793|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949794|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949795|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949796|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949797|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949798|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949799|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949800|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949801|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949802|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949803|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949804|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949805|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
160949806|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
160949807|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
160949808|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
160949809|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
160949810|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
160949811|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
160949812|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
160949813|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
160949814|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
160949815|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
160949816|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
160949817|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
160949818|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
160949819|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
160949820|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
160949821|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
160949822|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
160949823|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
160949824|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
160949825|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
160949826|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
160949827|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949828|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949829|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949830|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949831|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949832|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949833|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949834|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949835|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949836|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949837|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949838|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949839|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949840|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949841|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949842|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949843|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949844|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949845|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
160949846|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
160949847|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
160949848|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949849|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
160949850|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
160949851|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949852|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949853|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949854|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949855|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
161145181|NCT02032524|581914075|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
161145182|NCT02032524|581914076|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161145183|NCT02032524|581914077|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161145184|NCT02032524|581914078|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
161145185|NCT02032524|581914079|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
161145186|NCT02032524|581914074|FG000|Period 2: LTS13769 Study|Other|0|||
161145187|NCT02032524|581914075|FG001|Period 2: LTS13769 Study|Other|0|||
161145188|NCT02032524|581914076|FG002|Period 2: LTS13769 Study|Other|0|||
161145189|NCT02032524|581914077|FG003|Period 2: LTS13769 Study|Other|0|||
161145190|NCT02032524|581914078|FG004|Period 2: LTS13769 Study|Other|0|||
161145191|NCT02032524|581914079|FG005|Period 2: LTS13769 Study|Other|1|||
161145192|NCT02699515|581915566|FG000|Overall Study|Death|3|||
161145193|NCT02699515|581915567|FG001|Overall Study|Death|3|||
161145194|NCT02699515|581915568|FG002|Overall Study|Death|3|||
161145195|NCT02699515|581915569|FG003|Overall Study|Death|23|||
161145196|NCT02699515|581915570|FG004|Overall Study|Death|22|||
161145197|NCT02699515|581915571|FG005|Overall Study|Death|23|||
161145198|NCT02699515|581915572|FG006|Overall Study|Death|3|||
161145199|NCT02699515|581915573|FG007|Overall Study|Death|5|||
161145200|NCT02699515|581915566|FG000|Overall Study|Withdrawal by Subject|0|||
161145201|NCT02699515|581915567|FG001|Overall Study|Withdrawal by Subject|0|||
161145202|NCT02699515|581915568|FG002|Overall Study|Withdrawal by Subject|3|||
161145203|NCT02699515|581915569|FG003|Overall Study|Withdrawal by Subject|1|||
161145204|NCT02699515|581915570|FG004|Overall Study|Withdrawal by Subject|5|||
161145205|NCT02699515|581915571|FG005|Overall Study|Withdrawal by Subject|3|||
161145206|NCT02699515|581915572|FG006|Overall Study|Withdrawal by Subject|0|||
161145207|NCT02699515|581915573|FG007|Overall Study|Withdrawal by Subject|1|||
161145208|NCT02699515|581915566|FG000|Overall Study|Other|1|||
161145209|NCT02699515|581915567|FG001|Overall Study|Other|0|||
161145210|NCT02699515|581915568|FG002|Overall Study|Other|1|||
161145211|NCT02699515|581915569|FG003|Overall Study|Other|6|||
161145212|NCT02699515|581915570|FG004|Overall Study|Other|4|||
161145213|NCT02699515|581915571|FG005|Overall Study|Other|3|||
161145214|NCT02699515|581915572|FG006|Overall Study|Other|0|||
161145215|NCT02699515|581915573|FG007|Overall Study|Other|0|||
161145216|NCT05243550|581915574|FG000|Overall Study|Ongoing in the Study|171|||
161145217|NCT05243550|581915574|FG000|Overall Study|Withdrawal by Subject|10|||
161145218|NCT05243550|581915574|FG000|Overall Study|Lost to Follow-up|7|||
161145219|NCT05243550|581915574|FG000|Overall Study|Adverse Event|3|||
161145220|NCT05243550|581915574|FG000|Overall Study|Noncompliance|1|||
161145221|NCT05243550|581915574|FG000|Overall Study|Physician Decision|1|||
161145222|NCT05243550|581915574|FG000|Overall Study|Other Reason|4|||
161145223|NCT02452970|581915575|FG000|Overall Study|Adverse Event|1|||
161145224|NCT02100657|581915576|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
161145225|NCT02100657|581915577|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
161145226|NCT02100657|581915578|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
161145227|NCT02100657|581915576|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
161145228|NCT02100657|581915577|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
161145229|NCT02100657|581915578|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
161145230|NCT02100657|581915576|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
161145231|NCT02100657|581915577|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
161145232|NCT02100657|581915578|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
161145233|NCT02100657|581915576|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
161145234|NCT02100657|581915577|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
161145235|NCT02100657|581915578|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
161145236|NCT02100657|581915576|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
161145237|NCT02100657|581915577|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
161145238|NCT02100657|581915578|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
161145239|NCT02100657|581915576|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
161145240|NCT02100657|581915577|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
161145241|NCT02100657|581915578|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
161145242|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
161145243|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
161145244|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
161145245|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Death|0|||
161145246|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Death|0|||
161145247|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Death|1|||
161145248|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
161145249|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
161145250|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
161145251|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
161145252|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
161268408|NCT02799095|582366762|FG000|Part C|Adverse Event|0|||
161268409|NCT02799095|582366763|FG001|Part C|Adverse Event|0|||
161268410|NCT02799095|582366764|FG002|Part C|Adverse Event|0|||
161268411|NCT02799095|582366765|FG003|Part C|Adverse Event|0|||
160949856|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949857|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949858|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949859|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949860|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949861|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949862|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949863|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949864|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949865|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
160949866|NCT01490632|581204918|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949867|NCT01490632|581204919|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949868|NCT01490632|581204920|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949869|NCT01490632|581204921|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949870|NCT01490632|581204922|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
160949871|NCT01490632|581204923|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949872|NCT01490632|581204924|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949873|NCT01490632|581204925|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949874|NCT01490632|581204926|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949875|NCT01490632|581204927|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949876|NCT01490632|581204928|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949877|NCT01490632|581204929|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949878|NCT01490632|581204930|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949879|NCT01490632|581204931|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949880|NCT01490632|581204932|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949881|NCT01490632|581204933|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949882|NCT01490632|581204934|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949883|NCT01490632|581204935|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949884|NCT01490632|581204936|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949885|NCT01490632|581204937|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
160949886|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949887|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949888|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949889|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949890|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949891|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
160949892|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
160949893|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949894|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949895|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
160949896|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
160949897|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
160949898|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949899|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949900|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949901|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949902|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949903|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949904|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949905|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
160949906|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949907|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949908|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949909|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949910|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949911|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
161000337|NCT01244828|581385089|FG000|Overall Study|Other reason (not specified)|1|||
161000338|NCT00573833|581385090|FG000|Overall Study|Not Treated|2|||
161000339|NCT05052983|581385091|FG000|Overall Study|Lack of Efficacy|3|||
160949912|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
160949913|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949914|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
160949915|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
160949916|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
161000340|NCT05052983|581385092|FG001|Overall Study|Lack of Efficacy|12|||
160949917|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949918|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949919|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949920|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949921|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949922|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949923|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949924|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949925|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
160949926|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949927|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949928|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949929|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949930|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949931|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949932|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
160949933|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949934|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949935|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
160949936|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949937|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949938|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949939|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949940|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949941|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949942|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949943|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949944|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949945|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
160949946|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949947|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949948|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949949|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949950|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949951|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949952|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
160949953|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949954|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949955|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949956|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949957|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949958|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949959|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949960|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949961|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949962|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949963|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949964|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949965|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
160949966|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949967|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949968|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949969|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949970|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949971|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
160949972|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949973|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949974|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949975|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949976|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949977|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161000341|NCT05052983|581385091|FG000|Overall Study|Adverse Event|1|||
161000342|NCT05052983|581385092|FG001|Overall Study|Adverse Event|0|||
161000343|NCT04493242|581385093|FG000|Overall Study|Death|10|||
161000344|NCT04493242|581385094|FG001|Overall Study|Death|14|||
161000345|NCT04493242|581385095|FG002|Overall Study|Death|16|||
161000346|NCT04493242|581385093|FG000|Overall Study|Lost to Follow-up|1|||
161145253|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
161145254|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
161145255|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
160949978|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949979|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949980|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949981|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949982|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161145256|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
161145257|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
161145258|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
161145259|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
161145260|NCT02100657|581915576|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
161145261|NCT02100657|581915577|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
161145262|NCT02100657|581915578|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
161145263|NCT01269125|581915581|FG000|Overall Study|Adverse Event|3|||
161145264|NCT01269125|581915582|FG001|Overall Study|Adverse Event|5|||
161145265|NCT01269125|581915583|FG002|Overall Study|Adverse Event|0|||
161145266|NCT01269125|581915581|FG000|Overall Study|Lost to Follow-up|4|||
161145267|NCT01269125|581915582|FG001|Overall Study|Lost to Follow-up|0|||
161145268|NCT01269125|581915583|FG002|Overall Study|Lost to Follow-up|0|||
161145269|NCT01040832|581915585|FG000|Overall Study|Adverse Event|4|||
161145270|NCT01040832|581915586|FG001|Overall Study|Adverse Event|5|||
161145271|NCT01040832|581915585|FG000|Overall Study|Death|4|||
161145272|NCT01040832|581915586|FG001|Overall Study|Death|6|||
161145273|NCT01040832|581915585|FG000|Overall Study|Withdrawal by Subject|2|||
161145274|NCT01040832|581915586|FG001|Overall Study|Withdrawal by Subject|3|||
161145275|NCT01040832|581915585|FG000|Overall Study|Progressive disease|32|||
161145276|NCT01040832|581915586|FG001|Overall Study|Progressive disease|17|||
161145277|NCT01040832|581915585|FG000|Overall Study|Symptomatic deterioration|2|||
161145278|NCT01040832|581915586|FG001|Overall Study|Symptomatic deterioration|5|||
161145279|NCT01040832|581915585|FG000|Overall Study|Other|2|||
161145280|NCT01040832|581915586|FG001|Overall Study|Other|1|||
161145281|NCT01300286|581915587|FG000|Overall Study|did not get dosed|1|||
161145282|NCT03635190|581915588|FG000|Overall Study|Lost to Follow-up|4|||
161145283|NCT03635190|581915588|FG000|Overall Study|Death|3|||
161145284|NCT03635190|581915588|FG000|Overall Study|Withdrawal by Subject|1|||
161145285|NCT03635190|581915588|FG000|Overall Study|Patient moved and did not return for follow up|1|||
161145286|NCT02767570|581915589|FG000|Overall Study|Lost to Follow-up|3|||
161145287|NCT02767570|581915590|FG001|Overall Study|Lost to Follow-up|0|||
161145288|NCT02767570|581915589|FG000|Overall Study|COVID shutdown|2|||
161145289|NCT02767570|581915590|FG001|Overall Study|COVID shutdown|5|||
161145290|NCT02767570|581915589|FG000|Overall Study|Increased pain|2|||
161145291|NCT02767570|581915590|FG001|Overall Study|Increased pain|0|||
161145292|NCT02767570|581915589|FG000|Overall Study|Withdrawal by Subject|1|||
161145293|NCT02767570|581915590|FG001|Overall Study|Withdrawal by Subject|3|||
161145294|NCT02767570|581915589|FG000|Overall Study|Unrelated medical issue|1|||
161145295|NCT02767570|581915590|FG001|Overall Study|Unrelated medical issue|1|||
161145296|NCT02767570|581915589|FG000|Overall Study|Received intra-articular injection|0|||
161145297|NCT02767570|581915590|FG001|Overall Study|Received intra-articular injection|1|||
161145298|NCT03692910|581915591|FG000|Overall Study|Lost to Follow-up|4|||
161145299|NCT03692910|581915592|FG001|Overall Study|Lost to Follow-up|0|||
161145300|NCT03692910|581915593|FG002|Overall Study|Lost to Follow-up|0|||
161145301|NCT03692910|581915591|FG000|Overall Study|Withdrawal by Subject|2|||
161145302|NCT03692910|581915592|FG001|Overall Study|Withdrawal by Subject|0|||
161145303|NCT03692910|581915593|FG002|Overall Study|Withdrawal by Subject|0|||
161145304|NCT03060577|581915594|FG000|Overall Study|Withdrawal by Subject|25|||
161145305|NCT03060577|581915595|FG001|Overall Study|Withdrawal by Subject|5|||
161145306|NCT03060577|581915594|FG000|Overall Study|Physician Decision|4|||
161145307|NCT03060577|581915595|FG001|Overall Study|Physician Decision|3|||
161145308|NCT03060577|581915594|FG000|Overall Study|Lost to Follow-up|3|||
161145309|NCT03060577|581915595|FG001|Overall Study|Lost to Follow-up|0|||
160949983|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161145310|NCT03060577|581915594|FG000|Overall Study|Death|7|||
161145311|NCT03060577|581915595|FG001|Overall Study|Death|1|||
161145312|NCT03060577|581915594|FG000|Overall Study|Adverse Event|9|||
161145313|NCT03060577|581915595|FG001|Overall Study|Adverse Event|1|||
161145314|NCT03060577|581915594|FG000|Overall Study|Inclusion/Exclusion|1|||
161145315|NCT03060577|581915595|FG001|Overall Study|Inclusion/Exclusion|0|||
161145316|NCT03060577|581915594|FG000|Overall Study|Other|8|||
161145317|NCT03060577|581915595|FG001|Overall Study|Other|2|||
160949984|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
161145318|NCT03216265|581915596|FG000|Overall Study|Adverse Event|2|||
161145319|NCT03216265|581915597|FG001|Overall Study|Adverse Event|0|||
161145320|NCT03216265|581915598|FG002|Overall Study|Adverse Event|2|||
161145321|NCT03216265|581915596|FG000|Overall Study|Lost to Follow-up|0|||
161145322|NCT03216265|581915597|FG001|Overall Study|Lost to Follow-up|1|||
160949985|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
160949986|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161268412|NCT02799095|582366766|FG004|Part C|Adverse Event|0|||
161268413|NCT02799095|582366767|FG005|Part C|Adverse Event|0|||
161268414|NCT02799095|582366768|FG006|Part C|Adverse Event|0|||
160949987|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949988|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949989|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949990|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949991|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161000347|NCT04493242|581385094|FG001|Overall Study|Lost to Follow-up|1|||
161000348|NCT04493242|581385095|FG002|Overall Study|Lost to Follow-up|0|||
161000349|NCT04493242|581385093|FG000|Overall Study|Withdrawal by Subject|1|||
161000350|NCT04493242|581385094|FG001|Overall Study|Withdrawal by Subject|0|||
161000351|NCT04493242|581385095|FG002|Overall Study|Withdrawal by Subject|0|||
161000352|NCT04493242|581385093|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
161342757|NCT00157755|582642250|FG000|Overall Study|Death|2|||
161000353|NCT04493242|581385094|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
161268415|NCT02799095|582366769|FG007|Part C|Adverse Event|0|||
161268416|NCT02799095|582366770|FG008|Part C|Adverse Event|0|||
161268417|NCT02799095|582366771|FG009|Part C|Adverse Event|0|||
161268418|NCT02799095|582366772|FG010|Part C|Adverse Event|3|||
161268419|NCT02799095|582366773|FG011|Part C|Adverse Event|1|||
161268420|NCT02799095|582366774|FG012|Part C|Adverse Event|0|||
161268421|NCT02799095|582366775|FG013|Part C|Adverse Event|1|||
161268422|NCT02799095|582366776|FG014|Part C|Adverse Event|0|||
161268423|NCT02799095|582366777|FG015|Part C|Adverse Event|0|||
161268424|NCT02799095|582366778|FG016|Part C|Adverse Event|0|||
161268425|NCT02799095|582366762|FG000|Part C|Death|0|||
161268426|NCT02799095|582366763|FG001|Part C|Death|0|||
161342758|NCT00157755|582642251|FG001|Overall Study|Death|3|||
161342759|NCT00157755|582642252|FG002|Overall Study|Death|3|||
161342760|NCT00157755|582642253|FG003|Overall Study|Death|2|||
160949992|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
160949993|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949994|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
160949995|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
161000354|NCT04493242|581385095|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
161000355|NCT04493242|581385093|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
161000356|NCT04493242|581385094|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
161000357|NCT04493242|581385095|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
161000358|NCT00849147|581385096|FG000|Overall Study|Withdrawal by Subject|1|||
161000359|NCT00849147|581385096|FG000|Overall Study|Protocol Violation|2|||
161000360|NCT00849147|581385096|FG000|Overall Study|Disease Relapse/Progression|2|||
161000361|NCT05147233|581387072|FG000|Overall Study|Adverse Event|0|||
161000362|NCT05147233|581387073|FG001|Overall Study|Adverse Event|1|||
161000363|NCT05147233|581387072|FG000|Overall Study|Lost to Follow-up|1|||
161000364|NCT05147233|581387073|FG001|Overall Study|Lost to Follow-up|1|||
161000365|NCT05147233|581387072|FG000|Overall Study|Protocol Violation|0|||
161000366|NCT05147233|581387073|FG001|Overall Study|Protocol Violation|1|||
161000367|NCT05147233|581387072|FG000|Overall Study|Withdrawal by Subject|2|||
161000368|NCT05147233|581387073|FG001|Overall Study|Withdrawal by Subject|1|||
161000369|NCT04513522|581387074|FG000|Overall Study|Other reasons|1|||
161000370|NCT04513522|581387074|FG000|Overall Study|Adverse event unrelated to study drug|9|||
161000371|NCT04513522|581387074|FG000|Overall Study|Study drug toxicity|14|||
161000372|NCT04513522|581387074|FG000|Overall Study|Disease progression|39|||
161000373|NCT04513522|581387074|FG000|Overall Study|Participants withdrew consent|2|||
161000374|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Adverse Event|1|||
161000375|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Adverse Event|0|||
161000376|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Adverse Event|0|||
161000377|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
161000378|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
161000379|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
161000380|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
161000381|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
161268427|NCT02799095|582366764|FG002|Part C|Death|0|||
161000382|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
161000383|NCT04517864|581387075|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
161268428|NCT02799095|582366765|FG003|Part C|Death|0|||
161268429|NCT02799095|582366766|FG004|Part C|Death|0|||
161268430|NCT02799095|582366767|FG005|Part C|Death|0|||
161268431|NCT02799095|582366768|FG006|Part C|Death|0|||
161268432|NCT02799095|582366769|FG007|Part C|Death|0|||
161342761|NCT00157755|582642254|FG004|Overall Study|Death|0|||
161342762|NCT00157755|582642255|FG005|Overall Study|Death|0|||
161342763|NCT00157755|582642250|FG000|Overall Study|Lost to Follow-up|0|||
161342764|NCT00157755|582642251|FG001|Overall Study|Lost to Follow-up|0|||
160949996|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
160949997|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
160949998|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160949999|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950000|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950001|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950002|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950003|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950004|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950005|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
160950006|NCT01490632|581204918|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950007|NCT01490632|581204919|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950008|NCT01490632|581204920|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950009|NCT01490632|581204921|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950010|NCT01490632|581204922|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950011|NCT01490632|581204923|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
160950012|NCT01490632|581204924|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
160950013|NCT01490632|581204925|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
160950014|NCT01490632|581204926|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
160950015|NCT01490632|581204927|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
160950016|NCT01490632|581204928|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
160950017|NCT01490632|581204929|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
160950018|NCT01490632|581204930|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950019|NCT01490632|581204931|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950020|NCT01490632|581204932|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950021|NCT01490632|581204933|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950022|NCT01490632|581204934|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950023|NCT01490632|581204935|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950024|NCT01490632|581204936|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950025|NCT01490632|581204937|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
160950026|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950027|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950028|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950029|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950030|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950031|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950032|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950033|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950034|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950035|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950036|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950037|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950038|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950039|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950040|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
160950041|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
160950042|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950043|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950044|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950045|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
160950046|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950047|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950048|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950049|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950050|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950051|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950052|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950053|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161000384|NCT04517864|581387076|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
160950054|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161000385|NCT04517864|581387077|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
161000386|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Adverse Event|1|||
161000387|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Adverse Event|0|||
160950055|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950056|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950057|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950058|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950059|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
160950060|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950061|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
161145323|NCT03216265|581915598|FG002|Overall Study|Lost to Follow-up|0|||
161145324|NCT03216265|581915596|FG000|Overall Study|Withdrawal by Subject|0|||
161145325|NCT03216265|581915597|FG001|Overall Study|Withdrawal by Subject|0|||
161145326|NCT03216265|581915598|FG002|Overall Study|Withdrawal by Subject|1|||
161145327|NCT01306058|581915599|FG000|Overall Study|Death|1|||
161145328|NCT01306058|581915599|FG000|Overall Study|Enrolled but did not get treatment|1|||
161145329|NCT01539837|581915600|FG000|Overall Study|reduce neutrophil level|0|||
161145330|NCT01539837|581915601|FG001|Overall Study|reduce neutrophil level|1|||
161145331|NCT01539837|581915602|FG002|Overall Study|reduce neutrophil level|1|||
161145332|NCT01539837|581915600|FG000|Overall Study|bad compliance|0|||
161145333|NCT01539837|581915601|FG001|Overall Study|bad compliance|0|||
161145334|NCT01539837|581915602|FG002|Overall Study|bad compliance|1|||
161145335|NCT00849693|581915603|FG000|Acute Treatment Phase|Adverse Event|12|||
161145336|NCT00849693|581915604|FG001|Acute Treatment Phase|Adverse Event|7|||
161145337|NCT00849693|581915605|FG002|Acute Treatment Phase|Adverse Event|6|||
161145338|NCT00849693|581915606|FG003|Acute Treatment Phase|Adverse Event|4|||
161145339|NCT00849693|581915603|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
161145340|NCT00849693|581915604|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
161145341|NCT00849693|581915605|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
161145342|NCT00849693|581915606|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
161145343|NCT00849693|581915603|FG000|Acute Treatment Phase|Protocol Violation|1|||
161145344|NCT00849693|581915604|FG001|Acute Treatment Phase|Protocol Violation|5|||
161145345|NCT00849693|581915605|FG002|Acute Treatment Phase|Protocol Violation|2|||
161145346|NCT00849693|581915606|FG003|Acute Treatment Phase|Protocol Violation|6|||
161145347|NCT00849693|581915603|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
161145348|NCT00849693|581915604|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
161145349|NCT00849693|581915605|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
161145350|NCT00849693|581915606|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
161145351|NCT00849693|581915603|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
161145352|NCT00849693|581915604|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
161145353|NCT00849693|581915605|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
161145354|NCT00849693|581915606|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
161145355|NCT00849693|581915603|FG000|Acute Treatment Phase|Physician Decision|2|||
161145356|NCT00849693|581915604|FG001|Acute Treatment Phase|Physician Decision|1|||
161145357|NCT00849693|581915605|FG002|Acute Treatment Phase|Physician Decision|2|||
161145358|NCT00849693|581915606|FG003|Acute Treatment Phase|Physician Decision|1|||
161145359|NCT00849693|581915603|FG000|Acute Treatment Phase|Sponsor decision|0|||
161145360|NCT00849693|581915604|FG001|Acute Treatment Phase|Sponsor decision|0|||
161145361|NCT00849693|581915605|FG002|Acute Treatment Phase|Sponsor decision|1|||
161145362|NCT00849693|581915606|FG003|Acute Treatment Phase|Sponsor decision|0|||
161145363|NCT00849693|581915603|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
161145364|NCT00849693|581915604|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
161145365|NCT00849693|581915605|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
161145366|NCT00849693|581915606|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
161145367|NCT00849693|581915603|FG000|Extension Phase|Adverse Event|4|||
161145368|NCT00849693|581915604|FG001|Extension Phase|Adverse Event|6|||
161342765|NCT00157755|582642252|FG002|Overall Study|Lost to Follow-up|1|||
160950062|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950063|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950064|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950065|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
160950066|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950067|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950068|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950069|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950070|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950071|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950072|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950073|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950074|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
161145369|NCT00849693|581915605|FG002|Extension Phase|Adverse Event|3|||
161145370|NCT00849693|581915606|FG003|Extension Phase|Adverse Event|7|||
161145371|NCT00849693|581915603|FG000|Extension Phase|Lost to Follow-up|7|||
161145372|NCT00849693|581915604|FG001|Extension Phase|Lost to Follow-up|5|||
161342766|NCT00157755|582642253|FG003|Overall Study|Lost to Follow-up|0|||
160950075|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950076|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950077|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950078|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950079|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950080|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
160950081|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
160950082|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950083|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950084|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950085|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
160950086|NCT01490632|581204918|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950087|NCT01490632|581204919|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950088|NCT01490632|581204920|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950089|NCT01490632|581204921|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950090|NCT01490632|581204922|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950091|NCT01490632|581204923|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950092|NCT01490632|581204924|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950093|NCT01490632|581204925|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950094|NCT01490632|581204926|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950095|NCT01490632|581204927|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950096|NCT01490632|581204928|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950097|NCT01490632|581204929|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950098|NCT01490632|581204930|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
160950099|NCT01490632|581204931|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
160950100|NCT01490632|581204932|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
160950101|NCT01490632|581204933|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
160950102|NCT01490632|581204934|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950103|NCT01490632|581204935|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161000388|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Adverse Event|0|||
161000389|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
161000390|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
161000391|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
161000392|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
161000393|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
161000394|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
161000395|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Physician Decision|1|||
161000396|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Physician Decision|0|||
161000397|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Physician Decision|0|||
161000398|NCT04517864|581387075|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
161000399|NCT04517864|581387076|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
161000400|NCT04517864|581387077|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
161000401|NCT04517864|581387075|FG000|Extension Phase|Adverse Event|0|||
161000402|NCT04517864|581387076|FG001|Extension Phase|Adverse Event|0|||
161000403|NCT04517864|581387077|FG002|Extension Phase|Adverse Event|1|||
161000404|NCT04517864|581387075|FG000|Extension Phase|Lack of Efficacy|0|||
161000405|NCT04517864|581387076|FG001|Extension Phase|Lack of Efficacy|0|||
161000406|NCT04517864|581387077|FG002|Extension Phase|Lack of Efficacy|2|||
161000407|NCT04517864|581387075|FG000|Extension Phase|Study Terminated By Sponsor|0|||
161000408|NCT04517864|581387076|FG001|Extension Phase|Study Terminated By Sponsor|0|||
161000409|NCT04517864|581387077|FG002|Extension Phase|Study Terminated By Sponsor|32|||
161000410|NCT04517864|581387075|FG000|Extension Phase|Withdrawal by Subject|0|||
161000411|NCT04517864|581387076|FG001|Extension Phase|Withdrawal by Subject|0|||
161000412|NCT04517864|581387077|FG002|Extension Phase|Withdrawal by Subject|3|||
161000413|NCT04517864|581387075|FG000|Extension Phase|Approved Drug Available for Indication|0|||
161000414|NCT04517864|581387076|FG001|Extension Phase|Approved Drug Available for Indication|0|||
161000415|NCT04517864|581387077|FG002|Extension Phase|Approved Drug Available for Indication|7|||
161000416|NCT04722003|581387080|FG000|Overall Study|Lost to Follow-up|2|||
161145373|NCT00849693|581915605|FG002|Extension Phase|Lost to Follow-up|6|||
161145374|NCT00849693|581915606|FG003|Extension Phase|Lost to Follow-up|6|||
161000417|NCT04722003|581387081|FG001|Overall Study|Lost to Follow-up|0|||
161000418|NCT04722003|581387080|FG000|Overall Study|Physician Decision|1|||
161145375|NCT00849693|581915603|FG000|Extension Phase|Protocol Violation|0|||
161268433|NCT02799095|582366770|FG008|Part C|Death|0|||
161268434|NCT02799095|582366771|FG009|Part C|Death|0|||
161145376|NCT00849693|581915604|FG001|Extension Phase|Protocol Violation|3|||
161145377|NCT00849693|581915605|FG002|Extension Phase|Protocol Violation|2|||
161145378|NCT00849693|581915606|FG003|Extension Phase|Protocol Violation|3|||
161145379|NCT00849693|581915603|FG000|Extension Phase|Withdrawal by Subject|6|||
161145380|NCT00849693|581915604|FG001|Extension Phase|Withdrawal by Subject|9|||
161145381|NCT00849693|581915605|FG002|Extension Phase|Withdrawal by Subject|10|||
161145382|NCT00849693|581915606|FG003|Extension Phase|Withdrawal by Subject|15|||
161145383|NCT00849693|581915603|FG000|Extension Phase|Parent or caregiver decision|9|||
161145384|NCT00849693|581915604|FG001|Extension Phase|Parent or caregiver decision|4|||
161145385|NCT00849693|581915605|FG002|Extension Phase|Parent or caregiver decision|10|||
161145386|NCT00849693|581915606|FG003|Extension Phase|Parent or caregiver decision|5|||
161145387|NCT00849693|581915603|FG000|Extension Phase|Physician Decision|1|||
161145388|NCT00849693|581915604|FG001|Extension Phase|Physician Decision|1|||
161145389|NCT00849693|581915605|FG002|Extension Phase|Physician Decision|2|||
161145390|NCT00849693|581915606|FG003|Extension Phase|Physician Decision|0|||
161145391|NCT00849693|581915603|FG000|Extension Phase|Sponsor decision|1|||
161145392|NCT00849693|581915604|FG001|Extension Phase|Sponsor decision|0|||
161145393|NCT00849693|581915605|FG002|Extension Phase|Sponsor decision|0|||
161145394|NCT00849693|581915606|FG003|Extension Phase|Sponsor decision|1|||
161145395|NCT00849693|581915603|FG000|Extension Phase|Lack of Efficacy|2|||
161145396|NCT00849693|581915604|FG001|Extension Phase|Lack of Efficacy|2|||
161145397|NCT00849693|581915605|FG002|Extension Phase|Lack of Efficacy|2|||
161145398|NCT00849693|581915606|FG003|Extension Phase|Lack of Efficacy|1|||
161145399|NCT01978912|581915607|FG000|Overall Study|Adverse Event|0|||
161145400|NCT01978912|581915608|FG001|Overall Study|Adverse Event|1|||
161145401|NCT01978912|581915609|FG002|Overall Study|Adverse Event|0|||
161145402|NCT01978912|581915610|FG003|Overall Study|Adverse Event|0|||
161145403|NCT01978912|581915607|FG000|Overall Study|Lost to Follow-up|1|||
161145404|NCT01978912|581915608|FG001|Overall Study|Lost to Follow-up|1|||
161145405|NCT01978912|581915609|FG002|Overall Study|Lost to Follow-up|0|||
161145406|NCT01978912|581915610|FG003|Overall Study|Lost to Follow-up|1|||
161145407|NCT01978912|581915607|FG000|Overall Study|Withdrawal by Subject|1|||
161145408|NCT01978912|581915608|FG001|Overall Study|Withdrawal by Subject|0|||
161145409|NCT01978912|581915609|FG002|Overall Study|Withdrawal by Subject|2|||
161145410|NCT01978912|581915610|FG003|Overall Study|Withdrawal by Subject|2|||
161145411|NCT01978912|581915607|FG000|Overall Study|Lumbar Surgery|1|||
161145412|NCT01978912|581915608|FG001|Overall Study|Lumbar Surgery|0|||
161145413|NCT01978912|581915609|FG002|Overall Study|Lumbar Surgery|1|||
161145414|NCT01978912|581915610|FG003|Overall Study|Lumbar Surgery|0|||
161145415|NCT01978912|581915607|FG000|Overall Study|Intradiscal Steroid Injection|0|||
161145416|NCT01978912|581915608|FG001|Overall Study|Intradiscal Steroid Injection|1|||
161145417|NCT01978912|581915609|FG002|Overall Study|Intradiscal Steroid Injection|0|||
161145418|NCT01978912|581915610|FG003|Overall Study|Intradiscal Steroid Injection|0|||
161145419|NCT00224107|581915611|FG000|Overall Study|Adverse Event|20|||
161145420|NCT00224107|581915612|FG001|Overall Study|Adverse Event|6|||
161145421|NCT00224107|581915611|FG000|Overall Study|Protocol Violation|2|||
161145422|NCT00224107|581915612|FG001|Overall Study|Protocol Violation|3|||
161145423|NCT00224107|581915611|FG000|Overall Study|Withdrawal by Subject|1|||
161145424|NCT00224107|581915612|FG001|Overall Study|Withdrawal by Subject|4|||
161145425|NCT00224107|581915611|FG000|Overall Study|Lack of Efficacy|2|||
161145426|NCT00224107|581915612|FG001|Overall Study|Lack of Efficacy|0|||
161145427|NCT00224107|581915611|FG000|Overall Study|Lost to Follow-up|4|||
161145428|NCT00224107|581915612|FG001|Overall Study|Lost to Follow-up|0|||
161145429|NCT00224107|581915611|FG000|Overall Study|Physician Decision|1|||
161145430|NCT00224107|581915612|FG001|Overall Study|Physician Decision|0|||
161145431|NCT00224107|581915611|FG000|Overall Study|Other|1|||
161145432|NCT00224107|581915612|FG001|Overall Study|Other|1|||
161268435|NCT02799095|582366772|FG010|Part C|Death|7|||
161268436|NCT02799095|582366773|FG011|Part C|Death|5|||
161145433|NCT01408537|581915613|FG000|Overall Study|Withdrawal by Subject|2|||
161145434|NCT01408537|581915613|FG000|Overall Study|Protocol Violation|3|||
161145435|NCT01408537|581915613|FG000|Overall Study|Lost to Follow-up|3|||
161145436|NCT00098345|581915616|FG000|Overall Study|Adverse Event|7|||
161145437|NCT00098345|581915616|FG000|Overall Study|Withdrawal by Subject|2|||
161268437|NCT02799095|582366774|FG012|Part C|Death|6|||
161268438|NCT02799095|582366775|FG013|Part C|Death|8|||
161145438|NCT00098345|581915616|FG000|Overall Study|progression|4|||
161145439|NCT01183858|581915617|FG000|Overall Study|Death not related to Progressive Disease|5|||
161145440|NCT01183858|581915618|FG001|Overall Study|Death not related to Progressive Disease|6|||
161145441|NCT01183858|581915617|FG000|Overall Study|Adverse Event|14|||
161268439|NCT02799095|582366776|FG014|Part C|Death|1|||
161268440|NCT02799095|582366777|FG015|Part C|Death|8|||
161145442|NCT01183858|581915618|FG001|Overall Study|Adverse Event|11|||
161145443|NCT01183858|581915617|FG000|Overall Study|Investigator's Decision|0|||
161145444|NCT01183858|581915618|FG001|Overall Study|Investigator's Decision|3|||
161145445|NCT01183858|581915617|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161145446|NCT01183858|581915618|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161145447|NCT01183858|581915617|FG000|Overall Study|Refused Treatment|1|||
161268441|NCT02799095|582366778|FG016|Part C|Death|1|||
161268442|NCT02799095|582366762|FG000|Part C|Lost to Follow-up|0|||
161145448|NCT01183858|581915618|FG001|Overall Study|Refused Treatment|4|||
161145449|NCT01183858|581915617|FG000|Overall Study|Withdrew Consent|4|||
161145450|NCT01183858|581915618|FG001|Overall Study|Withdrew Consent|4|||
161145451|NCT01183858|581915617|FG000|Overall Study|Discontinued Smoking|3|||
161145452|NCT01183858|581915618|FG001|Overall Study|Discontinued Smoking|1|||
161145453|NCT01183858|581915617|FG000|Overall Study|Protocol Violation|1|||
161145454|NCT01183858|581915618|FG001|Overall Study|Protocol Violation|0|||
161145455|NCT01183858|581915617|FG000|Overall Study|Administrative/Other|6|||
161145456|NCT01183858|581915618|FG001|Overall Study|Administrative/Other|6|||
161145457|NCT01183858|581915617|FG000|Overall Study|Progressive Disease|112|||
161145458|NCT01183858|581915618|FG001|Overall Study|Progressive Disease|115|||
161145459|NCT01183858|581915617|FG000|Overall Study|Death related to Progressive Disease|4|||
161145460|NCT01183858|581915618|FG001|Overall Study|Death related to Progressive Disease|5|||
161145461|NCT01183858|581915617|FG000|Overall Study|Lost to Follow-up|1|||
161145462|NCT01183858|581915618|FG001|Overall Study|Lost to Follow-up|1|||
161145463|NCT03707977|581915621|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
161145464|NCT03707977|581915622|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
161145465|NCT03707977|581915623|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
161145466|NCT03707977|581915621|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
161145467|NCT03707977|581915622|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
161145468|NCT03707977|581915623|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
161145469|NCT03069690|581915624|FG000|Pregnancy Intervention|Pregnancy loss|9|||
161145470|NCT03069690|581915625|FG001|Pregnancy Intervention|Pregnancy loss|4|||
161145471|NCT03069690|581915626|FG002|Pregnancy Intervention|Pregnancy loss|0|||
161145472|NCT03069690|581915627|FG003|Pregnancy Intervention|Pregnancy loss|0|||
161145473|NCT03069690|581915628|FG004|Pregnancy Intervention|Pregnancy loss|0|||
161145474|NCT03069690|581915629|FG005|Pregnancy Intervention|Pregnancy loss|0|||
161145475|NCT03069690|581915624|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
161145476|NCT03069690|581915625|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
161145477|NCT03069690|581915626|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
161145478|NCT03069690|581915627|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
161145479|NCT03069690|581915628|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
161145480|NCT03069690|581915629|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
161145481|NCT03069690|581915624|FG000|Postpartum Intervention|Lost to Follow-up|0|||
161145482|NCT03069690|581915625|FG001|Postpartum Intervention|Lost to Follow-up|0|||
161145483|NCT03069690|581915626|FG002|Postpartum Intervention|Lost to Follow-up|5|||
161145484|NCT03069690|581915627|FG003|Postpartum Intervention|Lost to Follow-up|5|||
161145485|NCT03069690|581915628|FG004|Postpartum Intervention|Lost to Follow-up|2|||
161145486|NCT03069690|581915629|FG005|Postpartum Intervention|Lost to Follow-up|4|||
161145487|NCT02564120|581915630|FG000|Overall Study|Did not return release forms|160|||
161145488|NCT02564120|581915630|FG000|Overall Study|Death|58|||
161145489|NCT02564120|581915630|FG000|Overall Study|Withdrawal by Subject|204|||
161145490|NCT02564120|581915630|FG000|Overall Study|Other medical condition|24|||
161145491|NCT03842709|581915631|FG000|Overall Study|Withdrawal by Subject|3|||
161145492|NCT03842709|581915632|FG001|Overall Study|Withdrawal by Subject|3|||
161145493|NCT03842709|581915631|FG000|Overall Study|Lost to Follow-up|1|||
161145494|NCT03842709|581915632|FG001|Overall Study|Lost to Follow-up|0|||
161145495|NCT00641147|581915633|FG000|Completed 4 Months.|Physician Decision|1|||
161145496|NCT00641147|581915634|FG001|Completed 4 Months.|Physician Decision|0|||
161145497|NCT00641147|581915633|FG000|Completed 4 Months.|Adverse Event|1|||
161145498|NCT00641147|581915634|FG001|Completed 4 Months.|Adverse Event|0|||
161145499|NCT00641147|581915633|FG000|Completed 8 Months.|Physician Decision|2|||
161145500|NCT00641147|581915634|FG001|Completed 8 Months.|Physician Decision|1|||
161145501|NCT00641147|581915633|FG000|Completed 8 Months.|non compliance|1|||
161145502|NCT00641147|581915634|FG001|Completed 8 Months.|non compliance|0|||
161145503|NCT00641147|581915633|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
161145504|NCT00641147|581915634|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
161145505|NCT00641147|581915633|FG000|Completed 12 Months.|Physician Decision|1|||
161145506|NCT00641147|581915634|FG001|Completed 12 Months.|Physician Decision|1|||
161145507|NCT00641147|581915633|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
161145508|NCT00641147|581915634|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
161145509|NCT00641147|581915633|FG000|Completed 16 Months.|Physician Decision|1|||
161145510|NCT00641147|581915634|FG001|Completed 16 Months.|Physician Decision|0|||
161145511|NCT00641147|581915633|FG000|Completed 16 Months.|Lost to Follow-up|1|||
161145512|NCT00641147|581915634|FG001|Completed 16 Months.|Lost to Follow-up|0|||
161145513|NCT00791128|581915635|FG000|Overall Study|Adverse Event|4|||
161145514|NCT00791128|581915635|FG000|Overall Study|Device migration|2|||
161145515|NCT00791128|581915635|FG000|Overall Study|non-compliance by subject|2|||
161145516|NCT00791128|581915635|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
160950104|NCT01490632|581204936|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
161145517|NCT01629667|581915636|FG000|Overall Study|Lost to Follow-up|0|||
161145518|NCT01629667|581915637|FG001|Overall Study|Lost to Follow-up|1|||
161145519|NCT01629667|581915638|FG002|Overall Study|Lost to Follow-up|1|||
160950105|NCT01490632|581204937|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
160950106|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
160950107|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
160950108|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
160950109|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
160950110|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
160950111|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
160950112|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
160950113|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
160950114|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
160950115|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
160950116|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
160950117|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
160950118|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
160950119|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
161000419|NCT04722003|581387081|FG001|Overall Study|Physician Decision|0|||
161000420|NCT01376089|581387086|FG000|Overall Study|Patient received no contrast media|3|||
161000421|NCT01376089|581387087|FG001|Overall Study|Patient received no contrast media|4|||
161000422|NCT03262935|581387088|FG000|Overall Study|Withdrawal by Subject|6|||
161000423|NCT03262935|581387089|FG001|Overall Study|Withdrawal by Subject|7|||
161000424|NCT03262935|581387088|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
161000425|NCT03262935|581387089|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
161000426|NCT03262935|581387088|FG000|Overall Study|Death|181|||
161000427|NCT03262935|581387089|FG001|Overall Study|Death|94|||
161000428|NCT03262935|581387088|FG000|Overall Study|Lost to Follow-up|9|||
161000429|NCT03262935|581387089|FG001|Overall Study|Lost to Follow-up|4|||
161000430|NCT03262935|581387088|FG000|Overall Study|Other reason|5|||
161000431|NCT03262935|581387089|FG001|Overall Study|Other reason|0|||
161000432|NCT01811706|581387090|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
161000433|NCT01811706|581387091|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
161000434|NCT03557008|581387092|FG000|Overall Study|Withdrawal by Subject|2|||
161000435|NCT03557008|581387093|FG001|Overall Study|Withdrawal by Subject|2|||
161000436|NCT03557008|581387092|FG000|Overall Study|Early termination from study|3|||
161000437|NCT03557008|581387093|FG001|Overall Study|Early termination from study|1|||
161000438|NCT01458210|581387094|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
161000439|NCT01458210|581387094|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
161000440|NCT01458210|581387094|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
161000441|NCT01458210|581387094|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
161000442|NCT02224924|581387097|FG000|Overall Study|Withdrawal by Subject|7|||
161000443|NCT02224924|581387098|FG001|Overall Study|Withdrawal by Subject|6|||
161000444|NCT02224924|581387097|FG000|Overall Study|Biopsy cancelled|20|||
161000445|NCT02224924|581387098|FG001|Overall Study|Biopsy cancelled|14|||
161000446|NCT02224924|581387097|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
161000447|NCT02224924|581387098|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
161000448|NCT02224924|581387097|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
161000449|NCT02224924|581387098|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
161000450|NCT03020745|581387099|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000451|NCT03020745|581387100|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000452|NCT03020745|581387101|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000453|NCT03020745|581387102|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000454|NCT03020745|581387103|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000455|NCT03020745|581387104|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000456|NCT03020745|581387105|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000457|NCT03020745|581387106|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000458|NCT03020745|581387107|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
161000459|NCT03020745|581387108|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
161000460|NCT03020745|581387099|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000461|NCT03020745|581387100|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
160950120|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
160950121|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
161000462|NCT03020745|581387101|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000463|NCT03020745|581387102|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000464|NCT03020745|581387103|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000465|NCT03020745|581387104|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000466|NCT03020745|581387105|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000467|NCT03020745|581387106|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
161000468|NCT03020745|581387107|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
161000469|NCT03020745|581387108|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
160950122|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
161000470|NCT03020745|581387099|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000471|NCT03020745|581387100|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
160950123|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
161342767|NCT00157755|582642254|FG004|Overall Study|Lost to Follow-up|0|||
161342768|NCT00157755|582642255|FG005|Overall Study|Lost to Follow-up|0|||
160950124|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
160950125|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
160950126|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Death|0|||
160950127|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Death|0|||
160950128|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Death|0|||
160950129|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Death|0|||
160950130|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Death|0|||
160950131|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Death|0|||
160950132|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Death|0|||
160950133|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Death|0|||
160950134|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Death|0|||
161000472|NCT03020745|581387101|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000473|NCT03020745|581387102|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000474|NCT03020745|581387103|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000475|NCT03020745|581387104|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
161000476|NCT03020745|581387105|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000477|NCT03020745|581387106|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000478|NCT03020745|581387107|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
161000479|NCT03020745|581387108|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
161000480|NCT03020745|581387099|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000481|NCT03020745|581387100|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000482|NCT03020745|581387101|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000483|NCT03020745|581387102|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000484|NCT03020745|581387103|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000485|NCT03020745|581387104|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000486|NCT03020745|581387105|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000487|NCT03020745|581387106|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000488|NCT03020745|581387107|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
160950135|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Death|0|||
160950136|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Death|0|||
160950137|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Death|0|||
160950138|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Death|0|||
160950139|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Death|0|||
160950140|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Death|0|||
161000489|NCT03020745|581387108|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
161000490|NCT01867216|581387109|FG000|Overall Study|Withdrawal by Subject|2|||
161000491|NCT01867216|581387110|FG001|Overall Study|Withdrawal by Subject|0|||
161000492|NCT01867216|581387111|FG002|Overall Study|Withdrawal by Subject|0|||
161000493|NCT01867216|581387112|FG003|Overall Study|Withdrawal by Subject|0|||
161000494|NCT01867216|581387113|FG004|Overall Study|Withdrawal by Subject|1|||
161000495|NCT01867216|581387114|FG005|Overall Study|Withdrawal by Subject|0|||
161000496|NCT01867216|581387115|FG006|Overall Study|Withdrawal by Subject|1|||
161000497|NCT01867216|581387109|FG000|Overall Study|Physician Decision|1|||
161000498|NCT01867216|581387110|FG001|Overall Study|Physician Decision|0|||
161000499|NCT01867216|581387111|FG002|Overall Study|Physician Decision|0|||
161000500|NCT01867216|581387112|FG003|Overall Study|Physician Decision|0|||
161000501|NCT01867216|581387113|FG004|Overall Study|Physician Decision|0|||
161000502|NCT01867216|581387114|FG005|Overall Study|Physician Decision|0|||
161000503|NCT01867216|581387115|FG006|Overall Study|Physician Decision|0|||
161000504|NCT01867216|581387109|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
161342769|NCT00157755|582642250|FG000|Overall Study|Withdrawal by Subject|0|||
161342770|NCT00157755|582642251|FG001|Overall Study|Withdrawal by Subject|0|||
161342771|NCT00157755|582642252|FG002|Overall Study|Withdrawal by Subject|1|||
161342772|NCT00157755|582642253|FG003|Overall Study|Withdrawal by Subject|1|||
161342773|NCT00157755|582642254|FG004|Overall Study|Withdrawal by Subject|1|||
161342774|NCT00157755|582642255|FG005|Overall Study|Withdrawal by Subject|2|||
161342775|NCT00157755|582642250|FG000|Overall Study|Explant due to infection|0|||
161342776|NCT00157755|582642251|FG001|Overall Study|Explant due to infection|0|||
161342777|NCT00157755|582642252|FG002|Overall Study|Explant due to infection|1|||
161342778|NCT00157755|582642253|FG003|Overall Study|Explant due to infection|0|||
161342779|NCT00157755|582642254|FG004|Overall Study|Explant due to infection|0|||
161342780|NCT00157755|582642255|FG005|Overall Study|Explant due to infection|0|||
161342781|NCT00157755|582642250|FG000|Overall Study|Medical reason|0|||
161342782|NCT00157755|582642251|FG001|Overall Study|Medical reason|0|||
161342783|NCT00157755|582642252|FG002|Overall Study|Medical reason|1|||
161342784|NCT00157755|582642253|FG003|Overall Study|Medical reason|1|||
161342785|NCT00157755|582642254|FG004|Overall Study|Medical reason|0|||
161342786|NCT00157755|582642255|FG005|Overall Study|Medical reason|0|||
161342787|NCT00157755|582642250|FG000|Overall Study|Study site closure|0|||
161342788|NCT00157755|582642251|FG001|Overall Study|Study site closure|1|||
161342789|NCT00157755|582642252|FG002|Overall Study|Study site closure|0|||
161342790|NCT00157755|582642253|FG003|Overall Study|Study site closure|0|||
161342791|NCT00157755|582642254|FG004|Overall Study|Study site closure|0|||
160950141|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Death|0|||
160950142|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Death|0|||
160950143|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Death|0|||
160950144|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Death|1|||
160950145|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Death|0|||
160950146|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950147|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950148|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950149|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950150|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950151|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950152|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950153|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950154|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950155|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950156|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950157|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950158|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950159|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950160|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950161|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950162|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
160950163|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
160950164|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
160950165|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
160950166|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950167|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950168|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950169|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950170|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950171|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950172|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950173|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950174|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950175|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950176|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950177|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950178|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950179|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950180|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950181|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950182|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950183|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950184|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
160950185|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
160950186|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
160950187|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
160950188|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
160950189|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
160950190|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
160950191|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
160950192|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
160950193|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
160950194|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
160950195|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
160950196|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
160950197|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
160950198|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
160950199|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
160950200|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
160950201|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
160950202|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
160950203|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
160950204|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
160950205|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
160950206|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
160950207|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
160950208|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
160950209|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
161000505|NCT01867216|581387110|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161268443|NCT02799095|582366763|FG001|Part C|Lost to Follow-up|0|||
161268444|NCT02799095|582366764|FG002|Part C|Lost to Follow-up|0|||
161268445|NCT02799095|582366765|FG003|Part C|Lost to Follow-up|0|||
160950210|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
160950211|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
160950212|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
160950213|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
160950214|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
160950215|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
160950216|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
160950217|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
160950218|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
160950219|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
160950220|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
160950221|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
160950222|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
160950223|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
160950224|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
160950225|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
160950226|NCT01490632|581204918|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950227|NCT01490632|581204919|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950228|NCT01490632|581204920|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950229|NCT01490632|581204921|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950230|NCT01490632|581204922|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950231|NCT01490632|581204923|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950232|NCT01490632|581204924|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950233|NCT01490632|581204925|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950234|NCT01490632|581204926|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950235|NCT01490632|581204927|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950236|NCT01490632|581204928|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950237|NCT01490632|581204929|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950238|NCT01490632|581204930|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950239|NCT01490632|581204931|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950240|NCT01490632|581204932|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950241|NCT01490632|581204933|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950242|NCT01490632|581204934|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
160950243|NCT01490632|581204935|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
160950244|NCT01490632|581204936|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
160950245|NCT01490632|581204937|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
160950246|NCT02332720|581204938|FG000|Part A and Part B|Lost to Follow-up|1|||
161268446|NCT02799095|582366766|FG004|Part C|Lost to Follow-up|0|||
161268447|NCT02799095|582366767|FG005|Part C|Lost to Follow-up|0|||
161268448|NCT02799095|582366768|FG006|Part C|Lost to Follow-up|0|||
161268449|NCT02799095|582366769|FG007|Part C|Lost to Follow-up|0|||
160950247|NCT02332720|581204939|FG001|Part A and Part B|Lost to Follow-up|0|||
160950248|NCT02332720|581204940|FG002|Part A and Part B|Lost to Follow-up|0|||
160950249|NCT02332720|581204941|FG003|Part A and Part B|Lost to Follow-up|0|||
160950250|NCT02332720|581204942|FG004|Part A and Part B|Lost to Follow-up|0|||
160950251|NCT02332720|581204943|FG005|Part A and Part B|Lost to Follow-up|2|||
160950252|NCT02332720|581204944|FG006|Part A and Part B|Lost to Follow-up|1|||
160950253|NCT02332720|581204945|FG007|Part A and Part B|Lost to Follow-up|1|||
160950254|NCT02332720|581204946|FG008|Part A and Part B|Lost to Follow-up|0|||
160950255|NCT02332720|581204947|FG009|Part A and Part B|Lost to Follow-up|0|||
160950256|NCT02332720|581204948|FG010|Part A and Part B|Lost to Follow-up|0|||
160950257|NCT02332720|581204949|FG011|Part A and Part B|Lost to Follow-up|0|||
160950258|NCT02332720|581204950|FG012|Part A and Part B|Lost to Follow-up|0|||
160950259|NCT02332720|581204951|FG013|Part A and Part B|Lost to Follow-up|0|||
160950260|NCT02332720|581204952|FG014|Part A and Part B|Lost to Follow-up|0|||
160950261|NCT02332720|581204953|FG015|Part A and Part B|Lost to Follow-up|1|||
160950262|NCT02332720|581204954|FG016|Part A and Part B|Lost to Follow-up|0|||
160950263|NCT02332720|581204955|FG017|Part A and Part B|Lost to Follow-up|0|||
160950264|NCT02332720|581204956|FG018|Part A and Part B|Lost to Follow-up|0|||
160950265|NCT02332720|581204957|FG019|Part A and Part B|Lost to Follow-up|0|||
160950266|NCT02332720|581204958|FG020|Part A and Part B|Lost to Follow-up|0|||
160950267|NCT02332720|581204959|FG021|Part A and Part B|Lost to Follow-up|0|||
160950268|NCT02332720|581204960|FG022|Part A and Part B|Lost to Follow-up|0|||
160950269|NCT02332720|581204938|FG000|Part A and Part B|Adverse Event|0|||
160950270|NCT02332720|581204939|FG001|Part A and Part B|Adverse Event|0|||
160950271|NCT02332720|581204940|FG002|Part A and Part B|Adverse Event|0|||
160950272|NCT02332720|581204941|FG003|Part A and Part B|Adverse Event|0|||
161268450|NCT02799095|582366770|FG008|Part C|Lost to Follow-up|0|||
160950273|NCT02332720|581204942|FG004|Part A and Part B|Adverse Event|0|||
160950274|NCT02332720|581204943|FG005|Part A and Part B|Adverse Event|0|||
160950275|NCT02332720|581204944|FG006|Part A and Part B|Adverse Event|0|||
161268451|NCT02799095|582366771|FG009|Part C|Lost to Follow-up|0|||
160950276|NCT02332720|581204945|FG007|Part A and Part B|Adverse Event|0|||
160950277|NCT02332720|581204946|FG008|Part A and Part B|Adverse Event|0|||
160950278|NCT02332720|581204947|FG009|Part A and Part B|Adverse Event|0|||
160950279|NCT02332720|581204948|FG010|Part A and Part B|Adverse Event|0|||
160950280|NCT02332720|581204949|FG011|Part A and Part B|Adverse Event|0|||
160950281|NCT02332720|581204950|FG012|Part A and Part B|Adverse Event|0|||
160950282|NCT02332720|581204951|FG013|Part A and Part B|Adverse Event|0|||
160950283|NCT02332720|581204952|FG014|Part A and Part B|Adverse Event|0|||
160950284|NCT02332720|581204953|FG015|Part A and Part B|Adverse Event|0|||
160950285|NCT02332720|581204954|FG016|Part A and Part B|Adverse Event|0|||
160950286|NCT02332720|581204955|FG017|Part A and Part B|Adverse Event|1|||
160950287|NCT02332720|581204956|FG018|Part A and Part B|Adverse Event|0|||
160950288|NCT02332720|581204957|FG019|Part A and Part B|Adverse Event|0|||
160950289|NCT02332720|581204958|FG020|Part A and Part B|Adverse Event|0|||
160950290|NCT02332720|581204959|FG021|Part A and Part B|Adverse Event|0|||
160950291|NCT02332720|581204960|FG022|Part A and Part B|Adverse Event|0|||
160950292|NCT02332720|581204938|FG000|Part A and Part B|Physician Decision|0|||
160950293|NCT02332720|581204939|FG001|Part A and Part B|Physician Decision|0|||
160950294|NCT02332720|581204940|FG002|Part A and Part B|Physician Decision|0|||
160950295|NCT02332720|581204941|FG003|Part A and Part B|Physician Decision|0|||
160950296|NCT02332720|581204942|FG004|Part A and Part B|Physician Decision|0|||
160950297|NCT02332720|581204943|FG005|Part A and Part B|Physician Decision|0|||
160950298|NCT02332720|581204944|FG006|Part A and Part B|Physician Decision|0|||
160950299|NCT02332720|581204945|FG007|Part A and Part B|Physician Decision|0|||
160950300|NCT02332720|581204946|FG008|Part A and Part B|Physician Decision|0|||
160950301|NCT02332720|581204947|FG009|Part A and Part B|Physician Decision|0|||
160950302|NCT02332720|581204948|FG010|Part A and Part B|Physician Decision|0|||
160950303|NCT02332720|581204949|FG011|Part A and Part B|Physician Decision|0|||
160950304|NCT02332720|581204950|FG012|Part A and Part B|Physician Decision|0|||
160950305|NCT02332720|581204951|FG013|Part A and Part B|Physician Decision|0|||
160950306|NCT02332720|581204952|FG014|Part A and Part B|Physician Decision|0|||
161000506|NCT01867216|581387111|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000507|NCT01867216|581387112|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000508|NCT01867216|581387113|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000509|NCT01867216|581387114|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000510|NCT01867216|581387115|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
161000511|NCT00186186|581387116|FG000|Overall Study|Lack of Efficacy|3|||
161000512|NCT00186186|581387116|FG000|Overall Study|Withdrawal by Subject|3|||
161000513|NCT00186186|581387116|FG000|Overall Study|Not reported as to reason|2|||
161000514|NCT02567656|581387120|FG000|Overall Study|Premature discontinuation due to PD|1|||
161000515|NCT02567656|581387121|FG001|Overall Study|Premature discontinuation due to PD|1|||
161000516|NCT02567656|581387122|FG002|Overall Study|Premature discontinuation due to PD|2|||
161000517|NCT02567656|581387123|FG003|Overall Study|Premature discontinuation due to PD|0|||
161000518|NCT02567656|581387124|FG004|Overall Study|Premature discontinuation due to PD|0|||
161000519|NCT02567656|581387125|FG005|Overall Study|Premature discontinuation due to PD|0|||
161000520|NCT01616654|581387126|FG000|Overall Study|Lack of Efficacy|1|||
161000521|NCT01616654|581387127|FG001|Overall Study|Lack of Efficacy|0|||
161000522|NCT01616654|581387128|FG002|Overall Study|Lack of Efficacy|0|||
161000523|NCT01616654|581387129|FG003|Overall Study|Lack of Efficacy|0|||
161000524|NCT01616654|581387130|FG004|Overall Study|Lack of Efficacy|1|||
161000525|NCT01616654|581387126|FG000|Overall Study|Adverse Event|0|||
161000526|NCT01616654|581387127|FG001|Overall Study|Adverse Event|1|||
161000527|NCT01616654|581387128|FG002|Overall Study|Adverse Event|2|||
161145520|NCT01629667|581915636|FG000|Overall Study|Withdrawal by Subject|31|||
161145521|NCT01629667|581915637|FG001|Overall Study|Withdrawal by Subject|20|||
161145522|NCT01629667|581915638|FG002|Overall Study|Withdrawal by Subject|28|||
161145523|NCT01629667|581915636|FG000|Overall Study|Death|1|||
161145524|NCT01629667|581915637|FG001|Overall Study|Death|5|||
161145525|NCT01629667|581915638|FG002|Overall Study|Death|3|||
161145526|NCT01629667|581915636|FG000|Overall Study|Randomized, not treated|2|||
161145527|NCT01629667|581915637|FG001|Overall Study|Randomized, not treated|1|||
161145528|NCT01629667|581915638|FG002|Overall Study|Randomized, not treated|0|||
161145529|NCT01629667|581915636|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
161145530|NCT01629667|581915637|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
161342792|NCT00157755|582642255|FG005|Overall Study|Study site closure|0|||
160950307|NCT02332720|581204953|FG015|Part A and Part B|Physician Decision|0|||
160950308|NCT02332720|581204954|FG016|Part A and Part B|Physician Decision|0|||
160950309|NCT02332720|581204955|FG017|Part A and Part B|Physician Decision|0|||
160950310|NCT02332720|581204956|FG018|Part A and Part B|Physician Decision|1|||
160950311|NCT02332720|581204957|FG019|Part A and Part B|Physician Decision|0|||
160950312|NCT02332720|581204958|FG020|Part A and Part B|Physician Decision|0|||
161000528|NCT01616654|581387129|FG003|Overall Study|Adverse Event|1|||
161000529|NCT01616654|581387130|FG004|Overall Study|Adverse Event|0|||
161000530|NCT01616654|581387126|FG000|Overall Study|Withdrawal by Subject|2|||
161000531|NCT01616654|581387127|FG001|Overall Study|Withdrawal by Subject|2|||
161145531|NCT01629667|581915638|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
161145532|NCT01629667|581915636|FG000|Overall Study|Requiring lung transplant|2|||
161145533|NCT01629667|581915637|FG001|Overall Study|Requiring lung transplant|1|||
161145534|NCT01629667|581915638|FG002|Overall Study|Requiring lung transplant|3|||
161145535|NCT01629667|581915636|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
161145536|NCT01629667|581915637|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
161145537|NCT01629667|581915638|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
161145538|NCT01629667|581915636|FG000|Overall Study|Started other medicine|1|||
161145539|NCT01629667|581915637|FG001|Overall Study|Started other medicine|0|||
161145540|NCT01629667|581915638|FG002|Overall Study|Started other medicine|1|||
161145541|NCT01629667|581915636|FG000|Overall Study|Site error in safety follow-up|0|||
161145542|NCT01629667|581915637|FG001|Overall Study|Site error in safety follow-up|0|||
161145543|NCT01629667|581915638|FG002|Overall Study|Site error in safety follow-up|1|||
161145544|NCT01629667|581915636|FG000|Overall Study|Enrolled in another clinical study|0|||
161268452|NCT02799095|582366772|FG010|Part C|Lost to Follow-up|1|||
161268453|NCT02799095|582366773|FG011|Part C|Lost to Follow-up|1|||
160950313|NCT02332720|581204959|FG021|Part A and Part B|Physician Decision|0|||
160950314|NCT02332720|581204960|FG022|Part A and Part B|Physician Decision|0|||
160950315|NCT02332720|581204938|FG000|Part A and Part B|Withdrawal by Subject|0|||
160950316|NCT02332720|581204939|FG001|Part A and Part B|Withdrawal by Subject|0|||
160950317|NCT02332720|581204940|FG002|Part A and Part B|Withdrawal by Subject|0|||
160950318|NCT02332720|581204941|FG003|Part A and Part B|Withdrawal by Subject|0|||
160950319|NCT02332720|581204942|FG004|Part A and Part B|Withdrawal by Subject|0|||
160950320|NCT02332720|581204943|FG005|Part A and Part B|Withdrawal by Subject|1|||
160950321|NCT02332720|581204944|FG006|Part A and Part B|Withdrawal by Subject|0|||
160950322|NCT02332720|581204945|FG007|Part A and Part B|Withdrawal by Subject|0|||
160950323|NCT02332720|581204946|FG008|Part A and Part B|Withdrawal by Subject|0|||
160950324|NCT02332720|581204947|FG009|Part A and Part B|Withdrawal by Subject|0|||
160950325|NCT02332720|581204948|FG010|Part A and Part B|Withdrawal by Subject|0|||
160950326|NCT02332720|581204949|FG011|Part A and Part B|Withdrawal by Subject|0|||
160950327|NCT02332720|581204950|FG012|Part A and Part B|Withdrawal by Subject|0|||
160950328|NCT02332720|581204951|FG013|Part A and Part B|Withdrawal by Subject|0|||
160950329|NCT02332720|581204952|FG014|Part A and Part B|Withdrawal by Subject|0|||
160950330|NCT02332720|581204953|FG015|Part A and Part B|Withdrawal by Subject|0|||
160950331|NCT02332720|581204954|FG016|Part A and Part B|Withdrawal by Subject|0|||
160950332|NCT02332720|581204955|FG017|Part A and Part B|Withdrawal by Subject|0|||
160950333|NCT02332720|581204956|FG018|Part A and Part B|Withdrawal by Subject|0|||
160950334|NCT02332720|581204957|FG019|Part A and Part B|Withdrawal by Subject|1|||
160950335|NCT02332720|581204958|FG020|Part A and Part B|Withdrawal by Subject|0|||
160950336|NCT02332720|581204959|FG021|Part A and Part B|Withdrawal by Subject|0|||
160950337|NCT02332720|581204960|FG022|Part A and Part B|Withdrawal by Subject|0|||
160950338|NCT05732454|581204961|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
160950339|NCT05732454|581204962|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
160950340|NCT05732454|581204961|FG000|Part 1: DB Period|Adverse Event|1|||
160950341|NCT05732454|581204962|FG001|Part 1: DB Period|Adverse Event|0|||
160950342|NCT05732454|581204961|FG000|Part 1: DB Period|Lost to Follow-up|1|||
160950343|NCT05732454|581204962|FG001|Part 1: DB Period|Lost to Follow-up|0|||
160950344|NCT05732454|581204961|FG000|Part 1: DB Period|Protocol Violation|0|||
160950345|NCT05732454|581204962|FG001|Part 1: DB Period|Protocol Violation|1|||
160950346|NCT05732454|581204961|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
160950347|NCT05732454|581204962|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
160950348|NCT05732454|581204961|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
160950349|NCT05732454|581204962|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
160950350|NCT05732454|581204961|FG000|Part 1: OLE Period|Adverse Event|0|||
160950351|NCT05732454|581204962|FG001|Part 1: OLE Period|Adverse Event|1|||
160950352|NCT05732454|581204961|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
160950353|NCT05732454|581204962|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
160950354|NCT00838110|581204965|FG000|Overall Study|Death|0|||
161268454|NCT02799095|582366774|FG012|Part C|Lost to Follow-up|1|||
161268455|NCT02799095|582366775|FG013|Part C|Lost to Follow-up|3|||
161268456|NCT02799095|582366776|FG014|Part C|Lost to Follow-up|0|||
161268457|NCT02799095|582366777|FG015|Part C|Lost to Follow-up|0|||
160950355|NCT00838110|581204966|FG001|Overall Study|Death|0|||
160950356|NCT00838110|581204967|FG002|Overall Study|Death|1|||
160950357|NCT00838110|581204968|FG003|Overall Study|Death|2|||
160950358|NCT00838110|581204965|FG000|Overall Study|Adverse Event|11|||
160950359|NCT00838110|581204966|FG001|Overall Study|Adverse Event|10|||
160950360|NCT00838110|581204967|FG002|Overall Study|Adverse Event|8|||
161145545|NCT01629667|581915637|FG001|Overall Study|Enrolled in another clinical study|1|||
161145546|NCT01629667|581915638|FG002|Overall Study|Enrolled in another clinical study|0|||
161268458|NCT02799095|582366778|FG016|Part C|Lost to Follow-up|0|||
161268459|NCT02799095|582366762|FG000|Part C|Progressive Disease|0|||
160950361|NCT00838110|581204968|FG003|Overall Study|Adverse Event|7|||
160950362|NCT00838110|581204965|FG000|Overall Study|Withdrawal by Subject|5|||
160950363|NCT00838110|581204966|FG001|Overall Study|Withdrawal by Subject|6|||
160950364|NCT00838110|581204967|FG002|Overall Study|Withdrawal by Subject|3|||
160950365|NCT00838110|581204968|FG003|Overall Study|Withdrawal by Subject|4|||
161145547|NCT01629667|581915636|FG000|Overall Study|Code break|1|||
160950366|NCT00838110|581204965|FG000|Overall Study|Other|3|||
160950367|NCT00838110|581204966|FG001|Overall Study|Other|3|||
160950368|NCT00838110|581204967|FG002|Overall Study|Other|3|||
160950369|NCT00838110|581204968|FG003|Overall Study|Other|2|||
160950370|NCT00838110|581204965|FG000|Overall Study|Protocol Violation|0|||
160950371|NCT00838110|581204966|FG001|Overall Study|Protocol Violation|2|||
160950372|NCT00838110|581204967|FG002|Overall Study|Protocol Violation|1|||
160950373|NCT00838110|581204968|FG003|Overall Study|Protocol Violation|1|||
160950374|NCT00838110|581204965|FG000|Overall Study|Lost to Follow-up|3|||
160950375|NCT00838110|581204966|FG001|Overall Study|Lost to Follow-up|0|||
160950376|NCT00838110|581204967|FG002|Overall Study|Lost to Follow-up|0|||
160950377|NCT00838110|581204968|FG003|Overall Study|Lost to Follow-up|0|||
160950378|NCT00838110|581204965|FG000|Overall Study|Did not meet eligibility criteria|0|||
160950379|NCT00838110|581204966|FG001|Overall Study|Did not meet eligibility criteria|0|||
160950380|NCT00838110|581204967|FG002|Overall Study|Did not meet eligibility criteria|1|||
160950381|NCT00838110|581204968|FG003|Overall Study|Did not meet eligibility criteria|2|||
160950382|NCT00838110|581204965|FG000|Overall Study|Randomized but not treated|0|||
160950383|NCT00838110|581204966|FG001|Overall Study|Randomized but not treated|1|||
160950384|NCT00838110|581204967|FG002|Overall Study|Randomized but not treated|0|||
160950385|NCT00838110|581204968|FG003|Overall Study|Randomized but not treated|0|||
160950386|NCT00352365|581204969|FG000|Induction Therapy|Adverse Event|7|||
160950387|NCT00352365|581204969|FG000|Induction Therapy|Progression/Relapse|8|||
160950388|NCT00352365|581204969|FG000|Induction Therapy|Death|7|||
160950389|NCT00352365|581204969|FG000|Induction Therapy|Not protocol specified|1|||
160950390|NCT00352365|581204969|FG000|Induction Therapy|Not eligible|3|||
160950391|NCT00352365|581204969|FG000|Induction Therapy|Death before starting protocol therapy|1|||
160950392|NCT00352365|581204969|FG000|Maintenance Therapy|Progression/Relapse|3|||
160950393|NCT00352365|581204969|FG000|Maintenance Therapy|Death|2|||
160950394|NCT00352365|581204969|FG000|Maintenance Therapy|Not protocol specified|3|||
160950395|NCT00352365|581204969|FG000|Maintenance Therapy|Not eligible|4|||
160950396|NCT01262651|581204970|FG000|Overall Study|Adverse Event|40|||
160950397|NCT01262651|581204971|FG001|Overall Study|Adverse Event|35|||
160950398|NCT01262651|581204970|FG000|Overall Study|Withdrawal by Subject|15|||
160950399|NCT01262651|581204971|FG001|Overall Study|Withdrawal by Subject|11|||
160950400|NCT01262651|581204970|FG000|Overall Study|Withdrawal by Investigator|2|||
160950401|NCT01262651|581204971|FG001|Overall Study|Withdrawal by Investigator|2|||
160950402|NCT01262651|581204970|FG000|Overall Study|Met Withdrawal Criteria|1|||
160950403|NCT01262651|581204971|FG001|Overall Study|Met Withdrawal Criteria|0|||
160950404|NCT04743908|581204972|FG000|Overall Study|Death|1|||
160950405|NCT04743908|581204973|FG001|Overall Study|Death|0|||
160950406|NCT04743908|581204972|FG000|Overall Study|Lost to Follow-up|181|||
160950407|NCT04743908|581204973|FG001|Overall Study|Lost to Follow-up|180|||
160950408|NCT04743908|581204972|FG000|Overall Study|Withdrawal by Subject|1|||
160950409|NCT04743908|581204973|FG001|Overall Study|Withdrawal by Subject|2|||
160950410|NCT03822533|581204974|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
160950411|NCT03822533|581204975|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
160950412|NCT03822533|581204974|FG000|3 Month Follow-up|Lost to Follow-up|2|||
160950413|NCT03822533|581204975|FG001|3 Month Follow-up|Lost to Follow-up|2|||
160950414|NCT03822533|581204974|FG000|6 Month Follow-up|Lost to Follow-up|3|||
160950415|NCT03822533|581204975|FG001|6 Month Follow-up|Lost to Follow-up|0|||
160950416|NCT03822533|581204974|FG000|12 Month Follow-up|Lost to Follow-up|2|||
160950417|NCT03822533|581204975|FG001|12 Month Follow-up|Lost to Follow-up|3|||
160950418|NCT03822533|581204974|FG000|12 Month Follow-up|Pregnancy|0|||
160950419|NCT03822533|581204975|FG001|12 Month Follow-up|Pregnancy|1|||
160950420|NCT03822533|581204974|FG000|12 Month Follow-up|Surgery|2|||
160950421|NCT03822533|581204975|FG001|12 Month Follow-up|Surgery|0|||
160950422|NCT03822533|581204974|FG000|12 Month Follow-up|Wrong address|1|||
160950423|NCT03822533|581204975|FG001|12 Month Follow-up|Wrong address|0|||
160950424|NCT03822533|581204974|FG000|12 Month Follow-up|No symptoms|1|||
160950425|NCT03822533|581204975|FG001|12 Month Follow-up|No symptoms|0|||
160950426|NCT03822533|581204974|FG000|12 Month Follow-up|Changed primary care center|0|||
160950427|NCT03822533|581204975|FG001|12 Month Follow-up|Changed primary care center|1|||
160950428|NCT02261363|581204978|FG000|Overall Study|Lost to Follow-up|21|||
160950429|NCT01517802|581204979|FG000|Overall Study|Death|1|||
161145548|NCT01629667|581915637|FG001|Overall Study|Code break|0|||
160950430|NCT02605954|581204980|FG000|Overall Study|Adverse Event|5|||
160950431|NCT02605954|581204981|FG001|Overall Study|Adverse Event|1|||
160950432|NCT02605954|581204980|FG000|Overall Study|Investigator's Discretion|1|||
160950433|NCT02605954|581204981|FG001|Overall Study|Investigator's Discretion|0|||
160950434|NCT02605954|581204980|FG000|Overall Study|Non-Compliance with Study Drug|1|||
160950435|NCT02605954|581204981|FG001|Overall Study|Non-Compliance with Study Drug|0|||
160950436|NCT02605954|581204980|FG000|Overall Study|Withdrew Consent|2|||
160950437|NCT02605954|581204981|FG001|Overall Study|Withdrew Consent|2|||
160950438|NCT02605954|581204980|FG000|Overall Study|Lost to Follow-up|3|||
160950439|NCT02605954|581204981|FG001|Overall Study|Lost to Follow-up|0|||
160950440|NCT02605954|581204980|FG000|Overall Study|Randomized but not treated|0|||
160950441|NCT02605954|581204981|FG001|Overall Study|Randomized but not treated|1|||
161000532|NCT01616654|581387128|FG002|Overall Study|Withdrawal by Subject|3|||
161000533|NCT01616654|581387129|FG003|Overall Study|Withdrawal by Subject|1|||
161000534|NCT01616654|581387130|FG004|Overall Study|Withdrawal by Subject|5|||
161000535|NCT01616654|581387126|FG000|Overall Study|Protocol Violation|0|||
161000536|NCT01616654|581387127|FG001|Overall Study|Protocol Violation|5|||
161000537|NCT01616654|581387128|FG002|Overall Study|Protocol Violation|2|||
161000538|NCT01616654|581387129|FG003|Overall Study|Protocol Violation|4|||
161000539|NCT01616654|581387130|FG004|Overall Study|Protocol Violation|4|||
161000540|NCT01616654|581387126|FG000|Overall Study|Lost to Follow-up|1|||
161000541|NCT01616654|581387127|FG001|Overall Study|Lost to Follow-up|0|||
161000542|NCT01616654|581387128|FG002|Overall Study|Lost to Follow-up|3|||
161000543|NCT01616654|581387129|FG003|Overall Study|Lost to Follow-up|2|||
161000544|NCT01616654|581387130|FG004|Overall Study|Lost to Follow-up|1|||
161000545|NCT01616654|581387126|FG000|Overall Study|Pregnancy|1|||
161000546|NCT01616654|581387127|FG001|Overall Study|Pregnancy|0|||
161000547|NCT01616654|581387128|FG002|Overall Study|Pregnancy|0|||
161000548|NCT01616654|581387129|FG003|Overall Study|Pregnancy|0|||
161000549|NCT01616654|581387130|FG004|Overall Study|Pregnancy|1|||
161000550|NCT02057692|581387131|FG000|Overall Study|Adverse Event|1|||
161000551|NCT02057692|581387132|FG001|Overall Study|Adverse Event|0|||
161000552|NCT02057692|581387133|FG002|Overall Study|Adverse Event|0|||
161000553|NCT02057692|581387134|FG003|Overall Study|Adverse Event|0|||
161000554|NCT02057692|581387131|FG000|Overall Study|Lost to Follow-up|0|||
161000555|NCT02057692|581387132|FG001|Overall Study|Lost to Follow-up|0|||
161000556|NCT02057692|581387133|FG002|Overall Study|Lost to Follow-up|0|||
161000557|NCT02057692|581387134|FG003|Overall Study|Lost to Follow-up|1|||
161000558|NCT03923491|581387135|FG000|Overall Study|Lost to Follow-up|5|||
161000559|NCT03923491|581387136|FG001|Overall Study|Lost to Follow-up|8|||
161000560|NCT03923491|581387135|FG000|Overall Study|Withdrawal by Subject|4|||
161000561|NCT03923491|581387136|FG001|Overall Study|Withdrawal by Subject|6|||
161000562|NCT03622580|581387141|FG000|Overall Study|Death|16|||
161000563|NCT03622580|581387142|FG001|Overall Study|Death|21|||
161000564|NCT03622580|581387143|FG002|Overall Study|Death|13|||
161000565|NCT03622580|581387141|FG000|Overall Study|Adverse Event|6|||
161000566|NCT03622580|581387142|FG001|Overall Study|Adverse Event|6|||
161000567|NCT03622580|581387143|FG002|Overall Study|Adverse Event|5|||
161000568|NCT03622580|581387141|FG000|Overall Study|Withdrawal by Subject|12|||
161000569|NCT03622580|581387142|FG001|Overall Study|Withdrawal by Subject|7|||
161000570|NCT03622580|581387143|FG002|Overall Study|Withdrawal by Subject|19|||
161000571|NCT03622580|581387141|FG000|Overall Study|Lost to Follow-up|12|||
161000572|NCT03622580|581387142|FG001|Overall Study|Lost to Follow-up|9|||
161000573|NCT03622580|581387143|FG002|Overall Study|Lost to Follow-up|9|||
161000574|NCT03622580|581387141|FG000|Overall Study|Protocol Violation|1|||
161000575|NCT03622580|581387142|FG001|Overall Study|Protocol Violation|0|||
161000576|NCT03622580|581387143|FG002|Overall Study|Protocol Violation|1|||
161000577|NCT03622580|581387141|FG000|Overall Study|Physician Decision|3|||
161000578|NCT03622580|581387142|FG001|Overall Study|Physician Decision|0|||
161000579|NCT03622580|581387143|FG002|Overall Study|Physician Decision|1|||
161000580|NCT03622580|581387141|FG000|Overall Study|Pregnancy|0|||
161000581|NCT03622580|581387142|FG001|Overall Study|Pregnancy|1|||
161000582|NCT03622580|581387143|FG002|Overall Study|Pregnancy|0|||
161000583|NCT03622580|581387141|FG000|Overall Study|Lack of Efficacy|0|||
161000584|NCT03622580|581387142|FG001|Overall Study|Lack of Efficacy|0|||
161000585|NCT03622580|581387143|FG002|Overall Study|Lack of Efficacy|1|||
161000586|NCT03622580|581387141|FG000|Overall Study|Other|2|||
161000587|NCT03622580|581387142|FG001|Overall Study|Other|0|||
161000588|NCT03622580|581387143|FG002|Overall Study|Other|3|||
161000589|NCT03959241|581387148|FG000|Overall Study|Withdrawal by Subject|7|||
161000590|NCT03959241|581387149|FG001|Overall Study|Withdrawal by Subject|8|||
161000591|NCT03959241|581387148|FG000|Overall Study|Lost to Follow-up|1|||
161000592|NCT03959241|581387149|FG001|Overall Study|Lost to Follow-up|0|||
161000593|NCT03959241|581387148|FG000|Overall Study|Move to Hospice Care|1|||
161000594|NCT03959241|581387149|FG001|Overall Study|Move to Hospice Care|0|||
161000595|NCT03959241|581387148|FG000|Overall Study|Screen Failure|1|||
161000596|NCT03959241|581387149|FG001|Overall Study|Screen Failure|0|||
161000597|NCT03959241|581387148|FG000|Overall Study|Disease Relapse|0|||
161000598|NCT03959241|581387149|FG001|Overall Study|Disease Relapse|1|||
161000599|NCT03959241|581387148|FG000|Overall Study|Off Study|1|||
161000600|NCT03959241|581387149|FG001|Overall Study|Off Study|0|||
161000601|NCT00943735|581387150|FG000|Overall Study|Adverse Event|12|||
161000602|NCT00943735|581387150|FG000|Overall Study|Withdrawal by Subject|8|||
161000603|NCT00943735|581387150|FG000|Overall Study|Death|1|||
161000604|NCT00943735|581387150|FG000|Overall Study|Other|8|||
161000605|NCT00943735|581387150|FG000|Overall Study|Other|3|||
161000606|NCT00545844|581387151|FG000|Overall Study|Lost to Follow-up|9|||
161000607|NCT00545844|581387151|FG000|Overall Study|Protocol Violation|1|||
161000608|NCT00545844|581387151|FG000|Overall Study|Withdrawal by Subject|2|||
161000609|NCT01329328|581387152|FG000|Overall Study|Withdrawal by Subject|2|||
161000610|NCT01329328|581387153|FG001|Overall Study|Withdrawal by Subject|4|||
161000611|NCT01329328|581387154|FG002|Overall Study|Withdrawal by Subject|3|||
161000612|NCT01565928|581387155|FG000|Overall Study|Adverse Event|3|||
160950442|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
160950443|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
160950444|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Death|1|||
160950445|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Death|0|||
160950446|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
160950447|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
160950448|NCT00455195|581204982|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
160950449|NCT00455195|581204983|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
160950450|NCT02117570|581204984|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
160950451|NCT02117570|581204985|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
160950452|NCT02117570|581204986|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
160950453|NCT02117570|581204984|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
160950454|NCT02117570|581204985|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
160950455|NCT02117570|581204986|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
160950456|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
160950457|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
160950458|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
160950459|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
160950460|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
160950461|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
160950462|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
160950463|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
160950464|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
160950465|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
160950466|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
160950467|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
160950468|NCT02117570|581204984|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
160950469|NCT02117570|581204985|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
160950470|NCT02117570|581204986|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
160950471|NCT02148250|581204987|FG000|Screening|Withdrawal by Subject|5|||
160950472|NCT02148250|581204988|FG001|Screening|Withdrawal by Subject|0|||
160950473|NCT01286779|581204989|FG000|Overall Study|Withdrawal by Subject|9|||
160950474|NCT01286779|581204989|FG000|Overall Study|Protocol Violation|5|||
160950475|NCT01286779|581204989|FG000|Overall Study|Physician Decision|2|||
160950476|NCT01286779|581204989|FG000|Overall Study|Participant had scheduled surgery|1|||
160950477|NCT01286779|581204989|FG000|Overall Study|Participant moved to another country|1|||
160950478|NCT01286779|581204989|FG000|Overall Study|Discontinued by sponsor|1|||
160950479|NCT00563784|581204990|FG000|Overall Study|Withdrawal by Subject|2|||
161268460|NCT02799095|582366763|FG001|Part C|Progressive Disease|0|||
160950480|NCT00563784|581204990|FG000|Overall Study|Screen Failures|20|||
160950481|NCT04004611|581204991|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950482|NCT04004611|581204992|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950483|NCT04004611|581204993|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950484|NCT04004611|581204994|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950485|NCT04004611|581204995|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950486|NCT04004611|581204996|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950487|NCT04004611|581204997|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950488|NCT04004611|581204998|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
160950489|NCT04004611|581204999|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
160950490|NCT04004611|581204991|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950491|NCT04004611|581204992|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950492|NCT04004611|581204993|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950493|NCT04004611|581204994|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950494|NCT04004611|581204995|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950495|NCT04004611|581204996|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
160950496|NCT04004611|581204997|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
160950497|NCT04004611|581204998|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
160950498|NCT04004611|581204999|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
161000613|NCT01565928|581387155|FG000|Overall Study|Other|3|||
161000614|NCT01565928|581387155|FG000|Overall Study|Progressive Disease|13|||
161000615|NCT01565928|581387155|FG000|Overall Study|Withdrawal by Subject|1|||
161000616|NCT01565928|581387155|FG000|Overall Study|Death|2|||
161000617|NCT01191788|581387157|FG000|Overall Study|Lost to Follow-up|21|||
161268461|NCT02799095|582366764|FG002|Part C|Progressive Disease|0|||
161268462|NCT02799095|582366765|FG003|Part C|Progressive Disease|0|||
160950499|NCT04004611|581204991|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950500|NCT04004611|581204992|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950501|NCT04004611|581204993|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161000618|NCT01191788|581387158|FG001|Overall Study|Lost to Follow-up|22|||
161145549|NCT01629667|581915638|FG002|Overall Study|Code break|0|||
161145550|NCT00984659|581915639|FG000|2-week Run-in Period|Adverse Event|8|||
161145551|NCT00984659|581915640|FG001|2-week Run-in Period|Adverse Event|0|||
161145552|NCT00984659|581915641|FG002|2-week Run-in Period|Adverse Event|0|||
161145553|NCT00984659|581915642|FG003|2-week Run-in Period|Adverse Event|0|||
161145554|NCT00984659|581915639|FG000|2-week Run-in Period|Protocol Violation|5|||
161145555|NCT00984659|581915640|FG001|2-week Run-in Period|Protocol Violation|0|||
161145556|NCT00984659|581915641|FG002|2-week Run-in Period|Protocol Violation|0|||
161145557|NCT00984659|581915642|FG003|2-week Run-in Period|Protocol Violation|0|||
161145558|NCT00984659|581915639|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
161145559|NCT00984659|581915640|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
161145560|NCT00984659|581915641|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
161145561|NCT00984659|581915642|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
161145562|NCT00984659|581915639|FG000|2-week Run-in Period|Lost to Follow-up|3|||
161145563|NCT00984659|581915640|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161145564|NCT00984659|581915641|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161145565|NCT00984659|581915642|FG003|2-week Run-in Period|Lost to Follow-up|0|||
161145566|NCT00984659|581915639|FG000|2-week Run-in Period|Physician Decision|10|||
161145567|NCT00984659|581915640|FG001|2-week Run-in Period|Physician Decision|0|||
161145568|NCT00984659|581915641|FG002|2-week Run-in Period|Physician Decision|0|||
161145569|NCT00984659|581915642|FG003|2-week Run-in Period|Physician Decision|0|||
160950502|NCT04004611|581204994|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
161145570|NCT00984659|581915639|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
161145571|NCT00984659|581915640|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161145572|NCT00984659|581915641|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161145573|NCT00984659|581915642|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
161145574|NCT00984659|581915639|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
161145575|NCT00984659|581915640|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161145576|NCT00984659|581915641|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161145577|NCT00984659|581915642|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
161145578|NCT00984659|581915639|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
161145579|NCT00984659|581915640|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
160950503|NCT04004611|581204995|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
160950504|NCT04004611|581204996|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950505|NCT04004611|581204997|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950506|NCT04004611|581204998|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950507|NCT04004611|581204999|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
160950508|NCT04004611|581204991|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
160950509|NCT04004611|581204992|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
160950510|NCT04004611|581204993|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
160950511|NCT04004611|581204994|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
160950512|NCT04004611|581204995|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
160950513|NCT04004611|581204996|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
160950514|NCT04004611|581204997|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
160950515|NCT04004611|581204998|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
160950516|NCT04004611|581204999|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
160950517|NCT04004611|581204991|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
160950518|NCT04004611|581204992|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950519|NCT04004611|581204993|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
160950520|NCT04004611|581204994|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950521|NCT04004611|581204995|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950522|NCT04004611|581204996|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950523|NCT04004611|581204997|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950524|NCT04004611|581204998|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950525|NCT04004611|581204999|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
160950526|NCT04004611|581204991|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950527|NCT04004611|581204992|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
160950528|NCT04004611|581204993|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950529|NCT04004611|581204994|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950530|NCT04004611|581204995|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950531|NCT04004611|581204996|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950532|NCT04004611|581204997|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950533|NCT04004611|581204998|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950534|NCT04004611|581204999|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
160950535|NCT00304070|581205000|FG000|Overall Study|Death|0|||
160950536|NCT00304070|581205001|FG001|Overall Study|Death|0|||
160950537|NCT00304070|581205002|FG002|Overall Study|Death|3|||
160950538|NCT00304070|581205000|FG000|Overall Study|Lost to Follow-up|0|||
160950539|NCT00304070|581205001|FG001|Overall Study|Lost to Follow-up|0|||
160950540|NCT00304070|581205002|FG002|Overall Study|Lost to Follow-up|1|||
160950541|NCT00304070|581205000|FG000|Overall Study|Physician Decision|0|||
160950542|NCT00304070|581205001|FG001|Overall Study|Physician Decision|0|||
160950543|NCT00304070|581205002|FG002|Overall Study|Physician Decision|3|||
160950544|NCT00304070|581205000|FG000|Overall Study|Withdrawal by Subject|0|||
160950545|NCT00304070|581205001|FG001|Overall Study|Withdrawal by Subject|0|||
160950546|NCT00304070|581205002|FG002|Overall Study|Withdrawal by Subject|1|||
160950547|NCT00304070|581205000|FG000|Overall Study|Progressive Disease|3|||
160950548|NCT00304070|581205001|FG001|Overall Study|Progressive Disease|7|||
160950549|NCT00304070|581205002|FG002|Overall Study|Progressive Disease|4|||
160950550|NCT03950739|581205003|FG000|Treatment Phase|Adverse Event|2|||
160950551|NCT03950739|581205003|FG000|Optional Extension Phase|Death|1|||
160950552|NCT03950739|581205003|FG000|Optional Extension Phase|Progressive Disease|5|||
160950553|NCT03950739|581205003|FG000|Optional Extension Phase|Adverse Event|7|||
160950554|NCT03950739|581205003|FG000|Optional Extension Phase|Lost to Follow-up|2|||
160950555|NCT03950739|581205003|FG000|Optional Extension Phase|Site Closure|2|||
161145580|NCT00984659|581915641|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
161145581|NCT00984659|581915642|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
160950556|NCT03950739|581205003|FG000|Optional Extension Phase|Pregnancy|1|||
160950557|NCT03625570|581205004|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
160950558|NCT03625570|581205005|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
160950559|NCT03625570|581205004|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
160950560|NCT03625570|581205005|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
160950561|NCT03625570|581205004|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
160950562|NCT03625570|581205005|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
160950563|NCT00093145|581205006|FG000|Overall Study|Unacceptable Toxicity Only|2|||
160950564|NCT00093145|581205006|FG000|Overall Study|Physician Decision|5|||
160950565|NCT00093145|581205006|FG000|Overall Study|Withdrawal by Subject|9|||
160950566|NCT00093145|581205006|FG000|Overall Study|Other|1|||
160950567|NCT01175668|581205007|FG000|Overall Study|Withdrawal by Subject|2|||
160950568|NCT01175668|581205008|FG001|Overall Study|Withdrawal by Subject|0|||
160950569|NCT03359096|581205009|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
160950570|NCT03359096|581205010|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
160950571|NCT03359096|581205009|FG000|First Intervention (4 Weeks)|Death|1|||
160950572|NCT03359096|581205010|FG001|First Intervention (4 Weeks)|Death|0|||
160950573|NCT03359096|581205009|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
160950574|NCT03359096|581205010|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
160950575|NCT04102501|581205013|FG000|Overall Study|Withdrawal by Subject|7|||
160950576|NCT04102501|581205014|FG001|Overall Study|Withdrawal by Subject|9|||
160950577|NCT04102501|581205013|FG000|Overall Study|Adverse Event|1|||
160950578|NCT04102501|581205014|FG001|Overall Study|Adverse Event|3|||
160950579|NCT00968617|581205015|FG000|Overall Study|Study terminated by sponsor|6|||
160950580|NCT04433767|581205016|FG000|Overall Study|Adverse Event|1|||
160950581|NCT01434602|581205021|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950582|NCT01434602|581205022|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
160950583|NCT01434602|581205023|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950584|NCT01434602|581205024|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950585|NCT01434602|581205025|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
160950586|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950587|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950588|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950589|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
160950590|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
160950591|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950592|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950593|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950594|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
160950595|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
160950596|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160950597|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160950598|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
160950599|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
160950600|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
161268463|NCT02799095|582366766|FG004|Part C|Progressive Disease|0|||
160950601|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950602|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950603|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950604|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
160950605|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
160950606|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950607|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950608|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950609|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
160950610|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
160950611|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950612|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950613|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950614|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
160950615|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
160950616|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
160950617|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
160950618|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
160950619|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
160950620|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
160950621|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950622|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950623|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950624|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
160950625|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
160950626|NCT01434602|581205021|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950627|NCT01434602|581205022|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950628|NCT01434602|581205023|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950629|NCT01434602|581205024|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
160950630|NCT01434602|581205025|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
160950631|NCT03864900|581205032|FG000|Overall Study|Withdrawal by Subject|1|||
160950632|NCT03864900|581205033|FG001|Overall Study|Withdrawal by Subject|1|||
160950633|NCT03864900|581205032|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
160950634|NCT03864900|581205033|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
160950635|NCT00759109|581205036|FG000|Overall Study|Adverse Event|17|||
160950636|NCT00759109|581205037|FG001|Overall Study|Adverse Event|12|||
160950637|NCT00759109|581205036|FG000|Overall Study|Inability to comply|1|||
160950638|NCT00759109|581205037|FG001|Overall Study|Inability to comply|1|||
160950639|NCT00759109|581205036|FG000|Overall Study|Withdrawal by Subject|9|||
160950640|NCT00759109|581205037|FG001|Overall Study|Withdrawal by Subject|5|||
160950641|NCT00759109|581205036|FG000|Overall Study|Death|4|||
160950642|NCT00759109|581205037|FG001|Overall Study|Death|3|||
160950643|NCT00759109|581205036|FG000|Overall Study|Lost to Follow-up|4|||
160950644|NCT00759109|581205037|FG001|Overall Study|Lost to Follow-up|6|||
160950645|NCT00759109|581205036|FG000|Overall Study|Started new therapy|2|||
160950646|NCT00759109|581205037|FG001|Overall Study|Started new therapy|6|||
160950647|NCT00759109|581205036|FG000|Overall Study|HCV RNA negative|1|||
160950648|NCT00759109|581205037|FG001|Overall Study|HCV RNA negative|0|||
160950649|NCT00759109|581205036|FG000|Overall Study|Participant moved to a different city|0|||
160950650|NCT00759109|581205037|FG001|Overall Study|Participant moved to a different city|1|||
160950651|NCT00759109|581205036|FG000|Overall Study|Participant had a liver transplant|0|||
160950652|NCT00759109|581205037|FG001|Overall Study|Participant had a liver transplant|1|||
160950653|NCT00759109|581205036|FG000|Overall Study|Lost during study|1|||
160950654|NCT00759109|581205037|FG001|Overall Study|Lost during study|0|||
160950655|NCT03325712|581205043|FG000|Overall Study|Protocol Violation|0|||
160950656|NCT03325712|581205044|FG001|Overall Study|Protocol Violation|0|||
160950657|NCT03325712|581205045|FG002|Overall Study|Protocol Violation|0|||
160950658|NCT03325712|581205046|FG003|Overall Study|Protocol Violation|0|||
160950659|NCT03325712|581205047|FG004|Overall Study|Protocol Violation|1|||
160950660|NCT03325712|581205048|FG005|Overall Study|Protocol Violation|0|||
160950661|NCT03325712|581205049|FG006|Overall Study|Protocol Violation|0|||
161268464|NCT02799095|582366767|FG005|Part C|Progressive Disease|0|||
161268465|NCT02799095|582366768|FG006|Part C|Progressive Disease|0|||
161268466|NCT02799095|582366769|FG007|Part C|Progressive Disease|0|||
161268467|NCT02799095|582366770|FG008|Part C|Progressive Disease|0|||
160950662|NCT03325712|581205050|FG007|Overall Study|Protocol Violation|0|||
160950663|NCT03325712|581205043|FG000|Overall Study|Adverse Event|0|||
160950664|NCT03325712|581205044|FG001|Overall Study|Adverse Event|0|||
161268468|NCT02799095|582366771|FG009|Part C|Progressive Disease|2|||
161268469|NCT02799095|582366772|FG010|Part C|Progressive Disease|13|||
161000619|NCT03621761|581387163|FG000|Overall Study|Lost to Follow-up|1|||
161000620|NCT03621761|581387164|FG001|Overall Study|Lost to Follow-up|1|||
161000621|NCT03621761|581387165|FG002|Overall Study|Lost to Follow-up|2|||
161000622|NCT03621761|581387163|FG000|Overall Study|Withdrawal by Subject|2|||
161000623|NCT03621761|581387164|FG001|Overall Study|Withdrawal by Subject|1|||
160950665|NCT03325712|581205045|FG002|Overall Study|Adverse Event|0|||
160950666|NCT03325712|581205046|FG003|Overall Study|Adverse Event|0|||
161000624|NCT03621761|581387165|FG002|Overall Study|Withdrawal by Subject|1|||
161000625|NCT03621761|581387163|FG000|Overall Study|Became Ineligible|0|||
161000626|NCT03621761|581387164|FG001|Overall Study|Became Ineligible|2|||
161000627|NCT03621761|581387165|FG002|Overall Study|Became Ineligible|0|||
161000628|NCT01713530|581387168|FG000|Overall Study|Adverse Event|0|||
161000629|NCT01713530|581387169|FG001|Overall Study|Adverse Event|5|||
160950667|NCT03325712|581205047|FG004|Overall Study|Adverse Event|1|||
160950668|NCT03325712|581205048|FG005|Overall Study|Adverse Event|0|||
160950669|NCT03325712|581205049|FG006|Overall Study|Adverse Event|0|||
160950670|NCT03325712|581205050|FG007|Overall Study|Adverse Event|0|||
160950671|NCT02265237|581205051|FG000|As Treated (Overall Study)|Adverse Event|1|||
160950672|NCT02265237|581205052|FG001|As Treated (Overall Study)|Adverse Event|1|||
160950673|NCT02265237|581205053|FG002|As Treated (Overall Study)|Adverse Event|0|||
160950674|NCT02265237|581205054|FG003|As Treated (Overall Study)|Adverse Event|0|||
160950675|NCT02265237|581205051|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
160950676|NCT02265237|581205052|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
160950677|NCT02265237|581205053|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
160950678|NCT02265237|581205054|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
160950679|NCT02265237|581205051|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
160950680|NCT02265237|581205052|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
160950681|NCT02265237|581205053|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
160950682|NCT02265237|581205054|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
160950683|NCT02265237|581205051|FG000|As Treated (Overall Study)|Other|2|||
160950684|NCT02265237|581205052|FG001|As Treated (Overall Study)|Other|0|||
160950685|NCT02265237|581205053|FG002|As Treated (Overall Study)|Other|3|||
160950686|NCT02265237|581205054|FG003|As Treated (Overall Study)|Other|1|||
160950687|NCT01178853|581205056|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
160950688|NCT01178853|581205057|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
160950689|NCT01178853|581205056|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
160950690|NCT01178853|581205057|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
160950691|NCT01178853|581205056|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
160950692|NCT01178853|581205057|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
160950693|NCT01178853|581205056|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
160950694|NCT01178853|581205057|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
160950695|NCT01178853|581205056|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
160950696|NCT01178853|581205057|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
160950697|NCT03550313|581205058|FG000|Overall Study|Adverse Event|0|||
160950698|NCT03550313|581205059|FG001|Overall Study|Adverse Event|1|||
160950699|NCT03550313|581205060|FG002|Overall Study|Adverse Event|0|||
160950700|NCT03550313|581205058|FG000|Overall Study|Lost to Follow-up|5|||
160950701|NCT03550313|581205059|FG001|Overall Study|Lost to Follow-up|7|||
160950702|NCT03550313|581205060|FG002|Overall Study|Lost to Follow-up|12|||
160950703|NCT03550313|581205058|FG000|Overall Study|Study terminated by sponsor|44|||
160950704|NCT03550313|581205059|FG001|Overall Study|Study terminated by sponsor|37|||
160950705|NCT03550313|581205060|FG002|Overall Study|Study terminated by sponsor|48|||
160950706|NCT03550313|581205058|FG000|Overall Study|No longer met eligibility criteria|3|||
160950707|NCT03550313|581205059|FG001|Overall Study|No longer met eligibility criteria|5|||
161000630|NCT01713530|581387168|FG000|Overall Study|Withdrawal criteria|21|||
161000631|NCT01713530|581387169|FG001|Overall Study|Withdrawal criteria|12|||
161000632|NCT01713530|581387168|FG000|Overall Study|Unclassified|4|||
161000633|NCT01713530|581387169|FG001|Overall Study|Unclassified|2|||
161000634|NCT03939819|581387170|FG000|Overall Study|Death|2|||
161000635|NCT03939819|581387171|FG001|Overall Study|Death|0|||
161000636|NCT03987451|581387172|FG000|Overall Study|Lost to Follow-up|1|||
161000637|NCT03987451|581387173|FG001|Overall Study|Lost to Follow-up|0|||
161000638|NCT03987451|581387172|FG000|Overall Study|Withdrawal by Subject|1|||
161145582|NCT00984659|581915639|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
161145583|NCT00984659|581915640|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
161145584|NCT00984659|581915641|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
161268470|NCT02799095|582366773|FG011|Part C|Progressive Disease|2|||
160950708|NCT03550313|581205060|FG002|Overall Study|No longer met eligibility criteria|6|||
160950709|NCT03550313|581205058|FG000|Overall Study|Withdrawal by parent/guardian|20|||
160950710|NCT03550313|581205059|FG001|Overall Study|Withdrawal by parent/guardian|18|||
160950711|NCT03550313|581205060|FG002|Overall Study|Withdrawal by parent/guardian|26|||
160950712|NCT03550313|581205058|FG000|Overall Study|Other|4|||
160950713|NCT03550313|581205059|FG001|Overall Study|Other|2|||
160950714|NCT03550313|581205060|FG002|Overall Study|Other|2|||
160950715|NCT03550313|581205058|FG000|Overall Study|Randomized but not vaccinated|3|||
161000639|NCT03987451|581387173|FG001|Overall Study|Withdrawal by Subject|1|||
160950716|NCT03550313|581205059|FG001|Overall Study|Randomized but not vaccinated|23|||
160950717|NCT03550313|581205060|FG002|Overall Study|Randomized but not vaccinated|2|||
160950718|NCT03550313|581205058|FG000|Overall Study|Sites terminated due to quality issues|18|||
160950719|NCT03550313|581205059|FG001|Overall Study|Sites terminated due to quality issues|17|||
160950720|NCT03550313|581205060|FG002|Overall Study|Sites terminated due to quality issues|18|||
160950721|NCT00839072|581205061|FG000|First Intervention Period|Withdrawal by Subject|1|||
160950722|NCT00839072|581205062|FG001|First Intervention Period|Withdrawal by Subject|0|||
160950723|NCT00839072|581205061|FG000|First Intervention Period|Adverse Event|1|||
160950724|NCT00839072|581205062|FG001|First Intervention Period|Adverse Event|1|||
160950725|NCT00839072|581205061|FG000|Second Intervention Period|Withdrawal by Subject|1|||
160950726|NCT00839072|581205062|FG001|Second Intervention Period|Withdrawal by Subject|0|||
160950727|NCT00380068|581205063|FG000|Overall Study|Adverse Event|40|||
160950728|NCT00380068|581205063|FG000|Overall Study|Withdrawal by Subject|10|||
160950729|NCT00380068|581205063|FG000|Overall Study|Not compliant|6|||
160950730|NCT00380068|581205063|FG000|Overall Study|Lost to Follow-up|1|||
160950731|NCT00380068|581205063|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
160950732|NCT00380068|581205063|FG000|Overall Study|Lung transplant|3|||
160950733|NCT00380068|581205063|FG000|Overall Study|Physician Decision|2|||
160950734|NCT00380068|581205063|FG000|Overall Study|Partipant moved away|1|||
160950735|NCT00380068|581205063|FG000|Overall Study|Lack of Efficacy|5|||
160950736|NCT01297062|581205064|FG000|Overall Study|Adverse Event|2|||
160950737|NCT01297062|581205065|FG001|Overall Study|Adverse Event|0|||
160950738|NCT01297062|581205066|FG002|Overall Study|Adverse Event|1|||
160950739|NCT01297062|581205067|FG003|Overall Study|Adverse Event|0|||
160950740|NCT01297062|581205068|FG004|Overall Study|Adverse Event|0|||
160950741|NCT01297062|581205069|FG005|Overall Study|Adverse Event|0|||
160950742|NCT01297062|581205070|FG006|Overall Study|Adverse Event|0|||
160950743|NCT01297062|581205064|FG000|Overall Study|Physician Decision|1|||
160950744|NCT01297062|581205065|FG001|Overall Study|Physician Decision|0|||
160950745|NCT01297062|581205066|FG002|Overall Study|Physician Decision|1|||
160950746|NCT01297062|581205067|FG003|Overall Study|Physician Decision|0|||
160950747|NCT01297062|581205068|FG004|Overall Study|Physician Decision|0|||
160950748|NCT01297062|581205069|FG005|Overall Study|Physician Decision|0|||
160950749|NCT01297062|581205070|FG006|Overall Study|Physician Decision|6|||
160950750|NCT01297062|581205064|FG000|Overall Study|Protocol Violation|0|||
160950751|NCT01297062|581205065|FG001|Overall Study|Protocol Violation|0|||
160950752|NCT01297062|581205066|FG002|Overall Study|Protocol Violation|0|||
160950753|NCT01297062|581205067|FG003|Overall Study|Protocol Violation|0|||
160950754|NCT01297062|581205068|FG004|Overall Study|Protocol Violation|1|||
160950755|NCT01297062|581205069|FG005|Overall Study|Protocol Violation|0|||
160950756|NCT01297062|581205070|FG006|Overall Study|Protocol Violation|0|||
160950757|NCT01297062|581205064|FG000|Overall Study|Subject Decision|1|||
160950758|NCT01297062|581205065|FG001|Overall Study|Subject Decision|1|||
160950759|NCT01297062|581205066|FG002|Overall Study|Subject Decision|0|||
160950760|NCT01297062|581205067|FG003|Overall Study|Subject Decision|1|||
160950761|NCT01297062|581205068|FG004|Overall Study|Subject Decision|1|||
160950762|NCT01297062|581205069|FG005|Overall Study|Subject Decision|1|||
160950763|NCT01297062|581205070|FG006|Overall Study|Subject Decision|2|||
160950764|NCT04964089|581205071|FG000|Overall Study|Adverse Event|8|||
160950765|NCT04964089|581205072|FG001|Overall Study|Adverse Event|6|||
160950766|NCT04964089|581205071|FG000|Overall Study|Non-compliance with study schedule|1|||
160950767|NCT04964089|581205072|FG001|Overall Study|Non-compliance with study schedule|0|||
160950768|NCT04964089|581205071|FG000|Overall Study|Withdrawal by Subject|6|||
160950769|NCT04964089|581205072|FG001|Overall Study|Withdrawal by Subject|5|||
160950770|NCT04964089|581205071|FG000|Overall Study|Lost to Follow-up|1|||
160950771|NCT04964089|581205072|FG001|Overall Study|Lost to Follow-up|1|||
160950772|NCT04964089|581205071|FG000|Overall Study|Progressive disease|4|||
160950773|NCT04964089|581205072|FG001|Overall Study|Progressive disease|0|||
160950774|NCT04964089|581205071|FG000|Overall Study|Physician Decision|1|||
160950775|NCT04964089|581205072|FG001|Overall Study|Physician Decision|0|||
160950776|NCT04964089|581205071|FG000|Overall Study|Participant did not want to continue study treatment|1|||
160950777|NCT04964089|581205072|FG001|Overall Study|Participant did not want to continue study treatment|0|||
160950778|NCT04964089|581205071|FG000|Overall Study|Participant moved to different state|1|||
160950779|NCT04964089|581205072|FG001|Overall Study|Participant moved to different state|0|||
160950780|NCT04964089|581205071|FG000|Overall Study|Participant decided to discontinue|0|||
160950781|NCT04964089|581205072|FG001|Overall Study|Participant decided to discontinue|1|||
160950782|NCT03191903|581205073|FG000|Overall Study|Withdrawal by Subject|6|||
160950783|NCT03191903|581205074|FG001|Overall Study|Withdrawal by Subject|5|||
160950784|NCT03191903|581205075|FG002|Overall Study|Withdrawal by Subject|4|||
160950785|NCT03191903|581205073|FG000|Overall Study|Adverse Event|1|||
160950786|NCT03191903|581205074|FG001|Overall Study|Adverse Event|0|||
160950787|NCT03191903|581205075|FG002|Overall Study|Adverse Event|0|||
160950788|NCT00503685|581205079|FG000|Overall Study|Adverse Event|0|||
160950789|NCT00503685|581205080|FG001|Overall Study|Adverse Event|0|||
160950790|NCT00503685|581205081|FG002|Overall Study|Adverse Event|2|||
160950791|NCT00503685|581205079|FG000|Overall Study|Withdrawal by Subject|0|||
161000640|NCT02441036|581387174|FG000|Overall Study|No tissue resected|0|||
161145585|NCT00984659|581915642|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
161145586|NCT00984659|581915639|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
161145587|NCT00984659|581915640|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
161145588|NCT00984659|581915641|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
161145589|NCT00984659|581915642|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
161145590|NCT00984659|581915639|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161145591|NCT00984659|581915640|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161145592|NCT00984659|581915641|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
161145593|NCT00984659|581915642|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
161145594|NCT00984659|581915639|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161145595|NCT00984659|581915640|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
161145596|NCT00984659|581915641|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
161145597|NCT00984659|581915642|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
161145598|NCT00891657|581915645|FG000|Overall Study|Withdrawal by Subject|1|||
161145599|NCT00891657|581915646|FG001|Overall Study|Withdrawal by Subject|1|||
161145600|NCT03455543|581915652|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
161145601|NCT03455543|581915653|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
161145602|NCT03455543|581915654|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
161145603|NCT03455543|581915652|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
160950792|NCT00503685|581205080|FG001|Overall Study|Withdrawal by Subject|1|||
160950793|NCT00503685|581205081|FG002|Overall Study|Withdrawal by Subject|0|||
160950794|NCT00503685|581205079|FG000|Overall Study|Protocol Violation|0|||
160950795|NCT00503685|581205080|FG001|Overall Study|Protocol Violation|1|||
160950796|NCT00503685|581205081|FG002|Overall Study|Protocol Violation|0|||
160950797|NCT00503685|581205079|FG000|Overall Study|Eligibility Criteria Not Met|0|||
160950798|NCT00503685|581205080|FG001|Overall Study|Eligibility Criteria Not Met|1|||
160950799|NCT00503685|581205081|FG002|Overall Study|Eligibility Criteria Not Met|0|||
160950800|NCT00927927|581205082|FG000|Overall Study|Withdrawal by Subject|0|||
160950801|NCT00927927|581205083|FG001|Overall Study|Withdrawal by Subject|0|||
160950802|NCT00927927|581205084|FG002|Overall Study|Withdrawal by Subject|0|||
160950803|NCT00927927|581205085|FG003|Overall Study|Withdrawal by Subject|0|||
160950804|NCT00927927|581205086|FG004|Overall Study|Withdrawal by Subject|0|||
160950805|NCT00927927|581205087|FG005|Overall Study|Withdrawal by Subject|0|||
160950806|NCT00927927|581205088|FG006|Overall Study|Withdrawal by Subject|0|||
160950807|NCT00927927|581205089|FG007|Overall Study|Withdrawal by Subject|2|||
160950808|NCT00927927|581205090|FG008|Overall Study|Withdrawal by Subject|0|||
160950809|NCT00927927|581205091|FG009|Overall Study|Withdrawal by Subject|0|||
160950810|NCT00927927|581205092|FG010|Overall Study|Withdrawal by Subject|0|||
160950811|NCT00927927|581205093|FG011|Overall Study|Withdrawal by Subject|2|||
160950812|NCT00927927|581205094|FG012|Overall Study|Withdrawal by Subject|0|||
160950813|NCT00927927|581205095|FG013|Overall Study|Withdrawal by Subject|0|||
160950814|NCT00927927|581205096|FG014|Overall Study|Withdrawal by Subject|0|||
160950815|NCT03135522|581205105|FG000|Overall Study|Adverse Event|1|||
160950816|NCT03135522|581205106|FG001|Overall Study|Adverse Event|0|||
160950817|NCT03403634|581205107|FG000|Overall Study|Disease progression|3|||
160950818|NCT03403634|581205107|FG000|Overall Study|Did not meet eligibility criteria|4|||
160950819|NCT00924287|581207282|FG000|Overall Study|Death|1|||
160950820|NCT00156065|581207289|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
160950821|NCT00156065|581207290|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
160950822|NCT00156065|581207291|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
160950823|NCT00156065|581207289|FG000|Overall Study|Adverse Event|8|||
160950824|NCT00156065|581207290|FG001|Overall Study|Adverse Event|11|||
160950825|NCT00156065|581207291|FG002|Overall Study|Adverse Event|4|||
160950826|NCT00156065|581207289|FG000|Overall Study|Lack of Efficacy|2|||
160950827|NCT00156065|581207290|FG001|Overall Study|Lack of Efficacy|9|||
160950828|NCT00156065|581207291|FG002|Overall Study|Lack of Efficacy|3|||
160950829|NCT00156065|581207289|FG000|Overall Study|Withdrawal by Subject|13|||
160950830|NCT00156065|581207290|FG001|Overall Study|Withdrawal by Subject|26|||
160950831|NCT00156065|581207291|FG002|Overall Study|Withdrawal by Subject|16|||
160950832|NCT00156065|581207289|FG000|Overall Study|Lost to Follow-up|5|||
160950833|NCT00156065|581207290|FG001|Overall Study|Lost to Follow-up|7|||
160950834|NCT00156065|581207291|FG002|Overall Study|Lost to Follow-up|1|||
160950835|NCT00156065|581207289|FG000|Overall Study|Other|2|||
160950836|NCT00156065|581207290|FG001|Overall Study|Other|9|||
160950837|NCT00156065|581207291|FG002|Overall Study|Other|3|||
160950838|NCT01432366|581207292|FG000|Overall Study|Non-Responder|7|||
160950839|NCT01432366|581207292|FG000|Overall Study|Adverse Event|8|||
160950840|NCT01432366|581207292|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
160950841|NCT01432366|581207292|FG000|Overall Study|Pregnancy|1|||
160950842|NCT01432366|581207292|FG000|Overall Study|Lost to Follow-up|13|||
160950843|NCT01432366|581207292|FG000|Overall Study|Lack of Efficacy|1|||
160950844|NCT01432366|581207292|FG000|Overall Study|Site Closed|20|||
161000641|NCT02441036|581387175|FG001|Overall Study|No tissue resected|1|||
160950845|NCT01432366|581207292|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
160950846|NCT01432366|581207292|FG000|Overall Study|Other|14|||
160950847|NCT02395120|581207293|FG000|Overall Study|Missed follow-up dental exam|57|||
160950848|NCT02395120|581207294|FG001|Overall Study|Missed follow-up dental exam|62|||
160950849|NCT02395120|581207295|FG002|Overall Study|Missed follow-up dental exam|6|||
160950850|NCT02395120|581207296|FG003|Overall Study|Missed follow-up dental exam|6|||
160950851|NCT02395120|581207297|FG004|Overall Study|Missed follow-up dental exam|51|||
160950852|NCT04546581|581207299|FG000|Overall Study|Adverse Event|9|||
160950853|NCT04546581|581207300|FG001|Overall Study|Adverse Event|3|||
160950854|NCT04546581|581207299|FG000|Overall Study|Physician Decision|0|||
160950855|NCT04546581|581207300|FG001|Overall Study|Physician Decision|1|||
160950856|NCT04546581|581207299|FG000|Overall Study|Protocol Violation|1|||
160950857|NCT04546581|581207300|FG001|Overall Study|Protocol Violation|2|||
160950858|NCT04546581|581207299|FG000|Overall Study|Withdrawal by Subject|3|||
160950859|NCT04546581|581207300|FG001|Overall Study|Withdrawal by Subject|7|||
160950860|NCT02526693|581207301|FG000|Overall Study|Physician Decision|3|||
160950861|NCT02526693|581207302|FG001|Overall Study|Physician Decision|1|||
160950862|NCT01798927|581207303|FG000|Overall Study|Withdrawal by Subject|1|||
160950863|NCT01159691|581207304|FG000|Overall Study|Lost to Follow-up|2|||
160950864|NCT01159691|581207304|FG000|Overall Study|Unknown reasons|1|||
160950865|NCT01159691|581207304|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
160950866|NCT01159691|581207304|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
160950867|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
160950868|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
160950869|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
160950870|NCT01159691|581207304|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
160950871|NCT04579757|581207315|FG000|Overall Study|Adverse Event|0|||
160950872|NCT04579757|581207316|FG001|Overall Study|Adverse Event|0|||
160950873|NCT04579757|581207317|FG002|Overall Study|Adverse Event|0|||
160950874|NCT04579757|581207318|FG003|Overall Study|Adverse Event|2|||
160950875|NCT04579757|581207319|FG004|Overall Study|Adverse Event|1|||
160950876|NCT04579757|581207320|FG005|Overall Study|Adverse Event|1|||
160950877|NCT04579757|581207321|FG006|Overall Study|Adverse Event|0|||
160950878|NCT04579757|581207322|FG007|Overall Study|Adverse Event|0|||
160950879|NCT04579757|581207323|FG008|Overall Study|Adverse Event|0|||
160950880|NCT04579757|581207315|FG000|Overall Study|Death|4|||
160950881|NCT04579757|581207316|FG001|Overall Study|Death|1|||
160950882|NCT04579757|581207317|FG002|Overall Study|Death|14|||
160950883|NCT04579757|581207318|FG003|Overall Study|Death|3|||
160950884|NCT04579757|581207319|FG004|Overall Study|Death|2|||
160950885|NCT04579757|581207320|FG005|Overall Study|Death|7|||
160950886|NCT04579757|581207321|FG006|Overall Study|Death|0|||
160950887|NCT04579757|581207322|FG007|Overall Study|Death|1|||
160950888|NCT04579757|581207323|FG008|Overall Study|Death|3|||
160950889|NCT04579757|581207315|FG000|Overall Study|Physician Decision|0|||
160950890|NCT04579757|581207316|FG001|Overall Study|Physician Decision|0|||
160950891|NCT04579757|581207317|FG002|Overall Study|Physician Decision|0|||
160950892|NCT04579757|581207318|FG003|Overall Study|Physician Decision|2|||
160950893|NCT04579757|581207319|FG004|Overall Study|Physician Decision|1|||
160950894|NCT04579757|581207320|FG005|Overall Study|Physician Decision|1|||
160950895|NCT04579757|581207321|FG006|Overall Study|Physician Decision|1|||
160950896|NCT04579757|581207322|FG007|Overall Study|Physician Decision|0|||
160950897|NCT04579757|581207323|FG008|Overall Study|Physician Decision|0|||
160950898|NCT04579757|581207315|FG000|Overall Study|Study Terminated By Sponsor|0|||
160950899|NCT04579757|581207316|FG001|Overall Study|Study Terminated By Sponsor|0|||
160950900|NCT04579757|581207317|FG002|Overall Study|Study Terminated By Sponsor|0|||
160950901|NCT04579757|581207318|FG003|Overall Study|Study Terminated By Sponsor|0|||
161000642|NCT02441036|581387176|FG002|Overall Study|No tissue resected|0|||
161000643|NCT02441036|581387177|FG003|Overall Study|No tissue resected|1|||
160950902|NCT04579757|581207319|FG004|Overall Study|Study Terminated By Sponsor|2|||
160950903|NCT04579757|581207320|FG005|Overall Study|Study Terminated By Sponsor|0|||
160950904|NCT04579757|581207321|FG006|Overall Study|Study Terminated By Sponsor|0|||
160950905|NCT04579757|581207322|FG007|Overall Study|Study Terminated By Sponsor|2|||
160950906|NCT04579757|581207323|FG008|Overall Study|Study Terminated By Sponsor|0|||
160950907|NCT04579757|581207315|FG000|Overall Study|Withdrawal by Subject|1|||
160950908|NCT04579757|581207316|FG001|Overall Study|Withdrawal by Subject|1|||
161000644|NCT02441036|581387178|FG004|Overall Study|No tissue resected|0|||
161342793|NCT00157755|582642250|FG000|Overall Study|Subject non-compliance|0|||
160950909|NCT04579757|581207317|FG002|Overall Study|Withdrawal by Subject|0|||
160950910|NCT04579757|581207318|FG003|Overall Study|Withdrawal by Subject|0|||
160950911|NCT04579757|581207319|FG004|Overall Study|Withdrawal by Subject|2|||
160950912|NCT04579757|581207320|FG005|Overall Study|Withdrawal by Subject|1|||
160950913|NCT04579757|581207321|FG006|Overall Study|Withdrawal by Subject|0|||
160950914|NCT04579757|581207322|FG007|Overall Study|Withdrawal by Subject|3|||
160950915|NCT04579757|581207323|FG008|Overall Study|Withdrawal by Subject|0|||
160950916|NCT04579757|581207315|FG000|Overall Study|Radiological or Clinical PD|1|||
160950917|NCT04579757|581207316|FG001|Overall Study|Radiological or Clinical PD|4|||
160950918|NCT04579757|581207317|FG002|Overall Study|Radiological or Clinical PD|1|||
160950919|NCT04579757|581207318|FG003|Overall Study|Radiological or Clinical PD|3|||
160950920|NCT04579757|581207319|FG004|Overall Study|Radiological or Clinical PD|9|||
160950921|NCT04579757|581207320|FG005|Overall Study|Radiological or Clinical PD|4|||
160950922|NCT04579757|581207321|FG006|Overall Study|Radiological or Clinical PD|2|||
160950923|NCT04579757|581207322|FG007|Overall Study|Radiological or Clinical PD|2|||
160950924|NCT04579757|581207323|FG008|Overall Study|Radiological or Clinical PD|0|||
160950925|NCT04579757|581207315|FG000|Overall Study|Start of New Therapy|0|||
160950926|NCT04579757|581207316|FG001|Overall Study|Start of New Therapy|0|||
160950927|NCT04579757|581207317|FG002|Overall Study|Start of New Therapy|0|||
160950928|NCT04579757|581207318|FG003|Overall Study|Start of New Therapy|0|||
160950929|NCT04579757|581207319|FG004|Overall Study|Start of New Therapy|2|||
160950930|NCT04579757|581207320|FG005|Overall Study|Start of New Therapy|1|||
160950931|NCT04579757|581207321|FG006|Overall Study|Start of New Therapy|0|||
160950932|NCT04579757|581207322|FG007|Overall Study|Start of New Therapy|0|||
160950933|NCT04579757|581207323|FG008|Overall Study|Start of New Therapy|0|||
160950934|NCT01153633|581207324|FG000|Overall Study|Protocol Violation|1|||
160950935|NCT01153633|581207325|FG001|Overall Study|Protocol Violation|1|||
160950936|NCT01153633|581207324|FG000|Overall Study|Therapeutic failure|3|||
160950937|NCT01153633|581207325|FG001|Overall Study|Therapeutic failure|3|||
160950938|NCT00384085|581207326|FG000|Overall Study|Adverse Event|5|||
160950939|NCT00384085|581207327|FG001|Overall Study|Adverse Event|5|||
160950940|NCT00384085|581207328|FG002|Overall Study|Adverse Event|4|||
160950941|NCT00384085|581207326|FG000|Overall Study|Lack of Efficacy|0|||
160950942|NCT00384085|581207327|FG001|Overall Study|Lack of Efficacy|3|||
160950943|NCT00384085|581207328|FG002|Overall Study|Lack of Efficacy|2|||
160950944|NCT00384085|581207326|FG000|Overall Study|No longer Requires Study Treatment|1|||
160950945|NCT00384085|581207327|FG001|Overall Study|No longer Requires Study Treatment|0|||
160950946|NCT00384085|581207328|FG002|Overall Study|No longer Requires Study Treatment|1|||
160950947|NCT00384085|581207326|FG000|Overall Study|Protocol Violation|2|||
160950948|NCT00384085|581207327|FG001|Overall Study|Protocol Violation|2|||
160950949|NCT00384085|581207328|FG002|Overall Study|Protocol Violation|2|||
160950950|NCT00384085|581207326|FG000|Overall Study|Lost to Follow-up|9|||
160950951|NCT00384085|581207327|FG001|Overall Study|Lost to Follow-up|9|||
160950952|NCT00384085|581207328|FG002|Overall Study|Lost to Follow-up|10|||
160950953|NCT00384085|581207326|FG000|Overall Study|Progressive Disease|0|||
160950954|NCT00384085|581207327|FG001|Overall Study|Progressive Disease|1|||
160950955|NCT00384085|581207328|FG002|Overall Study|Progressive Disease|0|||
160950956|NCT00384085|581207326|FG000|Overall Study|Withdrawal by Subject|14|||
160950957|NCT00384085|581207327|FG001|Overall Study|Withdrawal by Subject|19|||
160950958|NCT00384085|581207328|FG002|Overall Study|Withdrawal by Subject|29|||
160950959|NCT00384085|581207326|FG000|Overall Study|Patient non-compliant|4|||
160950960|NCT00384085|581207327|FG001|Overall Study|Patient non-compliant|4|||
160950961|NCT00384085|581207328|FG002|Overall Study|Patient non-compliant|5|||
160950962|NCT00384085|581207326|FG000|Overall Study|Physician Decision|1|||
160950963|NCT00384085|581207327|FG001|Overall Study|Physician Decision|0|||
160950964|NCT00384085|581207328|FG002|Overall Study|Physician Decision|0|||
160950965|NCT00384085|581207326|FG000|Overall Study|Loss of site personnel|1|||
160950966|NCT00384085|581207327|FG001|Overall Study|Loss of site personnel|0|||
160950967|NCT00384085|581207328|FG002|Overall Study|Loss of site personnel|1|||
160950968|NCT00384085|581207326|FG000|Overall Study|Sponsor decision|1|||
160950969|NCT00384085|581207327|FG001|Overall Study|Sponsor decision|2|||
160950970|NCT00384085|581207328|FG002|Overall Study|Sponsor decision|1|||
160950971|NCT00384085|581207326|FG000|Overall Study|Patient moved|1|||
160950972|NCT00384085|581207327|FG001|Overall Study|Patient moved|0|||
160950973|NCT00384085|581207328|FG002|Overall Study|Patient moved|1|||
160950974|NCT00384085|581207326|FG000|Overall Study|Patient required surgery|0|||
160950975|NCT00384085|581207327|FG001|Overall Study|Patient required surgery|1|||
160950976|NCT00384085|581207328|FG002|Overall Study|Patient required surgery|0|||
160950977|NCT05912400|581207329|FG000|Overall Study|Lost to Follow-up|1|||
160950978|NCT05912400|581207330|FG001|Overall Study|Lost to Follow-up|0|||
160950979|NCT05912400|581207329|FG000|Overall Study|Physician Decision|6|||
160950980|NCT05912400|581207330|FG001|Overall Study|Physician Decision|0|||
160950981|NCT05912400|581207329|FG000|Overall Study|Withdrawal by Subject|1|||
160950982|NCT05912400|581207330|FG001|Overall Study|Withdrawal by Subject|0|||
160950983|NCT01944631|581207334|FG000|Overall Study|Adverse Event|1|||
160950984|NCT01944631|581207335|FG001|Overall Study|Adverse Event|0|||
160950985|NCT01944631|581207334|FG000|Overall Study|Lost to Follow-up|3|||
160950986|NCT01944631|581207335|FG001|Overall Study|Lost to Follow-up|1|||
160950987|NCT01944631|581207334|FG000|Overall Study|Withdrawal by Subject|0|||
160950988|NCT01944631|581207335|FG001|Overall Study|Withdrawal by Subject|1|||
160950989|NCT01843192|581207336|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
160950990|NCT01843192|581207337|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
160950991|NCT01843192|581207338|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
161000645|NCT00079183|581387181|FG000|Overall Study|Withdrawal by Subject|4|||
160950992|NCT00328510|581207341|FG000|Overall Study|Gag disorder, could not use frame|4|||
160950993|NCT00328510|581207342|FG001|Overall Study|Gag disorder, could not use frame|0|||
161268471|NCT02799095|582366774|FG012|Part C|Progressive Disease|0|||
160950994|NCT00328510|581207341|FG000|Overall Study|Dentition problems, could not use frame|1|||
160950995|NCT00328510|581207342|FG001|Overall Study|Dentition problems, could not use frame|0|||
160950996|NCT00328510|581207341|FG000|Overall Study|Withdrawal by Subject|4|||
160950997|NCT00328510|581207342|FG001|Overall Study|Withdrawal by Subject|2|||
160950998|NCT00328510|581207341|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
160950999|NCT00328510|581207342|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
160951000|NCT00328510|581207341|FG000|Overall Study|Treatment changed to a single fraction|1|||
160951001|NCT00328510|581207342|FG001|Overall Study|Treatment changed to a single fraction|1|||
160951002|NCT01412944|581207343|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951003|NCT01412944|581207344|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951004|NCT01412944|581207345|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
160951005|NCT01412944|581207346|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951006|NCT01412944|581207347|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951007|NCT01412944|581207348|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
160951008|NCT01412944|581207343|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951009|NCT01412944|581207344|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951010|NCT01412944|581207345|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951011|NCT01412944|581207346|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951012|NCT01412944|581207347|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
160951013|NCT01412944|581207348|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
161268472|NCT02799095|582366775|FG013|Part C|Progressive Disease|1|||
161268473|NCT02799095|582366776|FG014|Part C|Progressive Disease|0|||
161268474|NCT02799095|582366777|FG015|Part C|Progressive Disease|0|||
160951014|NCT01412944|581207343|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951015|NCT01412944|581207344|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951016|NCT01412944|581207345|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951017|NCT01412944|581207346|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951018|NCT01412944|581207347|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
160951019|NCT01412944|581207348|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
160951020|NCT01412944|581207343|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
160951021|NCT01412944|581207344|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951022|NCT01412944|581207345|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951023|NCT01412944|581207346|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951024|NCT01412944|581207347|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951025|NCT01412944|581207348|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
160951026|NCT01412944|581207343|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
160951027|NCT01412944|581207344|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
160951028|NCT01412944|581207345|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
160951029|NCT01412944|581207346|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
160951030|NCT01412944|581207347|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
160951031|NCT01412944|581207348|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
160951032|NCT01412944|581207343|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951033|NCT01412944|581207344|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
160951034|NCT01412944|581207345|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951035|NCT01412944|581207346|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951036|NCT01412944|581207347|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951037|NCT01412944|581207348|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
160951038|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951039|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951040|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951041|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951042|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951043|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951044|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Adverse Event|0|||
160951045|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Adverse Event|0|||
160951046|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Adverse Event|0|||
160951047|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Adverse Event|0|||
160951048|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Adverse Event|1|||
160951049|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Adverse Event|0|||
160951050|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
160951051|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
160951052|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
160951053|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
160951054|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
160951055|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
160951056|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951057|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951058|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
161268475|NCT02799095|582366778|FG016|Part C|Progressive Disease|0|||
161145604|NCT03455543|581915653|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
161145605|NCT03455543|581915654|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
161145606|NCT03455543|581915652|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
161145607|NCT03455543|581915653|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
161145608|NCT03455543|581915654|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
161145609|NCT03455543|581915652|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
161145610|NCT03455543|581915653|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
161145611|NCT03455543|581915654|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
161145612|NCT03455543|581915652|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
161145613|NCT03455543|581915653|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
161145614|NCT03455543|581915654|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
161145615|NCT03455543|581915652|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
161145616|NCT03455543|581915653|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
161145617|NCT03455543|581915654|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
161145618|NCT03455543|581915652|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
161145619|NCT03455543|581915653|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
161145620|NCT03455543|581915654|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
161145621|NCT03455543|581915652|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
161145622|NCT03455543|581915653|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
161145623|NCT03455543|581915654|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
161145624|NCT03455543|581915652|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
161145625|NCT03455543|581915653|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
161145626|NCT03455543|581915654|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
161145627|NCT00779038|581915655|FG000|Overall Study|Study Prematurely Terminated|13|||
161145628|NCT00909090|581915659|FG000|Overall Study|Lost to Follow-up|17|||
161145629|NCT00909090|581915660|FG001|Overall Study|Lost to Follow-up|17|||
161145630|NCT03633331|581915661|FG000|Overall Study|Withdrawal by Subject|1|||
161145631|NCT00414440|581915662|FG000|Core Period|Withdrawal by Subject|70|||
161145632|NCT00414440|581915663|FG001|Core Period|Withdrawal by Subject|32|||
161145633|NCT00414440|581915662|FG000|Extension Period|Lost to Follow-up|44|||
161145634|NCT00414440|581915663|FG001|Extension Period|Lost to Follow-up|52|||
161145635|NCT00414440|581915662|FG000|Extension Period|Did not consent to continue follow up|61|||
161145636|NCT00414440|581915663|FG001|Extension Period|Did not consent to continue follow up|54|||
161145637|NCT00414440|581915662|FG000|Extension Period|Other|1|||
161145638|NCT00414440|581915663|FG001|Extension Period|Other|1|||
161145639|NCT00414440|581915662|FG000|Extension Period|Administrative|16|||
161145640|NCT00414440|581915663|FG001|Extension Period|Administrative|16|||
161145641|NCT00414440|581915662|FG000|Extension Period|Death|1|||
161145642|NCT00414440|581915663|FG001|Extension Period|Death|2|||
161145643|NCT00414440|581915662|FG000|Extension Period|Withdrawal by Subject|9|||
161145644|NCT00414440|581915663|FG001|Extension Period|Withdrawal by Subject|7|||
161145645|NCT00414440|581915662|FG000|Extension Period|Not included in follow up period|18|||
161145646|NCT00414440|581915663|FG001|Extension Period|Not included in follow up period|8|||
161145647|NCT00940342|581915664|FG000|Overall Study|Adverse Event|0|||
161145648|NCT00940342|581915665|FG001|Overall Study|Adverse Event|2|||
161145649|NCT00940342|581915666|FG002|Overall Study|Adverse Event|1|||
161145650|NCT03249350|581915669|FG000|Overall Study|Participant did not initiate treatment|5|||
161145651|NCT03249350|581915670|FG001|Overall Study|Participant did not initiate treatment|8|||
161145652|NCT01716169|581915672|FG000|Overall Study|Adverse Event|1|||
161145653|NCT01716169|581915672|FG000|Overall Study|Lost to Follow-up|1|||
161145654|NCT01716169|581915672|FG000|Overall Study|Withdrawal by Subject|1|||
161145655|NCT01716169|581915672|FG000|Overall Study|inconsistent dressing application|1|||
161145656|NCT00553787|581915673|FG000|Overall Study|Adverse Event|34|||
161145657|NCT00553787|581915674|FG001|Overall Study|Adverse Event|21|||
161145658|NCT00553787|581915675|FG002|Overall Study|Adverse Event|67|||
161145659|NCT00553787|581915673|FG000|Overall Study|Lost to Follow-up|132|||
161145660|NCT00553787|581915674|FG001|Overall Study|Lost to Follow-up|44|||
161145661|NCT00553787|581915675|FG002|Overall Study|Lost to Follow-up|78|||
161145662|NCT00553787|581915673|FG000|Overall Study|Withdrawal by Subject|151|||
161145663|NCT00553787|581915674|FG001|Overall Study|Withdrawal by Subject|40|||
161145664|NCT00553787|581915675|FG002|Overall Study|Withdrawal by Subject|83|||
161145665|NCT00553787|581915673|FG000|Overall Study|Lack of Efficacy|31|||
161145666|NCT00553787|581915674|FG001|Overall Study|Lack of Efficacy|1|||
161145667|NCT00553787|581915675|FG002|Overall Study|Lack of Efficacy|3|||
161145668|NCT00553787|581915673|FG000|Overall Study|Pregnancy|0|||
161145669|NCT00553787|581915674|FG001|Overall Study|Pregnancy|1|||
161145670|NCT00553787|581915675|FG002|Overall Study|Pregnancy|2|||
161145671|NCT00553787|581915673|FG000|Overall Study|non compliance|4|||
161145672|NCT00553787|581915674|FG001|Overall Study|non compliance|0|||
161145673|NCT00553787|581915675|FG002|Overall Study|non compliance|11|||
161145674|NCT00553787|581915673|FG000|Overall Study|Requirement for restricted medication|8|||
161145675|NCT00553787|581915674|FG001|Overall Study|Requirement for restricted medication|7|||
160951059|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951060|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951061|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
160951062|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951063|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951064|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951065|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951066|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
160951067|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951068|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
160951069|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
160951070|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951071|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951072|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951073|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
160951074|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
160951075|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
160951076|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
160951077|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
160951078|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
160951079|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
160951080|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951081|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
160951082|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951083|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951084|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951085|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
160951086|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951087|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
160951088|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951089|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951090|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951091|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
160951092|NCT01412944|581207343|FG000|Entire: IV + Maintenance|Adverse Event|0|||
160951093|NCT01412944|581207344|FG001|Entire: IV + Maintenance|Adverse Event|1|||
160951094|NCT01412944|581207345|FG002|Entire: IV + Maintenance|Adverse Event|0|||
160951095|NCT01412944|581207346|FG003|Entire: IV + Maintenance|Adverse Event|0|||
160951096|NCT01412944|581207347|FG004|Entire: IV + Maintenance|Adverse Event|0|||
160951097|NCT01412944|581207348|FG005|Entire: IV + Maintenance|Adverse Event|0|||
160951098|NCT01990950|581207349|FG000|Overall Study|Death|3|||
160951099|NCT01990950|581207349|FG000|Overall Study|Lost to Follow-up|2|||
160951100|NCT01990950|581207349|FG000|Overall Study|Withdrawal by Subject|6|||
160951101|NCT02863926|581207350|FG000|Overall Study|Physician Decision|1|||
160951102|NCT02863926|581207351|FG001|Overall Study|Physician Decision|0|||
160951103|NCT02863926|581207350|FG000|Overall Study|Lost to Follow-up|1|||
160951104|NCT02863926|581207351|FG001|Overall Study|Lost to Follow-up|1|||
160951105|NCT02301143|581207354|FG000|Induction Period|Enrolled But Not Treated|1|||
160951106|NCT02301143|581207355|FG001|Induction Period|Enrolled But Not Treated|0|||
160951107|NCT02301143|581207354|FG000|Induction Period|Death|1|||
160951108|NCT02301143|581207355|FG001|Induction Period|Death|0|||
160951109|NCT02301143|581207354|FG000|Induction Period|Adverse Event|22|||
160951110|NCT02301143|581207355|FG001|Induction Period|Adverse Event|0|||
160951111|NCT02301143|581207354|FG000|Induction Period|Progressive Disease|8|||
160951112|NCT02301143|581207355|FG001|Induction Period|Progressive Disease|0|||
160951113|NCT02301143|581207354|FG000|Induction Period|Withdrawal by Subject|3|||
160951114|NCT02301143|581207355|FG001|Induction Period|Withdrawal by Subject|0|||
160951115|NCT02301143|581207354|FG000|Induction Period|Noncompliance with Study Drug|1|||
160951116|NCT02301143|581207355|FG001|Induction Period|Noncompliance with Study Drug|0|||
160951117|NCT02301143|581207354|FG000|Induction Period|Physician Decision|4|||
160951118|NCT02301143|581207355|FG001|Induction Period|Physician Decision|0|||
160951119|NCT02301143|581207354|FG000|Induction Period|Symptomatic Deterioration|2|||
160951120|NCT02301143|581207355|FG001|Induction Period|Symptomatic Deterioration|0|||
160951121|NCT02301143|581207354|FG000|Induction Period|Protocol Violation|2|||
160951122|NCT02301143|581207355|FG001|Induction Period|Protocol Violation|0|||
160951123|NCT02301143|581207354|FG000|Induction Period|Other|1|||
161268476|NCT02799095|582366762|FG000|Part C|Clinical Progression|0|||
160951124|NCT02301143|581207355|FG001|Induction Period|Other|0|||
160951125|NCT02301143|581207354|FG000|Investigator's Choice|Adverse Event|0|||
160951126|NCT02301143|581207355|FG001|Investigator's Choice|Adverse Event|3|||
160951127|NCT02301143|581207354|FG000|Investigator's Choice|Progressive Disease|0|||
160951128|NCT02301143|581207355|FG001|Investigator's Choice|Progressive Disease|3|||
160951129|NCT02301143|581207354|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
160951130|NCT02301143|581207355|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
160951131|NCT02301143|581207354|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
161145676|NCT00553787|581915675|FG002|Overall Study|Requirement for restricted medication|5|||
161145677|NCT00553787|581915673|FG000|Overall Study|Other|18|||
161145678|NCT00553787|581915674|FG001|Overall Study|Other|10|||
161145679|NCT00553787|581915675|FG002|Overall Study|Other|13|||
161145680|NCT01450137|581915676|FG000|Up to Week 12|Adverse Event|2|||
161145681|NCT01450137|581915677|FG001|Up to Week 12|Adverse Event|1|||
161145682|NCT01450137|581915676|FG000|Up to Week 12|Withdrawal by Subject|0|||
161145683|NCT01450137|581915677|FG001|Up to Week 12|Withdrawal by Subject|2|||
161145684|NCT01450137|581915676|FG000|Week 12 to Study End|Death|0|||
161145685|NCT01450137|581915677|FG001|Week 12 to Study End|Death|1|||
161145686|NCT01450137|581915676|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
161145687|NCT01450137|581915677|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
161145688|NCT01926886|581915678|FG000|Overall Study|Administrative/other|1|||
161145689|NCT01926886|581915679|FG001|Overall Study|Administrative/other|0|||
161145690|NCT01926886|581915678|FG000|Overall Study|Adverse event/intercurrent illness|4|||
161145691|NCT01926886|581915679|FG001|Overall Study|Adverse event/intercurrent illness|0|||
161145692|NCT01926886|581915678|FG000|Overall Study|Disease progression/recurrence|4|||
161145693|NCT01926886|581915679|FG001|Overall Study|Disease progression/recurrence|0|||
161145694|NCT01926886|581915678|FG000|Overall Study|Withdrawal by Subject|15|||
161145695|NCT01926886|581915679|FG001|Overall Study|Withdrawal by Subject|0|||
161145696|NCT01926886|581915678|FG000|Overall Study|Failure to return|3|||
161145697|NCT01926886|581915679|FG001|Overall Study|Failure to return|0|||
161145698|NCT01926886|581915678|FG000|Overall Study|Recurrence of disease|1|||
161145699|NCT01926886|581915679|FG001|Overall Study|Recurrence of disease|0|||
161145700|NCT01926886|581915678|FG000|Overall Study|Progression of disease|2|||
161145701|NCT01926886|581915679|FG001|Overall Study|Progression of disease|0|||
161145702|NCT01926886|581915678|FG000|Overall Study|Death|1|||
161000646|NCT00079183|581387181|FG000|Overall Study|Study medication non-compliance|2|||
161000647|NCT00079183|581387181|FG000|Overall Study|Specimen collection non-compliance|1|||
161000648|NCT00762606|581387182|FG000|Overall Study|Lost to Follow-up|18|||
161000649|NCT00762606|581387183|FG001|Overall Study|Lost to Follow-up|13|||
161000650|NCT03257813|581387184|FG000|Overall Study|Protocol Violation|6|||
161000651|NCT03257813|581387185|FG001|Overall Study|Protocol Violation|3|||
161000652|NCT01069341|581387188|FG000|Overall Study|Lost to Follow-up|1|||
161000653|NCT03299816|581387193|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
161000654|NCT03299816|581387194|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
161000655|NCT03299816|581387193|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
161145703|NCT01926886|581915679|FG001|Overall Study|Death|0|||
161145704|NCT01926886|581915678|FG000|Overall Study|Did not cooperate|1|||
161145705|NCT01926886|581915679|FG001|Overall Study|Did not cooperate|0|||
161145706|NCT00069121|581915680|FG000|Overall Study|Death|286|||
161145707|NCT00069121|581915681|FG001|Overall Study|Death|242|||
161145708|NCT00069121|581915680|FG000|Overall Study|Withdrawal by Subject|18|||
161145709|NCT00069121|581915681|FG001|Overall Study|Withdrawal by Subject|20|||
161145710|NCT00069121|581915680|FG000|Overall Study|Lost to Follow-up|63|||
161145711|NCT00069121|581915681|FG001|Overall Study|Lost to Follow-up|63|||
161145712|NCT02986373|581915682|FG000|Overall Study|Adverse Event|4|||
161145713|NCT02986373|581915682|FG000|Overall Study|Lost to Follow-up|1|||
161145714|NCT02986373|581915682|FG000|Overall Study|Withdrawal by Subject|10|||
161145715|NCT02986373|581915682|FG000|Overall Study|Other|24|||
161145716|NCT04800315|581915683|FG000|Randomization|Did not receive study treatment|1|||
161145717|NCT04800315|581915684|FG001|Randomization|Did not receive study treatment|0|||
161145718|NCT04800315|581915685|FG002|Randomization|Did not receive study treatment|0|||
161145719|NCT04800315|581915686|FG003|Randomization|Did not receive study treatment|0|||
161145720|NCT04800315|581915683|FG000|Treatment Period|Adverse Event|4|||
161145721|NCT04800315|581915684|FG001|Treatment Period|Adverse Event|2|||
161145722|NCT04800315|581915685|FG002|Treatment Period|Adverse Event|1|||
161145723|NCT04800315|581915686|FG003|Treatment Period|Adverse Event|2|||
161268477|NCT02799095|582366763|FG001|Part C|Clinical Progression|0|||
161268478|NCT02799095|582366764|FG002|Part C|Clinical Progression|0|||
161268479|NCT02799095|582366765|FG003|Part C|Clinical Progression|0|||
161268480|NCT02799095|582366766|FG004|Part C|Clinical Progression|0|||
161268481|NCT02799095|582366767|FG005|Part C|Clinical Progression|0|||
161268482|NCT02799095|582366768|FG006|Part C|Clinical Progression|0|||
161268483|NCT02799095|582366769|FG007|Part C|Clinical Progression|0|||
161268484|NCT02799095|582366770|FG008|Part C|Clinical Progression|0|||
161145724|NCT04800315|581915683|FG000|Treatment Period|Lack of Efficacy|1|||
161145725|NCT04800315|581915684|FG001|Treatment Period|Lack of Efficacy|0|||
161145726|NCT04800315|581915685|FG002|Treatment Period|Lack of Efficacy|0|||
161342794|NCT00157755|582642251|FG001|Overall Study|Subject non-compliance|0|||
161145727|NCT04800315|581915686|FG003|Treatment Period|Lack of Efficacy|3|||
161145728|NCT04800315|581915683|FG000|Treatment Period|Lost to Follow-up|0|||
161342795|NCT00157755|582642252|FG002|Overall Study|Subject non-compliance|0|||
161145729|NCT04800315|581915684|FG001|Treatment Period|Lost to Follow-up|1|||
161268485|NCT02799095|582366771|FG009|Part C|Clinical Progression|1|||
161268486|NCT02799095|582366772|FG010|Part C|Clinical Progression|3|||
161268487|NCT02799095|582366773|FG011|Part C|Clinical Progression|0|||
161145730|NCT04800315|581915685|FG002|Treatment Period|Lost to Follow-up|2|||
161145731|NCT04800315|581915686|FG003|Treatment Period|Lost to Follow-up|2|||
161145732|NCT04800315|581915683|FG000|Treatment Period|Withdrawal by participant|0|||
161145733|NCT04800315|581915684|FG001|Treatment Period|Withdrawal by participant|0|||
161145734|NCT04800315|581915685|FG002|Treatment Period|Withdrawal by participant|0|||
161145735|NCT04800315|581915686|FG003|Treatment Period|Withdrawal by participant|4|||
161145736|NCT04800315|581915683|FG000|Treatment Period|Other Reasons|0|||
161145737|NCT04800315|581915684|FG001|Treatment Period|Other Reasons|2|||
161145738|NCT04800315|581915685|FG002|Treatment Period|Other Reasons|0|||
161145739|NCT04800315|581915686|FG003|Treatment Period|Other Reasons|1|||
161145740|NCT00753922|581915687|FG000|Overall Study|Lost to Follow-up|155|||
161145741|NCT00753922|581915688|FG001|Overall Study|Lost to Follow-up|24|||
161145742|NCT00753922|581915689|FG002|Overall Study|Lost to Follow-up|28|||
161145743|NCT00753922|581915690|FG003|Overall Study|Lost to Follow-up|5|||
161145744|NCT00753922|581915687|FG000|Overall Study|Withdrawal by Subject|9|||
161145745|NCT00753922|581915688|FG001|Overall Study|Withdrawal by Subject|11|||
161145746|NCT00753922|581915689|FG002|Overall Study|Withdrawal by Subject|4|||
161145747|NCT00753922|581915690|FG003|Overall Study|Withdrawal by Subject|2|||
161145748|NCT00753922|581915687|FG000|Overall Study|Patient Non-compliance|55|||
161145749|NCT00753922|581915688|FG001|Overall Study|Patient Non-compliance|22|||
161145750|NCT00753922|581915689|FG002|Overall Study|Patient Non-compliance|14|||
161145751|NCT00753922|581915690|FG003|Overall Study|Patient Non-compliance|11|||
161145752|NCT00753922|581915687|FG000|Overall Study|Patients Not Completing Visit|11|||
161145753|NCT00753922|581915688|FG001|Overall Study|Patients Not Completing Visit|0|||
161268488|NCT02799095|582366774|FG012|Part C|Clinical Progression|0|||
161268489|NCT02799095|582366775|FG013|Part C|Clinical Progression|1|||
161268490|NCT02799095|582366776|FG014|Part C|Clinical Progression|0|||
161268491|NCT02799095|582366777|FG015|Part C|Clinical Progression|0|||
161268492|NCT02799095|582366778|FG016|Part C|Clinical Progression|0|||
161268493|NCT02799095|582366762|FG000|Part C|Withdrawal by Subject|0|||
161268494|NCT02799095|582366763|FG001|Part C|Withdrawal by Subject|0|||
161268495|NCT02799095|582366764|FG002|Part C|Withdrawal by Subject|0|||
161145754|NCT00753922|581915689|FG002|Overall Study|Patients Not Completing Visit|1|||
161145755|NCT00753922|581915690|FG003|Overall Study|Patients Not Completing Visit|0|||
161145756|NCT00753922|581915687|FG000|Overall Study|Death|2|||
161145757|NCT00753922|581915688|FG001|Overall Study|Death|23|||
161145758|NCT00753922|581915689|FG002|Overall Study|Death|2|||
161145759|NCT00753922|581915690|FG003|Overall Study|Death|1|||
161145760|NCT00753922|581915687|FG000|Overall Study|Discontinuation Due to Explantation|14|||
161145761|NCT00753922|581915688|FG001|Overall Study|Discontinuation Due to Explantation|14|||
161145762|NCT00753922|581915689|FG002|Overall Study|Discontinuation Due to Explantation|14|||
161145763|NCT00753922|581915690|FG003|Overall Study|Discontinuation Due to Explantation|4|||
161145764|NCT02983292|581915694|FG000|Overall Study|Participant unwell & cannot travel|2|||
161145765|NCT02983292|581915694|FG000|Overall Study|Lost to Follow-up|3|||
161145766|NCT02983292|581915694|FG000|Overall Study|Participant withdrew consent|2|||
161145767|NCT02983292|581915694|FG000|Overall Study|Revision|7|||
161145768|NCT02983292|581915694|FG000|Overall Study|Death|1|||
161145769|NCT02983292|581915694|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
161145770|NCT02983292|581915694|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
161145771|NCT02983292|581915694|FG000|Overall Study|Participant relocation|1|||
161145772|NCT04542291|581915695|FG000|Overall Study|Adverse Event|1|||
161145773|NCT04542291|581915695|FG000|Overall Study|Physician Decision|2|||
161145774|NCT00035815|581915696|FG000|Overall Study|Withdrawal by Subject|17|||
161145775|NCT00035815|581915697|FG001|Overall Study|Withdrawal by Subject|11|||
161145776|NCT04952389|581915698|FG000|Overall Study|Withdrawal by Subject|8|||
161145777|NCT04952389|581915699|FG001|Overall Study|Withdrawal by Subject|4|||
161145778|NCT04285723|581915702|FG000|Overall Study|Subject decision|1|||
161145779|NCT04285723|581915703|FG001|Overall Study|Subject decision|2|||
161145780|NCT04285723|581915702|FG000|Overall Study|Physician Decision|1|||
161145781|NCT04285723|581915703|FG001|Overall Study|Physician Decision|0|||
161268496|NCT02799095|582366765|FG003|Part C|Withdrawal by Subject|0|||
161268497|NCT02799095|582366766|FG004|Part C|Withdrawal by Subject|0|||
161342796|NCT00157755|582642253|FG003|Overall Study|Subject non-compliance|0|||
161342797|NCT00157755|582642254|FG004|Overall Study|Subject non-compliance|0|||
161342798|NCT00157755|582642255|FG005|Overall Study|Subject non-compliance|1|||
161145782|NCT04285723|581915702|FG000|Overall Study|No efficiency|1|||
161145783|NCT04285723|581915703|FG001|Overall Study|No efficiency|0|||
161000656|NCT03299816|581387194|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
161145784|NCT05635838|581916955|FG000|16-Week DBVC Period|Adverse Event|2|||
161145785|NCT05635838|581916956|FG001|16-Week DBVC Period|Adverse Event|0|||
161145786|NCT05635838|581916957|FG002|16-Week DBVC Period|Adverse Event|0|||
161145787|NCT05635838|581916958|FG003|16-Week DBVC Period|Adverse Event|0|||
161342799|NCT00157755|582642250|FG000|Overall Study|Study completion|0|||
161268498|NCT02799095|582366767|FG005|Part C|Withdrawal by Subject|0|||
161268499|NCT02799095|582366768|FG006|Part C|Withdrawal by Subject|0|||
161342800|NCT00157755|582642251|FG001|Overall Study|Study completion|0|||
161268500|NCT02799095|582366769|FG007|Part C|Withdrawal by Subject|0|||
161145788|NCT05635838|581916955|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
161145789|NCT05635838|581916956|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
161145790|NCT05635838|581916957|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
161145791|NCT05635838|581916958|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
161145792|NCT05635838|581916955|FG000|16-Week DBVC Period|Physician Decision|0|||
161145793|NCT05635838|581916956|FG001|16-Week DBVC Period|Physician Decision|1|||
161145794|NCT05635838|581916957|FG002|16-Week DBVC Period|Physician Decision|0|||
161145795|NCT05635838|581916958|FG003|16-Week DBVC Period|Physician Decision|0|||
161145796|NCT05635838|581916955|FG000|16-Week DBVC Period|Protocol Violation|1|||
161145797|NCT05635838|581916956|FG001|16-Week DBVC Period|Protocol Violation|0|||
161145798|NCT05635838|581916957|FG002|16-Week DBVC Period|Protocol Violation|0|||
161145799|NCT05635838|581916958|FG003|16-Week DBVC Period|Protocol Violation|0|||
161145800|NCT05635838|581916955|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
161145801|NCT05635838|581916956|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
161145802|NCT05635838|581916957|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
161145803|NCT05635838|581916958|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
161145804|NCT05635838|581916955|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
161145805|NCT05635838|581916956|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161145806|NCT05635838|581916957|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161145807|NCT05635838|581916958|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
161145808|NCT05635838|581916955|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
161145809|NCT05635838|581916956|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
161145810|NCT05635838|581916957|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
161145811|NCT05635838|581916958|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
161145812|NCT05635838|581916955|FG000|16-Week OLE Period|Adverse Event|0|||
161145813|NCT05635838|581916956|FG001|16-Week OLE Period|Adverse Event|0|||
161145814|NCT05635838|581916957|FG002|16-Week OLE Period|Adverse Event|0|||
161145815|NCT05635838|581916958|FG003|16-Week OLE Period|Adverse Event|2|||
161145816|NCT05635838|581916955|FG000|16-Week OLE Period|Lost to Follow-up|0|||
161145817|NCT05635838|581916956|FG001|16-Week OLE Period|Lost to Follow-up|0|||
161145818|NCT05635838|581916957|FG002|16-Week OLE Period|Lost to Follow-up|1|||
161145819|NCT05635838|581916958|FG003|16-Week OLE Period|Lost to Follow-up|3|||
161145820|NCT05635838|581916955|FG000|16-Week OLE Period|Physician Decision|0|||
161145821|NCT05635838|581916956|FG001|16-Week OLE Period|Physician Decision|0|||
161145822|NCT05635838|581916957|FG002|16-Week OLE Period|Physician Decision|0|||
161145823|NCT05635838|581916958|FG003|16-Week OLE Period|Physician Decision|1|||
161145824|NCT05635838|581916955|FG000|16-Week OLE Period|Protocol Violation|0|||
161145825|NCT05635838|581916956|FG001|16-Week OLE Period|Protocol Violation|0|||
161145826|NCT05635838|581916957|FG002|16-Week OLE Period|Protocol Violation|1|||
161145827|NCT05635838|581916958|FG003|16-Week OLE Period|Protocol Violation|1|||
161145828|NCT05635838|581916955|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
161145829|NCT05635838|581916956|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
161145830|NCT05635838|581916957|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
161145831|NCT05635838|581916958|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
161145832|NCT05635838|581916955|FG000|16-Week OLE Period|Pregnancy|0|||
161145833|NCT05635838|581916956|FG001|16-Week OLE Period|Pregnancy|0|||
161145834|NCT05635838|581916957|FG002|16-Week OLE Period|Pregnancy|1|||
161268501|NCT02799095|582366770|FG008|Part C|Withdrawal by Subject|0|||
161268502|NCT02799095|582366771|FG009|Part C|Withdrawal by Subject|0|||
161268503|NCT02799095|582366772|FG010|Part C|Withdrawal by Subject|13|||
161268504|NCT02799095|582366773|FG011|Part C|Withdrawal by Subject|15|||
161268505|NCT02799095|582366774|FG012|Part C|Withdrawal by Subject|13|||
161268506|NCT02799095|582366775|FG013|Part C|Withdrawal by Subject|21|||
161268507|NCT02799095|582366776|FG014|Part C|Withdrawal by Subject|0|||
161268508|NCT02799095|582366777|FG015|Part C|Withdrawal by Subject|12|||
161268509|NCT02799095|582366778|FG016|Part C|Withdrawal by Subject|1|||
161268510|NCT02799095|582366762|FG000|Part C|Physician Decision|0|||
161268511|NCT02799095|582366763|FG001|Part C|Physician Decision|0|||
161268512|NCT02799095|582366764|FG002|Part C|Physician Decision|0|||
161268513|NCT02799095|582366765|FG003|Part C|Physician Decision|0|||
160951132|NCT02301143|581207355|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
161145835|NCT05635838|581916958|FG003|16-Week OLE Period|Pregnancy|0|||
161145836|NCT01486316|581916959|FG000|Overall Study|Device explanted with/without re-implant|3|||
160951133|NCT02301143|581207354|FG000|Investigator's Choice|Other|0|||
161145837|NCT01486316|581916960|FG001|Overall Study|Device explanted with/without re-implant|2|||
161145838|NCT01486316|581916961|FG002|Overall Study|Device explanted with/without re-implant|0|||
161145839|NCT01486316|581916962|FG003|Overall Study|Device explanted with/without re-implant|2|||
161342801|NCT00157755|582642252|FG002|Overall Study|Study completion|0|||
161145840|NCT01486316|581916959|FG000|Overall Study|Not meeting eligibility criteria|0|||
161145841|NCT01486316|581916960|FG001|Overall Study|Not meeting eligibility criteria|0|||
161145842|NCT01486316|581916961|FG002|Overall Study|Not meeting eligibility criteria|1|||
161145843|NCT01486316|581916962|FG003|Overall Study|Not meeting eligibility criteria|0|||
161268514|NCT02799095|582366766|FG004|Part C|Physician Decision|0|||
161268515|NCT02799095|582366767|FG005|Part C|Physician Decision|0|||
161268516|NCT02799095|582366768|FG006|Part C|Physician Decision|0|||
161268517|NCT02799095|582366769|FG007|Part C|Physician Decision|0|||
160951134|NCT02301143|581207355|FG001|Investigator's Choice|Other|1|||
160951135|NCT02301143|581207354|FG000|Investigator's Choice|Unresectable Surgery|0|||
160951136|NCT02301143|581207355|FG001|Investigator's Choice|Unresectable Surgery|1|||
160951137|NCT03214367|581207358|FG000|Lead-in Period|Withdrawal by Subject|50|||
160951138|NCT03214367|581207359|FG001|Lead-in Period|Withdrawal by Subject|0|||
160951139|NCT03214367|581207360|FG002|Lead-in Period|Withdrawal by Subject|0|||
160951140|NCT03214367|581207361|FG003|Lead-in Period|Withdrawal by Subject|0|||
160951141|NCT03214367|581207362|FG004|Lead-in Period|Withdrawal by Subject|2|||
160951142|NCT03214367|581207363|FG005|Lead-in Period|Withdrawal by Subject|0|||
160951143|NCT03214367|581207364|FG006|Lead-in Period|Withdrawal by Subject|0|||
160951144|NCT03214367|581207365|FG007|Lead-in Period|Withdrawal by Subject|0|||
160951145|NCT03214367|581207358|FG000|Lead-in Period|Adverse Event|3|||
160951146|NCT03214367|581207359|FG001|Lead-in Period|Adverse Event|0|||
160951147|NCT03214367|581207360|FG002|Lead-in Period|Adverse Event|0|||
160951148|NCT03214367|581207361|FG003|Lead-in Period|Adverse Event|0|||
160951149|NCT03214367|581207362|FG004|Lead-in Period|Adverse Event|0|||
160951150|NCT03214367|581207363|FG005|Lead-in Period|Adverse Event|0|||
160951151|NCT03214367|581207364|FG006|Lead-in Period|Adverse Event|0|||
160951152|NCT03214367|581207365|FG007|Lead-in Period|Adverse Event|0|||
160951153|NCT03214367|581207358|FG000|Lead-in Period|Lost to Follow-up|12|||
160951154|NCT03214367|581207359|FG001|Lead-in Period|Lost to Follow-up|0|||
160951155|NCT03214367|581207360|FG002|Lead-in Period|Lost to Follow-up|0|||
160951156|NCT03214367|581207361|FG003|Lead-in Period|Lost to Follow-up|0|||
160951157|NCT03214367|581207362|FG004|Lead-in Period|Lost to Follow-up|0|||
160951158|NCT03214367|581207363|FG005|Lead-in Period|Lost to Follow-up|0|||
160951159|NCT03214367|581207364|FG006|Lead-in Period|Lost to Follow-up|0|||
160951160|NCT03214367|581207365|FG007|Lead-in Period|Lost to Follow-up|0|||
160951161|NCT03214367|581207358|FG000|Lead-in Period|Sponsor Decision|11|||
160951162|NCT03214367|581207359|FG001|Lead-in Period|Sponsor Decision|0|||
160951163|NCT03214367|581207360|FG002|Lead-in Period|Sponsor Decision|0|||
160951164|NCT03214367|581207361|FG003|Lead-in Period|Sponsor Decision|0|||
160951165|NCT03214367|581207362|FG004|Lead-in Period|Sponsor Decision|0|||
160951166|NCT03214367|581207363|FG005|Lead-in Period|Sponsor Decision|0|||
160951167|NCT03214367|581207364|FG006|Lead-in Period|Sponsor Decision|0|||
160951168|NCT03214367|581207365|FG007|Lead-in Period|Sponsor Decision|0|||
160951169|NCT03214367|581207358|FG000|Lead-in Period|Physician Decision|12|||
160951170|NCT03214367|581207359|FG001|Lead-in Period|Physician Decision|0|||
160951171|NCT03214367|581207360|FG002|Lead-in Period|Physician Decision|0|||
160951172|NCT03214367|581207361|FG003|Lead-in Period|Physician Decision|0|||
160951173|NCT03214367|581207362|FG004|Lead-in Period|Physician Decision|0|||
160951174|NCT03214367|581207363|FG005|Lead-in Period|Physician Decision|0|||
160951175|NCT03214367|581207364|FG006|Lead-in Period|Physician Decision|0|||
160951176|NCT03214367|581207365|FG007|Lead-in Period|Physician Decision|0|||
160951177|NCT03214367|581207358|FG000|Lead-in Period|Protocol Violation|5|||
160951178|NCT03214367|581207359|FG001|Lead-in Period|Protocol Violation|0|||
160951179|NCT03214367|581207360|FG002|Lead-in Period|Protocol Violation|0|||
160951180|NCT03214367|581207361|FG003|Lead-in Period|Protocol Violation|0|||
160951181|NCT03214367|581207362|FG004|Lead-in Period|Protocol Violation|0|||
160951182|NCT03214367|581207363|FG005|Lead-in Period|Protocol Violation|0|||
160951183|NCT03214367|581207364|FG006|Lead-in Period|Protocol Violation|0|||
160951184|NCT03214367|581207365|FG007|Lead-in Period|Protocol Violation|0|||
160951185|NCT03214367|581207358|FG000|Lead-in Period|Treatment Interruption|1|||
160951186|NCT03214367|581207359|FG001|Lead-in Period|Treatment Interruption|0|||
160951187|NCT03214367|581207360|FG002|Lead-in Period|Treatment Interruption|0|||
160951188|NCT03214367|581207361|FG003|Lead-in Period|Treatment Interruption|0|||
160951189|NCT03214367|581207362|FG004|Lead-in Period|Treatment Interruption|0|||
160951190|NCT03214367|581207363|FG005|Lead-in Period|Treatment Interruption|0|||
160951191|NCT03214367|581207364|FG006|Lead-in Period|Treatment Interruption|0|||
160951192|NCT03214367|581207365|FG007|Lead-in Period|Treatment Interruption|0|||
160951193|NCT03214367|581207358|FG000|Treatment Period|Adverse Event|0|||
160951194|NCT03214367|581207359|FG001|Treatment Period|Adverse Event|1|||
160951195|NCT03214367|581207360|FG002|Treatment Period|Adverse Event|4|||
160951196|NCT03214367|581207361|FG003|Treatment Period|Adverse Event|2|||
160951197|NCT03214367|581207362|FG004|Treatment Period|Adverse Event|0|||
160951198|NCT03214367|581207363|FG005|Treatment Period|Adverse Event|0|||
160951199|NCT03214367|581207364|FG006|Treatment Period|Adverse Event|0|||
160951200|NCT03214367|581207365|FG007|Treatment Period|Adverse Event|0|||
160951201|NCT03214367|581207358|FG000|Treatment Period|Death|0|||
160951202|NCT03214367|581207359|FG001|Treatment Period|Death|1|||
160951203|NCT03214367|581207360|FG002|Treatment Period|Death|1|||
160951204|NCT03214367|581207361|FG003|Treatment Period|Death|1|||
160951205|NCT03214367|581207362|FG004|Treatment Period|Death|0|||
160951206|NCT03214367|581207363|FG005|Treatment Period|Death|0|||
160951207|NCT03214367|581207364|FG006|Treatment Period|Death|0|||
160951208|NCT03214367|581207365|FG007|Treatment Period|Death|0|||
160951209|NCT03214367|581207358|FG000|Treatment Period|Lost to Follow-up|0|||
160951210|NCT03214367|581207359|FG001|Treatment Period|Lost to Follow-up|5|||
160951211|NCT03214367|581207360|FG002|Treatment Period|Lost to Follow-up|3|||
160951212|NCT03214367|581207361|FG003|Treatment Period|Lost to Follow-up|2|||
160951213|NCT03214367|581207362|FG004|Treatment Period|Lost to Follow-up|0|||
161000657|NCT03299816|581387193|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
161000658|NCT03299816|581387194|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
161000659|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
161000660|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
161000661|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
161000662|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
161000663|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
161000664|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
161000665|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
161000666|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
161000667|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
161000668|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
161000669|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
160951214|NCT03214367|581207363|FG005|Treatment Period|Lost to Follow-up|2|||
160951215|NCT03214367|581207364|FG006|Treatment Period|Lost to Follow-up|1|||
160951216|NCT03214367|581207365|FG007|Treatment Period|Lost to Follow-up|0|||
160951217|NCT03214367|581207358|FG000|Treatment Period|Sponsor Decision|0|||
160951218|NCT03214367|581207359|FG001|Treatment Period|Sponsor Decision|3|||
160951219|NCT03214367|581207360|FG002|Treatment Period|Sponsor Decision|0|||
160951220|NCT03214367|581207361|FG003|Treatment Period|Sponsor Decision|0|||
160951221|NCT03214367|581207362|FG004|Treatment Period|Sponsor Decision|0|||
160951222|NCT03214367|581207363|FG005|Treatment Period|Sponsor Decision|0|||
160951223|NCT03214367|581207364|FG006|Treatment Period|Sponsor Decision|0|||
160951224|NCT03214367|581207365|FG007|Treatment Period|Sponsor Decision|0|||
160951225|NCT03214367|581207358|FG000|Treatment Period|Physician Decision|0|||
160951226|NCT03214367|581207359|FG001|Treatment Period|Physician Decision|1|||
160951227|NCT03214367|581207360|FG002|Treatment Period|Physician Decision|2|||
161000670|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
161000671|NCT00790790|581387200|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
161000672|NCT00790790|581387201|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
161000673|NCT00790790|581387202|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
161000674|NCT02194933|581387203|FG000|Overall Study|Lost to Follow-up|1|||
161000675|NCT02194933|581387204|FG001|Overall Study|Lost to Follow-up|2|||
161000676|NCT02194933|581387203|FG000|Overall Study|Participant met withdrawal criteria|1|||
161000677|NCT02194933|581387204|FG001|Overall Study|Participant met withdrawal criteria|3|||
161000678|NCT02194933|581387203|FG000|Overall Study|Withdrawal by Subject|0|||
161000679|NCT02194933|581387204|FG001|Overall Study|Withdrawal by Subject|2|||
161000680|NCT02194933|581387203|FG000|Overall Study|Lack of Efficacy|1|||
161000681|NCT02194933|581387204|FG001|Overall Study|Lack of Efficacy|2|||
161000682|NCT00756730|581387207|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
161000683|NCT00756730|581387208|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
161000684|NCT00756730|581387207|FG000|Overall Study|persistent low-level viremmia|0|||
161000685|NCT00756730|581387208|FG001|Overall Study|persistent low-level viremmia|1|||
161000686|NCT05382104|581387212|FG000|Period 2 (2 Days)|Adverse Event|0|||
161000687|NCT05382104|581387213|FG001|Period 2 (2 Days)|Adverse Event|1|||
161000688|NCT05382104|581387214|FG002|Period 2 (2 Days)|Adverse Event|0|||
161000689|NCT05382104|581387215|FG003|Period 2 (2 Days)|Adverse Event|0|||
161000690|NCT05382104|581387216|FG004|Period 2 (2 Days)|Adverse Event|0|||
161000691|NCT05382104|581387217|FG005|Period 2 (2 Days)|Adverse Event|0|||
161000692|NCT02807493|581387219|FG000|Overall Study|Adverse Event|5|||
161000693|NCT02807493|581387220|FG001|Overall Study|Adverse Event|2|||
161000694|NCT02807493|581387219|FG000|Overall Study|Lost to Follow-up|6|||
161000695|NCT02807493|581387220|FG001|Overall Study|Lost to Follow-up|0|||
161000696|NCT02807493|581387219|FG000|Overall Study|Physician Decision|4|||
161000697|NCT02807493|581387220|FG001|Overall Study|Physician Decision|1|||
161000698|NCT02807493|581387219|FG000|Overall Study|Protocol Violation|7|||
161000699|NCT02807493|581387220|FG001|Overall Study|Protocol Violation|0|||
161000700|NCT02807493|581387219|FG000|Overall Study|Withdrawal by Subject|17|||
161000701|NCT02807493|581387220|FG001|Overall Study|Withdrawal by Subject|10|||
161268518|NCT02799095|582366770|FG008|Part C|Physician Decision|0|||
161268519|NCT02799095|582366771|FG009|Part C|Physician Decision|0|||
160951228|NCT03214367|581207361|FG003|Treatment Period|Physician Decision|0|||
160951229|NCT03214367|581207362|FG004|Treatment Period|Physician Decision|0|||
160951230|NCT03214367|581207363|FG005|Treatment Period|Physician Decision|0|||
161000702|NCT02807493|581387219|FG000|Overall Study|Other withdrawal|17|||
161000703|NCT02807493|581387220|FG001|Overall Study|Other withdrawal|0|||
161000704|NCT02807493|581387219|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
161000705|NCT02807493|581387220|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
161000706|NCT01493778|581387221|FG000|Overall Study|Withdrawal by Subject|8|||
161268520|NCT02799095|582366772|FG010|Part C|Physician Decision|1|||
161000707|NCT05190419|581387222|FG000|Overall Study|Lack of Efficacy|8|||
161268521|NCT02799095|582366773|FG011|Part C|Physician Decision|0|||
161268522|NCT02799095|582366774|FG012|Part C|Physician Decision|0|||
160951231|NCT03214367|581207364|FG006|Treatment Period|Physician Decision|0|||
161268523|NCT02799095|582366775|FG013|Part C|Physician Decision|0|||
161268524|NCT02799095|582366776|FG014|Part C|Physician Decision|0|||
160951232|NCT03214367|581207365|FG007|Treatment Period|Physician Decision|0|||
160951233|NCT03214367|581207358|FG000|Treatment Period|Protocol Violation|0|||
160951234|NCT03214367|581207359|FG001|Treatment Period|Protocol Violation|3|||
160951235|NCT03214367|581207360|FG002|Treatment Period|Protocol Violation|0|||
160951236|NCT03214367|581207361|FG003|Treatment Period|Protocol Violation|0|||
160951237|NCT03214367|581207362|FG004|Treatment Period|Protocol Violation|0|||
160951238|NCT03214367|581207363|FG005|Treatment Period|Protocol Violation|0|||
160951239|NCT03214367|581207364|FG006|Treatment Period|Protocol Violation|0|||
160951240|NCT03214367|581207365|FG007|Treatment Period|Protocol Violation|0|||
160951241|NCT03214367|581207358|FG000|Treatment Period|Withdrawal by Subject|0|||
160951242|NCT03214367|581207359|FG001|Treatment Period|Withdrawal by Subject|20|||
160951243|NCT03214367|581207360|FG002|Treatment Period|Withdrawal by Subject|23|||
160951244|NCT03214367|581207361|FG003|Treatment Period|Withdrawal by Subject|14|||
160951245|NCT03214367|581207362|FG004|Treatment Period|Withdrawal by Subject|0|||
160951246|NCT03214367|581207363|FG005|Treatment Period|Withdrawal by Subject|1|||
160951247|NCT03214367|581207364|FG006|Treatment Period|Withdrawal by Subject|1|||
160951248|NCT03214367|581207365|FG007|Treatment Period|Withdrawal by Subject|1|||
160951249|NCT03268811|581207368|FG000|Overall Study|Adverse Event|0|||
160951250|NCT03268811|581207369|FG001|Overall Study|Adverse Event|1|||
160951251|NCT00320216|581207370|FG000|Overall Study|Adverse Event|0|||
160951252|NCT00320216|581207371|FG001|Overall Study|Adverse Event|6|||
160951253|NCT00320216|581207372|FG002|Overall Study|Adverse Event|0|||
160951254|NCT00320216|581207373|FG003|Overall Study|Adverse Event|2|||
160951255|NCT00320216|581207374|FG004|Overall Study|Adverse Event|2|||
160951256|NCT00320216|581207370|FG000|Overall Study|Lack of Efficacy|6|||
160951257|NCT00320216|581207371|FG001|Overall Study|Lack of Efficacy|2|||
160951258|NCT00320216|581207372|FG002|Overall Study|Lack of Efficacy|1|||
160951259|NCT00320216|581207373|FG003|Overall Study|Lack of Efficacy|0|||
160951260|NCT00320216|581207374|FG004|Overall Study|Lack of Efficacy|1|||
160951261|NCT00320216|581207370|FG000|Overall Study|Lost to Follow-up|3|||
160951262|NCT00320216|581207371|FG001|Overall Study|Lost to Follow-up|0|||
160951263|NCT00320216|581207372|FG002|Overall Study|Lost to Follow-up|0|||
160951264|NCT00320216|581207373|FG003|Overall Study|Lost to Follow-up|0|||
160951265|NCT00320216|581207374|FG004|Overall Study|Lost to Follow-up|0|||
160951266|NCT00320216|581207370|FG000|Overall Study|Other|7|||
160951267|NCT00320216|581207371|FG001|Overall Study|Other|2|||
160951268|NCT00320216|581207372|FG002|Overall Study|Other|5|||
160951269|NCT00320216|581207373|FG003|Overall Study|Other|1|||
160951270|NCT00320216|581207374|FG004|Overall Study|Other|3|||
160951271|NCT00779246|581207383|FG000|Overall Study|Missing sufficient data for analysis|33|||
160951272|NCT00779246|581207384|FG001|Overall Study|Missing sufficient data for analysis|53|||
160951273|NCT02844946|581207386|FG000|Overall Study|Lost to Follow-up|7|||
160951274|NCT02844946|581207387|FG001|Overall Study|Lost to Follow-up|0|||
160951275|NCT02806986|581207388|FG000|Treatment Stage 1|Adverse Event|1|||
160951276|NCT02806986|581207388|FG000|Treatment Stage 2|Adverse Event|3|||
160951277|NCT02806986|581207388|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
160951278|NCT02334748|581207390|FG000|Overall Study|Adverse Event|1|||
160951279|NCT02334748|581207390|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
160951280|NCT02334748|581207390|FG000|Overall Study|Patient no longer required study drug|2|||
160951281|NCT02334748|581207390|FG000|Overall Study|Lack of Efficacy|4|||
160951282|NCT01046643|581207391|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
160951283|NCT01046643|581207392|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
160951284|NCT01046643|581207393|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
160951285|NCT01046643|581207394|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
160951286|NCT01310036|581207395|FG000|Overall Study|Administrative/other|10|||
160951287|NCT01310036|581207395|FG000|Overall Study|Withdrew Consent|11|||
160951288|NCT01310036|581207395|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
160951289|NCT01310036|581207395|FG000|Overall Study|Progression of Disease|164|||
160951290|NCT01310036|581207395|FG000|Overall Study|Death|1|||
160951291|NCT01310036|581207395|FG000|Overall Study|Adverse event or intercurrent illness|12|||
160951292|NCT00817089|581207396|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
160951293|NCT00817089|581207397|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
160951294|NCT00817089|581207398|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
160951295|NCT00817089|581207399|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
160951296|NCT00817089|581207396|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
160951297|NCT00817089|581207397|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
160951298|NCT00817089|581207398|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
160951299|NCT00817089|581207399|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
160951300|NCT00709722|581207400|FG000|Overall Study|Adverse Event|1|||
160951301|NCT04667117|581207401|FG000|Investigational Period|Lost to Follow-up|0|||
160951302|NCT04667117|581207402|FG001|Investigational Period|Lost to Follow-up|0|||
160951303|NCT04667117|581207403|FG002|Investigational Period|Lost to Follow-up|1|||
160951304|NCT04667117|581207401|FG000|Investigational Period|Protocol Deviation|0|||
160951305|NCT04667117|581207402|FG001|Investigational Period|Protocol Deviation|1|||
160951306|NCT04667117|581207403|FG002|Investigational Period|Protocol Deviation|0|||
160951307|NCT04667117|581207401|FG000|Extension Period|Lost to Follow-up|1|||
161145844|NCT01486316|581916959|FG000|Overall Study|Withdrawal by Subject|1|||
161145845|NCT01486316|581916960|FG001|Overall Study|Withdrawal by Subject|0|||
161145846|NCT01486316|581916961|FG002|Overall Study|Withdrawal by Subject|3|||
161145847|NCT01486316|581916962|FG003|Overall Study|Withdrawal by Subject|0|||
161145848|NCT01486316|581916959|FG000|Overall Study|Physician Decision|0|||
161145849|NCT01486316|581916960|FG001|Overall Study|Physician Decision|0|||
161145850|NCT01486316|581916961|FG002|Overall Study|Physician Decision|1|||
161145851|NCT01486316|581916962|FG003|Overall Study|Physician Decision|0|||
161145852|NCT01486316|581916959|FG000|Overall Study|Death|0|||
161145853|NCT01486316|581916960|FG001|Overall Study|Death|1|||
161145854|NCT01486316|581916961|FG002|Overall Study|Death|0|||
161145855|NCT01486316|581916962|FG003|Overall Study|Death|0|||
161145856|NCT05094154|581916970|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
161145857|NCT05094154|581916971|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
161145858|NCT05094154|581916970|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
161145859|NCT05094154|581916971|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
161145860|NCT02531035|581916978|FG000|Overall Study|Death|0|||
161145861|NCT02531035|581916979|FG001|Overall Study|Death|1|||
161145862|NCT02531035|581916978|FG000|Overall Study|Protocol Violation|1|||
161145863|NCT02531035|581916979|FG001|Overall Study|Protocol Violation|1|||
161145864|NCT02531035|581916978|FG000|Overall Study|Noncompliance with study drug|8|||
161145865|NCT02531035|581916979|FG001|Overall Study|Noncompliance with study drug|3|||
161145866|NCT02531035|581916978|FG000|Overall Study|Physician Decision|1|||
161145867|NCT02531035|581916979|FG001|Overall Study|Physician Decision|0|||
161145868|NCT02531035|581916978|FG000|Overall Study|Adverse Event|16|||
161145869|NCT02531035|581916979|FG001|Overall Study|Adverse Event|45|||
161145870|NCT02531035|581916978|FG000|Overall Study|Other|3|||
161145871|NCT02531035|581916979|FG001|Overall Study|Other|2|||
161145872|NCT02531035|581916978|FG000|Overall Study|Withdrawal by Subject|42|||
161145873|NCT02531035|581916979|FG001|Overall Study|Withdrawal by Subject|32|||
161145874|NCT02531035|581916978|FG000|Overall Study|Lost to Follow-up|8|||
161145875|NCT02531035|581916979|FG001|Overall Study|Lost to Follow-up|10|||
161145876|NCT02531035|581916978|FG000|Overall Study|Randomized, not treated|2|||
161145877|NCT02531035|581916979|FG001|Overall Study|Randomized, not treated|1|||
160951308|NCT04667117|581207402|FG001|Extension Period|Lost to Follow-up|0|||
160951309|NCT04667117|581207403|FG002|Extension Period|Lost to Follow-up|0|||
160951310|NCT01953926|581207414|FG000|Overall Study|Withdrawal by Subject|23|||
161145878|NCT01266148|581916980|FG000|Overall Study|Adverse Event|2|||
161145879|NCT01266148|581916981|FG001|Overall Study|Adverse Event|0|||
161145880|NCT01266148|581916980|FG000|Overall Study|Ongoing rejection|1|||
161145881|NCT01266148|581916981|FG001|Overall Study|Ongoing rejection|0|||
161145882|NCT01266148|581916980|FG000|Overall Study|2 2R rejections|1|||
161145883|NCT01266148|581916981|FG001|Overall Study|2 2R rejections|0|||
161145884|NCT01266148|581916980|FG000|Overall Study|Death|2|||
161145885|NCT01266148|581916981|FG001|Overall Study|Death|3|||
161145886|NCT01266148|581916980|FG000|Overall Study|missing mGFR value + AE|1|||
161145887|NCT01266148|581916981|FG001|Overall Study|missing mGFR value + AE|0|||
161145888|NCT01543490|581916982|FG000|Overall Study|Adverse Event|4|||
161145889|NCT01543490|581916983|FG001|Overall Study|Adverse Event|0|||
161145890|NCT01543490|581916982|FG000|Overall Study|Physician Decision|1|||
161145891|NCT01543490|581916983|FG001|Overall Study|Physician Decision|0|||
161145892|NCT01543490|581916982|FG000|Overall Study|Lack of Efficacy|3|||
161145893|NCT01543490|581916983|FG001|Overall Study|Lack of Efficacy|3|||
161145894|NCT01543490|581916982|FG000|Overall Study|Lost to Follow-up|5|||
161145895|NCT01543490|581916983|FG001|Overall Study|Lost to Follow-up|0|||
161145896|NCT01543490|581916982|FG000|Overall Study|Withdrawal by Subject|2|||
161145897|NCT01543490|581916983|FG001|Overall Study|Withdrawal by Subject|0|||
161145898|NCT01543490|581916982|FG000|Overall Study|Other-Various Administrative Reasons|1|||
161268525|NCT02799095|582366777|FG015|Part C|Physician Decision|0|||
161268526|NCT02799095|582366778|FG016|Part C|Physician Decision|0|||
160951311|NCT01953926|581207415|FG001|Overall Study|Withdrawal by Subject|3|||
160951312|NCT01953926|581207416|FG002|Overall Study|Withdrawal by Subject|3|||
160951313|NCT01953926|581207417|FG003|Overall Study|Withdrawal by Subject|5|||
161145899|NCT01543490|581916983|FG001|Overall Study|Other-Various Administrative Reasons|2|||
161145900|NCT01853228|581916987|FG000|Phase 1|Lack of Efficacy|8|||
160951314|NCT01953926|581207418|FG004|Overall Study|Withdrawal by Subject|6|||
160951315|NCT01953926|581207419|FG005|Overall Study|Withdrawal by Subject|0|||
160951316|NCT01953926|581207420|FG006|Overall Study|Withdrawal by Subject|1|||
161145901|NCT01853228|581916988|FG001|Phase 1|Lack of Efficacy|0|||
161145902|NCT01853228|581916987|FG000|Phase 1|Other|1|||
161145903|NCT01853228|581916988|FG001|Phase 1|Other|0|||
161145904|NCT01853228|581916987|FG000|Phase 2|Physician Decision|0|||
161145905|NCT01853228|581916988|FG001|Phase 2|Physician Decision|1|||
161145906|NCT01853228|581916987|FG000|Phase 2|Proceed To Transplant|0|||
161145907|NCT01853228|581916988|FG001|Phase 2|Proceed To Transplant|3|||
161145908|NCT01853228|581916987|FG000|Phase 2|Lack of Efficacy|0|||
161145909|NCT01853228|581916988|FG001|Phase 2|Lack of Efficacy|4|||
161145910|NCT02400346|581916994|FG000|Overall Study|Adverse Event|24|||
161268527|NCT02799095|582366762|FG000|Part C|Other|0|||
160951317|NCT01953926|581207414|FG000|Overall Study|Physician Decision|1|||
160951318|NCT01953926|581207415|FG001|Overall Study|Physician Decision|0|||
160951319|NCT01953926|581207416|FG002|Overall Study|Physician Decision|0|||
160951320|NCT01953926|581207417|FG003|Overall Study|Physician Decision|0|||
160951321|NCT01953926|581207418|FG004|Overall Study|Physician Decision|2|||
160951322|NCT01953926|581207419|FG005|Overall Study|Physician Decision|0|||
160951323|NCT01953926|581207420|FG006|Overall Study|Physician Decision|0|||
160951324|NCT01953926|581207414|FG000|Overall Study|Lost to Follow-up|18|||
160951325|NCT01953926|581207415|FG001|Overall Study|Lost to Follow-up|3|||
160951326|NCT01953926|581207416|FG002|Overall Study|Lost to Follow-up|0|||
160951327|NCT01953926|581207417|FG003|Overall Study|Lost to Follow-up|5|||
160951328|NCT01953926|581207418|FG004|Overall Study|Lost to Follow-up|3|||
160951329|NCT01953926|581207419|FG005|Overall Study|Lost to Follow-up|0|||
160951330|NCT01953926|581207420|FG006|Overall Study|Lost to Follow-up|0|||
160951331|NCT01953926|581207414|FG000|Overall Study|Protocol Violation|1|||
160951332|NCT01953926|581207415|FG001|Overall Study|Protocol Violation|0|||
160951333|NCT01953926|581207416|FG002|Overall Study|Protocol Violation|0|||
160951334|NCT01953926|581207417|FG003|Overall Study|Protocol Violation|0|||
160951335|NCT01953926|581207418|FG004|Overall Study|Protocol Violation|0|||
160951336|NCT01953926|581207419|FG005|Overall Study|Protocol Violation|0|||
160951337|NCT01953926|581207420|FG006|Overall Study|Protocol Violation|0|||
160951338|NCT01953926|581207414|FG000|Overall Study|Other, Disease progression|2|||
160951339|NCT01953926|581207415|FG001|Overall Study|Other, Disease progression|1|||
160951340|NCT01953926|581207416|FG002|Overall Study|Other, Disease progression|0|||
160951341|NCT01953926|581207417|FG003|Overall Study|Other, Disease progression|0|||
160951342|NCT01953926|581207418|FG004|Overall Study|Other, Disease progression|1|||
160951343|NCT01953926|581207419|FG005|Overall Study|Other, Disease progression|0|||
160951344|NCT01953926|581207420|FG006|Overall Study|Other, Disease progression|0|||
160951345|NCT01953926|581207414|FG000|Overall Study|Discontinuation of study by sponsor|41|||
160951346|NCT01953926|581207415|FG001|Overall Study|Discontinuation of study by sponsor|7|||
160951347|NCT01953926|581207416|FG002|Overall Study|Discontinuation of study by sponsor|5|||
160951348|NCT01953926|581207417|FG003|Overall Study|Discontinuation of study by sponsor|12|||
160951349|NCT01953926|581207418|FG004|Overall Study|Discontinuation of study by sponsor|46|||
160951350|NCT01953926|581207419|FG005|Overall Study|Discontinuation of study by sponsor|5|||
160951351|NCT01953926|581207420|FG006|Overall Study|Discontinuation of study by sponsor|6|||
160951352|NCT01953926|581207414|FG000|Overall Study|Not Treated|1|||
160951353|NCT01953926|581207415|FG001|Overall Study|Not Treated|0|||
160951354|NCT01953926|581207416|FG002|Overall Study|Not Treated|1|||
160951355|NCT01953926|581207417|FG003|Overall Study|Not Treated|0|||
160951356|NCT01953926|581207418|FG004|Overall Study|Not Treated|0|||
160951357|NCT01953926|581207419|FG005|Overall Study|Not Treated|0|||
160951358|NCT01953926|581207420|FG006|Overall Study|Not Treated|0|||
160951359|NCT01949480|581207422|FG000|Overall Study|Physician Decision|5|||
160951360|NCT01949480|581207423|FG001|Overall Study|Physician Decision|8|||
160951361|NCT00144339|581207424|FG000|Overall Study|Adverse Event|746|||
160951362|NCT00144339|581207425|FG001|Overall Study|Adverse Event|627|||
160951363|NCT00144339|581207424|FG000|Overall Study|Protocol Violation|75|||
160951364|NCT00144339|581207425|FG001|Overall Study|Protocol Violation|48|||
160951365|NCT00144339|581207424|FG000|Overall Study|Withdrawal by Subject|403|||
160951366|NCT00144339|581207425|FG001|Overall Study|Withdrawal by Subject|300|||
160951367|NCT00144339|581207424|FG000|Overall Study|Lost to Follow-up|76|||
160951368|NCT00144339|581207425|FG001|Overall Study|Lost to Follow-up|64|||
160951369|NCT00144339|581207424|FG000|Overall Study|Other|58|||
160951370|NCT00144339|581207425|FG001|Overall Study|Other|60|||
161145911|NCT02400346|581916994|FG000|Overall Study|Lack of Efficacy|9|||
161145912|NCT02400346|581916994|FG000|Overall Study|Non-compliance with IMP|1|||
160951371|NCT00305058|581207426|FG000|Overall Study|Participant too young|1|||
160951372|NCT00305058|581207427|FG001|Overall Study|Participant too young|0|||
160951373|NCT00305058|581207426|FG000|Overall Study|Missing data collection instrument|3|||
160951374|NCT00305058|581207427|FG001|Overall Study|Missing data collection instrument|2|||
160951375|NCT00305058|581207426|FG000|Overall Study|Missing outcome data|3|||
160951376|NCT00305058|581207427|FG001|Overall Study|Missing outcome data|2|||
160951377|NCT04798586|581207430|FG000|Overall Study|Death|2|||
160951378|NCT02308033|581207431|FG000|Overall Study|Normal Gram stain at Baseline|13|||
160951379|NCT02308033|581207432|FG001|Overall Study|Normal Gram stain at Baseline|10|||
160951380|NCT02308033|581207431|FG000|Overall Study|Positive for STD at Baseline|7|||
160951381|NCT02308033|581207432|FG001|Overall Study|Positive for STD at Baseline|4|||
160951382|NCT02308033|581207431|FG000|Overall Study|Lost to Follow-up|6|||
160951383|NCT02308033|581207432|FG001|Overall Study|Lost to Follow-up|5|||
160951384|NCT03165045|581207433|FG000|Visit 1|No registration after visit 1|9|||
160951385|NCT03165045|581207433|FG000|Visit 1|No treatment documented|10|||
161145913|NCT02400346|581916994|FG000|Overall Study|Withdrawal by Subject|7|||
160951386|NCT03165045|581207433|FG000|Visit 1|No visit 1|10|||
160951387|NCT03165045|581207433|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
160951388|NCT03165045|581207433|FG000|Visit 2|No available total CCQ score at all|29|||
160951389|NCT03165045|581207433|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
160951390|NCT04323436|581207439|FG000|Overall Study|Adverse Event|7|||
160951391|NCT04323436|581207440|FG001|Overall Study|Adverse Event|0|||
161145914|NCT02400346|581916994|FG000|Overall Study|Administrative or other reason(s)|2|||
161145915|NCT02400346|581916994|FG000|Overall Study|Lost to Follow-up|1|||
161145916|NCT03846947|581917002|FG000|Overall Study|technical issues with imaging sequence|2|||
161145917|NCT00537823|581917009|FG000|Overall Study|Adverse Event|2|||
161145918|NCT00537823|581917010|FG001|Overall Study|Adverse Event|0|||
161145919|NCT02717546|581917011|FG000|Overall Study|Lost to Follow-up|12|||
161145920|NCT02926573|581917013|FG000|Overall Study|Nausea|1|||
160951392|NCT04323436|581207441|FG002|Overall Study|Adverse Event|0|||
160951393|NCT04323436|581207439|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
160951394|NCT04323436|581207440|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
160951395|NCT04323436|581207441|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
161145921|NCT02926573|581917014|FG001|Overall Study|Nausea|0|||
161145922|NCT02926573|581917013|FG000|Overall Study|Remain intubated|2|||
161145923|NCT02926573|581917014|FG001|Overall Study|Remain intubated|2|||
161145924|NCT02926573|581917013|FG000|Overall Study|Change in surgery plan|3|||
161145925|NCT02926573|581917014|FG001|Overall Study|Change in surgery plan|1|||
161145926|NCT02926573|581917013|FG000|Overall Study|Change to outpatient status|5|||
161145927|NCT02926573|581917014|FG001|Overall Study|Change to outpatient status|1|||
161145928|NCT02926573|581917013|FG000|Overall Study|Withdrawal by Subject|0|||
161145929|NCT02926573|581917014|FG001|Overall Study|Withdrawal by Subject|2|||
161145930|NCT02926573|581917013|FG000|Overall Study|Return to operating room|0|||
161145931|NCT02926573|581917014|FG001|Overall Study|Return to operating room|2|||
161145932|NCT02926573|581917013|FG000|Overall Study|Delirium|0|||
161145933|NCT02926573|581917014|FG001|Overall Study|Delirium|1|||
161145934|NCT01009294|581917022|FG000|Overall Study|Study discontinued by Sponsor|6|||
161145935|NCT00949650|581917023|FG000|Overall Study|Progressive disease|188|||
161145936|NCT00949650|581917024|FG001|Overall Study|Progressive disease|19|||
161145937|NCT00949650|581917023|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
161145938|NCT00949650|581917024|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
161145939|NCT00949650|581917023|FG000|Overall Study|Other Adverse Event (AE)|28|||
161145940|NCT00949650|581917024|FG001|Overall Study|Other Adverse Event (AE)|17|||
161145941|NCT00949650|581917023|FG000|Overall Study|Protocol Violation|1|||
161145942|NCT00949650|581917024|FG001|Overall Study|Protocol Violation|4|||
161145943|NCT00949650|581917023|FG000|Overall Study|Refusal to continue medication|7|||
161145944|NCT00949650|581917024|FG001|Overall Study|Refusal to continue medication|11|||
161145945|NCT00949650|581917023|FG000|Overall Study|Not treated|1|||
161145946|NCT00949650|581917024|FG001|Overall Study|Not treated|4|||
161145947|NCT00949650|581917023|FG000|Overall Study|Other not specified above|5|||
161145948|NCT00949650|581917024|FG001|Overall Study|Other not specified above|0|||
161145949|NCT01507545|581917032|FG000|Overall Study|Withdrawal by Subject|6|||
161145950|NCT01507545|581917033|FG001|Overall Study|Withdrawal by Subject|2|||
161145951|NCT01507545|581917032|FG000|Overall Study|Lost to Follow-up|1|||
161145952|NCT01507545|581917033|FG001|Overall Study|Lost to Follow-up|0|||
161145953|NCT01507545|581917032|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
161145954|NCT01507545|581917033|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
161145955|NCT01507545|581917032|FG000|Overall Study|Progressive disease|60|||
161145956|NCT01507545|581917033|FG001|Overall Study|Progressive disease|27|||
161145957|NCT01507545|581917032|FG000|Overall Study|Other|6|||
161145958|NCT01507545|581917033|FG001|Overall Study|Other|4|||
161145959|NCT00790296|581917035|FG000|Overall Study|Did not meet study eligibility criteria|1|||
161145960|NCT00790296|581917036|FG001|Overall Study|Did not meet study eligibility criteria|1|||
161145961|NCT00790296|581917035|FG000|Overall Study|Adverse Event|0|||
161145962|NCT00790296|581917036|FG001|Overall Study|Adverse Event|1|||
161145963|NCT02612077|581917037|FG000|Overall Study|Adverse Event|3|||
161145964|NCT02612077|581917037|FG000|Overall Study|Withdrawal by Subject|9|||
161145965|NCT02612077|581917037|FG000|Overall Study|Protocol Violation|28|||
161145966|NCT02612077|581917037|FG000|Overall Study|Lost to Follow-up|20|||
161145967|NCT02612077|581917037|FG000|Overall Study|Death|377|||
160951396|NCT04323436|581207439|FG000|Overall Study|Death|1|||
160951397|NCT04323436|581207440|FG001|Overall Study|Death|0|||
160951398|NCT04323436|581207441|FG002|Overall Study|Death|0|||
160951399|NCT04323436|581207439|FG000|Overall Study|Physician Decision|2|||
160951400|NCT04323436|581207440|FG001|Overall Study|Physician Decision|0|||
160951401|NCT04323436|581207441|FG002|Overall Study|Physician Decision|0|||
160951402|NCT04323436|581207439|FG000|Overall Study|Progressive disease|10|||
161145968|NCT02612077|581917037|FG000|Overall Study|Moved or Changed Medical Team|23|||
161145969|NCT02612077|581917037|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
161145970|NCT02612077|581917037|FG000|Overall Study|Disease Progression|3|||
161145971|NCT02612077|581917037|FG000|Overall Study|Unknown reason|2|||
161145972|NCT01753518|581917038|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
161145973|NCT01753518|581917039|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
161145974|NCT01753518|581917038|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
161145975|NCT01753518|581917039|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
160951403|NCT04323436|581207440|FG001|Overall Study|Progressive disease|0|||
161145976|NCT01753518|581917038|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
161145977|NCT01753518|581917039|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
160951404|NCT04323436|581207441|FG002|Overall Study|Progressive disease|0|||
160951405|NCT04323436|581207439|FG000|Overall Study|Subject decision|3|||
160951406|NCT04323436|581207440|FG001|Overall Study|Subject decision|0|||
160951407|NCT04323436|581207441|FG002|Overall Study|Subject decision|0|||
160951408|NCT00142909|581207442|FG000|Randomization|Various Reasons|7|||
160951409|NCT00142909|581207443|FG001|Randomization|Various Reasons|10|||
160951410|NCT00142909|581207442|FG000|Medications Begin|Protocol Violation|2|||
160951411|NCT00142909|581207443|FG001|Medications Begin|Protocol Violation|0|||
160951412|NCT00142909|581207442|FG000|Medications Begin|Withdrawal by Subject|5|||
160951413|NCT00142909|581207443|FG001|Medications Begin|Withdrawal by Subject|3|||
160951414|NCT00142909|581207442|FG000|Medications Begin|Withdrawal by Subject|2|||
160951415|NCT00142909|581207443|FG001|Medications Begin|Withdrawal by Subject|0|||
160951416|NCT01682837|581207446|FG000|Baseline|Withdrawal by Subject|5|||
160951417|NCT03021187|581207449|FG000|Overall Study|Death|0|||
160951418|NCT03021187|581207450|FG001|Overall Study|Death|0|||
160951419|NCT03021187|581207451|FG002|Overall Study|Death|3|||
160951420|NCT03021187|581207452|FG003|Overall Study|Death|0|||
160951421|NCT03021187|581207449|FG000|Overall Study|Withdrawal by Subject|0|||
160951422|NCT03021187|581207450|FG001|Overall Study|Withdrawal by Subject|6|||
160951423|NCT03021187|581207451|FG002|Overall Study|Withdrawal by Subject|2|||
160951424|NCT03021187|581207452|FG003|Overall Study|Withdrawal by Subject|5|||
160951425|NCT03021187|581207449|FG000|Overall Study|Lost to Follow-up|10|||
160951426|NCT03021187|581207450|FG001|Overall Study|Lost to Follow-up|3|||
160951427|NCT03021187|581207451|FG002|Overall Study|Lost to Follow-up|1|||
160951428|NCT03021187|581207452|FG003|Overall Study|Lost to Follow-up|4|||
160951429|NCT01664078|581207453|FG000|Overall Study|Death|9|||
160951430|NCT01664078|581207453|FG000|Overall Study|Withdrawal by Subject|4|||
160951431|NCT01664078|581207453|FG000|Overall Study|Lost to Follow-up|2|||
160951432|NCT01664078|581207453|FG000|Overall Study|missed 5 year visit|1|||
160951433|NCT01664078|581207453|FG000|Overall Study|Other|53|||
160951434|NCT03351049|581207454|FG000|Overall Study|Withdrawal|26|||
160951435|NCT03351049|581207455|FG001|Overall Study|Withdrawal|22|||
160951436|NCT04726709|581209013|FG000|Overall Study|Withdrawal by Subject|2|||
160951437|NCT04726709|581209014|FG001|Overall Study|Withdrawal by Subject|2|||
160951438|NCT04447404|581209028|FG000|Overall Study|Death|2|||
160951439|NCT04447404|581209029|FG001|Overall Study|Death|0|||
160951440|NCT00574080|581209030|FG000|Overall Study|Death|10|||
160951441|NCT00574080|581209031|FG001|Overall Study|Death|10|||
160951442|NCT01221597|581209032|FG000|Overall Study|Adverse Event|4|||
160951443|NCT01221597|581209033|FG001|Overall Study|Adverse Event|1|||
160951444|NCT01221597|581209032|FG000|Overall Study|Withdrawal by Subject|20|||
160951445|NCT01221597|581209033|FG001|Overall Study|Withdrawal by Subject|6|||
160951446|NCT01221597|581209032|FG000|Overall Study|Lost to Follow-up|6|||
160951447|NCT01221597|581209033|FG001|Overall Study|Lost to Follow-up|5|||
160951448|NCT01221597|581209032|FG000|Overall Study|Protocol Violation|1|||
160951449|NCT01221597|581209033|FG001|Overall Study|Protocol Violation|0|||
160951450|NCT01221597|581209032|FG000|Overall Study|Other|3|||
160951451|NCT01221597|581209033|FG001|Overall Study|Other|4|||
160951452|NCT01221597|581209032|FG000|Overall Study|Death|2|||
160951453|NCT01221597|581209033|FG001|Overall Study|Death|0|||
160951454|NCT00148343|581209035|FG000|Overall Study|Withdrawal by Subject|12|||
160951455|NCT00148343|581209036|FG001|Overall Study|Withdrawal by Subject|7|||
160951456|NCT00148343|581209035|FG000|Overall Study|Physician Decision|3|||
160951457|NCT00148343|581209036|FG001|Overall Study|Physician Decision|4|||
160951458|NCT02384759|581209049|FG000|Overall Study|Patients not treated|3|||
160951459|NCT02384759|581209050|FG001|Overall Study|Patients not treated|2|||
160951460|NCT01605617|581209051|FG000|First Intervention|Adverse Event|0|||
160951461|NCT01605617|581209052|FG001|First Intervention|Adverse Event|1|||
160951462|NCT01605617|581209051|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
160951463|NCT01605617|581209052|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
160951464|NCT00121238|581209053|FG000|Overall Study|disease progression before intervention|1|||
160951465|NCT00121238|581209053|FG000|Overall Study|Protocol Violation|2|||
160951466|NCT01380327|581209054|FG000|Overall Study|Lost to Follow-up|0|||
161000708|NCT05190419|581387223|FG001|Overall Study|Lack of Efficacy|0|||
161000709|NCT05190419|581387224|FG002|Overall Study|Lack of Efficacy|1|||
160951467|NCT01380327|581209055|FG001|Overall Study|Lost to Follow-up|1|||
161000710|NCT05190419|581387225|FG003|Overall Study|Lack of Efficacy|0|||
161000711|NCT05190419|581387222|FG000|Overall Study|Withdrawal by Subject|7|||
160951468|NCT01380327|581209056|FG002|Overall Study|Lost to Follow-up|1|||
160951469|NCT01380327|581209054|FG000|Overall Study|Protocol Violation|3|||
160951470|NCT01380327|581209055|FG001|Overall Study|Protocol Violation|2|||
160951471|NCT01380327|581209056|FG002|Overall Study|Protocol Violation|3|||
160951472|NCT01380327|581209054|FG000|Overall Study|Withdrawal by Subject|0|||
160951473|NCT01380327|581209055|FG001|Overall Study|Withdrawal by Subject|0|||
160951474|NCT01380327|581209056|FG002|Overall Study|Withdrawal by Subject|1|||
160951475|NCT01380327|581209054|FG000|Overall Study|Housing situation precluded ability to k|0|||
160951476|NCT01380327|581209055|FG001|Overall Study|Housing situation precluded ability to k|0|||
160951477|NCT01380327|581209056|FG002|Overall Study|Housing situation precluded ability to k|1|||
161000712|NCT05190419|581387223|FG001|Overall Study|Withdrawal by Subject|1|||
160951478|NCT01380327|581209054|FG000|Overall Study|Questionable onset of epilepsy|0|||
160951479|NCT01380327|581209055|FG001|Overall Study|Questionable onset of epilepsy|0|||
160951480|NCT01380327|581209056|FG002|Overall Study|Questionable onset of epilepsy|1|||
160951481|NCT01540851|581209057|FG000|Overall Study|Lost to Follow-up|14|||
160951482|NCT01540851|581209058|FG001|Overall Study|Lost to Follow-up|15|||
160951483|NCT01540851|581209057|FG000|Overall Study|Withdrawal by Subject|7|||
160951484|NCT01540851|581209058|FG001|Overall Study|Withdrawal by Subject|3|||
161145978|NCT01753518|581917038|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
161145979|NCT01753518|581917039|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
161145980|NCT01971476|581917040|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
161145981|NCT01971476|581917041|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
161145982|NCT01971476|581917042|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
161145983|NCT01971476|581917040|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
161145984|NCT01971476|581917041|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
161145985|NCT01971476|581917042|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
161145986|NCT01971476|581917040|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
161145987|NCT01971476|581917041|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
161145988|NCT01971476|581917042|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
161145989|NCT05121103|581917043|FG000|Overall Study|Progressive disease|2|||
161145990|NCT05121103|581917044|FG001|Overall Study|Progressive disease|1|||
161145991|NCT05121103|581917045|FG002|Overall Study|Progressive disease|6|||
161145992|NCT05121103|581917043|FG000|Overall Study|Physician Decision|2|||
161145993|NCT05121103|581917044|FG001|Overall Study|Physician Decision|1|||
161145994|NCT05121103|581917045|FG002|Overall Study|Physician Decision|0|||
161145995|NCT05121103|581917043|FG000|Overall Study|Withdrawal by Subject|0|||
161145996|NCT05121103|581917044|FG001|Overall Study|Withdrawal by Subject|1|||
161145997|NCT05121103|581917045|FG002|Overall Study|Withdrawal by Subject|0|||
161145998|NCT00514449|581917048|FG000|Overall Study|Withdrawal by Subject|1|||
161145999|NCT00514449|581917049|FG001|Overall Study|Withdrawal by Subject|2|||
161146000|NCT00514449|581917048|FG000|Overall Study|Protocol Violation|1|||
161146001|NCT00514449|581917049|FG001|Overall Study|Protocol Violation|2|||
161146002|NCT00514449|581917048|FG000|Overall Study|Lost to Follow-up|1|||
161146003|NCT00514449|581917049|FG001|Overall Study|Lost to Follow-up|0|||
161146004|NCT05897853|581917057|FG000|Overall Study|Lost to Follow-up|2|||
161146005|NCT05897853|581917058|FG001|Overall Study|Lost to Follow-up|0|||
161146006|NCT05897853|581917057|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
161146007|NCT05897853|581917058|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
161146008|NCT04458857|581917065|FG000|Overall Study|Adverse Event|0|||
161146009|NCT04458857|581917066|FG001|Overall Study|Adverse Event|1|||
161146010|NCT04458857|581917067|FG002|Overall Study|Adverse Event|0|||
161146011|NCT04458857|581917065|FG000|Overall Study|Withdrawal by Subject|2|||
161146012|NCT04458857|581917066|FG001|Overall Study|Withdrawal by Subject|0|||
161146013|NCT04458857|581917067|FG002|Overall Study|Withdrawal by Subject|0|||
161146014|NCT04458857|581917065|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161146015|NCT04458857|581917066|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161146016|NCT04458857|581917067|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161146017|NCT04458857|581917065|FG000|Overall Study|Non-compliance with study drug|0|||
161146018|NCT04458857|581917066|FG001|Overall Study|Non-compliance with study drug|1|||
161146019|NCT04458857|581917067|FG002|Overall Study|Non-compliance with study drug|0|||
161146020|NCT04458857|581917065|FG000|Overall Study|Lost to Follow-up|4|||
161146021|NCT04458857|581917066|FG001|Overall Study|Lost to Follow-up|1|||
161146022|NCT04458857|581917067|FG002|Overall Study|Lost to Follow-up|0|||
161146023|NCT02609399|581917068|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
161146024|NCT02609399|581917069|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
161146025|NCT02609399|581917068|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
161146026|NCT02609399|581917069|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
161146027|NCT02609399|581917068|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
161146028|NCT02609399|581917069|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
161146029|NCT00306891|581917070|FG000|Part A|Withdrawal by Subject|1|||
161146030|NCT00306891|581917071|FG001|Part A|Withdrawal by Subject|1|||
161146031|NCT00306891|581917072|FG002|Part A|Withdrawal by Subject|0|||
161146032|NCT00306891|581917073|FG003|Part A|Withdrawal by Subject|0|||
161146033|NCT00306891|581917070|FG000|Part A|Condition under investigation worsened|2|||
161146034|NCT00306891|581917071|FG001|Part A|Condition under investigation worsened|2|||
161146035|NCT00306891|581917072|FG002|Part A|Condition under investigation worsened|0|||
161146036|NCT00306891|581917073|FG003|Part A|Condition under investigation worsened|0|||
161146037|NCT00306891|581917070|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
160951485|NCT03593655|581209059|FG000|First Product Use Period|Withdrawal by Subject|1|||
161146038|NCT00306891|581917071|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
161146039|NCT00306891|581917072|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161146040|NCT00306891|581917073|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
161146041|NCT00306891|581917070|FG000|Part A|Partial bowel obstruction|1|||
161268528|NCT02799095|582366763|FG001|Part C|Other|0|||
160951486|NCT03593655|581209060|FG001|First Product Use Period|Withdrawal by Subject|1|||
161000713|NCT05190419|581387224|FG002|Overall Study|Withdrawal by Subject|2|||
161000714|NCT05190419|581387225|FG003|Overall Study|Withdrawal by Subject|2|||
161000715|NCT05190419|581387222|FG000|Overall Study|Adverse Event|2|||
161000716|NCT05190419|581387223|FG001|Overall Study|Adverse Event|10|||
161000717|NCT05190419|581387224|FG002|Overall Study|Adverse Event|11|||
161000718|NCT05190419|581387225|FG003|Overall Study|Adverse Event|21|||
161000719|NCT05190419|581387222|FG000|Overall Study|Lost to Follow-up|1|||
161000720|NCT05190419|581387223|FG001|Overall Study|Lost to Follow-up|2|||
161000721|NCT05190419|581387224|FG002|Overall Study|Lost to Follow-up|3|||
161000722|NCT05190419|581387225|FG003|Overall Study|Lost to Follow-up|1|||
161000723|NCT05190419|581387222|FG000|Overall Study|Other|1|||
161000724|NCT05190419|581387223|FG001|Overall Study|Other|1|||
161000725|NCT05190419|581387224|FG002|Overall Study|Other|0|||
161000726|NCT05190419|581387225|FG003|Overall Study|Other|3|||
161000727|NCT01227707|581387226|FG000|Overall Study|Adverse Event|10|||
161000728|NCT01227707|581387226|FG000|Overall Study|Progression of disease|3|||
161000729|NCT01227707|581387226|FG000|Overall Study|Withdrawal by Subject|1|||
161000730|NCT01227707|581387226|FG000|Overall Study|Patient non-compliance|3|||
161000731|NCT01227707|581387226|FG000|Overall Study|Medical decision|6|||
161000732|NCT01227707|581387226|FG000|Overall Study|Death|1|||
161000733|NCT03210402|581387227|FG000|Overall Study|Withdrawal by Subject|0|||
161000734|NCT03210402|581387228|FG001|Overall Study|Withdrawal by Subject|1|||
161000735|NCT00811057|581387229|FG000|Overall Study|Protocol Violation|5|||
161000736|NCT00811057|581387230|FG001|Overall Study|Protocol Violation|10|||
161000737|NCT00811057|581387231|FG002|Overall Study|Protocol Violation|10|||
161000738|NCT05328297|581388860|FG000|Overall Study|Adverse Event|5|||
161000739|NCT05328297|581388861|FG001|Overall Study|Adverse Event|7|||
161146042|NCT00306891|581917071|FG001|Part A|Partial bowel obstruction|0|||
161146043|NCT00306891|581917072|FG002|Part A|Partial bowel obstruction|0|||
161146044|NCT00306891|581917073|FG003|Part A|Partial bowel obstruction|0|||
161000740|NCT05328297|581388860|FG000|Overall Study|Withdrawal by Subject|4|||
161000741|NCT05328297|581388861|FG001|Overall Study|Withdrawal by Subject|3|||
161000742|NCT05328297|581388860|FG000|Overall Study|Lack of Efficacy|1|||
161000743|NCT05328297|581388861|FG001|Overall Study|Lack of Efficacy|0|||
161000744|NCT05328297|581388860|FG000|Overall Study|Lost to Follow-up|1|||
161000745|NCT05328297|581388861|FG001|Overall Study|Lost to Follow-up|0|||
161000746|NCT05328297|581388860|FG000|Overall Study|Protocol Violation|1|||
161000747|NCT05328297|581388861|FG001|Overall Study|Protocol Violation|0|||
161000748|NCT05328297|581388860|FG000|Overall Study|Randomized but not treated|1|||
161000749|NCT05328297|581388861|FG001|Overall Study|Randomized but not treated|1|||
161000750|NCT00028769|581388864|FG000|Overall Study|Adverse Event|2|||
161146045|NCT00306891|581917070|FG000|Part A|Reaccumul. of ascites following drainage|0|||
161146046|NCT00306891|581917071|FG001|Part A|Reaccumul. of ascites following drainage|1|||
161146047|NCT00306891|581917072|FG002|Part A|Reaccumul. of ascites following drainage|0|||
161146048|NCT00306891|581917073|FG003|Part A|Reaccumul. of ascites following drainage|0|||
161146049|NCT00306891|581917070|FG000|Part A|Suspicion of second malignancy|0|||
161146050|NCT00306891|581917071|FG001|Part A|Suspicion of second malignancy|1|||
161146051|NCT00306891|581917072|FG002|Part A|Suspicion of second malignancy|0|||
161146052|NCT00306891|581917073|FG003|Part A|Suspicion of second malignancy|0|||
161146053|NCT00306891|581917070|FG000|Part A|QTC interval outwith elig. criteria|1|||
161146054|NCT00306891|581917071|FG001|Part A|QTC interval outwith elig. criteria|0|||
161146055|NCT00306891|581917072|FG002|Part A|QTC interval outwith elig. criteria|0|||
161146056|NCT00306891|581917073|FG003|Part A|QTC interval outwith elig. criteria|0|||
161146057|NCT00306891|581917070|FG000|Part B|Death|0|||
161146058|NCT00306891|581917071|FG001|Part B|Death|0|||
161000751|NCT00028769|581388864|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
161000752|NCT00028769|581388864|FG000|Overall Study|Progression or Death|31|||
161000753|NCT00028769|581388864|FG000|Overall Study|Other - Not Protocol Specified|1|||
161000754|NCT00028769|581388864|FG000|Overall Study|Ineligible|5|||
161000755|NCT00028769|581388864|FG000|Overall Study|Not Analyzable|1|||
161000756|NCT02496702|581388867|FG000|Overall Study|Lost to Follow-up|8|||
161000757|NCT02496702|581388868|FG001|Overall Study|Lost to Follow-up|6|||
161000758|NCT02496702|581388867|FG000|Overall Study|Only partially tested|0|||
161000759|NCT02496702|581388868|FG001|Overall Study|Only partially tested|2|||
161000760|NCT00941655|581388871|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
161000761|NCT00941655|581388872|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
161146059|NCT00306891|581917072|FG002|Part B|Death|1|||
161146060|NCT00306891|581917073|FG003|Part B|Death|2|||
161146061|NCT00306891|581917070|FG000|Part B|Adverse Event|0|||
161146062|NCT00306891|581917071|FG001|Part B|Adverse Event|0|||
161146063|NCT00306891|581917072|FG002|Part B|Adverse Event|5|||
161000762|NCT00941655|581388871|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
161146064|NCT00306891|581917073|FG003|Part B|Adverse Event|5|||
161146065|NCT00306891|581917070|FG000|Part B|Withdrawal by Subject|0|||
161146066|NCT00306891|581917071|FG001|Part B|Withdrawal by Subject|0|||
161146067|NCT00306891|581917072|FG002|Part B|Withdrawal by Subject|3|||
161146068|NCT00306891|581917073|FG003|Part B|Withdrawal by Subject|1|||
161000763|NCT00941655|581388872|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
161000764|NCT00941655|581388871|FG000|Overall Study|progressed while on chemo|0|||
161268529|NCT02799095|582366764|FG002|Part C|Other|0|||
161268530|NCT02799095|582366765|FG003|Part C|Other|0|||
161268531|NCT02799095|582366766|FG004|Part C|Other|0|||
161268532|NCT02799095|582366767|FG005|Part C|Other|0|||
161268533|NCT02799095|582366768|FG006|Part C|Other|0|||
160951487|NCT03593655|581209059|FG000|First Product Use Period|Lost to Follow-up|1|||
160951488|NCT03593655|581209060|FG001|First Product Use Period|Lost to Follow-up|3|||
160951489|NCT03593655|581209059|FG000|Second Product Use Period|Withdrawal by Subject|1|||
160951490|NCT03593655|581209060|FG001|Second Product Use Period|Withdrawal by Subject|1|||
160951491|NCT03593655|581209059|FG000|Second Product Use Period|Lost to Follow-up|1|||
160951492|NCT03593655|581209060|FG001|Second Product Use Period|Lost to Follow-up|0|||
160951493|NCT03593655|581209059|FG000|Third Product Use Period|Lost to Follow-up|1|||
160951494|NCT03593655|581209060|FG001|Third Product Use Period|Lost to Follow-up|2|||
160951495|NCT03593655|581209059|FG000|Third Product Use Period|Physician Decision|0|||
160951496|NCT03593655|581209060|FG001|Third Product Use Period|Physician Decision|1|||
160951497|NCT03593655|581209059|FG000|Third Product Use Period|Withdrawal by Subject|0|||
160951498|NCT03593655|581209060|FG001|Third Product Use Period|Withdrawal by Subject|1|||
160951499|NCT05046795|581209061|FG000|Overall Study|Adverse Event|13|||
160951500|NCT05046795|581209062|FG001|Overall Study|Adverse Event|15|||
160951501|NCT05046795|581209061|FG000|Overall Study|Withdrawal by Subject|4|||
160951502|NCT05046795|581209062|FG001|Overall Study|Withdrawal by Subject|7|||
160951503|NCT05046795|581209061|FG000|Overall Study|Physician Decision|1|||
161268534|NCT02799095|582366769|FG007|Part C|Other|0|||
161268535|NCT02799095|582366770|FG008|Part C|Other|0|||
161268536|NCT02799095|582366771|FG009|Part C|Other|0|||
160951504|NCT05046795|581209062|FG001|Overall Study|Physician Decision|2|||
160951505|NCT05046795|581209061|FG000|Overall Study|Protocol Violation|1|||
160951506|NCT05046795|581209062|FG001|Overall Study|Protocol Violation|2|||
160951507|NCT05046795|581209061|FG000|Overall Study|Death|1|||
160951508|NCT05046795|581209062|FG001|Overall Study|Death|0|||
160951509|NCT05046795|581209061|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
160951510|NCT05046795|581209062|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
160951511|NCT00690755|581209063|FG000|Overall Study|Physician Decision|2|||
160951512|NCT00690755|581209064|FG001|Overall Study|Physician Decision|0|||
160951513|NCT00690755|581209065|FG002|Overall Study|Physician Decision|46|||
160951514|NCT00690755|581209066|FG003|Overall Study|Physician Decision|5|||
160951515|NCT00690755|581209067|FG004|Overall Study|Physician Decision|0|||
160951516|NCT00690755|581209068|FG005|Overall Study|Physician Decision|4|||
160951517|NCT00690755|581209069|FG006|Overall Study|Physician Decision|0|||
160951518|NCT04287920|581209073|FG000|Overall Study|Lost to Follow-up|1|||
160951519|NCT04287920|581209074|FG001|Overall Study|Lost to Follow-up|1|||
160951520|NCT04287920|581209073|FG000|Overall Study|Withdrawal by Subject|0|||
160951521|NCT04287920|581209074|FG001|Overall Study|Withdrawal by Subject|3|||
160951522|NCT03538626|581209075|FG000|Overall Study|Withdrawal by Subject|0|||
160951523|NCT03538626|581209076|FG001|Overall Study|Withdrawal by Subject|1|||
160951524|NCT03538626|581209077|FG002|Overall Study|Withdrawal by Subject|0|||
160951525|NCT03538626|581209078|FG003|Overall Study|Withdrawal by Subject|0|||
160951526|NCT03538626|581209079|FG004|Overall Study|Withdrawal by Subject|0|||
160951527|NCT03538626|581209080|FG005|Overall Study|Withdrawal by Subject|0|||
160951528|NCT03538626|581209081|FG006|Overall Study|Withdrawal by Subject|0|||
160951529|NCT03538626|581209082|FG007|Overall Study|Withdrawal by Subject|0|||
160951530|NCT03538626|581209075|FG000|Overall Study|Lost to Follow-up|0|||
160951531|NCT03538626|581209076|FG001|Overall Study|Lost to Follow-up|0|||
160951532|NCT03538626|581209077|FG002|Overall Study|Lost to Follow-up|0|||
160951533|NCT03538626|581209078|FG003|Overall Study|Lost to Follow-up|0|||
160951534|NCT03538626|581209079|FG004|Overall Study|Lost to Follow-up|0|||
160951535|NCT03538626|581209080|FG005|Overall Study|Lost to Follow-up|0|||
160951536|NCT03538626|581209081|FG006|Overall Study|Lost to Follow-up|1|||
160951537|NCT03538626|581209082|FG007|Overall Study|Lost to Follow-up|0|||
160951538|NCT00288587|581209083|FG000|Overall Study|Death|4|||
160951539|NCT00288587|581209084|FG001|Overall Study|Death|4|||
161000765|NCT00941655|581388872|FG001|Overall Study|progressed while on chemo|2|||
160951540|NCT00288587|581209083|FG000|Overall Study|Transplant|0|||
160951541|NCT00288587|581209084|FG001|Overall Study|Transplant|3|||
161000766|NCT00941655|581388871|FG000|Overall Study|refused further treatment|0|||
161000767|NCT00941655|581388872|FG001|Overall Study|refused further treatment|1|||
161268537|NCT02799095|582366772|FG010|Part C|Other|0|||
160951542|NCT00288587|581209083|FG000|Overall Study|Adverse Event|0|||
160951543|NCT00288587|581209084|FG001|Overall Study|Adverse Event|1|||
160951544|NCT00288587|581209083|FG000|Overall Study|Physician Decision|0|||
160951545|NCT00288587|581209084|FG001|Overall Study|Physician Decision|2|||
160951546|NCT00288587|581209083|FG000|Overall Study|Severe Aortic Stenosis|1|||
160951547|NCT00288587|581209084|FG001|Overall Study|Severe Aortic Stenosis|0|||
160951548|NCT02232893|581209090|FG000|Overall Study|Withdrawal by Subject|4|||
160951549|NCT02232893|581209091|FG001|Overall Study|Withdrawal by Subject|1|||
160951550|NCT02232893|581209090|FG000|Overall Study|Adverse Event|0|||
161268538|NCT02799095|582366773|FG011|Part C|Other|2|||
161268539|NCT02799095|582366774|FG012|Part C|Other|2|||
161268540|NCT02799095|582366775|FG013|Part C|Other|0|||
161268541|NCT02799095|582366776|FG014|Part C|Other|0|||
160951551|NCT02232893|581209091|FG001|Overall Study|Adverse Event|1|||
160951552|NCT02232893|581209090|FG000|Overall Study|Sponsor request early termination|0|||
160951553|NCT02232893|581209091|FG001|Overall Study|Sponsor request early termination|1|||
160951554|NCT02232893|581209090|FG000|Overall Study|Developed exclusion criteria|0|||
160951555|NCT02232893|581209091|FG001|Overall Study|Developed exclusion criteria|1|||
160951556|NCT02232893|581209090|FG000|Overall Study|Other|0|||
160951557|NCT02232893|581209091|FG001|Overall Study|Other|3|||
160951558|NCT01764945|581209092|FG000|Overall Study|Adverse Event|0|||
160951559|NCT01764945|581209093|FG001|Overall Study|Adverse Event|1|||
160951560|NCT01764945|581209094|FG002|Overall Study|Adverse Event|0|||
160951561|NCT01764945|581209095|FG003|Overall Study|Adverse Event|0|||
160951562|NCT01764945|581209096|FG004|Overall Study|Adverse Event|0|||
160951563|NCT01764945|581209097|FG005|Overall Study|Adverse Event|0|||
160951564|NCT01764945|581209098|FG006|Overall Study|Adverse Event|1|||
160951565|NCT01764945|581209099|FG007|Overall Study|Adverse Event|0|||
160951566|NCT05077267|581209102|FG000|Treatment Period|Lost to Follow-up|0|||
160951567|NCT05077267|581209103|FG001|Treatment Period|Lost to Follow-up|1|||
160951568|NCT05077267|581209104|FG002|Treatment Period|Lost to Follow-up|0|||
160951569|NCT05077267|581209102|FG000|Treatment Period|Withdrawal by Subject|0|||
160951570|NCT05077267|581209103|FG001|Treatment Period|Withdrawal by Subject|1|||
160951571|NCT05077267|581209104|FG002|Treatment Period|Withdrawal by Subject|0|||
160951572|NCT05077267|581209102|FG000|Follow-up Period|Lost to Follow-up|0|||
160951573|NCT05077267|581209103|FG001|Follow-up Period|Lost to Follow-up|5|||
160951574|NCT05077267|581209104|FG002|Follow-up Period|Lost to Follow-up|7|||
160951575|NCT05077267|581209102|FG000|Follow-up Period|Withdrawal by Subject|0|||
160951576|NCT05077267|581209103|FG001|Follow-up Period|Withdrawal by Subject|2|||
160951577|NCT05077267|581209104|FG002|Follow-up Period|Withdrawal by Subject|5|||
160951578|NCT05077267|581209102|FG000|Follow-up Period|Study terminated by sponsor|0|||
160951579|NCT05077267|581209103|FG001|Follow-up Period|Study terminated by sponsor|27|||
160951580|NCT05077267|581209104|FG002|Follow-up Period|Study terminated by sponsor|23|||
160951581|NCT05077267|581209102|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
160951582|NCT05077267|581209103|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
160951583|NCT05077267|581209104|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
160951584|NCT05077267|581209102|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
160951585|NCT05077267|581209103|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
160951586|NCT05077267|581209104|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
160951587|NCT02911948|581209107|FG000|Overall Study|Protocol Violation|0|||
160951588|NCT02911948|581209108|FG001|Overall Study|Protocol Violation|1|||
160951589|NCT02911948|581209107|FG000|Overall Study|Withdrawal by Subject|0|||
160951590|NCT02911948|581209108|FG001|Overall Study|Withdrawal by Subject|2|||
160951591|NCT02911948|581209107|FG000|Overall Study|Lack of Efficacy|0|||
160951592|NCT02911948|581209108|FG001|Overall Study|Lack of Efficacy|1|||
160951593|NCT02911948|581209107|FG000|Overall Study|Unclassified|0|||
160951594|NCT02911948|581209108|FG001|Overall Study|Unclassified|3|||
160951595|NCT00586105|581209115|FG000|Overall Study|Adverse Event|4|||
160951596|NCT00586105|581209115|FG000|Overall Study|Death|2|||
160951597|NCT00586105|581209115|FG000|Overall Study|Protocol Violation|1|||
160951598|NCT00586105|581209115|FG000|Overall Study|Withdrawal by Subject|3|||
160951599|NCT00586105|581209115|FG000|Overall Study|Disease progression|19|||
160951600|NCT00586105|581209115|FG000|Overall Study|Switched to commercial drug|9|||
160951601|NCT00586105|581209115|FG000|Overall Study|Reason not reported|1|||
160951602|NCT01136291|581209119|FG000|Overall Study|Lost to Follow-up|1|||
160951603|NCT01136291|581209120|FG001|Overall Study|Lost to Follow-up|1|||
160951604|NCT03965052|581209121|FG000|Overall Study|Protocol Violation|1|||
160951605|NCT03965052|581209122|FG001|Overall Study|Protocol Violation|0|||
160951606|NCT01660763|581209137|FG000|Overall Study|Lack of Efficacy|45|||
160951607|NCT01660763|581209138|FG001|Overall Study|Lack of Efficacy|50|||
160951608|NCT01660763|581209137|FG000|Overall Study|Adverse Event|22|||
160951609|NCT01660763|581209138|FG001|Overall Study|Adverse Event|7|||
160951610|NCT01660763|581209137|FG000|Overall Study|Protocol Violation|1|||
160951611|NCT01660763|581209138|FG001|Overall Study|Protocol Violation|0|||
160951612|NCT01660763|581209137|FG000|Overall Study|Withdrawal by Subject|4|||
160951613|NCT01660763|581209138|FG001|Overall Study|Withdrawal by Subject|0|||
160951614|NCT01660763|581209137|FG000|Overall Study|Patient ready for early discharge|28|||
160951615|NCT01660763|581209138|FG001|Overall Study|Patient ready for early discharge|4|||
160951616|NCT00345397|581209139|FG000|Overall Study|Death|1|||
160951617|NCT04782323|581209140|FG000|Overall Study|Death|1|||
160951618|NCT04782323|581209141|FG001|Overall Study|Death|0|||
160951619|NCT04782323|581209142|FG002|Overall Study|Death|0|||
160951620|NCT04782323|581209143|FG003|Overall Study|Death|0|||
160951621|NCT04782323|581209144|FG004|Overall Study|Death|1|||
160951622|NCT04782323|581209145|FG005|Overall Study|Death|1|||
160951623|NCT04782323|581209146|FG006|Overall Study|Death|1|||
160951624|NCT04782323|581209147|FG007|Overall Study|Death|0|||
160951625|NCT04782323|581209140|FG000|Overall Study|Withdrawal by Subject|0|||
160951626|NCT04782323|581209141|FG001|Overall Study|Withdrawal by Subject|0|||
160951627|NCT04782323|581209142|FG002|Overall Study|Withdrawal by Subject|1|||
160951628|NCT04782323|581209143|FG003|Overall Study|Withdrawal by Subject|0|||
160951629|NCT04782323|581209144|FG004|Overall Study|Withdrawal by Subject|0|||
160951630|NCT04782323|581209145|FG005|Overall Study|Withdrawal by Subject|1|||
160951631|NCT04782323|581209146|FG006|Overall Study|Withdrawal by Subject|0|||
160951632|NCT04782323|581209147|FG007|Overall Study|Withdrawal by Subject|1|||
160951633|NCT04782323|581209140|FG000|Overall Study|Lost to Follow-up|0|||
160951634|NCT04782323|581209141|FG001|Overall Study|Lost to Follow-up|1|||
160951635|NCT04782323|581209142|FG002|Overall Study|Lost to Follow-up|1|||
160951636|NCT04782323|581209143|FG003|Overall Study|Lost to Follow-up|0|||
160951637|NCT04782323|581209144|FG004|Overall Study|Lost to Follow-up|0|||
160951638|NCT04782323|581209145|FG005|Overall Study|Lost to Follow-up|1|||
160951639|NCT04782323|581209146|FG006|Overall Study|Lost to Follow-up|1|||
160951640|NCT04782323|581209147|FG007|Overall Study|Lost to Follow-up|2|||
160951641|NCT04782323|581209140|FG000|Overall Study|randomization in error|1|||
160951642|NCT04782323|581209141|FG001|Overall Study|randomization in error|0|||
160951643|NCT04782323|581209142|FG002|Overall Study|randomization in error|0|||
160951644|NCT04782323|581209143|FG003|Overall Study|randomization in error|0|||
160951645|NCT04782323|581209144|FG004|Overall Study|randomization in error|0|||
160951646|NCT04782323|581209145|FG005|Overall Study|randomization in error|0|||
160951647|NCT04782323|581209146|FG006|Overall Study|randomization in error|0|||
160951648|NCT04782323|581209147|FG007|Overall Study|randomization in error|0|||
160951649|NCT04369469|581209148|FG000|Overall Study|Lost to Follow-up|2|||
160951650|NCT04369469|581209149|FG001|Overall Study|Lost to Follow-up|4|||
160951651|NCT04369469|581209148|FG000|Overall Study|Physician Decision|2|||
160951652|NCT04369469|581209149|FG001|Overall Study|Physician Decision|1|||
160951653|NCT04369469|581209148|FG000|Overall Study|Withdrawal by Subject|2|||
160951654|NCT04369469|581209149|FG001|Overall Study|Withdrawal by Subject|3|||
160951655|NCT04369469|581209148|FG000|Overall Study|Adverse Event|1|||
160951656|NCT04369469|581209149|FG001|Overall Study|Adverse Event|0|||
160951657|NCT04369469|581209148|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
160951658|NCT04369469|581209149|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
160951659|NCT04369469|581209148|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
160951660|NCT04369469|581209149|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
160951661|NCT04369469|581209148|FG000|Overall Study|Unable to Provide Consent|0|||
160951662|NCT04369469|581209149|FG001|Overall Study|Unable to Provide Consent|1|||
160951663|NCT03832192|581209152|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
160951664|NCT03832192|581209153|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
160951665|NCT03099382|581209154|FG000|Overall Study|Protocol Violation|2|||
160951666|NCT03099382|581209155|FG001|Overall Study|Protocol Violation|3|||
160951667|NCT00499369|581209158|FG000|Overall Study|Adverse Event|2|||
160951668|NCT00499369|581209159|FG001|Overall Study|Adverse Event|2|||
160951669|NCT00499369|581209160|FG002|Overall Study|Adverse Event|3|||
160951670|NCT00499369|581209161|FG003|Overall Study|Adverse Event|1|||
160951671|NCT00499369|581209162|FG004|Overall Study|Adverse Event|2|||
160951672|NCT00499369|581209158|FG000|Overall Study|Withdrawal by Subject|0|||
160951673|NCT00499369|581209159|FG001|Overall Study|Withdrawal by Subject|1|||
160951674|NCT00499369|581209160|FG002|Overall Study|Withdrawal by Subject|1|||
160951675|NCT00499369|581209161|FG003|Overall Study|Withdrawal by Subject|0|||
160951676|NCT00499369|581209162|FG004|Overall Study|Withdrawal by Subject|0|||
160951677|NCT00499369|581209158|FG000|Overall Study|Progression|10|||
160951678|NCT00499369|581209159|FG001|Overall Study|Progression|12|||
160951679|NCT00499369|581209160|FG002|Overall Study|Progression|9|||
160862540|NCT02260934|580889768|FG001|Overall Study|Withdrawal by Subject|2|||
160862541|NCT02260934|580889767|FG000|Overall Study|Participant Relocated|1|||
160862542|NCT02260934|580889768|FG001|Overall Study|Participant Relocated|0|||
160862543|NCT02260934|580889767|FG000|Overall Study|Site error|0|||
160862544|NCT02260934|580889768|FG001|Overall Study|Site error|1|||
160862545|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
160862546|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
160862547|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
160862548|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
160862549|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
160862550|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
160862551|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
160862552|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
160862553|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
160862554|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
160862555|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
160862556|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
160862557|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
160862558|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
160862559|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
160862560|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
160862561|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
160862562|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
160862563|NCT03605667|580889771|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
160862564|NCT03605667|580889772|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
160862565|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
160862566|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
160862567|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Other|6|||
160862568|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Other|8|||
160862569|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
160862570|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
160862571|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
160862572|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
160862573|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
160862574|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
160862575|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
160862576|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
160862577|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
160862578|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
160862579|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
160862580|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
160862581|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Death|0|||
160862582|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Death|2|||
160862583|NCT03605667|580889771|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
160862584|NCT03605667|580889772|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
160862585|NCT05632211|580889773|FG000|Overall Study|Withdrawal by Subject|2|||
160862586|NCT05632211|580889774|FG001|Overall Study|Withdrawal by Subject|0|||
160862587|NCT05632211|580889775|FG002|Overall Study|Withdrawal by Subject|2|||
160862588|NCT05632211|580889773|FG000|Overall Study|Other reasons|1|||
160862589|NCT05632211|580889774|FG001|Overall Study|Other reasons|1|||
160862590|NCT05632211|580889775|FG002|Overall Study|Other reasons|1|||
160862591|NCT02628873|580889776|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
160862592|NCT02628873|580889777|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
160862593|NCT02628873|580889776|FG000|Second Test (1 Hour)|Physician Decision|1|||
160862594|NCT02628873|580889777|FG001|Second Test (1 Hour)|Physician Decision|0|||
160862595|NCT03597347|580889780|FG000|Overall Study|Withdrawal by Subject|1|||
160862596|NCT03597347|580889781|FG001|Overall Study|Withdrawal by Subject|1|||
160862597|NCT03597347|580889782|FG002|Overall Study|Withdrawal by Subject|0|||
160862598|NCT03597347|580889780|FG000|Overall Study|Withdrawal due to Covid-19|3|||
160862599|NCT03597347|580889781|FG001|Overall Study|Withdrawal due to Covid-19|0|||
160862600|NCT03597347|580889782|FG002|Overall Study|Withdrawal due to Covid-19|0|||
160862601|NCT03597347|580889780|FG000|Overall Study|Sponsor decision to terminate study|3|||
160862602|NCT03597347|580889781|FG001|Overall Study|Sponsor decision to terminate study|2|||
160862603|NCT03597347|580889782|FG002|Overall Study|Sponsor decision to terminate study|4|||
160862604|NCT04606134|580889783|FG000|Overall Study|Adverse Event|0|||
160862605|NCT04606134|580889784|FG001|Overall Study|Adverse Event|1|||
160862606|NCT00541658|580889786|FG000|Overall Study|Adverse Event|28|||
160862607|NCT00541658|580889787|FG001|Overall Study|Adverse Event|37|||
160862608|NCT00541658|580889788|FG002|Overall Study|Adverse Event|25|||
160862609|NCT00541658|580889786|FG000|Overall Study|Physician Decision|0|||
160862610|NCT00541658|580889787|FG001|Overall Study|Physician Decision|0|||
160862611|NCT00541658|580889788|FG002|Overall Study|Physician Decision|4|||
160862612|NCT00541658|580889786|FG000|Overall Study|Lost to Follow-up|3|||
160862613|NCT00541658|580889787|FG001|Overall Study|Lost to Follow-up|3|||
160862614|NCT00541658|580889788|FG002|Overall Study|Lost to Follow-up|6|||
160862615|NCT00541658|580889786|FG000|Overall Study|Protocol Violation|0|||
160862616|NCT00541658|580889787|FG001|Overall Study|Protocol Violation|1|||
160862617|NCT00541658|580889788|FG002|Overall Study|Protocol Violation|1|||
160862618|NCT00541658|580889786|FG000|Overall Study|Withdrawal by Subject|28|||
160862619|NCT00541658|580889787|FG001|Overall Study|Withdrawal by Subject|32|||
160862620|NCT00541658|580889788|FG002|Overall Study|Withdrawal by Subject|32|||
160862621|NCT00541658|580889786|FG000|Overall Study|Took No Study Drug|1|||
160862622|NCT00541658|580889787|FG001|Overall Study|Took No Study Drug|0|||
160862623|NCT00541658|580889788|FG002|Overall Study|Took No Study Drug|0|||
160862624|NCT01099267|580889789|FG000|MDS-003 Study|Adverse Event|37|||
160862625|NCT01099267|580889789|FG000|MDS-003 Study|Lack of Efficacy|52|||
160862626|NCT01099267|580889789|FG000|MDS-003 Study|Withdrawal by Subject|8|||
160862627|NCT01099267|580889789|FG000|MDS-003 Study|Lost to Follow-up|1|||
160862628|NCT01099267|580889789|FG000|MDS-003 Study|Death|11|||
160862629|NCT01099267|580889789|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
160862630|NCT01099267|580889789|FG000|MDS-003 Study|Disease Progression|7|||
160862631|NCT01099267|580889789|FG000|MDS-003 Study|Investigator Decision|2|||
160862632|NCT01099267|580889789|FG000|MDS-003 Study|Non-Compliance|2|||
160862633|NCT01099267|580889789|FG000|MDS-003 Study|Loss of Response|1|||
160862634|NCT01099267|580889789|FG000|MDS-003 Study|Secondary Malign Disease|1|||
160862635|NCT04986904|580889790|FG000|Overall Study|Lost to Follow-up|11|||
160862636|NCT04986904|580889790|FG000|Overall Study|Withdrawal by Subject|1|||
160951680|NCT00499369|581209161|FG003|Overall Study|Progression|6|||
160862637|NCT05194124|580889802|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160951681|NCT00499369|581209162|FG004|Overall Study|Progression|10|||
160951682|NCT00499369|581209158|FG000|Overall Study|Death|0|||
160862638|NCT05194124|580889803|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862639|NCT05194124|580889804|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862640|NCT05194124|580889805|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
160862641|NCT05194124|580889806|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862642|NCT05194124|580889807|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
160862643|NCT05194124|580889808|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862644|NCT05194124|580889809|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862645|NCT05194124|580889810|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862646|NCT05194124|580889811|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
160862647|NCT05194124|580889802|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862648|NCT05194124|580889803|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862649|NCT05194124|580889804|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862650|NCT05194124|580889805|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862651|NCT05194124|580889806|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862652|NCT05194124|580889807|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862653|NCT05194124|580889808|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862654|NCT05194124|580889809|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862655|NCT05194124|580889810|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
160862656|NCT05194124|580889811|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
160862657|NCT05408429|580889816|FG000|Overall Study|Lost to Follow-up|1|||
160862658|NCT05408429|580889817|FG001|Overall Study|Lost to Follow-up|1|||
160862659|NCT05408429|580889818|FG002|Overall Study|Lost to Follow-up|0|||
160862660|NCT05408429|580889816|FG000|Overall Study|Withdrawal by Subject|5|||
160862661|NCT05408429|580889817|FG001|Overall Study|Withdrawal by Subject|0|||
160862662|NCT05408429|580889818|FG002|Overall Study|Withdrawal by Subject|1|||
160862663|NCT03642873|580889819|FG000|Third Intervention (1 Day)|Screen failure|0|||
160862664|NCT03642873|580889820|FG001|Third Intervention (1 Day)|Screen failure|0|||
160862665|NCT03642873|580889821|FG002|Third Intervention (1 Day)|Screen failure|0|||
160862666|NCT03642873|580889822|FG003|Third Intervention (1 Day)|Screen failure|0|||
160862667|NCT03642873|580889823|FG004|Third Intervention (1 Day)|Screen failure|1|||
160862668|NCT03642873|580889824|FG005|Third Intervention (1 Day)|Screen failure|0|||
160862669|NCT03312231|580889825|FG000|Overall Study|Lost to Follow-up|2|||
160862670|NCT03312231|580889826|FG001|Overall Study|Lost to Follow-up|6|||
160862671|NCT03312231|580889827|FG002|Overall Study|Lost to Follow-up|1|||
160862672|NCT03312231|580889828|FG003|Overall Study|Lost to Follow-up|3|||
160862673|NCT03312231|580889829|FG004|Overall Study|Lost to Follow-up|1|||
160862674|NCT03312231|580889825|FG000|Overall Study|Withdrawal by Subject|0|||
160862675|NCT03312231|580889826|FG001|Overall Study|Withdrawal by Subject|3|||
160862676|NCT03312231|580889827|FG002|Overall Study|Withdrawal by Subject|1|||
160862677|NCT03312231|580889828|FG003|Overall Study|Withdrawal by Subject|0|||
160862678|NCT03312231|580889829|FG004|Overall Study|Withdrawal by Subject|0|||
160951683|NCT00499369|581209159|FG001|Overall Study|Death|1|||
160951684|NCT00499369|581209160|FG002|Overall Study|Death|0|||
160951685|NCT00499369|581209161|FG003|Overall Study|Death|0|||
160951686|NCT00499369|581209162|FG004|Overall Study|Death|0|||
160951687|NCT00499369|581209158|FG000|Overall Study|Not protocol specified|2|||
160951688|NCT00499369|581209159|FG001|Overall Study|Not protocol specified|0|||
161000768|NCT00941655|581388871|FG000|Overall Study|withdrew consent|0|||
161000769|NCT00941655|581388872|FG001|Overall Study|withdrew consent|1|||
161000770|NCT00941655|581388871|FG000|Overall Study|non-compliant|0|||
160951689|NCT00499369|581209160|FG002|Overall Study|Not protocol specified|3|||
160951690|NCT00499369|581209161|FG003|Overall Study|Not protocol specified|1|||
160951691|NCT00499369|581209162|FG004|Overall Study|Not protocol specified|0|||
160951692|NCT00499369|581209158|FG000|Overall Study|Ineligible|2|||
160951693|NCT00499369|581209159|FG001|Overall Study|Ineligible|2|||
160951694|NCT00499369|581209160|FG002|Overall Study|Ineligible|1|||
160951695|NCT00499369|581209161|FG003|Overall Study|Ineligible|1|||
160951696|NCT00499369|581209162|FG004|Overall Study|Ineligible|0|||
160862679|NCT03312231|580889825|FG000|Overall Study|Death|0|||
160862680|NCT03312231|580889826|FG001|Overall Study|Death|1|||
160862681|NCT03312231|580889827|FG002|Overall Study|Death|1|||
160862682|NCT03312231|580889828|FG003|Overall Study|Death|0|||
160862683|NCT03312231|580889829|FG004|Overall Study|Death|0|||
160862684|NCT03312231|580889825|FG000|Overall Study|Study Vaccination not Received|1|||
160862685|NCT03312231|580889826|FG001|Overall Study|Study Vaccination not Received|1|||
160862686|NCT03312231|580889827|FG002|Overall Study|Study Vaccination not Received|1|||
160862687|NCT03312231|580889828|FG003|Overall Study|Study Vaccination not Received|0|||
160862688|NCT03312231|580889829|FG004|Overall Study|Study Vaccination not Received|0|||
160862689|NCT03157830|580889833|FG000|Overall Study|Lost to Follow-up|1|||
160951697|NCT01898195|581209164|FG000|Smoking Abstinence|Did not have good measurements|35|||
160951698|NCT01898195|581209165|FG001|Smoking Abstinence|Did not have good measurements|38|||
160862690|NCT03157830|580889833|FG000|Overall Study|Withdrawal by Subject|1|||
160862691|NCT04607005|580889834|FG000|Overall Study|Adverse Event|0|||
160862692|NCT04607005|580889835|FG001|Overall Study|Adverse Event|1|||
160862693|NCT04607005|580889834|FG000|Overall Study|Lack of Efficacy|1|||
160862694|NCT04607005|580889835|FG001|Overall Study|Lack of Efficacy|6|||
160862695|NCT04607005|580889834|FG000|Overall Study|Withdrawal by Subject|4|||
160862696|NCT04607005|580889835|FG001|Overall Study|Withdrawal by Subject|9|||
160862697|NCT04607005|580889834|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
160862698|NCT04607005|580889835|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
160862699|NCT03472885|580889836|FG000|24-Week Treatment Period|Adverse Event|1|||
160862700|NCT00091949|580891363|FG000|Overall Study|Withdrawal by Subject|117|||
160862701|NCT00091949|580891364|FG001|Overall Study|Withdrawal by Subject|110|||
160862702|NCT00091949|580891363|FG000|Overall Study|Lost to Follow-up|58|||
160862703|NCT00091949|580891364|FG001|Overall Study|Lost to Follow-up|41|||
160862704|NCT01256788|580891367|FG000|Overall Study|Lost to Follow-up|5|||
160862705|NCT01256788|580891368|FG001|Overall Study|Lost to Follow-up|8|||
160862706|NCT01256788|580891369|FG002|Overall Study|Lost to Follow-up|3|||
160862707|NCT01352715|580891371|FG000|Overall Study|Death|3|||
160862708|NCT01352715|580891372|FG001|Overall Study|Death|3|||
160862709|NCT01352715|580891371|FG000|Overall Study|Lost to Follow-up|5|||
160862710|NCT01352715|580891372|FG001|Overall Study|Lost to Follow-up|7|||
160862711|NCT01352715|580891371|FG000|Overall Study|Withdrawal by Subject|4|||
160862712|NCT01352715|580891372|FG001|Overall Study|Withdrawal by Subject|8|||
160862713|NCT01352715|580891371|FG000|Overall Study|site closure|16|||
160862714|NCT01352715|580891372|FG001|Overall Study|site closure|15|||
160862715|NCT01352715|580891371|FG000|Overall Study|no final visit in closeout period|15|||
160862716|NCT01352715|580891372|FG001|Overall Study|no final visit in closeout period|12|||
160862717|NCT01352715|580891371|FG000|Overall Study|major ineligibility|2|||
160862718|NCT01352715|580891372|FG001|Overall Study|major ineligibility|1|||
160862719|NCT02000440|580891373|FG000|Overall Study|Adverse Event|3|||
160862720|NCT02000440|580891373|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
160862721|NCT02383576|580891375|FG000|Overall Study|Death|53|||
160862722|NCT02383576|580891376|FG001|Overall Study|Death|33|||
160951699|NCT01898195|581209166|FG002|Smoking Abstinence|Did not have good measurements|36|||
160951700|NCT01802411|581209167|FG000|Overall Study|Death|2|||
160951701|NCT01802411|581209168|FG001|Overall Study|Death|1|||
160951702|NCT01802411|581209167|FG000|Overall Study|Adverse Event|2|||
160951703|NCT01802411|581209168|FG001|Overall Study|Adverse Event|7|||
160951704|NCT01802411|581209167|FG000|Overall Study|Lack of Efficacy|8|||
160951705|NCT01802411|581209168|FG001|Overall Study|Lack of Efficacy|10|||
160951706|NCT01802411|581209167|FG000|Overall Study|Withdrawal by Subject|0|||
160951707|NCT01802411|581209168|FG001|Overall Study|Withdrawal by Subject|2|||
160951708|NCT01802411|581209167|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
160951709|NCT01802411|581209168|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
160862723|NCT02383576|580891375|FG000|Overall Study|Lost to Follow-up|7|||
160862724|NCT02383576|580891376|FG001|Overall Study|Lost to Follow-up|1|||
160862725|NCT02383576|580891375|FG000|Overall Study|Withdrew Consent|1|||
160862726|NCT02383576|580891376|FG001|Overall Study|Withdrew Consent|6|||
160862727|NCT02383576|580891375|FG000|Overall Study|Investigator's Decision|0|||
160862728|NCT02383576|580891376|FG001|Overall Study|Investigator's Decision|1|||
160862729|NCT02383576|580891375|FG000|Overall Study|Administrative/Other|2|||
160862730|NCT02383576|580891376|FG001|Overall Study|Administrative/Other|4|||
160862731|NCT00871975|580891377|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
160862732|NCT00871975|580891377|FG000|Overall Study|Catheters could not be inserted|1|||
160862733|NCT00871975|580891377|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
160862734|NCT00871975|580891377|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
160862735|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
160862736|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
160862737|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
160862738|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
161268542|NCT02799095|582366777|FG015|Part C|Other|0|||
161268543|NCT02799095|582366778|FG016|Part C|Other|0|||
161268544|NCT03047473|582366783|FG000|Overall Study|Lost to Follow-up|2|||
161268545|NCT05327816|582366784|FG000|Overall Study|Lost to Follow-up|1|||
160862739|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
160862740|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
160862741|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
160862742|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160862743|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
160862744|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
160862745|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160862746|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
160862747|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
160862748|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
161268546|NCT05327816|582366785|FG001|Overall Study|Lost to Follow-up|0|||
160862749|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
160862750|NCT01436149|580891381|FG000|Antidepressant Lead-in Phase|Other|119|||
160862751|NCT01436149|580891382|FG001|Antidepressant Lead-in Phase|Other|0|||
160862752|NCT01436149|580891383|FG002|Antidepressant Lead-in Phase|Other|0|||
160862753|NCT01436149|580891381|FG000|Randomized Phase|Adverse Event|9|||
160862754|NCT01436149|580891382|FG001|Randomized Phase|Adverse Event|10|||
160862755|NCT01436149|580891383|FG002|Randomized Phase|Adverse Event|11|||
160862756|NCT01436149|580891381|FG000|Randomized Phase|Protocol Violation|4|||
160862757|NCT01436149|580891382|FG001|Randomized Phase|Protocol Violation|5|||
160862758|NCT01436149|580891383|FG002|Randomized Phase|Protocol Violation|0|||
160862759|NCT01436149|580891381|FG000|Randomized Phase|Withdrawal by Subject|16|||
160862760|NCT01436149|580891382|FG001|Randomized Phase|Withdrawal by Subject|10|||
160862761|NCT01436149|580891383|FG002|Randomized Phase|Withdrawal by Subject|10|||
160862762|NCT01436149|580891381|FG000|Randomized Phase|Lost to Follow-up|34|||
160862763|NCT01436149|580891382|FG001|Randomized Phase|Lost to Follow-up|5|||
160862764|NCT01436149|580891383|FG002|Randomized Phase|Lost to Follow-up|6|||
160862765|NCT01436149|580891381|FG000|Randomized Phase|Lack of Efficacy|0|||
160862766|NCT01436149|580891382|FG001|Randomized Phase|Lack of Efficacy|0|||
160862767|NCT01436149|580891383|FG002|Randomized Phase|Lack of Efficacy|1|||
160862768|NCT01436149|580891381|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
160862769|NCT01436149|580891382|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
160862770|NCT01436149|580891383|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
160951710|NCT01802411|581209167|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
160951711|NCT01802411|581209168|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
160951712|NCT01802411|581209167|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
160951713|NCT01802411|581209168|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
160951714|NCT01337245|581209172|FG000|Overall Study|Lost to Follow-up|1|||
160951715|NCT03930745|581209173|FG000|Overall Study|Lost to Follow-up|10|||
160951716|NCT03930745|581209174|FG001|Overall Study|Lost to Follow-up|5|||
160951717|NCT03930745|581209173|FG000|Overall Study|Withdrawal by Subject|1|||
160951718|NCT03930745|581209174|FG001|Overall Study|Withdrawal by Subject|2|||
160951719|NCT03930745|581209173|FG000|Overall Study|Protocol Violation|2|||
160951720|NCT03930745|581209174|FG001|Overall Study|Protocol Violation|2|||
160951721|NCT03930745|581209173|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
160951722|NCT03930745|581209174|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
160951723|NCT03930745|581209173|FG000|Overall Study|Adverse Event|0|||
160951724|NCT03930745|581209174|FG001|Overall Study|Adverse Event|1|||
160951725|NCT03930745|581209173|FG000|Overall Study|Pregnancy|0|||
160951726|NCT03930745|581209174|FG001|Overall Study|Pregnancy|1|||
160951727|NCT02715765|581209175|FG000|Overall Study|Study Termination|3|||
160951728|NCT02715765|581209176|FG001|Overall Study|Study Termination|0|||
160951729|NCT02715765|581209177|FG002|Overall Study|Study Termination|0|||
160951730|NCT04095858|581209178|FG000|Overall Study|Death|1|||
160951731|NCT04095858|581209179|FG001|Overall Study|Death|0|||
160951732|NCT04095858|581209178|FG000|Overall Study|Study terminated by Sponsor|2|||
160951733|NCT04095858|581209179|FG001|Overall Study|Study terminated by Sponsor|4|||
160951734|NCT01344460|581209180|FG000|Overall Study|Withdrawal by Subject|1|||
160951735|NCT01344460|581209180|FG000|Overall Study|Lost to Follow-up|2|||
160951736|NCT02838017|581209182|FG000|Overall Study|Lost to Follow-up|14|||
160951737|NCT02838017|581209183|FG001|Overall Study|Lost to Follow-up|11|||
160951738|NCT01692197|581209184|FG000|Overall Study|Failed Screening|3|||
160951739|NCT02120924|581209185|FG000|Overall Study|Lack of Efficacy|1|||
160951740|NCT02120924|581209186|FG001|Overall Study|Lack of Efficacy|2|||
160951741|NCT02120924|581209187|FG002|Overall Study|Lack of Efficacy|3|||
160951742|NCT02120924|581209185|FG000|Overall Study|Adverse Event|0|||
160951743|NCT02120924|581209186|FG001|Overall Study|Adverse Event|1|||
160951744|NCT02120924|581209187|FG002|Overall Study|Adverse Event|3|||
160951745|NCT02120924|581209185|FG000|Overall Study|Withdrawal by Subject|16|||
160951746|NCT02120924|581209186|FG001|Overall Study|Withdrawal by Subject|20|||
160951747|NCT02120924|581209187|FG002|Overall Study|Withdrawal by Subject|8|||
160951748|NCT02120924|581209185|FG000|Overall Study|Lost to Follow-up|14|||
160951749|NCT02120924|581209186|FG001|Overall Study|Lost to Follow-up|14|||
161000771|NCT00941655|581388872|FG001|Overall Study|non-compliant|1|||
161000772|NCT00446550|581388873|FG000|Overall Study|Adverse Event|1|||
161000773|NCT00446550|581388874|FG001|Overall Study|Adverse Event|0|||
160951750|NCT02120924|581209187|FG002|Overall Study|Lost to Follow-up|11|||
160951751|NCT02120924|581209185|FG000|Overall Study|Pregnancy|2|||
160951752|NCT02120924|581209186|FG001|Overall Study|Pregnancy|0|||
160951753|NCT02120924|581209187|FG002|Overall Study|Pregnancy|0|||
161000774|NCT02983617|581388875|FG000|Overall Study|Adverse Event|0|||
160951754|NCT02120924|581209185|FG000|Overall Study|Protocol Violation|3|||
160951755|NCT02120924|581209186|FG001|Overall Study|Protocol Violation|7|||
160951756|NCT02120924|581209187|FG002|Overall Study|Protocol Violation|2|||
160951757|NCT02120924|581209185|FG000|Overall Study|Physician Decision|0|||
160951758|NCT02120924|581209186|FG001|Overall Study|Physician Decision|1|||
160951759|NCT02120924|581209187|FG002|Overall Study|Physician Decision|1|||
160951760|NCT02120924|581209185|FG000|Overall Study|Death|1|||
160951761|NCT02120924|581209186|FG001|Overall Study|Death|0|||
161000775|NCT02983617|581388876|FG001|Overall Study|Adverse Event|7|||
161000776|NCT02983617|581388875|FG000|Overall Study|Death|0|||
161000777|NCT02983617|581388876|FG001|Overall Study|Death|1|||
161000778|NCT02983617|581388875|FG000|Overall Study|Investigator's Discretion|0|||
161000779|NCT02983617|581388876|FG001|Overall Study|Investigator's Discretion|1|||
161000780|NCT02027558|581388879|FG000|Overall Study|Death|0|||
161000781|NCT02027558|581388880|FG001|Overall Study|Death|1|||
161000782|NCT02027558|581388879|FG000|Overall Study|Withdrawal by Subject|2|||
161000783|NCT02027558|581388880|FG001|Overall Study|Withdrawal by Subject|0|||
161000784|NCT02027558|581388879|FG000|Overall Study|Lost to Follow-up|4|||
161000785|NCT02027558|581388880|FG001|Overall Study|Lost to Follow-up|1|||
161146069|NCT00306891|581917070|FG000|Part B|Condition under investigation worsened|0|||
160951762|NCT02120924|581209187|FG002|Overall Study|Death|0|||
160951763|NCT02120924|581209185|FG000|Overall Study|Compliance with IP|5|||
160951764|NCT02120924|581209186|FG001|Overall Study|Compliance with IP|1|||
160951765|NCT02120924|581209187|FG002|Overall Study|Compliance with IP|1|||
160951766|NCT03483623|581209188|FG000|Overall Study|43 complete sets achieved|1|||
160951767|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
160951768|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
160951769|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
160862771|NCT01436149|580891381|FG000|Randomized Phase|Other|12|||
160862772|NCT01436149|580891382|FG001|Randomized Phase|Other|5|||
160862773|NCT01436149|580891383|FG002|Randomized Phase|Other|11|||
160862774|NCT01690143|580891384|FG000|Overall Study|Withdrawal by Subject|1|||
160862775|NCT04849364|580891385|FG000|Overall Study|Eligibility criteria not meet|0|||
160862776|NCT04849364|580891386|FG001|Overall Study|Eligibility criteria not meet|1|||
160862777|NCT04849364|580891387|FG002|Overall Study|Eligibility criteria not meet|0|||
160862778|NCT01643668|580891388|FG000|Overall Study|Death|1|||
160862779|NCT00307801|580891397|FG000|Overall Study|Adverse Event|12|||
160862780|NCT00307801|580891398|FG001|Overall Study|Adverse Event|4|||
160862781|NCT00307801|580891397|FG000|Overall Study|Withdrawal by Subject|9|||
160862782|NCT00307801|580891398|FG001|Overall Study|Withdrawal by Subject|4|||
160862783|NCT00307801|580891397|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
160862784|NCT00307801|580891398|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
160862785|NCT00307801|580891397|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
160862786|NCT00307801|580891398|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
160862787|NCT00307801|580891397|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
160862788|NCT00307801|580891398|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
160862789|NCT00307801|580891397|FG000|Overall Study|Wrong Randomization|1|||
160951770|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
160951771|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
161000786|NCT02027558|581388879|FG000|Overall Study|Refused assessment|3|||
161000787|NCT02027558|581388880|FG001|Overall Study|Refused assessment|0|||
161000788|NCT04218110|581388881|FG000|Overall Study|Withdrawal by Subject|0|||
161000789|NCT04218110|581388882|FG001|Overall Study|Withdrawal by Subject|0|||
161146070|NCT00306891|581917071|FG001|Part B|Condition under investigation worsened|0|||
161146071|NCT00306891|581917072|FG002|Part B|Condition under investigation worsened|2|||
161146072|NCT00306891|581917073|FG003|Part B|Condition under investigation worsened|8|||
161146073|NCT00306891|581917070|FG000|Part B|Development of study specific disc crit.|0|||
161146074|NCT00306891|581917071|FG001|Part B|Development of study specific disc crit.|0|||
161146075|NCT00306891|581917072|FG002|Part B|Development of study specific disc crit.|0|||
161146076|NCT00306891|581917073|FG003|Part B|Development of study specific disc crit.|1|||
161146077|NCT00853905|581917077|FG000|Overall Study|Lost to Follow-up|1|||
161146078|NCT00853905|581917078|FG001|Overall Study|Lost to Follow-up|3|||
161146079|NCT00853905|581917077|FG000|Overall Study|Withdrawal by Subject|0|||
161146080|NCT00853905|581917078|FG001|Overall Study|Withdrawal by Subject|1|||
161146081|NCT00853905|581917077|FG000|Overall Study|never had surgery|1|||
161268547|NCT05327816|582366786|FG002|Overall Study|Lost to Follow-up|0|||
161268548|NCT05327816|582366787|FG003|Overall Study|Lost to Follow-up|0|||
161268549|NCT05327816|582366788|FG004|Overall Study|Lost to Follow-up|0|||
161268550|NCT05327816|582366789|FG005|Overall Study|Lost to Follow-up|0|||
161000790|NCT04218110|581388883|FG002|Overall Study|Withdrawal by Subject|0|||
161000791|NCT04218110|581388884|FG003|Overall Study|Withdrawal by Subject|1|||
161000792|NCT00516386|581388885|FG000|Overall Study|not interested in the study|4|||
161000793|NCT00516386|581388885|FG000|Overall Study|Lost to Follow-up|2|||
161146082|NCT00853905|581917078|FG001|Overall Study|never had surgery|0|||
161268551|NCT05327816|582366790|FG006|Overall Study|Lost to Follow-up|0|||
160951772|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
160951773|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
160951774|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
160951775|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
161000794|NCT02698891|581388886|FG000|Overall Study|Withdrawal by Subject|2|||
161000795|NCT02698891|581388886|FG000|Overall Study|deemed ineligible|1|||
161000796|NCT02698891|581388886|FG000|Overall Study|Adverse Event|9|||
161268552|NCT05327816|582366791|FG007|Overall Study|Lost to Follow-up|0|||
160862790|NCT00307801|580891398|FG001|Overall Study|Wrong Randomization|0|||
160862791|NCT00307801|580891397|FG000|Overall Study|Lack of Efficacy|0|||
160862792|NCT00307801|580891398|FG001|Overall Study|Lack of Efficacy|2|||
160862793|NCT00307801|580891397|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
160862794|NCT00307801|580891398|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
160862795|NCT00307801|580891397|FG000|Overall Study|Frustration with e-diary|1|||
160862796|NCT00307801|580891398|FG001|Overall Study|Frustration with e-diary|0|||
160862797|NCT00307801|580891397|FG000|Overall Study|Protocol Violation|3|||
160862798|NCT00307801|580891398|FG001|Overall Study|Protocol Violation|2|||
160862799|NCT00307801|580891397|FG000|Overall Study|No reason specified|2|||
160862800|NCT00307801|580891398|FG001|Overall Study|No reason specified|0|||
160862801|NCT00307801|580891397|FG000|Overall Study|Pregnancy|0|||
160862802|NCT00307801|580891398|FG001|Overall Study|Pregnancy|1|||
160862803|NCT03944577|580891404|FG000|Overall Study|Adverse Event|3|||
160862804|NCT03011099|580891407|FG000|Overall Study|Withdrawal by Subject|0|||
160862805|NCT03011099|580891408|FG001|Overall Study|Withdrawal by Subject|2|||
160862806|NCT01217229|580891411|FG000|Overall Study|Adverse Event|1|||
160862807|NCT01217229|580891411|FG000|Overall Study|Disease progression, deterioration|2|||
160862808|NCT01217229|580891411|FG000|Overall Study|Disease progression, Cheson criteria|14|||
160862809|NCT01217229|580891411|FG000|Overall Study|Protocol Violation|1|||
160862810|NCT01217229|580891411|FG000|Overall Study|Disease progression not confirmed|2|||
160862811|NCT00577889|580891414|FG000|Overall Study|Withdrawal by Subject|1|||
160862812|NCT00577889|580891415|FG001|Overall Study|Withdrawal by Subject|0|||
160862813|NCT00577889|580891416|FG002|Overall Study|Withdrawal by Subject|0|||
160862814|NCT01523756|580891418|FG000|Baseline Period|Adverse Event|0|||
160862815|NCT01523756|580891419|FG001|Baseline Period|Adverse Event|1|||
160862816|NCT01523756|580891418|FG000|Test Period 1|Adverse Event|1|||
160951776|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
160951777|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
160951778|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
160951779|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
161146083|NCT00847561|581917081|FG000|Overall Study|Withdrawal by Subject|4|||
161146084|NCT00847561|581917082|FG001|Overall Study|Withdrawal by Subject|3|||
161146085|NCT00847561|581917081|FG000|Overall Study|Unable to schedule|9|||
161146086|NCT00847561|581917082|FG001|Overall Study|Unable to schedule|1|||
161146087|NCT01333189|581917083|FG000|Overall Study|Time constraints|1|||
161146088|NCT01333189|581917084|FG001|Overall Study|Time constraints|0|||
161146089|NCT01333189|581917083|FG000|Overall Study|Adverse Event|1|||
161146090|NCT01333189|581917084|FG001|Overall Study|Adverse Event|0|||
161146091|NCT01333189|581917083|FG000|Overall Study|Transportation difficulties|0|||
161146092|NCT01333189|581917084|FG001|Overall Study|Transportation difficulties|1|||
161268553|NCT05327816|582366792|FG008|Overall Study|Lost to Follow-up|0|||
160862817|NCT01523756|580891419|FG001|Test Period 1|Adverse Event|0|||
160951780|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
160951781|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
160951782|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
160951783|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
160951784|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
160951785|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
160951786|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
160951787|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
160951788|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
160951789|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
160951790|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
160951791|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
160951792|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
160951793|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
160951794|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
160951795|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
160951796|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
160951797|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
160951798|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
160951799|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
160951800|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
160951801|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
160951802|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
160951803|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
160862818|NCT01523756|580891418|FG000|Test Period 2|Withdrawal by Subject|0|||
160862819|NCT01523756|580891419|FG001|Test Period 2|Withdrawal by Subject|1|||
161146093|NCT01333189|581917083|FG000|Overall Study|Moved from region|0|||
161268554|NCT05327816|582366793|FG009|Overall Study|Lost to Follow-up|1|||
160951804|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
160951805|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
160951806|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
160951807|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
160862820|NCT03224819|580891422|FG000|Overall Study|Withdrawal by Subject|0|||
160951808|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
160951809|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
160862821|NCT03224819|580891423|FG001|Overall Study|Withdrawal by Subject|0|||
160862822|NCT03224819|580891424|FG002|Overall Study|Withdrawal by Subject|0|||
160862823|NCT03224819|580891425|FG003|Overall Study|Withdrawal by Subject|0|||
160862824|NCT03224819|580891426|FG004|Overall Study|Withdrawal by Subject|0|||
160862825|NCT03224819|580891427|FG005|Overall Study|Withdrawal by Subject|0|||
160862826|NCT03224819|580891428|FG006|Overall Study|Withdrawal by Subject|0|||
160862827|NCT03224819|580891429|FG007|Overall Study|Withdrawal by Subject|0|||
160862828|NCT03224819|580891430|FG008|Overall Study|Withdrawal by Subject|0|||
160862829|NCT03224819|580891431|FG009|Overall Study|Withdrawal by Subject|0|||
160862830|NCT03224819|580891432|FG010|Overall Study|Withdrawal by Subject|0|||
160862831|NCT03224819|580891433|FG011|Overall Study|Withdrawal by Subject|0|||
160862832|NCT03224819|580891434|FG012|Overall Study|Withdrawal by Subject|1|||
160862833|NCT03224819|580891435|FG013|Overall Study|Withdrawal by Subject|0|||
160862834|NCT03224819|580891422|FG000|Overall Study|Sponsor Decision|0|||
160951810|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
160951811|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
160951812|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
160862835|NCT03224819|580891423|FG001|Overall Study|Sponsor Decision|0|||
160862836|NCT03224819|580891424|FG002|Overall Study|Sponsor Decision|0|||
160862837|NCT03224819|580891425|FG003|Overall Study|Sponsor Decision|1|||
160951813|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
160951814|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
160951815|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
160951816|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
161268555|NCT05327816|582366794|FG010|Overall Study|Lost to Follow-up|0|||
161268556|NCT05327816|582366784|FG000|Overall Study|Withdrawal by Subject|0|||
160862838|NCT03224819|580891426|FG004|Overall Study|Sponsor Decision|1|||
160862839|NCT03224819|580891427|FG005|Overall Study|Sponsor Decision|2|||
160862840|NCT03224819|580891428|FG006|Overall Study|Sponsor Decision|1|||
160862841|NCT03224819|580891429|FG007|Overall Study|Sponsor Decision|1|||
160862842|NCT03224819|580891430|FG008|Overall Study|Sponsor Decision|1|||
160862843|NCT03224819|580891431|FG009|Overall Study|Sponsor Decision|2|||
160862844|NCT03224819|580891432|FG010|Overall Study|Sponsor Decision|1|||
160862845|NCT03224819|580891433|FG011|Overall Study|Sponsor Decision|1|||
160862846|NCT03224819|580891434|FG012|Overall Study|Sponsor Decision|1|||
160862847|NCT03224819|580891435|FG013|Overall Study|Sponsor Decision|0|||
160862848|NCT03224819|580891422|FG000|Overall Study|Lost to Follow-up|0|||
160862849|NCT03224819|580891423|FG001|Overall Study|Lost to Follow-up|0|||
160951817|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
160951818|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
161146094|NCT01333189|581917084|FG001|Overall Study|Moved from region|1|||
160862850|NCT03224819|580891424|FG002|Overall Study|Lost to Follow-up|0|||
160862851|NCT03224819|580891425|FG003|Overall Study|Lost to Follow-up|0|||
160862852|NCT03224819|580891426|FG004|Overall Study|Lost to Follow-up|0|||
160862853|NCT03224819|580891427|FG005|Overall Study|Lost to Follow-up|0|||
160862854|NCT03224819|580891428|FG006|Overall Study|Lost to Follow-up|0|||
160862855|NCT03224819|580891429|FG007|Overall Study|Lost to Follow-up|0|||
160862856|NCT03224819|580891430|FG008|Overall Study|Lost to Follow-up|1|||
160862857|NCT03224819|580891431|FG009|Overall Study|Lost to Follow-up|0|||
160862858|NCT03224819|580891432|FG010|Overall Study|Lost to Follow-up|0|||
160862859|NCT03224819|580891433|FG011|Overall Study|Lost to Follow-up|0|||
160862860|NCT03224819|580891434|FG012|Overall Study|Lost to Follow-up|0|||
160862861|NCT03224819|580891435|FG013|Overall Study|Lost to Follow-up|0|||
160862862|NCT03224819|580891422|FG000|Overall Study|Death|0|||
160862863|NCT03224819|580891423|FG001|Overall Study|Death|1|||
160862864|NCT03224819|580891424|FG002|Overall Study|Death|0|||
160862865|NCT03224819|580891425|FG003|Overall Study|Death|0|||
160862866|NCT03224819|580891426|FG004|Overall Study|Death|0|||
160862867|NCT03224819|580891427|FG005|Overall Study|Death|0|||
160862868|NCT03224819|580891428|FG006|Overall Study|Death|0|||
160862869|NCT03224819|580891429|FG007|Overall Study|Death|1|||
160862870|NCT03224819|580891430|FG008|Overall Study|Death|0|||
160862871|NCT03224819|580891431|FG009|Overall Study|Death|0|||
160862872|NCT03224819|580891432|FG010|Overall Study|Death|0|||
160862873|NCT03224819|580891433|FG011|Overall Study|Death|1|||
160862874|NCT03224819|580891434|FG012|Overall Study|Death|0|||
160862875|NCT03224819|580891435|FG013|Overall Study|Death|0|||
160862876|NCT03783078|580891436|FG000|Overall Study|Death|31|||
160862877|NCT03783078|580891436|FG000|Overall Study|Sponsor Decision|23|||
160862878|NCT03783078|580891436|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
160862879|NCT01467960|580891437|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
160862880|NCT01467960|580891438|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
160862881|NCT01467960|580891439|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
160862882|NCT01467960|580891440|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
160862883|NCT01467960|580891441|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
160862884|NCT01467960|580891442|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
160862885|NCT00474812|580891443|FG000|Overall Study|Withdrawal by Subject|5|||
160862886|NCT00474812|580891443|FG000|Overall Study|No Initiation of treatment|2|||
160862887|NCT00737672|580891452|FG000|Overall Study|Graft Abandonment|48|||
160862888|NCT00737672|580891453|FG001|Overall Study|Graft Abandonment|56|||
160862889|NCT00737672|580891452|FG000|Overall Study|Death|23|||
160862890|NCT00737672|580891453|FG001|Overall Study|Death|22|||
160862891|NCT00737672|580891452|FG000|Overall Study|Withdrawal by Subject|1|||
160862892|NCT00737672|580891453|FG001|Overall Study|Withdrawal by Subject|2|||
160862893|NCT00737672|580891452|FG000|Overall Study|Lost to Follow-up|1|||
160862894|NCT00737672|580891453|FG001|Overall Study|Lost to Follow-up|0|||
160862895|NCT00737672|580891452|FG000|Overall Study|Miscellaneous|7|||
160862896|NCT00737672|580891453|FG001|Overall Study|Miscellaneous|1|||
160862897|NCT00737672|580891452|FG000|Overall Study|Physician Decision|0|||
160862898|NCT00737672|580891453|FG001|Overall Study|Physician Decision|2|||
160862899|NCT00107653|580891461|FG000|Overall Study|Adverse Event|24|||
160862900|NCT00107653|580891462|FG001|Overall Study|Adverse Event|43|||
160862901|NCT00107653|580891461|FG000|Overall Study|Insufficient Therapeutic Response|25|||
160862902|NCT00107653|580891462|FG001|Overall Study|Insufficient Therapeutic Response|11|||
160862903|NCT00107653|580891461|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
160862904|NCT00107653|580891462|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
160862905|NCT00107653|580891461|FG000|Overall Study|Protocol Violation|1|||
160862906|NCT00107653|580891462|FG001|Overall Study|Protocol Violation|0|||
160862907|NCT00107653|580891461|FG000|Overall Study|Withdrawal by Subject|12|||
160862908|NCT00107653|580891462|FG001|Overall Study|Withdrawal by Subject|13|||
160951819|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
160951820|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
160951821|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
160951822|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
160951823|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
160951824|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
160951825|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
160951826|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
160951827|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
160951828|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
161146095|NCT01739595|581917086|FG000|Overall Study|Adverse Event|3|||
161146096|NCT01739595|581917087|FG001|Overall Study|Adverse Event|0|||
160951829|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
160951830|NCT01884350|581209189|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
160951831|NCT01884350|581209190|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
160951832|NCT01884350|581209191|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
160951833|NCT03073603|581211002|FG000|Overall Study|Noncompliance|3|||
160951834|NCT03073603|581211003|FG001|Overall Study|Noncompliance|1|||
160951835|NCT03073603|581211002|FG000|Overall Study|Adverse Event|5|||
160951836|NCT03073603|581211003|FG001|Overall Study|Adverse Event|3|||
160951837|NCT03073603|581211002|FG000|Overall Study|Physician Decision|1|||
160951838|NCT03073603|581211003|FG001|Overall Study|Physician Decision|2|||
160951839|NCT03073603|581211002|FG000|Overall Study|Required treatment not allowed by protocol|1|||
160951840|NCT03073603|581211003|FG001|Overall Study|Required treatment not allowed by protocol|0|||
160951841|NCT03073603|581211002|FG000|Overall Study|Financial or insurance-related|8|||
160951842|NCT03073603|581211003|FG001|Overall Study|Financial or insurance-related|0|||
160951843|NCT03073603|581211002|FG000|Overall Study|Withdrawal by Subject|0|||
160951844|NCT03073603|581211003|FG001|Overall Study|Withdrawal by Subject|1|||
160951845|NCT03073603|581211002|FG000|Overall Study|Discontinued DMT|4|||
160951846|NCT03073603|581211003|FG001|Overall Study|Discontinued DMT|0|||
160951847|NCT03073603|581211002|FG000|Overall Study|Restarted DMT|0|||
160951848|NCT03073603|581211003|FG001|Overall Study|Restarted DMT|1|||
160951849|NCT02473952|581211006|FG000|Overall Study|Adverse Event|2|||
160951850|NCT02473952|581211007|FG001|Overall Study|Adverse Event|2|||
160951851|NCT02473952|581211006|FG000|Overall Study|Withdrawal by Subject|0|||
160951852|NCT02473952|581211007|FG001|Overall Study|Withdrawal by Subject|6|||
160951853|NCT02103439|581211010|FG000|Overall Study|Adverse Event|0|||
160951854|NCT02103439|581211011|FG001|Overall Study|Adverse Event|2|||
160951855|NCT02103439|581211010|FG000|Overall Study|Withdrawal by Subject|3|||
160951856|NCT02103439|581211011|FG001|Overall Study|Withdrawal by Subject|1|||
160951857|NCT02370602|581211013|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160862909|NCT00107653|580891461|FG000|Overall Study|Lost to Follow-up|13|||
160862910|NCT00107653|580891462|FG001|Overall Study|Lost to Follow-up|5|||
160862911|NCT00107653|580891461|FG000|Overall Study|Administrative Reasons|3|||
160862912|NCT00107653|580891462|FG001|Overall Study|Administrative Reasons|3|||
160862913|NCT02018562|580891465|FG000|Overall Study|Withdrawal by Subject|2|||
160951858|NCT02370602|581211014|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
160951859|NCT02370602|581211015|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
160951860|NCT02370602|581211016|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
160951861|NCT02370602|581211017|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
160951862|NCT02370602|581211018|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
160951863|NCT04827212|581211019|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
160862914|NCT02018562|580891466|FG001|Overall Study|Withdrawal by Subject|0|||
160862915|NCT02018562|580891465|FG000|Overall Study|Discharged prior to study completion|1|||
160862916|NCT02018562|580891466|FG001|Overall Study|Discharged prior to study completion|0|||
160862917|NCT03435211|580891467|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
160862918|NCT01253291|580891469|FG000|Overall Study|Withdrawal by Subject|1|||
160862919|NCT01253291|580891470|FG001|Overall Study|Withdrawal by Subject|1|||
160862920|NCT01253291|580891471|FG002|Overall Study|Withdrawal by Subject|0|||
160862921|NCT01253291|580891472|FG003|Overall Study|Withdrawal by Subject|0|||
160862922|NCT01253291|580891473|FG004|Overall Study|Withdrawal by Subject|0|||
160862923|NCT01253291|580891469|FG000|Overall Study|Adverse Event|0|||
160862924|NCT01253291|580891470|FG001|Overall Study|Adverse Event|1|||
160862925|NCT01253291|580891471|FG002|Overall Study|Adverse Event|0|||
160862926|NCT01253291|580891472|FG003|Overall Study|Adverse Event|0|||
160862927|NCT01253291|580891473|FG004|Overall Study|Adverse Event|0|||
160862928|NCT01253291|580891469|FG000|Overall Study|Lack of Efficacy|1|||
160862929|NCT01253291|580891470|FG001|Overall Study|Lack of Efficacy|0|||
160862930|NCT01253291|580891471|FG002|Overall Study|Lack of Efficacy|0|||
160862931|NCT01253291|580891472|FG003|Overall Study|Lack of Efficacy|0|||
160862932|NCT01253291|580891473|FG004|Overall Study|Lack of Efficacy|0|||
160862933|NCT01253291|580891469|FG000|Overall Study|Physician Decision|2|||
160862934|NCT01253291|580891470|FG001|Overall Study|Physician Decision|0|||
160862935|NCT01253291|580891471|FG002|Overall Study|Physician Decision|0|||
160862936|NCT01253291|580891472|FG003|Overall Study|Physician Decision|0|||
160862937|NCT01253291|580891473|FG004|Overall Study|Physician Decision|2|||
160862938|NCT01838395|580891477|FG000|Overall Study|Withdrawal by Subject|0|||
160862939|NCT01838395|580891478|FG001|Overall Study|Withdrawal by Subject|0|||
160862940|NCT01838395|580891479|FG002|Overall Study|Withdrawal by Subject|0|||
160862941|NCT01838395|580891480|FG003|Overall Study|Withdrawal by Subject|0|||
160862942|NCT01838395|580891481|FG004|Overall Study|Withdrawal by Subject|1|||
160862943|NCT01838395|580891482|FG005|Overall Study|Withdrawal by Subject|0|||
160862944|NCT01838395|580891477|FG000|Overall Study|Death|0|||
160862945|NCT01838395|580891478|FG001|Overall Study|Death|0|||
160862946|NCT01838395|580891479|FG002|Overall Study|Death|1|||
160862947|NCT01838395|580891480|FG003|Overall Study|Death|0|||
160862948|NCT01838395|580891481|FG004|Overall Study|Death|0|||
160862949|NCT01838395|580891482|FG005|Overall Study|Death|0|||
160862950|NCT01838395|580891477|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862951|NCT01838395|580891478|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
160862952|NCT01838395|580891479|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862953|NCT01838395|580891480|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862954|NCT01838395|580891481|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862955|NCT01838395|580891482|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
160862956|NCT02195518|580891483|FG000|Overall Study|Adverse Event|1|||
160862957|NCT02195518|580891483|FG000|Overall Study|Protocol Violation|4|||
160862958|NCT02195518|580891483|FG000|Overall Study|Pregnancy|2|||
160862959|NCT02195518|580891483|FG000|Overall Study|Withdrawal by Subject|1|||
160862960|NCT02195518|580891483|FG000|Overall Study|Lost to Follow-up|1|||
160862961|NCT00651742|580891491|FG000|Overall Study|Objective Disease Progression|22|||
160862962|NCT00651742|580891491|FG000|Overall Study|Toxicity|3|||
160862963|NCT00651742|580891491|FG000|Overall Study|Investigator Judgment|1|||
160862964|NCT00651742|580891491|FG000|Overall Study|Withdrawal of Consent|1|||
160862965|NCT00651742|580891491|FG000|Overall Study|Enrolled but not treated|1|||
160862966|NCT05720897|580891494|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
160862967|NCT05720897|580891495|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
160862968|NCT00400179|580891496|FG000|Overall Study|Adverse Event|2|||
160862969|NCT00400179|580891497|FG001|Overall Study|Adverse Event|2|||
160862970|NCT00400179|580891496|FG000|Overall Study|Death|1|||
160862971|NCT00400179|580891497|FG001|Overall Study|Death|2|||
160862972|NCT00400179|580891496|FG000|Overall Study|Withdrew Consent|1|||
160951864|NCT04827212|581211020|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
160951865|NCT04827212|581211019|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
160862973|NCT00400179|580891497|FG001|Overall Study|Withdrew Consent|5|||
160862974|NCT00400179|580891496|FG000|Overall Study|Disease progression|1|||
160862975|NCT00400179|580891497|FG001|Overall Study|Disease progression|1|||
160862976|NCT00400179|580891496|FG000|Overall Study|Intercurrent illness|0|||
160862977|NCT00400179|580891497|FG001|Overall Study|Intercurrent illness|1|||
160862978|NCT00400179|580891496|FG000|Overall Study|Investigator judgment|0|||
160862979|NCT00400179|580891497|FG001|Overall Study|Investigator judgment|1|||
160862980|NCT00400179|580891496|FG000|Overall Study|Randomization error/patient ineligible|1|||
160862981|NCT00400179|580891497|FG001|Overall Study|Randomization error/patient ineligible|6|||
160862982|NCT04780061|580891498|FG000|Overall Study|Withdrawal by Subject|5|||
160862983|NCT04780061|580891499|FG001|Overall Study|Withdrawal by Subject|8|||
160862984|NCT04780061|580891498|FG000|Overall Study|Adverse Event|2|||
160862985|NCT04780061|580891499|FG001|Overall Study|Adverse Event|2|||
160862986|NCT04780061|580891498|FG000|Overall Study|Lost to Follow-up|1|||
160951866|NCT04827212|581211020|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
160951867|NCT00599326|581211021|FG000|Overall Study|Lost to Follow-up|1|||
160951868|NCT00599326|581211021|FG000|Overall Study|Noncompliant|1|||
160951869|NCT00784810|581211022|FG000|Overall Study|Adverse Event|32|||
160951870|NCT00784810|581211023|FG001|Overall Study|Adverse Event|20|||
160951871|NCT00784810|581211022|FG000|Overall Study|Lack of Efficacy|14|||
160951872|NCT00784810|581211023|FG001|Overall Study|Lack of Efficacy|11|||
160951873|NCT00784810|581211022|FG000|Overall Study|Withdrawal by Subject|11|||
160862987|NCT04780061|580891499|FG001|Overall Study|Lost to Follow-up|5|||
160862988|NCT01535040|580891500|FG000|Overall Study|Physician Decision|0|||
160862989|NCT01535040|580891501|FG001|Overall Study|Physician Decision|1|||
160862990|NCT01535040|580891500|FG000|Overall Study|Withdrawal by Subject|13|||
160862991|NCT01535040|580891501|FG001|Overall Study|Withdrawal by Subject|10|||
160862992|NCT01535040|580891500|FG000|Overall Study|Never Started|9|||
160862993|NCT01535040|580891501|FG001|Overall Study|Never Started|4|||
160862994|NCT01535040|580891500|FG000|Overall Study|Toxicity|7|||
160862995|NCT01535040|580891501|FG001|Overall Study|Toxicity|5|||
160862996|NCT01535040|580891500|FG000|Overall Study|Multiple Reasons|1|||
160862997|NCT01535040|580891501|FG001|Overall Study|Multiple Reasons|1|||
160862998|NCT01074970|580891504|FG000|Overall Study|Never Treated|0|||
160862999|NCT01074970|580891505|FG001|Overall Study|Never Treated|0|||
160863000|NCT01074970|580891506|FG002|Overall Study|Never Treated|8|||
160863001|NCT01074970|580891507|FG003|Overall Study|Never Treated|1|||
160863002|NCT01074970|580891504|FG000|Overall Study|Adverse Event|1|||
160863003|NCT01074970|580891505|FG001|Overall Study|Adverse Event|0|||
160863004|NCT01074970|580891506|FG002|Overall Study|Adverse Event|4|||
160863005|NCT01074970|580891507|FG003|Overall Study|Adverse Event|3|||
160863006|NCT01074970|580891504|FG000|Overall Study|Disease progression during treatment|3|||
160863007|NCT01074970|580891505|FG001|Overall Study|Disease progression during treatment|1|||
160863008|NCT01074970|580891506|FG002|Overall Study|Disease progression during treatment|2|||
160863009|NCT01074970|580891507|FG003|Overall Study|Disease progression during treatment|9|||
160863010|NCT01074970|580891504|FG000|Overall Study|Lost to Follow-up|0|||
160863011|NCT01074970|580891505|FG001|Overall Study|Lost to Follow-up|0|||
160863012|NCT01074970|580891506|FG002|Overall Study|Lost to Follow-up|1|||
160863013|NCT01074970|580891507|FG003|Overall Study|Lost to Follow-up|0|||
160863014|NCT01074970|580891504|FG000|Overall Study|Withdrawal by Subject|0|||
160863015|NCT01074970|580891505|FG001|Overall Study|Withdrawal by Subject|0|||
160863016|NCT01074970|580891506|FG002|Overall Study|Withdrawal by Subject|6|||
160863017|NCT01074970|580891507|FG003|Overall Study|Withdrawal by Subject|4|||
160863018|NCT00734149|580891508|FG000|Overall Study|Withdrawal by Subject|1|||
160863019|NCT04314284|580891509|FG000|Overall Study|Withdrawal by Subject|4|||
160863020|NCT04314284|580891510|FG001|Overall Study|Withdrawal by Subject|7|||
160863021|NCT04314284|580891509|FG000|Overall Study|Consented but did not complete survey|0|||
160863022|NCT04314284|580891510|FG001|Overall Study|Consented but did not complete survey|6|||
160863023|NCT01652235|580891513|FG000|Overall Study|Death|9|||
161268557|NCT05327816|582366785|FG001|Overall Study|Withdrawal by Subject|0|||
161268558|NCT05327816|582366786|FG002|Overall Study|Withdrawal by Subject|0|||
161268559|NCT05327816|582366787|FG003|Overall Study|Withdrawal by Subject|0|||
160863024|NCT01652235|580891513|FG000|Overall Study|Lost to Follow-up|5|||
160863025|NCT01652235|580891513|FG000|Overall Study|Withdrawal by Subject|2|||
160863026|NCT02023086|580891516|FG000|Overall Study|Withdrawal by Subject|2|||
161268560|NCT05327816|582366788|FG004|Overall Study|Withdrawal by Subject|1|||
160863027|NCT02023086|580891517|FG001|Overall Study|Withdrawal by Subject|0|||
160863028|NCT03589859|580891518|FG000|Overall Study|Withdrawal by Subject|0|||
160863029|NCT03589859|580891519|FG001|Overall Study|Withdrawal by Subject|6|||
160863030|NCT03043794|580891522|FG000|Overall Study|Lost to Follow-up|1|||
160863031|NCT00626106|580891524|FG000|Overall Study|Withdrawal by Subject|2|||
160863032|NCT00626106|580891525|FG001|Overall Study|Withdrawal by Subject|1|||
160863033|NCT00626106|580891524|FG000|Overall Study|Lost to Follow-up|1|||
160863034|NCT00626106|580891525|FG001|Overall Study|Lost to Follow-up|4|||
160863035|NCT00626106|580891524|FG000|Overall Study|Death|64|||
160863036|NCT00626106|580891525|FG001|Overall Study|Death|19|||
160863037|NCT05417438|580891526|FG000|Overall Study|Withdrawal by Subject|3|||
160863038|NCT02201953|580891531|FG000|Overall Study|Randomized but Never Treated|1|||
160863039|NCT02201953|580891532|FG001|Overall Study|Randomized but Never Treated|5|||
160863040|NCT02201953|580891531|FG000|Overall Study|Lack of Efficacy|9|||
160863041|NCT02201953|580891532|FG001|Overall Study|Lack of Efficacy|30|||
160863042|NCT02201953|580891531|FG000|Overall Study|Lost to Follow-up|8|||
160863043|NCT02201953|580891532|FG001|Overall Study|Lost to Follow-up|8|||
160863044|NCT02201953|580891531|FG000|Overall Study|Withdrew Consent|2|||
160863045|NCT02201953|580891532|FG001|Overall Study|Withdrew Consent|5|||
160863046|NCT02201953|580891531|FG000|Overall Study|Adverse Event|0|||
160863047|NCT02201953|580891532|FG001|Overall Study|Adverse Event|5|||
160863048|NCT02201953|580891531|FG000|Overall Study|Death|0|||
160863049|NCT02201953|580891532|FG001|Overall Study|Death|3|||
160863050|NCT02266888|580892959|FG000|Overall Study|Death|2|||
160863051|NCT02266888|580892960|FG001|Overall Study|Death|2|||
160863052|NCT02266888|580892961|FG002|Overall Study|Death|4|||
160863053|NCT02266888|580892962|FG003|Overall Study|Death|2|||
160951874|NCT00784810|581211023|FG001|Overall Study|Withdrawal by Subject|9|||
160951875|NCT00784810|581211022|FG000|Overall Study|Administrative|5|||
160951876|NCT00784810|581211023|FG001|Overall Study|Administrative|8|||
160863054|NCT02266888|580892959|FG000|Overall Study|Physician Decision|0|||
160863055|NCT02266888|580892960|FG001|Overall Study|Physician Decision|1|||
160951877|NCT00784810|581211022|FG000|Overall Study|Lost to Follow-up|1|||
160951878|NCT00784810|581211023|FG001|Overall Study|Lost to Follow-up|1|||
160951879|NCT03966157|581211024|FG000|Overall Study|Physician Decision|1|||
160951880|NCT03966157|581211025|FG001|Overall Study|Physician Decision|0|||
160951881|NCT04969250|581211030|FG000|Overall Study|Protocol Violation|0|||
160951882|NCT04969250|581211031|FG001|Overall Study|Protocol Violation|2|||
160951883|NCT04969250|581211032|FG002|Overall Study|Protocol Violation|3|||
160951884|NCT04969250|581211033|FG003|Overall Study|Protocol Violation|8|||
160863056|NCT02266888|580892961|FG002|Overall Study|Physician Decision|2|||
160863057|NCT02266888|580892962|FG003|Overall Study|Physician Decision|2|||
160863058|NCT02266888|580892959|FG000|Overall Study|Study Terminated|5|||
160863059|NCT02266888|580892960|FG001|Overall Study|Study Terminated|1|||
160863060|NCT02266888|580892961|FG002|Overall Study|Study Terminated|0|||
160863061|NCT02266888|580892962|FG003|Overall Study|Study Terminated|0|||
160951885|NCT04969250|581211030|FG000|Overall Study|Withdrawal by Subject|0|||
160863062|NCT02266888|580892959|FG000|Overall Study|No Longer Eligible|0|||
160863063|NCT02266888|580892960|FG001|Overall Study|No Longer Eligible|0|||
160863064|NCT02266888|580892961|FG002|Overall Study|No Longer Eligible|0|||
160951886|NCT04969250|581211031|FG001|Overall Study|Withdrawal by Subject|1|||
160951887|NCT04969250|581211032|FG002|Overall Study|Withdrawal by Subject|0|||
160951888|NCT04969250|581211033|FG003|Overall Study|Withdrawal by Subject|0|||
160951889|NCT03305016|581211034|FG000|Overall Study|Withdrawal by Subject|2|||
160951890|NCT02119416|581211035|FG000|Overall Study|Protocol Violation|1|||
160951891|NCT02119416|581211036|FG001|Overall Study|Protocol Violation|1|||
160951892|NCT02119416|581211037|FG002|Overall Study|Protocol Violation|1|||
160951893|NCT02119416|581211035|FG000|Overall Study|wrong pubertal stage|1|||
160951894|NCT02119416|581211036|FG001|Overall Study|wrong pubertal stage|0|||
160951895|NCT02119416|581211037|FG002|Overall Study|wrong pubertal stage|1|||
160951896|NCT03434119|581211038|FG000|Overall Study|Randomized but not treated|1|||
160951897|NCT03434119|581211039|FG001|Overall Study|Randomized but not treated|0|||
160951898|NCT03434119|581211038|FG000|Overall Study|Adverse Event|1|||
161000797|NCT00002842|581388887|FG000|Overall Study|ineligible for surgical resection|27|||
161000798|NCT02694978|581388892|FG000|Overall Study|Adverse Event|10|||
161000799|NCT02694978|581388893|FG001|Overall Study|Adverse Event|9|||
161000800|NCT02694978|581388892|FG000|Overall Study|Withdrawal by Subject|22|||
161000801|NCT02694978|581388893|FG001|Overall Study|Withdrawal by Subject|19|||
161000802|NCT02694978|581388892|FG000|Overall Study|Lost to Follow-up|14|||
161000803|NCT02694978|581388893|FG001|Overall Study|Lost to Follow-up|17|||
161000804|NCT02694978|581388892|FG000|Overall Study|Death|4|||
161000805|NCT02694978|581388893|FG001|Overall Study|Death|1|||
161146097|NCT01739595|581917088|FG002|Overall Study|Adverse Event|0|||
160951899|NCT03434119|581211039|FG001|Overall Study|Adverse Event|0|||
161000806|NCT02694978|581388892|FG000|Overall Study|Other-Decision of Participant|6|||
160951900|NCT03434119|581211038|FG000|Overall Study|Poor Compliance to Protocol|0|||
161000807|NCT02694978|581388893|FG001|Overall Study|Other-Decision of Participant|1|||
161146098|NCT01739595|581917086|FG000|Overall Study|Lost to Follow-up|2|||
160951901|NCT03434119|581211039|FG001|Overall Study|Poor Compliance to Protocol|1|||
160951902|NCT03434119|581211038|FG000|Overall Study|Study Terminated by Sponsor|91|||
161000808|NCT02694978|581388892|FG000|Overall Study|Other-Investigator's decision|1|||
161146099|NCT01739595|581917087|FG001|Overall Study|Lost to Follow-up|0|||
160951903|NCT03434119|581211039|FG001|Overall Study|Study Terminated by Sponsor|102|||
160951904|NCT03434119|581211038|FG000|Overall Study|Withdrawal by Subject|7|||
161146100|NCT01739595|581917088|FG002|Overall Study|Lost to Follow-up|0|||
160951905|NCT03434119|581211039|FG001|Overall Study|Withdrawal by Subject|5|||
161000809|NCT02694978|581388893|FG001|Overall Study|Other-Investigator's decision|0|||
160951906|NCT03434119|581211038|FG000|Overall Study|Other than specified|7|||
160951907|NCT03434119|581211039|FG001|Overall Study|Other than specified|5|||
160863065|NCT02266888|580892962|FG003|Overall Study|No Longer Eligible|2|||
160951908|NCT04420689|581211040|FG000|Overall Study|COVID-19 related hospitalization|0|||
160951909|NCT04420689|581211041|FG001|Overall Study|COVID-19 related hospitalization|0|||
160951910|NCT04420689|581211042|FG002|Overall Study|COVID-19 related hospitalization|0|||
160951911|NCT04420689|581211043|FG003|Overall Study|COVID-19 related hospitalization|0|||
160951912|NCT04420689|581211044|FG004|Overall Study|COVID-19 related hospitalization|1|||
160951913|NCT04420689|581211045|FG005|Overall Study|COVID-19 related hospitalization|0|||
160951914|NCT04420689|581211046|FG006|Overall Study|COVID-19 related hospitalization|0|||
160951915|NCT04420689|581211040|FG000|Overall Study|Physician Decision|0|||
160951916|NCT04420689|581211041|FG001|Overall Study|Physician Decision|0|||
160951917|NCT04420689|581211042|FG002|Overall Study|Physician Decision|0|||
160951918|NCT04420689|581211043|FG003|Overall Study|Physician Decision|0|||
160951919|NCT04420689|581211044|FG004|Overall Study|Physician Decision|0|||
160951920|NCT04420689|581211045|FG005|Overall Study|Physician Decision|1|||
160951921|NCT04420689|581211046|FG006|Overall Study|Physician Decision|0|||
160951922|NCT04360824|581211049|FG000|Overall Study|Withdrawal by Subject|2|||
160951923|NCT04360824|581211050|FG001|Overall Study|Withdrawal by Subject|1|||
160951924|NCT04360824|581211049|FG000|Overall Study|Did not receive assigned treatment|1|||
160951925|NCT04360824|581211050|FG001|Overall Study|Did not receive assigned treatment|3|||
160951926|NCT02278328|581211054|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
160951927|NCT02278328|581211055|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
160951928|NCT02278328|581211056|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
160951929|NCT02278328|581211054|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
160951930|NCT02278328|581211055|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
160951931|NCT02278328|581211056|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
160951932|NCT02278328|581211054|FG000|Neuropsych Screening|incomplete consent|0|||
160951933|NCT02278328|581211055|FG001|Neuropsych Screening|incomplete consent|0|||
160951934|NCT02278328|581211056|FG002|Neuropsych Screening|incomplete consent|2|||
160951935|NCT00377676|581211057|FG000|Overall Study|Adverse Event|498|||
160951936|NCT00377676|581211058|FG001|Overall Study|Adverse Event|107|||
160951937|NCT00377676|581211057|FG000|Overall Study|Protocol Violation|33|||
160951938|NCT00377676|581211058|FG001|Overall Study|Protocol Violation|27|||
160951939|NCT00377676|581211057|FG000|Overall Study|Death|5|||
160951940|NCT00377676|581211058|FG001|Overall Study|Death|2|||
160951941|NCT00377676|581211057|FG000|Overall Study|Withdrawal by Subject|187|||
160951942|NCT00377676|581211058|FG001|Overall Study|Withdrawal by Subject|72|||
161000810|NCT02694978|581388892|FG000|Overall Study|Other-Unable to be reached|0|||
161000811|NCT02694978|581388893|FG001|Overall Study|Other-Unable to be reached|1|||
160863066|NCT02266888|580892959|FG000|Overall Study|Randomization Closed|0|||
160863067|NCT02266888|580892960|FG001|Overall Study|Randomization Closed|0|||
160863068|NCT02266888|580892961|FG002|Overall Study|Randomization Closed|4|||
160863069|NCT02266888|580892962|FG003|Overall Study|Randomization Closed|0|||
160863070|NCT02266888|580892959|FG000|Overall Study|Personnel unavailable at transplant|0|||
160863071|NCT02266888|580892960|FG001|Overall Study|Personnel unavailable at transplant|0|||
160863072|NCT02266888|580892961|FG002|Overall Study|Personnel unavailable at transplant|0|||
160863073|NCT02266888|580892962|FG003|Overall Study|Personnel unavailable at transplant|1|||
160863074|NCT02266888|580892959|FG000|Overall Study|Transfer of care|0|||
160863075|NCT02266888|580892960|FG001|Overall Study|Transfer of care|0|||
160863076|NCT02266888|580892961|FG002|Overall Study|Transfer of care|1|||
160863077|NCT02266888|580892962|FG003|Overall Study|Transfer of care|0|||
160863078|NCT03877510|580892965|FG000|Overall Study|Death|6|||
160863079|NCT03877510|580892965|FG000|Overall Study|Lost to Follow-up|2|||
160863080|NCT03877510|580892965|FG000|Overall Study|Non-compliance with study drug|2|||
161000812|NCT02694978|581388892|FG000|Overall Study|Other-Protocol noncompliant|2|||
161000813|NCT02694978|581388893|FG001|Overall Study|Other-Protocol noncompliant|1|||
161000814|NCT02694978|581388892|FG000|Overall Study|Other-Personal reasons|3|||
161000815|NCT02694978|581388893|FG001|Overall Study|Other-Personal reasons|3|||
161000816|NCT02694978|581388892|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
161000817|NCT02694978|581388893|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
161000818|NCT01613716|581388896|FG000|Overall Study|screen failures|3|||
161000819|NCT01613716|581388896|FG000|Overall Study|Lost to Follow-up|4|||
161000820|NCT02296424|581388899|FG000|Part 1|New therapy for study indication|0|||
161000821|NCT02296424|581388900|FG001|Part 1|New therapy for study indication|1|||
161000822|NCT02296424|581388901|FG002|Part 1|New therapy for study indication|0|||
161000823|NCT02296424|581388902|FG003|Part 1|New therapy for study indication|0|||
160863081|NCT03877510|580892965|FG000|Overall Study|Lack of Efficacy|14|||
160863082|NCT03877510|580892965|FG000|Overall Study|Adverse Event|20|||
160863083|NCT03877510|580892965|FG000|Overall Study|Withdrawal by Subject|22|||
160863084|NCT03877510|580892965|FG000|Overall Study|Miscellaneous|1|||
160863085|NCT03040336|580892966|FG000|Overall Study|Death|1|||
160863086|NCT03040336|580892967|FG001|Overall Study|Death|0|||
161000824|NCT02296424|581388899|FG000|Part 1|Protocol Violation|0|||
160863087|NCT03040336|580892966|FG000|Overall Study|Withdrawal by Subject|2|||
160863088|NCT03040336|580892967|FG001|Overall Study|Withdrawal by Subject|3|||
160863089|NCT01524796|580892969|FG000|Overall Study|Adverse Event|13|||
160863090|NCT01524796|580892969|FG000|Overall Study|Lack of Efficacy|3|||
160863091|NCT01524796|580892969|FG000|Overall Study|Lost to Follow-up|1|||
160863092|NCT01524796|580892969|FG000|Overall Study|The price|1|||
160863093|NCT01524796|580892969|FG000|Overall Study|Withdrawal by Subject|4|||
160863094|NCT01524796|580892969|FG000|Overall Study|Move|1|||
160863095|NCT01524796|580892969|FG000|Overall Study|Deterioration of pains|1|||
160863096|NCT01524796|580892969|FG000|Overall Study|Gall stone surgery|1|||
161146101|NCT01739595|581917086|FG000|Overall Study|Withdrawal by Subject|2|||
160863097|NCT01524796|580892969|FG000|Overall Study|Nervous about confidentiality|1|||
160863098|NCT01524796|580892969|FG000|Overall Study|Switch to carbamazapine|1|||
160863099|NCT01524796|580892969|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
160863100|NCT02435992|580892972|FG000|Overall Study|non compliance with protocol|2|||
160863101|NCT02435992|580892973|FG001|Overall Study|non compliance with protocol|0|||
160863102|NCT02435992|580892974|FG002|Overall Study|non compliance with protocol|1|||
160863103|NCT02435992|580892975|FG003|Overall Study|non compliance with protocol|0|||
160863104|NCT02435992|580892976|FG004|Overall Study|non compliance with protocol|0|||
160863105|NCT02435992|580892972|FG000|Overall Study|Adverse Event|11|||
160863106|NCT02435992|580892973|FG001|Overall Study|Adverse Event|6|||
160863107|NCT02435992|580892974|FG002|Overall Study|Adverse Event|12|||
160863108|NCT02435992|580892975|FG003|Overall Study|Adverse Event|0|||
160863109|NCT02435992|580892976|FG004|Overall Study|Adverse Event|0|||
160863110|NCT02435992|580892972|FG000|Overall Study|Lack of Efficacy|4|||
160863111|NCT02435992|580892973|FG001|Overall Study|Lack of Efficacy|10|||
160863112|NCT02435992|580892974|FG002|Overall Study|Lack of Efficacy|9|||
160863113|NCT02435992|580892975|FG003|Overall Study|Lack of Efficacy|0|||
160863114|NCT02435992|580892976|FG004|Overall Study|Lack of Efficacy|0|||
160863115|NCT02435992|580892972|FG000|Overall Study|Withdrawal by Subject|10|||
160863116|NCT02435992|580892973|FG001|Overall Study|Withdrawal by Subject|8|||
160863117|NCT02435992|580892974|FG002|Overall Study|Withdrawal by Subject|20|||
160863118|NCT02435992|580892975|FG003|Overall Study|Withdrawal by Subject|0|||
160863119|NCT02435992|580892976|FG004|Overall Study|Withdrawal by Subject|0|||
160863120|NCT02435992|580892972|FG000|Overall Study|Other Reason|1|||
160863121|NCT02435992|580892973|FG001|Overall Study|Other Reason|0|||
160863122|NCT02435992|580892974|FG002|Overall Study|Other Reason|0|||
160863123|NCT02435992|580892975|FG003|Overall Study|Other Reason|0|||
160863124|NCT02435992|580892976|FG004|Overall Study|Other Reason|0|||
160863125|NCT02435992|580892972|FG000|Overall Study|Physician Decision|0|||
160863126|NCT02435992|580892973|FG001|Overall Study|Physician Decision|0|||
161146102|NCT01739595|581917087|FG001|Overall Study|Withdrawal by Subject|1|||
161146103|NCT01739595|581917088|FG002|Overall Study|Withdrawal by Subject|2|||
161146104|NCT01739595|581917086|FG000|Overall Study|Eligibility issue|3|||
161146105|NCT01739595|581917087|FG001|Overall Study|Eligibility issue|0|||
161268561|NCT05327816|582366789|FG005|Overall Study|Withdrawal by Subject|1|||
161268562|NCT05327816|582366790|FG006|Overall Study|Withdrawal by Subject|0|||
161268563|NCT05327816|582366791|FG007|Overall Study|Withdrawal by Subject|0|||
160863127|NCT02435992|580892974|FG002|Overall Study|Physician Decision|1|||
160863128|NCT02435992|580892975|FG003|Overall Study|Physician Decision|0|||
160863129|NCT02435992|580892976|FG004|Overall Study|Physician Decision|0|||
160863130|NCT02224560|580892979|FG000|Overall Study|Protocol Deviation|1|||
160863131|NCT02224560|580892980|FG001|Overall Study|Protocol Deviation|0|||
160863132|NCT02224560|580892981|FG002|Overall Study|Protocol Deviation|0|||
160863133|NCT02224560|580892979|FG000|Overall Study|Withdrawal by Subject|2|||
160863134|NCT02224560|580892980|FG001|Overall Study|Withdrawal by Subject|0|||
160863135|NCT02224560|580892981|FG002|Overall Study|Withdrawal by Subject|1|||
160863136|NCT02224560|580892979|FG000|Overall Study|Met Withdrawal Criteria|1|||
160863137|NCT02224560|580892980|FG001|Overall Study|Met Withdrawal Criteria|0|||
160863138|NCT02224560|580892981|FG002|Overall Study|Met Withdrawal Criteria|0|||
160863139|NCT02224560|580892979|FG000|Overall Study|Adverse Event|4|||
160863140|NCT02224560|580892980|FG001|Overall Study|Adverse Event|1|||
160863141|NCT02224560|580892981|FG002|Overall Study|Adverse Event|1|||
160863142|NCT02224560|580892979|FG000|Overall Study|Withdrawn by Investigator|1|||
160863143|NCT02224560|580892980|FG001|Overall Study|Withdrawn by Investigator|1|||
160863144|NCT02224560|580892981|FG002|Overall Study|Withdrawn by Investigator|0|||
160863145|NCT00728689|580892982|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
160863146|NCT00728689|580892983|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
160863147|NCT01523366|580892984|FG000|Treatment Period 1|Withdrawal by Subject|1|||
160863148|NCT01523366|580892985|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161000825|NCT02296424|581388900|FG001|Part 1|Protocol Violation|1|||
161000826|NCT02296424|581388901|FG002|Part 1|Protocol Violation|0|||
160863149|NCT01523366|580892984|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
160863150|NCT01523366|580892985|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
160863151|NCT02461758|580892986|FG000|Overall Study|Lost to Follow-up|0|||
160863152|NCT02461758|580892987|FG001|Overall Study|Lost to Follow-up|1|||
160863153|NCT02461758|580892988|FG002|Overall Study|Lost to Follow-up|1|||
160863154|NCT02461758|580892989|FG003|Overall Study|Lost to Follow-up|0|||
160863155|NCT04543279|580892991|FG000|Overall Study|Withdrawal by Subject|1|||
160863156|NCT04543279|580892992|FG001|Overall Study|Withdrawal by Subject|0|||
160863157|NCT04543279|580892991|FG000|Overall Study|Adverse Event|1|||
161000827|NCT02296424|581388902|FG003|Part 1|Protocol Violation|0|||
161000828|NCT02296424|581388899|FG000|Part 1|Withdrawal by Subject|0|||
161000829|NCT02296424|581388900|FG001|Part 1|Withdrawal by Subject|2|||
161000830|NCT02296424|581388901|FG002|Part 1|Withdrawal by Subject|0|||
161000831|NCT02296424|581388902|FG003|Part 1|Withdrawal by Subject|0|||
161000832|NCT02296424|581388899|FG000|Part 1|Study terminated by sponsor|0|||
161000833|NCT02296424|581388900|FG001|Part 1|Study terminated by sponsor|1|||
161000834|NCT02296424|581388901|FG002|Part 1|Study terminated by sponsor|0|||
161000835|NCT02296424|581388902|FG003|Part 1|Study terminated by sponsor|0|||
161000836|NCT02296424|581388899|FG000|Part 1|Adverse Event|2|||
160863158|NCT04543279|580892992|FG001|Overall Study|Adverse Event|0|||
160863159|NCT04543279|580892991|FG000|Overall Study|Physician Decision|1|||
160863160|NCT04543279|580892992|FG001|Overall Study|Physician Decision|0|||
160863161|NCT00929695|580892995|FG000|Overall Study|Death|2|||
160863162|NCT00929695|580892996|FG001|Overall Study|Death|1|||
160863163|NCT00929695|580892995|FG000|Overall Study|Withdrawal by Subject|0|||
160863164|NCT00929695|580892996|FG001|Overall Study|Withdrawal by Subject|2|||
160863165|NCT00929695|580892995|FG000|Overall Study|discharge home|4|||
160863166|NCT00929695|580892996|FG001|Overall Study|discharge home|3|||
160863167|NCT00929695|580892995|FG000|Overall Study|incorrect stratification|2|||
160863168|NCT00929695|580892996|FG001|Overall Study|incorrect stratification|0|||
160863169|NCT04030143|580892997|FG000|Overall Study|Adverse Event|5|||
160863170|NCT04030143|580892998|FG001|Overall Study|Adverse Event|10|||
160863171|NCT04030143|580892997|FG000|Overall Study|Lost to Follow-up|3|||
160863172|NCT04030143|580892998|FG001|Overall Study|Lost to Follow-up|7|||
160863173|NCT04030143|580892997|FG000|Overall Study|Protocol Deviation|2|||
160863174|NCT04030143|580892998|FG001|Overall Study|Protocol Deviation|2|||
160863175|NCT04030143|580892997|FG000|Overall Study|Withdrawal by Subject|16|||
160863176|NCT04030143|580892998|FG001|Overall Study|Withdrawal by Subject|18|||
160863177|NCT04030143|580892997|FG000|Overall Study|Physician Decision|1|||
160863178|NCT04030143|580892998|FG001|Overall Study|Physician Decision|1|||
160863179|NCT04030143|580892997|FG000|Overall Study|Due to Covid-19|2|||
160863180|NCT04030143|580892998|FG001|Overall Study|Due to Covid-19|3|||
160863181|NCT04030143|580892997|FG000|Overall Study|Not Due to Covid-19|1|||
160863182|NCT04030143|580892998|FG001|Overall Study|Not Due to Covid-19|1|||
160863183|NCT03216226|580892999|FG000|Overall Study|Adverse Event|3|||
160863184|NCT03216226|580893000|FG001|Overall Study|Adverse Event|0|||
160863185|NCT03216226|580892999|FG000|Overall Study|Protocol Violation|1|||
160863186|NCT03216226|580893000|FG001|Overall Study|Protocol Violation|3|||
160863187|NCT03216226|580892999|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
160863188|NCT03216226|580893000|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
160863189|NCT03216226|580892999|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
160863190|NCT03216226|580893000|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
160863191|NCT03216226|580892999|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
160863192|NCT03216226|580893000|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
160863193|NCT01210313|580893006|FG000|Overall Study|Withdrawal by Subject|3|||
160863194|NCT01210313|580893006|FG000|Overall Study|Adverse Event|2|||
160863195|NCT01210313|580893006|FG000|Overall Study|Distant recurrence|4|||
160863196|NCT01210313|580893006|FG000|Overall Study|Non-compliance|7|||
160863197|NCT03113487|580893009|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
161268564|NCT05327816|582366792|FG008|Overall Study|Withdrawal by Subject|0|||
161268565|NCT05327816|582366793|FG009|Overall Study|Withdrawal by Subject|0|||
161268566|NCT05327816|582366794|FG010|Overall Study|Withdrawal by Subject|0|||
161268567|NCT05327816|582366784|FG000|Overall Study|Study Terminated by Sponsor|11|||
161268568|NCT05327816|582366785|FG001|Overall Study|Study Terminated by Sponsor|12|||
161268569|NCT05327816|582366786|FG002|Overall Study|Study Terminated by Sponsor|12|||
161268570|NCT05327816|582366787|FG003|Overall Study|Study Terminated by Sponsor|12|||
161268571|NCT05327816|582366788|FG004|Overall Study|Study Terminated by Sponsor|11|||
161268572|NCT05327816|582366789|FG005|Overall Study|Study Terminated by Sponsor|11|||
160863198|NCT01502293|580893010|FG000|Overall Study|Progressive Disease|20|||
161000837|NCT02296424|581388900|FG001|Part 1|Adverse Event|11|||
161000838|NCT02296424|581388901|FG002|Part 1|Adverse Event|0|||
161000839|NCT02296424|581388902|FG003|Part 1|Adverse Event|0|||
161000840|NCT02296424|581388899|FG000|Part 1|Lack of Efficacy|5|||
161000841|NCT02296424|581388900|FG001|Part 1|Lack of Efficacy|17|||
161000842|NCT02296424|581388901|FG002|Part 1|Lack of Efficacy|0|||
161268573|NCT05327816|582366790|FG006|Overall Study|Study Terminated by Sponsor|11|||
161268574|NCT05327816|582366791|FG007|Overall Study|Study Terminated by Sponsor|11|||
160863199|NCT01502293|580893011|FG001|Overall Study|Progressive Disease|12|||
160863200|NCT01502293|580893012|FG002|Overall Study|Progressive Disease|2|||
160863201|NCT01502293|580893010|FG000|Overall Study|Withdrawal by Subject|3|||
160863202|NCT01502293|580893011|FG001|Overall Study|Withdrawal by Subject|3|||
160863203|NCT01502293|580893012|FG002|Overall Study|Withdrawal by Subject|1|||
160863204|NCT01502293|580893010|FG000|Overall Study|Adverse Event|0|||
160863205|NCT01502293|580893011|FG001|Overall Study|Adverse Event|2|||
160863206|NCT01502293|580893012|FG002|Overall Study|Adverse Event|0|||
161268575|NCT05327816|582366792|FG008|Overall Study|Study Terminated by Sponsor|11|||
161268576|NCT05327816|582366793|FG009|Overall Study|Study Terminated by Sponsor|11|||
161268577|NCT05327816|582366794|FG010|Overall Study|Study Terminated by Sponsor|12|||
161268578|NCT05327816|582366784|FG000|Overall Study|Randomized but not treated|0|||
161268579|NCT05327816|582366785|FG001|Overall Study|Randomized but not treated|0|||
161268580|NCT05327816|582366786|FG002|Overall Study|Randomized but not treated|0|||
161268581|NCT05327816|582366787|FG003|Overall Study|Randomized but not treated|0|||
161268582|NCT05327816|582366788|FG004|Overall Study|Randomized but not treated|0|||
161268583|NCT05327816|582366789|FG005|Overall Study|Randomized but not treated|0|||
161268584|NCT05327816|582366790|FG006|Overall Study|Randomized but not treated|1|||
160863207|NCT01502293|580893010|FG000|Overall Study|Reason Not Specified|2|||
160863208|NCT01502293|580893011|FG001|Overall Study|Reason Not Specified|0|||
160863209|NCT01502293|580893012|FG002|Overall Study|Reason Not Specified|0|||
160863210|NCT01502293|580893010|FG000|Overall Study|Physician Decision|0|||
160863211|NCT01502293|580893011|FG001|Overall Study|Physician Decision|0|||
160863212|NCT01502293|580893012|FG002|Overall Study|Physician Decision|1|||
160863213|NCT00391586|580893014|FG000|Overall Study|Progressive disease|13|||
160863214|NCT00391586|580893014|FG000|Overall Study|Adverse Event|5|||
160863215|NCT00391586|580893014|FG000|Overall Study|Physician Decision|2|||
160863216|NCT00391586|580893014|FG000|Overall Study|Death|4|||
160863217|NCT01409707|580893015|FG000|Overall Study|Withdrawal by Subject|5|||
160863218|NCT01409707|580893016|FG001|Overall Study|Withdrawal by Subject|17|||
160863219|NCT01409707|580893017|FG002|Overall Study|Withdrawal by Subject|16|||
160863220|NCT03058146|580893018|FG000|Overall Study|Withdrawal by Subject|4|||
160863221|NCT03058146|580893019|FG001|Overall Study|Withdrawal by Subject|1|||
160863222|NCT03058146|580893018|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
160863223|NCT03058146|580893019|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
160863224|NCT00632229|580893020|FG000|Overall Study|Adverse Event|6|||
160863225|NCT00632229|580893021|FG001|Overall Study|Adverse Event|0|||
160863226|NCT00632229|580893020|FG000|Overall Study|Lost to Follow-up|0|||
160863227|NCT00632229|580893021|FG001|Overall Study|Lost to Follow-up|3|||
160863228|NCT00632229|580893020|FG000|Overall Study|Lack of Efficacy|0|||
160863229|NCT00632229|580893021|FG001|Overall Study|Lack of Efficacy|2|||
160863230|NCT00632229|580893020|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
160863231|NCT00632229|580893021|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
160863232|NCT03041181|580893022|FG000|Overall Study|Disease Progression|1|||
160863233|NCT03041181|580893023|FG001|Overall Study|Disease Progression|2|||
160863234|NCT01716234|580893024|FG000|Overall Study|Protocol Violation|0|||
160863235|NCT01716234|580893025|FG001|Overall Study|Protocol Violation|0|||
160863236|NCT01716234|580893026|FG002|Overall Study|Protocol Violation|0|||
160863237|NCT01716234|580893027|FG003|Overall Study|Protocol Violation|1|||
160863238|NCT01716234|580893028|FG004|Overall Study|Protocol Violation|1|||
160863239|NCT01716234|580893029|FG005|Overall Study|Protocol Violation|1|||
160863240|NCT01716234|580893030|FG006|Overall Study|Protocol Violation|0|||
160863241|NCT01716234|580893024|FG000|Overall Study|Lack of Efficacy|0|||
160863242|NCT01716234|580893025|FG001|Overall Study|Lack of Efficacy|0|||
160863243|NCT01716234|580893026|FG002|Overall Study|Lack of Efficacy|0|||
160863244|NCT01716234|580893027|FG003|Overall Study|Lack of Efficacy|1|||
160863245|NCT01716234|580893028|FG004|Overall Study|Lack of Efficacy|0|||
160863246|NCT01716234|580893029|FG005|Overall Study|Lack of Efficacy|0|||
160863247|NCT01716234|580893030|FG006|Overall Study|Lack of Efficacy|0|||
160863248|NCT01716234|580893024|FG000|Overall Study|Did not meet protocol eligibility|0|||
160863249|NCT01716234|580893025|FG001|Overall Study|Did not meet protocol eligibility|0|||
160863250|NCT01716234|580893026|FG002|Overall Study|Did not meet protocol eligibility|1|||
160863251|NCT01716234|580893027|FG003|Overall Study|Did not meet protocol eligibility|0|||
160863252|NCT01716234|580893028|FG004|Overall Study|Did not meet protocol eligibility|0|||
160863253|NCT01716234|580893029|FG005|Overall Study|Did not meet protocol eligibility|4|||
160863254|NCT01716234|580893030|FG006|Overall Study|Did not meet protocol eligibility|0|||
160863255|NCT01716234|580893024|FG000|Overall Study|Adverse Event|7|||
160951943|NCT00377676|581211057|FG000|Overall Study|Lost to Follow-up|120|||
160951944|NCT00377676|581211058|FG001|Overall Study|Lost to Follow-up|56|||
160951945|NCT00377676|581211057|FG000|Overall Study|Other|118|||
160951946|NCT00377676|581211058|FG001|Overall Study|Other|58|||
160951947|NCT03834779|581211064|FG000|Overall Study|Death|1|||
160951948|NCT03834779|581211065|FG001|Overall Study|Death|2|||
160951949|NCT03834779|581211064|FG000|Overall Study|Lost to Follow-up|6|||
161000843|NCT02296424|581388902|FG003|Part 1|Lack of Efficacy|0|||
161268585|NCT05327816|582366791|FG007|Overall Study|Randomized but not treated|1|||
161000844|NCT02296424|581388899|FG000|Part 1|16 directly started part II|16|||
161000845|NCT02296424|581388900|FG001|Part 1|16 directly started part II|0|||
161268586|NCT05327816|582366792|FG008|Overall Study|Randomized but not treated|1|||
161268587|NCT05327816|582366793|FG009|Overall Study|Randomized but not treated|0|||
160863256|NCT01716234|580893025|FG001|Overall Study|Adverse Event|10|||
160863257|NCT01716234|580893026|FG002|Overall Study|Adverse Event|2|||
160951950|NCT03834779|581211065|FG001|Overall Study|Lost to Follow-up|4|||
160951951|NCT03579459|581211066|FG000|Overall Study|Adverse Event|7|||
160951952|NCT03579459|581211067|FG001|Overall Study|Adverse Event|6|||
160951953|NCT03579459|581211068|FG002|Overall Study|Adverse Event|2|||
161268588|NCT05327816|582366794|FG010|Overall Study|Randomized but not treated|0|||
160863258|NCT01716234|580893027|FG003|Overall Study|Adverse Event|8|||
160863259|NCT01716234|580893028|FG004|Overall Study|Adverse Event|3|||
160951954|NCT03579459|581211069|FG003|Overall Study|Adverse Event|6|||
160951955|NCT03579459|581211066|FG000|Overall Study|Death|1|||
160951956|NCT03579459|581211067|FG001|Overall Study|Death|0|||
160951957|NCT03579459|581211068|FG002|Overall Study|Death|1|||
160951958|NCT03579459|581211069|FG003|Overall Study|Death|2|||
160951959|NCT03579459|581211066|FG000|Overall Study|Lost to Follow-up|6|||
160863260|NCT01716234|580893029|FG005|Overall Study|Adverse Event|6|||
160863261|NCT01716234|580893030|FG006|Overall Study|Adverse Event|0|||
160863262|NCT01716234|580893024|FG000|Overall Study|Withdrawal by Subject|3|||
160863263|NCT01716234|580893025|FG001|Overall Study|Withdrawal by Subject|0|||
160863264|NCT01716234|580893026|FG002|Overall Study|Withdrawal by Subject|2|||
160863265|NCT01716234|580893027|FG003|Overall Study|Withdrawal by Subject|2|||
160863266|NCT01716234|580893028|FG004|Overall Study|Withdrawal by Subject|1|||
160863267|NCT01716234|580893029|FG005|Overall Study|Withdrawal by Subject|3|||
160951960|NCT03579459|581211067|FG001|Overall Study|Lost to Follow-up|2|||
160951961|NCT03579459|581211068|FG002|Overall Study|Lost to Follow-up|4|||
160863268|NCT01716234|580893030|FG006|Overall Study|Withdrawal by Subject|0|||
160863269|NCT02667119|580893031|FG000|Overall Study|Lost to Follow-up|3|||
160951962|NCT03579459|581211069|FG003|Overall Study|Lost to Follow-up|1|||
160951963|NCT03579459|581211066|FG000|Overall Study|Physician Decision|0|||
160863270|NCT02667119|580893032|FG001|Overall Study|Lost to Follow-up|0|||
160863271|NCT00521079|580893035|FG000|Overall Study|Adverse Event|7|||
160863272|NCT00521079|580893036|FG001|Overall Study|Adverse Event|1|||
160863273|NCT00521079|580893035|FG000|Overall Study|Lost to Follow-up|2|||
160863274|NCT00521079|580893036|FG001|Overall Study|Lost to Follow-up|1|||
160863275|NCT00521079|580893035|FG000|Overall Study|Withdrawal by Subject|5|||
160863276|NCT00521079|580893036|FG001|Overall Study|Withdrawal by Subject|3|||
160863277|NCT02002598|580893039|FG000|Dose Level 1|Withdrawal by Subject|1|||
160863278|NCT02002598|580893040|FG001|Dose Level 1|Withdrawal by Subject|0|||
160863279|NCT02002598|580893041|FG002|Dose Level 1|Withdrawal by Subject|0|||
160863280|NCT02002598|580893042|FG003|Dose Level 1|Withdrawal by Subject|0|||
160863281|NCT02002598|580893043|FG004|Dose Level 1|Withdrawal by Subject|0|||
160951964|NCT03579459|581211067|FG001|Overall Study|Physician Decision|1|||
160951965|NCT03579459|581211068|FG002|Overall Study|Physician Decision|0|||
160951966|NCT03579459|581211069|FG003|Overall Study|Physician Decision|1|||
160951967|NCT03579459|581211066|FG000|Overall Study|Protocol Violation|1|||
160951968|NCT03579459|581211067|FG001|Overall Study|Protocol Violation|2|||
160951969|NCT03579459|581211068|FG002|Overall Study|Protocol Violation|3|||
160951970|NCT03579459|581211069|FG003|Overall Study|Protocol Violation|5|||
160951971|NCT03579459|581211066|FG000|Overall Study|Withdrawal by Subject|12|||
160951972|NCT03579459|581211067|FG001|Overall Study|Withdrawal by Subject|8|||
160863282|NCT04672239|580893044|FG000|Week 2 Survey|Failed survey check items|1|||
160863283|NCT04672239|580893045|FG001|Week 2 Survey|Failed survey check items|2|||
160863284|NCT04672239|580893046|FG002|Week 2 Survey|Failed survey check items|3|||
160863285|NCT04672239|580893044|FG000|Week 2 Survey|Partially completed survey|7|||
160863286|NCT04672239|580893045|FG001|Week 2 Survey|Partially completed survey|1|||
160863287|NCT04672239|580893046|FG002|Week 2 Survey|Partially completed survey|4|||
160863288|NCT04672239|580893044|FG000|Week 2 Survey|Withdrawal by Subject|0|||
160863289|NCT04672239|580893045|FG001|Week 2 Survey|Withdrawal by Subject|1|||
160863290|NCT04672239|580893046|FG002|Week 2 Survey|Withdrawal by Subject|0|||
160863291|NCT04672239|580893044|FG000|Week 2 Survey|Lost to Follow-up|3|||
160863292|NCT04672239|580893045|FG001|Week 2 Survey|Lost to Follow-up|2|||
160863293|NCT04672239|580893046|FG002|Week 2 Survey|Lost to Follow-up|5|||
160863294|NCT04672239|580893044|FG000|Week 6 Survey|Failed survey check items|2|||
160863295|NCT04672239|580893045|FG001|Week 6 Survey|Failed survey check items|2|||
160863296|NCT04672239|580893046|FG002|Week 6 Survey|Failed survey check items|2|||
160863297|NCT04672239|580893044|FG000|Week 6 Survey|Partially completed survey|3|||
160863298|NCT04672239|580893045|FG001|Week 6 Survey|Partially completed survey|3|||
160863299|NCT04672239|580893046|FG002|Week 6 Survey|Partially completed survey|2|||
160863300|NCT04672239|580893044|FG000|Week 6 Survey|Withdrawal by Subject|1|||
160863301|NCT04672239|580893045|FG001|Week 6 Survey|Withdrawal by Subject|1|||
160863302|NCT04672239|580893046|FG002|Week 6 Survey|Withdrawal by Subject|1|||
160863303|NCT04672239|580893044|FG000|Week 6 Survey|Withdrawn by PI|0|||
160863304|NCT04672239|580893045|FG001|Week 6 Survey|Withdrawn by PI|1|||
160863305|NCT04672239|580893046|FG002|Week 6 Survey|Withdrawn by PI|0|||
160863306|NCT04672239|580893044|FG000|Week 6 Survey|Lost to Follow-up|12|||
160863307|NCT04672239|580893045|FG001|Week 6 Survey|Lost to Follow-up|2|||
160863308|NCT04672239|580893046|FG002|Week 6 Survey|Lost to Follow-up|5|||
161146106|NCT01739595|581917088|FG002|Overall Study|Eligibility issue|0|||
161146107|NCT01739595|581917086|FG000|Overall Study|Protocol Violation|1|||
161146108|NCT01739595|581917087|FG001|Overall Study|Protocol Violation|0|||
161146109|NCT01739595|581917088|FG002|Overall Study|Protocol Violation|0|||
160863309|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
160863310|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
160863311|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
160951973|NCT03579459|581211068|FG002|Overall Study|Withdrawal by Subject|11|||
160863312|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
160863313|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
160863314|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
160863315|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
160863316|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
160863317|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
160863318|NCT04672239|580893044|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
160863319|NCT04672239|580893045|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
160863320|NCT04672239|580893046|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
160863321|NCT04672239|580893044|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
160863322|NCT04672239|580893045|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
160863323|NCT04672239|580893046|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
160863324|NCT04672239|580893044|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
160863325|NCT04672239|580893045|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
160863326|NCT04672239|580893046|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
160863327|NCT04672239|580893044|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
160863328|NCT04672239|580893045|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
160863329|NCT04672239|580893046|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
160863330|NCT04123470|580893047|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
160863331|NCT04123470|580893048|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
160863332|NCT04123470|580893047|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
160863333|NCT04123470|580893048|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
160863334|NCT04123470|580893047|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
160863335|NCT04123470|580893048|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
160863336|NCT04123470|580893047|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
160863337|NCT04123470|580893048|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
160863338|NCT05972993|580893049|FG000|Overall Study|Lost to Follow-up|2|||
160863339|NCT05972993|580893050|FG001|Overall Study|Lost to Follow-up|0|||
160863340|NCT05972993|580893051|FG002|Overall Study|Lost to Follow-up|1|||
160863341|NCT05972993|580893052|FG003|Overall Study|Lost to Follow-up|0|||
160863342|NCT05972993|580893053|FG004|Overall Study|Lost to Follow-up|0|||
160863343|NCT05972993|580893054|FG005|Overall Study|Lost to Follow-up|0|||
160863344|NCT05972993|580893055|FG006|Overall Study|Lost to Follow-up|0|||
160863345|NCT05972993|580893056|FG007|Overall Study|Lost to Follow-up|2|||
160863346|NCT05972993|580893057|FG008|Overall Study|Lost to Follow-up|0|||
160863347|NCT04825678|580893059|FG000|Overall Study|Decision by Sponsor|2|||
160863348|NCT04825678|580893060|FG001|Overall Study|Decision by Sponsor|3|||
160863349|NCT04825678|580893059|FG000|Overall Study|Withdrawal of Consent From Study|7|||
160863350|NCT04825678|580893060|FG001|Overall Study|Withdrawal of Consent From Study|9|||
160863351|NCT04825678|580893059|FG000|Overall Study|Lost to Follow-up|3|||
160863352|NCT04825678|580893060|FG001|Overall Study|Lost to Follow-up|4|||
160863353|NCT04825678|580893059|FG000|Overall Study|Never Received Investigational Product|1|||
160863354|NCT04825678|580893060|FG001|Overall Study|Never Received Investigational Product|1|||
160863355|NCT04050553|580893063|FG000|Period 1|Physician Decision|2|||
160863356|NCT04050553|580893064|FG001|Period 1|Physician Decision|2|||
160863357|NCT04050553|580893063|FG000|Period 1|Adverse Event|1|||
160863358|NCT04050553|580893064|FG001|Period 1|Adverse Event|1|||
160863359|NCT04050553|580893063|FG000|Period 1|Withdrawal by Subject|0|||
160863360|NCT04050553|580893064|FG001|Period 1|Withdrawal by Subject|1|||
160863361|NCT04050553|580893063|FG000|Wash-out|Adverse Event|0|||
160863362|NCT04050553|580893064|FG001|Wash-out|Adverse Event|1|||
160863363|NCT04050553|580893063|FG000|Wash-out|Withdrawal by Subject|0|||
160863364|NCT04050553|580893064|FG001|Wash-out|Withdrawal by Subject|1|||
160863365|NCT05430854|580893066|FG000|Overall Study|Trial terminated by Sponsor|39|||
160863366|NCT05430854|580893067|FG001|Overall Study|Trial terminated by Sponsor|50|||
160863367|NCT05430854|580893068|FG002|Overall Study|Trial terminated by Sponsor|46|||
160863368|NCT05430854|580893066|FG000|Overall Study|Withdrawal by Subject|0|||
160863369|NCT05430854|580893067|FG001|Overall Study|Withdrawal by Subject|3|||
160863370|NCT05430854|580893068|FG002|Overall Study|Withdrawal by Subject|0|||
160863371|NCT00911170|580893074|FG000|Treatment Period|Randomized in error|1|||
160863372|NCT00911170|580893075|FG001|Treatment Period|Randomized in error|1|||
160863373|NCT00911170|580893074|FG000|Treatment Period|Ineligibility determined|1|||
160863374|NCT00911170|580893075|FG001|Treatment Period|Ineligibility determined|3|||
160863375|NCT00911170|580893074|FG000|Treatment Period|Protocol deviation|1|||
160863376|NCT00911170|580893075|FG001|Treatment Period|Protocol deviation|2|||
160863377|NCT00911170|580893074|FG000|Treatment Period|Adverse Event|9|||
160863378|NCT00911170|580893075|FG001|Treatment Period|Adverse Event|10|||
160863379|NCT00911170|580893074|FG000|Treatment Period|Withdrawal by Subject|4|||
160863380|NCT00911170|580893075|FG001|Treatment Period|Withdrawal by Subject|4|||
160863381|NCT00911170|580893074|FG000|Treatment Period|Disease progression|0|||
160863382|NCT00911170|580893075|FG001|Treatment Period|Disease progression|2|||
160863383|NCT00911170|580893074|FG000|Treatment Period|Physician Decision|5|||
160863384|NCT00911170|580893075|FG001|Treatment Period|Physician Decision|5|||
160863385|NCT00911170|580893074|FG000|Treatment Period|Lost to Follow-up|0|||
160951974|NCT03579459|581211069|FG003|Overall Study|Withdrawal by Subject|8|||
160951975|NCT03579459|581211066|FG000|Overall Study|Medication error without associated adverse event|2|||
160951976|NCT03579459|581211067|FG001|Overall Study|Medication error without associated adverse event|1|||
160951977|NCT03579459|581211068|FG002|Overall Study|Medication error without associated adverse event|1|||
160951978|NCT03579459|581211069|FG003|Overall Study|Medication error without associated adverse event|0|||
160951979|NCT03579459|581211066|FG000|Overall Study|Other|0|||
160951980|NCT03579459|581211067|FG001|Overall Study|Other|1|||
160951981|NCT03579459|581211068|FG002|Overall Study|Other|1|||
160951982|NCT03579459|581211069|FG003|Overall Study|Other|0|||
160951983|NCT03579459|581211066|FG000|Overall Study|Randomized not vaccinated|0|||
160951984|NCT03579459|581211067|FG001|Overall Study|Randomized not vaccinated|2|||
160951985|NCT03579459|581211068|FG002|Overall Study|Randomized not vaccinated|0|||
160951986|NCT03579459|581211069|FG003|Overall Study|Randomized not vaccinated|1|||
160951987|NCT02528214|581211070|FG000|Overall Study|Protocol Violation|0|||
160951988|NCT02528214|581211071|FG001|Overall Study|Protocol Violation|1|||
160951989|NCT02528214|581211070|FG000|Overall Study|Adverse Event|0|||
160951990|NCT02528214|581211071|FG001|Overall Study|Adverse Event|1|||
160951991|NCT02528214|581211070|FG000|Overall Study|Other than specified above|0|||
160951992|NCT02528214|581211071|FG001|Overall Study|Other than specified above|1|||
160951993|NCT00407537|581211072|FG000|Overall Study|Death|5|||
160951994|NCT00407537|581211073|FG001|Overall Study|Death|2|||
160951995|NCT00407537|581211072|FG000|Overall Study|Adverse Event|36|||
160951996|NCT00407537|581211073|FG001|Overall Study|Adverse Event|0|||
160951997|NCT00407537|581211072|FG000|Overall Study|Lost to Follow-up|12|||
160951998|NCT00407537|581211073|FG001|Overall Study|Lost to Follow-up|19|||
160951999|NCT00407537|581211072|FG000|Overall Study|Other|6|||
160952000|NCT00407537|581211073|FG001|Overall Study|Other|7|||
160952001|NCT00407537|581211072|FG000|Overall Study|Withdrawal by Subject|34|||
161342802|NCT00157755|582642253|FG003|Overall Study|Study completion|0|||
161342803|NCT00157755|582642254|FG004|Overall Study|Study completion|1|||
161342804|NCT00157755|582642255|FG005|Overall Study|Study completion|2|||
161342805|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
161342806|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
161342807|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
161342808|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
161342809|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Death|38|||
161342810|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Death|10|||
161342811|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
161342812|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
161342813|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
161342814|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
161342815|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
161342816|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
161342817|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
161342818|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
161342819|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
161342820|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
161342821|NCT02421939|582642261|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
161342822|NCT02421939|582642262|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
161342823|NCT02421939|582642261|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
161342824|NCT02421939|582642262|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
161342825|NCT02421939|582642261|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
161342826|NCT02421939|582642262|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
161342827|NCT02421939|582642261|FG000|Long Term Follow up: up to 3 Years|Death|118|||
161342828|NCT02421939|582642262|FG001|Long Term Follow up: up to 3 Years|Death|65|||
161342829|NCT02421939|582642261|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
161342830|NCT02421939|582642262|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
161342831|NCT01035138|582642266|FG000|Overall Study|Adverse Event|4|||
161342832|NCT01035138|582642267|FG001|Overall Study|Adverse Event|0|||
161342833|NCT01035138|582642268|FG002|Overall Study|Adverse Event|2|||
161342834|NCT01035138|582642266|FG000|Overall Study|Caregiver Decision|2|||
161342835|NCT01035138|582642267|FG001|Overall Study|Caregiver Decision|0|||
161342836|NCT01035138|582642268|FG002|Overall Study|Caregiver Decision|1|||
161342837|NCT01035138|582642266|FG000|Overall Study|Withdrawal by Subject|1|||
161342838|NCT01035138|582642267|FG001|Overall Study|Withdrawal by Subject|0|||
161342839|NCT01035138|582642268|FG002|Overall Study|Withdrawal by Subject|0|||
161342840|NCT01035138|582642266|FG000|Overall Study|Physician Decision|0|||
161342841|NCT01035138|582642267|FG001|Overall Study|Physician Decision|0|||
161342842|NCT01035138|582642268|FG002|Overall Study|Physician Decision|1|||
161342843|NCT01035138|582642266|FG000|Overall Study|Sponsor Decision|66|||
161342844|NCT01035138|582642267|FG001|Overall Study|Sponsor Decision|60|||
161342845|NCT01035138|582642268|FG002|Overall Study|Sponsor Decision|42|||
161342846|NCT01035138|582642266|FG000|Overall Study|Lost to Follow-up|0|||
161342847|NCT01035138|582642267|FG001|Overall Study|Lost to Follow-up|0|||
161342848|NCT01035138|582642268|FG002|Overall Study|Lost to Follow-up|1|||
160952002|NCT00407537|581211073|FG001|Overall Study|Withdrawal by Subject|16|||
160952003|NCT03043664|581211075|FG000|Overall Study|Lost to Follow-up|1|||
160952004|NCT00325468|581211076|FG000|Overall Study|Adverse Event|1|||
160952005|NCT00325468|581211077|FG001|Overall Study|Adverse Event|1|||
160952006|NCT00325468|581211078|FG002|Overall Study|Adverse Event|0|||
160952007|NCT00325468|581211079|FG003|Overall Study|Adverse Event|5|||
160952008|NCT00325468|581211080|FG004|Overall Study|Adverse Event|1|||
160952009|NCT00325468|581211076|FG000|Overall Study|Death|2|||
160952010|NCT00325468|581211077|FG001|Overall Study|Death|0|||
160952011|NCT00325468|581211078|FG002|Overall Study|Death|2|||
160952012|NCT00325468|581211079|FG003|Overall Study|Death|4|||
160952013|NCT00325468|581211080|FG004|Overall Study|Death|0|||
160952014|NCT00325468|581211076|FG000|Overall Study|Lost to Follow-up|0|||
160952015|NCT00325468|581211077|FG001|Overall Study|Lost to Follow-up|0|||
160952016|NCT00325468|581211078|FG002|Overall Study|Lost to Follow-up|1|||
160952017|NCT00325468|581211079|FG003|Overall Study|Lost to Follow-up|2|||
160952018|NCT00325468|581211080|FG004|Overall Study|Lost to Follow-up|2|||
160952019|NCT00325468|581211076|FG000|Overall Study|Physician Decision|1|||
160952020|NCT00325468|581211077|FG001|Overall Study|Physician Decision|1|||
160952021|NCT00325468|581211078|FG002|Overall Study|Physician Decision|0|||
160952022|NCT00325468|581211079|FG003|Overall Study|Physician Decision|1|||
160952023|NCT00325468|581211080|FG004|Overall Study|Physician Decision|0|||
160952024|NCT00325468|581211076|FG000|Overall Study|Withdrawal by Subject|3|||
160952025|NCT00325468|581211077|FG001|Overall Study|Withdrawal by Subject|1|||
160952026|NCT00325468|581211078|FG002|Overall Study|Withdrawal by Subject|0|||
160952027|NCT00325468|581211079|FG003|Overall Study|Withdrawal by Subject|14|||
160952028|NCT00325468|581211080|FG004|Overall Study|Withdrawal by Subject|4|||
160952029|NCT00325468|581211076|FG000|Overall Study|site closure etc|4|||
161000846|NCT02296424|581388901|FG002|Part 1|16 directly started part II|0|||
161000847|NCT02296424|581388902|FG003|Part 1|16 directly started part II|0|||
161000848|NCT02296424|581388899|FG000|Part 2|Lack of Efficacy|0|||
161000849|NCT02296424|581388900|FG001|Part 2|Lack of Efficacy|0|||
161000850|NCT02296424|581388901|FG002|Part 2|Lack of Efficacy|1|||
161000851|NCT02296424|581388902|FG003|Part 2|Lack of Efficacy|0|||
161000852|NCT02296424|581388899|FG000|Part 2|Adverse Event|0|||
161000853|NCT02296424|581388900|FG001|Part 2|Adverse Event|0|||
161000854|NCT02296424|581388901|FG002|Part 2|Adverse Event|1|||
161000855|NCT02296424|581388902|FG003|Part 2|Adverse Event|0|||
160863386|NCT00911170|580893075|FG001|Treatment Period|Lost to Follow-up|1|||
160863387|NCT00911170|580893074|FG000|Treatment Period|Death|6|||
161000856|NCT02296424|581388899|FG000|Part 2|Lost to Follow-up|0|||
161000857|NCT02296424|581388900|FG001|Part 2|Lost to Follow-up|0|||
161000858|NCT02296424|581388901|FG002|Part 2|Lost to Follow-up|1|||
161000859|NCT02296424|581388902|FG003|Part 2|Lost to Follow-up|0|||
161000860|NCT00743444|581388903|FG000|First Intervention|Catheter placement problems|0|||
161000861|NCT00743444|581388904|FG001|First Intervention|Catheter placement problems|1|||
161000862|NCT00743444|581388903|FG000|Washout Period|Adverse Event|0|||
161000863|NCT00743444|581388904|FG001|Washout Period|Adverse Event|1|||
161000864|NCT00807144|581388905|FG000|Overall Study|Lost to Follow-up|0|||
161000865|NCT00807144|581388906|FG001|Overall Study|Lost to Follow-up|1|||
161000866|NCT03823300|581388922|FG000|Overall Study|Withdrawal by Subject|16|||
161000867|NCT03823300|581388923|FG001|Overall Study|Withdrawal by Subject|22|||
161000868|NCT03823300|581388922|FG000|Overall Study|Death|10|||
161000869|NCT03823300|581388923|FG001|Overall Study|Death|14|||
161000870|NCT03823300|581388922|FG000|Overall Study|Adverse Event|3|||
161000871|NCT03823300|581388923|FG001|Overall Study|Adverse Event|5|||
161000872|NCT03823300|581388922|FG000|Overall Study|Physician Decision|1|||
161000873|NCT03823300|581388923|FG001|Overall Study|Physician Decision|7|||
161000874|NCT03823300|581388922|FG000|Overall Study|Lost to Follow-up|1|||
161000875|NCT03823300|581388923|FG001|Overall Study|Lost to Follow-up|3|||
161000876|NCT03823300|581388922|FG000|Overall Study|Protocol Violation|1|||
161000877|NCT03823300|581388923|FG001|Overall Study|Protocol Violation|1|||
161146110|NCT01739595|581917086|FG000|Overall Study|Lab assessment|1|||
160863388|NCT00911170|580893075|FG001|Treatment Period|Death|9|||
160863389|NCT00911170|580893074|FG000|Long Term Follow-Up|Continuing in study|274|||
160863390|NCT00911170|580893075|FG001|Long Term Follow-Up|Continuing in study|269|||
160863391|NCT00911170|580893074|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
160863392|NCT00911170|580893075|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
160863393|NCT00911170|580893074|FG000|Long Term Follow-Up|Physician Decision|5|||
160863394|NCT00911170|580893075|FG001|Long Term Follow-Up|Physician Decision|4|||
160863395|NCT00911170|580893074|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
160863396|NCT00911170|580893075|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
160863397|NCT00911170|580893074|FG000|Long Term Follow-Up|Death|116|||
160863398|NCT00911170|580893075|FG001|Long Term Follow-Up|Death|121|||
160863399|NCT02681523|580893076|FG000|Overall Study|Adverse Event|1|||
160863400|NCT02681523|580893076|FG000|Overall Study|Patient Non-compliance|1|||
160863401|NCT03253393|580893080|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
160863402|NCT03253393|580893081|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
160863403|NCT03253393|580893082|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
160952030|NCT00325468|581211077|FG001|Overall Study|site closure etc|2|||
160952031|NCT00325468|581211078|FG002|Overall Study|site closure etc|1|||
160952032|NCT00325468|581211079|FG003|Overall Study|site closure etc|8|||
160952033|NCT00325468|581211080|FG004|Overall Study|site closure etc|1|||
160952034|NCT03732209|581211081|FG000|Overall Study|Lost to Follow-up|4|||
160952035|NCT03732209|581211082|FG001|Overall Study|Lost to Follow-up|4|||
160952036|NCT03732209|581211081|FG000|Overall Study|Withdrawal by Subject|8|||
160952037|NCT03732209|581211082|FG001|Overall Study|Withdrawal by Subject|9|||
160952038|NCT01127178|581211083|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
160952039|NCT01127178|581211084|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
160952040|NCT01127178|581211083|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
160952041|NCT01127178|581211084|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
160952042|NCT01127178|581211083|FG000|Dose Escalation: Treatment Phase|Other|2|||
160952043|NCT01127178|581211084|FG001|Dose Escalation: Treatment Phase|Other|0|||
160952044|NCT01127178|581211083|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
160952045|NCT01127178|581211084|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
160952046|NCT01127178|581211083|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
160952047|NCT01127178|581211084|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
160952048|NCT01127178|581211083|FG000|Dose Escalation: Extension Phase|Other|1|||
160952049|NCT01127178|581211084|FG001|Dose Escalation: Extension Phase|Other|0|||
160952050|NCT04139317|581211085|FG000|Overall Study|Adverse Event|10|||
160952051|NCT04139317|581211086|FG001|Overall Study|Adverse Event|2|||
160952052|NCT04139317|581211085|FG000|Overall Study|Death|6|||
160952053|NCT04139317|581211086|FG001|Overall Study|Death|4|||
160952054|NCT04139317|581211085|FG000|Overall Study|Lost to Follow-up|1|||
160952055|NCT04139317|581211086|FG001|Overall Study|Lost to Follow-up|0|||
160952056|NCT04139317|581211085|FG000|Overall Study|Physician Decision|3|||
160952057|NCT04139317|581211086|FG001|Overall Study|Physician Decision|1|||
160952058|NCT04139317|581211085|FG000|Overall Study|Progressive Disease|19|||
160952059|NCT04139317|581211086|FG001|Overall Study|Progressive Disease|9|||
160952060|NCT04139317|581211085|FG000|Overall Study|Subject Decision|2|||
160952061|NCT04139317|581211086|FG001|Overall Study|Subject Decision|2|||
160952062|NCT00782340|581211089|FG000|Open Label Titration|Adverse Event|12|||
160952063|NCT00782340|581211090|FG001|Open Label Titration|Adverse Event|0|||
160952064|NCT00782340|581211091|FG002|Open Label Titration|Adverse Event|0|||
160952065|NCT00782340|581211089|FG000|Open Label Titration|Treatment failure|50|||
160952066|NCT00782340|581211090|FG001|Open Label Titration|Treatment failure|0|||
160952067|NCT00782340|581211091|FG002|Open Label Titration|Treatment failure|0|||
160952068|NCT00782340|581211089|FG000|Open Label Titration|Protocol Violation|5|||
160952069|NCT00782340|581211090|FG001|Open Label Titration|Protocol Violation|0|||
160952070|NCT00782340|581211091|FG002|Open Label Titration|Protocol Violation|0|||
160952071|NCT00782340|581211089|FG000|Open Label Titration|Withdrawal by Subject|5|||
160952072|NCT00782340|581211090|FG001|Open Label Titration|Withdrawal by Subject|0|||
160952073|NCT00782340|581211091|FG002|Open Label Titration|Withdrawal by Subject|0|||
160952074|NCT00782340|581211089|FG000|Open Label Titration|Enrollment capped|16|||
160952075|NCT00782340|581211090|FG001|Open Label Titration|Enrollment capped|0|||
160952076|NCT00782340|581211091|FG002|Open Label Titration|Enrollment capped|0|||
160952077|NCT00782340|581211089|FG000|Open Label Titration|Did not meet responder criteria|2|||
160952078|NCT00782340|581211090|FG001|Open Label Titration|Did not meet responder criteria|0|||
160952079|NCT00782340|581211091|FG002|Open Label Titration|Did not meet responder criteria|0|||
160952080|NCT00782340|581211089|FG000|Open Label Titration|Lost to Follow-up|5|||
160952081|NCT00782340|581211090|FG001|Open Label Titration|Lost to Follow-up|0|||
160952082|NCT00782340|581211091|FG002|Open Label Titration|Lost to Follow-up|0|||
160952083|NCT00782340|581211089|FG000|Open Label Titration|Randomized in error|6|||
160952084|NCT00782340|581211090|FG001|Open Label Titration|Randomized in error|0|||
160952085|NCT00782340|581211091|FG002|Open Label Titration|Randomized in error|0|||
160952086|NCT02365467|581211092|FG000|Overall Study|Death|3|||
160952087|NCT01306162|581211093|FG000|Period 1|Adverse Event|0|||
160952088|NCT01306162|581211094|FG001|Period 1|Adverse Event|0|||
160952089|NCT01306162|581211095|FG002|Period 1|Adverse Event|0|||
160952090|NCT01306162|581211096|FG003|Period 1|Adverse Event|1|||
160952091|NCT01306162|581211093|FG000|Washout 1|Non-compliance to protocol|0|||
160952092|NCT01306162|581211094|FG001|Washout 1|Non-compliance to protocol|1|||
160952093|NCT01306162|581211095|FG002|Washout 1|Non-compliance to protocol|0|||
160952094|NCT01306162|581211096|FG003|Washout 1|Non-compliance to protocol|0|||
160952095|NCT01109992|581211097|FG000|Overall Study|Withdrawal by Subject|0|||
160952096|NCT01109992|581211098|FG001|Overall Study|Withdrawal by Subject|1|||
160952097|NCT01109992|581211097|FG000|Overall Study|Movement during rest scan.|0|||
160952098|NCT01109992|581211098|FG001|Overall Study|Movement during rest scan.|1|||
160952099|NCT02952924|581211101|FG000|Overall Study|Protocol Violation|0|||
160952100|NCT02952924|581211102|FG001|Overall Study|Protocol Violation|0|||
160952101|NCT02952924|581211103|FG002|Overall Study|Protocol Violation|0|||
160952102|NCT02952924|581211104|FG003|Overall Study|Protocol Violation|0|||
160952103|NCT02952924|581211105|FG004|Overall Study|Protocol Violation|0|||
160952104|NCT02952924|581211106|FG005|Overall Study|Protocol Violation|0|||
160952105|NCT02952924|581211107|FG006|Overall Study|Protocol Violation|0|||
160952106|NCT02952924|581211108|FG007|Overall Study|Protocol Violation|0|||
160952107|NCT02952924|581211109|FG008|Overall Study|Protocol Violation|0|||
160952108|NCT02952924|581211110|FG009|Overall Study|Protocol Violation|0|||
160952109|NCT02952924|581211111|FG010|Overall Study|Protocol Violation|0|||
160952110|NCT02952924|581211112|FG011|Overall Study|Protocol Violation|0|||
160952111|NCT02952924|581211113|FG012|Overall Study|Protocol Violation|0|||
160952112|NCT02952924|581211114|FG013|Overall Study|Protocol Violation|0|||
160952113|NCT02952924|581211115|FG014|Overall Study|Protocol Violation|0|||
160952114|NCT02952924|581211116|FG015|Overall Study|Protocol Violation|0|||
160952115|NCT02952924|581211117|FG016|Overall Study|Protocol Violation|0|||
160952116|NCT02952924|581211118|FG017|Overall Study|Protocol Violation|0|||
160952117|NCT02952924|581211119|FG018|Overall Study|Protocol Violation|0|||
160952118|NCT02952924|581211120|FG019|Overall Study|Protocol Violation|1|||
160952119|NCT02952924|581211121|FG020|Overall Study|Protocol Violation|0|||
160952120|NCT02952924|581211122|FG021|Overall Study|Protocol Violation|0|||
160952121|NCT02952924|581211101|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
160952122|NCT02952924|581211102|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
160952123|NCT02952924|581211103|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
160952124|NCT02952924|581211104|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
160952125|NCT02952924|581211105|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
160952126|NCT02952924|581211106|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
160952127|NCT02952924|581211107|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
160952128|NCT02952924|581211108|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
160952129|NCT02952924|581211109|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
160952130|NCT02952924|581211110|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
160952131|NCT02952924|581211111|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
160952132|NCT02952924|581211112|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
160952133|NCT02952924|581211113|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
160952134|NCT02952924|581211114|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
160952135|NCT02952924|581211115|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
160952136|NCT02952924|581211116|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
160952137|NCT02952924|581211117|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
160952138|NCT02952924|581211118|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
160952139|NCT02952924|581211119|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
160952140|NCT02952924|581211120|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
160952141|NCT02952924|581211121|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
160952142|NCT02952924|581211122|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
160952143|NCT02952924|581211101|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952144|NCT02952924|581211102|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952145|NCT02952924|581211103|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952146|NCT02952924|581211104|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952147|NCT02952924|581211105|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952148|NCT02952924|581211106|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952149|NCT02952924|581211107|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952150|NCT02952924|581211108|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952151|NCT02952924|581211109|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952152|NCT02952924|581211110|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952153|NCT02952924|581211111|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952154|NCT02952924|581211112|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952155|NCT02952924|581211113|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952156|NCT02952924|581211114|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952157|NCT02952924|581211115|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952158|NCT02952924|581211116|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952159|NCT02952924|581211117|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
161268589|NCT00759902|582366795|FG000|Overall Study|Adverse Event|0|||
160952160|NCT02952924|581211118|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952161|NCT02952924|581211119|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952162|NCT02952924|581211120|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952163|NCT02952924|581211121|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
160952164|NCT02952924|581211122|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
160952165|NCT02952924|581211101|FG000|Overall Study|Noncompliance with study drug|0|||
160952166|NCT02952924|581211102|FG001|Overall Study|Noncompliance with study drug|0|||
160952167|NCT02952924|581211103|FG002|Overall Study|Noncompliance with study drug|0|||
160952168|NCT02952924|581211104|FG003|Overall Study|Noncompliance with study drug|0|||
161000878|NCT03823300|581388922|FG000|Overall Study|Lack of Efficacy|1|||
160952169|NCT02952924|581211105|FG004|Overall Study|Noncompliance with study drug|0|||
161146111|NCT01739595|581917087|FG001|Overall Study|Lab assessment|0|||
160952170|NCT02952924|581211106|FG005|Overall Study|Noncompliance with study drug|0|||
160952171|NCT02952924|581211107|FG006|Overall Study|Noncompliance with study drug|0|||
160952172|NCT02952924|581211108|FG007|Overall Study|Noncompliance with study drug|0|||
160952173|NCT02952924|581211109|FG008|Overall Study|Noncompliance with study drug|0|||
160952174|NCT02952924|581211110|FG009|Overall Study|Noncompliance with study drug|0|||
160952175|NCT02952924|581211111|FG010|Overall Study|Noncompliance with study drug|0|||
160952176|NCT02952924|581211112|FG011|Overall Study|Noncompliance with study drug|0|||
160952177|NCT02952924|581211113|FG012|Overall Study|Noncompliance with study drug|0|||
160952178|NCT02952924|581211114|FG013|Overall Study|Noncompliance with study drug|0|||
160952179|NCT02952924|581211115|FG014|Overall Study|Noncompliance with study drug|0|||
160952180|NCT02952924|581211116|FG015|Overall Study|Noncompliance with study drug|0|||
160952181|NCT02952924|581211117|FG016|Overall Study|Noncompliance with study drug|0|||
160952182|NCT02952924|581211118|FG017|Overall Study|Noncompliance with study drug|0|||
160952183|NCT02952924|581211119|FG018|Overall Study|Noncompliance with study drug|0|||
160952184|NCT02952924|581211120|FG019|Overall Study|Noncompliance with study drug|0|||
160952185|NCT02952924|581211121|FG020|Overall Study|Noncompliance with study drug|0|||
160952186|NCT02952924|581211122|FG021|Overall Study|Noncompliance with study drug|1|||
160952187|NCT01435577|581211125|FG000|Overall Study|Adverse Event|10|||
160952188|NCT01435577|581211126|FG001|Overall Study|Adverse Event|0|||
160952189|NCT01435577|581211125|FG000|Overall Study|Lack of Efficacy|7|||
160952190|NCT01435577|581211126|FG001|Overall Study|Lack of Efficacy|51|||
160952191|NCT01435577|581211125|FG000|Overall Study|Alternative treatment started|0|||
160952192|NCT01435577|581211126|FG001|Overall Study|Alternative treatment started|1|||
160952193|NCT01934218|581211128|FG000|Double-blind Phase|Adverse Event|8|||
160952194|NCT01934218|581211129|FG001|Double-blind Phase|Adverse Event|8|||
160952195|NCT01934218|581211128|FG000|Double-blind Phase|Lack of Efficacy|6|||
160952196|NCT01934218|581211129|FG001|Double-blind Phase|Lack of Efficacy|7|||
160952197|NCT01934218|581211128|FG000|Double-blind Phase|Lost to Follow-up|7|||
160952198|NCT01934218|581211129|FG001|Double-blind Phase|Lost to Follow-up|14|||
160952199|NCT01934218|581211128|FG000|Double-blind Phase|Physician Decision|1|||
160952200|NCT01934218|581211129|FG001|Double-blind Phase|Physician Decision|2|||
160952201|NCT01934218|581211128|FG000|Double-blind Phase|Protocol Violation|4|||
160952202|NCT01934218|581211129|FG001|Double-blind Phase|Protocol Violation|0|||
160952203|NCT01934218|581211128|FG000|Double-blind Phase|Withdrawal by Subject|16|||
160952204|NCT01934218|581211129|FG001|Double-blind Phase|Withdrawal by Subject|13|||
160952205|NCT01934218|581211128|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
160952206|NCT01934218|581211129|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
160952207|NCT01934218|581211128|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
160952208|NCT01934218|581211129|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
161146112|NCT01739595|581917088|FG002|Overall Study|Lab assessment|0|||
161146113|NCT01739595|581917086|FG000|Overall Study|Drug discrepancy|1|||
161146114|NCT01739595|581917087|FG001|Overall Study|Drug discrepancy|0|||
161146115|NCT01739595|581917088|FG002|Overall Study|Drug discrepancy|0|||
161146116|NCT02725177|581917091|FG000|Overall Study|Physician Decision|4|||
160952209|NCT01934218|581211128|FG000|Open-Label Phase|Adverse Event|2|||
160952210|NCT01934218|581211129|FG001|Open-Label Phase|Adverse Event|4|||
161146117|NCT02725177|581917091|FG000|Overall Study|Adverse Event|1|||
160952211|NCT01934218|581211128|FG000|Open-Label Phase|Lack of Efficacy|1|||
160952212|NCT01934218|581211129|FG001|Open-Label Phase|Lack of Efficacy|4|||
160952213|NCT01934218|581211128|FG000|Open-Label Phase|Lost to Follow-up|4|||
160952214|NCT01934218|581211129|FG001|Open-Label Phase|Lost to Follow-up|2|||
160952215|NCT01934218|581211128|FG000|Open-Label Phase|Physician Decision|1|||
160952216|NCT01934218|581211129|FG001|Open-Label Phase|Physician Decision|0|||
160952217|NCT01934218|581211128|FG000|Open-Label Phase|Protocol Violation|1|||
160952218|NCT01934218|581211129|FG001|Open-Label Phase|Protocol Violation|0|||
160952219|NCT01934218|581211128|FG000|Open-Label Phase|Withdrawal by Subject|13|||
160952220|NCT01934218|581211129|FG001|Open-Label Phase|Withdrawal by Subject|11|||
161146118|NCT01089725|581917095|FG000|Overall Study|Adverse Event|1|||
160952221|NCT01934218|581211128|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
160952222|NCT01934218|581211129|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
161146119|NCT01089725|581917096|FG001|Overall Study|Adverse Event|1|||
161146120|NCT01089725|581917097|FG002|Overall Study|Adverse Event|0|||
161146121|NCT01089725|581917098|FG003|Overall Study|Adverse Event|0|||
161268590|NCT00759902|582366796|FG001|Overall Study|Adverse Event|1|||
161146122|NCT01089725|581917099|FG004|Overall Study|Adverse Event|2|||
161268591|NCT00658658|582366801|FG000|Overall Study|Withdrawal by Subject|0|||
160952223|NCT01934218|581211128|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
160952224|NCT01934218|581211129|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
161146123|NCT01089725|581917095|FG000|Overall Study|Lack of Efficacy|4|||
161146124|NCT01089725|581917096|FG001|Overall Study|Lack of Efficacy|3|||
161268592|NCT00658658|582366802|FG001|Overall Study|Withdrawal by Subject|1|||
161268593|NCT00658658|582366803|FG002|Overall Study|Withdrawal by Subject|0|||
160952225|NCT03273946|581211133|FG000|Overall Study|Withdrawal by Subject|5|||
160952226|NCT03273946|581211133|FG000|Overall Study|Unwillingness of the guardian|1|||
160952227|NCT03273946|581211133|FG000|Overall Study|Participant refused to use the drug|2|||
160952228|NCT03273946|581211133|FG000|Overall Study|Participant relative refused to use drug|1|||
160952229|NCT01220557|581211134|FG000|Overall Study|Lost to Follow-up|5|||
160952230|NCT01220557|581211135|FG001|Overall Study|Lost to Follow-up|3|||
160952231|NCT01220557|581211134|FG000|Overall Study|attended less than 6 lessons|1|||
160952232|NCT01220557|581211135|FG001|Overall Study|attended less than 6 lessons|2|||
160952233|NCT01090453|581211137|FG000|Overall Study|Withdrawal by Subject|1|||
160952234|NCT01090453|581211138|FG001|Overall Study|Withdrawal by Subject|2|||
160952235|NCT01090453|581211137|FG000|Overall Study|Lost to Follow-up|7|||
160952236|NCT01090453|581211138|FG001|Overall Study|Lost to Follow-up|7|||
160952237|NCT01090453|581211137|FG000|Overall Study|Non serious AEs|1|||
160952238|NCT01090453|581211138|FG001|Overall Study|Non serious AEs|0|||
160952239|NCT01090453|581211137|FG000|Overall Study|Protocol Violation|2|||
160952240|NCT01090453|581211138|FG001|Overall Study|Protocol Violation|0|||
160952241|NCT01090453|581211137|FG000|Overall Study|Other|2|||
160952242|NCT01090453|581211138|FG001|Overall Study|Other|4|||
160952243|NCT01090453|581211137|FG000|Overall Study|Eligibility Criteria|0|||
160952244|NCT01090453|581211138|FG001|Overall Study|Eligibility Criteria|1|||
160952245|NCT01870843|581211139|FG000|Overall Study|Adverse Event|10|||
160952246|NCT01870843|581211139|FG000|Overall Study|Lost to Follow-up|24|||
160952247|NCT01870843|581211139|FG000|Overall Study|Death|1|||
160952248|NCT01870843|581211139|FG000|Overall Study|Withdrawal by Subject|18|||
160952249|NCT03588572|581211143|FG000|Visitation 1|Lack of Efficacy|1|||
160952250|NCT03588572|581211144|FG001|Visitation 1|Lack of Efficacy|1|||
160952251|NCT03588572|581211143|FG000|Visitation 2|Lost to Follow-up|1|||
160952252|NCT03588572|581211144|FG001|Visitation 2|Lost to Follow-up|1|||
160952253|NCT03588572|581211143|FG000|Visitation 2|Lack of Efficacy|0|||
160952254|NCT03588572|581211144|FG001|Visitation 2|Lack of Efficacy|1|||
160952255|NCT03588572|581211143|FG000|Visitation 2|Withdrawal by Subject|1|||
160952256|NCT03588572|581211144|FG001|Visitation 2|Withdrawal by Subject|0|||
160952257|NCT03588572|581211143|FG000|Visitation 3|Lost to Follow-up|1|||
160952258|NCT03588572|581211144|FG001|Visitation 3|Lost to Follow-up|1|||
160952259|NCT03588572|581211143|FG000|Visitation 3|Physician Decision|1|||
160952260|NCT03588572|581211144|FG001|Visitation 3|Physician Decision|1|||
160952261|NCT03588572|581211143|FG000|Visitation 3|Withdrawal by Subject|1|||
160952262|NCT03588572|581211144|FG001|Visitation 3|Withdrawal by Subject|0|||
160952263|NCT01165281|581211145|FG000|Overall Study|Adverse Event|12|||
160952264|NCT01165281|581211146|FG001|Overall Study|Adverse Event|14|||
160952265|NCT01165281|581211145|FG000|Overall Study|Death|3|||
160952266|NCT01165281|581211146|FG001|Overall Study|Death|4|||
160952267|NCT01165281|581211145|FG000|Overall Study|Lack of Efficacy|4|||
160952268|NCT01165281|581211146|FG001|Overall Study|Lack of Efficacy|1|||
160952269|NCT01165281|581211145|FG000|Overall Study|Lost to Follow-up|0|||
160952270|NCT01165281|581211146|FG001|Overall Study|Lost to Follow-up|1|||
160952271|NCT01165281|581211145|FG000|Overall Study|Physician Decision|8|||
160952272|NCT01165281|581211146|FG001|Overall Study|Physician Decision|1|||
160952273|NCT01165281|581211145|FG000|Overall Study|Protocol Violation|6|||
160952274|NCT01165281|581211146|FG001|Overall Study|Protocol Violation|5|||
160952275|NCT01165281|581211145|FG000|Overall Study|Withdrawal by Subject|8|||
160952276|NCT01165281|581211146|FG001|Overall Study|Withdrawal by Subject|7|||
160952277|NCT01165281|581211145|FG000|Overall Study|Noncompliance with Study Drug|1|||
160952278|NCT01165281|581211146|FG001|Overall Study|Noncompliance with Study Drug|4|||
160952279|NCT01165281|581211145|FG000|Overall Study|Progressive Disease|10|||
160952280|NCT01165281|581211146|FG001|Overall Study|Progressive Disease|14|||
160952281|NCT01165281|581211145|FG000|Overall Study|Other|6|||
160952282|NCT01165281|581211146|FG001|Overall Study|Other|0|||
160952283|NCT02863991|581211147|FG000|Overall Study|Death|0|||
160952284|NCT02863991|581211148|FG001|Overall Study|Death|3|||
160952285|NCT02863991|581211147|FG000|Overall Study|Lack of Efficacy|0|||
160952286|NCT02863991|581211148|FG001|Overall Study|Lack of Efficacy|1|||
160952287|NCT02863991|581211147|FG000|Overall Study|Study Terminated|2|||
160952288|NCT02863991|581211148|FG001|Overall Study|Study Terminated|8|||
160952289|NCT00364858|581211149|FG000|Overall Study|Adverse Event|1|||
160952290|NCT00364858|581211150|FG001|Overall Study|Adverse Event|5|||
160952291|NCT00364858|581211149|FG000|Overall Study|Withdrawal by Subject|1|||
160952292|NCT00364858|581211150|FG001|Overall Study|Withdrawal by Subject|1|||
160952293|NCT00364858|581211149|FG000|Overall Study|Pregnancy|1|||
160952294|NCT00364858|581211150|FG001|Overall Study|Pregnancy|1|||
160952295|NCT00364858|581211149|FG000|Overall Study|Clinical failure|2|||
160952296|NCT00364858|581211150|FG001|Overall Study|Clinical failure|13|||
160952297|NCT00364858|581211149|FG000|Overall Study|Discontinuation at baseline|1|||
160952298|NCT00364858|581211150|FG001|Overall Study|Discontinuation at baseline|0|||
160952299|NCT00364858|581211149|FG000|Overall Study|Non-compliant|1|||
160952300|NCT00364858|581211150|FG001|Overall Study|Non-compliant|0|||
160952301|NCT00364858|581211149|FG000|Overall Study|Return to Q2 regimen|0|||
160952302|NCT00364858|581211150|FG001|Overall Study|Return to Q2 regimen|1|||
160952303|NCT00364858|581211149|FG000|Overall Study|Clinical baseline issue|0|||
160952304|NCT00364858|581211150|FG001|Overall Study|Clinical baseline issue|1|||
160952305|NCT00363766|581211151|FG000|Overall Study|Progressive Disease|15|||
160952306|NCT00363766|581211152|FG001|Overall Study|Progressive Disease|9|||
160952307|NCT00363766|581211151|FG000|Overall Study|Adverse Event|10|||
160952308|NCT00363766|581211152|FG001|Overall Study|Adverse Event|2|||
160952309|NCT00363766|581211151|FG000|Overall Study|Disease Related Death|1|||
160952310|NCT00363766|581211152|FG001|Overall Study|Disease Related Death|3|||
160952311|NCT00363766|581211151|FG000|Overall Study|Not Disease Related Death|3|||
160952312|NCT00363766|581211152|FG001|Overall Study|Not Disease Related Death|4|||
160952313|NCT00363766|581211151|FG000|Overall Study|Withdrawal by Subject|2|||
160952314|NCT00363766|581211152|FG001|Overall Study|Withdrawal by Subject|0|||
160952315|NCT00363766|581211151|FG000|Overall Study|Physician Decision|1|||
160952316|NCT00363766|581211152|FG001|Overall Study|Physician Decision|2|||
160952317|NCT00558285|581211153|FG000|Overall Study|Adverse Event|1|||
160952318|NCT00558285|581211154|FG001|Overall Study|Adverse Event|1|||
160952319|NCT00558285|581211155|FG002|Overall Study|Adverse Event|4|||
160952320|NCT00558285|581211156|FG003|Overall Study|Adverse Event|1|||
160952321|NCT00558285|581211157|FG004|Overall Study|Adverse Event|2|||
160952322|NCT00558285|581211153|FG000|Overall Study|Abnormal test procedure result(s)|1|||
160952323|NCT00558285|581211154|FG001|Overall Study|Abnormal test procedure result(s)|0|||
160952324|NCT00558285|581211155|FG002|Overall Study|Abnormal test procedure result(s)|0|||
160952325|NCT00558285|581211156|FG003|Overall Study|Abnormal test procedure result(s)|0|||
160952326|NCT00558285|581211157|FG004|Overall Study|Abnormal test procedure result(s)|0|||
160952327|NCT00558285|581211153|FG000|Overall Study|Subject withdrew consent|2|||
160952328|NCT00558285|581211154|FG001|Overall Study|Subject withdrew consent|0|||
160952329|NCT00558285|581211155|FG002|Overall Study|Subject withdrew consent|1|||
160952330|NCT00558285|581211156|FG003|Overall Study|Subject withdrew consent|1|||
160952331|NCT00558285|581211157|FG004|Overall Study|Subject withdrew consent|1|||
160952332|NCT00558285|581211153|FG000|Overall Study|Lost to Follow-up|1|||
160952333|NCT00558285|581211154|FG001|Overall Study|Lost to Follow-up|1|||
160952334|NCT00558285|581211155|FG002|Overall Study|Lost to Follow-up|0|||
160952335|NCT00558285|581211156|FG003|Overall Study|Lost to Follow-up|0|||
160952336|NCT00558285|581211157|FG004|Overall Study|Lost to Follow-up|0|||
160952337|NCT00558285|581211153|FG000|Overall Study|Administrative problems|0|||
160952338|NCT00558285|581211154|FG001|Overall Study|Administrative problems|0|||
160952339|NCT00558285|581211155|FG002|Overall Study|Administrative problems|0|||
160952340|NCT00558285|581211156|FG003|Overall Study|Administrative problems|1|||
160952341|NCT00558285|581211157|FG004|Overall Study|Administrative problems|1|||
160952342|NCT00558285|581211153|FG000|Overall Study|Protocol deviation|1|||
161342849|NCT02966834|582642269|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161342850|NCT02966834|582642270|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161342851|NCT02966834|582642271|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161342852|NCT02966834|582642272|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161342853|NCT02966834|582642273|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
161342854|NCT02966834|582642274|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
161342855|NCT02966834|582642269|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
161342856|NCT02966834|582642270|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161342857|NCT02966834|582642271|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161342858|NCT02966834|582642272|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161342859|NCT02966834|582642273|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161342860|NCT02966834|582642274|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161342861|NCT02966834|582642269|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161342862|NCT02966834|582642270|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161342863|NCT02966834|582642271|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
161342864|NCT02966834|582642272|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
161342865|NCT02966834|582642273|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
161342866|NCT02966834|582642274|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
161342867|NCT02966834|582642269|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161342868|NCT02966834|582642270|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161342869|NCT02966834|582642271|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
161342870|NCT02966834|582642272|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
161342871|NCT02966834|582642273|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
161342872|NCT02966834|582642274|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
161342873|NCT02966834|582642269|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161342874|NCT02966834|582642270|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161342875|NCT02966834|582642271|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161342876|NCT02966834|582642272|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
161342877|NCT02966834|582642273|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161342878|NCT02966834|582642274|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
161342879|NCT02966834|582642269|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
161342880|NCT02966834|582642270|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160952343|NCT00558285|581211154|FG001|Overall Study|Protocol deviation|1|||
160952344|NCT00558285|581211155|FG002|Overall Study|Protocol deviation|0|||
160952345|NCT00558285|581211156|FG003|Overall Study|Protocol deviation|1|||
160952346|NCT00558285|581211157|FG004|Overall Study|Protocol deviation|0|||
160952347|NCT02730819|581211164|FG000|Overall Study|Lost to Follow-up|9|||
160952348|NCT02345512|581211165|FG000|Overall Study|Adverse Event|1|||
160952349|NCT02345512|581211165|FG000|Overall Study|Withdrawal by Subject|1|||
160952350|NCT01660906|581211166|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
160952351|NCT02121847|581211167|FG000|Overall Study|Administrative Reasons|1|||
160952352|NCT02121847|581211167|FG000|Overall Study|Adverse Event|2|||
160952353|NCT01308580|581211176|FG000|Overall Study|Lost to Follow-up|12|||
160952354|NCT01308580|581211177|FG001|Overall Study|Lost to Follow-up|7|||
160952355|NCT03823651|581211178|FG000|Overall Study|Death|5|||
160952356|NCT03823651|581211179|FG001|Overall Study|Death|0|||
160952357|NCT03823651|581211178|FG000|Overall Study|Physician Decision|1|||
160952358|NCT03823651|581211179|FG001|Overall Study|Physician Decision|0|||
160952359|NCT03823651|581211178|FG000|Overall Study|Caregiver to patient who died|0|||
160952360|NCT03823651|581211179|FG001|Overall Study|Caregiver to patient who died|5|||
160952361|NCT03823651|581211178|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
160952362|NCT03823651|581211179|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
160952363|NCT03864614|581211183|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
160952364|NCT03864614|581211184|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
160952365|NCT03864614|581211185|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
160952366|NCT03864614|581211186|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
160952367|NCT03864614|581211183|FG000|Overall Study|Withdrawal by Subject|72|||
160952368|NCT03864614|581211184|FG001|Overall Study|Withdrawal by Subject|100|||
160952369|NCT03864614|581211185|FG002|Overall Study|Withdrawal by Subject|1|||
160952370|NCT03864614|581211186|FG003|Overall Study|Withdrawal by Subject|21|||
160952371|NCT03864614|581211183|FG000|Overall Study|Lost to Follow-up|45|||
160952372|NCT03864614|581211184|FG001|Overall Study|Lost to Follow-up|54|||
160952373|NCT03864614|581211185|FG002|Overall Study|Lost to Follow-up|0|||
160952374|NCT03864614|581211186|FG003|Overall Study|Lost to Follow-up|9|||
160952375|NCT03864614|581211183|FG000|Overall Study|Adverse Event|42|||
160952376|NCT03864614|581211184|FG001|Overall Study|Adverse Event|30|||
160952377|NCT03864614|581211185|FG002|Overall Study|Adverse Event|1|||
160952378|NCT03864614|581211186|FG003|Overall Study|Adverse Event|9|||
160952379|NCT03864614|581211183|FG000|Overall Study|Protocol Deviation|6|||
160952380|NCT03864614|581211184|FG001|Overall Study|Protocol Deviation|26|||
160952381|NCT03864614|581211185|FG002|Overall Study|Protocol Deviation|0|||
160952382|NCT03864614|581211186|FG003|Overall Study|Protocol Deviation|1|||
160952383|NCT03864614|581211183|FG000|Overall Study|Physician Decision|7|||
160952384|NCT03864614|581211184|FG001|Overall Study|Physician Decision|10|||
160952385|NCT03864614|581211185|FG002|Overall Study|Physician Decision|1|||
160952386|NCT03864614|581211186|FG003|Overall Study|Physician Decision|5|||
160952387|NCT03864614|581211183|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
160952388|NCT03864614|581211184|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
160952389|NCT03864614|581211185|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
160952390|NCT03864614|581211186|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
160952391|NCT03864614|581211183|FG000|Overall Study|Sponsor Decision|1|||
160952392|NCT03864614|581211184|FG001|Overall Study|Sponsor Decision|2|||
160952393|NCT03864614|581211185|FG002|Overall Study|Sponsor Decision|0|||
160952394|NCT03864614|581211186|FG003|Overall Study|Sponsor Decision|0|||
160952395|NCT03864614|581211183|FG000|Overall Study|Pregnancy|0|||
160952396|NCT03864614|581211184|FG001|Overall Study|Pregnancy|1|||
160952397|NCT03864614|581211185|FG002|Overall Study|Pregnancy|0|||
160952398|NCT03864614|581211186|FG003|Overall Study|Pregnancy|0|||
160952399|NCT03864614|581211183|FG000|Overall Study|Other|7|||
160952400|NCT03864614|581211184|FG001|Overall Study|Other|9|||
160952401|NCT03864614|581211185|FG002|Overall Study|Other|1|||
160952402|NCT03864614|581211186|FG003|Overall Study|Other|4|||
160952403|NCT03864614|581211183|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
160952404|NCT03864614|581211184|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
160952405|NCT03864614|581211185|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
160952406|NCT03864614|581211186|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
160952407|NCT01850004|581211187|FG000|Overall Study|Poor/Non-compliance|1|||
160952408|NCT01850004|581211187|FG000|Overall Study|Participant Withdrew Consent|9|||
160952409|NCT01850004|581211187|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
160952410|NCT01850004|581211187|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
160952411|NCT01850004|581211187|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
160952412|NCT01850004|581211187|FG000|Overall Study|Other Reasons|2|||
160952413|NCT01850004|581211187|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
160952414|NCT01850004|581211187|FG000|Overall Study|Maximum Clinical Benefit|4|||
160952415|NCT03147248|581213815|FG000|Overall Study|Adverse Event|0|||
160952416|NCT03147248|581213816|FG001|Overall Study|Adverse Event|2|||
160952417|NCT03147248|581213817|FG002|Overall Study|Adverse Event|2|||
160952418|NCT03147248|581213818|FG003|Overall Study|Adverse Event|2|||
160952419|NCT03147248|581213819|FG004|Overall Study|Adverse Event|6|||
160952420|NCT03147248|581213820|FG005|Overall Study|Adverse Event|11|||
160952421|NCT03147248|581213815|FG000|Overall Study|Disease progression|1|||
160952422|NCT03147248|581213816|FG001|Overall Study|Disease progression|0|||
160952423|NCT03147248|581213817|FG002|Overall Study|Disease progression|0|||
160952424|NCT03147248|581213818|FG003|Overall Study|Disease progression|0|||
160952425|NCT03147248|581213819|FG004|Overall Study|Disease progression|0|||
160952426|NCT03147248|581213820|FG005|Overall Study|Disease progression|2|||
160952427|NCT03147248|581213815|FG000|Overall Study|Withdrawal by Subject|0|||
160952428|NCT03147248|581213816|FG001|Overall Study|Withdrawal by Subject|0|||
160952429|NCT03147248|581213817|FG002|Overall Study|Withdrawal by Subject|0|||
160952430|NCT03147248|581213818|FG003|Overall Study|Withdrawal by Subject|0|||
160952431|NCT03147248|581213819|FG004|Overall Study|Withdrawal by Subject|12|||
160952432|NCT03147248|581213820|FG005|Overall Study|Withdrawal by Subject|9|||
160952433|NCT03147248|581213815|FG000|Overall Study|Protocol Violation|0|||
160952434|NCT03147248|581213816|FG001|Overall Study|Protocol Violation|0|||
160952435|NCT03147248|581213817|FG002|Overall Study|Protocol Violation|0|||
160952436|NCT03147248|581213818|FG003|Overall Study|Protocol Violation|0|||
160952437|NCT03147248|581213819|FG004|Overall Study|Protocol Violation|2|||
160952438|NCT03147248|581213820|FG005|Overall Study|Protocol Violation|0|||
160952439|NCT03147248|581213815|FG000|Overall Study|Lost to Follow-up|0|||
160952440|NCT03147248|581213816|FG001|Overall Study|Lost to Follow-up|0|||
160952441|NCT03147248|581213817|FG002|Overall Study|Lost to Follow-up|0|||
160952442|NCT03147248|581213818|FG003|Overall Study|Lost to Follow-up|0|||
160952443|NCT03147248|581213819|FG004|Overall Study|Lost to Follow-up|2|||
160952444|NCT03147248|581213820|FG005|Overall Study|Lost to Follow-up|0|||
160952445|NCT03147248|581213815|FG000|Overall Study|Pregnancy|0|||
160952446|NCT03147248|581213816|FG001|Overall Study|Pregnancy|0|||
160952447|NCT03147248|581213817|FG002|Overall Study|Pregnancy|0|||
160952448|NCT03147248|581213818|FG003|Overall Study|Pregnancy|0|||
160952449|NCT03147248|581213819|FG004|Overall Study|Pregnancy|1|||
160952450|NCT03147248|581213820|FG005|Overall Study|Pregnancy|0|||
160952451|NCT03147248|581213815|FG000|Overall Study|Death|0|||
160952452|NCT03147248|581213816|FG001|Overall Study|Death|0|||
160952453|NCT03147248|581213817|FG002|Overall Study|Death|0|||
160952454|NCT03147248|581213818|FG003|Overall Study|Death|0|||
160952455|NCT03147248|581213819|FG004|Overall Study|Death|0|||
160952456|NCT03147248|581213820|FG005|Overall Study|Death|4|||
160952457|NCT03147248|581213815|FG000|Overall Study|Physician Decision|0|||
160952458|NCT03147248|581213816|FG001|Overall Study|Physician Decision|0|||
160952459|NCT03147248|581213817|FG002|Overall Study|Physician Decision|0|||
160952460|NCT03147248|581213818|FG003|Overall Study|Physician Decision|0|||
160952461|NCT03147248|581213819|FG004|Overall Study|Physician Decision|2|||
160952462|NCT03147248|581213820|FG005|Overall Study|Physician Decision|4|||
160952463|NCT03147248|581213815|FG000|Overall Study|Prolonged Dosing Interval|0|||
160952464|NCT03147248|581213816|FG001|Overall Study|Prolonged Dosing Interval|0|||
160952465|NCT03147248|581213817|FG002|Overall Study|Prolonged Dosing Interval|0|||
160952466|NCT03147248|581213818|FG003|Overall Study|Prolonged Dosing Interval|0|||
160952467|NCT03147248|581213819|FG004|Overall Study|Prolonged Dosing Interval|1|||
160952468|NCT03147248|581213820|FG005|Overall Study|Prolonged Dosing Interval|1|||
160952469|NCT01914926|581213822|FG000|Overall Study|Adverse Event|1|||
160952470|NCT01914926|581213823|FG001|Overall Study|Adverse Event|0|||
160952471|NCT01914926|581213822|FG000|Overall Study|uncooperative, agitated and removed|0|||
160952472|NCT01914926|581213823|FG001|Overall Study|uncooperative, agitated and removed|1|||
160952473|NCT02536508|581213824|FG000|Overall Study|Withdrawal by Subject|18|||
160952474|NCT02536508|581213825|FG001|Overall Study|Withdrawal by Subject|13|||
160952475|NCT02536508|581213826|FG002|Overall Study|Withdrawal by Subject|7|||
160952476|NCT02536508|581213824|FG000|Overall Study|Adverse Event|14|||
160952477|NCT02536508|581213825|FG001|Overall Study|Adverse Event|13|||
160952478|NCT02536508|581213826|FG002|Overall Study|Adverse Event|6|||
160952479|NCT02536508|581213824|FG000|Overall Study|Lost to Follow-up|12|||
160952480|NCT02536508|581213825|FG001|Overall Study|Lost to Follow-up|4|||
161268594|NCT00658658|582366804|FG003|Overall Study|Withdrawal by Subject|0|||
161268595|NCT00658658|582366805|FG004|Overall Study|Withdrawal by Subject|0|||
160952481|NCT02536508|581213826|FG002|Overall Study|Lost to Follow-up|0|||
160952482|NCT02536508|581213824|FG000|Overall Study|Lack of Efficacy|3|||
160952483|NCT02536508|581213825|FG001|Overall Study|Lack of Efficacy|5|||
160952484|NCT02536508|581213826|FG002|Overall Study|Lack of Efficacy|4|||
160952485|NCT02536508|581213824|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
160952486|NCT02536508|581213825|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
160952487|NCT02536508|581213826|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
160952488|NCT02536508|581213824|FG000|Overall Study|Physician Decision|0|||
160952489|NCT02536508|581213825|FG001|Overall Study|Physician Decision|4|||
160952490|NCT02536508|581213826|FG002|Overall Study|Physician Decision|2|||
160952491|NCT02536508|581213824|FG000|Overall Study|Major Protocol Deviation|2|||
160952492|NCT02536508|581213825|FG001|Overall Study|Major Protocol Deviation|2|||
160952493|NCT02536508|581213826|FG002|Overall Study|Major Protocol Deviation|2|||
160952494|NCT02536508|581213824|FG000|Overall Study|Administrative Reasons|0|||
160952495|NCT02536508|581213825|FG001|Overall Study|Administrative Reasons|1|||
161268596|NCT00658658|582366801|FG000|Overall Study|Death|4|||
160952496|NCT02536508|581213826|FG002|Overall Study|Administrative Reasons|0|||
160952497|NCT00856856|581213832|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
160952498|NCT00856856|581213832|FG000|4-year Clinical Follow-up|Missed visit|1|||
160952499|NCT00434057|581213833|FG000|Overall Study|Withdrawal by Subject|1|||
160952500|NCT00823719|581213837|FG000|Overall Study|Adverse Event|1|||
160952501|NCT00823719|581213838|FG001|Overall Study|Adverse Event|2|||
160952502|NCT00823719|581213837|FG000|Overall Study|Physician Decision|1|||
160952503|NCT00823719|581213838|FG001|Overall Study|Physician Decision|4|||
160952504|NCT00823719|581213837|FG000|Overall Study|Withdrawal by Subject|0|||
160952505|NCT00823719|581213838|FG001|Overall Study|Withdrawal by Subject|1|||
160952506|NCT00823719|581213837|FG000|Overall Study|Disease Progression|4|||
160952507|NCT00823719|581213838|FG001|Overall Study|Disease Progression|4|||
160952508|NCT00922428|581213839|FG000|Overall Study|retrospective/extremely implausible data|2|||
160952509|NCT00922428|581213839|FG000|Overall Study|no medication use or questionable use|13|||
160952510|NCT03701555|581213841|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
160952511|NCT03701555|581213842|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
160952512|NCT03701555|581213843|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
160952513|NCT03701555|581213844|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
160952514|NCT03701555|581213845|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
160952515|NCT03701555|581213846|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
160952516|NCT03701555|581213847|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
160952517|NCT03701555|581213848|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
160952518|NCT03701555|581213849|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
160952519|NCT03701555|581213850|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
160952520|NCT03701555|581213851|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
160952521|NCT03701555|581213852|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
160952522|NCT03701555|581213853|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
160952523|NCT03701555|581213854|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
160952524|NCT03701555|581213855|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
160952525|NCT03701555|581213856|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
160952526|NCT03701555|581213857|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
160952527|NCT03701555|581213858|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
160952528|NCT03701555|581213859|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
160952529|NCT03701555|581213860|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
160952530|NCT03701555|581213861|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
160952531|NCT03701555|581213862|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
160952532|NCT03701555|581213863|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
160952533|NCT03701555|581213864|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
160952534|NCT03701555|581213865|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
160952535|NCT03701555|581213866|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
160952536|NCT03701555|581213867|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
160952537|NCT03701555|581213868|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
160952538|NCT03701555|581213869|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
160952539|NCT03701555|581213870|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
160952540|NCT03701555|581213871|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
160952541|NCT03701555|581213872|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
160952542|NCT03701555|581213873|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
160952543|NCT03701555|581213874|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
160952544|NCT03701555|581213875|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
160952545|NCT03701555|581213876|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
160952546|NCT03701555|581213841|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
161000879|NCT03823300|581388923|FG001|Overall Study|Lack of Efficacy|1|||
161000880|NCT03823300|581388922|FG000|Overall Study|Not Eligible|0|||
161000881|NCT03823300|581388923|FG001|Overall Study|Not Eligible|1|||
161000882|NCT03823300|581388922|FG000|Overall Study|Other|1|||
161000883|NCT03823300|581388923|FG001|Overall Study|Other|0|||
161000884|NCT00831415|581388924|FG000|Overall Study|Adverse Event|14|||
161000885|NCT00831415|581388924|FG000|Overall Study|Failed to return|3|||
161000886|NCT00831415|581388924|FG000|Overall Study|Physician Decision|6|||
161146125|NCT01089725|581917097|FG002|Overall Study|Lack of Efficacy|1|||
161146126|NCT01089725|581917098|FG003|Overall Study|Lack of Efficacy|0|||
161342881|NCT02966834|582642271|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160952547|NCT03701555|581213842|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
160952548|NCT03701555|581213843|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
160952549|NCT03701555|581213844|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
160952550|NCT03701555|581213845|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
161146127|NCT01089725|581917099|FG004|Overall Study|Lack of Efficacy|4|||
161146128|NCT01089725|581917095|FG000|Overall Study|Lost to Follow-up|2|||
160952551|NCT03701555|581213846|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
160952552|NCT03701555|581213847|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
160952553|NCT03701555|581213848|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
160952554|NCT03701555|581213849|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
160952555|NCT03701555|581213850|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
160952556|NCT03701555|581213851|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
160952557|NCT03701555|581213852|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
160952558|NCT03701555|581213853|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
160952559|NCT03701555|581213854|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
160952560|NCT03701555|581213855|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
161000887|NCT00831415|581388924|FG000|Overall Study|Lost to Follow-up|9|||
160952561|NCT03701555|581213856|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
160952562|NCT03701555|581213857|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
160952563|NCT03701555|581213858|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
160952564|NCT03701555|581213859|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
160952565|NCT03701555|581213860|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
160952566|NCT03701555|581213861|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
160952567|NCT03701555|581213862|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
160952568|NCT03701555|581213863|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
160952569|NCT03701555|581213864|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
160952570|NCT03701555|581213865|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
160952571|NCT03701555|581213866|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
160952572|NCT03701555|581213867|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
160952573|NCT03701555|581213868|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
160952574|NCT03701555|581213869|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
160952575|NCT03701555|581213870|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
160952576|NCT03701555|581213871|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
160952577|NCT03701555|581213872|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
160952578|NCT03701555|581213873|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
160952579|NCT03701555|581213874|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
160952580|NCT03701555|581213875|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
160952581|NCT03701555|581213876|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
160952582|NCT03701555|581213841|FG000|Part 2 (Day 1)|Other|0|||
160952583|NCT03701555|581213842|FG001|Part 2 (Day 1)|Other|0|||
160952584|NCT03701555|581213843|FG002|Part 2 (Day 1)|Other|0|||
160952585|NCT03701555|581213844|FG003|Part 2 (Day 1)|Other|0|||
160952586|NCT03701555|581213845|FG004|Part 2 (Day 1)|Other|0|||
160952587|NCT03701555|581213846|FG005|Part 2 (Day 1)|Other|0|||
160952588|NCT03701555|581213847|FG006|Part 2 (Day 1)|Other|0|||
160952589|NCT03701555|581213848|FG007|Part 2 (Day 1)|Other|0|||
160952590|NCT03701555|581213849|FG008|Part 2 (Day 1)|Other|0|||
160952591|NCT03701555|581213850|FG009|Part 2 (Day 1)|Other|0|||
160952592|NCT03701555|581213851|FG010|Part 2 (Day 1)|Other|3|||
160952593|NCT03701555|581213852|FG011|Part 2 (Day 1)|Other|1|||
160952594|NCT03701555|581213853|FG012|Part 2 (Day 1)|Other|0|||
160952595|NCT03701555|581213854|FG013|Part 2 (Day 1)|Other|1|||
160952596|NCT03701555|581213855|FG014|Part 2 (Day 1)|Other|0|||
160952597|NCT03701555|581213856|FG015|Part 2 (Day 1)|Other|2|||
160952598|NCT03701555|581213857|FG016|Part 2 (Day 1)|Other|2|||
160952599|NCT03701555|581213858|FG017|Part 2 (Day 1)|Other|0|||
160952600|NCT03701555|581213859|FG018|Part 2 (Day 1)|Other|0|||
160952601|NCT03701555|581213860|FG019|Part 2 (Day 1)|Other|0|||
160952602|NCT03701555|581213861|FG020|Part 2 (Day 1)|Other|0|||
160952603|NCT03701555|581213862|FG021|Part 2 (Day 1)|Other|0|||
160952604|NCT03701555|581213863|FG022|Part 2 (Day 1)|Other|0|||
160952605|NCT03701555|581213864|FG023|Part 2 (Day 1)|Other|0|||
160952606|NCT03701555|581213865|FG024|Part 2 (Day 1)|Other|0|||
160952607|NCT03701555|581213866|FG025|Part 2 (Day 1)|Other|0|||
160952608|NCT03701555|581213867|FG026|Part 2 (Day 1)|Other|0|||
160952609|NCT03701555|581213868|FG027|Part 2 (Day 1)|Other|0|||
160952610|NCT03701555|581213869|FG028|Part 2 (Day 1)|Other|0|||
160952611|NCT03701555|581213870|FG029|Part 2 (Day 1)|Other|0|||
160952612|NCT03701555|581213871|FG030|Part 2 (Day 1)|Other|0|||
160952613|NCT03701555|581213872|FG031|Part 2 (Day 1)|Other|0|||
160952614|NCT03701555|581213873|FG032|Part 2 (Day 1)|Other|0|||
160952615|NCT03701555|581213874|FG033|Part 2 (Day 1)|Other|0|||
161268597|NCT00658658|582366802|FG001|Overall Study|Death|0|||
160952616|NCT03701555|581213875|FG034|Part 2 (Day 1)|Other|0|||
160952617|NCT03701555|581213876|FG035|Part 2 (Day 1)|Other|0|||
160952618|NCT03701555|581213841|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
160952619|NCT03701555|581213842|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
160952620|NCT03701555|581213843|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
160952621|NCT03701555|581213844|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
160952622|NCT03701555|581213845|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
161268598|NCT00658658|582366803|FG002|Overall Study|Death|0|||
161268599|NCT00658658|582366804|FG003|Overall Study|Death|1|||
161268600|NCT00658658|582366805|FG004|Overall Study|Death|1|||
160952623|NCT03701555|581213846|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
160952624|NCT03701555|581213847|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
161268601|NCT00658658|582366801|FG000|Overall Study|Disease Progression|0|||
160952625|NCT03701555|581213848|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
160952626|NCT03701555|581213849|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
160952627|NCT03701555|581213850|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
160952628|NCT03701555|581213851|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
160952629|NCT03701555|581213852|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
160952630|NCT03701555|581213853|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
160952631|NCT03701555|581213854|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
160952632|NCT03701555|581213855|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
160952633|NCT03701555|581213856|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
160952634|NCT03701555|581213857|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
161268602|NCT00658658|582366802|FG001|Overall Study|Disease Progression|1|||
161268603|NCT00658658|582366803|FG002|Overall Study|Disease Progression|0|||
160952635|NCT03701555|581213858|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
160952636|NCT03701555|581213859|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
160952637|NCT03701555|581213860|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
160952638|NCT03701555|581213861|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
160952639|NCT03701555|581213862|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
160952640|NCT03701555|581213863|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
160952641|NCT03701555|581213864|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
160952642|NCT03701555|581213865|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
160952643|NCT03701555|581213866|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
160952644|NCT03701555|581213867|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
160952645|NCT03701555|581213868|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
160952646|NCT03701555|581213869|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
160952647|NCT03701555|581213870|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
160952648|NCT03701555|581213871|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
160952649|NCT03701555|581213872|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
160952650|NCT03701555|581213873|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
160952651|NCT03701555|581213874|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
160952652|NCT03701555|581213875|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
160952653|NCT03701555|581213876|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
160952654|NCT03701555|581213841|FG000|Part 3 (Day 1)|Subject Decision|0|||
160952655|NCT03701555|581213842|FG001|Part 3 (Day 1)|Subject Decision|0|||
160952656|NCT03701555|581213843|FG002|Part 3 (Day 1)|Subject Decision|0|||
160952657|NCT03701555|581213844|FG003|Part 3 (Day 1)|Subject Decision|0|||
160952658|NCT03701555|581213845|FG004|Part 3 (Day 1)|Subject Decision|0|||
160952659|NCT03701555|581213846|FG005|Part 3 (Day 1)|Subject Decision|0|||
160952660|NCT03701555|581213847|FG006|Part 3 (Day 1)|Subject Decision|0|||
160952661|NCT03701555|581213848|FG007|Part 3 (Day 1)|Subject Decision|0|||
160952662|NCT03701555|581213849|FG008|Part 3 (Day 1)|Subject Decision|0|||
160952663|NCT03701555|581213850|FG009|Part 3 (Day 1)|Subject Decision|0|||
160952664|NCT03701555|581213851|FG010|Part 3 (Day 1)|Subject Decision|0|||
160952665|NCT03701555|581213852|FG011|Part 3 (Day 1)|Subject Decision|0|||
160952666|NCT03701555|581213853|FG012|Part 3 (Day 1)|Subject Decision|0|||
160952667|NCT03701555|581213854|FG013|Part 3 (Day 1)|Subject Decision|0|||
160952668|NCT03701555|581213855|FG014|Part 3 (Day 1)|Subject Decision|0|||
160952669|NCT03701555|581213856|FG015|Part 3 (Day 1)|Subject Decision|0|||
160952670|NCT03701555|581213857|FG016|Part 3 (Day 1)|Subject Decision|0|||
160952671|NCT03701555|581213858|FG017|Part 3 (Day 1)|Subject Decision|0|||
160952672|NCT03701555|581213859|FG018|Part 3 (Day 1)|Subject Decision|0|||
160952673|NCT03701555|581213860|FG019|Part 3 (Day 1)|Subject Decision|0|||
160952674|NCT03701555|581213861|FG020|Part 3 (Day 1)|Subject Decision|0|||
160952675|NCT03701555|581213862|FG021|Part 3 (Day 1)|Subject Decision|0|||
160952676|NCT03701555|581213863|FG022|Part 3 (Day 1)|Subject Decision|0|||
160952677|NCT03701555|581213864|FG023|Part 3 (Day 1)|Subject Decision|0|||
160952678|NCT03701555|581213865|FG024|Part 3 (Day 1)|Subject Decision|0|||
160952679|NCT03701555|581213866|FG025|Part 3 (Day 1)|Subject Decision|0|||
160952680|NCT03701555|581213867|FG026|Part 3 (Day 1)|Subject Decision|1|||
160952681|NCT03701555|581213868|FG027|Part 3 (Day 1)|Subject Decision|0|||
160952682|NCT03701555|581213869|FG028|Part 3 (Day 1)|Subject Decision|0|||
160952683|NCT03701555|581213870|FG029|Part 3 (Day 1)|Subject Decision|0|||
160952684|NCT03701555|581213871|FG030|Part 3 (Day 1)|Subject Decision|0|||
160952685|NCT03701555|581213872|FG031|Part 3 (Day 1)|Subject Decision|2|||
160952686|NCT03701555|581213873|FG032|Part 3 (Day 1)|Subject Decision|1|||
160952687|NCT03701555|581213874|FG033|Part 3 (Day 1)|Subject Decision|1|||
160952688|NCT03701555|581213875|FG034|Part 3 (Day 1)|Subject Decision|0|||
160952689|NCT03701555|581213876|FG035|Part 3 (Day 1)|Subject Decision|0|||
160952690|NCT03701555|581213841|FG000|Part 3 (Day 1)|Other|0|||
160952691|NCT03701555|581213842|FG001|Part 3 (Day 1)|Other|0|||
160952692|NCT03701555|581213843|FG002|Part 3 (Day 1)|Other|0|||
160952693|NCT03701555|581213844|FG003|Part 3 (Day 1)|Other|0|||
160952694|NCT03701555|581213845|FG004|Part 3 (Day 1)|Other|0|||
161000888|NCT00831415|581388924|FG000|Overall Study|Protocol Violation|3|||
161000889|NCT00831415|581388924|FG000|Overall Study|Withdrawal by Subject|35|||
161000890|NCT00831415|581388924|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
161268604|NCT00658658|582366804|FG003|Overall Study|Disease Progression|1|||
161268605|NCT00658658|582366805|FG004|Overall Study|Disease Progression|3|||
160952695|NCT03701555|581213846|FG005|Part 3 (Day 1)|Other|0|||
160952696|NCT03701555|581213847|FG006|Part 3 (Day 1)|Other|0|||
160952697|NCT03701555|581213848|FG007|Part 3 (Day 1)|Other|0|||
160952698|NCT03701555|581213849|FG008|Part 3 (Day 1)|Other|0|||
160952699|NCT03701555|581213850|FG009|Part 3 (Day 1)|Other|0|||
160952700|NCT03701555|581213851|FG010|Part 3 (Day 1)|Other|0|||
160952701|NCT03701555|581213852|FG011|Part 3 (Day 1)|Other|0|||
160952702|NCT03701555|581213853|FG012|Part 3 (Day 1)|Other|0|||
160952703|NCT03701555|581213854|FG013|Part 3 (Day 1)|Other|0|||
160952704|NCT03701555|581213855|FG014|Part 3 (Day 1)|Other|0|||
160952705|NCT03701555|581213856|FG015|Part 3 (Day 1)|Other|0|||
160952706|NCT03701555|581213857|FG016|Part 3 (Day 1)|Other|0|||
160952707|NCT03701555|581213858|FG017|Part 3 (Day 1)|Other|0|||
160952708|NCT03701555|581213859|FG018|Part 3 (Day 1)|Other|0|||
160952709|NCT03701555|581213860|FG019|Part 3 (Day 1)|Other|0|||
160952710|NCT03701555|581213861|FG020|Part 3 (Day 1)|Other|0|||
160952711|NCT03701555|581213862|FG021|Part 3 (Day 1)|Other|0|||
160952712|NCT03701555|581213863|FG022|Part 3 (Day 1)|Other|0|||
160952713|NCT03701555|581213864|FG023|Part 3 (Day 1)|Other|0|||
160952714|NCT03701555|581213865|FG024|Part 3 (Day 1)|Other|1|||
160952715|NCT03701555|581213866|FG025|Part 3 (Day 1)|Other|1|||
160952716|NCT03701555|581213867|FG026|Part 3 (Day 1)|Other|0|||
160952717|NCT03701555|581213868|FG027|Part 3 (Day 1)|Other|0|||
160952718|NCT03701555|581213869|FG028|Part 3 (Day 1)|Other|0|||
160952719|NCT03701555|581213870|FG029|Part 3 (Day 1)|Other|1|||
160952720|NCT03701555|581213871|FG030|Part 3 (Day 1)|Other|1|||
160952721|NCT03701555|581213872|FG031|Part 3 (Day 1)|Other|0|||
160952722|NCT03701555|581213873|FG032|Part 3 (Day 1)|Other|1|||
160952723|NCT03701555|581213874|FG033|Part 3 (Day 1)|Other|1|||
160952724|NCT03701555|581213875|FG034|Part 3 (Day 1)|Other|0|||
160952725|NCT03701555|581213876|FG035|Part 3 (Day 1)|Other|0|||
160952726|NCT04757649|581213877|FG000|Overall Study|Withdrawal by Subject|1|||
160952727|NCT04757649|581213877|FG000|Overall Study|Adverse Event|1|||
160952728|NCT02508311|581213885|FG000|Overall Study|Withdrawal by Subject|1|||
160952729|NCT02508311|581213886|FG001|Overall Study|Withdrawal by Subject|0|||
160952730|NCT04862143|581213887|FG000|Overall Study|Adverse Event|1|||
160952731|NCT04862143|581213887|FG000|Overall Study|Study terminated by sponsor|1|||
160952732|NCT04955639|581213888|FG000|Overall Study|Withdrawal by Subject|2|||
160952733|NCT04955639|581213889|FG001|Overall Study|Withdrawal by Subject|2|||
160952734|NCT04955639|581213888|FG000|Overall Study|Week 26 survey not completed|2|||
160952735|NCT04955639|581213889|FG001|Overall Study|Week 26 survey not completed|2|||
160952736|NCT00413153|581213890|FG000|Overall Study|Withdrawal by Subject|1|||
160952737|NCT00413153|581213891|FG001|Overall Study|Withdrawal by Subject|1|||
160952738|NCT00413153|581213890|FG000|Overall Study|Adverse Event|1|||
160952739|NCT00413153|581213891|FG001|Overall Study|Adverse Event|0|||
160952740|NCT03204279|581213892|FG000|Overall Study|Withdrawal by Subject|0|||
160952741|NCT03204279|581213893|FG001|Overall Study|Withdrawal by Subject|1|||
160952742|NCT02862106|581213898|FG000|Overall Study|Adverse Event|4|||
160952743|NCT02862106|581213899|FG001|Overall Study|Adverse Event|0|||
160952744|NCT02862106|581213898|FG000|Overall Study|Protocol Violation|16|||
160952745|NCT02862106|581213899|FG001|Overall Study|Protocol Violation|1|||
160952746|NCT02862106|581213898|FG000|Overall Study|Lost to Follow-up|15|||
160952747|NCT02862106|581213899|FG001|Overall Study|Lost to Follow-up|5|||
160952748|NCT02862106|581213898|FG000|Overall Study|Withdrawal by Subject|2|||
160952749|NCT02862106|581213899|FG001|Overall Study|Withdrawal by Subject|0|||
160952750|NCT02862106|581213898|FG000|Overall Study|Subjects moved to other city|1|||
160952751|NCT02862106|581213899|FG001|Overall Study|Subjects moved to other city|0|||
160952752|NCT01040130|581213900|FG000|Overall Study|Adverse Event|1|||
160952753|NCT01040130|581213901|FG001|Overall Study|Adverse Event|1|||
160952754|NCT01040130|581213902|FG002|Overall Study|Adverse Event|0|||
160952755|NCT01040130|581213903|FG003|Overall Study|Adverse Event|5|||
160952756|NCT01040130|581213904|FG004|Overall Study|Adverse Event|0|||
160952757|NCT01040130|581213905|FG005|Overall Study|Adverse Event|3|||
160952758|NCT01040130|581213900|FG000|Overall Study|Protocol Violation|0|||
160952759|NCT01040130|581213901|FG001|Overall Study|Protocol Violation|0|||
160952760|NCT01040130|581213902|FG002|Overall Study|Protocol Violation|2|||
160952761|NCT01040130|581213903|FG003|Overall Study|Protocol Violation|0|||
160952762|NCT01040130|581213904|FG004|Overall Study|Protocol Violation|0|||
160952763|NCT01040130|581213905|FG005|Overall Study|Protocol Violation|0|||
160952764|NCT01040130|581213900|FG000|Overall Study|Withdrawal by Subject|0|||
160952765|NCT01040130|581213901|FG001|Overall Study|Withdrawal by Subject|2|||
160952766|NCT01040130|581213902|FG002|Overall Study|Withdrawal by Subject|0|||
160952767|NCT01040130|581213903|FG003|Overall Study|Withdrawal by Subject|0|||
160952768|NCT01040130|581213904|FG004|Overall Study|Withdrawal by Subject|0|||
160952769|NCT01040130|581213905|FG005|Overall Study|Withdrawal by Subject|1|||
160952770|NCT01040130|581213900|FG000|Overall Study|Other reasons not listed above|2|||
160952771|NCT01040130|581213901|FG001|Overall Study|Other reasons not listed above|0|||
161342882|NCT02966834|582642272|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
160952772|NCT01040130|581213902|FG002|Overall Study|Other reasons not listed above|0|||
160952773|NCT01040130|581213903|FG003|Overall Study|Other reasons not listed above|0|||
160952774|NCT01040130|581213904|FG004|Overall Study|Other reasons not listed above|0|||
160952775|NCT01040130|581213905|FG005|Overall Study|Other reasons not listed above|0|||
160952776|NCT00833989|581213911|FG000|Overall Study|Physician Decision|0|||
160952777|NCT00833989|581213912|FG001|Overall Study|Physician Decision|0|||
160952778|NCT00833989|581213913|FG002|Overall Study|Physician Decision|0|||
160952779|NCT00833989|581213914|FG003|Overall Study|Physician Decision|1|||
160952780|NCT00833989|581213911|FG000|Overall Study|Withdrawal by Subject|3|||
160952781|NCT00833989|581213912|FG001|Overall Study|Withdrawal by Subject|0|||
160952782|NCT00833989|581213913|FG002|Overall Study|Withdrawal by Subject|1|||
160952783|NCT00833989|581213914|FG003|Overall Study|Withdrawal by Subject|1|||
160952784|NCT02310750|581213917|FG000|HP Period 1|Lost to Follow-up|0|||
160952785|NCT02310750|581213918|FG001|HP Period 1|Lost to Follow-up|0|||
160952786|NCT02310750|581213919|FG002|HP Period 1|Lost to Follow-up|0|||
160952787|NCT02310750|581213920|FG003|HP Period 1|Lost to Follow-up|0|||
160952788|NCT02310750|581213921|FG004|HP Period 1|Lost to Follow-up|0|||
160952789|NCT02310750|581213922|FG005|HP Period 1|Lost to Follow-up|0|||
160952790|NCT02310750|581213923|FG006|HP Period 1|Lost to Follow-up|1|||
160952791|NCT02310750|581213924|FG007|HP Period 1|Lost to Follow-up|0|||
160952792|NCT02310750|581213925|FG008|HP Period 1|Lost to Follow-up|0|||
160952793|NCT02310750|581213926|FG009|HP Period 1|Lost to Follow-up|0|||
160952794|NCT02310750|581213927|FG010|HP Period 1|Lost to Follow-up|0|||
160952795|NCT02310750|581213928|FG011|HP Period 1|Lost to Follow-up|0|||
160952796|NCT02310750|581213929|FG012|HP Period 1|Lost to Follow-up|0|||
160952797|NCT02310750|581213930|FG013|HP Period 1|Lost to Follow-up|0|||
160952798|NCT02310750|581213931|FG014|HP Period 1|Lost to Follow-up|0|||
160952799|NCT02310750|581213932|FG015|HP Period 1|Lost to Follow-up|0|||
160952800|NCT02310750|581213917|FG000|HP Period 1|Withdrawal by Subject|1|||
160952801|NCT02310750|581213918|FG001|HP Period 1|Withdrawal by Subject|0|||
160952802|NCT02310750|581213919|FG002|HP Period 1|Withdrawal by Subject|0|||
160952803|NCT02310750|581213920|FG003|HP Period 1|Withdrawal by Subject|1|||
160952804|NCT02310750|581213921|FG004|HP Period 1|Withdrawal by Subject|0|||
160952805|NCT02310750|581213922|FG005|HP Period 1|Withdrawal by Subject|0|||
160952806|NCT02310750|581213923|FG006|HP Period 1|Withdrawal by Subject|0|||
160952807|NCT02310750|581213924|FG007|HP Period 1|Withdrawal by Subject|0|||
160952808|NCT02310750|581213925|FG008|HP Period 1|Withdrawal by Subject|0|||
160952809|NCT02310750|581213926|FG009|HP Period 1|Withdrawal by Subject|0|||
160952810|NCT02310750|581213927|FG010|HP Period 1|Withdrawal by Subject|0|||
160952811|NCT02310750|581213928|FG011|HP Period 1|Withdrawal by Subject|0|||
160952812|NCT02310750|581213929|FG012|HP Period 1|Withdrawal by Subject|0|||
160952813|NCT02310750|581213930|FG013|HP Period 1|Withdrawal by Subject|0|||
160952814|NCT02310750|581213931|FG014|HP Period 1|Withdrawal by Subject|0|||
160952815|NCT02310750|581213932|FG015|HP Period 1|Withdrawal by Subject|0|||
160952816|NCT02310750|581213917|FG000|HP Washout 1|Lost to Follow-up|0|||
160952817|NCT02310750|581213918|FG001|HP Washout 1|Lost to Follow-up|0|||
160952818|NCT02310750|581213919|FG002|HP Washout 1|Lost to Follow-up|1|||
160952819|NCT02310750|581213920|FG003|HP Washout 1|Lost to Follow-up|1|||
160952820|NCT02310750|581213921|FG004|HP Washout 1|Lost to Follow-up|2|||
160952821|NCT02310750|581213922|FG005|HP Washout 1|Lost to Follow-up|2|||
160952822|NCT02310750|581213923|FG006|HP Washout 1|Lost to Follow-up|3|||
160952823|NCT02310750|581213924|FG007|HP Washout 1|Lost to Follow-up|0|||
160952824|NCT02310750|581213925|FG008|HP Washout 1|Lost to Follow-up|0|||
160952825|NCT02310750|581213926|FG009|HP Washout 1|Lost to Follow-up|0|||
160952826|NCT02310750|581213927|FG010|HP Washout 1|Lost to Follow-up|0|||
160952827|NCT02310750|581213928|FG011|HP Washout 1|Lost to Follow-up|0|||
160952828|NCT02310750|581213929|FG012|HP Washout 1|Lost to Follow-up|0|||
160952829|NCT02310750|581213930|FG013|HP Washout 1|Lost to Follow-up|0|||
160952830|NCT02310750|581213931|FG014|HP Washout 1|Lost to Follow-up|0|||
160952831|NCT02310750|581213932|FG015|HP Washout 1|Lost to Follow-up|0|||
160952832|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952833|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952834|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952835|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
160952836|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952837|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
160952838|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952839|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952840|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
160952841|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
160952842|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952843|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952844|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952845|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952846|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952847|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
160952848|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952849|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952850|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952851|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952852|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952853|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952854|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952855|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952856|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952857|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
160952858|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952859|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952860|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952861|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952862|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952863|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
160952864|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952865|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952866|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952867|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952868|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952869|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952870|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952871|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
160952872|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
160952873|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
160952874|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952875|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952876|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952877|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952878|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952879|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
160952880|NCT02310750|581213917|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952881|NCT02310750|581213918|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952882|NCT02310750|581213919|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952883|NCT02310750|581213920|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952884|NCT02310750|581213921|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952885|NCT02310750|581213922|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952886|NCT02310750|581213923|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952887|NCT02310750|581213924|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
160952888|NCT02310750|581213925|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
160952889|NCT02310750|581213926|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952890|NCT02310750|581213927|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952891|NCT02310750|581213928|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952892|NCT02310750|581213929|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952893|NCT02310750|581213930|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952894|NCT02310750|581213931|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952895|NCT02310750|581213932|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
160952896|NCT02310750|581213917|FG000|HP Washout 2|Lost to Follow-up|0|||
160952897|NCT02310750|581213918|FG001|HP Washout 2|Lost to Follow-up|0|||
160952898|NCT02310750|581213919|FG002|HP Washout 2|Lost to Follow-up|0|||
160952899|NCT02310750|581213920|FG003|HP Washout 2|Lost to Follow-up|0|||
160952900|NCT02310750|581213921|FG004|HP Washout 2|Lost to Follow-up|1|||
160952901|NCT02310750|581213922|FG005|HP Washout 2|Lost to Follow-up|0|||
160952902|NCT02310750|581213923|FG006|HP Washout 2|Lost to Follow-up|7|||
160952903|NCT02310750|581213924|FG007|HP Washout 2|Lost to Follow-up|0|||
160952904|NCT02310750|581213925|FG008|HP Washout 2|Lost to Follow-up|0|||
160952905|NCT02310750|581213926|FG009|HP Washout 2|Lost to Follow-up|0|||
160952906|NCT02310750|581213927|FG010|HP Washout 2|Lost to Follow-up|0|||
160952907|NCT02310750|581213928|FG011|HP Washout 2|Lost to Follow-up|0|||
160952908|NCT02310750|581213929|FG012|HP Washout 2|Lost to Follow-up|0|||
160952909|NCT02310750|581213930|FG013|HP Washout 2|Lost to Follow-up|0|||
160952910|NCT02310750|581213931|FG014|HP Washout 2|Lost to Follow-up|0|||
160952911|NCT02310750|581213932|FG015|HP Washout 2|Lost to Follow-up|0|||
160952912|NCT03585244|581213933|FG000|Overall Study|Withdrawal by Subject|15|||
160952913|NCT02199028|581213938|FG000|Week 1|Adverse Event|1|||
161000891|NCT00831415|581388924|FG000|Overall Study|Death|1|||
161000892|NCT00486330|581388925|FG000|Overall Study|Adverse Event|2|||
161000893|NCT01290224|581388926|FG000|Overall Study|Adverse Event|1|||
161000894|NCT01290224|581388926|FG000|Overall Study|Refused Further Treatment|4|||
161000895|NCT01027286|581388927|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
161000896|NCT01027286|581388928|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
161146129|NCT01089725|581917096|FG001|Overall Study|Lost to Follow-up|2|||
161268606|NCT00658658|582366801|FG000|Overall Study|Protocol-specified Criteria|1|||
161268607|NCT00658658|582366802|FG001|Overall Study|Protocol-specified Criteria|0|||
161268608|NCT00658658|582366803|FG002|Overall Study|Protocol-specified Criteria|0|||
161268609|NCT00658658|582366804|FG003|Overall Study|Protocol-specified Criteria|0|||
161268610|NCT00658658|582366805|FG004|Overall Study|Protocol-specified Criteria|0|||
160952914|NCT02199028|581213939|FG001|Week 1|Adverse Event|0|||
160952915|NCT02199028|581213938|FG000|Week 3|Adverse Event|1|||
160952916|NCT02199028|581213939|FG001|Week 3|Adverse Event|0|||
160952917|NCT01881126|581213940|FG000|Overall Study|Non-compliance|1|||
160952918|NCT01881126|581213941|FG001|Overall Study|Non-compliance|1|||
160952919|NCT01881126|581213940|FG000|Overall Study|Adverse Event|0|||
160952920|NCT01881126|581213941|FG001|Overall Study|Adverse Event|1|||
160952921|NCT05045625|581213944|FG000|Overall Study|Lost to Follow-up|3|||
160952922|NCT03867734|581213945|FG000|Overall Study|Lost to Follow-up|2|||
161000897|NCT01027286|581388927|FG000|Overall Study|Lost to Follow-up|0|||
161268611|NCT00658658|582366801|FG000|Overall Study|Other|0|||
161268612|NCT00658658|582366802|FG001|Overall Study|Other|0|||
160952923|NCT01827904|581213946|FG000|Main Study|Withdrawal by Subject|1|||
160952924|NCT01827904|581213947|FG001|Main Study|Withdrawal by Subject|0|||
160952925|NCT01827904|581213948|FG002|Main Study|Withdrawal by Subject|0|||
160952926|NCT01827904|581213946|FG000|Main Study|Adverse Event|1|||
160952927|NCT01827904|581213947|FG001|Main Study|Adverse Event|0|||
160952928|NCT01827904|581213948|FG002|Main Study|Adverse Event|0|||
160952929|NCT01827904|581213946|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
160952930|NCT01827904|581213947|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
160952931|NCT01827904|581213948|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
160952932|NCT01827904|581213946|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
160952933|NCT01827904|581213947|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
160952934|NCT01827904|581213948|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
160952935|NCT01827904|581213946|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
160952936|NCT01827904|581213947|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
160952937|NCT01827904|581213948|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
160952938|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
160952939|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
160952940|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
160952941|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
160952942|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
160952943|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
160952944|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
160952945|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
160952946|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
160952947|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
160952948|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
160952949|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
160952950|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Physician Decision|1|||
160952951|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Physician Decision|0|||
160952952|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Physician Decision|0|||
160952953|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
160952954|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
160952955|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
160952956|NCT01827904|581213946|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
160952957|NCT01827904|581213947|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
160952958|NCT01827904|581213948|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
160952959|NCT01910519|581213949|FG000|Overall Study|Withdrawal by Subject|2|||
160952960|NCT01910519|581213950|FG001|Overall Study|Withdrawal by Subject|0|||
160952961|NCT01910519|581213949|FG000|Overall Study|Adverse Event|2|||
160952962|NCT01910519|581213950|FG001|Overall Study|Adverse Event|0|||
160952963|NCT04266028|581213951|FG000|Overall Study|Adverse Event|0|||
160952964|NCT04266028|581213952|FG001|Overall Study|Adverse Event|0|||
160952965|NCT04266028|581213953|FG002|Overall Study|Adverse Event|1|||
160952966|NCT04266028|581213954|FG003|Overall Study|Adverse Event|0|||
160952967|NCT04266028|581213955|FG004|Overall Study|Adverse Event|1|||
160952968|NCT04266028|581213956|FG005|Overall Study|Adverse Event|0|||
160952969|NCT04266028|581213957|FG006|Overall Study|Adverse Event|2|||
160952970|NCT04266028|581213958|FG007|Overall Study|Adverse Event|0|||
160952971|NCT04266028|581213951|FG000|Overall Study|temporary halt of the study|0|||
160952972|NCT04266028|581213952|FG001|Overall Study|temporary halt of the study|0|||
160952973|NCT04266028|581213953|FG002|Overall Study|temporary halt of the study|0|||
160952974|NCT04266028|581213954|FG003|Overall Study|temporary halt of the study|0|||
160952975|NCT04266028|581213955|FG004|Overall Study|temporary halt of the study|0|||
160952976|NCT04266028|581213956|FG005|Overall Study|temporary halt of the study|0|||
160952977|NCT04266028|581213957|FG006|Overall Study|temporary halt of the study|2|||
160952978|NCT04266028|581213958|FG007|Overall Study|temporary halt of the study|1|||
160952979|NCT04266028|581213951|FG000|Overall Study|Onset of birch pollen season|0|||
160952980|NCT04266028|581213952|FG001|Overall Study|Onset of birch pollen season|0|||
160952981|NCT04266028|581213953|FG002|Overall Study|Onset of birch pollen season|0|||
160952982|NCT04266028|581213954|FG003|Overall Study|Onset of birch pollen season|0|||
160952983|NCT04266028|581213955|FG004|Overall Study|Onset of birch pollen season|1|||
160952984|NCT04266028|581213956|FG005|Overall Study|Onset of birch pollen season|0|||
160952985|NCT04266028|581213957|FG006|Overall Study|Onset of birch pollen season|0|||
160952986|NCT04266028|581213958|FG007|Overall Study|Onset of birch pollen season|0|||
160952987|NCT01458574|581213959|FG000|Overall Study|Adverse Event|5|||
160952988|NCT01458574|581213960|FG001|Overall Study|Adverse Event|9|||
160952989|NCT01458574|581213961|FG002|Overall Study|Adverse Event|7|||
161268613|NCT00658658|582366803|FG002|Overall Study|Other|0|||
160952990|NCT01458574|581213959|FG000|Overall Study|Lack of Efficacy|70|||
160952991|NCT01458574|581213960|FG001|Overall Study|Lack of Efficacy|53|||
160952992|NCT01458574|581213961|FG002|Overall Study|Lack of Efficacy|132|||
161268614|NCT00658658|582366804|FG003|Overall Study|Other|0|||
160952993|NCT01458574|581213959|FG000|Overall Study|Lost to Follow-up|3|||
160952994|NCT01458574|581213960|FG001|Overall Study|Lost to Follow-up|2|||
160952995|NCT01458574|581213961|FG002|Overall Study|Lost to Follow-up|1|||
160952996|NCT01458574|581213959|FG000|Overall Study|Pregnancy|1|||
160952997|NCT01458574|581213960|FG001|Overall Study|Pregnancy|1|||
160952998|NCT01458574|581213961|FG002|Overall Study|Pregnancy|0|||
160952999|NCT01458574|581213959|FG000|Overall Study|Protocol Violation|0|||
160953000|NCT01458574|581213960|FG001|Overall Study|Protocol Violation|1|||
160953001|NCT01458574|581213961|FG002|Overall Study|Protocol Violation|0|||
160953002|NCT01458574|581213959|FG000|Overall Study|Withdrawal by Subject|6|||
160953003|NCT01458574|581213960|FG001|Overall Study|Withdrawal by Subject|3|||
160953004|NCT01458574|581213961|FG002|Overall Study|Withdrawal by Subject|5|||
160953005|NCT01458574|581213959|FG000|Overall Study|Other|2|||
160953006|NCT01458574|581213960|FG001|Overall Study|Other|1|||
160953007|NCT01458574|581213961|FG002|Overall Study|Other|0|||
160953008|NCT01458574|581213959|FG000|Overall Study|Randomized but not treated|0|||
160953009|NCT01458574|581213960|FG001|Overall Study|Randomized but not treated|1|||
160953010|NCT01458574|581213961|FG002|Overall Study|Randomized but not treated|0|||
160953011|NCT02125786|581213962|FG000|Overall Study|Still in Follow-up|3|||
160953012|NCT02125786|581213962|FG000|Overall Study|Screen Failure|2|||
160953013|NCT02125786|581213962|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
160953014|NCT02125786|581213962|FG000|Overall Study|Progressive Disease|44|||
160953015|NCT02125786|581213962|FG000|Overall Study|Death|8|||
160953016|NCT01365494|581213963|FG000|Overall Study|Adverse Event|1|||
160953017|NCT01365494|581213964|FG001|Overall Study|Adverse Event|0|||
160953018|NCT01365494|581213963|FG000|Overall Study|Withdrawal by Subject|0|||
160953019|NCT01365494|581213964|FG001|Overall Study|Withdrawal by Subject|1|||
160953020|NCT01365494|581213963|FG000|Overall Study|Lost to Follow-up|1|||
160953021|NCT01365494|581213964|FG001|Overall Study|Lost to Follow-up|2|||
160953022|NCT00718718|581213965|FG000|Prior to Week 12|Adverse Event|0|||
160953023|NCT00718718|581213966|FG001|Prior to Week 12|Adverse Event|0|||
160953024|NCT00718718|581213967|FG002|Prior to Week 12|Adverse Event|0|||
160953025|NCT00718718|581213968|FG003|Prior to Week 12|Adverse Event|0|||
160953026|NCT00718718|581213969|FG004|Prior to Week 12|Adverse Event|0|||
160953027|NCT00718718|581213970|FG005|Prior to Week 12|Adverse Event|0|||
160953028|NCT00718718|581213971|FG006|Prior to Week 12|Adverse Event|0|||
160953029|NCT00718718|581213972|FG007|Prior to Week 12|Adverse Event|1|||
160953030|NCT00718718|581213973|FG008|Prior to Week 12|Adverse Event|1|||
160953031|NCT00718718|581213974|FG009|Prior to Week 12|Adverse Event|0|||
160953032|NCT00718718|581213965|FG000|Prior to Week 12|Withdrawal by Subject|0|||
160953033|NCT00718718|581213966|FG001|Prior to Week 12|Withdrawal by Subject|0|||
160953034|NCT00718718|581213967|FG002|Prior to Week 12|Withdrawal by Subject|0|||
160953035|NCT00718718|581213968|FG003|Prior to Week 12|Withdrawal by Subject|0|||
160953036|NCT00718718|581213969|FG004|Prior to Week 12|Withdrawal by Subject|3|||
160953037|NCT00718718|581213970|FG005|Prior to Week 12|Withdrawal by Subject|0|||
160953038|NCT00718718|581213971|FG006|Prior to Week 12|Withdrawal by Subject|1|||
160953039|NCT00718718|581213972|FG007|Prior to Week 12|Withdrawal by Subject|1|||
161342883|NCT02966834|582642273|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160953040|NCT00718718|581213973|FG008|Prior to Week 12|Withdrawal by Subject|1|||
160953041|NCT00718718|581213974|FG009|Prior to Week 12|Withdrawal by Subject|0|||
160953042|NCT00718718|581213965|FG000|Prior to Week 12|Other|1|||
160953043|NCT00718718|581213966|FG001|Prior to Week 12|Other|0|||
160953044|NCT00718718|581213967|FG002|Prior to Week 12|Other|1|||
160953045|NCT00718718|581213968|FG003|Prior to Week 12|Other|0|||
160953046|NCT00718718|581213969|FG004|Prior to Week 12|Other|0|||
160953047|NCT00718718|581213970|FG005|Prior to Week 12|Other|0|||
160953048|NCT00718718|581213971|FG006|Prior to Week 12|Other|0|||
160953049|NCT00718718|581213972|FG007|Prior to Week 12|Other|0|||
160953050|NCT00718718|581213973|FG008|Prior to Week 12|Other|0|||
160953051|NCT00718718|581213974|FG009|Prior to Week 12|Other|0|||
160953052|NCT00718718|581213965|FG000|Week 12 to End of Study|Adverse Event|0|||
160953053|NCT00718718|581213966|FG001|Week 12 to End of Study|Adverse Event|0|||
160953054|NCT00718718|581213967|FG002|Week 12 to End of Study|Adverse Event|0|||
160953055|NCT00718718|581213968|FG003|Week 12 to End of Study|Adverse Event|0|||
160953056|NCT00718718|581213969|FG004|Week 12 to End of Study|Adverse Event|0|||
160953057|NCT00718718|581213970|FG005|Week 12 to End of Study|Adverse Event|0|||
160953058|NCT00718718|581213971|FG006|Week 12 to End of Study|Adverse Event|0|||
160953059|NCT00718718|581213972|FG007|Week 12 to End of Study|Adverse Event|1|||
161342884|NCT02966834|582642274|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
160953060|NCT00718718|581213973|FG008|Week 12 to End of Study|Adverse Event|0|||
160953061|NCT00718718|581213974|FG009|Week 12 to End of Study|Adverse Event|0|||
160953062|NCT00718718|581213965|FG000|Week 12 to End of Study|Death|0|||
160953063|NCT00718718|581213966|FG001|Week 12 to End of Study|Death|0|||
160953064|NCT00718718|581213967|FG002|Week 12 to End of Study|Death|0|||
160953065|NCT00718718|581213968|FG003|Week 12 to End of Study|Death|0|||
160953066|NCT00718718|581213969|FG004|Week 12 to End of Study|Death|0|||
160953067|NCT00718718|581213970|FG005|Week 12 to End of Study|Death|1|||
160953068|NCT00718718|581213971|FG006|Week 12 to End of Study|Death|0|||
160953069|NCT00718718|581213972|FG007|Week 12 to End of Study|Death|0|||
160953070|NCT00718718|581213973|FG008|Week 12 to End of Study|Death|0|||
160953071|NCT00718718|581213974|FG009|Week 12 to End of Study|Death|0|||
160953072|NCT00718718|581213965|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
160953073|NCT00718718|581213966|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
160953074|NCT00718718|581213967|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
160953075|NCT00718718|581213968|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
160953076|NCT00718718|581213969|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
160953077|NCT00718718|581213970|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
160953078|NCT00718718|581213971|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
160953079|NCT00718718|581213972|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
160953080|NCT00718718|581213973|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
160953081|NCT00718718|581213974|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
160953082|NCT00718718|581213965|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
160953083|NCT00718718|581213966|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
160953084|NCT00718718|581213967|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
160953085|NCT00718718|581213968|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
160953086|NCT00718718|581213969|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
160953087|NCT00718718|581213970|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
160953088|NCT00718718|581213971|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
160953089|NCT00718718|581213972|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
160953090|NCT00718718|581213973|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
160953091|NCT00718718|581213974|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
160953092|NCT00718718|581213965|FG000|Week 12 to End of Study|Other|0|||
160953093|NCT00718718|581213966|FG001|Week 12 to End of Study|Other|1|||
160953094|NCT00718718|581213967|FG002|Week 12 to End of Study|Other|0|||
160953095|NCT00718718|581213968|FG003|Week 12 to End of Study|Other|1|||
160953096|NCT00718718|581213969|FG004|Week 12 to End of Study|Other|0|||
160953097|NCT00718718|581213970|FG005|Week 12 to End of Study|Other|0|||
160953098|NCT00718718|581213971|FG006|Week 12 to End of Study|Other|1|||
160953099|NCT00718718|581213972|FG007|Week 12 to End of Study|Other|0|||
160953100|NCT00718718|581213973|FG008|Week 12 to End of Study|Other|0|||
160953101|NCT00718718|581213974|FG009|Week 12 to End of Study|Other|0|||
160953102|NCT02663128|581213975|FG000|Period 2|Physician Decision|0|||
160953103|NCT02663128|581213976|FG001|Period 2|Physician Decision|0|||
160953104|NCT02663128|581213977|FG002|Period 2|Physician Decision|0|||
160953105|NCT02663128|581213978|FG003|Period 2|Physician Decision|0|||
160953106|NCT02663128|581213979|FG004|Period 2|Physician Decision|1|||
160953107|NCT02663128|581213980|FG005|Period 2|Physician Decision|0|||
160953108|NCT02720484|581213984|FG000|Treatment on Study|Adverse Event|1|||
160953109|NCT02720484|581213984|FG000|Treatment on Study|Withdrawal by Subject|1|||
160953110|NCT02720484|581213984|FG000|Treatment on Study|Progressive Disease|4|||
160953111|NCT02720484|581213984|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
160953112|NCT02720484|581213984|FG000|Follow Up for 2 Years|Death|3|||
160953113|NCT02720484|581213984|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
160953114|NCT05070897|581213985|FG000|Overall Study|Protocol Violation|123|||
160953115|NCT05070897|581213986|FG001|Overall Study|Protocol Violation|68|||
160953116|NCT01617629|581213989|FG000|Overall Study|Death|2|||
160953117|NCT01617629|581213989|FG000|Overall Study|Investigator's Clinical Judgement|1|||
160953118|NCT01617629|581213989|FG000|Overall Study|Reason Not Specified|1|||
160953119|NCT01617629|581213989|FG000|Overall Study|Participant Withdrew Consent|2|||
160953120|NCT01663636|581213990|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
160953121|NCT01663636|581213991|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
160953122|NCT03832946|581213992|FG000|Overall Study|Adverse Event|3|||
160953123|NCT03832946|581213993|FG001|Overall Study|Adverse Event|1|||
160953124|NCT03832946|581213992|FG000|Overall Study|Lost to Follow-up|1|||
160953125|NCT03832946|581213993|FG001|Overall Study|Lost to Follow-up|0|||
160953126|NCT03832946|581213992|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
160953127|NCT03832946|581213993|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
160953128|NCT03832946|581213992|FG000|Overall Study|Lack of Efficacy|1|||
160953129|NCT03832946|581213993|FG001|Overall Study|Lack of Efficacy|0|||
160953130|NCT03832946|581213992|FG000|Overall Study|Withdrawal by Subject|12|||
160953131|NCT03832946|581213993|FG001|Overall Study|Withdrawal by Subject|9|||
160953132|NCT03394924|581213996|FG000|Overall Study|Adverse Event|0|||
161342885|NCT00655889|582642287|FG000|Overall Study|Inadequate cell growth|1|||
161342886|NCT00655889|582642287|FG000|Overall Study|Protocol Violation|1|||
160953133|NCT03394924|581213997|FG001|Overall Study|Adverse Event|5|||
160953134|NCT03394924|581213998|FG002|Overall Study|Adverse Event|0|||
160953135|NCT03394924|581213996|FG000|Overall Study|Withdrawal by Subject|2|||
160953136|NCT03394924|581213997|FG001|Overall Study|Withdrawal by Subject|0|||
160953137|NCT03394924|581213998|FG002|Overall Study|Withdrawal by Subject|0|||
160953138|NCT03394924|581213996|FG000|Overall Study|Lost to Follow-up|0|||
160953139|NCT03394924|581213997|FG001|Overall Study|Lost to Follow-up|1|||
160953140|NCT03394924|581213998|FG002|Overall Study|Lost to Follow-up|0|||
160953141|NCT03394924|581213996|FG000|Overall Study|Did not meet all inclusion criteria|1|||
160953142|NCT03394924|581213997|FG001|Overall Study|Did not meet all inclusion criteria|0|||
160953143|NCT03394924|581213998|FG002|Overall Study|Did not meet all inclusion criteria|0|||
161342887|NCT01925417|582642288|FG000|Overall Study|Withdrawal by Subject|2|||
160953144|NCT03277313|581214008|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
160953145|NCT03277313|581214009|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
160953146|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
160953147|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
160953148|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
160953149|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
160953150|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
160953151|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
160953152|NCT03277313|581214008|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
160953153|NCT03277313|581214009|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
160953154|NCT02005471|581214014|FG000|Main Study|Adverse Event|0|||
160953155|NCT02005471|581214015|FG001|Main Study|Adverse Event|1|||
160953156|NCT02005471|581214016|FG002|Main Study|Adverse Event|0|||
160953157|NCT02005471|581214017|FG003|Main Study|Adverse Event|0|||
160953158|NCT02005471|581214014|FG000|Main Study|Death|83|||
160953159|NCT02005471|581214015|FG001|Main Study|Death|52|||
160953160|NCT02005471|581214016|FG002|Main Study|Death|0|||
160953161|NCT02005471|581214017|FG003|Main Study|Death|0|||
160953162|NCT02005471|581214014|FG000|Main Study|Lost to Follow-up|4|||
160953163|NCT02005471|581214015|FG001|Main Study|Lost to Follow-up|5|||
160953164|NCT02005471|581214016|FG002|Main Study|Lost to Follow-up|0|||
160953165|NCT02005471|581214017|FG003|Main Study|Lost to Follow-up|0|||
160953166|NCT02005471|581214014|FG000|Main Study|Physician Decision|3|||
160953167|NCT02005471|581214015|FG001|Main Study|Physician Decision|1|||
160953168|NCT02005471|581214016|FG002|Main Study|Physician Decision|0|||
160953169|NCT02005471|581214017|FG003|Main Study|Physician Decision|0|||
160953170|NCT02005471|581214014|FG000|Main Study|Withdrawal by Subject|26|||
160953171|NCT02005471|581214015|FG001|Main Study|Withdrawal by Subject|11|||
160953172|NCT02005471|581214016|FG002|Main Study|Withdrawal by Subject|0|||
160953173|NCT02005471|581214017|FG003|Main Study|Withdrawal by Subject|0|||
160953174|NCT02005471|581214014|FG000|Main Study|Reason not Specified|0|||
160953175|NCT02005471|581214015|FG001|Main Study|Reason not Specified|6|||
160953176|NCT02005471|581214016|FG002|Main Study|Reason not Specified|0|||
160953177|NCT02005471|581214017|FG003|Main Study|Reason not Specified|0|||
160953178|NCT02005471|581214014|FG000|Main Study|Randomized but not Dosed|8|||
160953179|NCT02005471|581214015|FG001|Main Study|Randomized but not Dosed|0|||
160953180|NCT02005471|581214016|FG002|Main Study|Randomized but not Dosed|0|||
160953181|NCT02005471|581214017|FG003|Main Study|Randomized but not Dosed|0|||
160953182|NCT02005471|581214014|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
160953183|NCT02005471|581214015|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
160953184|NCT02005471|581214016|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
160953185|NCT02005471|581214017|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
160953186|NCT02005471|581214014|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
160953187|NCT02005471|581214015|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
160953188|NCT02005471|581214016|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
160953189|NCT02005471|581214017|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
160953190|NCT02005471|581214014|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
160953191|NCT02005471|581214015|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
160953192|NCT02005471|581214016|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
160953193|NCT02005471|581214017|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
160953194|NCT02663817|581214018|FG000|Overall Study|Screen failure|2|||
160953195|NCT03478891|581214019|FG000|Overall Study|Enrolled, but product never administered|0|||
160953196|NCT03478891|581214020|FG001|Overall Study|Enrolled, but product never administered|0|||
160953197|NCT03478891|581214021|FG002|Overall Study|Enrolled, but product never administered|1|||
160953198|NCT03478891|581214019|FG000|Overall Study|Moved from area|0|||
160953199|NCT03478891|581214020|FG001|Overall Study|Moved from area|0|||
160953200|NCT03478891|581214021|FG002|Overall Study|Moved from area|1|||
160953201|NCT03478891|581214019|FG000|Overall Study|Lost to Follow-up|1|||
160953202|NCT03478891|581214020|FG001|Overall Study|Lost to Follow-up|0|||
160953203|NCT03478891|581214021|FG002|Overall Study|Lost to Follow-up|1|||
160953204|NCT00932893|581214022|FG000|Overall Study|Death|115|||
160953205|NCT00932893|581214023|FG001|Overall Study|Death|24|||
160953206|NCT00932893|581214022|FG000|Overall Study|Lost to Follow-up|8|||
160953207|NCT00932893|581214023|FG001|Overall Study|Lost to Follow-up|0|||
160953208|NCT00932893|581214022|FG000|Overall Study|Withdrawal by Subject|5|||
160953209|NCT00932893|581214023|FG001|Overall Study|Withdrawal by Subject|2|||
161268615|NCT00658658|582366805|FG004|Overall Study|Other|1|||
161268616|NCT01167257|582366806|FG000|Overall Study|Lost to Follow-up|2|||
161268617|NCT01167257|582366807|FG001|Overall Study|Lost to Follow-up|2|||
161268618|NCT01167257|582366806|FG000|Overall Study|Withdrew consent|1|||
161000898|NCT01027286|581388928|FG001|Overall Study|Lost to Follow-up|1|||
161000899|NCT03804918|581388929|FG000|Overall Study|Participant did not use the app|1|||
161000900|NCT05694065|581388930|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
161000901|NCT05694065|581388930|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
161268619|NCT01167257|582366807|FG001|Overall Study|Withdrew consent|1|||
160953210|NCT00932893|581214022|FG000|Overall Study|Other|5|||
160953211|NCT00932893|581214023|FG001|Overall Study|Other|144|||
160953212|NCT05350449|581214028|FG000|Overall Study|Withdrawal by Subject|4|||
160953213|NCT05350449|581214029|FG001|Overall Study|Withdrawal by Subject|8|||
160953214|NCT01912612|581215966|FG000|Overall Study|Adverse Event|4|||
160953215|NCT01912612|581215967|FG001|Overall Study|Adverse Event|0|||
160953216|NCT01912612|581215968|FG002|Overall Study|Adverse Event|0|||
160953217|NCT01912612|581215966|FG000|Overall Study|Withdrew consent|1|||
160953218|NCT01912612|581215967|FG001|Overall Study|Withdrew consent|0|||
160953219|NCT01912612|581215968|FG002|Overall Study|Withdrew consent|0|||
160953220|NCT01912612|581215966|FG000|Overall Study|Study design change|0|||
160953221|NCT01912612|581215967|FG001|Overall Study|Study design change|0|||
160953222|NCT01912612|581215968|FG002|Overall Study|Study design change|3|||
160953223|NCT01588184|581215969|FG000|Overall Study|Death|1|||
160953224|NCT01588184|581215970|FG001|Overall Study|Death|0|||
160953225|NCT01588184|581215971|FG002|Overall Study|Death|0|||
160953226|NCT01588184|581215972|FG003|Overall Study|Death|1|||
160953227|NCT01588184|581215973|FG004|Overall Study|Death|1|||
160953228|NCT01588184|581215974|FG005|Overall Study|Death|1|||
160953229|NCT01588184|581215969|FG000|Overall Study|Withdrawal by Subject|2|||
160953230|NCT01588184|581215970|FG001|Overall Study|Withdrawal by Subject|4|||
160953231|NCT01588184|581215971|FG002|Overall Study|Withdrawal by Subject|0|||
160953232|NCT01588184|581215972|FG003|Overall Study|Withdrawal by Subject|1|||
160953233|NCT01588184|581215973|FG004|Overall Study|Withdrawal by Subject|0|||
160953234|NCT01588184|581215974|FG005|Overall Study|Withdrawal by Subject|0|||
160953235|NCT01588184|581215969|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
160953236|NCT01588184|581215970|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
160953237|NCT01588184|581215971|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
160953238|NCT01588184|581215972|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
160953239|NCT01588184|581215973|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
160953240|NCT01588184|581215974|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
161146130|NCT01089725|581917097|FG002|Overall Study|Lost to Follow-up|0|||
161146131|NCT01089725|581917098|FG003|Overall Study|Lost to Follow-up|3|||
161146132|NCT01089725|581917099|FG004|Overall Study|Lost to Follow-up|0|||
160953241|NCT01588184|581215969|FG000|Overall Study|multiple reasons|0|||
160953242|NCT01588184|581215970|FG001|Overall Study|multiple reasons|3|||
160953243|NCT01588184|581215971|FG002|Overall Study|multiple reasons|0|||
160953244|NCT01588184|581215972|FG003|Overall Study|multiple reasons|1|||
160953245|NCT01588184|581215973|FG004|Overall Study|multiple reasons|0|||
160953246|NCT01588184|581215974|FG005|Overall Study|multiple reasons|0|||
160953247|NCT01983293|581215976|FG000|Overall Study|Withdrawal by Subject|29|||
160953248|NCT01983293|581215977|FG001|Overall Study|Withdrawal by Subject|15|||
160953249|NCT01983293|581215976|FG000|Overall Study|Missing 12-month visit|3|||
160953250|NCT01983293|581215977|FG001|Overall Study|Missing 12-month visit|3|||
160953251|NCT01983293|581215976|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
160953252|NCT01983293|581215977|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
160953253|NCT03750552|581215978|FG000|Overall Study|Adverse Event|5|||
160953254|NCT03750552|581215979|FG001|Overall Study|Adverse Event|1|||
160953255|NCT03750552|581215978|FG000|Overall Study|Withdrawal by Subject|1|||
160953256|NCT03750552|581215979|FG001|Overall Study|Withdrawal by Subject|1|||
160953257|NCT03750552|581215978|FG000|Overall Study|Other|2|||
160953258|NCT03750552|581215979|FG001|Overall Study|Other|0|||
161146133|NCT01089725|581917095|FG000|Overall Study|Protocol Violation|0|||
160953259|NCT02062632|581215980|FG000|Overall Study|No treatment data|1|||
160953260|NCT00773968|581215983|FG000|Overall Study|Adverse Event|2|||
160953261|NCT00773968|581215983|FG000|Overall Study|Death|1|||
160953262|NCT00773968|581215983|FG000|Overall Study|Failure to Return|2|||
160953263|NCT00773968|581215983|FG000|Overall Study|Lack of Efficacy|3|||
160953264|NCT00773968|581215983|FG000|Overall Study|Protocol Violation|1|||
160953265|NCT00773968|581215983|FG000|Overall Study|Withdrawal by Subject|11|||
161146134|NCT01089725|581917096|FG001|Overall Study|Protocol Violation|0|||
160953266|NCT00773968|581215983|FG000|Overall Study|Screen Failure|17|||
160953267|NCT00773968|581215983|FG000|Overall Study|Other|8|||
160953268|NCT02008890|581215986|FG000|Period 1|Withdrawal by Subject|7|||
160953269|NCT02008890|581215987|FG001|Period 1|Withdrawal by Subject|7|||
160953270|NCT02008890|581215988|FG002|Period 1|Withdrawal by Subject|5|||
160953271|NCT02008890|581215989|FG003|Period 1|Withdrawal by Subject|0|||
160953272|NCT02008890|581215990|FG004|Period 1|Withdrawal by Subject|0|||
160953273|NCT02008890|581215986|FG000|Period 1|Pregnancy|1|||
161146135|NCT01089725|581917097|FG002|Overall Study|Protocol Violation|1|||
161146136|NCT01089725|581917098|FG003|Overall Study|Protocol Violation|1|||
161342888|NCT01925417|582642288|FG000|Overall Study|Death|1|||
160953274|NCT02008890|581215987|FG001|Period 1|Pregnancy|0|||
160953275|NCT02008890|581215988|FG002|Period 1|Pregnancy|0|||
160953276|NCT02008890|581215989|FG003|Period 1|Pregnancy|0|||
160953277|NCT02008890|581215990|FG004|Period 1|Pregnancy|0|||
160953278|NCT02008890|581215986|FG000|Period 1|Physician Decision|1|||
160953279|NCT02008890|581215987|FG001|Period 1|Physician Decision|0|||
160953280|NCT02008890|581215988|FG002|Period 1|Physician Decision|1|||
160953281|NCT02008890|581215989|FG003|Period 1|Physician Decision|0|||
160953282|NCT02008890|581215990|FG004|Period 1|Physician Decision|0|||
160953283|NCT02008890|581215986|FG000|Period 1|Adverse Event|6|||
160953284|NCT02008890|581215987|FG001|Period 1|Adverse Event|8|||
160953285|NCT02008890|581215988|FG002|Period 1|Adverse Event|6|||
160953286|NCT02008890|581215989|FG003|Period 1|Adverse Event|0|||
160953287|NCT02008890|581215990|FG004|Period 1|Adverse Event|0|||
160953288|NCT02008890|581215986|FG000|Period 2|Adverse Event|12|||
160953289|NCT02008890|581215987|FG001|Period 2|Adverse Event|7|||
160953290|NCT02008890|581215988|FG002|Period 2|Adverse Event|0|||
160953291|NCT02008890|581215989|FG003|Period 2|Adverse Event|5|||
160953292|NCT02008890|581215990|FG004|Period 2|Adverse Event|5|||
160953293|NCT02008890|581215986|FG000|Period 2|Withdrawal by Subject|11|||
160953294|NCT02008890|581215987|FG001|Period 2|Withdrawal by Subject|8|||
160953295|NCT02008890|581215988|FG002|Period 2|Withdrawal by Subject|0|||
160953296|NCT02008890|581215989|FG003|Period 2|Withdrawal by Subject|7|||
160953297|NCT02008890|581215990|FG004|Period 2|Withdrawal by Subject|2|||
160953298|NCT02008890|581215986|FG000|Period 2|Physician Decision|4|||
160953299|NCT02008890|581215987|FG001|Period 2|Physician Decision|0|||
160953300|NCT02008890|581215988|FG002|Period 2|Physician Decision|0|||
160953301|NCT02008890|581215989|FG003|Period 2|Physician Decision|2|||
160953302|NCT02008890|581215990|FG004|Period 2|Physician Decision|1|||
160953303|NCT02008890|581215986|FG000|Period 2|Lost to Follow-up|0|||
160953304|NCT02008890|581215987|FG001|Period 2|Lost to Follow-up|0|||
160953305|NCT02008890|581215988|FG002|Period 2|Lost to Follow-up|1|||
160953306|NCT02008890|581215989|FG003|Period 2|Lost to Follow-up|0|||
160953307|NCT02008890|581215990|FG004|Period 2|Lost to Follow-up|0|||
160953308|NCT02008890|581215986|FG000|Extension Period|Withdrawal by Subject|3|||
160953309|NCT02008890|581215987|FG001|Extension Period|Withdrawal by Subject|2|||
160953310|NCT02008890|581215988|FG002|Extension Period|Withdrawal by Subject|0|||
160953311|NCT02008890|581215989|FG003|Extension Period|Withdrawal by Subject|4|||
160953312|NCT02008890|581215990|FG004|Extension Period|Withdrawal by Subject|2|||
160953313|NCT02008890|581215986|FG000|Extension Period|Lost to Follow-up|1|||
160953314|NCT02008890|581215987|FG001|Extension Period|Lost to Follow-up|0|||
160953315|NCT02008890|581215988|FG002|Extension Period|Lost to Follow-up|0|||
160953316|NCT02008890|581215989|FG003|Extension Period|Lost to Follow-up|0|||
160953317|NCT02008890|581215990|FG004|Extension Period|Lost to Follow-up|0|||
160953318|NCT02008890|581215986|FG000|Extension Period|Adverse Event|1|||
160953319|NCT02008890|581215987|FG001|Extension Period|Adverse Event|3|||
160953320|NCT02008890|581215988|FG002|Extension Period|Adverse Event|0|||
160953321|NCT02008890|581215989|FG003|Extension Period|Adverse Event|0|||
160953322|NCT02008890|581215990|FG004|Extension Period|Adverse Event|2|||
160953323|NCT02207816|581215991|FG000|Overall Study|Serious Adverse Event|0|||
160953324|NCT02207816|581215992|FG001|Overall Study|Serious Adverse Event|5|||
161268620|NCT01523457|582366808|FG000|Overall Study|Withdrawal by Subject|7|||
161268621|NCT01523457|582366809|FG001|Overall Study|Withdrawal by Subject|2|||
161268622|NCT01367665|582366810|FG000|Overall Study|Death|102|||
161268623|NCT01367665|582366811|FG001|Overall Study|Death|19|||
161268624|NCT01367665|582366810|FG000|Overall Study|Lost to Follow-up|222|||
161268625|NCT01367665|582366811|FG001|Overall Study|Lost to Follow-up|22|||
161268626|NCT01367665|582366810|FG000|Overall Study|Not Done|118|||
161268627|NCT01367665|582366811|FG001|Overall Study|Not Done|14|||
160953325|NCT02207816|581215993|FG002|Overall Study|Serious Adverse Event|2|||
160953326|NCT02207816|581215991|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160953327|NCT02207816|581215992|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
160953328|NCT02207816|581215993|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
160953329|NCT02207816|581215991|FG000|Overall Study|Withdrawal by Subject|4|||
160953330|NCT02207816|581215992|FG001|Overall Study|Withdrawal by Subject|9|||
160953331|NCT02207816|581215993|FG002|Overall Study|Withdrawal by Subject|7|||
160953332|NCT02207816|581215991|FG000|Overall Study|Migrated/Moved From Study Area|41|||
160953333|NCT02207816|581215992|FG001|Overall Study|Migrated/Moved From Study Area|60|||
160953334|NCT02207816|581215993|FG002|Overall Study|Migrated/Moved From Study Area|51|||
160953335|NCT02207816|581215991|FG000|Overall Study|Lost to Follow-up|3|||
160953336|NCT02207816|581215992|FG001|Overall Study|Lost to Follow-up|9|||
161268628|NCT03283319|582366812|FG000|Overall Study|Lost to Follow-up|5|||
161268629|NCT03283319|582366813|FG001|Overall Study|Lost to Follow-up|4|||
160953337|NCT02207816|581215993|FG002|Overall Study|Lost to Follow-up|1|||
160953338|NCT02207816|581215991|FG000|Overall Study|Other|1|||
160953339|NCT02207816|581215992|FG001|Overall Study|Other|2|||
160953340|NCT02207816|581215993|FG002|Overall Study|Other|4|||
160953341|NCT02522494|581215994|FG000|Overall Study|Lost to Follow-up|6|||
160953342|NCT02522494|581215995|FG001|Overall Study|Lost to Follow-up|2|||
160953343|NCT02522494|581215994|FG000|Overall Study|Withdrawal by Subject|1|||
161268630|NCT03283319|582366814|FG002|Overall Study|Lost to Follow-up|5|||
161268631|NCT03283319|582366815|FG003|Overall Study|Lost to Follow-up|5|||
161342889|NCT03573297|582642292|FG000|Open Label Treatment Period|Adverse Event|67|||
160953344|NCT02522494|581215995|FG001|Overall Study|Withdrawal by Subject|0|||
160953345|NCT02522494|581215994|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
160953346|NCT02522494|581215995|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
161268632|NCT03283319|582366816|FG004|Overall Study|Lost to Follow-up|4|||
161268633|NCT03283319|582366817|FG005|Overall Study|Lost to Follow-up|3|||
161268634|NCT03283319|582366812|FG000|Overall Study|Withdrawal by Subject|2|||
161268635|NCT03283319|582366813|FG001|Overall Study|Withdrawal by Subject|2|||
161268636|NCT03283319|582366814|FG002|Overall Study|Withdrawal by Subject|2|||
161268637|NCT03283319|582366815|FG003|Overall Study|Withdrawal by Subject|1|||
161268638|NCT03283319|582366816|FG004|Overall Study|Withdrawal by Subject|0|||
161268639|NCT03283319|582366817|FG005|Overall Study|Withdrawal by Subject|1|||
161268640|NCT03283319|582366812|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
161268641|NCT03283319|582366813|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
161268642|NCT03283319|582366814|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
161268643|NCT03283319|582366815|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
161268644|NCT03283319|582366816|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
161268645|NCT03283319|582366817|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
161268646|NCT03954834|582366820|FG000|Overall Study|Adverse Event|1|||
161268647|NCT03954834|582366821|FG001|Overall Study|Adverse Event|3|||
160953347|NCT02522494|581215994|FG000|Overall Study|Participant did not watch the video|1|||
160953348|NCT02522494|581215995|FG001|Overall Study|Participant did not watch the video|0|||
160953349|NCT02522494|581215994|FG000|Overall Study|Death|0|||
160953350|NCT02522494|581215995|FG001|Overall Study|Death|1|||
160953351|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
160953352|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
160953353|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
160953354|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953355|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953356|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953357|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953358|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953359|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953360|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953361|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953362|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953363|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953364|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
160953365|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
160953366|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
160953367|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
160953368|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953369|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953370|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953371|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953372|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953373|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953374|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953375|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953376|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953377|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953378|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
160953379|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
160953380|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
160953381|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
160953382|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953383|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953384|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000902|NCT05694065|581388930|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
161000903|NCT00813904|581388931|FG000|Overall Study|Death|1|||
161000904|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
161000905|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161000906|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
160953385|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000907|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
160953386|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000908|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
161000909|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
161268648|NCT03954834|582366822|FG002|Overall Study|Adverse Event|1|||
161268649|NCT03954834|582366823|FG003|Overall Study|Adverse Event|1|||
160953387|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
161000910|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161000911|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
161268650|NCT03954834|582366820|FG000|Overall Study|Death|0|||
160953388|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953389|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953390|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953391|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953392|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
160953393|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
160953394|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
160953395|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
160953396|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953397|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953398|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953399|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953400|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953401|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953402|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953403|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953404|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953405|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953406|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
160953407|NCT02349295|581215998|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953408|NCT02349295|581215999|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
160953409|NCT02349295|581216000|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
160953410|NCT02349295|581216001|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953411|NCT02349295|581216002|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953412|NCT02349295|581216003|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953413|NCT02349295|581216004|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953414|NCT02349295|581216005|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953415|NCT02349295|581216006|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953416|NCT02349295|581216007|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953417|NCT02349295|581216008|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953418|NCT02349295|581216009|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953419|NCT02349295|581216010|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953420|NCT02349295|581216011|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
160953421|NCT02349295|581215998|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
160953422|NCT02349295|581215999|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
160953423|NCT02349295|581216000|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
160953424|NCT02349295|581216001|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
160953425|NCT02349295|581216002|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
160953426|NCT02349295|581216003|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
160953427|NCT02349295|581216004|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
161000912|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161268651|NCT03954834|582366821|FG001|Overall Study|Death|0|||
161268652|NCT03954834|582366822|FG002|Overall Study|Death|0|||
161268653|NCT03954834|582366823|FG003|Overall Study|Death|1|||
161268654|NCT03954834|582366820|FG000|Overall Study|Physician Decision|0|||
161268655|NCT03954834|582366821|FG001|Overall Study|Physician Decision|1|||
161268656|NCT03954834|582366822|FG002|Overall Study|Physician Decision|0|||
161268657|NCT03954834|582366823|FG003|Overall Study|Physician Decision|2|||
161268658|NCT03954834|582366820|FG000|Overall Study|Protocol Violation|1|||
161268659|NCT03954834|582366821|FG001|Overall Study|Protocol Violation|0|||
161268660|NCT03954834|582366822|FG002|Overall Study|Protocol Violation|0|||
161268661|NCT03954834|582366823|FG003|Overall Study|Protocol Violation|1|||
161268662|NCT03954834|582366820|FG000|Overall Study|Withdrawal by Subject|2|||
161268663|NCT03954834|582366821|FG001|Overall Study|Withdrawal by Subject|3|||
161342890|NCT03573297|582642293|FG001|Open Label Treatment Period|Adverse Event|0|||
160953428|NCT02349295|581216005|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
160953429|NCT02349295|581216006|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
160953430|NCT02349295|581216007|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
160953431|NCT02349295|581216008|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
160953432|NCT02349295|581216009|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
160953433|NCT02349295|581216010|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
160953434|NCT02349295|581216011|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
160953435|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953436|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953437|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953438|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953439|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953440|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
161268664|NCT03954834|582366822|FG002|Overall Study|Withdrawal by Subject|13|||
161342891|NCT03573297|582642294|FG002|Open Label Treatment Period|Adverse Event|0|||
160953441|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953442|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
160953443|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
160953444|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
160953445|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
160953446|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953447|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953448|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
160953449|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953450|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953451|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953452|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953453|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953454|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953455|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953456|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
160953457|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
160953458|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
160953459|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
160953460|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953461|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953462|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
160953463|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953464|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953465|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953466|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953467|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953468|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953469|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953470|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
160953471|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953472|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
160953473|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953474|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953475|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953476|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
160953477|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
160953478|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
160953479|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
160953480|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
160953481|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
160953482|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
160953483|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
160953484|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
160953485|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
160953486|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
160953487|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
160953488|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
160953489|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
160953490|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
160953491|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953492|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953493|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953494|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953495|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953496|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
161268665|NCT03954834|582366823|FG003|Overall Study|Withdrawal by Subject|6|||
161268666|NCT03954834|582366820|FG000|Overall Study|Participant left the country|0|||
161268667|NCT03954834|582366821|FG001|Overall Study|Participant left the country|0|||
161268668|NCT03954834|582366822|FG002|Overall Study|Participant left the country|1|||
160953497|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953498|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
160953499|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
160953500|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
161146137|NCT01089725|581917099|FG004|Overall Study|Protocol Violation|0|||
161268669|NCT03954834|582366823|FG003|Overall Study|Participant left the country|0|||
161146138|NCT01089725|581917095|FG000|Overall Study|Withdrawal by Subject|5|||
161146139|NCT01089725|581917096|FG001|Overall Study|Withdrawal by Subject|5|||
161146140|NCT01089725|581917097|FG002|Overall Study|Withdrawal by Subject|4|||
161146141|NCT01089725|581917098|FG003|Overall Study|Withdrawal by Subject|5|||
161146142|NCT01089725|581917099|FG004|Overall Study|Withdrawal by Subject|4|||
161146143|NCT01089725|581917095|FG000|Overall Study|Study Terminated by Sponsor|51|||
161146144|NCT01089725|581917096|FG001|Overall Study|Study Terminated by Sponsor|56|||
161146145|NCT01089725|581917097|FG002|Overall Study|Study Terminated by Sponsor|53|||
161146146|NCT01089725|581917098|FG003|Overall Study|Study Terminated by Sponsor|68|||
161146147|NCT01089725|581917099|FG004|Overall Study|Study Terminated by Sponsor|68|||
161146148|NCT01089725|581917095|FG000|Overall Study|Randomized, but not treated|0|||
161146149|NCT01089725|581917096|FG001|Overall Study|Randomized, but not treated|1|||
161146150|NCT01089725|581917097|FG002|Overall Study|Randomized, but not treated|2|||
161146151|NCT01089725|581917098|FG003|Overall Study|Randomized, but not treated|1|||
161146152|NCT01089725|581917099|FG004|Overall Study|Randomized, but not treated|2|||
161146153|NCT01089725|581917095|FG000|Overall Study|Other|3|||
161146154|NCT01089725|581917096|FG001|Overall Study|Other|0|||
161268670|NCT03954834|582366820|FG000|Overall Study|Lost to Follow-up|3|||
160953501|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
160953502|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953503|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953504|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
160953505|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953506|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953507|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953508|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953509|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953510|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953511|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953512|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
160953513|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
160953514|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953515|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953516|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953517|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953518|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
160953519|NCT02349295|581215998|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953520|NCT02349295|581215999|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953521|NCT02349295|581216000|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953522|NCT02349295|581216001|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953523|NCT02349295|581216002|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953524|NCT02349295|581216003|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953525|NCT02349295|581216004|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953526|NCT02349295|581216005|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
160953527|NCT02349295|581216006|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
160953528|NCT02349295|581216007|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953529|NCT02349295|581216008|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953530|NCT02349295|581216009|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953531|NCT02349295|581216010|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953532|NCT02349295|581216011|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
160953533|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953534|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953535|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953536|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
161000913|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
161146155|NCT01089725|581917097|FG002|Overall Study|Other|0|||
161146156|NCT01089725|581917098|FG003|Overall Study|Other|1|||
161146157|NCT01089725|581917099|FG004|Overall Study|Other|0|||
161146158|NCT01894516|581918368|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
161146159|NCT01894516|581918369|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
161146160|NCT01894516|581918370|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
161146161|NCT01894516|581918371|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
161146162|NCT01894516|581918368|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
161268671|NCT03954834|582366821|FG001|Overall Study|Lost to Follow-up|2|||
161146163|NCT01894516|581918369|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161146164|NCT01894516|581918370|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161268672|NCT03954834|582366822|FG002|Overall Study|Lost to Follow-up|3|||
160953537|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953538|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953539|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953540|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953541|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953542|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953543|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
160953544|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
160953545|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
160953546|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
160953547|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953548|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953549|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953550|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953551|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953552|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953553|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953554|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953555|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953556|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953557|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953558|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
160953559|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
160953560|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
160953561|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953562|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953563|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953564|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953565|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953566|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953567|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953568|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953569|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953570|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953571|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953572|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
160953573|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
160953574|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
160953575|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953576|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953577|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953578|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953579|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953580|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953581|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953582|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953583|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953584|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953585|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953586|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
160953587|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
161268673|NCT03954834|582366823|FG003|Overall Study|Lost to Follow-up|5|||
161268674|NCT00540293|582366829|FG000|Overall Study|Adverse event related to study drug|10|||
161268675|NCT00540293|582366829|FG000|Overall Study|Adverse event not related to study drug|7|||
161268676|NCT00540293|582366829|FG000|Overall Study|Withdrawal by Subject|6|||
161268677|NCT00540293|582366829|FG000|Overall Study|Protocol violation, & subject schedule|12|||
161268678|NCT04492020|582366832|FG000|Overall Study|Adverse Event|1|||
161268679|NCT04492020|582366833|FG001|Overall Study|Adverse Event|3|||
160953588|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
160953589|NCT02349295|581215998|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953590|NCT02349295|581215999|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161000914|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
161000915|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
161268680|NCT04492020|582366832|FG000|Overall Study|Withdrawal by Subject|4|||
161268681|NCT04492020|582366833|FG001|Overall Study|Withdrawal by Subject|3|||
161268682|NCT04492020|582366832|FG000|Overall Study|Lost to Follow-up|4|||
161146165|NCT01894516|581918371|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161146166|NCT01894516|581918368|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
161146167|NCT01894516|581918369|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
161146168|NCT01894516|581918370|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
161146169|NCT01894516|581918371|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
161146170|NCT01894516|581918368|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161146171|NCT01894516|581918369|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161146172|NCT01894516|581918370|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
161146173|NCT01894516|581918371|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
161146174|NCT01894516|581918368|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161146175|NCT01894516|581918369|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161146176|NCT01894516|581918370|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161146177|NCT01894516|581918371|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161146178|NCT01894516|581918368|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161146179|NCT01894516|581918369|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161146180|NCT01894516|581918370|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
161146181|NCT01894516|581918371|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161146182|NCT01894516|581918368|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
161146183|NCT01894516|581918369|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161146184|NCT01894516|581918370|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161146185|NCT01894516|581918371|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
160953591|NCT02349295|581216000|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
161146186|NCT01894516|581918368|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161146187|NCT01894516|581918369|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161146188|NCT01894516|581918370|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
161146189|NCT01894516|581918371|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161146190|NCT00893113|581918379|FG000|Overall Study|Lost to Follow-up|4|||
161146191|NCT00893113|581918380|FG001|Overall Study|Lost to Follow-up|8|||
161146192|NCT00893113|581918379|FG000|Overall Study|Early Termination|1|||
161146193|NCT00893113|581918380|FG001|Overall Study|Early Termination|1|||
161146194|NCT00893113|581918379|FG000|Overall Study|Withdrew Consent|8|||
161146195|NCT00893113|581918380|FG001|Overall Study|Withdrew Consent|7|||
161146196|NCT01240811|581918383|FG000|Overall Study|Physician Decision|0|||
161268683|NCT04492020|582366833|FG001|Overall Study|Lost to Follow-up|3|||
161268684|NCT04492020|582366832|FG000|Overall Study|Protocol Violation|5|||
161268685|NCT04492020|582366833|FG001|Overall Study|Protocol Violation|2|||
161268686|NCT04492020|582366832|FG000|Overall Study|Lack of Qualifying Event|25|||
161268687|NCT04492020|582366833|FG001|Overall Study|Lack of Qualifying Event|27|||
160953592|NCT02349295|581216001|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953593|NCT02349295|581216002|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953594|NCT02349295|581216003|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953595|NCT02349295|581216004|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953596|NCT02349295|581216005|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953597|NCT02349295|581216006|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953598|NCT02349295|581216007|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953599|NCT02349295|581216008|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953600|NCT02349295|581216009|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
160953601|NCT02349295|581216010|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953602|NCT02349295|581216011|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
160953603|NCT03240588|581216012|FG000|Overall Study|Death|3|||
160953604|NCT03240588|581216013|FG001|Overall Study|Death|0|||
160953605|NCT03240588|581216014|FG002|Overall Study|Death|0|||
160953606|NCT03240588|581216012|FG000|Overall Study|Adverse Event|5|||
160953607|NCT03240588|581216013|FG001|Overall Study|Adverse Event|4|||
160953608|NCT03240588|581216014|FG002|Overall Study|Adverse Event|0|||
160953609|NCT03240588|581216012|FG000|Overall Study|Lost to Follow-up|9|||
160953610|NCT03240588|581216013|FG001|Overall Study|Lost to Follow-up|4|||
160953611|NCT03240588|581216014|FG002|Overall Study|Lost to Follow-up|0|||
160953612|NCT03240588|581216012|FG000|Overall Study|Physician Decision|3|||
161146197|NCT01240811|581918384|FG001|Overall Study|Physician Decision|1|||
161146198|NCT01240811|581918385|FG002|Overall Study|Physician Decision|0|||
161146199|NCT01240811|581918383|FG000|Overall Study|Withdrawal by Subject|0|||
161146200|NCT01240811|581918384|FG001|Overall Study|Withdrawal by Subject|0|||
160953613|NCT03240588|581216013|FG001|Overall Study|Physician Decision|2|||
160953614|NCT03240588|581216014|FG002|Overall Study|Physician Decision|0|||
160953615|NCT03240588|581216012|FG000|Overall Study|Did not meet eligibility criteria|0|||
160953616|NCT03240588|581216013|FG001|Overall Study|Did not meet eligibility criteria|6|||
161146201|NCT01240811|581918385|FG002|Overall Study|Withdrawal by Subject|1|||
161146202|NCT04168645|581918395|FG000|Overall Study|Lost to Follow-up|23|||
161146203|NCT04168645|581918396|FG001|Overall Study|Lost to Follow-up|28|||
161000916|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
161146204|NCT04168645|581918397|FG002|Overall Study|Lost to Follow-up|15|||
161146205|NCT04168645|581918398|FG003|Overall Study|Lost to Follow-up|12|||
161146206|NCT04168645|581918395|FG000|Overall Study|Death|1|||
161146207|NCT04168645|581918396|FG001|Overall Study|Death|1|||
161146208|NCT04168645|581918397|FG002|Overall Study|Death|0|||
160953617|NCT03240588|581216014|FG002|Overall Study|Did not meet eligibility criteria|0|||
160953618|NCT03240588|581216012|FG000|Overall Study|No longer meets protocol criteria|12|||
160953619|NCT03240588|581216013|FG001|Overall Study|No longer meets protocol criteria|7|||
160953620|NCT03240588|581216014|FG002|Overall Study|No longer meets protocol criteria|0|||
160953621|NCT03240588|581216012|FG000|Overall Study|Withdrawal by Subject|60|||
160953622|NCT03240588|581216013|FG001|Overall Study|Withdrawal by Subject|52|||
160953623|NCT03240588|581216014|FG002|Overall Study|Withdrawal by Subject|7|||
160953624|NCT03240588|581216012|FG000|Overall Study|Other, additional details not available.|0|||
160953625|NCT03240588|581216013|FG001|Overall Study|Other, additional details not available.|12|||
160953626|NCT03240588|581216014|FG002|Overall Study|Other, additional details not available.|1|||
160953627|NCT03240588|581216012|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
160953628|NCT03240588|581216013|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
160953629|NCT03240588|581216014|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
160953630|NCT03240588|581216012|FG000|Overall Study|Closure of study|55|||
160953631|NCT03240588|581216013|FG001|Overall Study|Closure of study|3|||
160953632|NCT03240588|581216014|FG002|Overall Study|Closure of study|0|||
160953633|NCT03240588|581216012|FG000|Overall Study|Subject non-compliance|23|||
160953634|NCT03240588|581216013|FG001|Overall Study|Subject non-compliance|2|||
160953635|NCT03240588|581216014|FG002|Overall Study|Subject non-compliance|1|||
160953636|NCT03240588|581216012|FG000|Overall Study|Device Deficiency|1|||
161146209|NCT04168645|581918398|FG003|Overall Study|Death|0|||
161146210|NCT04168645|581918395|FG000|Overall Study|Withdrawal by Subject|5|||
161268688|NCT04492020|582366832|FG000|Overall Study|Non-compliance with Study Drug|2|||
161268689|NCT04492020|582366833|FG001|Overall Study|Non-compliance with Study Drug|1|||
161268690|NCT00325195|582366834|FG000|Randomized|Not dosed|5|||
161268691|NCT00325195|582366835|FG001|Randomized|Not dosed|5|||
161268692|NCT00325195|582366836|FG002|Randomized|Not dosed|3|||
161268693|NCT00325195|582366834|FG000|Received Intervention: ITT Population|Adverse Event|15|||
161268694|NCT00325195|582366835|FG001|Received Intervention: ITT Population|Adverse Event|17|||
161268695|NCT00325195|582366836|FG002|Received Intervention: ITT Population|Adverse Event|1|||
161268696|NCT00325195|582366834|FG000|Received Intervention: ITT Population|Death|3|||
161268697|NCT00325195|582366835|FG001|Received Intervention: ITT Population|Death|1|||
161268698|NCT00325195|582366836|FG002|Received Intervention: ITT Population|Death|0|||
161268699|NCT00325195|582366834|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
161268700|NCT00325195|582366835|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
161268701|NCT00325195|582366836|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
161268702|NCT00325195|582366834|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
161268703|NCT00325195|582366835|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
161268704|NCT00325195|582366836|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
161268705|NCT00325195|582366834|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
161268706|NCT00325195|582366835|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
161268707|NCT00325195|582366836|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
161268708|NCT04594707|582366837|FG000|Overall Study|Adverse Event|0|||
161268709|NCT04594707|582366838|FG001|Overall Study|Adverse Event|0|||
161268710|NCT04594707|582366839|FG002|Overall Study|Adverse Event|1|||
161268711|NCT04594707|582366837|FG000|Overall Study|Death|0|||
161268712|NCT04594707|582366838|FG001|Overall Study|Death|2|||
161268713|NCT04594707|582366839|FG002|Overall Study|Death|2|||
161268714|NCT04594707|582366837|FG000|Overall Study|Lung Transplant|0|||
161268715|NCT04594707|582366838|FG001|Overall Study|Lung Transplant|0|||
161268716|NCT04594707|582366839|FG002|Overall Study|Lung Transplant|1|||
161268717|NCT04594707|582366837|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
161268718|NCT04594707|582366838|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
161268719|NCT04594707|582366839|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
161268720|NCT04594707|582366837|FG000|Overall Study|Study Terminated By Sponsor|19|||
161268721|NCT04594707|582366838|FG001|Overall Study|Study Terminated By Sponsor|47|||
160953637|NCT03240588|581216013|FG001|Overall Study|Device Deficiency|0|||
161146211|NCT04168645|581918396|FG001|Overall Study|Withdrawal by Subject|2|||
161146212|NCT04168645|581918397|FG002|Overall Study|Withdrawal by Subject|2|||
161268722|NCT04594707|582366839|FG002|Overall Study|Study Terminated By Sponsor|41|||
161268723|NCT04594707|582366837|FG000|Overall Study|Withdrawal by Subject|1|||
160953638|NCT03240588|581216014|FG002|Overall Study|Device Deficiency|0|||
160953639|NCT03240588|581216012|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
161146213|NCT04168645|581918398|FG003|Overall Study|Withdrawal by Subject|2|||
161146214|NCT04168645|581918395|FG000|Overall Study|Administrative Withdrawal|3|||
161146215|NCT04168645|581918396|FG001|Overall Study|Administrative Withdrawal|1|||
160953640|NCT03240588|581216013|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
160953641|NCT03240588|581216014|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
160953642|NCT01259713|581216018|FG000|Overall Study|Adverse Event|54|||
160953643|NCT01259713|581216019|FG001|Overall Study|Adverse Event|23|||
160953644|NCT01259713|581216018|FG000|Overall Study|Death Not Related to IFI|8|||
160953645|NCT01259713|581216019|FG001|Overall Study|Death Not Related to IFI|1|||
160953646|NCT01259713|581216018|FG000|Overall Study|Investigators Discretion|14|||
160953647|NCT01259713|581216019|FG001|Overall Study|Investigators Discretion|6|||
160953648|NCT01259713|581216018|FG000|Overall Study|Lack of Efficacy|2|||
160953649|NCT01259713|581216019|FG001|Overall Study|Lack of Efficacy|0|||
160953650|NCT01259713|581216018|FG000|Overall Study|Protocol Violation|5|||
160953651|NCT01259713|581216019|FG001|Overall Study|Protocol Violation|4|||
160953652|NCT01259713|581216018|FG000|Overall Study|Subject Withdrew Consent|12|||
160953653|NCT01259713|581216019|FG001|Overall Study|Subject Withdrew Consent|7|||
160953654|NCT02091726|581216020|FG000|Overall Study|Lost to Follow-up|6|||
160953655|NCT06111742|581216027|FG000|Overall Study|Did not receive intervention|1|||
160953656|NCT06111742|581216028|FG001|Overall Study|Did not receive intervention|0|||
160953657|NCT06111742|581216029|FG002|Overall Study|Did not receive intervention|0|||
160953658|NCT06111742|581216027|FG000|Overall Study|Withdrawal by Subject|2|||
160953659|NCT06111742|581216028|FG001|Overall Study|Withdrawal by Subject|0|||
160953660|NCT06111742|581216029|FG002|Overall Study|Withdrawal by Subject|0|||
160953661|NCT03461003|581216030|FG000|Overall Study|Lost to Follow-up|2|||
160953662|NCT03461003|581216031|FG001|Overall Study|Lost to Follow-up|2|||
160953663|NCT03461003|581216030|FG000|Overall Study|Withdrawal by Subject|3|||
160953664|NCT03461003|581216031|FG001|Overall Study|Withdrawal by Subject|1|||
160953665|NCT00620750|581216037|FG000|Overall Study|Lost to Follow-up|25|||
160953666|NCT04477187|581216038|FG000|Overall Study|Lost to Follow-up|2|||
161000917|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
161000918|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
161000919|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
161000920|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
161000921|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
161000922|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
161000923|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
161000924|NCT01087762|581388932|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
161000925|NCT01087762|581388933|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
161000926|NCT01087762|581388934|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
161000927|NCT01087762|581388935|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
161000928|NCT01087762|581388936|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
161000929|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161000930|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161000931|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
161000932|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
161000933|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
161000934|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161000935|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161000936|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
161000937|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
161000938|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
161000939|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161000940|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161000941|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
161000942|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
161000943|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
161000944|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161000945|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161000946|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
161000947|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
161146216|NCT04168645|581918397|FG002|Overall Study|Administrative Withdrawal|1|||
161146217|NCT04168645|581918398|FG003|Overall Study|Administrative Withdrawal|3|||
161342892|NCT03573297|582642295|FG003|Open Label Treatment Period|Adverse Event|0|||
161146218|NCT02114203|581918399|FG000|Overall Study|Adverse Event|0|||
160953667|NCT02047045|581216039|FG000|Baseline|Withdrawal by Subject|3|||
160953668|NCT02047045|581216040|FG001|Baseline|Withdrawal by Subject|2|||
160953669|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
160953670|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
160953671|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
160953672|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
160953673|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
160953674|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
160953675|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
160953676|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
160953677|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
160953678|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
160953679|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
160953680|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
160953681|NCT02047045|581216039|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
160953682|NCT02047045|581216040|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
160953683|NCT02047045|581216039|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
160953684|NCT02047045|581216040|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
160953685|NCT03508843|581216042|FG000|Overall Study|Withdrawal by Subject|1|||
160953686|NCT03508843|581216042|FG000|Overall Study|technical difficulties|2|||
160953687|NCT04717596|581216043|FG000|Overall Study|Withdrawal by Subject|4|||
160953688|NCT00765843|581216044|FG000|Overall Study|Lost to Follow-up|1|||
160953689|NCT00765843|581216045|FG001|Overall Study|Lost to Follow-up|3|||
160953690|NCT00765843|581216046|FG002|Overall Study|Lost to Follow-up|2|||
160953691|NCT00765843|581216044|FG000|Overall Study|did not return to receive intervention|0|||
160953692|NCT00765843|581216045|FG001|Overall Study|did not return to receive intervention|1|||
160953693|NCT00765843|581216046|FG002|Overall Study|did not return to receive intervention|0|||
160953694|NCT00765843|581216044|FG000|Overall Study|Adverse Event|0|||
160953695|NCT00765843|581216045|FG001|Overall Study|Adverse Event|0|||
160953696|NCT00765843|581216046|FG002|Overall Study|Adverse Event|1|||
160953697|NCT03555396|581216047|FG000|Overall Study|Death|3|||
160953698|NCT03555396|581216048|FG001|Overall Study|Death|1|||
160953699|NCT03555396|581216047|FG000|Overall Study|Lost to Follow-up|0|||
160953700|NCT03555396|581216048|FG001|Overall Study|Lost to Follow-up|2|||
160953701|NCT04066114|581216049|FG000|Overall Study|Adverse Event|1|||
160953702|NCT04066114|581216050|FG001|Overall Study|Adverse Event|0|||
160953703|NCT04066114|581216051|FG002|Overall Study|Adverse Event|0|||
160953704|NCT04066114|581216049|FG000|Overall Study|Withdrawal by Subject|1|||
160953705|NCT04066114|581216050|FG001|Overall Study|Withdrawal by Subject|0|||
160953706|NCT04066114|581216051|FG002|Overall Study|Withdrawal by Subject|0|||
160953707|NCT04066114|581216049|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
160953708|NCT04066114|581216050|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
160953709|NCT04066114|581216051|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
160953710|NCT02460991|581216052|FG000|Overall Study|Withdrawal by Subject|0|||
160953711|NCT02460991|581216053|FG001|Overall Study|Withdrawal by Subject|2|||
160953712|NCT02564523|581216054|FG000|Overall Study|Withdrawal by Subject|3|||
160953713|NCT02564523|581216055|FG001|Overall Study|Withdrawal by Subject|0|||
160953714|NCT02564523|581216056|FG002|Overall Study|Withdrawal by Subject|1|||
160953715|NCT02564523|581216057|FG003|Overall Study|Withdrawal by Subject|0|||
160953716|NCT02564523|581216058|FG004|Overall Study|Withdrawal by Subject|1|||
160953717|NCT02564523|581216059|FG005|Overall Study|Withdrawal by Subject|0|||
160953718|NCT02564523|581216060|FG006|Overall Study|Withdrawal by Subject|1|||
160953719|NCT02564523|581216061|FG007|Overall Study|Withdrawal by Subject|0|||
160953720|NCT02564523|581216062|FG008|Overall Study|Withdrawal by Subject|0|||
160953721|NCT02564523|581216063|FG009|Overall Study|Withdrawal by Subject|0|||
160953722|NCT02564523|581216064|FG010|Overall Study|Withdrawal by Subject|1|||
160953723|NCT02564523|581216065|FG011|Overall Study|Withdrawal by Subject|0|||
160953724|NCT02564523|581216066|FG012|Overall Study|Withdrawal by Subject|1|||
160953725|NCT02564523|581216067|FG013|Overall Study|Withdrawal by Subject|0|||
160953726|NCT02564523|581216068|FG014|Overall Study|Withdrawal by Subject|0|||
160953727|NCT02564523|581216069|FG015|Overall Study|Withdrawal by Subject|0|||
160953728|NCT02564523|581216070|FG016|Overall Study|Withdrawal by Subject|0|||
160953729|NCT02564523|581216071|FG017|Overall Study|Withdrawal by Subject|0|||
160953730|NCT02564523|581216054|FG000|Overall Study|Adverse Event|0|||
160953731|NCT02564523|581216055|FG001|Overall Study|Adverse Event|0|||
160953732|NCT02564523|581216056|FG002|Overall Study|Adverse Event|0|||
160953733|NCT02564523|581216057|FG003|Overall Study|Adverse Event|0|||
160953734|NCT02564523|581216058|FG004|Overall Study|Adverse Event|0|||
160953735|NCT02564523|581216059|FG005|Overall Study|Adverse Event|0|||
160953736|NCT02564523|581216060|FG006|Overall Study|Adverse Event|0|||
160953737|NCT02564523|581216061|FG007|Overall Study|Adverse Event|0|||
160953738|NCT02564523|581216062|FG008|Overall Study|Adverse Event|0|||
161146219|NCT02114203|581918400|FG001|Overall Study|Adverse Event|1|||
161146220|NCT02114203|581918401|FG002|Overall Study|Adverse Event|0|||
160953739|NCT02564523|581216063|FG009|Overall Study|Adverse Event|0|||
160953740|NCT02564523|581216064|FG010|Overall Study|Adverse Event|0|||
160953741|NCT02564523|581216065|FG011|Overall Study|Adverse Event|0|||
160953742|NCT02564523|581216066|FG012|Overall Study|Adverse Event|0|||
160953743|NCT02564523|581216067|FG013|Overall Study|Adverse Event|0|||
160953744|NCT02564523|581216068|FG014|Overall Study|Adverse Event|0|||
160953745|NCT02564523|581216069|FG015|Overall Study|Adverse Event|0|||
161146221|NCT02114203|581918399|FG000|Overall Study|Withdrawal by Subject|0|||
160953746|NCT02564523|581216070|FG016|Overall Study|Adverse Event|0|||
160953747|NCT02564523|581216071|FG017|Overall Study|Adverse Event|1|||
160953748|NCT02564523|581216054|FG000|Overall Study|Death|0|||
161146222|NCT02114203|581918400|FG001|Overall Study|Withdrawal by Subject|1|||
161146223|NCT02114203|581918401|FG002|Overall Study|Withdrawal by Subject|0|||
161146224|NCT01518699|581918402|FG000|Period 2|Protocol Violation|1|||
161146225|NCT01518699|581918403|FG001|Period 2|Protocol Violation|1|||
161146226|NCT01518699|581918404|FG002|Period 2|Protocol Violation|0|||
161146227|NCT01518699|581918405|FG003|Period 2|Protocol Violation|0|||
160953749|NCT02564523|581216055|FG001|Overall Study|Death|0|||
160953750|NCT02564523|581216056|FG002|Overall Study|Death|0|||
160953751|NCT02564523|581216057|FG003|Overall Study|Death|0|||
160953752|NCT02564523|581216058|FG004|Overall Study|Death|0|||
160953753|NCT02564523|581216059|FG005|Overall Study|Death|0|||
160953754|NCT02564523|581216060|FG006|Overall Study|Death|1|||
160953755|NCT02564523|581216061|FG007|Overall Study|Death|0|||
160953756|NCT02564523|581216062|FG008|Overall Study|Death|0|||
160953757|NCT02564523|581216063|FG009|Overall Study|Death|0|||
160953758|NCT02564523|581216064|FG010|Overall Study|Death|1|||
160953759|NCT02564523|581216065|FG011|Overall Study|Death|0|||
160953760|NCT02564523|581216066|FG012|Overall Study|Death|0|||
160953761|NCT02564523|581216067|FG013|Overall Study|Death|0|||
160953762|NCT02564523|581216068|FG014|Overall Study|Death|0|||
160953763|NCT02564523|581216069|FG015|Overall Study|Death|0|||
160953764|NCT02564523|581216070|FG016|Overall Study|Death|0|||
160953765|NCT02564523|581216071|FG017|Overall Study|Death|0|||
160953766|NCT02564523|581216054|FG000|Overall Study|Lost to Follow-up|2|||
160953767|NCT02564523|581216055|FG001|Overall Study|Lost to Follow-up|1|||
160953768|NCT02564523|581216056|FG002|Overall Study|Lost to Follow-up|4|||
160953769|NCT02564523|581216057|FG003|Overall Study|Lost to Follow-up|0|||
160953770|NCT02564523|581216058|FG004|Overall Study|Lost to Follow-up|1|||
160953771|NCT02564523|581216059|FG005|Overall Study|Lost to Follow-up|0|||
160953772|NCT02564523|581216060|FG006|Overall Study|Lost to Follow-up|1|||
160953773|NCT02564523|581216061|FG007|Overall Study|Lost to Follow-up|0|||
160953774|NCT02564523|581216062|FG008|Overall Study|Lost to Follow-up|0|||
160953775|NCT02564523|581216063|FG009|Overall Study|Lost to Follow-up|0|||
160953776|NCT02564523|581216064|FG010|Overall Study|Lost to Follow-up|0|||
160953777|NCT02564523|581216065|FG011|Overall Study|Lost to Follow-up|1|||
160953778|NCT02564523|581216066|FG012|Overall Study|Lost to Follow-up|1|||
160953779|NCT02564523|581216067|FG013|Overall Study|Lost to Follow-up|0|||
160953780|NCT02564523|581216068|FG014|Overall Study|Lost to Follow-up|0|||
160953781|NCT02564523|581216069|FG015|Overall Study|Lost to Follow-up|0|||
160953782|NCT02564523|581216070|FG016|Overall Study|Lost to Follow-up|0|||
160953783|NCT02564523|581216071|FG017|Overall Study|Lost to Follow-up|0|||
160953784|NCT02564523|581216054|FG000|Overall Study|Physician Decision|0|||
160953785|NCT02564523|581216055|FG001|Overall Study|Physician Decision|0|||
160953786|NCT02564523|581216056|FG002|Overall Study|Physician Decision|0|||
160953787|NCT02564523|581216057|FG003|Overall Study|Physician Decision|0|||
160953788|NCT02564523|581216058|FG004|Overall Study|Physician Decision|1|||
160953789|NCT02564523|581216059|FG005|Overall Study|Physician Decision|0|||
160953790|NCT02564523|581216060|FG006|Overall Study|Physician Decision|0|||
160953791|NCT02564523|581216061|FG007|Overall Study|Physician Decision|0|||
160953792|NCT02564523|581216062|FG008|Overall Study|Physician Decision|0|||
160953793|NCT02564523|581216063|FG009|Overall Study|Physician Decision|0|||
160953794|NCT02564523|581216064|FG010|Overall Study|Physician Decision|1|||
160953795|NCT02564523|581216065|FG011|Overall Study|Physician Decision|0|||
160953796|NCT02564523|581216066|FG012|Overall Study|Physician Decision|0|||
160953797|NCT02564523|581216067|FG013|Overall Study|Physician Decision|0|||
160953798|NCT02564523|581216068|FG014|Overall Study|Physician Decision|0|||
160953799|NCT02564523|581216069|FG015|Overall Study|Physician Decision|0|||
160953800|NCT02564523|581216070|FG016|Overall Study|Physician Decision|0|||
160953801|NCT02564523|581216071|FG017|Overall Study|Physician Decision|0|||
160953802|NCT02564523|581216054|FG000|Overall Study|Protocol Violation|2|||
160953803|NCT02564523|581216055|FG001|Overall Study|Protocol Violation|2|||
160953804|NCT02564523|581216056|FG002|Overall Study|Protocol Violation|5|||
160953805|NCT02564523|581216057|FG003|Overall Study|Protocol Violation|0|||
160953806|NCT02564523|581216058|FG004|Overall Study|Protocol Violation|1|||
160953807|NCT02564523|581216059|FG005|Overall Study|Protocol Violation|0|||
160953808|NCT02564523|581216060|FG006|Overall Study|Protocol Violation|0|||
160953809|NCT02564523|581216061|FG007|Overall Study|Protocol Violation|0|||
160953810|NCT02564523|581216062|FG008|Overall Study|Protocol Violation|0|||
160953811|NCT02564523|581216063|FG009|Overall Study|Protocol Violation|0|||
160953812|NCT02564523|581216064|FG010|Overall Study|Protocol Violation|0|||
160953813|NCT02564523|581216065|FG011|Overall Study|Protocol Violation|0|||
160953814|NCT02564523|581216066|FG012|Overall Study|Protocol Violation|0|||
160953815|NCT02564523|581216067|FG013|Overall Study|Protocol Violation|0|||
160953816|NCT02564523|581216068|FG014|Overall Study|Protocol Violation|0|||
160953817|NCT02564523|581216069|FG015|Overall Study|Protocol Violation|0|||
160953818|NCT02564523|581216070|FG016|Overall Study|Protocol Violation|0|||
160953819|NCT02564523|581216071|FG017|Overall Study|Protocol Violation|0|||
160953820|NCT02564523|581216054|FG000|Overall Study|Other|3|||
160953821|NCT02564523|581216055|FG001|Overall Study|Other|0|||
160953822|NCT02564523|581216056|FG002|Overall Study|Other|0|||
160953823|NCT02564523|581216057|FG003|Overall Study|Other|1|||
161146228|NCT01518699|581918406|FG004|Period 2|Protocol Violation|0|||
160953824|NCT02564523|581216058|FG004|Overall Study|Other|0|||
160953825|NCT02564523|581216059|FG005|Overall Study|Other|0|||
160953826|NCT02564523|581216060|FG006|Overall Study|Other|0|||
160953827|NCT02564523|581216061|FG007|Overall Study|Other|0|||
160953828|NCT02564523|581216062|FG008|Overall Study|Other|0|||
160953829|NCT02564523|581216063|FG009|Overall Study|Other|0|||
160953830|NCT02564523|581216064|FG010|Overall Study|Other|0|||
160953831|NCT02564523|581216065|FG011|Overall Study|Other|0|||
160953832|NCT02564523|581216066|FG012|Overall Study|Other|0|||
160953833|NCT02564523|581216067|FG013|Overall Study|Other|0|||
160953834|NCT02564523|581216068|FG014|Overall Study|Other|0|||
160953835|NCT02564523|581216069|FG015|Overall Study|Other|0|||
160953836|NCT02564523|581216070|FG016|Overall Study|Other|0|||
160953837|NCT02564523|581216071|FG017|Overall Study|Other|0|||
160953838|NCT00448539|581216074|FG000|Overall Study|Medication non-compliance|4|||
160953839|NCT00448539|581216075|FG001|Overall Study|Medication non-compliance|1|||
160953840|NCT00448539|581216074|FG000|Overall Study|Protocol Violation|1|||
160953841|NCT00448539|581216075|FG001|Overall Study|Protocol Violation|0|||
160953842|NCT00448539|581216074|FG000|Overall Study|Request of the investigator or sponsor|67|||
160953843|NCT00448539|581216075|FG001|Overall Study|Request of the investigator or sponsor|54|||
160953844|NCT00448539|581216074|FG000|Overall Study|Withdrawal by Subject|20|||
160953845|NCT00448539|581216075|FG001|Overall Study|Withdrawal by Subject|24|||
160953846|NCT00448539|581216074|FG000|Overall Study|Diary non-compliance|1|||
160953847|NCT00448539|581216075|FG001|Overall Study|Diary non-compliance|0|||
160953848|NCT00448539|581216074|FG000|Overall Study|Adverse Event|9|||
160953849|NCT00448539|581216075|FG001|Overall Study|Adverse Event|26|||
160953850|NCT00448539|581216074|FG000|Overall Study|Lack of Efficacy|27|||
160953851|NCT00448539|581216075|FG001|Overall Study|Lack of Efficacy|40|||
160953852|NCT00448539|581216074|FG000|Overall Study|Miscellaneous|2|||
160953853|NCT00448539|581216075|FG001|Overall Study|Miscellaneous|1|||
160953854|NCT00448539|581216074|FG000|Overall Study|Change of meds|2|||
160953855|NCT00448539|581216075|FG001|Overall Study|Change of meds|3|||
160953856|NCT00448539|581216074|FG000|Overall Study|Lost to Follow-up|1|||
160953857|NCT00448539|581216075|FG001|Overall Study|Lost to Follow-up|3|||
160953858|NCT03349710|581216076|FG000|Treatment Period|Death|0|||
160953859|NCT03349710|581216077|FG001|Treatment Period|Death|0|||
160953860|NCT03349710|581216078|FG002|Treatment Period|Death|1|||
160953861|NCT03349710|581216079|FG003|Treatment Period|Death|0|||
160953862|NCT03349710|581216076|FG000|Treatment Period|Disease Progression|0|||
160953863|NCT03349710|581216077|FG001|Treatment Period|Disease Progression|2|||
160953864|NCT03349710|581216078|FG002|Treatment Period|Disease Progression|0|||
160953865|NCT03349710|581216079|FG003|Treatment Period|Disease Progression|1|||
160953866|NCT03349710|581216076|FG000|Treatment Period|Study Drug Toxicity|1|||
160953867|NCT03349710|581216077|FG001|Treatment Period|Study Drug Toxicity|0|||
160953868|NCT03349710|581216078|FG002|Treatment Period|Study Drug Toxicity|1|||
160953869|NCT03349710|581216079|FG003|Treatment Period|Study Drug Toxicity|1|||
160953870|NCT03349710|581216076|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
160953871|NCT03349710|581216077|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
160953872|NCT03349710|581216078|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
160953873|NCT03349710|581216079|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
160953874|NCT03349710|581216076|FG000|Treatment Period|admin reason by sponsor|0|||
160953875|NCT03349710|581216077|FG001|Treatment Period|admin reason by sponsor|7|||
160953876|NCT03349710|581216078|FG002|Treatment Period|admin reason by sponsor|0|||
160953877|NCT03349710|581216079|FG003|Treatment Period|admin reason by sponsor|19|||
160953878|NCT03349710|581216076|FG000|Treatment Period|Other Reason|2|||
160953879|NCT03349710|581216077|FG001|Treatment Period|Other Reason|0|||
160953880|NCT03349710|581216078|FG002|Treatment Period|Other Reason|2|||
160953881|NCT03349710|581216079|FG003|Treatment Period|Other Reason|1|||
160953882|NCT03349710|581216076|FG000|Treatment Period|completed|6|||
160953883|NCT03349710|581216077|FG001|Treatment Period|completed|0|||
160953884|NCT03349710|581216078|FG002|Treatment Period|completed|18|||
160953885|NCT03349710|581216079|FG003|Treatment Period|completed|1|||
160953886|NCT03349710|581216076|FG000|Treatment Period|participant request to discontinue|0|||
160953887|NCT03349710|581216077|FG001|Treatment Period|participant request to discontinue|0|||
160953888|NCT03349710|581216078|FG002|Treatment Period|participant request to discontinue|4|||
161146229|NCT01518699|581918407|FG005|Period 2|Protocol Violation|0|||
160953889|NCT03349710|581216079|FG003|Treatment Period|participant request to discontinue|0|||
160953890|NCT03349710|581216076|FG000|Treatment Period|participant withdrew consent|1|||
160953891|NCT03349710|581216077|FG001|Treatment Period|participant withdrew consent|0|||
160953892|NCT03349710|581216078|FG002|Treatment Period|participant withdrew consent|0|||
160953893|NCT03349710|581216079|FG003|Treatment Period|participant withdrew consent|0|||
160953894|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
160953895|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
160953896|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
160953897|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
160953898|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
160953899|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
160953900|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
160953901|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
160953902|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
160953903|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
160953904|NCT00695903|581216080|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
160953905|NCT00695903|581216081|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
160953906|NCT00695903|581216080|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
160953907|NCT00695903|581216081|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
160953908|NCT00695903|581216080|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
160953909|NCT00695903|581216081|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
160953910|NCT00695903|581216080|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
160953911|NCT00695903|581216081|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
160953912|NCT03621696|581216084|FG000|Overall Study|Not eligible|0|||
160953913|NCT03621696|581216085|FG001|Overall Study|Not eligible|0|||
160953914|NCT03621696|581216086|FG002|Overall Study|Not eligible|0|||
160953915|NCT03621696|581216087|FG003|Overall Study|Not eligible|5|||
160953916|NCT03621696|581216084|FG000|Overall Study|Withdrawal by Subject|1|||
160953917|NCT03621696|581216085|FG001|Overall Study|Withdrawal by Subject|1|||
160953918|NCT03621696|581216086|FG002|Overall Study|Withdrawal by Subject|1|||
160953919|NCT03621696|581216087|FG003|Overall Study|Withdrawal by Subject|0|||
160953920|NCT03621696|581216084|FG000|Overall Study|Physician Decision|0|||
160953921|NCT03621696|581216085|FG001|Overall Study|Physician Decision|0|||
160953922|NCT03621696|581216086|FG002|Overall Study|Physician Decision|1|||
160953923|NCT03621696|581216087|FG003|Overall Study|Physician Decision|0|||
160953924|NCT03526250|581216088|FG000|Overall Study|Adverse Event|4|||
160953925|NCT03526250|581216088|FG000|Overall Study|Progressive Disease|16|||
160953926|NCT03526250|581216088|FG000|Overall Study|No Treatment|3|||
160953927|NCT04420221|581216089|FG000|Overall Study|Withdrawal by Subject|0|||
160953928|NCT04420221|581216090|FG001|Overall Study|Withdrawal by Subject|0|||
160953929|NCT04420221|581216091|FG002|Overall Study|Withdrawal by Subject|0|||
160953930|NCT04420221|581216092|FG003|Overall Study|Withdrawal by Subject|0|||
160953931|NCT04420221|581216093|FG004|Overall Study|Withdrawal by Subject|0|||
160953932|NCT04420221|581216094|FG005|Overall Study|Withdrawal by Subject|20|||
160953933|NCT04420221|581216095|FG006|Overall Study|Withdrawal by Subject|5|||
160953934|NCT04420221|581216089|FG000|Overall Study|Other|0|||
160953935|NCT04420221|581216090|FG001|Overall Study|Other|0|||
160953936|NCT04420221|581216091|FG002|Overall Study|Other|0|||
160953937|NCT04420221|581216092|FG003|Overall Study|Other|0|||
160953938|NCT04420221|581216093|FG004|Overall Study|Other|0|||
160953939|NCT04420221|581216094|FG005|Overall Study|Other|1|||
160953940|NCT04420221|581216095|FG006|Overall Study|Other|1|||
160953941|NCT04420221|581216089|FG000|Overall Study|Lost to Follow-up|0|||
160953942|NCT04420221|581216090|FG001|Overall Study|Lost to Follow-up|0|||
160953943|NCT04420221|581216091|FG002|Overall Study|Lost to Follow-up|0|||
160953944|NCT04420221|581216092|FG003|Overall Study|Lost to Follow-up|0|||
160953945|NCT04420221|581216093|FG004|Overall Study|Lost to Follow-up|0|||
160953946|NCT04420221|581216094|FG005|Overall Study|Lost to Follow-up|3|||
160953947|NCT04420221|581216095|FG006|Overall Study|Lost to Follow-up|2|||
160953948|NCT04420221|581216089|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
160953949|NCT04420221|581216090|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
160953950|NCT04420221|581216091|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
160953951|NCT04420221|581216092|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
160953952|NCT04420221|581216093|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
160953953|NCT04420221|581216094|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
160953954|NCT04420221|581216095|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
160953955|NCT05348681|581216096|FG000|Overall Study|Study terminated by Sponsor|8|||
160953956|NCT05348681|581216097|FG001|Overall Study|Study terminated by Sponsor|3|||
160953957|NCT05348681|581216096|FG000|Overall Study|Withdrawal by Subject|1|||
160953958|NCT05348681|581216097|FG001|Overall Study|Withdrawal by Subject|1|||
160953959|NCT05348681|581216096|FG000|Overall Study|Lost to Follow-up|1|||
160953960|NCT05348681|581216097|FG001|Overall Study|Lost to Follow-up|1|||
160953961|NCT05348681|581216096|FG000|Overall Study|Adverse Event|1|||
160953962|NCT05348681|581216097|FG001|Overall Study|Adverse Event|0|||
161000948|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
161000949|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
160953963|NCT05348681|581216096|FG000|Overall Study|Other|2|||
160953964|NCT05348681|581216097|FG001|Overall Study|Other|1|||
160953965|NCT00553267|581216100|FG000|Overall Study|Adverse Event|8|||
160953966|NCT00553267|581216101|FG001|Overall Study|Adverse Event|10|||
160953967|NCT00553267|581216102|FG002|Overall Study|Adverse Event|5|||
160953968|NCT00553267|581216100|FG000|Overall Study|Non compliant with protocol|3|||
160953969|NCT00553267|581216101|FG001|Overall Study|Non compliant with protocol|3|||
160953970|NCT00553267|581216102|FG002|Overall Study|Non compliant with protocol|2|||
160953971|NCT00553267|581216100|FG000|Overall Study|Lost to Follow-up|0|||
160953972|NCT00553267|581216101|FG001|Overall Study|Lost to Follow-up|0|||
161000950|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
160953973|NCT00553267|581216102|FG002|Overall Study|Lost to Follow-up|1|||
160953974|NCT00553267|581216100|FG000|Overall Study|Consent withdrawn|2|||
160953975|NCT00553267|581216101|FG001|Overall Study|Consent withdrawn|3|||
160953976|NCT00553267|581216102|FG002|Overall Study|Consent withdrawn|1|||
160953977|NCT00553267|581216100|FG000|Overall Study|Specified category|1|||
160953978|NCT00553267|581216101|FG001|Overall Study|Specified category|2|||
160953979|NCT00553267|581216102|FG002|Overall Study|Specified category|1|||
160953980|NCT04389840|581216103|FG000|Overall Study|Adverse Event|0|||
160953981|NCT04389840|581216104|FG001|Overall Study|Adverse Event|0|||
160953982|NCT04389840|581216105|FG002|Overall Study|Adverse Event|0|||
160953983|NCT04389840|581216106|FG003|Overall Study|Adverse Event|1|||
160953984|NCT04389840|581216107|FG004|Overall Study|Adverse Event|0|||
160953985|NCT04389840|581216108|FG005|Overall Study|Adverse Event|0|||
160953986|NCT04389840|581216103|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
160953987|NCT04389840|581216104|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
160953988|NCT04389840|581216105|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
160953989|NCT04389840|581216106|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
160953990|NCT04389840|581216107|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
160953991|NCT04389840|581216108|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
160953992|NCT04389840|581216103|FG000|Overall Study|Death|0|||
160953993|NCT04389840|581216104|FG001|Overall Study|Death|1|||
160953994|NCT04389840|581216105|FG002|Overall Study|Death|0|||
160953995|NCT04389840|581216106|FG003|Overall Study|Death|0|||
160953996|NCT04389840|581216107|FG004|Overall Study|Death|0|||
160953997|NCT04389840|581216108|FG005|Overall Study|Death|0|||
160953998|NCT01618864|581216109|FG000|Overall Study|Withdrawal by Subject|2|||
160953999|NCT01618864|581216109|FG000|Overall Study|Lost to Follow-up|2|||
160954000|NCT00096135|581216115|FG000|Overall Study|Physician Decision|20|||
160954001|NCT00096135|581216116|FG001|Overall Study|Physician Decision|4|||
160954002|NCT00096135|581216115|FG000|Overall Study|Refusal of further protocol therapy|4|||
160954003|NCT00096135|581216116|FG001|Overall Study|Refusal of further protocol therapy|1|||
160954004|NCT00096135|581216115|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
160954005|NCT00096135|581216116|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
160954006|NCT00096135|581216115|FG000|Overall Study|Other, specify|15|||
160954007|NCT00096135|581216116|FG001|Overall Study|Other, specify|3|||
160954008|NCT00096135|581216115|FG000|Overall Study|Ineligible|2|||
160954009|NCT00096135|581216116|FG001|Overall Study|Ineligible|0|||
160954010|NCT01003249|581216127|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160954011|NCT01003249|581216128|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
160954012|NCT01003249|581216127|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
160954013|NCT01003249|581216128|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
160954014|NCT01003249|581216127|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
160954015|NCT01003249|581216128|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
160954016|NCT01003249|581216127|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
160954017|NCT01003249|581216128|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
160954018|NCT00627705|581216130|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
160954019|NCT00627705|581216131|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
160954020|NCT00627705|581216130|FG000|Overall Study|Adverse Event|1|||
160954021|NCT00627705|581216131|FG001|Overall Study|Adverse Event|0|||
160954022|NCT00627705|581216130|FG000|Overall Study|Withdrawal by Subject|0|||
160954023|NCT00627705|581216131|FG001|Overall Study|Withdrawal by Subject|2|||
160954024|NCT00627705|581216130|FG000|Overall Study|Lost to Follow-up|0|||
160954025|NCT00627705|581216131|FG001|Overall Study|Lost to Follow-up|1|||
160954026|NCT02535065|581216134|FG000|Overall Study|Death|13|||
160954027|NCT02535065|581216134|FG000|Overall Study|Lost to Follow-up|1|||
160954028|NCT02535065|581216134|FG000|Overall Study|Withdrawal by Subject|6|||
160954029|NCT03712917|581216135|FG000|Overall Study|Pregnancy|0|||
160954030|NCT03712917|581216136|FG001|Overall Study|Pregnancy|0|||
160954031|NCT03712917|581216137|FG002|Overall Study|Pregnancy|1|||
160954032|NCT03712917|581216135|FG000|Overall Study|Adverse Event|0|||
160954033|NCT03712917|581216136|FG001|Overall Study|Adverse Event|4|||
160954034|NCT03712917|581216137|FG002|Overall Study|Adverse Event|3|||
160954035|NCT03712917|581216135|FG000|Overall Study|Lost to Follow-up|9|||
160954036|NCT03712917|581216136|FG001|Overall Study|Lost to Follow-up|4|||
160954037|NCT03712917|581216137|FG002|Overall Study|Lost to Follow-up|5|||
160954038|NCT00110617|581216138|FG000|Overall Study|Adverse Event|2|||
160954039|NCT00110617|581216139|FG001|Overall Study|Adverse Event|4|||
160954040|NCT00110617|581216138|FG000|Overall Study|Abnormal Laboratory Value|4|||
160954041|NCT00110617|581216139|FG001|Overall Study|Abnormal Laboratory Value|2|||
160954042|NCT00110617|581216138|FG000|Overall Study|Lack of Efficacy|1|||
160954043|NCT00110617|581216139|FG001|Overall Study|Lack of Efficacy|0|||
160954044|NCT00110617|581216138|FG000|Overall Study|Patient no longer requires study drug|1|||
160954045|NCT00110617|581216139|FG001|Overall Study|Patient no longer requires study drug|0|||
160954046|NCT00110617|581216138|FG000|Overall Study|Protocol Violation|5|||
160954047|NCT00110617|581216139|FG001|Overall Study|Protocol Violation|0|||
160954048|NCT00110617|581216138|FG000|Overall Study|Withdrawal by Subject|10|||
160954049|NCT00110617|581216139|FG001|Overall Study|Withdrawal by Subject|4|||
160954050|NCT00110617|581216138|FG000|Overall Study|Lost to Follow-up|9|||
160954051|NCT00110617|581216139|FG001|Overall Study|Lost to Follow-up|1|||
160954052|NCT00110617|581216138|FG000|Overall Study|Administrative problems|6|||
160954053|NCT00110617|581216139|FG001|Overall Study|Administrative problems|5|||
160954054|NCT00110617|581216138|FG000|Overall Study|Death|1|||
160954055|NCT00110617|581216139|FG001|Overall Study|Death|1|||
160954056|NCT00110617|581216138|FG000|Overall Study|Did not receive study drug|0|||
160954057|NCT00110617|581216139|FG001|Overall Study|Did not receive study drug|12|||
160954058|NCT04764396|581216140|FG000|Overall Study|Physician Decision|1|||
160954059|NCT04764396|581216141|FG001|Overall Study|Physician Decision|0|||
160954060|NCT03230916|581216142|FG000|Overall Study|Withdrawal by Subject|0|||
160954061|NCT03230916|581216143|FG001|Overall Study|Withdrawal by Subject|0|||
160954062|NCT03230916|581216144|FG002|Overall Study|Withdrawal by Subject|0|||
160954063|NCT03230916|581216145|FG003|Overall Study|Withdrawal by Subject|0|||
160954064|NCT03230916|581216146|FG004|Overall Study|Withdrawal by Subject|0|||
160954065|NCT03230916|581216147|FG005|Overall Study|Withdrawal by Subject|1|||
160954066|NCT03230916|581216148|FG006|Overall Study|Withdrawal by Subject|0|||
160954067|NCT03230916|581216149|FG007|Overall Study|Withdrawal by Subject|0|||
160954068|NCT03230916|581216150|FG008|Overall Study|Withdrawal by Subject|0|||
160954069|NCT03230916|581216151|FG009|Overall Study|Withdrawal by Subject|0|||
160954070|NCT03230916|581216152|FG010|Overall Study|Withdrawal by Subject|0|||
160954071|NCT03156023|581216155|FG000|Overall Study|Withdrawal by Subject|1|||
160954072|NCT03156023|581216156|FG001|Overall Study|Withdrawal by Subject|0|||
160954073|NCT03156023|581216157|FG002|Overall Study|Withdrawal by Subject|2|||
160954074|NCT03156023|581216158|FG003|Overall Study|Withdrawal by Subject|1|||
160954075|NCT03156023|581216159|FG004|Overall Study|Withdrawal by Subject|1|||
160954076|NCT03156023|581216155|FG000|Overall Study|Lost to Follow-up|0|||
160954077|NCT03156023|581216156|FG001|Overall Study|Lost to Follow-up|0|||
160954078|NCT03156023|581216157|FG002|Overall Study|Lost to Follow-up|0|||
160954079|NCT03156023|581216158|FG003|Overall Study|Lost to Follow-up|0|||
160954080|NCT03156023|581216159|FG004|Overall Study|Lost to Follow-up|1|||
160954081|NCT01296568|581219154|FG000|Continued Access Phase|Lost to Follow-up|1|||
160954082|NCT01296568|581219154|FG000|Continued Access Phase|Withdrawal by Subject|1|||
160954083|NCT01296568|581219154|FG000|Continued Access Phase|Disease Progression|1|||
160954084|NCT00321854|581219157|FG000|Overall Study|Adverse Event|41|||
160954085|NCT00321854|581219158|FG001|Overall Study|Adverse Event|43|||
160954086|NCT00321854|581219157|FG000|Overall Study|Lack of Efficacy|9|||
160954087|NCT00321854|581219158|FG001|Overall Study|Lack of Efficacy|14|||
160954088|NCT00321854|581219157|FG000|Overall Study|Protocol Violation|6|||
160954089|NCT00321854|581219158|FG001|Overall Study|Protocol Violation|5|||
160954090|NCT00321854|581219157|FG000|Overall Study|Lost to Follow-up|0|||
160954091|NCT00321854|581219158|FG001|Overall Study|Lost to Follow-up|2|||
160954092|NCT00321854|581219157|FG000|Overall Study|Withdrawal by Subject|6|||
160954093|NCT00321854|581219158|FG001|Overall Study|Withdrawal by Subject|17|||
160954094|NCT00321854|581219157|FG000|Overall Study|Other|1|||
160954095|NCT00321854|581219158|FG001|Overall Study|Other|1|||
160954096|NCT01369342|581219159|FG000|Overall Study|Withdrawal by Subject|7|||
160954097|NCT01369342|581219160|FG001|Overall Study|Withdrawal by Subject|7|||
160954098|NCT01369342|581219161|FG002|Overall Study|Withdrawal by Subject|2|||
160954099|NCT01369342|581219159|FG000|Overall Study|Lost to Follow-up|5|||
160954100|NCT01369342|581219160|FG001|Overall Study|Lost to Follow-up|2|||
160954101|NCT01369342|581219161|FG002|Overall Study|Lost to Follow-up|1|||
160954102|NCT01369342|581219159|FG000|Overall Study|Not Treated|1|||
160954103|NCT01369342|581219160|FG001|Overall Study|Not Treated|0|||
160954104|NCT01369342|581219161|FG002|Overall Study|Not Treated|0|||
160954105|NCT01816594|581219162|FG000|Overall Study|Local Progress|0|||
160954106|NCT01816594|581219163|FG001|Overall Study|Local Progress|2|||
160954107|NCT01816594|581219162|FG000|Overall Study|Adverse Event|9|||
160954108|NCT01816594|581219163|FG001|Overall Study|Adverse Event|0|||
160954109|NCT01816594|581219162|FG000|Overall Study|Withdrawal by Subject|1|||
160954110|NCT01816594|581219163|FG001|Overall Study|Withdrawal by Subject|0|||
160954111|NCT01816594|581219162|FG000|Overall Study|Physician Decision|1|||
160954112|NCT01816594|581219163|FG001|Overall Study|Physician Decision|0|||
160954113|NCT03905655|581219164|FG000|Overall Study|Adverse Event|1|||
160954114|NCT03905655|581219165|FG001|Overall Study|Adverse Event|0|||
160954115|NCT03905655|581219166|FG002|Overall Study|Adverse Event|1|||
160954116|NCT03905655|581219167|FG003|Overall Study|Adverse Event|1|||
160954117|NCT04723576|581219168|FG000|Overall Study|Withdrawal by Subject|2133|||
160954118|NCT04723576|581219169|FG001|Overall Study|Withdrawal by Subject|3234|||
160954119|NCT02277106|581219173|FG000|Stage 2|Adverse Event|0|||
160954120|NCT02277106|581219174|FG001|Stage 2|Adverse Event|0|||
160954121|NCT02277106|581219175|FG002|Stage 2|Adverse Event|1|||
160954122|NCT01064739|581219176|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
160954123|NCT02479412|581219177|FG000|Overall Study|Adverse Event|0|||
160954124|NCT02479412|581219178|FG001|Overall Study|Adverse Event|0|||
160954125|NCT02479412|581219179|FG002|Overall Study|Adverse Event|1|||
160954126|NCT02479412|581219180|FG003|Overall Study|Adverse Event|0|||
160954127|NCT02479412|581219181|FG004|Overall Study|Adverse Event|0|||
160954128|NCT02479412|581219182|FG005|Overall Study|Adverse Event|0|||
160954129|NCT02479412|581219183|FG006|Overall Study|Adverse Event|0|||
160954130|NCT02479412|581219184|FG007|Overall Study|Adverse Event|0|||
160954131|NCT02479412|581219185|FG008|Overall Study|Adverse Event|0|||
160954132|NCT02479412|581219177|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160954133|NCT02479412|581219178|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160954134|NCT02479412|581219179|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160954135|NCT02479412|581219180|FG003|Overall Study|Study-specific withdrawal criteria|1|||
160954136|NCT02479412|581219181|FG004|Overall Study|Study-specific withdrawal criteria|0|||
160954137|NCT02479412|581219182|FG005|Overall Study|Study-specific withdrawal criteria|0|||
160954138|NCT02479412|581219183|FG006|Overall Study|Study-specific withdrawal criteria|0|||
160954139|NCT02479412|581219184|FG007|Overall Study|Study-specific withdrawal criteria|1|||
160954140|NCT02479412|581219185|FG008|Overall Study|Study-specific withdrawal criteria|1|||
160954141|NCT02479412|581219177|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
160954142|NCT02479412|581219178|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
160954143|NCT02479412|581219179|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
160954144|NCT02479412|581219180|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
160954145|NCT02479412|581219181|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
160954146|NCT02479412|581219182|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
160954147|NCT02479412|581219183|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
160954148|NCT02479412|581219184|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
160954149|NCT02479412|581219185|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
160954150|NCT00454051|581219186|FG000|Overall Study|Adverse Event|1|||
160954151|NCT00454051|581219187|FG001|Overall Study|Adverse Event|2|||
160954152|NCT00454051|581219186|FG000|Overall Study|Withdrawal by Subject|1|||
160954153|NCT00454051|581219187|FG001|Overall Study|Withdrawal by Subject|0|||
160954154|NCT00454051|581219186|FG000|Overall Study|Protocol Violation|1|||
160954155|NCT00454051|581219187|FG001|Overall Study|Protocol Violation|1|||
160954156|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
160954157|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
160954158|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
160954159|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
160954160|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
160954161|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
160954162|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
160954163|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
160954164|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
160954165|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
160954166|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
160954167|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
160954168|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
160954169|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
160954170|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
160954171|NCT01571362|581219188|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
160954172|NCT01571362|581219189|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
160954173|NCT01571362|581219190|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
160954174|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
160954175|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
160954176|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
160954177|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
160954178|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
160954179|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
160954180|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Adverse Event|0|||
160954181|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Adverse Event|9|||
160954182|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Adverse Event|14|||
160954183|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
160954184|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
160954185|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
160954186|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
160954187|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
160954188|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
160954189|NCT01571362|581219188|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
160954190|NCT01571362|581219189|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
160954191|NCT01571362|581219190|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
160954192|NCT04258020|581219191|FG000|Overall Study|Withdrawal by Subject|1|||
160954193|NCT04258020|581219192|FG001|Overall Study|Withdrawal by Subject|0|||
160954194|NCT02097472|581219193|FG000|Received Vaccination 2|Adverse Event|0|||
160954195|NCT02097472|581219194|FG001|Received Vaccination 2|Adverse Event|0|||
161000951|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
161000952|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
161000953|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
161000954|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
160954196|NCT02097472|581219195|FG002|Received Vaccination 2|Adverse Event|0|||
160954197|NCT02097472|581219196|FG003|Received Vaccination 2|Adverse Event|0|||
160954198|NCT02097472|581219197|FG004|Received Vaccination 2|Adverse Event|0|||
160954199|NCT02097472|581219198|FG005|Received Vaccination 2|Adverse Event|0|||
160954200|NCT02097472|581219199|FG006|Received Vaccination 2|Adverse Event|1|||
160954201|NCT02097472|581219200|FG007|Received Vaccination 2|Adverse Event|0|||
160954202|NCT03117738|581219203|FG000|Overall Study|Withdrawal by Subject|3|||
160954203|NCT03117738|581219204|FG001|Overall Study|Withdrawal by Subject|1|||
160954204|NCT03117738|581219203|FG000|Overall Study|Lost to Follow-up|1|||
160954205|NCT03117738|581219204|FG001|Overall Study|Lost to Follow-up|4|||
160954206|NCT01669629|581219205|FG000|Period 1|protocol deviation|1|||
160954207|NCT01669629|581219206|FG001|Period 1|protocol deviation|2|||
160954208|NCT01292928|581219207|FG000|Overall Study|Death|8|||
160954209|NCT01292928|581219207|FG000|Overall Study|Withdrawal by Subject|8|||
160954210|NCT01292928|581219207|FG000|Overall Study|Lost to Follow-up|6|||
160954211|NCT01292928|581219207|FG000|Overall Study|Physician Decision|2|||
160954212|NCT00130533|581219208|FG000|Overall Study|Withdrawal by Subject|33|||
160954213|NCT00130533|581219209|FG001|Overall Study|Withdrawal by Subject|6|||
160954214|NCT00130533|581219208|FG000|Overall Study|Adverse Event|34|||
160954215|NCT00130533|581219209|FG001|Overall Study|Adverse Event|1|||
160954216|NCT00130533|581219208|FG000|Overall Study|Disease relapse|9|||
160954217|NCT00130533|581219209|FG001|Overall Study|Disease relapse|13|||
160954218|NCT00130533|581219208|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
160954219|NCT00130533|581219209|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
160954220|NCT00130533|581219208|FG000|Overall Study|Death|4|||
160954221|NCT00130533|581219209|FG001|Overall Study|Death|2|||
160954222|NCT00130533|581219208|FG000|Overall Study|Protocol Violation|5|||
160954223|NCT00130533|581219209|FG001|Overall Study|Protocol Violation|1|||
160954224|NCT00130533|581219208|FG000|Overall Study|Lost to Follow-up|1|||
160954225|NCT00130533|581219209|FG001|Overall Study|Lost to Follow-up|1|||
160954226|NCT00130533|581219208|FG000|Overall Study|Sponsor´s decision|2|||
160954227|NCT00130533|581219209|FG001|Overall Study|Sponsor´s decision|0|||
160954228|NCT00130533|581219208|FG000|Overall Study|Second Primary Malignancy|0|||
160954229|NCT00130533|581219209|FG001|Overall Study|Second Primary Malignancy|1|||
160954230|NCT00130533|581219208|FG000|Overall Study|Other|12|||
160954231|NCT00130533|581219209|FG001|Overall Study|Other|5|||
160954232|NCT01059565|581219210|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
160954233|NCT01059565|581219211|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
160954234|NCT01059565|581219210|FG000|24-Week Randomized Phase|Adverse Event|5|||
160954235|NCT01059565|581219211|FG001|24-Week Randomized Phase|Adverse Event|0|||
160954236|NCT01059565|581219210|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
160954237|NCT01059565|581219211|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
160954238|NCT01059565|581219210|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
160954239|NCT01059565|581219211|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
160954240|NCT01059565|581219210|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
161000955|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
161000956|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
160954241|NCT01059565|581219211|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
160954242|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Adverse Event|2|||
160954243|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Adverse Event|0|||
160954244|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
160954245|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
160954246|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
160954247|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
160954248|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
160954249|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
160954250|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
160954251|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
160954252|NCT01059565|581219210|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
160954253|NCT01059565|581219211|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
161146230|NCT01518699|581918402|FG000|Period 2|Lost to Follow-up|0|||
160954254|NCT03927950|581219217|FG000|Overall Study|Adverse Event|9|||
160954255|NCT03263429|581219218|FG000|Overall Study|Withdrawal by Subject|0|||
160954256|NCT03263429|581219219|FG001|Overall Study|Withdrawal by Subject|1|||
160954257|NCT03263429|581219220|FG002|Overall Study|Withdrawal by Subject|0|||
160954258|NCT03263429|581219218|FG000|Overall Study|Follow-Up Period Completed|0|||
161146231|NCT01518699|581918403|FG001|Period 2|Lost to Follow-up|1|||
160954259|NCT03263429|581219219|FG001|Overall Study|Follow-Up Period Completed|2|||
160954260|NCT03263429|581219220|FG002|Overall Study|Follow-Up Period Completed|0|||
160954261|NCT03263429|581219218|FG000|Overall Study|Death|3|||
160954262|NCT03263429|581219219|FG001|Overall Study|Death|5|||
160954263|NCT03263429|581219220|FG002|Overall Study|Death|16|||
160954264|NCT03263429|581219218|FG000|Overall Study|Participant unable to return|0|||
160954265|NCT03263429|581219219|FG001|Overall Study|Participant unable to return|0|||
160954266|NCT03263429|581219220|FG002|Overall Study|Participant unable to return|1|||
160954267|NCT03263429|581219218|FG000|Overall Study|Study Closed|0|||
160954268|NCT03263429|581219219|FG001|Overall Study|Study Closed|0|||
160954269|NCT03263429|581219220|FG002|Overall Study|Study Closed|1|||
160954270|NCT04530448|581219221|FG000|Overall Study|Physician Decision|3|||
160954271|NCT04530448|581219222|FG001|Overall Study|Physician Decision|0|||
160954272|NCT01519206|581219223|FG000|Overall Study|Lost to Follow-up|3|||
160954273|NCT01519206|581219223|FG000|Overall Study|Missed Visit|2|||
160954274|NCT01491854|581219224|FG000|Overall Study|mainly due to premature termination|93|||
160954275|NCT01491854|581219224|FG000|Overall Study|Death|1|||
160954276|NCT01491854|581219224|FG000|Overall Study|Withdrawal by Subject|3|||
160954277|NCT01491854|581219224|FG000|Overall Study|Lost to Follow-up|33|||
160954278|NCT02014116|581219225|FG000|Overall Study|Progressive Disease|3|||
160954279|NCT02014116|581219226|FG001|Overall Study|Progressive Disease|4|||
160954280|NCT02014116|581219227|FG002|Overall Study|Progressive Disease|2|||
160954281|NCT02014116|581219228|FG003|Overall Study|Progressive Disease|6|||
160954282|NCT02014116|581219229|FG004|Overall Study|Progressive Disease|1|||
160954283|NCT02014116|581219230|FG005|Overall Study|Progressive Disease|13|||
160954284|NCT02014116|581219231|FG006|Overall Study|Progressive Disease|1|||
160954285|NCT02014116|581219232|FG007|Overall Study|Progressive Disease|3|||
160954286|NCT02014116|581219233|FG008|Overall Study|Progressive Disease|7|||
160954287|NCT02014116|581219225|FG000|Overall Study|Adverse Event|0|||
160954288|NCT02014116|581219226|FG001|Overall Study|Adverse Event|0|||
160954289|NCT02014116|581219227|FG002|Overall Study|Adverse Event|0|||
160954290|NCT02014116|581219228|FG003|Overall Study|Adverse Event|0|||
160954291|NCT02014116|581219229|FG004|Overall Study|Adverse Event|1|||
160954292|NCT02014116|581219230|FG005|Overall Study|Adverse Event|0|||
160954293|NCT02014116|581219231|FG006|Overall Study|Adverse Event|0|||
160954294|NCT02014116|581219232|FG007|Overall Study|Adverse Event|1|||
160954295|NCT02014116|581219233|FG008|Overall Study|Adverse Event|0|||
160954296|NCT02014116|581219225|FG000|Overall Study|Lost to Follow-up|0|||
160954297|NCT02014116|581219226|FG001|Overall Study|Lost to Follow-up|0|||
160954298|NCT02014116|581219227|FG002|Overall Study|Lost to Follow-up|0|||
160954299|NCT02014116|581219228|FG003|Overall Study|Lost to Follow-up|0|||
160954300|NCT02014116|581219229|FG004|Overall Study|Lost to Follow-up|0|||
160954301|NCT02014116|581219230|FG005|Overall Study|Lost to Follow-up|1|||
160954302|NCT02014116|581219231|FG006|Overall Study|Lost to Follow-up|0|||
160954303|NCT02014116|581219232|FG007|Overall Study|Lost to Follow-up|0|||
160954304|NCT02014116|581219233|FG008|Overall Study|Lost to Follow-up|1|||
160954305|NCT02014116|581219225|FG000|Overall Study|Death|0|||
160954306|NCT02014116|581219226|FG001|Overall Study|Death|0|||
160954307|NCT02014116|581219227|FG002|Overall Study|Death|0|||
160954308|NCT02014116|581219228|FG003|Overall Study|Death|0|||
160954309|NCT02014116|581219229|FG004|Overall Study|Death|0|||
160954310|NCT02014116|581219230|FG005|Overall Study|Death|0|||
160954311|NCT02014116|581219231|FG006|Overall Study|Death|0|||
160954312|NCT02014116|581219232|FG007|Overall Study|Death|1|||
160954313|NCT02014116|581219233|FG008|Overall Study|Death|1|||
160954314|NCT02014116|581219225|FG000|Overall Study|Withdrawal by Subject|0|||
160954315|NCT02014116|581219226|FG001|Overall Study|Withdrawal by Subject|0|||
160954316|NCT02014116|581219227|FG002|Overall Study|Withdrawal by Subject|1|||
160954317|NCT02014116|581219228|FG003|Overall Study|Withdrawal by Subject|1|||
160954318|NCT02014116|581219229|FG004|Overall Study|Withdrawal by Subject|0|||
160954319|NCT02014116|581219230|FG005|Overall Study|Withdrawal by Subject|1|||
161146232|NCT01518699|581918404|FG002|Period 2|Lost to Follow-up|0|||
161268724|NCT04594707|582366838|FG001|Overall Study|Withdrawal by Subject|0|||
161268725|NCT04594707|582366839|FG002|Overall Study|Withdrawal by Subject|2|||
161268726|NCT01175811|582366840|FG000|Overall Study|Adverse Event|1|||
161268727|NCT01175811|582366841|FG001|Overall Study|Adverse Event|1|||
161268728|NCT01175811|582366840|FG000|Overall Study|Entry criteria not met|3|||
161268729|NCT01175811|582366841|FG001|Overall Study|Entry criteria not met|1|||
161268730|NCT01175811|582366840|FG000|Overall Study|Lack of Efficacy|1|||
161268731|NCT01175811|582366841|FG001|Overall Study|Lack of Efficacy|0|||
161268732|NCT01175811|582366840|FG000|Overall Study|Lost to Follow-up|3|||
160954320|NCT02014116|581219231|FG006|Overall Study|Withdrawal by Subject|0|||
160954321|NCT02014116|581219232|FG007|Overall Study|Withdrawal by Subject|0|||
160954322|NCT02014116|581219233|FG008|Overall Study|Withdrawal by Subject|0|||
160954323|NCT02014116|581219225|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
160954324|NCT02014116|581219226|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
160954325|NCT02014116|581219227|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
160954326|NCT02014116|581219228|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
160954327|NCT02014116|581219229|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
160954328|NCT02014116|581219230|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
160954329|NCT02014116|581219231|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
160954330|NCT02014116|581219232|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
160954331|NCT02014116|581219233|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
160954332|NCT02014116|581219225|FG000|Overall Study|Physician Decision|0|||
160954333|NCT02014116|581219226|FG001|Overall Study|Physician Decision|0|||
160954334|NCT02014116|581219227|FG002|Overall Study|Physician Decision|0|||
160954335|NCT02014116|581219228|FG003|Overall Study|Physician Decision|0|||
160954336|NCT02014116|581219229|FG004|Overall Study|Physician Decision|0|||
160954337|NCT02014116|581219230|FG005|Overall Study|Physician Decision|0|||
160954338|NCT02014116|581219231|FG006|Overall Study|Physician Decision|0|||
160954339|NCT02014116|581219232|FG007|Overall Study|Physician Decision|0|||
160954340|NCT02014116|581219233|FG008|Overall Study|Physician Decision|1|||
160954341|NCT01026974|581219245|FG000|Overall Study|Withdrawal by Subject|0|||
160954342|NCT01026974|581219246|FG001|Overall Study|Withdrawal by Subject|1|||
160954343|NCT01026974|581219247|FG002|Overall Study|Withdrawal by Subject|7|||
160954344|NCT01026974|581219248|FG003|Overall Study|Withdrawal by Subject|2|||
160954345|NCT01026974|581219245|FG000|Overall Study|Lost to Follow-up|1|||
160954346|NCT01026974|581219246|FG001|Overall Study|Lost to Follow-up|1|||
160954347|NCT01026974|581219247|FG002|Overall Study|Lost to Follow-up|4|||
160954348|NCT01026974|581219248|FG003|Overall Study|Lost to Follow-up|0|||
160954349|NCT01026974|581219245|FG000|Overall Study|Adverse Event|0|||
160954350|NCT01026974|581219246|FG001|Overall Study|Adverse Event|0|||
160954351|NCT01026974|581219247|FG002|Overall Study|Adverse Event|0|||
160954352|NCT01026974|581219248|FG003|Overall Study|Adverse Event|1|||
160954353|NCT01026974|581219245|FG000|Overall Study|Inappropriate enrollment|0|||
160954354|NCT01026974|581219246|FG001|Overall Study|Inappropriate enrollment|0|||
160954355|NCT01026974|581219247|FG002|Overall Study|Inappropriate enrollment|1|||
160954356|NCT01026974|581219248|FG003|Overall Study|Inappropriate enrollment|0|||
160954357|NCT02864082|581219255|FG000|Overall Study|Adverse Event|1|||
160954358|NCT02864082|581219256|FG001|Overall Study|Adverse Event|1|||
160954359|NCT02864082|581219255|FG000|Overall Study|Lost to Follow-up|0|||
160954360|NCT02864082|581219256|FG001|Overall Study|Lost to Follow-up|1|||
160954361|NCT02864082|581219255|FG000|Overall Study|Withdrawal by Subject|2|||
160954362|NCT02864082|581219256|FG001|Overall Study|Withdrawal by Subject|2|||
160954363|NCT05545072|581219264|FG000|Overall Study|Lost to Follow-up|1|||
160954364|NCT05545072|581219265|FG001|Overall Study|Lost to Follow-up|0|||
160954365|NCT05545072|581219264|FG000|Overall Study|Study ended prematurely due to funding|2|||
160954366|NCT05545072|581219265|FG001|Overall Study|Study ended prematurely due to funding|2|||
160954367|NCT02395042|581219266|FG000|Treatment 1 Period|Adverse Event|1|||
160954368|NCT02395042|581219267|FG001|Treatment 1 Period|Adverse Event|3|||
160954369|NCT02395042|581219268|FG002|Treatment 1 Period|Adverse Event|1|||
160954370|NCT02395042|581219266|FG000|Treatment 1 Period|Lack of Efficacy|1|||
160954371|NCT02395042|581219267|FG001|Treatment 1 Period|Lack of Efficacy|1|||
160954372|NCT02395042|581219268|FG002|Treatment 1 Period|Lack of Efficacy|0|||
160954373|NCT02395042|581219266|FG000|Treatment 1 Period|Lost to Follow-up|1|||
160954374|NCT02395042|581219267|FG001|Treatment 1 Period|Lost to Follow-up|0|||
160954375|NCT02395042|581219268|FG002|Treatment 1 Period|Lost to Follow-up|0|||
160954376|NCT02395042|581219266|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
160954377|NCT02395042|581219267|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
160954378|NCT02395042|581219268|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
160954379|NCT02395042|581219266|FG000|Treatment 2 Period|Lack of Efficacy|1|||
160954380|NCT02395042|581219267|FG001|Treatment 2 Period|Lack of Efficacy|1|||
160954381|NCT02395042|581219268|FG002|Treatment 2 Period|Lack of Efficacy|0|||
160954382|NCT03638141|581219269|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
160954383|NCT03996473|581219270|FG000|Treatment Assignment|Withdrawal by Subject|1|||
160954384|NCT03996473|581219270|FG000|Treatment Assignment|Progressive disease|6|||
160954385|NCT03996473|581219270|FG000|Treatment Assignment|Study drug never administered|1|||
160954386|NCT03996473|581219270|FG000|Active Follow-up|Death|1|||
160954387|NCT03996473|581219270|FG000|Long-term Follow-up|Death|5|||
160954388|NCT03759873|581219271|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
160954389|NCT03759873|581219272|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
160954390|NCT03759873|581219273|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
160954391|NCT03759873|581219274|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
160954392|NCT03759873|581219271|FG000|Overall Study|Moved outside eligible area|0|||
160954393|NCT03759873|581219272|FG001|Overall Study|Moved outside eligible area|2|||
160954394|NCT03759873|581219273|FG002|Overall Study|Moved outside eligible area|0|||
160954395|NCT03759873|581219274|FG003|Overall Study|Moved outside eligible area|0|||
160954396|NCT03759873|581219271|FG000|Overall Study|Withdrawal by Subject|0|||
161342893|NCT03573297|582642292|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
161342894|NCT03573297|582642293|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
160954397|NCT03759873|581219272|FG001|Overall Study|Withdrawal by Subject|0|||
160954398|NCT03759873|581219273|FG002|Overall Study|Withdrawal by Subject|1|||
160954399|NCT03759873|581219274|FG003|Overall Study|Withdrawal by Subject|0|||
160954400|NCT03579563|581219277|FG000|Overall Study|Lost to Follow-up|0|||
160954401|NCT03579563|581219278|FG001|Overall Study|Lost to Follow-up|0|||
160954402|NCT03579563|581219279|FG002|Overall Study|Lost to Follow-up|0|||
160954403|NCT03579563|581219280|FG003|Overall Study|Lost to Follow-up|0|||
160954404|NCT03579563|581219281|FG004|Overall Study|Lost to Follow-up|1|||
160954405|NCT03579563|581219282|FG005|Overall Study|Lost to Follow-up|0|||
160954406|NCT03579563|581219277|FG000|Overall Study|Lack of Efficacy|1|||
160954407|NCT03579563|581219278|FG001|Overall Study|Lack of Efficacy|1|||
160954408|NCT03579563|581219279|FG002|Overall Study|Lack of Efficacy|4|||
160954409|NCT03579563|581219280|FG003|Overall Study|Lack of Efficacy|1|||
160954410|NCT03579563|581219281|FG004|Overall Study|Lack of Efficacy|2|||
160954411|NCT03579563|581219282|FG005|Overall Study|Lack of Efficacy|3|||
160954412|NCT03579563|581219277|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
160954413|NCT03579563|581219278|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
160954414|NCT03579563|581219279|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
160954415|NCT03579563|581219280|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
160954416|NCT03579563|581219281|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
160954417|NCT03579563|581219282|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
160954418|NCT03579563|581219277|FG000|Overall Study|Time/distance concern|0|||
160954419|NCT03579563|581219278|FG001|Overall Study|Time/distance concern|0|||
160954420|NCT03579563|581219279|FG002|Overall Study|Time/distance concern|1|||
160954421|NCT03579563|581219280|FG003|Overall Study|Time/distance concern|0|||
160954422|NCT03579563|581219281|FG004|Overall Study|Time/distance concern|0|||
160954423|NCT03579563|581219282|FG005|Overall Study|Time/distance concern|1|||
160954424|NCT03579563|581219277|FG000|Overall Study|COVID shutdown|2|||
160954425|NCT03579563|581219278|FG001|Overall Study|COVID shutdown|3|||
160954426|NCT03579563|581219279|FG002|Overall Study|COVID shutdown|4|||
160954427|NCT03579563|581219280|FG003|Overall Study|COVID shutdown|3|||
160954428|NCT03579563|581219281|FG004|Overall Study|COVID shutdown|1|||
160954429|NCT03579563|581219282|FG005|Overall Study|COVID shutdown|2|||
160954430|NCT03579563|581219277|FG000|Overall Study|Protocol administration error|1|||
160954431|NCT03579563|581219278|FG001|Overall Study|Protocol administration error|0|||
160954432|NCT03579563|581219279|FG002|Overall Study|Protocol administration error|1|||
160954433|NCT03579563|581219280|FG003|Overall Study|Protocol administration error|0|||
160954434|NCT03579563|581219281|FG004|Overall Study|Protocol administration error|1|||
160954435|NCT03579563|581219282|FG005|Overall Study|Protocol administration error|5|||
160954436|NCT02105948|581219284|FG000|Overall Study|Adverse Event|10|||
160954437|NCT02105948|581219285|FG001|Overall Study|Adverse Event|7|||
160954438|NCT02105948|581219286|FG002|Overall Study|Adverse Event|11|||
160954439|NCT02105948|581219287|FG003|Overall Study|Adverse Event|11|||
160954440|NCT02105948|581219284|FG000|Overall Study|Lack of Efficacy|0|||
160954441|NCT02105948|581219285|FG001|Overall Study|Lack of Efficacy|1|||
160954442|NCT02105948|581219286|FG002|Overall Study|Lack of Efficacy|3|||
160954443|NCT02105948|581219287|FG003|Overall Study|Lack of Efficacy|2|||
160954444|NCT02105948|581219284|FG000|Overall Study|Lost to Follow-up|0|||
160954445|NCT02105948|581219285|FG001|Overall Study|Lost to Follow-up|0|||
160954446|NCT02105948|581219286|FG002|Overall Study|Lost to Follow-up|2|||
160954447|NCT02105948|581219287|FG003|Overall Study|Lost to Follow-up|1|||
160954448|NCT02105948|581219284|FG000|Overall Study|Physician Decision|2|||
160954449|NCT02105948|581219285|FG001|Overall Study|Physician Decision|2|||
160954450|NCT02105948|581219286|FG002|Overall Study|Physician Decision|2|||
160954451|NCT02105948|581219287|FG003|Overall Study|Physician Decision|2|||
160954452|NCT02105948|581219284|FG000|Overall Study|Withdrawal by Subject|15|||
160954453|NCT02105948|581219285|FG001|Overall Study|Withdrawal by Subject|10|||
160954454|NCT02105948|581219286|FG002|Overall Study|Withdrawal by Subject|10|||
160954455|NCT02105948|581219287|FG003|Overall Study|Withdrawal by Subject|11|||
160954456|NCT00522275|581219288|FG000|Overall Study|Adverse Event|35|||
160954457|NCT00522275|581219288|FG000|Overall Study|Lack of Efficacy|80|||
160954458|NCT00522275|581219288|FG000|Overall Study|Subject withdrew consent|16|||
160954459|NCT00522275|581219288|FG000|Overall Study|Protocol deviation|1|||
160954460|NCT00522275|581219288|FG000|Overall Study|Unsatisfactory compliance|11|||
160954461|NCT00522275|581219288|FG000|Overall Study|Lost to Follow-up|8|||
160954462|NCT00522275|581219288|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
160954463|NCT00522275|581219288|FG000|Overall Study|Other: Subject is pregnant|2|||
160954464|NCT00522275|581219288|FG000|Overall Study|Other: Subject relocated|2|||
160954465|NCT00522275|581219288|FG000|Overall Study|Other: Subject arrested|1|||
160954466|NCT00522275|581219288|FG000|Overall Study|Other: Site / clinic closed|4|||
160954467|NCT00522275|581219288|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
160954468|NCT00522275|581219288|FG000|Overall Study|Other: Sponsor request|2|||
160954469|NCT00522275|581219288|FG000|Overall Study|Other: Subject ran out of medication|1|||
160954470|NCT00522275|581219288|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
160954471|NCT04558346|581219297|FG000|Overall Study|Withdrawal by Subject|2|||
160954472|NCT04558346|581219298|FG001|Overall Study|Withdrawal by Subject|0|||
160954473|NCT04558346|581219297|FG000|Overall Study|Lost to Follow-up|0|||
160954474|NCT04558346|581219298|FG001|Overall Study|Lost to Follow-up|1|||
161342895|NCT03573297|582642294|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
160954475|NCT04558346|581219297|FG000|Overall Study|Adverse Event|0|||
160954476|NCT04558346|581219298|FG001|Overall Study|Adverse Event|1|||
160954477|NCT01462344|581219301|FG000|Overall Study|Withdrawal by Subject|245|||
160954478|NCT01462344|581219302|FG001|Overall Study|Withdrawal by Subject|226|||
160954479|NCT01462344|581219301|FG000|Overall Study|Adverse Event|24|||
160954480|NCT01462344|581219302|FG001|Overall Study|Adverse Event|23|||
160954481|NCT01462344|581219301|FG000|Overall Study|Asthma Exacerbation|34|||
160954482|NCT01462344|581219302|FG001|Overall Study|Asthma Exacerbation|35|||
160954483|NCT01462344|581219301|FG000|Overall Study|Lack of Efficacy|5|||
160954484|NCT01462344|581219302|FG001|Overall Study|Lack of Efficacy|6|||
160954485|NCT01462344|581219301|FG000|Overall Study|Protocol Violation|68|||
160954486|NCT01462344|581219302|FG001|Overall Study|Protocol Violation|53|||
160954487|NCT01462344|581219301|FG000|Overall Study|Lost to Follow-up|7|||
160954488|NCT01462344|581219302|FG001|Overall Study|Lost to Follow-up|7|||
160954489|NCT00724971|581219303|FG000|Overall Study|Adverse Event|5|||
160954490|NCT00724971|581219303|FG000|Overall Study|Withdrawal by Subject|1|||
160954491|NCT01962974|581219304|FG000|Overall Study|Study termination|7|||
160954492|NCT02276482|581219305|FG000|Overall Study|Adverse Event|1|||
160954493|NCT02276482|581219306|FG001|Overall Study|Adverse Event|0|||
160954494|NCT02276482|581219305|FG000|Overall Study|Withdrawal by Subject|1|||
160954495|NCT02276482|581219306|FG001|Overall Study|Withdrawal by Subject|0|||
160954496|NCT02276482|581219305|FG000|Overall Study|Gram-negative infection|1|||
160954497|NCT02276482|581219306|FG001|Overall Study|Gram-negative infection|0|||
160954498|NCT02276482|581219305|FG000|Overall Study|Reason not specified|0|||
160954499|NCT02276482|581219306|FG001|Overall Study|Reason not specified|1|||
160954500|NCT01410448|581219312|FG000|Overall Study|No conversion to everolimus|0|||
160954501|NCT01410448|581219313|FG001|Overall Study|No conversion to everolimus|24|||
160954502|NCT01410448|581219312|FG000|Overall Study|Graft loss|4|||
160954503|NCT01410448|581219313|FG001|Overall Study|Graft loss|1|||
160954504|NCT01410448|581219312|FG000|Overall Study|Administrative issues|2|||
160954505|NCT01410448|581219313|FG001|Overall Study|Administrative issues|1|||
160954506|NCT01410448|581219312|FG000|Overall Study|Lost to Follow-up|1|||
160954507|NCT01410448|581219313|FG001|Overall Study|Lost to Follow-up|0|||
160954508|NCT01410448|581219312|FG000|Overall Study|Withdrawal by Subject|3|||
160954509|NCT01410448|581219313|FG001|Overall Study|Withdrawal by Subject|2|||
160954510|NCT01410448|581219312|FG000|Overall Study|Protocol Violation|0|||
160954511|NCT01410448|581219313|FG001|Overall Study|Protocol Violation|4|||
160954512|NCT01410448|581219312|FG000|Overall Study|Death|2|||
160954513|NCT01410448|581219313|FG001|Overall Study|Death|3|||
160954514|NCT01218438|581219316|FG000|Epoch 1|Physician Decision|2|||
160954515|NCT01218438|581219316|FG000|Epoch 1|Adverse Event|1|||
160954516|NCT01218438|581219316|FG000|Epoch 3|Withdrawal by Subject|3|||
160954517|NCT01218438|581219316|FG000|Epoch 3|Adverse Event|1|||
160954518|NCT01218438|581219316|FG000|Epoch 4|Physician Decision|1|||
160954519|NCT01218438|581219316|FG000|Epoch 4|Withdrawal by Subject|2|||
160954520|NCT01438541|581219319|FG000|Overall Study|Physician Decision|1|||
160954521|NCT01438541|581219319|FG000|Overall Study|Withdrawal by Subject|1|||
160954522|NCT01438541|581219319|FG000|Overall Study|discharge from the hospital|5|||
160954523|NCT02091167|581219320|FG000|Overall Study|Lost to Follow-up|0|||
160954524|NCT02091167|581219321|FG001|Overall Study|Lost to Follow-up|2|||
160954525|NCT01218646|581219322|FG000|Overall Study|Adverse Event|0|||
160954526|NCT01218646|581219323|FG001|Overall Study|Adverse Event|0|||
160954527|NCT01218646|581219324|FG002|Overall Study|Adverse Event|1|||
160954528|NCT01218646|581219325|FG003|Overall Study|Adverse Event|0|||
160954529|NCT01218646|581219322|FG000|Overall Study|Lost to Follow-up|1|||
160954530|NCT01218646|581219323|FG001|Overall Study|Lost to Follow-up|0|||
160954531|NCT01218646|581219324|FG002|Overall Study|Lost to Follow-up|0|||
160954532|NCT01218646|581219325|FG003|Overall Study|Lost to Follow-up|0|||
160954533|NCT01218646|581219322|FG000|Overall Study|Protocol Violation|0|||
160954534|NCT01218646|581219323|FG001|Overall Study|Protocol Violation|0|||
160954535|NCT01218646|581219324|FG002|Overall Study|Protocol Violation|1|||
161000957|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
161000958|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
161000959|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161000960|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
161000961|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
160954536|NCT01218646|581219325|FG003|Overall Study|Protocol Violation|1|||
160954537|NCT00722761|581219326|FG000|Overall Study|Lost to Follow-up|1|||
161342896|NCT03573297|582642295|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
160954538|NCT00722761|581219327|FG001|Overall Study|Lost to Follow-up|4|||
160954539|NCT00722761|581219326|FG000|Overall Study|Withdrawal by Subject|5|||
160954540|NCT00722761|581219327|FG001|Overall Study|Withdrawal by Subject|2|||
161146233|NCT01518699|581918405|FG003|Period 2|Lost to Follow-up|0|||
160954541|NCT02693665|581219333|FG000|Overall Study|Death|3|||
160954542|NCT02693665|581219334|FG001|Overall Study|Death|2|||
160954543|NCT02693665|581219333|FG000|Overall Study|Lost to Follow-up|7|||
160954544|NCT02693665|581219334|FG001|Overall Study|Lost to Follow-up|3|||
160954545|NCT02693665|581219333|FG000|Overall Study|Protocol Violation|1|||
160954546|NCT02693665|581219334|FG001|Overall Study|Protocol Violation|0|||
160954547|NCT02693665|581219333|FG000|Overall Study|Withdrawal by Subject|2|||
160954548|NCT02693665|581219334|FG001|Overall Study|Withdrawal by Subject|0|||
160954549|NCT02693665|581219333|FG000|Overall Study|patient wanted to leave it behind|1|||
160954550|NCT02693665|581219334|FG001|Overall Study|patient wanted to leave it behind|0|||
160954551|NCT02693665|581219333|FG000|Overall Study|anxiety|1|||
160954552|NCT02693665|581219334|FG001|Overall Study|anxiety|0|||
160954553|NCT02693665|581219333|FG000|Overall Study|family issues|1|||
160954554|NCT02693665|581219334|FG001|Overall Study|family issues|0|||
160954555|NCT02693665|581219333|FG000|Overall Study|no reason given|1|||
160954556|NCT02693665|581219334|FG001|Overall Study|no reason given|0|||
160954557|NCT03096782|581219335|FG000|Overall Study|Death|1|||
160954558|NCT03096782|581219335|FG000|Overall Study|Participant Relapsed|1|||
160954559|NCT02075593|581219336|FG000|Overall Study|Withdrawal by Subject|1|||
160954560|NCT05819749|581219341|FG000|Overall Study|Lost to Follow-up|1|||
160954561|NCT00844857|581221702|FG000|Overall Study|Adverse Event|24|||
160954562|NCT00844857|581221703|FG001|Overall Study|Adverse Event|5|||
160954563|NCT00844857|581221702|FG000|Overall Study|Sponsor Decision|1|||
160954564|NCT00844857|581221703|FG001|Overall Study|Sponsor Decision|1|||
160954565|NCT00844857|581221702|FG000|Overall Study|Physician Decision|2|||
160954566|NCT00844857|581221703|FG001|Overall Study|Physician Decision|0|||
160954567|NCT00844857|581221702|FG000|Overall Study|Parent/Caregiver Decision|6|||
160954568|NCT00844857|581221703|FG001|Overall Study|Parent/Caregiver Decision|2|||
160954569|NCT00844857|581221702|FG000|Overall Study|Withdrawal by Subject|8|||
160954570|NCT00844857|581221703|FG001|Overall Study|Withdrawal by Subject|7|||
160954571|NCT00844857|581221702|FG000|Overall Study|Protocol Violation|6|||
160954572|NCT00844857|581221703|FG001|Overall Study|Protocol Violation|0|||
160954573|NCT00844857|581221702|FG000|Overall Study|Lack of Efficacy|5|||
160954574|NCT00844857|581221703|FG001|Overall Study|Lack of Efficacy|5|||
160954575|NCT00844857|581221702|FG000|Overall Study|Clinical Relapse|0|||
160954576|NCT00844857|581221703|FG001|Overall Study|Clinical Relapse|1|||
160954577|NCT00844857|581221702|FG000|Overall Study|Entry Criteria Not Met|0|||
160954578|NCT00844857|581221703|FG001|Overall Study|Entry Criteria Not Met|1|||
160954579|NCT00844857|581221702|FG000|Overall Study|Lost to Follow-up|2|||
161000962|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
161000963|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
161000964|NCT01087762|581388932|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161000965|NCT01087762|581388933|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161000966|NCT01087762|581388934|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
161000967|NCT01087762|581388935|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
161000968|NCT01087762|581388936|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
161000969|NCT01405924|581388939|FG000|Overall Study|Protocol Violation|8|||
161000970|NCT01405924|581388939|FG000|Overall Study|Missing/Incomplete Data|2|||
161000971|NCT02393716|581388940|FG000|Overall Study|Death|29|||
161000972|NCT02393716|581388940|FG000|Overall Study|Withdrawal by Subject|8|||
161000973|NCT02393716|581388940|FG000|Overall Study|Device Explanted|8|||
161000974|NCT02393716|581388940|FG000|Overall Study|Missed visit|16|||
161000975|NCT01924767|581388941|FG000|Overall Study|Adverse Event|1|||
161000976|NCT01924767|581388942|FG001|Overall Study|Adverse Event|0|||
161000977|NCT01924767|581388943|FG002|Overall Study|Adverse Event|1|||
161000978|NCT01924767|581388944|FG003|Overall Study|Adverse Event|0|||
161000979|NCT01924767|581388945|FG004|Overall Study|Adverse Event|0|||
161000980|NCT01648140|581388946|FG000|Overall Study|Physician Decision|1|||
161000981|NCT01648140|581388947|FG001|Overall Study|Physician Decision|0|||
161000982|NCT01648140|581388948|FG002|Overall Study|Physician Decision|0|||
161000983|NCT01648140|581388949|FG003|Overall Study|Physician Decision|0|||
161000984|NCT01648140|581388946|FG000|Overall Study|Lack of Efficacy|4|||
161000985|NCT01648140|581388947|FG001|Overall Study|Lack of Efficacy|7|||
161000986|NCT01648140|581388948|FG002|Overall Study|Lack of Efficacy|1|||
161000987|NCT01648140|581388949|FG003|Overall Study|Lack of Efficacy|0|||
161000988|NCT01648140|581388946|FG000|Overall Study|Adverse Event|3|||
161000989|NCT01648140|581388947|FG001|Overall Study|Adverse Event|1|||
161268733|NCT01175811|582366841|FG001|Overall Study|Lost to Follow-up|2|||
161268734|NCT01175811|582366840|FG000|Overall Study|Physician Decision|1|||
161268735|NCT01175811|582366841|FG001|Overall Study|Physician Decision|1|||
161268736|NCT01175811|582366840|FG000|Overall Study|Protocol Violation|1|||
161000990|NCT01648140|581388948|FG002|Overall Study|Adverse Event|2|||
160954580|NCT00844857|581221703|FG001|Overall Study|Lost to Follow-up|3|||
160954581|NCT00844857|581221702|FG000|Overall Study|Did Not Take Study Drug|3|||
160954582|NCT00844857|581221703|FG001|Overall Study|Did Not Take Study Drug|1|||
161000991|NCT01648140|581388949|FG003|Overall Study|Adverse Event|0|||
161000992|NCT01648140|581388946|FG000|Overall Study|Withdrawal by Subject|2|||
161000993|NCT01648140|581388947|FG001|Overall Study|Withdrawal by Subject|3|||
161000994|NCT01648140|581388948|FG002|Overall Study|Withdrawal by Subject|3|||
160954583|NCT00844857|581221702|FG000|Overall Study|Good Clinical Practice Violations|21|||
160954584|NCT00844857|581221703|FG001|Overall Study|Good Clinical Practice Violations|11|||
160954585|NCT00570674|581221704|FG000|Overall Study|Withdrawal by Subject|0|||
160954586|NCT00570674|581221705|FG001|Overall Study|Withdrawal by Subject|0|||
160954587|NCT00570674|581221706|FG002|Overall Study|Withdrawal by Subject|1|||
161000995|NCT01648140|581388949|FG003|Overall Study|Withdrawal by Subject|2|||
161268737|NCT01175811|582366841|FG001|Overall Study|Protocol Violation|2|||
161268738|NCT01175811|582366840|FG000|Overall Study|Withdrawal by Subject|6|||
160954588|NCT00570674|581221707|FG003|Overall Study|Withdrawal by Subject|0|||
160954589|NCT00570674|581221708|FG004|Overall Study|Withdrawal by Subject|0|||
160954590|NCT00570674|581221709|FG005|Overall Study|Withdrawal by Subject|0|||
160954591|NCT00570674|581221710|FG006|Overall Study|Withdrawal by Subject|0|||
160954592|NCT03069482|581221711|FG000|Overall Study|Lost to Follow-up|0|||
160954593|NCT03069482|581221712|FG001|Overall Study|Lost to Follow-up|1|||
160954594|NCT03069482|581221711|FG000|Overall Study|Physician Decision|1|||
160954595|NCT03069482|581221712|FG001|Overall Study|Physician Decision|0|||
160954596|NCT01949311|581221723|FG000|Overall Study|Lost to Follow-up|73|||
160954597|NCT01949311|581221723|FG000|Overall Study|Terminated by Sponsor|708|||
160954598|NCT01949311|581221723|FG000|Overall Study|Withdrawal by Subject|375|||
160954599|NCT01949311|581221723|FG000|Overall Study|Lack of Efficacy|50|||
160954600|NCT01949311|581221723|FG000|Overall Study|Protocol Deviation|34|||
160954601|NCT01949311|581221723|FG000|Overall Study|Pregnancy|20|||
160954602|NCT01949311|581221723|FG000|Overall Study|Physician Decision|9|||
160954603|NCT01949311|581221723|FG000|Overall Study|Other|4|||
160954604|NCT01949311|581221723|FG000|Overall Study|Adverse Event|107|||
160954605|NCT02338154|581221724|FG000|Overall Study|Death|46|||
160954606|NCT02338154|581221724|FG000|Overall Study|Valve Implant Failure|17|||
160954607|NCT02338154|581221724|FG000|Overall Study|Valve Explant|11|||
160954608|NCT02338154|581221724|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
160954609|NCT02338154|581221724|FG000|Overall Study|Lost to Follow-up|8|||
160954610|NCT02338154|581221724|FG000|Overall Study|Other Reason|3|||
160954611|NCT02338154|581221724|FG000|Overall Study|Patients Without Exit Form|47|||
160954612|NCT02338154|581221724|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
160954613|NCT01559844|581221729|FG000|Overall Study|Consent Withdrawn|7|||
160954614|NCT01559844|581221729|FG000|Overall Study|Death|5|||
160954615|NCT01559844|581221729|FG000|Overall Study|Efficacy Failure|10|||
160954616|NCT01559844|581221729|FG000|Overall Study|No Longer A Transplant Candidate|3|||
160954617|NCT00951041|581221730|FG000|Overall Study|Withdrawal by Subject|1|||
160954618|NCT00951041|581221731|FG001|Overall Study|Withdrawal by Subject|1|||
160954619|NCT00951041|581221730|FG000|Overall Study|Lost to Follow-up|1|||
160954620|NCT00951041|581221731|FG001|Overall Study|Lost to Follow-up|0|||
160954621|NCT00951041|581221730|FG000|Overall Study|Other|3|||
160954622|NCT00951041|581221731|FG001|Overall Study|Other|0|||
160954623|NCT02388724|581221735|FG000|Overall Study|Reason not Specified|0|||
160954624|NCT02388724|581221736|FG001|Overall Study|Reason not Specified|1|||
160954625|NCT02388724|581221735|FG000|Overall Study|Major Protocol Deviation|3|||
160954626|NCT02388724|581221736|FG001|Overall Study|Major Protocol Deviation|3|||
160954627|NCT02388724|581221735|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
160954628|NCT02388724|581221736|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
160954629|NCT02388724|581221735|FG000|Overall Study|Voluntary Withdrawal|6|||
160954630|NCT02388724|581221736|FG001|Overall Study|Voluntary Withdrawal|5|||
160954631|NCT02388724|581221735|FG000|Overall Study|Randomized but not Treated|0|||
160954632|NCT02388724|581221736|FG001|Overall Study|Randomized but not Treated|2|||
160954633|NCT01217073|581221737|FG000|Base Period|Adverse Event|1|||
160954634|NCT01217073|581221738|FG001|Base Period|Adverse Event|0|||
160954635|NCT01217073|581221739|FG002|Base Period|Adverse Event|1|||
160954636|NCT01217073|581221740|FG003|Base Period|Adverse Event|0|||
160954637|NCT01217073|581221741|FG004|Base Period|Adverse Event|4|||
160954638|NCT01217073|581221742|FG005|Base Period|Adverse Event|1|||
160954639|NCT01217073|581221743|FG006|Base Period|Adverse Event|0|||
161268739|NCT01175811|582366841|FG001|Overall Study|Withdrawal by Subject|7|||
160954640|NCT01217073|581221744|FG007|Base Period|Adverse Event|0|||
160954641|NCT01217073|581221737|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
160954642|NCT01217073|581221738|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954643|NCT01217073|581221739|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954644|NCT01217073|581221740|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954645|NCT01217073|581221741|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954646|NCT01217073|581221742|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954647|NCT01217073|581221743|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
160954648|NCT01217073|581221744|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
161268740|NCT02628743|582366843|FG000|Overall Study|Other|3|||
160954649|NCT01217073|581221737|FG000|Base Period|Excluded medication|0|||
160954650|NCT01217073|581221738|FG001|Base Period|Excluded medication|0|||
160954651|NCT01217073|581221739|FG002|Base Period|Excluded medication|0|||
160954652|NCT01217073|581221740|FG003|Base Period|Excluded medication|0|||
160954653|NCT01217073|581221741|FG004|Base Period|Excluded medication|1|||
160954654|NCT01217073|581221742|FG005|Base Period|Excluded medication|0|||
161000996|NCT01648140|581388946|FG000|Overall Study|Lost to Follow-up|2|||
160954655|NCT01217073|581221743|FG006|Base Period|Excluded medication|0|||
160954656|NCT01217073|581221744|FG007|Base Period|Excluded medication|0|||
160954657|NCT01217073|581221737|FG000|Base Period|Lack of Efficacy|0|||
160954658|NCT01217073|581221738|FG001|Base Period|Lack of Efficacy|0|||
160954659|NCT01217073|581221739|FG002|Base Period|Lack of Efficacy|0|||
161268741|NCT02628743|582366843|FG000|Overall Study|Withdrawal by Subject|50|||
160954660|NCT01217073|581221740|FG003|Base Period|Lack of Efficacy|0|||
160954661|NCT01217073|581221741|FG004|Base Period|Lack of Efficacy|0|||
160954662|NCT01217073|581221742|FG005|Base Period|Lack of Efficacy|1|||
160954663|NCT01217073|581221743|FG006|Base Period|Lack of Efficacy|0|||
160954664|NCT01217073|581221744|FG007|Base Period|Lack of Efficacy|0|||
160954665|NCT01217073|581221737|FG000|Base Period|Lost to Follow-up|0|||
160954666|NCT01217073|581221738|FG001|Base Period|Lost to Follow-up|0|||
160954667|NCT01217073|581221739|FG002|Base Period|Lost to Follow-up|1|||
160954668|NCT01217073|581221740|FG003|Base Period|Lost to Follow-up|1|||
160954669|NCT01217073|581221741|FG004|Base Period|Lost to Follow-up|3|||
160954670|NCT01217073|581221742|FG005|Base Period|Lost to Follow-up|0|||
160954671|NCT01217073|581221743|FG006|Base Period|Lost to Follow-up|0|||
160954672|NCT01217073|581221744|FG007|Base Period|Lost to Follow-up|0|||
160954673|NCT01217073|581221737|FG000|Base Period|Physician Decision|0|||
160954674|NCT01217073|581221738|FG001|Base Period|Physician Decision|0|||
160954675|NCT01217073|581221739|FG002|Base Period|Physician Decision|0|||
160954676|NCT01217073|581221740|FG003|Base Period|Physician Decision|0|||
160954677|NCT01217073|581221741|FG004|Base Period|Physician Decision|1|||
160954678|NCT01217073|581221742|FG005|Base Period|Physician Decision|0|||
160954679|NCT01217073|581221743|FG006|Base Period|Physician Decision|0|||
160954680|NCT01217073|581221744|FG007|Base Period|Physician Decision|0|||
160954681|NCT01217073|581221737|FG000|Base Period|Protocol Violation|1|||
160954682|NCT01217073|581221738|FG001|Base Period|Protocol Violation|0|||
160954683|NCT01217073|581221739|FG002|Base Period|Protocol Violation|0|||
160954684|NCT01217073|581221740|FG003|Base Period|Protocol Violation|0|||
160954685|NCT01217073|581221741|FG004|Base Period|Protocol Violation|1|||
160954686|NCT01217073|581221742|FG005|Base Period|Protocol Violation|2|||
160954687|NCT01217073|581221743|FG006|Base Period|Protocol Violation|0|||
160954688|NCT01217073|581221744|FG007|Base Period|Protocol Violation|0|||
160954689|NCT01217073|581221737|FG000|Base Period|Withdrawal by Subject|4|||
160954690|NCT01217073|581221738|FG001|Base Period|Withdrawal by Subject|5|||
160954691|NCT01217073|581221739|FG002|Base Period|Withdrawal by Subject|5|||
160954692|NCT01217073|581221740|FG003|Base Period|Withdrawal by Subject|1|||
160954693|NCT01217073|581221741|FG004|Base Period|Withdrawal by Subject|5|||
160954694|NCT01217073|581221742|FG005|Base Period|Withdrawal by Subject|5|||
160954695|NCT01217073|581221743|FG006|Base Period|Withdrawal by Subject|0|||
160954696|NCT01217073|581221744|FG007|Base Period|Withdrawal by Subject|0|||
160954697|NCT01217073|581221737|FG000|Extension Period|Adverse Event|0|||
160954698|NCT01217073|581221738|FG001|Extension Period|Adverse Event|0|||
160954699|NCT01217073|581221739|FG002|Extension Period|Adverse Event|0|||
160954700|NCT01217073|581221740|FG003|Extension Period|Adverse Event|0|||
160954701|NCT01217073|581221741|FG004|Extension Period|Adverse Event|0|||
160954702|NCT01217073|581221742|FG005|Extension Period|Adverse Event|0|||
160954703|NCT01217073|581221743|FG006|Extension Period|Adverse Event|19|||
160954704|NCT01217073|581221744|FG007|Extension Period|Adverse Event|5|||
160954705|NCT01217073|581221737|FG000|Extension Period|ALT/AST|0|||
160954706|NCT01217073|581221738|FG001|Extension Period|ALT/AST|0|||
160954707|NCT01217073|581221739|FG002|Extension Period|ALT/AST|0|||
160954708|NCT01217073|581221740|FG003|Extension Period|ALT/AST|0|||
160954709|NCT01217073|581221741|FG004|Extension Period|ALT/AST|0|||
160954710|NCT01217073|581221742|FG005|Extension Period|ALT/AST|0|||
160954711|NCT01217073|581221743|FG006|Extension Period|ALT/AST|2|||
160954712|NCT01217073|581221744|FG007|Extension Period|ALT/AST|0|||
160954713|NCT01217073|581221737|FG000|Extension Period|Contraindication to study medication|0|||
160954714|NCT01217073|581221738|FG001|Extension Period|Contraindication to study medication|0|||
160954715|NCT01217073|581221739|FG002|Extension Period|Contraindication to study medication|0|||
160954716|NCT01217073|581221740|FG003|Extension Period|Contraindication to study medication|0|||
160954717|NCT01217073|581221741|FG004|Extension Period|Contraindication to study medication|0|||
160954718|NCT01217073|581221742|FG005|Extension Period|Contraindication to study medication|0|||
160954719|NCT01217073|581221743|FG006|Extension Period|Contraindication to study medication|1|||
161000997|NCT01648140|581388947|FG001|Overall Study|Lost to Follow-up|1|||
161000998|NCT01648140|581388948|FG002|Overall Study|Lost to Follow-up|2|||
161000999|NCT01648140|581388949|FG003|Overall Study|Lost to Follow-up|0|||
161001000|NCT01183780|581388951|FG000|Overall Study|Withdrawal by Subject|25|||
160954720|NCT01217073|581221744|FG007|Extension Period|Contraindication to study medication|0|||
160954721|NCT01217073|581221737|FG000|Extension Period|Creatinine/eGFR|0|||
161268742|NCT02628743|582366843|FG000|Overall Study|Study Terminated by Sponsor|76|||
160954722|NCT01217073|581221738|FG001|Extension Period|Creatinine/eGFR|0|||
160954723|NCT01217073|581221739|FG002|Extension Period|Creatinine/eGFR|0|||
161268743|NCT02628743|582366843|FG000|Overall Study|Physician Decision|2|||
160954724|NCT01217073|581221740|FG003|Extension Period|Creatinine/eGFR|0|||
161268744|NCT04715932|582366844|FG000|Overall Study|Lost to Follow-up|1|||
160954725|NCT01217073|581221741|FG004|Extension Period|Creatinine/eGFR|0|||
160954726|NCT01217073|581221742|FG005|Extension Period|Creatinine/eGFR|0|||
160954727|NCT01217073|581221743|FG006|Extension Period|Creatinine/eGFR|11|||
160954728|NCT01217073|581221744|FG007|Extension Period|Creatinine/eGFR|1|||
160954729|NCT01217073|581221737|FG000|Extension Period|Death|0|||
161001001|NCT01183780|581388952|FG001|Overall Study|Withdrawal by Subject|14|||
161001002|NCT01183780|581388951|FG000|Overall Study|Lost to Follow-up|6|||
160954730|NCT01217073|581221738|FG001|Extension Period|Death|0|||
160954731|NCT01217073|581221739|FG002|Extension Period|Death|0|||
160954732|NCT01217073|581221740|FG003|Extension Period|Death|0|||
160954733|NCT01217073|581221741|FG004|Extension Period|Death|0|||
160954734|NCT01217073|581221742|FG005|Extension Period|Death|0|||
160954735|NCT01217073|581221743|FG006|Extension Period|Death|1|||
160954736|NCT01217073|581221744|FG007|Extension Period|Death|0|||
160954737|NCT01217073|581221737|FG000|Extension Period|Excluded medication|0|||
160954738|NCT01217073|581221738|FG001|Extension Period|Excluded medication|0|||
160954739|NCT01217073|581221739|FG002|Extension Period|Excluded medication|0|||
160954740|NCT01217073|581221740|FG003|Extension Period|Excluded medication|0|||
160954741|NCT01217073|581221741|FG004|Extension Period|Excluded medication|0|||
160954742|NCT01217073|581221742|FG005|Extension Period|Excluded medication|0|||
160954743|NCT01217073|581221743|FG006|Extension Period|Excluded medication|2|||
160954744|NCT01217073|581221744|FG007|Extension Period|Excluded medication|0|||
160954745|NCT01217073|581221737|FG000|Extension Period|Lack of Efficacy|0|||
160954746|NCT01217073|581221738|FG001|Extension Period|Lack of Efficacy|0|||
160954747|NCT01217073|581221739|FG002|Extension Period|Lack of Efficacy|0|||
160954748|NCT01217073|581221740|FG003|Extension Period|Lack of Efficacy|0|||
160954749|NCT01217073|581221741|FG004|Extension Period|Lack of Efficacy|0|||
160954750|NCT01217073|581221742|FG005|Extension Period|Lack of Efficacy|0|||
160954751|NCT01217073|581221743|FG006|Extension Period|Lack of Efficacy|3|||
160954752|NCT01217073|581221744|FG007|Extension Period|Lack of Efficacy|0|||
160954753|NCT01217073|581221737|FG000|Extension Period|Lost to Follow-up|0|||
160954754|NCT01217073|581221738|FG001|Extension Period|Lost to Follow-up|0|||
160954755|NCT01217073|581221739|FG002|Extension Period|Lost to Follow-up|0|||
160954756|NCT01217073|581221740|FG003|Extension Period|Lost to Follow-up|0|||
160954757|NCT01217073|581221741|FG004|Extension Period|Lost to Follow-up|0|||
160954758|NCT01217073|581221742|FG005|Extension Period|Lost to Follow-up|0|||
160954759|NCT01217073|581221743|FG006|Extension Period|Lost to Follow-up|9|||
160954760|NCT01217073|581221744|FG007|Extension Period|Lost to Follow-up|1|||
160954761|NCT01217073|581221737|FG000|Extension Period|Non-compliance with study drug|0|||
160954762|NCT01217073|581221738|FG001|Extension Period|Non-compliance with study drug|0|||
160954763|NCT01217073|581221739|FG002|Extension Period|Non-compliance with study drug|0|||
160954764|NCT01217073|581221740|FG003|Extension Period|Non-compliance with study drug|0|||
160954765|NCT01217073|581221741|FG004|Extension Period|Non-compliance with study drug|0|||
160954766|NCT01217073|581221742|FG005|Extension Period|Non-compliance with study drug|0|||
160954767|NCT01217073|581221743|FG006|Extension Period|Non-compliance with study drug|0|||
160954768|NCT01217073|581221744|FG007|Extension Period|Non-compliance with study drug|1|||
160954769|NCT01217073|581221737|FG000|Extension Period|Physician Decision|0|||
160954770|NCT01217073|581221738|FG001|Extension Period|Physician Decision|0|||
160954771|NCT01217073|581221739|FG002|Extension Period|Physician Decision|0|||
160954772|NCT01217073|581221740|FG003|Extension Period|Physician Decision|0|||
160954773|NCT01217073|581221741|FG004|Extension Period|Physician Decision|0|||
160954774|NCT01217073|581221742|FG005|Extension Period|Physician Decision|0|||
160954775|NCT01217073|581221743|FG006|Extension Period|Physician Decision|4|||
161001003|NCT01183780|581388952|FG001|Overall Study|Lost to Follow-up|11|||
161001004|NCT01505881|581388953|FG000|Overall Study|Adverse Event|0|||
161001005|NCT01505881|581388954|FG001|Overall Study|Adverse Event|1|||
161268745|NCT04715932|582366845|FG001|Overall Study|Lost to Follow-up|0|||
161268746|NCT03560986|582366846|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
161268747|NCT03560986|582366847|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
161268748|NCT03560986|582366846|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161268749|NCT03560986|582366847|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161268750|NCT03560986|582366846|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
161268751|NCT03560986|582366847|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
161268752|NCT03560986|582366846|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
161268753|NCT03560986|582366847|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
161268754|NCT03560986|582366846|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
161268755|NCT03560986|582366847|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
161268756|NCT03560986|582366846|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
161268757|NCT03560986|582366847|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
161268758|NCT03560986|582366846|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
161268759|NCT03560986|582366847|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
161268760|NCT00326963|582366848|FG000|Overall Study|Adverse Event|2|||
161268761|NCT00326963|582366848|FG000|Overall Study|Injection site reaction|1|||
161268762|NCT00326963|582366848|FG000|Overall Study|Death|1|||
161268763|NCT00326963|582366848|FG000|Overall Study|Failure to return|10|||
160954776|NCT01217073|581221744|FG007|Extension Period|Physician Decision|1|||
160954777|NCT01217073|581221737|FG000|Extension Period|Protocol Violation|0|||
160954778|NCT01217073|581221738|FG001|Extension Period|Protocol Violation|0|||
160954779|NCT01217073|581221739|FG002|Extension Period|Protocol Violation|0|||
160954780|NCT01217073|581221740|FG003|Extension Period|Protocol Violation|0|||
161001006|NCT01505881|581388953|FG000|Overall Study|Lost to Follow-up|2|||
161001007|NCT01505881|581388954|FG001|Overall Study|Lost to Follow-up|0|||
160954781|NCT01217073|581221741|FG004|Extension Period|Protocol Violation|0|||
160954782|NCT01217073|581221742|FG005|Extension Period|Protocol Violation|0|||
160954783|NCT01217073|581221743|FG006|Extension Period|Protocol Violation|2|||
160954784|NCT01217073|581221744|FG007|Extension Period|Protocol Violation|1|||
160954785|NCT01217073|581221737|FG000|Extension Period|Site discontinued study participation|0|||
160954786|NCT01217073|581221738|FG001|Extension Period|Site discontinued study participation|0|||
160954787|NCT01217073|581221739|FG002|Extension Period|Site discontinued study participation|0|||
160954788|NCT01217073|581221740|FG003|Extension Period|Site discontinued study participation|0|||
160954789|NCT01217073|581221741|FG004|Extension Period|Site discontinued study participation|0|||
160954790|NCT01217073|581221742|FG005|Extension Period|Site discontinued study participation|0|||
160954791|NCT01217073|581221743|FG006|Extension Period|Site discontinued study participation|7|||
160954792|NCT01217073|581221744|FG007|Extension Period|Site discontinued study participation|2|||
160954793|NCT01217073|581221737|FG000|Extension Period|Withdrawal by Subject|0|||
160954794|NCT01217073|581221738|FG001|Extension Period|Withdrawal by Subject|0|||
160954795|NCT01217073|581221739|FG002|Extension Period|Withdrawal by Subject|0|||
160954796|NCT01217073|581221740|FG003|Extension Period|Withdrawal by Subject|0|||
160954797|NCT01217073|581221741|FG004|Extension Period|Withdrawal by Subject|0|||
160954798|NCT01217073|581221742|FG005|Extension Period|Withdrawal by Subject|0|||
160954799|NCT01217073|581221743|FG006|Extension Period|Withdrawal by Subject|30|||
160954800|NCT01217073|581221744|FG007|Extension Period|Withdrawal by Subject|8|||
160954801|NCT02696317|581221747|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
160954802|NCT02696317|581221748|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
160954803|NCT02696317|581221747|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
160954804|NCT02696317|581221748|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
160954805|NCT01343368|581221749|FG000|Overall Study|Death|1|||
160954806|NCT01343368|581221750|FG001|Overall Study|Death|0|||
160954807|NCT01343368|581221749|FG000|Overall Study|Lost to Follow-up|1|||
160954808|NCT01343368|581221750|FG001|Overall Study|Lost to Follow-up|0|||
160954809|NCT00237744|581221751|FG000|Overall Study|Withdrawal by Subject|3|||
160954810|NCT00237744|581221752|FG001|Overall Study|Withdrawal by Subject|1|||
160954811|NCT00237744|581221753|FG002|Overall Study|Withdrawal by Subject|0|||
160954812|NCT04402866|581221756|FG000|Overall Study|Discontinued Prior to Treatment|0|||
160954813|NCT04402866|581221757|FG001|Overall Study|Discontinued Prior to Treatment|0|||
160954814|NCT04402866|581221758|FG002|Overall Study|Discontinued Prior to Treatment|0|||
160954815|NCT04402866|581221759|FG003|Overall Study|Discontinued Prior to Treatment|0|||
160954816|NCT04402866|581221760|FG004|Overall Study|Discontinued Prior to Treatment|2|||
160954817|NCT04402866|581221761|FG005|Overall Study|Discontinued Prior to Treatment|3|||
160954818|NCT04402866|581221756|FG000|Overall Study|Adverse Event|2|||
160954819|NCT04402866|581221757|FG001|Overall Study|Adverse Event|1|||
160954820|NCT04402866|581221758|FG002|Overall Study|Adverse Event|0|||
160954821|NCT04402866|581221759|FG003|Overall Study|Adverse Event|0|||
160954822|NCT04402866|581221760|FG004|Overall Study|Adverse Event|13|||
160954823|NCT04402866|581221761|FG005|Overall Study|Adverse Event|8|||
160954824|NCT04402866|581221756|FG000|Overall Study|Miscellaneous|0|||
160954825|NCT04402866|581221757|FG001|Overall Study|Miscellaneous|0|||
160954826|NCT04402866|581221758|FG002|Overall Study|Miscellaneous|1|||
160954827|NCT04402866|581221759|FG003|Overall Study|Miscellaneous|0|||
161268764|NCT00326963|582366848|FG000|Overall Study|Withdrawal by Subject|10|||
161268765|NCT00326963|582366848|FG000|Overall Study|Refused treatment / did not cooperate|5|||
161268766|NCT00326963|582366848|FG000|Overall Study|Violation of selection criteria at entry|2|||
161268767|NCT00326963|582366848|FG000|Overall Study|Other protocol violation|1|||
161268768|NCT00326963|582366848|FG000|Overall Study|Administrative / other|1|||
161268769|NCT00699374|582366849|FG000|Overall Study|Death|93|||
161268770|NCT00699374|582366850|FG001|Overall Study|Death|83|||
161268771|NCT00699374|582366849|FG000|Overall Study|Adverse Event|70|||
161268772|NCT00699374|582366850|FG001|Overall Study|Adverse Event|67|||
161268773|NCT00699374|582366849|FG000|Overall Study|Global deterioration of health status|7|||
161268774|NCT00699374|582366850|FG001|Overall Study|Global deterioration of health status|8|||
161268775|NCT00699374|582366849|FG000|Overall Study|Lost to Follow-up|3|||
161268776|NCT00699374|582366850|FG001|Overall Study|Lost to Follow-up|5|||
161268777|NCT00699374|582366849|FG000|Overall Study|Withdrawal by Subject|34|||
161268778|NCT00699374|582366850|FG001|Overall Study|Withdrawal by Subject|44|||
161268779|NCT00699374|582366849|FG000|Overall Study|Objective progression or relapse|281|||
161268780|NCT00699374|582366850|FG001|Overall Study|Objective progression or relapse|277|||
161268781|NCT00699374|582366849|FG000|Overall Study|Other|18|||
161268782|NCT00699374|582366850|FG001|Overall Study|Other|15|||
161268783|NCT00699374|582366849|FG000|Overall Study|Protocol Violation|2|||
161268784|NCT00699374|582366850|FG001|Overall Study|Protocol Violation|6|||
161268785|NCT00699374|582366849|FG000|Overall Study|Study terminated by sponsor|13|||
161268786|NCT00699374|582366850|FG001|Overall Study|Study terminated by sponsor|28|||
161146234|NCT01518699|581918406|FG004|Period 2|Lost to Follow-up|0|||
161146235|NCT01518699|581918407|FG005|Period 2|Lost to Follow-up|0|||
161146236|NCT01518699|581918402|FG000|Period 2|Adverse Event|1|||
161146237|NCT01518699|581918403|FG001|Period 2|Adverse Event|0|||
161268787|NCT00699374|582366849|FG000|Overall Study|Randomized but not treated|4|||
160954828|NCT04402866|581221760|FG004|Overall Study|Miscellaneous|0|||
160954829|NCT04402866|581221761|FG005|Overall Study|Miscellaneous|0|||
160954830|NCT04402866|581221756|FG000|Overall Study|Lost to Follow-up|0|||
160954831|NCT04402866|581221757|FG001|Overall Study|Lost to Follow-up|0|||
160954832|NCT04402866|581221758|FG002|Overall Study|Lost to Follow-up|0|||
160954833|NCT04402866|581221759|FG003|Overall Study|Lost to Follow-up|0|||
160954834|NCT04402866|581221760|FG004|Overall Study|Lost to Follow-up|0|||
160954835|NCT04402866|581221761|FG005|Overall Study|Lost to Follow-up|1|||
160954836|NCT04402866|581221756|FG000|Overall Study|Withdrawal by Subject|0|||
160954837|NCT04402866|581221757|FG001|Overall Study|Withdrawal by Subject|0|||
160954838|NCT04402866|581221758|FG002|Overall Study|Withdrawal by Subject|0|||
161001008|NCT01505881|581388953|FG000|Overall Study|Withdrawal by Subject|2|||
161001009|NCT01505881|581388954|FG001|Overall Study|Withdrawal by Subject|0|||
161001010|NCT01147341|581388955|FG000|Double Blind Period|Lack of Efficacy|1|||
161001011|NCT01147341|581388956|FG001|Double Blind Period|Lack of Efficacy|1|||
161001012|NCT01147341|581388955|FG000|Double Blind Period|Withdrawal by Subject|0|||
161001013|NCT01147341|581388956|FG001|Double Blind Period|Withdrawal by Subject|1|||
161001014|NCT01147341|581388955|FG000|Open Label Period|Lack of Efficacy|3|||
161146238|NCT01518699|581918404|FG002|Period 2|Adverse Event|0|||
161146239|NCT01518699|581918405|FG003|Period 2|Adverse Event|0|||
161146240|NCT01518699|581918406|FG004|Period 2|Adverse Event|0|||
161146241|NCT01518699|581918407|FG005|Period 2|Adverse Event|0|||
161146242|NCT01259492|581918410|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
161146243|NCT01259492|581918411|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
161146244|NCT01259492|581918412|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
161146245|NCT01259492|581918413|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
161146246|NCT01259492|581918410|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
161146247|NCT01259492|581918411|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
161146248|NCT01259492|581918412|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
161146249|NCT01259492|581918413|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
161146250|NCT01259492|581918410|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
161146251|NCT01259492|581918411|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
161146252|NCT01259492|581918412|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
161146253|NCT01259492|581918413|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
161146254|NCT01259492|581918410|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
161146255|NCT01259492|581918411|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
161146256|NCT01259492|581918412|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
161146257|NCT01259492|581918413|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
161146258|NCT01259492|581918410|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
161146259|NCT01259492|581918411|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
161146260|NCT01259492|581918412|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
161146261|NCT01259492|581918413|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
161146262|NCT01259492|581918410|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
161146263|NCT01259492|581918411|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
161146264|NCT01259492|581918412|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
161146265|NCT01259492|581918413|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
161146266|NCT01259492|581918410|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
161146267|NCT01259492|581918411|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
161146268|NCT01259492|581918412|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
161146269|NCT01259492|581918413|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
161146270|NCT01259492|581918410|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
161146271|NCT01259492|581918411|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
161146272|NCT01259492|581918412|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
161146273|NCT01259492|581918413|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
161146274|NCT01259492|581918410|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
161146275|NCT01259492|581918411|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
161001015|NCT01147341|581388956|FG001|Open Label Period|Lack of Efficacy|0|||
161001016|NCT01147341|581388955|FG000|Open Label Period|Subject moved|1|||
161001017|NCT01147341|581388956|FG001|Open Label Period|Subject moved|0|||
161001018|NCT01596504|581388957|FG000|Overall Study|Participant's Private Reason|0|||
161146276|NCT01259492|581918412|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
161146277|NCT01259492|581918413|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
161146278|NCT01259492|581918410|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161268788|NCT00699374|582366850|FG001|Overall Study|Randomized but not treated|2|||
160954839|NCT04402866|581221759|FG003|Overall Study|Withdrawal by Subject|0|||
160954840|NCT04402866|581221760|FG004|Overall Study|Withdrawal by Subject|0|||
160954841|NCT04402866|581221761|FG005|Overall Study|Withdrawal by Subject|2|||
161001019|NCT01596504|581388958|FG001|Overall Study|Participant's Private Reason|1|||
161001020|NCT01596504|581388959|FG002|Overall Study|Participant's Private Reason|0|||
161001021|NCT01596504|581388957|FG000|Overall Study|Adverse Event|1|||
161001022|NCT01596504|581388958|FG001|Overall Study|Adverse Event|2|||
161146279|NCT01259492|581918411|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161146280|NCT01259492|581918412|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
161146281|NCT01259492|581918413|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
161146282|NCT01259492|581918410|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
160954842|NCT03667053|581221762|FG000|Overall Study|Withdrawal by Subject|1|||
160954843|NCT03667053|581221763|FG001|Overall Study|Withdrawal by Subject|0|||
160954844|NCT03667053|581221764|FG002|Overall Study|Withdrawal by Subject|0|||
160954845|NCT02732938|581221766|FG000|Overall Study|Death|0|||
160954846|NCT02732938|581221767|FG001|Overall Study|Death|11|||
160954847|NCT02732938|581221768|FG002|Overall Study|Death|0|||
160954848|NCT02732938|581221766|FG000|Overall Study|Randomized but did not receive treatment|0|||
160954849|NCT02732938|581221767|FG001|Overall Study|Randomized but did not receive treatment|1|||
160954850|NCT02732938|581221768|FG002|Overall Study|Randomized but did not receive treatment|0|||
160954851|NCT02732938|581221766|FG000|Overall Study|Refused further follow-up|1|||
160954852|NCT02732938|581221767|FG001|Overall Study|Refused further follow-up|0|||
160954853|NCT02732938|581221768|FG002|Overall Study|Refused further follow-up|0|||
160954854|NCT02732938|581221766|FG000|Overall Study|Study terminated by sponsor|3|||
160954855|NCT02732938|581221767|FG001|Overall Study|Study terminated by sponsor|6|||
160954856|NCT02732938|581221768|FG002|Overall Study|Study terminated by sponsor|0|||
160954857|NCT02015676|581221769|FG000|Overall Study|Adverse Event|2|||
160954858|NCT02015676|581221770|FG001|Overall Study|Adverse Event|18|||
160954859|NCT02015676|581221771|FG002|Overall Study|Adverse Event|0|||
160954860|NCT02015676|581221769|FG000|Overall Study|Lack of Efficacy|2|||
160954861|NCT02015676|581221770|FG001|Overall Study|Lack of Efficacy|4|||
160954862|NCT02015676|581221771|FG002|Overall Study|Lack of Efficacy|0|||
160954863|NCT02015676|581221769|FG000|Overall Study|Protocol Violation|1|||
160954864|NCT02015676|581221770|FG001|Overall Study|Protocol Violation|0|||
160954865|NCT02015676|581221771|FG002|Overall Study|Protocol Violation|0|||
160954866|NCT02015676|581221769|FG000|Overall Study|Withdrawal by Subject|1|||
160954867|NCT02015676|581221770|FG001|Overall Study|Withdrawal by Subject|7|||
160954868|NCT02015676|581221771|FG002|Overall Study|Withdrawal by Subject|1|||
160954869|NCT02015676|581221769|FG000|Overall Study|Administrative reasons|0|||
160954870|NCT02015676|581221770|FG001|Overall Study|Administrative reasons|3|||
160954871|NCT02015676|581221771|FG002|Overall Study|Administrative reasons|1|||
160954872|NCT02015676|581221769|FG000|Overall Study|Death|0|||
160954873|NCT02015676|581221770|FG001|Overall Study|Death|1|||
160954874|NCT02015676|581221771|FG002|Overall Study|Death|0|||
160954875|NCT02015676|581221769|FG000|Overall Study|Disease progression|3|||
160954876|NCT02015676|581221770|FG001|Overall Study|Disease progression|1|||
160954877|NCT02015676|581221771|FG002|Overall Study|Disease progression|1|||
160954878|NCT00476476|581221773|FG000|Overall Study|Adverse Event|2|||
160954879|NCT00476476|581221774|FG001|Overall Study|Adverse Event|7|||
160954880|NCT00476476|581221773|FG000|Overall Study|Progressive Disease|0|||
160954881|NCT00476476|581221774|FG001|Overall Study|Progressive Disease|17|||
161001023|NCT01596504|581388959|FG002|Overall Study|Adverse Event|1|||
161001024|NCT01596504|581388957|FG000|Overall Study|Withdrawal by Subject|1|||
161001025|NCT01596504|581388958|FG001|Overall Study|Withdrawal by Subject|0|||
161001026|NCT01596504|581388959|FG002|Overall Study|Withdrawal by Subject|0|||
161001027|NCT00949975|581388960|FG000|Overall Study|Voluntary discontinuation|6|||
161001028|NCT00949975|581388961|FG001|Overall Study|Voluntary discontinuation|5|||
161001029|NCT00949975|581388962|FG002|Overall Study|Voluntary discontinuation|3|||
161001030|NCT00949975|581388963|FG003|Overall Study|Voluntary discontinuation|6|||
161001031|NCT00949975|581388960|FG000|Overall Study|Adverse Event|11|||
161001032|NCT00949975|581388961|FG001|Overall Study|Adverse Event|11|||
161001033|NCT00949975|581388962|FG002|Overall Study|Adverse Event|10|||
161001034|NCT00949975|581388963|FG003|Overall Study|Adverse Event|10|||
161001035|NCT00949975|581388960|FG000|Overall Study|Safety reason|0|||
161001036|NCT00949975|581388961|FG001|Overall Study|Safety reason|1|||
161001037|NCT00949975|581388962|FG002|Overall Study|Safety reason|0|||
161001038|NCT00949975|581388963|FG003|Overall Study|Safety reason|0|||
161001039|NCT00949975|581388960|FG000|Overall Study|Study-specific criteria|0|||
161001040|NCT00949975|581388961|FG001|Overall Study|Study-specific criteria|1|||
161001041|NCT00949975|581388962|FG002|Overall Study|Study-specific criteria|1|||
161001042|NCT00949975|581388963|FG003|Overall Study|Study-specific criteria|0|||
161001043|NCT00949975|581388960|FG000|Overall Study|Incorrect enrolment|5|||
161001044|NCT00949975|581388961|FG001|Overall Study|Incorrect enrolment|10|||
161001045|NCT00949975|581388962|FG002|Overall Study|Incorrect enrolment|4|||
161001046|NCT00949975|581388963|FG003|Overall Study|Incorrect enrolment|7|||
161001047|NCT00949975|581388960|FG000|Overall Study|Severe non-compliance|3|||
161001048|NCT00949975|581388961|FG001|Overall Study|Severe non-compliance|1|||
160954882|NCT00971048|581221778|FG000|Overall Study|Protocol Violation|1|||
160954883|NCT00971048|581221779|FG001|Overall Study|Protocol Violation|2|||
160954884|NCT00971048|581221780|FG002|Overall Study|Protocol Violation|0|||
161001049|NCT00949975|581388962|FG002|Overall Study|Severe non-compliance|0|||
161001050|NCT00949975|581388963|FG003|Overall Study|Severe non-compliance|2|||
161001051|NCT00949975|581388960|FG000|Overall Study|Lost to Follow-up|1|||
161001052|NCT00949975|581388961|FG001|Overall Study|Lost to Follow-up|0|||
161001053|NCT00949975|581388962|FG002|Overall Study|Lost to Follow-up|1|||
161001054|NCT00949975|581388963|FG003|Overall Study|Lost to Follow-up|3|||
161001055|NCT00949975|581388960|FG000|Overall Study|Other|1|||
160954885|NCT00971048|581221781|FG003|Overall Study|Protocol Violation|1|||
161001056|NCT00949975|581388961|FG001|Overall Study|Other|0|||
161146283|NCT01259492|581918411|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
161146284|NCT01259492|581918412|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
161146285|NCT01259492|581918413|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
161146286|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
161146287|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
161146288|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
160954886|NCT00971048|581221778|FG000|Overall Study|Adverse Event|0|||
160954887|NCT00971048|581221779|FG001|Overall Study|Adverse Event|0|||
160954888|NCT00971048|581221780|FG002|Overall Study|Adverse Event|1|||
160954889|NCT00971048|581221781|FG003|Overall Study|Adverse Event|0|||
160954890|NCT00971048|581221778|FG000|Overall Study|Physician Decision|0|||
160954891|NCT00971048|581221779|FG001|Overall Study|Physician Decision|0|||
160954892|NCT00971048|581221780|FG002|Overall Study|Physician Decision|0|||
160954893|NCT00971048|581221781|FG003|Overall Study|Physician Decision|1|||
160954894|NCT04349553|581221785|FG000|Overall Study|Withdrawal by Subject|1|||
160954895|NCT04349553|581221786|FG001|Overall Study|Withdrawal by Subject|0|||
160954896|NCT04349553|581221787|FG002|Overall Study|Withdrawal by Subject|1|||
160954897|NCT04349553|581221788|FG003|Overall Study|Withdrawal by Subject|0|||
160954898|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
160954899|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
160954900|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
160954901|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
160954902|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
160954903|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
160954904|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
160954905|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
160954906|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
160954907|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
160954908|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
160954909|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
160954910|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
160954911|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
160954912|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
160954913|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
160954914|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
160954915|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
160954916|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
160954917|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
160954918|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
160954919|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
160954920|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
160954921|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
160954922|NCT01715805|581221789|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
160954923|NCT01715805|581221790|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
160954924|NCT01715805|581221791|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
160954925|NCT01715805|581221792|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
160954926|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
160954927|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
160954928|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
160954929|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
160954930|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
160954931|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
160954932|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
160954933|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
160954934|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
160954935|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
160954936|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
160954937|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
160954938|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
160954939|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
160954940|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
161146289|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
161146290|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
160954941|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
160954942|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
161001057|NCT00949975|581388962|FG002|Overall Study|Other|0|||
161146291|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161342897|NCT03573297|582642292|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
160954943|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
160954944|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
160954945|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
160954946|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
160954947|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
160954948|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
160954949|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
160954950|NCT01715805|581221789|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
160954951|NCT01715805|581221790|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
160954952|NCT01715805|581221791|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
160954953|NCT01715805|581221792|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
160954954|NCT02647359|581221795|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
160954955|NCT02647359|581221796|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
160954956|NCT02647359|581221795|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
160954957|NCT02647359|581221796|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
160954958|NCT02647359|581221795|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
161001058|NCT00949975|581388963|FG003|Overall Study|Other|0|||
161001059|NCT04246762|581388964|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
161001060|NCT02878330|581388965|FG000|Overall Study|Death|3|||
161001061|NCT02878330|581388966|FG001|Overall Study|Death|2|||
161268789|NCT00699374|582366849|FG000|Overall Study|Died 28 days after last dose|5|||
161268790|NCT00699374|582366850|FG001|Overall Study|Died 28 days after last dose|9|||
161268791|NCT01783548|582366854|FG000|Overall Study|Adverse Event|8|||
161268792|NCT01783548|582366855|FG001|Overall Study|Adverse Event|4|||
161268793|NCT01783548|582366854|FG000|Overall Study|Withdrawal by Subject|11|||
161268794|NCT01783548|582366855|FG001|Overall Study|Withdrawal by Subject|8|||
161268795|NCT01783548|582366854|FG000|Overall Study|Non-compliance|4|||
161268796|NCT01783548|582366855|FG001|Overall Study|Non-compliance|0|||
160954959|NCT02647359|581221796|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
160954960|NCT02647359|581221795|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
160954961|NCT02647359|581221796|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
161001062|NCT02878330|581388965|FG000|Overall Study|Lost to Follow-up|11|||
161001063|NCT02878330|581388966|FG001|Overall Study|Lost to Follow-up|26|||
161001064|NCT02878330|581388965|FG000|Overall Study|Withdrawal by Subject|11|||
161001065|NCT02878330|581388966|FG001|Overall Study|Withdrawal by Subject|21|||
161001066|NCT02878330|581388965|FG000|Overall Study|Other|4|||
161001067|NCT02878330|581388966|FG001|Overall Study|Other|7|||
161001068|NCT03615924|581388967|FG000|Overall Study|Withdrawal by Subject|2|||
161001069|NCT03615924|581388968|FG001|Overall Study|Withdrawal by Subject|5|||
161001070|NCT03615924|581388967|FG000|Overall Study|Death|3|||
161001071|NCT03615924|581388968|FG001|Overall Study|Death|1|||
161001072|NCT03615924|581388967|FG000|Overall Study|Lost to Follow-up|1|||
161001073|NCT03615924|581388968|FG001|Overall Study|Lost to Follow-up|0|||
161001074|NCT03615924|581388967|FG000|Overall Study|Randomized in error|1|||
161001075|NCT03615924|581388968|FG001|Overall Study|Randomized in error|0|||
161001076|NCT03615924|581388967|FG000|Overall Study|Study termination by Sponsor|94|||
161001077|NCT03615924|581388968|FG001|Overall Study|Study termination by Sponsor|86|||
161001078|NCT02954848|581388969|FG000|Overall Study|Randomized but Not Treated|0|||
161001079|NCT02954848|581388970|FG001|Overall Study|Randomized but Not Treated|1|||
161001080|NCT02954848|581388969|FG000|Overall Study|Adverse Event|2|||
161001081|NCT02954848|581388970|FG001|Overall Study|Adverse Event|3|||
161001082|NCT02954848|581388969|FG000|Overall Study|Withdrawal by Participant|0|||
161001083|NCT02954848|581388970|FG001|Overall Study|Withdrawal by Participant|1|||
161001084|NCT00922207|581388971|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
161001085|NCT00922207|581388972|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
161001086|NCT00922207|581388973|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
161001087|NCT00922207|581388971|FG000|Overall Study|Insufficient Therapeutic Response|0|||
161001088|NCT00922207|581388972|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161001089|NCT00922207|581388973|FG002|Overall Study|Insufficient Therapeutic Response|1|||
161146292|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
161146293|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
161268797|NCT01783548|582366854|FG000|Overall Study|Protocol Violation|2|||
161268798|NCT01783548|582366855|FG001|Overall Study|Protocol Violation|2|||
161268799|NCT01783548|582366854|FG000|Overall Study|Lost to Follow-up|8|||
161001090|NCT00922207|581388971|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161001091|NCT00922207|581388972|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161001092|NCT00922207|581388973|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
161001093|NCT00922207|581388971|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
161001094|NCT00922207|581388972|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161001095|NCT00922207|581388973|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161268800|NCT01783548|582366855|FG001|Overall Study|Lost to Follow-up|3|||
160954962|NCT02647359|581221795|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
160954963|NCT02647359|581221796|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
160954964|NCT02647359|581221795|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
160954965|NCT02647359|581221796|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
160954966|NCT00413413|581221797|FG000|Single-Blind|Adverse Event|0|||
160954967|NCT00413413|581221798|FG001|Single-Blind|Adverse Event|9|||
160954968|NCT00413413|581221799|FG002|Single-Blind|Adverse Event|0|||
160954969|NCT00413413|581221797|FG000|Single-Blind|Lack of Efficacy|0|||
160954970|NCT00413413|581221798|FG001|Single-Blind|Lack of Efficacy|5|||
160954971|NCT00413413|581221799|FG002|Single-Blind|Lack of Efficacy|0|||
160954972|NCT00413413|581221797|FG000|Single-Blind|Subject no longer requires study drug|0|||
160954973|NCT00413413|581221798|FG001|Single-Blind|Subject no longer requires study drug|151|||
160954974|NCT00413413|581221799|FG002|Single-Blind|Subject no longer requires study drug|0|||
160954975|NCT00413413|581221797|FG000|Single-Blind|Protocol Violation|0|||
160954976|NCT00413413|581221798|FG001|Single-Blind|Protocol Violation|16|||
160954977|NCT00413413|581221799|FG002|Single-Blind|Protocol Violation|0|||
160954978|NCT00413413|581221797|FG000|Single-Blind|Withdrawal by Subject|0|||
160954979|NCT00413413|581221798|FG001|Single-Blind|Withdrawal by Subject|27|||
160954980|NCT00413413|581221799|FG002|Single-Blind|Withdrawal by Subject|0|||
160954981|NCT00413413|581221797|FG000|Single-Blind|Lost to Follow-up|0|||
160954982|NCT00413413|581221798|FG001|Single-Blind|Lost to Follow-up|8|||
160954983|NCT00413413|581221799|FG002|Single-Blind|Lost to Follow-up|0|||
160954984|NCT00413413|581221797|FG000|Double-Blind|Adverse Event|6|||
160954985|NCT00413413|581221798|FG001|Double-Blind|Adverse Event|0|||
160954986|NCT00413413|581221799|FG002|Double-Blind|Adverse Event|5|||
160954987|NCT00413413|581221797|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
160954988|NCT00413413|581221798|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
160954989|NCT00413413|581221799|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
160954990|NCT00413413|581221797|FG000|Double-Blind|Protocol deviation|1|||
160954991|NCT00413413|581221798|FG001|Double-Blind|Protocol deviation|2|||
160954992|NCT00413413|581221799|FG002|Double-Blind|Protocol deviation|1|||
160954993|NCT00413413|581221797|FG000|Double-Blind|Subject withdrew consent|4|||
160954994|NCT00413413|581221798|FG001|Double-Blind|Subject withdrew consent|6|||
160954995|NCT00413413|581221799|FG002|Double-Blind|Subject withdrew consent|9|||
160954996|NCT00413413|581221797|FG000|Double-Blind|Lost to Follow-up|3|||
160954997|NCT00413413|581221798|FG001|Double-Blind|Lost to Follow-up|4|||
160954998|NCT00413413|581221799|FG002|Double-Blind|Lost to Follow-up|2|||
160954999|NCT02219932|581221806|FG000|Overall Study|Other|5|||
160955000|NCT02219932|581221807|FG001|Overall Study|Other|11|||
160955001|NCT02219932|581221806|FG000|Overall Study|Death|1|||
160955002|NCT02219932|581221807|FG001|Overall Study|Death|1|||
160955003|NCT02219932|581221806|FG000|Overall Study|Investigator Decision|0|||
160955004|NCT02219932|581221807|FG001|Overall Study|Investigator Decision|1|||
160955005|NCT02219932|581221806|FG000|Overall Study|Consent Withdrawn|11|||
160955006|NCT02219932|581221807|FG001|Overall Study|Consent Withdrawn|7|||
160955007|NCT02219932|581221806|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
160955008|NCT02219932|581221807|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
160955009|NCT02219932|581221806|FG000|Overall Study|Protocol Violation|10|||
160955010|NCT02219932|581221807|FG001|Overall Study|Protocol Violation|6|||
160955011|NCT02219932|581221806|FG000|Overall Study|Pregnancy|1|||
160955012|NCT02219932|581221807|FG001|Overall Study|Pregnancy|0|||
160955013|NCT02219932|581221806|FG000|Overall Study|Lost to Follow-up|4|||
160955014|NCT02219932|581221807|FG001|Overall Study|Lost to Follow-up|2|||
160955015|NCT02219932|581221806|FG000|Overall Study|Adverse Event|23|||
160955016|NCT02219932|581221807|FG001|Overall Study|Adverse Event|21|||
160955017|NCT00511004|581221810|FG000|Overall Study|Lost to Follow-up|0|||
160955018|NCT00511004|581221811|FG001|Overall Study|Lost to Follow-up|0|||
160955019|NCT00511004|581221812|FG002|Overall Study|Lost to Follow-up|4|||
160955020|NCT04642638|581221813|FG000|Overall Study|Withdrawal by Subject|23|||
160955021|NCT04642638|581221814|FG001|Overall Study|Withdrawal by Subject|29|||
160955022|NCT04642638|581221815|FG002|Overall Study|Withdrawal by Subject|9|||
160955023|NCT04642638|581221816|FG003|Overall Study|Withdrawal by Subject|7|||
160955024|NCT04642638|581221817|FG004|Overall Study|Withdrawal by Subject|61|||
160955025|NCT04642638|581221818|FG005|Overall Study|Withdrawal by Subject|27|||
160955026|NCT04642638|581221813|FG000|Overall Study|Lost to Follow-up|17|||
160955027|NCT04642638|581221814|FG001|Overall Study|Lost to Follow-up|18|||
160955028|NCT04642638|581221815|FG002|Overall Study|Lost to Follow-up|5|||
160955029|NCT04642638|581221816|FG003|Overall Study|Lost to Follow-up|5|||
160955030|NCT04642638|581221817|FG004|Overall Study|Lost to Follow-up|6|||
160955031|NCT04642638|581221818|FG005|Overall Study|Lost to Follow-up|3|||
160955032|NCT04642638|581221813|FG000|Overall Study|Adverse Event|0|||
160955033|NCT04642638|581221814|FG001|Overall Study|Adverse Event|0|||
160955034|NCT04642638|581221815|FG002|Overall Study|Adverse Event|1|||
160955035|NCT04642638|581221816|FG003|Overall Study|Adverse Event|0|||
160955036|NCT04642638|581221817|FG004|Overall Study|Adverse Event|10|||
160955037|NCT04642638|581221818|FG005|Overall Study|Adverse Event|3|||
160955038|NCT04642638|581221813|FG000|Overall Study|Reason Not Specified|1|||
160955039|NCT04642638|581221814|FG001|Overall Study|Reason Not Specified|4|||
160955040|NCT04642638|581221815|FG002|Overall Study|Reason Not Specified|0|||
160955041|NCT04642638|581221816|FG003|Overall Study|Reason Not Specified|0|||
160955042|NCT04642638|581221817|FG004|Overall Study|Reason Not Specified|38|||
160955043|NCT04642638|581221818|FG005|Overall Study|Reason Not Specified|16|||
160955044|NCT04642638|581221813|FG000|Overall Study|Physician Decision|0|||
160955045|NCT04642638|581221814|FG001|Overall Study|Physician Decision|0|||
160955046|NCT04642638|581221815|FG002|Overall Study|Physician Decision|0|||
160955047|NCT04642638|581221816|FG003|Overall Study|Physician Decision|0|||
160955048|NCT04642638|581221817|FG004|Overall Study|Physician Decision|2|||
160955049|NCT04642638|581221818|FG005|Overall Study|Physician Decision|1|||
160955050|NCT04642638|581221813|FG000|Overall Study|Protocol Deviation|0|||
160955051|NCT04642638|581221814|FG001|Overall Study|Protocol Deviation|0|||
160955052|NCT04642638|581221815|FG002|Overall Study|Protocol Deviation|0|||
160955053|NCT04642638|581221816|FG003|Overall Study|Protocol Deviation|0|||
160955054|NCT04642638|581221817|FG004|Overall Study|Protocol Deviation|1|||
160955055|NCT04642638|581221818|FG005|Overall Study|Protocol Deviation|3|||
160955056|NCT04642638|581221813|FG000|Overall Study|Study Terminated|0|||
160955057|NCT04642638|581221814|FG001|Overall Study|Study Terminated|0|||
160955058|NCT04642638|581221815|FG002|Overall Study|Study Terminated|0|||
160955059|NCT04642638|581221816|FG003|Overall Study|Study Terminated|0|||
160955060|NCT04642638|581221817|FG004|Overall Study|Study Terminated|484|||
160955061|NCT04642638|581221818|FG005|Overall Study|Study Terminated|250|||
160955062|NCT04642638|581221813|FG000|Overall Study|Pregnancy|0|||
160955063|NCT04642638|581221814|FG001|Overall Study|Pregnancy|0|||
160955064|NCT04642638|581221815|FG002|Overall Study|Pregnancy|0|||
160955065|NCT04642638|581221816|FG003|Overall Study|Pregnancy|0|||
160955066|NCT04642638|581221817|FG004|Overall Study|Pregnancy|1|||
160955067|NCT04642638|581221818|FG005|Overall Study|Pregnancy|0|||
160955068|NCT00990652|581221819|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
160955069|NCT00990652|581221819|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
160955070|NCT01869491|581221822|FG000|Overall Study|Adverse Event|3|||
160955071|NCT01869491|581221823|FG001|Overall Study|Adverse Event|5|||
160955072|NCT01869491|581221822|FG000|Overall Study|Lack of Efficacy|0|||
160955073|NCT01869491|581221823|FG001|Overall Study|Lack of Efficacy|3|||
160955074|NCT01869491|581221822|FG000|Overall Study|Withdrawal by Subject|6|||
160955075|NCT01869491|581221823|FG001|Overall Study|Withdrawal by Subject|7|||
160955076|NCT01869491|581221822|FG000|Overall Study|Lost to Follow-up|11|||
160955077|NCT01869491|581221823|FG001|Overall Study|Lost to Follow-up|9|||
160955078|NCT01869491|581221822|FG000|Overall Study|No further need of investigational product|1|||
160955079|NCT01869491|581221823|FG001|Overall Study|No further need of investigational product|0|||
160955080|NCT05177770|581221824|FG000|Overall Study|Death|4|||
160955081|NCT05177770|581221824|FG000|Overall Study|Withdrawal by Subject|1|||
160955082|NCT05177770|581221824|FG000|Overall Study|Adverse Event prior to dosing|1|||
160955083|NCT01672801|581221828|FG000|Overall Study|Screen Failure|0|||
160955084|NCT01672801|581221829|FG001|Overall Study|Screen Failure|1|||
161146294|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
160955085|NCT06476366|581221830|FG000|Overall Study|Lost to Follow-up|1|||
160955086|NCT06476366|581221831|FG001|Overall Study|Lost to Follow-up|3|||
160955087|NCT06476366|581221830|FG000|Overall Study|Adverse Event|1|||
160955088|NCT06476366|581221831|FG001|Overall Study|Adverse Event|0|||
160955089|NCT04313881|581221836|FG000|Overall Study|Death|138|||
160955090|NCT04313881|581221837|FG001|Overall Study|Death|126|||
160955091|NCT04313881|581221836|FG000|Overall Study|Study terminated by sponsor|108|||
160955092|NCT04313881|581221837|FG001|Overall Study|Study terminated by sponsor|129|||
160955093|NCT04313881|581221836|FG000|Overall Study|Consent withdrawn|19|||
160955094|NCT04313881|581221837|FG001|Overall Study|Consent withdrawn|15|||
160955095|NCT04313881|581221836|FG000|Overall Study|Reason not Specified|3|||
160955096|NCT04313881|581221837|FG001|Overall Study|Reason not Specified|1|||
160955097|NCT00727272|581221838|FG000|Washout Period A|Adverse Event|0|||
160955098|NCT00727272|581221839|FG001|Washout Period A|Adverse Event|0|||
160955099|NCT00727272|581221840|FG002|Washout Period A|Adverse Event|1|||
160955100|NCT00727272|581221838|FG000|Washout Period B|Withdrawal by Subject|0|||
160955101|NCT00727272|581221839|FG001|Washout Period B|Withdrawal by Subject|0|||
160955102|NCT00727272|581221840|FG002|Washout Period B|Withdrawal by Subject|1|||
160955103|NCT00651664|581221841|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
160955104|NCT00651664|581221842|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
160955105|NCT00651664|581221843|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
160955106|NCT00651664|581221844|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
160955107|NCT00651664|581221845|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
160955108|NCT00651664|581221846|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
160955109|NCT00651664|581221847|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
160955110|NCT00651664|581221848|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
160955111|NCT00651664|581221849|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
160955112|NCT00651664|581221850|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
160955113|NCT00651664|581221841|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955114|NCT00651664|581221842|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955115|NCT00651664|581221843|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955116|NCT00651664|581221844|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955117|NCT00651664|581221845|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955118|NCT00651664|581221846|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955119|NCT00651664|581221847|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955120|NCT00651664|581221848|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955121|NCT00651664|581221849|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
160955122|NCT00651664|581221850|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
160955123|NCT00651664|581221841|FG000|Overall Study|Progressive Disease|3|||
160955124|NCT00651664|581221842|FG001|Overall Study|Progressive Disease|3|||
160955125|NCT00651664|581221843|FG002|Overall Study|Progressive Disease|3|||
160955126|NCT00651664|581221844|FG003|Overall Study|Progressive Disease|12|||
160955127|NCT00651664|581221845|FG004|Overall Study|Progressive Disease|4|||
160955128|NCT00651664|581221846|FG005|Overall Study|Progressive Disease|1|||
160955129|NCT00651664|581221847|FG006|Overall Study|Progressive Disease|3|||
160955130|NCT00651664|581221848|FG007|Overall Study|Progressive Disease|6|||
160955131|NCT00651664|581221849|FG008|Overall Study|Progressive Disease|5|||
160955132|NCT00651664|581221850|FG009|Overall Study|Progressive Disease|5|||
160955133|NCT00651664|581221841|FG000|Overall Study|Patient Declined Further Treatment|0|||
160955134|NCT00651664|581221842|FG001|Overall Study|Patient Declined Further Treatment|0|||
160955135|NCT00651664|581221843|FG002|Overall Study|Patient Declined Further Treatment|0|||
160955136|NCT00651664|581221844|FG003|Overall Study|Patient Declined Further Treatment|1|||
160955137|NCT00651664|581221845|FG004|Overall Study|Patient Declined Further Treatment|1|||
160955138|NCT00651664|581221846|FG005|Overall Study|Patient Declined Further Treatment|1|||
160955139|NCT00651664|581221847|FG006|Overall Study|Patient Declined Further Treatment|0|||
160955140|NCT00651664|581221848|FG007|Overall Study|Patient Declined Further Treatment|0|||
160955141|NCT00651664|581221849|FG008|Overall Study|Patient Declined Further Treatment|0|||
161001096|NCT00922207|581388971|FG000|Overall Study|Withdrew Consent|2|||
161001097|NCT00922207|581388972|FG001|Overall Study|Withdrew Consent|5|||
161001098|NCT00922207|581388973|FG002|Overall Study|Withdrew Consent|2|||
160955142|NCT00651664|581221850|FG009|Overall Study|Patient Declined Further Treatment|1|||
160955143|NCT00651664|581221841|FG000|Overall Study|Symptomatic Deterioration|0|||
160955144|NCT00651664|581221842|FG001|Overall Study|Symptomatic Deterioration|0|||
160955145|NCT00651664|581221843|FG002|Overall Study|Symptomatic Deterioration|0|||
160955146|NCT00651664|581221844|FG003|Overall Study|Symptomatic Deterioration|1|||
160955147|NCT00651664|581221845|FG004|Overall Study|Symptomatic Deterioration|0|||
160955148|NCT00651664|581221846|FG005|Overall Study|Symptomatic Deterioration|0|||
160955149|NCT00651664|581221847|FG006|Overall Study|Symptomatic Deterioration|1|||
160955150|NCT00651664|581221848|FG007|Overall Study|Symptomatic Deterioration|0|||
160955151|NCT00651664|581221849|FG008|Overall Study|Symptomatic Deterioration|1|||
160955152|NCT00651664|581221850|FG009|Overall Study|Symptomatic Deterioration|0|||
160955153|NCT00651664|581221841|FG000|Overall Study|Reason not Specified|0|||
160955154|NCT00651664|581221842|FG001|Overall Study|Reason not Specified|0|||
160955155|NCT00651664|581221843|FG002|Overall Study|Reason not Specified|0|||
160955156|NCT00651664|581221844|FG003|Overall Study|Reason not Specified|0|||
160955157|NCT00651664|581221845|FG004|Overall Study|Reason not Specified|0|||
160955158|NCT00651664|581221846|FG005|Overall Study|Reason not Specified|0|||
160955159|NCT00651664|581221847|FG006|Overall Study|Reason not Specified|1|||
160955160|NCT00651664|581221848|FG007|Overall Study|Reason not Specified|0|||
160955161|NCT00651664|581221849|FG008|Overall Study|Reason not Specified|0|||
160955162|NCT00651664|581221850|FG009|Overall Study|Reason not Specified|0|||
160955163|NCT01272934|581221853|FG000|Overall Study|Adverse Event|0|||
160955164|NCT01272934|581221854|FG001|Overall Study|Adverse Event|1|||
160955165|NCT01272934|581221853|FG000|Overall Study|Abnormal Laboratory Value|0|||
161001099|NCT00922207|581388971|FG000|Overall Study|Abnormality of Laboratory Test|0|||
161001100|NCT00922207|581388972|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161001101|NCT00922207|581388973|FG002|Overall Study|Abnormality of Laboratory Test|1|||
161001102|NCT01802632|581388974|FG000|Overall Study|Death|28|||
161001103|NCT01802632|581388975|FG001|Overall Study|Death|1|||
161001104|NCT01802632|581388976|FG002|Overall Study|Death|38|||
161146295|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161146296|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
161146297|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
161268801|NCT01783548|582366854|FG000|Overall Study|Lack of Efficacy|1|||
160955166|NCT01272934|581221854|FG001|Overall Study|Abnormal Laboratory Value|1|||
160955167|NCT00214136|581221855|FG000|Overall Study|Death|5|||
160955168|NCT04313634|581221856|FG000|Overall Study|Adverse Event|2|||
160955169|NCT04313634|581221857|FG001|Overall Study|Adverse Event|2|||
160955170|NCT04313634|581221858|FG002|Overall Study|Adverse Event|0|||
160955171|NCT04313634|581221856|FG000|Overall Study|Withdrawal by Subject|1|||
161001105|NCT01802632|581388977|FG003|Overall Study|Death|0|||
161001106|NCT01802632|581388978|FG004|Overall Study|Death|2|||
161001107|NCT01802632|581388979|FG005|Overall Study|Death|0|||
161268802|NCT01783548|582366855|FG001|Overall Study|Lack of Efficacy|1|||
161001108|NCT01802632|581388974|FG000|Overall Study|Withdrawal by Subject|4|||
161001109|NCT01802632|581388975|FG001|Overall Study|Withdrawal by Subject|2|||
161146298|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
161146299|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
161146300|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
161146301|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
161146302|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
161146303|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161146304|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
161146305|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
160955172|NCT04313634|581221857|FG001|Overall Study|Withdrawal by Subject|0|||
160955173|NCT04313634|581221858|FG002|Overall Study|Withdrawal by Subject|1|||
160955174|NCT04313634|581221856|FG000|Overall Study|Protocol Violation|0|||
160955175|NCT04313634|581221857|FG001|Overall Study|Protocol Violation|0|||
160955176|NCT04313634|581221858|FG002|Overall Study|Protocol Violation|1|||
160955177|NCT00319098|581221861|FG000|Overall Study|Serious adverse event|3|||
160955178|NCT00319098|581221862|FG001|Overall Study|Serious adverse event|0|||
160955179|NCT00319098|581221861|FG000|Overall Study|Adverse Event|20|||
160955180|NCT00319098|581221862|FG001|Overall Study|Adverse Event|1|||
160955181|NCT00319098|581221861|FG000|Overall Study|Withdrawal by Subject|37|||
160955182|NCT00319098|581221862|FG001|Overall Study|Withdrawal by Subject|8|||
160955183|NCT00319098|581221861|FG000|Overall Study|Migrated/moved from study area|2|||
160955184|NCT00319098|581221862|FG001|Overall Study|Migrated/moved from study area|1|||
160955185|NCT00319098|581221861|FG000|Overall Study|Lost to Follow-up|37|||
160955186|NCT00319098|581221862|FG001|Overall Study|Lost to Follow-up|13|||
160955187|NCT00319098|581221861|FG000|Overall Study|Others|33|||
160955188|NCT00319098|581221862|FG001|Overall Study|Others|8|||
160955189|NCT00319098|581221861|FG000|Overall Study|Protocol Violation|3|||
160955190|NCT00319098|581221862|FG001|Overall Study|Protocol Violation|1|||
160955191|NCT03449030|581221863|FG000|Overall Study|Withdrawal by Subject|0|||
160955192|NCT03449030|581221864|FG001|Overall Study|Withdrawal by Subject|0|||
160955193|NCT03449030|581221865|FG002|Overall Study|Withdrawal by Subject|0|||
160955194|NCT03449030|581221866|FG003|Overall Study|Withdrawal by Subject|1|||
160955195|NCT03449030|581221867|FG004|Overall Study|Withdrawal by Subject|1|||
160955196|NCT03449030|581221868|FG005|Overall Study|Withdrawal by Subject|1|||
160955197|NCT03449030|581221869|FG006|Overall Study|Withdrawal by Subject|1|||
160955198|NCT03449030|581221870|FG007|Overall Study|Withdrawal by Subject|2|||
160955199|NCT03449030|581221871|FG008|Overall Study|Withdrawal by Subject|0|||
160955200|NCT03449030|581221872|FG009|Overall Study|Withdrawal by Subject|0|||
160955201|NCT03449030|581221863|FG000|Overall Study|Symptomatic Deterioration|0|||
160955202|NCT03449030|581221864|FG001|Overall Study|Symptomatic Deterioration|1|||
160955203|NCT03449030|581221865|FG002|Overall Study|Symptomatic Deterioration|0|||
160955204|NCT03449030|581221866|FG003|Overall Study|Symptomatic Deterioration|0|||
160955205|NCT03449030|581221867|FG004|Overall Study|Symptomatic Deterioration|0|||
160955206|NCT03449030|581221868|FG005|Overall Study|Symptomatic Deterioration|1|||
160955207|NCT03449030|581221869|FG006|Overall Study|Symptomatic Deterioration|1|||
160955208|NCT03449030|581221870|FG007|Overall Study|Symptomatic Deterioration|0|||
160955209|NCT03449030|581221871|FG008|Overall Study|Symptomatic Deterioration|2|||
160955210|NCT03449030|581221872|FG009|Overall Study|Symptomatic Deterioration|0|||
160955211|NCT03449030|581221863|FG000|Overall Study|Progressive Disease|1|||
160955212|NCT03449030|581221864|FG001|Overall Study|Progressive Disease|0|||
160955213|NCT03449030|581221865|FG002|Overall Study|Progressive Disease|1|||
160955214|NCT03449030|581221866|FG003|Overall Study|Progressive Disease|4|||
161146306|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
160955215|NCT03449030|581221867|FG004|Overall Study|Progressive Disease|5|||
160955216|NCT03449030|581221868|FG005|Overall Study|Progressive Disease|3|||
160955217|NCT03449030|581221869|FG006|Overall Study|Progressive Disease|0|||
160955218|NCT03449030|581221870|FG007|Overall Study|Progressive Disease|1|||
160955219|NCT03449030|581221871|FG008|Overall Study|Progressive Disease|1|||
160955220|NCT03449030|581221872|FG009|Overall Study|Progressive Disease|1|||
160955221|NCT03449030|581221863|FG000|Overall Study|Adverse Event|0|||
160955222|NCT03449030|581221864|FG001|Overall Study|Adverse Event|0|||
160955223|NCT03449030|581221865|FG002|Overall Study|Adverse Event|0|||
160955224|NCT03449030|581221866|FG003|Overall Study|Adverse Event|0|||
160955225|NCT03449030|581221867|FG004|Overall Study|Adverse Event|0|||
160955226|NCT03449030|581221868|FG005|Overall Study|Adverse Event|2|||
160955227|NCT03449030|581221869|FG006|Overall Study|Adverse Event|0|||
160955228|NCT03449030|581221870|FG007|Overall Study|Adverse Event|0|||
160955229|NCT03449030|581221871|FG008|Overall Study|Adverse Event|0|||
160955230|NCT03449030|581221872|FG009|Overall Study|Adverse Event|0|||
160955231|NCT03449030|581221863|FG000|Overall Study|Death|0|||
160955232|NCT03449030|581221864|FG001|Overall Study|Death|0|||
160955233|NCT03449030|581221865|FG002|Overall Study|Death|0|||
160955234|NCT03449030|581221866|FG003|Overall Study|Death|0|||
160955235|NCT03449030|581221867|FG004|Overall Study|Death|1|||
160955236|NCT03449030|581221868|FG005|Overall Study|Death|0|||
160955237|NCT03449030|581221869|FG006|Overall Study|Death|0|||
160955238|NCT03449030|581221870|FG007|Overall Study|Death|0|||
160955239|NCT03449030|581221871|FG008|Overall Study|Death|0|||
160955240|NCT03449030|581221872|FG009|Overall Study|Death|0|||
160955241|NCT00965523|581221873|FG000|Study 221|Progressive Disease|4|||
160955242|NCT00965523|581221873|FG000|Study 221|Physician Decision|3|||
160955243|NCT00965523|581221873|FG000|Study 224|Progressive Disease|5|||
160955244|NCT00965523|581221873|FG000|Study 224|Physician Decision|1|||
160955245|NCT04656847|581221878|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
161146307|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
161146308|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
161146309|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
161146310|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
161146311|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
161146312|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
161146313|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
161146314|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161146315|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161146316|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
161146317|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
161146318|NCT01259492|581918410|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
161146319|NCT01259492|581918411|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
161146320|NCT01259492|581918412|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
161146321|NCT01259492|581918413|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
161146322|NCT01981122|581918417|FG000|Overall Study|Withdrawal by Subject|0|||
161146323|NCT01981122|581918418|FG001|Overall Study|Withdrawal by Subject|2|||
161146324|NCT01981122|581918417|FG000|Overall Study|Protocol Violation|0|||
160955246|NCT03301051|581221879|FG000|Overall Study|Adverse Event|0|||
160955247|NCT03301051|581221880|FG001|Overall Study|Adverse Event|4|||
161146325|NCT01981122|581918418|FG001|Overall Study|Protocol Violation|1|||
160955248|NCT03301051|581221879|FG000|Overall Study|Withdrawal by Subject|59|||
160955249|NCT03301051|581221880|FG001|Overall Study|Withdrawal by Subject|65|||
160955250|NCT03301051|581221879|FG000|Overall Study|Lost to Follow-up|263|||
160955251|NCT03301051|581221880|FG001|Overall Study|Lost to Follow-up|282|||
160955252|NCT03301051|581221879|FG000|Overall Study|Protocol Violation|1|||
160955253|NCT03301051|581221880|FG001|Overall Study|Protocol Violation|3|||
160955254|NCT03301051|581221879|FG000|Overall Study|Physician Decision|1|||
160955255|NCT03301051|581221880|FG001|Overall Study|Physician Decision|3|||
160955256|NCT03301051|581221879|FG000|Overall Study|Death|1|||
160955257|NCT03301051|581221880|FG001|Overall Study|Death|1|||
160955258|NCT03301051|581221879|FG000|Overall Study|Miscellaneous|8|||
160955259|NCT03301051|581221880|FG001|Overall Study|Miscellaneous|4|||
160955260|NCT03301051|581221879|FG000|Overall Study|Randomized, not vaccinated|13|||
160955261|NCT03301051|581221880|FG001|Overall Study|Randomized, not vaccinated|10|||
160955262|NCT00047879|581221881|FG000|Overall Study|Progressive disease|4|||
160955263|NCT00047879|581221882|FG001|Overall Study|Progressive disease|3|||
160955264|NCT01196975|581221883|FG000|Overall Study|Adverse Event|2|||
160955265|NCT01196975|581221884|FG001|Overall Study|Adverse Event|2|||
160955266|NCT01196975|581221885|FG002|Overall Study|Adverse Event|0|||
160955267|NCT01196975|581221886|FG003|Overall Study|Adverse Event|0|||
160955268|NCT01196975|581221887|FG004|Overall Study|Adverse Event|2|||
160955269|NCT01196975|581221883|FG000|Overall Study|Withdrawal by Subject|2|||
160955270|NCT01196975|581221884|FG001|Overall Study|Withdrawal by Subject|1|||
160955271|NCT01196975|581221885|FG002|Overall Study|Withdrawal by Subject|0|||
160955272|NCT01196975|581221886|FG003|Overall Study|Withdrawal by Subject|1|||
160955273|NCT01196975|581221887|FG004|Overall Study|Withdrawal by Subject|0|||
160955274|NCT01196975|581221883|FG000|Overall Study|Lost to Follow-up|11|||
160955275|NCT01196975|581221884|FG001|Overall Study|Lost to Follow-up|6|||
160955276|NCT01196975|581221885|FG002|Overall Study|Lost to Follow-up|5|||
160955277|NCT01196975|581221886|FG003|Overall Study|Lost to Follow-up|5|||
160955278|NCT01196975|581221887|FG004|Overall Study|Lost to Follow-up|11|||
160955279|NCT01358526|581221895|FG000|Open-label Titration Period|Adverse Event|95|||
160955280|NCT01358526|581221896|FG001|Open-label Titration Period|Adverse Event|0|||
160955281|NCT01358526|581221897|FG002|Open-label Titration Period|Adverse Event|0|||
160955282|NCT01358526|581221895|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
160955283|NCT01358526|581221896|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
160955284|NCT01358526|581221897|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
160955285|NCT01358526|581221895|FG000|Open-label Titration Period|Lost to Follow-up|25|||
160955286|NCT01358526|581221896|FG001|Open-label Titration Period|Lost to Follow-up|0|||
160955287|NCT01358526|581221897|FG002|Open-label Titration Period|Lost to Follow-up|0|||
161146326|NCT01981122|581918417|FG000|Overall Study|Lost to Follow-up|0|||
160955288|NCT01358526|581221895|FG000|Open-label Titration Period|Lack of Efficacy|107|||
161146327|NCT01981122|581918418|FG001|Overall Study|Lost to Follow-up|1|||
160955289|NCT01358526|581221896|FG001|Open-label Titration Period|Lack of Efficacy|0|||
160955290|NCT01358526|581221897|FG002|Open-label Titration Period|Lack of Efficacy|0|||
160955291|NCT01358526|581221895|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
160955292|NCT01358526|581221896|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
160955293|NCT01358526|581221897|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
160955294|NCT01358526|581221895|FG000|Open-label Titration Period|Administrative|8|||
160955295|NCT01358526|581221896|FG001|Open-label Titration Period|Administrative|0|||
160955296|NCT01358526|581221897|FG002|Open-label Titration Period|Administrative|0|||
160955297|NCT01358526|581221895|FG000|Open-label Titration Period|Did not qualify|178|||
160955298|NCT01358526|581221896|FG001|Open-label Titration Period|Did not qualify|0|||
160955299|NCT01358526|581221897|FG002|Open-label Titration Period|Did not qualify|0|||
160955300|NCT01358526|581221895|FG000|Double-blind Phase|Adverse Event|0|||
160955301|NCT01358526|581221896|FG001|Double-blind Phase|Adverse Event|24|||
160955302|NCT01358526|581221897|FG002|Double-blind Phase|Adverse Event|23|||
160955303|NCT01358526|581221895|FG000|Double-blind Phase|Withdrawal by Subject|0|||
160955304|NCT01358526|581221896|FG001|Double-blind Phase|Withdrawal by Subject|10|||
160955305|NCT01358526|581221897|FG002|Double-blind Phase|Withdrawal by Subject|8|||
160955306|NCT01358526|581221895|FG000|Double-blind Phase|Lost to Follow-up|0|||
160955307|NCT01358526|581221896|FG001|Double-blind Phase|Lost to Follow-up|4|||
160955308|NCT01358526|581221897|FG002|Double-blind Phase|Lost to Follow-up|1|||
160955309|NCT01358526|581221895|FG000|Double-blind Phase|Lack of Efficacy|0|||
160955310|NCT01358526|581221896|FG001|Double-blind Phase|Lack of Efficacy|31|||
160955311|NCT01358526|581221897|FG002|Double-blind Phase|Lack of Efficacy|73|||
160955312|NCT01358526|581221895|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
160955313|NCT01358526|581221896|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
160955314|NCT01358526|581221897|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
160955315|NCT01358526|581221895|FG000|Double-blind Phase|Administrative|0|||
160955316|NCT01358526|581221896|FG001|Double-blind Phase|Administrative|6|||
160955317|NCT01358526|581221897|FG002|Double-blind Phase|Administrative|10|||
160955318|NCT00360529|581221898|FG000|Overall Study|Adverse Event|10|||
160955319|NCT00360529|581221899|FG001|Overall Study|Adverse Event|23|||
160955320|NCT00360529|581221900|FG002|Overall Study|Adverse Event|33|||
160955321|NCT00360529|581221898|FG000|Overall Study|Protocol Violation|3|||
160955322|NCT00360529|581221899|FG001|Overall Study|Protocol Violation|3|||
160955323|NCT00360529|581221900|FG002|Overall Study|Protocol Violation|11|||
160955324|NCT00360529|581221898|FG000|Overall Study|Lost to Follow-up|14|||
160955325|NCT00360529|581221899|FG001|Overall Study|Lost to Follow-up|10|||
160955326|NCT00360529|581221900|FG002|Overall Study|Lost to Follow-up|13|||
160955327|NCT00360529|581221898|FG000|Overall Study|Withdrawal by Subject|22|||
160955328|NCT00360529|581221899|FG001|Overall Study|Withdrawal by Subject|14|||
160955329|NCT00360529|581221900|FG002|Overall Study|Withdrawal by Subject|18|||
160955330|NCT00360529|581221898|FG000|Overall Study|Lack of Efficacy|8|||
160955331|NCT00360529|581221899|FG001|Overall Study|Lack of Efficacy|6|||
160955332|NCT00360529|581221900|FG002|Overall Study|Lack of Efficacy|5|||
160955333|NCT00360529|581221898|FG000|Overall Study|Reason discontinued not explained above|4|||
160955334|NCT00360529|581221899|FG001|Overall Study|Reason discontinued not explained above|9|||
160955335|NCT00360529|581221900|FG002|Overall Study|Reason discontinued not explained above|11|||
160955336|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
160955337|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
160955338|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
160955339|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
160955340|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
160955341|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
160955342|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
160955343|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
160955344|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
160955345|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
160955346|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
160955347|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
160955348|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
160955349|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
160955350|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
160955351|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
160955352|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
160955353|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
160955354|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
160955355|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
160955356|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
160955357|NCT01781572|581221905|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
160955358|NCT01781572|581221906|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
160955359|NCT01781572|581221907|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
160955360|NCT01781572|581221905|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
160955361|NCT01781572|581221906|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
161268803|NCT04645966|582366856|FG000|Vaccination Phase|Adverse Event|1|||
161268804|NCT04645966|582366857|FG001|Vaccination Phase|Adverse Event|0|||
161268805|NCT04645966|582366858|FG002|Vaccination Phase|Adverse Event|0|||
160955362|NCT01781572|581221907|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
160955363|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
160955364|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
160955365|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
160955366|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
160955367|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
160955368|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
160955369|NCT01781572|581221905|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
160955370|NCT01781572|581221906|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
160955371|NCT01781572|581221907|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
160955372|NCT01781572|581221905|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
160955373|NCT01781572|581221906|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
160955374|NCT01781572|581221907|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
160955375|NCT01781572|581221905|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
160955376|NCT01781572|581221906|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
160955377|NCT01781572|581221907|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
160955378|NCT01781572|581221905|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
160955379|NCT01781572|581221906|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
160955380|NCT01781572|581221907|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
160955381|NCT01781572|581221905|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
160955382|NCT01781572|581221906|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
160955383|NCT01781572|581221907|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
160955384|NCT01781572|581221905|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
160955385|NCT01781572|581221906|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
160955386|NCT01781572|581221907|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
160955387|NCT01781572|581221905|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
160955388|NCT01781572|581221906|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
160955389|NCT01781572|581221907|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
160955390|NCT00907153|581223513|FG000|Overall Study|Lost to Follow-up|1|||
160955391|NCT00907153|581223514|FG001|Overall Study|Lost to Follow-up|1|||
160955392|NCT00907153|581223513|FG000|Overall Study|Withdrawal by Subject|1|||
160955393|NCT00907153|581223514|FG001|Overall Study|Withdrawal by Subject|3|||
160955394|NCT03393000|581223522|FG000|Overall Study|Death|11|||
160955395|NCT03393000|581223522|FG000|Overall Study|Withdrawal by Subject|2|||
160955396|NCT03393000|581223522|FG000|Overall Study|Physician Decision|1|||
160955397|NCT01773070|581223523|FG000|Overall Study|Withdrawal by Subject|24|||
160955398|NCT01773070|581223523|FG000|Overall Study|Lost to Follow-up|39|||
160955399|NCT01773070|581223523|FG000|Overall Study|Other|15|||
160955400|NCT01773070|581223523|FG000|Overall Study|Death (unrelated to study procedures)|3|||
160955401|NCT02181803|581223524|FG000|Overall Study|Withdrawal by Subject|0|||
160955402|NCT02181803|581223525|FG001|Overall Study|Withdrawal by Subject|2|||
160955403|NCT02181803|581223526|FG002|Overall Study|Withdrawal by Subject|0|||
160955404|NCT02181803|581223527|FG003|Overall Study|Withdrawal by Subject|0|||
160955405|NCT02181803|581223528|FG004|Overall Study|Withdrawal by Subject|0|||
160955406|NCT02181803|581223529|FG005|Overall Study|Withdrawal by Subject|0|||
160955407|NCT02181803|581223530|FG006|Overall Study|Withdrawal by Subject|0|||
160955408|NCT02181803|581223531|FG007|Overall Study|Withdrawal by Subject|0|||
160955409|NCT02181803|581223532|FG008|Overall Study|Withdrawal by Subject|0|||
160955410|NCT02181803|581223524|FG000|Overall Study|Physician Decision|0|||
160955411|NCT02181803|581223525|FG001|Overall Study|Physician Decision|0|||
160955412|NCT02181803|581223526|FG002|Overall Study|Physician Decision|0|||
160955413|NCT02181803|581223527|FG003|Overall Study|Physician Decision|1|||
160955414|NCT02181803|581223528|FG004|Overall Study|Physician Decision|0|||
160955415|NCT02181803|581223529|FG005|Overall Study|Physician Decision|0|||
160955416|NCT02181803|581223530|FG006|Overall Study|Physician Decision|0|||
160955417|NCT02181803|581223531|FG007|Overall Study|Physician Decision|1|||
160955418|NCT02181803|581223532|FG008|Overall Study|Physician Decision|0|||
160955419|NCT02181803|581223524|FG000|Overall Study|Adverse Event|0|||
160955420|NCT02181803|581223525|FG001|Overall Study|Adverse Event|2|||
160955421|NCT02181803|581223526|FG002|Overall Study|Adverse Event|0|||
160955422|NCT02181803|581223527|FG003|Overall Study|Adverse Event|1|||
160955423|NCT02181803|581223528|FG004|Overall Study|Adverse Event|0|||
160955424|NCT02181803|581223529|FG005|Overall Study|Adverse Event|0|||
160955425|NCT02181803|581223530|FG006|Overall Study|Adverse Event|1|||
160955426|NCT02181803|581223531|FG007|Overall Study|Adverse Event|0|||
160955427|NCT02181803|581223532|FG008|Overall Study|Adverse Event|0|||
160955428|NCT04786444|581223534|FG000|Overall Study|Withdrawal by Subject|4|||
160955429|NCT04786444|581223535|FG001|Overall Study|Withdrawal by Subject|7|||
160955430|NCT04786444|581223536|FG002|Overall Study|Withdrawal by Subject|2|||
160955431|NCT04786444|581223534|FG000|Overall Study|Lost to Follow-up|11|||
160955432|NCT04786444|581223535|FG001|Overall Study|Lost to Follow-up|9|||
160955433|NCT04786444|581223536|FG002|Overall Study|Lost to Follow-up|10|||
160955434|NCT04786444|581223534|FG000|Overall Study|Subject would like to become pregnant|0|||
160955435|NCT04786444|581223535|FG001|Overall Study|Subject would like to become pregnant|1|||
160955436|NCT04786444|581223536|FG002|Overall Study|Subject would like to become pregnant|0|||
160955437|NCT03166618|581223537|FG000|Overall Study|Study was Terminated|0|||
160955438|NCT03166618|581223538|FG001|Overall Study|Study was Terminated|1|||
160955439|NCT01925950|581223539|FG000|Part 2|Withdrawal by Subject|1|||
160955440|NCT01925950|581223540|FG001|Part 2|Withdrawal by Subject|0|||
160955441|NCT03137303|581223542|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
160955442|NCT03137303|581223543|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
160955443|NCT03137303|581223542|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
160955444|NCT03137303|581223543|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
160955445|NCT03137303|581223542|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
160955446|NCT03137303|581223543|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
160955447|NCT03137303|581223542|FG000|T3: 9-month Follow-up|Death|1|||
160955448|NCT03137303|581223543|FG001|T3: 9-month Follow-up|Death|0|||
160955449|NCT03137303|581223542|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
160955450|NCT03137303|581223543|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
160955451|NCT03137303|581223542|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
160955452|NCT03137303|581223543|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
160955453|NCT03137303|581223542|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
160955454|NCT03137303|581223543|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
160955455|NCT03561090|581223544|FG000|Overall Study|Adverse Event|11|||
160955456|NCT03561090|581223545|FG001|Overall Study|Adverse Event|7|||
160955457|NCT03561090|581223544|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160955458|NCT03561090|581223545|FG001|Overall Study|Non-Compliance With Study Drug|0|||
160955459|NCT03561090|581223544|FG000|Overall Study|Protocol Violation|2|||
160955460|NCT03561090|581223545|FG001|Overall Study|Protocol Violation|2|||
160955461|NCT03561090|581223544|FG000|Overall Study|Withdrawal by Subject|7|||
160955462|NCT03561090|581223545|FG001|Overall Study|Withdrawal by Subject|7|||
160955463|NCT03561090|581223544|FG000|Overall Study|Lost to Follow-up|7|||
160955464|NCT03561090|581223545|FG001|Overall Study|Lost to Follow-up|2|||
160955465|NCT03561090|581223544|FG000|Overall Study|Study Terminated by Sponsor|10|||
160955466|NCT03561090|581223545|FG001|Overall Study|Study Terminated by Sponsor|15|||
160955467|NCT03561090|581223544|FG000|Overall Study|Randomized by Mistake|1|||
160955468|NCT03561090|581223545|FG001|Overall Study|Randomized by Mistake|1|||
160955469|NCT03561090|581223544|FG000|Overall Study|Other Not Specified|0|||
160955470|NCT03561090|581223545|FG001|Overall Study|Other Not Specified|2|||
160955471|NCT00725452|581223555|FG000|Overall Study|Adverse Event|3|||
160955472|NCT00725452|581223555|FG000|Overall Study|Lack of Efficacy|2|||
160955473|NCT00725452|581223555|FG000|Overall Study|Reason not specified|1|||
160955474|NCT00725452|581223555|FG000|Overall Study|Physician Decision|1|||
160955475|NCT00725452|581223555|FG000|Overall Study|Withdrawal by Subject|3|||
160955476|NCT00725452|581223555|FG000|Overall Study|Lost to Follow-up|1|||
160955477|NCT00713648|581223556|FG000|Overall Study|Adverse Event|1|||
160955478|NCT00713648|581223556|FG000|Overall Study|Unclassified|2|||
160955479|NCT00713648|581223556|FG000|Overall Study|According to Protocol|2|||
160955480|NCT00713648|581223556|FG000|Overall Study|Development of antibodies|3|||
160955481|NCT02566031|581223559|FG000|Overall Study|Patient/guardian decision|14|||
160955482|NCT02566031|581223560|FG001|Overall Study|Patient/guardian decision|7|||
160955483|NCT02566031|581223559|FG000|Overall Study|Protocol deviation|2|||
160955484|NCT02566031|581223560|FG001|Overall Study|Protocol deviation|3|||
160955485|NCT02566031|581223559|FG000|Overall Study|Adverse Event|3|||
160955486|NCT02566031|581223560|FG001|Overall Study|Adverse Event|1|||
160955487|NCT02566031|581223559|FG000|Overall Study|Lost to Follow-up|1|||
160955488|NCT02566031|581223560|FG001|Overall Study|Lost to Follow-up|1|||
160955489|NCT03031938|581223561|FG000|Overall Study|Death|1|||
160955490|NCT03031938|581223562|FG001|Overall Study|Death|0|||
160955491|NCT01910129|581223571|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
160955492|NCT01910129|581223572|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
160955493|NCT01910129|581223573|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
160955494|NCT01910129|581223571|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
160955495|NCT01910129|581223572|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
160955496|NCT01910129|581223573|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
160955497|NCT02415400|581223575|FG000|Overall Study|Adverse Event|0|||
160955498|NCT02415400|581223576|FG001|Overall Study|Adverse Event|1|||
160955499|NCT02415400|581223577|FG002|Overall Study|Adverse Event|1|||
160955500|NCT02415400|581223578|FG003|Overall Study|Adverse Event|2|||
160955501|NCT02415400|581223575|FG000|Overall Study|Participant request to stop therapy|4|||
160955502|NCT02415400|581223576|FG001|Overall Study|Participant request to stop therapy|3|||
160955503|NCT02415400|581223577|FG002|Overall Study|Participant request to stop therapy|8|||
160955504|NCT02415400|581223578|FG003|Overall Study|Participant request to stop therapy|6|||
160955505|NCT02415400|581223575|FG000|Overall Study|Participant withdrew consent|14|||
160955506|NCT02415400|581223576|FG001|Overall Study|Participant withdrew consent|12|||
160955507|NCT02415400|581223577|FG002|Overall Study|Participant withdrew consent|30|||
160955508|NCT02415400|581223578|FG003|Overall Study|Participant withdrew consent|21|||
160955509|NCT02415400|581223575|FG000|Overall Study|Death|39|||
160955510|NCT02415400|581223576|FG001|Overall Study|Death|41|||
160955511|NCT02415400|581223577|FG002|Overall Study|Death|35|||
160955512|NCT02415400|581223578|FG003|Overall Study|Death|42|||
160955513|NCT02415400|581223575|FG000|Overall Study|Lost to Follow-up|3|||
161001110|NCT01802632|581388976|FG002|Overall Study|Withdrawal by Subject|7|||
161001111|NCT01802632|581388977|FG003|Overall Study|Withdrawal by Subject|3|||
161001112|NCT01802632|581388978|FG004|Overall Study|Withdrawal by Subject|0|||
161001113|NCT01802632|581388979|FG005|Overall Study|Withdrawal by Subject|1|||
161001114|NCT01802632|581388974|FG000|Overall Study|Objective Disease Progression|1|||
161001115|NCT01802632|581388975|FG001|Overall Study|Objective Disease Progression|12|||
161146328|NCT01981122|581918417|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
161146329|NCT01981122|581918418|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
161146330|NCT01981122|581918417|FG000|Overall Study|Death|14|||
160955514|NCT02415400|581223576|FG001|Overall Study|Lost to Follow-up|3|||
160955515|NCT02415400|581223577|FG002|Overall Study|Lost to Follow-up|2|||
160955516|NCT02415400|581223578|FG003|Overall Study|Lost to Follow-up|5|||
160955517|NCT02415400|581223575|FG000|Overall Study|Poor/Non-Compliance|0|||
160955518|NCT02415400|581223576|FG001|Overall Study|Poor/Non-Compliance|1|||
160955519|NCT02415400|581223577|FG002|Overall Study|Poor/Non-Compliance|3|||
160955520|NCT02415400|581223578|FG003|Overall Study|Poor/Non-Compliance|4|||
160955521|NCT02415400|581223575|FG000|Overall Study|Participant no longer meets criteria|2|||
160955522|NCT02415400|581223576|FG001|Overall Study|Participant no longer meets criteria|0|||
160955523|NCT02415400|581223577|FG002|Overall Study|Participant no longer meets criteria|0|||
160955524|NCT02415400|581223578|FG003|Overall Study|Participant no longer meets criteria|1|||
160955525|NCT02415400|581223575|FG000|Overall Study|Participant doesn't answer phone|1|||
160955526|NCT02415400|581223576|FG001|Overall Study|Participant doesn't answer phone|0|||
160955527|NCT02415400|581223577|FG002|Overall Study|Participant doesn't answer phone|0|||
160955528|NCT02415400|581223578|FG003|Overall Study|Participant doesn't answer phone|0|||
160955529|NCT02415400|581223575|FG000|Overall Study|Participant wanted home visits|1|||
160955530|NCT02415400|581223576|FG001|Overall Study|Participant wanted home visits|0|||
160955531|NCT02415400|581223577|FG002|Overall Study|Participant wanted home visits|0|||
160955532|NCT02415400|581223578|FG003|Overall Study|Participant wanted home visits|0|||
160955533|NCT02415400|581223575|FG000|Overall Study|Randomized in error|2|||
160955534|NCT02415400|581223576|FG001|Overall Study|Randomized in error|0|||
160955535|NCT02415400|581223577|FG002|Overall Study|Randomized in error|0|||
160955536|NCT02415400|581223578|FG003|Overall Study|Randomized in error|0|||
160955537|NCT02415400|581223575|FG000|Overall Study|No study drug on site|0|||
160955538|NCT02415400|581223576|FG001|Overall Study|No study drug on site|1|||
160955539|NCT02415400|581223577|FG002|Overall Study|No study drug on site|0|||
160955540|NCT02415400|581223578|FG003|Overall Study|No study drug on site|0|||
160955541|NCT02415400|581223575|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
160955542|NCT02415400|581223576|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
160955543|NCT02415400|581223577|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
160955544|NCT02415400|581223578|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
160955545|NCT02415400|581223575|FG000|Overall Study|Coagulation values cannot be set|0|||
160955546|NCT02415400|581223576|FG001|Overall Study|Coagulation values cannot be set|0|||
160955547|NCT02415400|581223577|FG002|Overall Study|Coagulation values cannot be set|1|||
160955548|NCT02415400|581223578|FG003|Overall Study|Coagulation values cannot be set|0|||
160955549|NCT02415400|581223575|FG000|Overall Study|State regulations prevent participation|0|||
160955550|NCT02415400|581223576|FG001|Overall Study|State regulations prevent participation|0|||
160955551|NCT02415400|581223577|FG002|Overall Study|State regulations prevent participation|1|||
160955552|NCT02415400|581223578|FG003|Overall Study|State regulations prevent participation|0|||
160955553|NCT02415400|581223575|FG000|Overall Study|Poor treatment monitoring|0|||
160955554|NCT02415400|581223576|FG001|Overall Study|Poor treatment monitoring|0|||
160955555|NCT02415400|581223577|FG002|Overall Study|Poor treatment monitoring|1|||
160955556|NCT02415400|581223578|FG003|Overall Study|Poor treatment monitoring|0|||
160955557|NCT02415400|581223575|FG000|Overall Study|Participant in jail|0|||
160955558|NCT02415400|581223576|FG001|Overall Study|Participant in jail|0|||
160955559|NCT02415400|581223577|FG002|Overall Study|Participant in jail|1|||
160955560|NCT02415400|581223578|FG003|Overall Study|Participant in jail|0|||
160955561|NCT02415400|581223575|FG000|Overall Study|Investigator decision|0|||
160955562|NCT02415400|581223576|FG001|Overall Study|Investigator decision|0|||
160955563|NCT02415400|581223577|FG002|Overall Study|Investigator decision|1|||
160955564|NCT02415400|581223578|FG003|Overall Study|Investigator decision|1|||
160955565|NCT02415400|581223575|FG000|Overall Study|Site closure; participant won't transfer|0|||
160955566|NCT02415400|581223576|FG001|Overall Study|Site closure; participant won't transfer|0|||
160955567|NCT02415400|581223577|FG002|Overall Study|Site closure; participant won't transfer|0|||
160955568|NCT02415400|581223578|FG003|Overall Study|Site closure; participant won't transfer|1|||
160955569|NCT01226745|581223579|FG000|Overall Study|Did not complete schedule of assessments|8|||
160955570|NCT01226745|581223580|FG001|Overall Study|Did not complete schedule of assessments|3|||
160955571|NCT01226745|581223581|FG002|Overall Study|Did not complete schedule of assessments|6|||
160955572|NCT01226745|581223582|FG003|Overall Study|Did not complete schedule of assessments|0|||
161001116|NCT01802632|581388976|FG002|Overall Study|Objective Disease Progression|104|||
161001117|NCT01802632|581388977|FG003|Overall Study|Objective Disease Progression|6|||
161001118|NCT01802632|581388978|FG004|Overall Study|Objective Disease Progression|4|||
161146331|NCT01981122|581918418|FG001|Overall Study|Death|15|||
161268806|NCT04645966|582366859|FG003|Vaccination Phase|Adverse Event|0|||
160955573|NCT01226745|581223583|FG004|Overall Study|Did not complete schedule of assessments|0|||
160955574|NCT01226745|581223584|FG005|Overall Study|Did not complete schedule of assessments|1|||
160955575|NCT01226745|581223579|FG000|Overall Study|Lost to Follow-up|2|||
160955576|NCT01226745|581223580|FG001|Overall Study|Lost to Follow-up|6|||
160955577|NCT01226745|581223581|FG002|Overall Study|Lost to Follow-up|6|||
160955578|NCT01226745|581223582|FG003|Overall Study|Lost to Follow-up|1|||
160955579|NCT01226745|581223583|FG004|Overall Study|Lost to Follow-up|1|||
160955580|NCT01226745|581223584|FG005|Overall Study|Lost to Follow-up|2|||
160955581|NCT01226745|581223579|FG000|Overall Study|Death|1|||
160955582|NCT01226745|581223580|FG001|Overall Study|Death|0|||
160955583|NCT01226745|581223581|FG002|Overall Study|Death|0|||
160955584|NCT01226745|581223582|FG003|Overall Study|Death|0|||
160955585|NCT01226745|581223583|FG004|Overall Study|Death|0|||
160955586|NCT01226745|581223584|FG005|Overall Study|Death|1|||
160955587|NCT01226745|581223579|FG000|Overall Study|Other|6|||
160955588|NCT01226745|581223580|FG001|Overall Study|Other|7|||
160955589|NCT01226745|581223581|FG002|Overall Study|Other|8|||
160955590|NCT01226745|581223582|FG003|Overall Study|Other|4|||
160955591|NCT01226745|581223583|FG004|Overall Study|Other|3|||
160955592|NCT01226745|581223584|FG005|Overall Study|Other|1|||
160955593|NCT03595904|581223593|FG000|Overall Study|Protocol Violation|3|||
160955594|NCT03595904|581223594|FG001|Overall Study|Protocol Violation|1|||
160955595|NCT03595904|581223593|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
160955596|NCT03595904|581223594|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
161001119|NCT01802632|581388979|FG005|Overall Study|Objective Disease Progression|4|||
161001120|NCT01802632|581388974|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
161001121|NCT01802632|581388975|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
161001122|NCT01802632|581388976|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
161001123|NCT01802632|581388977|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
161001124|NCT01802632|581388978|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
161001125|NCT01802632|581388979|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
161001126|NCT01802632|581388974|FG000|Overall Study|Other (not specified)|0|||
161001127|NCT01802632|581388975|FG001|Overall Study|Other (not specified)|0|||
161001128|NCT01802632|581388976|FG002|Overall Study|Other (not specified)|7|||
161001129|NCT01802632|581388977|FG003|Overall Study|Other (not specified)|1|||
161001130|NCT01802632|581388978|FG004|Overall Study|Other (not specified)|0|||
161001131|NCT01802632|581388979|FG005|Overall Study|Other (not specified)|1|||
161001132|NCT00367991|581388980|FG000|Overall Study|Withdrawal by Subject|1|||
161001133|NCT00367991|581388981|FG001|Overall Study|Withdrawal by Subject|1|||
161001134|NCT00367991|581388980|FG000|Overall Study|Adverse Event|1|||
161001135|NCT00367991|581388981|FG001|Overall Study|Adverse Event|1|||
161001136|NCT01184508|581388985|FG000|Overall Study|Adverse Event|4|||
161001137|NCT01184508|581388986|FG001|Overall Study|Adverse Event|6|||
161001138|NCT01184508|581388985|FG000|Overall Study|Lack of Efficacy|1|||
161001139|NCT01184508|581388986|FG001|Overall Study|Lack of Efficacy|1|||
161001140|NCT01184508|581388985|FG000|Overall Study|Lost to Follow-up|1|||
161001141|NCT01184508|581388986|FG001|Overall Study|Lost to Follow-up|1|||
161001142|NCT01184508|581388985|FG000|Overall Study|Physician Decision|1|||
161001143|NCT01184508|581388986|FG001|Overall Study|Physician Decision|0|||
161001144|NCT01184508|581388985|FG000|Overall Study|Protocol Violation|3|||
161001145|NCT01184508|581388986|FG001|Overall Study|Protocol Violation|1|||
161001146|NCT01184508|581388985|FG000|Overall Study|Sponsor Decision|5|||
161001147|NCT01184508|581388986|FG001|Overall Study|Sponsor Decision|2|||
161001148|NCT01184508|581388985|FG000|Overall Study|Withdrawal by Subject|1|||
161146332|NCT00089843|581918424|FG000|Overall Study|Withdrawal by Subject|1|||
161146333|NCT00089843|581918425|FG001|Overall Study|Withdrawal by Subject|4|||
161146334|NCT00089843|581918426|FG002|Overall Study|Withdrawal by Subject|5|||
160955597|NCT03595904|581223593|FG000|Overall Study|Insurance complications|1|||
160955598|NCT03595904|581223594|FG001|Overall Study|Insurance complications|0|||
160955599|NCT03595904|581223593|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
160955600|NCT03595904|581223594|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
160955601|NCT01581281|581223595|FG000|Overall Study|Early Study Closure|15|||
160955602|NCT01581281|581223596|FG001|Overall Study|Early Study Closure|6|||
160955603|NCT01581281|581223597|FG002|Overall Study|Early Study Closure|12|||
160955604|NCT02187991|581223600|FG000|Overall Study|Adverse Event|13|||
161001149|NCT01184508|581388986|FG001|Overall Study|Withdrawal by Subject|3|||
161001150|NCT01184508|581388985|FG000|Overall Study|Randomized, Not Treated|0|||
161001151|NCT01184508|581388986|FG001|Overall Study|Randomized, Not Treated|1|||
161001152|NCT02969863|581388989|FG000|Overall Study|Physician Decision|1|||
161001153|NCT02969863|581388990|FG001|Overall Study|Physician Decision|0|||
161001154|NCT02969863|581388991|FG002|Overall Study|Physician Decision|0|||
161001155|NCT02969863|581388992|FG003|Overall Study|Physician Decision|0|||
161001156|NCT02969863|581388993|FG004|Overall Study|Physician Decision|0|||
161001157|NCT02969863|581388994|FG005|Overall Study|Physician Decision|0|||
161001158|NCT02705586|581388996|FG000|Overall Study|Health Issues|2|||
161001159|NCT02705586|581388996|FG000|Overall Study|Transportation Difficulties|5|||
161146335|NCT00089843|581918427|FG003|Overall Study|Withdrawal by Subject|6|||
161001160|NCT02705586|581388996|FG000|Overall Study|Vacation/Planned Absence|1|||
160955605|NCT02187991|581223601|FG001|Overall Study|Adverse Event|14|||
160955606|NCT02187991|581223602|FG002|Overall Study|Adverse Event|3|||
160955607|NCT02187991|581223603|FG003|Overall Study|Adverse Event|2|||
160955608|NCT02187991|581223600|FG000|Overall Study|Withdrawal by Subject|9|||
160955609|NCT02187991|581223601|FG001|Overall Study|Withdrawal by Subject|6|||
160955610|NCT02187991|581223602|FG002|Overall Study|Withdrawal by Subject|3|||
160955611|NCT02187991|581223603|FG003|Overall Study|Withdrawal by Subject|2|||
160955612|NCT02187991|581223600|FG000|Overall Study|Physician Decision|4|||
160955613|NCT02187991|581223601|FG001|Overall Study|Physician Decision|4|||
160955614|NCT02187991|581223602|FG002|Overall Study|Physician Decision|0|||
160955615|NCT02187991|581223603|FG003|Overall Study|Physician Decision|2|||
160955616|NCT02187991|581223600|FG000|Overall Study|Other, unrelated complication|7|||
160955617|NCT02187991|581223601|FG001|Overall Study|Other, unrelated complication|1|||
160955618|NCT02187991|581223602|FG002|Overall Study|Other, unrelated complication|1|||
160955619|NCT02187991|581223603|FG003|Overall Study|Other, unrelated complication|2|||
160955620|NCT02187991|581223600|FG000|Overall Study|Death|1|||
160955621|NCT02187991|581223601|FG001|Overall Study|Death|3|||
160955622|NCT02187991|581223602|FG002|Overall Study|Death|0|||
160955623|NCT02187991|581223603|FG003|Overall Study|Death|0|||
160955624|NCT01392560|581223606|FG000|Overall Study|Adverse Event|2|||
160955625|NCT01392560|581223606|FG000|Overall Study|not entered|8|||
160955626|NCT01392560|581223606|FG000|Overall Study|discontinued during placebo run-in|2|||
160955627|NCT00295750|581223609|FG000|Overall Study|Adverse Event|19|||
160955628|NCT00295750|581223610|FG001|Overall Study|Adverse Event|15|||
160955629|NCT00295750|581223611|FG002|Overall Study|Adverse Event|12|||
160955630|NCT00295750|581223609|FG000|Overall Study|Lack of Efficacy|1|||
160955631|NCT00295750|581223610|FG001|Overall Study|Lack of Efficacy|1|||
160955632|NCT00295750|581223611|FG002|Overall Study|Lack of Efficacy|0|||
160955633|NCT00295750|581223609|FG000|Overall Study|Lost to Follow-up|1|||
160955634|NCT00295750|581223610|FG001|Overall Study|Lost to Follow-up|4|||
160955635|NCT00295750|581223611|FG002|Overall Study|Lost to Follow-up|1|||
160955636|NCT00295750|581223609|FG000|Overall Study|Taking prohibited therapy|2|||
160955637|NCT00295750|581223610|FG001|Overall Study|Taking prohibited therapy|3|||
160955638|NCT00295750|581223611|FG002|Overall Study|Taking prohibited therapy|2|||
161001161|NCT02808338|581388997|FG000|Screening|Screen Failure|10|||
161001162|NCT02808338|581388997|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
161001163|NCT02808338|581388997|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
161001164|NCT00961636|581389011|FG000|Overall Study|Adverse Event|35|||
161001165|NCT00961636|581389012|FG001|Overall Study|Adverse Event|54|||
161001166|NCT00961636|581389013|FG002|Overall Study|Adverse Event|13|||
161001167|NCT00961636|581389011|FG000|Overall Study|Flushing Symptoms|29|||
161001168|NCT00961636|581389012|FG001|Overall Study|Flushing Symptoms|46|||
161001169|NCT00961636|581389013|FG002|Overall Study|Flushing Symptoms|3|||
161001170|NCT00961636|581389011|FG000|Overall Study|Lost to Follow-up|2|||
161001171|NCT00961636|581389012|FG001|Overall Study|Lost to Follow-up|3|||
161001172|NCT00961636|581389013|FG002|Overall Study|Lost to Follow-up|1|||
161001173|NCT00961636|581389011|FG000|Overall Study|Physician Decision|3|||
161001174|NCT00961636|581389012|FG001|Overall Study|Physician Decision|1|||
161001175|NCT00961636|581389013|FG002|Overall Study|Physician Decision|1|||
161001176|NCT00961636|581389011|FG000|Overall Study|Protocol Violation|9|||
161001177|NCT00961636|581389012|FG001|Overall Study|Protocol Violation|5|||
161001178|NCT00961636|581389013|FG002|Overall Study|Protocol Violation|1|||
161001179|NCT00961636|581389011|FG000|Overall Study|Withdrawal by Subject|29|||
161001180|NCT00961636|581389012|FG001|Overall Study|Withdrawal by Subject|22|||
161001181|NCT00961636|581389013|FG002|Overall Study|Withdrawal by Subject|13|||
161001182|NCT02041104|581389014|FG000|Overall Study|Lost to Follow-up|1|||
161146336|NCT00089843|581918424|FG000|Overall Study|Physician Decision|1|||
161146337|NCT00089843|581918425|FG001|Overall Study|Physician Decision|0|||
161146338|NCT00089843|581918426|FG002|Overall Study|Physician Decision|0|||
161146339|NCT00089843|581918427|FG003|Overall Study|Physician Decision|1|||
161146340|NCT01295905|581918440|FG000|Overall Study|Did not meet inclusion criteria|1|||
161146341|NCT01295905|581918441|FG001|Overall Study|Did not meet inclusion criteria|0|||
161001183|NCT02041104|581389015|FG001|Overall Study|Lost to Follow-up|4|||
161001184|NCT02041104|581389014|FG000|Overall Study|discomfort during OGTT|0|||
161001185|NCT02041104|581389015|FG001|Overall Study|discomfort during OGTT|3|||
160955639|NCT00295750|581223609|FG000|Overall Study|Administrative errors|2|||
160955640|NCT00295750|581223610|FG001|Overall Study|Administrative errors|4|||
160955641|NCT00295750|581223611|FG002|Overall Study|Administrative errors|5|||
160955642|NCT00295750|581223609|FG000|Overall Study|Trial drug errors|1|||
160955643|NCT00295750|581223610|FG001|Overall Study|Trial drug errors|1|||
160955644|NCT00295750|581223611|FG002|Overall Study|Trial drug errors|0|||
161001186|NCT03215927|581390499|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
161001187|NCT03215927|581390500|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
161001188|NCT03215927|581390499|FG000|Open Label Extension|Adverse Event|1|||
161001189|NCT03215927|581390500|FG001|Open Label Extension|Adverse Event|0|||
161146342|NCT01295905|581918440|FG000|Overall Study|Met exclusion criteria|1|||
161146343|NCT01295905|581918441|FG001|Overall Study|Met exclusion criteria|0|||
160955645|NCT00295750|581223609|FG000|Overall Study|Disease progression|2|||
160955646|NCT00295750|581223610|FG001|Overall Study|Disease progression|1|||
160955647|NCT00295750|581223611|FG002|Overall Study|Disease progression|0|||
160955648|NCT00295750|581223609|FG000|Overall Study|Personal reasons|0|||
160955649|NCT00295750|581223610|FG001|Overall Study|Personal reasons|1|||
160955650|NCT00295750|581223611|FG002|Overall Study|Personal reasons|0|||
160955651|NCT00295750|581223609|FG000|Overall Study|Randomized but never received trial drug|4|||
160955652|NCT00295750|581223610|FG001|Overall Study|Randomized but never received trial drug|3|||
160955653|NCT00295750|581223611|FG002|Overall Study|Randomized but never received trial drug|3|||
160955654|NCT00295750|581223609|FG000|Overall Study|Withdrawal by Subject|9|||
160955655|NCT00295750|581223610|FG001|Overall Study|Withdrawal by Subject|4|||
160955656|NCT00295750|581223611|FG002|Overall Study|Withdrawal by Subject|7|||
160955657|NCT00295750|581223609|FG000|Overall Study|Protocol Violation|2|||
160955658|NCT00295750|581223610|FG001|Overall Study|Protocol Violation|4|||
160955659|NCT00295750|581223611|FG002|Overall Study|Protocol Violation|2|||
160955660|NCT01650259|581223612|FG000|Overall Study|Improvement|105|||
160955661|NCT01650259|581223613|FG001|Overall Study|Improvement|0|||
160955662|NCT01650259|581223612|FG000|Overall Study|Adverse Event|127|||
160955663|NCT01650259|581223613|FG001|Overall Study|Adverse Event|0|||
160955664|NCT01650259|581223612|FG000|Overall Study|Lack of Efficacy|143|||
160955665|NCT01650259|581223613|FG001|Overall Study|Lack of Efficacy|0|||
160955666|NCT01650259|581223612|FG000|Overall Study|Lost to Follow-up|435|||
160955667|NCT01650259|581223613|FG001|Overall Study|Lost to Follow-up|0|||
160955668|NCT01650259|581223612|FG000|Overall Study|Patients had no visit after entry|70|||
160955669|NCT01650259|581223613|FG001|Overall Study|Patients had no visit after entry|0|||
160955670|NCT01650259|581223612|FG000|Overall Study|CRF not collected|98|||
160955671|NCT01650259|581223613|FG001|Overall Study|CRF not collected|82|||
160955672|NCT01650259|581223612|FG000|Overall Study|Not treated|1|||
160955673|NCT01650259|581223613|FG001|Overall Study|Not treated|7|||
160955674|NCT01650259|581223612|FG000|Overall Study|Other than listed|64|||
160955675|NCT01650259|581223613|FG001|Overall Study|Other than listed|146|||
160955676|NCT04072159|581223619|FG000|Overall Study|Lost to Follow-up|6|||
160955677|NCT04072159|581223620|FG001|Overall Study|Lost to Follow-up|6|||
160955678|NCT04072159|581223619|FG000|Overall Study|Withdrawal by Subject|2|||
160955679|NCT04072159|581223620|FG001|Overall Study|Withdrawal by Subject|0|||
160955680|NCT00659334|581223631|FG000|Overall Study|Screen Failure|8|||
160955681|NCT00659334|581223632|FG001|Overall Study|Screen Failure|5|||
160955682|NCT00659334|581223633|FG002|Overall Study|Screen Failure|0|||
160955683|NCT00659334|581223634|FG003|Overall Study|Screen Failure|0|||
160955684|NCT00659334|581223635|FG004|Overall Study|Screen Failure|0|||
160955685|NCT00659334|581223636|FG005|Overall Study|Screen Failure|0|||
160955686|NCT00659334|581223637|FG006|Overall Study|Screen Failure|1|||
160955687|NCT03034577|581223638|FG000|Overall Study|Withdrawal by Subject|6|||
160955688|NCT03034577|581223639|FG001|Overall Study|Withdrawal by Subject|9|||
160955689|NCT03034577|581223638|FG000|Overall Study|Lost to Follow-up|25|||
160955690|NCT03034577|581223639|FG001|Overall Study|Lost to Follow-up|26|||
160955691|NCT01174342|581223640|FG000|Overall Study|Conversion to cesarean section|4|||
160955692|NCT02625623|581223641|FG000|Overall Study|Participants randomized but not treated|9|||
160955693|NCT02625623|581223642|FG001|Overall Study|Participants randomized but not treated|1|||
160955694|NCT02298192|581223651|FG000|Overall Study|Unclassified|3|||
160955695|NCT02298192|581223652|FG001|Overall Study|Unclassified|2|||
160955696|NCT02298192|581223651|FG000|Overall Study|Withdrawal criteria|2|||
160955697|NCT02298192|581223652|FG001|Overall Study|Withdrawal criteria|0|||
160955698|NCT02298192|581223651|FG000|Overall Study|Withdrawal by Subject|6|||
160955699|NCT02298192|581223652|FG001|Overall Study|Withdrawal by Subject|1|||
160955700|NCT02298192|581223651|FG000|Overall Study|Lost to Follow-up|2|||
160955701|NCT02298192|581223652|FG001|Overall Study|Lost to Follow-up|1|||
160955702|NCT02298192|581223651|FG000|Overall Study|Adverse Event|6|||
160955703|NCT02298192|581223652|FG001|Overall Study|Adverse Event|2|||
160955704|NCT02352948|581223653|FG000|Overall Study|Death|47|||
160955705|NCT02352948|581223654|FG001|Overall Study|Death|48|||
160955706|NCT02352948|581223655|FG002|Overall Study|Death|114|||
160955707|NCT02352948|581223656|FG003|Overall Study|Death|74|||
161342898|NCT03573297|582642293|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
160955708|NCT02352948|581223657|FG004|Overall Study|Death|77|||
160955709|NCT02352948|581223658|FG005|Overall Study|Death|44|||
160955710|NCT02352948|581223653|FG000|Overall Study|Lost to Follow-up|1|||
160955711|NCT02352948|581223654|FG001|Overall Study|Lost to Follow-up|0|||
161342899|NCT03573297|582642294|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
160955712|NCT02352948|581223655|FG002|Overall Study|Lost to Follow-up|2|||
160955713|NCT02352948|581223656|FG003|Overall Study|Lost to Follow-up|1|||
160955714|NCT02352948|581223657|FG004|Overall Study|Lost to Follow-up|2|||
160955715|NCT02352948|581223658|FG005|Overall Study|Lost to Follow-up|1|||
161342900|NCT03573297|582642295|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
160955716|NCT02352948|581223653|FG000|Overall Study|Withdrawal by Subject|1|||
160955717|NCT02352948|581223654|FG001|Overall Study|Withdrawal by Subject|10|||
160955718|NCT02352948|581223655|FG002|Overall Study|Withdrawal by Subject|11|||
161001190|NCT03215927|581390499|FG000|Open Label Extension|Lack of Efficacy|1|||
161342901|NCT03573297|582642292|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
160955719|NCT02352948|581223656|FG003|Overall Study|Withdrawal by Subject|23|||
160955720|NCT02352948|581223657|FG004|Overall Study|Withdrawal by Subject|9|||
160955721|NCT02352948|581223658|FG005|Overall Study|Withdrawal by Subject|4|||
160955722|NCT02352948|581223653|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
160955723|NCT02352948|581223654|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
160955724|NCT02352948|581223655|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
160955725|NCT02352948|581223656|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
160955726|NCT02352948|581223657|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
160955727|NCT02352948|581223658|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
160955728|NCT02352948|581223653|FG000|Overall Study|Other|0|||
160955729|NCT02352948|581223654|FG001|Overall Study|Other|0|||
160955730|NCT02352948|581223655|FG002|Overall Study|Other|2|||
161342902|NCT03573297|582642293|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
161342903|NCT03573297|582642294|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
161342904|NCT03573297|582642295|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
161342905|NCT03573297|582642292|FG000|Open Label Treatment Period|Pregnancy|1|||
161342906|NCT03573297|582642293|FG001|Open Label Treatment Period|Pregnancy|0|||
161342907|NCT03573297|582642294|FG002|Open Label Treatment Period|Pregnancy|0|||
161342908|NCT03573297|582642295|FG003|Open Label Treatment Period|Pregnancy|0|||
161342909|NCT03573297|582642292|FG000|Open Label Treatment Period|Protocol Violation|17|||
161342910|NCT03573297|582642293|FG001|Open Label Treatment Period|Protocol Violation|0|||
161342911|NCT03573297|582642294|FG002|Open Label Treatment Period|Protocol Violation|0|||
161342912|NCT03573297|582642295|FG003|Open Label Treatment Period|Protocol Violation|0|||
161342913|NCT03573297|582642292|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
161342914|NCT03573297|582642293|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161342915|NCT03573297|582642294|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161342916|NCT03573297|582642295|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
161342917|NCT03573297|582642292|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
161342918|NCT03573297|582642293|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161342919|NCT03573297|582642294|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161342920|NCT03573297|582642295|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
161342921|NCT03573297|582642292|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
161342922|NCT03573297|582642293|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161342923|NCT03573297|582642294|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161342924|NCT03573297|582642295|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
161342925|NCT03573297|582642292|FG000|Open Label Treatment Period|Other, Not Specified|7|||
161342926|NCT03573297|582642293|FG001|Open Label Treatment Period|Other, Not Specified|0|||
161342927|NCT03573297|582642294|FG002|Open Label Treatment Period|Other, Not Specified|0|||
161342928|NCT03573297|582642295|FG003|Open Label Treatment Period|Other, Not Specified|0|||
161342929|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
161342930|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
160955731|NCT02352948|581223656|FG003|Overall Study|Other|0|||
160955732|NCT02352948|581223657|FG004|Overall Study|Other|0|||
160955733|NCT02352948|581223658|FG005|Overall Study|Other|0|||
160955734|NCT00045110|581223664|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
160955735|NCT00045110|581223665|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
160955736|NCT00045110|581223666|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
160955737|NCT00045110|581223664|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
160955738|NCT00045110|581223665|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
160955739|NCT00045110|581223666|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
160955740|NCT00045110|581223664|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
160955741|NCT00045110|581223665|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
160955742|NCT00045110|581223666|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
160955743|NCT03662750|581223668|FG000|Overall Study|Withdrawal by Subject|1|||
160955744|NCT02010060|581223669|FG000|Overall Study|Lost to Follow-up|1|||
160955745|NCT02010060|581223670|FG001|Overall Study|Lost to Follow-up|2|||
160955746|NCT02010060|581223671|FG002|Overall Study|Lost to Follow-up|2|||
160955747|NCT02010060|581223669|FG000|Overall Study|Injury|0|||
160955748|NCT02010060|581223670|FG001|Overall Study|Injury|1|||
161146344|NCT00553059|581918442|FG000|Overall Study|Deemed ineligible|1|||
161146345|NCT00553059|581918443|FG001|Overall Study|Deemed ineligible|1|||
161146346|NCT00553059|581918442|FG000|Overall Study|Drug supply not available|0|||
161342931|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
160955749|NCT02010060|581223671|FG002|Overall Study|Injury|0|||
160955750|NCT04414696|581223672|FG000|3-month Follow up|Withdrawal by Subject|1|||
161146347|NCT00553059|581918443|FG001|Overall Study|Drug supply not available|1|||
161342932|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
160955751|NCT04414696|581223673|FG001|3-month Follow up|Withdrawal by Subject|0|||
160955752|NCT04414696|581223672|FG000|3-month Follow up|Lost to Follow-up|22|||
160955753|NCT04414696|581223673|FG001|3-month Follow up|Lost to Follow-up|23|||
160955754|NCT04414696|581223672|FG000|6-month Follow up|Withdrawal by Subject|1|||
160955755|NCT04414696|581223673|FG001|6-month Follow up|Withdrawal by Subject|2|||
160955756|NCT04414696|581223672|FG000|6-month Follow up|Lost to Follow-up|5|||
160955757|NCT04414696|581223673|FG001|6-month Follow up|Lost to Follow-up|2|||
160955758|NCT00660010|581223676|FG000|Overall Study|Withdrawal by Subject|2|||
160955759|NCT00660010|581223676|FG000|Overall Study|Lost to Follow-up|3|||
160955760|NCT00660010|581223676|FG000|Overall Study|Adverse Event|1|||
160955761|NCT00660010|581223676|FG000|Overall Study|Noncompliance with visit schedule|3|||
160955762|NCT00726752|581223677|FG000|Overall Study|Lack of Efficacy|6|||
160955763|NCT06167031|581223680|FG000|Overall Study|Lost to Follow-up|5|||
160955764|NCT06167031|581223681|FG001|Overall Study|Lost to Follow-up|1|||
160955765|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955766|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955767|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955768|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
160955769|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955770|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
160955771|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
160955772|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
160955773|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
160955774|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
160955775|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
160955776|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
160955777|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955778|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955779|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
161342933|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161342934|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Adverse Event|1|||
161342935|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Adverse Event|5|||
161342936|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Adverse Event|1|||
161342937|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
161342938|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
161342939|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
161342940|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
161342941|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161342942|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
161342943|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
161342944|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
161342945|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161342946|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
161342947|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
161342948|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
161342949|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161342950|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
161342951|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
161342952|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
161342953|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
161342954|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
161342955|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
161342956|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
161342957|NCT03573297|582642292|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
161342958|NCT03573297|582642293|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
161342959|NCT03573297|582642294|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
161342960|NCT03573297|582642295|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
161342961|NCT02696798|582642297|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
161342962|NCT02696798|582642298|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
161342963|NCT02696798|582642299|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
161342964|NCT02696798|582642297|FG000|Blinded Treatment Dosing Period|Death|0|||
160955780|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
160955781|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955782|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
160955783|NCT01292603|581225807|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955784|NCT01292603|581225808|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955785|NCT01292603|581225809|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955786|NCT01292603|581225810|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
161342965|NCT02696798|582642298|FG001|Blinded Treatment Dosing Period|Death|0|||
161342966|NCT02696798|582642299|FG002|Blinded Treatment Dosing Period|Death|1|||
160955787|NCT01292603|581225811|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
161342967|NCT02696798|582642297|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
161342968|NCT02696798|582642298|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
160955788|NCT01292603|581225812|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
160955789|NCT01292603|581225807|FG000|Part 1: Regular Follow-Up Period|Death|3|||
160955790|NCT01292603|581225808|FG001|Part 1: Regular Follow-Up Period|Death|1|||
160955791|NCT01292603|581225809|FG002|Part 1: Regular Follow-Up Period|Death|3|||
160955792|NCT01292603|581225810|FG003|Part 1: Regular Follow-Up Period|Death|1|||
160955793|NCT01292603|581225811|FG004|Part 1: Regular Follow-Up Period|Death|0|||
160955794|NCT01292603|581225812|FG005|Part 1: Regular Follow-Up Period|Death|0|||
160955795|NCT01292603|581225807|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
160955796|NCT01292603|581225808|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
160955797|NCT01292603|581225809|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
160955798|NCT01292603|581225810|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
160955799|NCT01292603|581225811|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
160955800|NCT01292603|581225812|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
160955801|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Death|0|||
160955802|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Death|0|||
160955803|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Death|0|||
160955804|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Death|0|||
160955805|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Death|1|||
160955806|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Death|0|||
160955807|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955808|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955809|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955810|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955811|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
160955812|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
160955813|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955814|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955815|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955816|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
160955817|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
160955818|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
160955819|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955820|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955821|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955822|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
160955823|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
160955824|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
160955825|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955826|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955827|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955828|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
160955829|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
160955830|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
160955831|NCT01292603|581225807|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955832|NCT01292603|581225808|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955833|NCT01292603|581225809|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955834|NCT01292603|581225810|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955835|NCT01292603|581225811|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
160955836|NCT01292603|581225812|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
160955837|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Death|0|||
160955838|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Death|0|||
160955839|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Death|0|||
160955840|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Death|0|||
160955841|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Death|6|||
160955842|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Death|3|||
160955843|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
160955844|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
160955845|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
160955846|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
160955847|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
160955848|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
160955849|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
160955850|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
160955851|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
160955852|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
160955853|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
160955854|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
160955855|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955856|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
161146348|NCT01966731|581918444|FG000|Overall Study|Death|2|||
160955857|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955858|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955859|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
160955860|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
160955861|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955862|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955863|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955864|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955865|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
160955866|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
160955867|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
160955868|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
160955869|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
160955870|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
160955871|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
160955872|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
160955873|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955874|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955875|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955876|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
160955877|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
160955878|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
161342969|NCT02696798|582642299|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
161342970|NCT02696798|582642297|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
161342971|NCT02696798|582642298|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
161342972|NCT02696798|582642299|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
161342973|NCT02696798|582642297|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
161342974|NCT02696798|582642298|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
161342975|NCT02696798|582642299|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
161342976|NCT02696798|582642297|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
161342977|NCT02696798|582642298|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
161342978|NCT02696798|582642299|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
161342979|NCT02696798|582642297|FG000|Extended Treatment Period|Adverse Event|1|||
161342980|NCT02696798|582642298|FG001|Extended Treatment Period|Adverse Event|4|||
161342981|NCT02696798|582642299|FG002|Extended Treatment Period|Adverse Event|5|||
161342982|NCT02696798|582642297|FG000|Extended Treatment Period|Lack of Efficacy|7|||
161342983|NCT02696798|582642298|FG001|Extended Treatment Period|Lack of Efficacy|2|||
161342984|NCT02696798|582642299|FG002|Extended Treatment Period|Lack of Efficacy|2|||
161342985|NCT02696798|582642297|FG000|Extended Treatment Period|Lost to Follow-up|1|||
161342986|NCT02696798|582642298|FG001|Extended Treatment Period|Lost to Follow-up|0|||
161342987|NCT02696798|582642299|FG002|Extended Treatment Period|Lost to Follow-up|0|||
161342988|NCT02696798|582642297|FG000|Extended Treatment Period|Physician Decision|0|||
161342989|NCT02696798|582642298|FG001|Extended Treatment Period|Physician Decision|1|||
161342990|NCT02696798|582642299|FG002|Extended Treatment Period|Physician Decision|0|||
161342991|NCT02696798|582642297|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
161342992|NCT02696798|582642298|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
161342993|NCT02696798|582642299|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
161342994|NCT02696798|582642297|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
161342995|NCT02696798|582642298|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
161342996|NCT02696798|582642299|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
161342997|NCT02696798|582642297|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
161342998|NCT02696798|582642298|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
161342999|NCT02696798|582642299|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
161343000|NCT02696798|582642297|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
161343001|NCT02696798|582642298|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
161343002|NCT02696798|582642299|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
161343003|NCT02696798|582642297|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
161343004|NCT02696798|582642298|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
161343005|NCT02696798|582642299|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
161343006|NCT02696798|582642297|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
161343007|NCT02696798|582642298|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
161343008|NCT02696798|582642299|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
160955879|NCT01292603|581225807|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
161001191|NCT03215927|581390500|FG001|Open Label Extension|Lack of Efficacy|0|||
161343009|NCT02696798|582642297|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
161343010|NCT02696798|582642298|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
161343011|NCT02696798|582642299|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
160955880|NCT01292603|581225808|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
161001192|NCT03215927|581390499|FG000|Open Label Extension|Death|0|||
161343012|NCT04091451|582642300|FG000|Overall Study|Adverse Event|15|||
161343013|NCT04091451|582642301|FG001|Overall Study|Adverse Event|10|||
161343014|NCT04091451|582642300|FG000|Overall Study|Lost to Follow-up|8|||
161343015|NCT04091451|582642301|FG001|Overall Study|Lost to Follow-up|8|||
161343016|NCT04091451|582642300|FG000|Overall Study|Protocol Violation|5|||
161343017|NCT04091451|582642301|FG001|Overall Study|Protocol Violation|4|||
161343018|NCT04091451|582642300|FG000|Overall Study|Withdrawal by Subject|21|||
161343019|NCT04091451|582642301|FG001|Overall Study|Withdrawal by Subject|27|||
161343020|NCT04091451|582642300|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
161343021|NCT04091451|582642301|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
161343022|NCT04091451|582642300|FG000|Overall Study|Migrated/moved from the study area|3|||
161343023|NCT04091451|582642301|FG001|Overall Study|Migrated/moved from the study area|5|||
161343024|NCT04091451|582642300|FG000|Overall Study|Suspected HZ episode|1|||
161343025|NCT04091451|582642301|FG001|Overall Study|Suspected HZ episode|0|||
161343026|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
161343027|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
161343028|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
161343029|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
161343030|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
161343031|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
161343032|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
161343033|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
161343034|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
161343035|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
161343036|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
161343037|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
161343038|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
161343039|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
160955881|NCT01292603|581225809|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
160955882|NCT01292603|581225810|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
161343040|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
161343041|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
160955883|NCT01292603|581225811|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
160955884|NCT01292603|581225812|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
160955885|NCT01292603|581225807|FG000|Overall Survival Status|Death|3|||
160955886|NCT01292603|581225808|FG001|Overall Survival Status|Death|1|||
160955887|NCT01292603|581225809|FG002|Overall Survival Status|Death|3|||
160955888|NCT01292603|581225810|FG003|Overall Survival Status|Death|1|||
160955889|NCT01292603|581225811|FG004|Overall Survival Status|Death|16|||
160955890|NCT01292603|581225812|FG005|Overall Survival Status|Death|10|||
160955891|NCT02120027|581225813|FG000|Overall Study|Adverse Event|4|||
160955892|NCT02120027|581225814|FG001|Overall Study|Adverse Event|5|||
160955893|NCT02120027|581225813|FG000|Overall Study|Lack of Efficacy|3|||
160955894|NCT02120027|581225814|FG001|Overall Study|Lack of Efficacy|5|||
160955895|NCT02120027|581225813|FG000|Overall Study|Lost to Follow-up|5|||
160955896|NCT02120027|581225814|FG001|Overall Study|Lost to Follow-up|13|||
161343042|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
161343043|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
161343044|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
161343045|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
161343046|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
161343047|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
161343048|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
161343049|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
160955897|NCT02120027|581225813|FG000|Overall Study|Other|4|||
160955898|NCT02120027|581225814|FG001|Overall Study|Other|0|||
160955899|NCT02120027|581225813|FG000|Overall Study|Physician Decision|4|||
160955900|NCT02120027|581225814|FG001|Overall Study|Physician Decision|3|||
160955901|NCT02120027|581225813|FG000|Overall Study|Protocol Violation|18|||
160955902|NCT02120027|581225814|FG001|Overall Study|Protocol Violation|21|||
160955903|NCT02120027|581225813|FG000|Overall Study|Study terminated by Sponsor|45|||
160955904|NCT02120027|581225814|FG001|Overall Study|Study terminated by Sponsor|47|||
160955905|NCT02120027|581225813|FG000|Overall Study|Withdrawal by Subject|33|||
161146349|NCT01966731|581918444|FG000|Overall Study|Lost to Follow-up|1|||
161146350|NCT01966731|581918444|FG000|Overall Study|Physician Decision|2|||
161146351|NCT01966731|581918444|FG000|Overall Study|Follow up is not complete|600|||
160955906|NCT02120027|581225814|FG001|Overall Study|Withdrawal by Subject|25|||
160955907|NCT03162224|581225815|FG000|Overall Study|Death|4|||
160955908|NCT03162224|581225816|FG001|Overall Study|Death|5|||
160955909|NCT03162224|581225817|FG002|Overall Study|Death|8|||
160955910|NCT03162224|581225815|FG000|Overall Study|Withdrawal by Subject|1|||
160955911|NCT03162224|581225816|FG001|Overall Study|Withdrawal by Subject|0|||
160955912|NCT03162224|581225817|FG002|Overall Study|Withdrawal by Subject|1|||
160955913|NCT03162224|581225815|FG000|Overall Study|Lost to Follow-up|0|||
160955914|NCT03162224|581225816|FG001|Overall Study|Lost to Follow-up|1|||
160955915|NCT03162224|581225817|FG002|Overall Study|Lost to Follow-up|0|||
160955916|NCT03162224|581225815|FG000|Overall Study|Other|6|||
160955917|NCT03162224|581225816|FG001|Overall Study|Other|2|||
160955918|NCT03162224|581225817|FG002|Overall Study|Other|1|||
160955919|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
160955920|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
160955921|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
160955922|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
160955923|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
160955924|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
160955925|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
160955926|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
160955927|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
160955928|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
160955929|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
160955930|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
160955931|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
160955932|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
160955933|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
160955934|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
160955935|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
160955936|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
160955937|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
160955938|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
160955939|NCT04162769|581225818|FG000|Double-blind Treatment (12-Week)|Other|0|||
160955940|NCT04162769|581225819|FG001|Double-blind Treatment (12-Week)|Other|1|||
160955941|NCT04162769|581225820|FG002|Double-blind Treatment (12-Week)|Other|1|||
161268807|NCT04645966|582366860|FG004|Vaccination Phase|Adverse Event|0|||
161268808|NCT04645966|582366861|FG005|Vaccination Phase|Adverse Event|0|||
160955942|NCT04162769|581225821|FG003|Double-blind Treatment (12-Week)|Other|0|||
160955943|NCT04162769|581225818|FG000|OLE Period (52-Week)|Adverse Event|0|||
160955944|NCT04162769|581225819|FG001|OLE Period (52-Week)|Adverse Event|0|||
160955945|NCT04162769|581225820|FG002|OLE Period (52-Week)|Adverse Event|0|||
160955946|NCT04162769|581225821|FG003|OLE Period (52-Week)|Adverse Event|5|||
160955947|NCT04162769|581225818|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
160955948|NCT04162769|581225819|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
160955949|NCT04162769|581225820|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
160955950|NCT04162769|581225821|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
160955951|NCT04162769|581225818|FG000|OLE Period (52-Week)|Physician Decision|0|||
160955952|NCT04162769|581225819|FG001|OLE Period (52-Week)|Physician Decision|0|||
160955953|NCT04162769|581225820|FG002|OLE Period (52-Week)|Physician Decision|0|||
160955954|NCT04162769|581225821|FG003|OLE Period (52-Week)|Physician Decision|1|||
160955955|NCT04162769|581225818|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
160955956|NCT04162769|581225819|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
160955957|NCT04162769|581225820|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
160955958|NCT04162769|581225821|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
160955959|NCT04162769|581225818|FG000|OLE Period (52-Week)|Protocol deviation|0|||
161146352|NCT01966731|581918444|FG000|Overall Study|Screening Failure|29|||
161268809|NCT04645966|582366862|FG006|Vaccination Phase|Adverse Event|1|||
161268810|NCT04645966|582366863|FG007|Vaccination Phase|Adverse Event|0|||
161268811|NCT04645966|582366864|FG008|Vaccination Phase|Adverse Event|0|||
161268812|NCT04645966|582366856|FG000|Vaccination Phase|Death|0|||
161268813|NCT04645966|582366857|FG001|Vaccination Phase|Death|0|||
161268814|NCT04645966|582366858|FG002|Vaccination Phase|Death|0|||
161268815|NCT04645966|582366859|FG003|Vaccination Phase|Death|0|||
161268816|NCT04645966|582366860|FG004|Vaccination Phase|Death|0|||
161268817|NCT04645966|582366861|FG005|Vaccination Phase|Death|1|||
161268818|NCT04645966|582366862|FG006|Vaccination Phase|Death|0|||
161268819|NCT04645966|582366863|FG007|Vaccination Phase|Death|0|||
161268820|NCT04645966|582366864|FG008|Vaccination Phase|Death|0|||
161268821|NCT04645966|582366856|FG000|Vaccination Phase|Protocol Violation|0|||
161268822|NCT04645966|582366857|FG001|Vaccination Phase|Protocol Violation|0|||
161268823|NCT04645966|582366858|FG002|Vaccination Phase|Protocol Violation|0|||
161268824|NCT04645966|582366859|FG003|Vaccination Phase|Protocol Violation|0|||
161268825|NCT04645966|582366860|FG004|Vaccination Phase|Protocol Violation|1|||
160955960|NCT04162769|581225819|FG001|OLE Period (52-Week)|Protocol deviation|0|||
160955961|NCT04162769|581225820|FG002|OLE Period (52-Week)|Protocol deviation|0|||
160955962|NCT04162769|581225821|FG003|OLE Period (52-Week)|Protocol deviation|2|||
160955963|NCT01972841|581225824|FG000|Overall Study|Randomized but Never Received Treatment|2|||
160955964|NCT01972841|581225825|FG001|Overall Study|Randomized but Never Received Treatment|5|||
161268826|NCT04645966|582366861|FG005|Vaccination Phase|Protocol Violation|0|||
161343050|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
161343051|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
161343052|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
161343053|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
161343054|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
161343055|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
161343056|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
161343057|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
161343058|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
161343059|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
161343060|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
161343061|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
161343062|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
161343063|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
161001193|NCT03215927|581390500|FG001|Open Label Extension|Death|1|||
161343064|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
161343065|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
161343066|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
161343067|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
161343068|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
161343069|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
161343070|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
161343071|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
161343072|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
161343073|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
161343074|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
161343075|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
161343076|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
161343077|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
161343078|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
161343079|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
161343080|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
161343081|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
161343082|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
161343083|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
161343084|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
161343085|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
161343086|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
161343087|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
161343088|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
161343089|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
161343090|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
160955965|NCT01972841|581225826|FG002|Overall Study|Randomized but Never Received Treatment|4|||
160955966|NCT01972841|581225827|FG003|Overall Study|Randomized but Never Received Treatment|2|||
160955967|NCT01972841|581225828|FG004|Overall Study|Randomized but Never Received Treatment|6|||
160955968|NCT01972841|581225829|FG005|Overall Study|Randomized but Never Received Treatment|13|||
160955969|NCT01972841|581225824|FG000|Overall Study|Adverse Event|13|||
160955970|NCT01972841|581225825|FG001|Overall Study|Adverse Event|8|||
161001194|NCT03779048|581390501|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
161001195|NCT03779048|581390502|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
161001196|NCT03779048|581390503|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
161001197|NCT03779048|581390501|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
161001198|NCT03779048|581390502|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
161001199|NCT03779048|581390503|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
161001200|NCT03779048|581390501|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
160955971|NCT01972841|581225826|FG002|Overall Study|Adverse Event|12|||
161001201|NCT03779048|581390502|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
161001202|NCT03779048|581390503|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
161146353|NCT01966731|581918444|FG000|Overall Study|Found to be ineligible|1|||
161146354|NCT00592683|581918445|FG000|Overall Study|Found ineligible|0|||
161146355|NCT00592683|581918446|FG001|Overall Study|Found ineligible|1|||
161146356|NCT00592683|581918445|FG000|Overall Study|Withdrawal by Subject|1|||
160955972|NCT01972841|581225827|FG003|Overall Study|Adverse Event|9|||
161343091|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
161343092|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
161343093|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
161343094|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
161343095|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
161343096|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
161343097|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
161343098|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
161343099|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
161343100|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
161343101|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
160955973|NCT01972841|581225828|FG004|Overall Study|Adverse Event|21|||
160955974|NCT01972841|581225829|FG005|Overall Study|Adverse Event|26|||
160955975|NCT01972841|581225824|FG000|Overall Study|Lack of Efficacy|1|||
160955976|NCT01972841|581225825|FG001|Overall Study|Lack of Efficacy|0|||
160955977|NCT01972841|581225826|FG002|Overall Study|Lack of Efficacy|0|||
160955978|NCT01972841|581225827|FG003|Overall Study|Lack of Efficacy|2|||
160955979|NCT01972841|581225828|FG004|Overall Study|Lack of Efficacy|4|||
161343102|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
161343103|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
161343104|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
161343105|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
161343106|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
161343107|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
161343108|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
161343109|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
161343110|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
161343111|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
160955980|NCT01972841|581225829|FG005|Overall Study|Lack of Efficacy|1|||
161343112|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
161343113|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
161343114|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
161343115|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
160955981|NCT01972841|581225824|FG000|Overall Study|Lost to Follow-up|4|||
160955982|NCT01972841|581225825|FG001|Overall Study|Lost to Follow-up|2|||
160955983|NCT01972841|581225826|FG002|Overall Study|Lost to Follow-up|4|||
160955984|NCT01972841|581225827|FG003|Overall Study|Lost to Follow-up|2|||
160955985|NCT01972841|581225828|FG004|Overall Study|Lost to Follow-up|9|||
160955986|NCT01972841|581225829|FG005|Overall Study|Lost to Follow-up|3|||
160955987|NCT01972841|581225824|FG000|Overall Study|Protocol Violation|2|||
160955988|NCT01972841|581225825|FG001|Overall Study|Protocol Violation|2|||
160955989|NCT01972841|581225826|FG002|Overall Study|Protocol Violation|3|||
160955990|NCT01972841|581225827|FG003|Overall Study|Protocol Violation|5|||
160955991|NCT01972841|581225828|FG004|Overall Study|Protocol Violation|9|||
160955992|NCT01972841|581225829|FG005|Overall Study|Protocol Violation|4|||
160955993|NCT01972841|581225824|FG000|Overall Study|Withdrawal by participants|21|||
160955994|NCT01972841|581225825|FG001|Overall Study|Withdrawal by participants|27|||
160955995|NCT01972841|581225826|FG002|Overall Study|Withdrawal by participants|23|||
160955996|NCT01972841|581225827|FG003|Overall Study|Withdrawal by participants|16|||
160955997|NCT01972841|581225828|FG004|Overall Study|Withdrawal by participants|33|||
160955998|NCT01972841|581225829|FG005|Overall Study|Withdrawal by participants|34|||
160955999|NCT01972841|581225824|FG000|Overall Study|Miscellaneous|0|||
160956000|NCT01972841|581225825|FG001|Overall Study|Miscellaneous|0|||
160956001|NCT01972841|581225826|FG002|Overall Study|Miscellaneous|4|||
160956002|NCT01972841|581225827|FG003|Overall Study|Miscellaneous|1|||
161343116|NCT00090103|582644296|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
161343117|NCT00090103|582644297|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
161343118|NCT00090103|582644298|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
161343119|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
161343120|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
161343121|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
161343122|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
160956003|NCT01972841|581225828|FG004|Overall Study|Miscellaneous|0|||
160956004|NCT01972841|581225829|FG005|Overall Study|Miscellaneous|4|||
160956005|NCT01972841|581225824|FG000|Overall Study|Did not have end of treatment page|0|||
160956006|NCT01972841|581225825|FG001|Overall Study|Did not have end of treatment page|0|||
160956007|NCT01972841|581225826|FG002|Overall Study|Did not have end of treatment page|0|||
160956008|NCT01972841|581225827|FG003|Overall Study|Did not have end of treatment page|0|||
160956009|NCT01972841|581225828|FG004|Overall Study|Did not have end of treatment page|1|||
160956010|NCT01972841|581225829|FG005|Overall Study|Did not have end of treatment page|0|||
160956011|NCT02734212|581225830|FG000|Overall Study|Lost to Follow-up|5|||
160956012|NCT02734212|581225831|FG001|Overall Study|Lost to Follow-up|10|||
160956013|NCT00688636|581225832|FG000|Overall Study|Adverse Event|2|||
160956014|NCT00688636|581225833|FG001|Overall Study|Adverse Event|1|||
160956015|NCT01572727|581225834|FG000|Overall Study|Adverse Event|43|||
160956016|NCT01572727|581225835|FG001|Overall Study|Adverse Event|15|||
160956017|NCT01572727|581225834|FG000|Overall Study|Lost to Follow-up|1|||
160956018|NCT01572727|581225835|FG001|Overall Study|Lost to Follow-up|1|||
160956019|NCT01572727|581225834|FG000|Overall Study|Physician Decision|23|||
160956020|NCT01572727|581225835|FG001|Overall Study|Physician Decision|9|||
160956021|NCT01572727|581225834|FG000|Overall Study|Progressive disease|59|||
160956022|NCT01572727|581225835|FG001|Overall Study|Progressive disease|82|||
160956023|NCT01572727|581225834|FG000|Overall Study|Protocol Violation|0|||
160956024|NCT01572727|581225835|FG001|Overall Study|Protocol Violation|1|||
160956025|NCT01572727|581225834|FG000|Overall Study|Study terminated by sponsor|61|||
160956026|NCT01572727|581225835|FG001|Overall Study|Study terminated by sponsor|83|||
160956027|NCT01572727|581225834|FG000|Overall Study|Parent/guardian decision|14|||
160956028|NCT01572727|581225835|FG001|Overall Study|Parent/guardian decision|9|||
160956029|NCT01572727|581225834|FG000|Overall Study|Death|2|||
160956030|NCT01572727|581225835|FG001|Overall Study|Death|2|||
160956031|NCT01572727|581225834|FG000|Overall Study|Untreated|4|||
160956032|NCT01572727|581225835|FG001|Overall Study|Untreated|7|||
160956033|NCT04053764|581225836|FG000|Overall Study|Withdrawal by Subject|6|||
160956034|NCT04053764|581225837|FG001|Overall Study|Withdrawal by Subject|2|||
160956035|NCT04053764|581225836|FG000|Overall Study|Physician Decision|2|||
161001203|NCT01286272|581390504|FG000|Overall Study|Ineligible after beginning treatment|1|||
161001204|NCT01286272|581390505|FG001|Overall Study|Ineligible after beginning treatment|3|||
161001205|NCT03979365|581390508|FG000|Overall Study|Death|1|||
161001206|NCT03979365|581390509|FG001|Overall Study|Death|3|||
161001207|NCT03979365|581390508|FG000|Overall Study|Withdrawal by Subject|0|||
161001208|NCT03979365|581390509|FG001|Overall Study|Withdrawal by Subject|1|||
161001209|NCT03979365|581390508|FG000|Overall Study|Drug Conversion|0|||
161001210|NCT03979365|581390509|FG001|Overall Study|Drug Conversion|3|||
161001211|NCT04001829|581390510|FG000|Overall Study|Never start protocol therapy|5|||
161001212|NCT04001829|581390511|FG001|Overall Study|Never start protocol therapy|5|||
161001213|NCT04001829|581390510|FG000|Overall Study|Adverse Event|11|||
161001214|NCT04001829|581390511|FG001|Overall Study|Adverse Event|7|||
161001215|NCT04001829|581390510|FG000|Overall Study|Alternative therapy|1|||
161001216|NCT04001829|581390511|FG001|Overall Study|Alternative therapy|2|||
161001217|NCT04001829|581390510|FG000|Overall Study|Disease progression/relapse|2|||
161001218|NCT04001829|581390511|FG001|Overall Study|Disease progression/relapse|1|||
161001219|NCT04001829|581390510|FG000|Overall Study|Other complicating disease|1|||
161001220|NCT04001829|581390511|FG001|Overall Study|Other complicating disease|0|||
161001221|NCT04001829|581390510|FG000|Overall Study|Withdrawal by Subject|1|||
161268827|NCT04645966|582366862|FG006|Vaccination Phase|Protocol Violation|0|||
161268828|NCT04645966|582366863|FG007|Vaccination Phase|Protocol Violation|0|||
161268829|NCT04645966|582366864|FG008|Vaccination Phase|Protocol Violation|0|||
161268830|NCT04645966|582366856|FG000|Vaccination Phase|Study terminated by sponsor|0|||
161268831|NCT04645966|582366857|FG001|Vaccination Phase|Study terminated by sponsor|0|||
161268832|NCT04645966|582366858|FG002|Vaccination Phase|Study terminated by sponsor|14|||
161268833|NCT04645966|582366859|FG003|Vaccination Phase|Study terminated by sponsor|15|||
161268834|NCT04645966|582366860|FG004|Vaccination Phase|Study terminated by sponsor|47|||
161268835|NCT04645966|582366861|FG005|Vaccination Phase|Study terminated by sponsor|43|||
161268836|NCT04645966|582366862|FG006|Vaccination Phase|Study terminated by sponsor|29|||
161268837|NCT04645966|582366863|FG007|Vaccination Phase|Study terminated by sponsor|29|||
161268838|NCT04645966|582366864|FG008|Vaccination Phase|Study terminated by sponsor|12|||
161268839|NCT04645966|582366856|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
161268840|NCT04645966|582366857|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
161268841|NCT04645966|582366858|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
161268842|NCT04645966|582366859|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
161268843|NCT04645966|582366860|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
161268844|NCT04645966|582366861|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
161268845|NCT04645966|582366862|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
161268846|NCT04645966|582366863|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
160956036|NCT04053764|581225837|FG001|Overall Study|Physician Decision|1|||
161001222|NCT04001829|581390511|FG001|Overall Study|Withdrawal by Subject|4|||
161001223|NCT04001829|581390510|FG000|Overall Study|Ineligible|2|||
161001224|NCT04001829|581390511|FG001|Overall Study|Ineligible|2|||
161001225|NCT04001829|581390510|FG000|Overall Study|Reason missing due to delinquent data|1|||
161146357|NCT00592683|581918446|FG001|Overall Study|Withdrawal by Subject|0|||
161146358|NCT00592683|581918445|FG000|Overall Study|Adverse Event|0|||
161268847|NCT04645966|582366864|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
160956037|NCT04053764|581225836|FG000|Overall Study|Adverse Event|1|||
160956038|NCT04053764|581225837|FG001|Overall Study|Adverse Event|0|||
160956039|NCT04053764|581225836|FG000|Overall Study|Pregnancy|1|||
160956040|NCT04053764|581225837|FG001|Overall Study|Pregnancy|0|||
160956041|NCT02384954|581225841|FG000|Phase 1|Progressive Disease|2|||
160956042|NCT02384954|581225842|FG001|Phase 1|Progressive Disease|0|||
160956043|NCT02384954|581225843|FG002|Phase 1|Progressive Disease|1|||
160956044|NCT02384954|581225844|FG003|Phase 1|Progressive Disease|1|||
160956045|NCT02384954|581225845|FG004|Phase 1|Progressive Disease|0|||
160956046|NCT02384954|581225846|FG005|Phase 1|Progressive Disease|0|||
160956047|NCT02384954|581225847|FG006|Phase 1|Progressive Disease|0|||
160956048|NCT02384954|581225848|FG007|Phase 1|Progressive Disease|0|||
160956049|NCT02384954|581225849|FG008|Phase 1|Progressive Disease|0|||
160956050|NCT02384954|581225841|FG000|Phase 1|Adverse Event|0|||
160956051|NCT02384954|581225842|FG001|Phase 1|Adverse Event|0|||
160956052|NCT02384954|581225843|FG002|Phase 1|Adverse Event|1|||
160956053|NCT02384954|581225844|FG003|Phase 1|Adverse Event|0|||
161343123|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
161343124|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
161343125|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
161343126|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
161343127|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
161343128|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
161343129|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
161343130|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
160956054|NCT02384954|581225845|FG004|Phase 1|Adverse Event|0|||
160956055|NCT02384954|581225846|FG005|Phase 1|Adverse Event|0|||
160956056|NCT02384954|581225847|FG006|Phase 1|Adverse Event|0|||
160956057|NCT02384954|581225848|FG007|Phase 1|Adverse Event|0|||
160956058|NCT02384954|581225849|FG008|Phase 1|Adverse Event|0|||
160956059|NCT02384954|581225841|FG000|Phase 2|Progressive Disease|0|||
160956060|NCT02384954|581225842|FG001|Phase 2|Progressive Disease|0|||
160956061|NCT02384954|581225843|FG002|Phase 2|Progressive Disease|0|||
160956062|NCT02384954|581225844|FG003|Phase 2|Progressive Disease|0|||
160956063|NCT02384954|581225845|FG004|Phase 2|Progressive Disease|0|||
160956064|NCT02384954|581225846|FG005|Phase 2|Progressive Disease|0|||
160956065|NCT02384954|581225847|FG006|Phase 2|Progressive Disease|0|||
160956066|NCT02384954|581225848|FG007|Phase 2|Progressive Disease|1|||
160956067|NCT02384954|581225849|FG008|Phase 2|Progressive Disease|2|||
160956068|NCT02384954|581225841|FG000|Phase 2|Adverse Event|0|||
160956069|NCT02384954|581225842|FG001|Phase 2|Adverse Event|0|||
160956070|NCT02384954|581225843|FG002|Phase 2|Adverse Event|0|||
160956071|NCT02384954|581225844|FG003|Phase 2|Adverse Event|0|||
160956072|NCT02384954|581225845|FG004|Phase 2|Adverse Event|0|||
160956073|NCT02384954|581225846|FG005|Phase 2|Adverse Event|0|||
160956074|NCT02384954|581225847|FG006|Phase 2|Adverse Event|0|||
160956075|NCT02384954|581225848|FG007|Phase 2|Adverse Event|1|||
160956076|NCT02384954|581225849|FG008|Phase 2|Adverse Event|1|||
160956077|NCT02384954|581225841|FG000|Phase 2|Failure to meet continuation criteria|0|||
160956078|NCT02384954|581225842|FG001|Phase 2|Failure to meet continuation criteria|0|||
160956079|NCT02384954|581225843|FG002|Phase 2|Failure to meet continuation criteria|0|||
160956080|NCT02384954|581225844|FG003|Phase 2|Failure to meet continuation criteria|0|||
160956081|NCT02384954|581225845|FG004|Phase 2|Failure to meet continuation criteria|0|||
160956082|NCT02384954|581225846|FG005|Phase 2|Failure to meet continuation criteria|0|||
160956083|NCT02384954|581225847|FG006|Phase 2|Failure to meet continuation criteria|0|||
160956084|NCT02384954|581225848|FG007|Phase 2|Failure to meet continuation criteria|1|||
160956085|NCT02384954|581225849|FG008|Phase 2|Failure to meet continuation criteria|0|||
160956086|NCT04732286|581225850|FG000|Overall Study|Progressive Disease|2|||
160956087|NCT04732286|581225850|FG000|Overall Study|Physician Decision|1|||
160956088|NCT04732286|581225850|FG000|Overall Study|Study Terminated by Sponsor|31|||
160956089|NCT04732286|581225850|FG000|Overall Study|Withdrawal by Subject|10|||
160956090|NCT04732286|581225850|FG000|Overall Study|Non-compliance With Study Drug|1|||
160956091|NCT04732286|581225850|FG000|Overall Study|Lost to Follow-up|4|||
160956092|NCT04732286|581225850|FG000|Overall Study|Death|51|||
160956093|NCT02372396|581225856|FG000|Overall Study|Lost to Follow-up|7|||
160956094|NCT02372396|581225857|FG001|Overall Study|Lost to Follow-up|9|||
160956095|NCT02081846|581225860|FG000|Overall Study|Withdrawal by Subject|1|||
160956096|NCT02081846|581225861|FG001|Overall Study|Withdrawal by Subject|0|||
160956097|NCT02081846|581225860|FG000|Overall Study|invalid consent|1|||
160956098|NCT02081846|581225861|FG001|Overall Study|invalid consent|0|||
160956099|NCT03265600|581225862|FG000|Overall Study|Lost to Follow-up|17|||
160956100|NCT03265600|581225863|FG001|Overall Study|Lost to Follow-up|5|||
161343131|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
161343132|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
160956101|NCT03265600|581225862|FG000|Overall Study|Withdrawal by Subject|4|||
160956102|NCT03265600|581225863|FG001|Overall Study|Withdrawal by Subject|2|||
160956103|NCT03265600|581225862|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
160956104|NCT03265600|581225863|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
160956105|NCT00535730|581225864|FG000|Overall Study|Adverse Event|1|||
160956106|NCT00535730|581225865|FG001|Overall Study|Adverse Event|1|||
160956107|NCT00535730|581225864|FG000|Overall Study|Lost to Follow-up|0|||
160956108|NCT00535730|581225865|FG001|Overall Study|Lost to Follow-up|1|||
160956109|NCT00535730|581225864|FG000|Overall Study|Physician Decision|0|||
161001226|NCT04001829|581390511|FG001|Overall Study|Reason missing due to delinquent data|0|||
161001227|NCT04496960|581390512|FG000|Overall Study|Physician Decision|0|||
161001228|NCT04496960|581390513|FG001|Overall Study|Physician Decision|1|||
161001229|NCT03175172|581390514|FG000|Overall Study|Death|3|||
161001230|NCT03175172|581390514|FG000|Overall Study|Withdrawal by Subject|3|||
161001231|NCT03175172|581390514|FG000|Overall Study|Lost to Follow-up|1|||
160956110|NCT00535730|581225865|FG001|Overall Study|Physician Decision|1|||
160956111|NCT00535730|581225864|FG000|Overall Study|Protocol Violation|1|||
160956112|NCT00535730|581225865|FG001|Overall Study|Protocol Violation|0|||
160956113|NCT00535730|581225864|FG000|Overall Study|Withdrawal by Subject|0|||
160956114|NCT00535730|581225865|FG001|Overall Study|Withdrawal by Subject|4|||
160956115|NCT00936858|581225866|FG000|Overall Study|Death|3|||
160956116|NCT00936858|581225866|FG000|Overall Study|Progression|29|||
160956117|NCT00936858|581225866|FG000|Overall Study|Withdrawal by Subject|5|||
160956118|NCT00936858|581225866|FG000|Overall Study|Adverse Event|1|||
160956119|NCT00936858|581225866|FG000|Overall Study|Physician Decision|7|||
160956120|NCT00936858|581225866|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
160956121|NCT00936858|581225866|FG000|Overall Study|Lost to Follow-up|1|||
160956122|NCT00584727|581225872|FG000|First Intervention|Discontinuation|0|||
160956123|NCT00584727|581225873|FG001|First Intervention|Discontinuation|0|||
160956124|NCT00584727|581225874|FG002|First Intervention|Discontinuation|1|||
160956125|NCT00584727|581225875|FG003|First Intervention|Discontinuation|0|||
160956126|NCT00584727|581225876|FG004|First Intervention|Discontinuation|0|||
160956127|NCT00584727|581225877|FG005|First Intervention|Discontinuation|0|||
160956128|NCT00584727|581225872|FG000|Third Intervention|Protocol Violation|0|||
160956129|NCT00584727|581225873|FG001|Third Intervention|Protocol Violation|0|||
161001232|NCT03175172|581390514|FG000|Overall Study|Study Terminated by Sponsor|3|||
161001233|NCT05011396|581390517|FG000|Overall Study|Lost to Follow-up|3|||
161001234|NCT05011396|581390518|FG001|Overall Study|Lost to Follow-up|1|||
161001235|NCT05011396|581390517|FG000|Overall Study|Withdrawal by Subject|0|||
161001236|NCT05011396|581390518|FG001|Overall Study|Withdrawal by Subject|1|||
161001237|NCT05011396|581390517|FG000|Overall Study|Positive Drug Screen|0|||
161001238|NCT05011396|581390518|FG001|Overall Study|Positive Drug Screen|1|||
161001239|NCT05855655|581390527|FG000|Overall Study|Withdrawal by Subject|0|||
161001240|NCT05855655|581390528|FG001|Overall Study|Withdrawal by Subject|1|||
161001241|NCT05855655|581390527|FG000|Overall Study|Lost to Follow-up|4|||
161001242|NCT05855655|581390528|FG001|Overall Study|Lost to Follow-up|0|||
161001243|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Adverse Event|5|||
161001244|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Adverse Event|0|||
161001245|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Adverse Event|0|||
161001246|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
161001247|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
161001248|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
161001249|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
161001250|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
161001251|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
161001252|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
161001253|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
161001254|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
161001255|NCT01426269|581390529|FG000|Period 1: 12 Weeks|Pregnancy|1|||
161001256|NCT01426269|581390530|FG001|Period 1: 12 Weeks|Pregnancy|0|||
161001257|NCT01426269|581390531|FG002|Period 1: 12 Weeks|Pregnancy|0|||
161001258|NCT01426269|581390529|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
161001259|NCT01426269|581390530|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
161001260|NCT01426269|581390531|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
161001261|NCT01426269|581390529|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
161001262|NCT01426269|581390530|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
161001263|NCT01426269|581390531|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
161001264|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Adverse Event|0|||
161001265|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Adverse Event|1|||
161001266|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Adverse Event|2|||
161001267|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
161001268|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
161001269|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
161268848|NCT04645966|582366856|FG000|Vaccination Phase|Other|0|||
160956130|NCT00584727|581225874|FG002|Third Intervention|Protocol Violation|1|||
161001270|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
161001271|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
161001272|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
161001273|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
161001274|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
161001275|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
161268849|NCT04645966|582366857|FG001|Vaccination Phase|Other|0|||
160956131|NCT00584727|581225875|FG003|Third Intervention|Protocol Violation|0|||
160956132|NCT00584727|581225876|FG004|Third Intervention|Protocol Violation|4|||
160956133|NCT00584727|581225877|FG005|Third Intervention|Protocol Violation|2|||
160956134|NCT00989287|581225880|FG000|Overall Study|Adverse Event|1|||
160956135|NCT00989287|581225881|FG001|Overall Study|Adverse Event|0|||
160956136|NCT00989287|581225880|FG000|Overall Study|Lost to Follow-up|0|||
160956137|NCT00989287|581225881|FG001|Overall Study|Lost to Follow-up|1|||
160956138|NCT00695669|581225882|FG000|Overall Study|Adverse Event|0|||
160956139|NCT00695669|581225883|FG001|Overall Study|Adverse Event|0|||
160956140|NCT00695669|581225884|FG002|Overall Study|Adverse Event|2|||
160956141|NCT00695669|581225885|FG003|Overall Study|Adverse Event|0|||
160956142|NCT00695669|581225882|FG000|Overall Study|Lost to Follow-up|4|||
160956143|NCT00695669|581225883|FG001|Overall Study|Lost to Follow-up|4|||
160956144|NCT00695669|581225884|FG002|Overall Study|Lost to Follow-up|1|||
160956145|NCT00695669|581225885|FG003|Overall Study|Lost to Follow-up|4|||
160956146|NCT00092131|581225886|FG000|Treatment Period I|Adverse Event|1|||
160956147|NCT00092131|581225887|FG001|Treatment Period I|Adverse Event|0|||
160956148|NCT00092131|581225886|FG000|Treatment Period II|Adverse Event|0|||
160956149|NCT00092131|581225887|FG001|Treatment Period II|Adverse Event|1|||
160956150|NCT02341417|581225888|FG000|Overall Study|Withdrawal by Subject|0|||
160956151|NCT02341417|581225889|FG001|Overall Study|Withdrawal by Subject|2|||
160956152|NCT02341417|581225890|FG002|Overall Study|Withdrawal by Subject|0|||
160956153|NCT02341417|581225888|FG000|Overall Study|Decision by sponsor|2|||
160956154|NCT02341417|581225889|FG001|Overall Study|Decision by sponsor|0|||
160956155|NCT02341417|581225890|FG002|Overall Study|Decision by sponsor|0|||
161001276|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Site closed|0|||
161146359|NCT00592683|581918446|FG001|Overall Study|Adverse Event|2|||
161146360|NCT00592683|581918445|FG000|Overall Study|Protocol Violation|1|||
161146361|NCT00592683|581918446|FG001|Overall Study|Protocol Violation|0|||
161146362|NCT00592683|581918445|FG000|Overall Study|Study drug expired|1|||
161146363|NCT00592683|581918446|FG001|Overall Study|Study drug expired|0|||
161146364|NCT00592683|581918445|FG000|Overall Study|Other|1|||
161146365|NCT00592683|581918446|FG001|Overall Study|Other|0|||
161146366|NCT00592683|581918445|FG000|Overall Study|Lost to Follow-up|0|||
161146367|NCT00592683|581918446|FG001|Overall Study|Lost to Follow-up|1|||
161146368|NCT00201201|581918447|FG000|Overall Study|Death|0|||
161146369|NCT00201201|581918448|FG001|Overall Study|Death|2|||
161146370|NCT00201201|581918447|FG000|Overall Study|Withdrawal by Subject|5|||
161146371|NCT00201201|581918448|FG001|Overall Study|Withdrawal by Subject|5|||
161146372|NCT00611455|581918456|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
161146373|NCT00611455|581918457|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
161001277|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Site closed|6|||
161146374|NCT00611455|581918458|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161146375|NCT00611455|581918456|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
161268850|NCT04645966|582366858|FG002|Vaccination Phase|Other|0|||
161268851|NCT04645966|582366859|FG003|Vaccination Phase|Other|0|||
161268852|NCT04645966|582366860|FG004|Vaccination Phase|Other|0|||
161268853|NCT04645966|582366861|FG005|Vaccination Phase|Other|2|||
161268854|NCT04645966|582366862|FG006|Vaccination Phase|Other|0|||
161268855|NCT04645966|582366863|FG007|Vaccination Phase|Other|0|||
161268856|NCT04645966|582366864|FG008|Vaccination Phase|Other|0|||
161268857|NCT04645966|582366856|FG000|Vaccination Phase|Lost to Follow-up|0|||
161268858|NCT04645966|582366857|FG001|Vaccination Phase|Lost to Follow-up|0|||
161268859|NCT04645966|582366858|FG002|Vaccination Phase|Lost to Follow-up|0|||
161268860|NCT04645966|582366859|FG003|Vaccination Phase|Lost to Follow-up|0|||
161268861|NCT04645966|582366860|FG004|Vaccination Phase|Lost to Follow-up|0|||
161268862|NCT04645966|582366861|FG005|Vaccination Phase|Lost to Follow-up|0|||
161268863|NCT04645966|582366862|FG006|Vaccination Phase|Lost to Follow-up|0|||
161268864|NCT04645966|582366863|FG007|Vaccination Phase|Lost to Follow-up|1|||
161268865|NCT04645966|582366864|FG008|Vaccination Phase|Lost to Follow-up|0|||
161268866|NCT04645966|582366856|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
161268867|NCT04645966|582366857|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
161268868|NCT04645966|582366858|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
161268869|NCT04645966|582366859|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
160956156|NCT02341417|581225888|FG000|Overall Study|Death|0|||
160956157|NCT02341417|581225889|FG001|Overall Study|Death|0|||
160956158|NCT02341417|581225890|FG002|Overall Study|Death|1|||
160956159|NCT03570619|581225901|FG000|Overall Study|Adverse Event|2|||
160956160|NCT03570619|581225902|FG001|Overall Study|Adverse Event|0|||
161001278|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Site closed|5|||
161146376|NCT00611455|581918457|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161146377|NCT00611455|581918458|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161146378|NCT00611455|581918456|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
161146379|NCT00611455|581918457|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161146380|NCT00611455|581918458|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161268870|NCT04645966|582366860|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
161268871|NCT04645966|582366861|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
161268872|NCT04645966|582366862|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
161268873|NCT04645966|582366863|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
161268874|NCT04645966|582366864|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
161343133|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
161343134|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
161343135|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
161343136|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
161343137|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
161343138|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
161343139|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
161343140|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
161343141|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
161343142|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
161343143|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
161343144|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
161343145|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
161343146|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
161343147|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
161343148|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
161343149|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
161343150|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
161343151|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
161343152|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
161343153|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
161343154|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
161343155|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
161343156|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
161343157|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
161343158|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
161343159|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
161343160|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
161343161|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
161343162|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
161343163|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
161343164|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
161343165|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
161343166|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
161343167|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Death|1|||
161343168|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Death|0|||
161343169|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Death|1|||
161343170|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
161343171|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
161343172|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
161343173|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
161343174|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
161343175|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
161343176|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
161343177|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
161343178|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
161343179|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
161343180|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
161343181|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
161343182|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
161343183|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
161343184|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
161343185|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
161343186|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
161343187|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
161343188|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
161343189|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
161343190|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
161343191|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Depression|0|||
161343192|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Depression|1|||
161343193|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Depression|0|||
161343194|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
161343195|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
161343196|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
161343197|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Jailed|0|||
160956161|NCT03570619|581225903|FG002|Overall Study|Adverse Event|1|||
160956162|NCT03570619|581225901|FG000|Overall Study|new diagnosis of new malignancy|1|||
160956163|NCT03570619|581225902|FG001|Overall Study|new diagnosis of new malignancy|0|||
160956164|NCT03570619|581225903|FG002|Overall Study|new diagnosis of new malignancy|0|||
160956165|NCT03570619|581225901|FG000|Overall Study|Physician Decision|1|||
160956166|NCT03570619|581225902|FG001|Overall Study|Physician Decision|1|||
160956167|NCT03570619|581225903|FG002|Overall Study|Physician Decision|0|||
160956168|NCT03570619|581225901|FG000|Overall Study|Withdrawal by Subject|0|||
160956169|NCT03570619|581225902|FG001|Overall Study|Withdrawal by Subject|2|||
160956170|NCT03570619|581225903|FG002|Overall Study|Withdrawal by Subject|0|||
161268875|NCT04645966|582366856|FG000|Follow-up Phase|Lost to Follow-up|0|||
161268876|NCT04645966|582366857|FG001|Follow-up Phase|Lost to Follow-up|0|||
161343198|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Jailed|1|||
161343199|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Jailed|0|||
161343200|NCT00090103|582644296|FG000|16-Week Safety Follow-up Period|Other|0|||
161343201|NCT00090103|582644297|FG001|16-Week Safety Follow-up Period|Other|1|||
161343202|NCT00090103|582644298|FG002|16-Week Safety Follow-up Period|Other|0|||
161343203|NCT02566005|582644301|FG000|Overall Study|vaginal bleeding|0|||
161343204|NCT02566005|582644302|FG001|Overall Study|vaginal bleeding|1|||
161343205|NCT02566005|582644301|FG000|Overall Study|received foley|8|||
161343206|NCT02566005|582644302|FG001|Overall Study|received foley|0|||
161343207|NCT02566005|582644301|FG000|Overall Study|did not receive foley|0|||
161343208|NCT02566005|582644302|FG001|Overall Study|did not receive foley|1|||
161343209|NCT02566005|582644301|FG000|Overall Study|labor after randomization|0|||
161343210|NCT02566005|582644302|FG001|Overall Study|labor after randomization|4|||
161343211|NCT01134042|582644305|FG000|Overall Study|Adverse Event|3|||
161343212|NCT01134042|582644306|FG001|Overall Study|Adverse Event|7|||
161343213|NCT01134042|582644307|FG002|Overall Study|Adverse Event|2|||
161343214|NCT01134042|582644305|FG000|Overall Study|Lack of Efficacy|21|||
161343215|NCT01134042|582644306|FG001|Overall Study|Lack of Efficacy|6|||
161343216|NCT01134042|582644307|FG002|Overall Study|Lack of Efficacy|18|||
161343217|NCT01134042|582644305|FG000|Overall Study|Protocol Violation|5|||
161343218|NCT01134042|582644306|FG001|Overall Study|Protocol Violation|3|||
161343219|NCT01134042|582644307|FG002|Overall Study|Protocol Violation|5|||
161343220|NCT01134042|582644305|FG000|Overall Study|Lost to Follow-up|2|||
161343221|NCT01134042|582644306|FG001|Overall Study|Lost to Follow-up|0|||
161343222|NCT01134042|582644307|FG002|Overall Study|Lost to Follow-up|1|||
161343223|NCT01134042|582644305|FG000|Overall Study|Physician Decision|4|||
161343224|NCT01134042|582644306|FG001|Overall Study|Physician Decision|8|||
161343225|NCT01134042|582644307|FG002|Overall Study|Physician Decision|1|||
161343226|NCT01134042|582644305|FG000|Overall Study|Withdrawal by Subject|13|||
161343227|NCT01134042|582644306|FG001|Overall Study|Withdrawal by Subject|4|||
161343228|NCT01134042|582644307|FG002|Overall Study|Withdrawal by Subject|7|||
161343229|NCT03345004|582644308|FG000|Overall Study|Physician Decision|1|||
161343230|NCT03345004|582644309|FG001|Overall Study|Physician Decision|0|||
161343231|NCT03345004|582644308|FG000|Overall Study|Withdrawal by Subject|0|||
161343232|NCT03345004|582644309|FG001|Overall Study|Withdrawal by Subject|1|||
161268877|NCT04645966|582366858|FG002|Follow-up Phase|Lost to Follow-up|0|||
161268878|NCT04645966|582366859|FG003|Follow-up Phase|Lost to Follow-up|0|||
161268879|NCT04645966|582366860|FG004|Follow-up Phase|Lost to Follow-up|0|||
161268880|NCT04645966|582366861|FG005|Follow-up Phase|Lost to Follow-up|0|||
161268881|NCT04645966|582366862|FG006|Follow-up Phase|Lost to Follow-up|0|||
161268882|NCT04645966|582366863|FG007|Follow-up Phase|Lost to Follow-up|1|||
161268883|NCT04645966|582366864|FG008|Follow-up Phase|Lost to Follow-up|0|||
161268884|NCT00552578|582366868|FG000|Overall Study|Lost to Follow-up|1|||
161268885|NCT00552578|582366869|FG001|Overall Study|Lost to Follow-up|1|||
161268886|NCT02695537|582366879|FG000|Overall Study|Adverse Event|3|||
161268887|NCT02695537|582366879|FG000|Overall Study|Lack of Efficacy|28|||
161343233|NCT01091259|582644314|FG000|Overall Study|Adverse Event|3|||
161343234|NCT01091259|582644314|FG000|Overall Study|Lack of Efficacy|2|||
161343235|NCT01541748|582644315|FG000|Overall Study|Lost to Follow-up|17|||
160956171|NCT04773587|581225904|FG000|Overall Study|Lost to Follow-up|11|||
160956172|NCT04773587|581225905|FG001|Overall Study|Lost to Follow-up|3|||
160956173|NCT04773587|581225904|FG000|Overall Study|Adverse Event|6|||
160956174|NCT04773587|581225905|FG001|Overall Study|Adverse Event|3|||
160956175|NCT04773587|581225904|FG000|Overall Study|Lack of Efficacy|5|||
160956176|NCT04773587|581225905|FG001|Overall Study|Lack of Efficacy|2|||
160956177|NCT04773587|581225904|FG000|Overall Study|Withdrawal by Subject|4|||
160956178|NCT04773587|581225905|FG001|Overall Study|Withdrawal by Subject|5|||
161343236|NCT01541748|582644315|FG000|Overall Study|Moved out of state|1|||
161343237|NCT01541748|582644315|FG000|Overall Study|Withdrawal by Subject|7|||
161343238|NCT01541748|582644315|FG000|Overall Study|Screen failure|5|||
161343239|NCT01541748|582644315|FG000|Overall Study|Did not receive study device|1|||
161343240|NCT00785629|582644316|FG000|Overall Study|Adverse Event|2|||
161268888|NCT02695537|582366879|FG000|Overall Study|Withdrawal by Subject|4|||
161268889|NCT02695537|582366879|FG000|Overall Study|Protocol Violation|3|||
161268890|NCT04015908|582366880|FG000|Overall Study|Lost to Follow-up|0|||
161268891|NCT04015908|582366881|FG001|Overall Study|Lost to Follow-up|1|||
161343241|NCT00785629|582644317|FG001|Overall Study|Adverse Event|1|||
161146381|NCT00611455|581918456|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161146382|NCT00611455|581918457|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161146383|NCT00611455|581918458|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161146384|NCT00611455|581918456|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
161146385|NCT00611455|581918457|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
161146386|NCT00611455|581918458|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
161146387|NCT00611455|581918456|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
161146388|NCT00611455|581918457|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
161146389|NCT00611455|581918458|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
160956179|NCT04773587|581225904|FG000|Overall Study|Noncompliance|1|||
160956180|NCT04773587|581225905|FG001|Overall Study|Noncompliance|0|||
160956181|NCT04773587|581225904|FG000|Overall Study|Protocol Violation|1|||
160956182|NCT04773587|581225905|FG001|Overall Study|Protocol Violation|0|||
160956183|NCT04773587|581225904|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
160956184|NCT04773587|581225905|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
160956185|NCT02372409|581225906|FG000|Overall Study|Lost to Follow-up|1|||
160956186|NCT02372409|581225907|FG001|Overall Study|Lost to Follow-up|0|||
160956187|NCT02372409|581225906|FG000|Overall Study|Disease progression|1|||
160956188|NCT02372409|581225907|FG001|Overall Study|Disease progression|1|||
160956189|NCT01808313|581225910|FG000|Overall Study|Adverse Event|5|||
161146390|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161146391|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
160956190|NCT01808313|581225910|FG000|Overall Study|Protocol Violation|2|||
160956191|NCT01808313|581225910|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
160956192|NCT01808313|581225910|FG000|Overall Study|Lost to Follow-up|1|||
160956193|NCT01808313|581225910|FG000|Overall Study|Physician Decision|1|||
160956194|NCT03086447|581225916|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
160956195|NCT03086447|581225917|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
160956196|NCT03086447|581225916|FG000|Overall Study|Lost Lens|2|||
160956197|NCT03086447|581225917|FG001|Overall Study|Lost Lens|5|||
160956198|NCT03086447|581225916|FG000|Overall Study|Product quality complaint|0|||
160956199|NCT03086447|581225917|FG001|Overall Study|Product quality complaint|1|||
160956200|NCT03086447|581225916|FG000|Overall Study|Lens Damage|1|||
160956201|NCT03086447|581225917|FG001|Overall Study|Lens Damage|6|||
160956202|NCT03086447|581225916|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160956203|NCT03086447|581225917|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160956204|NCT03086447|581225916|FG000|Overall Study|Test Article No Longer Available|1|||
160956205|NCT03086447|581225917|FG001|Overall Study|Test Article No Longer Available|0|||
160956206|NCT03086447|581225916|FG000|Overall Study|Protocol Violation|2|||
161146392|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161146393|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161146394|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
161146395|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161146396|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161146397|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
161146398|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161146399|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161146400|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
161146401|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161146402|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161146403|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
161146404|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161146405|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
161146406|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
161146407|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
161146408|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161146409|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
161146410|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161146411|NCT00611455|581918456|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161146412|NCT00611455|581918457|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
161146413|NCT00611455|581918458|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161146414|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
161146415|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
161146416|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
161146417|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
161146418|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
161146419|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
161146420|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
160956207|NCT03086447|581225917|FG001|Overall Study|Protocol Violation|4|||
160956208|NCT03086447|581225916|FG000|Overall Study|Lost to Follow-up|0|||
160956209|NCT03086447|581225917|FG001|Overall Study|Lost to Follow-up|1|||
160956210|NCT03086447|581225916|FG000|Overall Study|Adverse Event|3|||
160956211|NCT03086447|581225917|FG001|Overall Study|Adverse Event|0|||
160956212|NCT03086447|581225916|FG000|Overall Study|Lens Discomfort|2|||
160956213|NCT03086447|581225917|FG001|Overall Study|Lens Discomfort|1|||
160956214|NCT00435370|581225919|FG000|Overall Study|Adverse Event|8|||
160956215|NCT00435370|581225920|FG001|Overall Study|Adverse Event|8|||
160956216|NCT00435370|581225919|FG000|Overall Study|Withdrawal by Subject|10|||
160956217|NCT00435370|581225920|FG001|Overall Study|Withdrawal by Subject|10|||
160956218|NCT00435370|581225919|FG000|Overall Study|Antipsychotic medication changed|4|||
160956219|NCT00435370|581225920|FG001|Overall Study|Antipsychotic medication changed|2|||
160956220|NCT02132611|581225921|FG000|Overall Study|Death|2|||
160956221|NCT01965834|581225923|FG000|Overall Study|Lack of Efficacy|4|||
160956222|NCT03674177|581225926|FG000|Overall Study|Lost to Follow-up|2|||
160956223|NCT03674177|581225927|FG001|Overall Study|Lost to Follow-up|1|||
160956224|NCT03674177|581225928|FG002|Overall Study|Lost to Follow-up|0|||
160956225|NCT03674177|581225929|FG003|Overall Study|Lost to Follow-up|2|||
160956226|NCT03387852|581225930|FG000|Overall Study|Adverse event (AE)|3|||
160956227|NCT03387852|581225931|FG001|Overall Study|Adverse event (AE)|0|||
160956228|NCT03387852|581225932|FG002|Overall Study|Adverse event (AE)|2|||
160956229|NCT03387852|581225933|FG003|Overall Study|Adverse event (AE)|0|||
160956230|NCT03387852|581225930|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
160956231|NCT03387852|581225931|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
160956232|NCT03387852|581225932|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
160956233|NCT03387852|581225933|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
160956234|NCT03387852|581225930|FG000|Overall Study|Withdrawal by participant|1|||
160956235|NCT03387852|581225931|FG001|Overall Study|Withdrawal by participant|1|||
160956236|NCT03387852|581225932|FG002|Overall Study|Withdrawal by participant|3|||
160956237|NCT03387852|581225933|FG003|Overall Study|Withdrawal by participant|2|||
160956238|NCT03387852|581225930|FG000|Overall Study|Other- Unspecified|1|||
160956239|NCT03387852|581225931|FG001|Overall Study|Other- Unspecified|1|||
160956240|NCT03387852|581225932|FG002|Overall Study|Other- Unspecified|2|||
160956241|NCT03387852|581225933|FG003|Overall Study|Other- Unspecified|1|||
160956242|NCT03387852|581225930|FG000|Overall Study|Poor compliance to protocol|0|||
160956243|NCT03387852|581225931|FG001|Overall Study|Poor compliance to protocol|0|||
160956244|NCT03387852|581225932|FG002|Overall Study|Poor compliance to protocol|0|||
160956245|NCT03387852|581225933|FG003|Overall Study|Poor compliance to protocol|1|||
160956246|NCT03387852|581225930|FG000|Overall Study|Randomized and not treated|0|||
160956247|NCT03387852|581225931|FG001|Overall Study|Randomized and not treated|0|||
160956248|NCT03387852|581225932|FG002|Overall Study|Randomized and not treated|0|||
160956249|NCT03387852|581225933|FG003|Overall Study|Randomized and not treated|1|||
161268892|NCT02792699|582366882|FG000|Overall Study|Adverse Event|1|||
160956250|NCT02194621|581225934|FG000|Overall Study|6 withdrew prior to randomization|2|||
160956251|NCT02194621|581225935|FG001|Overall Study|6 withdrew prior to randomization|2|||
160956252|NCT02194621|581225936|FG002|Overall Study|6 withdrew prior to randomization|2|||
160956253|NCT02194621|581225934|FG000|Overall Study|Withdrawal by Subject|4|||
160956254|NCT02194621|581225935|FG001|Overall Study|Withdrawal by Subject|4|||
160956255|NCT02194621|581225936|FG002|Overall Study|Withdrawal by Subject|7|||
160956256|NCT02493127|581225944|FG000|Overall Study|Lost to Follow-up|1|||
160956257|NCT02493127|581225945|FG001|Overall Study|Lost to Follow-up|1|||
160956258|NCT00714168|581225946|FG000|Overall Study|Pregnancy|5|||
160956259|NCT00714168|581225947|FG001|Overall Study|Pregnancy|4|||
160956260|NCT00714168|581225946|FG000|Overall Study|Lost to Follow-up|32|||
160956261|NCT00714168|581225947|FG001|Overall Study|Lost to Follow-up|50|||
160956262|NCT00714168|581225946|FG000|Overall Study|Relocation|4|||
160956263|NCT00714168|581225947|FG001|Overall Study|Relocation|3|||
160956264|NCT00714168|581225946|FG000|Overall Study|Non-study medical condition|3|||
160956265|NCT00714168|581225947|FG001|Overall Study|Non-study medical condition|2|||
160956266|NCT00809757|581225952|FG000|Overall Study|Adverse Event|2|||
160956267|NCT00809757|581225953|FG001|Overall Study|Adverse Event|3|||
160956268|NCT00809757|581225954|FG002|Overall Study|Adverse Event|3|||
160956269|NCT00809757|581225952|FG000|Overall Study|Lost to Follow-up|0|||
160956270|NCT00809757|581225953|FG001|Overall Study|Lost to Follow-up|0|||
160956271|NCT00809757|581225954|FG002|Overall Study|Lost to Follow-up|1|||
160956272|NCT00809757|581225952|FG000|Overall Study|Protocol Violation|1|||
160956273|NCT00809757|581225953|FG001|Overall Study|Protocol Violation|1|||
160956274|NCT00809757|581225954|FG002|Overall Study|Protocol Violation|1|||
160956275|NCT00809757|581225952|FG000|Overall Study|Withdrawal by Subject|2|||
160956276|NCT00809757|581225953|FG001|Overall Study|Withdrawal by Subject|1|||
160956277|NCT00809757|581225954|FG002|Overall Study|Withdrawal by Subject|3|||
160956278|NCT00809757|581225952|FG000|Overall Study|Subject Uncooperative|1|||
160956279|NCT00809757|581225953|FG001|Overall Study|Subject Uncooperative|0|||
160956280|NCT00809757|581225954|FG002|Overall Study|Subject Uncooperative|2|||
160956281|NCT00809757|581225952|FG000|Overall Study|Noncompliance with Medication|0|||
160956282|NCT00809757|581225953|FG001|Overall Study|Noncompliance with Medication|0|||
160956283|NCT00809757|581225954|FG002|Overall Study|Noncompliance with Medication|1|||
160956284|NCT00253864|581225955|FG000|Overall Study|Lost to Follow-up|5|||
160956285|NCT00253864|581225956|FG001|Overall Study|Lost to Follow-up|8|||
160956286|NCT00744653|581225957|FG000|Overall Study|antineoplastic treatment|11|||
160956287|NCT00744653|581225957|FG000|Overall Study|Death|1|||
160956288|NCT00744653|581225957|FG000|Overall Study|Lost to Follow-up|1|||
160956289|NCT00744653|581225957|FG000|Overall Study|Physician Decision|3|||
160956290|NCT03826667|581225958|FG000|Overall Study|Protocol deviation|21|||
160956291|NCT00808808|581225959|FG000|Overall Study|Vaccinated; survey not completed|131|||
160956292|NCT00808808|581225960|FG001|Overall Study|Vaccinated; survey not completed|169|||
160956293|NCT00808808|581225961|FG002|Overall Study|Vaccinated; survey not completed|302|||
160956294|NCT00808808|581225959|FG000|Overall Study|Employee was not vaccinated.|2686|||
160956295|NCT00808808|581225960|FG001|Overall Study|Employee was not vaccinated.|2268|||
160956296|NCT00808808|581225961|FG002|Overall Study|Employee was not vaccinated.|2255|||
160956297|NCT01453595|581225963|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161268893|NCT02792699|582366883|FG001|Overall Study|Adverse Event|2|||
161268894|NCT02792699|582366884|FG002|Overall Study|Adverse Event|4|||
161268895|NCT02792699|582366882|FG000|Overall Study|Withdrawal by Subject|4|||
160956298|NCT01453595|581225964|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160956299|NCT01453595|581225965|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161001279|NCT01426269|581390529|FG000|Period 2: 40 Weeks|Relapsed|0|||
161001280|NCT01426269|581390530|FG001|Period 2: 40 Weeks|Relapsed|9|||
161146421|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
161268896|NCT02792699|582366883|FG001|Overall Study|Withdrawal by Subject|4|||
161268897|NCT02792699|582366884|FG002|Overall Study|Withdrawal by Subject|3|||
161268898|NCT02792699|582366882|FG000|Overall Study|Lost to Follow-up|0|||
161268899|NCT02792699|582366883|FG001|Overall Study|Lost to Follow-up|1|||
161268900|NCT02792699|582366884|FG002|Overall Study|Lost to Follow-up|2|||
161268901|NCT02792699|582366882|FG000|Overall Study|Physician Decision|2|||
161268902|NCT02792699|582366883|FG001|Overall Study|Physician Decision|0|||
161268903|NCT02792699|582366884|FG002|Overall Study|Physician Decision|0|||
161268904|NCT02792699|582366882|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
161268905|NCT02792699|582366883|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
161268906|NCT02792699|582366884|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
161268907|NCT02792699|582366882|FG000|Overall Study|Other|1|||
161268908|NCT02792699|582366883|FG001|Overall Study|Other|0|||
161268909|NCT02792699|582366884|FG002|Overall Study|Other|0|||
161268910|NCT01715571|582366887|FG000|Overall Study|Lost to Follow-up|8|||
161268911|NCT00077857|582366890|FG000|Overall Study|Adverse Event|30|||
161268912|NCT00077857|582366891|FG001|Overall Study|Adverse Event|32|||
161268913|NCT00077857|582366890|FG000|Overall Study|Death|7|||
161268914|NCT00077857|582366891|FG001|Overall Study|Death|3|||
161268915|NCT00077857|582366890|FG000|Overall Study|Insufficient therapeutic response|112|||
161268916|NCT00077857|582366891|FG001|Overall Study|Insufficient therapeutic response|128|||
161268917|NCT00077857|582366890|FG000|Overall Study|Violation of selection criteria at entry|3|||
161268918|NCT00077857|582366891|FG001|Overall Study|Violation of selection criteria at entry|1|||
161268919|NCT00077857|582366890|FG000|Overall Study|Other protocol violation|0|||
161268920|NCT00077857|582366891|FG001|Overall Study|Other protocol violation|1|||
161268921|NCT00077857|582366890|FG000|Overall Study|Refused treatment|29|||
161268922|NCT00077857|582366891|FG001|Overall Study|Refused treatment|21|||
161268923|NCT00077857|582366890|FG000|Overall Study|Failure to return|5|||
161268924|NCT00077857|582366891|FG001|Overall Study|Failure to return|5|||
161268925|NCT00077857|582366890|FG000|Overall Study|Other|15|||
161268926|NCT00077857|582366891|FG001|Overall Study|Other|13|||
161268927|NCT05084963|582366895|FG000|Overall Study|Withdrawal by Subject|0|||
161268928|NCT05084963|582366896|FG001|Overall Study|Withdrawal by Subject|0|||
161268929|NCT05084963|582366897|FG002|Overall Study|Withdrawal by Subject|1|||
161268930|NCT06187909|582366898|FG000|Overall Study|Withdrawal by Subject|2|||
161268931|NCT06187909|582366899|FG001|Overall Study|Withdrawal by Subject|2|||
161268932|NCT03569228|582366900|FG000|Overall Study|Withdrawal by PI|0|||
161268933|NCT03569228|582366901|FG001|Overall Study|Withdrawal by PI|0|||
161268934|NCT03569228|582366902|FG002|Overall Study|Withdrawal by PI|2|||
161268935|NCT03569228|582366903|FG003|Overall Study|Withdrawal by PI|2|||
161268936|NCT03569228|582366904|FG004|Overall Study|Withdrawal by PI|1|||
161268937|NCT03569228|582366905|FG005|Overall Study|Withdrawal by PI|0|||
161268938|NCT03569228|582366906|FG006|Overall Study|Withdrawal by PI|0|||
160956300|NCT01128413|581225970|FG000|Overall Study|Withdrawal by Subject|1|||
160956301|NCT01128413|581225971|FG001|Overall Study|Withdrawal by Subject|0|||
160956302|NCT01128413|581225970|FG000|Overall Study|NICOM Monitor Problems|2|||
161268939|NCT03569228|582366907|FG007|Overall Study|Withdrawal by PI|0|||
161268940|NCT03569228|582366908|FG008|Overall Study|Withdrawal by PI|0|||
161268941|NCT03569228|582366900|FG000|Overall Study|Lost to Follow-up|0|||
161268942|NCT03569228|582366901|FG001|Overall Study|Lost to Follow-up|0|||
161268943|NCT03569228|582366902|FG002|Overall Study|Lost to Follow-up|0|||
161268944|NCT03569228|582366903|FG003|Overall Study|Lost to Follow-up|0|||
161268945|NCT03569228|582366904|FG004|Overall Study|Lost to Follow-up|0|||
161268946|NCT03569228|582366905|FG005|Overall Study|Lost to Follow-up|0|||
161268947|NCT03569228|582366906|FG006|Overall Study|Lost to Follow-up|0|||
161268948|NCT03569228|582366907|FG007|Overall Study|Lost to Follow-up|0|||
161268949|NCT03569228|582366908|FG008|Overall Study|Lost to Follow-up|1|||
161343242|NCT00785629|582644318|FG002|Overall Study|Adverse Event|1|||
161343243|NCT00785629|582644319|FG003|Overall Study|Adverse Event|5|||
161343244|NCT00785629|582644316|FG000|Overall Study|Protocol Violation|1|||
161343245|NCT00785629|582644317|FG001|Overall Study|Protocol Violation|2|||
161343246|NCT00785629|582644318|FG002|Overall Study|Protocol Violation|4|||
161343247|NCT00785629|582644319|FG003|Overall Study|Protocol Violation|5|||
161343248|NCT00785629|582644316|FG000|Overall Study|administrative decision|5|||
161343249|NCT00785629|582644317|FG001|Overall Study|administrative decision|1|||
161343250|NCT00785629|582644318|FG002|Overall Study|administrative decision|3|||
161343251|NCT00785629|582644319|FG003|Overall Study|administrative decision|4|||
161343252|NCT00785629|582644316|FG000|Overall Study|Withdrawal by Subject|0|||
161343253|NCT00785629|582644317|FG001|Overall Study|Withdrawal by Subject|1|||
161343254|NCT00785629|582644318|FG002|Overall Study|Withdrawal by Subject|2|||
161343255|NCT00785629|582644319|FG003|Overall Study|Withdrawal by Subject|2|||
160956303|NCT01128413|581225971|FG001|Overall Study|NICOM Monitor Problems|1|||
160956304|NCT01128413|581225970|FG000|Overall Study|Pt made DNR|1|||
160956305|NCT01128413|581225971|FG001|Overall Study|Pt made DNR|0|||
160956306|NCT03762473|581225972|FG000|Overall Study|Death|1|||
160956307|NCT03762473|581225973|FG001|Overall Study|Death|0|||
160956308|NCT01864564|581225974|FG000|Overall Study|Lost to Follow-up|17|||
160956309|NCT01864564|581225975|FG001|Overall Study|Lost to Follow-up|23|||
161268950|NCT03569228|582366900|FG000|Overall Study|Screen Fail|2|||
161268951|NCT03569228|582366901|FG001|Overall Study|Screen Fail|2|||
161268952|NCT03569228|582366902|FG002|Overall Study|Screen Fail|1|||
161268953|NCT03569228|582366903|FG003|Overall Study|Screen Fail|1|||
161268954|NCT03569228|582366904|FG004|Overall Study|Screen Fail|1|||
161268955|NCT03569228|582366905|FG005|Overall Study|Screen Fail|3|||
161268956|NCT03569228|582366906|FG006|Overall Study|Screen Fail|1|||
161268957|NCT03569228|582366907|FG007|Overall Study|Screen Fail|5|||
161268958|NCT03569228|582366908|FG008|Overall Study|Screen Fail|2|||
161268959|NCT06354998|582366909|FG000|Overall Study|Withdrawal by Subject|3|||
161268960|NCT06354998|582366910|FG001|Overall Study|Withdrawal by Subject|0|||
161268961|NCT05442866|582366911|FG000|Overall Study|Death|1|||
161268962|NCT05442866|582366911|FG000|Overall Study|Lost to Follow-up|9|||
161268963|NCT05442866|582366911|FG000|Overall Study|Protocol Violation|1|||
161268964|NCT03819049|582366912|FG000|Overall Study|Lost to Follow-up|1|||
161268965|NCT03819049|582366913|FG001|Overall Study|Lost to Follow-up|2|||
161268966|NCT03819049|582366914|FG002|Overall Study|Lost to Follow-up|9|||
161268967|NCT03819049|582366915|FG003|Overall Study|Lost to Follow-up|0|||
161268968|NCT03819049|582366916|FG004|Overall Study|Lost to Follow-up|3|||
161343256|NCT02020941|582644322|FG000|Overall Study|Adverse Event|1|||
160956310|NCT01864564|581225974|FG000|Overall Study|Withdrawal by Subject|20|||
160956311|NCT01864564|581225975|FG001|Overall Study|Withdrawal by Subject|11|||
160956312|NCT01864564|581225974|FG000|Overall Study|Protocol Violation|0|||
160956313|NCT01864564|581225975|FG001|Overall Study|Protocol Violation|27|||
160956314|NCT01864564|581225974|FG000|Overall Study|not reported|0|||
160956315|NCT01864564|581225975|FG001|Overall Study|not reported|34|||
160956316|NCT03077724|581225976|FG000|Overall Study|Lost to Follow-up|5|||
160956317|NCT03077724|581225977|FG001|Overall Study|Lost to Follow-up|1|||
160956318|NCT03077724|581225976|FG000|Overall Study|Withdrawal by Subject|3|||
160956319|NCT03077724|581225977|FG001|Overall Study|Withdrawal by Subject|1|||
160956320|NCT02269670|581225978|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
160956321|NCT00234065|581225979|FG000|Overall Study|Adverse Event|268|||
160956322|NCT00234065|581225980|FG001|Overall Study|Adverse Event|166|||
160956323|NCT00234065|581225979|FG000|Overall Study|Withdrawal by Subject|73|||
160956324|NCT00234065|581225980|FG001|Overall Study|Withdrawal by Subject|56|||
160956325|NCT00234065|581225979|FG000|Overall Study|Physician Decision|23|||
160956326|NCT00234065|581225980|FG001|Overall Study|Physician Decision|22|||
160956327|NCT00234065|581225979|FG000|Overall Study|Not Classified|111|||
160956328|NCT00234065|581225980|FG001|Overall Study|Not Classified|112|||
160956329|NCT00126438|581225981|FG000|Overall Study|Withdrawal due to adverse event|1|||
160956330|NCT00126438|581225982|FG001|Overall Study|Withdrawal due to adverse event|0|||
160956331|NCT00126438|581225981|FG000|Overall Study|Lost to Follow-up|22|||
160956332|NCT00126438|581225982|FG001|Overall Study|Lost to Follow-up|0|||
160956333|NCT00126438|581225981|FG000|Overall Study|Protocol Violation|8|||
160956334|NCT00126438|581225982|FG001|Overall Study|Protocol Violation|8|||
160956335|NCT00126438|581225981|FG000|Overall Study|Withdrawal by Subject|3|||
160956336|NCT00126438|581225982|FG001|Overall Study|Withdrawal by Subject|2|||
160956337|NCT02313428|581225983|FG000|Overall Study|Lost to Follow-up|1|||
161343257|NCT02020941|582644322|FG000|Overall Study|Physician Decision|2|||
161343258|NCT02020941|582644322|FG000|Overall Study|Withdrawal by Subject|1|||
161343259|NCT02020941|582644322|FG000|Overall Study|Disease Progression|4|||
160956338|NCT02313428|581225984|FG001|Overall Study|Lost to Follow-up|1|||
160956339|NCT05374421|581225985|FG000|Overall Study|Withdrawal by Subject|3|||
160956340|NCT05374421|581225986|FG001|Overall Study|Withdrawal by Subject|4|||
161268969|NCT03819049|582366917|FG005|Overall Study|Lost to Follow-up|1|||
161268970|NCT03819049|582366918|FG006|Overall Study|Lost to Follow-up|0|||
161268971|NCT03819049|582366912|FG000|Overall Study|Withdrawal by Subject|0|||
161268972|NCT03819049|582366913|FG001|Overall Study|Withdrawal by Subject|0|||
160956341|NCT00003508|581227950|FG000|Overall Study|Not evaluable|5|||
160956342|NCT02160314|581227951|FG000|Overall Study|Adverse Event|0|||
160956343|NCT02160314|581227952|FG001|Overall Study|Adverse Event|6|||
160956344|NCT02160314|581227951|FG000|Overall Study|Protocol Violation|0|||
160956345|NCT02160314|581227952|FG001|Overall Study|Protocol Violation|4|||
161268973|NCT03819049|582366914|FG002|Overall Study|Withdrawal by Subject|18|||
161268974|NCT03819049|582366915|FG003|Overall Study|Withdrawal by Subject|0|||
161268975|NCT03819049|582366916|FG004|Overall Study|Withdrawal by Subject|10|||
161268976|NCT03819049|582366917|FG005|Overall Study|Withdrawal by Subject|9|||
161268977|NCT03819049|582366918|FG006|Overall Study|Withdrawal by Subject|1|||
161268978|NCT03819049|582366912|FG000|Overall Study|Ongoing|0|||
161268979|NCT03819049|582366913|FG001|Overall Study|Ongoing|0|||
161268980|NCT03819049|582366914|FG002|Overall Study|Ongoing|75|||
161268981|NCT03819049|582366915|FG003|Overall Study|Ongoing|0|||
161268982|NCT03819049|582366916|FG004|Overall Study|Ongoing|41|||
161268983|NCT03819049|582366917|FG005|Overall Study|Ongoing|0|||
161268984|NCT03819049|582366918|FG006|Overall Study|Ongoing|0|||
161268985|NCT03819049|582366912|FG000|Overall Study|Other|0|||
161268986|NCT03819049|582366913|FG001|Overall Study|Other|0|||
161268987|NCT03819049|582366914|FG002|Overall Study|Other|2|||
161268988|NCT03819049|582366915|FG003|Overall Study|Other|0|||
161268989|NCT03819049|582366916|FG004|Overall Study|Other|0|||
161268990|NCT03819049|582366917|FG005|Overall Study|Other|0|||
161268991|NCT03819049|582366918|FG006|Overall Study|Other|0|||
161268992|NCT03819049|582366912|FG000|Overall Study|Randomized but not vaccinated|0|||
161268993|NCT03819049|582366913|FG001|Overall Study|Randomized but not vaccinated|0|||
161268994|NCT03819049|582366914|FG002|Overall Study|Randomized but not vaccinated|0|||
161268995|NCT03819049|582366915|FG003|Overall Study|Randomized but not vaccinated|1|||
161268996|NCT03819049|582366916|FG004|Overall Study|Randomized but not vaccinated|0|||
161268997|NCT03819049|582366917|FG005|Overall Study|Randomized but not vaccinated|2|||
161268998|NCT03819049|582366918|FG006|Overall Study|Randomized but not vaccinated|1|||
161268999|NCT03819049|582366912|FG000|Overall Study|Physician Decision|0|||
161269000|NCT03819049|582366913|FG001|Overall Study|Physician Decision|0|||
161269001|NCT03819049|582366914|FG002|Overall Study|Physician Decision|0|||
161269002|NCT03819049|582366915|FG003|Overall Study|Physician Decision|0|||
161269003|NCT03819049|582366916|FG004|Overall Study|Physician Decision|0|||
161269004|NCT03819049|582366917|FG005|Overall Study|Physician Decision|0|||
161269005|NCT03819049|582366918|FG006|Overall Study|Physician Decision|1|||
161269006|NCT02440568|582366919|FG000|Overall Study|Death|1|||
161269007|NCT02440568|582366920|FG001|Overall Study|Death|3|||
161269008|NCT02440568|582366921|FG002|Overall Study|Death|4|||
161269009|NCT02440568|582366922|FG003|Overall Study|Death|2|||
161269010|NCT02440568|582366919|FG000|Overall Study|Lack of Efficacy|2|||
161269011|NCT02440568|582366920|FG001|Overall Study|Lack of Efficacy|0|||
161269012|NCT02440568|582366921|FG002|Overall Study|Lack of Efficacy|1|||
161269013|NCT02440568|582366922|FG003|Overall Study|Lack of Efficacy|0|||
161269014|NCT02440568|582366919|FG000|Overall Study|Lost to Follow-up|1|||
161269015|NCT02440568|582366920|FG001|Overall Study|Lost to Follow-up|0|||
161269016|NCT02440568|582366921|FG002|Overall Study|Lost to Follow-up|0|||
161269017|NCT02440568|582366922|FG003|Overall Study|Lost to Follow-up|0|||
161269018|NCT01584843|582366926|FG000|First Treatment Period|Adverse Event|0|||
161269019|NCT01584843|582366927|FG001|First Treatment Period|Adverse Event|0|||
161269020|NCT01584843|582366928|FG002|First Treatment Period|Adverse Event|1|||
161269021|NCT01584843|582366929|FG003|First Treatment Period|Adverse Event|0|||
161269022|NCT01584843|582366930|FG004|First Treatment Period|Adverse Event|0|||
161269023|NCT01584843|582366931|FG005|First Treatment Period|Adverse Event|0|||
161269024|NCT01584843|582366926|FG000|First Treatment Period|Protocol Violation|0|||
161269025|NCT01584843|582366927|FG001|First Treatment Period|Protocol Violation|0|||
161269026|NCT01584843|582366928|FG002|First Treatment Period|Protocol Violation|0|||
161269027|NCT01584843|582366929|FG003|First Treatment Period|Protocol Violation|0|||
161269028|NCT01584843|582366930|FG004|First Treatment Period|Protocol Violation|0|||
161269029|NCT01584843|582366931|FG005|First Treatment Period|Protocol Violation|1|||
161269030|NCT01584843|582366926|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161269031|NCT01584843|582366927|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161269032|NCT01584843|582366928|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161269033|NCT01584843|582366929|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161343260|NCT00634504|582644323|FG000|Overall Study|Protocol Violation|1|||
160956346|NCT02160314|581227951|FG000|Overall Study|Withdrawal by Subject|1|||
160956347|NCT02160314|581227952|FG001|Overall Study|Withdrawal by Subject|2|||
161269034|NCT01584843|582366930|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
161269035|NCT01584843|582366931|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
161269036|NCT01584843|582366926|FG000|Second Treatment Period|Withdrawal by Subject|0|||
161269037|NCT01584843|582366927|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161269038|NCT01584843|582366928|FG002|Second Treatment Period|Withdrawal by Subject|0|||
161269039|NCT01584843|582366929|FG003|Second Treatment Period|Withdrawal by Subject|0|||
161269040|NCT01584843|582366930|FG004|Second Treatment Period|Withdrawal by Subject|0|||
161269041|NCT01584843|582366931|FG005|Second Treatment Period|Withdrawal by Subject|1|||
160956348|NCT02160314|581227951|FG000|Overall Study|Lost to Follow-up|0|||
160956349|NCT02160314|581227952|FG001|Overall Study|Lost to Follow-up|1|||
160956350|NCT00593567|581227953|FG000|Overall Study|Adverse Event|2|||
160956351|NCT00593567|581227954|FG001|Overall Study|Adverse Event|0|||
160956352|NCT00593567|581227953|FG000|Overall Study|Physician Decision|2|||
160956353|NCT00593567|581227954|FG001|Overall Study|Physician Decision|0|||
160956354|NCT00593567|581227953|FG000|Overall Study|Protocol Violation|13|||
160956355|NCT00593567|581227954|FG001|Overall Study|Protocol Violation|7|||
160956356|NCT00593567|581227953|FG000|Overall Study|Lack of Efficacy|2|||
160956357|NCT00593567|581227954|FG001|Overall Study|Lack of Efficacy|1|||
160956358|NCT00593567|581227953|FG000|Overall Study|Withdrawal by Subject|1|||
160956359|NCT00593567|581227954|FG001|Overall Study|Withdrawal by Subject|2|||
160956360|NCT03576768|581227960|FG000|Overall Study|Lost to Follow-up|3|||
160956361|NCT03576768|581227961|FG001|Overall Study|Lost to Follow-up|3|||
160956362|NCT03576768|581227962|FG002|Overall Study|Lost to Follow-up|0|||
160956363|NCT03576768|581227963|FG003|Overall Study|Lost to Follow-up|0|||
160956364|NCT00590902|581227964|FG000|Overall Study|Death|1|||
160956365|NCT00785291|581227965|FG000|Overall Study|Never began treatment|8|||
160956366|NCT00785291|581227966|FG001|Overall Study|Never began treatment|4|||
160956367|NCT00785291|581227967|FG002|Overall Study|Never began treatment|4|||
160956368|NCT00785291|581227965|FG000|Overall Study|Adverse Event|39|||
160956369|NCT00785291|581227966|FG001|Overall Study|Adverse Event|70|||
160956370|NCT00785291|581227967|FG002|Overall Study|Adverse Event|56|||
160956371|NCT00785291|581227965|FG000|Overall Study|Death|7|||
160956372|NCT00785291|581227966|FG001|Overall Study|Death|4|||
160956373|NCT00785291|581227967|FG002|Overall Study|Death|3|||
160956374|NCT00785291|581227965|FG000|Overall Study|Withdrawal by Subject|35|||
160956375|NCT00785291|581227966|FG001|Overall Study|Withdrawal by Subject|36|||
160956376|NCT00785291|581227967|FG002|Overall Study|Withdrawal by Subject|17|||
160956377|NCT00785291|581227965|FG000|Overall Study|Alternative Therapy|12|||
160956378|NCT00785291|581227966|FG001|Overall Study|Alternative Therapy|6|||
160956379|NCT00785291|581227967|FG002|Overall Study|Alternative Therapy|7|||
160956380|NCT00785291|581227965|FG000|Overall Study|Complicating illness|6|||
160956381|NCT00785291|581227966|FG001|Overall Study|Complicating illness|4|||
160956382|NCT00785291|581227967|FG002|Overall Study|Complicating illness|4|||
160956383|NCT00785291|581227965|FG000|Overall Study|Other Medical Reasons|29|||
160956384|NCT00785291|581227966|FG001|Overall Study|Other Medical Reasons|25|||
160956385|NCT00785291|581227967|FG002|Overall Study|Other Medical Reasons|15|||
160956386|NCT02119260|581227968|FG000|Overall Study|Adverse Event|1|||
160956387|NCT02119260|581227969|FG001|Overall Study|Adverse Event|0|||
160956388|NCT02119260|581227970|FG002|Overall Study|Adverse Event|0|||
160956389|NCT02119260|581227971|FG003|Overall Study|Adverse Event|0|||
160956390|NCT02119260|581227972|FG004|Overall Study|Adverse Event|0|||
160956391|NCT02119260|581227973|FG005|Overall Study|Adverse Event|0|||
160956392|NCT02119260|581227974|FG006|Overall Study|Adverse Event|0|||
160956393|NCT02119260|581227968|FG000|Overall Study|Withdrew consent|0|||
160956394|NCT02119260|581227969|FG001|Overall Study|Withdrew consent|1|||
160956395|NCT02119260|581227970|FG002|Overall Study|Withdrew consent|1|||
160956396|NCT02119260|581227971|FG003|Overall Study|Withdrew consent|0|||
160956397|NCT02119260|581227972|FG004|Overall Study|Withdrew consent|0|||
160956398|NCT02119260|581227973|FG005|Overall Study|Withdrew consent|0|||
160956399|NCT02119260|581227974|FG006|Overall Study|Withdrew consent|0|||
160956400|NCT02979639|581227976|FG000|Overall Study|Withdrawal based on medical judgement|1|||
160956401|NCT02979639|581227976|FG000|Overall Study|Lost to Follow-up|8|||
161146422|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
161269042|NCT00643565|582366932|FG000|Overall Study|Death|12|||
161269043|NCT00643565|582366933|FG001|Overall Study|Death|11|||
161269044|NCT00643565|582366932|FG000|Overall Study|Withdrawal by Subject|4|||
161269045|NCT00643565|582366933|FG001|Overall Study|Withdrawal by Subject|1|||
161269046|NCT00643565|582366932|FG000|Overall Study|Lost to Follow-up|0|||
161269047|NCT00643565|582366933|FG001|Overall Study|Lost to Follow-up|6|||
161269048|NCT00643565|582366932|FG000|Overall Study|Other|7|||
161269049|NCT00643565|582366933|FG001|Overall Study|Other|8|||
161269050|NCT00643565|582366932|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
161269051|NCT00643565|582366933|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
161269052|NCT00643565|582366932|FG000|Overall Study|Recurrence of Disease|2|||
161269053|NCT00643565|582366933|FG001|Overall Study|Recurrence of Disease|1|||
161269054|NCT00643565|582366932|FG000|Overall Study|Progression of Disease|18|||
161269055|NCT00643565|582366933|FG001|Overall Study|Progression of Disease|14|||
161269056|NCT00643565|582366932|FG000|Overall Study|Protocol Violation|3|||
161269057|NCT00643565|582366933|FG001|Overall Study|Protocol Violation|0|||
161269058|NCT00643565|582366932|FG000|Overall Study|Did Not Cooperate|0|||
161269059|NCT00643565|582366933|FG001|Overall Study|Did Not Cooperate|1|||
161269060|NCT00643565|582366932|FG000|Overall Study|Administrative|22|||
161269061|NCT00643565|582366933|FG001|Overall Study|Administrative|16|||
161269062|NCT00643565|582366932|FG000|Overall Study|Adverse Event|5|||
161269063|NCT00643565|582366933|FG001|Overall Study|Adverse Event|8|||
161269064|NCT02283983|582366934|FG000|Overall Study|Inclusion criteria not met|0|||
161269065|NCT02283983|582366935|FG001|Overall Study|Inclusion criteria not met|1|||
160956402|NCT02979639|581227976|FG000|Overall Study|Withdrawal by Subject|3|||
160956403|NCT02979639|581227976|FG000|Overall Study|Adverse Event|2|||
160956404|NCT01877408|581227980|FG000|Overall Study|Lost to Follow-up|0|||
160956405|NCT01877408|581227981|FG001|Overall Study|Lost to Follow-up|2|||
160956406|NCT03870763|581227984|FG000|Overall Study|Study terminated by sponsor|0|||
160956407|NCT03870763|581227985|FG001|Overall Study|Study terminated by sponsor|2|||
160956408|NCT03870763|581227986|FG002|Overall Study|Study terminated by sponsor|0|||
160956409|NCT03870763|581227984|FG000|Overall Study|Withdrawal by Subject|0|||
160956410|NCT03870763|581227985|FG001|Overall Study|Withdrawal by Subject|1|||
160956411|NCT03870763|581227986|FG002|Overall Study|Withdrawal by Subject|0|||
160956412|NCT03870763|581227984|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
160956413|NCT03870763|581227985|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
160956414|NCT03870763|581227986|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
160956415|NCT04279314|581227987|FG000|Overall Study|Adverse Event|55|||
160956416|NCT04279314|581227987|FG000|Overall Study|Withdrawal by Subject|5|||
160956417|NCT04279314|581227987|FG000|Overall Study|Lack of Efficacy|5|||
160956418|NCT04279314|581227987|FG000|Overall Study|Protocol Violation|3|||
160956419|NCT04279314|581227987|FG000|Overall Study|Other (not COVID-19 related)|2|||
160956420|NCT01471054|581227992|FG000|Overall Study|Study terminated prematurely|4|||
160956421|NCT01471054|581227993|FG001|Overall Study|Study terminated prematurely|0|||
160956422|NCT00360308|581227994|FG000|Overall Study|Adverse Event|15|||
160956423|NCT00360308|581227995|FG001|Overall Study|Adverse Event|14|||
160956424|NCT00360308|581227996|FG002|Overall Study|Adverse Event|25|||
160956425|NCT00360308|581227994|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
160956426|NCT00360308|581227995|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
160956427|NCT00360308|581227996|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
160956428|NCT00360308|581227994|FG000|Overall Study|Protocol Violation|2|||
160956429|NCT00360308|581227995|FG001|Overall Study|Protocol Violation|1|||
160956430|NCT00360308|581227996|FG002|Overall Study|Protocol Violation|2|||
160956431|NCT00360308|581227994|FG000|Overall Study|Withdrawal by Subject|11|||
160956432|NCT00360308|581227995|FG001|Overall Study|Withdrawal by Subject|7|||
161001281|NCT01426269|581390531|FG002|Period 2: 40 Weeks|Relapsed|18|||
161001282|NCT00419094|581390535|FG000|Overall Study|Adverse Event|3|||
161001283|NCT00419094|581390536|FG001|Overall Study|Adverse Event|7|||
161343261|NCT00634504|582644324|FG001|Overall Study|Protocol Violation|0|||
161343262|NCT03329989|582644325|FG000|Overall Study|Withdrawal by Subject|9|||
161343263|NCT03329989|582644325|FG000|Overall Study|Lost to Follow-up|8|||
161343264|NCT03329989|582644325|FG000|Overall Study|Adverse Event|5|||
161343265|NCT03329989|582644325|FG000|Overall Study|Protocol Violation|1|||
161343266|NCT01283386|582644326|FG000|Overall Study|Death|2|||
161343267|NCT01283386|582644327|FG001|Overall Study|Death|0|||
161343268|NCT01283386|582644326|FG000|Overall Study|Withdrawal by Subject|2|||
161343269|NCT01283386|582644327|FG001|Overall Study|Withdrawal by Subject|1|||
161343270|NCT01283386|582644326|FG000|Overall Study|Relapse of underlying disease|1|||
161343271|NCT01283386|582644327|FG001|Overall Study|Relapse of underlying disease|3|||
161343272|NCT01283386|582644326|FG000|Overall Study|Progression of underlying disease|2|||
161343273|NCT01283386|582644327|FG001|Overall Study|Progression of underlying disease|7|||
161343274|NCT01283386|582644326|FG000|Overall Study|Reason not specified|1|||
161343275|NCT01283386|582644327|FG001|Overall Study|Reason not specified|0|||
161343276|NCT01283386|582644326|FG000|Overall Study|Protocol Violation|0|||
161343277|NCT01283386|582644327|FG001|Overall Study|Protocol Violation|1|||
161343278|NCT02469857|582644328|FG000|Overall Study|Death|24|||
161343279|NCT02469857|582644329|FG001|Overall Study|Death|29|||
161343280|NCT02469857|582644328|FG000|Overall Study|Discontinuation|1|||
161343281|NCT02469857|582644329|FG001|Overall Study|Discontinuation|3|||
161343282|NCT00937950|582644330|FG000|Overall Study|Withdrawal by Subject|23|||
161343283|NCT00937950|582644330|FG000|Overall Study|Migrated/moved from study area|27|||
161343284|NCT00937950|582644330|FG000|Overall Study|Lost to Follow-up|144|||
161343285|NCT00937950|582644330|FG000|Overall Study|Missing confirmed|4|||
161343286|NCT00937950|582644330|FG000|Overall Study|Other|18|||
161001284|NCT00419094|581390535|FG000|Overall Study|Lack of Efficacy|1|||
161001285|NCT00419094|581390536|FG001|Overall Study|Lack of Efficacy|0|||
161343287|NCT01137786|582644333|FG000|Overall Study|Lost to Follow-up|0|||
161001286|NCT00419094|581390535|FG000|Overall Study|Lost to Follow-up|0|||
161001287|NCT00419094|581390536|FG001|Overall Study|Lost to Follow-up|2|||
161343288|NCT01137786|582644334|FG001|Overall Study|Lost to Follow-up|2|||
161343289|NCT01137786|582644333|FG000|Overall Study|Withdrawal by Subject|1|||
161343290|NCT01137786|582644334|FG001|Overall Study|Withdrawal by Subject|1|||
161343291|NCT01531153|582644337|FG000|Overall Study|Withdrawal by Subject|10|||
161343292|NCT01531153|582644338|FG001|Overall Study|Withdrawal by Subject|9|||
160956433|NCT00360308|581227996|FG002|Overall Study|Withdrawal by Subject|14|||
160956434|NCT00360308|581227994|FG000|Overall Study|Lack of Efficacy|3|||
160956435|NCT00360308|581227995|FG001|Overall Study|Lack of Efficacy|0|||
160956436|NCT00360308|581227996|FG002|Overall Study|Lack of Efficacy|2|||
160956437|NCT00360308|581227994|FG000|Overall Study|Other|2|||
161343293|NCT01531153|582644339|FG002|Overall Study|Withdrawal by Subject|15|||
161343294|NCT02475213|582644340|FG000|Overall Study|Adverse Event|2|||
161001288|NCT00419094|581390535|FG000|Overall Study|Protocol Violation|1|||
161001289|NCT00419094|581390536|FG001|Overall Study|Protocol Violation|14|||
161001290|NCT00419094|581390535|FG000|Overall Study|Withdrawal of consent|1|||
161001291|NCT00419094|581390536|FG001|Overall Study|Withdrawal of consent|5|||
161001292|NCT00419094|581390535|FG000|Overall Study|Other: Error determining exit criteria|1|||
161001293|NCT00419094|581390536|FG001|Overall Study|Other: Error determining exit criteria|0|||
161001294|NCT00419094|581390535|FG000|Overall Study|Other: Patient non-compliant|0|||
161001295|NCT00419094|581390536|FG001|Overall Study|Other: Patient non-compliant|1|||
161001296|NCT00419094|581390535|FG000|Overall Study|Other: No contact for extended period|0|||
161001297|NCT00419094|581390536|FG001|Overall Study|Other: No contact for extended period|1|||
161001298|NCT01337635|581390537|FG000|Overall Study|Lost to Follow-up|0|||
161001299|NCT01337635|581390538|FG001|Overall Study|Lost to Follow-up|1|||
161001300|NCT03287622|581390542|FG000|Overall Study|Withdrawal by Subject|1|||
161269066|NCT02283983|582366934|FG000|Overall Study|Withdrawal by Subject|4|||
161269067|NCT02283983|582366935|FG001|Overall Study|Withdrawal by Subject|2|||
161269068|NCT02283983|582366934|FG000|Overall Study|Protocol Violation|0|||
161269069|NCT02283983|582366935|FG001|Overall Study|Protocol Violation|4|||
161269070|NCT02283983|582366934|FG000|Overall Study|Physician Decision|2|||
161269071|NCT02283983|582366935|FG001|Overall Study|Physician Decision|4|||
161269072|NCT02283983|582366934|FG000|Overall Study|Death|1|||
161269073|NCT02283983|582366935|FG001|Overall Study|Death|0|||
161269074|NCT02283983|582366934|FG000|Overall Study|Adverse Event|1|||
161269075|NCT02283983|582366935|FG001|Overall Study|Adverse Event|0|||
161269076|NCT02283983|582366934|FG000|Overall Study|Lost to Follow-up|9|||
161269077|NCT02283983|582366935|FG001|Overall Study|Lost to Follow-up|8|||
161269078|NCT02283983|582366934|FG000|Overall Study|Relapse|1|||
161269079|NCT02283983|582366935|FG001|Overall Study|Relapse|0|||
161269080|NCT03275064|582366936|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161269081|NCT03275064|582366937|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161269082|NCT03275064|582366938|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161269083|NCT03275064|582366939|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
161269084|NCT03275064|582366940|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
161269085|NCT03275064|582366936|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
161269086|NCT03275064|582366937|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161269087|NCT03275064|582366938|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161269088|NCT03275064|582366939|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161269089|NCT03275064|582366940|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
161269090|NCT03275064|582366936|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
161269091|NCT03275064|582366937|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
161269092|NCT03275064|582366938|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
161269093|NCT03275064|582366939|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
161269094|NCT03275064|582366940|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
161269095|NCT03275064|582366936|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161269096|NCT03275064|582366937|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161269097|NCT03275064|582366938|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161269098|NCT03275064|582366939|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
161269099|NCT03275064|582366940|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
161269100|NCT03275064|582366936|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
161269101|NCT03275064|582366937|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161269102|NCT03275064|582366938|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
161269103|NCT03275064|582366939|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161269104|NCT03275064|582366940|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
161269105|NCT00620555|582366943|FG000|Overall Study|Adverse Event|4|||
161269106|NCT00620555|582366943|FG000|Overall Study|Protocol Violation|2|||
161269107|NCT00620555|582366943|FG000|Overall Study|Lack of Efficacy|12|||
161269108|NCT00620555|582366943|FG000|Overall Study|Withdrawal by Subject|1|||
161269109|NCT00620555|582366943|FG000|Overall Study|Choice of other treatment|1|||
161269110|NCT00620555|582366943|FG000|Overall Study|Visit failure against planned|1|||
161269111|NCT03796039|582366944|FG000|Overall Study|Death|2|||
161269112|NCT03796039|582366945|FG001|Overall Study|Death|1|||
161269113|NCT03796039|582366944|FG000|Overall Study|Withdrawal by Subject|7|||
161269114|NCT03796039|582366945|FG001|Overall Study|Withdrawal by Subject|4|||
161269115|NCT01140503|582366946|FG000|Overall Study|Withdrawal by Subject|1|||
161269116|NCT00669071|582366948|FG000|Overall Study|Lost to Follow-up|3|||
161269117|NCT00669071|582366948|FG000|Overall Study|Final visit 40 days out of window|1|||
161269118|NCT04305496|582366949|FG000|Global Cohort|Withdrawal by Subject|13|||
161269119|NCT04305496|582366950|FG001|Global Cohort|Withdrawal by Subject|6|||
161269120|NCT04305496|582366949|FG000|Global Cohort|Physician Decision|1|||
161269121|NCT04305496|582366950|FG001|Global Cohort|Physician Decision|1|||
161001301|NCT03287622|581390543|FG001|Overall Study|Withdrawal by Subject|0|||
161001302|NCT03287622|581390542|FG000|Overall Study|Lost to Follow-up|27|||
161001303|NCT03287622|581390543|FG001|Overall Study|Lost to Follow-up|15|||
161001304|NCT03287622|581390542|FG000|Overall Study|No prescripion after surgery|28|||
161269122|NCT04305496|582366949|FG000|Global Cohort|Subjective disease progression|16|||
161269123|NCT04305496|582366950|FG001|Global Cohort|Subjective disease progression|17|||
161269124|NCT04305496|582366949|FG000|Global Cohort|Condition under investigation worsened|209|||
161269125|NCT04305496|582366950|FG001|Global Cohort|Condition under investigation worsened|273|||
161269126|NCT04305496|582366949|FG000|Global Cohort|Protocol Violation|2|||
161269127|NCT04305496|582366950|FG001|Global Cohort|Protocol Violation|0|||
161269128|NCT04305496|582366949|FG000|Global Cohort|Adverse Event|44|||
161269129|NCT04305496|582366950|FG001|Global Cohort|Adverse Event|6|||
161269130|NCT04305496|582366949|FG000|Global Cohort|Death|3|||
161269131|NCT04305496|582366950|FG001|Global Cohort|Death|2|||
161269132|NCT04305496|582366949|FG000|Global Cohort|Any reason not specifically recorded|4|||
161269133|NCT04305496|582366950|FG001|Global Cohort|Any reason not specifically recorded|5|||
161269134|NCT04305496|582366949|FG000|China Cohort|Any reason not specifically recorded|1|||
161269135|NCT04305496|582366950|FG001|China Cohort|Any reason not specifically recorded|1|||
161269136|NCT04305496|582366949|FG000|China Cohort|Adverse Event|8|||
161269137|NCT04305496|582366950|FG001|China Cohort|Adverse Event|2|||
161269138|NCT04305496|582366949|FG000|China Cohort|Condition under investigation worsened|40|||
161269139|NCT04305496|582366950|FG001|China Cohort|Condition under investigation worsened|47|||
161269140|NCT04305496|582366949|FG000|China Cohort|Subjective disease progression|2|||
161269141|NCT04305496|582366950|FG001|China Cohort|Subjective disease progression|2|||
161269142|NCT04305496|582366949|FG000|China Cohort|Withdrawal by Subject|2|||
161269143|NCT04305496|582366950|FG001|China Cohort|Withdrawal by Subject|1|||
161269144|NCT01157897|582366952|FG000|Overall Study|Lost to Follow-up|2|||
161269145|NCT01157897|582366953|FG001|Overall Study|Lost to Follow-up|0|||
161269146|NCT01157897|582366954|FG002|Overall Study|Lost to Follow-up|0|||
161269147|NCT01157897|582366955|FG003|Overall Study|Lost to Follow-up|1|||
161269148|NCT01157897|582366952|FG000|Overall Study|Relocated|0|||
161269149|NCT01157897|582366953|FG001|Overall Study|Relocated|2|||
161269150|NCT01157897|582366954|FG002|Overall Study|Relocated|0|||
161269151|NCT01157897|582366955|FG003|Overall Study|Relocated|0|||
161269152|NCT00681590|582366957|FG000|Overall Study|Withdrawal by Subject|2|||
161269153|NCT00681590|582366958|FG001|Overall Study|Withdrawal by Subject|12|||
161269154|NCT01791153|582366961|FG000|Part 1: Blinded Period|Adverse Event|7|||
161269155|NCT01791153|582366962|FG001|Part 1: Blinded Period|Adverse Event|3|||
161269156|NCT01791153|582366963|FG002|Part 1: Blinded Period|Adverse Event|2|||
161269157|NCT01791153|582366964|FG003|Part 1: Blinded Period|Adverse Event|0|||
161269158|NCT01791153|582366965|FG004|Part 1: Blinded Period|Adverse Event|0|||
161269159|NCT01791153|582366966|FG005|Part 1: Blinded Period|Adverse Event|0|||
161269160|NCT01791153|582366967|FG006|Part 1: Blinded Period|Adverse Event|0|||
161269161|NCT01791153|582366968|FG007|Part 1: Blinded Period|Adverse Event|0|||
161269162|NCT01791153|582366961|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
161269163|NCT01791153|582366962|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
161269164|NCT01791153|582366963|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
161269165|NCT01791153|582366964|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
161269166|NCT01791153|582366965|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
161269167|NCT01791153|582366966|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
161269168|NCT01791153|582366967|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
161269169|NCT01791153|582366968|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
161269170|NCT01791153|582366961|FG000|Part 1: Blinded Period|Non-Compliance|1|||
161269171|NCT01791153|582366962|FG001|Part 1: Blinded Period|Non-Compliance|0|||
161269172|NCT01791153|582366963|FG002|Part 1: Blinded Period|Non-Compliance|0|||
161269173|NCT01791153|582366964|FG003|Part 1: Blinded Period|Non-Compliance|0|||
161269174|NCT01791153|582366965|FG004|Part 1: Blinded Period|Non-Compliance|0|||
161269175|NCT01791153|582366966|FG005|Part 1: Blinded Period|Non-Compliance|0|||
161269176|NCT01791153|582366967|FG006|Part 1: Blinded Period|Non-Compliance|0|||
161269177|NCT01791153|582366968|FG007|Part 1: Blinded Period|Non-Compliance|0|||
161269178|NCT01791153|582366961|FG000|Part 1: Blinded Period|Physician Decision|0|||
161269179|NCT01791153|582366962|FG001|Part 1: Blinded Period|Physician Decision|0|||
161269180|NCT01791153|582366963|FG002|Part 1: Blinded Period|Physician Decision|0|||
161269181|NCT01791153|582366964|FG003|Part 1: Blinded Period|Physician Decision|1|||
161269182|NCT01791153|582366965|FG004|Part 1: Blinded Period|Physician Decision|0|||
161269183|NCT01791153|582366966|FG005|Part 1: Blinded Period|Physician Decision|0|||
161269184|NCT01791153|582366967|FG006|Part 1: Blinded Period|Physician Decision|0|||
161001305|NCT03287622|581390543|FG001|Overall Study|No prescripion after surgery|31|||
161269185|NCT01791153|582366968|FG007|Part 1: Blinded Period|Physician Decision|0|||
161269186|NCT01791153|582366961|FG000|Part 1: Blinded Period|Protocol Violation|0|||
161269187|NCT01791153|582366962|FG001|Part 1: Blinded Period|Protocol Violation|0|||
161269188|NCT01791153|582366963|FG002|Part 1: Blinded Period|Protocol Violation|0|||
161269189|NCT01791153|582366964|FG003|Part 1: Blinded Period|Protocol Violation|1|||
161269190|NCT01791153|582366965|FG004|Part 1: Blinded Period|Protocol Violation|0|||
161269191|NCT01791153|582366966|FG005|Part 1: Blinded Period|Protocol Violation|0|||
161343295|NCT02475213|582644341|FG001|Overall Study|Adverse Event|0|||
161343296|NCT02475213|582644342|FG002|Overall Study|Adverse Event|0|||
161343297|NCT02475213|582644343|FG003|Overall Study|Adverse Event|1|||
161343298|NCT02475213|582644344|FG004|Overall Study|Adverse Event|1|||
161343299|NCT02475213|582644345|FG005|Overall Study|Adverse Event|4|||
161343300|NCT02475213|582644346|FG006|Overall Study|Adverse Event|6|||
161343301|NCT02475213|582644347|FG007|Overall Study|Adverse Event|2|||
161343302|NCT02475213|582644340|FG000|Overall Study|Physician Decision|1|||
161343303|NCT02475213|582644341|FG001|Overall Study|Physician Decision|1|||
161343304|NCT02475213|582644342|FG002|Overall Study|Physician Decision|1|||
161343305|NCT02475213|582644343|FG003|Overall Study|Physician Decision|0|||
161343306|NCT02475213|582644344|FG004|Overall Study|Physician Decision|0|||
161343307|NCT02475213|582644345|FG005|Overall Study|Physician Decision|1|||
161343308|NCT02475213|582644346|FG006|Overall Study|Physician Decision|4|||
161343309|NCT02475213|582644347|FG007|Overall Study|Physician Decision|0|||
161343310|NCT02475213|582644340|FG000|Overall Study|Progressive Disease|3|||
161343311|NCT02475213|582644341|FG001|Overall Study|Progressive Disease|2|||
161343312|NCT02475213|582644342|FG002|Overall Study|Progressive Disease|2|||
161343313|NCT02475213|582644343|FG003|Overall Study|Progressive Disease|13|||
161343314|NCT02475213|582644344|FG004|Overall Study|Progressive Disease|15|||
161343315|NCT02475213|582644345|FG005|Overall Study|Progressive Disease|25|||
161343316|NCT02475213|582644346|FG006|Overall Study|Progressive Disease|30|||
161343317|NCT02475213|582644347|FG007|Overall Study|Progressive Disease|10|||
161343318|NCT02475213|582644340|FG000|Overall Study|Death|0|||
161343319|NCT02475213|582644341|FG001|Overall Study|Death|0|||
161343320|NCT02475213|582644342|FG002|Overall Study|Death|0|||
161343321|NCT02475213|582644343|FG003|Overall Study|Death|0|||
161343322|NCT02475213|582644344|FG004|Overall Study|Death|0|||
161343323|NCT02475213|582644345|FG005|Overall Study|Death|4|||
161343324|NCT02475213|582644346|FG006|Overall Study|Death|1|||
161343325|NCT02475213|582644347|FG007|Overall Study|Death|0|||
161343326|NCT02475213|582644340|FG000|Overall Study|Protocol Violation|0|||
161343327|NCT02475213|582644341|FG001|Overall Study|Protocol Violation|0|||
161343328|NCT02475213|582644342|FG002|Overall Study|Protocol Violation|0|||
161343329|NCT02475213|582644343|FG003|Overall Study|Protocol Violation|0|||
161343330|NCT02475213|582644344|FG004|Overall Study|Protocol Violation|1|||
161343331|NCT02475213|582644345|FG005|Overall Study|Protocol Violation|0|||
161343332|NCT02475213|582644346|FG006|Overall Study|Protocol Violation|0|||
161343333|NCT02475213|582644347|FG007|Overall Study|Protocol Violation|0|||
161343334|NCT02475213|582644340|FG000|Overall Study|Withdrawal by Subject|0|||
161343335|NCT02475213|582644341|FG001|Overall Study|Withdrawal by Subject|0|||
161343336|NCT02475213|582644342|FG002|Overall Study|Withdrawal by Subject|0|||
161343337|NCT02475213|582644343|FG003|Overall Study|Withdrawal by Subject|1|||
161343338|NCT02475213|582644344|FG004|Overall Study|Withdrawal by Subject|0|||
161343339|NCT02475213|582644345|FG005|Overall Study|Withdrawal by Subject|2|||
161343340|NCT02475213|582644346|FG006|Overall Study|Withdrawal by Subject|2|||
161343341|NCT02475213|582644347|FG007|Overall Study|Withdrawal by Subject|0|||
161343342|NCT02475213|582644340|FG000|Overall Study|Other|0|||
161001306|NCT03287622|581390542|FG000|Overall Study|prolonged Length of stay|2|||
161001307|NCT03287622|581390543|FG001|Overall Study|prolonged Length of stay|0|||
161001308|NCT03287622|581390542|FG000|Overall Study|surgery related|0|||
161001309|NCT03287622|581390543|FG001|Overall Study|surgery related|2|||
161001310|NCT03192046|581390551|FG000|Overall Study|Withdrawal by Subject|1|||
161001311|NCT03192046|581390552|FG001|Overall Study|Withdrawal by Subject|1|||
161001312|NCT01194154|581390555|FG000|Overall Study|Adverse Event|12|||
161001313|NCT01194154|581390556|FG001|Overall Study|Adverse Event|7|||
161343343|NCT02475213|582644341|FG001|Overall Study|Other|0|||
160956438|NCT00360308|581227995|FG001|Overall Study|Other|1|||
160956439|NCT00360308|581227996|FG002|Overall Study|Other|1|||
160956440|NCT00360308|581227994|FG000|Overall Study|Study termination by sponsor|43|||
160956441|NCT00360308|581227995|FG001|Overall Study|Study termination by sponsor|55|||
161343344|NCT02475213|582644342|FG002|Overall Study|Other|0|||
161343345|NCT02475213|582644343|FG003|Overall Study|Other|1|||
161343346|NCT02475213|582644344|FG004|Overall Study|Other|3|||
161343347|NCT02475213|582644345|FG005|Overall Study|Other|1|||
161343348|NCT02475213|582644346|FG006|Overall Study|Other|0|||
161343349|NCT02475213|582644347|FG007|Overall Study|Other|0|||
161343350|NCT00505921|582644348|FG000|Overall Study|Ineligible|1|||
161343351|NCT00505921|582644348|FG000|Overall Study|Failed to Mobilize|8|||
161343352|NCT00797563|582644349|FG000|Overall Study|Adverse Event|1|||
161343353|NCT03416179|582644350|FG000|Overall Study|Death|90|||
161343354|NCT03416179|582644351|FG001|Overall Study|Death|87|||
161343355|NCT03416179|582644352|FG002|Overall Study|Death|117|||
161343356|NCT03416179|582644353|FG003|Overall Study|Death|113|||
160956442|NCT00360308|581227996|FG002|Overall Study|Study termination by sponsor|44|||
160956443|NCT00082173|581227997|FG000|Overall Study|Withdrawal by Subject|3|||
160956444|NCT00082173|581227998|FG001|Overall Study|Withdrawal by Subject|5|||
160956445|NCT00082173|581227997|FG000|Overall Study|Lost to Follow-up|1|||
160956446|NCT00082173|581227998|FG001|Overall Study|Lost to Follow-up|0|||
160956447|NCT00082173|581227997|FG000|Overall Study|Adverse Event|1|||
160956448|NCT00082173|581227998|FG001|Overall Study|Adverse Event|0|||
160956449|NCT00082173|581227997|FG000|Overall Study|Culture negative or resistant at baselin|5|||
161343357|NCT03416179|582644350|FG000|Overall Study|Withdrawal by Subject|15|||
161343358|NCT03416179|582644351|FG001|Overall Study|Withdrawal by Subject|20|||
161343359|NCT03416179|582644352|FG002|Overall Study|Withdrawal by Subject|6|||
160956450|NCT00082173|581227998|FG001|Overall Study|Culture negative or resistant at baselin|6|||
160956451|NCT01733732|581227999|FG000|Overall Study|Adverse Event|1|||
160956452|NCT01733732|581228000|FG001|Overall Study|Adverse Event|0|||
160956453|NCT01733732|581227999|FG000|Overall Study|Did not attend all study visits|1|||
160956454|NCT01733732|581228000|FG001|Overall Study|Did not attend all study visits|0|||
160956455|NCT03280121|581228003|FG000|Overall Study|Physician Decision|1|||
160956456|NCT03280121|581228003|FG000|Overall Study|Lost to Follow-up|1|||
160956457|NCT03280121|581228003|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
160956458|NCT02633137|581228018|FG000|Overall Study|Adverse Event|1|||
160956459|NCT02633137|581228018|FG000|Overall Study|Lack of Efficacy|2|||
160956460|NCT02633137|581228018|FG000|Overall Study|Withdrawal by Subject|1|||
160956461|NCT04307004|581228019|FG000|Randomization 1|Withdrawal by Subject|25|||
160956462|NCT04307004|581228020|FG001|Randomization 1|Withdrawal by Subject|26|||
160956463|NCT04307004|581228021|FG002|Randomization 1|Withdrawal by Subject|0|||
160956464|NCT04307004|581228022|FG003|Randomization 1|Withdrawal by Subject|0|||
160956465|NCT04307004|581228019|FG000|Randomization 2|Withdrawal by Subject|0|||
160956466|NCT04307004|581228020|FG001|Randomization 2|Withdrawal by Subject|0|||
160956467|NCT04307004|581228021|FG002|Randomization 2|Withdrawal by Subject|28|||
160956468|NCT04307004|581228022|FG003|Randomization 2|Withdrawal by Subject|23|||
160956469|NCT01324271|581228023|FG000|Overall Study|Lost to Follow-up|3|||
160956470|NCT01324271|581228024|FG001|Overall Study|Lost to Follow-up|0|||
160956471|NCT01324271|581228023|FG000|Overall Study|Physician Decision|1|||
161343360|NCT03416179|582644353|FG003|Overall Study|Withdrawal by Subject|9|||
161343361|NCT03416179|582644350|FG000|Overall Study|Lost to Follow-up|1|||
161343362|NCT03416179|582644351|FG001|Overall Study|Lost to Follow-up|1|||
161343363|NCT03416179|582644352|FG002|Overall Study|Lost to Follow-up|0|||
161343364|NCT03416179|582644353|FG003|Overall Study|Lost to Follow-up|3|||
161343365|NCT03416179|582644350|FG000|Overall Study|Study participation terminated by Sponsor|93|||
161343366|NCT03416179|582644351|FG001|Overall Study|Study participation terminated by Sponsor|91|||
161343367|NCT03416179|582644352|FG002|Overall Study|Study participation terminated by Sponsor|26|||
161343368|NCT03416179|582644353|FG003|Overall Study|Study participation terminated by Sponsor|31|||
161343369|NCT03416179|582644350|FG000|Overall Study|Other|2|||
161343370|NCT03416179|582644351|FG001|Overall Study|Other|3|||
161343371|NCT03416179|582644352|FG002|Overall Study|Other|1|||
161343372|NCT03416179|582644353|FG003|Overall Study|Other|0|||
161343373|NCT02313155|582644358|FG000|Overall Study|Lost to Follow-up|0|||
161343374|NCT02313155|582644359|FG001|Overall Study|Lost to Follow-up|1|||
161343375|NCT03822416|582644361|FG000|Overall Study|Lost to Follow-up|1|||
161343376|NCT03822416|582644362|FG001|Overall Study|Lost to Follow-up|0|||
161343377|NCT03822416|582644361|FG000|Overall Study|Withdrawal by Subject|0|||
161343378|NCT03822416|582644362|FG001|Overall Study|Withdrawal by Subject|1|||
161343379|NCT04666298|582644363|FG000|Overall Study|Subject decision|1|||
161343380|NCT04666298|582644364|FG001|Overall Study|Subject decision|0|||
161343381|NCT04666298|582644365|FG002|Overall Study|Subject decision|0|||
161343382|NCT04666298|582644366|FG003|Overall Study|Subject decision|2|||
161343383|NCT04666298|582644363|FG000|Overall Study|Death|1|||
161343384|NCT04666298|582644364|FG001|Overall Study|Death|0|||
161343385|NCT04666298|582644365|FG002|Overall Study|Death|0|||
161343386|NCT04666298|582644366|FG003|Overall Study|Death|0|||
161343387|NCT04666298|582644363|FG000|Overall Study|Lost to Follow-up|0|||
161343388|NCT04666298|582644364|FG001|Overall Study|Lost to Follow-up|0|||
161343389|NCT04666298|582644365|FG002|Overall Study|Lost to Follow-up|0|||
161343390|NCT04666298|582644366|FG003|Overall Study|Lost to Follow-up|1|||
161343391|NCT04666298|582644363|FG000|Overall Study|Physician Decision|0|||
161343392|NCT04666298|582644364|FG001|Overall Study|Physician Decision|0|||
161343393|NCT04666298|582644365|FG002|Overall Study|Physician Decision|0|||
161343394|NCT04666298|582644366|FG003|Overall Study|Physician Decision|1|||
161343395|NCT04666298|582644363|FG000|Overall Study|Protocol deviation|0|||
161343396|NCT04666298|582644364|FG001|Overall Study|Protocol deviation|0|||
161343397|NCT04666298|582644365|FG002|Overall Study|Protocol deviation|1|||
161343398|NCT04666298|582644366|FG003|Overall Study|Protocol deviation|0|||
161343399|NCT06438601|582644367|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
160956472|NCT01324271|581228024|FG001|Overall Study|Physician Decision|0|||
161343400|NCT06438601|582644368|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
161343401|NCT06438601|582644367|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
161343402|NCT06438601|582644368|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
161343403|NCT02178956|582644369|FG000|Overall Study|Lost to Follow-up|4|||
161343404|NCT02178956|582644370|FG001|Overall Study|Lost to Follow-up|4|||
161343405|NCT02178956|582644369|FG000|Overall Study|Sponsor terminated study|49|||
160956473|NCT02807558|581228025|FG000|Overall Study|Consent withdrawn by participant|4|||
160956474|NCT02807558|581228026|FG001|Overall Study|Consent withdrawn by participant|0|||
160956475|NCT02807558|581228027|FG002|Overall Study|Consent withdrawn by participant|4|||
160956476|NCT02807558|581228028|FG003|Overall Study|Consent withdrawn by participant|2|||
160956477|NCT02807558|581228029|FG004|Overall Study|Consent withdrawn by participant|1|||
160956478|NCT02807558|581228030|FG005|Overall Study|Consent withdrawn by participant|0|||
160956479|NCT02807558|581228025|FG000|Overall Study|Non-compliance with Study Drug|0|||
160956480|NCT02807558|581228026|FG001|Overall Study|Non-compliance with Study Drug|0|||
160956481|NCT02807558|581228027|FG002|Overall Study|Non-compliance with Study Drug|1|||
161146423|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
161146424|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
161146425|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
161146426|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
161146427|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
161146428|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
161146429|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
161146430|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
161146431|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
161146432|NCT00611455|581918456|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
161146433|NCT00611455|581918457|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
161146434|NCT00611455|581918458|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
161146435|NCT03240081|581918459|FG000|Overall Study|Withdrawal by Subject|0|||
161146436|NCT03240081|581918460|FG001|Overall Study|Withdrawal by Subject|2|||
161146437|NCT03240081|581918459|FG000|Overall Study|Lost to Follow-up|0|||
161146438|NCT03240081|581918460|FG001|Overall Study|Lost to Follow-up|1|||
161146439|NCT04601272|581918461|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
161146440|NCT04601272|581918462|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
161146441|NCT04601272|581918463|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
161146442|NCT03671369|581918466|FG000|Overall Study|Other|1|||
161146443|NCT03671369|581918466|FG000|Overall Study|Withdrawal by Subject|289|||
161146444|NCT03671369|581918466|FG000|Overall Study|Not willing to be vaccinated|1|||
161146445|NCT04382651|581918467|FG000|Overall Study|Death|26|||
161146446|NCT04382651|581918468|FG001|Overall Study|Death|23|||
161146447|NCT04382651|581918467|FG000|Overall Study|Lost to Follow-up|3|||
161146448|NCT04382651|581918468|FG001|Overall Study|Lost to Follow-up|4|||
161146449|NCT04382651|581918467|FG000|Overall Study|Withdrawal by Subject|2|||
161146450|NCT04382651|581918468|FG001|Overall Study|Withdrawal by Subject|0|||
161269192|NCT01791153|582366967|FG006|Part 1: Blinded Period|Protocol Violation|0|||
161269193|NCT01791153|582366968|FG007|Part 1: Blinded Period|Protocol Violation|0|||
161269194|NCT01791153|582366961|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
161269195|NCT01791153|582366962|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
161269196|NCT01791153|582366963|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
161269197|NCT01791153|582366964|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
161269198|NCT01791153|582366965|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
161269199|NCT01791153|582366966|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
161269200|NCT01791153|582366967|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
161269201|NCT01791153|582366968|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
161269202|NCT01791153|582366961|FG000|Part 2: Open-label Period|Adverse Event|0|||
161269203|NCT01791153|582366962|FG001|Part 2: Open-label Period|Adverse Event|0|||
161269204|NCT01791153|582366963|FG002|Part 2: Open-label Period|Adverse Event|0|||
161269205|NCT01791153|582366964|FG003|Part 2: Open-label Period|Adverse Event|0|||
161269206|NCT01791153|582366965|FG004|Part 2: Open-label Period|Adverse Event|0|||
161269207|NCT01791153|582366966|FG005|Part 2: Open-label Period|Adverse Event|1|||
161269208|NCT01791153|582366967|FG006|Part 2: Open-label Period|Adverse Event|1|||
161269209|NCT01791153|582366968|FG007|Part 2: Open-label Period|Adverse Event|2|||
161269210|NCT01791153|582366961|FG000|Part 2: Open-label Period|Death|0|||
161269211|NCT01791153|582366962|FG001|Part 2: Open-label Period|Death|0|||
161269212|NCT01791153|582366963|FG002|Part 2: Open-label Period|Death|0|||
161269213|NCT01791153|582366964|FG003|Part 2: Open-label Period|Death|0|||
161269214|NCT01791153|582366965|FG004|Part 2: Open-label Period|Death|0|||
161269215|NCT01791153|582366966|FG005|Part 2: Open-label Period|Death|1|||
161269216|NCT01791153|582366967|FG006|Part 2: Open-label Period|Death|1|||
161269217|NCT01791153|582366968|FG007|Part 2: Open-label Period|Death|1|||
161269218|NCT01791153|582366961|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
161269219|NCT01791153|582366962|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
161269220|NCT01791153|582366963|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
161269221|NCT01791153|582366964|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
160956482|NCT02807558|581228028|FG003|Overall Study|Non-compliance with Study Drug|0|||
160956483|NCT02807558|581228029|FG004|Overall Study|Non-compliance with Study Drug|0|||
161146451|NCT04382651|581918467|FG000|Overall Study|Physician Decision|0|||
160956484|NCT02807558|581228030|FG005|Overall Study|Non-compliance with Study Drug|0|||
161146452|NCT04382651|581918468|FG001|Overall Study|Physician Decision|1|||
161269222|NCT01791153|582366965|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
161269223|NCT01791153|582366966|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
161269224|NCT01791153|582366967|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
160956485|NCT02807558|581228025|FG000|Overall Study|Adverse Event|0|||
160956486|NCT02807558|581228026|FG001|Overall Study|Adverse Event|0|||
160956487|NCT02807558|581228027|FG002|Overall Study|Adverse Event|9|||
161343406|NCT02178956|582644370|FG001|Overall Study|Sponsor terminated study|58|||
161343407|NCT02178956|582644369|FG000|Overall Study|Withdrawal by Subject|15|||
161343408|NCT02178956|582644370|FG001|Overall Study|Withdrawal by Subject|11|||
161343409|NCT02178956|582644369|FG000|Overall Study|Various Reasons|3|||
161343410|NCT02178956|582644370|FG001|Overall Study|Various Reasons|5|||
161343411|NCT02709369|582644373|FG000|Overall Study|Lost to Follow-up|15|||
161343412|NCT02709369|582644373|FG000|Overall Study|Withdrawal by Subject|10|||
161343413|NCT02709369|582644373|FG000|Overall Study|Did not received intervention|2|||
161343414|NCT01104766|582644375|FG000|Overall Study|Did not meet inc/exc criteria|1|||
161343415|NCT01104766|582644376|FG001|Overall Study|Did not meet inc/exc criteria|0|||
161343416|NCT01104766|582644377|FG002|Overall Study|Did not meet inc/exc criteria|0|||
161343417|NCT01104766|582644378|FG003|Overall Study|Did not meet inc/exc criteria|0|||
161343418|NCT01104766|582644375|FG000|Overall Study|Adverse Event|17|||
161343419|NCT01104766|582644376|FG001|Overall Study|Adverse Event|15|||
161343420|NCT01104766|582644377|FG002|Overall Study|Adverse Event|20|||
161343421|NCT01104766|582644378|FG003|Overall Study|Adverse Event|14|||
161343422|NCT01104766|582644375|FG000|Overall Study|Lack of Efficacy|20|||
161343423|NCT01104766|582644376|FG001|Overall Study|Lack of Efficacy|15|||
161343424|NCT01104766|582644377|FG002|Overall Study|Lack of Efficacy|14|||
161343425|NCT01104766|582644378|FG003|Overall Study|Lack of Efficacy|8|||
161343426|NCT01104766|582644375|FG000|Overall Study|Protocol Violation|2|||
161343427|NCT01104766|582644376|FG001|Overall Study|Protocol Violation|0|||
161343428|NCT01104766|582644377|FG002|Overall Study|Protocol Violation|0|||
161343429|NCT01104766|582644378|FG003|Overall Study|Protocol Violation|0|||
161343430|NCT01104766|582644375|FG000|Overall Study|Withdrawal by Subject|17|||
161343431|NCT01104766|582644376|FG001|Overall Study|Withdrawal by Subject|19|||
161343432|NCT01104766|582644377|FG002|Overall Study|Withdrawal by Subject|25|||
161343433|NCT01104766|582644378|FG003|Overall Study|Withdrawal by Subject|15|||
161343434|NCT01104766|582644375|FG000|Overall Study|Lost to Follow-up|1|||
161343435|NCT01104766|582644376|FG001|Overall Study|Lost to Follow-up|2|||
161343436|NCT01104766|582644377|FG002|Overall Study|Lost to Follow-up|1|||
161343437|NCT01104766|582644378|FG003|Overall Study|Lost to Follow-up|1|||
161343438|NCT01341470|582644379|FG000|Overall Study|Sponsor decision|0|||
161343439|NCT01341470|582644380|FG001|Overall Study|Sponsor decision|0|||
161343440|NCT01341470|582644381|FG002|Overall Study|Sponsor decision|1|||
161343441|NCT01341470|582644382|FG003|Overall Study|Sponsor decision|1|||
161343442|NCT01341470|582644383|FG004|Overall Study|Sponsor decision|0|||
160956488|NCT02807558|581228028|FG003|Overall Study|Adverse Event|0|||
160956489|NCT02807558|581228029|FG004|Overall Study|Adverse Event|0|||
160956490|NCT02807558|581228030|FG005|Overall Study|Adverse Event|0|||
160956491|NCT02807558|581228025|FG000|Overall Study|Death|23|||
160956492|NCT02807558|581228026|FG001|Overall Study|Death|2|||
160956493|NCT02807558|581228027|FG002|Overall Study|Death|3|||
160956494|NCT02807558|581228028|FG003|Overall Study|Death|43|||
160956495|NCT02807558|581228029|FG004|Overall Study|Death|24|||
160956496|NCT02807558|581228030|FG005|Overall Study|Death|15|||
160956497|NCT02807558|581228025|FG000|Overall Study|Progressive Disease|0|||
160956498|NCT02807558|581228026|FG001|Overall Study|Progressive Disease|0|||
160956499|NCT02807558|581228027|FG002|Overall Study|Progressive Disease|1|||
160956500|NCT02807558|581228028|FG003|Overall Study|Progressive Disease|0|||
160956501|NCT02807558|581228029|FG004|Overall Study|Progressive Disease|0|||
160956502|NCT02807558|581228030|FG005|Overall Study|Progressive Disease|0|||
160956503|NCT02807558|581228025|FG000|Overall Study|Other than specified|1|||
160956504|NCT02807558|581228026|FG001|Overall Study|Other than specified|0|||
160956505|NCT02807558|581228027|FG002|Overall Study|Other than specified|2|||
160956506|NCT02807558|581228028|FG003|Overall Study|Other than specified|0|||
160956507|NCT02807558|581228029|FG004|Overall Study|Other than specified|1|||
160956508|NCT02807558|581228030|FG005|Overall Study|Other than specified|1|||
160956509|NCT02807558|581228025|FG000|Overall Study|Lack of Efficacy|0|||
161001314|NCT01194154|581390555|FG000|Overall Study|Lost to Follow-up|2|||
161343443|NCT01341470|582644384|FG005|Overall Study|Sponsor decision|1|||
160956510|NCT02807558|581228026|FG001|Overall Study|Lack of Efficacy|0|||
160956511|NCT02807558|581228027|FG002|Overall Study|Lack of Efficacy|9|||
160956512|NCT02807558|581228028|FG003|Overall Study|Lack of Efficacy|0|||
160956513|NCT02807558|581228029|FG004|Overall Study|Lack of Efficacy|0|||
160956514|NCT02807558|581228030|FG005|Overall Study|Lack of Efficacy|0|||
160956515|NCT06116591|581228031|FG000|Overall Study|No longer met eligibility criteria|0|||
160956516|NCT06116591|581228032|FG001|Overall Study|No longer met eligibility criteria|1|||
161343444|NCT05452239|582644388|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
161343445|NCT05452239|582644389|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
161343446|NCT05452239|582644388|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
161343447|NCT05452239|582644389|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
161343448|NCT05452239|582644388|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
161343449|NCT05452239|582644389|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
161343450|NCT05452239|582644388|FG000|Placebo-controlled Period|Randomized but not treated|2|||
161146453|NCT00995371|581918471|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
161146454|NCT00995371|581918472|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
161146455|NCT00206518|581918475|FG000|Overall Study|Lack of Efficacy|6|||
161146456|NCT00206518|581918476|FG001|Overall Study|Lack of Efficacy|4|||
161146457|NCT00206518|581918475|FG000|Overall Study|Adverse Event|2|||
161146458|NCT00206518|581918476|FG001|Overall Study|Adverse Event|1|||
161146459|NCT00206518|581918475|FG000|Overall Study|Physician Decision|1|||
161146460|NCT00206518|581918476|FG001|Overall Study|Physician Decision|0|||
161269225|NCT01791153|582366968|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
161269226|NCT01791153|582366961|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
161269227|NCT01791153|582366962|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
161269228|NCT01791153|582366963|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
160956517|NCT06116591|581228031|FG000|Overall Study|Other: Change in life situation|0|||
160956518|NCT06116591|581228032|FG001|Overall Study|Other: Change in life situation|1|||
160956519|NCT05585307|581228033|FG000|Overall Study|Lost to Follow-up|0|||
160956520|NCT05585307|581228034|FG001|Overall Study|Lost to Follow-up|0|||
160956521|NCT05585307|581228035|FG002|Overall Study|Lost to Follow-up|0|||
160956522|NCT05585307|581228036|FG003|Overall Study|Lost to Follow-up|0|||
160956523|NCT05585307|581228037|FG004|Overall Study|Lost to Follow-up|0|||
160956524|NCT05585307|581228038|FG005|Overall Study|Lost to Follow-up|0|||
160956525|NCT05585307|581228039|FG006|Overall Study|Lost to Follow-up|1|||
160956526|NCT05585307|581228040|FG007|Overall Study|Lost to Follow-up|0|||
160956527|NCT02085408|581228043|FG000|Step 1: Induction|Disease Progression|19|||
160956528|NCT02085408|581228044|FG001|Step 1: Induction|Disease Progression|19|||
160956529|NCT02085408|581228043|FG000|Step 1: Induction|Adverse Event|18|||
160956530|NCT02085408|581228044|FG001|Step 1: Induction|Adverse Event|17|||
160956531|NCT02085408|581228043|FG000|Step 1: Induction|Death|33|||
160956532|NCT02085408|581228044|FG001|Step 1: Induction|Death|30|||
161269229|NCT01791153|582366964|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
161269230|NCT01791153|582366965|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
160956533|NCT02085408|581228043|FG000|Step 1: Induction|Withdrawal by Subject|16|||
160956534|NCT02085408|581228044|FG001|Step 1: Induction|Withdrawal by Subject|8|||
160956535|NCT02085408|581228043|FG000|Step 1: Induction|Alternative Therapy|15|||
160956536|NCT02085408|581228044|FG001|Step 1: Induction|Alternative Therapy|19|||
160956537|NCT02085408|581228043|FG000|Step 1: Induction|Complicating Disease|2|||
160956538|NCT02085408|581228044|FG001|Step 1: Induction|Complicating Disease|3|||
160956539|NCT02085408|581228043|FG000|Step 1: Induction|Other|27|||
160956540|NCT02085408|581228044|FG001|Step 1: Induction|Other|39|||
160956541|NCT02085408|581228043|FG000|Step 1: Induction|Never started treatment|6|||
160956542|NCT02085408|581228044|FG001|Step 1: Induction|Never started treatment|4|||
160956543|NCT02085408|581228043|FG000|Step 2: Consolidation|Disease Progression|5|||
160956544|NCT02085408|581228044|FG001|Step 2: Consolidation|Disease Progression|20|||
160956545|NCT02085408|581228043|FG000|Step 2: Consolidation|Adverse Event|9|||
160956546|NCT02085408|581228044|FG001|Step 2: Consolidation|Adverse Event|8|||
160956547|NCT02085408|581228043|FG000|Step 2: Consolidation|Death|4|||
160956548|NCT02085408|581228044|FG001|Step 2: Consolidation|Death|3|||
160956549|NCT02085408|581228043|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
160956550|NCT02085408|581228044|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
160956551|NCT02085408|581228043|FG000|Step 2: Consolidation|Alternative Therapy|9|||
160956552|NCT02085408|581228044|FG001|Step 2: Consolidation|Alternative Therapy|3|||
160956553|NCT02085408|581228043|FG000|Step 2: Consolidation|Complicating Disease|0|||
160956554|NCT02085408|581228044|FG001|Step 2: Consolidation|Complicating Disease|2|||
160956555|NCT02085408|581228043|FG000|Step 2: Consolidation|Other|6|||
160956556|NCT02085408|581228044|FG001|Step 2: Consolidation|Other|6|||
160956557|NCT02085408|581228043|FG000|Step 2: Consolidation|Never started treatment|4|||
161269231|NCT01791153|582366966|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
161269232|NCT01791153|582366967|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
160956558|NCT02085408|581228044|FG001|Step 2: Consolidation|Never started treatment|3|||
160956559|NCT02085408|581228043|FG000|Step 3: Maintenance|Disease Progression|13|||
160956560|NCT02085408|581228044|FG001|Step 3: Maintenance|Disease Progression|11|||
160956561|NCT02085408|581228043|FG000|Step 3: Maintenance|Adverse Event|2|||
160956562|NCT02085408|581228044|FG001|Step 3: Maintenance|Adverse Event|4|||
161146461|NCT00206518|581918475|FG000|Overall Study|Protocol Violation|1|||
161146462|NCT00206518|581918476|FG001|Overall Study|Protocol Violation|1|||
161269233|NCT01791153|582366968|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
160956563|NCT02085408|581228043|FG000|Step 3: Maintenance|Death|1|||
160956564|NCT02085408|581228044|FG001|Step 3: Maintenance|Death|2|||
160956565|NCT02085408|581228043|FG000|Step 3: Maintenance|Alternative Therapy|1|||
160956566|NCT02085408|581228044|FG001|Step 3: Maintenance|Alternative Therapy|1|||
160956567|NCT02085408|581228043|FG000|Step 3: Maintenance|Complicating Disease|0|||
160956568|NCT02085408|581228044|FG001|Step 3: Maintenance|Complicating Disease|1|||
160956569|NCT02085408|581228043|FG000|Step 3: Maintenance|Other|3|||
160956570|NCT02085408|581228044|FG001|Step 3: Maintenance|Other|2|||
161001315|NCT01194154|581390556|FG001|Overall Study|Lost to Follow-up|3|||
161001316|NCT01194154|581390555|FG000|Overall Study|Protocol Violation|0|||
161269234|NCT01791153|582366961|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
161269235|NCT01791153|582366962|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
161269236|NCT01791153|582366963|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
161269237|NCT01791153|582366964|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
161269238|NCT01791153|582366965|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
161269239|NCT01791153|582366966|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
161269240|NCT01791153|582366967|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
160956571|NCT02085408|581228043|FG000|Step 3: Maintenance|Never started treatment|5|||
160956572|NCT02085408|581228044|FG001|Step 3: Maintenance|Never started treatment|1|||
160956573|NCT01474681|581228047|FG000|Overall Study|Death|0|||
160956574|NCT01474681|581228048|FG001|Overall Study|Death|3|||
160956575|NCT01474681|581228049|FG002|Overall Study|Death|2|||
160956576|NCT01474681|581228050|FG003|Overall Study|Death|6|||
160956577|NCT01483924|581228054|FG000|Overall Study|Withdrawal by Subject|2|||
160956578|NCT01483924|581228055|FG001|Overall Study|Withdrawal by Subject|0|||
160956579|NCT01483924|581228056|FG002|Overall Study|Withdrawal by Subject|0|||
160956580|NCT01483924|581228057|FG003|Overall Study|Withdrawal by Subject|1|||
160956581|NCT01483924|581228058|FG004|Overall Study|Withdrawal by Subject|1|||
160956582|NCT01483924|581228054|FG000|Overall Study|Adverse Event|0|||
160956583|NCT01483924|581228055|FG001|Overall Study|Adverse Event|0|||
160956584|NCT01483924|581228056|FG002|Overall Study|Adverse Event|1|||
160956585|NCT01483924|581228057|FG003|Overall Study|Adverse Event|1|||
160956586|NCT01483924|581228058|FG004|Overall Study|Adverse Event|0|||
160956587|NCT01483924|581228054|FG000|Overall Study|Non-compliance|0|||
160956588|NCT01483924|581228055|FG001|Overall Study|Non-compliance|0|||
160956589|NCT01483924|581228056|FG002|Overall Study|Non-compliance|0|||
160956590|NCT01483924|581228057|FG003|Overall Study|Non-compliance|1|||
160956591|NCT01483924|581228058|FG004|Overall Study|Non-compliance|1|||
160956592|NCT01483924|581228054|FG000|Overall Study|Sponsor concern over ECG result|0|||
160956593|NCT01483924|581228055|FG001|Overall Study|Sponsor concern over ECG result|0|||
160956594|NCT01483924|581228056|FG002|Overall Study|Sponsor concern over ECG result|0|||
160956595|NCT01483924|581228057|FG003|Overall Study|Sponsor concern over ECG result|1|||
160956596|NCT01483924|581228058|FG004|Overall Study|Sponsor concern over ECG result|0|||
160956597|NCT00003298|581228059|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
160956598|NCT00003298|581228059|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
160956599|NCT00003298|581228059|FG000|Surgery|Unresectable at surgery|3|||
160956600|NCT00003298|581228059|FG000|Surgery|Progression before surgery|2|||
160956601|NCT00003298|581228059|FG000|Surgery|Unevaluable and off study|2|||
160956602|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
160956603|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
160956604|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
160956605|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
160956606|NCT00003298|581228059|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
160956607|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
160956608|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
160956609|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
160956610|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
160956611|NCT00003298|581228059|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
160956612|NCT00335322|581228063|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
160956613|NCT00335322|581228064|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
160956614|NCT00335322|581228065|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
160956615|NCT02195986|581228066|FG000|Overall Study|Adverse Event|3|||
160956616|NCT02195986|581228067|FG001|Overall Study|Adverse Event|0|||
160956617|NCT02195986|581228068|FG002|Overall Study|Adverse Event|0|||
160956618|NCT02195986|581228066|FG000|Overall Study|Withdrawal by Subject|0|||
160956619|NCT02195986|581228067|FG001|Overall Study|Withdrawal by Subject|3|||
160956620|NCT02195986|581228068|FG002|Overall Study|Withdrawal by Subject|0|||
160956621|NCT02195986|581228066|FG000|Overall Study|Family Emergency|0|||
160956622|NCT02195986|581228067|FG001|Overall Study|Family Emergency|0|||
160956623|NCT02195986|581228068|FG002|Overall Study|Family Emergency|1|||
161146463|NCT02335450|581918477|FG000|Overall Study|Pregnancy|1|||
161269241|NCT01791153|582366968|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
161269242|NCT01791153|582366961|FG000|Part 2: Open-label Period|Physician Decision|0|||
161269243|NCT01791153|582366962|FG001|Part 2: Open-label Period|Physician Decision|0|||
160956624|NCT02195986|581228066|FG000|Overall Study|Protocol Violation|0|||
160956625|NCT02195986|581228067|FG001|Overall Study|Protocol Violation|1|||
160956626|NCT02195986|581228068|FG002|Overall Study|Protocol Violation|1|||
160956627|NCT02195986|581228066|FG000|Overall Study|Non-compliance|0|||
161001317|NCT01194154|581390556|FG001|Overall Study|Protocol Violation|1|||
160956628|NCT02195986|581228067|FG001|Overall Study|Non-compliance|1|||
160956629|NCT02195986|581228068|FG002|Overall Study|Non-compliance|0|||
160956630|NCT02834780|581228071|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
160956631|NCT02834780|581228072|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
160956632|NCT02834780|581228073|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
161269244|NCT01791153|582366963|FG002|Part 2: Open-label Period|Physician Decision|0|||
160956633|NCT02834780|581228074|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
160956634|NCT02834780|581228075|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
160956635|NCT02834780|581228076|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
160956636|NCT02834780|581228077|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
160956637|NCT02834780|581228078|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
160956638|NCT02834780|581228079|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
160956639|NCT02834780|581228080|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
160956640|NCT02834780|581228081|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
160956641|NCT02834780|581228082|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
161001318|NCT01194154|581390555|FG000|Overall Study|Withdrawal by Subject|5|||
161001319|NCT01194154|581390556|FG001|Overall Study|Withdrawal by Subject|6|||
161001320|NCT01194154|581390555|FG000|Overall Study|Blood pressure increase|5|||
161001321|NCT01194154|581390556|FG001|Overall Study|Blood pressure increase|3|||
161001322|NCT01194154|581390555|FG000|Overall Study|Hemoglobin decrease|0|||
161001323|NCT01194154|581390556|FG001|Overall Study|Hemoglobin decrease|1|||
161001324|NCT01194154|581390555|FG000|Overall Study|Hemoglobin increase|12|||
161001325|NCT01194154|581390556|FG001|Overall Study|Hemoglobin increase|3|||
161001326|NCT01194154|581390555|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
161001327|NCT01194154|581390556|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
161001328|NCT01194154|581390555|FG000|Overall Study|Treatment with prohibited medication|4|||
161001329|NCT01194154|581390556|FG001|Overall Study|Treatment with prohibited medication|5|||
161001330|NCT01194154|581390555|FG000|Overall Study|Other|4|||
161001331|NCT01194154|581390556|FG001|Overall Study|Other|0|||
161001332|NCT01194154|581390555|FG000|Overall Study|Did not receive study medication|2|||
161001333|NCT01194154|581390556|FG001|Overall Study|Did not receive study medication|4|||
161001334|NCT00842257|581390557|FG000|Overall Study|Adverse Event|1|||
161001335|NCT01901276|581390558|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
161001336|NCT01901276|581390559|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
161001337|NCT02314117|581390560|FG000|Overall Study|Lost to Follow-up|9|||
161001338|NCT02314117|581390561|FG001|Overall Study|Lost to Follow-up|14|||
161001339|NCT02314117|581390560|FG000|Overall Study|Withdrawal by Subject|3|||
161001340|NCT02314117|581390561|FG001|Overall Study|Withdrawal by Subject|2|||
161001341|NCT04347954|581390565|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
161001342|NCT04347954|581390566|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
161001343|NCT04347954|581390567|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
161001344|NCT04347954|581390565|FG000|Overall Study|Lost to Follow-up|0|||
161001345|NCT04347954|581390566|FG001|Overall Study|Lost to Follow-up|1|||
161001346|NCT04347954|581390567|FG002|Overall Study|Lost to Follow-up|0|||
161001347|NCT00909363|581390568|FG000|Overall Study|Withdrawal by Subject|1|||
161001348|NCT00909363|581390569|FG001|Overall Study|Withdrawal by Subject|0|||
161001349|NCT00909363|581390570|FG002|Overall Study|Withdrawal by Subject|0|||
161001350|NCT00909363|581390568|FG000|Overall Study|Lack of Efficacy|1|||
161001351|NCT00909363|581390569|FG001|Overall Study|Lack of Efficacy|0|||
161001352|NCT00909363|581390570|FG002|Overall Study|Lack of Efficacy|0|||
161001353|NCT05641311|581390571|FG000|Dosing Period 1|Adverse Event|1|||
161001354|NCT05641311|581390572|FG001|Dosing Period 1|Adverse Event|0|||
161001355|NCT03515304|581390579|FG000|Overall Study|Lost to Follow-up|0|||
161001356|NCT03515304|581390580|FG001|Overall Study|Lost to Follow-up|3|||
161001357|NCT02045836|581390583|FG000|Overall Study|Adverse Event|4|||
161001358|NCT02045836|581390584|FG001|Overall Study|Adverse Event|4|||
161001359|NCT02045836|581390583|FG000|Overall Study|Withdrawal by Subject|1|||
161001360|NCT02045836|581390584|FG001|Overall Study|Withdrawal by Subject|1|||
161001361|NCT02045836|581390583|FG000|Overall Study|Lost to Follow-up|4|||
161001362|NCT02045836|581390584|FG001|Overall Study|Lost to Follow-up|7|||
161001363|NCT02045836|581390583|FG000|Overall Study|Migrated from study area|0|||
161001364|NCT02045836|581390584|FG001|Overall Study|Migrated from study area|2|||
161001365|NCT00057837|581390585|FG000|Overall Study|Progression/relapse|12|||
161146464|NCT02613572|581918478|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
161146465|NCT02613572|581918479|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
161146466|NCT02613572|581918480|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
161146467|NCT02613572|581918478|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
161146468|NCT02613572|581918479|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
161146469|NCT02613572|581918480|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
161146470|NCT00231478|581918486|FG000|Overall Study|Protocol Violation|3|||
161001366|NCT00057837|581390586|FG001|Overall Study|Progression/relapse|14|||
161001367|NCT00057837|581390585|FG000|Overall Study|Adverse Event|2|||
161001368|NCT00057837|581390586|FG001|Overall Study|Adverse Event|12|||
161001369|NCT00057837|581390585|FG000|Overall Study|Death|5|||
161146471|NCT00231478|581918487|FG001|Overall Study|Protocol Violation|2|||
161146472|NCT00231478|581918486|FG000|Overall Study|Refused Treatment|1|||
160956642|NCT02834780|581228083|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
161001370|NCT00057837|581390586|FG001|Overall Study|Death|4|||
161001371|NCT00057837|581390585|FG000|Overall Study|Withdrawal by Subject|5|||
160956643|NCT02834780|581228071|FG000|Overall Study|Withdrawal by Subject|0|||
160956644|NCT02834780|581228072|FG001|Overall Study|Withdrawal by Subject|0|||
160956645|NCT02834780|581228073|FG002|Overall Study|Withdrawal by Subject|1|||
160956646|NCT02834780|581228074|FG003|Overall Study|Withdrawal by Subject|0|||
160956647|NCT02834780|581228075|FG004|Overall Study|Withdrawal by Subject|0|||
160956648|NCT02834780|581228076|FG005|Overall Study|Withdrawal by Subject|0|||
160956649|NCT02834780|581228077|FG006|Overall Study|Withdrawal by Subject|0|||
160956650|NCT02834780|581228078|FG007|Overall Study|Withdrawal by Subject|0|||
160956651|NCT02834780|581228079|FG008|Overall Study|Withdrawal by Subject|0|||
160956652|NCT02834780|581228080|FG009|Overall Study|Withdrawal by Subject|0|||
160956653|NCT02834780|581228081|FG010|Overall Study|Withdrawal by Subject|1|||
160956654|NCT02834780|581228082|FG011|Overall Study|Withdrawal by Subject|0|||
160956655|NCT02834780|581228083|FG012|Overall Study|Withdrawal by Subject|0|||
160956656|NCT02834780|581228071|FG000|Overall Study|Adverse Event|0|||
160956657|NCT02834780|581228072|FG001|Overall Study|Adverse Event|0|||
160956658|NCT02834780|581228073|FG002|Overall Study|Adverse Event|0|||
160956659|NCT02834780|581228074|FG003|Overall Study|Adverse Event|0|||
160956660|NCT02834780|581228075|FG004|Overall Study|Adverse Event|1|||
160956661|NCT02834780|581228076|FG005|Overall Study|Adverse Event|0|||
160956662|NCT02834780|581228077|FG006|Overall Study|Adverse Event|1|||
160956663|NCT02834780|581228078|FG007|Overall Study|Adverse Event|1|||
160956664|NCT02834780|581228079|FG008|Overall Study|Adverse Event|0|||
160956665|NCT02834780|581228080|FG009|Overall Study|Adverse Event|2|||
160956666|NCT02834780|581228081|FG010|Overall Study|Adverse Event|0|||
160956667|NCT02834780|581228082|FG011|Overall Study|Adverse Event|3|||
160956668|NCT02834780|581228083|FG012|Overall Study|Adverse Event|2|||
160956669|NCT02834780|581228071|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956670|NCT02834780|581228072|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
160956671|NCT02834780|581228073|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
160956672|NCT02834780|581228074|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956673|NCT02834780|581228075|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956674|NCT02834780|581228076|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956675|NCT02834780|581228077|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956676|NCT02834780|581228078|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
160956677|NCT02834780|581228079|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
160956678|NCT02834780|581228080|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
160956679|NCT02834780|581228081|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
160956680|NCT02834780|581228082|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
160956681|NCT02834780|581228083|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
160956682|NCT02834780|581228071|FG000|Overall Study|Other|1|||
160956683|NCT02834780|581228072|FG001|Overall Study|Other|0|||
160956684|NCT02834780|581228073|FG002|Overall Study|Other|1|||
160956685|NCT02834780|581228074|FG003|Overall Study|Other|2|||
160956686|NCT02834780|581228075|FG004|Overall Study|Other|0|||
160956687|NCT02834780|581228076|FG005|Overall Study|Other|0|||
160956688|NCT02834780|581228077|FG006|Overall Study|Other|0|||
160956689|NCT02834780|581228078|FG007|Overall Study|Other|0|||
160956690|NCT02834780|581228079|FG008|Overall Study|Other|0|||
160956691|NCT02834780|581228080|FG009|Overall Study|Other|0|||
160956692|NCT02834780|581228081|FG010|Overall Study|Other|0|||
160956693|NCT02834780|581228082|FG011|Overall Study|Other|0|||
160956694|NCT02834780|581228083|FG012|Overall Study|Other|1|||
160956695|NCT03150056|581228084|FG000|Overall Study|Withdrawal by Subject|0|||
160956696|NCT03150056|581228085|FG001|Overall Study|Withdrawal by Subject|0|||
160956697|NCT03150056|581228086|FG002|Overall Study|Withdrawal by Subject|0|||
160956698|NCT03150056|581228087|FG003|Overall Study|Withdrawal by Subject|0|||
160956699|NCT03150056|581228088|FG004|Overall Study|Withdrawal by Subject|0|||
160956700|NCT03150056|581228089|FG005|Overall Study|Withdrawal by Subject|2|||
160956701|NCT03150056|581228084|FG000|Overall Study|Study terminated by Sponsor|1|||
160956702|NCT03150056|581228085|FG001|Overall Study|Study terminated by Sponsor|3|||
160956703|NCT03150056|581228086|FG002|Overall Study|Study terminated by Sponsor|1|||
160956704|NCT03150056|581228087|FG003|Overall Study|Study terminated by Sponsor|1|||
160956705|NCT03150056|581228088|FG004|Overall Study|Study terminated by Sponsor|5|||
160956706|NCT03150056|581228089|FG005|Overall Study|Study terminated by Sponsor|6|||
160956707|NCT03150056|581228084|FG000|Overall Study|Death|9|||
160956708|NCT03150056|581228085|FG001|Overall Study|Death|2|||
160956709|NCT03150056|581228086|FG002|Overall Study|Death|2|||
160956710|NCT03150056|581228087|FG003|Overall Study|Death|7|||
160956711|NCT03150056|581228088|FG004|Overall Study|Death|8|||
160956712|NCT03150056|581228089|FG005|Overall Study|Death|10|||
160956713|NCT02270450|581228094|FG000|Overall Study|Refusal unrelated to adverse event|3|||
160956714|NCT02270450|581228095|FG001|Overall Study|Refusal unrelated to adverse event|1|||
160956715|NCT02270450|581228096|FG002|Overall Study|Refusal unrelated to adverse event|5|||
160956716|NCT02270450|581228097|FG003|Overall Study|Refusal unrelated to adverse event|14|||
160956717|NCT02270450|581228094|FG000|Overall Study|Progression/relapse|1|||
160956718|NCT02270450|581228095|FG001|Overall Study|Progression/relapse|2|||
160956719|NCT02270450|581228096|FG002|Overall Study|Progression/relapse|4|||
160956720|NCT02270450|581228097|FG003|Overall Study|Progression/relapse|9|||
160956721|NCT02270450|581228094|FG000|Overall Study|Death|19|||
160956722|NCT02270450|581228095|FG001|Overall Study|Death|19|||
160956723|NCT02270450|581228096|FG002|Overall Study|Death|31|||
160956724|NCT02270450|581228097|FG003|Overall Study|Death|59|||
160956725|NCT02363738|581228098|FG000|Overall Study|Adverse Event|5|||
160956726|NCT02363738|581228099|FG001|Overall Study|Adverse Event|2|||
160956727|NCT02363738|581228098|FG000|Overall Study|Lack of Efficacy|1|||
160956728|NCT02363738|581228099|FG001|Overall Study|Lack of Efficacy|2|||
160956729|NCT02363738|581228098|FG000|Overall Study|Lost to Follow-up|2|||
160956730|NCT02363738|581228099|FG001|Overall Study|Lost to Follow-up|1|||
160956731|NCT01939028|581228106|FG000|Overall Study|Withdrawal by Subject|5|||
160956732|NCT01939028|581228106|FG000|Overall Study|Physician Decision|7|||
160956733|NCT03282227|581228107|FG000|Overall Study|Exposure Goals Achieved|60|||
160956734|NCT03282227|581228107|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
160956735|NCT03282227|581228107|FG000|Overall Study|Adverse Event|15|||
160956736|NCT03282227|581228107|FG000|Overall Study|Lost to Follow-up|21|||
160956737|NCT03282227|581228107|FG000|Overall Study|Withdrawal by Subject|20|||
160956738|NCT03282227|581228107|FG000|Overall Study|Lack of Efficacy|12|||
160956739|NCT03282227|581228107|FG000|Overall Study|Sponsor decision|3|||
160956740|NCT03282227|581228107|FG000|Overall Study|Physician Decision|2|||
160956741|NCT03282227|581228107|FG000|Overall Study|Pregnancy|2|||
160956742|NCT03282227|581228107|FG000|Overall Study|Other|1|||
160956743|NCT00700401|581228111|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
160956744|NCT00700401|581228111|FG000|Overall Study|Adverse Event|5|||
160956745|NCT00700401|581228111|FG000|Overall Study|Refused Treatment|2|||
160956746|NCT00700401|581228111|FG000|Overall Study|Lost to Follow-up|1|||
160956747|NCT00700401|581228111|FG000|Overall Study|Treatment never started|1|||
160956748|NCT00700401|581228111|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
160956749|NCT00700401|581228111|FG000|Overall Study|Withdrawal by Subject|2|||
160956750|NCT02491671|581228112|FG000|Overall Study|Adverse Event|6|||
160956751|NCT02491671|581228113|FG001|Overall Study|Adverse Event|8|||
160956752|NCT02491671|581228112|FG000|Overall Study|Death|0|||
160956753|NCT02491671|581228113|FG001|Overall Study|Death|2|||
160956754|NCT02491671|581228112|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
160956755|NCT02491671|581228113|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
160956756|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
160956757|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
160956758|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
160956759|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
160956760|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
160956761|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
160956762|NCT02251990|581228117|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
160956763|NCT02251990|581228118|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
160956764|NCT02251990|581228117|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
160956765|NCT02251990|581228118|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
160956766|NCT02251990|581228117|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
160956767|NCT02251990|581228118|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
160956768|NCT00322348|581228119|FG000|Overall Study|Adverse Event|0|||
160956769|NCT00322348|581228120|FG001|Overall Study|Adverse Event|1|||
160956770|NCT00322348|581228119|FG000|Overall Study|Withdrawal by Subject|1|||
160956771|NCT00322348|581228120|FG001|Overall Study|Withdrawal by Subject|4|||
160956772|NCT00322348|581228119|FG000|Overall Study|Lost to Follow-up|1|||
160956773|NCT00322348|581228120|FG001|Overall Study|Lost to Follow-up|0|||
160956774|NCT00322348|581228119|FG000|Overall Study|Death|0|||
161001372|NCT00057837|581390586|FG001|Overall Study|Withdrawal by Subject|3|||
161001373|NCT00057837|581390585|FG000|Overall Study|Alternative therapy|0|||
161146473|NCT00231478|581918487|FG001|Overall Study|Refused Treatment|1|||
161146474|NCT00231478|581918486|FG000|Overall Study|Withdrawal by Subject|1|||
161146475|NCT00231478|581918487|FG001|Overall Study|Withdrawal by Subject|0|||
161269245|NCT01791153|582366964|FG003|Part 2: Open-label Period|Physician Decision|0|||
160956775|NCT00322348|581228120|FG001|Overall Study|Death|2|||
160956776|NCT00322348|581228119|FG000|Overall Study|Disease Progression|30|||
160956777|NCT00322348|581228120|FG001|Overall Study|Disease Progression|25|||
160956778|NCT00322348|581228119|FG000|Overall Study|Reasons not specified|5|||
160956779|NCT00322348|581228120|FG001|Overall Study|Reasons not specified|1|||
160956780|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
160956781|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
160956782|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
160956783|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
160956784|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
160956785|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161001374|NCT00057837|581390586|FG001|Overall Study|Alternative therapy|1|||
160956786|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
160956787|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
161001375|NCT00057837|581390585|FG000|Overall Study|Other complicating disease|2|||
161001376|NCT00057837|581390586|FG001|Overall Study|Other complicating disease|1|||
161001377|NCT00057837|581390585|FG000|Overall Study|Physician Decision|1|||
161001378|NCT00057837|581390586|FG001|Overall Study|Physician Decision|0|||
161001379|NCT00057837|581390585|FG000|Overall Study|Ineligible|3|||
161001380|NCT00057837|581390586|FG001|Overall Study|Ineligible|3|||
161001381|NCT00057837|581390585|FG000|Overall Study|Never started treatment|1|||
161001382|NCT00057837|581390586|FG001|Overall Study|Never started treatment|1|||
161001383|NCT02000817|581390587|FG000|Overall Study|Withdrawal by Subject|2|||
161001384|NCT02000817|581390588|FG001|Overall Study|Withdrawal by Subject|0|||
161001385|NCT02000817|581390589|FG002|Overall Study|Withdrawal by Subject|0|||
161001386|NCT02000817|581390590|FG003|Overall Study|Withdrawal by Subject|0|||
161001387|NCT02000817|581390587|FG000|Overall Study|Adverse Event|0|||
161001388|NCT02000817|581390588|FG001|Overall Study|Adverse Event|1|||
161001389|NCT02000817|581390589|FG002|Overall Study|Adverse Event|0|||
161001390|NCT02000817|581390590|FG003|Overall Study|Adverse Event|0|||
161001391|NCT02000817|581390587|FG000|Overall Study|Lost to Follow-up|0|||
161001392|NCT02000817|581390588|FG001|Overall Study|Lost to Follow-up|0|||
161001393|NCT02000817|581390589|FG002|Overall Study|Lost to Follow-up|1|||
161001394|NCT02000817|581390590|FG003|Overall Study|Lost to Follow-up|0|||
161001395|NCT03383146|581390591|FG000|Overall Study|Screen Failure|1|||
161001396|NCT03383146|581390592|FG001|Overall Study|Screen Failure|0|||
161001397|NCT03383146|581390591|FG000|Overall Study|Adverse Event|6|||
161001398|NCT03383146|581390592|FG001|Overall Study|Adverse Event|18|||
161001399|NCT03383146|581390591|FG000|Overall Study|Lack of Efficacy|0|||
161001400|NCT03383146|581390592|FG001|Overall Study|Lack of Efficacy|3|||
161001401|NCT03383146|581390591|FG000|Overall Study|Withdrawal by Subject|20|||
161001402|NCT03383146|581390592|FG001|Overall Study|Withdrawal by Subject|36|||
161001403|NCT03383146|581390591|FG000|Overall Study|Lost to Follow-up|5|||
161001404|NCT03383146|581390592|FG001|Overall Study|Lost to Follow-up|15|||
161001405|NCT03383146|581390591|FG000|Overall Study|Death|0|||
161001406|NCT03383146|581390592|FG001|Overall Study|Death|2|||
161001407|NCT03383146|581390591|FG000|Overall Study|Physician Decision|0|||
161001408|NCT03383146|581390592|FG001|Overall Study|Physician Decision|1|||
161001409|NCT03383146|581390591|FG000|Overall Study|Protocol Deviation|1|||
161001410|NCT03383146|581390592|FG001|Overall Study|Protocol Deviation|8|||
161001411|NCT03383146|581390591|FG000|Overall Study|Study Terminated by the Sponsor|48|||
161146476|NCT00231478|581918486|FG000|Overall Study|Adverse Event|0|||
161146477|NCT00231478|581918487|FG001|Overall Study|Adverse Event|1|||
161146478|NCT00231478|581918486|FG000|Overall Study|Administrative|3|||
161146479|NCT00231478|581918487|FG001|Overall Study|Administrative|2|||
161146480|NCT04538950|581918488|FG000|Overall Study|Pulmonary Issues|2|||
161146481|NCT04538950|581918488|FG000|Overall Study|illness|2|||
161146482|NCT05258058|581918489|FG000|Overall Study|Withdrawal by Subject|2|||
161146483|NCT04579393|581918492|FG000|Overall Study|Withdrawal by Subject|2|||
161146484|NCT04579393|581918493|FG001|Overall Study|Withdrawal by Subject|2|||
161146485|NCT04579393|581918492|FG000|Overall Study|Death|1|||
160956788|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
160956789|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
160956790|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
160956791|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
160956792|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
160956793|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
160956794|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
160956795|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160956796|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161001412|NCT03383146|581390592|FG001|Overall Study|Study Terminated by the Sponsor|95|||
160956797|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161001413|NCT03383146|581390591|FG000|Overall Study|Reason not Specified|4|||
161001414|NCT03383146|581390592|FG001|Overall Study|Reason not Specified|6|||
161001415|NCT01317420|581390593|FG000|Overall Study|Progressive disease according to RECIST|2|||
161001416|NCT01317420|581390594|FG001|Overall Study|Progressive disease according to RECIST|3|||
161001417|NCT01317420|581390595|FG002|Overall Study|Progressive disease according to RECIST|3|||
161001418|NCT01317420|581390596|FG003|Overall Study|Progressive disease according to RECIST|3|||
161146486|NCT04579393|581918493|FG001|Overall Study|Death|3|||
161146487|NCT00393458|581918494|FG000|Overall Study|Adverse Event|35|||
161146488|NCT00393458|581918495|FG001|Overall Study|Adverse Event|24|||
161001419|NCT01317420|581390597|FG004|Overall Study|Progressive disease according to RECIST|3|||
161146489|NCT00393458|581918496|FG002|Overall Study|Adverse Event|40|||
161146490|NCT00393458|581918497|FG003|Overall Study|Adverse Event|35|||
161146491|NCT00393458|581918494|FG000|Overall Study|Subject withdrew consent|27|||
161146492|NCT00393458|581918495|FG001|Overall Study|Subject withdrew consent|40|||
161146493|NCT00393458|581918496|FG002|Overall Study|Subject withdrew consent|33|||
161146494|NCT00393458|581918497|FG003|Overall Study|Subject withdrew consent|50|||
161146495|NCT00393458|581918494|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
161146496|NCT00393458|581918495|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
161001420|NCT01317420|581390598|FG005|Overall Study|Progressive disease according to RECIST|3|||
160956798|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160956799|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
160956800|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956801|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956802|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
160956803|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956804|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
160956805|NCT03152552|581228122|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956806|NCT03152552|581228123|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956807|NCT03152552|581228124|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956808|NCT03152552|581228125|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
160956809|NCT03152552|581228126|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
160956810|NCT03152552|581228122|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
160956811|NCT03152552|581228123|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
160956812|NCT03152552|581228124|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
160956813|NCT03152552|581228125|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
160956814|NCT03152552|581228126|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
160956815|NCT01857531|581228129|FG000|Overall Study|Withdrawal by Subject|4|||
160956816|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
160956817|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
160956818|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
160956819|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
160956820|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
160956821|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
160956822|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
160956823|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
160956824|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
160956825|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
160956826|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
160956827|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
160956828|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
160956829|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
160956830|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
160956831|NCT00355082|581228130|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
160956832|NCT00355082|581228131|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
160956833|NCT00355082|581228132|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
160956834|NCT00355082|581228130|FG000|Continuation Phase|Adverse Event|2|||
160956835|NCT00355082|581228131|FG001|Continuation Phase|Adverse Event|0|||
160956836|NCT00355082|581228132|FG002|Continuation Phase|Adverse Event|1|||
160956837|NCT00355082|581228130|FG000|Continuation Phase|Lost to Follow-up|2|||
160956838|NCT00355082|581228131|FG001|Continuation Phase|Lost to Follow-up|0|||
160956839|NCT00355082|581228132|FG002|Continuation Phase|Lost to Follow-up|1|||
160956840|NCT00355082|581228130|FG000|Continuation Phase|Protocol Violation|1|||
160956841|NCT00355082|581228131|FG001|Continuation Phase|Protocol Violation|0|||
160956842|NCT00355082|581228132|FG002|Continuation Phase|Protocol Violation|1|||
160956843|NCT00355082|581228130|FG000|Continuation Phase|Withdrawal by Subject|4|||
160956844|NCT00355082|581228131|FG001|Continuation Phase|Withdrawal by Subject|0|||
160956845|NCT00355082|581228132|FG002|Continuation Phase|Withdrawal by Subject|0|||
160956846|NCT00355082|581228130|FG000|Continuation Phase|Lack of Efficacy|5|||
160956847|NCT00355082|581228131|FG001|Continuation Phase|Lack of Efficacy|0|||
160956848|NCT00355082|581228132|FG002|Continuation Phase|Lack of Efficacy|0|||
160956849|NCT00355082|581228130|FG000|Continuation Phase|Site Closed by Sponsor|8|||
160956850|NCT00355082|581228131|FG001|Continuation Phase|Site Closed by Sponsor|0|||
160956851|NCT00355082|581228132|FG002|Continuation Phase|Site Closed by Sponsor|0|||
160956852|NCT00355082|581228130|FG000|Continuation Phase|Scheduling Error|1|||
160956853|NCT00355082|581228131|FG001|Continuation Phase|Scheduling Error|0|||
160956854|NCT00355082|581228132|FG002|Continuation Phase|Scheduling Error|0|||
160956855|NCT00355082|581228130|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
160956856|NCT00355082|581228131|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
160956857|NCT00355082|581228132|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
160956858|NCT00622167|581228133|FG000|Overall Study|Did not meet angiographic criteria|20|||
160956859|NCT03738150|581228142|FG000|Base Study|Withdrawal by Subject|1|||
160956860|NCT03738150|581228142|FG000|Extension Study|Withdrawal by Subject|1|||
160956861|NCT04598152|581228145|FG000|Overall Study|Lost to Follow-up|0|||
160956862|NCT04598152|581228146|FG001|Overall Study|Lost to Follow-up|1|||
160956863|NCT03346759|581228147|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
160956864|NCT03346759|581228148|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
160956865|NCT03346759|581228147|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
160956866|NCT03346759|581228148|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
161146497|NCT00393458|581918496|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
160956867|NCT03346759|581228147|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
160956868|NCT03346759|581228148|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
160956869|NCT03943095|581228149|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
160956870|NCT03943095|581228150|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
160956871|NCT03943095|581228149|FG000|Overall Study|Withdrawal by Subject|1|||
160956872|NCT03943095|581228150|FG001|Overall Study|Withdrawal by Subject|0|||
160956873|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
160956874|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
160956875|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
160956876|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160956877|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160956878|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
160956879|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956880|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956881|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
160956882|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956883|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956884|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
160956885|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
160956886|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
160956887|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956888|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956889|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956890|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
160956891|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
160956892|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
160956893|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
160956894|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160956895|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160956896|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
160956897|NCT04988308|581228151|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
160956898|NCT04988308|581228152|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
160956899|NCT04988308|581228153|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
160956900|NCT04988308|581228154|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
160956901|NCT04988308|581228155|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
160956902|NCT04988308|581228156|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
160956903|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160956904|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160956905|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
160956906|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
160956907|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
160956908|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
160956909|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160956910|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160956911|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
160956912|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
160956913|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
160956914|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
160956915|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160956916|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160956917|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
160956918|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
160956919|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
160956920|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
160956921|NCT04988308|581228151|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
160956922|NCT04988308|581228152|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
160956923|NCT04988308|581228153|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
160956924|NCT04988308|581228154|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
160956925|NCT04988308|581228155|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
160956926|NCT04988308|581228156|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
160956927|NCT04177758|581228166|FG000|Overall Study|Lost to Follow-up|19|||
160956928|NCT04177758|581228167|FG001|Overall Study|Lost to Follow-up|11|||
161343451|NCT05452239|582644389|FG001|Placebo-controlled Period|Randomized but not treated|2|||
161343452|NCT05452239|582644388|FG000|Placebo-controlled Period|Other than specified|1|||
161343453|NCT05452239|582644389|FG001|Placebo-controlled Period|Other than specified|1|||
160956929|NCT02763384|581228168|FG000|Overall Study|Physician Decision|1|||
160956930|NCT02763384|581228168|FG000|Overall Study|Rapid decline - went on hospice|1|||
160956931|NCT02057874|581230284|FG000|Overall Study|participant did not return for scan|1|||
160956932|NCT01738984|581230287|FG000|Overall Study|Pregnancy|4|||
160956933|NCT01738984|581230288|FG001|Overall Study|Pregnancy|0|||
160956934|NCT01738984|581230287|FG000|Overall Study|Withdrawal by Subject|1|||
160956935|NCT01738984|581230288|FG001|Overall Study|Withdrawal by Subject|0|||
160956936|NCT01738984|581230287|FG000|Overall Study|Lost to Follow-up|59|||
160956937|NCT01738984|581230288|FG001|Overall Study|Lost to Follow-up|39|||
160956938|NCT02621931|581230293|FG000|Overall Study|Death|0|||
160956939|NCT02621931|581230294|FG001|Overall Study|Death|1|||
160956940|NCT02621931|581230295|FG002|Overall Study|Death|0|||
160956941|NCT02621931|581230293|FG000|Overall Study|Adverse Event|8|||
160956942|NCT02621931|581230294|FG001|Overall Study|Adverse Event|5|||
160956943|NCT02621931|581230295|FG002|Overall Study|Adverse Event|7|||
160956944|NCT02621931|581230293|FG000|Overall Study|Withdrawal by Subject|12|||
160956945|NCT02621931|581230294|FG001|Overall Study|Withdrawal by Subject|10|||
160956946|NCT02621931|581230295|FG002|Overall Study|Withdrawal by Subject|11|||
160956947|NCT02621931|581230293|FG000|Overall Study|Protocol Violation|2|||
160956948|NCT02621931|581230294|FG001|Overall Study|Protocol Violation|2|||
160956949|NCT02621931|581230295|FG002|Overall Study|Protocol Violation|2|||
160956950|NCT02621931|581230293|FG000|Overall Study|Pregnancy|2|||
160956951|NCT02621931|581230294|FG001|Overall Study|Pregnancy|0|||
160956952|NCT02621931|581230295|FG002|Overall Study|Pregnancy|0|||
160956953|NCT02621931|581230293|FG000|Overall Study|Noncompliance to study procedures|0|||
160956954|NCT02621931|581230294|FG001|Overall Study|Noncompliance to study procedures|1|||
160956955|NCT02621931|581230295|FG002|Overall Study|Noncompliance to study procedures|2|||
160956956|NCT02621931|581230293|FG000|Overall Study|Lost to Follow-up|8|||
160956957|NCT02621931|581230294|FG001|Overall Study|Lost to Follow-up|7|||
160956958|NCT02621931|581230295|FG002|Overall Study|Lost to Follow-up|10|||
160956959|NCT02621931|581230293|FG000|Overall Study|Lack of Efficacy|0|||
160956960|NCT02621931|581230294|FG001|Overall Study|Lack of Efficacy|0|||
160956961|NCT02621931|581230295|FG002|Overall Study|Lack of Efficacy|1|||
160956962|NCT02621931|581230293|FG000|Overall Study|Other|1|||
160956963|NCT02621931|581230294|FG001|Overall Study|Other|1|||
160956964|NCT02621931|581230295|FG002|Overall Study|Other|3|||
160956965|NCT00920426|581230296|FG000|ITZ111451|Adverse Event|1|||
160956966|NCT00920426|581230297|FG001|ITZ111451|Adverse Event|0|||
160956967|NCT00920426|581230298|FG002|ITZ111451|Adverse Event|0|||
160956968|NCT00920426|581230299|FG003|ITZ111451|Adverse Event|0|||
160956969|NCT00886340|581230301|FG000|Overall Study|Withdrawal by Subject|0|||
160956970|NCT00886340|581230302|FG001|Overall Study|Withdrawal by Subject|7|||
160956971|NCT02985866|581230303|FG000|Overall Study|Poor CGM data|1|||
160956972|NCT02985866|581230304|FG001|Overall Study|Poor CGM data|1|||
160956973|NCT02925455|581230308|FG000|Overall Study|Withdrawal by Subject|2|||
160956974|NCT02925455|581230309|FG001|Overall Study|Withdrawal by Subject|0|||
160956975|NCT00985725|581230313|FG000|Overall Study|Adverse Event|4|||
160956976|NCT00985725|581230314|FG001|Overall Study|Adverse Event|1|||
160956977|NCT00985725|581230313|FG000|Overall Study|Protocol Violation|1|||
160956978|NCT00985725|581230314|FG001|Overall Study|Protocol Violation|3|||
160956979|NCT00985725|581230313|FG000|Overall Study|Withdrawal by Subject|4|||
160956980|NCT00985725|581230314|FG001|Overall Study|Withdrawal by Subject|4|||
160956981|NCT00985725|581230313|FG000|Overall Study|Lost to Follow-up|1|||
160956982|NCT00985725|581230314|FG001|Overall Study|Lost to Follow-up|1|||
160956983|NCT00985725|581230313|FG000|Overall Study|Lack of Efficacy|0|||
160956984|NCT00985725|581230314|FG001|Overall Study|Lack of Efficacy|1|||
160956985|NCT00985725|581230313|FG000|Overall Study|Non-compliance|1|||
160956986|NCT00985725|581230314|FG001|Overall Study|Non-compliance|2|||
160956987|NCT00985725|581230313|FG000|Overall Study|Out-of-window visits|0|||
160956988|NCT00985725|581230314|FG001|Overall Study|Out-of-window visits|1|||
160956989|NCT03151005|581230318|FG000|Overall Study|Lost to Follow-up|5|||
160956990|NCT03151005|581230319|FG001|Overall Study|Lost to Follow-up|5|||
160956991|NCT01549613|581230320|FG000|Overall Study|Lost to Follow-up|11|||
160956992|NCT01549613|581230321|FG001|Overall Study|Lost to Follow-up|11|||
161146498|NCT00393458|581918497|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
161146499|NCT00393458|581918494|FG000|Overall Study|Protocol deviation|11|||
160956993|NCT02131272|581230322|FG000|Overall Study|Withdrawal by parent|0|||
160956994|NCT02131272|581230323|FG001|Overall Study|Withdrawal by parent|1|||
160956995|NCT02131272|581230322|FG000|Overall Study|Withdrawal by Subject|0|||
160956996|NCT02131272|581230323|FG001|Overall Study|Withdrawal by Subject|1|||
160956997|NCT02131272|581230322|FG000|Overall Study|Withdrawal Criteria|1|||
160956998|NCT02131272|581230323|FG001|Overall Study|Withdrawal Criteria|0|||
160956999|NCT00381940|581230324|FG000|Overall Study|Lack of Efficacy|3|||
160957000|NCT00381940|581230324|FG000|Overall Study|Protocol Violation|1|||
160957001|NCT00381940|581230324|FG000|Overall Study|Ineligible|1|||
160957002|NCT00464815|581230325|FG000|Overall Study|Withdrawal by Subject|6|||
160957003|NCT00464815|581230326|FG001|Overall Study|Withdrawal by Subject|3|||
160957004|NCT00515502|581230334|FG000|Treatment Period 1|Adverse Event|0|||
160957005|NCT00515502|581230335|FG001|Treatment Period 1|Adverse Event|0|||
160957006|NCT00515502|581230336|FG002|Treatment Period 1|Adverse Event|0|||
160957007|NCT00515502|581230337|FG003|Treatment Period 1|Adverse Event|0|||
160957008|NCT00515502|581230338|FG004|Treatment Period 1|Adverse Event|0|||
160957009|NCT00515502|581230339|FG005|Treatment Period 1|Adverse Event|0|||
160957010|NCT00515502|581230340|FG006|Treatment Period 1|Adverse Event|1|||
160957011|NCT00515502|581230341|FG007|Treatment Period 1|Adverse Event|0|||
160957012|NCT00515502|581230342|FG008|Treatment Period 1|Adverse Event|1|||
160957013|NCT00515502|581230343|FG009|Treatment Period 1|Adverse Event|0|||
160957014|NCT00515502|581230344|FG010|Treatment Period 1|Adverse Event|0|||
160957015|NCT00515502|581230345|FG011|Treatment Period 1|Adverse Event|1|||
160957016|NCT00515502|581230334|FG000|Treatment Period 2|Adverse Event|0|||
160957017|NCT00515502|581230335|FG001|Treatment Period 2|Adverse Event|1|||
160957018|NCT00515502|581230336|FG002|Treatment Period 2|Adverse Event|0|||
160957019|NCT00515502|581230337|FG003|Treatment Period 2|Adverse Event|0|||
160957020|NCT00515502|581230338|FG004|Treatment Period 2|Adverse Event|0|||
160957021|NCT00515502|581230339|FG005|Treatment Period 2|Adverse Event|0|||
160957022|NCT00515502|581230340|FG006|Treatment Period 2|Adverse Event|0|||
160957023|NCT00515502|581230341|FG007|Treatment Period 2|Adverse Event|0|||
160957024|NCT00515502|581230342|FG008|Treatment Period 2|Adverse Event|0|||
160957025|NCT00515502|581230343|FG009|Treatment Period 2|Adverse Event|0|||
160957026|NCT00515502|581230344|FG010|Treatment Period 2|Adverse Event|0|||
160957027|NCT00515502|581230345|FG011|Treatment Period 2|Adverse Event|0|||
160957028|NCT03252587|581230346|FG000|Overall Study|Adverse Event|3|||
160957029|NCT03252587|581230347|FG001|Overall Study|Adverse Event|8|||
160957030|NCT03252587|581230348|FG002|Overall Study|Adverse Event|6|||
160957031|NCT03252587|581230349|FG003|Overall Study|Adverse Event|12|||
160957032|NCT03252587|581230346|FG000|Overall Study|Lack of Efficacy|7|||
160957033|NCT03252587|581230347|FG001|Overall Study|Lack of Efficacy|2|||
160957034|NCT03252587|581230348|FG002|Overall Study|Lack of Efficacy|2|||
160957035|NCT03252587|581230349|FG003|Overall Study|Lack of Efficacy|4|||
160957036|NCT03252587|581230346|FG000|Overall Study|Lost to Follow-up|2|||
160957037|NCT03252587|581230347|FG001|Overall Study|Lost to Follow-up|0|||
160957038|NCT03252587|581230348|FG002|Overall Study|Lost to Follow-up|0|||
160957039|NCT03252587|581230349|FG003|Overall Study|Lost to Follow-up|2|||
160957040|NCT03252587|581230346|FG000|Overall Study|Pregnancy|2|||
160957041|NCT03252587|581230347|FG001|Overall Study|Pregnancy|1|||
160957042|NCT03252587|581230348|FG002|Overall Study|Pregnancy|0|||
160957043|NCT03252587|581230349|FG003|Overall Study|Pregnancy|1|||
160957044|NCT03252587|581230346|FG000|Overall Study|Withdrawal by Subject|8|||
160957045|NCT03252587|581230347|FG001|Overall Study|Withdrawal by Subject|4|||
160957046|NCT03252587|581230348|FG002|Overall Study|Withdrawal by Subject|4|||
160957047|NCT03252587|581230349|FG003|Overall Study|Withdrawal by Subject|4|||
160957048|NCT03252587|581230346|FG000|Overall Study|Other Reasons|2|||
160957049|NCT03252587|581230347|FG001|Overall Study|Other Reasons|5|||
160957050|NCT03252587|581230348|FG002|Overall Study|Other Reasons|5|||
160957051|NCT03252587|581230349|FG003|Overall Study|Other Reasons|4|||
160957052|NCT04052204|581230350|FG000|Overall Study|Death|1|||
160957053|NCT04052204|581230351|FG001|Overall Study|Death|0|||
160957054|NCT04052204|581230352|FG002|Overall Study|Death|0|||
160957055|NCT04052204|581230350|FG000|Overall Study|Progressive disease|1|||
160957056|NCT04052204|581230351|FG001|Overall Study|Progressive disease|0|||
160957057|NCT04052204|581230352|FG002|Overall Study|Progressive disease|0|||
160957058|NCT04052204|581230350|FG000|Overall Study|Other|1|||
160957059|NCT04052204|581230351|FG001|Overall Study|Other|0|||
160957060|NCT04052204|581230352|FG002|Overall Study|Other|0|||
160957061|NCT03647501|581230353|FG000|Overall Study|Lost to Follow-up|1|||
160957062|NCT03647501|581230354|FG001|Overall Study|Lost to Follow-up|1|||
160957063|NCT03647501|581230353|FG000|Overall Study|Withdrawal by Subject|0|||
160957064|NCT03647501|581230354|FG001|Overall Study|Withdrawal by Subject|1|||
160957065|NCT03945188|581230355|FG000|Overall Study|Protocol Violation|1|||
161001421|NCT01317420|581390599|FG006|Overall Study|Progressive disease according to RECIST|3|||
161001422|NCT01317420|581390600|FG007|Overall Study|Progressive disease according to RECIST|3|||
161001423|NCT01317420|581390601|FG008|Overall Study|Progressive disease according to RECIST|3|||
161001424|NCT01317420|581390602|FG009|Overall Study|Progressive disease according to RECIST|2|||
161001425|NCT01317420|581390603|FG010|Overall Study|Progressive disease according to RECIST|3|||
161269246|NCT01791153|582366965|FG004|Part 2: Open-label Period|Physician Decision|1|||
160957066|NCT03945188|581230356|FG001|Overall Study|Protocol Violation|0|||
160957067|NCT03945188|581230355|FG000|Overall Study|Disease worsening|79|||
160957068|NCT03945188|581230356|FG001|Overall Study|Disease worsening|73|||
160957069|NCT03945188|581230355|FG000|Overall Study|Physician Decision|2|||
160957070|NCT03945188|581230356|FG001|Overall Study|Physician Decision|2|||
160957071|NCT03945188|581230355|FG000|Overall Study|Lack of Efficacy|7|||
160957072|NCT03945188|581230356|FG001|Overall Study|Lack of Efficacy|4|||
160957073|NCT03945188|581230355|FG000|Overall Study|Pregnancy|2|||
160957074|NCT03945188|581230356|FG001|Overall Study|Pregnancy|0|||
160957075|NCT03945188|581230355|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
160957076|NCT03945188|581230356|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
160957077|NCT03945188|581230355|FG000|Overall Study|Adverse Event|10|||
160957078|NCT03945188|581230356|FG001|Overall Study|Adverse Event|5|||
160957079|NCT03945188|581230355|FG000|Overall Study|Other|2|||
160957080|NCT03945188|581230356|FG001|Overall Study|Other|2|||
160957081|NCT03945188|581230355|FG000|Overall Study|Lost to Follow-up|1|||
160957082|NCT03945188|581230356|FG001|Overall Study|Lost to Follow-up|2|||
160957083|NCT01613248|581230357|FG000|Overall Study|Adverse Event|0|||
160957084|NCT01613248|581230358|FG001|Overall Study|Adverse Event|0|||
160957085|NCT01613248|581230359|FG002|Overall Study|Adverse Event|0|||
160957086|NCT01613248|581230360|FG003|Overall Study|Adverse Event|1|||
160957087|NCT01613248|581230361|FG004|Overall Study|Adverse Event|0|||
160957088|NCT01613248|581230362|FG005|Overall Study|Adverse Event|0|||
160957089|NCT01613248|581230357|FG000|Overall Study|Withdrawal by Subject|3|||
160957090|NCT01613248|581230358|FG001|Overall Study|Withdrawal by Subject|2|||
160957091|NCT01613248|581230359|FG002|Overall Study|Withdrawal by Subject|2|||
160957092|NCT01613248|581230360|FG003|Overall Study|Withdrawal by Subject|5|||
160957093|NCT01613248|581230361|FG004|Overall Study|Withdrawal by Subject|0|||
160957094|NCT01613248|581230362|FG005|Overall Study|Withdrawal by Subject|1|||
160957095|NCT01613248|581230357|FG000|Overall Study|Lost to Follow-up|5|||
160957096|NCT01613248|581230358|FG001|Overall Study|Lost to Follow-up|7|||
160957097|NCT01613248|581230359|FG002|Overall Study|Lost to Follow-up|4|||
160957098|NCT01613248|581230360|FG003|Overall Study|Lost to Follow-up|8|||
160957099|NCT01613248|581230361|FG004|Overall Study|Lost to Follow-up|4|||
160957100|NCT01613248|581230362|FG005|Overall Study|Lost to Follow-up|2|||
160957101|NCT01613248|581230357|FG000|Overall Study|Study Terminated by Sponsor|4|||
160957102|NCT01613248|581230358|FG001|Overall Study|Study Terminated by Sponsor|6|||
160957103|NCT01613248|581230359|FG002|Overall Study|Study Terminated by Sponsor|8|||
160957104|NCT01613248|581230360|FG003|Overall Study|Study Terminated by Sponsor|8|||
160957105|NCT01613248|581230361|FG004|Overall Study|Study Terminated by Sponsor|9|||
160957106|NCT01613248|581230362|FG005|Overall Study|Study Terminated by Sponsor|11|||
160957107|NCT01613248|581230357|FG000|Overall Study|Physician Decision|8|||
160957108|NCT01613248|581230358|FG001|Overall Study|Physician Decision|8|||
160957109|NCT01613248|581230359|FG002|Overall Study|Physician Decision|9|||
160957110|NCT01613248|581230360|FG003|Overall Study|Physician Decision|4|||
160957111|NCT01613248|581230361|FG004|Overall Study|Physician Decision|7|||
160957112|NCT01613248|581230362|FG005|Overall Study|Physician Decision|6|||
160957113|NCT01613248|581230357|FG000|Overall Study|Lack of Qualifying Event|9|||
160957114|NCT01613248|581230358|FG001|Overall Study|Lack of Qualifying Event|11|||
160957115|NCT01613248|581230359|FG002|Overall Study|Lack of Qualifying Event|10|||
160957116|NCT01613248|581230360|FG003|Overall Study|Lack of Qualifying Event|11|||
160957117|NCT01613248|581230361|FG004|Overall Study|Lack of Qualifying Event|15|||
160957118|NCT01613248|581230362|FG005|Overall Study|Lack of Qualifying Event|18|||
160957119|NCT01613248|581230357|FG000|Overall Study|Pregnancy|0|||
160957120|NCT01613248|581230358|FG001|Overall Study|Pregnancy|0|||
160957121|NCT01613248|581230359|FG002|Overall Study|Pregnancy|0|||
160957122|NCT01613248|581230360|FG003|Overall Study|Pregnancy|1|||
160957123|NCT01613248|581230361|FG004|Overall Study|Pregnancy|0|||
160957124|NCT01613248|581230362|FG005|Overall Study|Pregnancy|0|||
160957125|NCT01433354|581230364|FG000|Overall Study|Adverse Event|6|||
160957126|NCT01433354|581230364|FG000|Overall Study|Lost to Follow-up|1|||
160957127|NCT01433354|581230364|FG000|Overall Study|Administrative problems|90|||
160957128|NCT01433354|581230364|FG000|Overall Study|Protocol Violation|2|||
160957129|NCT01433354|581230364|FG000|Overall Study|Lack of Efficacy|17|||
160957130|NCT01433354|581230364|FG000|Overall Study|Subject Withdrew Consent|3|||
160957131|NCT03321396|581230373|FG000|Overall Study|Physician Decision|1|||
160957132|NCT04391023|581230376|FG000|Overall Study|Withdrawal by Subject|2|||
160957133|NCT04391023|581230377|FG001|Overall Study|Withdrawal by Subject|2|||
160957134|NCT01270347|581230379|FG000|Core Phase|Adverse Event|1|||
160957135|NCT01270347|581230380|FG001|Core Phase|Adverse Event|6|||
160957136|NCT01270347|581230379|FG000|Core Phase|Withdrawal by Subject|1|||
160957137|NCT01270347|581230380|FG001|Core Phase|Withdrawal by Subject|2|||
160957138|NCT01270347|581230379|FG000|Core Phase|Lost to Follow-up|0|||
160957139|NCT01270347|581230380|FG001|Core Phase|Lost to Follow-up|1|||
160957140|NCT01270347|581230379|FG000|Core Phase|Miscellaneous|8|||
160957141|NCT01270347|581230380|FG001|Core Phase|Miscellaneous|14|||
160957142|NCT01270347|581230379|FG000|Extension Phase|Adverse Event|1|||
160957143|NCT01270347|581230380|FG001|Extension Phase|Adverse Event|3|||
160957144|NCT01270347|581230379|FG000|Extension Phase|Withdrawal by Subject|3|||
160957145|NCT01270347|581230380|FG001|Extension Phase|Withdrawal by Subject|4|||
160957146|NCT01270347|581230379|FG000|Extension Phase|Miscellaneous|2|||
161001426|NCT01317420|581390604|FG011|Overall Study|Progressive disease according to RECIST|11|||
161001427|NCT01317420|581390605|FG012|Overall Study|Progressive disease according to RECIST|16|||
160957147|NCT01270347|581230380|FG001|Extension Phase|Miscellaneous|2|||
160957148|NCT00492284|581230381|FG000|Overall Study|Adverse Event|0|||
160957149|NCT00492284|581230382|FG001|Overall Study|Adverse Event|1|||
160957150|NCT00492284|581230383|FG002|Overall Study|Adverse Event|1|||
160957151|NCT00492284|581230384|FG003|Overall Study|Adverse Event|2|||
160957152|NCT00492284|581230381|FG000|Overall Study|Lost to Follow-up|0|||
160957153|NCT00492284|581230382|FG001|Overall Study|Lost to Follow-up|0|||
160957154|NCT00492284|581230383|FG002|Overall Study|Lost to Follow-up|3|||
160957155|NCT00492284|581230384|FG003|Overall Study|Lost to Follow-up|1|||
160957156|NCT00492284|581230381|FG000|Overall Study|Death|0|||
160957157|NCT00492284|581230382|FG001|Overall Study|Death|3|||
160957158|NCT00492284|581230383|FG002|Overall Study|Death|2|||
160957159|NCT00492284|581230384|FG003|Overall Study|Death|5|||
160957160|NCT00492284|581230381|FG000|Overall Study|Withdrawal by Subject|1|||
160957161|NCT00492284|581230382|FG001|Overall Study|Withdrawal by Subject|0|||
160957162|NCT00492284|581230383|FG002|Overall Study|Withdrawal by Subject|0|||
160957163|NCT00492284|581230384|FG003|Overall Study|Withdrawal by Subject|2|||
160957164|NCT02576678|581230387|FG000|Overall Study|Adverse Event|0|||
160957165|NCT02576678|581230388|FG001|Overall Study|Adverse Event|0|||
160957166|NCT02576678|581230389|FG002|Overall Study|Adverse Event|2|||
160957167|NCT02576678|581230387|FG000|Overall Study|Withdrawal by Subject|3|||
160957168|NCT02576678|581230388|FG001|Overall Study|Withdrawal by Subject|1|||
160957169|NCT02576678|581230389|FG002|Overall Study|Withdrawal by Subject|2|||
160957170|NCT02576678|581230387|FG000|Overall Study|Lost to Follow-up|0|||
160957171|NCT02576678|581230388|FG001|Overall Study|Lost to Follow-up|0|||
160957172|NCT02576678|581230389|FG002|Overall Study|Lost to Follow-up|1|||
160957173|NCT02576678|581230387|FG000|Overall Study|Miscellaneous|2|||
160957174|NCT02576678|581230388|FG001|Overall Study|Miscellaneous|0|||
160957175|NCT02576678|581230389|FG002|Overall Study|Miscellaneous|0|||
160957176|NCT02293538|581230397|FG000|Overall Study|Adverse Event|0|||
160957177|NCT02293538|581230398|FG001|Overall Study|Adverse Event|1|||
160957178|NCT02293538|581230397|FG000|Overall Study|Lost to Follow-up|1|||
160957179|NCT02293538|581230398|FG001|Overall Study|Lost to Follow-up|0|||
160957180|NCT02293538|581230397|FG000|Overall Study|Withdrawal by Subject|0|||
160957181|NCT02293538|581230398|FG001|Overall Study|Withdrawal by Subject|1|||
160957182|NCT01041638|581230399|FG000|Overall Study|Adverse Event|4|||
160957183|NCT01041638|581230399|FG000|Overall Study|Death|1|||
160957184|NCT01041638|581230399|FG000|Overall Study|Lack of Efficacy|7|||
160957185|NCT01041638|581230399|FG000|Overall Study|Physician Decision|4|||
160957186|NCT01041638|581230399|FG000|Overall Study|Withdrawal by Subject|11|||
160957187|NCT01922076|581230401|FG000|Overall Study|Adverse Event|0|||
160957188|NCT01922076|581230402|FG001|Overall Study|Adverse Event|0|||
160957189|NCT01922076|581230403|FG002|Overall Study|Adverse Event|0|||
160957190|NCT01922076|581230404|FG003|Overall Study|Adverse Event|0|||
160957191|NCT01922076|581230405|FG004|Overall Study|Adverse Event|1|||
160957192|NCT01922076|581230406|FG005|Overall Study|Adverse Event|0|||
160957193|NCT01922076|581230407|FG006|Overall Study|Adverse Event|0|||
160957194|NCT01922076|581230401|FG000|Overall Study|Physician Decision|0|||
160957195|NCT01922076|581230402|FG001|Overall Study|Physician Decision|0|||
160957196|NCT01922076|581230403|FG002|Overall Study|Physician Decision|1|||
160957197|NCT01922076|581230404|FG003|Overall Study|Physician Decision|0|||
160957198|NCT01922076|581230405|FG004|Overall Study|Physician Decision|0|||
160957199|NCT01922076|581230406|FG005|Overall Study|Physician Decision|0|||
160957200|NCT01922076|581230407|FG006|Overall Study|Physician Decision|0|||
160957201|NCT01922076|581230401|FG000|Overall Study|Withdrawal by Subject|0|||
160957202|NCT01922076|581230402|FG001|Overall Study|Withdrawal by Subject|0|||
160957203|NCT01922076|581230403|FG002|Overall Study|Withdrawal by Subject|0|||
160957204|NCT01922076|581230404|FG003|Overall Study|Withdrawal by Subject|1|||
160957205|NCT01922076|581230405|FG004|Overall Study|Withdrawal by Subject|0|||
160957206|NCT01922076|581230406|FG005|Overall Study|Withdrawal by Subject|1|||
160957207|NCT01922076|581230407|FG006|Overall Study|Withdrawal by Subject|1|||
160957208|NCT00683644|581230413|FG000|Overall Study|Withdrawal by Subject|4|||
160957209|NCT00683644|581230414|FG001|Overall Study|Withdrawal by Subject|2|||
160957210|NCT00683644|581230413|FG000|Overall Study|Lost to Follow-up|1|||
160957211|NCT00683644|581230414|FG001|Overall Study|Lost to Follow-up|4|||
160957212|NCT00683644|581230413|FG000|Overall Study|Adverse Event|1|||
160957213|NCT00683644|581230414|FG001|Overall Study|Adverse Event|2|||
160957214|NCT00683644|581230413|FG000|Overall Study|Low copper, other health problems,|7|||
160957215|NCT00683644|581230414|FG001|Overall Study|Low copper, other health problems,|6|||
160957216|NCT03240692|581230415|FG000|Overall Study|Physician Decision|1|||
160957217|NCT03240692|581230415|FG000|Overall Study|Withdrawal by Subject|1|||
160957218|NCT02576067|581230416|FG000|Overall Study|Death|0|||
161001428|NCT01317420|581390593|FG000|Overall Study|Other adverse event|1|||
161001429|NCT01317420|581390594|FG001|Overall Study|Other adverse event|0|||
160957219|NCT02576067|581230417|FG001|Overall Study|Death|1|||
160957220|NCT02576067|581230416|FG000|Overall Study|Lack of Efficacy|1|||
160957221|NCT02576067|581230417|FG001|Overall Study|Lack of Efficacy|0|||
160957222|NCT02576067|581230416|FG000|Overall Study|Lost to Follow-up|11|||
160957223|NCT02576067|581230417|FG001|Overall Study|Lost to Follow-up|0|||
160957224|NCT02576067|581230416|FG000|Overall Study|Withdrawal by Subject|11|||
160957225|NCT02576067|581230417|FG001|Overall Study|Withdrawal by Subject|2|||
160957226|NCT02576067|581230416|FG000|Overall Study|study closure of main CIRT trial)|0|||
161146500|NCT00393458|581918495|FG001|Overall Study|Protocol deviation|11|||
160957227|NCT02576067|581230417|FG001|Overall Study|study closure of main CIRT trial)|8|||
160957228|NCT02576067|581230416|FG000|Overall Study|not randomized, failed run-in|7|||
160957229|NCT02576067|581230417|FG001|Overall Study|not randomized, failed run-in|0|||
160957230|NCT02576067|581230416|FG000|Overall Study|screen failure/ re-enrolled|0|||
160957231|NCT02576067|581230417|FG001|Overall Study|screen failure/ re-enrolled|25|||
160957232|NCT02576067|581230416|FG000|Overall Study|Physician Decision|4|||
161001430|NCT01317420|581390595|FG002|Overall Study|Other adverse event|0|||
161001431|NCT01317420|581390596|FG003|Overall Study|Other adverse event|0|||
160957233|NCT02576067|581230417|FG001|Overall Study|Physician Decision|0|||
160957234|NCT04084314|581230418|FG000|Overall Study|Subject/guardian decision|91|||
160957235|NCT04084314|581230418|FG000|Overall Study|Adverse Event|24|||
160957236|NCT04084314|581230418|FG000|Overall Study|Lost to Follow-up|19|||
160957237|NCT04084314|581230418|FG000|Overall Study|New therapy for study indication|9|||
160957238|NCT04084314|581230418|FG000|Overall Study|Pregnancy|9|||
160957239|NCT04084314|581230418|FG000|Overall Study|Withdrawal of informed consent|8|||
160957240|NCT04084314|581230418|FG000|Overall Study|Physician Decision|4|||
160957241|NCT04084314|581230418|FG000|Overall Study|Protocol Deviation|3|||
160957242|NCT01300546|581230419|FG000|Overall Study|Withdrawal by Subject|1|||
160957243|NCT01300546|581230420|FG001|Overall Study|Withdrawal by Subject|0|||
160957244|NCT01300546|581230419|FG000|Overall Study|Lost to Follow-up|0|||
160957245|NCT01300546|581230420|FG001|Overall Study|Lost to Follow-up|2|||
160957246|NCT01300546|581230419|FG000|Overall Study|Lack of Efficacy|0|||
160957247|NCT01300546|581230420|FG001|Overall Study|Lack of Efficacy|3|||
160957248|NCT01300546|581230419|FG000|Overall Study|Adverse Event|0|||
160957249|NCT01300546|581230420|FG001|Overall Study|Adverse Event|1|||
160957250|NCT05207813|581230423|FG000|Overall Study|Lost to Follow-up|2|||
160957251|NCT01954017|581230424|FG000|Overall Study|Adverse Event|0|||
160957252|NCT01954017|581230425|FG001|Overall Study|Adverse Event|0|||
160957253|NCT01954017|581230426|FG002|Overall Study|Adverse Event|1|||
160957254|NCT01954017|581230424|FG000|Overall Study|Death|2|||
160957255|NCT01954017|581230425|FG001|Overall Study|Death|1|||
160957256|NCT01954017|581230426|FG002|Overall Study|Death|1|||
160957257|NCT01954017|581230424|FG000|Overall Study|Withdrawal by Subject|0|||
160957258|NCT01954017|581230425|FG001|Overall Study|Withdrawal by Subject|1|||
161269247|NCT01791153|582366966|FG005|Part 2: Open-label Period|Physician Decision|1|||
160957259|NCT01954017|581230426|FG002|Overall Study|Withdrawal by Subject|0|||
160957260|NCT01954017|581230424|FG000|Overall Study|Protocol Violation|0|||
160957261|NCT01954017|581230425|FG001|Overall Study|Protocol Violation|3|||
160957262|NCT01954017|581230426|FG002|Overall Study|Protocol Violation|2|||
160957263|NCT01954017|581230424|FG000|Overall Study|Necrotizing enterocolitis|1|||
160957264|NCT01954017|581230425|FG001|Overall Study|Necrotizing enterocolitis|0|||
160957265|NCT01954017|581230426|FG002|Overall Study|Necrotizing enterocolitis|1|||
160957266|NCT01954017|581230424|FG000|Overall Study|Enteral intake stopped >7 days|0|||
160957267|NCT01954017|581230425|FG001|Overall Study|Enteral intake stopped >7 days|1|||
160957268|NCT01954017|581230426|FG002|Overall Study|Enteral intake stopped >7 days|1|||
160957269|NCT01954017|581230424|FG000|Overall Study|All other reasons|2|||
160957270|NCT01954017|581230425|FG001|Overall Study|All other reasons|2|||
160957271|NCT01954017|581230426|FG002|Overall Study|All other reasons|7|||
160957272|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
160957273|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
160957274|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
160957275|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
161001432|NCT01317420|581390597|FG004|Overall Study|Other adverse event|0|||
161001433|NCT01317420|581390598|FG005|Overall Study|Other adverse event|0|||
161001434|NCT01317420|581390599|FG006|Overall Study|Other adverse event|0|||
161001435|NCT01317420|581390600|FG007|Overall Study|Other adverse event|0|||
161001436|NCT01317420|581390601|FG008|Overall Study|Other adverse event|0|||
161001437|NCT01317420|581390602|FG009|Overall Study|Other adverse event|0|||
161001438|NCT01317420|581390603|FG010|Overall Study|Other adverse event|0|||
161001439|NCT01317420|581390604|FG011|Overall Study|Other adverse event|0|||
161001440|NCT01317420|581390605|FG012|Overall Study|Other adverse event|2|||
161269248|NCT01791153|582366967|FG006|Part 2: Open-label Period|Physician Decision|0|||
161269249|NCT01791153|582366968|FG007|Part 2: Open-label Period|Physician Decision|0|||
160957276|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
160957277|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
160957278|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
160957279|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
160957280|NCT00679939|581230431|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
160957281|NCT00679939|581230432|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
160957282|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
160957283|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
160957284|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
160957285|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
160957286|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
160957287|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
160957288|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
160957289|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
160957290|NCT00679939|581230431|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
160957291|NCT00679939|581230432|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
160957292|NCT04657211|581230435|FG000|Overall Study|Withdrawal by Subject|21|||
161001441|NCT01317420|581390593|FG000|Overall Study|Non-compliant with protocol|0|||
161001442|NCT01317420|581390594|FG001|Overall Study|Non-compliant with protocol|0|||
161001443|NCT01317420|581390595|FG002|Overall Study|Non-compliant with protocol|0|||
160957293|NCT04657211|581230435|FG000|Overall Study|Lost to Follow-up|113|||
160957294|NCT04657211|581230435|FG000|Overall Study|Death|47|||
160957295|NCT04657211|581230435|FG000|Overall Study|Transfer to another institution|21|||
160957296|NCT04657211|581230435|FG000|Overall Study|Other|29|||
160957297|NCT06273774|581230436|FG000|Overall Study|Participant was out of state.|0|||
160957298|NCT06273774|581230437|FG001|Overall Study|Participant was out of state.|0|||
160957299|NCT06273774|581230438|FG002|Overall Study|Participant was out of state.|0|||
160957300|NCT06273774|581230439|FG003|Overall Study|Participant was out of state.|0|||
160957301|NCT06273774|581230440|FG004|Overall Study|Participant was out of state.|0|||
160957302|NCT06273774|581230441|FG005|Overall Study|Participant was out of state.|1|||
160957303|NCT06273774|581230436|FG000|Overall Study|Lost to Follow-up|0|||
160957304|NCT06273774|581230437|FG001|Overall Study|Lost to Follow-up|0|||
160957305|NCT06273774|581230438|FG002|Overall Study|Lost to Follow-up|0|||
160957306|NCT06273774|581230439|FG003|Overall Study|Lost to Follow-up|0|||
160957307|NCT06273774|581230440|FG004|Overall Study|Lost to Follow-up|1|||
160957308|NCT06273774|581230441|FG005|Overall Study|Lost to Follow-up|0|||
160957309|NCT00955357|581231947|FG000|Titration Phase|Adverse Event|9|||
160957310|NCT00955357|581231948|FG001|Titration Phase|Adverse Event|46|||
160957311|NCT00955357|581231947|FG000|Titration Phase|Lack of Efficacy|0|||
160957312|NCT00955357|581231948|FG001|Titration Phase|Lack of Efficacy|2|||
160957313|NCT00955357|581231947|FG000|Titration Phase|Protocol Violation|3|||
160957314|NCT00955357|581231948|FG001|Titration Phase|Protocol Violation|7|||
160957315|NCT00955357|581231947|FG000|Titration Phase|Lost to Follow-up|1|||
160957316|NCT00955357|581231948|FG001|Titration Phase|Lost to Follow-up|3|||
160957317|NCT00955357|581231947|FG000|Titration Phase|Withdrawal by Subject|3|||
160957318|NCT00955357|581231948|FG001|Titration Phase|Withdrawal by Subject|5|||
160957319|NCT00955357|581231947|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
160957320|NCT00955357|581231948|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
160957321|NCT00955357|581231947|FG000|Titration Phase|Study medication not tolerated|0|||
160957322|NCT00955357|581231948|FG001|Titration Phase|Study medication not tolerated|1|||
160957323|NCT00955357|581231947|FG000|Titration Phase|Non compliance to study procedures|0|||
160957324|NCT00955357|581231948|FG001|Titration Phase|Non compliance to study procedures|1|||
160957325|NCT00955357|581231947|FG000|Maintenance Phase|Adverse Event|3|||
160957326|NCT00955357|581231948|FG001|Maintenance Phase|Adverse Event|23|||
160957327|NCT00955357|581231947|FG000|Maintenance Phase|Lack of Efficacy|0|||
160957328|NCT00955357|581231948|FG001|Maintenance Phase|Lack of Efficacy|4|||
160957329|NCT00955357|581231947|FG000|Maintenance Phase|Protocol Violation|2|||
160957330|NCT00955357|581231948|FG001|Maintenance Phase|Protocol Violation|6|||
160957331|NCT00955357|581231947|FG000|Maintenance Phase|Lost to Follow-up|2|||
160957332|NCT00955357|581231948|FG001|Maintenance Phase|Lost to Follow-up|7|||
160957333|NCT00955357|581231947|FG000|Maintenance Phase|Withdrawal by Subject|4|||
160957334|NCT00955357|581231948|FG001|Maintenance Phase|Withdrawal by Subject|4|||
160957335|NCT00955357|581231947|FG000|Maintenance Phase|Patient moving out of area|0|||
160957336|NCT00955357|581231948|FG001|Maintenance Phase|Patient moving out of area|1|||
160957337|NCT00955357|581231947|FG000|Maintenance Phase|Non compliance to study procedures|1|||
160957338|NCT00955357|581231948|FG001|Maintenance Phase|Non compliance to study procedures|0|||
160957339|NCT02943408|581231949|FG000|Overall Study|Lost to Follow-up|7|||
160957340|NCT02943408|581231950|FG001|Overall Study|Lost to Follow-up|1|||
160957341|NCT02943408|581231949|FG000|Overall Study|Withdrawal by Subject|0|||
160957342|NCT02943408|581231950|FG001|Overall Study|Withdrawal by Subject|1|||
160957343|NCT03224182|581231951|FG000|Overall Study|Study Drug Not Instilled|6|||
160957344|NCT03224182|581231952|FG001|Overall Study|Study Drug Not Instilled|1|||
160957345|NCT03224182|581231951|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
160957346|NCT03224182|581231952|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
160957347|NCT03224182|581231951|FG000|Overall Study|Withdrew of Consent|4|||
161001444|NCT01317420|581390596|FG003|Overall Study|Non-compliant with protocol|0|||
161001445|NCT01317420|581390597|FG004|Overall Study|Non-compliant with protocol|0|||
161001446|NCT01317420|581390598|FG005|Overall Study|Non-compliant with protocol|0|||
161001447|NCT01317420|581390599|FG006|Overall Study|Non-compliant with protocol|0|||
161001448|NCT01317420|581390600|FG007|Overall Study|Non-compliant with protocol|0|||
161001449|NCT01317420|581390601|FG008|Overall Study|Non-compliant with protocol|0|||
161001450|NCT01317420|581390602|FG009|Overall Study|Non-compliant with protocol|0|||
161001451|NCT01317420|581390603|FG010|Overall Study|Non-compliant with protocol|0|||
160957348|NCT03224182|581231952|FG001|Overall Study|Withdrew of Consent|2|||
160957349|NCT03224182|581231951|FG000|Overall Study|Investigator Decision|3|||
160957350|NCT03224182|581231952|FG001|Overall Study|Investigator Decision|1|||
160957351|NCT03224182|581231951|FG000|Overall Study|Sponsor Decision|26|||
160957352|NCT03224182|581231952|FG001|Overall Study|Sponsor Decision|12|||
160957353|NCT03224182|581231951|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
160957354|NCT03224182|581231952|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
160957355|NCT03224182|581231951|FG000|Overall Study|Lost to Follow-up|1|||
160957356|NCT03224182|581231952|FG001|Overall Study|Lost to Follow-up|0|||
161001452|NCT01317420|581390604|FG011|Overall Study|Non-compliant with protocol|0|||
161001453|NCT01317420|581390605|FG012|Overall Study|Non-compliant with protocol|1|||
161146501|NCT00393458|581918496|FG002|Overall Study|Protocol deviation|11|||
161146502|NCT00393458|581918497|FG003|Overall Study|Protocol deviation|10|||
161146503|NCT00393458|581918494|FG000|Overall Study|Administrative problems|7|||
161146504|NCT00393458|581918495|FG001|Overall Study|Administrative problems|8|||
161146505|NCT00393458|581918496|FG002|Overall Study|Administrative problems|5|||
161146506|NCT00393458|581918497|FG003|Overall Study|Administrative problems|2|||
161146507|NCT00393458|581918494|FG000|Overall Study|Lost to Follow-up|5|||
161146508|NCT00393458|581918495|FG001|Overall Study|Lost to Follow-up|6|||
161146509|NCT00393458|581918496|FG002|Overall Study|Lost to Follow-up|5|||
161146510|NCT00393458|581918497|FG003|Overall Study|Lost to Follow-up|3|||
161146511|NCT00393458|581918494|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161146512|NCT00393458|581918495|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161146513|NCT00393458|581918496|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161146514|NCT00393458|581918497|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161146515|NCT00393458|581918494|FG000|Overall Study|Death|1|||
161146516|NCT00393458|581918495|FG001|Overall Study|Death|1|||
161146517|NCT00393458|581918496|FG002|Overall Study|Death|5|||
161146518|NCT00393458|581918497|FG003|Overall Study|Death|5|||
161146519|NCT00393458|581918494|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161146520|NCT00393458|581918495|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161146521|NCT00393458|581918496|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161146522|NCT00393458|581918497|FG003|Overall Study|Abnormal test procedure result(s)|2|||
161146523|NCT00393458|581918494|FG000|Overall Study|Subject no longer requires study drug|0|||
161146524|NCT00393458|581918495|FG001|Overall Study|Subject no longer requires study drug|1|||
161146525|NCT00393458|581918496|FG002|Overall Study|Subject no longer requires study drug|0|||
161146526|NCT00393458|581918497|FG003|Overall Study|Subject no longer requires study drug|0|||
161146527|NCT01282814|581918500|FG000|First Intervention|Emesis During Dosing Interval|0|||
161146528|NCT01282814|581918501|FG001|First Intervention|Emesis During Dosing Interval|3|||
161146529|NCT01282814|581918500|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
161146530|NCT01282814|581918501|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
161146531|NCT01524289|581918508|FG000|Overall Study|Lost to Follow-up|0|||
161146532|NCT01524289|581918509|FG001|Overall Study|Lost to Follow-up|1|||
161146533|NCT01524289|581918508|FG000|Overall Study|Physician Decision|1|||
161146534|NCT01524289|581918509|FG001|Overall Study|Physician Decision|0|||
161146535|NCT01524289|581918508|FG000|Overall Study|Protocol Violation|5|||
161146536|NCT01524289|581918509|FG001|Overall Study|Protocol Violation|1|||
161146537|NCT01524289|581918508|FG000|Overall Study|Withdrawal by Subject|11|||
161146538|NCT01524289|581918509|FG001|Overall Study|Withdrawal by Subject|7|||
161146539|NCT01524289|581918508|FG000|Overall Study|Adverse Event|12|||
161146540|NCT01524289|581918509|FG001|Overall Study|Adverse Event|5|||
161146541|NCT01524289|581918508|FG000|Overall Study|Did not take study medication|1|||
161146542|NCT01524289|581918509|FG001|Overall Study|Did not take study medication|0|||
161146543|NCT02704429|581918512|FG000|Part A: 24 Weeks|Adverse Event|3|||
161146544|NCT02704429|581918513|FG001|Part A: 24 Weeks|Adverse Event|0|||
160957357|NCT03224182|581231951|FG000|Overall Study|Participant Had Recurrence|11|||
160957358|NCT03224182|581231952|FG001|Overall Study|Participant Had Recurrence|5|||
160957359|NCT03224182|581231951|FG000|Overall Study|Death|0|||
160957360|NCT03224182|581231952|FG001|Overall Study|Death|1|||
160957361|NCT03224182|581231951|FG000|Overall Study|Reason not Specified|3|||
160957362|NCT03224182|581231952|FG001|Overall Study|Reason not Specified|3|||
160957363|NCT03224182|581231951|FG000|Overall Study|Other|1|||
160957364|NCT03224182|581231952|FG001|Overall Study|Other|0|||
160957365|NCT00643916|581231953|FG000|Overall Study|Protocol Violation|0|||
160957366|NCT00643916|581231954|FG001|Overall Study|Protocol Violation|1|||
160957367|NCT00643916|581231955|FG002|Overall Study|Protocol Violation|1|||
160957368|NCT00643916|581231956|FG003|Overall Study|Protocol Violation|1|||
160957369|NCT00643916|581231957|FG004|Overall Study|Protocol Violation|0|||
160957370|NCT00643916|581231958|FG005|Overall Study|Protocol Violation|0|||
160957371|NCT00643916|581231953|FG000|Overall Study|Lost to Follow-up|0|||
160957372|NCT00643916|581231954|FG001|Overall Study|Lost to Follow-up|1|||
160957373|NCT00643916|581231955|FG002|Overall Study|Lost to Follow-up|0|||
160957374|NCT00643916|581231956|FG003|Overall Study|Lost to Follow-up|0|||
161146545|NCT02704429|581918512|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
161146546|NCT02704429|581918513|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
161146547|NCT02519231|581918514|FG000|Overall Study|Lost to Follow-up|2|||
161146548|NCT02519231|581918515|FG001|Overall Study|Lost to Follow-up|5|||
161146549|NCT02519231|581918514|FG000|Overall Study|Withdrawal by Subject|0|||
161146550|NCT02519231|581918515|FG001|Overall Study|Withdrawal by Subject|1|||
161146551|NCT00104104|581918517|FG000|Overall Study|Adverse Event|8|||
161146552|NCT00104104|581918518|FG001|Overall Study|Adverse Event|8|||
161146553|NCT00104104|581918517|FG000|Overall Study|Abnormal laboratory value(s)|20|||
161146554|NCT00104104|581918518|FG001|Overall Study|Abnormal laboratory value(s)|14|||
161146555|NCT00104104|581918517|FG000|Overall Study|Lack of Efficacy|0|||
161146556|NCT00104104|581918518|FG001|Overall Study|Lack of Efficacy|3|||
161146557|NCT00104104|581918517|FG000|Overall Study|Condition no longer requires study drug|7|||
161146558|NCT00104104|581918518|FG001|Overall Study|Condition no longer requires study drug|4|||
160957375|NCT00643916|581231957|FG004|Overall Study|Lost to Follow-up|0|||
160957376|NCT00643916|581231958|FG005|Overall Study|Lost to Follow-up|0|||
160957377|NCT00643916|581231953|FG000|Overall Study|Withdrawal by Subject|2|||
160957378|NCT00643916|581231954|FG001|Overall Study|Withdrawal by Subject|2|||
160957379|NCT00643916|581231955|FG002|Overall Study|Withdrawal by Subject|2|||
160957380|NCT00643916|581231956|FG003|Overall Study|Withdrawal by Subject|1|||
160957381|NCT00643916|581231957|FG004|Overall Study|Withdrawal by Subject|0|||
160957382|NCT00643916|581231958|FG005|Overall Study|Withdrawal by Subject|1|||
160957383|NCT00643916|581231953|FG000|Overall Study|Not Vaccinated|2|||
160957384|NCT00643916|581231954|FG001|Overall Study|Not Vaccinated|2|||
160957385|NCT00643916|581231955|FG002|Overall Study|Not Vaccinated|3|||
160957386|NCT00643916|581231956|FG003|Overall Study|Not Vaccinated|0|||
160957387|NCT00643916|581231957|FG004|Overall Study|Not Vaccinated|2|||
160957388|NCT00643916|581231958|FG005|Overall Study|Not Vaccinated|0|||
160957389|NCT02184611|581231960|FG000|Overall Study|Lack of Efficacy|11|||
160957390|NCT02184611|581231961|FG001|Overall Study|Lack of Efficacy|15|||
160957391|NCT02184611|581231960|FG000|Overall Study|Withdrawal by Subject|5|||
160957392|NCT02184611|581231961|FG001|Overall Study|Withdrawal by Subject|6|||
160957393|NCT02184611|581231960|FG000|Overall Study|Adverse Event|4|||
160957394|NCT02184611|581231961|FG001|Overall Study|Adverse Event|5|||
160957395|NCT02184611|581231960|FG000|Overall Study|Protocol Violation|1|||
160957396|NCT02184611|581231961|FG001|Overall Study|Protocol Violation|1|||
160957397|NCT02184611|581231960|FG000|Overall Study|Protocol defined stopping criteria|0|||
160957398|NCT02184611|581231961|FG001|Overall Study|Protocol defined stopping criteria|1|||
160957399|NCT00686166|581231964|FG000|Overall Study|Adverse Event|7|||
160957400|NCT00686166|581231964|FG000|Overall Study|Withdrawal by Subject|1|||
160957401|NCT00686166|581231964|FG000|Overall Study|Progression/Relapse|1|||
160957402|NCT00686166|581231964|FG000|Overall Study|Death|1|||
160957403|NCT00686166|581231964|FG000|Overall Study|Not Protocol Specified|1|||
160957404|NCT00686166|581231964|FG000|Overall Study|Ineligible|5|||
160957405|NCT00686166|581231964|FG000|Overall Study|Did not begin protocol therapy|4|||
160957406|NCT01514448|581231965|FG000|Overall Study|Death|7|||
160957407|NCT01514448|581231966|FG001|Overall Study|Death|8|||
160957408|NCT01514448|581231965|FG000|Overall Study|Withdrawal by Subject|2|||
160957409|NCT01514448|581231966|FG001|Overall Study|Withdrawal by Subject|0|||
160957410|NCT01514448|581231965|FG000|Overall Study|Lost to Follow-up|2|||
160957411|NCT01514448|581231966|FG001|Overall Study|Lost to Follow-up|0|||
160957412|NCT01514448|581231965|FG000|Overall Study|New Cancer Therapy|1|||
160957413|NCT01514448|581231966|FG001|Overall Study|New Cancer Therapy|0|||
160957414|NCT02314624|581231967|FG000|Overall Study|No participating patient|16|||
160957415|NCT02314624|581231968|FG001|Overall Study|No participating patient|13|||
160957416|NCT02314624|581231967|FG000|Overall Study|Participant withdrew|7|||
160957417|NCT02314624|581231968|FG001|Overall Study|Participant withdrew|2|||
160957418|NCT02314624|581231967|FG000|Overall Study|Lost to Follow-up|2|||
160957419|NCT02314624|581231968|FG001|Overall Study|Lost to Follow-up|5|||
160957420|NCT02314624|581231967|FG000|Overall Study|Dropped/Excluded by PI|6|||
160957421|NCT02314624|581231968|FG001|Overall Study|Dropped/Excluded by PI|6|||
160957422|NCT03912259|581231969|FG000|Overall Study|Adverse Event (AE)|2|||
160957423|NCT03912259|581231970|FG001|Overall Study|Adverse Event (AE)|4|||
160957424|NCT03912259|581231969|FG000|Overall Study|Lack of Efficacy|4|||
160957425|NCT03912259|581231970|FG001|Overall Study|Lack of Efficacy|1|||
160957426|NCT03912259|581231969|FG000|Overall Study|Withdrawal by Subject|11|||
160957427|NCT03912259|581231970|FG001|Overall Study|Withdrawal by Subject|1|||
160957428|NCT05159622|581231973|FG000|Overall Study|Lost to Follow-up|4|||
160957429|NCT05159622|581231974|FG001|Overall Study|Lost to Follow-up|5|||
160957430|NCT02163733|581231975|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
160957431|NCT02163733|581231976|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
160957432|NCT02163733|581231977|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
160957433|NCT02163733|581231975|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
160957434|NCT02163733|581231976|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
160957435|NCT02163733|581231977|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
160957436|NCT02723864|581231978|FG000|Overall Study|Refused further treatment|1|||
160957437|NCT02723864|581231979|FG001|Overall Study|Refused further treatment|0|||
160957438|NCT02723864|581231980|FG002|Overall Study|Refused further treatment|0|||
160957439|NCT02723864|581231981|FG003|Overall Study|Refused further treatment|0|||
160957440|NCT02723864|581231982|FG004|Overall Study|Refused further treatment|1|||
160957441|NCT02723864|581231983|FG005|Overall Study|Refused further treatment|2|||
160957442|NCT02723864|581231984|FG006|Overall Study|Refused further treatment|0|||
160957443|NCT02723864|581231978|FG000|Overall Study|Exceed treatment hold time|0|||
160957444|NCT02723864|581231979|FG001|Overall Study|Exceed treatment hold time|1|||
160957445|NCT02723864|581231980|FG002|Overall Study|Exceed treatment hold time|0|||
160957446|NCT02723864|581231981|FG003|Overall Study|Exceed treatment hold time|0|||
160957447|NCT02723864|581231982|FG004|Overall Study|Exceed treatment hold time|0|||
160957448|NCT02723864|581231983|FG005|Overall Study|Exceed treatment hold time|0|||
160957449|NCT02723864|581231984|FG006|Overall Study|Exceed treatment hold time|0|||
160957450|NCT02723864|581231978|FG000|Overall Study|Clinical progression|0|||
160957451|NCT02723864|581231979|FG001|Overall Study|Clinical progression|0|||
160957452|NCT02723864|581231980|FG002|Overall Study|Clinical progression|1|||
160957453|NCT02723864|581231981|FG003|Overall Study|Clinical progression|0|||
160957454|NCT02723864|581231982|FG004|Overall Study|Clinical progression|0|||
160957455|NCT02723864|581231983|FG005|Overall Study|Clinical progression|3|||
160957456|NCT02723864|581231984|FG006|Overall Study|Clinical progression|1|||
160957457|NCT02723864|581231978|FG000|Overall Study|Physician Decision|0|||
160957458|NCT02723864|581231979|FG001|Overall Study|Physician Decision|0|||
160957459|NCT02723864|581231980|FG002|Overall Study|Physician Decision|0|||
160957460|NCT02723864|581231981|FG003|Overall Study|Physician Decision|0|||
160957461|NCT02723864|581231982|FG004|Overall Study|Physician Decision|0|||
160957462|NCT02723864|581231983|FG005|Overall Study|Physician Decision|0|||
160957463|NCT02723864|581231984|FG006|Overall Study|Physician Decision|1|||
160957464|NCT02723864|581231978|FG000|Overall Study|Changes in patient condition|0|||
160957465|NCT02723864|581231979|FG001|Overall Study|Changes in patient condition|0|||
160957466|NCT02723864|581231980|FG002|Overall Study|Changes in patient condition|0|||
160957467|NCT02723864|581231981|FG003|Overall Study|Changes in patient condition|0|||
160957468|NCT02723864|581231982|FG004|Overall Study|Changes in patient condition|0|||
160957469|NCT02723864|581231983|FG005|Overall Study|Changes in patient condition|1|||
160957470|NCT02723864|581231984|FG006|Overall Study|Changes in patient condition|0|||
160957471|NCT02723864|581231978|FG000|Overall Study|Patient choice|0|||
160957472|NCT02723864|581231979|FG001|Overall Study|Patient choice|0|||
160957473|NCT02723864|581231980|FG002|Overall Study|Patient choice|0|||
160957474|NCT02723864|581231981|FG003|Overall Study|Patient choice|0|||
160957475|NCT02723864|581231982|FG004|Overall Study|Patient choice|0|||
160957476|NCT02723864|581231983|FG005|Overall Study|Patient choice|1|||
160957477|NCT02723864|581231984|FG006|Overall Study|Patient choice|0|||
160957478|NCT02723864|581231978|FG000|Overall Study|Adverse Event|0|||
160957479|NCT02723864|581231979|FG001|Overall Study|Adverse Event|0|||
160957480|NCT02723864|581231980|FG002|Overall Study|Adverse Event|0|||
160957481|NCT02723864|581231981|FG003|Overall Study|Adverse Event|0|||
160957482|NCT02723864|581231982|FG004|Overall Study|Adverse Event|0|||
160957483|NCT02723864|581231983|FG005|Overall Study|Adverse Event|1|||
160957484|NCT02723864|581231984|FG006|Overall Study|Adverse Event|0|||
160957485|NCT02723864|581231978|FG000|Overall Study|Started new treatment|0|||
160957486|NCT02723864|581231979|FG001|Overall Study|Started new treatment|0|||
160957487|NCT02723864|581231980|FG002|Overall Study|Started new treatment|0|||
160957488|NCT02723864|581231981|FG003|Overall Study|Started new treatment|0|||
160957489|NCT02723864|581231982|FG004|Overall Study|Started new treatment|0|||
160957490|NCT02723864|581231983|FG005|Overall Study|Started new treatment|1|||
160957491|NCT02723864|581231984|FG006|Overall Study|Started new treatment|0|||
160957492|NCT02723864|581231978|FG000|Overall Study|Switched to alternative treatment|0|||
160957493|NCT02723864|581231979|FG001|Overall Study|Switched to alternative treatment|0|||
160957494|NCT02723864|581231980|FG002|Overall Study|Switched to alternative treatment|0|||
160957495|NCT02723864|581231981|FG003|Overall Study|Switched to alternative treatment|0|||
160957496|NCT02723864|581231982|FG004|Overall Study|Switched to alternative treatment|0|||
160957497|NCT02723864|581231983|FG005|Overall Study|Switched to alternative treatment|1|||
160957498|NCT02723864|581231984|FG006|Overall Study|Switched to alternative treatment|0|||
160957499|NCT02723864|581231978|FG000|Overall Study|Late determination of ineligibility|0|||
160957500|NCT02723864|581231979|FG001|Overall Study|Late determination of ineligibility|0|||
160957501|NCT02723864|581231980|FG002|Overall Study|Late determination of ineligibility|0|||
160957502|NCT02723864|581231981|FG003|Overall Study|Late determination of ineligibility|0|||
160957503|NCT02723864|581231982|FG004|Overall Study|Late determination of ineligibility|0|||
161146559|NCT00104104|581918517|FG000|Overall Study|Protocol Violation|5|||
161146560|NCT00104104|581918518|FG001|Overall Study|Protocol Violation|2|||
161269250|NCT02562482|582366969|FG000|Overall Study|Enrolled, but did not receive product|4|||
161269251|NCT02562482|582366970|FG001|Overall Study|Enrolled, but did not receive product|0|||
160957504|NCT02723864|581231983|FG005|Overall Study|Late determination of ineligibility|1|||
160957505|NCT02723864|581231984|FG006|Overall Study|Late determination of ineligibility|0|||
160957506|NCT03232983|581231985|FG000|Period 1|Physician Decision|0|||
160957507|NCT03232983|581231986|FG001|Period 1|Physician Decision|0|||
161269252|NCT02562482|582366969|FG000|Overall Study|Lost to Follow-up|9|||
160957508|NCT03232983|581231987|FG002|Period 1|Physician Decision|1|||
160957509|NCT03232983|581231988|FG003|Period 1|Physician Decision|0|||
160957510|NCT03232983|581231985|FG000|Washout Period 2|Physician Decision|0|||
160957511|NCT03232983|581231986|FG001|Washout Period 2|Physician Decision|0|||
160957512|NCT03232983|581231987|FG002|Washout Period 2|Physician Decision|1|||
160957513|NCT03232983|581231988|FG003|Washout Period 2|Physician Decision|0|||
160957514|NCT03232983|581231985|FG000|Washout Period 2|Withdrawal by Subject|0|||
160957515|NCT03232983|581231986|FG001|Washout Period 2|Withdrawal by Subject|0|||
160957516|NCT03232983|581231987|FG002|Washout Period 2|Withdrawal by Subject|0|||
160957517|NCT03232983|581231988|FG003|Washout Period 2|Withdrawal by Subject|1|||
161001454|NCT01317420|581390593|FG000|Overall Study|Refused to cont. taking trial medication|0|||
161001455|NCT01317420|581390594|FG001|Overall Study|Refused to cont. taking trial medication|0|||
160957518|NCT03232983|581231985|FG000|Period 4|Withdrawal by Subject|1|||
160957519|NCT03232983|581231986|FG001|Period 4|Withdrawal by Subject|0|||
161146561|NCT00104104|581918517|FG000|Overall Study|Withdrawal by Subject|11|||
160957520|NCT03232983|581231987|FG002|Period 4|Withdrawal by Subject|0|||
160957521|NCT03232983|581231988|FG003|Period 4|Withdrawal by Subject|0|||
160957522|NCT00746590|581231989|FG000|Overall Study|Death|1|||
160957523|NCT02633800|581231994|FG000|Overall Study|Death|3|||
160957524|NCT02633800|581231995|FG001|Overall Study|Death|3|||
160957525|NCT02633800|581231994|FG000|Overall Study|Reason not provided|1|||
160957526|NCT02633800|581231995|FG001|Overall Study|Reason not provided|0|||
160957527|NCT02633800|581231994|FG000|Overall Study|Radiologic(al) progression|23|||
160957528|NCT02633800|581231995|FG001|Overall Study|Radiologic(al) progression|23|||
160957529|NCT02633800|581231994|FG000|Overall Study|Clinical progression|3|||
160957530|NCT02633800|581231995|FG001|Overall Study|Clinical progression|6|||
160957531|NCT02633800|581231994|FG000|Overall Study|Study terminated by sponsor|6|||
160957532|NCT02633800|581231995|FG001|Overall Study|Study terminated by sponsor|5|||
160957533|NCT02633800|581231994|FG000|Overall Study|Adverse event, non-fatal|7|||
160957534|NCT02633800|581231995|FG001|Overall Study|Adverse event, non-fatal|2|||
160957535|NCT02633800|581231994|FG000|Overall Study|Withdrawal by Subject|0|||
160957536|NCT02633800|581231995|FG001|Overall Study|Withdrawal by Subject|3|||
160957537|NCT02633800|581231994|FG000|Overall Study|Patient Request|1|||
160957538|NCT02633800|581231995|FG001|Overall Study|Patient Request|1|||
160957539|NCT03643952|581231999|FG000|Overall Study|Lack of Efficacy|1|||
160957540|NCT01358968|581232000|FG000|Period 2|Adverse Event|0|||
160957541|NCT01358968|581232001|FG001|Period 2|Adverse Event|1|||
160957542|NCT01358968|581232002|FG002|Period 2|Adverse Event|0|||
160957543|NCT01358968|581232003|FG003|Period 2|Adverse Event|0|||
160957544|NCT01358968|581232000|FG000|Continued Access Phase|Progression of Disease|0|||
160957545|NCT01358968|581232001|FG001|Continued Access Phase|Progression of Disease|0|||
160957546|NCT01358968|581232002|FG002|Continued Access Phase|Progression of Disease|8|||
160957547|NCT01358968|581232003|FG003|Continued Access Phase|Progression of Disease|4|||
160957548|NCT01358968|581232000|FG000|Continued Access Phase|Protocol Violation|0|||
160957549|NCT01358968|581232001|FG001|Continued Access Phase|Protocol Violation|0|||
160957550|NCT01358968|581232002|FG002|Continued Access Phase|Protocol Violation|0|||
160957551|NCT01358968|581232003|FG003|Continued Access Phase|Protocol Violation|2|||
160957552|NCT01358968|581232000|FG000|Continued Access Phase|Withdrawal by Subject|0|||
160957553|NCT01358968|581232001|FG001|Continued Access Phase|Withdrawal by Subject|0|||
160957554|NCT01358968|581232002|FG002|Continued Access Phase|Withdrawal by Subject|3|||
160957555|NCT01358968|581232003|FG003|Continued Access Phase|Withdrawal by Subject|0|||
160957556|NCT01358968|581232000|FG000|Continued Access Phase|Death|0|||
160957557|NCT01358968|581232001|FG001|Continued Access Phase|Death|0|||
160957558|NCT01358968|581232002|FG002|Continued Access Phase|Death|1|||
160957559|NCT01358968|581232003|FG003|Continued Access Phase|Death|1|||
160957560|NCT01597050|581232004|FG000|Overall Study|Withdrawal by Subject|1|||
160957561|NCT01597050|581232005|FG001|Overall Study|Withdrawal by Subject|0|||
160957562|NCT00483184|581232006|FG000|Overall Study|Withdrawal by Subject|2|||
160957563|NCT00483184|581232007|FG001|Overall Study|Withdrawal by Subject|2|||
160957564|NCT00483184|581232008|FG002|Overall Study|Withdrawal by Subject|0|||
160957565|NCT00483184|581232006|FG000|Overall Study|Lost to Follow-up|1|||
160957566|NCT00483184|581232007|FG001|Overall Study|Lost to Follow-up|0|||
160957567|NCT00483184|581232008|FG002|Overall Study|Lost to Follow-up|0|||
160957568|NCT00483184|581232006|FG000|Overall Study|Adverse Event|1|||
160957569|NCT00483184|581232007|FG001|Overall Study|Adverse Event|2|||
160957570|NCT00483184|581232008|FG002|Overall Study|Adverse Event|2|||
160957571|NCT00483184|581232006|FG000|Overall Study|Protocol Violation|1|||
160957572|NCT00483184|581232007|FG001|Overall Study|Protocol Violation|0|||
160957573|NCT00483184|581232008|FG002|Overall Study|Protocol Violation|1|||
160957574|NCT00530855|581232012|FG000|Overall Study|Lack of Efficacy|20|||
160957575|NCT00530855|581232012|FG000|Overall Study|Withdrawal by Subject|30|||
160957576|NCT00530855|581232012|FG000|Overall Study|Fatal Serious AE|3|||
160957577|NCT00530855|581232012|FG000|Overall Study|Non Fatal Serious AE|7|||
160957578|NCT00530855|581232012|FG000|Overall Study|Non Fatal Non Serious AE|12|||
160957579|NCT00530855|581232012|FG000|Overall Study|Protocol Violation|3|||
160957580|NCT00530855|581232012|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
160957581|NCT00530855|581232012|FG000|Overall Study|Lost to Follow-up|9|||
160957582|NCT00530855|581232012|FG000|Overall Study|Other reason for premature termination|17|||
160957583|NCT01618162|581232017|FG000|Overall Study|Protocol Violation|13|||
160957584|NCT01618162|581232018|FG001|Overall Study|Protocol Violation|10|||
160957585|NCT01618162|581232017|FG000|Overall Study|Adverse Event|9|||
160957586|NCT01618162|581232018|FG001|Overall Study|Adverse Event|2|||
160957587|NCT01618162|581232017|FG000|Overall Study|Withdrawal Criteria|2|||
160957588|NCT01618162|581232018|FG001|Overall Study|Withdrawal Criteria|10|||
160957589|NCT01618162|581232017|FG000|Overall Study|Unclassified|14|||
160957590|NCT01618162|581232018|FG001|Overall Study|Unclassified|13|||
160957591|NCT04794803|581232019|FG000|Overall Study|Death|1|||
160957592|NCT04794803|581232020|FG001|Overall Study|Death|3|||
160957593|NCT04794803|581232019|FG000|Overall Study|Lost to Follow-up|2|||
160957594|NCT04794803|581232020|FG001|Overall Study|Lost to Follow-up|2|||
160957595|NCT04794803|581232019|FG000|Overall Study|Withdrawal by Subject|1|||
160957596|NCT04794803|581232020|FG001|Overall Study|Withdrawal by Subject|0|||
160957597|NCT04794803|581232019|FG000|Overall Study|Physician Decision|1|||
160957598|NCT04794803|581232020|FG001|Overall Study|Physician Decision|1|||
160957599|NCT04794803|581232019|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
160957600|NCT04794803|581232020|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
160957601|NCT04794803|581232019|FG000|Overall Study|Refused to continue the treatment|1|||
160957602|NCT04794803|581232020|FG001|Overall Study|Refused to continue the treatment|0|||
160957603|NCT04794803|581232019|FG000|Overall Study|Patient admitted to ICU|0|||
160957604|NCT04794803|581232020|FG001|Overall Study|Patient admitted to ICU|1|||
160957605|NCT04124926|581232021|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
160957606|NCT04124926|581232022|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
160957607|NCT04124926|581232023|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
160957608|NCT04124926|581232024|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
160957609|NCT04124926|581232025|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
160957610|NCT04124926|581232021|FG000|Healing Phase|Protocol Violation|0|||
160957611|NCT04124926|581232022|FG001|Healing Phase|Protocol Violation|1|||
160957612|NCT04124926|581232023|FG002|Healing Phase|Protocol Violation|0|||
160957613|NCT04124926|581232024|FG003|Healing Phase|Protocol Violation|0|||
160957614|NCT04124926|581232025|FG004|Healing Phase|Protocol Violation|0|||
160957615|NCT04124926|581232021|FG000|Healing Phase|Lost to Follow-up|5|||
160957616|NCT04124926|581232022|FG001|Healing Phase|Lost to Follow-up|4|||
160957617|NCT04124926|581232023|FG002|Healing Phase|Lost to Follow-up|0|||
160957618|NCT04124926|581232024|FG003|Healing Phase|Lost to Follow-up|0|||
160957619|NCT04124926|581232025|FG004|Healing Phase|Lost to Follow-up|0|||
160957620|NCT04124926|581232021|FG000|Healing Phase|Voluntary Withdrawal|10|||
160957621|NCT04124926|581232022|FG001|Healing Phase|Voluntary Withdrawal|7|||
160957622|NCT04124926|581232023|FG002|Healing Phase|Voluntary Withdrawal|0|||
160957623|NCT04124926|581232024|FG003|Healing Phase|Voluntary Withdrawal|0|||
160957624|NCT04124926|581232025|FG004|Healing Phase|Voluntary Withdrawal|0|||
160957625|NCT04124926|581232021|FG000|Healing Phase|Withdrawal of Consent|5|||
160957626|NCT04124926|581232022|FG001|Healing Phase|Withdrawal of Consent|3|||
160957627|NCT04124926|581232023|FG002|Healing Phase|Withdrawal of Consent|0|||
160957628|NCT04124926|581232024|FG003|Healing Phase|Withdrawal of Consent|0|||
160957629|NCT04124926|581232025|FG004|Healing Phase|Withdrawal of Consent|0|||
160957630|NCT04124926|581232021|FG000|Healing Phase|Miscellaneous|8|||
160957631|NCT04124926|581232022|FG001|Healing Phase|Miscellaneous|7|||
160957632|NCT04124926|581232023|FG002|Healing Phase|Miscellaneous|0|||
160957633|NCT04124926|581232024|FG003|Healing Phase|Miscellaneous|0|||
160957634|NCT04124926|581232025|FG004|Healing Phase|Miscellaneous|0|||
160957635|NCT04124926|581232021|FG000|Healing Phase|Randomized but not Treated|0|||
160957636|NCT04124926|581232022|FG001|Healing Phase|Randomized but not Treated|3|||
160957637|NCT04124926|581232023|FG002|Healing Phase|Randomized but not Treated|0|||
160957638|NCT04124926|581232024|FG003|Healing Phase|Randomized but not Treated|0|||
160957639|NCT04124926|581232025|FG004|Healing Phase|Randomized but not Treated|0|||
160957640|NCT04124926|581232021|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
160957641|NCT04124926|581232022|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
160957642|NCT04124926|581232023|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
160957643|NCT04124926|581232024|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
160957644|NCT04124926|581232025|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
160957645|NCT04124926|581232021|FG000|Maintenance Phase|Protocol Violation|0|||
160957646|NCT04124926|581232022|FG001|Maintenance Phase|Protocol Violation|0|||
160957647|NCT04124926|581232023|FG002|Maintenance Phase|Protocol Violation|3|||
160957648|NCT04124926|581232024|FG003|Maintenance Phase|Protocol Violation|0|||
160957649|NCT04124926|581232025|FG004|Maintenance Phase|Protocol Violation|0|||
160957650|NCT04124926|581232021|FG000|Maintenance Phase|Lost to Follow-up|0|||
160957651|NCT04124926|581232022|FG001|Maintenance Phase|Lost to Follow-up|0|||
160957652|NCT04124926|581232023|FG002|Maintenance Phase|Lost to Follow-up|7|||
160957653|NCT04124926|581232024|FG003|Maintenance Phase|Lost to Follow-up|8|||
160957654|NCT04124926|581232025|FG004|Maintenance Phase|Lost to Follow-up|9|||
160957655|NCT04124926|581232021|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
160957656|NCT04124926|581232022|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
160957657|NCT04124926|581232023|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
160957658|NCT04124926|581232024|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
160957659|NCT04124926|581232025|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
160957660|NCT04124926|581232021|FG000|Maintenance Phase|Pregnancy|0|||
160957661|NCT04124926|581232022|FG001|Maintenance Phase|Pregnancy|0|||
161001456|NCT01317420|581390595|FG002|Overall Study|Refused to cont. taking trial medication|0|||
160957662|NCT04124926|581232023|FG002|Maintenance Phase|Pregnancy|0|||
160957663|NCT04124926|581232024|FG003|Maintenance Phase|Pregnancy|1|||
160957664|NCT04124926|581232025|FG004|Maintenance Phase|Pregnancy|0|||
160957665|NCT04124926|581232021|FG000|Maintenance Phase|Lack of Efficacy|0|||
160957666|NCT04124926|581232022|FG001|Maintenance Phase|Lack of Efficacy|0|||
160957667|NCT04124926|581232023|FG002|Maintenance Phase|Lack of Efficacy|0|||
160957668|NCT04124926|581232024|FG003|Maintenance Phase|Lack of Efficacy|0|||
160957669|NCT04124926|581232025|FG004|Maintenance Phase|Lack of Efficacy|1|||
160957670|NCT04124926|581232021|FG000|Maintenance Phase|Withdrawal of Consent|0|||
161146562|NCT00104104|581918518|FG001|Overall Study|Withdrawal by Subject|15|||
161146563|NCT00104104|581918517|FG000|Overall Study|Lost to Follow-up|3|||
161146564|NCT00104104|581918518|FG001|Overall Study|Lost to Follow-up|7|||
161146565|NCT00104104|581918517|FG000|Overall Study|Administrative problems|12|||
161146566|NCT00104104|581918518|FG001|Overall Study|Administrative problems|13|||
160957671|NCT04124926|581232022|FG001|Maintenance Phase|Withdrawal of Consent|0|||
160957672|NCT04124926|581232023|FG002|Maintenance Phase|Withdrawal of Consent|5|||
160957673|NCT04124926|581232024|FG003|Maintenance Phase|Withdrawal of Consent|5|||
160957674|NCT04124926|581232025|FG004|Maintenance Phase|Withdrawal of Consent|5|||
160957675|NCT04124926|581232021|FG000|Maintenance Phase|Miscellaneous|0|||
160957676|NCT04124926|581232022|FG001|Maintenance Phase|Miscellaneous|0|||
160957677|NCT04124926|581232023|FG002|Maintenance Phase|Miscellaneous|1|||
160957678|NCT04124926|581232024|FG003|Maintenance Phase|Miscellaneous|2|||
160957679|NCT04124926|581232025|FG004|Maintenance Phase|Miscellaneous|4|||
160957680|NCT04124926|581232021|FG000|Maintenance Phase|Randomized but not Treated|0|||
160957681|NCT04124926|581232022|FG001|Maintenance Phase|Randomized but not Treated|0|||
160957682|NCT04124926|581232023|FG002|Maintenance Phase|Randomized but not Treated|2|||
160957683|NCT04124926|581232024|FG003|Maintenance Phase|Randomized but not Treated|2|||
160957684|NCT04124926|581232025|FG004|Maintenance Phase|Randomized but not Treated|0|||
160957685|NCT01654549|581232031|FG000|Overall Study|H.pylori eradication not successful|0|||
160957686|NCT01654549|581232032|FG001|Overall Study|H.pylori eradication not successful|1|||
160957687|NCT02013622|581232035|FG000|Overall Study|Lost to Follow-up|10|||
160957688|NCT02013622|581232035|FG000|Overall Study|Adverse Event|3|||
160957689|NCT02013622|581232035|FG000|Overall Study|Met Withdrawal Criteria|3|||
160957690|NCT02013622|581232035|FG000|Overall Study|Withdrawal by Subject|6|||
160957691|NCT02013622|581232035|FG000|Overall Study|Protocol Deviation|1|||
160957692|NCT02013622|581232035|FG000|Overall Study|Lack of Efficacy|1|||
160957693|NCT00937924|581232036|FG000|Overall Study|Lost to Follow-up|44|||
160957694|NCT00937924|581232037|FG001|Overall Study|Lost to Follow-up|44|||
160957695|NCT00937924|581232038|FG002|Overall Study|Lost to Follow-up|41|||
160957696|NCT00224874|581232041|FG000|Overall Study|Withdrawal by Subject|0|||
160957697|NCT00224874|581232042|FG001|Overall Study|Withdrawal by Subject|0|||
160957698|NCT00224874|581232043|FG002|Overall Study|Withdrawal by Subject|1|||
160957699|NCT00224874|581232044|FG003|Overall Study|Withdrawal by Subject|0|||
160957700|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
160957701|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
160957702|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
160957703|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
160957704|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
160957705|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
160957706|NCT02355002|581232045|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
160957707|NCT02355002|581232046|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
160957708|NCT02355002|581232045|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
160957709|NCT02355002|581232046|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
160957710|NCT02355002|581232045|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
160957711|NCT02355002|581232046|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
160957712|NCT02355002|581232045|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
160957713|NCT02355002|581232046|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
160957714|NCT03152526|581232047|FG000|Overall Study|Withdrawal by Subject|0|||
160957715|NCT03152526|581232048|FG001|Overall Study|Withdrawal by Subject|1|||
160957716|NCT05554237|581232049|FG000|Part 2 (7 Days)|Adverse Event|0|||
160957717|NCT05554237|581232050|FG001|Part 2 (7 Days)|Adverse Event|0|||
160957718|NCT05554237|581232051|FG002|Part 2 (7 Days)|Adverse Event|0|||
160957719|NCT05554237|581232052|FG003|Part 2 (7 Days)|Adverse Event|0|||
160957720|NCT05554237|581232053|FG004|Part 2 (7 Days)|Adverse Event|2|||
160957721|NCT05554237|581232054|FG005|Part 2 (7 Days)|Adverse Event|0|||
160957722|NCT05554237|581232055|FG006|Part 2 (7 Days)|Adverse Event|0|||
160957723|NCT05554237|581232056|FG007|Part 2 (7 Days)|Adverse Event|0|||
161146567|NCT00104104|581918517|FG000|Overall Study|Death|9|||
161146568|NCT00104104|581918518|FG001|Overall Study|Death|6|||
161146569|NCT00447421|581918519|FG000|Overall Study|Lack of Efficacy|1|||
160957724|NCT05554237|581232057|FG008|Part 2 (7 Days)|Adverse Event|0|||
160957725|NCT05554237|581232058|FG009|Part 2 (7 Days)|Adverse Event|1|||
160957726|NCT05554237|581232059|FG010|Part 2 (7 Days)|Adverse Event|0|||
160957727|NCT05554237|581232060|FG011|Part 2 (7 Days)|Adverse Event|0|||
160957728|NCT05554237|581232061|FG012|Part 2 (7 Days)|Adverse Event|1|||
160957729|NCT05554237|581232062|FG013|Part 2 (7 Days)|Adverse Event|0|||
161146570|NCT00447421|581918519|FG000|Overall Study|Adverse Event|3|||
161146571|NCT00447421|581918519|FG000|Overall Study|Sponsor Decision|2|||
161146572|NCT01707147|581918520|FG000|Overall Study|Administered Trajenta prior to contract|5|||
161146573|NCT01707147|581918520|FG000|Overall Study|Patients who have not taken Trajenta|1|||
161146574|NCT01707147|581918520|FG000|Overall Study|Follow-up failure|17|||
161269253|NCT02562482|582366970|FG001|Overall Study|Lost to Follow-up|6|||
160957730|NCT05130970|581232063|FG000|Overall Study|Adverse Event|1|||
160957731|NCT05130970|581232064|FG001|Overall Study|Adverse Event|1|||
160957732|NCT05130970|581232063|FG000|Overall Study|Death|0|||
160957733|NCT05130970|581232064|FG001|Overall Study|Death|1|||
160957734|NCT05130970|581232063|FG000|Overall Study|Lost to Follow-up|0|||
160957735|NCT05130970|581232064|FG001|Overall Study|Lost to Follow-up|1|||
160957736|NCT05130970|581232063|FG000|Overall Study|Physician Decision|0|||
160957737|NCT05130970|581232064|FG001|Overall Study|Physician Decision|1|||
160957738|NCT05130970|581232063|FG000|Overall Study|Withdrawal by Subject|1|||
160957739|NCT05130970|581232064|FG001|Overall Study|Withdrawal by Subject|1|||
160957740|NCT03644186|581232065|FG000|Overall Study|Withdrawal by Subject|1|||
160957741|NCT03644186|581232066|FG001|Overall Study|Withdrawal by Subject|1|||
160957742|NCT02701985|581232067|FG000|Overall Study|Withdrawal by Subject|1|||
160957743|NCT02701985|581232068|FG001|Overall Study|Withdrawal by Subject|1|||
160957744|NCT02701985|581232067|FG000|Overall Study|Lost to Follow-up|1|||
160957745|NCT02701985|581232068|FG001|Overall Study|Lost to Follow-up|0|||
160957746|NCT02701985|581232067|FG000|Overall Study|Death|1|||
160957747|NCT02701985|581232068|FG001|Overall Study|Death|0|||
160957748|NCT02701985|581232067|FG000|Overall Study|Adverse Event|0|||
160957749|NCT02701985|581232068|FG001|Overall Study|Adverse Event|5|||
160957750|NCT02192502|581232071|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
160957751|NCT02192502|581232072|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
160957752|NCT02192502|581232071|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
160957753|NCT02192502|581232072|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
160957754|NCT02192502|581232071|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
160957755|NCT02192502|581232072|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
160957756|NCT04009291|581232073|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957757|NCT04009291|581232074|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957758|NCT04009291|581232075|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957759|NCT04009291|581232076|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
160957760|NCT04009291|581232077|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
160957761|NCT04009291|581232073|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957762|NCT04009291|581232074|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957763|NCT04009291|581232075|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957764|NCT04009291|581232076|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
160957765|NCT04009291|581232077|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
160957766|NCT02189798|581232078|FG000|Extended Use Phase|Withdrawal by Subject|0|||
160957767|NCT02189798|581232079|FG001|Extended Use Phase|Withdrawal by Subject|4|||
160957768|NCT02189798|581232078|FG000|Extended Use Phase|Physician Decision|1|||
160957769|NCT02189798|581232079|FG001|Extended Use Phase|Physician Decision|0|||
160957770|NCT02189798|581232078|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
160957771|NCT02189798|581232079|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
160957772|NCT02189798|581232078|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
160957773|NCT02189798|581232079|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
160957774|NCT02189798|581232078|FG000|Extended Use Phase|Travel Issues|2|||
160957775|NCT02189798|581232079|FG001|Extended Use Phase|Travel Issues|1|||
160957776|NCT02189798|581232078|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
160957777|NCT02189798|581232079|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
160957778|NCT00729833|581232087|FG000|Overall Study|Death|5|||
160957779|NCT00729833|581232088|FG001|Overall Study|Death|1|||
160957780|NCT00729833|581232089|FG002|Overall Study|Death|3|||
160957781|NCT00729833|581232090|FG003|Overall Study|Death|5|||
160957782|NCT00729833|581232087|FG000|Overall Study|Study Terminated by Sponsor|0|||
160957783|NCT00729833|581232088|FG001|Overall Study|Study Terminated by Sponsor|0|||
160957784|NCT00729833|581232089|FG002|Overall Study|Study Terminated by Sponsor|1|||
160957785|NCT00729833|581232090|FG003|Overall Study|Study Terminated by Sponsor|0|||
160957786|NCT00729833|581232087|FG000|Overall Study|Lost to Follow-up|1|||
160957787|NCT00729833|581232088|FG001|Overall Study|Lost to Follow-up|0|||
160957788|NCT00729833|581232089|FG002|Overall Study|Lost to Follow-up|0|||
160957789|NCT00729833|581232090|FG003|Overall Study|Lost to Follow-up|0|||
160957790|NCT00729833|581232087|FG000|Overall Study|Withdrawal by Subject|3|||
160957791|NCT00729833|581232088|FG001|Overall Study|Withdrawal by Subject|1|||
160957792|NCT00729833|581232089|FG002|Overall Study|Withdrawal by Subject|3|||
160957793|NCT00729833|581232090|FG003|Overall Study|Withdrawal by Subject|0|||
160957794|NCT00729833|581232087|FG000|Overall Study|Unspecified Reasons|11|||
160957795|NCT00729833|581232088|FG001|Overall Study|Unspecified Reasons|5|||
160957796|NCT00729833|581232089|FG002|Overall Study|Unspecified Reasons|5|||
160957797|NCT00729833|581232090|FG003|Overall Study|Unspecified Reasons|1|||
160957798|NCT01687257|581232091|FG000|Overall Study|Efficacy Failure|6|||
160957799|NCT01687257|581232092|FG001|Overall Study|Efficacy Failure|0|||
160957800|NCT01687257|581232093|FG002|Overall Study|Efficacy Failure|5|||
161001457|NCT01317420|581390596|FG003|Overall Study|Refused to cont. taking trial medication|0|||
161001458|NCT01317420|581390597|FG004|Overall Study|Refused to cont. taking trial medication|0|||
160957801|NCT01687257|581232091|FG000|Overall Study|Subject Withdrew Consent|1|||
160957802|NCT01687257|581232092|FG001|Overall Study|Subject Withdrew Consent|1|||
160957803|NCT01687257|581232093|FG002|Overall Study|Subject Withdrew Consent|1|||
160957804|NCT01687257|581232091|FG000|Overall Study|Adverse Event|1|||
160957805|NCT01687257|581232092|FG001|Overall Study|Adverse Event|0|||
160957806|NCT01687257|581232093|FG002|Overall Study|Adverse Event|0|||
160957807|NCT01687257|581232091|FG000|Overall Study|Investigator's Discretion|0|||
160957808|NCT01687257|581232092|FG001|Overall Study|Investigator's Discretion|3|||
160957809|NCT01687257|581232093|FG002|Overall Study|Investigator's Discretion|0|||
160957810|NCT04899349|581232096|FG000|Overall Study|Study terminated by Sponsor|2|||
160957811|NCT04899349|581232097|FG001|Overall Study|Study terminated by Sponsor|0|||
160957812|NCT03336619|581232099|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
160957813|NCT03336619|581232100|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
160957814|NCT03336619|581232099|FG000|Overall Study|Withdrawal by Subject|17|||
160957815|NCT03336619|581232100|FG001|Overall Study|Withdrawal by Subject|16|||
160957816|NCT03336619|581232099|FG000|Overall Study|Adverse Event|2|||
160957817|NCT03336619|581232100|FG001|Overall Study|Adverse Event|5|||
160957818|NCT03336619|581232099|FG000|Overall Study|Physician Decision|3|||
160957819|NCT03336619|581232100|FG001|Overall Study|Physician Decision|0|||
160957820|NCT02820623|581232101|FG000|Overall Study|Withdrawal by Subject|1|||
160957821|NCT02820623|581232102|FG001|Overall Study|Withdrawal by Subject|3|||
160957822|NCT02820623|581232103|FG002|Overall Study|Withdrawal by Subject|3|||
160957823|NCT02820623|581232101|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
160957824|NCT02820623|581232102|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
161001459|NCT01317420|581390598|FG005|Overall Study|Refused to cont. taking trial medication|0|||
161001460|NCT01317420|581390599|FG006|Overall Study|Refused to cont. taking trial medication|0|||
161001461|NCT01317420|581390600|FG007|Overall Study|Refused to cont. taking trial medication|0|||
161001462|NCT01317420|581390601|FG008|Overall Study|Refused to cont. taking trial medication|0|||
161001463|NCT01317420|581390602|FG009|Overall Study|Refused to cont. taking trial medication|0|||
161001464|NCT01317420|581390603|FG010|Overall Study|Refused to cont. taking trial medication|0|||
161001465|NCT01317420|581390604|FG011|Overall Study|Refused to cont. taking trial medication|0|||
161001466|NCT01317420|581390605|FG012|Overall Study|Refused to cont. taking trial medication|1|||
161001467|NCT01317420|581390593|FG000|Overall Study|Reason other than those specified|0|||
161001468|NCT01317420|581390594|FG001|Overall Study|Reason other than those specified|0|||
161001469|NCT01317420|581390595|FG002|Overall Study|Reason other than those specified|0|||
161001470|NCT01317420|581390596|FG003|Overall Study|Reason other than those specified|0|||
161001471|NCT01317420|581390597|FG004|Overall Study|Reason other than those specified|0|||
161001472|NCT01317420|581390598|FG005|Overall Study|Reason other than those specified|0|||
161001473|NCT01317420|581390599|FG006|Overall Study|Reason other than those specified|0|||
161001474|NCT01317420|581390600|FG007|Overall Study|Reason other than those specified|0|||
161001475|NCT01317420|581390601|FG008|Overall Study|Reason other than those specified|0|||
161001476|NCT01317420|581390602|FG009|Overall Study|Reason other than those specified|1|||
161001477|NCT01317420|581390603|FG010|Overall Study|Reason other than those specified|0|||
161001478|NCT01317420|581390604|FG011|Overall Study|Reason other than those specified|0|||
161001479|NCT01317420|581390605|FG012|Overall Study|Reason other than those specified|0|||
161001480|NCT05686421|581390606|FG000|Overall Study|Screen failure|22|||
161001481|NCT05686421|581390607|FG001|Overall Study|Screen failure|0|||
161001482|NCT05686421|581390608|FG002|Overall Study|Screen failure|0|||
161001483|NCT05686421|581390609|FG003|Overall Study|Screen failure|0|||
161001484|NCT04210180|581390610|FG000|Overall Study|Withdrawal by Subject|2|||
161001485|NCT00367055|581390611|FG000|Overall Study|Adverse Event|6|||
161001486|NCT00367055|581390612|FG001|Overall Study|Adverse Event|3|||
161001487|NCT00367055|581390611|FG000|Overall Study|Patient's Willing|3|||
161001488|NCT00367055|581390612|FG001|Overall Study|Patient's Willing|2|||
161001489|NCT00367055|581390611|FG000|Overall Study|Lack of Efficacy|1|||
161001490|NCT00367055|581390612|FG001|Overall Study|Lack of Efficacy|2|||
161001491|NCT00367055|581390611|FG000|Overall Study|Lost to Follow-up|1|||
161001492|NCT00367055|581390612|FG001|Overall Study|Lost to Follow-up|1|||
161001493|NCT00367055|581390611|FG000|Overall Study|Protocol Violation|0|||
161001494|NCT00367055|581390612|FG001|Overall Study|Protocol Violation|1|||
160957825|NCT02820623|581232103|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
161001495|NCT00367055|581390611|FG000|Overall Study|Stopping Criterion Met|0|||
161001496|NCT00367055|581390612|FG001|Overall Study|Stopping Criterion Met|1|||
161001497|NCT00367055|581390611|FG000|Overall Study|Participant Living too Far from Hospital|0|||
161146575|NCT01707147|581918520|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
161146576|NCT02903511|581918524|FG000|Overall Study|Withdrawal by Subject|1|||
161146577|NCT02903511|581918525|FG001|Overall Study|Withdrawal by Subject|0|||
161146578|NCT02903511|581918524|FG000|Overall Study|Lost to Follow-up|3|||
161146579|NCT02903511|581918525|FG001|Overall Study|Lost to Follow-up|2|||
161146580|NCT00969618|581918526|FG000|Overall Study|Adverse Event|29|||
161001498|NCT00367055|581390612|FG001|Overall Study|Participant Living too Far from Hospital|1|||
161001499|NCT00324038|581390613|FG000|Overall Study|Adverse Event|38|||
161146581|NCT00969618|581918526|FG000|Overall Study|Entry Criteria Not Met|3|||
160957826|NCT02820623|581232101|FG000|Overall Study|Therapist unable to enroll clients|1|||
160957827|NCT02820623|581232102|FG001|Overall Study|Therapist unable to enroll clients|1|||
160957828|NCT02820623|581232103|FG002|Overall Study|Therapist unable to enroll clients|3|||
160957829|NCT02820623|581232101|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
160957830|NCT02820623|581232102|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
160957831|NCT02820623|581232103|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
160957832|NCT02653482|581232104|FG000|Overall Study|Death|1|||
160957833|NCT02653482|581232105|FG001|Overall Study|Death|1|||
160957834|NCT05132699|581232107|FG000|Overall Study|Withdrawal by Subject|3|||
160957835|NCT05132699|581232108|FG001|Overall Study|Withdrawal by Subject|0|||
160957836|NCT04370054|581232109|FG000|Treatment Phase|Lost to Follow-up|1|||
160957837|NCT04370054|581232109|FG000|Treatment Phase|Withdrawal by Subject|1|||
160957838|NCT04370054|581232109|FG000|Follow-Up Phase|Ongoing|75|||
160957839|NCT02096900|581232110|FG000|Overall Study|Did not receive medication|3|||
160957840|NCT02096900|581232111|FG001|Overall Study|Did not receive medication|1|||
160957841|NCT02096900|581232110|FG000|Overall Study|Surgery cancelled- medication received|1|||
160957842|NCT02096900|581232111|FG001|Overall Study|Surgery cancelled- medication received|1|||
160957843|NCT00710424|581232114|FG000|Overall Study|Adverse Event|30|||
160957844|NCT00710424|581232115|FG001|Overall Study|Adverse Event|12|||
160957845|NCT00710424|581232114|FG000|Overall Study|Lack of Efficacy|4|||
160957846|NCT00710424|581232115|FG001|Overall Study|Lack of Efficacy|5|||
160957847|NCT00710424|581232114|FG000|Overall Study|Withdrawal by Subject|5|||
160957848|NCT00710424|581232115|FG001|Overall Study|Withdrawal by Subject|3|||
160957849|NCT00710424|581232114|FG000|Overall Study|Lost to Follow-up|0|||
160957850|NCT00710424|581232115|FG001|Overall Study|Lost to Follow-up|1|||
160957851|NCT00710424|581232114|FG000|Overall Study|Refused medication, no side effects|1|||
160957852|NCT00710424|581232115|FG001|Overall Study|Refused medication, no side effects|0|||
160957853|NCT00710424|581232114|FG000|Overall Study|Non-compliance with stable analgesia|1|||
160957854|NCT00710424|581232115|FG001|Overall Study|Non-compliance with stable analgesia|0|||
160957855|NCT00710424|581232114|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
160957856|NCT00710424|581232115|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
160957857|NCT00710424|581232114|FG000|Overall Study|Subject thought medication changed|1|||
160957858|NCT00710424|581232115|FG001|Overall Study|Subject thought medication changed|0|||
160957859|NCT00710424|581232114|FG000|Overall Study|Ceased treatment due to travel|1|||
160957860|NCT00710424|581232115|FG001|Overall Study|Ceased treatment due to travel|0|||
160957861|NCT00710424|581232114|FG000|Overall Study|Subject preferred paracetamol|0|||
160957862|NCT00710424|581232115|FG001|Overall Study|Subject preferred paracetamol|1|||
160957863|NCT00710424|581232114|FG000|Overall Study|Felt good so stopped treatment|0|||
160957864|NCT00710424|581232115|FG001|Overall Study|Felt good so stopped treatment|1|||
160957865|NCT01621126|581234004|FG000|Overall Study|Physician Decision|6|||
160957866|NCT03751631|581234005|FG000|Overall Study|Withdrawal by Subject|0|||
160957867|NCT03751631|581234006|FG001|Overall Study|Withdrawal by Subject|0|||
160957868|NCT03751631|581234007|FG002|Overall Study|Withdrawal by Subject|1|||
160957869|NCT03751631|581234008|FG003|Overall Study|Withdrawal by Subject|1|||
160957870|NCT03751631|581234009|FG004|Overall Study|Withdrawal by Subject|0|||
160957871|NCT03751631|581234010|FG005|Overall Study|Withdrawal by Subject|0|||
160957872|NCT02481310|581234011|FG000|Follow up|Still in follow up|0|||
160957873|NCT02481310|581234012|FG001|Follow up|Still in follow up|3|||
160957874|NCT02481310|581234013|FG002|Follow up|Still in follow up|0|||
160957875|NCT00447057|581234017|FG000|Overall Study|Adverse Event|4|||
160957876|NCT00447057|581234018|FG001|Overall Study|Adverse Event|10|||
160957877|NCT00447057|581234019|FG002|Overall Study|Adverse Event|0|||
160957878|NCT00447057|581234020|FG003|Overall Study|Adverse Event|3|||
160957879|NCT00447057|581234017|FG000|Overall Study|Death due to study disease|6|||
160957880|NCT00447057|581234018|FG001|Overall Study|Death due to study disease|4|||
160957881|NCT00447057|581234019|FG002|Overall Study|Death due to study disease|1|||
160957882|NCT00447057|581234020|FG003|Overall Study|Death due to study disease|1|||
160957883|NCT00447057|581234017|FG000|Overall Study|Lost to Follow-up|0|||
160957884|NCT00447057|581234018|FG001|Overall Study|Lost to Follow-up|1|||
160957885|NCT00447057|581234019|FG002|Overall Study|Lost to Follow-up|0|||
160957886|NCT00447057|581234020|FG003|Overall Study|Lost to Follow-up|0|||
160957887|NCT00447057|581234017|FG000|Overall Study|Entry criteria not met|1|||
160957888|NCT00447057|581234018|FG001|Overall Study|Entry criteria not met|1|||
161001500|NCT00324038|581390614|FG001|Overall Study|Adverse Event|23|||
161146582|NCT00969618|581918526|FG000|Overall Study|Lack of Efficacy|2|||
161146583|NCT00969618|581918526|FG000|Overall Study|Lost to Follow-up|7|||
160957889|NCT00447057|581234019|FG002|Overall Study|Entry criteria not met|0|||
161146584|NCT00969618|581918526|FG000|Overall Study|Physician Decision|1|||
161146585|NCT00969618|581918526|FG000|Overall Study|Protocol Violation|9|||
161343454|NCT05452239|582644388|FG000|Open-label Period|Withdrawal by Subject|2|||
160957890|NCT00447057|581234020|FG003|Overall Study|Entry criteria not met|0|||
160957891|NCT00447057|581234017|FG000|Overall Study|Protocol Violation|0|||
160957892|NCT00447057|581234018|FG001|Overall Study|Protocol Violation|1|||
160957893|NCT00447057|581234019|FG002|Overall Study|Protocol Violation|0|||
161146586|NCT00969618|581918526|FG000|Overall Study|Withdrawal by Subject|27|||
160957894|NCT00447057|581234020|FG003|Overall Study|Protocol Violation|0|||
160957895|NCT00447057|581234017|FG000|Overall Study|Withdrawal by Subject|4|||
160957896|NCT00447057|581234018|FG001|Overall Study|Withdrawal by Subject|5|||
160957897|NCT00447057|581234019|FG002|Overall Study|Withdrawal by Subject|1|||
160957898|NCT00447057|581234020|FG003|Overall Study|Withdrawal by Subject|1|||
160957899|NCT00447057|581234017|FG000|Overall Study|Physician Decision|9|||
160957900|NCT00447057|581234018|FG001|Overall Study|Physician Decision|6|||
160957901|NCT00447057|581234019|FG002|Overall Study|Physician Decision|3|||
160957902|NCT00447057|581234020|FG003|Overall Study|Physician Decision|1|||
160957903|NCT00447057|581234017|FG000|Overall Study|Sponsor decision|1|||
160957904|NCT00447057|581234018|FG001|Overall Study|Sponsor decision|1|||
160957905|NCT00447057|581234019|FG002|Overall Study|Sponsor decision|0|||
160957906|NCT00447057|581234020|FG003|Overall Study|Sponsor decision|0|||
160957907|NCT00447057|581234017|FG000|Overall Study|Progressive disease|58|||
160957908|NCT00447057|581234018|FG001|Overall Study|Progressive disease|43|||
160957909|NCT00447057|581234019|FG002|Overall Study|Progressive disease|13|||
160957910|NCT00447057|581234020|FG003|Overall Study|Progressive disease|18|||
160957911|NCT00447057|581234017|FG000|Overall Study|Death due to adverse event|0|||
160957912|NCT00447057|581234018|FG001|Overall Study|Death due to adverse event|0|||
160957913|NCT00447057|581234019|FG002|Overall Study|Death due to adverse event|1|||
160957914|NCT00447057|581234020|FG003|Overall Study|Death due to adverse event|2|||
160957915|NCT00447057|581234017|FG000|Overall Study|Death, study drug related|0|||
160957916|NCT00447057|581234018|FG001|Overall Study|Death, study drug related|1|||
160957917|NCT00447057|581234019|FG002|Overall Study|Death, study drug related|0|||
160957918|NCT00447057|581234020|FG003|Overall Study|Death, study drug related|0|||
160957919|NCT00677833|581234021|FG000|Overall Study|Withdrawal by Subject|4|||
160957920|NCT00677833|581234022|FG001|Overall Study|Withdrawal by Subject|0|||
160957921|NCT00677833|581234023|FG002|Overall Study|Withdrawal by Subject|1|||
160957922|NCT00677833|581234024|FG003|Overall Study|Withdrawal by Subject|3|||
160957923|NCT00677833|581234021|FG000|Overall Study|Lost to Follow-up|0|||
160957924|NCT00677833|581234022|FG001|Overall Study|Lost to Follow-up|0|||
160957925|NCT00677833|581234023|FG002|Overall Study|Lost to Follow-up|1|||
160957926|NCT00677833|581234024|FG003|Overall Study|Lost to Follow-up|0|||
160957927|NCT02606279|581234029|FG000|Overall Study|Lost to Follow-up|0|||
160957928|NCT02606279|581234030|FG001|Overall Study|Lost to Follow-up|1|||
160957929|NCT03318523|581234031|FG000|PC Period: Up to Year 1|Adverse Event|1|||
160957930|NCT03318523|581234032|FG001|PC Period: Up to Year 1|Adverse Event|0|||
160957931|NCT03318523|581234033|FG002|PC Period: Up to Year 1|Adverse Event|2|||
160957932|NCT03318523|581234034|FG003|PC Period: Up to Year 1|Adverse Event|0|||
160957933|NCT03318523|581234035|FG004|PC Period: Up to Year 1|Adverse Event|0|||
160957934|NCT03318523|581234036|FG005|PC Period: Up to Year 1|Adverse Event|0|||
160957935|NCT03318523|581234037|FG006|PC Period: Up to Year 1|Adverse Event|0|||
160957936|NCT03318523|581234038|FG007|PC Period: Up to Year 1|Adverse Event|0|||
160957937|NCT03318523|581234039|FG008|PC Period: Up to Year 1|Adverse Event|0|||
160957938|NCT03318523|581234040|FG009|PC Period: Up to Year 1|Adverse Event|0|||
160957939|NCT03318523|581234031|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
160957940|NCT03318523|581234032|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
160957941|NCT03318523|581234033|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957942|NCT03318523|581234034|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
160957943|NCT03318523|581234035|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957944|NCT03318523|581234036|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957945|NCT03318523|581234037|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957946|NCT03318523|581234038|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957947|NCT03318523|581234039|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957948|NCT03318523|581234040|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
160957949|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957950|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957951|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957952|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957953|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
160957954|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957955|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957956|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
160957957|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
160957958|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
160957959|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160957960|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161146587|NCT01318902|581918527|FG000|Overall Study|Symptomatic Deterioration|0|||
160957961|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160957962|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161146588|NCT01318902|581918528|FG001|Overall Study|Symptomatic Deterioration|1|||
160957963|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
160957964|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
161001501|NCT00324038|581390613|FG000|Overall Study|Lack of Efficacy|5|||
160957965|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
160957966|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
160957967|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
160957968|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
160957969|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957970|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957971|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957972|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957973|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957974|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
160957975|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957976|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957977|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957978|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
160957979|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957980|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957981|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957982|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957983|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957984|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957985|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957986|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957987|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
160957988|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
160957989|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957990|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957991|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957992|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
160957993|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
160957994|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
160957995|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
160957996|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
160957997|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
160957998|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
160957999|NCT03318523|581234031|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958000|NCT03318523|581234032|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958001|NCT03318523|581234033|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958002|NCT03318523|581234034|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958003|NCT03318523|581234035|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
160958004|NCT03318523|581234036|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958005|NCT03318523|581234037|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958006|NCT03318523|581234038|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
160958007|NCT03318523|581234039|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
160958008|NCT03318523|581234040|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
160958009|NCT01615328|581234043|FG000|Overall Study|Lost to Follow-up|3|||
160958010|NCT01615328|581234044|FG001|Overall Study|Lost to Follow-up|5|||
161146589|NCT01318902|581918529|FG002|Overall Study|Symptomatic Deterioration|1|||
161146590|NCT01318902|581918530|FG003|Overall Study|Symptomatic Deterioration|2|||
161146591|NCT01318902|581918527|FG000|Overall Study|Withdrawal by Patient|0|||
161146592|NCT01318902|581918528|FG001|Overall Study|Withdrawal by Patient|1|||
161146593|NCT01318902|581918529|FG002|Overall Study|Withdrawal by Patient|0|||
161146594|NCT01318902|581918530|FG003|Overall Study|Withdrawal by Patient|3|||
161146595|NCT01318902|581918527|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
161146596|NCT01318902|581918528|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
161146597|NCT01318902|581918529|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
161146598|NCT01318902|581918530|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
160958021|NCT00815295|581234055|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
160958022|NCT00815295|581234056|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
160958023|NCT00815295|581234057|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
160958024|NCT02794285|581234060|FG000|Overall Study|Adverse Event|11|||
160958025|NCT02794285|581234061|FG001|Overall Study|Adverse Event|4|||
160958026|NCT02794285|581234062|FG002|Overall Study|Adverse Event|5|||
160958027|NCT02794285|581234063|FG003|Overall Study|Adverse Event|8|||
160958028|NCT02794285|581234060|FG000|Overall Study|Condition Under Investigation Improved|1|||
160958029|NCT02794285|581234061|FG001|Overall Study|Condition Under Investigation Improved|0|||
161001502|NCT00324038|581390614|FG001|Overall Study|Lack of Efficacy|13|||
161001503|NCT00324038|581390613|FG000|Overall Study|Lost to Follow-up|0|||
160958030|NCT02794285|581234062|FG002|Overall Study|Condition Under Investigation Improved|0|||
160958031|NCT02794285|581234063|FG003|Overall Study|Condition Under Investigation Improved|0|||
160958032|NCT02794285|581234060|FG000|Overall Study|Condition Under Investigation Worsened|0|||
160958033|NCT02794285|581234061|FG001|Overall Study|Condition Under Investigation Worsened|2|||
160958034|NCT02794285|581234062|FG002|Overall Study|Condition Under Investigation Worsened|1|||
160958035|NCT02794285|581234063|FG003|Overall Study|Condition Under Investigation Worsened|0|||
160958036|NCT02794285|581234060|FG000|Overall Study|Death|2|||
160958037|NCT02794285|581234061|FG001|Overall Study|Death|1|||
160958038|NCT02794285|581234062|FG002|Overall Study|Death|2|||
160958039|NCT02794285|581234063|FG003|Overall Study|Death|0|||
160958040|NCT02794285|581234060|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
160958041|NCT02794285|581234061|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
160958042|NCT02794285|581234062|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
160958043|NCT02794285|581234063|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
160958044|NCT02794285|581234060|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
160958045|NCT02794285|581234061|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
160958046|NCT02794285|581234062|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
160958047|NCT02794285|581234063|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
160958048|NCT02794285|581234060|FG000|Overall Study|Lack of Efficacy|10|||
160958049|NCT02794285|581234061|FG001|Overall Study|Lack of Efficacy|6|||
160958050|NCT02794285|581234062|FG002|Overall Study|Lack of Efficacy|3|||
160958051|NCT02794285|581234063|FG003|Overall Study|Lack of Efficacy|3|||
160958052|NCT02794285|581234060|FG000|Overall Study|Lost to Follow-up|5|||
160958053|NCT02794285|581234061|FG001|Overall Study|Lost to Follow-up|6|||
160958054|NCT02794285|581234062|FG002|Overall Study|Lost to Follow-up|3|||
160958055|NCT02794285|581234063|FG003|Overall Study|Lost to Follow-up|1|||
160958056|NCT02794285|581234060|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
160958057|NCT02794285|581234061|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
160958058|NCT02794285|581234062|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
160958059|NCT02794285|581234063|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
160958060|NCT02794285|581234060|FG000|Overall Study|Withdrawal by Subject|38|||
160958061|NCT02794285|581234061|FG001|Overall Study|Withdrawal by Subject|29|||
160958062|NCT02794285|581234062|FG002|Overall Study|Withdrawal by Subject|20|||
160958063|NCT02794285|581234063|FG003|Overall Study|Withdrawal by Subject|12|||
160958064|NCT02794285|581234060|FG000|Overall Study|Missing|1|||
160958065|NCT02794285|581234061|FG001|Overall Study|Missing|0|||
160958066|NCT02794285|581234062|FG002|Overall Study|Missing|0|||
160958067|NCT02794285|581234063|FG003|Overall Study|Missing|0|||
160958068|NCT02794285|581234060|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
160958069|NCT02794285|581234061|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
160958070|NCT02794285|581234062|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
160958071|NCT02794285|581234063|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
160958072|NCT02794285|581234060|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
160958073|NCT02794285|581234061|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
160958074|NCT02794285|581234062|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
160958075|NCT02794285|581234063|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
160958076|NCT04969198|581234082|FG000|Overall Study|Withdrawal by Subject|20|||
160958077|NCT04969198|581234082|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
160958078|NCT04969198|581234082|FG000|Overall Study|Lost to Follow-up|20|||
160958079|NCT01640808|581234083|FG000|Overall Study|Unable to continue dynamic CT|14|||
160958080|NCT01640808|581234084|FG001|Overall Study|Unable to continue dynamic CT|4|||
160958081|NCT01640808|581234083|FG000|Overall Study|Withdrawal by Subject|12|||
160958082|NCT01640808|581234084|FG001|Overall Study|Withdrawal by Subject|4|||
160958083|NCT01640808|581234083|FG000|Overall Study|Lost to Follow-up|4|||
160958084|NCT01640808|581234084|FG001|Overall Study|Lost to Follow-up|0|||
160958085|NCT01640808|581234083|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
160958086|NCT01640808|581234084|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
160958087|NCT01640808|581234083|FG000|Overall Study|Administration of anticancer drugs|2|||
160958088|NCT01640808|581234084|FG001|Overall Study|Administration of anticancer drugs|1|||
160958089|NCT01640808|581234083|FG000|Overall Study|Physician Decision|19|||
160958090|NCT01640808|581234084|FG001|Overall Study|Physician Decision|5|||
160958091|NCT01640808|581234083|FG000|Overall Study|Randomized but not treated|4|||
160958092|NCT01640808|581234084|FG001|Overall Study|Randomized but not treated|2|||
160958093|NCT02477111|581234085|FG000|Overall Study|Death|28|||
161343455|NCT05452239|582644389|FG001|Open-label Period|Withdrawal by Subject|1|||
160958094|NCT02477111|581234085|FG000|Overall Study|Withdrawal by Subject|19|||
160958095|NCT02477111|581234085|FG000|Overall Study|Lost to Follow-up|4|||
160958096|NCT01381692|581234086|FG000|Overall Study|Adverse Event|1|||
160958097|NCT01381692|581234087|FG001|Overall Study|Adverse Event|0|||
160958098|NCT01381692|581234088|FG002|Overall Study|Adverse Event|0|||
160958099|NCT01381692|581234089|FG003|Overall Study|Adverse Event|0|||
160958100|NCT01381692|581234090|FG004|Overall Study|Adverse Event|0|||
160958101|NCT01381692|581234091|FG005|Overall Study|Adverse Event|0|||
160958102|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
161146599|NCT01318902|581918527|FG000|Overall Study|Adverse Event|0|||
161146600|NCT01318902|581918528|FG001|Overall Study|Adverse Event|1|||
161146601|NCT01318902|581918529|FG002|Overall Study|Adverse Event|0|||
161146602|NCT01318902|581918530|FG003|Overall Study|Adverse Event|0|||
161146603|NCT01318902|581918527|FG000|Overall Study|Terminated by Sponsor|0|||
161146604|NCT01318902|581918528|FG001|Overall Study|Terminated by Sponsor|0|||
160958103|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
160958104|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
160958105|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
160958106|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
160958107|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
160958108|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
160958109|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
160958110|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
160958111|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
160958112|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
160958113|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
160958114|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
160958115|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
160958116|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
160958117|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
160958118|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
160958119|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
160958120|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
160958121|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
160958122|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
160958123|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
160958124|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
160958125|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
160958126|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
160958127|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
160958128|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
160958129|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
160958130|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
160958131|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
160958132|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
160958133|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
161001504|NCT00324038|581390614|FG001|Overall Study|Lost to Follow-up|2|||
161001505|NCT00324038|581390613|FG000|Overall Study|Other|6|||
161001506|NCT00324038|581390614|FG001|Overall Study|Other|13|||
161001507|NCT01579916|581390618|FG000|Overall Study|Lost to Follow-up|6|||
161001508|NCT01579916|581390619|FG001|Overall Study|Lost to Follow-up|1|||
161001509|NCT01579916|581390618|FG000|Overall Study|Withdrawal by Subject|1|||
161001510|NCT01579916|581390619|FG001|Overall Study|Withdrawal by Subject|1|||
161001511|NCT01579916|581390618|FG000|Overall Study|Death|1|||
161001512|NCT01579916|581390619|FG001|Overall Study|Death|0|||
161001513|NCT03264456|581390620|FG000|Overall Study|Withdrawal by Subject|3|||
161001514|NCT03264456|581390620|FG000|Overall Study|Lost to Follow-up|1|||
161001515|NCT01123083|581390623|FG000|Overall Study|Investigator recommendation|1|||
161001516|NCT01123083|581390624|FG001|Overall Study|Investigator recommendation|1|||
161146605|NCT01318902|581918529|FG002|Overall Study|Terminated by Sponsor|1|||
161146606|NCT01318902|581918530|FG003|Overall Study|Terminated by Sponsor|0|||
161146607|NCT00375934|581919802|FG000|Overall Study|Adverse Event|1|||
161146608|NCT00375934|581919803|FG001|Overall Study|Adverse Event|1|||
161146609|NCT00375934|581919802|FG000|Overall Study|Withdrawal by Subject|2|||
161146610|NCT00375934|581919803|FG001|Overall Study|Withdrawal by Subject|2|||
161146611|NCT00375934|581919802|FG000|Overall Study|Lack of Efficacy|0|||
161146612|NCT00375934|581919803|FG001|Overall Study|Lack of Efficacy|2|||
161146613|NCT00375934|581919802|FG000|Overall Study|Physician Decision|0|||
161146614|NCT00375934|581919803|FG001|Overall Study|Physician Decision|1|||
161146615|NCT03191396|581919805|FG000|Overall Study|Lost to Follow-up|0|||
161146616|NCT03191396|581919806|FG001|Overall Study|Lost to Follow-up|3|||
161146617|NCT03191396|581919805|FG000|Overall Study|Withdrawal by Subject|3|||
161146618|NCT03191396|581919806|FG001|Overall Study|Withdrawal by Subject|2|||
161001517|NCT01123083|581390623|FG000|Overall Study|Administrative reasons|0|||
161146619|NCT00486226|581919817|FG000|Overall Study|Death|3|||
161146620|NCT00486226|581919817|FG000|Overall Study|Adverse Event|1|||
161146621|NCT00486226|581919817|FG000|Overall Study|Withdrawal by Subject|1|||
161146622|NCT00486226|581919817|FG000|Overall Study|Lost to Follow-up|8|||
161146623|NCT00500149|581919818|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
160958134|NCT04818346|581234095|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
160958135|NCT04818346|581234096|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
160958136|NCT04818346|581234097|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
160958137|NCT04818346|581234098|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
160958138|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
160958139|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
160958140|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
160958141|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
160958142|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
160958143|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
160958144|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
160958145|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
160958146|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
160958147|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
160958148|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
160958149|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
160958150|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
160958151|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
160958152|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
160958153|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
160958154|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
160958155|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
160958156|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
160958157|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
160958158|NCT04818346|581234095|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
160958159|NCT04818346|581234096|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
160958160|NCT04818346|581234097|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
160958161|NCT04818346|581234098|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
160958162|NCT03896035|581234099|FG000|Overall Study|Lost to Follow-up|2|||
160958163|NCT03896035|581234100|FG001|Overall Study|Lost to Follow-up|6|||
160958164|NCT03896035|581234099|FG000|Overall Study|Withdrawal by Subject|0|||
160958165|NCT03896035|581234100|FG001|Overall Study|Withdrawal by Subject|1|||
160958166|NCT03896035|581234099|FG000|Overall Study|Health/family health issues during COVID|0|||
160958167|NCT03896035|581234100|FG001|Overall Study|Health/family health issues during COVID|4|||
160958168|NCT01362140|581234101|FG000|Overall Study|Noncompliance|1|||
160958169|NCT01362140|581234102|FG001|Overall Study|Noncompliance|0|||
160958170|NCT01362140|581234101|FG000|Overall Study|Adverse Event|2|||
160958171|NCT01362140|581234102|FG001|Overall Study|Adverse Event|2|||
160958172|NCT01362140|581234101|FG000|Overall Study|Withdrawal by Subject|3|||
160958173|NCT01362140|581234102|FG001|Overall Study|Withdrawal by Subject|3|||
160958174|NCT01362140|581234101|FG000|Overall Study|Administrative Decision|0|||
160958175|NCT01362140|581234102|FG001|Overall Study|Administrative Decision|1|||
160958176|NCT01362140|581234101|FG000|Overall Study|Death|2|||
160958177|NCT01362140|581234102|FG001|Overall Study|Death|1|||
160958178|NCT01362140|581234101|FG000|Overall Study|Other|1|||
160958179|NCT01362140|581234102|FG001|Overall Study|Other|1|||
160958180|NCT01362140|581234101|FG000|Overall Study|Protocol-specified Criteria|1|||
160958181|NCT01362140|581234102|FG001|Overall Study|Protocol-specified Criteria|2|||
160958182|NCT01362140|581234101|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
160958183|NCT01362140|581234102|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
160958184|NCT05553808|581234103|FG000|Overall Study|Death|25|||
160958185|NCT05553808|581234104|FG001|Overall Study|Death|62|||
160958186|NCT05553808|581234103|FG000|Overall Study|Site Closed|6|||
160958187|NCT05553808|581234104|FG001|Overall Study|Site Closed|6|||
160958188|NCT05553808|581234103|FG000|Overall Study|Lost to Follow-up|1|||
160958189|NCT05553808|581234104|FG001|Overall Study|Lost to Follow-up|0|||
160958190|NCT05553808|581234103|FG000|Overall Study|Withdrawal by Subject|3|||
160958191|NCT05553808|581234104|FG001|Overall Study|Withdrawal by Subject|2|||
160958192|NCT02273141|581234107|FG000|Overall Study|Adverse Event|0|||
161269254|NCT02562482|582366969|FG000|Overall Study|Moved from area|2|||
161269255|NCT02562482|582366970|FG001|Overall Study|Moved from area|3|||
160958193|NCT02273141|581234108|FG001|Overall Study|Adverse Event|1|||
160958194|NCT02273141|581234107|FG000|Overall Study|Lost to Follow-up|1|||
160958195|NCT02273141|581234108|FG001|Overall Study|Lost to Follow-up|3|||
160958196|NCT02273141|581234107|FG000|Overall Study|Withdrawal by Subject|10|||
161146624|NCT00500149|581919819|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
161146625|NCT00500149|581919818|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
161269256|NCT02562482|582366969|FG000|Overall Study|Withdrawal by Subject|5|||
161269257|NCT02562482|582366970|FG001|Overall Study|Withdrawal by Subject|3|||
161146626|NCT00500149|581919819|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
161146627|NCT00500149|581919818|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
161146628|NCT00500149|581919819|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
161146629|NCT00500149|581919818|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
161146630|NCT00500149|581919819|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
161146631|NCT00500149|581919818|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
161146632|NCT00500149|581919819|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
161146633|NCT00500149|581919818|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
161146634|NCT00500149|581919819|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
161146635|NCT00500149|581919818|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
160958197|NCT02273141|581234108|FG001|Overall Study|Withdrawal by Subject|15|||
160958198|NCT02273141|581234107|FG000|Overall Study|Various|6|||
160958199|NCT02273141|581234108|FG001|Overall Study|Various|6|||
160958200|NCT01556438|581234109|FG000|Overall Study|Adverse Event|4|||
160958201|NCT01556438|581234110|FG001|Overall Study|Adverse Event|2|||
160958202|NCT01556438|581234109|FG000|Overall Study|Sponsor Decision|0|||
160958203|NCT01556438|581234110|FG001|Overall Study|Sponsor Decision|2|||
160958204|NCT01556438|581234109|FG000|Overall Study|Progressive Disease|0|||
160958205|NCT01556438|581234110|FG001|Overall Study|Progressive Disease|6|||
160958206|NCT01556438|581234109|FG000|Overall Study|Death|0|||
160958207|NCT01556438|581234110|FG001|Overall Study|Death|1|||
160958208|NCT00529399|581234113|FG000|Overall Study|Lost to Follow-up|1|||
160958209|NCT00529399|581234114|FG001|Overall Study|Lost to Follow-up|0|||
160958210|NCT00529399|581234115|FG002|Overall Study|Lost to Follow-up|1|||
160958211|NCT00529399|581234113|FG000|Overall Study|Withdrawal by Subject|1|||
160958212|NCT00529399|581234114|FG001|Overall Study|Withdrawal by Subject|0|||
160958213|NCT00529399|581234115|FG002|Overall Study|Withdrawal by Subject|1|||
160958214|NCT00529399|581234113|FG000|Overall Study|Non-compliant|0|||
160958215|NCT00529399|581234114|FG001|Overall Study|Non-compliant|1|||
160958216|NCT00529399|581234115|FG002|Overall Study|Non-compliant|0|||
160958217|NCT03695172|581234116|FG000|Overall Study|Withdrawal by Subject|1|||
160958218|NCT03695172|581234117|FG001|Overall Study|Withdrawal by Subject|1|||
160958219|NCT03695172|581234118|FG002|Overall Study|Withdrawal by Subject|0|||
160958220|NCT01506193|581234119|FG000|Overall Study|Protocol Violation|1|||
160958221|NCT01506193|581234120|FG001|Overall Study|Protocol Violation|0|||
160958222|NCT01506193|581234121|FG002|Overall Study|Protocol Violation|1|||
160958223|NCT01506193|581234119|FG000|Overall Study|Migrated/moved from study area|0|||
160958224|NCT01506193|581234120|FG001|Overall Study|Migrated/moved from study area|0|||
160958225|NCT01506193|581234121|FG002|Overall Study|Migrated/moved from study area|1|||
160958226|NCT01506193|581234119|FG000|Overall Study|Adverse event, non-fatal|0|||
160958227|NCT01506193|581234120|FG001|Overall Study|Adverse event, non-fatal|0|||
160958228|NCT01506193|581234121|FG002|Overall Study|Adverse event, non-fatal|1|||
160958229|NCT01506193|581234119|FG000|Overall Study|Withdrawal by Subject|5|||
160958230|NCT01506193|581234120|FG001|Overall Study|Withdrawal by Subject|1|||
160958231|NCT01506193|581234121|FG002|Overall Study|Withdrawal by Subject|8|||
160958232|NCT01506193|581234119|FG000|Overall Study|Lost to Follow-up|8|||
160958233|NCT01506193|581234120|FG001|Overall Study|Lost to Follow-up|3|||
160958234|NCT01506193|581234121|FG002|Overall Study|Lost to Follow-up|3|||
160958235|NCT01388816|581234139|FG000|Overall Study|Adverse Event|0|||
160958236|NCT01388816|581234140|FG001|Overall Study|Adverse Event|2|||
160958237|NCT01388816|581234141|FG002|Overall Study|Adverse Event|0|||
160958238|NCT01388816|581234142|FG003|Overall Study|Adverse Event|0|||
160958239|NCT01388816|581234139|FG000|Overall Study|Lost to Follow-up|0|||
160958240|NCT01388816|581234140|FG001|Overall Study|Lost to Follow-up|1|||
161146636|NCT00500149|581919819|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
161146637|NCT01157169|581919820|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
161146638|NCT01157169|581919821|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
161146639|NCT01157169|581919820|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
161269258|NCT02562482|582366969|FG000|Overall Study|Physician Decision|1|||
161269259|NCT02562482|582366970|FG001|Overall Study|Physician Decision|3|||
161269260|NCT02562482|582366969|FG000|Overall Study|Illness/Injury unrelated to product|0|||
161269261|NCT02562482|582366970|FG001|Overall Study|Illness/Injury unrelated to product|1|||
161269262|NCT05896202|582366973|FG000|Overall Study|Lost to Follow-up|2|||
160958241|NCT01388816|581234141|FG002|Overall Study|Lost to Follow-up|0|||
160958242|NCT01388816|581234142|FG003|Overall Study|Lost to Follow-up|0|||
160958243|NCT01388816|581234139|FG000|Overall Study|Withdrawal by Subject|2|||
160958244|NCT01388816|581234140|FG001|Overall Study|Withdrawal by Subject|1|||
160958245|NCT01388816|581234141|FG002|Overall Study|Withdrawal by Subject|1|||
160958246|NCT01388816|581234142|FG003|Overall Study|Withdrawal by Subject|0|||
160958247|NCT01388816|581234139|FG000|Overall Study|Protocol Violation|0|||
160958248|NCT01388816|581234140|FG001|Overall Study|Protocol Violation|0|||
160958249|NCT01388816|581234141|FG002|Overall Study|Protocol Violation|2|||
160958250|NCT01388816|581234142|FG003|Overall Study|Protocol Violation|0|||
160958251|NCT04575467|581234143|FG000|Overall Study|Adverse Event|0|||
161269263|NCT05896202|582366974|FG001|Overall Study|Lost to Follow-up|2|||
161269264|NCT01181271|582366977|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
160958252|NCT04575467|581234144|FG001|Overall Study|Adverse Event|1|||
160958253|NCT04575467|581234145|FG002|Overall Study|Adverse Event|0|||
160958254|NCT04575467|581234146|FG003|Overall Study|Adverse Event|0|||
160958255|NCT00743366|581234147|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
160958256|NCT00743366|581234148|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
160958257|NCT01328574|581234149|FG000|Overall Study|Refused further treatment|1|||
160958258|NCT03206203|581234150|FG000|Treatment|Death|38|||
160958259|NCT03206203|581234151|FG001|Treatment|Death|26|||
160958260|NCT03206203|581234152|FG002|Treatment|Death|0|||
160958261|NCT03206203|581234150|FG000|Treatment|Withdrawal by Subject|1|||
160958262|NCT03206203|581234151|FG001|Treatment|Withdrawal by Subject|0|||
160958263|NCT03206203|581234152|FG002|Treatment|Withdrawal by Subject|0|||
161269265|NCT01181271|582366977|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
161269266|NCT01181271|582366977|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
161269267|NCT01181271|582366977|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
161269268|NCT02041091|582366978|FG000|Treatment|Adverse Event|3|||
161269269|NCT02041091|582366979|FG001|Treatment|Adverse Event|3|||
161269270|NCT02041091|582366978|FG000|Treatment|Withdrawal by Subject|2|||
161269271|NCT02041091|582366979|FG001|Treatment|Withdrawal by Subject|4|||
161269272|NCT02041091|582366978|FG000|Treatment|Physician Decision|1|||
161269273|NCT02041091|582366979|FG001|Treatment|Physician Decision|0|||
161269274|NCT02041091|582366978|FG000|Treatment|Sponsor Decision|15|||
161269275|NCT02041091|582366979|FG001|Treatment|Sponsor Decision|16|||
161269276|NCT02041091|582366978|FG000|Treatment|Lost to Follow-up|1|||
161269277|NCT02041091|582366979|FG001|Treatment|Lost to Follow-up|0|||
161269278|NCT02041091|582366978|FG000|Optional Safety Extension Period|Adverse Event|4|||
161269279|NCT02041091|582366979|FG001|Optional Safety Extension Period|Adverse Event|2|||
161269280|NCT02041091|582366978|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
161269281|NCT02041091|582366979|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
161269282|NCT02041091|582366978|FG000|Optional Safety Extension Period|Protocol Violation|2|||
161269283|NCT02041091|582366979|FG001|Optional Safety Extension Period|Protocol Violation|0|||
161269284|NCT02041091|582366978|FG000|Optional Safety Extension Period|Physician Decision|2|||
161269285|NCT02041091|582366979|FG001|Optional Safety Extension Period|Physician Decision|1|||
161269286|NCT02041091|582366978|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
161269287|NCT02041091|582366979|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
161269288|NCT02041091|582366978|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
161269289|NCT02041091|582366979|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
161269290|NCT03970837|582366980|FG000|Overall Study|Adverse Event|23|||
161269291|NCT03970837|582366981|FG001|Overall Study|Adverse Event|20|||
161269292|NCT03970837|582366982|FG002|Overall Study|Adverse Event|16|||
161269293|NCT03970837|582366983|FG003|Overall Study|Adverse Event|6|||
161269294|NCT03970837|582366984|FG004|Overall Study|Adverse Event|4|||
161269295|NCT03970837|582366985|FG005|Overall Study|Adverse Event|5|||
161269296|NCT03970837|582366986|FG006|Overall Study|Adverse Event|1|||
161269297|NCT03970837|582366987|FG007|Overall Study|Adverse Event|5|||
161269298|NCT03970837|582366988|FG008|Overall Study|Adverse Event|0|||
161269299|NCT03970837|582366989|FG009|Overall Study|Adverse Event|0|||
161269300|NCT03970837|582366990|FG010|Overall Study|Adverse Event|1|||
160958264|NCT03206203|581234150|FG000|Treatment|Lost to Follow-up|4|||
160958265|NCT03206203|581234151|FG001|Treatment|Lost to Follow-up|0|||
160958266|NCT03206203|581234152|FG002|Treatment|Lost to Follow-up|0|||
160958267|NCT03206203|581234150|FG000|Treatment|N/A in Follow-Up|8|||
160958268|NCT03206203|581234151|FG001|Treatment|N/A in Follow-Up|1|||
160958269|NCT03206203|581234152|FG002|Treatment|N/A in Follow-Up|0|||
160958270|NCT03206203|581234150|FG000|Treatment|Disease progression|0|||
160958271|NCT03206203|581234151|FG001|Treatment|Disease progression|1|||
160958272|NCT03206203|581234152|FG002|Treatment|Disease progression|0|||
160958273|NCT03206203|581234150|FG000|Treatment|Refused follow-up|0|||
160958274|NCT03206203|581234151|FG001|Treatment|Refused follow-up|1|||
160958275|NCT03206203|581234152|FG002|Treatment|Refused follow-up|0|||
161269301|NCT03970837|582366991|FG011|Overall Study|Adverse Event|1|||
161269302|NCT03970837|582366980|FG000|Overall Study|Lack of Efficacy|14|||
161269303|NCT03970837|582366981|FG001|Overall Study|Lack of Efficacy|12|||
161269304|NCT03970837|582366982|FG002|Overall Study|Lack of Efficacy|1|||
161269305|NCT03970837|582366983|FG003|Overall Study|Lack of Efficacy|2|||
161269306|NCT03970837|582366984|FG004|Overall Study|Lack of Efficacy|3|||
161269307|NCT03970837|582366985|FG005|Overall Study|Lack of Efficacy|4|||
161269308|NCT03970837|582366986|FG006|Overall Study|Lack of Efficacy|6|||
161269309|NCT03970837|582366987|FG007|Overall Study|Lack of Efficacy|1|||
161269310|NCT03970837|582366988|FG008|Overall Study|Lack of Efficacy|1|||
160958276|NCT03206203|581234150|FG000|Treatment|Cross over to Arm 1|0|||
160958277|NCT03206203|581234151|FG001|Treatment|Cross over to Arm 1|19|||
160958278|NCT03206203|581234152|FG002|Treatment|Cross over to Arm 1|0|||
160958279|NCT03206203|581234150|FG000|Optional Cross-Over|Death|0|||
160958280|NCT03206203|581234151|FG001|Optional Cross-Over|Death|0|||
160958281|NCT03206203|581234152|FG002|Optional Cross-Over|Death|14|||
160958282|NCT03206203|581234150|FG000|Optional Cross-Over|Refused follow-up|0|||
161269311|NCT03970837|582366989|FG009|Overall Study|Lack of Efficacy|0|||
160958283|NCT03206203|581234151|FG001|Optional Cross-Over|Refused follow-up|0|||
160958284|NCT03206203|581234152|FG002|Optional Cross-Over|Refused follow-up|2|||
160958285|NCT03998618|581234155|FG000|Overall Study|Death|7|||
160958286|NCT03998618|581234156|FG001|Overall Study|Death|11|||
160958287|NCT03998618|581234155|FG000|Overall Study|hospice enrollment|3|||
160958288|NCT03998618|581234156|FG001|Overall Study|hospice enrollment|3|||
160958289|NCT03998618|581234155|FG000|Overall Study|Not feeling well/health problems|3|||
160958290|NCT03998618|581234156|FG001|Overall Study|Not feeling well/health problems|5|||
161269312|NCT03970837|582366990|FG010|Overall Study|Lack of Efficacy|0|||
161269313|NCT03970837|582366991|FG011|Overall Study|Lack of Efficacy|0|||
161269314|NCT03970837|582366980|FG000|Overall Study|Lost to Follow-up|6|||
161269315|NCT03970837|582366981|FG001|Overall Study|Lost to Follow-up|5|||
161269316|NCT03970837|582366982|FG002|Overall Study|Lost to Follow-up|5|||
161269317|NCT03970837|582366983|FG003|Overall Study|Lost to Follow-up|1|||
161269318|NCT03970837|582366984|FG004|Overall Study|Lost to Follow-up|0|||
161269319|NCT03970837|582366985|FG005|Overall Study|Lost to Follow-up|2|||
161269320|NCT03970837|582366986|FG006|Overall Study|Lost to Follow-up|0|||
161269321|NCT03970837|582366987|FG007|Overall Study|Lost to Follow-up|0|||
161269322|NCT03970837|582366988|FG008|Overall Study|Lost to Follow-up|0|||
161269323|NCT03970837|582366989|FG009|Overall Study|Lost to Follow-up|0|||
161269324|NCT03970837|582366990|FG010|Overall Study|Lost to Follow-up|0|||
161269325|NCT03970837|582366991|FG011|Overall Study|Lost to Follow-up|0|||
161269326|NCT03970837|582366980|FG000|Overall Study|Protocol Violation|1|||
161269327|NCT03970837|582366981|FG001|Overall Study|Protocol Violation|0|||
161269328|NCT03970837|582366982|FG002|Overall Study|Protocol Violation|0|||
161269329|NCT03970837|582366983|FG003|Overall Study|Protocol Violation|0|||
161269330|NCT03970837|582366984|FG004|Overall Study|Protocol Violation|0|||
161269331|NCT03970837|582366985|FG005|Overall Study|Protocol Violation|0|||
161269332|NCT03970837|582366986|FG006|Overall Study|Protocol Violation|0|||
161269333|NCT03970837|582366987|FG007|Overall Study|Protocol Violation|0|||
161269334|NCT03970837|582366988|FG008|Overall Study|Protocol Violation|0|||
161269335|NCT03970837|582366989|FG009|Overall Study|Protocol Violation|0|||
161269336|NCT03970837|582366990|FG010|Overall Study|Protocol Violation|0|||
161269337|NCT03970837|582366991|FG011|Overall Study|Protocol Violation|0|||
161269338|NCT03970837|582366980|FG000|Overall Study|Physician Decision|5|||
161269339|NCT03970837|582366981|FG001|Overall Study|Physician Decision|8|||
161269340|NCT03970837|582366982|FG002|Overall Study|Physician Decision|4|||
161269341|NCT03970837|582366983|FG003|Overall Study|Physician Decision|1|||
161269342|NCT03970837|582366984|FG004|Overall Study|Physician Decision|5|||
161269343|NCT03970837|582366985|FG005|Overall Study|Physician Decision|2|||
161269344|NCT03970837|582366986|FG006|Overall Study|Physician Decision|4|||
161269345|NCT03970837|582366987|FG007|Overall Study|Physician Decision|5|||
161269346|NCT03970837|582366988|FG008|Overall Study|Physician Decision|0|||
161269347|NCT03970837|582366989|FG009|Overall Study|Physician Decision|1|||
161269348|NCT03970837|582366990|FG010|Overall Study|Physician Decision|0|||
161269349|NCT03970837|582366991|FG011|Overall Study|Physician Decision|0|||
161269350|NCT03970837|582366980|FG000|Overall Study|Withdrawal by Subject|32|||
161269351|NCT03970837|582366981|FG001|Overall Study|Withdrawal by Subject|35|||
161269352|NCT03970837|582366982|FG002|Overall Study|Withdrawal by Subject|12|||
161269353|NCT03970837|582366983|FG003|Overall Study|Withdrawal by Subject|8|||
161269354|NCT03970837|582366984|FG004|Overall Study|Withdrawal by Subject|6|||
161269355|NCT03970837|582366985|FG005|Overall Study|Withdrawal by Subject|8|||
161269356|NCT03970837|582366986|FG006|Overall Study|Withdrawal by Subject|2|||
161269357|NCT03970837|582366987|FG007|Overall Study|Withdrawal by Subject|3|||
161269358|NCT03970837|582366988|FG008|Overall Study|Withdrawal by Subject|0|||
161269359|NCT03970837|582366989|FG009|Overall Study|Withdrawal by Subject|0|||
161269360|NCT03970837|582366990|FG010|Overall Study|Withdrawal by Subject|0|||
161269361|NCT03970837|582366991|FG011|Overall Study|Withdrawal by Subject|1|||
161269362|NCT03970837|582366980|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
161343456|NCT05452239|582644388|FG000|Open-label Period|Lost to Follow-up|3|||
161343457|NCT05452239|582644389|FG001|Open-label Period|Lost to Follow-up|0|||
160958291|NCT03998618|581234155|FG000|Overall Study|Lost to Follow-up|6|||
160958292|NCT03998618|581234156|FG001|Overall Study|Lost to Follow-up|6|||
160958293|NCT03998618|581234155|FG000|Overall Study|Withdrawal by Subject|0|||
161269363|NCT03970837|582366981|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
160958294|NCT03998618|581234156|FG001|Overall Study|Withdrawal by Subject|4|||
161269364|NCT03970837|582366982|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
161269365|NCT03970837|582366983|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161269366|NCT03970837|582366984|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
161269367|NCT03970837|582366985|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161269368|NCT03970837|582366986|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160958295|NCT02308748|581234161|FG000|Period 1|Withdrawal by Subject|0|||
161269369|NCT03970837|582366987|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
160958296|NCT02308748|581234162|FG001|Period 1|Withdrawal by Subject|0|||
160958297|NCT02308748|581234163|FG002|Period 1|Withdrawal by Subject|1|||
160958298|NCT02308748|581234164|FG003|Period 1|Withdrawal by Subject|0|||
160958299|NCT02308748|581234165|FG004|Period 1|Withdrawal by Subject|0|||
161269370|NCT03970837|582366988|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
161269371|NCT03970837|582366989|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161269372|NCT03970837|582366990|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161269373|NCT03970837|582366991|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
161269374|NCT03970837|582366980|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161269375|NCT03970837|582366981|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161269376|NCT03970837|582366982|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161269377|NCT03970837|582366983|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161269378|NCT03970837|582366984|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161269379|NCT03970837|582366985|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161269380|NCT03970837|582366986|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
161269381|NCT03970837|582366987|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
161269382|NCT03970837|582366988|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
161269383|NCT03970837|582366989|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
161269384|NCT03970837|582366990|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
161269385|NCT03970837|582366991|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
161269386|NCT02370329|582370202|FG000|Overall Study|Alternate treatment|1|||
161269387|NCT02370329|582370202|FG000|Overall Study|Adverse Event|1|||
161269388|NCT02370329|582370202|FG000|Overall Study|Disease progression|3|||
161269389|NCT02370329|582370202|FG000|Overall Study|Physician Decision|2|||
161269390|NCT02370329|582370202|FG000|Overall Study|Study closure|4|||
160958300|NCT02308748|581234166|FG005|Period 1|Withdrawal by Subject|0|||
160958301|NCT02308748|581234167|FG006|Period 1|Withdrawal by Subject|0|||
160958302|NCT02308748|581234168|FG007|Period 1|Withdrawal by Subject|0|||
160958303|NCT02308748|581234169|FG008|Period 1|Withdrawal by Subject|0|||
161269391|NCT02022748|582370203|FG000|Overall Study|Adverse Event|1|||
161269392|NCT02022748|582370204|FG001|Overall Study|Adverse Event|1|||
161269393|NCT02022748|582370205|FG002|Overall Study|Adverse Event|0|||
160958304|NCT02308748|581234170|FG009|Period 1|Withdrawal by Subject|0|||
161269394|NCT02022748|582370203|FG000|Overall Study|Withdrawal by Subject|0|||
161269395|NCT02022748|582370204|FG001|Overall Study|Withdrawal by Subject|1|||
161269396|NCT02022748|582370205|FG002|Overall Study|Withdrawal by Subject|0|||
161269397|NCT04347122|582370207|FG000|Overall Study|Physician Decision|0|||
161269398|NCT04347122|582370208|FG001|Overall Study|Physician Decision|3|||
161269399|NCT04347122|582370209|FG002|Overall Study|Physician Decision|3|||
161269400|NCT04347122|582370210|FG003|Overall Study|Physician Decision|6|||
161269401|NCT03510598|582370211|FG000|Overall Study|Withdrawal by Subject|1|||
161269402|NCT00112866|582370212|FG000|Overall Study|Protocol Violation|1|||
161269403|NCT00112866|582370213|FG001|Overall Study|Protocol Violation|0|||
161269404|NCT00112866|582370212|FG000|Overall Study|did not start treatment post-op|1|||
161269405|NCT00112866|582370213|FG001|Overall Study|did not start treatment post-op|2|||
161269406|NCT04663295|582370214|FG000|Run-in Period|Withdrawal by Subject|3|||
161269407|NCT04663295|582370214|FG000|Overall Study Period|Pregnancy|1|||
161269408|NCT04663295|582370214|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
161269409|NCT00554190|582370215|FG000|Overall Study|Termination forms not completed|10|||
161269410|NCT01502410|582370216|FG000|Overall Study|Adverse Event|1|||
161269411|NCT01502410|582370217|FG001|Overall Study|Adverse Event|2|||
161269412|NCT01502410|582370218|FG002|Overall Study|Adverse Event|0|||
161269413|NCT01502410|582370219|FG003|Overall Study|Adverse Event|0|||
161269414|NCT01502410|582370216|FG000|Overall Study|Lack of Efficacy|7|||
161269415|NCT01502410|582370217|FG001|Overall Study|Lack of Efficacy|7|||
161269416|NCT01502410|582370218|FG002|Overall Study|Lack of Efficacy|0|||
161269417|NCT01502410|582370219|FG003|Overall Study|Lack of Efficacy|0|||
161269418|NCT01502410|582370216|FG000|Overall Study|Physician Decision|0|||
161269419|NCT01502410|582370217|FG001|Overall Study|Physician Decision|1|||
161269420|NCT01502410|582370218|FG002|Overall Study|Physician Decision|0|||
161269421|NCT01502410|582370219|FG003|Overall Study|Physician Decision|0|||
161269422|NCT01502410|582370216|FG000|Overall Study|Withdrawal by Subject|2|||
161269423|NCT01502410|582370217|FG001|Overall Study|Withdrawal by Subject|0|||
161269424|NCT01502410|582370218|FG002|Overall Study|Withdrawal by Subject|0|||
160958305|NCT02308748|581234161|FG000|Period 2|Adverse Event|0|||
160958306|NCT02308748|581234162|FG001|Period 2|Adverse Event|0|||
160958307|NCT02308748|581234163|FG002|Period 2|Adverse Event|0|||
160958308|NCT02308748|581234164|FG003|Period 2|Adverse Event|0|||
161146640|NCT01157169|581919821|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
161146641|NCT00663858|581919822|FG000|Overall Study|Adverse Event|9|||
161146642|NCT00663858|581919823|FG001|Overall Study|Adverse Event|1|||
161269425|NCT01502410|582370219|FG003|Overall Study|Withdrawal by Subject|0|||
161269426|NCT03700385|582370223|FG000|Overall Study|Lost to Follow-up|1|||
161269427|NCT00699283|582370224|FG000|Overall Study|Lack of Efficacy|15|||
161269428|NCT00699283|582370225|FG001|Overall Study|Lack of Efficacy|5|||
161269429|NCT00699283|582370224|FG000|Overall Study|Lost to Follow-up|2|||
161269430|NCT00699283|582370225|FG001|Overall Study|Lost to Follow-up|0|||
161269431|NCT00699283|582370224|FG000|Overall Study|Withdrawal by Subject|1|||
161269432|NCT00699283|582370225|FG001|Overall Study|Withdrawal by Subject|0|||
160958309|NCT02308748|581234165|FG004|Period 2|Adverse Event|0|||
160958310|NCT02308748|581234166|FG005|Period 2|Adverse Event|0|||
160958311|NCT02308748|581234167|FG006|Period 2|Adverse Event|0|||
161269433|NCT00699283|582370224|FG000|Overall Study|Other Reason|5|||
161269434|NCT00699283|582370225|FG001|Overall Study|Other Reason|1|||
161269435|NCT00699283|582370224|FG000|Overall Study|SAE, non-fatal|1|||
161269436|NCT00699283|582370225|FG001|Overall Study|SAE, non-fatal|1|||
161269437|NCT00699283|582370224|FG000|Overall Study|AE, non-serious non-fatal|8|||
161269438|NCT00699283|582370225|FG001|Overall Study|AE, non-serious non-fatal|1|||
161269439|NCT00699283|582370224|FG000|Overall Study|AE of unknown type|1|||
161269440|NCT00699283|582370225|FG001|Overall Study|AE of unknown type|0|||
161269441|NCT04590040|582370226|FG000|Treatment Period|Lost to Follow-up|2|||
161269442|NCT04590040|582370227|FG001|Treatment Period|Lost to Follow-up|5|||
161269443|NCT04590040|582370228|FG002|Treatment Period|Lost to Follow-up|0|||
161269444|NCT04590040|582370226|FG000|Treatment Period|Physician Decision|0|||
161269445|NCT04590040|582370227|FG001|Treatment Period|Physician Decision|0|||
161269446|NCT04590040|582370228|FG002|Treatment Period|Physician Decision|2|||
161269447|NCT00000378|582370236|FG000|Overall Study|Lack of Efficacy|16|||
161269448|NCT00000378|582370237|FG001|Overall Study|Lack of Efficacy|14|||
161269449|NCT01284361|582370240|FG000|Overall Study|Withdrawal by Subject|1|||
161269450|NCT01284361|582370240|FG000|Overall Study|Protocol Violation|5|||
161269451|NCT01284361|582370240|FG000|Overall Study|Adverse Event|1|||
161269452|NCT01284361|582370240|FG000|Overall Study|Lost to Follow-up|2|||
161269453|NCT02771795|582370241|FG000|Overall Study|Withdrawal by Subject|47|||
161269454|NCT02771795|582370242|FG001|Overall Study|Withdrawal by Subject|37|||
161269455|NCT02771795|582370241|FG000|Overall Study|Termination by premature discontinuation of study|168|||
161269456|NCT02771795|582370242|FG001|Overall Study|Termination by premature discontinuation of study|185|||
161269457|NCT01957397|582370243|FG000|Test Period 1|sudden leakage/small bag|1|||
161269458|NCT01957397|582370244|FG001|Test Period 1|sudden leakage/small bag|1|||
161269459|NCT01957397|582370243|FG000|Test Period 1|Withdrawal by Subject|1|||
161269460|NCT01957397|582370244|FG001|Test Period 1|Withdrawal by Subject|0|||
161269461|NCT01957397|582370243|FG000|Test Period 2|Adverse Event|0|||
161269462|NCT01957397|582370244|FG001|Test Period 2|Adverse Event|1|||
161269463|NCT01957397|582370243|FG000|Test Period 3|Adverse Event|1|||
161269464|NCT01957397|582370244|FG001|Test Period 3|Adverse Event|2|||
161269465|NCT01957397|582370243|FG000|Test Period 3|the adhesive did not work|1|||
160958312|NCT02308748|581234168|FG007|Period 2|Adverse Event|1|||
160958313|NCT02308748|581234169|FG008|Period 2|Adverse Event|0|||
160958314|NCT02308748|581234170|FG009|Period 2|Adverse Event|0|||
160958315|NCT02308748|581234161|FG000|Period 3|Protocol Violation|0|||
160958316|NCT02308748|581234162|FG001|Period 3|Protocol Violation|0|||
160958317|NCT02308748|581234163|FG002|Period 3|Protocol Violation|0|||
160958318|NCT02308748|581234164|FG003|Period 3|Protocol Violation|0|||
160958319|NCT02308748|581234165|FG004|Period 3|Protocol Violation|0|||
160958320|NCT02308748|581234166|FG005|Period 3|Protocol Violation|0|||
160958321|NCT02308748|581234167|FG006|Period 3|Protocol Violation|0|||
160958322|NCT02308748|581234168|FG007|Period 3|Protocol Violation|0|||
160958323|NCT02308748|581234169|FG008|Period 3|Protocol Violation|0|||
160958324|NCT02308748|581234170|FG009|Period 3|Protocol Violation|1|||
160958325|NCT02308748|581234161|FG000|Period 5|Adverse Event|1|||
160958326|NCT02308748|581234162|FG001|Period 5|Adverse Event|0|||
160958327|NCT02308748|581234163|FG002|Period 5|Adverse Event|0|||
160958328|NCT02308748|581234164|FG003|Period 5|Adverse Event|0|||
160958329|NCT02308748|581234165|FG004|Period 5|Adverse Event|0|||
160958330|NCT02308748|581234166|FG005|Period 5|Adverse Event|0|||
160958331|NCT02308748|581234167|FG006|Period 5|Adverse Event|0|||
160958332|NCT02308748|581234168|FG007|Period 5|Adverse Event|0|||
160958333|NCT02308748|581234169|FG008|Period 5|Adverse Event|1|||
160958334|NCT02308748|581234170|FG009|Period 5|Adverse Event|0|||
160958335|NCT01152580|581234171|FG000|Overall Study|Withdrawal by Subject|0|||
160958336|NCT01152580|581234172|FG001|Overall Study|Withdrawal by Subject|1|||
160958337|NCT01994954|581234173|FG000|Overall Study|Death|1|||
160958338|NCT01994954|581234174|FG001|Overall Study|Death|0|||
160958339|NCT01994954|581234173|FG000|Overall Study|Withdrawal by Subject|9|||
160958340|NCT01994954|581234174|FG001|Overall Study|Withdrawal by Subject|14|||
161146643|NCT00663858|581919824|FG002|Overall Study|Adverse Event|6|||
161146644|NCT00663858|581919822|FG000|Overall Study|Lack of Efficacy|5|||
160958341|NCT01994954|581234173|FG000|Overall Study|Physician Decision|2|||
161269466|NCT01957397|582370244|FG001|Test Period 3|the adhesive did not work|0|||
161269467|NCT00505375|582370245|FG000|Overall Study|Death|1|||
161269468|NCT00505375|582370246|FG001|Overall Study|Death|0|||
161269469|NCT00505375|582370245|FG000|Overall Study|Withdrawal by Subject|2|||
161269470|NCT00505375|582370246|FG001|Overall Study|Withdrawal by Subject|2|||
161269471|NCT00505375|582370245|FG000|Overall Study|Lost to Follow-up|0|||
161269472|NCT00505375|582370246|FG001|Overall Study|Lost to Follow-up|2|||
161269473|NCT00505375|582370245|FG000|Overall Study|Pregnancy|1|||
161269474|NCT00505375|582370246|FG001|Overall Study|Pregnancy|0|||
160958342|NCT01994954|581234174|FG001|Overall Study|Physician Decision|2|||
160958343|NCT01994954|581234173|FG000|Overall Study|Lost to Follow-up|8|||
160958344|NCT01994954|581234174|FG001|Overall Study|Lost to Follow-up|10|||
160958345|NCT01994954|581234173|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
160958346|NCT01994954|581234174|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
161146645|NCT00663858|581919823|FG001|Overall Study|Lack of Efficacy|1|||
161269475|NCT00505375|582370245|FG000|Overall Study|Travel issues|0|||
161269476|NCT00505375|582370246|FG001|Overall Study|Travel issues|1|||
161269477|NCT02906930|582370247|FG000|Overall Study|Withdrawal by Subject|0|||
161269478|NCT02906930|582370248|FG001|Overall Study|Withdrawal by Subject|5|||
161269479|NCT02906930|582370249|FG002|Overall Study|Withdrawal by Subject|5|||
161269480|NCT02906930|582370250|FG003|Overall Study|Withdrawal by Subject|4|||
160958347|NCT00449176|581234176|FG000|Overall Study|Withdrawal by Subject|39|||
160958348|NCT00449176|581234177|FG001|Overall Study|Withdrawal by Subject|43|||
160958349|NCT00449176|581234178|FG002|Overall Study|Withdrawal by Subject|59|||
160958350|NCT00449176|581234176|FG000|Overall Study|Lost to Follow-up|13|||
160958351|NCT00449176|581234177|FG001|Overall Study|Lost to Follow-up|8|||
160958352|NCT00449176|581234178|FG002|Overall Study|Lost to Follow-up|12|||
160958353|NCT00449176|581234176|FG000|Overall Study|Adverse Event|51|||
160958354|NCT00449176|581234177|FG001|Overall Study|Adverse Event|107|||
160958355|NCT00449176|581234178|FG002|Overall Study|Adverse Event|15|||
160958356|NCT00449176|581234176|FG000|Overall Study|Lack of Efficacy|13|||
160958357|NCT00449176|581234177|FG001|Overall Study|Lack of Efficacy|7|||
160958358|NCT00449176|581234178|FG002|Overall Study|Lack of Efficacy|50|||
160958359|NCT00449176|581234176|FG000|Overall Study|Study drug non-compliant|14|||
160958360|NCT00449176|581234177|FG001|Overall Study|Study drug non-compliant|11|||
160958361|NCT00449176|581234178|FG002|Overall Study|Study drug non-compliant|11|||
160958362|NCT00449176|581234176|FG000|Overall Study|all other|22|||
160958363|NCT00449176|581234177|FG001|Overall Study|all other|19|||
160958364|NCT00449176|581234178|FG002|Overall Study|all other|20|||
160958365|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
160958366|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
160958367|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|disease progression|58|||
160958368|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|disease progression|47|||
160958369|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Death|3|||
160958370|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Death|6|||
160958371|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
160958372|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
160958373|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
160958374|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
160958375|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
160958376|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
160958377|NCT02472964|581234179|FG000|Part 1 (up to Week 24)|Other|2|||
160958378|NCT02472964|581234180|FG001|Part 1 (up to Week 24)|Other|1|||
160958379|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
160958380|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
161269481|NCT02906930|582370247|FG000|Overall Study|Lost to Follow-up|5|||
161269482|NCT02906930|582370248|FG001|Overall Study|Lost to Follow-up|7|||
161269483|NCT02906930|582370249|FG002|Overall Study|Lost to Follow-up|5|||
161269484|NCT02906930|582370250|FG003|Overall Study|Lost to Follow-up|2|||
161269485|NCT02906930|582370247|FG000|Overall Study|Death|0|||
161269486|NCT02906930|582370248|FG001|Overall Study|Death|0|||
161269487|NCT02906930|582370249|FG002|Overall Study|Death|1|||
161269488|NCT02906930|582370250|FG003|Overall Study|Death|0|||
161269489|NCT02906930|582370247|FG000|Overall Study|Other|1|||
161269490|NCT02906930|582370248|FG001|Overall Study|Other|2|||
161269491|NCT02906930|582370249|FG002|Overall Study|Other|1|||
161269492|NCT02906930|582370250|FG003|Overall Study|Other|2|||
161269493|NCT04585789|582370251|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
161269494|NCT04585789|582370252|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
161269495|NCT04585789|582370253|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
161269496|NCT04585789|582370251|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
161269497|NCT04585789|582370252|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
161269498|NCT04585789|582370253|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
161269499|NCT05083585|582370254|FG000|Overall Study|Death|1|||
161269500|NCT05083585|582370255|FG001|Overall Study|Death|1|||
160958381|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
160958382|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
161269501|NCT05083585|582370254|FG000|Overall Study|Lost to Follow-up|1|||
161269502|NCT05083585|582370255|FG001|Overall Study|Lost to Follow-up|1|||
161269503|NCT05083585|582370254|FG000|Overall Study|Withdrawal by Subject|2|||
161269504|NCT05083585|582370255|FG001|Overall Study|Withdrawal by Subject|0|||
161269505|NCT05083585|582370254|FG000|Overall Study|Randomized but not vaccinated|2|||
161269506|NCT05083585|582370255|FG001|Overall Study|Randomized but not vaccinated|0|||
161343458|NCT05452239|582644388|FG000|Open-label Period|Other than specified|1|||
161343459|NCT05452239|582644389|FG001|Open-label Period|Other than specified|2|||
160958383|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Death|0|||
161269507|NCT03469336|582370256|FG000|Overall Study|Adverse Event|1|||
161343460|NCT03965923|582644390|FG000|Overall Study|Withdrawal by Subject|1|||
160958384|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Death|1|||
160958385|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
160958386|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
161269508|NCT02740699|582370259|FG000|Overall Study|Lost to Follow-up|5|||
161343461|NCT03965923|582644391|FG001|Overall Study|Withdrawal by Subject|2|||
161269509|NCT02740699|582370259|FG000|Overall Study|Withdrawal by Subject|14|||
161269510|NCT02740699|582370259|FG000|Overall Study|Physician Decision|5|||
161269511|NCT01359969|582370272|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
161269512|NCT00593736|582370276|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
161269513|NCT00593736|582370277|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
161269514|NCT00593736|582370278|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
161269515|NCT00593736|582370279|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
161269516|NCT00593736|582370276|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161269517|NCT00593736|582370277|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161269518|NCT00593736|582370278|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
161269519|NCT00593736|582370279|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
161269520|NCT00593736|582370276|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161269521|NCT00593736|582370277|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161269522|NCT00593736|582370278|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
161269523|NCT00593736|582370279|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
161269524|NCT00593736|582370276|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
161269525|NCT00593736|582370277|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
161269526|NCT00593736|582370278|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
161269527|NCT00593736|582370279|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
161269528|NCT00593736|582370276|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161269529|NCT00593736|582370277|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161269530|NCT00593736|582370278|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
161269531|NCT00593736|582370279|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
161269532|NCT00593736|582370276|FG000|Screening Period and Placebo Run-in|Various|0|||
161269533|NCT00593736|582370277|FG001|Screening Period and Placebo Run-in|Various|0|||
161269534|NCT00593736|582370278|FG002|Screening Period and Placebo Run-in|Various|0|||
161269535|NCT00593736|582370279|FG003|Screening Period and Placebo Run-in|Various|25|||
161269536|NCT00593736|582370276|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
161269537|NCT00593736|582370277|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
161269538|NCT00593736|582370278|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
161269539|NCT00593736|582370279|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
161269540|NCT00593736|582370276|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
161269541|NCT00593736|582370277|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
161269542|NCT00593736|582370278|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
161269543|NCT00593736|582370279|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
161269544|NCT00593736|582370276|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
161269545|NCT00593736|582370277|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
161269546|NCT00593736|582370278|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
161269547|NCT00593736|582370279|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
161269548|NCT00593736|582370276|FG000|Treatment Period and Placebo Run-out|Various|1|||
161269549|NCT00593736|582370277|FG001|Treatment Period and Placebo Run-out|Various|1|||
161269550|NCT00593736|582370278|FG002|Treatment Period and Placebo Run-out|Various|1|||
161269551|NCT00593736|582370279|FG003|Treatment Period and Placebo Run-out|Various|0|||
161269552|NCT01868893|582370280|FG000|Overall Study|Adverse Event|2|||
161269553|NCT01868893|582370280|FG000|Overall Study|Commercial availability of study drug|17|||
161269554|NCT01868893|582370280|FG000|Overall Study|Neutropenia|1|||
161269555|NCT01857271|582370281|FG000|Overall Study|Lost to Follow-up|1|||
161269556|NCT03825341|582370284|FG000|Overall Study|Withdrawal by Subject|0|||
161269557|NCT03825341|582370285|FG001|Overall Study|Withdrawal by Subject|1|||
161269558|NCT04283500|582370288|FG000|Overall Study|Lost to Follow-up|8|||
161269559|NCT04283500|582370288|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
161269560|NCT04729309|582370296|FG000|Period 1|Subject unable to return for Period 2|3|||
161269561|NCT04729309|582370297|FG001|Period 1|Subject unable to return for Period 2|0|||
161269562|NCT04729309|582370296|FG000|Period 1|Lost to Follow-up|1|||
161269563|NCT04729309|582370297|FG001|Period 1|Lost to Follow-up|0|||
161001518|NCT01123083|581390624|FG001|Overall Study|Administrative reasons|4|||
161001519|NCT01123083|581390623|FG000|Overall Study|Lost to Follow-up|2|||
161146646|NCT00663858|581919824|FG002|Overall Study|Lack of Efficacy|3|||
161269564|NCT00338455|582370300|FG000|Overall Study|Death|2|||
161269565|NCT00338455|582370301|FG001|Overall Study|Death|1|||
161269566|NCT00338455|582370300|FG000|Overall Study|Physician Decision|1|||
161269567|NCT00338455|582370301|FG001|Overall Study|Physician Decision|0|||
161269568|NCT01517373|582370302|FG000|Run-in Period|Death|1|||
161269569|NCT01517373|582370303|FG001|Run-in Period|Death|0|||
161269570|NCT01517373|582370304|FG002|Run-in Period|Death|0|||
161269571|NCT01517373|582370305|FG003|Run-in Period|Death|0|||
161269572|NCT01517373|582370306|FG004|Run-in Period|Death|0|||
161269573|NCT01517373|582370307|FG005|Run-in Period|Death|0|||
161269574|NCT01517373|582370302|FG000|Run-in Period|Adverse Event|5|||
161001520|NCT01123083|581390624|FG001|Overall Study|Lost to Follow-up|6|||
161146647|NCT00663858|581919822|FG000|Overall Study|Withdrawal by Subject|7|||
161146648|NCT00663858|581919823|FG001|Overall Study|Withdrawal by Subject|3|||
161146649|NCT00663858|581919824|FG002|Overall Study|Withdrawal by Subject|3|||
161146650|NCT00663858|581919822|FG000|Overall Study|Protocol Violation|5|||
161269575|NCT01517373|582370303|FG001|Run-in Period|Adverse Event|0|||
161269576|NCT01517373|582370304|FG002|Run-in Period|Adverse Event|0|||
161269577|NCT01517373|582370305|FG003|Run-in Period|Adverse Event|0|||
161269578|NCT01517373|582370306|FG004|Run-in Period|Adverse Event|0|||
161269579|NCT01517373|582370307|FG005|Run-in Period|Adverse Event|0|||
161269580|NCT01517373|582370302|FG000|Run-in Period|Did not meet eligibility criteria|34|||
161269581|NCT01517373|582370303|FG001|Run-in Period|Did not meet eligibility criteria|0|||
161269582|NCT01517373|582370304|FG002|Run-in Period|Did not meet eligibility criteria|0|||
161269583|NCT01517373|582370305|FG003|Run-in Period|Did not meet eligibility criteria|0|||
161269584|NCT01517373|582370306|FG004|Run-in Period|Did not meet eligibility criteria|0|||
161269585|NCT01517373|582370307|FG005|Run-in Period|Did not meet eligibility criteria|0|||
161269586|NCT01517373|582370302|FG000|Run-in Period|Lost to Follow-up|1|||
161269587|NCT01517373|582370303|FG001|Run-in Period|Lost to Follow-up|0|||
161269588|NCT01517373|582370304|FG002|Run-in Period|Lost to Follow-up|0|||
161269589|NCT01517373|582370305|FG003|Run-in Period|Lost to Follow-up|0|||
161269590|NCT01517373|582370306|FG004|Run-in Period|Lost to Follow-up|0|||
161269591|NCT01517373|582370307|FG005|Run-in Period|Lost to Follow-up|0|||
161269592|NCT01517373|582370302|FG000|Run-in Period|Withdrawal by Subject|12|||
161269593|NCT01517373|582370303|FG001|Run-in Period|Withdrawal by Subject|0|||
161269594|NCT01517373|582370304|FG002|Run-in Period|Withdrawal by Subject|0|||
161269595|NCT01517373|582370305|FG003|Run-in Period|Withdrawal by Subject|0|||
161269596|NCT01517373|582370306|FG004|Run-in Period|Withdrawal by Subject|0|||
161269597|NCT01517373|582370307|FG005|Run-in Period|Withdrawal by Subject|0|||
161269598|NCT01517373|582370302|FG000|Run-in Period|Sponsor Decision|3|||
161146651|NCT00663858|581919823|FG001|Overall Study|Protocol Violation|3|||
161146652|NCT00663858|581919824|FG002|Overall Study|Protocol Violation|4|||
161146653|NCT00663858|581919822|FG000|Overall Study|Other|8|||
161146654|NCT00663858|581919823|FG001|Overall Study|Other|2|||
161146655|NCT00663858|581919824|FG002|Overall Study|Other|4|||
161146656|NCT02940886|581919825|FG000|Overall Study|Adverse Event|7|||
161146657|NCT02940886|581919826|FG001|Overall Study|Adverse Event|3|||
161146658|NCT02940886|581919825|FG000|Overall Study|Protocol Violation|0|||
161146659|NCT02940886|581919826|FG001|Overall Study|Protocol Violation|2|||
161146660|NCT02940886|581919825|FG000|Overall Study|Withdrawal by Subject|28|||
161146661|NCT02940886|581919826|FG001|Overall Study|Withdrawal by Subject|20|||
161146662|NCT02940886|581919825|FG000|Overall Study|Death|1|||
161146663|NCT02940886|581919826|FG001|Overall Study|Death|0|||
161146664|NCT02940886|581919825|FG000|Overall Study|Lack of Efficacy|1|||
161269599|NCT01517373|582370303|FG001|Run-in Period|Sponsor Decision|0|||
161269600|NCT01517373|582370304|FG002|Run-in Period|Sponsor Decision|0|||
161269601|NCT01517373|582370305|FG003|Run-in Period|Sponsor Decision|0|||
161146665|NCT02940886|581919826|FG001|Overall Study|Lack of Efficacy|0|||
161146666|NCT02940886|581919825|FG000|Overall Study|Lost to Follow-up|49|||
161146667|NCT02940886|581919826|FG001|Overall Study|Lost to Follow-up|21|||
161146668|NCT02940886|581919825|FG000|Overall Study|Physician Decision|9|||
161146669|NCT02940886|581919826|FG001|Overall Study|Physician Decision|4|||
161146670|NCT02940886|581919825|FG000|Overall Study|Sponsor decision|0|||
161146671|NCT02940886|581919826|FG001|Overall Study|Sponsor decision|1|||
161146672|NCT02940886|581919825|FG000|Overall Study|No treatment|7|||
161146673|NCT02940886|581919826|FG001|Overall Study|No treatment|2|||
161146674|NCT02940886|581919825|FG000|Overall Study|Enrolment error|0|||
161146675|NCT02940886|581919826|FG001|Overall Study|Enrolment error|1|||
161146676|NCT03042611|581919827|FG000|Core Phase|Withdrawal by Subject|13|||
161146677|NCT03042611|581919828|FG001|Core Phase|Withdrawal by Subject|4|||
161146678|NCT03042611|581919829|FG002|Core Phase|Withdrawal by Subject|0|||
161146679|NCT03042611|581919830|FG003|Core Phase|Withdrawal by Subject|0|||
161269602|NCT01517373|582370306|FG004|Run-in Period|Sponsor Decision|0|||
161269603|NCT01517373|582370307|FG005|Run-in Period|Sponsor Decision|0|||
161146680|NCT03042611|581919827|FG000|Core Phase|Death|232|||
161269604|NCT01517373|582370302|FG000|Run-in Period|Other|1|||
161146681|NCT03042611|581919828|FG001|Core Phase|Death|110|||
161146682|NCT03042611|581919829|FG002|Core Phase|Death|0|||
161146683|NCT03042611|581919830|FG003|Core Phase|Death|0|||
161146684|NCT03042611|581919827|FG000|Core Phase|Lost to Follow-up|4|||
161146685|NCT03042611|581919828|FG001|Core Phase|Lost to Follow-up|7|||
161269605|NCT01517373|582370303|FG001|Run-in Period|Other|0|||
161269606|NCT01517373|582370304|FG002|Run-in Period|Other|0|||
161269607|NCT01517373|582370305|FG003|Run-in Period|Other|0|||
161269608|NCT01517373|582370306|FG004|Run-in Period|Other|0|||
161269609|NCT01517373|582370307|FG005|Run-in Period|Other|0|||
161269610|NCT01517373|582370302|FG000|Treatment Period|Adverse Event|0|||
161269611|NCT01517373|582370303|FG001|Treatment Period|Adverse Event|0|||
161269612|NCT01517373|582370304|FG002|Treatment Period|Adverse Event|0|||
161146686|NCT03042611|581919829|FG002|Core Phase|Lost to Follow-up|0|||
161146687|NCT03042611|581919830|FG003|Core Phase|Lost to Follow-up|0|||
161146688|NCT03042611|581919827|FG000|Core Phase|Physician Decision|7|||
161146689|NCT03042611|581919828|FG001|Core Phase|Physician Decision|2|||
161269613|NCT01517373|582370305|FG003|Treatment Period|Adverse Event|0|||
160958387|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
160958388|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
160958389|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
160958390|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
160958391|NCT02472964|581234179|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
160958392|NCT02472964|581234180|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
160958393|NCT01454583|581234181|FG000|1st Year|Lost to Follow-up|1057|||
160958394|NCT01454583|581234182|FG001|1st Year|Lost to Follow-up|318|||
160958395|NCT01454583|581234183|FG002|1st Year|Lost to Follow-up|180|||
160958396|NCT01454583|581234181|FG000|2nd Year|Lost to Follow-up|3965|||
160958397|NCT01454583|581234182|FG001|2nd Year|Lost to Follow-up|1049|||
160958398|NCT01454583|581234183|FG002|2nd Year|Lost to Follow-up|737|||
160958399|NCT01454583|581234181|FG000|3rd Year|Lost to Follow-up|1959|||
160958400|NCT01454583|581234182|FG001|3rd Year|Lost to Follow-up|512|||
160958401|NCT01454583|581234183|FG002|3rd Year|Lost to Follow-up|297|||
160958402|NCT04330638|581234186|FG000|Overall Study|Adverse Event|9|||
160958403|NCT04330638|581234187|FG001|Overall Study|Adverse Event|10|||
160958404|NCT04330638|581234188|FG002|Overall Study|Adverse Event|15|||
160958405|NCT04330638|581234189|FG003|Overall Study|Adverse Event|6|||
160958406|NCT04330638|581234190|FG004|Overall Study|Adverse Event|10|||
160958407|NCT04330638|581234191|FG005|Overall Study|Adverse Event|5|||
160958408|NCT04330638|581234186|FG000|Overall Study|Other|2|||
160958409|NCT04330638|581234187|FG001|Overall Study|Other|2|||
160958410|NCT04330638|581234188|FG002|Overall Study|Other|5|||
160958411|NCT04330638|581234189|FG003|Overall Study|Other|1|||
160958412|NCT04330638|581234190|FG004|Overall Study|Other|3|||
160958413|NCT04330638|581234191|FG005|Overall Study|Other|2|||
160958414|NCT04330638|581234186|FG000|Overall Study|Withdrawal by Subject|4|||
160958415|NCT04330638|581234187|FG001|Overall Study|Withdrawal by Subject|0|||
160958416|NCT04330638|581234188|FG002|Overall Study|Withdrawal by Subject|0|||
160958417|NCT04330638|581234189|FG003|Overall Study|Withdrawal by Subject|0|||
160958418|NCT04330638|581234190|FG004|Overall Study|Withdrawal by Subject|0|||
160958419|NCT04330638|581234191|FG005|Overall Study|Withdrawal by Subject|0|||
160958420|NCT04330638|581234186|FG000|Overall Study|Lost to Follow-up|3|||
160958421|NCT04330638|581234187|FG001|Overall Study|Lost to Follow-up|2|||
160958422|NCT04330638|581234188|FG002|Overall Study|Lost to Follow-up|3|||
160958423|NCT04330638|581234189|FG003|Overall Study|Lost to Follow-up|2|||
160958424|NCT04330638|581234190|FG004|Overall Study|Lost to Follow-up|3|||
160958425|NCT04330638|581234191|FG005|Overall Study|Lost to Follow-up|0|||
160958426|NCT01967732|581234193|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
160958427|NCT01967732|581234194|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
160958428|NCT01967732|581234195|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
160958429|NCT01967732|581234196|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
160958430|NCT01967732|581234193|FG000|First Intervention (Day 1)|Poor venous access|0|||
160958431|NCT01967732|581234194|FG001|First Intervention (Day 1)|Poor venous access|1|||
160958432|NCT01967732|581234195|FG002|First Intervention (Day 1)|Poor venous access|0|||
160958433|NCT01967732|581234196|FG003|First Intervention (Day 1)|Poor venous access|0|||
160958434|NCT01988779|581234205|FG000|Overall Study|Withdrawal by Subject|2|||
160958435|NCT01988779|581234206|FG001|Overall Study|Withdrawal by Subject|2|||
160958436|NCT01988779|581234205|FG000|Overall Study|Protocol Violation|1|||
160958437|NCT01988779|581234206|FG001|Overall Study|Protocol Violation|0|||
160958438|NCT02275065|581234207|FG000|Overall Study|Randomized but not treated|1|||
160958439|NCT02275065|581234208|FG001|Overall Study|Randomized but not treated|0|||
160958440|NCT02275065|581234209|FG002|Overall Study|Randomized but not treated|1|||
160958441|NCT02275065|581234210|FG003|Overall Study|Randomized but not treated|1|||
160958442|NCT02275065|581234211|FG004|Overall Study|Randomized but not treated|0|||
160958443|NCT00377403|581234212|FG000|Overall Study|Unable to contact for telephone intervie|4|||
160958444|NCT00377403|581234213|FG001|Overall Study|Unable to contact for telephone intervie|7|||
160958445|NCT00417079|581234215|FG000|Overall Study|Disease progression|267|||
160958446|NCT00417079|581234216|FG001|Overall Study|Disease progression|180|||
160958447|NCT00417079|581234215|FG000|Overall Study|Adverse Event|32|||
161269614|NCT01517373|582370306|FG004|Treatment Period|Adverse Event|0|||
161269615|NCT01517373|582370307|FG005|Treatment Period|Adverse Event|2|||
161269616|NCT01517373|582370302|FG000|Treatment Period|Lost to Follow-up|0|||
160958448|NCT00417079|581234216|FG001|Overall Study|Adverse Event|67|||
160958449|NCT00417079|581234215|FG000|Overall Study|Non-compliance to protocol|0|||
160958450|NCT00417079|581234216|FG001|Overall Study|Non-compliance to protocol|1|||
160958451|NCT00417079|581234215|FG000|Overall Study|Lost to Follow-up|2|||
160958452|NCT00417079|581234216|FG001|Overall Study|Lost to Follow-up|0|||
160958453|NCT00417079|581234215|FG000|Overall Study|Withdrawal by Subject|17|||
160958454|NCT00417079|581234216|FG001|Overall Study|Withdrawal by Subject|8|||
160958455|NCT00417079|581234215|FG000|Overall Study|Not treated|6|||
160958456|NCT00417079|581234216|FG001|Overall Study|Not treated|7|||
160958457|NCT00417079|581234215|FG000|Overall Study|Screened failure|2|||
161269617|NCT01517373|582370303|FG001|Treatment Period|Lost to Follow-up|0|||
161269618|NCT01517373|582370304|FG002|Treatment Period|Lost to Follow-up|1|||
161001521|NCT01123083|581390623|FG000|Overall Study|Adverse Event|1|||
161001522|NCT01123083|581390624|FG001|Overall Study|Adverse Event|0|||
161001523|NCT01123083|581390623|FG000|Overall Study|Withdrew for another reason not covered|0|||
161001524|NCT01123083|581390624|FG001|Overall Study|Withdrew for another reason not covered|1|||
161001525|NCT01123083|581390623|FG000|Overall Study|Participant/legal representative request|7|||
161001526|NCT01123083|581390624|FG001|Overall Study|Participant/legal representative request|3|||
161001527|NCT00290706|581390625|FG000|Overall Study|Withdrawal by Subject|2|||
161001528|NCT00290706|581390626|FG001|Overall Study|Withdrawal by Subject|0|||
161001529|NCT00290706|581390627|FG002|Overall Study|Withdrawal by Subject|0|||
161001530|NCT00290706|581390628|FG003|Overall Study|Withdrawal by Subject|0|||
161001531|NCT00290706|581390625|FG000|Overall Study|Progressive Disease|3|||
161001532|NCT00290706|581390626|FG001|Overall Study|Progressive Disease|5|||
161001533|NCT00290706|581390627|FG002|Overall Study|Progressive Disease|4|||
161001534|NCT00290706|581390628|FG003|Overall Study|Progressive Disease|10|||
161001535|NCT00290706|581390625|FG000|Overall Study|Adverse Event|0|||
161001536|NCT00290706|581390626|FG001|Overall Study|Adverse Event|1|||
161001537|NCT00290706|581390627|FG002|Overall Study|Adverse Event|2|||
161001538|NCT00290706|581390628|FG003|Overall Study|Adverse Event|0|||
161001539|NCT00290706|581390625|FG000|Overall Study|Receive auto transplant or radiation|0|||
161001540|NCT00290706|581390626|FG001|Overall Study|Receive auto transplant or radiation|0|||
161001541|NCT00290706|581390627|FG002|Overall Study|Receive auto transplant or radiation|0|||
161001542|NCT00290706|581390628|FG003|Overall Study|Receive auto transplant or radiation|1|||
161001543|NCT00290706|581390625|FG000|Overall Study|Physician Decision|0|||
161001544|NCT00290706|581390626|FG001|Overall Study|Physician Decision|0|||
161001545|NCT00290706|581390627|FG002|Overall Study|Physician Decision|0|||
161001546|NCT00290706|581390628|FG003|Overall Study|Physician Decision|1|||
161001547|NCT01196429|581390630|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161001548|NCT01196429|581390631|FG001|Overall Study|Ineligible - inadequate pathology|0|||
161001549|NCT01196429|581390630|FG000|Overall Study|Ineligible - wrong cell type|1|||
161001550|NCT01196429|581390631|FG001|Overall Study|Ineligible - wrong cell type|0|||
161001551|NCT01196429|581390630|FG000|Overall Study|Refused - Never Treated|1|||
161001552|NCT01196429|581390631|FG001|Overall Study|Refused - Never Treated|0|||
161001553|NCT00688519|581390632|FG000|Overall Study|Adverse Event|2|||
161001554|NCT00688519|581390633|FG001|Overall Study|Adverse Event|3|||
161001555|NCT00688519|581390632|FG000|Overall Study|Lost to Follow-up|3|||
161001556|NCT00688519|581390633|FG001|Overall Study|Lost to Follow-up|3|||
161001557|NCT00688519|581390632|FG000|Overall Study|Lack of Efficacy|3|||
161001558|NCT00688519|581390633|FG001|Overall Study|Lack of Efficacy|1|||
161001559|NCT00688519|581390632|FG000|Overall Study|Withdrawal by Subject|7|||
161001560|NCT00688519|581390633|FG001|Overall Study|Withdrawal by Subject|6|||
161001561|NCT00688519|581390632|FG000|Overall Study|Prohibited medication|1|||
161001562|NCT00688519|581390633|FG001|Overall Study|Prohibited medication|0|||
161001563|NCT00688519|581390632|FG000|Overall Study|Non-compliance|0|||
161001564|NCT00688519|581390633|FG001|Overall Study|Non-compliance|1|||
161001565|NCT00688519|581390632|FG000|Overall Study|Subject moved out of state|1|||
161001566|NCT00688519|581390633|FG001|Overall Study|Subject moved out of state|0|||
161001567|NCT00688519|581390632|FG000|Overall Study|Investigator decision|1|||
161001568|NCT00688519|581390633|FG001|Overall Study|Investigator decision|0|||
161001569|NCT00688519|581390632|FG000|Overall Study|Subject moved out of area|1|||
161001570|NCT00688519|581390633|FG001|Overall Study|Subject moved out of area|0|||
161001571|NCT00688519|581390632|FG000|Overall Study|Pregnancy|0|||
161001572|NCT00688519|581390633|FG001|Overall Study|Pregnancy|1|||
161001573|NCT02551055|581390634|FG000|Overall Study|Death|2|||
161001574|NCT02551055|581390635|FG001|Overall Study|Death|4|||
161001575|NCT02551055|581390636|FG002|Overall Study|Death|2|||
161001576|NCT02551055|581390637|FG003|Overall Study|Death|2|||
161001577|NCT02551055|581390638|FG004|Overall Study|Death|2|||
161001578|NCT02551055|581390639|FG005|Overall Study|Death|1|||
161001579|NCT02551055|581390640|FG006|Overall Study|Death|2|||
161001580|NCT02551055|581390641|FG007|Overall Study|Death|0|||
161001581|NCT02551055|581390634|FG000|Overall Study|Study Terminated by Sponsor|1|||
161001582|NCT02551055|581390635|FG001|Overall Study|Study Terminated by Sponsor|1|||
161001583|NCT02551055|581390636|FG002|Overall Study|Study Terminated by Sponsor|0|||
161001584|NCT02551055|581390637|FG003|Overall Study|Study Terminated by Sponsor|2|||
161001585|NCT02551055|581390638|FG004|Overall Study|Study Terminated by Sponsor|2|||
161001586|NCT02551055|581390639|FG005|Overall Study|Study Terminated by Sponsor|0|||
161001587|NCT02551055|581390640|FG006|Overall Study|Study Terminated by Sponsor|0|||
161001588|NCT02551055|581390641|FG007|Overall Study|Study Terminated by Sponsor|0|||
161001589|NCT02551055|581390634|FG000|Overall Study|Withdrawal by Subject|1|||
161001590|NCT02551055|581390635|FG001|Overall Study|Withdrawal by Subject|1|||
161001591|NCT02551055|581390636|FG002|Overall Study|Withdrawal by Subject|0|||
161343462|NCT03965923|582644392|FG002|Overall Study|Withdrawal by Subject|3|||
161001592|NCT02551055|581390637|FG003|Overall Study|Withdrawal by Subject|1|||
161001593|NCT02551055|581390638|FG004|Overall Study|Withdrawal by Subject|2|||
161001594|NCT02551055|581390639|FG005|Overall Study|Withdrawal by Subject|0|||
161001595|NCT02551055|581390640|FG006|Overall Study|Withdrawal by Subject|0|||
161001596|NCT02551055|581390641|FG007|Overall Study|Withdrawal by Subject|0|||
161269619|NCT01517373|582370305|FG003|Treatment Period|Lost to Follow-up|1|||
161269620|NCT01517373|582370306|FG004|Treatment Period|Lost to Follow-up|0|||
161269621|NCT01517373|582370307|FG005|Treatment Period|Lost to Follow-up|0|||
161269622|NCT01517373|582370302|FG000|Treatment Period|Withdrawal by Subject|0|||
161269623|NCT01517373|582370303|FG001|Treatment Period|Withdrawal by Subject|3|||
161269624|NCT01517373|582370304|FG002|Treatment Period|Withdrawal by Subject|2|||
161269625|NCT01517373|582370305|FG003|Treatment Period|Withdrawal by Subject|2|||
161269626|NCT01517373|582370306|FG004|Treatment Period|Withdrawal by Subject|2|||
161269627|NCT01517373|582370307|FG005|Treatment Period|Withdrawal by Subject|3|||
161269628|NCT01517373|582370302|FG000|Treatment Period|Other|0|||
161269629|NCT01517373|582370303|FG001|Treatment Period|Other|0|||
161269630|NCT01517373|582370304|FG002|Treatment Period|Other|0|||
161269631|NCT01517373|582370305|FG003|Treatment Period|Other|0|||
161269632|NCT01517373|582370306|FG004|Treatment Period|Other|1|||
161269633|NCT01517373|582370307|FG005|Treatment Period|Other|0|||
161269634|NCT01517373|582370302|FG000|Treatment Period|Protocol Violation|0|||
161269635|NCT01517373|582370303|FG001|Treatment Period|Protocol Violation|0|||
161269636|NCT01517373|582370304|FG002|Treatment Period|Protocol Violation|0|||
161269637|NCT01517373|582370305|FG003|Treatment Period|Protocol Violation|0|||
160958458|NCT00417079|581234216|FG001|Overall Study|Screened failure|1|||
160958459|NCT00417079|581234215|FG000|Overall Study|Investigator's decision|1|||
160958460|NCT00417079|581234216|FG001|Overall Study|Investigator's decision|4|||
160958461|NCT00417079|581234215|FG000|Overall Study|Non-confirmed Disease progression|1|||
160958462|NCT00417079|581234216|FG001|Overall Study|Non-confirmed Disease progression|1|||
160958463|NCT00417079|581234215|FG000|Overall Study|Clinical deterioration|1|||
160958464|NCT00417079|581234216|FG001|Overall Study|Clinical deterioration|0|||
161269638|NCT01517373|582370306|FG004|Treatment Period|Protocol Violation|1|||
161269639|NCT01517373|582370307|FG005|Treatment Period|Protocol Violation|0|||
161269640|NCT01517373|582370302|FG000|Treatment Period|Lack of Efficacy|0|||
161269641|NCT01517373|582370303|FG001|Treatment Period|Lack of Efficacy|1|||
161269642|NCT01517373|582370304|FG002|Treatment Period|Lack of Efficacy|1|||
161269643|NCT01517373|582370305|FG003|Treatment Period|Lack of Efficacy|3|||
161269644|NCT01517373|582370306|FG004|Treatment Period|Lack of Efficacy|2|||
161269645|NCT01517373|582370307|FG005|Treatment Period|Lack of Efficacy|0|||
161269646|NCT01517373|582370302|FG000|Treatment Period|Medication error without AEs|0|||
161269647|NCT01517373|582370303|FG001|Treatment Period|Medication error without AEs|0|||
161269648|NCT01517373|582370304|FG002|Treatment Period|Medication error without AEs|2|||
161269649|NCT01517373|582370305|FG003|Treatment Period|Medication error without AEs|1|||
161269650|NCT01517373|582370306|FG004|Treatment Period|Medication error without AEs|0|||
161269651|NCT01517373|582370307|FG005|Treatment Period|Medication error without AEs|2|||
161269652|NCT05005312|582370314|FG000|Overall Study|Enrolled, but not treated|0|||
161269653|NCT05005312|582370315|FG001|Overall Study|Enrolled, but not treated|1|||
161269654|NCT00851318|582370316|FG000|Overall Study|Withdrawal by Subject|7|||
161269655|NCT00851318|582370317|FG001|Overall Study|Withdrawal by Subject|1|||
161269656|NCT00851318|582370318|FG002|Overall Study|Withdrawal by Subject|5|||
161269657|NCT00851318|582370319|FG003|Overall Study|Withdrawal by Subject|3|||
161269658|NCT00851318|582370316|FG000|Overall Study|Adverse Event|13|||
161269659|NCT00851318|582370317|FG001|Overall Study|Adverse Event|2|||
161269660|NCT00851318|582370318|FG002|Overall Study|Adverse Event|9|||
161269661|NCT00851318|582370319|FG003|Overall Study|Adverse Event|12|||
161269662|NCT00851318|582370316|FG000|Overall Study|Pregnancy|0|||
161269663|NCT00851318|582370317|FG001|Overall Study|Pregnancy|0|||
161269664|NCT00851318|582370318|FG002|Overall Study|Pregnancy|1|||
161269665|NCT00851318|582370319|FG003|Overall Study|Pregnancy|1|||
161269666|NCT00851318|582370316|FG000|Overall Study|Lack of Efficacy|8|||
161269667|NCT00851318|582370317|FG001|Overall Study|Lack of Efficacy|2|||
161269668|NCT00851318|582370318|FG002|Overall Study|Lack of Efficacy|4|||
160958465|NCT00417079|581234215|FG000|Overall Study|Screening error|2|||
160958466|NCT00417079|581234216|FG001|Overall Study|Screening error|1|||
160958467|NCT00417079|581234215|FG000|Overall Study|Withdrawal by subject's family|0|||
160958468|NCT00417079|581234216|FG001|Overall Study|Withdrawal by subject's family|1|||
160958469|NCT00417079|581234215|FG000|Overall Study|Patient unable to come to the clinic|0|||
161269669|NCT00851318|582370319|FG003|Overall Study|Lack of Efficacy|2|||
161269670|NCT00851318|582370316|FG000|Overall Study|Non-compliance with Study Procedures|2|||
161269671|NCT00851318|582370317|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161269672|NCT00851318|582370318|FG002|Overall Study|Non-compliance with Study Procedures|1|||
161269673|NCT00851318|582370319|FG003|Overall Study|Non-compliance with Study Procedures|0|||
161269674|NCT00851318|582370316|FG000|Overall Study|Physician Decision|0|||
161269675|NCT00851318|582370317|FG001|Overall Study|Physician Decision|0|||
161269676|NCT00851318|582370318|FG002|Overall Study|Physician Decision|1|||
160958470|NCT00417079|581234216|FG001|Overall Study|Patient unable to come to the clinic|1|||
160958471|NCT00417079|581234215|FG000|Overall Study|abnormal liver function tests|0|||
160958472|NCT00417079|581234216|FG001|Overall Study|abnormal liver function tests|1|||
161269677|NCT00851318|582370319|FG003|Overall Study|Physician Decision|1|||
161269678|NCT00171951|582370320|FG000|Overall Study|Adverse Event|1|||
161269679|NCT00171951|582370320|FG000|Overall Study|Abnormal Laboratory Values|2|||
160958473|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
160958474|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
160958475|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
160958476|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
160958477|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
160958478|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
160958479|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
160958480|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
160958481|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
160958482|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
160958483|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
160958484|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
160958485|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
160958486|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
160958487|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
160958488|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
160958489|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
160958490|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
160958491|NCT00833638|581234217|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
160958492|NCT00833638|581234218|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
160958493|NCT00833638|581234219|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
160958494|NCT00833638|581234217|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
160958495|NCT00833638|581234218|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
160958496|NCT00833638|581234219|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
160958497|NCT00833638|581234217|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
160958498|NCT00833638|581234218|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
160958499|NCT00833638|581234219|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
160958500|NCT01178086|581234220|FG000|Overall Study|Participant refusal|7|||
160958501|NCT01178086|581234220|FG000|Overall Study|Physician Decision|44|||
160958502|NCT01178086|581234220|FG000|Overall Study|Switch to other CLL therapy|113|||
160958503|NCT01178086|581234220|FG000|Overall Study|Death|59|||
160958504|NCT01178086|581234220|FG000|Overall Study|Other unspecified|89|||
160958505|NCT01178086|581234220|FG000|Overall Study|Excluded from EAS|20|||
160958506|NCT04348604|581234223|FG000|Week 8|Withdrawal by Subject|1|||
160958507|NCT04348604|581234224|FG001|Week 8|Withdrawal by Subject|1|||
160958508|NCT04348604|581234223|FG000|Week 8|Lost to Follow-up|1|||
160958509|NCT04348604|581234224|FG001|Week 8|Lost to Follow-up|2|||
160958510|NCT04348604|581234223|FG000|Week 8|Suspended|0|||
160958511|NCT04348604|581234224|FG001|Week 8|Suspended|1|||
160958512|NCT04348604|581234223|FG000|Week 12|Lost to Follow-up|1|||
160958513|NCT04348604|581234224|FG001|Week 12|Lost to Follow-up|2|||
160958514|NCT04348604|581234223|FG000|Week 12|Withdrawal by Subject|1|||
160958515|NCT04348604|581234224|FG001|Week 12|Withdrawal by Subject|0|||
160958516|NCT04348604|581234223|FG000|Week 24|Lost to Follow-up|2|||
160958517|NCT04348604|581234224|FG001|Week 24|Lost to Follow-up|1|||
160958518|NCT02097108|581234225|FG000|Overall Study|Adverse Event|1|||
160958519|NCT02097108|581234225|FG000|Overall Study|patient was abroad for 6 months|1|||
160958520|NCT00127608|581234228|FG000|Overall Study|VZV DNA negative|1|||
160958521|NCT04918784|581236041|FG000|Overall Study|Amputation - no longer eligible|1|||
160958522|NCT04918784|581236042|FG001|Overall Study|Amputation - no longer eligible|2|||
160958523|NCT04918784|581236041|FG000|Overall Study|Death|1|||
160958524|NCT04918784|581236042|FG001|Overall Study|Death|0|||
160958525|NCT04918784|581236041|FG000|Overall Study|patient non-compliance|3|||
160958526|NCT04918784|581236042|FG001|Overall Study|patient non-compliance|1|||
160958527|NCT04918784|581236041|FG000|Overall Study|Adverse Event|1|||
160958528|NCT04918784|581236042|FG001|Overall Study|Adverse Event|0|||
160958529|NCT01986881|581236043|FG000|Overall Study|Death|228|||
160958530|NCT01986881|581236044|FG001|Overall Study|Death|233|||
160958531|NCT01986881|581236045|FG002|Overall Study|Death|247|||
160958532|NCT01986881|581236043|FG000|Overall Study|Lost to Follow-up|51|||
160958533|NCT01986881|581236044|FG001|Overall Study|Lost to Follow-up|44|||
160958534|NCT01986881|581236045|FG002|Overall Study|Lost to Follow-up|55|||
160958535|NCT01986881|581236043|FG000|Overall Study|Physician Decision|7|||
160958536|NCT01986881|581236044|FG001|Overall Study|Physician Decision|4|||
160958537|NCT01986881|581236045|FG002|Overall Study|Physician Decision|6|||
160958538|NCT01986881|581236043|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
160958539|NCT01986881|581236044|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
160958540|NCT01986881|581236045|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
160958541|NCT01986881|581236043|FG000|Overall Study|Withdrawal by Subject|41|||
160958542|NCT01986881|581236044|FG001|Overall Study|Withdrawal by Subject|60|||
160958543|NCT01986881|581236045|FG002|Overall Study|Withdrawal by Subject|45|||
160958544|NCT01986881|581236043|FG000|Overall Study|Subject Moved|0|||
160958545|NCT01986881|581236044|FG001|Overall Study|Subject Moved|1|||
160958546|NCT01986881|581236045|FG002|Overall Study|Subject Moved|0|||
161269680|NCT00171951|582370320|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161269681|NCT00171951|582370320|FG000|Overall Study|Participants Withdrew Consent|3|||
161269682|NCT00171951|582370320|FG000|Overall Study|New Cancer Therapy|5|||
161269683|NCT00171951|582370320|FG000|Overall Study|Reason not Specified|2|||
161269684|NCT02970318|582370321|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
161269685|NCT02970318|582370322|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
161269686|NCT02970318|582370323|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
161269687|NCT02970318|582370324|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
161269688|NCT02970318|582370321|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
161269689|NCT02970318|582370322|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
161269690|NCT02970318|582370323|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
161269691|NCT02970318|582370324|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
161001597|NCT02551055|581390634|FG000|Overall Study|Reason not specified|0|||
161001598|NCT02551055|581390635|FG001|Overall Study|Reason not specified|0|||
161001599|NCT02551055|581390636|FG002|Overall Study|Reason not specified|0|||
161001600|NCT02551055|581390637|FG003|Overall Study|Reason not specified|0|||
161001601|NCT02551055|581390638|FG004|Overall Study|Reason not specified|1|||
161001602|NCT02551055|581390639|FG005|Overall Study|Reason not specified|0|||
161001603|NCT02551055|581390640|FG006|Overall Study|Reason not specified|1|||
161001604|NCT02551055|581390641|FG007|Overall Study|Reason not specified|0|||
161001605|NCT00430300|581390642|FG000|Overall Study|Adverse Event|0|||
161001606|NCT00430300|581390643|FG001|Overall Study|Adverse Event|2|||
161001607|NCT00430300|581390644|FG002|Overall Study|Adverse Event|1|||
161001608|NCT00430300|581390645|FG003|Overall Study|Adverse Event|1|||
161001609|NCT00430300|581390642|FG000|Overall Study|Withdrawal by Subject|1|||
161001610|NCT00430300|581390643|FG001|Overall Study|Withdrawal by Subject|0|||
161001611|NCT00430300|581390644|FG002|Overall Study|Withdrawal by Subject|5|||
161001612|NCT00430300|581390645|FG003|Overall Study|Withdrawal by Subject|0|||
161001613|NCT00430300|581390642|FG000|Overall Study|Laboratory abnormality|1|||
161001614|NCT00430300|581390643|FG001|Overall Study|Laboratory abnormality|0|||
161001615|NCT00430300|581390644|FG002|Overall Study|Laboratory abnormality|0|||
161001616|NCT00430300|581390645|FG003|Overall Study|Laboratory abnormality|0|||
161001617|NCT00430300|581390642|FG000|Overall Study|Other|0|||
161001618|NCT00430300|581390643|FG001|Overall Study|Other|0|||
161001619|NCT00430300|581390644|FG002|Overall Study|Other|0|||
161001620|NCT00430300|581390645|FG003|Overall Study|Other|1|||
161001621|NCT01063517|581390650|FG000|Overall Study|Consent withdrawal|1|||
161001622|NCT01063517|581390651|FG001|Overall Study|Consent withdrawal|0|||
161001623|NCT01063517|581390650|FG000|Overall Study|Study reached data cut-off|19|||
161001624|NCT01063517|581390651|FG001|Overall Study|Study reached data cut-off|7|||
161001625|NCT01063517|581390650|FG000|Overall Study|Lost to Follow-up|4|||
161001626|NCT01063517|581390651|FG001|Overall Study|Lost to Follow-up|3|||
161001627|NCT01063517|581390650|FG000|Overall Study|Withdrawal by Subject|1|||
161001628|NCT01063517|581390651|FG001|Overall Study|Withdrawal by Subject|2|||
161001629|NCT01063517|581390650|FG000|Overall Study|Death|33|||
161001630|NCT01063517|581390651|FG001|Overall Study|Death|48|||
161001631|NCT02974634|581392954|FG000|Overall Study|Advanced disease|12|||
161001632|NCT02974634|581392955|FG001|Overall Study|Advanced disease|3|||
161001633|NCT02974634|581392954|FG000|Overall Study|Noncompliance|3|||
161001634|NCT02974634|581392955|FG001|Overall Study|Noncompliance|7|||
161001635|NCT02974634|581392954|FG000|Overall Study|intervention technology related issues|5|||
161001636|NCT02974634|581392955|FG001|Overall Study|intervention technology related issues|0|||
161001637|NCT02974634|581392954|FG000|Overall Study|Death|8|||
161001638|NCT02974634|581392955|FG001|Overall Study|Death|11|||
161001639|NCT04668339|581392956|FG000|Overall Study|Physician Decision|1|||
161001640|NCT04668339|581392957|FG001|Overall Study|Physician Decision|0|||
161001641|NCT04668339|581392958|FG002|Overall Study|Physician Decision|1|||
161001642|NCT04668339|581392959|FG003|Overall Study|Physician Decision|1|||
161001643|NCT04668339|581392956|FG000|Overall Study|Lost to Follow-up|14|||
161269692|NCT02970318|582370321|FG000|Overall for Arm A & Main for Arm B|Death|41|||
161001644|NCT04668339|581392957|FG001|Overall Study|Lost to Follow-up|12|||
161001645|NCT04668339|581392958|FG002|Overall Study|Lost to Follow-up|8|||
161001646|NCT04668339|581392959|FG003|Overall Study|Lost to Follow-up|5|||
161001647|NCT04668339|581392956|FG000|Overall Study|Adverse Event|0|||
161001648|NCT04668339|581392957|FG001|Overall Study|Adverse Event|0|||
161001649|NCT04668339|581392958|FG002|Overall Study|Adverse Event|1|||
161001650|NCT04668339|581392959|FG003|Overall Study|Adverse Event|0|||
161001651|NCT04668339|581392956|FG000|Overall Study|Other than specified|3|||
161001652|NCT04668339|581392957|FG001|Overall Study|Other than specified|0|||
161001653|NCT04668339|581392958|FG002|Overall Study|Other than specified|1|||
161001654|NCT04668339|581392959|FG003|Overall Study|Other than specified|0|||
161001655|NCT04668339|581392956|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
161001656|NCT04668339|581392957|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
161269693|NCT02970318|582370322|FG001|Overall for Arm A & Main for Arm B|Death|33|||
161001657|NCT04668339|581392958|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
161001658|NCT04668339|581392959|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
160958547|NCT01986881|581236043|FG000|Overall Study|Other|1|||
160958548|NCT01986881|581236044|FG001|Overall Study|Other|2|||
160958549|NCT01986881|581236045|FG002|Overall Study|Other|2|||
160958550|NCT04050865|581236046|FG000|Overall Study|Adverse Event|1|||
160958551|NCT04050865|581236047|FG001|Overall Study|Adverse Event|0|||
160958552|NCT04050865|581236046|FG000|Overall Study|no insert|1|||
160958553|NCT04050865|581236047|FG001|Overall Study|no insert|0|||
160958554|NCT04050865|581236046|FG000|Overall Study|Only 1 insert|2|||
161001659|NCT04668339|581392956|FG000|Overall Study|Vaccine not Administered|0|||
161001660|NCT04668339|581392957|FG001|Overall Study|Vaccine not Administered|0|||
161001661|NCT04668339|581392958|FG002|Overall Study|Vaccine not Administered|1|||
161001662|NCT04668339|581392959|FG003|Overall Study|Vaccine not Administered|0|||
161001663|NCT04668339|581392956|FG000|Overall Study|Protocol Violation|18|||
161269694|NCT02970318|582370323|FG002|Overall for Arm A & Main for Arm B|Death|0|||
161269695|NCT02970318|582370324|FG003|Overall for Arm A & Main for Arm B|Death|0|||
161269696|NCT02970318|582370321|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161269697|NCT02970318|582370322|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
161269698|NCT02970318|582370323|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161269699|NCT02970318|582370324|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
161269700|NCT02970318|582370321|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161269701|NCT02970318|582370322|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161269702|NCT02970318|582370323|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
161269703|NCT02970318|582370324|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
161269704|NCT02970318|582370321|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
161269705|NCT02970318|582370322|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
161269706|NCT02970318|582370323|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
161269707|NCT02970318|582370324|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
161269708|NCT02970318|582370321|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
161269709|NCT02970318|582370322|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
161269710|NCT02970318|582370323|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
161269711|NCT02970318|582370324|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
161269712|NCT03384654|582370325|FG000|Overall Study|Withdrawal by Subject|0|||
161269713|NCT03384654|582370326|FG001|Overall Study|Withdrawal by Subject|0|||
161269714|NCT03384654|582370327|FG002|Overall Study|Withdrawal by Subject|1|||
161269715|NCT03384654|582370328|FG003|Overall Study|Withdrawal by Subject|0|||
161269716|NCT01616953|582370329|FG000|Overall Study|Lost to Follow-up|1|||
161269717|NCT01616953|582370330|FG001|Overall Study|Lost to Follow-up|0|||
161269718|NCT01616953|582370329|FG000|Overall Study|lack of bone and soft tissue|1|||
161269719|NCT01616953|582370330|FG001|Overall Study|lack of bone and soft tissue|0|||
161269720|NCT00816361|582370332|FG000|Overall Study|Withdrawal by Subject|0|||
161269721|NCT00816361|582370333|FG001|Overall Study|Withdrawal by Subject|0|||
161269722|NCT00816361|582370334|FG002|Overall Study|Withdrawal by Subject|0|||
161269723|NCT00816361|582370335|FG003|Overall Study|Withdrawal by Subject|0|||
161269724|NCT00816361|582370336|FG004|Overall Study|Withdrawal by Subject|1|||
161269725|NCT00816361|582370337|FG005|Overall Study|Withdrawal by Subject|2|||
161269726|NCT00816361|582370338|FG006|Overall Study|Withdrawal by Subject|0|||
161269727|NCT00816361|582370339|FG007|Overall Study|Withdrawal by Subject|2|||
161269728|NCT00816361|582370340|FG008|Overall Study|Withdrawal by Subject|1|||
161269729|NCT00816361|582370332|FG000|Overall Study|Death|4|||
161269730|NCT00816361|582370333|FG001|Overall Study|Death|3|||
161269731|NCT00816361|582370334|FG002|Overall Study|Death|3|||
161269732|NCT00816361|582370335|FG003|Overall Study|Death|3|||
161269733|NCT00816361|582370336|FG004|Overall Study|Death|1|||
161269734|NCT00816361|582370337|FG005|Overall Study|Death|1|||
161269735|NCT00816361|582370338|FG006|Overall Study|Death|3|||
161269736|NCT00816361|582370339|FG007|Overall Study|Death|7|||
161269737|NCT00816361|582370340|FG008|Overall Study|Death|8|||
161269738|NCT00816361|582370332|FG000|Overall Study|Other|0|||
161269739|NCT00816361|582370333|FG001|Overall Study|Other|0|||
161269740|NCT00816361|582370334|FG002|Overall Study|Other|0|||
161269741|NCT00816361|582370335|FG003|Overall Study|Other|0|||
160958555|NCT04050865|581236047|FG001|Overall Study|Only 1 insert|3|||
160958556|NCT04050865|581236046|FG000|Overall Study|Physician Decision|0|||
160958557|NCT04050865|581236047|FG001|Overall Study|Physician Decision|1|||
161269742|NCT00816361|582370336|FG004|Overall Study|Other|0|||
161269743|NCT00816361|582370337|FG005|Overall Study|Other|0|||
161269744|NCT00816361|582370338|FG006|Overall Study|Other|0|||
161269745|NCT00816361|582370339|FG007|Overall Study|Other|0|||
161269746|NCT00816361|582370340|FG008|Overall Study|Other|1|||
161269747|NCT02500641|582370341|FG000|Overall Study|Adverse Event|0|||
161269748|NCT02500641|582370342|FG001|Overall Study|Adverse Event|2|||
161269749|NCT02500641|582370341|FG000|Overall Study|Withdrawal by Subject|4|||
161001664|NCT04668339|581392957|FG001|Overall Study|Protocol Violation|23|||
161001665|NCT04668339|581392958|FG002|Overall Study|Protocol Violation|12|||
161001666|NCT04668339|581392959|FG003|Overall Study|Protocol Violation|20|||
161001667|NCT04668339|581392956|FG000|Overall Study|Withdrawal by Subject|45|||
161269750|NCT02500641|582370342|FG001|Overall Study|Withdrawal by Subject|5|||
161269751|NCT02500641|582370341|FG000|Overall Study|Unable to follow study procedures|3|||
161269752|NCT02500641|582370342|FG001|Overall Study|Unable to follow study procedures|2|||
161269753|NCT02500641|582370341|FG000|Overall Study|Protocol Violation|1|||
161269754|NCT02500641|582370342|FG001|Overall Study|Protocol Violation|2|||
161001668|NCT04668339|581392957|FG001|Overall Study|Withdrawal by Subject|46|||
161001669|NCT04668339|581392958|FG002|Overall Study|Withdrawal by Subject|46|||
161001670|NCT04668339|581392959|FG003|Overall Study|Withdrawal by Subject|27|||
161001671|NCT04668339|581392956|FG000|Overall Study|Study Terminated by Sponsor|59|||
161001672|NCT04668339|581392957|FG001|Overall Study|Study Terminated by Sponsor|59|||
161001673|NCT04668339|581392958|FG002|Overall Study|Study Terminated by Sponsor|71|||
161001674|NCT04668339|581392959|FG003|Overall Study|Study Terminated by Sponsor|1|||
161001675|NCT03253848|581392963|FG000|Overall Study|Adverse Event|7|||
161001676|NCT03253848|581392963|FG000|Overall Study|Death|5|||
161001677|NCT03253848|581392963|FG000|Overall Study|initiation of other treatments|3|||
161001678|NCT03253848|581392963|FG000|Overall Study|Other complicating disease|1|||
161001679|NCT03253848|581392963|FG000|Overall Study|Withdrawal by Subject|1|||
161001680|NCT03253848|581392963|FG000|Overall Study|Declining health|1|||
161001681|NCT05758415|581392965|FG000|Overall Study|Subject Decision|2|||
161001682|NCT05758415|581392966|FG001|Overall Study|Subject Decision|5|||
161001683|NCT05758415|581392965|FG000|Overall Study|Lost to Follow-up|0|||
161001684|NCT05758415|581392966|FG001|Overall Study|Lost to Follow-up|1|||
161001685|NCT03622593|581392967|FG000|Overall Study|Withdrawal by Subject|11|||
161001686|NCT03622593|581392968|FG001|Overall Study|Withdrawal by Subject|9|||
161001687|NCT03622593|581392969|FG002|Overall Study|Withdrawal by Subject|13|||
161001688|NCT03622593|581392967|FG000|Overall Study|Death|12|||
161001689|NCT03622593|581392968|FG001|Overall Study|Death|9|||
161001690|NCT03622593|581392969|FG002|Overall Study|Death|10|||
161001691|NCT03622593|581392967|FG000|Overall Study|Lost to Follow-up|11|||
161001692|NCT03622593|581392968|FG001|Overall Study|Lost to Follow-up|5|||
161001693|NCT03622593|581392969|FG002|Overall Study|Lost to Follow-up|8|||
161001694|NCT03622593|581392967|FG000|Overall Study|Adverse Event|4|||
161001695|NCT03622593|581392968|FG001|Overall Study|Adverse Event|5|||
161001696|NCT03622593|581392969|FG002|Overall Study|Adverse Event|6|||
161001697|NCT03622593|581392967|FG000|Overall Study|Physician Decision|2|||
161001698|NCT03622593|581392968|FG001|Overall Study|Physician Decision|1|||
161001699|NCT03622593|581392969|FG002|Overall Study|Physician Decision|6|||
161001700|NCT03622593|581392967|FG000|Overall Study|Other|2|||
161001701|NCT03622593|581392968|FG001|Overall Study|Other|2|||
161001702|NCT03622593|581392969|FG002|Overall Study|Other|3|||
161001703|NCT03622593|581392967|FG000|Overall Study|Protocol Violation|0|||
161001704|NCT03622593|581392968|FG001|Overall Study|Protocol Violation|0|||
161001705|NCT03622593|581392969|FG002|Overall Study|Protocol Violation|1|||
161001706|NCT03622593|581392967|FG000|Overall Study|Pregnancy|0|||
161001707|NCT03622593|581392968|FG001|Overall Study|Pregnancy|0|||
161001708|NCT03622593|581392969|FG002|Overall Study|Pregnancy|1|||
161001709|NCT01393119|581392972|FG000|Overall Study|Adverse Event|1|||
161001710|NCT01393119|581392973|FG001|Overall Study|Adverse Event|1|||
161001711|NCT01393119|581392974|FG002|Overall Study|Adverse Event|0|||
161001712|NCT01393119|581392975|FG003|Overall Study|Adverse Event|1|||
161001713|NCT01393119|581392972|FG000|Overall Study|Withdrawal by Subject|0|||
161269755|NCT02500641|582370341|FG000|Overall Study|Lost to Follow-up|1|||
161269756|NCT02500641|582370342|FG001|Overall Study|Lost to Follow-up|0|||
161269757|NCT02500641|582370341|FG000|Overall Study|Sponsor decision|1|||
161269758|NCT02500641|582370342|FG001|Overall Study|Sponsor decision|0|||
161269759|NCT02500641|582370341|FG000|Overall Study|Non compliance to study drug|0|||
161343463|NCT03965923|582644393|FG003|Overall Study|Withdrawal by Subject|1|||
161001714|NCT01393119|581392973|FG001|Overall Study|Withdrawal by Subject|1|||
161001715|NCT01393119|581392974|FG002|Overall Study|Withdrawal by Subject|1|||
161001716|NCT01393119|581392975|FG003|Overall Study|Withdrawal by Subject|0|||
161001717|NCT01393119|581392972|FG000|Overall Study|Lack of Efficacy|1|||
161001718|NCT01393119|581392973|FG001|Overall Study|Lack of Efficacy|0|||
161001719|NCT01393119|581392974|FG002|Overall Study|Lack of Efficacy|2|||
161001720|NCT01393119|581392975|FG003|Overall Study|Lack of Efficacy|1|||
161001721|NCT01393119|581392972|FG000|Overall Study|Protocol Violation|0|||
161001722|NCT01393119|581392973|FG001|Overall Study|Protocol Violation|0|||
161001723|NCT01393119|581392974|FG002|Overall Study|Protocol Violation|1|||
161001724|NCT01393119|581392975|FG003|Overall Study|Protocol Violation|0|||
161001725|NCT01393119|581392972|FG000|Overall Study|Death|0|||
161001726|NCT01393119|581392973|FG001|Overall Study|Death|0|||
161001727|NCT01393119|581392974|FG002|Overall Study|Death|0|||
161001728|NCT01393119|581392975|FG003|Overall Study|Death|1|||
161001729|NCT01393119|581392972|FG000|Overall Study|Randomized but Not treated|1|||
161001730|NCT01393119|581392973|FG001|Overall Study|Randomized but Not treated|0|||
161001731|NCT01393119|581392974|FG002|Overall Study|Randomized but Not treated|1|||
161001732|NCT01393119|581392975|FG003|Overall Study|Randomized but Not treated|1|||
161001733|NCT01393119|581392972|FG000|Overall Study|Sponsor Termination of Study|11|||
161001734|NCT01393119|581392973|FG001|Overall Study|Sponsor Termination of Study|12|||
161001735|NCT01393119|581392974|FG002|Overall Study|Sponsor Termination of Study|9|||
161269760|NCT02500641|582370342|FG001|Overall Study|Non compliance to study drug|1|||
161269761|NCT01763684|582370343|FG000|Overall Study|Study terminated early due to low enrollment|126|||
161269762|NCT01763684|582370344|FG001|Overall Study|Study terminated early due to low enrollment|127|||
161269763|NCT01763684|582370343|FG000|Overall Study|Study surgery not performed|7|||
161269764|NCT01763684|582370344|FG001|Overall Study|Study surgery not performed|6|||
161269765|NCT02196701|582370345|FG000|Overall Study|Adverse Event|1|||
161269766|NCT02196701|582370345|FG000|Overall Study|Lost to Follow-up|1|||
161269767|NCT02196701|582370345|FG000|Overall Study|Non-adherence to Protocol|1|||
161269768|NCT01408628|582370351|FG000|Consented|Withdrawal by Subject|12|||
161269769|NCT01408628|582370351|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
161269770|NCT01408628|582370351|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
161269771|NCT01408628|582370351|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
161269772|NCT04156620|582370352|FG000|Overall Study|Adverse event - TP 1|5|||
161269773|NCT04156620|582370353|FG001|Overall Study|Adverse event - TP 1|2|||
161269774|NCT04156620|582370352|FG000|Overall Study|Lost to follow-up TP 1|1|||
161269775|NCT04156620|582370353|FG001|Overall Study|Lost to follow-up TP 1|1|||
161269776|NCT04156620|582370352|FG000|Overall Study|Progressive disease - TP 1|0|||
161269777|NCT04156620|582370353|FG001|Overall Study|Progressive disease - TP 1|1|||
160958558|NCT04050865|581236046|FG000|Overall Study|Withdrawal by Subject|0|||
161269778|NCT04156620|582370352|FG000|Overall Study|Subject decision - TP 1|3|||
161269779|NCT04156620|582370353|FG001|Overall Study|Subject decision - TP 1|5|||
161269780|NCT04156620|582370352|FG000|Overall Study|Adverse event - TP 2|5|||
161269781|NCT04156620|582370353|FG001|Overall Study|Adverse event - TP 2|6|||
161269782|NCT04156620|582370352|FG000|Overall Study|Death - TP 2|1|||
161269783|NCT04156620|582370353|FG001|Overall Study|Death - TP 2|0|||
161269784|NCT04156620|582370352|FG000|Overall Study|Lost to follow-up - TP 2|5|||
161269785|NCT04156620|582370353|FG001|Overall Study|Lost to follow-up - TP 2|2|||
161269786|NCT04156620|582370352|FG000|Overall Study|Physician decision - TP 2|4|||
161269787|NCT04156620|582370353|FG001|Overall Study|Physician decision - TP 2|2|||
161269788|NCT04156620|582370352|FG000|Overall Study|Pregnancy - TP 2|1|||
161269789|NCT04156620|582370353|FG001|Overall Study|Pregnancy - TP 2|1|||
161269790|NCT04156620|582370352|FG000|Overall Study|Subject decision - TP 2|11|||
161269791|NCT04156620|582370353|FG001|Overall Study|Subject decision - TP 2|9|||
161269792|NCT04156620|582370352|FG000|Overall Study|New therapy for study indication - TP 2|1|||
161269793|NCT04156620|582370353|FG001|Overall Study|New therapy for study indication - TP 2|0|||
161269794|NCT01855074|582370354|FG000|Overall Study|Adverse Event|1|||
161269795|NCT01855074|582370354|FG000|Overall Study|Lost to Follow-up|4|||
161269796|NCT01855074|582370354|FG000|Overall Study|Withdrawal by Subject|8|||
161269797|NCT01855074|582370354|FG000|Overall Study|Started but not treated|1|||
161269798|NCT02991430|582370355|FG000|Treatment Period 1|Adverse Event|1|||
161269799|NCT02991430|582370356|FG001|Treatment Period 1|Adverse Event|0|||
161269800|NCT02991430|582370357|FG002|Treatment Period 1|Adverse Event|2|||
161269801|NCT02991430|582370355|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161269802|NCT02991430|582370356|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161269803|NCT02991430|582370357|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161269804|NCT02991430|582370355|FG000|Treatment Period 2|Study Termination|6|||
161269805|NCT02991430|582370356|FG001|Treatment Period 2|Study Termination|3|||
161269806|NCT02991430|582370357|FG002|Treatment Period 2|Study Termination|3|||
161269807|NCT02991430|582370355|FG000|Treatment Period 2|Lost to Follow-up|0|||
161269808|NCT02991430|582370356|FG001|Treatment Period 2|Lost to Follow-up|0|||
161269809|NCT02991430|582370357|FG002|Treatment Period 2|Lost to Follow-up|1|||
161269810|NCT02991430|582370355|FG000|Post-treatment Observation Period|Study Termination|3|||
161269811|NCT02991430|582370356|FG001|Post-treatment Observation Period|Study Termination|6|||
161269812|NCT02991430|582370357|FG002|Post-treatment Observation Period|Study Termination|5|||
161269813|NCT01150890|582370358|FG000|Overall Study|Other|0|||
161269814|NCT01150890|582370359|FG001|Overall Study|Other|1|||
161269815|NCT01150890|582370360|FG002|Overall Study|Other|0|||
161269816|NCT01150890|582370361|FG003|Overall Study|Other|2|||
161269817|NCT01150890|582370358|FG000|Overall Study|Pregnancy|0|||
161269818|NCT01150890|582370359|FG001|Overall Study|Pregnancy|0|||
161269819|NCT01150890|582370360|FG002|Overall Study|Pregnancy|0|||
161269820|NCT01150890|582370361|FG003|Overall Study|Pregnancy|1|||
161269821|NCT01150890|582370358|FG000|Overall Study|Administrative Decision|4|||
160958559|NCT04050865|581236047|FG001|Overall Study|Withdrawal by Subject|1|||
161343464|NCT03965923|582644394|FG004|Overall Study|Withdrawal by Subject|2|||
160958560|NCT02035332|581236048|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
161269822|NCT01150890|582370359|FG001|Overall Study|Administrative Decision|4|||
161269823|NCT01150890|582370360|FG002|Overall Study|Administrative Decision|5|||
161269824|NCT01150890|582370361|FG003|Overall Study|Administrative Decision|6|||
161269825|NCT01150890|582370358|FG000|Overall Study|Ineligibility determined|0|||
161269826|NCT01150890|582370359|FG001|Overall Study|Ineligibility determined|1|||
161269827|NCT01150890|582370360|FG002|Overall Study|Ineligibility determined|0|||
161269828|NCT01150890|582370361|FG003|Overall Study|Ineligibility determined|0|||
161269829|NCT01150890|582370358|FG000|Overall Study|Adverse Event|0|||
161269830|NCT01150890|582370359|FG001|Overall Study|Adverse Event|0|||
161269831|NCT01150890|582370360|FG002|Overall Study|Adverse Event|2|||
161146690|NCT03042611|581919829|FG002|Core Phase|Physician Decision|0|||
161269832|NCT01150890|582370361|FG003|Overall Study|Adverse Event|0|||
160958561|NCT01258608|581236049|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
160958562|NCT01258608|581236050|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
160958563|NCT01258608|581236049|FG000|Overall Study|Clinical progression|1|||
160958564|NCT01258608|581236050|FG001|Overall Study|Clinical progression|0|||
160958565|NCT01258608|581236049|FG000|Overall Study|Sponsor decision|0|||
160958566|NCT01258608|581236050|FG001|Overall Study|Sponsor decision|1|||
160958567|NCT01258608|581236049|FG000|Overall Study|Physician Decision|6|||
160958568|NCT01258608|581236050|FG001|Overall Study|Physician Decision|1|||
160958569|NCT01258608|581236049|FG000|Overall Study|Lost to Follow-up|0|||
160958570|NCT01258608|581236050|FG001|Overall Study|Lost to Follow-up|1|||
161269833|NCT01150890|582370358|FG000|Overall Study|Withdrawal by Subject|0|||
161269834|NCT01150890|582370359|FG001|Overall Study|Withdrawal by Subject|0|||
161269835|NCT01150890|582370360|FG002|Overall Study|Withdrawal by Subject|2|||
161269836|NCT01150890|582370361|FG003|Overall Study|Withdrawal by Subject|1|||
161269837|NCT01150890|582370358|FG000|Overall Study|Disease progression|0|||
161269838|NCT01150890|582370359|FG001|Overall Study|Disease progression|7|||
161269839|NCT01150890|582370360|FG002|Overall Study|Disease progression|3|||
161269840|NCT01150890|582370361|FG003|Overall Study|Disease progression|7|||
161269841|NCT01672970|582370362|FG000|Overall Study|Lack of Efficacy|12|||
161269842|NCT01672970|582370362|FG000|Overall Study|Adverse Event|18|||
161269843|NCT01672970|582370362|FG000|Overall Study|Withdrawal by Subject|2|||
161269844|NCT01672970|582370362|FG000|Overall Study|Lost to Follow-up|5|||
161269845|NCT01672970|582370362|FG000|Overall Study|Other|9|||
161269846|NCT01672970|582370362|FG000|Overall Study|Enrolled but not treated|1|||
161269847|NCT03118570|582370363|FG000|Overall Study|Adverse Event|2|||
161269848|NCT03118570|582370364|FG001|Overall Study|Adverse Event|0|||
161269849|NCT03118570|582370365|FG002|Overall Study|Adverse Event|0|||
161269850|NCT03118570|582370366|FG003|Overall Study|Adverse Event|0|||
161269851|NCT03118570|582370367|FG004|Overall Study|Adverse Event|3|||
161269852|NCT03118570|582370363|FG000|Overall Study|Withdrawal by Subject|0|||
161269853|NCT03118570|582370364|FG001|Overall Study|Withdrawal by Subject|1|||
161269854|NCT03118570|582370365|FG002|Overall Study|Withdrawal by Subject|4|||
161269855|NCT03118570|582370366|FG003|Overall Study|Withdrawal by Subject|0|||
161269856|NCT03118570|582370367|FG004|Overall Study|Withdrawal by Subject|1|||
161269857|NCT03118570|582370363|FG000|Overall Study|Lost to Follow-up|2|||
160958571|NCT01258608|581236049|FG000|Overall Study|Lack of compliance|1|||
160958572|NCT01258608|581236050|FG001|Overall Study|Lack of compliance|0|||
160958573|NCT01258608|581236049|FG000|Overall Study|Lack of Efficacy|0|||
160958574|NCT01258608|581236050|FG001|Overall Study|Lack of Efficacy|1|||
160958575|NCT01258608|581236049|FG000|Overall Study|Adverse Event|6|||
160958576|NCT01258608|581236050|FG001|Overall Study|Adverse Event|10|||
160958577|NCT01258608|581236049|FG000|Overall Study|Withdrawal by Subject|6|||
160958578|NCT01258608|581236050|FG001|Overall Study|Withdrawal by Subject|5|||
160958579|NCT04205630|581236051|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
160958580|NCT04205630|581236051|FG000|Overall Study|Disease clinical progression|7|||
160958581|NCT04205630|581236051|FG000|Overall Study|Withdrawal by Subject|2|||
160958582|NCT04205630|581236051|FG000|Overall Study|Adverse Event|17|||
160958583|NCT04205630|581236051|FG000|Overall Study|Other|1|||
160958584|NCT00160680|581236056|FG000|Overall Study|Adverse Event|0|||
160958585|NCT00160680|581236057|FG001|Overall Study|Adverse Event|1|||
160958586|NCT00160680|581236056|FG000|Overall Study|Lack of Efficacy|2|||
160958587|NCT00160680|581236057|FG001|Overall Study|Lack of Efficacy|1|||
161146691|NCT03042611|581919830|FG003|Core Phase|Physician Decision|0|||
161146692|NCT03042611|581919827|FG000|Core Phase|Study Closed|0|||
160958588|NCT00160680|581236056|FG000|Overall Study|Lost to Follow-up|3|||
161269858|NCT03118570|582370364|FG001|Overall Study|Lost to Follow-up|3|||
161343465|NCT03965923|582644395|FG005|Overall Study|Withdrawal by Subject|0|||
161269859|NCT03118570|582370365|FG002|Overall Study|Lost to Follow-up|1|||
161269860|NCT03118570|582370366|FG003|Overall Study|Lost to Follow-up|0|||
161269861|NCT03118570|582370367|FG004|Overall Study|Lost to Follow-up|1|||
161269862|NCT03118570|582370363|FG000|Overall Study|Other, Not Specified|1|||
161269863|NCT03118570|582370364|FG001|Overall Study|Other, Not Specified|3|||
161343466|NCT03965923|582644396|FG006|Overall Study|Withdrawal by Subject|4|||
160958589|NCT00160680|581236057|FG001|Overall Study|Lost to Follow-up|2|||
160958590|NCT00160680|581236056|FG000|Overall Study|Withdrawal by Subject|4|||
160958591|NCT00160680|581236057|FG001|Overall Study|Withdrawal by Subject|9|||
160958592|NCT04493216|581236058|FG000|Overall Study|Study terminated by sponsor|30|||
160958593|NCT04493216|581236059|FG001|Overall Study|Study terminated by sponsor|33|||
160958594|NCT04493216|581236060|FG002|Overall Study|Study terminated by sponsor|28|||
161269864|NCT03118570|582370365|FG002|Overall Study|Other, Not Specified|0|||
161269865|NCT03118570|582370366|FG003|Overall Study|Other, Not Specified|0|||
160958595|NCT04493216|581236061|FG003|Overall Study|Study terminated by sponsor|27|||
160958596|NCT04493216|581236058|FG000|Overall Study|Withdrawal by Subject|2|||
160958597|NCT04493216|581236059|FG001|Overall Study|Withdrawal by Subject|1|||
161146693|NCT03042611|581919828|FG001|Core Phase|Study Closed|1|||
161269866|NCT03118570|582370367|FG004|Overall Study|Other, Not Specified|0|||
160958598|NCT04493216|581236060|FG002|Overall Study|Withdrawal by Subject|1|||
160958599|NCT04493216|581236061|FG003|Overall Study|Withdrawal by Subject|2|||
160958600|NCT04493216|581236058|FG000|Overall Study|Protocol Violation|1|||
160958601|NCT04493216|581236059|FG001|Overall Study|Protocol Violation|2|||
160958602|NCT04493216|581236060|FG002|Overall Study|Protocol Violation|0|||
160958603|NCT04493216|581236061|FG003|Overall Study|Protocol Violation|2|||
160958604|NCT04493216|581236058|FG000|Overall Study|Physician Decision|0|||
160958605|NCT04493216|581236059|FG001|Overall Study|Physician Decision|0|||
160958606|NCT04493216|581236060|FG002|Overall Study|Physician Decision|1|||
160958607|NCT04493216|581236061|FG003|Overall Study|Physician Decision|0|||
160958608|NCT04493216|581236058|FG000|Overall Study|Lost to Follow-up|2|||
160958609|NCT04493216|581236059|FG001|Overall Study|Lost to Follow-up|1|||
160958610|NCT04493216|581236060|FG002|Overall Study|Lost to Follow-up|0|||
160958611|NCT04493216|581236061|FG003|Overall Study|Lost to Follow-up|1|||
160958612|NCT04493216|581236058|FG000|Overall Study|Adverse Event|1|||
160958613|NCT04493216|581236059|FG001|Overall Study|Adverse Event|4|||
160958614|NCT04493216|581236060|FG002|Overall Study|Adverse Event|5|||
161146694|NCT03042611|581919829|FG002|Core Phase|Study Closed|0|||
160958615|NCT04493216|581236061|FG003|Overall Study|Adverse Event|2|||
160958616|NCT04493216|581236058|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
161146695|NCT03042611|581919830|FG003|Core Phase|Study Closed|0|||
161146696|NCT03042611|581919827|FG000|Extension Phase|Death|0|||
161146697|NCT03042611|581919828|FG001|Extension Phase|Death|0|||
161146698|NCT03042611|581919829|FG002|Extension Phase|Death|34|||
161146699|NCT03042611|581919830|FG003|Extension Phase|Death|16|||
161146700|NCT03042611|581919827|FG000|Extension Phase|Lost to Follow-up|0|||
161146701|NCT03042611|581919828|FG001|Extension Phase|Lost to Follow-up|0|||
161146702|NCT03042611|581919829|FG002|Extension Phase|Lost to Follow-up|1|||
161146703|NCT03042611|581919830|FG003|Extension Phase|Lost to Follow-up|1|||
161146704|NCT03042611|581919827|FG000|Extension Phase|Study Closed|0|||
161146705|NCT03042611|581919828|FG001|Extension Phase|Study Closed|0|||
161146706|NCT03042611|581919829|FG002|Extension Phase|Study Closed|17|||
161146707|NCT03042611|581919830|FG003|Extension Phase|Study Closed|11|||
161146708|NCT00474630|581919832|FG000|Overall Study|Adverse Event|98|||
161146709|NCT00474630|581919833|FG001|Overall Study|Adverse Event|26|||
161146710|NCT00474630|581919832|FG000|Overall Study|Lost to Follow-up|22|||
161146711|NCT00474630|581919833|FG001|Overall Study|Lost to Follow-up|15|||
161146712|NCT00474630|581919832|FG000|Overall Study|Withdrawal by Subject|21|||
161146713|NCT00474630|581919833|FG001|Overall Study|Withdrawal by Subject|15|||
161146714|NCT00474630|581919832|FG000|Overall Study|Protocol Violation|3|||
161146715|NCT00474630|581919833|FG001|Overall Study|Protocol Violation|4|||
161146716|NCT00474630|581919832|FG000|Overall Study|Lack of Efficacy|5|||
161146717|NCT00474630|581919833|FG001|Overall Study|Lack of Efficacy|6|||
161146718|NCT00474630|581919832|FG000|Overall Study|Drug noncompliance, other|11|||
161146719|NCT00474630|581919833|FG001|Overall Study|Drug noncompliance, other|4|||
161146720|NCT00915005|581919838|FG000|Overall Study|Withdrawal by Subject|4|||
161146721|NCT00915005|581919839|FG001|Overall Study|Withdrawal by Subject|4|||
161146722|NCT00915005|581919838|FG000|Overall Study|Patient preferred protons therapy|6|||
161146723|NCT00915005|581919839|FG001|Overall Study|Patient preferred protons therapy|0|||
161146724|NCT00915005|581919838|FG000|Overall Study|Insurance denial|3|||
161146725|NCT00915005|581919839|FG001|Overall Study|Insurance denial|15|||
161269867|NCT02132754|582370368|FG000|Overall Study|Adverse Event|0|||
161269868|NCT02132754|582370369|FG001|Overall Study|Adverse Event|0|||
161269869|NCT02132754|582370370|FG002|Overall Study|Adverse Event|0|||
161269870|NCT02132754|582370371|FG003|Overall Study|Adverse Event|0|||
161269871|NCT02132754|582370372|FG004|Overall Study|Adverse Event|0|||
161269872|NCT02132754|582370373|FG005|Overall Study|Adverse Event|0|||
161269873|NCT02132754|582370374|FG006|Overall Study|Adverse Event|0|||
161269874|NCT02132754|582370375|FG007|Overall Study|Adverse Event|0|||
161269875|NCT02132754|582370376|FG008|Overall Study|Adverse Event|0|||
161269876|NCT02132754|582370377|FG009|Overall Study|Adverse Event|0|||
161269877|NCT02132754|582370378|FG010|Overall Study|Adverse Event|0|||
161269878|NCT02132754|582370379|FG011|Overall Study|Adverse Event|0|||
161269879|NCT02132754|582370380|FG012|Overall Study|Adverse Event|0|||
161269880|NCT02132754|582370381|FG013|Overall Study|Adverse Event|0|||
161269881|NCT02132754|582370382|FG014|Overall Study|Adverse Event|0|||
161269882|NCT02132754|582370383|FG015|Overall Study|Adverse Event|0|||
161269883|NCT02132754|582370384|FG016|Overall Study|Adverse Event|0|||
161269884|NCT02132754|582370385|FG017|Overall Study|Adverse Event|1|||
161269885|NCT02132754|582370386|FG018|Overall Study|Adverse Event|0|||
161269886|NCT02132754|582370387|FG019|Overall Study|Adverse Event|0|||
161269887|NCT02132754|582370388|FG020|Overall Study|Adverse Event|0|||
161269888|NCT02132754|582370389|FG021|Overall Study|Adverse Event|0|||
161269889|NCT02132754|582370390|FG022|Overall Study|Adverse Event|0|||
161269890|NCT02132754|582370391|FG023|Overall Study|Adverse Event|0|||
161269891|NCT02132754|582370392|FG024|Overall Study|Adverse Event|0|||
161269892|NCT02132754|582370393|FG025|Overall Study|Adverse Event|1|||
161269893|NCT02132754|582370394|FG026|Overall Study|Adverse Event|1|||
161269894|NCT02132754|582370395|FG027|Overall Study|Adverse Event|0|||
161269895|NCT02132754|582370396|FG028|Overall Study|Adverse Event|0|||
161269896|NCT02132754|582370397|FG029|Overall Study|Adverse Event|0|||
161269897|NCT02132754|582370398|FG030|Overall Study|Adverse Event|1|||
161269898|NCT02132754|582370399|FG031|Overall Study|Adverse Event|0|||
160958617|NCT04493216|581236059|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
160958618|NCT04493216|581236060|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
161269899|NCT02132754|582370400|FG032|Overall Study|Adverse Event|1|||
161269900|NCT02132754|582370401|FG033|Overall Study|Adverse Event|1|||
161269901|NCT02132754|582370368|FG000|Overall Study|Clinical Progression|0|||
161269902|NCT02132754|582370369|FG001|Overall Study|Clinical Progression|0|||
161269903|NCT02132754|582370370|FG002|Overall Study|Clinical Progression|0|||
161269904|NCT02132754|582370371|FG003|Overall Study|Clinical Progression|0|||
161269905|NCT02132754|582370372|FG004|Overall Study|Clinical Progression|0|||
161269906|NCT02132754|582370373|FG005|Overall Study|Clinical Progression|0|||
161269907|NCT02132754|582370374|FG006|Overall Study|Clinical Progression|0|||
161269908|NCT02132754|582370375|FG007|Overall Study|Clinical Progression|0|||
161269909|NCT02132754|582370376|FG008|Overall Study|Clinical Progression|0|||
161269910|NCT02132754|582370377|FG009|Overall Study|Clinical Progression|1|||
161269911|NCT02132754|582370378|FG010|Overall Study|Clinical Progression|0|||
161269912|NCT02132754|582370379|FG011|Overall Study|Clinical Progression|0|||
161269913|NCT02132754|582370380|FG012|Overall Study|Clinical Progression|0|||
160958619|NCT04493216|581236061|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
160958620|NCT04605978|581236074|FG000|Overall Study|Adverse Event|2|||
160958621|NCT04605978|581236075|FG001|Overall Study|Adverse Event|1|||
160958622|NCT04605978|581236074|FG000|Overall Study|Withdrawal nonmedical reason|1|||
160958623|NCT04605978|581236075|FG001|Overall Study|Withdrawal nonmedical reason|1|||
160958624|NCT02583425|581236076|FG000|Screening|Did not meet entry criteria|12|||
160958625|NCT02583425|581236076|FG000|Baseline|Did not meet continued criteria|5|||
160958626|NCT02583425|581236076|FG000|Treatment Period|Adverse Event|1|||
161269914|NCT02132754|582370381|FG013|Overall Study|Clinical Progression|0|||
161269915|NCT02132754|582370382|FG014|Overall Study|Clinical Progression|0|||
161269916|NCT02132754|582370383|FG015|Overall Study|Clinical Progression|0|||
161269917|NCT02132754|582370384|FG016|Overall Study|Clinical Progression|1|||
161269918|NCT02132754|582370385|FG017|Overall Study|Clinical Progression|1|||
161269919|NCT02132754|582370386|FG018|Overall Study|Clinical Progression|0|||
161269920|NCT02132754|582370387|FG019|Overall Study|Clinical Progression|1|||
161269921|NCT02132754|582370388|FG020|Overall Study|Clinical Progression|0|||
161269922|NCT02132754|582370389|FG021|Overall Study|Clinical Progression|0|||
161269923|NCT02132754|582370390|FG022|Overall Study|Clinical Progression|1|||
161269924|NCT02132754|582370391|FG023|Overall Study|Clinical Progression|0|||
161269925|NCT02132754|582370392|FG024|Overall Study|Clinical Progression|1|||
161269926|NCT02132754|582370393|FG025|Overall Study|Clinical Progression|1|||
161269927|NCT02132754|582370394|FG026|Overall Study|Clinical Progression|0|||
161269928|NCT02132754|582370395|FG027|Overall Study|Clinical Progression|1|||
161269929|NCT02132754|582370396|FG028|Overall Study|Clinical Progression|1|||
161269930|NCT02132754|582370397|FG029|Overall Study|Clinical Progression|0|||
161269931|NCT02132754|582370398|FG030|Overall Study|Clinical Progression|1|||
161269932|NCT02132754|582370399|FG031|Overall Study|Clinical Progression|0|||
161269933|NCT02132754|582370400|FG032|Overall Study|Clinical Progression|0|||
161269934|NCT02132754|582370401|FG033|Overall Study|Clinical Progression|2|||
161269935|NCT02132754|582370368|FG000|Overall Study|Death|0|||
161269936|NCT02132754|582370369|FG001|Overall Study|Death|0|||
161269937|NCT02132754|582370370|FG002|Overall Study|Death|0|||
161269938|NCT02132754|582370371|FG003|Overall Study|Death|0|||
161269939|NCT02132754|582370372|FG004|Overall Study|Death|0|||
160958627|NCT01690130|581236077|FG000|Overall Study|Subject have cancelled visit.|1|||
160958628|NCT01690130|581236078|FG001|Overall Study|Subject have cancelled visit.|0|||
160958629|NCT01644734|581236079|FG000|Overall Study|Adverse Event|4|||
160958630|NCT01644734|581236079|FG000|Overall Study|Lost to Follow-up|17|||
160958631|NCT01644734|581236079|FG000|Overall Study|Reasons other than stated above|7|||
161146726|NCT02397655|581919842|FG000|Overall Study|data not completed|1301|||
161146727|NCT01342640|581919846|FG000|Overall Study|Adverse Event|3|||
161146728|NCT01342640|581919846|FG000|Overall Study|Protocol Violation|16|||
161146729|NCT01342640|581919846|FG000|Overall Study|Lost to Follow-up|21|||
161269940|NCT02132754|582370373|FG005|Overall Study|Death|0|||
161269941|NCT02132754|582370374|FG006|Overall Study|Death|0|||
161269942|NCT02132754|582370375|FG007|Overall Study|Death|0|||
161269943|NCT02132754|582370376|FG008|Overall Study|Death|0|||
161269944|NCT02132754|582370377|FG009|Overall Study|Death|0|||
161269945|NCT02132754|582370378|FG010|Overall Study|Death|0|||
161146730|NCT01342640|581919846|FG000|Overall Study|Other|1|||
161269946|NCT02132754|582370379|FG011|Overall Study|Death|0|||
161269947|NCT02132754|582370380|FG012|Overall Study|Death|0|||
161269948|NCT02132754|582370381|FG013|Overall Study|Death|0|||
161269949|NCT02132754|582370382|FG014|Overall Study|Death|0|||
161269950|NCT02132754|582370383|FG015|Overall Study|Death|1|||
161269951|NCT02132754|582370384|FG016|Overall Study|Death|0|||
161269952|NCT02132754|582370385|FG017|Overall Study|Death|0|||
161269953|NCT02132754|582370386|FG018|Overall Study|Death|0|||
160958632|NCT01644734|581236079|FG000|Overall Study|Missing documentation|238|||
160958633|NCT02216123|581236080|FG000|Overall Study|Lost to Follow-up|4|||
160958634|NCT02216123|581236081|FG001|Overall Study|Lost to Follow-up|2|||
160958635|NCT02216123|581236080|FG000|Overall Study|Withdrawal by Subject|2|||
160958636|NCT02216123|581236081|FG001|Overall Study|Withdrawal by Subject|0|||
160958637|NCT02157779|581236086|FG000|Overall Study|Logistical|9|||
160958638|NCT02157779|581236087|FG001|Overall Study|Logistical|3|||
160958639|NCT02157779|581236086|FG000|Overall Study|Stopped attending, reason unknown|11|||
160958640|NCT02157779|581236087|FG001|Overall Study|Stopped attending, reason unknown|7|||
160958641|NCT02157779|581236086|FG000|Overall Study|No response to outreach after Baseline|1|||
160958642|NCT02157779|581236087|FG001|Overall Study|No response to outreach after Baseline|1|||
160958643|NCT02157779|581236086|FG000|Overall Study|Moved|1|||
160958644|NCT02157779|581236087|FG001|Overall Study|Moved|0|||
160958645|NCT02157779|581236086|FG000|Overall Study|Medical|1|||
160958646|NCT02157779|581236087|FG001|Overall Study|Medical|0|||
160958647|NCT02157779|581236086|FG000|Overall Study|Legal issue|1|||
160958648|NCT02157779|581236087|FG001|Overall Study|Legal issue|0|||
160958649|NCT02548455|581236088|FG000|Overall Study|Withdrawal by Subject|27|||
160958650|NCT02548455|581236088|FG000|Overall Study|Death|26|||
160958651|NCT02548455|581236088|FG000|Overall Study|Lost to Follow-up|14|||
160958652|NCT02548455|581236088|FG000|Overall Study|Visit not completed|173|||
160958653|NCT00487162|581236090|FG000|Overall Study|Adverse Event|0|||
160958654|NCT00487162|581236091|FG001|Overall Study|Adverse Event|1|||
160958655|NCT00487162|581236090|FG000|Overall Study|Physician Decision|0|||
160958656|NCT00487162|581236091|FG001|Overall Study|Physician Decision|1|||
160958657|NCT00487162|581236090|FG000|Overall Study|Withdrawal by Subject|2|||
160958658|NCT00487162|581236091|FG001|Overall Study|Withdrawal by Subject|3|||
160958659|NCT01292876|581236092|FG000|Overall Study|Physician Decision|4|||
160958660|NCT01627327|581236093|FG000|Overall Study|Adverse Event|6|||
160958661|NCT01627327|581236094|FG001|Overall Study|Adverse Event|12|||
160958662|NCT01627327|581236093|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
160958663|NCT01627327|581236094|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
160958664|NCT01627327|581236093|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
160958665|NCT01627327|581236094|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
160958666|NCT01627327|581236093|FG000|Overall Study|Protocol Violation|4|||
160958667|NCT01627327|581236094|FG001|Overall Study|Protocol Violation|10|||
160958668|NCT01627327|581236093|FG000|Overall Study|Lost to Follow-up|1|||
160958669|NCT01627327|581236094|FG001|Overall Study|Lost to Follow-up|3|||
160958670|NCT01627327|581236093|FG000|Overall Study|Physician Decision|1|||
160958671|NCT01627327|581236094|FG001|Overall Study|Physician Decision|0|||
160958672|NCT01627327|581236093|FG000|Overall Study|Withdrawal by Subject|3|||
160958673|NCT01627327|581236094|FG001|Overall Study|Withdrawal by Subject|3|||
160958674|NCT01137474|581236100|FG000|Overall Study|Adverse Event|3|||
160958675|NCT01137474|581236101|FG001|Overall Study|Adverse Event|5|||
160958676|NCT01137474|581236102|FG002|Overall Study|Adverse Event|1|||
160958677|NCT01137474|581236103|FG003|Overall Study|Adverse Event|3|||
160958678|NCT01137474|581236100|FG000|Overall Study|Withdrawal by Subject|7|||
160958679|NCT01137474|581236101|FG001|Overall Study|Withdrawal by Subject|2|||
160958680|NCT01137474|581236102|FG002|Overall Study|Withdrawal by Subject|6|||
160958681|NCT01137474|581236103|FG003|Overall Study|Withdrawal by Subject|9|||
160958682|NCT01137474|581236100|FG000|Overall Study|No longer met study criteria|6|||
160958683|NCT01137474|581236101|FG001|Overall Study|No longer met study criteria|1|||
160958684|NCT01137474|581236102|FG002|Overall Study|No longer met study criteria|0|||
160958685|NCT01137474|581236103|FG003|Overall Study|No longer met study criteria|5|||
160958686|NCT01137474|581236100|FG000|Overall Study|Lost to Follow-up|5|||
160958687|NCT01137474|581236101|FG001|Overall Study|Lost to Follow-up|1|||
160958688|NCT01137474|581236102|FG002|Overall Study|Lost to Follow-up|0|||
160958689|NCT01137474|581236103|FG003|Overall Study|Lost to Follow-up|2|||
160958690|NCT01137474|581236100|FG000|Overall Study|Lack of Efficacy|0|||
160958691|NCT01137474|581236101|FG001|Overall Study|Lack of Efficacy|0|||
160958692|NCT01137474|581236102|FG002|Overall Study|Lack of Efficacy|0|||
160958693|NCT01137474|581236103|FG003|Overall Study|Lack of Efficacy|2|||
160958694|NCT01137474|581236100|FG000|Overall Study|Other|3|||
160958695|NCT01137474|581236101|FG001|Overall Study|Other|1|||
160958696|NCT01137474|581236102|FG002|Overall Study|Other|0|||
161001736|NCT01393119|581392975|FG003|Overall Study|Sponsor Termination of Study|12|||
161001737|NCT04860258|581392976|FG000|Overall Study|Withdrawal by Subject|0|||
161001738|NCT04860258|581392977|FG001|Overall Study|Withdrawal by Subject|0|||
161001739|NCT04860258|581392978|FG002|Overall Study|Withdrawal by Subject|4|||
161001740|NCT04860258|581392979|FG003|Overall Study|Withdrawal by Subject|1|||
161001741|NCT04860258|581392980|FG004|Overall Study|Withdrawal by Subject|4|||
161001742|NCT04860258|581392981|FG005|Overall Study|Withdrawal by Subject|1|||
160958697|NCT01137474|581236103|FG003|Overall Study|Other|0|||
160958698|NCT01137474|581236100|FG000|Overall Study|Pregnancy|0|||
160958699|NCT01137474|581236101|FG001|Overall Study|Pregnancy|1|||
161146731|NCT00545818|581919847|FG000|Overall Study|Protocol Violation|1|||
160958700|NCT01137474|581236102|FG002|Overall Study|Pregnancy|0|||
160958701|NCT01137474|581236103|FG003|Overall Study|Pregnancy|0|||
161001743|NCT04860258|581392982|FG006|Overall Study|Withdrawal by Subject|0|||
160958702|NCT01137474|581236100|FG000|Overall Study|Administrative reason by sponsor|0|||
160958703|NCT01137474|581236101|FG001|Overall Study|Administrative reason by sponsor|1|||
160958704|NCT01137474|581236102|FG002|Overall Study|Administrative reason by sponsor|0|||
160958705|NCT01137474|581236103|FG003|Overall Study|Administrative reason by sponsor|0|||
160958706|NCT02525874|581236106|FG000|Overall Study|Other|1|||
160958707|NCT02525874|581236106|FG000|Overall Study|Investigator Decision|1|||
160958708|NCT02525874|581236106|FG000|Overall Study|Consent withdrawn|22|||
160958709|NCT02525874|581236106|FG000|Overall Study|Non-compliance with study drug|3|||
160958710|NCT02525874|581236106|FG000|Overall Study|Adverse Event|17|||
160958711|NCT02525874|581236106|FG000|Overall Study|Lost to Follow-up|7|||
160958712|NCT02525874|581236106|FG000|Overall Study|Disease progression, defined by protocol|2|||
160958713|NCT02525874|581236106|FG000|Overall Study|Disease relapse|4|||
160958714|NCT02525874|581236106|FG000|Overall Study|Alternative Treatment for MS|2|||
160958715|NCT02525874|581236106|FG000|Overall Study|New lesions in Brain|1|||
160958716|NCT00675766|581236113|FG000|Overall Study|Lost to Follow-up|6|||
160958717|NCT00675766|581236114|FG001|Overall Study|Lost to Follow-up|5|||
160958718|NCT00675766|581236115|FG002|Overall Study|Lost to Follow-up|21|||
160958719|NCT00675766|581236116|FG003|Overall Study|Lost to Follow-up|26|||
160958720|NCT01207102|581236120|FG000|Overall Study|Withdrawal by Subject|5|||
160958721|NCT01207102|581236120|FG000|Overall Study|Adverse Event|2|||
160958722|NCT01207102|581236120|FG000|Overall Study|progression|2|||
160958723|NCT01207102|581236120|FG000|Overall Study|Withdrawal by Treating Physician|1|||
160958724|NCT01018394|581236121|FG000|Overall Study|Withdrawal by Subject|5|||
160958725|NCT01018394|581236122|FG001|Overall Study|Withdrawal by Subject|5|||
160958726|NCT01018394|581236121|FG000|Overall Study|Lost to Follow-up|4|||
160958727|NCT01018394|581236122|FG001|Overall Study|Lost to Follow-up|3|||
160958728|NCT03792126|581236123|FG000|Overall Study|Adverse Event|1|||
160958729|NCT03792126|581236124|FG001|Overall Study|Adverse Event|2|||
160958730|NCT03792126|581236123|FG000|Overall Study|Death|0|||
160958731|NCT03792126|581236124|FG001|Overall Study|Death|1|||
160958732|NCT03792126|581236123|FG000|Overall Study|Lost to Follow-up|1|||
160958733|NCT03792126|581236124|FG001|Overall Study|Lost to Follow-up|0|||
160958734|NCT03792126|581236123|FG000|Overall Study|Withdrawal by Subject|0|||
160958735|NCT03792126|581236124|FG001|Overall Study|Withdrawal by Subject|1|||
160958736|NCT03792126|581236123|FG000|Overall Study|COVID-19 Restrictions|1|||
160958737|NCT03792126|581236124|FG001|Overall Study|COVID-19 Restrictions|3|||
160958738|NCT03792126|581236123|FG000|Overall Study|Symptoms resolved|0|||
160958739|NCT03792126|581236124|FG001|Overall Study|Symptoms resolved|3|||
160958740|NCT00617344|581236126|FG000|Overall Study|Serious adverse event|1|||
160958741|NCT00617344|581236127|FG001|Overall Study|Serious adverse event|0|||
160958742|NCT00617344|581236128|FG002|Overall Study|Serious adverse event|0|||
161343467|NCT03965923|582644397|FG007|Overall Study|Withdrawal by Subject|3|||
160958743|NCT00617344|581236126|FG000|Overall Study|Other Adverse Event|1|||
160958744|NCT00617344|581236127|FG001|Overall Study|Other Adverse Event|1|||
160958745|NCT00617344|581236128|FG002|Overall Study|Other Adverse Event|0|||
160958746|NCT00617344|581236126|FG000|Overall Study|Protocol Violation|10|||
160958747|NCT00617344|581236127|FG001|Overall Study|Protocol Violation|8|||
160958748|NCT00617344|581236128|FG002|Overall Study|Protocol Violation|5|||
160958749|NCT00617344|581236126|FG000|Overall Study|Lost to Follow-up|5|||
160958750|NCT00617344|581236127|FG001|Overall Study|Lost to Follow-up|4|||
160958751|NCT00617344|581236128|FG002|Overall Study|Lost to Follow-up|1|||
160958752|NCT00617344|581236126|FG000|Overall Study|Withdrawal by Subject|8|||
160958753|NCT00617344|581236127|FG001|Overall Study|Withdrawal by Subject|9|||
160958754|NCT00617344|581236128|FG002|Overall Study|Withdrawal by Subject|2|||
160958755|NCT00490646|581236129|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
160958756|NCT00490646|581236130|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
160958757|NCT00490646|581236129|FG000|Overall Study|Never Treated (had an adverse event)|1|||
160958758|NCT00490646|581236130|FG001|Overall Study|Never Treated (had an adverse event)|0|||
160958759|NCT00490646|581236129|FG000|Overall Study|Never Treated (withdrew consent)|0|||
160958760|NCT00490646|581236130|FG001|Overall Study|Never Treated (withdrew consent)|1|||
160958761|NCT01400503|581236132|FG000|Overall Study|Withdrawal by Subject|1|||
160958762|NCT01400503|581236132|FG000|Overall Study|Study Terminated by Sponsor|58|||
160958763|NCT01400503|581236132|FG000|Overall Study|Other|1|||
160958764|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
160958765|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
160958766|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
160958767|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
160958768|NCT00983073|581236133|FG000|Titration and Optimal Dose Period|Other reason|4|||
160958769|NCT00983073|581236133|FG000|Maintenance Period|Adverse Event|5|||
160958770|NCT00983073|581236133|FG000|Maintenance Period|Withdrawal by Subject|2|||
160958771|NCT00983073|581236133|FG000|Maintenance Period|Lack of Efficacy|2|||
160958772|NCT00983073|581236133|FG000|Maintenance Period|Other Reason|7|||
160958773|NCT01669122|581236136|FG000|Period I|Lost to Follow-up|1|||
160958774|NCT01669122|581236136|FG000|Washout Period II|Protocol Violation|2|||
160958775|NCT02962908|581236137|FG000|Overall Study|Lost to Follow-up|0|||
161146732|NCT00545818|581919848|FG001|Overall Study|Protocol Violation|0|||
160958776|NCT02962908|581236138|FG001|Overall Study|Lost to Follow-up|3|||
160958777|NCT02962908|581236139|FG002|Overall Study|Lost to Follow-up|0|||
160958778|NCT02962908|581236140|FG003|Overall Study|Lost to Follow-up|1|||
160958779|NCT02962908|581236137|FG000|Overall Study|Withdrawal by Subject|0|||
160958780|NCT02962908|581236138|FG001|Overall Study|Withdrawal by Subject|3|||
160958781|NCT02962908|581236139|FG002|Overall Study|Withdrawal by Subject|0|||
160958782|NCT02962908|581236140|FG003|Overall Study|Withdrawal by Subject|2|||
160958783|NCT02962908|581236137|FG000|Overall Study|Protocol Violation|0|||
160958784|NCT02962908|581236138|FG001|Overall Study|Protocol Violation|1|||
160958785|NCT02962908|581236139|FG002|Overall Study|Protocol Violation|0|||
160958786|NCT02962908|581236140|FG003|Overall Study|Protocol Violation|0|||
160958787|NCT02962908|581236137|FG000|Overall Study|Physician Decision|0|||
160958788|NCT02962908|581236138|FG001|Overall Study|Physician Decision|1|||
160958789|NCT02962908|581236139|FG002|Overall Study|Physician Decision|0|||
160958790|NCT02962908|581236140|FG003|Overall Study|Physician Decision|0|||
160958791|NCT03543254|581236141|FG000|Overall Study|Lost to Follow-up|1|||
160958792|NCT02077166|581236142|FG000|Overall Study|Death|6|||
160958793|NCT02077166|581236143|FG001|Overall Study|Death|7|||
160958794|NCT02077166|581236144|FG002|Overall Study|Death|5|||
160958795|NCT02077166|581236145|FG003|Overall Study|Death|6|||
160958796|NCT02077166|581236146|FG004|Overall Study|Death|4|||
160958797|NCT02077166|581236147|FG005|Overall Study|Death|32|||
160958798|NCT02077166|581236148|FG006|Overall Study|Death|22|||
160958799|NCT02077166|581236142|FG000|Overall Study|Study Closure by Sponsor|3|||
160958800|NCT02077166|581236143|FG001|Overall Study|Study Closure by Sponsor|0|||
160958801|NCT02077166|581236144|FG002|Overall Study|Study Closure by Sponsor|2|||
160958802|NCT02077166|581236145|FG003|Overall Study|Study Closure by Sponsor|2|||
160958803|NCT02077166|581236146|FG004|Overall Study|Study Closure by Sponsor|2|||
160958804|NCT02077166|581236147|FG005|Overall Study|Study Closure by Sponsor|12|||
160958805|NCT02077166|581236148|FG006|Overall Study|Study Closure by Sponsor|4|||
160958806|NCT02077166|581236142|FG000|Overall Study|Lost to Follow-up|0|||
160958807|NCT02077166|581236143|FG001|Overall Study|Lost to Follow-up|0|||
160958808|NCT02077166|581236144|FG002|Overall Study|Lost to Follow-up|0|||
160958809|NCT02077166|581236145|FG003|Overall Study|Lost to Follow-up|0|||
160958810|NCT02077166|581236146|FG004|Overall Study|Lost to Follow-up|0|||
160958811|NCT02077166|581236147|FG005|Overall Study|Lost to Follow-up|1|||
160958812|NCT02077166|581236148|FG006|Overall Study|Lost to Follow-up|0|||
160958813|NCT02077166|581236142|FG000|Overall Study|Withdrawal by Subject|3|||
160958814|NCT02077166|581236143|FG001|Overall Study|Withdrawal by Subject|0|||
160958815|NCT02077166|581236144|FG002|Overall Study|Withdrawal by Subject|1|||
160958816|NCT02077166|581236145|FG003|Overall Study|Withdrawal by Subject|1|||
160958817|NCT02077166|581236146|FG004|Overall Study|Withdrawal by Subject|1|||
160958818|NCT02077166|581236147|FG005|Overall Study|Withdrawal by Subject|3|||
160958819|NCT02077166|581236148|FG006|Overall Study|Withdrawal by Subject|0|||
160958820|NCT02077166|581236142|FG000|Overall Study|Other, Not Specified|0|||
160958821|NCT02077166|581236143|FG001|Overall Study|Other, Not Specified|0|||
160958822|NCT02077166|581236144|FG002|Overall Study|Other, Not Specified|1|||
160958823|NCT02077166|581236145|FG003|Overall Study|Other, Not Specified|0|||
160958824|NCT02077166|581236146|FG004|Overall Study|Other, Not Specified|1|||
160958825|NCT02077166|581236147|FG005|Overall Study|Other, Not Specified|7|||
160958826|NCT02077166|581236148|FG006|Overall Study|Other, Not Specified|8|||
161001744|NCT01266265|581392983|FG000|Overall Study|Death|95|||
161001745|NCT01266265|581392984|FG001|Overall Study|Death|73|||
161001746|NCT01266265|581392983|FG000|Overall Study|Lost to Follow-up|23|||
161001747|NCT01266265|581392984|FG001|Overall Study|Lost to Follow-up|28|||
161001748|NCT01266265|581392983|FG000|Overall Study|Withdrawal by Subject|13|||
161001749|NCT01266265|581392984|FG001|Overall Study|Withdrawal by Subject|11|||
161001750|NCT01266265|581392983|FG000|Overall Study|Respiratory-related adverse event|2|||
161001751|NCT01266265|581392984|FG001|Overall Study|Respiratory-related adverse event|1|||
161001752|NCT01266265|581392983|FG000|Overall Study|Transferred care to another provider|22|||
161001753|NCT01266265|581392984|FG001|Overall Study|Transferred care to another provider|28|||
161001754|NCT01266265|581392983|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
161001755|NCT01266265|581392984|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
161001756|NCT01266265|581392983|FG000|Overall Study|Enrolled in another clinical study|15|||
161001757|NCT01266265|581392984|FG001|Overall Study|Enrolled in another clinical study|26|||
161001758|NCT01266265|581392983|FG000|Overall Study|Non-compliance|8|||
161001759|NCT01266265|581392984|FG001|Overall Study|Non-compliance|5|||
160958827|NCT01261338|581236149|FG000|Overall Study|Withdrawal by Subject|3|||
160958828|NCT01261338|581236150|FG001|Overall Study|Withdrawal by Subject|2|||
160958829|NCT02899728|581236156|FG000|Overall Study|Withdrawal by Subject|1|||
160958830|NCT02899728|581236157|FG001|Overall Study|Withdrawal by Subject|1|||
160958831|NCT05557942|581236158|FG000|Overall Study|Death|0|||
160958832|NCT05557942|581236159|FG001|Overall Study|Death|0|||
160958833|NCT05557942|581236160|FG002|Overall Study|Death|0|||
160958834|NCT05557942|581236161|FG003|Overall Study|Death|2|||
161001760|NCT01266265|581392983|FG000|Overall Study|Lung transplant|6|||
161001761|NCT01266265|581392984|FG001|Overall Study|Lung transplant|5|||
161001762|NCT01266265|581392983|FG000|Overall Study|Site closed early|4|||
161269954|NCT02132754|582370387|FG019|Overall Study|Death|1|||
161269955|NCT02132754|582370388|FG020|Overall Study|Death|0|||
161269956|NCT02132754|582370389|FG021|Overall Study|Death|1|||
161269957|NCT02132754|582370390|FG022|Overall Study|Death|0|||
161269958|NCT02132754|582370391|FG023|Overall Study|Death|0|||
161269959|NCT02132754|582370392|FG024|Overall Study|Death|0|||
161269960|NCT02132754|582370393|FG025|Overall Study|Death|0|||
161269961|NCT02132754|582370394|FG026|Overall Study|Death|1|||
161269962|NCT02132754|582370395|FG027|Overall Study|Death|0|||
161269963|NCT02132754|582370396|FG028|Overall Study|Death|0|||
161269964|NCT02132754|582370397|FG029|Overall Study|Death|0|||
161269965|NCT02132754|582370398|FG030|Overall Study|Death|0|||
161269966|NCT02132754|582370399|FG031|Overall Study|Death|0|||
161269967|NCT02132754|582370400|FG032|Overall Study|Death|0|||
161269968|NCT02132754|582370401|FG033|Overall Study|Death|2|||
161269969|NCT02132754|582370368|FG000|Overall Study|Excluded Medication|0|||
161269970|NCT02132754|582370369|FG001|Overall Study|Excluded Medication|0|||
161269971|NCT02132754|582370370|FG002|Overall Study|Excluded Medication|0|||
161269972|NCT02132754|582370371|FG003|Overall Study|Excluded Medication|0|||
161269973|NCT02132754|582370372|FG004|Overall Study|Excluded Medication|0|||
161269974|NCT02132754|582370373|FG005|Overall Study|Excluded Medication|0|||
161269975|NCT02132754|582370374|FG006|Overall Study|Excluded Medication|0|||
161269976|NCT02132754|582370375|FG007|Overall Study|Excluded Medication|0|||
161269977|NCT02132754|582370376|FG008|Overall Study|Excluded Medication|0|||
161269978|NCT02132754|582370377|FG009|Overall Study|Excluded Medication|0|||
161269979|NCT02132754|582370378|FG010|Overall Study|Excluded Medication|0|||
161269980|NCT02132754|582370379|FG011|Overall Study|Excluded Medication|0|||
161269981|NCT02132754|582370380|FG012|Overall Study|Excluded Medication|0|||
161269982|NCT02132754|582370381|FG013|Overall Study|Excluded Medication|0|||
161269983|NCT02132754|582370382|FG014|Overall Study|Excluded Medication|0|||
161269984|NCT02132754|582370383|FG015|Overall Study|Excluded Medication|0|||
160958835|NCT05557942|581236162|FG004|Overall Study|Death|1|||
160958836|NCT05557942|581236163|FG005|Overall Study|Death|1|||
160958837|NCT05557942|581236158|FG000|Overall Study|Physician Decision|1|||
160958838|NCT05557942|581236159|FG001|Overall Study|Physician Decision|1|||
160958839|NCT05557942|581236160|FG002|Overall Study|Physician Decision|2|||
160958840|NCT05557942|581236161|FG003|Overall Study|Physician Decision|3|||
160958841|NCT05557942|581236162|FG004|Overall Study|Physician Decision|0|||
161001763|NCT01266265|581392984|FG001|Overall Study|Site closed early|3|||
161269985|NCT02132754|582370384|FG016|Overall Study|Excluded Medication|0|||
161269986|NCT02132754|582370385|FG017|Overall Study|Excluded Medication|0|||
161269987|NCT02132754|582370386|FG018|Overall Study|Excluded Medication|0|||
161269988|NCT02132754|582370387|FG019|Overall Study|Excluded Medication|0|||
161269989|NCT02132754|582370388|FG020|Overall Study|Excluded Medication|1|||
161269990|NCT02132754|582370389|FG021|Overall Study|Excluded Medication|0|||
161269991|NCT02132754|582370390|FG022|Overall Study|Excluded Medication|0|||
161269992|NCT02132754|582370391|FG023|Overall Study|Excluded Medication|0|||
161269993|NCT02132754|582370392|FG024|Overall Study|Excluded Medication|0|||
161269994|NCT02132754|582370393|FG025|Overall Study|Excluded Medication|0|||
161269995|NCT02132754|582370394|FG026|Overall Study|Excluded Medication|0|||
161269996|NCT02132754|582370395|FG027|Overall Study|Excluded Medication|0|||
161269997|NCT02132754|582370396|FG028|Overall Study|Excluded Medication|0|||
161269998|NCT02132754|582370397|FG029|Overall Study|Excluded Medication|0|||
161269999|NCT02132754|582370398|FG030|Overall Study|Excluded Medication|0|||
161270000|NCT02132754|582370399|FG031|Overall Study|Excluded Medication|0|||
161270001|NCT02132754|582370400|FG032|Overall Study|Excluded Medication|0|||
161270002|NCT02132754|582370401|FG033|Overall Study|Excluded Medication|1|||
161001764|NCT01266265|581392983|FG000|Overall Study|Clinical worsening|1|||
161001765|NCT01266265|581392984|FG001|Overall Study|Clinical worsening|1|||
161001766|NCT01580293|581392985|FG000|Part A_Main Trial|Adverse Event|0|||
161001767|NCT01580293|581392986|FG001|Part A_Main Trial|Adverse Event|2|||
161001768|NCT01580293|581392987|FG002|Part A_Main Trial|Adverse Event|0|||
161270003|NCT02132754|582370368|FG000|Overall Study|Physician Decision|0|||
161270004|NCT02132754|582370369|FG001|Overall Study|Physician Decision|0|||
160958842|NCT05557942|581236163|FG005|Overall Study|Physician Decision|2|||
161270005|NCT02132754|582370370|FG002|Overall Study|Physician Decision|0|||
161270006|NCT02132754|582370371|FG003|Overall Study|Physician Decision|0|||
161270007|NCT02132754|582370372|FG004|Overall Study|Physician Decision|0|||
161270008|NCT02132754|582370373|FG005|Overall Study|Physician Decision|0|||
160958843|NCT05557942|581236158|FG000|Overall Study|Study terminated by sponsor|17|||
160958844|NCT05557942|581236159|FG001|Overall Study|Study terminated by sponsor|17|||
161001769|NCT01580293|581392985|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
161001770|NCT01580293|581392986|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
161270009|NCT02132754|582370374|FG006|Overall Study|Physician Decision|0|||
161270010|NCT02132754|582370375|FG007|Overall Study|Physician Decision|0|||
161270011|NCT02132754|582370376|FG008|Overall Study|Physician Decision|0|||
161270012|NCT02132754|582370377|FG009|Overall Study|Physician Decision|1|||
161270013|NCT02132754|582370378|FG010|Overall Study|Physician Decision|0|||
161270014|NCT02132754|582370379|FG011|Overall Study|Physician Decision|1|||
161270015|NCT02132754|582370380|FG012|Overall Study|Physician Decision|1|||
161270016|NCT02132754|582370381|FG013|Overall Study|Physician Decision|0|||
161270017|NCT02132754|582370382|FG014|Overall Study|Physician Decision|0|||
161270018|NCT02132754|582370383|FG015|Overall Study|Physician Decision|1|||
161270019|NCT02132754|582370384|FG016|Overall Study|Physician Decision|0|||
161270020|NCT02132754|582370385|FG017|Overall Study|Physician Decision|0|||
161270021|NCT02132754|582370386|FG018|Overall Study|Physician Decision|0|||
161270022|NCT02132754|582370387|FG019|Overall Study|Physician Decision|0|||
161270023|NCT02132754|582370388|FG020|Overall Study|Physician Decision|0|||
161270024|NCT02132754|582370389|FG021|Overall Study|Physician Decision|0|||
161270025|NCT02132754|582370390|FG022|Overall Study|Physician Decision|0|||
161270026|NCT02132754|582370391|FG023|Overall Study|Physician Decision|0|||
161270027|NCT02132754|582370392|FG024|Overall Study|Physician Decision|1|||
161270028|NCT02132754|582370393|FG025|Overall Study|Physician Decision|0|||
161270029|NCT02132754|582370394|FG026|Overall Study|Physician Decision|0|||
161270030|NCT02132754|582370395|FG027|Overall Study|Physician Decision|0|||
161270031|NCT02132754|582370396|FG028|Overall Study|Physician Decision|0|||
161270032|NCT02132754|582370397|FG029|Overall Study|Physician Decision|0|||
161270033|NCT02132754|582370398|FG030|Overall Study|Physician Decision|0|||
161270034|NCT02132754|582370399|FG031|Overall Study|Physician Decision|1|||
161270035|NCT02132754|582370400|FG032|Overall Study|Physician Decision|0|||
161270036|NCT02132754|582370401|FG033|Overall Study|Physician Decision|3|||
161270037|NCT02132754|582370368|FG000|Overall Study|Progressive Disease|1|||
161270038|NCT02132754|582370369|FG001|Overall Study|Progressive Disease|1|||
161270039|NCT02132754|582370370|FG002|Overall Study|Progressive Disease|1|||
161270040|NCT02132754|582370371|FG003|Overall Study|Progressive Disease|1|||
161270041|NCT02132754|582370372|FG004|Overall Study|Progressive Disease|1|||
160958845|NCT05557942|581236160|FG002|Overall Study|Study terminated by sponsor|14|||
160958846|NCT05557942|581236161|FG003|Overall Study|Study terminated by sponsor|40|||
160958847|NCT05557942|581236162|FG004|Overall Study|Study terminated by sponsor|45|||
160958848|NCT05557942|581236163|FG005|Overall Study|Study terminated by sponsor|37|||
160958849|NCT05557942|581236158|FG000|Overall Study|Protocol Violation|0|||
160958850|NCT05557942|581236159|FG001|Overall Study|Protocol Violation|0|||
160958851|NCT05557942|581236160|FG002|Overall Study|Protocol Violation|0|||
160958852|NCT05557942|581236161|FG003|Overall Study|Protocol Violation|0|||
160958853|NCT05557942|581236162|FG004|Overall Study|Protocol Violation|0|||
160958854|NCT05557942|581236163|FG005|Overall Study|Protocol Violation|1|||
160958855|NCT05557942|581236158|FG000|Overall Study|Withdrawal by Subject|0|||
160958856|NCT05557942|581236159|FG001|Overall Study|Withdrawal by Subject|0|||
161270042|NCT02132754|582370373|FG005|Overall Study|Progressive Disease|1|||
161270043|NCT02132754|582370374|FG006|Overall Study|Progressive Disease|1|||
161270044|NCT02132754|582370375|FG007|Overall Study|Progressive Disease|1|||
161270045|NCT02132754|582370376|FG008|Overall Study|Progressive Disease|1|||
161270046|NCT02132754|582370377|FG009|Overall Study|Progressive Disease|3|||
161270047|NCT02132754|582370378|FG010|Overall Study|Progressive Disease|3|||
161343468|NCT03965923|582644398|FG008|Overall Study|Withdrawal by Subject|4|||
161343469|NCT03965923|582644399|FG009|Overall Study|Withdrawal by Subject|0|||
161343470|NCT03965923|582644400|FG010|Overall Study|Withdrawal by Subject|2|||
160958857|NCT05557942|581236160|FG002|Overall Study|Withdrawal by Subject|0|||
160958858|NCT05557942|581236161|FG003|Overall Study|Withdrawal by Subject|0|||
160958859|NCT05557942|581236162|FG004|Overall Study|Withdrawal by Subject|2|||
160958860|NCT05557942|581236163|FG005|Overall Study|Withdrawal by Subject|0|||
161001771|NCT01580293|581392987|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
161001772|NCT01580293|581392985|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
161001773|NCT01580293|581392986|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
161001774|NCT01580293|581392987|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
161001775|NCT01580293|581392985|FG000|Part A_Extension|Adverse Event|0|||
161001776|NCT01580293|581392986|FG001|Part A_Extension|Adverse Event|2|||
161001777|NCT01580293|581392987|FG002|Part A_Extension|Adverse Event|0|||
161001778|NCT01580293|581392985|FG000|Part A_Extension|Withdrawal by Subject|0|||
161001779|NCT01580293|581392986|FG001|Part A_Extension|Withdrawal by Subject|3|||
161001780|NCT01580293|581392987|FG002|Part A_Extension|Withdrawal by Subject|0|||
161001781|NCT01580293|581392985|FG000|Part A_Extension|Lost to Follow-up|0|||
161001782|NCT01580293|581392986|FG001|Part A_Extension|Lost to Follow-up|1|||
161001783|NCT01580293|581392987|FG002|Part A_Extension|Lost to Follow-up|0|||
161001784|NCT01580293|581392985|FG000|Part A_Extension|Other Reason|0|||
161270048|NCT02132754|582370379|FG011|Overall Study|Progressive Disease|2|||
161270049|NCT02132754|582370380|FG012|Overall Study|Progressive Disease|2|||
161270050|NCT02132754|582370381|FG013|Overall Study|Progressive Disease|3|||
161270051|NCT02132754|582370382|FG014|Overall Study|Progressive Disease|2|||
161270052|NCT02132754|582370383|FG015|Overall Study|Progressive Disease|1|||
161270053|NCT02132754|582370384|FG016|Overall Study|Progressive Disease|2|||
161270054|NCT02132754|582370385|FG017|Overall Study|Progressive Disease|1|||
161270055|NCT02132754|582370386|FG018|Overall Study|Progressive Disease|3|||
161270056|NCT02132754|582370387|FG019|Overall Study|Progressive Disease|1|||
160958861|NCT01962493|581236164|FG000|Overall Study|Adverse Event|1|||
161001785|NCT01580293|581392986|FG001|Part A_Extension|Other Reason|1|||
161001786|NCT01580293|581392987|FG002|Part A_Extension|Other Reason|0|||
161001787|NCT01580293|581392985|FG000|Part A_Extension|Completed Japan only|0|||
161270057|NCT02132754|582370388|FG020|Overall Study|Progressive Disease|1|||
161270058|NCT02132754|582370389|FG021|Overall Study|Progressive Disease|3|||
161270059|NCT02132754|582370390|FG022|Overall Study|Progressive Disease|2|||
160958862|NCT01962493|581236165|FG001|Overall Study|Adverse Event|2|||
160958863|NCT01962493|581236164|FG000|Overall Study|Protocol Violation|0|||
160958864|NCT01962493|581236165|FG001|Overall Study|Protocol Violation|1|||
161270060|NCT02132754|582370391|FG023|Overall Study|Progressive Disease|3|||
161270061|NCT02132754|582370392|FG024|Overall Study|Progressive Disease|0|||
161270062|NCT02132754|582370393|FG025|Overall Study|Progressive Disease|1|||
161270063|NCT02132754|582370394|FG026|Overall Study|Progressive Disease|2|||
161270064|NCT02132754|582370395|FG027|Overall Study|Progressive Disease|1|||
161270065|NCT02132754|582370396|FG028|Overall Study|Progressive Disease|2|||
161270066|NCT02132754|582370397|FG029|Overall Study|Progressive Disease|3|||
161270067|NCT02132754|582370398|FG030|Overall Study|Progressive Disease|1|||
161270068|NCT02132754|582370399|FG031|Overall Study|Progressive Disease|1|||
161270069|NCT02132754|582370400|FG032|Overall Study|Progressive Disease|3|||
161270070|NCT02132754|582370401|FG033|Overall Study|Progressive Disease|6|||
161270071|NCT02132754|582370368|FG000|Overall Study|Screen Failure|0|||
161270072|NCT02132754|582370369|FG001|Overall Study|Screen Failure|0|||
161270073|NCT02132754|582370370|FG002|Overall Study|Screen Failure|0|||
161270074|NCT02132754|582370371|FG003|Overall Study|Screen Failure|0|||
161270075|NCT02132754|582370372|FG004|Overall Study|Screen Failure|0|||
161270076|NCT02132754|582370373|FG005|Overall Study|Screen Failure|0|||
161270077|NCT02132754|582370374|FG006|Overall Study|Screen Failure|0|||
161270078|NCT02132754|582370375|FG007|Overall Study|Screen Failure|0|||
161270079|NCT02132754|582370376|FG008|Overall Study|Screen Failure|0|||
161270080|NCT02132754|582370377|FG009|Overall Study|Screen Failure|0|||
161270081|NCT02132754|582370378|FG010|Overall Study|Screen Failure|0|||
161270082|NCT02132754|582370379|FG011|Overall Study|Screen Failure|0|||
161270083|NCT02132754|582370380|FG012|Overall Study|Screen Failure|0|||
161270084|NCT02132754|582370381|FG013|Overall Study|Screen Failure|0|||
161270085|NCT02132754|582370382|FG014|Overall Study|Screen Failure|0|||
161270086|NCT02132754|582370383|FG015|Overall Study|Screen Failure|0|||
161270087|NCT02132754|582370384|FG016|Overall Study|Screen Failure|0|||
161270088|NCT02132754|582370385|FG017|Overall Study|Screen Failure|0|||
161270089|NCT02132754|582370386|FG018|Overall Study|Screen Failure|0|||
161270090|NCT02132754|582370387|FG019|Overall Study|Screen Failure|1|||
161270091|NCT02132754|582370388|FG020|Overall Study|Screen Failure|0|||
161270092|NCT02132754|582370389|FG021|Overall Study|Screen Failure|1|||
161270093|NCT02132754|582370390|FG022|Overall Study|Screen Failure|0|||
161270094|NCT02132754|582370391|FG023|Overall Study|Screen Failure|0|||
161270095|NCT02132754|582370392|FG024|Overall Study|Screen Failure|0|||
161270096|NCT02132754|582370393|FG025|Overall Study|Screen Failure|0|||
161270097|NCT02132754|582370394|FG026|Overall Study|Screen Failure|0|||
161270098|NCT02132754|582370395|FG027|Overall Study|Screen Failure|0|||
161270099|NCT02132754|582370396|FG028|Overall Study|Screen Failure|0|||
161270100|NCT02132754|582370397|FG029|Overall Study|Screen Failure|0|||
161270101|NCT02132754|582370398|FG030|Overall Study|Screen Failure|0|||
161270102|NCT02132754|582370399|FG031|Overall Study|Screen Failure|0|||
161270103|NCT02132754|582370400|FG032|Overall Study|Screen Failure|0|||
161270104|NCT02132754|582370401|FG033|Overall Study|Screen Failure|0|||
161270105|NCT02132754|582370368|FG000|Overall Study|Transferred to Extension Study|0|||
161270106|NCT02132754|582370369|FG001|Overall Study|Transferred to Extension Study|0|||
161270107|NCT02132754|582370370|FG002|Overall Study|Transferred to Extension Study|0|||
161270108|NCT02132754|582370371|FG003|Overall Study|Transferred to Extension Study|0|||
161270109|NCT02132754|582370372|FG004|Overall Study|Transferred to Extension Study|0|||
161270110|NCT02132754|582370373|FG005|Overall Study|Transferred to Extension Study|0|||
161270111|NCT02132754|582370374|FG006|Overall Study|Transferred to Extension Study|0|||
161270112|NCT02132754|582370375|FG007|Overall Study|Transferred to Extension Study|0|||
160958865|NCT01962493|581236164|FG000|Overall Study|Withdrawal by Subject|4|||
160958866|NCT01962493|581236165|FG001|Overall Study|Withdrawal by Subject|2|||
161270113|NCT02132754|582370376|FG008|Overall Study|Transferred to Extension Study|0|||
161270114|NCT02132754|582370377|FG009|Overall Study|Transferred to Extension Study|0|||
160958867|NCT01951625|581236166|FG000|Treatment Period|Protocol Violation|2|||
160958868|NCT01951625|581236167|FG001|Treatment Period|Protocol Violation|0|||
160958869|NCT01951625|581236168|FG002|Treatment Period|Protocol Violation|1|||
160958870|NCT01951625|581236169|FG003|Treatment Period|Protocol Violation|3|||
161270115|NCT02132754|582370378|FG010|Overall Study|Transferred to Extension Study|0|||
160958871|NCT01951625|581236170|FG004|Treatment Period|Protocol Violation|2|||
161270116|NCT02132754|582370379|FG011|Overall Study|Transferred to Extension Study|0|||
161270117|NCT02132754|582370380|FG012|Overall Study|Transferred to Extension Study|0|||
161270118|NCT02132754|582370381|FG013|Overall Study|Transferred to Extension Study|0|||
161270119|NCT02132754|582370382|FG014|Overall Study|Transferred to Extension Study|0|||
161270120|NCT02132754|582370383|FG015|Overall Study|Transferred to Extension Study|0|||
161270121|NCT02132754|582370384|FG016|Overall Study|Transferred to Extension Study|0|||
161270122|NCT02132754|582370385|FG017|Overall Study|Transferred to Extension Study|0|||
161270123|NCT02132754|582370386|FG018|Overall Study|Transferred to Extension Study|0|||
161270124|NCT02132754|582370387|FG019|Overall Study|Transferred to Extension Study|0|||
161270125|NCT02132754|582370388|FG020|Overall Study|Transferred to Extension Study|0|||
160958872|NCT01951625|581236166|FG000|Treatment Period|Physician Decision|0|||
160958873|NCT01951625|581236167|FG001|Treatment Period|Physician Decision|0|||
160958874|NCT01951625|581236168|FG002|Treatment Period|Physician Decision|0|||
160958875|NCT01951625|581236169|FG003|Treatment Period|Physician Decision|0|||
160958876|NCT01951625|581236170|FG004|Treatment Period|Physician Decision|1|||
160958877|NCT01951625|581236166|FG000|Treatment Period|Protocol driven decision point|0|||
160958878|NCT01951625|581236167|FG001|Treatment Period|Protocol driven decision point|5|||
160958879|NCT01951625|581236168|FG002|Treatment Period|Protocol driven decision point|0|||
160958880|NCT01951625|581236169|FG003|Treatment Period|Protocol driven decision point|2|||
160958881|NCT01951625|581236170|FG004|Treatment Period|Protocol driven decision point|1|||
160958882|NCT01951625|581236166|FG000|Treatment Period|Non compliance with study drug|1|||
160958883|NCT01951625|581236167|FG001|Treatment Period|Non compliance with study drug|2|||
160958884|NCT01951625|581236168|FG002|Treatment Period|Non compliance with study drug|2|||
160958885|NCT01951625|581236169|FG003|Treatment Period|Non compliance with study drug|0|||
160958886|NCT01951625|581236170|FG004|Treatment Period|Non compliance with study drug|0|||
160958887|NCT01951625|581236166|FG000|Treatment Period|Death|3|||
160958888|NCT01951625|581236167|FG001|Treatment Period|Death|2|||
160958889|NCT01951625|581236168|FG002|Treatment Period|Death|2|||
160958890|NCT01951625|581236169|FG003|Treatment Period|Death|1|||
160958891|NCT01951625|581236170|FG004|Treatment Period|Death|2|||
160958892|NCT01951625|581236166|FG000|Treatment Period|Adverse Event|7|||
160958893|NCT01951625|581236167|FG001|Treatment Period|Adverse Event|10|||
160958894|NCT01951625|581236168|FG002|Treatment Period|Adverse Event|9|||
160958895|NCT01951625|581236169|FG003|Treatment Period|Adverse Event|8|||
160958896|NCT01951625|581236170|FG004|Treatment Period|Adverse Event|8|||
160958897|NCT01951625|581236166|FG000|Treatment Period|Withdrawal by Subject|5|||
160958898|NCT01951625|581236167|FG001|Treatment Period|Withdrawal by Subject|2|||
160958899|NCT01951625|581236168|FG002|Treatment Period|Withdrawal by Subject|1|||
160958900|NCT01951625|581236169|FG003|Treatment Period|Withdrawal by Subject|7|||
160958901|NCT01951625|581236170|FG004|Treatment Period|Withdrawal by Subject|3|||
160958902|NCT01951625|581236166|FG000|Treatment Period|Lost to Follow-up|1|||
160958903|NCT01951625|581236167|FG001|Treatment Period|Lost to Follow-up|0|||
160958904|NCT01951625|581236168|FG002|Treatment Period|Lost to Follow-up|0|||
160958905|NCT01951625|581236169|FG003|Treatment Period|Lost to Follow-up|1|||
160958906|NCT01951625|581236170|FG004|Treatment Period|Lost to Follow-up|0|||
160958907|NCT01951625|581236166|FG000|Follow Up Period|Non-compliance with study drug|1|||
160958908|NCT01951625|581236167|FG001|Follow Up Period|Non-compliance with study drug|0|||
160958909|NCT01951625|581236168|FG002|Follow Up Period|Non-compliance with study drug|0|||
160958910|NCT01951625|581236169|FG003|Follow Up Period|Non-compliance with study drug|0|||
160958911|NCT01951625|581236170|FG004|Follow Up Period|Non-compliance with study drug|0|||
160958912|NCT01951625|581236166|FG000|Follow Up Period|Death|1|||
160958913|NCT01951625|581236167|FG001|Follow Up Period|Death|3|||
160958914|NCT01951625|581236168|FG002|Follow Up Period|Death|2|||
160958915|NCT01951625|581236169|FG003|Follow Up Period|Death|2|||
160958916|NCT01951625|581236170|FG004|Follow Up Period|Death|1|||
160958917|NCT01951625|581236166|FG000|Follow Up Period|Logistical difficulties|1|||
160958918|NCT01951625|581236167|FG001|Follow Up Period|Logistical difficulties|2|||
160958919|NCT01951625|581236168|FG002|Follow Up Period|Logistical difficulties|0|||
160958920|NCT01951625|581236169|FG003|Follow Up Period|Logistical difficulties|0|||
160958921|NCT01951625|581236170|FG004|Follow Up Period|Logistical difficulties|0|||
160958922|NCT01951625|581236166|FG000|Follow Up Period|Adverse Event|0|||
160958923|NCT01951625|581236167|FG001|Follow Up Period|Adverse Event|3|||
160958924|NCT01951625|581236168|FG002|Follow Up Period|Adverse Event|2|||
160958925|NCT01951625|581236169|FG003|Follow Up Period|Adverse Event|3|||
160958926|NCT01951625|581236170|FG004|Follow Up Period|Adverse Event|5|||
160958927|NCT01951625|581236166|FG000|Follow Up Period|Withdrawal by Subject|4|||
160958928|NCT01951625|581236167|FG001|Follow Up Period|Withdrawal by Subject|1|||
161146733|NCT00545818|581919847|FG000|Overall Study|Adverse Event|1|||
161146734|NCT00545818|581919848|FG001|Overall Study|Adverse Event|1|||
161146735|NCT00545818|581919847|FG000|Overall Study|Lost to Follow-up|1|||
161146736|NCT00545818|581919848|FG001|Overall Study|Lost to Follow-up|6|||
161146737|NCT00670111|581919851|FG000|Enrollment to One Month|Testing Failure|0|||
161146738|NCT00670111|581919852|FG001|Enrollment to One Month|Testing Failure|0|||
161146739|NCT00670111|581919853|FG002|Enrollment to One Month|Testing Failure|13|||
161146740|NCT00670111|581919851|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
161146741|NCT00670111|581919852|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
161146742|NCT00670111|581919853|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
161146743|NCT00670111|581919851|FG000|Enrollment to One Month|Physician Decision|1|||
161146744|NCT00670111|581919852|FG001|Enrollment to One Month|Physician Decision|0|||
161146745|NCT00670111|581919853|FG002|Enrollment to One Month|Physician Decision|0|||
161146746|NCT02623361|581919854|FG000|Overall Study|Protocol Violation|0|||
161146747|NCT02623361|581919855|FG001|Overall Study|Protocol Violation|1|||
161146748|NCT02623361|581919854|FG000|Overall Study|Withdrawal by Subject|0|||
160958929|NCT01951625|581236168|FG002|Follow Up Period|Withdrawal by Subject|0|||
160958930|NCT01951625|581236169|FG003|Follow Up Period|Withdrawal by Subject|5|||
160958931|NCT01951625|581236170|FG004|Follow Up Period|Withdrawal by Subject|3|||
160958932|NCT01951625|581236166|FG000|Follow Up Period|Lost to Follow-up|1|||
160958933|NCT01951625|581236167|FG001|Follow Up Period|Lost to Follow-up|0|||
160958934|NCT01951625|581236168|FG002|Follow Up Period|Lost to Follow-up|0|||
160958935|NCT01951625|581236169|FG003|Follow Up Period|Lost to Follow-up|1|||
160958936|NCT01951625|581236170|FG004|Follow Up Period|Lost to Follow-up|1|||
160958937|NCT03754803|581236177|FG000|Overall Study|Withdrawal by Subject|2|||
160958938|NCT05338333|581236178|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
160958939|NCT05338333|581236179|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
160958940|NCT05245864|581236180|FG000|Overall Study|Withdrawal by Subject|1|||
160958941|NCT05245864|581236181|FG001|Overall Study|Withdrawal by Subject|1|||
160958942|NCT01712009|581237546|FG000|Overall Study|Withdrawal by Subject|24|||
160958943|NCT01712009|581237547|FG001|Overall Study|Withdrawal by Subject|15|||
160958944|NCT01712009|581237548|FG002|Overall Study|Withdrawal by Subject|8|||
160958945|NCT01712009|581237546|FG000|Overall Study|Lost to Follow-up|2|||
160958946|NCT01712009|581237547|FG001|Overall Study|Lost to Follow-up|0|||
160958947|NCT01712009|581237548|FG002|Overall Study|Lost to Follow-up|1|||
160958948|NCT01712009|581237546|FG000|Overall Study|Decision by Sponsor|12|||
160958949|NCT01712009|581237547|FG001|Overall Study|Decision by Sponsor|14|||
160958950|NCT01712009|581237548|FG002|Overall Study|Decision by Sponsor|12|||
160958951|NCT01111123|581237550|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
160958952|NCT01111123|581237551|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
160958953|NCT01111123|581237550|FG000|Maintenance Phase|Lost to Follow-up|0|||
161001788|NCT01580293|581392986|FG001|Part A_Extension|Completed Japan only|5|||
161001789|NCT01580293|581392987|FG002|Part A_Extension|Completed Japan only|0|||
161001790|NCT01580293|581392985|FG000|Part B|Withdrawal by Subject|0|||
161001791|NCT01580293|581392986|FG001|Part B|Withdrawal by Subject|0|||
161001792|NCT01580293|581392987|FG002|Part B|Withdrawal by Subject|1|||
161001793|NCT01580293|581392985|FG000|Part B|Other reason|0|||
161001794|NCT01580293|581392986|FG001|Part B|Other reason|0|||
161001795|NCT01580293|581392987|FG002|Part B|Other reason|1|||
161001796|NCT01134562|581392988|FG000|Overall Study|Adverse Event|0|||
161001797|NCT01134562|581392989|FG001|Overall Study|Adverse Event|1|||
161001798|NCT01134562|581392990|FG002|Overall Study|Adverse Event|0|||
161001799|NCT01134562|581392991|FG003|Overall Study|Adverse Event|0|||
161001800|NCT01134562|581392992|FG004|Overall Study|Adverse Event|0|||
161001801|NCT01499134|581392995|FG000|Overall Study|Withdrawal by Subject|0|||
161001802|NCT01499134|581392996|FG001|Overall Study|Withdrawal by Subject|1|||
161001803|NCT01400776|581392997|FG000|Overall Study|Adverse Event|7|||
161001804|NCT01400776|581392998|FG001|Overall Study|Adverse Event|2|||
161001805|NCT01400776|581392999|FG002|Overall Study|Adverse Event|9|||
161001806|NCT01400776|581393000|FG003|Overall Study|Adverse Event|2|||
161001807|NCT01400776|581392997|FG000|Overall Study|Lost to Follow-up|1|||
161001808|NCT01400776|581392998|FG001|Overall Study|Lost to Follow-up|0|||
161001809|NCT01400776|581392999|FG002|Overall Study|Lost to Follow-up|4|||
161001810|NCT01400776|581393000|FG003|Overall Study|Lost to Follow-up|1|||
161001811|NCT01400776|581392997|FG000|Overall Study|Withdrew Consent|4|||
161001812|NCT01400776|581392998|FG001|Overall Study|Withdrew Consent|2|||
161001813|NCT01400776|581392999|FG002|Overall Study|Withdrew Consent|6|||
161001814|NCT01400776|581393000|FG003|Overall Study|Withdrew Consent|1|||
161001815|NCT01400776|581392997|FG000|Overall Study|Protocol Deviation|6|||
161001816|NCT01400776|581392998|FG001|Overall Study|Protocol Deviation|1|||
161001817|NCT01400776|581392999|FG002|Overall Study|Protocol Deviation|5|||
161001818|NCT01400776|581393000|FG003|Overall Study|Protocol Deviation|2|||
161001819|NCT01400776|581392997|FG000|Overall Study|Reason not Specified|3|||
161146749|NCT02623361|581919855|FG001|Overall Study|Withdrawal by Subject|1|||
161146750|NCT02441803|581919858|FG000|Overall Study|Physician Decision|0|||
161146751|NCT02441803|581919859|FG001|Overall Study|Physician Decision|2|||
161146752|NCT02441803|581919860|FG002|Overall Study|Physician Decision|2|||
161146753|NCT02873221|581919861|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
160958954|NCT01111123|581237551|FG001|Maintenance Phase|Lost to Follow-up|2|||
160958955|NCT00857207|581237560|FG000|Overall Study|Withdrawal by Subject|13|||
160958956|NCT00857207|581237561|FG001|Overall Study|Withdrawal by Subject|0|||
161146754|NCT02873221|581919862|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
161146755|NCT02873221|581919863|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
160958957|NCT00857207|581237560|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
161001820|NCT01400776|581392998|FG001|Overall Study|Reason not Specified|0|||
161001821|NCT01400776|581392999|FG002|Overall Study|Reason not Specified|4|||
161001822|NCT01400776|581393000|FG003|Overall Study|Reason not Specified|3|||
161001823|NCT00423098|581393001|FG000|Overall Study|Adverse Event|1|||
161001824|NCT00423098|581393002|FG001|Overall Study|Adverse Event|2|||
161001825|NCT00423098|581393001|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161001826|NCT00423098|581393002|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161001827|NCT00423098|581393001|FG000|Overall Study|Administrative problems|0|||
161001828|NCT00423098|581393002|FG001|Overall Study|Administrative problems|1|||
161001829|NCT00423098|581393001|FG000|Overall Study|Death|2|||
161001830|NCT00423098|581393002|FG001|Overall Study|Death|0|||
161001831|NCT01111526|581393009|FG000|Overall Study|GVHD Disease Progression|0|||
161001832|NCT01111526|581393010|FG001|Overall Study|GVHD Disease Progression|1|||
160958958|NCT00857207|581237561|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
160958959|NCT00857207|581237560|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
160958960|NCT00857207|581237561|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
160958961|NCT02822222|581237566|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
160958962|NCT02822222|581237567|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
160958963|NCT00833560|581237568|FG000|Overall Study|Toxicity|13|||
160958964|NCT00833560|581237568|FG000|Overall Study|Adverse Event|11|||
160958965|NCT00833560|581237568|FG000|Overall Study|Protocol Violation|6|||
160958966|NCT00833560|581237568|FG000|Overall Study|Lack of Efficacy|4|||
160958967|NCT00833560|581237568|FG000|Overall Study|Death|2|||
160958968|NCT00833560|581237568|FG000|Overall Study|Pregression of other disease|1|||
160958969|NCT00833560|581237568|FG000|Overall Study|Other|5|||
160958970|NCT00440531|581237572|FG000|Overall Study|Adverse Event|1|||
160958971|NCT00440531|581237573|FG001|Overall Study|Adverse Event|0|||
160958972|NCT00440531|581237574|FG002|Overall Study|Adverse Event|2|||
160958973|NCT00440531|581237572|FG000|Overall Study|Withdrawal by Subject|2|||
160958974|NCT00440531|581237573|FG001|Overall Study|Withdrawal by Subject|0|||
160958975|NCT00440531|581237574|FG002|Overall Study|Withdrawal by Subject|0|||
160958976|NCT00440531|581237572|FG000|Overall Study|Protocol Violation|1|||
160958977|NCT00440531|581237573|FG001|Overall Study|Protocol Violation|2|||
160958978|NCT00440531|581237574|FG002|Overall Study|Protocol Violation|0|||
160958979|NCT00440531|581237572|FG000|Overall Study|Lost to Follow-up|4|||
160958980|NCT00440531|581237573|FG001|Overall Study|Lost to Follow-up|3|||
160958981|NCT00440531|581237574|FG002|Overall Study|Lost to Follow-up|5|||
160958982|NCT00440531|581237572|FG000|Overall Study|see pre-assignment details|2|||
161001833|NCT01111526|581393011|FG002|Overall Study|GVHD Disease Progression|2|||
161001834|NCT02013830|581393012|FG000|Overall Study|Adverse Event|3|||
161270126|NCT02132754|582370389|FG021|Overall Study|Transferred to Extension Study|0|||
161270127|NCT02132754|582370390|FG022|Overall Study|Transferred to Extension Study|0|||
161001835|NCT02013830|581393012|FG000|Overall Study|Death|1|||
161001836|NCT02013830|581393012|FG000|Overall Study|Insufficient therapeutic response|25|||
161001837|NCT02013830|581393012|FG000|Overall Study|Refused treatment|1|||
161001838|NCT04424641|581393013|FG000|Overall Study|Death|1|||
161001839|NCT04424641|581393014|FG001|Overall Study|Death|2|||
161001840|NCT04424641|581393015|FG002|Overall Study|Death|3|||
161001841|NCT04424641|581393016|FG003|Overall Study|Death|0|||
161001842|NCT04424641|581393017|FG004|Overall Study|Death|3|||
161001843|NCT04424641|581393018|FG005|Overall Study|Death|0|||
161001844|NCT04424641|581393019|FG006|Overall Study|Death|1|||
161001845|NCT04424641|581393020|FG007|Overall Study|Death|2|||
161001846|NCT04424641|581393013|FG000|Overall Study|Sponsor decision|0|||
161001847|NCT04424641|581393014|FG001|Overall Study|Sponsor decision|2|||
161001848|NCT04424641|581393015|FG002|Overall Study|Sponsor decision|3|||
161001849|NCT04424641|581393016|FG003|Overall Study|Sponsor decision|7|||
161001850|NCT04424641|581393017|FG004|Overall Study|Sponsor decision|2|||
161001851|NCT04424641|581393018|FG005|Overall Study|Sponsor decision|2|||
161001852|NCT04424641|581393019|FG006|Overall Study|Sponsor decision|3|||
161001853|NCT04424641|581393020|FG007|Overall Study|Sponsor decision|4|||
161001854|NCT04424641|581393013|FG000|Overall Study|Withdrawal by Subject|0|||
161270128|NCT02132754|582370391|FG023|Overall Study|Transferred to Extension Study|0|||
161270129|NCT02132754|582370392|FG024|Overall Study|Transferred to Extension Study|0|||
161270130|NCT02132754|582370393|FG025|Overall Study|Transferred to Extension Study|0|||
161001855|NCT04424641|581393014|FG001|Overall Study|Withdrawal by Subject|0|||
161001856|NCT04424641|581393015|FG002|Overall Study|Withdrawal by Subject|0|||
161001857|NCT04424641|581393016|FG003|Overall Study|Withdrawal by Subject|0|||
161001858|NCT04424641|581393017|FG004|Overall Study|Withdrawal by Subject|1|||
161001859|NCT04424641|581393018|FG005|Overall Study|Withdrawal by Subject|0|||
161001860|NCT04424641|581393019|FG006|Overall Study|Withdrawal by Subject|0|||
161001861|NCT04424641|581393020|FG007|Overall Study|Withdrawal by Subject|0|||
161001862|NCT04424641|581393013|FG000|Overall Study|Other|0|||
161001863|NCT04424641|581393014|FG001|Overall Study|Other|0|||
161001864|NCT04424641|581393015|FG002|Overall Study|Other|1|||
161270131|NCT02132754|582370394|FG026|Overall Study|Transferred to Extension Study|0|||
161270132|NCT02132754|582370395|FG027|Overall Study|Transferred to Extension Study|0|||
161270133|NCT02132754|582370396|FG028|Overall Study|Transferred to Extension Study|0|||
160958983|NCT00440531|581237573|FG001|Overall Study|see pre-assignment details|0|||
160958984|NCT00440531|581237574|FG002|Overall Study|see pre-assignment details|0|||
160958985|NCT01791725|581237575|FG000|Overall Study|Withdrawal by Subject|0|||
161001865|NCT04424641|581393016|FG003|Overall Study|Other|0|||
161001866|NCT04424641|581393017|FG004|Overall Study|Other|0|||
161001867|NCT04424641|581393018|FG005|Overall Study|Other|0|||
161001868|NCT04424641|581393019|FG006|Overall Study|Other|0|||
161001869|NCT04424641|581393020|FG007|Overall Study|Other|0|||
161001870|NCT01307267|581393021|FG000|Overall Study|Death|4|||
161001871|NCT01307267|581393022|FG001|Overall Study|Death|3|||
161001872|NCT01307267|581393023|FG002|Overall Study|Death|5|||
161001873|NCT01307267|581393024|FG003|Overall Study|Death|3|||
161001874|NCT01307267|581393025|FG004|Overall Study|Death|1|||
161001875|NCT01307267|581393026|FG005|Overall Study|Death|26|||
160958986|NCT01791725|581237576|FG001|Overall Study|Withdrawal by Subject|1|||
160958987|NCT01791725|581237577|FG002|Overall Study|Withdrawal by Subject|0|||
160958988|NCT02690974|581237580|FG000|Overall Study|Adverse Event|16|||
160958989|NCT02690974|581237580|FG000|Overall Study|Death|9|||
160958990|NCT02690974|581237580|FG000|Overall Study|Subject/guardian decision|4|||
160958991|NCT02690974|581237580|FG000|Overall Study|Lost to Follow-up|3|||
160958992|NCT02690974|581237580|FG000|Overall Study|Withdrawal of Informed Consent|3|||
160958993|NCT02690974|581237580|FG000|Overall Study|Physician Decision|2|||
160958994|NCT02690974|581237580|FG000|Overall Study|Non-compliance with study treatment|1|||
160958995|NCT02690974|581237580|FG000|Overall Study|Protocol-defined stopping criteria|1|||
160958996|NCT02690974|581237580|FG000|Overall Study|Protocol Deviation|1|||
160958997|NCT01666951|581237583|FG000|Overall Study|Not dosed|1|||
160958998|NCT01666951|581237584|FG001|Overall Study|Not dosed|1|||
160958999|NCT05763628|581237585|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
160959000|NCT05763628|581237586|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
160959001|NCT05763628|581237585|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
160959002|NCT05763628|581237586|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
160959003|NCT05763628|581237585|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
160959004|NCT05763628|581237586|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
160959005|NCT00868439|581237592|FG000|Overall Study|Adverse Event|4|||
160959006|NCT00868439|581237593|FG001|Overall Study|Adverse Event|3|||
160959007|NCT00868439|581237592|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
160959008|NCT00868439|581237593|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
160959009|NCT00868439|581237592|FG000|Overall Study|Death|0|||
160959010|NCT00868439|581237593|FG001|Overall Study|Death|1|||
160959011|NCT00868439|581237592|FG000|Overall Study|Protocol Violation|1|||
160959012|NCT00868439|581237593|FG001|Overall Study|Protocol Violation|1|||
160959013|NCT00868439|581237592|FG000|Overall Study|Physician Decision|1|||
160959014|NCT00868439|581237593|FG001|Overall Study|Physician Decision|0|||
160959015|NCT00868439|581237592|FG000|Overall Study|Withdrawal by Subject|0|||
160959016|NCT00868439|581237593|FG001|Overall Study|Withdrawal by Subject|1|||
160959017|NCT01132326|581237594|FG000|Overall Study|Lack of Efficacy|25|||
160959018|NCT01132326|581237594|FG000|Overall Study|Adverse Event|37|||
160959019|NCT01132326|581237594|FG000|Overall Study|Protocol Violation|1|||
160959020|NCT01132326|581237594|FG000|Overall Study|Lost to Follow-up|16|||
160959021|NCT01132326|581237594|FG000|Overall Study|Withdrawal by Subject|40|||
160959022|NCT01132326|581237594|FG000|Overall Study|Physician Decision|10|||
160959023|NCT01132326|581237594|FG000|Overall Study|Study Termination|80|||
160959024|NCT01132326|581237594|FG000|Overall Study|Declining Health|1|||
160959025|NCT01132326|581237594|FG000|Overall Study|Pregnancy|1|||
160959026|NCT01132326|581237594|FG000|Overall Study|Caregiver Withdrew Consent|1|||
160959027|NCT01132326|581237594|FG000|Overall Study|Death|5|||
160959028|NCT01132326|581237594|FG000|Overall Study|Subject Unable to Come To Visits|1|||
160959029|NCT00338884|581237597|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
160959030|NCT00338884|581237597|FG000|Overall Study|Adverse Event|14|||
160959031|NCT00338884|581237597|FG000|Overall Study|Death|8|||
160959032|NCT00338884|581237597|FG000|Overall Study|Other|4|||
160959033|NCT00338884|581237597|FG000|Overall Study|Global Deterioration of Health Status|3|||
160959034|NCT00338884|581237597|FG000|Overall Study|Withdrawal by Subject|3|||
160959035|NCT00338884|581237597|FG000|Overall Study|Lost to Follow-up|1|||
160959036|NCT00338884|581237597|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
160959037|NCT00423176|581237598|FG000|Overall Study|Adverse Event|4|||
160959038|NCT00423176|581237599|FG001|Overall Study|Adverse Event|6|||
160959039|NCT00423176|581237598|FG000|Overall Study|Treatment Failure|1|||
160959040|NCT00423176|581237599|FG001|Overall Study|Treatment Failure|6|||
160959041|NCT00423176|581237598|FG000|Overall Study|Lost to Follow-up|4|||
160959042|NCT00423176|581237599|FG001|Overall Study|Lost to Follow-up|7|||
160959043|NCT00423176|581237598|FG000|Overall Study|Withdrawal by Subject|4|||
161270134|NCT02132754|582370397|FG029|Overall Study|Transferred to Extension Study|0|||
161270135|NCT02132754|582370398|FG030|Overall Study|Transferred to Extension Study|0|||
161270136|NCT02132754|582370399|FG031|Overall Study|Transferred to Extension Study|0|||
161270137|NCT02132754|582370400|FG032|Overall Study|Transferred to Extension Study|0|||
161270138|NCT02132754|582370401|FG033|Overall Study|Transferred to Extension Study|6|||
161270139|NCT02132754|582370368|FG000|Overall Study|Withdrawal by Subject|0|||
160959044|NCT00423176|581237599|FG001|Overall Study|Withdrawal by Subject|3|||
160959045|NCT00423176|581237598|FG000|Overall Study|Protocol Violation|1|||
160959046|NCT00423176|581237599|FG001|Overall Study|Protocol Violation|3|||
160959047|NCT00423176|581237598|FG000|Overall Study|Did not meet protocol eligibility|2|||
160959048|NCT00423176|581237599|FG001|Overall Study|Did not meet protocol eligibility|4|||
160959049|NCT04535947|581237600|FG000|Overall Study|Adverse Event|1|||
160959050|NCT04535947|581237601|FG001|Overall Study|Adverse Event|4|||
160959051|NCT04535947|581237600|FG000|Overall Study|Other reasons not specified|2|||
160959052|NCT04535947|581237601|FG001|Overall Study|Other reasons not specified|0|||
160959053|NCT04535947|581237600|FG000|Overall Study|Withdrawal by Subject|1|||
160959054|NCT04535947|581237601|FG001|Overall Study|Withdrawal by Subject|1|||
161001876|NCT01307267|581393027|FG006|Overall Study|Death|2|||
160959055|NCT04867369|581237607|FG000|Overall Study|Withdrawal by Subject|1|||
160959056|NCT04867369|581237608|FG001|Overall Study|Withdrawal by Subject|0|||
160959057|NCT03492281|581237614|FG000|Overall Study|Withdrawal by Subject|21|||
160959058|NCT03492281|581237615|FG001|Overall Study|Withdrawal by Subject|14|||
160959059|NCT03492281|581237616|FG002|Overall Study|Withdrawal by Subject|13|||
160959060|NCT03492281|581237614|FG000|Overall Study|Lost to Follow-up|14|||
160959061|NCT03492281|581237615|FG001|Overall Study|Lost to Follow-up|15|||
160959062|NCT03492281|581237616|FG002|Overall Study|Lost to Follow-up|10|||
160959063|NCT03492281|581237614|FG000|Overall Study|Adverse Event|6|||
160959064|NCT03492281|581237615|FG001|Overall Study|Adverse Event|8|||
160959065|NCT03492281|581237616|FG002|Overall Study|Adverse Event|13|||
160959066|NCT03492281|581237614|FG000|Overall Study|Lack of Efficacy|3|||
160959067|NCT03492281|581237615|FG001|Overall Study|Lack of Efficacy|0|||
160959068|NCT03492281|581237616|FG002|Overall Study|Lack of Efficacy|1|||
160959069|NCT03492281|581237614|FG000|Overall Study|Physician Decision|1|||
160959070|NCT03492281|581237615|FG001|Overall Study|Physician Decision|0|||
160959071|NCT03492281|581237616|FG002|Overall Study|Physician Decision|3|||
160959072|NCT03492281|581237614|FG000|Overall Study|Protocol Violation|0|||
160959073|NCT03492281|581237615|FG001|Overall Study|Protocol Violation|2|||
160959074|NCT03492281|581237616|FG002|Overall Study|Protocol Violation|1|||
160959075|NCT03492281|581237614|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
160959076|NCT03492281|581237615|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
160959077|NCT03492281|581237616|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
160959078|NCT03492281|581237614|FG000|Overall Study|Death|0|||
160959079|NCT03492281|581237615|FG001|Overall Study|Death|0|||
160959080|NCT03492281|581237616|FG002|Overall Study|Death|1|||
160959081|NCT03492281|581237614|FG000|Overall Study|Captured as Other in Database|8|||
160959082|NCT03492281|581237615|FG001|Overall Study|Captured as Other in Database|6|||
160959083|NCT03492281|581237616|FG002|Overall Study|Captured as Other in Database|3|||
160959084|NCT01749982|581237619|FG000|Overall Study|Physician Decision|0|||
160959085|NCT01749982|581237620|FG001|Overall Study|Physician Decision|0|||
160959086|NCT01749982|581237621|FG002|Overall Study|Physician Decision|0|||
160959087|NCT01749982|581237622|FG003|Overall Study|Physician Decision|1|||
160959088|NCT01749982|581237619|FG000|Overall Study|Lost to Follow-up|0|||
160959089|NCT01749982|581237620|FG001|Overall Study|Lost to Follow-up|0|||
160959090|NCT01749982|581237621|FG002|Overall Study|Lost to Follow-up|0|||
160959091|NCT01749982|581237622|FG003|Overall Study|Lost to Follow-up|1|||
160959092|NCT01749982|581237619|FG000|Overall Study|Withdrawal by Subject|0|||
160959093|NCT01749982|581237620|FG001|Overall Study|Withdrawal by Subject|0|||
160959094|NCT01749982|581237621|FG002|Overall Study|Withdrawal by Subject|0|||
160959095|NCT01749982|581237622|FG003|Overall Study|Withdrawal by Subject|1|||
160959096|NCT02677116|581237623|FG000|Overall Study|Adverse Event|0|||
160959097|NCT02677116|581237624|FG001|Overall Study|Adverse Event|1|||
160959098|NCT02677116|581237625|FG002|Overall Study|Adverse Event|0|||
161001877|NCT01307267|581393028|FG007|Overall Study|Death|2|||
161001878|NCT01307267|581393029|FG008|Overall Study|Death|21|||
161001879|NCT01307267|581393030|FG009|Overall Study|Death|2|||
161001880|NCT01307267|581393031|FG010|Overall Study|Death|3|||
161001881|NCT01307267|581393032|FG011|Overall Study|Death|9|||
161001882|NCT01307267|581393033|FG012|Overall Study|Death|0|||
161001883|NCT01307267|581393034|FG013|Overall Study|Death|0|||
161001884|NCT01307267|581393035|FG014|Overall Study|Death|0|||
161001885|NCT01307267|581393036|FG015|Overall Study|Death|0|||
161001886|NCT01307267|581393037|FG016|Overall Study|Death|1|||
161001887|NCT01307267|581393038|FG017|Overall Study|Death|1|||
161001888|NCT01307267|581393039|FG018|Overall Study|Death|2|||
161001889|NCT01307267|581393040|FG019|Overall Study|Death|8|||
161001890|NCT01307267|581393041|FG020|Overall Study|Death|1|||
160959099|NCT02677116|581237626|FG003|Overall Study|Adverse Event|0|||
160959100|NCT02677116|581237627|FG004|Overall Study|Adverse Event|0|||
160959101|NCT02677116|581237628|FG005|Overall Study|Adverse Event|1|||
160959102|NCT02677116|581237629|FG006|Overall Study|Adverse Event|1|||
160959103|NCT02677116|581237630|FG007|Overall Study|Adverse Event|0|||
160959104|NCT02677116|581237631|FG008|Overall Study|Adverse Event|0|||
160959105|NCT02677116|581237623|FG000|Overall Study|Physician Decision|0|||
160959106|NCT02677116|581237624|FG001|Overall Study|Physician Decision|2|||
160959107|NCT02677116|581237625|FG002|Overall Study|Physician Decision|3|||
160959108|NCT02677116|581237626|FG003|Overall Study|Physician Decision|2|||
160959109|NCT02677116|581237627|FG004|Overall Study|Physician Decision|1|||
160959110|NCT02677116|581237628|FG005|Overall Study|Physician Decision|3|||
161001891|NCT01307267|581393042|FG021|Overall Study|Death|2|||
160959111|NCT02677116|581237629|FG006|Overall Study|Physician Decision|1|||
160959112|NCT02677116|581237630|FG007|Overall Study|Physician Decision|1|||
160959113|NCT02677116|581237631|FG008|Overall Study|Physician Decision|2|||
160959114|NCT02677116|581237623|FG000|Overall Study|Withdrawal by parent or guardian|2|||
160959115|NCT02677116|581237624|FG001|Overall Study|Withdrawal by parent or guardian|1|||
161001892|NCT01307267|581393043|FG022|Overall Study|Death|2|||
161001893|NCT01307267|581393021|FG000|Overall Study|Lost to Follow-up|0|||
161001894|NCT01307267|581393022|FG001|Overall Study|Lost to Follow-up|0|||
161001895|NCT01307267|581393023|FG002|Overall Study|Lost to Follow-up|0|||
161001896|NCT01307267|581393024|FG003|Overall Study|Lost to Follow-up|0|||
161270140|NCT02132754|582370369|FG001|Overall Study|Withdrawal by Subject|0|||
161270141|NCT02132754|582370370|FG002|Overall Study|Withdrawal by Subject|0|||
161270142|NCT02132754|582370371|FG003|Overall Study|Withdrawal by Subject|0|||
161270143|NCT02132754|582370372|FG004|Overall Study|Withdrawal by Subject|0|||
161270144|NCT02132754|582370373|FG005|Overall Study|Withdrawal by Subject|0|||
161270145|NCT02132754|582370374|FG006|Overall Study|Withdrawal by Subject|0|||
161270146|NCT02132754|582370375|FG007|Overall Study|Withdrawal by Subject|0|||
161270147|NCT02132754|582370376|FG008|Overall Study|Withdrawal by Subject|0|||
161270148|NCT02132754|582370377|FG009|Overall Study|Withdrawal by Subject|1|||
161270149|NCT02132754|582370378|FG010|Overall Study|Withdrawal by Subject|0|||
161270150|NCT02132754|582370379|FG011|Overall Study|Withdrawal by Subject|0|||
161270151|NCT02132754|582370380|FG012|Overall Study|Withdrawal by Subject|1|||
161270152|NCT02132754|582370381|FG013|Overall Study|Withdrawal by Subject|0|||
161270153|NCT02132754|582370382|FG014|Overall Study|Withdrawal by Subject|1|||
161270154|NCT02132754|582370383|FG015|Overall Study|Withdrawal by Subject|2|||
161270155|NCT02132754|582370384|FG016|Overall Study|Withdrawal by Subject|1|||
160959116|NCT02677116|581237625|FG002|Overall Study|Withdrawal by parent or guardian|0|||
160959117|NCT02677116|581237626|FG003|Overall Study|Withdrawal by parent or guardian|1|||
160959118|NCT02677116|581237627|FG004|Overall Study|Withdrawal by parent or guardian|0|||
160959119|NCT02677116|581237628|FG005|Overall Study|Withdrawal by parent or guardian|0|||
160959120|NCT02677116|581237629|FG006|Overall Study|Withdrawal by parent or guardian|2|||
160959121|NCT02677116|581237630|FG007|Overall Study|Withdrawal by parent or guardian|1|||
160959122|NCT02677116|581237631|FG008|Overall Study|Withdrawal by parent or guardian|0|||
160959123|NCT02677116|581237623|FG000|Overall Study|Withdrawal by Subject|1|||
160959124|NCT02677116|581237624|FG001|Overall Study|Withdrawal by Subject|0|||
160959125|NCT02677116|581237625|FG002|Overall Study|Withdrawal by Subject|0|||
160959126|NCT02677116|581237626|FG003|Overall Study|Withdrawal by Subject|0|||
160959127|NCT02677116|581237627|FG004|Overall Study|Withdrawal by Subject|0|||
160959128|NCT02677116|581237628|FG005|Overall Study|Withdrawal by Subject|0|||
160959129|NCT02677116|581237629|FG006|Overall Study|Withdrawal by Subject|0|||
160959130|NCT02677116|581237630|FG007|Overall Study|Withdrawal by Subject|0|||
160959131|NCT02677116|581237631|FG008|Overall Study|Withdrawal by Subject|0|||
160959132|NCT03342638|581237633|FG000|Overall Study|Withdrawal by Subject|1|||
160959133|NCT03342638|581237634|FG001|Overall Study|Withdrawal by Subject|0|||
160959134|NCT03342638|581237633|FG000|Overall Study|Physician Decision|0|||
160959135|NCT03342638|581237634|FG001|Overall Study|Physician Decision|1|||
160959136|NCT00113568|581237650|FG000|Overall Study|Adverse Event|97|||
160959137|NCT00113568|581237650|FG000|Overall Study|Death|1|||
160959138|NCT00113568|581237650|FG000|Overall Study|Lack of Efficacy|30|||
160959139|NCT00113568|581237650|FG000|Overall Study|Lost to Follow-up|156|||
160959140|NCT00113568|581237650|FG000|Overall Study|Protocol Violation|32|||
160959141|NCT00113568|581237650|FG000|Overall Study|Withdrawal by Subject|117|||
160959142|NCT00113568|581237650|FG000|Overall Study|Other|112|||
160959143|NCT02191267|581237652|FG000|Overall Study|Withdrawal by Subject|1|||
160959144|NCT02191267|581237653|FG001|Overall Study|Withdrawal by Subject|0|||
160959145|NCT02191267|581237654|FG002|Overall Study|Withdrawal by Subject|0|||
160959146|NCT03213158|581237657|FG000|Overall Study|Withdrawal by Subject|1|||
160959147|NCT03213158|581237657|FG000|Overall Study|Physician Decision|2|||
160959148|NCT00587964|581237661|FG000|Overall Study|Withdrawal by Subject|1|||
160959149|NCT00587964|581237661|FG000|Overall Study|Lost to Follow-up|1|||
160959150|NCT00587964|581237661|FG000|Overall Study|Patient found to be ineligible|1|||
160959151|NCT00587964|581237661|FG000|Overall Study|Patient did not receive intervention|5|||
160959152|NCT00587964|581237661|FG000|Overall Study|Progression of Disease|4|||
160959153|NCT01569438|581237663|FG000|Overall Study|Lack of Efficacy|1|||
161001897|NCT01307267|581393025|FG004|Overall Study|Lost to Follow-up|0|||
161001898|NCT01307267|581393026|FG005|Overall Study|Lost to Follow-up|7|||
161001899|NCT01307267|581393027|FG006|Overall Study|Lost to Follow-up|0|||
160959154|NCT01569438|581237664|FG001|Overall Study|Lack of Efficacy|2|||
160959155|NCT01569438|581237663|FG000|Overall Study|Withdrawal by Subject|0|||
160959156|NCT01569438|581237664|FG001|Overall Study|Withdrawal by Subject|3|||
161001900|NCT01307267|581393028|FG007|Overall Study|Lost to Follow-up|0|||
161001901|NCT01307267|581393029|FG008|Overall Study|Lost to Follow-up|1|||
161001902|NCT01307267|581393030|FG009|Overall Study|Lost to Follow-up|2|||
161146756|NCT02873221|581919861|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
161343471|NCT03965923|582644401|FG011|Overall Study|Withdrawal by Subject|0|||
160959157|NCT01569438|581237663|FG000|Overall Study|Adverse Event|2|||
161270156|NCT02132754|582370385|FG017|Overall Study|Withdrawal by Subject|0|||
160959158|NCT01569438|581237664|FG001|Overall Study|Adverse Event|15|||
160959159|NCT01569438|581237663|FG000|Overall Study|Protocol Violation|2|||
160959160|NCT01569438|581237664|FG001|Overall Study|Protocol Violation|0|||
160959161|NCT01569438|581237663|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
160959162|NCT01569438|581237664|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
160959163|NCT01569438|581237663|FG000|Overall Study|Sponsor/Physician decision|1|||
161001903|NCT01307267|581393031|FG010|Overall Study|Lost to Follow-up|1|||
161001904|NCT01307267|581393032|FG011|Overall Study|Lost to Follow-up|0|||
161270157|NCT02132754|582370386|FG018|Overall Study|Withdrawal by Subject|0|||
161270158|NCT02132754|582370387|FG019|Overall Study|Withdrawal by Subject|0|||
160959164|NCT01569438|581237664|FG001|Overall Study|Sponsor/Physician decision|1|||
160959165|NCT01569438|581237663|FG000|Overall Study|Unable to adhere to study schedule|0|||
160959166|NCT01569438|581237664|FG001|Overall Study|Unable to adhere to study schedule|1|||
160959167|NCT03649230|581237666|FG000|Overall Study|Adverse Event|12|||
160959168|NCT03649230|581237666|FG000|Overall Study|Death|8|||
160959169|NCT03649230|581237666|FG000|Overall Study|Withdrawal by Subject|6|||
160959170|NCT03649230|581237666|FG000|Overall Study|Physician Decision|5|||
160959171|NCT03649230|581237666|FG000|Overall Study|Disease progression|5|||
160959172|NCT03649230|581237666|FG000|Overall Study|Switched to non-HEC|5|||
160959173|NCT03649230|581237666|FG000|Overall Study|Chemotherapy discontinued|4|||
160959174|NCT03649230|581237666|FG000|Overall Study|Received only 3 HEC cycles|4|||
160959175|NCT03649230|581237666|FG000|Overall Study|Screen Failure|3|||
160959176|NCT03649230|581237666|FG000|Overall Study|Patient stopped treatment|2|||
160959177|NCT03649230|581237666|FG000|Overall Study|Protocol Violation|1|||
160959178|NCT03649230|581237666|FG000|Overall Study|Non-compliance|1|||
160959179|NCT03649230|581237666|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
160959180|NCT01693068|581237667|FG000|Randomization Period|On-study|2|||
160959181|NCT01693068|581237668|FG001|Randomization Period|On-study|5|||
160959182|NCT01693068|581237669|FG002|Randomization Period|On-study|0|||
160959183|NCT01693068|581237667|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
160959184|NCT01693068|581237668|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
160959185|NCT01693068|581237669|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
160959186|NCT00736645|581237676|FG000|Overall Study|Adverse Event|0|||
160959187|NCT00736645|581237677|FG001|Overall Study|Adverse Event|2|||
160959188|NCT00736645|581237678|FG002|Overall Study|Adverse Event|0|||
160959189|NCT00736645|581237679|FG003|Overall Study|Adverse Event|0|||
160959190|NCT04302350|581237680|FG000|Overall Study|Physician Decision|1|||
160959191|NCT04302350|581237681|FG001|Overall Study|Physician Decision|1|||
160959192|NCT04302350|581237682|FG002|Overall Study|Physician Decision|2|||
160959193|NCT04302350|581237680|FG000|Overall Study|Lack of Efficacy|1|||
160959194|NCT04302350|581237681|FG001|Overall Study|Lack of Efficacy|1|||
160959195|NCT04302350|581237682|FG002|Overall Study|Lack of Efficacy|4|||
160959196|NCT04302350|581237680|FG000|Overall Study|Adverse Event|0|||
160959197|NCT04302350|581237681|FG001|Overall Study|Adverse Event|1|||
160959198|NCT04302350|581237682|FG002|Overall Study|Adverse Event|2|||
160959199|NCT02137369|581237685|FG000|Overall Study|Withdrawal by Subject|3|||
160959200|NCT02137369|581237686|FG001|Overall Study|Withdrawal by Subject|2|||
160959201|NCT02137369|581237685|FG000|Overall Study|Adverse Event|2|||
160959202|NCT02137369|581237686|FG001|Overall Study|Adverse Event|0|||
160959203|NCT02137369|581237685|FG000|Overall Study|Lost to Follow-up|1|||
160959204|NCT02137369|581237686|FG001|Overall Study|Lost to Follow-up|0|||
160959205|NCT02137369|581237685|FG000|Overall Study|Moved away|2|||
160959206|NCT02137369|581237686|FG001|Overall Study|Moved away|0|||
160959207|NCT01475136|581237696|FG000|Overall Study|Sponsor Decision|0|||
160959208|NCT01475136|581237697|FG001|Overall Study|Sponsor Decision|1|||
160959209|NCT01475136|581237698|FG002|Overall Study|Sponsor Decision|0|||
160959210|NCT01475136|581237699|FG003|Overall Study|Sponsor Decision|0|||
160959211|NCT01475136|581237696|FG000|Overall Study|Entry Criteria Not Met|0|||
160959212|NCT01475136|581237697|FG001|Overall Study|Entry Criteria Not Met|2|||
160959213|NCT01475136|581237698|FG002|Overall Study|Entry Criteria Not Met|3|||
160959214|NCT01475136|581237699|FG003|Overall Study|Entry Criteria Not Met|1|||
161270159|NCT02132754|582370388|FG020|Overall Study|Withdrawal by Subject|1|||
161270160|NCT02132754|582370389|FG021|Overall Study|Withdrawal by Subject|0|||
161270161|NCT02132754|582370390|FG022|Overall Study|Withdrawal by Subject|0|||
161270162|NCT02132754|582370391|FG023|Overall Study|Withdrawal by Subject|0|||
161270163|NCT02132754|582370392|FG024|Overall Study|Withdrawal by Subject|1|||
161270164|NCT02132754|582370393|FG025|Overall Study|Withdrawal by Subject|0|||
160959215|NCT01475136|581237696|FG000|Overall Study|Withdrawal by Subject|0|||
160959216|NCT01475136|581237697|FG001|Overall Study|Withdrawal by Subject|0|||
160959217|NCT01475136|581237698|FG002|Overall Study|Withdrawal by Subject|0|||
160959218|NCT01475136|581237699|FG003|Overall Study|Withdrawal by Subject|2|||
160959219|NCT01475136|581237696|FG000|Overall Study|Adverse Event|1|||
160959220|NCT01475136|581237697|FG001|Overall Study|Adverse Event|0|||
160959221|NCT01475136|581237698|FG002|Overall Study|Adverse Event|0|||
160959222|NCT01475136|581237699|FG003|Overall Study|Adverse Event|1|||
160959223|NCT01475136|581237696|FG000|Overall Study|Death|0|||
160959224|NCT01475136|581237697|FG001|Overall Study|Death|0|||
160959225|NCT01475136|581237698|FG002|Overall Study|Death|0|||
160959226|NCT01475136|581237699|FG003|Overall Study|Death|1|||
160959227|NCT01329029|581237700|FG000|Overall Study|Withdrawal by Subject|117|||
160959228|NCT01329029|581237701|FG001|Overall Study|Withdrawal by Subject|87|||
160959229|NCT01329029|581237700|FG000|Overall Study|Adverse Event|82|||
160959230|NCT01329029|581237701|FG001|Overall Study|Adverse Event|29|||
160959231|NCT01329029|581237700|FG000|Overall Study|Death|16|||
160959232|NCT01329029|581237701|FG001|Overall Study|Death|19|||
161270165|NCT02132754|582370394|FG026|Overall Study|Withdrawal by Subject|0|||
161270166|NCT02132754|582370395|FG027|Overall Study|Withdrawal by Subject|1|||
161270167|NCT02132754|582370396|FG028|Overall Study|Withdrawal by Subject|0|||
161343472|NCT03965923|582644390|FG000|Overall Study|Lost to Follow-up|2|||
161001905|NCT01307267|581393033|FG012|Overall Study|Lost to Follow-up|0|||
161001906|NCT01307267|581393034|FG013|Overall Study|Lost to Follow-up|0|||
161001907|NCT01307267|581393035|FG014|Overall Study|Lost to Follow-up|0|||
161001908|NCT01307267|581393036|FG015|Overall Study|Lost to Follow-up|0|||
161001909|NCT01307267|581393037|FG016|Overall Study|Lost to Follow-up|0|||
161146757|NCT02873221|581919862|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
161146758|NCT02873221|581919863|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
161146759|NCT02873221|581919861|FG000|Treatment Period|Protocol Violation|2|||
161146760|NCT02873221|581919862|FG001|Treatment Period|Protocol Violation|5|||
161146761|NCT02873221|581919863|FG002|Treatment Period|Protocol Violation|8|||
161146762|NCT02873221|581919861|FG000|Treatment Period|Pregnancy|4|||
161146763|NCT02873221|581919862|FG001|Treatment Period|Pregnancy|6|||
161146764|NCT02873221|581919863|FG002|Treatment Period|Pregnancy|3|||
161146765|NCT02873221|581919861|FG000|Treatment Period|Lack of Qualifying Event|0|||
161146766|NCT02873221|581919862|FG001|Treatment Period|Lack of Qualifying Event|3|||
161146767|NCT02873221|581919863|FG002|Treatment Period|Lack of Qualifying Event|1|||
161146768|NCT02873221|581919861|FG000|Treatment Period|Withdrawal of Consent|52|||
161146769|NCT02873221|581919862|FG001|Treatment Period|Withdrawal of Consent|51|||
161146770|NCT02873221|581919863|FG002|Treatment Period|Withdrawal of Consent|41|||
161146771|NCT02873221|581919861|FG000|Treatment Period|Lack of Efficacy|0|||
161146772|NCT02873221|581919862|FG001|Treatment Period|Lack of Efficacy|17|||
161146773|NCT02873221|581919863|FG002|Treatment Period|Lack of Efficacy|12|||
161146774|NCT02873221|581919861|FG000|Treatment Period|Adverse Event|4|||
161146775|NCT02873221|581919862|FG001|Treatment Period|Adverse Event|9|||
161146776|NCT02873221|581919863|FG002|Treatment Period|Adverse Event|11|||
161146777|NCT02873221|581919861|FG000|Treatment Period|Lost to Follow-up|26|||
161146778|NCT02873221|581919862|FG001|Treatment Period|Lost to Follow-up|30|||
161146779|NCT02873221|581919863|FG002|Treatment Period|Lost to Follow-up|26|||
161146780|NCT02873221|581919861|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161146781|NCT02873221|581919862|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
161146782|NCT02873221|581919863|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
161146783|NCT02873221|581919861|FG000|Safety Follow-up Period|Protocol Violation|0|||
161146784|NCT02873221|581919862|FG001|Safety Follow-up Period|Protocol Violation|0|||
161146785|NCT02873221|581919863|FG002|Safety Follow-up Period|Protocol Violation|1|||
161146786|NCT02873221|581919861|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
161146787|NCT02873221|581919862|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
161146788|NCT02873221|581919863|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
161146789|NCT02873221|581919861|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
161146790|NCT02873221|581919862|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
161146791|NCT02873221|581919863|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
161146792|NCT01325493|581919864|FG000|Overall Study|Protocol Violation|0|||
161146793|NCT01325493|581919865|FG001|Overall Study|Protocol Violation|1|||
161146794|NCT01325493|581919864|FG000|Overall Study|loss of neuromonitoring signals|0|||
161146795|NCT01325493|581919865|FG001|Overall Study|loss of neuromonitoring signals|2|||
161146796|NCT01325493|581919864|FG000|Overall Study|Allergy|1|||
161146797|NCT01325493|581919865|FG001|Overall Study|Allergy|0|||
161146798|NCT01749735|581919866|FG000|Overall Study|Withdrawal by Subject|1|||
161146799|NCT01749735|581919867|FG001|Overall Study|Withdrawal by Subject|0|||
161146800|NCT02732912|581919868|FG000|Overall Study|Discharged before night|2|||
161146801|NCT02732912|581919869|FG001|Overall Study|Discharged before night|6|||
161146802|NCT02732912|581919868|FG000|Overall Study|Incomplete completion of questionnaire|2|||
161146803|NCT02732912|581919869|FG001|Overall Study|Incomplete completion of questionnaire|3|||
161146804|NCT02732912|581919868|FG000|Overall Study|No outcome; discharged or refused|6|||
161146805|NCT02732912|581919869|FG001|Overall Study|No outcome; discharged or refused|9|||
161146806|NCT01873742|581919870|FG000|Overall Study|Lost to Follow-up|68|||
161146807|NCT01873742|581919871|FG001|Overall Study|Lost to Follow-up|76|||
161146808|NCT02498821|581919872|FG000|Overall Study|Screen failure|3|||
161146809|NCT02498821|581919873|FG001|Overall Study|Screen failure|5|||
161146810|NCT00942708|581919875|FG000|Overall Study|Withdrawal by Subject|1|||
161146811|NCT01457339|581919876|FG000|Period 3 (100 mg)|Adverse Event|0|||
161146812|NCT01457339|581919877|FG001|Period 3 (100 mg)|Adverse Event|1|||
161146813|NCT01457339|581919876|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
161146814|NCT01457339|581919877|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
161146815|NCT01457339|581919876|FG000|Period 6 (250 mg)|Family Emergency|1|||
161146816|NCT01457339|581919877|FG001|Period 6 (250 mg)|Family Emergency|0|||
161146817|NCT01457339|581919876|FG000|Period 6 (250 mg)|Personal appointment|0|||
161146818|NCT01457339|581919877|FG001|Period 6 (250 mg)|Personal appointment|1|||
161146819|NCT00673673|581919878|FG000|Overall Study|Progressive disease|27|||
161146820|NCT00673673|581919878|FG000|Overall Study|Adverse Event|4|||
161146821|NCT00673673|581919878|FG000|Overall Study|Withdrawal by Subject|3|||
161146822|NCT00673673|581919878|FG000|Overall Study|Investigators' discretion|2|||
161146823|NCT01326962|581919885|FG000|Overall Study|Adverse Event|1|||
161146824|NCT01326962|581919885|FG000|Overall Study|Withdrawal by Subject|1|||
161001910|NCT01307267|581393038|FG017|Overall Study|Lost to Follow-up|0|||
161270168|NCT02132754|582370397|FG029|Overall Study|Withdrawal by Subject|0|||
161270169|NCT02132754|582370398|FG030|Overall Study|Withdrawal by Subject|0|||
161270170|NCT02132754|582370399|FG031|Overall Study|Withdrawal by Subject|1|||
161270171|NCT02132754|582370400|FG032|Overall Study|Withdrawal by Subject|0|||
161270172|NCT02132754|582370401|FG033|Overall Study|Withdrawal by Subject|2|||
161270173|NCT02011386|582370408|FG000|Overall Study|Non-compliance|2|||
161270174|NCT02011386|582370408|FG000|Overall Study|Lack of Efficacy|3|||
161270175|NCT01193127|582370409|FG000|Randomized|Surgery Cancelled|0|||
161270176|NCT01193127|582370410|FG001|Randomized|Surgery Cancelled|0|||
161270177|NCT01193127|582370411|FG002|Randomized|Surgery Cancelled|0|||
161270178|NCT01193127|582370412|FG003|Randomized|Surgery Cancelled|1|||
161270179|NCT01193127|582370409|FG000|Treated|Withdrawal by Subject|0|||
161270180|NCT01193127|582370410|FG001|Treated|Withdrawal by Subject|0|||
161270181|NCT01193127|582370411|FG002|Treated|Withdrawal by Subject|0|||
161270182|NCT01193127|582370412|FG003|Treated|Withdrawal by Subject|1|||
161270183|NCT00761865|582370416|FG000|Overall Study|Lost to Follow-up|8|||
161270184|NCT00761865|582370417|FG001|Overall Study|Lost to Follow-up|7|||
161270185|NCT04555720|582370418|FG000|Overall Study|Lost to Follow-up|2|||
161270186|NCT04555720|582370419|FG001|Overall Study|Lost to Follow-up|0|||
161270187|NCT04555720|582370420|FG002|Overall Study|Lost to Follow-up|0|||
161270188|NCT04555720|582370421|FG003|Overall Study|Lost to Follow-up|0|||
161270189|NCT04555720|582370418|FG000|Overall Study|Withdrawal by Subject|4|||
161270190|NCT04555720|582370419|FG001|Overall Study|Withdrawal by Subject|6|||
161270191|NCT04555720|582370420|FG002|Overall Study|Withdrawal by Subject|0|||
161270192|NCT04555720|582370421|FG003|Overall Study|Withdrawal by Subject|0|||
161270193|NCT00321737|582370422|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
161270194|NCT00321737|582370423|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
161270195|NCT00321737|582370424|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
161270196|NCT00321737|582370422|FG000|Overall Study|Adverse Event|11|||
161270197|NCT00321737|582370423|FG001|Overall Study|Adverse Event|3|||
161270198|NCT00321737|582370424|FG002|Overall Study|Adverse Event|6|||
161270199|NCT00321737|582370422|FG000|Overall Study|Lost to Follow-up|5|||
161270200|NCT00321737|582370423|FG001|Overall Study|Lost to Follow-up|5|||
161270201|NCT00321737|582370424|FG002|Overall Study|Lost to Follow-up|6|||
161270202|NCT00321737|582370422|FG000|Overall Study|Withdrawal by Subject|19|||
161270203|NCT00321737|582370423|FG001|Overall Study|Withdrawal by Subject|12|||
161270204|NCT00321737|582370424|FG002|Overall Study|Withdrawal by Subject|17|||
161270205|NCT00321737|582370422|FG000|Overall Study|Protocol Violation|0|||
161270206|NCT00321737|582370423|FG001|Overall Study|Protocol Violation|0|||
161270207|NCT00321737|582370424|FG002|Overall Study|Protocol Violation|1|||
161270208|NCT00321737|582370422|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
161270209|NCT00321737|582370423|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161270210|NCT00321737|582370424|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
161270211|NCT00321737|582370422|FG000|Overall Study|Possible Barrett's Esophagus|2|||
161270212|NCT00321737|582370423|FG001|Overall Study|Possible Barrett's Esophagus|1|||
161270213|NCT00321737|582370424|FG002|Overall Study|Possible Barrett's Esophagus|1|||
161270214|NCT00321737|582370422|FG000|Overall Study|Therapeutic Failure|6|||
161270215|NCT00321737|582370423|FG001|Overall Study|Therapeutic Failure|0|||
161270216|NCT00321737|582370424|FG002|Overall Study|Therapeutic Failure|2|||
161270217|NCT00321737|582370422|FG000|Overall Study|Pregnancy|0|||
161270218|NCT00321737|582370423|FG001|Overall Study|Pregnancy|2|||
161270219|NCT00321737|582370424|FG002|Overall Study|Pregnancy|0|||
161270220|NCT00321737|582370422|FG000|Overall Study|Noncompliance|2|||
161270221|NCT00321737|582370423|FG001|Overall Study|Noncompliance|0|||
161270222|NCT00321737|582370424|FG002|Overall Study|Noncompliance|0|||
161270223|NCT00321737|582370422|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
161001911|NCT01307267|581393039|FG018|Overall Study|Lost to Follow-up|0|||
161001912|NCT01307267|581393040|FG019|Overall Study|Lost to Follow-up|2|||
161146825|NCT01326962|581919885|FG000|Overall Study|Lost to Follow-up|3|||
161146826|NCT01326962|581919885|FG000|Overall Study|Other|2|||
161146827|NCT02053246|581919886|FG000|Overall Study|Withdrawal by Subject|3|||
161270224|NCT00321737|582370423|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
161270225|NCT00321737|582370424|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
161270226|NCT02283294|582370425|FG000|Overall Study|Lost to Follow-up|1|||
161270227|NCT02283294|582370426|FG001|Overall Study|Lost to Follow-up|1|||
161270228|NCT02283294|582370425|FG000|Overall Study|Withdrawal by Subject|1|||
161270229|NCT02283294|582370426|FG001|Overall Study|Withdrawal by Subject|6|||
161270230|NCT02283294|582370425|FG000|Overall Study|Protocol Violation|1|||
161270231|NCT02283294|582370426|FG001|Overall Study|Protocol Violation|0|||
161270232|NCT02283294|582370425|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
161270233|NCT02283294|582370426|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
161270234|NCT03190330|582372704|FG000|Overall Study|Adverse Event|2|||
161270235|NCT03190330|582372704|FG000|Overall Study|Death|10|||
161270236|NCT03190330|582372704|FG000|Overall Study|Lost to Follow-up|1|||
161146828|NCT02053246|581919886|FG000|Overall Study|Physician Decision|1|||
161270237|NCT03190330|582372704|FG000|Overall Study|Withdrawal by Subject|6|||
161270238|NCT03190330|582372704|FG000|Overall Study|Progressive Disease|1|||
161270239|NCT02081209|582372705|FG000|Overall Study|Withdrawal by Subject|1|||
161270240|NCT04994483|582372706|FG000|Overall Study|Adverse Event|26|||
161270241|NCT04994483|582372707|FG001|Overall Study|Adverse Event|17|||
161270242|NCT04994483|582372706|FG000|Overall Study|Lost to Follow-up|6|||
161270243|NCT04994483|582372707|FG001|Overall Study|Lost to Follow-up|10|||
161270244|NCT04994483|582372706|FG000|Overall Study|Noncompliance with study drug|8|||
161270245|NCT04994483|582372707|FG001|Overall Study|Noncompliance with study drug|5|||
161270246|NCT04994483|582372706|FG000|Overall Study|Physician Decision|5|||
161270247|NCT04994483|582372707|FG001|Overall Study|Physician Decision|0|||
161270248|NCT04994483|582372706|FG000|Overall Study|Withdrawal by Subject|41|||
161270249|NCT04994483|582372707|FG001|Overall Study|Withdrawal by Subject|38|||
161270250|NCT04994483|582372706|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
161270251|NCT04994483|582372707|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
161270252|NCT04994483|582372706|FG000|Overall Study|Met stopping criteria|1|||
161270253|NCT04994483|582372707|FG001|Overall Study|Met stopping criteria|0|||
161270254|NCT04994483|582372706|FG000|Overall Study|Randomized in error, not treated|4|||
161270255|NCT04994483|582372707|FG001|Overall Study|Randomized in error, not treated|3|||
161270256|NCT04994483|582372706|FG000|Overall Study|Lack of a reliable study partner|0|||
161270257|NCT04994483|582372707|FG001|Overall Study|Lack of a reliable study partner|1|||
161270258|NCT04994483|582372706|FG000|Overall Study|Met MRI exclusion criteria|0|||
161270259|NCT04994483|582372707|FG001|Overall Study|Met MRI exclusion criteria|1|||
161270260|NCT02213510|582372708|FG000|Overall Study|Death|0|||
161270261|NCT02213510|582372709|FG001|Overall Study|Death|1|||
161270262|NCT02213510|582372708|FG000|Overall Study|Lost to Follow-up|1|||
161270263|NCT02213510|582372709|FG001|Overall Study|Lost to Follow-up|0|||
161270264|NCT02903030|582372710|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
161270265|NCT02903030|582372711|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161270266|NCT00805675|582372716|FG000|Overall Study|Adverse Event|0|||
161270267|NCT00805675|582372717|FG001|Overall Study|Adverse Event|0|||
161270268|NCT00805675|582372718|FG002|Overall Study|Adverse Event|1|||
161270269|NCT03537599|582372723|FG000|Overall Study|Disease Progression|2|||
161270270|NCT03537599|582372724|FG001|Overall Study|Disease Progression|1|||
161270271|NCT03537599|582372723|FG000|Overall Study|Death|0|||
161270272|NCT03537599|582372724|FG001|Overall Study|Death|1|||
161270273|NCT00114166|582372725|FG000|Overall Study|Wrong primary|0|||
161270274|NCT00114166|582372726|FG001|Overall Study|Wrong primary|1|||
161270275|NCT02393248|582372727|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270276|NCT02393248|582372728|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161270277|NCT02393248|582372729|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270278|NCT02393248|582372730|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270279|NCT02393248|582372731|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270280|NCT02393248|582372732|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161270281|NCT02393248|582372733|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
161270282|NCT02393248|582372734|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270283|NCT02393248|582372735|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270284|NCT02393248|582372736|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270285|NCT02393248|582372737|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270286|NCT02393248|582372738|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270287|NCT02393248|582372739|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270288|NCT02393248|582372740|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270289|NCT02393248|582372741|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270290|NCT02393248|582372742|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270291|NCT02393248|582372743|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270292|NCT02393248|582372744|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161001913|NCT01307267|581393041|FG020|Overall Study|Lost to Follow-up|0|||
161001914|NCT01307267|581393042|FG021|Overall Study|Lost to Follow-up|0|||
161001915|NCT01307267|581393043|FG022|Overall Study|Lost to Follow-up|0|||
161001916|NCT01307267|581393021|FG000|Overall Study|Withdrawal by Subject|0|||
161001917|NCT01307267|581393022|FG001|Overall Study|Withdrawal by Subject|0|||
161001918|NCT01307267|581393023|FG002|Overall Study|Withdrawal by Subject|0|||
161146829|NCT02707757|581919887|FG000|Overall Study|Protocol Violation|3|||
161270293|NCT02393248|582372745|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270294|NCT02393248|582372746|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270295|NCT02393248|582372747|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270296|NCT02393248|582372748|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270297|NCT02393248|582372749|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270298|NCT02393248|582372750|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270299|NCT02393248|582372751|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
161270300|NCT02393248|582372727|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270301|NCT02393248|582372728|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
161270302|NCT02393248|582372729|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161001919|NCT01307267|581393024|FG003|Overall Study|Withdrawal by Subject|0|||
161001920|NCT01307267|581393025|FG004|Overall Study|Withdrawal by Subject|0|||
161270303|NCT02393248|582372730|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270304|NCT02393248|582372731|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270305|NCT02393248|582372732|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270306|NCT02393248|582372733|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270307|NCT02393248|582372734|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270308|NCT02393248|582372735|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270309|NCT02393248|582372736|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270310|NCT02393248|582372737|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270311|NCT02393248|582372738|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270312|NCT02393248|582372739|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270313|NCT02393248|582372740|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270314|NCT02393248|582372741|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270315|NCT02393248|582372742|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270316|NCT02393248|582372743|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270317|NCT02393248|582372744|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270318|NCT02393248|582372745|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270319|NCT02393248|582372746|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270320|NCT02393248|582372747|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270321|NCT02393248|582372748|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270322|NCT02393248|582372749|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270323|NCT02393248|582372750|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270324|NCT02393248|582372751|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
161270325|NCT02393248|582372727|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
161270326|NCT02393248|582372728|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
161270327|NCT02393248|582372729|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
161270328|NCT02393248|582372730|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
161270329|NCT02393248|582372731|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
160959233|NCT01329029|581237700|FG000|Overall Study|Other|14|||
160959234|NCT01329029|581237701|FG001|Overall Study|Other|20|||
160959235|NCT01329029|581237700|FG000|Overall Study|COPD Exacerbation|11|||
160959236|NCT01329029|581237701|FG001|Overall Study|COPD Exacerbation|18|||
160959237|NCT01329029|581237700|FG000|Overall Study|Physician Decision|16|||
160959238|NCT01329029|581237701|FG001|Overall Study|Physician Decision|13|||
160959239|NCT01329029|581237700|FG000|Overall Study|Lost to Follow-up|8|||
160959240|NCT01329029|581237701|FG001|Overall Study|Lost to Follow-up|5|||
160959241|NCT01329029|581237700|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
160959242|NCT01329029|581237701|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
160959243|NCT01323530|581239684|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
160959244|NCT01323530|581239685|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959245|NCT01323530|581239686|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959246|NCT01323530|581239687|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959247|NCT01323530|581239688|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959248|NCT01323530|581239689|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
160959249|NCT01323530|581239690|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
160959250|NCT01323530|581239684|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160959251|NCT01323530|581239685|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160959252|NCT01323530|581239686|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
160959253|NCT01323530|581239687|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
161270330|NCT02393248|582372732|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
161270331|NCT02393248|582372733|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
160959254|NCT01323530|581239688|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
160959255|NCT01323530|581239689|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160959256|NCT01323530|581239690|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
160959257|NCT01323530|581239684|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959258|NCT01323530|581239685|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
160959259|NCT01323530|581239686|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959260|NCT01323530|581239687|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959261|NCT01323530|581239688|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
160959262|NCT01323530|581239689|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
160959263|NCT01323530|581239690|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
160959264|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959265|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959266|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959267|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959268|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
161270332|NCT02393248|582372734|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
161270333|NCT02393248|582372735|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
161270334|NCT02393248|582372736|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
161270335|NCT02393248|582372737|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
161270336|NCT02393248|582372738|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
161270337|NCT02393248|582372739|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
161270338|NCT02393248|582372740|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
161270339|NCT02393248|582372741|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
161270340|NCT02393248|582372742|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
161270341|NCT02393248|582372743|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
161270342|NCT02393248|582372744|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
161270343|NCT02393248|582372745|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
161270344|NCT02393248|582372746|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
161270345|NCT02393248|582372747|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
161270346|NCT02393248|582372748|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
161270347|NCT02393248|582372749|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
161270348|NCT02393248|582372750|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
161270349|NCT02393248|582372751|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
161270350|NCT02393248|582372727|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
161270351|NCT02393248|582372728|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270352|NCT02393248|582372729|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270353|NCT02393248|582372730|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270354|NCT02393248|582372731|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270355|NCT02393248|582372732|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270356|NCT02393248|582372733|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270357|NCT02393248|582372734|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270358|NCT02393248|582372735|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270359|NCT02393248|582372736|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270360|NCT02393248|582372737|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270361|NCT02393248|582372738|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270362|NCT02393248|582372739|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270363|NCT02393248|582372740|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270364|NCT02393248|582372741|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270365|NCT02393248|582372742|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270366|NCT02393248|582372743|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270367|NCT02393248|582372744|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270368|NCT02393248|582372745|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270369|NCT02393248|582372746|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270370|NCT02393248|582372747|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270371|NCT02393248|582372748|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270372|NCT02393248|582372749|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270373|NCT02393248|582372750|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270374|NCT02393248|582372751|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
161270375|NCT02393248|582372727|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270376|NCT02393248|582372728|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270377|NCT02393248|582372729|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270378|NCT02393248|582372730|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270379|NCT02393248|582372731|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270380|NCT02393248|582372732|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
161270381|NCT02393248|582372733|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
161270382|NCT02393248|582372734|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270383|NCT02393248|582372735|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270384|NCT02393248|582372736|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
161270385|NCT02393248|582372737|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270386|NCT02393248|582372738|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270387|NCT02393248|582372739|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270388|NCT02393248|582372740|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270389|NCT02393248|582372741|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270390|NCT02393248|582372742|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270391|NCT02393248|582372743|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270392|NCT02393248|582372744|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270393|NCT02393248|582372745|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270394|NCT02393248|582372746|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160959269|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
160959270|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
161270395|NCT02393248|582372747|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270396|NCT02393248|582372748|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270397|NCT02393248|582372749|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270398|NCT02393248|582372750|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
160959271|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959272|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959273|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959274|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959275|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959276|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
160959277|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
160959278|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959279|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959280|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959281|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959282|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959283|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
160959284|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
160959285|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959286|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959287|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959288|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959289|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959290|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
160959291|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
160959292|NCT01323530|581239684|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959293|NCT01323530|581239685|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959294|NCT01323530|581239686|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959295|NCT01323530|581239687|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959296|NCT01323530|581239688|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959297|NCT01323530|581239689|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
160959298|NCT01323530|581239690|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
160959299|NCT01194570|581239691|FG000|Overall Study|Adverse Event|22|||
160959300|NCT01194570|581239692|FG001|Overall Study|Adverse Event|40|||
160959301|NCT01194570|581239691|FG000|Overall Study|Death|6|||
160959302|NCT01194570|581239692|FG001|Overall Study|Death|20|||
160959303|NCT01194570|581239691|FG000|Overall Study|Lack of Efficacy|32|||
160959304|NCT01194570|581239692|FG001|Overall Study|Lack of Efficacy|33|||
160959305|NCT01194570|581239691|FG000|Overall Study|Lost to Follow-up|4|||
160959306|NCT01194570|581239692|FG001|Overall Study|Lost to Follow-up|15|||
160959307|NCT01194570|581239691|FG000|Overall Study|Non-Compliance|2|||
160959308|NCT01194570|581239692|FG001|Overall Study|Non-Compliance|2|||
160959309|NCT01194570|581239691|FG000|Overall Study|Non-Compliance With Study Drug|2|||
160959310|NCT01194570|581239692|FG001|Overall Study|Non-Compliance With Study Drug|2|||
161270399|NCT02393248|582372751|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
161270400|NCT02393248|582372727|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270401|NCT02393248|582372728|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270402|NCT02393248|582372729|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270403|NCT02393248|582372730|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270404|NCT02393248|582372731|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270405|NCT02393248|582372732|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270406|NCT02393248|582372733|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
161270407|NCT02393248|582372734|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270408|NCT02393248|582372735|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270409|NCT02393248|582372736|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270410|NCT02393248|582372737|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270411|NCT02393248|582372738|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270412|NCT02393248|582372739|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
160959311|NCT01194570|581239691|FG000|Overall Study|Other|18|||
160959312|NCT01194570|581239692|FG001|Overall Study|Other|47|||
160959313|NCT01194570|581239691|FG000|Overall Study|Physician Decision|10|||
160959314|NCT01194570|581239692|FG001|Overall Study|Physician Decision|25|||
160959315|NCT01194570|581239691|FG000|Overall Study|Protocol Violation|1|||
161001921|NCT01307267|581393026|FG005|Overall Study|Withdrawal by Subject|1|||
161001922|NCT01307267|581393027|FG006|Overall Study|Withdrawal by Subject|0|||
161001923|NCT01307267|581393028|FG007|Overall Study|Withdrawal by Subject|1|||
161001924|NCT01307267|581393029|FG008|Overall Study|Withdrawal by Subject|5|||
161001925|NCT01307267|581393030|FG009|Overall Study|Withdrawal by Subject|1|||
161001926|NCT01307267|581393031|FG010|Overall Study|Withdrawal by Subject|1|||
161270413|NCT02393248|582372740|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161343473|NCT03965923|582644391|FG001|Overall Study|Lost to Follow-up|1|||
161343474|NCT03965923|582644392|FG002|Overall Study|Lost to Follow-up|1|||
160959316|NCT01194570|581239692|FG001|Overall Study|Protocol Violation|2|||
160959317|NCT01194570|581239691|FG000|Overall Study|Study Terminated By Sponsor|0|||
160959318|NCT01194570|581239692|FG001|Overall Study|Study Terminated By Sponsor|1|||
160959319|NCT01194570|581239691|FG000|Overall Study|Withdrawal by Subject|57|||
160959320|NCT01194570|581239692|FG001|Overall Study|Withdrawal by Subject|82|||
160959321|NCT01194570|581239691|FG000|Overall Study|Pregnancy|1|||
160959322|NCT01194570|581239692|FG001|Overall Study|Pregnancy|1|||
160959323|NCT01203930|581239702|FG000|Overall Study|Disease Progression|0|||
160959324|NCT01203930|581239703|FG001|Overall Study|Disease Progression|4|||
160959325|NCT01203930|581239702|FG000|Overall Study|Death|3|||
160959326|NCT01203930|581239703|FG001|Overall Study|Death|1|||
160959327|NCT01203930|581239702|FG000|Overall Study|Withdrew Consent|1|||
160959328|NCT01203930|581239703|FG001|Overall Study|Withdrew Consent|10|||
160959329|NCT01203930|581239702|FG000|Overall Study|Investigator Request|0|||
160959330|NCT01203930|581239703|FG001|Overall Study|Investigator Request|8|||
160959331|NCT01203930|581239702|FG000|Overall Study|Study Terminated by Sponsor|0|||
160959332|NCT01203930|581239703|FG001|Overall Study|Study Terminated by Sponsor|12|||
160959333|NCT01203930|581239702|FG000|Overall Study|Poor tolerance of study drug|0|||
160959334|NCT01203930|581239703|FG001|Overall Study|Poor tolerance of study drug|1|||
160959335|NCT01203930|581239702|FG000|Overall Study|Adverse Event|17|||
160959336|NCT01203930|581239703|FG001|Overall Study|Adverse Event|5|||
160959337|NCT01266850|581239704|FG000|Overall Study|Lost to Follow-up|19|||
160959338|NCT01266850|581239705|FG001|Overall Study|Lost to Follow-up|19|||
160959339|NCT01266850|581239706|FG002|Overall Study|Lost to Follow-up|13|||
160959340|NCT01266850|581239707|FG003|Overall Study|Lost to Follow-up|13|||
160959341|NCT01266850|581239708|FG004|Overall Study|Lost to Follow-up|12|||
160959342|NCT01266850|581239704|FG000|Overall Study|Withdrawal by Subject|8|||
160959343|NCT01266850|581239705|FG001|Overall Study|Withdrawal by Subject|9|||
160959344|NCT01266850|581239706|FG002|Overall Study|Withdrawal by Subject|6|||
160959345|NCT01266850|581239707|FG003|Overall Study|Withdrawal by Subject|9|||
160959346|NCT01266850|581239708|FG004|Overall Study|Withdrawal by Subject|12|||
160959347|NCT01266850|581239704|FG000|Overall Study|Physician Decision|3|||
160959348|NCT01266850|581239705|FG001|Overall Study|Physician Decision|6|||
160959349|NCT01266850|581239706|FG002|Overall Study|Physician Decision|4|||
160959350|NCT01266850|581239707|FG003|Overall Study|Physician Decision|4|||
160959351|NCT01266850|581239708|FG004|Overall Study|Physician Decision|3|||
160959352|NCT01266850|581239704|FG000|Overall Study|Protocol Violation|0|||
160959353|NCT01266850|581239705|FG001|Overall Study|Protocol Violation|1|||
160959354|NCT01266850|581239706|FG002|Overall Study|Protocol Violation|0|||
160959355|NCT01266850|581239707|FG003|Overall Study|Protocol Violation|1|||
160959356|NCT01266850|581239708|FG004|Overall Study|Protocol Violation|2|||
160959357|NCT01266850|581239704|FG000|Overall Study|Adverse Event|0|||
160959358|NCT01266850|581239705|FG001|Overall Study|Adverse Event|0|||
160959359|NCT01266850|581239706|FG002|Overall Study|Adverse Event|0|||
161146830|NCT02707757|581919888|FG001|Overall Study|Protocol Violation|2|||
161146831|NCT02707757|581919887|FG000|Overall Study|Withdrawal by Subject|2|||
161146832|NCT02707757|581919888|FG001|Overall Study|Withdrawal by Subject|0|||
161146833|NCT02707757|581919887|FG000|Overall Study|Death|0|||
161146834|NCT02707757|581919888|FG001|Overall Study|Death|1|||
161146835|NCT02707757|581919887|FG000|Overall Study|Adverse Event|6|||
161146836|NCT02707757|581919888|FG001|Overall Study|Adverse Event|4|||
161146837|NCT02707757|581919887|FG000|Overall Study|Renal transplant/elective operation|1|||
161146838|NCT02707757|581919888|FG001|Overall Study|Renal transplant/elective operation|5|||
161146839|NCT00815308|581919889|FG000|Overall Study|Adverse Event|4|||
161146840|NCT00815308|581919889|FG000|Overall Study|Withdrawal by Subject|0|||
161146841|NCT00815308|581919889|FG000|Overall Study|Protocol Violation|6|||
161146842|NCT01056523|581919890|FG000|Overall Study|Death|1|||
161146843|NCT01056523|581919891|FG001|Overall Study|Death|0|||
161146844|NCT01056523|581919892|FG002|Overall Study|Death|2|||
161146845|NCT01056523|581919893|FG003|Overall Study|Death|3|||
161146846|NCT01056523|581919894|FG004|Overall Study|Death|0|||
161146847|NCT01056523|581919895|FG005|Overall Study|Death|0|||
161146848|NCT01056523|581919896|FG006|Overall Study|Death|1|||
161146849|NCT03429556|581919899|FG000|Overall Study|Lost to Follow-up|0|||
161146850|NCT03429556|581919900|FG001|Overall Study|Lost to Follow-up|1|||
161146851|NCT03429556|581919901|FG002|Overall Study|Lost to Follow-up|0|||
161146852|NCT03429556|581919902|FG003|Overall Study|Lost to Follow-up|0|||
161146853|NCT00377299|581919903|FG000|Overall Study|Lost to Follow-up|14|||
161146854|NCT00377299|581919904|FG001|Overall Study|Lost to Follow-up|19|||
161146855|NCT00377299|581919903|FG000|Overall Study|Adverse Event|0|||
161146856|NCT00377299|581919904|FG001|Overall Study|Adverse Event|1|||
161146857|NCT00377299|581919903|FG000|Overall Study|Withdrawal by Subject|5|||
161146858|NCT00377299|581919904|FG001|Overall Study|Withdrawal by Subject|4|||
161146859|NCT02209597|581919906|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
160959360|NCT01266850|581239707|FG003|Overall Study|Adverse Event|0|||
160959361|NCT01266850|581239708|FG004|Overall Study|Adverse Event|1|||
160959362|NCT01266850|581239704|FG000|Overall Study|Site Closure|0|||
160959363|NCT01266850|581239705|FG001|Overall Study|Site Closure|1|||
160959364|NCT01266850|581239706|FG002|Overall Study|Site Closure|1|||
161146860|NCT02209597|581919906|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
160959365|NCT01266850|581239707|FG003|Overall Study|Site Closure|1|||
161270414|NCT02393248|582372741|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270415|NCT02393248|582372742|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270416|NCT02393248|582372743|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270417|NCT02393248|582372744|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270418|NCT02393248|582372745|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270419|NCT02393248|582372746|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270420|NCT02393248|582372747|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270421|NCT02393248|582372748|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270422|NCT02393248|582372749|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270423|NCT02393248|582372750|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270424|NCT02393248|582372751|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
161270425|NCT02393248|582372727|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270426|NCT02393248|582372728|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270427|NCT02393248|582372729|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270428|NCT02393248|582372730|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270429|NCT02393248|582372731|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270430|NCT02393248|582372732|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270431|NCT02393248|582372733|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270432|NCT02393248|582372734|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270433|NCT02393248|582372735|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270434|NCT02393248|582372736|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270435|NCT02393248|582372737|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270436|NCT02393248|582372738|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
161270437|NCT02393248|582372739|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
161270438|NCT02393248|582372740|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
161270439|NCT02393248|582372741|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
161270440|NCT02393248|582372742|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270441|NCT02393248|582372743|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270442|NCT02393248|582372744|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270443|NCT02393248|582372745|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270444|NCT02393248|582372746|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270445|NCT02393248|582372747|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161343475|NCT03965923|582644393|FG003|Overall Study|Lost to Follow-up|0|||
161343476|NCT03965923|582644394|FG004|Overall Study|Lost to Follow-up|2|||
161343477|NCT03965923|582644395|FG005|Overall Study|Lost to Follow-up|1|||
160959366|NCT01266850|581239708|FG004|Overall Study|Site Closure|0|||
160959367|NCT02030015|581239711|FG000|Overall Study|Withdrawal by Subject|3|||
160959368|NCT02030015|581239711|FG000|Overall Study|Death|13|||
160959369|NCT03014674|581239713|FG000|Overall Study|Withdrawal by Subject|1|||
160959370|NCT03014674|581239714|FG001|Overall Study|Withdrawal by Subject|0|||
160959371|NCT03014674|581239715|FG002|Overall Study|Withdrawal by Subject|0|||
160959372|NCT01332227|581239716|FG000|Overall Study|Adverse Event|4|||
160959373|NCT01332227|581239717|FG001|Overall Study|Adverse Event|1|||
160959374|NCT01332227|581239716|FG000|Overall Study|Withdrawal by Subject|5|||
160959375|NCT01332227|581239717|FG001|Overall Study|Withdrawal by Subject|1|||
160959376|NCT01332227|581239716|FG000|Overall Study|Lost to Follow-up|2|||
160959377|NCT01332227|581239717|FG001|Overall Study|Lost to Follow-up|0|||
160959378|NCT01332227|581239716|FG000|Overall Study|Lack of Efficacy|3|||
160959379|NCT01332227|581239717|FG001|Overall Study|Lack of Efficacy|1|||
160959380|NCT01332227|581239716|FG000|Overall Study|Poor compliance/noncompliance|1|||
160959381|NCT01332227|581239717|FG001|Overall Study|Poor compliance/noncompliance|1|||
160959382|NCT01332227|581239716|FG000|Overall Study|Patient moved from area|1|||
160959383|NCT01332227|581239717|FG001|Overall Study|Patient moved from area|0|||
160959384|NCT01332227|581239716|FG000|Overall Study|Patient began prohibited medication|0|||
160959385|NCT01332227|581239717|FG001|Overall Study|Patient began prohibited medication|1|||
160959386|NCT03382782|581239725|FG000|Cohort 1|Withdrawal by Subject|11|||
160959387|NCT03382782|581239726|FG001|Cohort 1|Withdrawal by Subject|5|||
160959388|NCT03382782|581239727|FG002|Cohort 1|Withdrawal by Subject|0|||
160959389|NCT03382782|581239725|FG000|Cohort 2|Withdrawal by Subject|1|||
160959390|NCT03382782|581239726|FG001|Cohort 2|Withdrawal by Subject|1|||
160959391|NCT03382782|581239727|FG002|Cohort 2|Withdrawal by Subject|0|||
160959392|NCT03382782|581239725|FG000|Cohort 3|Withdrawal by Subject|1|||
160959393|NCT03382782|581239726|FG001|Cohort 3|Withdrawal by Subject|2|||
160959394|NCT03382782|581239727|FG002|Cohort 3|Withdrawal by Subject|0|||
160959395|NCT00428090|581239732|FG000|Overall Study|Adverse Event|10|||
161146861|NCT02209597|581919906|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
160959396|NCT00428090|581239733|FG001|Overall Study|Adverse Event|8|||
160959397|NCT00428090|581239734|FG002|Overall Study|Adverse Event|10|||
161270446|NCT02393248|582372748|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270447|NCT02393248|582372749|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270448|NCT02393248|582372750|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270449|NCT02393248|582372751|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
161270450|NCT02393248|582372727|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270451|NCT02393248|582372728|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270452|NCT02393248|582372729|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270453|NCT02393248|582372730|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270454|NCT02393248|582372731|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270455|NCT02393248|582372732|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270456|NCT02393248|582372733|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270457|NCT02393248|582372734|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270458|NCT02393248|582372735|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270459|NCT02393248|582372736|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270460|NCT02393248|582372737|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
161270461|NCT02393248|582372738|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
161270462|NCT02393248|582372739|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270463|NCT02393248|582372740|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270464|NCT02393248|582372741|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270465|NCT02393248|582372742|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270466|NCT02393248|582372743|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270467|NCT02393248|582372744|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270468|NCT02393248|582372745|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270469|NCT02393248|582372746|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270470|NCT02393248|582372747|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270471|NCT02393248|582372748|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270472|NCT02393248|582372749|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270473|NCT02393248|582372750|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161146862|NCT02209597|581919906|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
161146863|NCT04799782|581919914|FG000|Washout|Physician Decision|2|||
161146864|NCT04799782|581919915|FG001|Washout|Physician Decision|0|||
161146865|NCT04799782|581919914|FG000|Washout|Withdrawal by Subject|0|||
161146866|NCT04799782|581919915|FG001|Washout|Withdrawal by Subject|2|||
161146867|NCT04799782|581919914|FG000|Washout|Lost to Follow-up|0|||
161270474|NCT02393248|582372751|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
161270475|NCT02393248|582372727|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
161270476|NCT02393248|582372728|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
161270477|NCT02393248|582372729|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
161270478|NCT02393248|582372730|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
161270479|NCT02393248|582372731|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
161270480|NCT02393248|582372732|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
161270481|NCT02393248|582372733|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
161270482|NCT02393248|582372734|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
161270483|NCT02393248|582372735|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
161270484|NCT02393248|582372736|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
161270485|NCT02393248|582372737|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
161270486|NCT02393248|582372738|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
161270487|NCT02393248|582372739|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
161270488|NCT02393248|582372740|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
161270489|NCT02393248|582372741|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
161270490|NCT02393248|582372742|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
161270491|NCT02393248|582372743|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
161270492|NCT02393248|582372744|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
161270493|NCT02393248|582372745|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
161270494|NCT02393248|582372746|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
161270495|NCT02393248|582372747|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
160959398|NCT00428090|581239735|FG003|Overall Study|Adverse Event|11|||
160959399|NCT00428090|581239732|FG000|Overall Study|Lost to Follow-up|3|||
160959400|NCT00428090|581239733|FG001|Overall Study|Lost to Follow-up|6|||
160959401|NCT00428090|581239734|FG002|Overall Study|Lost to Follow-up|1|||
160959402|NCT00428090|581239735|FG003|Overall Study|Lost to Follow-up|4|||
160959403|NCT00428090|581239732|FG000|Overall Study|Protocol Violation|3|||
160959404|NCT00428090|581239733|FG001|Overall Study|Protocol Violation|1|||
160959405|NCT00428090|581239734|FG002|Overall Study|Protocol Violation|3|||
160959406|NCT00428090|581239735|FG003|Overall Study|Protocol Violation|3|||
160959407|NCT00428090|581239732|FG000|Overall Study|Withdrawal by Subject|10|||
160959408|NCT00428090|581239733|FG001|Overall Study|Withdrawal by Subject|12|||
160959409|NCT00428090|581239734|FG002|Overall Study|Withdrawal by Subject|15|||
160959410|NCT00428090|581239735|FG003|Overall Study|Withdrawal by Subject|5|||
160959411|NCT00428090|581239732|FG000|Overall Study|Sponsor terminated study|0|||
160959412|NCT00428090|581239733|FG001|Overall Study|Sponsor terminated study|1|||
161270496|NCT02393248|582372748|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
161270497|NCT02393248|582372749|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
161270498|NCT02393248|582372750|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
161270499|NCT02393248|582372751|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
161270500|NCT02393248|582372727|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270501|NCT02393248|582372728|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270502|NCT02393248|582372729|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270503|NCT02393248|582372730|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270504|NCT02393248|582372731|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270505|NCT02393248|582372732|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270506|NCT02393248|582372733|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270507|NCT02393248|582372734|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270508|NCT02393248|582372735|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270509|NCT02393248|582372736|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161001927|NCT01307267|581393032|FG011|Overall Study|Withdrawal by Subject|1|||
161001928|NCT01307267|581393033|FG012|Overall Study|Withdrawal by Subject|0|||
161001929|NCT01307267|581393034|FG013|Overall Study|Withdrawal by Subject|0|||
161001930|NCT01307267|581393035|FG014|Overall Study|Withdrawal by Subject|0|||
161001931|NCT01307267|581393036|FG015|Overall Study|Withdrawal by Subject|0|||
161001932|NCT01307267|581393037|FG016|Overall Study|Withdrawal by Subject|0|||
161001933|NCT01307267|581393038|FG017|Overall Study|Withdrawal by Subject|0|||
161001934|NCT01307267|581393039|FG018|Overall Study|Withdrawal by Subject|0|||
161001935|NCT01307267|581393040|FG019|Overall Study|Withdrawal by Subject|3|||
161001936|NCT01307267|581393041|FG020|Overall Study|Withdrawal by Subject|0|||
161001937|NCT01307267|581393042|FG021|Overall Study|Withdrawal by Subject|0|||
161001938|NCT01307267|581393043|FG022|Overall Study|Withdrawal by Subject|0|||
161001939|NCT01307267|581393021|FG000|Overall Study|Other|0|||
161001940|NCT01307267|581393022|FG001|Overall Study|Other|0|||
161001941|NCT01307267|581393023|FG002|Overall Study|Other|0|||
161001942|NCT01307267|581393024|FG003|Overall Study|Other|0|||
161001943|NCT01307267|581393025|FG004|Overall Study|Other|0|||
161001944|NCT01307267|581393026|FG005|Overall Study|Other|7|||
161001945|NCT01307267|581393027|FG006|Overall Study|Other|0|||
161001946|NCT01307267|581393028|FG007|Overall Study|Other|1|||
161001947|NCT01307267|581393029|FG008|Overall Study|Other|3|||
161001948|NCT01307267|581393030|FG009|Overall Study|Other|0|||
161001949|NCT01307267|581393031|FG010|Overall Study|Other|1|||
161001950|NCT01307267|581393032|FG011|Overall Study|Other|1|||
161001951|NCT01307267|581393033|FG012|Overall Study|Other|1|||
161001952|NCT01307267|581393034|FG013|Overall Study|Other|0|||
161001953|NCT01307267|581393035|FG014|Overall Study|Other|2|||
161001954|NCT01307267|581393036|FG015|Overall Study|Other|1|||
161001955|NCT01307267|581393037|FG016|Overall Study|Other|0|||
161001956|NCT01307267|581393038|FG017|Overall Study|Other|0|||
161001957|NCT01307267|581393039|FG018|Overall Study|Other|0|||
161001958|NCT01307267|581393040|FG019|Overall Study|Other|19|||
161001959|NCT01307267|581393041|FG020|Overall Study|Other|2|||
161001960|NCT01307267|581393042|FG021|Overall Study|Other|3|||
161001961|NCT01307267|581393043|FG022|Overall Study|Other|2|||
161001962|NCT04956575|581393044|FG000|Overall Study|Death|1|||
161001963|NCT04956575|581393045|FG001|Overall Study|Death|0|||
161001964|NCT04956575|581393046|FG002|Overall Study|Death|0|||
161001965|NCT04956575|581393047|FG003|Overall Study|Death|0|||
161001966|NCT04956575|581393048|FG004|Overall Study|Death|0|||
161001967|NCT04956575|581393049|FG005|Overall Study|Death|0|||
161001968|NCT04956575|581393050|FG006|Overall Study|Death|0|||
161146868|NCT04799782|581919915|FG001|Washout|Lost to Follow-up|1|||
161146869|NCT02050048|581919916|FG000|Overall Study|Lost to Follow-up|0|||
161270510|NCT02393248|582372737|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161001969|NCT04956575|581393051|FG007|Overall Study|Death|1|||
161001970|NCT04956575|581393052|FG008|Overall Study|Death|0|||
161001971|NCT04956575|581393053|FG009|Overall Study|Death|1|||
161001972|NCT04956575|581393054|FG010|Overall Study|Death|0|||
161001973|NCT04956575|581393055|FG011|Overall Study|Death|0|||
161001974|NCT04956575|581393044|FG000|Overall Study|Lost to Follow-up|3|||
161146870|NCT02050048|581919917|FG001|Overall Study|Lost to Follow-up|1|||
161001975|NCT04956575|581393045|FG001|Overall Study|Lost to Follow-up|4|||
161001976|NCT04956575|581393046|FG002|Overall Study|Lost to Follow-up|2|||
161001977|NCT04956575|581393047|FG003|Overall Study|Lost to Follow-up|3|||
161001978|NCT04956575|581393048|FG004|Overall Study|Lost to Follow-up|1|||
161001979|NCT04956575|581393049|FG005|Overall Study|Lost to Follow-up|10|||
161001980|NCT04956575|581393050|FG006|Overall Study|Lost to Follow-up|11|||
161001981|NCT04956575|581393051|FG007|Overall Study|Lost to Follow-up|7|||
161001982|NCT04956575|581393052|FG008|Overall Study|Lost to Follow-up|4|||
161001983|NCT04956575|581393053|FG009|Overall Study|Lost to Follow-up|2|||
161001984|NCT04956575|581393054|FG010|Overall Study|Lost to Follow-up|3|||
161001985|NCT04956575|581393055|FG011|Overall Study|Lost to Follow-up|8|||
161270511|NCT02393248|582372738|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
161270512|NCT02393248|582372739|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270513|NCT02393248|582372740|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
161270514|NCT02393248|582372741|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270515|NCT02393248|582372742|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270516|NCT02393248|582372743|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270517|NCT02393248|582372744|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270518|NCT02393248|582372745|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270519|NCT02393248|582372746|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270520|NCT02393248|582372747|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270521|NCT02393248|582372748|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270522|NCT02393248|582372749|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270523|NCT02393248|582372750|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270524|NCT02393248|582372751|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
161270525|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270526|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270527|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270528|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270529|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270530|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270531|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270532|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270533|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270534|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270535|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270536|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270537|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270538|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270539|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270540|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270541|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270542|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270543|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161270544|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270545|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
161270546|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161270547|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270548|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
161270549|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
161270550|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Death|0|||
161270551|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Death|0|||
161270552|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Death|0|||
161270553|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Death|0|||
161270554|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Death|0|||
161270555|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Death|0|||
161270556|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Death|0|||
161270557|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Death|0|||
161270558|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Death|0|||
161270559|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Death|0|||
161270560|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Death|0|||
161270561|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Death|0|||
161270562|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Death|0|||
161270563|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Death|0|||
160959413|NCT00428090|581239734|FG002|Overall Study|Sponsor terminated study|0|||
160959414|NCT00428090|581239735|FG003|Overall Study|Sponsor terminated study|0|||
160959415|NCT00428090|581239732|FG000|Overall Study|Non-compliance|4|||
160959416|NCT00428090|581239733|FG001|Overall Study|Non-compliance|0|||
160959417|NCT00428090|581239734|FG002|Overall Study|Non-compliance|1|||
160959418|NCT00428090|581239735|FG003|Overall Study|Non-compliance|3|||
160959419|NCT00428090|581239732|FG000|Overall Study|Par. did not returned to visit|1|||
160959420|NCT00428090|581239733|FG001|Overall Study|Par. did not returned to visit|0|||
160959421|NCT00428090|581239734|FG002|Overall Study|Par. did not returned to visit|0|||
160959422|NCT00428090|581239735|FG003|Overall Study|Par. did not returned to visit|1|||
160959423|NCT00428090|581239732|FG000|Overall Study|Follow-Up visit not possible|1|||
160959424|NCT00428090|581239733|FG001|Overall Study|Follow-Up visit not possible|0|||
160959425|NCT00428090|581239734|FG002|Overall Study|Follow-Up visit not possible|0|||
160959426|NCT00428090|581239735|FG003|Overall Study|Follow-Up visit not possible|0|||
160959427|NCT00428090|581239732|FG000|Overall Study|Prohibited medication used for SAE|1|||
160959428|NCT00428090|581239733|FG001|Overall Study|Prohibited medication used for SAE|0|||
161270564|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Death|0|||
161270565|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Death|1|||
161270566|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Death|7|||
161270567|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Death|5|||
161270568|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Death|5|||
161270569|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Death|3|||
161270570|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Death|7|||
161270571|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Death|5|||
161270572|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Death|6|||
161270573|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Death|3|||
161270574|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Death|0|||
161270575|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270576|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270577|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270578|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270579|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270580|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270581|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270582|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270583|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270584|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270585|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270586|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270587|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270588|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270589|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270590|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270591|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270592|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161270593|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161270594|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
161270595|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161270596|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161270597|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161270598|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
161270599|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
161270600|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Disease Progression|0|||
161270601|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Disease Progression|0|||
161270602|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Disease Progression|0|||
161270603|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Disease Progression|0|||
161270604|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Disease Progression|0|||
161270605|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Disease Progression|0|||
161270606|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Disease Progression|0|||
161270607|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Disease Progression|0|||
161270608|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Disease Progression|0|||
161270609|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Disease Progression|0|||
161270610|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Disease Progression|0|||
161270611|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Disease Progression|0|||
161270612|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Disease Progression|0|||
161270613|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Disease Progression|0|||
161270614|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Disease Progression|0|||
161270615|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Disease Progression|0|||
161270616|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Disease Progression|0|||
161270617|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Disease Progression|0|||
161270618|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Disease Progression|0|||
161270619|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Disease Progression|0|||
161270620|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Disease Progression|2|||
161270621|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Disease Progression|1|||
161270622|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Disease Progression|0|||
161270623|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Disease Progression|0|||
161270624|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Disease Progression|0|||
161270625|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270626|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270627|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270628|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270629|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
161343478|NCT03965923|582644396|FG006|Overall Study|Lost to Follow-up|2|||
160959429|NCT00428090|581239734|FG002|Overall Study|Prohibited medication used for SAE|0|||
160959430|NCT00428090|581239735|FG003|Overall Study|Prohibited medication used for SAE|0|||
161270630|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270631|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270632|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270633|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270634|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270635|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270636|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270637|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270638|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270639|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270640|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270641|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270642|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270643|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270644|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270645|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
161270646|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
161270647|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270648|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270649|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
161270650|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270651|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270652|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270653|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270654|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270655|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270656|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270657|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270658|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
160959431|NCT00428090|581239732|FG000|Overall Study|Death of par.|1|||
160959432|NCT00428090|581239733|FG001|Overall Study|Death of par.|0|||
160959433|NCT00428090|581239734|FG002|Overall Study|Death of par.|1|||
160959434|NCT00428090|581239735|FG003|Overall Study|Death of par.|0|||
160959435|NCT00428090|581239732|FG000|Overall Study|Visit 7 exceed the visit window|0|||
160959436|NCT00428090|581239733|FG001|Overall Study|Visit 7 exceed the visit window|1|||
160959437|NCT00428090|581239734|FG002|Overall Study|Visit 7 exceed the visit window|0|||
161001986|NCT04956575|581393044|FG000|Overall Study|Withdrawal by Subject|1|||
161270659|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270660|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270661|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270662|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270663|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270664|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270665|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270666|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270667|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270668|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270669|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270670|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
161270671|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270672|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270673|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270674|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
161270675|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Adverse Event|0|||
161270676|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Adverse Event|0|||
161270677|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Adverse Event|0|||
161343479|NCT03965923|582644397|FG007|Overall Study|Lost to Follow-up|1|||
160959438|NCT00428090|581239735|FG003|Overall Study|Visit 7 exceed the visit window|0|||
160959439|NCT00428090|581239732|FG000|Overall Study|Medical monitor terminated par.|0|||
160959440|NCT00428090|581239733|FG001|Overall Study|Medical monitor terminated par.|1|||
160959441|NCT00428090|581239734|FG002|Overall Study|Medical monitor terminated par.|0|||
160959442|NCT00428090|581239735|FG003|Overall Study|Medical monitor terminated par.|0|||
160959443|NCT00428090|581239732|FG000|Overall Study|Mental status of par. was|0|||
160959444|NCT00428090|581239733|FG001|Overall Study|Mental status of par. was|1|||
161001987|NCT04956575|581393045|FG001|Overall Study|Withdrawal by Subject|2|||
160959445|NCT00428090|581239734|FG002|Overall Study|Mental status of par. was|0|||
161270678|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Adverse Event|0|||
161270679|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Adverse Event|0|||
161270680|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Adverse Event|0|||
161270681|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Adverse Event|0|||
161270682|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Adverse Event|0|||
161270683|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Adverse Event|0|||
161270684|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Adverse Event|0|||
161270685|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Adverse Event|0|||
161270686|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Adverse Event|0|||
161270687|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Adverse Event|0|||
161270688|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Adverse Event|0|||
161270689|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Adverse Event|0|||
161270690|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Adverse Event|0|||
161270691|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Adverse Event|0|||
161270692|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Adverse Event|0|||
161270693|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Adverse Event|0|||
161001988|NCT04956575|581393046|FG002|Overall Study|Withdrawal by Subject|1|||
161001989|NCT04956575|581393047|FG003|Overall Study|Withdrawal by Subject|4|||
161001990|NCT04956575|581393048|FG004|Overall Study|Withdrawal by Subject|2|||
161001991|NCT04956575|581393049|FG005|Overall Study|Withdrawal by Subject|8|||
161001992|NCT04956575|581393050|FG006|Overall Study|Withdrawal by Subject|5|||
161001993|NCT04956575|581393051|FG007|Overall Study|Withdrawal by Subject|1|||
161001994|NCT04956575|581393052|FG008|Overall Study|Withdrawal by Subject|1|||
161001995|NCT04956575|581393053|FG009|Overall Study|Withdrawal by Subject|0|||
161001996|NCT04956575|581393054|FG010|Overall Study|Withdrawal by Subject|3|||
161001997|NCT04956575|581393055|FG011|Overall Study|Withdrawal by Subject|1|||
161001998|NCT00854906|581393056|FG000|Overall Study|One person had no ocular history|1|||
161270694|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Adverse Event|0|||
161270695|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Adverse Event|0|||
161270696|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Adverse Event|0|||
161270697|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Adverse Event|0|||
161270698|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Adverse Event|1|||
161270699|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Adverse Event|0|||
161270700|NCT02393248|582372727|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270701|NCT02393248|582372728|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270702|NCT02393248|582372729|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270703|NCT02393248|582372730|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270704|NCT02393248|582372731|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270705|NCT02393248|582372732|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270706|NCT02393248|582372733|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270707|NCT02393248|582372734|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270708|NCT02393248|582372735|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270709|NCT02393248|582372736|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270710|NCT02393248|582372737|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270711|NCT02393248|582372738|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270712|NCT02393248|582372739|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270713|NCT02393248|582372740|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270714|NCT02393248|582372741|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161001999|NCT05526248|581393057|FG000|Overall Study|Lost to Follow-up|1|||
161002000|NCT05526248|581393057|FG000|Overall Study|Adverse Event|2|||
161002001|NCT05526248|581393057|FG000|Overall Study|Withdrawal by Subject|1|||
161270715|NCT02393248|582372742|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270716|NCT02393248|582372743|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270717|NCT02393248|582372744|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270718|NCT02393248|582372745|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270719|NCT02393248|582372746|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270720|NCT02393248|582372747|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270721|NCT02393248|582372748|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270722|NCT02393248|582372749|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270723|NCT02393248|582372750|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
161146871|NCT02050048|581919916|FG000|Overall Study|Death|1|||
161343480|NCT03965923|582644398|FG008|Overall Study|Lost to Follow-up|0|||
161343481|NCT03965923|582644399|FG009|Overall Study|Lost to Follow-up|2|||
161270724|NCT02393248|582372751|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
161270725|NCT02585934|582372752|FG000|Overall Study|Lost to Follow-up|2|||
161002002|NCT02459899|581393063|FG000|Overall Study|Adverse Event|1|||
161002003|NCT02459899|581393064|FG001|Overall Study|Adverse Event|1|||
161002004|NCT02459899|581393065|FG002|Overall Study|Adverse Event|0|||
161270726|NCT02585934|582372753|FG001|Overall Study|Lost to Follow-up|2|||
161270727|NCT02585934|582372752|FG000|Overall Study|Protocol Violation|14|||
161270728|NCT02585934|582372753|FG001|Overall Study|Protocol Violation|11|||
161270729|NCT02585934|582372752|FG000|Overall Study|Adverse Event|21|||
161270730|NCT02585934|582372753|FG001|Overall Study|Adverse Event|22|||
161270731|NCT02585934|582372752|FG000|Overall Study|Physician Decision|3|||
160959446|NCT00428090|581239735|FG003|Overall Study|Mental status of par. was|0|||
160959447|NCT00428090|581239732|FG000|Overall Study|Worsening of AD|0|||
160959448|NCT00428090|581239733|FG001|Overall Study|Worsening of AD|0|||
160959449|NCT00428090|581239734|FG002|Overall Study|Worsening of AD|1|||
160959450|NCT00428090|581239735|FG003|Overall Study|Worsening of AD|0|||
160959451|NCT00428090|581239732|FG000|Overall Study|Excluded for concerning QTc value|0|||
160959452|NCT00428090|581239733|FG001|Overall Study|Excluded for concerning QTc value|0|||
160959453|NCT00428090|581239734|FG002|Overall Study|Excluded for concerning QTc value|1|||
160959454|NCT00428090|581239735|FG003|Overall Study|Excluded for concerning QTc value|0|||
160959455|NCT00428090|581239732|FG000|Overall Study|Insufficient AD documentation|0|||
160959456|NCT00428090|581239733|FG001|Overall Study|Insufficient AD documentation|0|||
160959457|NCT00428090|581239734|FG002|Overall Study|Insufficient AD documentation|1|||
160959458|NCT00428090|581239735|FG003|Overall Study|Insufficient AD documentation|0|||
160959459|NCT00428090|581239732|FG000|Overall Study|High MMSE scores|0|||
160959460|NCT00428090|581239733|FG001|Overall Study|High MMSE scores|0|||
160959461|NCT00428090|581239734|FG002|Overall Study|High MMSE scores|1|||
160959462|NCT00428090|581239735|FG003|Overall Study|High MMSE scores|0|||
160959463|NCT00428090|581239732|FG000|Overall Study|Deterioration of cognitive status|0|||
160959464|NCT00428090|581239733|FG001|Overall Study|Deterioration of cognitive status|0|||
160959465|NCT00428090|581239734|FG002|Overall Study|Deterioration of cognitive status|1|||
160959466|NCT00428090|581239735|FG003|Overall Study|Deterioration of cognitive status|0|||
160959467|NCT00428090|581239732|FG000|Overall Study|Serious adverse event|0|||
160959468|NCT00428090|581239733|FG001|Overall Study|Serious adverse event|0|||
160959469|NCT00428090|581239734|FG002|Overall Study|Serious adverse event|1|||
160959470|NCT00428090|581239735|FG003|Overall Study|Serious adverse event|0|||
160959471|NCT00428090|581239732|FG000|Overall Study|Excluded for heart insufficiency|0|||
160959472|NCT00428090|581239733|FG001|Overall Study|Excluded for heart insufficiency|0|||
160959473|NCT00428090|581239734|FG002|Overall Study|Excluded for heart insufficiency|1|||
160959474|NCT00428090|581239735|FG003|Overall Study|Excluded for heart insufficiency|0|||
160959475|NCT00428090|581239732|FG000|Overall Study|Raised Creatinine Value|0|||
160959476|NCT00428090|581239733|FG001|Overall Study|Raised Creatinine Value|0|||
160959477|NCT00428090|581239734|FG002|Overall Study|Raised Creatinine Value|0|||
160959478|NCT00428090|581239735|FG003|Overall Study|Raised Creatinine Value|1|||
160959479|NCT03409666|581239736|FG000|Overall Study|Physician Decision|0|||
160959480|NCT03409666|581239737|FG001|Overall Study|Physician Decision|1|||
160959481|NCT03409666|581239736|FG000|Overall Study|Protocol Violation|0|||
160959482|NCT03409666|581239737|FG001|Overall Study|Protocol Violation|3|||
160959483|NCT00512148|581239741|FG000|Primay Study Period|Withdrawal by Subject|1|||
160959484|NCT02623322|581239742|FG000|Overall Study|Lost to Follow-up|2|||
161270732|NCT02585934|582372753|FG001|Overall Study|Physician Decision|2|||
160959485|NCT02623322|581239743|FG001|Overall Study|Lost to Follow-up|1|||
160959486|NCT02623322|581239744|FG002|Overall Study|Lost to Follow-up|0|||
160959487|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
160959488|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
160959489|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
160959490|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
160959491|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
160959492|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
160959493|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
160959494|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
160959495|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
160959496|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
160959497|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
160959498|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
160959499|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Death|6|||
160959500|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Death|3|||
160959501|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Death|0|||
160959502|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Death|1|||
160959503|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Death|1|||
160959504|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Death|0|||
160959505|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
160959506|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
160959507|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
161146872|NCT02050048|581919917|FG001|Overall Study|Death|0|||
160959508|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
161270733|NCT02585934|582372752|FG000|Overall Study|Withdrawal by Subject|7|||
161270734|NCT02585934|582372753|FG001|Overall Study|Withdrawal by Subject|21|||
161270735|NCT02585934|582372752|FG000|Overall Study|Lack of Efficacy|2|||
161270736|NCT02585934|582372753|FG001|Overall Study|Lack of Efficacy|1|||
160959509|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
160959510|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
160959511|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959512|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
160959513|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
160959514|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959515|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959516|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
160959517|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
160959518|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
160959519|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
160959520|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
160959521|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
160959522|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
160959523|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
160959524|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
160959525|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
160959526|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
160959527|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
160959528|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
160959529|NCT03104699|581239745|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
160959530|NCT03104699|581239746|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
160959531|NCT03104699|581239747|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
160959532|NCT03104699|581239748|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
160959533|NCT03104699|581239749|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
160959534|NCT03104699|581239750|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
160959535|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959536|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959537|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959538|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959539|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
160959540|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
160959541|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Death|0|||
160959542|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Death|0|||
160959543|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Death|0|||
160959544|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Death|0|||
160959545|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Death|0|||
160959546|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Death|107|||
160959547|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959548|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959549|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959550|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959551|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
160959552|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
160959553|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959554|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959555|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959556|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959557|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
160959558|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
160959559|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959560|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959561|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959562|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959563|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
160959564|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
160959565|NCT03104699|581239745|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
160959566|NCT03104699|581239746|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
160959567|NCT03104699|581239747|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
160959568|NCT03104699|581239748|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
160959569|NCT03104699|581239749|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
160959570|NCT03104699|581239750|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
160959571|NCT02450331|581239754|FG000|Overall Study|Death|162|||
160959572|NCT02450331|581239755|FG001|Overall Study|Death|171|||
160959573|NCT02450331|581239754|FG000|Overall Study|Lost to Follow-up|14|||
160959574|NCT02450331|581239755|FG001|Overall Study|Lost to Follow-up|12|||
160959575|NCT02450331|581239754|FG000|Overall Study|Withdrawal by Subject|55|||
160959576|NCT02450331|581239755|FG001|Overall Study|Withdrawal by Subject|44|||
160959577|NCT02450331|581239754|FG000|Overall Study|Non-specified other|1|||
160959578|NCT02450331|581239755|FG001|Overall Study|Non-specified other|1|||
160959579|NCT02080871|581239756|FG000|Overall Study|Death|1|||
161270737|NCT02585934|582372752|FG000|Overall Study|Death|2|||
161270738|NCT02585934|582372753|FG001|Overall Study|Death|0|||
161270739|NCT02585934|582372752|FG000|Overall Study|Caregiver Withdrew Consent|7|||
161270740|NCT02585934|582372753|FG001|Overall Study|Caregiver Withdrew Consent|7|||
160959580|NCT02080871|581239756|FG000|Overall Study|Lost to Follow-up|1|||
160959581|NCT01410474|581239757|FG000|Overall Study|Withdrawal by Subject|0|||
161270741|NCT02585934|582372752|FG000|Overall Study|Sponsor Termination|1|||
160959582|NCT01410474|581239758|FG001|Overall Study|Withdrawal by Subject|1|||
160959583|NCT02428296|581239759|FG000|Overall Study|Adverse Event|7|||
160959584|NCT02428296|581239759|FG000|Overall Study|Withdrawal by Subject|2|||
160959585|NCT04493931|581239764|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
160959586|NCT04493931|581239765|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959587|NCT04493931|581239766|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959588|NCT04493931|581239767|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959589|NCT04493931|581239768|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959590|NCT04493931|581239769|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959591|NCT04493931|581239770|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
160959592|NCT04493931|581239764|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959593|NCT04493931|581239765|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
160959594|NCT04493931|581239766|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959595|NCT04493931|581239767|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959596|NCT04493931|581239768|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959597|NCT04493931|581239769|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959598|NCT04493931|581239770|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
160959599|NCT04493931|581239764|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959600|NCT04493931|581239765|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
160959601|NCT04493931|581239766|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959602|NCT04493931|581239767|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959603|NCT04493931|581239768|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959604|NCT04493931|581239769|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959605|NCT04493931|581239770|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
160959606|NCT04493931|581239764|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959607|NCT04493931|581239765|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959608|NCT04493931|581239766|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
160959609|NCT04493931|581239767|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959610|NCT04493931|581239768|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959611|NCT04493931|581239769|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959612|NCT04493931|581239770|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
160959613|NCT03338894|581239771|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
160959614|NCT00420199|581239773|FG000|Overall Study|Participant no longer met study criteria|1|||
160959615|NCT00420199|581239774|FG001|Overall Study|Participant no longer met study criteria|0|||
160959616|NCT00254982|581239785|FG000|Overall Study|Other|2|||
160959617|NCT00254982|581239786|FG001|Overall Study|Other|1|||
160959618|NCT00254982|581239785|FG000|Overall Study|Lack of Efficacy|5|||
160959619|NCT00254982|581239786|FG001|Overall Study|Lack of Efficacy|3|||
160959620|NCT00254982|581239785|FG000|Overall Study|Lost to Follow-up|5|||
160959621|NCT00254982|581239786|FG001|Overall Study|Lost to Follow-up|3|||
160959622|NCT00254982|581239785|FG000|Overall Study|Adverse Event|18|||
160959623|NCT00254982|581239786|FG001|Overall Study|Adverse Event|16|||
160959624|NCT00254982|581239785|FG000|Overall Study|Withdrawal by Subject|1|||
160959625|NCT00254982|581239786|FG001|Overall Study|Withdrawal by Subject|1|||
160959626|NCT00254982|581239785|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
160959627|NCT00254982|581239786|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
160959628|NCT00254982|581239785|FG000|Overall Study|Protocol deviation|1|||
160959629|NCT00254982|581239786|FG001|Overall Study|Protocol deviation|1|||
160959630|NCT00254982|581239785|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
160959631|NCT00254982|581239786|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
160959632|NCT00254982|581239785|FG000|Overall Study|Malignancy|0|||
160959633|NCT00254982|581239786|FG001|Overall Study|Malignancy|2|||
160959634|NCT00254982|581239785|FG000|Overall Study|Opportunistic infection|1|||
160959635|NCT00254982|581239786|FG001|Overall Study|Opportunistic infection|0|||
160959636|NCT00254982|581239785|FG000|Overall Study|Abnormal liver function tests|2|||
160959637|NCT00254982|581239786|FG001|Overall Study|Abnormal liver function tests|1|||
161270742|NCT02585934|582372753|FG001|Overall Study|Sponsor Termination|2|||
161270743|NCT02585934|582372752|FG000|Overall Study|Another Reason|10|||
161270744|NCT02585934|582372753|FG001|Overall Study|Another Reason|5|||
161270745|NCT02603393|582372755|FG000|Overall Study|Patient/guardian decision|32|||
161270746|NCT02603393|582372756|FG001|Overall Study|Patient/guardian decision|18|||
161270747|NCT02603393|582372755|FG000|Overall Study|Adverse Event|17|||
161270748|NCT02603393|582372756|FG001|Overall Study|Adverse Event|15|||
160959638|NCT02261493|581239787|FG000|Overall Study|Noncompliance|0|||
160959639|NCT02261493|581239788|FG001|Overall Study|Noncompliance|0|||
160959640|NCT02261493|581239789|FG002|Overall Study|Noncompliance|2|||
160959641|NCT02261493|581239787|FG000|Overall Study|Physician Decision|0|||
161270749|NCT02603393|582372755|FG000|Overall Study|Technical problems|4|||
161270750|NCT02603393|582372756|FG001|Overall Study|Technical problems|7|||
161270751|NCT02603393|582372755|FG000|Overall Study|Lack of Efficacy|7|||
161270752|NCT02603393|582372756|FG001|Overall Study|Lack of Efficacy|2|||
161270753|NCT02603393|582372755|FG000|Overall Study|Death|3|||
161270754|NCT02603393|582372756|FG001|Overall Study|Death|4|||
161270755|NCT02603393|582372755|FG000|Overall Study|Physician Decision|3|||
161270756|NCT02603393|582372756|FG001|Overall Study|Physician Decision|3|||
161270757|NCT02603393|582372755|FG000|Overall Study|Protocol deviation|2|||
161270758|NCT02603393|582372756|FG001|Overall Study|Protocol deviation|3|||
161270759|NCT02603393|582372755|FG000|Overall Study|Lost to Follow-up|1|||
161270760|NCT02603393|582372756|FG001|Overall Study|Lost to Follow-up|2|||
161270761|NCT02603393|582372755|FG000|Overall Study|Non-compliance with study treatment|1|||
161270762|NCT02603393|582372756|FG001|Overall Study|Non-compliance with study treatment|0|||
161270763|NCT02603393|582372755|FG000|Overall Study|Sponsor decision|1|||
161270764|NCT02603393|582372756|FG001|Overall Study|Sponsor decision|0|||
161270765|NCT04053465|582372758|FG000|Overall Study|Withdrawal by Subject|4|||
161270766|NCT04053465|582372759|FG001|Overall Study|Withdrawal by Subject|4|||
161270767|NCT02085135|582372760|FG000|Overall Study|Adverse Event|4|||
161270768|NCT02085135|582372761|FG001|Overall Study|Adverse Event|7|||
161270769|NCT02085135|582372760|FG000|Overall Study|Lost to Follow-up|2|||
161270770|NCT02085135|582372761|FG001|Overall Study|Lost to Follow-up|2|||
161270771|NCT02085135|582372760|FG000|Overall Study|Withdrawal by Subject|3|||
161270772|NCT02085135|582372761|FG001|Overall Study|Withdrawal by Subject|0|||
161270773|NCT02085135|582372760|FG000|Overall Study|Lack of Efficacy|2|||
161270774|NCT02085135|582372761|FG001|Overall Study|Lack of Efficacy|0|||
161270775|NCT01085734|582372762|FG000|Overall Study|Adverse Event|0|||
161270776|NCT01085734|582372763|FG001|Overall Study|Adverse Event|2|||
161270777|NCT01085734|582372762|FG000|Overall Study|Death|1|||
161270778|NCT01085734|582372763|FG001|Overall Study|Death|0|||
161270779|NCT01085734|582372762|FG000|Overall Study|Lost to Follow-up|0|||
161270780|NCT01085734|582372763|FG001|Overall Study|Lost to Follow-up|1|||
161270781|NCT01085734|582372762|FG000|Overall Study|Withdrawal by Subject|0|||
161270782|NCT01085734|582372763|FG001|Overall Study|Withdrawal by Subject|1|||
161270783|NCT00742924|582372766|FG000|Overall Study|Adverse Event|0|||
161270784|NCT00742924|582372767|FG001|Overall Study|Adverse Event|0|||
161270785|NCT00742924|582372768|FG002|Overall Study|Adverse Event|1|||
161270786|NCT00742924|582372769|FG003|Overall Study|Adverse Event|1|||
161270787|NCT00742924|582372766|FG000|Overall Study|Lack of Efficacy|5|||
161270788|NCT00742924|582372767|FG001|Overall Study|Lack of Efficacy|1|||
161270789|NCT00742924|582372768|FG002|Overall Study|Lack of Efficacy|2|||
161270790|NCT00742924|582372769|FG003|Overall Study|Lack of Efficacy|4|||
161270791|NCT00742924|582372766|FG000|Overall Study|Physician Decision|0|||
161270792|NCT00742924|582372767|FG001|Overall Study|Physician Decision|0|||
161270793|NCT00742924|582372768|FG002|Overall Study|Physician Decision|0|||
161270794|NCT00742924|582372769|FG003|Overall Study|Physician Decision|1|||
161270795|NCT00742924|582372766|FG000|Overall Study|Withdrawal by Subject|0|||
161270796|NCT00742924|582372767|FG001|Overall Study|Withdrawal by Subject|1|||
161270797|NCT00742924|582372768|FG002|Overall Study|Withdrawal by Subject|1|||
161270798|NCT00742924|582372769|FG003|Overall Study|Withdrawal by Subject|0|||
161270799|NCT00660400|582372770|FG000|Overall Study|Lack of insurance approval|1|||
161270800|NCT00660400|582372770|FG000|Overall Study|Suboptimal organ function|1|||
161270801|NCT00660400|582372770|FG000|Overall Study|Intracranial hemorrhage|1|||
161270802|NCT00660400|582372770|FG000|Overall Study|Withdrawal by Subject|1|||
161270803|NCT01161407|582372771|FG000|Overall Study|Protocol Violation|3|||
161270804|NCT01161407|582372772|FG001|Overall Study|Protocol Violation|1|||
161270805|NCT01777620|582372773|FG000|Overall Study|Subject Withdrawal|1|||
161270806|NCT01777620|582372774|FG001|Overall Study|Subject Withdrawal|0|||
161270807|NCT04562155|582372777|FG000|Overall Study|COVID-19 pandemic|0|||
161270808|NCT04562155|582372778|FG001|Overall Study|COVID-19 pandemic|0|||
161270809|NCT04562155|582372779|FG002|Overall Study|COVID-19 pandemic|0|||
161270810|NCT04562155|582372780|FG003|Overall Study|COVID-19 pandemic|1|||
161146873|NCT02050048|581919916|FG000|Overall Study|Ineligible after ERCP|4|||
161270811|NCT04562155|582372777|FG000|Overall Study|Adverse Event|7|||
161270812|NCT04562155|582372778|FG001|Overall Study|Adverse Event|3|||
160959642|NCT02261493|581239788|FG001|Overall Study|Physician Decision|1|||
161270813|NCT04562155|582372779|FG002|Overall Study|Adverse Event|8|||
161270814|NCT04562155|582372780|FG003|Overall Study|Adverse Event|1|||
160959643|NCT02261493|581239789|FG002|Overall Study|Physician Decision|0|||
161270815|NCT04562155|582372777|FG000|Overall Study|Withdrawal by Subject|3|||
161270816|NCT04562155|582372778|FG001|Overall Study|Withdrawal by Subject|6|||
161270817|NCT04562155|582372779|FG002|Overall Study|Withdrawal by Subject|3|||
161270818|NCT04562155|582372780|FG003|Overall Study|Withdrawal by Subject|3|||
161270819|NCT04562155|582372777|FG000|Overall Study|Participant personal reason|1|||
161270820|NCT04562155|582372778|FG001|Overall Study|Participant personal reason|0|||
161343482|NCT03965923|582644400|FG010|Overall Study|Lost to Follow-up|0|||
161270821|NCT04562155|582372779|FG002|Overall Study|Participant personal reason|2|||
161270822|NCT04562155|582372780|FG003|Overall Study|Participant personal reason|1|||
161270823|NCT01755767|582372797|FG000|Overall Study|Progressive Disease|8|||
161270824|NCT01755767|582372798|FG001|Overall Study|Progressive Disease|7|||
161270825|NCT01755767|582372799|FG002|Overall Study|Progressive Disease|91|||
161270826|NCT01755767|582372800|FG003|Overall Study|Progressive Disease|43|||
161270827|NCT01755767|582372797|FG000|Overall Study|Clinical Disease Progression|4|||
161270828|NCT01755767|582372798|FG001|Overall Study|Clinical Disease Progression|2|||
161270829|NCT01755767|582372799|FG002|Overall Study|Clinical Disease Progression|29|||
161270830|NCT01755767|582372800|FG003|Overall Study|Clinical Disease Progression|20|||
161270831|NCT01755767|582372797|FG000|Overall Study|Radiographic Disease Progression|9|||
161270832|NCT01755767|582372798|FG001|Overall Study|Radiographic Disease Progression|4|||
161270833|NCT01755767|582372799|FG002|Overall Study|Radiographic Disease Progression|44|||
161270834|NCT01755767|582372800|FG003|Overall Study|Radiographic Disease Progression|27|||
161270835|NCT01755767|582372797|FG000|Overall Study|Adverse Event|6|||
161270836|NCT01755767|582372798|FG001|Overall Study|Adverse Event|0|||
161270837|NCT01755767|582372799|FG002|Overall Study|Adverse Event|28|||
161270838|NCT01755767|582372800|FG003|Overall Study|Adverse Event|11|||
161270839|NCT01755767|582372797|FG000|Overall Study|Death|1|||
161270840|NCT01755767|582372798|FG001|Overall Study|Death|2|||
161270841|NCT01755767|582372799|FG002|Overall Study|Death|15|||
161270842|NCT01755767|582372800|FG003|Overall Study|Death|4|||
161270843|NCT01755767|582372797|FG000|Overall Study|Subject Decision|0|||
161270844|NCT01755767|582372798|FG001|Overall Study|Subject Decision|0|||
161270845|NCT01755767|582372799|FG002|Overall Study|Subject Decision|10|||
161270846|NCT01755767|582372800|FG003|Overall Study|Subject Decision|3|||
161270847|NCT01755767|582372797|FG000|Overall Study|Withdrawal by Subject|0|||
161270848|NCT01755767|582372798|FG001|Overall Study|Withdrawal by Subject|0|||
161270849|NCT01755767|582372799|FG002|Overall Study|Withdrawal by Subject|2|||
161270850|NCT01755767|582372800|FG003|Overall Study|Withdrawal by Subject|1|||
161270851|NCT01755767|582372797|FG000|Overall Study|Other|0|||
161270852|NCT01755767|582372798|FG001|Overall Study|Other|0|||
161270853|NCT01755767|582372799|FG002|Overall Study|Other|2|||
161270854|NCT01755767|582372800|FG003|Overall Study|Other|3|||
161270855|NCT01755767|582372797|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
161270856|NCT01755767|582372798|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
161270857|NCT01755767|582372799|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
161270858|NCT01755767|582372800|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
161270859|NCT02865460|582372801|FG000|Overall Study|Adverse Event|1|||
161270860|NCT02865460|582372802|FG001|Overall Study|Adverse Event|0|||
161270861|NCT02865460|582372801|FG000|Overall Study|Withdrawal by Subject|1|||
161270862|NCT02865460|582372802|FG001|Overall Study|Withdrawal by Subject|1|||
161270863|NCT02865460|582372801|FG000|Overall Study|Lost to Follow-up|7|||
161270864|NCT02865460|582372802|FG001|Overall Study|Lost to Follow-up|4|||
161270865|NCT02865460|582372801|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
161270866|NCT02865460|582372802|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
161270867|NCT00901576|582372803|FG000|Second Intervention|Withdrawal by Subject|0|||
161270868|NCT00901576|582372804|FG001|Second Intervention|Withdrawal by Subject|0|||
161270869|NCT00901576|582372805|FG002|Second Intervention|Withdrawal by Subject|0|||
161270870|NCT00901576|582372806|FG003|Second Intervention|Withdrawal by Subject|1|||
161270871|NCT00901576|582372807|FG004|Second Intervention|Withdrawal by Subject|0|||
161270872|NCT00901576|582372808|FG005|Second Intervention|Withdrawal by Subject|1|||
161270873|NCT00901576|582372803|FG000|Second Intervention|Physician Decision|1|||
161270874|NCT00901576|582372804|FG001|Second Intervention|Physician Decision|0|||
161270875|NCT00901576|582372805|FG002|Second Intervention|Physician Decision|0|||
161270876|NCT00901576|582372806|FG003|Second Intervention|Physician Decision|0|||
161270877|NCT00901576|582372807|FG004|Second Intervention|Physician Decision|0|||
161270878|NCT00901576|582372808|FG005|Second Intervention|Physician Decision|0|||
160959644|NCT02261493|581239787|FG000|Overall Study|Undisclosed alcohol abuse|0|||
160959645|NCT02261493|581239788|FG001|Overall Study|Undisclosed alcohol abuse|1|||
160959646|NCT02261493|581239789|FG002|Overall Study|Undisclosed alcohol abuse|0|||
160959647|NCT02261493|581239787|FG000|Overall Study|Protocol Violation|1|||
161270879|NCT01696279|582372809|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
161270880|NCT01696279|582372810|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161270881|NCT01696279|582372811|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161270882|NCT01696279|582372812|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
161270883|NCT01696279|582372809|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161270884|NCT01696279|582372810|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
161270885|NCT01696279|582372811|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161270886|NCT01696279|582372812|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
161270887|NCT01696279|582372809|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161270888|NCT01696279|582372810|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
161270889|NCT01696279|582372811|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161270890|NCT01696279|582372812|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
161270891|NCT01696279|582372809|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161270892|NCT01696279|582372810|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
161270893|NCT01696279|582372811|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161270894|NCT01696279|582372812|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
161270895|NCT01696279|582372809|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161270896|NCT01696279|582372810|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
161270897|NCT01696279|582372811|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161270898|NCT01696279|582372812|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
161270899|NCT01696279|582372809|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161270900|NCT01696279|582372810|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
161270901|NCT01696279|582372811|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161270902|NCT01696279|582372812|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
161270903|NCT01696279|582372809|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161270904|NCT01696279|582372810|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
161270905|NCT01696279|582372811|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161270906|NCT01696279|582372812|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
161270907|NCT01696279|582372809|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161270908|NCT01696279|582372810|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
161270909|NCT01696279|582372811|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
161270910|NCT01696279|582372812|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
160959648|NCT02261493|581239788|FG001|Overall Study|Protocol Violation|0|||
160959649|NCT02261493|581239789|FG002|Overall Study|Protocol Violation|0|||
160959650|NCT02261493|581239787|FG000|Overall Study|Personal Reasons|14|||
160959651|NCT02261493|581239788|FG001|Overall Study|Personal Reasons|14|||
160959652|NCT02261493|581239789|FG002|Overall Study|Personal Reasons|16|||
160959653|NCT02261493|581239787|FG000|Overall Study|Lost to Follow-up|14|||
160959654|NCT02261493|581239788|FG001|Overall Study|Lost to Follow-up|27|||
160959655|NCT02261493|581239789|FG002|Overall Study|Lost to Follow-up|8|||
160959656|NCT02261493|581239787|FG000|Overall Study|Pregnancy|1|||
160959657|NCT02261493|581239788|FG001|Overall Study|Pregnancy|2|||
160959658|NCT02261493|581239789|FG002|Overall Study|Pregnancy|0|||
160959659|NCT02261493|581239787|FG000|Overall Study|Lack of Efficacy|0|||
160959660|NCT02261493|581239788|FG001|Overall Study|Lack of Efficacy|1|||
160959661|NCT02261493|581239789|FG002|Overall Study|Lack of Efficacy|0|||
160959662|NCT02261493|581239787|FG000|Overall Study|Adverse Event|0|||
160959663|NCT02261493|581239788|FG001|Overall Study|Adverse Event|1|||
160959664|NCT02261493|581239789|FG002|Overall Study|Adverse Event|0|||
160959665|NCT00558428|581239790|FG000|Overall Study|Adverse Event|6|||
160959666|NCT00558428|581239791|FG001|Overall Study|Adverse Event|22|||
160959667|NCT00558428|581239792|FG002|Overall Study|Adverse Event|3|||
160959668|NCT00558428|581239793|FG003|Overall Study|Adverse Event|4|||
160959669|NCT00558428|581239790|FG000|Overall Study|Lost to Follow-up|0|||
160959670|NCT00558428|581239791|FG001|Overall Study|Lost to Follow-up|1|||
160959671|NCT00558428|581239792|FG002|Overall Study|Lost to Follow-up|0|||
160959672|NCT00558428|581239793|FG003|Overall Study|Lost to Follow-up|0|||
160959673|NCT00558428|581239790|FG000|Overall Study|Lack of Efficacy|0|||
160959674|NCT00558428|581239791|FG001|Overall Study|Lack of Efficacy|0|||
160959675|NCT00558428|581239792|FG002|Overall Study|Lack of Efficacy|1|||
160959676|NCT00558428|581239793|FG003|Overall Study|Lack of Efficacy|2|||
160959677|NCT00558428|581239790|FG000|Overall Study|Non compliant with protocol|1|||
160959678|NCT00558428|581239791|FG001|Overall Study|Non compliant with protocol|0|||
160959679|NCT00558428|581239792|FG002|Overall Study|Non compliant with protocol|0|||
160959680|NCT00558428|581239793|FG003|Overall Study|Non compliant with protocol|3|||
160959681|NCT00558428|581239790|FG000|Overall Study|Consent withdrawn|2|||
160959682|NCT00558428|581239791|FG001|Overall Study|Consent withdrawn|1|||
160959683|NCT00558428|581239792|FG002|Overall Study|Consent withdrawn|0|||
160959684|NCT00558428|581239793|FG003|Overall Study|Consent withdrawn|1|||
160959685|NCT00558428|581239790|FG000|Overall Study|Other|3|||
160959686|NCT00558428|581239791|FG001|Overall Study|Other|0|||
160959687|NCT00558428|581239792|FG002|Overall Study|Other|0|||
160959688|NCT00558428|581239793|FG003|Overall Study|Other|1|||
160959689|NCT02570126|581239794|FG000|Overall Study|Lost to Follow-up|2|||
160959690|NCT02570126|581239795|FG001|Overall Study|Lost to Follow-up|0|||
160959691|NCT02570126|581239794|FG000|Overall Study|Unable To Arrange Visit 3|1|||
161146874|NCT02050048|581919917|FG001|Overall Study|Ineligible after ERCP|1|||
161146875|NCT03067311|581919919|FG000|Overall Study|Lost to Follow-up|1|||
160959692|NCT02570126|581239795|FG001|Overall Study|Unable To Arrange Visit 3|0|||
161146876|NCT03067311|581919920|FG001|Overall Study|Lost to Follow-up|1|||
161270911|NCT01696279|582372809|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
160959693|NCT02570126|581239794|FG000|Overall Study|Violation Of Procedures GSK|0|||
160959694|NCT02570126|581239795|FG001|Overall Study|Violation Of Procedures GSK|1|||
160959695|NCT02570126|581239794|FG000|Overall Study|Protocol Violation|0|||
160959696|NCT02570126|581239795|FG001|Overall Study|Protocol Violation|1|||
160959697|NCT02570126|581239794|FG000|Overall Study|Withdrawal by Subject|3|||
160959698|NCT02570126|581239795|FG001|Overall Study|Withdrawal by Subject|7|||
160959699|NCT00626028|581239796|FG000|Overall Study|Adverse Event|1|||
160959700|NCT00626028|581239797|FG001|Overall Study|Adverse Event|1|||
160959701|NCT00626028|581239796|FG000|Overall Study|Device Failure|0|||
160959702|NCT00626028|581239797|FG001|Overall Study|Device Failure|1|||
160959703|NCT00626028|581239796|FG000|Overall Study|Physician Decision|2|||
160959704|NCT00626028|581239797|FG001|Overall Study|Physician Decision|1|||
160959705|NCT00626028|581239796|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
160959706|NCT00626028|581239797|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
160959707|NCT05224050|581239798|FG000|Overall Study|Withdrawal by Subject|9|||
160959708|NCT05224050|581239798|FG000|Overall Study|Lost to Follow-up|3|||
160959709|NCT00917579|581239800|FG000|Washout >= 2 Weeks|Adverse Event|1|||
160959710|NCT00917579|581239801|FG001|Washout >= 2 Weeks|Adverse Event|0|||
160959711|NCT00917579|581239800|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
160959712|NCT00917579|581239801|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
160959713|NCT00754338|581239802|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959714|NCT00754338|581239803|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
160959715|NCT00754338|581239804|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
160959716|NCT00754338|581239805|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959717|NCT00754338|581239802|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959718|NCT00754338|581239803|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
160959719|NCT00754338|581239804|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
160959720|NCT00754338|581239805|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
160959721|NCT00831779|581239808|FG000|Overall Study|Lost to Follow-up|1|||
160959722|NCT00831779|581239809|FG001|Overall Study|Lost to Follow-up|0|||
160959723|NCT00831779|581239808|FG000|Overall Study|No longer met criteria|0|||
160959724|NCT00831779|581239809|FG001|Overall Study|No longer met criteria|1|||
160959725|NCT04020341|581239810|FG000|Overall Study|Adverse Event|8|||
160959726|NCT04020341|581239811|FG001|Overall Study|Adverse Event|6|||
160959727|NCT04020341|581239810|FG000|Overall Study|Lost to Follow-up|8|||
160959728|NCT04020341|581239811|FG001|Overall Study|Lost to Follow-up|2|||
160959729|NCT04020341|581239810|FG000|Overall Study|Withdrawal by Subject|16|||
160959730|NCT04020341|581239811|FG001|Overall Study|Withdrawal by Subject|16|||
160959731|NCT04020341|581239810|FG000|Overall Study|Participant not able to swallow the tablet|1|||
160959732|NCT04020341|581239811|FG001|Overall Study|Participant not able to swallow the tablet|0|||
160959733|NCT04020341|581239810|FG000|Overall Study|Physician Decision|0|||
160959734|NCT04020341|581239811|FG001|Overall Study|Physician Decision|2|||
160959735|NCT04020341|581239810|FG000|Overall Study|Protocol Deviation|0|||
160959736|NCT04020341|581239811|FG001|Overall Study|Protocol Deviation|2|||
160959737|NCT04528069|581239812|FG000|Overall Study|Adverse Event|1|||
160959738|NCT04528069|581239812|FG000|Overall Study|Lost to Follow-up|1|||
160959739|NCT04528069|581239812|FG000|Overall Study|Patient Unable to Come|1|||
160959740|NCT04528069|581239812|FG000|Overall Study|Patient Unable to Attend|1|||
160959741|NCT01814371|581239814|FG000|Overall Study|Lost to Follow-up|30|||
160959742|NCT01814371|581239815|FG001|Overall Study|Lost to Follow-up|27|||
160959743|NCT04683926|581239816|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
160959744|NCT04683926|581239817|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
160959745|NCT04683926|581239818|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
160959746|NCT04683926|581239819|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
160959747|NCT01692782|581239821|FG000|Overall Study|Adverse Event|12|||
160959748|NCT01692782|581239822|FG001|Overall Study|Adverse Event|32|||
160959749|NCT01692782|581239823|FG002|Overall Study|Adverse Event|2|||
160959750|NCT01692782|581239821|FG000|Overall Study|Lack of Efficacy|1|||
160959751|NCT01692782|581239822|FG001|Overall Study|Lack of Efficacy|2|||
160959752|NCT01692782|581239823|FG002|Overall Study|Lack of Efficacy|0|||
160959753|NCT01692782|581239821|FG000|Overall Study|Lost to Follow-up|2|||
160959754|NCT01692782|581239822|FG001|Overall Study|Lost to Follow-up|7|||
160959755|NCT01692782|581239823|FG002|Overall Study|Lost to Follow-up|1|||
160959756|NCT01692782|581239821|FG000|Overall Study|Pregnancy|1|||
160959757|NCT01692782|581239822|FG001|Overall Study|Pregnancy|0|||
160959758|NCT01692782|581239823|FG002|Overall Study|Pregnancy|0|||
160959759|NCT01692782|581239821|FG000|Overall Study|Protocol Violation|1|||
160959760|NCT01692782|581239822|FG001|Overall Study|Protocol Violation|0|||
160959761|NCT01692782|581239823|FG002|Overall Study|Protocol Violation|2|||
160959762|NCT01692782|581239821|FG000|Overall Study|Non-complance with study drug|0|||
160959763|NCT01692782|581239822|FG001|Overall Study|Non-complance with study drug|4|||
160959764|NCT01692782|581239823|FG002|Overall Study|Non-complance with study drug|1|||
160959765|NCT01692782|581239821|FG000|Overall Study|Non-compliant with study visits|0|||
160959766|NCT01692782|581239822|FG001|Overall Study|Non-compliant with study visits|0|||
160959767|NCT01692782|581239823|FG002|Overall Study|Non-compliant with study visits|1|||
160959768|NCT01692782|581239821|FG000|Overall Study|SAE not related to study drug|0|||
160959769|NCT01692782|581239822|FG001|Overall Study|SAE not related to study drug|1|||
160959770|NCT01692782|581239823|FG002|Overall Study|SAE not related to study drug|0|||
160959771|NCT01692782|581239821|FG000|Overall Study|Withdrawal by Subject|3|||
160959772|NCT01692782|581239822|FG001|Overall Study|Withdrawal by Subject|10|||
160959773|NCT01692782|581239823|FG002|Overall Study|Withdrawal by Subject|3|||
160959774|NCT00911534|581239832|FG000|Overall Study|Adverse Event|4|||
160959775|NCT00911534|581239833|FG001|Overall Study|Adverse Event|4|||
160959776|NCT00911534|581239832|FG000|Overall Study|Lost to Follow-up|2|||
160959777|NCT00911534|581239833|FG001|Overall Study|Lost to Follow-up|4|||
160959778|NCT00911534|581239832|FG000|Overall Study|Withdrawal by Subject|2|||
160959779|NCT00911534|581239833|FG001|Overall Study|Withdrawal by Subject|1|||
160959780|NCT00911534|581239832|FG000|Overall Study|Lack of Efficacy|4|||
160959781|NCT00911534|581239833|FG001|Overall Study|Lack of Efficacy|1|||
160959782|NCT00911534|581239832|FG000|Overall Study|Withdrawal of consent|1|||
160959783|NCT00911534|581239833|FG001|Overall Study|Withdrawal of consent|4|||
160959784|NCT00911534|581239832|FG000|Overall Study|Other|2|||
160959785|NCT00911534|581239833|FG001|Overall Study|Other|2|||
160959786|NCT05072080|581239837|FG000|Overall Study|Death|0|||
160959787|NCT05072080|581239838|FG001|Overall Study|Death|0|||
160959788|NCT05072080|581239839|FG002|Overall Study|Death|1|||
160959789|NCT05072080|581239840|FG003|Overall Study|Death|0|||
160959790|NCT05072080|581239837|FG000|Overall Study|Lost to Follow-up|65|||
160959791|NCT05072080|581239838|FG001|Overall Study|Lost to Follow-up|70|||
160959792|NCT05072080|581239839|FG002|Overall Study|Lost to Follow-up|58|||
160959793|NCT05072080|581239840|FG003|Overall Study|Lost to Follow-up|23|||
160959794|NCT05072080|581239837|FG000|Overall Study|Physician Decision|2|||
160959795|NCT05072080|581239838|FG001|Overall Study|Physician Decision|1|||
160959796|NCT05072080|581239839|FG002|Overall Study|Physician Decision|1|||
160959797|NCT05072080|581239840|FG003|Overall Study|Physician Decision|0|||
160959798|NCT05072080|581239837|FG000|Overall Study|Withdrawal by Subject|45|||
160959799|NCT05072080|581239838|FG001|Overall Study|Withdrawal by Subject|30|||
160959800|NCT05072080|581239839|FG002|Overall Study|Withdrawal by Subject|27|||
160959801|NCT05072080|581239840|FG003|Overall Study|Withdrawal by Subject|7|||
160959802|NCT05072080|581239837|FG000|Overall Study|Sponsor Decision|0|||
160959803|NCT05072080|581239838|FG001|Overall Study|Sponsor Decision|1|||
160959804|NCT05072080|581239839|FG002|Overall Study|Sponsor Decision|0|||
160959805|NCT05072080|581239840|FG003|Overall Study|Sponsor Decision|0|||
160959806|NCT05072080|581239837|FG000|Overall Study|Subject moved|1|||
160959807|NCT05072080|581239838|FG001|Overall Study|Subject moved|3|||
160959808|NCT05072080|581239839|FG002|Overall Study|Subject moved|5|||
160959809|NCT05072080|581239840|FG003|Overall Study|Subject moved|2|||
160959810|NCT05072080|581239837|FG000|Overall Study|Withdrawal by parent|0|||
160959811|NCT05072080|581239838|FG001|Overall Study|Withdrawal by parent|0|||
160959812|NCT05072080|581239839|FG002|Overall Study|Withdrawal by parent|1|||
160959813|NCT05072080|581239840|FG003|Overall Study|Withdrawal by parent|0|||
160959814|NCT05072080|581239837|FG000|Overall Study|Subject was deployed|0|||
160959815|NCT05072080|581239838|FG001|Overall Study|Subject was deployed|1|||
160959816|NCT05072080|581239839|FG002|Overall Study|Subject was deployed|0|||
160959817|NCT05072080|581239840|FG003|Overall Study|Subject was deployed|0|||
160959818|NCT05072080|581239837|FG000|Overall Study|Subject left site without receiving dose|0|||
160959819|NCT05072080|581239838|FG001|Overall Study|Subject left site without receiving dose|1|||
160959820|NCT05072080|581239839|FG002|Overall Study|Subject left site without receiving dose|0|||
160959821|NCT05072080|581239840|FG003|Overall Study|Subject left site without receiving dose|0|||
160959822|NCT05072080|581239837|FG000|Overall Study|Subject incarcerated|0|||
160959823|NCT05072080|581239838|FG001|Overall Study|Subject incarcerated|1|||
160959824|NCT05072080|581239839|FG002|Overall Study|Subject incarcerated|0|||
160959825|NCT05072080|581239840|FG003|Overall Study|Subject incarcerated|1|||
160959826|NCT05072080|581239837|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
160959827|NCT05072080|581239838|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
160959828|NCT05072080|581239839|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
160959829|NCT05072080|581239840|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
160959830|NCT05072080|581239837|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
160959831|NCT05072080|581239838|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
160959832|NCT05072080|581239839|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
160959833|NCT05072080|581239840|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
160959834|NCT02747238|581239841|FG000|Overall Study|Lack of Efficacy|0|||
160959835|NCT02747238|581239842|FG001|Overall Study|Lack of Efficacy|1|||
160959836|NCT02747238|581239841|FG000|Overall Study|Data lost|3|||
160959837|NCT02747238|581239842|FG001|Overall Study|Data lost|5|||
160959838|NCT03776136|581239844|FG000|Overall Study|Death|85|||
160959839|NCT03776136|581239844|FG000|Overall Study|Withdrawal by Subject|3|||
160959840|NCT03776136|581239844|FG000|Overall Study|Sponsor Decision|15|||
160959841|NCT00680407|581239854|FG000|Overall Study|Lost to Follow-up|3|||
160959842|NCT00680407|581239855|FG001|Overall Study|Lost to Follow-up|3|||
160959843|NCT00680407|581239856|FG002|Overall Study|Lost to Follow-up|1|||
160959844|NCT00680407|581239854|FG000|Overall Study|Withdrawal by Subject|5|||
160959845|NCT00680407|581239855|FG001|Overall Study|Withdrawal by Subject|2|||
160959846|NCT00680407|581239856|FG002|Overall Study|Withdrawal by Subject|2|||
160959847|NCT01377480|581242131|FG000|Overall Study|Protocol Violation|0|||
160959848|NCT01377480|581242132|FG001|Overall Study|Protocol Violation|0|||
160959849|NCT01377480|581242133|FG002|Overall Study|Protocol Violation|0|||
160959850|NCT01377480|581242134|FG003|Overall Study|Protocol Violation|4|||
160959851|NCT01377480|581242131|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
160959852|NCT01377480|581242132|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
160959853|NCT01377480|581242133|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
160959854|NCT01377480|581242134|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
160959855|NCT01377480|581242131|FG000|Overall Study|Withdrawal by Subject|0|||
160959856|NCT01377480|581242132|FG001|Overall Study|Withdrawal by Subject|0|||
160959857|NCT01377480|581242133|FG002|Overall Study|Withdrawal by Subject|1|||
160959858|NCT01377480|581242134|FG003|Overall Study|Withdrawal by Subject|0|||
160959859|NCT01377480|581242131|FG000|Overall Study|Serious adverse event|0|||
160959860|NCT01377480|581242132|FG001|Overall Study|Serious adverse event|0|||
160959861|NCT01377480|581242133|FG002|Overall Study|Serious adverse event|1|||
160959862|NCT01377480|581242134|FG003|Overall Study|Serious adverse event|1|||
160959863|NCT01377480|581242131|FG000|Overall Study|Other|0|||
160959864|NCT01377480|581242132|FG001|Overall Study|Other|0|||
160959865|NCT01377480|581242133|FG002|Overall Study|Other|7|||
160959866|NCT01377480|581242134|FG003|Overall Study|Other|6|||
160959867|NCT01735201|581242138|FG000|Overall Study|Adverse Event|1|||
160959868|NCT01735201|581242139|FG001|Overall Study|Adverse Event|1|||
160959869|NCT01735201|581242140|FG002|Overall Study|Adverse Event|0|||
160959870|NCT01735201|581242141|FG003|Overall Study|Adverse Event|1|||
160959871|NCT01735201|581242142|FG004|Overall Study|Adverse Event|1|||
160959872|NCT01735201|581242143|FG005|Overall Study|Adverse Event|3|||
160959873|NCT01735201|581242144|FG006|Overall Study|Adverse Event|2|||
160959874|NCT01735201|581242145|FG007|Overall Study|Adverse Event|1|||
160959875|NCT01735201|581242138|FG000|Overall Study|Personal Reasons|1|||
160959876|NCT01735201|581242139|FG001|Overall Study|Personal Reasons|0|||
160959877|NCT01735201|581242140|FG002|Overall Study|Personal Reasons|0|||
160959878|NCT01735201|581242141|FG003|Overall Study|Personal Reasons|0|||
160959879|NCT01735201|581242142|FG004|Overall Study|Personal Reasons|0|||
160959880|NCT01735201|581242143|FG005|Overall Study|Personal Reasons|0|||
160959881|NCT01735201|581242144|FG006|Overall Study|Personal Reasons|0|||
160959882|NCT01735201|581242145|FG007|Overall Study|Personal Reasons|0|||
160959883|NCT01735201|581242138|FG000|Overall Study|Protocol Violation|1|||
160959884|NCT01735201|581242139|FG001|Overall Study|Protocol Violation|0|||
160959885|NCT01735201|581242140|FG002|Overall Study|Protocol Violation|0|||
160959886|NCT01735201|581242141|FG003|Overall Study|Protocol Violation|0|||
161343483|NCT03965923|582644401|FG011|Overall Study|Lost to Follow-up|0|||
161343484|NCT03965923|582644390|FG000|Overall Study|Death|0|||
160959887|NCT01735201|581242142|FG004|Overall Study|Protocol Violation|0|||
160959888|NCT01735201|581242143|FG005|Overall Study|Protocol Violation|0|||
160959889|NCT01735201|581242144|FG006|Overall Study|Protocol Violation|0|||
160959890|NCT01735201|581242145|FG007|Overall Study|Protocol Violation|0|||
160959891|NCT01735201|581242138|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160959892|NCT01735201|581242139|FG001|Overall Study|Other Miscellaneous Reasons|0|||
160959893|NCT01735201|581242140|FG002|Overall Study|Other Miscellaneous Reasons|0|||
160959894|NCT01735201|581242141|FG003|Overall Study|Other Miscellaneous Reasons|1|||
160959895|NCT01735201|581242142|FG004|Overall Study|Other Miscellaneous Reasons|0|||
160959896|NCT01735201|581242143|FG005|Overall Study|Other Miscellaneous Reasons|2|||
160959897|NCT01735201|581242144|FG006|Overall Study|Other Miscellaneous Reasons|1|||
160959898|NCT01735201|581242145|FG007|Overall Study|Other Miscellaneous Reasons|1|||
160959899|NCT02178059|581242151|FG000|Washout|Physician Decision|1|||
160959900|NCT02178059|581242152|FG001|Washout|Physician Decision|0|||
160959901|NCT04128293|581242153|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959902|NCT04128293|581242154|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959903|NCT04128293|581242155|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959904|NCT04128293|581242156|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
160959905|NCT04098406|581242160|FG000|Overall Study|Adverse Event|2|||
160959906|NCT04098406|581242161|FG001|Overall Study|Adverse Event|1|||
160959907|NCT04098406|581242160|FG000|Overall Study|Withdrawal by Subject|1|||
160959908|NCT04098406|581242161|FG001|Overall Study|Withdrawal by Subject|0|||
160959909|NCT00514943|581242162|FG000|Stage 1|Progressive disease|4|||
160959910|NCT00514943|581242163|FG001|Stage 1|Progressive disease|8|||
160959911|NCT00514943|581242162|FG000|Stage 1|Other Adverse Event|16|||
161343485|NCT03965923|582644391|FG001|Overall Study|Death|0|||
160959912|NCT00514943|581242163|FG001|Stage 1|Other Adverse Event|6|||
160959913|NCT00514943|581242162|FG000|Stage 1|Not treated|1|||
160959914|NCT00514943|581242163|FG001|Stage 1|Not treated|2|||
160959915|NCT00514943|581242162|FG000|Stage 1|Patient refused to continue study meds|8|||
160959916|NCT00514943|581242163|FG001|Stage 1|Patient refused to continue study meds|3|||
160959917|NCT00514943|581242162|FG000|Stage 1|Other than stated above|1|||
160959918|NCT00514943|581242163|FG001|Stage 1|Other than stated above|7|||
160959919|NCT00514943|581242162|FG000|Stage 2|Progressive disease|27|||
160959920|NCT00514943|581242163|FG001|Stage 2|Progressive disease|24|||
160959921|NCT00514943|581242162|FG000|Stage 2|Other Adverse Event|3|||
160959922|NCT00514943|581242163|FG001|Stage 2|Other Adverse Event|10|||
160959923|NCT00514943|581242162|FG000|Stage 2|Patient refused to continue study meds|2|||
160959924|NCT00514943|581242163|FG001|Stage 2|Patient refused to continue study meds|0|||
161343486|NCT03965923|582644392|FG002|Overall Study|Death|0|||
160959925|NCT00514943|581242162|FG000|Stage 2|Other than stated above|0|||
160959926|NCT00514943|581242163|FG001|Stage 2|Other than stated above|2|||
160959927|NCT00499031|581242164|FG000|Overall Study|Improper pre-protocol treatment|1|||
160959928|NCT00499031|581242164|FG000|Overall Study|Required test not done|1|||
160959929|NCT00499031|581242164|FG000|Overall Study|Never treated|1|||
160959930|NCT02001194|581242166|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
160959931|NCT02001194|581242167|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
160959932|NCT02001194|581242168|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
160959933|NCT02001194|581242169|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
160959934|NCT02001194|581242166|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
160959935|NCT02001194|581242167|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
160959936|NCT02001194|581242168|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
160959937|NCT02001194|581242169|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
160959938|NCT02366910|581242170|FG000|Overall Study|Withdrawal by Subject|2|||
160959939|NCT02366910|581242170|FG000|Overall Study|Screen Failure|3|||
160959940|NCT03284788|581242171|FG000|Overall Study|Withdrawal by Subject|2|||
160959941|NCT01786512|581242172|FG000|Overall Study|Lost to Follow-up|0|||
160959942|NCT01786512|581242173|FG001|Overall Study|Lost to Follow-up|0|||
160959943|NCT01786512|581242174|FG002|Overall Study|Lost to Follow-up|0|||
160959944|NCT01786512|581242175|FG003|Overall Study|Lost to Follow-up|0|||
160959945|NCT01786512|581242176|FG004|Overall Study|Lost to Follow-up|0|||
160959946|NCT01786512|581242177|FG005|Overall Study|Lost to Follow-up|0|||
160959947|NCT01786512|581242178|FG006|Overall Study|Lost to Follow-up|0|||
160959948|NCT01786512|581242179|FG007|Overall Study|Lost to Follow-up|0|||
160959949|NCT01786512|581242180|FG008|Overall Study|Lost to Follow-up|0|||
160959950|NCT01786512|581242181|FG009|Overall Study|Lost to Follow-up|1|||
160959951|NCT01786512|581242182|FG010|Overall Study|Lost to Follow-up|0|||
160959952|NCT01786512|581242172|FG000|Overall Study|Decision by sponsor|0|||
160959953|NCT01786512|581242173|FG001|Overall Study|Decision by sponsor|0|||
160959954|NCT01786512|581242174|FG002|Overall Study|Decision by sponsor|0|||
160959955|NCT01786512|581242175|FG003|Overall Study|Decision by sponsor|0|||
160959956|NCT01786512|581242176|FG004|Overall Study|Decision by sponsor|0|||
160959957|NCT01786512|581242177|FG005|Overall Study|Decision by sponsor|0|||
160959958|NCT01786512|581242178|FG006|Overall Study|Decision by sponsor|0|||
160959959|NCT01786512|581242179|FG007|Overall Study|Decision by sponsor|0|||
160959960|NCT01786512|581242180|FG008|Overall Study|Decision by sponsor|0|||
160959961|NCT01786512|581242181|FG009|Overall Study|Decision by sponsor|0|||
160959962|NCT01786512|581242182|FG010|Overall Study|Decision by sponsor|2|||
160959963|NCT01786512|581242172|FG000|Overall Study|Withdrawal by Subject|0|||
160959964|NCT01786512|581242173|FG001|Overall Study|Withdrawal by Subject|1|||
160959965|NCT01786512|581242174|FG002|Overall Study|Withdrawal by Subject|0|||
160959966|NCT01786512|581242175|FG003|Overall Study|Withdrawal by Subject|0|||
160959967|NCT01786512|581242176|FG004|Overall Study|Withdrawal by Subject|0|||
160959968|NCT01786512|581242177|FG005|Overall Study|Withdrawal by Subject|0|||
160959969|NCT01786512|581242178|FG006|Overall Study|Withdrawal by Subject|1|||
160959970|NCT01786512|581242179|FG007|Overall Study|Withdrawal by Subject|0|||
160959971|NCT01786512|581242180|FG008|Overall Study|Withdrawal by Subject|0|||
160959972|NCT01786512|581242181|FG009|Overall Study|Withdrawal by Subject|3|||
160959973|NCT01786512|581242182|FG010|Overall Study|Withdrawal by Subject|7|||
160959974|NCT01786512|581242172|FG000|Overall Study|Death|0|||
160959975|NCT01786512|581242173|FG001|Overall Study|Death|0|||
160959976|NCT01786512|581242174|FG002|Overall Study|Death|0|||
160959977|NCT01786512|581242175|FG003|Overall Study|Death|0|||
160959978|NCT01786512|581242176|FG004|Overall Study|Death|0|||
160959979|NCT01786512|581242177|FG005|Overall Study|Death|0|||
160959980|NCT01786512|581242178|FG006|Overall Study|Death|0|||
160959981|NCT01786512|581242179|FG007|Overall Study|Death|0|||
160959982|NCT01786512|581242180|FG008|Overall Study|Death|4|||
160959983|NCT01786512|581242181|FG009|Overall Study|Death|1|||
160959984|NCT01786512|581242182|FG010|Overall Study|Death|3|||
160959985|NCT00605293|581242183|FG000|Overall Study|Death|2|||
160959986|NCT00605293|581242184|FG001|Overall Study|Death|1|||
161002005|NCT02459899|581393066|FG003|Overall Study|Adverse Event|0|||
160959987|NCT00605293|581242183|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160959988|NCT00605293|581242184|FG001|Overall Study|Insufficient Therapeutic Response|0|||
160959989|NCT00605293|581242183|FG000|Overall Study|Adverse Event|1|||
160959990|NCT00605293|581242184|FG001|Overall Study|Adverse Event|0|||
160959991|NCT00605293|581242183|FG000|Overall Study|Holidays Dialysis Out|1|||
160959992|NCT00605293|581242184|FG001|Overall Study|Holidays Dialysis Out|0|||
160959993|NCT00605293|581242183|FG000|Overall Study|Blood Transfusion|7|||
160959994|NCT00605293|581242184|FG001|Overall Study|Blood Transfusion|1|||
160959995|NCT00605293|581242183|FG000|Overall Study|Renal Transplantation|3|||
160959996|NCT00605293|581242184|FG001|Overall Study|Renal Transplantation|1|||
160959997|NCT00605293|581242183|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
160959998|NCT00605293|581242184|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
160959999|NCT00605293|581242183|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
160960000|NCT00605293|581242184|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
161002006|NCT02459899|581393063|FG000|Overall Study|Lost to Follow-up|1|||
160960001|NCT00605293|581242183|FG000|Overall Study|Principal Investigator Decision|0|||
161270912|NCT01696279|582372810|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161270913|NCT01696279|582372811|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
161270914|NCT01696279|582372812|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
161270915|NCT01696279|582372809|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161270916|NCT01696279|582372810|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
161270917|NCT01696279|582372811|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
160960002|NCT00605293|581242184|FG001|Overall Study|Principal Investigator Decision|1|||
160960003|NCT00234052|581242185|FG000|Treatment|Withdrawal by Subject|3|||
160960004|NCT00234052|581242185|FG000|Treatment|Adverse Event|5|||
160960005|NCT00234052|581242185|FG000|Treatment|Death|2|||
160960006|NCT00234052|581242185|FG000|Treatment|Progressive Disease|11|||
160960007|NCT00234052|581242185|FG000|Follow-up for 5 Years|Death|41|||
160960008|NCT00234052|581242185|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
160960009|NCT00234052|581242185|FG000|Follow-up for 5 Years|Other|7|||
160960010|NCT00952367|581242187|FG000|Overall Study|Withdrawal by Subject|2|||
160960011|NCT00952367|581242187|FG000|Overall Study|Noncoordination|1|||
160960012|NCT00952367|581242187|FG000|Overall Study|Protocol Violation|3|||
160960013|NCT00781391|581242190|FG000|Overall Study|never received study drug|24|||
160960014|NCT00781391|581242191|FG001|Overall Study|never received study drug|23|||
160960015|NCT00781391|581242192|FG002|Overall Study|never received study drug|32|||
160960016|NCT00781391|581242190|FG000|Overall Study|Protocol Violation|19|||
160960017|NCT00781391|581242191|FG001|Overall Study|Protocol Violation|17|||
160960018|NCT00781391|581242192|FG002|Overall Study|Protocol Violation|20|||
160960019|NCT00781391|581242190|FG000|Overall Study|Death|789|||
160960020|NCT00781391|581242191|FG001|Overall Study|Death|730|||
160960021|NCT00781391|581242192|FG002|Overall Study|Death|706|||
160960022|NCT00781391|581242190|FG000|Overall Study|Withdrawal by Subject|47|||
160960023|NCT00781391|581242191|FG001|Overall Study|Withdrawal by Subject|37|||
160960024|NCT00781391|581242192|FG002|Overall Study|Withdrawal by Subject|25|||
160960025|NCT00781391|581242190|FG000|Overall Study|Lost to Follow-up|0|||
160960026|NCT00781391|581242191|FG001|Overall Study|Lost to Follow-up|0|||
160960027|NCT00781391|581242192|FG002|Overall Study|Lost to Follow-up|1|||
160960028|NCT01984684|581242193|FG000|Overall Study|Lost to Follow-up|25|||
160960029|NCT01984684|581242194|FG001|Overall Study|Lost to Follow-up|24|||
160960030|NCT01984684|581242193|FG000|Overall Study|Adverse Event|8|||
160960031|NCT01984684|581242194|FG001|Overall Study|Adverse Event|12|||
160960032|NCT01984684|581242193|FG000|Overall Study|Withdrawal by Subject|9|||
160960033|NCT01984684|581242194|FG001|Overall Study|Withdrawal by Subject|9|||
160960034|NCT01984684|581242193|FG000|Overall Study|Lack of Efficacy|3|||
160960035|NCT01984684|581242194|FG001|Overall Study|Lack of Efficacy|6|||
160960036|NCT01984684|581242193|FG000|Overall Study|Physician Decision|4|||
160960037|NCT01984684|581242194|FG001|Overall Study|Physician Decision|2|||
160960038|NCT01984684|581242193|FG000|Overall Study|Protocol Violation|4|||
160960039|NCT01984684|581242194|FG001|Overall Study|Protocol Violation|2|||
160960040|NCT01984684|581242193|FG000|Overall Study|Death|0|||
160960041|NCT01984684|581242194|FG001|Overall Study|Death|1|||
160960042|NCT01984684|581242193|FG000|Overall Study|Noncompliance with study drug|2|||
160960043|NCT01984684|581242194|FG001|Overall Study|Noncompliance with study drug|1|||
161270918|NCT01696279|582372812|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
161270919|NCT01696279|582372809|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161270920|NCT01696279|582372810|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161270921|NCT01696279|582372811|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
161270922|NCT01696279|582372812|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
160960044|NCT01984684|581242193|FG000|Overall Study|Subject incarcerated|1|||
160960045|NCT01984684|581242194|FG001|Overall Study|Subject incarcerated|0|||
160960046|NCT01984684|581242193|FG000|Overall Study|Study drug not available at site|1|||
160960047|NCT01984684|581242194|FG001|Overall Study|Study drug not available at site|1|||
160960048|NCT01984684|581242193|FG000|Overall Study|Subject had inadequate IV access|0|||
160960049|NCT01984684|581242194|FG001|Overall Study|Subject had inadequate IV access|1|||
160960050|NCT03205371|581242204|FG000|Overall Study|Withdrawal by Subject|4|||
160960051|NCT03205371|581242205|FG001|Overall Study|Withdrawal by Subject|1|||
160960052|NCT03205371|581242206|FG002|Overall Study|Withdrawal by Subject|0|||
160960053|NCT03205371|581242207|FG003|Overall Study|Withdrawal by Subject|0|||
160960054|NCT03205371|581242208|FG004|Overall Study|Withdrawal by Subject|0|||
160960055|NCT03205371|581242209|FG005|Overall Study|Withdrawal by Subject|0|||
160960056|NCT03205371|581242210|FG006|Overall Study|Withdrawal by Subject|4|||
160960057|NCT03205371|581242211|FG007|Overall Study|Withdrawal by Subject|0|||
160960058|NCT03205371|581242212|FG008|Overall Study|Withdrawal by Subject|2|||
160960059|NCT03205371|581242213|FG009|Overall Study|Withdrawal by Subject|0|||
161270923|NCT06077149|582372813|FG000|Overall Study|Death|1|||
160960060|NCT03205371|581242214|FG010|Overall Study|Withdrawal by Subject|0|||
160960061|NCT03205371|581242215|FG011|Overall Study|Withdrawal by Subject|1|||
160960062|NCT03205371|581242204|FG000|Overall Study|Lost to Follow-up|0|||
160960063|NCT03205371|581242205|FG001|Overall Study|Lost to Follow-up|0|||
160960064|NCT03205371|581242206|FG002|Overall Study|Lost to Follow-up|0|||
160960065|NCT03205371|581242207|FG003|Overall Study|Lost to Follow-up|0|||
160960066|NCT03205371|581242208|FG004|Overall Study|Lost to Follow-up|0|||
160960067|NCT03205371|581242209|FG005|Overall Study|Lost to Follow-up|0|||
160960068|NCT03205371|581242210|FG006|Overall Study|Lost to Follow-up|5|||
160960069|NCT03205371|581242211|FG007|Overall Study|Lost to Follow-up|2|||
160960070|NCT03205371|581242212|FG008|Overall Study|Lost to Follow-up|3|||
160960071|NCT03205371|581242213|FG009|Overall Study|Lost to Follow-up|0|||
160960072|NCT03205371|581242214|FG010|Overall Study|Lost to Follow-up|0|||
160960073|NCT03205371|581242215|FG011|Overall Study|Lost to Follow-up|0|||
160960074|NCT03205371|581242204|FG000|Overall Study|Protocol Violation|0|||
160960075|NCT03205371|581242205|FG001|Overall Study|Protocol Violation|0|||
160960076|NCT03205371|581242206|FG002|Overall Study|Protocol Violation|0|||
160960077|NCT03205371|581242207|FG003|Overall Study|Protocol Violation|0|||
160960078|NCT03205371|581242208|FG004|Overall Study|Protocol Violation|0|||
160960079|NCT03205371|581242209|FG005|Overall Study|Protocol Violation|0|||
160960080|NCT03205371|581242210|FG006|Overall Study|Protocol Violation|1|||
160960081|NCT03205371|581242211|FG007|Overall Study|Protocol Violation|0|||
160960082|NCT03205371|581242212|FG008|Overall Study|Protocol Violation|0|||
160960083|NCT03205371|581242213|FG009|Overall Study|Protocol Violation|0|||
160960084|NCT03205371|581242214|FG010|Overall Study|Protocol Violation|0|||
160960085|NCT03205371|581242215|FG011|Overall Study|Protocol Violation|0|||
160960086|NCT03205371|581242204|FG000|Overall Study|Adverse Event|0|||
160960087|NCT03205371|581242205|FG001|Overall Study|Adverse Event|0|||
160960088|NCT03205371|581242206|FG002|Overall Study|Adverse Event|0|||
160960089|NCT03205371|581242207|FG003|Overall Study|Adverse Event|0|||
160960090|NCT03205371|581242208|FG004|Overall Study|Adverse Event|0|||
160960091|NCT03205371|581242209|FG005|Overall Study|Adverse Event|0|||
160960092|NCT03205371|581242210|FG006|Overall Study|Adverse Event|0|||
160960093|NCT03205371|581242211|FG007|Overall Study|Adverse Event|1|||
160960094|NCT03205371|581242212|FG008|Overall Study|Adverse Event|0|||
160960095|NCT03205371|581242213|FG009|Overall Study|Adverse Event|0|||
160960096|NCT03205371|581242214|FG010|Overall Study|Adverse Event|0|||
160960097|NCT03205371|581242215|FG011|Overall Study|Adverse Event|0|||
160960098|NCT02835339|581242216|FG000|Overall Study|Did not receive allocated intervention|13|||
160960099|NCT02835339|581242217|FG001|Overall Study|Did not receive allocated intervention|16|||
160960100|NCT01077544|581242218|FG000|Overall Study|New Cancer Therapy|3|||
160960101|NCT01077544|581242219|FG001|Overall Study|New Cancer Therapy|3|||
160960102|NCT01077544|581242218|FG000|Overall Study|Adverse Event|0|||
160960103|NCT01077544|581242219|FG001|Overall Study|Adverse Event|1|||
160960104|NCT01077544|581242218|FG000|Overall Study|Disease Progression|0|||
160960105|NCT01077544|581242219|FG001|Overall Study|Disease Progression|1|||
160960106|NCT03923959|581242220|FG000|Overall Study|Death|16|||
160960107|NCT03923959|581242221|FG001|Overall Study|Death|12|||
160960108|NCT03923959|581242220|FG000|Overall Study|Lost to Follow-up|56|||
160960109|NCT03923959|581242221|FG001|Overall Study|Lost to Follow-up|56|||
160960110|NCT03923959|581242220|FG000|Overall Study|Withdrawal by Subject|1|||
160960111|NCT03923959|581242221|FG001|Overall Study|Withdrawal by Subject|1|||
160960112|NCT03923959|581242220|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
160960113|NCT03923959|581242221|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
160960114|NCT04212091|581242223|FG000|Overall Study|Lost to Follow-up|0|||
160960115|NCT04212091|581242224|FG001|Overall Study|Lost to Follow-up|0|||
160960116|NCT04212091|581242225|FG002|Overall Study|Lost to Follow-up|0|||
160960117|NCT04212091|581242226|FG003|Overall Study|Lost to Follow-up|0|||
160960118|NCT04212091|581242227|FG004|Overall Study|Lost to Follow-up|1|||
160960119|NCT04212091|581242228|FG005|Overall Study|Lost to Follow-up|1|||
160960120|NCT04212091|581242223|FG000|Overall Study|Participant unable to adhere to visit|0|||
160960121|NCT04212091|581242224|FG001|Overall Study|Participant unable to adhere to visit|0|||
160960122|NCT04212091|581242225|FG002|Overall Study|Participant unable to adhere to visit|0|||
161002007|NCT02459899|581393064|FG001|Overall Study|Lost to Follow-up|2|||
161002008|NCT02459899|581393065|FG002|Overall Study|Lost to Follow-up|0|||
161002009|NCT02459899|581393066|FG003|Overall Study|Lost to Follow-up|1|||
161002010|NCT02459899|581393063|FG000|Overall Study|Non-compliance with the treatment|0|||
161002011|NCT02459899|581393064|FG001|Overall Study|Non-compliance with the treatment|0|||
161002012|NCT02459899|581393065|FG002|Overall Study|Non-compliance with the treatment|0|||
160960123|NCT04212091|581242226|FG003|Overall Study|Participant unable to adhere to visit|0|||
160960124|NCT04212091|581242227|FG004|Overall Study|Participant unable to adhere to visit|1|||
160960125|NCT04212091|581242228|FG005|Overall Study|Participant unable to adhere to visit|0|||
160960126|NCT04575051|581242229|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
160960127|NCT04575051|581242230|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
160960128|NCT04575051|581242231|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
160960129|NCT04575051|581242232|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
160960130|NCT04575051|581242233|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
160960131|NCT04575051|581242229|FG000|Time Period 1|Missing follow up|1|||
160960132|NCT04575051|581242230|FG001|Time Period 1|Missing follow up|3|||
160960133|NCT04575051|581242231|FG002|Time Period 1|Missing follow up|1|||
160960134|NCT04575051|581242232|FG003|Time Period 1|Missing follow up|3|||
160960135|NCT04575051|581242233|FG004|Time Period 1|Missing follow up|2|||
160960136|NCT04575051|581242229|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
160960137|NCT04575051|581242230|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
160960138|NCT04575051|581242231|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
160960139|NCT04575051|581242232|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
160960140|NCT04575051|581242233|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
160960141|NCT04575051|581242229|FG000|Time Period 2|Missing follow up|1|||
160960142|NCT04575051|581242230|FG001|Time Period 2|Missing follow up|8|||
160960143|NCT04575051|581242231|FG002|Time Period 2|Missing follow up|7|||
160960144|NCT04575051|581242232|FG003|Time Period 2|Missing follow up|0|||
160960145|NCT04575051|581242233|FG004|Time Period 2|Missing follow up|1|||
160960146|NCT04575051|581242229|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
160960147|NCT04575051|581242230|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
160960148|NCT04575051|581242231|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
160960149|NCT04575051|581242232|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
160960150|NCT04575051|581242233|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
160960151|NCT04575051|581242229|FG000|Time Period 3|Missing follow up|8|||
160960152|NCT04575051|581242230|FG001|Time Period 3|Missing follow up|6|||
160960153|NCT04575051|581242231|FG002|Time Period 3|Missing follow up|4|||
160960154|NCT04575051|581242232|FG003|Time Period 3|Missing follow up|3|||
160960155|NCT04575051|581242233|FG004|Time Period 3|Missing follow up|0|||
160960156|NCT04575051|581242229|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
160960157|NCT04575051|581242230|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
160960158|NCT04575051|581242231|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
160960159|NCT04575051|581242232|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
160960160|NCT04575051|581242233|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
160960161|NCT04575051|581242229|FG000|Time Period 4|Missing follow up|17|||
160960162|NCT04575051|581242230|FG001|Time Period 4|Missing follow up|3|||
160960163|NCT04575051|581242231|FG002|Time Period 4|Missing follow up|4|||
160960164|NCT04575051|581242232|FG003|Time Period 4|Missing follow up|2|||
160960165|NCT04575051|581242233|FG004|Time Period 4|Missing follow up|1|||
160960166|NCT04575051|581242229|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
160960167|NCT04575051|581242230|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
160960168|NCT04575051|581242231|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
160960169|NCT04575051|581242232|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
160960170|NCT04575051|581242233|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
160960171|NCT04575051|581242229|FG000|Time Period 5|Missing follow up|11|||
160960172|NCT04575051|581242230|FG001|Time Period 5|Missing follow up|8|||
160960173|NCT04575051|581242231|FG002|Time Period 5|Missing follow up|12|||
160960174|NCT04575051|581242232|FG003|Time Period 5|Missing follow up|3|||
160960175|NCT04575051|581242233|FG004|Time Period 5|Missing follow up|11|||
160960176|NCT03182868|581242234|FG000|Overall Study|Protocol Violation|3|||
160960177|NCT03182868|581242235|FG001|Overall Study|Protocol Violation|0|||
160960178|NCT03182868|581242236|FG002|Overall Study|Protocol Violation|4|||
160960179|NCT03182868|581242237|FG003|Overall Study|Protocol Violation|1|||
160960180|NCT03182868|581242238|FG004|Overall Study|Protocol Violation|8|||
160960181|NCT00295022|581242239|FG000|Overall Study|Adverse Event|1|||
160960182|NCT00295022|581242240|FG001|Overall Study|Adverse Event|1|||
160960183|NCT00295022|581242241|FG002|Overall Study|Adverse Event|2|||
160960184|NCT00295022|581242239|FG000|Overall Study|Lost to Follow-up|0|||
160960185|NCT00295022|581242240|FG001|Overall Study|Lost to Follow-up|0|||
160960186|NCT00295022|581242241|FG002|Overall Study|Lost to Follow-up|1|||
160960187|NCT00295022|581242239|FG000|Overall Study|Withdrawal by Subject|0|||
161270924|NCT06077149|582372814|FG001|Overall Study|Death|0|||
161270925|NCT06077149|582372813|FG000|Overall Study|Withdrawal by Subject|2|||
161270926|NCT06077149|582372814|FG001|Overall Study|Withdrawal by Subject|0|||
160960188|NCT00295022|581242240|FG001|Overall Study|Withdrawal by Subject|0|||
160960189|NCT00295022|581242241|FG002|Overall Study|Withdrawal by Subject|2|||
160960190|NCT00734630|581242243|FG000|Overall Study|Lack of Efficacy|4|||
160960191|NCT00734630|581242244|FG001|Overall Study|Lack of Efficacy|4|||
160960192|NCT00734630|581242243|FG000|Overall Study|Withdrawal by Subject|7|||
160960193|NCT00734630|581242244|FG001|Overall Study|Withdrawal by Subject|9|||
160960194|NCT00734630|581242243|FG000|Overall Study|Lost to Follow-up|13|||
160960195|NCT00734630|581242244|FG001|Overall Study|Lost to Follow-up|7|||
160960196|NCT00734630|581242243|FG000|Overall Study|Protocol Violation|0|||
160960197|NCT00734630|581242244|FG001|Overall Study|Protocol Violation|3|||
160960198|NCT00734630|581242243|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
160960199|NCT00734630|581242244|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
160960200|NCT00734630|581242243|FG000|Overall Study|Adverse Event|3|||
161002013|NCT02459899|581393066|FG003|Overall Study|Non-compliance with the treatment|1|||
161002014|NCT02459899|581393063|FG000|Overall Study|Withdrawal by Subject|1|||
160960201|NCT00734630|581242244|FG001|Overall Study|Adverse Event|6|||
160960202|NCT00734630|581242243|FG000|Overall Study|Randomized in Error|0|||
160960203|NCT00734630|581242244|FG001|Overall Study|Randomized in Error|1|||
160960204|NCT00734630|581242243|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
160960205|NCT00734630|581242244|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
160960206|NCT00734630|581242243|FG000|Overall Study|Poor Compliance|1|||
160960207|NCT00734630|581242244|FG001|Overall Study|Poor Compliance|1|||
160960208|NCT01239030|581242245|FG000|Double Blind|Adverse Event|0|||
160960209|NCT01239030|581242246|FG001|Double Blind|Adverse Event|1|||
160960210|NCT01239030|581242247|FG002|Double Blind|Adverse Event|0|||
160960211|NCT01239030|581242248|FG003|Double Blind|Adverse Event|2|||
160960212|NCT01239030|581242249|FG004|Double Blind|Adverse Event|0|||
160960213|NCT01239030|581242245|FG000|Double Blind|Withdrawal by Subject|0|||
160960214|NCT01239030|581242246|FG001|Double Blind|Withdrawal by Subject|1|||
160960215|NCT01239030|581242247|FG002|Double Blind|Withdrawal by Subject|1|||
160960216|NCT01239030|581242248|FG003|Double Blind|Withdrawal by Subject|0|||
160960217|NCT01239030|581242249|FG004|Double Blind|Withdrawal by Subject|1|||
160960218|NCT01239030|581242245|FG000|Double Blind|Lost to Follow-up|1|||
160960219|NCT01239030|581242246|FG001|Double Blind|Lost to Follow-up|1|||
160960220|NCT01239030|581242247|FG002|Double Blind|Lost to Follow-up|0|||
160960221|NCT01239030|581242248|FG003|Double Blind|Lost to Follow-up|0|||
160960222|NCT01239030|581242249|FG004|Double Blind|Lost to Follow-up|0|||
160960223|NCT01239030|581242245|FG000|Double Blind|Physician Decision|0|||
160960224|NCT01239030|581242246|FG001|Double Blind|Physician Decision|1|||
160960225|NCT01239030|581242247|FG002|Double Blind|Physician Decision|0|||
160960226|NCT01239030|581242248|FG003|Double Blind|Physician Decision|0|||
160960227|NCT01239030|581242249|FG004|Double Blind|Physician Decision|0|||
160960228|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
160960229|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
160960230|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
160960231|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
160960232|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
160960233|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
160960234|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
160960235|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
160960236|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
160960237|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
160960238|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
160960239|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
160960240|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
160960241|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
160960242|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
160960243|NCT01239030|581242245|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
160960244|NCT01239030|581242246|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
160960245|NCT01239030|581242247|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
160960246|NCT01239030|581242248|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
160960247|NCT01239030|581242249|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
160960248|NCT04403698|581242250|FG000|Overall Study|Adverse Event|1|||
160960249|NCT04403698|581242251|FG001|Overall Study|Adverse Event|1|||
160960250|NCT04403698|581242250|FG000|Overall Study|Lost to Follow-up|1|||
160960251|NCT04403698|581242251|FG001|Overall Study|Lost to Follow-up|0|||
160960252|NCT04403698|581242250|FG000|Overall Study|Protocol Violation|0|||
160960253|NCT04403698|581242251|FG001|Overall Study|Protocol Violation|1|||
160960254|NCT00977665|581242252|FG000|Overall Study|Withdrawal by Subject|1|||
160960255|NCT00977665|581242253|FG001|Overall Study|Withdrawal by Subject|3|||
160960256|NCT00977665|581242252|FG000|Overall Study|Physician Decision|2|||
160960257|NCT00977665|581242253|FG001|Overall Study|Physician Decision|1|||
160960258|NCT00977665|581242252|FG000|Overall Study|Sponsor requested withdrawal|0|||
160960259|NCT00977665|581242253|FG001|Overall Study|Sponsor requested withdrawal|1|||
160960260|NCT00977665|581242252|FG000|Overall Study|Lost to Follow-up|1|||
160960261|NCT00977665|581242253|FG001|Overall Study|Lost to Follow-up|0|||
160960262|NCT00977665|581242252|FG000|Overall Study|Death|3|||
161002015|NCT02459899|581393064|FG001|Overall Study|Withdrawal by Subject|3|||
161002016|NCT02459899|581393065|FG002|Overall Study|Withdrawal by Subject|0|||
160960263|NCT00977665|581242253|FG001|Overall Study|Death|2|||
160960264|NCT00977665|581242252|FG000|Overall Study|Adverse Event|14|||
160960265|NCT00977665|581242253|FG001|Overall Study|Adverse Event|7|||
160960266|NCT00977665|581242252|FG000|Overall Study|Treatment failure|0|||
160960267|NCT00977665|581242253|FG001|Overall Study|Treatment failure|1|||
160960268|NCT01330433|581242254|FG000|Overall Study|Death|1|||
160960269|NCT01330433|581242255|FG001|Overall Study|Death|3|||
160960270|NCT01330433|581242254|FG000|Overall Study|Lost to Follow-up|1|||
160960271|NCT01330433|581242255|FG001|Overall Study|Lost to Follow-up|0|||
160960272|NCT02300220|581242261|FG000|Overall Study|Lost to Follow-up|1|||
160960273|NCT02300220|581242262|FG001|Overall Study|Lost to Follow-up|2|||
160960274|NCT02300220|581242261|FG000|Overall Study|Death|1|||
160960275|NCT02300220|581242262|FG001|Overall Study|Death|1|||
160960276|NCT02300220|581242261|FG000|Overall Study|Adverse Event|1|||
160960277|NCT02300220|581242262|FG001|Overall Study|Adverse Event|1|||
160960278|NCT02300220|581242261|FG000|Overall Study|Protocol Violation|1|||
160960279|NCT02300220|581242262|FG001|Overall Study|Protocol Violation|0|||
160960280|NCT02300220|581242261|FG000|Overall Study|Withdrawal by Subject|0|||
160960281|NCT02300220|581242262|FG001|Overall Study|Withdrawal by Subject|2|||
160960282|NCT02300220|581242261|FG000|Overall Study|Did not tolerate IMP|0|||
160960283|NCT02300220|581242262|FG001|Overall Study|Did not tolerate IMP|1|||
160960284|NCT04322682|581242263|FG000|Overall Study|Withdrawal by Subject|33|||
160960285|NCT04322682|581242264|FG001|Overall Study|Withdrawal by Subject|47|||
160960286|NCT04322682|581242263|FG000|Overall Study|Death|5|||
160960287|NCT04322682|581242264|FG001|Overall Study|Death|9|||
160960288|NCT04322682|581242263|FG000|Overall Study|Lost to Follow-up|4|||
160960289|NCT04322682|581242264|FG001|Overall Study|Lost to Follow-up|8|||
160960290|NCT04322682|581242263|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
160960291|NCT04322682|581242264|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
160960292|NCT02238379|581242265|FG000|Overall Study|Lost to Follow-up|1|||
160960293|NCT02238379|581242266|FG001|Overall Study|Lost to Follow-up|0|||
160960294|NCT04123067|581242267|FG000|Overall Study|Lost to Follow-up|0|||
160960295|NCT04123067|581242268|FG001|Overall Study|Lost to Follow-up|1|||
160960296|NCT00441090|581242269|FG000|Overall Study|Adverse Event|0|||
160960297|NCT00441090|581242270|FG001|Overall Study|Adverse Event|1|||
160960298|NCT00441090|581242271|FG002|Overall Study|Adverse Event|1|||
160960299|NCT00441090|581242272|FG003|Overall Study|Adverse Event|0|||
160960300|NCT00441090|581242273|FG004|Overall Study|Adverse Event|0|||
160960301|NCT00441090|581242269|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960302|NCT00441090|581242270|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960303|NCT00441090|581242271|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960304|NCT00441090|581242272|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
160960305|NCT00441090|581242273|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
160960306|NCT00441090|581242269|FG000|Overall Study|Withdrawal by Subject|1|||
160960307|NCT00441090|581242270|FG001|Overall Study|Withdrawal by Subject|0|||
160960308|NCT00441090|581242271|FG002|Overall Study|Withdrawal by Subject|1|||
160960309|NCT00441090|581242272|FG003|Overall Study|Withdrawal by Subject|0|||
160960310|NCT00441090|581242273|FG004|Overall Study|Withdrawal by Subject|0|||
160960311|NCT00441090|581242269|FG000|Overall Study|Lack of Efficacy|1|||
160960312|NCT00441090|581242270|FG001|Overall Study|Lack of Efficacy|0|||
160960313|NCT00441090|581242271|FG002|Overall Study|Lack of Efficacy|0|||
160960314|NCT00441090|581242272|FG003|Overall Study|Lack of Efficacy|0|||
160960315|NCT00441090|581242273|FG004|Overall Study|Lack of Efficacy|0|||
160960316|NCT01441102|581242274|FG000|Overall Study|Adverse Event|1|||
160960317|NCT01441102|581242274|FG000|Overall Study|Withdrawal by Subject|2|||
160960318|NCT03085485|581242275|FG000|Overall Study|Death|1|||
161002017|NCT02459899|581393066|FG003|Overall Study|Withdrawal by Subject|0|||
161002018|NCT04221438|581393067|FG000|Overall Study|Adverse Event|1|||
161002019|NCT04221438|581393067|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
161002020|NCT02517307|581393072|FG000|Overall Study|Withdrawal by Subject|1|||
161002021|NCT02517307|581393073|FG001|Overall Study|Withdrawal by Subject|0|||
161002022|NCT02517307|581393074|FG002|Overall Study|Withdrawal by Subject|1|||
161002023|NCT02517307|581393075|FG003|Overall Study|Withdrawal by Subject|0|||
161002024|NCT02517307|581393072|FG000|Overall Study|Protocol Violation|0|||
161002025|NCT02517307|581393073|FG001|Overall Study|Protocol Violation|0|||
161002026|NCT02517307|581393074|FG002|Overall Study|Protocol Violation|1|||
161002027|NCT02517307|581393075|FG003|Overall Study|Protocol Violation|1|||
161002028|NCT03586544|581393076|FG000|First Intervention|Adverse Event|0|||
161270927|NCT06077149|582372813|FG000|Overall Study|RSV infection before vaccination|3|||
161270928|NCT06077149|582372814|FG001|Overall Study|RSV infection before vaccination|0|||
161270929|NCT04658095|582372815|FG000|Overall Study|Study terminated|5|||
161270930|NCT04658095|582372816|FG001|Overall Study|Study terminated|1|||
161270931|NCT04658095|582372817|FG002|Overall Study|Study terminated|4|||
160960319|NCT03085485|581242276|FG001|Overall Study|Death|0|||
160960320|NCT03085485|581242275|FG000|Overall Study|Lost to Follow-up|1|||
160960321|NCT03085485|581242276|FG001|Overall Study|Lost to Follow-up|0|||
161002029|NCT03586544|581393077|FG001|First Intervention|Adverse Event|1|||
161002030|NCT03586544|581393076|FG000|Second Intervention|Withdrawal by Subject|0|||
161002031|NCT03586544|581393077|FG001|Second Intervention|Withdrawal by Subject|1|||
161002032|NCT00539292|581393078|FG000|Overall Study|Physician Decision|1|||
161002033|NCT00539292|581393079|FG001|Overall Study|Physician Decision|0|||
160960322|NCT01022762|581242277|FG000|Overall Study|Adverse Event|3|||
160960323|NCT01022762|581242278|FG001|Overall Study|Adverse Event|1|||
160960324|NCT01022762|581242277|FG000|Overall Study|Lack of Efficacy|0|||
160960325|NCT01022762|581242278|FG001|Overall Study|Lack of Efficacy|1|||
160960326|NCT01022762|581242277|FG000|Overall Study|Protocol Violation|7|||
160960327|NCT01022762|581242278|FG001|Overall Study|Protocol Violation|6|||
160960328|NCT01022762|581242277|FG000|Overall Study|Unclassified|12|||
161002034|NCT00361283|581393090|FG000|Overall Study|Lost to Follow-up|27|||
161270932|NCT04154631|582372818|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
161146877|NCT03067311|581919919|FG000|Overall Study|Moved away|1|||
161146878|NCT03067311|581919920|FG001|Overall Study|Moved away|1|||
160960329|NCT01022762|581242278|FG001|Overall Study|Unclassified|20|||
160960330|NCT00605280|581242279|FG000|Year 1|Protocol Violation|0|||
160960331|NCT00605280|581242280|FG001|Year 1|Protocol Violation|0|||
160960332|NCT00605280|581242281|FG002|Year 1|Protocol Violation|0|||
160960333|NCT00605280|581242282|FG003|Year 1|Protocol Violation|1|||
160960334|NCT00605280|581242279|FG000|Year 1|Adverse Event|3|||
160960335|NCT00605280|581242280|FG001|Year 1|Adverse Event|1|||
160960336|NCT00605280|581242281|FG002|Year 1|Adverse Event|1|||
160960337|NCT00605280|581242282|FG003|Year 1|Adverse Event|5|||
160960338|NCT00605280|581242279|FG000|Year 1|Physician Decision|7|||
160960339|NCT00605280|581242280|FG001|Year 1|Physician Decision|4|||
160960340|NCT00605280|581242281|FG002|Year 1|Physician Decision|0|||
160960341|NCT00605280|581242282|FG003|Year 1|Physician Decision|6|||
160960342|NCT00605280|581242279|FG000|Year 1|Withdrawal by Subject|2|||
160960343|NCT00605280|581242280|FG001|Year 1|Withdrawal by Subject|4|||
160960344|NCT00605280|581242281|FG002|Year 1|Withdrawal by Subject|0|||
160960345|NCT00605280|581242282|FG003|Year 1|Withdrawal by Subject|4|||
160960346|NCT00605280|581242279|FG000|Year 1|Other|2|||
160960347|NCT00605280|581242280|FG001|Year 1|Other|1|||
160960348|NCT00605280|581242281|FG002|Year 1|Other|0|||
160960349|NCT00605280|581242282|FG003|Year 1|Other|1|||
160960350|NCT00605280|581242279|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
160960351|NCT00605280|581242280|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
160960352|NCT00605280|581242281|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
160960353|NCT00605280|581242282|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
160960354|NCT00605280|581242279|FG000|Year 2|Adverse Event|4|||
160960355|NCT00605280|581242280|FG001|Year 2|Adverse Event|0|||
160960356|NCT00605280|581242281|FG002|Year 2|Adverse Event|2|||
160960357|NCT00605280|581242282|FG003|Year 2|Adverse Event|4|||
160960358|NCT00605280|581242279|FG000|Year 2|Physician Decision|11|||
160960359|NCT00605280|581242280|FG001|Year 2|Physician Decision|6|||
160960360|NCT00605280|581242281|FG002|Year 2|Physician Decision|4|||
160960361|NCT00605280|581242282|FG003|Year 2|Physician Decision|11|||
160960362|NCT00605280|581242279|FG000|Year 2|Withdrawal by Subject|4|||
160960363|NCT00605280|581242280|FG001|Year 2|Withdrawal by Subject|0|||
160960364|NCT00605280|581242281|FG002|Year 2|Withdrawal by Subject|0|||
160960365|NCT00605280|581242282|FG003|Year 2|Withdrawal by Subject|4|||
160960366|NCT00605280|581242279|FG000|Year 2|Other|1|||
160960367|NCT00605280|581242280|FG001|Year 2|Other|0|||
160960368|NCT00605280|581242281|FG002|Year 2|Other|0|||
160960369|NCT00605280|581242282|FG003|Year 2|Other|1|||
160960370|NCT00605280|581242279|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
160960371|NCT00605280|581242280|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
161146879|NCT01589094|581919923|FG000|Overall Study|Did not receive treatment|2|||
161146880|NCT00907738|581919924|FG000|Overall Study|Adverse Event|2|||
161146881|NCT00907738|581919925|FG001|Overall Study|Adverse Event|0|||
161270933|NCT04154631|582372819|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
161270934|NCT01441947|582372820|FG000|Overall Study|Withdrawal by Subject|3|||
161270935|NCT01441947|582372821|FG001|Overall Study|Withdrawal by Subject|0|||
161270936|NCT02036775|582372823|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161270937|NCT02036775|582372824|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161270938|NCT02036775|582372825|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161270939|NCT02036775|582372826|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161270940|NCT02036775|582372827|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
161270941|NCT02036775|582372828|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
161270942|NCT02927366|582372829|FG000|Overall Study|Adverse Event|1|||
161270943|NCT02927366|582372830|FG001|Overall Study|Adverse Event|0|||
160960372|NCT00605280|581242281|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
160960373|NCT00605280|581242282|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
160960374|NCT00605280|581242279|FG000|Year 3 Extension|Adverse Event|2|||
160960375|NCT00605280|581242280|FG001|Year 3 Extension|Adverse Event|0|||
161146882|NCT00907738|581919926|FG002|Overall Study|Adverse Event|1|||
161146883|NCT00907738|581919927|FG003|Overall Study|Adverse Event|0|||
161270944|NCT02927366|582372829|FG000|Overall Study|Patient schedule|1|||
161270945|NCT02927366|582372830|FG001|Overall Study|Patient schedule|0|||
161270946|NCT03496610|582372833|FG000|Overall Study|Lost to Follow-up|3|||
160960376|NCT00605280|581242281|FG002|Year 3 Extension|Adverse Event|0|||
160960377|NCT00605280|581242282|FG003|Year 3 Extension|Adverse Event|2|||
160960378|NCT00605280|581242279|FG000|Year 3 Extension|Physician Decision|0|||
160960379|NCT00605280|581242280|FG001|Year 3 Extension|Physician Decision|0|||
160960380|NCT00605280|581242281|FG002|Year 3 Extension|Physician Decision|0|||
160960381|NCT00605280|581242282|FG003|Year 3 Extension|Physician Decision|2|||
160960382|NCT00605280|581242279|FG000|Year 3 Extension|Withdrawal by Subject|2|||
161002035|NCT01837641|581393091|FG000|Overall Study|Sponsor decision|1|||
160960383|NCT00605280|581242280|FG001|Year 3 Extension|Withdrawal by Subject|0|||
161146884|NCT00907738|581919928|FG004|Overall Study|Adverse Event|0|||
161270947|NCT03496610|582372834|FG001|Overall Study|Lost to Follow-up|2|||
161270948|NCT03496610|582372833|FG000|Overall Study|Physician Decision|1|||
161270949|NCT03496610|582372834|FG001|Overall Study|Physician Decision|0|||
160960384|NCT00605280|581242281|FG002|Year 3 Extension|Withdrawal by Subject|0|||
160960385|NCT00605280|581242282|FG003|Year 3 Extension|Withdrawal by Subject|5|||
160960386|NCT00605280|581242279|FG000|Year 3 Extension|Other|2|||
160960387|NCT00605280|581242280|FG001|Year 3 Extension|Other|0|||
160960388|NCT00605280|581242281|FG002|Year 3 Extension|Other|0|||
160960389|NCT00605280|581242282|FG003|Year 3 Extension|Other|0|||
160960390|NCT00605280|581242279|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
160960391|NCT00605280|581242280|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
160960392|NCT00605280|581242281|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
160960393|NCT00605280|581242282|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
160960394|NCT01775904|581242286|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
160960395|NCT01775904|581242286|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
160960396|NCT00518115|581242287|FG000|Overall Study|Adverse Event|6|||
160960397|NCT00518115|581242288|FG001|Overall Study|Adverse Event|1|||
160960398|NCT00518115|581242289|FG002|Overall Study|Adverse Event|5|||
160960399|NCT00518115|581242290|FG003|Overall Study|Adverse Event|6|||
160960400|NCT00518115|581242291|FG004|Overall Study|Adverse Event|5|||
160960401|NCT00518115|581242292|FG005|Overall Study|Adverse Event|5|||
160960402|NCT00518115|581242293|FG006|Overall Study|Adverse Event|5|||
160960403|NCT00518115|581242294|FG007|Overall Study|Adverse Event|10|||
160960404|NCT00518115|581242295|FG008|Overall Study|Adverse Event|2|||
160960405|NCT00518115|581242296|FG009|Overall Study|Adverse Event|9|||
160960406|NCT00518115|581242287|FG000|Overall Study|Lost to Follow-up|0|||
160960407|NCT00518115|581242288|FG001|Overall Study|Lost to Follow-up|0|||
160960408|NCT00518115|581242289|FG002|Overall Study|Lost to Follow-up|2|||
160960409|NCT00518115|581242290|FG003|Overall Study|Lost to Follow-up|3|||
160960410|NCT00518115|581242291|FG004|Overall Study|Lost to Follow-up|1|||
160960411|NCT00518115|581242292|FG005|Overall Study|Lost to Follow-up|3|||
160960412|NCT00518115|581242293|FG006|Overall Study|Lost to Follow-up|0|||
160960413|NCT00518115|581242294|FG007|Overall Study|Lost to Follow-up|1|||
160960414|NCT00518115|581242295|FG008|Overall Study|Lost to Follow-up|1|||
160960415|NCT00518115|581242296|FG009|Overall Study|Lost to Follow-up|1|||
160960416|NCT00518115|581242287|FG000|Overall Study|Protocol Violation|1|||
160960417|NCT00518115|581242288|FG001|Overall Study|Protocol Violation|3|||
160960418|NCT00518115|581242289|FG002|Overall Study|Protocol Violation|1|||
160960419|NCT00518115|581242290|FG003|Overall Study|Protocol Violation|0|||
160960420|NCT00518115|581242291|FG004|Overall Study|Protocol Violation|0|||
160960421|NCT00518115|581242292|FG005|Overall Study|Protocol Violation|0|||
160960422|NCT00518115|581242293|FG006|Overall Study|Protocol Violation|0|||
160960423|NCT00518115|581242294|FG007|Overall Study|Protocol Violation|0|||
160960424|NCT00518115|581242295|FG008|Overall Study|Protocol Violation|0|||
160960425|NCT00518115|581242296|FG009|Overall Study|Protocol Violation|0|||
160960426|NCT00518115|581242287|FG000|Overall Study|Withdrawal by Subject|1|||
161270950|NCT03496610|582372833|FG000|Overall Study|Withdrawal by Subject|1|||
161270951|NCT03496610|582372834|FG001|Overall Study|Withdrawal by Subject|0|||
161270952|NCT00426361|582372835|FG000|Overall Study|Lost to Follow-up|3|||
161270953|NCT00426361|582372836|FG001|Overall Study|Lost to Follow-up|2|||
161270954|NCT00426361|582372837|FG002|Overall Study|Lost to Follow-up|5|||
161270955|NCT00426361|582372835|FG000|Overall Study|Withdrawal by Subject|1|||
161270956|NCT00426361|582372836|FG001|Overall Study|Withdrawal by Subject|3|||
161270957|NCT00426361|582372837|FG002|Overall Study|Withdrawal by Subject|0|||
161270958|NCT01753336|582372838|FG000|Overall Study|Patient decision|12|||
161270959|NCT01753336|582372838|FG000|Overall Study|Lost to Follow-up|3|||
161270960|NCT01753336|582372838|FG000|Overall Study|Physician Decision|2|||
161270961|NCT01753336|582372838|FG000|Overall Study|Sponsor's decision|2|||
161270962|NCT01753336|582372838|FG000|Overall Study|Withdrawal by Subject|1|||
161270963|NCT01121666|582372839|FG000|Overall Study|Protocol Violation|29|||
160960427|NCT00518115|581242288|FG001|Overall Study|Withdrawal by Subject|1|||
160960428|NCT00518115|581242289|FG002|Overall Study|Withdrawal by Subject|5|||
160960429|NCT00518115|581242290|FG003|Overall Study|Withdrawal by Subject|0|||
160960430|NCT00518115|581242291|FG004|Overall Study|Withdrawal by Subject|2|||
160960431|NCT00518115|581242292|FG005|Overall Study|Withdrawal by Subject|1|||
160960432|NCT00518115|581242293|FG006|Overall Study|Withdrawal by Subject|0|||
160960433|NCT00518115|581242294|FG007|Overall Study|Withdrawal by Subject|2|||
160960434|NCT00518115|581242295|FG008|Overall Study|Withdrawal by Subject|1|||
160960435|NCT00518115|581242296|FG009|Overall Study|Withdrawal by Subject|3|||
160960436|NCT00518115|581242287|FG000|Overall Study|Lack of Efficacy|1|||
160960437|NCT00518115|581242288|FG001|Overall Study|Lack of Efficacy|0|||
160960438|NCT00518115|581242289|FG002|Overall Study|Lack of Efficacy|1|||
160960439|NCT00518115|581242290|FG003|Overall Study|Lack of Efficacy|1|||
160960440|NCT00518115|581242291|FG004|Overall Study|Lack of Efficacy|0|||
160960441|NCT00518115|581242292|FG005|Overall Study|Lack of Efficacy|0|||
160960442|NCT00518115|581242293|FG006|Overall Study|Lack of Efficacy|0|||
160960443|NCT00518115|581242294|FG007|Overall Study|Lack of Efficacy|1|||
161270964|NCT01121666|582372840|FG001|Overall Study|Protocol Violation|10|||
161270965|NCT03201211|582372843|FG000|Overall Study|Adverse Event|1|||
161270966|NCT03201211|582372844|FG001|Overall Study|Adverse Event|0|||
161270967|NCT03201211|582372845|FG002|Overall Study|Adverse Event|0|||
161270968|NCT03201211|582372843|FG000|Overall Study|Protocol Violation|1|||
160960444|NCT00518115|581242295|FG008|Overall Study|Lack of Efficacy|0|||
160960445|NCT00518115|581242296|FG009|Overall Study|Lack of Efficacy|0|||
160960446|NCT00518115|581242287|FG000|Overall Study|Non-Compliance|1|||
160960447|NCT00518115|581242288|FG001|Overall Study|Non-Compliance|0|||
160960448|NCT00518115|581242289|FG002|Overall Study|Non-Compliance|1|||
160960449|NCT00518115|581242290|FG003|Overall Study|Non-Compliance|0|||
160960450|NCT00518115|581242291|FG004|Overall Study|Non-Compliance|1|||
160960451|NCT00518115|581242292|FG005|Overall Study|Non-Compliance|1|||
160960452|NCT00518115|581242293|FG006|Overall Study|Non-Compliance|1|||
160960453|NCT00518115|581242294|FG007|Overall Study|Non-Compliance|1|||
160960454|NCT00518115|581242295|FG008|Overall Study|Non-Compliance|0|||
160960455|NCT00518115|581242296|FG009|Overall Study|Non-Compliance|1|||
160960456|NCT00518115|581242287|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
160960457|NCT00518115|581242288|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
160960458|NCT00518115|581242289|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960459|NCT00518115|581242290|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960460|NCT00518115|581242291|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960461|NCT00518115|581242292|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
160960462|NCT00518115|581242293|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960463|NCT00518115|581242294|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960464|NCT00518115|581242295|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960465|NCT00518115|581242296|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
160960466|NCT00518115|581242287|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
160960467|NCT00518115|581242288|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960468|NCT00518115|581242289|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960469|NCT00518115|581242290|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960470|NCT00518115|581242291|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960471|NCT00518115|581242292|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960472|NCT00518115|581242293|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960473|NCT00518115|581242294|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960474|NCT00518115|581242295|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960475|NCT00518115|581242296|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
160960476|NCT00518115|581242287|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960477|NCT00518115|581242288|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960478|NCT00518115|581242289|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
160960479|NCT00518115|581242290|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960480|NCT00518115|581242291|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960481|NCT00518115|581242292|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960482|NCT00518115|581242293|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960483|NCT00518115|581242294|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960484|NCT00518115|581242295|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
160960485|NCT00518115|581242296|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
160960486|NCT00518115|581242287|FG000|Overall Study|Wrong Monotherapy Administered|0|||
160960487|NCT00518115|581242288|FG001|Overall Study|Wrong Monotherapy Administered|0|||
160960488|NCT00518115|581242289|FG002|Overall Study|Wrong Monotherapy Administered|1|||
160960489|NCT00518115|581242290|FG003|Overall Study|Wrong Monotherapy Administered|0|||
160960490|NCT00518115|581242291|FG004|Overall Study|Wrong Monotherapy Administered|0|||
160960491|NCT00518115|581242292|FG005|Overall Study|Wrong Monotherapy Administered|0|||
160960492|NCT00518115|581242293|FG006|Overall Study|Wrong Monotherapy Administered|1|||
160960493|NCT00518115|581242294|FG007|Overall Study|Wrong Monotherapy Administered|0|||
160960494|NCT00518115|581242295|FG008|Overall Study|Wrong Monotherapy Administered|0|||
160960495|NCT00518115|581242296|FG009|Overall Study|Wrong Monotherapy Administered|0|||
160960496|NCT00518115|581242287|FG000|Overall Study|Violation of Exclusion Criteria|0|||
160960497|NCT00518115|581242288|FG001|Overall Study|Violation of Exclusion Criteria|0|||
160960498|NCT00518115|581242289|FG002|Overall Study|Violation of Exclusion Criteria|0|||
160960499|NCT00518115|581242290|FG003|Overall Study|Violation of Exclusion Criteria|1|||
160960500|NCT00518115|581242291|FG004|Overall Study|Violation of Exclusion Criteria|0|||
160960501|NCT00518115|581242292|FG005|Overall Study|Violation of Exclusion Criteria|0|||
160960502|NCT00518115|581242293|FG006|Overall Study|Violation of Exclusion Criteria|1|||
160960503|NCT00518115|581242294|FG007|Overall Study|Violation of Exclusion Criteria|0|||
160960504|NCT00518115|581242295|FG008|Overall Study|Violation of Exclusion Criteria|0|||
160960505|NCT00518115|581242296|FG009|Overall Study|Violation of Exclusion Criteria|0|||
160960506|NCT00518115|581242287|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
160960507|NCT00518115|581242288|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
160960508|NCT00518115|581242289|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
160960509|NCT00518115|581242290|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
160960510|NCT00518115|581242291|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
160960511|NCT00518115|581242292|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
160960512|NCT00518115|581242293|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
161002036|NCT01837641|581393092|FG001|Overall Study|Sponsor decision|0|||
160960513|NCT00518115|581242294|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
160960514|NCT00518115|581242295|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
160960515|NCT00518115|581242296|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
160960516|NCT00518115|581242287|FG000|Overall Study|Withdrew Consent|0|||
160960517|NCT00518115|581242288|FG001|Overall Study|Withdrew Consent|0|||
160960518|NCT00518115|581242289|FG002|Overall Study|Withdrew Consent|0|||
160960519|NCT00518115|581242290|FG003|Overall Study|Withdrew Consent|0|||
160960520|NCT00518115|581242291|FG004|Overall Study|Withdrew Consent|0|||
160960521|NCT00518115|581242292|FG005|Overall Study|Withdrew Consent|1|||
160960522|NCT00518115|581242293|FG006|Overall Study|Withdrew Consent|0|||
160960523|NCT00518115|581242294|FG007|Overall Study|Withdrew Consent|0|||
160960524|NCT00518115|581242295|FG008|Overall Study|Withdrew Consent|0|||
160960525|NCT00518115|581242296|FG009|Overall Study|Withdrew Consent|0|||
160960526|NCT00518115|581242287|FG000|Overall Study|Moved Out of State|0|||
160960527|NCT00518115|581242288|FG001|Overall Study|Moved Out of State|0|||
160960528|NCT00518115|581242289|FG002|Overall Study|Moved Out of State|0|||
160960529|NCT00518115|581242290|FG003|Overall Study|Moved Out of State|0|||
160960530|NCT00518115|581242291|FG004|Overall Study|Moved Out of State|0|||
160960531|NCT00518115|581242292|FG005|Overall Study|Moved Out of State|0|||
160960532|NCT00518115|581242293|FG006|Overall Study|Moved Out of State|0|||
160960533|NCT00518115|581242294|FG007|Overall Study|Moved Out of State|0|||
160960534|NCT00518115|581242295|FG008|Overall Study|Moved Out of State|0|||
160960535|NCT00518115|581242296|FG009|Overall Study|Moved Out of State|1|||
160960536|NCT04891419|581242297|FG000|Overall Study|Withdrawal by Subject|4|||
160960537|NCT04891419|581242298|FG001|Overall Study|Withdrawal by Subject|0|||
160960538|NCT04891419|581242297|FG000|Overall Study|Lost to Follow-up|1|||
160960539|NCT04891419|581242298|FG001|Overall Study|Lost to Follow-up|3|||
160960540|NCT00802074|581242302|FG000|Overall Study|Adverse Event|1|||
160960541|NCT00802074|581242303|FG001|Overall Study|Adverse Event|1|||
160960542|NCT00802074|581242304|FG002|Overall Study|Adverse Event|1|||
160960543|NCT00802074|581242305|FG003|Overall Study|Adverse Event|0|||
160960544|NCT00802074|581242306|FG004|Overall Study|Adverse Event|0|||
160960545|NCT00802074|581242307|FG005|Overall Study|Adverse Event|0|||
160960546|NCT00802074|581242302|FG000|Overall Study|Withdrawal by Subject|1|||
160960547|NCT00802074|581242303|FG001|Overall Study|Withdrawal by Subject|0|||
160960548|NCT00802074|581242304|FG002|Overall Study|Withdrawal by Subject|0|||
160960549|NCT00802074|581242305|FG003|Overall Study|Withdrawal by Subject|0|||
160960550|NCT00802074|581242306|FG004|Overall Study|Withdrawal by Subject|0|||
160960551|NCT00802074|581242307|FG005|Overall Study|Withdrawal by Subject|0|||
160960552|NCT00827918|581242308|FG000|Overall Study|Adverse Event|4|||
160960553|NCT00827918|581242309|FG001|Overall Study|Adverse Event|0|||
160960554|NCT00827918|581242310|FG002|Overall Study|Adverse Event|0|||
160960555|NCT00827918|581242308|FG000|Overall Study|Lack of Efficacy|16|||
160960556|NCT00827918|581242309|FG001|Overall Study|Lack of Efficacy|4|||
160960557|NCT00827918|581242310|FG002|Overall Study|Lack of Efficacy|15|||
160960558|NCT00827918|581242308|FG000|Overall Study|Physician Decision|1|||
160960559|NCT00827918|581242309|FG001|Overall Study|Physician Decision|0|||
160960560|NCT00827918|581242310|FG002|Overall Study|Physician Decision|0|||
160960561|NCT00827918|581242308|FG000|Overall Study|Pregnancy|0|||
161002037|NCT01837641|581393093|FG002|Overall Study|Sponsor decision|0|||
161002038|NCT01837641|581393094|FG003|Overall Study|Sponsor decision|0|||
161002039|NCT01837641|581393095|FG004|Overall Study|Sponsor decision|0|||
161146885|NCT00907738|581919924|FG000|Overall Study|not specified or withdrew consent|3|||
161146886|NCT00907738|581919925|FG001|Overall Study|not specified or withdrew consent|0|||
161146887|NCT00907738|581919926|FG002|Overall Study|not specified or withdrew consent|0|||
161146888|NCT00907738|581919927|FG003|Overall Study|not specified or withdrew consent|0|||
161146889|NCT00907738|581919928|FG004|Overall Study|not specified or withdrew consent|0|||
161146890|NCT00907738|581919924|FG000|Overall Study|Disease progression|8|||
161146891|NCT00907738|581919925|FG001|Overall Study|Disease progression|1|||
161146892|NCT00907738|581919926|FG002|Overall Study|Disease progression|6|||
161146893|NCT00907738|581919927|FG003|Overall Study|Disease progression|4|||
161146894|NCT00907738|581919928|FG004|Overall Study|Disease progression|2|||
161146895|NCT05363293|581919929|FG000|Overall Study|Withdrawal by Subject|1|||
161146896|NCT05363293|581919930|FG001|Overall Study|Withdrawal by Subject|0|||
160960562|NCT00827918|581242309|FG001|Overall Study|Pregnancy|1|||
160960563|NCT00827918|581242310|FG002|Overall Study|Pregnancy|0|||
160960564|NCT00827918|581242308|FG000|Overall Study|Progressive Disease|1|||
160960565|NCT00827918|581242309|FG001|Overall Study|Progressive Disease|1|||
160960566|NCT00827918|581242310|FG002|Overall Study|Progressive Disease|0|||
160960567|NCT00827918|581242308|FG000|Overall Study|Protocol Violation|0|||
160960568|NCT00827918|581242309|FG001|Overall Study|Protocol Violation|1|||
161146897|NCT05363293|581919931|FG002|Overall Study|Withdrawal by Subject|0|||
160960569|NCT00827918|581242310|FG002|Overall Study|Protocol Violation|0|||
160960570|NCT00827918|581242308|FG000|Overall Study|Withdrawal by Subject|6|||
160960571|NCT00827918|581242309|FG001|Overall Study|Withdrawal by Subject|2|||
160960572|NCT00827918|581242310|FG002|Overall Study|Withdrawal by Subject|6|||
160960573|NCT02291614|581242313|FG000|Overall Study|Lost to Follow-up|0|||
160960574|NCT02291614|581242314|FG001|Overall Study|Lost to Follow-up|0|||
160960575|NCT02291614|581242315|FG002|Overall Study|Lost to Follow-up|0|||
160960576|NCT02291614|581242316|FG003|Overall Study|Lost to Follow-up|0|||
160960577|NCT02291614|581242317|FG004|Overall Study|Lost to Follow-up|0|||
160960578|NCT02291614|581242318|FG005|Overall Study|Lost to Follow-up|0|||
160960579|NCT02291614|581242319|FG006|Overall Study|Lost to Follow-up|0|||
160960580|NCT02291614|581242320|FG007|Overall Study|Lost to Follow-up|1|||
160960581|NCT02291614|581242321|FG008|Overall Study|Lost to Follow-up|0|||
160960582|NCT02291614|581242322|FG009|Overall Study|Lost to Follow-up|0|||
160960583|NCT02291614|581242323|FG010|Overall Study|Lost to Follow-up|0|||
160960584|NCT02291614|581242313|FG000|Overall Study|Withdrawal by Subject|0|||
160960585|NCT02291614|581242314|FG001|Overall Study|Withdrawal by Subject|1|||
160960586|NCT02291614|581242315|FG002|Overall Study|Withdrawal by Subject|0|||
160960587|NCT02291614|581242316|FG003|Overall Study|Withdrawal by Subject|0|||
160960588|NCT02291614|581242317|FG004|Overall Study|Withdrawal by Subject|0|||
160960589|NCT02291614|581242318|FG005|Overall Study|Withdrawal by Subject|0|||
160960590|NCT02291614|581242319|FG006|Overall Study|Withdrawal by Subject|0|||
160960591|NCT02291614|581242320|FG007|Overall Study|Withdrawal by Subject|0|||
160960592|NCT02291614|581242321|FG008|Overall Study|Withdrawal by Subject|0|||
160960593|NCT02291614|581242322|FG009|Overall Study|Withdrawal by Subject|2|||
160960594|NCT02291614|581242323|FG010|Overall Study|Withdrawal by Subject|2|||
160960595|NCT02291614|581242313|FG000|Overall Study|Decision by sponsor|0|||
160960596|NCT02291614|581242314|FG001|Overall Study|Decision by sponsor|0|||
160960597|NCT02291614|581242315|FG002|Overall Study|Decision by sponsor|0|||
160960598|NCT02291614|581242316|FG003|Overall Study|Decision by sponsor|1|||
160960599|NCT02291614|581242317|FG004|Overall Study|Decision by sponsor|0|||
160960600|NCT02291614|581242318|FG005|Overall Study|Decision by sponsor|0|||
160960601|NCT02291614|581242319|FG006|Overall Study|Decision by sponsor|0|||
160960602|NCT02291614|581242320|FG007|Overall Study|Decision by sponsor|0|||
160960603|NCT02291614|581242321|FG008|Overall Study|Decision by sponsor|0|||
160960604|NCT02291614|581242322|FG009|Overall Study|Decision by sponsor|0|||
160960605|NCT02291614|581242323|FG010|Overall Study|Decision by sponsor|0|||
160960606|NCT02291614|581242313|FG000|Overall Study|Death|0|||
160960607|NCT02291614|581242314|FG001|Overall Study|Death|0|||
160960608|NCT02291614|581242315|FG002|Overall Study|Death|1|||
160960609|NCT02291614|581242316|FG003|Overall Study|Death|0|||
160960610|NCT02291614|581242317|FG004|Overall Study|Death|1|||
160960611|NCT02291614|581242318|FG005|Overall Study|Death|1|||
160960612|NCT02291614|581242319|FG006|Overall Study|Death|1|||
160960613|NCT02291614|581242320|FG007|Overall Study|Death|0|||
160960614|NCT02291614|581242321|FG008|Overall Study|Death|0|||
160960615|NCT02291614|581242322|FG009|Overall Study|Death|0|||
160960616|NCT02291614|581242323|FG010|Overall Study|Death|0|||
160960617|NCT00127101|581242324|FG000|Base Protocol|Adverse Event|0|||
160960618|NCT00127101|581242325|FG001|Base Protocol|Adverse Event|2|||
160960619|NCT00127101|581242326|FG002|Base Protocol|Adverse Event|1|||
160960620|NCT00127101|581242327|FG003|Base Protocol|Adverse Event|0|||
160960621|NCT00127101|581242328|FG004|Base Protocol|Adverse Event|0|||
160960622|NCT00127101|581242329|FG005|Base Protocol|Adverse Event|0|||
160960623|NCT00127101|581242324|FG000|Base Protocol|Lack of Efficacy|1|||
160960624|NCT00127101|581242325|FG001|Base Protocol|Lack of Efficacy|0|||
160960625|NCT00127101|581242326|FG002|Base Protocol|Lack of Efficacy|0|||
160960626|NCT00127101|581242327|FG003|Base Protocol|Lack of Efficacy|0|||
160960627|NCT00127101|581242328|FG004|Base Protocol|Lack of Efficacy|2|||
160960628|NCT00127101|581242329|FG005|Base Protocol|Lack of Efficacy|0|||
160960629|NCT00127101|581242324|FG000|Base Protocol|Withdrawal by Subject|1|||
160960630|NCT00127101|581242325|FG001|Base Protocol|Withdrawal by Subject|2|||
160960631|NCT00127101|581242326|FG002|Base Protocol|Withdrawal by Subject|1|||
160960632|NCT00127101|581242327|FG003|Base Protocol|Withdrawal by Subject|0|||
160960633|NCT00127101|581242328|FG004|Base Protocol|Withdrawal by Subject|0|||
160960634|NCT00127101|581242329|FG005|Base Protocol|Withdrawal by Subject|1|||
160960635|NCT00127101|581242324|FG000|Continuation Phase|Adverse Event|0|||
160960636|NCT00127101|581242325|FG001|Continuation Phase|Adverse Event|0|||
160960637|NCT00127101|581242326|FG002|Continuation Phase|Adverse Event|0|||
160960638|NCT00127101|581242327|FG003|Continuation Phase|Adverse Event|0|||
160960639|NCT00127101|581242328|FG004|Continuation Phase|Adverse Event|1|||
160960640|NCT00127101|581242329|FG005|Continuation Phase|Adverse Event|1|||
160960641|NCT00127101|581242324|FG000|Continuation Phase|Lack of Efficacy|0|||
160960642|NCT00127101|581242325|FG001|Continuation Phase|Lack of Efficacy|0|||
160960643|NCT00127101|581242326|FG002|Continuation Phase|Lack of Efficacy|0|||
160960644|NCT00127101|581242327|FG003|Continuation Phase|Lack of Efficacy|0|||
160960645|NCT00127101|581242328|FG004|Continuation Phase|Lack of Efficacy|0|||
160960646|NCT00127101|581242329|FG005|Continuation Phase|Lack of Efficacy|1|||
160960647|NCT00127101|581242324|FG000|Continuation Phase|Withdrawal by Subject|0|||
160960648|NCT00127101|581242325|FG001|Continuation Phase|Withdrawal by Subject|0|||
160960649|NCT00127101|581242326|FG002|Continuation Phase|Withdrawal by Subject|1|||
160960650|NCT00127101|581242327|FG003|Continuation Phase|Withdrawal by Subject|0|||
160960651|NCT00127101|581242328|FG004|Continuation Phase|Withdrawal by Subject|2|||
160960652|NCT00127101|581242329|FG005|Continuation Phase|Withdrawal by Subject|1|||
160960653|NCT00843167|581242330|FG000|Treatment Period|Adverse Event|1|||
160960654|NCT00843167|581242331|FG001|Treatment Period|Adverse Event|5|||
160960655|NCT00843167|581242330|FG000|Treatment Period|Withdrawal by Subject|2|||
160960656|NCT00843167|581242331|FG001|Treatment Period|Withdrawal by Subject|3|||
160960657|NCT03743038|581242332|FG000|Overall Study|Physician Decision|1|||
160960658|NCT01830127|581242334|FG000|Overall Study|Adverse Event|1|||
160960659|NCT01830127|581242335|FG001|Overall Study|Adverse Event|6|||
160960660|NCT01830127|581242334|FG000|Overall Study|Lack of Efficacy|3|||
160960661|NCT01830127|581242335|FG001|Overall Study|Lack of Efficacy|0|||
160960662|NCT01830127|581242334|FG000|Overall Study|Withdrawal by Subject|1|||
160960663|NCT01830127|581242335|FG001|Overall Study|Withdrawal by Subject|1|||
160960664|NCT01830127|581242334|FG000|Overall Study|Other reason not defined above|0|||
160960665|NCT01830127|581242335|FG001|Overall Study|Other reason not defined above|2|||
160960666|NCT01302847|581242338|FG000|Overall Study|Death|0|||
160960667|NCT01302847|581242339|FG001|Overall Study|Death|1|||
160960668|NCT01302847|581242340|FG002|Overall Study|Death|0|||
160960669|NCT01302847|581242341|FG003|Overall Study|Death|0|||
160960670|NCT01302847|581242342|FG004|Overall Study|Death|0|||
160960671|NCT01302847|581242343|FG005|Overall Study|Death|1|||
160960672|NCT01302847|581242344|FG006|Overall Study|Death|1|||
160960673|NCT01302847|581242345|FG007|Overall Study|Death|0|||
160960674|NCT01302847|581242338|FG000|Overall Study|Pregnancy|2|||
160960675|NCT01302847|581242339|FG001|Overall Study|Pregnancy|0|||
160960676|NCT01302847|581242340|FG002|Overall Study|Pregnancy|0|||
160960677|NCT01302847|581242341|FG003|Overall Study|Pregnancy|0|||
160960678|NCT01302847|581242342|FG004|Overall Study|Pregnancy|0|||
160960679|NCT01302847|581242343|FG005|Overall Study|Pregnancy|0|||
160960680|NCT01302847|581242344|FG006|Overall Study|Pregnancy|0|||
160960681|NCT01302847|581242345|FG007|Overall Study|Pregnancy|0|||
160960682|NCT01302847|581242338|FG000|Overall Study|Virologic failure|0|||
160960683|NCT01302847|581242339|FG001|Overall Study|Virologic failure|2|||
160960684|NCT01302847|581242340|FG002|Overall Study|Virologic failure|0|||
160960685|NCT01302847|581242341|FG003|Overall Study|Virologic failure|2|||
160960686|NCT01302847|581242342|FG004|Overall Study|Virologic failure|1|||
160960687|NCT01302847|581242343|FG005|Overall Study|Virologic failure|3|||
160960688|NCT01302847|581242344|FG006|Overall Study|Virologic failure|1|||
160960689|NCT01302847|581242345|FG007|Overall Study|Virologic failure|2|||
160960690|NCT01302847|581242338|FG000|Overall Study|Severe debilitation, unable to continue|0|||
160960691|NCT01302847|581242339|FG001|Overall Study|Severe debilitation, unable to continue|0|||
160960692|NCT01302847|581242340|FG002|Overall Study|Severe debilitation, unable to continue|0|||
160960693|NCT01302847|581242341|FG003|Overall Study|Severe debilitation, unable to continue|0|||
160960694|NCT01302847|581242342|FG004|Overall Study|Severe debilitation, unable to continue|0|||
160960695|NCT01302847|581242343|FG005|Overall Study|Severe debilitation, unable to continue|1|||
160960696|NCT01302847|581242344|FG006|Overall Study|Severe debilitation, unable to continue|1|||
160960697|NCT01302847|581242345|FG007|Overall Study|Severe debilitation, unable to continue|0|||
160960698|NCT01302847|581242338|FG000|Overall Study|Not able to get to clinic|1|||
160960699|NCT01302847|581242339|FG001|Overall Study|Not able to get to clinic|1|||
160960700|NCT01302847|581242340|FG002|Overall Study|Not able to get to clinic|0|||
160960701|NCT01302847|581242341|FG003|Overall Study|Not able to get to clinic|0|||
160960702|NCT01302847|581242342|FG004|Overall Study|Not able to get to clinic|0|||
160960703|NCT01302847|581242343|FG005|Overall Study|Not able to get to clinic|0|||
160960704|NCT01302847|581242344|FG006|Overall Study|Not able to get to clinic|0|||
160960705|NCT01302847|581242345|FG007|Overall Study|Not able to get to clinic|0|||
160960706|NCT01302847|581242338|FG000|Overall Study|Site closing|2|||
160960707|NCT01302847|581242339|FG001|Overall Study|Site closing|2|||
160960708|NCT01302847|581242340|FG002|Overall Study|Site closing|0|||
160960709|NCT01302847|581242341|FG003|Overall Study|Site closing|0|||
160960710|NCT01302847|581242342|FG004|Overall Study|Site closing|0|||
160960711|NCT01302847|581242343|FG005|Overall Study|Site closing|0|||
160960712|NCT01302847|581242344|FG006|Overall Study|Site closing|0|||
160960713|NCT01302847|581242345|FG007|Overall Study|Site closing|0|||
160960714|NCT01302847|581242338|FG000|Overall Study|Withdrawal by Subject|1|||
160960715|NCT01302847|581242339|FG001|Overall Study|Withdrawal by Subject|0|||
160960716|NCT01302847|581242340|FG002|Overall Study|Withdrawal by Subject|0|||
160960717|NCT01302847|581242341|FG003|Overall Study|Withdrawal by Subject|0|||
160960718|NCT01302847|581242342|FG004|Overall Study|Withdrawal by Subject|1|||
160960719|NCT01302847|581242343|FG005|Overall Study|Withdrawal by Subject|0|||
160960720|NCT01302847|581242344|FG006|Overall Study|Withdrawal by Subject|0|||
160960721|NCT01302847|581242345|FG007|Overall Study|Withdrawal by Subject|1|||
160960722|NCT01302847|581242338|FG000|Overall Study|Not willing to adhere to requirements|5|||
160960723|NCT01302847|581242339|FG001|Overall Study|Not willing to adhere to requirements|0|||
160960724|NCT01302847|581242340|FG002|Overall Study|Not willing to adhere to requirements|1|||
160960725|NCT01302847|581242341|FG003|Overall Study|Not willing to adhere to requirements|0|||
160960726|NCT01302847|581242342|FG004|Overall Study|Not willing to adhere to requirements|0|||
160960727|NCT01302847|581242343|FG005|Overall Study|Not willing to adhere to requirements|0|||
160960728|NCT01302847|581242344|FG006|Overall Study|Not willing to adhere to requirements|0|||
160960729|NCT01302847|581242345|FG007|Overall Study|Not willing to adhere to requirements|2|||
160960730|NCT01302847|581242338|FG000|Overall Study|Site unable to contact participant|2|||
160960731|NCT01302847|581242339|FG001|Overall Study|Site unable to contact participant|1|||
160960732|NCT01302847|581242340|FG002|Overall Study|Site unable to contact participant|0|||
160960733|NCT01302847|581242341|FG003|Overall Study|Site unable to contact participant|0|||
160960734|NCT01302847|581242342|FG004|Overall Study|Site unable to contact participant|0|||
160960735|NCT01302847|581242343|FG005|Overall Study|Site unable to contact participant|0|||
160960736|NCT01302847|581242344|FG006|Overall Study|Site unable to contact participant|2|||
160960737|NCT01302847|581242345|FG007|Overall Study|Site unable to contact participant|0|||
160960738|NCT03563716|581244571|FG000|Overall Study|Death|20|||
160960739|NCT03563716|581244572|FG001|Overall Study|Death|14|||
160960740|NCT03563716|581244571|FG000|Overall Study|Withdrawal by Subject|3|||
160960741|NCT03563716|581244572|FG001|Overall Study|Withdrawal by Subject|3|||
160960742|NCT03563716|581244571|FG000|Overall Study|Still on Study|45|||
160960743|NCT03563716|581244572|FG001|Overall Study|Still on Study|50|||
160960744|NCT03813238|581244575|FG000|Overall Study|Adverse Event|0|||
160960745|NCT03813238|581244576|FG001|Overall Study|Adverse Event|6|||
160960746|NCT03813238|581244575|FG000|Overall Study|Withdrawal by parent/guardian|0|||
160960747|NCT03813238|581244576|FG001|Overall Study|Withdrawal by parent/guardian|2|||
160960748|NCT03813238|581244575|FG000|Overall Study|Lost to Follow-up|0|||
160960749|NCT03813238|581244576|FG001|Overall Study|Lost to Follow-up|1|||
160960750|NCT03813238|581244575|FG000|Overall Study|Other than specified|1|||
160960751|NCT03813238|581244576|FG001|Overall Study|Other than specified|2|||
160960752|NCT02066402|581244577|FG000|Overall Study|Adverse Event|1|||
160960753|NCT02066402|581244578|FG001|Overall Study|Adverse Event|2|||
160960754|NCT02066402|581244577|FG000|Overall Study|Lost to Follow-up|11|||
160960755|NCT02066402|581244578|FG001|Overall Study|Lost to Follow-up|8|||
160960756|NCT02066402|581244577|FG000|Overall Study|Withdrawal by Subject|14|||
160960757|NCT02066402|581244578|FG001|Overall Study|Withdrawal by Subject|11|||
160960758|NCT02066402|581244577|FG000|Overall Study|Progressive disease-clinical progression|0|||
160960759|NCT02066402|581244578|FG001|Overall Study|Progressive disease-clinical progression|1|||
160960760|NCT02066402|581244577|FG000|Overall Study|Protocol driven decision point|0|||
160960761|NCT02066402|581244578|FG001|Overall Study|Protocol driven decision point|1|||
160960762|NCT00152464|581244579|FG000|Overall Study|Adverse Event|3|||
160960763|NCT00152464|581244580|FG001|Overall Study|Adverse Event|6|||
160960764|NCT00152464|581244579|FG000|Overall Study|Lost to Follow-up|8|||
160960765|NCT00152464|581244580|FG001|Overall Study|Lost to Follow-up|4|||
160960766|NCT00152464|581244579|FG000|Overall Study|Protocol Violation|3|||
160960767|NCT00152464|581244580|FG001|Overall Study|Protocol Violation|1|||
160960768|NCT00152464|581244579|FG000|Overall Study|Withdrawal by Subject|21|||
160960769|NCT00152464|581244580|FG001|Overall Study|Withdrawal by Subject|22|||
160960770|NCT00152464|581244579|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
160960771|NCT00152464|581244580|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
160960772|NCT00152464|581244579|FG000|Overall Study|Eczema deterioration|0|||
160960773|NCT00152464|581244580|FG001|Overall Study|Eczema deterioration|1|||
160960774|NCT00152464|581244579|FG000|Overall Study|Parent decision|1|||
160960775|NCT00152464|581244580|FG001|Overall Study|Parent decision|1|||
160960776|NCT00152464|581244579|FG000|Overall Study|Investigator decision|1|||
160960777|NCT00152464|581244580|FG001|Overall Study|Investigator decision|0|||
160960778|NCT00152464|581244579|FG000|Overall Study|Lack of Efficacy|1|||
160960779|NCT00152464|581244580|FG001|Overall Study|Lack of Efficacy|0|||
160960780|NCT00152464|581244579|FG000|Overall Study|Eczema poorly controlled|1|||
160960781|NCT00152464|581244580|FG001|Overall Study|Eczema poorly controlled|0|||
160960782|NCT00152464|581244579|FG000|Overall Study|Patient relocated|1|||
160960783|NCT00152464|581244580|FG001|Overall Study|Patient relocated|0|||
160960784|NCT02462876|581244581|FG000|Overall Study|Death|3|||
160960785|NCT02462876|581244581|FG000|Overall Study|Lost to Follow-up|7|||
161002040|NCT01837641|581393096|FG005|Overall Study|Sponsor decision|1|||
161002041|NCT01837641|581393097|FG006|Overall Study|Sponsor decision|0|||
161002042|NCT01837641|581393098|FG007|Overall Study|Sponsor decision|0|||
161002043|NCT01837641|581393091|FG000|Overall Study|Adverse Event|0|||
161002044|NCT01837641|581393092|FG001|Overall Study|Adverse Event|0|||
161002045|NCT01837641|581393093|FG002|Overall Study|Adverse Event|0|||
161002046|NCT01837641|581393094|FG003|Overall Study|Adverse Event|0|||
161002047|NCT01837641|581393095|FG004|Overall Study|Adverse Event|0|||
161002048|NCT01837641|581393096|FG005|Overall Study|Adverse Event|1|||
161002049|NCT01837641|581393097|FG006|Overall Study|Adverse Event|0|||
160960786|NCT02462876|581244581|FG000|Overall Study|Surgical Bypass|9|||
160960787|NCT02462876|581244581|FG000|Overall Study|Amputation Above the Metatarsals|1|||
160960788|NCT02462876|581244581|FG000|Overall Study|36 months follow-up visit missed|1|||
160960789|NCT02462876|581244581|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
160960790|NCT02462876|581244581|FG000|Overall Study|Patient did not come back to the vascular department|1|||
160960791|NCT02462876|581244581|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
160960792|NCT02462876|581244581|FG000|Overall Study|Patient refused to come back|1|||
160960793|NCT02462876|581244581|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
160960794|NCT02462876|581244581|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
160960795|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
161002050|NCT01837641|581393098|FG007|Overall Study|Adverse Event|0|||
160960796|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
160960797|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
160960798|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
160960799|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
160960800|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
160960801|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
160960802|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
160960803|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Other|18|||
160960804|NCT02565914|581244582|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
160960805|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
160960806|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Other|1|||
160960807|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
160960808|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
160960809|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
160960810|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
160960811|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
160960812|NCT02565914|581244582|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
160960813|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
160960814|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
160960815|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
160960816|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
160960817|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
160960818|NCT02565914|581244582|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
161002051|NCT01837641|581393091|FG000|Overall Study|Withdrawal by Subject|0|||
161002052|NCT01837641|581393092|FG001|Overall Study|Withdrawal by Subject|0|||
161002053|NCT01837641|581393093|FG002|Overall Study|Withdrawal by Subject|0|||
161002054|NCT01837641|581393094|FG003|Overall Study|Withdrawal by Subject|0|||
161002055|NCT01837641|581393095|FG004|Overall Study|Withdrawal by Subject|1|||
161002056|NCT01837641|581393096|FG005|Overall Study|Withdrawal by Subject|0|||
161002057|NCT01837641|581393097|FG006|Overall Study|Withdrawal by Subject|1|||
161002058|NCT01837641|581393098|FG007|Overall Study|Withdrawal by Subject|0|||
161002059|NCT03768206|581393105|FG000|Overall Study|Lost to Follow-up|2|||
161002060|NCT03768206|581393106|FG001|Overall Study|Lost to Follow-up|1|||
161002061|NCT03768206|581393105|FG000|Overall Study|Withdrawal by Subject|0|||
161002062|NCT03768206|581393106|FG001|Overall Study|Withdrawal by Subject|1|||
161002063|NCT02106442|581393109|FG000|Overall Study|Case Report Forms Uncollected|7|||
161002064|NCT02106442|581393109|FG000|Overall Study|Protocol Deviation|30|||
161002065|NCT03516942|581393111|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
161002066|NCT03516942|581393111|FG000|Registration through baseline survey com|Death|8|||
161002067|NCT03516942|581393111|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
161002068|NCT03516942|581393111|FG000|T0: Baseline|LOST|13|||
161002069|NCT03516942|581393111|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
161002070|NCT03516942|581393111|FG000|T1: 3 Months Survey|Death|10|||
161002071|NCT03516942|581393111|FG000|T1: 3 Months Survey|Lost|163|||
161002072|NCT03516942|581393111|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
161002073|NCT03516942|581393111|FG000|T2: 6 Month Survey|Death|14|||
161002074|NCT03516942|581393111|FG000|T2: 6 Month Survey|Lost|180|||
161002075|NCT03516942|581393111|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
161002076|NCT03516942|581393111|FG000|T3: 12 Month Survey|Death|19|||
161002077|NCT03516942|581393111|FG000|T3: 12 Month Survey|Lost|209|||
161002078|NCT06269640|581394520|FG000|Overall Study|Death|1|||
161002079|NCT00711958|581394521|FG000|Overall Study|Withdrawal by Subject|6|||
161002080|NCT00711958|581394522|FG001|Overall Study|Withdrawal by Subject|8|||
161002081|NCT00711958|581394521|FG000|Overall Study|Lack of Efficacy|3|||
161002082|NCT00711958|581394522|FG001|Overall Study|Lack of Efficacy|1|||
161002083|NCT00711958|581394521|FG000|Overall Study|Clinical deterioration|1|||
161002084|NCT00711958|581394522|FG001|Overall Study|Clinical deterioration|0|||
161002085|NCT00711958|581394521|FG000|Overall Study|Adverse Event|9|||
160960819|NCT03581981|581244583|FG000|Overall Study|Withdrawal by Subject|12|||
160960820|NCT03581981|581244584|FG001|Overall Study|Withdrawal by Subject|13|||
160960821|NCT03581981|581244583|FG000|Overall Study|Physician Decision|1|||
160960822|NCT03581981|581244584|FG001|Overall Study|Physician Decision|2|||
161002086|NCT00711958|581394522|FG001|Overall Study|Adverse Event|7|||
161002087|NCT00711958|581394521|FG000|Overall Study|Protocol Violation|1|||
161002088|NCT00711958|581394522|FG001|Overall Study|Protocol Violation|0|||
161002089|NCT00711958|581394521|FG000|Overall Study|Lost to Follow-up|2|||
161002090|NCT00711958|581394522|FG001|Overall Study|Lost to Follow-up|2|||
161002091|NCT00711958|581394521|FG000|Overall Study|Death|10|||
161002092|NCT00711958|581394522|FG001|Overall Study|Death|5|||
161002093|NCT00711958|581394521|FG000|Overall Study|Progression of disease|1|||
161002094|NCT00711958|581394522|FG001|Overall Study|Progression of disease|0|||
161002095|NCT02383472|581394523|FG000|Overall Study|Withdrawal by Subject|1|||
161002096|NCT02383472|581394524|FG001|Overall Study|Withdrawal by Subject|1|||
161002097|NCT02015546|581394525|FG000|Overall Study|Withdrawal by Subject|1|||
160960823|NCT03581981|581244583|FG000|Overall Study|Lost to Follow-up|0|||
160960824|NCT03581981|581244584|FG001|Overall Study|Lost to Follow-up|4|||
160960825|NCT00828984|581244585|FG000|Overall Study|Adverse Event|2|||
160960826|NCT00828984|581244586|FG001|Overall Study|Adverse Event|3|||
160960827|NCT00828984|581244587|FG002|Overall Study|Adverse Event|0|||
160960828|NCT00828984|581244585|FG000|Overall Study|Lost to Follow-up|5|||
160960829|NCT00828984|581244586|FG001|Overall Study|Lost to Follow-up|3|||
160960830|NCT00828984|581244587|FG002|Overall Study|Lost to Follow-up|1|||
160960831|NCT00828984|581244585|FG000|Overall Study|Withdrawal by Subject|4|||
160960832|NCT00828984|581244586|FG001|Overall Study|Withdrawal by Subject|4|||
160960833|NCT00828984|581244587|FG002|Overall Study|Withdrawal by Subject|4|||
160960834|NCT00828984|581244585|FG000|Overall Study|Ineligable|1|||
160960835|NCT00828984|581244586|FG001|Overall Study|Ineligable|2|||
160960836|NCT00828984|581244587|FG002|Overall Study|Ineligable|0|||
160960837|NCT00828984|581244585|FG000|Overall Study|Medical Contraindication|0|||
160960838|NCT00828984|581244586|FG001|Overall Study|Medical Contraindication|1|||
161002098|NCT02015546|581394526|FG001|Overall Study|Withdrawal by Subject|1|||
161002099|NCT02015546|581394527|FG002|Overall Study|Withdrawal by Subject|1|||
161002100|NCT02015546|581394525|FG000|Overall Study|Screem Failure|2|||
161002101|NCT02015546|581394526|FG001|Overall Study|Screem Failure|1|||
161002102|NCT02015546|581394527|FG002|Overall Study|Screem Failure|3|||
161002103|NCT01171625|581394528|FG000|Overall Study|On-Protocol|67|||
161002104|NCT01171625|581394528|FG000|Overall Study|Death|38|||
161002105|NCT01171625|581394528|FG000|Overall Study|Withdrawal by Subject|31|||
161002106|NCT01171625|581394528|FG000|Overall Study|Explanted|10|||
161002107|NCT01171625|581394528|FG000|Overall Study|Lost to Follow-up|5|||
161002108|NCT01171625|581394528|FG000|Overall Study|Patient received valve-in-valve|3|||
161002109|NCT01171625|581394528|FG000|Overall Study|Other|1|||
161002110|NCT01171625|581394528|FG000|Overall Study|Consented but did not receive device|25|||
161002111|NCT00799396|581394529|FG000|Clopidogrel Treatment|Adverse Event|6|||
161002112|NCT00799396|581394529|FG000|Clopidogrel Treatment|Physician Decision|5|||
161002113|NCT00799396|581394529|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
161002114|NCT00799396|581394529|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
161002115|NCT00799396|581394529|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
161002116|NCT01113931|581394530|FG000|Overall Study|Adverse Event|2|||
161002117|NCT01113931|581394531|FG001|Overall Study|Adverse Event|2|||
161002118|NCT01113931|581394530|FG000|Overall Study|Physician Decision|0|||
161002119|NCT01113931|581394531|FG001|Overall Study|Physician Decision|2|||
161002120|NCT01113931|581394530|FG000|Overall Study|Lost to Follow-up|12|||
161002121|NCT01113931|581394531|FG001|Overall Study|Lost to Follow-up|9|||
161002122|NCT01113931|581394530|FG000|Overall Study|Various|2|||
161002123|NCT01113931|581394531|FG001|Overall Study|Various|4|||
161002124|NCT01113931|581394530|FG000|Overall Study|Withdrawal by Subject|3|||
161002125|NCT01113931|581394531|FG001|Overall Study|Withdrawal by Subject|0|||
161002126|NCT06119113|581394536|FG000|Overall Study|Lost to Follow-up|15|||
161002127|NCT06119113|581394537|FG001|Overall Study|Lost to Follow-up|13|||
161002128|NCT06119113|581394538|FG002|Overall Study|Lost to Follow-up|21|||
161002129|NCT00424762|581394541|FG000|Overall Study|Withdrawal by Subject|18|||
161002130|NCT00424762|581394542|FG001|Overall Study|Withdrawal by Subject|19|||
161002131|NCT00424762|581394541|FG000|Overall Study|Lost to Follow-up|2|||
161002132|NCT00424762|581394542|FG001|Overall Study|Lost to Follow-up|3|||
161002133|NCT01145885|581394543|FG000|Overall Study|Progressive Disease|7|||
161002134|NCT02950558|581394547|FG000|Overall Study|Lost to Follow-up|2|||
161002135|NCT02950558|581394548|FG001|Overall Study|Lost to Follow-up|0|||
161146898|NCT05363293|581919932|FG003|Overall Study|Withdrawal by Subject|0|||
161146899|NCT05363293|581919933|FG004|Overall Study|Withdrawal by Subject|0|||
161146900|NCT05363293|581919934|FG005|Overall Study|Withdrawal by Subject|0|||
161146901|NCT05363293|581919935|FG006|Overall Study|Withdrawal by Subject|0|||
161146902|NCT05363293|581919936|FG007|Overall Study|Withdrawal by Subject|0|||
161146903|NCT05363293|581919937|FG008|Overall Study|Withdrawal by Subject|0|||
161146904|NCT05363293|581919938|FG009|Overall Study|Withdrawal by Subject|0|||
160960839|NCT00828984|581244587|FG002|Overall Study|Medical Contraindication|0|||
160960840|NCT00828984|581244585|FG000|Overall Study|Noncompliant|1|||
160960841|NCT00828984|581244586|FG001|Overall Study|Noncompliant|2|||
160960842|NCT00828984|581244587|FG002|Overall Study|Noncompliant|3|||
161146905|NCT04773041|581919939|FG000|Overall Study|Unable to data match|1|||
160960843|NCT00828984|581244585|FG000|Overall Study|ConMed|1|||
161146906|NCT04773041|581919940|FG001|Overall Study|Unable to data match|0|||
161146907|NCT04773041|581919941|FG002|Overall Study|Unable to data match|0|||
160960844|NCT00828984|581244586|FG001|Overall Study|ConMed|1|||
160960845|NCT00828984|581244587|FG002|Overall Study|ConMed|1|||
160960846|NCT04465357|581244590|FG000|Overall Study|Adverse Event|2|||
160960847|NCT04465357|581244590|FG000|Overall Study|Lack of Efficacy|1|||
161146908|NCT01666444|581922378|FG000|Overall Study|Did not initiate treatment|2|||
161146909|NCT01666444|581922379|FG001|Overall Study|Did not initiate treatment|1|||
161146910|NCT00950690|581922380|FG000|Overall Study|Death|4|||
161146911|NCT00950690|581922380|FG000|Overall Study|Adverse Event|15|||
161146912|NCT00950690|581922380|FG000|Overall Study|Lack of Efficacy|22|||
161146913|NCT00950690|581922380|FG000|Overall Study|Lost to Follow-up|40|||
160960848|NCT04465357|581244590|FG000|Overall Study|Lost to Follow-up|2|||
160960849|NCT04465357|581244590|FG000|Overall Study|Withdrawal by Subject|6|||
160960850|NCT04465357|581244590|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
160960851|NCT00863655|581244591|FG000|Overall Study|Protocol Violation|4|||
160960852|NCT00863655|581244592|FG001|Overall Study|Protocol Violation|0|||
160960853|NCT00863655|581244591|FG000|Overall Study|Adverse Event|52|||
160960854|NCT00863655|581244592|FG001|Overall Study|Adverse Event|8|||
160960855|NCT00863655|581244591|FG000|Overall Study|Withdrawal by Subject|47|||
160960856|NCT00863655|581244592|FG001|Overall Study|Withdrawal by Subject|7|||
160960857|NCT00863655|581244591|FG000|Overall Study|Administrative problems|1|||
160960858|NCT00863655|581244592|FG001|Overall Study|Administrative problems|0|||
160960859|NCT00863655|581244591|FG000|Overall Study|Death|7|||
160960860|NCT00863655|581244592|FG001|Overall Study|Death|1|||
160960861|NCT00863655|581244591|FG000|Overall Study|New cancer therapy|5|||
160960862|NCT00863655|581244592|FG001|Overall Study|New cancer therapy|1|||
160960863|NCT00863655|581244591|FG000|Overall Study|Disease progression|364|||
160960864|NCT00863655|581244592|FG001|Overall Study|Disease progression|221|||
160960865|NCT00863655|581244591|FG000|Overall Study|Treatment completed as per protocol|5|||
160960866|NCT00863655|581244592|FG001|Overall Study|Treatment completed as per protocol|1|||
160960867|NCT00716092|581244593|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
160960868|NCT00716092|581244594|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
160960869|NCT00716092|581244595|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
160960870|NCT02436330|581244596|FG000|Cohort 1|Lost to Follow-up|5|||
160960871|NCT02436330|581244597|FG001|Cohort 1|Lost to Follow-up|2|||
160960872|NCT02436330|581244596|FG000|Cohort 1|Withdrawal by Subject|0|||
160960873|NCT02436330|581244597|FG001|Cohort 1|Withdrawal by Subject|1|||
160960874|NCT02436330|581244596|FG000|Cohort 2|Lost to Follow-up|2|||
160960875|NCT02436330|581244597|FG001|Cohort 2|Lost to Follow-up|0|||
160960876|NCT02436330|581244596|FG000|Cohort 2|Withdrawal by Subject|2|||
160960877|NCT02436330|581244597|FG001|Cohort 2|Withdrawal by Subject|3|||
160960878|NCT02436330|581244596|FG000|Cohort 3|Lost to Follow-up|1|||
160960879|NCT02436330|581244597|FG001|Cohort 3|Lost to Follow-up|0|||
160960880|NCT02436330|581244596|FG000|Cohort 3|Withdrawal by Subject|4|||
160960881|NCT02436330|581244597|FG001|Cohort 3|Withdrawal by Subject|0|||
160960882|NCT02436330|581244596|FG000|Cohort 4|Lost to Follow-up|1|||
160960883|NCT02436330|581244597|FG001|Cohort 4|Lost to Follow-up|0|||
160960884|NCT02436330|581244596|FG000|Cohort 4|Withdrawal by Subject|1|||
160960885|NCT02436330|581244597|FG001|Cohort 4|Withdrawal by Subject|0|||
160960886|NCT02436330|581244596|FG000|Cohort 5|Lost to Follow-up|3|||
160960887|NCT02436330|581244597|FG001|Cohort 5|Lost to Follow-up|2|||
160960888|NCT02436330|581244596|FG000|Cohort 5|Withdrawal by Subject|3|||
160960889|NCT02436330|581244597|FG001|Cohort 5|Withdrawal by Subject|2|||
160960890|NCT02436330|581244596|FG000|Cohort 6|Lost to Follow-up|2|||
160960891|NCT02436330|581244597|FG001|Cohort 6|Lost to Follow-up|0|||
160960892|NCT02436330|581244596|FG000|Cohort 6|Withdrawal by Subject|1|||
160960893|NCT02436330|581244597|FG001|Cohort 6|Withdrawal by Subject|1|||
160960894|NCT02054806|581244598|FG000|Overall Study|Sponsor Decision|31|||
160960895|NCT02054806|581244598|FG000|Overall Study|Withdrawal by Subject|43|||
160960896|NCT02054806|581244598|FG000|Overall Study|Protocol Violation|2|||
160960897|NCT02054806|581244598|FG000|Overall Study|Lost to Follow-up|10|||
160960898|NCT02054806|581244598|FG000|Overall Study|Death|391|||
160960899|NCT00677235|581244599|FG000|Overall Study|Withdrawal by Subject|1|||
160960900|NCT00677235|581244600|FG001|Overall Study|Withdrawal by Subject|1|||
160960901|NCT00677235|581244599|FG000|Overall Study|Lost to Follow-up|2|||
161146914|NCT00950690|581922380|FG000|Overall Study|Other|163|||
161146915|NCT01713036|581922381|FG000|Overall Study|Death|1|||
161002154|NCT01135511|581394553|FG000|Overall Study|Adverse Event|0|||
161002155|NCT01135511|581394554|FG001|Overall Study|Adverse Event|1|||
161270969|NCT03201211|582372844|FG001|Overall Study|Protocol Violation|0|||
161270970|NCT03201211|582372845|FG002|Overall Study|Protocol Violation|0|||
161270971|NCT03201211|582372843|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160960902|NCT00677235|581244600|FG001|Overall Study|Lost to Follow-up|1|||
160960903|NCT00677235|581244599|FG000|Overall Study|Death|37|||
160960904|NCT00677235|581244600|FG001|Overall Study|Death|36|||
160960905|NCT00677235|581244599|FG000|Overall Study|Adverse Experience|1|||
160960906|NCT00677235|581244600|FG001|Overall Study|Adverse Experience|0|||
160960907|NCT01040260|581244601|FG000|Overall Study|Withdrawal by Subject|12|||
161002156|NCT01135511|581394555|FG002|Overall Study|Adverse Event|2|||
161002157|NCT01135511|581394556|FG003|Overall Study|Adverse Event|0|||
160960908|NCT01040260|581244602|FG001|Overall Study|Withdrawal by Subject|6|||
160960909|NCT01040260|581244601|FG000|Overall Study|Lost to Follow-up|3|||
160960910|NCT01040260|581244602|FG001|Overall Study|Lost to Follow-up|5|||
160960911|NCT00708916|581244615|FG000|Overall Study|Subject Noncompliance|2|||
160960912|NCT00708916|581244615|FG000|Overall Study|Adverse Event|2|||
160960913|NCT00951483|581244618|FG000|Overall Study|Physician Decision|4|||
160960914|NCT00951483|581244619|FG001|Overall Study|Physician Decision|0|||
160960915|NCT00951483|581244618|FG000|Overall Study|Withdrawal by Subject|15|||
160960916|NCT00951483|581244619|FG001|Overall Study|Withdrawal by Subject|0|||
161270972|NCT03201211|582372844|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
160960917|NCT03565887|581244620|FG000|Overall Study|Adverse Event|1|||
160960918|NCT03565887|581244621|FG001|Overall Study|Adverse Event|0|||
160960919|NCT03565887|581244620|FG000|Overall Study|Withdrawal by Subject|0|||
160960920|NCT03565887|581244621|FG001|Overall Study|Withdrawal by Subject|2|||
160960921|NCT00689221|581244622|FG000|Overall Study|Ongoing at cut-off date|39|||
160960922|NCT00689221|581244623|FG001|Overall Study|Ongoing at cut-off date|36|||
160960923|NCT01292239|581244624|FG000|Overall Study|Other|1|||
160960924|NCT01292239|581244625|FG001|Overall Study|Other|1|||
160960925|NCT01292239|581244624|FG000|Overall Study|Withdrawal by Subject|3|||
160960926|NCT01292239|581244625|FG001|Overall Study|Withdrawal by Subject|6|||
160960927|NCT00262821|581244626|FG000|Overall Study|Ineligible - wrong stage|0|||
160960928|NCT00262821|581244627|FG001|Overall Study|Ineligible - wrong stage|3|||
160960929|NCT00262821|581244626|FG000|Overall Study|Ineligible - wrong cell type|2|||
160960930|NCT00262821|581244627|FG001|Overall Study|Ineligible - wrong cell type|2|||
160960931|NCT00262821|581244626|FG000|Overall Study|Ineligible - wrong primary|0|||
160960932|NCT00262821|581244627|FG001|Overall Study|Ineligible - wrong primary|1|||
160960933|NCT00262821|581244626|FG000|Overall Study|Ineligible - inadequate pathology|1|||
160960934|NCT00262821|581244627|FG001|Overall Study|Ineligible - inadequate pathology|3|||
160960935|NCT00262821|581244626|FG000|Overall Study|Ineligible - elevated creatinine|0|||
160960936|NCT00262821|581244627|FG001|Overall Study|Ineligible - elevated creatinine|2|||
160960937|NCT00262821|581244626|FG000|Overall Study|Ineligible - required test not done|1|||
160960938|NCT00262821|581244627|FG001|Overall Study|Ineligible - required test not done|4|||
160960939|NCT00262821|581244626|FG000|Overall Study|Inevaluable - inadequate data|0|||
160960940|NCT00262821|581244627|FG001|Overall Study|Inevaluable - inadequate data|4|||
160960941|NCT01995461|581244628|FG000|Overall Study|Death|1|||
160960942|NCT01995461|581244628|FG000|Overall Study|Lost to Follow-up|2|||
161002158|NCT01135511|581394557|FG004|Overall Study|Adverse Event|0|||
161002159|NCT01135511|581394558|FG005|Overall Study|Adverse Event|1|||
161002160|NCT01135511|581394559|FG006|Overall Study|Adverse Event|0|||
161002161|NCT01135511|581394560|FG007|Overall Study|Adverse Event|1|||
161002162|NCT01135511|581394561|FG008|Overall Study|Adverse Event|0|||
161002163|NCT01135511|581394553|FG000|Overall Study|Lack of Efficacy|0|||
161002164|NCT01135511|581394554|FG001|Overall Study|Lack of Efficacy|1|||
161002165|NCT01135511|581394555|FG002|Overall Study|Lack of Efficacy|1|||
161002166|NCT01135511|581394556|FG003|Overall Study|Lack of Efficacy|2|||
161002167|NCT01135511|581394557|FG004|Overall Study|Lack of Efficacy|0|||
161002168|NCT01135511|581394558|FG005|Overall Study|Lack of Efficacy|0|||
161002169|NCT01135511|581394559|FG006|Overall Study|Lack of Efficacy|0|||
161002170|NCT01135511|581394560|FG007|Overall Study|Lack of Efficacy|0|||
160960943|NCT01995461|581244628|FG000|Overall Study|Withdrawal by Subject|2|||
160960944|NCT01777854|581244630|FG000|Overall Study|Physician Decision|3|||
160960945|NCT01777854|581244631|FG001|Overall Study|Physician Decision|3|||
160960946|NCT01939548|581244632|FG000|Overall Study|Non compliance|0|||
160960947|NCT01939548|581244633|FG001|Overall Study|Non compliance|2|||
160960948|NCT01939548|581244634|FG002|Overall Study|Non compliance|0|||
160960949|NCT01939548|581244632|FG000|Overall Study|Study Terminated by Sponsor|17|||
160960950|NCT01939548|581244633|FG001|Overall Study|Study Terminated by Sponsor|19|||
160960951|NCT01939548|581244634|FG002|Overall Study|Study Terminated by Sponsor|12|||
160960952|NCT01939548|581244632|FG000|Overall Study|Insufficient Clinical Response|1|||
161002171|NCT01135511|581394561|FG008|Overall Study|Lack of Efficacy|0|||
161002172|NCT01135511|581394553|FG000|Overall Study|Protocol Violation|0|||
161002173|NCT01135511|581394554|FG001|Overall Study|Protocol Violation|0|||
161002174|NCT01135511|581394555|FG002|Overall Study|Protocol Violation|3|||
161002175|NCT01135511|581394556|FG003|Overall Study|Protocol Violation|0|||
161002176|NCT01135511|581394557|FG004|Overall Study|Protocol Violation|0|||
161002177|NCT01135511|581394558|FG005|Overall Study|Protocol Violation|0|||
161002178|NCT01135511|581394559|FG006|Overall Study|Protocol Violation|0|||
161002179|NCT01135511|581394560|FG007|Overall Study|Protocol Violation|0|||
161146916|NCT00592358|581922382|FG000|Overall Study|Withdrawal by Subject|2|||
161146917|NCT00592358|581922382|FG000|Overall Study|Adverse Event|1|||
161146918|NCT00592358|581922382|FG000|Overall Study|Lack of Efficacy|2|||
160960953|NCT01939548|581244633|FG001|Overall Study|Insufficient Clinical Response|0|||
160960954|NCT01939548|581244634|FG002|Overall Study|Insufficient Clinical Response|0|||
160960955|NCT01939548|581244632|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
160960956|NCT01939548|581244633|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
160960957|NCT01939548|581244634|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
160960958|NCT01939548|581244632|FG000|Overall Study|Withdrawal by Subject|4|||
160960959|NCT01939548|581244633|FG001|Overall Study|Withdrawal by Subject|4|||
160960960|NCT01939548|581244634|FG002|Overall Study|Withdrawal by Subject|1|||
161002180|NCT01135511|581394561|FG008|Overall Study|Protocol Violation|0|||
161002181|NCT01135511|581394553|FG000|Overall Study|Pregnancy|0|||
161002182|NCT01135511|581394554|FG001|Overall Study|Pregnancy|0|||
161002183|NCT01135511|581394555|FG002|Overall Study|Pregnancy|0|||
161002184|NCT01135511|581394556|FG003|Overall Study|Pregnancy|1|||
160960961|NCT01939548|581244632|FG000|Overall Study|Protocol Violation|7|||
161002185|NCT01135511|581394557|FG004|Overall Study|Pregnancy|0|||
161002186|NCT01135511|581394558|FG005|Overall Study|Pregnancy|0|||
161002187|NCT01135511|581394559|FG006|Overall Study|Pregnancy|0|||
160960962|NCT01939548|581244633|FG001|Overall Study|Protocol Violation|6|||
160960963|NCT01939548|581244634|FG002|Overall Study|Protocol Violation|5|||
160960964|NCT01939548|581244632|FG000|Overall Study|Lost to Follow-up|5|||
160960965|NCT01939548|581244633|FG001|Overall Study|Lost to Follow-up|5|||
160960966|NCT01939548|581244634|FG002|Overall Study|Lost to Follow-up|3|||
160960967|NCT01939548|581244632|FG000|Overall Study|Adverse Event|2|||
160960968|NCT01939548|581244633|FG001|Overall Study|Adverse Event|9|||
160960969|NCT01939548|581244634|FG002|Overall Study|Adverse Event|7|||
160960970|NCT01939548|581244632|FG000|Overall Study|Death|0|||
160960971|NCT01939548|581244633|FG001|Overall Study|Death|0|||
160960972|NCT01939548|581244634|FG002|Overall Study|Death|1|||
160960973|NCT01939548|581244632|FG000|Overall Study|Participant dropped|0|||
160960974|NCT01939548|581244633|FG001|Overall Study|Participant dropped|0|||
160960975|NCT01939548|581244634|FG002|Overall Study|Participant dropped|1|||
160960976|NCT01939548|581244632|FG000|Overall Study|Participant unwilling to continue|0|||
160960977|NCT01939548|581244633|FG001|Overall Study|Participant unwilling to continue|1|||
160960978|NCT01939548|581244634|FG002|Overall Study|Participant unwilling to continue|0|||
160960979|NCT01939548|581244632|FG000|Overall Study|Participant withdrew consent|0|||
160960980|NCT01939548|581244633|FG001|Overall Study|Participant withdrew consent|2|||
160960981|NCT01939548|581244634|FG002|Overall Study|Participant withdrew consent|0|||
160960982|NCT01939548|581244632|FG000|Overall Study|Did not complete follow-up|0|||
160960983|NCT01939548|581244633|FG001|Overall Study|Did not complete follow-up|1|||
160960984|NCT01939548|581244634|FG002|Overall Study|Did not complete follow-up|0|||
160960985|NCT03311373|581244635|FG000|Overall Study|Adverse Event|1|||
160960986|NCT03311373|581244635|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
160960987|NCT03311373|581244635|FG000|Overall Study|Lost to Follow-up|1|||
160960988|NCT03311373|581244635|FG000|Overall Study|Physician Decision|1|||
160960989|NCT03311373|581244635|FG000|Overall Study|Withdrawal by Subject|3|||
160960990|NCT01302119|581244636|FG000|Overall Study|Withdrawal by Subject|30|||
160960991|NCT01302119|581244637|FG001|Overall Study|Withdrawal by Subject|20|||
160960992|NCT01302119|581244636|FG000|Overall Study|Lost to Follow-up|10|||
160960993|NCT01302119|581244637|FG001|Overall Study|Lost to Follow-up|4|||
160960994|NCT01302119|581244636|FG000|Overall Study|Adverse Event|2|||
160960995|NCT01302119|581244637|FG001|Overall Study|Adverse Event|1|||
160960996|NCT01302119|581244636|FG000|Overall Study|Non-compliance|4|||
160960997|NCT01302119|581244637|FG001|Overall Study|Non-compliance|2|||
160960998|NCT01302119|581244636|FG000|Overall Study|Non-specific|4|||
160960999|NCT01302119|581244637|FG001|Overall Study|Non-specific|1|||
160961000|NCT01565707|581244645|FG000|Overall Study|Adverse Event|1|||
160961001|NCT01565707|581244646|FG001|Overall Study|Adverse Event|6|||
160961002|NCT01565707|581244647|FG002|Overall Study|Adverse Event|2|||
160961003|NCT01565707|581244648|FG003|Overall Study|Adverse Event|1|||
160961004|NCT01565707|581244645|FG000|Overall Study|Lost to Follow-up|1|||
160961005|NCT01565707|581244646|FG001|Overall Study|Lost to Follow-up|0|||
160961006|NCT01565707|581244647|FG002|Overall Study|Lost to Follow-up|0|||
160961007|NCT01565707|581244648|FG003|Overall Study|Lost to Follow-up|0|||
160961008|NCT01565707|581244645|FG000|Overall Study|Protocol Violation|1|||
160961009|NCT01565707|581244646|FG001|Overall Study|Protocol Violation|0|||
160961010|NCT01565707|581244647|FG002|Overall Study|Protocol Violation|0|||
160961011|NCT01565707|581244648|FG003|Overall Study|Protocol Violation|1|||
160961012|NCT01565707|581244645|FG000|Overall Study|Withdrawal by Subject|3|||
160961013|NCT01565707|581244646|FG001|Overall Study|Withdrawal by Subject|1|||
160961014|NCT01565707|581244647|FG002|Overall Study|Withdrawal by Subject|1|||
160961015|NCT01565707|581244648|FG003|Overall Study|Withdrawal by Subject|1|||
160961016|NCT01565707|581244645|FG000|Overall Study|Randomized but not evaluable|2|||
160961017|NCT01565707|581244646|FG001|Overall Study|Randomized but not evaluable|0|||
160961018|NCT01565707|581244647|FG002|Overall Study|Randomized but not evaluable|0|||
160961019|NCT01565707|581244648|FG003|Overall Study|Randomized but not evaluable|0|||
160961020|NCT01565707|581244645|FG000|Overall Study|Miscellaneous|1|||
160961021|NCT01565707|581244646|FG001|Overall Study|Miscellaneous|1|||
160961022|NCT01565707|581244647|FG002|Overall Study|Miscellaneous|0|||
160961023|NCT01565707|581244648|FG003|Overall Study|Miscellaneous|2|||
160961024|NCT01371851|581244649|FG000|Overall Study|Lost to Follow-up|5|||
160961025|NCT01371851|581244650|FG001|Overall Study|Lost to Follow-up|8|||
160961026|NCT01371851|581244649|FG000|Overall Study|was arrested and put in jail|0|||
160961027|NCT01371851|581244650|FG001|Overall Study|was arrested and put in jail|1|||
160961028|NCT01371851|581244649|FG000|Overall Study|non study related adverse event|1|||
160961029|NCT01371851|581244650|FG001|Overall Study|non study related adverse event|0|||
160961030|NCT01371851|581244649|FG000|Overall Study|Blood Pressure outside study parameters|2|||
160961031|NCT01371851|581244650|FG001|Overall Study|Blood Pressure outside study parameters|0|||
160961032|NCT00450411|581244651|FG000|Overall Study|Protocol Violation|6|||
160961033|NCT00450411|581244651|FG000|Overall Study|No protocol treatment|2|||
160961034|NCT03969719|581244662|FG000|Overall Study|Other reasons not specified|1|||
160961035|NCT03969719|581244663|FG001|Overall Study|Other reasons not specified|1|||
160961036|NCT03969719|581244664|FG002|Overall Study|Other reasons not specified|3|||
160961037|NCT03969719|581244662|FG000|Overall Study|Withdrawal by Subject|2|||
161002188|NCT01135511|581394560|FG007|Overall Study|Pregnancy|0|||
161002189|NCT01135511|581394561|FG008|Overall Study|Pregnancy|0|||
160961038|NCT03969719|581244663|FG001|Overall Study|Withdrawal by Subject|3|||
160961039|NCT03969719|581244664|FG002|Overall Study|Withdrawal by Subject|2|||
161002190|NCT01135511|581394553|FG000|Overall Study|could not visit the clinic|0|||
161002191|NCT01135511|581394554|FG001|Overall Study|could not visit the clinic|1|||
161002192|NCT01135511|581394555|FG002|Overall Study|could not visit the clinic|2|||
161002193|NCT01135511|581394556|FG003|Overall Study|could not visit the clinic|0|||
160961040|NCT03969719|581244662|FG000|Overall Study|Protocol Violation|1|||
160961041|NCT03969719|581244663|FG001|Overall Study|Protocol Violation|2|||
160961042|NCT03969719|581244664|FG002|Overall Study|Protocol Violation|0|||
160961043|NCT03969719|581244662|FG000|Overall Study|Adverse Event|0|||
160961044|NCT03969719|581244663|FG001|Overall Study|Adverse Event|2|||
160961045|NCT03969719|581244664|FG002|Overall Study|Adverse Event|0|||
160961046|NCT03969719|581244662|FG000|Overall Study|Lost to Follow-up|0|||
160961047|NCT03969719|581244663|FG001|Overall Study|Lost to Follow-up|1|||
160961048|NCT03969719|581244664|FG002|Overall Study|Lost to Follow-up|0|||
160961049|NCT05608629|581244665|FG000|Overall Study|Lost to Follow-up|2|||
160961050|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
160961051|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
160961052|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
160961053|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
160961054|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
160961055|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
160961056|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
160961057|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
160961058|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
160961059|NCT02130193|581244666|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
160961060|NCT02130193|581244667|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
160961061|NCT02130193|581244668|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
160961062|NCT01297959|581244669|FG000|Overall Study|Adverse Event|0|||
160961063|NCT01297959|581244670|FG001|Overall Study|Adverse Event|1|||
160961064|NCT01297959|581244669|FG000|Overall Study|Protocol Violation|2|||
160961065|NCT01297959|581244670|FG001|Overall Study|Protocol Violation|1|||
160961066|NCT01297959|581244669|FG000|Overall Study|Withdrawal by Subject|5|||
160961067|NCT01297959|581244670|FG001|Overall Study|Withdrawal by Subject|4|||
160961068|NCT01297959|581244669|FG000|Overall Study|Physician Decision|0|||
160961069|NCT01297959|581244670|FG001|Overall Study|Physician Decision|1|||
160961070|NCT01297959|581244669|FG000|Overall Study|Unrelated medical illness / complication|0|||
160961071|NCT01297959|581244670|FG001|Overall Study|Unrelated medical illness / complication|2|||
160961072|NCT01297959|581244669|FG000|Overall Study|Other|13|||
160961073|NCT01297959|581244670|FG001|Overall Study|Other|7|||
160961074|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
160961075|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
160961076|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
160961077|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961078|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961079|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961080|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961081|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961082|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
160961083|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
160961084|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
160961085|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
160961086|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161002194|NCT01135511|581394557|FG004|Overall Study|could not visit the clinic|0|||
161002195|NCT01135511|581394558|FG005|Overall Study|could not visit the clinic|0|||
161002196|NCT01135511|581394559|FG006|Overall Study|could not visit the clinic|0|||
161002197|NCT01135511|581394560|FG007|Overall Study|could not visit the clinic|0|||
160961087|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961088|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
161002198|NCT01135511|581394561|FG008|Overall Study|could not visit the clinic|0|||
161270973|NCT03201211|582372845|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161270974|NCT03201211|582372843|FG000|Overall Study|OTHER unknown reasons|0|||
161270975|NCT03201211|582372844|FG001|Overall Study|OTHER unknown reasons|1|||
160961089|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961090|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961091|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
160961092|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
160961093|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
160961094|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
160961095|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
161270976|NCT03201211|582372845|FG002|Overall Study|OTHER unknown reasons|0|||
160961096|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961097|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961098|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961099|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961100|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
160961101|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
160961102|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961103|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
160961104|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961105|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961106|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961107|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961108|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961109|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
160961110|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961111|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961112|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
160961113|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961114|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961115|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961116|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961117|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961118|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
160961119|NCT01212770|581244671|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
160961120|NCT01212770|581244672|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
160961121|NCT01212770|581244673|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
160961122|NCT01212770|581244674|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961123|NCT01212770|581244675|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961124|NCT01212770|581244676|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961125|NCT01212770|581244677|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961126|NCT01212770|581244678|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961127|NCT01212770|581244679|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
160961128|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961129|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
160961130|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
160961131|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
160961132|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961133|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961134|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
160961135|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961136|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
160961137|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961138|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
160961139|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
160961140|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
160961141|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
160961142|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
160961143|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961144|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961145|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
160961146|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
161002199|NCT01135511|581394553|FG000|Overall Study|noncompliance with study drug taken|0|||
161270977|NCT01970865|582372846|FG000|Overall Study|Death|3|||
161270978|NCT01970865|582372847|FG001|Overall Study|Death|2|||
161270979|NCT01970865|582372848|FG002|Overall Study|Death|3|||
161270980|NCT01970865|582372849|FG003|Overall Study|Death|6|||
161270981|NCT01970865|582372850|FG004|Overall Study|Death|9|||
161270982|NCT01970865|582372851|FG005|Overall Study|Death|3|||
161270983|NCT01970865|582372852|FG006|Overall Study|Death|2|||
161270984|NCT01970865|582372853|FG007|Overall Study|Death|3|||
161270985|NCT01970865|582372854|FG008|Overall Study|Death|2|||
161270986|NCT01970865|582372855|FG009|Overall Study|Death|2|||
161270987|NCT01970865|582372856|FG010|Overall Study|Death|8|||
161270988|NCT01970865|582372857|FG011|Overall Study|Death|13|||
161270989|NCT01970865|582372858|FG012|Overall Study|Death|25|||
161270990|NCT01970865|582372859|FG013|Overall Study|Death|46|||
161270991|NCT01970865|582372860|FG014|Overall Study|Death|37|||
161270992|NCT01970865|582372861|FG015|Overall Study|Death|22|||
161270993|NCT01970865|582372862|FG016|Overall Study|Death|1|||
161270994|NCT01970865|582372863|FG017|Overall Study|Death|17|||
160961147|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
160961148|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
160961149|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
160961150|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
160961151|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
160961152|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
160961153|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
160961154|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
160961155|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961156|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961157|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
160961158|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961159|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961160|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961161|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961162|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961163|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
160961164|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961165|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961166|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961167|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
160961168|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961169|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961170|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961171|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961172|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
160961173|NCT01212770|581244671|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961174|NCT01212770|581244672|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961175|NCT01212770|581244673|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
160961176|NCT01212770|581244674|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
160961177|NCT01212770|581244675|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961178|NCT01212770|581244676|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961179|NCT01212770|581244677|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961180|NCT01212770|581244678|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961181|NCT01212770|581244679|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
160961182|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961183|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
160961184|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
160961185|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961186|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961187|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961188|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961189|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
160961190|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
160961191|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160961192|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
160961193|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
160961194|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161002200|NCT01135511|581394554|FG001|Overall Study|noncompliance with study drug taken|0|||
161002201|NCT01135511|581394555|FG002|Overall Study|noncompliance with study drug taken|0|||
161002202|NCT01135511|581394556|FG003|Overall Study|noncompliance with study drug taken|0|||
161002203|NCT01135511|581394557|FG004|Overall Study|noncompliance with study drug taken|1|||
161002204|NCT01135511|581394558|FG005|Overall Study|noncompliance with study drug taken|0|||
161002205|NCT01135511|581394559|FG006|Overall Study|noncompliance with study drug taken|0|||
161002206|NCT01135511|581394560|FG007|Overall Study|noncompliance with study drug taken|0|||
161002207|NCT01135511|581394561|FG008|Overall Study|noncompliance with study drug taken|0|||
161002208|NCT01135511|581394553|FG000|Overall Study|Withdrawal by Subject|0|||
161270995|NCT01970865|582372846|FG000|Overall Study|Lost to Follow-up|0|||
161270996|NCT01970865|582372847|FG001|Overall Study|Lost to Follow-up|0|||
161270997|NCT01970865|582372848|FG002|Overall Study|Lost to Follow-up|0|||
161270998|NCT01970865|582372849|FG003|Overall Study|Lost to Follow-up|1|||
160961195|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
160961196|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161002209|NCT01135511|581394554|FG001|Overall Study|Withdrawal by Subject|0|||
161002210|NCT01135511|581394555|FG002|Overall Study|Withdrawal by Subject|0|||
161002211|NCT01135511|581394556|FG003|Overall Study|Withdrawal by Subject|0|||
160961197|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
161270999|NCT01970865|582372850|FG004|Overall Study|Lost to Follow-up|1|||
160961198|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
160961199|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
160961200|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961201|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
160961202|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961203|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961204|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961205|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961206|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961207|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961208|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
160961209|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961210|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
160961211|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
160961212|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961213|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961214|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961215|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
160961216|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
160961217|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
160961218|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961219|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
160961220|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
160961221|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961222|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961223|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961224|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
160961225|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
160961226|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
160961227|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961228|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
160961229|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160961230|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961231|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961232|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961233|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961234|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
160961235|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
160961236|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961237|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
160961238|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
160961239|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961240|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961241|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961242|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
160961243|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
161002212|NCT01135511|581394557|FG004|Overall Study|Withdrawal by Subject|0|||
161002213|NCT01135511|581394558|FG005|Overall Study|Withdrawal by Subject|0|||
161002214|NCT01135511|581394559|FG006|Overall Study|Withdrawal by Subject|1|||
161002215|NCT01135511|581394560|FG007|Overall Study|Withdrawal by Subject|0|||
161002216|NCT01135511|581394561|FG008|Overall Study|Withdrawal by Subject|1|||
161002217|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
161002218|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
161002219|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161002220|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
161002221|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161002222|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
161002223|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
161002224|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
161002225|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
161002226|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
161002227|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002228|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002229|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002230|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002231|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002232|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
161002233|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002234|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
161146919|NCT00592358|581922382|FG000|Overall Study|Inability to swallow pills|1|||
160961244|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
160961245|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
161146920|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
160961246|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
160961247|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
160961248|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961249|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961250|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961251|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
160961252|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
160961253|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
160961254|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961255|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
160961256|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
160961257|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961258|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961259|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961260|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
160961261|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160961262|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
160961263|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961264|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
160961265|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961266|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961267|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961268|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961269|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961270|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961271|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
160961272|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961273|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961274|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961275|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961276|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961277|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961278|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961279|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
160961280|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
160961281|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160961282|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
160961283|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160961284|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161002235|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002236|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002237|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002238|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002239|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002240|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
161002241|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
161002242|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
161002243|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
161002244|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
161002245|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
161002246|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
161002247|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
161002248|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
161146921|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
161146922|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
160961285|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160961286|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
161002249|NCT03482011|581394568|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
161002250|NCT03482011|581394569|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
161146923|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
161146924|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
161146925|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
160961287|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
160961288|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
161146926|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
161146927|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
161146928|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
160961289|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
160961290|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961291|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
160961292|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
160961293|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961294|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961295|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961296|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961297|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
160961298|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
160961299|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961300|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
160961301|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
160961302|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961303|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961304|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961305|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961306|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
160961307|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
160961308|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961309|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
160961310|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
160961311|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961312|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961313|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961314|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961315|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
160961316|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
160961317|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961318|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
160961319|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
160961320|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961321|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961322|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961323|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961324|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961325|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
160961326|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961327|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961328|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
160961329|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961330|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961331|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961332|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961333|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961334|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
160961335|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961336|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
160961337|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961338|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961339|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961340|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961341|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961342|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
160961343|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
160961344|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
160961345|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
160961346|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
160961347|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
160961348|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
160961349|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
160961350|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
160961351|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
160961352|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
161146929|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
160961353|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961354|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961355|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
160961356|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961357|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961358|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961359|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961360|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961361|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
160961362|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961363|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961364|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
160961365|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961366|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961367|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961368|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961369|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
160961370|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
160961371|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961372|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961373|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
160961374|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961375|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961376|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961377|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961378|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961379|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
160961380|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961381|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
160961382|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160961383|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961384|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961385|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961386|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961387|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
160961388|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
160961389|NCT01212770|581244671|FG000|Long-term Safety Phase (Year 5)|Death|0|||
160961390|NCT01212770|581244672|FG001|Long-term Safety Phase (Year 5)|Death|0|||
160961391|NCT01212770|581244673|FG002|Long-term Safety Phase (Year 5)|Death|0|||
160961392|NCT01212770|581244674|FG003|Long-term Safety Phase (Year 5)|Death|0|||
160961393|NCT01212770|581244675|FG004|Long-term Safety Phase (Year 5)|Death|0|||
160961394|NCT01212770|581244676|FG005|Long-term Safety Phase (Year 5)|Death|0|||
160961395|NCT01212770|581244677|FG006|Long-term Safety Phase (Year 5)|Death|0|||
160961396|NCT01212770|581244678|FG007|Long-term Safety Phase (Year 5)|Death|1|||
160961397|NCT01212770|581244679|FG008|Long-term Safety Phase (Year 5)|Death|0|||
160961398|NCT00829387|581244682|FG000|Overall Study|Withdrawal by Subject|2|||
160961399|NCT00829387|581244683|FG001|Overall Study|Withdrawal by Subject|3|||
160961400|NCT00829387|581244682|FG000|Overall Study|Disqualified by PI|1|||
160961401|NCT00829387|581244683|FG001|Overall Study|Disqualified by PI|0|||
161002251|NCT03482011|581394570|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002252|NCT03482011|581394571|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002253|NCT03482011|581394572|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002254|NCT03482011|581394573|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002255|NCT03482011|581394574|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002256|NCT03482011|581394575|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161002257|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002258|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
160961402|NCT03519854|581244684|FG000|Overall Study|Technical Error|0|||
160961403|NCT03519854|581244685|FG001|Overall Study|Technical Error|0|||
160961404|NCT03519854|581244686|FG002|Overall Study|Technical Error|1|||
160961405|NCT03519854|581244687|FG003|Overall Study|Technical Error|0|||
161002259|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002260|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002261|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
161002262|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
161002263|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
161002264|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
161002265|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161002266|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
160961406|NCT03519854|581244688|FG004|Overall Study|Technical Error|0|||
160961407|NCT03519854|581244689|FG005|Overall Study|Technical Error|0|||
160961408|NCT03519854|581244690|FG006|Overall Study|Technical Error|0|||
160961409|NCT03519854|581244691|FG007|Overall Study|Technical Error|0|||
160961410|NCT03519854|581244692|FG008|Overall Study|Technical Error|0|||
160961411|NCT03519854|581244693|FG009|Overall Study|Technical Error|0|||
160961412|NCT03519854|581244694|FG010|Overall Study|Technical Error|0|||
160961413|NCT03519854|581244695|FG011|Overall Study|Technical Error|0|||
160961414|NCT03519854|581244696|FG012|Overall Study|Technical Error|0|||
161002267|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161002268|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
161002269|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161002270|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
161002271|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
161002272|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
161002273|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002274|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002275|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002276|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002277|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
160961415|NCT03519854|581244697|FG013|Overall Study|Technical Error|0|||
160961416|NCT03519854|581244698|FG014|Overall Study|Technical Error|0|||
160961417|NCT03519854|581244699|FG015|Overall Study|Technical Error|0|||
161002278|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002279|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
161002280|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
161002281|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002282|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002283|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002284|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002285|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
161002286|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002287|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002288|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
161002289|NCT03482011|581394568|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161002290|NCT03482011|581394569|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161002291|NCT03482011|581394570|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
161002292|NCT03482011|581394571|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
161002293|NCT03482011|581394572|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161002294|NCT03482011|581394573|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
161002295|NCT03482011|581394574|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161002296|NCT03482011|581394575|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
161002297|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002298|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002299|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002300|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
161002301|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161002302|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161002303|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161002304|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
161002305|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002306|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002307|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002308|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002309|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002310|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
161002311|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
161002312|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
161002313|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161002314|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161002315|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
161002316|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
161002317|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161146930|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
160961418|NCT03519854|581244700|FG016|Overall Study|Technical Error|0|||
161002318|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
160961419|NCT03519854|581244701|FG017|Overall Study|Technical Error|0|||
161002319|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
161002320|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
161002321|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002322|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
161271000|NCT01970865|582372851|FG005|Overall Study|Lost to Follow-up|0|||
160961420|NCT00707031|581244702|FG000|Overall Study|Adverse Event|45|||
160961421|NCT00707031|581244703|FG001|Overall Study|Adverse Event|45|||
160961422|NCT00707031|581244702|FG000|Overall Study|Lack of Efficacy|19|||
160961423|NCT00707031|581244703|FG001|Overall Study|Lack of Efficacy|6|||
160961424|NCT00707031|581244702|FG000|Overall Study|Lost to Follow-up|2|||
160961425|NCT00707031|581244703|FG001|Overall Study|Lost to Follow-up|1|||
160961426|NCT00707031|581244702|FG000|Overall Study|Protocol Violation|1|||
160961427|NCT00707031|581244703|FG001|Overall Study|Protocol Violation|0|||
160961428|NCT00707031|581244702|FG000|Overall Study|Withdrawal by Subject|7|||
160961429|NCT00707031|581244703|FG001|Overall Study|Withdrawal by Subject|8|||
160961430|NCT00707031|581244702|FG000|Overall Study|Poor Compliance to Protocol|7|||
160961431|NCT00707031|581244703|FG001|Overall Study|Poor Compliance to Protocol|13|||
160961432|NCT00707031|581244702|FG000|Overall Study|Familial or Personal Reasons|12|||
160961433|NCT00707031|581244703|FG001|Overall Study|Familial or Personal Reasons|15|||
160961434|NCT00707031|581244702|FG000|Overall Study|Serious Noncompliance|2|||
160961435|NCT00707031|581244703|FG001|Overall Study|Serious Noncompliance|3|||
160961436|NCT00707031|581244702|FG000|Overall Study|Sponsor Decision|9|||
160961437|NCT00707031|581244703|FG001|Overall Study|Sponsor Decision|8|||
160961438|NCT00951275|581244704|FG000|Overall Study|Administrative Reason|1|||
160961439|NCT00951275|581244704|FG000|Overall Study|Adverse Event|7|||
160961440|NCT00951275|581244704|FG000|Overall Study|Withdrawal by Subject|4|||
160961441|NCT00951275|581244704|FG000|Overall Study|Protocol Violation|1|||
160961442|NCT03260868|581244709|FG000|Overall Study|Poor Compliance to Protocol|0|||
160961443|NCT03260868|581244710|FG001|Overall Study|Poor Compliance to Protocol|2|||
160961444|NCT03260868|581244709|FG000|Overall Study|Study Terminated By Sponsor|2|||
160961445|NCT03260868|581244710|FG001|Overall Study|Study Terminated By Sponsor|1|||
160961446|NCT03260868|581244709|FG000|Overall Study|Other than specified above|1|||
160961447|NCT03260868|581244710|FG001|Overall Study|Other than specified above|0|||
160961448|NCT02925676|581244711|FG000|Overall Study|Withdrawal by Subject|1|||
160961449|NCT02048072|581244712|FG000|Overall Study|Adverse Event|3|||
160961450|NCT02048072|581244712|FG000|Overall Study|Lost to Follow-up|1|||
160961451|NCT02693743|581244715|FG000|Overall Study|Physician Decision|1|||
160961452|NCT02693743|581244716|FG001|Overall Study|Physician Decision|0|||
160961453|NCT02626780|581244717|FG000|Overall Study|Withdrawal by Subject|3|||
160961454|NCT04304833|581244718|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
160961455|NCT04304833|581244719|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
160961456|NCT02858895|581244720|FG000|Overall Study|Disease progression|31|||
160961457|NCT02858895|581244720|FG000|Overall Study|Death|2|||
160961458|NCT02858895|581244720|FG000|Overall Study|Adverse Event|1|||
160961459|NCT02858895|581244720|FG000|Overall Study|Withdrawal by Subject|3|||
160961460|NCT02858895|581244720|FG000|Overall Study|hospice,|1|||
160961461|NCT02858895|581244720|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
160961462|NCT05540522|581244721|FG000|Overall Study|Adverse Event|1|||
160961463|NCT05540522|581244722|FG001|Overall Study|Adverse Event|0|||
160961464|NCT05540522|581244723|FG002|Overall Study|Adverse Event|2|||
160961465|NCT05540522|581244724|FG003|Overall Study|Adverse Event|5|||
160961466|NCT05540522|581244721|FG000|Overall Study|Lost to Follow-up|487|||
160961467|NCT05540522|581244722|FG001|Overall Study|Lost to Follow-up|427|||
160961468|NCT05540522|581244723|FG002|Overall Study|Lost to Follow-up|146|||
160961469|NCT05540522|581244724|FG003|Overall Study|Lost to Follow-up|166|||
160961470|NCT05540522|581244721|FG000|Overall Study|Physician Decision|11|||
160961471|NCT05540522|581244722|FG001|Overall Study|Physician Decision|19|||
160961472|NCT05540522|581244723|FG002|Overall Study|Physician Decision|8|||
160961473|NCT05540522|581244724|FG003|Overall Study|Physician Decision|13|||
160961474|NCT05540522|581244721|FG000|Overall Study|Pregnancy|1|||
160961475|NCT05540522|581244722|FG001|Overall Study|Pregnancy|0|||
160961476|NCT05540522|581244723|FG002|Overall Study|Pregnancy|0|||
160961477|NCT05540522|581244724|FG003|Overall Study|Pregnancy|0|||
160961478|NCT05540522|581244721|FG000|Overall Study|Protocol Violation|3|||
160961479|NCT05540522|581244722|FG001|Overall Study|Protocol Violation|1|||
160961480|NCT05540522|581244723|FG002|Overall Study|Protocol Violation|9|||
160961481|NCT05540522|581244724|FG003|Overall Study|Protocol Violation|7|||
160961482|NCT05540522|581244721|FG000|Overall Study|Withdrawal by Subject|168|||
160961483|NCT05540522|581244722|FG001|Overall Study|Withdrawal by Subject|134|||
160961484|NCT05540522|581244723|FG002|Overall Study|Withdrawal by Subject|331|||
161146931|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
160961485|NCT05540522|581244724|FG003|Overall Study|Withdrawal by Subject|322|||
161146932|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
161146933|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
161146934|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
160961486|NCT05540522|581244721|FG000|Overall Study|Death|7|||
160961487|NCT05540522|581244722|FG001|Overall Study|Death|9|||
160961488|NCT05540522|581244723|FG002|Overall Study|Death|49|||
160961489|NCT05540522|581244724|FG003|Overall Study|Death|46|||
160961490|NCT05540522|581244721|FG000|Overall Study|Not vaccinated|34|||
160961491|NCT05540522|581244722|FG001|Overall Study|Not vaccinated|53|||
160961492|NCT05540522|581244723|FG002|Overall Study|Not vaccinated|57|||
160961493|NCT05540522|581244724|FG003|Overall Study|Not vaccinated|50|||
160961494|NCT05540522|581244721|FG000|Overall Study|No longer meets eligibility criteria|0|||
160961495|NCT05540522|581244722|FG001|Overall Study|No longer meets eligibility criteria|0|||
160961496|NCT05540522|581244723|FG002|Overall Study|No longer meets eligibility criteria|3|||
160961497|NCT05540522|581244724|FG003|Overall Study|No longer meets eligibility criteria|2|||
160961498|NCT05540522|581244721|FG000|Overall Study|Other (Unspecified)|8|||
160961499|NCT05540522|581244722|FG001|Overall Study|Other (Unspecified)|10|||
160961500|NCT05540522|581244723|FG002|Overall Study|Other (Unspecified)|4|||
160961501|NCT05540522|581244724|FG003|Overall Study|Other (Unspecified)|2|||
160961502|NCT00251745|581244731|FG000|Overall Study|Adverse Event|7|||
160961503|NCT00251745|581244732|FG001|Overall Study|Adverse Event|9|||
160961504|NCT00251745|581244733|FG002|Overall Study|Adverse Event|11|||
160961505|NCT00251745|581244731|FG000|Overall Study|Lost to Follow-up|4|||
160961506|NCT00251745|581244732|FG001|Overall Study|Lost to Follow-up|2|||
160961507|NCT00251745|581244733|FG002|Overall Study|Lost to Follow-up|5|||
160961508|NCT00251745|581244731|FG000|Overall Study|Withdrawal by Subject|13|||
160961509|NCT00251745|581244732|FG001|Overall Study|Withdrawal by Subject|7|||
160961510|NCT00251745|581244733|FG002|Overall Study|Withdrawal by Subject|3|||
160961511|NCT00251745|581244731|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
160961512|NCT00251745|581244732|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
160961513|NCT00251745|581244733|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
160961514|NCT00251745|581244731|FG000|Overall Study|Lack of Efficacy|3|||
160961515|NCT00251745|581244732|FG001|Overall Study|Lack of Efficacy|0|||
160961516|NCT00251745|581244733|FG002|Overall Study|Lack of Efficacy|0|||
160961517|NCT00251745|581244731|FG000|Overall Study|Noncompliant|0|||
160961518|NCT00251745|581244732|FG001|Overall Study|Noncompliant|2|||
160961519|NCT00251745|581244733|FG002|Overall Study|Noncompliant|2|||
160961520|NCT00251745|581244731|FG000|Overall Study|Pregnancy|0|||
160961521|NCT00251745|581244732|FG001|Overall Study|Pregnancy|1|||
160961522|NCT00251745|581244733|FG002|Overall Study|Pregnancy|0|||
160961523|NCT00251745|581244731|FG000|Overall Study|Per Subject Request|0|||
160961524|NCT00251745|581244732|FG001|Overall Study|Per Subject Request|0|||
160961525|NCT00251745|581244733|FG002|Overall Study|Per Subject Request|1|||
160961526|NCT00251745|581244731|FG000|Overall Study|Per Investigator Request|1|||
160961527|NCT00251745|581244732|FG001|Overall Study|Per Investigator Request|0|||
160961528|NCT00251745|581244733|FG002|Overall Study|Per Investigator Request|0|||
160961529|NCT04508699|581244738|FG000|Overall Study|Lack of Efficacy|2|||
160961530|NCT04508699|581244739|FG001|Overall Study|Lack of Efficacy|15|||
160961531|NCT04508699|581244738|FG000|Overall Study|Withdrawal by Subject|0|||
160961532|NCT04508699|581244739|FG001|Overall Study|Withdrawal by Subject|2|||
160961533|NCT02543658|581246366|FG000|Overall Study|Lack of Efficacy|0|||
160961534|NCT02543658|581246367|FG001|Overall Study|Lack of Efficacy|4|||
160961535|NCT00789815|581246368|FG000|Overall Study|Protocol Violation|6|||
160961536|NCT00789815|581246369|FG001|Overall Study|Protocol Violation|1|||
160961537|NCT00789815|581246368|FG000|Overall Study|Intubation due to massive bleeding|1|||
160961538|NCT00789815|581246369|FG001|Overall Study|Intubation due to massive bleeding|0|||
160961539|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
160961540|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
160961541|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
160961542|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
160961543|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
160961544|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
160961545|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Death|1|||
160961546|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Death|0|||
160961547|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Adverse Event|1|||
160961548|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Adverse Event|0|||
160961549|NCT02586025|581246378|FG000|Neoadjuvant Treatment|Physician Decision|2|||
160961550|NCT02586025|581246379|FG001|Neoadjuvant Treatment|Physician Decision|1|||
160961551|NCT02586025|581246378|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
160961552|NCT02586025|581246379|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
160961553|NCT02586025|581246378|FG000|Adjuvant Treatment|Recurrent Disease|4|||
160961554|NCT02586025|581246379|FG001|Adjuvant Treatment|Recurrent Disease|5|||
160961555|NCT02586025|581246378|FG000|Adjuvant Treatment|Physician Decision|0|||
160961556|NCT02586025|581246379|FG001|Adjuvant Treatment|Physician Decision|1|||
160961557|NCT02586025|581246378|FG000|Adjuvant Treatment|Pregnancy|1|||
160961558|NCT02586025|581246379|FG001|Adjuvant Treatment|Pregnancy|0|||
160961559|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Death|11|||
160961560|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Death|11|||
161271001|NCT01970865|582372852|FG006|Overall Study|Lost to Follow-up|0|||
160961561|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
160961562|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
160961563|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
160961564|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
160961565|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
160961566|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
160961567|NCT02586025|581246378|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
160961568|NCT02586025|581246379|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
160961569|NCT00175825|581246380|FG000|Overall Study|Adverse Event|3|||
160961570|NCT00175825|581246381|FG001|Overall Study|Adverse Event|2|||
160961571|NCT00175825|581246382|FG002|Overall Study|Adverse Event|1|||
160961572|NCT00175825|581246383|FG003|Overall Study|Adverse Event|1|||
160961573|NCT00175825|581246380|FG000|Overall Study|Lost to Follow-up|1|||
160961574|NCT00175825|581246381|FG001|Overall Study|Lost to Follow-up|2|||
160961575|NCT00175825|581246382|FG002|Overall Study|Lost to Follow-up|0|||
160961576|NCT00175825|581246383|FG003|Overall Study|Lost to Follow-up|0|||
160961577|NCT00175825|581246380|FG000|Overall Study|Withdrawal by Subject|1|||
160961578|NCT00175825|581246381|FG001|Overall Study|Withdrawal by Subject|0|||
160961579|NCT00175825|581246382|FG002|Overall Study|Withdrawal by Subject|0|||
160961580|NCT00175825|581246383|FG003|Overall Study|Withdrawal by Subject|0|||
160961581|NCT03704584|581246384|FG000|Overall Study|Withdrawal by Subject|1|||
160961582|NCT03704584|581246385|FG001|Overall Study|Withdrawal by Subject|0|||
160961583|NCT03412812|581246386|FG000|Level 1|Death|3|||
160961584|NCT03412812|581246387|FG001|Level 1|Death|0|||
160961585|NCT03412812|581246386|FG000|Level 1|Adverse Event|0|||
160961586|NCT03412812|581246387|FG001|Level 1|Adverse Event|1|||
160961587|NCT03548207|581246390|FG000|Overall Study|Death|10|||
160961588|NCT03548207|581246391|FG001|Overall Study|Death|23|||
160961589|NCT03548207|581246392|FG002|Overall Study|Death|3|||
160961590|NCT03548207|581246390|FG000|Overall Study|Lost to Follow-up|0|||
160961591|NCT03548207|581246391|FG001|Overall Study|Lost to Follow-up|2|||
160961592|NCT03548207|581246392|FG002|Overall Study|Lost to Follow-up|0|||
160961593|NCT03548207|581246390|FG000|Overall Study|Withdrawal by Subject|0|||
160961594|NCT03548207|581246391|FG001|Overall Study|Withdrawal by Subject|3|||
160961595|NCT03548207|581246392|FG002|Overall Study|Withdrawal by Subject|0|||
160961596|NCT03548207|581246390|FG000|Overall Study|Sponsor decision|19|||
160961597|NCT03548207|581246391|FG001|Overall Study|Sponsor decision|40|||
160961598|NCT03548207|581246392|FG002|Overall Study|Sponsor decision|6|||
160961599|NCT03548207|581246390|FG000|Overall Study|Randomized but not treated|6|||
160961600|NCT03548207|581246391|FG001|Overall Study|Randomized but not treated|10|||
160961601|NCT03548207|581246392|FG002|Overall Study|Randomized but not treated|4|||
160961602|NCT03822117|581246393|FG000|Overall Study|Death|18|||
160961603|NCT03822117|581246394|FG001|Overall Study|Death|17|||
160961604|NCT03822117|581246395|FG002|Overall Study|Death|12|||
160961605|NCT03822117|581246396|FG003|Overall Study|Death|4|||
160961606|NCT03822117|581246393|FG000|Overall Study|Lost to Follow-up|1|||
160961607|NCT03822117|581246394|FG001|Overall Study|Lost to Follow-up|2|||
160961608|NCT03822117|581246395|FG002|Overall Study|Lost to Follow-up|3|||
160961609|NCT03822117|581246396|FG003|Overall Study|Lost to Follow-up|0|||
160961610|NCT03822117|581246393|FG000|Overall Study|Study Terminated by Sponsor|25|||
160961611|NCT03822117|581246394|FG001|Overall Study|Study Terminated by Sponsor|11|||
160961612|NCT03822117|581246395|FG002|Overall Study|Study Terminated by Sponsor|6|||
160961613|NCT03822117|581246396|FG003|Overall Study|Study Terminated by Sponsor|0|||
160961614|NCT03822117|581246393|FG000|Overall Study|Withdrawal by Subject|4|||
160961615|NCT03822117|581246394|FG001|Overall Study|Withdrawal by Subject|0|||
160961616|NCT03822117|581246395|FG002|Overall Study|Withdrawal by Subject|3|||
160961617|NCT03822117|581246396|FG003|Overall Study|Withdrawal by Subject|0|||
160961618|NCT03822117|581246393|FG000|Overall Study|Disease Progression|1|||
160961619|NCT03822117|581246394|FG001|Overall Study|Disease Progression|2|||
160961620|NCT03822117|581246395|FG002|Overall Study|Disease Progression|1|||
160961621|NCT03822117|581246396|FG003|Overall Study|Disease Progression|0|||
160961622|NCT03822117|581246393|FG000|Overall Study|Never Returned to Hospital|0|||
160961623|NCT03822117|581246394|FG001|Overall Study|Never Returned to Hospital|0|||
160961624|NCT03822117|581246395|FG002|Overall Study|Never Returned to Hospital|1|||
160961625|NCT03822117|581246396|FG003|Overall Study|Never Returned to Hospital|0|||
160961626|NCT00415610|581246397|FG000|Overall Study|Death|3|||
160961627|NCT00415610|581246398|FG001|Overall Study|Death|2|||
160961628|NCT00415610|581246399|FG002|Overall Study|Death|5|||
160961629|NCT01357616|581246400|FG000|Overall Study|Adverse Event|1|||
160961630|NCT01357616|581246401|FG001|Overall Study|Adverse Event|1|||
160961631|NCT01357616|581246400|FG000|Overall Study|Lost to Follow-up|4|||
160961632|NCT01357616|581246401|FG001|Overall Study|Lost to Follow-up|3|||
160961633|NCT01357616|581246400|FG000|Overall Study|Protocol Violation|0|||
160961634|NCT01357616|581246401|FG001|Overall Study|Protocol Violation|2|||
160961635|NCT01357616|581246400|FG000|Overall Study|Inadequate Control of IOP|1|||
160961636|NCT01357616|581246401|FG001|Overall Study|Inadequate Control of IOP|2|||
160961637|NCT01357616|581246400|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
160961638|NCT01357616|581246401|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
160961639|NCT01357616|581246400|FG000|Overall Study|Withdrawal by Subject|1|||
160961640|NCT01357616|581246401|FG001|Overall Study|Withdrawal by Subject|0|||
160961641|NCT03255824|581246410|FG000|Overall Study|Under-sedation|2|||
160961642|NCT03255824|581246411|FG001|Overall Study|Under-sedation|1|||
160961643|NCT03432364|581246414|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
160961644|NCT00522301|581246415|FG000|Overall Study|Withdrawal by Subject|1|||
160961645|NCT00522301|581246415|FG000|Overall Study|Adverse Event|5|||
160961646|NCT03040713|581246416|FG000|Overall Study|Positive amyloid scan|3|||
160961647|NCT01699022|581246423|FG000|Overall Study|Early discontinuation from the study|3|||
160961648|NCT04539821|581246424|FG000|Overall Study|Withdrawal by Subject|2|||
160961649|NCT04539821|581246424|FG000|Overall Study|continued care with their physician|20|||
160961650|NCT04539821|581246424|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
160961651|NCT00430248|581246439|FG000|Overall Study|Adverse Event|49|||
160961652|NCT00430248|581246440|FG001|Overall Study|Adverse Event|61|||
160961653|NCT00430248|581246441|FG002|Overall Study|Adverse Event|64|||
160961654|NCT00430248|581246439|FG000|Overall Study|Protocol Violation|10|||
160961655|NCT00430248|581246440|FG001|Overall Study|Protocol Violation|2|||
160961656|NCT00430248|581246441|FG002|Overall Study|Protocol Violation|4|||
160961657|NCT00430248|581246439|FG000|Overall Study|Personal Reasons|12|||
160961658|NCT00430248|581246440|FG001|Overall Study|Personal Reasons|24|||
160961659|NCT00430248|581246441|FG002|Overall Study|Personal Reasons|9|||
160961660|NCT00430248|581246439|FG000|Overall Study|Lost to Follow-up|28|||
160961661|NCT00430248|581246440|FG001|Overall Study|Lost to Follow-up|33|||
160961662|NCT00430248|581246441|FG002|Overall Study|Lost to Follow-up|28|||
160961663|NCT00430248|581246439|FG000|Overall Study|Therapeutic Failure|1|||
160961664|NCT00430248|581246440|FG001|Overall Study|Therapeutic Failure|1|||
160961665|NCT00430248|581246441|FG002|Overall Study|Therapeutic Failure|1|||
160961666|NCT00430248|581246439|FG000|Overall Study|Withdrawal by Subject|14|||
160961667|NCT00430248|581246440|FG001|Overall Study|Withdrawal by Subject|20|||
160961668|NCT00430248|581246441|FG002|Overall Study|Withdrawal by Subject|16|||
160961669|NCT00430248|581246439|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160961670|NCT00430248|581246440|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
160961671|NCT00430248|581246441|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
160961672|NCT00430248|581246439|FG000|Overall Study|Gout Flare|3|||
160961673|NCT00430248|581246440|FG001|Overall Study|Gout Flare|7|||
160961674|NCT00430248|581246441|FG002|Overall Study|Gout Flare|2|||
160961675|NCT00430248|581246439|FG000|Overall Study|Reason Not Specified|8|||
160961676|NCT00430248|581246440|FG001|Overall Study|Reason Not Specified|8|||
160961677|NCT00430248|581246441|FG002|Overall Study|Reason Not Specified|11|||
160961678|NCT03466086|581246444|FG000|Period 1|Sponsor decision due to study timeline|1|||
160961679|NCT03466086|581246445|FG001|Period 1|Sponsor decision due to study timeline|0|||
160961680|NCT03466086|581246444|FG000|Period 1|Withdrawal by Subject|1|||
160961681|NCT03466086|581246445|FG001|Period 1|Withdrawal by Subject|0|||
160961682|NCT00002558|581246446|FG000|Overall Study|Withdrawal by Subject|0|||
160961683|NCT00002558|581246447|FG001|Overall Study|Withdrawal by Subject|1|||
160961684|NCT01260350|581246449|FG000|Overall Study|Lack of Efficacy|0|||
160961685|NCT01260350|581246450|FG001|Overall Study|Lack of Efficacy|0|||
160961686|NCT01260350|581246451|FG002|Overall Study|Lack of Efficacy|0|||
160961687|NCT01260350|581246452|FG003|Overall Study|Lack of Efficacy|0|||
160961688|NCT01260350|581246453|FG004|Overall Study|Lack of Efficacy|0|||
160961689|NCT01260350|581246454|FG005|Overall Study|Lack of Efficacy|0|||
160961690|NCT01260350|581246455|FG006|Overall Study|Lack of Efficacy|0|||
160961691|NCT01260350|581246456|FG007|Overall Study|Lack of Efficacy|0|||
160961692|NCT01260350|581246457|FG008|Overall Study|Lack of Efficacy|0|||
160961693|NCT01260350|581246458|FG009|Overall Study|Lack of Efficacy|0|||
160961694|NCT01260350|581246459|FG010|Overall Study|Lack of Efficacy|0|||
160961695|NCT01260350|581246460|FG011|Overall Study|Lack of Efficacy|0|||
160961696|NCT01260350|581246461|FG012|Overall Study|Lack of Efficacy|0|||
160961697|NCT01260350|581246462|FG013|Overall Study|Lack of Efficacy|0|||
160961698|NCT01260350|581246463|FG014|Overall Study|Lack of Efficacy|0|||
160961699|NCT01260350|581246464|FG015|Overall Study|Lack of Efficacy|0|||
160961700|NCT01260350|581246465|FG016|Overall Study|Lack of Efficacy|0|||
160961701|NCT01260350|581246466|FG017|Overall Study|Lack of Efficacy|1|||
160961702|NCT01260350|581246467|FG018|Overall Study|Lack of Efficacy|0|||
160961703|NCT01260350|581246468|FG019|Overall Study|Lack of Efficacy|0|||
160961704|NCT01260350|581246469|FG020|Overall Study|Lack of Efficacy|3|||
160961705|NCT01260350|581246470|FG021|Overall Study|Lack of Efficacy|0|||
160961706|NCT01260350|581246449|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961707|NCT01260350|581246450|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161002323|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
161271002|NCT01970865|582372853|FG007|Overall Study|Lost to Follow-up|0|||
161271003|NCT01970865|582372854|FG008|Overall Study|Lost to Follow-up|0|||
160961708|NCT01260350|581246451|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961709|NCT01260350|581246452|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961710|NCT01260350|581246453|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961711|NCT01260350|581246454|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961712|NCT01260350|581246455|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961713|NCT01260350|581246456|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961714|NCT01260350|581246457|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
160961715|NCT01260350|581246458|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961716|NCT01260350|581246459|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961717|NCT01260350|581246460|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961718|NCT01260350|581246461|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961719|NCT01260350|581246462|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961720|NCT01260350|581246463|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961721|NCT01260350|581246464|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961722|NCT01260350|581246465|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161146935|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
160961723|NCT01260350|581246466|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961724|NCT01260350|581246467|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961725|NCT01260350|581246468|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
161271004|NCT01970865|582372855|FG009|Overall Study|Lost to Follow-up|0|||
160961726|NCT01260350|581246469|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961727|NCT01260350|581246470|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
160961728|NCT04385368|581246479|FG000|Overall Study|Death|5|||
160961729|NCT04385368|581246480|FG001|Overall Study|Death|5|||
160961730|NCT04385368|581246479|FG000|Overall Study|Physician Decision|3|||
160961731|NCT04385368|581246480|FG001|Overall Study|Physician Decision|0|||
160961732|NCT04385368|581246479|FG000|Overall Study|Withdrawal by Subject|4|||
160961733|NCT04385368|581246480|FG001|Overall Study|Withdrawal by Subject|3|||
160961734|NCT02123108|581246488|FG000|Overall Study|Death|2|||
160961735|NCT02123108|581246489|FG001|Overall Study|Death|3|||
160961736|NCT02219048|581246490|FG000|Overall Study|Adverse Event|2|||
160961737|NCT02219048|581246491|FG001|Overall Study|Adverse Event|5|||
160961738|NCT02219048|581246490|FG000|Overall Study|No longer meets eligibility criteria|1|||
160961739|NCT02219048|581246491|FG001|Overall Study|No longer meets eligibility criteria|0|||
160961740|NCT02219048|581246490|FG000|Overall Study|Study terminated by sponsor|16|||
160961741|NCT02219048|581246491|FG001|Overall Study|Study terminated by sponsor|15|||
160961742|NCT02219048|581246490|FG000|Overall Study|Withdrawal by Subject|2|||
160961743|NCT02219048|581246491|FG001|Overall Study|Withdrawal by Subject|0|||
160961744|NCT02219048|581246490|FG000|Overall Study|Other|0|||
160961745|NCT02219048|581246491|FG001|Overall Study|Other|1|||
160961746|NCT04721925|581246492|FG000|2-Month Assessment|Lost to Follow-up|5|||
160961747|NCT04721925|581246493|FG001|2-Month Assessment|Lost to Follow-up|3|||
160961748|NCT04721925|581246492|FG000|4-Month Assessment|Lost to Follow-up|3|||
160961749|NCT04721925|581246493|FG001|4-Month Assessment|Lost to Follow-up|6|||
160961750|NCT02862457|581246494|FG000|Overall Study|Death|1|||
160961751|NCT02862457|581246495|FG001|Overall Study|Death|3|||
160961752|NCT02862457|581246496|FG002|Overall Study|Death|2|||
160961753|NCT02862457|581246497|FG003|Overall Study|Death|3|||
160961754|NCT02862457|581246498|FG004|Overall Study|Death|0|||
161271005|NCT01970865|582372856|FG010|Overall Study|Lost to Follow-up|1|||
161271006|NCT01970865|582372857|FG011|Overall Study|Lost to Follow-up|0|||
161271007|NCT01970865|582372858|FG012|Overall Study|Lost to Follow-up|2|||
160961755|NCT02862457|581246499|FG005|Overall Study|Death|2|||
160961756|NCT02862457|581246500|FG006|Overall Study|Death|1|||
160961757|NCT02862457|581246494|FG000|Overall Study|Lost to Follow-up|1|||
160961758|NCT02862457|581246495|FG001|Overall Study|Lost to Follow-up|0|||
160961759|NCT02862457|581246496|FG002|Overall Study|Lost to Follow-up|0|||
160961760|NCT02862457|581246497|FG003|Overall Study|Lost to Follow-up|1|||
160961761|NCT02862457|581246498|FG004|Overall Study|Lost to Follow-up|0|||
160961762|NCT02862457|581246499|FG005|Overall Study|Lost to Follow-up|0|||
160961763|NCT02862457|581246500|FG006|Overall Study|Lost to Follow-up|0|||
160961764|NCT02862457|581246494|FG000|Overall Study|Withdrawal by Subject|0|||
160961765|NCT02862457|581246495|FG001|Overall Study|Withdrawal by Subject|0|||
160961766|NCT02862457|581246496|FG002|Overall Study|Withdrawal by Subject|1|||
160961767|NCT02862457|581246497|FG003|Overall Study|Withdrawal by Subject|0|||
160961768|NCT02862457|581246498|FG004|Overall Study|Withdrawal by Subject|0|||
160961769|NCT02862457|581246499|FG005|Overall Study|Withdrawal by Subject|1|||
160961770|NCT02862457|581246500|FG006|Overall Study|Withdrawal by Subject|0|||
160961771|NCT03364751|581246501|FG000|Overall Study|Withdrawal by Subject|1|||
160961772|NCT03364751|581246502|FG001|Overall Study|Withdrawal by Subject|0|||
160961773|NCT03364751|581246503|FG002|Overall Study|Withdrawal by Subject|0|||
160961774|NCT03364751|581246504|FG003|Overall Study|Withdrawal by Subject|0|||
160961775|NCT03364751|581246501|FG000|Overall Study|Lost to Follow-up|0|||
161271008|NCT01970865|582372859|FG013|Overall Study|Lost to Follow-up|0|||
160961776|NCT03364751|581246502|FG001|Overall Study|Lost to Follow-up|1|||
160961777|NCT03364751|581246503|FG002|Overall Study|Lost to Follow-up|0|||
160961778|NCT03364751|581246504|FG003|Overall Study|Lost to Follow-up|0|||
160961779|NCT00765388|581246505|FG000|Period 1|Lack of Efficacy|1|||
160961780|NCT00765388|581246506|FG001|Period 1|Lack of Efficacy|2|||
160961781|NCT00765388|581246505|FG000|Period 1|Lost to Follow-up|0|||
160961782|NCT00765388|581246506|FG001|Period 1|Lost to Follow-up|1|||
160961783|NCT00765388|581246505|FG000|Period 1|Herpes Zoster|0|||
160961784|NCT00765388|581246506|FG001|Period 1|Herpes Zoster|1|||
160961785|NCT00765388|581246505|FG000|Period 1|Hip operation|0|||
160961786|NCT00765388|581246506|FG001|Period 1|Hip operation|1|||
160961787|NCT03923933|581246507|FG000|Overall Study|Lost to Follow-up|1|||
160961788|NCT03923933|581246508|FG001|Overall Study|Lost to Follow-up|0|||
161002324|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002325|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
160961789|NCT03923933|581246507|FG000|Overall Study|Withdrawal by Subject|0|||
160961790|NCT03923933|581246508|FG001|Overall Study|Withdrawal by Subject|1|||
160961791|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
160961792|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
160961793|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
161271009|NCT01970865|582372860|FG014|Overall Study|Lost to Follow-up|1|||
161146936|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
160961794|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
160961795|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
160961796|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
160961797|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961798|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961799|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961800|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
160961801|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
160961802|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961803|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961804|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961805|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
160961806|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
160961807|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
160961808|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
160961809|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
160961810|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
160961811|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
160961812|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961813|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961814|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961815|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
160961816|NCT01662310|581246511|FG000|Run-In or Stabilization Phase|Other|1|||
160961817|NCT01662310|581246512|FG001|Run-In or Stabilization Phase|Other|0|||
160961818|NCT01662310|581246513|FG002|Run-In or Stabilization Phase|Other|0|||
160961819|NCT01662310|581246514|FG003|Run-In or Stabilization Phase|Other|0|||
160961820|NCT01662310|581246515|FG004|Run-In or Stabilization Phase|Other|0|||
160961821|NCT01662310|581246511|FG000|Double-Blind Phase|Adverse Event|0|||
160961822|NCT01662310|581246512|FG001|Double-Blind Phase|Adverse Event|0|||
160961823|NCT01662310|581246513|FG002|Double-Blind Phase|Adverse Event|1|||
160961824|NCT01662310|581246514|FG003|Double-Blind Phase|Adverse Event|0|||
160961825|NCT01662310|581246515|FG004|Double-Blind Phase|Adverse Event|0|||
160961826|NCT01662310|581246511|FG000|Double-Blind Phase|Lost to Follow-up|0|||
160961827|NCT01662310|581246512|FG001|Double-Blind Phase|Lost to Follow-up|3|||
160961828|NCT01662310|581246513|FG002|Double-Blind Phase|Lost to Follow-up|0|||
160961829|NCT01662310|581246514|FG003|Double-Blind Phase|Lost to Follow-up|0|||
160961830|NCT01662310|581246515|FG004|Double-Blind Phase|Lost to Follow-up|0|||
160961831|NCT01662310|581246511|FG000|Double-Blind Phase|Pregnancy|0|||
160961832|NCT01662310|581246512|FG001|Double-Blind Phase|Pregnancy|2|||
160961833|NCT01662310|581246513|FG002|Double-Blind Phase|Pregnancy|0|||
160961834|NCT01662310|581246514|FG003|Double-Blind Phase|Pregnancy|0|||
160961835|NCT01662310|581246515|FG004|Double-Blind Phase|Pregnancy|0|||
160961836|NCT01662310|581246511|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
160961837|NCT01662310|581246512|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
160961838|NCT01662310|581246513|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
160961839|NCT01662310|581246514|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
160961840|NCT01662310|581246515|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
160961841|NCT01662310|581246511|FG000|Double-Blind Phase|Other|0|||
160961842|NCT01662310|581246512|FG001|Double-Blind Phase|Other|0|||
160961843|NCT01662310|581246513|FG002|Double-Blind Phase|Other|1|||
160961844|NCT01662310|581246514|FG003|Double-Blind Phase|Other|0|||
160961845|NCT01662310|581246515|FG004|Double-Blind Phase|Other|0|||
160961846|NCT01662310|581246511|FG000|Double-Blind Phase|Randomized but not treated|0|||
160961847|NCT01662310|581246512|FG001|Double-Blind Phase|Randomized but not treated|1|||
160961848|NCT01662310|581246513|FG002|Double-Blind Phase|Randomized but not treated|0|||
160961849|NCT01662310|581246514|FG003|Double-Blind Phase|Randomized but not treated|0|||
160961850|NCT01662310|581246515|FG004|Double-Blind Phase|Randomized but not treated|0|||
160961851|NCT01662310|581246511|FG000|Open-Label Extension Phase|Adverse Event|0|||
160961852|NCT01662310|581246512|FG001|Open-Label Extension Phase|Adverse Event|0|||
160961853|NCT01662310|581246513|FG002|Open-Label Extension Phase|Adverse Event|0|||
160961854|NCT01662310|581246514|FG003|Open-Label Extension Phase|Adverse Event|3|||
160961855|NCT01662310|581246515|FG004|Open-Label Extension Phase|Adverse Event|0|||
160961856|NCT01662310|581246511|FG000|Open-Label Extension Phase|Death|0|||
160961857|NCT01662310|581246512|FG001|Open-Label Extension Phase|Death|0|||
161146937|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
160961858|NCT01662310|581246513|FG002|Open-Label Extension Phase|Death|0|||
160961859|NCT01662310|581246514|FG003|Open-Label Extension Phase|Death|1|||
160961860|NCT01662310|581246515|FG004|Open-Label Extension Phase|Death|0|||
160961861|NCT01662310|581246511|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
160961862|NCT01662310|581246512|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
160961863|NCT01662310|581246513|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
160961864|NCT01662310|581246514|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
161207084|NCT05004181|582138118|FG009|Overall Study|Withdrawal by Subject|1|||
160961865|NCT01662310|581246515|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
160961866|NCT01662310|581246511|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
160961867|NCT01662310|581246512|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
160961868|NCT01662310|581246513|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
160961869|NCT01662310|581246514|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
160961870|NCT01662310|581246515|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
160961871|NCT01662310|581246511|FG000|Open-Label Extension Phase|Pregnancy|0|||
160961872|NCT01662310|581246512|FG001|Open-Label Extension Phase|Pregnancy|0|||
160961873|NCT01662310|581246513|FG002|Open-Label Extension Phase|Pregnancy|0|||
160961874|NCT01662310|581246514|FG003|Open-Label Extension Phase|Pregnancy|1|||
160961875|NCT01662310|581246515|FG004|Open-Label Extension Phase|Pregnancy|0|||
160961876|NCT01662310|581246511|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
160961877|NCT01662310|581246512|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
160961878|NCT01662310|581246513|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
160961879|NCT01662310|581246514|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
160961880|NCT01662310|581246515|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
160961881|NCT02432105|581246516|FG000|Overall Study|Lost to Follow-up|1|||
160961882|NCT02432105|581246517|FG001|Overall Study|Lost to Follow-up|1|||
160961883|NCT02432105|581246518|FG002|Overall Study|Lost to Follow-up|0|||
160961884|NCT02432105|581246516|FG000|Overall Study|Withdrawal by Subject|1|||
160961885|NCT02432105|581246517|FG001|Overall Study|Withdrawal by Subject|0|||
160961886|NCT02432105|581246518|FG002|Overall Study|Withdrawal by Subject|1|||
160961887|NCT02432105|581246516|FG000|Overall Study|Culture positive for yeast|0|||
160961888|NCT02432105|581246517|FG001|Overall Study|Culture positive for yeast|1|||
160961889|NCT02432105|581246518|FG002|Overall Study|Culture positive for yeast|0|||
160961890|NCT02432105|581246516|FG000|Overall Study|Randomized in error|0|||
160961891|NCT02432105|581246517|FG001|Overall Study|Randomized in error|0|||
160961892|NCT02432105|581246518|FG002|Overall Study|Randomized in error|2|||
160961893|NCT02085252|581246521|FG000|Overall Study|Withdrawal of Consent|1|||
160961894|NCT02085252|581246522|FG001|Overall Study|Withdrawal of Consent|0|||
160961895|NCT02085252|581246521|FG000|Overall Study|Adverse Event|0|||
160961896|NCT02085252|581246522|FG001|Overall Study|Adverse Event|1|||
160961897|NCT02085252|581246521|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
160961898|NCT02085252|581246522|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
160961899|NCT02085252|581246521|FG000|Overall Study|Reason Not Specified|0|||
160961900|NCT02085252|581246522|FG001|Overall Study|Reason Not Specified|1|||
160961901|NCT02085252|581246521|FG000|Overall Study|Reason Unknown|0|||
160961902|NCT02085252|581246522|FG001|Overall Study|Reason Unknown|1|||
160961903|NCT00541450|581246523|FG000|Phase A|Adverse Event|3|||
160961904|NCT00541450|581246524|FG001|Phase A|Adverse Event|0|||
160961905|NCT00541450|581246523|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
160961906|NCT00541450|581246524|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
160961907|NCT00541450|581246523|FG000|Phase A|Hyperglycemia|0|||
160961908|NCT00541450|581246524|FG001|Phase A|Hyperglycemia|1|||
160961909|NCT00541450|581246523|FG000|Phase A|Lost to Follow-up|6|||
160961910|NCT00541450|581246524|FG001|Phase A|Lost to Follow-up|4|||
160961911|NCT00541450|581246523|FG000|Phase A|Physician Decision|2|||
160961912|NCT00541450|581246524|FG001|Phase A|Physician Decision|0|||
160961913|NCT00541450|581246523|FG000|Phase A|Protocol Violation|2|||
160961914|NCT00541450|581246524|FG001|Phase A|Protocol Violation|3|||
160961915|NCT00541450|581246523|FG000|Phase A|Withdrawal by Subject|7|||
160961916|NCT00541450|581246524|FG001|Phase A|Withdrawal by Subject|7|||
160961917|NCT00541450|581246523|FG000|Phase B|Adverse Event|6|||
160961918|NCT00541450|581246524|FG001|Phase B|Adverse Event|6|||
160961919|NCT00541450|581246523|FG000|Phase B|Hyperglycemia|10|||
160961920|NCT00541450|581246524|FG001|Phase B|Hyperglycemia|9|||
160961921|NCT00541450|581246523|FG000|Phase B|Lost to Follow-up|6|||
160961922|NCT00541450|581246524|FG001|Phase B|Lost to Follow-up|4|||
160961923|NCT00541450|581246523|FG000|Phase B|Physician Decision|4|||
160961924|NCT00541450|581246524|FG001|Phase B|Physician Decision|2|||
160961925|NCT00541450|581246523|FG000|Phase B|Pregnancy|0|||
160961926|NCT00541450|581246524|FG001|Phase B|Pregnancy|1|||
160961927|NCT00541450|581246523|FG000|Phase B|Protocol Violation|3|||
160961928|NCT00541450|581246524|FG001|Phase B|Protocol Violation|3|||
160961929|NCT00541450|581246523|FG000|Phase B|Withdrawal by Subject|8|||
160961930|NCT00541450|581246524|FG001|Phase B|Withdrawal by Subject|6|||
160961931|NCT02816138|581246525|FG000|Overall Study|Adverse Event|1|||
160961932|NCT00981084|581246526|FG000|Post Intervention (Data Analysis)|poor effort|1|||
160961933|NCT00981084|581246527|FG001|Post Intervention (Data Analysis)|poor effort|1|||
160961934|NCT00981084|581246526|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
160961935|NCT00981084|581246527|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
160961936|NCT01112579|581246528|FG000|Overall Study|Missed Visit|1|||
160961937|NCT01112579|581246529|FG001|Overall Study|Missed Visit|1|||
160961938|NCT01112579|581246528|FG000|Overall Study|Death|0|||
160961939|NCT01112579|581246529|FG001|Overall Study|Death|2|||
160961940|NCT03645759|581246533|FG000|Overall Study|Lost to Follow-up|3|||
160961941|NCT03645759|581246534|FG001|Overall Study|Lost to Follow-up|2|||
160961942|NCT01648270|581246535|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
160961943|NCT00818753|581246536|FG000|Overall Study|Protocol Violation|1|||
160961944|NCT00818753|581246537|FG001|Overall Study|Protocol Violation|0|||
160961945|NCT00818753|581246538|FG002|Overall Study|Protocol Violation|0|||
160961946|NCT00818753|581246536|FG000|Overall Study|Other reason (not specified)|0|||
160961947|NCT00818753|581246537|FG001|Overall Study|Other reason (not specified)|0|||
160961948|NCT00818753|581246538|FG002|Overall Study|Other reason (not specified)|1|||
160961949|NCT00818753|581246536|FG000|Overall Study|Randomised and not treated|2|||
160961950|NCT00818753|581246537|FG001|Overall Study|Randomised and not treated|0|||
160961951|NCT00818753|581246538|FG002|Overall Study|Randomised and not treated|0|||
160961952|NCT01389973|581246539|FG000|Overall Study|Lost to Follow-up|1|||
160961953|NCT01389973|581246539|FG000|Overall Study|Trial Stopped by Sponsor|9|||
160961954|NCT01389973|581246539|FG000|Overall Study|Other|10|||
160961955|NCT00725296|581246540|FG000|Overall Study|Adverse Event|11|||
160961956|NCT00725296|581246540|FG000|Overall Study|Lack of Efficacy|7|||
160961957|NCT00725296|581246540|FG000|Overall Study|Withdrawal by Subject|3|||
160961958|NCT00725296|581246540|FG000|Overall Study|Non-Compliance|2|||
160961959|NCT00725296|581246540|FG000|Overall Study|Lost to Follow-up|1|||
160961960|NCT00725296|581246540|FG000|Overall Study|Other|38|||
160961961|NCT03360942|581246541|FG000|Overall Study|Device explanted|2|||
160961962|NCT03360942|581246541|FG000|Overall Study|Study closure|1|||
160961963|NCT03360942|581246541|FG000|Overall Study|Withdrawal by Subject|2|||
160961964|NCT03456700|581246542|FG000|Overall Study|Withdrawal by Subject|1|||
160961965|NCT00613951|581246545|FG000|Overall Study|Adverse Event|1|||
160961966|NCT00613951|581246546|FG001|Overall Study|Adverse Event|0|||
160961967|NCT00613951|581246547|FG002|Overall Study|Adverse Event|1|||
160961968|NCT00613951|581246545|FG000|Overall Study|Lack of Efficacy|0|||
160961969|NCT00613951|581246546|FG001|Overall Study|Lack of Efficacy|1|||
160961970|NCT00613951|581246547|FG002|Overall Study|Lack of Efficacy|1|||
160961971|NCT00613951|581246545|FG000|Overall Study|Protocol Violation|1|||
160961972|NCT00613951|581246546|FG001|Overall Study|Protocol Violation|1|||
160961973|NCT00613951|581246547|FG002|Overall Study|Protocol Violation|1|||
160961974|NCT00613951|581246545|FG000|Overall Study|Unclassified|5|||
160961975|NCT00613951|581246546|FG001|Overall Study|Unclassified|3|||
160961976|NCT00613951|581246547|FG002|Overall Study|Unclassified|2|||
160961977|NCT03053050|581246549|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
160961978|NCT03053050|581246550|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
160961979|NCT03053050|581246551|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
160961980|NCT03053050|581246552|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
160961981|NCT03053050|581246549|FG000|Randomized Phase|Withdrew Consent|16|||
160961982|NCT03053050|581246550|FG001|Randomized Phase|Withdrew Consent|8|||
160961983|NCT03053050|581246551|FG002|Randomized Phase|Withdrew Consent|9|||
160961984|NCT03053050|581246552|FG003|Randomized Phase|Withdrew Consent|0|||
160961985|NCT03053050|581246549|FG000|Randomized Phase|Investigator's Discretion|6|||
160961986|NCT03053050|581246550|FG001|Randomized Phase|Investigator's Discretion|6|||
160961987|NCT03053050|581246551|FG002|Randomized Phase|Investigator's Discretion|3|||
160961988|NCT03053050|581246552|FG003|Randomized Phase|Investigator's Discretion|0|||
160961989|NCT03053050|581246549|FG000|Randomized Phase|Lost to Follow-up|5|||
160961990|NCT03053050|581246550|FG001|Randomized Phase|Lost to Follow-up|1|||
160961991|NCT03053050|581246551|FG002|Randomized Phase|Lost to Follow-up|1|||
160961992|NCT03053050|581246552|FG003|Randomized Phase|Lost to Follow-up|0|||
160961993|NCT03053050|581246549|FG000|Randomized Phase|Adverse Event|0|||
160961994|NCT03053050|581246550|FG001|Randomized Phase|Adverse Event|1|||
160961995|NCT03053050|581246551|FG002|Randomized Phase|Adverse Event|0|||
160961996|NCT03053050|581246552|FG003|Randomized Phase|Adverse Event|0|||
160961997|NCT03053050|581246549|FG000|Randomized Phase|Randomized but Never Treated|2|||
160961998|NCT03053050|581246550|FG001|Randomized Phase|Randomized but Never Treated|2|||
160961999|NCT03053050|581246551|FG002|Randomized Phase|Randomized but Never Treated|2|||
160962000|NCT03053050|581246552|FG003|Randomized Phase|Randomized but Never Treated|0|||
160962001|NCT03053050|581246549|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
160962002|NCT03053050|581246550|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
160962003|NCT03053050|581246551|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
160962004|NCT03053050|581246552|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
160962005|NCT03053050|581246549|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
160962006|NCT03053050|581246550|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
160962007|NCT03053050|581246551|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
160962008|NCT03053050|581246552|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
160962009|NCT03053050|581246549|FG000|Open-label Phase|Withdrew Consent|0|||
160962010|NCT03053050|581246550|FG001|Open-label Phase|Withdrew Consent|0|||
160962011|NCT03053050|581246551|FG002|Open-label Phase|Withdrew Consent|0|||
160962012|NCT03053050|581246552|FG003|Open-label Phase|Withdrew Consent|6|||
160962013|NCT03053050|581246549|FG000|Open-label Phase|Investigator's Discretion|0|||
160962014|NCT03053050|581246550|FG001|Open-label Phase|Investigator's Discretion|0|||
160962015|NCT03053050|581246551|FG002|Open-label Phase|Investigator's Discretion|0|||
160962016|NCT03053050|581246552|FG003|Open-label Phase|Investigator's Discretion|4|||
160962017|NCT00655980|581246553|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
160962018|NCT00655980|581246554|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
160962019|NCT00655980|581246555|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
160962020|NCT02127372|581247834|FG000|Overall Study|Withdrawal by Subject|1|||
160962021|NCT02127372|581247835|FG001|Overall Study|Withdrawal by Subject|0|||
160962022|NCT03837509|581247836|FG000|Phase 1|Death|5|||
160962023|NCT03837509|581247837|FG001|Phase 1|Death|2|||
160962024|NCT03837509|581247838|FG002|Phase 1|Death|0|||
160962025|NCT03837509|581247839|FG003|Phase 1|Death|0|||
160962026|NCT03837509|581247840|FG004|Phase 1|Death|0|||
160962027|NCT03837509|581247836|FG000|Phase 2|Death|0|||
160962028|NCT03837509|581247837|FG001|Phase 2|Death|0|||
160962029|NCT03837509|581247838|FG002|Phase 2|Death|0|||
160962030|NCT03837509|581247839|FG003|Phase 2|Death|1|||
160962031|NCT03837509|581247840|FG004|Phase 2|Death|1|||
160962032|NCT01756352|581247843|FG000|Overall Study|moved away and lost to followup|1|||
160962033|NCT02641392|581247850|FG000|Overall Study|Lost to Follow-up|0|||
160962034|NCT02641392|581247851|FG001|Overall Study|Lost to Follow-up|0|||
160962035|NCT02641392|581247852|FG002|Overall Study|Lost to Follow-up|2|||
160962036|NCT02641392|581247850|FG000|Overall Study|Withdrawal by Subject|0|||
160962037|NCT02641392|581247851|FG001|Overall Study|Withdrawal by Subject|0|||
160962038|NCT02641392|581247852|FG002|Overall Study|Withdrawal by Subject|17|||
160962039|NCT02641392|581247850|FG000|Overall Study|Adverse Event|0|||
160962040|NCT02641392|581247851|FG001|Overall Study|Adverse Event|1|||
160962041|NCT02641392|581247852|FG002|Overall Study|Adverse Event|25|||
160962042|NCT02641392|581247850|FG000|Overall Study|Study Terminated by Sponsor|4|||
160962043|NCT02641392|581247851|FG001|Overall Study|Study Terminated by Sponsor|12|||
160962044|NCT02641392|581247852|FG002|Overall Study|Study Terminated by Sponsor|144|||
160962045|NCT02641392|581247850|FG000|Overall Study|Lack of Efficacy|0|||
160962046|NCT02641392|581247851|FG001|Overall Study|Lack of Efficacy|0|||
160962047|NCT02641392|581247852|FG002|Overall Study|Lack of Efficacy|101|||
160962048|NCT02641392|581247850|FG000|Overall Study|Miscellaneous|0|||
160962049|NCT02641392|581247851|FG001|Overall Study|Miscellaneous|0|||
160962050|NCT02641392|581247852|FG002|Overall Study|Miscellaneous|3|||
160962051|NCT02641392|581247850|FG000|Overall Study|Death|0|||
160962052|NCT02641392|581247851|FG001|Overall Study|Death|0|||
160962053|NCT02641392|581247852|FG002|Overall Study|Death|1|||
160962054|NCT01113502|581247853|FG000|Overall Study|Withdrawal by Subject|1|||
160962055|NCT01113502|581247854|FG001|Overall Study|Withdrawal by Subject|0|||
160962056|NCT01113502|581247855|FG002|Overall Study|Withdrawal by Subject|1|||
160962057|NCT01113502|581247856|FG003|Overall Study|Withdrawal by Subject|1|||
160962058|NCT01113502|581247857|FG004|Overall Study|Withdrawal by Subject|0|||
160962059|NCT01113502|581247853|FG000|Overall Study|Adverse Event|0|||
160962060|NCT01113502|581247854|FG001|Overall Study|Adverse Event|0|||
160962061|NCT01113502|581247855|FG002|Overall Study|Adverse Event|3|||
160962062|NCT01113502|581247856|FG003|Overall Study|Adverse Event|2|||
160962063|NCT01113502|581247857|FG004|Overall Study|Adverse Event|0|||
160962064|NCT03802123|581247860|FG000|Overall Study|Withdrawal by Subject|3|||
160962065|NCT03802123|581247860|FG000|Overall Study|Physician Decision|1|||
160962066|NCT03802123|581247860|FG000|Overall Study|Subject moved to hospice care|1|||
160962067|NCT03802123|581247860|FG000|Overall Study|technician error|1|||
160962068|NCT03802123|581247860|FG000|Overall Study|Death|3|||
160962069|NCT01274182|581247861|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
160962070|NCT01274182|581247862|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
160962071|NCT01274182|581247863|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
160962072|NCT01274182|581247861|FG000|Overall Study|Adverse Event|4|||
160962073|NCT01274182|581247862|FG001|Overall Study|Adverse Event|5|||
160962074|NCT01274182|581247863|FG002|Overall Study|Adverse Event|3|||
160962075|NCT01274182|581247861|FG000|Overall Study|Withdrawal by Subject|5|||
160962076|NCT01274182|581247862|FG001|Overall Study|Withdrawal by Subject|5|||
160962077|NCT01274182|581247863|FG002|Overall Study|Withdrawal by Subject|3|||
160962078|NCT01274182|581247861|FG000|Overall Study|Lost to Follow-up|2|||
160962079|NCT01274182|581247862|FG001|Overall Study|Lost to Follow-up|3|||
160962080|NCT01274182|581247863|FG002|Overall Study|Lost to Follow-up|1|||
160962081|NCT01274182|581247861|FG000|Overall Study|Protocol Violation|3|||
160962082|NCT01274182|581247862|FG001|Overall Study|Protocol Violation|2|||
160962083|NCT01274182|581247863|FG002|Overall Study|Protocol Violation|0|||
160962084|NCT01274182|581247861|FG000|Overall Study|Death|1|||
160962085|NCT01274182|581247862|FG001|Overall Study|Death|0|||
160962086|NCT01274182|581247863|FG002|Overall Study|Death|1|||
161146938|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
161146939|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
161146940|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
161146941|NCT00092547|581922383|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
161146942|NCT00092547|581922384|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
160962087|NCT01970982|581247864|FG000|Overall Study|Withdrawal by Subject|0|||
160962088|NCT01970982|581247865|FG001|Overall Study|Withdrawal by Subject|0|||
160962089|NCT01970982|581247866|FG002|Overall Study|Withdrawal by Subject|2|||
160962090|NCT04040751|581247871|FG000|Overall Study|Withdrawal by Subject|2|||
160962091|NCT04040751|581247872|FG001|Overall Study|Withdrawal by Subject|0|||
160962092|NCT04040751|581247873|FG002|Overall Study|Withdrawal by Subject|2|||
160962093|NCT04040751|581247874|FG003|Overall Study|Withdrawal by Subject|0|||
160962094|NCT03804710|581247876|FG000|Overall Study|Adverse Event|0|||
160962095|NCT03804710|581247877|FG001|Overall Study|Adverse Event|3|||
160962096|NCT03804710|581247876|FG000|Overall Study|Withdrawal by Subject|2|||
160962097|NCT03804710|581247877|FG001|Overall Study|Withdrawal by Subject|1|||
160962098|NCT03804710|581247876|FG000|Overall Study|Other|0|||
160962099|NCT03804710|581247877|FG001|Overall Study|Other|1|||
160962100|NCT04542018|581247878|FG000|Overall Study|Withdrawal by Subject|0|||
160962101|NCT04542018|581247879|FG001|Overall Study|Withdrawal by Subject|0|||
160962102|NCT04542018|581247880|FG002|Overall Study|Withdrawal by Subject|4|||
160962103|NCT04542018|581247878|FG000|Overall Study|Protocol Violation|0|||
160962104|NCT04542018|581247879|FG001|Overall Study|Protocol Violation|0|||
160962105|NCT04542018|581247880|FG002|Overall Study|Protocol Violation|2|||
160962106|NCT03583554|581247881|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
160962107|NCT03583554|581247882|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
160962108|NCT03583554|581247883|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
160962109|NCT03178266|581247884|FG000|Overall Study|Death|0|||
160962110|NCT03178266|581247885|FG001|Overall Study|Death|1|||
160962111|NCT03178266|581247884|FG000|Overall Study|Disont. Early|0|||
160962112|NCT03178266|581247885|FG001|Overall Study|Disont. Early|1|||
160962113|NCT03178266|581247884|FG000|Overall Study|Withdrawal by Subject|0|||
160962114|NCT03178266|581247885|FG001|Overall Study|Withdrawal by Subject|2|||
160962115|NCT01596582|581247897|FG000|Overall Study|Deemed ineligible after study visit|3|||
160962116|NCT01596582|581247898|FG001|Overall Study|Deemed ineligible after study visit|6|||
160962117|NCT01596582|581247897|FG000|Overall Study|Missing all outcome data|1|||
160962118|NCT01596582|581247898|FG001|Overall Study|Missing all outcome data|1|||
160962119|NCT02454101|581247902|FG000|Overall Study|Adverse Event|2|||
160962120|NCT02454101|581247903|FG001|Overall Study|Adverse Event|3|||
160962121|NCT02454101|581247902|FG000|Overall Study|Lost to Follow-up|3|||
160962122|NCT02454101|581247903|FG001|Overall Study|Lost to Follow-up|4|||
160962123|NCT02342886|581247904|FG000|Overall Study|Treatment non-compliance|1|||
160962124|NCT02342886|581247905|FG001|Overall Study|Treatment non-compliance|0|||
160962125|NCT02342886|581247906|FG002|Overall Study|Treatment non-compliance|0|||
160962126|NCT02342886|581247907|FG003|Overall Study|Treatment non-compliance|1|||
160962127|NCT02342886|581247908|FG004|Overall Study|Treatment non-compliance|0|||
160962128|NCT02342886|581247904|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
160962129|NCT02342886|581247905|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
160962130|NCT02342886|581247906|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
160962131|NCT02342886|581247907|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
160962132|NCT02342886|581247908|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
160962133|NCT02342886|581247904|FG000|Overall Study|Adverse event/specific toxicity|4|||
160962134|NCT02342886|581247905|FG001|Overall Study|Adverse event/specific toxicity|3|||
160962135|NCT02342886|581247906|FG002|Overall Study|Adverse event/specific toxicity|11|||
160962136|NCT02342886|581247907|FG003|Overall Study|Adverse event/specific toxicity|2|||
160962137|NCT02342886|581247908|FG004|Overall Study|Adverse event/specific toxicity|1|||
160962138|NCT02342886|581247904|FG000|Overall Study|Lost to Follow-up|1|||
160962139|NCT02342886|581247905|FG001|Overall Study|Lost to Follow-up|0|||
160962140|NCT02342886|581247906|FG002|Overall Study|Lost to Follow-up|0|||
160962141|NCT02342886|581247907|FG003|Overall Study|Lost to Follow-up|0|||
160962142|NCT02342886|581247908|FG004|Overall Study|Lost to Follow-up|0|||
160962143|NCT02342886|581247904|FG000|Overall Study|Death|1|||
160962144|NCT02342886|581247905|FG001|Overall Study|Death|2|||
160962145|NCT02342886|581247906|FG002|Overall Study|Death|1|||
160962146|NCT02342886|581247907|FG003|Overall Study|Death|0|||
160962147|NCT02342886|581247908|FG004|Overall Study|Death|1|||
160962148|NCT02342886|581247904|FG000|Overall Study|Withdrawal by Subject|0|||
160962149|NCT02342886|581247905|FG001|Overall Study|Withdrawal by Subject|1|||
160962150|NCT02342886|581247906|FG002|Overall Study|Withdrawal by Subject|0|||
160962151|NCT02342886|581247907|FG003|Overall Study|Withdrawal by Subject|1|||
160962152|NCT02342886|581247908|FG004|Overall Study|Withdrawal by Subject|0|||
160962153|NCT02342886|581247904|FG000|Overall Study|Investigator/sponsor decision|0|||
160962154|NCT02342886|581247905|FG001|Overall Study|Investigator/sponsor decision|2|||
160962155|NCT02342886|581247906|FG002|Overall Study|Investigator/sponsor decision|0|||
160962156|NCT02342886|581247907|FG003|Overall Study|Investigator/sponsor decision|3|||
160962157|NCT02342886|581247908|FG004|Overall Study|Investigator/sponsor decision|1|||
160962158|NCT02342886|581247904|FG000|Overall Study|Pregnancy|0|||
161146943|NCT00092547|581922385|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
161146944|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
160962159|NCT02342886|581247905|FG001|Overall Study|Pregnancy|0|||
160962160|NCT02342886|581247906|FG002|Overall Study|Pregnancy|2|||
161146945|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
160962161|NCT02342886|581247907|FG003|Overall Study|Pregnancy|0|||
160962162|NCT02342886|581247908|FG004|Overall Study|Pregnancy|0|||
161146946|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
161271010|NCT01970865|582372861|FG015|Overall Study|Lost to Follow-up|4|||
160962163|NCT02342886|581247904|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962164|NCT02342886|581247905|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962165|NCT02342886|581247906|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
160962166|NCT02342886|581247907|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962167|NCT02342886|581247908|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
160962168|NCT02342886|581247904|FG000|Overall Study|Protocol Violation|0|||
160962169|NCT02342886|581247905|FG001|Overall Study|Protocol Violation|0|||
160962170|NCT02342886|581247906|FG002|Overall Study|Protocol Violation|0|||
160962171|NCT02342886|581247907|FG003|Overall Study|Protocol Violation|2|||
160962172|NCT02342886|581247908|FG004|Overall Study|Protocol Violation|0|||
160962173|NCT00862134|581247912|FG000|Overall Study|Death|1|||
160962174|NCT00862134|581247913|FG001|Overall Study|Death|0|||
160962175|NCT00862134|581247912|FG000|Overall Study|Physician Decision|0|||
160962176|NCT00862134|581247913|FG001|Overall Study|Physician Decision|1|||
160962177|NCT00862134|581247912|FG000|Overall Study|Withdrawal by Subject|1|||
160962178|NCT00862134|581247913|FG001|Overall Study|Withdrawal by Subject|2|||
160962179|NCT00862134|581247912|FG000|Overall Study|Sponsor terminated study|5|||
160962180|NCT00862134|581247913|FG001|Overall Study|Sponsor terminated study|7|||
160962181|NCT00862134|581247912|FG000|Overall Study|Adverse Event|2|||
160962182|NCT00862134|581247913|FG001|Overall Study|Adverse Event|2|||
160962183|NCT00862134|581247912|FG000|Overall Study|Withdrew prior to dosing|2|||
160962184|NCT00862134|581247913|FG001|Overall Study|Withdrew prior to dosing|0|||
160962185|NCT00765674|581247914|FG000|Overall Study|Adverse Event|7|||
160962186|NCT00765674|581247915|FG001|Overall Study|Adverse Event|2|||
160962187|NCT00765674|581247916|FG002|Overall Study|Adverse Event|8|||
160962188|NCT00765674|581247917|FG003|Overall Study|Adverse Event|11|||
160962189|NCT00765674|581247914|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
160962190|NCT00765674|581247915|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
160962191|NCT00765674|581247916|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
160962192|NCT00765674|581247917|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
160962193|NCT00765674|581247914|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
160962194|NCT00765674|581247915|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
160962195|NCT00765674|581247916|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
160962196|NCT00765674|581247917|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
160962197|NCT00765674|581247914|FG000|Overall Study|Lack of Efficacy|2|||
160962198|NCT00765674|581247915|FG001|Overall Study|Lack of Efficacy|3|||
160962199|NCT00765674|581247916|FG002|Overall Study|Lack of Efficacy|1|||
160962200|NCT00765674|581247917|FG003|Overall Study|Lack of Efficacy|2|||
160962201|NCT00765674|581247914|FG000|Overall Study|Protocol Violation|2|||
160962202|NCT00765674|581247915|FG001|Overall Study|Protocol Violation|0|||
160962203|NCT00765674|581247916|FG002|Overall Study|Protocol Violation|1|||
160962204|NCT00765674|581247917|FG003|Overall Study|Protocol Violation|0|||
160962205|NCT00765674|581247914|FG000|Overall Study|Withdrawal by Subject|5|||
160962206|NCT00765674|581247915|FG001|Overall Study|Withdrawal by Subject|7|||
160962207|NCT00765674|581247916|FG002|Overall Study|Withdrawal by Subject|3|||
160962208|NCT00765674|581247917|FG003|Overall Study|Withdrawal by Subject|8|||
160962209|NCT00765674|581247914|FG000|Overall Study|Lost to Follow-up|4|||
160962210|NCT00765674|581247915|FG001|Overall Study|Lost to Follow-up|6|||
161271011|NCT01970865|582372862|FG016|Overall Study|Lost to Follow-up|0|||
160962211|NCT00765674|581247916|FG002|Overall Study|Lost to Follow-up|2|||
160962212|NCT00765674|581247917|FG003|Overall Study|Lost to Follow-up|1|||
160962213|NCT00765674|581247914|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
160962214|NCT00765674|581247915|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
160962215|NCT00765674|581247916|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
160962216|NCT00765674|581247917|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
160962217|NCT01813474|581247923|FG000|Overall Study|Withdrawal by Subject|0|||
160962218|NCT01813474|581247924|FG001|Overall Study|Withdrawal by Subject|0|||
160962219|NCT01813474|581247925|FG002|Overall Study|Withdrawal by Subject|1|||
160962220|NCT01813474|581247923|FG000|Overall Study|Adverse Event|1|||
160962221|NCT01813474|581247924|FG001|Overall Study|Adverse Event|1|||
160962222|NCT01813474|581247925|FG002|Overall Study|Adverse Event|0|||
160962223|NCT01813474|581247923|FG000|Overall Study|Lack of Efficacy|2|||
160962224|NCT01813474|581247924|FG001|Overall Study|Lack of Efficacy|6|||
161146947|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
160962225|NCT01813474|581247925|FG002|Overall Study|Lack of Efficacy|9|||
160962226|NCT01813474|581247923|FG000|Overall Study|Death|0|||
160962227|NCT01813474|581247924|FG001|Overall Study|Death|0|||
160962228|NCT01813474|581247925|FG002|Overall Study|Death|1|||
160962229|NCT03015402|581247926|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
160962230|NCT03015402|581247927|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
160962231|NCT03015402|581247926|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161271012|NCT01970865|582372863|FG017|Overall Study|Lost to Follow-up|1|||
160962232|NCT03015402|581247927|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
160962233|NCT00316082|581247928|FG000|Overall Study|Lack of Efficacy|2|||
160962234|NCT00316082|581247929|FG001|Overall Study|Lack of Efficacy|3|||
160962235|NCT00316082|581247930|FG002|Overall Study|Lack of Efficacy|3|||
160962236|NCT00316082|581247931|FG003|Overall Study|Lack of Efficacy|4|||
160962237|NCT00316082|581247932|FG004|Overall Study|Lack of Efficacy|6|||
160962238|NCT00316082|581247928|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
160962239|NCT00316082|581247929|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
160962240|NCT00316082|581247930|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
160962241|NCT00316082|581247931|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
160962242|NCT00316082|581247932|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
160962243|NCT00316082|581247928|FG000|Overall Study|Lost to Follow-up|7|||
160962244|NCT00316082|581247929|FG001|Overall Study|Lost to Follow-up|6|||
160962245|NCT00316082|581247930|FG002|Overall Study|Lost to Follow-up|7|||
160962246|NCT00316082|581247931|FG003|Overall Study|Lost to Follow-up|8|||
160962247|NCT00316082|581247932|FG004|Overall Study|Lost to Follow-up|6|||
160962248|NCT00316082|581247928|FG000|Overall Study|Poor/noncompliance|6|||
160962249|NCT00316082|581247929|FG001|Overall Study|Poor/noncompliance|1|||
160962250|NCT00316082|581247930|FG002|Overall Study|Poor/noncompliance|4|||
160962251|NCT00316082|581247931|FG003|Overall Study|Poor/noncompliance|1|||
160962252|NCT00316082|581247932|FG004|Overall Study|Poor/noncompliance|4|||
160962253|NCT00316082|581247928|FG000|Overall Study|Adverse Event|4|||
160962254|NCT00316082|581247929|FG001|Overall Study|Adverse Event|2|||
160962255|NCT00316082|581247930|FG002|Overall Study|Adverse Event|5|||
160962256|NCT00316082|581247931|FG003|Overall Study|Adverse Event|1|||
160962257|NCT00316082|581247932|FG004|Overall Study|Adverse Event|3|||
160962258|NCT00316082|581247928|FG000|Overall Study|Subject no longer meets study criteria|3|||
160962259|NCT00316082|581247929|FG001|Overall Study|Subject no longer meets study criteria|1|||
160962260|NCT00316082|581247930|FG002|Overall Study|Subject no longer meets study criteria|2|||
160962261|NCT00316082|581247931|FG003|Overall Study|Subject no longer meets study criteria|2|||
160962262|NCT00316082|581247932|FG004|Overall Study|Subject no longer meets study criteria|1|||
160962263|NCT00316082|581247928|FG000|Overall Study|Physician Decision|1|||
160962264|NCT00316082|581247929|FG001|Overall Study|Physician Decision|1|||
160962265|NCT00316082|581247930|FG002|Overall Study|Physician Decision|2|||
160962266|NCT00316082|581247931|FG003|Overall Study|Physician Decision|1|||
160962267|NCT00316082|581247932|FG004|Overall Study|Physician Decision|1|||
160962268|NCT00316082|581247928|FG000|Overall Study|Death|0|||
160962269|NCT00316082|581247929|FG001|Overall Study|Death|0|||
160962270|NCT00316082|581247930|FG002|Overall Study|Death|1|||
160962271|NCT00316082|581247931|FG003|Overall Study|Death|0|||
160962272|NCT00316082|581247932|FG004|Overall Study|Death|0|||
160962273|NCT00316082|581247928|FG000|Overall Study|Administrative reason by sponsor|0|||
160962274|NCT00316082|581247929|FG001|Overall Study|Administrative reason by sponsor|0|||
160962275|NCT00316082|581247930|FG002|Overall Study|Administrative reason by sponsor|1|||
160962276|NCT00316082|581247931|FG003|Overall Study|Administrative reason by sponsor|0|||
160962277|NCT00316082|581247932|FG004|Overall Study|Administrative reason by sponsor|0|||
160962278|NCT02216773|581247933|FG000|Overall Study|Disease progression|4|||
160962279|NCT02216773|581247934|FG001|Overall Study|Disease progression|2|||
160962280|NCT02216773|581247933|FG000|Overall Study|Insufficient FLRV|4|||
160962281|NCT02216773|581247934|FG001|Overall Study|Insufficient FLRV|0|||
160962282|NCT02216773|581247933|FG000|Overall Study|Abandoned|4|||
160962283|NCT02216773|581247934|FG001|Overall Study|Abandoned|3|||
160962284|NCT00528775|581247937|FG000|Overall Study|Other not specified|1|||
160962285|NCT02012491|581247948|FG000|Overall Study|Lost to Follow-up|1|||
160962286|NCT02012491|581247949|FG001|Overall Study|Lost to Follow-up|0|||
160962287|NCT02012491|581247948|FG000|Overall Study|Protocol Violation|0|||
160962288|NCT02012491|581247949|FG001|Overall Study|Protocol Violation|1|||
160962289|NCT02012491|581247948|FG000|Overall Study|Withdrawal by Subject|1|||
160962290|NCT02012491|581247949|FG001|Overall Study|Withdrawal by Subject|0|||
160962291|NCT01667432|581247955|FG000|Overall Study|Premature Study Termination|26|||
160962292|NCT01667432|581247955|FG000|Overall Study|Failure to Return|10|||
160962293|NCT01667432|581247955|FG000|Overall Study|Moved to Another Center|3|||
160962294|NCT01667432|581247955|FG000|Overall Study|Lost to Follow-up|3|||
160962295|NCT01667432|581247955|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
160962296|NCT01667432|581247955|FG000|Overall Study|Insufficient Therapeutic Response|4|||
160962297|NCT01667432|581247955|FG000|Overall Study|Adverse Event|1|||
161002326|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002327|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
161002328|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
161002329|NCT03482011|581394568|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161002330|NCT03482011|581394569|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161002331|NCT03482011|581394570|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160962298|NCT01667432|581247955|FG000|Overall Study|Protocol Deviation|2|||
160962299|NCT01667432|581247955|FG000|Overall Study|Principal Investigator Decision|1|||
160962300|NCT01667432|581247955|FG000|Overall Study|Reason Not Specified|2|||
161146948|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
160962301|NCT01667432|581247955|FG000|Overall Study|Missing Information|4|||
160962302|NCT00344461|581247956|FG000|Overall Study|Adverse Event|6|||
160962303|NCT00344461|581247956|FG000|Overall Study|Death|1|||
160962304|NCT00344461|581247956|FG000|Overall Study|Lack of Efficacy|2|||
160962305|NCT00344461|581247956|FG000|Overall Study|Lost to Follow-up|2|||
160962306|NCT00344461|581247956|FG000|Overall Study|Physician Decision|2|||
160962307|NCT00344461|581247956|FG000|Overall Study|Protocol Violation|6|||
160962308|NCT00344461|581247956|FG000|Overall Study|Withdrawal by Subject|2|||
160962309|NCT00553696|581247963|FG000|Overall Study|Adverse Event|2|||
160962310|NCT00553696|581247964|FG001|Overall Study|Adverse Event|4|||
160962311|NCT00553696|581247965|FG002|Overall Study|Adverse Event|0|||
160962312|NCT00553696|581247966|FG003|Overall Study|Adverse Event|1|||
160962313|NCT00553696|581247963|FG000|Overall Study|Global deterioration of health status|0|||
160962314|NCT00553696|581247964|FG001|Overall Study|Global deterioration of health status|2|||
160962315|NCT00553696|581247965|FG002|Overall Study|Global deterioration of health status|0|||
160962316|NCT00553696|581247966|FG003|Overall Study|Global deterioration of health status|0|||
160962317|NCT00553696|581247963|FG000|Overall Study|Objective progression or relapse|2|||
160962318|NCT00553696|581247964|FG001|Overall Study|Objective progression or relapse|9|||
160962319|NCT00553696|581247965|FG002|Overall Study|Objective progression or relapse|6|||
160962320|NCT00553696|581247966|FG003|Overall Study|Objective progression or relapse|0|||
160962321|NCT00553696|581247963|FG000|Overall Study|Withdrawal by Subject|0|||
160962322|NCT00553696|581247964|FG001|Overall Study|Withdrawal by Subject|1|||
160962323|NCT00553696|581247965|FG002|Overall Study|Withdrawal by Subject|0|||
160962324|NCT00553696|581247966|FG003|Overall Study|Withdrawal by Subject|0|||
160962325|NCT00941330|581247969|FG000|Overall Study|Other|1|||
160962326|NCT00941330|581247970|FG001|Overall Study|Other|0|||
160962327|NCT00941330|581247969|FG000|Overall Study|Physician Decision|0|||
160962328|NCT00941330|581247970|FG001|Overall Study|Physician Decision|2|||
160962329|NCT00686881|581247971|FG000|Overall Study|Withdrawal by Subject|11|||
160962330|NCT00686881|581247972|FG001|Overall Study|Withdrawal by Subject|18|||
160962331|NCT00686881|581247971|FG000|Overall Study|Lost to Follow-up|0|||
160962332|NCT00686881|581247972|FG001|Overall Study|Lost to Follow-up|1|||
160962333|NCT00686881|581247971|FG000|Overall Study|Treatment-related adverse event|10|||
160962334|NCT00686881|581247972|FG001|Overall Study|Treatment-related adverse event|9|||
160962335|NCT00686881|581247971|FG000|Overall Study|Met discontinuation criteria|5|||
160962336|NCT00686881|581247972|FG001|Overall Study|Met discontinuation criteria|0|||
160962337|NCT00686881|581247971|FG000|Overall Study|Onset of malignant tumor|11|||
160962338|NCT00686881|581247972|FG001|Overall Study|Onset of malignant tumor|11|||
160962339|NCT00686881|581247971|FG000|Overall Study|Lack of Efficacy|4|||
160962340|NCT00686881|581247972|FG001|Overall Study|Lack of Efficacy|3|||
160962341|NCT00686881|581247971|FG000|Overall Study|Physician Decision|1|||
160962342|NCT00686881|581247972|FG001|Overall Study|Physician Decision|0|||
160962343|NCT00686881|581247971|FG000|Overall Study|Circumstances of site|1|||
160962344|NCT00686881|581247972|FG001|Overall Study|Circumstances of site|1|||
160962345|NCT00686881|581247971|FG000|Overall Study|Did not meet protocol eligibility|1|||
160962346|NCT00686881|581247972|FG001|Overall Study|Did not meet protocol eligibility|0|||
160962347|NCT00686881|581247971|FG000|Overall Study|Irregular visits|1|||
160962348|NCT00686881|581247972|FG001|Overall Study|Irregular visits|0|||
160962349|NCT00686881|581247971|FG000|Overall Study|Study discontinuation|35|||
160962350|NCT00686881|581247972|FG001|Overall Study|Study discontinuation|32|||
160962351|NCT00686881|581247971|FG000|Overall Study|Never received study drug|2|||
160962352|NCT00686881|581247972|FG001|Overall Study|Never received study drug|6|||
160962353|NCT00671931|581247975|FG000|Overall Study|Physician Decision|1|||
160962354|NCT00671931|581247976|FG001|Overall Study|Physician Decision|0|||
160962355|NCT00671931|581247977|FG002|Overall Study|Physician Decision|0|||
160962356|NCT00671931|581247978|FG003|Overall Study|Physician Decision|2|||
160962357|NCT00671931|581247979|FG004|Overall Study|Physician Decision|1|||
160962358|NCT01298999|581247980|FG000|Overall Study|Physician Decision|0|||
160962359|NCT01298999|581247981|FG001|Overall Study|Physician Decision|1|||
160962360|NCT01298999|581247980|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
160962361|NCT01298999|581247981|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
160962362|NCT00902694|581247982|FG000|Overall Study|Death|1|||
160962363|NCT00902694|581247983|FG001|Overall Study|Death|3|||
160962364|NCT00902694|581247982|FG000|Overall Study|Lost to Follow-up|1|||
160962365|NCT00902694|581247983|FG001|Overall Study|Lost to Follow-up|0|||
160962366|NCT00902694|581247982|FG000|Overall Study|Censored per protocol|3|||
160962367|NCT00902694|581247983|FG001|Overall Study|Censored per protocol|1|||
160962368|NCT00902694|581247982|FG000|Overall Study|Pregnancy|1|||
160962369|NCT00902694|581247983|FG001|Overall Study|Pregnancy|1|||
160962370|NCT00902694|581247982|FG000|Overall Study|Incarceration|1|||
160962371|NCT00902694|581247983|FG001|Overall Study|Incarceration|0|||
160962372|NCT04969263|581247984|FG000|Overall Study|Death|1|||
161002332|NCT03482011|581394571|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161002333|NCT03482011|581394572|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
160962373|NCT04969263|581247984|FG000|Overall Study|Lost to Follow-up|2|||
160962374|NCT04969263|581247984|FG000|Overall Study|Withdrawal by Subject|5|||
160962375|NCT04969263|581247984|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
160962376|NCT04154787|581247985|FG000|Overall Study|Adverse Event|0|||
160962377|NCT04154787|581247986|FG001|Overall Study|Adverse Event|1|||
160962378|NCT04154787|581247987|FG002|Overall Study|Adverse Event|0|||
160962379|NCT04154787|581247985|FG000|Overall Study|Patient Requires Other Treatment|0|||
160962380|NCT04154787|581247986|FG001|Overall Study|Patient Requires Other Treatment|1|||
160962381|NCT04154787|581247987|FG002|Overall Study|Patient Requires Other Treatment|0|||
160962382|NCT04154787|581247985|FG000|Overall Study|Study Terminated By Sponsor|0|||
160962383|NCT04154787|581247986|FG001|Overall Study|Study Terminated By Sponsor|6|||
160962384|NCT04154787|581247987|FG002|Overall Study|Study Terminated By Sponsor|1|||
160962385|NCT04154787|581247985|FG000|Overall Study|Subject Decision|0|||
160962386|NCT04154787|581247986|FG001|Overall Study|Subject Decision|1|||
160962387|NCT04154787|581247987|FG002|Overall Study|Subject Decision|0|||
160962388|NCT04154787|581247985|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
160962389|NCT04154787|581247986|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
160962390|NCT04154787|581247987|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
160962391|NCT02459574|581247988|FG000|Overall Study|Withdrawal by Subject|6|||
160962392|NCT02459574|581247989|FG001|Overall Study|Withdrawal by Subject|6|||
160962393|NCT02459574|581247990|FG002|Overall Study|Withdrawal by Subject|2|||
160962394|NCT02459574|581247988|FG000|Overall Study|Lost to Follow-up|1|||
160962395|NCT02459574|581247989|FG001|Overall Study|Lost to Follow-up|1|||
160962396|NCT02459574|581247990|FG002|Overall Study|Lost to Follow-up|0|||
160962397|NCT02459574|581247988|FG000|Overall Study|Death|0|||
160962398|NCT02459574|581247989|FG001|Overall Study|Death|1|||
160962399|NCT02459574|581247990|FG002|Overall Study|Death|0|||
160962400|NCT04866017|581247991|FG000|Overall Study|Study Terminated by Sponsor|13|||
160962401|NCT04866017|581247992|FG001|Overall Study|Study Terminated by Sponsor|14|||
160962402|NCT04866017|581247993|FG002|Overall Study|Study Terminated by Sponsor|13|||
160962403|NCT04866017|581247991|FG000|Overall Study|Death|8|||
160962404|NCT04866017|581247992|FG001|Overall Study|Death|4|||
160962405|NCT04866017|581247993|FG002|Overall Study|Death|8|||
160962406|NCT04866017|581247991|FG000|Overall Study|Withdrawal by Subject|1|||
160962407|NCT04866017|581247992|FG001|Overall Study|Withdrawal by Subject|0|||
160962408|NCT04866017|581247993|FG002|Overall Study|Withdrawal by Subject|1|||
160962409|NCT04866017|581247991|FG000|Overall Study|Physician Decision|0|||
160962410|NCT04866017|581247992|FG001|Overall Study|Physician Decision|1|||
160962411|NCT04866017|581247993|FG002|Overall Study|Physician Decision|0|||
160962412|NCT01553318|581249663|FG000|Overall Study|Protocol Violation|3|||
160962413|NCT01553318|581249664|FG001|Overall Study|Protocol Violation|2|||
160962414|NCT04244396|581249666|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
160962415|NCT04244396|581249666|FG000|Overall Study|Withdrawal by Subject|2|||
160962416|NCT04244396|581249666|FG000|Overall Study|Study termination|37|||
160962417|NCT01787097|581249667|FG000|Overall Study|Withdrawal by Subject|1|||
160962418|NCT01787097|581249668|FG001|Overall Study|Withdrawal by Subject|0|||
160962419|NCT01787097|581249669|FG002|Overall Study|Withdrawal by Subject|0|||
160962420|NCT01787097|581249670|FG003|Overall Study|Withdrawal by Subject|0|||
160962421|NCT00245102|581249671|FG000|Overall Study|Not Treated|1|||
160962422|NCT00245102|581249672|FG001|Overall Study|Not Treated|0|||
160962423|NCT00245102|581249673|FG002|Overall Study|Not Treated|1|||
160962424|NCT00245102|581249674|FG003|Overall Study|Not Treated|0|||
160962425|NCT00245102|581249675|FG004|Overall Study|Not Treated|0|||
160962426|NCT00245102|581249676|FG005|Overall Study|Not Treated|0|||
160962427|NCT00245102|581249671|FG000|Overall Study|Protocol Violation|1|||
160962428|NCT00245102|581249672|FG001|Overall Study|Protocol Violation|0|||
160962429|NCT00245102|581249673|FG002|Overall Study|Protocol Violation|0|||
160962430|NCT00245102|581249674|FG003|Overall Study|Protocol Violation|0|||
160962431|NCT00245102|581249675|FG004|Overall Study|Protocol Violation|0|||
160962432|NCT00245102|581249676|FG005|Overall Study|Protocol Violation|0|||
160962433|NCT00245102|581249671|FG000|Overall Study|Death|0|||
160962434|NCT00245102|581249672|FG001|Overall Study|Death|0|||
160962435|NCT00245102|581249673|FG002|Overall Study|Death|0|||
160962436|NCT00245102|581249674|FG003|Overall Study|Death|1|||
160962437|NCT00245102|581249675|FG004|Overall Study|Death|0|||
160962438|NCT00245102|581249676|FG005|Overall Study|Death|0|||
160962439|NCT00245102|581249671|FG000|Overall Study|Adverse Event|4|||
160962440|NCT00245102|581249672|FG001|Overall Study|Adverse Event|2|||
160962441|NCT00245102|581249673|FG002|Overall Study|Adverse Event|5|||
160962442|NCT00245102|581249674|FG003|Overall Study|Adverse Event|1|||
160962443|NCT00245102|581249675|FG004|Overall Study|Adverse Event|0|||
160962444|NCT00245102|581249676|FG005|Overall Study|Adverse Event|2|||
160962445|NCT00245102|581249671|FG000|Overall Study|Decline in performance|0|||
160962446|NCT00245102|581249672|FG001|Overall Study|Decline in performance|2|||
160962447|NCT00245102|581249673|FG002|Overall Study|Decline in performance|0|||
160962448|NCT00245102|581249674|FG003|Overall Study|Decline in performance|1|||
160962449|NCT00245102|581249675|FG004|Overall Study|Decline in performance|0|||
160962450|NCT00245102|581249676|FG005|Overall Study|Decline in performance|2|||
160962451|NCT00245102|581249671|FG000|Overall Study|Participant needed surgery|0|||
160962452|NCT00245102|581249672|FG001|Overall Study|Participant needed surgery|0|||
160962453|NCT00245102|581249673|FG002|Overall Study|Participant needed surgery|1|||
160962454|NCT00245102|581249674|FG003|Overall Study|Participant needed surgery|0|||
160962455|NCT00245102|581249675|FG004|Overall Study|Participant needed surgery|0|||
160962456|NCT00245102|581249676|FG005|Overall Study|Participant needed surgery|0|||
160962457|NCT00245102|581249671|FG000|Overall Study|Clinical progression|1|||
160962458|NCT00245102|581249672|FG001|Overall Study|Clinical progression|0|||
160962459|NCT00245102|581249673|FG002|Overall Study|Clinical progression|0|||
160962460|NCT00245102|581249674|FG003|Overall Study|Clinical progression|0|||
160962461|NCT00245102|581249675|FG004|Overall Study|Clinical progression|0|||
160962462|NCT00245102|581249676|FG005|Overall Study|Clinical progression|0|||
160962463|NCT00289887|581249677|FG000|Overall Study|Adverse Event|3|||
160962464|NCT00289887|581249678|FG001|Overall Study|Adverse Event|3|||
160962465|NCT00289887|581249677|FG000|Overall Study|Lack of Efficacy|3|||
160962466|NCT00289887|581249678|FG001|Overall Study|Lack of Efficacy|11|||
160962467|NCT00289887|581249677|FG000|Overall Study|Lost to Follow-up|3|||
160962468|NCT00289887|581249678|FG001|Overall Study|Lost to Follow-up|3|||
160962469|NCT00289887|581249677|FG000|Overall Study|Protocol Violation|3|||
160962470|NCT00289887|581249678|FG001|Overall Study|Protocol Violation|1|||
160962471|NCT00289887|581249677|FG000|Overall Study|Withdrawal by Subject|3|||
160962472|NCT00289887|581249678|FG001|Overall Study|Withdrawal by Subject|8|||
160962473|NCT00289887|581249677|FG000|Overall Study|Other|7|||
160962474|NCT00289887|581249678|FG001|Overall Study|Other|3|||
160962475|NCT02293395|581249681|FG000|Overall Study|Lost to Follow-up|1|||
160962476|NCT02293395|581249682|FG001|Overall Study|Lost to Follow-up|0|||
160962477|NCT02293395|581249681|FG000|Overall Study|Withdrawal by Subject|8|||
160962478|NCT02293395|581249682|FG001|Overall Study|Withdrawal by Subject|7|||
160962479|NCT01464021|581249683|FG000|Overall Study|Withdrawal by Subject|13|||
160962480|NCT01464021|581249683|FG000|Overall Study|Lost to Follow-up|1|||
160962481|NCT01464021|581249683|FG000|Overall Study|Lack of Efficacy|1|||
160962482|NCT01464021|581249683|FG000|Overall Study|various|11|||
160962483|NCT00224770|581249689|FG000|Overall Study|Lost to Follow-up|4|||
160962484|NCT00224770|581249690|FG001|Overall Study|Lost to Follow-up|2|||
160962485|NCT00224770|581249691|FG002|Overall Study|Lost to Follow-up|0|||
160962486|NCT01106430|581249692|FG000|Overall Study|Adverse Event|8|||
160962487|NCT01106430|581249693|FG001|Overall Study|Adverse Event|10|||
160962488|NCT01106430|581249692|FG000|Overall Study|Lack of Efficacy|2|||
160962489|NCT01106430|581249693|FG001|Overall Study|Lack of Efficacy|13|||
160962490|NCT01106430|581249692|FG000|Overall Study|Lost to Follow-up|5|||
160962491|NCT01106430|581249693|FG001|Overall Study|Lost to Follow-up|1|||
160962492|NCT01106430|581249692|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
160962493|NCT01106430|581249693|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
160962494|NCT01106430|581249692|FG000|Overall Study|Moved Out Of State|0|||
160962495|NCT01106430|581249693|FG001|Overall Study|Moved Out Of State|1|||
160962496|NCT01106430|581249692|FG000|Overall Study|Refused To Take Medication|0|||
160962497|NCT01106430|581249693|FG001|Overall Study|Refused To Take Medication|1|||
160962498|NCT01106430|581249692|FG000|Overall Study|Noncompliance|0|||
160962499|NCT01106430|581249693|FG001|Overall Study|Noncompliance|1|||
160962500|NCT01106430|581249692|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
160962501|NCT01106430|581249693|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
160962502|NCT01106430|581249692|FG000|Overall Study|Previous Use Of Marijuana|1|||
160962503|NCT01106430|581249693|FG001|Overall Study|Previous Use Of Marijuana|0|||
160962504|NCT01106430|581249692|FG000|Overall Study|Protocol Violation|7|||
160962505|NCT01106430|581249693|FG001|Overall Study|Protocol Violation|2|||
160962506|NCT01106430|581249692|FG000|Overall Study|Withdrawal by Subject|8|||
160962507|NCT01106430|581249693|FG001|Overall Study|Withdrawal by Subject|4|||
160962508|NCT00437645|581249696|FG000|Overall Study|Adverse Event|15|||
160962509|NCT00437645|581249697|FG001|Overall Study|Adverse Event|84|||
160962510|NCT00437645|581249696|FG000|Overall Study|Withdrawal by Subject|10|||
160962511|NCT00437645|581249697|FG001|Overall Study|Withdrawal by Subject|22|||
160962512|NCT00437645|581249696|FG000|Overall Study|Protocol Violation|3|||
160962513|NCT00437645|581249697|FG001|Overall Study|Protocol Violation|3|||
160962514|NCT00437645|581249696|FG000|Overall Study|Lost to Follow-up|2|||
160962515|NCT00437645|581249697|FG001|Overall Study|Lost to Follow-up|3|||
160962516|NCT00437645|581249696|FG000|Overall Study|Administrative problems|2|||
160962517|NCT00437645|581249697|FG001|Overall Study|Administrative problems|1|||
160962518|NCT00437645|581249696|FG000|Overall Study|Lack of Efficacy|2|||
160962519|NCT00437645|581249697|FG001|Overall Study|Lack of Efficacy|1|||
160962520|NCT00437645|581249696|FG000|Overall Study|Condition no longer requires study drug|1|||
160962521|NCT00437645|581249697|FG001|Overall Study|Condition no longer requires study drug|1|||
160962522|NCT00989092|581249702|FG000|Overall Study|Physician Decision|9|||
160962523|NCT00989092|581249703|FG001|Overall Study|Physician Decision|6|||
161271013|NCT01970865|582372846|FG000|Overall Study|Other|0|||
161271014|NCT01970865|582372847|FG001|Overall Study|Other|1|||
160962524|NCT00989092|581249702|FG000|Overall Study|Adverse Event|20|||
160962525|NCT00989092|581249703|FG001|Overall Study|Adverse Event|1|||
160962526|NCT00989092|581249702|FG000|Overall Study|Chemotherapy initiated|12|||
160962527|NCT00989092|581249703|FG001|Overall Study|Chemotherapy initiated|4|||
160962528|NCT00989092|581249702|FG000|Overall Study|Withdrawal by Subject|17|||
160962529|NCT00989092|581249703|FG001|Overall Study|Withdrawal by Subject|9|||
160962530|NCT00989092|581249702|FG000|Overall Study|Death|14|||
160962531|NCT00989092|581249703|FG001|Overall Study|Death|2|||
160962532|NCT00989092|581249702|FG000|Overall Study|Ineligibility determined|3|||
160962533|NCT00989092|581249703|FG001|Overall Study|Ineligibility determined|3|||
160962534|NCT00989092|581249702|FG000|Overall Study|Lost to Follow-up|6|||
160962535|NCT00989092|581249703|FG001|Overall Study|Lost to Follow-up|2|||
161271015|NCT01970865|582372848|FG002|Overall Study|Other|0|||
160962536|NCT00989092|581249702|FG000|Overall Study|Other|3|||
160962537|NCT00989092|581249703|FG001|Overall Study|Other|1|||
160962538|NCT00989092|581249702|FG000|Overall Study|Protocol deviation|2|||
160962539|NCT00989092|581249703|FG001|Overall Study|Protocol deviation|0|||
160962540|NCT00989092|581249702|FG000|Overall Study|Erythropoietin therapy initiated|2|||
160962541|NCT00989092|581249703|FG001|Overall Study|Erythropoietin therapy initiated|0|||
160962542|NCT00989092|581249702|FG000|Overall Study|Did not receive study drug|2|||
160962543|NCT00989092|581249703|FG001|Overall Study|Did not receive study drug|0|||
160962544|NCT02472652|581249706|FG000|Overall Study|Lost to Follow-up|1|||
160962545|NCT03185832|581249707|FG000|Overall Study|Death|9|||
160962546|NCT03185832|581249708|FG001|Overall Study|Death|14|||
160962547|NCT03185832|581249709|FG002|Overall Study|Death|9|||
160962548|NCT03185832|581249710|FG003|Overall Study|Death|7|||
160962549|NCT03185832|581249707|FG000|Overall Study|Withdrawn - vital status available|0|||
160962550|NCT03185832|581249708|FG001|Overall Study|Withdrawn - vital status available|1|||
160962551|NCT03185832|581249709|FG002|Overall Study|Withdrawn - vital status available|1|||
160962552|NCT03185832|581249710|FG003|Overall Study|Withdrawn - vital status available|4|||
160962553|NCT02230956|581249713|FG000|Overall Study|Adverse Event|1|||
160962554|NCT02230956|581249714|FG001|Overall Study|Adverse Event|1|||
160962555|NCT02230956|581249715|FG002|Overall Study|Adverse Event|0|||
160962556|NCT02230956|581249713|FG000|Overall Study|Lack of Efficacy|1|||
160962557|NCT02230956|581249714|FG001|Overall Study|Lack of Efficacy|1|||
160962558|NCT02230956|581249715|FG002|Overall Study|Lack of Efficacy|1|||
160962559|NCT02230956|581249713|FG000|Overall Study|Lost to Follow-up|1|||
160962560|NCT02230956|581249714|FG001|Overall Study|Lost to Follow-up|1|||
160962561|NCT02230956|581249715|FG002|Overall Study|Lost to Follow-up|2|||
160962562|NCT02230956|581249713|FG000|Overall Study|Personal Reasons|2|||
160962563|NCT02230956|581249714|FG001|Overall Study|Personal Reasons|1|||
160962564|NCT02230956|581249715|FG002|Overall Study|Personal Reasons|1|||
160962565|NCT02230956|581249713|FG000|Overall Study|Protocol Violation|0|||
161146949|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
161146950|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
161146951|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
160962566|NCT02230956|581249714|FG001|Overall Study|Protocol Violation|1|||
160962567|NCT02230956|581249715|FG002|Overall Study|Protocol Violation|1|||
160962568|NCT02230956|581249713|FG000|Overall Study|Other Miscellaneous Reason|0|||
160962569|NCT02230956|581249714|FG001|Overall Study|Other Miscellaneous Reason|1|||
160962570|NCT02230956|581249715|FG002|Overall Study|Other Miscellaneous Reason|2|||
160962571|NCT01445652|581249716|FG000|Overall Study|Not comfortable in lenses|5|||
160962572|NCT01445652|581249717|FG001|Overall Study|Not comfortable in lenses|0|||
160962573|NCT01445652|581249716|FG000|Overall Study|Failed to attend scheduled visit|2|||
160962574|NCT01445652|581249717|FG001|Overall Study|Failed to attend scheduled visit|3|||
160962575|NCT01445652|581249716|FG000|Overall Study|Failed teach session|2|||
160962576|NCT01445652|581249717|FG001|Overall Study|Failed teach session|0|||
160962577|NCT01445652|581249716|FG000|Overall Study|Adverse Event|1|||
160962578|NCT01445652|581249717|FG001|Overall Study|Adverse Event|0|||
160962579|NCT03002610|581249718|FG000|Overall Study|Withdrawal by Subject|6|||
160962580|NCT03002610|581249719|FG001|Overall Study|Withdrawal by Subject|25|||
160962581|NCT03002610|581249720|FG002|Overall Study|Withdrawal by Subject|13|||
160962582|NCT01822587|581249721|FG000|Overall Study|Lost to Follow-up|7|||
160962583|NCT01822587|581249722|FG001|Overall Study|Lost to Follow-up|9|||
160962584|NCT01822587|581249723|FG002|Overall Study|Lost to Follow-up|12|||
160962585|NCT01822587|581249721|FG000|Overall Study|Physician Decision|9|||
160962586|NCT01822587|581249722|FG001|Overall Study|Physician Decision|6|||
160962587|NCT01822587|581249723|FG002|Overall Study|Physician Decision|6|||
160962588|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
160962589|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
160962590|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
160962591|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
160962592|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
160962593|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
160962594|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
160962595|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
160962596|NCT00117676|581249724|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
160962597|NCT00117676|581249725|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
160962598|NCT00117676|581249724|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
160962599|NCT00117676|581249725|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
160962600|NCT00117676|581249724|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
160962601|NCT00117676|581249725|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
160962602|NCT00117676|581249724|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
161146952|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
160962603|NCT00117676|581249725|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
161146953|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
161271016|NCT01970865|582372849|FG003|Overall Study|Other|1|||
160962604|NCT00117676|581249724|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
160962605|NCT00117676|581249725|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
160962606|NCT00117676|581249724|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
160962607|NCT00117676|581249725|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
160962608|NCT00117676|581249724|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
160962609|NCT00117676|581249725|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
160962610|NCT00117676|581249724|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
160962611|NCT00117676|581249725|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
160962612|NCT00117676|581249724|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
160962613|NCT00117676|581249725|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
160962614|NCT00117676|581249724|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
160962615|NCT00117676|581249725|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
160962616|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
160962617|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
160962618|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
160962619|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
160962620|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
160962621|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
160962622|NCT00117676|581249724|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
160962623|NCT00117676|581249725|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
160962624|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
160962625|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
160962626|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
160962627|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
160962628|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
160962629|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
160962630|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
160962631|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
160962632|NCT00117676|581249724|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
160962633|NCT00117676|581249725|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
160962634|NCT00117676|581249724|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
160962635|NCT00117676|581249725|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
160962636|NCT00117676|581249724|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
160962637|NCT00117676|581249725|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
160962638|NCT00117676|581249724|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
160962639|NCT00117676|581249725|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
160962640|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
160962641|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
160962642|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
160962643|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
160962644|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
160962645|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
160962646|NCT00117676|581249724|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
160962647|NCT00117676|581249725|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
160962648|NCT00117676|581249724|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
160962649|NCT00117676|581249725|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
160962650|NCT00117676|581249724|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
160962651|NCT00117676|581249725|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
160962652|NCT00117676|581249724|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
160962653|NCT00117676|581249725|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
160962654|NCT00117676|581249724|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
160962655|NCT00117676|581249725|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
160962656|NCT00117676|581249724|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
160962657|NCT00117676|581249725|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
160962658|NCT00952822|581249726|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
160962659|NCT00952822|581249727|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
160962660|NCT00952822|581249728|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
160962661|NCT00952822|581249729|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
160962662|NCT00952822|581249726|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
160962663|NCT00952822|581249727|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
160962664|NCT00952822|581249728|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
160962665|NCT00952822|581249729|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
161271017|NCT01970865|582372850|FG004|Overall Study|Other|1|||
160962666|NCT04555096|581249731|FG000|Overall Study|Death|4|||
160962667|NCT04555096|581249732|FG001|Overall Study|Death|4|||
160962668|NCT04555096|581249731|FG000|Overall Study|Withdrawal by Subject|1|||
160962669|NCT04555096|581249732|FG001|Overall Study|Withdrawal by Subject|0|||
160962670|NCT04555096|581249731|FG000|Overall Study|Other|0|||
160962671|NCT04555096|581249732|FG001|Overall Study|Other|1|||
160962672|NCT00594854|581249734|FG000|Overall Study|Study terminated|7|||
160962673|NCT00594854|581249735|FG001|Overall Study|Study terminated|10|||
160962674|NCT04918147|581249746|FG000|Overall Study|Disease flare as defined in protocol|0|||
160962675|NCT04918147|581249747|FG001|Overall Study|Disease flare as defined in protocol|2|||
160962676|NCT03292146|581249748|FG000|Baseline to 12 months|Relocation|1|||
160962677|NCT03292146|581249749|FG001|Baseline to 12 months|Relocation|0|||
160962678|NCT03292146|581249748|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
160962679|NCT03292146|581249749|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
160962680|NCT03292146|581249748|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
160962681|NCT03292146|581249749|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
160962682|NCT03292146|581249748|FG000|12 months to 24 months|Planning pregnancy|2|||
160962683|NCT03292146|581249749|FG001|12 months to 24 months|Planning pregnancy|2|||
160962684|NCT03292146|581249748|FG000|12 months to 24 months|Personal reasons|1|||
160962685|NCT03292146|581249749|FG001|12 months to 24 months|Personal reasons|0|||
160962686|NCT03292146|581249748|FG000|12 months to 24 months|Lost to Follow-up|0|||
160962687|NCT03292146|581249749|FG001|12 months to 24 months|Lost to Follow-up|1|||
160962688|NCT06134180|581249750|FG000|Overall Study|Lost to Follow-up|4|||
160962689|NCT01362439|581249751|FG000|Overall Study|Adverse Event|1|||
160962690|NCT01362439|581249751|FG000|Overall Study|Lack of Efficacy|3|||
160962691|NCT01362439|581249751|FG000|Overall Study|Lost to Follow-up|2|||
160962692|NCT01362439|581249751|FG000|Overall Study|Study medication non-compliant|1|||
160962693|NCT01362439|581249751|FG000|Overall Study|Participant who withdrew consent|8|||
160962694|NCT03575325|581249755|FG000|Overall Study|Death|1|||
160962695|NCT03440372|581249756|FG000|Treatment|Adverse Event|16|||
160962696|NCT03440372|581249757|FG001|Treatment|Adverse Event|8|||
160962697|NCT03440372|581249756|FG000|Treatment|Lack of Efficacy|4|||
160962698|NCT03440372|581249757|FG001|Treatment|Lack of Efficacy|2|||
160962699|NCT03440372|581249756|FG000|Treatment|Withdrawal by Subject|12|||
160962700|NCT03440372|581249757|FG001|Treatment|Withdrawal by Subject|8|||
160962701|NCT03440372|581249756|FG000|Treatment|Lost to Follow-up|1|||
160962702|NCT03440372|581249757|FG001|Treatment|Lost to Follow-up|0|||
160962703|NCT03440372|581249756|FG000|Treatment|Pregnancy|1|||
160962704|NCT03440372|581249757|FG001|Treatment|Pregnancy|0|||
160962705|NCT03440372|581249756|FG000|Treatment|Study Terminated by Sponsor|2|||
160962706|NCT03440372|581249757|FG001|Treatment|Study Terminated by Sponsor|1|||
160962707|NCT03440372|581249756|FG000|Treatment|Other Reason|2|||
160962708|NCT03440372|581249757|FG001|Treatment|Other Reason|3|||
160962709|NCT05711641|581249758|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
160962710|NCT05711641|581249759|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
160962711|NCT05711641|581249758|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
160962712|NCT05711641|581249759|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
160962713|NCT03574597|581249760|FG000|Overall Study|Withdrawal by Subject|67|||
160962714|NCT03574597|581249761|FG001|Overall Study|Withdrawal by Subject|96|||
160962715|NCT03574597|581249760|FG000|Overall Study|Lost to Follow-up|192|||
160962716|NCT03574597|581249761|FG001|Overall Study|Lost to Follow-up|188|||
160962717|NCT02355743|581249762|FG000|Overall Study|Withdrawal by Subject|1|||
160962718|NCT02355743|581249762|FG000|Overall Study|Lost to Follow-up|1|||
160962719|NCT02712905|581249765|FG000|Monotherapy|Death|2|||
160962720|NCT02712905|581249766|FG001|Monotherapy|Death|5|||
160962721|NCT02712905|581249767|FG002|Monotherapy|Death|0|||
161146954|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
161146955|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
161146956|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
161146957|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
161146958|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
161146959|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
161146960|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
161271018|NCT01970865|582372851|FG005|Overall Study|Other|0|||
160962722|NCT02712905|581249768|FG003|Monotherapy|Death|3|||
160962723|NCT02712905|581249769|FG004|Monotherapy|Death|15|||
160962724|NCT02712905|581249770|FG005|Monotherapy|Death|1|||
160962725|NCT02712905|581249771|FG006|Monotherapy|Death|3|||
160962726|NCT02712905|581249772|FG007|Monotherapy|Death|3|||
160962727|NCT02712905|581249773|FG008|Monotherapy|Death|0|||
160962728|NCT02712905|581249774|FG009|Monotherapy|Death|27|||
160962729|NCT02712905|581249775|FG010|Monotherapy|Death|2|||
160962730|NCT02712905|581249776|FG011|Monotherapy|Death|5|||
160962731|NCT02712905|581249777|FG012|Monotherapy|Death|0|||
160962732|NCT02712905|581249778|FG013|Monotherapy|Death|0|||
160962733|NCT02712905|581249779|FG014|Monotherapy|Death|0|||
160962734|NCT02712905|581249780|FG015|Monotherapy|Death|0|||
160962735|NCT02712905|581249781|FG016|Monotherapy|Death|0|||
160962736|NCT02712905|581249782|FG017|Monotherapy|Death|0|||
160962737|NCT02712905|581249765|FG000|Monotherapy|Lost to Follow-up|0|||
160962738|NCT02712905|581249766|FG001|Monotherapy|Lost to Follow-up|1|||
160962739|NCT02712905|581249767|FG002|Monotherapy|Lost to Follow-up|0|||
160962740|NCT02712905|581249768|FG003|Monotherapy|Lost to Follow-up|1|||
160962741|NCT02712905|581249769|FG004|Monotherapy|Lost to Follow-up|0|||
160962742|NCT02712905|581249770|FG005|Monotherapy|Lost to Follow-up|0|||
160962743|NCT02712905|581249771|FG006|Monotherapy|Lost to Follow-up|0|||
160962744|NCT02712905|581249772|FG007|Monotherapy|Lost to Follow-up|0|||
160962745|NCT02712905|581249773|FG008|Monotherapy|Lost to Follow-up|0|||
160962746|NCT02712905|581249774|FG009|Monotherapy|Lost to Follow-up|2|||
160962747|NCT02712905|581249775|FG010|Monotherapy|Lost to Follow-up|0|||
160962748|NCT02712905|581249776|FG011|Monotherapy|Lost to Follow-up|0|||
160962749|NCT02712905|581249777|FG012|Monotherapy|Lost to Follow-up|0|||
160962750|NCT02712905|581249778|FG013|Monotherapy|Lost to Follow-up|0|||
160962751|NCT02712905|581249779|FG014|Monotherapy|Lost to Follow-up|0|||
160962752|NCT02712905|581249780|FG015|Monotherapy|Lost to Follow-up|0|||
160962753|NCT02712905|581249781|FG016|Monotherapy|Lost to Follow-up|0|||
160962754|NCT02712905|581249782|FG017|Monotherapy|Lost to Follow-up|0|||
160962755|NCT02712905|581249765|FG000|Monotherapy|Physician Decision|1|||
160962756|NCT02712905|581249766|FG001|Monotherapy|Physician Decision|0|||
160962757|NCT02712905|581249767|FG002|Monotherapy|Physician Decision|0|||
160962758|NCT02712905|581249768|FG003|Monotherapy|Physician Decision|1|||
160962759|NCT02712905|581249769|FG004|Monotherapy|Physician Decision|0|||
160962760|NCT02712905|581249770|FG005|Monotherapy|Physician Decision|0|||
160962761|NCT02712905|581249771|FG006|Monotherapy|Physician Decision|0|||
160962762|NCT02712905|581249772|FG007|Monotherapy|Physician Decision|0|||
160962763|NCT02712905|581249773|FG008|Monotherapy|Physician Decision|0|||
160962764|NCT02712905|581249774|FG009|Monotherapy|Physician Decision|1|||
160962765|NCT02712905|581249775|FG010|Monotherapy|Physician Decision|0|||
160962766|NCT02712905|581249776|FG011|Monotherapy|Physician Decision|0|||
160962767|NCT02712905|581249777|FG012|Monotherapy|Physician Decision|0|||
160962768|NCT02712905|581249778|FG013|Monotherapy|Physician Decision|0|||
160962769|NCT02712905|581249779|FG014|Monotherapy|Physician Decision|0|||
160962770|NCT02712905|581249780|FG015|Monotherapy|Physician Decision|0|||
160962771|NCT02712905|581249781|FG016|Monotherapy|Physician Decision|0|||
160962772|NCT02712905|581249782|FG017|Monotherapy|Physician Decision|0|||
160962773|NCT02712905|581249765|FG000|Monotherapy|Study Terminated by Sponsor|0|||
160962774|NCT02712905|581249766|FG001|Monotherapy|Study Terminated by Sponsor|0|||
160962775|NCT02712905|581249767|FG002|Monotherapy|Study Terminated by Sponsor|0|||
160962776|NCT02712905|581249768|FG003|Monotherapy|Study Terminated by Sponsor|0|||
160962777|NCT02712905|581249769|FG004|Monotherapy|Study Terminated by Sponsor|1|||
160962778|NCT02712905|581249770|FG005|Monotherapy|Study Terminated by Sponsor|0|||
160962779|NCT02712905|581249771|FG006|Monotherapy|Study Terminated by Sponsor|0|||
160962780|NCT02712905|581249772|FG007|Monotherapy|Study Terminated by Sponsor|0|||
160962781|NCT02712905|581249773|FG008|Monotherapy|Study Terminated by Sponsor|0|||
160962782|NCT02712905|581249774|FG009|Monotherapy|Study Terminated by Sponsor|2|||
160962783|NCT02712905|581249775|FG010|Monotherapy|Study Terminated by Sponsor|0|||
160962784|NCT02712905|581249776|FG011|Monotherapy|Study Terminated by Sponsor|0|||
160962785|NCT02712905|581249777|FG012|Monotherapy|Study Terminated by Sponsor|0|||
160962786|NCT02712905|581249778|FG013|Monotherapy|Study Terminated by Sponsor|0|||
160962787|NCT02712905|581249779|FG014|Monotherapy|Study Terminated by Sponsor|0|||
160962788|NCT02712905|581249780|FG015|Monotherapy|Study Terminated by Sponsor|0|||
160962789|NCT02712905|581249781|FG016|Monotherapy|Study Terminated by Sponsor|0|||
160962790|NCT02712905|581249782|FG017|Monotherapy|Study Terminated by Sponsor|0|||
160962791|NCT02712905|581249765|FG000|Monotherapy|Withdrawal by Subject|0|||
160962792|NCT02712905|581249766|FG001|Monotherapy|Withdrawal by Subject|0|||
160962793|NCT02712905|581249767|FG002|Monotherapy|Withdrawal by Subject|1|||
160962794|NCT02712905|581249768|FG003|Monotherapy|Withdrawal by Subject|0|||
160962795|NCT02712905|581249769|FG004|Monotherapy|Withdrawal by Subject|2|||
160962796|NCT02712905|581249770|FG005|Monotherapy|Withdrawal by Subject|0|||
160962797|NCT02712905|581249771|FG006|Monotherapy|Withdrawal by Subject|0|||
160962798|NCT02712905|581249772|FG007|Monotherapy|Withdrawal by Subject|0|||
160962799|NCT02712905|581249773|FG008|Monotherapy|Withdrawal by Subject|0|||
161002334|NCT03482011|581394573|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161271019|NCT01970865|582372852|FG006|Overall Study|Other|1|||
161271020|NCT01970865|582372853|FG007|Overall Study|Other|0|||
161271021|NCT01970865|582372854|FG008|Overall Study|Other|0|||
161271022|NCT01970865|582372855|FG009|Overall Study|Other|0|||
160962800|NCT02712905|581249774|FG009|Monotherapy|Withdrawal by Subject|4|||
160962801|NCT02712905|581249775|FG010|Monotherapy|Withdrawal by Subject|1|||
160962802|NCT02712905|581249776|FG011|Monotherapy|Withdrawal by Subject|2|||
160962803|NCT02712905|581249777|FG012|Monotherapy|Withdrawal by Subject|0|||
161002335|NCT03482011|581394574|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161271023|NCT01970865|582372856|FG010|Overall Study|Other|2|||
160962804|NCT02712905|581249778|FG013|Monotherapy|Withdrawal by Subject|0|||
160962805|NCT02712905|581249779|FG014|Monotherapy|Withdrawal by Subject|0|||
160962806|NCT02712905|581249780|FG015|Monotherapy|Withdrawal by Subject|0|||
160962807|NCT02712905|581249781|FG016|Monotherapy|Withdrawal by Subject|0|||
160962808|NCT02712905|581249782|FG017|Monotherapy|Withdrawal by Subject|0|||
161271024|NCT01970865|582372857|FG011|Overall Study|Other|3|||
161271025|NCT01970865|582372858|FG012|Overall Study|Other|8|||
161271026|NCT01970865|582372859|FG013|Overall Study|Other|3|||
161271027|NCT01970865|582372860|FG014|Overall Study|Other|2|||
161271028|NCT01970865|582372861|FG015|Overall Study|Other|3|||
161271029|NCT01970865|582372862|FG016|Overall Study|Other|0|||
160962809|NCT02712905|581249765|FG000|Monotherapy|Started New Cancer Drug|0|||
160962810|NCT02712905|581249766|FG001|Monotherapy|Started New Cancer Drug|0|||
160962811|NCT02712905|581249767|FG002|Monotherapy|Started New Cancer Drug|0|||
160962812|NCT02712905|581249768|FG003|Monotherapy|Started New Cancer Drug|0|||
160962813|NCT02712905|581249769|FG004|Monotherapy|Started New Cancer Drug|0|||
160962814|NCT02712905|581249770|FG005|Monotherapy|Started New Cancer Drug|1|||
160962815|NCT02712905|581249771|FG006|Monotherapy|Started New Cancer Drug|0|||
160962816|NCT02712905|581249772|FG007|Monotherapy|Started New Cancer Drug|0|||
160962817|NCT02712905|581249773|FG008|Monotherapy|Started New Cancer Drug|0|||
160962818|NCT02712905|581249774|FG009|Monotherapy|Started New Cancer Drug|0|||
160962819|NCT02712905|581249775|FG010|Monotherapy|Started New Cancer Drug|0|||
160962820|NCT02712905|581249776|FG011|Monotherapy|Started New Cancer Drug|0|||
160962821|NCT02712905|581249777|FG012|Monotherapy|Started New Cancer Drug|0|||
160962822|NCT02712905|581249778|FG013|Monotherapy|Started New Cancer Drug|0|||
160962823|NCT02712905|581249779|FG014|Monotherapy|Started New Cancer Drug|0|||
160962824|NCT02712905|581249780|FG015|Monotherapy|Started New Cancer Drug|0|||
160962825|NCT02712905|581249781|FG016|Monotherapy|Started New Cancer Drug|0|||
160962826|NCT02712905|581249782|FG017|Monotherapy|Started New Cancer Drug|0|||
160962827|NCT02712905|581249765|FG000|Monotherapy|Adverse Event|0|||
160962828|NCT02712905|581249766|FG001|Monotherapy|Adverse Event|0|||
160962829|NCT02712905|581249767|FG002|Monotherapy|Adverse Event|0|||
160962830|NCT02712905|581249768|FG003|Monotherapy|Adverse Event|0|||
160962831|NCT02712905|581249769|FG004|Monotherapy|Adverse Event|0|||
160962832|NCT02712905|581249770|FG005|Monotherapy|Adverse Event|0|||
160962833|NCT02712905|581249771|FG006|Monotherapy|Adverse Event|0|||
160962834|NCT02712905|581249772|FG007|Monotherapy|Adverse Event|0|||
160962835|NCT02712905|581249773|FG008|Monotherapy|Adverse Event|1|||
160962836|NCT02712905|581249774|FG009|Monotherapy|Adverse Event|0|||
160962837|NCT02712905|581249775|FG010|Monotherapy|Adverse Event|0|||
160962838|NCT02712905|581249776|FG011|Monotherapy|Adverse Event|0|||
160962839|NCT02712905|581249777|FG012|Monotherapy|Adverse Event|0|||
160962840|NCT02712905|581249778|FG013|Monotherapy|Adverse Event|0|||
160962841|NCT02712905|581249779|FG014|Monotherapy|Adverse Event|0|||
160962842|NCT02712905|581249780|FG015|Monotherapy|Adverse Event|0|||
160962843|NCT02712905|581249781|FG016|Monotherapy|Adverse Event|0|||
160962844|NCT02712905|581249782|FG017|Monotherapy|Adverse Event|0|||
160962845|NCT02712905|581249765|FG000|Combination Therapy|Death|0|||
160962846|NCT02712905|581249766|FG001|Combination Therapy|Death|0|||
160962847|NCT02712905|581249767|FG002|Combination Therapy|Death|0|||
160962848|NCT02712905|581249768|FG003|Combination Therapy|Death|0|||
160962849|NCT02712905|581249769|FG004|Combination Therapy|Death|0|||
160962850|NCT02712905|581249770|FG005|Combination Therapy|Death|0|||
160962851|NCT02712905|581249771|FG006|Combination Therapy|Death|0|||
160962852|NCT02712905|581249772|FG007|Combination Therapy|Death|0|||
160962853|NCT02712905|581249773|FG008|Combination Therapy|Death|0|||
161271030|NCT01970865|582372863|FG017|Overall Study|Other|2|||
161271031|NCT01970865|582372846|FG000|Overall Study|Participant refused further follow-up|0|||
161271032|NCT01970865|582372847|FG001|Overall Study|Participant refused further follow-up|0|||
161271033|NCT01970865|582372848|FG002|Overall Study|Participant refused further follow-up|0|||
160962854|NCT02712905|581249774|FG009|Combination Therapy|Death|0|||
160962855|NCT02712905|581249775|FG010|Combination Therapy|Death|0|||
160962856|NCT02712905|581249776|FG011|Combination Therapy|Death|0|||
160962857|NCT02712905|581249777|FG012|Combination Therapy|Death|5|||
160962858|NCT02712905|581249778|FG013|Combination Therapy|Death|6|||
160962859|NCT02712905|581249779|FG014|Combination Therapy|Death|1|||
160962860|NCT02712905|581249780|FG015|Combination Therapy|Death|3|||
160962861|NCT02712905|581249781|FG016|Combination Therapy|Death|1|||
160962862|NCT02712905|581249782|FG017|Combination Therapy|Death|3|||
161271034|NCT01970865|582372849|FG003|Overall Study|Participant refused further follow-up|2|||
161271035|NCT01970865|582372850|FG004|Overall Study|Participant refused further follow-up|3|||
160962863|NCT02712905|581249765|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
160962864|NCT02712905|581249766|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
160962865|NCT02712905|581249767|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
160962866|NCT02712905|581249768|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
160962867|NCT02712905|581249769|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
160962868|NCT02712905|581249770|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
160962869|NCT02712905|581249771|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
160962870|NCT02712905|581249772|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
160962871|NCT02712905|581249773|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
160962872|NCT02712905|581249774|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
160962873|NCT02712905|581249775|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
160962874|NCT02712905|581249776|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
160962875|NCT02712905|581249777|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
160962876|NCT02712905|581249778|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
161343487|NCT03965923|582644393|FG003|Overall Study|Death|0|||
160962877|NCT02712905|581249779|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
160962878|NCT02712905|581249780|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
160962879|NCT02712905|581249781|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
160962880|NCT02712905|581249782|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
160962881|NCT02712905|581249765|FG000|Combination Therapy|Withdrawal by Subject|0|||
160962882|NCT02712905|581249766|FG001|Combination Therapy|Withdrawal by Subject|0|||
160962883|NCT02712905|581249767|FG002|Combination Therapy|Withdrawal by Subject|0|||
160962884|NCT02712905|581249768|FG003|Combination Therapy|Withdrawal by Subject|0|||
160962885|NCT02712905|581249769|FG004|Combination Therapy|Withdrawal by Subject|0|||
160962886|NCT02712905|581249770|FG005|Combination Therapy|Withdrawal by Subject|0|||
160962887|NCT02712905|581249771|FG006|Combination Therapy|Withdrawal by Subject|0|||
160962888|NCT02712905|581249772|FG007|Combination Therapy|Withdrawal by Subject|0|||
160962889|NCT02712905|581249773|FG008|Combination Therapy|Withdrawal by Subject|0|||
160962890|NCT02712905|581249774|FG009|Combination Therapy|Withdrawal by Subject|0|||
160962891|NCT02712905|581249775|FG010|Combination Therapy|Withdrawal by Subject|0|||
160962892|NCT02712905|581249776|FG011|Combination Therapy|Withdrawal by Subject|0|||
160962893|NCT02712905|581249777|FG012|Combination Therapy|Withdrawal by Subject|0|||
160962894|NCT02712905|581249778|FG013|Combination Therapy|Withdrawal by Subject|0|||
160962895|NCT02712905|581249779|FG014|Combination Therapy|Withdrawal by Subject|0|||
160962896|NCT02712905|581249780|FG015|Combination Therapy|Withdrawal by Subject|1|||
160962897|NCT02712905|581249781|FG016|Combination Therapy|Withdrawal by Subject|0|||
160962898|NCT02712905|581249782|FG017|Combination Therapy|Withdrawal by Subject|2|||
160962899|NCT02712905|581249765|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962900|NCT02712905|581249766|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962901|NCT02712905|581249767|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962902|NCT02712905|581249768|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962903|NCT02712905|581249769|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962904|NCT02712905|581249770|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962905|NCT02712905|581249771|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962906|NCT02712905|581249772|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962907|NCT02712905|581249773|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962908|NCT02712905|581249774|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962909|NCT02712905|581249775|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962910|NCT02712905|581249776|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962911|NCT02712905|581249777|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962912|NCT02712905|581249778|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962913|NCT02712905|581249779|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962914|NCT02712905|581249780|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
160962915|NCT02712905|581249781|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962916|NCT02712905|581249782|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
160962917|NCT03624504|581249783|FG000|Overall Study|Unsuccessful Implant|1|||
160962918|NCT02975973|581249786|FG000|Overall Study|Adverse Event|1|||
160962919|NCT02975973|581249787|FG001|Overall Study|Adverse Event|1|||
160962920|NCT02975973|581249788|FG002|Overall Study|Adverse Event|1|||
160962921|NCT02975973|581249789|FG003|Overall Study|Adverse Event|0|||
160962922|NCT01812655|581249790|FG000|Overall Study|Protocol Violation|1|||
160962923|NCT01812655|581249791|FG001|Overall Study|Protocol Violation|1|||
160962924|NCT01812655|581249792|FG002|Overall Study|Protocol Violation|0|||
160962925|NCT01428076|581249793|FG000|Overall Study|Adverse Event|0|||
160962926|NCT01428076|581249794|FG001|Overall Study|Adverse Event|1|||
160962927|NCT04435665|581249795|FG000|Overall Study|Lost to Follow-up|0|||
160962928|NCT04435665|581249796|FG001|Overall Study|Lost to Follow-up|0|||
160962929|NCT04435665|581249797|FG002|Overall Study|Lost to Follow-up|0|||
160962930|NCT04435665|581249798|FG003|Overall Study|Lost to Follow-up|1|||
160962931|NCT00419263|581249799|FG000|Overall Study|Lost to Follow-up|2|||
160962932|NCT00419263|581249800|FG001|Overall Study|Lost to Follow-up|1|||
160962933|NCT00419263|581249801|FG002|Overall Study|Lost to Follow-up|1|||
160962934|NCT00419263|581249799|FG000|Overall Study|Randomized in Error, Not Treated|1|||
160962935|NCT00419263|581249800|FG001|Overall Study|Randomized in Error, Not Treated|1|||
160962936|NCT00419263|581249801|FG002|Overall Study|Randomized in Error, Not Treated|0|||
160962937|NCT00419263|581249799|FG000|Overall Study|Adverse Event|0|||
161002336|NCT03482011|581394575|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
161146961|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
161146962|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
161146963|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
161146964|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
160962938|NCT00419263|581249800|FG001|Overall Study|Adverse Event|0|||
160962939|NCT00419263|581249801|FG002|Overall Study|Adverse Event|1|||
160962940|NCT00419263|581249799|FG000|Overall Study|Withdrawal by Subject|0|||
160962941|NCT00419263|581249800|FG001|Overall Study|Withdrawal by Subject|0|||
160962942|NCT00419263|581249801|FG002|Overall Study|Withdrawal by Subject|1|||
160962943|NCT00540124|581249802|FG000|Overall Study|Adverse Event|0|||
160962944|NCT00540124|581249803|FG001|Overall Study|Adverse Event|2|||
160962945|NCT00540124|581249804|FG002|Overall Study|Adverse Event|1|||
160962946|NCT00540124|581249802|FG000|Overall Study|Entry Criteria Not Met|2|||
160962947|NCT00540124|581249803|FG001|Overall Study|Entry Criteria Not Met|0|||
160962948|NCT00540124|581249804|FG002|Overall Study|Entry Criteria Not Met|0|||
160962949|NCT00540124|581249802|FG000|Overall Study|Lack of Efficacy|1|||
160962950|NCT00540124|581249803|FG001|Overall Study|Lack of Efficacy|0|||
160962951|NCT00540124|581249804|FG002|Overall Study|Lack of Efficacy|0|||
160962952|NCT00540124|581249802|FG000|Overall Study|Withdrawal by Subject|1|||
160962953|NCT00540124|581249803|FG001|Overall Study|Withdrawal by Subject|1|||
160962954|NCT00540124|581249804|FG002|Overall Study|Withdrawal by Subject|0|||
160962955|NCT02124265|581249805|FG000|Overall Study|Adverse Event|1|||
160962956|NCT00058123|581249807|FG000|Overall Study|Wrong histology|9|||
160962957|NCT00058123|581249807|FG000|Overall Study|Received >3 prior treatments|1|||
160962958|NCT04839965|581249810|FG000|Overall Study|Death|6|||
160962959|NCT04839965|581249811|FG001|Overall Study|Death|6|||
160962960|NCT04839965|581249810|FG000|Overall Study|Lost to Follow-up|1|||
160962961|NCT04839965|581249811|FG001|Overall Study|Lost to Follow-up|0|||
160962962|NCT02291679|581249812|FG000|Overall Study|Adverse Event|2|||
160962963|NCT02291679|581249813|FG001|Overall Study|Adverse Event|12|||
160962964|NCT02291679|581249814|FG002|Overall Study|Adverse Event|19|||
160962965|NCT02291679|581249812|FG000|Overall Study|Protocol Violation|5|||
160962966|NCT02291679|581249813|FG001|Overall Study|Protocol Violation|1|||
160962967|NCT02291679|581249814|FG002|Overall Study|Protocol Violation|7|||
160962968|NCT02291679|581249812|FG000|Overall Study|Withdrew Consent|18|||
160962969|NCT02291679|581249813|FG001|Overall Study|Withdrew Consent|10|||
160962970|NCT02291679|581249814|FG002|Overall Study|Withdrew Consent|15|||
160962971|NCT02291679|581249812|FG000|Overall Study|Lost to Follow-up|12|||
160962972|NCT02291679|581249813|FG001|Overall Study|Lost to Follow-up|10|||
160962973|NCT02291679|581249814|FG002|Overall Study|Lost to Follow-up|9|||
160962974|NCT02291679|581249812|FG000|Overall Study|Insufficient Therapeutic Response|5|||
160962975|NCT02291679|581249813|FG001|Overall Study|Insufficient Therapeutic Response|5|||
160962976|NCT02291679|581249814|FG002|Overall Study|Insufficient Therapeutic Response|7|||
160962977|NCT02291679|581249812|FG000|Overall Study|Other|2|||
160962978|NCT02291679|581249813|FG001|Overall Study|Other|4|||
160962979|NCT02291679|581249814|FG002|Overall Study|Other|2|||
160962980|NCT01266642|581249815|FG000|Overall Study|Protocol Violation|0|||
160962981|NCT01266642|581249816|FG001|Overall Study|Protocol Violation|1|||
160962982|NCT02532179|581251317|FG000|Overall Study|Lost to Follow-up|1|||
160962983|NCT02532179|581251317|FG000|Overall Study|Pregnancy|1|||
160962984|NCT02532179|581251317|FG000|Overall Study|Subject received depot steroid injection|1|||
160962985|NCT01337674|581251321|FG000|Treatment Period 1|Adverse Event|0|||
160962986|NCT01337674|581251322|FG001|Treatment Period 1|Adverse Event|1|||
160962987|NCT01337674|581251323|FG002|Treatment Period 1|Adverse Event|0|||
160962988|NCT01337674|581251324|FG003|Treatment Period 1|Adverse Event|0|||
161002337|NCT00468052|581394576|FG000|Overall Study|Protocol Violation|7|||
161002338|NCT00468052|581394577|FG001|Overall Study|Protocol Violation|8|||
161002339|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
161002340|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
161002341|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
161146965|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
161146966|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
161146967|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
161146968|NCT00092547|581922383|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
160962989|NCT01337674|581251321|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
160962990|NCT01337674|581251322|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
160962991|NCT01337674|581251323|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
160962992|NCT01337674|581251324|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
160962993|NCT01337674|581251321|FG000|Treatment Period 2|Withdrawal by Subject|0|||
160962994|NCT01337674|581251322|FG001|Treatment Period 2|Withdrawal by Subject|0|||
160962995|NCT01337674|581251323|FG002|Treatment Period 2|Withdrawal by Subject|1|||
160962996|NCT01337674|581251324|FG003|Treatment Period 2|Withdrawal by Subject|0|||
160962997|NCT02240108|581251325|FG000|Overall Study|Other than specified|8|||
160962998|NCT02240108|581251326|FG001|Overall Study|Other than specified|6|||
160962999|NCT02240108|581251325|FG000|Overall Study|Adverse Event|1|||
160963000|NCT02240108|581251326|FG001|Overall Study|Adverse Event|9|||
160963001|NCT02240108|581251325|FG000|Overall Study|Pregnancy|1|||
160963002|NCT02240108|581251326|FG001|Overall Study|Pregnancy|0|||
160963003|NCT02240108|581251325|FG000|Overall Study|Withdrawal by Subject|4|||
160963004|NCT02240108|581251326|FG001|Overall Study|Withdrawal by Subject|9|||
160963005|NCT02240108|581251325|FG000|Overall Study|StudyTerminated by Sponsor|0|||
160963006|NCT02240108|581251326|FG001|Overall Study|StudyTerminated by Sponsor|1|||
160963007|NCT00119405|581251327|FG000|Overall Study|Withdrawal by Subject|1|||
160963008|NCT00939484|581251329|FG000|Overall Study|Progression/Relapse|8|||
160963009|NCT00939484|581251330|FG001|Overall Study|Progression/Relapse|20|||
160963010|NCT00939484|581251331|FG002|Overall Study|Progression/Relapse|3|||
160963011|NCT04233372|581251332|FG000|Overall Study|Lost to Follow-up|104|||
160963012|NCT04233372|581251332|FG000|Overall Study|Adverse Event|8|||
160963013|NCT04233372|581251332|FG000|Overall Study|Withdrawal by Subject|2|||
160963014|NCT04958785|581251333|FG000|Overall Study|Study Terminated by Sponsor|4|||
160963015|NCT04958785|581251334|FG001|Overall Study|Study Terminated by Sponsor|10|||
160963016|NCT04958785|581251335|FG002|Overall Study|Study Terminated by Sponsor|7|||
160963017|NCT04958785|581251336|FG003|Overall Study|Study Terminated by Sponsor|6|||
160963018|NCT04958785|581251337|FG004|Overall Study|Study Terminated by Sponsor|34|||
160963019|NCT04958785|581251333|FG000|Overall Study|Death|2|||
160963020|NCT04958785|581251334|FG001|Overall Study|Death|3|||
160963021|NCT04958785|581251335|FG002|Overall Study|Death|4|||
160963022|NCT04958785|581251336|FG003|Overall Study|Death|5|||
160963023|NCT04958785|581251337|FG004|Overall Study|Death|5|||
160963024|NCT04958785|581251333|FG000|Overall Study|Withdrew consent|2|||
160963025|NCT04958785|581251334|FG001|Overall Study|Withdrew consent|0|||
160963026|NCT04958785|581251335|FG002|Overall Study|Withdrew consent|3|||
160963027|NCT04958785|581251336|FG003|Overall Study|Withdrew consent|1|||
160963028|NCT04958785|581251337|FG004|Overall Study|Withdrew consent|0|||
160963029|NCT04958785|581251333|FG000|Overall Study|Investigator's discretion|0|||
160963030|NCT04958785|581251334|FG001|Overall Study|Investigator's discretion|1|||
160963031|NCT04958785|581251335|FG002|Overall Study|Investigator's discretion|0|||
160963032|NCT04958785|581251336|FG003|Overall Study|Investigator's discretion|1|||
160963033|NCT04958785|581251337|FG004|Overall Study|Investigator's discretion|2|||
160963034|NCT04958785|581251333|FG000|Overall Study|Adverse Event|0|||
160963035|NCT04958785|581251334|FG001|Overall Study|Adverse Event|0|||
160963036|NCT04958785|581251335|FG002|Overall Study|Adverse Event|0|||
160963037|NCT04958785|581251336|FG003|Overall Study|Adverse Event|0|||
160963038|NCT04958785|581251337|FG004|Overall Study|Adverse Event|1|||
160963039|NCT04958785|581251333|FG000|Overall Study|Lost to Follow-up|0|||
160963040|NCT04958785|581251334|FG001|Overall Study|Lost to Follow-up|0|||
160963041|NCT04958785|581251335|FG002|Overall Study|Lost to Follow-up|0|||
160963042|NCT04958785|581251336|FG003|Overall Study|Lost to Follow-up|0|||
160963043|NCT04958785|581251337|FG004|Overall Study|Lost to Follow-up|1|||
161146969|NCT00092547|581922384|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
161146970|NCT00092547|581922385|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
161146971|NCT00092547|581922383|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
160963047|NCT01090310|581251339|FG000|Core Study|Adverse Event|2|||
160963048|NCT01090310|581251340|FG001|Core Study|Adverse Event|2|||
160963049|NCT01090310|581251341|FG002|Core Study|Adverse Event|1|||
160963050|NCT01090310|581251342|FG003|Core Study|Adverse Event|1|||
160963051|NCT01090310|581251339|FG000|Core Study|Subject withdrew consent|0|||
160963052|NCT01090310|581251340|FG001|Core Study|Subject withdrew consent|3|||
160963053|NCT01090310|581251341|FG002|Core Study|Subject withdrew consent|1|||
160963054|NCT01090310|581251342|FG003|Core Study|Subject withdrew consent|1|||
160963055|NCT01090310|581251339|FG000|Core Study|Abnormal test procedure result|0|||
160963056|NCT01090310|581251340|FG001|Core Study|Abnormal test procedure result|0|||
160963057|NCT01090310|581251341|FG002|Core Study|Abnormal test procedure result|1|||
160963058|NCT01090310|581251342|FG003|Core Study|Abnormal test procedure result|0|||
160963059|NCT01090310|581251339|FG000|Core Study|Administrative reasons|5|||
160963060|NCT01090310|581251340|FG001|Core Study|Administrative reasons|6|||
160963061|NCT01090310|581251341|FG002|Core Study|Administrative reasons|4|||
160963062|NCT01090310|581251342|FG003|Core Study|Administrative reasons|4|||
160963063|NCT01090310|581251339|FG000|Core Study|Protocol deviation|1|||
160963064|NCT01090310|581251340|FG001|Core Study|Protocol deviation|0|||
160963065|NCT01090310|581251341|FG002|Core Study|Protocol deviation|0|||
160963066|NCT01090310|581251342|FG003|Core Study|Protocol deviation|1|||
160963067|NCT01090310|581251339|FG000|Extension Study|Aministrative problems|13|||
161146972|NCT00092547|581922384|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
161146973|NCT00092547|581922385|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
160963068|NCT01090310|581251340|FG001|Extension Study|Aministrative problems|15|||
160963069|NCT01090310|581251341|FG002|Extension Study|Aministrative problems|14|||
160963070|NCT01090310|581251342|FG003|Extension Study|Aministrative problems|18|||
160963071|NCT01090310|581251339|FG000|Extension Study|Adverse Event|0|||
161146974|NCT00092547|581922383|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
161343488|NCT03965923|582644394|FG004|Overall Study|Death|0|||
160963072|NCT01090310|581251340|FG001|Extension Study|Adverse Event|0|||
160963073|NCT01090310|581251341|FG002|Extension Study|Adverse Event|0|||
160963074|NCT01090310|581251342|FG003|Extension Study|Adverse Event|1|||
160963075|NCT01090310|581251339|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
160963076|NCT01090310|581251340|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
160963077|NCT01090310|581251341|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
160963078|NCT01090310|581251342|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
160963079|NCT01090310|581251339|FG000|Extension Study|Subject withdrew consent|0|||
160963080|NCT01090310|581251340|FG001|Extension Study|Subject withdrew consent|1|||
160963081|NCT01090310|581251341|FG002|Extension Study|Subject withdrew consent|0|||
160963082|NCT01090310|581251342|FG003|Extension Study|Subject withdrew consent|0|||
160963083|NCT00695786|581251343|FG000|Overall Study|Adverse Event|0|||
160963084|NCT00695786|581251344|FG001|Overall Study|Adverse Event|3|||
160963085|NCT00695786|581251345|FG002|Overall Study|Adverse Event|4|||
160963086|NCT00695786|581251346|FG003|Overall Study|Adverse Event|2|||
160963087|NCT00695786|581251343|FG000|Overall Study|Lost to Follow-up|0|||
160963088|NCT00695786|581251344|FG001|Overall Study|Lost to Follow-up|5|||
160963089|NCT00695786|581251345|FG002|Overall Study|Lost to Follow-up|1|||
160963090|NCT00695786|581251346|FG003|Overall Study|Lost to Follow-up|1|||
160963091|NCT00695786|581251343|FG000|Overall Study|Withdrawal by Subject|0|||
160963092|NCT00695786|581251344|FG001|Overall Study|Withdrawal by Subject|4|||
160963093|NCT00695786|581251345|FG002|Overall Study|Withdrawal by Subject|3|||
160963094|NCT00695786|581251346|FG003|Overall Study|Withdrawal by Subject|1|||
160963095|NCT00695786|581251343|FG000|Overall Study|Deemed Ineligible|1|||
160963096|NCT00695786|581251344|FG001|Overall Study|Deemed Ineligible|0|||
160963097|NCT00695786|581251345|FG002|Overall Study|Deemed Ineligible|0|||
160963098|NCT00695786|581251346|FG003|Overall Study|Deemed Ineligible|0|||
160963099|NCT00695786|581251343|FG000|Overall Study|Lack of Efficacy|0|||
160963100|NCT00695786|581251344|FG001|Overall Study|Lack of Efficacy|0|||
160963101|NCT00695786|581251345|FG002|Overall Study|Lack of Efficacy|0|||
160963102|NCT00695786|581251346|FG003|Overall Study|Lack of Efficacy|4|||
160963103|NCT01224925|581251347|FG000|Overall Study|Lost to Follow-up|3|||
160963104|NCT01224925|581251348|FG001|Overall Study|Lost to Follow-up|2|||
160963105|NCT03439189|581251352|FG000|Overall Study|Protocol Violation|19|||
160963106|NCT03439189|581251352|FG000|Overall Study|Lack of Efficacy|63|||
160963107|NCT02173548|581251353|FG000|Overall Study|Lost to Follow-up|0|||
160963108|NCT02173548|581251354|FG001|Overall Study|Lost to Follow-up|2|||
160963109|NCT02173548|581251353|FG000|Overall Study|Withdrawal by Subject|1|||
160963110|NCT02173548|581251354|FG001|Overall Study|Withdrawal by Subject|0|||
160963111|NCT03597568|581251355|FG000|Overall Study|Withdrawal by Subject|1|||
160963112|NCT03597568|581251356|FG001|Overall Study|Withdrawal by Subject|1|||
160963113|NCT03597568|581251355|FG000|Overall Study|Unable to analyze vascular data|1|||
160963114|NCT03597568|581251356|FG001|Overall Study|Unable to analyze vascular data|1|||
160963115|NCT00999466|581251357|FG000|Main Part|Withdrawal by Subject|0|||
160963116|NCT00999466|581251358|FG001|Main Part|Withdrawal by Subject|0|||
160963117|NCT00999466|581251359|FG002|Main Part|Withdrawal by Subject|2|||
160963118|NCT00999466|581251357|FG000|Main Part|Adverse Event|0|||
160963119|NCT00999466|581251358|FG001|Main Part|Adverse Event|4|||
160963120|NCT00999466|581251359|FG002|Main Part|Adverse Event|2|||
160963121|NCT00526630|581251360|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
160963122|NCT00526630|581251361|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
160963123|NCT00526630|581251360|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
160963124|NCT00526630|581251361|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
160963125|NCT00337272|581251362|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
160963126|NCT00337272|581251363|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
160963127|NCT00337272|581251362|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
160963128|NCT00337272|581251363|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
160963129|NCT00337272|581251362|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
160963130|NCT00337272|581251363|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
160963131|NCT00337272|581251362|FG000|Treatment Period|Non-compliance|1|||
160963132|NCT00337272|581251363|FG001|Treatment Period|Non-compliance|1|||
160963133|NCT00337272|581251362|FG000|Treatment Period|Withdrawal by Subject|0|||
160963134|NCT00337272|581251363|FG001|Treatment Period|Withdrawal by Subject|1|||
160963135|NCT00337272|581251362|FG000|Withdrawal Period|Non-compliance|0|||
160963136|NCT00337272|581251363|FG001|Withdrawal Period|Non-compliance|1|||
160963137|NCT03320018|581251364|FG000|Treatment Period|Withdrawal by Subject|1|||
160963138|NCT03320018|581251365|FG001|Treatment Period|Withdrawal by Subject|0|||
160963139|NCT03320018|581251364|FG000|Day 90 Follow up|Death|0|||
160963140|NCT03320018|581251365|FG001|Day 90 Follow up|Death|1|||
160963141|NCT01127646|581251368|FG000|Overall Study|Entry Criteria Not Met|1|||
160963142|NCT01127646|581251369|FG001|Overall Study|Entry Criteria Not Met|0|||
160963143|NCT01127646|581251368|FG000|Overall Study|Protocol Violation|0|||
160963144|NCT01127646|581251369|FG001|Overall Study|Protocol Violation|1|||
160963145|NCT00595504|581251373|FG000|Overall Study|Withdrawal by Subject|1|||
160963146|NCT00595504|581251374|FG001|Overall Study|Withdrawal by Subject|3|||
160963147|NCT00595504|581251373|FG000|Overall Study|Physician Decision|1|||
160963148|NCT00595504|581251374|FG001|Overall Study|Physician Decision|0|||
160963149|NCT01662063|581251375|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
160963150|NCT01662063|581251376|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
160963151|NCT01662063|581251377|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
160963152|NCT01662063|581251375|FG000|Overall Study|Lack of Efficacy|1|||
160963153|NCT01662063|581251376|FG001|Overall Study|Lack of Efficacy|6|||
160963154|NCT01662063|581251377|FG002|Overall Study|Lack of Efficacy|0|||
160963155|NCT01662063|581251375|FG000|Overall Study|Lost to Follow-up|0|||
160963156|NCT01662063|581251376|FG001|Overall Study|Lost to Follow-up|4|||
160963157|NCT01662063|581251377|FG002|Overall Study|Lost to Follow-up|0|||
160963158|NCT01662063|581251375|FG000|Overall Study|Protocol Violation|1|||
160963159|NCT01662063|581251376|FG001|Overall Study|Protocol Violation|0|||
160963160|NCT01662063|581251377|FG002|Overall Study|Protocol Violation|0|||
160963161|NCT01662063|581251375|FG000|Overall Study|Withdrawal by Subject|2|||
160963162|NCT01662063|581251376|FG001|Overall Study|Withdrawal by Subject|4|||
160963163|NCT01662063|581251377|FG002|Overall Study|Withdrawal by Subject|1|||
160963164|NCT01662063|581251375|FG000|Overall Study|Physician Decision|0|||
160963165|NCT01662063|581251376|FG001|Overall Study|Physician Decision|2|||
160963166|NCT01662063|581251377|FG002|Overall Study|Physician Decision|0|||
160963167|NCT01662063|581251375|FG000|Overall Study|Other|0|||
160963168|NCT01662063|581251376|FG001|Overall Study|Other|1|||
160963169|NCT01662063|581251377|FG002|Overall Study|Other|0|||
160963170|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
160963171|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
160963172|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
160963173|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
160963174|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
160963175|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
160963176|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
160963177|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
160963178|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
160963179|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
160963180|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
160963181|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
160963182|NCT00293267|581251381|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
160963183|NCT00293267|581251382|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
160963184|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
160963185|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
160963186|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
160963187|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
160963188|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
160963189|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
160963190|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
160963191|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
160963192|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Death|3|||
160963193|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Death|0|||
160963194|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
160963195|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
160963196|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
160963197|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
160963198|NCT00293267|581251381|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
160963199|NCT00293267|581251382|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
160963200|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
160963201|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
160963202|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
160963203|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
160963204|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
160963205|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
160963206|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
160963207|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
160963208|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
160963209|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
160963210|NCT00293267|581251381|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
160963211|NCT00293267|581251382|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
160963212|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
160963213|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
160963214|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
160963215|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
160963216|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
160963217|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
161002342|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
161002343|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
161002344|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
161002345|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
160963218|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
161271036|NCT01970865|582372851|FG005|Overall Study|Participant refused further follow-up|0|||
161271037|NCT01970865|582372852|FG006|Overall Study|Participant refused further follow-up|0|||
161002346|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
161002347|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
161002348|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161002349|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161002350|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
160963219|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
160963220|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
160963221|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
160963222|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
160963223|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
160963224|NCT00293267|581251381|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
160963225|NCT00293267|581251382|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
160963226|NCT01477853|581251383|FG000|Phase A|Adverse Event|1|||
160963227|NCT01477853|581251384|FG001|Phase A|Adverse Event|2|||
160963228|NCT01477853|581251385|FG002|Phase A|Adverse Event|2|||
160963229|NCT01477853|581251383|FG000|Phase A|Lost to Follow-up|4|||
160963230|NCT01477853|581251384|FG001|Phase A|Lost to Follow-up|3|||
160963231|NCT01477853|581251385|FG002|Phase A|Lost to Follow-up|2|||
160963232|NCT01477853|581251383|FG000|Phase A|Physician Decision|1|||
160963233|NCT01477853|581251384|FG001|Phase A|Physician Decision|0|||
160963234|NCT01477853|581251385|FG002|Phase A|Physician Decision|1|||
160963235|NCT01477853|581251383|FG000|Phase A|Study terminated by sponsor|37|||
160963236|NCT01477853|581251384|FG001|Phase A|Study terminated by sponsor|40|||
160963237|NCT01477853|581251385|FG002|Phase A|Study terminated by sponsor|39|||
160963238|NCT01477853|581251383|FG000|Phase B|Lost to Follow-up|0|||
160963239|NCT01477853|581251384|FG001|Phase B|Lost to Follow-up|1|||
160963240|NCT01477853|581251385|FG002|Phase B|Lost to Follow-up|0|||
160963241|NCT01477853|581251383|FG000|Phase B|Study terminated by sponsor|12|||
160963242|NCT01477853|581251384|FG001|Phase B|Study terminated by sponsor|10|||
160963243|NCT01477853|581251385|FG002|Phase B|Study terminated by sponsor|11|||
160963244|NCT01804816|581251386|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
160963245|NCT01804816|581251386|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
160963246|NCT01050816|581251387|FG000|Overall Study|Lost to Follow-up|2|||
160963247|NCT01050816|581251387|FG000|Overall Study|patient's refusal|2|||
160963248|NCT01754467|581251388|FG000|Overall Study|Lost to Follow-up|1|||
160963249|NCT01970462|581251391|FG000|Overall Study|Lost to Follow-up|0|||
160963250|NCT01970462|581251392|FG001|Overall Study|Lost to Follow-up|2|||
160963251|NCT01123382|581251393|FG000|Overall Study|Withdrawal by Subject|1|||
160963252|NCT01123382|581251394|FG001|Overall Study|Withdrawal by Subject|4|||
161002351|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
161002352|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
161002353|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161002354|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002355|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002356|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
161002357|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002358|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002359|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002360|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002361|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002362|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002363|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002364|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
161002365|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
161002366|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
161002367|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
161146975|NCT00092547|581922384|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
161271038|NCT01970865|582372853|FG007|Overall Study|Participant refused further follow-up|0|||
161271039|NCT01970865|582372854|FG008|Overall Study|Participant refused further follow-up|0|||
161271040|NCT01970865|582372855|FG009|Overall Study|Participant refused further follow-up|0|||
161271041|NCT01970865|582372856|FG010|Overall Study|Participant refused further follow-up|1|||
161271042|NCT01970865|582372857|FG011|Overall Study|Participant refused further follow-up|4|||
161271043|NCT01970865|582372858|FG012|Overall Study|Participant refused further follow-up|7|||
160963253|NCT01123382|581251393|FG000|Overall Study|Lost to Follow-up|1|||
160963254|NCT01123382|581251394|FG001|Overall Study|Lost to Follow-up|2|||
160963255|NCT02740049|581251395|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
160963256|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
161002368|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
161002369|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
161271044|NCT01970865|582372859|FG013|Overall Study|Participant refused further follow-up|8|||
160963257|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
161271045|NCT01970865|582372860|FG014|Overall Study|Participant refused further follow-up|3|||
161271046|NCT01970865|582372861|FG015|Overall Study|Participant refused further follow-up|11|||
161271047|NCT01970865|582372862|FG016|Overall Study|Participant refused further follow-up|0|||
161271048|NCT01970865|582372863|FG017|Overall Study|Participant refused further follow-up|6|||
160963258|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
160963259|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
160963260|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
160963261|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
160963262|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
160963263|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
160963264|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963265|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963266|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963267|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
160963268|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
160963269|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
160963270|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
160963271|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
160963272|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
160963273|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
160963274|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
160963275|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963276|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
160963277|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963278|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963279|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
160963280|NCT01256411|581251396|FG000|Extension by Maximum Treatment|Adverse Event|4|||
160963281|NCT01256411|581251397|FG001|Extension by Maximum Treatment|Adverse Event|2|||
160963282|NCT01256411|581251398|FG002|Extension by Maximum Treatment|Adverse Event|1|||
160963283|NCT01256411|581251399|FG003|Extension by Maximum Treatment|Adverse Event|0|||
160963284|NCT01256411|581251400|FG004|Extension by Maximum Treatment|Adverse Event|0|||
160963285|NCT01256411|581251401|FG005|Extension by Maximum Treatment|Adverse Event|0|||
160963286|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963287|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963288|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963289|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
160963290|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
160963291|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
160963292|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963293|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963294|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963295|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963296|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
160963297|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
160963298|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963299|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963300|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963301|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963302|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
160963303|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
160963304|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963305|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963306|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963307|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
160963308|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
160963309|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
160963310|NCT01256411|581251396|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160963311|NCT01256411|581251397|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160963312|NCT01256411|581251398|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
160963313|NCT01256411|581251399|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
161146976|NCT00092547|581922385|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
161271049|NCT01629966|582372864|FG000|Overall Study|Pregnancy|0|||
161271050|NCT01629966|582372865|FG001|Overall Study|Pregnancy|1|||
160963314|NCT01256411|581251400|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
160963315|NCT01256411|581251401|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
161271051|NCT01629966|582372866|FG002|Overall Study|Pregnancy|0|||
161271052|NCT01629966|582372864|FG000|Overall Study|Lost to Follow-up|10|||
160963316|NCT02274857|581251402|FG000|Overall Study|Adverse Event|1|||
160963317|NCT02274857|581251403|FG001|Overall Study|Adverse Event|0|||
160963318|NCT02274857|581251402|FG000|Overall Study|Death|1|||
160963319|NCT02274857|581251403|FG001|Overall Study|Death|2|||
161146977|NCT00092547|581922383|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
161146978|NCT00092547|581922384|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
161146979|NCT00092547|581922385|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
161146980|NCT00092547|581922383|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
161146981|NCT00092547|581922384|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
161146982|NCT00092547|581922385|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
161146983|NCT00084682|581922386|FG000|Overall Study|Withdrawal by Subject|1|||
161146984|NCT01166659|581922387|FG000|Overall Study|Subject Decision|8|||
161146985|NCT01166659|581922387|FG000|Overall Study|Investigator Decision|2|||
161146986|NCT01166659|581922387|FG000|Overall Study|Death|1|||
161146987|NCT01166659|581922387|FG000|Overall Study|Lost to Follow-up|1|||
161146988|NCT01166659|581922387|FG000|Overall Study|Study Closed at Site|1|||
161146989|NCT01650779|581922398|FG000|Overall Study|Withdrawal by Subject|1|||
161146990|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
161146991|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161146992|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161146993|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
161146994|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
161146995|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161146996|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161146997|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
161146998|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
161146999|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161147000|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161147001|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
161147002|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
161147003|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161147004|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
161147005|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
160963320|NCT02274857|581251402|FG000|Overall Study|Lost to Follow-up|3|||
160963321|NCT02274857|581251403|FG001|Overall Study|Lost to Follow-up|0|||
160963322|NCT02274857|581251402|FG000|Overall Study|Physician Decision|2|||
160963323|NCT02274857|581251403|FG001|Overall Study|Physician Decision|0|||
160963324|NCT02274857|581251402|FG000|Overall Study|Trial screen failure|0|||
160963325|NCT02274857|581251403|FG001|Overall Study|Trial screen failure|2|||
160963326|NCT02274857|581251402|FG000|Overall Study|Withdrawal by Subject|11|||
160963327|NCT02274857|581251403|FG001|Overall Study|Withdrawal by Subject|2|||
160963328|NCT02274857|581251402|FG000|Overall Study|Other|2|||
160963329|NCT02274857|581251403|FG001|Overall Study|Other|0|||
160963330|NCT02403180|581251406|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
160963331|NCT02403180|581251407|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
160963332|NCT02403180|581251406|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
160963333|NCT02403180|581251407|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
160963334|NCT00929162|581251409|FG000|Overall Study|Adverse Event|8|||
160963335|NCT00929162|581251410|FG001|Overall Study|Adverse Event|5|||
160963336|NCT00929162|581251409|FG000|Overall Study|Withdrawal by Subject|3|||
160963337|NCT00929162|581251410|FG001|Overall Study|Withdrawal by Subject|1|||
160963338|NCT00929162|581251409|FG000|Overall Study|Protocol Violation|32|||
160963339|NCT00929162|581251410|FG001|Overall Study|Protocol Violation|30|||
160963340|NCT00929162|581251409|FG000|Overall Study|Other termination reason|5|||
160963341|NCT00929162|581251410|FG001|Overall Study|Other termination reason|6|||
160963342|NCT00658567|581251412|FG000|Overall Study|Adverse Event|5|||
160963343|NCT00658567|581251413|FG001|Overall Study|Adverse Event|2|||
160963344|NCT00658567|581251414|FG002|Overall Study|Adverse Event|3|||
160963345|NCT00658567|581251412|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
160963346|NCT00658567|581251413|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
160963347|NCT00658567|581251414|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
160963348|NCT00658567|581251412|FG000|Overall Study|Physician Decision|0|||
160963349|NCT00658567|581251413|FG001|Overall Study|Physician Decision|1|||
160963350|NCT00658567|581251414|FG002|Overall Study|Physician Decision|0|||
160963351|NCT00658567|581251412|FG000|Overall Study|At Discretion of Sponsor|1|||
160963352|NCT00658567|581251413|FG001|Overall Study|At Discretion of Sponsor|1|||
160963353|NCT00658567|581251414|FG002|Overall Study|At Discretion of Sponsor|1|||
160963354|NCT01755702|581251415|FG000|Wash Out Period I|Other Reason|3|||
161147006|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
161147007|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
160963355|NCT01755702|581251415|FG000|Washout Period II|Other Reason|5|||
160963356|NCT00691938|581251416|FG000|Overall Study|QTc prolongation|1|||
160963357|NCT00691938|581251417|FG001|Overall Study|QTc prolongation|0|||
160963358|NCT00691938|581251418|FG002|Overall Study|QTc prolongation|0|||
161271053|NCT01629966|582372865|FG001|Overall Study|Lost to Follow-up|13|||
161271054|NCT01629966|582372866|FG002|Overall Study|Lost to Follow-up|9|||
161271055|NCT01629966|582372864|FG000|Overall Study|Withdrawal by Subject|8|||
161271056|NCT01629966|582372865|FG001|Overall Study|Withdrawal by Subject|9|||
160963359|NCT00691938|581251419|FG003|Overall Study|QTc prolongation|0|||
160963360|NCT00691938|581251420|FG004|Overall Study|QTc prolongation|0|||
160963361|NCT00691938|581251421|FG005|Overall Study|QTc prolongation|0|||
160963362|NCT00691938|581251422|FG006|Overall Study|QTc prolongation|0|||
160963363|NCT04860518|581251424|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
160963364|NCT04860518|581251425|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
160963365|NCT03172702|581251429|FG000|Overall Study|Adverse Event|9|||
160963366|NCT03172702|581251429|FG000|Overall Study|Death|2|||
160963367|NCT03172702|581251429|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
160963368|NCT03172702|581251429|FG000|Overall Study|Withdrawal by Subject|5|||
160963369|NCT03172702|581251429|FG000|Overall Study|Other|2|||
160963370|NCT02355028|581251430|FG000|Overall Study|Adverse Event|2|||
160963371|NCT02355028|581251431|FG001|Overall Study|Adverse Event|0|||
160963372|NCT02355028|581251430|FG000|Overall Study|Withdrawal by Subject|1|||
160963373|NCT02355028|581251431|FG001|Overall Study|Withdrawal by Subject|1|||
160963374|NCT02355028|581251430|FG000|Overall Study|Deemed ineligible after randomization|8|||
160963375|NCT02355028|581251431|FG001|Overall Study|Deemed ineligible after randomization|4|||
160963376|NCT02276222|581251432|FG000|Overall Study|Adverse Event|62|||
160963377|NCT02276222|581251433|FG001|Overall Study|Adverse Event|11|||
160963378|NCT02276222|581251432|FG000|Overall Study|Death|3|||
160963379|NCT02276222|581251433|FG001|Overall Study|Death|4|||
160963380|NCT02276222|581251432|FG000|Overall Study|Lack of Efficacy|13|||
160963381|NCT02276222|581251433|FG001|Overall Study|Lack of Efficacy|3|||
160963382|NCT02276222|581251432|FG000|Overall Study|Protocol Violation|3|||
160963383|NCT02276222|581251433|FG001|Overall Study|Protocol Violation|2|||
160963384|NCT02276222|581251432|FG000|Overall Study|Withdrawal by Subject|79|||
160963385|NCT02276222|581251433|FG001|Overall Study|Withdrawal by Subject|33|||
160963386|NCT02276222|581251432|FG000|Overall Study|non compliance with study medication|6|||
160963387|NCT02276222|581251433|FG001|Overall Study|non compliance with study medication|2|||
160963388|NCT02276222|581251432|FG000|Overall Study|sponsor decision|0|||
160963389|NCT02276222|581251433|FG001|Overall Study|sponsor decision|3|||
160963390|NCT02276222|581251432|FG000|Overall Study|Lost to Follow-up|15|||
160963391|NCT02276222|581251433|FG001|Overall Study|Lost to Follow-up|5|||
160963392|NCT02276222|581251432|FG000|Overall Study|Physician Decision|2|||
160963393|NCT02276222|581251433|FG001|Overall Study|Physician Decision|1|||
160963394|NCT02276222|581251432|FG000|Overall Study|sheduling conflict|1|||
160963395|NCT02276222|581251433|FG001|Overall Study|sheduling conflict|0|||
160963396|NCT02276222|581251432|FG000|Overall Study|subject withdrew after randomization|1|||
160963397|NCT02276222|581251433|FG001|Overall Study|subject withdrew after randomization|0|||
160963398|NCT04102579|581251434|FG000|Overall Study|Withdrawal by Subject|3|||
160963399|NCT04102579|581251435|FG001|Overall Study|Withdrawal by Subject|4|||
160963400|NCT04102579|581251434|FG000|Overall Study|Lost to Follow-up|0|||
160963401|NCT04102579|581251435|FG001|Overall Study|Lost to Follow-up|1|||
160963402|NCT04102579|581251434|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
160963403|NCT04102579|581251435|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
160963404|NCT04102579|581251434|FG000|Overall Study|Other than Specified|1|||
160963405|NCT04102579|581251435|FG001|Overall Study|Other than Specified|0|||
160963406|NCT04102579|581251434|FG000|Overall Study|Not Dosed with Study Drug|0|||
160963407|NCT04102579|581251435|FG001|Overall Study|Not Dosed with Study Drug|1|||
160963408|NCT05899686|581251436|FG000|Overall Study|Protocol Violation|1|||
160963409|NCT02170025|581251437|FG000|Overall Study|Adverse Event|2|||
160963410|NCT02170025|581251438|FG001|Overall Study|Adverse Event|0|||
160963411|NCT01525602|581251439|FG000|Overall Study|Adverse Event|1|||
160963412|NCT01525602|581251440|FG001|Overall Study|Adverse Event|0|||
160963413|NCT01525602|581251441|FG002|Overall Study|Adverse Event|1|||
160963414|NCT01525602|581251442|FG003|Overall Study|Adverse Event|1|||
160963415|NCT01525602|581251443|FG004|Overall Study|Adverse Event|3|||
160963416|NCT01525602|581251444|FG005|Overall Study|Adverse Event|3|||
160963417|NCT01525602|581251445|FG006|Overall Study|Adverse Event|0|||
160963418|NCT01525602|581251446|FG007|Overall Study|Adverse Event|1|||
160963419|NCT01525602|581251439|FG000|Overall Study|Disease progression|6|||
160963420|NCT01525602|581251440|FG001|Overall Study|Disease progression|3|||
160963421|NCT01525602|581251441|FG002|Overall Study|Disease progression|2|||
160963422|NCT01525602|581251442|FG003|Overall Study|Disease progression|5|||
160963423|NCT01525602|581251443|FG004|Overall Study|Disease progression|22|||
160963424|NCT01525602|581251444|FG005|Overall Study|Disease progression|2|||
160963425|NCT01525602|581251445|FG006|Overall Study|Disease progression|3|||
160963426|NCT01525602|581251446|FG007|Overall Study|Disease progression|3|||
160963427|NCT01525602|581251439|FG000|Overall Study|Clinical progression|2|||
160963428|NCT01525602|581251440|FG001|Overall Study|Clinical progression|0|||
160963429|NCT01525602|581251441|FG002|Overall Study|Clinical progression|0|||
160963430|NCT01525602|581251442|FG003|Overall Study|Clinical progression|0|||
161271057|NCT01629966|582372866|FG002|Overall Study|Withdrawal by Subject|16|||
160963431|NCT01525602|581251443|FG004|Overall Study|Clinical progression|0|||
160963432|NCT01525602|581251444|FG005|Overall Study|Clinical progression|0|||
160963433|NCT01525602|581251445|FG006|Overall Study|Clinical progression|1|||
160963434|NCT01525602|581251446|FG007|Overall Study|Clinical progression|1|||
160963435|NCT01525602|581251439|FG000|Overall Study|Non-compliance|0|||
160963436|NCT01525602|581251440|FG001|Overall Study|Non-compliance|0|||
160963437|NCT01525602|581251441|FG002|Overall Study|Non-compliance|0|||
160963438|NCT01525602|581251442|FG003|Overall Study|Non-compliance|0|||
160963439|NCT01525602|581251443|FG004|Overall Study|Non-compliance|1|||
160963440|NCT01525602|581251444|FG005|Overall Study|Non-compliance|0|||
160963441|NCT01525602|581251445|FG006|Overall Study|Non-compliance|0|||
160963442|NCT01525602|581251446|FG007|Overall Study|Non-compliance|0|||
160963443|NCT01525602|581251439|FG000|Overall Study|Withdrawal by Subject|0|||
160963444|NCT01525602|581251440|FG001|Overall Study|Withdrawal by Subject|0|||
160963445|NCT01525602|581251441|FG002|Overall Study|Withdrawal by Subject|0|||
160963446|NCT01525602|581251442|FG003|Overall Study|Withdrawal by Subject|0|||
160963447|NCT01525602|581251443|FG004|Overall Study|Withdrawal by Subject|3|||
160963448|NCT01525602|581251444|FG005|Overall Study|Withdrawal by Subject|1|||
160963449|NCT01525602|581251445|FG006|Overall Study|Withdrawal by Subject|0|||
160963450|NCT01525602|581251446|FG007|Overall Study|Withdrawal by Subject|1|||
160963451|NCT01525602|581251439|FG000|Overall Study|Physician Decision|0|||
160963452|NCT01525602|581251440|FG001|Overall Study|Physician Decision|0|||
160963453|NCT01525602|581251441|FG002|Overall Study|Physician Decision|0|||
160963454|NCT01525602|581251442|FG003|Overall Study|Physician Decision|0|||
160963455|NCT01525602|581251443|FG004|Overall Study|Physician Decision|3|||
160963456|NCT01525602|581251444|FG005|Overall Study|Physician Decision|0|||
160963457|NCT01525602|581251445|FG006|Overall Study|Physician Decision|1|||
160963458|NCT01525602|581251446|FG007|Overall Study|Physician Decision|0|||
160963459|NCT01525602|581251439|FG000|Overall Study|Death|0|||
160963460|NCT01525602|581251440|FG001|Overall Study|Death|0|||
160963461|NCT01525602|581251441|FG002|Overall Study|Death|0|||
160963462|NCT01525602|581251442|FG003|Overall Study|Death|0|||
160963463|NCT01525602|581251443|FG004|Overall Study|Death|1|||
160963464|NCT01525602|581251444|FG005|Overall Study|Death|1|||
160963465|NCT01525602|581251445|FG006|Overall Study|Death|0|||
160963466|NCT01525602|581251446|FG007|Overall Study|Death|0|||
160963467|NCT01525602|581251439|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963468|NCT01525602|581251440|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963469|NCT01525602|581251441|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963470|NCT01525602|581251442|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963471|NCT01525602|581251443|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963472|NCT01525602|581251444|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
160963473|NCT01525602|581251445|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
160963474|NCT01525602|581251446|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
160963475|NCT03703466|581251452|FG000|Overall Study|Death|2|||
160963476|NCT03703466|581251453|FG001|Overall Study|Death|1|||
160963477|NCT03703466|581251454|FG002|Overall Study|Death|0|||
160963478|NCT03703466|581251452|FG000|Overall Study|Withdrawal by Subject|0|||
160963479|NCT03703466|581251453|FG001|Overall Study|Withdrawal by Subject|3|||
160963480|NCT03703466|581251454|FG002|Overall Study|Withdrawal by Subject|0|||
160963481|NCT03703466|581251452|FG000|Overall Study|Completed < 3 Cycles|2|||
160963482|NCT03703466|581251453|FG001|Overall Study|Completed < 3 Cycles|2|||
160963483|NCT03703466|581251454|FG002|Overall Study|Completed < 3 Cycles|2|||
160963484|NCT02412137|581251455|FG000|Overall Study|Withdrawal by Subject|2|||
160963485|NCT02412137|581251456|FG001|Overall Study|Withdrawal by Subject|0|||
160963486|NCT02412137|581251455|FG000|Overall Study|Lost to Follow-up|21|||
160963487|NCT02412137|581251456|FG001|Overall Study|Lost to Follow-up|14|||
160963488|NCT02412137|581251455|FG000|Overall Study|Physician Decision|28|||
160963489|NCT02412137|581251456|FG001|Overall Study|Physician Decision|9|||
160963490|NCT00506493|581251459|FG000|Overall Study|Death|6|||
160963491|NCT00506493|581251459|FG000|Overall Study|Withdrawal by Subject|5|||
160963492|NCT03076970|581253269|FG000|Washout Period 2|Adverse Event|0|||
160963493|NCT03076970|581253270|FG001|Washout Period 2|Adverse Event|0|||
161271058|NCT01629966|582372864|FG000|Overall Study|Protocol Violation|7|||
160963494|NCT03076970|581253271|FG002|Washout Period 2|Adverse Event|0|||
160963495|NCT03076970|581253272|FG003|Washout Period 2|Adverse Event|0|||
160963496|NCT03076970|581253273|FG004|Washout Period 2|Adverse Event|1|||
160963497|NCT03076970|581253274|FG005|Washout Period 2|Adverse Event|0|||
160963498|NCT03076970|581253269|FG000|Period 3|Withdrawal by Subject|0|||
160963499|NCT03076970|581253270|FG001|Period 3|Withdrawal by Subject|0|||
160963500|NCT03076970|581253271|FG002|Period 3|Withdrawal by Subject|0|||
160963501|NCT03076970|581253272|FG003|Period 3|Withdrawal by Subject|0|||
160963502|NCT03076970|581253273|FG004|Period 3|Withdrawal by Subject|0|||
160963503|NCT03076970|581253274|FG005|Period 3|Withdrawal by Subject|1|||
160963504|NCT03076970|581253269|FG000|Period 3|Failure to meet I/E criteria|0|||
160963505|NCT03076970|581253270|FG001|Period 3|Failure to meet I/E criteria|0|||
160963506|NCT03076970|581253271|FG002|Period 3|Failure to meet I/E criteria|0|||
160963507|NCT03076970|581253272|FG003|Period 3|Failure to meet I/E criteria|0|||
161271059|NCT01629966|582372865|FG001|Overall Study|Protocol Violation|9|||
161271060|NCT01629966|582372866|FG002|Overall Study|Protocol Violation|7|||
161271061|NCT01629966|582372864|FG000|Overall Study|Lack of Efficacy|5|||
161271062|NCT01629966|582372865|FG001|Overall Study|Lack of Efficacy|2|||
160963508|NCT03076970|581253273|FG004|Period 3|Failure to meet I/E criteria|1|||
160963509|NCT03076970|581253274|FG005|Period 3|Failure to meet I/E criteria|0|||
160963510|NCT05178121|581253280|FG000|Overall Study|Other|4|||
160963511|NCT05178121|581253280|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
160963512|NCT00949884|581253281|FG000|Overall Study|Adverse Event|14|||
160963513|NCT00949884|581253282|FG001|Overall Study|Adverse Event|3|||
160963514|NCT00949884|581253283|FG002|Overall Study|Adverse Event|12|||
160963515|NCT00949884|581253281|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
160963516|NCT00949884|581253282|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
160963517|NCT00949884|581253283|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
160963518|NCT00949884|581253281|FG000|Overall Study|Lost to Follow-up|7|||
160963519|NCT00949884|581253282|FG001|Overall Study|Lost to Follow-up|5|||
160963520|NCT00949884|581253283|FG002|Overall Study|Lost to Follow-up|5|||
160963521|NCT00949884|581253281|FG000|Overall Study|Physician Decision|5|||
160963522|NCT00949884|581253282|FG001|Overall Study|Physician Decision|0|||
160963523|NCT00949884|581253283|FG002|Overall Study|Physician Decision|6|||
160963524|NCT00949884|581253281|FG000|Overall Study|Treatment non-compliance|5|||
160963525|NCT00949884|581253282|FG001|Overall Study|Treatment non-compliance|0|||
160963526|NCT00949884|581253283|FG002|Overall Study|Treatment non-compliance|8|||
160963527|NCT00949884|581253281|FG000|Overall Study|Withdrawal by Subject|13|||
160963528|NCT00949884|581253282|FG001|Overall Study|Withdrawal by Subject|4|||
160963529|NCT00949884|581253283|FG002|Overall Study|Withdrawal by Subject|16|||
160963530|NCT00949884|581253281|FG000|Overall Study|Lack of Efficacy|4|||
160963531|NCT00949884|581253282|FG001|Overall Study|Lack of Efficacy|2|||
160963532|NCT00949884|581253283|FG002|Overall Study|Lack of Efficacy|7|||
160963533|NCT00949884|581253281|FG000|Overall Study|Study terminated by sponsor|0|||
160963534|NCT00949884|581253282|FG001|Overall Study|Study terminated by sponsor|0|||
160963535|NCT00949884|581253283|FG002|Overall Study|Study terminated by sponsor|1|||
160963536|NCT01953003|581253284|FG000|Overall Study|Not treated|0|||
160963537|NCT01953003|581253285|FG001|Overall Study|Not treated|1|||
160963538|NCT01953003|581253284|FG000|Overall Study|Progressive disease|35|||
160963539|NCT01953003|581253285|FG001|Overall Study|Progressive disease|45|||
160963540|NCT01953003|581253284|FG000|Overall Study|Related Adverse events|7|||
160963541|NCT01953003|581253285|FG001|Overall Study|Related Adverse events|2|||
160963542|NCT01953003|581253284|FG000|Overall Study|Non-related adverse events|0|||
160963543|NCT01953003|581253285|FG001|Overall Study|Non-related adverse events|2|||
160963544|NCT01953003|581253284|FG000|Overall Study|Protocol Violation|0|||
160963545|NCT01953003|581253285|FG001|Overall Study|Protocol Violation|1|||
160963546|NCT01953003|581253284|FG000|Overall Study|Withdrawal by Subject|14|||
160963547|NCT01953003|581253285|FG001|Overall Study|Withdrawal by Subject|4|||
160963548|NCT03391765|581253291|FG000|Overall Study|Adverse Event|2|||
160963549|NCT03391765|581253292|FG001|Overall Study|Adverse Event|0|||
160963550|NCT03391765|581253293|FG002|Overall Study|Adverse Event|0|||
160963551|NCT03391765|581253294|FG003|Overall Study|Adverse Event|2|||
160963552|NCT03391765|581253291|FG000|Overall Study|Withdrew consent|5|||
160963553|NCT03391765|581253292|FG001|Overall Study|Withdrew consent|7|||
160963554|NCT03391765|581253293|FG002|Overall Study|Withdrew consent|2|||
160963555|NCT03391765|581253294|FG003|Overall Study|Withdrew consent|5|||
160963556|NCT03391765|581253291|FG000|Overall Study|Other, not specified|44|||
160963557|NCT03391765|581253292|FG001|Overall Study|Other, not specified|38|||
160963558|NCT03391765|581253293|FG002|Overall Study|Other, not specified|21|||
160963559|NCT03391765|581253294|FG003|Overall Study|Other, not specified|16|||
160963560|NCT00662857|581253299|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
160963561|NCT00662857|581253300|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
160963562|NCT00662857|581253299|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
160963563|NCT00662857|581253300|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
160963564|NCT00662857|581253299|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
160963565|NCT00662857|581253300|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
160963566|NCT03966053|581253301|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
160963567|NCT02832622|581253303|FG000|Overall Study|MPP not programmed|1259|||
160963568|NCT02832622|581253303|FG000|Overall Study|Withdrawal by Subject|123|||
160963569|NCT02832622|581253303|FG000|Overall Study|Death|119|||
160963570|NCT02832622|581253303|FG000|Overall Study|Unsuccessful CRT implant|93|||
160963571|NCT02832622|581253303|FG000|Overall Study|Lost to Follow-up|45|||
160963572|NCT02832622|581253303|FG000|Overall Study|Patient non-compliance|42|||
160963573|NCT02832622|581253303|FG000|Overall Study|Withdrawal by other reasons|25|||
160963574|NCT02832622|581253303|FG000|Overall Study|System explant|24|||
160963575|NCT02832622|581253303|FG000|Overall Study|Physician Decision|6|||
160963576|NCT04586569|581253304|FG000|Overall Study|Withdrawal by Subject|0|||
160963577|NCT04586569|581253305|FG001|Overall Study|Withdrawal by Subject|2|||
161002370|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161271063|NCT01629966|582372866|FG002|Overall Study|Lack of Efficacy|4|||
161271064|NCT01629966|582372864|FG000|Overall Study|Adverse Event|11|||
160963578|NCT04586569|581253304|FG000|Overall Study|No longer eligible|2|||
160963579|NCT04586569|581253305|FG001|Overall Study|No longer eligible|3|||
160963580|NCT04586569|581253304|FG000|Overall Study|Physician Decision|1|||
160963581|NCT04586569|581253305|FG001|Overall Study|Physician Decision|0|||
160963582|NCT00998400|581253306|FG000|Overall Study|Lack of interest/motivation|1|||
160963583|NCT00998400|581253307|FG001|Overall Study|Lack of interest/motivation|2|||
160963584|NCT00998400|581253306|FG000|Overall Study|Logistical problems|1|||
160963585|NCT00998400|581253307|FG001|Overall Study|Logistical problems|0|||
160963586|NCT01083641|581253309|FG000|Overall Study|Withdrawal by Subject|2|||
160963587|NCT01777321|581253310|FG000|Overall Study|Withdrawal by Subject|0|||
160963588|NCT01777321|581253311|FG001|Overall Study|Withdrawal by Subject|1|||
160963589|NCT05131165|581253314|FG000|Overall Study|Death|1|||
160963590|NCT05131165|581253315|FG001|Overall Study|Death|1|||
160963591|NCT05131165|581253316|FG002|Overall Study|Death|0|||
160963592|NCT05131165|581253314|FG000|Overall Study|Lost to Follow-up|2|||
160963593|NCT05131165|581253315|FG001|Overall Study|Lost to Follow-up|2|||
161271065|NCT01629966|582372865|FG001|Overall Study|Adverse Event|18|||
161271066|NCT01629966|582372866|FG002|Overall Study|Adverse Event|30|||
161271067|NCT04430855|582372867|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
160963594|NCT05131165|581253316|FG002|Overall Study|Lost to Follow-up|5|||
160963595|NCT05131165|581253314|FG000|Overall Study|Transferred out of clinic|1|||
160963596|NCT05131165|581253315|FG001|Overall Study|Transferred out of clinic|0|||
160963597|NCT05131165|581253316|FG002|Overall Study|Transferred out of clinic|3|||
160963598|NCT05131165|581253314|FG000|Overall Study|Dropped out|1|||
160963599|NCT05131165|581253315|FG001|Overall Study|Dropped out|2|||
160963600|NCT05131165|581253316|FG002|Overall Study|Dropped out|0|||
160963601|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
160963602|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
160963603|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
160963604|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
160963605|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
160963606|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
160963607|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
160963608|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
160963609|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
160963610|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
160963611|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
160963612|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
160963613|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
160963614|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
160963615|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
160963616|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
160963617|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
160963618|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
160963619|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
160963620|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
160963621|NCT00549757|581253322|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
160963622|NCT00549757|581253323|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
160963623|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Death|143|||
161002371|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
161002372|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161002373|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
161002374|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161002375|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161002376|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161002377|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
161271068|NCT04430855|582372868|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
161271069|NCT04430855|582372867|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
160963624|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Death|136|||
160963625|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
160963626|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
160963627|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
161002378|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002379|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
160963628|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
160963629|NCT00549757|581253322|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
161002380|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
161002381|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161271070|NCT04430855|582372868|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
161343489|NCT03965923|582644395|FG005|Overall Study|Death|0|||
160963630|NCT00549757|581253323|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
160963631|NCT02691182|581253326|FG000|Overall Study|Withdrawal by Subject|4|||
160963632|NCT02691182|581253327|FG001|Overall Study|Withdrawal by Subject|7|||
160963633|NCT02691182|581253328|FG002|Overall Study|Withdrawal by Subject|6|||
160963634|NCT02691182|581253329|FG003|Overall Study|Withdrawal by Subject|8|||
160963635|NCT02691182|581253326|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
160963636|NCT02691182|581253327|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
160963637|NCT02691182|581253328|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
160963638|NCT02691182|581253329|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
160963639|NCT02691182|581253326|FG000|Overall Study|Lost to Follow-up|8|||
160963640|NCT02691182|581253327|FG001|Overall Study|Lost to Follow-up|33|||
160963641|NCT02691182|581253328|FG002|Overall Study|Lost to Follow-up|19|||
160963642|NCT02691182|581253329|FG003|Overall Study|Lost to Follow-up|22|||
160963643|NCT02691182|581253326|FG000|Overall Study|Adverse Event|3|||
160963644|NCT02691182|581253327|FG001|Overall Study|Adverse Event|10|||
160963645|NCT02691182|581253328|FG002|Overall Study|Adverse Event|10|||
160963646|NCT02691182|581253329|FG003|Overall Study|Adverse Event|11|||
160963647|NCT02691182|581253326|FG000|Overall Study|Physician Decision|3|||
160963648|NCT02691182|581253327|FG001|Overall Study|Physician Decision|7|||
160963649|NCT02691182|581253328|FG002|Overall Study|Physician Decision|14|||
160963650|NCT02691182|581253329|FG003|Overall Study|Physician Decision|8|||
160963651|NCT02691182|581253326|FG000|Overall Study|Lack of Efficacy|0|||
160963652|NCT02691182|581253327|FG001|Overall Study|Lack of Efficacy|0|||
160963653|NCT02691182|581253328|FG002|Overall Study|Lack of Efficacy|0|||
160963654|NCT02691182|581253329|FG003|Overall Study|Lack of Efficacy|4|||
160963655|NCT02691182|581253326|FG000|Overall Study|Protocol Violation|2|||
160963656|NCT02691182|581253327|FG001|Overall Study|Protocol Violation|6|||
160963657|NCT02691182|581253328|FG002|Overall Study|Protocol Violation|6|||
160963658|NCT02691182|581253329|FG003|Overall Study|Protocol Violation|8|||
160963659|NCT02691182|581253326|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
160963660|NCT02691182|581253327|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
160963661|NCT02691182|581253328|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
160963662|NCT02691182|581253329|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
160963663|NCT02691182|581253326|FG000|Overall Study|Missing|0|||
160963664|NCT02691182|581253327|FG001|Overall Study|Missing|5|||
160963665|NCT02691182|581253328|FG002|Overall Study|Missing|1|||
160963666|NCT02691182|581253329|FG003|Overall Study|Missing|5|||
160963667|NCT00105235|581253330|FG000|Overall Study|Death|4|||
160963668|NCT00105235|581253330|FG000|Overall Study|Physician Decision|1|||
160963669|NCT00105235|581253330|FG000|Overall Study|Withdrawal by Subject|2|||
160963670|NCT02052310|581253331|FG000|Overall Study|Death|64|||
160963671|NCT02052310|581253332|FG001|Overall Study|Death|54|||
160963672|NCT02052310|581253331|FG000|Overall Study|Withdrawal by Subject|37|||
160963673|NCT02052310|581253332|FG001|Overall Study|Withdrawal by Subject|49|||
160963674|NCT02052310|581253331|FG000|Overall Study|Other than specified|32|||
160963675|NCT02052310|581253332|FG001|Overall Study|Other than specified|29|||
160963676|NCT02052310|581253331|FG000|Overall Study|Adverse Event|29|||
160963677|NCT02052310|581253332|FG001|Overall Study|Adverse Event|22|||
160963678|NCT02052310|581253331|FG000|Overall Study|Kidney Transplant|23|||
160963679|NCT02052310|581253332|FG001|Overall Study|Kidney Transplant|29|||
160963680|NCT02052310|581253331|FG000|Overall Study|Physician Decision|14|||
160963681|NCT02052310|581253332|FG001|Overall Study|Physician Decision|7|||
160963682|NCT02052310|581253331|FG000|Overall Study|Lack of Efficacy|6|||
160963683|NCT02052310|581253332|FG001|Overall Study|Lack of Efficacy|1|||
160963684|NCT02052310|581253331|FG000|Overall Study|Site Terminated by Sponsor|5|||
160963685|NCT02052310|581253332|FG001|Overall Study|Site Terminated by Sponsor|13|||
160963686|NCT02052310|581253331|FG000|Overall Study|Lost to Follow-up|4|||
160963687|NCT02052310|581253332|FG001|Overall Study|Lost to Follow-up|2|||
160963688|NCT02052310|581253331|FG000|Overall Study|Protocol Violation|1|||
160963689|NCT02052310|581253332|FG001|Overall Study|Protocol Violation|6|||
161271071|NCT04430855|582372867|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
160963690|NCT01964326|581253333|FG000|Overall Study|Adverse Event|48|||
160963691|NCT01964326|581253333|FG000|Overall Study|Death|2|||
160963692|NCT01964326|581253333|FG000|Overall Study|Protocol Violation|4|||
160963693|NCT01964326|581253333|FG000|Overall Study|Lost to Follow-up|88|||
160963694|NCT01964326|581253333|FG000|Overall Study|Withdrawal by Subject|87|||
160963695|NCT01964326|581253333|FG000|Overall Study|Pregnancy|1|||
160963696|NCT01964326|581253333|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
160963697|NCT01964326|581253333|FG000|Overall Study|Physician Decision|55|||
160963698|NCT01964326|581253333|FG000|Overall Study|Investigator Discretion|1|||
160963699|NCT01964326|581253333|FG000|Overall Study|Other|9|||
160963700|NCT01964326|581253333|FG000|Overall Study|Did not meet eligibility criteria|1|||
160963701|NCT03518125|581253342|FG000|Overall Study|Lost to Follow-up|0|||
160963702|NCT03518125|581253343|FG001|Overall Study|Lost to Follow-up|2|||
160963703|NCT03518125|581253344|FG002|Overall Study|Lost to Follow-up|0|||
160963704|NCT03518125|581253345|FG003|Overall Study|Lost to Follow-up|0|||
161271072|NCT04430855|582372868|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
161271073|NCT04430855|582372867|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
161271074|NCT04430855|582372868|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
161271075|NCT04430855|582372867|FG000|Period 1 (Weeks 1-12)|Other|0|||
160963705|NCT03518125|581253346|FG004|Overall Study|Lost to Follow-up|3|||
160963706|NCT03518125|581253347|FG005|Overall Study|Lost to Follow-up|5|||
160963707|NCT03518125|581253342|FG000|Overall Study|Physician Decision|0|||
160963708|NCT03518125|581253343|FG001|Overall Study|Physician Decision|1|||
160963709|NCT03518125|581253344|FG002|Overall Study|Physician Decision|0|||
160963710|NCT03518125|581253345|FG003|Overall Study|Physician Decision|0|||
160963711|NCT03518125|581253346|FG004|Overall Study|Physician Decision|0|||
160963712|NCT03518125|581253347|FG005|Overall Study|Physician Decision|0|||
160963713|NCT03518125|581253342|FG000|Overall Study|Withdrawal by Subject|1|||
160963714|NCT03518125|581253343|FG001|Overall Study|Withdrawal by Subject|1|||
160963715|NCT03518125|581253344|FG002|Overall Study|Withdrawal by Subject|0|||
160963716|NCT03518125|581253345|FG003|Overall Study|Withdrawal by Subject|1|||
160963717|NCT03518125|581253346|FG004|Overall Study|Withdrawal by Subject|1|||
160963718|NCT03518125|581253347|FG005|Overall Study|Withdrawal by Subject|3|||
160963719|NCT03518125|581253342|FG000|Overall Study|Missed Day 394 Visit|1|||
160963720|NCT03518125|581253343|FG001|Overall Study|Missed Day 394 Visit|0|||
160963721|NCT03518125|581253344|FG002|Overall Study|Missed Day 394 Visit|0|||
160963722|NCT03518125|581253345|FG003|Overall Study|Missed Day 394 Visit|0|||
160963723|NCT03518125|581253346|FG004|Overall Study|Missed Day 394 Visit|0|||
160963724|NCT03518125|581253347|FG005|Overall Study|Missed Day 394 Visit|0|||
160963725|NCT02093663|581253352|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
160963726|NCT02093663|581253353|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963727|NCT02093663|581253354|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963728|NCT02093663|581253355|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963729|NCT02093663|581253356|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
160963730|NCT02093663|581253352|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
160963731|NCT02093663|581253353|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963732|NCT02093663|581253354|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963733|NCT02093663|581253355|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963734|NCT02093663|581253356|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963735|NCT02093663|581253352|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
160963736|NCT02093663|581253353|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
160963737|NCT02093663|581253354|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
160963738|NCT02093663|581253355|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
160963739|NCT02093663|581253356|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
160963740|NCT02093663|581253352|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963741|NCT02093663|581253353|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963742|NCT02093663|581253354|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
160963743|NCT02093663|581253355|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963744|NCT02093663|581253356|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
160963745|NCT02093663|581253352|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963746|NCT02093663|581253353|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963747|NCT02093663|581253354|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
160963748|NCT02093663|581253355|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963749|NCT02093663|581253356|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
160963750|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
160963751|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
161271076|NCT04430855|582372868|FG001|Period 1 (Weeks 1-12)|Other|1|||
160963752|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
160963753|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
160963754|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
160963755|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
160963756|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
160963757|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
160963758|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
160963759|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
160963760|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
160963761|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
160963762|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
161271077|NCT04430855|582372867|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
161271078|NCT04430855|582372868|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
160963763|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
160963764|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
160963765|NCT02093663|581253352|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
161271079|NCT04430855|582372867|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
161271080|NCT04430855|582372868|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
160963766|NCT02093663|581253353|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963767|NCT02093663|581253354|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963768|NCT02093663|581253355|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
160963769|NCT02093663|581253356|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
161147008|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161147009|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
161147010|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
161147011|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
161343490|NCT03965923|582644396|FG006|Overall Study|Death|0|||
160963775|NCT00508404|581253362|FG000|Overall Study|Ongoing at Data Cut-off|12|||
160963776|NCT00508404|581253362|FG000|Overall Study|Adverse Event|2|||
160963777|NCT00508404|581253362|FG000|Overall Study|Death|16|||
160963778|NCT00508404|581253362|FG000|Overall Study|Physician Decision|2|||
160963779|NCT00508404|581253362|FG000|Overall Study|Withdrawal by Subject|3|||
160963780|NCT00508404|581253362|FG000|Overall Study|Protocol-specified Criteria|2|||
160963781|NCT00508404|581253362|FG000|Overall Study|Lost to Follow-up|2|||
160963782|NCT00508404|581253362|FG000|Overall Study|Other - Not Specified|3|||
160963783|NCT05453110|581253363|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
160963784|NCT05453110|581253364|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
160963785|NCT05453110|581253365|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
160963786|NCT05906368|581253366|FG000|Overall Study|Withdrawal by Subject|1|||
160963787|NCT05906368|581253367|FG001|Overall Study|Withdrawal by Subject|1|||
160963788|NCT05906368|581253366|FG000|Overall Study|Ineligibility criteria identified|2|||
160963789|NCT05906368|581253367|FG001|Overall Study|Ineligibility criteria identified|0|||
160963790|NCT00266825|581253368|FG000|Completed Follow-Up|Lost to Follow-up|14|||
160963791|NCT00266825|581253369|FG001|Completed Follow-Up|Lost to Follow-up|19|||
160963792|NCT00266825|581253368|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
160963793|NCT00266825|581253369|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
160963794|NCT02799784|581253372|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
160963795|NCT02799784|581253373|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
160963796|NCT02799784|581253372|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
160963797|NCT02799784|581253373|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
160963798|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
160963799|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
160963800|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
160963801|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
160963802|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
160963803|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
160963804|NCT02799784|581253372|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
160963805|NCT02799784|581253373|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
160963806|NCT01949870|581253374|FG000|Overall Study|Lack of Efficacy|2|||
160963807|NCT01949870|581253374|FG000|Overall Study|Adverse Event|1|||
160963808|NCT01949870|581253374|FG000|Overall Study|Study termination|1|||
160963809|NCT01949870|581253374|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
160963810|NCT01235546|581253375|FG000|Overall Study|Staff error, medication not administered|1|||
160963811|NCT01235546|581253376|FG001|Overall Study|Staff error, medication not administered|0|||
160963812|NCT01235546|581253375|FG000|Overall Study|Protocol Violation|1|||
160963813|NCT01235546|581253376|FG001|Overall Study|Protocol Violation|1|||
160963814|NCT02954354|581253377|FG000|Overall Study|Adverse Event|2|||
160963815|NCT02954354|581253378|FG001|Overall Study|Adverse Event|2|||
160963816|NCT02954354|581253379|FG002|Overall Study|Adverse Event|4|||
160963817|NCT02954354|581253377|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
160963818|NCT02954354|581253378|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
160963819|NCT02954354|581253379|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
160963820|NCT02954354|581253377|FG000|Overall Study|Lack of Efficacy|0|||
160963821|NCT02954354|581253378|FG001|Overall Study|Lack of Efficacy|2|||
160963822|NCT02954354|581253379|FG002|Overall Study|Lack of Efficacy|0|||
161002382|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
161002383|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
160963823|NCT02954354|581253377|FG000|Overall Study|Withdrawal by Subject|17|||
160963824|NCT02954354|581253378|FG001|Overall Study|Withdrawal by Subject|9|||
160963825|NCT02954354|581253379|FG002|Overall Study|Withdrawal by Subject|11|||
160963826|NCT02954354|581253377|FG000|Overall Study|Lost to Follow-up|12|||
160963827|NCT02954354|581253378|FG001|Overall Study|Lost to Follow-up|5|||
160963828|NCT02954354|581253379|FG002|Overall Study|Lost to Follow-up|0|||
160963829|NCT02954354|581253377|FG000|Overall Study|Miscellaneous|2|||
160963830|NCT02954354|581253378|FG001|Overall Study|Miscellaneous|2|||
160963831|NCT02954354|581253379|FG002|Overall Study|Miscellaneous|1|||
160963832|NCT02279043|581253390|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
160963833|NCT02279043|581253391|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
160963834|NCT02279043|581253392|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
161271081|NCT04430855|582372867|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
161271082|NCT04430855|582372868|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
161271083|NCT01770392|582372874|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
161271084|NCT03401450|582372875|FG000|Overall Study|Lost to Follow-up|4|||
161271085|NCT03401450|582372876|FG001|Overall Study|Lost to Follow-up|6|||
161271086|NCT03401450|582372875|FG000|Overall Study|Anesthesia plan changed|2|||
160963835|NCT02279043|581253390|FG000|Overall Study|Lost to Follow-up|46|||
160963836|NCT02279043|581253391|FG001|Overall Study|Lost to Follow-up|88|||
160963837|NCT02279043|581253392|FG002|Overall Study|Lost to Follow-up|0|||
160963838|NCT00490282|581253393|FG000|Overall Study|Withdrawal by Subject|3|||
160963839|NCT01494584|581253400|FG000|Overall Study|Study Closed/Terminated|1|||
160963840|NCT01256567|581253407|FG000|Overall Study|Withdrawal by Subject|1|||
160963841|NCT00567190|581253413|FG000|Overall Study|Death|235|||
160963842|NCT00567190|581253414|FG001|Overall Study|Death|280|||
160963843|NCT00567190|581253413|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
160963844|NCT00567190|581253414|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
160963845|NCT00374322|581253418|FG000|Overall Study|Lost to Follow-up|92|||
160963846|NCT00374322|581253419|FG001|Overall Study|Lost to Follow-up|90|||
160963847|NCT00374322|581253418|FG000|Overall Study|Protocol Violation|8|||
160963848|NCT00374322|581253419|FG001|Overall Study|Protocol Violation|3|||
160963849|NCT00374322|581253418|FG000|Overall Study|Withdrawal by Subject|235|||
160963850|NCT00374322|581253419|FG001|Overall Study|Withdrawal by Subject|167|||
160963851|NCT00374322|581253418|FG000|Overall Study|Sponsor Terminated Study|866|||
160963852|NCT00374322|581253419|FG001|Overall Study|Sponsor Terminated Study|990|||
160963853|NCT00374322|581253418|FG000|Overall Study|Physician Decision|36|||
160963854|NCT00374322|581253419|FG001|Overall Study|Physician Decision|32|||
161147012|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
160963855|NCT00374322|581253418|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
160963856|NCT00374322|581253419|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
160963857|NCT00374322|581253418|FG000|Overall Study|Sponsor Decision|2|||
160963858|NCT00374322|581253419|FG001|Overall Study|Sponsor Decision|3|||
160963859|NCT00374322|581253418|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
160963860|NCT00374322|581253419|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
160963861|NCT00374322|581253418|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
160963862|NCT00374322|581253419|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
160963863|NCT00374322|581253418|FG000|Overall Study|Severe Toxicity|1|||
160963864|NCT00374322|581253419|FG001|Overall Study|Severe Toxicity|0|||
160963865|NCT00374322|581253418|FG000|Overall Study|Site Closed|2|||
160963866|NCT00374322|581253419|FG001|Overall Study|Site Closed|2|||
160963867|NCT00374322|581253418|FG000|Overall Study|Participant Changed Physician|1|||
160963868|NCT00374322|581253419|FG001|Overall Study|Participant Changed Physician|0|||
160963869|NCT00374322|581253418|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
160963870|NCT00374322|581253419|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
160963871|NCT00374322|581253418|FG000|Overall Study|Noncompliance with Study Requirements|0|||
160963872|NCT00374322|581253419|FG001|Overall Study|Noncompliance with Study Requirements|1|||
160963873|NCT00374322|581253418|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
160963874|NCT00374322|581253419|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
160963875|NCT00374322|581253418|FG000|Overall Study|Did Not Receive Study Medication|8|||
160963876|NCT00374322|581253419|FG001|Overall Study|Did Not Receive Study Medication|6|||
160963877|NCT00636610|581253423|FG000|Overall Study|Adverse Event|4|||
160963878|NCT00636610|581253424|FG001|Overall Study|Adverse Event|4|||
160963879|NCT00636610|581253423|FG000|Overall Study|Death|6|||
160963880|NCT00636610|581253424|FG001|Overall Study|Death|3|||
160963881|NCT00636610|581253423|FG000|Overall Study|Physician decision to withdraw patient|15|||
160963882|NCT00636610|581253424|FG001|Overall Study|Physician decision to withdraw patient|9|||
160963883|NCT00636610|581253423|FG000|Overall Study|Subject decision to withdraw|15|||
160963884|NCT00636610|581253424|FG001|Overall Study|Subject decision to withdraw|11|||
160963885|NCT00636610|581253423|FG000|Overall Study|Disease progression - radiographic|41|||
161271087|NCT03401450|582372876|FG001|Overall Study|Anesthesia plan changed|2|||
161271088|NCT03401450|582372875|FG000|Overall Study|Did not complete medication diary|4|||
161271089|NCT03401450|582372876|FG001|Overall Study|Did not complete medication diary|2|||
161271090|NCT03401450|582372875|FG000|Overall Study|post surgery medication change|2|||
161271091|NCT03401450|582372876|FG001|Overall Study|post surgery medication change|1|||
160963886|NCT00636610|581253424|FG001|Overall Study|Disease progression - radiographic|51|||
160963887|NCT00636610|581253423|FG000|Overall Study|Disease progression - clinical|8|||
160963888|NCT00636610|581253424|FG001|Overall Study|Disease progression - clinical|3|||
161271092|NCT03401450|582372875|FG000|Overall Study|Cancelled surgery|0|||
160963889|NCT00636610|581253423|FG000|Overall Study|Reason for discontinuation not available|3|||
160963890|NCT00636610|581253424|FG001|Overall Study|Reason for discontinuation not available|2|||
161147013|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
160963891|NCT02495025|581253425|FG000|Overall Study|Lost to Follow-up|21|||
161271093|NCT03401450|582372876|FG001|Overall Study|Cancelled surgery|2|||
161271094|NCT00390221|582372877|FG000|Overall Study|Lost to Follow-up|0|||
161271095|NCT00390221|582372878|FG001|Overall Study|Lost to Follow-up|3|||
160963892|NCT02495025|581253426|FG001|Overall Study|Lost to Follow-up|14|||
160963893|NCT02495025|581253425|FG000|Overall Study|Withdrawal by Subject|5|||
160963894|NCT02495025|581253426|FG001|Overall Study|Withdrawal by Subject|0|||
160963895|NCT02151266|581253431|FG000|Overall Study|Lost to Follow-up|1|||
160963896|NCT02151266|581253432|FG001|Overall Study|Lost to Follow-up|4|||
160963897|NCT02151266|581253433|FG002|Overall Study|Lost to Follow-up|1|||
160963898|NCT02151266|581253431|FG000|Overall Study|Did NOT receive intervention|3|||
160963899|NCT02151266|581253432|FG001|Overall Study|Did NOT receive intervention|6|||
160963900|NCT02151266|581253433|FG002|Overall Study|Did NOT receive intervention|2|||
160963901|NCT02151266|581253431|FG000|Overall Study|Not able to exercise|4|||
160963902|NCT02151266|581253432|FG001|Overall Study|Not able to exercise|5|||
160963903|NCT02151266|581253433|FG002|Overall Study|Not able to exercise|4|||
160963904|NCT01169675|581253434|FG000|Overall Study|Progressive disease|13|||
160963905|NCT01169675|581253435|FG001|Overall Study|Progressive disease|2|||
160963906|NCT01169675|581253436|FG002|Overall Study|Progressive disease|5|||
160963907|NCT01169675|581253437|FG003|Overall Study|Progressive disease|15|||
160963908|NCT01169675|581253438|FG004|Overall Study|Progressive disease|1|||
160963909|NCT01169675|581253434|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
160963910|NCT01169675|581253435|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160963911|NCT01169675|581253436|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160963912|NCT01169675|581253437|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
160963913|NCT01169675|581253438|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
160963914|NCT01169675|581253434|FG000|Overall Study|Adverse Event|5|||
160963915|NCT01169675|581253435|FG001|Overall Study|Adverse Event|1|||
160963916|NCT01169675|581253436|FG002|Overall Study|Adverse Event|2|||
160963917|NCT01169675|581253437|FG003|Overall Study|Adverse Event|0|||
160963918|NCT01169675|581253438|FG004|Overall Study|Adverse Event|0|||
160963919|NCT01169675|581253434|FG000|Overall Study|Withdrawal by Subject|1|||
160963920|NCT01169675|581253435|FG001|Overall Study|Withdrawal by Subject|0|||
160963921|NCT01169675|581253436|FG002|Overall Study|Withdrawal by Subject|0|||
160963922|NCT01169675|581253437|FG003|Overall Study|Withdrawal by Subject|1|||
160963923|NCT01169675|581253438|FG004|Overall Study|Withdrawal by Subject|2|||
160963924|NCT01169675|581253434|FG000|Overall Study|Other Reason Not Defined Above|0|||
160963925|NCT01169675|581253435|FG001|Overall Study|Other Reason Not Defined Above|0|||
160963926|NCT01169675|581253436|FG002|Overall Study|Other Reason Not Defined Above|0|||
160963927|NCT01169675|581253437|FG003|Overall Study|Other Reason Not Defined Above|1|||
160963928|NCT01169675|581253438|FG004|Overall Study|Other Reason Not Defined Above|1|||
160963929|NCT00572195|581253441|FG000|Overall Study|Withdrawal by Subject|50|||
160963930|NCT00572195|581253441|FG000|Overall Study|Death|9|||
160963931|NCT00572195|581253441|FG000|Overall Study|Adverse Event|4|||
160963932|NCT00572195|581253441|FG000|Overall Study|Lost to Follow-up|5|||
160963933|NCT01984697|581255598|FG000|Overall Study|Adverse Event|0|||
160963934|NCT01984697|581255599|FG001|Overall Study|Adverse Event|0|||
160963935|NCT01984697|581255600|FG002|Overall Study|Adverse Event|2|||
160963936|NCT01984697|581255601|FG003|Overall Study|Adverse Event|0|||
160963937|NCT01984697|581255602|FG004|Overall Study|Adverse Event|0|||
160963938|NCT01984697|581255598|FG000|Overall Study|Lost to Follow-up|14|||
160963939|NCT01984697|581255599|FG001|Overall Study|Lost to Follow-up|5|||
160963940|NCT01984697|581255600|FG002|Overall Study|Lost to Follow-up|10|||
160963941|NCT01984697|581255601|FG003|Overall Study|Lost to Follow-up|6|||
160963942|NCT01984697|581255602|FG004|Overall Study|Lost to Follow-up|21|||
160963943|NCT01984697|581255598|FG000|Overall Study|Physician Decision|3|||
160963944|NCT01984697|581255599|FG001|Overall Study|Physician Decision|0|||
160963945|NCT01984697|581255600|FG002|Overall Study|Physician Decision|0|||
160963946|NCT01984697|581255601|FG003|Overall Study|Physician Decision|1|||
160963947|NCT01984697|581255602|FG004|Overall Study|Physician Decision|0|||
160963948|NCT01984697|581255598|FG000|Overall Study|Protocol Violation|8|||
160963949|NCT01984697|581255599|FG001|Overall Study|Protocol Violation|5|||
160963950|NCT01984697|581255600|FG002|Overall Study|Protocol Violation|3|||
160963951|NCT01984697|581255601|FG003|Overall Study|Protocol Violation|2|||
160963952|NCT01984697|581255602|FG004|Overall Study|Protocol Violation|0|||
160963953|NCT01984697|581255598|FG000|Overall Study|Withdrawal by Subject|15|||
160963954|NCT01984697|581255599|FG001|Overall Study|Withdrawal by Subject|21|||
160963955|NCT01984697|581255600|FG002|Overall Study|Withdrawal by Subject|13|||
160963956|NCT01984697|581255601|FG003|Overall Study|Withdrawal by Subject|11|||
160963957|NCT01984697|581255602|FG004|Overall Study|Withdrawal by Subject|13|||
160963958|NCT01984697|581255598|FG000|Overall Study|Missed last follow-up visit|1|||
160963959|NCT01984697|581255599|FG001|Overall Study|Missed last follow-up visit|0|||
160963960|NCT01984697|581255600|FG002|Overall Study|Missed last follow-up visit|0|||
160963961|NCT01984697|581255601|FG003|Overall Study|Missed last follow-up visit|0|||
160963962|NCT01984697|581255602|FG004|Overall Study|Missed last follow-up visit|0|||
160963963|NCT01984697|581255598|FG000|Overall Study|Death|0|||
160963964|NCT01984697|581255599|FG001|Overall Study|Death|0|||
160963965|NCT01984697|581255600|FG002|Overall Study|Death|0|||
160963966|NCT01984697|581255601|FG003|Overall Study|Death|1|||
160963967|NCT01984697|581255602|FG004|Overall Study|Death|0|||
160963968|NCT01984697|581255598|FG000|Overall Study|Pregnancy|2|||
161147014|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
161147015|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161147016|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
161147017|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
160963969|NCT01984697|581255599|FG001|Overall Study|Pregnancy|0|||
160963970|NCT01984697|581255600|FG002|Overall Study|Pregnancy|1|||
160963971|NCT01984697|581255601|FG003|Overall Study|Pregnancy|0|||
160963972|NCT01984697|581255602|FG004|Overall Study|Pregnancy|1|||
160963973|NCT01345630|581255603|FG000|Overall Study|Adverse Event|22|||
160963974|NCT01345630|581255604|FG001|Overall Study|Adverse Event|23|||
160963975|NCT01345630|581255603|FG000|Overall Study|Lost to Follow-up|17|||
160963976|NCT01345630|581255604|FG001|Overall Study|Lost to Follow-up|16|||
160963977|NCT01345630|581255603|FG000|Overall Study|Protocol Violation|4|||
160963978|NCT01345630|581255604|FG001|Overall Study|Protocol Violation|1|||
160963979|NCT01345630|581255603|FG000|Overall Study|Medication error without associated AE|0|||
160963980|NCT01345630|581255604|FG001|Overall Study|Medication error without associated AE|1|||
160963981|NCT01345630|581255603|FG000|Overall Study|Study terminated by sponsor|254|||
160963982|NCT01345630|581255604|FG001|Overall Study|Study terminated by sponsor|285|||
160963983|NCT01345630|581255603|FG000|Overall Study|Other reasons|6|||
160963984|NCT01345630|581255604|FG001|Overall Study|Other reasons|8|||
160963985|NCT01345630|581255603|FG000|Overall Study|Withdrawn due to pregnancy|1|||
160963986|NCT01345630|581255604|FG001|Overall Study|Withdrawn due to pregnancy|2|||
160963987|NCT01345630|581255603|FG000|Overall Study|No longer willing to participate|9|||
160963988|NCT01345630|581255604|FG001|Overall Study|No longer willing to participate|12|||
160963989|NCT01345630|581255603|FG000|Overall Study|Insufficient clinical response|48|||
160963990|NCT01345630|581255604|FG001|Overall Study|Insufficient clinical response|11|||
160963991|NCT01364922|581255607|FG000|Open-label (OL) Period|Adverse Event|7|||
160963992|NCT01364922|581255608|FG001|Open-label (OL) Period|Adverse Event|0|||
160963993|NCT01364922|581255609|FG002|Open-label (OL) Period|Adverse Event|0|||
160963994|NCT01364922|581255607|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
160963995|NCT01364922|581255608|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
160963996|NCT01364922|581255609|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
160963997|NCT01364922|581255607|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
160963998|NCT01364922|581255608|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
160963999|NCT01364922|581255609|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
160964000|NCT01364922|581255607|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
160964001|NCT01364922|581255608|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
160964002|NCT01364922|581255609|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
160964003|NCT01364922|581255607|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
160964004|NCT01364922|581255608|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
161147018|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
160964005|NCT01364922|581255609|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
160964006|NCT01364922|581255607|FG000|Open-label (OL) Period|Other, Unspecified|1|||
160964007|NCT01364922|581255608|FG001|Open-label (OL) Period|Other, Unspecified|0|||
160964008|NCT01364922|581255609|FG002|Open-label (OL) Period|Other, Unspecified|0|||
160964009|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
160964010|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
160964011|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
160964012|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
160964013|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
160964014|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
160964015|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Adverse Event|0|||
160964016|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Adverse Event|0|||
160964017|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Adverse Event|1|||
160964018|NCT01364922|581255607|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
160964019|NCT01364922|581255608|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
160964020|NCT01364922|581255609|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
160964021|NCT01582789|581255613|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
160964022|NCT01582789|581255614|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
160964023|NCT00800202|581255615|FG000|Overall Study|Adverse Event|7|||
161147019|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161147020|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
161147021|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
160964024|NCT00800202|581255616|FG001|Overall Study|Adverse Event|6|||
160964025|NCT00800202|581255615|FG000|Overall Study|Death|1|||
160964026|NCT00800202|581255616|FG001|Overall Study|Death|0|||
160964027|NCT00800202|581255615|FG000|Overall Study|Other|5|||
161002384|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161147022|NCT00958568|581922399|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
161147023|NCT00958568|581922400|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
160964028|NCT00800202|581255616|FG001|Overall Study|Other|0|||
160964029|NCT00800202|581255615|FG000|Overall Study|Disease Progression|54|||
160964030|NCT00800202|581255616|FG001|Overall Study|Disease Progression|18|||
160964031|NCT05674890|581255619|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
160964032|NCT05674890|581255620|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
160964033|NCT05674890|581255619|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
160964034|NCT05674890|581255620|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
160964035|NCT05674890|581255619|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
160964036|NCT05674890|581255620|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
160964037|NCT02563002|581255623|FG000|Overall Study|Death|72|||
160964038|NCT02563002|581255624|FG001|Overall Study|Death|87|||
160964039|NCT02563002|581255623|FG000|Overall Study|Lost to Follow-up|5|||
160964040|NCT02563002|581255624|FG001|Overall Study|Lost to Follow-up|0|||
160964041|NCT02563002|581255623|FG000|Overall Study|Physician Decision|0|||
160964042|NCT02563002|581255624|FG001|Overall Study|Physician Decision|2|||
160964043|NCT02563002|581255623|FG000|Overall Study|Withdrawal by Subject|2|||
160964044|NCT02563002|581255624|FG001|Overall Study|Withdrawal by Subject|10|||
160964045|NCT02563002|581255623|FG000|Overall Study|Sponsor decision|74|||
160964046|NCT02563002|581255624|FG001|Overall Study|Sponsor decision|55|||
160964047|NCT01505387|581255625|FG000|Overall Study|Protocol Violation|1|||
160964048|NCT01505387|581255626|FG001|Overall Study|Protocol Violation|0|||
160964049|NCT01505387|581255625|FG000|Overall Study|Withdrawal by Subject|1|||
160964050|NCT01505387|581255626|FG001|Overall Study|Withdrawal by Subject|1|||
160964051|NCT01197508|581255627|FG000|Overall Study|Withdrawal by Subject|8|||
160964052|NCT01197508|581255628|FG001|Overall Study|Withdrawal by Subject|7|||
160964053|NCT01197508|581255629|FG002|Overall Study|Withdrawal by Subject|15|||
160964054|NCT01197508|581255630|FG003|Overall Study|Withdrawal by Subject|4|||
160964055|NCT01197508|581255627|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
160964056|NCT01197508|581255628|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
160964057|NCT01197508|581255629|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
160964058|NCT01197508|581255630|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
160964059|NCT01197508|581255627|FG000|Overall Study|Adverse Event|10|||
160964060|NCT01197508|581255628|FG001|Overall Study|Adverse Event|13|||
160964061|NCT01197508|581255629|FG002|Overall Study|Adverse Event|23|||
160964062|NCT01197508|581255630|FG003|Overall Study|Adverse Event|3|||
160964063|NCT01197508|581255627|FG000|Overall Study|Severe non-compliance to protocol|0|||
160964064|NCT01197508|581255628|FG001|Overall Study|Severe non-compliance to protocol|3|||
160964065|NCT01197508|581255629|FG002|Overall Study|Severe non-compliance to protocol|1|||
160964066|NCT01197508|581255630|FG003|Overall Study|Severe non-compliance to protocol|3|||
160964067|NCT01197508|581255627|FG000|Overall Study|Condition under investigation worsened|1|||
160964068|NCT01197508|581255628|FG001|Overall Study|Condition under investigation worsened|1|||
160964069|NCT01197508|581255629|FG002|Overall Study|Condition under investigation worsened|1|||
160964070|NCT01197508|581255630|FG003|Overall Study|Condition under investigation worsened|1|||
160964071|NCT01197508|581255627|FG000|Overall Study|Lack of Efficacy|1|||
160964072|NCT01197508|581255628|FG001|Overall Study|Lack of Efficacy|2|||
160964073|NCT01197508|581255629|FG002|Overall Study|Lack of Efficacy|2|||
160964074|NCT01197508|581255630|FG003|Overall Study|Lack of Efficacy|1|||
160964075|NCT01197508|581255627|FG000|Overall Study|Study-specific withdrawal criteria|0|||
160964076|NCT01197508|581255628|FG001|Overall Study|Study-specific withdrawal criteria|0|||
160964077|NCT01197508|581255629|FG002|Overall Study|Study-specific withdrawal criteria|1|||
160964078|NCT01197508|581255630|FG003|Overall Study|Study-specific withdrawal criteria|2|||
160964079|NCT01197508|581255627|FG000|Overall Study|Lost to Follow-up|1|||
160964080|NCT01197508|581255628|FG001|Overall Study|Lost to Follow-up|1|||
160964081|NCT01197508|581255629|FG002|Overall Study|Lost to Follow-up|2|||
160964082|NCT01197508|581255630|FG003|Overall Study|Lost to Follow-up|0|||
160964083|NCT01197508|581255627|FG000|Overall Study|Other|2|||
160964084|NCT01197508|581255628|FG001|Overall Study|Other|3|||
161002385|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002386|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002387|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002388|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002389|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002390|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
161002391|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161002392|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
161002393|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161002394|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
161002395|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
161002396|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
160964085|NCT01197508|581255629|FG002|Overall Study|Other|2|||
160964086|NCT01197508|581255630|FG003|Overall Study|Other|2|||
160964087|NCT03086330|581255631|FG000|Overall Study|Withdrawal by Subject|3|||
160964088|NCT03086330|581255632|FG001|Overall Study|Withdrawal by Subject|2|||
160964089|NCT03086330|581255631|FG000|Overall Study|Lost to Follow-up|1|||
160964090|NCT03086330|581255632|FG001|Overall Study|Lost to Follow-up|2|||
160964091|NCT00330174|581255634|FG000|Overall Study|Withdrawal by Subject|7|||
160964092|NCT00330174|581255635|FG001|Overall Study|Withdrawal by Subject|7|||
160964093|NCT00330174|581255634|FG000|Overall Study|Lost to Follow-up|4|||
160964094|NCT00330174|581255635|FG001|Overall Study|Lost to Follow-up|1|||
160964095|NCT00330174|581255634|FG000|Overall Study|Clinical deterioration|1|||
160964096|NCT00330174|581255635|FG001|Overall Study|Clinical deterioration|2|||
160964097|NCT00330174|581255634|FG000|Overall Study|Excessive missed visits|3|||
160964098|NCT00330174|581255635|FG001|Overall Study|Excessive missed visits|8|||
160964099|NCT00330174|581255634|FG000|Overall Study|Miscellaneous reasons|7|||
160964100|NCT00330174|581255635|FG001|Overall Study|Miscellaneous reasons|1|||
160964101|NCT02316769|581255638|FG000|Overall Study|Physician Decision|1|||
160964102|NCT02316769|581255639|FG001|Overall Study|Physician Decision|0|||
160964103|NCT02316769|581255638|FG000|Overall Study|Withdrawal by Subject|1|||
160964104|NCT02316769|581255639|FG001|Overall Study|Withdrawal by Subject|0|||
160964105|NCT04570436|581255640|FG000|Overall Study|Adverse Event|0|||
160964106|NCT04570436|581255641|FG001|Overall Study|Adverse Event|0|||
160964107|NCT04570436|581255642|FG002|Overall Study|Adverse Event|1|||
160964108|NCT04570436|581255643|FG003|Overall Study|Adverse Event|0|||
160964109|NCT04570436|581255644|FG004|Overall Study|Adverse Event|0|||
160964110|NCT04570436|581255645|FG005|Overall Study|Adverse Event|0|||
160964111|NCT04570436|581255646|FG006|Overall Study|Adverse Event|0|||
160964112|NCT04570436|581255647|FG007|Overall Study|Adverse Event|0|||
160964113|NCT04570436|581255648|FG008|Overall Study|Adverse Event|0|||
160964114|NCT04570436|581255649|FG009|Overall Study|Adverse Event|0|||
160964115|NCT04570436|581255640|FG000|Overall Study|Physician Decision|1|||
160964116|NCT04570436|581255641|FG001|Overall Study|Physician Decision|0|||
160964117|NCT04570436|581255642|FG002|Overall Study|Physician Decision|0|||
160964118|NCT04570436|581255643|FG003|Overall Study|Physician Decision|0|||
160964119|NCT04570436|581255644|FG004|Overall Study|Physician Decision|0|||
160964120|NCT04570436|581255645|FG005|Overall Study|Physician Decision|0|||
160964121|NCT04570436|581255646|FG006|Overall Study|Physician Decision|0|||
160964122|NCT04570436|581255647|FG007|Overall Study|Physician Decision|0|||
160964123|NCT04570436|581255648|FG008|Overall Study|Physician Decision|0|||
160964124|NCT04570436|581255649|FG009|Overall Study|Physician Decision|0|||
160964125|NCT00645164|581255650|FG000|Overall Study|Lost to Follow-up|2|||
160964126|NCT00645164|581255650|FG000|Overall Study|Withdrawal by Subject|4|||
160964127|NCT00645164|581255650|FG000|Overall Study|Protocol Violation|1|||
160964128|NCT03039023|581255651|FG000|Overall Study|Withdrawal by Subject|1|||
160964129|NCT03039023|581255652|FG001|Overall Study|Withdrawal by Subject|0|||
160964130|NCT03039023|581255653|FG002|Overall Study|Withdrawal by Subject|1|||
160964131|NCT03039023|581255654|FG003|Overall Study|Withdrawal by Subject|1|||
160964132|NCT03039023|581255655|FG004|Overall Study|Withdrawal by Subject|0|||
160964133|NCT03039023|581255651|FG000|Overall Study|Physician Decision|0|||
160964134|NCT03039023|581255652|FG001|Overall Study|Physician Decision|0|||
160964135|NCT03039023|581255653|FG002|Overall Study|Physician Decision|0|||
160964136|NCT03039023|581255654|FG003|Overall Study|Physician Decision|1|||
160964137|NCT03039023|581255655|FG004|Overall Study|Physician Decision|0|||
160964138|NCT03338829|581255656|FG000|Overall Study|Lost to Follow-up|4|||
160964139|NCT03338829|581255657|FG001|Overall Study|Lost to Follow-up|2|||
160964140|NCT03338829|581255658|FG002|Overall Study|Lost to Follow-up|4|||
160964141|NCT03338829|581255656|FG000|Overall Study|Pregnancy loss|1|||
160964142|NCT03338829|581255657|FG001|Overall Study|Pregnancy loss|1|||
160964143|NCT03338829|581255658|FG002|Overall Study|Pregnancy loss|0|||
160964144|NCT03338829|581255656|FG000|Overall Study|Protocol Violation|0|||
160964145|NCT03338829|581255657|FG001|Overall Study|Protocol Violation|1|||
160964146|NCT03338829|581255658|FG002|Overall Study|Protocol Violation|0|||
160964147|NCT03701399|581255662|FG000|Overall Study|Adverse Event|3|||
160964148|NCT03701399|581255663|FG001|Overall Study|Adverse Event|5|||
160964149|NCT03701399|581255662|FG000|Overall Study|Withdrawal by Subject|6|||
160964150|NCT03701399|581255663|FG001|Overall Study|Withdrawal by Subject|3|||
160964151|NCT03701399|581255662|FG000|Overall Study|Investigators decision|1|||
160964152|NCT03701399|581255663|FG001|Overall Study|Investigators decision|2|||
160964153|NCT03701399|581255662|FG000|Overall Study|Lost to Follow-up|1|||
161002397|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002398|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002399|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
160964154|NCT03701399|581255663|FG001|Overall Study|Lost to Follow-up|2|||
160964155|NCT03701399|581255662|FG000|Overall Study|Death|1|||
160964156|NCT03701399|581255663|FG001|Overall Study|Death|1|||
160964157|NCT03701399|581255662|FG000|Overall Study|Randomized but not treated|1|||
160964158|NCT03701399|581255663|FG001|Overall Study|Randomized but not treated|0|||
160964159|NCT04179032|581255664|FG000|Part B (Up to Week 52)|Adverse Event|1|||
160964160|NCT04179032|581255664|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
160964161|NCT04179032|581255664|FG000|Access Extension Phase|Ongoing|11|||
160964162|NCT00448448|581255665|FG000|Overall Study|Withdrawal by Subject|13|||
160964163|NCT00448448|581255666|FG001|Overall Study|Withdrawal by Subject|2|||
160964164|NCT00448448|581255665|FG000|Overall Study|On protocol when study ended|83|||
160964165|NCT00448448|581255666|FG001|Overall Study|On protocol when study ended|36|||
160964166|NCT00448448|581255665|FG000|Overall Study|Lost to Follow-up|2|||
160964167|NCT00448448|581255666|FG001|Overall Study|Lost to Follow-up|1|||
160964168|NCT00448448|581255665|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
160964169|NCT00448448|581255666|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
160964170|NCT00448448|581255665|FG000|Overall Study|Signed consent lost|0|||
160964171|NCT00448448|581255666|FG001|Overall Study|Signed consent lost|1|||
160964172|NCT02340026|581255667|FG000|Treatment Phase|Withdrawal by Subject|2|||
160964173|NCT02340026|581255668|FG001|Treatment Phase|Withdrawal by Subject|2|||
160964174|NCT02340026|581255667|FG000|Follow-up Phase|Lost to Follow-up|1|||
160964175|NCT02340026|581255668|FG001|Follow-up Phase|Lost to Follow-up|0|||
160964176|NCT03945292|581255669|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
160964177|NCT03945292|581255670|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964178|NCT03945292|581255671|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
160964179|NCT03945292|581255672|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964180|NCT03945292|581255673|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964181|NCT03945292|581255674|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964182|NCT03945292|581255675|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964183|NCT03945292|581255676|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
160964184|NCT03945292|581255669|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964185|NCT03945292|581255670|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964186|NCT03945292|581255671|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
160964187|NCT03945292|581255672|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964188|NCT03945292|581255673|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964189|NCT03945292|581255674|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964190|NCT03945292|581255675|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964191|NCT03945292|581255676|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
160964192|NCT03945292|581255669|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964193|NCT03945292|581255670|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964194|NCT03945292|581255671|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964195|NCT03945292|581255672|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964196|NCT03945292|581255673|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964197|NCT03945292|581255674|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964198|NCT03945292|581255675|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
160964199|NCT03945292|581255676|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
160964200|NCT02684006|581255677|FG000|Overall Study|Other|18|||
160964201|NCT02684006|581255678|FG001|Overall Study|Other|6|||
160964202|NCT02684006|581255677|FG000|Overall Study|Protocol Violation|2|||
160964203|NCT02684006|581255678|FG001|Overall Study|Protocol Violation|1|||
160964204|NCT02684006|581255677|FG000|Overall Study|Non-compliance with study drug|1|||
160964205|NCT02684006|581255678|FG001|Overall Study|Non-compliance with study drug|1|||
160964206|NCT02684006|581255677|FG000|Overall Study|No longer met eligibility criteria|6|||
160964207|NCT02684006|581255678|FG001|Overall Study|No longer met eligibility criteria|2|||
160964208|NCT02684006|581255677|FG000|Overall Study|Lost to Follow-up|0|||
160964209|NCT02684006|581255678|FG001|Overall Study|Lost to Follow-up|1|||
160964210|NCT02684006|581255677|FG000|Overall Study|Death|25|||
160964211|NCT02684006|581255678|FG001|Overall Study|Death|22|||
160964212|NCT02684006|581255677|FG000|Overall Study|Global deterioration of health status|18|||
160964213|NCT02684006|581255678|FG001|Overall Study|Global deterioration of health status|20|||
160964214|NCT02684006|581255677|FG000|Overall Study|Physician Decision|15|||
160964215|NCT02684006|581255678|FG001|Overall Study|Physician Decision|8|||
160964216|NCT02684006|581255677|FG000|Overall Study|Adverse Event|86|||
160964217|NCT02684006|581255678|FG001|Overall Study|Adverse Event|65|||
160964218|NCT02684006|581255677|FG000|Overall Study|Withdrawal by Subject|29|||
160964219|NCT02684006|581255678|FG001|Overall Study|Withdrawal by Subject|43|||
160964220|NCT02684006|581255677|FG000|Overall Study|Progressive disease|236|||
160964221|NCT02684006|581255678|FG001|Overall Study|Progressive disease|266|||
160964222|NCT02684006|581255677|FG000|Overall Study|Participation terminated by sponsor|6|||
160964223|NCT02684006|581255678|FG001|Overall Study|Participation terminated by sponsor|9|||
160964224|NCT04642898|581255679|FG000|Overall Study|Withdrawal by Subject|2|||
160964225|NCT04642898|581255680|FG001|Overall Study|Withdrawal by Subject|4|||
160964226|NCT04642898|581255681|FG002|Overall Study|Withdrawal by Subject|4|||
160964227|NCT04642898|581255682|FG003|Overall Study|Withdrawal by Subject|6|||
160964228|NCT04642898|581255683|FG004|Overall Study|Withdrawal by Subject|2|||
160964229|NCT04642898|581255684|FG005|Overall Study|Withdrawal by Subject|6|||
160964230|NCT04642898|581255679|FG000|Overall Study|Lost to Follow-up|0|||
160964231|NCT04642898|581255680|FG001|Overall Study|Lost to Follow-up|0|||
160964232|NCT04642898|581255681|FG002|Overall Study|Lost to Follow-up|0|||
160964233|NCT04642898|581255682|FG003|Overall Study|Lost to Follow-up|2|||
160964234|NCT04642898|581255683|FG004|Overall Study|Lost to Follow-up|0|||
160964235|NCT04642898|581255684|FG005|Overall Study|Lost to Follow-up|1|||
160964236|NCT04642898|581255679|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
160964237|NCT04642898|581255680|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
161271096|NCT00390221|582372879|FG002|Overall Study|Lost to Follow-up|0|||
161002400|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002401|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002402|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002403|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
161002404|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161002405|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002406|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002407|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002408|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002409|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161002410|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
161002411|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
161002412|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002413|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002414|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002415|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002416|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
161002417|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
161002418|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
161002419|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
161002420|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
161002421|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
161002422|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161002423|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
161002424|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161002425|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
161002426|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161002427|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
160964238|NCT04642898|581255681|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
160964239|NCT04642898|581255682|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
160964240|NCT04642898|581255683|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
160964241|NCT04642898|581255684|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
160964242|NCT04642898|581255679|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964243|NCT04642898|581255680|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964244|NCT04642898|581255681|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964245|NCT04642898|581255682|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964246|NCT04642898|581255683|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
160964247|NCT04642898|581255684|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
160964248|NCT04495179|581255685|FG000|Overall Study|Lost to Follow-up|0|||
160964249|NCT04495179|581255686|FG001|Overall Study|Lost to Follow-up|1|||
160964250|NCT04495179|581255685|FG000|Overall Study|Withdrawal by Subject|2|||
160964251|NCT04495179|581255686|FG001|Overall Study|Withdrawal by Subject|4|||
160964252|NCT04495179|581255685|FG000|Overall Study|Study terminated by sponsor|0|||
160964253|NCT04495179|581255686|FG001|Overall Study|Study terminated by sponsor|18|||
160964254|NCT04495179|581255685|FG000|Overall Study|Death|0|||
160964255|NCT04495179|581255686|FG001|Overall Study|Death|4|||
160964256|NCT04495179|581255685|FG000|Overall Study|Adverse Event|0|||
160964257|NCT04495179|581255686|FG001|Overall Study|Adverse Event|1|||
160964258|NCT04280562|581255687|FG000|Study|Adverse Event|2|||
160964259|NCT04280562|581255688|FG001|Study|Adverse Event|0|||
160964260|NCT04280562|581255687|FG000|Study|Lost to Follow-up|3|||
160964261|NCT04280562|581255688|FG001|Study|Lost to Follow-up|3|||
160964262|NCT00946296|581255689|FG000|Overall Study|Physician Decision|3|||
160964263|NCT00946296|581255690|FG001|Overall Study|Physician Decision|0|||
160964264|NCT03434678|581255693|FG000|Overall Study|Withdrawal by Subject|13|||
160964265|NCT03434678|581255694|FG001|Overall Study|Withdrawal by Subject|13|||
160964266|NCT03434678|581255693|FG000|Overall Study|Found to be ineligible post randomization|2|||
160964267|NCT03434678|581255694|FG001|Overall Study|Found to be ineligible post randomization|1|||
161002428|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161002429|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
161002430|NCT04707313|581394579|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002431|NCT04707313|581394580|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002432|NCT04707313|581394581|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
161002433|NCT04707313|581394582|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
160964268|NCT01368965|581255698|FG000|Overall Study|Lost to Follow-up|12|||
160964269|NCT06060457|581255699|FG000|Overall Study|Adverse Event|1|||
160964270|NCT06060457|581255700|FG001|Overall Study|Adverse Event|1|||
160964271|NCT06060457|581255699|FG000|Overall Study|Death|2|||
160964272|NCT06060457|581255700|FG001|Overall Study|Death|2|||
161147024|NCT00958568|581922401|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161147025|NCT00958568|581922402|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
161147026|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161147027|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
161147028|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
161147029|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
160964273|NCT06060457|581255699|FG000|Overall Study|Lost to Follow-up|17|||
160964274|NCT06060457|581255700|FG001|Overall Study|Lost to Follow-up|19|||
160964275|NCT06060457|581255699|FG000|Overall Study|Physician Decision|0|||
160964276|NCT06060457|581255700|FG001|Overall Study|Physician Decision|1|||
160964277|NCT06060457|581255699|FG000|Overall Study|Protocol Violation|1|||
160964278|NCT06060457|581255700|FG001|Overall Study|Protocol Violation|1|||
160964279|NCT06060457|581255699|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
160964280|NCT06060457|581255700|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
160964281|NCT06060457|581255699|FG000|Overall Study|Withdrawal by Subject|12|||
160964282|NCT06060457|581255700|FG001|Overall Study|Withdrawal by Subject|15|||
160964283|NCT06060457|581255699|FG000|Overall Study|Other Than Specified|2|||
160964284|NCT06060457|581255700|FG001|Overall Study|Other Than Specified|1|||
160964285|NCT02061202|581255701|FG000|Overall Study|Lost to Follow-up|1|||
160964286|NCT02061202|581255702|FG001|Overall Study|Lost to Follow-up|1|||
160964287|NCT00162370|581255703|FG000|Efficacy Population|Lost to Follow-up|51|||
160964288|NCT00569582|581255714|FG000|Overall Study|Withdrawal by Subject|5|||
160964289|NCT00569582|581255714|FG000|Overall Study|Death|2|||
160964290|NCT00569582|581255714|FG000|Overall Study|Adverse Event|7|||
160964291|NCT00569582|581255714|FG000|Overall Study|Subject was too ill to travel.|1|||
160964292|NCT00569582|581255714|FG000|Overall Study|Subject was non-compliant.|1|||
160964293|NCT04559568|581255718|FG000|Overall Study|Physician Decision|0|||
160964294|NCT04559568|581255719|FG001|Overall Study|Physician Decision|0|||
160964295|NCT04559568|581255720|FG002|Overall Study|Physician Decision|0|||
160964296|NCT04559568|581255721|FG003|Overall Study|Physician Decision|0|||
160964297|NCT04559568|581255722|FG004|Overall Study|Physician Decision|0|||
160964298|NCT04559568|581255723|FG005|Overall Study|Physician Decision|0|||
160964299|NCT04559568|581255724|FG006|Overall Study|Physician Decision|0|||
160964300|NCT04559568|581255725|FG007|Overall Study|Physician Decision|0|||
160964301|NCT04559568|581255726|FG008|Overall Study|Physician Decision|0|||
160964302|NCT04559568|581255727|FG009|Overall Study|Physician Decision|1|||
160964303|NCT04559568|581255728|FG010|Overall Study|Physician Decision|0|||
160964304|NCT04559568|581255718|FG000|Overall Study|Withdrawal by Subject|0|||
160964305|NCT04559568|581255719|FG001|Overall Study|Withdrawal by Subject|0|||
160964306|NCT04559568|581255720|FG002|Overall Study|Withdrawal by Subject|0|||
160964307|NCT04559568|581255721|FG003|Overall Study|Withdrawal by Subject|0|||
160964308|NCT04559568|581255722|FG004|Overall Study|Withdrawal by Subject|0|||
160964309|NCT04559568|581255723|FG005|Overall Study|Withdrawal by Subject|0|||
160964310|NCT04559568|581255724|FG006|Overall Study|Withdrawal by Subject|0|||
160964311|NCT04559568|581255725|FG007|Overall Study|Withdrawal by Subject|0|||
160964312|NCT04559568|581255726|FG008|Overall Study|Withdrawal by Subject|0|||
160964313|NCT04559568|581255727|FG009|Overall Study|Withdrawal by Subject|0|||
160964314|NCT04559568|581255728|FG010|Overall Study|Withdrawal by Subject|1|||
160964315|NCT04085328|581255730|FG000|Overall Study|Witihdrew Consent|16|||
160964316|NCT04085328|581255731|FG001|Overall Study|Witihdrew Consent|16|||
160964317|NCT04085328|581255730|FG000|Overall Study|Adverse Event|8|||
160964318|NCT04085328|581255731|FG001|Overall Study|Adverse Event|7|||
160964319|NCT04085328|581255730|FG000|Overall Study|Lost to Follow-up|7|||
160964320|NCT04085328|581255731|FG001|Overall Study|Lost to Follow-up|2|||
160964321|NCT04085328|581255730|FG000|Overall Study|Physician Decision|0|||
160964322|NCT04085328|581255731|FG001|Overall Study|Physician Decision|1|||
160964323|NCT04085328|581255730|FG000|Overall Study|Pregnancy|0|||
160964324|NCT04085328|581255731|FG001|Overall Study|Pregnancy|1|||
160964325|NCT04085328|581255730|FG000|Overall Study|Reasons Related to COVID-19|5|||
160964326|NCT04085328|581255731|FG001|Overall Study|Reasons Related to COVID-19|8|||
160964327|NCT04085328|581255730|FG000|Overall Study|Did not meet inclusion criteria|1|||
160964328|NCT04085328|581255731|FG001|Overall Study|Did not meet inclusion criteria|1|||
160964329|NCT04085328|581255730|FG000|Overall Study|Early termination|1|||
160964330|NCT04085328|581255731|FG001|Overall Study|Early termination|0|||
160964331|NCT01422408|581255732|FG000|Overall Study|Adverse Event|1|||
161147030|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161147031|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
161147032|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161147033|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
161147034|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161271097|NCT00390221|582372877|FG000|Overall Study|Adverse Event|1|||
160964332|NCT01422408|581255732|FG000|Overall Study|Withdrawal by Subject|3|||
160964333|NCT00724152|581255736|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
160964334|NCT00724152|581255737|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
161271098|NCT00390221|582372878|FG001|Overall Study|Adverse Event|4|||
161271099|NCT00390221|582372879|FG002|Overall Study|Adverse Event|3|||
160964335|NCT00724152|581255738|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
160964336|NCT00724152|581255736|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
160964337|NCT00724152|581255737|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
160964338|NCT00724152|581255738|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
160964339|NCT01328080|581255739|FG000|Overall Study|Lost to Follow-up|5|||
160964340|NCT03266770|581255740|FG000|Overall Study|Physician Decision|3|||
160964341|NCT03266770|581255740|FG000|Overall Study|Insufficient study supplies|1|||
160964342|NCT03266770|581255740|FG000|Overall Study|Adverse Event|1|||
160964343|NCT04274894|581255741|FG000|Overall Study|Adverse Event|7|||
160964344|NCT04274894|581255741|FG000|Overall Study|Withdrew consent|5|||
160964345|NCT04274894|581255741|FG000|Overall Study|Lost to Follow-up|9|||
160964346|NCT04274894|581255741|FG000|Overall Study|COVID-19 infection|1|||
160964347|NCT04274894|581255741|FG000|Overall Study|Other, not specified|20|||
160964348|NCT01936857|581255742|FG000|Overall Study|Sent to prison or 06 center|11|||
160964349|NCT01936857|581255743|FG001|Overall Study|Sent to prison or 06 center|12|||
160964350|NCT01936857|581255742|FG000|Overall Study|Lost to Follow-up|10|||
160964351|NCT01936857|581255743|FG001|Overall Study|Lost to Follow-up|7|||
160964352|NCT01936857|581255742|FG000|Overall Study|Death|7|||
160964353|NCT01936857|581255743|FG001|Overall Study|Death|3|||
160964354|NCT01936857|581255742|FG000|Overall Study|Moved|2|||
160964355|NCT01936857|581255743|FG001|Overall Study|Moved|1|||
160964356|NCT01936857|581255742|FG000|Overall Study|Withdrawal by Subject|1|||
160964357|NCT01936857|581255743|FG001|Overall Study|Withdrawal by Subject|0|||
160964358|NCT01936857|581255742|FG000|Overall Study|Side effect of medication|1|||
160964359|NCT01936857|581255743|FG001|Overall Study|Side effect of medication|0|||
160964360|NCT01936857|581255742|FG000|Overall Study|Other|2|||
160964361|NCT01936857|581255743|FG001|Overall Study|Other|2|||
160964362|NCT04510675|581255744|FG000|Overall Study|Withdrawal by Subject|5|||
160964363|NCT01499082|581255747|FG000|Overall Study|Randomized but not Treated|0|||
160964364|NCT01499082|581255748|FG001|Overall Study|Randomized but not Treated|1|||
160964365|NCT01499082|581255747|FG000|Overall Study|Adverse Event|12|||
160964366|NCT01499082|581255748|FG001|Overall Study|Adverse Event|16|||
160964367|NCT01499082|581255747|FG000|Overall Study|Lack of Efficacy|1|||
160964368|NCT01499082|581255748|FG001|Overall Study|Lack of Efficacy|1|||
160964369|NCT01499082|581255747|FG000|Overall Study|Protocol Violation|6|||
160964370|NCT01499082|581255748|FG001|Overall Study|Protocol Violation|8|||
160964371|NCT01499082|581255747|FG000|Overall Study|Diverse Reasons|18|||
160964372|NCT01499082|581255748|FG001|Overall Study|Diverse Reasons|14|||
160964373|NCT01499082|581255747|FG000|Overall Study|Site Closure for Noncompliance|5|||
160964374|NCT01499082|581255748|FG001|Overall Study|Site Closure for Noncompliance|2|||
160964375|NCT01499082|581255747|FG000|Overall Study|Hypoglycemia|2|||
160964376|NCT01499082|581255748|FG001|Overall Study|Hypoglycemia|3|||
160964377|NCT01499082|581255747|FG000|Overall Study|Lost to Follow-up|1|||
160964378|NCT01499082|581255748|FG001|Overall Study|Lost to Follow-up|3|||
160964379|NCT01218126|581255749|FG000|Overall Study|Adverse Event|8|||
160964380|NCT01218126|581255750|FG001|Overall Study|Adverse Event|10|||
160964381|NCT01218126|581255751|FG002|Overall Study|Adverse Event|12|||
160964382|NCT01218126|581255752|FG003|Overall Study|Adverse Event|16|||
160964383|NCT01218126|581255749|FG000|Overall Study|Lack of Efficacy|7|||
160964384|NCT01218126|581255750|FG001|Overall Study|Lack of Efficacy|2|||
160964385|NCT01218126|581255751|FG002|Overall Study|Lack of Efficacy|2|||
160964386|NCT01218126|581255752|FG003|Overall Study|Lack of Efficacy|6|||
160964387|NCT01218126|581255749|FG000|Overall Study|Protocol Violation|5|||
160964388|NCT01218126|581255750|FG001|Overall Study|Protocol Violation|2|||
160964389|NCT01218126|581255751|FG002|Overall Study|Protocol Violation|2|||
160964390|NCT01218126|581255752|FG003|Overall Study|Protocol Violation|3|||
160964391|NCT01218126|581255749|FG000|Overall Study|Protocol-defined stopping criteria|1|||
160964392|NCT01218126|581255750|FG001|Overall Study|Protocol-defined stopping criteria|1|||
160964393|NCT01218126|581255751|FG002|Overall Study|Protocol-defined stopping criteria|0|||
160964394|NCT01218126|581255752|FG003|Overall Study|Protocol-defined stopping criteria|0|||
160964395|NCT01218126|581255749|FG000|Overall Study|Lost to Follow-up|0|||
160964396|NCT01218126|581255750|FG001|Overall Study|Lost to Follow-up|0|||
160964397|NCT01218126|581255751|FG002|Overall Study|Lost to Follow-up|0|||
160964398|NCT01218126|581255752|FG003|Overall Study|Lost to Follow-up|2|||
160964399|NCT01218126|581255749|FG000|Overall Study|Physician Decision|1|||
160964400|NCT01218126|581255750|FG001|Overall Study|Physician Decision|2|||
160964401|NCT01218126|581255751|FG002|Overall Study|Physician Decision|4|||
160964402|NCT01218126|581255752|FG003|Overall Study|Physician Decision|2|||
160964403|NCT01218126|581255749|FG000|Overall Study|Withdrawal by Subject|2|||
160964404|NCT01218126|581255750|FG001|Overall Study|Withdrawal by Subject|5|||
160964405|NCT01218126|581255751|FG002|Overall Study|Withdrawal by Subject|4|||
160964406|NCT01218126|581255752|FG003|Overall Study|Withdrawal by Subject|6|||
160964407|NCT05380947|581255753|FG000|Washout Period 1|Not attend visit|1|||
160964408|NCT05380947|581255754|FG001|Washout Period 1|Not attend visit|0|||
160964409|NCT05380947|581255755|FG002|Washout Period 1|Not attend visit|0|||
160964410|NCT05380947|581255756|FG003|Washout Period 1|Not attend visit|0|||
160964411|NCT05380947|581255753|FG000|Washout Period 2|Adverse Event|1|||
160964412|NCT05380947|581255754|FG001|Washout Period 2|Adverse Event|0|||
160964413|NCT05380947|581255755|FG002|Washout Period 2|Adverse Event|0|||
160964414|NCT05380947|581255756|FG003|Washout Period 2|Adverse Event|0|||
160964415|NCT05380947|581255753|FG000|Washout Period 3|Adverse Event|0|||
160964416|NCT05380947|581255754|FG001|Washout Period 3|Adverse Event|1|||
160964417|NCT05380947|581255755|FG002|Washout Period 3|Adverse Event|0|||
160964418|NCT05380947|581255756|FG003|Washout Period 3|Adverse Event|0|||
160964419|NCT05380947|581255753|FG000|Washout Period 3|Not attend visit|0|||
160964420|NCT05380947|581255754|FG001|Washout Period 3|Not attend visit|1|||
160964421|NCT05380947|581255755|FG002|Washout Period 3|Not attend visit|0|||
160964422|NCT05380947|581255756|FG003|Washout Period 3|Not attend visit|1|||
160964423|NCT01563536|581255757|FG000|Overall Study|Withdrawal by Subject|0|||
160964424|NCT01563536|581255758|FG001|Overall Study|Withdrawal by Subject|2|||
160964425|NCT01563536|581255757|FG000|Overall Study|Lost to Follow-up|1|||
160964426|NCT01563536|581255758|FG001|Overall Study|Lost to Follow-up|0|||
160964427|NCT01860703|581255759|FG000|Overall Study|Adverse Event|1|||
160964428|NCT01860703|581255760|FG001|Overall Study|Adverse Event|4|||
160964429|NCT01860703|581255761|FG002|Overall Study|Adverse Event|0|||
160964430|NCT01860703|581255762|FG003|Overall Study|Adverse Event|2|||
160964431|NCT01860703|581255759|FG000|Overall Study|Withdrawal by Subject|0|||
160964432|NCT01860703|581255760|FG001|Overall Study|Withdrawal by Subject|1|||
160964433|NCT01860703|581255761|FG002|Overall Study|Withdrawal by Subject|0|||
160964434|NCT01860703|581255762|FG003|Overall Study|Withdrawal by Subject|0|||
160964435|NCT01860703|581255759|FG000|Overall Study|Personal reason|1|||
160964436|NCT01860703|581255760|FG001|Overall Study|Personal reason|0|||
160964437|NCT01860703|581255761|FG002|Overall Study|Personal reason|1|||
160964438|NCT01860703|581255762|FG003|Overall Study|Personal reason|0|||
160964439|NCT06213701|581255766|FG000|Overall Study|Withdrawal by Subject|2|||
160964440|NCT06213701|581255767|FG001|Overall Study|Withdrawal by Subject|1|||
160964441|NCT06213701|581255768|FG002|Overall Study|Withdrawal by Subject|0|||
160964442|NCT00538590|581255769|FG000|Overall Study|Death|1|||
160964443|NCT00538590|581255770|FG001|Overall Study|Death|0|||
160964444|NCT03184792|581255775|FG000|Overall Study|Pandemic|2|||
160964445|NCT03184792|581255776|FG001|Overall Study|Pandemic|2|||
160964446|NCT00313820|581255777|FG000|Assigned to Treatment|Other|1|||
160964447|NCT00313820|581255778|FG001|Assigned to Treatment|Other|0|||
160964448|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
160964449|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
160964450|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
160964451|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
160964452|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
160964453|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
160964454|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
160964455|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
160964456|NCT00313820|581255777|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
160964457|NCT00313820|581255778|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
160964458|NCT02453685|581255779|FG000|Overall Study|Adverse Event|0|||
160964459|NCT02453685|581255780|FG001|Overall Study|Adverse Event|1|||
160964460|NCT02453685|581255779|FG000|Overall Study|Protocol Violation|7|||
160964461|NCT02453685|581255780|FG001|Overall Study|Protocol Violation|4|||
160964462|NCT02453685|581255779|FG000|Overall Study|Lost to Follow-up|0|||
160964463|NCT02453685|581255780|FG001|Overall Study|Lost to Follow-up|1|||
160964464|NCT02453685|581255779|FG000|Overall Study|Withdrawal by Subject|8|||
160964465|NCT02453685|581255780|FG001|Overall Study|Withdrawal by Subject|4|||
160964466|NCT02453685|581255779|FG000|Overall Study|Unclassified|4|||
160964467|NCT02453685|581255780|FG001|Overall Study|Unclassified|2|||
160964468|NCT02778100|581255781|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
160964469|NCT02778100|581255782|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
160964470|NCT01515748|581255783|FG000|Overall Study|Withdrawal by Subject|32|||
160964471|NCT01515748|581255784|FG001|Overall Study|Withdrawal by Subject|41|||
160964472|NCT01515748|581255783|FG000|Overall Study|Lost to Follow-up|2|||
160964473|NCT01515748|581255784|FG001|Overall Study|Lost to Follow-up|4|||
160964474|NCT01515748|581255783|FG000|Overall Study|Other than specified above|5|||
160964475|NCT01515748|581255784|FG001|Overall Study|Other than specified above|10|||
160964476|NCT05809596|581255787|FG000|Overall Study|Death|16|||
160964477|NCT05809596|581255787|FG000|Overall Study|Withdrawal by Subject|4|||
160964478|NCT05809596|581255787|FG000|Overall Study|Physician Decision|1|||
160964479|NCT05809596|581255787|FG000|Overall Study|Missed Visit|2|||
160964480|NCT05809596|581255787|FG000|Overall Study|Other|3|||
160964481|NCT03770494|581255788|FG000|Overall Study|Lost to Follow-up|0|||
160964482|NCT03770494|581255789|FG001|Overall Study|Lost to Follow-up|0|||
160964483|NCT03770494|581255790|FG002|Overall Study|Lost to Follow-up|1|||
160964484|NCT03770494|581255791|FG003|Overall Study|Lost to Follow-up|1|||
160964485|NCT03770494|581255792|FG004|Overall Study|Lost to Follow-up|1|||
160964486|NCT03770494|581255793|FG005|Overall Study|Lost to Follow-up|0|||
160964487|NCT03770494|581255794|FG006|Overall Study|Lost to Follow-up|0|||
160964488|NCT03770494|581255795|FG007|Overall Study|Lost to Follow-up|0|||
161002434|NCT04707313|581394583|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002435|NCT04707313|581394584|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002436|NCT04707313|581394585|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002437|NCT04707313|581394586|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
161002438|NCT04707313|581394587|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002439|NCT04707313|581394588|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002440|NCT04707313|581394589|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002441|NCT04707313|581394590|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002442|NCT04707313|581394591|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
161002443|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002444|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002445|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002446|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002447|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002448|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002449|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002450|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
160964489|NCT03770494|581255796|FG008|Overall Study|Lost to Follow-up|0|||
160964490|NCT03770494|581255797|FG009|Overall Study|Lost to Follow-up|0|||
160964491|NCT03770494|581255798|FG010|Overall Study|Lost to Follow-up|0|||
160964492|NCT03770494|581255799|FG011|Overall Study|Lost to Follow-up|0|||
160964493|NCT03770494|581255800|FG012|Overall Study|Lost to Follow-up|0|||
160964494|NCT03770494|581255801|FG013|Overall Study|Lost to Follow-up|0|||
160964495|NCT03770494|581255788|FG000|Overall Study|Study terminated by sponsor|1|||
160964496|NCT03770494|581255789|FG001|Overall Study|Study terminated by sponsor|2|||
160964497|NCT03770494|581255790|FG002|Overall Study|Study terminated by sponsor|1|||
160964498|NCT03770494|581255791|FG003|Overall Study|Study terminated by sponsor|1|||
160964499|NCT03770494|581255792|FG004|Overall Study|Study terminated by sponsor|1|||
160964500|NCT03770494|581255793|FG005|Overall Study|Study terminated by sponsor|2|||
160964501|NCT03770494|581255794|FG006|Overall Study|Study terminated by sponsor|1|||
160964502|NCT03770494|581255795|FG007|Overall Study|Study terminated by sponsor|2|||
160964503|NCT03770494|581255796|FG008|Overall Study|Study terminated by sponsor|1|||
160964504|NCT03770494|581255797|FG009|Overall Study|Study terminated by sponsor|2|||
160964505|NCT03770494|581255798|FG010|Overall Study|Study terminated by sponsor|1|||
160964506|NCT03770494|581255799|FG011|Overall Study|Study terminated by sponsor|2|||
160964507|NCT03770494|581255800|FG012|Overall Study|Study terminated by sponsor|0|||
160964508|NCT03770494|581255801|FG013|Overall Study|Study terminated by sponsor|0|||
160964509|NCT03770494|581255788|FG000|Overall Study|Withdrawal by Subject|1|||
160964510|NCT03770494|581255789|FG001|Overall Study|Withdrawal by Subject|1|||
160964511|NCT03770494|581255790|FG002|Overall Study|Withdrawal by Subject|0|||
160964512|NCT03770494|581255791|FG003|Overall Study|Withdrawal by Subject|0|||
160964513|NCT03770494|581255792|FG004|Overall Study|Withdrawal by Subject|2|||
160964514|NCT03770494|581255793|FG005|Overall Study|Withdrawal by Subject|2|||
160964515|NCT03770494|581255794|FG006|Overall Study|Withdrawal by Subject|2|||
160964516|NCT03770494|581255795|FG007|Overall Study|Withdrawal by Subject|0|||
160964517|NCT03770494|581255796|FG008|Overall Study|Withdrawal by Subject|2|||
160964518|NCT03770494|581255797|FG009|Overall Study|Withdrawal by Subject|3|||
160964519|NCT03770494|581255798|FG010|Overall Study|Withdrawal by Subject|1|||
160964520|NCT03770494|581255799|FG011|Overall Study|Withdrawal by Subject|0|||
160964521|NCT03770494|581255800|FG012|Overall Study|Withdrawal by Subject|0|||
160964522|NCT03770494|581255801|FG013|Overall Study|Withdrawal by Subject|0|||
160964523|NCT00553501|581257168|FG000|Overall Study|Adverse Event|2|||
160964524|NCT00553501|581257168|FG000|Overall Study|Death|1|||
160964525|NCT00553501|581257168|FG000|Overall Study|Progression|1|||
160964526|NCT00949715|581257171|FG000|Overall Study|Physician Decision|1|||
160964527|NCT00949715|581257172|FG001|Overall Study|Physician Decision|0|||
160964528|NCT00949715|581257171|FG000|Overall Study|Lost to Follow-up|1|||
160964529|NCT00949715|581257172|FG001|Overall Study|Lost to Follow-up|0|||
160964530|NCT00949715|581257171|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
161002451|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161002452|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
161271100|NCT00390221|582372877|FG000|Overall Study|Investigator Decision|0|||
160964531|NCT00949715|581257172|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
160964532|NCT00840801|581257176|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
160964533|NCT00840801|581257177|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
161271101|NCT00390221|582372878|FG001|Overall Study|Investigator Decision|0|||
160964534|NCT00840801|581257178|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
160964535|NCT00840801|581257176|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
160964536|NCT00840801|581257177|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
160964537|NCT00840801|581257178|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
160964538|NCT00840801|581257176|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
160964539|NCT00840801|581257177|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
160964540|NCT00840801|581257178|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
161002453|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
161002454|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
161002455|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
161002456|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002457|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002458|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002459|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002460|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002461|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002462|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002463|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002464|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002465|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
161002466|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
161002467|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
161002468|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
161002469|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002470|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002471|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002472|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002473|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002474|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002475|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002476|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002477|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
161002478|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
161002479|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
161002480|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
161002481|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
161002482|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002483|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002484|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002485|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002486|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002487|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002488|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002489|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002490|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002491|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002492|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
161002493|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
161002494|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
161002495|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002496|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002497|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
160964541|NCT00840801|581257176|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
160964542|NCT00840801|581257177|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
160964543|NCT00840801|581257178|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
160964544|NCT00335452|581257179|FG000|Overall Study|Death|156|||
160964545|NCT00335452|581257180|FG001|Overall Study|Death|144|||
160964546|NCT00335452|581257181|FG002|Overall Study|Death|158|||
160964547|NCT00335452|581257182|FG003|Overall Study|Death|129|||
160964548|NCT00335452|581257179|FG000|Overall Study|Lost to Follow-up|2|||
160964549|NCT00335452|581257180|FG001|Overall Study|Lost to Follow-up|3|||
160964550|NCT00335452|581257181|FG002|Overall Study|Lost to Follow-up|1|||
160964551|NCT00335452|581257182|FG003|Overall Study|Lost to Follow-up|2|||
160964552|NCT02421666|581257185|FG000|6-month Follow-up|Lost to Follow-up|8|||
160964553|NCT02421666|581257186|FG001|6-month Follow-up|Lost to Follow-up|7|||
160964554|NCT02421666|581257185|FG000|6-month Follow-up|Withdrawal by Subject|5|||
160964555|NCT02421666|581257186|FG001|6-month Follow-up|Withdrawal by Subject|6|||
160964556|NCT02421666|581257185|FG000|12-month Follow-up|Lost to Follow-up|5|||
160964557|NCT02421666|581257186|FG001|12-month Follow-up|Lost to Follow-up|5|||
160964558|NCT02421666|581257185|FG000|12-month Follow-up|Withdrawal by Subject|6|||
160964559|NCT02421666|581257186|FG001|12-month Follow-up|Withdrawal by Subject|11|||
160964560|NCT01078155|581257188|FG000|Overall Study|Adverse Event|7|||
160964561|NCT01078155|581257188|FG000|Overall Study|Lack of Efficacy|16|||
160964562|NCT01078155|581257188|FG000|Overall Study|Participant's Decision|6|||
160964563|NCT01078155|581257188|FG000|Overall Study|Lost to Follow-up|15|||
161002498|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002499|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002500|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
160964564|NCT01621880|581257189|FG000|Overall Study|Adverse Event|5|||
160964565|NCT01621880|581257190|FG001|Overall Study|Adverse Event|1|||
160964566|NCT01621880|581257189|FG000|Overall Study|Withdrawal by Subject|5|||
160964567|NCT01621880|581257190|FG001|Overall Study|Withdrawal by Subject|4|||
160964568|NCT04044456|581257200|FG000|Overall Study|Lost to Follow-up|4|||
160964569|NCT04044456|581257201|FG001|Overall Study|Lost to Follow-up|1|||
160964570|NCT04044456|581257200|FG000|Overall Study|Withdrawal by Subject|1|||
160964571|NCT04044456|581257201|FG001|Overall Study|Withdrawal by Subject|0|||
160964572|NCT04209725|581257211|FG000|Overall Study|Adverse Event|1|||
160964573|NCT01281644|581257214|FG000|Overall Study|Lost to Follow-up|3|||
160964574|NCT01281644|581257214|FG000|Overall Study|Withdrawal by Subject|2|||
160964575|NCT03721965|581257222|FG000|Overall Study|Death|1|||
160964576|NCT03721965|581257222|FG000|Overall Study|Study Terminated by Sponsor|1|||
160964577|NCT05103384|581257223|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
160964578|NCT02612311|581257224|FG000|Overall Study|Adverse Event|16|||
160964579|NCT02612311|581257225|FG001|Overall Study|Adverse Event|12|||
160964580|NCT02612311|581257226|FG002|Overall Study|Adverse Event|7|||
160964581|NCT02612311|581257227|FG003|Overall Study|Adverse Event|13|||
160964582|NCT02612311|581257224|FG000|Overall Study|Death|29|||
160964583|NCT02612311|581257225|FG001|Overall Study|Death|10|||
160964584|NCT02612311|581257226|FG002|Overall Study|Death|11|||
160964585|NCT02612311|581257227|FG003|Overall Study|Death|11|||
160964586|NCT02612311|581257224|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
160964587|NCT02612311|581257225|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
160964588|NCT02612311|581257226|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
160964589|NCT02612311|581257227|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
160964590|NCT02612311|581257224|FG000|Overall Study|Investigator's Decision|11|||
160964591|NCT02612311|581257225|FG001|Overall Study|Investigator's Decision|15|||
160964592|NCT02612311|581257226|FG002|Overall Study|Investigator's Decision|6|||
160964593|NCT02612311|581257227|FG003|Overall Study|Investigator's Decision|6|||
160964594|NCT02612311|581257224|FG000|Overall Study|Lack of Efficacy|0|||
160964595|NCT02612311|581257225|FG001|Overall Study|Lack of Efficacy|0|||
160964596|NCT02612311|581257226|FG002|Overall Study|Lack of Efficacy|1|||
160964597|NCT02612311|581257227|FG003|Overall Study|Lack of Efficacy|1|||
160964598|NCT02612311|581257224|FG000|Overall Study|Lost to Follow-up|2|||
160964599|NCT02612311|581257225|FG001|Overall Study|Lost to Follow-up|2|||
160964600|NCT02612311|581257226|FG002|Overall Study|Lost to Follow-up|1|||
160964601|NCT02612311|581257227|FG003|Overall Study|Lost to Follow-up|2|||
160964602|NCT02612311|581257224|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
160964603|NCT02612311|581257225|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
160964604|NCT02612311|581257226|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
160964605|NCT02612311|581257227|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
160964606|NCT02612311|581257224|FG000|Overall Study|Site Terminated by Sponsor|29|||
160964607|NCT02612311|581257225|FG001|Overall Study|Site Terminated by Sponsor|12|||
160964608|NCT02612311|581257226|FG002|Overall Study|Site Terminated by Sponsor|13|||
160964609|NCT02612311|581257227|FG003|Overall Study|Site Terminated by Sponsor|5|||
160964610|NCT02612311|581257224|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
160964611|NCT02612311|581257225|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
160964612|NCT02612311|581257226|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
160964613|NCT02612311|581257227|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
160964614|NCT02612311|581257224|FG000|Overall Study|Reason Not Specified|3|||
160964615|NCT02612311|581257225|FG001|Overall Study|Reason Not Specified|7|||
160964616|NCT02612311|581257226|FG002|Overall Study|Reason Not Specified|4|||
160964617|NCT02612311|581257227|FG003|Overall Study|Reason Not Specified|5|||
160964618|NCT02612311|581257224|FG000|Overall Study|Unknown/Missing|10|||
160964619|NCT02612311|581257225|FG001|Overall Study|Unknown/Missing|13|||
160964620|NCT02612311|581257226|FG002|Overall Study|Unknown/Missing|4|||
160964621|NCT02612311|581257227|FG003|Overall Study|Unknown/Missing|0|||
160964622|NCT02612311|581257224|FG000|Overall Study|Non-Compliance with Study|1|||
160964623|NCT02612311|581257225|FG001|Overall Study|Non-Compliance with Study|0|||
160964624|NCT02612311|581257226|FG002|Overall Study|Non-Compliance with Study|0|||
160964625|NCT02612311|581257227|FG003|Overall Study|Non-Compliance with Study|0|||
160964626|NCT05608499|581257231|FG000|Overall Study|Lack of Efficacy|1|||
160964627|NCT05608499|581257232|FG001|Overall Study|Lack of Efficacy|0|||
160964628|NCT05608499|581257231|FG000|Overall Study|Lost to Follow-up|0|||
160964629|NCT05608499|581257232|FG001|Overall Study|Lost to Follow-up|1|||
160964630|NCT00514735|581257233|FG000|Overall Study|Withdrawal by Subject|13|||
161147035|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
161271102|NCT00390221|582372879|FG002|Overall Study|Investigator Decision|1|||
161271103|NCT00390221|582372877|FG000|Overall Study|Withdrawal by Subject|13|||
160964631|NCT00514735|581257234|FG001|Overall Study|Withdrawal by Subject|5|||
160964632|NCT00514735|581257233|FG000|Overall Study|Death|1|||
160964633|NCT00514735|581257234|FG001|Overall Study|Death|0|||
160964634|NCT00514735|581257233|FG000|Overall Study|Lost to Follow-up|0|||
160964635|NCT00514735|581257234|FG001|Overall Study|Lost to Follow-up|1|||
160964636|NCT04751942|581257238|FG000|Overall Study|Lost to Follow-up|9|||
160964637|NCT04751942|581257239|FG001|Overall Study|Lost to Follow-up|6|||
161002501|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002502|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002503|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002504|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
161147036|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161147037|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
161147038|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161147039|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
161147040|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161147041|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
161147042|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161147043|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
161147044|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161147045|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
161147046|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161147047|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
161147048|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161147049|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
161147050|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161147051|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
161147052|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161147053|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
161147054|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161147055|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
161147056|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161147057|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
161147058|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161147059|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
161147060|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161271104|NCT00390221|582372878|FG001|Overall Study|Withdrawal by Subject|9|||
161271105|NCT00390221|582372879|FG002|Overall Study|Withdrawal by Subject|7|||
161271106|NCT00390221|582372877|FG000|Overall Study|Subject Non-compliance|1|||
161271107|NCT00390221|582372878|FG001|Overall Study|Subject Non-compliance|0|||
161271108|NCT00390221|582372879|FG002|Overall Study|Subject Non-compliance|2|||
161271109|NCT00390221|582372877|FG000|Overall Study|Other|3|||
161271110|NCT00390221|582372878|FG001|Overall Study|Other|4|||
160964638|NCT00045305|581257244|FG000|Overall Study|Lack of Efficacy|6|||
160964639|NCT00045305|581257244|FG000|Overall Study|Adverse Event|3|||
160964640|NCT00045305|581257244|FG000|Overall Study|Death|3|||
160964641|NCT00045305|581257244|FG000|Overall Study|site error|2|||
160964642|NCT03848403|581257245|FG000|Period 2 (Day 8)|Adverse Event|1|||
160964643|NCT03848403|581257246|FG001|Period 2 (Day 8)|Adverse Event|2|||
160964644|NCT03848403|581257247|FG002|Period 2 (Day 8)|Adverse Event|2|||
160964645|NCT03848403|581257245|FG000|Period 2 (Day 8)|Physician Decision|0|||
160964646|NCT03848403|581257246|FG001|Period 2 (Day 8)|Physician Decision|1|||
160964647|NCT03848403|581257247|FG002|Period 2 (Day 8)|Physician Decision|0|||
160964648|NCT03848403|581257245|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
160964649|NCT03848403|581257246|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
160964650|NCT03848403|581257247|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
160964651|NCT00168038|581257248|FG000|Overall Study|Adverse Event|1|||
160964652|NCT00168038|581257248|FG000|Overall Study|Therapy failure|1|||
160964653|NCT03221387|581257274|FG000|Overall Study|Lost to Follow-up|1|||
160964654|NCT03221387|581257274|FG000|Overall Study|Lung transplant|1|||
160964655|NCT00522626|581257275|FG000|Overall Study|Lost to Follow-up|7|||
160964656|NCT00803452|581257276|FG000|Overall Study|Adverse Event|0|||
160964657|NCT00803452|581257277|FG001|Overall Study|Adverse Event|2|||
160964658|NCT00803452|581257276|FG000|Overall Study|Lost to Follow-up|0|||
160964659|NCT00803452|581257277|FG001|Overall Study|Lost to Follow-up|3|||
160964660|NCT02365519|581257279|FG000|Randomized and Treated|Adverse Event|0|||
160964661|NCT02365519|581257280|FG001|Randomized and Treated|Adverse Event|1|||
160964662|NCT02365519|581257281|FG002|Randomized and Treated|Adverse Event|0|||
160964663|NCT02365519|581257279|FG000|Randomized and Treated|Withdrawal by Subject|0|||
160964664|NCT02365519|581257280|FG001|Randomized and Treated|Withdrawal by Subject|1|||
160964665|NCT02365519|581257281|FG002|Randomized and Treated|Withdrawal by Subject|1|||
160964666|NCT01971723|581257282|FG000|Overall Study|Withdrawal by Subject|1|||
160964667|NCT01971723|581257283|FG001|Overall Study|Withdrawal by Subject|1|||
160964668|NCT01971723|581257282|FG000|Overall Study|Protocol Violation|1|||
160964669|NCT01971723|581257283|FG001|Overall Study|Protocol Violation|2|||
161271111|NCT00390221|582372879|FG002|Overall Study|Other|2|||
161271112|NCT01709838|582372896|FG000|Overall Study|Withdrawal by Subject|21|||
161271113|NCT01709838|582372896|FG000|Overall Study|Lost to Follow-up|16|||
160964670|NCT03017079|581257287|FG000|Overall Study|Physician Decision|1|||
161271114|NCT01709838|582372896|FG000|Overall Study|Pregnancy|10|||
161271115|NCT01709838|582372896|FG000|Overall Study|Subject/guardian decision|8|||
161271116|NCT01709838|582372896|FG000|Overall Study|Adverse Event|4|||
161271117|NCT01709838|582372896|FG000|Overall Study|Physician Decision|4|||
161271118|NCT01709838|582372896|FG000|Overall Study|Death|3|||
161271119|NCT01709838|582372896|FG000|Overall Study|Protocol Violation|1|||
160964671|NCT03017079|581257288|FG001|Overall Study|Physician Decision|1|||
160964672|NCT03017079|581257287|FG000|Overall Study|Death|3|||
160964673|NCT03017079|581257288|FG001|Overall Study|Death|2|||
160964674|NCT03017079|581257287|FG000|Overall Study|Lack of Efficacy|2|||
160964675|NCT03017079|581257288|FG001|Overall Study|Lack of Efficacy|2|||
160964676|NCT03017079|581257287|FG000|Overall Study|Protocol Violation|0|||
160964677|NCT03017079|581257288|FG001|Overall Study|Protocol Violation|1|||
160964678|NCT04120233|581257294|FG000|Overall Study|Adverse Event|0|||
160964679|NCT04120233|581257295|FG001|Overall Study|Adverse Event|0|||
160964680|NCT04120233|581257296|FG002|Overall Study|Adverse Event|0|||
160964681|NCT04120233|581257297|FG003|Overall Study|Adverse Event|0|||
160964682|NCT04120233|581257298|FG004|Overall Study|Adverse Event|1|||
160964683|NCT04120233|581257299|FG005|Overall Study|Adverse Event|0|||
160964684|NCT06223373|581257300|FG000|Overall Study|Lost to Follow-up|1|||
160964685|NCT06223373|581257301|FG001|Overall Study|Lost to Follow-up|2|||
160964686|NCT03355326|581257309|FG000|Overall Study|Protocol Violation|3|||
160964687|NCT03355326|581257310|FG001|Overall Study|Protocol Violation|3|||
160964688|NCT00608582|581257315|FG000|Overall Study|Lost to Follow-up|2|||
160964689|NCT00608582|581257316|FG001|Overall Study|Lost to Follow-up|0|||
160964690|NCT00608582|581257315|FG000|Overall Study|No Best Response in Phase 1 located|1|||
160964691|NCT00608582|581257316|FG001|Overall Study|No Best Response in Phase 1 located|1|||
160964692|NCT00608582|581257315|FG000|Overall Study|Illicit Drug Use|1|||
160964693|NCT00608582|581257316|FG001|Overall Study|Illicit Drug Use|0|||
160964694|NCT00608582|581257315|FG000|Overall Study|Early stage Design Change|0|||
160964695|NCT00608582|581257316|FG001|Overall Study|Early stage Design Change|3|||
160964696|NCT04922554|581257317|FG000|Overall Study|Adverse Event|4|||
160964697|NCT04922554|581257318|FG001|Overall Study|Adverse Event|0|||
160964698|NCT04922554|581257317|FG000|Overall Study|Withdrawal by Subject|1|||
160964699|NCT04922554|581257318|FG001|Overall Study|Withdrawal by Subject|0|||
160964700|NCT00861614|581259339|FG000|Overall Study|Disease Progression|182|||
160964701|NCT00861614|581259340|FG001|Overall Study|Disease Progression|263|||
160964702|NCT00861614|581259339|FG000|Overall Study|Study Drug Toxicity|79|||
160964703|NCT00861614|581259340|FG001|Overall Study|Study Drug Toxicity|6|||
160964704|NCT00861614|581259339|FG000|Overall Study|Death|32|||
160964705|NCT00861614|581259340|FG001|Overall Study|Death|19|||
160964706|NCT00861614|581259339|FG000|Overall Study|Adverse Event|27|||
160964707|NCT00861614|581259340|FG001|Overall Study|Adverse Event|23|||
160964708|NCT00861614|581259339|FG000|Overall Study|Withdrawal by Subject|34|||
160964709|NCT00861614|581259340|FG001|Overall Study|Withdrawal by Subject|35|||
160964710|NCT00861614|581259339|FG000|Overall Study|Other|17|||
160964711|NCT00861614|581259340|FG001|Overall Study|Other|22|||
160964712|NCT00944658|581259341|FG000|Treatment 12 Weeks|Adverse Event|0|||
160964713|NCT00944658|581259342|FG001|Treatment 12 Weeks|Adverse Event|2|||
160964714|NCT01255592|581259343|FG000|Overall Study|Adverse Event|5|||
160964715|NCT01255592|581259344|FG001|Overall Study|Adverse Event|0|||
160964716|NCT01255592|581259343|FG000|Overall Study|Withdrawal by Subject|1|||
160964717|NCT01255592|581259344|FG001|Overall Study|Withdrawal by Subject|0|||
160964718|NCT01255592|581259343|FG000|Overall Study|Other|0|||
160964719|NCT01255592|581259344|FG001|Overall Study|Other|1|||
160964720|NCT02259517|581259345|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
160964721|NCT02259517|581259346|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
160964722|NCT02259517|581259347|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
160964723|NCT02259517|581259345|FG000|Overall Study|Withdrawal by Subject|0|||
160964724|NCT02259517|581259346|FG001|Overall Study|Withdrawal by Subject|0|||
160964725|NCT02259517|581259347|FG002|Overall Study|Withdrawal by Subject|3|||
160964726|NCT01289418|581259351|FG000|Day 8 Survey|email address invalid|283|||
160964727|NCT01289418|581259351|FG000|Day 8 Survey|participants did not complete the survey|1935|||
160964728|NCT01289418|581259351|FG000|Day 29 Survey|email address invalid|283|||
160964729|NCT01289418|581259351|FG000|Day 29 Survey|participants did not complete the survey|2185|||
160964730|NCT01352585|581259352|FG000|Overall Study|Adverse Event|2|||
160964731|NCT01352585|581259353|FG001|Overall Study|Adverse Event|1|||
160964732|NCT01352585|581259352|FG000|Overall Study|Lost to Follow-up|1|||
161002505|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
160964733|NCT01352585|581259353|FG001|Overall Study|Lost to Follow-up|0|||
160964734|NCT01352585|581259352|FG000|Overall Study|Other|5|||
160964735|NCT01352585|581259353|FG001|Overall Study|Other|2|||
160964736|NCT00838682|581259356|FG000|Overall Study|Lost to Follow-up|21|||
160964737|NCT00838682|581259357|FG001|Overall Study|Lost to Follow-up|14|||
160964738|NCT00838682|581259356|FG000|Overall Study|detection of exclusion criteria|4|||
160964739|NCT00838682|581259357|FG001|Overall Study|detection of exclusion criteria|3|||
161002506|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161271120|NCT02352779|582372897|FG000|Overall Study|Personal Issues|1|||
161271121|NCT02352779|582372898|FG001|Overall Study|Personal Issues|1|||
161147061|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
161147062|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161147063|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
161147064|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
161271122|NCT02352779|582372899|FG002|Overall Study|Personal Issues|0|||
160964740|NCT00838682|581259356|FG000|Overall Study|Protocol Violation|0|||
160964741|NCT00838682|581259357|FG001|Overall Study|Protocol Violation|1|||
160964742|NCT00838682|581259356|FG000|Overall Study|Withdrawal by Subject|0|||
160964743|NCT00838682|581259357|FG001|Overall Study|Withdrawal by Subject|1|||
160964744|NCT05050578|581259358|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
160964745|NCT05050578|581259359|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
160964746|NCT05050578|581259358|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
160964747|NCT05050578|581259359|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
160964748|NCT05050578|581259358|FG000|Period 2, 30 Days|Protocol Violation|0|||
160964749|NCT05050578|581259359|FG001|Period 2, 30 Days|Protocol Violation|1|||
160964750|NCT02243280|581259360|FG000|Treated|Adverse Event|1|||
160964751|NCT02243280|581259361|FG001|Treated|Adverse Event|0|||
160964752|NCT02243280|581259362|FG002|Treated|Adverse Event|0|||
160964753|NCT02243280|581259363|FG003|Treated|Adverse Event|0|||
160964754|NCT02243280|581259364|FG004|Treated|Adverse Event|0|||
160964755|NCT02243280|581259365|FG005|Treated|Adverse Event|0|||
160964756|NCT02243280|581259366|FG006|Treated|Adverse Event|0|||
160964757|NCT02243280|581259367|FG007|Treated|Adverse Event|0|||
160964758|NCT02243280|581259368|FG008|Treated|Adverse Event|0|||
160964759|NCT02243280|581259369|FG009|Treated|Adverse Event|0|||
160964760|NCT02243280|581259370|FG010|Treated|Adverse Event|1|||
160964761|NCT02243280|581259360|FG000|Treated|Lost to Follow-up|0|||
160964762|NCT02243280|581259361|FG001|Treated|Lost to Follow-up|0|||
160964763|NCT02243280|581259362|FG002|Treated|Lost to Follow-up|0|||
160964764|NCT02243280|581259363|FG003|Treated|Lost to Follow-up|0|||
160964765|NCT02243280|581259364|FG004|Treated|Lost to Follow-up|0|||
160964766|NCT02243280|581259365|FG005|Treated|Lost to Follow-up|0|||
160964767|NCT02243280|581259366|FG006|Treated|Lost to Follow-up|0|||
160964768|NCT02243280|581259367|FG007|Treated|Lost to Follow-up|0|||
160964769|NCT02243280|581259368|FG008|Treated|Lost to Follow-up|1|||
160964770|NCT02243280|581259369|FG009|Treated|Lost to Follow-up|0|||
160964771|NCT02243280|581259370|FG010|Treated|Lost to Follow-up|2|||
160964772|NCT03386032|581259379|FG000|Overall Study|Lack of Efficacy|6|||
160964773|NCT03386032|581259380|FG001|Overall Study|Lack of Efficacy|2|||
160964774|NCT03386032|581259381|FG002|Overall Study|Lack of Efficacy|0|||
160964775|NCT03386032|581259379|FG000|Overall Study|Adverse Event|2|||
160964776|NCT03386032|581259380|FG001|Overall Study|Adverse Event|2|||
160964777|NCT03386032|581259381|FG002|Overall Study|Adverse Event|0|||
160964778|NCT03386032|581259379|FG000|Overall Study|Withdrawal by Subject|1|||
160964779|NCT03386032|581259380|FG001|Overall Study|Withdrawal by Subject|0|||
160964780|NCT03386032|581259381|FG002|Overall Study|Withdrawal by Subject|0|||
160964781|NCT03386032|581259379|FG000|Overall Study|Lost to Follow-up|9|||
160964782|NCT03386032|581259380|FG001|Overall Study|Lost to Follow-up|3|||
160964783|NCT03386032|581259381|FG002|Overall Study|Lost to Follow-up|0|||
160964784|NCT01807156|581259386|FG000|Overall Study|Physician Decision|1|||
160964785|NCT03928028|581259391|FG000|Overall Study|Physician Decision|9|||
160964786|NCT03928028|581259392|FG001|Overall Study|Physician Decision|6|||
160964787|NCT03928028|581259393|FG002|Overall Study|Physician Decision|3|||
160964788|NCT03928028|581259391|FG000|Overall Study|Withdrawal by Subject|12|||
160964789|NCT03928028|581259392|FG001|Overall Study|Withdrawal by Subject|3|||
160964790|NCT03928028|581259393|FG002|Overall Study|Withdrawal by Subject|3|||
160964791|NCT02710292|581259399|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
160964792|NCT02710292|581259400|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
160964793|NCT02710292|581259399|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
160964794|NCT02710292|581259400|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
160964795|NCT04525547|581259401|FG000|Overall Study|Not treated with Ofev|2|||
160964796|NCT04525547|581259401|FG000|Overall Study|Off-label use|2|||
160964797|NCT04525547|581259401|FG000|Overall Study|Lost to Follow-up|1|||
161147065|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
160964798|NCT03122119|581259402|FG000|Overall Study|Did not meet eligibility critria|1|||
160964799|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
160964800|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
160964801|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
160964802|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
160964803|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
160964804|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
160964805|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
160964806|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
160964807|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
161271123|NCT02352779|582372897|FG000|Overall Study|Too Many Forms|2|||
160964808|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
160964809|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
160964810|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
160964811|NCT01493687|581259415|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
160964812|NCT01493687|581259416|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
160964813|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
160964814|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
160964815|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
160964816|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
160964817|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
160964818|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
160964819|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
160964820|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
160964821|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
160964822|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
160964823|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
160964824|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
160964825|NCT01493687|581259415|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
160964826|NCT01493687|581259416|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
160964827|NCT01493687|581259415|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
160964828|NCT01493687|581259416|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
160964829|NCT02364180|581259419|FG000|Overall Study|Screen Fail|1|||
160964830|NCT02323646|581259420|FG000|Treatment Course 1|Adverse Event|1|||
160964831|NCT02323646|581259421|FG001|Treatment Course 1|Adverse Event|0|||
160964832|NCT02323646|581259422|FG002|Treatment Course 1|Adverse Event|1|||
160964833|NCT02323646|581259420|FG000|Treatment Course 1|Heavy Bleeding|1|||
160964834|NCT02323646|581259421|FG001|Treatment Course 1|Heavy Bleeding|1|||
160964835|NCT02323646|581259422|FG002|Treatment Course 1|Heavy Bleeding|0|||
160964836|NCT02323646|581259420|FG000|Treatment Course 1|Lost to Follow-up|1|||
160964837|NCT02323646|581259421|FG001|Treatment Course 1|Lost to Follow-up|0|||
160964838|NCT02323646|581259422|FG002|Treatment Course 1|Lost to Follow-up|2|||
160964839|NCT02323646|581259420|FG000|Treatment Course 1|Withdrawal by Subject|0|||
160964840|NCT02323646|581259421|FG001|Treatment Course 1|Withdrawal by Subject|2|||
160964841|NCT02323646|581259422|FG002|Treatment Course 1|Withdrawal by Subject|0|||
160964842|NCT02323646|581259420|FG000|Treatment Course 2|Adverse Event|1|||
160964843|NCT02323646|581259421|FG001|Treatment Course 2|Adverse Event|0|||
160964844|NCT02323646|581259422|FG002|Treatment Course 2|Adverse Event|1|||
160964845|NCT02323646|581259420|FG000|Treatment Course 2|Lost to Follow-up|0|||
160964846|NCT02323646|581259421|FG001|Treatment Course 2|Lost to Follow-up|0|||
160964847|NCT02323646|581259422|FG002|Treatment Course 2|Lost to Follow-up|1|||
161147066|NCT00958568|581922399|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161147067|NCT00958568|581922400|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
161147068|NCT00958568|581922401|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161147069|NCT00958568|581922402|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
161147070|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
161147071|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
161147072|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
161147073|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
161147074|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
161147075|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
161147076|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
161147077|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
161147078|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
161147079|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
161147080|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
161147081|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
161147082|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
161147083|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
161147084|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
161147085|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
161147086|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
161147087|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
161147088|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
161147089|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
161147090|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
161147091|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
161147092|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
161147093|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
161147094|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
160964848|NCT02323646|581259420|FG000|Treatment Course 2|Non-compliance|0|||
160964849|NCT02323646|581259421|FG001|Treatment Course 2|Non-compliance|1|||
160964850|NCT02323646|581259422|FG002|Treatment Course 2|Non-compliance|1|||
160964851|NCT01783418|581259423|FG000|Overall Study|Withdrawal by Subject|1|||
160964852|NCT01783418|581259424|FG001|Overall Study|Withdrawal by Subject|0|||
160964853|NCT00521144|581259425|FG000|Overall Study|Not Treated|0|||
160964854|NCT00521144|581259426|FG001|Overall Study|Not Treated|0|||
160964855|NCT00521144|581259427|FG002|Overall Study|Not Treated|0|||
160964856|NCT00521144|581259428|FG003|Overall Study|Not Treated|1|||
160964857|NCT00521144|581259429|FG004|Overall Study|Not Treated|0|||
160964858|NCT00521144|581259425|FG000|Overall Study|Adverse Event|0|||
160964859|NCT00521144|581259426|FG001|Overall Study|Adverse Event|1|||
160964860|NCT00521144|581259427|FG002|Overall Study|Adverse Event|0|||
160964861|NCT00521144|581259428|FG003|Overall Study|Adverse Event|0|||
160964862|NCT00521144|581259429|FG004|Overall Study|Adverse Event|1|||
160964863|NCT00521144|581259425|FG000|Overall Study|Progressive Disease|4|||
160964864|NCT00521144|581259426|FG001|Overall Study|Progressive Disease|2|||
160964865|NCT00521144|581259427|FG002|Overall Study|Progressive Disease|2|||
160964866|NCT00521144|581259428|FG003|Overall Study|Progressive Disease|0|||
160964867|NCT00521144|581259429|FG004|Overall Study|Progressive Disease|6|||
160964868|NCT00089141|581259431|FG000|Overall Study|Termination of trial|18|||
160964869|NCT00089141|581259432|FG001|Overall Study|Termination of trial|24|||
160964870|NCT00508261|581259435|FG000|Overall Study|Other|0|||
160964871|NCT00508261|581259436|FG001|Overall Study|Other|1|||
160964872|NCT00508261|581259437|FG002|Overall Study|Other|1|||
160964873|NCT00508261|581259438|FG003|Overall Study|Other|0|||
160964874|NCT00508261|581259435|FG000|Overall Study|Serious Adverse Event|0|||
160964875|NCT00508261|581259436|FG001|Overall Study|Serious Adverse Event|1|||
160964876|NCT00508261|581259437|FG002|Overall Study|Serious Adverse Event|0|||
160964877|NCT00508261|581259438|FG003|Overall Study|Serious Adverse Event|0|||
160964878|NCT00508261|581259435|FG000|Overall Study|Withdrawal by Subject|3|||
160964879|NCT00508261|581259436|FG001|Overall Study|Withdrawal by Subject|4|||
160964880|NCT00508261|581259437|FG002|Overall Study|Withdrawal by Subject|4|||
160964881|NCT00508261|581259438|FG003|Overall Study|Withdrawal by Subject|0|||
160964882|NCT00508261|581259435|FG000|Overall Study|Migrated/ moved from study area|0|||
160964883|NCT00508261|581259436|FG001|Overall Study|Migrated/ moved from study area|1|||
160964884|NCT00508261|581259437|FG002|Overall Study|Migrated/ moved from study area|0|||
160964885|NCT00508261|581259438|FG003|Overall Study|Migrated/ moved from study area|0|||
160964886|NCT00508261|581259435|FG000|Overall Study|Lost to Follow-up|0|||
160964887|NCT00508261|581259436|FG001|Overall Study|Lost to Follow-up|1|||
160964888|NCT00508261|581259437|FG002|Overall Study|Lost to Follow-up|1|||
160964889|NCT00508261|581259438|FG003|Overall Study|Lost to Follow-up|1|||
160964890|NCT00180479|581259439|FG000|Overall Study|Death|4|||
160964891|NCT00180479|581259440|FG001|Overall Study|Death|2|||
160964892|NCT00180479|581259439|FG000|Overall Study|Lost to Follow-up|9|||
160964893|NCT00180479|581259440|FG001|Overall Study|Lost to Follow-up|7|||
160964894|NCT00180479|581259439|FG000|Overall Study|Withdrawal by Subject|3|||
160964895|NCT00180479|581259440|FG001|Overall Study|Withdrawal by Subject|3|||
160964896|NCT00180479|581259439|FG000|Overall Study|Informed consent not signed|0|||
160964897|NCT00180479|581259440|FG001|Overall Study|Informed consent not signed|1|||
160964898|NCT03315143|581259445|FG000|Overall Study|Death|240|||
160964899|NCT03315143|581259446|FG001|Overall Study|Death|246|||
160964900|NCT03315143|581259445|FG000|Overall Study|Withdrawal by Subject|57|||
160964901|NCT03315143|581259446|FG001|Overall Study|Withdrawal by Subject|68|||
160964902|NCT03315143|581259445|FG000|Overall Study|Site Terminated by Sponsor|256|||
160964903|NCT03315143|581259446|FG001|Overall Study|Site Terminated by Sponsor|282|||
160964904|NCT03315143|581259445|FG000|Overall Study|Study Terminated by Sponsor|4723|||
160964905|NCT03315143|581259446|FG001|Overall Study|Study Terminated by Sponsor|4664|||
160964906|NCT03315143|581259445|FG000|Overall Study|Reason not Specified|16|||
160964907|NCT03315143|581259446|FG001|Overall Study|Reason not Specified|32|||
160964908|NCT02459262|581259447|FG000|Overall Study|Withdrawal by Subject|0|||
160964909|NCT02459262|581259448|FG001|Overall Study|Withdrawal by Subject|0|||
161271124|NCT02352779|582372898|FG001|Overall Study|Too Many Forms|0|||
161271125|NCT02352779|582372899|FG002|Overall Study|Too Many Forms|0|||
160964910|NCT02459262|581259449|FG002|Overall Study|Withdrawal by Subject|0|||
160964911|NCT02459262|581259450|FG003|Overall Study|Withdrawal by Subject|0|||
160964912|NCT02459262|581259451|FG004|Overall Study|Withdrawal by Subject|0|||
160964913|NCT02459262|581259452|FG005|Overall Study|Withdrawal by Subject|0|||
160964914|NCT02459262|581259453|FG006|Overall Study|Withdrawal by Subject|0|||
160964915|NCT02459262|581259454|FG007|Overall Study|Withdrawal by Subject|0|||
160964916|NCT02459262|581259455|FG008|Overall Study|Withdrawal by Subject|0|||
160964917|NCT02459262|581259456|FG009|Overall Study|Withdrawal by Subject|1|||
160964918|NCT02459262|581259457|FG010|Overall Study|Withdrawal by Subject|0|||
160964919|NCT05168579|581259458|FG000|Overall Study|Lack of Consent|1|||
160964920|NCT05168579|581259459|FG001|Overall Study|Lack of Consent|0|||
160964921|NCT05168579|581259458|FG000|Overall Study|Conflicts with time|2|||
160964922|NCT05168579|581259459|FG001|Overall Study|Conflicts with time|0|||
160964923|NCT05168579|581259458|FG000|Overall Study|Time slots were full|3|||
161271126|NCT02352779|582372897|FG000|Overall Study|Feeling Overwhelmed|1|||
161002507|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
161002508|NCT04707313|581394579|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002509|NCT04707313|581394580|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002510|NCT04707313|581394581|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002511|NCT04707313|581394582|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002512|NCT04707313|581394583|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002513|NCT04707313|581394584|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002514|NCT04707313|581394585|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002515|NCT04707313|581394586|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002516|NCT04707313|581394587|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
161002517|NCT04707313|581394588|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
161002518|NCT04707313|581394589|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
161002519|NCT04707313|581394590|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
161002520|NCT04707313|581394591|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
161002521|NCT02739035|581394592|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
161002522|NCT02739035|581394593|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
161002523|NCT02739035|581394592|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
161002524|NCT02739035|581394593|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
161002525|NCT02739035|581394592|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
161002526|NCT02739035|581394593|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
161002527|NCT02739035|581394592|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
161002528|NCT02739035|581394593|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
161002529|NCT00940992|581394596|FG000|Overall Study|Adverse Event|2|||
161002530|NCT00940992|581394597|FG001|Overall Study|Adverse Event|0|||
161002531|NCT00940992|581394598|FG002|Overall Study|Adverse Event|1|||
161002532|NCT00940992|581394596|FG000|Overall Study|subject request|2|||
161002533|NCT00940992|581394597|FG001|Overall Study|subject request|1|||
161002534|NCT00940992|581394598|FG002|Overall Study|subject request|0|||
161002535|NCT00940992|581394596|FG000|Overall Study|Lost to Follow-up|0|||
161002536|NCT00940992|581394597|FG001|Overall Study|Lost to Follow-up|1|||
161002537|NCT00940992|581394598|FG002|Overall Study|Lost to Follow-up|1|||
161002538|NCT04446117|581394599|FG000|Overall Study|No Study Treatment Given|4|||
161002539|NCT04446117|581394600|FG001|Overall Study|No Study Treatment Given|3|||
161002540|NCT04446117|581394599|FG000|Overall Study|Radiographic Disease Progression|132|||
161002541|NCT04446117|581394600|FG001|Overall Study|Radiographic Disease Progression|158|||
161002542|NCT04446117|581394599|FG000|Overall Study|Adverse Event|79|||
161002543|NCT04446117|581394600|FG001|Overall Study|Adverse Event|43|||
161002544|NCT04446117|581394599|FG000|Overall Study|Lack of Clinical Benefit|1|||
161002545|NCT04446117|581394600|FG001|Overall Study|Lack of Clinical Benefit|1|||
161002546|NCT04446117|581394599|FG000|Overall Study|Withdrawal by Subject|24|||
161002547|NCT04446117|581394600|FG001|Overall Study|Withdrawal by Subject|22|||
161002548|NCT04446117|581394599|FG000|Overall Study|Lost to Follow-up|0|||
161002549|NCT04446117|581394600|FG001|Overall Study|Lost to Follow-up|3|||
161002550|NCT04446117|581394599|FG000|Overall Study|Miscellaneous|26|||
161002551|NCT04446117|581394600|FG001|Overall Study|Miscellaneous|36|||
161002552|NCT04446117|581394599|FG000|Overall Study|Missing Data/Data not yet Received|1|||
161002553|NCT04446117|581394600|FG001|Overall Study|Missing Data/Data not yet Received|0|||
161002554|NCT00843882|581394604|FG000|Step 1|Lack of Efficacy|14|||
161002555|NCT00843882|581394605|FG001|Step 1|Lack of Efficacy|10|||
161002556|NCT00843882|581394606|FG002|Step 1|Lack of Efficacy|21|||
161002557|NCT00843882|581394604|FG000|Step 1|Adverse Event|8|||
161002558|NCT00843882|581394605|FG001|Step 1|Adverse Event|17|||
161002559|NCT00843882|581394606|FG002|Step 1|Adverse Event|20|||
161002560|NCT00843882|581394604|FG000|Step 1|Death|1|||
161002561|NCT00843882|581394605|FG001|Step 1|Death|2|||
161002562|NCT00843882|581394606|FG002|Step 1|Death|4|||
161002563|NCT00843882|581394604|FG000|Step 1|Withdrawal by Subject|6|||
161002564|NCT00843882|581394605|FG001|Step 1|Withdrawal by Subject|12|||
161002565|NCT00843882|581394606|FG002|Step 1|Withdrawal by Subject|9|||
161002566|NCT00843882|581394604|FG000|Step 1|Physician Decision|0|||
161002567|NCT00843882|581394605|FG001|Step 1|Physician Decision|5|||
161002568|NCT00843882|581394606|FG002|Step 1|Physician Decision|1|||
161002569|NCT00843882|581394604|FG000|Step 1|Patient and physician's decision|0|||
161002570|NCT00843882|581394605|FG001|Step 1|Patient and physician's decision|0|||
161002571|NCT00843882|581394606|FG002|Step 1|Patient and physician's decision|1|||
161002572|NCT00843882|581394604|FG000|Step 1|Other complicating disease|1|||
161002573|NCT00843882|581394605|FG001|Step 1|Other complicating disease|3|||
161002574|NCT00843882|581394606|FG002|Step 1|Other complicating disease|4|||
161002575|NCT00843882|581394604|FG000|Step 1|Alternative therapy|0|||
161002576|NCT00843882|581394605|FG001|Step 1|Alternative therapy|1|||
161002577|NCT00843882|581394606|FG002|Step 1|Alternative therapy|1|||
161002578|NCT00843882|581394604|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
161002579|NCT00843882|581394605|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
161002580|NCT00843882|581394606|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
161002581|NCT00843882|581394604|FG000|Step 1|Off treatment reason unknown|0|||
161002582|NCT00843882|581394605|FG001|Step 1|Off treatment reason unknown|1|||
160964924|NCT05168579|581259459|FG001|Overall Study|Time slots were full|0|||
160964925|NCT05168579|581259458|FG000|Overall Study|Lost to Follow-up|0|||
160964926|NCT05168579|581259459|FG001|Overall Study|Lost to Follow-up|15|||
160964927|NCT01242748|581259460|FG000|Overall Study|Adverse Event|10|||
160964928|NCT01242748|581259461|FG001|Overall Study|Adverse Event|5|||
160964929|NCT01242748|581259460|FG000|Overall Study|Lost to Follow-up|6|||
160964930|NCT01242748|581259461|FG001|Overall Study|Lost to Follow-up|2|||
160964931|NCT01242748|581259460|FG000|Overall Study|Physician Decision|3|||
160964932|NCT01242748|581259461|FG001|Overall Study|Physician Decision|2|||
160964933|NCT01242748|581259460|FG000|Overall Study|Protocol Violation|1|||
160964934|NCT01242748|581259461|FG001|Overall Study|Protocol Violation|0|||
160964935|NCT01242748|581259460|FG000|Overall Study|Withdrawal by Subject|10|||
160964936|NCT01242748|581259461|FG001|Overall Study|Withdrawal by Subject|2|||
160964937|NCT01242748|581259460|FG000|Overall Study|Miscellaneous reasons|8|||
160964938|NCT01242748|581259461|FG001|Overall Study|Miscellaneous reasons|3|||
160964939|NCT02736825|581259462|FG000|Overall Study|Lost to Follow-up|10|||
160964940|NCT02736825|581259463|FG001|Overall Study|Lost to Follow-up|11|||
160964941|NCT02736825|581259462|FG000|Overall Study|Early Termination|0|||
160964942|NCT02736825|581259463|FG001|Overall Study|Early Termination|1|||
160964943|NCT00790452|581259464|FG000|Overall Study|Drug supply issue|1|||
160964944|NCT00790452|581259465|FG001|Overall Study|Drug supply issue|0|||
160964945|NCT02901626|581259466|FG000|Overall Study|Lost to Follow-up|1|||
160964946|NCT02901626|581259467|FG001|Overall Study|Lost to Follow-up|1|||
160964947|NCT04082884|581259468|FG000|Overall Study|Withdrawal by Subject|1|||
160964948|NCT00387894|581259469|FG000|Overall Study|Withdrawal by Subject|1|||
160964949|NCT00659490|581259472|FG000|Overall Study|Lost to Follow-up|2|||
160964950|NCT00659490|581259473|FG001|Overall Study|Lost to Follow-up|0|||
160964951|NCT00659490|581259474|FG002|Overall Study|Lost to Follow-up|1|||
160964952|NCT00827541|581259475|FG000|Overall Study|Exitus|1|||
160964953|NCT00827541|581259476|FG001|Overall Study|Exitus|8|||
160964954|NCT00827541|581259475|FG000|Overall Study|Other|1|||
160964955|NCT00827541|581259476|FG001|Overall Study|Other|3|||
160964956|NCT00827541|581259475|FG000|Overall Study|Pathogen not susceptible|1|||
160964957|NCT00827541|581259476|FG001|Overall Study|Pathogen not susceptible|0|||
160964958|NCT00827541|581259475|FG000|Overall Study|Lack of effectiveness|1|||
160964959|NCT00827541|581259476|FG001|Overall Study|Lack of effectiveness|0|||
160964960|NCT01649232|581259477|FG000|Overall Study|Physician Decision|2|||
160964961|NCT01649232|581259478|FG001|Overall Study|Physician Decision|0|||
160964962|NCT01750879|581259479|FG000|Overall Study|Adverse Event|8|||
160964963|NCT01750879|581259480|FG001|Overall Study|Adverse Event|0|||
160964964|NCT01750879|581259479|FG000|Overall Study|Lack of Efficacy|1|||
160964965|NCT01750879|581259480|FG001|Overall Study|Lack of Efficacy|0|||
160964966|NCT01750879|581259479|FG000|Overall Study|Withdrawal by Subject|1|||
160964967|NCT01750879|581259480|FG001|Overall Study|Withdrawal by Subject|0|||
160964968|NCT01750879|581259479|FG000|Overall Study|Did not complete per protocol|0|||
160964969|NCT01750879|581259480|FG001|Overall Study|Did not complete per protocol|3|||
160964970|NCT02347657|581259481|FG000|Overall Study|Physician Decision|0|||
160964971|NCT02347657|581259482|FG001|Overall Study|Physician Decision|1|||
160964972|NCT02347657|581259481|FG000|Overall Study|Adverse Event|8|||
160964973|NCT02347657|581259482|FG001|Overall Study|Adverse Event|4|||
160964974|NCT02347657|581259481|FG000|Overall Study|Withdrawal by Subject|6|||
160964975|NCT02347657|581259482|FG001|Overall Study|Withdrawal by Subject|7|||
160964976|NCT02347657|581259481|FG000|Overall Study|Randomized but not treated|1|||
160964977|NCT02347657|581259482|FG001|Overall Study|Randomized but not treated|0|||
160964978|NCT02347657|581259481|FG000|Overall Study|Other|3|||
160964979|NCT02347657|581259482|FG001|Overall Study|Other|3|||
160964980|NCT03033225|581259489|FG000|Overall Study|Withdrawal by Subject|5|||
160964981|NCT02618967|581259490|FG000|Overall Study|Lost to Follow-up|0|||
160964982|NCT02618967|581259491|FG001|Overall Study|Lost to Follow-up|0|||
160964983|NCT02618967|581259492|FG002|Overall Study|Lost to Follow-up|1|||
161271127|NCT02352779|582372898|FG001|Overall Study|Feeling Overwhelmed|0|||
161271128|NCT02352779|582372899|FG002|Overall Study|Feeling Overwhelmed|0|||
161271129|NCT02352779|582372897|FG000|Overall Study|Disliked Intervention|1|||
160964984|NCT02618967|581259493|FG003|Overall Study|Lost to Follow-up|0|||
160964985|NCT02618967|581259494|FG004|Overall Study|Lost to Follow-up|2|||
160964986|NCT02618967|581259495|FG005|Overall Study|Lost to Follow-up|0|||
160964987|NCT02618967|581259496|FG006|Overall Study|Lost to Follow-up|0|||
160964988|NCT02618967|581259497|FG007|Overall Study|Lost to Follow-up|0|||
160964989|NCT02618967|581259490|FG000|Overall Study|Withdrawal by Subject|1|||
160964990|NCT02618967|581259491|FG001|Overall Study|Withdrawal by Subject|0|||
160964991|NCT02618967|581259492|FG002|Overall Study|Withdrawal by Subject|0|||
160964992|NCT02618967|581259493|FG003|Overall Study|Withdrawal by Subject|0|||
160964993|NCT02618967|581259494|FG004|Overall Study|Withdrawal by Subject|0|||
160964994|NCT02618967|581259495|FG005|Overall Study|Withdrawal by Subject|0|||
160964995|NCT02618967|581259496|FG006|Overall Study|Withdrawal by Subject|0|||
160964996|NCT02618967|581259497|FG007|Overall Study|Withdrawal by Subject|0|||
160964997|NCT05614089|581259498|FG000|Overall Study|Pregnancy|5|||
160964998|NCT05614089|581259499|FG001|Overall Study|Pregnancy|2|||
161271130|NCT02352779|582372898|FG001|Overall Study|Disliked Intervention|0|||
161002583|NCT00843882|581394606|FG002|Step 1|Off treatment reason unknown|4|||
161002584|NCT00843882|581394604|FG000|Step 1|Never started treatment|2|||
161002585|NCT00843882|581394605|FG001|Step 1|Never started treatment|0|||
161002586|NCT00843882|581394606|FG002|Step 1|Never started treatment|0|||
161002587|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
161002588|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
161002589|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
161002590|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
161002591|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
161002592|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
161002593|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
161002594|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
161002595|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
161002596|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
161002597|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
161002598|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
161002599|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
161002600|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
161002601|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
161002602|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
161002603|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
161002604|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
161002605|NCT00843882|581394604|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
161002606|NCT00843882|581394605|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
161002607|NCT00843882|581394606|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
161002608|NCT02248480|581394607|FG000|Overall Study|Lack of Efficacy|4|||
161002609|NCT02248480|581394608|FG001|Overall Study|Lack of Efficacy|6|||
161002610|NCT02248480|581394607|FG000|Overall Study|Adverse Event|11|||
161002611|NCT02248480|581394608|FG001|Overall Study|Adverse Event|2|||
161002612|NCT02248480|581394607|FG000|Overall Study|Withdrawal by Subject|2|||
161002613|NCT02248480|581394608|FG001|Overall Study|Withdrawal by Subject|4|||
161002614|NCT02248480|581394607|FG000|Overall Study|Entry Criteria Not Met|0|||
161002615|NCT02248480|581394608|FG001|Overall Study|Entry Criteria Not Met|1|||
161002616|NCT02248480|581394607|FG000|Overall Study|Other:Physician Decision|0|||
161002617|NCT02248480|581394608|FG001|Overall Study|Other:Physician Decision|1|||
161002618|NCT00630786|581394609|FG000|Overall Study|Physician Decision|0|||
161002619|NCT00630786|581394610|FG001|Overall Study|Physician Decision|0|||
161002620|NCT00630786|581394611|FG002|Overall Study|Physician Decision|1|||
161002621|NCT00630786|581394609|FG000|Overall Study|Withdrawal by Subject|0|||
161002622|NCT00630786|581394610|FG001|Overall Study|Withdrawal by Subject|1|||
161002623|NCT00630786|581394611|FG002|Overall Study|Withdrawal by Subject|1|||
161002624|NCT00630786|581394609|FG000|Overall Study|Lost to Follow-up|0|||
161002625|NCT00630786|581394610|FG001|Overall Study|Lost to Follow-up|1|||
161002626|NCT00630786|581394611|FG002|Overall Study|Lost to Follow-up|0|||
161002627|NCT00630786|581394609|FG000|Overall Study|Other|1|||
161002628|NCT00630786|581394610|FG001|Overall Study|Other|0|||
161002629|NCT00630786|581394611|FG002|Overall Study|Other|0|||
161002630|NCT01582269|581394612|FG000|Overall Study|Withdrawal by Subject|1|||
161002631|NCT01582269|581394613|FG001|Overall Study|Withdrawal by Subject|0|||
161002632|NCT01582269|581394614|FG002|Overall Study|Withdrawal by Subject|0|||
161002633|NCT02770248|581394616|FG000|Overall Study|Adverse Event|0|||
161002634|NCT02770248|581394617|FG001|Overall Study|Adverse Event|1|||
161002635|NCT02770248|581394616|FG000|Overall Study|Randomized in error, prior to treatment|0|||
161002636|NCT02770248|581394617|FG001|Overall Study|Randomized in error, prior to treatment|1|||
161002637|NCT05076266|581394618|FG000|Overall Study|Survey not complete - Participant refusal|2|||
161002638|NCT05076266|581394619|FG001|Overall Study|Survey not complete - Participant refusal|0|||
161002639|NCT02486588|581394624|FG000|Overall Study|Randomized in error- ineligible|738|||
161002640|NCT02486588|581394625|FG001|Overall Study|Randomized in error- ineligible|750|||
161002641|NCT02486588|581394626|FG002|Overall Study|Randomized in error- ineligible|755|||
161002642|NCT02486588|581394627|FG003|Overall Study|Randomized in error- ineligible|738|||
161002643|NCT02486588|581394628|FG004|Overall Study|Randomized in error- ineligible|746|||
161002644|NCT02486588|581394629|FG005|Overall Study|Randomized in error- ineligible|746|||
161002645|NCT00546871|581394630|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
161002646|NCT00546871|581394631|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
161002647|NCT00546871|581394630|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
161002648|NCT00546871|581394631|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
161002649|NCT00546871|581394630|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
161002650|NCT00546871|581394631|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
161002651|NCT00546871|581394630|FG000|Study Extension Period|Protocol Violation|1|||
161002652|NCT00546871|581394631|FG001|Study Extension Period|Protocol Violation|0|||
161002653|NCT00546871|581394630|FG000|Study Extension Period|Withdrawal by Subject|0|||
161002654|NCT00546871|581394631|FG001|Study Extension Period|Withdrawal by Subject|1|||
161002655|NCT05136443|581395420|FG000|Overall Study|Lost to Follow-up|2|||
161271131|NCT02352779|582372899|FG002|Overall Study|Disliked Intervention|0|||
161271132|NCT02352779|582372897|FG000|Overall Study|Changed Mind|1|||
161271133|NCT02352779|582372898|FG001|Overall Study|Changed Mind|0|||
161271134|NCT02352779|582372899|FG002|Overall Study|Changed Mind|0|||
161271135|NCT02352779|582372897|FG000|Overall Study|Study Related Symptoms|1|||
161271136|NCT02352779|582372898|FG001|Overall Study|Study Related Symptoms|0|||
161271137|NCT02352779|582372899|FG002|Overall Study|Study Related Symptoms|0|||
161271138|NCT02352779|582372897|FG000|Overall Study|Absence of Symptoms|1|||
161271139|NCT02352779|582372898|FG001|Overall Study|Absence of Symptoms|0|||
161271140|NCT02352779|582372899|FG002|Overall Study|Absence of Symptoms|0|||
161271141|NCT02352779|582372897|FG000|Overall Study|Other Medical Reason|0|||
161271142|NCT02352779|582372898|FG001|Overall Study|Other Medical Reason|0|||
161271143|NCT02352779|582372899|FG002|Overall Study|Other Medical Reason|1|||
161271144|NCT02352779|582372897|FG000|Overall Study|No Reason|0|||
160964999|NCT05614089|581259498|FG000|Overall Study|Lost to Follow-up|5|||
160965000|NCT05614089|581259499|FG001|Overall Study|Lost to Follow-up|1|||
160965001|NCT05614089|581259498|FG000|Overall Study|Death|0|||
160965002|NCT05614089|581259499|FG001|Overall Study|Death|1|||
160965003|NCT05614089|581259498|FG000|Overall Study|Adverse Event|1|||
160965004|NCT05614089|581259499|FG001|Overall Study|Adverse Event|0|||
160965005|NCT04393441|581259500|FG000|Overall Study|Adverse Event|0|||
160965006|NCT04393441|581259501|FG001|Overall Study|Adverse Event|3|||
160965007|NCT04393441|581259500|FG000|Overall Study|Withdrawal by Subject|5|||
160965008|NCT04393441|581259501|FG001|Overall Study|Withdrawal by Subject|7|||
160965009|NCT04393441|581259500|FG000|Overall Study|Lost to Follow-up|0|||
160965010|NCT04393441|581259501|FG001|Overall Study|Lost to Follow-up|2|||
160965011|NCT04393441|581259500|FG000|Overall Study|Protocol Deviation|2|||
160965012|NCT04393441|581259501|FG001|Overall Study|Protocol Deviation|1|||
160965013|NCT04393441|581259500|FG000|Overall Study|Reason not Specified|1|||
160965014|NCT04393441|581259501|FG001|Overall Study|Reason not Specified|1|||
160965015|NCT02782169|581259502|FG000|Overall Study|Lost to Follow-up|1|||
160965016|NCT02782169|581259503|FG001|Overall Study|Lost to Follow-up|2|||
160965017|NCT00771810|581259504|FG000|Overall Study|Adverse Event|3|||
160965018|NCT00771810|581259505|FG001|Overall Study|Adverse Event|0|||
160965019|NCT00771810|581259506|FG002|Overall Study|Adverse Event|2|||
160965020|NCT00771810|581259504|FG000|Overall Study|Lost to Follow-up|0|||
160965021|NCT00771810|581259505|FG001|Overall Study|Lost to Follow-up|0|||
160965022|NCT00771810|581259506|FG002|Overall Study|Lost to Follow-up|1|||
160965023|NCT00771810|581259504|FG000|Overall Study|Physician Decision|1|||
160965024|NCT00771810|581259505|FG001|Overall Study|Physician Decision|2|||
160965025|NCT00771810|581259506|FG002|Overall Study|Physician Decision|2|||
160965026|NCT00771810|581259504|FG000|Overall Study|Protocol Violation|0|||
160965027|NCT00771810|581259505|FG001|Overall Study|Protocol Violation|1|||
160965028|NCT00771810|581259506|FG002|Overall Study|Protocol Violation|1|||
160965029|NCT00771810|581259504|FG000|Overall Study|Withdrawal by Subject|1|||
160965030|NCT00771810|581259505|FG001|Overall Study|Withdrawal by Subject|2|||
160965031|NCT00771810|581259506|FG002|Overall Study|Withdrawal by Subject|0|||
160965032|NCT00771810|581259504|FG000|Overall Study|Other|0|||
160965033|NCT00771810|581259505|FG001|Overall Study|Other|0|||
160965034|NCT00771810|581259506|FG002|Overall Study|Other|1|||
160965035|NCT02660827|581259511|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
160965036|NCT02660827|581259511|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
160965037|NCT02660827|581259511|FG000|From Study to End of Continued Access|Adverse Event|3|||
160965038|NCT02660827|581259511|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
160965039|NCT02660827|581259511|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
160965040|NCT02660827|581259511|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
160965041|NCT02660827|581259511|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
160965042|NCT02660827|581259511|FG000|Period 2: Continued Access Period|Adverse Event|3|||
160965043|NCT02953938|581259512|FG000|Overall Study|Adverse Event|0|||
160965044|NCT02953938|581259513|FG001|Overall Study|Adverse Event|1|||
160965045|NCT02953938|581259512|FG000|Overall Study|Withdrawal by Subject|1|||
160965046|NCT02953938|581259513|FG001|Overall Study|Withdrawal by Subject|1|||
160965047|NCT02657031|581259517|FG000|Overall Study|Adverse Event|1|||
160965048|NCT02657031|581259518|FG001|Overall Study|Adverse Event|2|||
160965049|NCT04198805|581259519|FG000|Overall Study|Death|0|||
160965050|NCT04198805|581259520|FG001|Overall Study|Death|0|||
160965051|NCT04198805|581259521|FG002|Overall Study|Death|0|||
160965052|NCT04198805|581259522|FG003|Overall Study|Death|1|||
160965053|NCT04198805|581259519|FG000|Overall Study|Early Termination|8|||
160965054|NCT04198805|581259520|FG001|Overall Study|Early Termination|4|||
160965055|NCT04198805|581259521|FG002|Overall Study|Early Termination|6|||
160965056|NCT04198805|581259522|FG003|Overall Study|Early Termination|9|||
160965057|NCT03599349|581259523|FG000|Overall Study|Lost to Follow-up|1|||
160965058|NCT00810264|581259526|FG000|Overall Study|Lost to Follow-up|191|||
160965059|NCT00810264|581259526|FG000|Overall Study|Withdrawal by subject or physician|721|||
160965060|NCT00810264|581259526|FG000|Overall Study|Death|641|||
161002656|NCT05136443|581395420|FG000|Overall Study|Adverse Event|2|||
161002657|NCT01786564|581395425|FG000|Overall Study|Lost to Follow-up|47|||
161002658|NCT01786564|581395425|FG000|Overall Study|Ineligible|17|||
161271145|NCT02352779|582372898|FG001|Overall Study|No Reason|0|||
161271146|NCT02352779|582372899|FG002|Overall Study|No Reason|1|||
161271147|NCT00968799|582372900|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
161271148|NCT00719849|582372903|FG000|Overall Study|Death|0|||
161002659|NCT05299606|581395428|FG000|Overall Study|Death|1|||
161002660|NCT03460756|581395430|FG000|Overall Study|Adverse Event|0|||
161002661|NCT03460756|581395431|FG001|Overall Study|Adverse Event|0|||
161002662|NCT03460756|581395432|FG002|Overall Study|Adverse Event|0|||
161002663|NCT03460756|581395433|FG003|Overall Study|Adverse Event|1|||
161002664|NCT03460756|581395430|FG000|Overall Study|Lack of Efficacy|0|||
161002665|NCT03460756|581395431|FG001|Overall Study|Lack of Efficacy|0|||
161002666|NCT03460756|581395432|FG002|Overall Study|Lack of Efficacy|0|||
161002667|NCT03460756|581395433|FG003|Overall Study|Lack of Efficacy|2|||
161002668|NCT03460756|581395430|FG000|Overall Study|Lost to Follow-up|0|||
161002669|NCT03460756|581395431|FG001|Overall Study|Lost to Follow-up|1|||
161002670|NCT03460756|581395432|FG002|Overall Study|Lost to Follow-up|2|||
161002671|NCT03460756|581395433|FG003|Overall Study|Lost to Follow-up|1|||
161002672|NCT03460756|581395430|FG000|Overall Study|Pregnancy|0|||
161002673|NCT03460756|581395431|FG001|Overall Study|Pregnancy|0|||
161002674|NCT03460756|581395432|FG002|Overall Study|Pregnancy|0|||
161002675|NCT03460756|581395433|FG003|Overall Study|Pregnancy|1|||
161002676|NCT03460756|581395430|FG000|Overall Study|Protocol Violation|0|||
161002677|NCT03460756|581395431|FG001|Overall Study|Protocol Violation|0|||
161002678|NCT03460756|581395432|FG002|Overall Study|Protocol Violation|0|||
161002679|NCT03460756|581395433|FG003|Overall Study|Protocol Violation|1|||
161002680|NCT03460756|581395430|FG000|Overall Study|Withdrawal by Subject|0|||
161002681|NCT03460756|581395431|FG001|Overall Study|Withdrawal by Subject|4|||
161002682|NCT03460756|581395432|FG002|Overall Study|Withdrawal by Subject|7|||
161002683|NCT03460756|581395433|FG003|Overall Study|Withdrawal by Subject|3|||
161002684|NCT00723450|581395435|FG000|Open-Label Phase|Adverse Event|26|||
161002685|NCT00723450|581395436|FG001|Open-Label Phase|Adverse Event|0|||
161002686|NCT00723450|581395437|FG002|Open-Label Phase|Adverse Event|0|||
161002687|NCT00723450|581395435|FG000|Open-Label Phase|Lack of Efficacy|18|||
161002688|NCT00723450|581395436|FG001|Open-Label Phase|Lack of Efficacy|0|||
161002689|NCT00723450|581395437|FG002|Open-Label Phase|Lack of Efficacy|0|||
161002690|NCT00723450|581395435|FG000|Open-Label Phase|Protocol Violation|35|||
161002691|NCT00723450|581395436|FG001|Open-Label Phase|Protocol Violation|0|||
161002692|NCT00723450|581395437|FG002|Open-Label Phase|Protocol Violation|0|||
161002693|NCT00723450|581395435|FG000|Open-Label Phase|Lost to Follow-up|7|||
161002694|NCT00723450|581395436|FG001|Open-Label Phase|Lost to Follow-up|0|||
161002695|NCT00723450|581395437|FG002|Open-Label Phase|Lost to Follow-up|0|||
161002696|NCT00723450|581395435|FG000|Open-Label Phase|Physician Decision|2|||
161002697|NCT00723450|581395436|FG001|Open-Label Phase|Physician Decision|0|||
161002698|NCT00723450|581395437|FG002|Open-Label Phase|Physician Decision|0|||
161002699|NCT00723450|581395435|FG000|Open-Label Phase|Withdrawal by Subject|37|||
161002700|NCT00723450|581395436|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161002701|NCT00723450|581395437|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161002702|NCT00723450|581395435|FG000|Randomized Phase|Adverse Event|0|||
161002703|NCT00723450|581395436|FG001|Randomized Phase|Adverse Event|26|||
161002704|NCT00723450|581395437|FG002|Randomized Phase|Adverse Event|17|||
161002705|NCT00723450|581395435|FG000|Randomized Phase|Lack of Efficacy|0|||
161002706|NCT00723450|581395436|FG001|Randomized Phase|Lack of Efficacy|11|||
161002707|NCT00723450|581395437|FG002|Randomized Phase|Lack of Efficacy|11|||
161271149|NCT00719849|582372904|FG001|Overall Study|Death|1|||
161002708|NCT00723450|581395435|FG000|Randomized Phase|Protocol Violation|0|||
161002709|NCT00723450|581395436|FG001|Randomized Phase|Protocol Violation|9|||
161002710|NCT00723450|581395437|FG002|Randomized Phase|Protocol Violation|13|||
161002711|NCT00723450|581395435|FG000|Randomized Phase|Lost to Follow-up|0|||
161002712|NCT00723450|581395436|FG001|Randomized Phase|Lost to Follow-up|2|||
161002713|NCT00723450|581395437|FG002|Randomized Phase|Lost to Follow-up|3|||
161002714|NCT00723450|581395435|FG000|Randomized Phase|Physician Decision|0|||
161002715|NCT00723450|581395436|FG001|Randomized Phase|Physician Decision|3|||
161002716|NCT00723450|581395437|FG002|Randomized Phase|Physician Decision|1|||
161002717|NCT00723450|581395435|FG000|Randomized Phase|Withdrawal by Subject|0|||
161002718|NCT00723450|581395436|FG001|Randomized Phase|Withdrawal by Subject|14|||
161002719|NCT00723450|581395437|FG002|Randomized Phase|Withdrawal by Subject|22|||
161002720|NCT02537522|581395443|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
161002721|NCT02537522|581395444|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
161271150|NCT00389831|582372908|FG000|Overall Study|Lack of Efficacy|0|||
161002722|NCT02537522|581395445|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
161002723|NCT02537522|581395446|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
161002724|NCT02537522|581395443|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
161002725|NCT02537522|581395444|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
161271151|NCT00389831|582372909|FG001|Overall Study|Lack of Efficacy|2|||
161271152|NCT00389831|582372908|FG000|Overall Study|Did not receive treatment.|0|||
161147095|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
161271153|NCT00389831|582372909|FG001|Overall Study|Did not receive treatment.|2|||
161271154|NCT00389831|582372908|FG000|Overall Study|Other reasons|0|||
161271155|NCT00389831|582372909|FG001|Overall Study|Other reasons|2|||
161271156|NCT00389831|582372908|FG000|Overall Study|Lost to Follow-up|0|||
161271157|NCT00389831|582372909|FG001|Overall Study|Lost to Follow-up|1|||
161271158|NCT00594646|582372914|FG000|Overall Study|Withdrawal by Subject|1|||
161271159|NCT00594646|582372914|FG000|Overall Study|Lost to Follow-up|15|||
161271160|NCT03907462|582372915|FG000|Overall Study|Physician Decision|1|||
161271161|NCT03907462|582372916|FG001|Overall Study|Physician Decision|3|||
161271162|NCT03907462|582372917|FG002|Overall Study|Physician Decision|1|||
161271163|NCT03907462|582372915|FG000|Overall Study|Withdrawal by Subject|6|||
161271164|NCT03907462|582372916|FG001|Overall Study|Withdrawal by Subject|3|||
160965061|NCT00696410|581259527|FG000|Overall Study|Lost to Follow-up|2|||
160965062|NCT00696410|581259528|FG001|Overall Study|Lost to Follow-up|0|||
160965063|NCT00696410|581259527|FG000|Overall Study|Withdrawal by Subject|8|||
160965064|NCT00696410|581259528|FG001|Overall Study|Withdrawal by Subject|0|||
160965065|NCT00696410|581259527|FG000|Overall Study|Physician Decision|3|||
160965066|NCT00696410|581259528|FG001|Overall Study|Physician Decision|0|||
160965067|NCT00453986|581259530|FG000|Overall Study|Lost to Follow-up|6|||
160965068|NCT00453986|581259531|FG001|Overall Study|Lost to Follow-up|5|||
160965069|NCT00453986|581259532|FG002|Overall Study|Lost to Follow-up|6|||
160965070|NCT00453986|581259533|FG003|Overall Study|Lost to Follow-up|2|||
160965071|NCT00453986|581259534|FG004|Overall Study|Lost to Follow-up|0|||
160965072|NCT03419364|581259536|FG000|Overall Study|Delivery due to maternal condition|2|||
160965073|NCT03419364|581259537|FG001|Overall Study|Delivery due to maternal condition|0|||
160965074|NCT03419364|581259538|FG002|Overall Study|Delivery due to maternal condition|0|||
160965075|NCT03559218|581261037|FG000|Overall Study|Withdrawal by Subject|1|||
160965076|NCT03559218|581261038|FG001|Overall Study|Withdrawal by Subject|0|||
160965077|NCT04737109|581261048|FG000|Study Treatment|Disease Progression|5|||
160965078|NCT04737109|581261049|FG001|Study Treatment|Disease Progression|0|||
160965079|NCT04737109|581261050|FG002|Study Treatment|Disease Progression|0|||
160965080|NCT04737109|581261051|FG003|Study Treatment|Disease Progression|0|||
160965081|NCT04737109|581261048|FG000|Study Treatment|Death on study|1|||
160965082|NCT04737109|581261049|FG001|Study Treatment|Death on study|0|||
160965083|NCT04737109|581261050|FG002|Study Treatment|Death on study|0|||
160965084|NCT04737109|581261051|FG003|Study Treatment|Death on study|0|||
160965085|NCT03092375|581261052|FG000|Overall Study|Lack of Efficacy|0|||
160965086|NCT03092375|581261053|FG001|Overall Study|Lack of Efficacy|1|||
160965087|NCT03092375|581261054|FG002|Overall Study|Lack of Efficacy|1|||
160965088|NCT03092375|581261055|FG003|Overall Study|Lack of Efficacy|0|||
160965089|NCT01679301|581261056|FG000|Screening Period|screen failure|3|||
160965090|NCT01679301|581261057|FG001|Screening Period|screen failure|0|||
160965091|NCT01679301|581261058|FG002|Screening Period|screen failure|0|||
160965092|NCT02305381|581261062|FG000|Overall Study|Unclassified|5|||
160965093|NCT02305381|581261063|FG001|Overall Study|Unclassified|5|||
161147096|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
161147097|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
161147098|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
160965094|NCT02305381|581261064|FG002|Overall Study|Unclassified|7|||
160965095|NCT02276066|581261065|FG000|Overall Study|Lost to Follow-up|21|||
160965096|NCT02276066|581261066|FG001|Overall Study|Lost to Follow-up|11|||
160965097|NCT02882282|581261067|FG000|Overall Study|Adverse Event|1|||
160965098|NCT02882282|581261068|FG001|Overall Study|Adverse Event|0|||
160965099|NCT03642938|581261073|FG000|Overall Study|Withdrawal by Subject|0|||
160965100|NCT03642938|581261074|FG001|Overall Study|Withdrawal by Subject|0|||
160965101|NCT03642938|581261075|FG002|Overall Study|Withdrawal by Subject|0|||
160965102|NCT03642938|581261076|FG003|Overall Study|Withdrawal by Subject|1|||
160965103|NCT01424930|581261077|FG000|Overall Study|Adverse Event|0|||
160965104|NCT01424930|581261078|FG001|Overall Study|Adverse Event|1|||
160965105|NCT01424930|581261077|FG000|Overall Study|Death|1|||
160965106|NCT01424930|581261078|FG001|Overall Study|Death|0|||
160965107|NCT01424930|581261077|FG000|Overall Study|Progressive Disease|3|||
160965108|NCT01424930|581261078|FG001|Overall Study|Progressive Disease|6|||
160965109|NCT01424930|581261077|FG000|Overall Study|Screen Failure|0|||
160965110|NCT01424930|581261078|FG001|Overall Study|Screen Failure|1|||
160965111|NCT01424930|581261077|FG000|Overall Study|Reason not specified|0|||
160965112|NCT01424930|581261078|FG001|Overall Study|Reason not specified|6|||
160965113|NCT03286751|581261083|FG000|Washout Period 1|Withdrawal by Subject|0|||
160965114|NCT03286751|581261084|FG001|Washout Period 1|Withdrawal by Subject|0|||
160965115|NCT03286751|581261085|FG002|Washout Period 1|Withdrawal by Subject|0|||
160965116|NCT03286751|581261086|FG003|Washout Period 1|Withdrawal by Subject|0|||
160965117|NCT03286751|581261087|FG004|Washout Period 1|Withdrawal by Subject|1|||
161271165|NCT03907462|582372917|FG002|Overall Study|Withdrawal by Subject|3|||
161271166|NCT03907462|582372915|FG000|Overall Study|Pregnancy|4|||
161271167|NCT03907462|582372916|FG001|Overall Study|Pregnancy|2|||
161271168|NCT03907462|582372917|FG002|Overall Study|Pregnancy|6|||
161271169|NCT03907462|582372915|FG000|Overall Study|Lost to Follow-up|16|||
161002726|NCT02537522|581395445|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
161002727|NCT02537522|581395446|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
161002728|NCT02537522|581395443|FG000|Phase I - Contralateral|incorrect randomization|0|||
161002729|NCT02537522|581395444|FG001|Phase I - Contralateral|incorrect randomization|1|||
161002730|NCT02537522|581395445|FG002|Phase I - Contralateral|incorrect randomization|0|||
161002731|NCT02537522|581395446|FG003|Phase I - Contralateral|incorrect randomization|0|||
161002732|NCT02537522|581395443|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161002733|NCT02537522|581395444|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
161002734|NCT02537522|581395445|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161002735|NCT02537522|581395446|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
161002736|NCT02537522|581395443|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
161002737|NCT02537522|581395444|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
161002738|NCT02537522|581395445|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
161002739|NCT02537522|581395446|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
161002740|NCT03920215|581395448|FG000|Overall Study|Lost to Follow-up|1|||
161002741|NCT03920215|581395449|FG001|Overall Study|Lost to Follow-up|2|||
161002742|NCT03920215|581395450|FG002|Overall Study|Lost to Follow-up|0|||
161002743|NCT03920215|581395451|FG003|Overall Study|Lost to Follow-up|0|||
161002744|NCT03920215|581395448|FG000|Overall Study|Death|0|||
161002745|NCT03920215|581395449|FG001|Overall Study|Death|0|||
161002746|NCT03920215|581395450|FG002|Overall Study|Death|0|||
161002747|NCT03920215|581395451|FG003|Overall Study|Death|1|||
161002748|NCT02425111|581395454|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
161002749|NCT02425111|581395454|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
161002750|NCT02425111|581395454|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
161002751|NCT02425111|581395454|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
161002752|NCT02425111|581395454|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
161002753|NCT02425111|581395454|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
161002754|NCT00585533|581395455|FG000|Overall Study|objective or symptomatic progression|9|||
161002755|NCT02798835|581395456|FG000|Overall Study|Protocol Violation|0|||
161002756|NCT02798835|581395457|FG001|Overall Study|Protocol Violation|0|||
161002757|NCT02798835|581395458|FG002|Overall Study|Protocol Violation|3|||
161002758|NCT03024606|581395463|FG000|Overall Study|Withdrawal by Subject|9|||
161002759|NCT03024606|581395464|FG001|Overall Study|Withdrawal by Subject|10|||
161002760|NCT02547922|581395474|FG000|Overall Study|Withdrawal by Subject|9|||
161002761|NCT02547922|581395475|FG001|Overall Study|Withdrawal by Subject|6|||
161002762|NCT02547922|581395476|FG002|Overall Study|Withdrawal by Subject|10|||
161002763|NCT02547922|581395474|FG000|Overall Study|Adverse Event|3|||
161002764|NCT02547922|581395475|FG001|Overall Study|Adverse Event|1|||
161002765|NCT02547922|581395476|FG002|Overall Study|Adverse Event|2|||
161002766|NCT02547922|581395474|FG000|Overall Study|Lost to Follow-up|1|||
161002767|NCT02547922|581395475|FG001|Overall Study|Lost to Follow-up|0|||
161002768|NCT02547922|581395476|FG002|Overall Study|Lost to Follow-up|0|||
161002769|NCT02547922|581395474|FG000|Overall Study|Lack of Efficacy|5|||
161002770|NCT02547922|581395475|FG001|Overall Study|Lack of Efficacy|7|||
161002771|NCT02547922|581395476|FG002|Overall Study|Lack of Efficacy|4|||
161002772|NCT02547922|581395474|FG000|Overall Study|Death|1|||
161002773|NCT02547922|581395475|FG001|Overall Study|Death|0|||
161002774|NCT02547922|581395476|FG002|Overall Study|Death|0|||
161002775|NCT02547922|581395474|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
161002776|NCT02547922|581395475|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
161002777|NCT02547922|581395476|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
161002778|NCT02547922|581395474|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
161002779|NCT02547922|581395475|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
161002780|NCT02547922|581395476|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
161002781|NCT02547922|581395474|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
161002782|NCT02547922|581395475|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
161002783|NCT02547922|581395476|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
161002784|NCT02547922|581395474|FG000|Overall Study|Physician Decision|2|||
161002785|NCT02547922|581395475|FG001|Overall Study|Physician Decision|1|||
161147099|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161147100|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
161147101|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
161002786|NCT02547922|581395476|FG002|Overall Study|Physician Decision|2|||
161002787|NCT02547922|581395474|FG000|Overall Study|Patients did not receive IP|1|||
161002788|NCT02547922|581395475|FG001|Overall Study|Patients did not receive IP|1|||
161002789|NCT02547922|581395476|FG002|Overall Study|Patients did not receive IP|0|||
161002790|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
161002791|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002792|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002793|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002794|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
161002795|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
161002796|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002797|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002798|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002799|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
161002800|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
161002801|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002802|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002803|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002804|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
161002805|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
161002806|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002807|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002808|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002809|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
161002810|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
161002811|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002812|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002813|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002814|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
161002815|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
161002816|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002817|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002818|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002819|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
161002820|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
161002821|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002822|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002823|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002824|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
161002825|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
161002826|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002827|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002828|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002829|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
161002830|NCT02709655|581395478|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
161002831|NCT02709655|581395479|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161002832|NCT02709655|581395480|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161343491|NCT03965923|582644397|FG007|Overall Study|Death|1|||
160965118|NCT03286751|581261088|FG005|Washout Period 1|Withdrawal by Subject|0|||
160965119|NCT03286751|581261083|FG000|Washout Period 2|Personal Reasons|0|||
160965120|NCT03286751|581261084|FG001|Washout Period 2|Personal Reasons|1|||
160965121|NCT03286751|581261085|FG002|Washout Period 2|Personal Reasons|0|||
160965122|NCT03286751|581261086|FG003|Washout Period 2|Personal Reasons|0|||
160965123|NCT03286751|581261087|FG004|Washout Period 2|Personal Reasons|0|||
160965124|NCT03286751|581261088|FG005|Washout Period 2|Personal Reasons|0|||
160965125|NCT03286751|581261083|FG000|Washout Period 5|Adverse Event|0|||
160965126|NCT03286751|581261084|FG001|Washout Period 5|Adverse Event|0|||
160965127|NCT03286751|581261085|FG002|Washout Period 5|Adverse Event|0|||
160965128|NCT03286751|581261086|FG003|Washout Period 5|Adverse Event|0|||
160965129|NCT03286751|581261087|FG004|Washout Period 5|Adverse Event|1|||
160965130|NCT03286751|581261088|FG005|Washout Period 5|Adverse Event|0|||
160965131|NCT01119768|581261089|FG000|Treatment Period|Lack of Efficacy|18|||
160965132|NCT01119768|581261090|FG001|Treatment Period|Lack of Efficacy|25|||
160965133|NCT01301391|581261091|FG000|Overall Study|Death|13|||
161002833|NCT02709655|581395481|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161002834|NCT02709655|581395482|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
161002835|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
161002836|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
161002837|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
161002838|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
161002839|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
161002840|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161002841|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
161147102|NCT00958568|581922399|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161271170|NCT03907462|582372916|FG001|Overall Study|Lost to Follow-up|18|||
161271171|NCT03907462|582372917|FG002|Overall Study|Lost to Follow-up|22|||
161271172|NCT00633243|582375062|FG000|Overall Study|Withdrawal by Subject|0|||
161271173|NCT00633243|582375063|FG001|Overall Study|Withdrawal by Subject|1|||
160965134|NCT01301391|581261091|FG000|Overall Study|Lost to Follow-up|3|||
160965135|NCT01301391|581261091|FG000|Overall Study|Physician Decision|2|||
160965136|NCT01301391|581261091|FG000|Overall Study|Sponsor's decision|8|||
161002842|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161002843|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
161002844|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
161002845|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
161002846|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
161002847|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
161002848|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
161002849|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
161002850|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002851|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
161002852|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002853|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002854|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
161002855|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
161002856|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161002857|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161002858|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
161002859|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
161002860|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161002861|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
161002862|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161002863|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
161002864|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
161002865|NCT02709655|581395478|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
161002866|NCT02709655|581395479|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
161002867|NCT02709655|581395480|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
161002868|NCT02709655|581395481|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
161002869|NCT02709655|581395482|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
161002870|NCT00102063|581395483|FG000|Overall Study|Lack of Efficacy|5|||
161002871|NCT00102063|581395484|FG001|Overall Study|Lack of Efficacy|1|||
161002872|NCT00102063|581395485|FG002|Overall Study|Lack of Efficacy|1|||
161002873|NCT00102063|581395483|FG000|Overall Study|Adverse Event|7|||
161002874|NCT00102063|581395484|FG001|Overall Study|Adverse Event|4|||
161002875|NCT00102063|581395485|FG002|Overall Study|Adverse Event|2|||
161002876|NCT00102063|581395483|FG000|Overall Study|Withdrawal by Subject|4|||
161002877|NCT00102063|581395484|FG001|Overall Study|Withdrawal by Subject|12|||
161002878|NCT00102063|581395485|FG002|Overall Study|Withdrawal by Subject|5|||
161002879|NCT00102063|581395483|FG000|Overall Study|Lost to Follow-up|0|||
161002880|NCT00102063|581395484|FG001|Overall Study|Lost to Follow-up|0|||
161002881|NCT00102063|581395485|FG002|Overall Study|Lost to Follow-up|1|||
161002882|NCT00102063|581395483|FG000|Overall Study|Protocol Violation|0|||
161002883|NCT00102063|581395484|FG001|Overall Study|Protocol Violation|1|||
161002884|NCT00102063|581395485|FG002|Overall Study|Protocol Violation|1|||
161002885|NCT00857649|581395486|FG000|Overall Study|Adverse Event|15|||
161002886|NCT00857649|581395487|FG001|Overall Study|Adverse Event|10|||
161002887|NCT00857649|581395486|FG000|Overall Study|Non-compliance|1|||
161002888|NCT00857649|581395487|FG001|Overall Study|Non-compliance|1|||
161002889|NCT00857649|581395486|FG000|Overall Study|Protocol Violation|2|||
161002890|NCT00857649|581395487|FG001|Overall Study|Protocol Violation|2|||
161002891|NCT00857649|581395486|FG000|Overall Study|Withdrawal of Consent|10|||
161002892|NCT00857649|581395487|FG001|Overall Study|Withdrawal of Consent|7|||
161002893|NCT00857649|581395486|FG000|Overall Study|Nursing Home Placement|2|||
161002894|NCT00857649|581395487|FG001|Overall Study|Nursing Home Placement|9|||
161002895|NCT00857649|581395486|FG000|Overall Study|Other Reasons|1|||
161002896|NCT00857649|581395487|FG001|Overall Study|Other Reasons|3|||
161002897|NCT01713946|581395494|FG000|Overall Study|Death|0|||
161002898|NCT01713946|581395495|FG001|Overall Study|Death|2|||
161271174|NCT00633243|582375062|FG000|Overall Study|incarceration|0|||
161271175|NCT00633243|582375063|FG001|Overall Study|incarceration|2|||
161271176|NCT00633243|582375062|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
161271177|NCT00633243|582375063|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
161002899|NCT01713946|581395496|FG002|Overall Study|Death|2|||
161002900|NCT01713946|581395494|FG000|Overall Study|Adverse Event|19|||
161002901|NCT01713946|581395495|FG001|Overall Study|Adverse Event|14|||
161002902|NCT01713946|581395496|FG002|Overall Study|Adverse Event|13|||
161002903|NCT01713946|581395494|FG000|Overall Study|Withdrawal by Subject|12|||
161002904|NCT01713946|581395495|FG001|Overall Study|Withdrawal by Subject|12|||
161002905|NCT01713946|581395496|FG002|Overall Study|Withdrawal by Subject|8|||
161002906|NCT01713946|581395494|FG000|Overall Study|Lack of Efficacy|8|||
161002907|NCT01713946|581395495|FG001|Overall Study|Lack of Efficacy|8|||
161002908|NCT01713946|581395496|FG002|Overall Study|Lack of Efficacy|14|||
161002909|NCT01713946|581395494|FG000|Overall Study|Protocol Violation|2|||
161002910|NCT01713946|581395495|FG001|Overall Study|Protocol Violation|4|||
161002911|NCT01713946|581395496|FG002|Overall Study|Protocol Violation|1|||
161343492|NCT03965923|582644398|FG008|Overall Study|Death|4|||
161271178|NCT00633243|582375062|FG000|Overall Study|Not comfortable with self-injecting|0|||
161271179|NCT00633243|582375063|FG001|Overall Study|Not comfortable with self-injecting|1|||
161271180|NCT00633243|582375062|FG000|Overall Study|Mental Health--Depression|0|||
161271181|NCT00633243|582375063|FG001|Overall Study|Mental Health--Depression|1|||
161271182|NCT00633243|582375062|FG000|Overall Study|Couldn't tolerate side-effects|1|||
161271183|NCT00633243|582375063|FG001|Overall Study|Couldn't tolerate side-effects|1|||
161271184|NCT01682863|582375064|FG000|Overall Study|Subject/guardian decision|19|||
161002912|NCT01713946|581395494|FG000|Overall Study|Lost to Follow-up|0|||
161002913|NCT01713946|581395495|FG001|Overall Study|Lost to Follow-up|0|||
161002914|NCT01713946|581395496|FG002|Overall Study|Lost to Follow-up|1|||
161002915|NCT01713946|581395494|FG000|Overall Study|Administrative problems|1|||
161002916|NCT01713946|581395495|FG001|Overall Study|Administrative problems|0|||
161002917|NCT01713946|581395496|FG002|Overall Study|Administrative problems|0|||
161002918|NCT01713946|581395494|FG000|Overall Study|Did not continue in Ext|0|||
161002919|NCT01713946|581395495|FG001|Overall Study|Did not continue in Ext|3|||
161002920|NCT01713946|581395496|FG002|Overall Study|Did not continue in Ext|0|||
161002921|NCT01713946|581395494|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
161002922|NCT01713946|581395495|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
161002923|NCT01713946|581395496|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
161002924|NCT01713946|581395494|FG000|Overall Study|Patients never switched to everolimus|0|||
161002925|NCT01713946|581395495|FG001|Overall Study|Patients never switched to everolimus|0|||
161002926|NCT01713946|581395496|FG002|Overall Study|Patients never switched to everolimus|5|||
161002927|NCT03723616|581396541|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
161002928|NCT03723616|581396542|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
161002929|NCT03723616|581396543|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
161002930|NCT03723616|581396544|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
161002931|NCT03723616|581396545|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
161002932|NCT03723616|581396546|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
161002933|NCT06001177|581396549|FG000|Treatment Phase|Adverse Event|1|||
161002934|NCT06001177|581396550|FG001|Treatment Phase|Adverse Event|0|||
161002935|NCT06001177|581396549|FG000|Treatment Phase|Withdrawal by Subject|1|||
161002936|NCT06001177|581396550|FG001|Treatment Phase|Withdrawal by Subject|0|||
161002937|NCT06001177|581396549|FG000|Observation Phase|Adverse Event|1|||
161002938|NCT06001177|581396550|FG001|Observation Phase|Adverse Event|1|||
161002939|NCT06001177|581396549|FG000|Observation Phase|Withdrawal by Subject|0|||
161002940|NCT06001177|581396550|FG001|Observation Phase|Withdrawal by Subject|1|||
161002941|NCT03593876|581396553|FG000|Overall Study|Withdrawal by Subject|1|||
161002942|NCT03593876|581396553|FG000|Overall Study|Discharged home before intervention completion|2|||
161002943|NCT05309668|581396554|FG000|Overall Study|Ongoing at data cut-off|14|||
161002944|NCT05309668|581396555|FG001|Overall Study|Ongoing at data cut-off|17|||
161002945|NCT05309668|581396556|FG002|Overall Study|Ongoing at data cut-off|4|||
161002946|NCT02696707|581396557|FG000|Per Protocol Population|Physician Decision|2|||
161002947|NCT02696707|581396558|FG001|Per Protocol Population|Physician Decision|1|||
161002948|NCT02696707|581396557|FG000|Per Protocol Population|Participant Decision|0|||
161002949|NCT02696707|581396558|FG001|Per Protocol Population|Participant Decision|2|||
161002950|NCT02696707|581396557|FG000|Completed Study as Planned|Reason = LVEF|2|||
161002951|NCT02696707|581396558|FG001|Completed Study as Planned|Reason = LVEF|2|||
161002952|NCT02696707|581396557|FG000|Completed Study as Planned|Protocol Violation|2|||
161002953|NCT02696707|581396558|FG001|Completed Study as Planned|Protocol Violation|6|||
161002954|NCT02696707|581396557|FG000|Completed Study as Planned|Metastatic disease|3|||
161002955|NCT02696707|581396558|FG001|Completed Study as Planned|Metastatic disease|0|||
161271185|NCT01682863|582375065|FG001|Overall Study|Subject/guardian decision|12|||
161271186|NCT01682863|582375066|FG002|Overall Study|Subject/guardian decision|10|||
161271187|NCT01682863|582375064|FG000|Overall Study|Lost to Follow-up|5|||
161271188|NCT01682863|582375065|FG001|Overall Study|Lost to Follow-up|1|||
161271189|NCT01682863|582375066|FG002|Overall Study|Lost to Follow-up|6|||
161271190|NCT01682863|582375064|FG000|Overall Study|Death|1|||
161002956|NCT02696707|581396557|FG000|Completed Study as Planned|Location|1|||
161002957|NCT02696707|581396558|FG001|Completed Study as Planned|Location|1|||
161002958|NCT00071799|581396559|FG000|Overall Study|Adverse Event|19|||
161002959|NCT00071799|581396560|FG001|Overall Study|Adverse Event|10|||
161002960|NCT00071799|581396559|FG000|Overall Study|Protocol Violation|1|||
161002961|NCT00071799|581396560|FG001|Overall Study|Protocol Violation|7|||
161002962|NCT00071799|581396559|FG000|Overall Study|Lost to Follow-up|1|||
161002963|NCT00071799|581396560|FG001|Overall Study|Lost to Follow-up|1|||
161002964|NCT00071799|581396559|FG000|Overall Study|Withdrawal by Subject|15|||
161002965|NCT00071799|581396560|FG001|Overall Study|Withdrawal by Subject|37|||
161002966|NCT00071799|581396559|FG000|Overall Study|Physician Decision|0|||
161002967|NCT00071799|581396560|FG001|Overall Study|Physician Decision|2|||
161002968|NCT00071799|581396559|FG000|Overall Study|Lack of Efficacy|11|||
161271191|NCT01682863|582375065|FG001|Overall Study|Death|3|||
161271192|NCT01682863|582375066|FG002|Overall Study|Death|4|||
161271193|NCT01682863|582375064|FG000|Overall Study|Protocol deviation|1|||
161271194|NCT01682863|582375065|FG001|Overall Study|Protocol deviation|0|||
161271195|NCT01682863|582375066|FG002|Overall Study|Protocol deviation|1|||
161271196|NCT01682863|582375064|FG000|Overall Study|Technical problems|1|||
160965137|NCT01059643|581261092|FG000|Overall Study|Adverse Event|3|||
160965138|NCT01059643|581261092|FG000|Overall Study|Withdrawal by Subject|2|||
160965139|NCT01059643|581261092|FG000|Overall Study|Physician Decision|1|||
160965140|NCT00677352|581261101|FG000|Treatment Phase|Adverse Event|14|||
160965141|NCT00677352|581261102|FG001|Treatment Phase|Adverse Event|22|||
160965142|NCT00677352|581261101|FG000|Treatment Phase|Lack of Efficacy|2|||
160965143|NCT00677352|581261102|FG001|Treatment Phase|Lack of Efficacy|3|||
160965144|NCT00677352|581261101|FG000|Treatment Phase|Lost to Follow-up|0|||
160965145|NCT00677352|581261102|FG001|Treatment Phase|Lost to Follow-up|1|||
160965146|NCT00677352|581261101|FG000|Treatment Phase|Withdrawal by Subject|7|||
160965147|NCT00677352|581261102|FG001|Treatment Phase|Withdrawal by Subject|7|||
160965148|NCT00677352|581261101|FG000|Treatment Phase|Physician Decision|1|||
160965149|NCT00677352|581261102|FG001|Treatment Phase|Physician Decision|0|||
160965150|NCT00677352|581261101|FG000|Treatment Phase|Pregnancy|0|||
160965151|NCT00677352|581261102|FG001|Treatment Phase|Pregnancy|1|||
160965152|NCT00677352|581261101|FG000|Treatment Phase|Protocol Violation|1|||
160965153|NCT00677352|581261102|FG001|Treatment Phase|Protocol Violation|1|||
160965154|NCT00677352|581261101|FG000|Treatment Phase|Transference or work related matter|0|||
160965155|NCT00677352|581261102|FG001|Treatment Phase|Transference or work related matter|5|||
160965156|NCT00677352|581261101|FG000|Treatment Phase|Not treated|0|||
160965157|NCT00677352|581261102|FG001|Treatment Phase|Not treated|2|||
160965158|NCT00677352|581261101|FG000|Tapering Phase|Adverse Event|1|||
160965159|NCT00677352|581261102|FG001|Tapering Phase|Adverse Event|5|||
160965160|NCT00677352|581261101|FG000|Tapering Phase|Withdrawal by Subject|5|||
160965161|NCT00677352|581261102|FG001|Tapering Phase|Withdrawal by Subject|3|||
160965162|NCT00677352|581261101|FG000|Tapering Phase|Pregnancy|0|||
160965163|NCT00677352|581261102|FG001|Tapering Phase|Pregnancy|1|||
160965164|NCT00677352|581261101|FG000|Tapering Phase|Job transfer|0|||
160965165|NCT00677352|581261102|FG001|Tapering Phase|Job transfer|1|||
160965166|NCT02182973|581261105|FG000|Overall Study|Withdrawal by Subject|3|||
160965167|NCT02182973|581261106|FG001|Overall Study|Withdrawal by Subject|0|||
160965168|NCT00238433|581261107|FG000|Overall Study|Screen failure|1|||
160965169|NCT00238433|581261107|FG000|Overall Study|Lost to Follow-up|1|||
160965170|NCT00238433|581261107|FG000|Overall Study|Death|1|||
160965171|NCT01814748|581261108|FG000|Overall Study|Lost to Follow-up|1|||
160965172|NCT01814748|581261109|FG001|Overall Study|Lost to Follow-up|2|||
160965173|NCT01814748|581261108|FG000|Overall Study|Study site terminated by sponsor|1|||
160965174|NCT01814748|581261109|FG001|Overall Study|Study site terminated by sponsor|1|||
160965175|NCT01814748|581261108|FG000|Overall Study|Withdrawal by Subject|6|||
160965176|NCT01814748|581261109|FG001|Overall Study|Withdrawal by Subject|4|||
160965177|NCT00409682|581261116|FG000|Open-label Induction Period|Adverse Event|1|||
160965178|NCT00409682|581261117|FG001|Open-label Induction Period|Adverse Event|0|||
160965179|NCT00409682|581261118|FG002|Open-label Induction Period|Adverse Event|0|||
160965180|NCT00409682|581261116|FG000|Open-label Induction Period|Lack of Efficacy|1|||
160965181|NCT00409682|581261117|FG001|Open-label Induction Period|Lack of Efficacy|0|||
160965182|NCT00409682|581261118|FG002|Open-label Induction Period|Lack of Efficacy|0|||
160965183|NCT00409682|581261116|FG000|Open-label Induction Period|Protocol Violation|1|||
160965184|NCT00409682|581261117|FG001|Open-label Induction Period|Protocol Violation|0|||
160965185|NCT00409682|581261118|FG002|Open-label Induction Period|Protocol Violation|0|||
160965186|NCT00409682|581261116|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
160965187|NCT00409682|581261117|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
160965188|NCT00409682|581261118|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
160965189|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
160965190|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
160965191|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
160965192|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
160965193|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
160965194|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
160965195|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
160965196|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
160965197|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
160965198|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
160965199|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
160965200|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
160965201|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
160965202|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
160965203|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
160965204|NCT00409682|581261116|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
160965205|NCT00409682|581261117|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
160965206|NCT00409682|581261118|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
161147103|NCT00958568|581922400|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161147104|NCT00958568|581922401|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
161271197|NCT01682863|582375065|FG001|Overall Study|Technical problems|0|||
161271198|NCT01682863|582375066|FG002|Overall Study|Technical problems|0|||
161002969|NCT00071799|581396560|FG001|Overall Study|Lack of Efficacy|18|||
161002970|NCT00071799|581396559|FG000|Overall Study|Disease Progression|23|||
161002971|NCT00071799|581396560|FG001|Overall Study|Disease Progression|20|||
161002972|NCT00071799|581396559|FG000|Overall Study|Different Central+Local Pathology Review|0|||
161002973|NCT00071799|581396560|FG001|Overall Study|Different Central+Local Pathology Review|1|||
161002974|NCT00071799|581396559|FG000|Overall Study|Not Documented|0|||
161002975|NCT00071799|581396560|FG001|Overall Study|Not Documented|2|||
161002976|NCT04527549|581396563|FG000|Overall Study|Withdrawal by Subject|1|||
161002977|NCT04527549|581396564|FG001|Overall Study|Withdrawal by Subject|1|||
161002978|NCT00814346|581396565|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
161002979|NCT00814346|581396566|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
161002980|NCT00814346|581396565|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
161002981|NCT00814346|581396566|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
161002982|NCT00814346|581396565|FG000|Open Phase (17 Months)|Adverse Event|5|||
161002983|NCT00814346|581396566|FG001|Open Phase (17 Months)|Adverse Event|0|||
161002984|NCT00814346|581396565|FG000|Open Phase (17 Months)|Consent|2|||
161002985|NCT00814346|581396566|FG001|Open Phase (17 Months)|Consent|0|||
161002986|NCT00814346|581396565|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
161002987|NCT00814346|581396566|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
161002988|NCT00814346|581396565|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
161002989|NCT00814346|581396566|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
161002990|NCT05764161|581396568|FG000|12-week DBVC Period|Lack of Efficacy|2|||
161002991|NCT05764161|581396569|FG001|12-week DBVC Period|Lack of Efficacy|1|||
161002992|NCT05764161|581396568|FG000|12-week DBVC Period|Lost to Follow-up|0|||
161002993|NCT05764161|581396569|FG001|12-week DBVC Period|Lost to Follow-up|2|||
161002994|NCT05764161|581396568|FG000|12-week DBVC Period|Protocol Violation|2|||
161002995|NCT05764161|581396569|FG001|12-week DBVC Period|Protocol Violation|4|||
161002996|NCT05764161|581396568|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
161002997|NCT05764161|581396569|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
161002998|NCT05764161|581396568|FG000|40-week OLE Period|Lack of Efficacy|0|||
161002999|NCT05764161|581396569|FG001|40-week OLE Period|Lack of Efficacy|1|||
161003000|NCT05764161|581396568|FG000|40-week OLE Period|Lost to Follow-up|1|||
161003001|NCT05764161|581396569|FG001|40-week OLE Period|Lost to Follow-up|4|||
161003002|NCT05764161|581396568|FG000|40-week OLE Period|Withdrawal by Subject|2|||
161003003|NCT05764161|581396569|FG001|40-week OLE Period|Withdrawal by Subject|7|||
161003004|NCT05764161|581396568|FG000|40-week OLE Period|Extended Travel|0|||
161003005|NCT05764161|581396569|FG001|40-week OLE Period|Extended Travel|1|||
161003006|NCT05764161|581396568|FG000|40-week OLE Period|Ongoing|66|||
161003007|NCT05764161|581396569|FG001|40-week OLE Period|Ongoing|59|||
161003008|NCT00507689|581396576|FG000|Pre-Randomization Period|Adverse Event|1|||
161003009|NCT00507689|581396577|FG001|Pre-Randomization Period|Adverse Event|0|||
161003010|NCT00507689|581396576|FG000|Pre-Randomization Period|Physician Decision|1|||
161003011|NCT00507689|581396577|FG001|Pre-Randomization Period|Physician Decision|0|||
161003012|NCT00507689|581396576|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
161003013|NCT00507689|581396577|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
161003014|NCT00507689|581396576|FG000|Randomized Period|Adverse Event|1|||
161003015|NCT00507689|581396577|FG001|Randomized Period|Adverse Event|1|||
161003016|NCT00507689|581396576|FG000|Randomized Period|Withdrawal by Subject|0|||
161003017|NCT00507689|581396577|FG001|Randomized Period|Withdrawal by Subject|1|||
161271199|NCT01682863|582375064|FG000|Overall Study|Adverse Event|0|||
161271200|NCT01682863|582375065|FG001|Overall Study|Adverse Event|1|||
161003018|NCT01241292|581396578|FG000|Overall Study|Administrative Reason by Sponsor|1|||
161003019|NCT01241292|581396579|FG001|Overall Study|Administrative Reason by Sponsor|0|||
161003020|NCT01241292|581396578|FG000|Overall Study|Disease Progression|2|||
161003021|NCT01241292|581396579|FG001|Overall Study|Disease Progression|0|||
161271201|NCT01682863|582375066|FG002|Overall Study|Adverse Event|2|||
161271202|NCT01682863|582375064|FG000|Overall Study|Physician Decision|0|||
161003022|NCT01241292|581396578|FG000|Overall Study|Study Drug Toxicity|0|||
161003023|NCT01241292|581396579|FG001|Overall Study|Study Drug Toxicity|1|||
161003024|NCT01241292|581396578|FG000|Overall Study|Participant Discontinued Treatment|0|||
161003025|NCT01241292|581396579|FG001|Overall Study|Participant Discontinued Treatment|2|||
161003026|NCT03034915|581396582|FG000|Overall Study|Adverse Event|29|||
161147105|NCT00958568|581922402|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
161003027|NCT03034915|581396583|FG001|Overall Study|Adverse Event|32|||
161003028|NCT03034915|581396584|FG002|Overall Study|Adverse Event|22|||
161003029|NCT03034915|581396582|FG000|Overall Study|Lost to Follow-up|5|||
161003030|NCT03034915|581396583|FG001|Overall Study|Lost to Follow-up|13|||
161003031|NCT03034915|581396584|FG002|Overall Study|Lost to Follow-up|3|||
161003032|NCT03034915|581396582|FG000|Overall Study|Withdrawal by Subject|29|||
161147106|NCT01736683|581922403|FG000|Overall Study|Disease Relapse|0|||
161271203|NCT01682863|582375065|FG001|Overall Study|Physician Decision|0|||
161003033|NCT03034915|581396583|FG001|Overall Study|Withdrawal by Subject|46|||
161003034|NCT03034915|581396584|FG002|Overall Study|Withdrawal by Subject|41|||
161003035|NCT03034915|581396582|FG000|Overall Study|Protocol Deviation|2|||
161003036|NCT03034915|581396583|FG001|Overall Study|Protocol Deviation|14|||
161003037|NCT03034915|581396584|FG002|Overall Study|Protocol Deviation|7|||
161003038|NCT03034915|581396582|FG000|Overall Study|Lack of Efficacy|8|||
161003039|NCT03034915|581396583|FG001|Overall Study|Lack of Efficacy|16|||
161003040|NCT03034915|581396584|FG002|Overall Study|Lack of Efficacy|18|||
161003041|NCT03034915|581396582|FG000|Overall Study|Site closed|2|||
161003042|NCT03034915|581396583|FG001|Overall Study|Site closed|2|||
161003043|NCT03034915|581396584|FG002|Overall Study|Site closed|4|||
161003044|NCT03034915|581396582|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
161003045|NCT03034915|581396583|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
161003046|NCT03034915|581396584|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
161003047|NCT03034915|581396582|FG000|Overall Study|Physician Decision|1|||
161003048|NCT03034915|581396583|FG001|Overall Study|Physician Decision|5|||
161003049|NCT03034915|581396584|FG002|Overall Study|Physician Decision|2|||
161003050|NCT03861767|581396585|FG000|Overall Study|Withdrawal by Subject|2|||
161003051|NCT03861767|581396586|FG001|Overall Study|Withdrawal by Subject|1|||
161003052|NCT03861767|581396587|FG002|Overall Study|Withdrawal by Subject|0|||
161003053|NCT03861767|581396588|FG003|Overall Study|Withdrawal by Subject|5|||
161003054|NCT03861767|581396589|FG004|Overall Study|Withdrawal by Subject|2|||
161003055|NCT03861767|581396590|FG005|Overall Study|Withdrawal by Subject|1|||
161003056|NCT03861767|581396591|FG006|Overall Study|Withdrawal by Subject|3|||
161003057|NCT03861767|581396592|FG007|Overall Study|Withdrawal by Subject|1|||
161003058|NCT03861767|581396593|FG008|Overall Study|Withdrawal by Subject|0|||
161003059|NCT03861767|581396594|FG009|Overall Study|Withdrawal by Subject|5|||
161003060|NCT00346333|581396595|FG000|Overall Study|Death|1|||
161003061|NCT00346333|581396596|FG001|Overall Study|Death|0|||
161003062|NCT00346333|581396595|FG000|Overall Study|unwilling or unable to continue|4|||
161003063|NCT00346333|581396596|FG001|Overall Study|unwilling or unable to continue|8|||
161003064|NCT00117286|581396602|FG000|Overall Study|Adverse Event|12|||
161003065|NCT00117286|581396603|FG001|Overall Study|Adverse Event|6|||
161003066|NCT00117286|581396602|FG000|Overall Study|Lost to Follow-up|2|||
161003067|NCT00117286|581396603|FG001|Overall Study|Lost to Follow-up|0|||
161147107|NCT01736683|581922404|FG001|Overall Study|Disease Relapse|0|||
161147108|NCT01736683|581922405|FG002|Overall Study|Disease Relapse|2|||
161147109|NCT01736683|581922406|FG003|Overall Study|Disease Relapse|1|||
161003068|NCT00117286|581396602|FG000|Overall Study|Protocol Violation|3|||
161003069|NCT00117286|581396603|FG001|Overall Study|Protocol Violation|3|||
161003070|NCT00117286|581396602|FG000|Overall Study|Withdrawal by Subject|6|||
161003071|NCT00117286|581396603|FG001|Overall Study|Withdrawal by Subject|2|||
161003072|NCT00117286|581396602|FG000|Overall Study|Physician Decision|3|||
161003073|NCT00117286|581396603|FG001|Overall Study|Physician Decision|7|||
161003074|NCT00117286|581396602|FG000|Overall Study|Lack of Efficacy|2|||
161003075|NCT00117286|581396603|FG001|Overall Study|Lack of Efficacy|1|||
161003076|NCT00117286|581396602|FG000|Overall Study|Research site closing|0|||
161003077|NCT00117286|581396603|FG001|Overall Study|Research site closing|2|||
161003078|NCT00189202|581396604|FG000|Overall Study|Physician Decision|5|||
161003079|NCT01595061|581396609|FG000|Overall Study|Never Treated|3|||
161003080|NCT01595061|581396609|FG000|Overall Study|Inadequate Pathology|1|||
161003081|NCT03388632|581396613|FG000|Triplet C|Clinical progression|0|||
161003082|NCT03388632|581396614|FG001|Triplet C|Clinical progression|0|||
161003083|NCT03388632|581396615|FG002|Triplet C|Clinical progression|0|||
161003084|NCT03388632|581396616|FG003|Triplet C|Clinical progression|0|||
161003085|NCT03388632|581396617|FG004|Triplet C|Clinical progression|1|||
161003086|NCT03388632|581396618|FG005|Triplet C|Clinical progression|0|||
161003087|NCT03388632|581396619|FG006|Triplet C|Clinical progression|0|||
161003088|NCT03388632|581396620|FG007|Triplet C|Clinical progression|0|||
161003089|NCT03388632|581396621|FG008|Triplet C|Clinical progression|0|||
161147110|NCT01736683|581922407|FG004|Overall Study|Disease Relapse|0|||
161271204|NCT01682863|582375066|FG002|Overall Study|Physician Decision|1|||
161003090|NCT03388632|581396613|FG000|Triplet C|42-day lapse in tx|0|||
161003091|NCT03388632|581396614|FG001|Triplet C|42-day lapse in tx|0|||
161003092|NCT03388632|581396615|FG002|Triplet C|42-day lapse in tx|0|||
161271205|NCT00918138|582375067|FG000|Overall Study|Subject withdrew consent|1|||
161003093|NCT03388632|581396616|FG003|Triplet C|42-day lapse in tx|0|||
161003094|NCT03388632|581396617|FG004|Triplet C|42-day lapse in tx|1|||
161003095|NCT03388632|581396618|FG005|Triplet C|42-day lapse in tx|0|||
161003096|NCT03388632|581396619|FG006|Triplet C|42-day lapse in tx|0|||
161003097|NCT03388632|581396620|FG007|Triplet C|42-day lapse in tx|0|||
161003098|NCT03388632|581396621|FG008|Triplet C|42-day lapse in tx|0|||
161003099|NCT03388632|581396613|FG000|Triplet C|Adverse Event|0|||
161003100|NCT03388632|581396614|FG001|Triplet C|Adverse Event|0|||
161003101|NCT03388632|581396615|FG002|Triplet C|Adverse Event|0|||
161003102|NCT03388632|581396616|FG003|Triplet C|Adverse Event|0|||
161003103|NCT03388632|581396617|FG004|Triplet C|Adverse Event|0|||
161147111|NCT01736683|581922403|FG000|Overall Study|Adverse Event|0|||
161147112|NCT01736683|581922404|FG001|Overall Study|Adverse Event|2|||
161343493|NCT03965923|582644399|FG009|Overall Study|Death|0|||
160965207|NCT01896869|581261119|FG000|Overall Study|Withdrawal by Subject|0|||
160965208|NCT01896869|581261120|FG001|Overall Study|Withdrawal by Subject|6|||
160965209|NCT01896869|581261119|FG000|Overall Study|Lost to Follow-up|1|||
160965210|NCT01896869|581261120|FG001|Overall Study|Lost to Follow-up|0|||
160965211|NCT02436811|581261124|FG000|Overall Study|Lost to Follow-up|2|||
160965212|NCT02436811|581261125|FG001|Overall Study|Lost to Follow-up|9|||
160965213|NCT02436811|581261126|FG002|Overall Study|Lost to Follow-up|7|||
160965214|NCT02831257|581261127|FG000|Overall Study|Lack of Efficacy|3|||
160965215|NCT02831257|581261127|FG000|Overall Study|Adverse Event|2|||
160965216|NCT02831257|581261127|FG000|Overall Study|Physician Decision|1|||
160965217|NCT02831257|581261127|FG000|Overall Study|Withdrawal by Subject|6|||
160965218|NCT02496767|581261129|FG000|Open-label Lead-in Phase|Adverse Event|176|||
160965219|NCT02496767|581261130|FG001|Open-label Lead-in Phase|Adverse Event|0|||
160965220|NCT02496767|581261131|FG002|Open-label Lead-in Phase|Adverse Event|0|||
160965221|NCT02496767|581261132|FG003|Open-label Lead-in Phase|Adverse Event|0|||
160965222|NCT02496767|581261133|FG004|Open-label Lead-in Phase|Adverse Event|0|||
160965223|NCT02496767|581261134|FG005|Open-label Lead-in Phase|Adverse Event|0|||
160965224|NCT02496767|581261135|FG006|Open-label Lead-in Phase|Adverse Event|0|||
160965225|NCT02496767|581261136|FG007|Open-label Lead-in Phase|Adverse Event|0|||
160965226|NCT02496767|581261129|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
160965227|NCT02496767|581261130|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
160965228|NCT02496767|581261131|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
160965229|NCT02496767|581261132|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
160965230|NCT02496767|581261133|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
160965231|NCT02496767|581261134|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
160965232|NCT02496767|581261135|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
160965233|NCT02496767|581261136|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
160965234|NCT02496767|581261129|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
160965235|NCT02496767|581261130|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965236|NCT02496767|581261131|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965237|NCT02496767|581261132|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965238|NCT02496767|581261133|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965239|NCT02496767|581261134|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965240|NCT02496767|581261135|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965241|NCT02496767|581261136|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
160965242|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965243|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
160965244|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
160965245|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
160965246|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
160965247|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965248|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965249|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
160965250|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965251|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
160965252|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
160965253|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
160965254|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
160965255|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965256|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965257|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
160965258|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
160965259|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
160965260|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
160965261|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
160965262|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
160965263|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
160965264|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
160965265|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
160965266|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
160965267|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
160965268|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
160965269|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
161147113|NCT01736683|581922405|FG002|Overall Study|Adverse Event|2|||
160965270|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
160965271|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
160965272|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
160965273|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
161147114|NCT01736683|581922406|FG003|Overall Study|Adverse Event|3|||
161147115|NCT01736683|581922407|FG004|Overall Study|Adverse Event|2|||
161147116|NCT01736683|581922403|FG000|Overall Study|Withdrawal by Subject|0|||
161003104|NCT03388632|581396618|FG005|Triplet C|Adverse Event|0|||
161003105|NCT03388632|581396619|FG006|Triplet C|Adverse Event|0|||
161003106|NCT03388632|581396620|FG007|Triplet C|Adverse Event|0|||
161003107|NCT03388632|581396621|FG008|Triplet C|Adverse Event|1|||
161003108|NCT03388632|581396613|FG000|Triplet C|Switched to alternative treatment|0|||
161003109|NCT03388632|581396614|FG001|Triplet C|Switched to alternative treatment|0|||
161003110|NCT03388632|581396615|FG002|Triplet C|Switched to alternative treatment|0|||
161003111|NCT03388632|581396616|FG003|Triplet C|Switched to alternative treatment|0|||
161003112|NCT03388632|581396617|FG004|Triplet C|Switched to alternative treatment|0|||
161003113|NCT03388632|581396618|FG005|Triplet C|Switched to alternative treatment|0|||
161003114|NCT03388632|581396619|FG006|Triplet C|Switched to alternative treatment|0|||
161003115|NCT03388632|581396620|FG007|Triplet C|Switched to alternative treatment|1|||
161003116|NCT03388632|581396621|FG008|Triplet C|Switched to alternative treatment|0|||
161003117|NCT03388632|581396613|FG000|Triplet C|Participant choice|0|||
161003118|NCT03388632|581396614|FG001|Triplet C|Participant choice|0|||
161003119|NCT03388632|581396615|FG002|Triplet C|Participant choice|0|||
161003120|NCT03388632|581396616|FG003|Triplet C|Participant choice|0|||
161003121|NCT03388632|581396617|FG004|Triplet C|Participant choice|0|||
161003122|NCT03388632|581396618|FG005|Triplet C|Participant choice|1|||
161003123|NCT03388632|581396619|FG006|Triplet C|Participant choice|0|||
161003124|NCT03388632|581396620|FG007|Triplet C|Participant choice|0|||
161003125|NCT03388632|581396621|FG008|Triplet C|Participant choice|0|||
161003126|NCT02115282|581396622|FG000|Overall Study|Disease progression during treatment|216|||
161003127|NCT02115282|581396623|FG001|Overall Study|Disease progression during treatment|229|||
161003128|NCT02115282|581396622|FG000|Overall Study|Adverse Event|49|||
161003129|NCT02115282|581396623|FG001|Overall Study|Adverse Event|23|||
161003130|NCT02115282|581396622|FG000|Overall Study|Death|1|||
161003131|NCT02115282|581396623|FG001|Overall Study|Death|3|||
161003132|NCT02115282|581396622|FG000|Overall Study|Alternative therapy|1|||
161003133|NCT02115282|581396623|FG001|Overall Study|Alternative therapy|1|||
161003134|NCT02115282|581396622|FG000|Overall Study|Complicating disease|0|||
161003135|NCT02115282|581396623|FG001|Overall Study|Complicating disease|3|||
161003136|NCT02115282|581396622|FG000|Overall Study|Withdrawal by Subject|12|||
161003137|NCT02115282|581396623|FG001|Overall Study|Withdrawal by Subject|10|||
161003138|NCT02115282|581396622|FG000|Overall Study|Symptomatic progression/deterioration|7|||
161003139|NCT02115282|581396623|FG001|Overall Study|Symptomatic progression/deterioration|18|||
161003140|NCT02115282|581396622|FG000|Overall Study|Non-compliance|5|||
161003141|NCT02115282|581396623|FG001|Overall Study|Non-compliance|1|||
161003142|NCT02115282|581396622|FG000|Overall Study|Protocol Violation|2|||
161003143|NCT02115282|581396623|FG001|Overall Study|Protocol Violation|2|||
161003144|NCT02115282|581396622|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
161003145|NCT02115282|581396623|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
161003146|NCT02115282|581396622|FG000|Overall Study|Not start protocol therapy|9|||
161003147|NCT02115282|581396623|FG001|Overall Study|Not start protocol therapy|10|||
161003148|NCT06218251|581396626|FG000|Overall Study|Lost to Follow-up|4|||
161003149|NCT00997386|581396629|FG000|Overall Study|Death|7|||
161003150|NCT03492177|581396630|FG000|Overall Study|Adverse Event|1|||
161003151|NCT03492177|581396631|FG001|Overall Study|Adverse Event|0|||
161003152|NCT03492177|581396632|FG002|Overall Study|Adverse Event|0|||
161003153|NCT03492177|581396630|FG000|Overall Study|Death|3|||
161003154|NCT03492177|581396631|FG001|Overall Study|Death|0|||
161003155|NCT03492177|581396632|FG002|Overall Study|Death|3|||
161003156|NCT03492177|581396630|FG000|Overall Study|Lack of Efficacy|1|||
161003157|NCT03492177|581396631|FG001|Overall Study|Lack of Efficacy|2|||
161003158|NCT03492177|581396632|FG002|Overall Study|Lack of Efficacy|0|||
161003159|NCT03492177|581396630|FG000|Overall Study|Other|1|||
161003160|NCT03492177|581396631|FG001|Overall Study|Other|0|||
161003161|NCT03492177|581396632|FG002|Overall Study|Other|0|||
161003162|NCT03492177|581396630|FG000|Overall Study|Ongoing|16|||
161003163|NCT03492177|581396631|FG001|Overall Study|Ongoing|19|||
161003164|NCT03492177|581396632|FG002|Overall Study|Ongoing|17|||
161003165|NCT03889925|581397969|FG000|Overall Study|Lost to Follow-up|11|||
161003166|NCT03889925|581397970|FG001|Overall Study|Lost to Follow-up|10|||
161271206|NCT00918138|582375068|FG001|Overall Study|Subject withdrew consent|1|||
161271207|NCT00918138|582375067|FG000|Overall Study|Death|1|||
161003167|NCT05777785|581397971|FG000|Overall Study|Withdrawal by Subject|5|||
161003168|NCT05777785|581397971|FG000|Overall Study|Lost to Follow-up|1|||
161003169|NCT05644444|581397976|FG000|Tolerance Phase|Adverse Event|0|||
161003170|NCT05644444|581397977|FG001|Tolerance Phase|Adverse Event|2|||
161003171|NCT05644444|581397976|FG000|Treatment Phase|Adverse Event|0|||
161003172|NCT05644444|581397977|FG001|Treatment Phase|Adverse Event|2|||
161003173|NCT00493649|581397978|FG000|Overall Study|Adverse Event|44|||
161003174|NCT00493649|581397978|FG000|Overall Study|Patient Request|21|||
161003175|NCT00493649|581397978|FG000|Overall Study|Investigator Request|2|||
161003176|NCT00493649|581397978|FG000|Overall Study|Disease Progression|1|||
161003177|NCT00493649|581397978|FG000|Overall Study|Lost to Follow-up|1|||
161003178|NCT00493649|581397978|FG000|Overall Study|Other|13|||
161003179|NCT00925899|581397981|FG000|Part 1|Death|1|||
161271208|NCT00918138|582375068|FG001|Overall Study|Death|0|||
161003180|NCT00925899|581397982|FG001|Part 1|Death|2|||
161003181|NCT00925899|581397981|FG000|Part 1|Withdrawal by Subject|10|||
161003182|NCT00925899|581397982|FG001|Part 1|Withdrawal by Subject|9|||
161003183|NCT00683696|581397983|FG000|Overall Study|Withdrawn due to study closure|337|||
161003184|NCT00683696|581397984|FG001|Overall Study|Withdrawn due to study closure|338|||
161003185|NCT00683696|581397983|FG000|Overall Study|Withdrawn prior to study closure|13|||
161003186|NCT00683696|581397984|FG001|Overall Study|Withdrawn prior to study closure|28|||
161003187|NCT00683696|581397983|FG000|Overall Study|Lost to Follow-up|5|||
161003188|NCT00683696|581397984|FG001|Overall Study|Lost to Follow-up|6|||
161003189|NCT00683696|581397983|FG000|Overall Study|Vital status follow-up only|3|||
161003190|NCT00683696|581397984|FG001|Overall Study|Vital status follow-up only|3|||
161003191|NCT00683696|581397983|FG000|Overall Study|Death|46|||
161003192|NCT00683696|581397984|FG001|Overall Study|Death|30|||
161003193|NCT00089544|581397985|FG000|Overall Study|Ineligible|1|||
161003194|NCT00089544|581397986|FG001|Overall Study|Ineligible|0|||
161003195|NCT02396316|581397989|FG000|Overall Study|Physician Decision|1|||
161003196|NCT02396316|581397990|FG001|Overall Study|Physician Decision|0|||
161003197|NCT02396316|581397989|FG000|Overall Study|Progressive disease|6|||
161003198|NCT02396316|581397990|FG001|Overall Study|Progressive disease|3|||
161003199|NCT02396316|581397989|FG000|Overall Study|Protocol Violation|0|||
161003200|NCT02396316|581397990|FG001|Overall Study|Protocol Violation|1|||
161003201|NCT02396316|581397989|FG000|Overall Study|Treatment unblinded|0|||
161003202|NCT02396316|581397990|FG001|Overall Study|Treatment unblinded|1|||
161003203|NCT01823536|581397991|FG000|Overall Study|Lost to Follow-up|1|||
161003204|NCT01823536|581397992|FG001|Overall Study|Lost to Follow-up|0|||
161003205|NCT01823536|581397993|FG002|Overall Study|Lost to Follow-up|0|||
161003206|NCT01823536|581397994|FG003|Overall Study|Lost to Follow-up|1|||
161003207|NCT01823536|581397995|FG004|Overall Study|Lost to Follow-up|1|||
161003208|NCT01823536|581397996|FG005|Overall Study|Lost to Follow-up|0|||
161003209|NCT01823536|581397991|FG000|Overall Study|Protocol Violation|0|||
161003210|NCT01823536|581397992|FG001|Overall Study|Protocol Violation|1|||
161003211|NCT01823536|581397993|FG002|Overall Study|Protocol Violation|0|||
161003212|NCT01823536|581397994|FG003|Overall Study|Protocol Violation|0|||
161003213|NCT01823536|581397995|FG004|Overall Study|Protocol Violation|0|||
161003214|NCT01823536|581397996|FG005|Overall Study|Protocol Violation|0|||
161003215|NCT01823536|581397991|FG000|Overall Study|Withdrawal by Subject|1|||
161003216|NCT01823536|581397992|FG001|Overall Study|Withdrawal by Subject|1|||
161003217|NCT01823536|581397993|FG002|Overall Study|Withdrawal by Subject|0|||
161003218|NCT01823536|581397994|FG003|Overall Study|Withdrawal by Subject|0|||
161003219|NCT01823536|581397995|FG004|Overall Study|Withdrawal by Subject|0|||
161003220|NCT01823536|581397996|FG005|Overall Study|Withdrawal by Subject|0|||
161003221|NCT01823536|581397991|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003222|NCT01823536|581397992|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003223|NCT01823536|581397993|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
161003224|NCT01823536|581397994|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003225|NCT01823536|581397995|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003226|NCT01823536|581397996|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
161003227|NCT01823536|581397991|FG000|Overall Study|Met exclusion criterion No 6|0|||
161003228|NCT01823536|581397992|FG001|Overall Study|Met exclusion criterion No 6|0|||
161003229|NCT01823536|581397993|FG002|Overall Study|Met exclusion criterion No 6|0|||
161003230|NCT01823536|581397994|FG003|Overall Study|Met exclusion criterion No 6|1|||
161003231|NCT01823536|581397995|FG004|Overall Study|Met exclusion criterion No 6|0|||
161003232|NCT01823536|581397996|FG005|Overall Study|Met exclusion criterion No 6|0|||
161003233|NCT01823536|581397991|FG000|Overall Study|Subject moved out of the state|0|||
161003234|NCT01823536|581397992|FG001|Overall Study|Subject moved out of the state|0|||
161003235|NCT01823536|581397993|FG002|Overall Study|Subject moved out of the state|0|||
161003236|NCT01823536|581397994|FG003|Overall Study|Subject moved out of the state|0|||
161003237|NCT01823536|581397995|FG004|Overall Study|Subject moved out of the state|1|||
161003238|NCT01823536|581397996|FG005|Overall Study|Subject moved out of the state|0|||
161003239|NCT03648762|581397997|FG000|Overall Study|Lost to Follow-up|1|||
161003240|NCT03648762|581397998|FG001|Overall Study|Lost to Follow-up|2|||
161003241|NCT03648762|581397999|FG002|Overall Study|Lost to Follow-up|0|||
161003242|NCT03648762|581397997|FG000|Overall Study|Withdrawal by Subject|5|||
161003243|NCT03648762|581397998|FG001|Overall Study|Withdrawal by Subject|2|||
161003244|NCT03648762|581397999|FG002|Overall Study|Withdrawal by Subject|1|||
161003245|NCT01662336|581398012|FG000|Overall Study|Adverse Event|1|||
161003246|NCT01662336|581398012|FG000|Overall Study|No longer on LPV/r|30|||
161003247|NCT01662336|581398012|FG000|Overall Study|Other|29|||
161003248|NCT01662336|581398012|FG000|Overall Study|Withdrawal by Subject|6|||
161003249|NCT02189252|581398013|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161003250|NCT02189252|581398014|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
161003251|NCT02189252|581398015|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161003252|NCT02189252|581398016|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
161003253|NCT02189252|581398013|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161003254|NCT02189252|581398014|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
161003255|NCT02189252|581398015|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161147117|NCT01736683|581922404|FG001|Overall Study|Withdrawal by Subject|0|||
161147118|NCT01736683|581922405|FG002|Overall Study|Withdrawal by Subject|3|||
161147119|NCT01736683|581922406|FG003|Overall Study|Withdrawal by Subject|1|||
161147120|NCT01736683|581922407|FG004|Overall Study|Withdrawal by Subject|1|||
160965274|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965275|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
160965276|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
160965277|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
160965278|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
160965279|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965280|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965281|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
160965282|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965283|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
160965284|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
160965285|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965286|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965287|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965288|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965289|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
160965290|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965291|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
160965292|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965293|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
160965294|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
160965295|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965296|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965297|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
160965298|NCT02496767|581261129|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965299|NCT02496767|581261130|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
160965300|NCT02496767|581261131|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965301|NCT02496767|581261132|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965302|NCT02496767|581261133|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965303|NCT02496767|581261134|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965304|NCT02496767|581261135|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965305|NCT02496767|581261136|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
160965306|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965307|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965308|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965309|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965310|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965311|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
160965312|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
160965313|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
160965314|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965315|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965316|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965317|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965318|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
160965319|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
160965320|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
160965321|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
160965322|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Death|0|||
160965323|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Death|0|||
160965324|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Death|0|||
160965325|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Death|0|||
160965326|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Death|0|||
160965327|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Death|0|||
160965328|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Death|1|||
160965329|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Death|2|||
160965330|NCT02496767|581261129|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965331|NCT02496767|581261130|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965332|NCT02496767|581261131|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
161147121|NCT01736683|581922403|FG000|Overall Study|Lack of Therapeutic Effect|7|||
161147122|NCT01736683|581922404|FG001|Overall Study|Lack of Therapeutic Effect|4|||
161147123|NCT01736683|581922405|FG002|Overall Study|Lack of Therapeutic Effect|13|||
161147124|NCT01736683|581922406|FG003|Overall Study|Lack of Therapeutic Effect|20|||
161147125|NCT01736683|581922407|FG004|Overall Study|Lack of Therapeutic Effect|1|||
161003256|NCT02189252|581398016|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
161003257|NCT00566735|581398017|FG000|Overall Study|Withdrawal by Subject|0|||
161003258|NCT00566735|581398018|FG001|Overall Study|Withdrawal by Subject|1|||
161003259|NCT00566735|581398017|FG000|Overall Study|Refused neuropsychological testing|2|||
161003260|NCT00566735|581398018|FG001|Overall Study|Refused neuropsychological testing|5|||
161003261|NCT00566735|581398017|FG000|Overall Study|Switched into a manic episode|0|||
161003262|NCT00566735|581398018|FG001|Overall Study|Switched into a manic episode|1|||
161003263|NCT00768664|581398019|FG000|Overall Study|Death|57|||
161003264|NCT00768664|581398019|FG000|Overall Study|Lost to Follow-up|2|||
161003265|NCT00768664|581398019|FG000|Overall Study|Other|9|||
161003266|NCT00768664|581398019|FG000|Overall Study|Participant refused|1|||
161003267|NCT02544152|581398020|FG000|Overall Study|Adverse Event|0|||
161003268|NCT02544152|581398021|FG001|Overall Study|Adverse Event|4|||
161003269|NCT02544152|581398020|FG000|Overall Study|Withdrawal by Subject|0|||
161003270|NCT02544152|581398021|FG001|Overall Study|Withdrawal by Subject|3|||
161003271|NCT02544152|581398020|FG000|Overall Study|Other|1|||
161003272|NCT02544152|581398021|FG001|Overall Study|Other|0|||
161003273|NCT02320123|581398022|FG000|Overall Study|Lost to Follow-up|4|||
161003274|NCT02320123|581398023|FG001|Overall Study|Lost to Follow-up|6|||
161003275|NCT02320123|581398022|FG000|Overall Study|Death|6|||
161003276|NCT02320123|581398023|FG001|Overall Study|Death|5|||
161003277|NCT04480827|581398024|FG000|Overall Study|Adverse Event|0|||
161003278|NCT04480827|581398025|FG001|Overall Study|Adverse Event|0|||
161003279|NCT04480827|581398026|FG002|Overall Study|Adverse Event|0|||
161003280|NCT04480827|581398027|FG003|Overall Study|Adverse Event|0|||
161003281|NCT04480827|581398028|FG004|Overall Study|Adverse Event|0|||
161003282|NCT04480827|581398029|FG005|Overall Study|Adverse Event|1|||
161003283|NCT04480827|581398030|FG006|Overall Study|Adverse Event|0|||
161003284|NCT00465816|581398031|FG000|Overall Study|Lost to Follow-up|0|||
161003285|NCT00465816|581398032|FG001|Overall Study|Lost to Follow-up|0|||
161003286|NCT00465816|581398033|FG002|Overall Study|Lost to Follow-up|2|||
161003287|NCT03194958|581398034|FG000|Overall Study|Death|0|||
161003288|NCT03194958|581398035|FG001|Overall Study|Death|1|||
161003289|NCT03194958|581398036|FG002|Overall Study|Death|1|||
161003290|NCT03194958|581398037|FG003|Overall Study|Death|1|||
161003291|NCT03194958|581398034|FG000|Overall Study|Withdrawal by Subject|24|||
161003292|NCT03194958|581398035|FG001|Overall Study|Withdrawal by Subject|27|||
161003293|NCT03194958|581398036|FG002|Overall Study|Withdrawal by Subject|7|||
161003294|NCT03194958|581398037|FG003|Overall Study|Withdrawal by Subject|22|||
161003295|NCT03194958|581398034|FG000|Overall Study|Lost to Follow-up|168|||
161003296|NCT03194958|581398035|FG001|Overall Study|Lost to Follow-up|196|||
161003297|NCT03194958|581398036|FG002|Overall Study|Lost to Follow-up|174|||
161003298|NCT03194958|581398037|FG003|Overall Study|Lost to Follow-up|186|||
161003299|NCT01179334|581398040|FG000|Treatment Period|Adverse Event|1|||
161003300|NCT01179334|581398041|FG001|Treatment Period|Adverse Event|0|||
161003301|NCT01179334|581398040|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
161003302|NCT01179334|581398041|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
161003303|NCT01179334|581398040|FG000|Long-term Extension (LTE) Period|Death|3|||
161003304|NCT01179334|581398041|FG001|Long-term Extension (LTE) Period|Death|0|||
161003305|NCT01179334|581398040|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
161003306|NCT01179334|581398041|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
161003307|NCT03654768|581398044|FG000|Overall Study|Adverse Event|1|||
161003308|NCT03654768|581398045|FG001|Overall Study|Adverse Event|6|||
161003309|NCT03654768|581398044|FG000|Overall Study|Loss of response|2|||
161003310|NCT03654768|581398045|FG001|Overall Study|Loss of response|2|||
161003311|NCT03654768|581398044|FG000|Overall Study|Non-compliance|0|||
161003312|NCT03654768|581398045|FG001|Overall Study|Non-compliance|1|||
161003313|NCT03654768|581398044|FG000|Overall Study|Refusal not related to toxicity|1|||
161003314|NCT03654768|581398045|FG001|Overall Study|Refusal not related to toxicity|5|||
161003315|NCT03654768|581398044|FG000|Overall Study|Did not receive protocol therapy|1|||
161003316|NCT03654768|581398045|FG001|Overall Study|Did not receive protocol therapy|1|||
161003317|NCT00588770|581398046|FG000|Overall Study|Disease progression|85|||
161003318|NCT00588770|581398047|FG001|Overall Study|Disease progression|68|||
161003319|NCT00588770|581398046|FG000|Overall Study|Adverse Event|29|||
161003320|NCT00588770|581398047|FG001|Overall Study|Adverse Event|58|||
161003321|NCT00588770|581398046|FG000|Overall Study|Death|13|||
161003322|NCT00588770|581398047|FG001|Overall Study|Death|22|||
161003323|NCT00588770|581398046|FG000|Overall Study|Withdrawal by Subject|15|||
161003324|NCT00588770|581398047|FG001|Overall Study|Withdrawal by Subject|25|||
161003325|NCT00588770|581398046|FG000|Overall Study|Alternative therapy|2|||
161003326|NCT00588770|581398047|FG001|Overall Study|Alternative therapy|4|||
161271209|NCT00977379|582375069|FG000|Overall Study|Withdrawal by Subject|1|||
161271210|NCT00977379|582375070|FG001|Overall Study|Withdrawal by Subject|1|||
161271211|NCT00977379|582375069|FG000|Overall Study|Death|7|||
161003327|NCT00588770|581398046|FG000|Overall Study|Other complicating disease|3|||
161003328|NCT00588770|581398047|FG001|Overall Study|Other complicating disease|2|||
161003329|NCT00588770|581398046|FG000|Overall Study|Not start protocol therapy|0|||
161003330|NCT00588770|581398047|FG001|Overall Study|Not start protocol therapy|9|||
161271212|NCT00977379|582375070|FG001|Overall Study|Death|9|||
161003331|NCT00588770|581398046|FG000|Overall Study|Lack of Efficacy|8|||
161003332|NCT00588770|581398047|FG001|Overall Study|Lack of Efficacy|10|||
161003333|NCT00588770|581398046|FG000|Overall Study|Physician discretion|2|||
161003334|NCT00588770|581398047|FG001|Overall Study|Physician discretion|0|||
161003335|NCT00588770|581398046|FG000|Overall Study|Patient non-compliance|2|||
161003336|NCT00588770|581398047|FG001|Overall Study|Patient non-compliance|2|||
161003337|NCT04697628|581398048|FG000|Overall Study|Withdrawal by Subject|17|||
161003338|NCT04697628|581398049|FG001|Overall Study|Withdrawal by Subject|23|||
161003339|NCT04697628|581398048|FG000|Overall Study|Lost to Follow-up|0|||
161003340|NCT04697628|581398049|FG001|Overall Study|Lost to Follow-up|4|||
161003341|NCT04697628|581398048|FG000|Overall Study|On-going in study|122|||
161003342|NCT04697628|581398049|FG001|Overall Study|On-going in study|91|||
161003343|NCT04177394|581398052|FG000|Overall Study|Death|16|||
161003344|NCT04177394|581398052|FG000|Overall Study|Withdrawal by Subject|19|||
161003345|NCT04177394|581398052|FG000|Overall Study|Missed visits|61|||
161003346|NCT04177394|581398052|FG000|Overall Study|Expected Visits|15|||
161003347|NCT00256243|581398053|FG000|Overall Study|Lost to Follow-up|2|||
161003348|NCT00256243|581398053|FG000|Overall Study|Death|7|||
161003349|NCT00256243|581398053|FG000|Overall Study|Not treated|1|||
161003350|NCT01152190|581398054|FG000|Overall Study|Adverse Event|2|||
161003351|NCT01152190|581398055|FG001|Overall Study|Adverse Event|4|||
161003352|NCT01152190|581398054|FG000|Overall Study|Death|1|||
161003353|NCT01152190|581398055|FG001|Overall Study|Death|0|||
161003354|NCT01152190|581398054|FG000|Overall Study|Protocol Violation|1|||
161003355|NCT01152190|581398055|FG001|Overall Study|Protocol Violation|1|||
161003356|NCT01152190|581398054|FG000|Overall Study|Withdrawal by Subject|1|||
161003357|NCT01152190|581398055|FG001|Overall Study|Withdrawal by Subject|3|||
161003358|NCT06129045|581398056|FG000|Overall Study|Lost to Follow-up|1|||
161003359|NCT06129045|581398057|FG001|Overall Study|Lost to Follow-up|1|||
161003360|NCT06129045|581398058|FG002|Overall Study|Lost to Follow-up|4|||
161003361|NCT02031471|581398059|FG000|24 Week Treatment Period|Adverse Event|6|||
161003362|NCT02031471|581398059|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
161003363|NCT02031471|581398059|FG000|24 Week Treatment Period|Protocol Violation|1|||
161003364|NCT02031471|581398059|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
161003365|NCT02031471|581398059|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
161003366|NCT02031471|581398059|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
161003367|NCT02031471|581398059|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
161003368|NCT03070483|581398060|FG000|Overall Study|Lost to Follow-up|2|||
161003369|NCT05797155|581398061|FG000|Overall Study|Lost to Follow-up|33|||
161003370|NCT05797155|581398062|FG001|Overall Study|Lost to Follow-up|12|||
161003371|NCT00617201|581398068|FG000|Overall Study|Lost to Follow-up|9|||
161003372|NCT00617201|581398069|FG001|Overall Study|Lost to Follow-up|13|||
161003373|NCT01350804|581398070|FG000|Core Study|Withdrawal by Subject|11|||
161003374|NCT01350804|581398071|FG001|Core Study|Withdrawal by Subject|17|||
161003375|NCT01350804|581398072|FG002|Core Study|Withdrawal by Subject|16|||
161003376|NCT01350804|581398073|FG003|Core Study|Withdrawal by Subject|7|||
161003377|NCT01350804|581398070|FG000|Core Study|Study terminated by Sponsor|0|||
161003378|NCT01350804|581398071|FG001|Core Study|Study terminated by Sponsor|0|||
161003379|NCT01350804|581398072|FG002|Core Study|Study terminated by Sponsor|0|||
161003380|NCT01350804|581398073|FG003|Core Study|Study terminated by Sponsor|2|||
161003381|NCT01350804|581398070|FG000|Core Study|Protocol deviation|1|||
161003382|NCT01350804|581398071|FG001|Core Study|Protocol deviation|0|||
161003383|NCT01350804|581398072|FG002|Core Study|Protocol deviation|1|||
161003384|NCT01350804|581398073|FG003|Core Study|Protocol deviation|0|||
161003385|NCT01350804|581398070|FG000|Core Study|Physician Decision|1|||
161003386|NCT01350804|581398071|FG001|Core Study|Physician Decision|0|||
161003387|NCT01350804|581398072|FG002|Core Study|Physician Decision|1|||
161003388|NCT01350804|581398073|FG003|Core Study|Physician Decision|3|||
161003389|NCT01350804|581398070|FG000|Core Study|Lost to Follow-up|3|||
161003390|NCT01350804|581398071|FG001|Core Study|Lost to Follow-up|0|||
161003391|NCT01350804|581398072|FG002|Core Study|Lost to Follow-up|2|||
161003392|NCT01350804|581398073|FG003|Core Study|Lost to Follow-up|1|||
161003393|NCT01350804|581398070|FG000|Core Study|Lack of Efficacy|16|||
161271213|NCT00977379|582375069|FG000|Overall Study|Premature Study Termination|4|||
161003394|NCT01350804|581398071|FG001|Core Study|Lack of Efficacy|19|||
161003395|NCT01350804|581398072|FG002|Core Study|Lack of Efficacy|18|||
161003396|NCT01350804|581398073|FG003|Core Study|Lack of Efficacy|5|||
161003397|NCT01350804|581398070|FG000|Core Study|Death|1|||
161003398|NCT01350804|581398071|FG001|Core Study|Death|1|||
161271214|NCT00977379|582375070|FG001|Overall Study|Premature Study Termination|0|||
161003399|NCT01350804|581398072|FG002|Core Study|Death|1|||
161003400|NCT01350804|581398073|FG003|Core Study|Death|0|||
161003401|NCT01350804|581398070|FG000|Core Study|Adverse Event|8|||
161003402|NCT01350804|581398071|FG001|Core Study|Adverse Event|10|||
161003403|NCT01350804|581398072|FG002|Core Study|Adverse Event|8|||
161003404|NCT01350804|581398073|FG003|Core Study|Adverse Event|8|||
161003405|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
161003406|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
161003407|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
161271215|NCT00977379|582375069|FG000|Overall Study|Participant Moving House|0|||
161271216|NCT00977379|582375070|FG001|Overall Study|Participant Moving House|1|||
161271217|NCT00977379|582375069|FG000|Overall Study|Randomization Error|0|||
161271218|NCT00977379|582375070|FG001|Overall Study|Randomization Error|1|||
161271219|NCT03972163|582375071|FG000|Overall Study|Death|0|||
161271220|NCT03972163|582375072|FG001|Overall Study|Death|1|||
161271221|NCT01212588|582375075|FG000|Overall Study|Physician Decision|0|||
161271222|NCT01212588|582375076|FG001|Overall Study|Physician Decision|1|||
161271223|NCT01212588|582375075|FG000|Overall Study|Protocol Violation|1|||
161271224|NCT01212588|582375076|FG001|Overall Study|Protocol Violation|1|||
161271225|NCT02885181|582375077|FG000|Overall Study|Investigator's Discretion|0|||
161271226|NCT02885181|582375078|FG001|Overall Study|Investigator's Discretion|1|||
161271227|NCT02885181|582375079|FG002|Overall Study|Investigator's Discretion|0|||
161271228|NCT02885181|582375080|FG003|Overall Study|Investigator's Discretion|1|||
161271229|NCT02885181|582375077|FG000|Overall Study|Adverse Event|0|||
161271230|NCT02885181|582375078|FG001|Overall Study|Adverse Event|0|||
161271231|NCT02885181|582375079|FG002|Overall Study|Adverse Event|0|||
161271232|NCT02885181|582375080|FG003|Overall Study|Adverse Event|1|||
160965333|NCT02496767|581261132|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965334|NCT02496767|581261133|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
160965335|NCT02496767|581261134|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
160965336|NCT02496767|581261135|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
160965337|NCT02496767|581261136|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
160965338|NCT03641313|581261145|FG000|Overall Study|Death|1|||
160965339|NCT03641313|581261145|FG000|Overall Study|Withdrawal by Subject|2|||
160965340|NCT03641313|581261145|FG000|Overall Study|Declining health|1|||
160965341|NCT03641313|581261145|FG000|Overall Study|Adverse Event|1|||
160965342|NCT01533493|581261148|FG000|Overall Study|Adverse Event|2|||
160965343|NCT01533493|581261149|FG001|Overall Study|Adverse Event|1|||
160965344|NCT01533493|581261148|FG000|Overall Study|Withdrawal by Subject|1|||
160965345|NCT01533493|581261149|FG001|Overall Study|Withdrawal by Subject|2|||
160965346|NCT01533493|581261148|FG000|Overall Study|Lost to Follow-up|2|||
160965347|NCT01533493|581261149|FG001|Overall Study|Lost to Follow-up|0|||
160965348|NCT02521285|581261153|FG000|Overall Study|Lost to Follow-up|1|||
160965349|NCT02521285|581261154|FG001|Overall Study|Lost to Follow-up|1|||
160965350|NCT02521285|581261153|FG000|Overall Study|Withdrawal by Subject|1|||
160965351|NCT02521285|581261154|FG001|Overall Study|Withdrawal by Subject|1|||
160965352|NCT02521285|581261153|FG000|Overall Study|Adverse Event|0|||
160965353|NCT02521285|581261154|FG001|Overall Study|Adverse Event|1|||
160965354|NCT05701995|581261156|FG000|Pre-Treatment|Randomization Error|1|||
160965355|NCT05701995|581261157|FG001|Pre-Treatment|Randomization Error|1|||
160965356|NCT05701995|581261156|FG000|Treatment|Withdrawal by Subject|8|||
160965357|NCT05701995|581261157|FG001|Treatment|Withdrawal by Subject|4|||
160965358|NCT05701995|581261156|FG000|Treatment|Lost to Follow-up|2|||
160965359|NCT05701995|581261157|FG001|Treatment|Lost to Follow-up|3|||
160965360|NCT05701995|581261156|FG000|Treatment|Adverse Event|3|||
160965361|NCT05701995|581261157|FG001|Treatment|Adverse Event|1|||
160965362|NCT05701995|581261156|FG000|Treatment|Other Reason|1|||
160965363|NCT05701995|581261157|FG001|Treatment|Other Reason|1|||
160965364|NCT05701995|581261156|FG000|Treatment|Death|1|||
160965365|NCT05701995|581261157|FG001|Treatment|Death|0|||
160965366|NCT05701995|581261156|FG000|Treatment|Physician Decision|0|||
160965367|NCT05701995|581261157|FG001|Treatment|Physician Decision|1|||
160965368|NCT00715429|581261158|FG000|Overall Study|Did not complete the study diary|0|||
160965369|NCT00715429|581261159|FG001|Overall Study|Did not complete the study diary|1|||
160965370|NCT04899245|581261164|FG000|Overall Study|Withdrawal by Subject|3|||
160965371|NCT04899245|581261165|FG001|Overall Study|Withdrawal by Subject|5|||
160965372|NCT04899245|581261166|FG002|Overall Study|Withdrawal by Subject|2|||
160965373|NCT04899245|581261164|FG000|Overall Study|No longer eligible - Left staff position|0|||
160965374|NCT04899245|581261165|FG001|Overall Study|No longer eligible - Left staff position|0|||
160965375|NCT04899245|581261166|FG002|Overall Study|No longer eligible - Left staff position|1|||
160965376|NCT04899245|581261164|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
160965377|NCT04899245|581261165|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
160965378|NCT04899245|581261166|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
161003408|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
160965379|NCT04899245|581261164|FG000|Overall Study|No longer eligible - Moved away from area|2|||
160965380|NCT04899245|581261165|FG001|Overall Study|No longer eligible - Moved away from area|2|||
160965381|NCT04899245|581261166|FG002|Overall Study|No longer eligible - Moved away from area|0|||
161003409|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
160965382|NCT03937219|581261175|FG000|Overall Study|Death|223|||
160965383|NCT03937219|581261176|FG001|Overall Study|Death|211|||
161271233|NCT02885181|582375077|FG000|Overall Study|Withdrawal by Subject|0|||
161271234|NCT02885181|582375078|FG001|Overall Study|Withdrawal by Subject|0|||
161271235|NCT02885181|582375079|FG002|Overall Study|Withdrawal by Subject|0|||
161271236|NCT02885181|582375080|FG003|Overall Study|Withdrawal by Subject|1|||
161271237|NCT04005352|582375089|FG000|Overall Study|Adverse Event|4|||
161343494|NCT03965923|582644400|FG010|Overall Study|Death|4|||
161343495|NCT03965923|582644401|FG011|Overall Study|Death|0|||
160965384|NCT03937219|581261175|FG000|Overall Study|Withdrawal by Subject|17|||
160965385|NCT03937219|581261176|FG001|Overall Study|Withdrawal by Subject|25|||
160965386|NCT03937219|581261175|FG000|Overall Study|Lost to Follow-up|3|||
160965387|NCT03937219|581261176|FG001|Overall Study|Lost to Follow-up|4|||
160965388|NCT04003610|581261177|FG000|Overall Study|Lost to Follow-up|0|||
160965389|NCT04003610|581261178|FG001|Overall Study|Lost to Follow-up|1|||
160965390|NCT04003610|581261179|FG002|Overall Study|Lost to Follow-up|0|||
160965391|NCT04003610|581261177|FG000|Overall Study|Death|0|||
160965392|NCT04003610|581261178|FG001|Overall Study|Death|0|||
160965393|NCT04003610|581261179|FG002|Overall Study|Death|3|||
160965394|NCT04003610|581261177|FG000|Overall Study|Study Terminated by Sponsor|0|||
160965395|NCT04003610|581261178|FG001|Overall Study|Study Terminated by Sponsor|0|||
160965396|NCT04003610|581261179|FG002|Overall Study|Study Terminated by Sponsor|3|||
160965397|NCT03078816|581261183|FG000|Overall Study|Withdrawal by Subject|1|||
160965398|NCT02114151|581261184|FG000|Overall Study|Death|1|||
160965399|NCT02114151|581261184|FG000|Overall Study|Lost to Follow-up|1|||
160965400|NCT02114151|581261184|FG000|Overall Study|Withdrawal by Subject|5|||
160965401|NCT00500903|581261185|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
160965402|NCT00500903|581261186|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
160965403|NCT00500903|581261187|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
160965404|NCT00500903|581261185|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
160965405|NCT00500903|581261186|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
160965406|NCT00500903|581261187|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
160965407|NCT00500903|581261185|FG000|Overall Study|Progressive Disease|41|||
160965408|NCT00500903|581261186|FG001|Overall Study|Progressive Disease|2|||
160965409|NCT00500903|581261187|FG002|Overall Study|Progressive Disease|15|||
160965410|NCT00500903|581261185|FG000|Overall Study|Patient Declined Further Treatment|0|||
160965411|NCT00500903|581261186|FG001|Overall Study|Patient Declined Further Treatment|0|||
160965412|NCT00500903|581261187|FG002|Overall Study|Patient Declined Further Treatment|3|||
160965413|NCT00500903|581261185|FG000|Overall Study|Symptomatic Deterioration|2|||
160965414|NCT00500903|581261186|FG001|Overall Study|Symptomatic Deterioration|0|||
160965415|NCT00500903|581261187|FG002|Overall Study|Symptomatic Deterioration|0|||
160965416|NCT00500903|581261185|FG000|Overall Study|Reason Not Specified|10|||
160965417|NCT00500903|581261186|FG001|Overall Study|Reason Not Specified|0|||
160965418|NCT00500903|581261187|FG002|Overall Study|Reason Not Specified|2|||
160965419|NCT01648348|581261190|FG000|Overall Study|Cancel|1|||
160965420|NCT01648348|581261191|FG001|Overall Study|Cancel|0|||
160965421|NCT01648348|581261192|FG002|Overall Study|Cancel|0|||
160965422|NCT01648348|581261193|FG003|Overall Study|Cancel|0|||
160965423|NCT01648348|581261194|FG004|Overall Study|Cancel|3|||
160965424|NCT01648348|581261195|FG005|Overall Study|Cancel|6|||
160965425|NCT01648348|581261190|FG000|Overall Study|Replaced for MTD analysis|1|||
160965426|NCT01648348|581261191|FG001|Overall Study|Replaced for MTD analysis|0|||
160965427|NCT01648348|581261192|FG002|Overall Study|Replaced for MTD analysis|1|||
160965428|NCT01648348|581261193|FG003|Overall Study|Replaced for MTD analysis|0|||
160965429|NCT01648348|581261194|FG004|Overall Study|Replaced for MTD analysis|0|||
160965430|NCT01648348|581261195|FG005|Overall Study|Replaced for MTD analysis|0|||
160965431|NCT00265889|581261199|FG000|Overall Study|Physician Decision|1|||
160965432|NCT00265889|581261199|FG000|Overall Study|Protocol Violation|1|||
160965433|NCT00265889|581261199|FG000|Overall Study|Insurance denied the request|3|||
160965434|NCT02134587|581261200|FG000|Overall Study|Did not completed all meetings|30|||
160965435|NCT03308825|581262905|FG000|Overall Study|Lost to Follow-up|2|||
160965436|NCT03308825|581262906|FG001|Overall Study|Lost to Follow-up|2|||
160965437|NCT03308825|581262907|FG002|Overall Study|Lost to Follow-up|1|||
160965438|NCT03308825|581262908|FG003|Overall Study|Lost to Follow-up|0|||
160965439|NCT03308825|581262905|FG000|Overall Study|Protocol Violation|0|||
160965440|NCT03308825|581262906|FG001|Overall Study|Protocol Violation|2|||
160965441|NCT03308825|581262907|FG002|Overall Study|Protocol Violation|0|||
160965442|NCT03308825|581262908|FG003|Overall Study|Protocol Violation|0|||
160965443|NCT02790073|581262909|FG000|Overall Study|Death|1|||
160965444|NCT02790073|581262909|FG000|Overall Study|Withdrawal from HD|1|||
160965445|NCT02790073|581262909|FG000|Overall Study|Withdrawal by Subject|1|||
160965446|NCT03328143|581262910|FG000|Overall Study|Declined|3|||
160965447|NCT03328143|581262910|FG000|Overall Study|Required increased sedation|4|||
160965448|NCT03328143|581262910|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
160965449|NCT03328143|581262910|FG000|Overall Study|Surgery cancelled|1|||
160965450|NCT01370525|581262911|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
160965451|NCT01370525|581262912|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
160965452|NCT01370525|581262911|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
160965453|NCT01370525|581262912|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
160965454|NCT01370525|581262911|FG000|Overall Study|Adverse Event|0|||
160965455|NCT01370525|581262912|FG001|Overall Study|Adverse Event|1|||
160965456|NCT01370525|581262911|FG000|Overall Study|Protocol Violation|2|||
160965457|NCT01370525|581262912|FG001|Overall Study|Protocol Violation|1|||
160965458|NCT01370525|581262911|FG000|Overall Study|Lost to follow up|2|||
161343496|NCT03965923|582644390|FG000|Overall Study|Other reason|0|||
161271238|NCT04005352|582375090|FG001|Overall Study|Adverse Event|5|||
161271239|NCT04005352|582375089|FG000|Overall Study|Death|4|||
161271240|NCT04005352|582375090|FG001|Overall Study|Death|2|||
161271241|NCT04005352|582375089|FG000|Overall Study|Lost to Follow-up|6|||
161271242|NCT04005352|582375090|FG001|Overall Study|Lost to Follow-up|2|||
160965459|NCT01370525|581262912|FG001|Overall Study|Lost to follow up|6|||
160965460|NCT00106184|581262913|FG000|Overall Study|Withdrawal by Subject|3|||
160965461|NCT00106184|581262914|FG001|Overall Study|Withdrawal by Subject|2|||
160965462|NCT05292534|581262915|FG000|Overall Study|Protocol Violation|3|||
160965463|NCT05292534|581262916|FG001|Overall Study|Protocol Violation|4|||
160965464|NCT05292534|581262915|FG000|Overall Study|Withdrawal by Subject|0|||
160965465|NCT05292534|581262916|FG001|Overall Study|Withdrawal by Subject|1|||
160965466|NCT04710927|581262919|FG000|Overall Study|Lost to Follow-up|7|||
160965467|NCT04710927|581262920|FG001|Overall Study|Lost to Follow-up|6|||
160965468|NCT04710927|581262921|FG002|Overall Study|Lost to Follow-up|5|||
160965469|NCT01376323|581262925|FG000|Overall Study|Adverse Event|1|||
160965470|NCT01376323|581262926|FG001|Overall Study|Adverse Event|0|||
160965471|NCT01376323|581262927|FG002|Overall Study|Adverse Event|0|||
160965472|NCT01376323|581262928|FG003|Overall Study|Adverse Event|2|||
160965473|NCT01376323|581262929|FG004|Overall Study|Adverse Event|0|||
160965474|NCT01376323|581262925|FG000|Overall Study|Lost to Follow-up|0|||
160965475|NCT01376323|581262926|FG001|Overall Study|Lost to Follow-up|0|||
160965476|NCT01376323|581262927|FG002|Overall Study|Lost to Follow-up|0|||
160965477|NCT01376323|581262928|FG003|Overall Study|Lost to Follow-up|2|||
160965478|NCT01376323|581262929|FG004|Overall Study|Lost to Follow-up|0|||
160965479|NCT01376323|581262925|FG000|Overall Study|Physician Decision|1|||
160965480|NCT01376323|581262926|FG001|Overall Study|Physician Decision|0|||
160965481|NCT01376323|581262927|FG002|Overall Study|Physician Decision|2|||
160965482|NCT01376323|581262928|FG003|Overall Study|Physician Decision|1|||
160965483|NCT01376323|581262929|FG004|Overall Study|Physician Decision|1|||
160965484|NCT01376323|581262925|FG000|Overall Study|Withdrawal by Subject|0|||
160965485|NCT01376323|581262926|FG001|Overall Study|Withdrawal by Subject|1|||
160965486|NCT01376323|581262927|FG002|Overall Study|Withdrawal by Subject|1|||
160965487|NCT01376323|581262928|FG003|Overall Study|Withdrawal by Subject|0|||
160965488|NCT01376323|581262929|FG004|Overall Study|Withdrawal by Subject|0|||
160965489|NCT00454571|581262930|FG000|Overall Study|Adverse Event|2|||
160965490|NCT00454571|581262931|FG001|Overall Study|Adverse Event|0|||
160965491|NCT00454571|581262930|FG000|Overall Study|Physician Decision|0|||
160965492|NCT00454571|581262931|FG001|Overall Study|Physician Decision|1|||
160965493|NCT00454571|581262930|FG000|Overall Study|Protocol Violation|1|||
160965494|NCT00454571|581262931|FG001|Overall Study|Protocol Violation|0|||
160965495|NCT00454571|581262930|FG000|Overall Study|Withdrawal by Subject|10|||
160965496|NCT00454571|581262931|FG001|Overall Study|Withdrawal by Subject|5|||
160965497|NCT04681729|581262932|FG000|Overall Study|Lack of Efficacy|2|||
160965498|NCT04681729|581262933|FG001|Overall Study|Lack of Efficacy|2|||
160965499|NCT04681729|581262932|FG000|Overall Study|Withdrawal by Subject|8|||
160965500|NCT04681729|581262933|FG001|Overall Study|Withdrawal by Subject|9|||
160965501|NCT03595332|581262934|FG000|Overall Study|Lost to Follow-up|16|||
160965502|NCT03595332|581262935|FG001|Overall Study|Lost to Follow-up|22|||
160965503|NCT03595332|581262934|FG000|Overall Study|Unable to retrieve ID from school|0|||
160965504|NCT03595332|581262935|FG001|Overall Study|Unable to retrieve ID from school|2|||
160965505|NCT00792103|581262936|FG000|Overall Study|Enrolled, not treated|15|||
160965506|NCT00792103|581262936|FG000|Overall Study|Lost to Follow-up|17|||
160965507|NCT00792103|581262936|FG000|Overall Study|Adverse Event|25|||
160965508|NCT00792103|581262936|FG000|Overall Study|Withdrawal by Subject|52|||
160965509|NCT00792103|581262936|FG000|Overall Study|Protocol Violation|10|||
160965510|NCT00792103|581262936|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
160965511|NCT02227875|581262937|FG000|Overall Study|Protocol Violation|10|||
160965512|NCT02227875|581262938|FG001|Overall Study|Protocol Violation|7|||
160965513|NCT02227875|581262937|FG000|Overall Study|Other|1|||
160965514|NCT02227875|581262938|FG001|Overall Study|Other|3|||
160965515|NCT02227875|581262937|FG000|Overall Study|Physician Decision|1|||
160965516|NCT02227875|581262938|FG001|Overall Study|Physician Decision|0|||
160965517|NCT02227875|581262937|FG000|Overall Study|Adverse Event|3|||
160965518|NCT02227875|581262938|FG001|Overall Study|Adverse Event|0|||
160965519|NCT02227875|581262937|FG000|Overall Study|Withdrawal by Subject|12|||
160965520|NCT02227875|581262938|FG001|Overall Study|Withdrawal by Subject|13|||
160965521|NCT02227875|581262937|FG000|Overall Study|Lost to Follow-up|10|||
160965522|NCT02227875|581262938|FG001|Overall Study|Lost to Follow-up|10|||
160965523|NCT01201811|581262939|FG000|Overall Study|Adverse Event|6|||
160965524|NCT01201811|581262939|FG000|Overall Study|Disease progression|3|||
160965525|NCT01201811|581262939|FG000|Overall Study|Withdrawal by Subject|3|||
160965526|NCT01201811|581262939|FG000|Overall Study|Death|4|||
160965527|NCT01201811|581262939|FG000|Overall Study|Treatment Failure|2|||
160965528|NCT01201811|581262939|FG000|Overall Study|Physician Decision|1|||
160965529|NCT02856113|581262940|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
160965530|NCT02856113|581262941|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161147126|NCT01736683|581922403|FG000|Overall Study|Progressive Disease|0|||
161271243|NCT04005352|582375089|FG000|Overall Study|Physician Decision|7|||
161271244|NCT04005352|582375090|FG001|Overall Study|Physician Decision|13|||
161271245|NCT04005352|582375089|FG000|Overall Study|Protocol Violation|0|||
161271246|NCT04005352|582375090|FG001|Overall Study|Protocol Violation|1|||
161271247|NCT04005352|582375089|FG000|Overall Study|Withdrawal by Subject|28|||
161271248|NCT04005352|582375090|FG001|Overall Study|Withdrawal by Subject|38|||
161271249|NCT01283035|582375091|FG000|Overall Study|Subject later found ineligible|1|||
161271250|NCT03597529|582375094|FG000|Overall Study|Lost to Follow-up|10|||
161271251|NCT03597529|582375095|FG001|Overall Study|Lost to Follow-up|12|||
161271252|NCT03597529|582375094|FG000|Overall Study|Physician Decision|3|||
161271253|NCT03597529|582375095|FG001|Overall Study|Physician Decision|1|||
161271254|NCT03597529|582375094|FG000|Overall Study|Withdrawal by Subject|6|||
161271255|NCT03597529|582375095|FG001|Overall Study|Withdrawal by Subject|3|||
161271256|NCT03597529|582375094|FG000|Overall Study|Non-compliant with study activities|1|||
161271257|NCT03597529|582375095|FG001|Overall Study|Non-compliant with study activities|2|||
161271258|NCT00191165|582375096|FG000|Overall Study|Adverse Event|2|||
161271259|NCT00191165|582375097|FG001|Overall Study|Adverse Event|0|||
161271260|NCT00191165|582375096|FG000|Overall Study|Protocol Violation|0|||
161271261|NCT00191165|582375097|FG001|Overall Study|Protocol Violation|1|||
160965531|NCT02856113|581262940|FG000|Overall Study|Significant Protocol Deviation|1|||
160965532|NCT02856113|581262941|FG001|Overall Study|Significant Protocol Deviation|0|||
160965533|NCT02856113|581262940|FG000|Overall Study|Lost to Follow-up|3|||
160965534|NCT02856113|581262941|FG001|Overall Study|Lost to Follow-up|5|||
160965535|NCT02856113|581262940|FG000|Overall Study|Voluntary Withdrawal|3|||
160965536|NCT02856113|581262941|FG001|Overall Study|Voluntary Withdrawal|5|||
160965537|NCT02856113|581262940|FG000|Overall Study|Pregnancy|0|||
160965538|NCT02856113|581262941|FG001|Overall Study|Pregnancy|1|||
160965539|NCT02856113|581262940|FG000|Overall Study|Principal Investigator Discretion|2|||
160965540|NCT02856113|581262941|FG001|Overall Study|Principal Investigator Discretion|1|||
160965541|NCT02856113|581262940|FG000|Overall Study|Randomized but not Treated|1|||
160965542|NCT02856113|581262941|FG001|Overall Study|Randomized but not Treated|0|||
160965543|NCT02856113|581262940|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
160965544|NCT02856113|581262941|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
160965545|NCT03494166|581262942|FG000|Overall Study|Death|0|||
160965546|NCT03494166|581262943|FG001|Overall Study|Death|0|||
160965547|NCT03494166|581262944|FG002|Overall Study|Death|0|||
160965548|NCT03494166|581262945|FG003|Overall Study|Death|1|||
160965549|NCT03494166|581262946|FG004|Overall Study|Death|3|||
160965550|NCT03494166|581262947|FG005|Overall Study|Death|0|||
160965551|NCT03494166|581262942|FG000|Overall Study|Lost to Follow-up|2|||
160965552|NCT03494166|581262943|FG001|Overall Study|Lost to Follow-up|2|||
160965553|NCT03494166|581262944|FG002|Overall Study|Lost to Follow-up|2|||
160965554|NCT03494166|581262945|FG003|Overall Study|Lost to Follow-up|2|||
160965555|NCT03494166|581262946|FG004|Overall Study|Lost to Follow-up|14|||
160965556|NCT03494166|581262947|FG005|Overall Study|Lost to Follow-up|0|||
160965557|NCT03494166|581262942|FG000|Overall Study|Withdrawal by Subject|10|||
160965558|NCT03494166|581262943|FG001|Overall Study|Withdrawal by Subject|7|||
160965559|NCT03494166|581262944|FG002|Overall Study|Withdrawal by Subject|0|||
160965560|NCT03494166|581262945|FG003|Overall Study|Withdrawal by Subject|5|||
160965561|NCT03494166|581262946|FG004|Overall Study|Withdrawal by Subject|3|||
160965562|NCT03494166|581262947|FG005|Overall Study|Withdrawal by Subject|17|||
160965563|NCT03494166|581262942|FG000|Overall Study|Screen failure|1|||
160965564|NCT03494166|581262943|FG001|Overall Study|Screen failure|0|||
160965565|NCT03494166|581262944|FG002|Overall Study|Screen failure|0|||
160965566|NCT03494166|581262945|FG003|Overall Study|Screen failure|0|||
160965567|NCT03494166|581262946|FG004|Overall Study|Screen failure|1|||
160965568|NCT03494166|581262947|FG005|Overall Study|Screen failure|0|||
160965569|NCT02857426|581262948|FG000|Overall Study|Disease progression|34|||
160965570|NCT02857426|581262949|FG001|Overall Study|Disease progression|13|||
160965571|NCT02857426|581262948|FG000|Overall Study|Study drug toxicity|4|||
160965572|NCT02857426|581262949|FG001|Overall Study|Study drug toxicity|1|||
160965573|NCT02857426|581262948|FG000|Overall Study|Death|1|||
160965574|NCT02857426|581262949|FG001|Overall Study|Death|0|||
160965575|NCT02857426|581262948|FG000|Overall Study|Adverse event unrelated to study drug|6|||
160965576|NCT02857426|581262949|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161271262|NCT00191165|582375096|FG000|Overall Study|Participant Moved Away|0|||
160965577|NCT02857426|581262948|FG000|Overall Study|Participant withdrew consent|1|||
160965578|NCT02857426|581262949|FG001|Overall Study|Participant withdrew consent|1|||
160965579|NCT02857426|581262948|FG000|Overall Study|Maximum clinical benefit|1|||
160965580|NCT02857426|581262949|FG001|Overall Study|Maximum clinical benefit|0|||
160965581|NCT02857426|581262948|FG000|Overall Study|Completed treatment|0|||
160965582|NCT02857426|581262949|FG001|Overall Study|Completed treatment|2|||
160965583|NCT01960725|581262950|FG000|Overall Study|Lost to Follow-up|4|||
160965584|NCT01960725|581262951|FG001|Overall Study|Lost to Follow-up|3|||
161147127|NCT01736683|581922404|FG001|Overall Study|Progressive Disease|0|||
161271263|NCT00191165|582375097|FG001|Overall Study|Participant Moved Away|1|||
161271264|NCT03200912|582375098|FG000|Overall Study|Adverse Event|3|||
161271265|NCT03200912|582375099|FG001|Overall Study|Adverse Event|0|||
161271266|NCT03200912|582375100|FG002|Overall Study|Adverse Event|0|||
161003410|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
161003411|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
161003412|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
161003413|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
161003414|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
161147128|NCT01736683|581922405|FG002|Overall Study|Progressive Disease|0|||
161147129|NCT01736683|581922406|FG003|Overall Study|Progressive Disease|1|||
161147130|NCT01736683|581922407|FG004|Overall Study|Progressive Disease|0|||
161147131|NCT01736683|581922403|FG000|Overall Study|Other|0|||
161147132|NCT01736683|581922404|FG001|Overall Study|Other|0|||
161147133|NCT01736683|581922405|FG002|Overall Study|Other|1|||
161147134|NCT01736683|581922406|FG003|Overall Study|Other|9|||
161147135|NCT01736683|581922407|FG004|Overall Study|Other|1|||
161147136|NCT00283712|581922413|FG000|Overall Study|Death|0|||
161147137|NCT00283712|581922414|FG001|Overall Study|Death|1|||
161147138|NCT02046564|581922418|FG000|Overall Study|Adverse Event|6|||
161147139|NCT02046564|581922419|FG001|Overall Study|Adverse Event|3|||
161147140|NCT02046564|581922418|FG000|Overall Study|Physician Decision|0|||
161147141|NCT02046564|581922419|FG001|Overall Study|Physician Decision|1|||
161147142|NCT02046564|581922418|FG000|Overall Study|Protocol Violation|3|||
161147143|NCT02046564|581922419|FG001|Overall Study|Protocol Violation|1|||
161147144|NCT02046564|581922418|FG000|Overall Study|Withdrawal by Subject|4|||
161147145|NCT02046564|581922419|FG001|Overall Study|Withdrawal by Subject|10|||
161147146|NCT02046564|581922418|FG000|Overall Study|Subject met withdrawal criteria|2|||
161147147|NCT02046564|581922419|FG001|Overall Study|Subject met withdrawal criteria|5|||
161147148|NCT00907478|581922420|FG000|Overall Study|Ineligibility determined|0|||
161147149|NCT00907478|581922421|FG001|Overall Study|Ineligibility determined|0|||
161147150|NCT00907478|581922422|FG002|Overall Study|Ineligibility determined|1|||
161147151|NCT00907478|581922420|FG000|Overall Study|Noncompliance|0|||
161147152|NCT00907478|581922421|FG001|Overall Study|Noncompliance|0|||
161147153|NCT00907478|581922422|FG002|Overall Study|Noncompliance|1|||
161147154|NCT00907478|581922420|FG000|Overall Study|Adverse Event|3|||
161147155|NCT00907478|581922421|FG001|Overall Study|Adverse Event|1|||
161147156|NCT00907478|581922422|FG002|Overall Study|Adverse Event|2|||
161271267|NCT03200912|582375098|FG000|Overall Study|Withdrawal by Subject|1|||
161271268|NCT03200912|582375099|FG001|Overall Study|Withdrawal by Subject|2|||
161271269|NCT03200912|582375100|FG002|Overall Study|Withdrawal by Subject|4|||
161271270|NCT03200912|582375098|FG000|Overall Study|Non-compliance with study drug|0|||
161271271|NCT03200912|582375099|FG001|Overall Study|Non-compliance with study drug|1|||
161271272|NCT03200912|582375100|FG002|Overall Study|Non-compliance with study drug|0|||
161003415|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
161003416|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
161003417|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161003418|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
161003419|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161003420|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
161003421|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
161003422|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
161003423|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
161003424|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
161003425|NCT01350804|581398070|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
161147157|NCT00907478|581922420|FG000|Overall Study|Withdrawal by Subject|8|||
161147158|NCT00907478|581922421|FG001|Overall Study|Withdrawal by Subject|9|||
161147159|NCT00907478|581922422|FG002|Overall Study|Withdrawal by Subject|6|||
161271273|NCT03196635|582375101|FG000|Overall Study|Withdrawal by Subject|1|||
161271274|NCT00998309|582375102|FG000|Overall Study|Protocol Violation|4|||
161147160|NCT00907478|581922420|FG000|Overall Study|Requirement for alternative therapy|1|||
161147161|NCT00907478|581922421|FG001|Overall Study|Requirement for alternative therapy|2|||
160965585|NCT01960725|581262950|FG000|Overall Study|Withdrawal by Subject|1|||
160965586|NCT01960725|581262951|FG001|Overall Study|Withdrawal by Subject|0|||
160965587|NCT01960725|581262950|FG000|Overall Study|unable to obtain blood sample|1|||
160965588|NCT01960725|581262951|FG001|Overall Study|unable to obtain blood sample|2|||
160965589|NCT00611858|581262956|FG000|Overall Study|Adverse Event|2|||
160965590|NCT00611858|581262956|FG000|Overall Study|Withdrawal by Subject|2|||
160965591|NCT01844284|581262957|FG000|Overall Study|Lost to Follow-up|12|||
160965592|NCT01844284|581262958|FG001|Overall Study|Lost to Follow-up|7|||
160965593|NCT01058304|581262959|FG000|Overall Study|Withdrawal by Subject|8|||
160965594|NCT01058304|581262960|FG001|Overall Study|Withdrawal by Subject|5|||
160965595|NCT01058304|581262959|FG000|Overall Study|Lost to Follow-up|13|||
160965596|NCT01058304|581262960|FG001|Overall Study|Lost to Follow-up|16|||
160965597|NCT01058304|581262959|FG000|Overall Study|Developed exclusion criterion|6|||
161147162|NCT00907478|581922422|FG002|Overall Study|Requirement for alternative therapy|3|||
161147163|NCT00907478|581922420|FG000|Overall Study|Physician Decision|2|||
161147164|NCT00907478|581922421|FG001|Overall Study|Physician Decision|0|||
161147165|NCT00907478|581922422|FG002|Overall Study|Physician Decision|3|||
161147166|NCT00907478|581922420|FG000|Overall Study|Death|4|||
161147167|NCT00907478|581922421|FG001|Overall Study|Death|2|||
161147168|NCT00907478|581922422|FG002|Overall Study|Death|1|||
161147169|NCT00907478|581922420|FG000|Overall Study|Protocol-specified criteria|5|||
161147170|NCT00907478|581922421|FG001|Overall Study|Protocol-specified criteria|2|||
161147171|NCT00907478|581922422|FG002|Overall Study|Protocol-specified criteria|3|||
161147172|NCT00907478|581922420|FG000|Overall Study|Pregnancy|0|||
161271275|NCT05788289|582375105|FG000|Overall Study|Death|3|||
160965598|NCT01058304|581262960|FG001|Overall Study|Developed exclusion criterion|12|||
160965599|NCT01820559|581262961|FG000|Overall Study|Adverse Event|4|||
160965600|NCT01820559|581262962|FG001|Overall Study|Adverse Event|6|||
160965601|NCT01820559|581262963|FG002|Overall Study|Adverse Event|13|||
160965602|NCT01820559|581262961|FG000|Overall Study|Withdrawal by Subject|1|||
160965603|NCT01820559|581262962|FG001|Overall Study|Withdrawal by Subject|2|||
160965604|NCT01820559|581262963|FG002|Overall Study|Withdrawal by Subject|5|||
160965605|NCT01820559|581262961|FG000|Overall Study|Protocol Violation|2|||
160965606|NCT01820559|581262962|FG001|Overall Study|Protocol Violation|1|||
160965607|NCT01820559|581262963|FG002|Overall Study|Protocol Violation|3|||
160965608|NCT01820559|581262961|FG000|Overall Study|Subject's non-compliance|1|||
160965609|NCT01820559|581262962|FG001|Overall Study|Subject's non-compliance|0|||
160965610|NCT01820559|581262963|FG002|Overall Study|Subject's non-compliance|2|||
160965611|NCT01820559|581262961|FG000|Overall Study|Lost to Follow-up|3|||
160965612|NCT01820559|581262962|FG001|Overall Study|Lost to Follow-up|2|||
160965613|NCT01820559|581262963|FG002|Overall Study|Lost to Follow-up|2|||
160965614|NCT01820559|581262961|FG000|Overall Study|At sponsor request|0|||
160965615|NCT01820559|581262962|FG001|Overall Study|At sponsor request|0|||
160965616|NCT01820559|581262963|FG002|Overall Study|At sponsor request|1|||
160965617|NCT01820559|581262961|FG000|Overall Study|Lack of Efficacy|3|||
160965618|NCT01820559|581262962|FG001|Overall Study|Lack of Efficacy|2|||
160965619|NCT01820559|581262963|FG002|Overall Study|Lack of Efficacy|3|||
160965620|NCT00166296|581262965|FG000|Overall Study|Withdrawal by Subject|1|||
160965621|NCT00166296|581262966|FG001|Overall Study|Withdrawal by Subject|3|||
160965622|NCT00166296|581262965|FG000|Overall Study|Adverse Event|2|||
160965623|NCT00166296|581262966|FG001|Overall Study|Adverse Event|4|||
160965624|NCT00166296|581262965|FG000|Overall Study|Lost to Follow-up|4|||
160965625|NCT00166296|581262966|FG001|Overall Study|Lost to Follow-up|2|||
160965626|NCT04035200|581262967|FG000|Overall Study|Lost to Follow-up|0|||
160965627|NCT04035200|581262968|FG001|Overall Study|Lost to Follow-up|1|||
160965628|NCT04035200|581262969|FG002|Overall Study|Lost to Follow-up|0|||
160965629|NCT04035200|581262967|FG000|Overall Study|Withdrawal by Subject|1|||
160965630|NCT04035200|581262968|FG001|Overall Study|Withdrawal by Subject|4|||
160965631|NCT04035200|581262969|FG002|Overall Study|Withdrawal by Subject|4|||
160965632|NCT04035200|581262967|FG000|Overall Study|COVID-19|1|||
160965633|NCT04035200|581262968|FG001|Overall Study|COVID-19|0|||
160965634|NCT04035200|581262969|FG002|Overall Study|COVID-19|0|||
160965635|NCT04035200|581262967|FG000|Overall Study|Early Termination|0|||
160965636|NCT04035200|581262968|FG001|Overall Study|Early Termination|1|||
160965637|NCT04035200|581262969|FG002|Overall Study|Early Termination|0|||
160965638|NCT04035200|581262967|FG000|Overall Study|Non-compliance|0|||
160965639|NCT04035200|581262968|FG001|Overall Study|Non-compliance|1|||
160965640|NCT04035200|581262969|FG002|Overall Study|Non-compliance|0|||
160965641|NCT02277990|581262970|FG000|Overall Study|Death|170|||
160965642|NCT02277990|581262971|FG001|Overall Study|Death|188|||
160965643|NCT02277990|581262970|FG000|Overall Study|Withdrawal by Subject|64|||
160965644|NCT02277990|581262971|FG001|Overall Study|Withdrawal by Subject|53|||
160965645|NCT02277990|581262970|FG000|Overall Study|Physician Decision|40|||
160965646|NCT02277990|581262971|FG001|Overall Study|Physician Decision|34|||
160965647|NCT02277990|581262970|FG000|Overall Study|Lost to Follow-up|66|||
160965648|NCT02277990|581262971|FG001|Overall Study|Lost to Follow-up|69|||
160965649|NCT02277990|581262970|FG000|Overall Study|Had other reason|26|||
160965650|NCT02277990|581262971|FG001|Overall Study|Had other reason|32|||
160965651|NCT03351738|581262972|FG000|Overall Study|Withdrawal by Subject|0|||
160965652|NCT03351738|581262973|FG001|Overall Study|Withdrawal by Subject|1|||
160965653|NCT03351738|581262974|FG002|Overall Study|Withdrawal by Subject|0|||
160965654|NCT03351738|581262975|FG003|Overall Study|Withdrawal by Subject|1|||
160965655|NCT03351738|581262976|FG004|Overall Study|Withdrawal by Subject|0|||
160965656|NCT03351738|581262977|FG005|Overall Study|Withdrawal by Subject|0|||
160965657|NCT03138733|581262982|FG000|Overall Study|Death|17|||
160965658|NCT03138733|581262983|FG001|Overall Study|Death|18|||
160965659|NCT03138733|581262982|FG000|Overall Study|Withdrawal by Subject|11|||
160965660|NCT03138733|581262983|FG001|Overall Study|Withdrawal by Subject|6|||
160965661|NCT03138733|581262982|FG000|Overall Study|Lost to Follow-up|3|||
160965662|NCT03138733|581262983|FG001|Overall Study|Lost to Follow-up|2|||
160965663|NCT03138733|581262982|FG000|Overall Study|Adverse Event|1|||
160965664|NCT03138733|581262983|FG001|Overall Study|Adverse Event|0|||
161003426|NCT01350804|581398071|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
161147173|NCT00907478|581922421|FG001|Overall Study|Pregnancy|1|||
160965665|NCT03138733|581262982|FG000|Overall Study|Protocol Violation|1|||
160965666|NCT03138733|581262983|FG001|Overall Study|Protocol Violation|3|||
161147174|NCT00907478|581922422|FG002|Overall Study|Pregnancy|1|||
161003427|NCT01350804|581398072|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
161003428|NCT01350804|581398073|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
161003429|NCT02445391|581398074|FG000|Overall Study|No active protocol treatment|3|||
161003430|NCT02445391|581398075|FG001|Overall Study|No active protocol treatment|0|||
161003431|NCT02445391|581398076|FG002|Overall Study|No active protocol treatment|0|||
161003432|NCT02445391|581398074|FG000|Overall Study|Adverse Event|0|||
161003433|NCT02445391|581398075|FG001|Overall Study|Adverse Event|21|||
161003434|NCT02445391|581398076|FG002|Overall Study|Adverse Event|12|||
161003435|NCT02445391|581398074|FG000|Overall Study|Alternative therapy|0|||
161003436|NCT02445391|581398075|FG001|Overall Study|Alternative therapy|0|||
161003437|NCT02445391|581398076|FG002|Overall Study|Alternative therapy|1|||
161003438|NCT02445391|581398074|FG000|Overall Study|Disease progression|0|||
161003439|NCT02445391|581398075|FG001|Overall Study|Disease progression|7|||
161003440|NCT02445391|581398076|FG002|Overall Study|Disease progression|22|||
161003441|NCT02445391|581398074|FG000|Overall Study|Complicating disease|0|||
161003442|NCT02445391|581398075|FG001|Overall Study|Complicating disease|2|||
161003443|NCT02445391|581398076|FG002|Overall Study|Complicating disease|1|||
161003444|NCT02445391|581398074|FG000|Overall Study|Withdrawal by Subject|0|||
161003445|NCT02445391|581398075|FG001|Overall Study|Withdrawal by Subject|4|||
161003446|NCT02445391|581398076|FG002|Overall Study|Withdrawal by Subject|9|||
161003447|NCT02445391|581398074|FG000|Overall Study|Financial issue|0|||
161003448|NCT02445391|581398075|FG001|Overall Study|Financial issue|0|||
161003449|NCT02445391|581398076|FG002|Overall Study|Financial issue|2|||
161003450|NCT02445391|581398074|FG000|Overall Study|Still on treatment|0|||
161003451|NCT02445391|581398075|FG001|Overall Study|Still on treatment|7|||
161003452|NCT02445391|581398076|FG002|Overall Study|Still on treatment|16|||
161003453|NCT02445391|581398074|FG000|Overall Study|Not start protocol therapy|0|||
161003454|NCT02445391|581398075|FG001|Overall Study|Not start protocol therapy|12|||
161003455|NCT02445391|581398076|FG002|Overall Study|Not start protocol therapy|9|||
161003456|NCT02611037|581398077|FG000|Overall Study|Withdrawal prior to treatment|2|||
161003457|NCT02611037|581398078|FG001|Overall Study|Withdrawal prior to treatment|0|||
161003458|NCT05850520|581398080|FG000|Overall Study|Withdrawal by Subject|8|||
161003459|NCT05850520|581398081|FG001|Overall Study|Withdrawal by Subject|8|||
161003460|NCT05850520|581398082|FG002|Overall Study|Withdrawal by Subject|16|||
161003461|NCT05850520|581398080|FG000|Overall Study|Lost to Follow-up|2|||
161003462|NCT05850520|581398081|FG001|Overall Study|Lost to Follow-up|2|||
161003463|NCT05850520|581398082|FG002|Overall Study|Lost to Follow-up|2|||
161003464|NCT05850520|581398080|FG000|Overall Study|Death|2|||
161003465|NCT05850520|581398081|FG001|Overall Study|Death|2|||
161003466|NCT05850520|581398082|FG002|Overall Study|Death|3|||
161003467|NCT05850520|581398080|FG000|Overall Study|Adverse Event|2|||
161003468|NCT05850520|581398081|FG001|Overall Study|Adverse Event|0|||
161003469|NCT05850520|581398082|FG002|Overall Study|Adverse Event|1|||
161003470|NCT05850520|581398080|FG000|Overall Study|Physician Decision|0|||
161003471|NCT05850520|581398081|FG001|Overall Study|Physician Decision|1|||
161003472|NCT05850520|581398082|FG002|Overall Study|Physician Decision|0|||
161003473|NCT05850520|581398080|FG000|Overall Study|Protocol deviation|0|||
161003474|NCT05850520|581398081|FG001|Overall Study|Protocol deviation|0|||
161003475|NCT05850520|581398082|FG002|Overall Study|Protocol deviation|1|||
161003476|NCT05850520|581398080|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
161003477|NCT05850520|581398081|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
161003478|NCT05850520|581398082|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
161003479|NCT03785782|581399019|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
161003480|NCT03785782|581399020|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
161003481|NCT03785782|581399019|FG000|Overall Study|Withdrawal by Subject|1|||
161003482|NCT03785782|581399020|FG001|Overall Study|Withdrawal by Subject|1|||
161003483|NCT03785782|581399019|FG000|Overall Study|insufficient image quality.|3|||
161003484|NCT03785782|581399020|FG001|Overall Study|insufficient image quality.|0|||
161003485|NCT04817670|581399021|FG000|Overall Study|Withdrawal by Subject|1|||
161003486|NCT04817670|581399022|FG001|Overall Study|Withdrawal by Subject|0|||
161003487|NCT04817670|581399023|FG002|Overall Study|Withdrawal by Subject|0|||
161003488|NCT04817670|581399024|FG003|Overall Study|Withdrawal by Subject|0|||
161003489|NCT04817670|581399025|FG004|Overall Study|Withdrawal by Subject|0|||
161003490|NCT04817670|581399021|FG000|Overall Study|Lost to Follow-up|0|||
161003491|NCT04817670|581399022|FG001|Overall Study|Lost to Follow-up|0|||
161003492|NCT04817670|581399023|FG002|Overall Study|Lost to Follow-up|1|||
161147175|NCT00907478|581922420|FG000|Overall Study|Lost to Follow-up|1|||
161343497|NCT03965923|582644391|FG001|Overall Study|Other reason|0|||
161003493|NCT04817670|581399024|FG003|Overall Study|Lost to Follow-up|0|||
161147176|NCT00907478|581922421|FG001|Overall Study|Lost to Follow-up|0|||
161343498|NCT03965923|582644392|FG002|Overall Study|Other reason|0|||
161003494|NCT04817670|581399025|FG004|Overall Study|Lost to Follow-up|0|||
161003495|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
161147177|NCT00907478|581922422|FG002|Overall Study|Lost to Follow-up|0|||
161147178|NCT00907478|581922420|FG000|Overall Study|Other|3|||
161343499|NCT03965923|582644393|FG003|Overall Study|Other reason|1|||
161003496|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
161003497|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
161003498|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
161003499|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
161003500|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
161003501|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
161003502|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
161003503|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
161003504|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
161003505|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
161003506|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
161003507|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
161003508|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
161003509|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
161003510|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
161003511|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
161003512|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
161003513|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
161003514|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
161003515|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
161003516|NCT00304031|581399027|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
161003517|NCT00304031|581399028|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
161003518|NCT00304031|581399029|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
161003519|NCT00304031|581399027|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161003520|NCT00304031|581399028|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
161003521|NCT00304031|581399029|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
161003522|NCT01188655|581399033|FG000|Overall Study|Lack of Efficacy|1|||
161003523|NCT01188655|581399033|FG000|Overall Study|Lost to Follow-up|1|||
161003524|NCT01188655|581399033|FG000|Overall Study|Other|11|||
161003525|NCT04603924|581399034|FG000|Overall Study|Not Dosed|2|||
161003526|NCT04603924|581399035|FG001|Overall Study|Not Dosed|1|||
161003527|NCT04603924|581399034|FG000|Overall Study|Withdrawal by Subject|6|||
161003528|NCT04603924|581399035|FG001|Overall Study|Withdrawal by Subject|6|||
161003529|NCT04603924|581399034|FG000|Overall Study|Adverse Event|2|||
161003530|NCT04603924|581399035|FG001|Overall Study|Adverse Event|2|||
161003531|NCT03762668|581399038|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
161003532|NCT03762668|581399039|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
161003533|NCT02731755|581399045|FG000|First Intervention|Withdrawal by Subject|0|||
161003534|NCT02731755|581399046|FG001|First Intervention|Withdrawal by Subject|2|||
161003535|NCT02139046|581399047|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161003536|NCT02139046|581399048|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
161003537|NCT02139046|581399049|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
161003538|NCT02139046|581399050|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
161003539|NCT02139046|581399051|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
161003540|NCT02139046|581399047|FG000|Overall Study|Major Protocol Deviation|9|||
161003541|NCT02139046|581399048|FG001|Overall Study|Major Protocol Deviation|10|||
161003542|NCT02139046|581399049|FG002|Overall Study|Major Protocol Deviation|16|||
161003543|NCT02139046|581399050|FG003|Overall Study|Major Protocol Deviation|12|||
161003544|NCT02139046|581399051|FG004|Overall Study|Major Protocol Deviation|6|||
161003545|NCT02139046|581399047|FG000|Overall Study|Lost to Follow-up|13|||
161003546|NCT02139046|581399048|FG001|Overall Study|Lost to Follow-up|16|||
161003547|NCT02139046|581399049|FG002|Overall Study|Lost to Follow-up|16|||
161003548|NCT02139046|581399050|FG003|Overall Study|Lost to Follow-up|18|||
161343500|NCT03965923|582644394|FG004|Overall Study|Other reason|0|||
161343501|NCT03965923|582644395|FG005|Overall Study|Other reason|0|||
161003549|NCT02139046|581399051|FG004|Overall Study|Lost to Follow-up|13|||
161003550|NCT02139046|581399047|FG000|Overall Study|Voluntary Withdrawal|20|||
161003551|NCT02139046|581399048|FG001|Overall Study|Voluntary Withdrawal|8|||
161003552|NCT02139046|581399049|FG002|Overall Study|Voluntary Withdrawal|10|||
161003553|NCT02139046|581399050|FG003|Overall Study|Voluntary Withdrawal|15|||
161003554|NCT02139046|581399051|FG004|Overall Study|Voluntary Withdrawal|16|||
161003555|NCT02139046|581399047|FG000|Overall Study|Lack of Efficacy|0|||
161003556|NCT02139046|581399048|FG001|Overall Study|Lack of Efficacy|1|||
161003557|NCT02139046|581399049|FG002|Overall Study|Lack of Efficacy|2|||
161003558|NCT02139046|581399050|FG003|Overall Study|Lack of Efficacy|1|||
161003559|NCT02139046|581399051|FG004|Overall Study|Lack of Efficacy|2|||
161003560|NCT02139046|581399047|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
161003561|NCT02139046|581399048|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
161003562|NCT02139046|581399049|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
161003563|NCT02139046|581399050|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
161343502|NCT03965923|582644396|FG006|Overall Study|Other reason|0|||
160965667|NCT03138733|581262982|FG000|Overall Study|Administrative or logistical reason|1|||
160965668|NCT03138733|581262983|FG001|Overall Study|Administrative or logistical reason|0|||
160965669|NCT03138733|581262982|FG000|Overall Study|The patient was transferred to another hospital|1|||
160965670|NCT03138733|581262983|FG001|Overall Study|The patient was transferred to another hospital|0|||
160965671|NCT01089374|581262985|FG000|Overall Study|Lost to Follow-up|3|||
160965672|NCT01089374|581262986|FG001|Overall Study|Lost to Follow-up|0|||
160965673|NCT01089374|581262985|FG000|Overall Study|Withdrawal by Subject|1|||
160965674|NCT01089374|581262986|FG001|Overall Study|Withdrawal by Subject|0|||
160965675|NCT01089374|581262985|FG000|Overall Study|Study closed early - low accrual|6|||
160965676|NCT01089374|581262986|FG001|Overall Study|Study closed early - low accrual|0|||
160965677|NCT02597036|581262997|FG000|Overall Study|Progressive Disease|0|||
160965678|NCT02597036|581262998|FG001|Overall Study|Progressive Disease|0|||
160965679|NCT02597036|581262999|FG002|Overall Study|Progressive Disease|0|||
160965680|NCT02597036|581263000|FG003|Overall Study|Progressive Disease|0|||
160965681|NCT02597036|581263001|FG004|Overall Study|Progressive Disease|1|||
160965682|NCT02597036|581263002|FG005|Overall Study|Progressive Disease|1|||
160965683|NCT02597036|581263003|FG006|Overall Study|Progressive Disease|1|||
160965684|NCT02597036|581263004|FG007|Overall Study|Progressive Disease|0|||
160965685|NCT02597036|581263005|FG008|Overall Study|Progressive Disease|0|||
160965686|NCT02597036|581263006|FG009|Overall Study|Progressive Disease|0|||
160965687|NCT02597036|581263007|FG010|Overall Study|Progressive Disease|0|||
160965688|NCT02597036|581263008|FG011|Overall Study|Progressive Disease|0|||
160965689|NCT02597036|581262997|FG000|Overall Study|Adverse Event|0|||
160965690|NCT02597036|581262998|FG001|Overall Study|Adverse Event|0|||
160965691|NCT02597036|581262999|FG002|Overall Study|Adverse Event|0|||
160965692|NCT02597036|581263000|FG003|Overall Study|Adverse Event|0|||
160965693|NCT02597036|581263001|FG004|Overall Study|Adverse Event|0|||
160965694|NCT02597036|581263002|FG005|Overall Study|Adverse Event|0|||
160965695|NCT02597036|581263003|FG006|Overall Study|Adverse Event|0|||
160965696|NCT02597036|581263004|FG007|Overall Study|Adverse Event|1|||
160965697|NCT02597036|581263005|FG008|Overall Study|Adverse Event|0|||
160965698|NCT02597036|581263006|FG009|Overall Study|Adverse Event|0|||
160965699|NCT02597036|581263007|FG010|Overall Study|Adverse Event|0|||
160965700|NCT02597036|581263008|FG011|Overall Study|Adverse Event|1|||
160965701|NCT02597036|581262997|FG000|Overall Study|Death|0|||
160965702|NCT02597036|581262998|FG001|Overall Study|Death|0|||
160965703|NCT02597036|581262999|FG002|Overall Study|Death|0|||
160965704|NCT02597036|581263000|FG003|Overall Study|Death|0|||
160965705|NCT02597036|581263001|FG004|Overall Study|Death|0|||
160965706|NCT02597036|581263002|FG005|Overall Study|Death|0|||
160965707|NCT02597036|581263003|FG006|Overall Study|Death|0|||
160965708|NCT02597036|581263004|FG007|Overall Study|Death|0|||
160965709|NCT02597036|581263005|FG008|Overall Study|Death|0|||
160965710|NCT02597036|581263006|FG009|Overall Study|Death|1|||
160965711|NCT02597036|581263007|FG010|Overall Study|Death|1|||
160965712|NCT02597036|581263008|FG011|Overall Study|Death|0|||
160965713|NCT02597036|581262997|FG000|Overall Study|Lost to Follow-up|0|||
160965714|NCT02597036|581262998|FG001|Overall Study|Lost to Follow-up|0|||
160965715|NCT02597036|581262999|FG002|Overall Study|Lost to Follow-up|0|||
160965716|NCT02597036|581263000|FG003|Overall Study|Lost to Follow-up|0|||
160965717|NCT02597036|581263001|FG004|Overall Study|Lost to Follow-up|0|||
160965718|NCT02597036|581263002|FG005|Overall Study|Lost to Follow-up|0|||
160965719|NCT02597036|581263003|FG006|Overall Study|Lost to Follow-up|0|||
160965720|NCT02597036|581263004|FG007|Overall Study|Lost to Follow-up|0|||
160965721|NCT02597036|581263005|FG008|Overall Study|Lost to Follow-up|0|||
160965722|NCT02597036|581263006|FG009|Overall Study|Lost to Follow-up|0|||
160965723|NCT02597036|581263007|FG010|Overall Study|Lost to Follow-up|1|||
160965724|NCT02597036|581263008|FG011|Overall Study|Lost to Follow-up|0|||
160965725|NCT02597036|581262997|FG000|Overall Study|Withdrawal by Subject|0|||
160965726|NCT02597036|581262998|FG001|Overall Study|Withdrawal by Subject|0|||
160965727|NCT02597036|581262999|FG002|Overall Study|Withdrawal by Subject|0|||
160965728|NCT02597036|581263000|FG003|Overall Study|Withdrawal by Subject|0|||
160965729|NCT02597036|581263001|FG004|Overall Study|Withdrawal by Subject|0|||
160965730|NCT02597036|581263002|FG005|Overall Study|Withdrawal by Subject|0|||
160965731|NCT02597036|581263003|FG006|Overall Study|Withdrawal by Subject|0|||
160965732|NCT02597036|581263004|FG007|Overall Study|Withdrawal by Subject|0|||
160965733|NCT02597036|581263005|FG008|Overall Study|Withdrawal by Subject|0|||
160965734|NCT02597036|581263006|FG009|Overall Study|Withdrawal by Subject|0|||
160965735|NCT02597036|581263007|FG010|Overall Study|Withdrawal by Subject|0|||
160965736|NCT02597036|581263008|FG011|Overall Study|Withdrawal by Subject|1|||
160965737|NCT05163522|581263011|FG000|Overall Study|Withdrawal by Subject|0|||
160965738|NCT05163522|581263012|FG001|Overall Study|Withdrawal by Subject|0|||
160965739|NCT05163522|581263013|FG002|Overall Study|Withdrawal by Subject|1|||
160965740|NCT05163522|581263014|FG003|Overall Study|Withdrawal by Subject|0|||
160965741|NCT05163522|581263015|FG004|Overall Study|Withdrawal by Subject|0|||
161003564|NCT02139046|581399051|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
160965742|NCT05163522|581263016|FG005|Overall Study|Withdrawal by Subject|0|||
160965743|NCT05163522|581263017|FG006|Overall Study|Withdrawal by Subject|0|||
160965744|NCT05163522|581263018|FG007|Overall Study|Withdrawal by Subject|0|||
161271276|NCT02238795|582375107|FG000|Overall Study|Patient without purpura fulminans|1|||
161271277|NCT05187013|582375108|FG000|Overall Study|Withdrawal by Subject|1|||
161271278|NCT05187013|582375109|FG001|Overall Study|Withdrawal by Subject|1|||
161271279|NCT05187013|582375110|FG002|Overall Study|Withdrawal by Subject|0|||
161271280|NCT05187013|582375108|FG000|Overall Study|Death|0|||
161271281|NCT05187013|582375109|FG001|Overall Study|Death|1|||
161271282|NCT05187013|582375110|FG002|Overall Study|Death|0|||
161271283|NCT05187013|582375108|FG000|Overall Study|Lost to Follow-up|20|||
160965745|NCT05163522|581263019|FG008|Overall Study|Withdrawal by Subject|0|||
160965746|NCT05163522|581263020|FG009|Overall Study|Withdrawal by Subject|0|||
160965747|NCT05163522|581263021|FG010|Overall Study|Withdrawal by Subject|0|||
160965748|NCT04672941|581263026|FG000|Overall Study|Investigator decision|1|||
160965749|NCT04672941|581263026|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
160965750|NCT04672941|581263026|FG000|Overall Study|COVID-19 related but no adverse event|1|||
160965751|NCT04672941|581263026|FG000|Overall Study|Adverse Event|2|||
160965752|NCT04672941|581263026|FG000|Overall Study|Lost to Follow-up|2|||
160965753|NCT00386022|581263032|FG000|Plus Estrogen|Lost to Follow-up|2|||
160965754|NCT00386022|581263033|FG001|Plus Estrogen|Lost to Follow-up|0|||
160965755|NCT00386022|581263032|FG000|Plus Estrogen|Adverse Event|0|||
160965756|NCT00386022|581263033|FG001|Plus Estrogen|Adverse Event|1|||
160965757|NCT03988166|581263038|FG000|Overall Study|Lost to Follow-up|2|||
160965758|NCT03988166|581263038|FG000|Overall Study|Death|1|||
160965759|NCT03933826|581263039|FG000|Overall Study|Withdrawal by Subject|8|||
160965760|NCT03933826|581263040|FG001|Overall Study|Withdrawal by Subject|1|||
160965761|NCT03933826|581263039|FG000|Overall Study|Death|19|||
160965762|NCT03933826|581263040|FG001|Overall Study|Death|11|||
160965763|NCT03933826|581263039|FG000|Overall Study|Lost to Follow-up|41|||
160965764|NCT03933826|581263040|FG001|Overall Study|Lost to Follow-up|13|||
160965765|NCT02638948|581263041|FG000|Overall Study|Withdrawal by Subject|4|||
160965766|NCT02638948|581263042|FG001|Overall Study|Withdrawal by Subject|5|||
160965767|NCT02638948|581263043|FG002|Overall Study|Withdrawal by Subject|3|||
160965768|NCT02638948|581263044|FG003|Overall Study|Withdrawal by Subject|1|||
160965769|NCT02638948|581263041|FG000|Overall Study|Administrative Reason by Sponsor|0|||
160965770|NCT02638948|581263042|FG001|Overall Study|Administrative Reason by Sponsor|1|||
160965771|NCT02638948|581263043|FG002|Overall Study|Administrative Reason by Sponsor|0|||
160965772|NCT02638948|581263044|FG003|Overall Study|Administrative Reason by Sponsor|4|||
160965773|NCT02638948|581263041|FG000|Overall Study|Adverse Event|0|||
160965774|NCT02638948|581263042|FG001|Overall Study|Adverse Event|0|||
160965775|NCT02638948|581263043|FG002|Overall Study|Adverse Event|1|||
160965776|NCT02638948|581263044|FG003|Overall Study|Adverse Event|1|||
160965777|NCT02638948|581263041|FG000|Overall Study|Lack of Efficacy|1|||
160965778|NCT02638948|581263042|FG001|Overall Study|Lack of Efficacy|1|||
160965779|NCT02638948|581263043|FG002|Overall Study|Lack of Efficacy|0|||
160965780|NCT02638948|581263044|FG003|Overall Study|Lack of Efficacy|0|||
160965781|NCT02638948|581263041|FG000|Overall Study|Lost to Follow-up|0|||
160965782|NCT02638948|581263042|FG001|Overall Study|Lost to Follow-up|0|||
160965783|NCT02638948|581263043|FG002|Overall Study|Lost to Follow-up|1|||
160965784|NCT02638948|581263044|FG003|Overall Study|Lost to Follow-up|1|||
160965785|NCT02638948|581263041|FG000|Overall Study|Poor/Non-Compliance|0|||
160965786|NCT02638948|581263042|FG001|Overall Study|Poor/Non-Compliance|2|||
160965787|NCT02638948|581263043|FG002|Overall Study|Poor/Non-Compliance|1|||
160965788|NCT02638948|581263044|FG003|Overall Study|Poor/Non-Compliance|0|||
160965789|NCT02638948|581263041|FG000|Overall Study|Participant no longer met study criteria|0|||
160965790|NCT02638948|581263042|FG001|Overall Study|Participant no longer met study criteria|1|||
160965791|NCT02638948|581263043|FG002|Overall Study|Participant no longer met study criteria|0|||
160965792|NCT02638948|581263044|FG003|Overall Study|Participant no longer met study criteria|0|||
160965793|NCT02638948|581263041|FG000|Overall Study|Other than specified above|4|||
160965794|NCT02638948|581263042|FG001|Overall Study|Other than specified above|1|||
160965795|NCT02638948|581263043|FG002|Overall Study|Other than specified above|1|||
160965796|NCT02638948|581263044|FG003|Overall Study|Other than specified above|1|||
160965797|NCT04992546|581263045|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
160965798|NCT04992546|581263045|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
160965799|NCT04992546|581263045|FG000|Open-Label Treatment Period|Adverse Event|3|||
160965800|NCT04992546|581263045|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
160965801|NCT05007392|581263047|FG000|Overall Study|Randomized but not treated|1|||
160965802|NCT05007392|581263048|FG001|Overall Study|Randomized but not treated|2|||
161343503|NCT03965923|582644397|FG007|Overall Study|Other reason|0|||
160965803|NCT05007392|581263047|FG000|Overall Study|Other|5|||
160965804|NCT05007392|581263048|FG001|Overall Study|Other|4|||
161343504|NCT03965923|582644398|FG008|Overall Study|Other reason|0|||
160965805|NCT05007392|581263047|FG000|Overall Study|Lost to Follow-up|1|||
160965806|NCT05007392|581263048|FG001|Overall Study|Lost to Follow-up|2|||
161343505|NCT03965923|582644399|FG009|Overall Study|Other reason|0|||
160965807|NCT05007392|581263047|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
161271284|NCT05187013|582375109|FG001|Overall Study|Lost to Follow-up|17|||
161343506|NCT03965923|582644400|FG010|Overall Study|Other reason|2|||
160965808|NCT05007392|581263048|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
160965809|NCT05007392|581263047|FG000|Overall Study|Use of prohibited concomitant drug|1|||
161343507|NCT03965923|582644401|FG011|Overall Study|Other reason|0|||
160965810|NCT05007392|581263048|FG001|Overall Study|Use of prohibited concomitant drug|1|||
160965811|NCT05007392|581263047|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
160965812|NCT05007392|581263048|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
160965813|NCT05007392|581263047|FG000|Overall Study|Adverse Event|10|||
160965814|NCT05007392|581263048|FG001|Overall Study|Adverse Event|6|||
160965815|NCT05007392|581263047|FG000|Overall Study|Participant choice|5|||
160965816|NCT05007392|581263048|FG001|Overall Study|Participant choice|10|||
160965817|NCT05007392|581263047|FG000|Overall Study|Withdrawal of consent|5|||
160965818|NCT05007392|581263048|FG001|Overall Study|Withdrawal of consent|4|||
160965819|NCT02703922|581263049|FG000|Overall Study|Death|5|||
160965820|NCT02703922|581263050|FG001|Overall Study|Death|8|||
160965821|NCT02703922|581263049|FG000|Overall Study|Lost to Follow-up|10|||
160965822|NCT02703922|581263050|FG001|Overall Study|Lost to Follow-up|10|||
160965823|NCT05805657|581263055|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
160965824|NCT05805657|581263056|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
160965825|NCT04058353|581263057|FG000|Overall Study|Adverse Event|2|||
160965826|NCT04058353|581263058|FG001|Overall Study|Adverse Event|1|||
160965827|NCT04058353|581263057|FG000|Overall Study|Physician Decision|1|||
160965828|NCT04058353|581263058|FG001|Overall Study|Physician Decision|0|||
160965829|NCT04058353|581263057|FG000|Overall Study|Other|1|||
160965830|NCT04058353|581263058|FG001|Overall Study|Other|0|||
160965831|NCT00316173|581263062|FG000|Run-in Phase|Adverse Event|1|||
160965832|NCT00316173|581263063|FG001|Run-in Phase|Adverse Event|0|||
160965833|NCT00316173|581263062|FG000|Run-in Phase|Protocol Violation|1|||
160965834|NCT00316173|581263063|FG001|Run-in Phase|Protocol Violation|0|||
160965835|NCT00316173|581263062|FG000|Run-in Phase|Study Follow-up Stopped|5|||
160965836|NCT00316173|581263063|FG001|Run-in Phase|Study Follow-up Stopped|0|||
160965837|NCT00316173|581263062|FG000|Treatment Phase|Adverse Event|0|||
160965838|NCT00316173|581263063|FG001|Treatment Phase|Adverse Event|1|||
160965839|NCT00316173|581263062|FG000|Treatment Phase|Lack of Efficacy|0|||
160965840|NCT00316173|581263063|FG001|Treatment Phase|Lack of Efficacy|3|||
160965841|NCT00316173|581263062|FG000|Treatment Phase|Lost to Follow-up|0|||
160965842|NCT00316173|581263063|FG001|Treatment Phase|Lost to Follow-up|3|||
160965843|NCT00316173|581263062|FG000|Treatment Phase|Withdrawal by Subject|0|||
160965844|NCT00316173|581263063|FG001|Treatment Phase|Withdrawal by Subject|1|||
160965845|NCT00316173|581263062|FG000|Treatment Phase|Study Follow-up Stopped|0|||
160965846|NCT00316173|581263063|FG001|Treatment Phase|Study Follow-up Stopped|34|||
160965847|NCT01338025|581263067|FG000|Overall Study|Unexpected closure of study|10|||
160965848|NCT01338025|581263068|FG001|Overall Study|Unexpected closure of study|9|||
160965849|NCT01338025|581263067|FG000|Overall Study|Withdrawal by Subject|0|||
160965850|NCT01338025|581263068|FG001|Overall Study|Withdrawal by Subject|2|||
160965851|NCT01338025|581263067|FG000|Overall Study|Found ineligible after starting|1|||
160965852|NCT01338025|581263068|FG001|Overall Study|Found ineligible after starting|0|||
160965853|NCT03188055|581263069|FG000|Overall Study|Unavailable for training|0|||
160965854|NCT03188055|581263070|FG001|Overall Study|Unavailable for training|0|||
160965855|NCT03188055|581263071|FG002|Overall Study|Unavailable for training|19|||
160965856|NCT03188055|581263072|FG003|Overall Study|Unavailable for training|0|||
160965857|NCT03188055|581263073|FG004|Overall Study|Unavailable for training|0|||
160965858|NCT03188055|581263074|FG005|Overall Study|Unavailable for training|0|||
160965859|NCT03188055|581263069|FG000|Overall Study|Lost to Follow-up|0|||
160965860|NCT03188055|581263070|FG001|Overall Study|Lost to Follow-up|18|||
160965861|NCT03188055|581263071|FG002|Overall Study|Lost to Follow-up|0|||
160965862|NCT03188055|581263072|FG003|Overall Study|Lost to Follow-up|11|||
160965863|NCT03188055|581263073|FG004|Overall Study|Lost to Follow-up|0|||
160965864|NCT03188055|581263074|FG005|Overall Study|Lost to Follow-up|0|||
160965865|NCT03188055|581263069|FG000|Overall Study|Withdrawal by Subject|0|||
160965866|NCT03188055|581263070|FG001|Overall Study|Withdrawal by Subject|1|||
160965867|NCT03188055|581263071|FG002|Overall Study|Withdrawal by Subject|0|||
160965868|NCT03188055|581263072|FG003|Overall Study|Withdrawal by Subject|1|||
160965869|NCT03188055|581263073|FG004|Overall Study|Withdrawal by Subject|0|||
160965870|NCT03188055|581263074|FG005|Overall Study|Withdrawal by Subject|0|||
160965871|NCT03657277|581263075|FG000|Overall Study|Physician Decision|2|||
160965872|NCT03657277|581263075|FG000|Overall Study|Lost to Follow-up|1|||
160965873|NCT03657277|581263075|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
160965874|NCT01024608|581263078|FG000|Overall Study|Adverse Event|1|||
160965875|NCT01024608|581263079|FG001|Overall Study|Adverse Event|0|||
160965876|NCT01024608|581263078|FG000|Overall Study|Withdrawal by Subject|1|||
160965877|NCT01024608|581263079|FG001|Overall Study|Withdrawal by Subject|0|||
160965878|NCT01024608|581263078|FG000|Overall Study|Lost to Follow-up|0|||
160965879|NCT01024608|581263079|FG001|Overall Study|Lost to Follow-up|1|||
160965880|NCT01024608|581263078|FG000|Overall Study|Protocol Violation|0|||
160965881|NCT01024608|581263079|FG001|Overall Study|Protocol Violation|3|||
160965882|NCT01024608|581263078|FG000|Overall Study|Never received study treatment|2|||
161003565|NCT02139046|581399047|FG000|Overall Study|Other Miscellaneous Reasons|10|||
161003566|NCT02139046|581399048|FG001|Overall Study|Other Miscellaneous Reasons|9|||
161003567|NCT02139046|581399049|FG002|Overall Study|Other Miscellaneous Reasons|4|||
161003568|NCT02139046|581399050|FG003|Overall Study|Other Miscellaneous Reasons|9|||
161003569|NCT02139046|581399051|FG004|Overall Study|Other Miscellaneous Reasons|12|||
161003570|NCT00818454|581399054|FG000|Treatment Period 1|Adverse Event|0|||
161003571|NCT00818454|581399055|FG001|Treatment Period 1|Adverse Event|1|||
161003572|NCT00818454|581399056|FG002|Treatment Period 1|Adverse Event|0|||
161003573|NCT00818454|581399057|FG003|Treatment Period 1|Adverse Event|0|||
161003574|NCT00818454|581399054|FG000|Treatment Period 1|Other|3|||
161003575|NCT00818454|581399055|FG001|Treatment Period 1|Other|0|||
161003576|NCT00818454|581399056|FG002|Treatment Period 1|Other|0|||
161003577|NCT00818454|581399057|FG003|Treatment Period 1|Other|0|||
161003578|NCT00818454|581399054|FG000|Washout Period of 1 Week|Adverse Event|1|||
161003579|NCT00818454|581399055|FG001|Washout Period of 1 Week|Adverse Event|1|||
161003580|NCT00818454|581399056|FG002|Washout Period of 1 Week|Adverse Event|0|||
161003581|NCT00818454|581399057|FG003|Washout Period of 1 Week|Adverse Event|0|||
161003582|NCT00818454|581399054|FG000|Washout Period of 1 Week|Protocol Violation|2|||
161003583|NCT00818454|581399055|FG001|Washout Period of 1 Week|Protocol Violation|0|||
161003584|NCT00818454|581399056|FG002|Washout Period of 1 Week|Protocol Violation|0|||
161003585|NCT00818454|581399057|FG003|Washout Period of 1 Week|Protocol Violation|0|||
161003586|NCT00818454|581399054|FG000|Washout Period of 1 Week|Other|1|||
161003587|NCT00818454|581399055|FG001|Washout Period of 1 Week|Other|2|||
161003588|NCT00818454|581399056|FG002|Washout Period of 1 Week|Other|0|||
161003589|NCT00818454|581399057|FG003|Washout Period of 1 Week|Other|0|||
161003590|NCT00818454|581399054|FG000|Treatment Period 2|Other|2|||
161003591|NCT00818454|581399055|FG001|Treatment Period 2|Other|1|||
161003592|NCT00818454|581399056|FG002|Treatment Period 2|Other|0|||
161003593|NCT00818454|581399057|FG003|Treatment Period 2|Other|0|||
161003594|NCT00818454|581399054|FG000|Treatment Period 3|Adverse Event|0|||
161003595|NCT00818454|581399055|FG001|Treatment Period 3|Adverse Event|0|||
161003596|NCT00818454|581399056|FG002|Treatment Period 3|Adverse Event|0|||
161003597|NCT00818454|581399057|FG003|Treatment Period 3|Adverse Event|1|||
161003598|NCT01765543|581399064|FG000|Overall Study|Death|1|||
161003599|NCT01765543|581399064|FG000|Overall Study|Withdrawal by Subject|2|||
161003600|NCT03454529|581399065|FG000|Overall Study|Did not receive treatment|6|||
161003601|NCT03454529|581399065|FG000|Overall Study|Received < 80% doses|1|||
161003602|NCT01040689|581399070|FG000|Overall Study|Adverse Event|0|||
161003603|NCT01040689|581399071|FG001|Overall Study|Adverse Event|0|||
161003604|NCT01040689|581399072|FG002|Overall Study|Adverse Event|2|||
161003605|NCT01040689|581399073|FG003|Overall Study|Adverse Event|4|||
161003606|NCT01040689|581399070|FG000|Overall Study|Lack of Efficacy|0|||
161003607|NCT01040689|581399071|FG001|Overall Study|Lack of Efficacy|0|||
161003608|NCT01040689|581399072|FG002|Overall Study|Lack of Efficacy|1|||
161003609|NCT01040689|581399073|FG003|Overall Study|Lack of Efficacy|0|||
161003610|NCT01040689|581399070|FG000|Overall Study|Lost to Follow-up|1|||
161003611|NCT01040689|581399071|FG001|Overall Study|Lost to Follow-up|0|||
161003612|NCT01040689|581399072|FG002|Overall Study|Lost to Follow-up|0|||
161003613|NCT01040689|581399073|FG003|Overall Study|Lost to Follow-up|0|||
161003614|NCT01040689|581399070|FG000|Overall Study|Withdrawal by Subject|2|||
161003615|NCT01040689|581399071|FG001|Overall Study|Withdrawal by Subject|1|||
161003616|NCT01040689|581399072|FG002|Overall Study|Withdrawal by Subject|1|||
161003617|NCT01040689|581399073|FG003|Overall Study|Withdrawal by Subject|0|||
161003618|NCT01040689|581399070|FG000|Overall Study|Other reasons not listed above|0|||
161003619|NCT01040689|581399071|FG001|Overall Study|Other reasons not listed above|1|||
161003620|NCT01040689|581399072|FG002|Overall Study|Other reasons not listed above|0|||
161003621|NCT01040689|581399073|FG003|Overall Study|Other reasons not listed above|0|||
161003622|NCT02755805|581399076|FG000|Overall Study|Lost to Follow-up|1|||
161003623|NCT02755805|581399077|FG001|Overall Study|Lost to Follow-up|2|||
161003624|NCT02755805|581399076|FG000|Overall Study|Refused assessments|1|||
161003625|NCT02755805|581399077|FG001|Overall Study|Refused assessments|0|||
161003626|NCT02755805|581399076|FG000|Overall Study|Withdrawal by Subject|0|||
161003627|NCT02755805|581399077|FG001|Overall Study|Withdrawal by Subject|2|||
161003628|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
161003629|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161003630|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161003631|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
161003632|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
161003633|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161003634|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161003635|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
161003636|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
161003637|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161003638|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161003639|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
161003640|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
161003641|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161003642|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161003643|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
161003644|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
161003645|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
161003646|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
161003647|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
161003648|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
161003649|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161003650|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161003651|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
161003652|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
161003653|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161003654|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161003655|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
161003656|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
161003657|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161003658|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161003659|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
161003660|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
161003661|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161003662|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161003663|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
161003664|NCT03593213|581399080|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
161003665|NCT03593213|581399081|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161003666|NCT03593213|581399082|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161003667|NCT03593213|581399083|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
161003668|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
161003669|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
161003670|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
161003671|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
161003672|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
161003673|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
161003674|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
161003675|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
161003676|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
161003677|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
161003678|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
161003679|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
161003680|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
161003681|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
161003682|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
161003683|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
161003684|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161003685|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161003686|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
161003687|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
161003688|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
161003689|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
161003690|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
161003691|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
161003692|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
161003693|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
161003694|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
161003695|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
161003696|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
161003697|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
161003698|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
161003699|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
161003700|NCT03593213|581399080|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
161003701|NCT03593213|581399081|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
161003702|NCT03593213|581399082|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
161003703|NCT03593213|581399083|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
161003704|NCT03184558|581399084|FG000|Overall Study|Withdrawal by Subject|2|||
161003705|NCT03184558|581399084|FG000|Overall Study|Death|16|||
161003706|NCT03184558|581399084|FG000|Overall Study|Lost to Follow-up|2|||
161003707|NCT03184558|581399084|FG000|Overall Study|Other|9|||
161003708|NCT01831791|581399085|FG000|Overall Study|Withdrawal by Subject|10|||
161003709|NCT01190007|581399086|FG000|Overall Study|Withdrawal by Subject|4|||
161003710|NCT01190007|581399086|FG000|Overall Study|Adverse Event|8|||
161003711|NCT01190007|581399086|FG000|Overall Study|Difficulty of visit for complications|1|||
161003712|NCT01190007|581399086|FG000|Overall Study|Participant was arrested|1|||
161003713|NCT02880241|581399090|FG000|Overall Study|Lack of Efficacy|1|||
161003714|NCT02880241|581399091|FG001|Overall Study|Lack of Efficacy|0|||
161003715|NCT02880241|581399092|FG002|Overall Study|Lack of Efficacy|0|||
161003716|NCT02880241|581399093|FG003|Overall Study|Lack of Efficacy|0|||
161003717|NCT02880241|581399094|FG004|Overall Study|Lack of Efficacy|0|||
161003718|NCT02880241|581399095|FG005|Overall Study|Lack of Efficacy|0|||
161003719|NCT00356265|581399097|FG000|Overall Study|Withdrawal by Subject|0|||
161003720|NCT00356265|581399098|FG001|Overall Study|Withdrawal by Subject|0|||
161003721|NCT00356265|581399099|FG002|Overall Study|Withdrawal by Subject|1|||
161003722|NCT00373529|581399103|FG000|Overall Study|Physician Decision|19|||
161003723|NCT00373529|581399103|FG000|Overall Study|Withdrawal by Subject|7|||
161003724|NCT00373529|581399103|FG000|Overall Study|Adverse Event|7|||
161003725|NCT00373529|581399103|FG000|Overall Study|Treatment failure|36|||
161003726|NCT00373529|581399103|FG000|Overall Study|Disease recurrence|10|||
161003727|NCT00373529|581399103|FG000|Overall Study|Death|16|||
161003728|NCT00373529|581399103|FG000|Overall Study|Need for treatment prohibited by study|1|||
161003729|NCT00373529|581399103|FG000|Overall Study|Other|8|||
161003730|NCT00373529|581399103|FG000|Overall Study|Failed independent confirmation of AML|3|||
161003731|NCT00373529|581399103|FG000|Overall Study|Consent violation|1|||
161003732|NCT04795752|581399104|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
161003733|NCT04795752|581399105|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
161003734|NCT04795752|581399104|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
161003735|NCT04795752|581399105|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
161003736|NCT04795752|581399104|FG000|Primary Endpoint Phase|Physician Decision|2|||
161003737|NCT04795752|581399105|FG001|Primary Endpoint Phase|Physician Decision|0|||
161003738|NCT04795752|581399104|FG000|Primary Endpoint Phase|Other|4|||
161003739|NCT04795752|581399105|FG001|Primary Endpoint Phase|Other|1|||
161003740|NCT04795752|581399104|FG000|Primary Endpoint Phase|Protocol Violation|1|||
161003741|NCT04795752|581399105|FG001|Primary Endpoint Phase|Protocol Violation|0|||
161003742|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
161003743|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
161003744|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
161003745|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
161003746|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
161003747|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
161003748|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
161003749|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
161003750|NCT04795752|581399104|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
161003751|NCT04795752|581399105|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
161003752|NCT00792948|581399106|FG000|Overall Study|Adverse Event|6|||
161003753|NCT00792948|581399106|FG000|Overall Study|Death|4|||
161003754|NCT00792948|581399106|FG000|Overall Study|Withdrawal by Subject|3|||
161003755|NCT00792948|581399106|FG000|Overall Study|Ineligible|2|||
161003756|NCT00792948|581399106|FG000|Overall Study|Insurance denial - not treated|1|||
161147179|NCT00907478|581922421|FG001|Overall Study|Other|0|||
161147180|NCT00907478|581922422|FG002|Overall Study|Other|1|||
161147181|NCT02747043|581922423|FG000|Overall Study|Other|1|||
161271285|NCT05187013|582375110|FG002|Overall Study|Lost to Follow-up|0|||
161271286|NCT05187013|582375108|FG000|Overall Study|Ongoing Participants|3|||
161271287|NCT05187013|582375109|FG001|Overall Study|Ongoing Participants|5|||
161003757|NCT00792948|581399106|FG000|Overall Study|Physician Decision|11|||
161003758|NCT00792948|581399106|FG000|Overall Study|Protocol Violation|1|||
161003759|NCT01585558|581399113|FG000|Overall Study|Withdrawal by Subject|4|||
161003760|NCT01585558|581399114|FG001|Overall Study|Withdrawal by Subject|5|||
161003761|NCT01585558|581399115|FG002|Overall Study|Withdrawal by Subject|8|||
161003762|NCT01585558|581399113|FG000|Overall Study|Lost to Follow-up|2|||
161003763|NCT01585558|581399114|FG001|Overall Study|Lost to Follow-up|0|||
161003764|NCT01585558|581399115|FG002|Overall Study|Lost to Follow-up|3|||
161003765|NCT01585558|581399113|FG000|Overall Study|Adverse Event|3|||
161003766|NCT01585558|581399114|FG001|Overall Study|Adverse Event|4|||
161003767|NCT01585558|581399115|FG002|Overall Study|Adverse Event|1|||
161003768|NCT01585558|581399113|FG000|Overall Study|Protocol Violation|4|||
161147182|NCT02747043|581922424|FG001|Overall Study|Other|1|||
161147183|NCT02747043|581922423|FG000|Overall Study|Adverse Event|3|||
161147184|NCT02747043|581922424|FG001|Overall Study|Adverse Event|1|||
161003769|NCT01585558|581399114|FG001|Overall Study|Protocol Violation|3|||
161003770|NCT01585558|581399115|FG002|Overall Study|Protocol Violation|2|||
161003771|NCT01585558|581399113|FG000|Overall Study|Lack of Efficacy|0|||
161003772|NCT01585558|581399114|FG001|Overall Study|Lack of Efficacy|0|||
161003773|NCT01585558|581399115|FG002|Overall Study|Lack of Efficacy|1|||
161003774|NCT01390402|581399124|FG000|Overall Study|Death|1|||
161003775|NCT01390402|581399124|FG000|Overall Study|Disease Progression|4|||
161003776|NCT01170026|581400037|FG000|Overall Study|Lost to Follow-up|4|||
161003777|NCT01170026|581400038|FG001|Overall Study|Lost to Follow-up|2|||
161003778|NCT00686855|581400044|FG000|Overall Study|Lost to Follow-up|1|||
161003779|NCT00686855|581400045|FG001|Overall Study|Lost to Follow-up|0|||
161003780|NCT00686855|581400044|FG000|Overall Study|Progressive GVHD|0|||
161003781|NCT00686855|581400045|FG001|Overall Study|Progressive GVHD|1|||
161003782|NCT05876949|581400048|FG000|Overall Study|Withdrawal by Subject|1|||
161003783|NCT05876949|581400049|FG001|Overall Study|Withdrawal by Subject|3|||
161003784|NCT05876949|581400048|FG000|Overall Study|Physician Decision|0|||
161003785|NCT05876949|581400049|FG001|Overall Study|Physician Decision|2|||
161003786|NCT05876949|581400048|FG000|Overall Study|Death|0|||
161003787|NCT05876949|581400049|FG001|Overall Study|Death|1|||
161003788|NCT03718767|581400057|FG000|Overall Study|Declined to participate (before treatment started)|0|||
161003789|NCT03718767|581400058|FG001|Overall Study|Declined to participate (before treatment started)|0|||
161003790|NCT03718767|581400059|FG002|Overall Study|Declined to participate (before treatment started)|7|||
161003791|NCT03718767|581400057|FG000|Overall Study|Ineligible|0|||
161003792|NCT03718767|581400058|FG001|Overall Study|Ineligible|0|||
161003793|NCT03718767|581400059|FG002|Overall Study|Ineligible|17|||
161003794|NCT00494442|581400060|FG000|Overall Study|Death|1|||
161003795|NCT00494442|581400061|FG001|Overall Study|Death|1|||
161003796|NCT00494442|581400060|FG000|Overall Study|Lack of Efficacy|16|||
161003797|NCT00494442|581400061|FG001|Overall Study|Lack of Efficacy|10|||
161003798|NCT00494442|581400060|FG000|Overall Study|Adverse Event|0|||
161003799|NCT00494442|581400061|FG001|Overall Study|Adverse Event|2|||
161003800|NCT00494442|581400060|FG000|Overall Study|Physician Decision|0|||
161003801|NCT00494442|581400061|FG001|Overall Study|Physician Decision|1|||
161003802|NCT00494442|581400060|FG000|Overall Study|Non-compliance|0|||
161003803|NCT00494442|581400061|FG001|Overall Study|Non-compliance|1|||
161003804|NCT00494442|581400060|FG000|Overall Study|Intercurrent illness|0|||
161003805|NCT00494442|581400061|FG001|Overall Study|Intercurrent illness|1|||
161003806|NCT03691428|581400066|FG000|Overall Study|Withdrawal by Subject|6|||
161003807|NCT03691428|581400067|FG001|Overall Study|Withdrawal by Subject|8|||
161003808|NCT01460290|581400068|FG000|Overall Study|Adverse Event|3|||
161003809|NCT01460290|581400068|FG000|Overall Study|Elevated liver function|1|||
161003810|NCT01254019|581400073|FG000|Overall Study|Adverse Event|0|||
161003811|NCT01254019|581400074|FG001|Overall Study|Adverse Event|2|||
161003812|NCT01254019|581400073|FG000|Overall Study|Protocol Violation|1|||
161003813|NCT01254019|581400074|FG001|Overall Study|Protocol Violation|0|||
161003814|NCT01254019|581400073|FG000|Overall Study|Withdrawal by Subject|0|||
161003815|NCT01254019|581400074|FG001|Overall Study|Withdrawal by Subject|2|||
161003816|NCT03061474|581400075|FG000|Overall Study|Adverse Event|2|||
161003817|NCT03061474|581400076|FG001|Overall Study|Adverse Event|0|||
161003818|NCT03061474|581400075|FG000|Overall Study|Safety Risk|0|||
161003819|NCT03061474|581400076|FG001|Overall Study|Safety Risk|1|||
161003820|NCT03061474|581400075|FG000|Overall Study|Participant unwilling or unable to participate|0|||
161003821|NCT03061474|581400076|FG001|Overall Study|Participant unwilling or unable to participate|2|||
161003822|NCT03061474|581400075|FG000|Overall Study|Lost to Follow-up|0|||
161003823|NCT03061474|581400076|FG001|Overall Study|Lost to Follow-up|1|||
161003824|NCT00845832|581400079|FG000|Treatment Period|Adverse Event|0|||
161003825|NCT00845832|581400080|FG001|Treatment Period|Adverse Event|2|||
161003826|NCT00845832|581400081|FG002|Treatment Period|Adverse Event|0|||
161003827|NCT00845832|581400079|FG000|Treatment Period|Protocol Violation|1|||
161003828|NCT00845832|581400080|FG001|Treatment Period|Protocol Violation|1|||
161003829|NCT00845832|581400081|FG002|Treatment Period|Protocol Violation|0|||
161003830|NCT00845832|581400079|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
161003831|NCT00845832|581400080|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
161147185|NCT02747043|581922423|FG000|Overall Study|Withdrawal by Subject|1|||
161147186|NCT02747043|581922424|FG001|Overall Study|Withdrawal by Subject|1|||
161147187|NCT02747043|581922423|FG000|Overall Study|Physician Decision|1|||
161003832|NCT00845832|581400081|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
161003833|NCT00845832|581400079|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
161003834|NCT00845832|581400080|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
161147188|NCT02747043|581922424|FG001|Overall Study|Physician Decision|1|||
161003835|NCT00845832|581400081|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
161003836|NCT01391130|581400082|FG000|Overall Study|Withdrawal by Subject|3|||
161003837|NCT01391130|581400083|FG001|Overall Study|Withdrawal by Subject|2|||
161003838|NCT01391130|581400082|FG000|Overall Study|Physician Decision|2|||
161147189|NCT02747043|581922423|FG000|Overall Study|Protocol Violation|0|||
161003839|NCT01391130|581400083|FG001|Overall Study|Physician Decision|3|||
161003840|NCT01391130|581400082|FG000|Overall Study|Did not Receive Drug|1|||
161003841|NCT01391130|581400083|FG001|Overall Study|Did not Receive Drug|1|||
161003842|NCT03520413|581400090|FG000|Overall Study|Lost to Follow-up|1|||
161003843|NCT03520413|581400091|FG001|Overall Study|Lost to Follow-up|1|||
161003844|NCT03520413|581400090|FG000|Overall Study|Withdrawal by Subject|1|||
161003845|NCT03520413|581400091|FG001|Overall Study|Withdrawal by Subject|2|||
161003846|NCT03520413|581400090|FG000|Overall Study|Death|0|||
161003847|NCT03520413|581400091|FG001|Overall Study|Death|1|||
161003848|NCT03520413|581400090|FG000|Overall Study|Physician Decision|3|||
161003849|NCT03520413|581400091|FG001|Overall Study|Physician Decision|3|||
161003850|NCT03520413|581400090|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
161003851|NCT03520413|581400091|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
161003852|NCT00869323|581400092|FG000|Maintenance Therapy|concurrent illness|1|||
161003853|NCT00638963|581400093|FG000|Overall Study|Withdrawal by Subject|1|||
161003854|NCT00638963|581400094|FG001|Overall Study|Withdrawal by Subject|0|||
161003855|NCT00959946|581400099|FG000|Overall Study|Adverse Event|0|||
161003856|NCT00959946|581400100|FG001|Overall Study|Adverse Event|0|||
161003857|NCT00959946|581400101|FG002|Overall Study|Adverse Event|2|||
161003858|NCT00959946|581400102|FG003|Overall Study|Adverse Event|1|||
161003859|NCT00959946|581400103|FG004|Overall Study|Adverse Event|0|||
161003860|NCT00959946|581400104|FG005|Overall Study|Adverse Event|1|||
161003861|NCT00959946|581400105|FG006|Overall Study|Adverse Event|0|||
161003862|NCT00959946|581400106|FG007|Overall Study|Adverse Event|0|||
161003863|NCT00959946|581400099|FG000|Overall Study|Death|0|||
161003864|NCT00959946|581400100|FG001|Overall Study|Death|0|||
161003865|NCT00959946|581400101|FG002|Overall Study|Death|0|||
161003866|NCT00959946|581400102|FG003|Overall Study|Death|0|||
161003867|NCT00959946|581400103|FG004|Overall Study|Death|0|||
161003868|NCT00959946|581400104|FG005|Overall Study|Death|1|||
161003869|NCT00959946|581400105|FG006|Overall Study|Death|0|||
161003870|NCT00959946|581400106|FG007|Overall Study|Death|0|||
161003871|NCT00959946|581400099|FG000|Overall Study|Disease Progression|2|||
161003872|NCT00959946|581400100|FG001|Overall Study|Disease Progression|4|||
161003873|NCT00959946|581400101|FG002|Overall Study|Disease Progression|2|||
161003874|NCT00959946|581400102|FG003|Overall Study|Disease Progression|4|||
161003875|NCT00959946|581400103|FG004|Overall Study|Disease Progression|4|||
161003876|NCT00959946|581400104|FG005|Overall Study|Disease Progression|6|||
161003877|NCT00959946|581400105|FG006|Overall Study|Disease Progression|2|||
161003878|NCT00959946|581400106|FG007|Overall Study|Disease Progression|2|||
161003879|NCT00959946|581400099|FG000|Overall Study|Withdrawal by Subject|0|||
161003880|NCT00959946|581400100|FG001|Overall Study|Withdrawal by Subject|0|||
161003881|NCT00959946|581400101|FG002|Overall Study|Withdrawal by Subject|0|||
161003882|NCT00959946|581400102|FG003|Overall Study|Withdrawal by Subject|0|||
161003883|NCT00959946|581400103|FG004|Overall Study|Withdrawal by Subject|0|||
161003884|NCT00959946|581400104|FG005|Overall Study|Withdrawal by Subject|1|||
161003885|NCT00959946|581400105|FG006|Overall Study|Withdrawal by Subject|0|||
161003886|NCT00959946|581400106|FG007|Overall Study|Withdrawal by Subject|0|||
161003887|NCT00457743|581400107|FG000|Overall Study|Adverse Event|0|||
161003888|NCT00457743|581400108|FG001|Overall Study|Adverse Event|4|||
161003889|NCT00457743|581400109|FG002|Overall Study|Adverse Event|0|||
161003890|NCT00457743|581400107|FG000|Overall Study|Lack of Efficacy|3|||
161003891|NCT00457743|581400108|FG001|Overall Study|Lack of Efficacy|23|||
161003892|NCT00457743|581400109|FG002|Overall Study|Lack of Efficacy|3|||
161003893|NCT00566527|581400110|FG000|Overall Study|Reason not provided|3|||
161003894|NCT00566527|581400111|FG001|Overall Study|Reason not provided|11|||
161003895|NCT00566527|581400112|FG002|Overall Study|Reason not provided|10|||
161003896|NCT00566527|581400110|FG000|Overall Study|Adverse Event|2|||
161003897|NCT00566527|581400111|FG001|Overall Study|Adverse Event|0|||
161003898|NCT00566527|581400112|FG002|Overall Study|Adverse Event|1|||
161003899|NCT00566527|581400110|FG000|Overall Study|Physician Decision|3|||
161003900|NCT00566527|581400111|FG001|Overall Study|Physician Decision|8|||
161003901|NCT00566527|581400112|FG002|Overall Study|Physician Decision|20|||
161003902|NCT00566527|581400110|FG000|Overall Study|Lost to Follow-up|3|||
161003903|NCT00566527|581400111|FG001|Overall Study|Lost to Follow-up|4|||
161003904|NCT00566527|581400112|FG002|Overall Study|Lost to Follow-up|4|||
161003905|NCT00566527|581400110|FG000|Overall Study|Withdrawal by Subject|6|||
161003906|NCT00566527|581400111|FG001|Overall Study|Withdrawal by Subject|43|||
161271288|NCT05187013|582375110|FG002|Overall Study|Ongoing Participants|0|||
161003907|NCT00566527|581400112|FG002|Overall Study|Withdrawal by Subject|43|||
161003908|NCT01837966|581400114|FG000|Overall Study|Withdrawal by Subject|2|||
161003909|NCT01837966|581400115|FG001|Overall Study|Withdrawal by Subject|1|||
161003910|NCT04975308|581400119|FG000|Overall Study|Withdrawal by Subject|6|||
161003911|NCT04975308|581400120|FG001|Overall Study|Withdrawal by Subject|16|||
161003912|NCT04975308|581400121|FG002|Overall Study|Withdrawal by Subject|6|||
161003913|NCT04975308|581400119|FG000|Overall Study|Physician Decision|0|||
161003914|NCT04975308|581400120|FG001|Overall Study|Physician Decision|3|||
161003915|NCT04975308|581400121|FG002|Overall Study|Physician Decision|1|||
161003916|NCT04975308|581400119|FG000|Overall Study|Adverse Event|10|||
161003917|NCT04975308|581400120|FG001|Overall Study|Adverse Event|1|||
161003918|NCT04975308|581400121|FG002|Overall Study|Adverse Event|12|||
161003919|NCT04975308|581400119|FG000|Overall Study|On study treatment (Ongoing)|65|||
161003920|NCT04975308|581400120|FG001|Overall Study|On study treatment (Ongoing)|43|||
161003921|NCT04975308|581400121|FG002|Overall Study|On study treatment (Ongoing)|75|||
161003922|NCT04975308|581400119|FG000|Overall Study|Protocol Deviation|4|||
161003923|NCT04975308|581400120|FG001|Overall Study|Protocol Deviation|3|||
161003924|NCT04975308|581400121|FG002|Overall Study|Protocol Deviation|2|||
161003925|NCT01943916|581400124|FG000|Overall Study|Technically invalid images|10|||
161003926|NCT01943916|581400124|FG000|Overall Study|Enrollment Failure|23|||
161003927|NCT01943916|581400124|FG000|Overall Study|Pilot Phase exclusion|100|||
161003928|NCT01943916|581400124|FG000|Overall Study|Quality Assurance Reader Fail|130|||
161003929|NCT01943916|581400124|FG000|Overall Study|Technical Failure|39|||
161003930|NCT01943916|581400124|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
161003931|NCT01943916|581400124|FG000|Overall Study|No Truth Panel Review|38|||
161003932|NCT01943916|581400124|FG000|Overall Study|Protocol Deviation|1|||
161003933|NCT00547118|581400126|FG000|Overall Study|Did not qualify prior to starting drug|1|||
161003934|NCT00547118|581400127|FG001|Overall Study|Did not qualify prior to starting drug|1|||
161003935|NCT00547118|581400126|FG000|Overall Study|Study suspended|7|||
161003936|NCT00547118|581400127|FG001|Overall Study|Study suspended|8|||
161003937|NCT01595321|581400128|FG000|Overall Study|Adverse Event|1|||
161003938|NCT01595321|581400129|FG001|Overall Study|Adverse Event|1|||
161003939|NCT01595321|581400130|FG002|Overall Study|Adverse Event|1|||
161003940|NCT01595321|581400128|FG000|Overall Study|Lack of Efficacy|0|||
161003941|NCT01595321|581400129|FG001|Overall Study|Lack of Efficacy|0|||
161003942|NCT01595321|581400130|FG002|Overall Study|Lack of Efficacy|4|||
161003943|NCT00834834|581400131|FG000|Overall Study|Withdrawal by Subject|4|||
161003944|NCT00834834|581400132|FG001|Overall Study|Withdrawal by Subject|3|||
161003945|NCT01810263|581400137|FG000|Overall Study|Lost to Follow-up|8|||
161003946|NCT01810263|581400138|FG001|Overall Study|Lost to Follow-up|7|||
161003947|NCT00026312|581400141|FG000|Overall Study|Adverse Event|0|||
161003948|NCT00026312|581400142|FG001|Overall Study|Adverse Event|32|||
161003949|NCT00026312|581400141|FG000|Overall Study|Death|1|||
161003950|NCT00026312|581400142|FG001|Overall Study|Death|7|||
161003951|NCT00026312|581400141|FG000|Overall Study|Lack of Efficacy|19|||
161003952|NCT00026312|581400142|FG001|Overall Study|Lack of Efficacy|114|||
161003953|NCT00026312|581400141|FG000|Overall Study|Lost to Follow-up|0|||
161003954|NCT00026312|581400142|FG001|Overall Study|Lost to Follow-up|5|||
161003955|NCT00026312|581400141|FG000|Overall Study|Physician Decision|1|||
161003956|NCT00026312|581400142|FG001|Overall Study|Physician Decision|37|||
161003957|NCT00026312|581400141|FG000|Overall Study|Protocol Violation|0|||
161003958|NCT00026312|581400142|FG001|Overall Study|Protocol Violation|3|||
161003959|NCT00026312|581400141|FG000|Overall Study|Withdrawal by Subject|1|||
161003960|NCT00026312|581400142|FG001|Overall Study|Withdrawal by Subject|6|||
161003961|NCT00026312|581400141|FG000|Overall Study|Ineligible|4|||
161003962|NCT00026312|581400142|FG001|Overall Study|Ineligible|5|||
161003963|NCT00026312|581400141|FG000|Overall Study|Entry onto another COG study|0|||
161003964|NCT00026312|581400142|FG001|Overall Study|Entry onto another COG study|1|||
161003965|NCT00026312|581400141|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
161003966|NCT00026312|581400142|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
161003967|NCT01185561|581401110|FG000|Overall Study|Lost to Follow-up|0|||
161003968|NCT01185561|581401111|FG001|Overall Study|Lost to Follow-up|4|||
161003969|NCT01185561|581401110|FG000|Overall Study|Withdrawal by Subject|2|||
161003970|NCT01185561|581401111|FG001|Overall Study|Withdrawal by Subject|8|||
161003971|NCT01078116|581401114|FG000|Overall Study|Lost to Follow-up|17|||
161003972|NCT01078116|581401114|FG000|Overall Study|Adverse Event|5|||
161003973|NCT01078116|581401114|FG000|Overall Study|Withdrawal by Subject|8|||
161003974|NCT01078116|581401114|FG000|Overall Study|Lack of effectiveness|15|||
161003975|NCT01078116|581401114|FG000|Overall Study|Case report form not completed|3|||
161003976|NCT00585052|581401115|FG000|Overall Study|Withdrawal by Subject|1|||
161003977|NCT02616900|581401116|FG000|Overall Study|Lack of Efficacy|7|||
161003978|NCT02616900|581401116|FG000|Overall Study|Lost to Follow-up|2|||
161271289|NCT01096368|582375112|FG000|Overall Study|Death|0|||
161271290|NCT01096368|582375113|FG001|Overall Study|Death|1|||
161271291|NCT01096368|582375114|FG002|Overall Study|Death|0|||
161271292|NCT01096368|582375115|FG003|Overall Study|Death|0|||
161003979|NCT02616900|581401116|FG000|Overall Study|Protocol Violation|5|||
161271293|NCT01096368|582375116|FG004|Overall Study|Death|0|||
161003980|NCT02616900|581401116|FG000|Overall Study|Withdrawal by Subject|3|||
161271294|NCT01096368|582375112|FG000|Overall Study|Physician Decision|0|||
161003981|NCT02616900|581401116|FG000|Overall Study|Incomplete data|6|||
161003982|NCT02613871|581401117|FG000|Overall Study|Death|2|||
161003983|NCT02613871|581401117|FG000|Overall Study|Withdrew Consent|1|||
161003984|NCT02527148|581401118|FG000|Overall Study|Did not receive study intervention|1|||
161003985|NCT02527148|581401119|FG001|Overall Study|Did not receive study intervention|0|||
161003986|NCT00309907|581401120|FG000|Overall Study|Death|4|||
161003987|NCT00309907|581401120|FG000|Overall Study|Physician Decision|1|||
161003988|NCT00309907|581401120|FG000|Overall Study|Ineligible|11|||
161003989|NCT00309907|581401120|FG000|Overall Study|Major infectious event|4|||
161003990|NCT00494780|581401121|FG000|Overall Study|Adverse Event|1|||
161271295|NCT01096368|582375113|FG001|Overall Study|Physician Decision|13|||
161271296|NCT01096368|582375114|FG002|Overall Study|Physician Decision|2|||
161003991|NCT00494780|581401122|FG001|Overall Study|Adverse Event|0|||
161003992|NCT00494780|581401121|FG000|Overall Study|Withdrew before Dosed|0|||
161271297|NCT01096368|582375115|FG003|Overall Study|Physician Decision|4|||
161271298|NCT01096368|582375116|FG004|Overall Study|Physician Decision|6|||
161003993|NCT00494780|581401122|FG001|Overall Study|Withdrew before Dosed|1|||
161003994|NCT00494780|581401121|FG000|Overall Study|Progression of Study Disease|7|||
161003995|NCT00494780|581401122|FG001|Overall Study|Progression of Study Disease|8|||
161003996|NCT00494780|581401121|FG000|Overall Study|New Treatment|2|||
161003997|NCT00494780|581401122|FG001|Overall Study|New Treatment|2|||
161003998|NCT00494780|581401121|FG000|Overall Study|Non-compliance|1|||
161003999|NCT00494780|581401122|FG001|Overall Study|Non-compliance|0|||
161004000|NCT00494780|581401121|FG000|Overall Study|Residual Tumour Mass|0|||
161004001|NCT00494780|581401122|FG001|Overall Study|Residual Tumour Mass|1|||
161004002|NCT00494780|581401121|FG000|Overall Study|Insurance Issues|0|||
161004003|NCT00494780|581401122|FG001|Overall Study|Insurance Issues|1|||
161004004|NCT02448446|581401123|FG000|Overall Study|Withdrawal by Subject|1|||
161004005|NCT02448446|581401124|FG001|Overall Study|Withdrawal by Subject|0|||
161004006|NCT03260140|581401125|FG000|Overall Study|Death|4|||
161004007|NCT03260140|581401126|FG001|Overall Study|Death|1|||
161004008|NCT03260140|581401125|FG000|Overall Study|Withdrawal by Subject|1|||
161004009|NCT03260140|581401126|FG001|Overall Study|Withdrawal by Subject|4|||
161004010|NCT00463788|581401127|FG000|Overall Study|Progressive Disease|86|||
161004011|NCT00463788|581401128|FG001|Overall Study|Progressive Disease|42|||
161004012|NCT00463788|581401127|FG000|Overall Study|Adverse Event|6|||
161004013|NCT00463788|581401128|FG001|Overall Study|Adverse Event|2|||
161004014|NCT00463788|581401127|FG000|Overall Study|Withdrawal by Subject|6|||
161004015|NCT00463788|581401128|FG001|Overall Study|Withdrawal by Subject|2|||
161004016|NCT00463788|581401127|FG000|Overall Study|Death|4|||
161004017|NCT00463788|581401128|FG001|Overall Study|Death|3|||
161004018|NCT00463788|581401127|FG000|Overall Study|Symptomatic Deterioration|2|||
161004019|NCT00463788|581401128|FG001|Overall Study|Symptomatic Deterioration|3|||
161004020|NCT00463788|581401127|FG000|Overall Study|Lost to Follow-up|1|||
161004021|NCT00463788|581401128|FG001|Overall Study|Lost to Follow-up|0|||
161004022|NCT00463788|581401127|FG000|Overall Study|Protocol Violation|0|||
161004023|NCT00463788|581401128|FG001|Overall Study|Protocol Violation|1|||
161004024|NCT00463788|581401127|FG000|Overall Study|Other|3|||
161004025|NCT00463788|581401128|FG001|Overall Study|Other|0|||
161004026|NCT00463788|581401127|FG000|Overall Study|Randomized but not treated|1|||
161004027|NCT00463788|581401128|FG001|Overall Study|Randomized but not treated|1|||
161004028|NCT00360698|581401129|FG000|Run-In|Physician Decision|0|||
161004029|NCT00360698|581401130|FG001|Run-In|Physician Decision|1|||
161004030|NCT00360698|581401129|FG000|Run-In|Withdrawal by Subject|0|||
161004031|NCT00360698|581401130|FG001|Run-In|Withdrawal by Subject|2|||
161004032|NCT00360698|581401129|FG000|Run-In|Non compliance with treatment procedure|0|||
161004033|NCT00360698|581401130|FG001|Run-In|Non compliance with treatment procedure|1|||
161004034|NCT00360698|581401129|FG000|Run-In|Sponsor request|0|||
161004035|NCT00360698|581401130|FG001|Run-In|Sponsor request|2|||
161004036|NCT00360698|581401129|FG000|Run-In|Patient did not meet inclusion criteria|0|||
161004037|NCT00360698|581401130|FG001|Run-In|Patient did not meet inclusion criteria|1|||
161004038|NCT00360698|581401129|FG000|Run-In|Patient personal reasons|0|||
161004039|NCT00360698|581401130|FG001|Run-In|Patient personal reasons|2|||
161004040|NCT00360698|581401129|FG000|Run-In|Need of insulin with meals|0|||
161004041|NCT00360698|581401130|FG001|Run-In|Need of insulin with meals|1|||
161004042|NCT00360698|581401129|FG000|Treatment Period|Non compliance with treatment procedure|1|||
161004043|NCT00360698|581401130|FG001|Treatment Period|Non compliance with treatment procedure|0|||
161004044|NCT00360698|581401129|FG000|Treatment Period|Early termination by error|0|||
161004045|NCT00360698|581401130|FG001|Treatment Period|Early termination by error|1|||
161004046|NCT01692938|581401139|FG000|Overall Study|Protocol Deviation|1|||
161271299|NCT01096368|582375112|FG000|Overall Study|Withdrawal by Subject|0|||
161271300|NCT01096368|582375113|FG001|Overall Study|Withdrawal by Subject|52|||
161271301|NCT01096368|582375114|FG002|Overall Study|Withdrawal by Subject|0|||
161271302|NCT01096368|582375115|FG003|Overall Study|Withdrawal by Subject|10|||
161271303|NCT01096368|582375116|FG004|Overall Study|Withdrawal by Subject|14|||
161004047|NCT01692938|581401140|FG001|Overall Study|Protocol Deviation|1|||
161004048|NCT01692938|581401139|FG000|Overall Study|Study completed prior to site completion|3|||
161004049|NCT01692938|581401140|FG001|Overall Study|Study completed prior to site completion|3|||
161004050|NCT02423291|581401144|FG000|Overall Study|Lack of Efficacy|14|||
161004051|NCT02423291|581401144|FG000|Overall Study|Adverse Event|1|||
161004052|NCT05283395|581401147|FG000|Overall Study|Adverse Event|4|||
161004053|NCT05283395|581401148|FG001|Overall Study|Adverse Event|4|||
161271304|NCT01096368|582375112|FG000|Overall Study|Ineligible|0|||
161004054|NCT05283395|581401149|FG002|Overall Study|Adverse Event|0|||
161004055|NCT05283395|581401147|FG000|Overall Study|Patient Lost to Follow-Up|0|||
161004056|NCT05283395|581401148|FG001|Overall Study|Patient Lost to Follow-Up|0|||
161147190|NCT02747043|581922424|FG001|Overall Study|Protocol Violation|1|||
161004057|NCT05283395|581401149|FG002|Overall Study|Patient Lost to Follow-Up|1|||
161271305|NCT01096368|582375113|FG001|Overall Study|Ineligible|3|||
161271306|NCT01096368|582375114|FG002|Overall Study|Ineligible|2|||
161004058|NCT05283395|581401147|FG000|Overall Study|Patient Withdrawal|2|||
161004059|NCT05283395|581401148|FG001|Overall Study|Patient Withdrawal|4|||
161004060|NCT05283395|581401149|FG002|Overall Study|Patient Withdrawal|2|||
161004061|NCT05283395|581401147|FG000|Overall Study|Investigator Decision|1|||
161004062|NCT05283395|581401148|FG001|Overall Study|Investigator Decision|0|||
161004063|NCT05283395|581401149|FG002|Overall Study|Investigator Decision|1|||
161004064|NCT05283395|581401147|FG000|Overall Study|Enrolled in error|0|||
161004065|NCT05283395|581401148|FG001|Overall Study|Enrolled in error|0|||
161004066|NCT05283395|581401149|FG002|Overall Study|Enrolled in error|1|||
161004067|NCT00712335|581401151|FG000|Overall Study|Withdrawal by Subject|0|||
161004068|NCT00712335|581401152|FG001|Overall Study|Withdrawal by Subject|7|||
161004069|NCT00712335|581401153|FG002|Overall Study|Withdrawal by Subject|2|||
161004070|NCT00712335|581401154|FG003|Overall Study|Withdrawal by Subject|3|||
161004071|NCT00712335|581401155|FG004|Overall Study|Withdrawal by Subject|0|||
161004072|NCT00712335|581401151|FG000|Overall Study|Lost to Follow-up|2|||
161147191|NCT02747043|581922423|FG000|Overall Study|Disease progression|4|||
161147192|NCT02747043|581922424|FG001|Overall Study|Disease progression|0|||
161147193|NCT01936649|581922429|FG000|Overall Study|Withdrawal by Subject|4|||
161147194|NCT01936649|581922429|FG000|Overall Study|Physician Decision|2|||
161147195|NCT01936649|581922429|FG000|Overall Study|Protocol Violation|2|||
161147196|NCT01936649|581922429|FG000|Overall Study|Other than specified above|5|||
161147197|NCT03648476|581922438|FG000|Overall Study|Withdrawal by Subject|2|||
161147198|NCT03648476|581922439|FG001|Overall Study|Withdrawal by Subject|1|||
161147199|NCT00907881|581922445|FG000|Overall Study|Lost to Follow-up|59|||
161147200|NCT00907881|581922445|FG000|Overall Study|Noncompliance|5|||
161147201|NCT00907881|581922445|FG000|Overall Study|Withdrawal by Subject|5|||
161147202|NCT00907881|581922445|FG000|Overall Study|Protocol Violation|1|||
161147203|NCT00907881|581922445|FG000|Overall Study|Missing discontinuation information|15|||
161147204|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
161147205|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
161147206|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
161147207|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161147208|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161147209|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161147210|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161147211|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
161147212|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
161147213|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
161147214|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
161147215|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161147216|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161147217|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161147218|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161147219|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
161147220|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
161147221|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
161147222|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
161147223|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161147224|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161147225|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161147226|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161147227|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
161147228|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161147229|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
161147230|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161147231|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161147232|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161147233|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161147234|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161343508|NCT03282097|582644402|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
161343509|NCT03282097|582644403|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
161147235|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
161147236|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
161147237|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
161004073|NCT00712335|581401152|FG001|Overall Study|Lost to Follow-up|5|||
161004074|NCT00712335|581401153|FG002|Overall Study|Lost to Follow-up|0|||
161004075|NCT00712335|581401154|FG003|Overall Study|Lost to Follow-up|1|||
161004076|NCT00712335|581401155|FG004|Overall Study|Lost to Follow-up|0|||
161004077|NCT00712335|581401151|FG000|Overall Study|Protocol Violation|1|||
161004078|NCT00712335|581401152|FG001|Overall Study|Protocol Violation|2|||
161004079|NCT00712335|581401153|FG002|Overall Study|Protocol Violation|1|||
161004080|NCT00712335|581401154|FG003|Overall Study|Protocol Violation|0|||
161004081|NCT00712335|581401155|FG004|Overall Study|Protocol Violation|0|||
161004082|NCT00712335|581401151|FG000|Overall Study|Lack of Efficacy|0|||
161004083|NCT00712335|581401152|FG001|Overall Study|Lack of Efficacy|0|||
161004084|NCT00712335|581401153|FG002|Overall Study|Lack of Efficacy|1|||
161004085|NCT00712335|581401154|FG003|Overall Study|Lack of Efficacy|1|||
161004086|NCT00712335|581401155|FG004|Overall Study|Lack of Efficacy|0|||
161004087|NCT00712335|581401151|FG000|Overall Study|Other Reason|0|||
161004088|NCT00712335|581401152|FG001|Overall Study|Other Reason|3|||
161004089|NCT00712335|581401153|FG002|Overall Study|Other Reason|1|||
161004090|NCT00712335|581401154|FG003|Overall Study|Other Reason|0|||
161004091|NCT00712335|581401155|FG004|Overall Study|Other Reason|0|||
161004092|NCT03401112|581401156|FG000|Overall Study|Adverse Event|1|||
161004093|NCT03401112|581401157|FG001|Overall Study|Adverse Event|2|||
161004094|NCT03401112|581401158|FG002|Overall Study|Adverse Event|3|||
161004095|NCT03401112|581401159|FG003|Overall Study|Adverse Event|2|||
161004096|NCT03401112|581401160|FG004|Overall Study|Adverse Event|0|||
161004097|NCT03401112|581401156|FG000|Overall Study|Lost to Follow-up|1|||
161004098|NCT03401112|581401157|FG001|Overall Study|Lost to Follow-up|0|||
161004099|NCT03401112|581401158|FG002|Overall Study|Lost to Follow-up|0|||
161004100|NCT03401112|581401159|FG003|Overall Study|Lost to Follow-up|0|||
161004101|NCT03401112|581401160|FG004|Overall Study|Lost to Follow-up|0|||
161004102|NCT03401112|581401156|FG000|Overall Study|Noncompliance|1|||
161004103|NCT03401112|581401157|FG001|Overall Study|Noncompliance|2|||
161004104|NCT03401112|581401158|FG002|Overall Study|Noncompliance|3|||
161004105|NCT03401112|581401159|FG003|Overall Study|Noncompliance|0|||
161004106|NCT03401112|581401160|FG004|Overall Study|Noncompliance|0|||
161004107|NCT03401112|581401156|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
161004108|NCT03401112|581401157|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
161004109|NCT03401112|581401158|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
161004110|NCT03401112|581401159|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
161004111|NCT03401112|581401160|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
161004112|NCT03401112|581401156|FG000|Overall Study|Withdrawal by Subject|0|||
161004113|NCT03401112|581401157|FG001|Overall Study|Withdrawal by Subject|3|||
161004114|NCT03401112|581401158|FG002|Overall Study|Withdrawal by Subject|2|||
161004115|NCT03401112|581401159|FG003|Overall Study|Withdrawal by Subject|1|||
161004116|NCT03401112|581401160|FG004|Overall Study|Withdrawal by Subject|0|||
161004117|NCT03401112|581401156|FG000|Overall Study|Physician Decision|0|||
161004118|NCT03401112|581401157|FG001|Overall Study|Physician Decision|0|||
161004119|NCT03401112|581401158|FG002|Overall Study|Physician Decision|0|||
161004120|NCT03401112|581401159|FG003|Overall Study|Physician Decision|2|||
161004121|NCT03401112|581401160|FG004|Overall Study|Physician Decision|0|||
161004122|NCT03401112|581401156|FG000|Overall Study|Study was Terminated by Sponsor|0|||
161004123|NCT03401112|581401157|FG001|Overall Study|Study was Terminated by Sponsor|0|||
161004124|NCT03401112|581401158|FG002|Overall Study|Study was Terminated by Sponsor|0|||
161004125|NCT03401112|581401159|FG003|Overall Study|Study was Terminated by Sponsor|1|||
161004126|NCT03401112|581401160|FG004|Overall Study|Study was Terminated by Sponsor|0|||
161004127|NCT03401112|581401156|FG000|Overall Study|Day 1 Assessment not Done|1|||
161004128|NCT03401112|581401157|FG001|Overall Study|Day 1 Assessment not Done|0|||
161004129|NCT03401112|581401158|FG002|Overall Study|Day 1 Assessment not Done|0|||
161004130|NCT03401112|581401159|FG003|Overall Study|Day 1 Assessment not Done|0|||
161004131|NCT03401112|581401160|FG004|Overall Study|Day 1 Assessment not Done|0|||
161004132|NCT03401112|581401156|FG000|Overall Study|Not Dosed|0|||
161004133|NCT03401112|581401157|FG001|Overall Study|Not Dosed|0|||
161004134|NCT03401112|581401158|FG002|Overall Study|Not Dosed|1|||
161004135|NCT03401112|581401159|FG003|Overall Study|Not Dosed|0|||
161004136|NCT03401112|581401160|FG004|Overall Study|Not Dosed|0|||
161004137|NCT03401112|581401156|FG000|Overall Study|Missed Clinical Visit|0|||
161004138|NCT03401112|581401157|FG001|Overall Study|Missed Clinical Visit|0|||
161004139|NCT03401112|581401158|FG002|Overall Study|Missed Clinical Visit|1|||
161271307|NCT01096368|582375115|FG003|Overall Study|Ineligible|0|||
161004140|NCT03401112|581401159|FG003|Overall Study|Missed Clinical Visit|0|||
161004141|NCT03401112|581401160|FG004|Overall Study|Missed Clinical Visit|0|||
161004142|NCT03401112|581401156|FG000|Overall Study|Missed Doses|0|||
161004143|NCT03401112|581401157|FG001|Overall Study|Missed Doses|0|||
161004144|NCT03401112|581401158|FG002|Overall Study|Missed Doses|1|||
161004145|NCT03401112|581401159|FG003|Overall Study|Missed Doses|0|||
161004146|NCT03401112|581401160|FG004|Overall Study|Missed Doses|0|||
161271308|NCT01096368|582375116|FG004|Overall Study|Ineligible|25|||
161271309|NCT01096368|582375112|FG000|Overall Study|Did not start treatment|0|||
161004147|NCT01264679|581401161|FG000|Overall Study|Participation in Another Clinical Trial|1|||
161004148|NCT01264679|581401161|FG000|Overall Study|Physician Decision|1|||
161004149|NCT01264679|581401161|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
161004150|NCT01264679|581401161|FG000|Overall Study|Withdrawal by Subject|1|||
161004151|NCT03475316|581401162|FG000|6 Month Intervention|Adverse Event|2|||
161004152|NCT03475316|581401163|FG001|6 Month Intervention|Adverse Event|1|||
161271310|NCT01096368|582375113|FG001|Overall Study|Did not start treatment|4|||
161004153|NCT03475316|581401162|FG000|6 Month Intervention|Withdrawal by Subject|2|||
161004154|NCT03475316|581401163|FG001|6 Month Intervention|Withdrawal by Subject|0|||
161004155|NCT03475316|581401162|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
161004156|NCT03475316|581401163|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
161004157|NCT03475316|581401162|FG000|9 Months|Study stopped due to COVID pandemic|3|||
161004158|NCT03475316|581401163|FG001|9 Months|Study stopped due to COVID pandemic|4|||
161004159|NCT00424645|581401168|FG000|Overall Study|Death|1|||
161004160|NCT00424645|581401169|FG001|Overall Study|Death|0|||
161004161|NCT02555215|581401170|FG000|Overall Study|Other|1|||
161004162|NCT02555215|581401170|FG000|Overall Study|Investigator Decision|2|||
161004163|NCT00529789|581401171|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
161004164|NCT00529789|581401171|FG000|Study Period II/III|Adverse Event|3|||
161004165|NCT00529789|581401171|FG000|Study Period II/III|Lack of Efficacy|2|||
161004166|NCT00529789|581401171|FG000|Study Period II/III|Withdrawal by Subject|1|||
161004167|NCT00529789|581401171|FG000|Study Period II/III|Protocol Violation|3|||
161004168|NCT00529789|581401171|FG000|Study Period II/III|Physician Decision|3|||
161004169|NCT00529789|581401171|FG000|Study Period II/III|Lost to Follow-up|3|||
161004170|NCT00529789|581401171|FG000|Study Period IV|Parent/Caregiver Decision|1|||
161004171|NCT00529789|581401171|FG000|Study Period IV|Adverse Event|1|||
161004172|NCT00529789|581401171|FG000|Study Period IV|Lack of Efficacy|1|||
161004173|NCT00529789|581401171|FG000|Study Period IV|Lost to Follow-up|3|||
161004174|NCT00468910|581401172|FG000|Overall Study|Lost to Follow-up|2|||
161004175|NCT00468910|581401173|FG001|Overall Study|Lost to Follow-up|1|||
161004176|NCT00468910|581401172|FG000|Overall Study|Withdrawal by Subject|2|||
161004177|NCT00468910|581401173|FG001|Overall Study|Withdrawal by Subject|1|||
161004178|NCT00468910|581401172|FG000|Overall Study|Medical Contraindication|0|||
161004179|NCT00468910|581401173|FG001|Overall Study|Medical Contraindication|1|||
161004180|NCT01909778|581401174|FG000|Overall Study|failed screening|1|||
161004181|NCT05323734|581401175|FG000|Overall Study|Adverse Event|5|||
161004182|NCT05323734|581401176|FG001|Overall Study|Adverse Event|2|||
161004183|NCT05323734|581401175|FG000|Overall Study|Physician Decision|1|||
161004184|NCT05323734|581401176|FG001|Overall Study|Physician Decision|0|||
161004185|NCT05323734|581401175|FG000|Overall Study|Lack of Efficacy|1|||
161004186|NCT05323734|581401176|FG001|Overall Study|Lack of Efficacy|2|||
161004187|NCT05323734|581401175|FG000|Overall Study|Withdrawal by Subject|2|||
161004188|NCT05323734|581401176|FG001|Overall Study|Withdrawal by Subject|0|||
161004189|NCT05323734|581401175|FG000|Overall Study|Participant Withdrawn Due|0|||
161004190|NCT05323734|581401176|FG001|Overall Study|Participant Withdrawn Due|1|||
161004191|NCT00841035|581401181|FG000|Phase 1 Overall Study|Physician Decision|13|||
161004192|NCT00433199|581401186|FG000|Double-Blind Period|Adverse Event|0|||
161004193|NCT00433199|581401187|FG001|Double-Blind Period|Adverse Event|25|||
161004194|NCT00433199|581401186|FG000|Double-Blind Period|Lack of Efficacy|0|||
161004195|NCT00433199|581401187|FG001|Double-Blind Period|Lack of Efficacy|2|||
161004196|NCT00433199|581401186|FG000|Double-Blind Period|Lost to Follow-up|2|||
161004197|NCT00433199|581401187|FG001|Double-Blind Period|Lost to Follow-up|5|||
161004198|NCT00433199|581401186|FG000|Double-Blind Period|Withdrawal by Subject|8|||
161004199|NCT00433199|581401187|FG001|Double-Blind Period|Withdrawal by Subject|19|||
161004200|NCT00433199|581401186|FG000|Double-Blind Period|Protocol Violation|1|||
161004201|NCT00433199|581401187|FG001|Double-Blind Period|Protocol Violation|10|||
161004202|NCT00433199|581401186|FG000|Double-Blind Period|Administrative|1|||
161004203|NCT00433199|581401187|FG001|Double-Blind Period|Administrative|5|||
161004204|NCT00433199|581401186|FG000|Open-Label Period|Adverse Event|0|||
161004205|NCT00433199|581401187|FG001|Open-Label Period|Adverse Event|19|||
161004206|NCT00433199|581401186|FG000|Open-Label Period|Lack of Efficacy|0|||
161004207|NCT00433199|581401187|FG001|Open-Label Period|Lack of Efficacy|2|||
161004208|NCT00433199|581401186|FG000|Open-Label Period|Lost to Follow-up|0|||
161004209|NCT00433199|581401187|FG001|Open-Label Period|Lost to Follow-up|3|||
161004210|NCT00433199|581401186|FG000|Open-Label Period|Withdrawal by Subject|0|||
161004211|NCT00433199|581401187|FG001|Open-Label Period|Withdrawal by Subject|7|||
161004212|NCT00433199|581401186|FG000|Open-Label Period|Protocol Violation|0|||
161004213|NCT00433199|581401187|FG001|Open-Label Period|Protocol Violation|2|||
161004214|NCT00433199|581401186|FG000|Open-Label Period|Administrative|0|||
161004215|NCT00433199|581401187|FG001|Open-Label Period|Administrative|1|||
161004216|NCT00357097|581401188|FG000|Overall Study|Did not meet inclusion criteria|5|||
161004217|NCT00357097|581401189|FG001|Overall Study|Did not meet inclusion criteria|3|||
161004218|NCT00357097|581401188|FG000|Overall Study|Adverse Event|34|||
161004219|NCT00357097|581401189|FG001|Overall Study|Adverse Event|6|||
161004220|NCT00357097|581401188|FG000|Overall Study|Withdrawal by Subject|8|||
161004221|NCT00357097|581401189|FG001|Overall Study|Withdrawal by Subject|7|||
161004222|NCT00357097|581401188|FG000|Overall Study|Non-compliance|1|||
161004223|NCT00357097|581401189|FG001|Overall Study|Non-compliance|2|||
161004224|NCT00357097|581401188|FG000|Overall Study|Lack of Efficacy|2|||
161004225|NCT00357097|581401189|FG001|Overall Study|Lack of Efficacy|8|||
161004226|NCT00357097|581401188|FG000|Overall Study|Met Exclusion Criteria|3|||
161004227|NCT00357097|581401189|FG001|Overall Study|Met Exclusion Criteria|1|||
161004228|NCT00357097|581401188|FG000|Overall Study|Other|1|||
161271311|NCT01096368|582375114|FG002|Overall Study|Did not start treatment|4|||
161271312|NCT01096368|582375115|FG003|Overall Study|Did not start treatment|0|||
161271313|NCT01096368|582375116|FG004|Overall Study|Did not start treatment|0|||
161271314|NCT01096368|582375112|FG000|Overall Study|Progressive disease|0|||
161271315|NCT01096368|582375113|FG001|Overall Study|Progressive disease|6|||
161271316|NCT01096368|582375114|FG002|Overall Study|Progressive disease|0|||
161271317|NCT01096368|582375115|FG003|Overall Study|Progressive disease|10|||
161271318|NCT01096368|582375116|FG004|Overall Study|Progressive disease|3|||
161271319|NCT01096368|582375112|FG000|Overall Study|Other|0|||
161004229|NCT00357097|581401189|FG001|Overall Study|Other|1|||
161004230|NCT00357097|581401188|FG000|Overall Study|Increase of RLS Symptoms|0|||
161004231|NCT00357097|581401189|FG001|Overall Study|Increase of RLS Symptoms|1|||
161004232|NCT00658996|581401190|FG000|First Intervention|Positive slit lamp finding|1|||
161004233|NCT00658996|581401191|FG001|First Intervention|Positive slit lamp finding|0|||
161004234|NCT00658996|581401190|FG000|First Intervention|Lack of lenses|0|||
161004235|NCT00658996|581401191|FG001|First Intervention|Lack of lenses|1|||
161004236|NCT00658996|581401190|FG000|Crossover Period|Physician Decision|1|||
161004237|NCT00658996|581401191|FG001|Crossover Period|Physician Decision|0|||
161004238|NCT00658996|581401190|FG000|Crossover Period|Ineligible|1|||
161004239|NCT00658996|581401191|FG001|Crossover Period|Ineligible|1|||
161004240|NCT00658996|581401190|FG000|Second Intervention|Developed a stye on upper lid|1|||
161004241|NCT00658996|581401191|FG001|Second Intervention|Developed a stye on upper lid|0|||
161004242|NCT00658996|581401190|FG000|Second Intervention|Positive slit lamp finding|0|||
161004243|NCT00658996|581401191|FG001|Second Intervention|Positive slit lamp finding|1|||
161004244|NCT02994654|581401194|FG000|Overall Study|Lost to Follow-up|1|||
161004245|NCT03603717|581401201|FG000|Overall Study|Lost to Follow-up|20|||
161004246|NCT03603717|581401202|FG001|Overall Study|Lost to Follow-up|20|||
161004247|NCT03603717|581401201|FG000|Overall Study|Withdrawal by Subject|16|||
161004248|NCT03603717|581401202|FG001|Overall Study|Withdrawal by Subject|10|||
161004249|NCT00732381|581401205|FG000|Overall Study|Adverse Event|1|||
161004250|NCT00732381|581401206|FG001|Overall Study|Adverse Event|0|||
161004251|NCT00732381|581401205|FG000|Overall Study|Treatment Failure|1|||
161004252|NCT00732381|581401206|FG001|Overall Study|Treatment Failure|1|||
161004253|NCT00457691|581401207|FG000|Overall Study|Adverse Event|4|||
161004254|NCT00457691|581401208|FG001|Overall Study|Adverse Event|1|||
161004255|NCT00457691|581401207|FG000|Overall Study|Death|163|||
161004256|NCT00457691|581401208|FG001|Overall Study|Death|148|||
161004257|NCT00457691|581401207|FG000|Overall Study|Protocol Violation|1|||
161004258|NCT00457691|581401208|FG001|Overall Study|Protocol Violation|3|||
161004259|NCT00457691|581401207|FG000|Overall Study|Lost to Follow-up|23|||
161004260|NCT00457691|581401208|FG001|Overall Study|Lost to Follow-up|14|||
161004261|NCT00457691|581401207|FG000|Overall Study|Study terminated by Sponsor|1|||
161004262|NCT00457691|581401208|FG001|Overall Study|Study terminated by Sponsor|1|||
161004263|NCT00457691|581401207|FG000|Overall Study|Subject refused (reason other than AE)|14|||
161004264|NCT00457691|581401208|FG001|Overall Study|Subject refused (reason other than AE)|19|||
161004265|NCT00457691|581401207|FG000|Overall Study|Disease progression, study terminated|180|||
161004266|NCT00457691|581401208|FG001|Overall Study|Disease progression, study terminated|196|||
161004267|NCT01460446|581402742|FG000|Overall Study|Non-compliance|2|||
161004268|NCT01460446|581402743|FG001|Overall Study|Non-compliance|9|||
161004269|NCT01460446|581402742|FG000|Overall Study|Consent Withdrawn|0|||
161004270|NCT01460446|581402743|FG001|Overall Study|Consent Withdrawn|4|||
161004271|NCT01460446|581402742|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
161004272|NCT01460446|581402743|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
161004273|NCT01460446|581402742|FG000|Overall Study|Surgery/Illness|1|||
161004274|NCT01460446|581402743|FG001|Overall Study|Surgery/Illness|1|||
161004275|NCT01460446|581402742|FG000|Overall Study|Pregnancy|1|||
161004276|NCT01460446|581402743|FG001|Overall Study|Pregnancy|0|||
161004277|NCT01460446|581402742|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
161004278|NCT01460446|581402743|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
161004279|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
161004280|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
161004281|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
161004282|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
161004283|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
161004284|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
161004285|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
161004286|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
161004287|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
161004288|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
161004289|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
161004290|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
161004291|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
161271320|NCT01096368|582375113|FG001|Overall Study|Other|0|||
161004292|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
161271321|NCT01096368|582375114|FG002|Overall Study|Other|1|||
161271322|NCT01096368|582375115|FG003|Overall Study|Other|0|||
161004293|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
161004294|NCT00516321|581402744|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
161004295|NCT00516321|581402745|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
161004296|NCT00516321|581402746|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
161004297|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
161004298|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
161004299|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
161004300|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
161004301|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
161004302|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
161004303|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
161004304|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
161004305|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
161004306|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
161004307|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
161004308|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
161004309|NCT00516321|581402744|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
161004310|NCT00516321|581402745|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
161004311|NCT00516321|581402746|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
161004312|NCT00414544|581402747|FG000|Overall Study|Lost to Follow-up|14|||
161004313|NCT01318382|581402749|FG000|Overall Study|Physician Decision|2|||
161004314|NCT01318382|581402749|FG000|Overall Study|Device Malfunction|10|||
161004315|NCT01318382|581402749|FG000|Overall Study|Protocol Violation|1|||
161004316|NCT01599104|581402752|FG000|Overall Study|Withdrawal by Subject|1|||
161271323|NCT01096368|582375116|FG004|Overall Study|Other|0|||
161271324|NCT01096368|582375112|FG000|Overall Study|Treated with institutional review|0|||
161271325|NCT01096368|582375113|FG001|Overall Study|Treated with institutional review|0|||
161004317|NCT01599104|581402753|FG001|Overall Study|Withdrawal by Subject|1|||
161004318|NCT01599104|581402754|FG002|Overall Study|Withdrawal by Subject|2|||
161004319|NCT01599104|581402752|FG000|Overall Study|Technical Problems|1|||
161004320|NCT01599104|581402753|FG001|Overall Study|Technical Problems|0|||
161004321|NCT01599104|581402754|FG002|Overall Study|Technical Problems|0|||
161004322|NCT01599104|581402752|FG000|Overall Study|Physician Decision|3|||
161004323|NCT01599104|581402753|FG001|Overall Study|Physician Decision|2|||
161004324|NCT01599104|581402754|FG002|Overall Study|Physician Decision|2|||
161004325|NCT01599104|581402752|FG000|Overall Study|Non-compliance with study treatment|0|||
161004326|NCT01599104|581402753|FG001|Overall Study|Non-compliance with study treatment|1|||
161004327|NCT01599104|581402754|FG002|Overall Study|Non-compliance with study treatment|0|||
161004328|NCT01599104|581402752|FG000|Overall Study|Lack of Efficacy|4|||
161004329|NCT01599104|581402753|FG001|Overall Study|Lack of Efficacy|4|||
161004330|NCT01599104|581402754|FG002|Overall Study|Lack of Efficacy|10|||
161004331|NCT01599104|581402752|FG000|Overall Study|Adverse Event|7|||
161004332|NCT01599104|581402753|FG001|Overall Study|Adverse Event|6|||
161004333|NCT01599104|581402754|FG002|Overall Study|Adverse Event|12|||
161004334|NCT00714714|581402757|FG000|Overall Study|Adverse Event|1|||
161004335|NCT02271854|581402760|FG000|Overall Study|Withdrawal by Subject|2|||
161004336|NCT02271854|581402760|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
161004337|NCT02271854|581402760|FG000|Overall Study|Lost to Follow-up|1|||
161004338|NCT01308567|581402761|FG000|Overall Study|Lost to Follow-up|2|||
161004339|NCT01308567|581402762|FG001|Overall Study|Lost to Follow-up|4|||
161004340|NCT01308567|581402763|FG002|Overall Study|Lost to Follow-up|4|||
161004341|NCT01582100|581402764|FG000|Overall Study|Adverse Event|1|||
161004342|NCT01582100|581402764|FG000|Overall Study|Withdrawal by Subject|1|||
161004343|NCT04425863|581402765|FG000|Overall Study|Death|0|||
161004344|NCT04425863|581402766|FG001|Overall Study|Death|0|||
161004345|NCT04425863|581402767|FG002|Overall Study|Death|1|||
161004346|NCT02242487|581402768|FG000|Overall Study|Adverse Event|13|||
161004347|NCT02242487|581402769|FG001|Overall Study|Adverse Event|15|||
161271326|NCT01096368|582375114|FG002|Overall Study|Treated with institutional review|0|||
161004348|NCT02242487|581402768|FG000|Overall Study|Lack of Efficacy|4|||
161004349|NCT02242487|581402769|FG001|Overall Study|Lack of Efficacy|6|||
161004350|NCT02242487|581402768|FG000|Overall Study|Protocol Violation|2|||
161271327|NCT01096368|582375115|FG003|Overall Study|Treated with institutional review|0|||
161271328|NCT01096368|582375116|FG004|Overall Study|Treated with institutional review|1|||
161271329|NCT01568320|582375118|FG000|Overall Study|Death|20|||
161271330|NCT01568320|582375118|FG000|Overall Study|Lost to Follow-up|9|||
161004351|NCT02242487|581402769|FG001|Overall Study|Protocol Violation|0|||
161004352|NCT02242487|581402768|FG000|Overall Study|Lost to Follow-up|2|||
161004353|NCT02242487|581402769|FG001|Overall Study|Lost to Follow-up|1|||
161004354|NCT02242487|581402768|FG000|Overall Study|Other - Miscellaneous|4|||
161004355|NCT02242487|581402769|FG001|Overall Study|Other - Miscellaneous|6|||
161004356|NCT02242487|581402768|FG000|Overall Study|Withdrawal by Subject|37|||
161004357|NCT02242487|581402769|FG001|Overall Study|Withdrawal by Subject|19|||
161004358|NCT02564744|581402771|FG000|Overall Study|Investigator decision|0|||
161004359|NCT02564744|581402772|FG001|Overall Study|Investigator decision|0|||
161004360|NCT02564744|581402773|FG002|Overall Study|Investigator decision|0|||
161004361|NCT02564744|581402774|FG003|Overall Study|Investigator decision|0|||
161004362|NCT02564744|581402775|FG004|Overall Study|Investigator decision|1|||
161004363|NCT02564744|581402771|FG000|Overall Study|Death|10|||
161004364|NCT02564744|581402772|FG001|Overall Study|Death|5|||
161004365|NCT02564744|581402773|FG002|Overall Study|Death|4|||
161004366|NCT02564744|581402774|FG003|Overall Study|Death|16|||
161004367|NCT02564744|581402775|FG004|Overall Study|Death|16|||
161004368|NCT02564744|581402771|FG000|Overall Study|End of study Page Missing|0|||
161004369|NCT02564744|581402772|FG001|Overall Study|End of study Page Missing|0|||
161004370|NCT02564744|581402773|FG002|Overall Study|End of study Page Missing|3|||
161004371|NCT02564744|581402774|FG003|Overall Study|End of study Page Missing|3|||
161004372|NCT02564744|581402775|FG004|Overall Study|End of study Page Missing|0|||
161004373|NCT02564744|581402771|FG000|Overall Study|Subject Withdrew Consent|1|||
161004374|NCT02564744|581402772|FG001|Overall Study|Subject Withdrew Consent|1|||
161004375|NCT02564744|581402773|FG002|Overall Study|Subject Withdrew Consent|1|||
161004376|NCT02564744|581402774|FG003|Overall Study|Subject Withdrew Consent|0|||
161004377|NCT02564744|581402775|FG004|Overall Study|Subject Withdrew Consent|2|||
161004378|NCT02564744|581402771|FG000|Overall Study|Lost to Follow-up|0|||
161004379|NCT02564744|581402772|FG001|Overall Study|Lost to Follow-up|1|||
161004380|NCT02564744|581402773|FG002|Overall Study|Lost to Follow-up|0|||
161004381|NCT02564744|581402774|FG003|Overall Study|Lost to Follow-up|0|||
161004382|NCT02564744|581402775|FG004|Overall Study|Lost to Follow-up|1|||
161004383|NCT02564744|581402771|FG000|Overall Study|Reason not specified|1|||
161004384|NCT02564744|581402772|FG001|Overall Study|Reason not specified|0|||
161004385|NCT02564744|581402773|FG002|Overall Study|Reason not specified|0|||
161004386|NCT02564744|581402774|FG003|Overall Study|Reason not specified|0|||
161004387|NCT02564744|581402775|FG004|Overall Study|Reason not specified|0|||
161004388|NCT02918279|581402786|FG000|Overall Study|Lost to Follow-up|3|||
161004389|NCT02918279|581402787|FG001|Overall Study|Lost to Follow-up|6|||
161004390|NCT02918279|581402786|FG000|Overall Study|Withdrawal by Subject|5|||
161004391|NCT02918279|581402787|FG001|Overall Study|Withdrawal by Subject|15|||
161004392|NCT02918279|581402786|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161004393|NCT02918279|581402787|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161004394|NCT02918279|581402786|FG000|Overall Study|Other|3|||
161004395|NCT02918279|581402787|FG001|Overall Study|Other|1|||
161004396|NCT01140048|581402788|FG000|Overall Study|Physician Decision|1|||
161004397|NCT01140048|581402788|FG000|Overall Study|Withdrawal by Subject|13|||
161271331|NCT01568320|582375118|FG000|Overall Study|Withdrawal by Subject|10|||
161271332|NCT01568320|582375118|FG000|Overall Study|Conversion to open repair|1|||
161271333|NCT01568320|582375118|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
161271334|NCT03233230|582375119|FG000|Overall Study|Adverse Event|6|||
161271335|NCT03233230|582375120|FG001|Overall Study|Adverse Event|3|||
161271336|NCT03233230|582375121|FG002|Overall Study|Adverse Event|6|||
161271337|NCT03233230|582375122|FG003|Overall Study|Adverse Event|3|||
161271338|NCT03233230|582375119|FG000|Overall Study|Protocol Violation|1|||
161343510|NCT03282097|582644402|FG000|Intervention Visit Complete|Patient Death|13|||
161004398|NCT01140048|581402788|FG000|Overall Study|Lost to Follow-up|31|||
161004399|NCT02888080|581402789|FG000|Overall Study|Subject / Guardian decision|1|||
161004400|NCT02888080|581402790|FG001|Overall Study|Subject / Guardian decision|3|||
161004401|NCT02888080|581402789|FG000|Overall Study|New Therapy for study indication|1|||
161004402|NCT02888080|581402790|FG001|Overall Study|New Therapy for study indication|0|||
161004403|NCT02888080|581402789|FG000|Overall Study|Lack of Efficacy|0|||
161004404|NCT02888080|581402790|FG001|Overall Study|Lack of Efficacy|1|||
161343511|NCT03282097|582644403|FG001|Intervention Visit Complete|Patient Death|15|||
161004405|NCT02888080|581402789|FG000|Overall Study|Adverse Event|0|||
161004406|NCT02888080|581402790|FG001|Overall Study|Adverse Event|1|||
161004407|NCT01641198|581402791|FG000|After 12 Months of Function|Lost to Follow-up|3|||
161004408|NCT01641198|581402792|FG001|After 12 Months of Function|Lost to Follow-up|2|||
161004409|NCT01641198|581402793|FG002|After 12 Months of Function|Lost to Follow-up|2|||
161004410|NCT01641198|581402791|FG000|After 12 Months of Function|Protocol Violation|1|||
161004411|NCT01641198|581402792|FG001|After 12 Months of Function|Protocol Violation|0|||
161004412|NCT01641198|581402793|FG002|After 12 Months of Function|Protocol Violation|0|||
161004413|NCT01641198|581402791|FG000|After 12 Months of Function|Adverse Event|0|||
161004414|NCT01641198|581402792|FG001|After 12 Months of Function|Adverse Event|1|||
161004415|NCT01641198|581402793|FG002|After 12 Months of Function|Adverse Event|0|||
161004416|NCT01641198|581402791|FG000|After 24 Months of Function|Lost to Follow-up|4|||
161004417|NCT01641198|581402792|FG001|After 24 Months of Function|Lost to Follow-up|9|||
161004418|NCT01641198|581402793|FG002|After 24 Months of Function|Lost to Follow-up|6|||
161004419|NCT01641198|581402791|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
161004420|NCT01641198|581402792|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
161004421|NCT01641198|581402793|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
161004422|NCT01641198|581402791|FG000|At 15-20 Years of Function|Death|1|||
161004423|NCT01641198|581402792|FG001|At 15-20 Years of Function|Death|0|||
161271339|NCT03233230|582375120|FG001|Overall Study|Protocol Violation|2|||
161004424|NCT01641198|581402793|FG002|At 15-20 Years of Function|Death|1|||
161004425|NCT01039688|581402794|FG000|Overall Study|Adverse Event|38|||
161004426|NCT01039688|581402795|FG001|Overall Study|Adverse Event|39|||
161004427|NCT01039688|581402796|FG002|Overall Study|Adverse Event|24|||
161004428|NCT01039688|581402794|FG000|Overall Study|Lack of Efficacy|20|||
161004429|NCT01039688|581402795|FG001|Overall Study|Lack of Efficacy|11|||
161004430|NCT01039688|581402796|FG002|Overall Study|Lack of Efficacy|26|||
161004431|NCT01039688|581402794|FG000|Overall Study|Lost to Follow-up|11|||
161004432|NCT01039688|581402795|FG001|Overall Study|Lost to Follow-up|9|||
161004433|NCT01039688|581402796|FG002|Overall Study|Lost to Follow-up|5|||
161004434|NCT01039688|581402794|FG000|Overall Study|Other|13|||
161004435|NCT01039688|581402795|FG001|Overall Study|Other|25|||
161004436|NCT01039688|581402796|FG002|Overall Study|Other|12|||
161004437|NCT01039688|581402794|FG000|Overall Study|Withdrawal by Subject|23|||
161004438|NCT01039688|581402795|FG001|Overall Study|Withdrawal by Subject|27|||
161004439|NCT01039688|581402796|FG002|Overall Study|Withdrawal by Subject|13|||
161004440|NCT01039688|581402794|FG000|Overall Study|Death|2|||
161004441|NCT01039688|581402795|FG001|Overall Study|Death|0|||
161004442|NCT01039688|581402796|FG002|Overall Study|Death|0|||
161004443|NCT00346151|581402800|FG000|Overall Study|Withdrawal by Subject|3|||
161004444|NCT01075217|581402801|FG000|Overall Study|Adverse Event|1|||
161004445|NCT01075217|581402802|FG001|Overall Study|Adverse Event|1|||
161004446|NCT01075217|581402801|FG000|Overall Study|Physician Decision|1|||
161004447|NCT01075217|581402802|FG001|Overall Study|Physician Decision|0|||
161004448|NCT03737240|581402805|FG000|Overall Study|Lost to Follow-up|16|||
161004449|NCT03737240|581402806|FG001|Overall Study|Lost to Follow-up|15|||
161004450|NCT00891930|581402807|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
161004451|NCT00891930|581402807|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
161004452|NCT00891930|581402807|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
161004453|NCT00891930|581402807|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
161004454|NCT00891930|581402807|FG000|Part 2 Panitumumab + AMG479|Death|30|||
161004455|NCT02512965|581402810|FG000|Overall Study|Withdrawal by Subject|0|||
161004456|NCT02512965|581402811|FG001|Overall Study|Withdrawal by Subject|4|||
161004457|NCT01444417|581402814|FG000|Overall Study|Ineligibility Determined|0|||
161004458|NCT01444417|581402815|FG001|Overall Study|Ineligibility Determined|1|||
161004459|NCT01444417|581402814|FG000|Overall Study|Withdrawal by Subject|2|||
161004460|NCT01444417|581402815|FG001|Overall Study|Withdrawal by Subject|0|||
161004461|NCT02755116|581402817|FG000|Overall Study|surgery converted to open, pt admitted|3|||
161004462|NCT02755116|581402818|FG001|Overall Study|surgery converted to open, pt admitted|1|||
161004463|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
161004464|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
161004465|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
161004466|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
161004467|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
161004468|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
161004469|NCT02200770|581402819|FG000|Randomized-controlled Period (RCP)|Other|1|||
161004470|NCT02200770|581402820|FG001|Randomized-controlled Period (RCP)|Other|2|||
161004471|NCT02200770|581402819|FG000|Open-label Period (OLP)|Adverse Event|1|||
161004472|NCT02200770|581402820|FG001|Open-label Period (OLP)|Adverse Event|2|||
161004473|NCT02200770|581402819|FG000|Open-label Period (OLP)|Death|1|||
161004474|NCT02200770|581402820|FG001|Open-label Period (OLP)|Death|2|||
161004475|NCT02200770|581402819|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
161004476|NCT02200770|581402820|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
161004477|NCT02200770|581402819|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
161004478|NCT02200770|581402820|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
161004479|NCT02200770|581402819|FG000|Open-label Period (OLP)|Other|6|||
161004480|NCT02200770|581402820|FG001|Open-label Period (OLP)|Other|15|||
161004481|NCT02214160|581402823|FG000|Overall Study|Withdrawal by Subject|1|||
161004482|NCT02214160|581402824|FG001|Overall Study|Withdrawal by Subject|0|||
161004483|NCT02214160|581402825|FG002|Overall Study|Withdrawal by Subject|6|||
161004484|NCT02214160|581402823|FG000|Overall Study|Death|2|||
161004485|NCT02214160|581402824|FG001|Overall Study|Death|2|||
161004486|NCT02214160|581402825|FG002|Overall Study|Death|1|||
161004487|NCT02214160|581402823|FG000|Overall Study|Subject Non-Compliance|0|||
161271340|NCT03233230|582375121|FG002|Overall Study|Protocol Violation|1|||
161271341|NCT03233230|582375122|FG003|Overall Study|Protocol Violation|1|||
161004488|NCT02214160|581402824|FG001|Overall Study|Subject Non-Compliance|3|||
161271342|NCT03233230|582375119|FG000|Overall Study|Lack of Efficacy|1|||
161004489|NCT02214160|581402825|FG002|Overall Study|Subject Non-Compliance|1|||
161004490|NCT02214160|581402823|FG000|Overall Study|Adverse Event|0|||
161004491|NCT02214160|581402824|FG001|Overall Study|Adverse Event|1|||
161004492|NCT02214160|581402825|FG002|Overall Study|Adverse Event|1|||
161004493|NCT02214160|581402823|FG000|Overall Study|Sponsor Decision|0|||
161004494|NCT02214160|581402824|FG001|Overall Study|Sponsor Decision|2|||
161004495|NCT02214160|581402825|FG002|Overall Study|Sponsor Decision|0|||
161004496|NCT02214160|581402823|FG000|Overall Study|Protocol Violation|1|||
161271343|NCT03233230|582375120|FG001|Overall Study|Lack of Efficacy|0|||
161004497|NCT02214160|581402824|FG001|Overall Study|Protocol Violation|0|||
161004498|NCT02214160|581402825|FG002|Overall Study|Protocol Violation|0|||
161004499|NCT02214160|581402823|FG000|Overall Study|Physician Decision|0|||
161004500|NCT02214160|581402824|FG001|Overall Study|Physician Decision|0|||
161004501|NCT02214160|581402825|FG002|Overall Study|Physician Decision|1|||
161004502|NCT01063972|581402826|FG000|Overall Study|Death|12|||
161004503|NCT01063972|581402827|FG001|Overall Study|Death|11|||
161004504|NCT01063972|581402826|FG000|Overall Study|Incarcerated|2|||
161004505|NCT01063972|581402827|FG001|Overall Study|Incarcerated|1|||
161004506|NCT01510717|581402828|FG000|Overall Study|Adverse Event|1|||
161004507|NCT01510717|581402829|FG001|Overall Study|Adverse Event|2|||
161004508|NCT01510717|581402828|FG000|Overall Study|Death|1|||
161004509|NCT01510717|581402829|FG001|Overall Study|Death|0|||
161004510|NCT01510717|581402828|FG000|Overall Study|Lost to Follow-up|0|||
161004511|NCT01510717|581402829|FG001|Overall Study|Lost to Follow-up|1|||
161004512|NCT01510717|581402828|FG000|Overall Study|Withdrawal by Subject|0|||
161004513|NCT01510717|581402829|FG001|Overall Study|Withdrawal by Subject|2|||
161004514|NCT01430611|581402831|FG000|Overall Study|Adverse Event|0|||
161004515|NCT01430611|581402832|FG001|Overall Study|Adverse Event|1|||
161004516|NCT01430611|581402831|FG000|Overall Study|Protocol Violation|1|||
161004517|NCT01430611|581402832|FG001|Overall Study|Protocol Violation|0|||
161004518|NCT01430611|581402831|FG000|Overall Study|Lost to Follow-up|1|||
161004519|NCT01430611|581402832|FG001|Overall Study|Lost to Follow-up|0|||
161004520|NCT01430611|581402831|FG000|Overall Study|Withdrawal by Subject|15|||
161004521|NCT01430611|581402832|FG001|Overall Study|Withdrawal by Subject|14|||
161004522|NCT02204982|581402833|FG000|Overall Study|Patient ineligible-medical monitor|1|||
161004523|NCT02204982|581402834|FG001|Overall Study|Patient ineligible-medical monitor|0|||
161004524|NCT02204982|581402833|FG000|Overall Study|Withdrawal by Subject|1|||
161004525|NCT02204982|581402834|FG001|Overall Study|Withdrawal by Subject|0|||
161004526|NCT02204982|581402833|FG000|Overall Study|Adverse Event|1|||
161004527|NCT02204982|581402834|FG001|Overall Study|Adverse Event|0|||
161004528|NCT02204982|581402833|FG000|Overall Study|Adverse Event and Investigator decision|1|||
161004529|NCT02204982|581402834|FG001|Overall Study|Adverse Event and Investigator decision|0|||
161004530|NCT02204982|581402833|FG000|Overall Study|Physician Decision|0|||
161004531|NCT02204982|581402834|FG001|Overall Study|Physician Decision|2|||
161004532|NCT02204982|581402833|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
161004533|NCT02204982|581402834|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
161004534|NCT02204982|581402833|FG000|Overall Study|Termination of Study bySponsor|0|||
161004535|NCT02204982|581402834|FG001|Overall Study|Termination of Study bySponsor|1|||
161004536|NCT01968226|581402835|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
161004537|NCT00919763|581402836|FG000|Overall Study|Adverse Event|7|||
161004538|NCT00919763|581402837|FG001|Overall Study|Adverse Event|1|||
161004539|NCT00919763|581402836|FG000|Overall Study|Lost to Follow-up|1|||
161004540|NCT00919763|581402837|FG001|Overall Study|Lost to Follow-up|0|||
161004541|NCT00919763|581402836|FG000|Overall Study|Protocol Violation|1|||
161004542|NCT00919763|581402837|FG001|Overall Study|Protocol Violation|1|||
161004543|NCT00919763|581402836|FG000|Overall Study|Withdrawal by Subject|3|||
161004544|NCT00919763|581402837|FG001|Overall Study|Withdrawal by Subject|1|||
161004545|NCT00919763|581402836|FG000|Overall Study|Non-compliance|0|||
161004546|NCT00919763|581402837|FG001|Overall Study|Non-compliance|1|||
161004547|NCT04740164|581402838|FG000|Overall Study|Lack of Efficacy|4|||
161004548|NCT04740164|581402839|FG001|Overall Study|Lack of Efficacy|0|||
161004549|NCT04740164|581402838|FG000|Overall Study|Physician Decision|3|||
161004550|NCT04740164|581402839|FG001|Overall Study|Physician Decision|3|||
161004551|NCT00258895|581402845|FG000|Overall Study|Lost to Follow-up|3|||
161004552|NCT00258895|581402846|FG001|Overall Study|Lost to Follow-up|1|||
161004553|NCT00258895|581402845|FG000|Overall Study|Protocol Violation|6|||
161004554|NCT00258895|581402846|FG001|Overall Study|Protocol Violation|2|||
161004555|NCT00258895|581402845|FG000|Overall Study|Withdrawal by Subject|1|||
161004556|NCT00258895|581402846|FG001|Overall Study|Withdrawal by Subject|0|||
161004557|NCT00442117|581402847|FG000|Overall Study|Adverse Event|3|||
161004558|NCT00442117|581402848|FG001|Overall Study|Adverse Event|2|||
161004559|NCT00442117|581402847|FG000|Overall Study|Lack of Efficacy|2|||
161004560|NCT00442117|581402848|FG001|Overall Study|Lack of Efficacy|6|||
161271344|NCT03233230|582375121|FG002|Overall Study|Lack of Efficacy|0|||
161004561|NCT00442117|581402847|FG000|Overall Study|Lost to Follow-up|1|||
161004562|NCT00442117|581402848|FG001|Overall Study|Lost to Follow-up|2|||
161004563|NCT00442117|581402847|FG000|Overall Study|Withdrawal by Subject|2|||
161004564|NCT00442117|581402848|FG001|Overall Study|Withdrawal by Subject|2|||
161271345|NCT03233230|582375122|FG003|Overall Study|Lack of Efficacy|0|||
161271346|NCT03233230|582375119|FG000|Overall Study|Other|5|||
161004565|NCT00442117|581402847|FG000|Overall Study|Major Deviation|25|||
161004566|NCT00442117|581402848|FG001|Overall Study|Major Deviation|20|||
161004567|NCT00442117|581402847|FG000|Overall Study|Non compliance with protocol|3|||
161004568|NCT00442117|581402848|FG001|Overall Study|Non compliance with protocol|5|||
161004569|NCT00442117|581402847|FG000|Overall Study|Met Withdrawal Criteria|2|||
161004570|NCT00442117|581402848|FG001|Overall Study|Met Withdrawal Criteria|1|||
161004571|NCT01121549|581402854|FG000|Overall Study|Adverse Event|10|||
161004572|NCT01121549|581402854|FG000|Overall Study|Lack of Efficacy|11|||
161004573|NCT01121549|581402854|FG000|Overall Study|Lost to Follow-up|12|||
161004574|NCT01121549|581402854|FG000|Overall Study|Did not meet entrance criteria|9|||
161004575|NCT01121549|581402854|FG000|Overall Study|Study terminated by sponsor|197|||
161004576|NCT01121549|581402854|FG000|Overall Study|Pregnancy|1|||
161004577|NCT01121549|581402854|FG000|Overall Study|Protocol Violation|33|||
161004578|NCT01121549|581402854|FG000|Overall Study|Withdrawal by Subject|16|||
161004579|NCT01121549|581402854|FG000|Overall Study|Other|58|||
161004580|NCT03073941|581404619|FG000|Overall Study|Received non-study device intraoperatively|0|||
161004581|NCT03073941|581404620|FG001|Overall Study|Received non-study device intraoperatively|2|||
161004582|NCT03073941|581404619|FG000|Overall Study|Death|1|||
161004583|NCT03073941|581404620|FG001|Overall Study|Death|0|||
161004584|NCT03073941|581404619|FG000|Overall Study|Withdrawal by Subject|1|||
161004585|NCT03073941|581404620|FG001|Overall Study|Withdrawal by Subject|3|||
161004586|NCT03073941|581404619|FG000|Overall Study|Lost to Follow-up|5|||
161004587|NCT03073941|581404620|FG001|Overall Study|Lost to Follow-up|4|||
161004588|NCT03073941|581404619|FG000|Overall Study|Adverse Event|4|||
161004589|NCT03073941|581404620|FG001|Overall Study|Adverse Event|2|||
161004590|NCT03073941|581404619|FG000|Overall Study|Met an exclusion criterion|0|||
161004591|NCT03073941|581404620|FG001|Overall Study|Met an exclusion criterion|1|||
161004592|NCT04250883|581404622|FG000|Overall Study|Lost to Follow-up|1|||
161004593|NCT04250883|581404623|FG001|Overall Study|Lost to Follow-up|0|||
161004594|NCT02763319|581404624|FG000|Overall Study|Adverse Event|12|||
161004595|NCT02763319|581404625|FG001|Overall Study|Adverse Event|3|||
161004596|NCT02763319|581404624|FG000|Overall Study|Death|123|||
161004597|NCT02763319|581404625|FG001|Overall Study|Death|123|||
161004598|NCT02763319|581404624|FG000|Overall Study|Lost to Follow-up|6|||
161004599|NCT02763319|581404625|FG001|Overall Study|Lost to Follow-up|7|||
161004600|NCT02763319|581404624|FG000|Overall Study|Noncompliance with Study Drug|2|||
161004601|NCT02763319|581404625|FG001|Overall Study|Noncompliance with Study Drug|0|||
161004602|NCT02763319|581404624|FG000|Overall Study|"Captured as Other in Database"|29|||
161004603|NCT02763319|581404625|FG001|Overall Study|"Captured as Other in Database"|34|||
161004604|NCT02763319|581404624|FG000|Overall Study|Physician Decision|1|||
161004605|NCT02763319|581404625|FG001|Overall Study|Physician Decision|7|||
161004606|NCT02763319|581404624|FG000|Overall Study|Progressive Disease|24|||
161004607|NCT02763319|581404625|FG001|Overall Study|Progressive Disease|27|||
161004608|NCT02763319|581404624|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
161004609|NCT02763319|581404625|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
161004610|NCT02763319|581404624|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
161004611|NCT02763319|581404625|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
161004612|NCT02763319|581404624|FG000|Overall Study|Withdrawal by Subject|26|||
161004613|NCT02763319|581404625|FG001|Overall Study|Withdrawal by Subject|25|||
161004614|NCT03936660|581404627|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
161004615|NCT03936660|581404628|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
161004616|NCT00722046|581404629|FG000|Overall Study|Adverse Event|0|||
161004617|NCT00722046|581404630|FG001|Overall Study|Adverse Event|1|||
161004618|NCT00722046|581404631|FG002|Overall Study|Adverse Event|2|||
161004619|NCT00722046|581404632|FG003|Overall Study|Adverse Event|1|||
161004620|NCT00722046|581404633|FG004|Overall Study|Adverse Event|2|||
161004621|NCT00722046|581404634|FG005|Overall Study|Adverse Event|1|||
161004622|NCT00722046|581404635|FG006|Overall Study|Adverse Event|0|||
161004623|NCT00722046|581404629|FG000|Overall Study|Death|0|||
161004624|NCT00722046|581404630|FG001|Overall Study|Death|1|||
161004625|NCT00722046|581404631|FG002|Overall Study|Death|0|||
161004626|NCT00722046|581404632|FG003|Overall Study|Death|0|||
161004627|NCT00722046|581404633|FG004|Overall Study|Death|0|||
161004628|NCT00722046|581404634|FG005|Overall Study|Death|0|||
161004629|NCT00722046|581404635|FG006|Overall Study|Death|2|||
161004630|NCT00722046|581404629|FG000|Overall Study|Protocol Violation|1|||
161004631|NCT00722046|581404630|FG001|Overall Study|Protocol Violation|0|||
161004632|NCT00722046|581404631|FG002|Overall Study|Protocol Violation|0|||
161004633|NCT00722046|581404632|FG003|Overall Study|Protocol Violation|0|||
161271347|NCT03233230|582375120|FG001|Overall Study|Other|5|||
161004634|NCT00722046|581404633|FG004|Overall Study|Protocol Violation|0|||
161004635|NCT00722046|581404634|FG005|Overall Study|Protocol Violation|1|||
161004636|NCT00722046|581404635|FG006|Overall Study|Protocol Violation|0|||
161004637|NCT00722046|581404629|FG000|Overall Study|Withdrawal by Subject|3|||
161004638|NCT00722046|581404630|FG001|Overall Study|Withdrawal by Subject|3|||
161004639|NCT00722046|581404631|FG002|Overall Study|Withdrawal by Subject|4|||
161004640|NCT00722046|581404632|FG003|Overall Study|Withdrawal by Subject|4|||
161004641|NCT00722046|581404633|FG004|Overall Study|Withdrawal by Subject|4|||
161004642|NCT00722046|581404634|FG005|Overall Study|Withdrawal by Subject|7|||
161004643|NCT00722046|581404635|FG006|Overall Study|Withdrawal by Subject|3|||
161004644|NCT00722046|581404629|FG000|Overall Study|Randomized, but not treated|1|||
161271348|NCT03233230|582375121|FG002|Overall Study|Other|5|||
161004645|NCT00722046|581404630|FG001|Overall Study|Randomized, but not treated|1|||
161004646|NCT00722046|581404631|FG002|Overall Study|Randomized, but not treated|0|||
161271349|NCT03233230|582375122|FG003|Overall Study|Other|3|||
161271350|NCT03233230|582375119|FG000|Overall Study|Withdrawal by Subject|2|||
161004647|NCT00722046|581404632|FG003|Overall Study|Randomized, but not treated|2|||
161004648|NCT00722046|581404633|FG004|Overall Study|Randomized, but not treated|0|||
161004649|NCT00722046|581404634|FG005|Overall Study|Randomized, but not treated|0|||
161004650|NCT00722046|581404635|FG006|Overall Study|Randomized, but not treated|0|||
161004651|NCT00722046|581404629|FG000|Overall Study|Other|0|||
161004652|NCT00722046|581404630|FG001|Overall Study|Other|0|||
161004653|NCT00722046|581404631|FG002|Overall Study|Other|1|||
161004654|NCT00722046|581404632|FG003|Overall Study|Other|1|||
161004655|NCT00722046|581404633|FG004|Overall Study|Other|3|||
161004656|NCT00722046|581404634|FG005|Overall Study|Other|2|||
161004657|NCT00722046|581404635|FG006|Overall Study|Other|1|||
161004658|NCT00925587|581404636|FG000|Overall Study|Protocol Specified Criteria|6|||
161004659|NCT00925587|581404637|FG001|Overall Study|Protocol Specified Criteria|6|||
161004660|NCT00925587|581404636|FG000|Overall Study|Physician Decision|4|||
161004661|NCT00925587|581404637|FG001|Overall Study|Physician Decision|1|||
161004662|NCT00925587|581404636|FG000|Overall Study|Protocol Violation|6|||
161004663|NCT00925587|581404637|FG001|Overall Study|Protocol Violation|4|||
161004664|NCT00925587|581404636|FG000|Overall Study|Withdrawal by Subject|9|||
161004665|NCT00925587|581404637|FG001|Overall Study|Withdrawal by Subject|6|||
161004666|NCT00925587|581404636|FG000|Overall Study|Death|5|||
161004667|NCT00925587|581404637|FG001|Overall Study|Death|5|||
161004668|NCT00925587|581404636|FG000|Overall Study|Adverse Event|6|||
161004669|NCT00925587|581404637|FG001|Overall Study|Adverse Event|2|||
161004670|NCT00925587|581404636|FG000|Overall Study|Lost to Follow-up|0|||
161004671|NCT00925587|581404637|FG001|Overall Study|Lost to Follow-up|1|||
161004672|NCT01571596|581404647|FG000|Overall Study|Adverse Event|2|||
161004673|NCT01571596|581404648|FG001|Overall Study|Adverse Event|0|||
161004674|NCT01571596|581404649|FG002|Overall Study|Adverse Event|0|||
161004675|NCT01571596|581404647|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161004676|NCT01571596|581404648|FG001|Overall Study|Study Terminated by the Sponsor|1|||
161004677|NCT01571596|581404649|FG002|Overall Study|Study Terminated by the Sponsor|1|||
161004678|NCT00774397|581404654|FG000|Overall Study|Adverse Event|1|||
161004679|NCT00774397|581404655|FG001|Overall Study|Adverse Event|3|||
161004680|NCT00774397|581404656|FG002|Overall Study|Adverse Event|16|||
161004681|NCT00774397|581404657|FG003|Overall Study|Adverse Event|8|||
161004682|NCT00774397|581404658|FG004|Overall Study|Adverse Event|8|||
161004683|NCT00774397|581404659|FG005|Overall Study|Adverse Event|3|||
161004684|NCT00774397|581404660|FG006|Overall Study|Adverse Event|16|||
161004685|NCT00774397|581404654|FG000|Overall Study|Lack of Efficacy|11|||
161004686|NCT00774397|581404655|FG001|Overall Study|Lack of Efficacy|4|||
161004687|NCT00774397|581404656|FG002|Overall Study|Lack of Efficacy|5|||
161004688|NCT00774397|581404657|FG003|Overall Study|Lack of Efficacy|3|||
161004689|NCT00774397|581404658|FG004|Overall Study|Lack of Efficacy|27|||
161004690|NCT00774397|581404659|FG005|Overall Study|Lack of Efficacy|15|||
161004691|NCT00774397|581404660|FG006|Overall Study|Lack of Efficacy|9|||
161004692|NCT00774397|581404654|FG000|Overall Study|Protocol Violation|0|||
161004693|NCT00774397|581404655|FG001|Overall Study|Protocol Violation|1|||
161004694|NCT00774397|581404656|FG002|Overall Study|Protocol Violation|3|||
161004695|NCT00774397|581404657|FG003|Overall Study|Protocol Violation|1|||
161004696|NCT00774397|581404658|FG004|Overall Study|Protocol Violation|2|||
161004697|NCT00774397|581404659|FG005|Overall Study|Protocol Violation|1|||
161004698|NCT00774397|581404660|FG006|Overall Study|Protocol Violation|0|||
161004699|NCT00774397|581404654|FG000|Overall Study|Lost to Follow-up|0|||
161004700|NCT00774397|581404655|FG001|Overall Study|Lost to Follow-up|1|||
161004701|NCT00774397|581404656|FG002|Overall Study|Lost to Follow-up|1|||
161004702|NCT00774397|581404657|FG003|Overall Study|Lost to Follow-up|1|||
161004703|NCT00774397|581404658|FG004|Overall Study|Lost to Follow-up|0|||
161004704|NCT00774397|581404659|FG005|Overall Study|Lost to Follow-up|1|||
161004705|NCT00774397|581404660|FG006|Overall Study|Lost to Follow-up|0|||
161004706|NCT00774397|581404654|FG000|Overall Study|Refused to continue trial medication|1|||
161271351|NCT03233230|582375120|FG001|Overall Study|Withdrawal by Subject|2|||
161271352|NCT03233230|582375121|FG002|Overall Study|Withdrawal by Subject|0|||
161004707|NCT00774397|581404655|FG001|Overall Study|Refused to continue trial medication|3|||
161004708|NCT00774397|581404656|FG002|Overall Study|Refused to continue trial medication|2|||
161004709|NCT00774397|581404657|FG003|Overall Study|Refused to continue trial medication|2|||
161004710|NCT00774397|581404658|FG004|Overall Study|Refused to continue trial medication|6|||
161004711|NCT00774397|581404659|FG005|Overall Study|Refused to continue trial medication|2|||
161004712|NCT00774397|581404660|FG006|Overall Study|Refused to continue trial medication|3|||
161004713|NCT00774397|581404654|FG000|Overall Study|Not treated|0|||
161004714|NCT00774397|581404655|FG001|Overall Study|Not treated|0|||
161004715|NCT00774397|581404656|FG002|Overall Study|Not treated|0|||
161271353|NCT03233230|582375122|FG003|Overall Study|Withdrawal by Subject|1|||
161004716|NCT00774397|581404657|FG003|Overall Study|Not treated|0|||
161004717|NCT00774397|581404658|FG004|Overall Study|Not treated|1|||
161004718|NCT00774397|581404659|FG005|Overall Study|Not treated|0|||
161004719|NCT00774397|581404660|FG006|Overall Study|Not treated|1|||
161004720|NCT00774397|581404654|FG000|Overall Study|Other than those stated above|1|||
161271354|NCT03233230|582375119|FG000|Overall Study|Lost to Follow-up|0|||
161004721|NCT00774397|581404655|FG001|Overall Study|Other than those stated above|1|||
161004722|NCT00774397|581404656|FG002|Overall Study|Other than those stated above|3|||
161004723|NCT00774397|581404657|FG003|Overall Study|Other than those stated above|2|||
161004724|NCT00774397|581404658|FG004|Overall Study|Other than those stated above|2|||
161004725|NCT00774397|581404659|FG005|Overall Study|Other than those stated above|0|||
161004726|NCT00774397|581404660|FG006|Overall Study|Other than those stated above|1|||
161004727|NCT02499159|581404661|FG000|Randomization|Protocol Violation|1|||
161004728|NCT02499159|581404662|FG001|Randomization|Protocol Violation|1|||
161004729|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
161004730|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
161004731|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
161004732|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
161004733|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
161004734|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
161004735|NCT02499159|581404661|FG000|30-Day Follow-Up Phone Call|Other|1|||
161004736|NCT02499159|581404662|FG001|30-Day Follow-Up Phone Call|Other|0|||
161004737|NCT03644849|581404663|FG000|Overall Study|Lost to Follow-up|1|||
161004738|NCT03644849|581404664|FG001|Overall Study|Lost to Follow-up|3|||
161004739|NCT00979992|581404665|FG000|Overall Study|Ineligible - inadequate pathology|1|||
161004740|NCT00979992|581404665|FG000|Overall Study|Ineligible - wrong cell type|2|||
161004741|NCT00979992|581404665|FG000|Overall Study|Refused - Never Treated|2|||
161004742|NCT00869258|581404666|FG000|Overall Study|Physician Decision|1|||
161004743|NCT00980330|581404668|FG000|Overall Study|Adverse Event|0|||
161004744|NCT00980330|581404669|FG001|Overall Study|Adverse Event|0|||
161004745|NCT00980330|581404670|FG002|Overall Study|Adverse Event|0|||
161004746|NCT00980330|581404671|FG003|Overall Study|Adverse Event|1|||
161004747|NCT00980330|581404672|FG004|Overall Study|Adverse Event|0|||
161004748|NCT00980330|581404673|FG005|Overall Study|Adverse Event|0|||
161004749|NCT00980330|581404674|FG006|Overall Study|Adverse Event|0|||
161004750|NCT00980330|581404668|FG000|Overall Study|Lost to Follow-up|1|||
161004751|NCT00980330|581404669|FG001|Overall Study|Lost to Follow-up|1|||
161004752|NCT00980330|581404670|FG002|Overall Study|Lost to Follow-up|4|||
161004753|NCT00980330|581404671|FG003|Overall Study|Lost to Follow-up|2|||
161004754|NCT00980330|581404672|FG004|Overall Study|Lost to Follow-up|1|||
161004755|NCT00980330|581404673|FG005|Overall Study|Lost to Follow-up|1|||
161004756|NCT00980330|581404674|FG006|Overall Study|Lost to Follow-up|2|||
161004757|NCT00980330|581404668|FG000|Overall Study|Withdrawal by Subject|2|||
161004758|NCT00980330|581404669|FG001|Overall Study|Withdrawal by Subject|4|||
161004759|NCT00980330|581404670|FG002|Overall Study|Withdrawal by Subject|4|||
161004760|NCT00980330|581404671|FG003|Overall Study|Withdrawal by Subject|1|||
161004761|NCT00980330|581404672|FG004|Overall Study|Withdrawal by Subject|3|||
161004762|NCT00980330|581404673|FG005|Overall Study|Withdrawal by Subject|2|||
161004763|NCT00980330|581404674|FG006|Overall Study|Withdrawal by Subject|5|||
161004764|NCT00980330|581404668|FG000|Overall Study|(not specified)|2|||
161004765|NCT00980330|581404669|FG001|Overall Study|(not specified)|0|||
161004766|NCT00980330|581404670|FG002|Overall Study|(not specified)|0|||
161004767|NCT00980330|581404671|FG003|Overall Study|(not specified)|1|||
161004768|NCT00980330|581404672|FG004|Overall Study|(not specified)|1|||
161004769|NCT00980330|581404673|FG005|Overall Study|(not specified)|1|||
161004770|NCT00980330|581404674|FG006|Overall Study|(not specified)|0|||
161004771|NCT03844269|581404679|FG000|Overall Study|Withdrawal pre-intervention|1|||
161004772|NCT03844269|581404679|FG000|Overall Study|Did not complete the intervention|2|||
161004773|NCT02570711|581404686|FG000|Overall Study|Death|1|||
161004774|NCT02570711|581404687|FG001|Overall Study|Death|0|||
161004775|NCT02570711|581404686|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
161004776|NCT02570711|581404687|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
161004777|NCT05001945|581404688|FG000|Overall Study|Adverse Event|0|||
161004778|NCT05001945|581404689|FG001|Overall Study|Adverse Event|0|||
161004779|NCT05001945|581404690|FG002|Overall Study|Adverse Event|0|||
161004780|NCT05001945|581404691|FG003|Overall Study|Adverse Event|1|||
161004781|NCT05001945|581404692|FG004|Overall Study|Adverse Event|0|||
161004782|NCT05001945|581404693|FG005|Overall Study|Adverse Event|0|||
161004783|NCT05001945|581404694|FG006|Overall Study|Adverse Event|0|||
161004784|NCT05001945|581404695|FG007|Overall Study|Adverse Event|0|||
161004785|NCT05001945|581404688|FG000|Overall Study|Lost to Follow-up|0|||
161004786|NCT05001945|581404689|FG001|Overall Study|Lost to Follow-up|1|||
161004787|NCT05001945|581404690|FG002|Overall Study|Lost to Follow-up|1|||
161147238|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
161147239|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161004788|NCT05001945|581404691|FG003|Overall Study|Lost to Follow-up|2|||
161004789|NCT05001945|581404692|FG004|Overall Study|Lost to Follow-up|0|||
161004790|NCT05001945|581404693|FG005|Overall Study|Lost to Follow-up|1|||
161147240|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161271355|NCT03233230|582375120|FG001|Overall Study|Lost to Follow-up|3|||
161004791|NCT05001945|581404694|FG006|Overall Study|Lost to Follow-up|0|||
161004792|NCT05001945|581404695|FG007|Overall Study|Lost to Follow-up|0|||
161271356|NCT03233230|582375121|FG002|Overall Study|Lost to Follow-up|0|||
161271357|NCT03233230|582375122|FG003|Overall Study|Lost to Follow-up|0|||
161271358|NCT04159935|582375123|FG000|Overall Study|Study terminated due to COVID-19|1|||
160965883|NCT01024608|581263079|FG001|Overall Study|Never received study treatment|0|||
160965884|NCT04349280|581263080|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
160965885|NCT04349280|581263081|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
160965886|NCT04349280|581263080|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
160965887|NCT04349280|581263081|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
160965888|NCT04349280|581263080|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
160965889|NCT04349280|581263081|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
160965890|NCT00657618|581263084|FG000|Overall Study|Adverse Event|32|||
160965891|NCT00657618|581263084|FG000|Overall Study|Withdrawal by Subject|8|||
160965892|NCT00657618|581263084|FG000|Overall Study|negative for leishmaniasis|2|||
160965893|NCT00657618|581263084|FG000|Overall Study|didn't start due to schedule conflicts|1|||
160965894|NCT00045708|581264747|FG000|Phase 1|early progressive disease|0|||
160965895|NCT00045708|581264748|FG001|Phase 1|early progressive disease|1|||
160965896|NCT00045708|581264749|FG002|Phase 1|early progressive disease|0|||
160965897|NCT00685945|581264751|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
160965898|NCT00847405|581264753|FG000|First Intervention|Adverse Event|0|||
160965899|NCT00847405|581264754|FG001|First Intervention|Adverse Event|1|||
160965900|NCT00847405|581264753|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
160965901|NCT00847405|581264754|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
160965902|NCT01728792|581264755|FG000|Overall Study|Withdrawal of Consent|1|||
160965903|NCT01728792|581264756|FG001|Overall Study|Withdrawal of Consent|1|||
160965904|NCT01728792|581264757|FG002|Overall Study|Withdrawal of Consent|0|||
160965905|NCT01728792|581264758|FG003|Overall Study|Withdrawal of Consent|1|||
160965906|NCT01728792|581264759|FG004|Overall Study|Withdrawal of Consent|0|||
160965907|NCT01728792|581264755|FG000|Overall Study|Lost to Follow-up|2|||
160965908|NCT01728792|581264756|FG001|Overall Study|Lost to Follow-up|1|||
160965909|NCT01728792|581264757|FG002|Overall Study|Lost to Follow-up|4|||
160965910|NCT01728792|581264758|FG003|Overall Study|Lost to Follow-up|2|||
160965911|NCT01728792|581264759|FG004|Overall Study|Lost to Follow-up|0|||
160965912|NCT04277455|581264760|FG000|Overall Study|Lost to Follow-up|1|||
160965913|NCT04791761|581264762|FG000|Overall Study|Lost to Follow-up|8|||
160965914|NCT04791761|581264763|FG001|Overall Study|Lost to Follow-up|6|||
160965915|NCT04791761|581264764|FG002|Overall Study|Lost to Follow-up|10|||
160965916|NCT04791761|581264762|FG000|Overall Study|Withdrawal by Subject|0|||
160965917|NCT04791761|581264763|FG001|Overall Study|Withdrawal by Subject|1|||
160965918|NCT04791761|581264764|FG002|Overall Study|Withdrawal by Subject|1|||
160965919|NCT04791761|581264762|FG000|Overall Study|Protocol Violation|0|||
160965920|NCT04791761|581264763|FG001|Overall Study|Protocol Violation|1|||
160965921|NCT04791761|581264764|FG002|Overall Study|Protocol Violation|1|||
160965922|NCT00514683|581264765|FG000|Overall Study|Not treated|2|||
160965923|NCT00514683|581264766|FG001|Overall Study|Not treated|1|||
160965924|NCT00514683|581264767|FG002|Overall Study|Not treated|0|||
160965925|NCT00514683|581264768|FG003|Overall Study|Not treated|0|||
160965926|NCT00514683|581264769|FG004|Overall Study|Not treated|1|||
160965927|NCT00514683|581264765|FG000|Overall Study|Adverse Event|21|||
160965928|NCT00514683|581264766|FG001|Overall Study|Adverse Event|20|||
160965929|NCT00514683|581264767|FG002|Overall Study|Adverse Event|15|||
160965930|NCT00514683|581264768|FG003|Overall Study|Adverse Event|13|||
160965931|NCT00514683|581264769|FG004|Overall Study|Adverse Event|27|||
160965932|NCT00514683|581264765|FG000|Overall Study|Protocol Violation|1|||
160965933|NCT00514683|581264766|FG001|Overall Study|Protocol Violation|1|||
160965934|NCT00514683|581264767|FG002|Overall Study|Protocol Violation|0|||
160965935|NCT00514683|581264768|FG003|Overall Study|Protocol Violation|1|||
160965936|NCT00514683|581264769|FG004|Overall Study|Protocol Violation|0|||
160965937|NCT00514683|581264765|FG000|Overall Study|Withdrawal by Subject|2|||
160965938|NCT00514683|581264766|FG001|Overall Study|Withdrawal by Subject|2|||
160965939|NCT00514683|581264767|FG002|Overall Study|Withdrawal by Subject|1|||
160965940|NCT00514683|581264768|FG003|Overall Study|Withdrawal by Subject|0|||
160965941|NCT00514683|581264769|FG004|Overall Study|Withdrawal by Subject|4|||
161271359|NCT04159935|582375124|FG001|Overall Study|Study terminated due to COVID-19|3|||
161271360|NCT01341782|582375125|FG000|Overall Study|Adverse Event|1|||
161271361|NCT01341782|582375126|FG001|Overall Study|Adverse Event|1|||
161271362|NCT01341782|582375125|FG000|Overall Study|Withdrawal by Subject|6|||
160965942|NCT00514683|581264765|FG000|Overall Study|Reason other than listed above|0|||
160965943|NCT00514683|581264766|FG001|Overall Study|Reason other than listed above|1|||
160965944|NCT00514683|581264767|FG002|Overall Study|Reason other than listed above|2|||
161004793|NCT05001945|581404688|FG000|Overall Study|Protocol Violation|1|||
161271363|NCT01341782|582375126|FG001|Overall Study|Withdrawal by Subject|5|||
160965945|NCT00514683|581264768|FG003|Overall Study|Reason other than listed above|0|||
160965946|NCT00514683|581264769|FG004|Overall Study|Reason other than listed above|1|||
160965947|NCT02487498|581264770|FG000|Period: Period 1|Adverse Event|2|||
160965948|NCT02487498|581264771|FG001|Period: Period 1|Adverse Event|4|||
160965949|NCT02487498|581264770|FG000|Period: Period 1|Subject/guardian decision|2|||
160965950|NCT02487498|581264771|FG001|Period: Period 1|Subject/guardian decision|4|||
161271364|NCT01341782|582375125|FG000|Overall Study|Missed 3 consecutive doses|0|||
161004794|NCT05001945|581404689|FG001|Overall Study|Protocol Violation|0|||
161004795|NCT05001945|581404690|FG002|Overall Study|Protocol Violation|1|||
161004796|NCT05001945|581404691|FG003|Overall Study|Protocol Violation|1|||
161004797|NCT05001945|581404692|FG004|Overall Study|Protocol Violation|0|||
161004798|NCT05001945|581404693|FG005|Overall Study|Protocol Violation|1|||
161004799|NCT05001945|581404694|FG006|Overall Study|Protocol Violation|0|||
161004800|NCT05001945|581404695|FG007|Overall Study|Protocol Violation|0|||
161004801|NCT05001945|581404688|FG000|Overall Study|Withdrawal by Subject|0|||
161004802|NCT05001945|581404689|FG001|Overall Study|Withdrawal by Subject|0|||
161004803|NCT05001945|581404690|FG002|Overall Study|Withdrawal by Subject|0|||
161004804|NCT05001945|581404691|FG003|Overall Study|Withdrawal by Subject|1|||
161004805|NCT05001945|581404692|FG004|Overall Study|Withdrawal by Subject|1|||
161004806|NCT05001945|581404693|FG005|Overall Study|Withdrawal by Subject|1|||
161004807|NCT05001945|581404694|FG006|Overall Study|Withdrawal by Subject|0|||
161004808|NCT05001945|581404695|FG007|Overall Study|Withdrawal by Subject|1|||
161004809|NCT05001945|581404688|FG000|Overall Study|Not specified by Investigator|0|||
161004810|NCT05001945|581404689|FG001|Overall Study|Not specified by Investigator|3|||
161004811|NCT05001945|581404690|FG002|Overall Study|Not specified by Investigator|0|||
161004812|NCT05001945|581404691|FG003|Overall Study|Not specified by Investigator|0|||
161004813|NCT05001945|581404692|FG004|Overall Study|Not specified by Investigator|1|||
161004814|NCT05001945|581404693|FG005|Overall Study|Not specified by Investigator|0|||
161004815|NCT05001945|581404694|FG006|Overall Study|Not specified by Investigator|0|||
161004816|NCT05001945|581404695|FG007|Overall Study|Not specified by Investigator|0|||
161004817|NCT01369498|581404697|FG000|Overall Study|Lack of Efficacy|9|||
161004818|NCT01369498|581404698|FG001|Overall Study|Lack of Efficacy|9|||
161004819|NCT01369498|581404699|FG002|Overall Study|Lack of Efficacy|1|||
161004820|NCT01369498|581404700|FG003|Overall Study|Lack of Efficacy|3|||
161004821|NCT01369498|581404697|FG000|Overall Study|Adverse Event|1|||
161004822|NCT01369498|581404698|FG001|Overall Study|Adverse Event|2|||
161004823|NCT01369498|581404699|FG002|Overall Study|Adverse Event|0|||
161004824|NCT01369498|581404700|FG003|Overall Study|Adverse Event|1|||
161004825|NCT01369498|581404697|FG000|Overall Study|Withdrawal of Consent|0|||
161004826|NCT01369498|581404698|FG001|Overall Study|Withdrawal of Consent|1|||
161004827|NCT01369498|581404699|FG002|Overall Study|Withdrawal of Consent|1|||
161004828|NCT01369498|581404700|FG003|Overall Study|Withdrawal of Consent|1|||
161004829|NCT01369498|581404697|FG000|Overall Study|Death|0|||
161004830|NCT01369498|581404698|FG001|Overall Study|Death|0|||
161004831|NCT01369498|581404699|FG002|Overall Study|Death|1|||
161004832|NCT01369498|581404700|FG003|Overall Study|Death|0|||
161004833|NCT01369498|581404697|FG000|Overall Study|Investigator's Discretion|1|||
161004834|NCT01369498|581404698|FG001|Overall Study|Investigator's Discretion|0|||
161004835|NCT01369498|581404699|FG002|Overall Study|Investigator's Discretion|1|||
161004836|NCT01369498|581404700|FG003|Overall Study|Investigator's Discretion|3|||
161004837|NCT01369498|581404697|FG000|Overall Study|Unknown Reason|1|||
161004838|NCT01369498|581404698|FG001|Overall Study|Unknown Reason|0|||
161004839|NCT01369498|581404699|FG002|Overall Study|Unknown Reason|11|||
161004840|NCT01369498|581404700|FG003|Overall Study|Unknown Reason|6|||
161004841|NCT01369498|581404697|FG000|Overall Study|Disease Progression|0|||
161004842|NCT01369498|581404698|FG001|Overall Study|Disease Progression|0|||
161004843|NCT01369498|581404699|FG002|Overall Study|Disease Progression|0|||
161004844|NCT01369498|581404700|FG003|Overall Study|Disease Progression|1|||
161004845|NCT00545077|581404701|FG000|Overall Study|Treatment not received|5|||
161004846|NCT00545077|581404702|FG001|Overall Study|Treatment not received|1|||
161004847|NCT00545077|581404701|FG000|Overall Study|Disease Progression|131|||
161004848|NCT00545077|581404702|FG001|Overall Study|Disease Progression|98|||
161004849|NCT00545077|581404701|FG000|Overall Study|Withdrawal by Subject|3|||
161004850|NCT00545077|581404702|FG001|Overall Study|Withdrawal by Subject|14|||
161004851|NCT00545077|581404701|FG000|Overall Study|Physician Decision|6|||
161004852|NCT00545077|581404702|FG001|Overall Study|Physician Decision|3|||
161004853|NCT00545077|581404701|FG000|Overall Study|Lost to Follow-up|2|||
161004854|NCT00545077|581404702|FG001|Overall Study|Lost to Follow-up|0|||
161004855|NCT00545077|581404701|FG000|Overall Study|Protocol Violation|1|||
161004856|NCT00545077|581404702|FG001|Overall Study|Protocol Violation|0|||
161004857|NCT00545077|581404701|FG000|Overall Study|Adverse Event|0|||
161004858|NCT00545077|581404702|FG001|Overall Study|Adverse Event|31|||
161004859|NCT00545077|581404701|FG000|Overall Study|Death|0|||
161004860|NCT00545077|581404702|FG001|Overall Study|Death|8|||
161004861|NCT02202499|581404703|FG000|Overall Study|Cancer diagnosis|0|||
161004862|NCT02202499|581404704|FG001|Overall Study|Cancer diagnosis|0|||
161004863|NCT02202499|581404705|FG002|Overall Study|Cancer diagnosis|1|||
161004864|NCT02202499|581404703|FG000|Overall Study|Moved from area|0|||
161004865|NCT02202499|581404704|FG001|Overall Study|Moved from area|0|||
161004866|NCT02202499|581404705|FG002|Overall Study|Moved from area|1|||
161004867|NCT02202499|581404703|FG000|Overall Study|Declined before randomization|1|||
161004868|NCT02202499|581404704|FG001|Overall Study|Declined before randomization|0|||
161004869|NCT02202499|581404705|FG002|Overall Study|Declined before randomization|0|||
161004870|NCT02202499|581404703|FG000|Overall Study|Auto accident|1|||
161004871|NCT02202499|581404704|FG001|Overall Study|Auto accident|0|||
161004872|NCT02202499|581404705|FG002|Overall Study|Auto accident|0|||
161004873|NCT00535145|581404709|FG000|Phase I|Adverse Event|3|||
161004874|NCT00535145|581404709|FG000|Phase I|Lost to Follow-up|7|||
161004875|NCT00535145|581404709|FG000|Phase I|Withdrawal by Subject|6|||
161004876|NCT00535145|581404709|FG000|Phase I|(eligibility)|8|||
161004877|NCT00535145|581404709|FG000|Phase I|(protocol violation)|1|||
161004878|NCT00535145|581404709|FG000|Phase I|(PI decision)|1|||
161004879|NCT00535145|581404709|FG000|Phase I|(diagnosis)|3|||
161004880|NCT00535145|581404709|FG000|Phase II|Adverse Event|2|||
161004881|NCT00535145|581404709|FG000|Phase II|Lack of Efficacy|1|||
161004882|NCT00535145|581404709|FG000|Phase II|Lost to Follow-up|5|||
161004883|NCT00535145|581404709|FG000|Phase II|Withdrawal by Subject|5|||
161004884|NCT00535145|581404709|FG000|Phase II|Subject non-compliance|2|||
161004885|NCT05082935|581404716|FG000|Overall Study|Lost to Follow-up|549|||
161004886|NCT05082935|581404717|FG001|Overall Study|Lost to Follow-up|631|||
161004887|NCT05082935|581404716|FG000|Overall Study|Withdrawal by Subject|27|||
161004888|NCT05082935|581404717|FG001|Overall Study|Withdrawal by Subject|58|||
161004889|NCT02957136|581404718|FG000|Overall Study|Withdrawal by Subject|2|||
161004890|NCT02957136|581404719|FG001|Overall Study|Withdrawal by Subject|1|||
161004891|NCT00439569|581404720|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
161004892|NCT00439569|581404720|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
161004893|NCT00439569|581404720|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
161004894|NCT01124734|581404722|FG000|Overall Study|Disease progression|13|||
161004895|NCT01124734|581404722|FG000|Overall Study|Adverse Event|1|||
161004896|NCT01124734|581404722|FG000|Overall Study|Withdrawal by Subject|1|||
161004897|NCT01124734|581404722|FG000|Overall Study|Elected for alternative treatment|2|||
161004898|NCT02423798|581404723|FG000|Overall Study|Withdrawal by Subject|3|||
161004899|NCT02928224|581404727|FG000|Overall Study|Lost to Follow-up|1|||
161004900|NCT02928224|581404728|FG001|Overall Study|Lost to Follow-up|1|||
161004901|NCT02928224|581404729|FG002|Overall Study|Lost to Follow-up|3|||
161004902|NCT02928224|581404730|FG003|Overall Study|Lost to Follow-up|0|||
161004903|NCT02928224|581404727|FG000|Overall Study|Death|30|||
161004904|NCT02928224|581404728|FG001|Overall Study|Death|209|||
161004905|NCT02928224|581404729|FG002|Overall Study|Death|193|||
161004906|NCT02928224|581404730|FG003|Overall Study|Death|198|||
161004907|NCT02928224|581404727|FG000|Overall Study|Withdrawal by Subject|0|||
161004908|NCT02928224|581404728|FG001|Overall Study|Withdrawal by Subject|3|||
161004909|NCT02928224|581404729|FG002|Overall Study|Withdrawal by Subject|7|||
161004910|NCT02928224|581404730|FG003|Overall Study|Withdrawal by Subject|20|||
161004911|NCT02928224|581404727|FG000|Overall Study|Study participation terminated by sponsor|3|||
161004912|NCT02928224|581404728|FG001|Overall Study|Study participation terminated by sponsor|8|||
161004913|NCT02928224|581404729|FG002|Overall Study|Study participation terminated by sponsor|12|||
161004914|NCT02928224|581404730|FG003|Overall Study|Study participation terminated by sponsor|3|||
161004915|NCT02928224|581404727|FG000|Overall Study|Other|3|||
161004916|NCT02928224|581404728|FG001|Overall Study|Other|3|||
161004917|NCT02928224|581404729|FG002|Overall Study|Other|5|||
161004918|NCT02928224|581404730|FG003|Overall Study|Other|0|||
161004919|NCT02538107|581404731|FG000|Overall Study|Did not receive any Mircera dose|11|||
161004920|NCT02538107|581404731|FG000|Overall Study|Missing|5|||
161004921|NCT02538107|581404731|FG000|Overall Study|Necessity of dialysis|20|||
161004922|NCT02538107|581404731|FG000|Overall Study|Administration of other ESA|11|||
161004923|NCT02538107|581404731|FG000|Overall Study|No further treatment necessary|18|||
161004924|NCT02538107|581404731|FG000|Overall Study|Withdrawal by Subject|17|||
161004925|NCT02538107|581404731|FG000|Overall Study|Death|4|||
161004926|NCT02538107|581404731|FG000|Overall Study|Administrative reason|5|||
161004927|NCT02538107|581404731|FG000|Overall Study|Adverse Event|4|||
161004928|NCT02538107|581404731|FG000|Overall Study|Surgery|1|||
161004929|NCT02538107|581404731|FG000|Overall Study|Other|7|||
161004930|NCT02538107|581404731|FG000|Overall Study|Not recorded|7|||
161004931|NCT01278394|581404732|FG000|Overall Study|Lost to Follow-up|1|||
161004932|NCT02115139|581404733|FG000|Overall Study|Protocol Violation|1|||
161004933|NCT02115139|581404733|FG000|Overall Study|treatment discontinuation|6|||
161271365|NCT01341782|582375126|FG001|Overall Study|Missed 3 consecutive doses|4|||
161271366|NCT01341782|582375125|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
161271367|NCT01341782|582375126|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
161004934|NCT02471755|581404734|FG000|Overall Study|Withdrawal by Subject|1|||
161004935|NCT02471755|581404735|FG001|Overall Study|Withdrawal by Subject|0|||
161004936|NCT02471755|581404734|FG000|Overall Study|Lost to Follow-up|0|||
161004937|NCT02471755|581404735|FG001|Overall Study|Lost to Follow-up|1|||
161004938|NCT00305695|581404741|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
161004939|NCT00305695|581404742|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
161004940|NCT00305695|581404741|FG000|Overall Study|Did not have baseline scan|1|||
161004941|NCT00305695|581404742|FG001|Overall Study|Did not have baseline scan|1|||
161004942|NCT01597258|581404745|FG000|Overall Study|No Drug Administration|1|||
161004943|NCT04789408|581404746|FG000|Overall Study|Death|4|||
161004944|NCT04789408|581404747|FG001|Overall Study|Death|3|||
161004945|NCT04789408|581404748|FG002|Overall Study|Death|6|||
161004946|NCT04789408|581404746|FG000|Overall Study|Did not meet eligibility criteria|1|||
161004947|NCT04789408|581404747|FG001|Overall Study|Did not meet eligibility criteria|0|||
161004948|NCT04789408|581404748|FG002|Overall Study|Did not meet eligibility criteria|0|||
161004949|NCT04789408|581404746|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
161004950|NCT04789408|581404747|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
161004951|NCT04789408|581404748|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
161004952|NCT05938413|581406174|FG000|Overall Study|Lost to Follow-up|1|||
161004953|NCT05938413|581406175|FG001|Overall Study|Lost to Follow-up|7|||
161004954|NCT05938413|581406174|FG000|Overall Study|Withdrawal by Subject|1|||
161004955|NCT05938413|581406175|FG001|Overall Study|Withdrawal by Subject|1|||
161004956|NCT03312907|581406176|FG000|Overall Study|Adverse Event|1|||
161004957|NCT03312907|581406177|FG001|Overall Study|Adverse Event|6|||
161004958|NCT03312907|581406178|FG002|Overall Study|Adverse Event|1|||
161004959|NCT03312907|581406176|FG000|Overall Study|Protocol Violation|2|||
161004960|NCT03312907|581406177|FG001|Overall Study|Protocol Violation|3|||
161004961|NCT03312907|581406178|FG002|Overall Study|Protocol Violation|4|||
161004962|NCT03312907|581406176|FG000|Overall Study|Lost to Follow-up|2|||
161004963|NCT03312907|581406177|FG001|Overall Study|Lost to Follow-up|3|||
161004964|NCT03312907|581406178|FG002|Overall Study|Lost to Follow-up|2|||
161004965|NCT03312907|581406176|FG000|Overall Study|Physician Decision|3|||
161004966|NCT03312907|581406177|FG001|Overall Study|Physician Decision|4|||
161004967|NCT03312907|581406178|FG002|Overall Study|Physician Decision|2|||
161004968|NCT03312907|581406176|FG000|Overall Study|Withdrawal by Subject|9|||
161004969|NCT03312907|581406177|FG001|Overall Study|Withdrawal by Subject|14|||
161004970|NCT03312907|581406178|FG002|Overall Study|Withdrawal by Subject|10|||
161004971|NCT01780298|581406184|FG000|Overall Study|Physician Decision|1|||
161004972|NCT01780298|581406185|FG001|Overall Study|Physician Decision|5|||
161004973|NCT01780298|581406186|FG002|Overall Study|Physician Decision|1|||
161004974|NCT01780298|581406187|FG003|Overall Study|Physician Decision|1|||
161004975|NCT01780298|581406184|FG000|Overall Study|Subject not matched|1|||
161004976|NCT01780298|581406185|FG001|Overall Study|Subject not matched|0|||
161004977|NCT01780298|581406186|FG002|Overall Study|Subject not matched|1|||
161004978|NCT01780298|581406187|FG003|Overall Study|Subject not matched|0|||
161004979|NCT01780298|581406184|FG000|Overall Study|Adverse Event|0|||
161004980|NCT01780298|581406185|FG001|Overall Study|Adverse Event|0|||
161004981|NCT01780298|581406186|FG002|Overall Study|Adverse Event|2|||
161004982|NCT01780298|581406187|FG003|Overall Study|Adverse Event|0|||
161004983|NCT02407249|581406204|FG000|Overall Study|Did not complete 12-month follow-up|13|||
161004984|NCT02407249|581406204|FG000|Overall Study|Not treated|13|||
161004985|NCT00840177|581406205|FG000|Overall Study|Adverse Event|5|||
161004986|NCT00840177|581406206|FG001|Overall Study|Adverse Event|1|||
161004987|NCT00840177|581406207|FG002|Overall Study|Adverse Event|1|||
161004988|NCT00840177|581406205|FG000|Overall Study|Refusal unrelated to adverse events|1|||
161004989|NCT00840177|581406206|FG001|Overall Study|Refusal unrelated to adverse events|0|||
161004990|NCT00840177|581406207|FG002|Overall Study|Refusal unrelated to adverse events|1|||
161004991|NCT00840177|581406205|FG000|Overall Study|Progression/relapse|2|||
161004992|NCT00840177|581406206|FG001|Overall Study|Progression/relapse|0|||
161004993|NCT00840177|581406207|FG002|Overall Study|Progression/relapse|0|||
161004994|NCT00840177|581406205|FG000|Overall Study|Death|4|||
161004995|NCT00840177|581406206|FG001|Overall Study|Death|5|||
161004996|NCT00840177|581406207|FG002|Overall Study|Death|5|||
161004997|NCT00840177|581406205|FG000|Overall Study|not protocol specified|6|||
161004998|NCT00840177|581406206|FG001|Overall Study|not protocol specified|3|||
161004999|NCT00840177|581406207|FG002|Overall Study|not protocol specified|0|||
161005000|NCT00840177|581406205|FG000|Overall Study|Ineligible|0|||
161005001|NCT00840177|581406206|FG001|Overall Study|Ineligible|0|||
161005002|NCT00840177|581406207|FG002|Overall Study|Ineligible|3|||
161005003|NCT00840177|581406205|FG000|Overall Study|Did not start treatment|0|||
161005004|NCT00840177|581406206|FG001|Overall Study|Did not start treatment|0|||
161005005|NCT00840177|581406207|FG002|Overall Study|Did not start treatment|1|||
161005006|NCT01391832|581406208|FG000|Overall Study|Withdrawal by Subject|21|||
161005007|NCT01391832|581406209|FG001|Overall Study|Withdrawal by Subject|22|||
161005008|NCT01391832|581406208|FG000|Overall Study|Lost to Follow-up|0|||
161005009|NCT01391832|581406209|FG001|Overall Study|Lost to Follow-up|1|||
161005010|NCT03345901|581406215|FG000|Overall Study|The study was terminated|18|||
161005011|NCT01599793|581406216|FG000|Overall Study|Adverse Event|2|||
161005012|NCT01972724|581406217|FG000|Double-Blind|Rescue Criteria Met|1|||
161005013|NCT01972724|581406218|FG001|Double-Blind|Rescue Criteria Met|0|||
161005014|NCT01972724|581406219|FG002|Double-Blind|Rescue Criteria Met|0|||
161005015|NCT01972724|581406217|FG000|Double-Blind|Adverse Event|1|||
161005016|NCT01972724|581406218|FG001|Double-Blind|Adverse Event|0|||
161005017|NCT01972724|581406219|FG002|Double-Blind|Adverse Event|0|||
161005018|NCT01972724|581406217|FG000|Double-Blind|Withdrawal of Consent|2|||
161005019|NCT01972724|581406218|FG001|Double-Blind|Withdrawal of Consent|1|||
161005020|NCT01972724|581406219|FG002|Double-Blind|Withdrawal of Consent|0|||
161005021|NCT01972724|581406217|FG000|Double-Blind|Significant Protocol Deviation|5|||
161005022|NCT01972724|581406218|FG001|Double-Blind|Significant Protocol Deviation|8|||
161005023|NCT01972724|581406219|FG002|Double-Blind|Significant Protocol Deviation|0|||
161005024|NCT01972724|581406217|FG000|Open-Label|Withdrew Consent|0|||
161271368|NCT01341782|582375125|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
161271369|NCT01341782|582375126|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
161271370|NCT01341782|582375125|FG000|Overall Study|Other|5|||
161005025|NCT01972724|581406218|FG001|Open-Label|Withdrew Consent|0|||
161005026|NCT01972724|581406219|FG002|Open-Label|Withdrew Consent|3|||
161005027|NCT01972724|581406217|FG000|Open-Label|Significant Protocol Deviation|0|||
161005028|NCT01972724|581406218|FG001|Open-Label|Significant Protocol Deviation|0|||
161005029|NCT01972724|581406219|FG002|Open-Label|Significant Protocol Deviation|2|||
161005030|NCT00277355|581406227|FG000|Overall Study|Withdrawal by Subject|3|||
161005031|NCT00277355|581406228|FG001|Overall Study|Withdrawal by Subject|3|||
161005032|NCT00277355|581406227|FG000|Overall Study|Lost to Follow-up|2|||
161005033|NCT00277355|581406228|FG001|Overall Study|Lost to Follow-up|2|||
161005034|NCT00277355|581406227|FG000|Overall Study|Adverse Event|5|||
161005035|NCT00277355|581406228|FG001|Overall Study|Adverse Event|0|||
161005036|NCT00277355|581406227|FG000|Overall Study|Death|3|||
161005037|NCT00277355|581406228|FG001|Overall Study|Death|0|||
161005038|NCT00277355|581406227|FG000|Overall Study|Physician Decision|1|||
161005039|NCT00277355|581406228|FG001|Overall Study|Physician Decision|0|||
161005040|NCT02675244|581406233|FG000|Overall Study|Death|9|||
161005041|NCT02675244|581406234|FG001|Overall Study|Death|6|||
161005042|NCT02675244|581406233|FG000|Overall Study|Withdrawal by Subject|3|||
161005043|NCT02675244|581406234|FG001|Overall Study|Withdrawal by Subject|6|||
161005044|NCT02675244|581406233|FG000|Overall Study|Lost to Follow-up|1|||
161005045|NCT02675244|581406234|FG001|Overall Study|Lost to Follow-up|1|||
161005046|NCT02675244|581406233|FG000|Overall Study|Ongoing at 2 Years|190|||
161005047|NCT02675244|581406234|FG001|Overall Study|Ongoing at 2 Years|185|||
161005048|NCT02652442|581406238|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
161005049|NCT02252042|581406239|FG000|Overall Study|Adverse Event|9|||
161005050|NCT02252042|581406240|FG001|Overall Study|Adverse Event|6|||
161005051|NCT02252042|581406239|FG000|Overall Study|Death|209|||
161005052|NCT02252042|581406240|FG001|Overall Study|Death|217|||
161005053|NCT02252042|581406239|FG000|Overall Study|Physician Decision|0|||
161005054|NCT02252042|581406240|FG001|Overall Study|Physician Decision|2|||
161005055|NCT02252042|581406239|FG000|Overall Study|Transferred to Extension Study|7|||
161005056|NCT02252042|581406240|FG001|Overall Study|Transferred to Extension Study|1|||
161005057|NCT02252042|581406239|FG000|Overall Study|Did Not Continue on Extension Study|7|||
161005058|NCT02252042|581406240|FG001|Overall Study|Did Not Continue on Extension Study|2|||
161005059|NCT02252042|581406239|FG000|Overall Study|Withdrawal by Subject|15|||
161005060|NCT02252042|581406240|FG001|Overall Study|Withdrawal by Subject|20|||
161005061|NCT02593149|581406243|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
161005062|NCT02593149|581406244|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
161005063|NCT02593149|581406243|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
161005064|NCT02593149|581406244|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
161005065|NCT01177670|581406245|FG000|Overall Study|Study Terminated|115|||
161005066|NCT01177670|581406245|FG000|Overall Study|Physician Decision|50|||
161005067|NCT01177670|581406245|FG000|Overall Study|Withdrawal by Subject|4|||
161005068|NCT01636687|581406246|FG000|Induction Period|Withdrawal by Subject|1|||
161005069|NCT01636687|581406247|FG001|Induction Period|Withdrawal by Subject|0|||
161005070|NCT01636687|581406248|FG002|Induction Period|Withdrawal by Subject|0|||
161005071|NCT01636687|581406249|FG003|Induction Period|Withdrawal by Subject|0|||
161005072|NCT01636687|581406250|FG004|Induction Period|Withdrawal by Subject|0|||
161005073|NCT01636687|581406246|FG000|Induction Period|Adverse Event|1|||
161005074|NCT01636687|581406247|FG001|Induction Period|Adverse Event|0|||
161005075|NCT01636687|581406248|FG002|Induction Period|Adverse Event|0|||
161005076|NCT01636687|581406249|FG003|Induction Period|Adverse Event|0|||
161005077|NCT01636687|581406250|FG004|Induction Period|Adverse Event|1|||
161005078|NCT01636687|581406246|FG000|Induction Period|Lack of Efficacy|0|||
161005079|NCT01636687|581406247|FG001|Induction Period|Lack of Efficacy|0|||
161005080|NCT01636687|581406248|FG002|Induction Period|Lack of Efficacy|0|||
161005081|NCT01636687|581406249|FG003|Induction Period|Lack of Efficacy|0|||
161005082|NCT01636687|581406250|FG004|Induction Period|Lack of Efficacy|1|||
161005083|NCT01636687|581406246|FG000|Induction Period|Physician Decision|1|||
161005084|NCT01636687|581406247|FG001|Induction Period|Physician Decision|0|||
161005085|NCT01636687|581406248|FG002|Induction Period|Physician Decision|0|||
161005086|NCT01636687|581406249|FG003|Induction Period|Physician Decision|0|||
161005087|NCT01636687|581406250|FG004|Induction Period|Physician Decision|0|||
161005088|NCT01636687|581406246|FG000|Maintenance Period|Withdrawal by Subject|2|||
161005089|NCT01636687|581406247|FG001|Maintenance Period|Withdrawal by Subject|0|||
161005090|NCT01636687|581406248|FG002|Maintenance Period|Withdrawal by Subject|2|||
161005091|NCT01636687|581406249|FG003|Maintenance Period|Withdrawal by Subject|0|||
161005092|NCT01636687|581406250|FG004|Maintenance Period|Withdrawal by Subject|0|||
161005093|NCT01636687|581406246|FG000|Maintenance Period|Adverse Event|1|||
161005094|NCT01636687|581406247|FG001|Maintenance Period|Adverse Event|0|||
161005095|NCT01636687|581406248|FG002|Maintenance Period|Adverse Event|0|||
161005096|NCT01636687|581406249|FG003|Maintenance Period|Adverse Event|0|||
161005097|NCT01636687|581406250|FG004|Maintenance Period|Adverse Event|0|||
161005098|NCT01636687|581406246|FG000|Maintenance Period|Lack of Efficacy|4|||
161271371|NCT01341782|582375126|FG001|Overall Study|Other|0|||
161005099|NCT01636687|581406247|FG001|Maintenance Period|Lack of Efficacy|1|||
161005100|NCT01636687|581406248|FG002|Maintenance Period|Lack of Efficacy|0|||
161005101|NCT01636687|581406249|FG003|Maintenance Period|Lack of Efficacy|0|||
161005102|NCT01636687|581406250|FG004|Maintenance Period|Lack of Efficacy|0|||
161005103|NCT01636687|581406246|FG000|Maintenance Period|Lost to Follow-up|1|||
161005104|NCT01636687|581406247|FG001|Maintenance Period|Lost to Follow-up|1|||
161005105|NCT01636687|581406248|FG002|Maintenance Period|Lost to Follow-up|0|||
161005106|NCT01636687|581406249|FG003|Maintenance Period|Lost to Follow-up|0|||
161005107|NCT01636687|581406250|FG004|Maintenance Period|Lost to Follow-up|1|||
161005108|NCT01636687|581406246|FG000|Maintenance Period|Physician Decision|0|||
161005109|NCT01636687|581406247|FG001|Maintenance Period|Physician Decision|0|||
161005110|NCT01636687|581406248|FG002|Maintenance Period|Physician Decision|0|||
161005111|NCT01636687|581406249|FG003|Maintenance Period|Physician Decision|0|||
161005112|NCT01636687|581406250|FG004|Maintenance Period|Physician Decision|1|||
161005113|NCT01636687|581406246|FG000|Extension Period|technical problems|0|||
161005114|NCT01636687|581406247|FG001|Extension Period|technical problems|1|||
161005115|NCT01636687|581406248|FG002|Extension Period|technical problems|2|||
161005116|NCT01636687|581406249|FG003|Extension Period|technical problems|1|||
161005117|NCT01636687|581406250|FG004|Extension Period|technical problems|0|||
161005118|NCT01636687|581406246|FG000|Extension Period|Adverse Event|4|||
161005119|NCT01636687|581406247|FG001|Extension Period|Adverse Event|3|||
161271372|NCT00587990|582375132|FG000|Overall Study|Death|0|||
160965951|NCT02487498|581264770|FG000|Period: Period 1|Lost to Follow-up|0|||
160965952|NCT02487498|581264771|FG001|Period: Period 1|Lost to Follow-up|2|||
160965953|NCT02487498|581264770|FG000|Period: Period 1|Lack of Efficacy|1|||
160965954|NCT02487498|581264771|FG001|Period: Period 1|Lack of Efficacy|0|||
160965955|NCT02487498|581264770|FG000|Period: Period 1|Physician Decision|0|||
160965956|NCT02487498|581264771|FG001|Period: Period 1|Physician Decision|1|||
160965957|NCT02487498|581264770|FG000|Period: Period 1|Protocol deviation|1|||
160965958|NCT02487498|581264771|FG001|Period: Period 1|Protocol deviation|0|||
160965959|NCT02487498|581264770|FG000|Period: Washout|Subject/guardian decision|0|||
160965960|NCT02487498|581264771|FG001|Period: Washout|Subject/guardian decision|5|||
160965961|NCT02487498|581264770|FG000|Period: Washout|Lack of Efficacy|1|||
160965962|NCT02487498|581264771|FG001|Period: Washout|Lack of Efficacy|1|||
160965963|NCT02487498|581264770|FG000|Period: Washout|Physician Decision|1|||
160965964|NCT02487498|581264771|FG001|Period: Washout|Physician Decision|0|||
160965965|NCT02487498|581264770|FG000|Period: Washout|Non-compliance with study treatment|0|||
160965966|NCT02487498|581264771|FG001|Period: Washout|Non-compliance with study treatment|1|||
160965967|NCT02487498|581264770|FG000|Period: Period 2|Adverse Event|2|||
160965968|NCT02487498|581264771|FG001|Period: Period 2|Adverse Event|2|||
160965969|NCT02487498|581264770|FG000|Period: Period 2|Subject/guardian decision|2|||
160965970|NCT02487498|581264771|FG001|Period: Period 2|Subject/guardian decision|1|||
160965971|NCT02487498|581264770|FG000|Period: Period 2|Lost to Follow-up|1|||
160965972|NCT02487498|581264771|FG001|Period: Period 2|Lost to Follow-up|1|||
160965973|NCT02487498|581264770|FG000|Period: Period 2|Death|0|||
160965974|NCT02487498|581264771|FG001|Period: Period 2|Death|1|||
160965975|NCT02487498|581264770|FG000|Period: Period 2|Physician Decision|1|||
160965976|NCT02487498|581264771|FG001|Period: Period 2|Physician Decision|0|||
160965977|NCT00676130|581264778|FG000|Overall Study|Lost to Follow-up|0|||
160965978|NCT00676130|581264779|FG001|Overall Study|Lost to Follow-up|1|||
160965979|NCT00676130|581264778|FG000|Overall Study|Found ineligible|3|||
160965980|NCT00676130|581264779|FG001|Overall Study|Found ineligible|2|||
160965981|NCT00676130|581264778|FG000|Overall Study|Withdrawal by Subject|0|||
160965982|NCT00676130|581264779|FG001|Overall Study|Withdrawal by Subject|1|||
160965983|NCT01564368|581264780|FG000|Overall Study|Ineligible|18|||
160965984|NCT01564368|581264780|FG000|Overall Study|Not Randomized in Parent study|116|||
160965985|NCT01564368|581264780|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
160965986|NCT01564368|581264780|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
160965987|NCT02940574|581264782|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
160965988|NCT02940574|581264783|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
161005120|NCT01636687|581406248|FG002|Extension Period|Adverse Event|2|||
161005121|NCT01636687|581406249|FG003|Extension Period|Adverse Event|1|||
161005122|NCT01636687|581406250|FG004|Extension Period|Adverse Event|0|||
161005123|NCT01636687|581406246|FG000|Extension Period|Lack of Efficacy|7|||
161005124|NCT01636687|581406247|FG001|Extension Period|Lack of Efficacy|0|||
161005125|NCT01636687|581406248|FG002|Extension Period|Lack of Efficacy|2|||
161005126|NCT01636687|581406249|FG003|Extension Period|Lack of Efficacy|1|||
161005127|NCT01636687|581406250|FG004|Extension Period|Lack of Efficacy|0|||
161005128|NCT01636687|581406246|FG000|Extension Period|Lost to Follow-up|1|||
161005129|NCT01636687|581406247|FG001|Extension Period|Lost to Follow-up|0|||
161271373|NCT00587990|582375133|FG001|Overall Study|Death|0|||
160965989|NCT02940574|581264782|FG000|1-year Follow-up|Lost to Follow-up|3|||
160965990|NCT02940574|581264783|FG001|1-year Follow-up|Lost to Follow-up|4|||
160965991|NCT00520975|581264784|FG000|Overall Study|Disease progression|31|||
160965992|NCT00520975|581264785|FG001|Overall Study|Disease progression|23|||
160965993|NCT00520975|581264784|FG000|Overall Study|Adverse Event|7|||
161271374|NCT00587990|582375134|FG002|Overall Study|Death|1|||
161005130|NCT01636687|581406248|FG002|Extension Period|Lost to Follow-up|1|||
161005131|NCT01636687|581406249|FG003|Extension Period|Lost to Follow-up|0|||
161005132|NCT01636687|581406250|FG004|Extension Period|Lost to Follow-up|0|||
161005133|NCT01636687|581406246|FG000|Extension Period|Physician Decision|1|||
161005134|NCT01636687|581406247|FG001|Extension Period|Physician Decision|0|||
161005135|NCT01636687|581406248|FG002|Extension Period|Physician Decision|0|||
161005136|NCT01636687|581406249|FG003|Extension Period|Physician Decision|1|||
161005137|NCT01636687|581406250|FG004|Extension Period|Physician Decision|0|||
161005138|NCT01636687|581406246|FG000|Extension Period|study terminated by sponsor|33|||
161005139|NCT01636687|581406247|FG001|Extension Period|study terminated by sponsor|50|||
161005140|NCT01636687|581406248|FG002|Extension Period|study terminated by sponsor|17|||
161005141|NCT01636687|581406249|FG003|Extension Period|study terminated by sponsor|23|||
161005142|NCT01636687|581406250|FG004|Extension Period|study terminated by sponsor|0|||
161005143|NCT01636687|581406246|FG000|Extension Period|Withdrawal by Subject|1|||
161005144|NCT01636687|581406247|FG001|Extension Period|Withdrawal by Subject|0|||
161005145|NCT01636687|581406248|FG002|Extension Period|Withdrawal by Subject|1|||
161005146|NCT01636687|581406249|FG003|Extension Period|Withdrawal by Subject|1|||
161005147|NCT01636687|581406250|FG004|Extension Period|Withdrawal by Subject|0|||
161005148|NCT01636687|581406246|FG000|Follow-up Period|Withdrawal by Subject|1|||
161005149|NCT01636687|581406247|FG001|Follow-up Period|Withdrawal by Subject|0|||
161005150|NCT01636687|581406248|FG002|Follow-up Period|Withdrawal by Subject|0|||
161005151|NCT01636687|581406249|FG003|Follow-up Period|Withdrawal by Subject|0|||
161005152|NCT01636687|581406250|FG004|Follow-up Period|Withdrawal by Subject|1|||
161005153|NCT00666276|581406253|FG000|Overall Study|Protocol Violation|34|||
161005154|NCT02594735|581406254|FG000|Overall Study|Adverse Event|1|||
161005155|NCT00101010|581406255|FG000|Overall Study|Physician Decision|1|||
161005156|NCT00364013|581406262|FG000|Overall Study|Ineligibility determined|4|||
161005157|NCT00364013|581406263|FG001|Overall Study|Ineligibility determined|2|||
161005158|NCT00364013|581406262|FG000|Overall Study|Adverse Event|4|||
161005159|NCT00364013|581406263|FG001|Overall Study|Adverse Event|3|||
161005160|NCT00364013|581406262|FG000|Overall Study|Withdrawal by Subject|13|||
161005161|NCT00364013|581406263|FG001|Overall Study|Withdrawal by Subject|18|||
161005162|NCT00364013|581406262|FG000|Overall Study|Physician Decision|3|||
161005163|NCT00364013|581406263|FG001|Overall Study|Physician Decision|3|||
161005164|NCT00364013|581406262|FG000|Overall Study|Lost to Follow-up|10|||
161005165|NCT00364013|581406263|FG001|Overall Study|Lost to Follow-up|3|||
161005166|NCT00364013|581406262|FG000|Overall Study|Protocol-specified criteria|6|||
161005167|NCT00364013|581406263|FG001|Overall Study|Protocol-specified criteria|6|||
161005168|NCT00364013|581406262|FG000|Overall Study|Other|41|||
161005169|NCT00364013|581406263|FG001|Overall Study|Other|47|||
161005170|NCT00364013|581406262|FG000|Overall Study|Ongoing|20|||
161005171|NCT00364013|581406263|FG001|Overall Study|Ongoing|13|||
161005172|NCT00835770|581406264|FG000|Overall Study|MS Relapse|17|||
161005173|NCT00835770|581406265|FG001|Overall Study|MS Relapse|23|||
161005174|NCT00835770|581406264|FG000|Overall Study|MS Progression|14|||
161005175|NCT00835770|581406265|FG001|Overall Study|MS Progression|9|||
161005176|NCT00835770|581406264|FG000|Overall Study|Adverse Event|113|||
161005177|NCT00835770|581406265|FG001|Overall Study|Adverse Event|124|||
161005178|NCT00835770|581406264|FG000|Overall Study|Lost to Follow-up|22|||
161005179|NCT00835770|581406265|FG001|Overall Study|Lost to Follow-up|19|||
161005180|NCT00835770|581406264|FG000|Overall Study|Consent Withdrawn|144|||
161005181|NCT00835770|581406265|FG001|Overall Study|Consent Withdrawn|156|||
161005182|NCT00835770|581406264|FG000|Overall Study|Investigator Decision|42|||
161005183|NCT00835770|581406265|FG001|Overall Study|Investigator Decision|42|||
161005184|NCT00835770|581406264|FG000|Overall Study|Participant Non-Compliance|11|||
161005185|NCT00835770|581406265|FG001|Overall Study|Participant Non-Compliance|9|||
161005186|NCT00835770|581406264|FG000|Overall Study|Death|4|||
161005187|NCT00835770|581406265|FG001|Overall Study|Death|6|||
161005188|NCT00835770|581406264|FG000|Overall Study|Other|115|||
161005189|NCT00835770|581406265|FG001|Overall Study|Other|104|||
161005190|NCT00835770|581406264|FG000|Overall Study|Other|2|||
161005191|NCT00835770|581406265|FG001|Overall Study|Other|1|||
161005192|NCT00939510|581406269|FG000|Overall Study|Withdrawal by Subject|1|||
161005193|NCT01202955|581406270|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
161271375|NCT00206323|582375135|FG000|Overall Study|Lack of Efficacy|4|||
161005194|NCT01202955|581406271|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
161005195|NCT00159783|581406276|FG000|Overall Study|Adverse Event|5|||
161005196|NCT00159783|581406277|FG001|Overall Study|Adverse Event|7|||
161005197|NCT00159783|581406278|FG002|Overall Study|Adverse Event|9|||
161005198|NCT00159783|581406276|FG000|Overall Study|Lack of Efficacy|1|||
161005199|NCT00159783|581406277|FG001|Overall Study|Lack of Efficacy|2|||
161005200|NCT00159783|581406278|FG002|Overall Study|Lack of Efficacy|3|||
161005201|NCT00159783|581406276|FG000|Overall Study|Withdrawal by Subject|7|||
161005202|NCT00159783|581406277|FG001|Overall Study|Withdrawal by Subject|11|||
161005203|NCT00159783|581406278|FG002|Overall Study|Withdrawal by Subject|12|||
161005204|NCT00159783|581406276|FG000|Overall Study|Lost to Follow-up|6|||
161005205|NCT00159783|581406277|FG001|Overall Study|Lost to Follow-up|5|||
161005206|NCT00159783|581406278|FG002|Overall Study|Lost to Follow-up|11|||
161005207|NCT00159783|581406276|FG000|Overall Study|Other|0|||
161005208|NCT00159783|581406277|FG001|Overall Study|Other|2|||
161005209|NCT00159783|581406278|FG002|Overall Study|Other|4|||
161005210|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
161005211|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
161005212|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
161005213|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
161005214|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
161005215|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
161005216|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
161005217|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
161005218|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
161005219|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
161005220|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
161005221|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
161005222|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
161005223|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
161005224|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
161005225|NCT00958633|581406279|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
161005226|NCT00958633|581406280|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
161005227|NCT00958633|581406281|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
161005228|NCT00958633|581406279|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
161005229|NCT00958633|581406280|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
161005230|NCT00958633|581406281|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
161005231|NCT00094575|581406284|FG000|Overall Study|Death|146|||
161005232|NCT00094575|581406285|FG001|Overall Study|Death|146|||
161005233|NCT00794118|581406286|FG000|Overall Study|Lost to Follow-up|16|||
161005234|NCT00794118|581406286|FG000|Overall Study|Withdrawal by Subject|9|||
161005235|NCT00794118|581406286|FG000|Overall Study|Changed hospital center|2|||
161005236|NCT00206375|581406287|FG000|Overall Study|Lost to Follow-up|1|||
161005237|NCT00206375|581406288|FG001|Overall Study|Lost to Follow-up|0|||
161005238|NCT00206375|581406289|FG002|Overall Study|Lost to Follow-up|0|||
161005239|NCT00206375|581406287|FG000|Overall Study|Withdrawal by Subject|2|||
161005240|NCT00206375|581406288|FG001|Overall Study|Withdrawal by Subject|1|||
161005241|NCT00206375|581406289|FG002|Overall Study|Withdrawal by Subject|3|||
161005242|NCT00206375|581406287|FG000|Overall Study|Study terminated due to lack of funds|0|||
161005243|NCT00206375|581406288|FG001|Overall Study|Study terminated due to lack of funds|1|||
161005244|NCT00206375|581406289|FG002|Overall Study|Study terminated due to lack of funds|1|||
161005245|NCT00837616|581406292|FG000|Overall Study|Withdrawal by Subject|0|||
161005246|NCT00837616|581406293|FG001|Overall Study|Withdrawal by Subject|1|||
161005247|NCT03512756|581406301|FG000|Part 1|Death|23|||
161005248|NCT03512756|581406302|FG001|Part 1|Death|18|||
161005249|NCT03512756|581406303|FG002|Part 1|Death|0|||
161005250|NCT03512756|581406304|FG003|Part 1|Death|0|||
161005251|NCT03512756|581406301|FG000|Part 1|Lost to Follow-up|0|||
161005252|NCT03512756|581406302|FG001|Part 1|Lost to Follow-up|3|||
161005253|NCT03512756|581406303|FG002|Part 1|Lost to Follow-up|0|||
161005254|NCT03512756|581406304|FG003|Part 1|Lost to Follow-up|0|||
160965994|NCT00520975|581264785|FG001|Overall Study|Adverse Event|10|||
160965995|NCT00520975|581264784|FG000|Overall Study|Death|0|||
160965996|NCT00520975|581264785|FG001|Overall Study|Death|2|||
160965997|NCT00520975|581264784|FG000|Overall Study|Withdrawal by Subject|3|||
160965998|NCT00520975|581264785|FG001|Overall Study|Withdrawal by Subject|5|||
160965999|NCT00520975|581264784|FG000|Overall Study|Other therapy|2|||
160966000|NCT00520975|581264785|FG001|Overall Study|Other therapy|4|||
160966001|NCT00520975|581264784|FG000|Overall Study|Other reasons|4|||
160966002|NCT00520975|581264785|FG001|Overall Study|Other reasons|2|||
160966003|NCT00520975|581264784|FG000|Overall Study|Not start protocol therapy|1|||
160966004|NCT00520975|581264785|FG001|Overall Study|Not start protocol therapy|2|||
160966005|NCT04810221|581264786|FG000|Overall Study|Physician Decision|3|||
160966006|NCT01181726|581264787|FG000|First Intervention|Adverse Event|1|||
160966007|NCT01181726|581264788|FG001|First Intervention|Adverse Event|0|||
160966008|NCT00642902|581264789|FG000|Overall Study|Adverse Event|0|||
160966009|NCT00642902|581264790|FG001|Overall Study|Adverse Event|1|||
160966010|NCT00642902|581264791|FG002|Overall Study|Adverse Event|3|||
160966011|NCT00642902|581264792|FG003|Overall Study|Adverse Event|1|||
160966012|NCT00642902|581264789|FG000|Overall Study|Lost to Follow-up|1|||
160966013|NCT00642902|581264790|FG001|Overall Study|Lost to Follow-up|1|||
160966014|NCT00642902|581264791|FG002|Overall Study|Lost to Follow-up|0|||
161005255|NCT03512756|581406301|FG000|Part 1|Physician Decision|0|||
161005256|NCT03512756|581406302|FG001|Part 1|Physician Decision|1|||
161005257|NCT03512756|581406303|FG002|Part 1|Physician Decision|0|||
161005258|NCT03512756|581406304|FG003|Part 1|Physician Decision|0|||
161005259|NCT03512756|581406301|FG000|Part 1|Withdrawal by Subject|2|||
160966015|NCT00642902|581264792|FG003|Overall Study|Lost to Follow-up|0|||
160966016|NCT00642902|581264789|FG000|Overall Study|Lack of Efficacy|0|||
161005260|NCT03512756|581406302|FG001|Part 1|Withdrawal by Subject|2|||
161005261|NCT03512756|581406303|FG002|Part 1|Withdrawal by Subject|0|||
161005262|NCT03512756|581406304|FG003|Part 1|Withdrawal by Subject|0|||
161005263|NCT03512756|581406301|FG000|Part 2|Death|0|||
161005264|NCT03512756|581406302|FG001|Part 2|Death|0|||
161005265|NCT03512756|581406303|FG002|Part 2|Death|32|||
161005266|NCT03512756|581406304|FG003|Part 2|Death|21|||
161005267|NCT03512756|581406301|FG000|Part 2|Lost to Follow-up|0|||
161005268|NCT03512756|581406302|FG001|Part 2|Lost to Follow-up|0|||
161005269|NCT03512756|581406303|FG002|Part 2|Lost to Follow-up|1|||
161005270|NCT03512756|581406304|FG003|Part 2|Lost to Follow-up|0|||
161005271|NCT03512756|581406301|FG000|Part 2|Physician Decision|0|||
161005272|NCT03512756|581406302|FG001|Part 2|Physician Decision|0|||
161005273|NCT03512756|581406303|FG002|Part 2|Physician Decision|2|||
161005274|NCT03512756|581406304|FG003|Part 2|Physician Decision|4|||
161005275|NCT03512756|581406301|FG000|Part 2|Study Terminated by Sponsor|0|||
161005276|NCT03512756|581406302|FG001|Part 2|Study Terminated by Sponsor|0|||
161005277|NCT03512756|581406303|FG002|Part 2|Study Terminated by Sponsor|2|||
161005278|NCT03512756|581406304|FG003|Part 2|Study Terminated by Sponsor|6|||
161005279|NCT03512756|581406301|FG000|Part 2|Protocol Violation|0|||
161005280|NCT03512756|581406302|FG001|Part 2|Protocol Violation|0|||
161005281|NCT03512756|581406303|FG002|Part 2|Protocol Violation|1|||
161005282|NCT03512756|581406304|FG003|Part 2|Protocol Violation|0|||
161005283|NCT03512756|581406301|FG000|Part 2|Withdrawal by Subject|0|||
161005284|NCT03512756|581406302|FG001|Part 2|Withdrawal by Subject|0|||
161005285|NCT03512756|581406303|FG002|Part 2|Withdrawal by Subject|3|||
161005286|NCT03512756|581406304|FG003|Part 2|Withdrawal by Subject|9|||
161005287|NCT01212991|581406305|FG000|Double-blind|Lost to Follow-up|8|||
161005288|NCT01212991|581406306|FG001|Double-blind|Lost to Follow-up|4|||
161005289|NCT01212991|581406307|FG002|Double-blind|Lost to Follow-up|0|||
161005290|NCT01212991|581406305|FG000|Double-blind|Death|699|||
161005291|NCT01212991|581406306|FG001|Double-blind|Death|550|||
161005292|NCT01212991|581406307|FG002|Double-blind|Death|0|||
161005293|NCT01212991|581406305|FG000|Double-blind|Withdrawal by Subject|16|||
161005294|NCT01212991|581406306|FG001|Double-blind|Withdrawal by Subject|19|||
161005295|NCT01212991|581406307|FG002|Double-blind|Withdrawal by Subject|0|||
161005296|NCT01212991|581406305|FG000|Double-blind|Other|7|||
161005297|NCT01212991|581406306|FG001|Double-blind|Other|0|||
161005298|NCT01212991|581406307|FG002|Double-blind|Other|0|||
161005299|NCT01212991|581406305|FG000|Double-blind|Sponsor decision|142|||
161005300|NCT01212991|581406306|FG001|Double-blind|Sponsor decision|38|||
161005301|NCT01212991|581406307|FG002|Double-blind|Sponsor decision|0|||
161005302|NCT01212991|581406305|FG000|Open-label|Death|0|||
161005303|NCT01212991|581406306|FG001|Open-label|Death|0|||
161005304|NCT01212991|581406307|FG002|Open-label|Death|166|||
161005305|NCT01212991|581406305|FG000|Open-label|Lost to Follow-up|0|||
161005306|NCT01212991|581406306|FG001|Open-label|Lost to Follow-up|0|||
161005307|NCT01212991|581406307|FG002|Open-label|Lost to Follow-up|5|||
161005308|NCT01212991|581406305|FG000|Open-label|Withdrawal by Subject|0|||
161005309|NCT01212991|581406306|FG001|Open-label|Withdrawal by Subject|0|||
161005310|NCT01212991|581406307|FG002|Open-label|Withdrawal by Subject|7|||
161005311|NCT01212991|581406305|FG000|Open-label|Sponsor decision|0|||
161005312|NCT01212991|581406306|FG001|Open-label|Sponsor decision|0|||
161005313|NCT01212991|581406307|FG002|Open-label|Sponsor decision|53|||
161005314|NCT01212991|581406305|FG000|Open-label|Other|0|||
161005315|NCT01212991|581406306|FG001|Open-label|Other|0|||
161005316|NCT01212991|581406307|FG002|Open-label|Other|3|||
161005317|NCT04411056|581407822|FG000|Overall Study|surgery cancelled|1|||
161005318|NCT04411056|581407823|FG001|Overall Study|surgery cancelled|0|||
161005319|NCT04411056|581407822|FG000|Overall Study|Equipment problem during intubation|0|||
161005320|NCT04411056|581407823|FG001|Overall Study|Equipment problem during intubation|1|||
161005321|NCT04623008|581407824|FG000|Baseline to T2|Withdrawal by Subject|4|||
161005322|NCT04623008|581407825|FG001|Baseline to T2|Withdrawal by Subject|2|||
161005323|NCT04623008|581407824|FG000|Baseline to T3|Withdrawal by Subject|4|||
161005324|NCT04623008|581407825|FG001|Baseline to T3|Withdrawal by Subject|2|||
161147241|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161005325|NCT04688450|581407834|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
161005326|NCT04688450|581407834|FG000|Overall Study|Withdrawal by Subject|1|||
161005327|NCT03481777|581407835|FG000|Overall Study|Withdrawal by Subject|36|||
161005328|NCT03481777|581407836|FG001|Overall Study|Withdrawal by Subject|31|||
161147242|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161147243|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
161005329|NCT03481777|581407835|FG000|Overall Study|Non stroke = non target population|277|||
161005330|NCT03481777|581407836|FG001|Overall Study|Non stroke = non target population|254|||
161005331|NCT03189524|581407837|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
161005332|NCT03189524|581407838|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
161005333|NCT03189524|581407839|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
161005334|NCT03189524|581407837|FG000|Overall Study|Death|2|||
161005335|NCT03189524|581407838|FG001|Overall Study|Death|2|||
161005336|NCT03189524|581407839|FG002|Overall Study|Death|1|||
161005337|NCT03189524|581407837|FG000|Overall Study|Lost to Follow-up|1|||
161005338|NCT03189524|581407838|FG001|Overall Study|Lost to Follow-up|0|||
161005339|NCT03189524|581407839|FG002|Overall Study|Lost to Follow-up|8|||
161005340|NCT03189524|581407837|FG000|Overall Study|Withdrawal by Subject|1|||
161005341|NCT03189524|581407838|FG001|Overall Study|Withdrawal by Subject|1|||
161005342|NCT03189524|581407839|FG002|Overall Study|Withdrawal by Subject|3|||
161005343|NCT03189524|581407837|FG000|Overall Study|Progressive Disease|0|||
161005344|NCT03189524|581407838|FG001|Overall Study|Progressive Disease|2|||
161005345|NCT03189524|581407839|FG002|Overall Study|Progressive Disease|0|||
161005346|NCT04252586|581407840|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161005347|NCT04252586|581407840|FG000|Overall Study|Adverse Event|1|||
161005348|NCT04252586|581407840|FG000|Overall Study|Death|2|||
161005349|NCT04252586|581407840|FG000|Overall Study|Study terminated by sponsor|4|||
161005350|NCT04252586|581407840|FG000|Overall Study|Sponsor request|10|||
161005351|NCT04252586|581407840|FG000|Overall Study|Did not complete treatment period|1|||
161005352|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Death|186|||
161005353|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Death|222|||
161005354|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Death|0|||
161005355|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
161005356|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
161005357|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
161005358|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
161005359|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
161005360|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
161005361|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
161005362|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
161005363|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
161005364|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Adverse Event|83|||
161005365|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Adverse Event|100|||
161005366|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Adverse Event|0|||
161005367|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Other|70|||
161005368|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Other|75|||
161005369|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Other|0|||
161005370|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
161005371|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
161005372|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
161005373|NCT00232180|581407841|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
161005374|NCT00232180|581407842|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
161005375|NCT00232180|581407843|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
161005376|NCT00232180|581407841|FG000|Open Label Phase|Death|0|||
161005377|NCT00232180|581407842|FG001|Open Label Phase|Death|0|||
161005378|NCT00232180|581407843|FG002|Open Label Phase|Death|48|||
161005379|NCT00232180|581407841|FG000|Open Label Phase|Lost to Follow-up|0|||
161005380|NCT00232180|581407842|FG001|Open Label Phase|Lost to Follow-up|0|||
161005381|NCT00232180|581407843|FG002|Open Label Phase|Lost to Follow-up|5|||
161005382|NCT00232180|581407841|FG000|Open Label Phase|Protocol Violation|0|||
161005383|NCT00232180|581407842|FG001|Open Label Phase|Protocol Violation|0|||
161005384|NCT00232180|581407843|FG002|Open Label Phase|Protocol Violation|3|||
161005385|NCT00232180|581407841|FG000|Open Label Phase|Study terminated by sponsor|0|||
161005386|NCT00232180|581407842|FG001|Open Label Phase|Study terminated by sponsor|0|||
161005387|NCT00232180|581407843|FG002|Open Label Phase|Study terminated by sponsor|3|||
161005388|NCT00232180|581407841|FG000|Open Label Phase|Withdrawal by Subject|0|||
161005389|NCT00232180|581407842|FG001|Open Label Phase|Withdrawal by Subject|0|||
161005390|NCT00232180|581407843|FG002|Open Label Phase|Withdrawal by Subject|37|||
161005391|NCT00232180|581407841|FG000|Open Label Phase|Other|0|||
161005392|NCT00232180|581407842|FG001|Open Label Phase|Other|0|||
161005393|NCT00232180|581407843|FG002|Open Label Phase|Other|16|||
161005394|NCT00232180|581407841|FG000|Open Label Phase|Adverse Event|0|||
161005395|NCT00232180|581407842|FG001|Open Label Phase|Adverse Event|0|||
161005396|NCT00232180|581407843|FG002|Open Label Phase|Adverse Event|25|||
161005397|NCT00232180|581407841|FG000|Open Label Phase|Laboratory abnormality|0|||
161005398|NCT00232180|581407842|FG001|Open Label Phase|Laboratory abnormality|0|||
161005399|NCT00232180|581407843|FG002|Open Label Phase|Laboratory abnormality|10|||
161005400|NCT00232180|581407841|FG000|Open Label Phase|Randomized but not treated|0|||
161005401|NCT00232180|581407842|FG001|Open Label Phase|Randomized but not treated|0|||
161005402|NCT00232180|581407843|FG002|Open Label Phase|Randomized but not treated|1|||
161005403|NCT02748317|581407844|FG000|Overall Study|Withdrawal by Subject|14|||
161005404|NCT02748317|581407844|FG000|Overall Study|Lost to Follow-up|8|||
161005405|NCT02748317|581407844|FG000|Overall Study|Death|1|||
161005406|NCT00434304|581407845|FG000|Overall Study|Adverse Event|14|||
161005407|NCT00434304|581407845|FG000|Overall Study|Lack of Efficacy|2|||
161005408|NCT00434304|581407845|FG000|Overall Study|Withdrawal by Subject|4|||
161005409|NCT05262738|581407846|FG000|Overall Study|Withdrawal by Subject|1|||
161005410|NCT05262738|581407847|FG001|Overall Study|Withdrawal by Subject|0|||
161005411|NCT01149369|581407851|FG000|Overall Study|Adverse Event|6|||
161005412|NCT01149369|581407852|FG001|Overall Study|Adverse Event|3|||
161005413|NCT01424397|581407853|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005414|NCT01424397|581407854|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005415|NCT01424397|581407855|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
161005416|NCT01424397|581407856|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005417|NCT01424397|581407857|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005418|NCT01424397|581407858|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005419|NCT01424397|581407859|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005420|NCT01424397|581407860|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005421|NCT01424397|581407861|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005422|NCT01424397|581407862|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005423|NCT01424397|581407863|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005424|NCT01424397|581407864|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
161005425|NCT02767765|581407865|FG000|Overall Study|Adverse Event|4|||
161005426|NCT02767765|581407865|FG000|Overall Study|Death|1|||
161005427|NCT02767765|581407865|FG000|Overall Study|Insufficient response|1|||
161005428|NCT02767765|581407865|FG000|Overall Study|Lost to Follow-up|2|||
161005429|NCT02767765|581407865|FG000|Overall Study|Investigator decision|1|||
161005430|NCT02767765|581407865|FG000|Overall Study|Non-Compliance|1|||
161005431|NCT02767765|581407865|FG000|Overall Study|Withdrawal by Subject|1|||
161005432|NCT00636207|581407871|FG000|Overall Study|Adverse Event|1|||
161005433|NCT00636207|581407872|FG001|Overall Study|Adverse Event|0|||
161005434|NCT00636207|581407873|FG002|Overall Study|Adverse Event|0|||
161005435|NCT00636207|581407874|FG003|Overall Study|Adverse Event|0|||
161005436|NCT00636207|581407875|FG004|Overall Study|Adverse Event|0|||
161005437|NCT00636207|581407876|FG005|Overall Study|Adverse Event|0|||
161005438|NCT00636207|581407877|FG006|Overall Study|Adverse Event|0|||
161005439|NCT00636207|581407871|FG000|Overall Study|Withdrawal by Subject|0|||
161005440|NCT00636207|581407872|FG001|Overall Study|Withdrawal by Subject|1|||
161005441|NCT00636207|581407873|FG002|Overall Study|Withdrawal by Subject|0|||
161005442|NCT00636207|581407874|FG003|Overall Study|Withdrawal by Subject|0|||
161005443|NCT00636207|581407875|FG004|Overall Study|Withdrawal by Subject|1|||
161005444|NCT00636207|581407876|FG005|Overall Study|Withdrawal by Subject|0|||
161005445|NCT00636207|581407877|FG006|Overall Study|Withdrawal by Subject|0|||
161005446|NCT04054635|581407878|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
161005447|NCT04054635|581407879|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
161005448|NCT04054635|581407880|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
161005449|NCT04054635|581407878|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
161005450|NCT04054635|581407879|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
161005451|NCT04054635|581407880|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
161005452|NCT01185782|581407887|FG000|Overall Study|Adverse Event|0|||
161005453|NCT01185782|581407888|FG001|Overall Study|Adverse Event|1|||
161005454|NCT01185782|581407887|FG000|Overall Study|Protocol Violation|1|||
161005455|NCT01185782|581407888|FG001|Overall Study|Protocol Violation|0|||
161005456|NCT01185782|581407887|FG000|Overall Study|Poor Response to Treatment|3|||
161005457|NCT01185782|581407888|FG001|Overall Study|Poor Response to Treatment|1|||
161005458|NCT01185782|581407887|FG000|Overall Study|Other|2|||
161005459|NCT01185782|581407888|FG001|Overall Study|Other|5|||
161005460|NCT01185782|581407887|FG000|Overall Study|Randomized but not treated|0|||
161005461|NCT01185782|581407888|FG001|Overall Study|Randomized but not treated|4|||
161005462|NCT02507752|581407889|FG000|Overall Study|Adverse Event|1|||
161005463|NCT02507752|581407889|FG000|Overall Study|Protocol Violation|6|||
161005464|NCT02507752|581407889|FG000|Overall Study|Lost to Follow-up|7|||
161005465|NCT02507752|581407889|FG000|Overall Study|Infusion reaction at first infusion|1|||
161005466|NCT02507752|581407889|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
161005467|NCT02507752|581407889|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
161005468|NCT01254188|581407895|FG000|Overall Study|Disease Progression|6|||
161005469|NCT01254188|581407895|FG000|Overall Study|Protocol Violation|6|||
161005470|NCT01254188|581407895|FG000|Overall Study|Pregnancy|2|||
161005471|NCT01254188|581407895|FG000|Overall Study|Death|4|||
161005472|NCT01254188|581407895|FG000|Overall Study|Lost to Follow-up|5|||
161005473|NCT01254188|581407895|FG000|Overall Study|Withdrawal by Subject|7|||
161005474|NCT01254188|581407895|FG000|Overall Study|Adverse Event|43|||
161005475|NCT01254188|581407895|FG000|Overall Study|per investigator discretion|20|||
161005476|NCT04530747|581407896|FG000|Overall Study|Withdrawal by Subject|1|||
161005477|NCT04530747|581407897|FG001|Overall Study|Withdrawal by Subject|0|||
161005478|NCT03292913|581407898|FG000|Overall Study|Death|9|||
161005479|NCT03292913|581407899|FG001|Overall Study|Death|3|||
161005480|NCT03292913|581407898|FG000|Overall Study|Lost to Follow-up|49|||
161005481|NCT03292913|581407899|FG001|Overall Study|Lost to Follow-up|49|||
161005482|NCT03292913|581407898|FG000|Overall Study|Withdrawal by Subject|2|||
161005483|NCT03292913|581407899|FG001|Overall Study|Withdrawal by Subject|0|||
161005484|NCT03292913|581407898|FG000|Overall Study|Clinic closed due to COVID|22|||
161005485|NCT03292913|581407899|FG001|Overall Study|Clinic closed due to COVID|36|||
161005486|NCT03950622|581407900|FG000|Overall Study|Withdrawal by Subject|1|||
161005487|NCT03950622|581407901|FG001|Overall Study|Withdrawal by Subject|0|||
161005488|NCT03950622|581407900|FG000|Overall Study|Protocol Deviation|0|||
161005489|NCT03950622|581407901|FG001|Overall Study|Protocol Deviation|1|||
161005490|NCT03950622|581407900|FG000|Overall Study|Physician Decision|1|||
161271376|NCT00206323|582375136|FG001|Overall Study|Lack of Efficacy|1|||
161271377|NCT00206323|582375135|FG000|Overall Study|Adverse Event|1|||
161271378|NCT00206323|582375136|FG001|Overall Study|Adverse Event|1|||
161005491|NCT03950622|581407901|FG001|Overall Study|Physician Decision|0|||
161005492|NCT03950622|581407900|FG000|Overall Study|Lost to Follow-up|5|||
161005493|NCT03950622|581407901|FG001|Overall Study|Lost to Follow-up|5|||
161005494|NCT03950622|581407900|FG000|Overall Study|Death|1|||
161005495|NCT03950622|581407901|FG001|Overall Study|Death|1|||
161005496|NCT03531840|581407905|FG000|Overall Study|Death on study|3|||
161005497|NCT03531840|581407906|FG001|Overall Study|Death on study|2|||
161005498|NCT03531840|581407907|FG002|Overall Study|Death on study|1|||
161005499|NCT03531840|581407908|FG003|Overall Study|Death on study|2|||
161005500|NCT03531840|581407905|FG000|Overall Study|Death during follow up|2|||
161005501|NCT03531840|581407906|FG001|Overall Study|Death during follow up|3|||
161005502|NCT03531840|581407907|FG002|Overall Study|Death during follow up|4|||
161005503|NCT03531840|581407908|FG003|Overall Study|Death during follow up|1|||
161005504|NCT02267824|581407910|FG000|Overall Study|Pregnancy|1|||
161005505|NCT02267824|581407911|FG001|Overall Study|Pregnancy|1|||
161005506|NCT02267824|581407910|FG000|Overall Study|Lost to Follow-up|4|||
161005507|NCT02267824|581407911|FG001|Overall Study|Lost to Follow-up|0|||
161005508|NCT02267824|581407910|FG000|Overall Study|Protocol Violation|3|||
161005509|NCT02267824|581407911|FG001|Overall Study|Protocol Violation|0|||
161005510|NCT02267824|581407910|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
161005511|NCT02267824|581407911|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
161005512|NCT01546753|581407912|FG000|Overall Study|anxiety|1|||
161005513|NCT01546753|581407913|FG001|Overall Study|anxiety|1|||
161005514|NCT01546753|581407912|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
161005515|NCT01546753|581407913|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
161005516|NCT01236560|581407921|FG000|Overall Study|Adverse Event|0|||
161005517|NCT01236560|581407922|FG001|Overall Study|Adverse Event|2|||
161005518|NCT01236560|581407923|FG002|Overall Study|Adverse Event|1|||
161005519|NCT01236560|581407924|FG003|Overall Study|Adverse Event|3|||
161005520|NCT01236560|581407925|FG004|Overall Study|Adverse Event|0|||
161005521|NCT01236560|581407926|FG005|Overall Study|Adverse Event|0|||
161005522|NCT01236560|581407921|FG000|Overall Study|Death|0|||
161005523|NCT01236560|581407922|FG001|Overall Study|Death|1|||
161005524|NCT01236560|581407923|FG002|Overall Study|Death|0|||
161005525|NCT01236560|581407924|FG003|Overall Study|Death|1|||
161005526|NCT01236560|581407925|FG004|Overall Study|Death|0|||
161005527|NCT01236560|581407926|FG005|Overall Study|Death|0|||
161005528|NCT01236560|581407921|FG000|Overall Study|Lost to Follow-up|0|||
161005529|NCT01236560|581407922|FG001|Overall Study|Lost to Follow-up|1|||
161005530|NCT01236560|581407923|FG002|Overall Study|Lost to Follow-up|1|||
161005531|NCT01236560|581407924|FG003|Overall Study|Lost to Follow-up|0|||
161005532|NCT01236560|581407925|FG004|Overall Study|Lost to Follow-up|0|||
161005533|NCT01236560|581407926|FG005|Overall Study|Lost to Follow-up|0|||
161005534|NCT01236560|581407921|FG000|Overall Study|Physician Decision|0|||
161005535|NCT01236560|581407922|FG001|Overall Study|Physician Decision|1|||
161005536|NCT01236560|581407923|FG002|Overall Study|Physician Decision|8|||
161005537|NCT01236560|581407924|FG003|Overall Study|Physician Decision|0|||
161005538|NCT01236560|581407925|FG004|Overall Study|Physician Decision|0|||
161005539|NCT01236560|581407926|FG005|Overall Study|Physician Decision|0|||
161005540|NCT01236560|581407921|FG000|Overall Study|Withdrawal by Subject|0|||
161005541|NCT01236560|581407922|FG001|Overall Study|Withdrawal by Subject|0|||
161005542|NCT01236560|581407923|FG002|Overall Study|Withdrawal by Subject|1|||
161005543|NCT01236560|581407924|FG003|Overall Study|Withdrawal by Subject|2|||
161005544|NCT01236560|581407925|FG004|Overall Study|Withdrawal by Subject|0|||
161005545|NCT01236560|581407926|FG005|Overall Study|Withdrawal by Subject|0|||
161005546|NCT01236560|581407921|FG000|Overall Study|Progressive disease|5|||
161005547|NCT01236560|581407922|FG001|Overall Study|Progressive disease|19|||
161005548|NCT01236560|581407923|FG002|Overall Study|Progressive disease|9|||
161005549|NCT01236560|581407924|FG003|Overall Study|Progressive disease|16|||
161005550|NCT01236560|581407925|FG004|Overall Study|Progressive disease|0|||
161005551|NCT01236560|581407926|FG005|Overall Study|Progressive disease|0|||
161005552|NCT01576484|581407929|FG000|Overall Study|Adverse Event|1|||
161005553|NCT01576484|581407930|FG001|Overall Study|Adverse Event|1|||
161005554|NCT01576484|581407929|FG000|Overall Study|Protocol Violation|0|||
161005555|NCT01576484|581407930|FG001|Overall Study|Protocol Violation|2|||
161005556|NCT01576484|581407929|FG000|Overall Study|Sponsor Decision|2|||
161005557|NCT01576484|581407930|FG001|Overall Study|Sponsor Decision|8|||
161005558|NCT01576484|581407929|FG000|Overall Study|Withdrawal by Subject|0|||
161005559|NCT01576484|581407930|FG001|Overall Study|Withdrawal by Subject|3|||
161005560|NCT01576484|581407929|FG000|Overall Study|Other|2|||
161005561|NCT01576484|581407930|FG001|Overall Study|Other|5|||
161271379|NCT00206323|582375135|FG000|Overall Study|Lost to Follow-up|1|||
161005562|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
161005563|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
161005564|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
161005565|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
161271380|NCT00206323|582375136|FG001|Overall Study|Lost to Follow-up|1|||
161271381|NCT02910063|582375137|FG000|Phase 2|Withdrawal by Subject|3|||
161271382|NCT02910063|582375138|FG001|Phase 2|Withdrawal by Subject|0|||
161271383|NCT02910063|582375139|FG002|Phase 2|Withdrawal by Subject|0|||
161271384|NCT02910063|582375137|FG000|Phase 2|Lost to Follow-up|1|||
161271385|NCT02910063|582375138|FG001|Phase 2|Lost to Follow-up|0|||
160966017|NCT00642902|581264790|FG001|Overall Study|Lack of Efficacy|3|||
160966018|NCT00642902|581264791|FG002|Overall Study|Lack of Efficacy|3|||
160966019|NCT00642902|581264792|FG003|Overall Study|Lack of Efficacy|0|||
160966020|NCT00642902|581264789|FG000|Overall Study|Death|1|||
160966021|NCT00642902|581264790|FG001|Overall Study|Death|0|||
160966022|NCT00642902|581264791|FG002|Overall Study|Death|0|||
160966023|NCT00642902|581264792|FG003|Overall Study|Death|0|||
160966024|NCT00642902|581264789|FG000|Overall Study|Premature termination of clinical trial|37|||
160966025|NCT00642902|581264790|FG001|Overall Study|Premature termination of clinical trial|32|||
160966026|NCT00642902|581264791|FG002|Overall Study|Premature termination of clinical trial|35|||
160966027|NCT00642902|581264792|FG003|Overall Study|Premature termination of clinical trial|35|||
160966028|NCT00642902|581264789|FG000|Overall Study|Randomized, but not treated|0|||
160966029|NCT00642902|581264790|FG001|Overall Study|Randomized, but not treated|0|||
160966030|NCT00642902|581264791|FG002|Overall Study|Randomized, but not treated|1|||
160966031|NCT00642902|581264792|FG003|Overall Study|Randomized, but not treated|0|||
160966032|NCT00642902|581264789|FG000|Overall Study|Other|1|||
160966033|NCT00642902|581264790|FG001|Overall Study|Other|5|||
160966034|NCT00642902|581264791|FG002|Overall Study|Other|1|||
160966035|NCT00642902|581264792|FG003|Overall Study|Other|4|||
160966036|NCT03953898|581264793|FG000|Overall Study|Lack of Efficacy|8|||
160966037|NCT03953898|581264793|FG000|Overall Study|Death|3|||
160966038|NCT03953898|581264793|FG000|Overall Study|Withdrawal by Subject|2|||
160966039|NCT03953898|581264793|FG000|Overall Study|Adverse Event|1|||
160966040|NCT01226511|581264796|FG000|Acute Treatment Period|Adverse Event|7|||
160966041|NCT01226511|581264797|FG001|Acute Treatment Period|Adverse Event|6|||
160966042|NCT01226511|581264796|FG000|Acute Treatment Period|Lack of Efficacy|2|||
160966043|NCT01226511|581264797|FG001|Acute Treatment Period|Lack of Efficacy|1|||
160966044|NCT01226511|581264796|FG000|Acute Treatment Period|Lost to Follow-up|3|||
160966045|NCT01226511|581264797|FG001|Acute Treatment Period|Lost to Follow-up|6|||
160966046|NCT01226511|581264796|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
160966047|NCT01226511|581264797|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
160966048|NCT01226511|581264796|FG000|Acute Treatment Period|Protocol Violation|5|||
160966049|NCT01226511|581264797|FG001|Acute Treatment Period|Protocol Violation|5|||
160966050|NCT01226511|581264796|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
160966051|NCT01226511|581264797|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
160966052|NCT01226511|581264796|FG000|Extension Treatment Period|Adverse Event|8|||
160966053|NCT01226511|581264797|FG001|Extension Treatment Period|Adverse Event|8|||
160966054|NCT01226511|581264796|FG000|Extension Treatment Period|Lack of Efficacy|3|||
160966055|NCT01226511|581264797|FG001|Extension Treatment Period|Lack of Efficacy|2|||
160966056|NCT01226511|581264796|FG000|Extension Treatment Period|Lost to Follow-up|4|||
160966057|NCT01226511|581264797|FG001|Extension Treatment Period|Lost to Follow-up|3|||
160966058|NCT01226511|581264796|FG000|Extension Treatment Period|Protocol Violation|2|||
160966059|NCT01226511|581264797|FG001|Extension Treatment Period|Protocol Violation|2|||
160966060|NCT01226511|581264796|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
160966061|NCT01226511|581264797|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
160966062|NCT01226511|581264796|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
160966063|NCT01226511|581264797|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
160966064|NCT01226511|581264796|FG000|Extension Treatment Period|Sponsor Decision|1|||
160966065|NCT01226511|581264797|FG001|Extension Treatment Period|Sponsor Decision|1|||
160966066|NCT01226511|581264796|FG000|Taper Period|Adverse Event|1|||
160966067|NCT01226511|581264797|FG001|Taper Period|Adverse Event|0|||
160966068|NCT01226511|581264796|FG000|Taper Period|Lost to Follow-up|2|||
160966069|NCT01226511|581264797|FG001|Taper Period|Lost to Follow-up|2|||
160966070|NCT01226511|581264796|FG000|Taper Period|Protocol Violation|1|||
160966071|NCT01226511|581264797|FG001|Taper Period|Protocol Violation|0|||
160966072|NCT01226511|581264796|FG000|Taper Period|Parent/Caregiver Decision|1|||
160966073|NCT01226511|581264797|FG001|Taper Period|Parent/Caregiver Decision|1|||
160966074|NCT05267600|581264802|FG000|Overall Study|Adverse Event|1|||
161005566|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
161271386|NCT02910063|582375139|FG002|Phase 2|Lost to Follow-up|0|||
161271387|NCT02910063|582375137|FG000|Phase 2|Death|24|||
161271388|NCT02910063|582375138|FG001|Phase 2|Death|0|||
160966075|NCT05267600|581264803|FG001|Overall Study|Adverse Event|4|||
160966076|NCT05267600|581264802|FG000|Overall Study|Death|1|||
160966077|NCT05267600|581264803|FG001|Overall Study|Death|2|||
160966078|NCT05267600|581264802|FG000|Overall Study|Lack of Efficacy|1|||
160966079|NCT05267600|581264803|FG001|Overall Study|Lack of Efficacy|2|||
160966080|NCT05267600|581264802|FG000|Overall Study|Lost to Follow-up|3|||
160966081|NCT05267600|581264803|FG001|Overall Study|Lost to Follow-up|0|||
161271389|NCT02910063|582375139|FG002|Phase 2|Death|0|||
161271390|NCT03334617|582375142|FG000|Overall Study|Adverse Event|0|||
161271391|NCT03334617|582375143|FG001|Overall Study|Adverse Event|0|||
161271392|NCT03334617|582375144|FG002|Overall Study|Adverse Event|0|||
160966082|NCT05267600|581264802|FG000|Overall Study|Physician Decision|4|||
160966083|NCT05267600|581264803|FG001|Overall Study|Physician Decision|0|||
160966084|NCT05267600|581264802|FG000|Overall Study|Treatment Unblinded|0|||
160966085|NCT05267600|581264803|FG001|Overall Study|Treatment Unblinded|1|||
160966086|NCT05267600|581264802|FG000|Overall Study|Withdrawal by Subject|5|||
160966087|NCT05267600|581264803|FG001|Overall Study|Withdrawal by Subject|4|||
160966088|NCT01520402|581264806|FG000|Overall Study|Withdrawal by Subject|2|||
160966089|NCT01520402|581264806|FG000|Overall Study|Physician Decision|3|||
160966090|NCT01722162|581264814|FG000|Overall Study|Withdrawal by Subject|1|||
160966091|NCT01722162|581264815|FG001|Overall Study|Withdrawal by Subject|1|||
160966092|NCT01722162|581264814|FG000|Overall Study|Found ineligible|1|||
160966093|NCT01722162|581264815|FG001|Overall Study|Found ineligible|0|||
160966094|NCT01722162|581264814|FG000|Overall Study|Unrelated to study adverse event|2|||
160966095|NCT01722162|581264815|FG001|Overall Study|Unrelated to study adverse event|2|||
160966096|NCT01722162|581264814|FG000|Overall Study|Adverse Event|1|||
160966097|NCT01722162|581264815|FG001|Overall Study|Adverse Event|1|||
160966098|NCT01722162|581264814|FG000|Overall Study|Insurance denial post enrollment|0|||
160966099|NCT01722162|581264815|FG001|Overall Study|Insurance denial post enrollment|1|||
160966100|NCT01722162|581264814|FG000|Overall Study|Noncompliance|0|||
160966101|NCT01722162|581264815|FG001|Overall Study|Noncompliance|1|||
160966102|NCT00643123|581264816|FG000|Overall Study|Lost to Follow-up|4|||
160966103|NCT00643123|581264817|FG001|Overall Study|Lost to Follow-up|0|||
160966104|NCT00643123|581264816|FG000|Overall Study|Withdrawal by Subject|1|||
160966105|NCT00643123|581264817|FG001|Overall Study|Withdrawal by Subject|1|||
160966106|NCT01538472|581264818|FG000|Overall Study|Disease Progression|3|||
160966107|NCT01538472|581264818|FG000|Overall Study|Death|1|||
160966108|NCT02133872|581264819|FG000|Overall Study|Withdrawal by Subject|5|||
160966109|NCT02133872|581264820|FG001|Overall Study|Withdrawal by Subject|3|||
160966110|NCT02133872|581264821|FG002|Overall Study|Withdrawal by Subject|0|||
160966111|NCT02923739|581264822|FG000|Overall Study|Withdrawal by Subject|2|||
160966112|NCT02923739|581264823|FG001|Overall Study|Withdrawal by Subject|0|||
160966113|NCT02923739|581264824|FG002|Overall Study|Withdrawal by Subject|0|||
160966114|NCT02923739|581264825|FG003|Overall Study|Withdrawal by Subject|0|||
160966115|NCT02923739|581264822|FG000|Overall Study|Failed Screening|3|||
160966116|NCT02923739|581264823|FG001|Overall Study|Failed Screening|0|||
160966117|NCT02923739|581264824|FG002|Overall Study|Failed Screening|0|||
160966118|NCT02923739|581264825|FG003|Overall Study|Failed Screening|0|||
160966119|NCT01972529|581264828|FG000|Overall Study|Adverse Event|0|||
160966120|NCT01972529|581264829|FG001|Overall Study|Adverse Event|1|||
160966121|NCT01972529|581264830|FG002|Overall Study|Adverse Event|0|||
160966122|NCT01972529|581264831|FG003|Overall Study|Adverse Event|0|||
160966123|NCT01972529|581264828|FG000|Overall Study|Lost to Follow-up|1|||
160966124|NCT01972529|581264829|FG001|Overall Study|Lost to Follow-up|0|||
160966125|NCT01972529|581264830|FG002|Overall Study|Lost to Follow-up|0|||
160966126|NCT01972529|581264831|FG003|Overall Study|Lost to Follow-up|0|||
160966127|NCT01972529|581264828|FG000|Overall Study|Participant Choice|0|||
160966128|NCT01972529|581264829|FG001|Overall Study|Participant Choice|1|||
160966129|NCT01972529|581264830|FG002|Overall Study|Participant Choice|0|||
160966130|NCT01972529|581264831|FG003|Overall Study|Participant Choice|0|||
160966131|NCT01972529|581264828|FG000|Overall Study|Withdrawl of Consent|1|||
160966132|NCT01972529|581264829|FG001|Overall Study|Withdrawl of Consent|2|||
160966133|NCT01972529|581264830|FG002|Overall Study|Withdrawl of Consent|0|||
160966134|NCT01972529|581264831|FG003|Overall Study|Withdrawl of Consent|1|||
160966135|NCT01972529|581264828|FG000|Overall Study|Other|0|||
160966136|NCT01972529|581264829|FG001|Overall Study|Other|0|||
160966137|NCT01972529|581264830|FG002|Overall Study|Other|0|||
160966138|NCT01972529|581264831|FG003|Overall Study|Other|2|||
160966139|NCT01972529|581264828|FG000|Overall Study|Not treated|0|||
160966140|NCT01972529|581264829|FG001|Overall Study|Not treated|1|||
160966141|NCT01972529|581264830|FG002|Overall Study|Not treated|2|||
160966142|NCT01972529|581264831|FG003|Overall Study|Not treated|1|||
160966143|NCT01889186|581264832|FG000|Overall Study|Adverse event- not related to progression|18|||
160966144|NCT01889186|581264833|FG001|Overall Study|Adverse event- not related to progression|5|||
160966145|NCT01889186|581264832|FG000|Overall Study|Adverse event- related to progression|7|||
160966146|NCT01889186|581264833|FG001|Overall Study|Adverse event- related to progression|2|||
160966147|NCT01889186|581264832|FG000|Overall Study|COVID-19 logistical restrictions|1|||
160966148|NCT01889186|581264833|FG001|Overall Study|COVID-19 logistical restrictions|0|||
160966149|NCT01889186|581264832|FG000|Overall Study|Investigator request|1|||
160966150|NCT01889186|581264833|FG001|Overall Study|Investigator request|1|||
160966151|NCT01889186|581264832|FG000|Overall Study|Progressive disease- Richter's|12|||
160966152|NCT01889186|581264833|FG001|Overall Study|Progressive disease- Richter's|7|||
160966153|NCT01889186|581264832|FG000|Overall Study|Progressive disease per protocol|46|||
160966154|NCT01889186|581264833|FG001|Overall Study|Progressive disease per protocol|17|||
160966155|NCT01889186|581264832|FG000|Overall Study|Stem cell transplant|2|||
160966156|NCT01889186|581264833|FG001|Overall Study|Stem cell transplant|1|||
160966157|NCT01889186|581264832|FG000|Overall Study|Withdrew consent|2|||
160966158|NCT01889186|581264833|FG001|Overall Study|Withdrew consent|3|||
160966159|NCT01889186|581264832|FG000|Overall Study|Other, not specified|18|||
161005567|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
161005568|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
161005569|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
161005570|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
161005571|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
161005572|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
161005573|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
161005574|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
161005575|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
161005576|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
161005577|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
161005578|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
161005579|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
161005580|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
161005581|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
161005582|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
161005583|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
161005584|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
161005585|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
161005586|NCT00311363|581407933|FG000|24-Week Single-Blind Treatment Period|Death|1|||
161005587|NCT00311363|581407934|FG001|24-Week Single-Blind Treatment Period|Death|0|||
161005588|NCT00311363|581407935|FG002|24-Week Single-Blind Treatment Period|Death|0|||
161005589|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
161005590|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
161005591|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
161005592|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161005593|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161005594|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161005595|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
161005596|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
161005597|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
161005598|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
161005599|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
161005600|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
161005601|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
161005602|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
161005603|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
161005604|NCT00311363|581407933|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
161005605|NCT00311363|581407934|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
161005606|NCT00311363|581407935|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
161005607|NCT00396084|581407936|FG000|Overall Study|Adverse Event|0|||
161005608|NCT00396084|581407937|FG001|Overall Study|Adverse Event|0|||
161005609|NCT00396084|581407938|FG002|Overall Study|Adverse Event|0|||
161005610|NCT00396084|581407939|FG003|Overall Study|Adverse Event|0|||
161005611|NCT00396084|581407940|FG004|Overall Study|Adverse Event|1|||
161005612|NCT00396084|581407941|FG005|Overall Study|Adverse Event|2|||
161005613|NCT00396084|581407936|FG000|Overall Study|Withdrawal by Subject|0|||
161005614|NCT00396084|581407937|FG001|Overall Study|Withdrawal by Subject|0|||
161005615|NCT00396084|581407938|FG002|Overall Study|Withdrawal by Subject|0|||
161005616|NCT00396084|581407939|FG003|Overall Study|Withdrawal by Subject|1|||
161005617|NCT00396084|581407940|FG004|Overall Study|Withdrawal by Subject|0|||
161005618|NCT00396084|581407941|FG005|Overall Study|Withdrawal by Subject|0|||
161005619|NCT04009577|581407942|FG000|Core Study|Adverse Event|1|||
161005620|NCT04009577|581407943|FG001|Core Study|Adverse Event|0|||
161005621|NCT04009577|581407944|FG002|Core Study|Adverse Event|2|||
161005622|NCT04009577|581407945|FG003|Core Study|Adverse Event|4|||
161005623|NCT04009577|581407942|FG000|Core Study|Withdrawal by Subject|0|||
161005624|NCT04009577|581407943|FG001|Core Study|Withdrawal by Subject|0|||
161005625|NCT04009577|581407944|FG002|Core Study|Withdrawal by Subject|2|||
161147244|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
161005626|NCT04009577|581407945|FG003|Core Study|Withdrawal by Subject|0|||
161005627|NCT04009577|581407942|FG000|Core Study|Other|0|||
161005628|NCT04009577|581407943|FG001|Core Study|Other|0|||
161005629|NCT04009577|581407944|FG002|Core Study|Other|0|||
161005630|NCT04009577|581407945|FG003|Core Study|Other|1|||
161005631|NCT04009577|581407942|FG000|Extension Phase|Adverse Event|0|||
161005632|NCT04009577|581407943|FG001|Extension Phase|Adverse Event|0|||
161005633|NCT04009577|581407944|FG002|Extension Phase|Adverse Event|0|||
161005634|NCT04009577|581407945|FG003|Extension Phase|Adverse Event|1|||
161005635|NCT04009577|581407942|FG000|Extension Phase|Inadequate therapeutic effect|0|||
161005636|NCT04009577|581407943|FG001|Extension Phase|Inadequate therapeutic effect|0|||
161005637|NCT04009577|581407944|FG002|Extension Phase|Inadequate therapeutic effect|1|||
161005638|NCT04009577|581407945|FG003|Extension Phase|Inadequate therapeutic effect|0|||
161005639|NCT04009577|581407942|FG000|Extension Phase|Withdrawal by Subject|0|||
161005640|NCT04009577|581407943|FG001|Extension Phase|Withdrawal by Subject|0|||
161005641|NCT04009577|581407944|FG002|Extension Phase|Withdrawal by Subject|1|||
161005642|NCT04009577|581407945|FG003|Extension Phase|Withdrawal by Subject|0|||
161005643|NCT04009577|581407942|FG000|Extension Phase|Not Treated|0|||
161005644|NCT04009577|581407943|FG001|Extension Phase|Not Treated|0|||
161005645|NCT04009577|581407944|FG002|Extension Phase|Not Treated|2|||
161005646|NCT04009577|581407945|FG003|Extension Phase|Not Treated|0|||
161005647|NCT01832480|581407946|FG000|Overall Study|Lost to Follow-up|33|||
161005648|NCT01832480|581407947|FG001|Overall Study|Lost to Follow-up|30|||
161005649|NCT01832480|581407946|FG000|Overall Study|Withdrawal by Subject|0|||
161005650|NCT01832480|581407947|FG001|Overall Study|Withdrawal by Subject|2|||
161005651|NCT01832480|581407946|FG000|Overall Study|post randomization ineligible|8|||
161005652|NCT01832480|581407947|FG001|Overall Study|post randomization ineligible|10|||
161005653|NCT02674750|581407952|FG000|Overall Study|Death|4|||
161005654|NCT02674750|581407953|FG001|Overall Study|Death|5|||
161005655|NCT02674750|581407954|FG002|Overall Study|Death|8|||
161005656|NCT02674750|581407952|FG000|Overall Study|Lost to Follow-up|0|||
161005657|NCT02674750|581407953|FG001|Overall Study|Lost to Follow-up|8|||
161005658|NCT02674750|581407954|FG002|Overall Study|Lost to Follow-up|0|||
161005659|NCT02674750|581407952|FG000|Overall Study|Lack of Efficacy|1|||
161005660|NCT02674750|581407953|FG001|Overall Study|Lack of Efficacy|17|||
161005661|NCT02674750|581407954|FG002|Overall Study|Lack of Efficacy|3|||
161005662|NCT02674750|581407952|FG000|Overall Study|Withdrawal by Subject|0|||
161005663|NCT02674750|581407953|FG001|Overall Study|Withdrawal by Subject|7|||
161005664|NCT02674750|581407954|FG002|Overall Study|Withdrawal by Subject|1|||
161005665|NCT02674750|581407952|FG000|Overall Study|Other|0|||
161005666|NCT02674750|581407953|FG001|Overall Study|Other|8|||
161005667|NCT02674750|581407954|FG002|Overall Study|Other|0|||
161005668|NCT01685606|581407957|FG000|Overall Study|Withdrawal by Subject|1|||
161005669|NCT01353963|581407958|FG000|Overall Study|Adverse Event|2|||
161005670|NCT02079844|581407959|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
161005671|NCT02079844|581407960|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
161005672|NCT02079844|581407961|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
161005673|NCT02079844|581407959|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
161005674|NCT02079844|581407960|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
161005675|NCT02079844|581407961|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
161005676|NCT01420549|581407962|FG000|Overall Study|Adverse Event|1|||
161005677|NCT01420549|581407963|FG001|Overall Study|Adverse Event|1|||
161005678|NCT01420549|581407962|FG000|Overall Study|Lost to Follow-up|2|||
161005679|NCT01420549|581407963|FG001|Overall Study|Lost to Follow-up|2|||
161005680|NCT01420549|581407962|FG000|Overall Study|Protocol Violation|0|||
161005681|NCT01420549|581407963|FG001|Overall Study|Protocol Violation|1|||
161005682|NCT01420549|581407962|FG000|Overall Study|Non-adherence to medication|4|||
161005683|NCT01420549|581407963|FG001|Overall Study|Non-adherence to medication|1|||
161005684|NCT03394885|581407964|FG000|Overall Study|Adverse Event|4|||
161005685|NCT03394885|581407964|FG000|Overall Study|Lack of Efficacy|1|||
161005686|NCT03394885|581407964|FG000|Overall Study|Physician Decision|1|||
161005687|NCT03394885|581407964|FG000|Overall Study|Withdrawal by Subject|8|||
161005688|NCT03394885|581407964|FG000|Overall Study|Alternative Therapy|1|||
161005689|NCT00203411|581407965|FG000|Follow-up|Progressive Disease|4|||
161005690|NCT04980755|581407966|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
161005691|NCT04980755|581407966|FG000|Body Reprogramming Courses|Work commitment|2|||
161005692|NCT04980755|581407966|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
161005693|NCT04980755|581407966|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
161005694|NCT00632424|581407971|FG000|Overall Study|Disease Progression|17|||
161005695|NCT00632424|581407971|FG000|Overall Study|Study Drug Toxicity|1|||
161005696|NCT05985044|581409164|FG000|Overall Study|Death|6|||
161005697|NCT05985044|581409164|FG000|Overall Study|Lost to Follow-up|4|||
161005698|NCT05985044|581409164|FG000|Overall Study|Incapacitation|3|||
161005699|NCT05985044|581409164|FG000|Overall Study|Withdrawal by Subject|2|||
161005700|NCT02279095|581409167|FG000|Overall Study|Non-Compliance|1|||
161005701|NCT02279095|581409167|FG000|Overall Study|Withdrawal by Subject|8|||
161005702|NCT02279095|581409167|FG000|Overall Study|Adverse Event|2|||
161005703|NCT02279095|581409167|FG000|Overall Study|Other|7|||
161005704|NCT02279095|581409167|FG000|Overall Study|Lost to Follow-up|1|||
161005705|NCT05672667|581409171|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
161005706|NCT04524390|581409172|FG000|Double Blind|Consent Withdrawal by subject|2|||
161005707|NCT04524390|581409173|FG001|Double Blind|Consent Withdrawal by subject|1|||
161005708|NCT04524390|581409174|FG002|Double Blind|Consent Withdrawal by subject|0|||
161005709|NCT04524390|581409172|FG000|Double Blind|Adverse Event|5|||
161005710|NCT04524390|581409173|FG001|Double Blind|Adverse Event|3|||
161005711|NCT04524390|581409174|FG002|Double Blind|Adverse Event|0|||
161005712|NCT04524390|581409172|FG000|Double Blind|Liver Transplant|5|||
161005713|NCT04524390|581409173|FG001|Double Blind|Liver Transplant|6|||
161005714|NCT04524390|581409174|FG002|Double Blind|Liver Transplant|0|||
161005715|NCT04524390|581409172|FG000|Double Blind|Disease Progression|0|||
161005716|NCT04524390|581409173|FG001|Double Blind|Disease Progression|1|||
161005717|NCT04524390|581409174|FG002|Double Blind|Disease Progression|0|||
161005718|NCT04524390|581409172|FG000|Open-Label|Drug interruption criteria|0|||
161005719|NCT04524390|581409173|FG001|Open-Label|Drug interruption criteria|0|||
161005720|NCT04524390|581409174|FG002|Open-Label|Drug interruption criteria|1|||
161005721|NCT04524390|581409172|FG000|Open-Label|Liver Transplant|0|||
161005722|NCT04524390|581409173|FG001|Open-Label|Liver Transplant|0|||
161005723|NCT04524390|581409174|FG002|Open-Label|Liver Transplant|1|||
161005724|NCT04524390|581409172|FG000|Open-Label|Disease Progression|0|||
161005725|NCT04524390|581409173|FG001|Open-Label|Disease Progression|0|||
161005726|NCT04524390|581409174|FG002|Open-Label|Disease Progression|1|||
161005727|NCT04524390|581409172|FG000|Open-Label|Adverse Event|0|||
161005728|NCT04524390|581409173|FG001|Open-Label|Adverse Event|0|||
161005729|NCT04524390|581409174|FG002|Open-Label|Adverse Event|3|||
161005730|NCT04524390|581409172|FG000|Open-Label|Study Termination by sponsor|0|||
161005731|NCT04524390|581409173|FG001|Open-Label|Study Termination by sponsor|0|||
161005732|NCT04524390|581409174|FG002|Open-Label|Study Termination by sponsor|45|||
161005733|NCT03613740|581409175|FG000|Overall Study|Lost to Follow-up|1|||
161005734|NCT03613740|581409176|FG001|Overall Study|Lost to Follow-up|1|||
161005735|NCT01693120|581409177|FG000|Enrollment|Lost to Follow-up|1|||
161005736|NCT01693120|581409177|FG000|Enrollment|Withdrawal by Subject|10|||
161005737|NCT01693120|581409177|FG000|Enrollment|Protocol Violation|46|||
161005738|NCT01693120|581409177|FG000|Enrollment|Physician Decision|3|||
161005739|NCT01693120|581409177|FG000|Enrollment|Adverse Event|1|||
161005740|NCT01693120|581409177|FG000|Enrollment|Study closed|8|||
161005741|NCT01693120|581409177|FG000|Enrollment|Other|1|||
161005742|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
161005743|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
161005744|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
161005745|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
161005746|NCT01693120|581409177|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
161005747|NCT02300298|581409181|FG000|Disposition for Nintedanib|Progressive disease|10|||
161005748|NCT02300298|581409182|FG001|Disposition for Nintedanib|Progressive disease|0|||
161005749|NCT02300298|581409181|FG000|Disposition for Docetaxel|Progressive disease|0|||
161005750|NCT02300298|581409182|FG001|Disposition for Docetaxel|Progressive disease|6|||
161005751|NCT02300298|581409181|FG000|Disposition for Docetaxel|other adverse event|0|||
161005752|NCT02300298|581409182|FG001|Disposition for Docetaxel|other adverse event|4|||
161005753|NCT03452189|581409184|FG000|First Intervention (3 Months)|Adverse Event|1|||
161005754|NCT03452189|581409185|FG001|First Intervention (3 Months)|Adverse Event|0|||
161005755|NCT03452189|581409184|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
161005756|NCT03452189|581409185|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
161005757|NCT02724592|581409186|FG000|Overall Study|Lost to Follow-up|4|||
161005758|NCT02724592|581409187|FG001|Overall Study|Lost to Follow-up|1|||
161005759|NCT01951170|581409188|FG000|Overall Study|Investigator decision|1|||
161005760|NCT04723394|581409199|FG000|Overall Study|Adverse Event|0|||
161005761|NCT04723394|581409200|FG001|Overall Study|Adverse Event|3|||
161005762|NCT04723394|581409199|FG000|Overall Study|Death|8|||
161005763|NCT04723394|581409200|FG001|Overall Study|Death|8|||
161005764|NCT04723394|581409199|FG000|Overall Study|Lost to Follow-up|20|||
161005765|NCT04723394|581409200|FG001|Overall Study|Lost to Follow-up|17|||
161005766|NCT04723394|581409199|FG000|Overall Study|Physician Decision|1|||
161005767|NCT04723394|581409200|FG001|Overall Study|Physician Decision|0|||
161005768|NCT04723394|581409199|FG000|Overall Study|Withdrawal by Subject|20|||
161005769|NCT04723394|581409200|FG001|Overall Study|Withdrawal by Subject|34|||
161005770|NCT04723394|581409199|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
161005771|NCT04723394|581409200|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
161005772|NCT00077675|581409202|FG000|Overall Study|Adverse Event|1|||
161005773|NCT00077675|581409203|FG001|Overall Study|Adverse Event|2|||
161271393|NCT03334617|582375145|FG003|Overall Study|Adverse Event|0|||
161271394|NCT03334617|582375146|FG004|Overall Study|Adverse Event|0|||
161005774|NCT00077675|581409202|FG000|Overall Study|Lost to Follow-up|6|||
161005775|NCT00077675|581409203|FG001|Overall Study|Lost to Follow-up|3|||
161005776|NCT00077675|581409202|FG000|Overall Study|Withdrawal by Subject|1|||
161005777|NCT00077675|581409203|FG001|Overall Study|Withdrawal by Subject|0|||
161005778|NCT00077675|581409202|FG000|Overall Study|Other|0|||
161005779|NCT00077675|581409203|FG001|Overall Study|Other|1|||
161005780|NCT00077675|581409202|FG000|Overall Study|Never received study treatment|3|||
161005781|NCT00077675|581409203|FG001|Overall Study|Never received study treatment|3|||
161005782|NCT02597920|581409205|FG000|Overall Study|Worsening of other pre-existing disease|0|||
161005783|NCT02597920|581409206|FG001|Overall Study|Worsening of other pre-existing disease|1|||
161005784|NCT02597920|581409207|FG002|Overall Study|Worsening of other pre-existing disease|0|||
161005785|NCT02597920|581409205|FG000|Overall Study|Other adverse event|20|||
161271395|NCT03334617|582375147|FG005|Overall Study|Adverse Event|0|||
161005786|NCT02597920|581409206|FG001|Overall Study|Other adverse event|30|||
161005787|NCT02597920|581409207|FG002|Overall Study|Other adverse event|0|||
161005788|NCT02597920|581409205|FG000|Overall Study|Lost to Follow-up|7|||
161271396|NCT03334617|582375148|FG006|Overall Study|Adverse Event|0|||
161271397|NCT03334617|582375149|FG007|Overall Study|Adverse Event|0|||
161005789|NCT02597920|581409206|FG001|Overall Study|Lost to Follow-up|9|||
161005790|NCT02597920|581409207|FG002|Overall Study|Lost to Follow-up|0|||
161005791|NCT02597920|581409205|FG000|Overall Study|Refuse to continue in the study|3|||
161005792|NCT02597920|581409206|FG001|Overall Study|Refuse to continue in the study|13|||
161005793|NCT02597920|581409207|FG002|Overall Study|Refuse to continue in the study|1|||
161005794|NCT02597920|581409205|FG000|Overall Study|Other than specified|10|||
161005795|NCT02597920|581409206|FG001|Overall Study|Other than specified|31|||
161005796|NCT02597920|581409207|FG002|Overall Study|Other than specified|5|||
161005797|NCT02597920|581409205|FG000|Overall Study|Other|1|||
161005798|NCT02597920|581409206|FG001|Overall Study|Other|0|||
161005799|NCT02597920|581409207|FG002|Overall Study|Other|0|||
161005800|NCT04532528|581409211|FG000|Overall Study|Adverse Event|12|||
161005801|NCT04532528|581409212|FG001|Overall Study|Adverse Event|17|||
161005802|NCT04532528|581409211|FG000|Overall Study|Withdrawal of consent|16|||
161005803|NCT04532528|581409212|FG001|Overall Study|Withdrawal of consent|17|||
161005804|NCT04532528|581409211|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
161005805|NCT04532528|581409212|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
161005806|NCT04532528|581409211|FG000|Overall Study|Lost to Follow-up|69|||
161005807|NCT04532528|581409212|FG001|Overall Study|Lost to Follow-up|68|||
161005808|NCT04532528|581409211|FG000|Overall Study|Administrative problems|12|||
161005809|NCT04532528|581409212|FG001|Overall Study|Administrative problems|14|||
161005810|NCT04532528|581409211|FG000|Overall Study|Death|3|||
161005811|NCT04532528|581409212|FG001|Overall Study|Death|3|||
161005812|NCT04532528|581409211|FG000|Overall Study|Other|38|||
161005813|NCT04532528|581409212|FG001|Overall Study|Other|46|||
161005814|NCT00668863|581409217|FG000|Overall Study|Objective Progression or Relapse|42|||
161005815|NCT00668863|581409217|FG000|Overall Study|Adverse Event|13|||
161005816|NCT00668863|581409217|FG000|Overall Study|Study Terminated by Sponsor|8|||
161005817|NCT00668863|581409217|FG000|Overall Study|Global Deterioration of Health Status|4|||
161005818|NCT00668863|581409217|FG000|Overall Study|Withdrawal by Subject|1|||
161005819|NCT00668863|581409217|FG000|Overall Study|Surgery|1|||
161005820|NCT00668863|581409217|FG000|Overall Study|Subject's work scheduling problem|1|||
161005821|NCT00668863|581409217|FG000|Overall Study|Physician Decision|1|||
161005822|NCT00665444|581409218|FG000|Overall Study|Physician Decision|1|||
161005823|NCT00665444|581409218|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
161005824|NCT01068743|581409221|FG000|Period 3|Adverse Event|0|||
161005825|NCT01068743|581409222|FG001|Period 3|Adverse Event|1|||
161005826|NCT01068743|581409223|FG002|Period 3|Adverse Event|0|||
161005827|NCT01068743|581409224|FG003|Period 3|Adverse Event|0|||
161005828|NCT00293293|581409225|FG000|Overall Study|Withdrawal by Subject|1|||
161005829|NCT00293293|581409226|FG001|Overall Study|Withdrawal by Subject|1|||
161005830|NCT00293293|581409225|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
161005831|NCT00293293|581409226|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
161005832|NCT00293293|581409225|FG000|Overall Study|Patient discontinued chemotherapy|0|||
161005833|NCT00293293|581409226|FG001|Overall Study|Patient discontinued chemotherapy|1|||
161005834|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
161005835|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
161005836|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
161005837|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
161005838|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
161271398|NCT03334617|582375150|FG008|Overall Study|Adverse Event|1|||
161271399|NCT03334617|582375151|FG009|Overall Study|Adverse Event|0|||
161271400|NCT03334617|582375152|FG010|Overall Study|Adverse Event|0|||
161271401|NCT03334617|582375153|FG011|Overall Study|Adverse Event|0|||
161271402|NCT03334617|582375154|FG012|Overall Study|Adverse Event|1|||
161005839|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
161005840|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
161005841|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
161005842|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
161005843|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
161005844|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
161005845|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
161005846|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
161005847|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
161005848|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
161005849|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
161005850|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
161271403|NCT03334617|582375155|FG013|Overall Study|Adverse Event|0|||
161271404|NCT03334617|582375156|FG014|Overall Study|Adverse Event|0|||
161005851|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
161005852|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
161005853|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
161005854|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
161005855|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
161005856|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
161005857|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
161005858|NCT01061151|581409227|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
161005859|NCT01061151|581409228|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
161005860|NCT01061151|581409229|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
161005861|NCT01061151|581409230|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
161005862|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
161005863|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
161005864|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
161005865|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
161005866|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
161005867|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161005868|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161005869|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
161005870|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
161005871|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
161005872|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
161005873|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
161005874|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
161005875|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
161005876|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
161005877|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
161005878|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
161005879|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
161005880|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
161271405|NCT03334617|582375157|FG015|Overall Study|Adverse Event|0|||
161271406|NCT03334617|582375158|FG016|Overall Study|Adverse Event|0|||
161271407|NCT03334617|582375159|FG017|Overall Study|Adverse Event|0|||
161005881|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
161005882|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
161005883|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
161005884|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
161005885|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
161005886|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
161005887|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
161005888|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
161005889|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
161147245|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
161147246|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161147247|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161147248|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161147249|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161147250|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161271408|NCT03334617|582375160|FG018|Overall Study|Adverse Event|0|||
161271409|NCT03334617|582375161|FG019|Overall Study|Adverse Event|0|||
161147251|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
161147252|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
161271410|NCT03334617|582375162|FG020|Overall Study|Adverse Event|0|||
161271411|NCT03334617|582375163|FG021|Overall Study|Adverse Event|0|||
161271412|NCT03334617|582375142|FG000|Overall Study|Death|18|||
161271413|NCT03334617|582375143|FG001|Overall Study|Death|18|||
161271414|NCT03334617|582375144|FG002|Overall Study|Death|20|||
161271415|NCT03334617|582375145|FG003|Overall Study|Death|21|||
161271416|NCT03334617|582375146|FG004|Overall Study|Death|20|||
161271417|NCT03334617|582375147|FG005|Overall Study|Death|16|||
161271418|NCT03334617|582375148|FG006|Overall Study|Death|28|||
161271419|NCT03334617|582375149|FG007|Overall Study|Death|35|||
161271420|NCT03334617|582375150|FG008|Overall Study|Death|47|||
161147253|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
161271421|NCT03334617|582375151|FG009|Overall Study|Death|0|||
161271422|NCT03334617|582375152|FG010|Overall Study|Death|19|||
161271423|NCT03334617|582375153|FG011|Overall Study|Death|6|||
161271424|NCT03334617|582375154|FG012|Overall Study|Death|20|||
161271425|NCT03334617|582375155|FG013|Overall Study|Death|22|||
161271426|NCT03334617|582375156|FG014|Overall Study|Death|17|||
161271427|NCT03334617|582375157|FG015|Overall Study|Death|18|||
161271428|NCT03334617|582375158|FG016|Overall Study|Death|12|||
161271429|NCT03334617|582375159|FG017|Overall Study|Death|15|||
161271430|NCT03334617|582375160|FG018|Overall Study|Death|16|||
161271431|NCT03334617|582375161|FG019|Overall Study|Death|27|||
161271432|NCT03334617|582375162|FG020|Overall Study|Death|14|||
161271433|NCT03334617|582375163|FG021|Overall Study|Death|27|||
160966160|NCT01889186|581264833|FG001|Overall Study|Other, not specified|15|||
160966161|NCT00118716|581264835|FG000|Overall Study|Adverse Event|2|||
160966162|NCT00118716|581264836|FG001|Overall Study|Adverse Event|7|||
160966163|NCT00118716|581264835|FG000|Overall Study|Protocol Violation|5|||
160966164|NCT00118716|581264836|FG001|Overall Study|Protocol Violation|4|||
160966165|NCT00118716|581264835|FG000|Overall Study|Withdrawal by Subject|0|||
160966166|NCT00118716|581264836|FG001|Overall Study|Withdrawal by Subject|1|||
160966167|NCT00118716|581264835|FG000|Overall Study|Exacerbation|2|||
160966168|NCT00118716|581264836|FG001|Overall Study|Exacerbation|2|||
160966169|NCT00118716|581264835|FG000|Overall Study|Discontinued by sponsor|1|||
160966170|NCT00118716|581264836|FG001|Overall Study|Discontinued by sponsor|1|||
160966171|NCT00118716|581264835|FG000|Overall Study|Non-compliance|1|||
160966172|NCT00118716|581264836|FG001|Overall Study|Non-compliance|3|||
160966173|NCT00118716|581264835|FG000|Overall Study|misrandomized|1|||
160966174|NCT00118716|581264836|FG001|Overall Study|misrandomized|1|||
160966175|NCT00118716|581264835|FG000|Overall Study|Expired drug use|1|||
160966176|NCT00118716|581264836|FG001|Overall Study|Expired drug use|2|||
160966177|NCT00118716|581264835|FG000|Overall Study|Investigator discretion|0|||
160966178|NCT00118716|581264836|FG001|Overall Study|Investigator discretion|1|||
160966179|NCT00855062|581264838|FG000|Step1|Early Study Closure|5|||
160966180|NCT00855062|581264839|FG001|Step1|Early Study Closure|7|||
160966181|NCT00855062|581264838|FG000|Step1|Adverse Event|1|||
160966182|NCT00855062|581264839|FG001|Step1|Adverse Event|1|||
160966183|NCT00855062|581264838|FG000|Step1|Protocol Violation|1|||
160966184|NCT00855062|581264839|FG001|Step1|Protocol Violation|0|||
160966185|NCT00855062|581264838|FG000|Step1|Pregnancy|1|||
160966186|NCT00855062|581264839|FG001|Step1|Pregnancy|0|||
160966187|NCT00855062|581264838|FG000|Step1|Withdrawal by Subject|2|||
160966188|NCT00855062|581264839|FG001|Step1|Withdrawal by Subject|3|||
160966189|NCT00855062|581264838|FG000|Step2|Early Study Closure|6|||
160966190|NCT00855062|581264839|FG001|Step2|Early Study Closure|2|||
160966191|NCT00855062|581264838|FG000|Step2|Adverse Event|0|||
160966192|NCT00855062|581264839|FG001|Step2|Adverse Event|3|||
160966193|NCT00855062|581264838|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
160966194|NCT00855062|581264839|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
160966195|NCT02110901|581264840|FG000|Overall Study|Death|6|||
160966196|NCT02110901|581264841|FG001|Overall Study|Death|3|||
160966197|NCT02110901|581264840|FG000|Overall Study|Lost to Follow-up|12|||
160966198|NCT02110901|581264841|FG001|Overall Study|Lost to Follow-up|8|||
160966199|NCT02110901|581264840|FG000|Overall Study|Withdrawal by Subject|7|||
160966200|NCT02110901|581264841|FG001|Overall Study|Withdrawal by Subject|3|||
160966201|NCT02110901|581264840|FG000|Overall Study|received a kidney transplant|5|||
160966202|NCT02110901|581264841|FG001|Overall Study|received a kidney transplant|0|||
160966203|NCT00855595|581264843|FG000|Overall Study|Withdrawal by Subject|1|||
160966204|NCT00855595|581264844|FG001|Overall Study|Withdrawal by Subject|2|||
160966205|NCT00855595|581264843|FG000|Overall Study|Lost to Follow-up|3|||
160966206|NCT00855595|581264844|FG001|Overall Study|Lost to Follow-up|3|||
160966207|NCT00855595|581264843|FG000|Overall Study|Adverse Event|1|||
160966208|NCT00855595|581264844|FG001|Overall Study|Adverse Event|1|||
160966209|NCT00855595|581264843|FG000|Overall Study|patient moved out of state|1|||
160966210|NCT00855595|581264844|FG001|Overall Study|patient moved out of state|0|||
160966211|NCT00855595|581264843|FG000|Overall Study|patient left country|0|||
161005890|NCT01061151|581409227|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
160966212|NCT00855595|581264844|FG001|Overall Study|patient left country|1|||
160966213|NCT02755597|581264845|FG000|Overall Study|Withdrew consent|27|||
160966214|NCT02755597|581264846|FG001|Overall Study|Withdrew consent|11|||
160966215|NCT02755597|581264845|FG000|Overall Study|Lost to Follow-up|1|||
160966216|NCT02755597|581264846|FG001|Overall Study|Lost to Follow-up|0|||
161005891|NCT01061151|581409228|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
160966217|NCT02755597|581264845|FG000|Overall Study|Death|78|||
160966218|NCT02755597|581264846|FG001|Overall Study|Death|36|||
160966219|NCT02755597|581264845|FG000|Overall Study|Study terminated by Sponsor|67|||
160966220|NCT02755597|581264846|FG001|Overall Study|Study terminated by Sponsor|47|||
160966221|NCT02755597|581264845|FG000|Overall Study|Other, not specified|20|||
160966222|NCT02755597|581264846|FG001|Overall Study|Other, not specified|3|||
160966223|NCT02755597|581264845|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
160966224|NCT02755597|581264846|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
160966225|NCT04581200|581264847|FG000|Overall Study|Lost to Follow-up|6|||
160966226|NCT04581200|581264848|FG001|Overall Study|Lost to Follow-up|5|||
160966227|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
161271434|NCT03334617|582375142|FG000|Overall Study|Lost to Follow-up|0|||
161271435|NCT03334617|582375143|FG001|Overall Study|Lost to Follow-up|0|||
161271436|NCT03334617|582375144|FG002|Overall Study|Lost to Follow-up|0|||
161005892|NCT01061151|581409229|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
161005893|NCT01061151|581409230|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
161005894|NCT03740009|581409231|FG000|Overall Study|Physician Decision|9|||
161005895|NCT03740009|581409231|FG000|Overall Study|Lost to Follow-up|1|||
161005896|NCT00960141|581409236|FG000|Overall Study|Adverse Event|4|||
161005897|NCT00960141|581409237|FG001|Overall Study|Adverse Event|8|||
161005898|NCT00960141|581409238|FG002|Overall Study|Adverse Event|2|||
161005899|NCT00960141|581409236|FG000|Overall Study|Lack of Efficacy|3|||
161005900|NCT00960141|581409237|FG001|Overall Study|Lack of Efficacy|4|||
161005901|NCT00960141|581409238|FG002|Overall Study|Lack of Efficacy|2|||
161005902|NCT00960141|581409236|FG000|Overall Study|Lost to Follow-up|1|||
161005903|NCT00960141|581409237|FG001|Overall Study|Lost to Follow-up|0|||
161005904|NCT00960141|581409238|FG002|Overall Study|Lost to Follow-up|0|||
161005905|NCT00960141|581409236|FG000|Overall Study|Protocol Violation|1|||
161005906|NCT00960141|581409237|FG001|Overall Study|Protocol Violation|3|||
161005907|NCT00960141|581409238|FG002|Overall Study|Protocol Violation|2|||
161005908|NCT00960141|581409236|FG000|Overall Study|Withdrawal by Subject|1|||
161005909|NCT00960141|581409237|FG001|Overall Study|Withdrawal by Subject|2|||
161005910|NCT00960141|581409238|FG002|Overall Study|Withdrawal by Subject|1|||
161005911|NCT03036813|581409239|FG000|Overall Study|Adverse Event|6|||
161005912|NCT03036813|581409240|FG001|Overall Study|Adverse Event|11|||
161005913|NCT03036813|581409241|FG002|Overall Study|Adverse Event|6|||
161005914|NCT03036813|581409239|FG000|Overall Study|Withdrawal by Subject|12|||
161005915|NCT03036813|581409240|FG001|Overall Study|Withdrawal by Subject|6|||
161005916|NCT03036813|581409241|FG002|Overall Study|Withdrawal by Subject|10|||
161005917|NCT03036813|581409239|FG000|Overall Study|Lost to Follow-up|1|||
161005918|NCT03036813|581409240|FG001|Overall Study|Lost to Follow-up|1|||
161005919|NCT03036813|581409241|FG002|Overall Study|Lost to Follow-up|0|||
161147254|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161147255|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161147256|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161147257|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161147258|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161147259|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
161147260|NCT01097616|581922448|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147261|NCT01097616|581922449|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147262|NCT01097616|581922450|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
161147263|NCT01097616|581922451|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147264|NCT01097616|581922452|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147265|NCT01097616|581922453|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147266|NCT01097616|581922454|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147267|NCT01097616|581922455|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
161147268|NCT01097616|581922448|FG000|Optional DB EXT Phase|Adverse Event|0|||
161147269|NCT01097616|581922449|FG001|Optional DB EXT Phase|Adverse Event|7|||
161147270|NCT01097616|581922450|FG002|Optional DB EXT Phase|Adverse Event|2|||
161147271|NCT01097616|581922451|FG003|Optional DB EXT Phase|Adverse Event|0|||
161147272|NCT01097616|581922452|FG004|Optional DB EXT Phase|Adverse Event|0|||
161147273|NCT01097616|581922453|FG005|Optional DB EXT Phase|Adverse Event|0|||
161147274|NCT01097616|581922454|FG006|Optional DB EXT Phase|Adverse Event|0|||
161147275|NCT01097616|581922455|FG007|Optional DB EXT Phase|Adverse Event|0|||
161147276|NCT01097616|581922448|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
161147277|NCT01097616|581922449|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
161147278|NCT01097616|581922450|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
161147279|NCT01097616|581922451|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
161147280|NCT01097616|581922452|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
161147281|NCT01097616|581922453|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
161147282|NCT01097616|581922454|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
161147283|NCT01097616|581922455|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
161147284|NCT01097616|581922448|FG000|Optional DB EXT Phase|Protocol Violation|0|||
161147285|NCT01097616|581922449|FG001|Optional DB EXT Phase|Protocol Violation|2|||
161147286|NCT01097616|581922450|FG002|Optional DB EXT Phase|Protocol Violation|3|||
161147287|NCT01097616|581922451|FG003|Optional DB EXT Phase|Protocol Violation|0|||
161005920|NCT03036813|581409239|FG000|Overall Study|Physician Decision|2|||
161005921|NCT03036813|581409240|FG001|Overall Study|Physician Decision|1|||
161005922|NCT03036813|581409241|FG002|Overall Study|Physician Decision|1|||
161005923|NCT03036813|581409239|FG000|Overall Study|Non-Compliance|1|||
161005924|NCT03036813|581409240|FG001|Overall Study|Non-Compliance|5|||
161147288|NCT01097616|581922452|FG004|Optional DB EXT Phase|Protocol Violation|0|||
161147289|NCT01097616|581922453|FG005|Optional DB EXT Phase|Protocol Violation|0|||
161147290|NCT01097616|581922454|FG006|Optional DB EXT Phase|Protocol Violation|0|||
161271437|NCT03334617|582375145|FG003|Overall Study|Lost to Follow-up|1|||
161271438|NCT03334617|582375146|FG004|Overall Study|Lost to Follow-up|0|||
161005925|NCT03036813|581409241|FG002|Overall Study|Non-Compliance|3|||
161005926|NCT03036813|581409239|FG000|Overall Study|Pregnancy|0|||
160966228|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
160966229|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
160966230|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
160966231|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
160966232|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
160966233|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
161005927|NCT03036813|581409240|FG001|Overall Study|Pregnancy|0|||
161005928|NCT03036813|581409241|FG002|Overall Study|Pregnancy|1|||
161005929|NCT03036813|581409239|FG000|Overall Study|Other|0|||
161005930|NCT03036813|581409240|FG001|Overall Study|Other|3|||
161005931|NCT03036813|581409241|FG002|Overall Study|Other|5|||
161005932|NCT01102231|581409242|FG000|Overall Study|Protocol Violation|3|||
161005933|NCT01102231|581409242|FG000|Overall Study|Lack of Efficacy|2|||
161005934|NCT01102231|581409242|FG000|Overall Study|Death|2|||
161005935|NCT01102231|581409242|FG000|Overall Study|Adverse Event|3|||
161005936|NCT01102231|581409242|FG000|Overall Study|Withdrawal by Subject|1|||
161005937|NCT01102231|581409242|FG000|Overall Study|Did not received the treatment|4|||
161005938|NCT00546754|581409243|FG000|Overall Study|Serious Adverse Event|1|||
161005939|NCT00546754|581409244|FG001|Overall Study|Serious Adverse Event|1|||
161005940|NCT00546754|581409243|FG000|Overall Study|Adverse Event|11|||
161005941|NCT00546754|581409244|FG001|Overall Study|Adverse Event|16|||
161005942|NCT00546754|581409243|FG000|Overall Study|Lack of Efficacy|1|||
161005943|NCT00546754|581409244|FG001|Overall Study|Lack of Efficacy|1|||
161005944|NCT00546754|581409243|FG000|Overall Study|Lost to Follow-up|9|||
161005945|NCT00546754|581409244|FG001|Overall Study|Lost to Follow-up|15|||
161005946|NCT00546754|581409243|FG000|Overall Study|Protocol Violation|3|||
161005947|NCT00546754|581409244|FG001|Overall Study|Protocol Violation|0|||
161005948|NCT00546754|581409243|FG000|Overall Study|Withdrawal by Subject|6|||
161005949|NCT00546754|581409244|FG001|Overall Study|Withdrawal by Subject|7|||
161005950|NCT00546754|581409243|FG000|Overall Study|Dyspnea|1|||
161005951|NCT00546754|581409244|FG001|Overall Study|Dyspnea|0|||
161005952|NCT00546754|581409243|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
161005953|NCT00546754|581409244|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
161005954|NCT00546754|581409243|FG000|Overall Study|Hip Replacement|1|||
161005955|NCT00546754|581409244|FG001|Overall Study|Hip Replacement|0|||
161005956|NCT00546754|581409243|FG000|Overall Study|Suicide|1|||
161005957|NCT00546754|581409244|FG001|Overall Study|Suicide|0|||
161005958|NCT00546754|581409243|FG000|Overall Study|Missing Cooperation|1|||
161005959|NCT00546754|581409244|FG001|Overall Study|Missing Cooperation|0|||
161005960|NCT00546754|581409243|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
161005961|NCT00546754|581409244|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
161005962|NCT00546754|581409243|FG000|Overall Study|Patient's Decision|0|||
161005963|NCT00546754|581409244|FG001|Overall Study|Patient's Decision|1|||
161005964|NCT00546754|581409243|FG000|Overall Study|Missing|14|||
161005965|NCT00546754|581409244|FG001|Overall Study|Missing|7|||
161005966|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161005967|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161005968|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
161005969|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005970|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005971|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005972|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
160966234|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
160966235|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
160966236|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
160966237|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
160966238|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
160966239|NCT04711603|581264849|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
161005973|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005974|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005975|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005976|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005977|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
161005978|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
161005979|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
161005980|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
161005981|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
161005982|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
161005983|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
161005984|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
161005985|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
161005986|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
160966240|NCT04711603|581264850|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
161271439|NCT03334617|582375147|FG005|Overall Study|Lost to Follow-up|1|||
161271440|NCT03334617|582375148|FG006|Overall Study|Lost to Follow-up|0|||
161271441|NCT03334617|582375149|FG007|Overall Study|Lost to Follow-up|0|||
161271442|NCT03334617|582375150|FG008|Overall Study|Lost to Follow-up|1|||
161271443|NCT03334617|582375151|FG009|Overall Study|Lost to Follow-up|0|||
161271444|NCT03334617|582375152|FG010|Overall Study|Lost to Follow-up|0|||
161271445|NCT03334617|582375153|FG011|Overall Study|Lost to Follow-up|0|||
161271446|NCT03334617|582375154|FG012|Overall Study|Lost to Follow-up|0|||
161271447|NCT03334617|582375155|FG013|Overall Study|Lost to Follow-up|0|||
161271448|NCT03334617|582375156|FG014|Overall Study|Lost to Follow-up|0|||
161271449|NCT03334617|582375157|FG015|Overall Study|Lost to Follow-up|0|||
160966241|NCT04711603|581264851|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
160966242|NCT04711603|581264852|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
160966243|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
160966244|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
160966245|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
160966246|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
160966247|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
160966248|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
160966249|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
160966250|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
160966251|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
160966252|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
160966253|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
160966254|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
160966255|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
160966256|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
160966257|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
160966258|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
160966259|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
160966260|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
160966261|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
160966262|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
160966263|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
160966264|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
160966265|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
160966266|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
160966267|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
160966268|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
160966269|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
160966270|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
160966271|NCT04711603|581264849|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
160966272|NCT04711603|581264850|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
160966273|NCT04711603|581264851|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
160966274|NCT04711603|581264852|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
160966275|NCT03759834|581264853|FG000|Overall Study|Withdrawal by Subject|1|||
160966276|NCT00504426|581264856|FG000|Overall Study|Adverse Event|0|||
160966277|NCT00504426|581264857|FG001|Overall Study|Adverse Event|0|||
160966278|NCT00504426|581264858|FG002|Overall Study|Adverse Event|2|||
160966279|NCT00504426|581264859|FG003|Overall Study|Adverse Event|0|||
160966280|NCT00504426|581264856|FG000|Overall Study|Protocol Violation|1|||
160966281|NCT00504426|581264857|FG001|Overall Study|Protocol Violation|1|||
160966282|NCT00504426|581264858|FG002|Overall Study|Protocol Violation|2|||
160966283|NCT00504426|581264859|FG003|Overall Study|Protocol Violation|0|||
160966284|NCT00504426|581264856|FG000|Overall Study|Withdrawal by Subject|2|||
160966285|NCT00504426|581264857|FG001|Overall Study|Withdrawal by Subject|0|||
160966286|NCT00504426|581264858|FG002|Overall Study|Withdrawal by Subject|0|||
160966287|NCT00504426|581264859|FG003|Overall Study|Withdrawal by Subject|0|||
160966288|NCT03685591|581264863|FG000|Overall Study|Global Deterioration of Health Status|0|||
160966289|NCT03685591|581264864|FG001|Overall Study|Global Deterioration of Health Status|0|||
160966290|NCT03685591|581264865|FG002|Overall Study|Global Deterioration of Health Status|0|||
160966291|NCT03685591|581264866|FG003|Overall Study|Global Deterioration of Health Status|1|||
160966292|NCT03685591|581264867|FG004|Overall Study|Global Deterioration of Health Status|2|||
160966293|NCT03685591|581264868|FG005|Overall Study|Global Deterioration of Health Status|4|||
160966294|NCT03685591|581264869|FG006|Overall Study|Global Deterioration of Health Status|1|||
160966295|NCT03685591|581264870|FG007|Overall Study|Global Deterioration of Health Status|1|||
161271450|NCT03334617|582375158|FG016|Overall Study|Lost to Follow-up|0|||
161271451|NCT03334617|582375159|FG017|Overall Study|Lost to Follow-up|0|||
161271452|NCT03334617|582375160|FG018|Overall Study|Lost to Follow-up|0|||
161271453|NCT03334617|582375161|FG019|Overall Study|Lost to Follow-up|0|||
161271454|NCT03334617|582375162|FG020|Overall Study|Lost to Follow-up|0|||
161271455|NCT03334617|582375163|FG021|Overall Study|Lost to Follow-up|0|||
161271456|NCT03334617|582375142|FG000|Overall Study|Withdrawal by Subject|0|||
161271457|NCT03334617|582375143|FG001|Overall Study|Withdrawal by Subject|1|||
161271458|NCT03334617|582375144|FG002|Overall Study|Withdrawal by Subject|0|||
161271459|NCT03334617|582375145|FG003|Overall Study|Withdrawal by Subject|0|||
161271460|NCT03334617|582375146|FG004|Overall Study|Withdrawal by Subject|1|||
161271461|NCT03334617|582375147|FG005|Overall Study|Withdrawal by Subject|1|||
161271462|NCT03334617|582375148|FG006|Overall Study|Withdrawal by Subject|1|||
161005987|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
161005988|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
161005989|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
161005990|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
161005991|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005992|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005993|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005994|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005995|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005996|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005997|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005998|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161005999|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161006000|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161006001|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
161006002|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006003|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006004|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
161006005|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006006|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006007|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006008|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006009|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006010|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006011|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006012|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006013|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
161006014|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161006015|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161006016|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
161006017|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
161006018|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006019|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006020|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006021|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006022|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006023|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006024|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006025|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
161006026|NCT05061693|581409251|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161006027|NCT05061693|581409252|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
161006028|NCT05061693|581409253|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161006029|NCT05061693|581409254|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
161006030|NCT05061693|581409255|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006031|NCT05061693|581409256|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006032|NCT05061693|581409257|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006033|NCT05061693|581409258|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006034|NCT05061693|581409259|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006035|NCT05061693|581409260|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006036|NCT05061693|581409261|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006037|NCT05061693|581409262|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
161006038|NCT05061693|581409251|FG000|24-week Extension Period|Adverse Event|0|||
161006039|NCT05061693|581409252|FG001|24-week Extension Period|Adverse Event|0|||
161147291|NCT01097616|581922455|FG007|Optional DB EXT Phase|Protocol Violation|0|||
161271463|NCT03334617|582375149|FG007|Overall Study|Withdrawal by Subject|2|||
161271464|NCT03334617|582375150|FG008|Overall Study|Withdrawal by Subject|0|||
161006040|NCT05061693|581409253|FG002|24-week Extension Period|Adverse Event|0|||
161006041|NCT05061693|581409254|FG003|24-week Extension Period|Adverse Event|0|||
161006042|NCT05061693|581409255|FG004|24-week Extension Period|Adverse Event|0|||
161006043|NCT05061693|581409256|FG005|24-week Extension Period|Adverse Event|0|||
161006044|NCT05061693|581409257|FG006|24-week Extension Period|Adverse Event|0|||
161006045|NCT05061693|581409258|FG007|24-week Extension Period|Adverse Event|2|||
161006046|NCT05061693|581409259|FG008|24-week Extension Period|Adverse Event|2|||
161006047|NCT05061693|581409260|FG009|24-week Extension Period|Adverse Event|0|||
161006048|NCT05061693|581409261|FG010|24-week Extension Period|Adverse Event|1|||
161006049|NCT05061693|581409262|FG011|24-week Extension Period|Adverse Event|3|||
161006050|NCT05061693|581409251|FG000|24-week Extension Period|Lack of Efficacy|0|||
161006051|NCT05061693|581409252|FG001|24-week Extension Period|Lack of Efficacy|0|||
161006052|NCT05061693|581409253|FG002|24-week Extension Period|Lack of Efficacy|0|||
161006053|NCT05061693|581409254|FG003|24-week Extension Period|Lack of Efficacy|0|||
161006054|NCT05061693|581409255|FG004|24-week Extension Period|Lack of Efficacy|0|||
161006055|NCT05061693|581409256|FG005|24-week Extension Period|Lack of Efficacy|0|||
161006056|NCT05061693|581409257|FG006|24-week Extension Period|Lack of Efficacy|0|||
161006057|NCT05061693|581409258|FG007|24-week Extension Period|Lack of Efficacy|0|||
161006058|NCT05061693|581409259|FG008|24-week Extension Period|Lack of Efficacy|0|||
161006059|NCT05061693|581409260|FG009|24-week Extension Period|Lack of Efficacy|0|||
161006060|NCT05061693|581409261|FG010|24-week Extension Period|Lack of Efficacy|2|||
161006061|NCT05061693|581409262|FG011|24-week Extension Period|Lack of Efficacy|0|||
161006062|NCT05061693|581409251|FG000|24-week Extension Period|Lost to Follow-up|0|||
161006063|NCT05061693|581409252|FG001|24-week Extension Period|Lost to Follow-up|0|||
161006064|NCT05061693|581409253|FG002|24-week Extension Period|Lost to Follow-up|0|||
161006065|NCT05061693|581409254|FG003|24-week Extension Period|Lost to Follow-up|0|||
161006066|NCT05061693|581409255|FG004|24-week Extension Period|Lost to Follow-up|0|||
161006067|NCT05061693|581409256|FG005|24-week Extension Period|Lost to Follow-up|0|||
161006068|NCT05061693|581409257|FG006|24-week Extension Period|Lost to Follow-up|1|||
161006069|NCT05061693|581409258|FG007|24-week Extension Period|Lost to Follow-up|0|||
161006070|NCT05061693|581409259|FG008|24-week Extension Period|Lost to Follow-up|1|||
161006071|NCT05061693|581409260|FG009|24-week Extension Period|Lost to Follow-up|1|||
161006072|NCT05061693|581409261|FG010|24-week Extension Period|Lost to Follow-up|0|||
161006073|NCT05061693|581409262|FG011|24-week Extension Period|Lost to Follow-up|0|||
161006074|NCT05061693|581409251|FG000|24-week Extension Period|Withdrawal by Subject|0|||
161006075|NCT05061693|581409252|FG001|24-week Extension Period|Withdrawal by Subject|0|||
161006076|NCT05061693|581409253|FG002|24-week Extension Period|Withdrawal by Subject|0|||
161006077|NCT05061693|581409254|FG003|24-week Extension Period|Withdrawal by Subject|0|||
161006078|NCT05061693|581409255|FG004|24-week Extension Period|Withdrawal by Subject|0|||
161006079|NCT05061693|581409256|FG005|24-week Extension Period|Withdrawal by Subject|0|||
161006080|NCT05061693|581409257|FG006|24-week Extension Period|Withdrawal by Subject|0|||
161006081|NCT05061693|581409258|FG007|24-week Extension Period|Withdrawal by Subject|0|||
161006082|NCT05061693|581409259|FG008|24-week Extension Period|Withdrawal by Subject|1|||
161006083|NCT05061693|581409260|FG009|24-week Extension Period|Withdrawal by Subject|2|||
161006084|NCT05061693|581409261|FG010|24-week Extension Period|Withdrawal by Subject|2|||
161006085|NCT05061693|581409262|FG011|24-week Extension Period|Withdrawal by Subject|1|||
161006086|NCT05061693|581409251|FG000|24-week Extension Period|Sponsor Decision|0|||
161006087|NCT05061693|581409252|FG001|24-week Extension Period|Sponsor Decision|0|||
161006088|NCT05061693|581409253|FG002|24-week Extension Period|Sponsor Decision|0|||
161006089|NCT05061693|581409254|FG003|24-week Extension Period|Sponsor Decision|0|||
161006090|NCT05061693|581409255|FG004|24-week Extension Period|Sponsor Decision|0|||
161006091|NCT05061693|581409256|FG005|24-week Extension Period|Sponsor Decision|0|||
161006092|NCT05061693|581409257|FG006|24-week Extension Period|Sponsor Decision|0|||
161006093|NCT05061693|581409258|FG007|24-week Extension Period|Sponsor Decision|1|||
161006094|NCT05061693|581409259|FG008|24-week Extension Period|Sponsor Decision|0|||
161006095|NCT05061693|581409260|FG009|24-week Extension Period|Sponsor Decision|0|||
161006096|NCT05061693|581409261|FG010|24-week Extension Period|Sponsor Decision|0|||
161006097|NCT05061693|581409262|FG011|24-week Extension Period|Sponsor Decision|0|||
161006098|NCT05061693|581409251|FG000|24-week Extension Period|Site Closure|0|||
161006099|NCT05061693|581409252|FG001|24-week Extension Period|Site Closure|0|||
161006100|NCT05061693|581409253|FG002|24-week Extension Period|Site Closure|0|||
161147292|NCT01097616|581922448|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
161147293|NCT01097616|581922449|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
161147294|NCT01097616|581922450|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
161006101|NCT05061693|581409254|FG003|24-week Extension Period|Site Closure|0|||
161006102|NCT05061693|581409255|FG004|24-week Extension Period|Site Closure|0|||
161006103|NCT05061693|581409256|FG005|24-week Extension Period|Site Closure|0|||
161006104|NCT05061693|581409257|FG006|24-week Extension Period|Site Closure|0|||
161006105|NCT05061693|581409258|FG007|24-week Extension Period|Site Closure|0|||
161006106|NCT05061693|581409259|FG008|24-week Extension Period|Site Closure|1|||
161006107|NCT05061693|581409260|FG009|24-week Extension Period|Site Closure|0|||
161006108|NCT05061693|581409261|FG010|24-week Extension Period|Site Closure|0|||
161006109|NCT05061693|581409262|FG011|24-week Extension Period|Site Closure|1|||
161271465|NCT03334617|582375151|FG009|Overall Study|Withdrawal by Subject|0|||
161271466|NCT03334617|582375152|FG010|Overall Study|Withdrawal by Subject|0|||
161271467|NCT03334617|582375153|FG011|Overall Study|Withdrawal by Subject|1|||
161271468|NCT03334617|582375154|FG012|Overall Study|Withdrawal by Subject|1|||
161271469|NCT03334617|582375155|FG013|Overall Study|Withdrawal by Subject|0|||
160966296|NCT03685591|581264871|FG008|Overall Study|Global Deterioration of Health Status|0|||
160966297|NCT03685591|581264863|FG000|Overall Study|Progressive Disease|1|||
160966298|NCT03685591|581264864|FG001|Overall Study|Progressive Disease|1|||
160966299|NCT03685591|581264865|FG002|Overall Study|Progressive Disease|0|||
160966300|NCT03685591|581264866|FG003|Overall Study|Progressive Disease|3|||
160966301|NCT03685591|581264867|FG004|Overall Study|Progressive Disease|5|||
160966302|NCT03685591|581264868|FG005|Overall Study|Progressive Disease|4|||
160966303|NCT03685591|581264869|FG006|Overall Study|Progressive Disease|3|||
160966304|NCT03685591|581264870|FG007|Overall Study|Progressive Disease|2|||
160966305|NCT03685591|581264871|FG008|Overall Study|Progressive Disease|1|||
160966306|NCT03685591|581264863|FG000|Overall Study|Other|0|||
160966307|NCT03685591|581264864|FG001|Overall Study|Other|0|||
160966308|NCT03685591|581264865|FG002|Overall Study|Other|1|||
160966309|NCT03685591|581264866|FG003|Overall Study|Other|0|||
160966310|NCT03685591|581264867|FG004|Overall Study|Other|2|||
160966311|NCT03685591|581264868|FG005|Overall Study|Other|3|||
160966312|NCT03685591|581264869|FG006|Overall Study|Other|0|||
160966313|NCT03685591|581264870|FG007|Overall Study|Other|0|||
160966314|NCT03685591|581264871|FG008|Overall Study|Other|0|||
160966315|NCT03685591|581264863|FG000|Overall Study|Withdrawal by Subject|0|||
160966316|NCT03685591|581264864|FG001|Overall Study|Withdrawal by Subject|0|||
160966317|NCT03685591|581264865|FG002|Overall Study|Withdrawal by Subject|0|||
160966318|NCT03685591|581264866|FG003|Overall Study|Withdrawal by Subject|0|||
160966319|NCT03685591|581264867|FG004|Overall Study|Withdrawal by Subject|3|||
160966320|NCT03685591|581264868|FG005|Overall Study|Withdrawal by Subject|2|||
160966321|NCT03685591|581264869|FG006|Overall Study|Withdrawal by Subject|0|||
160966322|NCT03685591|581264870|FG007|Overall Study|Withdrawal by Subject|0|||
160966323|NCT03685591|581264871|FG008|Overall Study|Withdrawal by Subject|1|||
160966324|NCT03685591|581264863|FG000|Overall Study|Adverse Event|0|||
160966325|NCT03685591|581264864|FG001|Overall Study|Adverse Event|0|||
160966326|NCT03685591|581264865|FG002|Overall Study|Adverse Event|0|||
160966327|NCT03685591|581264866|FG003|Overall Study|Adverse Event|1|||
160966328|NCT03685591|581264867|FG004|Overall Study|Adverse Event|1|||
160966329|NCT03685591|581264868|FG005|Overall Study|Adverse Event|4|||
160966330|NCT03685591|581264869|FG006|Overall Study|Adverse Event|0|||
160966331|NCT03685591|581264870|FG007|Overall Study|Adverse Event|1|||
160966332|NCT03685591|581264871|FG008|Overall Study|Adverse Event|1|||
160966333|NCT00689026|581264874|FG000|Overall Study|Withdrawal by Subject|13|||
160966334|NCT00689026|581264875|FG001|Overall Study|Withdrawal by Subject|6|||
160966335|NCT02390531|581264879|FG000|Overall Study|Death|0|||
160966336|NCT02390531|581264880|FG001|Overall Study|Death|2|||
160966337|NCT02390531|581264881|FG002|Overall Study|Death|0|||
160966338|NCT02390531|581264882|FG003|Overall Study|Death|1|||
160966339|NCT02390531|581264883|FG004|Overall Study|Death|0|||
160966340|NCT02390531|581264884|FG005|Overall Study|Death|0|||
160966341|NCT02390531|581264885|FG006|Overall Study|Death|0|||
160966342|NCT02390531|581264886|FG007|Overall Study|Death|1|||
160966343|NCT02390531|581264879|FG000|Overall Study|Protocol Violation|0|||
160966344|NCT02390531|581264880|FG001|Overall Study|Protocol Violation|0|||
160966345|NCT02390531|581264881|FG002|Overall Study|Protocol Violation|0|||
160966346|NCT02390531|581264882|FG003|Overall Study|Protocol Violation|0|||
160966347|NCT02390531|581264883|FG004|Overall Study|Protocol Violation|1|||
160966348|NCT02390531|581264884|FG005|Overall Study|Protocol Violation|0|||
160966349|NCT02390531|581264885|FG006|Overall Study|Protocol Violation|2|||
160966350|NCT02390531|581264886|FG007|Overall Study|Protocol Violation|0|||
160966351|NCT01951638|581264887|FG000|Treatment Period|Protocol Violation|0|||
160966352|NCT01951638|581264888|FG001|Treatment Period|Protocol Violation|0|||
160966353|NCT01951638|581264889|FG002|Treatment Period|Protocol Violation|0|||
160966354|NCT01951638|581264890|FG003|Treatment Period|Protocol Violation|2|||
160966355|NCT01951638|581264891|FG004|Treatment Period|Protocol Violation|0|||
160966356|NCT01951638|581264887|FG000|Treatment Period|Protocol-driven decision point|1|||
160966357|NCT01951638|581264888|FG001|Treatment Period|Protocol-driven decision point|3|||
160966358|NCT01951638|581264889|FG002|Treatment Period|Protocol-driven decision point|0|||
160966359|NCT01951638|581264890|FG003|Treatment Period|Protocol-driven decision point|0|||
160966360|NCT01951638|581264891|FG004|Treatment Period|Protocol-driven decision point|0|||
160966361|NCT01951638|581264887|FG000|Treatment Period|Logistical difficulties|0|||
160966362|NCT01951638|581264888|FG001|Treatment Period|Logistical difficulties|1|||
160966363|NCT01951638|581264889|FG002|Treatment Period|Logistical difficulties|1|||
161271470|NCT03334617|582375156|FG014|Overall Study|Withdrawal by Subject|2|||
160966364|NCT01951638|581264890|FG003|Treatment Period|Logistical difficulties|0|||
161271471|NCT03334617|582375157|FG015|Overall Study|Withdrawal by Subject|1|||
161271472|NCT03334617|582375158|FG016|Overall Study|Withdrawal by Subject|0|||
160966365|NCT01951638|581264891|FG004|Treatment Period|Logistical difficulties|0|||
160966366|NCT01951638|581264887|FG000|Treatment Period|Withdrawal by Subject|9|||
161006110|NCT03823911|581409263|FG000|Overall Study|Lost to Follow-up|1|||
161006111|NCT03823911|581409264|FG001|Overall Study|Lost to Follow-up|5|||
161006112|NCT03823911|581409265|FG002|Overall Study|Lost to Follow-up|2|||
161006113|NCT03823911|581409263|FG000|Overall Study|Did not meet eligibility criteria|13|||
161006114|NCT03823911|581409264|FG001|Overall Study|Did not meet eligibility criteria|7|||
161006115|NCT03823911|581409265|FG002|Overall Study|Did not meet eligibility criteria|4|||
161006116|NCT03823911|581409263|FG000|Overall Study|Death|0|||
161006117|NCT03823911|581409264|FG001|Overall Study|Death|1|||
161006118|NCT03823911|581409265|FG002|Overall Study|Death|0|||
161006119|NCT02261467|581409269|FG000|Overall Study|Enrolled in Error|1|||
161006120|NCT02261467|581409270|FG001|Overall Study|Enrolled in Error|0|||
161006121|NCT02261467|581409269|FG000|Overall Study|Protocol Violation|0|||
161006122|NCT02261467|581409270|FG001|Overall Study|Protocol Violation|1|||
161006123|NCT02261467|581409269|FG000|Overall Study|Personal Reasons|17|||
161006124|NCT02261467|581409270|FG001|Overall Study|Personal Reasons|22|||
161006125|NCT02261467|581409269|FG000|Overall Study|Lost to Follow-up|2|||
161006126|NCT02261467|581409270|FG001|Overall Study|Lost to Follow-up|13|||
161006127|NCT02261467|581409269|FG000|Overall Study|Adverse Event|1|||
161006128|NCT02261467|581409270|FG001|Overall Study|Adverse Event|1|||
161006129|NCT04305405|581409273|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161006130|NCT04305405|581409274|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161006131|NCT01787760|581409275|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
161006132|NCT01787760|581409276|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
161006133|NCT01787760|581409277|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
161006134|NCT01787760|581409275|FG000|Overall Study|Decompensated on left exotropia|0|||
161006135|NCT01787760|581409276|FG001|Overall Study|Decompensated on left exotropia|0|||
161006136|NCT01787760|581409277|FG002|Overall Study|Decompensated on left exotropia|1|||
161006137|NCT01787760|581409275|FG000|Overall Study|Dryness|0|||
161006138|NCT01787760|581409276|FG001|Overall Study|Dryness|1|||
161006139|NCT01787760|581409277|FG002|Overall Study|Dryness|0|||
161006140|NCT01787760|581409275|FG000|Overall Study|Relocation|1|||
161006141|NCT01787760|581409276|FG001|Overall Study|Relocation|1|||
161006142|NCT01787760|581409277|FG002|Overall Study|Relocation|0|||
161006143|NCT01787760|581409275|FG000|Overall Study|Lens discomfort|3|||
161006144|NCT01787760|581409276|FG001|Overall Study|Lens discomfort|0|||
161006145|NCT01787760|581409277|FG002|Overall Study|Lens discomfort|0|||
161006146|NCT01787760|581409275|FG000|Overall Study|Lens handling difficulty|1|||
161006147|NCT01787760|581409276|FG001|Overall Study|Lens handling difficulty|2|||
161006148|NCT01787760|581409277|FG002|Overall Study|Lens handling difficulty|0|||
161006149|NCT01787760|581409275|FG000|Overall Study|Protocol Violation|6|||
161006150|NCT01787760|581409276|FG001|Overall Study|Protocol Violation|0|||
161006151|NCT01787760|581409277|FG002|Overall Study|Protocol Violation|1|||
161006152|NCT01787760|581409275|FG000|Overall Study|Withdrawal by Subject|5|||
161006153|NCT01787760|581409276|FG001|Overall Study|Withdrawal by Subject|1|||
161006154|NCT01787760|581409277|FG002|Overall Study|Withdrawal by Subject|2|||
161006155|NCT01787760|581409275|FG000|Overall Study|Lost to Follow-up|1|||
161006156|NCT01787760|581409276|FG001|Overall Study|Lost to Follow-up|0|||
161006157|NCT01787760|581409277|FG002|Overall Study|Lost to Follow-up|1|||
161006158|NCT01787760|581409275|FG000|Overall Study|Stroke|1|||
161006159|NCT01787760|581409276|FG001|Overall Study|Stroke|0|||
161006160|NCT01787760|581409277|FG002|Overall Study|Stroke|0|||
161006161|NCT01787760|581409275|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
161006162|NCT01787760|581409276|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
161006163|NCT01787760|581409277|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
161006164|NCT01787760|581409275|FG000|Overall Study|Unsatisfactory physiological response|2|||
161006165|NCT01787760|581409276|FG001|Overall Study|Unsatisfactory physiological response|4|||
161006166|NCT01787760|581409277|FG002|Overall Study|Unsatisfactory physiological response|0|||
161006167|NCT01787760|581409275|FG000|Overall Study|Unsatisfactory visual response|1|||
161006168|NCT01787760|581409276|FG001|Overall Study|Unsatisfactory visual response|1|||
161006169|NCT01787760|581409277|FG002|Overall Study|Unsatisfactory visual response|0|||
161006170|NCT01787760|581409275|FG000|Overall Study|Near vision blur|1|||
161006171|NCT01787760|581409276|FG001|Overall Study|Near vision blur|0|||
161006172|NCT01787760|581409277|FG002|Overall Study|Near vision blur|0|||
161006173|NCT03473340|581409278|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
161006174|NCT03473340|581409279|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
161006175|NCT03473340|581409278|FG000|Overall Study|Withdrawal by Subject|1|||
161006176|NCT03473340|581409279|FG001|Overall Study|Withdrawal by Subject|0|||
161006177|NCT03473340|581409278|FG000|Overall Study|Lost to Follow-up|1|||
161006178|NCT03473340|581409279|FG001|Overall Study|Lost to Follow-up|2|||
161006179|NCT02531113|581409282|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
161006180|NCT02531113|581409282|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
161006181|NCT02531113|581409282|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
161006182|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
161006183|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
161006184|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
161006185|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
161006186|NCT02531113|581409282|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
161006187|NCT00801983|581409283|FG000|Period 1|Lost to Follow-up|2|||
161006188|NCT00801983|581409284|FG001|Period 1|Lost to Follow-up|0|||
161006189|NCT00801983|581409283|FG000|Period 1|Withdrawal by Subject|2|||
161006190|NCT00801983|581409284|FG001|Period 1|Withdrawal by Subject|8|||
161006191|NCT00801983|581409283|FG000|Period 2|Withdrawal by Subject|2|||
161006192|NCT00801983|581409284|FG001|Period 2|Withdrawal by Subject|1|||
161006193|NCT03122886|581410636|FG000|Overall Study|Withdrawal by Subject|1|||
161006194|NCT03122886|581410637|FG001|Overall Study|Withdrawal by Subject|2|||
161006195|NCT03237481|581410642|FG000|Overall Study|Lost to Follow-up|1|||
161006196|NCT03237481|581410643|FG001|Overall Study|Lost to Follow-up|0|||
161006197|NCT03237481|581410644|FG002|Overall Study|Lost to Follow-up|0|||
161006198|NCT03237481|581410642|FG000|Overall Study|Protocol Violation|1|||
161006199|NCT03237481|581410643|FG001|Overall Study|Protocol Violation|0|||
161006200|NCT03237481|581410644|FG002|Overall Study|Protocol Violation|0|||
161006201|NCT03237481|581410642|FG000|Overall Study|Withdrawal by Subject|3|||
161006202|NCT03237481|581410643|FG001|Overall Study|Withdrawal by Subject|2|||
161006203|NCT03237481|581410644|FG002|Overall Study|Withdrawal by Subject|1|||
161006204|NCT02544074|581410645|FG000|Overall Study|Withdrawal by Subject|0|||
161006205|NCT02544074|581410646|FG001|Overall Study|Withdrawal by Subject|1|||
161006206|NCT02544074|581410647|FG002|Overall Study|Withdrawal by Subject|0|||
161006207|NCT02544074|581410648|FG003|Overall Study|Withdrawal by Subject|0|||
161006208|NCT02544074|581410649|FG004|Overall Study|Withdrawal by Subject|0|||
161006209|NCT02544074|581410650|FG005|Overall Study|Withdrawal by Subject|0|||
161006210|NCT02544074|581410651|FG006|Overall Study|Withdrawal by Subject|0|||
161006211|NCT02544074|581410652|FG007|Overall Study|Withdrawal by Subject|0|||
161006212|NCT02544074|581410653|FG008|Overall Study|Withdrawal by Subject|0|||
161006213|NCT02544074|581410654|FG009|Overall Study|Withdrawal by Subject|0|||
161006214|NCT02544074|581410655|FG010|Overall Study|Withdrawal by Subject|0|||
161006215|NCT02544074|581410656|FG011|Overall Study|Withdrawal by Subject|0|||
161006216|NCT02544074|581410657|FG012|Overall Study|Withdrawal by Subject|0|||
161006217|NCT02544074|581410658|FG013|Overall Study|Withdrawal by Subject|0|||
161006218|NCT02544074|581410659|FG014|Overall Study|Withdrawal by Subject|0|||
161006219|NCT02544074|581410660|FG015|Overall Study|Withdrawal by Subject|0|||
161006220|NCT02544074|581410661|FG016|Overall Study|Withdrawal by Subject|0|||
161006221|NCT02544074|581410662|FG017|Overall Study|Withdrawal by Subject|0|||
161006222|NCT02544074|581410663|FG018|Overall Study|Withdrawal by Subject|0|||
161006223|NCT02544074|581410664|FG019|Overall Study|Withdrawal by Subject|0|||
161006224|NCT02544074|581410665|FG020|Overall Study|Withdrawal by Subject|0|||
161006225|NCT02544074|581410645|FG000|Overall Study|Tablet error|0|||
161006226|NCT02544074|581410646|FG001|Overall Study|Tablet error|0|||
161006227|NCT02544074|581410647|FG002|Overall Study|Tablet error|0|||
161006228|NCT02544074|581410648|FG003|Overall Study|Tablet error|0|||
161006229|NCT02544074|581410649|FG004|Overall Study|Tablet error|0|||
161006230|NCT02544074|581410650|FG005|Overall Study|Tablet error|1|||
161006231|NCT02544074|581410651|FG006|Overall Study|Tablet error|0|||
161006232|NCT02544074|581410652|FG007|Overall Study|Tablet error|0|||
161006233|NCT02544074|581410653|FG008|Overall Study|Tablet error|0|||
161006234|NCT02544074|581410654|FG009|Overall Study|Tablet error|1|||
161006235|NCT02544074|581410655|FG010|Overall Study|Tablet error|0|||
161006236|NCT02544074|581410656|FG011|Overall Study|Tablet error|0|||
161006237|NCT02544074|581410657|FG012|Overall Study|Tablet error|0|||
161006238|NCT02544074|581410658|FG013|Overall Study|Tablet error|0|||
161006239|NCT02544074|581410659|FG014|Overall Study|Tablet error|0|||
161006240|NCT02544074|581410660|FG015|Overall Study|Tablet error|0|||
161006241|NCT02544074|581410661|FG016|Overall Study|Tablet error|0|||
161006242|NCT02544074|581410662|FG017|Overall Study|Tablet error|0|||
161006243|NCT02544074|581410663|FG018|Overall Study|Tablet error|0|||
161006244|NCT02544074|581410664|FG019|Overall Study|Tablet error|0|||
161006245|NCT02544074|581410665|FG020|Overall Study|Tablet error|0|||
161006246|NCT04714320|581410670|FG000|Overall Study|Voluntary Withdrawal|4|||
161006247|NCT04714320|581410671|FG001|Overall Study|Voluntary Withdrawal|1|||
161006248|NCT04714320|581410672|FG002|Overall Study|Voluntary Withdrawal|2|||
161006249|NCT04714320|581410670|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161006250|NCT04714320|581410671|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
161006251|NCT04714320|581410672|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
161006252|NCT04714320|581410670|FG000|Overall Study|Reason Not Specified|1|||
161006253|NCT04714320|581410671|FG001|Overall Study|Reason Not Specified|3|||
161006254|NCT04714320|581410672|FG002|Overall Study|Reason Not Specified|3|||
161006255|NCT03873779|581410673|FG000|Overall Study|Withdrawal by Subject|1|||
161006256|NCT02581215|581410674|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
161006257|NCT02581215|581410675|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
161006258|NCT02581215|581410674|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161006259|NCT02581215|581410675|FG001|Overall Study|Eligibility Criteria Not Met|1|||
161006260|NCT04153565|581410676|FG000|Overall Study|Death|13|||
161271473|NCT03334617|582375159|FG017|Overall Study|Withdrawal by Subject|1|||
161271474|NCT03334617|582375160|FG018|Overall Study|Withdrawal by Subject|1|||
161271475|NCT03334617|582375161|FG019|Overall Study|Withdrawal by Subject|1|||
161271476|NCT03334617|582375162|FG020|Overall Study|Withdrawal by Subject|0|||
161271477|NCT03334617|582375163|FG021|Overall Study|Withdrawal by Subject|1|||
161271478|NCT03334617|582375142|FG000|Overall Study|Other|1|||
161271479|NCT03334617|582375143|FG001|Overall Study|Other|2|||
161271480|NCT03334617|582375144|FG002|Overall Study|Other|0|||
161006261|NCT02374463|581410686|FG000|Overall Study|Withdrawal by Subject|3|||
161006262|NCT02374463|581410687|FG001|Overall Study|Withdrawal by Subject|3|||
161006263|NCT00446459|581410690|FG000|8 Months|Protocol Violation|12|||
161006264|NCT00446459|581410690|FG000|12 Months|Protocol Violation|4|||
161006265|NCT00446459|581410690|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
161006266|NCT00858117|581410691|FG000|Treatment on Study|Adverse Event|2|||
161006267|NCT00858117|581410691|FG000|Follow up for 5 Years|Death|4|||
161006268|NCT00858117|581410691|FG000|Follow up for 5 Years|No further data collected for study|9|||
161006269|NCT00371787|581410692|FG000|Overall Study|Withdrawal by Subject|3|||
161006270|NCT00371787|581410693|FG001|Overall Study|Withdrawal by Subject|1|||
161006271|NCT02601820|581410694|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
161006272|NCT02601820|581410694|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
161006273|NCT02601820|581410694|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
161006274|NCT02601820|581410694|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
161006275|NCT01414738|581410708|FG000|Overall Study|Death|26|||
161006276|NCT01414738|581410708|FG000|Overall Study|Refused testing|5|||
161006277|NCT01414738|581410708|FG000|Overall Study|Lost to Follow-up|2|||
161006278|NCT01414738|581410708|FG000|Overall Study|Refused, disease progression|8|||
161006279|NCT01414738|581410708|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
161006280|NCT01266122|581410709|FG000|Overall Study|Lost to Follow-up|6|||
161006281|NCT01266122|581410710|FG001|Overall Study|Lost to Follow-up|6|||
161006282|NCT03756571|581410711|FG000|Overall Study|Lost to Follow-up|1|||
161006283|NCT03756571|581410712|FG001|Overall Study|Lost to Follow-up|1|||
161006284|NCT02379819|581410713|FG000|Overall Study|Withdrawal by Subject|10|||
161006285|NCT02379819|581410713|FG000|Overall Study|Death|2|||
161006286|NCT02379819|581410713|FG000|Overall Study|Lack of Efficacy|1|||
161006287|NCT02379819|581410713|FG000|Overall Study|Lost to Follow-up|1|||
161006288|NCT03752151|581410714|FG000|Overall Study|Withdrawal by Subject|1|||
161006289|NCT03752151|581410714|FG000|Overall Study|Protocol Violation|1|||
161006290|NCT00529516|581410715|FG000|Overall Study|Adverse Event|2|||
161006291|NCT00529516|581410716|FG001|Overall Study|Adverse Event|1|||
161006292|NCT00529516|581410717|FG002|Overall Study|Adverse Event|0|||
161006293|NCT00529516|581410715|FG000|Overall Study|Withdrawal by Subject|1|||
161006294|NCT00529516|581410716|FG001|Overall Study|Withdrawal by Subject|1|||
161006295|NCT00529516|581410717|FG002|Overall Study|Withdrawal by Subject|0|||
161006296|NCT00529516|581410715|FG000|Overall Study|Lost to Follow-up|0|||
161006297|NCT00529516|581410716|FG001|Overall Study|Lost to Follow-up|0|||
161006298|NCT00529516|581410717|FG002|Overall Study|Lost to Follow-up|1|||
161006299|NCT04056624|581410718|FG000|Overall Study|Withdrawal by Subject|0|||
161006300|NCT04056624|581410719|FG001|Overall Study|Withdrawal by Subject|0|||
161006301|NCT04056624|581410720|FG002|Overall Study|Withdrawal by Subject|1|||
161006302|NCT04056624|581410718|FG000|Overall Study|Protocol Violation|1|||
161006303|NCT04056624|581410719|FG001|Overall Study|Protocol Violation|2|||
161006304|NCT04056624|581410720|FG002|Overall Study|Protocol Violation|0|||
161006305|NCT00703820|581410724|FG000|Overall Study|Adverse Event|12|||
161006306|NCT00703820|581410725|FG001|Overall Study|Adverse Event|17|||
161006307|NCT00703820|581410724|FG000|Overall Study|Death|5|||
161006308|NCT00703820|581410725|FG001|Overall Study|Death|0|||
161006309|NCT00703820|581410724|FG000|Overall Study|Lack of Efficacy|11|||
161006310|NCT00703820|581410725|FG001|Overall Study|Lack of Efficacy|11|||
161271481|NCT03334617|582375145|FG003|Overall Study|Other|1|||
161271482|NCT03334617|582375146|FG004|Overall Study|Other|1|||
161271483|NCT03334617|582375147|FG005|Overall Study|Other|0|||
161271484|NCT03334617|582375148|FG006|Overall Study|Other|2|||
161271485|NCT03334617|582375149|FG007|Overall Study|Other|1|||
161271486|NCT03334617|582375150|FG008|Overall Study|Other|8|||
161006311|NCT00703820|581410724|FG000|Overall Study|Received non-protocol therapy|1|||
161271487|NCT03334617|582375151|FG009|Overall Study|Other|0|||
161006312|NCT00703820|581410725|FG001|Overall Study|Received non-protocol therapy|0|||
161006313|NCT00703820|581410724|FG000|Overall Study|Physician Decision|4|||
161006314|NCT00703820|581410725|FG001|Overall Study|Physician Decision|5|||
161006315|NCT00703820|581410724|FG000|Overall Study|Withdrawal by Subject|2|||
161006316|NCT00703820|581410725|FG001|Overall Study|Withdrawal by Subject|1|||
161006317|NCT02092116|581410729|FG000|Overall Study|Withdrawal by Subject|0|||
161271488|NCT03334617|582375152|FG010|Overall Study|Other|3|||
161006318|NCT02092116|581410730|FG001|Overall Study|Withdrawal by Subject|3|||
161006319|NCT02092116|581410729|FG000|Overall Study|Adverse Event|0|||
161006320|NCT02092116|581410730|FG001|Overall Study|Adverse Event|1|||
161006321|NCT01007396|581410731|FG000|Overall Study|Lost to Follow-up|47|||
161271489|NCT03334617|582375153|FG011|Overall Study|Other|1|||
161271490|NCT03334617|582375154|FG012|Overall Study|Other|3|||
161006322|NCT01792830|581410732|FG000|Overall Study|Withdrawal by Subject|22|||
161006323|NCT01792830|581410733|FG001|Overall Study|Withdrawal by Subject|0|||
161006324|NCT01792830|581410734|FG002|Overall Study|Withdrawal by Subject|0|||
161006325|NCT01792830|581410735|FG003|Overall Study|Withdrawal by Subject|2|||
161006326|NCT01792830|581410736|FG004|Overall Study|Withdrawal by Subject|1|||
161006327|NCT01792830|581410737|FG005|Overall Study|Withdrawal by Subject|1|||
161006328|NCT01792830|581410738|FG006|Overall Study|Withdrawal by Subject|1|||
161006329|NCT01792830|581410739|FG007|Overall Study|Withdrawal by Subject|1|||
161006330|NCT01792830|581410740|FG008|Overall Study|Withdrawal by Subject|7|||
161006331|NCT01792830|581410741|FG009|Overall Study|Withdrawal by Subject|0|||
161006332|NCT01792830|581410742|FG010|Overall Study|Withdrawal by Subject|2|||
161006333|NCT01792830|581410732|FG000|Overall Study|Death|3|||
161006334|NCT01792830|581410733|FG001|Overall Study|Death|0|||
161006335|NCT01792830|581410734|FG002|Overall Study|Death|0|||
161006336|NCT01792830|581410735|FG003|Overall Study|Death|1|||
161006337|NCT01792830|581410736|FG004|Overall Study|Death|0|||
161006338|NCT01792830|581410737|FG005|Overall Study|Death|0|||
161006339|NCT01792830|581410738|FG006|Overall Study|Death|1|||
161006340|NCT01792830|581410739|FG007|Overall Study|Death|0|||
161006341|NCT01792830|581410740|FG008|Overall Study|Death|1|||
161006342|NCT01792830|581410741|FG009|Overall Study|Death|0|||
161006343|NCT01792830|581410742|FG010|Overall Study|Death|1|||
161006344|NCT01792830|581410732|FG000|Overall Study|Adverse Event|0|||
161006345|NCT01792830|581410733|FG001|Overall Study|Adverse Event|0|||
161006346|NCT01792830|581410734|FG002|Overall Study|Adverse Event|0|||
161006347|NCT01792830|581410735|FG003|Overall Study|Adverse Event|0|||
161006348|NCT01792830|581410736|FG004|Overall Study|Adverse Event|0|||
161006349|NCT01792830|581410737|FG005|Overall Study|Adverse Event|0|||
161006350|NCT01792830|581410738|FG006|Overall Study|Adverse Event|0|||
161006351|NCT01792830|581410739|FG007|Overall Study|Adverse Event|0|||
161006352|NCT01792830|581410740|FG008|Overall Study|Adverse Event|1|||
161006353|NCT01792830|581410741|FG009|Overall Study|Adverse Event|0|||
161006354|NCT01792830|581410742|FG010|Overall Study|Adverse Event|0|||
161006355|NCT05274217|581410758|FG000|Overall Study|Study terminated.|11|||
161006356|NCT05274217|581410759|FG001|Overall Study|Study terminated.|0|||
161006357|NCT03811574|581410760|FG000|Overall Study|Withdrawal by Subject|2|||
161006358|NCT03811574|581410761|FG001|Overall Study|Withdrawal by Subject|4|||
161006359|NCT03811574|581410762|FG002|Overall Study|Withdrawal by Subject|0|||
161006360|NCT01697969|581410765|FG000|Overall Study|Did not meet inc/exc criteria|3|||
161006361|NCT00736853|581410768|FG000|Open-Label Period|Physician Decision|2|||
161006362|NCT00736853|581410769|FG001|Open-Label Period|Physician Decision|0|||
161006363|NCT00736853|581410770|FG002|Open-Label Period|Physician Decision|0|||
161006364|NCT00736853|581410768|FG000|Open-Label Period|Adverse Event|31|||
161006365|NCT00736853|581410769|FG001|Open-Label Period|Adverse Event|0|||
161006366|NCT00736853|581410770|FG002|Open-Label Period|Adverse Event|0|||
161006367|NCT00736853|581410768|FG000|Open-Label Period|Withdrawal by Subject|16|||
161006368|NCT00736853|581410769|FG001|Open-Label Period|Withdrawal by Subject|0|||
161006369|NCT00736853|581410770|FG002|Open-Label Period|Withdrawal by Subject|0|||
161006370|NCT00736853|581410768|FG000|Open-Label Period|Started but not treated|42|||
161006371|NCT00736853|581410769|FG001|Open-Label Period|Started but not treated|0|||
161006372|NCT00736853|581410770|FG002|Open-Label Period|Started but not treated|0|||
161006373|NCT00736853|581410768|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
161006374|NCT00736853|581410769|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
161006375|NCT00736853|581410770|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
161006376|NCT00736853|581410768|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
161006377|NCT00736853|581410769|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
161006378|NCT00736853|581410770|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
161006379|NCT00736853|581410768|FG000|Double-Blind Period|Lack of Efficacy|0|||
161006380|NCT00736853|581410769|FG001|Double-Blind Period|Lack of Efficacy|19|||
161006381|NCT00736853|581410770|FG002|Double-Blind Period|Lack of Efficacy|42|||
161271491|NCT03334617|582375155|FG013|Overall Study|Other|1|||
161271492|NCT03334617|582375156|FG014|Overall Study|Other|1|||
161271493|NCT03334617|582375157|FG015|Overall Study|Other|3|||
161006382|NCT00736853|581410768|FG000|Double-Blind Period|Adverse Event|0|||
161271494|NCT03334617|582375158|FG016|Overall Study|Other|3|||
161271495|NCT03334617|582375159|FG017|Overall Study|Other|3|||
161271496|NCT03334617|582375160|FG018|Overall Study|Other|7|||
161006383|NCT00736853|581410769|FG001|Double-Blind Period|Adverse Event|3|||
161006384|NCT00736853|581410770|FG002|Double-Blind Period|Adverse Event|2|||
161006385|NCT00736853|581410768|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161006386|NCT00736853|581410769|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161006387|NCT00736853|581410770|FG002|Double-Blind Period|Withdrawal by Subject|4|||
161271497|NCT03334617|582375161|FG019|Overall Study|Other|4|||
161006388|NCT00736853|581410768|FG000|Double-Blind Period|Ineligible to participate the study|0|||
161006389|NCT00736853|581410769|FG001|Double-Blind Period|Ineligible to participate the study|1|||
161006390|NCT00736853|581410770|FG002|Double-Blind Period|Ineligible to participate the study|0|||
161271498|NCT03334617|582375162|FG020|Overall Study|Other|1|||
161271499|NCT03334617|582375163|FG021|Overall Study|Other|4|||
161271500|NCT03334617|582375142|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
161271501|NCT03334617|582375143|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
161271502|NCT03334617|582375144|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
161271503|NCT03334617|582375145|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
161271504|NCT03334617|582375146|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
161271505|NCT03334617|582375147|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
161271506|NCT03334617|582375148|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
161271507|NCT03334617|582375149|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
161271508|NCT03334617|582375150|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
161271509|NCT03334617|582375151|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
161271510|NCT03334617|582375152|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
161271511|NCT03334617|582375153|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
161271512|NCT03334617|582375154|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
161271513|NCT03334617|582375155|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
161271514|NCT03334617|582375156|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
161271515|NCT03334617|582375157|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
161271516|NCT03334617|582375158|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
161271517|NCT03334617|582375159|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
160966367|NCT01951638|581264888|FG001|Treatment Period|Withdrawal by Subject|6|||
160966368|NCT01951638|581264889|FG002|Treatment Period|Withdrawal by Subject|4|||
160966369|NCT01951638|581264890|FG003|Treatment Period|Withdrawal by Subject|5|||
160966370|NCT01951638|581264891|FG004|Treatment Period|Withdrawal by Subject|4|||
160966371|NCT01951638|581264887|FG000|Treatment Period|Death|0|||
160966372|NCT01951638|581264888|FG001|Treatment Period|Death|0|||
160966373|NCT01951638|581264889|FG002|Treatment Period|Death|0|||
160966374|NCT01951638|581264890|FG003|Treatment Period|Death|3|||
160966375|NCT01951638|581264891|FG004|Treatment Period|Death|1|||
160966376|NCT01951638|581264887|FG000|Treatment Period|Adverse Event|3|||
160966377|NCT01951638|581264888|FG001|Treatment Period|Adverse Event|4|||
160966378|NCT01951638|581264889|FG002|Treatment Period|Adverse Event|8|||
160966379|NCT01951638|581264890|FG003|Treatment Period|Adverse Event|6|||
160966380|NCT01951638|581264891|FG004|Treatment Period|Adverse Event|5|||
160966381|NCT01951638|581264887|FG000|Follow-up Period|Protocol Violation|0|||
160966382|NCT01951638|581264888|FG001|Follow-up Period|Protocol Violation|0|||
160966383|NCT01951638|581264889|FG002|Follow-up Period|Protocol Violation|0|||
160966384|NCT01951638|581264890|FG003|Follow-up Period|Protocol Violation|1|||
160966385|NCT01951638|581264891|FG004|Follow-up Period|Protocol Violation|0|||
160966386|NCT01951638|581264887|FG000|Follow-up Period|Logistical difficulties|0|||
160966387|NCT01951638|581264888|FG001|Follow-up Period|Logistical difficulties|2|||
160966388|NCT01951638|581264889|FG002|Follow-up Period|Logistical difficulties|0|||
160966389|NCT01951638|581264890|FG003|Follow-up Period|Logistical difficulties|0|||
160966390|NCT01951638|581264891|FG004|Follow-up Period|Logistical difficulties|1|||
160966391|NCT01951638|581264887|FG000|Follow-up Period|Withdrawal by Subject|1|||
160966392|NCT01951638|581264888|FG001|Follow-up Period|Withdrawal by Subject|5|||
160966393|NCT01951638|581264889|FG002|Follow-up Period|Withdrawal by Subject|2|||
160966394|NCT01951638|581264890|FG003|Follow-up Period|Withdrawal by Subject|1|||
160966395|NCT01951638|581264891|FG004|Follow-up Period|Withdrawal by Subject|2|||
160966396|NCT01951638|581264887|FG000|Follow-up Period|Lost to Follow-up|0|||
160966397|NCT01951638|581264888|FG001|Follow-up Period|Lost to Follow-up|1|||
160966398|NCT01951638|581264889|FG002|Follow-up Period|Lost to Follow-up|0|||
160966399|NCT01951638|581264890|FG003|Follow-up Period|Lost to Follow-up|1|||
160966400|NCT01951638|581264891|FG004|Follow-up Period|Lost to Follow-up|0|||
160966401|NCT01951638|581264887|FG000|Follow-up Period|Death|1|||
160966402|NCT01951638|581264888|FG001|Follow-up Period|Death|0|||
160966403|NCT01951638|581264889|FG002|Follow-up Period|Death|1|||
160966404|NCT01951638|581264890|FG003|Follow-up Period|Death|4|||
160966405|NCT01951638|581264891|FG004|Follow-up Period|Death|1|||
160966406|NCT01951638|581264887|FG000|Follow-up Period|Adverse Event|0|||
160966407|NCT01951638|581264888|FG001|Follow-up Period|Adverse Event|1|||
160966408|NCT01951638|581264889|FG002|Follow-up Period|Adverse Event|2|||
160966409|NCT01951638|581264890|FG003|Follow-up Period|Adverse Event|1|||
160966410|NCT01951638|581264891|FG004|Follow-up Period|Adverse Event|1|||
160966411|NCT03764072|581264892|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966412|NCT03764072|581264893|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966413|NCT03764072|581264894|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
160966414|NCT03764072|581264895|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966415|NCT03764072|581264896|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966416|NCT03764072|581264897|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
160966417|NCT03764072|581264892|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
160966418|NCT03764072|581264893|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
160966419|NCT03764072|581264894|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
161147295|NCT01097616|581922451|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
160966420|NCT03764072|581264895|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
160966421|NCT03764072|581264896|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
160966422|NCT03764072|581264897|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
160966423|NCT03764072|581264892|FG000|Overall Study|Lost to Follow-up|0|||
160966424|NCT03764072|581264893|FG001|Overall Study|Lost to Follow-up|0|||
160966425|NCT03764072|581264894|FG002|Overall Study|Lost to Follow-up|0|||
160966426|NCT03764072|581264895|FG003|Overall Study|Lost to Follow-up|0|||
160966427|NCT03764072|581264896|FG004|Overall Study|Lost to Follow-up|1|||
160966428|NCT03764072|581264897|FG005|Overall Study|Lost to Follow-up|0|||
160966429|NCT00552084|581264898|FG000|Overall Study|Adverse Event|2|||
160966430|NCT00552084|581264899|FG001|Overall Study|Adverse Event|3|||
160966431|NCT00552084|581264898|FG000|Overall Study|Withdrawal by Subject|4|||
160966432|NCT00552084|581264899|FG001|Overall Study|Withdrawal by Subject|5|||
160966433|NCT00552084|581264898|FG000|Overall Study|Protocol Violation|1|||
160966434|NCT00552084|581264899|FG001|Overall Study|Protocol Violation|0|||
160966435|NCT00552084|581264898|FG000|Overall Study|change in anti-arrythmic drug|1|||
160966436|NCT00552084|581264899|FG001|Overall Study|change in anti-arrythmic drug|1|||
160966437|NCT02286089|581264900|FG000|Overall Study|Ongoing in Study|1|||
160966438|NCT02286089|581264901|FG001|Overall Study|Ongoing in Study|1|||
160966439|NCT02286089|581264902|FG002|Overall Study|Ongoing in Study|4|||
160966440|NCT02286089|581264903|FG003|Overall Study|Ongoing in Study|10|||
160966441|NCT02286089|581264900|FG000|Overall Study|Withdrawal by Subject|0|||
160966442|NCT02286089|581264901|FG001|Overall Study|Withdrawal by Subject|0|||
160966443|NCT02286089|581264902|FG002|Overall Study|Withdrawal by Subject|2|||
160966444|NCT02286089|581264903|FG003|Overall Study|Withdrawal by Subject|2|||
160966445|NCT04981678|581264905|FG000|Overall Study|Lost to Follow-up|0|||
160966446|NCT04981678|581264906|FG001|Overall Study|Lost to Follow-up|1|||
160966447|NCT03779906|581264907|FG000|Overall Study|Lost to Follow-up|7|||
160966448|NCT03779906|581264907|FG000|Overall Study|COVID pandemic|1|||
160966449|NCT02044848|581266691|FG000|Overall Study|Administrative Problems|2|||
160966450|NCT02044848|581266692|FG001|Overall Study|Administrative Problems|3|||
160966451|NCT03183388|581266693|FG000|Overall Study|Lost to Follow-up|3|||
160966452|NCT03183388|581266694|FG001|Overall Study|Lost to Follow-up|5|||
160966453|NCT03183388|581266693|FG000|Overall Study|Physician Decision|1|||
160966454|NCT03183388|581266694|FG001|Overall Study|Physician Decision|4|||
160966455|NCT03183388|581266693|FG000|Overall Study|Withdrawal by Subject|4|||
160966456|NCT03183388|581266694|FG001|Overall Study|Withdrawal by Subject|1|||
160966457|NCT03183388|581266693|FG000|Overall Study|Moved|1|||
160966458|NCT03183388|581266694|FG001|Overall Study|Moved|0|||
160966459|NCT03183388|581266693|FG000|Overall Study|Met Exclusion Criteria|2|||
160966460|NCT03183388|581266694|FG001|Overall Study|Met Exclusion Criteria|2|||
160966461|NCT03183388|581266693|FG000|Overall Study|COVID Pandemic Related|2|||
160966462|NCT03183388|581266694|FG001|Overall Study|COVID Pandemic Related|4|||
160966463|NCT00284141|581266699|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
160966464|NCT00284141|581266699|FG000|Overall Study|Adverse Event|19|||
160966465|NCT00284141|581266699|FG000|Overall Study|Participant's request|9|||
160966466|NCT00284141|581266699|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
160966467|NCT00284141|581266699|FG000|Overall Study|Clinical deterioration / death|2|||
160966468|NCT00284141|581266699|FG000|Overall Study|General decline|1|||
160966469|NCT00284141|581266699|FG000|Overall Study|Pneumonia|1|||
160966470|NCT00284141|581266699|FG000|Overall Study|Did not take study medication|2|||
160966471|NCT00284141|581266699|FG000|Overall Study|Ongoing treatment|2|||
160966472|NCT01782742|581266702|FG000|Double-blind Treatment Phase|Adverse Event|1|||
160966473|NCT01782742|581266703|FG001|Double-blind Treatment Phase|Adverse Event|0|||
160966474|NCT00803101|581266704|FG000|Overall Study|Death / Serious Adverse Event|4|||
160966475|NCT00803101|581266705|FG001|Overall Study|Death / Serious Adverse Event|6|||
160966476|NCT00803101|581266704|FG000|Overall Study|Withdrawal by Subject|6|||
160966477|NCT00803101|581266705|FG001|Overall Study|Withdrawal by Subject|4|||
160966478|NCT00803101|581266704|FG000|Overall Study|Lost to Follow-up|2|||
160966479|NCT00803101|581266705|FG001|Overall Study|Lost to Follow-up|2|||
160966480|NCT00803101|581266704|FG000|Overall Study|Protocol Violation|1|||
160966481|NCT00803101|581266705|FG001|Overall Study|Protocol Violation|7|||
160966482|NCT00803101|581266704|FG000|Overall Study|Surgery finished outside protocol window|1|||
160966483|NCT00803101|581266705|FG001|Overall Study|Surgery finished outside protocol window|1|||
160966484|NCT00803101|581266704|FG000|Overall Study|Patient died outside SAE report period|1|||
160966485|NCT00803101|581266705|FG001|Overall Study|Patient died outside SAE report period|0|||
161147296|NCT01097616|581922452|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
160966486|NCT00803101|581266704|FG000|Overall Study|Patient did not attend scheduled visit|2|||
160966487|NCT00803101|581266705|FG001|Overall Study|Patient did not attend scheduled visit|1|||
160966488|NCT00803101|581266704|FG000|Overall Study|Patient did not have surgery|1|||
160966489|NCT00803101|581266705|FG001|Overall Study|Patient did not have surgery|1|||
160966490|NCT01529008|581266706|FG000|Bone Marrow Harvesting|Physician Decision|1|||
160966491|NCT01529008|581266707|FG001|Bone Marrow Harvesting|Physician Decision|1|||
160966492|NCT01529008|581266706|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
160966493|NCT01529008|581266707|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
160966494|NCT01529008|581266706|FG000|Treatment|Adverse Event|6|||
160966495|NCT01529008|581266707|FG001|Treatment|Adverse Event|0|||
160966496|NCT01529008|581266706|FG000|Treatment|Other|3|||
160966497|NCT01529008|581266707|FG001|Treatment|Other|1|||
160966498|NCT01529008|581266706|FG000|Efficacy Analysis|Protocol Violation|2|||
160966499|NCT01529008|581266707|FG001|Efficacy Analysis|Protocol Violation|0|||
160966500|NCT01529008|581266706|FG000|Efficacy Analysis|Physician Decision|0|||
160966501|NCT01529008|581266707|FG001|Efficacy Analysis|Physician Decision|1|||
160966502|NCT01529008|581266706|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
160966503|NCT01529008|581266707|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
160966504|NCT04170686|581266708|FG000|Screening|Physician Decision|12|||
160966505|NCT04170686|581266709|FG001|Screening|Physician Decision|13|||
160966506|NCT04170686|581266708|FG000|Randomization and Treatment|Lost to Follow-up|26|||
160966507|NCT04170686|581266709|FG001|Randomization and Treatment|Lost to Follow-up|15|||
160966508|NCT04425902|581266712|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
160966509|NCT01191840|581266713|FG000|Overall Study|withdrew consent|2|||
160966510|NCT01191840|581266714|FG001|Overall Study|withdrew consent|1|||
160966511|NCT01191840|581266713|FG000|Overall Study|Subject discontinued treatment|1|||
160966512|NCT01191840|581266714|FG001|Overall Study|Subject discontinued treatment|2|||
160966513|NCT01191840|581266713|FG000|Overall Study|Lost to Follow-up|4|||
160966514|NCT01191840|581266714|FG001|Overall Study|Lost to Follow-up|6|||
160966515|NCT01191840|581266713|FG000|Overall Study|Non Staph Infection|4|||
160966516|NCT01191840|581266714|FG001|Overall Study|Non Staph Infection|3|||
160966517|NCT01191840|581266713|FG000|Overall Study|ineligible at enrollment|1|||
160966518|NCT01191840|581266714|FG001|Overall Study|ineligible at enrollment|0|||
160966519|NCT01191840|581266713|FG000|Overall Study|IRB approval lapse|0|||
160966520|NCT01191840|581266714|FG001|Overall Study|IRB approval lapse|2|||
160966521|NCT01191840|581266713|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
160966522|NCT01191840|581266714|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
160966523|NCT01191840|581266713|FG000|Overall Study|Withdrawal by Subject|2|||
160966524|NCT01191840|581266714|FG001|Overall Study|Withdrawal by Subject|0|||
160966525|NCT04669600|581266715|FG000|Overall Study|Withdrawal by Subject|1|||
160966526|NCT04669600|581266715|FG000|Overall Study|Other|6|||
160966527|NCT01802437|581266721|FG000|Overall Study|Lost to Follow-up|1|||
160966528|NCT01802437|581266722|FG001|Overall Study|Lost to Follow-up|0|||
160966529|NCT01802437|581266721|FG000|Overall Study|Withdrawal by Subject|3|||
160966530|NCT01802437|581266722|FG001|Overall Study|Withdrawal by Subject|4|||
160966531|NCT04857034|581266727|FG000|Placebo-Controlled Period|Request to discontinue|2|||
160966532|NCT04857034|581266728|FG001|Placebo-Controlled Period|Request to discontinue|2|||
160966533|NCT04857034|581266729|FG002|Placebo-Controlled Period|Request to discontinue|0|||
160966534|NCT04857034|581266730|FG003|Placebo-Controlled Period|Request to discontinue|0|||
160966535|NCT04857034|581266731|FG004|Placebo-Controlled Period|Request to discontinue|0|||
160966536|NCT04857034|581266727|FG000|Placebo-Controlled Period|withdrew consent|1|||
160966537|NCT04857034|581266728|FG001|Placebo-Controlled Period|withdrew consent|1|||
160966538|NCT04857034|581266729|FG002|Placebo-Controlled Period|withdrew consent|2|||
160966539|NCT04857034|581266730|FG003|Placebo-Controlled Period|withdrew consent|0|||
160966540|NCT04857034|581266731|FG004|Placebo-Controlled Period|withdrew consent|0|||
160966541|NCT04857034|581266727|FG000|Placebo-Controlled Period|Pregnancy|1|||
160966542|NCT04857034|581266728|FG001|Placebo-Controlled Period|Pregnancy|1|||
160966543|NCT04857034|581266729|FG002|Placebo-Controlled Period|Pregnancy|0|||
160966544|NCT04857034|581266730|FG003|Placebo-Controlled Period|Pregnancy|0|||
160966545|NCT04857034|581266731|FG004|Placebo-Controlled Period|Pregnancy|0|||
160966546|NCT04857034|581266727|FG000|Placebo-Controlled Period|Ongoing study period|0|||
160966547|NCT04857034|581266728|FG001|Placebo-Controlled Period|Ongoing study period|1|||
160966548|NCT04857034|581266729|FG002|Placebo-Controlled Period|Ongoing study period|0|||
160966549|NCT04857034|581266730|FG003|Placebo-Controlled Period|Ongoing study period|0|||
160966550|NCT04857034|581266731|FG004|Placebo-Controlled Period|Ongoing study period|0|||
160966551|NCT04857034|581266727|FG000|Active Treatment Period|Lack of Efficacy|1|||
160966552|NCT04857034|581266728|FG001|Active Treatment Period|Lack of Efficacy|0|||
160966553|NCT04857034|581266729|FG002|Active Treatment Period|Lack of Efficacy|0|||
160966554|NCT04857034|581266730|FG003|Active Treatment Period|Lack of Efficacy|0|||
160966555|NCT04857034|581266731|FG004|Active Treatment Period|Lack of Efficacy|0|||
160966556|NCT04857034|581266727|FG000|Active Treatment Period|request to discontinue|0|||
160966557|NCT04857034|581266728|FG001|Active Treatment Period|request to discontinue|1|||
160966558|NCT04857034|581266729|FG002|Active Treatment Period|request to discontinue|0|||
161006391|NCT01764464|581410771|FG000|First Intervention|Withdrawal by Subject|1|||
160966559|NCT04857034|581266730|FG003|Active Treatment Period|request to discontinue|1|||
160966560|NCT04857034|581266731|FG004|Active Treatment Period|request to discontinue|0|||
160966561|NCT04857034|581266727|FG000|Active Treatment Period|administrative reason by sponsor|1|||
160966562|NCT04857034|581266728|FG001|Active Treatment Period|administrative reason by sponsor|5|||
160966563|NCT04857034|581266729|FG002|Active Treatment Period|administrative reason by sponsor|0|||
160966564|NCT04857034|581266730|FG003|Active Treatment Period|administrative reason by sponsor|2|||
160966565|NCT04857034|581266731|FG004|Active Treatment Period|administrative reason by sponsor|2|||
161006392|NCT01764464|581410772|FG001|First Intervention|Withdrawal by Subject|0|||
161006393|NCT01764464|581410771|FG000|First Intervention|Lost to Follow-up|1|||
161006394|NCT01764464|581410772|FG001|First Intervention|Lost to Follow-up|0|||
161006395|NCT01764464|581410771|FG000|First Intervention|Adverse Event|0|||
161006396|NCT01764464|581410772|FG001|First Intervention|Adverse Event|2|||
161006397|NCT01764464|581410771|FG000|First Intervention|did not receive study drug|0|||
161006398|NCT01764464|581410772|FG001|First Intervention|did not receive study drug|1|||
161006399|NCT01764464|581410771|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
161006400|NCT01764464|581410772|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
161006401|NCT01616459|581410777|FG000|Overall Study|Adverse Event|1|||
161006402|NCT01616459|581410778|FG001|Overall Study|Adverse Event|1|||
161006403|NCT01616459|581410779|FG002|Overall Study|Adverse Event|2|||
161006404|NCT01616459|581410780|FG003|Overall Study|Adverse Event|0|||
161006405|NCT01616459|581410777|FG000|Overall Study|Lost to Follow-up|1|||
160966566|NCT04857034|581266727|FG000|Active Treatment Period|other reasons|1|||
160966567|NCT04857034|581266728|FG001|Active Treatment Period|other reasons|1|||
160966568|NCT04857034|581266729|FG002|Active Treatment Period|other reasons|0|||
160966569|NCT04857034|581266730|FG003|Active Treatment Period|other reasons|0|||
160966570|NCT04857034|581266731|FG004|Active Treatment Period|other reasons|1|||
160966571|NCT04857034|581266727|FG000|Active Treatment Period|Ongoing Study Period|2|||
160966572|NCT04857034|581266728|FG001|Active Treatment Period|Ongoing Study Period|4|||
160966573|NCT04857034|581266729|FG002|Active Treatment Period|Ongoing Study Period|0|||
160966574|NCT04857034|581266730|FG003|Active Treatment Period|Ongoing Study Period|1|||
160966575|NCT04857034|581266731|FG004|Active Treatment Period|Ongoing Study Period|0|||
160966576|NCT01682213|581266734|FG000|Overall Study|Withdrawal by Subject|2|||
160966577|NCT01264380|581266735|FG000|Period C|Disease Progression|0|||
160966578|NCT01264380|581266736|FG001|Period C|Disease Progression|0|||
160966579|NCT01264380|581266737|FG002|Period C|Disease Progression|4|||
160966580|NCT01264380|581266735|FG000|Period C|Death|0|||
160966581|NCT01264380|581266736|FG001|Period C|Death|0|||
160966582|NCT01264380|581266737|FG002|Period C|Death|2|||
160966583|NCT01264380|581266735|FG000|Period C|Follow-up for survival status|0|||
160966584|NCT01264380|581266736|FG001|Period C|Follow-up for survival status|0|||
160966585|NCT01264380|581266737|FG002|Period C|Follow-up for survival status|6|||
160966586|NCT01264380|581266735|FG000|Period C|Withdrawal by Subject|0|||
160966587|NCT01264380|581266736|FG001|Period C|Withdrawal by Subject|0|||
160966588|NCT01264380|581266737|FG002|Period C|Withdrawal by Subject|1|||
160966589|NCT01264380|581266735|FG000|Period C|Adverse Event|0|||
160966590|NCT01264380|581266736|FG001|Period C|Adverse Event|0|||
160966591|NCT01264380|581266737|FG002|Period C|Adverse Event|1|||
160966592|NCT04382924|581266739|FG000|Overall Study|Death|2|||
160966593|NCT04382924|581266740|FG001|Overall Study|Death|5|||
160966594|NCT04382924|581266741|FG002|Overall Study|Death|4|||
160966595|NCT04382924|581266739|FG000|Overall Study|Protocol Violation|0|||
160966596|NCT04382924|581266740|FG001|Overall Study|Protocol Violation|1|||
160966597|NCT04382924|581266741|FG002|Overall Study|Protocol Violation|1|||
160966598|NCT04382924|581266739|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
160966599|NCT04382924|581266740|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
160966600|NCT04382924|581266741|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
160966601|NCT04382924|581266739|FG000|Overall Study|Withdrawal by Subject|6|||
160966602|NCT04382924|581266740|FG001|Overall Study|Withdrawal by Subject|3|||
160966603|NCT04382924|581266741|FG002|Overall Study|Withdrawal by Subject|6|||
160966604|NCT04998604|581266742|FG000|Overall Study|Adverse Event|3|||
160966605|NCT04998604|581266743|FG001|Overall Study|Adverse Event|2|||
160966606|NCT04998604|581266742|FG000|Overall Study|Withdrawal by Subject|2|||
160966607|NCT04998604|581266743|FG001|Overall Study|Withdrawal by Subject|4|||
160966608|NCT04998604|581266742|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
160966609|NCT04998604|581266743|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
160966610|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
160966611|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
160966612|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
160966613|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
160966614|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
160966615|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
160966616|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
160966617|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
161006406|NCT01616459|581410778|FG001|Overall Study|Lost to Follow-up|11|||
161006407|NCT01616459|581410779|FG002|Overall Study|Lost to Follow-up|3|||
161006408|NCT01616459|581410780|FG003|Overall Study|Lost to Follow-up|2|||
160966618|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
160966619|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
160966620|NCT00261495|581266748|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
160966621|NCT00261495|581266749|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
160966622|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
160966623|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
161006409|NCT01616459|581410777|FG000|Overall Study|Protocol Violation|0|||
161006410|NCT01616459|581410778|FG001|Overall Study|Protocol Violation|0|||
161006411|NCT01616459|581410779|FG002|Overall Study|Protocol Violation|0|||
161006412|NCT01616459|581410780|FG003|Overall Study|Protocol Violation|2|||
161006413|NCT01616459|581410777|FG000|Overall Study|Withdrawal by Subject|2|||
161006414|NCT01616459|581410778|FG001|Overall Study|Withdrawal by Subject|4|||
161006415|NCT01616459|581410779|FG002|Overall Study|Withdrawal by Subject|4|||
161006416|NCT01616459|581410780|FG003|Overall Study|Withdrawal by Subject|4|||
161006417|NCT01616459|581410777|FG000|Overall Study|Other reason|0|||
161006418|NCT01616459|581410778|FG001|Overall Study|Other reason|1|||
161006419|NCT01616459|581410779|FG002|Overall Study|Other reason|1|||
161006420|NCT01616459|581410780|FG003|Overall Study|Other reason|0|||
161006421|NCT04755660|581412378|FG000|Overall Study|Lost to Follow-up|1|||
161006422|NCT04755660|581412379|FG001|Overall Study|Lost to Follow-up|1|||
161006423|NCT04755660|581412380|FG002|Overall Study|Lost to Follow-up|0|||
161006424|NCT04755660|581412378|FG000|Overall Study|Withdrawal by Subject|0|||
161006425|NCT04755660|581412379|FG001|Overall Study|Withdrawal by Subject|1|||
161006426|NCT04755660|581412380|FG002|Overall Study|Withdrawal by Subject|1|||
161006427|NCT04755660|581412378|FG000|Overall Study|Physician Decision|0|||
161006428|NCT04755660|581412379|FG001|Overall Study|Physician Decision|0|||
161006429|NCT04755660|581412380|FG002|Overall Study|Physician Decision|1|||
161271518|NCT03334617|582375160|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
161271519|NCT03334617|582375161|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
161271520|NCT03334617|582375162|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
161271521|NCT03334617|582375163|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
161271522|NCT03657342|582375165|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
160966624|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
160966625|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
160966626|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
160966627|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
160966628|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
160966629|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
160966630|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
160966631|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
160966632|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
160966633|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
160966634|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
160966635|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
160966636|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
160966637|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
160966638|NCT00261495|581266748|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
160966639|NCT00261495|581266749|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
160966640|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
160966641|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
160966642|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
160966643|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
160966644|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
160966645|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
160966646|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
160966647|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
160966648|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
160966649|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
160966650|NCT00261495|581266748|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
160966651|NCT00261495|581266749|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
160966652|NCT00429663|581266750|FG000|Overall Study|Lost to Follow-up|24|||
160966653|NCT00429663|581266751|FG001|Overall Study|Lost to Follow-up|31|||
160966654|NCT00429663|581266750|FG000|Overall Study|Physician Decision|6|||
160966655|NCT00429663|581266751|FG001|Overall Study|Physician Decision|3|||
160966656|NCT00429663|581266750|FG000|Overall Study|Withdrawal by Subject|2|||
160966657|NCT00429663|581266751|FG001|Overall Study|Withdrawal by Subject|5|||
160966658|NCT00429663|581266750|FG000|Overall Study|Death|4|||
160966659|NCT00429663|581266751|FG001|Overall Study|Death|0|||
160966660|NCT04207840|581266752|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
160966661|NCT04207840|581266753|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
160966662|NCT04207840|581266754|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
160966663|NCT04207840|581266752|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
161006430|NCT04279574|581412383|FG000|Overall Study|Death|1|||
161006431|NCT04279574|581412384|FG001|Overall Study|Death|0|||
161006432|NCT04279574|581412383|FG000|Overall Study|lost restoration, tooth fracture|1|||
161006433|NCT04279574|581412384|FG001|Overall Study|lost restoration, tooth fracture|0|||
161006434|NCT04279574|581412383|FG000|Overall Study|Lost to Follow-up|0|||
161006435|NCT04279574|581412384|FG001|Overall Study|Lost to Follow-up|1|||
161006436|NCT02991807|581412386|FG000|Overall Study|Withdrawal by Subject|2|||
161006437|NCT02991807|581412387|FG001|Overall Study|Withdrawal by Subject|1|||
161006438|NCT02991807|581412386|FG000|Overall Study|Physician Decision|0|||
161006439|NCT02991807|581412387|FG001|Overall Study|Physician Decision|1|||
161006440|NCT02991807|581412386|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
161006441|NCT02991807|581412387|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
161006442|NCT02566902|581412388|FG000|Overall Study|Protocol Violation|2|||
161006443|NCT02566902|581412389|FG001|Overall Study|Protocol Violation|1|||
161006444|NCT01875848|581412390|FG000|Overall Study|Withdrawal by Subject|2|||
161006445|NCT01875848|581412391|FG001|Overall Study|Withdrawal by Subject|0|||
161006446|NCT02411084|581412392|FG000|Overall Study|Lack of Efficacy|6|||
161006447|NCT02411084|581412393|FG001|Overall Study|Lack of Efficacy|3|||
161006448|NCT02411084|581412392|FG000|Overall Study|Death|5|||
161006449|NCT02411084|581412393|FG001|Overall Study|Death|4|||
161006450|NCT02411084|581412392|FG000|Overall Study|Adverse Event|2|||
161006451|NCT02411084|581412393|FG001|Overall Study|Adverse Event|1|||
161006452|NCT02411084|581412392|FG000|Overall Study|Other reasons|0|||
161006453|NCT02411084|581412393|FG001|Overall Study|Other reasons|5|||
161006454|NCT01622868|581412394|FG000|Overall Study|Protocol Violation|7|||
161006455|NCT01622868|581412395|FG001|Overall Study|Protocol Violation|0|||
161006456|NCT03285763|581412397|FG000|Overall Study|Death|470|||
161006457|NCT03285763|581412397|FG000|Overall Study|Lost to Follow-up|18|||
161006458|NCT03285763|581412397|FG000|Overall Study|Physician Decision|2|||
161006459|NCT03285763|581412397|FG000|Overall Study|Study Terminated By Sponsor|79|||
161006460|NCT03285763|581412397|FG000|Overall Study|Withdrawal by Subject|33|||
161006461|NCT04425629|581412398|FG000|Overall Study|Adverse Event|0|||
161006462|NCT04425629|581412399|FG001|Overall Study|Adverse Event|0|||
161006463|NCT04425629|581412400|FG002|Overall Study|Adverse Event|0|||
161006464|NCT04425629|581412401|FG003|Overall Study|Adverse Event|0|||
161006465|NCT04425629|581412402|FG004|Overall Study|Adverse Event|1|||
161006466|NCT04425629|581412403|FG005|Overall Study|Adverse Event|0|||
161006467|NCT04425629|581412404|FG006|Overall Study|Adverse Event|0|||
161006468|NCT04425629|581412405|FG007|Overall Study|Adverse Event|0|||
161006469|NCT04425629|581412406|FG008|Overall Study|Adverse Event|0|||
161006470|NCT04425629|581412407|FG009|Overall Study|Adverse Event|3|||
161006471|NCT04425629|581412408|FG010|Overall Study|Adverse Event|2|||
161006472|NCT04425629|581412409|FG011|Overall Study|Adverse Event|1|||
161006473|NCT04425629|581412410|FG012|Overall Study|Adverse Event|1|||
161006474|NCT04425629|581412411|FG013|Overall Study|Adverse Event|0|||
161006475|NCT04425629|581412412|FG014|Overall Study|Adverse Event|0|||
161006476|NCT04425629|581412413|FG015|Overall Study|Adverse Event|0|||
161006477|NCT04425629|581412414|FG016|Overall Study|Adverse Event|0|||
161006478|NCT04425629|581412415|FG017|Overall Study|Adverse Event|0|||
161006479|NCT04425629|581412416|FG018|Overall Study|Adverse Event|0|||
161006480|NCT04425629|581412398|FG000|Overall Study|Lost to Follow-up|1|||
161006481|NCT04425629|581412399|FG001|Overall Study|Lost to Follow-up|3|||
161006482|NCT04425629|581412400|FG002|Overall Study|Lost to Follow-up|1|||
161006483|NCT04425629|581412401|FG003|Overall Study|Lost to Follow-up|7|||
161006484|NCT04425629|581412402|FG004|Overall Study|Lost to Follow-up|1|||
161006485|NCT04425629|581412403|FG005|Overall Study|Lost to Follow-up|2|||
161006486|NCT04425629|581412404|FG006|Overall Study|Lost to Follow-up|1|||
161006487|NCT04425629|581412405|FG007|Overall Study|Lost to Follow-up|0|||
161006488|NCT04425629|581412406|FG008|Overall Study|Lost to Follow-up|1|||
161006489|NCT04425629|581412407|FG009|Overall Study|Lost to Follow-up|64|||
161006490|NCT04425629|581412408|FG010|Overall Study|Lost to Follow-up|70|||
161006491|NCT04425629|581412409|FG011|Overall Study|Lost to Follow-up|98|||
161006492|NCT04425629|581412410|FG012|Overall Study|Lost to Follow-up|30|||
161006493|NCT04425629|581412411|FG013|Overall Study|Lost to Follow-up|0|||
161006494|NCT04425629|581412412|FG014|Overall Study|Lost to Follow-up|5|||
161006495|NCT04425629|581412413|FG015|Overall Study|Lost to Follow-up|4|||
161006496|NCT04425629|581412414|FG016|Overall Study|Lost to Follow-up|0|||
161006497|NCT04425629|581412415|FG017|Overall Study|Lost to Follow-up|3|||
161006498|NCT04425629|581412416|FG018|Overall Study|Lost to Follow-up|1|||
161006499|NCT04425629|581412398|FG000|Overall Study|Subject Decision|0|||
161006500|NCT04425629|581412399|FG001|Overall Study|Subject Decision|2|||
161006501|NCT04425629|581412400|FG002|Overall Study|Subject Decision|1|||
161006502|NCT04425629|581412401|FG003|Overall Study|Subject Decision|3|||
161006503|NCT04425629|581412402|FG004|Overall Study|Subject Decision|6|||
161006504|NCT04425629|581412403|FG005|Overall Study|Subject Decision|6|||
161006505|NCT04425629|581412404|FG006|Overall Study|Subject Decision|3|||
161006506|NCT04425629|581412405|FG007|Overall Study|Subject Decision|3|||
161006507|NCT04425629|581412406|FG008|Overall Study|Subject Decision|1|||
161006508|NCT04425629|581412407|FG009|Overall Study|Subject Decision|70|||
161006509|NCT04425629|581412408|FG010|Overall Study|Subject Decision|95|||
161006510|NCT04425629|581412409|FG011|Overall Study|Subject Decision|124|||
161006511|NCT04425629|581412410|FG012|Overall Study|Subject Decision|25|||
161006512|NCT04425629|581412411|FG013|Overall Study|Subject Decision|0|||
161006513|NCT04425629|581412412|FG014|Overall Study|Subject Decision|1|||
161006514|NCT04425629|581412413|FG015|Overall Study|Subject Decision|4|||
161006515|NCT04425629|581412414|FG016|Overall Study|Subject Decision|1|||
161006516|NCT04425629|581412415|FG017|Overall Study|Subject Decision|0|||
161006517|NCT04425629|581412416|FG018|Overall Study|Subject Decision|2|||
161006518|NCT04425629|581412398|FG000|Overall Study|Death|0|||
161006519|NCT04425629|581412399|FG001|Overall Study|Death|0|||
161006520|NCT04425629|581412400|FG002|Overall Study|Death|0|||
161006521|NCT04425629|581412401|FG003|Overall Study|Death|0|||
161006522|NCT04425629|581412402|FG004|Overall Study|Death|0|||
161006523|NCT04425629|581412403|FG005|Overall Study|Death|0|||
161006524|NCT04425629|581412404|FG006|Overall Study|Death|0|||
161006525|NCT04425629|581412405|FG007|Overall Study|Death|0|||
161006526|NCT04425629|581412406|FG008|Overall Study|Death|0|||
161006527|NCT04425629|581412407|FG009|Overall Study|Death|11|||
161006528|NCT04425629|581412408|FG010|Overall Study|Death|2|||
161006529|NCT04425629|581412409|FG011|Overall Study|Death|4|||
161006530|NCT04425629|581412410|FG012|Overall Study|Death|0|||
161006531|NCT04425629|581412411|FG013|Overall Study|Death|0|||
161006532|NCT04425629|581412412|FG014|Overall Study|Death|0|||
161006533|NCT04425629|581412413|FG015|Overall Study|Death|0|||
161006534|NCT04425629|581412414|FG016|Overall Study|Death|0|||
161006535|NCT04425629|581412415|FG017|Overall Study|Death|0|||
161006536|NCT04425629|581412416|FG018|Overall Study|Death|0|||
161006537|NCT04425629|581412398|FG000|Overall Study|Sponsor Request|0|||
161006538|NCT04425629|581412399|FG001|Overall Study|Sponsor Request|0|||
161006539|NCT04425629|581412400|FG002|Overall Study|Sponsor Request|0|||
161006540|NCT04425629|581412401|FG003|Overall Study|Sponsor Request|2|||
161006541|NCT04425629|581412402|FG004|Overall Study|Sponsor Request|2|||
161006542|NCT04425629|581412403|FG005|Overall Study|Sponsor Request|2|||
161006543|NCT04425629|581412404|FG006|Overall Study|Sponsor Request|1|||
161006544|NCT04425629|581412405|FG007|Overall Study|Sponsor Request|0|||
161006545|NCT04425629|581412406|FG008|Overall Study|Sponsor Request|0|||
161006546|NCT04425629|581412407|FG009|Overall Study|Sponsor Request|9|||
161006547|NCT04425629|581412408|FG010|Overall Study|Sponsor Request|9|||
161006548|NCT04425629|581412409|FG011|Overall Study|Sponsor Request|10|||
161006549|NCT04425629|581412410|FG012|Overall Study|Sponsor Request|8|||
161006550|NCT04425629|581412411|FG013|Overall Study|Sponsor Request|0|||
161006551|NCT04425629|581412412|FG014|Overall Study|Sponsor Request|0|||
161006552|NCT04425629|581412413|FG015|Overall Study|Sponsor Request|1|||
161006553|NCT04425629|581412414|FG016|Overall Study|Sponsor Request|0|||
161006554|NCT04425629|581412415|FG017|Overall Study|Sponsor Request|0|||
161006555|NCT04425629|581412416|FG018|Overall Study|Sponsor Request|0|||
161006556|NCT04425629|581412398|FG000|Overall Study|Physician Decision|0|||
161006557|NCT04425629|581412399|FG001|Overall Study|Physician Decision|0|||
161006558|NCT04425629|581412400|FG002|Overall Study|Physician Decision|0|||
161006559|NCT04425629|581412401|FG003|Overall Study|Physician Decision|0|||
161006560|NCT04425629|581412402|FG004|Overall Study|Physician Decision|0|||
161006561|NCT04425629|581412403|FG005|Overall Study|Physician Decision|0|||
161006562|NCT04425629|581412404|FG006|Overall Study|Physician Decision|0|||
161006563|NCT04425629|581412405|FG007|Overall Study|Physician Decision|0|||
161271523|NCT03657342|582375166|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
161271524|NCT03657342|582375165|FG000|Overall Study|Withdrawal by Subject|4|||
161271525|NCT03657342|582375166|FG001|Overall Study|Withdrawal by Subject|4|||
161271526|NCT03657342|582375165|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
161271527|NCT03657342|582375166|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
160966664|NCT04207840|581266753|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
160966665|NCT04207840|581266754|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
160966666|NCT03243422|581266755|FG000|Overall Study|Death|20|||
160966667|NCT03243422|581266756|FG001|Overall Study|Death|21|||
160966668|NCT03243422|581266755|FG000|Overall Study|Lost to Follow-up|9|||
160966669|NCT03243422|581266756|FG001|Overall Study|Lost to Follow-up|21|||
160966670|NCT03243422|581266755|FG000|Overall Study|Withdrawal by Subject|22|||
160966671|NCT03243422|581266756|FG001|Overall Study|Withdrawal by Subject|8|||
160966672|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
160966673|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
160966674|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
161006564|NCT04425629|581412406|FG008|Overall Study|Physician Decision|0|||
161006565|NCT04425629|581412407|FG009|Overall Study|Physician Decision|4|||
161006566|NCT04425629|581412408|FG010|Overall Study|Physician Decision|3|||
161006567|NCT04425629|581412409|FG011|Overall Study|Physician Decision|5|||
161006568|NCT04425629|581412410|FG012|Overall Study|Physician Decision|1|||
161006569|NCT04425629|581412411|FG013|Overall Study|Physician Decision|0|||
161006570|NCT04425629|581412412|FG014|Overall Study|Physician Decision|0|||
161006571|NCT04425629|581412413|FG015|Overall Study|Physician Decision|1|||
161006572|NCT04425629|581412414|FG016|Overall Study|Physician Decision|0|||
161006573|NCT04425629|581412415|FG017|Overall Study|Physician Decision|0|||
161006574|NCT04425629|581412416|FG018|Overall Study|Physician Decision|0|||
161006575|NCT04425629|581412398|FG000|Overall Study|Lack of Efficacy|0|||
161006576|NCT04425629|581412399|FG001|Overall Study|Lack of Efficacy|0|||
161006577|NCT04425629|581412400|FG002|Overall Study|Lack of Efficacy|0|||
161006578|NCT04425629|581412401|FG003|Overall Study|Lack of Efficacy|0|||
161006579|NCT04425629|581412402|FG004|Overall Study|Lack of Efficacy|0|||
161006580|NCT04425629|581412403|FG005|Overall Study|Lack of Efficacy|0|||
161006581|NCT04425629|581412404|FG006|Overall Study|Lack of Efficacy|0|||
161006582|NCT04425629|581412405|FG007|Overall Study|Lack of Efficacy|0|||
161006583|NCT04425629|581412406|FG008|Overall Study|Lack of Efficacy|0|||
161006584|NCT04425629|581412407|FG009|Overall Study|Lack of Efficacy|0|||
161006585|NCT04425629|581412408|FG010|Overall Study|Lack of Efficacy|1|||
161006586|NCT04425629|581412409|FG011|Overall Study|Lack of Efficacy|0|||
161006587|NCT04425629|581412410|FG012|Overall Study|Lack of Efficacy|0|||
161006588|NCT04425629|581412411|FG013|Overall Study|Lack of Efficacy|0|||
161006589|NCT04425629|581412412|FG014|Overall Study|Lack of Efficacy|0|||
161006590|NCT04425629|581412413|FG015|Overall Study|Lack of Efficacy|0|||
161006591|NCT04425629|581412414|FG016|Overall Study|Lack of Efficacy|0|||
161006592|NCT04425629|581412415|FG017|Overall Study|Lack of Efficacy|0|||
161006593|NCT04425629|581412416|FG018|Overall Study|Lack of Efficacy|0|||
161006594|NCT00610649|581412419|FG000|Overall Study|Adverse Event|1|||
161006595|NCT00610649|581412420|FG001|Overall Study|Adverse Event|0|||
161006596|NCT00610649|581412421|FG002|Overall Study|Adverse Event|0|||
161006597|NCT00610649|581412422|FG003|Overall Study|Adverse Event|0|||
161006598|NCT00610649|581412423|FG004|Overall Study|Adverse Event|0|||
161006599|NCT00610649|581412424|FG005|Overall Study|Adverse Event|0|||
161006600|NCT00610649|581412425|FG006|Overall Study|Adverse Event|0|||
161006601|NCT00610649|581412426|FG007|Overall Study|Adverse Event|0|||
161006602|NCT00610649|581412427|FG008|Overall Study|Adverse Event|0|||
161006603|NCT00610649|581412428|FG009|Overall Study|Adverse Event|0|||
161006604|NCT00610649|581412429|FG010|Overall Study|Adverse Event|1|||
161006605|NCT00610649|581412419|FG000|Overall Study|Family Emergency|0|||
161006606|NCT00610649|581412420|FG001|Overall Study|Family Emergency|1|||
161006607|NCT00610649|581412421|FG002|Overall Study|Family Emergency|0|||
161006608|NCT00610649|581412422|FG003|Overall Study|Family Emergency|0|||
161006609|NCT00610649|581412423|FG004|Overall Study|Family Emergency|0|||
161006610|NCT00610649|581412424|FG005|Overall Study|Family Emergency|0|||
161006611|NCT00610649|581412425|FG006|Overall Study|Family Emergency|0|||
161006612|NCT00610649|581412426|FG007|Overall Study|Family Emergency|0|||
161006613|NCT00610649|581412427|FG008|Overall Study|Family Emergency|0|||
161006614|NCT00610649|581412428|FG009|Overall Study|Family Emergency|0|||
161006615|NCT00610649|581412429|FG010|Overall Study|Family Emergency|0|||
161006616|NCT00610649|581412419|FG000|Overall Study|Withdrawal by Subject|0|||
161006617|NCT00610649|581412420|FG001|Overall Study|Withdrawal by Subject|0|||
161006618|NCT00610649|581412421|FG002|Overall Study|Withdrawal by Subject|0|||
161006619|NCT00610649|581412422|FG003|Overall Study|Withdrawal by Subject|0|||
161006620|NCT00610649|581412423|FG004|Overall Study|Withdrawal by Subject|0|||
161006621|NCT00610649|581412424|FG005|Overall Study|Withdrawal by Subject|0|||
161006622|NCT00610649|581412425|FG006|Overall Study|Withdrawal by Subject|0|||
161006623|NCT00610649|581412426|FG007|Overall Study|Withdrawal by Subject|0|||
161006624|NCT00610649|581412427|FG008|Overall Study|Withdrawal by Subject|0|||
161006625|NCT00610649|581412428|FG009|Overall Study|Withdrawal by Subject|1|||
161006626|NCT00610649|581412429|FG010|Overall Study|Withdrawal by Subject|0|||
161006627|NCT04259450|581412430|FG000|Overall Study|Adverse event/ Toxicity|0|||
161006628|NCT04259450|581412431|FG001|Overall Study|Adverse event/ Toxicity|3|||
161006629|NCT04259450|581412432|FG002|Overall Study|Adverse event/ Toxicity|0|||
161006630|NCT04259450|581412433|FG003|Overall Study|Adverse event/ Toxicity|1|||
161006631|NCT04259450|581412434|FG004|Overall Study|Adverse event/ Toxicity|0|||
161006632|NCT04259450|581412435|FG005|Overall Study|Adverse event/ Toxicity|0|||
161006633|NCT04259450|581412436|FG006|Overall Study|Adverse event/ Toxicity|0|||
161006634|NCT04259450|581412437|FG007|Overall Study|Adverse event/ Toxicity|1|||
161006635|NCT04259450|581412438|FG008|Overall Study|Adverse event/ Toxicity|0|||
161006636|NCT04259450|581412439|FG009|Overall Study|Adverse event/ Toxicity|3|||
161006637|NCT04259450|581412430|FG000|Overall Study|Disease progression|2|||
161006638|NCT04259450|581412431|FG001|Overall Study|Disease progression|3|||
161271528|NCT03657342|582375165|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
161271529|NCT03657342|582375166|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
161271530|NCT00827632|582375167|FG000|Overall Study|Lost to Follow-up|8|||
161271531|NCT00827632|582375168|FG001|Overall Study|Lost to Follow-up|12|||
161271532|NCT00827632|582375167|FG000|Overall Study|Early withdrawal|14|||
161006639|NCT04259450|581412432|FG002|Overall Study|Disease progression|4|||
161006640|NCT04259450|581412433|FG003|Overall Study|Disease progression|4|||
161006641|NCT04259450|581412434|FG004|Overall Study|Disease progression|6|||
161006642|NCT04259450|581412435|FG005|Overall Study|Disease progression|6|||
161006643|NCT04259450|581412436|FG006|Overall Study|Disease progression|6|||
161006644|NCT04259450|581412437|FG007|Overall Study|Disease progression|15|||
161006645|NCT04259450|581412438|FG008|Overall Study|Disease progression|6|||
161006646|NCT04259450|581412439|FG009|Overall Study|Disease progression|18|||
161006647|NCT04259450|581412430|FG000|Overall Study|Death|0|||
161006648|NCT04259450|581412431|FG001|Overall Study|Death|0|||
161006649|NCT04259450|581412432|FG002|Overall Study|Death|0|||
161006650|NCT04259450|581412433|FG003|Overall Study|Death|0|||
161006651|NCT04259450|581412434|FG004|Overall Study|Death|0|||
161006652|NCT04259450|581412435|FG005|Overall Study|Death|0|||
161006653|NCT04259450|581412436|FG006|Overall Study|Death|0|||
161006654|NCT04259450|581412437|FG007|Overall Study|Death|1|||
161006655|NCT04259450|581412438|FG008|Overall Study|Death|1|||
161006656|NCT04259450|581412439|FG009|Overall Study|Death|0|||
161006657|NCT04259450|581412430|FG000|Overall Study|Withdrawal by Subject|0|||
161006658|NCT04259450|581412431|FG001|Overall Study|Withdrawal by Subject|0|||
161006659|NCT04259450|581412432|FG002|Overall Study|Withdrawal by Subject|0|||
161006660|NCT04259450|581412433|FG003|Overall Study|Withdrawal by Subject|0|||
161006661|NCT04259450|581412434|FG004|Overall Study|Withdrawal by Subject|0|||
161006662|NCT04259450|581412435|FG005|Overall Study|Withdrawal by Subject|0|||
161006663|NCT04259450|581412436|FG006|Overall Study|Withdrawal by Subject|0|||
160966675|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
160966676|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
160966677|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
160966678|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
160966679|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
161006664|NCT04259450|581412437|FG007|Overall Study|Withdrawal by Subject|1|||
161006665|NCT04259450|581412438|FG008|Overall Study|Withdrawal by Subject|0|||
161006666|NCT04259450|581412439|FG009|Overall Study|Withdrawal by Subject|0|||
161006667|NCT04259450|581412430|FG000|Overall Study|Other than listed|0|||
161006668|NCT04259450|581412431|FG001|Overall Study|Other than listed|0|||
160966680|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
160966681|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
160966682|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
160966683|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
160966684|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160966685|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160966686|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
160966687|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
160966688|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
160966689|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160966690|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160966691|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
160966692|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Death|2|||
160966693|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Death|2|||
160966694|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Death|0|||
160966695|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Death|0|||
160966696|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Death|0|||
160966697|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
160966698|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
160966699|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
160966700|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
160966701|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
160966702|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966703|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
160966704|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966705|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966706|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
160966707|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
160966708|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
160966709|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
160966710|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
160966711|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
160966712|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
160966713|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966714|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966715|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966716|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
160966717|NCT03420781|581266759|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
160966718|NCT03420781|581266760|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
160966719|NCT03420781|581266761|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161006669|NCT04259450|581412432|FG002|Overall Study|Other than listed|0|||
161271533|NCT00827632|582375168|FG001|Overall Study|Early withdrawal|11|||
160966720|NCT03420781|581266762|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
161006670|NCT04259450|581412433|FG003|Overall Study|Other than listed|0|||
161006671|NCT04259450|581412434|FG004|Overall Study|Other than listed|0|||
161006672|NCT04259450|581412435|FG005|Overall Study|Other than listed|0|||
161006673|NCT04259450|581412436|FG006|Overall Study|Other than listed|0|||
161006674|NCT04259450|581412437|FG007|Overall Study|Other than listed|1|||
161271534|NCT00407758|582375183|FG000|Overall Study|ineligible -improper prior treatment|1|||
161271535|NCT04669691|582375196|FG000|Overall Study|Death|0|||
161006675|NCT04259450|581412438|FG008|Overall Study|Other than listed|1|||
161006676|NCT04259450|581412439|FG009|Overall Study|Other than listed|2|||
161006677|NCT00332241|581412440|FG000|Overall Study|Lack of Efficacy|6|||
161006678|NCT00332241|581412441|FG001|Overall Study|Lack of Efficacy|1|||
161006679|NCT00332241|581412440|FG000|Overall Study|Adverse Event|3|||
161006680|NCT00332241|581412441|FG001|Overall Study|Adverse Event|5|||
161006681|NCT00332241|581412440|FG000|Overall Study|Withdrawal by Subject|2|||
161006682|NCT00332241|581412441|FG001|Overall Study|Withdrawal by Subject|1|||
161006683|NCT00332241|581412440|FG000|Overall Study|Lost to Follow-up|4|||
161006684|NCT00332241|581412441|FG001|Overall Study|Lost to Follow-up|1|||
161006685|NCT00542789|581412443|FG000|Overall Study|Adverse Event|18|||
161006686|NCT00542789|581412444|FG001|Overall Study|Adverse Event|17|||
161006687|NCT00542789|581412443|FG000|Overall Study|Withdrawal by Subject|7|||
161006688|NCT00542789|581412444|FG001|Overall Study|Withdrawal by Subject|3|||
161006689|NCT00542789|581412443|FG000|Overall Study|Protocol Violation|8|||
161006690|NCT00542789|581412444|FG001|Overall Study|Protocol Violation|1|||
161006691|NCT00542789|581412443|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
161006692|NCT00542789|581412444|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
161006693|NCT02584829|581412445|FG000|Overall Study|Physician Decision|1|||
161006694|NCT02584829|581412446|FG001|Overall Study|Physician Decision|0|||
161006695|NCT02584829|581412445|FG000|Overall Study|Withdrawal by Subject|0|||
161006696|NCT02584829|581412446|FG001|Overall Study|Withdrawal by Subject|1|||
161006697|NCT02584829|581412445|FG000|Overall Study|Progressive Disease|0|||
161006698|NCT02584829|581412446|FG001|Overall Study|Progressive Disease|3|||
161006699|NCT02765100|581412452|FG000|Overall Study|subject found ineligible after baseline|1|||
161006700|NCT02765100|581412453|FG001|Overall Study|subject found ineligible after baseline|1|||
161006701|NCT02765100|581412452|FG000|Overall Study|Lost to Follow-up|0|||
161006702|NCT02765100|581412453|FG001|Overall Study|Lost to Follow-up|1|||
161006703|NCT00244855|581412459|FG000|Overall Study|Withdrawal by Subject|0|||
161006704|NCT00244855|581412460|FG001|Overall Study|Withdrawal by Subject|1|||
161006705|NCT00106080|581412461|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
161006706|NCT00106080|581412462|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
161006707|NCT01236001|581412463|FG000|Overall Study|Adverse Event|5|||
161006708|NCT01236001|581412464|FG001|Overall Study|Adverse Event|14|||
161006709|NCT01236001|581412463|FG000|Overall Study|Lack of Efficacy|6|||
161006710|NCT01236001|581412464|FG001|Overall Study|Lack of Efficacy|6|||
161006711|NCT01236001|581412463|FG000|Overall Study|Lost to Follow-up|6|||
161006712|NCT01236001|581412464|FG001|Overall Study|Lost to Follow-up|1|||
161006713|NCT01236001|581412463|FG000|Overall Study|Incompliance|1|||
161006714|NCT01236001|581412464|FG001|Overall Study|Incompliance|0|||
161006715|NCT01236001|581412463|FG000|Overall Study|Planned Visit After End of Study|0|||
161006716|NCT01236001|581412464|FG001|Overall Study|Planned Visit After End of Study|1|||
161006717|NCT01839331|581412465|FG000|Overall Study|Early Termination|3|||
161006718|NCT01839331|581412466|FG001|Overall Study|Early Termination|0|||
161006719|NCT01839331|581412467|FG002|Overall Study|Early Termination|1|||
161006720|NCT01839331|581412468|FG003|Overall Study|Early Termination|2|||
161006721|NCT01839331|581412465|FG000|Overall Study|Protocol Violation|1|||
161006722|NCT01839331|581412466|FG001|Overall Study|Protocol Violation|6|||
161006723|NCT01839331|581412467|FG002|Overall Study|Protocol Violation|4|||
161006724|NCT01839331|581412468|FG003|Overall Study|Protocol Violation|3|||
161006725|NCT00761605|581412469|FG000|Overall Study|Adverse Event|26|||
161006726|NCT00761605|581412469|FG000|Overall Study|Death|2|||
161006727|NCT00761605|581412469|FG000|Overall Study|Lack of Efficacy|26|||
161006728|NCT00761605|581412469|FG000|Overall Study|Lost to Follow-up|29|||
161006729|NCT00761605|581412469|FG000|Overall Study|Withdrawal by Subject|37|||
161006730|NCT00761605|581412469|FG000|Overall Study|Other|21|||
161006731|NCT03074331|581412470|FG000|Overall Study|Enrolled but Not Treated|1|||
161006732|NCT03074331|581412470|FG000|Overall Study|Lost to Follow-up|5|||
161006733|NCT03074331|581412470|FG000|Overall Study|Withdrew Consent|1|||
161006734|NCT03451721|581412471|FG000|Overall Study|Death|1|||
161006735|NCT03283371|581412474|FG000|Placebo-controlled|Adverse Event|1|||
161006736|NCT03283371|581412475|FG001|Placebo-controlled|Adverse Event|1|||
161006737|NCT03283371|581412476|FG002|Placebo-controlled|Adverse Event|0|||
161006738|NCT03283371|581412477|FG003|Placebo-controlled|Adverse Event|0|||
161006739|NCT03283371|581412474|FG000|Placebo-controlled|Lack of Efficacy|1|||
161006740|NCT03283371|581412475|FG001|Placebo-controlled|Lack of Efficacy|0|||
161006741|NCT03283371|581412476|FG002|Placebo-controlled|Lack of Efficacy|0|||
161006742|NCT03283371|581412477|FG003|Placebo-controlled|Lack of Efficacy|0|||
161006743|NCT03283371|581412474|FG000|Placebo-controlled|Withdrawal by Subject|1|||
161006744|NCT03283371|581412475|FG001|Placebo-controlled|Withdrawal by Subject|1|||
161006745|NCT03283371|581412476|FG002|Placebo-controlled|Withdrawal by Subject|0|||
161006746|NCT03283371|581412477|FG003|Placebo-controlled|Withdrawal by Subject|0|||
161006747|NCT03283371|581412474|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161006748|NCT03283371|581412475|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
161006749|NCT03283371|581412476|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161006750|NCT03283371|581412477|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
161006751|NCT03283371|581412474|FG000|Open-label Phase|Adverse Event|0|||
161006752|NCT03283371|581412475|FG001|Open-label Phase|Adverse Event|0|||
161006753|NCT03283371|581412476|FG002|Open-label Phase|Adverse Event|2|||
161006754|NCT03283371|581412477|FG003|Open-label Phase|Adverse Event|0|||
161006755|NCT03283371|581412474|FG000|Open-label Phase|Withdrawal by Subject|0|||
161006756|NCT03283371|581412475|FG001|Open-label Phase|Withdrawal by Subject|0|||
161006757|NCT03283371|581412476|FG002|Open-label Phase|Withdrawal by Subject|1|||
161006758|NCT03283371|581412477|FG003|Open-label Phase|Withdrawal by Subject|0|||
161006759|NCT03283371|581412474|FG000|Open-label Phase|Other|0|||
161006760|NCT03283371|581412475|FG001|Open-label Phase|Other|0|||
161006761|NCT03283371|581412476|FG002|Open-label Phase|Other|1|||
161006762|NCT03283371|581412477|FG003|Open-label Phase|Other|1|||
161006763|NCT01290341|581412478|FG000|Overall Study|Protocol Violation|7|||
161006764|NCT01290341|581412479|FG001|Overall Study|Protocol Violation|3|||
161006765|NCT01290341|581412478|FG000|Overall Study|Adverse Event|1|||
161006766|NCT01290341|581412479|FG001|Overall Study|Adverse Event|0|||
161006767|NCT01290341|581412478|FG000|Overall Study|Lost to Follow-up|21|||
161006768|NCT01290341|581412479|FG001|Overall Study|Lost to Follow-up|10|||
161006769|NCT01290341|581412478|FG000|Overall Study|Withdrawal by Subject|19|||
161006770|NCT01290341|581412479|FG001|Overall Study|Withdrawal by Subject|5|||
161006771|NCT01290341|581412478|FG000|Overall Study|Negative baseline culture and others|44|||
161006772|NCT01290341|581412479|FG001|Overall Study|Negative baseline culture and others|11|||
161006773|NCT01943799|581412481|FG000|Overall Study|Lost to Follow-up|0|||
161006774|NCT01943799|581412482|FG001|Overall Study|Lost to Follow-up|1|||
161006775|NCT01943799|581412483|FG002|Overall Study|Lost to Follow-up|1|||
161006776|NCT01943799|581412484|FG003|Overall Study|Lost to Follow-up|0|||
161006777|NCT01943799|581412481|FG000|Overall Study|Protocol Violation|1|||
161006778|NCT01943799|581412482|FG001|Overall Study|Protocol Violation|0|||
161006779|NCT01943799|581412483|FG002|Overall Study|Protocol Violation|0|||
161006780|NCT01943799|581412484|FG003|Overall Study|Protocol Violation|0|||
161006781|NCT01943799|581412481|FG000|Overall Study|Withdrawal by Subject|4|||
161006782|NCT01943799|581412482|FG001|Overall Study|Withdrawal by Subject|2|||
161006783|NCT01943799|581412483|FG002|Overall Study|Withdrawal by Subject|1|||
161006784|NCT01943799|581412484|FG003|Overall Study|Withdrawal by Subject|0|||
161006785|NCT04594759|581412485|FG000|Overall Study|Lost to Follow-up|3|||
161006786|NCT04556981|581412489|FG000|Overall Study|Death|0|||
161006787|NCT04556981|581412490|FG001|Overall Study|Death|1|||
161006788|NCT04556981|581412489|FG000|Overall Study|Lost to Follow-up|2|||
161006789|NCT04556981|581412490|FG001|Overall Study|Lost to Follow-up|11|||
161006790|NCT04556981|581412489|FG000|Overall Study|Moved from the study area|1|||
161006791|NCT04556981|581412490|FG001|Overall Study|Moved from the study area|4|||
161006792|NCT04556981|581412489|FG000|Overall Study|Withdrawal by Subject|2|||
161006793|NCT04556981|581412490|FG001|Overall Study|Withdrawal by Subject|2|||
161006794|NCT04556981|581412489|FG000|Overall Study|Other|2|||
161006795|NCT04556981|581412490|FG001|Overall Study|Other|1|||
161006796|NCT03764475|581412491|FG000|Overall Study|Adverse Event|11|||
161006797|NCT03764475|581412492|FG001|Overall Study|Adverse Event|2|||
161006798|NCT03764475|581412491|FG000|Overall Study|Lost to Follow-up|24|||
161006799|NCT03764475|581412492|FG001|Overall Study|Lost to Follow-up|10|||
161006800|NCT03764475|581412491|FG000|Overall Study|Withdrawal by Subject|26|||
161006801|NCT03764475|581412492|FG001|Overall Study|Withdrawal by Subject|10|||
161006802|NCT03764475|581412491|FG000|Overall Study|Lack of Efficacy|3|||
161006803|NCT03764475|581412492|FG001|Overall Study|Lack of Efficacy|0|||
161006804|NCT03764475|581412491|FG000|Overall Study|COVID-19 Disruption|2|||
161006805|NCT03764475|581412492|FG001|Overall Study|COVID-19 Disruption|0|||
161006806|NCT00580866|581412493|FG000|Overall Study|Lost to Follow-up|2|||
161006807|NCT00580866|581412494|FG001|Overall Study|Lost to Follow-up|2|||
161006808|NCT02574455|581412498|FG000|Overall Study|Death|197|||
161006809|NCT02574455|581412499|FG001|Overall Study|Death|210|||
161006810|NCT02574455|581412498|FG000|Overall Study|Withdrawal of Consent|11|||
161147297|NCT01097616|581922453|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
161147298|NCT01097616|581922454|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
161147299|NCT01097616|581922455|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
161147300|NCT01097616|581922448|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
161147301|NCT01097616|581922449|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
161147302|NCT01097616|581922450|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
161147303|NCT01097616|581922451|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
161147304|NCT01097616|581922452|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
161147305|NCT01097616|581922453|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
161147306|NCT01097616|581922454|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
161006811|NCT02574455|581412499|FG001|Overall Study|Withdrawal of Consent|28|||
161006812|NCT02574455|581412498|FG000|Overall Study|Lost to Follow-up|4|||
161006813|NCT02574455|581412499|FG001|Overall Study|Lost to Follow-up|4|||
161006814|NCT02574455|581412498|FG000|Overall Study|Sponsor's Decision|55|||
161006815|NCT02574455|581412499|FG001|Overall Study|Sponsor's Decision|20|||
161006816|NCT03144674|581412508|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
161006817|NCT03144674|581412509|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
161006818|NCT03144674|581412510|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
161006819|NCT03144674|581412511|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
161006820|NCT03144674|581412508|FG000|Overall Study|Death|3|||
161006821|NCT03144674|581412509|FG001|Overall Study|Death|2|||
161006822|NCT03144674|581412510|FG002|Overall Study|Death|6|||
161006823|NCT03144674|581412511|FG003|Overall Study|Death|24|||
161006824|NCT03144674|581412508|FG000|Overall Study|Lost to Follow-up|0|||
161006825|NCT03144674|581412509|FG001|Overall Study|Lost to Follow-up|1|||
161006826|NCT03144674|581412510|FG002|Overall Study|Lost to Follow-up|0|||
161006827|NCT03144674|581412511|FG003|Overall Study|Lost to Follow-up|4|||
161006828|NCT03144674|581412508|FG000|Overall Study|Withdrawal by Participant|0|||
161006829|NCT03144674|581412509|FG001|Overall Study|Withdrawal by Participant|0|||
161006830|NCT03144674|581412510|FG002|Overall Study|Withdrawal by Participant|2|||
161006831|NCT03144674|581412511|FG003|Overall Study|Withdrawal by Participant|6|||
161006832|NCT03144674|581412508|FG000|Overall Study|Discharged from the Trust|0|||
161006833|NCT03144674|581412509|FG001|Overall Study|Discharged from the Trust|0|||
161006834|NCT03144674|581412510|FG002|Overall Study|Discharged from the Trust|1|||
161006835|NCT03144674|581412511|FG003|Overall Study|Discharged from the Trust|0|||
161006836|NCT03144674|581412508|FG000|Overall Study|Exclusion Criteria Met|0|||
161006837|NCT03144674|581412509|FG001|Overall Study|Exclusion Criteria Met|0|||
161006838|NCT03144674|581412510|FG002|Overall Study|Exclusion Criteria Met|1|||
161006839|NCT03144674|581412511|FG003|Overall Study|Exclusion Criteria Met|0|||
161006840|NCT03144674|581412508|FG000|Overall Study|Changed Physicians|0|||
161006841|NCT03144674|581412509|FG001|Overall Study|Changed Physicians|0|||
161006842|NCT03144674|581412510|FG002|Overall Study|Changed Physicians|0|||
161006843|NCT03144674|581412511|FG003|Overall Study|Changed Physicians|1|||
161006844|NCT03144674|581412508|FG000|Overall Study|Removed for Safety|0|||
161006845|NCT03144674|581412509|FG001|Overall Study|Removed for Safety|0|||
161006846|NCT03144674|581412510|FG002|Overall Study|Removed for Safety|0|||
161006847|NCT03144674|581412511|FG003|Overall Study|Removed for Safety|1|||
161006848|NCT03144674|581412508|FG000|Overall Study|Site Closed|0|||
161006849|NCT03144674|581412509|FG001|Overall Study|Site Closed|0|||
161006850|NCT03144674|581412510|FG002|Overall Study|Site Closed|0|||
161006851|NCT03144674|581412511|FG003|Overall Study|Site Closed|1|||
161006852|NCT03144674|581412508|FG000|Overall Study|Histological Criteria Not Met|0|||
161006853|NCT03144674|581412509|FG001|Overall Study|Histological Criteria Not Met|0|||
161006854|NCT03144674|581412510|FG002|Overall Study|Histological Criteria Not Met|0|||
161006855|NCT03144674|581412511|FG003|Overall Study|Histological Criteria Not Met|1|||
161006856|NCT03144674|581412508|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
161006857|NCT03144674|581412509|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
161006858|NCT03144674|581412510|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
161006859|NCT03144674|581412511|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
160966721|NCT03420781|581266763|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
160966722|NCT03420781|581266759|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966723|NCT03420781|581266760|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966724|NCT03420781|581266761|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966725|NCT03420781|581266762|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
160966726|NCT03420781|581266763|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
160966727|NCT03420781|581266759|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966728|NCT03420781|581266760|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966729|NCT03420781|581266761|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966730|NCT03420781|581266762|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
160966731|NCT03420781|581266763|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
160966732|NCT03420781|581266759|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
160966733|NCT03420781|581266760|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
160966734|NCT03420781|581266761|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
160966735|NCT03420781|581266762|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
160966736|NCT03420781|581266763|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
160966737|NCT01330316|581266764|FG000|Overall Study|Adverse Event|2|||
160966738|NCT01330316|581266765|FG001|Overall Study|Adverse Event|2|||
160966739|NCT01330316|581266764|FG000|Overall Study|Lack of Efficacy|0|||
160966740|NCT01330316|581266765|FG001|Overall Study|Lack of Efficacy|10|||
160966741|NCT01330316|581266764|FG000|Overall Study|Lost to Follow-up|0|||
160966742|NCT01330316|581266765|FG001|Overall Study|Lost to Follow-up|1|||
160966743|NCT01330316|581266764|FG000|Overall Study|Withdrawal by Subject|0|||
160966744|NCT01330316|581266765|FG001|Overall Study|Withdrawal by Subject|1|||
160966745|NCT01330316|581266764|FG000|Overall Study|other than above|0|||
160966746|NCT01330316|581266765|FG001|Overall Study|other than above|1|||
160966747|NCT00246337|581266768|FG000|Overall Study|Lost to Follow-up|3|||
160966748|NCT00246337|581266769|FG001|Overall Study|Lost to Follow-up|0|||
160966749|NCT00246337|581266770|FG002|Overall Study|Lost to Follow-up|0|||
161006860|NCT03144674|581412508|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161006861|NCT03144674|581412509|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161006862|NCT03144674|581412510|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
161006863|NCT03144674|581412511|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
161006864|NCT05510245|581412512|FG000|Overall Study|Withdrawal by Subject|1|||
161006865|NCT05510245|581412513|FG001|Overall Study|Withdrawal by Subject|0|||
161006866|NCT05510245|581412514|FG002|Overall Study|Withdrawal by Subject|0|||
161006867|NCT01373346|581412515|FG000|Overall Study|Death|1|||
161006868|NCT01198028|581412516|FG000|Overall Study|Adverse Event|5|||
161006869|NCT01198028|581412516|FG000|Overall Study|Death|3|||
161006870|NCT01198028|581412516|FG000|Overall Study|Physician Decision|2|||
161006871|NCT01395758|581412518|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
161006872|NCT01395758|581412519|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161006873|NCT01395758|581412520|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161006874|NCT01565148|581412521|FG000|Overall Study|Withdrawal by Subject|1|||
161006875|NCT01565148|581412522|FG001|Overall Study|Withdrawal by Subject|1|||
161006876|NCT01565148|581412523|FG002|Overall Study|Withdrawal by Subject|1|||
161006877|NCT01565148|581412524|FG003|Overall Study|Withdrawal by Subject|2|||
161006878|NCT01565148|581412521|FG000|Overall Study|Lost to Follow-up|4|||
161006879|NCT01565148|581412522|FG001|Overall Study|Lost to Follow-up|4|||
161006880|NCT01565148|581412523|FG002|Overall Study|Lost to Follow-up|0|||
161006881|NCT01565148|581412524|FG003|Overall Study|Lost to Follow-up|3|||
161006882|NCT01565148|581412521|FG000|Overall Study|Rescue Therapy|8|||
161006883|NCT01565148|581412522|FG001|Overall Study|Rescue Therapy|5|||
161006884|NCT01565148|581412523|FG002|Overall Study|Rescue Therapy|5|||
161006885|NCT01565148|581412524|FG003|Overall Study|Rescue Therapy|8|||
161006886|NCT01565148|581412521|FG000|Overall Study|Death|0|||
161006887|NCT01565148|581412522|FG001|Overall Study|Death|0|||
161006888|NCT01565148|581412523|FG002|Overall Study|Death|1|||
161006889|NCT01565148|581412524|FG003|Overall Study|Death|0|||
161006890|NCT01565148|581412521|FG000|Overall Study|Physician Decision|2|||
161006891|NCT01565148|581412522|FG001|Overall Study|Physician Decision|5|||
161006892|NCT01565148|581412523|FG002|Overall Study|Physician Decision|0|||
161006893|NCT01565148|581412524|FG003|Overall Study|Physician Decision|0|||
161006894|NCT01759771|581412525|FG000|Overall Study|Withdrawal by Subject|1|||
161006895|NCT01759771|581412526|FG001|Overall Study|Withdrawal by Subject|1|||
161006896|NCT00529659|581412529|FG000|Overall Study|Adverse Event|8|||
161006897|NCT00529659|581412530|FG001|Overall Study|Adverse Event|7|||
161006898|NCT00529659|581412529|FG000|Overall Study|Lost to Follow-up|0|||
161006899|NCT00529659|581412530|FG001|Overall Study|Lost to Follow-up|2|||
161006900|NCT00529659|581412529|FG000|Overall Study|Physician Decision|0|||
161006901|NCT00529659|581412530|FG001|Overall Study|Physician Decision|2|||
161006902|NCT00529659|581412529|FG000|Overall Study|Protocol Violation|2|||
161006903|NCT00529659|581412530|FG001|Overall Study|Protocol Violation|6|||
161006904|NCT00529659|581412529|FG000|Overall Study|Withdrawal by Subject|1|||
161006905|NCT00529659|581412530|FG001|Overall Study|Withdrawal by Subject|6|||
161006906|NCT01692730|581412533|FG000|Overall Study|Lost to Follow-up|225|||
161006907|NCT01692730|581412534|FG001|Overall Study|Lost to Follow-up|227|||
161006908|NCT01415349|581412535|FG000|Treatment Period 1|Adverse Event|0|||
161006909|NCT01415349|581412536|FG001|Treatment Period 1|Adverse Event|1|||
161006910|NCT01415349|581412535|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161006911|NCT01415349|581412536|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161006912|NCT02139943|581412537|FG000|Overall Study|Adverse Event|0|||
161006913|NCT02139943|581412538|FG001|Overall Study|Adverse Event|1|||
161006914|NCT02139943|581412539|FG002|Overall Study|Adverse Event|2|||
161006915|NCT02139943|581412537|FG000|Overall Study|Lost to Follow-up|3|||
161006916|NCT02139943|581412538|FG001|Overall Study|Lost to Follow-up|2|||
161006917|NCT02139943|581412539|FG002|Overall Study|Lost to Follow-up|2|||
161006918|NCT02139943|581412537|FG000|Overall Study|Withdrawal by Subject|4|||
161006919|NCT02139943|581412538|FG001|Overall Study|Withdrawal by Subject|3|||
161006920|NCT02139943|581412539|FG002|Overall Study|Withdrawal by Subject|0|||
161006921|NCT02139943|581412537|FG000|Overall Study|Other|0|||
161006922|NCT02139943|581412538|FG001|Overall Study|Other|0|||
161006923|NCT02139943|581412539|FG002|Overall Study|Other|1|||
161006924|NCT02139943|581412537|FG000|Overall Study|Participant wishes to discontinue|2|||
161006925|NCT02139943|581412538|FG001|Overall Study|Participant wishes to discontinue|0|||
161006926|NCT02139943|581412539|FG002|Overall Study|Participant wishes to discontinue|0|||
161006927|NCT02139943|581412537|FG000|Overall Study|Participant in Poor Compliance|1|||
161006928|NCT02139943|581412538|FG001|Overall Study|Participant in Poor Compliance|0|||
161006929|NCT02139943|581412539|FG002|Overall Study|Participant in Poor Compliance|1|||
161006930|NCT02139943|581412537|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
161006931|NCT02139943|581412538|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
161006932|NCT02139943|581412539|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
161006933|NCT01041417|581412540|FG000|Overall Study|Adverse Event|5|||
161006934|NCT01041417|581412541|FG001|Overall Study|Adverse Event|2|||
161006935|NCT01041417|581412540|FG000|Overall Study|Lost to Follow-up|1|||
161006936|NCT01041417|581412541|FG001|Overall Study|Lost to Follow-up|1|||
161006937|NCT01041417|581412540|FG000|Overall Study|Death|1|||
161006938|NCT01041417|581412541|FG001|Overall Study|Death|0|||
161006939|NCT02918071|581412547|FG000|Overall Study|Withdrawal by Subject|2|||
161006940|NCT02918071|581412547|FG000|Overall Study|Lost to Follow-up|1|||
161091126|NCT02581631|581723820|FG002|Overall Study|AE unrelated to study drug|1|||
161091127|NCT02581631|581723821|FG003|Overall Study|AE unrelated to study drug|0|||
161091128|NCT02581631|581723822|FG004|Overall Study|AE unrelated to study drug|2|||
161091129|NCT02581631|581723818|FG000|Overall Study|Request to discontinue|1|||
161091130|NCT02581631|581723819|FG001|Overall Study|Request to discontinue|0|||
161091131|NCT02581631|581723820|FG002|Overall Study|Request to discontinue|3|||
161006941|NCT03960463|581414277|FG000|Overall Study|Withdrawal by Subject|2|||
161006942|NCT03960463|581414278|FG001|Overall Study|Withdrawal by Subject|0|||
161006943|NCT03422276|581414279|FG000|Overall Study|Withdrawal by Subject|21|||
161006944|NCT03422276|581414280|FG001|Overall Study|Withdrawal by Subject|25|||
161006945|NCT03422276|581414281|FG002|Overall Study|Withdrawal by Subject|14|||
161006946|NCT03422276|581414282|FG003|Overall Study|Withdrawal by Subject|16|||
161006947|NCT03422276|581414279|FG000|Overall Study|Death|14|||
161006948|NCT03422276|581414280|FG001|Overall Study|Death|21|||
161006949|NCT03422276|581414281|FG002|Overall Study|Death|3|||
161006950|NCT03422276|581414282|FG003|Overall Study|Death|1|||
161006951|NCT03422276|581414279|FG000|Overall Study|Discontinued, ineligible|4|||
161006952|NCT03422276|581414280|FG001|Overall Study|Discontinued, ineligible|3|||
161006953|NCT03422276|581414281|FG002|Overall Study|Discontinued, ineligible|0|||
161006954|NCT03422276|581414282|FG003|Overall Study|Discontinued, ineligible|0|||
161006955|NCT03422276|581414279|FG000|Overall Study|Lost to Follow-up|15|||
161006956|NCT03422276|581414280|FG001|Overall Study|Lost to Follow-up|8|||
161006957|NCT03422276|581414281|FG002|Overall Study|Lost to Follow-up|13|||
161006958|NCT03422276|581414282|FG003|Overall Study|Lost to Follow-up|4|||
161006959|NCT03422276|581414279|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
161006960|NCT03422276|581414280|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
161006961|NCT03422276|581414281|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
161006962|NCT03422276|581414282|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
161006963|NCT03422276|581414279|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
161006964|NCT03422276|581414280|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
161006965|NCT03422276|581414281|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
161006966|NCT03422276|581414282|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
161006967|NCT03422276|581414279|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
161006968|NCT03422276|581414280|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
161006969|NCT03422276|581414281|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
161006970|NCT03422276|581414282|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
161006971|NCT03422276|581414279|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
161006972|NCT03422276|581414280|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
161006973|NCT03422276|581414281|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
161006974|NCT03422276|581414282|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
161006975|NCT03422276|581414279|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161006976|NCT03422276|581414280|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161006977|NCT03422276|581414281|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
161006978|NCT03422276|581414282|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
161006979|NCT05194917|581414283|FG000|Overall Study|Lost to Follow-up|7|||
161006980|NCT05194917|581414284|FG001|Overall Study|Lost to Follow-up|5|||
161006981|NCT05194917|581414285|FG002|Overall Study|Lost to Follow-up|6|||
161006982|NCT05194917|581414286|FG003|Overall Study|Lost to Follow-up|5|||
161006983|NCT04922021|581414287|FG000|Overall Study|Withdrawal by Subject|4|||
161006984|NCT04922021|581414288|FG001|Overall Study|Withdrawal by Subject|10|||
161006985|NCT04922021|581414287|FG000|Overall Study|Adverse Event|2|||
161006986|NCT04922021|581414288|FG001|Overall Study|Adverse Event|2|||
161006987|NCT04922021|581414287|FG000|Overall Study|Lack of Efficacy|0|||
161006988|NCT04922021|581414288|FG001|Overall Study|Lack of Efficacy|1|||
161006989|NCT04922021|581414287|FG000|Overall Study|Multiple reasons|1|||
161006990|NCT04922021|581414288|FG001|Overall Study|Multiple reasons|0|||
161006991|NCT04941287|581414298|FG000|Overall Study|Rapid decline before starting treatment|3|||
161006992|NCT04941287|581414299|FG001|Overall Study|Rapid decline before starting treatment|1|||
161006993|NCT01998984|581414304|FG000|Overall Study|Adverse Event|0|||
161006994|NCT01998984|581414305|FG001|Overall Study|Adverse Event|0|||
161006995|NCT01998984|581414306|FG002|Overall Study|Adverse Event|0|||
161006996|NCT01998984|581414307|FG003|Overall Study|Adverse Event|1|||
161006997|NCT01998984|581414304|FG000|Overall Study|Lost to Follow-up|0|||
161006998|NCT01998984|581414305|FG001|Overall Study|Lost to Follow-up|1|||
161006999|NCT01998984|581414306|FG002|Overall Study|Lost to Follow-up|0|||
161147307|NCT01097616|581922455|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
161147308|NCT01097616|581922448|FG000|Optional DB EXT Phase|Physician Decision|1|||
161147309|NCT01097616|581922449|FG001|Optional DB EXT Phase|Physician Decision|0|||
161147310|NCT01097616|581922450|FG002|Optional DB EXT Phase|Physician Decision|0|||
161147311|NCT01097616|581922451|FG003|Optional DB EXT Phase|Physician Decision|0|||
161147312|NCT01097616|581922452|FG004|Optional DB EXT Phase|Physician Decision|0|||
161007000|NCT01998984|581414307|FG003|Overall Study|Lost to Follow-up|1|||
161007001|NCT01998984|581414304|FG000|Overall Study|Withdrawal by Subject|0|||
161007002|NCT01998984|581414305|FG001|Overall Study|Withdrawal by Subject|0|||
161007003|NCT01998984|581414306|FG002|Overall Study|Withdrawal by Subject|1|||
161007004|NCT01998984|581414307|FG003|Overall Study|Withdrawal by Subject|0|||
161147313|NCT01097616|581922453|FG005|Optional DB EXT Phase|Physician Decision|0|||
161007005|NCT01998984|581414304|FG000|Overall Study|Other|0|||
161007006|NCT01998984|581414305|FG001|Overall Study|Other|0|||
161007007|NCT01998984|581414306|FG002|Overall Study|Other|0|||
161007008|NCT01998984|581414307|FG003|Overall Study|Other|1|||
161007009|NCT04300647|581414308|FG000|Pre-Crossover|Death|19|||
161007010|NCT04300647|581414309|FG001|Pre-Crossover|Death|58|||
161007011|NCT04300647|581414310|FG002|Pre-Crossover|Death|0|||
161007012|NCT04300647|581414308|FG000|Pre-Crossover|Lost to Follow-up|0|||
161007013|NCT04300647|581414309|FG001|Pre-Crossover|Lost to Follow-up|3|||
161007014|NCT04300647|581414310|FG002|Pre-Crossover|Lost to Follow-up|0|||
161007015|NCT04300647|581414308|FG000|Pre-Crossover|Withdrawal by Subject|2|||
161007016|NCT04300647|581414309|FG001|Pre-Crossover|Withdrawal by Subject|4|||
161007017|NCT04300647|581414310|FG002|Pre-Crossover|Withdrawal by Subject|0|||
161007018|NCT04300647|581414308|FG000|Pre-Crossover|On-going in Study|24|||
161007019|NCT04300647|581414309|FG001|Pre-Crossover|On-going in Study|61|||
161007020|NCT04300647|581414310|FG002|Pre-Crossover|On-going in Study|0|||
161007021|NCT04300647|581414308|FG000|Post-Crossover|Death|0|||
161007022|NCT04300647|581414309|FG001|Post-Crossover|Death|0|||
161007023|NCT04300647|581414310|FG002|Post-Crossover|Death|3|||
161007024|NCT04300647|581414308|FG000|Post-Crossover|Lost to Follow-up|0|||
161007025|NCT04300647|581414309|FG001|Post-Crossover|Lost to Follow-up|0|||
161007026|NCT04300647|581414310|FG002|Post-Crossover|Lost to Follow-up|1|||
161007027|NCT04300647|581414308|FG000|Post-Crossover|Withdrawal by Subject|0|||
161007028|NCT04300647|581414309|FG001|Post-Crossover|Withdrawal by Subject|0|||
161007029|NCT04300647|581414310|FG002|Post-Crossover|Withdrawal by Subject|1|||
161007030|NCT04300647|581414308|FG000|Post-Crossover|On-going in Study|0|||
161007031|NCT04300647|581414309|FG001|Post-Crossover|On-going in Study|0|||
161007032|NCT04300647|581414310|FG002|Post-Crossover|On-going in Study|8|||
161007033|NCT05386238|581414311|FG000|Overall Study|Lost to Follow-up|3|||
161007034|NCT05386238|581414312|FG001|Overall Study|Lost to Follow-up|2|||
161007035|NCT05386238|581414311|FG000|Overall Study|Withdrawal by Subject|0|||
161007036|NCT05386238|581414312|FG001|Overall Study|Withdrawal by Subject|1|||
161007037|NCT04907474|581414313|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
161007038|NCT04907474|581414314|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
161007039|NCT01353313|581414317|FG000|Overall Study|Lost to Follow-up|22|||
161007040|NCT01353313|581414318|FG001|Overall Study|Lost to Follow-up|23|||
161007041|NCT01353313|581414317|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
161007042|NCT01353313|581414318|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
161007043|NCT02647905|581414332|FG000|Overall Study|Lost to Follow-up|1|||
161007044|NCT02647905|581414332|FG000|Overall Study|Withdrawal by Subject|2|||
161007045|NCT05119855|581414333|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
161007046|NCT05119855|581414334|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
161007047|NCT05119855|581414333|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
161007048|NCT05119855|581414334|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
161007049|NCT05119855|581414333|FG000|Overall Study|Lost to Follow-up|6|||
161007050|NCT05119855|581414334|FG001|Overall Study|Lost to Follow-up|8|||
161007051|NCT00642850|581414339|FG000|Overall Study|Death|7|||
161007052|NCT00642850|581414339|FG000|Overall Study|Adverse Event|2|||
161007053|NCT00642850|581414339|FG000|Overall Study|Lack of Efficacy|1|||
161007054|NCT00642850|581414339|FG000|Overall Study|Protocol Violation|2|||
161007055|NCT00642850|581414339|FG000|Overall Study|Kidney transplantation|8|||
161007056|NCT00642850|581414339|FG000|Overall Study|Blood transfusion|6|||
161007057|NCT00642850|581414339|FG000|Overall Study|Other reasons|7|||
161007058|NCT00391898|581414340|FG000|Overall Study|Adverse Event|3|||
161007059|NCT00391898|581414341|FG001|Overall Study|Adverse Event|0|||
161007060|NCT00391898|581414340|FG000|Overall Study|Other|8|||
161007061|NCT00391898|581414341|FG001|Overall Study|Other|10|||
161007062|NCT05489484|581414342|FG000|Overall Study|withdrawn|1|||
161147314|NCT01097616|581922454|FG006|Optional DB EXT Phase|Physician Decision|0|||
161271536|NCT04669691|582375197|FG001|Overall Study|Death|1|||
161271537|NCT04669691|582375198|FG002|Overall Study|Death|0|||
161271538|NCT04669691|582375199|FG003|Overall Study|Death|0|||
161271539|NCT04669691|582375200|FG004|Overall Study|Death|0|||
161007063|NCT00444600|581414345|FG000|Overall Study|Death|7|||
161007064|NCT00444600|581414346|FG001|Overall Study|Death|5|||
161007065|NCT00444600|581414347|FG002|Overall Study|Death|3|||
161007066|NCT00444600|581414348|FG003|Overall Study|Death|2|||
161007067|NCT00444600|581414345|FG000|Overall Study|Dropped|11|||
161007068|NCT00444600|581414346|FG001|Overall Study|Dropped|11|||
161007069|NCT00444600|581414347|FG002|Overall Study|Dropped|7|||
161007070|NCT00444600|581414348|FG003|Overall Study|Dropped|7|||
161007071|NCT00444600|581414345|FG000|Overall Study|Missed visit|1|||
161007072|NCT00444600|581414346|FG001|Overall Study|Missed visit|0|||
161007073|NCT00444600|581414347|FG002|Overall Study|Missed visit|0|||
161007074|NCT00444600|581414348|FG003|Overall Study|Missed visit|1|||
161271540|NCT04669691|582375201|FG005|Overall Study|Death|0|||
161007075|NCT02988817|581414349|FG000|Overall Study|Withdrawal by Subject|1|||
161007076|NCT02988817|581414350|FG001|Overall Study|Withdrawal by Subject|0|||
161007077|NCT02988817|581414351|FG002|Overall Study|Withdrawal by Subject|0|||
161271541|NCT00750308|582375202|FG000|First Treatment|Adverse Event|0|||
161007078|NCT02988817|581414352|FG003|Overall Study|Withdrawal by Subject|1|||
161007079|NCT02988817|581414353|FG004|Overall Study|Withdrawal by Subject|3|||
161007080|NCT02988817|581414354|FG005|Overall Study|Withdrawal by Subject|1|||
161007081|NCT02988817|581414355|FG006|Overall Study|Withdrawal by Subject|2|||
161007082|NCT02988817|581414356|FG007|Overall Study|Withdrawal by Subject|1|||
161007083|NCT02988817|581414357|FG008|Overall Study|Withdrawal by Subject|1|||
161007084|NCT02988817|581414358|FG009|Overall Study|Withdrawal by Subject|1|||
161007085|NCT02988817|581414359|FG010|Overall Study|Withdrawal by Subject|1|||
161007086|NCT02988817|581414360|FG011|Overall Study|Withdrawal by Subject|12|||
161007087|NCT02988817|581414361|FG012|Overall Study|Withdrawal by Subject|6|||
161007088|NCT02988817|581414362|FG013|Overall Study|Withdrawal by Subject|6|||
161007089|NCT02988817|581414363|FG014|Overall Study|Withdrawal by Subject|4|||
161007090|NCT02988817|581414364|FG015|Overall Study|Withdrawal by Subject|5|||
161007091|NCT02988817|581414365|FG016|Overall Study|Withdrawal by Subject|4|||
161007092|NCT02988817|581414366|FG017|Overall Study|Withdrawal by Subject|11|||
161007093|NCT02988817|581414367|FG018|Overall Study|Withdrawal by Subject|4|||
161007094|NCT02988817|581414368|FG019|Overall Study|Withdrawal by Subject|2|||
161007095|NCT02988817|581414349|FG000|Overall Study|Death|0|||
161007096|NCT02988817|581414350|FG001|Overall Study|Death|1|||
161007097|NCT02988817|581414351|FG002|Overall Study|Death|3|||
161007098|NCT02988817|581414352|FG003|Overall Study|Death|1|||
161007099|NCT02988817|581414353|FG004|Overall Study|Death|6|||
161007100|NCT02988817|581414354|FG005|Overall Study|Death|10|||
161007101|NCT02988817|581414355|FG006|Overall Study|Death|1|||
161007102|NCT02988817|581414356|FG007|Overall Study|Death|2|||
161007103|NCT02988817|581414357|FG008|Overall Study|Death|1|||
161007104|NCT02988817|581414358|FG009|Overall Study|Death|5|||
161007105|NCT02988817|581414359|FG010|Overall Study|Death|1|||
161007106|NCT02988817|581414360|FG011|Overall Study|Death|8|||
161007107|NCT02988817|581414361|FG012|Overall Study|Death|9|||
161007108|NCT02988817|581414362|FG013|Overall Study|Death|17|||
161007109|NCT02988817|581414363|FG014|Overall Study|Death|18|||
161007110|NCT02988817|581414364|FG015|Overall Study|Death|30|||
161007111|NCT02988817|581414365|FG016|Overall Study|Death|17|||
161007112|NCT02988817|581414366|FG017|Overall Study|Death|38|||
161007113|NCT02988817|581414367|FG018|Overall Study|Death|14|||
161007114|NCT02988817|581414368|FG019|Overall Study|Death|16|||
161007115|NCT02988817|581414349|FG000|Overall Study|Other|0|||
161007116|NCT02988817|581414350|FG001|Overall Study|Other|0|||
161007117|NCT02988817|581414351|FG002|Overall Study|Other|0|||
161007118|NCT02988817|581414352|FG003|Overall Study|Other|1|||
161007119|NCT02988817|581414353|FG004|Overall Study|Other|1|||
161007120|NCT02988817|581414354|FG005|Overall Study|Other|0|||
161007121|NCT02988817|581414355|FG006|Overall Study|Other|0|||
161007122|NCT02988817|581414356|FG007|Overall Study|Other|0|||
161007123|NCT02988817|581414357|FG008|Overall Study|Other|0|||
161007124|NCT02988817|581414358|FG009|Overall Study|Other|0|||
161007125|NCT02988817|581414359|FG010|Overall Study|Other|0|||
161007126|NCT02988817|581414360|FG011|Overall Study|Other|0|||
161007127|NCT02988817|581414361|FG012|Overall Study|Other|0|||
161007128|NCT02988817|581414362|FG013|Overall Study|Other|0|||
161007129|NCT02988817|581414363|FG014|Overall Study|Other|0|||
161007130|NCT02988817|581414364|FG015|Overall Study|Other|1|||
161007131|NCT02988817|581414365|FG016|Overall Study|Other|0|||
161007132|NCT02988817|581414366|FG017|Overall Study|Other|0|||
161007133|NCT02988817|581414367|FG018|Overall Study|Other|0|||
161007134|NCT02988817|581414368|FG019|Overall Study|Other|0|||
161007135|NCT02988817|581414349|FG000|Overall Study|Lost to Follow-up|0|||
161007136|NCT02988817|581414350|FG001|Overall Study|Lost to Follow-up|0|||
161007137|NCT02988817|581414351|FG002|Overall Study|Lost to Follow-up|0|||
161007138|NCT02988817|581414352|FG003|Overall Study|Lost to Follow-up|0|||
161007139|NCT02988817|581414353|FG004|Overall Study|Lost to Follow-up|0|||
161007140|NCT02988817|581414354|FG005|Overall Study|Lost to Follow-up|0|||
161007141|NCT02988817|581414355|FG006|Overall Study|Lost to Follow-up|0|||
161007142|NCT02988817|581414356|FG007|Overall Study|Lost to Follow-up|0|||
161007143|NCT02988817|581414357|FG008|Overall Study|Lost to Follow-up|1|||
161007144|NCT02988817|581414358|FG009|Overall Study|Lost to Follow-up|0|||
161007145|NCT02988817|581414359|FG010|Overall Study|Lost to Follow-up|1|||
161007146|NCT02988817|581414360|FG011|Overall Study|Lost to Follow-up|1|||
161007147|NCT02988817|581414361|FG012|Overall Study|Lost to Follow-up|0|||
161007148|NCT02988817|581414362|FG013|Overall Study|Lost to Follow-up|0|||
161007149|NCT02988817|581414363|FG014|Overall Study|Lost to Follow-up|1|||
161007150|NCT02988817|581414364|FG015|Overall Study|Lost to Follow-up|1|||
161007151|NCT02988817|581414365|FG016|Overall Study|Lost to Follow-up|2|||
161007152|NCT02988817|581414366|FG017|Overall Study|Lost to Follow-up|3|||
161007153|NCT02988817|581414367|FG018|Overall Study|Lost to Follow-up|0|||
161007154|NCT02988817|581414368|FG019|Overall Study|Lost to Follow-up|0|||
161007155|NCT02988817|581414349|FG000|Overall Study|Sponsor decision|0|||
161007156|NCT02988817|581414350|FG001|Overall Study|Sponsor decision|0|||
161007157|NCT02988817|581414351|FG002|Overall Study|Sponsor decision|0|||
161007158|NCT02988817|581414352|FG003|Overall Study|Sponsor decision|0|||
161007159|NCT02988817|581414353|FG004|Overall Study|Sponsor decision|0|||
161007160|NCT02988817|581414354|FG005|Overall Study|Sponsor decision|0|||
161007161|NCT02988817|581414355|FG006|Overall Study|Sponsor decision|0|||
161007162|NCT02988817|581414356|FG007|Overall Study|Sponsor decision|0|||
161007163|NCT02988817|581414357|FG008|Overall Study|Sponsor decision|0|||
161007164|NCT02988817|581414358|FG009|Overall Study|Sponsor decision|0|||
161007165|NCT02988817|581414359|FG010|Overall Study|Sponsor decision|0|||
161007166|NCT02988817|581414360|FG011|Overall Study|Sponsor decision|1|||
161007167|NCT02988817|581414361|FG012|Overall Study|Sponsor decision|1|||
161007168|NCT02988817|581414362|FG013|Overall Study|Sponsor decision|2|||
161007169|NCT02988817|581414363|FG014|Overall Study|Sponsor decision|2|||
161007170|NCT02988817|581414364|FG015|Overall Study|Sponsor decision|6|||
161007171|NCT02988817|581414365|FG016|Overall Study|Sponsor decision|2|||
161007172|NCT02988817|581414366|FG017|Overall Study|Sponsor decision|3|||
161007173|NCT02988817|581414367|FG018|Overall Study|Sponsor decision|2|||
161007174|NCT02988817|581414368|FG019|Overall Study|Sponsor decision|7|||
161007175|NCT02988817|581414349|FG000|Overall Study|Physician Decision|0|||
161007176|NCT02988817|581414350|FG001|Overall Study|Physician Decision|0|||
161007177|NCT02988817|581414351|FG002|Overall Study|Physician Decision|0|||
161007178|NCT02988817|581414352|FG003|Overall Study|Physician Decision|0|||
161007179|NCT02988817|581414353|FG004|Overall Study|Physician Decision|0|||
161007180|NCT02988817|581414354|FG005|Overall Study|Physician Decision|0|||
161007181|NCT02988817|581414355|FG006|Overall Study|Physician Decision|0|||
161007182|NCT02988817|581414356|FG007|Overall Study|Physician Decision|0|||
161007183|NCT02988817|581414357|FG008|Overall Study|Physician Decision|0|||
161007184|NCT02988817|581414358|FG009|Overall Study|Physician Decision|0|||
161007185|NCT02988817|581414359|FG010|Overall Study|Physician Decision|0|||
161007186|NCT02988817|581414360|FG011|Overall Study|Physician Decision|0|||
161007187|NCT02988817|581414361|FG012|Overall Study|Physician Decision|0|||
161007188|NCT02988817|581414362|FG013|Overall Study|Physician Decision|0|||
161007189|NCT02988817|581414363|FG014|Overall Study|Physician Decision|0|||
161007190|NCT02988817|581414364|FG015|Overall Study|Physician Decision|1|||
161007191|NCT02988817|581414365|FG016|Overall Study|Physician Decision|0|||
161007192|NCT02988817|581414366|FG017|Overall Study|Physician Decision|0|||
161271542|NCT00750308|582375203|FG001|First Treatment|Adverse Event|1|||
161271543|NCT00750308|582375204|FG002|First Treatment|Adverse Event|0|||
161271544|NCT00750308|582375205|FG003|First Treatment|Adverse Event|0|||
161271545|NCT00750308|582375206|FG004|First Treatment|Adverse Event|0|||
161271546|NCT00750308|582375207|FG005|First Treatment|Adverse Event|0|||
161271547|NCT00750308|582375208|FG006|First Treatment|Adverse Event|0|||
161271548|NCT00750308|582375209|FG007|First Treatment|Adverse Event|0|||
161271549|NCT00750308|582375210|FG008|First Treatment|Adverse Event|0|||
161271550|NCT00750308|582375211|FG009|First Treatment|Adverse Event|0|||
161271551|NCT00750308|582375212|FG010|First Treatment|Adverse Event|1|||
161271552|NCT00750308|582375213|FG011|First Treatment|Adverse Event|1|||
161271553|NCT00750308|582375202|FG000|First Treatment|Withdrawal by Subject|0|||
161271554|NCT00750308|582375203|FG001|First Treatment|Withdrawal by Subject|0|||
161271555|NCT00750308|582375204|FG002|First Treatment|Withdrawal by Subject|0|||
161271556|NCT00750308|582375205|FG003|First Treatment|Withdrawal by Subject|1|||
161271557|NCT00750308|582375206|FG004|First Treatment|Withdrawal by Subject|0|||
161271558|NCT00750308|582375207|FG005|First Treatment|Withdrawal by Subject|0|||
161271559|NCT00750308|582375208|FG006|First Treatment|Withdrawal by Subject|0|||
161271560|NCT00750308|582375209|FG007|First Treatment|Withdrawal by Subject|1|||
160966750|NCT00246337|581266771|FG003|Overall Study|Lost to Follow-up|0|||
160966751|NCT00246337|581266772|FG004|Overall Study|Lost to Follow-up|2|||
160966752|NCT00246337|581266773|FG005|Overall Study|Lost to Follow-up|2|||
160966753|NCT00246337|581266774|FG006|Overall Study|Lost to Follow-up|1|||
160966754|NCT00246337|581266775|FG007|Overall Study|Lost to Follow-up|2|||
160966755|NCT00246337|581266776|FG008|Overall Study|Lost to Follow-up|0|||
160966756|NCT00246337|581266768|FG000|Overall Study|Protocol Violation|1|||
160966757|NCT00246337|581266769|FG001|Overall Study|Protocol Violation|0|||
160966758|NCT00246337|581266770|FG002|Overall Study|Protocol Violation|0|||
160966759|NCT00246337|581266771|FG003|Overall Study|Protocol Violation|0|||
160966760|NCT00246337|581266772|FG004|Overall Study|Protocol Violation|1|||
160966761|NCT00246337|581266773|FG005|Overall Study|Protocol Violation|0|||
160966762|NCT00246337|581266774|FG006|Overall Study|Protocol Violation|1|||
160966763|NCT00246337|581266775|FG007|Overall Study|Protocol Violation|1|||
160966764|NCT00246337|581266776|FG008|Overall Study|Protocol Violation|0|||
160966765|NCT00246337|581266768|FG000|Overall Study|Withdrawal by Subject|2|||
161007193|NCT02988817|581414367|FG018|Overall Study|Physician Decision|1|||
161007194|NCT02988817|581414368|FG019|Overall Study|Physician Decision|1|||
161007195|NCT00350792|581414373|FG000|Overall Study|Adverse Event|11|||
161007196|NCT00350792|581414373|FG000|Overall Study|Death from Study Disease|1|||
161007197|NCT00350792|581414373|FG000|Overall Study|Death from Study Drug Toxicity|1|||
161007198|NCT00350792|581414373|FG000|Overall Study|Death Not Study Drug Related|2|||
161007199|NCT00350792|581414373|FG000|Overall Study|Protocol Violation|1|||
161007200|NCT00350792|581414373|FG000|Overall Study|Withdrawal by Subject|4|||
161271561|NCT00750308|582375210|FG008|First Treatment|Withdrawal by Subject|0|||
161271562|NCT00750308|582375211|FG009|First Treatment|Withdrawal by Subject|0|||
160966766|NCT00246337|581266769|FG001|Overall Study|Withdrawal by Subject|0|||
161007201|NCT00350792|581414373|FG000|Overall Study|Physician Decision|2|||
161007202|NCT00350792|581414373|FG000|Overall Study|Lack of Efficacy|11|||
161007203|NCT03076515|581414380|FG000|Overall Study|DMC decision based on interim analysis|25|||
161007204|NCT03076515|581414381|FG001|Overall Study|DMC decision based on interim analysis|29|||
161007205|NCT00174382|581414382|FG000|Overall Study|Death|2|||
161007206|NCT00174382|581414382|FG000|Overall Study|Adverse Event|19|||
161007207|NCT00174382|581414382|FG000|Overall Study|Withdrawal by Subject|6|||
161007208|NCT00174382|581414382|FG000|Overall Study|Protocol Violation|3|||
161007209|NCT00174382|581414382|FG000|Overall Study|Arrived early for last visit in error|1|||
161007210|NCT00174382|581414382|FG000|Overall Study|Subject felt pill not effective enough|1|||
161007211|NCT00174382|581414382|FG000|Overall Study|Lost to Follow-up|1|||
161007212|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
161007213|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
161007214|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007215|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007216|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007217|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
161007218|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
161007219|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
161007220|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007221|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007222|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007223|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007224|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
161007225|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
161007226|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
160966767|NCT00246337|581266770|FG002|Overall Study|Withdrawal by Subject|0|||
160966768|NCT00246337|581266771|FG003|Overall Study|Withdrawal by Subject|0|||
160966769|NCT00246337|581266772|FG004|Overall Study|Withdrawal by Subject|0|||
160966770|NCT00246337|581266773|FG005|Overall Study|Withdrawal by Subject|0|||
160966771|NCT00246337|581266774|FG006|Overall Study|Withdrawal by Subject|1|||
160966772|NCT00246337|581266775|FG007|Overall Study|Withdrawal by Subject|1|||
160966773|NCT00246337|581266776|FG008|Overall Study|Withdrawal by Subject|0|||
160966774|NCT00246337|581266768|FG000|Overall Study|Lack of Qualifying Event|8|||
160966775|NCT00246337|581266769|FG001|Overall Study|Lack of Qualifying Event|2|||
160966776|NCT00246337|581266770|FG002|Overall Study|Lack of Qualifying Event|1|||
160966777|NCT00246337|581266771|FG003|Overall Study|Lack of Qualifying Event|1|||
160966778|NCT00246337|581266772|FG004|Overall Study|Lack of Qualifying Event|1|||
160966779|NCT00246337|581266773|FG005|Overall Study|Lack of Qualifying Event|3|||
160966780|NCT00246337|581266774|FG006|Overall Study|Lack of Qualifying Event|3|||
160966781|NCT00246337|581266775|FG007|Overall Study|Lack of Qualifying Event|2|||
160966782|NCT00246337|581266776|FG008|Overall Study|Lack of Qualifying Event|5|||
160966783|NCT00246337|581266768|FG000|Overall Study|Site Terminated|10|||
160966784|NCT00246337|581266769|FG001|Overall Study|Site Terminated|0|||
160966785|NCT00246337|581266770|FG002|Overall Study|Site Terminated|0|||
160966786|NCT00246337|581266771|FG003|Overall Study|Site Terminated|0|||
160966787|NCT00246337|581266772|FG004|Overall Study|Site Terminated|0|||
160966788|NCT00246337|581266773|FG005|Overall Study|Site Terminated|7|||
160966789|NCT00246337|581266774|FG006|Overall Study|Site Terminated|1|||
160966790|NCT00246337|581266775|FG007|Overall Study|Site Terminated|6|||
160966791|NCT00246337|581266776|FG008|Overall Study|Site Terminated|2|||
160966792|NCT00246337|581266768|FG000|Overall Study|Abnormal baseline lab values|7|||
160966793|NCT00246337|581266769|FG001|Overall Study|Abnormal baseline lab values|0|||
160966794|NCT00246337|581266770|FG002|Overall Study|Abnormal baseline lab values|2|||
160966795|NCT00246337|581266771|FG003|Overall Study|Abnormal baseline lab values|0|||
160966796|NCT00246337|581266772|FG004|Overall Study|Abnormal baseline lab values|0|||
160966797|NCT00246337|581266773|FG005|Overall Study|Abnormal baseline lab values|2|||
160966798|NCT00246337|581266774|FG006|Overall Study|Abnormal baseline lab values|2|||
160966799|NCT00246337|581266775|FG007|Overall Study|Abnormal baseline lab values|0|||
160966800|NCT00246337|581266776|FG008|Overall Study|Abnormal baseline lab values|4|||
160966801|NCT00246337|581266768|FG000|Overall Study|Overwhelmed|0|||
160966802|NCT00246337|581266769|FG001|Overall Study|Overwhelmed|0|||
160966803|NCT00246337|581266770|FG002|Overall Study|Overwhelmed|0|||
160966804|NCT00246337|581266771|FG003|Overall Study|Overwhelmed|0|||
160966805|NCT00246337|581266772|FG004|Overall Study|Overwhelmed|0|||
160966806|NCT00246337|581266773|FG005|Overall Study|Overwhelmed|1|||
160966807|NCT00246337|581266774|FG006|Overall Study|Overwhelmed|0|||
160966808|NCT00246337|581266775|FG007|Overall Study|Overwhelmed|0|||
161007227|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
161007228|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007229|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
160966809|NCT00246337|581266776|FG008|Overall Study|Overwhelmed|0|||
160966810|NCT00246337|581266768|FG000|Overall Study|Protocol Violator|1|||
160966811|NCT00246337|581266769|FG001|Overall Study|Protocol Violator|0|||
160966812|NCT00246337|581266770|FG002|Overall Study|Protocol Violator|0|||
160966813|NCT00246337|581266771|FG003|Overall Study|Protocol Violator|0|||
160966814|NCT00246337|581266772|FG004|Overall Study|Protocol Violator|0|||
160966815|NCT00246337|581266773|FG005|Overall Study|Protocol Violator|0|||
161007230|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007231|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007232|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007233|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
161007234|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
161007235|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
161007236|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007237|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
161007238|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007239|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007240|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007241|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007242|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007243|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
161007244|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007245|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007246|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007247|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
161007248|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
161007249|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007250|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007251|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
161007252|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007253|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007254|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007255|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
161007256|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007257|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007258|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007259|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
161007260|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007261|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
161007262|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007263|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007264|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
161007265|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
161007266|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
161007267|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
161007268|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
161007269|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007270|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007271|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007272|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007273|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
161007274|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007275|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
161007276|NCT03903822|581414383|FG000|Treatment Phase (6 Weeks)|Other|2|||
161007277|NCT03903822|581414384|FG001|Treatment Phase (6 Weeks)|Other|1|||
161007278|NCT03903822|581414385|FG002|Treatment Phase (6 Weeks)|Other|0|||
161007279|NCT03903822|581414386|FG003|Treatment Phase (6 Weeks)|Other|0|||
161007280|NCT03903822|581414387|FG004|Treatment Phase (6 Weeks)|Other|1|||
161007281|NCT03903822|581414388|FG005|Treatment Phase (6 Weeks)|Other|1|||
161007282|NCT03903822|581414389|FG006|Treatment Phase (6 Weeks)|Other|0|||
161007283|NCT03903822|581414390|FG007|Treatment Phase (6 Weeks)|Other|0|||
161007284|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
161007285|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
161007286|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
161007287|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
161007288|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
161271563|NCT00750308|582375212|FG010|First Treatment|Withdrawal by Subject|0|||
161271564|NCT00750308|582375213|FG011|First Treatment|Withdrawal by Subject|0|||
161271565|NCT00750308|582375202|FG000|Second Treatment|Adverse Event|0|||
161271566|NCT00750308|582375203|FG001|Second Treatment|Adverse Event|0|||
161271567|NCT00750308|582375204|FG002|Second Treatment|Adverse Event|0|||
161271568|NCT00750308|582375205|FG003|Second Treatment|Adverse Event|0|||
161271569|NCT00750308|582375206|FG004|Second Treatment|Adverse Event|0|||
161007289|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
161007290|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
161007291|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
161271570|NCT00750308|582375207|FG005|Second Treatment|Adverse Event|1|||
161007292|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161271571|NCT00750308|582375208|FG006|Second Treatment|Adverse Event|0|||
161271572|NCT00750308|582375209|FG007|Second Treatment|Adverse Event|0|||
161007293|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007294|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007295|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007296|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
161007297|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007298|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007299|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
161007300|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
161007301|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007302|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007303|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007304|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007305|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
161007306|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
161007307|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
161007308|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007309|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007310|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007311|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
161147315|NCT01097616|581922455|FG007|Optional DB EXT Phase|Physician Decision|0|||
161147316|NCT01097616|581922448|FG000|DB RO Phase|Adverse Event|0|||
161147317|NCT01097616|581922449|FG001|DB RO Phase|Adverse Event|0|||
161147318|NCT01097616|581922450|FG002|DB RO Phase|Adverse Event|0|||
161007312|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
161007313|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007314|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007315|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
161007316|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007317|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
161007318|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161007319|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007320|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007321|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
161007322|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161007323|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
161007324|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007325|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007326|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007327|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007328|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007329|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
161007330|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007331|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
161007332|NCT03903822|581414383|FG000|Follow up Phase (4 Weeks)|Other|1|||
161007333|NCT03903822|581414384|FG001|Follow up Phase (4 Weeks)|Other|1|||
161007334|NCT03903822|581414385|FG002|Follow up Phase (4 Weeks)|Other|0|||
161007335|NCT03903822|581414386|FG003|Follow up Phase (4 Weeks)|Other|0|||
161007336|NCT03903822|581414387|FG004|Follow up Phase (4 Weeks)|Other|0|||
161007337|NCT03903822|581414388|FG005|Follow up Phase (4 Weeks)|Other|0|||
161007338|NCT03903822|581414389|FG006|Follow up Phase (4 Weeks)|Other|0|||
161007339|NCT03903822|581414390|FG007|Follow up Phase (4 Weeks)|Other|0|||
161007340|NCT00296036|581414391|FG000|Overall Study|Withdrawal by Subject|1|||
161007341|NCT00296036|581414392|FG001|Overall Study|Withdrawal by Subject|0|||
161007342|NCT00296036|581414393|FG002|Overall Study|Withdrawal by Subject|2|||
161007343|NCT00296036|581414394|FG003|Overall Study|Withdrawal by Subject|1|||
161007344|NCT00296036|581414395|FG004|Overall Study|Withdrawal by Subject|2|||
161147319|NCT01097616|581922451|FG003|DB RO Phase|Adverse Event|0|||
161147320|NCT01097616|581922452|FG004|DB RO Phase|Adverse Event|0|||
161147321|NCT01097616|581922453|FG005|DB RO Phase|Adverse Event|0|||
161147322|NCT01097616|581922454|FG006|DB RO Phase|Adverse Event|1|||
161147323|NCT01097616|581922455|FG007|DB RO Phase|Adverse Event|0|||
161147324|NCT01097616|581922448|FG000|DB RO Phase|Withdrawal by Subject|0|||
161147325|NCT01097616|581922449|FG001|DB RO Phase|Withdrawal by Subject|0|||
161007345|NCT00296036|581414396|FG005|Overall Study|Withdrawal by Subject|1|||
161147326|NCT01097616|581922450|FG002|DB RO Phase|Withdrawal by Subject|0|||
161147327|NCT01097616|581922451|FG003|DB RO Phase|Withdrawal by Subject|0|||
161147328|NCT01097616|581922452|FG004|DB RO Phase|Withdrawal by Subject|0|||
161007346|NCT00296036|581414391|FG000|Overall Study|Protocol Violation|0|||
161007347|NCT00296036|581414392|FG001|Overall Study|Protocol Violation|0|||
161007348|NCT00296036|581414393|FG002|Overall Study|Protocol Violation|0|||
161147329|NCT01097616|581922453|FG005|DB RO Phase|Withdrawal by Subject|1|||
161147330|NCT01097616|581922454|FG006|DB RO Phase|Withdrawal by Subject|0|||
161147331|NCT01097616|581922455|FG007|DB RO Phase|Withdrawal by Subject|0|||
161147332|NCT01097616|581922448|FG000|DB RO Phase|Lost to Follow-up|0|||
161007349|NCT00296036|581414394|FG003|Overall Study|Protocol Violation|0|||
161007350|NCT00296036|581414395|FG004|Overall Study|Protocol Violation|0|||
161007351|NCT00296036|581414396|FG005|Overall Study|Protocol Violation|3|||
161007352|NCT00785512|581414399|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
161007353|NCT00785512|581414400|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
161007354|NCT00785512|581414399|FG000|Overall Study|Adverse Event|0|||
161007355|NCT00785512|581414400|FG001|Overall Study|Adverse Event|0|||
161007356|NCT00785512|581414399|FG000|Overall Study|Lack of Efficacy|0|||
161007357|NCT00785512|581414400|FG001|Overall Study|Lack of Efficacy|2|||
161007358|NCT00785512|581414399|FG000|Overall Study|Withdrawal by Subject|0|||
161007359|NCT00785512|581414400|FG001|Overall Study|Withdrawal by Subject|1|||
161007360|NCT00785512|581414399|FG000|Overall Study|Lost to Follow-up|3|||
161007361|NCT00785512|581414400|FG001|Overall Study|Lost to Follow-up|0|||
161007362|NCT00785512|581414399|FG000|Overall Study|Precedure Refused|0|||
161007363|NCT00785512|581414400|FG001|Overall Study|Precedure Refused|0|||
161007364|NCT00785512|581414399|FG000|Overall Study|IVRS Programing Error|0|||
161007365|NCT00785512|581414400|FG001|Overall Study|IVRS Programing Error|0|||
161007366|NCT00785512|581414399|FG000|Overall Study|Physician Decision|0|||
161007367|NCT00785512|581414400|FG001|Overall Study|Physician Decision|0|||
161007368|NCT00785512|581414399|FG000|Overall Study|Lack of compliance|0|||
161007369|NCT00785512|581414400|FG001|Overall Study|Lack of compliance|1|||
161007370|NCT02477605|581414401|FG000|Overall Study|Discontinued prior to treatment|1|||
161007371|NCT02477605|581414402|FG001|Overall Study|Discontinued prior to treatment|0|||
161007372|NCT02477605|581414401|FG000|Overall Study|Lost to Follow-up|0|||
161007373|NCT02477605|581414402|FG001|Overall Study|Lost to Follow-up|2|||
161007374|NCT02477605|581414401|FG000|Overall Study|Withdrawal by Subject|0|||
161007375|NCT02477605|581414402|FG001|Overall Study|Withdrawal by Subject|1|||
161007376|NCT02477605|581414401|FG000|Overall Study|Administered gas during surgery|0|||
161007377|NCT02477605|581414402|FG001|Overall Study|Administered gas during surgery|1|||
161007378|NCT00970359|581414404|FG000|Overall Study|Not Treated|4|||
161007379|NCT01388361|581414405|FG000|Overall Study|Adverse Event|0|||
161007380|NCT01388361|581414406|FG001|Overall Study|Adverse Event|5|||
161007381|NCT01388361|581414407|FG002|Overall Study|Adverse Event|1|||
161007382|NCT01388361|581414405|FG000|Overall Study|Protocol Violation|0|||
161007383|NCT01388361|581414406|FG001|Overall Study|Protocol Violation|0|||
161007384|NCT01388361|581414407|FG002|Overall Study|Protocol Violation|2|||
161007385|NCT01388361|581414405|FG000|Overall Study|Withdrawal criteria|12|||
161007386|NCT01388361|581414406|FG001|Overall Study|Withdrawal criteria|7|||
161007387|NCT01388361|581414407|FG002|Overall Study|Withdrawal criteria|10|||
161007388|NCT01388361|581414405|FG000|Overall Study|Unclassified|0|||
161007389|NCT01388361|581414406|FG001|Overall Study|Unclassified|0|||
161007390|NCT01388361|581414407|FG002|Overall Study|Unclassified|1|||
161007391|NCT03942042|581414408|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
161007392|NCT03942042|581414409|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
161007393|NCT03942042|581414408|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
161007394|NCT03942042|581414409|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
161007395|NCT01499199|581414412|FG000|Overall Study|Adverse Event|1|||
161007396|NCT01499199|581414412|FG000|Overall Study|Lack of Efficacy|1|||
161007397|NCT01199705|581414413|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
161007398|NCT00933400|581414414|FG000|Overall Study|Withdrawal by Subject|21|||
161007399|NCT00933400|581414415|FG001|Overall Study|Withdrawal by Subject|1|||
161007400|NCT01849055|581414416|FG000|Overall Study|Withdrawal by Subject|0|||
161007401|NCT01849055|581414417|FG001|Overall Study|Withdrawal by Subject|0|||
161007402|NCT01849055|581414418|FG002|Overall Study|Withdrawal by Subject|1|||
161007403|NCT01849055|581414419|FG003|Overall Study|Withdrawal by Subject|0|||
161007404|NCT01849055|581414420|FG004|Overall Study|Withdrawal by Subject|0|||
161007405|NCT01849055|581414421|FG005|Overall Study|Withdrawal by Subject|0|||
161007406|NCT00223795|581414422|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
161007407|NCT00223795|581414423|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
161007408|NCT00223795|581414422|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
161007409|NCT00223795|581414423|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
161007410|NCT00716859|581414426|FG000|Overall Study|Adverse Event|4|||
161007411|NCT00716859|581414427|FG001|Overall Study|Adverse Event|1|||
161007412|NCT00716859|581414426|FG000|Overall Study|Lack of Efficacy|3|||
161147333|NCT01097616|581922449|FG001|DB RO Phase|Lost to Follow-up|0|||
161007413|NCT00716859|581414427|FG001|Overall Study|Lack of Efficacy|0|||
161007414|NCT00716859|581414426|FG000|Overall Study|Withdrawal by Subject|1|||
161007415|NCT00716859|581414427|FG001|Overall Study|Withdrawal by Subject|3|||
161007416|NCT00716859|581414426|FG000|Overall Study|Not treated|1|||
161007417|NCT00716859|581414427|FG001|Overall Study|Not treated|1|||
161007418|NCT03783026|581416659|FG000|Treatment Phase|Adverse Event|15|||
161007419|NCT03783026|581416659|FG000|Treatment Phase|Lack of Efficacy|11|||
161007420|NCT03783026|581416659|FG000|Treatment Phase|Withdrawal by Subject|6|||
161007421|NCT03783026|581416659|FG000|Treatment Phase|Lost to Follow-up|2|||
161007422|NCT03783026|581416659|FG000|Treatment Phase|Protocol Deviation|8|||
161007423|NCT03783026|581416659|FG000|Treatment Phase|Did Not Receive Treatment|1|||
161007424|NCT03783026|581416659|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
161007425|NCT04814186|581416660|FG000|Treatment Phase|Adverse Event|1|||
161007426|NCT04814186|581416660|FG000|Treatment Phase|Death|6|||
161007427|NCT04814186|581416660|FG000|Treatment Phase|Withdrawal by Subject|2|||
161007428|NCT04814186|581416660|FG000|Treatment Phase|Other|1|||
161007429|NCT04814186|581416660|FG000|Follow-Up Phase|Adverse Event|1|||
161007430|NCT04814186|581416660|FG000|Follow-Up Phase|Death|6|||
161007431|NCT04814186|581416660|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
161007432|NCT04814186|581416660|FG000|Follow-Up Phase|Other|1|||
161007433|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
161007434|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
161007435|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
161007436|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
161007437|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
161007438|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
161007439|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
161007440|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
161007441|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
161007442|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
161007443|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
161007444|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
161007445|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007446|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
161007447|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
161007448|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007449|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007450|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
161007451|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
161007452|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
161007453|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
161007454|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161007455|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161007456|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
161007457|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007458|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
161007459|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007460|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007461|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007462|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
161007463|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
161007464|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007465|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007466|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007467|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007468|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
161007469|NCT04043455|581416665|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007470|NCT04043455|581416666|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
161007471|NCT04043455|581416667|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007472|NCT04043455|581416668|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007473|NCT04043455|581416669|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007474|NCT04043455|581416670|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
161007475|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007476|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007477|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007478|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007479|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
161007480|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
161007481|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007482|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007483|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007484|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
161007485|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
161007486|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
161007487|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161271573|NCT00750308|582375210|FG008|Second Treatment|Adverse Event|1|||
160966816|NCT00246337|581266774|FG006|Overall Study|Protocol Violator|0|||
160966817|NCT00246337|581266775|FG007|Overall Study|Protocol Violator|0|||
160966818|NCT00246337|581266776|FG008|Overall Study|Protocol Violator|0|||
160966819|NCT00246337|581266768|FG000|Overall Study|Reported as completing trial in error|0|||
160966820|NCT00246337|581266769|FG001|Overall Study|Reported as completing trial in error|0|||
160966821|NCT00246337|581266770|FG002|Overall Study|Reported as completing trial in error|0|||
160966822|NCT00246337|581266771|FG003|Overall Study|Reported as completing trial in error|0|||
160966823|NCT00246337|581266772|FG004|Overall Study|Reported as completing trial in error|0|||
160966824|NCT00246337|581266773|FG005|Overall Study|Reported as completing trial in error|0|||
160966825|NCT00246337|581266774|FG006|Overall Study|Reported as completing trial in error|0|||
160966826|NCT00246337|581266775|FG007|Overall Study|Reported as completing trial in error|1|||
160966827|NCT00246337|581266776|FG008|Overall Study|Reported as completing trial in error|0|||
160966828|NCT02696564|581266779|FG000|Overall Study|Death|1|||
160966829|NCT02696564|581266780|FG001|Overall Study|Death|2|||
160966830|NCT02696564|581266779|FG000|Overall Study|Withdrawal by Subject|3|||
160966831|NCT02696564|581266780|FG001|Overall Study|Withdrawal by Subject|2|||
160966832|NCT02696564|581266779|FG000|Overall Study|Lost to Follow-up|3|||
160966833|NCT02696564|581266780|FG001|Overall Study|Lost to Follow-up|3|||
160966834|NCT02696564|581266779|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
160966835|NCT02696564|581266780|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
160966836|NCT02696564|581266779|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
160966837|NCT02696564|581266780|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
160966838|NCT02696564|581266779|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
160966839|NCT02696564|581266780|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
160966840|NCT02696564|581266779|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
160966841|NCT02696564|581266780|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
160966842|NCT02696564|581266779|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
160966843|NCT02696564|581266780|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
160966844|NCT04067401|581266781|FG000|Overall Study|Withdrawal by Subject|7|||
160966845|NCT04067401|581266782|FG001|Overall Study|Withdrawal by Subject|0|||
160966846|NCT04067401|581266781|FG000|Overall Study|no data provided|1|||
160966847|NCT04067401|581266782|FG001|Overall Study|no data provided|0|||
160966848|NCT03633929|581266783|FG000|Overall Study|Lost to Follow-up|1|||
160966849|NCT03633929|581266783|FG000|Overall Study|Did not login to software. Did not participate|3|||
160966850|NCT02287584|581266785|FG000|the Double-blind Phase|Adverse Event|17|||
160966851|NCT02287584|581266786|FG001|the Double-blind Phase|Adverse Event|17|||
160966852|NCT02287584|581266787|FG002|the Double-blind Phase|Adverse Event|12|||
160966853|NCT02287584|581266788|FG003|the Double-blind Phase|Adverse Event|0|||
160966854|NCT02287584|581266789|FG004|the Double-blind Phase|Adverse Event|0|||
160966855|NCT02287584|581266790|FG005|the Double-blind Phase|Adverse Event|0|||
160966856|NCT02287584|581266785|FG000|the Double-blind Phase|Lack of Efficacy|18|||
160966857|NCT02287584|581266786|FG001|the Double-blind Phase|Lack of Efficacy|8|||
160966858|NCT02287584|581266787|FG002|the Double-blind Phase|Lack of Efficacy|8|||
160966859|NCT02287584|581266788|FG003|the Double-blind Phase|Lack of Efficacy|0|||
160966860|NCT02287584|581266789|FG004|the Double-blind Phase|Lack of Efficacy|0|||
160966861|NCT02287584|581266790|FG005|the Double-blind Phase|Lack of Efficacy|0|||
160966862|NCT02287584|581266785|FG000|the Double-blind Phase|Lost to Follow-up|0|||
160966863|NCT02287584|581266786|FG001|the Double-blind Phase|Lost to Follow-up|1|||
160966864|NCT02287584|581266787|FG002|the Double-blind Phase|Lost to Follow-up|1|||
160966865|NCT02287584|581266788|FG003|the Double-blind Phase|Lost to Follow-up|0|||
160966866|NCT02287584|581266789|FG004|the Double-blind Phase|Lost to Follow-up|0|||
160966867|NCT02287584|581266790|FG005|the Double-blind Phase|Lost to Follow-up|0|||
160966868|NCT02287584|581266785|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
160966869|NCT02287584|581266786|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
160966870|NCT02287584|581266787|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
160966871|NCT02287584|581266788|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
160966872|NCT02287584|581266789|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
160966873|NCT02287584|581266790|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
160966874|NCT02287584|581266785|FG000|the Double-blind Phase|Pregnancy|0|||
160966875|NCT02287584|581266786|FG001|the Double-blind Phase|Pregnancy|1|||
160966876|NCT02287584|581266787|FG002|the Double-blind Phase|Pregnancy|0|||
160966877|NCT02287584|581266788|FG003|the Double-blind Phase|Pregnancy|0|||
160966878|NCT02287584|581266789|FG004|the Double-blind Phase|Pregnancy|0|||
160966879|NCT02287584|581266790|FG005|the Double-blind Phase|Pregnancy|0|||
160966880|NCT02287584|581266785|FG000|the Double-blind Phase|Protocol Violation|0|||
160966881|NCT02287584|581266786|FG001|the Double-blind Phase|Protocol Violation|3|||
160966882|NCT02287584|581266787|FG002|the Double-blind Phase|Protocol Violation|0|||
160966883|NCT02287584|581266788|FG003|the Double-blind Phase|Protocol Violation|0|||
160966884|NCT02287584|581266789|FG004|the Double-blind Phase|Protocol Violation|0|||
160966885|NCT02287584|581266790|FG005|the Double-blind Phase|Protocol Violation|0|||
161271574|NCT00750308|582375211|FG009|Second Treatment|Adverse Event|0|||
161007488|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007489|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007490|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007491|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
161007492|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
161007493|NCT04043455|581416665|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007494|NCT04043455|581416666|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007495|NCT04043455|581416667|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007496|NCT04043455|581416668|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
161007497|NCT04043455|581416669|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
161007498|NCT04043455|581416670|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
161007499|NCT01643070|581416671|FG000|Overall Study|Withdrawal by Subject|3|||
161007500|NCT01643070|581416672|FG001|Overall Study|Withdrawal by Subject|1|||
161007501|NCT01643070|581416671|FG000|Overall Study|Death|1|||
161007502|NCT01643070|581416672|FG001|Overall Study|Death|0|||
161007503|NCT01643070|581416671|FG000|Overall Study|Pregressive disease|0|||
161271575|NCT00750308|582375212|FG010|Second Treatment|Adverse Event|0|||
161271576|NCT00750308|582375213|FG011|Second Treatment|Adverse Event|0|||
161271577|NCT00750308|582375202|FG000|Second Treatment|Withdrawal by Subject|0|||
161271578|NCT00750308|582375203|FG001|Second Treatment|Withdrawal by Subject|0|||
161271579|NCT00750308|582375204|FG002|Second Treatment|Withdrawal by Subject|0|||
161271580|NCT00750308|582375205|FG003|Second Treatment|Withdrawal by Subject|0|||
161271581|NCT00750308|582375206|FG004|Second Treatment|Withdrawal by Subject|1|||
161271582|NCT00750308|582375207|FG005|Second Treatment|Withdrawal by Subject|0|||
161271583|NCT00750308|582375208|FG006|Second Treatment|Withdrawal by Subject|0|||
161271584|NCT00750308|582375209|FG007|Second Treatment|Withdrawal by Subject|0|||
161271585|NCT00750308|582375210|FG008|Second Treatment|Withdrawal by Subject|0|||
161271586|NCT00750308|582375211|FG009|Second Treatment|Withdrawal by Subject|0|||
161271587|NCT00750308|582375212|FG010|Second Treatment|Withdrawal by Subject|0|||
161271588|NCT00750308|582375213|FG011|Second Treatment|Withdrawal by Subject|0|||
161271589|NCT00750308|582375202|FG000|Third Treatment|Withdrawal by Subject|0|||
161271590|NCT00750308|582375203|FG001|Third Treatment|Withdrawal by Subject|1|||
161271591|NCT00750308|582375204|FG002|Third Treatment|Withdrawal by Subject|0|||
161271592|NCT00750308|582375205|FG003|Third Treatment|Withdrawal by Subject|0|||
161271593|NCT00750308|582375206|FG004|Third Treatment|Withdrawal by Subject|0|||
160966886|NCT02287584|581266785|FG000|the Double-blind Phase|other reasons|0|||
160966887|NCT02287584|581266786|FG001|the Double-blind Phase|other reasons|0|||
160966888|NCT02287584|581266787|FG002|the Double-blind Phase|other reasons|1|||
160966889|NCT02287584|581266788|FG003|the Double-blind Phase|other reasons|0|||
160966890|NCT02287584|581266789|FG004|the Double-blind Phase|other reasons|0|||
160966891|NCT02287584|581266790|FG005|the Double-blind Phase|other reasons|0|||
160966892|NCT02287584|581266785|FG000|the Open-label Phase|Did not receive drug|0|||
160966893|NCT02287584|581266786|FG001|the Open-label Phase|Did not receive drug|0|||
160966894|NCT02287584|581266787|FG002|the Open-label Phase|Did not receive drug|0|||
160966895|NCT02287584|581266788|FG003|the Open-label Phase|Did not receive drug|7|||
160966896|NCT02287584|581266789|FG004|the Open-label Phase|Did not receive drug|6|||
160966897|NCT02287584|581266790|FG005|the Open-label Phase|Did not receive drug|4|||
160966898|NCT02287584|581266785|FG000|the Open-label Phase|Adverse Event|0|||
160966899|NCT02287584|581266786|FG001|the Open-label Phase|Adverse Event|0|||
160966900|NCT02287584|581266787|FG002|the Open-label Phase|Adverse Event|0|||
160966901|NCT02287584|581266788|FG003|the Open-label Phase|Adverse Event|15|||
160966902|NCT02287584|581266789|FG004|the Open-label Phase|Adverse Event|12|||
160966903|NCT02287584|581266790|FG005|the Open-label Phase|Adverse Event|16|||
160966904|NCT02287584|581266785|FG000|the Open-label Phase|Lack of Efficacy|0|||
160966905|NCT02287584|581266786|FG001|the Open-label Phase|Lack of Efficacy|0|||
160966906|NCT02287584|581266787|FG002|the Open-label Phase|Lack of Efficacy|0|||
160966907|NCT02287584|581266788|FG003|the Open-label Phase|Lack of Efficacy|8|||
160966908|NCT02287584|581266789|FG004|the Open-label Phase|Lack of Efficacy|3|||
160966909|NCT02287584|581266790|FG005|the Open-label Phase|Lack of Efficacy|7|||
160966910|NCT02287584|581266785|FG000|the Open-label Phase|Lost to Follow-up|0|||
160966911|NCT02287584|581266786|FG001|the Open-label Phase|Lost to Follow-up|0|||
160966912|NCT02287584|581266787|FG002|the Open-label Phase|Lost to Follow-up|0|||
160966913|NCT02287584|581266788|FG003|the Open-label Phase|Lost to Follow-up|4|||
160966914|NCT02287584|581266789|FG004|the Open-label Phase|Lost to Follow-up|1|||
160966915|NCT02287584|581266790|FG005|the Open-label Phase|Lost to Follow-up|2|||
160966916|NCT02287584|581266785|FG000|the Open-label Phase|Withdrawal by Subject|0|||
160966917|NCT02287584|581266786|FG001|the Open-label Phase|Withdrawal by Subject|0|||
160966918|NCT02287584|581266787|FG002|the Open-label Phase|Withdrawal by Subject|0|||
160966919|NCT02287584|581266788|FG003|the Open-label Phase|Withdrawal by Subject|18|||
160966920|NCT02287584|581266789|FG004|the Open-label Phase|Withdrawal by Subject|29|||
161271594|NCT00750308|582375207|FG005|Third Treatment|Withdrawal by Subject|0|||
161271595|NCT00750308|582375208|FG006|Third Treatment|Withdrawal by Subject|0|||
161007504|NCT01643070|581416672|FG001|Overall Study|Pregressive disease|2|||
161007505|NCT02652260|581416674|FG000|Base Study|Pregnancy|0|||
161007506|NCT02652260|581416675|FG001|Base Study|Pregnancy|1|||
161007507|NCT02652260|581416674|FG000|Base Study|Withdrawal by Subject|0|||
161007508|NCT02652260|581416675|FG001|Base Study|Withdrawal by Subject|1|||
161007509|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
161007510|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
161007511|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
161007512|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
161007513|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
161007514|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
161007515|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
161007516|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
161007517|NCT02652260|581416674|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
161007518|NCT02652260|581416675|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
161007519|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
161007520|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
161007521|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
161007522|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
161007523|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
161007524|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
161007525|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
161007526|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
161007527|NCT02652260|581416674|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
161007528|NCT02652260|581416675|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
161007529|NCT02652260|581416674|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
161007530|NCT02652260|581416675|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
161007531|NCT02652260|581416674|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
161007532|NCT02652260|581416675|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
161007533|NCT04999085|581416678|FG000|Overall Study|Death|1|||
161007534|NCT05056246|581416679|FG000|Overall Study|Adverse Event|0|||
161007535|NCT05056246|581416680|FG001|Overall Study|Adverse Event|0|||
161007536|NCT05056246|581416681|FG002|Overall Study|Adverse Event|0|||
161007537|NCT05056246|581416682|FG003|Overall Study|Adverse Event|0|||
161007538|NCT05056246|581416683|FG004|Overall Study|Adverse Event|1|||
161007539|NCT05056246|581416679|FG000|Overall Study|Lost to Follow-up|0|||
161007540|NCT05056246|581416680|FG001|Overall Study|Lost to Follow-up|0|||
161007541|NCT05056246|581416681|FG002|Overall Study|Lost to Follow-up|0|||
161007542|NCT05056246|581416682|FG003|Overall Study|Lost to Follow-up|2|||
161007543|NCT05056246|581416683|FG004|Overall Study|Lost to Follow-up|0|||
161007544|NCT05056246|581416679|FG000|Overall Study|Withdrawal by Subject|0|||
161007545|NCT05056246|581416680|FG001|Overall Study|Withdrawal by Subject|1|||
161007546|NCT05056246|581416681|FG002|Overall Study|Withdrawal by Subject|0|||
161007547|NCT05056246|581416682|FG003|Overall Study|Withdrawal by Subject|0|||
161007548|NCT05056246|581416683|FG004|Overall Study|Withdrawal by Subject|0|||
161007549|NCT02824029|581416684|FG000|Overall Study|Didn't receive treatment|2|||
161007550|NCT02824029|581416684|FG000|Overall Study|Patient decision to discontinue treatment|3|||
161007551|NCT02824029|581416684|FG000|Overall Study|Non-compliant|5|||
161007552|NCT02824029|581416684|FG000|Overall Study|Progression of disease|15|||
161007553|NCT02824029|581416684|FG000|Overall Study|Inadequate response to therapy|2|||
161007554|NCT02824029|581416684|FG000|Overall Study|Possible progression per treating physician|1|||
161007555|NCT04440176|581416686|FG000|Overall Study|Withdrawal by Subject|5|||
161007556|NCT04440176|581416687|FG001|Overall Study|Withdrawal by Subject|3|||
161007557|NCT04440176|581416686|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161007558|NCT04440176|581416687|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161007559|NCT04440176|581416686|FG000|Overall Study|Adverse Event|2|||
161007560|NCT04440176|581416687|FG001|Overall Study|Adverse Event|6|||
161007561|NCT04440176|581416686|FG000|Overall Study|Lost to Follow-up|22|||
161007562|NCT04440176|581416687|FG001|Overall Study|Lost to Follow-up|23|||
161007563|NCT04440176|581416686|FG000|Overall Study|Medication error without associated adverse event|0|||
161007564|NCT04440176|581416687|FG001|Overall Study|Medication error without associated adverse event|1|||
161007565|NCT04440176|581416686|FG000|Overall Study|No longer met eligibility criteria|7|||
161007566|NCT04440176|581416687|FG001|Overall Study|No longer met eligibility criteria|1|||
161007567|NCT04440176|581416686|FG000|Overall Study|Other|1|||
161007568|NCT04440176|581416687|FG001|Overall Study|Other|2|||
161007569|NCT04440176|581416686|FG000|Overall Study|Protocol deviation|6|||
161007570|NCT04440176|581416687|FG001|Overall Study|Protocol deviation|8|||
161007571|NCT04440176|581416686|FG000|Overall Study|Randomized but not vaccinated|6|||
161007572|NCT04440176|581416687|FG001|Overall Study|Randomized but not vaccinated|3|||
161007573|NCT01631214|581416691|FG000|Overall Study|Withdrawal by Subject|276|||
161007574|NCT01631214|581416692|FG001|Overall Study|Withdrawal by Subject|290|||
161007575|NCT01631214|581416691|FG000|Overall Study|Death|113|||
161007576|NCT01631214|581416692|FG001|Overall Study|Death|106|||
161007577|NCT01631214|581416691|FG000|Overall Study|Lost to Follow-up|54|||
161007578|NCT01631214|581416692|FG001|Overall Study|Lost to Follow-up|40|||
161007579|NCT01631214|581416691|FG000|Overall Study|Adverse Event|45|||
161007580|NCT01631214|581416692|FG001|Overall Study|Adverse Event|45|||
161007581|NCT01631214|581416691|FG000|Overall Study|Other|22|||
161007582|NCT01631214|581416692|FG001|Overall Study|Other|19|||
161007583|NCT01631214|581416691|FG000|Overall Study|Noncompliance|16|||
161007584|NCT01631214|581416692|FG001|Overall Study|Noncompliance|15|||
161007585|NCT01631214|581416691|FG000|Overall Study|Requirement for Alternative Therapy|8|||
161007586|NCT01631214|581416692|FG001|Overall Study|Requirement for Alternative Therapy|3|||
161007587|NCT01631214|581416691|FG000|Overall Study|Protocol Deviation|4|||
161007588|NCT01631214|581416692|FG001|Overall Study|Protocol Deviation|3|||
161007589|NCT01631214|581416691|FG000|Overall Study|Ineligibility determined|5|||
161007590|NCT01631214|581416692|FG001|Overall Study|Ineligibility determined|2|||
161147334|NCT01097616|581922450|FG002|DB RO Phase|Lost to Follow-up|0|||
161147335|NCT01097616|581922451|FG003|DB RO Phase|Lost to Follow-up|1|||
161147336|NCT01097616|581922452|FG004|DB RO Phase|Lost to Follow-up|1|||
161147337|NCT01097616|581922453|FG005|DB RO Phase|Lost to Follow-up|0|||
161147338|NCT01097616|581922454|FG006|DB RO Phase|Lost to Follow-up|0|||
161007591|NCT01631214|581416691|FG000|Overall Study|Administrative Decision|1|||
161007592|NCT01631214|581416692|FG001|Overall Study|Administrative Decision|0|||
161007593|NCT03575052|581416693|FG000|Overall Study|Adverse Event|6|||
161007594|NCT03575052|581416694|FG001|Overall Study|Adverse Event|10|||
161147339|NCT01097616|581922455|FG007|DB RO Phase|Lost to Follow-up|1|||
161147340|NCT01097616|581922448|FG000|DB RO Phase|Not Treated in RO|0|||
161147341|NCT01097616|581922449|FG001|DB RO Phase|Not Treated in RO|0|||
161147342|NCT01097616|581922450|FG002|DB RO Phase|Not Treated in RO|0|||
161147343|NCT01097616|581922451|FG003|DB RO Phase|Not Treated in RO|0|||
161147344|NCT01097616|581922452|FG004|DB RO Phase|Not Treated in RO|0|||
161147345|NCT01097616|581922453|FG005|DB RO Phase|Not Treated in RO|1|||
161147346|NCT01097616|581922454|FG006|DB RO Phase|Not Treated in RO|0|||
161147347|NCT01097616|581922455|FG007|DB RO Phase|Not Treated in RO|0|||
161147348|NCT00589472|581922462|FG000|Overall Study|Adverse Event|1|||
161147349|NCT00117338|581922463|FG000|Overall Study|Adverse Event|0|||
161147350|NCT00117338|581922464|FG001|Overall Study|Adverse Event|1|||
161147351|NCT00117338|581922463|FG000|Overall Study|Protocol Violation|3|||
161147352|NCT00117338|581922464|FG001|Overall Study|Protocol Violation|2|||
161147353|NCT00117338|581922463|FG000|Overall Study|Withdrawal by Subject|1|||
161147354|NCT00117338|581922464|FG001|Overall Study|Withdrawal by Subject|0|||
161147355|NCT00117338|581922463|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
161147356|NCT00117338|581922464|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
161147357|NCT00117338|581922463|FG000|Overall Study|Lack of Efficacy|0|||
161147358|NCT00117338|581922464|FG001|Overall Study|Lack of Efficacy|1|||
161147359|NCT01380093|581922465|FG000|Naloxone Challenge Phase|Screen failures|21|||
161147360|NCT01380093|581922466|FG001|Naloxone Challenge Phase|Screen failures|0|||
161147361|NCT01380093|581922467|FG002|Naloxone Challenge Phase|Screen failures|0|||
161147362|NCT01380093|581922468|FG003|Naloxone Challenge Phase|Screen failures|0|||
161147363|NCT01380093|581922469|FG004|Naloxone Challenge Phase|Screen failures|0|||
161147364|NCT01380093|581922470|FG005|Naloxone Challenge Phase|Screen failures|0|||
161147365|NCT01380093|581922471|FG006|Naloxone Challenge Phase|Screen failures|0|||
161007595|NCT03575052|581416693|FG000|Overall Study|Not further specified|5|||
161007596|NCT03575052|581416694|FG001|Overall Study|Not further specified|7|||
161007597|NCT03575052|581416693|FG000|Overall Study|Withdrawal by Subject|5|||
161007598|NCT03575052|581416694|FG001|Overall Study|Withdrawal by Subject|6|||
161147366|NCT01380093|581922472|FG007|Naloxone Challenge Phase|Screen failures|0|||
161147367|NCT01380093|581922473|FG008|Naloxone Challenge Phase|Screen failures|0|||
161147368|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147369|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
161271596|NCT00750308|582375209|FG007|Third Treatment|Withdrawal by Subject|0|||
160966921|NCT02287584|581266790|FG005|the Open-label Phase|Withdrawal by Subject|21|||
160966922|NCT02287584|581266785|FG000|the Open-label Phase|non-compliance|0|||
160966923|NCT02287584|581266786|FG001|the Open-label Phase|non-compliance|0|||
160966924|NCT02287584|581266787|FG002|the Open-label Phase|non-compliance|0|||
160966925|NCT02287584|581266788|FG003|the Open-label Phase|non-compliance|2|||
160966926|NCT02287584|581266789|FG004|the Open-label Phase|non-compliance|5|||
160966927|NCT02287584|581266790|FG005|the Open-label Phase|non-compliance|1|||
160966928|NCT02287584|581266785|FG000|the Open-label Phase|other reasons|0|||
160966929|NCT02287584|581266786|FG001|the Open-label Phase|other reasons|0|||
160966930|NCT02287584|581266787|FG002|the Open-label Phase|other reasons|0|||
160966931|NCT02287584|581266788|FG003|the Open-label Phase|other reasons|3|||
160966932|NCT02287584|581266789|FG004|the Open-label Phase|other reasons|6|||
161007599|NCT03575052|581416693|FG000|Overall Study|Lost to Follow-up|3|||
161147370|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147371|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147372|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161007600|NCT03575052|581416694|FG001|Overall Study|Lost to Follow-up|0|||
161007601|NCT03575052|581416693|FG000|Overall Study|Death|2|||
161007602|NCT03575052|581416694|FG001|Overall Study|Death|1|||
161007603|NCT03575052|581416693|FG000|Overall Study|Lack of Efficacy|2|||
161007604|NCT03575052|581416694|FG001|Overall Study|Lack of Efficacy|1|||
161007605|NCT03575052|581416693|FG000|Overall Study|Study drug noncompliance|1|||
161007606|NCT03575052|581416694|FG001|Overall Study|Study drug noncompliance|2|||
161007607|NCT03575052|581416693|FG000|Overall Study|Protocol Violation|0|||
161007608|NCT03575052|581416694|FG001|Overall Study|Protocol Violation|2|||
161007609|NCT03575052|581416693|FG000|Overall Study|Physician Decision|1|||
161007610|NCT03575052|581416694|FG001|Overall Study|Physician Decision|0|||
161007611|NCT03624972|581416704|FG000|Overall Study|Lost to Follow-up|2|||
161007612|NCT03624972|581416705|FG001|Overall Study|Lost to Follow-up|0|||
161007613|NCT03624972|581416706|FG002|Overall Study|Lost to Follow-up|0|||
161007614|NCT03624972|581416704|FG000|Overall Study|Withdrawal by Subject|0|||
161007615|NCT03624972|581416705|FG001|Overall Study|Withdrawal by Subject|2|||
161007616|NCT03624972|581416706|FG002|Overall Study|Withdrawal by Subject|0|||
161007617|NCT03112174|581416707|FG000|Overall Study|Withdrawal by Subject|3|||
161007618|NCT03112174|581416708|FG001|Overall Study|Withdrawal by Subject|0|||
161007619|NCT03112174|581416709|FG002|Overall Study|Withdrawal by Subject|11|||
161007620|NCT03112174|581416710|FG003|Overall Study|Withdrawal by Subject|9|||
161007621|NCT03112174|581416711|FG004|Overall Study|Withdrawal by Subject|7|||
161007622|NCT03112174|581416707|FG000|Overall Study|Lost to Follow-up|1|||
161007623|NCT03112174|581416708|FG001|Overall Study|Lost to Follow-up|1|||
161007624|NCT03112174|581416709|FG002|Overall Study|Lost to Follow-up|2|||
161007625|NCT03112174|581416710|FG003|Overall Study|Lost to Follow-up|3|||
161007626|NCT03112174|581416711|FG004|Overall Study|Lost to Follow-up|2|||
161007627|NCT03112174|581416707|FG000|Overall Study|Death|8|||
161007628|NCT03112174|581416708|FG001|Overall Study|Death|3|||
161007629|NCT03112174|581416709|FG002|Overall Study|Death|67|||
161007630|NCT03112174|581416710|FG003|Overall Study|Death|73|||
161007631|NCT03112174|581416711|FG004|Overall Study|Death|18|||
161007632|NCT03112174|581416707|FG000|Overall Study|Other, Not Specified|1|||
161007633|NCT03112174|581416708|FG001|Overall Study|Other, Not Specified|0|||
161007634|NCT03112174|581416709|FG002|Overall Study|Other, Not Specified|1|||
161007635|NCT03112174|581416710|FG003|Overall Study|Other, Not Specified|2|||
161007636|NCT03112174|581416711|FG004|Overall Study|Other, Not Specified|0|||
161007637|NCT04512482|581416712|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
161007638|NCT04512482|581416713|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
161007639|NCT02529995|581416714|FG000|Part A|Ongoing Study at Data Cut-off|14|||
161007640|NCT02529995|581416715|FG001|Part A|Ongoing Study at Data Cut-off|16|||
161007641|NCT02529995|581416714|FG000|Part A|Discontinued Study|1|||
161007642|NCT02529995|581416715|FG001|Part A|Discontinued Study|0|||
161007643|NCT02529995|581416714|FG000|Part B|Ongoing Study at Data Cut-off|0|||
161007644|NCT02529995|581416715|FG001|Part B|Ongoing Study at Data Cut-off|7|||
161007645|NCT02529995|581416714|FG000|Part B|Discontinued Study|6|||
161007646|NCT02529995|581416715|FG001|Part B|Discontinued Study|5|||
161007647|NCT05132478|581416716|FG000|Overall Study|did not complete survey after consent|1|||
161007648|NCT05132478|581416717|FG001|Overall Study|did not complete survey after consent|1|||
161007649|NCT05132478|581416716|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
161007650|NCT05132478|581416717|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
161007651|NCT02549170|581416718|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
161007652|NCT02549170|581416719|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
161007653|NCT02549170|581416720|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161007654|NCT02549170|581416721|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161007655|NCT02549170|581416722|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
161007656|NCT02549170|581416718|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
161007657|NCT02549170|581416719|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
161007658|NCT02549170|581416720|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161007659|NCT02549170|581416721|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161007660|NCT02549170|581416722|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
161007661|NCT02549170|581416718|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
161007662|NCT02549170|581416719|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
161007663|NCT02549170|581416720|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161007664|NCT02549170|581416721|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161007665|NCT02549170|581416722|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
161007666|NCT00421889|581416723|FG000|Overall Study|Adverse Event|1|||
161271597|NCT00750308|582375210|FG008|Third Treatment|Withdrawal by Subject|0|||
161271598|NCT00750308|582375211|FG009|Third Treatment|Withdrawal by Subject|0|||
161271599|NCT00750308|582375212|FG010|Third Treatment|Withdrawal by Subject|0|||
161271600|NCT00750308|582375213|FG011|Third Treatment|Withdrawal by Subject|0|||
161007667|NCT00421889|581416724|FG001|Overall Study|Adverse Event|0|||
161007668|NCT00421889|581416725|FG002|Overall Study|Adverse Event|1|||
161271601|NCT02980874|582375214|FG000|Overall Study|Adverse Event|2|||
161007669|NCT00421889|581416726|FG003|Overall Study|Adverse Event|1|||
161007670|NCT00421889|581416727|FG004|Overall Study|Adverse Event|1|||
161007671|NCT00421889|581416728|FG005|Overall Study|Adverse Event|4|||
161007672|NCT00421889|581416729|FG006|Overall Study|Adverse Event|1|||
161007673|NCT00421889|581416730|FG007|Overall Study|Adverse Event|0|||
161007674|NCT00421889|581416731|FG008|Overall Study|Adverse Event|2|||
161007675|NCT00421889|581416723|FG000|Overall Study|Withdrawal by Subject|1|||
161007676|NCT00421889|581416724|FG001|Overall Study|Withdrawal by Subject|3|||
161007677|NCT00421889|581416725|FG002|Overall Study|Withdrawal by Subject|0|||
161007678|NCT00421889|581416726|FG003|Overall Study|Withdrawal by Subject|0|||
161007679|NCT00421889|581416727|FG004|Overall Study|Withdrawal by Subject|2|||
161007680|NCT00421889|581416728|FG005|Overall Study|Withdrawal by Subject|0|||
161007681|NCT00421889|581416729|FG006|Overall Study|Withdrawal by Subject|0|||
161007682|NCT00421889|581416730|FG007|Overall Study|Withdrawal by Subject|0|||
161007683|NCT00421889|581416731|FG008|Overall Study|Withdrawal by Subject|0|||
161007684|NCT00421889|581416723|FG000|Overall Study|Death|0|||
161007685|NCT00421889|581416724|FG001|Overall Study|Death|0|||
161007686|NCT00421889|581416725|FG002|Overall Study|Death|0|||
161007687|NCT00421889|581416726|FG003|Overall Study|Death|0|||
161007688|NCT00421889|581416727|FG004|Overall Study|Death|1|||
161007689|NCT00421889|581416728|FG005|Overall Study|Death|1|||
161007690|NCT00421889|581416729|FG006|Overall Study|Death|0|||
161007691|NCT00421889|581416730|FG007|Overall Study|Death|0|||
161007692|NCT00421889|581416731|FG008|Overall Study|Death|0|||
161007693|NCT00421889|581416723|FG000|Overall Study|Progressive disease|3|||
161007694|NCT00421889|581416724|FG001|Overall Study|Progressive disease|2|||
161007695|NCT00421889|581416725|FG002|Overall Study|Progressive disease|2|||
161007696|NCT00421889|581416726|FG003|Overall Study|Progressive disease|3|||
161007697|NCT00421889|581416727|FG004|Overall Study|Progressive disease|2|||
161007698|NCT00421889|581416728|FG005|Overall Study|Progressive disease|21|||
161007699|NCT00421889|581416729|FG006|Overall Study|Progressive disease|3|||
161007700|NCT00421889|581416730|FG007|Overall Study|Progressive disease|1|||
161007701|NCT00421889|581416731|FG008|Overall Study|Progressive disease|5|||
161007702|NCT00421889|581416723|FG000|Overall Study|Patient/Investigator request|0|||
161007703|NCT00421889|581416724|FG001|Overall Study|Patient/Investigator request|0|||
161007704|NCT00421889|581416725|FG002|Overall Study|Patient/Investigator request|0|||
161007705|NCT00421889|581416726|FG003|Overall Study|Patient/Investigator request|0|||
161007706|NCT00421889|581416727|FG004|Overall Study|Patient/Investigator request|0|||
161007707|NCT00421889|581416728|FG005|Overall Study|Patient/Investigator request|9|||
161007708|NCT00421889|581416729|FG006|Overall Study|Patient/Investigator request|0|||
161007709|NCT00421889|581416730|FG007|Overall Study|Patient/Investigator request|1|||
161007710|NCT00421889|581416731|FG008|Overall Study|Patient/Investigator request|3|||
161007711|NCT00421889|581416723|FG000|Overall Study|Lost to Follow-up|0|||
161007712|NCT00421889|581416724|FG001|Overall Study|Lost to Follow-up|0|||
161007713|NCT00421889|581416725|FG002|Overall Study|Lost to Follow-up|0|||
161007714|NCT00421889|581416726|FG003|Overall Study|Lost to Follow-up|0|||
161007715|NCT00421889|581416727|FG004|Overall Study|Lost to Follow-up|0|||
161007716|NCT00421889|581416728|FG005|Overall Study|Lost to Follow-up|0|||
161007717|NCT00421889|581416729|FG006|Overall Study|Lost to Follow-up|0|||
161007718|NCT00421889|581416730|FG007|Overall Study|Lost to Follow-up|0|||
161007719|NCT00421889|581416731|FG008|Overall Study|Lost to Follow-up|1|||
161007720|NCT03051165|581416732|FG000|Overall Study|Withdrawal by Subject|1|||
161007721|NCT03051165|581416732|FG000|Overall Study|Early termination of study|12|||
161007722|NCT03684044|581416737|FG000|Overall Study|Adverse Event|3|||
161271602|NCT02980874|582375215|FG001|Overall Study|Adverse Event|7|||
161271603|NCT02980874|582375214|FG000|Overall Study|Withdrawal by Subject|7|||
161271604|NCT02980874|582375215|FG001|Overall Study|Withdrawal by Subject|2|||
161007723|NCT03684044|581416738|FG001|Overall Study|Adverse Event|0|||
161007724|NCT03684044|581416737|FG000|Overall Study|Death|4|||
161007725|NCT03684044|581416738|FG001|Overall Study|Death|7|||
161007726|NCT03684044|581416737|FG000|Overall Study|Lost to Follow-up|3|||
161007727|NCT03684044|581416738|FG001|Overall Study|Lost to Follow-up|2|||
161007728|NCT03684044|581416737|FG000|Overall Study|Patient Not Available|0|||
161271605|NCT02980874|582375214|FG000|Overall Study|Lost to Follow-up|5|||
161007729|NCT03684044|581416738|FG001|Overall Study|Patient Not Available|2|||
161271606|NCT02980874|582375215|FG001|Overall Study|Lost to Follow-up|5|||
161007730|NCT03684044|581416737|FG000|Overall Study|Physician Decision|1|||
161007731|NCT03684044|581416738|FG001|Overall Study|Physician Decision|0|||
161007732|NCT03684044|581416737|FG000|Overall Study|Withdrawal by Subject|11|||
161007733|NCT03684044|581416738|FG001|Overall Study|Withdrawal by Subject|9|||
161007734|NCT03703336|581416739|FG000|Overall Study|Parent withdrew consent|29|||
161007735|NCT03703336|581416740|FG001|Overall Study|Parent withdrew consent|8|||
161007736|NCT03703336|581416739|FG000|Overall Study|Migration|3|||
161007737|NCT03703336|581416740|FG001|Overall Study|Migration|3|||
161007738|NCT03703336|581416739|FG000|Overall Study|Protocol Violation|3|||
161007739|NCT03703336|581416740|FG001|Overall Study|Protocol Violation|1|||
161007740|NCT03703336|581416739|FG000|Overall Study|Physician Decision|2|||
161007741|NCT03703336|581416740|FG001|Overall Study|Physician Decision|0|||
161007742|NCT03703336|581416739|FG000|Overall Study|Adverse Event|0|||
161007743|NCT03703336|581416740|FG001|Overall Study|Adverse Event|2|||
161007744|NCT03703336|581416739|FG000|Overall Study|Lost to Follow-up|1|||
161007745|NCT03703336|581416740|FG001|Overall Study|Lost to Follow-up|0|||
161007746|NCT00595413|581416741|FG000|Overall Study|Adverse Event|0|||
161007747|NCT00595413|581416742|FG001|Overall Study|Adverse Event|2|||
161007748|NCT00595413|581416743|FG002|Overall Study|Adverse Event|1|||
161007749|NCT00595413|581416744|FG003|Overall Study|Adverse Event|1|||
161007750|NCT00595413|581416741|FG000|Overall Study|Lost to Follow-up|2|||
161007751|NCT00595413|581416742|FG001|Overall Study|Lost to Follow-up|2|||
161007752|NCT00595413|581416743|FG002|Overall Study|Lost to Follow-up|1|||
161007753|NCT00595413|581416744|FG003|Overall Study|Lost to Follow-up|3|||
161007754|NCT00595413|581416741|FG000|Overall Study|Death|0|||
161007755|NCT00595413|581416742|FG001|Overall Study|Death|0|||
161007756|NCT00595413|581416743|FG002|Overall Study|Death|1|||
161271607|NCT02980874|582375214|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
161271608|NCT02980874|582375215|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
161271609|NCT02980874|582375214|FG000|Overall Study|Unknown study completion status|1|||
161271610|NCT02980874|582375215|FG001|Overall Study|Unknown study completion status|0|||
161271611|NCT02450526|582375216|FG000|DB Period (Cycle 1)|Adverse Event|0|||
161271612|NCT02450526|582375217|FG001|DB Period (Cycle 1)|Adverse Event|0|||
161271613|NCT02450526|582375218|FG002|DB Period (Cycle 1)|Adverse Event|2|||
161271614|NCT02450526|582375219|FG003|DB Period (Cycle 1)|Adverse Event|0|||
161271615|NCT02450526|582375220|FG004|DB Period (Cycle 1)|Adverse Event|0|||
161271616|NCT02450526|582375216|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
161271617|NCT02450526|582375217|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
161271618|NCT02450526|582375218|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
161271619|NCT02450526|582375219|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
161271620|NCT02450526|582375220|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
161271621|NCT02450526|582375216|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
161271622|NCT02450526|582375217|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
161007757|NCT00595413|581416744|FG003|Overall Study|Death|0|||
161007758|NCT00595413|581416741|FG000|Overall Study|Other|5|||
161007759|NCT00595413|581416742|FG001|Overall Study|Other|1|||
161007760|NCT00595413|581416743|FG002|Overall Study|Other|5|||
161007761|NCT00595413|581416744|FG003|Overall Study|Other|0|||
161007762|NCT00807937|581416745|FG000|Overall Study|Adverse Event|12|||
161007763|NCT00807937|581416746|FG001|Overall Study|Adverse Event|12|||
161007764|NCT00807937|581416747|FG002|Overall Study|Adverse Event|5|||
161007765|NCT00807937|581416748|FG003|Overall Study|Adverse Event|4|||
161007766|NCT00807937|581416745|FG000|Overall Study|Protocol Violation|4|||
161007767|NCT00807937|581416746|FG001|Overall Study|Protocol Violation|5|||
161007768|NCT00807937|581416747|FG002|Overall Study|Protocol Violation|3|||
161007769|NCT00807937|581416748|FG003|Overall Study|Protocol Violation|3|||
161007770|NCT00807937|581416745|FG000|Overall Study|Withdrawal by Subject|5|||
161007771|NCT00807937|581416746|FG001|Overall Study|Withdrawal by Subject|4|||
161007772|NCT00807937|581416747|FG002|Overall Study|Withdrawal by Subject|1|||
161007773|NCT00807937|581416748|FG003|Overall Study|Withdrawal by Subject|4|||
161007774|NCT00807937|581416745|FG000|Overall Study|Lost to Follow-up|4|||
161007775|NCT00807937|581416746|FG001|Overall Study|Lost to Follow-up|0|||
161007776|NCT00807937|581416747|FG002|Overall Study|Lost to Follow-up|2|||
161007777|NCT00807937|581416748|FG003|Overall Study|Lost to Follow-up|1|||
161007778|NCT00807937|581416745|FG000|Overall Study|Lack of Efficacy|0|||
161007779|NCT00807937|581416746|FG001|Overall Study|Lack of Efficacy|0|||
161007780|NCT00807937|581416747|FG002|Overall Study|Lack of Efficacy|1|||
161271623|NCT02450526|582375218|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
161271624|NCT02450526|582375219|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
161271625|NCT02450526|582375220|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
161271626|NCT02450526|582375216|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
161271627|NCT02450526|582375217|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
161271628|NCT02450526|582375218|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
161271629|NCT02450526|582375219|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
161007781|NCT00807937|581416748|FG003|Overall Study|Lack of Efficacy|2|||
161007782|NCT00807937|581416745|FG000|Overall Study|Intake of prohibited medicine|0|||
161007783|NCT00807937|581416746|FG001|Overall Study|Intake of prohibited medicine|0|||
161007784|NCT00807937|581416747|FG002|Overall Study|Intake of prohibited medicine|2|||
161271630|NCT02450526|582375220|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
161271631|NCT02450526|582375216|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
161271632|NCT02450526|582375217|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
161007785|NCT00807937|581416748|FG003|Overall Study|Intake of prohibited medicine|0|||
161007786|NCT00807937|581416745|FG000|Overall Study|All other reasons (not provided)|2|||
161007787|NCT00807937|581416746|FG001|Overall Study|All other reasons (not provided)|4|||
161007788|NCT00807937|581416747|FG002|Overall Study|All other reasons (not provided)|0|||
161007789|NCT00807937|581416748|FG003|Overall Study|All other reasons (not provided)|1|||
161007790|NCT04629950|581416751|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
161007791|NCT04629950|581416752|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
161007792|NCT04629950|581416753|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
161007793|NCT04629950|581416754|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
161007794|NCT04629950|581416751|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161007795|NCT04629950|581416752|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
161007796|NCT04629950|581416753|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161007797|NCT04629950|581416754|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
161007798|NCT04629950|581416751|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161007799|NCT04629950|581416752|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
161007800|NCT04629950|581416753|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161007801|NCT04629950|581416754|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
161007802|NCT04629950|581416751|FG000|Extension Study|Withdrawal by Subject|0|||
161007803|NCT04629950|581416752|FG001|Extension Study|Withdrawal by Subject|0|||
161007804|NCT04629950|581416753|FG002|Extension Study|Withdrawal by Subject|1|||
161007805|NCT04629950|581416754|FG003|Extension Study|Withdrawal by Subject|0|||
161007806|NCT04629950|581416751|FG000|Extension Study|Adverse Event|0|||
161007807|NCT04629950|581416752|FG001|Extension Study|Adverse Event|0|||
161007808|NCT04629950|581416753|FG002|Extension Study|Adverse Event|0|||
161007809|NCT04629950|581416754|FG003|Extension Study|Adverse Event|1|||
161007810|NCT03233633|581416755|FG000|Overall Study|Adverse Event|2|||
161007811|NCT03233633|581416755|FG000|Overall Study|Less Than 3 Days of Data|6|||
161007812|NCT02708108|581416756|FG000|Overall Study|Death|1|||
161007813|NCT02708108|581416757|FG001|Overall Study|Death|2|||
161007814|NCT02708108|581416756|FG000|Overall Study|Regimen change|1|||
161007815|NCT02708108|581416757|FG001|Overall Study|Regimen change|0|||
161007816|NCT02708108|581416756|FG000|Overall Study|No MRD and no imaging available|0|||
161007817|NCT02708108|581416757|FG001|Overall Study|No MRD and no imaging available|1|||
161007818|NCT02568683|581416759|FG000|Overall Study|Death|0|||
161007819|NCT02568683|581416760|FG001|Overall Study|Death|2|||
161007820|NCT02568683|581416759|FG000|Overall Study|Withdrew Consent|1|||
161007821|NCT02568683|581416760|FG001|Overall Study|Withdrew Consent|0|||
161007822|NCT02568683|581416759|FG000|Overall Study|Study Terminated By Sponsor|5|||
161007823|NCT02568683|581416760|FG001|Overall Study|Study Terminated By Sponsor|2|||
161007824|NCT01561989|581416763|FG000|Overall Study|accural target not met.|5|||
161007825|NCT01561989|581416764|FG001|Overall Study|accural target not met.|6|||
161007826|NCT03485950|581416765|FG000|Overall Study|Adverse Event|1|||
161007827|NCT03485950|581416766|FG001|Overall Study|Adverse Event|0|||
161007828|NCT03485950|581416765|FG000|Overall Study|Death|3|||
161007829|NCT03485950|581416766|FG001|Overall Study|Death|2|||
161007830|NCT03485950|581416765|FG000|Overall Study|Withdrawal by Subject|3|||
161007831|NCT03485950|581416766|FG001|Overall Study|Withdrawal by Subject|0|||
161007832|NCT05368831|581416777|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
161007833|NCT03565315|581416779|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161007834|NCT03565315|581416780|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161007835|NCT03565315|581416781|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
161007836|NCT03565315|581416782|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
161007837|NCT03887650|581416783|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
161007838|NCT03887650|581416784|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
161007839|NCT03887650|581416783|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
161007840|NCT03887650|581416784|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
161007841|NCT03887650|581416783|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
161007842|NCT03887650|581416784|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
161007843|NCT01170962|581416785|FG000|Treatment Period|Lack of Efficacy|96|||
161007844|NCT01170962|581416786|FG001|Treatment Period|Lack of Efficacy|91|||
161007845|NCT01170962|581416787|FG002|Treatment Period|Lack of Efficacy|7|||
161007846|NCT01170962|581416785|FG000|Treatment Period|Adverse Event|11|||
161007847|NCT01170962|581416786|FG001|Treatment Period|Adverse Event|12|||
161007848|NCT01170962|581416787|FG002|Treatment Period|Adverse Event|3|||
161007849|NCT01170962|581416785|FG000|Treatment Period|Withdrawal by Subject|2|||
161007850|NCT01170962|581416786|FG001|Treatment Period|Withdrawal by Subject|1|||
161007851|NCT01170962|581416787|FG002|Treatment Period|Withdrawal by Subject|0|||
161007852|NCT01170962|581416785|FG000|Treatment Period|Lost to Follow-up|1|||
161007853|NCT01170962|581416786|FG001|Treatment Period|Lost to Follow-up|1|||
161007854|NCT01170962|581416787|FG002|Treatment Period|Lost to Follow-up|1|||
161007855|NCT01170962|581416785|FG000|Treatment Period|Participant no longer meets criteria|0|||
161007856|NCT01170962|581416786|FG001|Treatment Period|Participant no longer meets criteria|1|||
161007857|NCT01170962|581416787|FG002|Treatment Period|Participant no longer meets criteria|0|||
161007858|NCT01170962|581416785|FG000|Treatment Period|Request to discontinue treatment|7|||
161007859|NCT01170962|581416786|FG001|Treatment Period|Request to discontinue treatment|3|||
161007860|NCT01170962|581416787|FG002|Treatment Period|Request to discontinue treatment|1|||
161007861|NCT01170962|581416785|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
161007862|NCT01170962|581416786|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
161007863|NCT01170962|581416787|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
161007864|NCT01170962|581416785|FG000|Follow up Period|Withdrawal by Subject|14|||
161007865|NCT01170962|581416786|FG001|Follow up Period|Withdrawal by Subject|10|||
161007866|NCT01170962|581416787|FG002|Follow up Period|Withdrawal by Subject|2|||
161007867|NCT01170962|581416785|FG000|Follow up Period|Lost to Follow-up|13|||
161007868|NCT01170962|581416786|FG001|Follow up Period|Lost to Follow-up|8|||
161007869|NCT01170962|581416787|FG002|Follow up Period|Lost to Follow-up|1|||
161007870|NCT01170962|581416785|FG000|Follow up Period|Death|2|||
161007871|NCT01170962|581416786|FG001|Follow up Period|Death|2|||
161271633|NCT02450526|582375218|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
161271634|NCT02450526|582375219|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
161271635|NCT02450526|582375220|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
161271636|NCT02450526|582375216|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161271637|NCT02450526|582375217|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161271638|NCT02450526|582375218|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161271639|NCT02450526|582375219|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
161007872|NCT01170962|581416787|FG002|Follow up Period|Death|0|||
161007873|NCT01170962|581416785|FG000|Follow up Period|Others|10|||
161007874|NCT01170962|581416786|FG001|Follow up Period|Others|7|||
161271640|NCT02450526|582375220|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
161007875|NCT01170962|581416787|FG002|Follow up Period|Others|3|||
161007876|NCT01083316|581416788|FG000|Overall Study|Adverse Event|2|||
161007877|NCT01083316|581416788|FG000|Overall Study|Withdrawal by Subject|1|||
161007878|NCT04200365|581416789|FG000|Overall Study|Adverse Event|2|||
161007879|NCT04200365|581416789|FG000|Overall Study|Progressive Disease|4|||
161007880|NCT04200365|581416789|FG000|Overall Study|Lack of Efficacy|1|||
161007881|NCT04200365|581416789|FG000|Overall Study|Study Closure|4|||
161007882|NCT01199575|581416790|FG000|Overall Study|Withdrawal by Subject|5|||
161007883|NCT00704184|581416795|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
161007884|NCT00704184|581416796|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
161007885|NCT00704184|581416797|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
161007886|NCT00704184|581416798|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
161007887|NCT00704184|581416799|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
161007888|NCT00704184|581416795|FG000|Open-Label Treatment|Adverse Event|0|||
161007889|NCT00704184|581416796|FG001|Open-Label Treatment|Adverse Event|0|||
161007890|NCT00704184|581416797|FG002|Open-Label Treatment|Adverse Event|2|||
161271641|NCT02450526|582375216|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161271642|NCT02450526|582375217|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161271643|NCT02450526|582375218|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161271644|NCT02450526|582375219|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
161271645|NCT02450526|582375220|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
161271646|NCT02450526|582375216|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
161271647|NCT02450526|582375217|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
161343512|NCT03282097|582644402|FG000|Intervention Visit Complete|Caregiver Death|0|||
161343513|NCT03282097|582644403|FG001|Intervention Visit Complete|Caregiver Death|3|||
161343514|NCT03282097|582644402|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
161343515|NCT03282097|582644403|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
161343516|NCT03282097|582644402|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
160966933|NCT02287584|581266790|FG005|the Open-label Phase|other reasons|6|||
160966934|NCT03124199|581266791|FG000|Overall Study|Lost to Follow-up|4|||
160966935|NCT03086018|581266793|FG000|Final Testing for End of Trial|Adverse Event|1|||
160966936|NCT03086018|581266793|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
160966937|NCT02309112|581266794|FG000|Overall Study|Withdrawal by Subject|1|||
160966938|NCT02309112|581266795|FG001|Overall Study|Withdrawal by Subject|0|||
160966939|NCT02309112|581266796|FG002|Overall Study|Withdrawal by Subject|1|||
160966940|NCT02309112|581266794|FG000|Overall Study|Lost to Follow-up|0|||
160966941|NCT02309112|581266795|FG001|Overall Study|Lost to Follow-up|1|||
160966942|NCT02309112|581266796|FG002|Overall Study|Lost to Follow-up|0|||
160966943|NCT01892345|581266797|FG000|Overall Study|Adverse Event|0|||
160966944|NCT01892345|581266798|FG001|Overall Study|Adverse Event|2|||
160966945|NCT01892345|581266797|FG000|Overall Study|Death|1|||
160966946|NCT01892345|581266798|FG001|Overall Study|Death|0|||
160966947|NCT01892345|581266797|FG000|Overall Study|Lost to Follow-up|3|||
160966948|NCT01892345|581266798|FG001|Overall Study|Lost to Follow-up|0|||
160966949|NCT01892345|581266797|FG000|Overall Study|Withdrawal by Subject|12|||
160966950|NCT01892345|581266798|FG001|Overall Study|Withdrawal by Subject|1|||
160966951|NCT00659984|581266802|FG000|Overall Study|Adverse Event|1|||
160966952|NCT00948974|581266805|FG000|Overall Study|Lost to Follow-up|23|||
160966953|NCT00948974|581266806|FG001|Overall Study|Lost to Follow-up|20|||
160966954|NCT02487810|581266807|FG000|Overall Study|Withdrawal by Subject|1|||
160966955|NCT02487810|581266808|FG001|Overall Study|Withdrawal by Subject|0|||
161007891|NCT00704184|581416798|FG003|Open-Label Treatment|Adverse Event|0|||
161007892|NCT00704184|581416799|FG004|Open-Label Treatment|Adverse Event|1|||
161007893|NCT00704184|581416795|FG000|Open-Label Treatment|Lack of Efficacy|0|||
161007894|NCT00704184|581416796|FG001|Open-Label Treatment|Lack of Efficacy|2|||
161007895|NCT00704184|581416797|FG002|Open-Label Treatment|Lack of Efficacy|2|||
161007896|NCT00704184|581416798|FG003|Open-Label Treatment|Lack of Efficacy|2|||
160966956|NCT00621543|581266811|FG000|Overall Study|Lost to Follow-up|23|||
160966957|NCT04252742|581266812|FG000|Overall Study|Decision by sponsor|0|||
160966958|NCT04252742|581266813|FG001|Overall Study|Decision by sponsor|2|||
161007897|NCT00704184|581416799|FG004|Open-Label Treatment|Lack of Efficacy|1|||
161007898|NCT00704184|581416795|FG000|Open-Label Treatment|Physician Decision|0|||
161007899|NCT00704184|581416796|FG001|Open-Label Treatment|Physician Decision|0|||
161007900|NCT00704184|581416797|FG002|Open-Label Treatment|Physician Decision|0|||
161007901|NCT00704184|581416798|FG003|Open-Label Treatment|Physician Decision|0|||
161007902|NCT00704184|581416799|FG004|Open-Label Treatment|Physician Decision|1|||
161007903|NCT00704184|581416795|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
161007904|NCT00704184|581416796|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
161007905|NCT00704184|581416797|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
161007906|NCT00704184|581416798|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
161007907|NCT00704184|581416799|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
161007908|NCT02178098|581416800|FG000|Overall Study|Withdrawal by Subject|0|||
161007909|NCT02178098|581416801|FG001|Overall Study|Withdrawal by Subject|6|||
161007910|NCT02178098|581416800|FG000|Overall Study|Adverse Event|1|||
161007911|NCT02178098|581416801|FG001|Overall Study|Adverse Event|2|||
161007912|NCT02178098|581416800|FG000|Overall Study|Protocol Violation|1|||
161007913|NCT02178098|581416801|FG001|Overall Study|Protocol Violation|1|||
161007914|NCT02178098|581416800|FG000|Overall Study|Lost to Follow-up|0|||
161007915|NCT02178098|581416801|FG001|Overall Study|Lost to Follow-up|1|||
161007916|NCT02178098|581416800|FG000|Overall Study|Sponsor Request|1|||
161007917|NCT02178098|581416801|FG001|Overall Study|Sponsor Request|0|||
161007918|NCT02178098|581416800|FG000|Overall Study|Other|2|||
161007919|NCT02178098|581416801|FG001|Overall Study|Other|2|||
161007920|NCT01109524|581416807|FG000|Overall Study|Disease Progression|29|||
161007921|NCT01109524|581416807|FG000|Overall Study|Study Drug toxicity|6|||
161007922|NCT01109524|581416807|FG000|Overall Study|Adverse Event|4|||
161007923|NCT01109524|581416807|FG000|Overall Study|Withdrawal by Subject|2|||
161007924|NCT01109524|581416807|FG000|Overall Study|Maximum clinical benefit|3|||
161007925|NCT01109524|581416807|FG000|Overall Study|Death|2|||
161007926|NCT01109524|581416807|FG000|Overall Study|No longer meets criteria|2|||
161007927|NCT01109524|581416807|FG000|Overall Study|Participant requested to end treatment|4|||
161007928|NCT01109524|581416807|FG000|Overall Study|Other|5|||
161007929|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
161007930|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007931|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007932|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007933|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
161007934|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
161007935|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007936|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007937|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007938|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
161007939|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
161007940|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007941|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007942|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007943|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
161007944|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
161007945|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007946|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007947|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007948|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
161007949|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
161007950|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007951|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007952|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007953|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
161007954|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
161271648|NCT02450526|582375218|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
161271649|NCT02450526|582375219|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
161271650|NCT02450526|582375220|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
161271651|NCT00911807|582375221|FG000|Overall Study|Adverse Event|2|||
161271652|NCT00911807|582375222|FG001|Overall Study|Adverse Event|1|||
161007955|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161007956|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161007957|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161271653|NCT00911807|582375223|FG002|Overall Study|Adverse Event|5|||
161271654|NCT00911807|582375221|FG000|Overall Study|Death|0|||
161271655|NCT00911807|582375222|FG001|Overall Study|Death|0|||
161271656|NCT00911807|582375223|FG002|Overall Study|Death|1|||
161007958|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
161007959|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
161007960|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007961|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007962|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007963|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
161007964|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
161007965|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007966|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007967|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007968|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
161007969|NCT02409667|581416808|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
161007970|NCT02409667|581416809|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007971|NCT02409667|581416810|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007972|NCT02409667|581416811|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007973|NCT02409667|581416812|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
161007974|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
161007975|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
161007976|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
161007977|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
161007978|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
161007979|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007980|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007981|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007982|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
161007983|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
161007984|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
161007985|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
161007986|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
161007987|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
161007988|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
161007989|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161007990|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
161007991|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
161007992|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161007993|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
161007994|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
161007995|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
161007996|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
161007997|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
161007998|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
161007999|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161008000|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161008001|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
161008002|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
161008003|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
161008004|NCT02409667|581416808|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008005|NCT02409667|581416809|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008006|NCT02409667|581416810|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
161008007|NCT02409667|581416811|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008008|NCT02409667|581416812|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
161008009|NCT01925339|581416813|FG000|Overall Study|Adverse Event|2|||
161008010|NCT01925339|581416814|FG001|Overall Study|Adverse Event|0|||
161008011|NCT04992390|581416829|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
161147373|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147374|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147375|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147376|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
161147377|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161147378|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
161147379|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
161147380|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161147381|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161147382|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161271657|NCT00911807|582375221|FG000|Overall Study|Protocol Violation|6|||
161008012|NCT04992390|581416830|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
161008013|NCT04992390|581416831|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
161008014|NCT04992390|581416829|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
161008015|NCT04992390|581416830|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
161008016|NCT04992390|581416831|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
161008017|NCT04992390|581416829|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
161008018|NCT04992390|581416830|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
161008019|NCT04992390|581416831|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
161008020|NCT04992390|581416829|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
161008021|NCT04992390|581416830|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
161008022|NCT04992390|581416831|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
161008023|NCT04992390|581416829|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
161008024|NCT04992390|581416830|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
161008025|NCT04992390|581416831|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
161008026|NCT04992390|581416829|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
161008027|NCT04992390|581416830|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
161008028|NCT04992390|581416831|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
161008029|NCT04992390|581416829|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
161008030|NCT04992390|581416830|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
161008031|NCT04992390|581416831|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
161271658|NCT00911807|582375222|FG001|Overall Study|Protocol Violation|4|||
161271659|NCT00911807|582375223|FG002|Overall Study|Protocol Violation|9|||
161271660|NCT00911807|582375221|FG000|Overall Study|Withdrawal by Subject|8|||
161271661|NCT00911807|582375222|FG001|Overall Study|Withdrawal by Subject|10|||
160966959|NCT04252742|581266812|FG000|Overall Study|Withdrawal by Subject|15|||
160966960|NCT04252742|581266813|FG001|Overall Study|Withdrawal by Subject|9|||
160966961|NCT04252742|581266812|FG000|Overall Study|Lost to Follow-up|0|||
160966962|NCT04252742|581266813|FG001|Overall Study|Lost to Follow-up|1|||
160966963|NCT00031486|581266816|FG000|Overall Study|Adverse Event|1|||
160966964|NCT00031486|581266817|FG001|Overall Study|Adverse Event|0|||
160966965|NCT00031486|581266816|FG000|Overall Study|Lost to Follow-up|0|||
160966966|NCT00031486|581266817|FG001|Overall Study|Lost to Follow-up|1|||
160966967|NCT00031486|581266816|FG000|Overall Study|Withdrawal by Subject|3|||
160966968|NCT00031486|581266817|FG001|Overall Study|Withdrawal by Subject|2|||
160966969|NCT00031486|581266816|FG000|Overall Study|Death|0|||
160966970|NCT00031486|581266817|FG001|Overall Study|Death|3|||
160966971|NCT00031486|581266816|FG000|Overall Study|Non-compliant|0|||
160966972|NCT00031486|581266817|FG001|Overall Study|Non-compliant|4|||
160966973|NCT00031486|581266816|FG000|Overall Study|Did not meet eligibility requirement|2|||
160966974|NCT00031486|581266817|FG001|Overall Study|Did not meet eligibility requirement|1|||
160966975|NCT00031486|581266816|FG000|Overall Study|Other|1|||
160966976|NCT00031486|581266817|FG001|Overall Study|Other|1|||
160966977|NCT01685138|581266818|FG000|Overall Study|Lost to Follow-up|1|||
160966978|NCT01685138|581266818|FG000|Overall Study|Protocol Violation|1|||
160966979|NCT01685138|581266818|FG000|Overall Study|No longer requires treatment|1|||
160966980|NCT01685138|581266818|FG000|Overall Study|Subject/guardian decision|2|||
160966981|NCT01685138|581266818|FG000|Overall Study|Physician Decision|6|||
160966982|NCT01685138|581266818|FG000|Overall Study|Death|10|||
160966983|NCT01685138|581266818|FG000|Overall Study|Adverse Event|18|||
160966984|NCT01685138|581266818|FG000|Overall Study|Progressive disease|53|||
160966985|NCT03996291|581266823|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
160966986|NCT03996291|581266824|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
160966987|NCT03996291|581266825|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
160966988|NCT03996291|581266826|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
160966989|NCT03996291|581266827|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
160966990|NCT03996291|581266828|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
160966991|NCT03996291|581266829|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
160966992|NCT03996291|581266830|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
160966993|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966994|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966995|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966996|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966997|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160966998|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
160966999|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
160967000|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
160967001|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967002|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967003|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967004|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967005|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
160967006|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
161008032|NCT04992390|581416829|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
161008033|NCT04992390|581416830|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
161008034|NCT04992390|581416831|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
161008035|NCT04992390|581416829|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
161008036|NCT04992390|581416830|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
161008037|NCT04992390|581416831|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
161008038|NCT04992390|581416829|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
161008039|NCT04992390|581416830|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
161008040|NCT04992390|581416831|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
161008041|NCT04992390|581416829|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
161008042|NCT04992390|581416830|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
161008043|NCT04992390|581416831|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
161008044|NCT04992390|581416829|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
161008045|NCT04992390|581416830|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
161008046|NCT04992390|581416831|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
161008047|NCT04992390|581416829|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
161008048|NCT04992390|581416830|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
161008049|NCT04992390|581416831|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
161008050|NCT04992390|581416829|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
161008051|NCT04992390|581416830|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
161008052|NCT04992390|581416831|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
161008053|NCT04992390|581416829|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
161008054|NCT04992390|581416830|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
161008055|NCT04992390|581416831|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
161008056|NCT04992390|581416829|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
161008057|NCT04992390|581416830|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
160967007|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
160967008|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
160967009|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
160967010|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
160967011|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
160967012|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
160967013|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
160967014|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
160967015|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
160967016|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
160967017|NCT03996291|581266823|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967018|NCT03996291|581266824|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967019|NCT03996291|581266825|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967020|NCT03996291|581266826|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967021|NCT03996291|581266827|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
160967022|NCT03996291|581266828|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967023|NCT03996291|581266829|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967024|NCT03996291|581266830|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
160967025|NCT01659151|581266833|FG000|Overall Study|Inadequate TIL growth|1|||
160967026|NCT05774197|581266834|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
160967027|NCT05073133|581266837|FG000|Overall Study|Death|2|||
160967028|NCT05002218|581266841|FG000|Overall Study|Lost to Follow-up|5|||
160967029|NCT05002218|581266842|FG001|Overall Study|Lost to Follow-up|6|||
160967030|NCT03421808|581266843|FG000|Overall Study|COVID related problems|2|||
160967031|NCT03421808|581266844|FG001|Overall Study|COVID related problems|0|||
160967032|NCT03421808|581266843|FG000|Overall Study|Withdrawal by Subject|1|||
160967033|NCT03421808|581266844|FG001|Overall Study|Withdrawal by Subject|0|||
160967034|NCT03421808|581266843|FG000|Overall Study|Protocol Violation|0|||
160967035|NCT03421808|581266844|FG001|Overall Study|Protocol Violation|1|||
160967036|NCT03764774|581266847|FG000|Overall Study|Withdrawal by Subject|0|||
160967037|NCT03764774|581266848|FG001|Overall Study|Withdrawal by Subject|0|||
160967038|NCT03764774|581266849|FG002|Overall Study|Withdrawal by Subject|0|||
160967039|NCT03764774|581266850|FG003|Overall Study|Withdrawal by Subject|0|||
160967040|NCT03764774|581266851|FG004|Overall Study|Withdrawal by Subject|0|||
160967041|NCT03764774|581266852|FG005|Overall Study|Withdrawal by Subject|0|||
160967042|NCT03764774|581266853|FG006|Overall Study|Withdrawal by Subject|0|||
160967043|NCT03764774|581266854|FG007|Overall Study|Withdrawal by Subject|0|||
160967044|NCT03764774|581266855|FG008|Overall Study|Withdrawal by Subject|0|||
161008058|NCT04992390|581416831|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
160967045|NCT03764774|581266856|FG009|Overall Study|Withdrawal by Subject|0|||
160967046|NCT03764774|581266857|FG010|Overall Study|Withdrawal by Subject|1|||
161008059|NCT02769858|581416834|FG000|Overall Study|Withdrawal by Subject|2|||
161147383|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161147384|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161147385|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
161147386|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161147387|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
161008066|NCT04939246|581416837|FG000|After Treatment|Death|4|||
161008067|NCT04939246|581416837|FG000|After Treatment|Lost to Follow-up|1|||
161008068|NCT04939246|581416837|FG000|After Treatment|Discharged to hospice|2|||
161008069|NCT01853748|581418711|FG000|Allocation|Withdrawal by Subject|1|||
161008070|NCT01853748|581418712|FG001|Allocation|Withdrawal by Subject|13|||
161008071|NCT01853748|581418711|FG000|Allocation|not sufficient to receive intervention|0|||
161008072|NCT01853748|581418712|FG001|Allocation|not sufficient to receive intervention|1|||
161008073|NCT01853748|581418711|FG000|Follow-Up|Withdrawal by Subject|7|||
161008074|NCT01853748|581418712|FG001|Follow-Up|Withdrawal by Subject|6|||
161008075|NCT01853748|581418711|FG000|Follow-Up|Adverse Event|67|||
161008076|NCT01853748|581418712|FG001|Follow-Up|Adverse Event|7|||
161008077|NCT01853748|581418711|FG000|Follow-Up|not available for data collection|16|||
161008078|NCT01853748|581418712|FG001|Follow-Up|not available for data collection|4|||
161008079|NCT05505045|581418713|FG000|Overall Study|Withdrawal by Subject|2|||
161008080|NCT05505045|581418714|FG001|Overall Study|Withdrawal by Subject|1|||
161008081|NCT04201834|581418718|FG000|Overall Study|Screen fail|1|||
161008082|NCT04104321|581418722|FG000|Overall Study|didn't take the study drug|3|||
161008083|NCT04842500|581418723|FG000|Overall Study|Withdrawal by Subject|4|||
161008084|NCT04842500|581418724|FG001|Overall Study|Withdrawal by Subject|1|||
161008085|NCT04842500|581418725|FG002|Overall Study|Withdrawal by Subject|2|||
161008086|NCT04842500|581418726|FG003|Overall Study|Withdrawal by Subject|3|||
161008087|NCT04842500|581418723|FG000|Overall Study|Protocol Violation|1|||
161008088|NCT04842500|581418724|FG001|Overall Study|Protocol Violation|0|||
161008089|NCT04842500|581418725|FG002|Overall Study|Protocol Violation|0|||
161008090|NCT04842500|581418726|FG003|Overall Study|Protocol Violation|1|||
161008091|NCT02980276|581418727|FG000|Overall Study|Withdrawal by Subject|4|||
161008092|NCT02980276|581418728|FG001|Overall Study|Withdrawal by Subject|4|||
161008093|NCT02980276|581418727|FG000|Overall Study|Physician Decision|0|||
161008094|NCT02980276|581418728|FG001|Overall Study|Physician Decision|1|||
161008095|NCT02980276|581418727|FG000|Overall Study|Lost to Follow-up|18|||
161008096|NCT02980276|581418728|FG001|Overall Study|Lost to Follow-up|18|||
161008097|NCT02980276|581418727|FG000|Overall Study|Death|1|||
161008098|NCT02980276|581418728|FG001|Overall Study|Death|0|||
161008099|NCT02980276|581418727|FG000|Overall Study|Miscellaneous other|10|||
161008100|NCT02980276|581418728|FG001|Overall Study|Miscellaneous other|4|||
161008101|NCT04139668|581418729|FG000|Overall Study|Withdrawal by Subject|1|||
161008102|NCT03554265|581418730|FG000|Overall Study|Withdrawal by Subject|2|||
161008103|NCT03554265|581418731|FG001|Overall Study|Withdrawal by Subject|2|||
161008104|NCT03554265|581418732|FG002|Overall Study|Withdrawal by Subject|3|||
161008105|NCT03554265|581418730|FG000|Overall Study|Physician Decision|0|||
161008106|NCT03554265|581418731|FG001|Overall Study|Physician Decision|0|||
161008107|NCT03554265|581418732|FG002|Overall Study|Physician Decision|1|||
161008108|NCT03025789|581418733|FG000|Overall Study|Lack of Efficacy|6|||
161008109|NCT03025789|581418734|FG001|Overall Study|Lack of Efficacy|1|||
161008110|NCT03025789|581418733|FG000|Overall Study|Death|1|||
161008111|NCT03025789|581418734|FG001|Overall Study|Death|0|||
161008112|NCT03025789|581418733|FG000|Overall Study|Withdrawal by Subject|0|||
161008113|NCT03025789|581418734|FG001|Overall Study|Withdrawal by Subject|2|||
161008114|NCT05057897|581418735|FG000|Overall Study|Site closure|2|||
161008115|NCT05057897|581418736|FG001|Overall Study|Site closure|2|||
161008116|NCT05057897|581418735|FG000|Overall Study|Death|1|||
161008117|NCT05057897|581418736|FG001|Overall Study|Death|0|||
161008118|NCT01903811|581418748|FG000|Overall Study|No measurable disease|1|||
161008119|NCT01903811|581418749|FG001|Overall Study|No measurable disease|1|||
161008120|NCT01903811|581418748|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
161008121|NCT01903811|581418749|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
161008122|NCT01903811|581418748|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
161008123|NCT01903811|581418749|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
161008124|NCT01903811|581418748|FG000|Overall Study|Withdrawal by Subject|0|||
161008125|NCT01903811|581418749|FG001|Overall Study|Withdrawal by Subject|1|||
161008126|NCT04188379|581418750|FG000|Overall Study|Withdrawal by Subject|10|||
161008127|NCT04188379|581418751|FG001|Overall Study|Withdrawal by Subject|3|||
161008128|NCT04188379|581418750|FG000|Overall Study|Physician Decision|0|||
161008129|NCT04188379|581418751|FG001|Overall Study|Physician Decision|1|||
161008130|NCT04188379|581418750|FG000|Overall Study|Adverse Event|3|||
161008131|NCT04188379|581418751|FG001|Overall Study|Adverse Event|1|||
161008132|NCT04188379|581418750|FG000|Overall Study|Pregnancy|1|||
161008133|NCT04188379|581418751|FG001|Overall Study|Pregnancy|0|||
161008134|NCT04188379|581418750|FG000|Overall Study|Lack of Efficacy|8|||
161008135|NCT04188379|581418751|FG001|Overall Study|Lack of Efficacy|5|||
161008136|NCT04188379|581418750|FG000|Overall Study|Other|0|||
161008137|NCT04188379|581418751|FG001|Overall Study|Other|3|||
161008138|NCT02932579|581418760|FG000|Overall Study|Withdrawal by Subject|4|||
161008139|NCT02932579|581418761|FG001|Overall Study|Withdrawal by Subject|1|||
161008140|NCT02706717|581418762|FG000|Overall Study|Withdrawal by Subject|1|||
161008141|NCT02706717|581418763|FG001|Overall Study|Withdrawal by Subject|8|||
161008142|NCT02706717|581418762|FG000|Overall Study|Lost to Follow-up|0|||
161008143|NCT02706717|581418763|FG001|Overall Study|Lost to Follow-up|1|||
161008144|NCT02706717|581418762|FG000|Overall Study|Physician Decision|0|||
161008145|NCT02706717|581418763|FG001|Overall Study|Physician Decision|1|||
161008146|NCT02706717|581418762|FG000|Overall Study|Death|0|||
161008147|NCT02706717|581418763|FG001|Overall Study|Death|1|||
161008148|NCT00978042|581418768|FG000|Initial Treatment Period|Treated in Error|0|||
161008149|NCT00978042|581418769|FG001|Initial Treatment Period|Treated in Error|3|||
161008150|NCT00978042|581418768|FG000|Initial Treatment Period|Ineligibility|1|||
161008151|NCT00978042|581418769|FG001|Initial Treatment Period|Ineligibility|0|||
161008152|NCT00978042|581418768|FG000|Initial Treatment Period|Lost to Follow-up|21|||
161008153|NCT00978042|581418769|FG001|Initial Treatment Period|Lost to Follow-up|3|||
161008154|NCT00978042|581418768|FG000|Initial Treatment Period|Adverse Event|2|||
161008155|NCT00978042|581418769|FG001|Initial Treatment Period|Adverse Event|0|||
161008156|NCT00978042|581418768|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
161008157|NCT00978042|581418769|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
161008158|NCT00978042|581418768|FG000|Initial Treatment Period|Consent withdrawn|22|||
161008159|NCT00978042|581418769|FG001|Initial Treatment Period|Consent withdrawn|9|||
161008160|NCT00978042|581418768|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
161008161|NCT00978042|581418769|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
161008162|NCT00111813|581418770|FG000|Overall Study|Adverse Event|1|||
161008163|NCT00111813|581418771|FG001|Overall Study|Adverse Event|2|||
161008164|NCT00111813|581418772|FG002|Overall Study|Adverse Event|4|||
161008165|NCT00111813|581418773|FG003|Overall Study|Adverse Event|2|||
161008166|NCT00111813|581418774|FG004|Overall Study|Adverse Event|2|||
161008167|NCT00111813|581418775|FG005|Overall Study|Adverse Event|2|||
161008168|NCT00111813|581418770|FG000|Overall Study|Progressive disease|2|||
161008169|NCT00111813|581418771|FG001|Overall Study|Progressive disease|1|||
161008170|NCT00111813|581418772|FG002|Overall Study|Progressive disease|5|||
161008171|NCT00111813|581418773|FG003|Overall Study|Progressive disease|3|||
161008172|NCT00111813|581418774|FG004|Overall Study|Progressive disease|4|||
161008173|NCT00111813|581418775|FG005|Overall Study|Progressive disease|3|||
161008174|NCT00111813|581418770|FG000|Overall Study|Lack of Efficacy|0|||
161008175|NCT00111813|581418771|FG001|Overall Study|Lack of Efficacy|0|||
161008176|NCT00111813|581418772|FG002|Overall Study|Lack of Efficacy|0|||
161008177|NCT00111813|581418773|FG003|Overall Study|Lack of Efficacy|0|||
161008178|NCT00111813|581418774|FG004|Overall Study|Lack of Efficacy|0|||
161008179|NCT00111813|581418775|FG005|Overall Study|Lack of Efficacy|1|||
161008180|NCT00111813|581418770|FG000|Overall Study|Other|0|||
161008181|NCT00111813|581418771|FG001|Overall Study|Other|0|||
161008182|NCT00111813|581418772|FG002|Overall Study|Other|1|||
161008183|NCT00111813|581418773|FG003|Overall Study|Other|0|||
161008184|NCT00111813|581418774|FG004|Overall Study|Other|0|||
161008185|NCT00111813|581418775|FG005|Overall Study|Other|0|||
161008186|NCT01610297|581418776|FG000|Overall Study|Lost to Follow-up|1|||
161008187|NCT00818246|581418777|FG000|Overall Study|Impossible to match pictures|5|||
161008188|NCT02121002|581418778|FG000|Overall Study|Physician Decision|2|||
161008189|NCT02121002|581418779|FG001|Overall Study|Physician Decision|0|||
161008190|NCT02121002|581418780|FG002|Overall Study|Physician Decision|0|||
161008191|NCT02121002|581418778|FG000|Overall Study|Withdrawal by Subject|3|||
161271662|NCT00911807|582375223|FG002|Overall Study|Withdrawal by Subject|7|||
161271663|NCT00911807|582375221|FG000|Overall Study|Organizational reasons|1|||
161008192|NCT02121002|581418779|FG001|Overall Study|Withdrawal by Subject|1|||
161008193|NCT02121002|581418780|FG002|Overall Study|Withdrawal by Subject|4|||
161008194|NCT02121002|581418778|FG000|Overall Study|Protocol Violation|1|||
161008195|NCT02121002|581418779|FG001|Overall Study|Protocol Violation|2|||
161008196|NCT02121002|581418780|FG002|Overall Study|Protocol Violation|4|||
161008197|NCT02121002|581418778|FG000|Overall Study|Concomitant therapy|0|||
161008198|NCT02121002|581418779|FG001|Overall Study|Concomitant therapy|1|||
161271664|NCT00911807|582375222|FG001|Overall Study|Organizational reasons|3|||
161008199|NCT02121002|581418780|FG002|Overall Study|Concomitant therapy|1|||
161008200|NCT02121002|581418778|FG000|Overall Study|Others|1|||
161008201|NCT02121002|581418779|FG001|Overall Study|Others|0|||
161008202|NCT02121002|581418780|FG002|Overall Study|Others|1|||
161008203|NCT02590432|581418781|FG000|Open-label Treatment Period|Adverse Event|97|||
161008204|NCT02590432|581418782|FG001|Open-label Treatment Period|Adverse Event|79|||
161008205|NCT02590432|581418783|FG002|Open-label Treatment Period|Adverse Event|0|||
161008206|NCT02590432|581418784|FG003|Open-label Treatment Period|Adverse Event|0|||
161008207|NCT02590432|581418785|FG004|Open-label Treatment Period|Adverse Event|0|||
161008208|NCT02590432|581418786|FG005|Open-label Treatment Period|Adverse Event|0|||
161008209|NCT02590432|581418787|FG006|Open-label Treatment Period|Adverse Event|0|||
161008210|NCT02590432|581418788|FG007|Open-label Treatment Period|Adverse Event|0|||
161008211|NCT02590432|581418789|FG008|Open-label Treatment Period|Adverse Event|0|||
161008212|NCT02590432|581418781|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
161008213|NCT02590432|581418782|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
161008214|NCT02590432|581418783|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
161008215|NCT02590432|581418784|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
161008216|NCT02590432|581418785|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
161008217|NCT02590432|581418786|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
161008218|NCT02590432|581418787|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
161008219|NCT02590432|581418788|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
161008220|NCT02590432|581418789|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
161008221|NCT02590432|581418781|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
161008222|NCT02590432|581418782|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
161008223|NCT02590432|581418783|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
161008224|NCT02590432|581418784|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
161008225|NCT02590432|581418785|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
161008226|NCT02590432|581418786|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
161008227|NCT02590432|581418787|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
161008228|NCT02590432|581418788|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
161008229|NCT02590432|581418789|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
161008230|NCT02590432|581418781|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
161008231|NCT02590432|581418782|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
161008232|NCT02590432|581418783|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161008233|NCT02590432|581418784|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161008234|NCT02590432|581418785|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
161008235|NCT02590432|581418786|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
161008236|NCT02590432|581418787|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
161008237|NCT02590432|581418788|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
161008238|NCT02590432|581418789|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
161008239|NCT02590432|581418781|FG000|Open-label Treatment Period|Protocol Violation|10|||
161008240|NCT02590432|581418782|FG001|Open-label Treatment Period|Protocol Violation|4|||
161008241|NCT02590432|581418783|FG002|Open-label Treatment Period|Protocol Violation|0|||
161008242|NCT02590432|581418784|FG003|Open-label Treatment Period|Protocol Violation|0|||
161008243|NCT02590432|581418785|FG004|Open-label Treatment Period|Protocol Violation|0|||
161008244|NCT02590432|581418786|FG005|Open-label Treatment Period|Protocol Violation|0|||
161008245|NCT02590432|581418787|FG006|Open-label Treatment Period|Protocol Violation|0|||
161008246|NCT02590432|581418788|FG007|Open-label Treatment Period|Protocol Violation|0|||
161008247|NCT02590432|581418789|FG008|Open-label Treatment Period|Protocol Violation|0|||
161008248|NCT02590432|581418781|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
161008249|NCT02590432|581418782|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
161008250|NCT02590432|581418783|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008251|NCT02590432|581418784|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008252|NCT02590432|581418785|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008253|NCT02590432|581418786|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008254|NCT02590432|581418787|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008255|NCT02590432|581418788|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008256|NCT02590432|581418789|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
161008257|NCT02590432|581418781|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
161008258|NCT02590432|581418782|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
161008259|NCT02590432|581418783|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008260|NCT02590432|581418784|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008261|NCT02590432|581418785|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008262|NCT02590432|581418786|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008263|NCT02590432|581418787|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008264|NCT02590432|581418788|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008265|NCT02590432|581418789|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
161008266|NCT02590432|581418781|FG000|Double-blind Treatment Period|Adverse Event|0|||
161008267|NCT02590432|581418782|FG001|Double-blind Treatment Period|Adverse Event|0|||
161008268|NCT02590432|581418783|FG002|Double-blind Treatment Period|Adverse Event|14|||
161008269|NCT02590432|581418784|FG003|Double-blind Treatment Period|Adverse Event|12|||
161008270|NCT02590432|581418785|FG004|Double-blind Treatment Period|Adverse Event|6|||
161008271|NCT02590432|581418786|FG005|Double-blind Treatment Period|Adverse Event|22|||
161008272|NCT02590432|581418787|FG006|Double-blind Treatment Period|Adverse Event|20|||
161008273|NCT02590432|581418788|FG007|Double-blind Treatment Period|Adverse Event|0|||
161008274|NCT02590432|581418789|FG008|Double-blind Treatment Period|Adverse Event|0|||
161008275|NCT02590432|581418781|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161008276|NCT02590432|581418782|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161008277|NCT02590432|581418783|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161147388|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161147389|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161147390|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161008278|NCT02590432|581418784|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161008279|NCT02590432|581418785|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
161008280|NCT02590432|581418786|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
161008281|NCT02590432|581418787|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
161008282|NCT02590432|581418788|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
161008283|NCT02590432|581418789|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
161008284|NCT02590432|581418781|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008285|NCT02590432|581418782|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008286|NCT02590432|581418783|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
161008287|NCT02590432|581418784|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
161008288|NCT02590432|581418785|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
161008289|NCT02590432|581418786|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
161008290|NCT02590432|581418787|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
161008291|NCT02590432|581418788|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008292|NCT02590432|581418789|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
161008293|NCT02590432|581418781|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161008294|NCT02590432|581418782|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161008295|NCT02590432|581418783|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161008296|NCT02590432|581418784|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161008297|NCT02590432|581418785|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
161008298|NCT02590432|581418786|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
161008299|NCT02590432|581418787|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
161008300|NCT02590432|581418788|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
161008301|NCT02590432|581418789|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
161008302|NCT02590432|581418781|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008303|NCT02590432|581418782|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008304|NCT02590432|581418783|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008305|NCT02590432|581418784|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008306|NCT02590432|581418785|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008307|NCT02590432|581418786|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
161008308|NCT02590432|581418787|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008309|NCT02590432|581418788|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008310|NCT02590432|581418789|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
161008311|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008312|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008313|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008314|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008315|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008316|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008317|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
161008318|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
161008319|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
161008320|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008321|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008322|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008323|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008324|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008325|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008326|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008327|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
161008328|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
161008329|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008330|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008331|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008332|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008333|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008334|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008335|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
161008336|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
161008337|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
161008338|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008339|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008340|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008341|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161147391|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161008342|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008343|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008344|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008345|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
161008346|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
161008347|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008348|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008349|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008350|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008351|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008352|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008353|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008354|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
161008355|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
161008356|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008357|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008358|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008359|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008360|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008361|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008362|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008363|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
161008364|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
161008365|NCT02590432|581418781|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008366|NCT02590432|581418782|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008367|NCT02590432|581418783|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008368|NCT02590432|581418784|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008369|NCT02590432|581418785|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008370|NCT02590432|581418786|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008371|NCT02590432|581418787|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008372|NCT02590432|581418788|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
161008373|NCT02590432|581418789|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
161008374|NCT00409838|581418790|FG000|Short-term Period|Adverse Event|0|||
161008375|NCT00409838|581418791|FG001|Short-term Period|Adverse Event|1|||
161008376|NCT00409838|581418790|FG000|Short-term Period|Lost to Follow-up|0|||
161008377|NCT00409838|581418791|FG001|Short-term Period|Lost to Follow-up|1|||
161008378|NCT00409838|581418790|FG000|Short-term Period|Withdrawal by Subject|2|||
161008379|NCT00409838|581418791|FG001|Short-term Period|Withdrawal by Subject|3|||
161008380|NCT00409838|581418790|FG000|Short-term Period|Never Treated|1|||
161008381|NCT00409838|581418791|FG001|Short-term Period|Never Treated|0|||
161008382|NCT00409838|581418790|FG000|Long-term Extension Period|Adverse Event|10|||
161008383|NCT00409838|581418791|FG001|Long-term Extension Period|Adverse Event|0|||
161008384|NCT00409838|581418790|FG000|Long-term Extension Period|Death|1|||
161008385|NCT00409838|581418791|FG001|Long-term Extension Period|Death|0|||
161008386|NCT00409838|581418790|FG000|Long-term Extension Period|Lack of Efficacy|2|||
161008387|NCT00409838|581418791|FG001|Long-term Extension Period|Lack of Efficacy|0|||
161008388|NCT00409838|581418790|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
161008389|NCT00409838|581418791|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
161008390|NCT00409838|581418790|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
161008391|NCT00409838|581418791|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
161008392|NCT00409838|581418790|FG000|Long-term Extension Period|Pregnancy|1|||
161008393|NCT00409838|581418791|FG001|Long-term Extension Period|Pregnancy|0|||
161008394|NCT04788641|581418793|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161008395|NCT04788641|581418794|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161008396|NCT04788641|581418795|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
161008397|NCT04788641|581418796|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
161008398|NCT04788641|581418793|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
161008399|NCT04788641|581418794|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161008400|NCT04788641|581418795|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161008401|NCT04788641|581418796|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
161147392|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161271665|NCT00911807|582375223|FG002|Overall Study|Organizational reasons|1|||
161271666|NCT00855803|582375225|FG000|Overall Study|Death|2|||
161271667|NCT00855803|582375225|FG000|Overall Study|Lost to Follow-up|2|||
161008402|NCT04788641|581418793|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
161008403|NCT04788641|581418794|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
161008404|NCT04788641|581418795|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
161008405|NCT04788641|581418796|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
161008406|NCT01250769|581418797|FG000|Overall Study|Withdrawal by Subject|0|||
161008407|NCT01250769|581418798|FG001|Overall Study|Withdrawal by Subject|1|||
161008408|NCT01250769|581418799|FG002|Overall Study|Withdrawal by Subject|1|||
161008409|NCT01250769|581418800|FG003|Overall Study|Withdrawal by Subject|0|||
161008410|NCT01250769|581418797|FG000|Overall Study|Adverse Event|0|||
161008411|NCT01250769|581418798|FG001|Overall Study|Adverse Event|0|||
161008412|NCT01250769|581418799|FG002|Overall Study|Adverse Event|1|||
161008413|NCT01250769|581418800|FG003|Overall Study|Adverse Event|0|||
161008414|NCT01985334|581418801|FG000|Overall Study|Administrative problems|1|||
161008415|NCT01985334|581418802|FG001|Overall Study|Administrative problems|1|||
161008416|NCT01985334|581418803|FG002|Overall Study|Administrative problems|0|||
161008417|NCT01985334|581418804|FG003|Overall Study|Administrative problems|2|||
161008418|NCT01985334|581418805|FG004|Overall Study|Administrative problems|0|||
161008419|NCT01985334|581418806|FG005|Overall Study|Administrative problems|1|||
161008420|NCT01985334|581418807|FG006|Overall Study|Administrative problems|1|||
161008421|NCT01985334|581418808|FG007|Overall Study|Administrative problems|3|||
161008422|NCT01985334|581418801|FG000|Overall Study|Death|1|||
161008423|NCT01985334|581418802|FG001|Overall Study|Death|0|||
161008424|NCT01985334|581418803|FG002|Overall Study|Death|0|||
161008425|NCT01985334|581418804|FG003|Overall Study|Death|3|||
161008426|NCT01985334|581418805|FG004|Overall Study|Death|0|||
161008427|NCT01985334|581418806|FG005|Overall Study|Death|0|||
161008428|NCT01985334|581418807|FG006|Overall Study|Death|1|||
161008429|NCT01985334|581418808|FG007|Overall Study|Death|2|||
161008430|NCT01985334|581418801|FG000|Overall Study|Worsening of disease|0|||
161008431|NCT01985334|581418802|FG001|Overall Study|Worsening of disease|0|||
161008432|NCT01985334|581418803|FG002|Overall Study|Worsening of disease|0|||
161008433|NCT01985334|581418804|FG003|Overall Study|Worsening of disease|1|||
161008434|NCT01985334|581418805|FG004|Overall Study|Worsening of disease|0|||
161008435|NCT01985334|581418806|FG005|Overall Study|Worsening of disease|3|||
161008436|NCT01985334|581418807|FG006|Overall Study|Worsening of disease|0|||
161008437|NCT01985334|581418808|FG007|Overall Study|Worsening of disease|1|||
161008438|NCT01985334|581418801|FG000|Overall Study|Other|2|||
161008439|NCT01985334|581418802|FG001|Overall Study|Other|9|||
161008440|NCT01985334|581418803|FG002|Overall Study|Other|7|||
161008441|NCT01985334|581418804|FG003|Overall Study|Other|17|||
161008442|NCT01985334|581418805|FG004|Overall Study|Other|4|||
161008443|NCT01985334|581418806|FG005|Overall Study|Other|8|||
161008444|NCT01985334|581418807|FG006|Overall Study|Other|4|||
161008445|NCT01985334|581418808|FG007|Overall Study|Other|7|||
161008446|NCT01985334|581418801|FG000|Overall Study|Protocol deviation|6|||
161008447|NCT01985334|581418802|FG001|Overall Study|Protocol deviation|31|||
161008448|NCT01985334|581418803|FG002|Overall Study|Protocol deviation|25|||
161008449|NCT01985334|581418804|FG003|Overall Study|Protocol deviation|84|||
161008450|NCT01985334|581418805|FG004|Overall Study|Protocol deviation|17|||
161008451|NCT01985334|581418806|FG005|Overall Study|Protocol deviation|47|||
161008452|NCT01985334|581418807|FG006|Overall Study|Protocol deviation|15|||
161008453|NCT01985334|581418808|FG007|Overall Study|Protocol deviation|42|||
161008454|NCT01985334|581418801|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
161008455|NCT01985334|581418802|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
161008456|NCT01985334|581418803|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
161008457|NCT01985334|581418804|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
161008458|NCT01985334|581418805|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
161008459|NCT01985334|581418806|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
161008460|NCT01985334|581418807|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
161008461|NCT01985334|581418808|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
161008462|NCT01985334|581418801|FG000|Overall Study|Subject withdrawal of consent|3|||
161008463|NCT01985334|581418802|FG001|Overall Study|Subject withdrawal of consent|6|||
161008464|NCT01985334|581418803|FG002|Overall Study|Subject withdrawal of consent|2|||
161008465|NCT01985334|581418804|FG003|Overall Study|Subject withdrawal of consent|28|||
161147393|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161008466|NCT01985334|581418805|FG004|Overall Study|Subject withdrawal of consent|4|||
161008467|NCT01985334|581418806|FG005|Overall Study|Subject withdrawal of consent|19|||
161008468|NCT01985334|581418807|FG006|Overall Study|Subject withdrawal of consent|0|||
161008469|NCT01985334|581418808|FG007|Overall Study|Subject withdrawal of consent|20|||
161008470|NCT01985334|581418801|FG000|Overall Study|Adverse Event|0|||
161008471|NCT01985334|581418802|FG001|Overall Study|Adverse Event|8|||
161147394|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
161147395|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161008472|NCT01985334|581418803|FG002|Overall Study|Adverse Event|2|||
161008473|NCT01985334|581418804|FG003|Overall Study|Adverse Event|26|||
161008474|NCT01985334|581418805|FG004|Overall Study|Adverse Event|3|||
161008475|NCT01985334|581418806|FG005|Overall Study|Adverse Event|18|||
161008476|NCT01985334|581418807|FG006|Overall Study|Adverse Event|3|||
161008477|NCT01985334|581418808|FG007|Overall Study|Adverse Event|15|||
161008478|NCT01985334|581418801|FG000|Overall Study|Other|4|||
161008479|NCT01985334|581418802|FG001|Overall Study|Other|2|||
161008480|NCT01985334|581418803|FG002|Overall Study|Other|3|||
161008481|NCT01985334|581418804|FG003|Overall Study|Other|10|||
161008482|NCT01985334|581418805|FG004|Overall Study|Other|1|||
161008483|NCT01985334|581418806|FG005|Overall Study|Other|6|||
161008484|NCT01985334|581418807|FG006|Overall Study|Other|2|||
161008485|NCT01985334|581418808|FG007|Overall Study|Other|2|||
161008486|NCT01985334|581418801|FG000|Overall Study|Medication non-compliance|0|||
161008487|NCT01985334|581418802|FG001|Overall Study|Medication non-compliance|4|||
161008488|NCT01985334|581418803|FG002|Overall Study|Medication non-compliance|1|||
161008489|NCT01985334|581418804|FG003|Overall Study|Medication non-compliance|6|||
161008490|NCT01985334|581418805|FG004|Overall Study|Medication non-compliance|2|||
161008491|NCT01985334|581418806|FG005|Overall Study|Medication non-compliance|3|||
161008492|NCT01985334|581418807|FG006|Overall Study|Medication non-compliance|1|||
161008493|NCT01985334|581418808|FG007|Overall Study|Medication non-compliance|3|||
161008494|NCT01985334|581418801|FG000|Overall Study|Use of prohibited treatment|1|||
161008495|NCT01985334|581418802|FG001|Overall Study|Use of prohibited treatment|4|||
161008496|NCT01985334|581418803|FG002|Overall Study|Use of prohibited treatment|1|||
161008497|NCT01985334|581418804|FG003|Overall Study|Use of prohibited treatment|2|||
161008498|NCT01985334|581418805|FG004|Overall Study|Use of prohibited treatment|1|||
161008499|NCT01985334|581418806|FG005|Overall Study|Use of prohibited treatment|6|||
161008500|NCT01985334|581418807|FG006|Overall Study|Use of prohibited treatment|2|||
161008501|NCT01985334|581418808|FG007|Overall Study|Use of prohibited treatment|0|||
161008502|NCT01985334|581418801|FG000|Overall Study|Investigator decision|0|||
161008503|NCT01985334|581418802|FG001|Overall Study|Investigator decision|3|||
161008504|NCT01985334|581418803|FG002|Overall Study|Investigator decision|0|||
161008505|NCT01985334|581418804|FG003|Overall Study|Investigator decision|7|||
161008506|NCT01985334|581418805|FG004|Overall Study|Investigator decision|1|||
161008507|NCT01985334|581418806|FG005|Overall Study|Investigator decision|1|||
161008508|NCT01985334|581418807|FG006|Overall Study|Investigator decision|0|||
161008509|NCT01985334|581418808|FG007|Overall Study|Investigator decision|4|||
161008510|NCT01985334|581418801|FG000|Overall Study|Lost to Follow-up|0|||
161008511|NCT01985334|581418802|FG001|Overall Study|Lost to Follow-up|2|||
161008512|NCT01985334|581418803|FG002|Overall Study|Lost to Follow-up|0|||
161008513|NCT01985334|581418804|FG003|Overall Study|Lost to Follow-up|3|||
161008514|NCT01985334|581418805|FG004|Overall Study|Lost to Follow-up|1|||
161008515|NCT01985334|581418806|FG005|Overall Study|Lost to Follow-up|4|||
161008516|NCT01985334|581418807|FG006|Overall Study|Lost to Follow-up|0|||
161008517|NCT01985334|581418808|FG007|Overall Study|Lost to Follow-up|3|||
161008518|NCT00093015|581418809|FG000|Overall Study|Withdrawal by Subject|194|||
161008519|NCT00093015|581418810|FG001|Overall Study|Withdrawal by Subject|171|||
161008520|NCT00093015|581418809|FG000|Overall Study|Lost to Follow-up|96|||
161008521|NCT00093015|581418810|FG001|Overall Study|Lost to Follow-up|108|||
161008522|NCT00093015|581418809|FG000|Overall Study|Death|375|||
161008523|NCT00093015|581418810|FG001|Overall Study|Death|385|||
161008524|NCT03951805|581418815|FG000|Overall Study|Adverse Event|1|||
161008525|NCT03951805|581418816|FG001|Overall Study|Adverse Event|0|||
161008526|NCT03951805|581418817|FG002|Overall Study|Adverse Event|0|||
161008527|NCT03951805|581418818|FG003|Overall Study|Adverse Event|0|||
161008528|NCT01198145|581418821|FG000|Overall Study|Withdrawal by Subject|1|||
161008529|NCT01198145|581418822|FG001|Overall Study|Withdrawal by Subject|1|||
161008530|NCT00603954|581418823|FG000|Overall Study|Protocol Violation|1|||
161008531|NCT00603954|581418824|FG001|Overall Study|Protocol Violation|2|||
161008532|NCT02528188|581418825|FG000|Overall Study|Adverse Event|23|||
161008533|NCT02528188|581418826|FG001|Overall Study|Adverse Event|22|||
161008534|NCT02528188|581418827|FG002|Overall Study|Adverse Event|8|||
161008535|NCT02528188|581418825|FG000|Overall Study|Protocol Violation|4|||
161008536|NCT02528188|581418826|FG001|Overall Study|Protocol Violation|6|||
161008537|NCT02528188|581418827|FG002|Overall Study|Protocol Violation|4|||
161008538|NCT02528188|581418825|FG000|Overall Study|Lack of Efficacy|19|||
161008539|NCT02528188|581418826|FG001|Overall Study|Lack of Efficacy|21|||
161008540|NCT02528188|581418827|FG002|Overall Study|Lack of Efficacy|22|||
161008541|NCT02528188|581418825|FG000|Overall Study|Withdrawal by Subject|97|||
161008542|NCT02528188|581418826|FG001|Overall Study|Withdrawal by Subject|104|||
161008543|NCT02528188|581418827|FG002|Overall Study|Withdrawal by Subject|100|||
161008544|NCT02528188|581418825|FG000|Overall Study|Lost to Follow-up|25|||
161008545|NCT02528188|581418826|FG001|Overall Study|Lost to Follow-up|21|||
161008546|NCT02528188|581418827|FG002|Overall Study|Lost to Follow-up|31|||
161008547|NCT02528188|581418825|FG000|Overall Study|Death|4|||
161008548|NCT02528188|581418826|FG001|Overall Study|Death|4|||
161008549|NCT02528188|581418827|FG002|Overall Study|Death|0|||
161008550|NCT02528188|581418825|FG000|Overall Study|Other|89|||
161008551|NCT02528188|581418826|FG001|Overall Study|Other|91|||
161008552|NCT02528188|581418827|FG002|Overall Study|Other|74|||
161008553|NCT02528188|581418825|FG000|Overall Study|Randomized but not treated|6|||
161008554|NCT02528188|581418826|FG001|Overall Study|Randomized but not treated|7|||
161008555|NCT02528188|581418827|FG002|Overall Study|Randomized but not treated|12|||
161008556|NCT01239316|581418833|FG000|Overall Study|Progression/Relapse|11|||
161008557|NCT01239316|581418833|FG000|Overall Study|Adverse Event|1|||
161008558|NCT02299375|581418839|FG000|Overall Study|Adverse Event, serious fatal|1|||
161008559|NCT02299375|581418840|FG001|Overall Study|Adverse Event, serious fatal|3|||
161008560|NCT02299375|581418839|FG000|Overall Study|Adverse Event, non-fatal|8|||
161008561|NCT02299375|581418840|FG001|Overall Study|Adverse Event, non-fatal|9|||
161008562|NCT02299375|581418839|FG000|Overall Study|Lack of Efficacy|1|||
161008563|NCT02299375|581418840|FG001|Overall Study|Lack of Efficacy|3|||
161008564|NCT02299375|581418839|FG000|Overall Study|Protocol Violation|1|||
161008565|NCT02299375|581418840|FG001|Overall Study|Protocol Violation|3|||
161008566|NCT02299375|581418839|FG000|Overall Study|Other: Met stopping criteria|1|||
161008567|NCT02299375|581418840|FG001|Overall Study|Other: Met stopping criteria|0|||
161008568|NCT02299375|581418839|FG000|Overall Study|Other: Study closed/terminated|66|||
161008569|NCT02299375|581418840|FG001|Overall Study|Other: Study closed/terminated|55|||
161008570|NCT02299375|581418839|FG000|Overall Study|Lost to Follow-up|0|||
161008571|NCT02299375|581418840|FG001|Overall Study|Lost to Follow-up|2|||
161008572|NCT02299375|581418839|FG000|Overall Study|Physician Decision|1|||
161008573|NCT02299375|581418840|FG001|Overall Study|Physician Decision|1|||
161008574|NCT02299375|581418839|FG000|Overall Study|Withdrawal by Subject|1|||
161008575|NCT02299375|581418840|FG001|Overall Study|Withdrawal by Subject|4|||
161008576|NCT00411216|581418844|FG000|Overall Study|Ten participants were entered into the c|0|||
161008577|NCT00411216|581418845|FG001|Overall Study|Ten participants were entered into the c|2|||
161008578|NCT01205048|581418846|FG000|Overall Study|Withdrawal by Subject|14|||
161008579|NCT01205048|581418846|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
161008580|NCT01205048|581418846|FG000|Overall Study|Lost to Follow-up|4|||
161008581|NCT01205048|581418846|FG000|Overall Study|Other|2|||
161008582|NCT00823472|581418847|FG000|Overall Study|Physician Decision|24|||
161008583|NCT00823472|581418848|FG001|Overall Study|Physician Decision|28|||
161008584|NCT01251354|581418850|FG000|Overall Study|Adverse Event|1|||
161008585|NCT01251354|581418850|FG000|Overall Study|Investigator's Decision|1|||
161008586|NCT01251354|581418850|FG000|Overall Study|Disease Progression|4|||
161008587|NCT03997916|581418854|FG000|Overall Study|Protocol Violation|35|||
161008588|NCT00780416|581421294|FG000|Overall Study|Physician Decision|3|||
161008589|NCT00780416|581421295|FG001|Overall Study|Physician Decision|3|||
161008590|NCT00780416|581421294|FG000|Overall Study|Protocol Violation|1|||
161008591|NCT00780416|581421295|FG001|Overall Study|Protocol Violation|0|||
161008592|NCT00780416|581421294|FG000|Overall Study|Withdrawal by Subject|8|||
161008593|NCT00780416|581421295|FG001|Overall Study|Withdrawal by Subject|6|||
161008594|NCT02916706|581421296|FG000|Overall Study|Adverse Event|0|||
161008595|NCT02916706|581421297|FG001|Overall Study|Adverse Event|1|||
161008596|NCT02916706|581421296|FG000|Overall Study|Lost to Follow-up|0|||
161008597|NCT02916706|581421297|FG001|Overall Study|Lost to Follow-up|1|||
161008598|NCT02916706|581421296|FG000|Overall Study|Physician Decision|1|||
161008599|NCT02916706|581421297|FG001|Overall Study|Physician Decision|0|||
161008600|NCT02916706|581421296|FG000|Overall Study|Protocol Violation|3|||
161008601|NCT02916706|581421297|FG001|Overall Study|Protocol Violation|1|||
161008602|NCT02916706|581421296|FG000|Overall Study|Withdrawal by Subject|6|||
161008603|NCT02916706|581421297|FG001|Overall Study|Withdrawal by Subject|9|||
161008604|NCT02916706|581421296|FG000|Overall Study|Other|5|||
161008605|NCT02916706|581421297|FG001|Overall Study|Other|19|||
161008606|NCT02723955|581421298|FG000|Escalation Phase|Death|1|||
161008607|NCT02723955|581421299|FG001|Escalation Phase|Death|1|||
161008608|NCT02723955|581421300|FG002|Escalation Phase|Death|2|||
161008609|NCT02723955|581421301|FG003|Escalation Phase|Death|7|||
161008610|NCT02723955|581421302|FG004|Escalation Phase|Death|18|||
161008611|NCT02723955|581421303|FG005|Escalation Phase|Death|17|||
161008612|NCT02723955|581421304|FG006|Escalation Phase|Death|11|||
161008613|NCT02723955|581421305|FG007|Escalation Phase|Death|21|||
161008614|NCT02723955|581421306|FG008|Escalation Phase|Death|3|||
161008615|NCT02723955|581421307|FG009|Escalation Phase|Death|0|||
161008616|NCT02723955|581421308|FG010|Escalation Phase|Death|0|||
161008617|NCT02723955|581421309|FG011|Escalation Phase|Death|0|||
161008618|NCT02723955|581421310|FG012|Escalation Phase|Death|2|||
161008619|NCT02723955|581421311|FG013|Escalation Phase|Death|4|||
161271668|NCT00855803|582375225|FG000|Overall Study|Technical inability to undergo procedure|2|||
161008620|NCT02723955|581421312|FG014|Escalation Phase|Death|5|||
161008621|NCT02723955|581421313|FG015|Escalation Phase|Death|6|||
161008622|NCT02723955|581421314|FG016|Escalation Phase|Death|6|||
161008623|NCT02723955|581421315|FG017|Escalation Phase|Death|7|||
161008624|NCT02723955|581421316|FG018|Escalation Phase|Death|1|||
161008625|NCT02723955|581421317|FG019|Escalation Phase|Death|3|||
161008626|NCT02723955|581421318|FG020|Escalation Phase|Death|13|||
161008627|NCT02723955|581421319|FG021|Escalation Phase|Death|3|||
161008628|NCT02723955|581421320|FG022|Escalation Phase|Death|2|||
161008629|NCT02723955|581421321|FG023|Escalation Phase|Death|4|||
161008630|NCT02723955|581421322|FG024|Escalation Phase|Death|31|||
161008631|NCT02723955|581421323|FG025|Escalation Phase|Death|7|||
161008632|NCT02723955|581421324|FG026|Escalation Phase|Death|13|||
161008633|NCT02723955|581421325|FG027|Escalation Phase|Death|0|||
161008634|NCT02723955|581421326|FG028|Escalation Phase|Death|1|||
161008635|NCT02723955|581421327|FG029|Escalation Phase|Death|0|||
161008636|NCT02723955|581421328|FG030|Escalation Phase|Death|0|||
161008637|NCT02723955|581421329|FG031|Escalation Phase|Death|0|||
161008638|NCT02723955|581421330|FG032|Escalation Phase|Death|0|||
161008639|NCT02723955|581421331|FG033|Escalation Phase|Death|0|||
161008640|NCT02723955|581421332|FG034|Escalation Phase|Death|0|||
161008641|NCT02723955|581421333|FG035|Escalation Phase|Death|0|||
161008642|NCT02723955|581421334|FG036|Escalation Phase|Death|0|||
161008643|NCT02723955|581421335|FG037|Escalation Phase|Death|0|||
161008644|NCT02723955|581421336|FG038|Escalation Phase|Death|0|||
161008645|NCT02723955|581421337|FG039|Escalation Phase|Death|0|||
161008646|NCT02723955|581421338|FG040|Escalation Phase|Death|0|||
161008647|NCT02723955|581421339|FG041|Escalation Phase|Death|0|||
161008648|NCT02723955|581421340|FG042|Escalation Phase|Death|0|||
161008649|NCT02723955|581421298|FG000|Escalation Phase|Lost to Follow-up|0|||
161008650|NCT02723955|581421299|FG001|Escalation Phase|Lost to Follow-up|0|||
161008651|NCT02723955|581421300|FG002|Escalation Phase|Lost to Follow-up|0|||
161008652|NCT02723955|581421301|FG003|Escalation Phase|Lost to Follow-up|0|||
161008653|NCT02723955|581421302|FG004|Escalation Phase|Lost to Follow-up|0|||
161008654|NCT02723955|581421303|FG005|Escalation Phase|Lost to Follow-up|2|||
161008655|NCT02723955|581421304|FG006|Escalation Phase|Lost to Follow-up|1|||
161008656|NCT02723955|581421305|FG007|Escalation Phase|Lost to Follow-up|1|||
161008657|NCT02723955|581421306|FG008|Escalation Phase|Lost to Follow-up|1|||
161008658|NCT02723955|581421307|FG009|Escalation Phase|Lost to Follow-up|0|||
161008659|NCT02723955|581421308|FG010|Escalation Phase|Lost to Follow-up|0|||
161008660|NCT02723955|581421309|FG011|Escalation Phase|Lost to Follow-up|0|||
161008661|NCT02723955|581421310|FG012|Escalation Phase|Lost to Follow-up|1|||
161008662|NCT02723955|581421311|FG013|Escalation Phase|Lost to Follow-up|0|||
161008663|NCT02723955|581421312|FG014|Escalation Phase|Lost to Follow-up|0|||
161008664|NCT02723955|581421313|FG015|Escalation Phase|Lost to Follow-up|0|||
161008665|NCT02723955|581421314|FG016|Escalation Phase|Lost to Follow-up|1|||
161008666|NCT02723955|581421315|FG017|Escalation Phase|Lost to Follow-up|2|||
161008667|NCT02723955|581421316|FG018|Escalation Phase|Lost to Follow-up|0|||
161008668|NCT02723955|581421317|FG019|Escalation Phase|Lost to Follow-up|1|||
161008669|NCT02723955|581421318|FG020|Escalation Phase|Lost to Follow-up|2|||
161008670|NCT02723955|581421319|FG021|Escalation Phase|Lost to Follow-up|1|||
161008671|NCT02723955|581421320|FG022|Escalation Phase|Lost to Follow-up|0|||
161008672|NCT02723955|581421321|FG023|Escalation Phase|Lost to Follow-up|0|||
161008673|NCT02723955|581421322|FG024|Escalation Phase|Lost to Follow-up|1|||
161008674|NCT02723955|581421323|FG025|Escalation Phase|Lost to Follow-up|1|||
161008675|NCT02723955|581421324|FG026|Escalation Phase|Lost to Follow-up|3|||
161008676|NCT02723955|581421325|FG027|Escalation Phase|Lost to Follow-up|0|||
161008677|NCT02723955|581421326|FG028|Escalation Phase|Lost to Follow-up|1|||
161008678|NCT02723955|581421327|FG029|Escalation Phase|Lost to Follow-up|0|||
161008679|NCT02723955|581421328|FG030|Escalation Phase|Lost to Follow-up|0|||
161008680|NCT02723955|581421329|FG031|Escalation Phase|Lost to Follow-up|0|||
161008681|NCT02723955|581421330|FG032|Escalation Phase|Lost to Follow-up|0|||
161008682|NCT02723955|581421331|FG033|Escalation Phase|Lost to Follow-up|0|||
161008683|NCT02723955|581421332|FG034|Escalation Phase|Lost to Follow-up|0|||
161008684|NCT02723955|581421333|FG035|Escalation Phase|Lost to Follow-up|0|||
161008685|NCT02723955|581421334|FG036|Escalation Phase|Lost to Follow-up|0|||
161008686|NCT02723955|581421335|FG037|Escalation Phase|Lost to Follow-up|0|||
161008687|NCT02723955|581421336|FG038|Escalation Phase|Lost to Follow-up|0|||
161008688|NCT02723955|581421337|FG039|Escalation Phase|Lost to Follow-up|0|||
161008689|NCT02723955|581421338|FG040|Escalation Phase|Lost to Follow-up|0|||
161008690|NCT02723955|581421339|FG041|Escalation Phase|Lost to Follow-up|0|||
161008691|NCT02723955|581421340|FG042|Escalation Phase|Lost to Follow-up|0|||
161008692|NCT02723955|581421298|FG000|Escalation Phase|Physician Decision|0|||
161008693|NCT02723955|581421299|FG001|Escalation Phase|Physician Decision|0|||
161147396|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
161147397|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
161147398|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161147399|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161147400|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161147401|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161147402|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161147403|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
161008694|NCT02723955|581421300|FG002|Escalation Phase|Physician Decision|0|||
161008695|NCT02723955|581421301|FG003|Escalation Phase|Physician Decision|0|||
161008696|NCT02723955|581421302|FG004|Escalation Phase|Physician Decision|0|||
161008697|NCT02723955|581421303|FG005|Escalation Phase|Physician Decision|2|||
161008698|NCT02723955|581421304|FG006|Escalation Phase|Physician Decision|0|||
161008699|NCT02723955|581421305|FG007|Escalation Phase|Physician Decision|0|||
161008700|NCT02723955|581421306|FG008|Escalation Phase|Physician Decision|0|||
161008701|NCT02723955|581421307|FG009|Escalation Phase|Physician Decision|0|||
161008702|NCT02723955|581421308|FG010|Escalation Phase|Physician Decision|0|||
161008703|NCT02723955|581421309|FG011|Escalation Phase|Physician Decision|0|||
161008704|NCT02723955|581421310|FG012|Escalation Phase|Physician Decision|0|||
161008705|NCT02723955|581421311|FG013|Escalation Phase|Physician Decision|0|||
161008706|NCT02723955|581421312|FG014|Escalation Phase|Physician Decision|0|||
161008707|NCT02723955|581421313|FG015|Escalation Phase|Physician Decision|0|||
161008708|NCT02723955|581421314|FG016|Escalation Phase|Physician Decision|0|||
161008709|NCT02723955|581421315|FG017|Escalation Phase|Physician Decision|0|||
161008710|NCT02723955|581421316|FG018|Escalation Phase|Physician Decision|0|||
161008711|NCT02723955|581421317|FG019|Escalation Phase|Physician Decision|0|||
161008712|NCT02723955|581421318|FG020|Escalation Phase|Physician Decision|0|||
161008713|NCT02723955|581421319|FG021|Escalation Phase|Physician Decision|0|||
161008714|NCT02723955|581421320|FG022|Escalation Phase|Physician Decision|0|||
161008715|NCT02723955|581421321|FG023|Escalation Phase|Physician Decision|0|||
161008716|NCT02723955|581421322|FG024|Escalation Phase|Physician Decision|0|||
161008717|NCT02723955|581421323|FG025|Escalation Phase|Physician Decision|0|||
161008718|NCT02723955|581421324|FG026|Escalation Phase|Physician Decision|2|||
161008719|NCT02723955|581421325|FG027|Escalation Phase|Physician Decision|0|||
161008720|NCT02723955|581421326|FG028|Escalation Phase|Physician Decision|0|||
161008721|NCT02723955|581421327|FG029|Escalation Phase|Physician Decision|0|||
161008722|NCT02723955|581421328|FG030|Escalation Phase|Physician Decision|0|||
161008723|NCT02723955|581421329|FG031|Escalation Phase|Physician Decision|0|||
161008724|NCT02723955|581421330|FG032|Escalation Phase|Physician Decision|0|||
161008725|NCT02723955|581421331|FG033|Escalation Phase|Physician Decision|0|||
161008726|NCT02723955|581421332|FG034|Escalation Phase|Physician Decision|0|||
161008727|NCT02723955|581421333|FG035|Escalation Phase|Physician Decision|0|||
161008728|NCT02723955|581421334|FG036|Escalation Phase|Physician Decision|0|||
161008729|NCT02723955|581421335|FG037|Escalation Phase|Physician Decision|0|||
161008730|NCT02723955|581421336|FG038|Escalation Phase|Physician Decision|0|||
161008731|NCT02723955|581421337|FG039|Escalation Phase|Physician Decision|0|||
161008732|NCT02723955|581421338|FG040|Escalation Phase|Physician Decision|0|||
161008733|NCT02723955|581421339|FG041|Escalation Phase|Physician Decision|0|||
161008734|NCT02723955|581421340|FG042|Escalation Phase|Physician Decision|0|||
161008735|NCT02723955|581421298|FG000|Escalation Phase|Withdrawal by Subject|0|||
161008736|NCT02723955|581421299|FG001|Escalation Phase|Withdrawal by Subject|0|||
161008737|NCT02723955|581421300|FG002|Escalation Phase|Withdrawal by Subject|0|||
161008738|NCT02723955|581421301|FG003|Escalation Phase|Withdrawal by Subject|0|||
161008739|NCT02723955|581421302|FG004|Escalation Phase|Withdrawal by Subject|1|||
161008740|NCT02723955|581421303|FG005|Escalation Phase|Withdrawal by Subject|1|||
161008741|NCT02723955|581421304|FG006|Escalation Phase|Withdrawal by Subject|1|||
161008742|NCT02723955|581421305|FG007|Escalation Phase|Withdrawal by Subject|1|||
161008743|NCT02723955|581421306|FG008|Escalation Phase|Withdrawal by Subject|0|||
161008744|NCT02723955|581421307|FG009|Escalation Phase|Withdrawal by Subject|0|||
161008745|NCT02723955|581421308|FG010|Escalation Phase|Withdrawal by Subject|0|||
161008746|NCT02723955|581421309|FG011|Escalation Phase|Withdrawal by Subject|0|||
161008747|NCT02723955|581421310|FG012|Escalation Phase|Withdrawal by Subject|1|||
161008748|NCT02723955|581421311|FG013|Escalation Phase|Withdrawal by Subject|0|||
161008749|NCT02723955|581421312|FG014|Escalation Phase|Withdrawal by Subject|0|||
161008750|NCT02723955|581421313|FG015|Escalation Phase|Withdrawal by Subject|0|||
161008751|NCT02723955|581421314|FG016|Escalation Phase|Withdrawal by Subject|1|||
161008752|NCT02723955|581421315|FG017|Escalation Phase|Withdrawal by Subject|0|||
161008753|NCT02723955|581421316|FG018|Escalation Phase|Withdrawal by Subject|0|||
161008754|NCT02723955|581421317|FG019|Escalation Phase|Withdrawal by Subject|0|||
161008755|NCT02723955|581421318|FG020|Escalation Phase|Withdrawal by Subject|0|||
161008756|NCT02723955|581421319|FG021|Escalation Phase|Withdrawal by Subject|0|||
161008757|NCT02723955|581421320|FG022|Escalation Phase|Withdrawal by Subject|0|||
161008758|NCT02723955|581421321|FG023|Escalation Phase|Withdrawal by Subject|2|||
161008759|NCT02723955|581421322|FG024|Escalation Phase|Withdrawal by Subject|0|||
161008760|NCT02723955|581421323|FG025|Escalation Phase|Withdrawal by Subject|1|||
161008761|NCT02723955|581421324|FG026|Escalation Phase|Withdrawal by Subject|0|||
161008762|NCT02723955|581421325|FG027|Escalation Phase|Withdrawal by Subject|0|||
161008763|NCT02723955|581421326|FG028|Escalation Phase|Withdrawal by Subject|1|||
161008764|NCT02723955|581421327|FG029|Escalation Phase|Withdrawal by Subject|0|||
161008765|NCT02723955|581421328|FG030|Escalation Phase|Withdrawal by Subject|0|||
161343517|NCT03282097|582644403|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
161343518|NCT03282097|582644402|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
161343519|NCT03282097|582644403|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
161008766|NCT02723955|581421329|FG031|Escalation Phase|Withdrawal by Subject|0|||
161343520|NCT03282097|582644402|FG000|Primary Outcome Data Collection Complete|Missing|2|||
161008767|NCT02723955|581421330|FG032|Escalation Phase|Withdrawal by Subject|0|||
161008768|NCT02723955|581421331|FG033|Escalation Phase|Withdrawal by Subject|0|||
161008769|NCT02723955|581421332|FG034|Escalation Phase|Withdrawal by Subject|0|||
161008770|NCT02723955|581421333|FG035|Escalation Phase|Withdrawal by Subject|0|||
161008771|NCT02723955|581421334|FG036|Escalation Phase|Withdrawal by Subject|0|||
161343521|NCT03282097|582644403|FG001|Primary Outcome Data Collection Complete|Missing|3|||
161271669|NCT00855803|582375225|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
161271670|NCT00855803|582375225|FG000|Overall Study|Withdrawal by Subject|3|||
161271671|NCT00855803|582375225|FG000|Overall Study|Physician Decision|3|||
161271672|NCT00809159|582375226|FG000|Part 1|Adverse Event|1|||
161271673|NCT00809159|582375227|FG001|Part 1|Adverse Event|1|||
161008772|NCT02723955|581421335|FG037|Escalation Phase|Withdrawal by Subject|0|||
161008773|NCT02723955|581421336|FG038|Escalation Phase|Withdrawal by Subject|0|||
161008774|NCT02723955|581421337|FG039|Escalation Phase|Withdrawal by Subject|0|||
161008775|NCT02723955|581421338|FG040|Escalation Phase|Withdrawal by Subject|0|||
161008776|NCT02723955|581421339|FG041|Escalation Phase|Withdrawal by Subject|0|||
161008777|NCT02723955|581421340|FG042|Escalation Phase|Withdrawal by Subject|0|||
161008778|NCT02723955|581421298|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008779|NCT02723955|581421299|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008780|NCT02723955|581421300|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008781|NCT02723955|581421301|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008782|NCT02723955|581421302|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
161008783|NCT02723955|581421303|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
161008784|NCT02723955|581421304|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
161008785|NCT02723955|581421305|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
161008786|NCT02723955|581421306|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
161008787|NCT02723955|581421307|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008788|NCT02723955|581421308|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008789|NCT02723955|581421309|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008790|NCT02723955|581421310|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008791|NCT02723955|581421311|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008792|NCT02723955|581421312|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008793|NCT02723955|581421313|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008794|NCT02723955|581421314|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008795|NCT02723955|581421315|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008796|NCT02723955|581421316|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008797|NCT02723955|581421317|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008798|NCT02723955|581421318|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008799|NCT02723955|581421319|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008800|NCT02723955|581421320|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008801|NCT02723955|581421321|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008802|NCT02723955|581421322|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008803|NCT02723955|581421323|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008804|NCT02723955|581421324|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008805|NCT02723955|581421325|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008806|NCT02723955|581421326|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008807|NCT02723955|581421327|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008808|NCT02723955|581421328|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008809|NCT02723955|581421329|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008810|NCT02723955|581421330|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008811|NCT02723955|581421331|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008812|NCT02723955|581421332|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161147404|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161271674|NCT00809159|582375228|FG002|Part 1|Adverse Event|0|||
161271675|NCT00809159|582375229|FG003|Part 1|Adverse Event|0|||
161271676|NCT00809159|582375230|FG004|Part 1|Adverse Event|0|||
161271677|NCT00809159|582375231|FG005|Part 1|Adverse Event|0|||
161271678|NCT00809159|582375226|FG000|Part 1|Lost to Follow-up|1|||
161271679|NCT00809159|582375227|FG001|Part 1|Lost to Follow-up|0|||
161271680|NCT00809159|582375228|FG002|Part 1|Lost to Follow-up|0|||
161271681|NCT00809159|582375229|FG003|Part 1|Lost to Follow-up|0|||
161271682|NCT00809159|582375230|FG004|Part 1|Lost to Follow-up|0|||
161271683|NCT00809159|582375231|FG005|Part 1|Lost to Follow-up|0|||
161271684|NCT00809159|582375226|FG000|Part 1|Withdrawal by Subject|3|||
161271685|NCT00809159|582375227|FG001|Part 1|Withdrawal by Subject|1|||
161271686|NCT00809159|582375228|FG002|Part 1|Withdrawal by Subject|0|||
161343522|NCT03282097|582644402|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
161008813|NCT02723955|581421333|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008814|NCT02723955|581421334|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008815|NCT02723955|581421335|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008816|NCT02723955|581421336|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008817|NCT02723955|581421337|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008818|NCT02723955|581421338|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008819|NCT02723955|581421339|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008820|NCT02723955|581421340|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
161008821|NCT02723955|581421298|FG000|Escalation Phase|Site Closed|0|||
161008822|NCT02723955|581421299|FG001|Escalation Phase|Site Closed|0|||
161008823|NCT02723955|581421300|FG002|Escalation Phase|Site Closed|0|||
161008824|NCT02723955|581421301|FG003|Escalation Phase|Site Closed|0|||
161008825|NCT02723955|581421302|FG004|Escalation Phase|Site Closed|0|||
161008826|NCT02723955|581421303|FG005|Escalation Phase|Site Closed|0|||
161008827|NCT02723955|581421304|FG006|Escalation Phase|Site Closed|0|||
161008828|NCT02723955|581421305|FG007|Escalation Phase|Site Closed|0|||
161008829|NCT02723955|581421306|FG008|Escalation Phase|Site Closed|0|||
161008830|NCT02723955|581421307|FG009|Escalation Phase|Site Closed|0|||
161008831|NCT02723955|581421308|FG010|Escalation Phase|Site Closed|0|||
161008832|NCT02723955|581421309|FG011|Escalation Phase|Site Closed|0|||
161008833|NCT02723955|581421310|FG012|Escalation Phase|Site Closed|0|||
161008834|NCT02723955|581421311|FG013|Escalation Phase|Site Closed|0|||
161008835|NCT02723955|581421312|FG014|Escalation Phase|Site Closed|0|||
161008836|NCT02723955|581421313|FG015|Escalation Phase|Site Closed|1|||
161008837|NCT02723955|581421314|FG016|Escalation Phase|Site Closed|0|||
161008838|NCT02723955|581421315|FG017|Escalation Phase|Site Closed|2|||
161008839|NCT02723955|581421316|FG018|Escalation Phase|Site Closed|0|||
161008840|NCT02723955|581421317|FG019|Escalation Phase|Site Closed|0|||
161008841|NCT02723955|581421318|FG020|Escalation Phase|Site Closed|1|||
161008842|NCT02723955|581421319|FG021|Escalation Phase|Site Closed|0|||
161008843|NCT02723955|581421320|FG022|Escalation Phase|Site Closed|0|||
161008844|NCT02723955|581421321|FG023|Escalation Phase|Site Closed|0|||
161008845|NCT02723955|581421322|FG024|Escalation Phase|Site Closed|3|||
161008846|NCT02723955|581421323|FG025|Escalation Phase|Site Closed|1|||
161008847|NCT02723955|581421324|FG026|Escalation Phase|Site Closed|3|||
161008848|NCT02723955|581421325|FG027|Escalation Phase|Site Closed|1|||
161008849|NCT02723955|581421326|FG028|Escalation Phase|Site Closed|1|||
161008850|NCT02723955|581421327|FG029|Escalation Phase|Site Closed|0|||
161008851|NCT02723955|581421328|FG030|Escalation Phase|Site Closed|0|||
161008852|NCT02723955|581421329|FG031|Escalation Phase|Site Closed|0|||
161008853|NCT02723955|581421330|FG032|Escalation Phase|Site Closed|0|||
161008854|NCT02723955|581421331|FG033|Escalation Phase|Site Closed|0|||
161008855|NCT02723955|581421332|FG034|Escalation Phase|Site Closed|0|||
161008856|NCT02723955|581421333|FG035|Escalation Phase|Site Closed|0|||
161008857|NCT02723955|581421334|FG036|Escalation Phase|Site Closed|0|||
161008858|NCT02723955|581421335|FG037|Escalation Phase|Site Closed|0|||
161008859|NCT02723955|581421336|FG038|Escalation Phase|Site Closed|0|||
161008860|NCT02723955|581421337|FG039|Escalation Phase|Site Closed|0|||
161008861|NCT02723955|581421338|FG040|Escalation Phase|Site Closed|0|||
161008862|NCT02723955|581421339|FG041|Escalation Phase|Site Closed|0|||
161008863|NCT02723955|581421340|FG042|Escalation Phase|Site Closed|0|||
161008864|NCT02723955|581421298|FG000|Expansion Phase|Death|0|||
161008865|NCT02723955|581421299|FG001|Expansion Phase|Death|0|||
161008866|NCT02723955|581421300|FG002|Expansion Phase|Death|0|||
161008867|NCT02723955|581421301|FG003|Expansion Phase|Death|0|||
161008868|NCT02723955|581421302|FG004|Expansion Phase|Death|0|||
161008869|NCT02723955|581421303|FG005|Expansion Phase|Death|0|||
161008870|NCT02723955|581421304|FG006|Expansion Phase|Death|0|||
161008871|NCT02723955|581421305|FG007|Expansion Phase|Death|0|||
161008872|NCT02723955|581421306|FG008|Expansion Phase|Death|0|||
161008873|NCT02723955|581421307|FG009|Expansion Phase|Death|25|||
161008874|NCT02723955|581421308|FG010|Expansion Phase|Death|69|||
161008875|NCT02723955|581421309|FG011|Expansion Phase|Death|48|||
161008876|NCT02723955|581421310|FG012|Expansion Phase|Death|0|||
161008877|NCT02723955|581421311|FG013|Expansion Phase|Death|0|||
161008878|NCT02723955|581421312|FG014|Expansion Phase|Death|0|||
161008879|NCT02723955|581421313|FG015|Expansion Phase|Death|0|||
161008880|NCT02723955|581421314|FG016|Expansion Phase|Death|0|||
161008881|NCT02723955|581421315|FG017|Expansion Phase|Death|0|||
161008882|NCT02723955|581421316|FG018|Expansion Phase|Death|0|||
161008883|NCT02723955|581421317|FG019|Expansion Phase|Death|0|||
161008884|NCT02723955|581421318|FG020|Expansion Phase|Death|0|||
161008885|NCT02723955|581421319|FG021|Expansion Phase|Death|0|||
161008886|NCT02723955|581421320|FG022|Expansion Phase|Death|0|||
161008887|NCT02723955|581421321|FG023|Expansion Phase|Death|0|||
161008888|NCT02723955|581421322|FG024|Expansion Phase|Death|0|||
161008889|NCT02723955|581421323|FG025|Expansion Phase|Death|0|||
161008890|NCT02723955|581421324|FG026|Expansion Phase|Death|0|||
161008891|NCT02723955|581421325|FG027|Expansion Phase|Death|0|||
161008892|NCT02723955|581421326|FG028|Expansion Phase|Death|0|||
161008893|NCT02723955|581421327|FG029|Expansion Phase|Death|12|||
161008894|NCT02723955|581421328|FG030|Expansion Phase|Death|202|||
161008895|NCT02723955|581421329|FG031|Expansion Phase|Death|31|||
161008896|NCT02723955|581421330|FG032|Expansion Phase|Death|17|||
161008897|NCT02723955|581421331|FG033|Expansion Phase|Death|2|||
161008898|NCT02723955|581421332|FG034|Expansion Phase|Death|3|||
161008899|NCT02723955|581421333|FG035|Expansion Phase|Death|3|||
161008900|NCT02723955|581421334|FG036|Expansion Phase|Death|1|||
161008901|NCT02723955|581421335|FG037|Expansion Phase|Death|0|||
161008902|NCT02723955|581421336|FG038|Expansion Phase|Death|0|||
161008903|NCT02723955|581421337|FG039|Expansion Phase|Death|0|||
161008904|NCT02723955|581421338|FG040|Expansion Phase|Death|0|||
161008905|NCT02723955|581421339|FG041|Expansion Phase|Death|0|||
161008906|NCT02723955|581421340|FG042|Expansion Phase|Death|0|||
161008907|NCT02723955|581421298|FG000|Expansion Phase|Lost to Follow-up|0|||
161008908|NCT02723955|581421299|FG001|Expansion Phase|Lost to Follow-up|0|||
161008909|NCT02723955|581421300|FG002|Expansion Phase|Lost to Follow-up|0|||
161008910|NCT02723955|581421301|FG003|Expansion Phase|Lost to Follow-up|0|||
161008911|NCT02723955|581421302|FG004|Expansion Phase|Lost to Follow-up|0|||
161008912|NCT02723955|581421303|FG005|Expansion Phase|Lost to Follow-up|0|||
161008913|NCT02723955|581421304|FG006|Expansion Phase|Lost to Follow-up|0|||
161008914|NCT02723955|581421305|FG007|Expansion Phase|Lost to Follow-up|0|||
161008915|NCT02723955|581421306|FG008|Expansion Phase|Lost to Follow-up|0|||
161008916|NCT02723955|581421307|FG009|Expansion Phase|Lost to Follow-up|0|||
161008917|NCT02723955|581421308|FG010|Expansion Phase|Lost to Follow-up|4|||
161008918|NCT02723955|581421309|FG011|Expansion Phase|Lost to Follow-up|1|||
161008919|NCT02723955|581421310|FG012|Expansion Phase|Lost to Follow-up|0|||
161008920|NCT02723955|581421311|FG013|Expansion Phase|Lost to Follow-up|0|||
161008921|NCT02723955|581421312|FG014|Expansion Phase|Lost to Follow-up|0|||
161008922|NCT02723955|581421313|FG015|Expansion Phase|Lost to Follow-up|0|||
161008923|NCT02723955|581421314|FG016|Expansion Phase|Lost to Follow-up|0|||
161008924|NCT02723955|581421315|FG017|Expansion Phase|Lost to Follow-up|0|||
161008925|NCT02723955|581421316|FG018|Expansion Phase|Lost to Follow-up|0|||
161008926|NCT02723955|581421317|FG019|Expansion Phase|Lost to Follow-up|0|||
161008927|NCT02723955|581421318|FG020|Expansion Phase|Lost to Follow-up|0|||
161008928|NCT02723955|581421319|FG021|Expansion Phase|Lost to Follow-up|0|||
161008929|NCT02723955|581421320|FG022|Expansion Phase|Lost to Follow-up|0|||
161008930|NCT02723955|581421321|FG023|Expansion Phase|Lost to Follow-up|0|||
161008931|NCT02723955|581421322|FG024|Expansion Phase|Lost to Follow-up|0|||
161008932|NCT02723955|581421323|FG025|Expansion Phase|Lost to Follow-up|0|||
161008933|NCT02723955|581421324|FG026|Expansion Phase|Lost to Follow-up|0|||
161008934|NCT02723955|581421325|FG027|Expansion Phase|Lost to Follow-up|0|||
161008935|NCT02723955|581421326|FG028|Expansion Phase|Lost to Follow-up|0|||
161008936|NCT02723955|581421327|FG029|Expansion Phase|Lost to Follow-up|1|||
161008937|NCT02723955|581421328|FG030|Expansion Phase|Lost to Follow-up|19|||
161008938|NCT02723955|581421329|FG031|Expansion Phase|Lost to Follow-up|2|||
161008939|NCT02723955|581421330|FG032|Expansion Phase|Lost to Follow-up|1|||
161008940|NCT02723955|581421331|FG033|Expansion Phase|Lost to Follow-up|0|||
161008941|NCT02723955|581421332|FG034|Expansion Phase|Lost to Follow-up|0|||
161008942|NCT02723955|581421333|FG035|Expansion Phase|Lost to Follow-up|0|||
161008943|NCT02723955|581421334|FG036|Expansion Phase|Lost to Follow-up|0|||
161008944|NCT02723955|581421335|FG037|Expansion Phase|Lost to Follow-up|0|||
161008945|NCT02723955|581421336|FG038|Expansion Phase|Lost to Follow-up|0|||
161008946|NCT02723955|581421337|FG039|Expansion Phase|Lost to Follow-up|0|||
161008947|NCT02723955|581421338|FG040|Expansion Phase|Lost to Follow-up|0|||
161008948|NCT02723955|581421339|FG041|Expansion Phase|Lost to Follow-up|0|||
161008949|NCT02723955|581421340|FG042|Expansion Phase|Lost to Follow-up|0|||
161008950|NCT02723955|581421298|FG000|Expansion Phase|Physician Decision|0|||
161008951|NCT02723955|581421299|FG001|Expansion Phase|Physician Decision|0|||
161008952|NCT02723955|581421300|FG002|Expansion Phase|Physician Decision|0|||
161008953|NCT02723955|581421301|FG003|Expansion Phase|Physician Decision|0|||
161008954|NCT02723955|581421302|FG004|Expansion Phase|Physician Decision|0|||
161008955|NCT02723955|581421303|FG005|Expansion Phase|Physician Decision|0|||
161008956|NCT02723955|581421304|FG006|Expansion Phase|Physician Decision|0|||
161008957|NCT02723955|581421305|FG007|Expansion Phase|Physician Decision|0|||
161008958|NCT02723955|581421306|FG008|Expansion Phase|Physician Decision|0|||
161343523|NCT03282097|582644403|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
161343524|NCT03282097|582644402|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
161008959|NCT02723955|581421307|FG009|Expansion Phase|Physician Decision|0|||
161008960|NCT02723955|581421308|FG010|Expansion Phase|Physician Decision|0|||
161008961|NCT02723955|581421309|FG011|Expansion Phase|Physician Decision|0|||
161008962|NCT02723955|581421310|FG012|Expansion Phase|Physician Decision|0|||
161008963|NCT02723955|581421311|FG013|Expansion Phase|Physician Decision|0|||
161008964|NCT02723955|581421312|FG014|Expansion Phase|Physician Decision|0|||
161008965|NCT02723955|581421313|FG015|Expansion Phase|Physician Decision|0|||
161008966|NCT02723955|581421314|FG016|Expansion Phase|Physician Decision|0|||
161008967|NCT02723955|581421315|FG017|Expansion Phase|Physician Decision|0|||
161008968|NCT02723955|581421316|FG018|Expansion Phase|Physician Decision|0|||
161008969|NCT02723955|581421317|FG019|Expansion Phase|Physician Decision|0|||
161008970|NCT02723955|581421318|FG020|Expansion Phase|Physician Decision|0|||
161008971|NCT02723955|581421319|FG021|Expansion Phase|Physician Decision|0|||
161008972|NCT02723955|581421320|FG022|Expansion Phase|Physician Decision|0|||
161008973|NCT02723955|581421321|FG023|Expansion Phase|Physician Decision|0|||
161008974|NCT02723955|581421322|FG024|Expansion Phase|Physician Decision|0|||
161008975|NCT02723955|581421323|FG025|Expansion Phase|Physician Decision|0|||
161008976|NCT02723955|581421324|FG026|Expansion Phase|Physician Decision|0|||
161008977|NCT02723955|581421325|FG027|Expansion Phase|Physician Decision|0|||
161008978|NCT02723955|581421326|FG028|Expansion Phase|Physician Decision|0|||
161008979|NCT02723955|581421327|FG029|Expansion Phase|Physician Decision|0|||
161008980|NCT02723955|581421328|FG030|Expansion Phase|Physician Decision|1|||
161008981|NCT02723955|581421329|FG031|Expansion Phase|Physician Decision|1|||
161008982|NCT02723955|581421330|FG032|Expansion Phase|Physician Decision|0|||
161008983|NCT02723955|581421331|FG033|Expansion Phase|Physician Decision|0|||
161008984|NCT02723955|581421332|FG034|Expansion Phase|Physician Decision|0|||
161008985|NCT02723955|581421333|FG035|Expansion Phase|Physician Decision|0|||
161008986|NCT02723955|581421334|FG036|Expansion Phase|Physician Decision|0|||
161008987|NCT02723955|581421335|FG037|Expansion Phase|Physician Decision|0|||
161008988|NCT02723955|581421336|FG038|Expansion Phase|Physician Decision|0|||
161008989|NCT02723955|581421337|FG039|Expansion Phase|Physician Decision|0|||
161008990|NCT02723955|581421338|FG040|Expansion Phase|Physician Decision|0|||
161008991|NCT02723955|581421339|FG041|Expansion Phase|Physician Decision|0|||
161008992|NCT02723955|581421340|FG042|Expansion Phase|Physician Decision|0|||
161008993|NCT02723955|581421298|FG000|Expansion Phase|Withdrawal by Subject|0|||
161008994|NCT02723955|581421299|FG001|Expansion Phase|Withdrawal by Subject|0|||
161008995|NCT02723955|581421300|FG002|Expansion Phase|Withdrawal by Subject|0|||
161008996|NCT02723955|581421301|FG003|Expansion Phase|Withdrawal by Subject|0|||
161008997|NCT02723955|581421302|FG004|Expansion Phase|Withdrawal by Subject|0|||
161008998|NCT02723955|581421303|FG005|Expansion Phase|Withdrawal by Subject|0|||
161008999|NCT02723955|581421304|FG006|Expansion Phase|Withdrawal by Subject|0|||
161009000|NCT02723955|581421305|FG007|Expansion Phase|Withdrawal by Subject|0|||
161009001|NCT02723955|581421306|FG008|Expansion Phase|Withdrawal by Subject|0|||
161009002|NCT02723955|581421307|FG009|Expansion Phase|Withdrawal by Subject|2|||
161009003|NCT02723955|581421308|FG010|Expansion Phase|Withdrawal by Subject|1|||
161009004|NCT02723955|581421309|FG011|Expansion Phase|Withdrawal by Subject|0|||
161009005|NCT02723955|581421310|FG012|Expansion Phase|Withdrawal by Subject|0|||
161009006|NCT02723955|581421311|FG013|Expansion Phase|Withdrawal by Subject|0|||
161009007|NCT02723955|581421312|FG014|Expansion Phase|Withdrawal by Subject|0|||
161009008|NCT02723955|581421313|FG015|Expansion Phase|Withdrawal by Subject|0|||
161009009|NCT02723955|581421314|FG016|Expansion Phase|Withdrawal by Subject|0|||
161009010|NCT02723955|581421315|FG017|Expansion Phase|Withdrawal by Subject|0|||
161009011|NCT02723955|581421316|FG018|Expansion Phase|Withdrawal by Subject|0|||
161009012|NCT02723955|581421317|FG019|Expansion Phase|Withdrawal by Subject|0|||
161009013|NCT02723955|581421318|FG020|Expansion Phase|Withdrawal by Subject|0|||
161009014|NCT02723955|581421319|FG021|Expansion Phase|Withdrawal by Subject|0|||
161009015|NCT02723955|581421320|FG022|Expansion Phase|Withdrawal by Subject|0|||
161009016|NCT02723955|581421321|FG023|Expansion Phase|Withdrawal by Subject|0|||
161009017|NCT02723955|581421322|FG024|Expansion Phase|Withdrawal by Subject|0|||
161009018|NCT02723955|581421323|FG025|Expansion Phase|Withdrawal by Subject|0|||
161009019|NCT02723955|581421324|FG026|Expansion Phase|Withdrawal by Subject|0|||
161009020|NCT02723955|581421325|FG027|Expansion Phase|Withdrawal by Subject|0|||
161009021|NCT02723955|581421326|FG028|Expansion Phase|Withdrawal by Subject|0|||
161009022|NCT02723955|581421327|FG029|Expansion Phase|Withdrawal by Subject|0|||
161009023|NCT02723955|581421328|FG030|Expansion Phase|Withdrawal by Subject|8|||
161009024|NCT02723955|581421329|FG031|Expansion Phase|Withdrawal by Subject|4|||
161009025|NCT02723955|581421330|FG032|Expansion Phase|Withdrawal by Subject|0|||
161009026|NCT02723955|581421331|FG033|Expansion Phase|Withdrawal by Subject|0|||
161009027|NCT02723955|581421332|FG034|Expansion Phase|Withdrawal by Subject|0|||
161009028|NCT02723955|581421333|FG035|Expansion Phase|Withdrawal by Subject|1|||
161009029|NCT02723955|581421334|FG036|Expansion Phase|Withdrawal by Subject|0|||
161009030|NCT02723955|581421335|FG037|Expansion Phase|Withdrawal by Subject|0|||
161009031|NCT02723955|581421336|FG038|Expansion Phase|Withdrawal by Subject|0|||
161009032|NCT02723955|581421337|FG039|Expansion Phase|Withdrawal by Subject|0|||
161009033|NCT02723955|581421338|FG040|Expansion Phase|Withdrawal by Subject|0|||
161009034|NCT02723955|581421339|FG041|Expansion Phase|Withdrawal by Subject|0|||
161009035|NCT02723955|581421340|FG042|Expansion Phase|Withdrawal by Subject|0|||
161009036|NCT02723955|581421298|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161271687|NCT00809159|582375229|FG003|Part 1|Withdrawal by Subject|0|||
161009037|NCT02723955|581421299|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009038|NCT02723955|581421300|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009039|NCT02723955|581421301|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009040|NCT02723955|581421302|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009041|NCT02723955|581421303|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009042|NCT02723955|581421304|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009043|NCT02723955|581421305|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009044|NCT02723955|581421306|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009045|NCT02723955|581421307|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
161009046|NCT02723955|581421308|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
161009047|NCT02723955|581421309|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
161009048|NCT02723955|581421310|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009049|NCT02723955|581421311|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009050|NCT02723955|581421312|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009051|NCT02723955|581421313|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009052|NCT02723955|581421314|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009053|NCT02723955|581421315|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009054|NCT02723955|581421316|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009055|NCT02723955|581421317|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009056|NCT02723955|581421318|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009057|NCT02723955|581421319|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009058|NCT02723955|581421320|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009059|NCT02723955|581421321|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009060|NCT02723955|581421322|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009061|NCT02723955|581421323|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009062|NCT02723955|581421324|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009063|NCT02723955|581421325|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009064|NCT02723955|581421326|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009065|NCT02723955|581421327|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009066|NCT02723955|581421328|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
161009067|NCT02723955|581421329|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009068|NCT02723955|581421330|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009069|NCT02723955|581421331|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009070|NCT02723955|581421332|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009071|NCT02723955|581421333|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009072|NCT02723955|581421334|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009073|NCT02723955|581421335|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009074|NCT02723955|581421336|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009075|NCT02723955|581421337|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009076|NCT02723955|581421338|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009077|NCT02723955|581421339|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009078|NCT02723955|581421340|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
161009079|NCT02723955|581421298|FG000|Expansion Phase|Site Closed|0|||
161009080|NCT02723955|581421299|FG001|Expansion Phase|Site Closed|0|||
161009081|NCT02723955|581421300|FG002|Expansion Phase|Site Closed|0|||
161009082|NCT02723955|581421301|FG003|Expansion Phase|Site Closed|0|||
161009083|NCT02723955|581421302|FG004|Expansion Phase|Site Closed|0|||
161009084|NCT02723955|581421303|FG005|Expansion Phase|Site Closed|0|||
161009085|NCT02723955|581421304|FG006|Expansion Phase|Site Closed|0|||
161009086|NCT02723955|581421305|FG007|Expansion Phase|Site Closed|0|||
161009087|NCT02723955|581421306|FG008|Expansion Phase|Site Closed|0|||
161009088|NCT02723955|581421307|FG009|Expansion Phase|Site Closed|1|||
161009089|NCT02723955|581421308|FG010|Expansion Phase|Site Closed|2|||
161009090|NCT02723955|581421309|FG011|Expansion Phase|Site Closed|6|||
161009091|NCT02723955|581421310|FG012|Expansion Phase|Site Closed|0|||
161009092|NCT02723955|581421311|FG013|Expansion Phase|Site Closed|0|||
161009093|NCT02723955|581421312|FG014|Expansion Phase|Site Closed|0|||
161009094|NCT02723955|581421313|FG015|Expansion Phase|Site Closed|0|||
161009095|NCT02723955|581421314|FG016|Expansion Phase|Site Closed|0|||
161009096|NCT02723955|581421315|FG017|Expansion Phase|Site Closed|0|||
161009097|NCT02723955|581421316|FG018|Expansion Phase|Site Closed|0|||
161009098|NCT02723955|581421317|FG019|Expansion Phase|Site Closed|0|||
161009099|NCT02723955|581421318|FG020|Expansion Phase|Site Closed|0|||
161009100|NCT02723955|581421319|FG021|Expansion Phase|Site Closed|0|||
161009101|NCT02723955|581421320|FG022|Expansion Phase|Site Closed|0|||
161009102|NCT02723955|581421321|FG023|Expansion Phase|Site Closed|0|||
161009103|NCT02723955|581421322|FG024|Expansion Phase|Site Closed|0|||
161009104|NCT02723955|581421323|FG025|Expansion Phase|Site Closed|0|||
161009105|NCT02723955|581421324|FG026|Expansion Phase|Site Closed|0|||
161009106|NCT02723955|581421325|FG027|Expansion Phase|Site Closed|0|||
161009107|NCT02723955|581421326|FG028|Expansion Phase|Site Closed|0|||
161009108|NCT02723955|581421327|FG029|Expansion Phase|Site Closed|0|||
161009109|NCT02723955|581421328|FG030|Expansion Phase|Site Closed|8|||
161009110|NCT02723955|581421329|FG031|Expansion Phase|Site Closed|4|||
161009111|NCT02723955|581421330|FG032|Expansion Phase|Site Closed|2|||
161009112|NCT02723955|581421331|FG033|Expansion Phase|Site Closed|2|||
161009113|NCT02723955|581421332|FG034|Expansion Phase|Site Closed|0|||
161009114|NCT02723955|581421333|FG035|Expansion Phase|Site Closed|0|||
161009115|NCT02723955|581421334|FG036|Expansion Phase|Site Closed|0|||
161009116|NCT02723955|581421335|FG037|Expansion Phase|Site Closed|0|||
161009117|NCT02723955|581421336|FG038|Expansion Phase|Site Closed|0|||
161009118|NCT02723955|581421337|FG039|Expansion Phase|Site Closed|0|||
161009119|NCT02723955|581421338|FG040|Expansion Phase|Site Closed|0|||
161009120|NCT02723955|581421339|FG041|Expansion Phase|Site Closed|0|||
161009121|NCT02723955|581421340|FG042|Expansion Phase|Site Closed|0|||
161009122|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Death|0|||
161009123|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Death|0|||
161009124|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Death|0|||
161009125|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Death|0|||
161009126|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Death|0|||
161009127|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Death|0|||
161009128|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Death|0|||
161009129|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Death|0|||
161009130|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Death|0|||
161009131|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Death|0|||
161009132|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Death|0|||
161009133|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Death|0|||
161009134|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Death|0|||
161009135|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Death|0|||
161009136|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Death|0|||
161009137|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Death|0|||
161009138|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Death|0|||
161009139|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Death|0|||
161009140|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Death|0|||
161009141|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Death|0|||
161009142|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Death|0|||
161009143|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Death|0|||
161009144|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Death|0|||
161009145|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Death|0|||
161009146|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Death|0|||
161009147|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Death|0|||
161009148|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Death|0|||
161009149|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Death|0|||
161009150|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Death|0|||
161009151|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Death|0|||
161147405|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
161009152|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Death|0|||
161009153|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Death|0|||
161009154|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Death|0|||
161009155|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Death|0|||
161009156|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Death|0|||
161009157|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Death|0|||
161009158|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Death|0|||
161009159|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Death|1|||
161009160|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Death|14|||
161009161|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Death|32|||
161009162|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Death|2|||
161009163|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Death|1|||
161009164|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Death|0|||
161009165|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009166|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009167|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009168|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161147406|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
161147407|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161009169|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009170|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009171|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009172|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009173|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009174|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009175|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009176|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009177|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009178|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009179|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009180|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009181|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009182|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009183|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009184|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009185|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009186|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009187|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009188|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009189|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009190|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009191|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009192|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009193|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009194|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009195|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009196|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009197|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009198|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009199|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009200|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009201|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009202|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009203|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009204|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
161009205|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009206|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009207|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
161009208|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009209|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009210|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009211|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009212|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009213|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009214|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009215|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009216|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009217|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009218|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009219|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009220|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009221|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009222|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009223|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009224|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009225|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009226|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009227|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009228|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009229|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009230|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009231|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009232|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009233|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009234|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009235|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009236|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009237|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009238|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009239|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009240|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009241|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009242|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009243|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009244|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009245|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009246|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
161009247|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
161009248|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009249|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
161009250|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
161009251|NCT02723955|581421298|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
161009252|NCT02723955|581421299|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
161009253|NCT02723955|581421300|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
161009254|NCT02723955|581421301|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
161009255|NCT02723955|581421302|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
161009256|NCT02723955|581421303|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
161009257|NCT02723955|581421304|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
161009258|NCT02723955|581421305|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
161009259|NCT02723955|581421306|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
161009260|NCT02723955|581421307|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
161009261|NCT02723955|581421308|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
161009262|NCT02723955|581421309|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
161009263|NCT02723955|581421310|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
161009264|NCT02723955|581421311|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
161009265|NCT02723955|581421312|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
161009266|NCT02723955|581421313|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
161009267|NCT02723955|581421314|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
161009268|NCT02723955|581421315|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
161009269|NCT02723955|581421316|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
161009270|NCT02723955|581421317|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
161009271|NCT02723955|581421318|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
161009272|NCT02723955|581421319|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
161009273|NCT02723955|581421320|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
161009274|NCT02723955|581421321|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
161009275|NCT02723955|581421322|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
161009276|NCT02723955|581421323|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
161009277|NCT02723955|581421324|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
161009278|NCT02723955|581421325|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
161009279|NCT02723955|581421326|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
161009280|NCT02723955|581421327|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
161009281|NCT02723955|581421328|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
161009282|NCT02723955|581421329|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
161009283|NCT02723955|581421330|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
161009284|NCT02723955|581421331|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
161009285|NCT02723955|581421332|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
161009286|NCT02723955|581421333|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
161009287|NCT02723955|581421334|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
161009288|NCT02723955|581421335|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
161009289|NCT02723955|581421336|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
161271688|NCT00809159|582375230|FG004|Part 1|Withdrawal by Subject|0|||
161009290|NCT02723955|581421337|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
161009291|NCT02723955|581421338|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
161009292|NCT02723955|581421339|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
161009293|NCT02723955|581421340|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
161009294|NCT03088813|581421343|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161009295|NCT03088813|581421344|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
161009296|NCT03088813|581421345|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161009297|NCT03088813|581421346|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
161009298|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161009299|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161009300|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
161009301|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
161009302|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
161009303|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
161009304|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
161009305|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
161009306|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
161009307|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
161009308|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
161009309|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
161009310|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
161009311|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
161271689|NCT00809159|582375231|FG005|Part 1|Withdrawal by Subject|0|||
161271690|NCT00809159|582375226|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
161271691|NCT00809159|582375227|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
161271692|NCT00809159|582375228|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
161271693|NCT00809159|582375229|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
161271694|NCT00809159|582375230|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
161271695|NCT00809159|582375231|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
161271696|NCT00809159|582375226|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
161271697|NCT00809159|582375227|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
161271698|NCT00809159|582375228|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
161271699|NCT00809159|582375229|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
161271700|NCT00809159|582375230|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
161271701|NCT00809159|582375231|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
161271702|NCT00809159|582375226|FG000|Part 1 and 2|Administrative problems|0|||
161147408|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161147409|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
160967047|NCT03764774|581266858|FG011|Overall Study|Withdrawal by Subject|0|||
160967048|NCT03764774|581266859|FG012|Overall Study|Withdrawal by Subject|0|||
160967049|NCT03764774|581266860|FG013|Overall Study|Withdrawal by Subject|0|||
160967050|NCT03764774|581266847|FG000|Overall Study|Adverse Event|0|||
160967051|NCT03764774|581266848|FG001|Overall Study|Adverse Event|0|||
160967052|NCT03764774|581266849|FG002|Overall Study|Adverse Event|0|||
160967053|NCT03764774|581266850|FG003|Overall Study|Adverse Event|0|||
160967054|NCT03764774|581266851|FG004|Overall Study|Adverse Event|0|||
160967055|NCT03764774|581266852|FG005|Overall Study|Adverse Event|0|||
160967056|NCT03764774|581266853|FG006|Overall Study|Adverse Event|0|||
160967057|NCT03764774|581266854|FG007|Overall Study|Adverse Event|0|||
160967058|NCT03764774|581266855|FG008|Overall Study|Adverse Event|0|||
160967059|NCT03764774|581266856|FG009|Overall Study|Adverse Event|0|||
160967060|NCT03764774|581266857|FG010|Overall Study|Adverse Event|0|||
160967061|NCT03764774|581266858|FG011|Overall Study|Adverse Event|0|||
160967062|NCT03764774|581266859|FG012|Overall Study|Adverse Event|2|||
160967063|NCT03764774|581266860|FG013|Overall Study|Adverse Event|0|||
160967064|NCT03764774|581266847|FG000|Overall Study|Lost to Follow-up|0|||
160967065|NCT03764774|581266848|FG001|Overall Study|Lost to Follow-up|0|||
160967066|NCT03764774|581266849|FG002|Overall Study|Lost to Follow-up|0|||
160967067|NCT03764774|581266850|FG003|Overall Study|Lost to Follow-up|0|||
160967068|NCT03764774|581266851|FG004|Overall Study|Lost to Follow-up|0|||
160967069|NCT03764774|581266852|FG005|Overall Study|Lost to Follow-up|0|||
160967070|NCT03764774|581266853|FG006|Overall Study|Lost to Follow-up|0|||
160967071|NCT03764774|581266854|FG007|Overall Study|Lost to Follow-up|0|||
160967072|NCT03764774|581266855|FG008|Overall Study|Lost to Follow-up|0|||
160967073|NCT03764774|581266856|FG009|Overall Study|Lost to Follow-up|0|||
160967074|NCT03764774|581266857|FG010|Overall Study|Lost to Follow-up|0|||
160967075|NCT03764774|581266858|FG011|Overall Study|Lost to Follow-up|0|||
160967076|NCT03764774|581266859|FG012|Overall Study|Lost to Follow-up|0|||
160967077|NCT03764774|581266860|FG013|Overall Study|Lost to Follow-up|1|||
160967078|NCT03764774|581266847|FG000|Overall Study|Physician Decision|0|||
160967079|NCT03764774|581266848|FG001|Overall Study|Physician Decision|0|||
160967080|NCT03764774|581266849|FG002|Overall Study|Physician Decision|0|||
160967081|NCT03764774|581266850|FG003|Overall Study|Physician Decision|0|||
160967082|NCT03764774|581266851|FG004|Overall Study|Physician Decision|0|||
160967083|NCT03764774|581266852|FG005|Overall Study|Physician Decision|0|||
160967084|NCT03764774|581266853|FG006|Overall Study|Physician Decision|0|||
160967085|NCT03764774|581266854|FG007|Overall Study|Physician Decision|0|||
160967086|NCT03764774|581266855|FG008|Overall Study|Physician Decision|0|||
160967087|NCT03764774|581266856|FG009|Overall Study|Physician Decision|4|||
160967088|NCT03764774|581266857|FG010|Overall Study|Physician Decision|1|||
160967089|NCT03764774|581266858|FG011|Overall Study|Physician Decision|4|||
160967090|NCT03764774|581266859|FG012|Overall Study|Physician Decision|9|||
160967091|NCT03764774|581266860|FG013|Overall Study|Physician Decision|0|||
160967092|NCT03764774|581266847|FG000|Overall Study|Study Termination|0|||
160967093|NCT03764774|581266848|FG001|Overall Study|Study Termination|0|||
160967094|NCT03764774|581266849|FG002|Overall Study|Study Termination|0|||
160967095|NCT03764774|581266850|FG003|Overall Study|Study Termination|0|||
160967096|NCT03764774|581266851|FG004|Overall Study|Study Termination|0|||
160967097|NCT03764774|581266852|FG005|Overall Study|Study Termination|0|||
161271703|NCT00809159|582375227|FG001|Part 1 and 2|Administrative problems|0|||
160967098|NCT03764774|581266853|FG006|Overall Study|Study Termination|0|||
160967099|NCT03764774|581266854|FG007|Overall Study|Study Termination|0|||
160967100|NCT03764774|581266855|FG008|Overall Study|Study Termination|0|||
160967101|NCT03764774|581266856|FG009|Overall Study|Study Termination|1|||
160967102|NCT03764774|581266857|FG010|Overall Study|Study Termination|0|||
160967103|NCT03764774|581266858|FG011|Overall Study|Study Termination|0|||
160967104|NCT03764774|581266859|FG012|Overall Study|Study Termination|0|||
160967105|NCT03764774|581266860|FG013|Overall Study|Study Termination|2|||
160967106|NCT00755222|581268146|FG000|Overall Study|Withdrawal by Subject|4|||
160967107|NCT00755222|581268147|FG001|Overall Study|Withdrawal by Subject|2|||
160967108|NCT00755222|581268146|FG000|Overall Study|Adverse Event|2|||
160967109|NCT00755222|581268147|FG001|Overall Study|Adverse Event|0|||
161009312|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
161009313|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
161009314|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161009315|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161009316|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
161009317|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
161009318|NCT03088813|581421343|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161009319|NCT03088813|581421344|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161009320|NCT03088813|581421345|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
161009321|NCT03088813|581421346|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
161009322|NCT04878354|581421347|FG000|Overall Study|Adverse Event|4|||
161009323|NCT04878354|581421348|FG001|Overall Study|Adverse Event|13|||
161009324|NCT04878354|581421347|FG000|Overall Study|Withdrawal by Subject|14|||
161009325|NCT04878354|581421348|FG001|Overall Study|Withdrawal by Subject|12|||
161009326|NCT04878354|581421347|FG000|Overall Study|Lost to Follow-up|4|||
161009327|NCT04878354|581421348|FG001|Overall Study|Lost to Follow-up|1|||
161009328|NCT04878354|581421347|FG000|Overall Study|Lack of Efficacy|1|||
161009329|NCT04878354|581421348|FG001|Overall Study|Lack of Efficacy|0|||
161009330|NCT04878354|581421347|FG000|Overall Study|Protocol Violation|0|||
161009331|NCT04878354|581421348|FG001|Overall Study|Protocol Violation|1|||
161009332|NCT04878354|581421347|FG000|Overall Study|"Reason stated as other in CRF"|2|||
161009333|NCT04878354|581421348|FG001|Overall Study|"Reason stated as other in CRF"|3|||
161009334|NCT04540913|581421349|FG000|Overall Study|Withdrawal by Subject|14|||
161009335|NCT04540913|581421350|FG001|Overall Study|Withdrawal by Subject|3|||
161009336|NCT02118961|581421351|FG000|Overall Study|Withdrawal by Subject|1|||
161009337|NCT02118961|581421352|FG001|Overall Study|Withdrawal by Subject|0|||
161009338|NCT05288283|581421353|FG000|Overall Study|Study Terminated Early|1|||
161009339|NCT05288283|581421354|FG001|Overall Study|Study Terminated Early|1|||
161009340|NCT02992925|581421355|FG000|Cohort 2|Physician Decision|0|||
161009341|NCT02992925|581421356|FG001|Cohort 2|Physician Decision|0|||
161009342|NCT02992925|581421357|FG002|Cohort 2|Physician Decision|1|||
161009343|NCT02992925|581421358|FG003|Cohort 2|Physician Decision|0|||
161009344|NCT02992925|581421355|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
161009345|NCT02992925|581421356|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
161009346|NCT02992925|581421357|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
161009347|NCT02992925|581421358|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
161009348|NCT05678998|581421359|FG000|Overall Study|Withdrawal by Subject|1|||
161009349|NCT05678998|581421360|FG001|Overall Study|Withdrawal by Subject|1|||
161009350|NCT05678998|581421361|FG002|Overall Study|Withdrawal by Subject|3|||
161009351|NCT05678998|581421362|FG003|Overall Study|Withdrawal by Subject|0|||
161009352|NCT05678998|581421363|FG004|Overall Study|Withdrawal by Subject|1|||
161009353|NCT05678998|581421359|FG000|Overall Study|Lost to Follow-up|0|||
161009354|NCT05678998|581421360|FG001|Overall Study|Lost to Follow-up|0|||
161009355|NCT05678998|581421361|FG002|Overall Study|Lost to Follow-up|0|||
161009356|NCT05678998|581421362|FG003|Overall Study|Lost to Follow-up|0|||
161009357|NCT05678998|581421363|FG004|Overall Study|Lost to Follow-up|1|||
161009358|NCT05678998|581421359|FG000|Overall Study|Death|0|||
161009359|NCT05678998|581421360|FG001|Overall Study|Death|0|||
161009360|NCT05678998|581421361|FG002|Overall Study|Death|0|||
161009361|NCT05678998|581421362|FG003|Overall Study|Death|3|||
161009362|NCT05678998|581421363|FG004|Overall Study|Death|4|||
161009363|NCT05678998|581421359|FG000|Overall Study|Other|0|||
161009364|NCT05678998|581421360|FG001|Overall Study|Other|0|||
161009365|NCT05678998|581421361|FG002|Overall Study|Other|0|||
161009366|NCT05678998|581421362|FG003|Overall Study|Other|2|||
161009367|NCT05678998|581421363|FG004|Overall Study|Other|1|||
161009368|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
161009369|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
161009370|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
161009371|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
161009372|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
161009373|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
161009374|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
161009375|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
161009376|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
161009377|NCT03990649|581421366|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
161009378|NCT03990649|581421367|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
161009379|NCT03990649|581421368|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
161009380|NCT03990649|581421366|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
161009381|NCT03990649|581421367|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
161009382|NCT03990649|581421368|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
161009383|NCT03990649|581421366|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
161009384|NCT03990649|581421367|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
161009385|NCT03990649|581421368|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
161009386|NCT03990649|581421366|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
161009387|NCT03990649|581421367|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
161009388|NCT03990649|581421368|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
161009389|NCT05773313|581421369|FG000|Overall Study|Lost to Follow-up|3|||
161009390|NCT03050814|581421370|FG000|Overall Study|Screen failures|0|||
161009391|NCT03050814|581421371|FG001|Overall Study|Screen failures|0|||
161009392|NCT03050814|581421372|FG002|Overall Study|Screen failures|4|||
161009393|NCT05137236|581421373|FG000|Part A|Other than Specified|1|||
161009394|NCT05137236|581421374|FG001|Part A|Other than Specified|0|||
161009395|NCT05137236|581421375|FG002|Part A|Other than Specified|0|||
161009396|NCT05137236|581421376|FG003|Part A|Other than Specified|0|||
161009397|NCT05137236|581421377|FG004|Part A|Other than Specified|0|||
161009398|NCT05137236|581421378|FG005|Part A|Other than Specified|0|||
161009399|NCT05137236|581421379|FG006|Part A|Other than Specified|0|||
161009400|NCT05137236|581421380|FG007|Part A|Other than Specified|0|||
161009401|NCT05137236|581421373|FG000|Part A|Withdrawal by Subject|0|||
161009402|NCT05137236|581421374|FG001|Part A|Withdrawal by Subject|4|||
161009403|NCT05137236|581421375|FG002|Part A|Withdrawal by Subject|1|||
161009404|NCT05137236|581421376|FG003|Part A|Withdrawal by Subject|1|||
161009405|NCT05137236|581421377|FG004|Part A|Withdrawal by Subject|3|||
161009406|NCT05137236|581421378|FG005|Part A|Withdrawal by Subject|2|||
161009407|NCT05137236|581421379|FG006|Part A|Withdrawal by Subject|0|||
161009408|NCT05137236|581421380|FG007|Part A|Withdrawal by Subject|0|||
161009409|NCT05137236|581421373|FG000|Part A|Lost to Follow-up|5|||
161009410|NCT05137236|581421374|FG001|Part A|Lost to Follow-up|7|||
161009411|NCT05137236|581421375|FG002|Part A|Lost to Follow-up|1|||
161009412|NCT05137236|581421376|FG003|Part A|Lost to Follow-up|3|||
161009413|NCT05137236|581421377|FG004|Part A|Lost to Follow-up|3|||
161009414|NCT05137236|581421378|FG005|Part A|Lost to Follow-up|8|||
161009415|NCT05137236|581421379|FG006|Part A|Lost to Follow-up|0|||
161009416|NCT05137236|581421380|FG007|Part A|Lost to Follow-up|0|||
161009417|NCT05137236|581421373|FG000|Part B|Withdrawal by Subject|0|||
161009418|NCT05137236|581421374|FG001|Part B|Withdrawal by Subject|0|||
161009419|NCT05137236|581421375|FG002|Part B|Withdrawal by Subject|0|||
161009420|NCT05137236|581421376|FG003|Part B|Withdrawal by Subject|0|||
161009421|NCT05137236|581421377|FG004|Part B|Withdrawal by Subject|0|||
161009422|NCT05137236|581421378|FG005|Part B|Withdrawal by Subject|0|||
161009423|NCT05137236|581421379|FG006|Part B|Withdrawal by Subject|0|||
161009424|NCT05137236|581421380|FG007|Part B|Withdrawal by Subject|2|||
161009425|NCT05137236|581421373|FG000|Part B|Lost to Follow-up|0|||
161009426|NCT05137236|581421374|FG001|Part B|Lost to Follow-up|0|||
161009427|NCT05137236|581421375|FG002|Part B|Lost to Follow-up|0|||
161009428|NCT05137236|581421376|FG003|Part B|Lost to Follow-up|0|||
161009429|NCT05137236|581421377|FG004|Part B|Lost to Follow-up|0|||
161009430|NCT05137236|581421378|FG005|Part B|Lost to Follow-up|0|||
161009431|NCT05137236|581421379|FG006|Part B|Lost to Follow-up|5|||
161009432|NCT05137236|581421380|FG007|Part B|Lost to Follow-up|5|||
161009433|NCT05137236|581421373|FG000|Part B|Death|0|||
161009434|NCT05137236|581421374|FG001|Part B|Death|0|||
161009435|NCT05137236|581421375|FG002|Part B|Death|0|||
161009436|NCT05137236|581421376|FG003|Part B|Death|0|||
161009437|NCT05137236|581421377|FG004|Part B|Death|0|||
161009438|NCT05137236|581421378|FG005|Part B|Death|0|||
161009439|NCT05137236|581421379|FG006|Part B|Death|0|||
161009440|NCT05137236|581421380|FG007|Part B|Death|2|||
161009441|NCT01534494|581421381|FG000|Overall Study|Withdrawal by Subject|1|||
161009442|NCT00802464|581421382|FG000|Month 0 - Month 8|Adverse Event|0|||
161009443|NCT00802464|581421383|FG001|Month 0 - Month 8|Adverse Event|1|||
161009444|NCT00802464|581421384|FG002|Month 0 - Month 8|Adverse Event|1|||
161009445|NCT00802464|581421385|FG003|Month 0 - Month 8|Adverse Event|2|||
161009446|NCT00802464|581421382|FG000|Month 0 - Month 8|Protocol Violation|0|||
161009447|NCT00802464|581421383|FG001|Month 0 - Month 8|Protocol Violation|0|||
161009448|NCT00802464|581421384|FG002|Month 0 - Month 8|Protocol Violation|1|||
161147410|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161009449|NCT00802464|581421385|FG003|Month 0 - Month 8|Protocol Violation|0|||
161009450|NCT00802464|581421382|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
161009451|NCT00802464|581421383|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
161009452|NCT00802464|581421384|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
161009453|NCT00802464|581421385|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
161009454|NCT00802464|581421382|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
161009455|NCT00802464|581421383|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
161009456|NCT00802464|581421384|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
161009457|NCT00802464|581421385|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
161009458|NCT00802464|581421382|FG000|Month 0 - Month 8|Other|0|||
161009459|NCT00802464|581421383|FG001|Month 0 - Month 8|Other|0|||
161009460|NCT00802464|581421384|FG002|Month 0 - Month 8|Other|1|||
161009461|NCT00802464|581421385|FG003|Month 0 - Month 8|Other|0|||
161009462|NCT00802464|581421382|FG000|Month 8 - Month 14|Adverse Event|0|||
161009463|NCT00802464|581421383|FG001|Month 8 - Month 14|Adverse Event|1|||
161009464|NCT00802464|581421384|FG002|Month 8 - Month 14|Adverse Event|0|||
161009465|NCT00802464|581421385|FG003|Month 8 - Month 14|Adverse Event|0|||
161009466|NCT00802464|581421382|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
161009467|NCT00802464|581421383|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
161009468|NCT00802464|581421384|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
161009469|NCT00802464|581421385|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
161009470|NCT00802464|581421382|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
161009471|NCT00802464|581421383|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
161009472|NCT00802464|581421384|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
161009473|NCT00802464|581421385|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
161009474|NCT00402246|581421386|FG000|Overall Study|Death|62|||
161009475|NCT00402246|581421387|FG001|Overall Study|Death|58|||
161009476|NCT00402246|581421386|FG000|Overall Study|Lost to Follow-up|20|||
161009477|NCT00402246|581421387|FG001|Overall Study|Lost to Follow-up|28|||
161009478|NCT00402246|581421386|FG000|Overall Study|Withdrawal by Subject|72|||
161009479|NCT00402246|581421387|FG001|Overall Study|Withdrawal by Subject|87|||
161009480|NCT00402246|581421386|FG000|Overall Study|Physician Decision|24|||
161009481|NCT00402246|581421387|FG001|Overall Study|Physician Decision|26|||
161009482|NCT00402246|581421386|FG000|Overall Study|Protocol Violation|25|||
161009483|NCT00402246|581421387|FG001|Overall Study|Protocol Violation|24|||
161009484|NCT00402246|581421386|FG000|Overall Study|Missed Final Visit|1|||
161009485|NCT00402246|581421387|FG001|Overall Study|Missed Final Visit|2|||
161009486|NCT00402246|581421386|FG000|Overall Study|Insurance Issues|2|||
161009487|NCT00402246|581421387|FG001|Overall Study|Insurance Issues|1|||
161009488|NCT00402246|581421386|FG000|Overall Study|Heart Transplant|0|||
161009489|NCT00402246|581421387|FG001|Overall Study|Heart Transplant|1|||
161009490|NCT00402246|581421386|FG000|Overall Study|Patient's device explanted|6|||
161009491|NCT00402246|581421387|FG001|Overall Study|Patient's device explanted|2|||
161009492|NCT00402246|581421386|FG000|Overall Study|Center Closure|5|||
161009493|NCT00402246|581421387|FG001|Overall Study|Center Closure|3|||
161009494|NCT00402246|581421386|FG000|Overall Study|Deterioriating Condition|3|||
161009495|NCT00402246|581421387|FG001|Overall Study|Deterioriating Condition|2|||
161009496|NCT02622568|581421397|FG000|Overall Study|Lost to Follow-up|5|||
161009497|NCT02622568|581421398|FG001|Overall Study|Lost to Follow-up|5|||
161009498|NCT01939899|581421399|FG000|Lead-in Dose Finding Phase|Death|0|||
161009499|NCT01939899|581421400|FG001|Lead-in Dose Finding Phase|Death|3|||
161009500|NCT01939899|581421401|FG002|Lead-in Dose Finding Phase|Death|1|||
161009501|NCT01939899|581421402|FG003|Lead-in Dose Finding Phase|Death|0|||
161009502|NCT01939899|581421403|FG004|Lead-in Dose Finding Phase|Death|0|||
161009503|NCT01939899|581421399|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
161009504|NCT01939899|581421400|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
161009505|NCT01939899|581421401|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
161009506|NCT01939899|581421402|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
161009507|NCT01939899|581421403|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
161009508|NCT01939899|581421399|FG000|Lead-in Dose Finding Phase|Other|0|||
161009509|NCT01939899|581421400|FG001|Lead-in Dose Finding Phase|Other|0|||
161009510|NCT01939899|581421401|FG002|Lead-in Dose Finding Phase|Other|1|||
161009511|NCT01939899|581421402|FG003|Lead-in Dose Finding Phase|Other|0|||
161009512|NCT01939899|581421403|FG004|Lead-in Dose Finding Phase|Other|0|||
161009513|NCT01939899|581421399|FG000|Phase 2|Withdrawal by Subject|0|||
161009514|NCT01939899|581421400|FG001|Phase 2|Withdrawal by Subject|0|||
161009515|NCT01939899|581421401|FG002|Phase 2|Withdrawal by Subject|0|||
161009516|NCT01939899|581421402|FG003|Phase 2|Withdrawal by Subject|2|||
161009517|NCT01939899|581421403|FG004|Phase 2|Withdrawal by Subject|0|||
161009518|NCT01939899|581421399|FG000|Phase 2|Disease Progression|0|||
161009519|NCT01939899|581421400|FG001|Phase 2|Disease Progression|0|||
161009520|NCT01939899|581421401|FG002|Phase 2|Disease Progression|0|||
161009521|NCT01939899|581421402|FG003|Phase 2|Disease Progression|9|||
161009522|NCT01939899|581421403|FG004|Phase 2|Disease Progression|1|||
161009523|NCT02015520|581421406|FG000|Overall Study|Lack of Efficacy|1|||
161009524|NCT02015520|581421407|FG001|Overall Study|Lack of Efficacy|0|||
161009525|NCT02015520|581421408|FG002|Overall Study|Lack of Efficacy|3|||
161009526|NCT02015520|581421409|FG003|Overall Study|Lack of Efficacy|2|||
161009527|NCT02015520|581421406|FG000|Overall Study|Adverse Event|0|||
161009528|NCT02015520|581421407|FG001|Overall Study|Adverse Event|0|||
161147411|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161147412|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
161147413|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
161009529|NCT02015520|581421408|FG002|Overall Study|Adverse Event|0|||
161009530|NCT02015520|581421409|FG003|Overall Study|Adverse Event|1|||
161009531|NCT02015520|581421406|FG000|Overall Study|Withdrawal by Subject|2|||
161009532|NCT02015520|581421407|FG001|Overall Study|Withdrawal by Subject|2|||
161009533|NCT02015520|581421408|FG002|Overall Study|Withdrawal by Subject|1|||
161009534|NCT02015520|581421409|FG003|Overall Study|Withdrawal by Subject|0|||
161009535|NCT02015520|581421406|FG000|Overall Study|Death|1|||
161009536|NCT02015520|581421407|FG001|Overall Study|Death|0|||
161009537|NCT02015520|581421408|FG002|Overall Study|Death|0|||
161009538|NCT02015520|581421409|FG003|Overall Study|Death|0|||
161009539|NCT02015520|581421406|FG000|Overall Study|Lost to Follow-up|0|||
161009540|NCT02015520|581421407|FG001|Overall Study|Lost to Follow-up|0|||
161009541|NCT02015520|581421408|FG002|Overall Study|Lost to Follow-up|1|||
161009542|NCT02015520|581421409|FG003|Overall Study|Lost to Follow-up|0|||
161009543|NCT02015520|581421406|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161009544|NCT02015520|581421407|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161147414|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
161147415|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
161147416|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
161147417|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
161147418|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
161009545|NCT02015520|581421408|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
161009546|NCT02015520|581421409|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
161009547|NCT02015520|581421406|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
161009548|NCT02015520|581421407|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
161009549|NCT02015520|581421408|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
161009550|NCT02015520|581421409|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
161009551|NCT01854385|581421411|FG000|Pre-Treatment|Withdrawal by Subject|4|||
161009552|NCT01854385|581421411|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
161009553|NCT01854385|581421411|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
161009554|NCT01854385|581421411|FG000|Pre-Treatment|Unable to come for study visits|1|||
161009555|NCT01854385|581421411|FG000|Treatment|Lost to Follow-up|1|||
161009556|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
161009557|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
161009558|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
161009559|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
161009560|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
161009561|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009562|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009563|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
161009564|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009565|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
161009566|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
161009567|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
161009568|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
161009569|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
161009570|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
161009571|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161009572|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
161009573|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
161009574|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161009575|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
161009576|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
161009577|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
161009578|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
161009579|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
161009580|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
161009581|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009582|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009583|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
161009584|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009585|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
161009586|NCT04759833|581421414|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009587|NCT04759833|581421415|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
161009588|NCT04759833|581421416|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009589|NCT04759833|581421417|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009590|NCT04759833|581421418|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
161009591|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161009592|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161009593|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
161009594|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
161009595|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
161009596|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161147419|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
161271704|NCT00809159|582375228|FG002|Part 1 and 2|Administrative problems|0|||
161009597|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161271705|NCT00809159|582375229|FG003|Part 1 and 2|Administrative problems|1|||
161271706|NCT00809159|582375230|FG004|Part 1 and 2|Administrative problems|0|||
161271707|NCT00809159|582375231|FG005|Part 1 and 2|Administrative problems|0|||
161271708|NCT00809159|582375226|FG000|Part 1 and 2|Adverse Event|0|||
161009598|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161009599|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
161009600|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
161009601|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161009602|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161009603|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
161009604|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
161009605|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
161009606|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161009607|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161009608|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
161009609|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
161009610|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
161009611|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161009612|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161009613|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
161009614|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
161009615|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
161009616|NCT04759833|581421414|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161009617|NCT04759833|581421415|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161009618|NCT04759833|581421416|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
161009619|NCT04759833|581421417|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
161009620|NCT04759833|581421418|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
161009621|NCT00508924|581421419|FG000|Overall Study|Protocol Violation|0|||
161009622|NCT00508924|581421420|FG001|Overall Study|Protocol Violation|0|||
161009623|NCT00508924|581421421|FG002|Overall Study|Protocol Violation|1|||
161009624|NCT00508924|581421422|FG003|Overall Study|Protocol Violation|1|||
161009625|NCT00630058|581421423|FG000|Overall Study|Adverse Event|1|||
161009626|NCT00630058|581421424|FG001|Overall Study|Adverse Event|1|||
161009627|NCT00630058|581421423|FG000|Overall Study|Withdrawal by Subject|0|||
161009628|NCT00630058|581421424|FG001|Overall Study|Withdrawal by Subject|1|||
161009629|NCT00630058|581421423|FG000|Overall Study|stopping criteria|3|||
161009630|NCT00630058|581421424|FG001|Overall Study|stopping criteria|2|||
161009631|NCT00415519|581421429|FG000|Overall Study|Adverse Event|1|||
161009632|NCT00415519|581421430|FG001|Overall Study|Adverse Event|0|||
161009633|NCT00415519|581421429|FG000|Overall Study|Withdrawal by Subject|2|||
161009634|NCT00415519|581421430|FG001|Overall Study|Withdrawal by Subject|0|||
161009635|NCT00415519|581421429|FG000|Overall Study|Patient's convenience|1|||
161009636|NCT00415519|581421430|FG001|Overall Study|Patient's convenience|0|||
161009637|NCT04163718|581421431|FG000|Overall Study|Study terminated|12|||
161009638|NCT04872738|581421432|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
161009639|NCT04872738|581421433|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
161009640|NCT02924064|581421436|FG000|Overall Study|Adverse Event|2|||
161009641|NCT02924064|581421437|FG001|Overall Study|Adverse Event|2|||
161009642|NCT02924064|581421436|FG000|Overall Study|Lost to Follow-up|0|||
161009643|NCT02924064|581421437|FG001|Overall Study|Lost to Follow-up|2|||
161009644|NCT02924064|581421436|FG000|Overall Study|Physician Decision|0|||
161009645|NCT02924064|581421437|FG001|Overall Study|Physician Decision|2|||
161009646|NCT02924064|581421436|FG000|Overall Study|Protocol Violation|1|||
161009647|NCT02924064|581421437|FG001|Overall Study|Protocol Violation|3|||
161009648|NCT02924064|581421436|FG000|Overall Study|Withdrawal by Subject|4|||
161009649|NCT02924064|581421437|FG001|Overall Study|Withdrawal by Subject|5|||
161009650|NCT02924064|581421436|FG000|Overall Study|Other|17|||
161009651|NCT02924064|581421437|FG001|Overall Study|Other|29|||
161009652|NCT00529100|581421440|FG000|Overall Study|Adverse Event|0|||
161009653|NCT00529100|581421441|FG001|Overall Study|Adverse Event|5|||
161009654|NCT00529100|581421440|FG000|Overall Study|Protocol Violation|0|||
161271709|NCT00809159|582375227|FG001|Part 1 and 2|Adverse Event|0|||
161009655|NCT00529100|581421441|FG001|Overall Study|Protocol Violation|1|||
161009656|NCT00529100|581421440|FG000|Overall Study|Progressive Disease|0|||
161009657|NCT00529100|581421441|FG001|Overall Study|Progressive Disease|1|||
161009658|NCT00529100|581421440|FG000|Overall Study|Withdrawal by Subject|0|||
161009659|NCT00529100|581421441|FG001|Overall Study|Withdrawal by Subject|1|||
161009660|NCT00529100|581421440|FG000|Overall Study|Participant Ineligibility|0|||
161009661|NCT00529100|581421441|FG001|Overall Study|Participant Ineligibility|1|||
161009662|NCT05524454|581421443|FG000|Overall Study|Withdrawal by Subject|1|||
161009663|NCT05999435|581421444|FG000|Overall Study|Adverse Event|1|||
161009664|NCT05999435|581421445|FG001|Overall Study|Adverse Event|0|||
161009665|NCT05999435|581421446|FG002|Overall Study|Adverse Event|0|||
161009666|NCT05999435|581421444|FG000|Overall Study|Withdrawal by Subject|2|||
161009667|NCT05999435|581421445|FG001|Overall Study|Withdrawal by Subject|1|||
161009668|NCT05999435|581421446|FG002|Overall Study|Withdrawal by Subject|0|||
161009669|NCT05054725|581421450|FG000|Overall Study|Withdrawal by Subject|3|||
161009670|NCT05054725|581421451|FG001|Overall Study|Withdrawal by Subject|4|||
161009671|NCT05054725|581421450|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
161009672|NCT05054725|581421451|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
161009673|NCT05054725|581421450|FG000|Overall Study|Death|1|||
161009674|NCT05054725|581421451|FG001|Overall Study|Death|21|||
161009675|NCT05054725|581421450|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
161009676|NCT05054725|581421451|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
161009677|NCT05054725|581421450|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
161009678|NCT05054725|581421451|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
161009679|NCT05054725|581421450|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
161009680|NCT05054725|581421451|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
161009681|NCT05054725|581421450|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
161009682|NCT05054725|581421451|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
161009683|NCT05054725|581421450|FG000|Overall Study|Physician discretion due to subject progression|0|||
161009684|NCT05054725|581421451|FG001|Overall Study|Physician discretion due to subject progression|1|||
161009685|NCT03674411|581421452|FG000|Overall Study|Non-treatment|4|||
161009686|NCT03674411|581421453|FG001|Overall Study|Non-treatment|0|||
161009687|NCT00781274|581421455|FG000|Overall Study|Withdrawal by Subject|2|||
161009688|NCT04705480|581421457|FG000|Overall Study|Withdrawal by Subject|1|||
161147420|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
161147421|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
161147422|NCT01380093|581922465|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161147423|NCT01380093|581922466|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161147424|NCT01380093|581922467|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
161147425|NCT01380093|581922468|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161271710|NCT00809159|582375228|FG002|Part 1 and 2|Adverse Event|1|||
161271711|NCT00809159|582375229|FG003|Part 1 and 2|Adverse Event|0|||
160967110|NCT00755222|581268146|FG000|Overall Study|Protocol Violation|2|||
160967111|NCT00755222|581268147|FG001|Overall Study|Protocol Violation|0|||
160967112|NCT01337986|581268150|FG000|Overall Study|Adverse Event|2|||
160967113|NCT01337986|581268151|FG001|Overall Study|Adverse Event|2|||
160967114|NCT01337986|581268150|FG000|Overall Study|Lost to Follow-up|1|||
160967115|NCT01337986|581268151|FG001|Overall Study|Lost to Follow-up|0|||
160967116|NCT01337986|581268150|FG000|Overall Study|Protocol Violation|0|||
160967117|NCT01337986|581268151|FG001|Overall Study|Protocol Violation|3|||
160967118|NCT03430063|581268152|FG000|Overall Study|Adverse Event|0|||
160967119|NCT03430063|581268153|FG001|Overall Study|Adverse Event|1|||
160967120|NCT03430063|581268154|FG002|Overall Study|Adverse Event|0|||
160967121|NCT03430063|581268152|FG000|Overall Study|Death|3|||
160967122|NCT03430063|581268153|FG001|Overall Study|Death|2|||
160967123|NCT03430063|581268154|FG002|Overall Study|Death|3|||
160967124|NCT03430063|581268152|FG000|Overall Study|Lost to Follow-up|0|||
160967125|NCT03430063|581268153|FG001|Overall Study|Lost to Follow-up|1|||
160967126|NCT03430063|581268154|FG002|Overall Study|Lost to Follow-up|0|||
160967127|NCT03430063|581268152|FG000|Overall Study|Withdrawal by Subject|0|||
160967128|NCT03430063|581268153|FG001|Overall Study|Withdrawal by Subject|0|||
160967129|NCT03430063|581268154|FG002|Overall Study|Withdrawal by Subject|1|||
160967130|NCT03430063|581268152|FG000|Overall Study|Withdrawal of consent|3|||
160967131|NCT03430063|581268153|FG001|Overall Study|Withdrawal of consent|1|||
160967132|NCT03430063|581268154|FG002|Overall Study|Withdrawal of consent|2|||
160967133|NCT03430063|581268152|FG000|Overall Study|Progressive disease|1|||
160967134|NCT03430063|581268153|FG001|Overall Study|Progressive disease|2|||
161009689|NCT04705480|581421458|FG001|Overall Study|Withdrawal by Subject|0|||
161009690|NCT04705480|581421459|FG002|Overall Study|Withdrawal by Subject|1|||
161009691|NCT04705480|581421457|FG000|Overall Study|Protocol Violation|2|||
161009692|NCT04705480|581421458|FG001|Overall Study|Protocol Violation|0|||
161009693|NCT04705480|581421459|FG002|Overall Study|Protocol Violation|2|||
161009694|NCT04705480|581421457|FG000|Overall Study|Decision to discharge before intervention|2|||
161009695|NCT04705480|581421458|FG001|Overall Study|Decision to discharge before intervention|0|||
161009696|NCT04705480|581421459|FG002|Overall Study|Decision to discharge before intervention|0|||
161009697|NCT00861692|581421460|FG000|Overall Study|Death|6|||
161009698|NCT06429163|581421461|FG000|Overall Study|uterine fibroid type 7|1|||
161009699|NCT06429163|581421462|FG001|Overall Study|uterine fibroid type 7|1|||
161009700|NCT06429163|581421463|FG002|Overall Study|uterine fibroid type 7|1|||
161009701|NCT06429163|581421461|FG000|Overall Study|severe adhesions|1|||
161009702|NCT06429163|581421462|FG001|Overall Study|severe adhesions|2|||
161009703|NCT06429163|581421463|FG002|Overall Study|severe adhesions|1|||
161009704|NCT06429163|581421461|FG000|Overall Study|conversion to laparotomy|0|||
161009705|NCT06429163|581421462|FG001|Overall Study|conversion to laparotomy|1|||
161009706|NCT06429163|581421463|FG002|Overall Study|conversion to laparotomy|0|||
161009707|NCT06429163|581421461|FG000|Overall Study|concomitant procedure|1|||
161009708|NCT06429163|581421462|FG001|Overall Study|concomitant procedure|0|||
161009709|NCT06429163|581421463|FG002|Overall Study|concomitant procedure|0|||
161009710|NCT04970654|581421464|FG000|Overall Study|Withdrawal by parents/guardian|1|||
161009711|NCT04970654|581421465|FG001|Overall Study|Withdrawal by parents/guardian|2|||
161009712|NCT04970654|581421464|FG000|Overall Study|Unclassified|2|||
161009713|NCT04970654|581421465|FG001|Overall Study|Unclassified|1|||
161009714|NCT04970654|581421464|FG000|Overall Study|Lost to Follow-up|1|||
161009715|NCT04970654|581421465|FG001|Overall Study|Lost to Follow-up|0|||
161009716|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Adverse Event|1|||
161009717|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Adverse Event|6|||
161009718|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Adverse Event|2|||
161009719|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Adverse Event|1|||
161009720|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Adverse Event|0|||
161009721|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Adverse Event|0|||
161009722|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161009723|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161009724|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161009725|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
161009726|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161009727|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
161009728|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009729|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
161009730|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009731|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
161009732|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009733|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
161009734|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Physician Decision|0|||
161009735|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Physician Decision|2|||
161009736|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Physician Decision|0|||
161009737|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Physician Decision|0|||
161009738|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Physician Decision|0|||
161009739|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Physician Decision|0|||
161009740|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
161009741|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
161009742|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
161009743|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
161009744|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
161009745|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
161009746|NCT04929483|581421466|FG000|Main Study (24 Weeks)|Randomized in error|0|||
161009747|NCT04929483|581421467|FG001|Main Study (24 Weeks)|Randomized in error|1|||
161009748|NCT04929483|581421468|FG002|Main Study (24 Weeks)|Randomized in error|0|||
161009749|NCT04929483|581421469|FG003|Main Study (24 Weeks)|Randomized in error|2|||
161009750|NCT04929483|581421470|FG004|Main Study (24 Weeks)|Randomized in error|0|||
161009751|NCT04929483|581421471|FG005|Main Study (24 Weeks)|Randomized in error|0|||
161009752|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009753|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009754|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
161009755|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009756|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
161009757|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
161009758|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161009759|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161009760|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161009761|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161009762|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
161009763|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
161009764|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Other than specified|1|||
161009765|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Other than specified|0|||
161009766|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Other than specified|1|||
161009767|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Other than specified|0|||
161009768|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Other than specified|1|||
161009769|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Other than specified|0|||
161009770|NCT04929483|581421466|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
161009771|NCT04929483|581421467|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
161009772|NCT04929483|581421468|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
161009773|NCT04929483|581421469|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
161009774|NCT04929483|581421470|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
161009775|NCT04929483|581421471|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
161009776|NCT01626885|581421472|FG000|Overall Study|Adverse Event|8|||
161009777|NCT01626885|581421472|FG000|Overall Study|Withdrawal by Subject|4|||
161009778|NCT04083781|581421479|FG000|Main Part|Physician Decision|0|||
161009779|NCT04083781|581421480|FG001|Main Part|Physician Decision|1|||
161009780|NCT04083781|581421481|FG002|Main Part|Physician Decision|2|||
161009781|NCT04083781|581421482|FG003|Main Part|Physician Decision|0|||
161009782|NCT04083781|581421479|FG000|Main Part|Death|1|||
161009783|NCT04083781|581421480|FG001|Main Part|Death|3|||
161009784|NCT04083781|581421481|FG002|Main Part|Death|1|||
161009785|NCT04083781|581421482|FG003|Main Part|Death|0|||
161009786|NCT04083781|581421479|FG000|Main Part|Withdrawal by Subject|5|||
161009787|NCT04083781|581421480|FG001|Main Part|Withdrawal by Subject|2|||
161009788|NCT04083781|581421481|FG002|Main Part|Withdrawal by Subject|3|||
161009789|NCT04083781|581421482|FG003|Main Part|Withdrawal by Subject|7|||
161009790|NCT04083781|581421479|FG000|Extension Part|Physician Decision|0|||
161009791|NCT04083781|581421480|FG001|Extension Part|Physician Decision|0|||
161009792|NCT04083781|581421481|FG002|Extension Part|Physician Decision|0|||
161009793|NCT04083781|581421482|FG003|Extension Part|Physician Decision|1|||
161009794|NCT04083781|581421479|FG000|Extension Part|Death|0|||
161009795|NCT04083781|581421480|FG001|Extension Part|Death|1|||
161009796|NCT04083781|581421481|FG002|Extension Part|Death|0|||
161009797|NCT04083781|581421482|FG003|Extension Part|Death|1|||
161009798|NCT04083781|581421479|FG000|Extension Part|Withdrawal by Subject|0|||
161009799|NCT04083781|581421480|FG001|Extension Part|Withdrawal by Subject|1|||
161009800|NCT04083781|581421481|FG002|Extension Part|Withdrawal by Subject|0|||
161009801|NCT04083781|581421482|FG003|Extension Part|Withdrawal by Subject|0|||
161009802|NCT04083781|581421479|FG000|Extension Part|Ongoing|13|||
161009803|NCT04083781|581421480|FG001|Extension Part|Ongoing|25|||
161009804|NCT04083781|581421481|FG002|Extension Part|Ongoing|15|||
161009805|NCT04083781|581421482|FG003|Extension Part|Ongoing|51|||
161009806|NCT01466192|581421483|FG000|Overall Study|Physician Decision|1|||
161009807|NCT01466192|581421483|FG000|Overall Study|Withdrawal by Subject|3|||
161009808|NCT05600283|581421484|FG000|Overall Study|Withdrawal by Subject|3|||
161009809|NCT05600283|581421485|FG001|Overall Study|Withdrawal by Subject|8|||
161009810|NCT05600283|581421484|FG000|Overall Study|Invalid Vaginal Swab|2|||
161009811|NCT05600283|581421485|FG001|Overall Study|Invalid Vaginal Swab|2|||
161009812|NCT05600283|581421484|FG000|Overall Study|Missing Clinician Collection|3|||
161009813|NCT05600283|581421485|FG001|Overall Study|Missing Clinician Collection|6|||
161009814|NCT05600283|581421484|FG000|Overall Study|Screen Failure|1|||
161009815|NCT05600283|581421485|FG001|Overall Study|Screen Failure|2|||
161009816|NCT05600283|581421484|FG000|Overall Study|Sample Lost in Transit|1|||
161009817|NCT05600283|581421485|FG001|Overall Study|Sample Lost in Transit|0|||
161009818|NCT00068601|581421486|FG000|Overall Study|Ineligible|11|||
161009819|NCT00068601|581421487|FG001|Overall Study|Ineligible|13|||
161009820|NCT00068601|581421486|FG000|Overall Study|Not evaluable: withdrew consent|5|||
161009821|NCT00068601|581421487|FG001|Overall Study|Not evaluable: withdrew consent|4|||
161009822|NCT00068601|581421486|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
161009823|NCT00068601|581421487|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
161009824|NCT00068601|581421486|FG000|Overall Study|Death|11|||
161009825|NCT00068601|581421487|FG001|Overall Study|Death|3|||
161009826|NCT00068601|581421486|FG000|Overall Study|Lost to Follow-up|3|||
161009827|NCT00068601|581421487|FG001|Overall Study|Lost to Follow-up|2|||
161009828|NCT00068601|581421486|FG000|Overall Study|Missing primary outcome data|30|||
161009829|NCT00068601|581421487|FG001|Overall Study|Missing primary outcome data|34|||
161009830|NCT02468128|581421488|FG000|Overall Study|Protocol Violation|6|||
161009831|NCT02468128|581421489|FG001|Overall Study|Protocol Violation|6|||
161009832|NCT00440011|581421493|FG000|Overall Study|Adverse Event|2|||
161009833|NCT00440011|581421494|FG001|Overall Study|Adverse Event|0|||
161009834|NCT00440011|581421493|FG000|Overall Study|Lost to Follow-up|0|||
161009835|NCT00440011|581421494|FG001|Overall Study|Lost to Follow-up|2|||
161009836|NCT00440011|581421493|FG000|Overall Study|Protocol Violation|1|||
161147426|NCT01380093|581922469|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161009837|NCT00440011|581421494|FG001|Overall Study|Protocol Violation|1|||
161009838|NCT00440011|581421493|FG000|Overall Study|Withdrawal by Subject|1|||
161147427|NCT01380093|581922470|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161147428|NCT01380093|581922471|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161009839|NCT00440011|581421494|FG001|Overall Study|Withdrawal by Subject|0|||
161009840|NCT00621296|581421495|FG000|Overall Study|Adverse Event|2|||
161009841|NCT00621296|581421495|FG000|Overall Study|Lack of Efficacy|1|||
161009842|NCT00621296|581421495|FG000|Overall Study|Physician Decision|7|||
161009843|NCT00621296|581421495|FG000|Overall Study|Unmatch Criteria|1|||
161009844|NCT00621296|581421495|FG000|Overall Study|Stopping Criteria|3|||
161009845|NCT04166058|581421496|FG000|Overall Study|Adverse Event|1|||
161009846|NCT04166058|581421497|FG001|Overall Study|Adverse Event|1|||
161009847|NCT04166058|581421498|FG002|Overall Study|Adverse Event|0|||
161009848|NCT04166058|581421499|FG003|Overall Study|Adverse Event|0|||
161009849|NCT04166058|581421496|FG000|Overall Study|Withdrawal by Subject|4|||
161009850|NCT04166058|581421497|FG001|Overall Study|Withdrawal by Subject|4|||
161009851|NCT04166058|581421498|FG002|Overall Study|Withdrawal by Subject|1|||
161009852|NCT04166058|581421499|FG003|Overall Study|Withdrawal by Subject|10|||
161009853|NCT04166058|581421496|FG000|Overall Study|Lost to Follow-up|9|||
161009854|NCT04166058|581421497|FG001|Overall Study|Lost to Follow-up|2|||
161009855|NCT04166058|581421498|FG002|Overall Study|Lost to Follow-up|1|||
161009856|NCT04166058|581421499|FG003|Overall Study|Lost to Follow-up|1|||
161009857|NCT04166058|581421496|FG000|Overall Study|Pregnancy|1|||
161009858|NCT04166058|581421497|FG001|Overall Study|Pregnancy|0|||
161009859|NCT04166058|581421498|FG002|Overall Study|Pregnancy|0|||
161009860|NCT04166058|581421499|FG003|Overall Study|Pregnancy|0|||
161009861|NCT04166058|581421496|FG000|Overall Study|Physician Decision|2|||
161009862|NCT04166058|581421497|FG001|Overall Study|Physician Decision|0|||
161009863|NCT04166058|581421498|FG002|Overall Study|Physician Decision|0|||
161009864|NCT04166058|581421499|FG003|Overall Study|Physician Decision|2|||
161009865|NCT04166058|581421496|FG000|Overall Study|Protocol Violation|1|||
161009866|NCT04166058|581421497|FG001|Overall Study|Protocol Violation|0|||
161009867|NCT04166058|581421498|FG002|Overall Study|Protocol Violation|0|||
161009868|NCT04166058|581421499|FG003|Overall Study|Protocol Violation|0|||
161009869|NCT04166058|581421496|FG000|Overall Study|Lack of Efficacy|2|||
161009870|NCT04166058|581421497|FG001|Overall Study|Lack of Efficacy|0|||
161009871|NCT04166058|581421498|FG002|Overall Study|Lack of Efficacy|0|||
161009872|NCT04166058|581421499|FG003|Overall Study|Lack of Efficacy|0|||
161009873|NCT04166058|581421496|FG000|Overall Study|Other|1|||
161009874|NCT04166058|581421497|FG001|Overall Study|Other|0|||
161009875|NCT04166058|581421498|FG002|Overall Study|Other|0|||
161009876|NCT04166058|581421499|FG003|Overall Study|Other|1|||
161009877|NCT04166058|581421496|FG000|Overall Study|Non-compliance with study drug|0|||
161009878|NCT04166058|581421497|FG001|Overall Study|Non-compliance with study drug|0|||
161009879|NCT04166058|581421498|FG002|Overall Study|Non-compliance with study drug|0|||
161009880|NCT04166058|581421499|FG003|Overall Study|Non-compliance with study drug|2|||
161009881|NCT02998528|581421500|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
161009882|NCT02998528|581421501|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
161009883|NCT02998528|581421502|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
161009884|NCT02998528|581421500|FG000|Randomization Period|Participant withdrew consent|0|||
161009885|NCT02998528|581421501|FG001|Randomization Period|Participant withdrew consent|3|||
161009886|NCT02998528|581421502|FG002|Randomization Period|Participant withdrew consent|0|||
161009887|NCT02998528|581421500|FG000|Randomization Period|Participant no longer meets study criteria|1|||
161009888|NCT02998528|581421501|FG001|Randomization Period|Participant no longer meets study criteria|3|||
161009889|NCT02998528|581421502|FG002|Randomization Period|Participant no longer meets study criteria|2|||
161009890|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
161009891|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
161009892|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
161009893|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
161009894|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
161009895|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
161009896|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
161009897|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
161009898|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
161009899|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
161009900|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
161009901|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
161271712|NCT00809159|582375230|FG004|Part 1 and 2|Adverse Event|1|||
161271713|NCT00809159|582375231|FG005|Part 1 and 2|Adverse Event|1|||
160967135|NCT03430063|581268154|FG002|Overall Study|Progressive disease|1|||
160967136|NCT03430063|581268152|FG000|Overall Study|Other un-specified|1|||
160967137|NCT03430063|581268153|FG001|Overall Study|Other un-specified|1|||
160967138|NCT03430063|581268154|FG002|Overall Study|Other un-specified|0|||
160967139|NCT03430063|581268152|FG000|Overall Study|Randomized, but never treated|0|||
160967140|NCT03430063|581268153|FG001|Overall Study|Randomized, but never treated|0|||
160967141|NCT03430063|581268154|FG002|Overall Study|Randomized, but never treated|1|||
160967142|NCT01287611|581268156|FG000|Overall Study|Lost to Follow-up|29|||
160967143|NCT01287611|581268157|FG001|Overall Study|Lost to Follow-up|16|||
160967144|NCT01287611|581268156|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
160967145|NCT01287611|581268157|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
160967146|NCT02192970|581268160|FG000|Overall Study|Lost to Follow-up|6|||
160967147|NCT02192970|581268161|FG001|Overall Study|Lost to Follow-up|0|||
161009902|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
161009903|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
161009904|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
161009905|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Death|1|||
161009906|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Death|0|||
161009907|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Death|0|||
161009908|NCT02998528|581421500|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
161271714|NCT00809159|582375226|FG000|Part 1 and 2|Lost to Follow-up|0|||
161271715|NCT00809159|582375227|FG001|Part 1 and 2|Lost to Follow-up|0|||
161271716|NCT00809159|582375228|FG002|Part 1 and 2|Lost to Follow-up|1|||
161271717|NCT00809159|582375229|FG003|Part 1 and 2|Lost to Follow-up|1|||
161271718|NCT00809159|582375230|FG004|Part 1 and 2|Lost to Follow-up|0|||
161271719|NCT00809159|582375231|FG005|Part 1 and 2|Lost to Follow-up|0|||
161271720|NCT00809159|582375226|FG000|Part 1 and 2|Withdrawal by Subject|0|||
161271721|NCT00809159|582375227|FG001|Part 1 and 2|Withdrawal by Subject|0|||
161271722|NCT00809159|582375228|FG002|Part 1 and 2|Withdrawal by Subject|4|||
161271723|NCT00809159|582375229|FG003|Part 1 and 2|Withdrawal by Subject|0|||
161271724|NCT00809159|582375230|FG004|Part 1 and 2|Withdrawal by Subject|0|||
161271725|NCT00809159|582375231|FG005|Part 1 and 2|Withdrawal by Subject|1|||
161271726|NCT03918109|582375236|FG000|Overall Study|Withdrawal by Subject|0|||
161271727|NCT03918109|582375237|FG001|Overall Study|Withdrawal by Subject|0|||
161271728|NCT03918109|582375238|FG002|Overall Study|Withdrawal by Subject|2|||
161271729|NCT03918109|582375239|FG003|Overall Study|Withdrawal by Subject|1|||
161271730|NCT03918109|582375236|FG000|Overall Study|Lost to Follow-up|0|||
161009909|NCT02998528|581421501|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
161009910|NCT02998528|581421502|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
161009911|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
161009912|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
161009913|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
161009914|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
161009915|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
161009916|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
161009917|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
161009918|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
161009919|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
161009920|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
161009921|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
161009922|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
161009923|NCT02998528|581421500|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
161009924|NCT02998528|581421501|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
161009925|NCT02998528|581421502|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
161009926|NCT00591214|581421503|FG000|Overall Study|Physician Decision|7|||
161009927|NCT00591214|581421503|FG000|Overall Study|Withdrawal by Subject|1|||
161009928|NCT01753570|581421504|FG000|Overall Study|Adverse Event|1|||
161009929|NCT01753570|581421505|FG001|Overall Study|Adverse Event|0|||
161009930|NCT01753570|581421506|FG002|Overall Study|Adverse Event|1|||
161009931|NCT01753570|581421504|FG000|Overall Study|Physician Decision|0|||
161009932|NCT01753570|581421505|FG001|Overall Study|Physician Decision|1|||
161009933|NCT01753570|581421506|FG002|Overall Study|Physician Decision|0|||
161009934|NCT01753570|581421504|FG000|Overall Study|Withdrawal by Subject|1|||
161009935|NCT01753570|581421505|FG001|Overall Study|Withdrawal by Subject|4|||
161009936|NCT01753570|581421506|FG002|Overall Study|Withdrawal by Subject|0|||
161009937|NCT05308316|581421507|FG000|Overall Study|Withdrawal by Subject|2|||
161009938|NCT05308316|581421507|FG000|Overall Study|Physician Decision|1|||
161009939|NCT03103321|581422711|FG000|Overall Study|Protocol Violation|1|||
161009940|NCT03103321|581422712|FG001|Overall Study|Protocol Violation|1|||
161009941|NCT03103321|581422713|FG002|Overall Study|Protocol Violation|1|||
161009942|NCT03103321|581422714|FG003|Overall Study|Protocol Violation|0|||
161009943|NCT06375421|581422716|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
161009944|NCT06375421|581422717|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
161009945|NCT06375421|581422718|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
161009946|NCT06375421|581422719|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
161009947|NCT05760313|581422725|FG000|Overall Study|Withdrawal by Subject|0|||
161009948|NCT05760313|581422726|FG001|Overall Study|Withdrawal by Subject|0|||
161009949|NCT05760313|581422727|FG002|Overall Study|Withdrawal by Subject|1|||
161009950|NCT05760313|581422725|FG000|Overall Study|Other|1|||
161009951|NCT05760313|581422726|FG001|Overall Study|Other|0|||
161009952|NCT05760313|581422727|FG002|Overall Study|Other|0|||
161271731|NCT03918109|582375237|FG001|Overall Study|Lost to Follow-up|0|||
161271732|NCT03918109|582375238|FG002|Overall Study|Lost to Follow-up|0|||
161271733|NCT03918109|582375239|FG003|Overall Study|Lost to Follow-up|1|||
161271734|NCT03050060|582375244|FG000|Overall Study|Adverse Event|7|||
161271735|NCT03050060|582375244|FG000|Overall Study|Withdrawal by Subject|1|||
161271736|NCT03050060|582375244|FG000|Overall Study|Progression|7|||
161009953|NCT00956007|581422728|FG000|Overall Study|Protocol Violation|27|||
161009954|NCT00956007|581422729|FG001|Overall Study|Protocol Violation|23|||
161009955|NCT05228470|581422730|FG000|Overall Study|Death|6|||
161009956|NCT05228470|581422731|FG001|Overall Study|Death|11|||
161009957|NCT05228470|581422730|FG000|Overall Study|Withdrawal by Subject|1|||
161009958|NCT05228470|581422731|FG001|Overall Study|Withdrawal by Subject|8|||
161009959|NCT05228470|581422730|FG000|Overall Study|Ongoing|1|||
161271737|NCT04568031|582375245|FG000|Overall Study|Lost to Follow-up|1|||
161009960|NCT05228470|581422731|FG001|Overall Study|Ongoing|11|||
161009961|NCT03885037|581422732|FG000|Overall Study|Protocol Violation|16|||
161009962|NCT01492686|581422733|FG000|Double-blind Phase|Adverse Event|0|||
161009963|NCT01492686|581422734|FG001|Double-blind Phase|Adverse Event|2|||
161009964|NCT01492686|581422733|FG000|Double-blind Phase|Physician Decision|0|||
161009965|NCT01492686|581422734|FG001|Double-blind Phase|Physician Decision|1|||
161009966|NCT01492686|581422733|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161009967|NCT01492686|581422734|FG001|Double-blind Phase|Withdrawal by Subject|2|||
161009968|NCT01492686|581422733|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
161009969|NCT01492686|581422734|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
161009970|NCT01492686|581422733|FG000|Open-label Phase|Adverse Event|1|||
161009971|NCT01492686|581422734|FG001|Open-label Phase|Adverse Event|2|||
161009972|NCT01492686|581422733|FG000|Open-label Phase|Physician Decision|1|||
161009973|NCT01492686|581422734|FG001|Open-label Phase|Physician Decision|0|||
161009974|NCT01492686|581422733|FG000|Open-label Phase|Withdrawal by Subject|6|||
161009975|NCT01492686|581422734|FG001|Open-label Phase|Withdrawal by Subject|7|||
161009976|NCT01492686|581422733|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
161009977|NCT01492686|581422734|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
161009978|NCT03314987|581422737|FG000|Overall Study|Lost to Follow-up|13|||
161009979|NCT03314987|581422738|FG001|Overall Study|Lost to Follow-up|13|||
161009980|NCT05552963|581422739|FG000|Overall Study|Lost to Follow-up|1|||
161009981|NCT05552963|581422739|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
161009982|NCT00431834|581422742|FG000|Overall Study|Withdrawal by Subject|7|||
161009983|NCT00431834|581422742|FG000|Overall Study|Death|3|||
161009984|NCT00431834|581422742|FG000|Overall Study|Missed Endpoint Visit|2|||
161009985|NCT00431834|581422742|FG000|Overall Study|Lost to Follow-up|1|||
161009986|NCT05529979|581422745|FG000|Overall Study|Lost to Follow-up|6|||
161009987|NCT05529979|581422745|FG000|Overall Study|Physician Decision|1|||
161009988|NCT05529979|581422745|FG000|Overall Study|non-feasibility cases|4|||
161009989|NCT05529979|581422745|FG000|Overall Study|Lack of Efficacy|3|||
161009990|NCT05529979|581422745|FG000|Overall Study|ablation not performed|1|||
161009991|NCT04191499|581422746|FG000|Overall Study|Adverse Event|1|||
161009992|NCT04191499|581422747|FG001|Overall Study|Adverse Event|0|||
161009993|NCT04191499|581422746|FG000|Overall Study|Death|42|||
161009994|NCT04191499|581422747|FG001|Overall Study|Death|55|||
161009995|NCT04191499|581422746|FG000|Overall Study|Lost to Follow-up|4|||
161009996|NCT04191499|581422747|FG001|Overall Study|Lost to Follow-up|1|||
161009997|NCT04191499|581422746|FG000|Overall Study|Physician Decision|1|||
161009998|NCT04191499|581422747|FG001|Overall Study|Physician Decision|0|||
161009999|NCT04191499|581422746|FG000|Overall Study|Progressive Disease|1|||
161010000|NCT04191499|581422747|FG001|Overall Study|Progressive Disease|0|||
161010001|NCT04191499|581422746|FG000|Overall Study|Symptomatic Deterioration|1|||
161010002|NCT04191499|581422747|FG001|Overall Study|Symptomatic Deterioration|0|||
161010003|NCT04191499|581422746|FG000|Overall Study|Withdrawal by Subject|7|||
161010004|NCT04191499|581422747|FG001|Overall Study|Withdrawal by Subject|11|||
161010005|NCT04191499|581422746|FG000|Overall Study|Ongoing in the study|104|||
161010006|NCT04191499|581422747|FG001|Overall Study|Ongoing in the study|97|||
161010007|NCT03403413|581422748|FG000|Overall Study|Lack of Efficacy|2|||
161010008|NCT04982315|581422749|FG000|Overall Study|Death|1|||
161010009|NCT04982315|581422750|FG001|Overall Study|Death|0|||
161010010|NCT04982315|581422751|FG002|Overall Study|Death|1|||
161010011|NCT04982315|581422749|FG000|Overall Study|Lack of Efficacy|0|||
161010012|NCT04982315|581422750|FG001|Overall Study|Lack of Efficacy|0|||
161010013|NCT04982315|581422751|FG002|Overall Study|Lack of Efficacy|2|||
161010014|NCT04982315|581422749|FG000|Overall Study|Withdrawal by Subject|24|||
161010015|NCT04982315|581422750|FG001|Overall Study|Withdrawal by Subject|1|||
161010016|NCT04982315|581422751|FG002|Overall Study|Withdrawal by Subject|2|||
161010017|NCT04982315|581422749|FG000|Overall Study|Dealing with health/life issues|3|||
161010018|NCT04982315|581422750|FG001|Overall Study|Dealing with health/life issues|4|||
161010019|NCT04982315|581422751|FG002|Overall Study|Dealing with health/life issues|7|||
161010020|NCT04982315|581422749|FG000|Overall Study|Privacy concerns|1|||
161010021|NCT04982315|581422750|FG001|Overall Study|Privacy concerns|0|||
161010022|NCT04982315|581422751|FG002|Overall Study|Privacy concerns|0|||
161147429|NCT01380093|581922472|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161010023|NCT04982315|581422749|FG000|Overall Study|Withdrawal by research team|0|||
161010024|NCT04982315|581422750|FG001|Overall Study|Withdrawal by research team|0|||
161010025|NCT04982315|581422751|FG002|Overall Study|Withdrawal by research team|1|||
161010026|NCT00780910|581422752|FG000|Overall Study|Adverse Event|2|||
161010027|NCT01143337|581422757|FG000|Overall Study|Adverse Event|3|||
161010028|NCT01143337|581422758|FG001|Overall Study|Adverse Event|9|||
161010029|NCT01143337|581422759|FG002|Overall Study|Adverse Event|5|||
161010030|NCT01143337|581422757|FG000|Overall Study|Lack of Efficacy|6|||
161010031|NCT01143337|581422758|FG001|Overall Study|Lack of Efficacy|2|||
161010032|NCT01143337|581422759|FG002|Overall Study|Lack of Efficacy|1|||
161010033|NCT01143337|581422757|FG000|Overall Study|Protocol Violation|1|||
161010034|NCT01143337|581422758|FG001|Overall Study|Protocol Violation|0|||
161010035|NCT01143337|581422759|FG002|Overall Study|Protocol Violation|0|||
161271738|NCT04568031|582375246|FG001|Overall Study|Lost to Follow-up|0|||
161010036|NCT01143337|581422757|FG000|Overall Study|Withdrawal by Subject|0|||
161010037|NCT01143337|581422758|FG001|Overall Study|Withdrawal by Subject|0|||
161010038|NCT01143337|581422759|FG002|Overall Study|Withdrawal by Subject|1|||
161010039|NCT01143337|581422757|FG000|Overall Study|Other reason|0|||
161010040|NCT01143337|581422758|FG001|Overall Study|Other reason|0|||
161010041|NCT01143337|581422759|FG002|Overall Study|Other reason|5|||
161010042|NCT03671811|581422761|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
161010043|NCT03671811|581422762|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
161010044|NCT00424463|581422770|FG000|Overall Study|Adverse Event|2|||
161010045|NCT00424463|581422771|FG001|Overall Study|Adverse Event|3|||
161010046|NCT00424463|581422772|FG002|Overall Study|Adverse Event|2|||
161010047|NCT00424463|581422770|FG000|Overall Study|Physician Decision|0|||
161010048|NCT00424463|581422771|FG001|Overall Study|Physician Decision|2|||
161010049|NCT00424463|581422772|FG002|Overall Study|Physician Decision|2|||
161010050|NCT00424463|581422770|FG000|Overall Study|Withdrawal by Subject|4|||
161010051|NCT00424463|581422771|FG001|Overall Study|Withdrawal by Subject|2|||
161010052|NCT00424463|581422772|FG002|Overall Study|Withdrawal by Subject|5|||
161010053|NCT00424463|581422770|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
161010054|NCT00424463|581422771|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
161010055|NCT00424463|581422772|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
161010056|NCT00424463|581422770|FG000|Overall Study|Patient's convenience|0|||
161010057|NCT00424463|581422771|FG001|Overall Study|Patient's convenience|0|||
161010058|NCT00424463|581422772|FG002|Overall Study|Patient's convenience|1|||
161010059|NCT03570892|581422773|FG000|Overall Study|Death|51|||
161010060|NCT03570892|581422774|FG001|Overall Study|Death|45|||
161010061|NCT03570892|581422773|FG000|Overall Study|Subject decision|5|||
161010062|NCT03570892|581422774|FG001|Overall Study|Subject decision|3|||
161010063|NCT03570892|581422773|FG000|Overall Study|Protocol Violation|1|||
161010064|NCT03570892|581422774|FG001|Overall Study|Protocol Violation|4|||
161010065|NCT03570892|581422773|FG000|Overall Study|Physician Decision|0|||
161010066|NCT03570892|581422774|FG001|Overall Study|Physician Decision|2|||
161010067|NCT03891758|581422775|FG000|Overall Study|Adverse Event|2|||
161010068|NCT03891758|581422776|FG001|Overall Study|Adverse Event|0|||
161010069|NCT03891758|581422775|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161010070|NCT03891758|581422776|FG001|Overall Study|Withdrawal by parent/guardian|2|||
161010071|NCT04434729|581422779|FG000|Overall Study|Adverse Event|1|||
161010072|NCT04434729|581422779|FG000|Overall Study|Physician Decision|1|||
161010073|NCT00975819|581422780|FG000|Overall Study|Lack of Efficacy|8|||
161010074|NCT00975819|581422780|FG000|Overall Study|Adverse Event|2|||
161010075|NCT00975819|581422780|FG000|Overall Study|Physician Decision|2|||
161010076|NCT00975819|581422780|FG000|Overall Study|Withdrawal by Subject|2|||
161010077|NCT00975819|581422780|FG000|Overall Study|Protocol Violation|1|||
161010078|NCT01968109|581422781|FG000|Overall Study|DISEASE PROGRESSION|4|||
161010079|NCT01968109|581422782|FG001|Overall Study|DISEASE PROGRESSION|4|||
161010080|NCT01968109|581422783|FG002|Overall Study|DISEASE PROGRESSION|3|||
161010081|NCT01968109|581422784|FG003|Overall Study|DISEASE PROGRESSION|9|||
161010082|NCT01968109|581422785|FG004|Overall Study|DISEASE PROGRESSION|5|||
161010083|NCT01968109|581422786|FG005|Overall Study|DISEASE PROGRESSION|6|||
161010084|NCT01968109|581422787|FG006|Overall Study|DISEASE PROGRESSION|6|||
161010085|NCT01968109|581422788|FG007|Overall Study|DISEASE PROGRESSION|6|||
161010086|NCT01968109|581422789|FG008|Overall Study|DISEASE PROGRESSION|4|||
161010087|NCT01968109|581422790|FG009|Overall Study|DISEASE PROGRESSION|5|||
161010088|NCT01968109|581422791|FG010|Overall Study|DISEASE PROGRESSION|8|||
161010089|NCT01968109|581422792|FG011|Overall Study|DISEASE PROGRESSION|4|||
161010090|NCT01968109|581422793|FG012|Overall Study|DISEASE PROGRESSION|7|||
161010091|NCT01968109|581422794|FG013|Overall Study|DISEASE PROGRESSION|14|||
161010092|NCT01968109|581422795|FG014|Overall Study|DISEASE PROGRESSION|14|||
161010093|NCT01968109|581422796|FG015|Overall Study|DISEASE PROGRESSION|13|||
161010094|NCT01968109|581422797|FG016|Overall Study|DISEASE PROGRESSION|34|||
161010095|NCT01968109|581422798|FG017|Overall Study|DISEASE PROGRESSION|20|||
161010096|NCT01968109|581422799|FG018|Overall Study|DISEASE PROGRESSION|54|||
161343525|NCT03282097|582644403|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
161010097|NCT01968109|581422800|FG019|Overall Study|DISEASE PROGRESSION|46|||
161010098|NCT01968109|581422801|FG020|Overall Study|DISEASE PROGRESSION|77|||
161010099|NCT01968109|581422802|FG021|Overall Study|DISEASE PROGRESSION|25|||
161010100|NCT01968109|581422803|FG022|Overall Study|DISEASE PROGRESSION|47|||
161010101|NCT01968109|581422804|FG023|Overall Study|DISEASE PROGRESSION|125|||
161010102|NCT01968109|581422805|FG024|Overall Study|DISEASE PROGRESSION|155|||
161010103|NCT01968109|581422806|FG025|Overall Study|DISEASE PROGRESSION|63|||
161010104|NCT01968109|581422807|FG026|Overall Study|DISEASE PROGRESSION|65|||
161010105|NCT01968109|581422808|FG027|Overall Study|DISEASE PROGRESSION|137|||
161010106|NCT01968109|581422809|FG028|Overall Study|DISEASE PROGRESSION|35|||
161010107|NCT01968109|581422810|FG029|Overall Study|DISEASE PROGRESSION|23|||
161010108|NCT01968109|581422811|FG030|Overall Study|DISEASE PROGRESSION|71|||
161010109|NCT01968109|581422781|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010110|NCT01968109|581422782|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010111|NCT01968109|581422783|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010112|NCT01968109|581422784|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010113|NCT01968109|581422785|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010114|NCT01968109|581422786|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010115|NCT01968109|581422787|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010116|NCT01968109|581422788|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010117|NCT01968109|581422789|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010118|NCT01968109|581422790|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010119|NCT01968109|581422791|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010120|NCT01968109|581422792|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010121|NCT01968109|581422793|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010122|NCT01968109|581422794|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010123|NCT01968109|581422795|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010124|NCT01968109|581422796|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010125|NCT01968109|581422797|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010126|NCT01968109|581422798|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010127|NCT01968109|581422799|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
161010128|NCT01968109|581422800|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010129|NCT01968109|581422801|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010130|NCT01968109|581422802|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161010131|NCT01968109|581422803|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010132|NCT01968109|581422804|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
161010133|NCT01968109|581422805|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
161010134|NCT01968109|581422806|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010135|NCT01968109|581422807|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161010136|NCT01968109|581422808|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010137|NCT01968109|581422809|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
161010138|NCT01968109|581422810|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
161010139|NCT01968109|581422811|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161010140|NCT01968109|581422781|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
161010141|NCT01968109|581422782|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
161010142|NCT01968109|581422783|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
161010143|NCT01968109|581422784|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
161010144|NCT01968109|581422785|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
161010145|NCT01968109|581422786|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
161010146|NCT01968109|581422787|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
161010147|NCT01968109|581422788|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
161010148|NCT01968109|581422789|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
161010149|NCT01968109|581422790|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
161010150|NCT01968109|581422791|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
161010151|NCT01968109|581422792|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
161010152|NCT01968109|581422793|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
161010153|NCT01968109|581422794|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
161010154|NCT01968109|581422795|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
161010155|NCT01968109|581422796|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
161010156|NCT01968109|581422797|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
161010157|NCT01968109|581422798|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
161010158|NCT01968109|581422799|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
161010159|NCT01968109|581422800|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
161010160|NCT01968109|581422801|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
161010161|NCT01968109|581422802|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
161010162|NCT01968109|581422803|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
161010163|NCT01968109|581422804|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
161010164|NCT01968109|581422805|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
161010165|NCT01968109|581422806|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
161010166|NCT01968109|581422807|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
161010167|NCT01968109|581422808|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
161010168|NCT01968109|581422809|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
161010169|NCT01968109|581422810|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
161010170|NCT01968109|581422811|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
161010171|NCT01968109|581422781|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010172|NCT01968109|581422782|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161271739|NCT04568031|582375247|FG002|Overall Study|Lost to Follow-up|0|||
161010173|NCT01968109|581422783|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010174|NCT01968109|581422784|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010175|NCT01968109|581422785|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010176|NCT01968109|581422786|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010177|NCT01968109|581422787|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010178|NCT01968109|581422788|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010179|NCT01968109|581422789|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010180|NCT01968109|581422790|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161147430|NCT01380093|581922473|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
161010181|NCT01968109|581422791|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010182|NCT01968109|581422792|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010183|NCT01968109|581422793|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010184|NCT01968109|581422794|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010185|NCT01968109|581422795|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010186|NCT01968109|581422796|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010187|NCT01968109|581422797|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010188|NCT01968109|581422798|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010189|NCT01968109|581422799|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010190|NCT01968109|581422800|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010191|NCT01968109|581422801|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010192|NCT01968109|581422802|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010193|NCT01968109|581422803|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010194|NCT01968109|581422804|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010195|NCT01968109|581422805|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
161010196|NCT01968109|581422806|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
161010197|NCT01968109|581422807|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010198|NCT01968109|581422808|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
161010199|NCT01968109|581422809|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
161010200|NCT01968109|581422810|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010201|NCT01968109|581422811|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
161010202|NCT01968109|581422781|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010203|NCT01968109|581422782|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010204|NCT01968109|581422783|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010205|NCT01968109|581422784|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010206|NCT01968109|581422785|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010207|NCT01968109|581422786|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010208|NCT01968109|581422787|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010209|NCT01968109|581422788|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010210|NCT01968109|581422789|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010211|NCT01968109|581422790|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010212|NCT01968109|581422791|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010213|NCT01968109|581422792|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010214|NCT01968109|581422793|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010215|NCT01968109|581422794|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010216|NCT01968109|581422795|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010217|NCT01968109|581422796|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010218|NCT01968109|581422797|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010219|NCT01968109|581422798|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
161010220|NCT01968109|581422799|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010221|NCT01968109|581422800|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161010222|NCT01968109|581422801|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010223|NCT01968109|581422802|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161010224|NCT01968109|581422803|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010225|NCT01968109|581422804|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
161010226|NCT01968109|581422805|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
161010227|NCT01968109|581422806|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
161010228|NCT01968109|581422807|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010229|NCT01968109|581422808|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
161010230|NCT01968109|581422809|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161271740|NCT04568031|582375248|FG003|Overall Study|Lost to Follow-up|0|||
161271741|NCT04568031|582375245|FG000|Overall Study|Physician Decision|1|||
161271742|NCT04568031|582375246|FG001|Overall Study|Physician Decision|0|||
161271743|NCT04568031|582375247|FG002|Overall Study|Physician Decision|1|||
161271744|NCT04568031|582375248|FG003|Overall Study|Physician Decision|0|||
161271745|NCT04568031|582375245|FG000|Overall Study|Withdrawal by Subject|1|||
161271746|NCT04568031|582375246|FG001|Overall Study|Withdrawal by Subject|0|||
161271747|NCT04568031|582375247|FG002|Overall Study|Withdrawal by Subject|4|||
161010231|NCT01968109|581422810|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
161010232|NCT01968109|581422811|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
161010233|NCT01968109|581422781|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010234|NCT01968109|581422782|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010235|NCT01968109|581422783|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010236|NCT01968109|581422784|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010237|NCT01968109|581422785|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010238|NCT01968109|581422786|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010239|NCT01968109|581422787|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010240|NCT01968109|581422788|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161271748|NCT04568031|582375248|FG003|Overall Study|Withdrawal by Subject|1|||
161343526|NCT03282097|582644402|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
161010241|NCT01968109|581422789|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010242|NCT01968109|581422790|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010243|NCT01968109|581422791|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010244|NCT01968109|581422792|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010245|NCT01968109|581422793|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010246|NCT01968109|581422794|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010247|NCT01968109|581422795|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010248|NCT01968109|581422796|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
161010249|NCT01968109|581422797|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
161010250|NCT01968109|581422798|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010251|NCT01968109|581422799|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010252|NCT01968109|581422800|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010253|NCT01968109|581422801|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
161010254|NCT01968109|581422802|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010255|NCT01968109|581422803|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010256|NCT01968109|581422804|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
161010257|NCT01968109|581422805|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
161010258|NCT01968109|581422806|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010259|NCT01968109|581422807|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010260|NCT01968109|581422808|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
161010261|NCT01968109|581422809|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010262|NCT01968109|581422810|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
161010263|NCT01968109|581422811|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
161010264|NCT01968109|581422781|FG000|Overall Study|OTHER REASONS|0|||
161010265|NCT01968109|581422782|FG001|Overall Study|OTHER REASONS|0|||
161010266|NCT01968109|581422783|FG002|Overall Study|OTHER REASONS|0|||
161010267|NCT01968109|581422784|FG003|Overall Study|OTHER REASONS|1|||
161010268|NCT01968109|581422785|FG004|Overall Study|OTHER REASONS|0|||
161010269|NCT01968109|581422786|FG005|Overall Study|OTHER REASONS|0|||
161010270|NCT01968109|581422787|FG006|Overall Study|OTHER REASONS|0|||
161010271|NCT01968109|581422788|FG007|Overall Study|OTHER REASONS|0|||
161010272|NCT01968109|581422789|FG008|Overall Study|OTHER REASONS|0|||
161010273|NCT01968109|581422790|FG009|Overall Study|OTHER REASONS|0|||
161010274|NCT01968109|581422791|FG010|Overall Study|OTHER REASONS|0|||
161010275|NCT01968109|581422792|FG011|Overall Study|OTHER REASONS|1|||
161010276|NCT01968109|581422793|FG012|Overall Study|OTHER REASONS|0|||
161010277|NCT01968109|581422794|FG013|Overall Study|OTHER REASONS|0|||
161010278|NCT01968109|581422795|FG014|Overall Study|OTHER REASONS|1|||
161010279|NCT01968109|581422796|FG015|Overall Study|OTHER REASONS|1|||
161010280|NCT01968109|581422797|FG016|Overall Study|OTHER REASONS|1|||
161010281|NCT01968109|581422798|FG017|Overall Study|OTHER REASONS|0|||
161010282|NCT01968109|581422799|FG018|Overall Study|OTHER REASONS|0|||
161010283|NCT01968109|581422800|FG019|Overall Study|OTHER REASONS|0|||
161010284|NCT01968109|581422801|FG020|Overall Study|OTHER REASONS|0|||
161010285|NCT01968109|581422802|FG021|Overall Study|OTHER REASONS|2|||
161010286|NCT01968109|581422803|FG022|Overall Study|OTHER REASONS|0|||
161010287|NCT01968109|581422804|FG023|Overall Study|OTHER REASONS|0|||
161010288|NCT01968109|581422805|FG024|Overall Study|OTHER REASONS|3|||
161010289|NCT01968109|581422806|FG025|Overall Study|OTHER REASONS|0|||
161010290|NCT01968109|581422807|FG026|Overall Study|OTHER REASONS|3|||
161010291|NCT01968109|581422808|FG027|Overall Study|OTHER REASONS|3|||
161010292|NCT01968109|581422809|FG028|Overall Study|OTHER REASONS|6|||
161147431|NCT01380093|581922465|FG000|Treatment Phase: Second Intervention|Other|0|||
161271749|NCT02304458|582375249|FG000|Overall Study|Adverse Event|0|||
161271750|NCT02304458|582375250|FG001|Overall Study|Adverse Event|0|||
161271751|NCT02304458|582375251|FG002|Overall Study|Adverse Event|7|||
161271752|NCT02304458|582375252|FG003|Overall Study|Adverse Event|0|||
161271753|NCT02304458|582375253|FG004|Overall Study|Adverse Event|0|||
161271754|NCT02304458|582375254|FG005|Overall Study|Adverse Event|0|||
161271755|NCT02304458|582375255|FG006|Overall Study|Adverse Event|3|||
161271756|NCT02304458|582375256|FG007|Overall Study|Adverse Event|4|||
161271757|NCT02304458|582375249|FG000|Overall Study|Death|0|||
161271758|NCT02304458|582375250|FG001|Overall Study|Death|0|||
161271759|NCT02304458|582375251|FG002|Overall Study|Death|2|||
161010293|NCT01968109|581422810|FG029|Overall Study|OTHER REASONS|7|||
161271760|NCT02304458|582375252|FG003|Overall Study|Death|0|||
161271761|NCT02304458|582375253|FG004|Overall Study|Death|0|||
161271762|NCT02304458|582375254|FG005|Overall Study|Death|0|||
161271763|NCT02304458|582375255|FG006|Overall Study|Death|1|||
161010294|NCT01968109|581422811|FG030|Overall Study|OTHER REASONS|3|||
161010295|NCT01968109|581422781|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010296|NCT01968109|581422782|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010297|NCT01968109|581422783|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010298|NCT01968109|581422784|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010299|NCT01968109|581422785|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161147432|NCT01380093|581922466|FG001|Treatment Phase: Second Intervention|Other|0|||
161271764|NCT02304458|582375256|FG007|Overall Study|Death|0|||
161010300|NCT01968109|581422786|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010301|NCT01968109|581422787|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010302|NCT01968109|581422788|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010303|NCT01968109|581422789|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010304|NCT01968109|581422790|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010305|NCT01968109|581422791|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010306|NCT01968109|581422792|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010307|NCT01968109|581422793|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010308|NCT01968109|581422794|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010309|NCT01968109|581422795|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010310|NCT01968109|581422796|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010311|NCT01968109|581422797|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
161010312|NCT01968109|581422798|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161010313|NCT01968109|581422799|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010314|NCT01968109|581422800|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010315|NCT01968109|581422801|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161010316|NCT01968109|581422802|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010317|NCT01968109|581422803|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010318|NCT01968109|581422804|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010319|NCT01968109|581422805|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
161010320|NCT01968109|581422806|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
161010321|NCT01968109|581422807|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010322|NCT01968109|581422808|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010323|NCT01968109|581422809|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
161010324|NCT01968109|581422810|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
161010325|NCT01968109|581422811|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
161010326|NCT01968109|581422781|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010327|NCT01968109|581422782|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010328|NCT01968109|581422783|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010329|NCT01968109|581422784|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010330|NCT01968109|581422785|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010331|NCT01968109|581422786|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010332|NCT01968109|581422787|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010333|NCT01968109|581422788|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010334|NCT01968109|581422789|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010335|NCT01968109|581422790|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010336|NCT01968109|581422791|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010337|NCT01968109|581422792|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010338|NCT01968109|581422793|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010339|NCT01968109|581422794|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010340|NCT01968109|581422795|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010341|NCT01968109|581422796|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010342|NCT01968109|581422797|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010343|NCT01968109|581422798|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010344|NCT01968109|581422799|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010345|NCT01968109|581422800|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010346|NCT01968109|581422801|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
161010347|NCT01968109|581422802|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010348|NCT01968109|581422803|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010349|NCT01968109|581422804|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
161010350|NCT01968109|581422805|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010351|NCT01968109|581422806|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010352|NCT01968109|581422807|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010353|NCT01968109|581422808|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010354|NCT01968109|581422809|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010355|NCT01968109|581422810|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010356|NCT01968109|581422811|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
161010357|NCT01968109|581422781|FG000|Overall Study|Death|0|||
161010358|NCT01968109|581422782|FG001|Overall Study|Death|0|||
161010359|NCT01968109|581422783|FG002|Overall Study|Death|0|||
161010360|NCT01968109|581422784|FG003|Overall Study|Death|0|||
161010361|NCT01968109|581422785|FG004|Overall Study|Death|0|||
161010362|NCT01968109|581422786|FG005|Overall Study|Death|0|||
161010363|NCT01968109|581422787|FG006|Overall Study|Death|0|||
161010364|NCT01968109|581422788|FG007|Overall Study|Death|0|||
161010365|NCT01968109|581422789|FG008|Overall Study|Death|0|||
161010366|NCT01968109|581422790|FG009|Overall Study|Death|0|||
161010367|NCT01968109|581422791|FG010|Overall Study|Death|0|||
161010368|NCT01968109|581422792|FG011|Overall Study|Death|0|||
161010369|NCT01968109|581422793|FG012|Overall Study|Death|0|||
161010370|NCT01968109|581422794|FG013|Overall Study|Death|0|||
161010371|NCT01968109|581422795|FG014|Overall Study|Death|0|||
161010372|NCT01968109|581422796|FG015|Overall Study|Death|0|||
161010373|NCT01968109|581422797|FG016|Overall Study|Death|0|||
161010374|NCT01968109|581422798|FG017|Overall Study|Death|0|||
161010375|NCT01968109|581422799|FG018|Overall Study|Death|0|||
161010376|NCT01968109|581422800|FG019|Overall Study|Death|0|||
161010377|NCT01968109|581422801|FG020|Overall Study|Death|0|||
161010378|NCT01968109|581422802|FG021|Overall Study|Death|1|||
161010379|NCT01968109|581422803|FG022|Overall Study|Death|0|||
161010380|NCT01968109|581422804|FG023|Overall Study|Death|0|||
161010381|NCT01968109|581422805|FG024|Overall Study|Death|0|||
161010382|NCT01968109|581422806|FG025|Overall Study|Death|0|||
161010383|NCT01968109|581422807|FG026|Overall Study|Death|0|||
161010384|NCT01968109|581422808|FG027|Overall Study|Death|0|||
161010385|NCT01968109|581422809|FG028|Overall Study|Death|0|||
161010386|NCT01968109|581422810|FG029|Overall Study|Death|0|||
161010387|NCT01968109|581422811|FG030|Overall Study|Death|1|||
161010388|NCT03899792|581422812|FG000|Phase 2|Ongoing Treatment|0|||
161010389|NCT03899792|581422813|FG001|Phase 2|Ongoing Treatment|13|||
161010390|NCT03899792|581422814|FG002|Phase 2|Ongoing Treatment|14|||
161010391|NCT03899792|581422815|FG003|Phase 2|Ongoing Treatment|2|||
161010392|NCT03899792|581422812|FG000|Phase 2|Death|0|||
161010393|NCT03899792|581422813|FG001|Phase 2|Death|0|||
161010394|NCT03899792|581422814|FG002|Phase 2|Death|0|||
161010395|NCT03899792|581422815|FG003|Phase 2|Death|4|||
161010396|NCT03899792|581422812|FG000|Phase 2|Lost to Follow-up|0|||
161010397|NCT03899792|581422813|FG001|Phase 2|Lost to Follow-up|1|||
161010398|NCT03899792|581422814|FG002|Phase 2|Lost to Follow-up|1|||
161010399|NCT03899792|581422815|FG003|Phase 2|Lost to Follow-up|0|||
161010400|NCT03899792|581422812|FG000|Phase 2|Withdrawal by Subject|0|||
161010401|NCT03899792|581422813|FG001|Phase 2|Withdrawal by Subject|1|||
161010402|NCT03899792|581422814|FG002|Phase 2|Withdrawal by Subject|0|||
161010403|NCT03899792|581422815|FG003|Phase 2|Withdrawal by Subject|0|||
161010404|NCT02152137|581423894|FG000|Overall Study|Withdrawal by Subject|1|||
161010405|NCT02152137|581423894|FG000|Overall Study|Originally assigned to Arm B|3|||
161010406|NCT03358875|581423895|FG000|Overall Study|Death|409|||
161010407|NCT03358875|581423896|FG001|Overall Study|Death|223|||
161010408|NCT03358875|581423895|FG000|Overall Study|Study Closed by Sponsor|66|||
161010409|NCT03358875|581423896|FG001|Overall Study|Study Closed by Sponsor|29|||
161010410|NCT03358875|581423895|FG000|Overall Study|Withdrawal by Subject|13|||
161010411|NCT03358875|581423896|FG001|Overall Study|Withdrawal by Subject|16|||
161010412|NCT03358875|581423895|FG000|Overall Study|Lost to Follow-up|13|||
161010413|NCT03358875|581423896|FG001|Overall Study|Lost to Follow-up|2|||
161010414|NCT03358875|581423895|FG000|Overall Study|Miscellaneous|33|||
161010415|NCT03358875|581423896|FG001|Overall Study|Miscellaneous|0|||
161010416|NCT03358875|581423895|FG000|Overall Study|Remained on Study|1|||
161010417|NCT03358875|581423896|FG001|Overall Study|Remained on Study|0|||
161010418|NCT03460236|581423911|FG000|Overall Study|failed radiographic screening|16|||
161010419|NCT03460236|581423911|FG000|Overall Study|Withdrawal by Subject|11|||
161010420|NCT06194214|581423912|FG000|Overall Study|Adverse Event|1|||
161010421|NCT05613205|581423913|FG000|Overall Study|Lost to Follow-up|0|||
161010422|NCT05613205|581423914|FG001|Overall Study|Lost to Follow-up|0|||
161010423|NCT05613205|581423915|FG002|Overall Study|Lost to Follow-up|1|||
161010424|NCT05613205|581423916|FG003|Overall Study|Lost to Follow-up|1|||
161010425|NCT05613205|581423917|FG004|Overall Study|Lost to Follow-up|0|||
161010426|NCT05613205|581423913|FG000|Overall Study|Withdrawal by Subject|0|||
161010427|NCT05613205|581423914|FG001|Overall Study|Withdrawal by Subject|0|||
161010428|NCT05613205|581423915|FG002|Overall Study|Withdrawal by Subject|1|||
161010429|NCT05613205|581423916|FG003|Overall Study|Withdrawal by Subject|1|||
161010430|NCT05613205|581423917|FG004|Overall Study|Withdrawal by Subject|0|||
161010431|NCT04608045|581423921|FG000|Overall Study|Physician Decision|1|||
161010432|NCT04847999|581423922|FG000|Overall Study|Lost to Follow-up|0|||
161010433|NCT04847999|581423923|FG001|Overall Study|Lost to Follow-up|1|||
161010434|NCT03602014|581423925|FG000|Overall Study|Lost to Follow-up|2|||
161010435|NCT03602014|581423926|FG001|Overall Study|Lost to Follow-up|0|||
161010436|NCT03602014|581423927|FG002|Overall Study|Lost to Follow-up|0|||
161010437|NCT04300231|581423928|FG000|Overall Study|Protocol Violation|4|||
161147433|NCT01380093|581922467|FG002|Treatment Phase: Second Intervention|Other|0|||
161271765|NCT02304458|582375249|FG000|Overall Study|Lack of Efficacy|4|||
161010438|NCT04300231|581423929|FG001|Overall Study|Protocol Violation|3|||
161010439|NCT04300231|581423930|FG002|Overall Study|Protocol Violation|0|||
161010440|NCT04300231|581423931|FG003|Overall Study|Protocol Violation|2|||
161010441|NCT05846646|581423937|FG000|Overall Study|Physician Decision|1|||
161010442|NCT05846646|581423938|FG001|Overall Study|Physician Decision|0|||
161010443|NCT05846646|581423939|FG002|Overall Study|Physician Decision|0|||
161010444|NCT05846646|581423937|FG000|Overall Study|Lack of Efficacy|1|||
161010445|NCT05846646|581423938|FG001|Overall Study|Lack of Efficacy|1|||
161010446|NCT05846646|581423939|FG002|Overall Study|Lack of Efficacy|0|||
161010447|NCT05846646|581423937|FG000|Overall Study|Early Study Termination|1|||
161010448|NCT05846646|581423938|FG001|Overall Study|Early Study Termination|2|||
161010449|NCT05846646|581423939|FG002|Overall Study|Early Study Termination|0|||
161010450|NCT03733119|581423942|FG000|Overall Study|Physician Decision|2|||
161010451|NCT03733119|581423943|FG001|Overall Study|Physician Decision|1|||
161010452|NCT03733119|581423942|FG000|Overall Study|ineligible to treat per protocol|0|||
161010453|NCT03733119|581423943|FG001|Overall Study|ineligible to treat per protocol|1|||
161010454|NCT05052996|581423944|FG000|Overall Study|Still on study|0|||
161010455|NCT05052996|581423945|FG001|Overall Study|Still on study|0|||
161010456|NCT05052996|581423946|FG002|Overall Study|Still on study|47|||
161010457|NCT05052996|581423947|FG003|Overall Study|Still on study|44|||
161010458|NCT05052996|581423944|FG000|Overall Study|Cohort terminated by sponsor|21|||
161010459|NCT05052996|581423945|FG001|Overall Study|Cohort terminated by sponsor|12|||
161010460|NCT05052996|581423946|FG002|Overall Study|Cohort terminated by sponsor|0|||
161010461|NCT05052996|581423947|FG003|Overall Study|Cohort terminated by sponsor|0|||
161010462|NCT05052996|581423944|FG000|Overall Study|Withdrew consent|1|||
160967148|NCT04074590|581268162|FG000|Overall Study|Adverse Event|1|||
160967149|NCT04074590|581268163|FG001|Overall Study|Adverse Event|0|||
160967150|NCT04074590|581268162|FG000|Overall Study|Physician Decision|1|||
160967151|NCT04074590|581268163|FG001|Overall Study|Physician Decision|0|||
160967152|NCT04074590|581268162|FG000|Overall Study|Withdrawal by Subject|2|||
160967153|NCT04074590|581268163|FG001|Overall Study|Withdrawal by Subject|0|||
160967154|NCT03745222|581268166|FG000|Overall Study|Withdrawal by Subject|0|||
160967155|NCT03745222|581268167|FG001|Overall Study|Withdrawal by Subject|1|||
160967156|NCT03745222|581268168|FG002|Overall Study|Withdrawal by Subject|0|||
160967157|NCT02657317|581268169|FG000|Overall Study|Withdrawal by Subject|2|||
160967158|NCT02657317|581268170|FG001|Overall Study|Withdrawal by Subject|0|||
160967159|NCT02657317|581268169|FG000|Overall Study|Lost to Follow-up|3|||
160967160|NCT02657317|581268170|FG001|Overall Study|Lost to Follow-up|3|||
160967161|NCT02634788|581268171|FG000|Overall Study|Adverse Event|0|||
160967162|NCT02634788|581268172|FG001|Overall Study|Adverse Event|8|||
160967163|NCT02634788|581268173|FG002|Overall Study|Adverse Event|3|||
160967164|NCT02634788|581268174|FG003|Overall Study|Adverse Event|1|||
160967165|NCT02634788|581268171|FG000|Overall Study|Lack of Efficacy|4|||
160967166|NCT02634788|581268172|FG001|Overall Study|Lack of Efficacy|0|||
160967167|NCT02634788|581268173|FG002|Overall Study|Lack of Efficacy|1|||
160967168|NCT02634788|581268174|FG003|Overall Study|Lack of Efficacy|4|||
160967169|NCT02634788|581268171|FG000|Overall Study|Lost to Follow-up|0|||
160967170|NCT02634788|581268172|FG001|Overall Study|Lost to Follow-up|1|||
160967171|NCT02634788|581268173|FG002|Overall Study|Lost to Follow-up|0|||
160967172|NCT02634788|581268174|FG003|Overall Study|Lost to Follow-up|0|||
160967173|NCT02634788|581268171|FG000|Overall Study|Withdrawal by Subject|0|||
160967174|NCT02634788|581268172|FG001|Overall Study|Withdrawal by Subject|1|||
160967175|NCT02634788|581268173|FG002|Overall Study|Withdrawal by Subject|1|||
160967176|NCT02634788|581268174|FG003|Overall Study|Withdrawal by Subject|0|||
160967177|NCT00758459|581268175|FG000|Overall Study|Adverse Event|3|||
160967178|NCT00758459|581268176|FG001|Overall Study|Adverse Event|2|||
160967179|NCT00758459|581268175|FG000|Overall Study|Protocol Violation|0|||
160967180|NCT00758459|581268176|FG001|Overall Study|Protocol Violation|1|||
160967181|NCT00758459|581268175|FG000|Overall Study|Withdrawal by Subject|0|||
160967182|NCT00758459|581268176|FG001|Overall Study|Withdrawal by Subject|1|||
160967183|NCT01780935|581268180|FG000|Overall Study|Admin problems due to early termination|321|||
160967184|NCT01780935|581268181|FG001|Overall Study|Admin problems due to early termination|309|||
160967185|NCT01780935|581268180|FG000|Overall Study|Adverse Event|2|||
160967186|NCT01780935|581268181|FG001|Overall Study|Adverse Event|4|||
160967187|NCT01780935|581268180|FG000|Overall Study|Death|1|||
160967188|NCT01780935|581268181|FG001|Overall Study|Death|6|||
160967189|NCT01780935|581268180|FG000|Overall Study|Lost to Follow-up|2|||
160967190|NCT01780935|581268181|FG001|Overall Study|Lost to Follow-up|6|||
160967191|NCT01780935|581268180|FG000|Overall Study|Physician Decision|1|||
160967192|NCT01780935|581268181|FG001|Overall Study|Physician Decision|1|||
160967193|NCT01780935|581268180|FG000|Overall Study|Protocol deviation|0|||
160967194|NCT01780935|581268181|FG001|Overall Study|Protocol deviation|1|||
160967195|NCT01780935|581268180|FG000|Overall Study|Patient withdrew consent|8|||
160967196|NCT01780935|581268181|FG001|Overall Study|Patient withdrew consent|9|||
160967197|NCT01281202|581268182|FG000|Overall Study|Adverse Event|2|||
160967198|NCT01281202|581268183|FG001|Overall Study|Adverse Event|0|||
160967199|NCT01281202|581268182|FG000|Overall Study|Withdrawal by Subject|2|||
160967200|NCT01281202|581268183|FG001|Overall Study|Withdrawal by Subject|2|||
160967201|NCT01281202|581268182|FG000|Overall Study|Protocol Violation|11|||
160967202|NCT01281202|581268183|FG001|Overall Study|Protocol Violation|10|||
160967203|NCT01281202|581268182|FG000|Overall Study|Administrative|2|||
160967204|NCT01281202|581268183|FG001|Overall Study|Administrative|8|||
160967205|NCT01281202|581268182|FG000|Overall Study|Lost to Follow-up|11|||
160967206|NCT01281202|581268183|FG001|Overall Study|Lost to Follow-up|13|||
160967207|NCT01281202|581268182|FG000|Overall Study|Incarceration|0|||
160967208|NCT01281202|581268183|FG001|Overall Study|Incarceration|3|||
160967209|NCT01215357|581268184|FG000|Overall Study|Withdrawal by Subject|3|||
160967210|NCT01215357|581268184|FG000|Overall Study|Protocol Violation|9|||
160967211|NCT05479604|581268185|FG000|Overall Study|Lost to Follow-up|1|||
160967212|NCT05479604|581268186|FG001|Overall Study|Lost to Follow-up|5|||
160967213|NCT01591382|581268187|FG000|Overall Study|Discharged Prior to Study Completion|2|||
161010463|NCT05052996|581423945|FG001|Overall Study|Withdrew consent|0|||
161010464|NCT05052996|581423946|FG002|Overall Study|Withdrew consent|1|||
161010465|NCT05052996|581423947|FG003|Overall Study|Withdrew consent|2|||
161010466|NCT05052996|581423944|FG000|Overall Study|Lost to Follow-up|1|||
161010467|NCT05052996|581423945|FG001|Overall Study|Lost to Follow-up|0|||
161010468|NCT05052996|581423946|FG002|Overall Study|Lost to Follow-up|0|||
161010469|NCT05052996|581423947|FG003|Overall Study|Lost to Follow-up|2|||
161010470|NCT05052996|581423944|FG000|Overall Study|Adverse Event|0|||
161010471|NCT05052996|581423945|FG001|Overall Study|Adverse Event|0|||
161010472|NCT05052996|581423946|FG002|Overall Study|Adverse Event|2|||
161010473|NCT05052996|581423947|FG003|Overall Study|Adverse Event|0|||
161010474|NCT05052996|581423944|FG000|Overall Study|Randomized but never treated|0|||
161010475|NCT05052996|581423945|FG001|Overall Study|Randomized but never treated|0|||
161010476|NCT05052996|581423946|FG002|Overall Study|Randomized but never treated|1|||
161010477|NCT05052996|581423947|FG003|Overall Study|Randomized but never treated|1|||
161010478|NCT05052996|581423944|FG000|Overall Study|Protocol Violation|1|||
161010479|NCT05052996|581423945|FG001|Overall Study|Protocol Violation|0|||
161010480|NCT05052996|581423946|FG002|Overall Study|Protocol Violation|0|||
161010481|NCT05052996|581423947|FG003|Overall Study|Protocol Violation|0|||
161010482|NCT02088853|581423948|FG000|Overall Study|Pregnancy|1|||
161010483|NCT02088853|581423949|FG001|Overall Study|Pregnancy|0|||
161010484|NCT04704284|581423950|FG000|Overall Study|Withdrawal by Subject|1|||
161010485|NCT01061671|581423958|FG000|Overall Study|Withdrawal by Subject|16|||
161010486|NCT01061671|581423959|FG001|Overall Study|Withdrawal by Subject|20|||
161010487|NCT01061671|581423958|FG000|Overall Study|Lost to Follow-up|3|||
161010488|NCT01061671|581423959|FG001|Overall Study|Lost to Follow-up|5|||
161010489|NCT01061671|581423958|FG000|Overall Study|Death|28|||
161010490|NCT01061671|581423959|FG001|Overall Study|Death|30|||
161010491|NCT00419341|581423970|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
161010492|NCT00419341|581423970|FG000|Wash in/Wash Out Period|Adverse Event|2|||
161010493|NCT00419341|581423970|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
161010494|NCT00419341|581423970|FG000|Efficacy Period|Withdrawal by Subject|6|||
161010495|NCT00419341|581423970|FG000|Efficacy Period|Protocol Violation|1|||
161010496|NCT00419341|581423970|FG000|Efficacy Period|Lost to Follow-up|1|||
161010497|NCT00419341|581423970|FG000|Efficacy Period|Non-compliance|1|||
161010498|NCT00419341|581423970|FG000|Efficacy Period|Termination of study site|1|||
161010499|NCT00331136|581423971|FG000|Overall Study|Adverse Event|3|||
161010500|NCT00331136|581423972|FG001|Overall Study|Adverse Event|5|||
161010501|NCT00331136|581423973|FG002|Overall Study|Adverse Event|0|||
161010502|NCT00331136|581423974|FG003|Overall Study|Adverse Event|1|||
161010503|NCT00331136|581423971|FG000|Overall Study|Withdrawal by Subject|0|||
161010504|NCT00331136|581423972|FG001|Overall Study|Withdrawal by Subject|1|||
161010505|NCT00331136|581423973|FG002|Overall Study|Withdrawal by Subject|0|||
161010506|NCT00331136|581423974|FG003|Overall Study|Withdrawal by Subject|0|||
161010507|NCT00331136|581423971|FG000|Overall Study|Lost to Follow-up|0|||
161010508|NCT00331136|581423972|FG001|Overall Study|Lost to Follow-up|1|||
161010509|NCT00331136|581423973|FG002|Overall Study|Lost to Follow-up|0|||
161010510|NCT00331136|581423974|FG003|Overall Study|Lost to Follow-up|0|||
161147434|NCT01380093|581922468|FG003|Treatment Phase: Second Intervention|Other|1|||
161147435|NCT01380093|581922469|FG004|Treatment Phase: Second Intervention|Other|0|||
161147436|NCT01380093|581922470|FG005|Treatment Phase: Second Intervention|Other|0|||
161147437|NCT01380093|581922471|FG006|Treatment Phase: Second Intervention|Other|0|||
161147438|NCT01380093|581922472|FG007|Treatment Phase: Second Intervention|Other|0|||
161147439|NCT01380093|581922473|FG008|Treatment Phase: Second Intervention|Other|0|||
161147440|NCT01380093|581922465|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
161147441|NCT01380093|581922466|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
161147442|NCT01380093|581922467|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
161147443|NCT01380093|581922468|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
161147444|NCT01380093|581922469|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
161010511|NCT00331136|581423971|FG000|Overall Study|Protocol Violation|1|||
161010512|NCT00331136|581423972|FG001|Overall Study|Protocol Violation|0|||
161010513|NCT00331136|581423973|FG002|Overall Study|Protocol Violation|0|||
161010514|NCT00331136|581423974|FG003|Overall Study|Protocol Violation|0|||
161147445|NCT01380093|581922470|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
161010515|NCT00331136|581423971|FG000|Overall Study|Not treated|1|||
161010516|NCT00331136|581423972|FG001|Overall Study|Not treated|0|||
161010517|NCT00331136|581423973|FG002|Overall Study|Not treated|0|||
161010518|NCT00331136|581423974|FG003|Overall Study|Not treated|0|||
161010519|NCT02321514|581423975|FG000|Overall Study|Death|15|||
161010520|NCT02321514|581423975|FG000|Overall Study|Missed Visit|7|||
161010521|NCT02321514|581423975|FG000|Overall Study|Study Exit|3|||
161010522|NCT04578106|581423985|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
161010523|NCT01207492|581423986|FG000|Overall Study|Still on study|1|||
161010524|NCT01207492|581423986|FG000|Overall Study|Withdrawal by Subject|9|||
161010525|NCT01207492|581423986|FG000|Overall Study|Physician Decision|1|||
161010526|NCT01207492|581423986|FG000|Overall Study|Progressive disease|3|||
161010527|NCT01207492|581423986|FG000|Overall Study|Toxicity|1|||
161010528|NCT04690556|581423987|FG000|Overall Study|Adverse Event|6|||
161010529|NCT04690556|581423988|FG001|Overall Study|Adverse Event|4|||
161010530|NCT04690556|581423987|FG000|Overall Study|Death|3|||
161010531|NCT04690556|581423988|FG001|Overall Study|Death|4|||
161010532|NCT04690556|581423987|FG000|Overall Study|Lost to Follow-up|3|||
161010533|NCT04690556|581423988|FG001|Overall Study|Lost to Follow-up|2|||
161010534|NCT04690556|581423987|FG000|Overall Study|Protocol Violation|1|||
161010535|NCT04690556|581423988|FG001|Overall Study|Protocol Violation|4|||
161010536|NCT04690556|581423987|FG000|Overall Study|Physician Decision|2|||
161010537|NCT04690556|581423988|FG001|Overall Study|Physician Decision|0|||
161010538|NCT04690556|581423987|FG000|Overall Study|Withdrawal by Subject|25|||
161010539|NCT04690556|581423988|FG001|Overall Study|Withdrawal by Subject|17|||
161010540|NCT04690556|581423987|FG000|Overall Study|Prohibited medications and other reasons|3|||
161010541|NCT04690556|581423988|FG001|Overall Study|Prohibited medications and other reasons|1|||
161010542|NCT00497198|581423989|FG000|Overall Study|Adverse Event|4|||
161010543|NCT00497198|581423990|FG001|Overall Study|Adverse Event|2|||
161010544|NCT00497198|581423989|FG000|Overall Study|Physician Decision|1|||
161010545|NCT00497198|581423990|FG001|Overall Study|Physician Decision|2|||
161010546|NCT00497198|581423989|FG000|Overall Study|Withdrawal by Subject|0|||
161010547|NCT00497198|581423990|FG001|Overall Study|Withdrawal by Subject|1|||
161010548|NCT05028582|581423992|FG000|Overall Study|Lost to Follow-up|11|||
161010549|NCT05028582|581423993|FG001|Overall Study|Lost to Follow-up|9|||
161010550|NCT05028582|581423992|FG000|Overall Study|Withdrawal by Subject|9|||
161010551|NCT05028582|581423993|FG001|Overall Study|Withdrawal by Subject|10|||
161010552|NCT05028582|581423992|FG000|Overall Study|Adverse Event|5|||
161010553|NCT05028582|581423993|FG001|Overall Study|Adverse Event|2|||
161010554|NCT05028582|581423992|FG000|Overall Study|Miscellaneous|3|||
161010555|NCT05028582|581423993|FG001|Overall Study|Miscellaneous|2|||
161010556|NCT05028582|581423992|FG000|Overall Study|Lack of Efficacy|3|||
161010557|NCT05028582|581423993|FG001|Overall Study|Lack of Efficacy|1|||
161010558|NCT05028582|581423992|FG000|Overall Study|Physician Decision|0|||
161010559|NCT05028582|581423993|FG001|Overall Study|Physician Decision|1|||
161010560|NCT06938230|581423997|FG000|Overall Study|Lost to Follow-up|56|||
161010561|NCT06938230|581423998|FG001|Overall Study|Lost to Follow-up|18|||
161010562|NCT00330681|581424002|FG000|Overall Study|Adverse Event|3|||
161010563|NCT00330681|581424003|FG001|Overall Study|Adverse Event|6|||
161010564|NCT00330681|581424002|FG000|Overall Study|Protocol Violation|0|||
161010565|NCT00330681|581424003|FG001|Overall Study|Protocol Violation|1|||
161010566|NCT00330681|581424002|FG000|Overall Study|Withdrawal by Subject|5|||
161010567|NCT00330681|581424003|FG001|Overall Study|Withdrawal by Subject|5|||
161010568|NCT00330681|581424002|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
161010569|NCT00330681|581424003|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
161010570|NCT04310735|581425444|FG000|Overall Study|Withdrawal by Subject|1|||
161010571|NCT04310735|581425445|FG001|Overall Study|Withdrawal by Subject|3|||
161010572|NCT04310735|581425446|FG002|Overall Study|Withdrawal by Subject|8|||
161010573|NCT04310735|581425444|FG000|Overall Study|Equipment malfunction|0|||
161010574|NCT04310735|581425445|FG001|Overall Study|Equipment malfunction|1|||
161010575|NCT04310735|581425446|FG002|Overall Study|Equipment malfunction|0|||
161010576|NCT03012841|581425447|FG000|Overall Study|Protocol Violation|0|||
161010577|NCT03012841|581425448|FG001|Overall Study|Protocol Violation|10|||
161010578|NCT03012841|581425447|FG000|Overall Study|Lost to Follow-up|6|||
161010579|NCT03012841|581425448|FG001|Overall Study|Lost to Follow-up|1|||
161010580|NCT03012841|581425447|FG000|Overall Study|Withdrawal by Subject|6|||
161010581|NCT03012841|581425448|FG001|Overall Study|Withdrawal by Subject|0|||
161010582|NCT03012841|581425447|FG000|Overall Study|Unable to complete 12 month visit|6|||
161010583|NCT03012841|581425448|FG001|Overall Study|Unable to complete 12 month visit|0|||
161010584|NCT03012841|581425447|FG000|Overall Study|Subject relocation|1|||
161010585|NCT03012841|581425448|FG001|Overall Study|Subject relocation|0|||
161010586|NCT03012841|581425447|FG000|Overall Study|Seasonal winter travel|1|||
161010587|NCT03012841|581425448|FG001|Overall Study|Seasonal winter travel|0|||
161010588|NCT03012841|581425447|FG000|Overall Study|Physician Decision|0|||
161010589|NCT03012841|581425448|FG001|Overall Study|Physician Decision|2|||
161010590|NCT03012841|581425447|FG000|Overall Study|No ablation performed|0|||
161010591|NCT03012841|581425448|FG001|Overall Study|No ablation performed|2|||
161010592|NCT03012841|581425447|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
161271766|NCT02304458|582375250|FG001|Overall Study|Lack of Efficacy|6|||
161271767|NCT02304458|582375251|FG002|Overall Study|Lack of Efficacy|38|||
161010593|NCT03012841|581425448|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
161010594|NCT03012841|581425447|FG000|Overall Study|Insurance change|0|||
161010595|NCT03012841|581425448|FG001|Overall Study|Insurance change|1|||
161010596|NCT05696080|581425449|FG000|Overall Study|Lost to Follow-up|2|||
161010597|NCT05696080|581425450|FG001|Overall Study|Lost to Follow-up|1|||
161010598|NCT05696080|581425449|FG000|Overall Study|Physician Decision|1|||
161010599|NCT05696080|581425450|FG001|Overall Study|Physician Decision|0|||
161010600|NCT05696080|581425449|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161010601|NCT05696080|581425450|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161010602|NCT05696080|581425449|FG000|Overall Study|Withdrawal by Subject|12|||
161010603|NCT05696080|581425450|FG001|Overall Study|Withdrawal by Subject|0|||
161010604|NCT03398200|581425451|FG000|Overall Study|Withdrawal by Subject|0|||
161010605|NCT03398200|581425452|FG001|Overall Study|Withdrawal by Subject|1|||
161010606|NCT04065048|581425453|FG000|Overall Study|Withdrawal by Subject|1|||
161010607|NCT04065048|581425454|FG001|Overall Study|Withdrawal by Subject|2|||
161010608|NCT04065048|581425455|FG002|Overall Study|Withdrawal by Subject|1|||
161010609|NCT04065048|581425456|FG003|Overall Study|Withdrawal by Subject|1|||
161010610|NCT04065048|581425453|FG000|Overall Study|Adverse Event|1|||
161010611|NCT04065048|581425454|FG001|Overall Study|Adverse Event|0|||
161010612|NCT04065048|581425455|FG002|Overall Study|Adverse Event|1|||
161010613|NCT04065048|581425456|FG003|Overall Study|Adverse Event|0|||
161010614|NCT03397108|581425457|FG000|Overall Study|Lost to Follow-up|15|||
161010615|NCT03397108|581425458|FG001|Overall Study|Lost to Follow-up|0|||
161010616|NCT03397108|581425457|FG000|Overall Study|Insufficient milk production|3|||
161010617|NCT03397108|581425458|FG001|Overall Study|Insufficient milk production|2|||
161010618|NCT03397108|581425457|FG000|Overall Study|Withdrawal by Subject|2|||
161010619|NCT03397108|581425458|FG001|Overall Study|Withdrawal by Subject|0|||
161010620|NCT05096819|581425461|FG000|Overall Study|Withdrawal by Subject|3|||
161010621|NCT05096819|581425462|FG001|Overall Study|Withdrawal by Subject|0|||
161010622|NCT03324984|581425463|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
161010623|NCT03324984|581425464|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
161010624|NCT04607044|581425465|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
161010625|NCT04607044|581425465|FG000|Overall Study|Adverse Event|1|||
161010626|NCT04607044|581425465|FG000|Overall Study|Did not receive study device|3|||
161010627|NCT04607044|581425465|FG000|Overall Study|Death|1|||
161010628|NCT04337372|581425469|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
161010629|NCT04337372|581425470|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
161010630|NCT04337372|581425471|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
161010631|NCT04337372|581425472|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
161010632|NCT04337372|581425469|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
161010633|NCT04337372|581425470|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
161010634|NCT04337372|581425471|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
161010635|NCT04337372|581425472|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
161010636|NCT04337372|581425469|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
161010637|NCT04337372|581425470|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
161010638|NCT04337372|581425471|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
161010639|NCT04337372|581425472|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
161010640|NCT04337372|581425469|FG000|Day 2: EEG Measures|Protocol Violation|6|||
161010641|NCT04337372|581425470|FG001|Day 2: EEG Measures|Protocol Violation|6|||
161010642|NCT04337372|581425471|FG002|Day 2: EEG Measures|Protocol Violation|5|||
161010643|NCT04337372|581425472|FG003|Day 2: EEG Measures|Protocol Violation|17|||
161010644|NCT05307783|581425473|FG000|Overall Study|Death|7|||
161010645|NCT05307783|581425473|FG000|Overall Study|Lost to Follow-up|4|||
161010646|NCT04883645|581425474|FG000|Overall Study|Death|1|||
161010647|NCT04869982|581425479|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
161010648|NCT04869982|581425480|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
161010649|NCT04869982|581425479|FG000|Overall Study|Migrated / moved from the study area|1|||
161010650|NCT04869982|581425480|FG001|Overall Study|Migrated / moved from the study area|1|||
161010651|NCT04869982|581425479|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
161010652|NCT04869982|581425480|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
161010653|NCT04869982|581425479|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
161010654|NCT04869982|581425480|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
161010655|NCT04869982|581425479|FG000|Overall Study|Solicited adverse event|2|||
161010656|NCT04869982|581425480|FG001|Overall Study|Solicited adverse event|1|||
161010657|NCT02473250|581425482|FG000|Overall Study|Lost to Follow-up|10|||
161010658|NCT02473250|581425482|FG000|Overall Study|Physician Decision|5|||
161010659|NCT02473250|581425482|FG000|Overall Study|Did not tolerate medication washout|3|||
161010660|NCT02473250|581425482|FG000|Overall Study|Antidepressant effect of divalproex|2|||
161010661|NCT01704079|581425486|FG000|Overall Study|Withdrawal by Subject|5|||
161010662|NCT01704079|581425487|FG001|Overall Study|Withdrawal by Subject|7|||
161010663|NCT01704079|581425486|FG000|Overall Study|Lost to Follow-up|2|||
161010664|NCT01704079|581425487|FG001|Overall Study|Lost to Follow-up|5|||
161010665|NCT01704079|581425486|FG000|Overall Study|Adverse Event|4|||
161010666|NCT01704079|581425487|FG001|Overall Study|Adverse Event|7|||
161010667|NCT01704079|581425486|FG000|Overall Study|Protocol Violation|1|||
161010668|NCT01704079|581425487|FG001|Overall Study|Protocol Violation|0|||
161010669|NCT01704079|581425486|FG000|Overall Study|Subject noncompliance|2|||
161010670|NCT01704079|581425487|FG001|Overall Study|Subject noncompliance|3|||
161147446|NCT01380093|581922471|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
161010671|NCT01704079|581425486|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
161010672|NCT01704079|581425487|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
161010673|NCT03584516|581425488|FG000|Part 1|Death|2|||
161010674|NCT03584516|581425489|FG001|Part 1|Death|3|||
161010675|NCT03584516|581425490|FG002|Part 1|Death|0|||
160967214|NCT01591382|581268188|FG001|Overall Study|Discharged Prior to Study Completion|1|||
160967215|NCT01591382|581268187|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
160967216|NCT01591382|581268188|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
160967217|NCT01784068|581268192|FG000|NTCS Phase|Adverse Event|5|||
160967218|NCT01784068|581268193|FG001|NTCS Phase|Adverse Event|0|||
160967219|NCT01784068|581268192|FG000|NTCS Phase|Physician Decision|2|||
160967220|NCT01784068|581268193|FG001|NTCS Phase|Physician Decision|0|||
160967221|NCT01784068|581268192|FG000|NTCS Phase|Patient/guardian decision|3|||
160967222|NCT01784068|581268193|FG001|NTCS Phase|Patient/guardian decision|0|||
160967223|NCT01784068|581268192|FG000|NTCS Phase|Death|2|||
160967224|NCT01784068|581268193|FG001|NTCS Phase|Death|0|||
160967225|NCT01784068|581268192|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
160967226|NCT01784068|581268193|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
160967227|NCT01784068|581268192|FG000|TFR Phase|Physician Decision|0|||
160967228|NCT01784068|581268193|FG001|TFR Phase|Physician Decision|1|||
160967229|NCT01784068|581268192|FG000|TFR Phase|Patient/guardian decision|0|||
160967230|NCT01784068|581268193|FG001|TFR Phase|Patient/guardian decision|3|||
160967231|NCT01784068|581268192|FG000|TFR Phase|Death|0|||
160967232|NCT01784068|581268193|FG001|TFR Phase|Death|1|||
160967233|NCT01784068|581268192|FG000|TFR Phase|Lack of Efficacy|0|||
160967234|NCT01784068|581268193|FG001|TFR Phase|Lack of Efficacy|88|||
160967235|NCT06351371|581268194|FG000|Overall Study|Mutation Status Not Confirmed|9|||
160967236|NCT06351371|581268194|FG000|Overall Study|Ineligible|1|||
160967237|NCT06351371|581268194|FG000|Overall Study|Adverse Event|4|||
160967238|NCT06351371|581268194|FG000|Overall Study|Death|1|||
160967239|NCT06351371|581268194|FG000|Overall Study|Disease progression|14|||
160967240|NCT06351371|581268194|FG000|Overall Study|Withdrawal by Subject|3|||
160967241|NCT06351371|581268194|FG000|Overall Study|Physician Decision|3|||
160967242|NCT04359784|581268195|FG000|Overall Study|Death|2|||
160967243|NCT02063828|581268196|FG000|Overall Study|Withdrawal by Subject|4|||
160967244|NCT02063828|581268197|FG001|Overall Study|Withdrawal by Subject|6|||
160967245|NCT02063828|581268198|FG002|Overall Study|Withdrawal by Subject|3|||
160967246|NCT02063828|581268196|FG000|Overall Study|Death|0|||
160967247|NCT02063828|581268197|FG001|Overall Study|Death|0|||
160967248|NCT02063828|581268198|FG002|Overall Study|Death|1|||
160967249|NCT02753595|581268199|FG000|Overall Study|Sponsor termination|2|||
160967250|NCT02753595|581268200|FG001|Overall Study|Sponsor termination|2|||
160967251|NCT02515279|581268204|FG000|Overall Study|Adverse Event|7|||
160967252|NCT02515279|581268204|FG000|Overall Study|Lack of Efficacy|31|||
160967253|NCT02515279|581268204|FG000|Overall Study|Lost to Follow-up|9|||
160967254|NCT02515279|581268204|FG000|Overall Study|Withdrawal by Subject|18|||
160967255|NCT02515279|581268204|FG000|Overall Study|End-of-treatment visit not attended|17|||
160967256|NCT02515279|581268204|FG000|Overall Study|Other|22|||
160967257|NCT01800968|581268205|FG000|Overall Study|Death|23|||
160967258|NCT01800968|581268206|FG001|Overall Study|Death|16|||
160967259|NCT01800968|581268205|FG000|Overall Study|Lost to Follow-up|5|||
160967260|NCT01800968|581268206|FG001|Overall Study|Lost to Follow-up|7|||
160967261|NCT01800968|581268205|FG000|Overall Study|Withdrawal by Subject|7|||
160967262|NCT01800968|581268206|FG001|Overall Study|Withdrawal by Subject|9|||
160967263|NCT01800968|581268205|FG000|Overall Study|Physician Decision|1|||
160967264|NCT01800968|581268206|FG001|Overall Study|Physician Decision|0|||
160967265|NCT04987762|581268208|FG000|Overall Study|Study was Terminated by Sponsor|103|||
160967266|NCT03185481|581268209|FG000|Overall Study|Adverse Event|1|||
160967267|NCT03185481|581268209|FG000|Overall Study|Study Terminated by Sponsor|4|||
160967268|NCT00701038|581268215|FG000|Overall Study|study amended pilot group of patients|4|||
160967269|NCT00701038|581268216|FG001|Overall Study|study amended pilot group of patients|4|||
160967270|NCT03371940|581268219|FG000|Overall Study|Withdrawal by Subject|8|||
160967271|NCT03371940|581268220|FG001|Overall Study|Withdrawal by Subject|1|||
160967272|NCT03371940|581268221|FG002|Overall Study|Withdrawal by Subject|3|||
160967273|NCT03371940|581268222|FG003|Overall Study|Withdrawal by Subject|4|||
160967274|NCT05099926|581268225|FG000|Overall Study|Lost to Follow-up|1|||
160967275|NCT02068495|581268231|FG000|Overall Study|Case Report Forms Uncollected|60|||
160967276|NCT02068495|581268231|FG000|Overall Study|Protocol Deviation|49|||
160967277|NCT01666808|581268234|FG000|Overall Study|Lost to Follow-up|9|||
160967278|NCT01666808|581268235|FG001|Overall Study|Lost to Follow-up|15|||
160967279|NCT01666808|581268234|FG000|Overall Study|Withdrawal by Subject|3|||
160967280|NCT01666808|581268235|FG001|Overall Study|Withdrawal by Subject|1|||
160967281|NCT01666808|581268234|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
160967282|NCT01666808|581268235|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
160967283|NCT02220894|581268236|FG000|Overall Study|Adverse Event|127|||
160967284|NCT02220894|581268237|FG001|Overall Study|Adverse Event|74|||
160967285|NCT02220894|581268236|FG000|Overall Study|Death|418|||
161271768|NCT02304458|582375252|FG003|Overall Study|Lack of Efficacy|5|||
161271769|NCT02304458|582375253|FG004|Overall Study|Lack of Efficacy|6|||
161271770|NCT02304458|582375254|FG005|Overall Study|Lack of Efficacy|6|||
160967286|NCT02220894|581268237|FG001|Overall Study|Death|508|||
160967287|NCT02220894|581268236|FG000|Overall Study|Lost to Follow-up|0|||
160967288|NCT02220894|581268237|FG001|Overall Study|Lost to Follow-up|4|||
161010676|NCT03584516|581425491|FG003|Part 1|Death|0|||
161010677|NCT03584516|581425492|FG004|Part 1|Death|0|||
161010678|NCT03584516|581425493|FG005|Part 1|Death|0|||
161010679|NCT03584516|581425488|FG000|Part 1|Withdrawal by Subject|2|||
161010680|NCT03584516|581425489|FG001|Part 1|Withdrawal by Subject|0|||
161010681|NCT03584516|581425490|FG002|Part 1|Withdrawal by Subject|0|||
161010682|NCT03584516|581425491|FG003|Part 1|Withdrawal by Subject|0|||
161010683|NCT03584516|581425492|FG004|Part 1|Withdrawal by Subject|0|||
161010684|NCT03584516|581425493|FG005|Part 1|Withdrawal by Subject|0|||
161010685|NCT03584516|581425488|FG000|Part 1|Lost to Follow-up|1|||
161010686|NCT03584516|581425489|FG001|Part 1|Lost to Follow-up|0|||
161010687|NCT03584516|581425490|FG002|Part 1|Lost to Follow-up|0|||
161010688|NCT03584516|581425491|FG003|Part 1|Lost to Follow-up|0|||
161010689|NCT03584516|581425492|FG004|Part 1|Lost to Follow-up|0|||
161010690|NCT03584516|581425493|FG005|Part 1|Lost to Follow-up|0|||
161010691|NCT03584516|581425488|FG000|Part 1|Study Terminated by Sponsor|0|||
161010692|NCT03584516|581425489|FG001|Part 1|Study Terminated by Sponsor|2|||
161010693|NCT03584516|581425490|FG002|Part 1|Study Terminated by Sponsor|0|||
161010694|NCT03584516|581425491|FG003|Part 1|Study Terminated by Sponsor|0|||
161010695|NCT03584516|581425492|FG004|Part 1|Study Terminated by Sponsor|0|||
161010696|NCT03584516|581425493|FG005|Part 1|Study Terminated by Sponsor|0|||
161010697|NCT03584516|581425488|FG000|Part 1 Expansion|Death|0|||
161010698|NCT03584516|581425489|FG001|Part 1 Expansion|Death|0|||
161010699|NCT03584516|581425490|FG002|Part 1 Expansion|Death|9|||
161010700|NCT03584516|581425491|FG003|Part 1 Expansion|Death|8|||
161010701|NCT03584516|581425492|FG004|Part 1 Expansion|Death|4|||
161010702|NCT03584516|581425493|FG005|Part 1 Expansion|Death|5|||
161010703|NCT03584516|581425488|FG000|Part 1 Expansion|Lost to Follow-up|0|||
161010704|NCT03584516|581425489|FG001|Part 1 Expansion|Lost to Follow-up|0|||
161010705|NCT03584516|581425490|FG002|Part 1 Expansion|Lost to Follow-up|0|||
161010706|NCT03584516|581425491|FG003|Part 1 Expansion|Lost to Follow-up|1|||
161010707|NCT03584516|581425492|FG004|Part 1 Expansion|Lost to Follow-up|0|||
161010708|NCT03584516|581425493|FG005|Part 1 Expansion|Lost to Follow-up|0|||
161010709|NCT03584516|581425488|FG000|Part 1 Expansion|Physician Decision|0|||
161010710|NCT03584516|581425489|FG001|Part 1 Expansion|Physician Decision|0|||
161010711|NCT03584516|581425490|FG002|Part 1 Expansion|Physician Decision|4|||
161010712|NCT03584516|581425491|FG003|Part 1 Expansion|Physician Decision|3|||
161010713|NCT03584516|581425492|FG004|Part 1 Expansion|Physician Decision|2|||
161010714|NCT03584516|581425493|FG005|Part 1 Expansion|Physician Decision|3|||
161010715|NCT03584516|581425488|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
161010716|NCT03584516|581425489|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
161010717|NCT03584516|581425490|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
161010718|NCT03584516|581425491|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
161010719|NCT03584516|581425492|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
161010720|NCT03584516|581425493|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
161010721|NCT03584516|581425488|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
161010722|NCT03584516|581425489|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
161010723|NCT03584516|581425490|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
161010724|NCT03584516|581425491|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
161010725|NCT03584516|581425492|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
161010726|NCT03584516|581425493|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
161010727|NCT03584516|581425488|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010728|NCT03584516|581425489|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010729|NCT03584516|581425490|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010730|NCT03584516|581425491|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
161010731|NCT03584516|581425492|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161147447|NCT01380093|581922472|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
161010732|NCT03584516|581425493|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
161010733|NCT03584516|581425488|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010734|NCT03584516|581425489|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010735|NCT03584516|581425490|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161147448|NCT01380093|581922473|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
161147449|NCT01380093|581922465|FG000|Treatment Phase: Third Intervention|Other|0|||
161147450|NCT01380093|581922466|FG001|Treatment Phase: Third Intervention|Other|0|||
161147451|NCT01380093|581922467|FG002|Treatment Phase: Third Intervention|Other|0|||
161147452|NCT01380093|581922468|FG003|Treatment Phase: Third Intervention|Other|0|||
161147453|NCT01380093|581922469|FG004|Treatment Phase: Third Intervention|Other|0|||
161147454|NCT01380093|581922470|FG005|Treatment Phase: Third Intervention|Other|0|||
161147455|NCT01380093|581922471|FG006|Treatment Phase: Third Intervention|Other|0|||
161147456|NCT01380093|581922472|FG007|Treatment Phase: Third Intervention|Other|0|||
161147457|NCT01380093|581922473|FG008|Treatment Phase: Third Intervention|Other|1|||
161010736|NCT03584516|581425491|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010737|NCT03584516|581425492|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
161010738|NCT03584516|581425493|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
161010739|NCT01443845|581425500|FG000|Overall Study|Protocol Violation|43|||
161010740|NCT01443845|581425501|FG001|Overall Study|Protocol Violation|45|||
161010741|NCT01443845|581425500|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
161010742|NCT01443845|581425501|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
161010743|NCT01443845|581425500|FG000|Overall Study|Deterioration in pulmonary function|1|||
161010744|NCT01443845|581425501|FG001|Overall Study|Deterioration in pulmonary function|4|||
161010745|NCT01443845|581425500|FG000|Overall Study|Lack of Efficacy|10|||
161010746|NCT01443845|581425501|FG001|Overall Study|Lack of Efficacy|5|||
161010747|NCT01443845|581425500|FG000|Overall Study|Adverse Event|64|||
161010748|NCT01443845|581425501|FG001|Overall Study|Adverse Event|138|||
161010749|NCT01443845|581425500|FG000|Overall Study|Withdrawal by Subject|63|||
161010750|NCT01443845|581425501|FG001|Overall Study|Withdrawal by Subject|67|||
161010751|NCT01443845|581425500|FG000|Overall Study|Military Conflict - Site Terminated|20|||
161010752|NCT01443845|581425501|FG001|Overall Study|Military Conflict - Site Terminated|21|||
161010753|NCT01443845|581425500|FG000|Overall Study|Lost to Follow-up|9|||
161010754|NCT01443845|581425501|FG001|Overall Study|Lost to Follow-up|13|||
161010755|NCT01471691|581425504|FG000|Overall Study|Lack of Efficacy|0|||
161010756|NCT01471691|581425505|FG001|Overall Study|Lack of Efficacy|1|||
161010757|NCT01808339|581425506|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010758|NCT01808339|581425507|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010759|NCT01808339|581425508|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010760|NCT01808339|581425509|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161010761|NCT01808339|581425510|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
161010762|NCT01808339|581425511|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161010763|NCT01808339|581425506|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010764|NCT01808339|581425507|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161010765|NCT01808339|581425508|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010766|NCT01808339|581425509|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161010767|NCT01808339|581425510|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010768|NCT01808339|581425511|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161010769|NCT01808339|581425506|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010770|NCT01808339|581425507|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010771|NCT01808339|581425508|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
161010772|NCT01808339|581425509|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010773|NCT01808339|581425510|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010774|NCT01808339|581425511|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
161010775|NCT02461628|581425512|FG000|Overall Study|Refused to complete survey|4|||
161010776|NCT02461628|581425513|FG001|Overall Study|Refused to complete survey|7|||
161010777|NCT02462759|581425516|FG000|Part 1: Double Blind|Death|1|||
161010778|NCT02462759|581425517|FG001|Part 1: Double Blind|Death|0|||
161010779|NCT02462759|581425518|FG002|Part 1: Double Blind|Death|0|||
161010780|NCT00243503|581425519|FG000|Overall Study|Adverse Event|11|||
161010781|NCT00243503|581425519|FG000|Overall Study|Withdrawal by Subject|1|||
161010782|NCT00243503|581425519|FG000|Overall Study|Lack of Efficacy|44|||
161010783|NCT00243503|581425519|FG000|Overall Study|Death|1|||
161010784|NCT00243503|581425519|FG000|Overall Study|Other|1|||
161010785|NCT00520546|581425523|FG000|Overall Study|Withdrawal by Subject|1|||
161010786|NCT00520546|581425523|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
161010787|NCT03988023|581425525|FG000|Overall Study|Non-compliance|3|||
161010788|NCT03988023|581425526|FG001|Overall Study|Non-compliance|0|||
161010789|NCT03988023|581425525|FG000|Overall Study|Withdrawal by Subject|39|||
161010790|NCT03988023|581425526|FG001|Overall Study|Withdrawal by Subject|37|||
161010791|NCT03988023|581425525|FG000|Overall Study|Adverse Event|0|||
161010792|NCT03988023|581425526|FG001|Overall Study|Adverse Event|2|||
161010793|NCT03988023|581425525|FG000|Overall Study|Physician Decision|0|||
161010794|NCT03988023|581425526|FG001|Overall Study|Physician Decision|1|||
161010795|NCT03988023|581425525|FG000|Overall Study|Lost to Follow-up|5|||
161010796|NCT03988023|581425526|FG001|Overall Study|Lost to Follow-up|8|||
161010797|NCT03988023|581425525|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
161010798|NCT03988023|581425526|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
161010799|NCT03988023|581425525|FG000|Overall Study|Lack of Efficacy|3|||
161010800|NCT03988023|581425526|FG001|Overall Study|Lack of Efficacy|1|||
161010801|NCT03988023|581425525|FG000|Overall Study|COVID-19 pandemic|225|||
161010802|NCT03988023|581425526|FG001|Overall Study|COVID-19 pandemic|227|||
161271771|NCT02304458|582375255|FG006|Overall Study|Lack of Efficacy|21|||
161271772|NCT02304458|582375256|FG007|Overall Study|Lack of Efficacy|4|||
161271773|NCT02304458|582375249|FG000|Overall Study|Physician Decision|2|||
161010803|NCT02101281|581425527|FG000|Overall Study|Adverse Event|0|||
161010804|NCT02101281|581425528|FG001|Overall Study|Adverse Event|1|||
161010805|NCT02554786|581425531|FG000|Overall Study|Subject/guardian decision|29|||
161010806|NCT02554786|581425532|FG001|Overall Study|Subject/guardian decision|17|||
161010807|NCT02554786|581425533|FG002|Overall Study|Subject/guardian decision|18|||
161271774|NCT02304458|582375250|FG001|Overall Study|Physician Decision|0|||
161271775|NCT02304458|582375251|FG002|Overall Study|Physician Decision|16|||
161271776|NCT02304458|582375252|FG003|Overall Study|Physician Decision|1|||
161271777|NCT02304458|582375253|FG004|Overall Study|Physician Decision|0|||
161271778|NCT02304458|582375254|FG005|Overall Study|Physician Decision|0|||
161271779|NCT02304458|582375255|FG006|Overall Study|Physician Decision|3|||
161271780|NCT02304458|582375256|FG007|Overall Study|Physician Decision|0|||
161271781|NCT02304458|582375249|FG000|Overall Study|Protocol Violation|0|||
161271782|NCT02304458|582375250|FG001|Overall Study|Protocol Violation|0|||
161010808|NCT02554786|581425534|FG003|Overall Study|Subject/guardian decision|30|||
161010809|NCT02554786|581425535|FG004|Overall Study|Subject/guardian decision|20|||
161010810|NCT02554786|581425531|FG000|Overall Study|Lost to Follow-up|4|||
161010811|NCT02554786|581425532|FG001|Overall Study|Lost to Follow-up|3|||
161010812|NCT02554786|581425533|FG002|Overall Study|Lost to Follow-up|4|||
161010813|NCT02554786|581425534|FG003|Overall Study|Lost to Follow-up|2|||
161010814|NCT02554786|581425535|FG004|Overall Study|Lost to Follow-up|2|||
161010815|NCT02554786|581425531|FG000|Overall Study|Protocol deviation|1|||
161010816|NCT02554786|581425532|FG001|Overall Study|Protocol deviation|3|||
161010817|NCT02554786|581425533|FG002|Overall Study|Protocol deviation|3|||
161010818|NCT02554786|581425534|FG003|Overall Study|Protocol deviation|4|||
161010819|NCT02554786|581425535|FG004|Overall Study|Protocol deviation|2|||
161010820|NCT02554786|581425531|FG000|Overall Study|Technical problems|1|||
161010821|NCT02554786|581425532|FG001|Overall Study|Technical problems|1|||
161010822|NCT02554786|581425533|FG002|Overall Study|Technical problems|0|||
161010823|NCT02554786|581425534|FG003|Overall Study|Technical problems|2|||
161010824|NCT02554786|581425535|FG004|Overall Study|Technical problems|1|||
161010825|NCT02554786|581425531|FG000|Overall Study|Adverse Event|0|||
161010826|NCT02554786|581425532|FG001|Overall Study|Adverse Event|0|||
161010827|NCT02554786|581425533|FG002|Overall Study|Adverse Event|0|||
161010828|NCT02554786|581425534|FG003|Overall Study|Adverse Event|0|||
161010829|NCT02554786|581425535|FG004|Overall Study|Adverse Event|2|||
161010830|NCT02554786|581425531|FG000|Overall Study|Death|0|||
161010831|NCT02554786|581425532|FG001|Overall Study|Death|0|||
161010832|NCT02554786|581425533|FG002|Overall Study|Death|0|||
161010833|NCT02554786|581425534|FG003|Overall Study|Death|1|||
161010834|NCT02554786|581425535|FG004|Overall Study|Death|0|||
161010835|NCT02554786|581425531|FG000|Overall Study|Non-compliance with study treatment|0|||
161010836|NCT02554786|581425532|FG001|Overall Study|Non-compliance with study treatment|1|||
161010837|NCT02554786|581425533|FG002|Overall Study|Non-compliance with study treatment|1|||
161010838|NCT02554786|581425534|FG003|Overall Study|Non-compliance with study treatment|0|||
161010839|NCT02554786|581425535|FG004|Overall Study|Non-compliance with study treatment|1|||
161010840|NCT02554786|581425531|FG000|Overall Study|Physician Decision|0|||
161010841|NCT02554786|581425532|FG001|Overall Study|Physician Decision|1|||
161010842|NCT02554786|581425533|FG002|Overall Study|Physician Decision|4|||
161010843|NCT02554786|581425534|FG003|Overall Study|Physician Decision|1|||
161010844|NCT02554786|581425535|FG004|Overall Study|Physician Decision|1|||
161010845|NCT02554786|581425531|FG000|Overall Study|Pregnancy|0|||
161010846|NCT02554786|581425532|FG001|Overall Study|Pregnancy|0|||
161010847|NCT02554786|581425533|FG002|Overall Study|Pregnancy|0|||
161010848|NCT02554786|581425534|FG003|Overall Study|Pregnancy|1|||
161010849|NCT02554786|581425535|FG004|Overall Study|Pregnancy|1|||
161010850|NCT01695954|581425536|FG000|Overall Study|Withdrawal by Subject|4|||
161010851|NCT01695954|581425537|FG001|Overall Study|Withdrawal by Subject|0|||
161010852|NCT01695954|581425536|FG000|Overall Study|Adverse Event|0|||
161271783|NCT02304458|582375251|FG002|Overall Study|Protocol Violation|1|||
161010853|NCT01695954|581425537|FG001|Overall Study|Adverse Event|2|||
161010854|NCT01248936|581425548|FG000|Overall Study|Sponsor Decision|259|||
161010855|NCT01248936|581425548|FG000|Overall Study|Progression of Disease|50|||
161010856|NCT01248936|581425548|FG000|Overall Study|Death|26|||
161010857|NCT01248936|581425548|FG000|Overall Study|Withdrawal of Consent|20|||
161010858|NCT01248936|581425548|FG000|Overall Study|Adverse Event|8|||
161010859|NCT01248936|581425548|FG000|Overall Study|Lost to Follow-up|7|||
161010860|NCT01248936|581425548|FG000|Overall Study|Refused Treatment|1|||
161010861|NCT01248936|581425548|FG000|Overall Study|Other reason|3|||
161010862|NCT03930420|581425549|FG000|Overall Study|Withdrawal by Subject|7|||
161271784|NCT02304458|582375252|FG003|Overall Study|Protocol Violation|0|||
161271785|NCT02304458|582375253|FG004|Overall Study|Protocol Violation|0|||
161010863|NCT03930420|581425550|FG001|Overall Study|Withdrawal by Subject|9|||
161010864|NCT05609032|581425551|FG000|Overall Study|Lost to Follow-up|3|||
161010865|NCT05609032|581425552|FG001|Overall Study|Lost to Follow-up|1|||
161010866|NCT05609032|581425551|FG000|Overall Study|Withdrawal by Subject|1|||
161010867|NCT05609032|581425552|FG001|Overall Study|Withdrawal by Subject|0|||
161010868|NCT00609336|581425553|FG000|Overall Study|Protocol Violation|3|||
161010869|NCT00609336|581425553|FG000|Overall Study|Death|1|||
161271786|NCT02304458|582375254|FG005|Overall Study|Protocol Violation|0|||
161010870|NCT00609336|581425553|FG000|Overall Study|LA or Met at Surgery|9|||
161010871|NCT00567489|581425554|FG000|Overall Study|Adverse Event|6|||
161010872|NCT00567489|581425555|FG001|Overall Study|Adverse Event|14|||
161010873|NCT00567489|581425554|FG000|Overall Study|Physician Decision|0|||
161010874|NCT00567489|581425555|FG001|Overall Study|Physician Decision|4|||
161010875|NCT00567489|581425554|FG000|Overall Study|Withdrawal by Subject|0|||
161010876|NCT00567489|581425555|FG001|Overall Study|Withdrawal by Subject|2|||
161010877|NCT00567489|581425554|FG000|Overall Study|Renal Transplantation|0|||
161010878|NCT00567489|581425555|FG001|Overall Study|Renal Transplantation|3|||
161010879|NCT00567489|581425554|FG000|Overall Study|Other|1|||
161010880|NCT00567489|581425555|FG001|Overall Study|Other|0|||
161010881|NCT02692417|581425558|FG000|Overall Study|Withdrawal by Subject|5|||
161010882|NCT02692417|581425559|FG001|Overall Study|Withdrawal by Subject|1|||
161010883|NCT02692417|581425558|FG000|Overall Study|Adverse Event|1|||
161010884|NCT02692417|581425559|FG001|Overall Study|Adverse Event|0|||
161010885|NCT01551355|581425582|FG000|Overall Study|Lost to Follow-up|51|||
161010886|NCT01551355|581425583|FG001|Overall Study|Lost to Follow-up|49|||
161010887|NCT01551355|581425584|FG002|Overall Study|Lost to Follow-up|34|||
161010888|NCT01551355|581425585|FG003|Overall Study|Lost to Follow-up|24|||
161010889|NCT01551355|581425586|FG004|Overall Study|Lost to Follow-up|9|||
161010890|NCT01551355|581425587|FG005|Overall Study|Lost to Follow-up|6|||
161010891|NCT00031694|581425588|FG000|Overall Study|Adverse Event|12|||
161010892|NCT00031694|581425588|FG000|Overall Study|Death|2|||
161010893|NCT00031694|581425588|FG000|Overall Study|Withdrawal by Subject|5|||
161010894|NCT01255670|581425591|FG000|Overall Study|Adverse Event|10|||
161010895|NCT01255670|581425592|FG001|Overall Study|Adverse Event|10|||
161010896|NCT01255670|581425591|FG000|Overall Study|Lost to Follow-up|16|||
161010897|NCT01255670|581425592|FG001|Overall Study|Lost to Follow-up|10|||
161010898|NCT03892564|581425593|FG000|Overall Study|Withdrawal by Subject|2|||
161010899|NCT03664960|581425594|FG000|Overall Study|Adverse Event|0|||
161010900|NCT03664960|581425595|FG001|Overall Study|Adverse Event|3|||
161010901|NCT03664960|581425594|FG000|Overall Study|Lost to Follow-up|3|||
161010902|NCT03664960|581425595|FG001|Overall Study|Lost to Follow-up|2|||
161010903|NCT03664960|581425594|FG000|Overall Study|Physician Decision|1|||
161010904|NCT03664960|581425595|FG001|Overall Study|Physician Decision|0|||
161010905|NCT03664960|581425594|FG000|Overall Study|Withdrawal by Subject|3|||
161010906|NCT03664960|581425595|FG001|Overall Study|Withdrawal by Subject|14|||
161010907|NCT03664960|581425594|FG000|Overall Study|Sponsor Decision|1|||
161010908|NCT03664960|581425595|FG001|Overall Study|Sponsor Decision|1|||
161010909|NCT03664960|581425594|FG000|Overall Study|Other|1|||
161010910|NCT03664960|581425595|FG001|Overall Study|Other|2|||
161010911|NCT04019444|581425596|FG000|Overall Study|Withdrawal by Subject|0|||
161010912|NCT04019444|581425597|FG001|Overall Study|Withdrawal by Subject|1|||
161010913|NCT04019444|581425598|FG002|Overall Study|Withdrawal by Subject|0|||
161010914|NCT04019444|581425599|FG003|Overall Study|Withdrawal by Subject|1|||
161010915|NCT04019444|581425596|FG000|Overall Study|Solicited Event|0|||
161010916|NCT04019444|581425597|FG001|Overall Study|Solicited Event|0|||
161010917|NCT04019444|581425598|FG002|Overall Study|Solicited Event|2|||
161010918|NCT04019444|581425599|FG003|Overall Study|Solicited Event|0|||
161010919|NCT03807778|581425600|FG000|Overall Study|Adverse Event|0|||
161010920|NCT03807778|581425601|FG001|Overall Study|Adverse Event|0|||
161010921|NCT03807778|581425602|FG002|Overall Study|Adverse Event|3|||
161010922|NCT03807778|581425603|FG003|Overall Study|Adverse Event|5|||
161010923|NCT03807778|581425600|FG000|Overall Study|Progressive Disease|4|||
161010924|NCT03807778|581425601|FG001|Overall Study|Progressive Disease|2|||
161010925|NCT03807778|581425602|FG002|Overall Study|Progressive Disease|8|||
161010926|NCT03807778|581425603|FG003|Overall Study|Progressive Disease|15|||
161010927|NCT03807778|581425600|FG000|Overall Study|Symptomatic Deterioration|0|||
161010928|NCT03807778|581425601|FG001|Overall Study|Symptomatic Deterioration|1|||
161010929|NCT03807778|581425602|FG002|Overall Study|Symptomatic Deterioration|0|||
161147458|NCT03952650|581922474|FG000|Overall Study|TRAVEL|0|||
161147459|NCT03952650|581922475|FG001|Overall Study|TRAVEL|4|||
161147460|NCT03952650|581922476|FG002|Overall Study|TRAVEL|0|||
161147461|NCT03952650|581922477|FG003|Overall Study|TRAVEL|4|||
161147462|NCT03952650|581922478|FG004|Overall Study|TRAVEL|0|||
161147463|NCT03952650|581922479|FG005|Overall Study|TRAVEL|3|||
161147464|NCT03952650|581922480|FG006|Overall Study|TRAVEL|2|||
161147465|NCT03952650|581922474|FG000|Overall Study|Withdrawal by Subject|0|||
161010930|NCT03807778|581425603|FG003|Overall Study|Symptomatic Deterioration|1|||
161147466|NCT03952650|581922475|FG001|Overall Study|Withdrawal by Subject|2|||
161147467|NCT03952650|581922476|FG002|Overall Study|Withdrawal by Subject|0|||
161147468|NCT03952650|581922477|FG003|Overall Study|Withdrawal by Subject|3|||
161010931|NCT03807778|581425600|FG000|Overall Study|Withdrawal by Subject|0|||
161010932|NCT03807778|581425601|FG001|Overall Study|Withdrawal by Subject|1|||
161010933|NCT03807778|581425602|FG002|Overall Study|Withdrawal by Subject|0|||
161010934|NCT03807778|581425603|FG003|Overall Study|Withdrawal by Subject|1|||
161010935|NCT03807778|581425600|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
161010936|NCT03807778|581425601|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
161010937|NCT03807778|581425602|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
161010938|NCT03807778|581425603|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
161010939|NCT04278586|581427273|FG000|Overall Study|Withdrawal by Subject|13|||
161010940|NCT04278586|581427274|FG001|Overall Study|Withdrawal by Subject|6|||
161010941|NCT04278586|581427273|FG000|Overall Study|Lost to Follow-up|37|||
161010942|NCT04278586|581427274|FG001|Overall Study|Lost to Follow-up|24|||
161010943|NCT03954184|581427281|FG000|Overall Study|Lost to Follow-up|500|||
161271787|NCT02304458|582375255|FG006|Overall Study|Protocol Violation|0|||
161271788|NCT02304458|582375256|FG007|Overall Study|Protocol Violation|0|||
161271789|NCT02304458|582375249|FG000|Overall Study|Withdrawal by Subject|1|||
161271790|NCT02304458|582375250|FG001|Overall Study|Withdrawal by Subject|0|||
161271791|NCT02304458|582375251|FG002|Overall Study|Withdrawal by Subject|7|||
161271792|NCT02304458|582375252|FG003|Overall Study|Withdrawal by Subject|0|||
161271793|NCT02304458|582375253|FG004|Overall Study|Withdrawal by Subject|0|||
161271794|NCT02304458|582375254|FG005|Overall Study|Withdrawal by Subject|0|||
160967289|NCT02220894|581268236|FG000|Overall Study|Site Terminated by Sponsor|2|||
160967290|NCT02220894|581268237|FG001|Overall Study|Site Terminated by Sponsor|0|||
160967291|NCT02220894|581268236|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
160967292|NCT02220894|581268237|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
160967293|NCT02220894|581268236|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
160967294|NCT02220894|581268237|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
160967295|NCT02220894|581268236|FG000|Overall Study|Withdrawal by Subject|10|||
160967296|NCT02220894|581268237|FG001|Overall Study|Withdrawal by Subject|9|||
160967297|NCT03217747|581268238|FG000|Overall Study|Adverse Event|0|||
160967298|NCT03217747|581268239|FG001|Overall Study|Adverse Event|1|||
160967299|NCT03217747|581268240|FG002|Overall Study|Adverse Event|0|||
160967300|NCT03217747|581268241|FG003|Overall Study|Adverse Event|0|||
160967301|NCT03217747|581268242|FG004|Overall Study|Adverse Event|0|||
160967302|NCT03217747|581268243|FG005|Overall Study|Adverse Event|0|||
160967303|NCT03217747|581268244|FG006|Overall Study|Adverse Event|0|||
160967304|NCT03217747|581268245|FG007|Overall Study|Adverse Event|0|||
160967305|NCT03217747|581268246|FG008|Overall Study|Adverse Event|0|||
160967306|NCT03217747|581268247|FG009|Overall Study|Adverse Event|0|||
160967307|NCT03217747|581268248|FG010|Overall Study|Adverse Event|0|||
160967308|NCT03217747|581268249|FG011|Overall Study|Adverse Event|0|||
160967309|NCT03217747|581268250|FG012|Overall Study|Adverse Event|1|||
160967310|NCT03217747|581268251|FG013|Overall Study|Adverse Event|1|||
160967311|NCT03217747|581268238|FG000|Overall Study|Death|0|||
160967312|NCT03217747|581268239|FG001|Overall Study|Death|0|||
160967313|NCT03217747|581268240|FG002|Overall Study|Death|0|||
160967314|NCT03217747|581268241|FG003|Overall Study|Death|0|||
160967315|NCT03217747|581268242|FG004|Overall Study|Death|0|||
160967316|NCT03217747|581268243|FG005|Overall Study|Death|0|||
160967317|NCT03217747|581268244|FG006|Overall Study|Death|0|||
160967318|NCT03217747|581268245|FG007|Overall Study|Death|0|||
160967319|NCT03217747|581268246|FG008|Overall Study|Death|1|||
160967320|NCT03217747|581268247|FG009|Overall Study|Death|0|||
160967321|NCT03217747|581268248|FG010|Overall Study|Death|0|||
160967322|NCT03217747|581268249|FG011|Overall Study|Death|0|||
160967323|NCT03217747|581268250|FG012|Overall Study|Death|0|||
160967324|NCT03217747|581268251|FG013|Overall Study|Death|0|||
160967325|NCT03217747|581268238|FG000|Overall Study|Lack of Efficacy|12|||
160967326|NCT03217747|581268239|FG001|Overall Study|Lack of Efficacy|6|||
160967327|NCT03217747|581268240|FG002|Overall Study|Lack of Efficacy|15|||
160967328|NCT03217747|581268241|FG003|Overall Study|Lack of Efficacy|11|||
160967329|NCT03217747|581268242|FG004|Overall Study|Lack of Efficacy|3|||
160967330|NCT03217747|581268243|FG005|Overall Study|Lack of Efficacy|14|||
160967331|NCT03217747|581268244|FG006|Overall Study|Lack of Efficacy|10|||
160967332|NCT03217747|581268245|FG007|Overall Study|Lack of Efficacy|4|||
160967333|NCT03217747|581268246|FG008|Overall Study|Lack of Efficacy|2|||
160967334|NCT03217747|581268247|FG009|Overall Study|Lack of Efficacy|7|||
160967335|NCT03217747|581268248|FG010|Overall Study|Lack of Efficacy|3|||
160967336|NCT03217747|581268249|FG011|Overall Study|Lack of Efficacy|1|||
160967337|NCT03217747|581268250|FG012|Overall Study|Lack of Efficacy|3|||
160967338|NCT03217747|581268251|FG013|Overall Study|Lack of Efficacy|1|||
160967339|NCT03217747|581268238|FG000|Overall Study|Withdrawal by Subject|2|||
160967340|NCT03217747|581268239|FG001|Overall Study|Withdrawal by Subject|1|||
160967341|NCT03217747|581268240|FG002|Overall Study|Withdrawal by Subject|1|||
160967342|NCT03217747|581268241|FG003|Overall Study|Withdrawal by Subject|1|||
161271795|NCT02304458|582375255|FG006|Overall Study|Withdrawal by Subject|1|||
161271796|NCT02304458|582375256|FG007|Overall Study|Withdrawal by Subject|0|||
161271797|NCT00186043|582375257|FG000|Overall Study|Lack of Efficacy|1|||
160967343|NCT03217747|581268242|FG004|Overall Study|Withdrawal by Subject|1|||
160967344|NCT03217747|581268243|FG005|Overall Study|Withdrawal by Subject|2|||
160967345|NCT03217747|581268244|FG006|Overall Study|Withdrawal by Subject|1|||
160967346|NCT03217747|581268245|FG007|Overall Study|Withdrawal by Subject|0|||
160967347|NCT03217747|581268246|FG008|Overall Study|Withdrawal by Subject|0|||
160967348|NCT03217747|581268247|FG009|Overall Study|Withdrawal by Subject|0|||
160967349|NCT03217747|581268248|FG010|Overall Study|Withdrawal by Subject|0|||
160967350|NCT03217747|581268249|FG011|Overall Study|Withdrawal by Subject|1|||
160967351|NCT03217747|581268250|FG012|Overall Study|Withdrawal by Subject|0|||
160967352|NCT03217747|581268251|FG013|Overall Study|Withdrawal by Subject|1|||
160967353|NCT03217747|581268238|FG000|Overall Study|Toxicity and progression|1|||
160967354|NCT03217747|581268239|FG001|Overall Study|Toxicity and progression|0|||
161271798|NCT00186043|582375258|FG001|Overall Study|Lack of Efficacy|3|||
161271799|NCT00186043|582375257|FG000|Overall Study|Lost to Follow-up|4|||
161147469|NCT03952650|581922478|FG004|Overall Study|Withdrawal by Subject|0|||
161147470|NCT03952650|581922479|FG005|Overall Study|Withdrawal by Subject|1|||
161147471|NCT03952650|581922480|FG006|Overall Study|Withdrawal by Subject|1|||
161147472|NCT03952650|581922474|FG000|Overall Study|Lost to Follow-up|0|||
160967355|NCT03217747|581268240|FG002|Overall Study|Toxicity and progression|0|||
160967356|NCT03217747|581268241|FG003|Overall Study|Toxicity and progression|0|||
160967357|NCT03217747|581268242|FG004|Overall Study|Toxicity and progression|0|||
160967358|NCT03217747|581268243|FG005|Overall Study|Toxicity and progression|0|||
160967359|NCT03217747|581268244|FG006|Overall Study|Toxicity and progression|0|||
160967360|NCT03217747|581268245|FG007|Overall Study|Toxicity and progression|0|||
160967361|NCT03217747|581268246|FG008|Overall Study|Toxicity and progression|0|||
160967362|NCT03217747|581268247|FG009|Overall Study|Toxicity and progression|0|||
160967363|NCT03217747|581268248|FG010|Overall Study|Toxicity and progression|0|||
160967364|NCT03217747|581268249|FG011|Overall Study|Toxicity and progression|0|||
160967365|NCT03217747|581268250|FG012|Overall Study|Toxicity and progression|0|||
160967366|NCT03217747|581268251|FG013|Overall Study|Toxicity and progression|0|||
160967367|NCT03217747|581268238|FG000|Overall Study|Removal of sole target lesion|1|||
160967368|NCT03217747|581268239|FG001|Overall Study|Removal of sole target lesion|0|||
160967369|NCT03217747|581268240|FG002|Overall Study|Removal of sole target lesion|0|||
160967370|NCT03217747|581268241|FG003|Overall Study|Removal of sole target lesion|0|||
160967371|NCT03217747|581268242|FG004|Overall Study|Removal of sole target lesion|0|||
160967372|NCT03217747|581268243|FG005|Overall Study|Removal of sole target lesion|0|||
160967373|NCT03217747|581268244|FG006|Overall Study|Removal of sole target lesion|0|||
160967374|NCT03217747|581268245|FG007|Overall Study|Removal of sole target lesion|0|||
160967375|NCT03217747|581268246|FG008|Overall Study|Removal of sole target lesion|0|||
160967376|NCT03217747|581268247|FG009|Overall Study|Removal of sole target lesion|0|||
160967377|NCT03217747|581268248|FG010|Overall Study|Removal of sole target lesion|0|||
160967378|NCT03217747|581268249|FG011|Overall Study|Removal of sole target lesion|0|||
160967379|NCT03217747|581268250|FG012|Overall Study|Removal of sole target lesion|0|||
160967380|NCT03217747|581268251|FG013|Overall Study|Removal of sole target lesion|0|||
160967381|NCT03217747|581268238|FG000|Overall Study|Stroke|0|||
160967382|NCT03217747|581268239|FG001|Overall Study|Stroke|0|||
160967383|NCT03217747|581268240|FG002|Overall Study|Stroke|0|||
160967384|NCT03217747|581268241|FG003|Overall Study|Stroke|0|||
160967385|NCT03217747|581268242|FG004|Overall Study|Stroke|0|||
160967386|NCT03217747|581268243|FG005|Overall Study|Stroke|1|||
160967387|NCT03217747|581268244|FG006|Overall Study|Stroke|0|||
160967388|NCT03217747|581268245|FG007|Overall Study|Stroke|0|||
160967389|NCT03217747|581268246|FG008|Overall Study|Stroke|0|||
160967390|NCT03217747|581268247|FG009|Overall Study|Stroke|0|||
160967391|NCT03217747|581268248|FG010|Overall Study|Stroke|0|||
160967392|NCT03217747|581268249|FG011|Overall Study|Stroke|1|||
160967393|NCT03217747|581268250|FG012|Overall Study|Stroke|0|||
160967394|NCT03217747|581268251|FG013|Overall Study|Stroke|0|||
160967395|NCT03248375|581268252|FG000|Overall Study|Lost to Follow-up|5|||
160967396|NCT00394355|581268253|FG000|Overall Study|Adverse Event|10|||
160967397|NCT00394355|581268254|FG001|Overall Study|Adverse Event|6|||
160967398|NCT00394355|581268255|FG002|Overall Study|Adverse Event|7|||
160967399|NCT00394355|581268256|FG003|Overall Study|Adverse Event|8|||
160967400|NCT00394355|581268253|FG000|Overall Study|Did not meet protocol eligibility|1|||
160967401|NCT00394355|581268254|FG001|Overall Study|Did not meet protocol eligibility|5|||
160967402|NCT00394355|581268255|FG002|Overall Study|Did not meet protocol eligibility|4|||
160967403|NCT00394355|581268256|FG003|Overall Study|Did not meet protocol eligibility|2|||
160967404|NCT00394355|581268253|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
160967405|NCT00394355|581268254|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
160967406|NCT00394355|581268255|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
160967407|NCT00394355|581268256|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
160967408|NCT00394355|581268253|FG000|Overall Study|Subject withdrawal - related to drug|1|||
160967409|NCT00394355|581268254|FG001|Overall Study|Subject withdrawal - related to drug|0|||
160967410|NCT00394355|581268255|FG002|Overall Study|Subject withdrawal - related to drug|0|||
160967411|NCT00394355|581268256|FG003|Overall Study|Subject withdrawal - related to drug|0|||
160967412|NCT00394355|581268253|FG000|Overall Study|Lost to Follow-up|7|||
160967413|NCT00394355|581268254|FG001|Overall Study|Lost to Follow-up|5|||
160967414|NCT00394355|581268255|FG002|Overall Study|Lost to Follow-up|4|||
160967415|NCT00394355|581268256|FG003|Overall Study|Lost to Follow-up|3|||
160967416|NCT00394355|581268253|FG000|Overall Study|Noncompliance with protocol|4|||
160967417|NCT00394355|581268254|FG001|Overall Study|Noncompliance with protocol|3|||
160967418|NCT00394355|581268255|FG002|Overall Study|Noncompliance with protocol|10|||
160967419|NCT00394355|581268256|FG003|Overall Study|Noncompliance with protocol|8|||
160967420|NCT00394355|581268253|FG000|Overall Study|Administrative|0|||
160967421|NCT00394355|581268254|FG001|Overall Study|Administrative|1|||
160967422|NCT00394355|581268255|FG002|Overall Study|Administrative|1|||
160967423|NCT00394355|581268256|FG003|Overall Study|Administrative|1|||
160967424|NCT00394355|581268253|FG000|Overall Study|Lack of Efficacy|0|||
161147473|NCT03952650|581922475|FG001|Overall Study|Lost to Follow-up|1|||
161147474|NCT03952650|581922476|FG002|Overall Study|Lost to Follow-up|0|||
161010944|NCT03954184|581427282|FG001|Overall Study|Lost to Follow-up|0|||
161010945|NCT05403801|581427285|FG000|Overall Study|Withdrawal by Subject|2|||
161010946|NCT02879448|581427286|FG000|Overall Study|Death|251|||
161010947|NCT02879448|581427287|FG001|Overall Study|Death|263|||
161010948|NCT02879448|581427286|FG000|Overall Study|Lost to Follow-up|23|||
161010949|NCT02879448|581427287|FG001|Overall Study|Lost to Follow-up|28|||
161010950|NCT02879448|581427286|FG000|Overall Study|Withdrawal by Subject|42|||
161010951|NCT02879448|581427287|FG001|Overall Study|Withdrawal by Subject|79|||
161010952|NCT02879448|581427286|FG000|Overall Study|Other Reasons|8|||
161010953|NCT02879448|581427287|FG001|Overall Study|Other Reasons|12|||
161010954|NCT02819843|581427290|FG000|Overall Study|Disease progression before RT|0|||
161010955|NCT02819843|581427291|FG001|Overall Study|Disease progression before RT|1|||
161010956|NCT02728557|581427292|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
161010957|NCT02728557|581427293|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
161010958|NCT02728557|581427292|FG000|Overall Study|Dissatisfaction with research tasks|0|||
161010959|NCT02728557|581427293|FG001|Overall Study|Dissatisfaction with research tasks|1|||
161010960|NCT02728557|581427292|FG000|Overall Study|Scheduling or change in availability|1|||
161010961|NCT02728557|581427293|FG001|Overall Study|Scheduling or change in availability|1|||
161010962|NCT01718743|581427294|FG000|Overall Study|Physician Decision|7|||
161010963|NCT01718743|581427294|FG000|Overall Study|Withdrawal by Subject|14|||
161010964|NCT01718743|581427294|FG000|Overall Study|Progressive Disease|22|||
161010965|NCT01718743|581427294|FG000|Overall Study|Toxicity|1|||
161010966|NCT01718743|581427294|FG000|Overall Study|Malignancy|1|||
161010967|NCT03416010|581427295|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
161010968|NCT03416010|581427296|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
161010969|NCT03416010|581427295|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
161010970|NCT03416010|581427296|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
161010971|NCT03416010|581427295|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
161010972|NCT03416010|581427296|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
161010973|NCT03416010|581427295|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
161010974|NCT03416010|581427296|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
161010975|NCT03416010|581427295|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
161010976|NCT03416010|581427296|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
161010977|NCT03416010|581427295|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
161010978|NCT03416010|581427296|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
161010979|NCT03416010|581427295|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
161010980|NCT03416010|581427296|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
161010981|NCT03948763|581427300|FG000|Overall Study|Sponsor's decision|0|||
161010982|NCT03948763|581427301|FG001|Overall Study|Sponsor's decision|2|||
161010983|NCT03948763|581427302|FG002|Overall Study|Sponsor's decision|6|||
161010984|NCT03948763|581427303|FG003|Overall Study|Sponsor's decision|4|||
161010985|NCT03948763|581427304|FG004|Overall Study|Sponsor's decision|0|||
161010986|NCT03948763|581427300|FG000|Overall Study|Physician Decision|0|||
161010987|NCT03948763|581427301|FG001|Overall Study|Physician Decision|0|||
161010988|NCT03948763|581427302|FG002|Overall Study|Physician Decision|1|||
161010989|NCT03948763|581427303|FG003|Overall Study|Physician Decision|0|||
161010990|NCT03948763|581427304|FG004|Overall Study|Physician Decision|0|||
161010991|NCT03948763|581427300|FG000|Overall Study|Lost to Follow-up|0|||
161010992|NCT03948763|581427301|FG001|Overall Study|Lost to Follow-up|0|||
161010993|NCT03948763|581427302|FG002|Overall Study|Lost to Follow-up|0|||
161010994|NCT03948763|581427303|FG003|Overall Study|Lost to Follow-up|0|||
161010995|NCT03948763|581427304|FG004|Overall Study|Lost to Follow-up|1|||
161010996|NCT03948763|581427300|FG000|Overall Study|Death|2|||
161010997|NCT03948763|581427301|FG001|Overall Study|Death|12|||
161010998|NCT03948763|581427302|FG002|Overall Study|Death|13|||
161010999|NCT03948763|581427303|FG003|Overall Study|Death|10|||
161011000|NCT03948763|581427304|FG004|Overall Study|Death|11|||
161011001|NCT03948763|581427300|FG000|Overall Study|Withdrawal by Subject|1|||
161011002|NCT03948763|581427301|FG001|Overall Study|Withdrawal by Subject|1|||
161011003|NCT03948763|581427302|FG002|Overall Study|Withdrawal by Subject|0|||
161011004|NCT03948763|581427303|FG003|Overall Study|Withdrawal by Subject|2|||
161011005|NCT03948763|581427304|FG004|Overall Study|Withdrawal by Subject|4|||
161011006|NCT06629454|581427305|FG000|Overall Study|Withdraw by Clinician Decision|1|||
161011007|NCT06023082|581427306|FG000|Overall Study|Withdrawal by Subject|2|||
161011008|NCT06023082|581427306|FG000|Overall Study|Lost to Follow-up|15|||
161011009|NCT06023082|581427306|FG000|Overall Study|Side effects|5|||
161011010|NCT05986565|581427307|FG000|Overall Study|Lost to Follow-up|8|||
161011011|NCT05986565|581427308|FG001|Overall Study|Lost to Follow-up|3|||
161011012|NCT05986565|581427307|FG000|Overall Study|Withdrawal by Subject|0|||
161011013|NCT05986565|581427308|FG001|Overall Study|Withdrawal by Subject|1|||
161011014|NCT00670046|581427309|FG000|Overall Study|Lost to Follow-up|1|||
161011015|NCT00670046|581427310|FG001|Overall Study|Lost to Follow-up|1|||
161011016|NCT00670046|581427309|FG000|Overall Study|Withdrawal by Subject|0|||
161011017|NCT00670046|581427310|FG001|Overall Study|Withdrawal by Subject|1|||
161011018|NCT02006758|581427324|FG000|Overall Study|Protocol Violation|1|||
161011019|NCT02006758|581427324|FG000|Overall Study|Death|1|||
161011020|NCT02006758|581427324|FG000|Overall Study|Lost to Follow-up|4|||
161011021|NCT02006758|581427324|FG000|Overall Study|Withdrawal by Subject|4|||
161011022|NCT02006758|581427324|FG000|Overall Study|Procedurally excluded|1|||
161011023|NCT02006758|581427324|FG000|Overall Study|Other|2|||
161011024|NCT02740231|581427325|FG000|Overall Study|Withdrawal by Subject|1|||
161011025|NCT02740231|581427326|FG001|Overall Study|Withdrawal by Subject|1|||
161011026|NCT02740231|581427327|FG002|Overall Study|Withdrawal by Subject|1|||
161011027|NCT02740231|581427328|FG003|Overall Study|Withdrawal by Subject|0|||
161011028|NCT02740231|581427325|FG000|Overall Study|Lack of Efficacy|0|||
161011029|NCT02740231|581427326|FG001|Overall Study|Lack of Efficacy|1|||
161011030|NCT02740231|581427327|FG002|Overall Study|Lack of Efficacy|0|||
161011031|NCT02740231|581427328|FG003|Overall Study|Lack of Efficacy|4|||
161011032|NCT02740231|581427325|FG000|Overall Study|Lost to Follow-up|1|||
161011033|NCT02740231|581427326|FG001|Overall Study|Lost to Follow-up|3|||
161011034|NCT02740231|581427327|FG002|Overall Study|Lost to Follow-up|0|||
161011035|NCT02740231|581427328|FG003|Overall Study|Lost to Follow-up|3|||
161011036|NCT02740231|581427325|FG000|Overall Study|Adverse Event|0|||
161011037|NCT02740231|581427326|FG001|Overall Study|Adverse Event|1|||
161011038|NCT02740231|581427327|FG002|Overall Study|Adverse Event|0|||
161011039|NCT02740231|581427328|FG003|Overall Study|Adverse Event|1|||
161011040|NCT00914589|581427329|FG000|Overall Study|Adverse Event|1|||
161011041|NCT00914589|581427330|FG001|Overall Study|Adverse Event|0|||
161011042|NCT00914589|581427331|FG002|Overall Study|Adverse Event|1|||
161011043|NCT00914589|581427329|FG000|Overall Study|Protocol Violation|8|||
161011044|NCT00914589|581427330|FG001|Overall Study|Protocol Violation|6|||
161011045|NCT00914589|581427331|FG002|Overall Study|Protocol Violation|3|||
161011046|NCT00914589|581427329|FG000|Overall Study|unclassified|16|||
161011047|NCT00914589|581427330|FG001|Overall Study|unclassified|9|||
161011048|NCT00914589|581427331|FG002|Overall Study|unclassified|7|||
161011049|NCT00914589|581427329|FG000|Overall Study|Death|0|||
161011050|NCT00914589|581427330|FG001|Overall Study|Death|1|||
161011051|NCT00914589|581427331|FG002|Overall Study|Death|1|||
161011052|NCT04110054|581427332|FG000|Overall Study|COVID-19 reason other than AE|0|||
161011053|NCT04110054|581427333|FG001|Overall Study|COVID-19 reason other than AE|0|||
161011054|NCT04110054|581427334|FG002|Overall Study|COVID-19 reason other than AE|2|||
161011055|NCT04110054|581427335|FG003|Overall Study|COVID-19 reason other than AE|0|||
161011056|NCT04110054|581427332|FG000|Overall Study|Withdrawal by Subject|0|||
161011057|NCT04110054|581427333|FG001|Overall Study|Withdrawal by Subject|3|||
161011058|NCT04110054|581427334|FG002|Overall Study|Withdrawal by Subject|2|||
161011059|NCT04110054|581427335|FG003|Overall Study|Withdrawal by Subject|0|||
161011060|NCT04110054|581427332|FG000|Overall Study|Adverse Event|1|||
161011061|NCT04110054|581427333|FG001|Overall Study|Adverse Event|1|||
161011062|NCT04110054|581427334|FG002|Overall Study|Adverse Event|4|||
161011063|NCT04110054|581427335|FG003|Overall Study|Adverse Event|3|||
161011064|NCT04149002|581427343|FG000|Overall Study|Lost to Follow-up|1|||
161011065|NCT04149002|581427344|FG001|Overall Study|Lost to Follow-up|0|||
161011066|NCT04149002|581427343|FG000|Overall Study|Withdrawal by Subject|1|||
161011067|NCT04149002|581427344|FG001|Overall Study|Withdrawal by Subject|0|||
161011068|NCT04583423|581427349|FG000|Overall Study|Lost to Follow-up|0|||
161011069|NCT04583423|581427350|FG001|Overall Study|Lost to Follow-up|1|||
161011070|NCT04583423|581427351|FG002|Overall Study|Lost to Follow-up|0|||
161011071|NCT04583423|581427352|FG003|Overall Study|Lost to Follow-up|2|||
161011072|NCT04583423|581427349|FG000|Overall Study|Study Terminated by Sponsor|32|||
161011073|NCT04583423|581427350|FG001|Overall Study|Study Terminated by Sponsor|35|||
161011074|NCT04583423|581427351|FG002|Overall Study|Study Terminated by Sponsor|36|||
161011075|NCT04583423|581427352|FG003|Overall Study|Study Terminated by Sponsor|33|||
161011076|NCT04583423|581427349|FG000|Overall Study|Withdrawal by Subject|3|||
161011077|NCT04583423|581427350|FG001|Overall Study|Withdrawal by Subject|1|||
161011078|NCT04583423|581427351|FG002|Overall Study|Withdrawal by Subject|2|||
161011079|NCT04583423|581427352|FG003|Overall Study|Withdrawal by Subject|1|||
161011080|NCT06061081|581427353|FG000|Overall Study|Withdrawal by Subject|1|||
161011081|NCT06061081|581427354|FG001|Overall Study|Withdrawal by Subject|0|||
161011082|NCT06061081|581427355|FG002|Overall Study|Withdrawal by Subject|0|||
161011083|NCT06061081|581427356|FG003|Overall Study|Withdrawal by Subject|0|||
161011084|NCT06061081|581427357|FG004|Overall Study|Withdrawal by Subject|0|||
161011085|NCT00510887|581427358|FG000|Overall Study|Lost to Follow-up|1|||
161011086|NCT01736215|581427359|FG000|Overall Study|Early termination of erythropoietin use|1|||
161011087|NCT01736215|581427359|FG000|Overall Study|Adverse Event|4|||
161011088|NCT01736215|581427359|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
161011089|NCT01736215|581427359|FG000|Overall Study|Insufficient data to perform analysis|8|||
161011090|NCT03447249|581427362|FG000|Overall Study|Adverse Event|1|||
161011091|NCT03447249|581427363|FG001|Overall Study|Adverse Event|0|||
161011092|NCT03447249|581427362|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
161011093|NCT03447249|581427363|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
161011094|NCT03447249|581427362|FG000|Overall Study|Other|3|||
161011095|NCT03447249|581427363|FG001|Overall Study|Other|0|||
161011096|NCT02372253|581427367|FG000|Overall Study|Non Compliance|2|||
161271800|NCT00186043|582375258|FG001|Overall Study|Lost to Follow-up|6|||
160967425|NCT00394355|581268254|FG001|Overall Study|Lack of Efficacy|0|||
160967426|NCT00394355|581268255|FG002|Overall Study|Lack of Efficacy|2|||
160967427|NCT00394355|581268256|FG003|Overall Study|Lack of Efficacy|3|||
160967428|NCT02618616|581268259|FG000|Overall Study|Lack of Efficacy|4|||
160967429|NCT02618616|581268260|FG001|Overall Study|Lack of Efficacy|0|||
160967430|NCT02618616|581268259|FG000|Overall Study|Pregnancy|0|||
160967431|NCT02618616|581268260|FG001|Overall Study|Pregnancy|1|||
160967432|NCT02618616|581268259|FG000|Overall Study|Adverse Event|8|||
160967433|NCT02618616|581268260|FG001|Overall Study|Adverse Event|0|||
160967434|NCT02618616|581268259|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
160967435|NCT02618616|581268260|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
160967436|NCT02618616|581268259|FG000|Overall Study|Consent withdrawn by subject|8|||
160967437|NCT02618616|581268260|FG001|Overall Study|Consent withdrawn by subject|5|||
160967438|NCT02618616|581268259|FG000|Overall Study|Lost to Follow-up|0|||
160967439|NCT02618616|581268260|FG001|Overall Study|Lost to Follow-up|1|||
160967440|NCT00459342|581268263|FG000|Overall Study|Not eligible|1|||
160967441|NCT02686034|581268264|FG000|Run-In Period 1|Eligibility|12|||
160967442|NCT02686034|581268265|FG001|Run-In Period 1|Eligibility|10|||
160967443|NCT02686034|581268264|FG000|Run-In Period 1|Withdrawal by Subject|4|||
160967444|NCT02686034|581268265|FG001|Run-In Period 1|Withdrawal by Subject|3|||
160967445|NCT02686034|581268264|FG000|Run-In Period 1|Lost to Follow-up|4|||
160967446|NCT02686034|581268265|FG001|Run-In Period 1|Lost to Follow-up|4|||
160967447|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
160967448|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
160967449|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
160967450|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
160967451|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Adverse Event|0|||
160967452|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Adverse Event|2|||
160967453|NCT02686034|581268264|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
160967454|NCT02686034|581268265|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
160967455|NCT02686034|581268264|FG000|Open Label Period 3|Lost to Follow-up|0|||
160967456|NCT02686034|581268265|FG001|Open Label Period 3|Lost to Follow-up|1|||
160967457|NCT01678131|581268266|FG000|Overall Study|Adverse Event|0|||
160967458|NCT01678131|581268267|FG001|Overall Study|Adverse Event|1|||
160967459|NCT01678131|581268268|FG002|Overall Study|Adverse Event|0|||
160967460|NCT01678131|581268266|FG000|Overall Study|Withdrawal by Subject|0|||
160967461|NCT01678131|581268267|FG001|Overall Study|Withdrawal by Subject|0|||
160967462|NCT01678131|581268268|FG002|Overall Study|Withdrawal by Subject|2|||
160967463|NCT00558064|581268270|FG000|Overall Study|Adverse Event|3|||
160967464|NCT00558064|581268271|FG001|Overall Study|Adverse Event|2|||
160967465|NCT00558064|581268270|FG000|Overall Study|Lack of Efficacy|0|||
160967466|NCT00558064|581268271|FG001|Overall Study|Lack of Efficacy|1|||
160967467|NCT00558064|581268270|FG000|Overall Study|Protocol Violation|1|||
160967468|NCT00558064|581268271|FG001|Overall Study|Protocol Violation|0|||
160967469|NCT00558064|581268270|FG000|Overall Study|Lost to Follow-up|0|||
160967470|NCT00558064|581268271|FG001|Overall Study|Lost to Follow-up|1|||
160967471|NCT00558064|581268270|FG000|Overall Study|Withdrawal by Subject|0|||
160967472|NCT00558064|581268271|FG001|Overall Study|Withdrawal by Subject|1|||
160967473|NCT00558064|581268270|FG000|Overall Study|No visit within allowance period|1|||
160967474|NCT00558064|581268271|FG001|Overall Study|No visit within allowance period|0|||
160967475|NCT02027402|581268272|FG000|Overall Study|Withdrawal by Subject|4|||
160967476|NCT02027402|581268273|FG001|Overall Study|Withdrawal by Subject|1|||
160967477|NCT00941798|581268274|FG000|Overall Study|Withdrawal by Subject|72|||
160967478|NCT00941798|581268275|FG001|Overall Study|Withdrawal by Subject|74|||
160967479|NCT00941798|581268274|FG000|Overall Study|Adverse Event|43|||
160967480|NCT00941798|581268275|FG001|Overall Study|Adverse Event|23|||
160967481|NCT00941798|581268274|FG000|Overall Study|Lost to Follow-up|29|||
160967482|NCT00941798|581268275|FG001|Overall Study|Lost to Follow-up|23|||
160967483|NCT00941798|581268274|FG000|Overall Study|Protocol Violation|17|||
160967484|NCT00941798|581268275|FG001|Overall Study|Protocol Violation|20|||
160967485|NCT00941798|581268274|FG000|Overall Study|Administrative problems|13|||
160967486|NCT00941798|581268275|FG001|Overall Study|Administrative problems|23|||
161271801|NCT00186043|582375257|FG000|Overall Study|Withdrawal by Subject|1|||
161271802|NCT00186043|582375258|FG001|Overall Study|Withdrawal by Subject|0|||
160967487|NCT00941798|581268274|FG000|Overall Study|Lack of Efficacy|10|||
160967488|NCT00941798|581268275|FG001|Overall Study|Lack of Efficacy|17|||
160967489|NCT00941798|581268274|FG000|Overall Study|Patient's inability to use device|6|||
160967490|NCT00941798|581268275|FG001|Overall Study|Patient's inability to use device|1|||
160967491|NCT00941798|581268274|FG000|Overall Study|Abnormal test procedure results|3|||
160967492|NCT00941798|581268275|FG001|Overall Study|Abnormal test procedure results|1|||
160967493|NCT00941798|581268274|FG000|Overall Study|Abnormal laboratory values|1|||
160967494|NCT00941798|581268275|FG001|Overall Study|Abnormal laboratory values|2|||
161011097|NCT02372253|581427368|FG001|Overall Study|Non Compliance|0|||
161011098|NCT03201562|581427369|FG000|Overall Study|Physician Decision|0|||
161271803|NCT00186043|582375257|FG000|Overall Study|Adverse Event|7|||
161271804|NCT00186043|582375258|FG001|Overall Study|Adverse Event|3|||
161271805|NCT00186043|582375257|FG000|Overall Study|Protocol Violation|2|||
161271806|NCT00186043|582375258|FG001|Overall Study|Protocol Violation|1|||
161271807|NCT04874636|582375259|FG000|Overall Study|Adverse Event|17|||
161271808|NCT04874636|582375260|FG001|Overall Study|Adverse Event|7|||
161271809|NCT04874636|582375259|FG000|Overall Study|Lost to Follow-up|1|||
161271810|NCT04874636|582375260|FG001|Overall Study|Lost to Follow-up|0|||
161271811|NCT04874636|582375259|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161271812|NCT04874636|582375260|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161271813|NCT04874636|582375259|FG000|Overall Study|Physician Decision|1|||
161343527|NCT03282097|582644403|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
160967495|NCT00941798|581268274|FG000|Overall Study|Death|0|||
160967496|NCT00941798|581268275|FG001|Overall Study|Death|1|||
160967497|NCT05597722|581268278|FG000|Overall Study|Study was terminated|6|||
160967498|NCT05597722|581268279|FG001|Overall Study|Study was terminated|1|||
160967499|NCT00404495|581268280|FG000|Overall Study|Death|37|||
160967500|NCT00404495|581268281|FG001|Overall Study|Death|11|||
160967501|NCT00404495|581268280|FG000|Overall Study|Lost to Follow-up|5|||
160967502|NCT00404495|581268281|FG001|Overall Study|Lost to Follow-up|0|||
160967503|NCT00404495|581268280|FG000|Overall Study|Other|1|||
160967504|NCT00404495|581268281|FG001|Overall Study|Other|0|||
160967505|NCT00404495|581268280|FG000|Overall Study|Withdrawal by Subject|1|||
160967506|NCT00404495|581268281|FG001|Overall Study|Withdrawal by Subject|0|||
160967507|NCT04108000|581268282|FG000|Overall Study|Death of patient|1|||
160967508|NCT04108000|581268283|FG001|Overall Study|Death of patient|0|||
160967509|NCT04108000|581268284|FG002|Overall Study|Death of patient|1|||
160967510|NCT04108000|581268285|FG003|Overall Study|Death of patient|0|||
160967511|NCT04108000|581268282|FG000|Overall Study|Withdrawal by Subject|2|||
160967512|NCT04108000|581268283|FG001|Overall Study|Withdrawal by Subject|2|||
160967513|NCT04108000|581268284|FG002|Overall Study|Withdrawal by Subject|0|||
160967514|NCT04108000|581268285|FG003|Overall Study|Withdrawal by Subject|0|||
160967515|NCT04108000|581268282|FG000|Overall Study|Death of surrogate partner|0|||
160967516|NCT04108000|581268283|FG001|Overall Study|Death of surrogate partner|1|||
160967517|NCT04108000|581268284|FG002|Overall Study|Death of surrogate partner|0|||
160967518|NCT04108000|581268285|FG003|Overall Study|Death of surrogate partner|1|||
160967519|NCT03904043|581268288|FG000|Overall Study|Adverse Event|1|||
160967520|NCT03904043|581268289|FG001|Overall Study|Adverse Event|1|||
160967521|NCT03904043|581268288|FG000|Overall Study|Withdrawal by Subject|1|||
160967522|NCT03904043|581268289|FG001|Overall Study|Withdrawal by Subject|0|||
160967523|NCT03904043|581268288|FG000|Overall Study|Non-compliance|1|||
160967524|NCT03904043|581268289|FG001|Overall Study|Non-compliance|0|||
160967525|NCT03904043|581268288|FG000|Overall Study|Did not start treatment|1|||
160967526|NCT03904043|581268289|FG001|Overall Study|Did not start treatment|0|||
160967527|NCT03750006|581268290|FG000|Overall Study|Withdrawal by Subject|8|||
160967528|NCT03750006|581268290|FG000|Overall Study|COVID PANDEMIC|11|||
160967529|NCT00766675|581269998|FG000|Overall Study|Adverse Event|16|||
160967530|NCT00766675|581269998|FG000|Overall Study|Lost to Follow-up|2|||
160967531|NCT00766675|581269998|FG000|Overall Study|Withdrawal by Subject|11|||
160967532|NCT00766675|581269998|FG000|Overall Study|Protocol Violation|8|||
160967533|NCT00766675|581269998|FG000|Overall Study|Participant took prohibited medication|1|||
160967534|NCT00766675|581269998|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
160967535|NCT00766675|581269998|FG000|Overall Study|Insufficient therapy|1|||
160967536|NCT01679236|581269999|FG000|Overall Study|Lost to Follow-up|15|||
160967537|NCT01679236|581270000|FG001|Overall Study|Lost to Follow-up|15|||
160967538|NCT03935217|581270003|FG000|Overall Study|Adverse Event|1|||
160967539|NCT03935217|581270004|FG001|Overall Study|Adverse Event|0|||
160967540|NCT03935217|581270003|FG000|Overall Study|Lost to Follow-up|0|||
160967541|NCT03935217|581270004|FG001|Overall Study|Lost to Follow-up|1|||
160967542|NCT03935217|581270003|FG000|Overall Study|Withdrawal by Subject|0|||
160967543|NCT03935217|581270004|FG001|Overall Study|Withdrawal by Subject|2|||
160967544|NCT01160484|581270011|FG000|Overall Study|Lack of Efficacy|9|||
160967545|NCT01160484|581270011|FG000|Overall Study|Adverse Event|6|||
160967546|NCT01160484|581270011|FG000|Overall Study|Withdrawal by Subject|2|||
160967547|NCT01160484|581270011|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
160967548|NCT02026232|581270014|FG000|Overall Study|incomplete visit/missing data|3|||
160967549|NCT02026232|581270015|FG001|Overall Study|incomplete visit/missing data|2|||
160967550|NCT01382602|581270016|FG000|Overall Study|Protocol Violation|0|||
160967551|NCT01382602|581270017|FG001|Overall Study|Protocol Violation|3|||
160967552|NCT01382602|581270016|FG000|Overall Study|Withdrawal by Subject|0|||
160967553|NCT01382602|581270017|FG001|Overall Study|Withdrawal by Subject|1|||
161271814|NCT04874636|582375260|FG001|Overall Study|Physician Decision|0|||
160967554|NCT00331344|581270023|FG000|Phase I|Adverse Event|0|||
160967555|NCT00331344|581270024|FG001|Phase I|Adverse Event|0|||
160967556|NCT00331344|581270025|FG002|Phase I|Adverse Event|0|||
160967557|NCT00331344|581270026|FG003|Phase I|Adverse Event|1|||
161271815|NCT04874636|582375259|FG000|Overall Study|Withdrawal by Subject|6|||
160967558|NCT00331344|581270027|FG004|Phase I|Adverse Event|2|||
160967559|NCT00331344|581270028|FG005|Phase I|Adverse Event|2|||
160967560|NCT00331344|581270029|FG006|Phase I|Adverse Event|0|||
161271816|NCT04874636|582375260|FG001|Overall Study|Withdrawal by Subject|5|||
161271817|NCT04188301|582375263|FG000|Month 3|Lost to Follow-up|0|||
161271818|NCT04188301|582375264|FG001|Month 3|Lost to Follow-up|0|||
161271819|NCT04188301|582375265|FG002|Month 3|Lost to Follow-up|1|||
161271820|NCT04188301|582375263|FG000|Month 12|Lost to Follow-up|0|||
161271821|NCT04188301|582375264|FG001|Month 12|Lost to Follow-up|0|||
161271822|NCT04188301|582375265|FG002|Month 12|Lost to Follow-up|2|||
161271823|NCT04188301|582375263|FG000|Month 12|Death|1|||
161271824|NCT04188301|582375264|FG001|Month 12|Death|1|||
161271825|NCT04188301|582375265|FG002|Month 12|Death|0|||
161271826|NCT04188301|582375263|FG000|Month 18|Lost to Follow-up|6|||
161271827|NCT04188301|582375264|FG001|Month 18|Lost to Follow-up|0|||
161271828|NCT04188301|582375265|FG002|Month 18|Lost to Follow-up|0|||
161271829|NCT00228423|582375266|FG000|Overall Study|Adverse Event|2|||
161271830|NCT00228423|582375267|FG001|Overall Study|Adverse Event|5|||
161271831|NCT00228423|582375266|FG000|Overall Study|Withdrawal by Subject|7|||
161271832|NCT00228423|582375267|FG001|Overall Study|Withdrawal by Subject|3|||
161011099|NCT03201562|581427370|FG001|Overall Study|Physician Decision|0|||
161011100|NCT03201562|581427371|FG002|Overall Study|Physician Decision|1|||
161011101|NCT03201562|581427369|FG000|Overall Study|Adverse Event|0|||
161011102|NCT03201562|581427370|FG001|Overall Study|Adverse Event|0|||
161011103|NCT03201562|581427371|FG002|Overall Study|Adverse Event|1|||
161011104|NCT03201562|581427369|FG000|Overall Study|Lost to Follow-up|0|||
161011105|NCT03201562|581427370|FG001|Overall Study|Lost to Follow-up|1|||
161271833|NCT00228423|582375266|FG000|Overall Study|Protocol Violation|1|||
161271834|NCT00228423|582375267|FG001|Overall Study|Protocol Violation|3|||
161271835|NCT00228423|582375266|FG000|Overall Study|Physician Decision|0|||
161271836|NCT00228423|582375267|FG001|Overall Study|Physician Decision|1|||
161271837|NCT02582866|582375272|FG000|Overall Study|Death|1|||
161271838|NCT02582866|582375272|FG000|Overall Study|Lack of Efficacy|2|||
161271839|NCT02582866|582375272|FG000|Overall Study|Lost to Follow-up|2|||
161271840|NCT02582866|582375272|FG000|Overall Study|Withdrawal by Subject|7|||
160967561|NCT00331344|581270030|FG007|Phase I|Adverse Event|1|||
160967562|NCT00331344|581270031|FG008|Phase I|Adverse Event|0|||
160967563|NCT00331344|581270023|FG000|Phase II|Death|0|||
160967564|NCT00331344|581270024|FG001|Phase II|Death|0|||
160967565|NCT00331344|581270025|FG002|Phase II|Death|0|||
160967566|NCT00331344|581270026|FG003|Phase II|Death|0|||
160967567|NCT00331344|581270027|FG004|Phase II|Death|0|||
160967568|NCT00331344|581270028|FG005|Phase II|Death|0|||
160967569|NCT00331344|581270029|FG006|Phase II|Death|0|||
160967570|NCT00331344|581270030|FG007|Phase II|Death|0|||
160967571|NCT00331344|581270031|FG008|Phase II|Death|4|||
160967572|NCT04538144|581270037|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
160967573|NCT04538144|581270038|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
160967574|NCT04538144|581270039|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
160967575|NCT04538144|581270040|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
160967576|NCT02228967|581270041|FG000|Overall Study|Lost to Follow-up|146|||
160967577|NCT02228967|581270042|FG001|Overall Study|Lost to Follow-up|142|||
160967578|NCT02228967|581270041|FG000|Overall Study|Withdrawal by Subject|13|||
160967579|NCT02228967|581270042|FG001|Overall Study|Withdrawal by Subject|18|||
160967580|NCT01995539|581270045|FG000|Overall Study|Screening Failure|1|||
160967581|NCT01995539|581270045|FG000|Overall Study|Withdrawal by Investigator|15|||
160967582|NCT01995539|581270045|FG000|Overall Study|Withdrawal by Subject|11|||
160967583|NCT01995539|581270045|FG000|Overall Study|Lost to Follow-up|5|||
160967584|NCT01995539|581270045|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
160967585|NCT03261271|581270049|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
160967586|NCT03261271|581270050|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
160967587|NCT02173054|581270051|FG000|Overall Study|lack of compliance|1|||
160967588|NCT02173054|581270052|FG001|Overall Study|lack of compliance|0|||
160967589|NCT02173054|581270053|FG002|Overall Study|lack of compliance|0|||
160967590|NCT02173054|581270051|FG000|Overall Study|Withdrawal by Subject|0|||
160967591|NCT02173054|581270052|FG001|Overall Study|Withdrawal by Subject|0|||
160967592|NCT02173054|581270053|FG002|Overall Study|Withdrawal by Subject|1|||
160967593|NCT01932697|581270054|FG000|Overall Study|Received a different amount of tx|1|||
160967594|NCT01932697|581270055|FG001|Overall Study|Received a different amount of tx|0|||
160967595|NCT01932697|581270054|FG000|Overall Study|Ineligible|1|||
160967596|NCT01932697|581270055|FG001|Overall Study|Ineligible|0|||
160967597|NCT00215540|581270060|FG000|Overall Study|Withdrew from study medication|1|||
160967598|NCT00215540|581270061|FG001|Overall Study|Withdrew from study medication|0|||
160967599|NCT00215540|581270062|FG002|Overall Study|Withdrew from study medication|0|||
160967600|NCT00674570|581270064|FG000|Overall Study|Withdrawal by Subject|0|||
160967601|NCT00674570|581270065|FG001|Overall Study|Withdrawal by Subject|2|||
160967602|NCT00674570|581270066|FG002|Overall Study|Withdrawal by Subject|0|||
160967603|NCT02313909|581270067|FG000|Overall Study|Consent withdrawn by participant|33|||
160967604|NCT02313909|581270068|FG001|Overall Study|Consent withdrawn by participant|33|||
160967605|NCT02313909|581270067|FG000|Overall Study|Lost to Follow-up|24|||
160967606|NCT02313909|581270068|FG001|Overall Study|Lost to Follow-up|17|||
161011106|NCT03201562|581427371|FG002|Overall Study|Lost to Follow-up|2|||
161011107|NCT01803555|581427372|FG000|Overall Study|Adverse Event|3|||
161011108|NCT01803555|581427373|FG001|Overall Study|Adverse Event|2|||
161011109|NCT01803555|581427372|FG000|Overall Study|Withdrawal by Subject|3|||
161011110|NCT01803555|581427373|FG001|Overall Study|Withdrawal by Subject|3|||
161011111|NCT01803555|581427372|FG000|Overall Study|Non-compliance|1|||
161011112|NCT01803555|581427373|FG001|Overall Study|Non-compliance|1|||
161011113|NCT01803555|581427372|FG000|Overall Study|Protocol Violation|3|||
161011114|NCT01803555|581427373|FG001|Overall Study|Protocol Violation|5|||
161011115|NCT01803555|581427372|FG000|Overall Study|Lost to Follow-up|0|||
161011116|NCT01803555|581427373|FG001|Overall Study|Lost to Follow-up|2|||
161011117|NCT01803555|581427372|FG000|Overall Study|Other than specified|3|||
161011118|NCT01803555|581427373|FG001|Overall Study|Other than specified|5|||
161011119|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
161011120|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
161011121|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
161011122|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
161011123|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
161011124|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
161011125|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
161011126|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
161011127|NCT00393484|581427374|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
161011128|NCT00393484|581427375|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
161011129|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
161011130|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
161011131|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
161147475|NCT03952650|581922477|FG003|Overall Study|Lost to Follow-up|0|||
161147476|NCT03952650|581922478|FG004|Overall Study|Lost to Follow-up|0|||
161147477|NCT03952650|581922479|FG005|Overall Study|Lost to Follow-up|1|||
161147478|NCT03952650|581922480|FG006|Overall Study|Lost to Follow-up|1|||
161147479|NCT03952650|581922474|FG000|Overall Study|Received wrong vaccine and travelled|0|||
161147480|NCT03952650|581922475|FG001|Overall Study|Received wrong vaccine and travelled|0|||
161147481|NCT03952650|581922476|FG002|Overall Study|Received wrong vaccine and travelled|0|||
161343528|NCT02755090|582644404|FG000|Overall Study|equipment malfunction|1|||
161343529|NCT02755090|582644405|FG001|Overall Study|equipment malfunction|0|||
161343530|NCT00207740|582644406|FG000|Overall Study|Adverse Event|4|||
160967607|NCT02798211|581270069|FG000|Period 1|Adverse Event|1|||
160967608|NCT02798211|581270070|FG001|Period 1|Adverse Event|1|||
160967609|NCT02798211|581270071|FG002|Period 1|Adverse Event|0|||
160967610|NCT02798211|581270072|FG003|Period 1|Adverse Event|0|||
160967611|NCT02798211|581270073|FG004|Period 1|Adverse Event|0|||
160967612|NCT02798211|581270074|FG005|Period 1|Adverse Event|0|||
160967613|NCT02798211|581270069|FG000|Period 1|Lost to Follow-up|2|||
160967614|NCT02798211|581270070|FG001|Period 1|Lost to Follow-up|1|||
160967615|NCT02798211|581270071|FG002|Period 1|Lost to Follow-up|0|||
160967616|NCT02798211|581270072|FG003|Period 1|Lost to Follow-up|0|||
160967617|NCT02798211|581270073|FG004|Period 1|Lost to Follow-up|0|||
160967618|NCT02798211|581270074|FG005|Period 1|Lost to Follow-up|0|||
160967619|NCT02798211|581270069|FG000|Period 1|Protocol Violation|0|||
160967620|NCT02798211|581270070|FG001|Period 1|Protocol Violation|0|||
160967621|NCT02798211|581270071|FG002|Period 1|Protocol Violation|2|||
160967622|NCT02798211|581270072|FG003|Period 1|Protocol Violation|0|||
160967623|NCT02798211|581270073|FG004|Period 1|Protocol Violation|0|||
160967624|NCT02798211|581270074|FG005|Period 1|Protocol Violation|0|||
160967625|NCT02798211|581270069|FG000|Period 1|Withdrawal by Subject|1|||
160967626|NCT02798211|581270070|FG001|Period 1|Withdrawal by Subject|1|||
160967627|NCT02798211|581270071|FG002|Period 1|Withdrawal by Subject|0|||
160967628|NCT02798211|581270072|FG003|Period 1|Withdrawal by Subject|0|||
160967629|NCT02798211|581270073|FG004|Period 1|Withdrawal by Subject|0|||
160967630|NCT02798211|581270074|FG005|Period 1|Withdrawal by Subject|0|||
160967631|NCT02798211|581270069|FG000|Period 1|Death|0|||
160967632|NCT02798211|581270070|FG001|Period 1|Death|0|||
160967633|NCT02798211|581270071|FG002|Period 1|Death|1|||
160967634|NCT02798211|581270072|FG003|Period 1|Death|0|||
160967635|NCT02798211|581270073|FG004|Period 1|Death|0|||
160967636|NCT02798211|581270074|FG005|Period 1|Death|0|||
160967637|NCT02798211|581270069|FG000|Period 1|Withdrawal of Informed Consent|2|||
160967638|NCT02798211|581270070|FG001|Period 1|Withdrawal of Informed Consent|7|||
160967639|NCT02798211|581270071|FG002|Period 1|Withdrawal of Informed Consent|3|||
160967640|NCT02798211|581270072|FG003|Period 1|Withdrawal of Informed Consent|0|||
160967641|NCT02798211|581270073|FG004|Period 1|Withdrawal of Informed Consent|0|||
160967642|NCT02798211|581270074|FG005|Period 1|Withdrawal of Informed Consent|0|||
160967643|NCT02798211|581270069|FG000|Period 2|Withdrawal by Subject|2|||
160967644|NCT02798211|581270070|FG001|Period 2|Withdrawal by Subject|0|||
160967645|NCT02798211|581270071|FG002|Period 2|Withdrawal by Subject|0|||
160967646|NCT02798211|581270072|FG003|Period 2|Withdrawal by Subject|0|||
161011132|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
161011133|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
161011134|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
161011135|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
161011136|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
161011137|NCT00393484|581427374|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
161271841|NCT02582866|582375272|FG000|Overall Study|Investigator decision|5|||
161271842|NCT02582866|582375272|FG000|Overall Study|Participant wants to get pregnant|1|||
161271843|NCT02582866|582375272|FG000|Overall Study|Pregnancy|2|||
161271844|NCT02582866|582375272|FG000|Overall Study|Sponsor decision|1|||
161011138|NCT00393484|581427375|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
161011139|NCT03101371|581427378|FG000|Overall Study|Physician Decision|0|||
161011140|NCT03101371|581427379|FG001|Overall Study|Physician Decision|1|||
161011141|NCT03101371|581427378|FG000|Overall Study|Lost to Follow-up|1|||
161011142|NCT03101371|581427379|FG001|Overall Study|Lost to Follow-up|4|||
161011143|NCT03101371|581427378|FG000|Overall Study|Did not meet eligibility criteria|2|||
161011144|NCT03101371|581427379|FG001|Overall Study|Did not meet eligibility criteria|1|||
161011145|NCT02318134|581427383|FG000|Overall Study|Withdrawal by Subject|2|||
161011146|NCT02318134|581427384|FG001|Overall Study|Withdrawal by Subject|1|||
161011147|NCT01094184|581427385|FG000|Overall Study|Death|35|||
161011148|NCT01094184|581427386|FG001|Overall Study|Death|11|||
161011149|NCT03988842|581427387|FG000|Overall Study|Death|1|||
161011150|NCT04766034|581427388|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011151|NCT04766034|581427389|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011152|NCT04766034|581427390|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011153|NCT04766034|581427391|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
161011154|NCT04766034|581427392|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
161011155|NCT04766034|581427388|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011156|NCT04766034|581427389|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011157|NCT04766034|581427390|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011158|NCT04766034|581427391|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
161011159|NCT04766034|581427392|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
161011160|NCT04766034|581427388|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
161011161|NCT04766034|581427389|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
161011162|NCT04766034|581427390|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
161011163|NCT04766034|581427391|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
161011164|NCT04766034|581427392|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
161011165|NCT04766034|581427388|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
161011166|NCT04766034|581427389|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
161011167|NCT04766034|581427390|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
161011168|NCT04766034|581427391|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
161011169|NCT04766034|581427392|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
161011170|NCT01976312|581427393|FG000|Overall Study|Pregnancy|0|||
161011171|NCT01976312|581427394|FG001|Overall Study|Pregnancy|1|||
161011172|NCT01976312|581427393|FG000|Overall Study|Lost to Follow-up|2|||
161011173|NCT01976312|581427394|FG001|Overall Study|Lost to Follow-up|0|||
161011174|NCT01976312|581427393|FG000|Overall Study|Withdrawal by Subject|7|||
161011175|NCT01976312|581427394|FG001|Overall Study|Withdrawal by Subject|2|||
161011176|NCT01976312|581427393|FG000|Overall Study|Adverse Event|6|||
161011177|NCT01976312|581427394|FG001|Overall Study|Adverse Event|6|||
161011178|NCT01976312|581427393|FG000|Overall Study|Protocol Violation|2|||
161011179|NCT01976312|581427394|FG001|Overall Study|Protocol Violation|0|||
161011180|NCT01538719|581427399|FG000|Overall Study|Lost to Follow-up|2|||
161011181|NCT01538719|581427400|FG001|Overall Study|Lost to Follow-up|0|||
161271845|NCT02582866|582375272|FG000|Overall Study|Withdrawal due to personal reasons|1|||
161271846|NCT03567382|582375273|FG000|Overall Study|Lost to Follow-up|1|||
161011182|NCT02807779|581427401|FG000|Overall Study|Lost to Follow-up|1|||
161011183|NCT02807779|581427402|FG001|Overall Study|Lost to Follow-up|0|||
161011184|NCT02807779|581427403|FG002|Overall Study|Lost to Follow-up|0|||
161271847|NCT03567382|582375274|FG001|Overall Study|Lost to Follow-up|21|||
161271848|NCT03567382|582375275|FG002|Overall Study|Lost to Follow-up|1|||
161271849|NCT03567382|582375276|FG003|Overall Study|Lost to Follow-up|21|||
161011185|NCT02807779|581427401|FG000|Overall Study|Physician Decision|2|||
161011186|NCT02807779|581427402|FG001|Overall Study|Physician Decision|0|||
161271850|NCT03567382|582375273|FG000|Overall Study|Withdrawal by Subject|2|||
161271851|NCT03567382|582375274|FG001|Overall Study|Withdrawal by Subject|14|||
161271852|NCT03567382|582375275|FG002|Overall Study|Withdrawal by Subject|1|||
161271853|NCT03567382|582375276|FG003|Overall Study|Withdrawal by Subject|12|||
161271854|NCT00620659|582375277|FG000|Treatment Period 1|Adverse Event|1|||
161271855|NCT00620659|582375278|FG001|Treatment Period 1|Adverse Event|0|||
161271856|NCT00620659|582375279|FG002|Treatment Period 1|Adverse Event|0|||
161271857|NCT00620659|582375280|FG003|Treatment Period 1|Adverse Event|3|||
161271858|NCT00620659|582375281|FG004|Treatment Period 1|Adverse Event|0|||
161271859|NCT00620659|582375282|FG005|Treatment Period 1|Adverse Event|0|||
161271860|NCT00620659|582375277|FG000|Treatment Period 1|Protocol Violation|1|||
161271861|NCT00620659|582375278|FG001|Treatment Period 1|Protocol Violation|0|||
161271862|NCT00620659|582375279|FG002|Treatment Period 1|Protocol Violation|0|||
161271863|NCT00620659|582375280|FG003|Treatment Period 1|Protocol Violation|0|||
161271864|NCT00620659|582375281|FG004|Treatment Period 1|Protocol Violation|0|||
161271865|NCT00620659|582375282|FG005|Treatment Period 1|Protocol Violation|0|||
161271866|NCT00620659|582375277|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161271867|NCT00620659|582375278|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161271868|NCT00620659|582375279|FG002|Treatment Period 1|Withdrawal by Subject|1|||
161271869|NCT00620659|582375280|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161271870|NCT00620659|582375281|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161271871|NCT00620659|582375282|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161271872|NCT00620659|582375277|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
161271873|NCT00620659|582375278|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
161271874|NCT00620659|582375279|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
161271875|NCT00620659|582375280|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
161271876|NCT00620659|582375281|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
161271877|NCT00620659|582375282|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
161271878|NCT00620659|582375277|FG000|Treatment Period 2|Adverse Event|0|||
161271879|NCT00620659|582375278|FG001|Treatment Period 2|Adverse Event|3|||
161271880|NCT00620659|582375279|FG002|Treatment Period 2|Adverse Event|0|||
161271881|NCT00620659|582375280|FG003|Treatment Period 2|Adverse Event|0|||
161271882|NCT00620659|582375281|FG004|Treatment Period 2|Adverse Event|2|||
161271883|NCT00620659|582375282|FG005|Treatment Period 2|Adverse Event|0|||
161271884|NCT00620659|582375277|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161271885|NCT00620659|582375278|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161271886|NCT00620659|582375279|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161271887|NCT00620659|582375280|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161271888|NCT00620659|582375281|FG004|Treatment Period 2|Withdrawal by Subject|3|||
161271889|NCT00620659|582375282|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161271890|NCT00620659|582375277|FG000|Placebo Washout Period 2|Adverse Event|2|||
161271891|NCT00620659|582375278|FG001|Placebo Washout Period 2|Adverse Event|0|||
160967647|NCT02798211|581270073|FG004|Period 2|Withdrawal by Subject|2|||
160967648|NCT02798211|581270074|FG005|Period 2|Withdrawal by Subject|2|||
160967649|NCT02798211|581270069|FG000|Period 2|Adverse Event|5|||
160967650|NCT02798211|581270070|FG001|Period 2|Adverse Event|0|||
160967651|NCT02798211|581270071|FG002|Period 2|Adverse Event|0|||
160967652|NCT02798211|581270072|FG003|Period 2|Adverse Event|0|||
160967653|NCT02798211|581270073|FG004|Period 2|Adverse Event|1|||
160967654|NCT02798211|581270074|FG005|Period 2|Adverse Event|0|||
160967655|NCT02798211|581270069|FG000|Period 2|Lack of Efficacy|1|||
160967656|NCT02798211|581270070|FG001|Period 2|Lack of Efficacy|0|||
160967657|NCT02798211|581270071|FG002|Period 2|Lack of Efficacy|0|||
160967658|NCT02798211|581270072|FG003|Period 2|Lack of Efficacy|1|||
160967659|NCT02798211|581270073|FG004|Period 2|Lack of Efficacy|0|||
160967660|NCT02798211|581270074|FG005|Period 2|Lack of Efficacy|1|||
160967661|NCT02798211|581270069|FG000|Period 2|Lost to Follow-up|3|||
160967662|NCT02798211|581270070|FG001|Period 2|Lost to Follow-up|0|||
160967663|NCT02798211|581270071|FG002|Period 2|Lost to Follow-up|0|||
160967664|NCT02798211|581270072|FG003|Period 2|Lost to Follow-up|0|||
160967665|NCT02798211|581270073|FG004|Period 2|Lost to Follow-up|2|||
160967666|NCT02798211|581270074|FG005|Period 2|Lost to Follow-up|0|||
160967667|NCT02798211|581270069|FG000|Period 2|Physician Decision|1|||
160967668|NCT02798211|581270070|FG001|Period 2|Physician Decision|0|||
160967669|NCT02798211|581270071|FG002|Period 2|Physician Decision|0|||
160967670|NCT02798211|581270072|FG003|Period 2|Physician Decision|1|||
160967671|NCT02798211|581270073|FG004|Period 2|Physician Decision|1|||
160967672|NCT02798211|581270074|FG005|Period 2|Physician Decision|0|||
160967673|NCT02798211|581270069|FG000|Period 2|Pregnancy|0|||
160967674|NCT02798211|581270070|FG001|Period 2|Pregnancy|0|||
160967675|NCT02798211|581270071|FG002|Period 2|Pregnancy|0|||
160967676|NCT02798211|581270072|FG003|Period 2|Pregnancy|2|||
160967677|NCT02798211|581270073|FG004|Period 2|Pregnancy|0|||
160967678|NCT02798211|581270074|FG005|Period 2|Pregnancy|0|||
160967679|NCT02798211|581270069|FG000|Period 2|Technical problems|1|||
160967680|NCT02798211|581270070|FG001|Period 2|Technical problems|0|||
160967681|NCT02798211|581270071|FG002|Period 2|Technical problems|0|||
160967682|NCT02798211|581270072|FG003|Period 2|Technical problems|1|||
160967683|NCT02798211|581270073|FG004|Period 2|Technical problems|0|||
160967684|NCT02798211|581270074|FG005|Period 2|Technical problems|0|||
160967685|NCT02798211|581270069|FG000|Period 2|Withdrawal of Informed Consent|1|||
160967686|NCT02798211|581270070|FG001|Period 2|Withdrawal of Informed Consent|0|||
160967687|NCT02798211|581270071|FG002|Period 2|Withdrawal of Informed Consent|0|||
161011187|NCT02807779|581427403|FG002|Overall Study|Physician Decision|1|||
161271892|NCT00620659|582375279|FG002|Placebo Washout Period 2|Adverse Event|0|||
161271893|NCT00620659|582375280|FG003|Placebo Washout Period 2|Adverse Event|0|||
161271894|NCT00620659|582375281|FG004|Placebo Washout Period 2|Adverse Event|0|||
161271895|NCT00620659|582375282|FG005|Placebo Washout Period 2|Adverse Event|0|||
161271896|NCT00620659|582375277|FG000|Treatment Period 3|Adverse Event|0|||
161011188|NCT02807779|581427401|FG000|Overall Study|Death|1|||
161011189|NCT02807779|581427402|FG001|Overall Study|Death|1|||
161011190|NCT02807779|581427403|FG002|Overall Study|Death|0|||
161011191|NCT03582722|581427404|FG000|Overall Study|Lost to Follow-up|1|||
161011192|NCT03582722|581427405|FG001|Overall Study|Lost to Follow-up|4|||
161011193|NCT03582722|581427404|FG000|Overall Study|Withdrawal by Subject|3|||
161011194|NCT03582722|581427405|FG001|Overall Study|Withdrawal by Subject|3|||
161011195|NCT01216176|581428705|FG000|Overall Study|Adverse Event|0|||
161011196|NCT01216176|581428706|FG001|Overall Study|Adverse Event|8|||
161011197|NCT01216176|581428707|FG002|Overall Study|Adverse Event|0|||
161011198|NCT01216176|581428705|FG000|Overall Study|Physician Decision|0|||
161011199|NCT01216176|581428706|FG001|Overall Study|Physician Decision|0|||
161011200|NCT01216176|581428707|FG002|Overall Study|Physician Decision|1|||
161011201|NCT03481660|581428710|FG000|Overall Study|Adverse Event|5|||
161011202|NCT03481660|581428711|FG001|Overall Study|Adverse Event|4|||
161011203|NCT03481660|581428710|FG000|Overall Study|Death|13|||
161011204|NCT03481660|581428711|FG001|Overall Study|Death|9|||
161011205|NCT03481660|581428710|FG000|Overall Study|Lost to Follow-up|2|||
161011206|NCT03481660|581428711|FG001|Overall Study|Lost to Follow-up|2|||
161011207|NCT03481660|581428710|FG000|Overall Study|Physician Decision|2|||
161011208|NCT03481660|581428711|FG001|Overall Study|Physician Decision|3|||
161011209|NCT03481660|581428710|FG000|Overall Study|Withdrawal by Subject|14|||
161011210|NCT03481660|581428711|FG001|Overall Study|Withdrawal by Subject|7|||
161011211|NCT05687903|581428714|FG000|Overall Study|Protocol Deviation|1|||
161011212|NCT05687903|581428715|FG001|Overall Study|Protocol Deviation|1|||
161011213|NCT05687903|581428716|FG002|Overall Study|Protocol Deviation|0|||
161011214|NCT05687903|581428717|FG003|Overall Study|Protocol Deviation|1|||
161011215|NCT05687903|581428718|FG004|Overall Study|Protocol Deviation|0|||
161011216|NCT05215847|581428719|FG000|Overall Study|Lost to Follow-up|1|||
161011217|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011218|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011219|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011220|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
161011221|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
161011222|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011223|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011224|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011225|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
161011226|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
161011227|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011228|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011229|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011230|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
161011231|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
161011232|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011233|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011234|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011235|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
161011236|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
161011237|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011238|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011239|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011240|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
161011241|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
161147482|NCT03952650|581922477|FG003|Overall Study|Received wrong vaccine and travelled|0|||
161147483|NCT03952650|581922478|FG004|Overall Study|Received wrong vaccine and travelled|0|||
161147484|NCT03952650|581922479|FG005|Overall Study|Received wrong vaccine and travelled|1|||
161011242|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011243|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011244|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011245|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
161011246|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
161147485|NCT03952650|581922480|FG006|Overall Study|Received wrong vaccine and travelled|0|||
161147486|NCT03952650|581922474|FG000|Overall Study|Unable to make study visit|0|||
161271897|NCT00620659|582375278|FG001|Treatment Period 3|Adverse Event|2|||
161271898|NCT00620659|582375279|FG002|Treatment Period 3|Adverse Event|0|||
161271899|NCT00620659|582375280|FG003|Treatment Period 3|Adverse Event|0|||
161271900|NCT00620659|582375281|FG004|Treatment Period 3|Adverse Event|0|||
161011247|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011248|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011249|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011250|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
161011251|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
161011252|NCT01898494|581428730|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011253|NCT01898494|581428731|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011254|NCT01898494|581428732|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011255|NCT01898494|581428733|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
161011256|NCT01898494|581428734|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
161011257|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161011258|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161011259|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
161011260|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
161011261|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
161011262|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161011263|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161011264|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
161011265|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
161011266|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
161011267|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
161011268|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
161011269|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
161011270|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
161011271|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
161011272|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011273|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
161011274|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011275|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011276|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
161011277|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011278|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011279|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
161011280|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011281|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
161011282|NCT01898494|581428730|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
161011283|NCT01898494|581428731|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
161011284|NCT01898494|581428732|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
161011285|NCT01898494|581428733|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
161011286|NCT01898494|581428734|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
161011287|NCT04732494|581428735|FG000|Overall Study|Death|39|||
161011288|NCT04732494|581428736|FG001|Overall Study|Death|36|||
161011289|NCT04732494|581428735|FG000|Overall Study|Study Closed by Sponsor|20|||
161011290|NCT04732494|581428736|FG001|Overall Study|Study Closed by Sponsor|15|||
161011291|NCT04732494|581428735|FG000|Overall Study|Withdrawal by Subject|2|||
161011292|NCT04732494|581428736|FG001|Overall Study|Withdrawal by Subject|7|||
161011293|NCT04732494|581428735|FG000|Overall Study|Lost to Follow-up|1|||
161011294|NCT04732494|581428736|FG001|Overall Study|Lost to Follow-up|5|||
161011295|NCT03055858|581428737|FG000|Overall Study|Death|9|||
161011296|NCT03055858|581428737|FG000|Overall Study|Withdrawal by Subject|11|||
161011297|NCT03055858|581428737|FG000|Overall Study|Lost to Follow-up|6|||
161011298|NCT03055858|581428737|FG000|Overall Study|Missed Follow-Up Visits|18|||
161011299|NCT05136404|581428738|FG000|Period 1|Adverse Event|0|||
161011300|NCT05136404|581428739|FG001|Period 1|Adverse Event|1|||
161011301|NCT05136404|581428740|FG002|Period 1|Adverse Event|1|||
161011302|NCT05136404|581428738|FG000|Period 2|Inappropriate Behavior|0|||
161011303|NCT05136404|581428739|FG001|Period 2|Inappropriate Behavior|0|||
161011304|NCT05136404|581428740|FG002|Period 2|Inappropriate Behavior|1|||
161011305|NCT05136404|581428738|FG000|Period 3|Adverse Event|0|||
161011306|NCT05136404|581428739|FG001|Period 3|Adverse Event|0|||
161011307|NCT05136404|581428740|FG002|Period 3|Adverse Event|1|||
161011308|NCT02553642|581428746|FG000|Overall Study|Withdrawal by Subject|0|||
161011309|NCT02553642|581428747|FG001|Overall Study|Withdrawal by Subject|3|||
161011310|NCT02553642|581428746|FG000|Overall Study|Physician Decision|0|||
161011311|NCT02553642|581428747|FG001|Overall Study|Physician Decision|1|||
161011312|NCT02553642|581428746|FG000|Overall Study|Additional cancer dx|0|||
161011313|NCT02553642|581428747|FG001|Overall Study|Additional cancer dx|1|||
161011314|NCT02553642|581428746|FG000|Overall Study|Never started treatment|0|||
161011315|NCT02553642|581428747|FG001|Overall Study|Never started treatment|1|||
161011316|NCT01820260|581428753|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011317|NCT01820260|581428754|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011318|NCT01820260|581428755|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161271901|NCT00620659|582375282|FG005|Treatment Period 3|Adverse Event|0|||
161271902|NCT00620659|582375277|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161011319|NCT01820260|581428756|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011320|NCT01820260|581428757|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011321|NCT01820260|581428758|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011322|NCT01820260|581428759|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
161011323|NCT01820260|581428760|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011324|NCT01820260|581428761|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011325|NCT01820260|581428762|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011326|NCT01820260|581428763|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011327|NCT01820260|581428764|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011328|NCT01820260|581428765|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011329|NCT01820260|581428766|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
161011330|NCT01820260|581428753|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011331|NCT01820260|581428754|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011332|NCT01820260|581428755|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011333|NCT01820260|581428756|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011334|NCT01820260|581428757|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011335|NCT01820260|581428758|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011336|NCT01820260|581428759|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011337|NCT01820260|581428760|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011338|NCT01820260|581428761|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011339|NCT01820260|581428762|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
161011340|NCT01820260|581428763|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011341|NCT01820260|581428764|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011342|NCT01820260|581428765|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011343|NCT01820260|581428766|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
161011344|NCT05444192|581428767|FG000|Overall Study|Lost to Follow-up|1|||
161011345|NCT05444192|581428768|FG001|Overall Study|Lost to Follow-up|0|||
161011346|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
161011347|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
161011348|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
161011349|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
161011350|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
161011351|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
161011352|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011353|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011354|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011355|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
161011356|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
161011357|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011358|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011359|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011360|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
161011361|NCT04424927|581428772|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
161011362|NCT04424927|581428773|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011363|NCT04424927|581428774|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011364|NCT04424927|581428775|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011365|NCT04424927|581428776|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
161011366|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161011367|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
161011368|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
161011369|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161011370|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
161011371|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
161011372|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
161011373|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
161011374|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
161011375|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
161011376|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161011377|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
161147487|NCT03952650|581922475|FG001|Overall Study|Unable to make study visit|0|||
161011378|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161011379|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
161011380|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
161147488|NCT03952650|581922476|FG002|Overall Study|Unable to make study visit|0|||
161271903|NCT00620659|582375278|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161011381|NCT04424927|581428772|FG000|Double-blind Period (24 Weeks)|Other|0|||
161011382|NCT04424927|581428773|FG001|Double-blind Period (24 Weeks)|Other|1|||
161011383|NCT04424927|581428774|FG002|Double-blind Period (24 Weeks)|Other|3|||
161011384|NCT04424927|581428775|FG003|Double-blind Period (24 Weeks)|Other|1|||
161011385|NCT04424927|581428776|FG004|Double-blind Period (24 Weeks)|Other|0|||
161011386|NCT00505934|581428777|FG000|Overall Study|Adverse Event|1|||
161011387|NCT00505934|581428777|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
161011388|NCT00505934|581428777|FG000|Overall Study|Other: IV dose needed to be changed|1|||
161011389|NCT01121991|581428780|FG000|Overall Study|Lack of Ovarian Response|2|||
161011390|NCT01121991|581428780|FG000|Overall Study|No Oocytes Retrieved|3|||
161011391|NCT01121991|581428780|FG000|Overall Study|No Fertilization|1|||
161011392|NCT01619410|581428781|FG000|Overall Study|Lost to Follow-up|7|||
161011393|NCT01619410|581428782|FG001|Overall Study|Lost to Follow-up|4|||
161011394|NCT01000480|581428783|FG000|Induction Phase|Adverse Event|2|||
161011395|NCT01000480|581428783|FG000|Induction Phase|Lost to Follow-up|1|||
161011396|NCT01000480|581428783|FG000|Induction Phase|Physician Decision|1|||
161011397|NCT01000480|581428783|FG000|Induction Phase|Entry Criteria Not Met|3|||
161011398|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Adverse Event|4|||
161011399|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
161011400|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
161011401|NCT01000480|581428783|FG000|Concurrent Therapy Phase|Physician Decision|1|||
161011402|NCT03655262|581428788|FG000|Overall Study|Withdrawal by Subject|0|||
161011403|NCT03655262|581428789|FG001|Overall Study|Withdrawal by Subject|0|||
161011404|NCT03655262|581428790|FG002|Overall Study|Withdrawal by Subject|1|||
161147489|NCT03952650|581922477|FG003|Overall Study|Unable to make study visit|0|||
161147490|NCT03952650|581922478|FG004|Overall Study|Unable to make study visit|0|||
161147491|NCT03952650|581922479|FG005|Overall Study|Unable to make study visit|1|||
161011408|NCT03330795|581428797|FG000|Overall Study|Death|3|||
161011409|NCT03330795|581428797|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
161011410|NCT05782231|581428798|FG000|Overall Study|Withdrawal by Subject|1|||
161011411|NCT02252172|581428799|FG000|Overall Study|Lost to Follow-up|9|||
161011412|NCT02252172|581428800|FG001|Overall Study|Lost to Follow-up|6|||
161011413|NCT02252172|581428799|FG000|Overall Study|Death|218|||
161011414|NCT02252172|581428800|FG001|Overall Study|Death|175|||
161147492|NCT03952650|581922480|FG006|Overall Study|Unable to make study visit|0|||
161147493|NCT02234583|581922485|FG000|Overall Study|Adverse Event|172|||
161271904|NCT00620659|582375279|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161271905|NCT00620659|582375280|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161271906|NCT00620659|582375281|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161271907|NCT00620659|582375282|FG005|Treatment Period 3|Withdrawal by Subject|0|||
161271908|NCT03246646|582375285|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
161271909|NCT03246646|582375286|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
161271910|NCT03246646|582375285|FG000|Overall Study|Withdrawal by Subject|3|||
161271911|NCT03246646|582375286|FG001|Overall Study|Withdrawal by Subject|0|||
161271912|NCT03246646|582375285|FG000|Overall Study|Lost to Follow-up|7|||
161271913|NCT03246646|582375286|FG001|Overall Study|Lost to Follow-up|0|||
161271914|NCT02201290|582375291|FG000|Overall Study|Withdrawal by Subject|2|||
161011415|NCT02252172|581428799|FG000|Overall Study|Withdrawal by Subject|20|||
161011416|NCT02252172|581428800|FG001|Overall Study|Withdrawal by Subject|15|||
161011417|NCT02252172|581428799|FG000|Overall Study|Physician Decision|0|||
161011418|NCT02252172|581428800|FG001|Overall Study|Physician Decision|1|||
161011419|NCT02252172|581428799|FG000|Overall Study|End of data collection|122|||
161011420|NCT02252172|581428800|FG001|Overall Study|End of data collection|170|||
161011421|NCT02252172|581428799|FG000|Overall Study|Site closure|0|||
161011422|NCT02252172|581428800|FG001|Overall Study|Site closure|1|||
161011423|NCT05575076|581428801|FG000|Overall Study|Adverse Event|24|||
161011424|NCT05575076|581428801|FG000|Overall Study|Death|7|||
161011425|NCT05575076|581428801|FG000|Overall Study|Lost to Follow-up|16|||
161011426|NCT05575076|581428801|FG000|Overall Study|Non-Compliance|3|||
161011427|NCT05575076|581428801|FG000|Overall Study|Physician Decision|6|||
161011428|NCT05575076|581428801|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
161271915|NCT02201290|582375291|FG000|Overall Study|Lack of Efficacy|2|||
161011429|NCT05575076|581428801|FG000|Overall Study|Withdrawal by Subject|71|||
161011430|NCT05575076|581428801|FG000|Overall Study|Study Terminated by Sponsor|630|||
161011431|NCT05575076|581428801|FG000|Overall Study|Other|17|||
161011432|NCT03830866|581428802|FG000|Overall Study|Death|90|||
161011433|NCT03830866|581428803|FG001|Overall Study|Death|111|||
161011434|NCT03830866|581428802|FG000|Overall Study|Lost to Follow-up|7|||
161011435|NCT03830866|581428803|FG001|Overall Study|Lost to Follow-up|7|||
161011436|NCT03830866|581428802|FG000|Overall Study|Withdrawal by Subject|19|||
161011437|NCT03830866|581428803|FG001|Overall Study|Withdrawal by Subject|16|||
161011438|NCT03830866|581428802|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
161011439|NCT03830866|581428803|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
161011440|NCT03830866|581428802|FG000|Overall Study|Other|1|||
161271916|NCT02201290|582375291|FG000|Overall Study|Adverse Event|1|||
161271917|NCT04639713|582375294|FG000|Overall Study|Protocol Noncompliance|2|||
161011441|NCT03830866|581428803|FG001|Overall Study|Other|1|||
161011442|NCT02376790|581428813|FG000|Overall Study|Withdrawal by Subject|43|||
161011443|NCT02376790|581428814|FG001|Overall Study|Withdrawal by Subject|36|||
161011444|NCT02376790|581428815|FG002|Overall Study|Withdrawal by Subject|37|||
161011445|NCT02376790|581428813|FG000|Overall Study|Decision by Sponsor|2|||
161011446|NCT02376790|581428814|FG001|Overall Study|Decision by Sponsor|1|||
161011447|NCT02376790|581428815|FG002|Overall Study|Decision by Sponsor|4|||
161011448|NCT02376790|581428813|FG000|Overall Study|Lost to Follow-up|15|||
161011449|NCT02376790|581428814|FG001|Overall Study|Lost to Follow-up|10|||
161011450|NCT02376790|581428815|FG002|Overall Study|Lost to Follow-up|12|||
161011451|NCT00988858|581428816|FG000|Overall Study|Adverse Event|7|||
161011452|NCT00988858|581428816|FG000|Overall Study|Death|1|||
161011453|NCT00988858|581428816|FG000|Overall Study|Physician Decision|1|||
161011454|NCT00988858|581428816|FG000|Overall Study|Sponsor Decision|1|||
161011455|NCT03014453|581428817|FG000|Overall Study|Lost to Follow-up|12|||
161011456|NCT03014453|581428817|FG000|Overall Study|Discontinued GER|3|||
161011457|NCT03014453|581428817|FG000|Overall Study|Excluded|19|||
161011458|NCT03014453|581428817|FG000|Overall Study|Refused to take part in|37|||
161011459|NCT02238483|581428818|FG000|Overall Study|Withdrawal by Subject|2|||
161011460|NCT02238483|581428819|FG001|Overall Study|Withdrawal by Subject|7|||
161011461|NCT02238483|581428818|FG000|Overall Study|Lost to Follow-up|1|||
161147494|NCT02234583|581922486|FG001|Overall Study|Adverse Event|156|||
161147495|NCT02234583|581922485|FG000|Overall Study|Withdrawal by Subject|109|||
161147496|NCT02234583|581922486|FG001|Overall Study|Withdrawal by Subject|157|||
161147497|NCT02234583|581922485|FG000|Overall Study|Lost to Follow-up|0|||
161147498|NCT02234583|581922486|FG001|Overall Study|Lost to Follow-up|1|||
161147499|NCT02234583|581922485|FG000|Overall Study|Lack of Efficacy|58|||
161147500|NCT02234583|581922486|FG001|Overall Study|Lack of Efficacy|103|||
161147501|NCT02234583|581922485|FG000|Overall Study|Protocol Violation|35|||
161147502|NCT02234583|581922486|FG001|Overall Study|Protocol Violation|42|||
161147503|NCT02234583|581922485|FG000|Overall Study|Other|39|||
161147504|NCT02234583|581922486|FG001|Overall Study|Other|97|||
161147505|NCT01849250|581922487|FG000|Overall Study|Withdrawal by Subject|1|||
161147506|NCT01849250|581922488|FG001|Overall Study|Withdrawal by Subject|0|||
161147507|NCT01849250|581922487|FG000|Overall Study|Not Evaluable|5|||
161147508|NCT01849250|581922488|FG001|Overall Study|Not Evaluable|3|||
161147509|NCT01849250|581922487|FG000|Overall Study|Screen Failure|1|||
161147510|NCT01849250|581922488|FG001|Overall Study|Screen Failure|0|||
161147511|NCT04504032|581922491|FG000|Overall Study|Adverse Event|1|||
161147512|NCT04504032|581922492|FG001|Overall Study|Adverse Event|2|||
161147513|NCT04504032|581922491|FG000|Overall Study|Lost to Follow-up|6|||
161147514|NCT04504032|581922492|FG001|Overall Study|Lost to Follow-up|9|||
161147515|NCT04504032|581922491|FG000|Overall Study|Protocol Violation|2|||
161147516|NCT04504032|581922492|FG001|Overall Study|Protocol Violation|0|||
161147517|NCT04504032|581922491|FG000|Overall Study|Study terminated by sponsor|1|||
161147518|NCT04504032|581922492|FG001|Overall Study|Study terminated by sponsor|2|||
161147519|NCT04504032|581922491|FG000|Overall Study|Withdrawal by Subject|9|||
161147520|NCT04504032|581922492|FG001|Overall Study|Withdrawal by Subject|11|||
161147521|NCT04504032|581922491|FG000|Overall Study|Disease progression prior to dosing|15|||
161147522|NCT04504032|581922492|FG001|Overall Study|Disease progression prior to dosing|3|||
161147523|NCT04504032|581922491|FG000|Overall Study|Drug supply issues|1|||
161147524|NCT04504032|581922492|FG001|Overall Study|Drug supply issues|1|||
161147525|NCT04504032|581922491|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
161147526|NCT04504032|581922492|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
161147527|NCT00771030|581922493|FG000|Overall Study|Adverse Event|0|||
161147528|NCT00771030|581922494|FG001|Overall Study|Adverse Event|1|||
161147529|NCT00771030|581922495|FG002|Overall Study|Adverse Event|0|||
161147530|NCT00771030|581922496|FG003|Overall Study|Adverse Event|0|||
161147531|NCT00771030|581922497|FG004|Overall Study|Adverse Event|0|||
161011462|NCT02238483|581428819|FG001|Overall Study|Lost to Follow-up|1|||
161011463|NCT02238483|581428818|FG000|Overall Study|Protocol Violation|1|||
161011464|NCT02238483|581428819|FG001|Overall Study|Protocol Violation|2|||
161011465|NCT02238483|581428818|FG000|Overall Study|Death|1|||
161011466|NCT02238483|581428819|FG001|Overall Study|Death|0|||
161011467|NCT02238483|581428818|FG000|Overall Study|Adverse Event|7|||
161011468|NCT02238483|581428819|FG001|Overall Study|Adverse Event|3|||
161011469|NCT02238483|581428818|FG000|Overall Study|Withdrawn due to physician decision|1|||
161147532|NCT00771030|581922498|FG005|Overall Study|Adverse Event|0|||
161147533|NCT00771030|581922499|FG006|Overall Study|Adverse Event|0|||
161147534|NCT04156646|581922505|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
161147535|NCT04156646|581922506|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
161147536|NCT01208181|581922507|FG000|Part 1|Withdrawal by Subject|11|||
161147537|NCT01208181|581922508|FG001|Part 1|Withdrawal by Subject|10|||
161147538|NCT01208181|581922509|FG002|Part 1|Withdrawal by Subject|0|||
161147539|NCT01208181|581922510|FG003|Part 1|Withdrawal by Subject|0|||
161147540|NCT01208181|581922511|FG004|Part 1|Withdrawal by Subject|0|||
161147541|NCT01208181|581922507|FG000|Part 1|Technical problem|5|||
161011470|NCT02238483|581428819|FG001|Overall Study|Withdrawn due to physician decision|0|||
161147542|NCT01208181|581922508|FG001|Part 1|Technical problem|0|||
161011471|NCT02238483|581428818|FG000|Overall Study|Completion status not recorded|1|||
161011472|NCT02238483|581428819|FG001|Overall Study|Completion status not recorded|1|||
161011473|NCT02238483|581428818|FG000|Overall Study|Illness in family member|1|||
161011474|NCT02238483|581428819|FG001|Overall Study|Illness in family member|0|||
161011475|NCT02538341|581428827|FG000|Overall Study|Lost to Follow-up|51|||
161011476|NCT02538341|581428828|FG001|Overall Study|Lost to Follow-up|46|||
161011477|NCT02538341|581428827|FG000|Overall Study|Withdrawal by Subject|3|||
161011478|NCT02538341|581428828|FG001|Overall Study|Withdrawal by Subject|1|||
161011479|NCT02538341|581428827|FG000|Overall Study|Death|2|||
161011480|NCT02538341|581428828|FG001|Overall Study|Death|0|||
161011481|NCT03750968|581428829|FG000|Overall Study|Adverse Event|2|||
161011482|NCT03750968|581428830|FG001|Overall Study|Adverse Event|0|||
161011483|NCT03750968|581428829|FG000|Overall Study|Lost to Follow-up|1|||
161011484|NCT03750968|581428830|FG001|Overall Study|Lost to Follow-up|3|||
161011485|NCT02539225|581428833|FG000|Part A|Adverse Event|13|||
161011486|NCT02539225|581428834|FG001|Part A|Adverse Event|4|||
161011487|NCT02539225|581428833|FG000|Part A|Withdrawal by Subject|2|||
161011488|NCT02539225|581428834|FG001|Part A|Withdrawal by Subject|4|||
161011489|NCT02539225|581428833|FG000|Part A|Physician Decision|4|||
161011490|NCT02539225|581428834|FG001|Part A|Physician Decision|7|||
161011491|NCT02539225|581428833|FG000|Part A|Did Not Receive study Drug|1|||
161011492|NCT02539225|581428834|FG001|Part A|Did Not Receive study Drug|1|||
161011493|NCT02539225|581428833|FG000|Pre Treatment for Part B|Progressive disease|1|||
161011494|NCT02539225|581428834|FG001|Pre Treatment for Part B|Progressive disease|1|||
161011495|NCT02539225|581428833|FG000|Pre Treatment for Part B|Adverse Event|1|||
161011496|NCT02539225|581428834|FG001|Pre Treatment for Part B|Adverse Event|1|||
161011497|NCT02539225|581428833|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
161011498|NCT02539225|581428834|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
161011499|NCT02539225|581428833|FG000|Pre Treatment for Part B|Physician Decision|2|||
161011500|NCT02539225|581428834|FG001|Pre Treatment for Part B|Physician Decision|0|||
161011501|NCT02539225|581428833|FG000|Part B|Adverse Event|4|||
161011502|NCT02539225|581428834|FG001|Part B|Adverse Event|4|||
161011503|NCT02539225|581428833|FG000|Part B|Withdrawal by Subject|0|||
161011504|NCT02539225|581428834|FG001|Part B|Withdrawal by Subject|3|||
161011505|NCT02539225|581428833|FG000|Part B|Physician Decision|0|||
161011506|NCT02539225|581428834|FG001|Part B|Physician Decision|9|||
161011507|NCT02759016|581428835|FG000|Overall Study|Not treated with BI 836826|1|||
161011508|NCT02759016|581428836|FG001|Overall Study|Not treated with BI 836826|0|||
161011509|NCT02759016|581428835|FG000|Overall Study|Progressive disease|1|||
161011510|NCT02759016|581428836|FG001|Overall Study|Progressive disease|0|||
161011511|NCT02759016|581428835|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
161011512|NCT02759016|581428836|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
161011513|NCT02759016|581428835|FG000|Overall Study|Other not defined above|2|||
161011514|NCT02759016|581428836|FG001|Overall Study|Other not defined above|1|||
161011515|NCT02891915|581428841|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
161011516|NCT02891915|581428842|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
161011517|NCT02891915|581428841|FG000|Overall Study|Withdrawal by Subject|3|||
161011518|NCT02891915|581428842|FG001|Overall Study|Withdrawal by Subject|3|||
161011519|NCT02891915|581428841|FG000|Overall Study|Became Ineligible After Enrollment|2|||
161011520|NCT02891915|581428842|FG001|Overall Study|Became Ineligible After Enrollment|1|||
161011521|NCT02891915|581428841|FG000|Overall Study|Lost to Follow-up|1|||
161011522|NCT02891915|581428842|FG001|Overall Study|Lost to Follow-up|4|||
161011523|NCT02891915|581428841|FG000|Overall Study|Physician Decision|1|||
161011524|NCT02891915|581428842|FG001|Overall Study|Physician Decision|0|||
161011525|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
161011526|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
161011527|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
161011528|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
161011529|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
161011530|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
161011531|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
161011532|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
161011533|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
161011534|NCT03939312|581428843|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
161011535|NCT03939312|581428843|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
161011536|NCT03939312|581428843|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
161011537|NCT01609218|581428845|FG000|Period 1|Adverse Event|3|||
161011538|NCT01609218|581428846|FG001|Period 1|Adverse Event|5|||
161011539|NCT01609218|581428845|FG000|Period 1|Sponsor Decision|0|||
161011540|NCT01609218|581428846|FG001|Period 1|Sponsor Decision|1|||
161011541|NCT01609218|581428845|FG000|Period 2|Adverse Event|1|||
161271918|NCT04639713|582375294|FG000|Overall Study|Withdrawal by Subject|1|||
161271919|NCT03589768|582377518|FG000|Overall Study|Death|1|||
161011542|NCT01609218|581428846|FG001|Period 2|Adverse Event|0|||
161011543|NCT02576509|581430660|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
161011544|NCT02576509|581430661|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
161011545|NCT02576509|581430660|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161011546|NCT02576509|581430661|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
161271920|NCT03589768|582377519|FG001|Overall Study|Death|0|||
161271921|NCT03589768|582377520|FG002|Overall Study|Death|8|||
161271922|NCT03589768|582377521|FG003|Overall Study|Death|3|||
161271923|NCT03589768|582377518|FG000|Overall Study|Withdrawal by Subject|2|||
161271924|NCT03589768|582377519|FG001|Overall Study|Withdrawal by Subject|0|||
161271925|NCT03589768|582377520|FG002|Overall Study|Withdrawal by Subject|0|||
161011547|NCT02576509|581430660|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
161011548|NCT02576509|581430661|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
161011549|NCT02576509|581430660|FG000|Treatment Period|Disease progression|263|||
161011550|NCT02576509|581430661|FG001|Treatment Period|Disease progression|244|||
161011551|NCT02576509|581430660|FG000|Treatment Period|Study drug toxicity|37|||
161011552|NCT02576509|581430661|FG001|Treatment Period|Study drug toxicity|41|||
161011553|NCT02576509|581430660|FG000|Treatment Period|Death|1|||
161011554|NCT02576509|581430661|FG001|Treatment Period|Death|1|||
161011555|NCT02576509|581430660|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
161011556|NCT02576509|581430661|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
161011557|NCT02576509|581430660|FG000|Treatment Period|Participant request to stop treatment|8|||
161011558|NCT02576509|581430661|FG001|Treatment Period|Participant request to stop treatment|18|||
161011559|NCT02576509|581430660|FG000|Treatment Period|Participant withdrew consent|3|||
161011560|NCT02576509|581430661|FG001|Treatment Period|Participant withdrew consent|7|||
161011561|NCT02576509|581430660|FG000|Treatment Period|Lost to Follow-up|0|||
161011562|NCT02576509|581430661|FG001|Treatment Period|Lost to Follow-up|1|||
161011563|NCT02576509|581430660|FG000|Treatment Period|Maximum clinical benefit|1|||
161011564|NCT02576509|581430661|FG001|Treatment Period|Maximum clinical benefit|0|||
161011565|NCT02576509|581430660|FG000|Treatment Period|Poor/non-compliance|1|||
161011566|NCT02576509|581430661|FG001|Treatment Period|Poor/non-compliance|1|||
161011567|NCT02576509|581430660|FG000|Treatment Period|Participant no longer meets criteria|1|||
161011568|NCT02576509|581430661|FG001|Treatment Period|Participant no longer meets criteria|0|||
161011569|NCT02576509|581430660|FG000|Treatment Period|Other reason|12|||
161011570|NCT02576509|581430661|FG001|Treatment Period|Other reason|8|||
161011571|NCT02576509|581430660|FG000|Treatment Period|NOT REPORTED|1|||
161011572|NCT02576509|581430661|FG001|Treatment Period|NOT REPORTED|0|||
161147543|NCT01208181|581922509|FG002|Part 1|Technical problem|0|||
161147544|NCT01208181|581922510|FG003|Part 1|Technical problem|0|||
161147545|NCT01208181|581922511|FG004|Part 1|Technical problem|0|||
161147546|NCT01208181|581922507|FG000|Part 1|Protocol Violation|10|||
161147547|NCT01208181|581922508|FG001|Part 1|Protocol Violation|5|||
161147548|NCT01208181|581922509|FG002|Part 1|Protocol Violation|0|||
161147549|NCT01208181|581922510|FG003|Part 1|Protocol Violation|0|||
161147550|NCT01208181|581922511|FG004|Part 1|Protocol Violation|0|||
161147551|NCT01208181|581922507|FG000|Part 1|Physician Decision|4|||
161147552|NCT01208181|581922508|FG001|Part 1|Physician Decision|0|||
161147553|NCT01208181|581922509|FG002|Part 1|Physician Decision|0|||
161147554|NCT01208181|581922510|FG003|Part 1|Physician Decision|0|||
161147555|NCT01208181|581922511|FG004|Part 1|Physician Decision|0|||
161147556|NCT01208181|581922507|FG000|Part 1|Non-compliance with study drug|1|||
161147557|NCT01208181|581922508|FG001|Part 1|Non-compliance with study drug|1|||
161147558|NCT01208181|581922509|FG002|Part 1|Non-compliance with study drug|0|||
161147559|NCT01208181|581922510|FG003|Part 1|Non-compliance with study drug|0|||
161147560|NCT01208181|581922511|FG004|Part 1|Non-compliance with study drug|0|||
161147561|NCT01208181|581922507|FG000|Part 1|Lost to Follow-up|5|||
161147562|NCT01208181|581922508|FG001|Part 1|Lost to Follow-up|3|||
161147563|NCT01208181|581922509|FG002|Part 1|Lost to Follow-up|0|||
161147564|NCT01208181|581922510|FG003|Part 1|Lost to Follow-up|0|||
161147565|NCT01208181|581922511|FG004|Part 1|Lost to Follow-up|1|||
161147566|NCT01208181|581922507|FG000|Part 1|Lack of Efficacy|37|||
161147567|NCT01208181|581922508|FG001|Part 1|Lack of Efficacy|12|||
161147568|NCT01208181|581922509|FG002|Part 1|Lack of Efficacy|0|||
161271926|NCT03589768|582377521|FG003|Overall Study|Withdrawal by Subject|0|||
161343531|NCT00207740|582644407|FG001|Overall Study|Adverse Event|14|||
161011573|NCT02576509|581430660|FG000|Treatment Period|Administrative reason by sponsor|0|||
161011574|NCT02576509|581430661|FG001|Treatment Period|Administrative reason by sponsor|1|||
161011575|NCT00212355|581430662|FG000|Overall Study|Adverse Event|1|||
161011576|NCT00212355|581430662|FG000|Overall Study|Withdrawal by Subject|1|||
161147569|NCT01208181|581922510|FG003|Part 1|Lack of Efficacy|0|||
161147570|NCT01208181|581922511|FG004|Part 1|Lack of Efficacy|17|||
161147571|NCT01208181|581922507|FG000|Part 1|Adverse Event|26|||
161147572|NCT01208181|581922508|FG001|Part 1|Adverse Event|24|||
161147573|NCT01208181|581922509|FG002|Part 1|Adverse Event|0|||
161147574|NCT01208181|581922510|FG003|Part 1|Adverse Event|0|||
161147575|NCT01208181|581922511|FG004|Part 1|Adverse Event|4|||
161147576|NCT01208181|581922507|FG000|Part 2|Adverse Event|0|||
161147577|NCT01208181|581922508|FG001|Part 2|Adverse Event|0|||
161147578|NCT01208181|581922509|FG002|Part 2|Adverse Event|6|||
161147579|NCT01208181|581922510|FG003|Part 2|Adverse Event|7|||
161147580|NCT01208181|581922511|FG004|Part 2|Adverse Event|0|||
161271927|NCT03589768|582377518|FG000|Overall Study|Protocol Violation|1|||
161343532|NCT00207740|582644408|FG002|Overall Study|Adverse Event|14|||
161011577|NCT00212355|581430662|FG000|Overall Study|A change of address|1|||
161011578|NCT00186992|581430668|FG000|Overall Study|Withdrawal by Subject|5|||
161011579|NCT00186992|581430668|FG000|Overall Study|Physician's discretion|13|||
161011580|NCT00186992|581430668|FG000|Overall Study|PI Discretion|4|||
161011581|NCT00186992|581430668|FG000|Overall Study|Ineligible|2|||
161011582|NCT00186992|581430668|FG000|Overall Study|Lost to Follow-up|2|||
161011583|NCT00186992|581430668|FG000|Overall Study|Still on Study|9|||
161011584|NCT05104697|581430669|FG000|Overall Study|Withdrawal by Subject|0|||
161011585|NCT05104697|581430670|FG001|Overall Study|Withdrawal by Subject|1|||
161011586|NCT03913195|581430671|FG000|Overall Study|Adverse Event|0|||
161011587|NCT03913195|581430672|FG001|Overall Study|Adverse Event|0|||
161011588|NCT03913195|581430673|FG002|Overall Study|Adverse Event|1|||
161011589|NCT03913195|581430674|FG003|Overall Study|Adverse Event|1|||
161011590|NCT03913195|581430675|FG004|Overall Study|Adverse Event|0|||
161011591|NCT03913195|581430671|FG000|Overall Study|Withdrawal by Subject|0|||
161011592|NCT03913195|581430672|FG001|Overall Study|Withdrawal by Subject|0|||
161011593|NCT03913195|581430673|FG002|Overall Study|Withdrawal by Subject|1|||
161011594|NCT03913195|581430674|FG003|Overall Study|Withdrawal by Subject|0|||
161011595|NCT03913195|581430675|FG004|Overall Study|Withdrawal by Subject|1|||
161011596|NCT03913195|581430671|FG000|Overall Study|non adherence to study|0|||
161011597|NCT03913195|581430672|FG001|Overall Study|non adherence to study|0|||
161011598|NCT03913195|581430673|FG002|Overall Study|non adherence to study|1|||
161011599|NCT03913195|581430674|FG003|Overall Study|non adherence to study|0|||
161011600|NCT03913195|581430675|FG004|Overall Study|non adherence to study|0|||
161011601|NCT03899961|581430676|FG000|Overall Study|-delivery prior to|2|||
161011602|NCT03899961|581430677|FG001|Overall Study|-delivery prior to|7|||
161011603|NCT03899961|581430676|FG000|Overall Study|req general anesth|1|||
161011604|NCT03899961|581430677|FG001|Overall Study|req general anesth|2|||
161011605|NCT03899961|581430676|FG000|Overall Study|capacity|5|||
161011606|NCT03899961|581430677|FG001|Overall Study|capacity|6|||
161011607|NCT03899961|581430676|FG000|Overall Study|Withdrawal by Subject|1|||
161011608|NCT03899961|581430677|FG001|Overall Study|Withdrawal by Subject|1|||
161011609|NCT05307978|581430678|FG000|Overall Study|Lost to Follow-up|0|||
161011610|NCT05307978|581430679|FG001|Overall Study|Lost to Follow-up|1|||
161011611|NCT05307978|581430680|FG002|Overall Study|Lost to Follow-up|0|||
161011612|NCT05307978|581430681|FG003|Overall Study|Lost to Follow-up|4|||
161011613|NCT05307978|581430682|FG004|Overall Study|Lost to Follow-up|0|||
161011614|NCT05307978|581430683|FG005|Overall Study|Lost to Follow-up|0|||
161011615|NCT05307978|581430684|FG006|Overall Study|Lost to Follow-up|1|||
161011616|NCT03416023|581430685|FG000|Overall Study|Exclusion criteria failure|1|||
161011617|NCT03416023|581430685|FG000|Overall Study|Withdrawal by Subject|6|||
161011618|NCT03416023|581430685|FG000|Overall Study|Explanted|7|||
161011619|NCT03416023|581430685|FG000|Overall Study|Physician Decision|1|||
161011620|NCT03416023|581430685|FG000|Overall Study|Lost to Follow-up|1|||
161011621|NCT03416023|581430685|FG000|Overall Study|Death|1|||
161011622|NCT03651895|581430686|FG000|First Drug Assignment|Adverse Event|4|||
161011623|NCT03651895|581430687|FG001|First Drug Assignment|Adverse Event|5|||
161011624|NCT03651895|581430686|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
161011625|NCT03651895|581430687|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
161011626|NCT02837510|581430688|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161011627|NCT02837510|581430689|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
161011628|NCT02837510|581430688|FG000|Washout (2 Weeks)|Adverse Event|0|||
161011629|NCT02837510|581430689|FG001|Washout (2 Weeks)|Adverse Event|1|||
161011630|NCT02837510|581430688|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161011631|NCT02837510|581430689|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
161011632|NCT02837510|581430688|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
161011633|NCT02837510|581430689|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
161011634|NCT02837510|581430688|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
161011635|NCT02837510|581430689|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
161011636|NCT02837510|581430688|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
161011637|NCT02837510|581430689|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
161011638|NCT05510232|581430690|FG000|Overall Study|Withdrawal by Subject|2|||
161011639|NCT05510232|581430691|FG001|Overall Study|Withdrawal by Subject|7|||
161011640|NCT05510232|581430692|FG002|Overall Study|Withdrawal by Subject|6|||
161011641|NCT04468776|581430702|FG000|Overall Study|Lost to Follow-up|4|||
161011642|NCT04468776|581430703|FG001|Overall Study|Lost to Follow-up|3|||
161011643|NCT04468776|581430704|FG002|Overall Study|Lost to Follow-up|4|||
161011644|NCT04468776|581430702|FG000|Overall Study|Withdrawal by Subject|1|||
161011645|NCT04468776|581430703|FG001|Overall Study|Withdrawal by Subject|10|||
161343533|NCT00207740|582644409|FG003|Overall Study|Adverse Event|11|||
161011646|NCT04468776|581430704|FG002|Overall Study|Withdrawal by Subject|4|||
161011647|NCT04468776|581430702|FG000|Overall Study|Physician Decision|0|||
161011648|NCT04468776|581430703|FG001|Overall Study|Physician Decision|1|||
161011649|NCT04468776|581430704|FG002|Overall Study|Physician Decision|1|||
161011650|NCT03857620|581430708|FG000|Overall Study|Death|4|||
161011651|NCT03857620|581430709|FG001|Overall Study|Death|5|||
161011652|NCT03857620|581430710|FG002|Overall Study|Death|7|||
161011653|NCT03857620|581430708|FG000|Overall Study|Lost to Follow-up|2|||
161011654|NCT03857620|581430709|FG001|Overall Study|Lost to Follow-up|5|||
161011655|NCT03857620|581430710|FG002|Overall Study|Lost to Follow-up|3|||
161011656|NCT03857620|581430708|FG000|Overall Study|Disease progression or relapse after study registration|1|||
161011657|NCT03857620|581430709|FG001|Overall Study|Disease progression or relapse after study registration|5|||
161011658|NCT03857620|581430710|FG002|Overall Study|Disease progression or relapse after study registration|1|||
161011659|NCT03857620|581430708|FG000|Overall Study|Ineligible|5|||
161011660|NCT03857620|581430709|FG001|Overall Study|Ineligible|0|||
161011661|NCT03857620|581430710|FG002|Overall Study|Ineligible|2|||
161011662|NCT03857620|581430708|FG000|Overall Study|No malignancy|1|||
161011663|NCT03857620|581430709|FG001|Overall Study|No malignancy|0|||
161011664|NCT03857620|581430710|FG002|Overall Study|No malignancy|1|||
161011665|NCT03857620|581430708|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
161011666|NCT03857620|581430709|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
161011667|NCT03857620|581430710|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
161011668|NCT03857620|581430708|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
161011669|NCT03857620|581430709|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
161011670|NCT03857620|581430710|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
161011671|NCT03857620|581430708|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161011672|NCT03857620|581430709|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
161011673|NCT03857620|581430710|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
161011674|NCT03857620|581430708|FG000|Overall Study|Surgery not performed, patient decision|0|||
161011675|NCT03857620|581430709|FG001|Overall Study|Surgery not performed, patient decision|3|||
161011676|NCT03857620|581430710|FG002|Overall Study|Surgery not performed, patient decision|1|||
161011677|NCT03857620|581430708|FG000|Overall Study|Surgery not performed, other reason|3|||
161011678|NCT03857620|581430709|FG001|Overall Study|Surgery not performed, other reason|1|||
161011679|NCT03857620|581430710|FG002|Overall Study|Surgery not performed, other reason|4|||
161011680|NCT03857620|581430708|FG000|Overall Study|Worsening performance status after surgery performed|0|||
161011681|NCT03857620|581430709|FG001|Overall Study|Worsening performance status after surgery performed|1|||
161011682|NCT03857620|581430710|FG002|Overall Study|Worsening performance status after surgery performed|1|||
161011683|NCT04118452|581430711|FG000|Overall Study|Lost to Follow-up|5|||
161011684|NCT04118452|581430712|FG001|Overall Study|Lost to Follow-up|5|||
161011685|NCT04118452|581430711|FG000|Overall Study|Withdrawal by Subject|17|||
161011686|NCT04118452|581430712|FG001|Overall Study|Withdrawal by Subject|17|||
161011687|NCT03433339|581430713|FG000|Overall Study|Lost to Follow-up|2|||
161271928|NCT03589768|582377519|FG001|Overall Study|Protocol Violation|0|||
161011688|NCT03433339|581430714|FG001|Overall Study|Lost to Follow-up|0|||
161011689|NCT03433339|581430713|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
161011690|NCT03433339|581430714|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
161011691|NCT03433339|581430713|FG000|Overall Study|Withdrawal by Subject|0|||
161011692|NCT03433339|581430714|FG001|Overall Study|Withdrawal by Subject|2|||
161011693|NCT04905407|581430719|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
161011694|NCT04905407|581430720|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
161011695|NCT04905407|581430721|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
161011696|NCT04905407|581430722|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
161011697|NCT04905407|581430719|FG000|Part 1 and Part 2|Death|7|||
161011698|NCT04905407|581430720|FG001|Part 1 and Part 2|Death|7|||
161011699|NCT04905407|581430721|FG002|Part 1 and Part 2|Death|7|||
161011700|NCT04905407|581430722|FG003|Part 1 and Part 2|Death|0|||
161011701|NCT04905407|581430719|FG000|Part 1 and Part 2|Other than specified|0|||
161011702|NCT04905407|581430720|FG001|Part 1 and Part 2|Other than specified|0|||
161011703|NCT04905407|581430721|FG002|Part 1 and Part 2|Other than specified|1|||
161011704|NCT04905407|581430722|FG003|Part 1 and Part 2|Other than specified|0|||
161011705|NCT04905407|581430719|FG000|Part 3|Death|0|||
161011706|NCT04905407|581430720|FG001|Part 3|Death|0|||
161011707|NCT04905407|581430721|FG002|Part 3|Death|0|||
161011708|NCT04905407|581430722|FG003|Part 3|Death|2|||
161011709|NCT04868110|581430729|FG000|Overall Study|Withdrawal by Subject|3|||
161011710|NCT04868110|581430730|FG001|Overall Study|Withdrawal by Subject|4|||
161011711|NCT01046136|581430735|FG000|Overall Study|Withdrawal by Subject|0|||
161011712|NCT01046136|581430736|FG001|Overall Study|Withdrawal by Subject|4|||
161271929|NCT03589768|582377520|FG002|Overall Study|Protocol Violation|0|||
161011713|NCT01046136|581430735|FG000|Overall Study|Physician Decision|1|||
161011714|NCT01046136|581430736|FG001|Overall Study|Physician Decision|1|||
161011715|NCT01046136|581430735|FG000|Overall Study|Lost to Follow-up|3|||
161011716|NCT01046136|581430736|FG001|Overall Study|Lost to Follow-up|3|||
161011717|NCT02058108|581430737|FG000|Overall Study|Abnormal Laboratory Values|0|||
161011718|NCT02058108|581430738|FG001|Overall Study|Abnormal Laboratory Values|1|||
161011719|NCT02058108|581430737|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
161011720|NCT02058108|581430738|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
161011721|NCT02058108|581430737|FG000|Overall Study|No longer requires study drug|0|||
161011722|NCT02058108|581430738|FG001|Overall Study|No longer requires study drug|1|||
161011723|NCT02058108|581430737|FG000|Overall Study|Withdrawal by Subject|1|||
161011724|NCT02058108|581430738|FG001|Overall Study|Withdrawal by Subject|0|||
161011725|NCT02058108|581430737|FG000|Overall Study|Administrative problems|3|||
161011726|NCT02058108|581430738|FG001|Overall Study|Administrative problems|3|||
161011727|NCT02058108|581430737|FG000|Overall Study|Protocol Violation|0|||
161011728|NCT02058108|581430738|FG001|Overall Study|Protocol Violation|1|||
161011729|NCT01376700|581430742|FG000|Overall Study|Sponsor terminated study early|8|||
161271930|NCT03589768|582377521|FG003|Overall Study|Protocol Violation|0|||
161271931|NCT00191113|582377524|FG000|Core Study|Withdrawal by Subject|25|||
161271932|NCT00191113|582377525|FG001|Core Study|Withdrawal by Subject|9|||
161271933|NCT00191113|582377524|FG000|Core Study|Protocol Violation|6|||
161271934|NCT00191113|582377525|FG001|Core Study|Protocol Violation|2|||
161271935|NCT00191113|582377524|FG000|Core Study|Lost to Follow-up|3|||
161011730|NCT01376700|581430742|FG000|Overall Study|Low or high titer inhibitor|8|||
161011731|NCT00727909|581430743|FG000|Overall Study|Withdrawal by Subject|5|||
161011732|NCT00727909|581430744|FG001|Overall Study|Withdrawal by Subject|11|||
161011733|NCT00727909|581430745|FG002|Overall Study|Withdrawal by Subject|8|||
161011734|NCT00727909|581430746|FG003|Overall Study|Withdrawal by Subject|5|||
161011735|NCT00727909|581430743|FG000|Overall Study|Death|0|||
161011736|NCT00727909|581430744|FG001|Overall Study|Death|0|||
161011737|NCT00727909|581430745|FG002|Overall Study|Death|1|||
161011738|NCT00727909|581430746|FG003|Overall Study|Death|0|||
161011739|NCT01696773|581430747|FG000|Days 15-27, Washout|Adverse Event|1|||
161011740|NCT01696773|581430748|FG001|Days 15-27, Washout|Adverse Event|0|||
161011741|NCT03446157|581430749|FG000|Overall Study|Death|11|||
161011742|NCT03446157|581430750|FG001|Overall Study|Death|9|||
161011743|NCT03446157|581430749|FG000|Overall Study|Lost to Follow-up|0|||
161011744|NCT03446157|581430750|FG001|Overall Study|Lost to Follow-up|1|||
161011745|NCT03446157|581430749|FG000|Overall Study|Withdrawal by Subject|2|||
161011746|NCT03446157|581430750|FG001|Overall Study|Withdrawal by Subject|1|||
161011747|NCT02386553|581430751|FG000|Overall Study|Reason Not Specified|1|||
161011748|NCT02386553|581430752|FG001|Overall Study|Reason Not Specified|1|||
161011749|NCT02386553|581430751|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
161011750|NCT02386553|581430752|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
161147581|NCT01208181|581922507|FG000|Part 2|Withdrawal by Subject|0|||
161147582|NCT01208181|581922508|FG001|Part 2|Withdrawal by Subject|0|||
161147583|NCT01208181|581922509|FG002|Part 2|Withdrawal by Subject|1|||
161147584|NCT01208181|581922510|FG003|Part 2|Withdrawal by Subject|1|||
161147585|NCT01208181|581922511|FG004|Part 2|Withdrawal by Subject|0|||
161147586|NCT01208181|581922507|FG000|Part 2|Protocol Violation|0|||
161147587|NCT01208181|581922508|FG001|Part 2|Protocol Violation|0|||
161147588|NCT01208181|581922509|FG002|Part 2|Protocol Violation|1|||
161147589|NCT01208181|581922510|FG003|Part 2|Protocol Violation|0|||
161147590|NCT01208181|581922511|FG004|Part 2|Protocol Violation|0|||
161147591|NCT01208181|581922507|FG000|Part 2|Physician Decision|0|||
161147592|NCT01208181|581922508|FG001|Part 2|Physician Decision|0|||
161147593|NCT01208181|581922509|FG002|Part 2|Physician Decision|1|||
161147594|NCT01208181|581922510|FG003|Part 2|Physician Decision|2|||
161147595|NCT01208181|581922511|FG004|Part 2|Physician Decision|0|||
161147596|NCT01208181|581922507|FG000|Part 2|Non-compliance with study drug|0|||
161147597|NCT01208181|581922508|FG001|Part 2|Non-compliance with study drug|0|||
161147598|NCT01208181|581922509|FG002|Part 2|Non-compliance with study drug|1|||
161147599|NCT01208181|581922510|FG003|Part 2|Non-compliance with study drug|1|||
161271936|NCT00191113|582377525|FG001|Core Study|Lost to Follow-up|0|||
161271937|NCT00191113|582377524|FG000|Core Study|Adverse Event|0|||
160967688|NCT02798211|581270072|FG003|Period 2|Withdrawal of Informed Consent|2|||
160967689|NCT02798211|581270073|FG004|Period 2|Withdrawal of Informed Consent|2|||
160967690|NCT02798211|581270074|FG005|Period 2|Withdrawal of Informed Consent|3|||
160967691|NCT01782872|581270075|FG000|Overall Study|Protocol Violation|0|||
160967692|NCT01782872|581270076|FG001|Overall Study|Protocol Violation|0|||
160967693|NCT01782872|581270077|FG002|Overall Study|Protocol Violation|0|||
160967694|NCT01782872|581270078|FG003|Overall Study|Protocol Violation|1|||
160967695|NCT01782872|581270075|FG000|Overall Study|Withdrawal by Subject|0|||
160967696|NCT01782872|581270076|FG001|Overall Study|Withdrawal by Subject|1|||
160967697|NCT01782872|581270077|FG002|Overall Study|Withdrawal by Subject|0|||
160967698|NCT01782872|581270078|FG003|Overall Study|Withdrawal by Subject|0|||
160967699|NCT03505476|581270079|FG000|Overall Study|Physician Decision|18|||
161011751|NCT05623345|581430761|FG000|Overall Study|Withdrawal by Subject|14|||
161011752|NCT05623345|581430762|FG001|Overall Study|Withdrawal by Subject|0|||
161011753|NCT05623345|581430763|FG002|Overall Study|Withdrawal by Subject|9|||
161011754|NCT05623345|581430764|FG003|Overall Study|Withdrawal by Subject|20|||
161147600|NCT01208181|581922511|FG004|Part 2|Non-compliance with study drug|0|||
161271938|NCT00191113|582377525|FG001|Core Study|Adverse Event|2|||
160967700|NCT03505476|581270079|FG000|Overall Study|Device Malfunctioned|101|||
161147601|NCT01208181|581922507|FG000|Part 2|Lost to Follow-up|0|||
161147602|NCT01208181|581922508|FG001|Part 2|Lost to Follow-up|0|||
161011755|NCT05623345|581430761|FG000|Overall Study|Lost to Follow-up|3|||
161147603|NCT01208181|581922509|FG002|Part 2|Lost to Follow-up|1|||
161147604|NCT01208181|581922510|FG003|Part 2|Lost to Follow-up|2|||
161271939|NCT00191113|582377524|FG000|Core Study|Lack of Efficacy|0|||
160967701|NCT03505476|581270079|FG000|Overall Study|Data Corrupt|6|||
161011756|NCT05623345|581430762|FG001|Overall Study|Lost to Follow-up|0|||
161011757|NCT05623345|581430763|FG002|Overall Study|Lost to Follow-up|7|||
161011758|NCT05623345|581430764|FG003|Overall Study|Lost to Follow-up|2|||
161011759|NCT05623345|581430761|FG000|Overall Study|Termination of Study By Sponsor|37|||
161011760|NCT05623345|581430762|FG001|Overall Study|Termination of Study By Sponsor|4|||
161011761|NCT05623345|581430763|FG002|Overall Study|Termination of Study By Sponsor|40|||
161011762|NCT05623345|581430764|FG003|Overall Study|Termination of Study By Sponsor|38|||
161011763|NCT05384730|581430765|FG000|Overall Study|Adverse Event|1|||
161011764|NCT05384730|581430766|FG001|Overall Study|Adverse Event|0|||
161011765|NCT05384730|581430765|FG000|Overall Study|Lack of social support|2|||
161011766|NCT05384730|581430766|FG001|Overall Study|Lack of social support|0|||
161011767|NCT05384730|581430765|FG000|Overall Study|Hospital readmission|2|||
161011768|NCT05384730|581430766|FG001|Overall Study|Hospital readmission|0|||
161011769|NCT05384730|581430765|FG000|Overall Study|Disease progression|5|||
161011770|NCT05384730|581430766|FG001|Overall Study|Disease progression|0|||
161011771|NCT05384730|581430765|FG000|Overall Study|Overwhelmed with College commitments|0|||
161011772|NCT05384730|581430766|FG001|Overall Study|Overwhelmed with College commitments|2|||
161011773|NCT02886286|581430775|FG000|Overall Study|pump motor stall|0|||
161011774|NCT02886286|581430776|FG001|Overall Study|pump motor stall|1|||
161011775|NCT01426412|581430777|FG000|Overall Study|Withdrawal by Subject|1|||
161011776|NCT01426412|581430778|FG001|Overall Study|Withdrawal by Subject|0|||
161011777|NCT01426412|581430779|FG002|Overall Study|Withdrawal by Subject|0|||
161011778|NCT01426412|581430780|FG003|Overall Study|Withdrawal by Subject|0|||
161011779|NCT01426412|581430781|FG004|Overall Study|Withdrawal by Subject|1|||
161011780|NCT01426412|581430782|FG005|Overall Study|Withdrawal by Subject|0|||
161011781|NCT01426412|581430783|FG006|Overall Study|Withdrawal by Subject|0|||
161011782|NCT01426412|581430784|FG007|Overall Study|Withdrawal by Subject|3|||
161011783|NCT01426412|581430785|FG008|Overall Study|Withdrawal by Subject|1|||
161011784|NCT00262301|581430788|FG000|Double-blind Phase|Lost to Follow-up|1|||
161011785|NCT00262301|581430789|FG001|Double-blind Phase|Lost to Follow-up|0|||
161011786|NCT00262301|581430790|FG002|Double-blind Phase|Lost to Follow-up|0|||
161011787|NCT00262301|581430788|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
161011788|NCT00262301|581430789|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
161011789|NCT00262301|581430790|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
161011790|NCT01017146|581430791|FG000|Overall Study|Adverse Event|11|||
161011791|NCT01017146|581430792|FG001|Overall Study|Adverse Event|1|||
161011792|NCT01017146|581430791|FG000|Overall Study|Lost to Follow-up|14|||
161011793|NCT01017146|581430792|FG001|Overall Study|Lost to Follow-up|14|||
161011794|NCT01017146|581430791|FG000|Overall Study|Noncompliance with Study Product|1|||
161011795|NCT01017146|581430792|FG001|Overall Study|Noncompliance with Study Product|1|||
161011796|NCT01017146|581430791|FG000|Overall Study|Withdrawal by Subject|32|||
161011797|NCT01017146|581430792|FG001|Overall Study|Withdrawal by Subject|16|||
161011798|NCT01017146|581430791|FG000|Overall Study|Relocation|0|||
161011799|NCT01017146|581430792|FG001|Overall Study|Relocation|4|||
161011800|NCT01017146|581430791|FG000|Overall Study|Pregnancy|2|||
161011801|NCT01017146|581430792|FG001|Overall Study|Pregnancy|1|||
161011802|NCT01017146|581430791|FG000|Overall Study|Protocol Violation|2|||
161011803|NCT01017146|581430792|FG001|Overall Study|Protocol Violation|0|||
161011804|NCT01017146|581430791|FG000|Overall Study|Took Excluded Medication|2|||
161011805|NCT01017146|581430792|FG001|Overall Study|Took Excluded Medication|0|||
161011806|NCT01017146|581430791|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161011807|NCT01017146|581430792|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
161011808|NCT01017146|581430791|FG000|Overall Study|Change in Work Situation|1|||
161011809|NCT01017146|581430792|FG001|Overall Study|Change in Work Situation|0|||
161011810|NCT00976495|581430793|FG000|Overall Study|Withdrawal by Subject|0|||
161011811|NCT00976495|581430794|FG001|Overall Study|Withdrawal by Subject|1|||
161011812|NCT00976495|581430795|FG002|Overall Study|Withdrawal by Subject|0|||
161011813|NCT04154384|581430796|FG000|Overall Study|Lost to Follow-up|24|||
161011814|NCT04154384|581430797|FG001|Overall Study|Lost to Follow-up|33|||
161011815|NCT04154384|581430798|FG002|Overall Study|Lost to Follow-up|0|||
161011816|NCT04154384|581430796|FG000|Overall Study|Withdrawal by Subject|7|||
161011817|NCT04154384|581430797|FG001|Overall Study|Withdrawal by Subject|18|||
161011818|NCT04154384|581430798|FG002|Overall Study|Withdrawal by Subject|0|||
161011819|NCT04154384|581430796|FG000|Overall Study|Missing outcome data|1|||
161011820|NCT04154384|581430797|FG001|Overall Study|Missing outcome data|0|||
161011821|NCT04154384|581430798|FG002|Overall Study|Missing outcome data|0|||
161011822|NCT04732338|581430803|FG000|Overall Study|Lost to Follow-up|3|||
161011823|NCT04732338|581430804|FG001|Overall Study|Lost to Follow-up|3|||
161011824|NCT04484935|581430806|FG000|Overall Study|Other|0|||
161011825|NCT04484935|581430807|FG001|Overall Study|Other|1|||
161011826|NCT04484935|581430806|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161011827|NCT04484935|581430807|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161011828|NCT04484935|581430806|FG000|Overall Study|Lost to Follow-up|1|||
161011829|NCT04484935|581430807|FG001|Overall Study|Lost to Follow-up|0|||
161011830|NCT04484935|581430806|FG000|Overall Study|Death|2|||
161011831|NCT04484935|581430807|FG001|Overall Study|Death|1|||
161011832|NCT02556138|581430811|FG000|Overall Study|Withdrawal by Subject|1|||
161011833|NCT05094141|581430816|FG000|Overall Study|Death|0|||
161011834|NCT05094141|581430817|FG001|Overall Study|Death|0|||
161011835|NCT05094141|581430818|FG002|Overall Study|Death|1|||
161147605|NCT01208181|581922511|FG004|Part 2|Lost to Follow-up|0|||
161147606|NCT01208181|581922507|FG000|Part 2|Lack of Efficacy|0|||
161147607|NCT01208181|581922508|FG001|Part 2|Lack of Efficacy|0|||
161147608|NCT01208181|581922509|FG002|Part 2|Lack of Efficacy|5|||
161147609|NCT01208181|581922510|FG003|Part 2|Lack of Efficacy|7|||
161147610|NCT01208181|581922511|FG004|Part 2|Lack of Efficacy|0|||
161147611|NCT01164501|581922523|FG000|Overall Study|Not treated|2|||
161147612|NCT01164501|581922524|FG001|Overall Study|Not treated|0|||
161147613|NCT01164501|581922525|FG002|Overall Study|Not treated|1|||
161147614|NCT01164501|581922523|FG000|Overall Study|Adverse Event|18|||
161147615|NCT01164501|581922524|FG001|Overall Study|Adverse Event|4|||
161147616|NCT01164501|581922525|FG002|Overall Study|Adverse Event|21|||
161147617|NCT01164501|581922523|FG000|Overall Study|Lack of Efficacy|0|||
161147618|NCT01164501|581922524|FG001|Overall Study|Lack of Efficacy|0|||
161147619|NCT01164501|581922525|FG002|Overall Study|Lack of Efficacy|1|||
161147620|NCT01164501|581922523|FG000|Overall Study|Non compliant with protocol|1|||
161147621|NCT01164501|581922524|FG001|Overall Study|Non compliant with protocol|1|||
161147622|NCT01164501|581922525|FG002|Overall Study|Non compliant with protocol|4|||
161147623|NCT01164501|581922523|FG000|Overall Study|Lost to Follow-up|3|||
161147624|NCT01164501|581922524|FG001|Overall Study|Lost to Follow-up|0|||
161147625|NCT01164501|581922525|FG002|Overall Study|Lost to Follow-up|3|||
161147626|NCT01164501|581922523|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
161147627|NCT01164501|581922524|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
161147628|NCT01164501|581922525|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
161147629|NCT01164501|581922523|FG000|Overall Study|Other reason not defined above|9|||
161147630|NCT01164501|581922524|FG001|Overall Study|Other reason not defined above|1|||
161147631|NCT01164501|581922525|FG002|Overall Study|Other reason not defined above|4|||
161147632|NCT01096667|581922526|FG000|Overall Study|Lost to Follow-up|1|||
161147633|NCT01096667|581922527|FG001|Overall Study|Lost to Follow-up|1|||
161147634|NCT01096667|581922528|FG002|Overall Study|Lost to Follow-up|1|||
161147635|NCT01096667|581922529|FG003|Overall Study|Lost to Follow-up|0|||
160967702|NCT03505476|581270079|FG000|Overall Study|Device application insufficiant|3|||
160967703|NCT01059630|581270082|FG000|Overall Study|Death|100|||
160967704|NCT01059630|581270083|FG001|Overall Study|Death|84|||
160967705|NCT01059630|581270082|FG000|Overall Study|Lost to Follow-up|4|||
160967706|NCT01059630|581270083|FG001|Overall Study|Lost to Follow-up|1|||
160967707|NCT01059630|581270082|FG000|Overall Study|Physician Decision|2|||
160967708|NCT01059630|581270083|FG001|Overall Study|Physician Decision|4|||
160967709|NCT01059630|581270082|FG000|Overall Study|Withdrawal by Subject|21|||
160967710|NCT01059630|581270083|FG001|Overall Study|Withdrawal by Subject|14|||
160967711|NCT02569437|581270084|FG000|Overall Study|Lost to Follow-up|12|||
160967712|NCT02569437|581270085|FG001|Overall Study|Lost to Follow-up|14|||
160967713|NCT00441701|581270086|FG000|Overall Study|Adverse Event|3|||
160967714|NCT00441701|581270087|FG001|Overall Study|Adverse Event|2|||
160967715|NCT00441701|581270088|FG002|Overall Study|Adverse Event|1|||
160967716|NCT00441701|581270089|FG003|Overall Study|Adverse Event|0|||
160967717|NCT00441701|581270090|FG004|Overall Study|Adverse Event|2|||
160967718|NCT00441701|581270091|FG005|Overall Study|Adverse Event|2|||
160967719|NCT00441701|581270092|FG006|Overall Study|Adverse Event|0|||
160967720|NCT00441701|581270093|FG007|Overall Study|Adverse Event|0|||
160967721|NCT00441701|581270094|FG008|Overall Study|Adverse Event|0|||
160967722|NCT00441701|581270095|FG009|Overall Study|Adverse Event|0|||
160967723|NCT00441701|581270086|FG000|Overall Study|Lack of Efficacy|2|||
160967724|NCT00441701|581270087|FG001|Overall Study|Lack of Efficacy|0|||
160967725|NCT00441701|581270088|FG002|Overall Study|Lack of Efficacy|2|||
160967726|NCT00441701|581270089|FG003|Overall Study|Lack of Efficacy|2|||
160967727|NCT00441701|581270090|FG004|Overall Study|Lack of Efficacy|0|||
160967728|NCT00441701|581270091|FG005|Overall Study|Lack of Efficacy|1|||
160967729|NCT00441701|581270092|FG006|Overall Study|Lack of Efficacy|0|||
160967730|NCT00441701|581270093|FG007|Overall Study|Lack of Efficacy|0|||
160967731|NCT00441701|581270094|FG008|Overall Study|Lack of Efficacy|0|||
160967732|NCT00441701|581270095|FG009|Overall Study|Lack of Efficacy|0|||
161011836|NCT05094141|581430816|FG000|Overall Study|Withdrawal by Subject|0|||
161147636|NCT01096667|581922530|FG004|Overall Study|Lost to Follow-up|0|||
160967733|NCT00441701|581270086|FG000|Overall Study|Withdrawal by Subject|0|||
160967734|NCT00441701|581270087|FG001|Overall Study|Withdrawal by Subject|2|||
160967735|NCT00441701|581270088|FG002|Overall Study|Withdrawal by Subject|1|||
161147637|NCT01096667|581922526|FG000|Overall Study|Withdrawal by Subject|1|||
161147638|NCT01096667|581922527|FG001|Overall Study|Withdrawal by Subject|0|||
161147639|NCT01096667|581922528|FG002|Overall Study|Withdrawal by Subject|0|||
161147640|NCT01096667|581922529|FG003|Overall Study|Withdrawal by Subject|1|||
160967736|NCT00441701|581270089|FG003|Overall Study|Withdrawal by Subject|1|||
160967737|NCT00441701|581270090|FG004|Overall Study|Withdrawal by Subject|0|||
160967738|NCT00441701|581270091|FG005|Overall Study|Withdrawal by Subject|0|||
161147641|NCT01096667|581922530|FG004|Overall Study|Withdrawal by Subject|0|||
161147642|NCT01096667|581922526|FG000|Overall Study|Reason not available|0|||
161011837|NCT05094141|581430817|FG001|Overall Study|Withdrawal by Subject|0|||
161011838|NCT05094141|581430818|FG002|Overall Study|Withdrawal by Subject|1|||
161011839|NCT05094141|581430816|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
161011840|NCT05094141|581430817|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
161011841|NCT05094141|581430818|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
161011842|NCT05094141|581430816|FG000|Overall Study|Did not participate in randomization|0|||
161011843|NCT05094141|581430817|FG001|Overall Study|Did not participate in randomization|0|||
161011844|NCT05094141|581430818|FG002|Overall Study|Did not participate in randomization|33|||
161011845|NCT03725722|581432619|FG000|Overall Study|Lack of Efficacy|2|||
161011846|NCT03725722|581432620|FG001|Overall Study|Lack of Efficacy|1|||
161011847|NCT03725722|581432621|FG002|Overall Study|Lack of Efficacy|2|||
161011848|NCT03725722|581432622|FG003|Overall Study|Lack of Efficacy|0|||
161011849|NCT03725722|581432623|FG004|Overall Study|Lack of Efficacy|2|||
161011850|NCT03725722|581432619|FG000|Overall Study|Adverse Event|2|||
161011851|NCT03725722|581432620|FG001|Overall Study|Adverse Event|2|||
161011852|NCT03725722|581432621|FG002|Overall Study|Adverse Event|1|||
161011853|NCT03725722|581432622|FG003|Overall Study|Adverse Event|0|||
161011854|NCT03725722|581432623|FG004|Overall Study|Adverse Event|6|||
161011855|NCT03725722|581432619|FG000|Overall Study|Withdrawal by Subject|4|||
161011856|NCT03725722|581432620|FG001|Overall Study|Withdrawal by Subject|1|||
161011857|NCT03725722|581432621|FG002|Overall Study|Withdrawal by Subject|0|||
161011858|NCT03725722|581432622|FG003|Overall Study|Withdrawal by Subject|4|||
161011859|NCT03725722|581432623|FG004|Overall Study|Withdrawal by Subject|4|||
161011860|NCT03725722|581432619|FG000|Overall Study|Lost to Follow-up|3|||
161011861|NCT03725722|581432620|FG001|Overall Study|Lost to Follow-up|1|||
161011862|NCT03725722|581432621|FG002|Overall Study|Lost to Follow-up|2|||
161011863|NCT03725722|581432622|FG003|Overall Study|Lost to Follow-up|2|||
161011864|NCT03725722|581432623|FG004|Overall Study|Lost to Follow-up|1|||
161011865|NCT03725722|581432619|FG000|Overall Study|Personal reasons|0|||
161011866|NCT03725722|581432620|FG001|Overall Study|Personal reasons|0|||
161011867|NCT03725722|581432621|FG002|Overall Study|Personal reasons|1|||
161011868|NCT03725722|581432622|FG003|Overall Study|Personal reasons|0|||
161011869|NCT03725722|581432623|FG004|Overall Study|Personal reasons|1|||
161011870|NCT03725722|581432619|FG000|Overall Study|COVID-19 situation|0|||
161011871|NCT03725722|581432620|FG001|Overall Study|COVID-19 situation|1|||
161011872|NCT03725722|581432621|FG002|Overall Study|COVID-19 situation|0|||
161011873|NCT03725722|581432622|FG003|Overall Study|COVID-19 situation|0|||
161011874|NCT03725722|581432623|FG004|Overall Study|COVID-19 situation|0|||
161011875|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
161011876|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
161011877|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
161011878|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
161011879|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
161011880|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
161011881|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
161011882|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
161011883|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
161011884|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
161011885|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
161011886|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
161011887|NCT01600014|581432624|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
161011888|NCT01600014|581432625|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
161011889|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
161011890|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
161011891|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
161011892|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
161011893|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
161011894|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
161011895|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
161011896|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
161011897|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
161011898|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
161011899|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
161011900|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
161011901|NCT01600014|581432624|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
161011902|NCT01600014|581432625|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
161011903|NCT01600014|581432624|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
161011904|NCT01600014|581432625|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
161343534|NCT00207740|582644406|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161011905|NCT01600014|581432624|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
161271940|NCT00191113|582377525|FG001|Core Study|Lack of Efficacy|2|||
161271941|NCT00191113|582377524|FG000|Core Study|Death|1|||
161271942|NCT00191113|582377525|FG001|Core Study|Death|0|||
161271943|NCT01555671|582377528|FG000|Overall Study|Physician Decision|20|||
161271944|NCT01555671|582377529|FG001|Overall Study|Physician Decision|25|||
161011906|NCT01600014|581432625|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
161011907|NCT01600014|581432624|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
161011908|NCT01600014|581432625|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
161011909|NCT03398148|581432629|FG000|Substudy 1 Period 1|Adverse Event|5|||
161011910|NCT03398148|581432630|FG001|Substudy 1 Period 1|Adverse Event|2|||
161011911|NCT03398148|581432631|FG002|Substudy 1 Period 1|Adverse Event|2|||
161011912|NCT03398148|581432632|FG003|Substudy 1 Period 1|Adverse Event|0|||
161011913|NCT03398148|581432633|FG004|Substudy 1 Period 1|Adverse Event|8|||
161011914|NCT03398148|581432634|FG005|Substudy 1 Period 1|Adverse Event|0|||
161011915|NCT03398148|581432635|FG006|Substudy 1 Period 1|Adverse Event|0|||
161011916|NCT03398148|581432636|FG007|Substudy 1 Period 1|Adverse Event|0|||
161011917|NCT03398148|581432637|FG008|Substudy 1 Period 1|Adverse Event|0|||
161011918|NCT03398148|581432638|FG009|Substudy 1 Period 1|Adverse Event|0|||
161011919|NCT03398148|581432639|FG010|Substudy 1 Period 1|Adverse Event|0|||
161011920|NCT03398148|581432640|FG011|Substudy 1 Period 1|Adverse Event|0|||
161011921|NCT03398148|581432641|FG012|Substudy 1 Period 1|Adverse Event|0|||
161011922|NCT03398148|581432642|FG013|Substudy 1 Period 1|Adverse Event|0|||
161011923|NCT03398148|581432643|FG014|Substudy 1 Period 1|Adverse Event|0|||
161011924|NCT03398148|581432629|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
161011925|NCT03398148|581432630|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
161011926|NCT03398148|581432631|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011927|NCT03398148|581432632|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
161011928|NCT03398148|581432633|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
161011929|NCT03398148|581432634|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011930|NCT03398148|581432635|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011931|NCT03398148|581432636|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011932|NCT03398148|581432637|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011933|NCT03398148|581432638|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011934|NCT03398148|581432639|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011935|NCT03398148|581432640|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011936|NCT03398148|581432641|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011937|NCT03398148|581432642|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011938|NCT03398148|581432643|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
161011939|NCT03398148|581432629|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
161011940|NCT03398148|581432630|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
161011941|NCT03398148|581432631|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
161011942|NCT03398148|581432632|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
161011943|NCT03398148|581432633|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
161011944|NCT03398148|581432634|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
161011945|NCT03398148|581432635|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
161011946|NCT03398148|581432636|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
161011947|NCT03398148|581432637|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
161011948|NCT03398148|581432638|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
161011949|NCT03398148|581432639|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
161011950|NCT03398148|581432640|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
161011951|NCT03398148|581432641|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
161011952|NCT03398148|581432642|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
161011953|NCT03398148|581432643|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
161011954|NCT03398148|581432629|FG000|Substudy 1 Period 1|Other|0|||
161011955|NCT03398148|581432630|FG001|Substudy 1 Period 1|Other|1|||
161011956|NCT03398148|581432631|FG002|Substudy 1 Period 1|Other|0|||
161011957|NCT03398148|581432632|FG003|Substudy 1 Period 1|Other|0|||
161011958|NCT03398148|581432633|FG004|Substudy 1 Period 1|Other|3|||
161011959|NCT03398148|581432634|FG005|Substudy 1 Period 1|Other|0|||
161011960|NCT03398148|581432635|FG006|Substudy 1 Period 1|Other|0|||
161011961|NCT03398148|581432636|FG007|Substudy 1 Period 1|Other|0|||
161011962|NCT03398148|581432637|FG008|Substudy 1 Period 1|Other|0|||
161011963|NCT03398148|581432638|FG009|Substudy 1 Period 1|Other|0|||
161011964|NCT03398148|581432639|FG010|Substudy 1 Period 1|Other|0|||
161011965|NCT03398148|581432640|FG011|Substudy 1 Period 1|Other|0|||
161011966|NCT03398148|581432641|FG012|Substudy 1 Period 1|Other|0|||
161011967|NCT03398148|581432642|FG013|Substudy 1 Period 1|Other|0|||
161011968|NCT03398148|581432643|FG014|Substudy 1 Period 1|Other|0|||
161011969|NCT03398148|581432629|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011970|NCT03398148|581432630|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011971|NCT03398148|581432631|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011972|NCT03398148|581432632|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
161271945|NCT00631657|582377530|FG000|6-Month Treatment Period|Adverse Event|47|||
161271946|NCT00631657|582377531|FG001|6-Month Treatment Period|Adverse Event|0|||
161011973|NCT03398148|581432633|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
161011974|NCT03398148|581432634|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011975|NCT03398148|581432635|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
161271947|NCT00631657|582377532|FG002|6-Month Treatment Period|Adverse Event|7|||
161011976|NCT03398148|581432636|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011977|NCT03398148|581432637|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011978|NCT03398148|581432638|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011979|NCT03398148|581432639|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011980|NCT03398148|581432640|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011981|NCT03398148|581432641|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011982|NCT03398148|581432642|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011983|NCT03398148|581432643|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
161011984|NCT03398148|581432629|FG000|Substudy 1 Period 2|Adverse Event|0|||
161011985|NCT03398148|581432630|FG001|Substudy 1 Period 2|Adverse Event|0|||
161011986|NCT03398148|581432631|FG002|Substudy 1 Period 2|Adverse Event|0|||
161011987|NCT03398148|581432632|FG003|Substudy 1 Period 2|Adverse Event|0|||
161011988|NCT03398148|581432633|FG004|Substudy 1 Period 2|Adverse Event|0|||
161011989|NCT03398148|581432634|FG005|Substudy 1 Period 2|Adverse Event|2|||
161011990|NCT03398148|581432635|FG006|Substudy 1 Period 2|Adverse Event|4|||
161011991|NCT03398148|581432636|FG007|Substudy 1 Period 2|Adverse Event|0|||
161011992|NCT03398148|581432637|FG008|Substudy 1 Period 2|Adverse Event|0|||
161011993|NCT03398148|581432638|FG009|Substudy 1 Period 2|Adverse Event|0|||
161011994|NCT03398148|581432639|FG010|Substudy 1 Period 2|Adverse Event|0|||
161011995|NCT03398148|581432640|FG011|Substudy 1 Period 2|Adverse Event|0|||
161011996|NCT03398148|581432641|FG012|Substudy 1 Period 2|Adverse Event|0|||
161011997|NCT03398148|581432642|FG013|Substudy 1 Period 2|Adverse Event|0|||
161011998|NCT03398148|581432643|FG014|Substudy 1 Period 2|Adverse Event|0|||
161011999|NCT03398148|581432629|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012000|NCT03398148|581432630|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012001|NCT03398148|581432631|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012002|NCT03398148|581432632|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012003|NCT03398148|581432633|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012004|NCT03398148|581432634|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012005|NCT03398148|581432635|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
161012006|NCT03398148|581432636|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
161012007|NCT03398148|581432637|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012008|NCT03398148|581432638|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012009|NCT03398148|581432639|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012010|NCT03398148|581432640|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012011|NCT03398148|581432641|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012012|NCT03398148|581432642|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012013|NCT03398148|581432643|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
161012014|NCT03398148|581432629|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
161012015|NCT03398148|581432630|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
161012016|NCT03398148|581432631|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
161012017|NCT03398148|581432632|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
161012018|NCT03398148|581432633|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
161012019|NCT03398148|581432634|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
161012020|NCT03398148|581432635|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
161012021|NCT03398148|581432636|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
161012022|NCT03398148|581432637|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
161012023|NCT03398148|581432638|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
161012024|NCT03398148|581432639|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
161012025|NCT03398148|581432640|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
161012026|NCT03398148|581432641|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
161012027|NCT03398148|581432642|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
161012028|NCT03398148|581432643|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
161012029|NCT03398148|581432629|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012030|NCT03398148|581432630|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012031|NCT03398148|581432631|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012032|NCT03398148|581432632|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012033|NCT03398148|581432633|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012034|NCT03398148|581432634|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012035|NCT03398148|581432635|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
161012036|NCT03398148|581432636|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012037|NCT03398148|581432637|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012038|NCT03398148|581432638|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012039|NCT03398148|581432639|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012040|NCT03398148|581432640|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012041|NCT03398148|581432641|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012042|NCT03398148|581432642|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012043|NCT03398148|581432643|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012044|NCT03398148|581432629|FG000|Substudy 1 Period 2|Other|0|||
161012045|NCT03398148|581432630|FG001|Substudy 1 Period 2|Other|0|||
161012046|NCT03398148|581432631|FG002|Substudy 1 Period 2|Other|0|||
161012047|NCT03398148|581432632|FG003|Substudy 1 Period 2|Other|0|||
161012048|NCT03398148|581432633|FG004|Substudy 1 Period 2|Other|0|||
161012049|NCT03398148|581432634|FG005|Substudy 1 Period 2|Other|0|||
161012050|NCT03398148|581432635|FG006|Substudy 1 Period 2|Other|1|||
161012051|NCT03398148|581432636|FG007|Substudy 1 Period 2|Other|0|||
161012052|NCT03398148|581432637|FG008|Substudy 1 Period 2|Other|0|||
161012053|NCT03398148|581432638|FG009|Substudy 1 Period 2|Other|0|||
161012054|NCT03398148|581432639|FG010|Substudy 1 Period 2|Other|0|||
161012055|NCT03398148|581432640|FG011|Substudy 1 Period 2|Other|0|||
161012056|NCT03398148|581432641|FG012|Substudy 1 Period 2|Other|0|||
161012057|NCT03398148|581432642|FG013|Substudy 1 Period 2|Other|0|||
161012058|NCT03398148|581432643|FG014|Substudy 1 Period 2|Other|0|||
161012059|NCT03398148|581432629|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012060|NCT03398148|581432630|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012061|NCT03398148|581432631|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012062|NCT03398148|581432632|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012063|NCT03398148|581432633|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012064|NCT03398148|581432634|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012065|NCT03398148|581432635|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
161012066|NCT03398148|581432636|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012067|NCT03398148|581432637|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012068|NCT03398148|581432638|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012069|NCT03398148|581432639|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012070|NCT03398148|581432640|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012071|NCT03398148|581432641|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012072|NCT03398148|581432642|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012073|NCT03398148|581432643|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
161012074|NCT03398148|581432629|FG000|Substudy 2 Period 1|Adverse Event|0|||
161012075|NCT03398148|581432630|FG001|Substudy 2 Period 1|Adverse Event|0|||
161012076|NCT03398148|581432631|FG002|Substudy 2 Period 1|Adverse Event|0|||
161012077|NCT03398148|581432632|FG003|Substudy 2 Period 1|Adverse Event|0|||
161012078|NCT03398148|581432633|FG004|Substudy 2 Period 1|Adverse Event|0|||
161012079|NCT03398148|581432634|FG005|Substudy 2 Period 1|Adverse Event|0|||
161012080|NCT03398148|581432635|FG006|Substudy 2 Period 1|Adverse Event|0|||
161012081|NCT03398148|581432636|FG007|Substudy 2 Period 1|Adverse Event|0|||
161012082|NCT03398148|581432637|FG008|Substudy 2 Period 1|Adverse Event|0|||
161012083|NCT03398148|581432638|FG009|Substudy 2 Period 1|Adverse Event|12|||
161012084|NCT03398148|581432639|FG010|Substudy 2 Period 1|Adverse Event|2|||
161012085|NCT03398148|581432640|FG011|Substudy 2 Period 1|Adverse Event|0|||
161012086|NCT03398148|581432641|FG012|Substudy 2 Period 1|Adverse Event|0|||
161012087|NCT03398148|581432642|FG013|Substudy 2 Period 1|Adverse Event|0|||
161012088|NCT03398148|581432643|FG014|Substudy 2 Period 1|Adverse Event|0|||
161012089|NCT03398148|581432629|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161271948|NCT00631657|582377530|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
161271949|NCT00631657|582377531|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
161271950|NCT00631657|582377532|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
161271951|NCT00631657|582377530|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
161271952|NCT00631657|582377531|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
161271953|NCT00631657|582377532|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
161271954|NCT00631657|582377530|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
161012090|NCT03398148|581432630|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012091|NCT03398148|581432631|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012092|NCT03398148|581432632|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012093|NCT03398148|581432633|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012094|NCT03398148|581432634|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012095|NCT03398148|581432635|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012096|NCT03398148|581432636|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012097|NCT03398148|581432637|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012098|NCT03398148|581432638|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
161012099|NCT03398148|581432639|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
161012100|NCT03398148|581432640|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012101|NCT03398148|581432641|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012102|NCT03398148|581432642|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012103|NCT03398148|581432643|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
161012104|NCT03398148|581432629|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
161012105|NCT03398148|581432630|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
161012106|NCT03398148|581432631|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
161012107|NCT03398148|581432632|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
161012108|NCT03398148|581432633|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
161012109|NCT03398148|581432634|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
161012110|NCT03398148|581432635|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
161012111|NCT03398148|581432636|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
161271955|NCT00631657|582377531|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
161271956|NCT00631657|582377532|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
161012112|NCT03398148|581432637|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
161012113|NCT03398148|581432638|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
161012114|NCT03398148|581432639|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
161012115|NCT03398148|581432640|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
161012116|NCT03398148|581432641|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
161012117|NCT03398148|581432642|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
161012118|NCT03398148|581432643|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
161012119|NCT03398148|581432629|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012120|NCT03398148|581432630|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012121|NCT03398148|581432631|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012122|NCT03398148|581432632|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012123|NCT03398148|581432633|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012124|NCT03398148|581432634|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012125|NCT03398148|581432635|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012126|NCT03398148|581432636|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012127|NCT03398148|581432637|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012128|NCT03398148|581432638|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012129|NCT03398148|581432639|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
161012130|NCT03398148|581432640|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012131|NCT03398148|581432641|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012132|NCT03398148|581432642|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012133|NCT03398148|581432643|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
161012134|NCT03398148|581432629|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012135|NCT03398148|581432630|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012136|NCT03398148|581432631|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012137|NCT03398148|581432632|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012138|NCT03398148|581432633|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012139|NCT03398148|581432634|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012140|NCT03398148|581432635|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012141|NCT03398148|581432636|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012142|NCT03398148|581432637|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012143|NCT03398148|581432638|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012144|NCT03398148|581432639|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
161012145|NCT03398148|581432640|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012146|NCT03398148|581432641|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012147|NCT03398148|581432642|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161012148|NCT03398148|581432643|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
161147643|NCT01096667|581922527|FG001|Overall Study|Reason not available|1|||
161147644|NCT01096667|581922528|FG002|Overall Study|Reason not available|1|||
161147645|NCT01096667|581922529|FG003|Overall Study|Reason not available|1|||
161271957|NCT00631657|582377530|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
161271958|NCT00631657|582377531|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
161271959|NCT00631657|582377532|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
161271960|NCT00631657|582377530|FG000|6-Month Treatment Period|Other|16|||
161271961|NCT00631657|582377531|FG001|6-Month Treatment Period|Other|0|||
161271962|NCT00631657|582377532|FG002|6-Month Treatment Period|Other|4|||
161271963|NCT00631657|582377530|FG000|6-Month Treatment Period|Not Treated|2|||
161271964|NCT00631657|582377531|FG001|6-Month Treatment Period|Not Treated|0|||
161271965|NCT00631657|582377532|FG002|6-Month Treatment Period|Not Treated|1|||
161271966|NCT00631657|582377530|FG000|7-Day Discontinuation Period|Not Treated|1|||
161271967|NCT00631657|582377531|FG001|7-Day Discontinuation Period|Not Treated|1|||
161271968|NCT00631657|582377532|FG002|7-Day Discontinuation Period|Not Treated|1|||
161271969|NCT00631657|582377530|FG000|7-Day Discontinuation Period|Other|1|||
161271970|NCT00631657|582377531|FG001|7-Day Discontinuation Period|Other|0|||
161271971|NCT00631657|582377532|FG002|7-Day Discontinuation Period|Other|0|||
161271972|NCT04003896|582377533|FG000|Overall Study|Withdrawal by Subject|3|||
161271973|NCT04003896|582377533|FG000|Overall Study|Physician Decision|1|||
161271974|NCT03929757|582377536|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
161271975|NCT03929757|582377537|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
161271976|NCT03929757|582377538|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
161271977|NCT03929757|582377536|FG000|Main Study: Up to Day 365|Other|1|||
161271978|NCT03929757|582377537|FG001|Main Study: Up to Day 365|Other|0|||
161271979|NCT03929757|582377538|FG002|Main Study: Up to Day 365|Other|0|||
161271980|NCT03929757|582377536|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
161271981|NCT03929757|582377537|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
161271982|NCT03929757|582377538|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
161271983|NCT01154816|582377539|FG000|Overall Study|Withdrawal by Subject|1|||
161271984|NCT01154816|582377540|FG001|Overall Study|Withdrawal by Subject|0|||
161271985|NCT01154816|582377541|FG002|Overall Study|Withdrawal by Subject|0|||
161271986|NCT01154816|582377542|FG003|Overall Study|Withdrawal by Subject|1|||
161012149|NCT03398148|581432629|FG000|Substudy 2 Period 1|Other|0|||
161012150|NCT03398148|581432630|FG001|Substudy 2 Period 1|Other|0|||
161012151|NCT03398148|581432631|FG002|Substudy 2 Period 1|Other|0|||
161147646|NCT01096667|581922530|FG004|Overall Study|Reason not available|0|||
161147647|NCT01096667|581922526|FG000|Overall Study|Protocol Violation|0|||
161147648|NCT01096667|581922527|FG001|Overall Study|Protocol Violation|0|||
161271987|NCT01154816|582377543|FG004|Overall Study|Withdrawal by Subject|0|||
161012152|NCT03398148|581432632|FG003|Substudy 2 Period 1|Other|0|||
161012153|NCT03398148|581432633|FG004|Substudy 2 Period 1|Other|0|||
161012154|NCT03398148|581432634|FG005|Substudy 2 Period 1|Other|0|||
161012155|NCT03398148|581432635|FG006|Substudy 2 Period 1|Other|0|||
161012156|NCT03398148|581432636|FG007|Substudy 2 Period 1|Other|0|||
161012157|NCT03398148|581432637|FG008|Substudy 2 Period 1|Other|0|||
161012158|NCT03398148|581432638|FG009|Substudy 2 Period 1|Other|4|||
161012159|NCT03398148|581432639|FG010|Substudy 2 Period 1|Other|4|||
161012160|NCT03398148|581432640|FG011|Substudy 2 Period 1|Other|0|||
161012161|NCT03398148|581432641|FG012|Substudy 2 Period 1|Other|0|||
161012162|NCT03398148|581432642|FG013|Substudy 2 Period 1|Other|0|||
161012163|NCT03398148|581432643|FG014|Substudy 2 Period 1|Other|0|||
161012164|NCT03398148|581432629|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012165|NCT03398148|581432630|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012166|NCT03398148|581432631|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012167|NCT03398148|581432632|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012168|NCT03398148|581432633|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012169|NCT03398148|581432634|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012170|NCT03398148|581432635|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012171|NCT03398148|581432636|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012172|NCT03398148|581432637|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012173|NCT03398148|581432638|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012174|NCT03398148|581432639|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
161012175|NCT03398148|581432640|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012176|NCT03398148|581432641|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
161271988|NCT01154816|582377544|FG005|Overall Study|Withdrawal by Subject|0|||
161271989|NCT01154816|582377545|FG006|Overall Study|Withdrawal by Subject|0|||
161271990|NCT01154816|582377546|FG007|Overall Study|Withdrawal by Subject|0|||
161271991|NCT01154816|582377547|FG008|Overall Study|Withdrawal by Subject|1|||
161271992|NCT01154816|582377548|FG009|Overall Study|Withdrawal by Subject|3|||
161271993|NCT01154816|582377549|FG010|Overall Study|Withdrawal by Subject|0|||
161012177|NCT03398148|581432642|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012178|NCT03398148|581432643|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
161012179|NCT03398148|581432629|FG000|Substudy 2 Period 2|Adverse Event|0|||
161012180|NCT03398148|581432630|FG001|Substudy 2 Period 2|Adverse Event|0|||
161012181|NCT03398148|581432631|FG002|Substudy 2 Period 2|Adverse Event|0|||
161012182|NCT03398148|581432632|FG003|Substudy 2 Period 2|Adverse Event|0|||
161012183|NCT03398148|581432633|FG004|Substudy 2 Period 2|Adverse Event|0|||
161012184|NCT03398148|581432634|FG005|Substudy 2 Period 2|Adverse Event|0|||
161012185|NCT03398148|581432635|FG006|Substudy 2 Period 2|Adverse Event|0|||
161012186|NCT03398148|581432636|FG007|Substudy 2 Period 2|Adverse Event|0|||
161012187|NCT03398148|581432637|FG008|Substudy 2 Period 2|Adverse Event|0|||
161012188|NCT03398148|581432638|FG009|Substudy 2 Period 2|Adverse Event|0|||
161012189|NCT03398148|581432639|FG010|Substudy 2 Period 2|Adverse Event|0|||
161012190|NCT03398148|581432640|FG011|Substudy 2 Period 2|Adverse Event|0|||
161012191|NCT03398148|581432641|FG012|Substudy 2 Period 2|Adverse Event|0|||
161012192|NCT03398148|581432642|FG013|Substudy 2 Period 2|Adverse Event|1|||
161012193|NCT03398148|581432643|FG014|Substudy 2 Period 2|Adverse Event|3|||
161012194|NCT03398148|581432629|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
161012195|NCT03398148|581432630|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
161012196|NCT03398148|581432631|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
161012197|NCT03398148|581432632|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
161012198|NCT03398148|581432633|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
161012199|NCT03398148|581432634|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
161012200|NCT03398148|581432635|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
161012201|NCT03398148|581432636|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
161012202|NCT03398148|581432637|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
161012203|NCT03398148|581432638|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
161012204|NCT03398148|581432639|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
161012205|NCT03398148|581432640|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
161012206|NCT03398148|581432641|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
161147649|NCT01096667|581922528|FG002|Overall Study|Protocol Violation|0|||
161147650|NCT01096667|581922529|FG003|Overall Study|Protocol Violation|1|||
161147651|NCT01096667|581922530|FG004|Overall Study|Protocol Violation|0|||
161271994|NCT01154816|582377550|FG011|Overall Study|Withdrawal by Subject|0|||
161271995|NCT01154816|582377539|FG000|Overall Study|Progressive Disease|13|||
161012207|NCT03398148|581432642|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
161012208|NCT03398148|581432643|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
161147652|NCT01096667|581922526|FG000|Overall Study|Not treated|1|||
161343535|NCT00207740|582644407|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161012209|NCT03398148|581432629|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012210|NCT03398148|581432630|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012211|NCT03398148|581432631|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161271996|NCT01154816|582377540|FG001|Overall Study|Progressive Disease|8|||
161012212|NCT03398148|581432632|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012213|NCT03398148|581432633|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012214|NCT03398148|581432634|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161147653|NCT01096667|581922527|FG001|Overall Study|Not treated|0|||
161012215|NCT03398148|581432635|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012216|NCT03398148|581432636|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012217|NCT03398148|581432637|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012218|NCT03398148|581432638|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012219|NCT03398148|581432639|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012220|NCT03398148|581432640|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
161012221|NCT03398148|581432641|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
161012222|NCT03398148|581432642|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
161012223|NCT03398148|581432643|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
161012224|NCT03398148|581432629|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
161271997|NCT01154816|582377541|FG002|Overall Study|Progressive Disease|9|||
161012225|NCT03398148|581432630|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
161012226|NCT03398148|581432631|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
161012227|NCT03398148|581432632|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
161012228|NCT03398148|581432633|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
161012229|NCT03398148|581432634|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
161012230|NCT03398148|581432635|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
161012231|NCT03398148|581432636|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
161012232|NCT03398148|581432637|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
161012233|NCT03398148|581432638|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
161012234|NCT03398148|581432639|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
161012235|NCT03398148|581432640|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
161012236|NCT03398148|581432641|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
161012237|NCT03398148|581432642|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
161012238|NCT03398148|581432643|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
161012239|NCT03398148|581432629|FG000|Substudy 2 Period 2|Other|0|||
161012240|NCT03398148|581432630|FG001|Substudy 2 Period 2|Other|0|||
161012241|NCT03398148|581432631|FG002|Substudy 2 Period 2|Other|0|||
161012242|NCT03398148|581432632|FG003|Substudy 2 Period 2|Other|0|||
161012243|NCT03398148|581432633|FG004|Substudy 2 Period 2|Other|0|||
161012244|NCT03398148|581432634|FG005|Substudy 2 Period 2|Other|0|||
161012245|NCT03398148|581432635|FG006|Substudy 2 Period 2|Other|0|||
161012246|NCT03398148|581432636|FG007|Substudy 2 Period 2|Other|0|||
161012247|NCT03398148|581432637|FG008|Substudy 2 Period 2|Other|0|||
161012248|NCT03398148|581432638|FG009|Substudy 2 Period 2|Other|0|||
161012249|NCT03398148|581432639|FG010|Substudy 2 Period 2|Other|0|||
161012250|NCT03398148|581432640|FG011|Substudy 2 Period 2|Other|0|||
161012251|NCT03398148|581432641|FG012|Substudy 2 Period 2|Other|0|||
161012252|NCT03398148|581432642|FG013|Substudy 2 Period 2|Other|1|||
161012253|NCT03398148|581432643|FG014|Substudy 2 Period 2|Other|1|||
161012254|NCT03398148|581432629|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012255|NCT03398148|581432630|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012256|NCT03398148|581432631|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012257|NCT03398148|581432632|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012258|NCT03398148|581432633|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012259|NCT03398148|581432634|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012260|NCT03398148|581432635|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012261|NCT03398148|581432636|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012262|NCT03398148|581432637|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012263|NCT03398148|581432638|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012264|NCT03398148|581432639|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012265|NCT03398148|581432640|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
161271998|NCT01154816|582377542|FG003|Overall Study|Progressive Disease|9|||
161271999|NCT01154816|582377543|FG004|Overall Study|Progressive Disease|8|||
161272000|NCT01154816|582377544|FG005|Overall Study|Progressive Disease|8|||
161272001|NCT01154816|582377545|FG006|Overall Study|Progressive Disease|5|||
161272002|NCT01154816|582377546|FG007|Overall Study|Progressive Disease|6|||
161272003|NCT01154816|582377547|FG008|Overall Study|Progressive Disease|8|||
161272004|NCT01154816|582377548|FG009|Overall Study|Progressive Disease|6|||
161272005|NCT01154816|582377549|FG010|Overall Study|Progressive Disease|10|||
161012266|NCT03398148|581432641|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
161012267|NCT03398148|581432642|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
161012268|NCT03398148|581432643|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
161012269|NCT02791230|581432644|FG000|Overall Study|Adverse Event|10|||
161012270|NCT02791230|581432645|FG001|Overall Study|Adverse Event|9|||
161012271|NCT02791230|581432646|FG002|Overall Study|Adverse Event|66|||
161012272|NCT02791230|581432644|FG000|Overall Study|Death|38|||
161272006|NCT01154816|582377550|FG011|Overall Study|Progressive Disease|3|||
161012273|NCT02791230|581432645|FG001|Overall Study|Death|25|||
161012274|NCT02791230|581432646|FG002|Overall Study|Death|184|||
161012275|NCT02791230|581432644|FG000|Overall Study|Lack of Efficacy|1|||
161012276|NCT02791230|581432645|FG001|Overall Study|Lack of Efficacy|0|||
161012277|NCT02791230|581432646|FG002|Overall Study|Lack of Efficacy|3|||
161012278|NCT02791230|581432644|FG000|Overall Study|Lost to Follow-up|0|||
161012279|NCT02791230|581432645|FG001|Overall Study|Lost to Follow-up|0|||
161012280|NCT02791230|581432646|FG002|Overall Study|Lost to Follow-up|10|||
161012281|NCT02791230|581432644|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
161272007|NCT01154816|582377539|FG000|Overall Study|Physician Decision|1|||
161272008|NCT01154816|582377540|FG001|Overall Study|Physician Decision|0|||
161272009|NCT01154816|582377541|FG002|Overall Study|Physician Decision|1|||
161272010|NCT01154816|582377542|FG003|Overall Study|Physician Decision|0|||
161272011|NCT01154816|582377543|FG004|Overall Study|Physician Decision|2|||
161272012|NCT01154816|582377544|FG005|Overall Study|Physician Decision|0|||
161272013|NCT01154816|582377545|FG006|Overall Study|Physician Decision|0|||
161272014|NCT01154816|582377546|FG007|Overall Study|Physician Decision|0|||
161272015|NCT01154816|582377547|FG008|Overall Study|Physician Decision|0|||
161272016|NCT01154816|582377548|FG009|Overall Study|Physician Decision|1|||
161272017|NCT01154816|582377549|FG010|Overall Study|Physician Decision|1|||
161272018|NCT01154816|582377550|FG011|Overall Study|Physician Decision|1|||
161272019|NCT01154816|582377539|FG000|Overall Study|Adverse Event|5|||
161272020|NCT01154816|582377540|FG001|Overall Study|Adverse Event|2|||
161272021|NCT01154816|582377541|FG002|Overall Study|Adverse Event|0|||
161272022|NCT01154816|582377542|FG003|Overall Study|Adverse Event|0|||
161272023|NCT01154816|582377543|FG004|Overall Study|Adverse Event|0|||
161272024|NCT01154816|582377544|FG005|Overall Study|Adverse Event|0|||
161272025|NCT01154816|582377545|FG006|Overall Study|Adverse Event|1|||
161012282|NCT02791230|581432645|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161012283|NCT02791230|581432646|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
161012284|NCT02791230|581432644|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
161012285|NCT02791230|581432645|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
161012286|NCT02791230|581432646|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
161012287|NCT02791230|581432644|FG000|Overall Study|Study sites terminated by sponsor|1|||
161012288|NCT02791230|581432645|FG001|Overall Study|Study sites terminated by sponsor|0|||
161012289|NCT02791230|581432646|FG002|Overall Study|Study sites terminated by sponsor|5|||
161012290|NCT02791230|581432644|FG000|Overall Study|Other|9|||
161012291|NCT02791230|581432645|FG001|Overall Study|Other|1|||
161012292|NCT02791230|581432646|FG002|Overall Study|Other|28|||
161012293|NCT02791230|581432644|FG000|Overall Study|Protocol Violation|0|||
161012294|NCT02791230|581432645|FG001|Overall Study|Protocol Violation|0|||
161012295|NCT02791230|581432646|FG002|Overall Study|Protocol Violation|4|||
161012296|NCT02791230|581432644|FG000|Overall Study|Withdrawal by Subject|24|||
161012297|NCT02791230|581432645|FG001|Overall Study|Withdrawal by Subject|13|||
161012298|NCT02791230|581432646|FG002|Overall Study|Withdrawal by Subject|172|||
161012299|NCT02791230|581432644|FG000|Overall Study|Enrolled but not treated|0|||
161012300|NCT02791230|581432645|FG001|Overall Study|Enrolled but not treated|0|||
161012301|NCT02791230|581432646|FG002|Overall Study|Enrolled but not treated|5|||
161012302|NCT03683069|581432649|FG000|Overall Study|see limitations|12|||
161012303|NCT03683069|581432650|FG001|Overall Study|see limitations|13|||
161012304|NCT05478525|581432651|FG000|Overall Study|Withdrawal by Subject|0|||
161012305|NCT05478525|581432652|FG001|Overall Study|Withdrawal by Subject|1|||
161012306|NCT05478525|581432653|FG002|Overall Study|Withdrawal by Subject|2|||
161012307|NCT05478525|581432654|FG003|Overall Study|Withdrawal by Subject|0|||
161012308|NCT05478525|581432651|FG000|Overall Study|COVID-19 Infection|2|||
161012309|NCT05478525|581432652|FG001|Overall Study|COVID-19 Infection|0|||
161012310|NCT05478525|581432653|FG002|Overall Study|COVID-19 Infection|1|||
161012311|NCT05478525|581432654|FG003|Overall Study|COVID-19 Infection|1|||
161272026|NCT01154816|582377546|FG007|Overall Study|Adverse Event|1|||
161272027|NCT01154816|582377547|FG008|Overall Study|Adverse Event|0|||
161272028|NCT01154816|582377548|FG009|Overall Study|Adverse Event|0|||
161272029|NCT01154816|582377549|FG010|Overall Study|Adverse Event|0|||
161272030|NCT01154816|582377550|FG011|Overall Study|Adverse Event|0|||
161272031|NCT00806286|582377551|FG000|Overall Study|Adverse Event|5|||
161272032|NCT00806286|582377552|FG001|Overall Study|Adverse Event|2|||
161272033|NCT00806286|582377553|FG002|Overall Study|Adverse Event|0|||
161272034|NCT00806286|582377551|FG000|Overall Study|Disease progression|31|||
161272035|NCT00806286|582377552|FG001|Overall Study|Disease progression|38|||
161012312|NCT01649271|581432655|FG000|Overall Study|Progressive disease|4|||
161012313|NCT01649271|581432656|FG001|Overall Study|Progressive disease|5|||
161012314|NCT01649271|581432655|FG000|Overall Study|Other Adverse Event|0|||
161012315|NCT01649271|581432656|FG001|Overall Study|Other Adverse Event|2|||
161012316|NCT01649271|581432655|FG000|Overall Study|Withdrawal by Subject|1|||
161012317|NCT01649271|581432656|FG001|Overall Study|Withdrawal by Subject|0|||
161012318|NCT01649271|581432655|FG000|Overall Study|Other than stated above|1|||
161012319|NCT01649271|581432656|FG001|Overall Study|Other than stated above|0|||
161012320|NCT05644002|581432659|FG000|Overall Study|Lost to Follow-up|1|||
161012321|NCT05644002|581432660|FG001|Overall Study|Lost to Follow-up|2|||
161272036|NCT00806286|582377553|FG002|Overall Study|Disease progression|1|||
161272037|NCT00806286|582377551|FG000|Overall Study|Death|1|||
161272038|NCT00806286|582377552|FG001|Overall Study|Death|6|||
161272039|NCT00806286|582377553|FG002|Overall Study|Death|0|||
161012322|NCT05644002|581432659|FG000|Overall Study|Withdrawal by Subject|0|||
161012323|NCT05644002|581432660|FG001|Overall Study|Withdrawal by Subject|1|||
161012324|NCT04038957|581432664|FG000|Overall Study|Withdrawal by Subject|1|||
161272040|NCT00806286|582377551|FG000|Overall Study|Lost to Follow-up|0|||
161272041|NCT00806286|582377552|FG001|Overall Study|Lost to Follow-up|1|||
161272042|NCT00806286|582377553|FG002|Overall Study|Lost to Follow-up|0|||
161272043|NCT00806286|582377551|FG000|Overall Study|Withdrawal by Subject|8|||
161272044|NCT00806286|582377552|FG001|Overall Study|Withdrawal by Subject|3|||
161272045|NCT00806286|582377553|FG002|Overall Study|Withdrawal by Subject|1|||
161272046|NCT00806286|582377551|FG000|Overall Study|Physician Decision|2|||
161272047|NCT00806286|582377552|FG001|Overall Study|Physician Decision|2|||
161272048|NCT00806286|582377553|FG002|Overall Study|Physician Decision|0|||
161272049|NCT00806286|582377551|FG000|Overall Study|Due to a variety of reasons|7|||
161272050|NCT00806286|582377552|FG001|Overall Study|Due to a variety of reasons|2|||
161272051|NCT00806286|582377553|FG002|Overall Study|Due to a variety of reasons|1|||
161272052|NCT00686075|582377554|FG000|Overall Study|Withdrawal by Subject|4|||
161272053|NCT00686075|582377555|FG001|Overall Study|Withdrawal by Subject|3|||
161272054|NCT00686075|582377556|FG002|Overall Study|Withdrawal by Subject|3|||
161272055|NCT00686075|582377557|FG003|Overall Study|Withdrawal by Subject|7|||
161272056|NCT00686075|582377558|FG004|Overall Study|Withdrawal by Subject|1|||
161272057|NCT00686075|582377559|FG005|Overall Study|Withdrawal by Subject|0|||
161012325|NCT04038957|581432664|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
161012326|NCT03821844|581432665|FG000|Overall Study|Death|37|||
161012327|NCT03821844|581432666|FG001|Overall Study|Death|31|||
161012328|NCT03821844|581432665|FG000|Overall Study|Discharged|10|||
161012329|NCT03821844|581432666|FG001|Overall Study|Discharged|14|||
161012330|NCT03821844|581432665|FG000|Overall Study|Not present in facility at followup|2|||
161012331|NCT03821844|581432666|FG001|Overall Study|Not present in facility at followup|3|||
161012332|NCT02605837|581432667|FG000|Overall Study|Adverse Event|3|||
161012333|NCT02605837|581432668|FG001|Overall Study|Adverse Event|1|||
161012334|NCT02605837|581432667|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161012335|NCT02605837|581432668|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161012336|NCT02605837|581432667|FG000|Overall Study|Withdrawal by Subject|8|||
161012337|NCT02605837|581432668|FG001|Overall Study|Withdrawal by Subject|8|||
161012338|NCT02605837|581432667|FG000|Overall Study|Physician Decision|0|||
161012339|NCT02605837|581432668|FG001|Overall Study|Physician Decision|1|||
161012340|NCT05656911|581432671|FG000|Treatment Phase|Physician Decision|2|||
161012341|NCT05656911|581432672|FG001|Treatment Phase|Physician Decision|0|||
161012342|NCT05656911|581432671|FG000|Treatment Phase|Lack of Efficacy|6|||
161012343|NCT05656911|581432672|FG001|Treatment Phase|Lack of Efficacy|3|||
161012344|NCT05656911|581432671|FG000|Treatment Phase|Subject Decision|4|||
161012345|NCT05656911|581432672|FG001|Treatment Phase|Subject Decision|2|||
161012346|NCT05656911|581432671|FG000|Treatment Phase|Other Reasons|1|||
161012347|NCT05656911|581432672|FG001|Treatment Phase|Other Reasons|0|||
161012348|NCT05656911|581432671|FG000|Treatment Phase|Adverse Event|3|||
161012349|NCT05656911|581432672|FG001|Treatment Phase|Adverse Event|1|||
161012350|NCT05656911|581432671|FG000|Follow-up Phase|Subject Decision|0|||
161012351|NCT05656911|581432672|FG001|Follow-up Phase|Subject Decision|1|||
161012352|NCT05656911|581432671|FG000|Follow-up Phase|Missing|1|||
161012353|NCT05656911|581432672|FG001|Follow-up Phase|Missing|0|||
161012354|NCT05075408|581432679|FG000|Overall Study|Withdrawal by Subject|5|||
161012355|NCT05075408|581432680|FG001|Overall Study|Withdrawal by Subject|3|||
161012356|NCT05075408|581432681|FG002|Overall Study|Withdrawal by Subject|4|||
161012357|NCT05075408|581432679|FG000|Overall Study|Adverse Event|5|||
161012358|NCT05075408|581432680|FG001|Overall Study|Adverse Event|7|||
161012359|NCT05075408|581432681|FG002|Overall Study|Adverse Event|8|||
161012360|NCT05075408|581432679|FG000|Overall Study|Protocol Violation|0|||
161012361|NCT05075408|581432680|FG001|Overall Study|Protocol Violation|1|||
161012362|NCT05075408|581432681|FG002|Overall Study|Protocol Violation|0|||
161012363|NCT05075408|581432679|FG000|Overall Study|Lost to Follow-up|2|||
161012364|NCT05075408|581432680|FG001|Overall Study|Lost to Follow-up|1|||
161012365|NCT05075408|581432681|FG002|Overall Study|Lost to Follow-up|1|||
161012366|NCT05075408|581432679|FG000|Overall Study|Physician Decision|1|||
161012367|NCT05075408|581432680|FG001|Overall Study|Physician Decision|0|||
161012368|NCT05075408|581432681|FG002|Overall Study|Physician Decision|0|||
161272058|NCT00686075|582377560|FG006|Overall Study|Withdrawal by Subject|0|||
161272059|NCT00686075|582377561|FG007|Overall Study|Withdrawal by Subject|2|||
161272060|NCT00686075|582377562|FG008|Overall Study|Withdrawal by Subject|4|||
161272061|NCT00686075|582377563|FG009|Overall Study|Withdrawal by Subject|6|||
161012369|NCT05075408|581432679|FG000|Overall Study|Other-unspecified|3|||
161012370|NCT05075408|581432680|FG001|Overall Study|Other-unspecified|2|||
161012371|NCT05075408|581432681|FG002|Overall Study|Other-unspecified|0|||
161012372|NCT05419505|581432683|FG000|Overall Study|Adverse Event|0|||
161012373|NCT05419505|581432684|FG001|Overall Study|Adverse Event|0|||
161012374|NCT05419505|581432685|FG002|Overall Study|Adverse Event|0|||
161012375|NCT05419505|581432686|FG003|Overall Study|Adverse Event|1|||
161012376|NCT05419505|581432687|FG004|Overall Study|Adverse Event|0|||
161272062|NCT00686075|582377554|FG000|Overall Study|Lost to Follow-up|3|||
161272063|NCT00686075|582377555|FG001|Overall Study|Lost to Follow-up|6|||
161272064|NCT00686075|582377556|FG002|Overall Study|Lost to Follow-up|3|||
161272065|NCT00686075|582377557|FG003|Overall Study|Lost to Follow-up|2|||
161012377|NCT05419505|581432688|FG005|Overall Study|Adverse Event|0|||
161012378|NCT05419505|581432689|FG006|Overall Study|Adverse Event|0|||
161012379|NCT05419505|581432690|FG007|Overall Study|Adverse Event|0|||
161012380|NCT05419505|581432683|FG000|Overall Study|Withdrawal by Subject|1|||
161012381|NCT05419505|581432684|FG001|Overall Study|Withdrawal by Subject|2|||
161012382|NCT05419505|581432685|FG002|Overall Study|Withdrawal by Subject|0|||
161012383|NCT05419505|581432686|FG003|Overall Study|Withdrawal by Subject|0|||
161012384|NCT05419505|581432687|FG004|Overall Study|Withdrawal by Subject|0|||
161012385|NCT05419505|581432688|FG005|Overall Study|Withdrawal by Subject|0|||
161012386|NCT05419505|581432689|FG006|Overall Study|Withdrawal by Subject|1|||
161012387|NCT05419505|581432690|FG007|Overall Study|Withdrawal by Subject|0|||
161012388|NCT05419505|581432683|FG000|Overall Study|Lost to Follow-up|2|||
161012389|NCT05419505|581432684|FG001|Overall Study|Lost to Follow-up|1|||
161012390|NCT05419505|581432685|FG002|Overall Study|Lost to Follow-up|0|||
161012391|NCT05419505|581432686|FG003|Overall Study|Lost to Follow-up|0|||
161012392|NCT05419505|581432687|FG004|Overall Study|Lost to Follow-up|1|||
161012393|NCT05419505|581432688|FG005|Overall Study|Lost to Follow-up|2|||
161012394|NCT05419505|581432689|FG006|Overall Study|Lost to Follow-up|0|||
161012395|NCT05419505|581432690|FG007|Overall Study|Lost to Follow-up|1|||
161012396|NCT02780388|581432693|FG000|Overall Study|Lost to Follow-up|0|||
161012397|NCT02780388|581432694|FG001|Overall Study|Lost to Follow-up|1|||
161012398|NCT02780388|581432695|FG002|Overall Study|Lost to Follow-up|0|||
161012399|NCT02780388|581432696|FG003|Overall Study|Lost to Follow-up|0|||
161012400|NCT02780388|581432697|FG004|Overall Study|Lost to Follow-up|0|||
161012401|NCT02780388|581432693|FG000|Overall Study|Withdrawal by Subject|1|||
161012402|NCT02780388|581432694|FG001|Overall Study|Withdrawal by Subject|1|||
161012403|NCT02780388|581432695|FG002|Overall Study|Withdrawal by Subject|0|||
161012404|NCT02780388|581432696|FG003|Overall Study|Withdrawal by Subject|0|||
161012405|NCT02780388|581432697|FG004|Overall Study|Withdrawal by Subject|0|||
161012406|NCT04527146|581432698|FG000|Overall Study|Withdrawal by Subject|12|||
161012407|NCT04527146|581432699|FG001|Overall Study|Withdrawal by Subject|15|||
161012408|NCT04527146|581432700|FG002|Overall Study|Withdrawal by Subject|7|||
161012409|NCT04527146|581432701|FG003|Overall Study|Withdrawal by Subject|16|||
161012410|NCT04527146|581432698|FG000|Overall Study|Lost to Follow-up|13|||
161012411|NCT04527146|581432699|FG001|Overall Study|Lost to Follow-up|9|||
161012412|NCT04527146|581432700|FG002|Overall Study|Lost to Follow-up|16|||
161012413|NCT04527146|581432701|FG003|Overall Study|Lost to Follow-up|13|||
161012414|NCT04527146|581432698|FG000|Overall Study|Death|0|||
161012415|NCT04527146|581432699|FG001|Overall Study|Death|1|||
161012416|NCT04527146|581432700|FG002|Overall Study|Death|1|||
161012417|NCT04527146|581432701|FG003|Overall Study|Death|0|||
161012418|NCT04527146|581432698|FG000|Overall Study|Adverse Event|0|||
161012419|NCT04527146|581432699|FG001|Overall Study|Adverse Event|0|||
161012420|NCT04527146|581432700|FG002|Overall Study|Adverse Event|1|||
161012421|NCT04527146|581432701|FG003|Overall Study|Adverse Event|0|||
161012422|NCT04527146|581432698|FG000|Overall Study|Ineligible after randomization|2|||
161012423|NCT04527146|581432699|FG001|Overall Study|Ineligible after randomization|0|||
161012424|NCT04527146|581432700|FG002|Overall Study|Ineligible after randomization|2|||
161012425|NCT04527146|581432701|FG003|Overall Study|Ineligible after randomization|2|||
161012426|NCT04527146|581432698|FG000|Overall Study|Moved to a different group|6|||
161012427|NCT04527146|581432699|FG001|Overall Study|Moved to a different group|3|||
161012428|NCT04527146|581432700|FG002|Overall Study|Moved to a different group|0|||
161012429|NCT04527146|581432701|FG003|Overall Study|Moved to a different group|2|||
161012430|NCT05107401|581432702|FG000|Overall Study|Lost to Follow-up|13|||
161012431|NCT05107401|581432703|FG001|Overall Study|Lost to Follow-up|12|||
161012432|NCT04855760|581432704|FG000|Overall Study|Adverse Event|21|||
161012433|NCT04855760|581432704|FG000|Overall Study|Withdrawal by Subject|116|||
161147654|NCT01096667|581922528|FG002|Overall Study|Not treated|0|||
161147655|NCT01096667|581922529|FG003|Overall Study|Not treated|0|||
161147656|NCT01096667|581922530|FG004|Overall Study|Not treated|0|||
161147657|NCT01845077|581922531|FG000|Washout Period|Lost to Follow-up|0|||
161147658|NCT01845077|581922532|FG001|Washout Period|Lost to Follow-up|1|||
161272066|NCT00686075|582377558|FG004|Overall Study|Lost to Follow-up|3|||
161147659|NCT01845077|581922533|FG002|Washout Period|Lost to Follow-up|0|||
161012434|NCT04855760|581432704|FG000|Overall Study|Lack of Efficacy|21|||
161012435|NCT04855760|581432704|FG000|Overall Study|Lost to Follow-up|49|||
161012436|NCT04855760|581432704|FG000|Overall Study|Protocol Violation|2|||
161012437|NCT04855760|581432704|FG000|Overall Study|Physician Decision|5|||
161012438|NCT04855760|581432704|FG000|Overall Study|Pregnancy|1|||
161012439|NCT04855760|581432704|FG000|Overall Study|Non-Compliance with Study Drug|11|||
161012440|NCT04855760|581432704|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
161147660|NCT01845077|581922534|FG003|Washout Period|Lost to Follow-up|1|||
161012441|NCT04855760|581432704|FG000|Overall Study|Study Completed by Sponsor|202|||
161012442|NCT04855760|581432704|FG000|Overall Study|Other|13|||
161012443|NCT04840199|581432707|FG000|Overall Study|Study Terminated by Sponsor|8|||
161012444|NCT04840199|581432708|FG001|Overall Study|Study Terminated by Sponsor|9|||
161012445|NCT04840199|581432707|FG000|Overall Study|Lost to Follow-up|0|||
161147661|NCT01845077|581922535|FG004|Washout Period|Lost to Follow-up|0|||
161272067|NCT00686075|582377559|FG005|Overall Study|Lost to Follow-up|3|||
161012446|NCT04840199|581432708|FG001|Overall Study|Lost to Follow-up|2|||
161012447|NCT04840199|581432707|FG000|Overall Study|Withdrawal by Subject|2|||
161012448|NCT04840199|581432708|FG001|Overall Study|Withdrawal by Subject|0|||
161147662|NCT01845077|581922536|FG005|Washout Period|Lost to Follow-up|1|||
161272068|NCT00686075|582377560|FG006|Overall Study|Lost to Follow-up|0|||
161272069|NCT00686075|582377561|FG007|Overall Study|Lost to Follow-up|0|||
161272070|NCT00686075|582377562|FG008|Overall Study|Lost to Follow-up|2|||
161272071|NCT00686075|582377563|FG009|Overall Study|Lost to Follow-up|3|||
161272072|NCT00686075|582377554|FG000|Overall Study|Other|1|||
161272073|NCT00686075|582377555|FG001|Overall Study|Other|1|||
161272074|NCT00686075|582377556|FG002|Overall Study|Other|0|||
161272075|NCT00686075|582377557|FG003|Overall Study|Other|0|||
161272076|NCT00686075|582377558|FG004|Overall Study|Other|0|||
161272077|NCT00686075|582377559|FG005|Overall Study|Other|0|||
161272078|NCT00686075|582377560|FG006|Overall Study|Other|0|||
161272079|NCT00686075|582377561|FG007|Overall Study|Other|0|||
161272080|NCT00686075|582377562|FG008|Overall Study|Other|0|||
161272081|NCT00686075|582377563|FG009|Overall Study|Other|1|||
161272082|NCT04713553|582377564|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
161272083|NCT04713553|582377565|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
161272084|NCT04713553|582377566|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
161272085|NCT04713553|582377567|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
161147663|NCT01845077|581922531|FG000|Washout Period|Adverse Event|1|||
161147664|NCT01845077|581922532|FG001|Washout Period|Adverse Event|0|||
161272086|NCT04713553|582377568|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
161272087|NCT04713553|582377569|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
161272088|NCT04713553|582377570|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
161012449|NCT04840199|581432707|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
161012450|NCT04840199|581432708|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
161012451|NCT05952076|581432709|FG000|Overall Study|Death|1|||
161012452|NCT05952076|581432710|FG001|Overall Study|Death|1|||
161012453|NCT05952076|581432709|FG000|Overall Study|Lost to Follow-up|0|||
161012454|NCT05952076|581432710|FG001|Overall Study|Lost to Follow-up|1|||
161012455|NCT00150813|581432711|FG000|Overall Study|Adverse Event|1|||
161012456|NCT00150813|581432711|FG000|Overall Study|Lack of Efficacy|1|||
161012457|NCT00150813|581432711|FG000|Overall Study|Lost to Follow-up|5|||
161012458|NCT00150813|581432711|FG000|Overall Study|Withdrawal by Subject|5|||
161012459|NCT00150813|581432711|FG000|Overall Study|Remission|3|||
161012460|NCT00150813|581432711|FG000|Overall Study|Planned pregancy|1|||
161012461|NCT00150813|581432711|FG000|Overall Study|Switch to commercially available LEV|2|||
161012462|NCT00894543|581432712|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
161012463|NCT00894543|581432713|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
161012464|NCT00894543|581432712|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
161012465|NCT00894543|581432713|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
161012466|NCT04048681|581432714|FG000|Overall Study|family emergency|0|||
161012467|NCT04048681|581432715|FG001|Overall Study|family emergency|0|||
161012468|NCT04048681|581432716|FG002|Overall Study|family emergency|0|||
161012469|NCT04048681|581432717|FG003|Overall Study|family emergency|1|||
161012470|NCT04048681|581432718|FG004|Overall Study|family emergency|0|||
161012471|NCT04579250|581432719|FG000|Overall Study|Withdrawal by Subject|1|||
161012472|NCT04579250|581432720|FG001|Overall Study|Withdrawal by Subject|1|||
161012473|NCT04579250|581432721|FG002|Overall Study|Withdrawal by Subject|0|||
161012474|NCT04579250|581432719|FG000|Overall Study|Lost to Follow-up|1|||
161012475|NCT04579250|581432720|FG001|Overall Study|Lost to Follow-up|1|||
161012476|NCT04579250|581432721|FG002|Overall Study|Lost to Follow-up|0|||
161012477|NCT04579250|581432719|FG000|Overall Study|Moved from area|0|||
161012478|NCT04579250|581432720|FG001|Overall Study|Moved from area|1|||
161012479|NCT04579250|581432721|FG002|Overall Study|Moved from area|2|||
161012480|NCT02919449|581432722|FG000|Overall Study|Withdrawal by Subject|1|||
161012481|NCT02919449|581432722|FG000|Overall Study|Investigator decision|1|||
161012482|NCT00411151|581432723|FG000|Overall Study|Death|38|||
161012483|NCT00411151|581432723|FG000|Overall Study|Withdrawal by Subject|2|||
161012484|NCT00411151|581432723|FG000|Overall Study|Lost to Follow-up|2|||
161012485|NCT00411151|581432723|FG000|Overall Study|Protocol Violation|1|||
161012486|NCT00411151|581432723|FG000|Overall Study|Trial prematurely closed|4|||
161147665|NCT01845077|581922533|FG002|Washout Period|Adverse Event|0|||
161272089|NCT04713553|582377564|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161272090|NCT04713553|582377565|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161012487|NCT04452318|581432727|FG000|Overall Study|Physician Decision|1|||
161012488|NCT04452318|581432728|FG001|Overall Study|Physician Decision|2|||
161012489|NCT04452318|581432729|FG002|Overall Study|Physician Decision|0|||
161272091|NCT04713553|582377566|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161012490|NCT04452318|581432730|FG003|Overall Study|Physician Decision|2|||
161012491|NCT04452318|581432731|FG004|Overall Study|Physician Decision|0|||
161012492|NCT04452318|581432732|FG005|Overall Study|Physician Decision|2|||
161012493|NCT04452318|581432733|FG006|Overall Study|Physician Decision|5|||
161012494|NCT04452318|581432727|FG000|Overall Study|Death|2|||
161012495|NCT04452318|581432728|FG001|Overall Study|Death|3|||
161272092|NCT04713553|582377567|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
161272093|NCT04713553|582377568|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161272094|NCT04713553|582377569|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161272095|NCT04713553|582377570|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
161272096|NCT04713553|582377564|FG000|Primary Study (2 Months)|Other|1|||
161272097|NCT04713553|582377565|FG001|Primary Study (2 Months)|Other|2|||
161272098|NCT04713553|582377566|FG002|Primary Study (2 Months)|Other|0|||
161272099|NCT04713553|582377567|FG003|Primary Study (2 Months)|Other|0|||
161272100|NCT04713553|582377568|FG004|Primary Study (2 Months)|Other|1|||
161272101|NCT04713553|582377569|FG005|Primary Study (2 Months)|Other|0|||
161272102|NCT04713553|582377570|FG006|Primary Study (2 Months)|Other|0|||
161272103|NCT04713553|582377564|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
161272104|NCT04713553|582377565|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
161272105|NCT04713553|582377566|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
161272106|NCT04713553|582377567|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
161272107|NCT04713553|582377568|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
161272108|NCT04713553|582377569|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
161272109|NCT04713553|582377570|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
161272110|NCT04713553|582377564|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
161272111|NCT04713553|582377565|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
161272112|NCT04713553|582377566|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
161272113|NCT04713553|582377567|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
161272114|NCT04713553|582377568|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
161272115|NCT04713553|582377569|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
161272116|NCT04713553|582377570|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
161272117|NCT03783039|582377571|FG000|Overall Study|Death|2|||
161272118|NCT03783039|582377572|FG001|Overall Study|Death|1|||
161272119|NCT01199471|582377573|FG000|Overall Study|Protocol Violation|4|||
161272120|NCT01199471|582377573|FG000|Overall Study|Withdrawal by Subject|1|||
161272121|NCT01199471|582377573|FG000|Overall Study|Physician Decision|1|||
161272122|NCT02006693|582377574|FG000|Overall Study|No Reason Specified|6|||
161272123|NCT02006693|582377575|FG001|Overall Study|No Reason Specified|8|||
160967739|NCT00441701|581270092|FG006|Overall Study|Withdrawal by Subject|0|||
160967740|NCT00441701|581270093|FG007|Overall Study|Withdrawal by Subject|0|||
160967741|NCT00441701|581270094|FG008|Overall Study|Withdrawal by Subject|0|||
160967742|NCT00441701|581270095|FG009|Overall Study|Withdrawal by Subject|0|||
160967743|NCT00985985|581270099|FG000|Overall Study|Adverse Event|4|||
160967744|NCT00985985|581270100|FG001|Overall Study|Adverse Event|2|||
160967745|NCT00985985|581270101|FG002|Overall Study|Adverse Event|2|||
160967746|NCT00985985|581270102|FG003|Overall Study|Adverse Event|2|||
160967747|NCT00985985|581270099|FG000|Overall Study|Lost to Follow-up|4|||
160967748|NCT00985985|581270100|FG001|Overall Study|Lost to Follow-up|11|||
160967749|NCT00985985|581270101|FG002|Overall Study|Lost to Follow-up|2|||
160967750|NCT00985985|581270102|FG003|Overall Study|Lost to Follow-up|3|||
160967751|NCT00985985|581270099|FG000|Overall Study|Protocol Violation|1|||
160967752|NCT00985985|581270100|FG001|Overall Study|Protocol Violation|2|||
160967753|NCT00985985|581270101|FG002|Overall Study|Protocol Violation|0|||
160967754|NCT00985985|581270102|FG003|Overall Study|Protocol Violation|1|||
160967755|NCT00985985|581270099|FG000|Overall Study|Lack of Efficacy|5|||
160967756|NCT00985985|581270100|FG001|Overall Study|Lack of Efficacy|6|||
160967757|NCT00985985|581270101|FG002|Overall Study|Lack of Efficacy|1|||
160967758|NCT00985985|581270102|FG003|Overall Study|Lack of Efficacy|3|||
160967759|NCT00985985|581270099|FG000|Overall Study|Withdrawal by Subject|4|||
160967760|NCT00985985|581270100|FG001|Overall Study|Withdrawal by Subject|2|||
160967761|NCT00985985|581270101|FG002|Overall Study|Withdrawal by Subject|2|||
160967762|NCT00985985|581270102|FG003|Overall Study|Withdrawal by Subject|2|||
160967763|NCT00985985|581270099|FG000|Overall Study|Other Reason|6|||
160967764|NCT00985985|581270100|FG001|Overall Study|Other Reason|1|||
160967765|NCT00985985|581270101|FG002|Overall Study|Other Reason|4|||
160967766|NCT00985985|581270102|FG003|Overall Study|Other Reason|2|||
160967767|NCT02255357|581270106|FG000|Overall Study|Physician Decision|10|||
160967768|NCT02255357|581270107|FG001|Overall Study|Physician Decision|24|||
160967769|NCT00509236|581270112|FG000|Overall Study|Adverse Event|7|||
160967770|NCT00509236|581270113|FG001|Overall Study|Adverse Event|9|||
160967771|NCT00509236|581270112|FG000|Overall Study|Withdrawal by Subject|5|||
160967772|NCT00509236|581270113|FG001|Overall Study|Withdrawal by Subject|10|||
160967773|NCT00509236|581270112|FG000|Overall Study|Protocol Violation|3|||
160967774|NCT00509236|581270113|FG001|Overall Study|Protocol Violation|0|||
160967775|NCT00509236|581270112|FG000|Overall Study|Excluded Medication|1|||
160967776|NCT00509236|581270113|FG001|Overall Study|Excluded Medication|1|||
160967777|NCT00509236|581270112|FG000|Overall Study|Scheduled Kidney Transplant|1|||
160967778|NCT00509236|581270113|FG001|Overall Study|Scheduled Kidney Transplant|0|||
160967779|NCT02709005|581270125|FG000|Overall Study|Lost to Follow-up|1|||
160967780|NCT02709005|581270126|FG001|Overall Study|Lost to Follow-up|1|||
160967781|NCT02709005|581270125|FG000|Overall Study|Withdrawal by Subject|3|||
160967782|NCT02709005|581270126|FG001|Overall Study|Withdrawal by Subject|0|||
160967783|NCT01572389|581270127|FG000|Overall Study|Death|1|||
161272124|NCT02006693|582377574|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
161272125|NCT02006693|582377575|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
161272126|NCT02006693|582377574|FG000|Overall Study|XEN Implant Explantation|0|||
161272127|NCT02006693|582377575|FG001|Overall Study|XEN Implant Explantation|1|||
161272128|NCT02006693|582377574|FG000|Overall Study|Death|2|||
161272129|NCT02006693|582377575|FG001|Overall Study|Death|2|||
161272130|NCT02006693|582377574|FG000|Overall Study|Lost to Follow-up|4|||
161272131|NCT02006693|582377575|FG001|Overall Study|Lost to Follow-up|1|||
161272132|NCT02006693|582377574|FG000|Overall Study|Patient Decision|4|||
161272133|NCT02006693|582377575|FG001|Overall Study|Patient Decision|0|||
161272134|NCT03151408|582377576|FG000|Overall Study|Adverse Event|24|||
161272135|NCT03151408|582377577|FG001|Overall Study|Adverse Event|23|||
161272136|NCT03151408|582377576|FG000|Overall Study|Death|46|||
161272137|NCT03151408|582377577|FG001|Overall Study|Death|26|||
161272138|NCT03151408|582377576|FG000|Overall Study|Physician Decision|13|||
161272139|NCT03151408|582377577|FG001|Overall Study|Physician Decision|19|||
161272140|NCT03151408|582377576|FG000|Overall Study|Withdrawal by Subject|16|||
161272141|NCT03151408|582377577|FG001|Overall Study|Withdrawal by Subject|20|||
161272142|NCT03151408|582377576|FG000|Overall Study|Progressive disease|45|||
160967784|NCT01572389|581270128|FG001|Overall Study|Death|3|||
160967785|NCT01572389|581270127|FG000|Overall Study|Withdrawal by Subject|14|||
160967786|NCT01572389|581270128|FG001|Overall Study|Withdrawal by Subject|2|||
160967787|NCT01572389|581270127|FG000|Overall Study|Lost to Follow-up|25|||
160967788|NCT01572389|581270128|FG001|Overall Study|Lost to Follow-up|14|||
160967789|NCT01572389|581270127|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
160967790|NCT01572389|581270128|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
160967791|NCT00499863|581270133|FG000|Overall Study|Lack of Efficacy|21|||
160967792|NCT00499863|581270134|FG001|Overall Study|Lack of Efficacy|27|||
160967793|NCT00499863|581270133|FG000|Overall Study|Protocol Violation|12|||
160967794|NCT00499863|581270134|FG001|Overall Study|Protocol Violation|7|||
160967795|NCT00499863|581270133|FG000|Overall Study|Withdrawal by Subject|6|||
160967796|NCT00499863|581270134|FG001|Overall Study|Withdrawal by Subject|4|||
160967797|NCT00499863|581270133|FG000|Overall Study|Adverse Event|8|||
160967798|NCT00499863|581270134|FG001|Overall Study|Adverse Event|2|||
160967799|NCT00499863|581270133|FG000|Overall Study|Sponsor decision|2|||
160967800|NCT00499863|581270134|FG001|Overall Study|Sponsor decision|2|||
160967801|NCT00499863|581270133|FG000|Overall Study|Lost to Follow-up|1|||
160967802|NCT00499863|581270134|FG001|Overall Study|Lost to Follow-up|1|||
160967803|NCT02535364|581270135|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
160967804|NCT02535364|581270135|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
160967805|NCT02535364|581270135|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
160967806|NCT02535364|581270135|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
160967807|NCT02535364|581270135|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
160967808|NCT02535364|581270135|FG000|Part B Screening|Death|2|||
160967809|NCT02535364|581270135|FG000|Part B Screening|Physician Decision|1|||
160967810|NCT02535364|581270135|FG000|Part B Screening|Withdrawal by Subject|1|||
160967811|NCT02535364|581270135|FG000|Part B Screening|Adverse Event|1|||
160967812|NCT02535364|581270135|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
160967813|NCT02535364|581270135|FG000|Study Treatment|Death|1|||
160967814|NCT02535364|581270135|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
160967815|NCT02535364|581270135|FG000|12-Month Follow-up Period|Disease progression|22|||
160967816|NCT02535364|581270135|FG000|12-Month Follow-up Period|Death|5|||
160967817|NCT02535364|581270135|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
160967818|NCT02535364|581270135|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
160967819|NCT02535364|581270135|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
160967820|NCT00571701|581270136|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
160967821|NCT00571701|581270137|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
160967822|NCT00571701|581270136|FG000|First Intervention 12 Months|Death|1|||
160967823|NCT00571701|581270137|FG001|First Intervention 12 Months|Death|0|||
160967824|NCT00571701|581270136|FG000|Second Intervention 12 Months|Adverse Event|0|||
160967825|NCT00571701|581270137|FG001|Second Intervention 12 Months|Adverse Event|1|||
160967826|NCT00571701|581270136|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
160967827|NCT00571701|581270137|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
160967828|NCT00691132|581270138|FG000|Overall Study|Adverse Event|2|||
160967829|NCT00691132|581270139|FG001|Overall Study|Adverse Event|3|||
160967830|NCT00691132|581270138|FG000|Overall Study|Withdrawal by Subject|10|||
160967831|NCT00691132|581270139|FG001|Overall Study|Withdrawal by Subject|10|||
160967832|NCT01959347|581270150|FG000|Overall Study|Protocol Violation|9|||
160967833|NCT01959347|581270151|FG001|Overall Study|Protocol Violation|7|||
160967834|NCT01282801|581270152|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
160967835|NCT01282801|581270153|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
160967836|NCT01375205|581270161|FG000|Overall Study|Lost to Follow-up|15|||
160967837|NCT01375205|581270162|FG001|Overall Study|Lost to Follow-up|12|||
160967838|NCT01375205|581270161|FG000|Overall Study|Withdrawal by Subject|6|||
161272143|NCT03151408|582377577|FG001|Overall Study|Progressive disease|61|||
161272144|NCT03151408|582377576|FG000|Overall Study|non-compliance by patient|1|||
161272145|NCT03151408|582377577|FG001|Overall Study|non-compliance by patient|0|||
161272146|NCT03151408|582377576|FG000|Overall Study|other reasons|56|||
161012496|NCT04452318|581432729|FG002|Overall Study|Death|0|||
161012497|NCT04452318|581432730|FG003|Overall Study|Death|0|||
161012498|NCT04452318|581432731|FG004|Overall Study|Death|0|||
161012499|NCT04452318|581432732|FG005|Overall Study|Death|0|||
161012500|NCT04452318|581432733|FG006|Overall Study|Death|0|||
161012501|NCT04452318|581432727|FG000|Overall Study|Lost to Follow-up|38|||
161012502|NCT04452318|581432728|FG001|Overall Study|Lost to Follow-up|28|||
161012503|NCT04452318|581432729|FG002|Overall Study|Lost to Follow-up|0|||
161012504|NCT04452318|581432730|FG003|Overall Study|Lost to Follow-up|3|||
161012505|NCT04452318|581432731|FG004|Overall Study|Lost to Follow-up|3|||
161012506|NCT04452318|581432732|FG005|Overall Study|Lost to Follow-up|2|||
161012507|NCT04452318|581432733|FG006|Overall Study|Lost to Follow-up|1|||
161012508|NCT04452318|581432727|FG000|Overall Study|Withdrawal by Subject|46|||
161012509|NCT04452318|581432728|FG001|Overall Study|Withdrawal by Subject|40|||
161012510|NCT04452318|581432729|FG002|Overall Study|Withdrawal by Subject|0|||
161012511|NCT04452318|581432730|FG003|Overall Study|Withdrawal by Subject|18|||
161012512|NCT04452318|581432731|FG004|Overall Study|Withdrawal by Subject|6|||
161012513|NCT04452318|581432732|FG005|Overall Study|Withdrawal by Subject|8|||
161012514|NCT04452318|581432733|FG006|Overall Study|Withdrawal by Subject|6|||
161012515|NCT03380390|581432738|FG000|Overall Study|Adverse Event|3|||
161012516|NCT05494788|581432740|FG000|Initial Treatment Period|Adverse Event|2|||
161012517|NCT05494788|581432740|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
161012518|NCT05494788|581432740|FG000|Extension Period|Adverse Event|1|||
161012519|NCT05494788|581432740|FG000|Extension Period|Withdrawal by Subject|1|||
161012520|NCT00073749|581432741|FG000|Overall Study|Disease Progression|2|||
161012521|NCT00073749|581432742|FG001|Overall Study|Disease Progression|0|||
161012522|NCT00073749|581432743|FG002|Overall Study|Disease Progression|3|||
161012523|NCT00073749|581432744|FG003|Overall Study|Disease Progression|2|||
161012524|NCT00073749|581432745|FG004|Overall Study|Disease Progression|3|||
161012525|NCT00073749|581432746|FG005|Overall Study|Disease Progression|1|||
161012526|NCT00073749|581432747|FG006|Overall Study|Disease Progression|3|||
161012527|NCT00073749|581432741|FG000|Overall Study|Death|0|||
161147666|NCT01845077|581922534|FG003|Washout Period|Adverse Event|0|||
161147667|NCT01845077|581922535|FG004|Washout Period|Adverse Event|0|||
160967839|NCT01375205|581270162|FG001|Overall Study|Withdrawal by Subject|1|||
160967840|NCT01859793|581270163|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
160967841|NCT01859793|581270164|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
160967842|NCT01859793|581270163|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
160967843|NCT01859793|581270164|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
160967844|NCT01859793|581270163|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
160967845|NCT01859793|581270164|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
160967846|NCT01859793|581270163|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
160967847|NCT01859793|581270164|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
160967848|NCT01064297|581270171|FG000|Overall Study|Lost to Follow-up|791|||
160967849|NCT01064297|581270172|FG001|Overall Study|Lost to Follow-up|48|||
160967850|NCT01064297|581270173|FG002|Overall Study|Lost to Follow-up|133|||
160967851|NCT00542880|581270181|FG000|Period 1|Eligibility criteria not fulfilled|2|||
160967852|NCT00542880|581270182|FG001|Period 1|Eligibility criteria not fulfilled|6|||
160967853|NCT00542880|581270181|FG000|Period 1|Adverse Event|2|||
160967854|NCT00542880|581270182|FG001|Period 1|Adverse Event|2|||
160967855|NCT00542880|581270181|FG000|Period 1|Development of study-specific criteria|1|||
160967856|NCT00542880|581270182|FG001|Period 1|Development of study-specific criteria|2|||
160967857|NCT00542880|581270181|FG000|Period 1|Withdrawal by Subject|1|||
160967858|NCT00542880|581270182|FG001|Period 1|Withdrawal by Subject|1|||
160967859|NCT00542880|581270181|FG000|Period 1|Protocol Violation|0|||
160967860|NCT00542880|581270182|FG001|Period 1|Protocol Violation|1|||
160967861|NCT00542880|581270181|FG000|Period 2|Adverse Event|5|||
160967862|NCT00542880|581270182|FG001|Period 2|Adverse Event|7|||
160967863|NCT00542880|581270181|FG000|Period 2|Eligibility not fulfilled|0|||
160967864|NCT00542880|581270182|FG001|Period 2|Eligibility not fulfilled|1|||
160967865|NCT00542880|581270181|FG000|Period 2|Discontinuation criteria|2|||
160967866|NCT00542880|581270182|FG001|Period 2|Discontinuation criteria|0|||
160967867|NCT00542880|581270181|FG000|Period 2|Severe non-compliance|0|||
160967868|NCT00542880|581270182|FG001|Period 2|Severe non-compliance|1|||
160967869|NCT00542880|581270181|FG000|Period 2|Other|0|||
160967870|NCT00542880|581270182|FG001|Period 2|Other|1|||
160967871|NCT00542880|581270181|FG000|Period 3|Adverse Event|0|||
160967872|NCT00542880|581270182|FG001|Period 3|Adverse Event|2|||
160967873|NCT00982930|581270187|FG000|Overall Study|Adverse Event|1|||
160967874|NCT00982930|581270187|FG000|Overall Study|Withdrawal by Subject|1|||
160967875|NCT00982930|581270187|FG000|Overall Study|Administrative Problems|2|||
160967876|NCT04179721|581270188|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
160967877|NCT04179721|581270189|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
160967878|NCT04179721|581270188|FG000|Overall Study|Lost to Follow-up|0|||
161012528|NCT00073749|581432742|FG001|Overall Study|Death|1|||
161012529|NCT00073749|581432743|FG002|Overall Study|Death|1|||
161012530|NCT00073749|581432744|FG003|Overall Study|Death|0|||
161012531|NCT00073749|581432745|FG004|Overall Study|Death|0|||
161012532|NCT00073749|581432746|FG005|Overall Study|Death|0|||
161012533|NCT00073749|581432747|FG006|Overall Study|Death|29|||
161012534|NCT00073749|581432741|FG000|Overall Study|Adverse Event|0|||
161012535|NCT00073749|581432742|FG001|Overall Study|Adverse Event|3|||
161012536|NCT00073749|581432743|FG002|Overall Study|Adverse Event|6|||
161012537|NCT00073749|581432744|FG003|Overall Study|Adverse Event|4|||
161012538|NCT00073749|581432745|FG004|Overall Study|Adverse Event|2|||
161012539|NCT00073749|581432746|FG005|Overall Study|Adverse Event|1|||
161012540|NCT00073749|581432747|FG006|Overall Study|Adverse Event|0|||
161012541|NCT00073749|581432741|FG000|Overall Study|Physician Decision|0|||
161012542|NCT00073749|581432742|FG001|Overall Study|Physician Decision|0|||
161012543|NCT00073749|581432743|FG002|Overall Study|Physician Decision|1|||
161012544|NCT00073749|581432744|FG003|Overall Study|Physician Decision|0|||
161012545|NCT00073749|581432745|FG004|Overall Study|Physician Decision|0|||
161012546|NCT00073749|581432746|FG005|Overall Study|Physician Decision|2|||
161012547|NCT00073749|581432747|FG006|Overall Study|Physician Decision|0|||
161012548|NCT00073749|581432741|FG000|Overall Study|Withdrawal by Subject|0|||
161012549|NCT00073749|581432742|FG001|Overall Study|Withdrawal by Subject|1|||
161012550|NCT00073749|581432743|FG002|Overall Study|Withdrawal by Subject|0|||
161012551|NCT00073749|581432744|FG003|Overall Study|Withdrawal by Subject|0|||
161012552|NCT00073749|581432745|FG004|Overall Study|Withdrawal by Subject|1|||
161012553|NCT00073749|581432746|FG005|Overall Study|Withdrawal by Subject|0|||
161012554|NCT00073749|581432747|FG006|Overall Study|Withdrawal by Subject|2|||
161012555|NCT00073749|581432741|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161012556|NCT00073749|581432742|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161012557|NCT00073749|581432743|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161012558|NCT00073749|581432744|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161012559|NCT00073749|581432745|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161012560|NCT00073749|581432746|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161272147|NCT03151408|582377577|FG001|Overall Study|other reasons|52|||
161272148|NCT03151408|582377576|FG000|Overall Study|randomized and not treated|2|||
161272149|NCT03151408|582377577|FG001|Overall Study|randomized and not treated|2|||
161012561|NCT00073749|581432747|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
161012562|NCT00073749|581432741|FG000|Overall Study|Lost to Follow-up|0|||
161012563|NCT00073749|581432742|FG001|Overall Study|Lost to Follow-up|0|||
161012564|NCT00073749|581432743|FG002|Overall Study|Lost to Follow-up|0|||
161012565|NCT00073749|581432744|FG003|Overall Study|Lost to Follow-up|0|||
161012566|NCT00073749|581432745|FG004|Overall Study|Lost to Follow-up|0|||
161012567|NCT00073749|581432746|FG005|Overall Study|Lost to Follow-up|0|||
161012568|NCT00073749|581432747|FG006|Overall Study|Lost to Follow-up|2|||
161012569|NCT00073749|581432741|FG000|Overall Study|Other|0|||
161012570|NCT00073749|581432742|FG001|Overall Study|Other|0|||
161012571|NCT00073749|581432743|FG002|Overall Study|Other|0|||
161012572|NCT00073749|581432744|FG003|Overall Study|Other|0|||
161012573|NCT00073749|581432745|FG004|Overall Study|Other|0|||
161012574|NCT00073749|581432746|FG005|Overall Study|Other|2|||
161012575|NCT00073749|581432747|FG006|Overall Study|Other|0|||
161012576|NCT02272816|581432748|FG000|Overall Study|Adverse Event|1|||
161012577|NCT00065260|581432752|FG000|Overall Study|Death|0|||
161012578|NCT00065260|581432753|FG001|Overall Study|Death|1|||
161012579|NCT00001277|581432754|FG000|Overall Study|Adverse Event|0|||
161012580|NCT00001277|581432755|FG001|Overall Study|Adverse Event|0|||
161012581|NCT00001277|581432756|FG002|Overall Study|Adverse Event|1|||
161012582|NCT00001277|581432754|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
161012583|NCT00001277|581432755|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
161012584|NCT00001277|581432756|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
161012585|NCT00088413|581432759|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161012586|NCT00088413|581432760|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161147668|NCT01845077|581922536|FG005|Washout Period|Adverse Event|0|||
161147669|NCT01845077|581922531|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
161272150|NCT01119508|582377578|FG000|Overall Study|Adverse Event|56|||
161272151|NCT01119508|582377578|FG000|Overall Study|Withdrawal by Subject|2|||
161272152|NCT01119508|582377578|FG000|Overall Study|Died before tumor response evaluation|1|||
161272153|NCT00265395|582377579|FG000|Overall Study|Adverse Event|3|||
161012587|NCT00088413|581432761|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
161012588|NCT00088413|581432762|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
161012589|NCT00088413|581432759|FG000|Overall Study|Adverse Events/Side Effects|0|||
161012590|NCT00088413|581432760|FG001|Overall Study|Adverse Events/Side Effects|1|||
161012591|NCT00088413|581432761|FG002|Overall Study|Adverse Events/Side Effects|1|||
161012592|NCT00088413|581432762|FG003|Overall Study|Adverse Events/Side Effects|0|||
161012593|NCT00088413|581432759|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
161012594|NCT00088413|581432760|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
161012595|NCT00088413|581432761|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
161012596|NCT00088413|581432762|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
161012597|NCT00088413|581432759|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
161147670|NCT01845077|581922532|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
161272154|NCT00265395|582377580|FG001|Overall Study|Adverse Event|6|||
161012598|NCT00088413|581432760|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
161012599|NCT00088413|581432761|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
161012600|NCT00088413|581432762|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
161012601|NCT00088413|581432759|FG000|Overall Study|Death|0|||
161012602|NCT00088413|581432760|FG001|Overall Study|Death|1|||
161012603|NCT00088413|581432761|FG002|Overall Study|Death|0|||
161012604|NCT00088413|581432762|FG003|Overall Study|Death|0|||
161012605|NCT00088413|581432759|FG000|Overall Study|Progressive disease|9|||
161012606|NCT00088413|581432760|FG001|Overall Study|Progressive disease|11|||
161012607|NCT00088413|581432761|FG002|Overall Study|Progressive disease|8|||
161012608|NCT00088413|581432762|FG003|Overall Study|Progressive disease|14|||
161012609|NCT00088413|581432759|FG000|Overall Study|Other|0|||
161012610|NCT00088413|581432760|FG001|Overall Study|Other|1|||
161012611|NCT00088413|581432761|FG002|Overall Study|Other|0|||
161012612|NCT00088413|581432762|FG003|Overall Study|Other|0|||
161012613|NCT00088413|581432759|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
161012614|NCT00088413|581432760|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
161012615|NCT00088413|581432761|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
161012616|NCT00088413|581432762|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
161012617|NCT04820686|581432763|FG000|Overall Study|Withdrawal by Subject|5|||
161012618|NCT04820686|581432764|FG001|Overall Study|Withdrawal by Subject|2|||
161012619|NCT04820686|581432765|FG002|Overall Study|Withdrawal by Subject|3|||
161012620|NCT04820686|581432763|FG000|Overall Study|Study Termination|25|||
161012621|NCT04820686|581432764|FG001|Overall Study|Study Termination|13|||
161012622|NCT04820686|581432765|FG002|Overall Study|Study Termination|14|||
161012623|NCT04820686|581432763|FG000|Overall Study|Adverse Event|0|||
161012624|NCT04820686|581432764|FG001|Overall Study|Adverse Event|1|||
161012625|NCT04820686|581432765|FG002|Overall Study|Adverse Event|0|||
161012626|NCT04048382|581432766|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
161012627|NCT04048382|581432767|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
161012628|NCT04048382|581432766|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
161012629|NCT04048382|581432767|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
161012630|NCT04048382|581432766|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
161012631|NCT04048382|581432767|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
161012632|NCT02119650|581432771|FG000|Overall Study|Adverse Event|3|||
161012633|NCT02119650|581432772|FG001|Overall Study|Adverse Event|4|||
161012634|NCT02119650|581432771|FG000|Overall Study|Subject decision|2|||
161012635|NCT02119650|581432772|FG001|Overall Study|Subject decision|3|||
161012636|NCT02119650|581432771|FG000|Overall Study|Disease progression|11|||
161012637|NCT02119650|581432772|FG001|Overall Study|Disease progression|14|||
161012638|NCT02119650|581432771|FG000|Overall Study|Death|5|||
161012639|NCT02119650|581432772|FG001|Overall Study|Death|1|||
161012640|NCT02119650|581432771|FG000|Overall Study|Noncompliance with study treatment|1|||
161012641|NCT02119650|581432772|FG001|Overall Study|Noncompliance with study treatment|1|||
161012642|NCT02119650|581432771|FG000|Overall Study|Study terminated by the sponsor|1|||
161012643|NCT02119650|581432772|FG001|Overall Study|Study terminated by the sponsor|0|||
161012644|NCT02119650|581432771|FG000|Overall Study|Physician Decision|0|||
161012645|NCT02119650|581432772|FG001|Overall Study|Physician Decision|2|||
161012646|NCT02119650|581432771|FG000|Overall Study|Multiple reasons for termination|2|||
161012647|NCT02119650|581432772|FG001|Overall Study|Multiple reasons for termination|1|||
161012648|NCT01037985|581432774|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
161012649|NCT01037985|581432775|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
161012650|NCT01037985|581432774|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
161012651|NCT01037985|581432775|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
161012652|NCT01037985|581432774|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
161012653|NCT01037985|581432775|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
161012654|NCT01037985|581432774|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
161012655|NCT01037985|581432775|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
161012656|NCT02269475|581432776|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
161012657|NCT02269475|581432777|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
161012658|NCT02269475|581432776|FG000|Overall Study|Withdrawal by Subject|0|||
161147671|NCT01845077|581922533|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
161147672|NCT01845077|581922534|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
161012659|NCT02269475|581432777|FG001|Overall Study|Withdrawal by Subject|1|||
161012660|NCT03481816|581432778|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
161012661|NCT03481816|581432779|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
161012662|NCT03481816|581432778|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
161012663|NCT03481816|581432779|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
161012664|NCT03481816|581432778|FG000|Dose Expansion|Withdrawal by Subject|0|||
161012665|NCT03481816|581432779|FG001|Dose Expansion|Withdrawal by Subject|2|||
161012666|NCT03481816|581432778|FG000|Dose Expansion|Physician Decision|0|||
161012667|NCT03481816|581432779|FG001|Dose Expansion|Physician Decision|5|||
161012668|NCT02730871|581432782|FG000|Overall Study|Adverse Event|6|||
161012669|NCT02730871|581432783|FG001|Overall Study|Adverse Event|0|||
161012670|NCT05368558|581432785|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
161012671|NCT05368558|581432786|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
161012672|NCT05368558|581432787|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
161012673|NCT05368558|581432788|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012674|NCT05368558|581432789|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012675|NCT05368558|581432790|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012676|NCT05368558|581432791|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012677|NCT05368558|581432792|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012678|NCT05368558|581432793|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012679|NCT05368558|581432794|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012680|NCT05368558|581432795|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012681|NCT05368558|581432796|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
161012682|NCT05368558|581432785|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012683|NCT05368558|581432786|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012684|NCT05368558|581432787|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012685|NCT05368558|581432788|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
161012686|NCT05368558|581432789|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
160967879|NCT04179721|581270189|FG001|Overall Study|Lost to Follow-up|1|||
160967880|NCT01392300|581271338|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
160967881|NCT01392300|581271339|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
160967882|NCT01392300|581271340|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
160967883|NCT01392300|581271338|FG000|Main Period (MP)|Withdrawal by Subject|5|||
160967884|NCT01392300|581271339|FG001|Main Period (MP)|Withdrawal by Subject|1|||
160967885|NCT01392300|581271340|FG002|Main Period (MP)|Withdrawal by Subject|0|||
160967886|NCT01392300|581271338|FG000|Main Period (MP)|Lost to Follow-up|3|||
160967887|NCT01392300|581271339|FG001|Main Period (MP)|Lost to Follow-up|3|||
160967888|NCT01392300|581271340|FG002|Main Period (MP)|Lost to Follow-up|0|||
160967889|NCT01392300|581271338|FG000|Main Period (MP)|Non-compliance|1|||
160967890|NCT01392300|581271339|FG001|Main Period (MP)|Non-compliance|0|||
160967891|NCT01392300|581271340|FG002|Main Period (MP)|Non-compliance|0|||
160967892|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
160967893|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
160967894|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
160967895|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
160967896|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
160967897|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
160967898|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
160967899|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
160967900|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
160967901|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Death|0|||
160967902|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Death|0|||
160967903|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Death|4|||
160967904|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
160967905|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
160967906|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
160967907|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
160967908|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
160967909|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
160967910|NCT01392300|581271338|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
160967911|NCT01392300|581271339|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
160967912|NCT01392300|581271340|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
160967913|NCT01147822|581271345|FG000|Overall Study|Lost to Follow-up|14|||
160967914|NCT01147822|581271346|FG001|Overall Study|Lost to Follow-up|6|||
160967915|NCT01147822|581271345|FG000|Overall Study|Withdrawal by Subject|10|||
160967916|NCT01147822|581271346|FG001|Overall Study|Withdrawal by Subject|16|||
160967917|NCT01147822|581271345|FG000|Overall Study|Physician Decision|9|||
160967918|NCT01147822|581271346|FG001|Overall Study|Physician Decision|8|||
160967919|NCT01147822|581271345|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
160967920|NCT01147822|581271346|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
160967921|NCT01147822|581271345|FG000|Overall Study|Protocol Violation|1|||
160967922|NCT01147822|581271346|FG001|Overall Study|Protocol Violation|1|||
160967923|NCT03010462|581271350|FG000|Overall Study|Withdrawal by Subject|3|||
160967924|NCT03010462|581271351|FG001|Overall Study|Withdrawal by Subject|1|||
160967925|NCT01966003|581271352|FG000|Overall Study|Death|43|||
160967926|NCT01966003|581271353|FG001|Overall Study|Death|36|||
160967927|NCT01966003|581271352|FG000|Overall Study|Protocol Violation|6|||
160967928|NCT01966003|581271353|FG001|Overall Study|Protocol Violation|4|||
160967929|NCT01966003|581271352|FG000|Overall Study|Lost to Follow-up|4|||
160967930|NCT01966003|581271353|FG001|Overall Study|Lost to Follow-up|3|||
161012687|NCT05368558|581432790|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
161012688|NCT05368558|581432791|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012689|NCT05368558|581432792|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012690|NCT05368558|581432793|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012691|NCT05368558|581432794|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012692|NCT05368558|581432795|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161012693|NCT05368558|581432796|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
161343536|NCT00207740|582644408|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161012694|NCT05368558|581432785|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012695|NCT05368558|581432786|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012696|NCT05368558|581432787|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012697|NCT05368558|581432788|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
161012698|NCT05368558|581432789|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012699|NCT05368558|581432790|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012700|NCT05368558|581432791|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012701|NCT05368558|581432792|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012702|NCT05368558|581432793|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012703|NCT05368558|581432794|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012704|NCT05368558|581432795|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012705|NCT05368558|581432796|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
161012706|NCT05368558|581432785|FG000|Blinded Extension Period (BEP)|other|0|||
161012707|NCT05368558|581432786|FG001|Blinded Extension Period (BEP)|other|0|||
161012708|NCT05368558|581432787|FG002|Blinded Extension Period (BEP)|other|0|||
161012709|NCT05368558|581432788|FG003|Blinded Extension Period (BEP)|other|0|||
161012710|NCT05368558|581432789|FG004|Blinded Extension Period (BEP)|other|0|||
161012711|NCT05368558|581432790|FG005|Blinded Extension Period (BEP)|other|1|||
161012712|NCT05368558|581432791|FG006|Blinded Extension Period (BEP)|other|0|||
161012713|NCT05368558|581432792|FG007|Blinded Extension Period (BEP)|other|0|||
161012714|NCT05368558|581432793|FG008|Blinded Extension Period (BEP)|other|0|||
161012715|NCT05368558|581432794|FG009|Blinded Extension Period (BEP)|other|0|||
161012716|NCT05368558|581432795|FG010|Blinded Extension Period (BEP)|other|0|||
161012717|NCT05368558|581432796|FG011|Blinded Extension Period (BEP)|other|0|||
161012718|NCT00774852|581432797|FG000|Overall Study|Adverse Event|9|||
161012719|NCT00774852|581432798|FG001|Overall Study|Adverse Event|6|||
161012720|NCT00774852|581432797|FG000|Overall Study|Death|2|||
161012721|NCT00774852|581432798|FG001|Overall Study|Death|1|||
161012722|NCT00774852|581432797|FG000|Overall Study|Lack of Efficacy|3|||
161012723|NCT00774852|581432798|FG001|Overall Study|Lack of Efficacy|7|||
161012724|NCT00774852|581432797|FG000|Overall Study|Lost to Follow-up|9|||
161012725|NCT00774852|581432798|FG001|Overall Study|Lost to Follow-up|5|||
161012726|NCT00774852|581432797|FG000|Overall Study|Physician Decision|2|||
161012727|NCT00774852|581432798|FG001|Overall Study|Physician Decision|6|||
161012728|NCT00774852|581432797|FG000|Overall Study|Pregnancy|1|||
161012729|NCT00774852|581432798|FG001|Overall Study|Pregnancy|2|||
161012730|NCT00774852|581432797|FG000|Overall Study|Withdrawal by Subject|2|||
161012731|NCT00774852|581432798|FG001|Overall Study|Withdrawal by Subject|2|||
161012732|NCT00774852|581432797|FG000|Overall Study|Non-responder|15|||
161012733|NCT00774852|581432798|FG001|Overall Study|Non-responder|11|||
161012734|NCT00774852|581432797|FG000|Overall Study|Subject non-compliance|0|||
161012735|NCT00774852|581432798|FG001|Overall Study|Subject non-compliance|1|||
161012736|NCT00774852|581432797|FG000|Overall Study|Protocol Violation|1|||
161012737|NCT00774852|581432798|FG001|Overall Study|Protocol Violation|0|||
161012738|NCT00774852|581432797|FG000|Overall Study|Subject received prohibited medication|1|||
161012739|NCT00774852|581432798|FG001|Overall Study|Subject received prohibited medication|0|||
161012740|NCT04428112|581432799|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
161012741|NCT04428112|581432800|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
161012742|NCT04428112|581432799|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
161012743|NCT04428112|581432800|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
161012744|NCT04428112|581432799|FG000|Overall Study|Withdrawal by Subject|9|||
161012745|NCT04428112|581432800|FG001|Overall Study|Withdrawal by Subject|4|||
161012746|NCT04428112|581432799|FG000|Overall Study|Lost to Follow-up|27|||
161012747|NCT04428112|581432800|FG001|Overall Study|Lost to Follow-up|7|||
161012748|NCT01303445|581432803|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
161012749|NCT01303445|581432804|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
161012750|NCT01303445|581432803|FG000|Second Intervention (7 Days)|Adverse Event|0|||
161012751|NCT01303445|581432804|FG001|Second Intervention (7 Days)|Adverse Event|2|||
161012752|NCT01303445|581432803|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
161012753|NCT01303445|581432804|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
161012754|NCT01303445|581432803|FG000|Washout (14 Days)|Protocol Violation|1|||
161012755|NCT01303445|581432804|FG001|Washout (14 Days)|Protocol Violation|0|||
161012756|NCT01303445|581432803|FG000|Washout (14 Days)|Lost to Follow-up|0|||
161012757|NCT01303445|581432804|FG001|Washout (14 Days)|Lost to Follow-up|2|||
161012758|NCT01303445|581432803|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
161012759|NCT01303445|581432804|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
161012760|NCT01303445|581432803|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
161012761|NCT01303445|581432804|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
161012762|NCT04459416|581434881|FG000|Overall Study|Lost to Follow-up|2|||
161012763|NCT04459416|581434882|FG001|Overall Study|Lost to Follow-up|0|||
161012764|NCT04459416|581434881|FG000|Overall Study|Withdrawal by Subject|8|||
161012765|NCT04459416|581434882|FG001|Overall Study|Withdrawal by Subject|10|||
161012766|NCT04459416|581434881|FG000|Overall Study|Disease progression|0|||
161012767|NCT04459416|581434882|FG001|Overall Study|Disease progression|3|||
161012768|NCT03744312|581434883|FG000|Overall Study|Withdrawal by Subject|0|||
161012769|NCT03744312|581434884|FG001|Overall Study|Withdrawal by Subject|1|||
161012770|NCT03744312|581434883|FG000|Overall Study|Screen fail|0|||
161012771|NCT03744312|581434884|FG001|Overall Study|Screen fail|1|||
161012772|NCT05134337|581434885|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
161012773|NCT05134337|581434886|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
161012774|NCT04923347|581434887|FG000|Overall Study|Withdrawal by Subject|14|||
161012775|NCT01259401|581434888|FG000|4-month Follow-up|Death|0|||
161012776|NCT01259401|581434889|FG001|4-month Follow-up|Death|1|||
161012777|NCT01259401|581434888|FG000|4-month Follow-up|Lost to Follow-up|0|||
161012778|NCT01259401|581434889|FG001|4-month Follow-up|Lost to Follow-up|1|||
161012779|NCT05756075|581434894|FG000|Overall Study|Withdrawal by Subject|16|||
161012780|NCT05756075|581434895|FG001|Overall Study|Withdrawal by Subject|9|||
161012781|NCT01991977|581434896|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
161012782|NCT01991977|581434896|FG000|Overall Study|Withdrew after start of treatment|5|||
161012783|NCT02201108|581434898|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
161012784|NCT02201108|581434899|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
161012785|NCT02201108|581434900|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
161012786|NCT02201108|581434898|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
161012787|NCT02201108|581434899|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
161012788|NCT02201108|581434900|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
161012789|NCT02201108|581434898|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
161012790|NCT02201108|581434899|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
161012791|NCT02201108|581434900|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
161012792|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
161012793|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
161012794|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
161012795|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
161012796|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
161012797|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
161012798|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Other reason|4|||
161012799|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Other reason|7|||
161012800|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Other reason|0|||
161012801|NCT02201108|581434898|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
161012802|NCT02201108|581434899|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
161012803|NCT02201108|581434900|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
161012804|NCT02201108|581434898|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
161012805|NCT02201108|581434899|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
161012806|NCT02201108|581434900|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
161012807|NCT02201108|581434898|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
161012808|NCT02201108|581434899|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
161012809|NCT02201108|581434900|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
161012810|NCT03055377|581434901|FG000|Treatment Phase|Lost to Follow-up|28|||
161012811|NCT03055377|581434902|FG001|Treatment Phase|Lost to Follow-up|24|||
161012812|NCT03055377|581434901|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
161012813|NCT03055377|581434902|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
161012814|NCT04143061|581434903|FG000|Overall Study|Protocol Deviation|0|||
161012815|NCT04143061|581434904|FG001|Overall Study|Protocol Deviation|0|||
161012816|NCT04143061|581434905|FG002|Overall Study|Protocol Deviation|0|||
161012817|NCT04143061|581434906|FG003|Overall Study|Protocol Deviation|0|||
161147673|NCT01845077|581922535|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
161147674|NCT01845077|581922536|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
161147675|NCT01845077|581922531|FG000|Washout Period|Protocol Violation|0|||
161012818|NCT04143061|581434907|FG004|Overall Study|Protocol Deviation|0|||
161012819|NCT04143061|581434908|FG005|Overall Study|Protocol Deviation|0|||
161147676|NCT01845077|581922532|FG001|Washout Period|Protocol Violation|0|||
161012820|NCT04143061|581434909|FG006|Overall Study|Protocol Deviation|5|||
161012821|NCT04143061|581434910|FG007|Overall Study|Protocol Deviation|5|||
161012822|NCT04143061|581434903|FG000|Overall Study|Withdrawal by Subject|2|||
161012823|NCT04143061|581434904|FG001|Overall Study|Withdrawal by Subject|0|||
161012824|NCT04143061|581434905|FG002|Overall Study|Withdrawal by Subject|0|||
161012825|NCT04143061|581434906|FG003|Overall Study|Withdrawal by Subject|0|||
161012826|NCT04143061|581434907|FG004|Overall Study|Withdrawal by Subject|0|||
161012827|NCT04143061|581434908|FG005|Overall Study|Withdrawal by Subject|1|||
161012828|NCT04143061|581434909|FG006|Overall Study|Withdrawal by Subject|0|||
161012829|NCT04143061|581434910|FG007|Overall Study|Withdrawal by Subject|0|||
161272155|NCT00265395|582377579|FG000|Overall Study|Lost to Follow-up|2|||
161272156|NCT00265395|582377580|FG001|Overall Study|Lost to Follow-up|1|||
161272157|NCT00265395|582377579|FG000|Overall Study|Withdrawal by Subject|1|||
161012830|NCT04143061|581434903|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161012831|NCT04143061|581434904|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161012832|NCT04143061|581434905|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161012833|NCT04143061|581434906|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161012834|NCT04143061|581434907|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
161012835|NCT04143061|581434908|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
161012836|NCT04143061|581434909|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
161012837|NCT04143061|581434910|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
161012838|NCT03289039|581434911|FG000|Overall Study|Withdrawal by Subject|0|||
161012839|NCT03289039|581434912|FG001|Overall Study|Withdrawal by Subject|1|||
161012840|NCT03289039|581434911|FG000|Overall Study|Became ineligible prior to treatment start|0|||
161012841|NCT03289039|581434912|FG001|Overall Study|Became ineligible prior to treatment start|1|||
161012842|NCT03289039|581434911|FG000|Overall Study|progressed before treatment start|1|||
161012843|NCT03289039|581434912|FG001|Overall Study|progressed before treatment start|0|||
161012844|NCT04586920|581434913|FG000|Overall Study|Lost to Follow-up|0|||
161012845|NCT04586920|581434914|FG001|Overall Study|Lost to Follow-up|0|||
161012846|NCT04586920|581434915|FG002|Overall Study|Lost to Follow-up|0|||
161012847|NCT04586920|581434916|FG003|Overall Study|Lost to Follow-up|0|||
161012848|NCT04586920|581434917|FG004|Overall Study|Lost to Follow-up|0|||
161012849|NCT04586920|581434918|FG005|Overall Study|Lost to Follow-up|0|||
161012850|NCT04586920|581434919|FG006|Overall Study|Lost to Follow-up|1|||
161012851|NCT04586920|581434920|FG007|Overall Study|Lost to Follow-up|1|||
161012852|NCT04586920|581434921|FG008|Overall Study|Lost to Follow-up|0|||
161012853|NCT04586920|581434922|FG009|Overall Study|Lost to Follow-up|1|||
161012854|NCT04586920|581434923|FG010|Overall Study|Lost to Follow-up|0|||
161012855|NCT04586920|581434924|FG011|Overall Study|Lost to Follow-up|0|||
161012856|NCT04586920|581434925|FG012|Overall Study|Lost to Follow-up|0|||
161012857|NCT04586920|581434926|FG013|Overall Study|Lost to Follow-up|1|||
161012858|NCT04586920|581434927|FG014|Overall Study|Lost to Follow-up|0|||
161012859|NCT04586920|581434928|FG015|Overall Study|Lost to Follow-up|0|||
161012860|NCT04586920|581434929|FG016|Overall Study|Lost to Follow-up|0|||
161012861|NCT04586920|581434930|FG017|Overall Study|Lost to Follow-up|0|||
161012862|NCT04586920|581434913|FG000|Overall Study|Withdrawal by Subject|0|||
161012863|NCT04586920|581434914|FG001|Overall Study|Withdrawal by Subject|0|||
161012864|NCT04586920|581434915|FG002|Overall Study|Withdrawal by Subject|0|||
161012865|NCT04586920|581434916|FG003|Overall Study|Withdrawal by Subject|0|||
161012866|NCT04586920|581434917|FG004|Overall Study|Withdrawal by Subject|0|||
161012867|NCT04586920|581434918|FG005|Overall Study|Withdrawal by Subject|0|||
161012868|NCT04586920|581434919|FG006|Overall Study|Withdrawal by Subject|0|||
161012869|NCT04586920|581434920|FG007|Overall Study|Withdrawal by Subject|1|||
161012870|NCT04586920|581434921|FG008|Overall Study|Withdrawal by Subject|0|||
161012871|NCT04586920|581434922|FG009|Overall Study|Withdrawal by Subject|1|||
161012872|NCT04586920|581434923|FG010|Overall Study|Withdrawal by Subject|0|||
161012873|NCT04586920|581434924|FG011|Overall Study|Withdrawal by Subject|1|||
161012874|NCT04586920|581434925|FG012|Overall Study|Withdrawal by Subject|0|||
161012875|NCT04586920|581434926|FG013|Overall Study|Withdrawal by Subject|0|||
161012876|NCT04586920|581434927|FG014|Overall Study|Withdrawal by Subject|0|||
161012877|NCT04586920|581434928|FG015|Overall Study|Withdrawal by Subject|0|||
161012878|NCT04586920|581434929|FG016|Overall Study|Withdrawal by Subject|0|||
161012879|NCT04586920|581434930|FG017|Overall Study|Withdrawal by Subject|0|||
161012880|NCT02287311|581434931|FG000|Cohort 1: Dose Level 1|Death|2|||
161272158|NCT00265395|582377580|FG001|Overall Study|Withdrawal by Subject|6|||
161272159|NCT00265395|582377579|FG000|Overall Study|Protocol Violation|2|||
161012881|NCT02287311|581434932|FG001|Cohort 1: Dose Level 1|Death|0|||
161012882|NCT02287311|581434933|FG002|Cohort 1: Dose Level 1|Death|0|||
161012883|NCT02287311|581434934|FG003|Cohort 1: Dose Level 1|Death|3|||
161012884|NCT02287311|581434935|FG004|Cohort 1: Dose Level 1|Death|0|||
161012885|NCT02287311|581434936|FG005|Cohort 1: Dose Level 1|Death|0|||
161012886|NCT02287311|581434937|FG006|Cohort 1: Dose Level 1|Death|1|||
161012887|NCT02287311|581434938|FG007|Cohort 1: Dose Level 1|Death|0|||
161272160|NCT00265395|582377580|FG001|Overall Study|Protocol Violation|2|||
161012888|NCT02287311|581434939|FG008|Cohort 1: Dose Level 1|Death|0|||
161012889|NCT02287311|581434931|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012890|NCT02287311|581434932|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012891|NCT02287311|581434933|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012892|NCT02287311|581434934|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
161012893|NCT02287311|581434935|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012894|NCT02287311|581434936|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012895|NCT02287311|581434937|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
161012896|NCT02287311|581434938|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012897|NCT02287311|581434939|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
161012898|NCT02287311|581434931|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
161012899|NCT02287311|581434932|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
161012900|NCT02287311|581434933|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
161012901|NCT02287311|581434934|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
161012902|NCT02287311|581434935|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
161012903|NCT02287311|581434936|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
161012904|NCT02287311|581434937|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
161012905|NCT02287311|581434938|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
161012906|NCT02287311|581434939|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
161012907|NCT02287311|581434931|FG000|Cohort 2: Dose Level 2|Death|0|||
161012908|NCT02287311|581434932|FG001|Cohort 2: Dose Level 2|Death|2|||
161012909|NCT02287311|581434933|FG002|Cohort 2: Dose Level 2|Death|0|||
161012910|NCT02287311|581434934|FG003|Cohort 2: Dose Level 2|Death|0|||
161012911|NCT02287311|581434935|FG004|Cohort 2: Dose Level 2|Death|2|||
161012912|NCT02287311|581434936|FG005|Cohort 2: Dose Level 2|Death|0|||
161012913|NCT02287311|581434937|FG006|Cohort 2: Dose Level 2|Death|0|||
161012914|NCT02287311|581434938|FG007|Cohort 2: Dose Level 2|Death|2|||
161012915|NCT02287311|581434939|FG008|Cohort 2: Dose Level 2|Death|0|||
161012916|NCT02287311|581434931|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012917|NCT02287311|581434932|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012918|NCT02287311|581434933|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012919|NCT02287311|581434934|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012920|NCT02287311|581434935|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
161012921|NCT02287311|581434936|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012922|NCT02287311|581434937|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012923|NCT02287311|581434938|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012924|NCT02287311|581434939|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
161012925|NCT02287311|581434931|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012926|NCT02287311|581434932|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
161012927|NCT02287311|581434933|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012928|NCT02287311|581434934|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012929|NCT02287311|581434935|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012930|NCT02287311|581434936|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012931|NCT02287311|581434937|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012932|NCT02287311|581434938|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012933|NCT02287311|581434939|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
161012934|NCT02287311|581434931|FG000|Cohort 3: Dose Level 3|Death|0|||
161012935|NCT02287311|581434932|FG001|Cohort 3: Dose Level 3|Death|0|||
161012936|NCT02287311|581434933|FG002|Cohort 3: Dose Level 3|Death|4|||
161012937|NCT02287311|581434934|FG003|Cohort 3: Dose Level 3|Death|0|||
161012938|NCT02287311|581434935|FG004|Cohort 3: Dose Level 3|Death|0|||
161012939|NCT02287311|581434936|FG005|Cohort 3: Dose Level 3|Death|4|||
161012940|NCT02287311|581434937|FG006|Cohort 3: Dose Level 3|Death|0|||
161012941|NCT02287311|581434938|FG007|Cohort 3: Dose Level 3|Death|0|||
161012942|NCT02287311|581434939|FG008|Cohort 3: Dose Level 3|Death|2|||
161012943|NCT02287311|581434931|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012944|NCT02287311|581434932|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012945|NCT02287311|581434933|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
161012946|NCT02287311|581434934|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012947|NCT02287311|581434935|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012948|NCT02287311|581434936|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
161012949|NCT02287311|581434937|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012950|NCT02287311|581434938|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012951|NCT02287311|581434939|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
161012952|NCT02287311|581434931|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012953|NCT02287311|581434932|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012954|NCT02287311|581434933|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012955|NCT02287311|581434934|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012956|NCT02287311|581434935|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012957|NCT02287311|581434936|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
161147677|NCT01845077|581922533|FG002|Washout Period|Protocol Violation|0|||
161147678|NCT01845077|581922534|FG003|Washout Period|Protocol Violation|1|||
161012958|NCT02287311|581434937|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161012959|NCT02287311|581434938|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
161147679|NCT01845077|581922535|FG004|Washout Period|Protocol Violation|1|||
161147680|NCT01845077|581922536|FG005|Washout Period|Protocol Violation|0|||
161012960|NCT02287311|581434939|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
161012961|NCT02724956|581434944|FG000|Overall Study|Physician Decision|1|||
161012962|NCT02724956|581434945|FG001|Overall Study|Physician Decision|0|||
161012963|NCT02724956|581434944|FG000|Overall Study|Lack of Efficacy|0|||
161012964|NCT02724956|581434945|FG001|Overall Study|Lack of Efficacy|1|||
161147681|NCT00312377|581922539|FG000|Overall Study|Death|403|||
161012965|NCT02724956|581434944|FG000|Overall Study|Withdrawal by Subject|0|||
161012966|NCT02724956|581434945|FG001|Overall Study|Withdrawal by Subject|1|||
161012967|NCT04436107|581434951|FG000|Overall Study|Sponsor Ended Study|2|||
161012968|NCT04436107|581434952|FG001|Overall Study|Sponsor Ended Study|4|||
161012969|NCT04436107|581434953|FG002|Overall Study|Sponsor Ended Study|8|||
161012970|NCT04436107|581434954|FG003|Overall Study|Sponsor Ended Study|20|||
161012971|NCT04436107|581434951|FG000|Overall Study|Death|3|||
161012972|NCT04436107|581434952|FG001|Overall Study|Death|5|||
161012973|NCT04436107|581434953|FG002|Overall Study|Death|3|||
161012974|NCT04436107|581434954|FG003|Overall Study|Death|18|||
161012975|NCT04436107|581434951|FG000|Overall Study|Withdrawal by Subject|1|||
161012976|NCT04436107|581434952|FG001|Overall Study|Withdrawal by Subject|1|||
161012977|NCT04436107|581434953|FG002|Overall Study|Withdrawal by Subject|0|||
161012978|NCT04436107|581434954|FG003|Overall Study|Withdrawal by Subject|1|||
161012979|NCT01095796|581434955|FG000|Overall Study|Randomized but Not Treated|5|||
161012980|NCT01095796|581434956|FG001|Overall Study|Randomized but Not Treated|2|||
161012981|NCT01095796|581434955|FG000|Overall Study|Adverse Event|9|||
161012982|NCT01095796|581434956|FG001|Overall Study|Adverse Event|19|||
161012983|NCT01095796|581434955|FG000|Overall Study|Death|3|||
161012984|NCT01095796|581434956|FG001|Overall Study|Death|2|||
161012985|NCT01095796|581434955|FG000|Overall Study|Pregnancy|2|||
161012986|NCT01095796|581434956|FG001|Overall Study|Pregnancy|0|||
161012987|NCT01095796|581434955|FG000|Overall Study|Lack of Efficacy|5|||
161012988|NCT01095796|581434956|FG001|Overall Study|Lack of Efficacy|3|||
161012989|NCT01095796|581434955|FG000|Overall Study|Investigator's Discretion|7|||
161012990|NCT01095796|581434956|FG001|Overall Study|Investigator's Discretion|2|||
161012991|NCT01095796|581434955|FG000|Overall Study|Withdrew Consent|16|||
161012992|NCT01095796|581434956|FG001|Overall Study|Withdrew Consent|22|||
161012993|NCT01095796|581434955|FG000|Overall Study|Lost to Follow-up|27|||
161012994|NCT01095796|581434956|FG001|Overall Study|Lost to Follow-up|29|||
161012995|NCT01095796|581434955|FG000|Overall Study|Participant Noncompliance|5|||
161012996|NCT01095796|581434956|FG001|Overall Study|Participant Noncompliance|10|||
161012997|NCT01095796|581434955|FG000|Overall Study|Protocol Violation|1|||
161012998|NCT01095796|581434956|FG001|Overall Study|Protocol Violation|0|||
161012999|NCT01095796|581434955|FG000|Overall Study|Participant Transferred to Another Study|215|||
161013000|NCT01095796|581434956|FG001|Overall Study|Participant Transferred to Another Study|200|||
161013001|NCT02374307|581434959|FG000|3-months Follow-up|Lost to Follow-up|1|||
161013002|NCT02374307|581434960|FG001|3-months Follow-up|Lost to Follow-up|2|||
161013003|NCT02374307|581434959|FG000|3-months Follow-up|Withdrawal by Subject|1|||
161013004|NCT02374307|581434960|FG001|3-months Follow-up|Withdrawal by Subject|4|||
161013005|NCT02374307|581434959|FG000|3-months Follow-up|Death|1|||
161013006|NCT02374307|581434960|FG001|3-months Follow-up|Death|2|||
161013007|NCT02374307|581434959|FG000|3-months Follow-up|Missed first follow-up|5|||
161013008|NCT02374307|581434960|FG001|3-months Follow-up|Missed first follow-up|1|||
161013009|NCT02374307|581434959|FG000|6-months Follow-up|Lost to Follow-up|1|||
161013010|NCT02374307|581434960|FG001|6-months Follow-up|Lost to Follow-up|2|||
161013011|NCT02374307|581434959|FG000|6-months Follow-up|Death|2|||
161013012|NCT02374307|581434960|FG001|6-months Follow-up|Death|1|||
161013013|NCT02374307|581434959|FG000|6-months Follow-up|Withdrawal by Subject|0|||
161013014|NCT02374307|581434960|FG001|6-months Follow-up|Withdrawal by Subject|3|||
161013015|NCT01989455|581434961|FG000|Overall Study|Adverse Event|0|||
161013016|NCT01989455|581434962|FG001|Overall Study|Adverse Event|1|||
161013017|NCT01989455|581434963|FG002|Overall Study|Adverse Event|0|||
161013018|NCT01989455|581434964|FG003|Overall Study|Adverse Event|0|||
161013019|NCT01989455|581434965|FG004|Overall Study|Adverse Event|0|||
161013020|NCT01989455|581434961|FG000|Overall Study|Withdrawal by Subject|0|||
161013021|NCT01989455|581434962|FG001|Overall Study|Withdrawal by Subject|1|||
161013022|NCT01989455|581434963|FG002|Overall Study|Withdrawal by Subject|0|||
161147682|NCT00312377|581922540|FG001|Overall Study|Death|418|||
161147683|NCT00312377|581922539|FG000|Overall Study|Withdrawal by Subject|23|||
161147684|NCT00312377|581922540|FG001|Overall Study|Withdrawal by Subject|30|||
161147685|NCT00312377|581922539|FG000|Overall Study|Lost to Follow-up|9|||
161147686|NCT00312377|581922540|FG001|Overall Study|Lost to Follow-up|12|||
161147687|NCT00312377|581922539|FG000|Overall Study|Non-compliance|0|||
161147688|NCT00312377|581922540|FG001|Overall Study|Non-compliance|2|||
161147689|NCT00312377|581922539|FG000|Overall Study|Randomised but never received treatment|6|||
161272161|NCT00265395|582377579|FG000|Overall Study|Lack of Efficacy|0|||
161013023|NCT01989455|581434964|FG003|Overall Study|Withdrawal by Subject|0|||
161013024|NCT01989455|581434965|FG004|Overall Study|Withdrawal by Subject|0|||
161013025|NCT01989455|581434961|FG000|Overall Study|Technical problems with infusion|0|||
161013026|NCT01989455|581434962|FG001|Overall Study|Technical problems with infusion|0|||
161013027|NCT01989455|581434963|FG002|Overall Study|Technical problems with infusion|1|||
161013028|NCT01989455|581434964|FG003|Overall Study|Technical problems with infusion|0|||
161013029|NCT01989455|581434965|FG004|Overall Study|Technical problems with infusion|1|||
161013030|NCT00632203|581434966|FG000|Overall Study|Did not start study treatment|1|||
161013031|NCT00632203|581434967|FG001|Overall Study|Did not start study treatment|0|||
161013032|NCT00448669|581434973|FG000|Overall Study|Lost to Follow-up|52|||
161147690|NCT00312377|581922540|FG001|Overall Study|Randomised but never received treatment|6|||
161272162|NCT00265395|582377580|FG001|Overall Study|Lack of Efficacy|1|||
161272163|NCT00265395|582377579|FG000|Overall Study|Administrative|0|||
161272164|NCT00265395|582377580|FG001|Overall Study|Administrative|1|||
161272165|NCT00837473|582377583|FG000|Overall Study|Lost to Follow-up|1|||
161272166|NCT00837473|582377583|FG000|Overall Study|Withdrawal by Subject|2|||
161272167|NCT03400943|582377584|FG000|Treatment Period 1|Adverse Event|0|||
161272168|NCT03400943|582377585|FG001|Treatment Period 1|Adverse Event|0|||
161272169|NCT03400943|582377586|FG002|Treatment Period 1|Adverse Event|0|||
161272170|NCT03400943|582377587|FG003|Treatment Period 1|Adverse Event|1|||
161272171|NCT03400943|582377584|FG000|Treatment Period 1|Lost to Follow-up|1|||
161272172|NCT03400943|582377585|FG001|Treatment Period 1|Lost to Follow-up|0|||
161272173|NCT03400943|582377586|FG002|Treatment Period 1|Lost to Follow-up|0|||
161272174|NCT03400943|582377587|FG003|Treatment Period 1|Lost to Follow-up|0|||
161272175|NCT03400943|582377584|FG000|Treatment Period 1|Protocol Violation|0|||
161272176|NCT03400943|582377585|FG001|Treatment Period 1|Protocol Violation|1|||
161272177|NCT03400943|582377586|FG002|Treatment Period 1|Protocol Violation|1|||
161272178|NCT03400943|582377587|FG003|Treatment Period 1|Protocol Violation|0|||
161272179|NCT03400943|582377584|FG000|Treatment Period 1|Study terminated by sponsor|2|||
161272180|NCT03400943|582377585|FG001|Treatment Period 1|Study terminated by sponsor|0|||
161272181|NCT03400943|582377586|FG002|Treatment Period 1|Study terminated by sponsor|0|||
161272182|NCT03400943|582377587|FG003|Treatment Period 1|Study terminated by sponsor|1|||
161272183|NCT03400943|582377584|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161272184|NCT03400943|582377585|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161272185|NCT03400943|582377586|FG002|Treatment Period 1|Withdrawal by Subject|3|||
161272186|NCT03400943|582377587|FG003|Treatment Period 1|Withdrawal by Subject|1|||
161272187|NCT03400943|582377584|FG000|Treatment Period 1|Other|2|||
161272188|NCT03400943|582377585|FG001|Treatment Period 1|Other|1|||
161272189|NCT03400943|582377586|FG002|Treatment Period 1|Other|2|||
161272190|NCT03400943|582377587|FG003|Treatment Period 1|Other|2|||
161272191|NCT03400943|582377584|FG000|Post-treatment Period 1|Adverse Event|2|||
161272192|NCT03400943|582377585|FG001|Post-treatment Period 1|Adverse Event|0|||
161272193|NCT03400943|582377586|FG002|Post-treatment Period 1|Adverse Event|0|||
161272194|NCT03400943|582377587|FG003|Post-treatment Period 1|Adverse Event|0|||
161272195|NCT03400943|582377584|FG000|Post-treatment Period 1|Protocol Violation|1|||
161272196|NCT03400943|582377585|FG001|Post-treatment Period 1|Protocol Violation|0|||
161013033|NCT00448669|581434974|FG001|Overall Study|Lost to Follow-up|63|||
161013034|NCT00448669|581434973|FG000|Overall Study|Withdrawal by Subject|90|||
161013035|NCT00448669|581434974|FG001|Overall Study|Withdrawal by Subject|74|||
161013036|NCT00448669|581434973|FG000|Overall Study|Relocated|49|||
161013037|NCT00448669|581434974|FG001|Overall Study|Relocated|36|||
161013038|NCT00448669|581434973|FG000|Overall Study|Were withdrawn by investigator|10|||
161013039|NCT00448669|581434974|FG001|Overall Study|Were withdrawn by investigator|6|||
161013040|NCT00448669|581434973|FG000|Overall Study|Death|2|||
161013041|NCT00448669|581434974|FG001|Overall Study|Death|4|||
161013042|NCT00448669|581434973|FG000|Overall Study|Had other reasons|5|||
161013043|NCT00448669|581434974|FG001|Overall Study|Had other reasons|6|||
161013044|NCT00448669|581434973|FG000|Overall Study|HIV-infected at enrollment|1|||
161013045|NCT00448669|581434974|FG001|Overall Study|HIV-infected at enrollment|2|||
161013046|NCT00448669|581434973|FG000|Overall Study|Never started drug|9|||
161013047|NCT00448669|581434974|FG001|Overall Study|Never started drug|7|||
161013048|NCT04287985|581434975|FG000|Overall Study|Adverse Event|1|||
161013049|NCT04287985|581434976|FG001|Overall Study|Adverse Event|0|||
161013050|NCT04287985|581434977|FG002|Overall Study|Adverse Event|0|||
161013051|NCT04287985|581434978|FG003|Overall Study|Adverse Event|0|||
161013052|NCT04287985|581434975|FG000|Overall Study|Protocol Violation|0|||
161013053|NCT04287985|581434976|FG001|Overall Study|Protocol Violation|1|||
161013054|NCT04287985|581434977|FG002|Overall Study|Protocol Violation|0|||
161013055|NCT04287985|581434978|FG003|Overall Study|Protocol Violation|0|||
161013056|NCT04287985|581434975|FG000|Overall Study|Physician Decision|0|||
161013057|NCT04287985|581434976|FG001|Overall Study|Physician Decision|0|||
161013058|NCT04287985|581434977|FG002|Overall Study|Physician Decision|0|||
161013059|NCT04287985|581434978|FG003|Overall Study|Physician Decision|1|||
161013060|NCT04287985|581434975|FG000|Overall Study|Withdrawal by Subject|2|||
161013061|NCT04287985|581434976|FG001|Overall Study|Withdrawal by Subject|1|||
161013062|NCT04287985|581434977|FG002|Overall Study|Withdrawal by Subject|1|||
161013063|NCT04287985|581434978|FG003|Overall Study|Withdrawal by Subject|2|||
161272197|NCT03400943|582377586|FG002|Post-treatment Period 1|Protocol Violation|0|||
161272198|NCT03400943|582377587|FG003|Post-treatment Period 1|Protocol Violation|0|||
161272199|NCT03400943|582377584|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
161272200|NCT03400943|582377585|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
161272201|NCT03400943|582377586|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
161272202|NCT03400943|582377587|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
161013064|NCT02638337|581434983|FG000|Overall Study|Adverse Event|6|||
161013065|NCT02638337|581434984|FG001|Overall Study|Adverse Event|10|||
161013066|NCT02638337|581434983|FG000|Overall Study|Protocol Violation|3|||
161272203|NCT03400943|582377584|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
161272204|NCT03400943|582377585|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
161013067|NCT02638337|581434984|FG001|Overall Study|Protocol Violation|0|||
161013068|NCT02638337|581434983|FG000|Overall Study|Withdrawal by Subject|13|||
161013069|NCT02638337|581434984|FG001|Overall Study|Withdrawal by Subject|16|||
161013070|NCT02638337|581434983|FG000|Overall Study|Lost to Follow-up|7|||
161013071|NCT02638337|581434984|FG001|Overall Study|Lost to Follow-up|7|||
161013072|NCT02638337|581434983|FG000|Overall Study|Other - Miscellaneous|4|||
161013073|NCT02638337|581434984|FG001|Overall Study|Other - Miscellaneous|3|||
161013074|NCT00604669|581434985|FG000|Overall Study|lack of information in chart|7|||
161013075|NCT01340066|581434986|FG000|Placebo Run in Period|Screen Failures|27|||
161013076|NCT01340066|581434987|FG001|Placebo Run in Period|Screen Failures|0|||
161013077|NCT01340066|581434988|FG002|Placebo Run in Period|Screen Failures|0|||
161013078|NCT01340066|581434986|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
161013079|NCT01340066|581434987|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
161013080|NCT01340066|581434988|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
161013081|NCT01340066|581434986|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
161013082|NCT01340066|581434987|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
161013083|NCT01340066|581434988|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
161013084|NCT01340066|581434986|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
161013085|NCT01340066|581434987|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
161013086|NCT01340066|581434988|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
161013087|NCT03771352|581434996|FG000|Overall Study|Screen failure|2|||
161013088|NCT03771352|581434996|FG000|Overall Study|Withdrawal by Subject|2|||
161013089|NCT04315181|581434997|FG000|Overall Study|Non-responsive to drug conditions.|1|||
161013090|NCT01948661|581434998|FG000|Overall Study|Withdrawal by Subject|2|||
161013091|NCT01948661|581434999|FG001|Overall Study|Withdrawal by Subject|4|||
161013092|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Adverse Event|4|||
161013093|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Adverse Event|1|||
161013094|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
161013095|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
161013096|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
161013097|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
161013098|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
161013099|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
161013100|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
161013101|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
161013102|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Other|6|||
161013103|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Other|1|||
161013104|NCT03271489|581435000|FG000|Double-Blind (DB) Period|Missing|1|||
161013105|NCT03271489|581435001|FG001|Double-Blind (DB) Period|Missing|0|||
161013106|NCT03271489|581435000|FG000|Open-Label (OL) Period|Adverse Event|2|||
161013107|NCT03271489|581435001|FG001|Open-Label (OL) Period|Adverse Event|0|||
161013108|NCT03271489|581435000|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
161013109|NCT03271489|581435001|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
161013110|NCT03271489|581435000|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
161013111|NCT03271489|581435001|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
161013112|NCT03271489|581435000|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
161013113|NCT03271489|581435001|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
161013114|NCT03271489|581435000|FG000|Open-Label (OL) Period|No Specified|2|||
161013115|NCT03271489|581435001|FG001|Open-Label (OL) Period|No Specified|2|||
161013116|NCT03271489|581435000|FG000|Open-Label (OL) Period|Missing|2|||
161013117|NCT03271489|581435001|FG001|Open-Label (OL) Period|Missing|0|||
161013118|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
161013119|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
161013120|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
161013121|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
161013122|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
161013123|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
161013124|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
161013125|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
161013126|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
161013127|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
161013128|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
161013129|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
161013130|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
161147691|NCT00312377|581922539|FG000|Overall Study|Discontinue treatment survival follow up|202|||
161147692|NCT00312377|581922540|FG001|Overall Study|Discontinue treatment survival follow up|200|||
161147693|NCT00312377|581922539|FG000|Overall Study|Site ended participation in study|1|||
161013131|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
161013132|NCT03271489|581435000|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
161013133|NCT03271489|581435001|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
161013134|NCT01127373|581435002|FG000|Overall Study|Not Treated|3|||
161013135|NCT01127373|581435002|FG000|Overall Study|Lost to Follow-up|7|||
161013136|NCT01127373|581435002|FG000|Overall Study|Withdrawal by Subject|1|||
161013137|NCT01127373|581435002|FG000|Overall Study|Disease progression|1|||
161013138|NCT00522951|581435005|FG000|Period 1|body motion|0|||
161013139|NCT00522951|581435006|FG001|Period 1|body motion|1|||
161013140|NCT00522951|581435005|FG000|Washout Period|Adverse Event|0|||
161013141|NCT00522951|581435006|FG001|Washout Period|Adverse Event|1|||
161013142|NCT00522951|581435005|FG000|Washout Period|Death|0|||
161013143|NCT00522951|581435006|FG001|Washout Period|Death|1|||
161013144|NCT00522951|581435005|FG000|Period 2|Withdrawal by Subject|1|||
161013145|NCT00522951|581435006|FG001|Period 2|Withdrawal by Subject|0|||
161013146|NCT00522951|581435005|FG000|Period 2|residual contrast medium|1|||
161013147|NCT00522951|581435006|FG001|Period 2|residual contrast medium|1|||
161013148|NCT00136435|581435010|FG000|Overall Study|Ineligible|8|||
161013149|NCT00136435|581435010|FG000|Overall Study|Induction Death|1|||
161013150|NCT00136435|581435010|FG000|Overall Study|Induction Failure|10|||
161013151|NCT00136435|581435010|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
161013152|NCT00136435|581435010|FG000|Overall Study|Withdrawal by Subject|3|||
161013153|NCT00136435|581435010|FG000|Overall Study|Adverse Event|19|||
161013154|NCT00136435|581435010|FG000|Overall Study|Relapse|4|||
161013155|NCT00136435|581435010|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
161013156|NCT00390299|581435015|FG000|Overall Study|Cancellation|1|||
161013157|NCT00390299|581435016|FG001|Overall Study|Cancellation|0|||
161013158|NCT00390299|581435017|FG002|Overall Study|Cancellation|0|||
161013159|NCT00390299|581435018|FG003|Overall Study|Cancellation|0|||
161013160|NCT00390299|581435019|FG004|Overall Study|Cancellation|0|||
161013161|NCT00539734|581435021|FG000|Overall Study|Protocol Violation|1|||
161013162|NCT01070069|581435022|FG000|Overall Study|Death|1|||
161013163|NCT01070069|581435023|FG001|Overall Study|Death|0|||
161013164|NCT01070069|581435024|FG002|Overall Study|Death|2|||
161013165|NCT01070069|581435025|FG003|Overall Study|Death|0|||
161013166|NCT01070069|581435026|FG004|Overall Study|Death|1|||
161013167|NCT01070069|581435022|FG000|Overall Study|Withdrawal by Subject|1|||
161013168|NCT01070069|581435023|FG001|Overall Study|Withdrawal by Subject|1|||
161013169|NCT01070069|581435024|FG002|Overall Study|Withdrawal by Subject|4|||
161013170|NCT01070069|581435025|FG003|Overall Study|Withdrawal by Subject|0|||
161013171|NCT01070069|581435026|FG004|Overall Study|Withdrawal by Subject|0|||
161013172|NCT01070069|581435022|FG000|Overall Study|Lost to Follow-up|4|||
161013173|NCT01070069|581435023|FG001|Overall Study|Lost to Follow-up|1|||
161013174|NCT01070069|581435024|FG002|Overall Study|Lost to Follow-up|0|||
161013175|NCT01070069|581435025|FG003|Overall Study|Lost to Follow-up|0|||
161013176|NCT01070069|581435026|FG004|Overall Study|Lost to Follow-up|3|||
161013177|NCT03101930|581435027|FG000|Overall Study|Withdrawal by Subject|2|||
161013178|NCT03101930|581435028|FG001|Overall Study|Withdrawal by Subject|1|||
161013179|NCT03101930|581435029|FG002|Overall Study|Withdrawal by Subject|2|||
161013180|NCT02814838|581435030|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
161013181|NCT02814838|581435031|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
161013182|NCT02814838|581435030|FG000|Overall Study|Consent withdrawal|1|||
161013183|NCT02814838|581435031|FG001|Overall Study|Consent withdrawal|1|||
161013184|NCT01771731|581435035|FG000|Overall Study|Physician Decision|1|||
161013185|NCT01771731|581435036|FG001|Overall Study|Physician Decision|0|||
161013186|NCT01771731|581435035|FG000|Overall Study|Protocol Violation|0|||
161013187|NCT01771731|581435036|FG001|Overall Study|Protocol Violation|1|||
161013188|NCT01771731|581435035|FG000|Overall Study|Adverse event: Pain Crisis|1|||
161013189|NCT01771731|581435036|FG001|Overall Study|Adverse event: Pain Crisis|1|||
161013190|NCT00087139|581435037|FG000|Overall Study|Adverse Event|18|||
161013191|NCT00087139|581435038|FG001|Overall Study|Adverse Event|17|||
161013192|NCT00087139|581435039|FG002|Overall Study|Adverse Event|13|||
161013193|NCT00087139|581435037|FG000|Overall Study|Death|2|||
161013194|NCT00087139|581435038|FG001|Overall Study|Death|1|||
161013195|NCT00087139|581435039|FG002|Overall Study|Death|0|||
161013196|NCT00087139|581435037|FG000|Overall Study|Withdrawal by Subject|3|||
161013197|NCT00087139|581435038|FG001|Overall Study|Withdrawal by Subject|2|||
161013198|NCT00087139|581435039|FG002|Overall Study|Withdrawal by Subject|2|||
161013199|NCT00087139|581435037|FG000|Overall Study|Physician Decision|1|||
161013200|NCT00087139|581435038|FG001|Overall Study|Physician Decision|1|||
161013201|NCT00087139|581435039|FG002|Overall Study|Physician Decision|1|||
161013202|NCT00087139|581435037|FG000|Overall Study|Disease progression|9|||
161013203|NCT00087139|581435038|FG001|Overall Study|Disease progression|19|||
161013204|NCT00087139|581435039|FG002|Overall Study|Disease progression|12|||
161013205|NCT00087139|581435037|FG000|Overall Study|Ineligible|4|||
161013206|NCT00087139|581435038|FG001|Overall Study|Ineligible|7|||
161013207|NCT00087139|581435039|FG002|Overall Study|Ineligible|4|||
161013208|NCT00087139|581435037|FG000|Overall Study|Symptomatic deterioration|1|||
161013209|NCT00087139|581435038|FG001|Overall Study|Symptomatic deterioration|1|||
161272205|NCT03400943|582377586|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
161272206|NCT03400943|582377587|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
161272207|NCT03400943|582377584|FG000|Post-treatment Period 1|Other|2|||
161272208|NCT03400943|582377585|FG001|Post-treatment Period 1|Other|0|||
161272209|NCT03400943|582377586|FG002|Post-treatment Period 1|Other|4|||
161272210|NCT03400943|582377587|FG003|Post-treatment Period 1|Other|5|||
161272211|NCT03400943|582377584|FG000|Treatment Period 2|Study terminated by sponsor|0|||
161272212|NCT03400943|582377585|FG001|Treatment Period 2|Study terminated by sponsor|1|||
161272213|NCT03400943|582377586|FG002|Treatment Period 2|Study terminated by sponsor|0|||
161272214|NCT03400943|582377587|FG003|Treatment Period 2|Study terminated by sponsor|0|||
161272215|NCT03400943|582377584|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161272216|NCT03400943|582377585|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161272217|NCT03400943|582377586|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161272218|NCT03400943|582377587|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161013210|NCT00087139|581435039|FG002|Overall Study|Symptomatic deterioration|3|||
161013211|NCT00087139|581435037|FG000|Overall Study|Use of coumadin|1|||
161013212|NCT00087139|581435038|FG001|Overall Study|Use of coumadin|0|||
161013213|NCT00087139|581435039|FG002|Overall Study|Use of coumadin|0|||
161013214|NCT00087139|581435037|FG000|Overall Study|Response achieved|0|||
161013215|NCT00087139|581435038|FG001|Overall Study|Response achieved|1|||
161013216|NCT00087139|581435039|FG002|Overall Study|Response achieved|0|||
161013217|NCT00087139|581435037|FG000|Overall Study|Extradural disease|0|||
161013218|NCT00087139|581435038|FG001|Overall Study|Extradural disease|0|||
161013219|NCT00087139|581435039|FG002|Overall Study|Extradural disease|1|||
161013220|NCT04095104|581435047|FG000|Overall Study|Withdrawal by Subject|0|||
161013221|NCT04095104|581435048|FG001|Overall Study|Withdrawal by Subject|1|||
161013222|NCT01136876|581435049|FG000|Overall Study|Lost to Follow-up|0|||
161013223|NCT01136876|581435050|FG001|Overall Study|Lost to Follow-up|1|||
161013224|NCT01136876|581435049|FG000|Overall Study|Physician Decision|3|||
161013225|NCT01136876|581435050|FG001|Overall Study|Physician Decision|5|||
161013226|NCT01136876|581435049|FG000|Overall Study|Missing NGAL measurement|2|||
161013227|NCT01136876|581435050|FG001|Overall Study|Missing NGAL measurement|5|||
161013228|NCT05321069|581435051|FG000|Overall Study|Adverse Event|52|||
161013229|NCT05321069|581435052|FG001|Overall Study|Adverse Event|52|||
161013230|NCT05321069|581435053|FG002|Overall Study|Adverse Event|64|||
161013231|NCT05321069|581435051|FG000|Overall Study|Protocol Violation|1|||
161013232|NCT05321069|581435052|FG001|Overall Study|Protocol Violation|1|||
161013233|NCT05321069|581435053|FG002|Overall Study|Protocol Violation|0|||
161013234|NCT05321069|581435051|FG000|Overall Study|Withdrawal by Subject|23|||
161013235|NCT05321069|581435052|FG001|Overall Study|Withdrawal by Subject|18|||
161013236|NCT05321069|581435053|FG002|Overall Study|Withdrawal by Subject|12|||
161013237|NCT05321069|581435051|FG000|Overall Study|Lost to Follow-up|1|||
161013238|NCT05321069|581435052|FG001|Overall Study|Lost to Follow-up|0|||
161013239|NCT05321069|581435053|FG002|Overall Study|Lost to Follow-up|1|||
161013240|NCT05321069|581435051|FG000|Overall Study|No reason stated by the participants|23|||
161013241|NCT05321069|581435052|FG001|Overall Study|No reason stated by the participants|22|||
161013242|NCT05321069|581435053|FG002|Overall Study|No reason stated by the participants|16|||
161013243|NCT05321069|581435051|FG000|Overall Study|Lack of Efficacy|1|||
161013244|NCT05321069|581435052|FG001|Overall Study|Lack of Efficacy|1|||
161013245|NCT05321069|581435053|FG002|Overall Study|Lack of Efficacy|0|||
161013246|NCT05048186|581435056|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
161013247|NCT05048186|581435057|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
161013248|NCT05048186|581435056|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
161013249|NCT05048186|581435057|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
161013250|NCT02412748|581435060|FG000|Overall Study|Lost to Follow-up|38|||
161013251|NCT02412748|581435061|FG001|Overall Study|Lost to Follow-up|39|||
161013252|NCT00976937|581435062|FG000|Overall Study|Adverse Event|4|||
161013253|NCT00976937|581435063|FG001|Overall Study|Adverse Event|5|||
161013254|NCT00976937|581435062|FG000|Overall Study|Lost to Follow-up|2|||
161013255|NCT00976937|581435063|FG001|Overall Study|Lost to Follow-up|1|||
161013256|NCT00976937|581435062|FG000|Overall Study|Withdrawal by Subject|5|||
161013257|NCT00976937|581435063|FG001|Overall Study|Withdrawal by Subject|3|||
161013258|NCT00976937|581435062|FG000|Overall Study|Poor compliance to protocol|3|||
161013259|NCT00976937|581435063|FG001|Overall Study|Poor compliance to protocol|0|||
161013260|NCT00976937|581435062|FG000|Overall Study|Personal and Familial Reason|2|||
161013261|NCT00976937|581435063|FG001|Overall Study|Personal and Familial Reason|2|||
161013262|NCT04218266|581435064|FG000|Overall Study|Death|1|||
161013263|NCT04218266|581435065|FG001|Overall Study|Death|2|||
161272219|NCT03400943|582377584|FG000|Treatment Period 2|Other|1|||
161272220|NCT03400943|582377585|FG001|Treatment Period 2|Other|6|||
161343537|NCT00207740|582644409|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
161013264|NCT04218266|581435066|FG002|Overall Study|Death|3|||
161013265|NCT04218266|581435064|FG000|Overall Study|Adverse Event|13|||
161013266|NCT04218266|581435065|FG001|Overall Study|Adverse Event|14|||
161272221|NCT03400943|582377586|FG002|Treatment Period 2|Other|0|||
161013267|NCT04218266|581435066|FG002|Overall Study|Adverse Event|11|||
161272222|NCT03400943|582377587|FG003|Treatment Period 2|Other|0|||
161272223|NCT03400943|582377584|FG000|Follow-up Period|Withdrawal by Subject|1|||
161272224|NCT03400943|582377585|FG001|Follow-up Period|Withdrawal by Subject|0|||
161272225|NCT03400943|582377586|FG002|Follow-up Period|Withdrawal by Subject|0|||
161013268|NCT04218266|581435064|FG000|Overall Study|Other|7|||
161013269|NCT04218266|581435065|FG001|Overall Study|Other|5|||
161013270|NCT04218266|581435066|FG002|Overall Study|Other|14|||
161013271|NCT04218266|581435064|FG000|Overall Study|Physician Decision|1|||
161013272|NCT04218266|581435065|FG001|Overall Study|Physician Decision|3|||
161013273|NCT04218266|581435066|FG002|Overall Study|Physician Decision|2|||
161013274|NCT04218266|581435064|FG000|Overall Study|Non-compliance with study drug|0|||
161013275|NCT04218266|581435065|FG001|Overall Study|Non-compliance with study drug|0|||
161013276|NCT04218266|581435066|FG002|Overall Study|Non-compliance with study drug|1|||
161013277|NCT04218266|581435064|FG000|Overall Study|Withdrawal by Subject|1|||
161013278|NCT04218266|581435065|FG001|Overall Study|Withdrawal by Subject|3|||
161013279|NCT04218266|581435066|FG002|Overall Study|Withdrawal by Subject|1|||
161013280|NCT04218266|581435064|FG000|Overall Study|Study drug never administered|2|||
161013281|NCT04218266|581435065|FG001|Overall Study|Study drug never administered|0|||
161013282|NCT04218266|581435066|FG002|Overall Study|Study drug never administered|0|||
161013283|NCT01044303|581435067|FG000|Overall Study|Lost to Follow-up|2|||
161013284|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
161013285|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
161013286|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
161013287|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
161013288|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
161013289|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
161013290|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
161013291|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
161013292|NCT01424670|581435068|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
161013293|NCT01424670|581435069|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
161013294|NCT01424670|581435068|FG000|Continuation Period|Adverse Event|13|||
161013295|NCT01424670|581435069|FG001|Continuation Period|Adverse Event|5|||
161013296|NCT01424670|581435068|FG000|Continuation Period|Lost to Follow-up|2|||
161013297|NCT01424670|581435069|FG001|Continuation Period|Lost to Follow-up|0|||
161013298|NCT01424670|581435068|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
161013299|NCT01424670|581435069|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
161013300|NCT01424670|581435068|FG000|Continuation Period|Physician Decision|5|||
161013301|NCT01424670|581435069|FG001|Continuation Period|Physician Decision|4|||
161013302|NCT01424670|581435068|FG000|Continuation Period|Withdrawal by Subject|13|||
161013303|NCT01424670|581435069|FG001|Continuation Period|Withdrawal by Subject|4|||
161013304|NCT00761189|581435070|FG000|Overall Study|Adverse Event|42|||
161013305|NCT00761189|581435070|FG000|Overall Study|Lack of Efficacy|45|||
161013306|NCT00761189|581435070|FG000|Overall Study|Lost to Follow-up|36|||
161013307|NCT00761189|581435070|FG000|Overall Study|Withdrawal by Subject|49|||
161013308|NCT00761189|581435070|FG000|Overall Study|Other|13|||
161013309|NCT04377308|581435071|FG000|Overall Study|Withdrawal by Subject|0|||
161013310|NCT04377308|581435072|FG001|Overall Study|Withdrawal by Subject|1|||
161013311|NCT01494922|581435073|FG000|Overall Study|Adverse Event|1|||
161013312|NCT00709098|581435081|FG000|Double-blind Period|Withdrawal of consent|3|||
161013313|NCT00709098|581435082|FG001|Double-blind Period|Withdrawal of consent|3|||
161013314|NCT00709098|581435083|FG002|Double-blind Period|Withdrawal of consent|0|||
161013315|NCT00709098|581435081|FG000|Double-blind Period|Administrative reason|1|||
161013316|NCT00709098|581435082|FG001|Double-blind Period|Administrative reason|3|||
161013317|NCT00709098|581435083|FG002|Double-blind Period|Administrative reason|0|||
161013318|NCT00709098|581435081|FG000|Double-blind Period|Death|1|||
161013319|NCT00709098|581435082|FG001|Double-blind Period|Death|1|||
161013320|NCT00709098|581435083|FG002|Double-blind Period|Death|0|||
161013321|NCT00709098|581435081|FG000|Double-blind Period|Lost to Follow-up|1|||
161013322|NCT00709098|581435082|FG001|Double-blind Period|Lost to Follow-up|1|||
161147694|NCT00312377|581922540|FG001|Overall Study|Site ended participation in study|0|||
161147695|NCT01001494|581922546|FG000|Overall Study|Adverse Event|8|||
161272226|NCT03400943|582377587|FG003|Follow-up Period|Withdrawal by Subject|0|||
161272227|NCT02563106|582377588|FG000|Overall Study|Withdrawal by Subject|7|||
161272228|NCT02563106|582377589|FG001|Overall Study|Withdrawal by Subject|8|||
161272229|NCT02563106|582377588|FG000|Overall Study|Adverse Event|17|||
161272230|NCT02563106|582377589|FG001|Overall Study|Adverse Event|15|||
161272231|NCT02563106|582377588|FG000|Overall Study|Protocol Violation|1|||
161013323|NCT00709098|581435083|FG002|Double-blind Period|Lost to Follow-up|0|||
161013324|NCT00709098|581435081|FG000|Open-label Period|Withdrawal of consent|0|||
161147696|NCT01001494|581922547|FG001|Overall Study|Adverse Event|4|||
161272232|NCT02563106|582377589|FG001|Overall Study|Protocol Violation|0|||
161013325|NCT00709098|581435082|FG001|Open-label Period|Withdrawal of consent|0|||
161013326|NCT00709098|581435083|FG002|Open-label Period|Withdrawal of consent|7|||
161013327|NCT00709098|581435081|FG000|Open-label Period|Administrative reason|0|||
161147697|NCT01001494|581922548|FG002|Overall Study|Adverse Event|6|||
161013328|NCT00709098|581435082|FG001|Open-label Period|Administrative reason|0|||
161013329|NCT00709098|581435083|FG002|Open-label Period|Administrative reason|5|||
161013330|NCT00709098|581435081|FG000|Open-label Period|Death|0|||
161013331|NCT00709098|581435082|FG001|Open-label Period|Death|0|||
161013332|NCT00709098|581435083|FG002|Open-label Period|Death|1|||
161013333|NCT00709098|581435081|FG000|Open-label Period|Lost to Follow-up|0|||
161013334|NCT00709098|581435082|FG001|Open-label Period|Lost to Follow-up|0|||
161013335|NCT00709098|581435083|FG002|Open-label Period|Lost to Follow-up|1|||
161013336|NCT01227265|581435084|FG000|Overall Study|Did Not Receive Treatment|1|||
161013337|NCT01227265|581435085|FG001|Overall Study|Did Not Receive Treatment|2|||
161013338|NCT01227265|581435086|FG002|Overall Study|Did Not Receive Treatment|0|||
161013339|NCT01227265|581435084|FG000|Overall Study|Administrative|1|||
161013340|NCT01227265|581435085|FG001|Overall Study|Administrative|0|||
161013341|NCT01227265|581435086|FG002|Overall Study|Administrative|2|||
161013342|NCT01227265|581435084|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161013343|NCT01227265|581435085|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161013344|NCT01227265|581435086|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
161013345|NCT01227265|581435084|FG000|Overall Study|Protocol Violation|2|||
161013346|NCT01227265|581435085|FG001|Overall Study|Protocol Violation|1|||
161013347|NCT01227265|581435086|FG002|Overall Study|Protocol Violation|0|||
161013348|NCT01227265|581435084|FG000|Overall Study|Withdrawal by Subject|7|||
161013349|NCT01227265|581435085|FG001|Overall Study|Withdrawal by Subject|7|||
161013350|NCT01227265|581435086|FG002|Overall Study|Withdrawal by Subject|3|||
161013351|NCT01227265|581435084|FG000|Overall Study|Lost to Follow-up|2|||
161013352|NCT01227265|581435085|FG001|Overall Study|Lost to Follow-up|0|||
161013353|NCT01227265|581435086|FG002|Overall Study|Lost to Follow-up|3|||
161013354|NCT01227265|581435084|FG000|Overall Study|Adverse Event|6|||
161013355|NCT01227265|581435085|FG001|Overall Study|Adverse Event|10|||
161013356|NCT01227265|581435086|FG002|Overall Study|Adverse Event|5|||
161013357|NCT06024174|581435088|FG000|Overall Study|Other Reasons|1|||
161013358|NCT06024174|581435088|FG000|Overall Study|Study terminated by Sponsor|4|||
161013359|NCT04994509|581435089|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
161013360|NCT04994509|581435090|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
161013361|NCT04994509|581435091|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
161013362|NCT04994509|581435089|FG000|Overall Study|Withdrew Consent|73|||
161013363|NCT04994509|581435090|FG001|Overall Study|Withdrew Consent|72|||
161013364|NCT04994509|581435091|FG002|Overall Study|Withdrew Consent|46|||
161013365|NCT04994509|581435089|FG000|Overall Study|Lost to Follow-up|39|||
161013366|NCT04994509|581435090|FG001|Overall Study|Lost to Follow-up|36|||
161013367|NCT04994509|581435091|FG002|Overall Study|Lost to Follow-up|26|||
161013368|NCT04994509|581435089|FG000|Overall Study|HIV-1 Infection|4|||
161013369|NCT04994509|581435090|FG001|Overall Study|HIV-1 Infection|20|||
161013370|NCT04994509|581435091|FG002|Overall Study|HIV-1 Infection|12|||
161013371|NCT04994509|581435089|FG000|Overall Study|Investigator's Discretion|9|||
161013372|NCT04994509|581435090|FG001|Overall Study|Investigator's Discretion|8|||
161013373|NCT04994509|581435091|FG002|Overall Study|Investigator's Discretion|11|||
161013374|NCT04994509|581435089|FG000|Overall Study|Randomized but Never Treated|10|||
161013375|NCT04994509|581435090|FG001|Overall Study|Randomized but Never Treated|10|||
161013376|NCT04994509|581435091|FG002|Overall Study|Randomized but Never Treated|3|||
161013377|NCT04994509|581435089|FG000|Overall Study|Pregnancy|5|||
161013378|NCT04994509|581435090|FG001|Overall Study|Pregnancy|5|||
161013379|NCT04994509|581435091|FG002|Overall Study|Pregnancy|0|||
161013380|NCT04994509|581435089|FG000|Overall Study|Death|0|||
161013381|NCT04994509|581435090|FG001|Overall Study|Death|5|||
161013382|NCT04994509|581435091|FG002|Overall Study|Death|0|||
161013383|NCT04994509|581435089|FG000|Overall Study|Adverse Event|2|||
161013384|NCT04994509|581435090|FG001|Overall Study|Adverse Event|1|||
161013385|NCT04994509|581435091|FG002|Overall Study|Adverse Event|0|||
161013386|NCT04994509|581435089|FG000|Overall Study|Non-compliance With Study Drug|1|||
161013387|NCT04994509|581435090|FG001|Overall Study|Non-compliance With Study Drug|1|||
161013388|NCT04994509|581435091|FG002|Overall Study|Non-compliance With Study Drug|1|||
161013389|NCT04994509|581435089|FG000|Overall Study|Withdrew Assent|3|||
161013390|NCT04994509|581435090|FG001|Overall Study|Withdrew Assent|0|||
161013391|NCT04994509|581435091|FG002|Overall Study|Withdrew Assent|0|||
161013392|NCT04994509|581435089|FG000|Overall Study|Protocol Violation|1|||
161013393|NCT04994509|581435090|FG001|Overall Study|Protocol Violation|0|||
161013394|NCT04994509|581435091|FG002|Overall Study|Protocol Violation|0|||
161013395|NCT04402294|581435093|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
161013396|NCT04402294|581435094|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
161013397|NCT04402294|581435093|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
161013398|NCT04402294|581435094|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
161013399|NCT04924062|581437598|FG000|Overall Study|Death|49|||
161013400|NCT04924062|581437599|FG001|Overall Study|Death|63|||
161013401|NCT04924062|581437598|FG000|Overall Study|Participant On-going|26|||
161013402|NCT04924062|581437599|FG001|Overall Study|Participant On-going|20|||
161013403|NCT03845465|581437600|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
161013404|NCT03845465|581437601|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
161013405|NCT03845465|581437600|FG000|6-month Data Collection|Withdrawal by Subject|0|||
161013406|NCT03845465|581437601|FG001|6-month Data Collection|Withdrawal by Subject|2|||
161013407|NCT03845465|581437600|FG000|12-month Data Collection|Withdrawal by Subject|0|||
161013408|NCT03845465|581437601|FG001|12-month Data Collection|Withdrawal by Subject|2|||
161013409|NCT03547908|581437604|FG000|Blinded Phase|Lost to Follow-up|3|||
161013410|NCT03547908|581437605|FG001|Blinded Phase|Lost to Follow-up|3|||
161013411|NCT03547908|581437606|FG002|Blinded Phase|Lost to Follow-up|0|||
161013412|NCT03547908|581437607|FG003|Blinded Phase|Lost to Follow-up|0|||
161013413|NCT03547908|581437604|FG000|Blinded Phase|Withdrew Consent|2|||
161013414|NCT03547908|581437605|FG001|Blinded Phase|Withdrew Consent|3|||
161013415|NCT03547908|581437606|FG002|Blinded Phase|Withdrew Consent|0|||
161013416|NCT03547908|581437607|FG003|Blinded Phase|Withdrew Consent|0|||
161013417|NCT03547908|581437604|FG000|Blinded Phase|Investigator's Discretion|2|||
161013418|NCT03547908|581437605|FG001|Blinded Phase|Investigator's Discretion|1|||
161013419|NCT03547908|581437606|FG002|Blinded Phase|Investigator's Discretion|0|||
161013420|NCT03547908|581437607|FG003|Blinded Phase|Investigator's Discretion|0|||
161013421|NCT03547908|581437604|FG000|Blinded Phase|Death|2|||
161013422|NCT03547908|581437605|FG001|Blinded Phase|Death|0|||
161013423|NCT03547908|581437606|FG002|Blinded Phase|Death|0|||
161013424|NCT03547908|581437607|FG003|Blinded Phase|Death|0|||
161013425|NCT03547908|581437604|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
161013426|NCT03547908|581437605|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
161013427|NCT03547908|581437606|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
161013428|NCT03547908|581437607|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
161013429|NCT03547908|581437604|FG000|Blinded Phase|Adverse Event|1|||
161013430|NCT03547908|581437605|FG001|Blinded Phase|Adverse Event|0|||
161013431|NCT03547908|581437606|FG002|Blinded Phase|Adverse Event|0|||
161013432|NCT03547908|581437607|FG003|Blinded Phase|Adverse Event|0|||
161013433|NCT03547908|581437604|FG000|Blinded Phase|Randomized But Never Treated|1|||
161013434|NCT03547908|581437605|FG001|Blinded Phase|Randomized But Never Treated|0|||
161013435|NCT03547908|581437606|FG002|Blinded Phase|Randomized But Never Treated|0|||
161013436|NCT03547908|581437607|FG003|Blinded Phase|Randomized But Never Treated|0|||
161013437|NCT03547908|581437604|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
161013438|NCT03547908|581437605|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
161013439|NCT03547908|581437606|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
161013440|NCT03547908|581437607|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
161013441|NCT03547908|581437604|FG000|Open-label Extension Phase|Death|0|||
161013442|NCT03547908|581437605|FG001|Open-label Extension Phase|Death|0|||
161013443|NCT03547908|581437606|FG002|Open-label Extension Phase|Death|1|||
161013444|NCT03547908|581437607|FG003|Open-label Extension Phase|Death|0|||
161013445|NCT04059354|581437610|FG000|Overall Study|COVID-19 pandemic|3|||
161013446|NCT02349412|581437612|FG000|Overall Study|Withdrawal by Subject|7|||
161013447|NCT02349412|581437613|FG001|Overall Study|Withdrawal by Subject|7|||
161013448|NCT00979576|581437616|FG000|Combination Treatment Phase|Progressive disease|3|||
161013449|NCT00979576|581437617|FG001|Combination Treatment Phase|Progressive disease|1|||
161013450|NCT00979576|581437618|FG002|Combination Treatment Phase|Progressive disease|5|||
161013451|NCT00979576|581437616|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
161013452|NCT00979576|581437617|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
161013453|NCT00979576|581437618|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
161013454|NCT00979576|581437616|FG000|Combination Treatment Phase|Adverse Event|0|||
161013455|NCT00979576|581437617|FG001|Combination Treatment Phase|Adverse Event|2|||
161013456|NCT00979576|581437618|FG002|Combination Treatment Phase|Adverse Event|2|||
161013457|NCT00979576|581437616|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
161013458|NCT00979576|581437617|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
161013459|NCT00979576|581437618|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
161013460|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
161013461|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161013462|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161013463|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161013464|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
161147698|NCT01001494|581922546|FG000|Overall Study|Protocol Violation|0|||
161147699|NCT01001494|581922547|FG001|Overall Study|Protocol Violation|1|||
161013465|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
161013466|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
161013467|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161013468|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161013469|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
161013470|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
161013471|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
161013472|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161147700|NCT01001494|581922548|FG002|Overall Study|Protocol Violation|1|||
161013473|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161013474|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
161013475|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
161013476|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013477|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013478|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013479|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
161013480|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
161013481|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
161013482|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161013483|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161013484|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
161013485|NCT05338086|581437619|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
161013486|NCT05338086|581437620|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
161013487|NCT05338086|581437621|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
161013488|NCT05338086|581437622|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
161013489|NCT05338086|581437623|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
161013490|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Death|0|||
161013491|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Death|0|||
161013492|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Death|1|||
161013493|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Death|0|||
161013494|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Death|0|||
161013495|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
161013496|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
161013497|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
161013498|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
161013499|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
161013500|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013501|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013502|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
161013503|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013504|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
161013505|NCT05338086|581437619|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
161013506|NCT05338086|581437620|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
161013507|NCT05338086|581437621|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
161013508|NCT05338086|581437622|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
161013509|NCT05338086|581437623|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
161013510|NCT03424811|581437628|FG000|Overall Study|Lost to Follow-up|9|||
161013511|NCT03424811|581437629|FG001|Overall Study|Lost to Follow-up|0|||
161013512|NCT00567398|581437631|FG000|Overall Study|Adverse Event|6|||
161013513|NCT00567398|581437632|FG001|Overall Study|Adverse Event|14|||
161013514|NCT00567398|581437631|FG000|Overall Study|Physician Decision|0|||
161013515|NCT00567398|581437632|FG001|Overall Study|Physician Decision|4|||
161013516|NCT00567398|581437631|FG000|Overall Study|Withdrawal by Subject|0|||
161013517|NCT00567398|581437632|FG001|Overall Study|Withdrawal by Subject|2|||
161013518|NCT00567398|581437631|FG000|Overall Study|Renal Transplantation|0|||
161013519|NCT00567398|581437632|FG001|Overall Study|Renal Transplantation|3|||
161013520|NCT00567398|581437631|FG000|Overall Study|Other|1|||
161013521|NCT00567398|581437632|FG001|Overall Study|Other|0|||
161013522|NCT03517553|581437633|FG000|Overall Study|Withdrawal by Subject|2|||
161013523|NCT03271151|581437634|FG000|Overall Study|Lost to Follow-up|1|||
161013524|NCT03271151|581437635|FG001|Overall Study|Lost to Follow-up|3|||
161013525|NCT03271151|581437634|FG000|Overall Study|Withdrawal by Subject|1|||
161147701|NCT01001494|581922546|FG000|Overall Study|Lost to Follow-up|2|||
161147702|NCT01001494|581922547|FG001|Overall Study|Lost to Follow-up|0|||
161147703|NCT01001494|581922548|FG002|Overall Study|Lost to Follow-up|1|||
161147704|NCT01001494|581922546|FG000|Overall Study|Withdrawal by Subject|9|||
161147705|NCT01001494|581922547|FG001|Overall Study|Withdrawal by Subject|7|||
161147706|NCT01001494|581922548|FG002|Overall Study|Withdrawal by Subject|17|||
161147707|NCT01001494|581922546|FG000|Overall Study|COPD exacerbation|3|||
161147708|NCT01001494|581922547|FG001|Overall Study|COPD exacerbation|4|||
161147709|NCT01001494|581922548|FG002|Overall Study|COPD exacerbation|5|||
161147710|NCT01001494|581922546|FG000|Overall Study|Lack of Efficacy|2|||
161147711|NCT01001494|581922547|FG001|Overall Study|Lack of Efficacy|0|||
161147712|NCT01001494|581922548|FG002|Overall Study|Lack of Efficacy|8|||
161147713|NCT01001494|581922546|FG000|Overall Study|Other|0|||
161343538|NCT00207740|582644406|FG000|Overall Study|Lost to Follow-up|0|||
161013526|NCT03271151|581437635|FG001|Overall Study|Withdrawal by Subject|0|||
161147714|NCT01001494|581922547|FG001|Overall Study|Other|1|||
161343539|NCT00207740|582644407|FG001|Overall Study|Lost to Follow-up|2|||
161013527|NCT04093362|581437638|FG000|Overall Study|Study Termination|1|||
161013528|NCT04093362|581437639|FG001|Overall Study|Study Termination|1|||
161013529|NCT04093362|581437638|FG000|Overall Study|Withdrawal of Consent|1|||
161013530|NCT04093362|581437639|FG001|Overall Study|Withdrawal of Consent|0|||
161013531|NCT04093362|581437638|FG000|Overall Study|Death|1|||
161013532|NCT04093362|581437639|FG001|Overall Study|Death|3|||
161013533|NCT04093362|581437638|FG000|Overall Study|Reason not Specified|1|||
161013534|NCT04093362|581437639|FG001|Overall Study|Reason not Specified|2|||
161013535|NCT03438188|581437651|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161013536|NCT03438188|581437652|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161013537|NCT03438188|581437653|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
161013538|NCT03438188|581437651|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
161013539|NCT03438188|581437652|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
161013540|NCT03438188|581437653|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
161013541|NCT03438188|581437651|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
161013542|NCT03438188|581437652|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
161013543|NCT03438188|581437653|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
161013544|NCT03438188|581437651|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
161013545|NCT03438188|581437652|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
161013546|NCT03438188|581437653|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
161013547|NCT03438188|581437651|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
161013548|NCT03438188|581437652|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
161013549|NCT03438188|581437653|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
161013550|NCT04823611|581437658|FG000|Overall Study|Adverse Event|2|||
161013551|NCT04823611|581437659|FG001|Overall Study|Adverse Event|0|||
161013552|NCT04823611|581437660|FG002|Overall Study|Adverse Event|1|||
161013553|NCT04823611|581437661|FG003|Overall Study|Adverse Event|0|||
161013554|NCT04823611|581437662|FG004|Overall Study|Adverse Event|0|||
161013555|NCT04823611|581437663|FG005|Overall Study|Adverse Event|0|||
161013556|NCT04823611|581437664|FG006|Overall Study|Adverse Event|0|||
161013557|NCT01673984|581437666|FG000|Overall Study|Adverse Event|1|||
161013558|NCT01673984|581437667|FG001|Overall Study|Adverse Event|0|||
161013559|NCT01673984|581437666|FG000|Overall Study|Study termination|9|||
161013560|NCT01673984|581437667|FG001|Overall Study|Study termination|6|||
161013561|NCT02651324|581437670|FG000|Overall Study|drug not administered, due dispensing issue|1|||
161013562|NCT02651324|581437671|FG001|Overall Study|drug not administered, due dispensing issue|0|||
161013563|NCT04437433|581437674|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
161013564|NCT04437433|581437675|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
161013565|NCT04437433|581437674|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
161013566|NCT04437433|581437675|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
161013567|NCT04437433|581437674|FG000|Overall Study|Adverse Event|9|||
161013568|NCT04437433|581437675|FG001|Overall Study|Adverse Event|0|||
161013569|NCT04437433|581437674|FG000|Overall Study|Lack of Efficacy|4|||
161013570|NCT04437433|581437675|FG001|Overall Study|Lack of Efficacy|0|||
161013571|NCT04437433|581437674|FG000|Overall Study|Withdrawal by Subject|4|||
161013572|NCT04437433|581437675|FG001|Overall Study|Withdrawal by Subject|1|||
161013573|NCT04437433|581437674|FG000|Overall Study|Protocol Deviation|0|||
161013574|NCT04437433|581437675|FG001|Overall Study|Protocol Deviation|1|||
161013575|NCT04437433|581437674|FG000|Overall Study|Other, not specified|0|||
161013576|NCT04437433|581437675|FG001|Overall Study|Other, not specified|1|||
161013577|NCT02365766|581437676|FG000|Overall Study|Withdrawal by Subject|0|||
161013578|NCT02365766|581437677|FG001|Overall Study|Withdrawal by Subject|0|||
161147715|NCT01001494|581922548|FG002|Overall Study|Other|3|||
161147716|NCT02179398|581922549|FG000|Overall Study|Lack of obligatory data|3|||
161147717|NCT02179398|581922550|FG001|Overall Study|Lack of obligatory data|3|||
161147718|NCT02179398|581922549|FG000|Overall Study|Lost to Follow-up|0|||
161147719|NCT02179398|581922550|FG001|Overall Study|Lost to Follow-up|1|||
161147720|NCT00408681|581922551|FG000|Overall Study|Lack of Efficacy|2|||
161147721|NCT00408681|581922551|FG000|Overall Study|Adverse Event|7|||
161343540|NCT00207740|582644408|FG002|Overall Study|Lost to Follow-up|1|||
161343541|NCT00207740|582644409|FG003|Overall Study|Lost to Follow-up|1|||
161013579|NCT02365766|581437678|FG002|Overall Study|Withdrawal by Subject|1|||
161013580|NCT02365766|581437676|FG000|Overall Study|Eligibility Criteria Not Met|0|||
161013581|NCT02365766|581437677|FG001|Overall Study|Eligibility Criteria Not Met|0|||
161013582|NCT02365766|581437678|FG002|Overall Study|Eligibility Criteria Not Met|1|||
161013583|NCT03385629|581437682|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
161013584|NCT03385629|581437683|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
161013585|NCT03385629|581437682|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
161013586|NCT03385629|581437683|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
161013587|NCT03385629|581437682|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
161147722|NCT01787591|581922559|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161147723|NCT01787591|581922560|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161013588|NCT03385629|581437683|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
161013589|NCT04711135|581437687|FG000|Overall Study|Physician Decision|0|||
161013590|NCT04711135|581437688|FG001|Overall Study|Physician Decision|1|||
161013591|NCT04711135|581437687|FG000|Overall Study|Ongoing treatment|0|||
161013592|NCT04711135|581437688|FG001|Overall Study|Ongoing treatment|1|||
161013593|NCT02538900|581437696|FG000|Overall Study|Death|2|||
161013594|NCT02538900|581437697|FG001|Overall Study|Death|2|||
161013595|NCT02538900|581437698|FG002|Overall Study|Death|2|||
161013596|NCT02538900|581437696|FG000|Overall Study|Withdrawal by Subject|18|||
161013597|NCT02538900|581437697|FG001|Overall Study|Withdrawal by Subject|16|||
161013598|NCT02538900|581437698|FG002|Overall Study|Withdrawal by Subject|15|||
161013599|NCT04600752|581437699|FG000|Overall Study|Physician Decision|0|||
161013600|NCT04600752|581437700|FG001|Overall Study|Physician Decision|0|||
161013601|NCT04600752|581437701|FG002|Overall Study|Physician Decision|1|||
161013602|NCT04600752|581437699|FG000|Overall Study|Adverse Event|0|||
161013603|NCT04600752|581437700|FG001|Overall Study|Adverse Event|1|||
161013604|NCT04600752|581437701|FG002|Overall Study|Adverse Event|0|||
161013605|NCT04600752|581437699|FG000|Overall Study|Withdrawal by Subject|2|||
161013606|NCT04600752|581437700|FG001|Overall Study|Withdrawal by Subject|1|||
161013607|NCT04600752|581437701|FG002|Overall Study|Withdrawal by Subject|0|||
161013608|NCT04600752|581437699|FG000|Overall Study|Lack of Efficacy|1|||
161013609|NCT04600752|581437700|FG001|Overall Study|Lack of Efficacy|0|||
161013610|NCT04600752|581437701|FG002|Overall Study|Lack of Efficacy|0|||
161013611|NCT04431726|581437702|FG000|Overall Study|Ongoing in the Study|55|||
161013612|NCT03732820|581437703|FG000|Overall Study|Death|168|||
161013613|NCT03732820|581437704|FG001|Overall Study|Death|203|||
161013614|NCT03732820|581437703|FG000|Overall Study|Other|2|||
161013615|NCT03732820|581437704|FG001|Overall Study|Other|2|||
161013616|NCT03732820|581437703|FG000|Overall Study|Failure to meet randomisation criteria|1|||
161013617|NCT03732820|581437704|FG001|Overall Study|Failure to meet randomisation criteria|1|||
161013618|NCT03732820|581437703|FG000|Overall Study|Patient decision|14|||
161013619|NCT03732820|581437704|FG001|Overall Study|Patient decision|10|||
161013620|NCT03732820|581437703|FG000|Overall Study|Screen failure|0|||
161013621|NCT03732820|581437704|FG001|Overall Study|Screen failure|1|||
161013622|NCT03732820|581437703|FG000|Overall Study|Patients ongoing study at data cut off|210|||
161013623|NCT03732820|581437704|FG001|Overall Study|Patients ongoing study at data cut off|178|||
161013624|NCT03732820|581437703|FG000|Overall Study|Lost to Follow-up|4|||
161013625|NCT03732820|581437704|FG001|Overall Study|Lost to Follow-up|2|||
161013626|NCT00999167|581437707|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
161013627|NCT00999167|581437708|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
161013628|NCT00999167|581437709|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
161013629|NCT00999167|581437707|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
161013630|NCT00999167|581437708|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
161013631|NCT00999167|581437709|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
161013632|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
161013633|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
161013634|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
161013635|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
161013636|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
161013637|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
161013638|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
161013639|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
161013640|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
161013641|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
161013642|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
161013643|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
161013644|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
161013645|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
161013646|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
161013647|NCT00999167|581437707|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
161013648|NCT00999167|581437708|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
161013649|NCT00999167|581437709|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
161013650|NCT02789020|581437712|FG000|Overall Study|Withdrawal by Subject|6|||
161013651|NCT02789020|581437713|FG001|Overall Study|Withdrawal by Subject|5|||
161013652|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161013653|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161013654|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
161013655|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
161013656|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
161013657|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
161013658|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
161343542|NCT00207740|582644406|FG000|Overall Study|Death|0|||
161013659|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
161013660|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161013661|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161013662|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
161013663|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
161013664|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161013665|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161013666|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
161013667|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
161013668|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
161013669|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
161147724|NCT01787591|581922561|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
161147725|NCT01787591|581922562|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
161147726|NCT02489630|581922565|FG000|Overall Study|Oversedation|1|||
161147727|NCT02489630|581922566|FG001|Overall Study|Oversedation|1|||
161147728|NCT02489630|581922565|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
161147729|NCT02489630|581922566|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
161147730|NCT02975349|581922570|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161147731|NCT02975349|581922571|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161147732|NCT02975349|581922572|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161147733|NCT02975349|581922573|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161147734|NCT02975349|581922574|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161147735|NCT02975349|581922575|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161147736|NCT02975349|581922576|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161147737|NCT02975349|581922570|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161147738|NCT02975349|581922571|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161147739|NCT02975349|581922572|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161147740|NCT02975349|581922573|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161147741|NCT02975349|581922574|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161147742|NCT02975349|581922575|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161147743|NCT02975349|581922576|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161147744|NCT02975349|581922570|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
161147745|NCT02975349|581922571|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
161147746|NCT02975349|581922572|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
161147747|NCT02975349|581922573|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161147748|NCT02975349|581922574|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161147749|NCT02975349|581922575|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
161147750|NCT02975349|581922576|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
161147751|NCT02975349|581922570|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161147752|NCT02975349|581922571|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161147753|NCT02975349|581922572|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161147754|NCT02975349|581922573|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161147755|NCT02975349|581922574|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
161147756|NCT02975349|581922575|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
161147757|NCT02975349|581922576|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
161147758|NCT02975349|581922570|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161147759|NCT02975349|581922571|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
161147760|NCT02975349|581922572|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161147761|NCT02975349|581922573|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
161147762|NCT02975349|581922574|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
161147763|NCT02975349|581922575|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
161147764|NCT02975349|581922576|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
161147765|NCT02975349|581922570|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161147766|NCT02975349|581922571|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161147767|NCT02975349|581922572|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161147768|NCT02975349|581922573|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
161147769|NCT02975349|581922574|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161147770|NCT02975349|581922575|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161147771|NCT02975349|581922576|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
161147772|NCT02975349|581922570|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161147773|NCT02975349|581922571|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
161147774|NCT02975349|581922572|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161147775|NCT02975349|581922573|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161147776|NCT02975349|581922574|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161013670|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
161147777|NCT02975349|581922575|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161343543|NCT00207740|582644407|FG001|Overall Study|Death|0|||
161013671|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
161013672|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
161013673|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
161013674|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
161013675|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
161013676|NCT03338816|581437716|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161013677|NCT03338816|581437717|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161013678|NCT03338816|581437718|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
161013679|NCT03338816|581437719|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
161013680|NCT04238247|581437725|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
161013681|NCT04238247|581437726|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
161013682|NCT04238247|581437727|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
161013683|NCT04238247|581437728|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
161013684|NCT04238247|581437725|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
161013685|NCT04238247|581437726|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
161013686|NCT04238247|581437727|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
161013687|NCT04238247|581437728|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
161013688|NCT04238247|581437725|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
161013689|NCT04238247|581437726|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
161013690|NCT04238247|581437727|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
161013691|NCT04238247|581437728|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
161013692|NCT04238247|581437725|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
161013693|NCT04238247|581437726|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
161013694|NCT04238247|581437727|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
161013695|NCT04238247|581437728|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
161013696|NCT05512962|581437729|FG000|Overall Study|Withdrawal by Subject|1|||
161013697|NCT05512962|581437730|FG001|Overall Study|Withdrawal by Subject|0|||
161013698|NCT04950127|581437731|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
161013699|NCT04950127|581437732|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
161013700|NCT04950127|581437733|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013701|NCT04950127|581437734|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013702|NCT04950127|581437735|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013703|NCT04950127|581437736|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
161013704|NCT04950127|581437731|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
161013705|NCT04950127|581437732|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
161013706|NCT04950127|581437733|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013707|NCT04950127|581437734|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013708|NCT04950127|581437735|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013709|NCT04950127|581437736|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
161013710|NCT04950127|581437731|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
161013711|NCT04950127|581437732|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
161013712|NCT04950127|581437733|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013713|NCT04950127|581437734|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013714|NCT04950127|581437735|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013715|NCT04950127|581437736|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
161013716|NCT04950127|581437731|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161147778|NCT02975349|581922576|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
161147779|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
161147780|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
161147781|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
161147782|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161147783|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161013717|NCT04950127|581437732|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013718|NCT04950127|581437733|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013719|NCT04950127|581437734|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013720|NCT04950127|581437735|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
161013721|NCT04950127|581437736|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
161013722|NCT04950127|581437731|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013723|NCT04950127|581437732|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013724|NCT04950127|581437733|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013725|NCT04950127|581437734|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013726|NCT04950127|581437735|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
161013727|NCT04950127|581437736|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
161013728|NCT01711632|581437737|FG000|Overall Study|Adverse Event|4|||
161013729|NCT01711632|581437737|FG000|Overall Study|Death|3|||
161343544|NCT00207740|582644408|FG002|Overall Study|Death|0|||
161343545|NCT00207740|582644409|FG003|Overall Study|Death|1|||
161013730|NCT01711632|581437737|FG000|Overall Study|Lost to Follow-up|3|||
161013731|NCT01711632|581437737|FG000|Overall Study|Withdrawal by Subject|4|||
161272233|NCT02563106|582377588|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
161272234|NCT02563106|582377589|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
161013732|NCT01711632|581437737|FG000|Overall Study|Progressive disease|2|||
161013733|NCT01711632|581437737|FG000|Overall Study|No follow up required in re-treatment|3|||
161013734|NCT01711632|581437737|FG000|Overall Study|No follow up required in re-treatment|3|||
161013735|NCT03517969|581437738|FG000|Overall Study|Never started protocol treatment|3|||
161013736|NCT03517969|581437739|FG001|Overall Study|Never started protocol treatment|5|||
161013737|NCT03517969|581437738|FG000|Overall Study|Disease progression|11|||
161013738|NCT03517969|581437739|FG001|Overall Study|Disease progression|16|||
161013739|NCT03517969|581437738|FG000|Overall Study|PSA progression|8|||
161013740|NCT03517969|581437739|FG001|Overall Study|PSA progression|1|||
161013741|NCT03517969|581437738|FG000|Overall Study|Clinical progression|4|||
161013742|NCT03517969|581437739|FG001|Overall Study|Clinical progression|2|||
161013743|NCT03517969|581437738|FG000|Overall Study|Adverse Event|5|||
161013744|NCT03517969|581437739|FG001|Overall Study|Adverse Event|4|||
161013745|NCT03517969|581437738|FG000|Overall Study|Intercurrent illness|1|||
161013746|NCT03517969|581437739|FG001|Overall Study|Intercurrent illness|2|||
161013747|NCT03517969|581437738|FG000|Overall Study|Death|1|||
161013748|NCT03517969|581437739|FG001|Overall Study|Death|1|||
161013749|NCT03517969|581437738|FG000|Overall Study|Withdrawal by Subject|1|||
161013750|NCT03517969|581437739|FG001|Overall Study|Withdrawal by Subject|2|||
161013751|NCT03517969|581437738|FG000|Overall Study|Physician Decision|1|||
161013752|NCT03517969|581437739|FG001|Overall Study|Physician Decision|1|||
161013753|NCT03517969|581437738|FG000|Overall Study|No clinical benefit|1|||
161013754|NCT03517969|581437739|FG001|Overall Study|No clinical benefit|0|||
161013755|NCT03517969|581437738|FG000|Overall Study|Delayed treatment for dental treatment|1|||
161013756|NCT03517969|581437739|FG001|Overall Study|Delayed treatment for dental treatment|0|||
161013757|NCT03517969|581437738|FG000|Overall Study|Difficult to maintain appointment|0|||
161013758|NCT03517969|581437739|FG001|Overall Study|Difficult to maintain appointment|1|||
161013759|NCT03517969|581437738|FG000|Overall Study|Protocol Violation|0|||
161013760|NCT03517969|581437739|FG001|Overall Study|Protocol Violation|1|||
161013761|NCT02860130|581437740|FG000|Overall Study|Adverse Event|2|||
161013762|NCT02860130|581437741|FG001|Overall Study|Adverse Event|3|||
161013763|NCT02860130|581437740|FG000|Overall Study|Protocol Violation|1|||
161013764|NCT02860130|581437741|FG001|Overall Study|Protocol Violation|1|||
161013765|NCT02860130|581437740|FG000|Overall Study|Withdrawal by Subject|0|||
161013766|NCT02860130|581437741|FG001|Overall Study|Withdrawal by Subject|2|||
161013767|NCT02860130|581437740|FG000|Overall Study|Physician Decision|2|||
161013768|NCT02860130|581437741|FG001|Overall Study|Physician Decision|2|||
161013769|NCT02860130|581437740|FG000|Overall Study|Other|2|||
161013770|NCT02860130|581437741|FG001|Overall Study|Other|1|||
161013771|NCT02140645|581437746|FG000|Overall Study|Not linked|5489|||
161013772|NCT02140645|581437747|FG001|Overall Study|Not linked|61654|||
161013773|NCT02140645|581437748|FG002|Overall Study|Not linked|4236|||
161013774|NCT02140645|581437749|FG003|Overall Study|Not linked|13833|||
161013775|NCT02140645|581437750|FG004|Overall Study|Not linked|3286|||
161013776|NCT02140645|581437751|FG005|Overall Study|Not linked|70896|||
161013777|NCT05450458|581437752|FG000|Overall Study|Lost to Follow-up|4|||
161013778|NCT01101451|581437753|FG000|Overall Study|Eligible and never treated|0|||
161013779|NCT01101451|581437754|FG001|Overall Study|Eligible and never treated|5|||
161013780|NCT01101451|581437753|FG000|Overall Study|Ineligible and treated|12|||
161013781|NCT01101451|581437754|FG001|Overall Study|Ineligible and treated|8|||
161013782|NCT01101451|581437753|FG000|Overall Study|Ineligible and never treated|2|||
161013783|NCT01101451|581437754|FG001|Overall Study|Ineligible and never treated|2|||
161013784|NCT05480943|581437755|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
161013785|NCT05480943|581437755|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
161013786|NCT05480943|581437755|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
161013787|NCT05480943|581437755|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
161013788|NCT02965846|581437756|FG000|Overall Study|Lost to Follow-up|1|||
161013789|NCT02965846|581437757|FG001|Overall Study|Lost to Follow-up|0|||
161013790|NCT02965846|581437758|FG002|Overall Study|Lost to Follow-up|0|||
161013791|NCT02965846|581437756|FG000|Overall Study|Withdrawal by Subject|0|||
161013792|NCT02965846|581437757|FG001|Overall Study|Withdrawal by Subject|1|||
161272235|NCT02563106|582377588|FG000|Overall Study|Lost to Follow-up|3|||
161013793|NCT02965846|581437758|FG002|Overall Study|Withdrawal by Subject|0|||
161013794|NCT02965846|581437756|FG000|Overall Study|Study Terminated By Sponsor|4|||
161013795|NCT02965846|581437757|FG001|Overall Study|Study Terminated By Sponsor|4|||
161013796|NCT02965846|581437758|FG002|Overall Study|Study Terminated By Sponsor|0|||
161013797|NCT02965846|581437756|FG000|Overall Study|Participants not randomized|0|||
161013798|NCT02965846|581437757|FG001|Overall Study|Participants not randomized|0|||
161013799|NCT02965846|581437758|FG002|Overall Study|Participants not randomized|33|||
161013800|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161013801|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161013802|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
161013803|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
161013804|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161147784|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
161147785|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
161147786|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161147787|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161272236|NCT02563106|582377589|FG001|Overall Study|Lost to Follow-up|2|||
161013805|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161013806|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
161013807|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
161013808|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161013809|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161013810|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161013811|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
161013812|NCT02794480|581437759|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161013813|NCT02794480|581437760|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
161013814|NCT02794480|581437761|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161013815|NCT02794480|581437762|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161013816|NCT02794480|581437759|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161013817|NCT02794480|581437760|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161013818|NCT02794480|581437761|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161013819|NCT02794480|581437762|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161013820|NCT01747486|581437763|FG000|Stage 1|Physician Decision|3|||
161013821|NCT01747486|581437764|FG001|Stage 1|Physician Decision|0|||
161013822|NCT01747486|581437763|FG000|Stage 1|Withdrawal by Subject|4|||
161013823|NCT01747486|581437764|FG001|Stage 1|Withdrawal by Subject|3|||
161013824|NCT01747486|581437763|FG000|Stage 1|Disease progression|4|||
161013825|NCT01747486|581437764|FG001|Stage 1|Disease progression|9|||
161013826|NCT01747486|581437763|FG000|Stage 1|Death|1|||
161013827|NCT01747486|581437764|FG001|Stage 1|Death|1|||
161013828|NCT01747486|581437763|FG000|Stage 2|Physician Decision|2|||
161013829|NCT01747486|581437764|FG001|Stage 2|Physician Decision|0|||
161013830|NCT01747486|581437763|FG000|Stage 2|Withdrawal by Subject|1|||
161013831|NCT01747486|581437764|FG001|Stage 2|Withdrawal by Subject|0|||
161013832|NCT01747486|581437763|FG000|Stage 2|New Cancer Therapy|3|||
161013833|NCT01747486|581437764|FG001|Stage 2|New Cancer Therapy|0|||
161013834|NCT01747486|581437763|FG000|Stage 2|Disease Progression|3|||
161013835|NCT01747486|581437764|FG001|Stage 2|Disease Progression|0|||
161013836|NCT00632749|581437765|FG000|Overall Study|Progressive disease|3|||
161013837|NCT00632749|581437766|FG001|Overall Study|Progressive disease|2|||
161013838|NCT00632749|581437767|FG002|Overall Study|Progressive disease|2|||
161013839|NCT00632749|581437768|FG003|Overall Study|Progressive disease|2|||
161013840|NCT00632749|581437769|FG004|Overall Study|Progressive disease|4|||
161013841|NCT00632749|581437770|FG005|Overall Study|Progressive disease|4|||
161013842|NCT00632749|581437771|FG006|Overall Study|Progressive disease|3|||
161013843|NCT00632749|581437772|FG007|Overall Study|Progressive disease|2|||
161013844|NCT00632749|581437773|FG008|Overall Study|Progressive disease|3|||
161013845|NCT00632749|581437774|FG009|Overall Study|Progressive disease|2|||
161013846|NCT00632749|581437775|FG010|Overall Study|Progressive disease|4|||
161013847|NCT00632749|581437776|FG011|Overall Study|Progressive disease|3|||
161013848|NCT00632749|581437777|FG012|Overall Study|Progressive disease|2|||
161013849|NCT00632749|581437778|FG013|Overall Study|Progressive disease|4|||
161013850|NCT00632749|581437765|FG000|Overall Study|Other Adverse event|1|||
161013851|NCT00632749|581437766|FG001|Overall Study|Other Adverse event|1|||
161013852|NCT00632749|581437767|FG002|Overall Study|Other Adverse event|1|||
161013853|NCT00632749|581437768|FG003|Overall Study|Other Adverse event|1|||
161013854|NCT00632749|581437769|FG004|Overall Study|Other Adverse event|2|||
161013855|NCT00632749|581437770|FG005|Overall Study|Other Adverse event|4|||
161013856|NCT00632749|581437771|FG006|Overall Study|Other Adverse event|1|||
161013857|NCT00632749|581437772|FG007|Overall Study|Other Adverse event|2|||
161013858|NCT00632749|581437773|FG008|Overall Study|Other Adverse event|2|||
161013859|NCT00632749|581437774|FG009|Overall Study|Other Adverse event|0|||
161013860|NCT00632749|581437775|FG010|Overall Study|Other Adverse event|1|||
161013861|NCT00632749|581437776|FG011|Overall Study|Other Adverse event|0|||
161272237|NCT02563106|582377588|FG000|Overall Study|Physician Decision|3|||
161272238|NCT02563106|582377589|FG001|Overall Study|Physician Decision|1|||
161272239|NCT02563106|582377588|FG000|Overall Study|Other reason - not specified|2|||
161013862|NCT00632749|581437777|FG012|Overall Study|Other Adverse event|1|||
161013863|NCT00632749|581437778|FG013|Overall Study|Other Adverse event|0|||
161013864|NCT00632749|581437765|FG000|Overall Study|Refuse to continue medication|0|||
161013865|NCT00632749|581437766|FG001|Overall Study|Refuse to continue medication|0|||
161013866|NCT00632749|581437767|FG002|Overall Study|Refuse to continue medication|0|||
161013867|NCT00632749|581437768|FG003|Overall Study|Refuse to continue medication|1|||
161272240|NCT02563106|582377589|FG001|Overall Study|Other reason - not specified|1|||
161013868|NCT00632749|581437769|FG004|Overall Study|Refuse to continue medication|0|||
161013869|NCT00632749|581437770|FG005|Overall Study|Refuse to continue medication|0|||
161013870|NCT00632749|581437771|FG006|Overall Study|Refuse to continue medication|0|||
161013871|NCT00632749|581437772|FG007|Overall Study|Refuse to continue medication|0|||
161013872|NCT00632749|581437773|FG008|Overall Study|Refuse to continue medication|0|||
161013873|NCT00632749|581437774|FG009|Overall Study|Refuse to continue medication|1|||
161013874|NCT00632749|581437775|FG010|Overall Study|Refuse to continue medication|0|||
161013875|NCT00632749|581437776|FG011|Overall Study|Refuse to continue medication|0|||
161013876|NCT00632749|581437777|FG012|Overall Study|Refuse to continue medication|0|||
161013877|NCT00632749|581437778|FG013|Overall Study|Refuse to continue medication|0|||
161013878|NCT00632749|581437765|FG000|Overall Study|Reason other than those specified above|0|||
161013879|NCT00632749|581437766|FG001|Overall Study|Reason other than those specified above|2|||
161013880|NCT00632749|581437767|FG002|Overall Study|Reason other than those specified above|0|||
161013881|NCT00632749|581437768|FG003|Overall Study|Reason other than those specified above|0|||
161013882|NCT00632749|581437769|FG004|Overall Study|Reason other than those specified above|1|||
161013883|NCT00632749|581437770|FG005|Overall Study|Reason other than those specified above|0|||
161013884|NCT00632749|581437771|FG006|Overall Study|Reason other than those specified above|1|||
161013885|NCT00632749|581437772|FG007|Overall Study|Reason other than those specified above|0|||
161013886|NCT00632749|581437773|FG008|Overall Study|Reason other than those specified above|0|||
161013887|NCT00632749|581437774|FG009|Overall Study|Reason other than those specified above|0|||
161013888|NCT00632749|581437775|FG010|Overall Study|Reason other than those specified above|2|||
161013889|NCT00632749|581437776|FG011|Overall Study|Reason other than those specified above|1|||
161013890|NCT00632749|581437777|FG012|Overall Study|Reason other than those specified above|0|||
161013891|NCT00632749|581437778|FG013|Overall Study|Reason other than those specified above|2|||
161013892|NCT00611559|581437779|FG000|Overall Study|Lost to Follow-up|0|||
161013893|NCT00611559|581437780|FG001|Overall Study|Lost to Follow-up|1|||
161013894|NCT00611559|581437781|FG002|Overall Study|Lost to Follow-up|0|||
161013895|NCT00611559|581437779|FG000|Overall Study|Protocol Violation|1|||
161013896|NCT00611559|581437780|FG001|Overall Study|Protocol Violation|0|||
161013897|NCT00611559|581437781|FG002|Overall Study|Protocol Violation|1|||
161013898|NCT00879333|581437782|FG000|Overall Study|Adverse Event|94|||
161013899|NCT00879333|581437783|FG001|Overall Study|Adverse Event|34|||
161013900|NCT00879333|581437782|FG000|Overall Study|Abnormal Laboratory Value|1|||
161013901|NCT00879333|581437783|FG001|Overall Study|Abnormal Laboratory Value|0|||
161013902|NCT00879333|581437782|FG000|Overall Study|Withdrawal by Subject|20|||
161013903|NCT00879333|581437783|FG001|Overall Study|Withdrawal by Subject|7|||
161013904|NCT00879333|581437782|FG000|Overall Study|Lost to Follow-up|2|||
161013905|NCT00879333|581437783|FG001|Overall Study|Lost to Follow-up|1|||
161013906|NCT00879333|581437782|FG000|Overall Study|Administrative Problems|2|||
161013907|NCT00879333|581437783|FG001|Overall Study|Administrative Problems|0|||
161013908|NCT00879333|581437782|FG000|Overall Study|Death|16|||
161013909|NCT00879333|581437783|FG001|Overall Study|Death|5|||
161013910|NCT00879333|581437782|FG000|Overall Study|Disease Progression|292|||
161013911|NCT00879333|581437783|FG001|Overall Study|Disease Progression|169|||
161013912|NCT00879333|581437782|FG000|Overall Study|Protocol Violation|1|||
161013913|NCT00879333|581437783|FG001|Overall Study|Protocol Violation|1|||
161013914|NCT04999592|581437784|FG000|Overall Study|Withdrawal by Subject|1|||
161013915|NCT04999592|581437785|FG001|Overall Study|Withdrawal by Subject|0|||
161013916|NCT02671435|581437786|FG000|Overall Study|Death|1|||
161013917|NCT02671435|581437787|FG001|Overall Study|Death|3|||
161013918|NCT02671435|581437788|FG002|Overall Study|Death|0|||
161013919|NCT02671435|581437789|FG003|Overall Study|Death|16|||
161013920|NCT02671435|581437790|FG004|Overall Study|Death|14|||
161013921|NCT02671435|581437791|FG005|Overall Study|Death|29|||
161013922|NCT02671435|581437792|FG006|Overall Study|Death|34|||
161013923|NCT02671435|581437793|FG007|Overall Study|Death|28|||
161013924|NCT02671435|581437794|FG008|Overall Study|Death|19|||
161013925|NCT02671435|581437795|FG009|Overall Study|Death|10|||
161013926|NCT02671435|581437796|FG010|Overall Study|Death|8|||
161013927|NCT02671435|581437797|FG011|Overall Study|Death|29|||
161013928|NCT02671435|581437798|FG012|Overall Study|Death|29|||
161013929|NCT02671435|581437799|FG013|Overall Study|Death|29|||
161013930|NCT02671435|581437800|FG014|Overall Study|Death|27|||
161013931|NCT02671435|581437786|FG000|Overall Study|Lost to Follow-up|0|||
161013932|NCT02671435|581437787|FG001|Overall Study|Lost to Follow-up|0|||
161013933|NCT02671435|581437788|FG002|Overall Study|Lost to Follow-up|1|||
161013934|NCT02671435|581437789|FG003|Overall Study|Lost to Follow-up|0|||
161013935|NCT02671435|581437790|FG004|Overall Study|Lost to Follow-up|1|||
161013936|NCT02671435|581437791|FG005|Overall Study|Lost to Follow-up|1|||
161013937|NCT02671435|581437792|FG006|Overall Study|Lost to Follow-up|2|||
161013938|NCT02671435|581437793|FG007|Overall Study|Lost to Follow-up|2|||
161013939|NCT02671435|581437794|FG008|Overall Study|Lost to Follow-up|0|||
161013940|NCT02671435|581437795|FG009|Overall Study|Lost to Follow-up|2|||
161013941|NCT02671435|581437796|FG010|Overall Study|Lost to Follow-up|0|||
161013942|NCT02671435|581437797|FG011|Overall Study|Lost to Follow-up|3|||
161013943|NCT02671435|581437798|FG012|Overall Study|Lost to Follow-up|3|||
161013944|NCT02671435|581437799|FG013|Overall Study|Lost to Follow-up|2|||
161013945|NCT02671435|581437800|FG014|Overall Study|Lost to Follow-up|0|||
161013946|NCT02671435|581437786|FG000|Overall Study|Withdrawal by Subject|2|||
161013947|NCT02671435|581437787|FG001|Overall Study|Withdrawal by Subject|0|||
161013948|NCT02671435|581437788|FG002|Overall Study|Withdrawal by Subject|2|||
161013949|NCT02671435|581437789|FG003|Overall Study|Withdrawal by Subject|2|||
161013950|NCT02671435|581437790|FG004|Overall Study|Withdrawal by Subject|2|||
161013951|NCT02671435|581437791|FG005|Overall Study|Withdrawal by Subject|7|||
161013952|NCT02671435|581437792|FG006|Overall Study|Withdrawal by Subject|2|||
161013953|NCT02671435|581437793|FG007|Overall Study|Withdrawal by Subject|7|||
161013954|NCT02671435|581437794|FG008|Overall Study|Withdrawal by Subject|1|||
161013955|NCT02671435|581437795|FG009|Overall Study|Withdrawal by Subject|1|||
161013956|NCT02671435|581437796|FG010|Overall Study|Withdrawal by Subject|2|||
161013957|NCT02671435|581437797|FG011|Overall Study|Withdrawal by Subject|4|||
161013958|NCT02671435|581437798|FG012|Overall Study|Withdrawal by Subject|4|||
161013959|NCT02671435|581437799|FG013|Overall Study|Withdrawal by Subject|4|||
161013960|NCT02671435|581437800|FG014|Overall Study|Withdrawal by Subject|2|||
161013961|NCT02671435|581437786|FG000|Overall Study|Un-specified|0|||
161013962|NCT02671435|581437787|FG001|Overall Study|Un-specified|0|||
161013963|NCT02671435|581437788|FG002|Overall Study|Un-specified|0|||
161013964|NCT02671435|581437789|FG003|Overall Study|Un-specified|0|||
161013965|NCT02671435|581437790|FG004|Overall Study|Un-specified|1|||
161013966|NCT02671435|581437791|FG005|Overall Study|Un-specified|3|||
161013967|NCT02671435|581437792|FG006|Overall Study|Un-specified|2|||
161013968|NCT02671435|581437793|FG007|Overall Study|Un-specified|3|||
161013969|NCT02671435|581437794|FG008|Overall Study|Un-specified|0|||
161013970|NCT02671435|581437795|FG009|Overall Study|Un-specified|5|||
161013971|NCT02671435|581437796|FG010|Overall Study|Un-specified|8|||
161013972|NCT02671435|581437797|FG011|Overall Study|Un-specified|4|||
161013973|NCT02671435|581437798|FG012|Overall Study|Un-specified|5|||
161013974|NCT02671435|581437799|FG013|Overall Study|Un-specified|9|||
161013975|NCT02671435|581437800|FG014|Overall Study|Un-specified|8|||
161013976|NCT04128319|581437801|FG000|Overall Study|Death|3|||
161013977|NCT02910713|581437804|FG000|Overall Study|Protocol Violation|2|||
161013978|NCT02910713|581437804|FG000|Overall Study|Subject Choice|4|||
161013979|NCT02910713|581437804|FG000|Overall Study|Received One Application|10|||
161013980|NCT02910713|581437804|FG000|Overall Study|Received Neither Application|18|||
161013981|NCT02910713|581437804|FG000|Overall Study|Enrollment cap|7|||
161013982|NCT02910713|581437804|FG000|Overall Study|Investigator Discretion|1|||
161013983|NCT04442126|581437808|FG000|Overall Study|Withdrawal by Subject|0|||
161013984|NCT04442126|581437809|FG001|Overall Study|Withdrawal by Subject|0|||
161013985|NCT04442126|581437810|FG002|Overall Study|Withdrawal by Subject|0|||
161013986|NCT04442126|581437811|FG003|Overall Study|Withdrawal by Subject|2|||
161013987|NCT04442126|581437812|FG004|Overall Study|Withdrawal by Subject|1|||
161013988|NCT04442126|581437813|FG005|Overall Study|Withdrawal by Subject|0|||
161013989|NCT04442126|581437814|FG006|Overall Study|Withdrawal by Subject|1|||
161013990|NCT04442126|581437815|FG007|Overall Study|Withdrawal by Subject|1|||
161013991|NCT04442126|581437816|FG008|Overall Study|Withdrawal by Subject|3|||
161013992|NCT04442126|581437808|FG000|Overall Study|Death|1|||
161013993|NCT04442126|581437809|FG001|Overall Study|Death|0|||
161013994|NCT04442126|581437810|FG002|Overall Study|Death|0|||
161013995|NCT04442126|581437811|FG003|Overall Study|Death|1|||
161013996|NCT04442126|581437812|FG004|Overall Study|Death|2|||
161013997|NCT04442126|581437813|FG005|Overall Study|Death|2|||
161013998|NCT04442126|581437814|FG006|Overall Study|Death|4|||
161013999|NCT04442126|581437815|FG007|Overall Study|Death|1|||
161014000|NCT04442126|581437816|FG008|Overall Study|Death|5|||
161014001|NCT04442126|581437808|FG000|Overall Study|Study Terminated by Sponsor|0|||
161014002|NCT04442126|581437809|FG001|Overall Study|Study Terminated by Sponsor|0|||
161014003|NCT04442126|581437810|FG002|Overall Study|Study Terminated by Sponsor|0|||
161014004|NCT04442126|581437811|FG003|Overall Study|Study Terminated by Sponsor|0|||
161014005|NCT04442126|581437812|FG004|Overall Study|Study Terminated by Sponsor|0|||
161014006|NCT04442126|581437813|FG005|Overall Study|Study Terminated by Sponsor|1|||
161014007|NCT04442126|581437814|FG006|Overall Study|Study Terminated by Sponsor|4|||
161014008|NCT04442126|581437815|FG007|Overall Study|Study Terminated by Sponsor|2|||
161014009|NCT04442126|581437816|FG008|Overall Study|Study Terminated by Sponsor|10|||
161014010|NCT04442126|581437808|FG000|Overall Study|Lost to Follow-up|0|||
161014011|NCT04442126|581437809|FG001|Overall Study|Lost to Follow-up|0|||
161014012|NCT04442126|581437810|FG002|Overall Study|Lost to Follow-up|0|||
161147788|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161147789|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161147790|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
161343546|NCT00207740|582644406|FG000|Overall Study|Sponsor Directive|22|||
161014013|NCT04442126|581437811|FG003|Overall Study|Lost to Follow-up|0|||
161014014|NCT04442126|581437812|FG004|Overall Study|Lost to Follow-up|0|||
161014015|NCT04442126|581437813|FG005|Overall Study|Lost to Follow-up|0|||
161014016|NCT04442126|581437814|FG006|Overall Study|Lost to Follow-up|0|||
161014017|NCT04442126|581437815|FG007|Overall Study|Lost to Follow-up|1|||
161014018|NCT04442126|581437816|FG008|Overall Study|Lost to Follow-up|2|||
161014019|NCT04442126|581437808|FG000|Overall Study|Progressive Disease|0|||
161014020|NCT04442126|581437809|FG001|Overall Study|Progressive Disease|1|||
161014021|NCT04442126|581437810|FG002|Overall Study|Progressive Disease|3|||
161272241|NCT02338193|582377590|FG000|Overall Study|Withdrawal by Subject|0|||
161272242|NCT02338193|582377591|FG001|Overall Study|Withdrawal by Subject|0|||
161272243|NCT02338193|582377592|FG002|Overall Study|Withdrawal by Subject|2|||
161272244|NCT02338193|582377590|FG000|Overall Study|Pregnancy|0|||
161272245|NCT02338193|582377591|FG001|Overall Study|Pregnancy|1|||
161272246|NCT02338193|582377592|FG002|Overall Study|Pregnancy|1|||
161272247|NCT02338193|582377590|FG000|Overall Study|Noncompliant with visits|2|||
161272248|NCT02338193|582377591|FG001|Overall Study|Noncompliant with visits|2|||
161272249|NCT02338193|582377592|FG002|Overall Study|Noncompliant with visits|7|||
161272250|NCT02338193|582377590|FG000|Overall Study|moved out of state|0|||
161272251|NCT02338193|582377591|FG001|Overall Study|moved out of state|1|||
161272252|NCT02338193|582377592|FG002|Overall Study|moved out of state|0|||
161272253|NCT02338193|582377590|FG000|Overall Study|intolerant of side effects|1|||
161272254|NCT02338193|582377591|FG001|Overall Study|intolerant of side effects|0|||
161272255|NCT02338193|582377592|FG002|Overall Study|intolerant of side effects|0|||
161272256|NCT01136967|582377597|FG000|Overall Study|Adverse Event|9|||
161272257|NCT01136967|582377598|FG001|Overall Study|Adverse Event|12|||
161272258|NCT01136967|582377597|FG000|Overall Study|Participant Choice|8|||
161272259|NCT01136967|582377598|FG001|Overall Study|Participant Choice|3|||
161272260|NCT01136967|582377597|FG000|Overall Study|Lost to Follow-up|0|||
161272261|NCT01136967|582377598|FG001|Overall Study|Lost to Follow-up|1|||
161272262|NCT01136967|582377597|FG000|Overall Study|Withdrawal by Subject|1|||
161272263|NCT01136967|582377598|FG001|Overall Study|Withdrawal by Subject|2|||
161272264|NCT01136967|582377597|FG000|Overall Study|Clinical Progression|3|||
161272265|NCT01136967|582377598|FG001|Overall Study|Clinical Progression|5|||
161272266|NCT01136967|582377597|FG000|Overall Study|Radiation|1|||
161272267|NCT01136967|582377598|FG001|Overall Study|Radiation|0|||
161272268|NCT01136967|582377597|FG000|Overall Study|Non-compliance|1|||
161272269|NCT01136967|582377598|FG001|Overall Study|Non-compliance|0|||
161272270|NCT01136967|582377597|FG000|Overall Study|Investigator's Choice|1|||
161272271|NCT01136967|582377598|FG001|Overall Study|Investigator's Choice|1|||
161272272|NCT01136967|582377597|FG000|Overall Study|Increase in Lesion Size|0|||
161272273|NCT01136967|582377598|FG001|Overall Study|Increase in Lesion Size|2|||
161272274|NCT01136967|582377597|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
160967931|NCT01966003|581271352|FG000|Overall Study|Physician Decision|12|||
160967932|NCT01966003|581271353|FG001|Overall Study|Physician Decision|13|||
160967933|NCT01966003|581271352|FG000|Overall Study|Withdrawal by Subject|29|||
160967934|NCT01966003|581271353|FG001|Overall Study|Withdrawal by Subject|19|||
160967935|NCT01966003|581271352|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
160967936|NCT01966003|581271353|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
160967937|NCT01966003|581271352|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
160967938|NCT01966003|581271353|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
160967939|NCT01966003|581271352|FG000|Overall Study|Other|1|||
160967940|NCT01966003|581271353|FG001|Overall Study|Other|1|||
160967941|NCT02748694|581271358|FG000|Overall Study|Voluntary Withdrawal|0|||
160967942|NCT02748694|581271359|FG001|Overall Study|Voluntary Withdrawal|0|||
160967943|NCT02748694|581271360|FG002|Overall Study|Voluntary Withdrawal|0|||
160967944|NCT02748694|581271361|FG003|Overall Study|Voluntary Withdrawal|0|||
160967945|NCT02748694|581271362|FG004|Overall Study|Voluntary Withdrawal|0|||
160967946|NCT02748694|581271363|FG005|Overall Study|Voluntary Withdrawal|0|||
160967947|NCT02748694|581271364|FG006|Overall Study|Voluntary Withdrawal|0|||
160967948|NCT02748694|581271365|FG007|Overall Study|Voluntary Withdrawal|0|||
160967949|NCT02748694|581271366|FG008|Overall Study|Voluntary Withdrawal|0|||
160967950|NCT02748694|581271367|FG009|Overall Study|Voluntary Withdrawal|0|||
160967951|NCT02748694|581271368|FG010|Overall Study|Voluntary Withdrawal|0|||
160967952|NCT02748694|581271369|FG011|Overall Study|Voluntary Withdrawal|0|||
160967953|NCT02748694|581271370|FG012|Overall Study|Voluntary Withdrawal|0|||
160967954|NCT02748694|581271371|FG013|Overall Study|Voluntary Withdrawal|0|||
160967955|NCT02748694|581271372|FG014|Overall Study|Voluntary Withdrawal|2|||
160967956|NCT04026165|581271375|FG000|Run-in Placebo Period|Enrollment Error|13|||
160967957|NCT04026165|581271376|FG001|Run-in Placebo Period|Enrollment Error|0|||
160967958|NCT04026165|581271377|FG002|Run-in Placebo Period|Enrollment Error|0|||
160967959|NCT04026165|581271378|FG003|Run-in Placebo Period|Enrollment Error|0|||
160967960|NCT04026165|581271375|FG000|Run-in Placebo Period|Run-in Failure|4|||
160967961|NCT04026165|581271376|FG001|Run-in Placebo Period|Run-in Failure|0|||
160967962|NCT04026165|581271377|FG002|Run-in Placebo Period|Run-in Failure|0|||
160967963|NCT04026165|581271378|FG003|Run-in Placebo Period|Run-in Failure|0|||
160967964|NCT04026165|581271375|FG000|Run-in Placebo Period|Protocol Violation|2|||
160967965|NCT04026165|581271376|FG001|Run-in Placebo Period|Protocol Violation|0|||
161272275|NCT01136967|582377598|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
161272276|NCT03317834|582377599|FG000|Overall Study|Death|2|||
161272277|NCT03317834|582377599|FG000|Overall Study|Device Revision|5|||
161272278|NCT03317834|582377599|FG000|Overall Study|Withdrawal by Subject|13|||
160967966|NCT04026165|581271377|FG002|Run-in Placebo Period|Protocol Violation|0|||
160967967|NCT04026165|581271378|FG003|Run-in Placebo Period|Protocol Violation|0|||
160967968|NCT04026165|581271375|FG000|Run-in Placebo Period|Withdrew Consent|2|||
160967969|NCT04026165|581271376|FG001|Run-in Placebo Period|Withdrew Consent|0|||
161014022|NCT04442126|581437811|FG003|Overall Study|Progressive Disease|0|||
161014023|NCT04442126|581437812|FG004|Overall Study|Progressive Disease|3|||
161014024|NCT04442126|581437813|FG005|Overall Study|Progressive Disease|0|||
161014025|NCT04442126|581437814|FG006|Overall Study|Progressive Disease|0|||
161014026|NCT04442126|581437815|FG007|Overall Study|Progressive Disease|0|||
161014027|NCT04442126|581437816|FG008|Overall Study|Progressive Disease|0|||
161014028|NCT04442126|581437808|FG000|Overall Study|Other|0|||
161014029|NCT04442126|581437809|FG001|Overall Study|Other|0|||
161014030|NCT04442126|581437810|FG002|Overall Study|Other|0|||
161014031|NCT04442126|581437811|FG003|Overall Study|Other|0|||
161014032|NCT04442126|581437812|FG004|Overall Study|Other|0|||
161014033|NCT04442126|581437813|FG005|Overall Study|Other|0|||
161014034|NCT04442126|581437814|FG006|Overall Study|Other|0|||
161014035|NCT04442126|581437815|FG007|Overall Study|Other|0|||
161014036|NCT04442126|581437816|FG008|Overall Study|Other|1|||
161014037|NCT06450405|581437817|FG000|Overall Study|Study funding terminated.|0|||
161014038|NCT06450405|581437818|FG001|Overall Study|Study funding terminated.|2|||
161014039|NCT03152786|581438866|FG000|Overall Study|Withdrawal by Subject|2|||
161014040|NCT03152786|581438867|FG001|Overall Study|Withdrawal by Subject|1|||
161014041|NCT02525692|581438868|FG000|Overall Study|Withdrawal by Subject|1|||
161014042|NCT02525692|581438869|FG001|Overall Study|Withdrawal by Subject|1|||
161014043|NCT02525692|581438870|FG002|Overall Study|Withdrawal by Subject|0|||
161014044|NCT02525692|581438871|FG003|Overall Study|Withdrawal by Subject|5|||
161014045|NCT02525692|581438872|FG004|Overall Study|Withdrawal by Subject|0|||
161014046|NCT02525692|581438873|FG005|Overall Study|Withdrawal by Subject|1|||
161014047|NCT02525692|581438868|FG000|Overall Study|Death|16|||
161014048|NCT02525692|581438869|FG001|Overall Study|Death|18|||
161014049|NCT02525692|581438870|FG002|Overall Study|Death|7|||
161014050|NCT02525692|581438871|FG003|Overall Study|Death|20|||
161014051|NCT02525692|581438872|FG004|Overall Study|Death|3|||
161014052|NCT02525692|581438873|FG005|Overall Study|Death|6|||
161014053|NCT02525692|581438868|FG000|Overall Study|Lost to Follow-up|0|||
161014054|NCT02525692|581438869|FG001|Overall Study|Lost to Follow-up|0|||
161014055|NCT02525692|581438870|FG002|Overall Study|Lost to Follow-up|1|||
161014056|NCT02525692|581438871|FG003|Overall Study|Lost to Follow-up|5|||
161014057|NCT02525692|581438872|FG004|Overall Study|Lost to Follow-up|0|||
161014058|NCT02525692|581438873|FG005|Overall Study|Lost to Follow-up|0|||
161014059|NCT02396199|581438874|FG000|Overall Study|Lost to Follow-up|1|||
161014060|NCT02396199|581438874|FG000|Overall Study|Death|4|||
161014061|NCT04247542|581438877|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
161014062|NCT04247542|581438878|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
161014063|NCT04247542|581438879|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
161014064|NCT04247542|581438877|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
161014065|NCT04247542|581438878|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
161014066|NCT04247542|581438879|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
161014067|NCT06066541|581438880|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
161014068|NCT06066541|581438881|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
161014069|NCT06066541|581438882|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
161014070|NCT06066541|581438883|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
161014071|NCT06066541|581438884|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
161014072|NCT06066541|581438885|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161014073|NCT06066541|581438886|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
161014074|NCT06066541|581438880|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
161014075|NCT06066541|581438881|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
161343547|NCT00207740|582644407|FG001|Overall Study|Sponsor Directive|15|||
161014076|NCT06066541|581438882|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
161014077|NCT06066541|581438883|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
161014078|NCT06066541|581438884|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
161014079|NCT06066541|581438885|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
161014080|NCT06066541|581438886|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
161014081|NCT04533022|581438887|FG000|Overall Study|Withdrawal by Subject|15|||
161014082|NCT04533022|581438887|FG000|Overall Study|Adverse Event|6|||
161147791|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161014083|NCT04533022|581438887|FG000|Overall Study|Death|1|||
161014084|NCT04533022|581438887|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
161014085|NCT04533022|581438887|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
161147792|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
161343548|NCT00207740|582644408|FG002|Overall Study|Sponsor Directive|16|||
161014086|NCT02163447|581438888|FG000|Overall Study|Withdrawal by Subject|2|||
161343549|NCT00207740|582644409|FG003|Overall Study|Sponsor Directive|21|||
161147793|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161343550|NCT00207740|582644406|FG000|Overall Study|Other|2|||
161014087|NCT02163447|581438889|FG001|Overall Study|Withdrawal by Subject|0|||
161014088|NCT02163447|581438890|FG002|Overall Study|Withdrawal by Subject|1|||
161014089|NCT02163447|581438888|FG000|Overall Study|Lost to Follow-up|1|||
161014090|NCT02163447|581438889|FG001|Overall Study|Lost to Follow-up|3|||
161014091|NCT02163447|581438890|FG002|Overall Study|Lost to Follow-up|0|||
161014092|NCT02163447|581438888|FG000|Overall Study|Moved out of study area|2|||
161014093|NCT02163447|581438889|FG001|Overall Study|Moved out of study area|3|||
161014094|NCT02163447|581438890|FG002|Overall Study|Moved out of study area|2|||
161014095|NCT02163447|581438888|FG000|Overall Study|Became HIV infected at time of delivery|1|||
161014096|NCT02163447|581438889|FG001|Overall Study|Became HIV infected at time of delivery|0|||
161014097|NCT02163447|581438890|FG002|Overall Study|Became HIV infected at time of delivery|0|||
161014098|NCT03157167|581438891|FG000|Overall Study|Withdrawal by Subject|1|||
161014099|NCT03157167|581438892|FG001|Overall Study|Withdrawal by Subject|0|||
161014100|NCT03157167|581438893|FG002|Overall Study|Withdrawal by Subject|0|||
161014101|NCT02597946|581438895|FG000|Overall Study|Withdrawal by Subject|1|||
161014102|NCT02597946|581438895|FG000|Overall Study|Progressive disease|16|||
161014103|NCT02597946|581438895|FG000|Overall Study|Other than above|1|||
161014104|NCT03263026|581438896|FG000|Overall Study|Withdrawal by Subject|1|||
161014105|NCT03263026|581438897|FG001|Overall Study|Withdrawal by Subject|0|||
161014106|NCT03263026|581438896|FG000|Overall Study|Death|1|||
161014107|NCT03263026|581438897|FG001|Overall Study|Death|0|||
161014108|NCT03263026|581438896|FG000|Overall Study|Other/ Various|41|||
161014109|NCT03263026|581438897|FG001|Overall Study|Other/ Various|29|||
161014110|NCT01938547|581438906|FG000|Overall Study|Physician Decision|1|||
161014111|NCT05320432|581438911|FG000|Overall Study|Withdrawal by Subject|0|||
161014112|NCT05320432|581438912|FG001|Overall Study|Withdrawal by Subject|2|||
161014113|NCT05038566|581438913|FG000|Overall Study|Technical Difficulties with the Device|0|||
161343551|NCT00207740|582644407|FG001|Overall Study|Other|10|||
160967970|NCT04026165|581271377|FG002|Run-in Placebo Period|Withdrew Consent|0|||
160967971|NCT04026165|581271378|FG003|Run-in Placebo Period|Withdrew Consent|0|||
160967972|NCT04026165|581271375|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
160967973|NCT04026165|581271376|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
160967974|NCT04026165|581271377|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
160967975|NCT04026165|581271378|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
160967976|NCT04026165|581271375|FG000|Run-in SEL Period|Run-in Failure|0|||
160967977|NCT04026165|581271376|FG001|Run-in SEL Period|Run-in Failure|26|||
160967978|NCT04026165|581271377|FG002|Run-in SEL Period|Run-in Failure|0|||
160967979|NCT04026165|581271378|FG003|Run-in SEL Period|Run-in Failure|0|||
160967980|NCT04026165|581271375|FG000|Run-in SEL Period|Withdrew Consent|0|||
160967981|NCT04026165|581271376|FG001|Run-in SEL Period|Withdrew Consent|10|||
160967982|NCT04026165|581271377|FG002|Run-in SEL Period|Withdrew Consent|0|||
160967983|NCT04026165|581271378|FG003|Run-in SEL Period|Withdrew Consent|0|||
160967984|NCT04026165|581271375|FG000|Run-in SEL Period|Enrollment Error|0|||
160967985|NCT04026165|581271376|FG001|Run-in SEL Period|Enrollment Error|4|||
160967986|NCT04026165|581271377|FG002|Run-in SEL Period|Enrollment Error|0|||
160967987|NCT04026165|581271378|FG003|Run-in SEL Period|Enrollment Error|0|||
160967988|NCT04026165|581271375|FG000|Run-in SEL Period|Protocol Violation|0|||
160967989|NCT04026165|581271376|FG001|Run-in SEL Period|Protocol Violation|3|||
160967990|NCT04026165|581271377|FG002|Run-in SEL Period|Protocol Violation|0|||
160967991|NCT04026165|581271378|FG003|Run-in SEL Period|Protocol Violation|0|||
160967992|NCT04026165|581271375|FG000|Run-in SEL Period|Investigator's Discretion|0|||
160967993|NCT04026165|581271376|FG001|Run-in SEL Period|Investigator's Discretion|2|||
160967994|NCT04026165|581271377|FG002|Run-in SEL Period|Investigator's Discretion|0|||
160967995|NCT04026165|581271378|FG003|Run-in SEL Period|Investigator's Discretion|0|||
160967996|NCT04026165|581271375|FG000|Run-in SEL Period|Death|0|||
160967997|NCT04026165|581271376|FG001|Run-in SEL Period|Death|1|||
160967998|NCT04026165|581271377|FG002|Run-in SEL Period|Death|0|||
160967999|NCT04026165|581271378|FG003|Run-in SEL Period|Death|0|||
160968000|NCT04026165|581271375|FG000|Randomized Period|Withdrew Consent|0|||
160968001|NCT04026165|581271376|FG001|Randomized Period|Withdrew Consent|0|||
160968002|NCT04026165|581271377|FG002|Randomized Period|Withdrew Consent|5|||
160968003|NCT04026165|581271378|FG003|Randomized Period|Withdrew Consent|8|||
160968004|NCT04026165|581271375|FG000|Randomized Period|Death|0|||
160968005|NCT04026165|581271376|FG001|Randomized Period|Death|0|||
160968006|NCT04026165|581271377|FG002|Randomized Period|Death|5|||
160968007|NCT04026165|581271378|FG003|Randomized Period|Death|7|||
160968008|NCT04026165|581271375|FG000|Randomized Period|Investigator's Discretion|0|||
160968009|NCT04026165|581271376|FG001|Randomized Period|Investigator's Discretion|0|||
160968010|NCT04026165|581271377|FG002|Randomized Period|Investigator's Discretion|2|||
160968011|NCT04026165|581271378|FG003|Randomized Period|Investigator's Discretion|2|||
160968012|NCT04026165|581271375|FG000|Randomized Period|Lost to Follow-up|0|||
160968013|NCT04026165|581271376|FG001|Randomized Period|Lost to Follow-up|0|||
161147794|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161147795|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
160968014|NCT04026165|581271377|FG002|Randomized Period|Lost to Follow-up|2|||
161147796|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161272279|NCT03317834|582377599|FG000|Overall Study|Lost to Follow-up|13|||
160968015|NCT04026165|581271378|FG003|Randomized Period|Lost to Follow-up|2|||
160968016|NCT03170375|581271379|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
160968017|NCT03170375|581271380|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
160968018|NCT03170375|581271381|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
160968019|NCT03170375|581271379|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
160968020|NCT03170375|581271380|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
160968021|NCT03170375|581271381|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
160968022|NCT00077064|581271382|FG000|Overall Study|Adverse Event|0|||
160968023|NCT00077064|581271383|FG001|Overall Study|Adverse Event|4|||
160968024|NCT00077064|581271382|FG000|Overall Study|Patient refusal|0|||
160968025|NCT00077064|581271383|FG001|Overall Study|Patient refusal|2|||
160968026|NCT02007434|581271384|FG000|Overall Study|Lost to Follow-up|0|||
160968027|NCT02007434|581271385|FG001|Overall Study|Lost to Follow-up|1|||
160968028|NCT02007434|581271386|FG002|Overall Study|Lost to Follow-up|0|||
160968029|NCT02007434|581271387|FG003|Overall Study|Lost to Follow-up|0|||
160968030|NCT02007434|581271388|FG004|Overall Study|Lost to Follow-up|0|||
160968031|NCT02007434|581271389|FG005|Overall Study|Lost to Follow-up|0|||
160968032|NCT02007434|581271390|FG006|Overall Study|Lost to Follow-up|0|||
160968033|NCT02007434|581271391|FG007|Overall Study|Lost to Follow-up|0|||
160968034|NCT02007434|581271384|FG000|Overall Study|Non-compliance|1|||
160968035|NCT02007434|581271385|FG001|Overall Study|Non-compliance|0|||
160968036|NCT02007434|581271386|FG002|Overall Study|Non-compliance|1|||
160968037|NCT02007434|581271387|FG003|Overall Study|Non-compliance|0|||
160968038|NCT02007434|581271388|FG004|Overall Study|Non-compliance|0|||
160968039|NCT02007434|581271389|FG005|Overall Study|Non-compliance|0|||
160968040|NCT02007434|581271390|FG006|Overall Study|Non-compliance|0|||
160968041|NCT02007434|581271391|FG007|Overall Study|Non-compliance|0|||
160968042|NCT00763958|581271392|FG000|Overall Study|did not meet final criteria|4|||
160968043|NCT00763958|581271393|FG001|Overall Study|did not meet final criteria|4|||
160968044|NCT00763958|581271392|FG000|Overall Study|Lost to Follow-up|10|||
160968045|NCT00763958|581271393|FG001|Overall Study|Lost to Follow-up|2|||
160968046|NCT00763958|581271392|FG000|Overall Study|Believed they were receiving placebo|0|||
160968047|NCT00763958|581271393|FG001|Overall Study|Believed they were receiving placebo|5|||
160968048|NCT00927355|581271394|FG000|Overall Study|Adverse Event|1|||
160968049|NCT00927355|581271395|FG001|Overall Study|Adverse Event|1|||
160968050|NCT03299686|581271396|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
160968051|NCT03299686|581271397|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
160968052|NCT03299686|581271396|FG000|Treatment Epoch|Physician Decision|1|||
160968053|NCT03299686|581271397|FG001|Treatment Epoch|Physician Decision|0|||
160968054|NCT03299686|581271396|FG000|Treatment Epoch|Adverse Event|8|||
160968055|NCT03299686|581271397|FG001|Treatment Epoch|Adverse Event|4|||
160968056|NCT03299686|581271396|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
160968057|NCT03299686|581271397|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
160968058|NCT02889133|581271399|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
160968059|NCT02889133|581271400|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
160968060|NCT02889133|581271399|FG000|Completed Primary Outcome|Manufacturing error|3|||
160968061|NCT02889133|581271400|FG001|Completed Primary Outcome|Manufacturing error|8|||
160968062|NCT02889133|581271399|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
160968063|NCT02889133|581271400|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
160968064|NCT02889133|581271399|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
160968065|NCT02889133|581271400|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
160968066|NCT02889133|581271399|FG000|Completed Primary Outcome|Protocol Violation|1|||
160968067|NCT02889133|581271400|FG001|Completed Primary Outcome|Protocol Violation|0|||
160968068|NCT02889133|581271399|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
160968069|NCT02889133|581271400|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
160968070|NCT02889133|581271399|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
160968071|NCT02889133|581271400|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
160968072|NCT02889133|581271399|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
160968073|NCT02889133|581271400|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
160968074|NCT02889133|581271399|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
160968075|NCT02889133|581271400|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
160968076|NCT02889133|581271399|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
160968077|NCT02889133|581271400|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
160968078|NCT01060553|581271401|FG000|Overall Study|Lost to Follow-up|3|||
160968079|NCT01060553|581271402|FG001|Overall Study|Lost to Follow-up|5|||
160968080|NCT01060553|581271401|FG000|Overall Study|Withdrawal by Subject|5|||
160968081|NCT01060553|581271402|FG001|Overall Study|Withdrawal by Subject|5|||
160968082|NCT01060553|581271401|FG000|Overall Study|Lack of Efficacy|1|||
160968083|NCT01060553|581271402|FG001|Overall Study|Lack of Efficacy|0|||
160968084|NCT01781390|581271406|FG000|Overall Study|Withdrawal of Consent|0|||
160968085|NCT01781390|581271407|FG001|Overall Study|Withdrawal of Consent|3|||
160968086|NCT01781390|581271408|FG002|Overall Study|Withdrawal of Consent|1|||
160968087|NCT01781390|581271406|FG000|Overall Study|Lost to Follow-up|1|||
161014114|NCT05038566|581438914|FG001|Overall Study|Technical Difficulties with the Device|1|||
161014115|NCT05387447|581438923|FG000|Overall Study|Participants changed their minds about study participation.|3|||
161014116|NCT05387447|581438924|FG001|Overall Study|Participants changed their minds about study participation.|5|||
161014117|NCT04178733|581438925|FG000|Overall Study|Investigator Decision|0|||
161014118|NCT04178733|581438926|FG001|Overall Study|Investigator Decision|0|||
161014119|NCT04178733|581438927|FG002|Overall Study|Investigator Decision|0|||
161014120|NCT04178733|581438928|FG003|Overall Study|Investigator Decision|1|||
161014121|NCT04178733|581438929|FG004|Overall Study|Investigator Decision|2|||
161014122|NCT03655132|581438932|FG000|Overall Study|Lost to Follow-up|2|||
161014123|NCT03655132|581438933|FG001|Overall Study|Lost to Follow-up|1|||
161014124|NCT03655132|581438932|FG000|Overall Study|Withdrawal by Subject|0|||
161014125|NCT03655132|581438933|FG001|Overall Study|Withdrawal by Subject|1|||
161014126|NCT03655132|581438932|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
161014127|NCT03655132|581438933|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
161014128|NCT05919082|581438937|FG000|Overall Study|Adverse Event|3|||
161272280|NCT03839823|582377603|FG000|Overall Study|Adverse Event|8|||
161272281|NCT03839823|582377604|FG001|Overall Study|Adverse Event|4|||
161272282|NCT03839823|582377603|FG000|Overall Study|Death|1|||
161272283|NCT03839823|582377604|FG001|Overall Study|Death|0|||
161272284|NCT03839823|582377603|FG000|Overall Study|Physician Decision|1|||
161272285|NCT03839823|582377604|FG001|Overall Study|Physician Decision|5|||
161272286|NCT03839823|582377603|FG000|Overall Study|Progressive Disease (PD)|65|||
161272287|NCT03839823|582377604|FG001|Overall Study|Progressive Disease (PD)|65|||
161272288|NCT03839823|582377603|FG000|Overall Study|Subject Decision|2|||
161272289|NCT03839823|582377604|FG001|Overall Study|Subject Decision|9|||
161272290|NCT03839823|582377603|FG000|Overall Study|Not Treated|0|||
161272291|NCT03839823|582377604|FG001|Overall Study|Not Treated|10|||
161272292|NCT01716715|582377605|FG000|Overall Study|Never Treated|2|||
161272293|NCT01716715|582377606|FG001|Overall Study|Never Treated|4|||
161272294|NCT04228783|582377607|FG000|Overall Study|Adverse Event|1|||
161272295|NCT04228783|582377608|FG001|Overall Study|Adverse Event|0|||
161272296|NCT04228783|582377609|FG002|Overall Study|Adverse Event|2|||
161272297|NCT04228783|582377610|FG003|Overall Study|Adverse Event|0|||
161272298|NCT04228783|582377611|FG004|Overall Study|Adverse Event|0|||
161272299|NCT04228783|582377612|FG005|Overall Study|Adverse Event|1|||
161272300|NCT04228783|582377607|FG000|Overall Study|Death|0|||
161272301|NCT04228783|582377608|FG001|Overall Study|Death|0|||
161272302|NCT04228783|582377609|FG002|Overall Study|Death|0|||
161272303|NCT04228783|582377610|FG003|Overall Study|Death|0|||
161272304|NCT04228783|582377611|FG004|Overall Study|Death|1|||
161272305|NCT04228783|582377612|FG005|Overall Study|Death|0|||
161272306|NCT04228783|582377607|FG000|Overall Study|Lost to Follow-up|36|||
161272307|NCT04228783|582377608|FG001|Overall Study|Lost to Follow-up|36|||
161272308|NCT04228783|582377609|FG002|Overall Study|Lost to Follow-up|28|||
161272309|NCT04228783|582377610|FG003|Overall Study|Lost to Follow-up|6|||
161272310|NCT04228783|582377611|FG004|Overall Study|Lost to Follow-up|14|||
161272311|NCT04228783|582377612|FG005|Overall Study|Lost to Follow-up|3|||
161272312|NCT04228783|582377607|FG000|Overall Study|Physician Decision|1|||
161272313|NCT04228783|582377608|FG001|Overall Study|Physician Decision|2|||
161272314|NCT04228783|582377609|FG002|Overall Study|Physician Decision|0|||
161272315|NCT04228783|582377610|FG003|Overall Study|Physician Decision|0|||
161272316|NCT04228783|582377611|FG004|Overall Study|Physician Decision|0|||
161272317|NCT04228783|582377612|FG005|Overall Study|Physician Decision|0|||
161272318|NCT04228783|582377607|FG000|Overall Study|Protocol Violation|0|||
161272319|NCT04228783|582377608|FG001|Overall Study|Protocol Violation|0|||
161272320|NCT04228783|582377609|FG002|Overall Study|Protocol Violation|0|||
161272321|NCT04228783|582377610|FG003|Overall Study|Protocol Violation|1|||
161272322|NCT04228783|582377611|FG004|Overall Study|Protocol Violation|0|||
161272323|NCT04228783|582377612|FG005|Overall Study|Protocol Violation|0|||
161272324|NCT04228783|582377607|FG000|Overall Study|Withdrawal by Subject|6|||
161272325|NCT04228783|582377608|FG001|Overall Study|Withdrawal by Subject|10|||
161272326|NCT04228783|582377609|FG002|Overall Study|Withdrawal by Subject|19|||
161272327|NCT04228783|582377610|FG003|Overall Study|Withdrawal by Subject|1|||
161272328|NCT04228783|582377611|FG004|Overall Study|Withdrawal by Subject|2|||
161272329|NCT04228783|582377612|FG005|Overall Study|Withdrawal by Subject|0|||
161272330|NCT04228783|582377607|FG000|Overall Study|Other|4|||
161272331|NCT04228783|582377608|FG001|Overall Study|Other|3|||
161272332|NCT04228783|582377609|FG002|Overall Study|Other|2|||
161272333|NCT04228783|582377610|FG003|Overall Study|Other|1|||
161272334|NCT04228783|582377611|FG004|Overall Study|Other|0|||
161272335|NCT04228783|582377612|FG005|Overall Study|Other|0|||
161272336|NCT00626392|582377613|FG000|Run-in Period|Adverse Event|0|||
161272337|NCT00626392|582377614|FG001|Run-in Period|Adverse Event|0|||
161272338|NCT00626392|582377615|FG002|Run-in Period|Adverse Event|1|||
161272339|NCT00626392|582377616|FG003|Run-in Period|Adverse Event|0|||
161272340|NCT00626392|582377617|FG004|Run-in Period|Adverse Event|1|||
161272341|NCT00626392|582377618|FG005|Run-in Period|Adverse Event|0|||
161272342|NCT00626392|582377613|FG000|Run-in Period|Withdrawal by Subject|0|||
161343552|NCT00207740|582644408|FG002|Overall Study|Other|7|||
161014129|NCT05919082|581438938|FG001|Overall Study|Adverse Event|0|||
161014130|NCT05919082|581438937|FG000|Overall Study|Lost to Follow-up|0|||
161014131|NCT05919082|581438938|FG001|Overall Study|Lost to Follow-up|1|||
161014132|NCT05919082|581438937|FG000|Overall Study|Withdrawal by Subject|8|||
161014133|NCT05919082|581438938|FG001|Overall Study|Withdrawal by Subject|9|||
161014134|NCT05919082|581438937|FG000|Overall Study|Lack of Efficacy|0|||
161014135|NCT05919082|581438938|FG001|Overall Study|Lack of Efficacy|1|||
161014136|NCT05919082|581438937|FG000|Overall Study|Investigator Decision|1|||
161014137|NCT05919082|581438938|FG001|Overall Study|Investigator Decision|0|||
161014138|NCT05439603|581438939|FG000|Overall Study|met withdrawal criteria|2|||
161014139|NCT03896516|581438943|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
161014140|NCT03896516|581438944|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
161014141|NCT03896516|581438943|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
161014142|NCT03896516|581438944|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
161014143|NCT03896516|581438943|FG000|Washout Period|Physician Decision|3|||
161014144|NCT03896516|581438944|FG001|Washout Period|Physician Decision|1|||
161014145|NCT03896516|581438943|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
161014146|NCT03896516|581438944|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
161014147|NCT05461131|581438945|FG000|Overall Study|Lost to Follow-up|0|||
161014148|NCT05461131|581438946|FG001|Overall Study|Lost to Follow-up|2|||
161014149|NCT04549168|581438952|FG000|Randomization Phase|Adverse Event|0|||
161014150|NCT04549168|581438953|FG001|Randomization Phase|Adverse Event|0|||
161014151|NCT04549168|581438954|FG002|Randomization Phase|Adverse Event|1|||
161014152|NCT04549168|581438952|FG000|Randomization Phase|Other|0|||
161014153|NCT04549168|581438953|FG001|Randomization Phase|Other|2|||
161014154|NCT04549168|581438954|FG002|Randomization Phase|Other|0|||
161014155|NCT04549168|581438952|FG000|Randomization Phase|Withdrawal by Subject|0|||
161014156|NCT04549168|581438953|FG001|Randomization Phase|Withdrawal by Subject|2|||
161014157|NCT04549168|581438954|FG002|Randomization Phase|Withdrawal by Subject|1|||
161014158|NCT04791709|581438963|FG000|Overall Study|Withdrawal by Subject|3|||
161014159|NCT03578536|581438964|FG000|Overall Study|Lost to Follow-up|1|||
161014160|NCT00274469|581438965|FG000|Overall Study|Death|63|||
161014161|NCT00274469|581438966|FG001|Overall Study|Death|74|||
161014162|NCT00274469|581438965|FG000|Overall Study|Did not consent to OS follow-up|16|||
161014163|NCT00274469|581438966|FG001|Overall Study|Did not consent to OS follow-up|19|||
161014164|NCT04623775|581438975|FG000|Randomization|No Longer Meets Study Criteria|2|||
161014165|NCT04623775|581438976|FG001|Randomization|No Longer Meets Study Criteria|1|||
161014166|NCT04623775|581438977|FG002|Randomization|No Longer Meets Study Criteria|0|||
161014167|NCT04623775|581438978|FG003|Randomization|No Longer Meets Study Criteria|0|||
161014168|NCT04623775|581438975|FG000|Randomization|Withdrew Consent|0|||
161014169|NCT04623775|581438976|FG001|Randomization|Withdrew Consent|0|||
161014170|NCT04623775|581438977|FG002|Randomization|Withdrew Consent|0|||
161014171|NCT04623775|581438978|FG003|Randomization|Withdrew Consent|1|||
161014172|NCT04623775|581438975|FG000|Randomization|Other Reasons|0|||
161014173|NCT04623775|581438976|FG001|Randomization|Other Reasons|0|||
161014174|NCT04623775|581438977|FG002|Randomization|Other Reasons|0|||
161014175|NCT04623775|581438978|FG003|Randomization|Other Reasons|1|||
161014176|NCT04623775|581438975|FG000|Treatment Period|participant withdrew consent|4|||
161014177|NCT04623775|581438976|FG001|Treatment Period|participant withdrew consent|0|||
161014178|NCT04623775|581438977|FG002|Treatment Period|participant withdrew consent|1|||
161014179|NCT04623775|581438978|FG003|Treatment Period|participant withdrew consent|2|||
161014180|NCT04623775|581438975|FG000|Treatment Period|Death|3|||
161014181|NCT04623775|581438976|FG001|Treatment Period|Death|1|||
161014182|NCT04623775|581438977|FG002|Treatment Period|Death|4|||
161014183|NCT04623775|581438978|FG003|Treatment Period|Death|2|||
161014184|NCT04623775|581438975|FG000|Treatment Period|Lost to Follow-up|0|||
161014185|NCT04623775|581438976|FG001|Treatment Period|Lost to Follow-up|2|||
161014186|NCT04623775|581438977|FG002|Treatment Period|Lost to Follow-up|0|||
161014187|NCT04623775|581438978|FG003|Treatment Period|Lost to Follow-up|0|||
161014188|NCT04623775|581438975|FG000|Treatment Period|poor/non compliance|0|||
161014189|NCT04623775|581438976|FG001|Treatment Period|poor/non compliance|0|||
161014190|NCT04623775|581438977|FG002|Treatment Period|poor/non compliance|1|||
161014191|NCT04623775|581438978|FG003|Treatment Period|poor/non compliance|0|||
161014192|NCT04623775|581438975|FG000|Treatment Period|participant no longer meets study criteria|0|||
161014193|NCT04623775|581438976|FG001|Treatment Period|participant no longer meets study criteria|1|||
161014194|NCT04623775|581438977|FG002|Treatment Period|participant no longer meets study criteria|0|||
161147797|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
161272343|NCT00626392|582377614|FG001|Run-in Period|Withdrawal by Subject|1|||
161272344|NCT00626392|582377615|FG002|Run-in Period|Withdrawal by Subject|1|||
161014195|NCT04623775|581438978|FG003|Treatment Period|participant no longer meets study criteria|0|||
161014196|NCT04623775|581438975|FG000|Treatment Period|administrative reasons by sponsor|3|||
161014197|NCT04623775|581438976|FG001|Treatment Period|administrative reasons by sponsor|2|||
161014198|NCT04623775|581438977|FG002|Treatment Period|administrative reasons by sponsor|0|||
161014199|NCT04623775|581438978|FG003|Treatment Period|administrative reasons by sponsor|0|||
161014200|NCT04623775|581438975|FG000|Treatment Period|other reasons|2|||
161014201|NCT04623775|581438976|FG001|Treatment Period|other reasons|0|||
161014202|NCT04623775|581438977|FG002|Treatment Period|other reasons|1|||
161014203|NCT04623775|581438978|FG003|Treatment Period|other reasons|1|||
161014204|NCT04623775|581438975|FG000|Treatment Period|disease progression|40|||
161014205|NCT04623775|581438976|FG001|Treatment Period|disease progression|35|||
161014206|NCT04623775|581438977|FG002|Treatment Period|disease progression|63|||
161014207|NCT04623775|581438978|FG003|Treatment Period|disease progression|63|||
161014208|NCT04623775|581438975|FG000|Treatment Period|study drug toxicity|12|||
161014209|NCT04623775|581438976|FG001|Treatment Period|study drug toxicity|15|||
161014210|NCT04623775|581438977|FG002|Treatment Period|study drug toxicity|13|||
161014211|NCT04623775|581438978|FG003|Treatment Period|study drug toxicity|12|||
161014212|NCT04623775|581438975|FG000|Treatment Period|AE unrelated to study drug|4|||
161014213|NCT04623775|581438976|FG001|Treatment Period|AE unrelated to study drug|9|||
161014214|NCT04623775|581438977|FG002|Treatment Period|AE unrelated to study drug|12|||
161014215|NCT04623775|581438978|FG003|Treatment Period|AE unrelated to study drug|9|||
161014216|NCT04623775|581438975|FG000|Treatment Period|participant request to discontinue treatment|0|||
161014217|NCT04623775|581438976|FG001|Treatment Period|participant request to discontinue treatment|2|||
161014218|NCT04623775|581438977|FG002|Treatment Period|participant request to discontinue treatment|2|||
161014219|NCT04623775|581438978|FG003|Treatment Period|participant request to discontinue treatment|0|||
161014220|NCT03767517|581438979|FG000|Overall Study|Lost to Follow-up|16|||
161014221|NCT03767517|581438980|FG001|Overall Study|Lost to Follow-up|10|||
161014222|NCT03767517|581438979|FG000|Overall Study|Death|2|||
161014223|NCT03767517|581438980|FG001|Overall Study|Death|3|||
161014224|NCT04112316|581440079|FG000|First Period (8 Weeks)|Protocol Violation|1|||
161014225|NCT04112316|581440080|FG001|First Period (8 Weeks)|Protocol Violation|0|||
161014226|NCT04112316|581440079|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
161014227|NCT04112316|581440080|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
161014228|NCT03775109|581440096|FG000|Overall Study|Adverse Event|1|||
161014229|NCT03775109|581440097|FG001|Overall Study|Adverse Event|0|||
161014230|NCT03775109|581440096|FG000|Overall Study|COVID-19 outbreak|2|||
161014231|NCT03775109|581440097|FG001|Overall Study|COVID-19 outbreak|0|||
161014232|NCT03775109|581440096|FG000|Overall Study|Lost to Follow-up|0|||
161014233|NCT03775109|581440097|FG001|Overall Study|Lost to Follow-up|2|||
161014234|NCT03775109|581440096|FG000|Overall Study|Withdrawal by Subject|1|||
161014235|NCT03775109|581440097|FG001|Overall Study|Withdrawal by Subject|1|||
161014236|NCT03775109|581440096|FG000|Overall Study|Death|0|||
161014237|NCT03775109|581440097|FG001|Overall Study|Death|1|||
161014238|NCT03775109|581440096|FG000|Overall Study|Lack of Efficacy|1|||
161014239|NCT03775109|581440097|FG001|Overall Study|Lack of Efficacy|0|||
161014240|NCT04850807|581440107|FG000|Overall Study|Death|50|||
161014241|NCT04850807|581440108|FG001|Overall Study|Death|55|||
161014242|NCT04850807|581440107|FG000|Overall Study|Discharged|17|||
161014243|NCT04850807|581440108|FG001|Overall Study|Discharged|13|||
161272345|NCT00626392|582377616|FG003|Run-in Period|Withdrawal by Subject|1|||
161272346|NCT00626392|582377617|FG004|Run-in Period|Withdrawal by Subject|3|||
161272347|NCT00626392|582377618|FG005|Run-in Period|Withdrawal by Subject|1|||
161272348|NCT00626392|582377613|FG000|Run-in Period|Noncompliance|1|||
161272349|NCT00626392|582377614|FG001|Run-in Period|Noncompliance|0|||
161272350|NCT00626392|582377615|FG002|Run-in Period|Noncompliance|1|||
161272351|NCT00626392|582377616|FG003|Run-in Period|Noncompliance|0|||
161272352|NCT00626392|582377617|FG004|Run-in Period|Noncompliance|0|||
161272353|NCT00626392|582377618|FG005|Run-in Period|Noncompliance|0|||
161272354|NCT00626392|582377613|FG000|Coadministration Period|Adverse Event|3|||
161272355|NCT00626392|582377614|FG001|Coadministration Period|Adverse Event|1|||
161272356|NCT00626392|582377615|FG002|Coadministration Period|Adverse Event|7|||
161272357|NCT00626392|582377616|FG003|Coadministration Period|Adverse Event|4|||
161272358|NCT00626392|582377617|FG004|Coadministration Period|Adverse Event|3|||
161272359|NCT00626392|582377618|FG005|Coadministration Period|Adverse Event|4|||
161272360|NCT00626392|582377613|FG000|Coadministration Period|Withdrawal by Subject|1|||
161272361|NCT00626392|582377614|FG001|Coadministration Period|Withdrawal by Subject|1|||
161343553|NCT00207740|582644409|FG003|Overall Study|Other|5|||
161014244|NCT04850807|581440107|FG000|Overall Study|Incomplete baseline data|3|||
161014245|NCT04850807|581440108|FG001|Overall Study|Incomplete baseline data|2|||
161014246|NCT03739996|581440115|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
161014247|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
161014248|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
161014249|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
161014250|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
161014251|NCT03739996|581440115|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
161014252|NCT03739996|581440115|FG000|Step 3 (SOC ART)|Death|1|||
161014253|NCT03739996|581440115|FG000|Step 3 (SOC ART)|Participant moved|1|||
161014254|NCT05141903|581440116|FG000|Overall Study|Withdrawal by Subject|0|||
161272362|NCT00626392|582377615|FG002|Coadministration Period|Withdrawal by Subject|0|||
161272363|NCT00626392|582377616|FG003|Coadministration Period|Withdrawal by Subject|1|||
161272364|NCT00626392|582377617|FG004|Coadministration Period|Withdrawal by Subject|0|||
161014255|NCT05141903|581440117|FG001|Overall Study|Withdrawal by Subject|1|||
161014256|NCT05141903|581440118|FG002|Overall Study|Withdrawal by Subject|1|||
161014257|NCT05141903|581440119|FG003|Overall Study|Withdrawal by Subject|0|||
161014258|NCT05141903|581440120|FG004|Overall Study|Withdrawal by Subject|0|||
161014259|NCT05141903|581440116|FG000|Overall Study|Other|1|||
161014260|NCT05141903|581440117|FG001|Overall Study|Other|1|||
161014261|NCT05141903|581440118|FG002|Overall Study|Other|0|||
161014262|NCT05141903|581440119|FG003|Overall Study|Other|0|||
161014263|NCT05141903|581440120|FG004|Overall Study|Other|0|||
161014264|NCT04737772|581440123|FG000|Phase 2 Study|Lost to Follow-up|15|||
161014265|NCT04737772|581440124|FG001|Phase 2 Study|Lost to Follow-up|15|||
161014266|NCT04737772|581440123|FG000|Phase 2 Study|Withdrawal by Subject|0|||
161014267|NCT04737772|581440124|FG001|Phase 2 Study|Withdrawal by Subject|1|||
161014268|NCT04737772|581440123|FG000|Phase 2 Study|Did not take any coaching calls|4|||
161014269|NCT04737772|581440124|FG001|Phase 2 Study|Did not take any coaching calls|0|||
161014270|NCT04737772|581440123|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
161014271|NCT04737772|581440124|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
161014272|NCT04737772|581440123|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
161014273|NCT04737772|581440124|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
161014274|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
161014275|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
161014276|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
161014277|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
161014278|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
161014279|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
161014280|NCT02549339|581440125|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161014281|NCT02549339|581440126|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
161014282|NCT02549339|581440125|FG000|12-month Follow-up|Lack of Efficacy|0|||
161014283|NCT02549339|581440126|FG001|12-month Follow-up|Lack of Efficacy|2|||
161014284|NCT02549339|581440125|FG000|12-month Follow-up|Withdrawal by Subject|8|||
161014285|NCT02549339|581440126|FG001|12-month Follow-up|Withdrawal by Subject|3|||
161014286|NCT02549339|581440125|FG000|12-month Follow-up|Lost to Follow-up|1|||
161014287|NCT02549339|581440126|FG001|12-month Follow-up|Lost to Follow-up|3|||
161014288|NCT02549339|581440125|FG000|12-month Follow-up|Other|0|||
161014289|NCT02549339|581440126|FG001|12-month Follow-up|Other|3|||
161014290|NCT02728076|581440127|FG000|Overall Study|Physician Decision|4|||
161014291|NCT05054374|581440144|FG000|Overall Study|Withdrawal by Subject|1|||
161014292|NCT05054374|581440145|FG001|Overall Study|Withdrawal by Subject|0|||
161014293|NCT05054374|581440146|FG002|Overall Study|Withdrawal by Subject|0|||
161014294|NCT05054374|581440147|FG003|Overall Study|Withdrawal by Subject|0|||
161014295|NCT05054374|581440144|FG000|Overall Study|Progressive Disease|5|||
161014296|NCT05054374|581440145|FG001|Overall Study|Progressive Disease|0|||
161014297|NCT05054374|581440146|FG002|Overall Study|Progressive Disease|0|||
161014298|NCT05054374|581440147|FG003|Overall Study|Progressive Disease|0|||
161014299|NCT05691309|581440148|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
161014300|NCT05691309|581440148|FG000|Overall Study|vancomycin levels not evaluable|2|||
161014301|NCT01707030|581440149|FG000|Overall Study|Death|1|||
161014302|NCT01707030|581440150|FG001|Overall Study|Death|1|||
161014303|NCT01707030|581440149|FG000|Overall Study|Withdrawal by Subject|2|||
161014304|NCT01707030|581440150|FG001|Overall Study|Withdrawal by Subject|3|||
161014305|NCT01707030|581440149|FG000|Overall Study|Lost to Follow-up|8|||
161014306|NCT01707030|581440150|FG001|Overall Study|Lost to Follow-up|13|||
161014307|NCT05415410|581440152|FG000|Overall Study|Death|3|||
161014308|NCT05415410|581440153|FG001|Overall Study|Death|6|||
161014309|NCT05415410|581440154|FG002|Overall Study|Death|1|||
161014310|NCT05415410|581440152|FG000|Overall Study|Trial Terminated by Sponsor|1|||
161014311|NCT05415410|581440153|FG001|Overall Study|Trial Terminated by Sponsor|5|||
161014312|NCT05415410|581440154|FG002|Overall Study|Trial Terminated by Sponsor|0|||
161014313|NCT05415410|581440152|FG000|Overall Study|Adverse Event|2|||
161014314|NCT05415410|581440153|FG001|Overall Study|Adverse Event|1|||
161014315|NCT05415410|581440154|FG002|Overall Study|Adverse Event|0|||
161014316|NCT05415410|581440152|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
161014317|NCT05415410|581440153|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
161014318|NCT05415410|581440154|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
161014319|NCT05415410|581440152|FG000|Overall Study|Withdrawal by Subject|1|||
161014320|NCT05415410|581440153|FG001|Overall Study|Withdrawal by Subject|0|||
161014321|NCT05415410|581440154|FG002|Overall Study|Withdrawal by Subject|0|||
161014322|NCT05415410|581440152|FG000|Overall Study|Pregnancy|5|||
161014323|NCT05415410|581440153|FG001|Overall Study|Pregnancy|2|||
161014324|NCT05415410|581440154|FG002|Overall Study|Pregnancy|0|||
161014325|NCT02927769|581440155|FG000|Induction Phase|Study drug toxicity|1|||
161014326|NCT02927769|581440156|FG001|Induction Phase|Study drug toxicity|1|||
161014327|NCT02927769|581440155|FG000|Induction Phase|Disease progression|0|||
161014328|NCT02927769|581440156|FG001|Induction Phase|Disease progression|1|||
161014329|NCT02927769|581440155|FG000|Intensification Phase|Study drug toxicity|1|||
161014330|NCT02927769|581440156|FG001|Intensification Phase|Study drug toxicity|0|||
161014331|NCT01532388|581440161|FG000|3-month Follow-up|Lost to Follow-up|68|||
161014332|NCT01532388|581440162|FG001|3-month Follow-up|Lost to Follow-up|68|||
161014333|NCT01532388|581440161|FG000|6-month Follow-up|Lost to Follow-up|74|||
161014334|NCT01532388|581440162|FG001|6-month Follow-up|Lost to Follow-up|66|||
161014335|NCT01532388|581440161|FG000|12-month Follow-up|Lost to Follow-up|69|||
161014336|NCT01532388|581440162|FG001|12-month Follow-up|Lost to Follow-up|67|||
161014337|NCT00792636|581440163|FG000|Overall Study|Protocol Violation|17|||
161014338|NCT00792636|581440164|FG001|Overall Study|Protocol Violation|23|||
161014339|NCT00792636|581440165|FG002|Overall Study|Protocol Violation|20|||
161014340|NCT00792636|581440163|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
161014341|NCT00792636|581440164|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
161014342|NCT00792636|581440165|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
161014343|NCT00792636|581440163|FG000|Overall Study|Lost to Follow-up|13|||
161014344|NCT00792636|581440164|FG001|Overall Study|Lost to Follow-up|19|||
161014345|NCT00792636|581440165|FG002|Overall Study|Lost to Follow-up|14|||
161014346|NCT00792636|581440163|FG000|Overall Study|Withdrew Consent|10|||
161014347|NCT00792636|581440164|FG001|Overall Study|Withdrew Consent|13|||
161014348|NCT00792636|581440165|FG002|Overall Study|Withdrew Consent|9|||
161014349|NCT00792636|581440163|FG000|Overall Study|Lack of Efficacy|3|||
161014350|NCT00792636|581440164|FG001|Overall Study|Lack of Efficacy|4|||
161014351|NCT00792636|581440165|FG002|Overall Study|Lack of Efficacy|13|||
161014352|NCT00792636|581440163|FG000|Overall Study|Adverse Event|4|||
161014353|NCT00792636|581440164|FG001|Overall Study|Adverse Event|2|||
161014354|NCT00792636|581440165|FG002|Overall Study|Adverse Event|3|||
161014355|NCT00792636|581440163|FG000|Overall Study|Investigator Discretion|2|||
161014356|NCT00792636|581440164|FG001|Overall Study|Investigator Discretion|0|||
161014357|NCT00792636|581440165|FG002|Overall Study|Investigator Discretion|2|||
161014358|NCT00593489|581440166|FG000|Allocation|did not attend workshop; allocation not|2|||
161014359|NCT00593489|581440167|FG001|Allocation|did not attend workshop; allocation not|1|||
161014360|NCT03069313|581440168|FG000|Overall Study|Adverse Event|5|||
161014361|NCT01011946|581440169|FG000|Overall Study|Transferred to another hospital|2|||
161014362|NCT01011946|581440169|FG000|Overall Study|No pathological lab value|1|||
161014363|NCT03912831|581440171|FG000|Overall Study|Death|1|||
161014364|NCT03912831|581440172|FG001|Overall Study|Death|1|||
161014365|NCT03912831|581440173|FG002|Overall Study|Death|1|||
161014366|NCT03912831|581440174|FG003|Overall Study|Death|1|||
161014367|NCT03912831|581440175|FG004|Overall Study|Death|1|||
161014368|NCT03912831|581440176|FG005|Overall Study|Death|1|||
161014369|NCT03912831|581440171|FG000|Overall Study|Reason not Specified|0|||
161014370|NCT03912831|581440172|FG001|Overall Study|Reason not Specified|0|||
161014371|NCT03912831|581440173|FG002|Overall Study|Reason not Specified|0|||
161014372|NCT03912831|581440174|FG003|Overall Study|Reason not Specified|0|||
161014373|NCT03912831|581440175|FG004|Overall Study|Reason not Specified|1|||
161014374|NCT03912831|581440176|FG005|Overall Study|Reason not Specified|0|||
161014375|NCT03912831|581440171|FG000|Overall Study|Withdrawal by Participant|0|||
161014376|NCT03912831|581440172|FG001|Overall Study|Withdrawal by Participant|0|||
161014377|NCT03912831|581440173|FG002|Overall Study|Withdrawal by Participant|0|||
161014378|NCT03912831|581440174|FG003|Overall Study|Withdrawal by Participant|0|||
161014379|NCT03912831|581440175|FG004|Overall Study|Withdrawal by Participant|1|||
161014380|NCT03912831|581440176|FG005|Overall Study|Withdrawal by Participant|0|||
161014381|NCT03580369|581440177|FG000|Overall Study|No treatment due to mis-randomization|1|||
161014382|NCT03580369|581440178|FG001|Overall Study|No treatment due to mis-randomization|0|||
161014383|NCT03580369|581440179|FG002|Overall Study|No treatment due to mis-randomization|0|||
161014384|NCT03580369|581440180|FG003|Overall Study|No treatment due to mis-randomization|0|||
161014385|NCT03580369|581440181|FG004|Overall Study|No treatment due to mis-randomization|3|||
161014386|NCT03580369|581440182|FG005|Overall Study|No treatment due to mis-randomization|0|||
161014387|NCT03580369|581440183|FG006|Overall Study|No treatment due to mis-randomization|0|||
161014388|NCT03580369|581440184|FG007|Overall Study|No treatment due to mis-randomization|0|||
161014389|NCT03580369|581440177|FG000|Overall Study|Reason unknown|0|||
161014390|NCT03580369|581440178|FG001|Overall Study|Reason unknown|0|||
161014391|NCT03580369|581440179|FG002|Overall Study|Reason unknown|1|||
161147798|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
161014392|NCT03580369|581440180|FG003|Overall Study|Reason unknown|0|||
161014393|NCT03580369|581440181|FG004|Overall Study|Reason unknown|0|||
161272365|NCT00626392|582377618|FG005|Coadministration Period|Withdrawal by Subject|1|||
161014394|NCT03580369|581440182|FG005|Overall Study|Reason unknown|0|||
161014395|NCT03580369|581440183|FG006|Overall Study|Reason unknown|0|||
161014396|NCT03580369|581440184|FG007|Overall Study|Reason unknown|0|||
161014397|NCT03580369|581440177|FG000|Overall Study|Technical problems|0|||
161014398|NCT03580369|581440178|FG001|Overall Study|Technical problems|0|||
161272366|NCT00626392|582377613|FG000|Coadministration Period|Protocol Violation|0|||
161014399|NCT03580369|581440179|FG002|Overall Study|Technical problems|0|||
161147799|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
161147800|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
161014400|NCT03580369|581440180|FG003|Overall Study|Technical problems|0|||
161014401|NCT03580369|581440181|FG004|Overall Study|Technical problems|1|||
161014402|NCT03580369|581440182|FG005|Overall Study|Technical problems|0|||
161014403|NCT03580369|581440183|FG006|Overall Study|Technical problems|2|||
161014404|NCT03580369|581440184|FG007|Overall Study|Technical problems|0|||
161014405|NCT03580369|581440177|FG000|Overall Study|Pregnancy|2|||
161014406|NCT03580369|581440178|FG001|Overall Study|Pregnancy|0|||
161014407|NCT03580369|581440179|FG002|Overall Study|Pregnancy|3|||
161014408|NCT03580369|581440180|FG003|Overall Study|Pregnancy|0|||
161014409|NCT03580369|581440181|FG004|Overall Study|Pregnancy|2|||
161014410|NCT03580369|581440182|FG005|Overall Study|Pregnancy|0|||
161014411|NCT03580369|581440183|FG006|Overall Study|Pregnancy|0|||
161014412|NCT03580369|581440184|FG007|Overall Study|Pregnancy|0|||
161014413|NCT03580369|581440177|FG000|Overall Study|Lost to Follow-up|2|||
161014414|NCT03580369|581440178|FG001|Overall Study|Lost to Follow-up|0|||
161014415|NCT03580369|581440179|FG002|Overall Study|Lost to Follow-up|2|||
161014416|NCT03580369|581440180|FG003|Overall Study|Lost to Follow-up|0|||
161014417|NCT03580369|581440181|FG004|Overall Study|Lost to Follow-up|3|||
161014418|NCT03580369|581440182|FG005|Overall Study|Lost to Follow-up|0|||
161014419|NCT03580369|581440183|FG006|Overall Study|Lost to Follow-up|1|||
161014420|NCT03580369|581440184|FG007|Overall Study|Lost to Follow-up|0|||
161014421|NCT03580369|581440177|FG000|Overall Study|Physician Decision|4|||
161014422|NCT03580369|581440178|FG001|Overall Study|Physician Decision|0|||
161014423|NCT03580369|581440179|FG002|Overall Study|Physician Decision|4|||
161014424|NCT03580369|581440180|FG003|Overall Study|Physician Decision|1|||
161014425|NCT03580369|581440181|FG004|Overall Study|Physician Decision|1|||
161014426|NCT03580369|581440182|FG005|Overall Study|Physician Decision|0|||
161014427|NCT03580369|581440183|FG006|Overall Study|Physician Decision|0|||
161014428|NCT03580369|581440184|FG007|Overall Study|Physician Decision|0|||
161014429|NCT03580369|581440177|FG000|Overall Study|Lack of Efficacy|3|||
161014430|NCT03580369|581440178|FG001|Overall Study|Lack of Efficacy|0|||
161014431|NCT03580369|581440179|FG002|Overall Study|Lack of Efficacy|7|||
161014432|NCT03580369|581440180|FG003|Overall Study|Lack of Efficacy|0|||
161014433|NCT03580369|581440181|FG004|Overall Study|Lack of Efficacy|2|||
161014434|NCT03580369|581440182|FG005|Overall Study|Lack of Efficacy|0|||
161014435|NCT03580369|581440183|FG006|Overall Study|Lack of Efficacy|3|||
161014436|NCT03580369|581440184|FG007|Overall Study|Lack of Efficacy|0|||
161014437|NCT03580369|581440177|FG000|Overall Study|Protocol Violation|6|||
161014438|NCT03580369|581440178|FG001|Overall Study|Protocol Violation|0|||
161014439|NCT03580369|581440179|FG002|Overall Study|Protocol Violation|6|||
161014440|NCT03580369|581440180|FG003|Overall Study|Protocol Violation|1|||
161014441|NCT03580369|581440181|FG004|Overall Study|Protocol Violation|8|||
161014442|NCT03580369|581440182|FG005|Overall Study|Protocol Violation|2|||
161014443|NCT03580369|581440183|FG006|Overall Study|Protocol Violation|1|||
161014444|NCT03580369|581440184|FG007|Overall Study|Protocol Violation|0|||
161014445|NCT03580369|581440177|FG000|Overall Study|Adverse Event|7|||
161014446|NCT03580369|581440178|FG001|Overall Study|Adverse Event|0|||
161014447|NCT03580369|581440179|FG002|Overall Study|Adverse Event|14|||
161014448|NCT03580369|581440180|FG003|Overall Study|Adverse Event|1|||
161014449|NCT03580369|581440181|FG004|Overall Study|Adverse Event|6|||
161014450|NCT03580369|581440182|FG005|Overall Study|Adverse Event|0|||
161014451|NCT03580369|581440183|FG006|Overall Study|Adverse Event|1|||
161014452|NCT03580369|581440184|FG007|Overall Study|Adverse Event|0|||
161014453|NCT03580369|581440177|FG000|Overall Study|Withdrawal by Subject|19|||
161014454|NCT03580369|581440178|FG001|Overall Study|Withdrawal by Subject|0|||
161014455|NCT03580369|581440179|FG002|Overall Study|Withdrawal by Subject|17|||
161014456|NCT03580369|581440180|FG003|Overall Study|Withdrawal by Subject|0|||
161014457|NCT03580369|581440181|FG004|Overall Study|Withdrawal by Subject|16|||
161014458|NCT03580369|581440182|FG005|Overall Study|Withdrawal by Subject|1|||
161014459|NCT03580369|581440183|FG006|Overall Study|Withdrawal by Subject|7|||
161014460|NCT03580369|581440184|FG007|Overall Study|Withdrawal by Subject|0|||
161014461|NCT05239039|581440186|FG000|Overall Study|Withdrawal by Subject|0|||
161014462|NCT05239039|581440187|FG001|Overall Study|Withdrawal by Subject|1|||
161014463|NCT03897686|581441621|FG000|Overall Study|Protocol Violation|1|||
161014464|NCT03897686|581441622|FG001|Overall Study|Protocol Violation|1|||
161014465|NCT03897686|581441621|FG000|Overall Study|Withdrawal by Subject|1|||
161014466|NCT03897686|581441622|FG001|Overall Study|Withdrawal by Subject|1|||
161014467|NCT05415436|581441623|FG000|Overall Study|Surgeon cancelled procedure|1|||
161014468|NCT05415436|581441624|FG001|Overall Study|Surgeon cancelled procedure|0|||
161014469|NCT05415436|581441623|FG000|Overall Study|Death|1|||
161014470|NCT05415436|581441624|FG001|Overall Study|Death|0|||
161014471|NCT05386355|581441633|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014472|NCT05386355|581441634|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014473|NCT05386355|581441635|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014474|NCT05386355|581441636|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
161014475|NCT05691452|581441639|FG000|Overall Study|Withdrawal by Subject|1|||
161014476|NCT05691452|581441640|FG001|Overall Study|Withdrawal by Subject|1|||
161147801|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
161147802|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
161014477|NCT05691452|581441641|FG002|Overall Study|Withdrawal by Subject|0|||
161014478|NCT05691452|581441639|FG000|Overall Study|Physician Decision|1|||
161014479|NCT05691452|581441640|FG001|Overall Study|Physician Decision|0|||
161014480|NCT05691452|581441641|FG002|Overall Study|Physician Decision|0|||
161014481|NCT05691452|581441639|FG000|Overall Study|Lost to Follow-up|0|||
161014482|NCT05691452|581441640|FG001|Overall Study|Lost to Follow-up|0|||
161014483|NCT05691452|581441641|FG002|Overall Study|Lost to Follow-up|1|||
161014484|NCT05691452|581441639|FG000|Overall Study|Adverse Event|0|||
161014485|NCT05691452|581441640|FG001|Overall Study|Adverse Event|0|||
161014486|NCT05691452|581441641|FG002|Overall Study|Adverse Event|1|||
161014487|NCT03484702|581441642|FG000|Treatment Period|Death|3|||
161014488|NCT03484702|581441643|FG001|Treatment Period|Death|1|||
161014489|NCT03484702|581441644|FG002|Treatment Period|Death|0|||
161014490|NCT03484702|581441645|FG003|Treatment Period|Death|0|||
161014491|NCT03484702|581441646|FG004|Treatment Period|Death|0|||
161014492|NCT03484702|581441647|FG005|Treatment Period|Death|0|||
161014493|NCT03484702|581441642|FG000|Treatment Period|Adverse Event|1|||
161014494|NCT03484702|581441643|FG001|Treatment Period|Adverse Event|0|||
161014495|NCT03484702|581441644|FG002|Treatment Period|Adverse Event|0|||
161014496|NCT03484702|581441645|FG003|Treatment Period|Adverse Event|0|||
161014497|NCT03484702|581441646|FG004|Treatment Period|Adverse Event|0|||
161014498|NCT03484702|581441647|FG005|Treatment Period|Adverse Event|0|||
161014499|NCT03484702|581441642|FG000|Treatment Period|Participant Withdrew from Study|0|||
161014500|NCT03484702|581441643|FG001|Treatment Period|Participant Withdrew from Study|1|||
161014501|NCT03484702|581441644|FG002|Treatment Period|Participant Withdrew from Study|0|||
161272367|NCT00626392|582377614|FG001|Coadministration Period|Protocol Violation|1|||
161272368|NCT00626392|582377615|FG002|Coadministration Period|Protocol Violation|0|||
161147803|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
161147804|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
161272369|NCT00626392|582377616|FG003|Coadministration Period|Protocol Violation|1|||
161272370|NCT00626392|582377617|FG004|Coadministration Period|Protocol Violation|1|||
161272371|NCT00626392|582377618|FG005|Coadministration Period|Protocol Violation|0|||
161272372|NCT00626392|582377613|FG000|Coadministration Period|Other|0|||
161272373|NCT00626392|582377614|FG001|Coadministration Period|Other|2|||
161272374|NCT00626392|582377615|FG002|Coadministration Period|Other|3|||
161272375|NCT00626392|582377616|FG003|Coadministration Period|Other|1|||
161272376|NCT00626392|582377617|FG004|Coadministration Period|Other|1|||
161272377|NCT00626392|582377618|FG005|Coadministration Period|Other|1|||
161272378|NCT03327792|582377619|FG000|Overall Study|Adverse Event|4|||
161272379|NCT03327792|582377620|FG001|Overall Study|Adverse Event|0|||
161272380|NCT03327792|582377619|FG000|Overall Study|Family/Personal issues|3|||
161272381|NCT03327792|582377620|FG001|Overall Study|Family/Personal issues|2|||
161272382|NCT03327792|582377619|FG000|Overall Study|Lost to Follow-up|0|||
161272383|NCT03327792|582377620|FG001|Overall Study|Lost to Follow-up|1|||
161272384|NCT04576923|582377621|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
161272385|NCT03151811|582377625|FG000|Overall Study|Randomized But Not Treated|18|||
161272386|NCT03151811|582377626|FG001|Overall Study|Randomized But Not Treated|3|||
161272387|NCT03151811|582377625|FG000|Overall Study|Progressive Disease|130|||
161272388|NCT03151811|582377626|FG001|Overall Study|Progressive Disease|170|||
161272389|NCT03151811|582377625|FG000|Overall Study|Adverse Event|49|||
161272390|NCT03151811|582377626|FG001|Overall Study|Adverse Event|40|||
161272391|NCT03151811|582377625|FG000|Overall Study|Lack of Efficacy|6|||
161272392|NCT03151811|582377626|FG001|Overall Study|Lack of Efficacy|8|||
161272393|NCT03151811|582377625|FG000|Overall Study|Physician Decision|21|||
161272394|NCT03151811|582377626|FG001|Overall Study|Physician Decision|9|||
161272395|NCT03151811|582377625|FG000|Overall Study|Withdrawal by Subject|17|||
161272396|NCT03151811|582377626|FG001|Overall Study|Withdrawal by Subject|7|||
161272397|NCT03151811|582377625|FG000|Overall Study|Lost to Follow-up|0|||
161272398|NCT03151811|582377626|FG001|Overall Study|Lost to Follow-up|1|||
161272399|NCT03151811|582377625|FG000|Overall Study|Study Terminated by Sponsor|5|||
161272400|NCT03151811|582377626|FG001|Overall Study|Study Terminated by Sponsor|11|||
161272401|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
161272402|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
161272403|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
161272404|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
161272405|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
161272406|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
161272407|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
161272408|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
161014502|NCT03484702|581441645|FG003|Treatment Period|Participant Withdrew from Study|0|||
161014503|NCT03484702|581441646|FG004|Treatment Period|Participant Withdrew from Study|0|||
161014504|NCT03484702|581441647|FG005|Treatment Period|Participant Withdrew from Study|0|||
161014505|NCT03484702|581441642|FG000|Treatment Period|Physician Decision|0|||
161014506|NCT03484702|581441643|FG001|Treatment Period|Physician Decision|1|||
161014507|NCT03484702|581441644|FG002|Treatment Period|Physician Decision|0|||
161272409|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
161014508|NCT03484702|581441645|FG003|Treatment Period|Physician Decision|0|||
161014509|NCT03484702|581441646|FG004|Treatment Period|Physician Decision|0|||
161014510|NCT03484702|581441647|FG005|Treatment Period|Physician Decision|1|||
161014511|NCT01894061|581441651|FG000|Overall Study|Screen failure|1|||
161014512|NCT01894061|581441651|FG000|Overall Study|Withdrawal by Subject|1|||
161014513|NCT00739648|581441652|FG000|Overall Study|Adverse Event|3|||
161014514|NCT00739648|581441653|FG001|Overall Study|Adverse Event|15|||
161014515|NCT00739648|581441652|FG000|Overall Study|Withdrawal by Subject|13|||
161014516|NCT00739648|581441653|FG001|Overall Study|Withdrawal by Subject|25|||
161014517|NCT00739648|581441652|FG000|Overall Study|Lost to Follow-up|4|||
161014518|NCT00739648|581441653|FG001|Overall Study|Lost to Follow-up|7|||
161014519|NCT00739648|581441652|FG000|Overall Study|Death|2|||
161014520|NCT00739648|581441653|FG001|Overall Study|Death|0|||
161014521|NCT00739648|581441652|FG000|Overall Study|Do not know|4|||
161014522|NCT00739648|581441653|FG001|Overall Study|Do not know|6|||
161014523|NCT05110495|581441654|FG000|Overall Study|Lost to Follow-up|1|||
161014524|NCT05110495|581441654|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
161014525|NCT04173663|581441655|FG000|Overall Study|Withdrawal by Subject|1|||
161014526|NCT04173663|581441656|FG001|Overall Study|Withdrawal by Subject|6|||
161014527|NCT04173663|581441655|FG000|Overall Study|Lost to Follow-up|17|||
161014528|NCT04173663|581441656|FG001|Overall Study|Lost to Follow-up|24|||
161014529|NCT02840474|581441658|FG000|Overall Study|Lost to Follow-up|1|||
161147805|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
161147806|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
161147807|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161014530|NCT02840474|581441659|FG001|Overall Study|Lost to Follow-up|0|||
161014531|NCT04716634|581441660|FG000|Overall Study|Death|24|||
161014532|NCT04716634|581441661|FG001|Overall Study|Death|24|||
161147808|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161147809|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
161147810|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161147811|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161147812|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
161147813|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
161147814|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161147815|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161147816|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
161147817|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161147818|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161147819|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
161147820|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
161147821|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
161147822|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
161147823|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
161147824|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
161147825|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
161147826|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
161147827|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
161147828|NCT02975349|581922570|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
161147829|NCT02975349|581922571|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
161147830|NCT02975349|581922572|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
161147831|NCT02975349|581922573|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
161147832|NCT02975349|581922574|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
161147833|NCT02975349|581922575|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
161147834|NCT02975349|581922576|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
161147835|NCT01988012|581924437|FG000|Overall Study|Adverse Event|5|||
161147836|NCT01988012|581924437|FG000|Overall Study|Insufficient Therapeutic Response|3|||
161147837|NCT01988012|581924437|FG000|Overall Study|Patient Withdrawal of Consent|4|||
161147838|NCT01988012|581924437|FG000|Overall Study|Lost to Follow-up|1|||
161147839|NCT01988012|581924437|FG000|Overall Study|Physician Decision|1|||
161147840|NCT01988012|581924437|FG000|Overall Study|Protocol Violation|1|||
161147841|NCT00521339|581924438|FG000|Treatment Phase|Adverse Event|2|||
161147842|NCT00521339|581924439|FG001|Treatment Phase|Adverse Event|0|||
161147843|NCT00521339|581924440|FG002|Treatment Phase|Adverse Event|0|||
161147844|NCT00521339|581924438|FG000|Treatment Phase|Intolerability to study drug|2|||
161147845|NCT00521339|581924439|FG001|Treatment Phase|Intolerability to study drug|0|||
161014533|NCT04716634|581441662|FG002|Overall Study|Death|8|||
161014534|NCT04716634|581441660|FG000|Overall Study|Closed by Sponsor|4|||
161014535|NCT04716634|581441661|FG001|Overall Study|Closed by Sponsor|4|||
161014536|NCT04716634|581441662|FG002|Overall Study|Closed by Sponsor|5|||
161014537|NCT04716634|581441660|FG000|Overall Study|Lost to Follow-up|1|||
161014538|NCT04716634|581441661|FG001|Overall Study|Lost to Follow-up|0|||
161014539|NCT04716634|581441662|FG002|Overall Study|Lost to Follow-up|1|||
161272410|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
161272411|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Death|1|||
161272412|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Death|0|||
161272413|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Death|0|||
161272414|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Death|0|||
161272415|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Death|0|||
161272416|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161272417|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
161272418|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
161272419|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161272420|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161272421|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
161272422|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
161272423|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161272424|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
161272425|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
161272426|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
161272427|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161147846|NCT00521339|581924440|FG002|Treatment Phase|Intolerability to study drug|0|||
161147847|NCT00521339|581924438|FG000|Treatment Phase|Lack of Efficacy|3|||
161147848|NCT00521339|581924439|FG001|Treatment Phase|Lack of Efficacy|0|||
161147849|NCT00521339|581924440|FG002|Treatment Phase|Lack of Efficacy|0|||
161147850|NCT00521339|581924438|FG000|Treatment Phase|Withdrawal by Subject|3|||
161147851|NCT00521339|581924439|FG001|Treatment Phase|Withdrawal by Subject|0|||
161147852|NCT00521339|581924440|FG002|Treatment Phase|Withdrawal by Subject|0|||
161147853|NCT00521339|581924438|FG000|Treatment Phase|Lost to Follow-up|1|||
161147854|NCT00521339|581924439|FG001|Treatment Phase|Lost to Follow-up|0|||
161147855|NCT00521339|581924440|FG002|Treatment Phase|Lost to Follow-up|0|||
161147856|NCT00521339|581924438|FG000|Treatment Phase|Protocol Violation|1|||
161147857|NCT00521339|581924439|FG001|Treatment Phase|Protocol Violation|0|||
161147858|NCT00521339|581924440|FG002|Treatment Phase|Protocol Violation|0|||
161147859|NCT00521339|581924438|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
161147860|NCT00521339|581924439|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
161147861|NCT00521339|581924440|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
161147862|NCT00521339|581924438|FG000|Treatment Extension Phase|Death|0|||
161147863|NCT00521339|581924439|FG001|Treatment Extension Phase|Death|0|||
161147864|NCT00521339|581924440|FG002|Treatment Extension Phase|Death|1|||
161147865|NCT01058369|581924441|FG000|Overall Study|Adverse Event|1|||
161147866|NCT01058369|581924441|FG000|Overall Study|Early termination study|1|||
161147867|NCT03314519|581924442|FG000|Overall Study|Protocol Violation|3|||
161147868|NCT03314519|581924443|FG001|Overall Study|Protocol Violation|2|||
161147869|NCT01277289|581924448|FG000|Overall Study|fragile vein|1|||
161147870|NCT01277289|581924449|FG001|Overall Study|fragile vein|0|||
161147871|NCT01277289|581924448|FG000|Overall Study|Physician Decision|1|||
161147872|NCT01277289|581924449|FG001|Overall Study|Physician Decision|0|||
161147873|NCT01277289|581924448|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
161147874|NCT01277289|581924449|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
161147875|NCT01277289|581924448|FG000|Overall Study|Protocol Violation|1|||
161147876|NCT01277289|581924449|FG001|Overall Study|Protocol Violation|1|||
161147877|NCT01277289|581924448|FG000|Overall Study|Adverse Event|2|||
161147878|NCT01277289|581924449|FG001|Overall Study|Adverse Event|1|||
161147879|NCT01277289|581924448|FG000|Overall Study|consent withdrawn|1|||
161147880|NCT01277289|581924449|FG001|Overall Study|consent withdrawn|1|||
161147881|NCT01277289|581924448|FG000|Overall Study|premature closure of the study|4|||
161147882|NCT01277289|581924449|FG001|Overall Study|premature closure of the study|2|||
161147883|NCT00634543|581924454|FG000|Overall Study|Other|1|||
161147884|NCT00634543|581924455|FG001|Overall Study|Other|2|||
161147885|NCT00634543|581924454|FG000|Overall Study|Protocol Violation|3|||
161147886|NCT00634543|581924455|FG001|Overall Study|Protocol Violation|3|||
161147887|NCT00634543|581924454|FG000|Overall Study|Adverse Event|11|||
161147888|NCT00634543|581924455|FG001|Overall Study|Adverse Event|11|||
161147889|NCT00634543|581924454|FG000|Overall Study|Withdrawal by Subject|4|||
161147890|NCT00634543|581924455|FG001|Overall Study|Withdrawal by Subject|4|||
161147891|NCT00634543|581924454|FG000|Overall Study|Lost to Follow-up|0|||
161147892|NCT00634543|581924455|FG001|Overall Study|Lost to Follow-up|1|||
161147893|NCT01013883|581924456|FG000|Overall Study|Lost to Follow-up|2|||
161272428|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
161147894|NCT01013883|581924457|FG001|Overall Study|Lost to Follow-up|2|||
161147895|NCT01371838|581924458|FG000|Overall Study|Withdrawal by Subject|27|||
161147896|NCT01371838|581924459|FG001|Overall Study|Withdrawal by Subject|33|||
161147897|NCT01371838|581924458|FG000|Overall Study|Lost to Follow-up|10|||
161147898|NCT01371838|581924459|FG001|Overall Study|Lost to Follow-up|20|||
161147899|NCT01371838|581924458|FG000|Overall Study|Death|3|||
161147900|NCT01371838|581924459|FG001|Overall Study|Death|4|||
161272429|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161014540|NCT04716634|581441660|FG000|Overall Study|Withdrawal by Subject|0|||
161014541|NCT04716634|581441661|FG001|Overall Study|Withdrawal by Subject|0|||
161014542|NCT04716634|581441662|FG002|Overall Study|Withdrawal by Subject|1|||
161014543|NCT05418296|581441678|FG000|Overall Study|Withdrawal by Subject|4|||
161014544|NCT05418296|581441679|FG001|Overall Study|Withdrawal by Subject|1|||
161014545|NCT04703322|581441681|FG000|Overall Study|Ongoing|8|||
161014546|NCT04703322|581441681|FG000|Overall Study|Withdrawal by Subject|1|||
161014547|NCT04638998|581441682|FG000|Overall Study|Withdrawal by Subject|1|||
161014548|NCT04638998|581441683|FG001|Overall Study|Withdrawal by Subject|3|||
161014549|NCT04419168|581441686|FG000|Overall Study|Protocol Violation|1|||
161014550|NCT04419168|581441687|FG001|Overall Study|Protocol Violation|1|||
161014551|NCT04419168|581441686|FG000|Overall Study|Lost to Follow-up|7|||
161014552|NCT04419168|581441687|FG001|Overall Study|Lost to Follow-up|7|||
161014553|NCT04419168|581441686|FG000|Overall Study|Missed 6-month Visit|48|||
161014554|NCT04419168|581441687|FG001|Overall Study|Missed 6-month Visit|45|||
161014555|NCT03713086|581441691|FG000|Overall Study|Withdrawal by Subject|0|||
161014556|NCT03713086|581441692|FG001|Overall Study|Withdrawal by Subject|2|||
161014557|NCT03713086|581441693|FG002|Overall Study|Withdrawal by Subject|1|||
161014558|NCT03713086|581441694|FG003|Overall Study|Withdrawal by Subject|0|||
161014559|NCT03713086|581441691|FG000|Overall Study|Lost to Follow-up|0|||
161014560|NCT03713086|581441692|FG001|Overall Study|Lost to Follow-up|1|||
161014561|NCT03713086|581441693|FG002|Overall Study|Lost to Follow-up|0|||
161014562|NCT03713086|581441694|FG003|Overall Study|Lost to Follow-up|1|||
161014563|NCT05009251|581441695|FG000|Overall Study|Protocol Violation|100|||
161014564|NCT05009251|581441696|FG001|Overall Study|Protocol Violation|105|||
161014565|NCT05009251|581441697|FG002|Overall Study|Protocol Violation|119|||
161014566|NCT05009251|581441698|FG003|Overall Study|Protocol Violation|120|||
161014567|NCT05009251|581441699|FG004|Overall Study|Protocol Violation|119|||
161014568|NCT05009251|581441695|FG000|Overall Study|Death|25|||
161014569|NCT05009251|581441696|FG001|Overall Study|Death|22|||
161014570|NCT05009251|581441697|FG002|Overall Study|Death|24|||
161014571|NCT05009251|581441698|FG003|Overall Study|Death|19|||
161014572|NCT05009251|581441699|FG004|Overall Study|Death|15|||
161014573|NCT05374837|581441705|FG000|Overall Study|Lost to Follow-up|17|||
161014574|NCT05374837|581441706|FG001|Overall Study|Lost to Follow-up|18|||
161014575|NCT05406921|581441709|FG000|Overall Study|Withdrawal by Subject|25|||
161014576|NCT05406921|581441710|FG001|Overall Study|Withdrawal by Subject|0|||
161014577|NCT05406921|581441711|FG002|Overall Study|Withdrawal by Subject|25|||
161014578|NCT05406921|581441709|FG000|Overall Study|Protocol Violation|0|||
161014579|NCT05406921|581441710|FG001|Overall Study|Protocol Violation|12|||
161014580|NCT05406921|581441711|FG002|Overall Study|Protocol Violation|0|||
161014581|NCT04831281|581441714|FG000|Overall Study|Adverse Event|1|||
161014582|NCT04831281|581441715|FG001|Overall Study|Adverse Event|0|||
161014583|NCT04831281|581441716|FG002|Overall Study|Adverse Event|3|||
161014584|NCT04831281|581441714|FG000|Overall Study|Withdrawal by Subject|0|||
161014585|NCT04831281|581441715|FG001|Overall Study|Withdrawal by Subject|1|||
161014586|NCT04831281|581441716|FG002|Overall Study|Withdrawal by Subject|2|||
161014587|NCT04831281|581441714|FG000|Overall Study|Undetermined|1|||
161014588|NCT04831281|581441715|FG001|Overall Study|Undetermined|1|||
161014589|NCT04831281|581441716|FG002|Overall Study|Undetermined|0|||
161014590|NCT02249949|581441717|FG000|Overall Study|Cancelled prior to treatment|2|||
161014591|NCT02097420|581441720|FG000|Overall Study|Death|6|||
161014592|NCT02097420|581441720|FG000|Overall Study|Valve explanted|13|||
161014593|NCT02097420|581441720|FG000|Overall Study|Other Reason|1|||
161014594|NCT04263311|581441721|FG000|Overall Study|Lost to Follow-up|1|||
161014595|NCT04263311|581441722|FG001|Overall Study|Lost to Follow-up|2|||
161014596|NCT04263311|581441723|FG002|Overall Study|Lost to Follow-up|0|||
161014597|NCT04263311|581441721|FG000|Overall Study|Health Issues|1|||
161014598|NCT04263311|581441722|FG001|Overall Study|Health Issues|0|||
161014599|NCT04263311|581441723|FG002|Overall Study|Health Issues|0|||
161014600|NCT04263311|581441721|FG000|Overall Study|Left the country|1|||
161014601|NCT04263311|581441722|FG001|Overall Study|Left the country|0|||
161014602|NCT04263311|581441723|FG002|Overall Study|Left the country|0|||
161014603|NCT04263311|581441721|FG000|Overall Study|Unable to maintain time commitment|1|||
161014604|NCT04263311|581441722|FG001|Overall Study|Unable to maintain time commitment|0|||
161014605|NCT04263311|581441723|FG002|Overall Study|Unable to maintain time commitment|0|||
161014606|NCT04263311|581441721|FG000|Overall Study|No longer interested|1|||
161014607|NCT04263311|581441722|FG001|Overall Study|No longer interested|0|||
161014608|NCT04263311|581441723|FG002|Overall Study|No longer interested|0|||
161014609|NCT04263311|581441721|FG000|Overall Study|Ineligible post consent|0|||
161014610|NCT04263311|581441722|FG001|Overall Study|Ineligible post consent|0|||
161014611|NCT04263311|581441723|FG002|Overall Study|Ineligible post consent|5|||
161014612|NCT04820855|581441724|FG000|Overall Study|Lost to Follow-up|6|||
161014613|NCT04820855|581441725|FG001|Overall Study|Lost to Follow-up|9|||
161014614|NCT04838262|581441726|FG000|Overall Study|Withdrawal by Subject|9|||
161014615|NCT04838262|581441727|FG001|Overall Study|Withdrawal by Subject|4|||
161014616|NCT05524233|581441730|FG000|Overall Study|Lost to Follow-up|2|||
161014617|NCT05524233|581441730|FG000|Overall Study|Adverse Event|2|||
161014618|NCT05524233|581441730|FG000|Overall Study|Withdrawal by Subject|1|||
161014619|NCT02307565|581441731|FG000|Overall Study|Adverse Event|3|||
161014620|NCT02307565|581441732|FG001|Overall Study|Adverse Event|2|||
161014621|NCT02307565|581441731|FG000|Overall Study|Withdrawal by Subject|2|||
161014622|NCT02307565|581441732|FG001|Overall Study|Withdrawal by Subject|2|||
161014623|NCT00650104|581441733|FG000|Overall Study|Adverse Event|17|||
161014624|NCT00650104|581441733|FG000|Overall Study|Death|2|||
161014625|NCT00650104|581441733|FG000|Overall Study|Withdrawal by Subject|11|||
161014626|NCT00650104|581441733|FG000|Overall Study|Physician Decision|7|||
161014627|NCT00650104|581441733|FG000|Overall Study|Lost to Follow-up|1|||
161014628|NCT00650104|581441733|FG000|Overall Study|Non-compliance|2|||
161014629|NCT00650104|581441733|FG000|Overall Study|Sponsor Terminated Dosing|1|||
161014630|NCT02697136|581441740|FG000|Overall Study|Adverse Event|3|||
161014631|NCT02697136|581441741|FG001|Overall Study|Adverse Event|0|||
161014632|NCT05633407|581441745|FG000|Overall Study|Physician Decision|2|||
161014633|NCT05633407|581441746|FG001|Overall Study|Physician Decision|0|||
161014634|NCT05633407|581441745|FG000|Overall Study|Adverse Event|1|||
161014635|NCT05633407|581441746|FG001|Overall Study|Adverse Event|0|||
161014636|NCT05633407|581441745|FG000|Overall Study|Withdrawal by Subject|1|||
161014637|NCT05633407|581441746|FG001|Overall Study|Withdrawal by Subject|0|||
161014638|NCT05633407|581441745|FG000|Overall Study|Other|1|||
161014639|NCT05633407|581441746|FG001|Overall Study|Other|1|||
161014640|NCT03527160|581441747|FG000|Overall Study|No urine collected|13|||
161014641|NCT03527160|581441747|FG000|Overall Study|No clinical serum creatinine collected|6|||
161014642|NCT03527160|581441747|FG000|Overall Study|Did not meet inclusion|2|||
161014643|NCT01721291|581441749|FG000|Overall Study|Withdrawal by Subject|1|||
161014644|NCT01721291|581441750|FG001|Overall Study|Withdrawal by Subject|0|||
161014645|NCT01721291|581441749|FG000|Overall Study|did not like the treatment|1|||
161014646|NCT01721291|581441750|FG001|Overall Study|did not like the treatment|0|||
161014647|NCT03690206|581441752|FG000|Overall Study|Withdrawal by Subject|2|||
161014648|NCT03690206|581441753|FG001|Overall Study|Withdrawal by Subject|0|||
161014649|NCT03690206|581441754|FG002|Overall Study|Withdrawal by Subject|0|||
161014650|NCT03690206|581441752|FG000|Overall Study|ICF withdrawal|2|||
161014651|NCT03690206|581441753|FG001|Overall Study|ICF withdrawal|0|||
161014652|NCT03690206|581441754|FG002|Overall Study|ICF withdrawal|0|||
161014653|NCT04833777|581443407|FG000|Overall Study|Lost to Follow-up|1|||
161014654|NCT04833777|581443408|FG001|Overall Study|Lost to Follow-up|0|||
161014655|NCT03089398|581443409|FG000|Overall Study|Death|4|||
161014656|NCT03089398|581443410|FG001|Overall Study|Death|9|||
161014657|NCT03089398|581443409|FG000|Overall Study|Lost to Follow-up|21|||
161014658|NCT03089398|581443410|FG001|Overall Study|Lost to Follow-up|30|||
161014659|NCT03089398|581443409|FG000|Overall Study|Withdrawal by Subject|2|||
161014660|NCT03089398|581443410|FG001|Overall Study|Withdrawal by Subject|2|||
161014661|NCT05249439|581443411|FG000|Overall Study|Withdrawal by Subject|2|||
161014662|NCT05249439|581443412|FG001|Overall Study|Withdrawal by Subject|5|||
161014663|NCT05249439|581443411|FG000|Overall Study|Physician Decision|3|||
161014664|NCT05249439|581443412|FG001|Overall Study|Physician Decision|1|||
161014665|NCT00616967|581443413|FG000|Overall Study|Withdrawal by Subject|0|||
161014666|NCT00616967|581443414|FG001|Overall Study|Withdrawal by Subject|0|||
161014667|NCT00616967|581443415|FG002|Overall Study|Withdrawal by Subject|1|||
161014668|NCT02910583|581443416|FG000|Overall Study|Death|7|||
161014669|NCT02910583|581443417|FG001|Overall Study|Death|3|||
161014670|NCT02910583|581443416|FG000|Overall Study|Lost to Follow-up|1|||
161014671|NCT02910583|581443417|FG001|Overall Study|Lost to Follow-up|0|||
161014672|NCT02910583|581443416|FG000|Overall Study|Withdrawal by Subject|12|||
161014673|NCT02910583|581443417|FG001|Overall Study|Withdrawal by Subject|8|||
161014674|NCT02910583|581443416|FG000|Overall Study|Other, Not Specified|6|||
161014675|NCT02910583|581443417|FG001|Overall Study|Other, Not Specified|3|||
161014676|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
161014677|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
161014678|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
161014679|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
161014680|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
161014681|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
161014682|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
161014683|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
161014684|NCT05059262|581443418|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
161014685|NCT05059262|581443419|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
161014686|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
161014687|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
161014688|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
161014689|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
161014690|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
161014691|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
161014692|NCT05059262|581443418|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
161014693|NCT05059262|581443419|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
161272430|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
161272431|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
161272432|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
161272433|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
160968088|NCT01781390|581271407|FG001|Overall Study|Lost to Follow-up|1|||
160968089|NCT01781390|581271408|FG002|Overall Study|Lost to Follow-up|1|||
160968090|NCT01781390|581271406|FG000|Overall Study|Adverse Event|1|||
160968091|NCT01781390|581271407|FG001|Overall Study|Adverse Event|2|||
160968092|NCT01781390|581271408|FG002|Overall Study|Adverse Event|1|||
160968093|NCT01781390|581271406|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
160968094|NCT01781390|581271407|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
160968095|NCT01781390|581271408|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
160968096|NCT01862796|581271411|FG000|Overall Study|Prohibited medications|0|||
160968097|NCT01862796|581271412|FG001|Overall Study|Prohibited medications|0|||
160968098|NCT01862796|581271413|FG002|Overall Study|Prohibited medications|1|||
160968099|NCT02612064|581271421|FG000|Overall Study|Withdrawal by Subject|1|||
160968100|NCT02612064|581271422|FG001|Overall Study|Withdrawal by Subject|1|||
160968101|NCT02612064|581271421|FG000|Overall Study|Other|0|||
160968102|NCT02612064|581271422|FG001|Overall Study|Other|2|||
160968103|NCT05918978|581271425|FG000|Overall Study|Study Terminated by Sponsor|17|||
160968104|NCT05918978|581271426|FG001|Overall Study|Study Terminated by Sponsor|11|||
160968105|NCT05918978|581271425|FG000|Overall Study|Withdrawal by Subject|1|||
160968106|NCT05918978|581271426|FG001|Overall Study|Withdrawal by Subject|1|||
160968107|NCT05918978|581271425|FG000|Overall Study|Adverse Event|1|||
160968108|NCT05918978|581271426|FG001|Overall Study|Adverse Event|0|||
160968109|NCT05918978|581271425|FG000|Overall Study|Other|0|||
160968110|NCT05918978|581271426|FG001|Overall Study|Other|1|||
160968111|NCT00622180|581271427|FG000|Overall Study|Lost to Follow-up|1|||
160968112|NCT00622180|581271428|FG001|Overall Study|Lost to Follow-up|2|||
160968113|NCT00511875|581271434|FG000|Overall Study|Lost to Follow-up|4|||
160968114|NCT00511875|581271435|FG001|Overall Study|Lost to Follow-up|0|||
160968115|NCT00511875|581271434|FG000|Overall Study|Missing variables|1|||
160968116|NCT00511875|581271435|FG001|Overall Study|Missing variables|0|||
160968117|NCT05559866|581271438|FG000|Overall Study|Withdrawal by Subject|1|||
160968118|NCT05559866|581271439|FG001|Overall Study|Withdrawal by Subject|0|||
160968119|NCT03538951|581271440|FG000|Overall Study|Withdrawal by Subject|1|||
160968120|NCT03538951|581271441|FG001|Overall Study|Withdrawal by Subject|2|||
160968121|NCT03444376|581271443|FG000|Part A|Disease relapse or Progression|1|||
160968122|NCT03444376|581271443|FG000|Part A|Withdrawal by Subject|2|||
160968123|NCT03444376|581271443|FG000|Part A|Adverse Event|1|||
160968124|NCT03444376|581271443|FG000|Part B|Disease relapse or Progression|18|||
160968125|NCT03444376|581271443|FG000|Part B|Withdrawal by Subject|2|||
160968126|NCT03444376|581271443|FG000|Part B|Adverse Event|2|||
160968127|NCT03444376|581271443|FG000|Part B|Physician Decision|1|||
160968128|NCT03444376|581271443|FG000|Part C|Disease relapse or Progression|43|||
160968129|NCT03444376|581271443|FG000|Part C|Withdrawal by Subject|5|||
160968130|NCT03444376|581271443|FG000|Part C|Adverse Event|2|||
160968131|NCT03444376|581271443|FG000|Part C|Physician Decision|2|||
160968132|NCT03444376|581271443|FG000|Part C|Death|1|||
160968133|NCT06027619|581271447|FG000|Overall Study|Adverse Event|0|||
160968134|NCT06027619|581271448|FG001|Overall Study|Adverse Event|0|||
160968135|NCT06027619|581271449|FG002|Overall Study|Adverse Event|1|||
160968136|NCT01493960|581273302|FG000|Overall Study|Adverse Event|0|||
160968137|NCT01493960|581273303|FG001|Overall Study|Adverse Event|1|||
160968138|NCT01493960|581273302|FG000|Overall Study|Lack of Efficacy|15|||
160968139|NCT01493960|581273303|FG001|Overall Study|Lack of Efficacy|9|||
160968140|NCT01493960|581273302|FG000|Overall Study|Protocol Violation|3|||
160968141|NCT01493960|581273303|FG001|Overall Study|Protocol Violation|0|||
160968142|NCT01493960|581273302|FG000|Overall Study|Withdrawal by Subject|10|||
160968143|NCT01493960|581273303|FG001|Overall Study|Withdrawal by Subject|4|||
160968144|NCT01493960|581273302|FG000|Overall Study|Non-specified|4|||
161272434|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
160968145|NCT01493960|581273303|FG001|Overall Study|Non-specified|4|||
160968146|NCT00871403|581273306|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
160968147|NCT00871403|581273307|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
160968148|NCT00871403|581273308|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
160968149|NCT00871403|581273306|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
160968150|NCT00871403|581273307|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
160968151|NCT00871403|581273308|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
160968152|NCT00871403|581273306|FG000|Combination Treatment Phase|Adverse Event|0|||
160968153|NCT00871403|581273307|FG001|Combination Treatment Phase|Adverse Event|17|||
160968154|NCT00871403|581273308|FG002|Combination Treatment Phase|Adverse Event|2|||
160968155|NCT00871403|581273306|FG000|Combination Treatment Phase|Disease Progression|0|||
160968156|NCT00871403|581273307|FG001|Combination Treatment Phase|Disease Progression|8|||
160968157|NCT00871403|581273308|FG002|Combination Treatment Phase|Disease Progression|5|||
160968158|NCT00871403|581273306|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
161014694|NCT05021640|581443422|FG000|Overall Study|Lost to Follow-up|0|||
160968159|NCT00871403|581273307|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
160968160|NCT00871403|581273308|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
160968161|NCT00871403|581273306|FG000|Combination Treatment Phase|Physician Decision|0|||
160968162|NCT00871403|581273307|FG001|Combination Treatment Phase|Physician Decision|1|||
160968163|NCT00871403|581273308|FG002|Combination Treatment Phase|Physician Decision|3|||
160968164|NCT00871403|581273306|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
160968165|NCT00871403|581273307|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
160968166|NCT00871403|581273308|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
160968167|NCT00871403|581273306|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
160968168|NCT00871403|581273307|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
160968169|NCT00871403|581273308|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
160968170|NCT01446796|581273309|FG000|Overall Study|Withdrawal by Subject|1|||
160968171|NCT01446796|581273310|FG001|Overall Study|Withdrawal by Subject|0|||
160968172|NCT00954733|581273312|FG000|Overall Study|blood gas machine did not work|1|||
160968173|NCT03131960|581273313|FG000|Overall Study|Adverse Event|0|||
160968174|NCT03131960|581273314|FG001|Overall Study|Adverse Event|1|||
160968175|NCT04707196|581273315|FG000|Overall Study|Withdrawal by Subject|9|||
160968176|NCT04707196|581273316|FG001|Overall Study|Withdrawal by Subject|6|||
160968177|NCT04707196|581273315|FG000|Overall Study|Lost to Follow-up|1|||
160968178|NCT04707196|581273316|FG001|Overall Study|Lost to Follow-up|0|||
160968179|NCT04707196|581273315|FG000|Overall Study|Protocol Violation|4|||
160968180|NCT04707196|581273316|FG001|Overall Study|Protocol Violation|1|||
160968181|NCT04707196|581273315|FG000|Overall Study|Adverse Event|2|||
160968182|NCT04707196|581273316|FG001|Overall Study|Adverse Event|2|||
160968183|NCT04707196|581273315|FG000|Overall Study|Death|3|||
160968184|NCT04707196|581273316|FG001|Overall Study|Death|1|||
160968185|NCT04707196|581273315|FG000|Overall Study|Non-compliance with study drug|1|||
160968186|NCT04707196|581273316|FG001|Overall Study|Non-compliance with study drug|0|||
160968187|NCT04707196|581273315|FG000|Overall Study|Progressive disease|9|||
160968188|NCT04707196|581273316|FG001|Overall Study|Progressive disease|10|||
160968189|NCT01462162|581273318|FG000|Overall Study|Adverse Event|5|||
160968190|NCT01462162|581273318|FG000|Overall Study|Lack of Efficacy|4|||
160968191|NCT01462162|581273318|FG000|Overall Study|Abnormal laboratory parameters|1|||
160968192|NCT01462162|581273318|FG000|Overall Study|Other|2|||
160968193|NCT03485911|581273319|FG000|Part 1|Perceived lack of efficacy|1|||
160968194|NCT03485911|581273320|FG001|Part 1|Perceived lack of efficacy|1|||
160968195|NCT03485911|581273321|FG002|Part 1|Perceived lack of efficacy|2|||
160968196|NCT03485911|581273322|FG003|Part 1|Perceived lack of efficacy|0|||
160968197|NCT03485911|581273319|FG000|Part 1|Subject withdrew consent|0|||
160968198|NCT03485911|581273320|FG001|Part 1|Subject withdrew consent|1|||
160968199|NCT03485911|581273321|FG002|Part 1|Subject withdrew consent|0|||
160968200|NCT03485911|581273322|FG003|Part 1|Subject withdrew consent|1|||
160968201|NCT03485911|581273319|FG000|Part 1|Lab abnormalities/AEs|3|||
160968202|NCT03485911|581273320|FG001|Part 1|Lab abnormalities/AEs|1|||
160968203|NCT03485911|581273321|FG002|Part 1|Lab abnormalities/AEs|1|||
160968204|NCT03485911|581273322|FG003|Part 1|Lab abnormalities/AEs|0|||
160968205|NCT03485911|581273319|FG000|Part 1|Withdrew Consent prior to dosing|0|||
160968206|NCT03485911|581273320|FG001|Part 1|Withdrew Consent prior to dosing|0|||
160968207|NCT03485911|581273321|FG002|Part 1|Withdrew Consent prior to dosing|0|||
160968208|NCT03485911|581273322|FG003|Part 1|Withdrew Consent prior to dosing|1|||
160968209|NCT03485911|581273319|FG000|Part 1|Other NOS|0|||
160968210|NCT03485911|581273320|FG001|Part 1|Other NOS|0|||
160968211|NCT03485911|581273321|FG002|Part 1|Other NOS|0|||
160968212|NCT03485911|581273322|FG003|Part 1|Other NOS|1|||
160968213|NCT03485911|581273319|FG000|Part 2|Perceived lack of efficacy|5|||
160968214|NCT03485911|581273320|FG001|Part 2|Perceived lack of efficacy|3|||
160968215|NCT03485911|581273321|FG002|Part 2|Perceived lack of efficacy|0|||
160968216|NCT03485911|581273322|FG003|Part 2|Perceived lack of efficacy|2|||
160968217|NCT03485911|581273319|FG000|Part 2|Subject withdrew consent|1|||
160968218|NCT03485911|581273320|FG001|Part 2|Subject withdrew consent|0|||
160968219|NCT03485911|581273321|FG002|Part 2|Subject withdrew consent|2|||
160968220|NCT03485911|581273322|FG003|Part 2|Subject withdrew consent|1|||
160968221|NCT03485911|581273319|FG000|Part 2|Lab abnormalities/AEs|1|||
160968222|NCT03485911|581273320|FG001|Part 2|Lab abnormalities/AEs|2|||
160968223|NCT03485911|581273321|FG002|Part 2|Lab abnormalities/AEs|0|||
160968224|NCT03485911|581273322|FG003|Part 2|Lab abnormalities/AEs|0|||
160968225|NCT03485911|581273319|FG000|Part 2|Other NOS|0|||
160968226|NCT03485911|581273320|FG001|Part 2|Other NOS|1|||
160968227|NCT03485911|581273321|FG002|Part 2|Other NOS|0|||
160968228|NCT03485911|581273322|FG003|Part 2|Other NOS|0|||
160968229|NCT03485911|581273319|FG000|Part 2|Intercurrent illness/new medical condition|1|||
160968230|NCT03485911|581273320|FG001|Part 2|Intercurrent illness/new medical condition|0|||
161014695|NCT05021640|581443423|FG001|Overall Study|Lost to Follow-up|0|||
160968231|NCT03485911|581273321|FG002|Part 2|Intercurrent illness/new medical condition|0|||
160968232|NCT03485911|581273322|FG003|Part 2|Intercurrent illness/new medical condition|0|||
160968233|NCT03485911|581273319|FG000|Part 2|Investigator judgement|1|||
160968234|NCT03485911|581273320|FG001|Part 2|Investigator judgement|0|||
160968235|NCT03485911|581273321|FG002|Part 2|Investigator judgement|0|||
161014696|NCT05021640|581443424|FG002|Overall Study|Lost to Follow-up|0|||
161014697|NCT05021640|581443425|FG003|Overall Study|Lost to Follow-up|0|||
161272435|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161272436|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161272437|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161272438|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161272439|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161272440|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161272441|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Other|4|||
161272442|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Other|4|||
161272443|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Other|3|||
161272444|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Other|1|||
161272445|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Other|0|||
161272446|NCT01081834|582377635|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
161272447|NCT01081834|582377636|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
161272448|NCT01081834|582377637|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161272449|NCT01081834|582377638|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161272450|NCT01081834|582377639|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
161272451|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161272452|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161272453|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161272454|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161272455|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
161272456|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Death|1|||
161272457|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Death|0|||
161272458|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161272459|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Death|0|||
161272460|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Death|0|||
161272461|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
161272462|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
161272463|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161272464|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161272465|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161272466|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161272467|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161272468|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161272469|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161272470|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161272471|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161272472|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
161272473|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161272474|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161272475|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
161272476|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161272477|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161272478|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161272479|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161272480|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161272481|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161272482|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
161272483|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161272484|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161272485|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
161272486|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Other|4|||
161272487|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161272488|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161272489|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Other|0|||
161272490|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Other|0|||
161272491|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
161272492|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
161014698|NCT05021640|581443426|FG004|Overall Study|Lost to Follow-up|1|||
161014699|NCT02312960|581443427|FG000|Overall Study|Death|24|||
161014700|NCT02312960|581443428|FG001|Overall Study|Death|32|||
161014701|NCT02312960|581443429|FG002|Overall Study|Death|25|||
161014702|NCT02312960|581443430|FG003|Overall Study|Death|11|||
161014703|NCT02312960|581443431|FG004|Overall Study|Death|5|||
161014704|NCT02312960|581443432|FG005|Overall Study|Death|5|||
161014705|NCT02312960|581443433|FG006|Overall Study|Death|8|||
161014706|NCT02312960|581443434|FG007|Overall Study|Death|5|||
161014707|NCT02312960|581443435|FG008|Overall Study|Death|7|||
161014708|NCT02312960|581443436|FG009|Overall Study|Death|3|||
161014709|NCT02312960|581443437|FG010|Overall Study|Death|3|||
161014710|NCT02312960|581443438|FG011|Overall Study|Death|1|||
161014711|NCT02312960|581443439|FG012|Overall Study|Death|25|||
161014712|NCT02312960|581443440|FG013|Overall Study|Death|19|||
161014713|NCT02312960|581443427|FG000|Overall Study|Missing|0|||
161014714|NCT02312960|581443428|FG001|Overall Study|Missing|0|||
161014715|NCT02312960|581443429|FG002|Overall Study|Missing|2|||
161014716|NCT02312960|581443430|FG003|Overall Study|Missing|0|||
161014717|NCT02312960|581443431|FG004|Overall Study|Missing|0|||
161014718|NCT02312960|581443432|FG005|Overall Study|Missing|0|||
161014719|NCT02312960|581443433|FG006|Overall Study|Missing|0|||
161014720|NCT02312960|581443434|FG007|Overall Study|Missing|0|||
161014721|NCT02312960|581443435|FG008|Overall Study|Missing|0|||
161014722|NCT02312960|581443436|FG009|Overall Study|Missing|0|||
161014723|NCT02312960|581443437|FG010|Overall Study|Missing|0|||
161014724|NCT02312960|581443438|FG011|Overall Study|Missing|0|||
161014725|NCT02312960|581443439|FG012|Overall Study|Missing|0|||
161014726|NCT02312960|581443440|FG013|Overall Study|Missing|0|||
161014727|NCT02312960|581443427|FG000|Overall Study|Lost to Follow-up|0|||
161014728|NCT02312960|581443428|FG001|Overall Study|Lost to Follow-up|0|||
161014729|NCT02312960|581443429|FG002|Overall Study|Lost to Follow-up|1|||
161014730|NCT02312960|581443430|FG003|Overall Study|Lost to Follow-up|0|||
161014731|NCT02312960|581443431|FG004|Overall Study|Lost to Follow-up|0|||
161014732|NCT02312960|581443432|FG005|Overall Study|Lost to Follow-up|0|||
161014733|NCT02312960|581443433|FG006|Overall Study|Lost to Follow-up|1|||
161014734|NCT02312960|581443434|FG007|Overall Study|Lost to Follow-up|1|||
161014735|NCT02312960|581443435|FG008|Overall Study|Lost to Follow-up|0|||
161014736|NCT02312960|581443436|FG009|Overall Study|Lost to Follow-up|1|||
161014737|NCT02312960|581443437|FG010|Overall Study|Lost to Follow-up|0|||
161014738|NCT02312960|581443438|FG011|Overall Study|Lost to Follow-up|0|||
161014739|NCT02312960|581443439|FG012|Overall Study|Lost to Follow-up|1|||
161014740|NCT02312960|581443440|FG013|Overall Study|Lost to Follow-up|0|||
161014741|NCT02312960|581443427|FG000|Overall Study|Withdrawal by Subject|1|||
161014742|NCT02312960|581443428|FG001|Overall Study|Withdrawal by Subject|2|||
161014743|NCT02312960|581443429|FG002|Overall Study|Withdrawal by Subject|0|||
161014744|NCT02312960|581443430|FG003|Overall Study|Withdrawal by Subject|0|||
161014745|NCT02312960|581443431|FG004|Overall Study|Withdrawal by Subject|1|||
161014746|NCT02312960|581443432|FG005|Overall Study|Withdrawal by Subject|0|||
161014747|NCT02312960|581443433|FG006|Overall Study|Withdrawal by Subject|1|||
161014748|NCT02312960|581443434|FG007|Overall Study|Withdrawal by Subject|2|||
161014749|NCT02312960|581443435|FG008|Overall Study|Withdrawal by Subject|2|||
161014750|NCT02312960|581443436|FG009|Overall Study|Withdrawal by Subject|3|||
161014751|NCT02312960|581443437|FG010|Overall Study|Withdrawal by Subject|0|||
161014752|NCT02312960|581443438|FG011|Overall Study|Withdrawal by Subject|0|||
161014753|NCT02312960|581443439|FG012|Overall Study|Withdrawal by Subject|2|||
161014754|NCT02312960|581443440|FG013|Overall Study|Withdrawal by Subject|0|||
161014755|NCT03131648|581443441|FG000|Initial Treatment Period|Not dosed|2|||
161014756|NCT03131648|581443442|FG001|Initial Treatment Period|Not dosed|2|||
161014757|NCT03131648|581443443|FG002|Initial Treatment Period|Not dosed|0|||
161014758|NCT03131648|581443444|FG003|Initial Treatment Period|Not dosed|0|||
161014759|NCT03131648|581443445|FG004|Initial Treatment Period|Not dosed|0|||
161147901|NCT01371838|581924458|FG000|Overall Study|Protocol Violation|3|||
161147902|NCT01371838|581924459|FG001|Overall Study|Protocol Violation|0|||
161147903|NCT01371838|581924458|FG000|Overall Study|Investigator Decision|3|||
161147904|NCT01371838|581924459|FG001|Overall Study|Investigator Decision|8|||
161014760|NCT03131648|581443446|FG005|Initial Treatment Period|Not dosed|0|||
161014761|NCT03131648|581443447|FG006|Initial Treatment Period|Not dosed|0|||
161014762|NCT03131648|581443448|FG007|Initial Treatment Period|Not dosed|0|||
161014763|NCT03131648|581443441|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
161014764|NCT03131648|581443442|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
161014765|NCT03131648|581443443|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014766|NCT03131648|581443444|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014767|NCT03131648|581443445|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014768|NCT03131648|581443446|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014769|NCT03131648|581443447|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014770|NCT03131648|581443448|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161014771|NCT03131648|581443441|FG000|Open-label Treatment|Discontinued IMP|0|||
161014772|NCT03131648|581443442|FG001|Open-label Treatment|Discontinued IMP|0|||
161147905|NCT01371838|581924458|FG000|Overall Study|Last follow-up visit not conducted|2|||
161014773|NCT03131648|581443443|FG002|Open-label Treatment|Discontinued IMP|0|||
161014774|NCT03131648|581443444|FG003|Open-label Treatment|Discontinued IMP|0|||
161014775|NCT03131648|581443445|FG004|Open-label Treatment|Discontinued IMP|0|||
161014776|NCT03131648|581443446|FG005|Open-label Treatment|Discontinued IMP|0|||
161014777|NCT03131648|581443447|FG006|Open-label Treatment|Discontinued IMP|112|||
161014778|NCT03131648|581443448|FG007|Open-label Treatment|Discontinued IMP|0|||
161014779|NCT03131648|581443441|FG000|Open-label Treatment|Completed Week 50|0|||
161014780|NCT03131648|581443442|FG001|Open-label Treatment|Completed Week 50|0|||
161014781|NCT03131648|581443443|FG002|Open-label Treatment|Completed Week 50|0|||
161014782|NCT03131648|581443444|FG003|Open-label Treatment|Completed Week 50|0|||
161014783|NCT03131648|581443445|FG004|Open-label Treatment|Completed Week 50|0|||
161014784|NCT03131648|581443446|FG005|Open-label Treatment|Completed Week 50|0|||
161014785|NCT03131648|581443447|FG006|Open-label Treatment|Completed Week 50|6|||
161014786|NCT03131648|581443448|FG007|Open-label Treatment|Completed Week 50|0|||
161014787|NCT03131648|581443441|FG000|Maintenance Treatment Period|Not dosed|0|||
161014788|NCT03131648|581443442|FG001|Maintenance Treatment Period|Not dosed|0|||
161014789|NCT03131648|581443443|FG002|Maintenance Treatment Period|Not dosed|3|||
161014790|NCT03131648|581443444|FG003|Maintenance Treatment Period|Not dosed|2|||
161014791|NCT03131648|581443445|FG004|Maintenance Treatment Period|Not dosed|1|||
161014792|NCT03131648|581443446|FG005|Maintenance Treatment Period|Not dosed|0|||
161014793|NCT03131648|581443447|FG006|Maintenance Treatment Period|Not dosed|0|||
161014794|NCT03131648|581443448|FG007|Maintenance Treatment Period|Not dosed|0|||
161014795|NCT03131648|581443441|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
161014796|NCT03131648|581443442|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
161014797|NCT03131648|581443443|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
161014798|NCT03131648|581443444|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
161014799|NCT03131648|581443445|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
161014800|NCT03131648|581443446|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
161014801|NCT03131648|581443447|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
161014802|NCT03131648|581443448|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
161014803|NCT03131648|581443441|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014804|NCT03131648|581443442|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014805|NCT03131648|581443443|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
161014806|NCT03131648|581443444|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
161014807|NCT03131648|581443445|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
161014808|NCT03131648|581443446|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
161014809|NCT03131648|581443447|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014810|NCT03131648|581443448|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161014811|NCT03131648|581443441|FG000|Maintenance Treatment Period|Completed Week 50|0|||
161014812|NCT03131648|581443442|FG001|Maintenance Treatment Period|Completed Week 50|0|||
161014813|NCT03131648|581443443|FG002|Maintenance Treatment Period|Completed Week 50|0|||
161014814|NCT03131648|581443444|FG003|Maintenance Treatment Period|Completed Week 50|0|||
161014815|NCT03131648|581443445|FG004|Maintenance Treatment Period|Completed Week 50|1|||
161014816|NCT03131648|581443446|FG005|Maintenance Treatment Period|Completed Week 50|0|||
161014817|NCT03131648|581443447|FG006|Maintenance Treatment Period|Completed Week 50|0|||
161014818|NCT03131648|581443448|FG007|Maintenance Treatment Period|Completed Week 50|0|||
161014819|NCT03131648|581443441|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014820|NCT03131648|581443442|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014821|NCT03131648|581443443|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014822|NCT03131648|581443444|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014823|NCT03131648|581443445|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014824|NCT03131648|581443446|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014825|NCT03131648|581443447|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
161014826|NCT03131648|581443448|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
161014827|NCT02724878|581443449|FG000|Overall Study|Still on Active Therapy|15|||
161014828|NCT02724878|581443449|FG000|Overall Study|Disease Progression|31|||
161014829|NCT02724878|581443449|FG000|Overall Study|Toxicity|5|||
161014830|NCT02724878|581443449|FG000|Overall Study|Death|1|||
161014831|NCT02724878|581443449|FG000|Overall Study|Withdrawal by Subject|4|||
161014832|NCT02724878|581443449|FG000|Overall Study|Lost to Follow-up|2|||
161014833|NCT02724878|581443449|FG000|Overall Study|Protocol Violation|1|||
161147906|NCT01371838|581924459|FG001|Overall Study|Last follow-up visit not conducted|0|||
161147907|NCT01371838|581924458|FG000|Overall Study|Lack of therapeutic response|0|||
161147908|NCT01371838|581924459|FG001|Overall Study|Lack of therapeutic response|1|||
161147909|NCT01371838|581924458|FG000|Overall Study|Surgery|1|||
161147910|NCT01371838|581924459|FG001|Overall Study|Surgery|0|||
161014834|NCT02724878|581443449|FG000|Overall Study|Ineligible for Study Drug|5|||
161014835|NCT02724878|581443449|FG000|Overall Study|not started|1|||
161014836|NCT02954341|581443450|FG000|Overall Study|Attempted Implant unsuccessful|5|||
161014837|NCT02954341|581443450|FG000|Overall Study|Death|90|||
161014838|NCT02954341|581443450|FG000|Overall Study|Withdrawal by Subject|4|||
161147911|NCT00641043|581924464|FG000|Overall Study|Adverse Event|6|||
161147912|NCT00641043|581924465|FG001|Overall Study|Adverse Event|4|||
161272493|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161014839|NCT02954341|581443450|FG000|Overall Study|Physician Decision|13|||
161014840|NCT02954341|581443450|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
161014841|NCT02954341|581443450|FG000|Overall Study|Not implanted due to physician's decision|1|||
161014842|NCT02954341|581443450|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
161014843|NCT05227209|581443451|FG000|Overall Study|Adverse Event|11|||
161014844|NCT05227209|581443451|FG000|Overall Study|Lost to Follow-up|1|||
161014845|NCT05227209|581443451|FG000|Overall Study|Withdrawal by Subject|7|||
161014846|NCT05227209|581443451|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
161014847|NCT05633953|581443452|FG000|Overall Study|Adverse Event|7|||
161014848|NCT05633953|581443452|FG000|Overall Study|Death|30|||
161014849|NCT05633953|581443452|FG000|Overall Study|Lost to Follow-up|1|||
161014850|NCT05633953|581443452|FG000|Overall Study|Osilodrostat discontinued|4|||
161014851|NCT05633953|581443452|FG000|Overall Study|Physician Decision|1|||
161014852|NCT05633953|581443452|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
161014853|NCT05633953|581443452|FG000|Overall Study|Progressive disease|2|||
161014854|NCT04245501|581443455|FG000|Overall Study|Adverse Event|2|||
161014855|NCT04245501|581443456|FG001|Overall Study|Adverse Event|0|||
161014856|NCT04245501|581443455|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
161014857|NCT04245501|581443456|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
161147913|NCT00641043|581924464|FG000|Overall Study|Protocol Violation|2|||
161147914|NCT00641043|581924465|FG001|Overall Study|Protocol Violation|3|||
161343554|NCT03034967|582644412|FG000|Overall Study|Withdrawal by Subject|9|||
161343555|NCT03034967|582644413|FG001|Overall Study|Withdrawal by Subject|2|||
160968236|NCT03485911|581273322|FG003|Part 2|Investigator judgement|0|||
160968237|NCT03485911|581273319|FG000|Part 3|Perceived lack of efficacy|2|||
160968238|NCT03485911|581273320|FG001|Part 3|Perceived lack of efficacy|2|||
160968239|NCT03485911|581273321|FG002|Part 3|Perceived lack of efficacy|2|||
160968240|NCT03485911|581273322|FG003|Part 3|Perceived lack of efficacy|0|||
160968241|NCT03485911|581273319|FG000|Part 3|Subject withdrew consent|1|||
160968242|NCT03485911|581273320|FG001|Part 3|Subject withdrew consent|4|||
160968243|NCT03485911|581273321|FG002|Part 3|Subject withdrew consent|0|||
160968244|NCT03485911|581273322|FG003|Part 3|Subject withdrew consent|1|||
160968245|NCT03485911|581273319|FG000|Part 3|Lab abnormalities/AEs|1|||
160968246|NCT03485911|581273320|FG001|Part 3|Lab abnormalities/AEs|1|||
160968247|NCT03485911|581273321|FG002|Part 3|Lab abnormalities/AEs|0|||
160968248|NCT03485911|581273322|FG003|Part 3|Lab abnormalities/AEs|2|||
160968249|NCT03485911|581273319|FG000|Part 3|Other NOS|1|||
160968250|NCT03485911|581273320|FG001|Part 3|Other NOS|1|||
160968251|NCT03485911|581273321|FG002|Part 3|Other NOS|0|||
160968252|NCT03485911|581273322|FG003|Part 3|Other NOS|0|||
160968253|NCT03485911|581273319|FG000|Part 3|Intercurrent illness/new medical condition|0|||
160968254|NCT03485911|581273320|FG001|Part 3|Intercurrent illness/new medical condition|1|||
160968255|NCT03485911|581273321|FG002|Part 3|Intercurrent illness/new medical condition|1|||
160968256|NCT03485911|581273322|FG003|Part 3|Intercurrent illness/new medical condition|0|||
160968257|NCT03485911|581273319|FG000|Part 3|Sponsor discontinuation|1|||
160968258|NCT03485911|581273320|FG001|Part 3|Sponsor discontinuation|0|||
160968259|NCT03485911|581273321|FG002|Part 3|Sponsor discontinuation|0|||
160968260|NCT03485911|581273322|FG003|Part 3|Sponsor discontinuation|0|||
160968261|NCT03485911|581273319|FG000|Part 3|Berotralstat provided by alternative means|13|||
160968262|NCT03485911|581273320|FG001|Part 3|Berotralstat provided by alternative means|13|||
160968263|NCT03485911|581273321|FG002|Part 3|Berotralstat provided by alternative means|7|||
160968264|NCT03485911|581273322|FG003|Part 3|Berotralstat provided by alternative means|7|||
160968265|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
160968266|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
160968267|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
160968268|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
160968269|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
160968270|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
160968271|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
160968272|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
160968273|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
160968274|NCT03333928|581273323|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
160968275|NCT03333928|581273324|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
160968276|NCT03333928|581273325|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
160968277|NCT03333928|581273323|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
160968278|NCT03333928|581273324|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
160968279|NCT03333928|581273325|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
160968280|NCT03333928|581273323|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
160968281|NCT03333928|581273324|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
161014858|NCT01772472|581443457|FG000|Overall Study|Death|126|||
161014859|NCT01772472|581443458|FG001|Overall Study|Death|94|||
161014860|NCT01772472|581443457|FG000|Overall Study|Lost to Follow-up|51|||
161343556|NCT03034967|582644414|FG002|Overall Study|Withdrawal by Subject|6|||
161014861|NCT01772472|581443458|FG001|Overall Study|Lost to Follow-up|50|||
161014862|NCT01772472|581443457|FG000|Overall Study|Other|9|||
161014863|NCT01772472|581443458|FG001|Overall Study|Other|7|||
161014864|NCT01772472|581443457|FG000|Overall Study|Physician Decision|1|||
161014865|NCT01772472|581443458|FG001|Overall Study|Physician Decision|7|||
161014866|NCT01772472|581443457|FG000|Overall Study|Withdrawal by Subject|115|||
161014867|NCT01772472|581443458|FG001|Overall Study|Withdrawal by Subject|90|||
161014868|NCT01772472|581443457|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
161014869|NCT01772472|581443458|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
161014870|NCT04391894|581443459|FG000|Overall Study|Adverse Event|1|||
161014871|NCT04391894|581443460|FG001|Overall Study|Adverse Event|1|||
161014872|NCT04391894|581443461|FG002|Overall Study|Adverse Event|1|||
161014873|NCT04391894|581443462|FG003|Overall Study|Adverse Event|1|||
161014874|NCT04391894|581443463|FG004|Overall Study|Adverse Event|1|||
161014875|NCT04391894|581443459|FG000|Overall Study|Lost to Follow-up|1|||
161014876|NCT04391894|581443460|FG001|Overall Study|Lost to Follow-up|0|||
161014877|NCT04391894|581443461|FG002|Overall Study|Lost to Follow-up|0|||
161014878|NCT04391894|581443462|FG003|Overall Study|Lost to Follow-up|0|||
161014879|NCT04391894|581443463|FG004|Overall Study|Lost to Follow-up|0|||
161014880|NCT04391894|581443459|FG000|Overall Study|Protocol Violation|0|||
161014881|NCT04391894|581443460|FG001|Overall Study|Protocol Violation|0|||
161014882|NCT04391894|581443461|FG002|Overall Study|Protocol Violation|0|||
161014883|NCT04391894|581443462|FG003|Overall Study|Protocol Violation|1|||
161014884|NCT04391894|581443463|FG004|Overall Study|Protocol Violation|0|||
161014885|NCT04391894|581443459|FG000|Overall Study|Withdrawal by Subject|2|||
161014886|NCT04391894|581443460|FG001|Overall Study|Withdrawal by Subject|0|||
161014887|NCT04391894|581443461|FG002|Overall Study|Withdrawal by Subject|3|||
161014888|NCT04391894|581443462|FG003|Overall Study|Withdrawal by Subject|0|||
161272494|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161272495|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
161272496|NCT01081834|582377635|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161272497|NCT01081834|582377636|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161272498|NCT01081834|582377637|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161272499|NCT01081834|582377638|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161272500|NCT01081834|582377639|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161272501|NCT02045147|582377640|FG000|Overall Study|Withdrawal by Subject|2|||
161272502|NCT02045147|582377641|FG001|Overall Study|Withdrawal by Subject|0|||
161272503|NCT02045147|582377642|FG002|Overall Study|Withdrawal by Subject|0|||
161272504|NCT02045147|582377643|FG003|Overall Study|Withdrawal by Subject|0|||
161272505|NCT02045147|582377644|FG004|Overall Study|Withdrawal by Subject|0|||
161272506|NCT02045147|582377645|FG005|Overall Study|Withdrawal by Subject|0|||
161272507|NCT02045147|582377646|FG006|Overall Study|Withdrawal by Subject|0|||
161272508|NCT02045147|582377647|FG007|Overall Study|Withdrawal by Subject|1|||
161272509|NCT02045147|582377640|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
161272510|NCT02045147|582377641|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
161272511|NCT02045147|582377642|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
161272512|NCT02045147|582377643|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
161272513|NCT02045147|582377644|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
161272514|NCT02045147|582377645|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
161272515|NCT02045147|582377646|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
161272516|NCT02045147|582377647|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
161272517|NCT04839692|582377648|FG000|Overall Study|Withdrawal by Subject|0|||
161272518|NCT04839692|582377649|FG001|Overall Study|Withdrawal by Subject|3|||
161272519|NCT04839692|582377648|FG000|Overall Study|Physician Decision|1|||
161272520|NCT04839692|582377649|FG001|Overall Study|Physician Decision|0|||
161272521|NCT00049530|582377650|FG000|Overall Study|Lack of Efficacy|25|||
161272522|NCT00049530|582377650|FG000|Overall Study|Adverse Event|2|||
161272523|NCT00049530|582377650|FG000|Overall Study|Death|1|||
161272524|NCT00049530|582377650|FG000|Overall Study|symptomatic deterioration|1|||
161272525|NCT00049530|582377650|FG000|Overall Study|ineligible|3|||
161272526|NCT03511326|582377652|FG000|Overall Study|Withdrawal by Subject|1|||
161272527|NCT00849186|582377655|FG000|Overall Study|Adverse Event|2|||
161014889|NCT04391894|581443463|FG004|Overall Study|Withdrawal by Subject|1|||
161272528|NCT00849186|582377655|FG000|Overall Study|Withdrawal by Subject|1|||
161272529|NCT00849186|582377655|FG000|Overall Study|not treated|6|||
161272530|NCT00849186|582377655|FG000|Overall Study|Other|1|||
161272531|NCT00936897|582377658|FG000|Overall Study|Withdrawal by Subject|9|||
161014890|NCT04391894|581443459|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014891|NCT04391894|581443460|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014892|NCT04391894|581443461|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014893|NCT04391894|581443462|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
161014894|NCT04391894|581443463|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
161014895|NCT02323321|581443467|FG000|Overall Study|Re-Transplant|1|||
161014896|NCT02323321|581443467|FG000|Overall Study|Death|12|||
161014897|NCT00446225|581443468|FG000|Overall Study|Protocol Violation|1|||
161014898|NCT00446225|581443469|FG001|Overall Study|Protocol Violation|0|||
161014899|NCT02500758|581443472|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
161014900|NCT02500758|581443473|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
161014901|NCT02500758|581443472|FG000|Washout (1 Week)|Lost to Follow-up|2|||
161014902|NCT02500758|581443473|FG001|Washout (1 Week)|Lost to Follow-up|2|||
161014903|NCT02500758|581443472|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
161014904|NCT02500758|581443473|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
161014905|NCT02500758|581443472|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
161014906|NCT02500758|581443473|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
161014907|NCT02500758|581443472|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
161014908|NCT02500758|581443473|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
161014909|NCT00220740|581443474|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
161014910|NCT00220740|581443475|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
161014911|NCT00220740|581443474|FG000|Efficacy Period|Adverse Event|1|||
161014912|NCT00220740|581443475|FG001|Efficacy Period|Adverse Event|1|||
161014913|NCT00220740|581443474|FG000|Efficacy Period|Withdrawal by Subject|1|||
161014914|NCT00220740|581443475|FG001|Efficacy Period|Withdrawal by Subject|0|||
161014915|NCT00220740|581443474|FG000|Efficacy Period|Protocol Violation|1|||
161014916|NCT00220740|581443475|FG001|Efficacy Period|Protocol Violation|0|||
161014917|NCT00220740|581443474|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
161014918|NCT00220740|581443475|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
161014919|NCT01057433|581443476|FG000|Overall Study|Adverse Event|1|||
161014920|NCT02874534|581443478|FG000|Overall Study|Withdrawal by Subject|5|||
161014921|NCT02874534|581443479|FG001|Overall Study|Withdrawal by Subject|8|||
161014922|NCT02874534|581443478|FG000|Overall Study|Lost to Follow-up|2|||
161014923|NCT02874534|581443479|FG001|Overall Study|Lost to Follow-up|2|||
161014924|NCT02874534|581443478|FG000|Overall Study|Ongoing in study|1|||
161014925|NCT02874534|581443479|FG001|Overall Study|Ongoing in study|1|||
161014926|NCT05198310|581443480|FG000|Overall Study|Lost to Follow-up|0|||
161014927|NCT05198310|581443481|FG001|Overall Study|Lost to Follow-up|1|||
161014928|NCT05198310|581443482|FG002|Overall Study|Lost to Follow-up|0|||
161014929|NCT05198310|581443483|FG003|Overall Study|Lost to Follow-up|0|||
161014930|NCT05198310|581443484|FG004|Overall Study|Lost to Follow-up|0|||
161014931|NCT05198310|581443485|FG005|Overall Study|Lost to Follow-up|0|||
161014932|NCT05198310|581443486|FG006|Overall Study|Lost to Follow-up|0|||
161014933|NCT05198310|581443487|FG007|Overall Study|Lost to Follow-up|0|||
161014934|NCT05198310|581443480|FG000|Overall Study|Withdrawal by Subject|0|||
161014935|NCT05198310|581443481|FG001|Overall Study|Withdrawal by Subject|0|||
161014936|NCT05198310|581443482|FG002|Overall Study|Withdrawal by Subject|0|||
161014937|NCT05198310|581443483|FG003|Overall Study|Withdrawal by Subject|2|||
161014938|NCT05198310|581443484|FG004|Overall Study|Withdrawal by Subject|0|||
161014939|NCT05198310|581443485|FG005|Overall Study|Withdrawal by Subject|2|||
161014940|NCT05198310|581443486|FG006|Overall Study|Withdrawal by Subject|1|||
161014941|NCT05198310|581443487|FG007|Overall Study|Withdrawal by Subject|3|||
161014942|NCT04116736|581443490|FG000|Overall Study|Withdrew consent during study|3|||
161014943|NCT04116736|581443491|FG001|Overall Study|Withdrew consent during study|1|||
161014944|NCT04116736|581443490|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
161014945|NCT04116736|581443491|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
161014946|NCT04116736|581443490|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
161014947|NCT04116736|581443491|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
161014948|NCT04116736|581443490|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
161014949|NCT04116736|581443491|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
161014950|NCT04116736|581443490|FG000|Overall Study|Subject was enrolled in error|2|||
161014951|NCT04116736|581443491|FG001|Overall Study|Subject was enrolled in error|0|||
161014952|NCT04116736|581443490|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
161014953|NCT04116736|581443491|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
161014954|NCT04116736|581443490|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
161014955|NCT04116736|581443491|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
161014956|NCT04116736|581443490|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
161272532|NCT00936897|582377659|FG001|Overall Study|Withdrawal by Subject|19|||
161272533|NCT00936897|582377658|FG000|Overall Study|Adverse Event|4|||
161272534|NCT00936897|582377659|FG001|Overall Study|Adverse Event|13|||
161014957|NCT04116736|581443491|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
161014958|NCT03941860|581443498|FG000|Overall Study|Withdrawal by Subject|0|||
161014959|NCT03941860|581443499|FG001|Overall Study|Withdrawal by Subject|1|||
161014960|NCT03361748|581443500|FG000|Overall Study|Death|77|||
161272535|NCT00936897|582377658|FG000|Overall Study|Other|3|||
161014961|NCT03361748|581443500|FG000|Overall Study|Lost to Follow-up|4|||
161272536|NCT00936897|582377659|FG001|Overall Study|Other|9|||
161014962|NCT03361748|581443500|FG000|Overall Study|Withdrawal by Subject|20|||
161014963|NCT04093752|581443501|FG000|Overall Study|Adverse Event|7|||
161014964|NCT04093752|581443502|FG001|Overall Study|Adverse Event|19|||
161014965|NCT04093752|581443503|FG002|Overall Study|Adverse Event|18|||
161014966|NCT04093752|581443504|FG003|Overall Study|Adverse Event|4|||
161014967|NCT04093752|581443501|FG000|Overall Study|Withdrawal by Subject|6|||
161014968|NCT04093752|581443502|FG001|Overall Study|Withdrawal by Subject|6|||
161014969|NCT04093752|581443503|FG002|Overall Study|Withdrawal by Subject|8|||
161014970|NCT04093752|581443504|FG003|Overall Study|Withdrawal by Subject|20|||
161014971|NCT04093752|581443501|FG000|Overall Study|Lost to Follow-up|2|||
161272537|NCT00936897|582377658|FG000|Overall Study|Lost to Follow-up|1|||
161272538|NCT00936897|582377659|FG001|Overall Study|Lost to Follow-up|10|||
161272539|NCT00936897|582377658|FG000|Overall Study|Administrative Decision|1|||
161272540|NCT00936897|582377659|FG001|Overall Study|Administrative Decision|2|||
161272541|NCT00936897|582377658|FG000|Overall Study|Protocol Violation|1|||
161272542|NCT00936897|582377659|FG001|Overall Study|Protocol Violation|1|||
161272543|NCT00936897|582377658|FG000|Overall Study|Ineligibility Determined|0|||
161272544|NCT00936897|582377659|FG001|Overall Study|Ineligibility Determined|3|||
161272545|NCT00936897|582377658|FG000|Overall Study|Noncompliance|0|||
161272546|NCT00936897|582377659|FG001|Overall Study|Noncompliance|2|||
161272547|NCT00936897|582377658|FG000|Overall Study|Death|0|||
161272548|NCT00936897|582377659|FG001|Overall Study|Death|1|||
161272549|NCT00417170|582377660|FG000|Overall Study|Adverse Event|1|||
161272550|NCT00417170|582377661|FG001|Overall Study|Adverse Event|1|||
160968282|NCT03333928|581273325|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
160968283|NCT03333928|581273323|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
160968284|NCT03333928|581273324|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
160968285|NCT03333928|581273325|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
160968286|NCT03333928|581273323|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
160968287|NCT03333928|581273324|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
160968288|NCT03333928|581273325|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
160968289|NCT01674621|581273326|FG000|Overall Study|Adverse Event|3|||
160968290|NCT01674621|581273327|FG001|Overall Study|Adverse Event|2|||
160968291|NCT01674621|581273328|FG002|Overall Study|Adverse Event|5|||
160968292|NCT01674621|581273329|FG003|Overall Study|Adverse Event|5|||
160968293|NCT01674621|581273330|FG004|Overall Study|Adverse Event|1|||
160968294|NCT01674621|581273326|FG000|Overall Study|Inability to Complete Study Procedures|0|||
160968295|NCT01674621|581273327|FG001|Overall Study|Inability to Complete Study Procedures|0|||
160968296|NCT01674621|581273328|FG002|Overall Study|Inability to Complete Study Procedures|0|||
160968297|NCT01674621|581273329|FG003|Overall Study|Inability to Complete Study Procedures|0|||
160968298|NCT01674621|581273330|FG004|Overall Study|Inability to Complete Study Procedures|2|||
160968299|NCT01674621|581273326|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968300|NCT01674621|581273327|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968301|NCT01674621|581273328|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968302|NCT01674621|581273329|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
160968303|NCT01674621|581273330|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
160968304|NCT01674621|581273326|FG000|Overall Study|Withdrawal by Subject|2|||
160968305|NCT01674621|581273327|FG001|Overall Study|Withdrawal by Subject|5|||
160968306|NCT01674621|581273328|FG002|Overall Study|Withdrawal by Subject|2|||
160968307|NCT01674621|581273329|FG003|Overall Study|Withdrawal by Subject|0|||
160968308|NCT01674621|581273330|FG004|Overall Study|Withdrawal by Subject|1|||
160968309|NCT01674621|581273326|FG000|Overall Study|Other than specified|0|||
160968310|NCT01674621|581273327|FG001|Overall Study|Other than specified|1|||
160968311|NCT01674621|581273328|FG002|Overall Study|Other than specified|0|||
160968312|NCT01674621|581273329|FG003|Overall Study|Other than specified|0|||
160968313|NCT01674621|581273330|FG004|Overall Study|Other than specified|2|||
160968314|NCT04543188|581273331|FG000|Phase 1a|Adverse Event|0|||
160968315|NCT04543188|581273332|FG001|Phase 1a|Adverse Event|0|||
160968316|NCT04543188|581273333|FG002|Phase 1a|Adverse Event|0|||
160968317|NCT04543188|581273334|FG003|Phase 1a|Adverse Event|1|||
160968318|NCT04543188|581273335|FG004|Phase 1a|Adverse Event|0|||
160968319|NCT04543188|581273336|FG005|Phase 1a|Adverse Event|0|||
160968320|NCT04543188|581273337|FG006|Phase 1a|Adverse Event|1|||
160968321|NCT04543188|581273338|FG007|Phase 1a|Adverse Event|0|||
160968322|NCT04543188|581273339|FG008|Phase 1a|Adverse Event|0|||
160968323|NCT04543188|581273340|FG009|Phase 1a|Adverse Event|0|||
160968324|NCT04543188|581273341|FG010|Phase 1a|Adverse Event|0|||
160968325|NCT04543188|581273342|FG011|Phase 1a|Adverse Event|0|||
160968326|NCT04543188|581273343|FG012|Phase 1a|Adverse Event|0|||
160968327|NCT04543188|581273344|FG013|Phase 1a|Adverse Event|0|||
160968328|NCT04543188|581273345|FG014|Phase 1a|Adverse Event|0|||
160968329|NCT04543188|581273331|FG000|Phase 1a|Other (Death)|0|||
160968330|NCT04543188|581273332|FG001|Phase 1a|Other (Death)|1|||
160968331|NCT04543188|581273333|FG002|Phase 1a|Other (Death)|0|||
160968332|NCT04543188|581273334|FG003|Phase 1a|Other (Death)|0|||
160968333|NCT04543188|581273335|FG004|Phase 1a|Other (Death)|1|||
160968334|NCT04543188|581273336|FG005|Phase 1a|Other (Death)|0|||
160968335|NCT04543188|581273337|FG006|Phase 1a|Other (Death)|0|||
161014972|NCT04093752|581443502|FG001|Overall Study|Lost to Follow-up|1|||
161014973|NCT04093752|581443503|FG002|Overall Study|Lost to Follow-up|1|||
161014974|NCT04093752|581443504|FG003|Overall Study|Lost to Follow-up|1|||
161014975|NCT04093752|581443501|FG000|Overall Study|Death|0|||
161014976|NCT04093752|581443502|FG001|Overall Study|Death|0|||
161014977|NCT04093752|581443503|FG002|Overall Study|Death|1|||
161014978|NCT04093752|581443504|FG003|Overall Study|Death|2|||
161014979|NCT04093752|581443501|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
161014980|NCT04093752|581443502|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
161014981|NCT04093752|581443503|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
161014982|NCT04093752|581443504|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
160968336|NCT04543188|581273338|FG007|Phase 1a|Other (Death)|0|||
160968337|NCT04543188|581273339|FG008|Phase 1a|Other (Death)|0|||
160968338|NCT04543188|581273340|FG009|Phase 1a|Other (Death)|1|||
160968339|NCT04543188|581273341|FG010|Phase 1a|Other (Death)|0|||
160968340|NCT04543188|581273342|FG011|Phase 1a|Other (Death)|0|||
160968341|NCT04543188|581273343|FG012|Phase 1a|Other (Death)|0|||
160968342|NCT04543188|581273344|FG013|Phase 1a|Other (Death)|0|||
160968343|NCT04543188|581273345|FG014|Phase 1a|Other (Death)|0|||
160968344|NCT04543188|581273331|FG000|Phase 1a|Lost to Follow-up|0|||
160968345|NCT04543188|581273332|FG001|Phase 1a|Lost to Follow-up|0|||
160968346|NCT04543188|581273333|FG002|Phase 1a|Lost to Follow-up|0|||
160968347|NCT04543188|581273334|FG003|Phase 1a|Lost to Follow-up|0|||
160968348|NCT04543188|581273335|FG004|Phase 1a|Lost to Follow-up|0|||
160968349|NCT04543188|581273336|FG005|Phase 1a|Lost to Follow-up|0|||
160968350|NCT04543188|581273337|FG006|Phase 1a|Lost to Follow-up|0|||
160968351|NCT04543188|581273338|FG007|Phase 1a|Lost to Follow-up|0|||
160968352|NCT04543188|581273339|FG008|Phase 1a|Lost to Follow-up|0|||
160968353|NCT04543188|581273340|FG009|Phase 1a|Lost to Follow-up|0|||
160968354|NCT04543188|581273341|FG010|Phase 1a|Lost to Follow-up|1|||
160968355|NCT04543188|581273342|FG011|Phase 1a|Lost to Follow-up|0|||
160968356|NCT04543188|581273343|FG012|Phase 1a|Lost to Follow-up|0|||
160968357|NCT04543188|581273344|FG013|Phase 1a|Lost to Follow-up|0|||
160968358|NCT04543188|581273345|FG014|Phase 1a|Lost to Follow-up|0|||
160968359|NCT04543188|581273331|FG000|Phase 1a|Progressive Disease|2|||
160968360|NCT04543188|581273332|FG001|Phase 1a|Progressive Disease|2|||
160968361|NCT04543188|581273333|FG002|Phase 1a|Progressive Disease|3|||
160968362|NCT04543188|581273334|FG003|Phase 1a|Progressive Disease|1|||
160968363|NCT04543188|581273335|FG004|Phase 1a|Progressive Disease|4|||
160968364|NCT04543188|581273336|FG005|Phase 1a|Progressive Disease|2|||
160968365|NCT04543188|581273337|FG006|Phase 1a|Progressive Disease|3|||
160968366|NCT04543188|581273338|FG007|Phase 1a|Progressive Disease|4|||
160968367|NCT04543188|581273339|FG008|Phase 1a|Progressive Disease|1|||
160968368|NCT04543188|581273340|FG009|Phase 1a|Progressive Disease|0|||
160968369|NCT04543188|581273341|FG010|Phase 1a|Progressive Disease|4|||
160968370|NCT04543188|581273342|FG011|Phase 1a|Progressive Disease|0|||
160968371|NCT04543188|581273343|FG012|Phase 1a|Progressive Disease|0|||
160968372|NCT04543188|581273344|FG013|Phase 1a|Progressive Disease|0|||
160968373|NCT04543188|581273345|FG014|Phase 1a|Progressive Disease|0|||
160968374|NCT04543188|581273331|FG000|Phase 1a|Study terminated by sponsor|0|||
160968375|NCT04543188|581273332|FG001|Phase 1a|Study terminated by sponsor|0|||
160968376|NCT04543188|581273333|FG002|Phase 1a|Study terminated by sponsor|0|||
160968377|NCT04543188|581273334|FG003|Phase 1a|Study terminated by sponsor|0|||
160968378|NCT04543188|581273335|FG004|Phase 1a|Study terminated by sponsor|1|||
160968379|NCT04543188|581273336|FG005|Phase 1a|Study terminated by sponsor|0|||
160968380|NCT04543188|581273337|FG006|Phase 1a|Study terminated by sponsor|0|||
160968381|NCT04543188|581273338|FG007|Phase 1a|Study terminated by sponsor|0|||
160968382|NCT04543188|581273339|FG008|Phase 1a|Study terminated by sponsor|0|||
160968383|NCT04543188|581273340|FG009|Phase 1a|Study terminated by sponsor|0|||
160968384|NCT04543188|581273341|FG010|Phase 1a|Study terminated by sponsor|1|||
160968385|NCT04543188|581273342|FG011|Phase 1a|Study terminated by sponsor|0|||
160968386|NCT04543188|581273343|FG012|Phase 1a|Study terminated by sponsor|0|||
160968387|NCT04543188|581273344|FG013|Phase 1a|Study terminated by sponsor|0|||
160968388|NCT04543188|581273345|FG014|Phase 1a|Study terminated by sponsor|0|||
160968389|NCT04543188|581273331|FG000|Phase 1a|Withdrawal by Subject|0|||
160968390|NCT04543188|581273332|FG001|Phase 1a|Withdrawal by Subject|0|||
160968391|NCT04543188|581273333|FG002|Phase 1a|Withdrawal by Subject|0|||
160968392|NCT04543188|581273334|FG003|Phase 1a|Withdrawal by Subject|0|||
160968393|NCT04543188|581273335|FG004|Phase 1a|Withdrawal by Subject|3|||
160968394|NCT04543188|581273336|FG005|Phase 1a|Withdrawal by Subject|0|||
160968395|NCT04543188|581273337|FG006|Phase 1a|Withdrawal by Subject|0|||
160968396|NCT04543188|581273338|FG007|Phase 1a|Withdrawal by Subject|0|||
160968397|NCT04543188|581273339|FG008|Phase 1a|Withdrawal by Subject|1|||
160968398|NCT04543188|581273340|FG009|Phase 1a|Withdrawal by Subject|1|||
160968399|NCT04543188|581273341|FG010|Phase 1a|Withdrawal by Subject|2|||
160968400|NCT04543188|581273342|FG011|Phase 1a|Withdrawal by Subject|0|||
160968401|NCT04543188|581273343|FG012|Phase 1a|Withdrawal by Subject|0|||
160968402|NCT04543188|581273344|FG013|Phase 1a|Withdrawal by Subject|0|||
160968403|NCT04543188|581273345|FG014|Phase 1a|Withdrawal by Subject|0|||
161272551|NCT00417170|582377660|FG000|Overall Study|Withdrawal by Subject|1|||
161272552|NCT00417170|582377661|FG001|Overall Study|Withdrawal by Subject|1|||
161272553|NCT00417170|582377660|FG000|Overall Study|Lost to Follow-up|0|||
161272554|NCT00417170|582377661|FG001|Overall Study|Lost to Follow-up|1|||
161272555|NCT04058067|582377662|FG000|Overall Study|Adverse Event|2|||
161272556|NCT04058067|582377663|FG001|Overall Study|Adverse Event|0|||
161272557|NCT04058067|582377662|FG000|Overall Study|Death|0|||
161272558|NCT04058067|582377663|FG001|Overall Study|Death|1|||
161272559|NCT04058067|582377662|FG000|Overall Study|Physician Decision|3|||
161272560|NCT04058067|582377663|FG001|Overall Study|Physician Decision|1|||
161272561|NCT04058067|582377662|FG000|Overall Study|Protocol Violation|0|||
161272562|NCT04058067|582377663|FG001|Overall Study|Protocol Violation|1|||
161272563|NCT04058067|582377662|FG000|Overall Study|Withdrawal by Subject|7|||
160968404|NCT04543188|581273331|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
160968405|NCT04543188|581273332|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
160968406|NCT04543188|581273333|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
160968407|NCT04543188|581273334|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
160968408|NCT04543188|581273335|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
160968409|NCT04543188|581273336|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
160968410|NCT04543188|581273337|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
160968411|NCT04543188|581273338|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
160968412|NCT04543188|581273339|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
160968413|NCT04543188|581273340|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
160968414|NCT04543188|581273341|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
160968415|NCT04543188|581273342|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
160968416|NCT04543188|581273343|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
160968417|NCT04543188|581273344|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
160968418|NCT04543188|581273345|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
160968419|NCT04543188|581273331|FG000|Phase 1a|Other|0|||
160968420|NCT04543188|581273332|FG001|Phase 1a|Other|0|||
160968421|NCT04543188|581273333|FG002|Phase 1a|Other|0|||
160968422|NCT04543188|581273334|FG003|Phase 1a|Other|0|||
160968423|NCT04543188|581273335|FG004|Phase 1a|Other|0|||
160968424|NCT04543188|581273336|FG005|Phase 1a|Other|0|||
160968425|NCT04543188|581273337|FG006|Phase 1a|Other|0|||
160968426|NCT04543188|581273338|FG007|Phase 1a|Other|0|||
160968427|NCT04543188|581273339|FG008|Phase 1a|Other|0|||
160968428|NCT04543188|581273340|FG009|Phase 1a|Other|1|||
160968429|NCT04543188|581273341|FG010|Phase 1a|Other|0|||
160968430|NCT04543188|581273342|FG011|Phase 1a|Other|0|||
160968431|NCT04543188|581273343|FG012|Phase 1a|Other|0|||
160968432|NCT04543188|581273344|FG013|Phase 1a|Other|0|||
160968433|NCT04543188|581273345|FG014|Phase 1a|Other|0|||
160968434|NCT04543188|581273331|FG000|Phase 1b|Adverse Event|0|||
160968435|NCT04543188|581273332|FG001|Phase 1b|Adverse Event|0|||
160968436|NCT04543188|581273333|FG002|Phase 1b|Adverse Event|0|||
160968437|NCT04543188|581273334|FG003|Phase 1b|Adverse Event|0|||
160968438|NCT04543188|581273335|FG004|Phase 1b|Adverse Event|0|||
160968439|NCT04543188|581273336|FG005|Phase 1b|Adverse Event|0|||
160968440|NCT04543188|581273337|FG006|Phase 1b|Adverse Event|0|||
160968441|NCT04543188|581273338|FG007|Phase 1b|Adverse Event|0|||
160968442|NCT04543188|581273339|FG008|Phase 1b|Adverse Event|0|||
160968443|NCT04543188|581273340|FG009|Phase 1b|Adverse Event|0|||
160968444|NCT04543188|581273341|FG010|Phase 1b|Adverse Event|0|||
160968445|NCT04543188|581273342|FG011|Phase 1b|Adverse Event|0|||
160968446|NCT04543188|581273343|FG012|Phase 1b|Adverse Event|0|||
160968447|NCT04543188|581273344|FG013|Phase 1b|Adverse Event|0|||
160968448|NCT04543188|581273345|FG014|Phase 1b|Adverse Event|2|||
160968449|NCT04543188|581273331|FG000|Phase 1b|Other (Death)|0|||
160968450|NCT04543188|581273332|FG001|Phase 1b|Other (Death)|0|||
160968451|NCT04543188|581273333|FG002|Phase 1b|Other (Death)|0|||
160968452|NCT04543188|581273334|FG003|Phase 1b|Other (Death)|0|||
160968453|NCT04543188|581273335|FG004|Phase 1b|Other (Death)|0|||
160968454|NCT04543188|581273336|FG005|Phase 1b|Other (Death)|0|||
160968455|NCT04543188|581273337|FG006|Phase 1b|Other (Death)|0|||
160968456|NCT04543188|581273338|FG007|Phase 1b|Other (Death)|0|||
160968457|NCT04543188|581273339|FG008|Phase 1b|Other (Death)|0|||
161014983|NCT04093752|581443501|FG000|Overall Study|Covid 19|0|||
161272564|NCT04058067|582377663|FG001|Overall Study|Withdrawal by Subject|8|||
160968458|NCT04543188|581273340|FG009|Phase 1b|Other (Death)|0|||
160968459|NCT04543188|581273341|FG010|Phase 1b|Other (Death)|0|||
160968460|NCT04543188|581273342|FG011|Phase 1b|Other (Death)|0|||
160968461|NCT04543188|581273343|FG012|Phase 1b|Other (Death)|1|||
160968462|NCT04543188|581273344|FG013|Phase 1b|Other (Death)|0|||
160968463|NCT04543188|581273345|FG014|Phase 1b|Other (Death)|1|||
160968464|NCT04543188|581273331|FG000|Phase 1b|Progressive Disease|0|||
160968465|NCT04543188|581273332|FG001|Phase 1b|Progressive Disease|0|||
160968466|NCT04543188|581273333|FG002|Phase 1b|Progressive Disease|0|||
160968467|NCT04543188|581273334|FG003|Phase 1b|Progressive Disease|0|||
160968468|NCT04543188|581273335|FG004|Phase 1b|Progressive Disease|0|||
160968469|NCT04543188|581273336|FG005|Phase 1b|Progressive Disease|0|||
160968470|NCT04543188|581273337|FG006|Phase 1b|Progressive Disease|0|||
160968471|NCT04543188|581273338|FG007|Phase 1b|Progressive Disease|0|||
161014984|NCT04093752|581443502|FG001|Overall Study|Covid 19|0|||
161014985|NCT04093752|581443503|FG002|Overall Study|Covid 19|0|||
161014986|NCT04093752|581443504|FG003|Overall Study|Covid 19|1|||
161014987|NCT04093752|581443501|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161014988|NCT04093752|581443502|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161014989|NCT04093752|581443503|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
161014990|NCT04093752|581443504|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
161014991|NCT04093752|581443501|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
161014992|NCT04093752|581443502|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
161014993|NCT04093752|581443503|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
161014994|NCT04093752|581443504|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
161014995|NCT04093752|581443501|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
161147915|NCT00641043|581924464|FG000|Overall Study|Lost to Follow-up|3|||
161147916|NCT00641043|581924465|FG001|Overall Study|Lost to Follow-up|2|||
161147917|NCT00641043|581924464|FG000|Overall Study|Withdrawal by Subject|4|||
161147918|NCT00641043|581924465|FG001|Overall Study|Withdrawal by Subject|4|||
161147919|NCT00641043|581924464|FG000|Overall Study|Other incl. lack of efficacy|4|||
161147920|NCT00641043|581924465|FG001|Overall Study|Other incl. lack of efficacy|2|||
161147921|NCT03515538|581924466|FG000|Overall Study|Lack of Efficacy|2|||
161272565|NCT01844856|582377666|FG000|Overall Study|Lost to Follow-up|15|||
161272566|NCT01844856|582377667|FG001|Overall Study|Lost to Follow-up|3|||
161272567|NCT01844856|582377666|FG000|Overall Study|Adverse Event|3|||
160968472|NCT04543188|581273339|FG008|Phase 1b|Progressive Disease|0|||
160968473|NCT04543188|581273340|FG009|Phase 1b|Progressive Disease|0|||
160968474|NCT04543188|581273341|FG010|Phase 1b|Progressive Disease|0|||
160968475|NCT04543188|581273342|FG011|Phase 1b|Progressive Disease|0|||
160968476|NCT04543188|581273343|FG012|Phase 1b|Progressive Disease|2|||
160968477|NCT04543188|581273344|FG013|Phase 1b|Progressive Disease|1|||
160968478|NCT04543188|581273345|FG014|Phase 1b|Progressive Disease|5|||
160968479|NCT04543188|581273331|FG000|Phase 1b|Study Terminated By Sponsor|0|||
160968480|NCT04543188|581273332|FG001|Phase 1b|Study Terminated By Sponsor|0|||
160968481|NCT04543188|581273333|FG002|Phase 1b|Study Terminated By Sponsor|0|||
160968482|NCT04543188|581273334|FG003|Phase 1b|Study Terminated By Sponsor|0|||
160968483|NCT04543188|581273335|FG004|Phase 1b|Study Terminated By Sponsor|0|||
160968484|NCT04543188|581273336|FG005|Phase 1b|Study Terminated By Sponsor|0|||
160968485|NCT04543188|581273337|FG006|Phase 1b|Study Terminated By Sponsor|0|||
160968486|NCT04543188|581273338|FG007|Phase 1b|Study Terminated By Sponsor|0|||
160968487|NCT04543188|581273339|FG008|Phase 1b|Study Terminated By Sponsor|0|||
160968488|NCT04543188|581273340|FG009|Phase 1b|Study Terminated By Sponsor|0|||
160968489|NCT04543188|581273341|FG010|Phase 1b|Study Terminated By Sponsor|0|||
160968490|NCT04543188|581273342|FG011|Phase 1b|Study Terminated By Sponsor|1|||
160968491|NCT04543188|581273343|FG012|Phase 1b|Study Terminated By Sponsor|1|||
160968492|NCT04543188|581273344|FG013|Phase 1b|Study Terminated By Sponsor|0|||
160968493|NCT04543188|581273345|FG014|Phase 1b|Study Terminated By Sponsor|1|||
160968494|NCT04543188|581273331|FG000|Phase 1b|Withdrawal by Subject|0|||
160968495|NCT04543188|581273332|FG001|Phase 1b|Withdrawal by Subject|0|||
160968496|NCT04543188|581273333|FG002|Phase 1b|Withdrawal by Subject|0|||
160968497|NCT04543188|581273334|FG003|Phase 1b|Withdrawal by Subject|0|||
160968498|NCT04543188|581273335|FG004|Phase 1b|Withdrawal by Subject|0|||
160968499|NCT04543188|581273336|FG005|Phase 1b|Withdrawal by Subject|0|||
160968500|NCT04543188|581273337|FG006|Phase 1b|Withdrawal by Subject|0|||
160968501|NCT04543188|581273338|FG007|Phase 1b|Withdrawal by Subject|0|||
160968502|NCT04543188|581273339|FG008|Phase 1b|Withdrawal by Subject|0|||
160968503|NCT04543188|581273340|FG009|Phase 1b|Withdrawal by Subject|0|||
160968504|NCT04543188|581273341|FG010|Phase 1b|Withdrawal by Subject|0|||
160968505|NCT04543188|581273342|FG011|Phase 1b|Withdrawal by Subject|0|||
160968506|NCT04543188|581273343|FG012|Phase 1b|Withdrawal by Subject|0|||
160968507|NCT04543188|581273344|FG013|Phase 1b|Withdrawal by Subject|0|||
160968508|NCT04543188|581273345|FG014|Phase 1b|Withdrawal by Subject|2|||
160968509|NCT03815019|581273346|FG000|Overall Study|Withdrawal by Subject|6|||
160968510|NCT03815019|581273347|FG001|Overall Study|Withdrawal by Subject|8|||
160968511|NCT04270747|581273349|FG000|Through Week 16|Adverse Event|1|||
160968512|NCT04270747|581273350|FG001|Through Week 16|Adverse Event|2|||
160968513|NCT04270747|581273351|FG002|Through Week 16|Adverse Event|0|||
160968514|NCT04270747|581273349|FG000|Through Week 16|Death|0|||
160968515|NCT04270747|581273350|FG001|Through Week 16|Death|2|||
160968516|NCT04270747|581273351|FG002|Through Week 16|Death|0|||
160968517|NCT04270747|581273349|FG000|Through Week 16|Consent Withdrawn|3|||
160968518|NCT04270747|581273350|FG001|Through Week 16|Consent Withdrawn|3|||
160968519|NCT04270747|581273351|FG002|Through Week 16|Consent Withdrawn|0|||
160968520|NCT04270747|581273349|FG000|Through Week 16|Physician Decision|1|||
160968521|NCT04270747|581273350|FG001|Through Week 16|Physician Decision|1|||
161147922|NCT03515538|581924467|FG001|Overall Study|Lack of Efficacy|0|||
161147923|NCT03515538|581924468|FG002|Overall Study|Lack of Efficacy|2|||
161147924|NCT03515538|581924469|FG003|Overall Study|Lack of Efficacy|0|||
161272568|NCT01844856|582377667|FG001|Overall Study|Adverse Event|6|||
160968522|NCT04270747|581273351|FG002|Through Week 16|Physician Decision|0|||
160968523|NCT04270747|581273349|FG000|Through Week 16|Lost to Follow-up|2|||
161014996|NCT04093752|581443502|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
161014997|NCT04093752|581443503|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
161014998|NCT04093752|581443504|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
161014999|NCT04838613|581443508|FG000|Overall Study|Withdrawal by Subject|3|||
161015000|NCT04838613|581443509|FG001|Overall Study|Withdrawal by Subject|6|||
161015001|NCT04838613|581443508|FG000|Overall Study|Protocol Deviation|3|||
161015002|NCT04838613|581443509|FG001|Overall Study|Protocol Deviation|2|||
161015003|NCT04838613|581443508|FG000|Overall Study|Technical Problems|0|||
161015004|NCT04838613|581443509|FG001|Overall Study|Technical Problems|5|||
161015005|NCT04838613|581443508|FG000|Overall Study|Physician Decision|2|||
161015006|NCT04838613|581443509|FG001|Overall Study|Physician Decision|0|||
161015007|NCT04854096|581443510|FG000|Overall Study|Adverse Event|1|||
161015008|NCT04854096|581443511|FG001|Overall Study|Adverse Event|0|||
161015009|NCT04854096|581443510|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
161015010|NCT04854096|581443511|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
161015011|NCT04854096|581443510|FG000|Overall Study|Withdrawal by Subject|1|||
161015012|NCT04854096|581443511|FG001|Overall Study|Withdrawal by Subject|0|||
161015013|NCT04854096|581443510|FG000|Overall Study|Other reasons|1|||
161015014|NCT04854096|581443511|FG001|Overall Study|Other reasons|0|||
161015015|NCT04757610|581443512|FG000|Overall Study|Adverse Event|13|||
161015016|NCT04757610|581443513|FG001|Overall Study|Adverse Event|10|||
161015017|NCT04757610|581443514|FG002|Overall Study|Adverse Event|5|||
161015018|NCT04757610|581443512|FG000|Overall Study|Death|5|||
161015019|NCT04757610|581443513|FG001|Overall Study|Death|13|||
161015020|NCT04757610|581443514|FG002|Overall Study|Death|8|||
161015021|NCT04757610|581443512|FG000|Overall Study|Lack of Efficacy|1|||
161015022|NCT04757610|581443513|FG001|Overall Study|Lack of Efficacy|2|||
161015023|NCT04757610|581443514|FG002|Overall Study|Lack of Efficacy|3|||
161015024|NCT04757610|581443512|FG000|Overall Study|Lost to Follow-up|7|||
161015025|NCT04757610|581443513|FG001|Overall Study|Lost to Follow-up|2|||
161015026|NCT04757610|581443514|FG002|Overall Study|Lost to Follow-up|7|||
161015027|NCT04757610|581443512|FG000|Overall Study|Physician Decision|4|||
161015028|NCT04757610|581443513|FG001|Overall Study|Physician Decision|1|||
161015029|NCT04757610|581443514|FG002|Overall Study|Physician Decision|2|||
161015030|NCT04757610|581443512|FG000|Overall Study|Withdrawal by Subject|26|||
161015031|NCT04757610|581443513|FG001|Overall Study|Withdrawal by Subject|25|||
161015032|NCT04757610|581443514|FG002|Overall Study|Withdrawal by Subject|25|||
161015033|NCT04757610|581443512|FG000|Overall Study|Study Terminated by Sponsor|105|||
161015034|NCT04757610|581443513|FG001|Overall Study|Study Terminated by Sponsor|105|||
161015035|NCT04757610|581443514|FG002|Overall Study|Study Terminated by Sponsor|110|||
161015036|NCT04757610|581443512|FG000|Overall Study|Randomized in Error|1|||
161015037|NCT04757610|581443513|FG001|Overall Study|Randomized in Error|0|||
161015038|NCT04757610|581443514|FG002|Overall Study|Randomized in Error|0|||
161015039|NCT00901901|581443519|FG000|Treatment Period|Adverse Event|120|||
161015040|NCT00901901|581443520|FG001|Treatment Period|Adverse Event|128|||
161015041|NCT00901901|581443519|FG000|Treatment Period|Withdrawal by Subject|26|||
161015042|NCT00901901|581443520|FG001|Treatment Period|Withdrawal by Subject|24|||
161015043|NCT00901901|581443519|FG000|Treatment Period|Physician Decision|2|||
161015044|NCT00901901|581443520|FG001|Treatment Period|Physician Decision|2|||
161015045|NCT00901901|581443519|FG000|Treatment Period|Lost to Follow-up|3|||
161015046|NCT00901901|581443520|FG001|Treatment Period|Lost to Follow-up|5|||
161015047|NCT00901901|581443519|FG000|Treatment Period|Noncompliance with study medication|4|||
161015048|NCT00901901|581443520|FG001|Treatment Period|Noncompliance with study medication|1|||
161015049|NCT00901901|581443519|FG000|Treatment Period|Missing|1|||
161015050|NCT00901901|581443520|FG001|Treatment Period|Missing|0|||
161015051|NCT00901901|581443519|FG000|Treatment Period|Never treated|0|||
161015052|NCT00901901|581443520|FG001|Treatment Period|Never treated|3|||
161015053|NCT00901901|581443519|FG000|Treatment Period|Protocol driven decision point|0|||
161015054|NCT00901901|581443520|FG001|Treatment Period|Protocol driven decision point|2|||
161015055|NCT00901901|581443519|FG000|Treatment Period|Study terminated by sponsor|2|||
161015056|NCT00901901|581443520|FG001|Treatment Period|Study terminated by sponsor|0|||
161015057|NCT00901901|581443519|FG000|Treatment Period|Protocol Violation|5|||
161015058|NCT00901901|581443520|FG001|Treatment Period|Protocol Violation|9|||
161015059|NCT00901901|581443519|FG000|Treatment Period|Switch to commercial drug|1|||
161015060|NCT00901901|581443520|FG001|Treatment Period|Switch to commercial drug|1|||
161015061|NCT00901901|581443519|FG000|Treatment Period|Transfer to treatment continuation study|5|||
161015062|NCT00901901|581443520|FG001|Treatment Period|Transfer to treatment continuation study|2|||
161015063|NCT00901901|581443519|FG000|Follow-up Period|Death|181|||
161015064|NCT00901901|581443520|FG001|Follow-up Period|Death|208|||
161015065|NCT00901901|581443519|FG000|Follow-up Period|Protocol driven decision point|47|||
161015066|NCT00901901|581443520|FG001|Follow-up Period|Protocol driven decision point|36|||
161015067|NCT00901901|581443519|FG000|Follow-up Period|Withdrawal by Subject|6|||
161015068|NCT00901901|581443520|FG001|Follow-up Period|Withdrawal by Subject|9|||
161015069|NCT00901901|581443519|FG000|Follow-up Period|Lost to Follow-up|12|||
161015070|NCT00901901|581443520|FG001|Follow-up Period|Lost to Follow-up|8|||
161015071|NCT00901901|581443519|FG000|Follow-up Period|Missing|94|||
161272569|NCT01844856|582377666|FG000|Overall Study|Withdrawal by Subject|3|||
161272570|NCT01844856|582377667|FG001|Overall Study|Withdrawal by Subject|2|||
161272571|NCT01844856|582377666|FG000|Overall Study|Noncompliance|2|||
161272572|NCT01844856|582377667|FG001|Overall Study|Noncompliance|3|||
161272573|NCT01844856|582377666|FG000|Overall Study|Enterococcus Resistant|0|||
161272574|NCT01844856|582377667|FG001|Overall Study|Enterococcus Resistant|1|||
161272575|NCT01844856|582377666|FG000|Overall Study|Inadvertently Not Scheduled|1|||
161272576|NCT01844856|582377667|FG001|Overall Study|Inadvertently Not Scheduled|0|||
161272577|NCT01844856|582377666|FG000|Overall Study|Randomized but was a Screen Failure|0|||
161272578|NCT01844856|582377667|FG001|Overall Study|Randomized but was a Screen Failure|1|||
161272579|NCT01001988|582377668|FG000|Overall Study|Protocol Violation|84|||
161272580|NCT01001988|582377668|FG000|Overall Study|Withdrawal by Subject|18|||
161272581|NCT01001988|582377668|FG000|Overall Study|Lost to Follow-up|15|||
161272582|NCT01221363|582377669|FG000|Overall Study|Pregnancy|1|||
161272583|NCT01221363|582377670|FG001|Overall Study|Pregnancy|0|||
161272584|NCT01221363|582377669|FG000|Overall Study|Withdrawal by Subject|11|||
161272585|NCT01221363|582377670|FG001|Overall Study|Withdrawal by Subject|5|||
161272586|NCT04628793|582377671|FG000|Overall Study|Study terminated by sponsor|0|||
161272587|NCT04628793|582377672|FG001|Overall Study|Study terminated by sponsor|0|||
161272588|NCT04628793|582377673|FG002|Overall Study|Study terminated by sponsor|8|||
161272589|NCT04628793|582377671|FG000|Overall Study|Withdrawal by Subject|2|||
161272590|NCT04628793|582377672|FG001|Overall Study|Withdrawal by Subject|3|||
161272591|NCT04628793|582377673|FG002|Overall Study|Withdrawal by Subject|0|||
161272592|NCT04628793|582377671|FG000|Overall Study|Lost to Follow-up|0|||
161272593|NCT04628793|582377672|FG001|Overall Study|Lost to Follow-up|1|||
161272594|NCT04628793|582377673|FG002|Overall Study|Lost to Follow-up|0|||
161272595|NCT01329549|582377680|FG000|Overall Study|Withdrawal by Subject|1|||
161272596|NCT01329549|582377680|FG000|Overall Study|Adverse Event|1|||
160968524|NCT04270747|581273350|FG001|Through Week 16|Lost to Follow-up|0|||
160968525|NCT04270747|581273351|FG002|Through Week 16|Lost to Follow-up|0|||
160968526|NCT04270747|581273349|FG000|Through Week 16|Protocol Violation|1|||
160968527|NCT04270747|581273350|FG001|Through Week 16|Protocol Violation|2|||
160968528|NCT04270747|581273351|FG002|Through Week 16|Protocol Violation|0|||
160968529|NCT04270747|581273349|FG000|Through Week 16|Protocol Specified Criteria|6|||
160968530|NCT04270747|581273350|FG001|Through Week 16|Protocol Specified Criteria|7|||
160968531|NCT04270747|581273351|FG002|Through Week 16|Protocol Specified Criteria|0|||
160968532|NCT04270747|581273349|FG000|Through Week 16|Miscellaneous|1|||
160968533|NCT04270747|581273350|FG001|Through Week 16|Miscellaneous|1|||
160968534|NCT04270747|581273351|FG002|Through Week 16|Miscellaneous|0|||
160968535|NCT04270747|581273349|FG000|Post Week 16|Adverse Event|7|||
160968536|NCT04270747|581273350|FG001|Post Week 16|Adverse Event|5|||
160968537|NCT04270747|581273351|FG002|Post Week 16|Adverse Event|1|||
160968538|NCT04270747|581273349|FG000|Post Week 16|Death|2|||
160968539|NCT04270747|581273350|FG001|Post Week 16|Death|0|||
160968540|NCT04270747|581273351|FG002|Post Week 16|Death|2|||
160968541|NCT04270747|581273349|FG000|Post Week 16|Consent Withdrawn|4|||
160968542|NCT04270747|581273350|FG001|Post Week 16|Consent Withdrawn|3|||
160968543|NCT04270747|581273351|FG002|Post Week 16|Consent Withdrawn|6|||
160968544|NCT04270747|581273349|FG000|Post Week 16|Physician Decision|3|||
160968545|NCT04270747|581273350|FG001|Post Week 16|Physician Decision|1|||
160968546|NCT04270747|581273351|FG002|Post Week 16|Physician Decision|1|||
160968547|NCT04270747|581273349|FG000|Post Week 16|Lost to Follow-up|2|||
160968548|NCT04270747|581273350|FG001|Post Week 16|Lost to Follow-up|1|||
160968549|NCT04270747|581273351|FG002|Post Week 16|Lost to Follow-up|0|||
160968550|NCT04270747|581273349|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
160968551|NCT04270747|581273350|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
160968552|NCT04270747|581273351|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
160968553|NCT04270747|581273349|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
160968554|NCT04270747|581273350|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
160968555|NCT04270747|581273351|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
160968556|NCT04270747|581273349|FG000|Post Week 16|Miscellaneous|1|||
160968557|NCT04270747|581273350|FG001|Post Week 16|Miscellaneous|0|||
160968558|NCT04270747|581273351|FG002|Post Week 16|Miscellaneous|1|||
160968559|NCT05960097|581273352|FG000|Overall Study|Lost to Follow-up|3|||
160968560|NCT05960097|581273353|FG001|Overall Study|Lost to Follow-up|1|||
160968561|NCT05960097|581273354|FG002|Overall Study|Lost to Follow-up|1|||
161015072|NCT00901901|581443520|FG001|Follow-up Period|Missing|80|||
161272597|NCT01756079|582377681|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
160968562|NCT05960097|581273355|FG003|Overall Study|Lost to Follow-up|2|||
160968563|NCT05960097|581273356|FG004|Overall Study|Lost to Follow-up|1|||
160968564|NCT05960097|581273357|FG005|Overall Study|Lost to Follow-up|1|||
160968565|NCT05960097|581273358|FG006|Overall Study|Lost to Follow-up|2|||
160968566|NCT05960097|581273359|FG007|Overall Study|Lost to Follow-up|3|||
160968567|NCT05960097|581273352|FG000|Overall Study|Physician Decision|0|||
160968568|NCT05960097|581273353|FG001|Overall Study|Physician Decision|0|||
160968569|NCT05960097|581273354|FG002|Overall Study|Physician Decision|0|||
161272598|NCT01756079|582377681|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
161015073|NCT00951379|581443521|FG000|Overall Study|Adverse Event|4|||
161015074|NCT00951379|581443522|FG001|Overall Study|Adverse Event|1|||
161015075|NCT00951379|581443521|FG000|Overall Study|Withdrawal by Subject|1|||
161015076|NCT00951379|581443522|FG001|Overall Study|Withdrawal by Subject|0|||
161015077|NCT00951379|581443521|FG000|Overall Study|Noncompliance|1|||
161015078|NCT00951379|581443522|FG001|Overall Study|Noncompliance|0|||
161015079|NCT00951379|581443521|FG000|Overall Study|Disease Progression|0|||
161015080|NCT00951379|581443522|FG001|Overall Study|Disease Progression|1|||
161015081|NCT02742519|581443525|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
161015082|NCT02742519|581443526|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
161015083|NCT02742519|581443527|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
161015084|NCT02742519|581443525|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
161015085|NCT02742519|581443526|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
161015086|NCT02742519|581443527|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
161015087|NCT02742519|581443525|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
161015088|NCT02742519|581443526|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
161015089|NCT02742519|581443527|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
161015090|NCT03432858|581443529|FG000|Overall Study|Protocol Violation|2|||
161015091|NCT03432858|581443530|FG001|Overall Study|Protocol Violation|1|||
161015092|NCT03432858|581443531|FG002|Overall Study|Protocol Violation|9|||
161015093|NCT03432858|581443529|FG000|Overall Study|Withdrawal by Subject|0|||
161015094|NCT03432858|581443530|FG001|Overall Study|Withdrawal by Subject|1|||
161015095|NCT03432858|581443531|FG002|Overall Study|Withdrawal by Subject|1|||
161015096|NCT03432858|581443529|FG000|Overall Study|Procedure canceled/rescheduled|0|||
161015097|NCT03432858|581443530|FG001|Overall Study|Procedure canceled/rescheduled|9|||
161015098|NCT03432858|581443531|FG002|Overall Study|Procedure canceled/rescheduled|6|||
161015099|NCT03432858|581443529|FG000|Overall Study|Required postop mobilization with splinting|0|||
161015100|NCT03432858|581443530|FG001|Overall Study|Required postop mobilization with splinting|0|||
161015101|NCT03432858|581443531|FG002|Overall Study|Required postop mobilization with splinting|1|||
161015102|NCT01872078|581443533|FG000|Overall Study|Adverse Event|0|||
161015103|NCT01872078|581443534|FG001|Overall Study|Adverse Event|0|||
161015104|NCT01872078|581443535|FG002|Overall Study|Adverse Event|1|||
161015105|NCT01872078|581443536|FG003|Overall Study|Adverse Event|0|||
161015106|NCT01872078|581443533|FG000|Overall Study|Dose administration non-compliance|0|||
161015107|NCT01872078|581443534|FG001|Overall Study|Dose administration non-compliance|0|||
161015108|NCT01872078|581443535|FG002|Overall Study|Dose administration non-compliance|0|||
161015109|NCT01872078|581443536|FG003|Overall Study|Dose administration non-compliance|1|||
161015110|NCT01872078|581443533|FG000|Overall Study|Protocol Violation|0|||
161015111|NCT01872078|581443534|FG001|Overall Study|Protocol Violation|0|||
161015112|NCT01872078|581443535|FG002|Overall Study|Protocol Violation|1|||
161015113|NCT01872078|581443536|FG003|Overall Study|Protocol Violation|0|||
161015114|NCT01872078|581443533|FG000|Overall Study|Withdrawal by Subject|0|||
161015115|NCT01872078|581443534|FG001|Overall Study|Withdrawal by Subject|0|||
161015116|NCT01872078|581443535|FG002|Overall Study|Withdrawal by Subject|1|||
161015117|NCT01872078|581443536|FG003|Overall Study|Withdrawal by Subject|0|||
161015118|NCT01872078|581443533|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
161015119|NCT01872078|581443534|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
161015120|NCT01872078|581443535|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
161015121|NCT01872078|581443536|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
161015122|NCT03978637|581443542|FG000|Overall Study|Death|0|||
161015123|NCT03978637|581443543|FG001|Overall Study|Death|2|||
161015124|NCT03978637|581443544|FG002|Overall Study|Death|2|||
161015125|NCT03978637|581443545|FG003|Overall Study|Death|0|||
161015126|NCT03978637|581443542|FG000|Overall Study|Withdrawal by Subject|0|||
161015127|NCT03978637|581443543|FG001|Overall Study|Withdrawal by Subject|0|||
161015128|NCT03978637|581443544|FG002|Overall Study|Withdrawal by Subject|1|||
161015129|NCT03978637|581443545|FG003|Overall Study|Withdrawal by Subject|0|||
161015130|NCT03978637|581443542|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
161015131|NCT03978637|581443543|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
161015132|NCT03978637|581443544|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
161015133|NCT03978637|581443545|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
161015134|NCT01959698|581443546|FG000|Overall Study|Adverse Event|0|||
161147925|NCT03515538|581924466|FG000|Overall Study|Death|0|||
161015135|NCT01959698|581443547|FG001|Overall Study|Adverse Event|0|||
161015136|NCT01959698|581443548|FG002|Overall Study|Adverse Event|0|||
161015137|NCT01959698|581443549|FG003|Overall Study|Adverse Event|0|||
161015138|NCT01959698|581443550|FG004|Overall Study|Adverse Event|0|||
161015139|NCT01959698|581443551|FG005|Overall Study|Adverse Event|0|||
161015140|NCT01959698|581443552|FG006|Overall Study|Adverse Event|1|||
161015141|NCT01959698|581443546|FG000|Overall Study|Physician Decision|1|||
161015142|NCT01959698|581443547|FG001|Overall Study|Physician Decision|0|||
161147926|NCT03515538|581924467|FG001|Overall Study|Death|0|||
161147927|NCT03515538|581924468|FG002|Overall Study|Death|1|||
161147928|NCT03515538|581924469|FG003|Overall Study|Death|0|||
161272599|NCT01756079|582377681|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
161272600|NCT01756079|582377681|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
161272601|NCT01756079|582377681|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
161272602|NCT02677714|582377682|FG000|Overall Study|Withdrawal by Subject|2|||
161272603|NCT02677714|582377683|FG001|Overall Study|Withdrawal by Subject|0|||
161272604|NCT03421730|582377684|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272605|NCT03421730|582377685|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
161272606|NCT03421730|582377686|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272607|NCT03421730|582377687|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272608|NCT03421730|582377688|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272609|NCT03421730|582377689|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272610|NCT03421730|582377690|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272611|NCT03421730|582377691|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272612|NCT03421730|582377692|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272613|NCT03421730|582377693|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272614|NCT03421730|582377694|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272615|NCT03421730|582377695|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
161272616|NCT03421730|582377684|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272617|NCT03421730|582377685|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272618|NCT03421730|582377686|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272619|NCT03421730|582377687|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272620|NCT03421730|582377688|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
161272621|NCT03421730|582377689|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272622|NCT03421730|582377690|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161015143|NCT01959698|581443548|FG002|Overall Study|Physician Decision|1|||
161015144|NCT01959698|581443549|FG003|Overall Study|Physician Decision|2|||
161015145|NCT01959698|581443550|FG004|Overall Study|Physician Decision|0|||
161015146|NCT01959698|581443551|FG005|Overall Study|Physician Decision|3|||
161015147|NCT01959698|581443552|FG006|Overall Study|Physician Decision|3|||
161015148|NCT03819686|581445250|FG000|Overall Study|Lost to Follow-up|2|||
161015149|NCT03819686|581445251|FG001|Overall Study|Lost to Follow-up|3|||
161015150|NCT06143670|581445252|FG000|Overall Study|Lost to Follow-up|0|||
161015151|NCT06143670|581445253|FG001|Overall Study|Lost to Follow-up|1|||
161015152|NCT06143670|581445252|FG000|Overall Study|Withdrawal by Subject|3|||
161015153|NCT06143670|581445253|FG001|Overall Study|Withdrawal by Subject|0|||
161015154|NCT03747484|581445254|FG000|Overall Study|Lack of Efficacy|0|||
161015155|NCT03747484|581445255|FG001|Overall Study|Lack of Efficacy|1|||
161015156|NCT03747484|581445256|FG002|Overall Study|Lack of Efficacy|1|||
161015157|NCT03747484|581445257|FG003|Overall Study|Lack of Efficacy|2|||
161015158|NCT03747484|581445258|FG004|Overall Study|Lack of Efficacy|2|||
161015159|NCT03625882|581445261|FG000|Overall Study|Protocol Violation|3|||
161015160|NCT05058391|581445262|FG000|Overall Study|Adverse Event|1|||
161015161|NCT03833245|581445265|FG000|Overall Study|Death|0|||
161015162|NCT03833245|581445266|FG001|Overall Study|Death|1|||
161015163|NCT03347383|581445267|FG000|Overall Study|Death|39|||
161015164|NCT03347383|581445267|FG000|Overall Study|Withdrawal by Subject|3|||
161272623|NCT03421730|582377691|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272624|NCT03421730|582377692|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272625|NCT03421730|582377693|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272626|NCT03421730|582377694|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161272627|NCT03421730|582377695|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
161015165|NCT03347383|581445267|FG000|Overall Study|Lost to Follow-up|9|||
161015166|NCT04842643|581445269|FG000|Overall Study|Physician Decision|1|||
161015167|NCT04842643|581445269|FG000|Overall Study|Other|1|||
161272628|NCT01661062|582377704|FG000|Overall Study|Completed Treatment Off Study|3|||
161343557|NCT03034967|582644415|FG003|Overall Study|Withdrawal by Subject|6|||
161015168|NCT02662062|581445271|FG000|Overall Study|Withdrawal by Subject|1|||
161015169|NCT00676715|581445272|FG000|Treatment Period (TP)|Adverse Event|0|||
161015170|NCT00676715|581445273|FG001|Treatment Period (TP)|Adverse Event|3|||
161015171|NCT00676715|581445274|FG002|Treatment Period (TP)|Adverse Event|2|||
161015172|NCT00676715|581445275|FG003|Treatment Period (TP)|Adverse Event|2|||
161015173|NCT00676715|581445272|FG000|Treatment Period (TP)|Death|0|||
161015174|NCT00676715|581445273|FG001|Treatment Period (TP)|Death|0|||
161015175|NCT00676715|581445274|FG002|Treatment Period (TP)|Death|1|||
161015176|NCT00676715|581445275|FG003|Treatment Period (TP)|Death|0|||
161015177|NCT00676715|581445272|FG000|Treatment Period (TP)|Failure to return|1|||
161015178|NCT00676715|581445273|FG001|Treatment Period (TP)|Failure to return|0|||
161147929|NCT03515538|581924466|FG000|Overall Study|Protocol Violation|0|||
161015179|NCT00676715|581445274|FG002|Treatment Period (TP)|Failure to return|0|||
161272629|NCT01661062|582377704|FG000|Overall Study|Withdrawal by Subject|2|||
161272630|NCT02387983|582377706|FG000|Overall Study|Adverse Event|4|||
161015180|NCT00676715|581445275|FG003|Treatment Period (TP)|Failure to return|0|||
161015181|NCT00676715|581445272|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161015182|NCT00676715|581445273|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161015183|NCT00676715|581445274|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
161015184|NCT00676715|581445275|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
161015185|NCT00676715|581445272|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
161015186|NCT00676715|581445273|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
161015187|NCT00676715|581445274|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
161015188|NCT00676715|581445275|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
161015189|NCT00676715|581445272|FG000|Treatment Period (TP)|Withdrew consent|3|||
161015190|NCT00676715|581445273|FG001|Treatment Period (TP)|Withdrew consent|3|||
161015191|NCT00676715|581445274|FG002|Treatment Period (TP)|Withdrew consent|3|||
161015192|NCT00676715|581445275|FG003|Treatment Period (TP)|Withdrew consent|3|||
161015193|NCT00676715|581445272|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
161015194|NCT00676715|581445273|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
161015195|NCT00676715|581445274|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
161015196|NCT00676715|581445275|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
161015197|NCT00676715|581445272|FG000|Treatment Period (TP)|Administrative|0|||
161015198|NCT00676715|581445273|FG001|Treatment Period (TP)|Administrative|0|||
161015199|NCT00676715|581445274|FG002|Treatment Period (TP)|Administrative|0|||
161015200|NCT00676715|581445275|FG003|Treatment Period (TP)|Administrative|1|||
161015201|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
161015202|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
161015203|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
161015204|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
161015205|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
161015206|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
161015207|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
161015208|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
161015209|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161015210|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161015211|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
161015212|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
161015213|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
161015214|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
161015215|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
161015216|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
161015217|NCT00676715|581445272|FG000|Treatment-free Period (TFP)|Death|1|||
161015218|NCT00676715|581445273|FG001|Treatment-free Period (TFP)|Death|1|||
161015219|NCT00676715|581445274|FG002|Treatment-free Period (TFP)|Death|1|||
161015220|NCT00676715|581445275|FG003|Treatment-free Period (TFP)|Death|0|||
161015221|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Reason not provided|3|||
161147930|NCT03515538|581924467|FG001|Overall Study|Protocol Violation|0|||
161272631|NCT02387983|582377706|FG000|Overall Study|Protocol Violation|1|||
161272632|NCT02387983|582377706|FG000|Overall Study|Withdrawal by Subject|2|||
161272633|NCT02730351|582377707|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
161272634|NCT02730351|582377708|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
161272635|NCT02730351|582377707|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
161015222|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Reason not provided|4|||
161015223|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Reason not provided|1|||
161015224|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Reason not provided|4|||
161015225|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
161015226|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
161015227|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
161015228|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
161015229|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
161015230|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
161015231|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
161015232|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
161015233|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Adverse Event|0|||
161015234|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Adverse Event|3|||
161015235|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Adverse Event|1|||
161015236|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Adverse Event|0|||
161015237|NCT00676715|581445272|FG000|Open Label Extension (OLE)|Death|2|||
161015238|NCT00676715|581445273|FG001|Open Label Extension (OLE)|Death|0|||
161015239|NCT00676715|581445274|FG002|Open Label Extension (OLE)|Death|2|||
161015240|NCT00676715|581445275|FG003|Open Label Extension (OLE)|Death|2|||
161147931|NCT03515538|581924468|FG002|Overall Study|Protocol Violation|0|||
161272636|NCT02730351|582377708|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
161343558|NCT03034967|582644416|FG004|Overall Study|Withdrawal by Subject|9|||
161272637|NCT02730351|582377707|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
161272638|NCT02730351|582377708|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
161272639|NCT02730351|582377707|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
161272640|NCT02730351|582377708|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
161272641|NCT02730351|582377707|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
161272642|NCT02730351|582377708|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
161272643|NCT06281171|582377711|FG000|Timepoint 2|Lost to Follow-up|6|||
161272644|NCT06281171|582377712|FG001|Timepoint 2|Lost to Follow-up|4|||
161272645|NCT06281171|582377711|FG000|Timepoint 3|Lost to Follow-up|0|||
161272646|NCT06281171|582377712|FG001|Timepoint 3|Lost to Follow-up|5|||
161272647|NCT01822275|582377713|FG000|Overall Study|Withdrawal by Subject|3|||
161272648|NCT01822275|582377713|FG000|Overall Study|Adverse Event|3|||
161272649|NCT01822275|582377713|FG000|Overall Study|Progression|14|||
161272650|NCT01822275|582377713|FG000|Overall Study|Physician Decision|2|||
161272651|NCT00513682|582377714|FG000|Washout Phase|Adverse Event|2|||
161272652|NCT00510289|582377715|FG000|Overall Study|Withdrawal by Subject|7|||
161272653|NCT00510289|582377715|FG000|Overall Study|Refused bone marrow biopsy|2|||
161272654|NCT00510289|582377715|FG000|Overall Study|Lost to Follow-up|1|||
161272655|NCT00510289|582377715|FG000|Overall Study|Progressed prior to starting drug|2|||
161272656|NCT03258853|582377720|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
161272657|NCT03258853|582377721|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
161272658|NCT00758680|582377724|FG000|Overall Study|Adverse Event|0|||
161272659|NCT00758680|582377725|FG001|Overall Study|Adverse Event|0|||
161272660|NCT00758680|582377726|FG002|Overall Study|Adverse Event|0|||
161343559|NCT03034967|582644417|FG005|Overall Study|Withdrawal by Subject|2|||
161343560|NCT03034967|582644412|FG000|Overall Study|Physician Decision|1|||
161015241|NCT03315754|581445291|FG000|Overall Study|COVID-19 complications leading to death|1|||
161015242|NCT03315754|581445291|FG000|Overall Study|insurance coverage issue|1|||
161015243|NCT03526861|581445306|FG000|Initial Treatment Period|Not dosed|1|||
161015244|NCT03526861|581445307|FG001|Initial Treatment Period|Not dosed|1|||
161015245|NCT03526861|581445308|FG002|Initial Treatment Period|Not dosed|1|||
161015246|NCT03526861|581445309|FG003|Initial Treatment Period|Not dosed|0|||
161015247|NCT03526861|581445310|FG004|Initial Treatment Period|Not dosed|0|||
161015248|NCT03526861|581445311|FG005|Initial Treatment Period|Not dosed|0|||
161015249|NCT03526861|581445312|FG006|Initial Treatment Period|Not dosed|0|||
161015250|NCT03526861|581445313|FG007|Initial Treatment Period|Not dosed|0|||
161015251|NCT03526861|581445314|FG008|Initial Treatment Period|Not dosed|0|||
161015252|NCT03526861|581445306|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
161015253|NCT03526861|581445307|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
161015254|NCT03526861|581445308|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
161015255|NCT03526861|581445309|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015256|NCT03526861|581445310|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015257|NCT03526861|581445311|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015258|NCT03526861|581445312|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015259|NCT03526861|581445313|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015260|NCT03526861|581445314|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015261|NCT03526861|581445306|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
161015262|NCT03526861|581445307|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
161015263|NCT03526861|581445308|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
161015264|NCT03526861|581445309|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015265|NCT03526861|581445310|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015266|NCT03526861|581445311|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015267|NCT03526861|581445312|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015268|NCT03526861|581445313|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015269|NCT03526861|581445314|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
161015270|NCT03526861|581445306|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015271|NCT03526861|581445307|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015272|NCT03526861|581445308|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015273|NCT03526861|581445309|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161015274|NCT03526861|581445310|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161272661|NCT00758680|582377727|FG003|Overall Study|Adverse Event|0|||
161272662|NCT00758680|582377728|FG004|Overall Study|Adverse Event|0|||
161272663|NCT00758680|582377729|FG005|Overall Study|Adverse Event|0|||
161272664|NCT00758680|582377730|FG006|Overall Study|Adverse Event|0|||
161272665|NCT00758680|582377731|FG007|Overall Study|Adverse Event|1|||
161343561|NCT03034967|582644413|FG001|Overall Study|Physician Decision|0|||
161147932|NCT03515538|581924469|FG003|Overall Study|Protocol Violation|1|||
161147933|NCT03515538|581924466|FG000|Overall Study|Screen failure (baseline dropout)|0|||
161343562|NCT03034967|582644414|FG002|Overall Study|Physician Decision|1|||
161343563|NCT03034967|582644415|FG003|Overall Study|Physician Decision|1|||
161015275|NCT03526861|581445311|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015276|NCT03526861|581445312|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
161015277|NCT03526861|581445313|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015278|NCT03526861|581445314|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015279|NCT03526861|581445306|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015280|NCT03526861|581445307|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015281|NCT03526861|581445308|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015282|NCT03526861|581445309|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
161015283|NCT03526861|581445310|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
161015284|NCT03526861|581445311|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
161015285|NCT03526861|581445312|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
161015286|NCT03526861|581445313|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
161015287|NCT03526861|581445314|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
161015288|NCT03526861|581445306|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015289|NCT03526861|581445307|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015290|NCT03526861|581445308|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015291|NCT03526861|581445309|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
161015292|NCT03526861|581445310|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015293|NCT03526861|581445311|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015294|NCT03526861|581445312|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015295|NCT03526861|581445313|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015296|NCT03526861|581445314|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015297|NCT03526861|581445306|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015298|NCT03526861|581445307|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015299|NCT03526861|581445308|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015300|NCT03526861|581445309|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015301|NCT03526861|581445310|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015302|NCT03526861|581445311|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015303|NCT03526861|581445312|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015304|NCT03526861|581445313|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
161015305|NCT03526861|581445314|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
161015306|NCT03526861|581445306|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015307|NCT03526861|581445307|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015308|NCT03526861|581445308|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015309|NCT03526861|581445309|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015310|NCT03526861|581445310|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015311|NCT03526861|581445311|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015312|NCT03526861|581445312|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015313|NCT03526861|581445313|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
161015314|NCT03526861|581445314|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
161147934|NCT03515538|581924467|FG001|Overall Study|Screen failure (baseline dropout)|1|||
161147935|NCT03515538|581924468|FG002|Overall Study|Screen failure (baseline dropout)|0|||
161147936|NCT03515538|581924469|FG003|Overall Study|Screen failure (baseline dropout)|0|||
161147937|NCT03515538|581924466|FG000|Overall Study|Withdrawal by Subject|2|||
161147938|NCT03515538|581924467|FG001|Overall Study|Withdrawal by Subject|2|||
161147939|NCT03515538|581924468|FG002|Overall Study|Withdrawal by Subject|1|||
161147940|NCT03515538|581924469|FG003|Overall Study|Withdrawal by Subject|3|||
161343564|NCT03034967|582644416|FG004|Overall Study|Physician Decision|1|||
161343565|NCT03034967|582644417|FG005|Overall Study|Physician Decision|0|||
161343566|NCT03034967|582644412|FG000|Overall Study|Lost to Follow-up|0|||
161015315|NCT03526861|581445306|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015316|NCT03526861|581445307|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015317|NCT03526861|581445308|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015318|NCT03526861|581445309|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015319|NCT03526861|581445310|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015320|NCT03526861|581445311|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015321|NCT03526861|581445312|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015322|NCT03526861|581445313|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
161015323|NCT03526861|581445314|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
161015324|NCT02506959|581445316|FG000|Overall Study|Physician Decision|2|||
161015325|NCT02506959|581445317|FG001|Overall Study|Physician Decision|1|||
161015326|NCT03453619|581445319|FG000|Core Study (Part A)|Physician Decision|0|||
161015327|NCT03453619|581445320|FG001|Core Study (Part A)|Physician Decision|0|||
161015328|NCT03453619|581445321|FG002|Core Study (Part A)|Physician Decision|2|||
161015329|NCT03453619|581445322|FG003|Core Study (Part A)|Physician Decision|0|||
161015330|NCT03453619|581445319|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
161015331|NCT03453619|581445320|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
161015332|NCT03453619|581445321|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
161015333|NCT03453619|581445322|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
161015334|NCT03453619|581445319|FG000|Core Study (Part A)|Other|0|||
161015335|NCT03453619|581445320|FG001|Core Study (Part A)|Other|1|||
161015336|NCT03453619|581445321|FG002|Core Study (Part A)|Other|0|||
161015337|NCT03453619|581445322|FG003|Core Study (Part A)|Other|0|||
161015338|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
161015339|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
161015340|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
161015341|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
161015342|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
161015343|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
161015344|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
161015345|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
161015346|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161015347|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161015348|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
161015349|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
161015350|NCT03453619|581445319|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
161015351|NCT03453619|581445320|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
161015352|NCT03453619|581445321|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
161015353|NCT03453619|581445322|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
161015354|NCT03932682|581445323|FG000|Overall Study|Death|1|||
161015355|NCT03932682|581445324|FG001|Overall Study|Death|2|||
161015356|NCT03932682|581445323|FG000|Overall Study|Withdrawal by Subject|37|||
161015357|NCT03932682|581445324|FG001|Overall Study|Withdrawal by Subject|45|||
161015358|NCT03932682|581445323|FG000|Overall Study|Lost to Follow-up|19|||
161015359|NCT03932682|581445324|FG001|Overall Study|Lost to Follow-up|25|||
161015360|NCT03932682|581445323|FG000|Overall Study|Protocol Violation|0|||
161015361|NCT03932682|581445324|FG001|Overall Study|Protocol Violation|2|||
161015362|NCT03932682|581445323|FG000|Overall Study|Other|9|||
161015363|NCT03932682|581445324|FG001|Overall Study|Other|23|||
161015364|NCT05470400|581445325|FG000|Overall Study|Lost to Follow-up|0|||
161015365|NCT05470400|581445326|FG001|Overall Study|Lost to Follow-up|0|||
161015366|NCT05470400|581445327|FG002|Overall Study|Lost to Follow-up|0|||
161015367|NCT05470400|581445328|FG003|Overall Study|Lost to Follow-up|0|||
161015368|NCT05470400|581445329|FG004|Overall Study|Lost to Follow-up|0|||
161015369|NCT05470400|581445330|FG005|Overall Study|Lost to Follow-up|0|||
161015370|NCT05470400|581445331|FG006|Overall Study|Lost to Follow-up|0|||
161015371|NCT05470400|581445332|FG007|Overall Study|Lost to Follow-up|1|||
161015372|NCT05470400|581445325|FG000|Overall Study|Withdrawal by Subject|1|||
161015373|NCT05470400|581445326|FG001|Overall Study|Withdrawal by Subject|0|||
161015374|NCT05470400|581445327|FG002|Overall Study|Withdrawal by Subject|0|||
161015375|NCT05470400|581445328|FG003|Overall Study|Withdrawal by Subject|0|||
161015376|NCT05470400|581445329|FG004|Overall Study|Withdrawal by Subject|0|||
161147941|NCT03515538|581924466|FG000|Overall Study|Physician Decision|1|||
161147942|NCT03515538|581924467|FG001|Overall Study|Physician Decision|0|||
161343567|NCT03034967|582644413|FG001|Overall Study|Lost to Follow-up|0|||
161147943|NCT03515538|581924468|FG002|Overall Study|Physician Decision|0|||
161015377|NCT05470400|581445330|FG005|Overall Study|Withdrawal by Subject|1|||
161015378|NCT05470400|581445331|FG006|Overall Study|Withdrawal by Subject|0|||
161015379|NCT05470400|581445332|FG007|Overall Study|Withdrawal by Subject|2|||
160968570|NCT05960097|581273355|FG003|Overall Study|Physician Decision|0|||
161015380|NCT05956002|581445333|FG000|Treatment Period 3|Adverse Event|0|||
161015381|NCT05956002|581445334|FG001|Treatment Period 3|Adverse Event|0|||
161015382|NCT05956002|581445335|FG002|Treatment Period 3|Adverse Event|1|||
161015383|NCT05956002|581445336|FG003|Treatment Period 3|Adverse Event|0|||
161015384|NCT05323084|581445340|FG000|Period 2 - Washout|Lost to Follow-up|0|||
161015385|NCT05323084|581445341|FG001|Period 2 - Washout|Lost to Follow-up|1|||
161015386|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
161015387|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
160968571|NCT05960097|581273356|FG004|Overall Study|Physician Decision|0|||
160968572|NCT05960097|581273357|FG005|Overall Study|Physician Decision|0|||
160968573|NCT05960097|581273358|FG006|Overall Study|Physician Decision|1|||
160968574|NCT05960097|581273359|FG007|Overall Study|Physician Decision|0|||
160968575|NCT05960097|581273352|FG000|Overall Study|Withdrawal by Subject|1|||
160968576|NCT05960097|581273353|FG001|Overall Study|Withdrawal by Subject|0|||
160968577|NCT05960097|581273354|FG002|Overall Study|Withdrawal by Subject|0|||
160968578|NCT05960097|581273355|FG003|Overall Study|Withdrawal by Subject|1|||
160968579|NCT05960097|581273356|FG004|Overall Study|Withdrawal by Subject|1|||
160968580|NCT05960097|581273357|FG005|Overall Study|Withdrawal by Subject|0|||
160968581|NCT05960097|581273358|FG006|Overall Study|Withdrawal by Subject|0|||
160968582|NCT05960097|581273359|FG007|Overall Study|Withdrawal by Subject|0|||
160968583|NCT05960097|581273352|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968584|NCT05960097|581273353|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968585|NCT05960097|581273354|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
160968586|NCT05960097|581273355|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968587|NCT05960097|581273356|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968588|NCT05960097|581273357|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968589|NCT05960097|581273358|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968590|NCT05960097|581273359|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
160968591|NCT00728962|581273360|FG000|Implant Placement Surgery|Adverse Event|8|||
160968592|NCT00728962|581273360|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
160968593|NCT00728962|581273360|FG000|Implant Placement Surgery|Protocol Violation|1|||
160968594|NCT00728962|581273360|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
160968595|NCT00728962|581273360|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
160968596|NCT04954586|581273361|FG000|Overall Study|Withdrawal by Subject|5|||
160968597|NCT01987817|581273373|FG000|Overall Study|Adverse Event|4|||
160968598|NCT01987817|581273374|FG001|Overall Study|Adverse Event|0|||
160968599|NCT01987817|581273373|FG000|Overall Study|Withdrawal by Subject|1|||
160968600|NCT01987817|581273374|FG001|Overall Study|Withdrawal by Subject|1|||
160968601|NCT01987817|581273373|FG000|Overall Study|Physician Decision|1|||
160968602|NCT01987817|581273374|FG001|Overall Study|Physician Decision|0|||
160968603|NCT04098250|581273377|FG000|Overall Study|Withdrawal by Subject|1|||
160968604|NCT04098250|581273378|FG001|Overall Study|Withdrawal by Subject|0|||
160968605|NCT04098250|581273377|FG000|Overall Study|Lost to Follow-up|0|||
160968606|NCT04098250|581273378|FG001|Overall Study|Lost to Follow-up|1|||
160968607|NCT00633464|581273379|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
160968608|NCT00633464|581273380|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
160968609|NCT00633464|581273379|FG000|Overall Study|Never Treated (Randomized in error)|0|||
160968610|NCT00633464|581273380|FG001|Overall Study|Never Treated (Randomized in error)|1|||
160968611|NCT06387472|581273381|FG000|Overall Study|Withdrawal by Subject|1|||
160968612|NCT06387472|581273381|FG000|Overall Study|Lost to Follow-up|2|||
160968613|NCT06387472|581273381|FG000|Overall Study|Physician Decision|1|||
160968614|NCT04182880|581273382|FG000|Overall Study|Pregnancy|1|||
160968615|NCT04182880|581273383|FG001|Overall Study|Pregnancy|0|||
160968616|NCT02036645|581273384|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968617|NCT02036645|581273385|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968618|NCT02036645|581273386|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968619|NCT02036645|581273387|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968620|NCT02036645|581273388|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968621|NCT02036645|581273389|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968622|NCT02036645|581273390|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
160968623|NCT02036645|581273391|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968624|NCT02036645|581273392|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968625|NCT02036645|581273393|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968626|NCT02036645|581273394|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968627|NCT02036645|581273395|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
160968628|NCT02036645|581273384|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968629|NCT02036645|581273385|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968630|NCT02036645|581273386|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968631|NCT02036645|581273387|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
161015388|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
161015389|NCT04294225|581445342|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
161272666|NCT00758680|582377732|FG008|Overall Study|Adverse Event|0|||
161272667|NCT00758680|582377733|FG009|Overall Study|Adverse Event|1|||
161272668|NCT00758680|582377724|FG000|Overall Study|Laboratory Adverse Event|0|||
161272669|NCT00758680|582377725|FG001|Overall Study|Laboratory Adverse Event|0|||
161272670|NCT00758680|582377726|FG002|Overall Study|Laboratory Adverse Event|0|||
161015390|NCT04294225|581445342|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
161015391|NCT04812535|581445350|FG000|Overall Study|Withdrawal by Subject|0|||
161015392|NCT04812535|581445351|FG001|Overall Study|Withdrawal by Subject|0|||
161015393|NCT04812535|581445352|FG002|Overall Study|Withdrawal by Subject|0|||
161015394|NCT04812535|581445353|FG003|Overall Study|Withdrawal by Subject|1|||
161015395|NCT04812535|581445350|FG000|Overall Study|Death|7|||
161015396|NCT04812535|581445351|FG001|Overall Study|Death|2|||
161015397|NCT04812535|581445352|FG002|Overall Study|Death|4|||
161015398|NCT04812535|581445353|FG003|Overall Study|Death|1|||
161015399|NCT04812535|581445350|FG000|Overall Study|Due to premature study termination by sponsor|2|||
161015400|NCT04812535|581445351|FG001|Overall Study|Due to premature study termination by sponsor|0|||
161015401|NCT04812535|581445352|FG002|Overall Study|Due to premature study termination by sponsor|1|||
161015402|NCT04812535|581445353|FG003|Overall Study|Due to premature study termination by sponsor|3|||
161015403|NCT03436745|581445354|FG000|Overall Study|Ineligible|0|||
161015404|NCT03436745|581445355|FG001|Overall Study|Ineligible|0|||
161015405|NCT03436745|581445356|FG002|Overall Study|Ineligible|1|||
161015406|NCT04401800|581445359|FG000|Overall Study|Death|17|||
161015407|NCT04401800|581445359|FG000|Overall Study|Lost to Follow-up|5|||
161015408|NCT04401800|581445359|FG000|Overall Study|Withdrawal by Subject|4|||
161015409|NCT04927065|581445360|FG000|First Booster|Adverse Event|1|||
161015410|NCT04927065|581445361|FG001|First Booster|Adverse Event|0|||
161015411|NCT04927065|581445362|FG002|First Booster|Adverse Event|0|||
161015412|NCT04927065|581445363|FG003|First Booster|Adverse Event|0|||
161015413|NCT04927065|581445364|FG004|First Booster|Adverse Event|0|||
161015414|NCT04927065|581445365|FG005|First Booster|Adverse Event|0|||
161015415|NCT04927065|581445366|FG006|First Booster|Adverse Event|0|||
161015416|NCT04927065|581445367|FG007|First Booster|Adverse Event|1|||
161015417|NCT04927065|581445368|FG008|First Booster|Adverse Event|0|||
161015418|NCT04927065|581445369|FG009|First Booster|Adverse Event|0|||
161015419|NCT04927065|581445370|FG010|First Booster|Adverse Event|0|||
161015420|NCT04927065|581445371|FG011|First Booster|Adverse Event|0|||
161015421|NCT04927065|581445372|FG012|First Booster|Adverse Event|0|||
161015422|NCT04927065|581445373|FG013|First Booster|Adverse Event|0|||
161015423|NCT04927065|581445374|FG014|First Booster|Adverse Event|0|||
161015424|NCT04927065|581445375|FG015|First Booster|Adverse Event|0|||
161015425|NCT04927065|581445360|FG000|First Booster|Death|1|||
161015426|NCT04927065|581445361|FG001|First Booster|Death|0|||
161015427|NCT04927065|581445362|FG002|First Booster|Death|0|||
161015428|NCT04927065|581445363|FG003|First Booster|Death|1|||
161015429|NCT04927065|581445364|FG004|First Booster|Death|0|||
161015430|NCT04927065|581445365|FG005|First Booster|Death|1|||
161015431|NCT04927065|581445366|FG006|First Booster|Death|0|||
161015432|NCT04927065|581445367|FG007|First Booster|Death|0|||
161015433|NCT04927065|581445368|FG008|First Booster|Death|0|||
161015434|NCT04927065|581445369|FG009|First Booster|Death|0|||
161015435|NCT04927065|581445370|FG010|First Booster|Death|0|||
161015436|NCT04927065|581445371|FG011|First Booster|Death|0|||
161015437|NCT04927065|581445372|FG012|First Booster|Death|0|||
161015438|NCT04927065|581445373|FG013|First Booster|Death|0|||
161015439|NCT04927065|581445374|FG014|First Booster|Death|0|||
161015440|NCT04927065|581445375|FG015|First Booster|Death|0|||
161015441|NCT04927065|581445360|FG000|First Booster|Lost to Follow-up|8|||
161015442|NCT04927065|581445361|FG001|First Booster|Lost to Follow-up|20|||
161015443|NCT04927065|581445362|FG002|First Booster|Lost to Follow-up|0|||
161015444|NCT04927065|581445363|FG003|First Booster|Lost to Follow-up|11|||
161015445|NCT04927065|581445364|FG004|First Booster|Lost to Follow-up|43|||
161272671|NCT00758680|582377727|FG003|Overall Study|Laboratory Adverse Event|0|||
161147944|NCT03515538|581924469|FG003|Overall Study|Physician Decision|1|||
161147945|NCT02225223|581924471|FG000|Overall Study|Death|10|||
161015446|NCT04927065|581445365|FG005|First Booster|Lost to Follow-up|30|||
161147946|NCT02225223|581924472|FG001|Overall Study|Death|1|||
161147947|NCT02225223|581924471|FG000|Overall Study|Lost to Follow-up|5|||
161272672|NCT00758680|582377728|FG004|Overall Study|Laboratory Adverse Event|0|||
161015447|NCT04927065|581445366|FG006|First Booster|Lost to Follow-up|28|||
161015448|NCT04927065|581445367|FG007|First Booster|Lost to Follow-up|23|||
161015449|NCT04927065|581445368|FG008|First Booster|Lost to Follow-up|4|||
161015450|NCT04927065|581445369|FG009|First Booster|Lost to Follow-up|15|||
161015451|NCT04927065|581445370|FG010|First Booster|Lost to Follow-up|0|||
161015452|NCT04927065|581445371|FG011|First Booster|Lost to Follow-up|0|||
161015453|NCT04927065|581445372|FG012|First Booster|Lost to Follow-up|0|||
161015454|NCT04927065|581445373|FG013|First Booster|Lost to Follow-up|0|||
161015455|NCT04927065|581445374|FG014|First Booster|Lost to Follow-up|0|||
161015456|NCT04927065|581445375|FG015|First Booster|Lost to Follow-up|0|||
161015457|NCT04927065|581445360|FG000|First Booster|Physician Decision|1|||
161015458|NCT04927065|581445361|FG001|First Booster|Physician Decision|0|||
161015459|NCT04927065|581445362|FG002|First Booster|Physician Decision|0|||
161272673|NCT00758680|582377729|FG005|Overall Study|Laboratory Adverse Event|0|||
161272674|NCT00758680|582377730|FG006|Overall Study|Laboratory Adverse Event|0|||
161272675|NCT00758680|582377731|FG007|Overall Study|Laboratory Adverse Event|0|||
161272676|NCT00758680|582377732|FG008|Overall Study|Laboratory Adverse Event|1|||
161272677|NCT00758680|582377733|FG009|Overall Study|Laboratory Adverse Event|0|||
161272678|NCT00758680|582377724|FG000|Overall Study|Withdrawal by Subject|0|||
161272679|NCT00758680|582377725|FG001|Overall Study|Withdrawal by Subject|0|||
161272680|NCT00758680|582377726|FG002|Overall Study|Withdrawal by Subject|0|||
160968632|NCT02036645|581273388|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968633|NCT02036645|581273389|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968634|NCT02036645|581273390|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968635|NCT02036645|581273391|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968636|NCT02036645|581273392|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968637|NCT02036645|581273393|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968638|NCT02036645|581273394|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968639|NCT02036645|581273395|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
160968640|NCT00717860|581273396|FG000|Overall Study|Clinical adverse experience|5|||
160968641|NCT00717860|581273397|FG001|Overall Study|Clinical adverse experience|9|||
160968642|NCT00717860|581273396|FG000|Overall Study|Laboratory adverse experience|2|||
160968643|NCT00717860|581273397|FG001|Overall Study|Laboratory adverse experience|2|||
160968644|NCT00717860|581273396|FG000|Overall Study|Lack of Efficacy|7|||
160968645|NCT00717860|581273397|FG001|Overall Study|Lack of Efficacy|13|||
160968646|NCT00717860|581273396|FG000|Overall Study|Discontinued for other reason|6|||
160968647|NCT00717860|581273397|FG001|Overall Study|Discontinued for other reason|1|||
160968648|NCT00717860|581273396|FG000|Overall Study|Withdrew consent|7|||
160968649|NCT00717860|581273397|FG001|Overall Study|Withdrew consent|3|||
160968650|NCT00698646|581273398|FG000|Overall Study|Adverse Event|8|||
160968651|NCT00698646|581273399|FG001|Overall Study|Adverse Event|7|||
160968652|NCT00698646|581273400|FG002|Overall Study|Adverse Event|8|||
160968653|NCT00698646|581273398|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
160968654|NCT00698646|581273399|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
160968655|NCT00698646|581273400|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
160968656|NCT00698646|581273398|FG000|Overall Study|Protocol Deviation|6|||
160968657|NCT00698646|581273399|FG001|Overall Study|Protocol Deviation|2|||
160968658|NCT00698646|581273400|FG002|Overall Study|Protocol Deviation|3|||
160968659|NCT00698646|581273398|FG000|Overall Study|Withdrawal by Subject|10|||
160968660|NCT00698646|581273399|FG001|Overall Study|Withdrawal by Subject|11|||
160968661|NCT00698646|581273400|FG002|Overall Study|Withdrawal by Subject|8|||
160968662|NCT00698646|581273398|FG000|Overall Study|Lost to Follow-up|0|||
160968663|NCT00698646|581273399|FG001|Overall Study|Lost to Follow-up|0|||
160968664|NCT00698646|581273400|FG002|Overall Study|Lost to Follow-up|2|||
160968665|NCT00698646|581273398|FG000|Overall Study|Administrative problems|1|||
160968666|NCT00698646|581273399|FG001|Overall Study|Administrative problems|0|||
160968667|NCT00698646|581273400|FG002|Overall Study|Administrative problems|1|||
160968668|NCT00279201|581273403|FG000|Initiation|Death|1|||
160968669|NCT00279201|581273404|FG001|Initiation|Death|5|||
160968670|NCT00279201|581273405|FG002|Initiation|Death|0|||
160968671|NCT00279201|581273406|FG003|Initiation|Death|0|||
160968672|NCT00279201|581273407|FG004|Initiation|Death|0|||
160968673|NCT00279201|581273408|FG005|Initiation|Death|0|||
160968674|NCT00279201|581273403|FG000|Initiation|Adverse Event|6|||
160968675|NCT00279201|581273404|FG001|Initiation|Adverse Event|15|||
160968676|NCT00279201|581273405|FG002|Initiation|Adverse Event|0|||
160968677|NCT00279201|581273406|FG003|Initiation|Adverse Event|0|||
160968678|NCT00279201|581273407|FG004|Initiation|Adverse Event|0|||
160968679|NCT00279201|581273408|FG005|Initiation|Adverse Event|0|||
160968680|NCT00279201|581273403|FG000|Initiation|Lost to Follow-up|42|||
160968681|NCT00279201|581273404|FG001|Initiation|Lost to Follow-up|41|||
160968682|NCT00279201|581273405|FG002|Initiation|Lost to Follow-up|0|||
160968683|NCT00279201|581273406|FG003|Initiation|Lost to Follow-up|0|||
160968684|NCT00279201|581273407|FG004|Initiation|Lost to Follow-up|0|||
160968685|NCT00279201|581273408|FG005|Initiation|Lost to Follow-up|0|||
160968686|NCT00279201|581273403|FG000|Initiation|Entry Criteria Exclusion|7|||
160968687|NCT00279201|581273404|FG001|Initiation|Entry Criteria Exclusion|9|||
160968688|NCT00279201|581273405|FG002|Initiation|Entry Criteria Exclusion|0|||
160968689|NCT00279201|581273406|FG003|Initiation|Entry Criteria Exclusion|0|||
160968690|NCT00279201|581273407|FG004|Initiation|Entry Criteria Exclusion|0|||
160968691|NCT00279201|581273408|FG005|Initiation|Entry Criteria Exclusion|0|||
160968692|NCT00279201|581273403|FG000|Initiation|Protocol Violation|9|||
160968693|NCT00279201|581273404|FG001|Initiation|Protocol Violation|10|||
160968694|NCT00279201|581273405|FG002|Initiation|Protocol Violation|0|||
160968695|NCT00279201|581273406|FG003|Initiation|Protocol Violation|0|||
160968696|NCT00279201|581273407|FG004|Initiation|Protocol Violation|0|||
160968697|NCT00279201|581273408|FG005|Initiation|Protocol Violation|0|||
160968698|NCT00279201|581273403|FG000|Initiation|Withdrawal by Subject|35|||
160968699|NCT00279201|581273404|FG001|Initiation|Withdrawal by Subject|41|||
161272681|NCT00758680|582377727|FG003|Overall Study|Withdrawal by Subject|0|||
160968700|NCT00279201|581273405|FG002|Initiation|Withdrawal by Subject|0|||
161015460|NCT04927065|581445363|FG003|First Booster|Physician Decision|3|||
161015461|NCT04927065|581445364|FG004|First Booster|Physician Decision|1|||
161015462|NCT04927065|581445365|FG005|First Booster|Physician Decision|1|||
161015463|NCT04927065|581445366|FG006|First Booster|Physician Decision|0|||
161015464|NCT04927065|581445367|FG007|First Booster|Physician Decision|3|||
161015465|NCT04927065|581445368|FG008|First Booster|Physician Decision|0|||
161015466|NCT04927065|581445369|FG009|First Booster|Physician Decision|0|||
161015467|NCT04927065|581445370|FG010|First Booster|Physician Decision|0|||
161015468|NCT04927065|581445371|FG011|First Booster|Physician Decision|0|||
161015469|NCT04927065|581445372|FG012|First Booster|Physician Decision|0|||
161015470|NCT04927065|581445373|FG013|First Booster|Physician Decision|0|||
161015471|NCT04927065|581445374|FG014|First Booster|Physician Decision|0|||
161015472|NCT04927065|581445375|FG015|First Booster|Physician Decision|0|||
161015473|NCT04927065|581445360|FG000|First Booster|Protocol Violation|4|||
161015474|NCT04927065|581445361|FG001|First Booster|Protocol Violation|4|||
161015475|NCT04927065|581445362|FG002|First Booster|Protocol Violation|0|||
161015476|NCT04927065|581445363|FG003|First Booster|Protocol Violation|3|||
161015477|NCT04927065|581445364|FG004|First Booster|Protocol Violation|0|||
161015478|NCT04927065|581445365|FG005|First Booster|Protocol Violation|0|||
161015479|NCT04927065|581445366|FG006|First Booster|Protocol Violation|0|||
161015480|NCT04927065|581445367|FG007|First Booster|Protocol Violation|2|||
161015481|NCT04927065|581445368|FG008|First Booster|Protocol Violation|0|||
161015482|NCT04927065|581445369|FG009|First Booster|Protocol Violation|0|||
161015483|NCT04927065|581445370|FG010|First Booster|Protocol Violation|0|||
161015484|NCT04927065|581445371|FG011|First Booster|Protocol Violation|0|||
161015485|NCT04927065|581445372|FG012|First Booster|Protocol Violation|0|||
161015486|NCT04927065|581445373|FG013|First Booster|Protocol Violation|0|||
161015487|NCT04927065|581445374|FG014|First Booster|Protocol Violation|0|||
161015488|NCT04927065|581445375|FG015|First Booster|Protocol Violation|0|||
161015489|NCT04927065|581445360|FG000|First Booster|Withdrawal by Subject|8|||
161015490|NCT04927065|581445361|FG001|First Booster|Withdrawal by Subject|23|||
161015491|NCT04927065|581445362|FG002|First Booster|Withdrawal by Subject|0|||
161015492|NCT04927065|581445363|FG003|First Booster|Withdrawal by Subject|19|||
161015493|NCT04927065|581445364|FG004|First Booster|Withdrawal by Subject|20|||
161015494|NCT04927065|581445365|FG005|First Booster|Withdrawal by Subject|15|||
161015495|NCT04927065|581445366|FG006|First Booster|Withdrawal by Subject|6|||
161015496|NCT04927065|581445367|FG007|First Booster|Withdrawal by Subject|24|||
161015497|NCT04927065|581445368|FG008|First Booster|Withdrawal by Subject|0|||
161015498|NCT04927065|581445369|FG009|First Booster|Withdrawal by Subject|4|||
161015499|NCT04927065|581445370|FG010|First Booster|Withdrawal by Subject|0|||
161015500|NCT04927065|581445371|FG011|First Booster|Withdrawal by Subject|0|||
161015501|NCT04927065|581445372|FG012|First Booster|Withdrawal by Subject|0|||
161015502|NCT04927065|581445373|FG013|First Booster|Withdrawal by Subject|0|||
161015503|NCT04927065|581445374|FG014|First Booster|Withdrawal by Subject|0|||
161015504|NCT04927065|581445375|FG015|First Booster|Withdrawal by Subject|0|||
161015505|NCT04927065|581445360|FG000|First Booster|Other Than Specified|1|||
161015506|NCT04927065|581445361|FG001|First Booster|Other Than Specified|1|||
161015507|NCT04927065|581445362|FG002|First Booster|Other Than Specified|0|||
161015508|NCT04927065|581445363|FG003|First Booster|Other Than Specified|1|||
161015509|NCT04927065|581445364|FG004|First Booster|Other Than Specified|2|||
161015510|NCT04927065|581445365|FG005|First Booster|Other Than Specified|3|||
161015511|NCT04927065|581445366|FG006|First Booster|Other Than Specified|2|||
161015512|NCT04927065|581445367|FG007|First Booster|Other Than Specified|6|||
161015513|NCT04927065|581445368|FG008|First Booster|Other Than Specified|0|||
161015514|NCT04927065|581445369|FG009|First Booster|Other Than Specified|4|||
161015515|NCT04927065|581445370|FG010|First Booster|Other Than Specified|0|||
161015516|NCT04927065|581445371|FG011|First Booster|Other Than Specified|0|||
161015517|NCT04927065|581445372|FG012|First Booster|Other Than Specified|0|||
161015518|NCT04927065|581445373|FG013|First Booster|Other Than Specified|0|||
161272682|NCT00758680|582377728|FG004|Overall Study|Withdrawal by Subject|0|||
161272683|NCT00758680|582377729|FG005|Overall Study|Withdrawal by Subject|0|||
161015519|NCT04927065|581445374|FG014|First Booster|Other Than Specified|0|||
161015520|NCT04927065|581445375|FG015|First Booster|Other Than Specified|0|||
161015521|NCT04927065|581445360|FG000|Second Booster|Death|0|||
161015522|NCT04927065|581445361|FG001|Second Booster|Death|0|||
161015523|NCT04927065|581445362|FG002|Second Booster|Death|0|||
161015524|NCT04927065|581445363|FG003|Second Booster|Death|0|||
161015525|NCT04927065|581445364|FG004|Second Booster|Death|0|||
161015526|NCT04927065|581445365|FG005|Second Booster|Death|0|||
161015527|NCT04927065|581445366|FG006|Second Booster|Death|0|||
161015528|NCT04927065|581445367|FG007|Second Booster|Death|0|||
161015529|NCT04927065|581445368|FG008|Second Booster|Death|0|||
161015530|NCT04927065|581445369|FG009|Second Booster|Death|0|||
161015531|NCT04927065|581445370|FG010|Second Booster|Death|2|||
161015532|NCT04927065|581445371|FG011|Second Booster|Death|0|||
161015533|NCT04927065|581445372|FG012|Second Booster|Death|2|||
161015534|NCT04927065|581445373|FG013|Second Booster|Death|2|||
161015535|NCT04927065|581445374|FG014|Second Booster|Death|0|||
161015536|NCT04927065|581445375|FG015|Second Booster|Death|0|||
161015537|NCT04927065|581445360|FG000|Second Booster|Lost to Follow-up|0|||
161272684|NCT00758680|582377730|FG006|Overall Study|Withdrawal by Subject|1|||
161272685|NCT00758680|582377731|FG007|Overall Study|Withdrawal by Subject|0|||
161272686|NCT00758680|582377732|FG008|Overall Study|Withdrawal by Subject|1|||
161272687|NCT00758680|582377733|FG009|Overall Study|Withdrawal by Subject|0|||
161272688|NCT00319982|582377734|FG000|Overall Study|Withdrawal by Subject|1|||
161272689|NCT00319982|582377735|FG001|Overall Study|Withdrawal by Subject|0|||
161272690|NCT03480386|582377736|FG000|Overall Study|Did not complete measures at 3-months|17|||
161272691|NCT03480386|582377737|FG001|Overall Study|Did not complete measures at 3-months|14|||
161272692|NCT03480386|582377736|FG000|Overall Study|No baseline measures|11|||
161272693|NCT03480386|582377737|FG001|Overall Study|No baseline measures|14|||
161272694|NCT03480386|582377736|FG000|Overall Study|Death|0|||
161272695|NCT03480386|582377737|FG001|Overall Study|Death|5|||
161272696|NCT03480386|582377736|FG000|Overall Study|Withdrawal by Subject|12|||
161272697|NCT03480386|582377737|FG001|Overall Study|Withdrawal by Subject|8|||
161272698|NCT03480386|582377736|FG000|Overall Study|Lost to Follow-up|2|||
161015538|NCT04927065|581445361|FG001|Second Booster|Lost to Follow-up|0|||
161015539|NCT04927065|581445362|FG002|Second Booster|Lost to Follow-up|3|||
161015540|NCT04927065|581445363|FG003|Second Booster|Lost to Follow-up|0|||
161015541|NCT04927065|581445364|FG004|Second Booster|Lost to Follow-up|0|||
161015542|NCT04927065|581445365|FG005|Second Booster|Lost to Follow-up|0|||
161015543|NCT04927065|581445366|FG006|Second Booster|Lost to Follow-up|0|||
161015544|NCT04927065|581445367|FG007|Second Booster|Lost to Follow-up|0|||
161015545|NCT04927065|581445368|FG008|Second Booster|Lost to Follow-up|0|||
161015546|NCT04927065|581445369|FG009|Second Booster|Lost to Follow-up|0|||
161015547|NCT04927065|581445370|FG010|Second Booster|Lost to Follow-up|14|||
161015548|NCT04927065|581445371|FG011|Second Booster|Lost to Follow-up|10|||
161015549|NCT04927065|581445372|FG012|Second Booster|Lost to Follow-up|13|||
161015550|NCT04927065|581445373|FG013|Second Booster|Lost to Follow-up|16|||
161015551|NCT04927065|581445374|FG014|Second Booster|Lost to Follow-up|0|||
161015552|NCT04927065|581445375|FG015|Second Booster|Lost to Follow-up|0|||
161015553|NCT04927065|581445360|FG000|Second Booster|Physician Decision|0|||
161015554|NCT04927065|581445361|FG001|Second Booster|Physician Decision|0|||
161015555|NCT04927065|581445362|FG002|Second Booster|Physician Decision|0|||
161015556|NCT04927065|581445363|FG003|Second Booster|Physician Decision|0|||
161015557|NCT04927065|581445364|FG004|Second Booster|Physician Decision|0|||
161015558|NCT04927065|581445365|FG005|Second Booster|Physician Decision|0|||
161015559|NCT04927065|581445366|FG006|Second Booster|Physician Decision|0|||
161015560|NCT04927065|581445367|FG007|Second Booster|Physician Decision|0|||
161015561|NCT04927065|581445368|FG008|Second Booster|Physician Decision|0|||
161015562|NCT04927065|581445369|FG009|Second Booster|Physician Decision|0|||
161015563|NCT04927065|581445370|FG010|Second Booster|Physician Decision|0|||
161015564|NCT04927065|581445371|FG011|Second Booster|Physician Decision|3|||
161015565|NCT04927065|581445372|FG012|Second Booster|Physician Decision|0|||
161015566|NCT04927065|581445373|FG013|Second Booster|Physician Decision|1|||
161015567|NCT04927065|581445374|FG014|Second Booster|Physician Decision|0|||
161015568|NCT04927065|581445375|FG015|Second Booster|Physician Decision|0|||
161015569|NCT04927065|581445360|FG000|Second Booster|Withdrawal by Subject|0|||
161015570|NCT04927065|581445361|FG001|Second Booster|Withdrawal by Subject|0|||
161015571|NCT04927065|581445362|FG002|Second Booster|Withdrawal by Subject|4|||
161015572|NCT04927065|581445363|FG003|Second Booster|Withdrawal by Subject|0|||
161015573|NCT04927065|581445364|FG004|Second Booster|Withdrawal by Subject|0|||
161015574|NCT04927065|581445365|FG005|Second Booster|Withdrawal by Subject|0|||
161015575|NCT04927065|581445366|FG006|Second Booster|Withdrawal by Subject|0|||
161015576|NCT04927065|581445367|FG007|Second Booster|Withdrawal by Subject|0|||
161015577|NCT04927065|581445368|FG008|Second Booster|Withdrawal by Subject|0|||
161015578|NCT04927065|581445369|FG009|Second Booster|Withdrawal by Subject|0|||
161015579|NCT04927065|581445370|FG010|Second Booster|Withdrawal by Subject|3|||
161015580|NCT04927065|581445371|FG011|Second Booster|Withdrawal by Subject|16|||
161015581|NCT04927065|581445372|FG012|Second Booster|Withdrawal by Subject|13|||
161015582|NCT04927065|581445373|FG013|Second Booster|Withdrawal by Subject|9|||
161015583|NCT04927065|581445374|FG014|Second Booster|Withdrawal by Subject|0|||
161015584|NCT04927065|581445375|FG015|Second Booster|Withdrawal by Subject|0|||
161015585|NCT04927065|581445360|FG000|Second Booster|Other Than Specified|0|||
161015586|NCT04927065|581445361|FG001|Second Booster|Other Than Specified|0|||
161015587|NCT04927065|581445362|FG002|Second Booster|Other Than Specified|0|||
161015588|NCT04927065|581445363|FG003|Second Booster|Other Than Specified|0|||
161015589|NCT04927065|581445364|FG004|Second Booster|Other Than Specified|0|||
161015590|NCT04927065|581445365|FG005|Second Booster|Other Than Specified|0|||
161015591|NCT04927065|581445366|FG006|Second Booster|Other Than Specified|0|||
161015592|NCT04927065|581445367|FG007|Second Booster|Other Than Specified|0|||
161015593|NCT04927065|581445368|FG008|Second Booster|Other Than Specified|0|||
161015594|NCT04927065|581445369|FG009|Second Booster|Other Than Specified|0|||
161272699|NCT03480386|582377737|FG001|Overall Study|Lost to Follow-up|1|||
161272700|NCT03480386|582377736|FG000|Overall Study|Complicating disease|0|||
161272701|NCT03480386|582377737|FG001|Overall Study|Complicating disease|1|||
161272702|NCT03480386|582377736|FG000|Overall Study|Disease progression|3|||
161015595|NCT04927065|581445370|FG010|Second Booster|Other Than Specified|1|||
161015596|NCT04927065|581445371|FG011|Second Booster|Other Than Specified|1|||
161272703|NCT03480386|582377737|FG001|Overall Study|Disease progression|0|||
161272704|NCT03480386|582377736|FG000|Overall Study|Became ineligible|0|||
160968701|NCT00279201|581273406|FG003|Initiation|Withdrawal by Subject|0|||
160968702|NCT00279201|581273407|FG004|Initiation|Withdrawal by Subject|0|||
160968703|NCT00279201|581273408|FG005|Initiation|Withdrawal by Subject|0|||
160968704|NCT00279201|581273403|FG000|Initiation|Physician Decision|15|||
160968705|NCT00279201|581273404|FG001|Initiation|Physician Decision|18|||
160968706|NCT00279201|581273405|FG002|Initiation|Physician Decision|0|||
160968707|NCT00279201|581273406|FG003|Initiation|Physician Decision|0|||
160968708|NCT00279201|581273407|FG004|Initiation|Physician Decision|0|||
160968709|NCT00279201|581273408|FG005|Initiation|Physician Decision|0|||
160968710|NCT00279201|581273403|FG000|Initiation|Sponsor Decision|13|||
160968711|NCT00279201|581273404|FG001|Initiation|Sponsor Decision|5|||
160968712|NCT00279201|581273405|FG002|Initiation|Sponsor Decision|0|||
160968713|NCT00279201|581273406|FG003|Initiation|Sponsor Decision|0|||
160968714|NCT00279201|581273407|FG004|Initiation|Sponsor Decision|0|||
160968715|NCT00279201|581273408|FG005|Initiation|Sponsor Decision|0|||
160968716|NCT00279201|581273403|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968717|NCT00279201|581273404|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
160968718|NCT00279201|581273405|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968719|NCT00279201|581273406|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968720|NCT00279201|581273407|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968721|NCT00279201|581273408|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
160968722|NCT00279201|581273403|FG000|Maintenance|Lack of Efficacy|32|||
160968723|NCT00279201|581273404|FG001|Maintenance|Lack of Efficacy|30|||
160968724|NCT00279201|581273405|FG002|Maintenance|Lack of Efficacy|0|||
160968725|NCT00279201|581273406|FG003|Maintenance|Lack of Efficacy|0|||
160968726|NCT00279201|581273407|FG004|Maintenance|Lack of Efficacy|0|||
160968727|NCT00279201|581273408|FG005|Maintenance|Lack of Efficacy|0|||
160968728|NCT00279201|581273403|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
160968729|NCT00279201|581273404|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
160968730|NCT00279201|581273405|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968731|NCT00279201|581273406|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968732|NCT00279201|581273407|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968733|NCT00279201|581273408|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
160968734|NCT00279201|581273403|FG000|Maintenance|Adverse Event|4|||
160968735|NCT00279201|581273404|FG001|Maintenance|Adverse Event|4|||
160968736|NCT00279201|581273405|FG002|Maintenance|Adverse Event|0|||
160968737|NCT00279201|581273406|FG003|Maintenance|Adverse Event|0|||
160968738|NCT00279201|581273407|FG004|Maintenance|Adverse Event|0|||
160968739|NCT00279201|581273408|FG005|Maintenance|Adverse Event|0|||
160968740|NCT00279201|581273403|FG000|Maintenance|Death|4|||
160968741|NCT00279201|581273404|FG001|Maintenance|Death|4|||
160968742|NCT00279201|581273405|FG002|Maintenance|Death|0|||
160968743|NCT00279201|581273406|FG003|Maintenance|Death|0|||
160968744|NCT00279201|581273407|FG004|Maintenance|Death|0|||
160968745|NCT00279201|581273408|FG005|Maintenance|Death|0|||
160968746|NCT00279201|581273403|FG000|Maintenance|Lost to Follow-up|17|||
160968747|NCT00279201|581273404|FG001|Maintenance|Lost to Follow-up|13|||
160968748|NCT00279201|581273405|FG002|Maintenance|Lost to Follow-up|0|||
160968749|NCT00279201|581273406|FG003|Maintenance|Lost to Follow-up|0|||
160968750|NCT00279201|581273407|FG004|Maintenance|Lost to Follow-up|0|||
160968751|NCT00279201|581273408|FG005|Maintenance|Lost to Follow-up|0|||
160968752|NCT00279201|581273403|FG000|Maintenance|Entry Criteria Exclusion|1|||
160968753|NCT00279201|581273404|FG001|Maintenance|Entry Criteria Exclusion|4|||
160968754|NCT00279201|581273405|FG002|Maintenance|Entry Criteria Exclusion|0|||
160968755|NCT00279201|581273406|FG003|Maintenance|Entry Criteria Exclusion|0|||
160968756|NCT00279201|581273407|FG004|Maintenance|Entry Criteria Exclusion|0|||
160968757|NCT00279201|581273408|FG005|Maintenance|Entry Criteria Exclusion|0|||
160968758|NCT00279201|581273403|FG000|Maintenance|Protocol Violation|16|||
160968759|NCT00279201|581273404|FG001|Maintenance|Protocol Violation|24|||
160968760|NCT00279201|581273405|FG002|Maintenance|Protocol Violation|0|||
160968761|NCT00279201|581273406|FG003|Maintenance|Protocol Violation|0|||
160968762|NCT00279201|581273407|FG004|Maintenance|Protocol Violation|0|||
160968763|NCT00279201|581273408|FG005|Maintenance|Protocol Violation|0|||
160968764|NCT00279201|581273403|FG000|Maintenance|Withdrawal by Subject|18|||
160968765|NCT00279201|581273404|FG001|Maintenance|Withdrawal by Subject|18|||
160968766|NCT00279201|581273405|FG002|Maintenance|Withdrawal by Subject|0|||
160968767|NCT00279201|581273406|FG003|Maintenance|Withdrawal by Subject|0|||
160968768|NCT00279201|581273407|FG004|Maintenance|Withdrawal by Subject|0|||
160968769|NCT00279201|581273408|FG005|Maintenance|Withdrawal by Subject|0|||
160968770|NCT00279201|581273403|FG000|Maintenance|Physician Decision|9|||
160968771|NCT00279201|581273404|FG001|Maintenance|Physician Decision|9|||
160968772|NCT00279201|581273405|FG002|Maintenance|Physician Decision|0|||
160968773|NCT00279201|581273406|FG003|Maintenance|Physician Decision|0|||
160968774|NCT00279201|581273407|FG004|Maintenance|Physician Decision|0|||
161147948|NCT02225223|581924472|FG001|Overall Study|Lost to Follow-up|0|||
161147949|NCT02225223|581924471|FG000|Overall Study|Other|1|||
161147950|NCT02225223|581924472|FG001|Overall Study|Other|2|||
161147951|NCT02225223|581924471|FG000|Overall Study|Physician Decision|1|||
161147952|NCT02225223|581924472|FG001|Overall Study|Physician Decision|0|||
161147953|NCT02225223|581924471|FG000|Overall Study|Withdrawal by Subject|2|||
161147954|NCT02225223|581924472|FG001|Overall Study|Withdrawal by Subject|2|||
161147955|NCT03567291|581924473|FG000|Period I|Adverse Event|14|||
161147956|NCT03567291|581924474|FG001|Period I|Adverse Event|0|||
161147957|NCT03567291|581924475|FG002|Period I|Adverse Event|0|||
161147958|NCT03567291|581924476|FG003|Period I|Adverse Event|0|||
161147959|NCT03567291|581924473|FG000|Period I|Protocol Violation|1|||
161147960|NCT03567291|581924474|FG001|Period I|Protocol Violation|0|||
161147961|NCT03567291|581924475|FG002|Period I|Protocol Violation|0|||
160968775|NCT00279201|581273408|FG005|Maintenance|Physician Decision|0|||
160968776|NCT00279201|581273403|FG000|Maintenance|Sponsor Decision|4|||
160968777|NCT00279201|581273404|FG001|Maintenance|Sponsor Decision|0|||
160968778|NCT00279201|581273405|FG002|Maintenance|Sponsor Decision|0|||
160968779|NCT00279201|581273406|FG003|Maintenance|Sponsor Decision|0|||
160968780|NCT00279201|581273407|FG004|Maintenance|Sponsor Decision|0|||
160968781|NCT00279201|581273408|FG005|Maintenance|Sponsor Decision|0|||
160968782|NCT00279201|581273403|FG000|Maintenance|HbA1c>7.5%|123|||
160968783|NCT00279201|581273404|FG001|Maintenance|HbA1c>7.5%|126|||
160968784|NCT00279201|581273405|FG002|Maintenance|HbA1c>7.5%|0|||
160968785|NCT00279201|581273406|FG003|Maintenance|HbA1c>7.5%|0|||
160968786|NCT00279201|581273407|FG004|Maintenance|HbA1c>7.5%|0|||
160968787|NCT00279201|581273408|FG005|Maintenance|HbA1c>7.5%|0|||
160968788|NCT00279201|581273403|FG000|Intensification Addendum|Withdrawal by Subject|0|||
160968789|NCT00279201|581273404|FG001|Intensification Addendum|Withdrawal by Subject|0|||
160968790|NCT00279201|581273405|FG002|Intensification Addendum|Withdrawal by Subject|12|||
160968791|NCT00279201|581273406|FG003|Intensification Addendum|Withdrawal by Subject|14|||
160968792|NCT00279201|581273407|FG004|Intensification Addendum|Withdrawal by Subject|9|||
160968793|NCT00279201|581273408|FG005|Intensification Addendum|Withdrawal by Subject|18|||
160968794|NCT00279201|581273403|FG000|Intensification Addendum|Lost to Follow-up|0|||
160968795|NCT00279201|581273404|FG001|Intensification Addendum|Lost to Follow-up|0|||
160968796|NCT00279201|581273405|FG002|Intensification Addendum|Lost to Follow-up|4|||
160968797|NCT00279201|581273406|FG003|Intensification Addendum|Lost to Follow-up|6|||
160968798|NCT00279201|581273407|FG004|Intensification Addendum|Lost to Follow-up|7|||
160968799|NCT00279201|581273408|FG005|Intensification Addendum|Lost to Follow-up|7|||
160968800|NCT00279201|581273403|FG000|Intensification Addendum|Protocol Violation|0|||
160968801|NCT00279201|581273404|FG001|Intensification Addendum|Protocol Violation|0|||
160968802|NCT00279201|581273405|FG002|Intensification Addendum|Protocol Violation|2|||
160968803|NCT00279201|581273406|FG003|Intensification Addendum|Protocol Violation|2|||
160968804|NCT00279201|581273407|FG004|Intensification Addendum|Protocol Violation|6|||
160968805|NCT00279201|581273408|FG005|Intensification Addendum|Protocol Violation|6|||
160968806|NCT00279201|581273403|FG000|Intensification Addendum|Adverse Event|0|||
160968807|NCT00279201|581273404|FG001|Intensification Addendum|Adverse Event|0|||
160968808|NCT00279201|581273405|FG002|Intensification Addendum|Adverse Event|0|||
160968809|NCT00279201|581273406|FG003|Intensification Addendum|Adverse Event|4|||
160968810|NCT00279201|581273407|FG004|Intensification Addendum|Adverse Event|1|||
160968811|NCT00279201|581273408|FG005|Intensification Addendum|Adverse Event|3|||
160968812|NCT00279201|581273403|FG000|Intensification Addendum|Physician Decision|0|||
160968813|NCT00279201|581273404|FG001|Intensification Addendum|Physician Decision|0|||
160968814|NCT00279201|581273405|FG002|Intensification Addendum|Physician Decision|4|||
160968815|NCT00279201|581273406|FG003|Intensification Addendum|Physician Decision|1|||
160968816|NCT00279201|581273407|FG004|Intensification Addendum|Physician Decision|3|||
160968817|NCT00279201|581273408|FG005|Intensification Addendum|Physician Decision|2|||
160968818|NCT00279201|581273403|FG000|Intensification Addendum|Sponsor Decision|0|||
160968819|NCT00279201|581273404|FG001|Intensification Addendum|Sponsor Decision|0|||
160968820|NCT00279201|581273405|FG002|Intensification Addendum|Sponsor Decision|0|||
160968821|NCT00279201|581273406|FG003|Intensification Addendum|Sponsor Decision|0|||
160968822|NCT00279201|581273407|FG004|Intensification Addendum|Sponsor Decision|1|||
160968823|NCT00279201|581273408|FG005|Intensification Addendum|Sponsor Decision|1|||
160968824|NCT00279201|581273403|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
160968825|NCT00279201|581273404|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
160968826|NCT00279201|581273405|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
160968827|NCT00279201|581273406|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
160968828|NCT00279201|581273407|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
160968829|NCT00279201|581273408|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
160968830|NCT00279201|581273403|FG000|Intensification Addendum|Lack of Efficacy|0|||
160968831|NCT00279201|581273404|FG001|Intensification Addendum|Lack of Efficacy|0|||
160968832|NCT00279201|581273405|FG002|Intensification Addendum|Lack of Efficacy|0|||
160968833|NCT00279201|581273406|FG003|Intensification Addendum|Lack of Efficacy|1|||
161015597|NCT04927065|581445372|FG012|Second Booster|Other Than Specified|4|||
161015598|NCT04927065|581445373|FG013|Second Booster|Other Than Specified|0|||
161015599|NCT04927065|581445374|FG014|Second Booster|Other Than Specified|0|||
161015600|NCT04927065|581445375|FG015|Second Booster|Other Than Specified|0|||
161015601|NCT04927065|581445360|FG000|Third Booster|Lost to Follow-up|0|||
161015602|NCT04927065|581445361|FG001|Third Booster|Lost to Follow-up|0|||
161015603|NCT04927065|581445362|FG002|Third Booster|Lost to Follow-up|0|||
161015604|NCT04927065|581445363|FG003|Third Booster|Lost to Follow-up|0|||
161015605|NCT04927065|581445364|FG004|Third Booster|Lost to Follow-up|0|||
161015606|NCT04927065|581445365|FG005|Third Booster|Lost to Follow-up|0|||
161015607|NCT04927065|581445366|FG006|Third Booster|Lost to Follow-up|0|||
161015608|NCT04927065|581445367|FG007|Third Booster|Lost to Follow-up|0|||
161015609|NCT04927065|581445368|FG008|Third Booster|Lost to Follow-up|0|||
161015610|NCT04927065|581445369|FG009|Third Booster|Lost to Follow-up|0|||
161015611|NCT04927065|581445370|FG010|Third Booster|Lost to Follow-up|0|||
161015612|NCT04927065|581445371|FG011|Third Booster|Lost to Follow-up|0|||
161015613|NCT04927065|581445372|FG012|Third Booster|Lost to Follow-up|0|||
161015614|NCT04927065|581445373|FG013|Third Booster|Lost to Follow-up|0|||
161015615|NCT04927065|581445374|FG014|Third Booster|Lost to Follow-up|0|||
161015616|NCT04927065|581445375|FG015|Third Booster|Lost to Follow-up|1|||
161015617|NCT04927065|581445360|FG000|Third Booster|Withdrawal by Subject|0|||
161015618|NCT04927065|581445361|FG001|Third Booster|Withdrawal by Subject|0|||
161015619|NCT04927065|581445362|FG002|Third Booster|Withdrawal by Subject|0|||
161015620|NCT04927065|581445363|FG003|Third Booster|Withdrawal by Subject|0|||
161015621|NCT04927065|581445364|FG004|Third Booster|Withdrawal by Subject|0|||
161015622|NCT04927065|581445365|FG005|Third Booster|Withdrawal by Subject|0|||
161015623|NCT04927065|581445366|FG006|Third Booster|Withdrawal by Subject|0|||
161015624|NCT04927065|581445367|FG007|Third Booster|Withdrawal by Subject|0|||
161015625|NCT04927065|581445368|FG008|Third Booster|Withdrawal by Subject|0|||
161015626|NCT04927065|581445369|FG009|Third Booster|Withdrawal by Subject|0|||
161015627|NCT04927065|581445370|FG010|Third Booster|Withdrawal by Subject|0|||
161015628|NCT04927065|581445371|FG011|Third Booster|Withdrawal by Subject|0|||
161015629|NCT04927065|581445372|FG012|Third Booster|Withdrawal by Subject|0|||
161015630|NCT04927065|581445373|FG013|Third Booster|Withdrawal by Subject|0|||
161015631|NCT04927065|581445374|FG014|Third Booster|Withdrawal by Subject|0|||
161015632|NCT04927065|581445375|FG015|Third Booster|Withdrawal by Subject|1|||
161015633|NCT03846505|581445376|FG000|Treatment Phase|Withdrawal by Subject|9|||
161015634|NCT03846505|581445377|FG001|Treatment Phase|Withdrawal by Subject|11|||
161015635|NCT03846505|581445376|FG000|Treatment Phase|Lost to Follow-up|6|||
161015636|NCT03846505|581445377|FG001|Treatment Phase|Lost to Follow-up|2|||
161015637|NCT03846505|581445376|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
161015638|NCT03846505|581445377|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
161015639|NCT03846505|581445376|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
161015640|NCT03846505|581445377|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
161015641|NCT04021602|581445384|FG000|Overall Study|Lost to Follow-up|3|||
161015642|NCT04021602|581445385|FG001|Overall Study|Lost to Follow-up|3|||
161015643|NCT04021602|581445386|FG002|Overall Study|Lost to Follow-up|1|||
161015644|NCT04021602|581445384|FG000|Overall Study|Adverse Event|1|||
161015645|NCT04021602|581445385|FG001|Overall Study|Adverse Event|0|||
161015646|NCT04021602|581445386|FG002|Overall Study|Adverse Event|1|||
161015647|NCT05592418|581445387|FG000|Overall Study|Adverse Event|1|||
161015648|NCT05592418|581445388|FG001|Overall Study|Adverse Event|0|||
161015649|NCT05592418|581445387|FG000|Overall Study|Lost to Follow-up|1|||
161015650|NCT05592418|581445388|FG001|Overall Study|Lost to Follow-up|3|||
161015651|NCT05592418|581445387|FG000|Overall Study|Withdrawal by Subject|2|||
161015652|NCT05592418|581445388|FG001|Overall Study|Withdrawal by Subject|7|||
161015653|NCT04450342|581445391|FG000|Overall Study|Adverse Event|1|||
161015654|NCT04450342|581445392|FG001|Overall Study|Adverse Event|1|||
161015655|NCT04450342|581445393|FG002|Overall Study|Adverse Event|0|||
161015656|NCT04450342|581445391|FG000|Overall Study|Device not used|1|||
161015657|NCT04450342|581445392|FG001|Overall Study|Device not used|0|||
161015658|NCT04450342|581445393|FG002|Overall Study|Device not used|0|||
161015659|NCT04450342|581445391|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
161015660|NCT04450342|581445392|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
161015661|NCT04450342|581445393|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
161015662|NCT04450342|581445391|FG000|Overall Study|Physician Decision|1|||
161015663|NCT04450342|581445392|FG001|Overall Study|Physician Decision|0|||
161015664|NCT04450342|581445393|FG002|Overall Study|Physician Decision|1|||
161015665|NCT04450342|581445391|FG000|Overall Study|Protocol Deviation|0|||
161272705|NCT03480386|582377737|FG001|Overall Study|Became ineligible|2|||
161015666|NCT04450342|581445392|FG001|Overall Study|Protocol Deviation|1|||
161015667|NCT04450342|581445393|FG002|Overall Study|Protocol Deviation|0|||
161015668|NCT04450342|581445391|FG000|Overall Study|Reoperation|1|||
161015669|NCT04450342|581445392|FG001|Overall Study|Reoperation|1|||
161015670|NCT04450342|581445393|FG002|Overall Study|Reoperation|0|||
161015671|NCT04450342|581445391|FG000|Overall Study|Screen Failures|0|||
161015672|NCT04450342|581445392|FG001|Overall Study|Screen Failures|0|||
161015673|NCT04450342|581445393|FG002|Overall Study|Screen Failures|2|||
161015674|NCT04450342|581445391|FG000|Overall Study|Site Terminated by Sponsor|1|||
161015675|NCT04450342|581445392|FG001|Overall Study|Site Terminated by Sponsor|1|||
161015676|NCT04450342|581445393|FG002|Overall Study|Site Terminated by Sponsor|1|||
161015677|NCT04450342|581445391|FG000|Overall Study|Study Terminated by Sponsor|31|||
161015678|NCT04450342|581445392|FG001|Overall Study|Study Terminated by Sponsor|29|||
161015679|NCT04450342|581445393|FG002|Overall Study|Study Terminated by Sponsor|6|||
161015680|NCT04450342|581445391|FG000|Overall Study|Withdrawal by Subject|0|||
161015681|NCT04450342|581445392|FG001|Overall Study|Withdrawal by Subject|1|||
161015682|NCT04450342|581445393|FG002|Overall Study|Withdrawal by Subject|2|||
161015683|NCT05481320|581445394|FG000|Overall Study|Withdrawal by Subject|1|||
161015684|NCT05481320|581445395|FG001|Overall Study|Withdrawal by Subject|1|||
161015685|NCT05481320|581445394|FG000|Overall Study|Care recipent passed away|0|||
161015686|NCT05481320|581445395|FG001|Overall Study|Care recipent passed away|1|||
161015687|NCT05481320|581445394|FG000|Overall Study|Out-of-window assessment|0|||
161015688|NCT05481320|581445395|FG001|Overall Study|Out-of-window assessment|1|||
161015689|NCT05481320|581445394|FG000|Overall Study|No longer a primary caregiver|3|||
161015690|NCT05481320|581445395|FG001|Overall Study|No longer a primary caregiver|0|||
161015691|NCT05481320|581445394|FG000|Overall Study|Unable to contact|1|||
161015692|NCT05481320|581445395|FG001|Overall Study|Unable to contact|0|||
161015693|NCT02923180|581445396|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
161015694|NCT02923180|581445396|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
161015695|NCT01084707|581445400|FG000|Overall Study|Withdrawal by Subject|6|||
161015696|NCT03930342|581445404|FG000|Overall Study|Lost to Follow-up|70|||
161015697|NCT03930342|581445405|FG001|Overall Study|Lost to Follow-up|77|||
161015698|NCT01091168|581445406|FG000|Overall Study|Progressive disease|250|||
161015699|NCT01091168|581445407|FG001|Overall Study|Progressive disease|234|||
161015700|NCT01091168|581445406|FG000|Overall Study|Adverse Event|21|||
161015701|NCT01091168|581445407|FG001|Overall Study|Adverse Event|24|||
161015702|NCT01091168|581445406|FG000|Overall Study|Lost to Follow-up|0|||
161015703|NCT01091168|581445407|FG001|Overall Study|Lost to Follow-up|1|||
161015704|NCT01091168|581445406|FG000|Overall Study|Physician, patient's decision, other|27|||
161015705|NCT01091168|581445407|FG001|Overall Study|Physician, patient's decision, other|37|||
161015706|NCT04774237|581445410|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015707|NCT04774237|581445411|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015708|NCT04774237|581445412|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015709|NCT04774237|581445413|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015710|NCT04774237|581445414|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
161015711|NCT04774237|581445415|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
161015712|NCT05792423|581445416|FG000|Overall Study|Withdrawal by Subject|2|||
161015713|NCT04052516|581447710|FG000|Overall Study|Withdrawal by Subject|4|||
161015714|NCT04052516|581447711|FG001|Overall Study|Withdrawal by Subject|5|||
161015715|NCT04052516|581447712|FG002|Overall Study|Withdrawal by Subject|6|||
161015716|NCT04052516|581447710|FG000|Overall Study|Adverse Event|3|||
161015717|NCT04052516|581447711|FG001|Overall Study|Adverse Event|2|||
161015718|NCT04052516|581447712|FG002|Overall Study|Adverse Event|8|||
161015719|NCT04052516|581447710|FG000|Overall Study|Lost to Follow-up|2|||
161015720|NCT04052516|581447711|FG001|Overall Study|Lost to Follow-up|5|||
161015721|NCT04052516|581447712|FG002|Overall Study|Lost to Follow-up|3|||
161015722|NCT04052516|581447710|FG000|Overall Study|Protocol Violation|1|||
161015723|NCT04052516|581447711|FG001|Overall Study|Protocol Violation|1|||
161015724|NCT04052516|581447712|FG002|Overall Study|Protocol Violation|0|||
161015725|NCT04052516|581447710|FG000|Overall Study|Death|1|||
161015726|NCT04052516|581447711|FG001|Overall Study|Death|0|||
161015727|NCT04052516|581447712|FG002|Overall Study|Death|0|||
161015728|NCT04052516|581447710|FG000|Overall Study|Physician Decision|0|||
161015729|NCT04052516|581447711|FG001|Overall Study|Physician Decision|1|||
161015730|NCT04052516|581447712|FG002|Overall Study|Physician Decision|0|||
161015731|NCT04052516|581447710|FG000|Overall Study|Pregnancy|1|||
161272706|NCT04241315|582379496|FG000|Overall Study|Withdrawal by Subject|0|||
161015732|NCT04052516|581447711|FG001|Overall Study|Pregnancy|0|||
161015733|NCT04052516|581447712|FG002|Overall Study|Pregnancy|0|||
161015734|NCT04052516|581447710|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
161015735|NCT04052516|581447711|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
161015736|NCT04052516|581447712|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
161015737|NCT04052516|581447710|FG000|Overall Study|Reason not recorded|0|||
161015738|NCT04052516|581447711|FG001|Overall Study|Reason not recorded|1|||
161015739|NCT04052516|581447712|FG002|Overall Study|Reason not recorded|0|||
161147962|NCT03567291|581924476|FG003|Period I|Protocol Violation|0|||
161147963|NCT03567291|581924473|FG000|Period I|Withdrawal by Subject|23|||
161147964|NCT03567291|581924474|FG001|Period I|Withdrawal by Subject|0|||
161147965|NCT03567291|581924475|FG002|Period I|Withdrawal by Subject|0|||
161147966|NCT03567291|581924476|FG003|Period I|Withdrawal by Subject|0|||
161147967|NCT03567291|581924473|FG000|Period I|Lost to Follow-up|2|||
161147968|NCT03567291|581924474|FG001|Period I|Lost to Follow-up|0|||
161147969|NCT03567291|581924475|FG002|Period I|Lost to Follow-up|0|||
161147970|NCT03567291|581924476|FG003|Period I|Lost to Follow-up|0|||
161147971|NCT03567291|581924473|FG000|Period I|Terminated by sponsor|44|||
161147972|NCT03567291|581924474|FG001|Period I|Terminated by sponsor|0|||
161147973|NCT03567291|581924475|FG002|Period I|Terminated by sponsor|0|||
161147974|NCT03567291|581924476|FG003|Period I|Terminated by sponsor|0|||
161147975|NCT03567291|581924473|FG000|Period I|Missing or unknown|7|||
161147976|NCT03567291|581924474|FG001|Period I|Missing or unknown|0|||
161147977|NCT03567291|581924475|FG002|Period I|Missing or unknown|0|||
161147978|NCT03567291|581924476|FG003|Period I|Missing or unknown|0|||
161147979|NCT03567291|581924473|FG000|Period II|Adverse Event|0|||
161147980|NCT03567291|581924474|FG001|Period II|Adverse Event|1|||
161015758|NCT05062265|581447727|FG000|Overall Study|Withdrawal by Subject|1|||
161015759|NCT05062265|581447728|FG001|Overall Study|Withdrawal by Subject|0|||
161015760|NCT03101904|581447732|FG000|Wash Out (10 Days)|Adverse Event|1|||
161015761|NCT03101904|581447733|FG001|Wash Out (10 Days)|Adverse Event|0|||
161015762|NCT03101904|581447732|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
161015763|NCT03101904|581447733|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
161015764|NCT04538417|581447734|FG000|Overall Study|Withdrawal by Subject|2|||
161015765|NCT01331005|581447736|FG000|Overall Study|Lost to Follow-up|2|||
161015766|NCT01331005|581447737|FG001|Overall Study|Lost to Follow-up|1|||
161015767|NCT01331005|581447736|FG000|Overall Study|Withdrawal by Subject|2|||
161015768|NCT01331005|581447737|FG001|Overall Study|Withdrawal by Subject|3|||
161015769|NCT03161379|581447738|FG000|Overall Study|Withdrawal by Subject|4|||
161015770|NCT03161379|581447738|FG000|Overall Study|disease progression during chemotherapy|5|||
161015771|NCT03161379|581447738|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
161015772|NCT03161379|581447738|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
161015773|NCT03393975|581447739|FG000|Urgent Treatment Period|Physician Decision|0|||
161015774|NCT03393975|581447740|FG001|Urgent Treatment Period|Physician Decision|0|||
161272707|NCT04241315|582379497|FG001|Overall Study|Withdrawal by Subject|1|||
161272708|NCT03047330|582379498|FG000|Sleep Block 1|Withdrawal by Subject|3|||
161272709|NCT00663026|582379505|FG000|Overall Study|Lost to Follow-up|1|||
161272710|NCT00663026|582379506|FG001|Overall Study|Lost to Follow-up|0|||
161272711|NCT00663026|582379507|FG002|Overall Study|Lost to Follow-up|0|||
161272712|NCT00663026|582379505|FG000|Overall Study|Other|1|||
161272713|NCT00663026|582379506|FG001|Overall Study|Other|2|||
161272714|NCT00663026|582379507|FG002|Overall Study|Other|0|||
161272715|NCT00663026|582379505|FG000|Overall Study|Adverse Event|0|||
161272716|NCT00663026|582379506|FG001|Overall Study|Adverse Event|2|||
161272717|NCT00663026|582379507|FG002|Overall Study|Adverse Event|3|||
161015775|NCT03393975|581447741|FG002|Urgent Treatment Period|Physician Decision|0|||
161015776|NCT03393975|581447742|FG003|Urgent Treatment Period|Physician Decision|1|||
161015777|NCT03393975|581447739|FG000|Prophylaxis Period 1|Reason not Specified|0|||
161015778|NCT03393975|581447740|FG001|Prophylaxis Period 1|Reason not Specified|1|||
161015779|NCT03393975|581447741|FG002|Prophylaxis Period 1|Reason not Specified|0|||
161015780|NCT03393975|581447742|FG003|Prophylaxis Period 1|Reason not Specified|0|||
161015781|NCT03393975|581447739|FG000|Prophylaxis Period 2|Reason not Specified|0|||
161015782|NCT03393975|581447740|FG001|Prophylaxis Period 2|Reason not Specified|1|||
161015783|NCT03393975|581447741|FG002|Prophylaxis Period 2|Reason not Specified|0|||
161015784|NCT03393975|581447742|FG003|Prophylaxis Period 2|Reason not Specified|0|||
161015785|NCT01140880|581447745|FG000|Overall Study|Death|0|||
161015786|NCT01140880|581447746|FG001|Overall Study|Death|1|||
161015787|NCT01140880|581447745|FG000|Overall Study|Withdrawal by Subject|6|||
161015788|NCT01140880|581447746|FG001|Overall Study|Withdrawal by Subject|3|||
161147981|NCT03567291|581924475|FG002|Period II|Adverse Event|0|||
161147982|NCT03567291|581924476|FG003|Period II|Adverse Event|0|||
161147983|NCT03567291|581924473|FG000|Period II|Missing or unknown|0|||
161147984|NCT03567291|581924474|FG001|Period II|Missing or unknown|2|||
161147985|NCT03567291|581924475|FG002|Period II|Missing or unknown|1|||
161147986|NCT03567291|581924476|FG003|Period II|Missing or unknown|0|||
161147987|NCT03567291|581924473|FG000|Period III|Adverse Event|0|||
161147988|NCT03567291|581924474|FG001|Period III|Adverse Event|0|||
161147989|NCT03567291|581924475|FG002|Period III|Adverse Event|0|||
161147990|NCT03567291|581924476|FG003|Period III|Adverse Event|4|||
161147991|NCT03567291|581924473|FG000|Period III|Withdrawal by Subject|0|||
161147992|NCT03567291|581924474|FG001|Period III|Withdrawal by Subject|0|||
161147993|NCT03567291|581924475|FG002|Period III|Withdrawal by Subject|0|||
161147994|NCT03567291|581924476|FG003|Period III|Withdrawal by Subject|4|||
161147995|NCT03567291|581924473|FG000|Period III|Lost to Follow-up|0|||
161147996|NCT03567291|581924474|FG001|Period III|Lost to Follow-up|0|||
161272718|NCT00663026|582379505|FG000|Overall Study|Caregiver Request|0|||
161015789|NCT01140880|581447745|FG000|Overall Study|Lost to Follow-up|8|||
161015790|NCT01140880|581447746|FG001|Overall Study|Lost to Follow-up|10|||
161015791|NCT01140880|581447745|FG000|Overall Study|Protocol Violation|0|||
161015792|NCT01140880|581447746|FG001|Overall Study|Protocol Violation|30|||
161147997|NCT03567291|581924475|FG002|Period III|Lost to Follow-up|0|||
161147998|NCT03567291|581924476|FG003|Period III|Lost to Follow-up|1|||
161147999|NCT03567291|581924473|FG000|Period III|Terminated by sponsor|0|||
161272719|NCT00663026|582379506|FG001|Overall Study|Caregiver Request|2|||
161272720|NCT00663026|582379507|FG002|Overall Study|Caregiver Request|0|||
161272721|NCT00663026|582379505|FG000|Overall Study|Withdrawal by Subject|0|||
161015793|NCT03779204|581447747|FG000|Overall Study|Lost to Follow-up|2|||
161015794|NCT03779204|581447748|FG001|Overall Study|Lost to Follow-up|0|||
161015795|NCT04258709|581447749|FG000|Overall Study|Lost to Follow-up|10|||
161015796|NCT04258709|581447750|FG001|Overall Study|Lost to Follow-up|4|||
161015797|NCT04258709|581447749|FG000|Overall Study|Withdrawal by Subject|1|||
161015798|NCT04258709|581447750|FG001|Overall Study|Withdrawal by Subject|0|||
161015799|NCT04258709|581447749|FG000|Overall Study|Fetal demise|0|||
161015800|NCT04258709|581447750|FG001|Overall Study|Fetal demise|1|||
161015801|NCT04258709|581447749|FG000|Overall Study|Protocol Violation|1|||
161015802|NCT04258709|581447750|FG001|Overall Study|Protocol Violation|1|||
161015803|NCT02592330|581447751|FG000|Overall Study|Withdrawal by Subject|1|||
161015804|NCT02592330|581447752|FG001|Overall Study|Withdrawal by Subject|0|||
161015805|NCT02592330|581447751|FG000|Overall Study|Failed Biopsy|1|||
161015806|NCT02592330|581447752|FG001|Overall Study|Failed Biopsy|0|||
161015807|NCT03958955|581447753|FG000|Overall Study|Adverse Event|1|||
161015808|NCT02807636|581447754|FG000|Overall Study|Lost to Follow-up|10|||
161015809|NCT02807636|581447755|FG001|Overall Study|Lost to Follow-up|13|||
161015810|NCT02807636|581447756|FG002|Overall Study|Lost to Follow-up|6|||
161015811|NCT02807636|581447754|FG000|Overall Study|Protocol Deviation|1|||
161015812|NCT02807636|581447755|FG001|Overall Study|Protocol Deviation|0|||
161015813|NCT02807636|581447756|FG002|Overall Study|Protocol Deviation|0|||
161015814|NCT02807636|581447754|FG000|Overall Study|Symptomatic Deterioration|0|||
161015815|NCT02807636|581447755|FG001|Overall Study|Symptomatic Deterioration|1|||
161015816|NCT02807636|581447756|FG002|Overall Study|Symptomatic Deterioration|0|||
161015817|NCT02807636|581447754|FG000|Overall Study|Withdrawal by Subject|39|||
161015818|NCT02807636|581447755|FG001|Overall Study|Withdrawal by Subject|28|||
161015819|NCT02807636|581447756|FG002|Overall Study|Withdrawal by Subject|24|||
161015820|NCT02807636|581447754|FG000|Overall Study|Death|303|||
161015821|NCT02807636|581447755|FG001|Overall Study|Death|332|||
161015822|NCT02807636|581447756|FG002|Overall Study|Death|272|||
161015823|NCT02807636|581447754|FG000|Overall Study|Study Terminated By Sponsor|47|||
161015824|NCT02807636|581447755|FG001|Overall Study|Study Terminated By Sponsor|76|||
161015825|NCT02807636|581447756|FG002|Overall Study|Study Terminated By Sponsor|60|||
161015826|NCT02807636|581447754|FG000|Overall Study|Physician Decision|0|||
161015827|NCT02807636|581447755|FG001|Overall Study|Physician Decision|1|||
161015828|NCT02807636|581447756|FG002|Overall Study|Physician Decision|0|||
161015829|NCT05337748|581447760|FG000|Overall Study|Withdrawal by Subject|1|||
161015830|NCT05337748|581447761|FG001|Overall Study|Withdrawal by Subject|0|||
161015831|NCT05337748|581447760|FG000|Overall Study|Death|1|||
161015832|NCT05337748|581447761|FG001|Overall Study|Death|0|||
161015833|NCT04089371|581447764|FG000|Overall Study|Withdrawal by Subject|0|||
161015834|NCT04089371|581447765|FG001|Overall Study|Withdrawal by Subject|1|||
161015835|NCT04089371|581447764|FG000|Overall Study|Study terminated early|0|||
161015836|NCT04089371|581447765|FG001|Overall Study|Study terminated early|9|||
161015837|NCT04382898|581447766|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
161015838|NCT04382898|581447767|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015839|NCT04382898|581447768|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015840|NCT04382898|581447769|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015841|NCT04382898|581447770|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
161015842|NCT04382898|581447766|FG000|Part 1: Dose Titration|Death|6|||
161015843|NCT04382898|581447767|FG001|Part 1: Dose Titration|Death|0|||
161015844|NCT04382898|581447768|FG002|Part 1: Dose Titration|Death|0|||
161015845|NCT04382898|581447769|FG003|Part 1: Dose Titration|Death|0|||
161015846|NCT04382898|581447770|FG004|Part 1: Dose Titration|Death|0|||
161015847|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015848|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015849|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
161015850|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015851|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
161015852|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015853|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015854|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
161015855|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015856|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
161015857|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Death|0|||
161015858|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Death|17|||
161015859|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Death|13|||
161015860|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Death|1|||
161015861|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Death|0|||
161343568|NCT03034967|582644414|FG002|Overall Study|Lost to Follow-up|0|||
161015862|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
161015863|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
161015864|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
161015865|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
161015866|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
161015867|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161015868|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161015869|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161015870|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
161015871|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
161015872|NCT04382898|581447766|FG000|Part 2: Dose Expansion|Other|0|||
161015873|NCT04382898|581447767|FG001|Part 2: Dose Expansion|Other|0|||
161015874|NCT04382898|581447768|FG002|Part 2: Dose Expansion|Other|1|||
161015875|NCT04382898|581447769|FG003|Part 2: Dose Expansion|Other|0|||
161015876|NCT04382898|581447770|FG004|Part 2: Dose Expansion|Other|0|||
161015877|NCT05229120|581447771|FG000|Overall Study|Withdrawal by Subject|8|||
161015878|NCT04321031|581447774|FG000|Overall Study|Adverse Event|0|||
161015879|NCT04321031|581447775|FG001|Overall Study|Adverse Event|2|||
161015880|NCT04321031|581447776|FG002|Overall Study|Adverse Event|2|||
161015881|NCT04321031|581447777|FG003|Overall Study|Adverse Event|2|||
161015882|NCT04321031|581447778|FG004|Overall Study|Adverse Event|2|||
161015883|NCT04321031|581447779|FG005|Overall Study|Adverse Event|2|||
161015884|NCT04321031|581447780|FG006|Overall Study|Adverse Event|0|||
161015885|NCT04321031|581447774|FG000|Overall Study|Lost to Follow-up|0|||
161015886|NCT04321031|581447775|FG001|Overall Study|Lost to Follow-up|0|||
161015887|NCT04321031|581447776|FG002|Overall Study|Lost to Follow-up|0|||
161015888|NCT04321031|581447777|FG003|Overall Study|Lost to Follow-up|1|||
161015889|NCT04321031|581447778|FG004|Overall Study|Lost to Follow-up|0|||
161015890|NCT04321031|581447779|FG005|Overall Study|Lost to Follow-up|2|||
161015891|NCT04321031|581447780|FG006|Overall Study|Lost to Follow-up|1|||
161015892|NCT04321031|581447774|FG000|Overall Study|Withdrawal by Subject|2|||
161015893|NCT04321031|581447775|FG001|Overall Study|Withdrawal by Subject|2|||
161015894|NCT04321031|581447776|FG002|Overall Study|Withdrawal by Subject|1|||
161015895|NCT04321031|581447777|FG003|Overall Study|Withdrawal by Subject|3|||
161015896|NCT04321031|581447778|FG004|Overall Study|Withdrawal by Subject|1|||
161015897|NCT04321031|581447779|FG005|Overall Study|Withdrawal by Subject|0|||
161015898|NCT04321031|581447780|FG006|Overall Study|Withdrawal by Subject|1|||
161015899|NCT04321031|581447774|FG000|Overall Study|Non-compliance with study drug|0|||
161015900|NCT04321031|581447775|FG001|Overall Study|Non-compliance with study drug|0|||
161015901|NCT04321031|581447776|FG002|Overall Study|Non-compliance with study drug|0|||
161015902|NCT04321031|581447777|FG003|Overall Study|Non-compliance with study drug|0|||
161015903|NCT04321031|581447778|FG004|Overall Study|Non-compliance with study drug|0|||
161015904|NCT04321031|581447779|FG005|Overall Study|Non-compliance with study drug|1|||
161015905|NCT04321031|581447780|FG006|Overall Study|Non-compliance with study drug|0|||
161015906|NCT04321031|581447774|FG000|Overall Study|Other|0|||
161015907|NCT04321031|581447775|FG001|Overall Study|Other|0|||
161015908|NCT04321031|581447776|FG002|Overall Study|Other|0|||
161015909|NCT04321031|581447777|FG003|Overall Study|Other|1|||
161015910|NCT04321031|581447778|FG004|Overall Study|Other|0|||
161015911|NCT04321031|581447779|FG005|Overall Study|Other|0|||
161015912|NCT04321031|581447780|FG006|Overall Study|Other|0|||
161015913|NCT04237298|581447781|FG000|Overall Study|Lost to Follow-up|4|||
161015914|NCT04237298|581447782|FG001|Overall Study|Lost to Follow-up|5|||
161015915|NCT04556656|581447786|FG000|Overall Study|Withdrawal by Subject|14|||
161015916|NCT04556656|581447787|FG001|Overall Study|Withdrawal by Subject|12|||
161015917|NCT04556656|581447786|FG000|Overall Study|Physician Decision|1|||
161015918|NCT04556656|581447787|FG001|Overall Study|Physician Decision|0|||
161015919|NCT04556656|581447786|FG000|Overall Study|Adverse Event|4|||
161015920|NCT04556656|581447787|FG001|Overall Study|Adverse Event|7|||
161015921|NCT04556656|581447786|FG000|Overall Study|Death|4|||
161015922|NCT04556656|581447787|FG001|Overall Study|Death|0|||
161015923|NCT04556656|581447786|FG000|Overall Study|Lost to Follow-up|3|||
161015924|NCT04556656|581447787|FG001|Overall Study|Lost to Follow-up|2|||
161015925|NCT04556656|581447786|FG000|Overall Study|Not further specified|2|||
161015926|NCT04556656|581447787|FG001|Overall Study|Not further specified|1|||
161015927|NCT04541706|581447788|FG000|Overall Study|Withdrawal by Subject|3|||
161015928|NCT04541706|581447788|FG000|Overall Study|Progressive disease|33|||
161015929|NCT04541706|581447788|FG000|Overall Study|Physician Decision|1|||
161015930|NCT04541706|581447788|FG000|Overall Study|Lost to Follow-up|2|||
161015931|NCT04541706|581447788|FG000|Overall Study|Death|5|||
161015932|NCT04541706|581447788|FG000|Overall Study|Adverse Event|1|||
161015933|NCT05536440|581447789|FG000|Overall Study|Adverse Event|0|||
161015934|NCT05536440|581447790|FG001|Overall Study|Adverse Event|0|||
161015935|NCT05536440|581447791|FG002|Overall Study|Adverse Event|0|||
161015936|NCT05536440|581447792|FG003|Overall Study|Adverse Event|0|||
161015937|NCT05536440|581447793|FG004|Overall Study|Adverse Event|0|||
161148000|NCT03567291|581924474|FG001|Period III|Terminated by sponsor|0|||
161272722|NCT00663026|582379506|FG001|Overall Study|Withdrawal by Subject|0|||
161015938|NCT05536440|581447794|FG005|Overall Study|Adverse Event|0|||
161015939|NCT05536440|581447795|FG006|Overall Study|Adverse Event|0|||
161015940|NCT05536440|581447796|FG007|Overall Study|Adverse Event|0|||
161015941|NCT05536440|581447797|FG008|Overall Study|Adverse Event|1|||
161015942|NCT01566695|581447800|FG000|Overall Study|Lack of Efficacy|1|||
161015943|NCT01566695|581447801|FG001|Overall Study|Lack of Efficacy|0|||
161015944|NCT01566695|581447800|FG000|Overall Study|Adverse Event|3|||
161015945|NCT01566695|581447801|FG001|Overall Study|Adverse Event|0|||
161015946|NCT01566695|581447800|FG000|Overall Study|Death|79|||
161015947|NCT01566695|581447801|FG001|Overall Study|Death|86|||
161015948|NCT01566695|581447800|FG000|Overall Study|Withdrawal by Subject|13|||
161015949|NCT01566695|581447801|FG001|Overall Study|Withdrawal by Subject|12|||
161015950|NCT01566695|581447800|FG000|Overall Study|Lost to Follow-up|0|||
161015951|NCT01566695|581447801|FG001|Overall Study|Lost to Follow-up|3|||
161015952|NCT01566695|581447800|FG000|Overall Study|Other reasons|11|||
161015953|NCT01566695|581447801|FG001|Overall Study|Other reasons|8|||
161015954|NCT01416831|581447803|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
161015955|NCT01416831|581447804|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
161015956|NCT04784559|581447805|FG000|Overall Study|Withdrawal by Subject|3|||
161015957|NCT04784559|581447806|FG001|Overall Study|Withdrawal by Subject|2|||
161015958|NCT04784559|581447807|FG002|Overall Study|Withdrawal by Subject|1|||
161015959|NCT04784559|581447805|FG000|Overall Study|Death|2|||
161015960|NCT04784559|581447806|FG001|Overall Study|Death|1|||
161015961|NCT04784559|581447807|FG002|Overall Study|Death|2|||
161015962|NCT04784559|581447805|FG000|Overall Study|Lost to Follow-up|0|||
161015963|NCT04784559|581447806|FG001|Overall Study|Lost to Follow-up|0|||
161015964|NCT04784559|581447807|FG002|Overall Study|Lost to Follow-up|2|||
161015965|NCT04784559|581447805|FG000|Overall Study|Participant worsened, PI decision|1|||
161015966|NCT04784559|581447806|FG001|Overall Study|Participant worsened, PI decision|0|||
161015967|NCT04784559|581447807|FG002|Overall Study|Participant worsened, PI decision|0|||
161015968|NCT04784559|581447805|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
161015969|NCT04784559|581447806|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
161015970|NCT04784559|581447807|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
161015971|NCT04784559|581447805|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
161015972|NCT04784559|581447806|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
161015973|NCT04784559|581447807|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
161015974|NCT04784559|581447805|FG000|Overall Study|Did not meet all inclusion criteria|0|||
161015975|NCT04784559|581447806|FG001|Overall Study|Did not meet all inclusion criteria|1|||
161015976|NCT04784559|581447807|FG002|Overall Study|Did not meet all inclusion criteria|0|||
161015977|NCT04784559|581447805|FG000|Overall Study|The participant was transferred to IRCU|0|||
161015978|NCT04784559|581447806|FG001|Overall Study|The participant was transferred to IRCU|1|||
161015979|NCT04784559|581447807|FG002|Overall Study|The participant was transferred to IRCU|0|||
161015980|NCT04784559|581447805|FG000|Overall Study|SAE|0|||
161015981|NCT04784559|581447806|FG001|Overall Study|SAE|1|||
161015982|NCT04784559|581447807|FG002|Overall Study|SAE|0|||
161015983|NCT04784559|581447805|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
161015984|NCT04784559|581447806|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
161015985|NCT04784559|581447807|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
161015986|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
161015987|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
161015988|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
161015989|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015990|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015991|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015992|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015993|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015994|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015995|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015996|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015997|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015998|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
161015999|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
161016000|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
161016001|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016002|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016003|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016004|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016005|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016006|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016007|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016008|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016009|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016010|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016011|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
161016012|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
161016013|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
161016014|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016015|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016016|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016017|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016018|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016019|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016020|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016021|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016022|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016023|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016024|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
161016025|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
161016026|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
161016027|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016028|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016029|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016030|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016031|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016032|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016033|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016034|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016035|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016036|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016037|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
161016038|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
161016039|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
161016040|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
161016041|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016042|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016043|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016044|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016045|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016046|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016047|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016048|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016049|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016050|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
161016051|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161016052|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161016053|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
161016054|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016055|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016056|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016057|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016058|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016059|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016060|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016061|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016062|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016063|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
161016064|NCT01261312|581447808|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
161016065|NCT01261312|581447809|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016066|NCT01261312|581447810|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
161016067|NCT01261312|581447811|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016068|NCT01261312|581447812|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016069|NCT01261312|581447813|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016070|NCT01261312|581447814|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016071|NCT01261312|581447815|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016072|NCT01261312|581447816|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016073|NCT01261312|581447817|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016074|NCT01261312|581447818|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161148001|NCT03567291|581924475|FG002|Period III|Terminated by sponsor|0|||
161016075|NCT01261312|581447819|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016076|NCT01261312|581447820|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
161016077|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016078|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016079|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016080|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
161016081|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
161016082|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
161016083|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016084|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016085|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016086|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016087|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016088|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016089|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
161016090|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016091|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016092|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016093|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016094|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
161016095|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
161016096|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016097|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016098|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016099|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016100|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016101|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016102|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
161016103|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016104|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016105|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016106|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016107|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
161016108|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
161016109|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016110|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016111|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016112|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016113|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016114|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016115|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
161016116|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016117|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016118|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016119|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
161016120|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
161016121|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
161016122|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016123|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016124|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016125|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016126|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016127|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016128|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
161016129|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016130|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016131|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016132|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016133|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016134|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
161016135|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016136|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016137|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016138|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016139|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016140|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016141|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
161016142|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016143|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016144|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016145|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
161016146|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
161016147|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
161016148|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016149|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016150|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016151|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016152|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016153|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016154|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
161016155|NCT01261312|581447808|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016156|NCT01261312|581447809|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016157|NCT01261312|581447810|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016158|NCT01261312|581447811|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
161016159|NCT01261312|581447812|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161016160|NCT01261312|581447813|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
161016161|NCT01261312|581447814|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016162|NCT01261312|581447815|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016163|NCT01261312|581447816|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016164|NCT01261312|581447817|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016165|NCT01261312|581447818|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016166|NCT01261312|581447819|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016167|NCT01261312|581447820|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
161016168|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016169|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016170|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016171|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016172|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016173|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016174|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
161016175|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
161016176|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
161016177|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016178|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016179|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016180|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
161016181|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016182|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016183|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016184|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016185|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016186|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016187|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016188|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
161016189|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
161016190|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016191|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016192|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016193|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
161016194|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016195|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016196|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016197|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016198|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016199|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016200|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161016201|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161016202|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
161016203|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016204|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016205|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016206|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
161016207|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
161016208|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
161016209|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
161016210|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
161016211|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
161272723|NCT00663026|582379507|FG002|Overall Study|Withdrawal by Subject|1|||
161016212|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
161016213|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
161016214|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
161016215|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
161016216|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
161343569|NCT03034967|582644415|FG003|Overall Study|Lost to Follow-up|1|||
161016217|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
161016218|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
161016219|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
161016220|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016221|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016222|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016223|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016224|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016225|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016226|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161016227|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
161016228|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
161016229|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016230|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016231|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016232|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
161016233|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016234|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016235|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016236|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016237|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016238|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016239|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
161016240|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
161016241|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
161016242|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016243|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016244|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016245|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
161016246|NCT01261312|581447808|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016247|NCT01261312|581447809|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016248|NCT01261312|581447810|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016249|NCT01261312|581447811|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016250|NCT01261312|581447812|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016251|NCT01261312|581447813|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016252|NCT01261312|581447814|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
161016253|NCT01261312|581447815|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
161016254|NCT01261312|581447816|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
161016255|NCT01261312|581447817|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016256|NCT01261312|581447818|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016257|NCT01261312|581447819|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016258|NCT01261312|581447820|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
161016259|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016260|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016261|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016262|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016263|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016264|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016265|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016266|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016267|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
161016268|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
161016269|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
161016270|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
161016271|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
161016272|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016273|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161148002|NCT03567291|581924476|FG003|Period III|Terminated by sponsor|68|||
161016274|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016275|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016276|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016277|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016278|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016279|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016280|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016281|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
161016282|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
161016283|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
161016284|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
161016285|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016286|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016287|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016288|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016289|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016290|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016291|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016292|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016293|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
161016294|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
161016295|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
161016296|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
161016297|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
161016298|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016299|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016300|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016301|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016302|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016303|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016304|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016305|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016306|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
161016307|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
161016308|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
161016309|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
161016310|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
161016311|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016312|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016313|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016314|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016315|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016316|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016317|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016318|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016319|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
161016320|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
161016321|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
161016322|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
161016323|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
161016324|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016325|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016326|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016327|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016328|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016329|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016330|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161148003|NCT03567291|581924473|FG000|Period III|Missing or unknown|0|||
161148004|NCT03567291|581924474|FG001|Period III|Missing or unknown|0|||
161272724|NCT01392963|582379511|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
161272725|NCT01392963|582379512|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
161272726|NCT01392963|582379511|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
161272727|NCT01392963|582379512|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
161272728|NCT01392963|582379511|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
161272729|NCT01392963|582379512|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
161272730|NCT01475097|582379513|FG000|Overall Study|Protocol Violation|1|||
161016331|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016332|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
161016333|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
161016334|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
161016335|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
161016336|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
161016337|NCT01261312|581447808|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016338|NCT01261312|581447809|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016339|NCT01261312|581447810|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016340|NCT01261312|581447811|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016341|NCT01261312|581447812|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016342|NCT01261312|581447813|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016343|NCT01261312|581447814|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016344|NCT01261312|581447815|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016345|NCT01261312|581447816|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
161016346|NCT01261312|581447817|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161016347|NCT01261312|581447818|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161016348|NCT01261312|581447819|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
161016349|NCT01261312|581447820|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
161016350|NCT03336333|581447821|FG000|Overall Study|Remained on study at time of data cut-off|202|||
161016351|NCT03336333|581447822|FG001|Overall Study|Remained on study at time of data cut-off|219|||
161016352|NCT03336333|581447823|FG002|Overall Study|Remained on study at time of data cut-off|102|||
161016353|NCT03336333|581447821|FG000|Overall Study|Death|14|||
161016354|NCT03336333|581447822|FG001|Overall Study|Death|16|||
161016355|NCT03336333|581447823|FG002|Overall Study|Death|8|||
161016356|NCT03336333|581447821|FG000|Overall Study|Withdrawal by Subject|16|||
161016357|NCT03336333|581447822|FG001|Overall Study|Withdrawal by Subject|5|||
161016358|NCT03336333|581447823|FG002|Overall Study|Withdrawal by Subject|1|||
161016359|NCT03336333|581447821|FG000|Overall Study|Physician Decision|5|||
161016360|NCT03336333|581447822|FG001|Overall Study|Physician Decision|1|||
161016361|NCT03336333|581447823|FG002|Overall Study|Physician Decision|0|||
161016362|NCT03336333|581447821|FG000|Overall Study|Lost to Follow-up|1|||
161016363|NCT03336333|581447822|FG001|Overall Study|Lost to Follow-up|0|||
161016364|NCT03336333|581447823|FG002|Overall Study|Lost to Follow-up|0|||
161016365|NCT00931710|581447826|FG000|Overall Study|Adverse Event|16|||
161016366|NCT00931710|581447827|FG001|Overall Study|Adverse Event|10|||
161016367|NCT00931710|581447826|FG000|Overall Study|Abnormal test procedure results|2|||
161016368|NCT00931710|581447827|FG001|Overall Study|Abnormal test procedure results|0|||
161016369|NCT00931710|581447826|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
161016370|NCT00931710|581447827|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
161016371|NCT00931710|581447826|FG000|Overall Study|Patient withdrew consent|4|||
161016372|NCT00931710|581447827|FG001|Overall Study|Patient withdrew consent|9|||
161016373|NCT00931710|581447826|FG000|Overall Study|Lost to Follow-up|6|||
161016374|NCT00931710|581447827|FG001|Overall Study|Lost to Follow-up|5|||
161016375|NCT00931710|581447826|FG000|Overall Study|Protocol deviation|1|||
161016376|NCT00931710|581447827|FG001|Overall Study|Protocol deviation|2|||
161016377|NCT03338790|581447833|FG000|Overall Study|Disease Progression|65|||
161016378|NCT03338790|581447834|FG001|Overall Study|Disease Progression|43|||
161016379|NCT03338790|581447835|FG002|Overall Study|Disease Progression|50|||
161016380|NCT03338790|581447836|FG003|Overall Study|Disease Progression|37|||
161016381|NCT03338790|581447833|FG000|Overall Study|Study Drug Toxicity|9|||
161016382|NCT03338790|581447834|FG001|Overall Study|Study Drug Toxicity|8|||
161016383|NCT03338790|581447835|FG002|Overall Study|Study Drug Toxicity|15|||
161016384|NCT03338790|581447836|FG003|Overall Study|Study Drug Toxicity|0|||
161016385|NCT03338790|581447833|FG000|Overall Study|Death|1|||
161016386|NCT03338790|581447834|FG001|Overall Study|Death|1|||
161016387|NCT03338790|581447835|FG002|Overall Study|Death|1|||
161016388|NCT03338790|581447836|FG003|Overall Study|Death|0|||
161016389|NCT03338790|581447833|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
161016390|NCT03338790|581447834|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
161016391|NCT03338790|581447835|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
161016392|NCT03338790|581447836|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
161016393|NCT03338790|581447833|FG000|Overall Study|Participant request to discontinue study treatment|3|||
161016394|NCT03338790|581447834|FG001|Overall Study|Participant request to discontinue study treatment|3|||
161016395|NCT03338790|581447835|FG002|Overall Study|Participant request to discontinue study treatment|2|||
161016396|NCT03338790|581447836|FG003|Overall Study|Participant request to discontinue study treatment|1|||
161016397|NCT03338790|581447833|FG000|Overall Study|Poor/non-compliance|0|||
161016398|NCT03338790|581447834|FG001|Overall Study|Poor/non-compliance|1|||
161016399|NCT03338790|581447835|FG002|Overall Study|Poor/non-compliance|0|||
161016400|NCT03338790|581447836|FG003|Overall Study|Poor/non-compliance|0|||
161016401|NCT03338790|581447833|FG000|Overall Study|Participant withdrew consent|1|||
161148005|NCT03567291|581924475|FG002|Period III|Missing or unknown|0|||
161016402|NCT03338790|581447834|FG001|Overall Study|Participant withdrew consent|0|||
161016403|NCT03338790|581447835|FG002|Overall Study|Participant withdrew consent|1|||
161016404|NCT03338790|581447836|FG003|Overall Study|Participant withdrew consent|1|||
161016405|NCT03338790|581447833|FG000|Overall Study|Other reasons|0|||
161016406|NCT03338790|581447834|FG001|Overall Study|Other reasons|5|||
161016407|NCT03338790|581447835|FG002|Overall Study|Other reasons|0|||
161016408|NCT03338790|581447836|FG003|Overall Study|Other reasons|2|||
161016409|NCT03338790|581447833|FG000|Overall Study|Not reported|0|||
161016410|NCT03338790|581447834|FG001|Overall Study|Not reported|0|||
161016411|NCT03338790|581447835|FG002|Overall Study|Not reported|1|||
161016412|NCT03338790|581447836|FG003|Overall Study|Not reported|0|||
161016413|NCT03338790|581447833|FG000|Overall Study|Completed treatment period|1|||
161016414|NCT03338790|581447834|FG001|Overall Study|Completed treatment period|2|||
161016415|NCT03338790|581447835|FG002|Overall Study|Completed treatment period|0|||
161016416|NCT03338790|581447836|FG003|Overall Study|Completed treatment period|0|||
161016417|NCT04588298|581447837|FG000|Overall Study|Adverse Event|0|||
161016418|NCT04588298|581447838|FG001|Overall Study|Adverse Event|0|||
161016419|NCT04588298|581447839|FG002|Overall Study|Adverse Event|1|||
161016420|NCT04588298|581447840|FG003|Overall Study|Adverse Event|0|||
161016421|NCT04588298|581447841|FG004|Overall Study|Adverse Event|2|||
161016422|NCT04588298|581447837|FG000|Overall Study|Withdrawal by Subject|1|||
161016423|NCT04588298|581447838|FG001|Overall Study|Withdrawal by Subject|0|||
161016424|NCT04588298|581447839|FG002|Overall Study|Withdrawal by Subject|0|||
161016425|NCT04588298|581447840|FG003|Overall Study|Withdrawal by Subject|1|||
161016426|NCT04588298|581447841|FG004|Overall Study|Withdrawal by Subject|0|||
161016427|NCT02281955|581447842|FG000|Overall Study|Death|1|||
161016428|NCT03892616|581447843|FG000|Washout Period 2|Met discontinuation criterion|0|||
161016429|NCT03892616|581447844|FG001|Washout Period 2|Met discontinuation criterion|0|||
161016430|NCT03892616|581447845|FG002|Washout Period 2|Met discontinuation criterion|0|||
161148006|NCT03567291|581924476|FG003|Period III|Missing or unknown|8|||
161148007|NCT03666143|581924477|FG000|Overall Study|Death|158|||
161148008|NCT03666143|581924477|FG000|Overall Study|Sponsor Decision|31|||
161148009|NCT03666143|581924477|FG000|Overall Study|Withdrawal by Subject|11|||
161148010|NCT03666143|581924477|FG000|Overall Study|Lost to Follow-up|5|||
161148011|NCT03666143|581924477|FG000|Overall Study|Physician Decision|1|||
161148012|NCT03666143|581924477|FG000|Overall Study|Rolled into extension study|9|||
161148013|NCT03666143|581924477|FG000|Overall Study|Progressive Disease|1|||
161148014|NCT01103349|581924480|FG000|Overall Study|Adverse Event|8|||
161148015|NCT01103349|581924481|FG001|Overall Study|Adverse Event|5|||
161148016|NCT01103349|581924482|FG002|Overall Study|Adverse Event|3|||
161148017|NCT01103349|581924480|FG000|Overall Study|Consent withdrawn|1|||
161148018|NCT01103349|581924481|FG001|Overall Study|Consent withdrawn|0|||
161148019|NCT01103349|581924482|FG002|Overall Study|Consent withdrawn|0|||
161148020|NCT01103349|581924480|FG000|Overall Study|Incorrectly included in the trial|1|||
161148021|NCT01103349|581924481|FG001|Overall Study|Incorrectly included in the trial|0|||
161148022|NCT01103349|581924482|FG002|Overall Study|Incorrectly included in the trial|0|||
161148023|NCT01103349|581924480|FG000|Overall Study|Withdrawal by Subject|1|||
161016431|NCT03892616|581447846|FG003|Washout Period 2|Met discontinuation criterion|0|||
161016432|NCT03892616|581447847|FG004|Washout Period 2|Met discontinuation criterion|0|||
161016433|NCT03892616|581447848|FG005|Washout Period 2|Met discontinuation criterion|0|||
161016434|NCT03892616|581447849|FG006|Washout Period 2|Met discontinuation criterion|0|||
161016435|NCT03892616|581447850|FG007|Washout Period 2|Met discontinuation criterion|0|||
161016436|NCT03892616|581447851|FG008|Washout Period 2|Met discontinuation criterion|1|||
161016437|NCT03892616|581447852|FG009|Washout Period 2|Met discontinuation criterion|0|||
161016438|NCT03892616|581447853|FG010|Washout Period 2|Met discontinuation criterion|0|||
161016439|NCT03892616|581447854|FG011|Washout Period 2|Met discontinuation criterion|0|||
161016440|NCT03683719|581447855|FG000|Overall Study|Lack of Efficacy|1|||
161016441|NCT03683719|581447856|FG001|Overall Study|Lack of Efficacy|3|||
161016442|NCT03683719|581447857|FG002|Overall Study|Lack of Efficacy|4|||
161016443|NCT03683719|581447858|FG003|Overall Study|Lack of Efficacy|0|||
161016444|NCT03683719|581447859|FG004|Overall Study|Lack of Efficacy|4|||
161016445|NCT03683719|581447855|FG000|Overall Study|Adverse Event|6|||
161016446|NCT03683719|581447856|FG001|Overall Study|Adverse Event|6|||
161016447|NCT03683719|581447857|FG002|Overall Study|Adverse Event|0|||
161016448|NCT03683719|581447858|FG003|Overall Study|Adverse Event|1|||
161016449|NCT03683719|581447859|FG004|Overall Study|Adverse Event|3|||
161016450|NCT03683719|581447855|FG000|Overall Study|Withdrawal by Subject|4|||
161016451|NCT03683719|581447856|FG001|Overall Study|Withdrawal by Subject|4|||
161148024|NCT01103349|581924481|FG001|Overall Study|Withdrawal by Subject|1|||
161148025|NCT01103349|581924482|FG002|Overall Study|Withdrawal by Subject|0|||
161148026|NCT01103349|581924480|FG000|Overall Study|did not want to take trial medication|0|||
161148027|NCT01103349|581924481|FG001|Overall Study|did not want to take trial medication|1|||
161016452|NCT03683719|581447857|FG002|Overall Study|Withdrawal by Subject|3|||
161016453|NCT03683719|581447858|FG003|Overall Study|Withdrawal by Subject|5|||
161016454|NCT03683719|581447859|FG004|Overall Study|Withdrawal by Subject|5|||
161016455|NCT03683719|581447855|FG000|Overall Study|Lost to Follow-up|1|||
161016456|NCT03683719|581447856|FG001|Overall Study|Lost to Follow-up|0|||
161016457|NCT03683719|581447857|FG002|Overall Study|Lost to Follow-up|0|||
161016458|NCT03683719|581447858|FG003|Overall Study|Lost to Follow-up|1|||
161016459|NCT03683719|581447859|FG004|Overall Study|Lost to Follow-up|1|||
161016460|NCT03683719|581447855|FG000|Overall Study|Other personal reasons|0|||
161016461|NCT03683719|581447856|FG001|Overall Study|Other personal reasons|0|||
161016462|NCT03683719|581447857|FG002|Overall Study|Other personal reasons|1|||
161016463|NCT03683719|581447858|FG003|Overall Study|Other personal reasons|0|||
161016464|NCT03683719|581447859|FG004|Overall Study|Other personal reasons|1|||
161016465|NCT00601900|581447860|FG000|Overall Study|Withdrawal by Subject|0|||
161016466|NCT00601900|581447861|FG001|Overall Study|Withdrawal by Subject|3|||
161016467|NCT03924986|581447862|FG000|Overall Study|Death|57|||
161016468|NCT03924986|581447863|FG001|Overall Study|Death|66|||
161016469|NCT03924986|581447862|FG000|Overall Study|Study Concluded by Sponsor|51|||
161016470|NCT03924986|581447863|FG001|Overall Study|Study Concluded by Sponsor|41|||
161016471|NCT03924986|581447862|FG000|Overall Study|Withdrawal by Subject|15|||
161016472|NCT03924986|581447863|FG001|Overall Study|Withdrawal by Subject|20|||
161016473|NCT03924986|581447862|FG000|Overall Study|Lost to Follow-up|7|||
161016474|NCT03924986|581447863|FG001|Overall Study|Lost to Follow-up|5|||
161016475|NCT03924986|581447862|FG000|Overall Study|Miscellaneous|1|||
161016476|NCT03924986|581447863|FG001|Overall Study|Miscellaneous|0|||
161016477|NCT02689284|581447869|FG000|Overall Study|Adverse Event|1|||
161016478|NCT02689284|581447870|FG001|Overall Study|Adverse Event|8|||
161016479|NCT02689284|581447869|FG000|Overall Study|Death|0|||
161016480|NCT02689284|581447870|FG001|Overall Study|Death|1|||
161016481|NCT02689284|581447869|FG000|Overall Study|Physician Decision|1|||
161016482|NCT02689284|581447870|FG001|Overall Study|Physician Decision|2|||
161016483|NCT02689284|581447869|FG000|Overall Study|Withdrawal by Subject|0|||
161016484|NCT02689284|581447870|FG001|Overall Study|Withdrawal by Subject|1|||
161016485|NCT02689284|581447869|FG000|Overall Study|progression of cancer|1|||
161016486|NCT02689284|581447870|FG001|Overall Study|progression of cancer|72|||
161016487|NCT02689284|581447869|FG000|Overall Study|decreased heart function|0|||
161016488|NCT02689284|581447870|FG001|Overall Study|decreased heart function|1|||
161016489|NCT02689284|581447869|FG000|Overall Study|concern for anemia|0|||
161016490|NCT02689284|581447870|FG001|Overall Study|concern for anemia|1|||
161016491|NCT02689284|581447869|FG000|Overall Study|no measurable cancer for evaluation|0|||
161016492|NCT02689284|581447870|FG001|Overall Study|no measurable cancer for evaluation|1|||
161016493|NCT05569252|581447871|FG000|Overall Study|Adverse event (central vision loss)|1|||
161016494|NCT05569252|581447872|FG001|Overall Study|Adverse event (central vision loss)|0|||
161016495|NCT05569252|581447873|FG002|Overall Study|Adverse event (central vision loss)|0|||
161016496|NCT05569252|581447874|FG003|Overall Study|Adverse event (central vision loss)|0|||
161016497|NCT03665597|581447875|FG000|Period 1|Adverse Event|1|||
161016498|NCT03665597|581447876|FG001|Period 1|Adverse Event|0|||
161016499|NCT03665597|581447877|FG002|Period 1|Adverse Event|0|||
161016500|NCT03665597|581447878|FG003|Period 1|Adverse Event|1|||
161148028|NCT01103349|581924482|FG002|Overall Study|did not want to take trial medication|0|||
161148029|NCT01103349|581924480|FG000|Overall Study|forgot to take medication|0|||
161148030|NCT01103349|581924481|FG001|Overall Study|forgot to take medication|0|||
161148031|NCT01103349|581924482|FG002|Overall Study|forgot to take medication|1|||
161148032|NCT00972244|581924486|FG000|Overall Study|Incorrect Enrolment|1|||
161148033|NCT00972244|581924487|FG001|Overall Study|Incorrect Enrolment|0|||
161148034|NCT00972244|581924488|FG002|Overall Study|Incorrect Enrolment|0|||
161148035|NCT00972244|581924489|FG003|Overall Study|Incorrect Enrolment|0|||
161148036|NCT00972244|581924490|FG004|Overall Study|Incorrect Enrolment|0|||
161148037|NCT00972244|581924486|FG000|Overall Study|Adverse Event|0|||
161148038|NCT00972244|581924487|FG001|Overall Study|Adverse Event|1|||
161148039|NCT00972244|581924488|FG002|Overall Study|Adverse Event|1|||
161148040|NCT00972244|581924489|FG003|Overall Study|Adverse Event|0|||
161148041|NCT00972244|581924490|FG004|Overall Study|Adverse Event|0|||
161148042|NCT00972244|581924486|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
161148043|NCT00972244|581924487|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
161148044|NCT00972244|581924488|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
161148045|NCT00972244|581924489|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
161148046|NCT00972244|581924490|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
161343570|NCT03034967|582644416|FG004|Overall Study|Lost to Follow-up|0|||
161148047|NCT00972244|581924486|FG000|Overall Study|Withdrawal by Subject|1|||
161148048|NCT00972244|581924487|FG001|Overall Study|Withdrawal by Subject|2|||
161148049|NCT00972244|581924488|FG002|Overall Study|Withdrawal by Subject|1|||
161016501|NCT03665597|581447879|FG004|Period 1|Adverse Event|0|||
161016502|NCT03665597|581447880|FG005|Period 1|Adverse Event|0|||
161016503|NCT03665597|581447881|FG006|Period 1|Adverse Event|0|||
161016504|NCT03665597|581447875|FG000|Period 1|Screen Failure|0|||
161016505|NCT03665597|581447876|FG001|Period 1|Screen Failure|0|||
161016506|NCT03665597|581447877|FG002|Period 1|Screen Failure|0|||
161016507|NCT03665597|581447878|FG003|Period 1|Screen Failure|1|||
161016508|NCT03665597|581447879|FG004|Period 1|Screen Failure|0|||
161016509|NCT03665597|581447880|FG005|Period 1|Screen Failure|0|||
161016510|NCT03665597|581447881|FG006|Period 1|Screen Failure|0|||
161016511|NCT03665597|581447875|FG000|Period 1|Death|0|||
161016512|NCT03665597|581447876|FG001|Period 1|Death|0|||
161016513|NCT03665597|581447877|FG002|Period 1|Death|0|||
161016514|NCT03665597|581447878|FG003|Period 1|Death|0|||
161016515|NCT03665597|581447879|FG004|Period 1|Death|0|||
161016516|NCT03665597|581447880|FG005|Period 1|Death|0|||
161016517|NCT03665597|581447881|FG006|Period 1|Death|45|||
161016518|NCT03665597|581447875|FG000|Period 1|Withdrawal by Subject|0|||
161016519|NCT03665597|581447876|FG001|Period 1|Withdrawal by Subject|0|||
161016520|NCT03665597|581447877|FG002|Period 1|Withdrawal by Subject|0|||
161016521|NCT03665597|581447878|FG003|Period 1|Withdrawal by Subject|0|||
161016522|NCT03665597|581447879|FG004|Period 1|Withdrawal by Subject|0|||
161016523|NCT03665597|581447880|FG005|Period 1|Withdrawal by Subject|0|||
161016524|NCT03665597|581447881|FG006|Period 1|Withdrawal by Subject|5|||
161016525|NCT03665597|581447875|FG000|Period 2|Adverse Event|0|||
161016526|NCT03665597|581447876|FG001|Period 2|Adverse Event|0|||
161016527|NCT03665597|581447877|FG002|Period 2|Adverse Event|0|||
161016528|NCT03665597|581447878|FG003|Period 2|Adverse Event|0|||
161016529|NCT03665597|581447879|FG004|Period 2|Adverse Event|0|||
161016530|NCT03665597|581447880|FG005|Period 2|Adverse Event|1|||
161016531|NCT03665597|581447881|FG006|Period 2|Adverse Event|0|||
161016532|NCT03665597|581447875|FG000|Period 3|Adverse Event|0|||
161016533|NCT03665597|581447876|FG001|Period 3|Adverse Event|1|||
161016534|NCT03665597|581447877|FG002|Period 3|Adverse Event|0|||
161016535|NCT03665597|581447878|FG003|Period 3|Adverse Event|0|||
161016536|NCT03665597|581447879|FG004|Period 3|Adverse Event|0|||
161016537|NCT03665597|581447880|FG005|Period 3|Adverse Event|0|||
161016538|NCT03665597|581447881|FG006|Period 3|Adverse Event|0|||
161016539|NCT03665597|581447875|FG000|Period 3|Death|0|||
161016540|NCT03665597|581447876|FG001|Period 3|Death|0|||
161016541|NCT03665597|581447877|FG002|Period 3|Death|0|||
161016542|NCT03665597|581447878|FG003|Period 3|Death|0|||
161016543|NCT03665597|581447879|FG004|Period 3|Death|1|||
161016544|NCT03665597|581447880|FG005|Period 3|Death|0|||
161016545|NCT03665597|581447881|FG006|Period 3|Death|0|||
161016546|NCT03665597|581447875|FG000|Period 4|Adverse Event|2|||
161016547|NCT03665597|581447876|FG001|Period 4|Adverse Event|2|||
161016548|NCT03665597|581447877|FG002|Period 4|Adverse Event|2|||
161016549|NCT03665597|581447878|FG003|Period 4|Adverse Event|2|||
161016550|NCT03665597|581447879|FG004|Period 4|Adverse Event|1|||
161016551|NCT03665597|581447880|FG005|Period 4|Adverse Event|0|||
161016552|NCT03665597|581447881|FG006|Period 4|Adverse Event|0|||
161016553|NCT03665597|581447875|FG000|Period 4|Death|0|||
161016554|NCT03665597|581447876|FG001|Period 4|Death|0|||
161016555|NCT03665597|581447877|FG002|Period 4|Death|2|||
161016556|NCT03665597|581447878|FG003|Period 4|Death|0|||
161016557|NCT03665597|581447879|FG004|Period 4|Death|0|||
161016558|NCT03665597|581447880|FG005|Period 4|Death|0|||
161016559|NCT03665597|581447881|FG006|Period 4|Death|0|||
161016560|NCT03665597|581447875|FG000|Period 4|Physician Decision|1|||
161016561|NCT03665597|581447876|FG001|Period 4|Physician Decision|2|||
161016562|NCT03665597|581447877|FG002|Period 4|Physician Decision|0|||
161016563|NCT03665597|581447878|FG003|Period 4|Physician Decision|0|||
161016564|NCT03665597|581447879|FG004|Period 4|Physician Decision|0|||
161016565|NCT03665597|581447880|FG005|Period 4|Physician Decision|0|||
161016566|NCT03665597|581447881|FG006|Period 4|Physician Decision|0|||
161016567|NCT05516147|581447882|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
161016568|NCT05371652|581447886|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
161016569|NCT05371652|581447886|FG000|Overall Study|Withdrawal by Subject|12|||
161016570|NCT05371652|581447886|FG000|Overall Study|Adverse Event|1|||
161016571|NCT05371652|581447886|FG000|Overall Study|Other|11|||
161016572|NCT05256706|581447887|FG000|Overall Study|Lost to Follow-up|9|||
161016573|NCT05256706|581447888|FG001|Overall Study|Lost to Follow-up|3|||
161016574|NCT05256706|581447887|FG000|Overall Study|Withdrawal by Subject|7|||
161016575|NCT05256706|581447888|FG001|Overall Study|Withdrawal by Subject|11|||
161016576|NCT05256706|581447887|FG000|Overall Study|Screen Failures|3|||
161016577|NCT05256706|581447888|FG001|Overall Study|Screen Failures|0|||
161016578|NCT04410042|581447890|FG000|Overall Study|Not Eligible|1|||
161016579|NCT04410042|581447891|FG001|Overall Study|Not Eligible|1|||
161016580|NCT01494662|581447892|FG000|Overall Study|Withdrawal by Subject|0|||
161016581|NCT01494662|581447893|FG001|Overall Study|Withdrawal by Subject|0|||
161016582|NCT01494662|581447894|FG002|Overall Study|Withdrawal by Subject|1|||
161016583|NCT01494662|581447895|FG003|Overall Study|Withdrawal by Subject|0|||
161016584|NCT01494662|581447896|FG004|Overall Study|Withdrawal by Subject|0|||
161016585|NCT01494662|581447897|FG005|Overall Study|Withdrawal by Subject|0|||
161016586|NCT01494662|581447898|FG006|Overall Study|Withdrawal by Subject|0|||
161016587|NCT01494662|581447892|FG000|Overall Study|Physician Decision|0|||
161016588|NCT01494662|581447893|FG001|Overall Study|Physician Decision|0|||
161016589|NCT01494662|581447894|FG002|Overall Study|Physician Decision|1|||
161016590|NCT01494662|581447895|FG003|Overall Study|Physician Decision|0|||
161016591|NCT01494662|581447896|FG004|Overall Study|Physician Decision|0|||
161016592|NCT01494662|581447897|FG005|Overall Study|Physician Decision|0|||
161016593|NCT01494662|581447898|FG006|Overall Study|Physician Decision|0|||
161016594|NCT03302494|581447899|FG000|Overall Study|Other|7|||
161016595|NCT03302494|581447900|FG001|Overall Study|Other|4|||
161016596|NCT03302494|581447901|FG002|Overall Study|Other|6|||
161016597|NCT03302494|581447899|FG000|Overall Study|Withdrawal by Subject|10|||
161016598|NCT03302494|581447900|FG001|Overall Study|Withdrawal by Subject|2|||
161016599|NCT03302494|581447901|FG002|Overall Study|Withdrawal by Subject|9|||
161016600|NCT03302494|581447899|FG000|Overall Study|Study Terminated by Sponsor|32|||
161016601|NCT03302494|581447900|FG001|Overall Study|Study Terminated by Sponsor|29|||
161016602|NCT03302494|581447901|FG002|Overall Study|Study Terminated by Sponsor|30|||
161016603|NCT03302494|581447899|FG000|Overall Study|Physician Decision|1|||
161016604|NCT03302494|581447900|FG001|Overall Study|Physician Decision|0|||
161016605|NCT03302494|581447901|FG002|Overall Study|Physician Decision|1|||
161016606|NCT03302494|581447899|FG000|Overall Study|Lost to Follow-up|1|||
161016607|NCT03302494|581447900|FG001|Overall Study|Lost to Follow-up|3|||
161016608|NCT03302494|581447901|FG002|Overall Study|Lost to Follow-up|3|||
161016609|NCT03302494|581447899|FG000|Overall Study|Death|13|||
161016610|NCT03302494|581447900|FG001|Overall Study|Death|11|||
161016611|NCT03302494|581447901|FG002|Overall Study|Death|4|||
161016612|NCT03302494|581447899|FG000|Overall Study|Adverse Event|1|||
161016613|NCT03302494|581447900|FG001|Overall Study|Adverse Event|2|||
161016614|NCT03302494|581447901|FG002|Overall Study|Adverse Event|0|||
161016615|NCT03302494|581447899|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
161016616|NCT03302494|581447900|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
161016617|NCT03302494|581447901|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
161016618|NCT02596126|581447910|FG000|Overall Study|Lost to Follow-up|12|||
161016619|NCT02596126|581447911|FG001|Overall Study|Lost to Follow-up|21|||
161016620|NCT02596126|581447910|FG000|Overall Study|Protocol Violation|7|||
161016621|NCT02596126|581447911|FG001|Overall Study|Protocol Violation|9|||
161016622|NCT00753090|581449444|FG000|Overall Study|Withdrawal by Subject|10|||
161016623|NCT00753090|581449445|FG001|Overall Study|Withdrawal by Subject|10|||
161016624|NCT00753090|581449444|FG000|Overall Study|Death|17|||
161016625|NCT00753090|581449445|FG001|Overall Study|Death|6|||
161016626|NCT00753090|581449444|FG000|Overall Study|Study Prosthesis Removed|12|||
161016627|NCT00753090|581449445|FG001|Overall Study|Study Prosthesis Removed|3|||
161016628|NCT00753090|581449444|FG000|Overall Study|Lost to Follow-up|2|||
161016629|NCT00753090|581449445|FG001|Overall Study|Lost to Follow-up|2|||
161016630|NCT00753090|581449444|FG000|Overall Study|Other|127|||
161016631|NCT00753090|581449445|FG001|Overall Study|Other|75|||
161016632|NCT05113966|581449448|FG000|Overall Study|Death|21|||
161016633|NCT05113966|581449448|FG000|Overall Study|Study Terminated by Sponsor|9|||
161016634|NCT04521478|581449449|FG000|Overall Study|Protocol Violation|2|||
161016635|NCT04521478|581449450|FG001|Overall Study|Protocol Violation|0|||
161016636|NCT04521478|581449451|FG002|Overall Study|Protocol Violation|1|||
161016637|NCT04521478|581449452|FG003|Overall Study|Protocol Violation|0|||
161016638|NCT04521478|581449453|FG004|Overall Study|Protocol Violation|0|||
161016639|NCT04521478|581449454|FG005|Overall Study|Protocol Violation|0|||
161016640|NCT04521478|581449449|FG000|Overall Study|Technical Problems|0|||
161016641|NCT04521478|581449450|FG001|Overall Study|Technical Problems|0|||
161016642|NCT04521478|581449451|FG002|Overall Study|Technical Problems|0|||
161016643|NCT04521478|581449452|FG003|Overall Study|Technical Problems|1|||
161016644|NCT04521478|581449453|FG004|Overall Study|Technical Problems|0|||
161016645|NCT04521478|581449454|FG005|Overall Study|Technical Problems|0|||
161016646|NCT04521478|581449449|FG000|Overall Study|Burden of Study Procedures|1|||
161016647|NCT04521478|581449450|FG001|Overall Study|Burden of Study Procedures|0|||
161016648|NCT04521478|581449451|FG002|Overall Study|Burden of Study Procedures|0|||
161016649|NCT04521478|581449452|FG003|Overall Study|Burden of Study Procedures|1|||
161016650|NCT04521478|581449453|FG004|Overall Study|Burden of Study Procedures|0|||
161148050|NCT00972244|581924489|FG003|Overall Study|Withdrawal by Subject|0|||
161148051|NCT00972244|581924490|FG004|Overall Study|Withdrawal by Subject|1|||
161148052|NCT00972244|581924486|FG000|Overall Study|Safety|0|||
161148053|NCT00972244|581924487|FG001|Overall Study|Safety|0|||
161148054|NCT00972244|581924488|FG002|Overall Study|Safety|0|||
161016651|NCT04521478|581449454|FG005|Overall Study|Burden of Study Procedures|1|||
161016652|NCT04521478|581449449|FG000|Overall Study|Lack of Efficacy|0|||
161016653|NCT04521478|581449450|FG001|Overall Study|Lack of Efficacy|0|||
161016654|NCT04521478|581449451|FG002|Overall Study|Lack of Efficacy|0|||
161016655|NCT04521478|581449452|FG003|Overall Study|Lack of Efficacy|0|||
161016656|NCT04521478|581449453|FG004|Overall Study|Lack of Efficacy|1|||
161016657|NCT04521478|581449454|FG005|Overall Study|Lack of Efficacy|1|||
161016658|NCT04521478|581449449|FG000|Overall Study|Adverse Event|7|||
161016659|NCT04521478|581449450|FG001|Overall Study|Adverse Event|0|||
161016660|NCT04521478|581449451|FG002|Overall Study|Adverse Event|2|||
161016661|NCT04521478|581449452|FG003|Overall Study|Adverse Event|1|||
161016662|NCT04521478|581449453|FG004|Overall Study|Adverse Event|2|||
161016663|NCT04521478|581449454|FG005|Overall Study|Adverse Event|7|||
161016664|NCT04521478|581449449|FG000|Overall Study|No Reason Available|0|||
161016665|NCT04521478|581449450|FG001|Overall Study|No Reason Available|2|||
161016666|NCT04521478|581449451|FG002|Overall Study|No Reason Available|0|||
161016667|NCT04521478|581449452|FG003|Overall Study|No Reason Available|0|||
161016668|NCT04521478|581449453|FG004|Overall Study|No Reason Available|1|||
161148055|NCT00972244|581924489|FG003|Overall Study|Safety|0|||
161016669|NCT04521478|581449454|FG005|Overall Study|No Reason Available|0|||
161016670|NCT04521478|581449449|FG000|Overall Study|Other than listed|3|||
161016671|NCT04521478|581449450|FG001|Overall Study|Other than listed|3|||
161016672|NCT04521478|581449451|FG002|Overall Study|Other than listed|3|||
161016673|NCT04521478|581449452|FG003|Overall Study|Other than listed|2|||
161016674|NCT04521478|581449453|FG004|Overall Study|Other than listed|3|||
161016675|NCT04521478|581449454|FG005|Overall Study|Other than listed|3|||
161016676|NCT04521478|581449449|FG000|Overall Study|Not treated|0|||
161016677|NCT04521478|581449450|FG001|Overall Study|Not treated|0|||
161016678|NCT04521478|581449451|FG002|Overall Study|Not treated|0|||
161016679|NCT04521478|581449452|FG003|Overall Study|Not treated|0|||
161016680|NCT04521478|581449453|FG004|Overall Study|Not treated|0|||
161016681|NCT04521478|581449454|FG005|Overall Study|Not treated|1|||
161016682|NCT02630823|581449469|FG000|Overall Study|Withdrawal by Subject|1|||
161016683|NCT02630823|581449469|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
161016684|NCT02682316|581449483|FG000|Overall Study|Benign Final Pathology|27|||
161016685|NCT02682316|581449484|FG001|Overall Study|Benign Final Pathology|26|||
161016686|NCT02682316|581449483|FG000|Overall Study|Reoperation before 30 days|7|||
161016687|NCT02682316|581449484|FG001|Overall Study|Reoperation before 30 days|6|||
161016688|NCT02682316|581449483|FG000|Overall Study|Ineligible|1|||
161016689|NCT02682316|581449484|FG001|Overall Study|Ineligible|0|||
161016690|NCT02682316|581449483|FG000|Overall Study|Death|1|||
161016691|NCT02682316|581449484|FG001|Overall Study|Death|0|||
161016692|NCT02682316|581449483|FG000|Overall Study|Lost to Follow-up|7|||
161016693|NCT02682316|581449484|FG001|Overall Study|Lost to Follow-up|3|||
161016694|NCT04630262|581449486|FG000|Overall Study|Intraoperative Screen Failure|5|||
161016695|NCT04630262|581449486|FG000|Overall Study|Study terminated prematurely|71|||
161016696|NCT04630262|581449486|FG000|Overall Study|Withdrawal by Subject|2|||
161016697|NCT04630262|581449486|FG000|Overall Study|Physician Decision|2|||
161016698|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior use|4424|||
161016699|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior use|24726|||
161016700|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior use|0|||
161016701|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior use|0|||
161016702|NCT03692676|581449488|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
161016703|NCT03692676|581449489|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
161016704|NCT03692676|581449490|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
161016705|NCT03692676|581449491|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
161016706|NCT03692676|581449488|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
161016707|NCT03692676|581449489|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
161016708|NCT03692676|581449490|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
161016709|NCT03692676|581449491|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
161016710|NCT03692676|581449488|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
161016711|NCT03692676|581449489|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
161016712|NCT03692676|581449490|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
161016713|NCT03692676|581449491|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
161016714|NCT03692676|581449488|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
161016715|NCT03692676|581449489|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
161016716|NCT03692676|581449490|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
161016717|NCT03692676|581449491|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
161016718|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
161016719|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
161016720|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
161016721|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
161016722|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
161016723|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
161016724|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
161016725|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
161016726|NCT03692676|581449488|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
161016727|NCT03692676|581449489|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
161016728|NCT03692676|581449490|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
161148056|NCT00972244|581924490|FG004|Overall Study|Safety|1|||
161148057|NCT00972244|581924486|FG000|Overall Study|Death|1|||
161272731|NCT01475097|582379514|FG001|Overall Study|Protocol Violation|1|||
161343571|NCT03034967|582644417|FG005|Overall Study|Lost to Follow-up|2|||
161016729|NCT03692676|581449491|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
161016730|NCT03692676|581449488|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
161148058|NCT00972244|581924487|FG001|Overall Study|Death|0|||
161148059|NCT00972244|581924488|FG002|Overall Study|Death|0|||
161016731|NCT03692676|581449489|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
161016732|NCT03692676|581449490|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
161016733|NCT03692676|581449491|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
161016734|NCT03692676|581449488|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
161016735|NCT03692676|581449489|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
161016736|NCT03692676|581449490|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
161016737|NCT03692676|581449491|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
161016738|NCT03692676|581449488|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161016739|NCT03692676|581449489|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161016740|NCT03692676|581449490|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
161016741|NCT03692676|581449491|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
161016742|NCT03692676|581449488|FG000|Overall Study|Other|0|||
161016743|NCT03692676|581449489|FG001|Overall Study|Other|805|||
161016744|NCT03692676|581449490|FG002|Overall Study|Other|758|||
161016745|NCT03692676|581449491|FG003|Overall Study|Other|277|||
161016746|NCT03692676|581449488|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161016747|NCT03692676|581449489|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161016748|NCT03692676|581449490|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
161016749|NCT03692676|581449491|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
161016750|NCT01180634|581449492|FG000|Overall Study|Adverse Event|4|||
161016751|NCT01180634|581449493|FG001|Overall Study|Adverse Event|1|||
161016752|NCT01180634|581449492|FG000|Overall Study|Miscellaneous|2|||
161016753|NCT01180634|581449493|FG001|Overall Study|Miscellaneous|0|||
161016754|NCT01180634|581449492|FG000|Overall Study|Withdrawal by Subject|4|||
161016755|NCT01180634|581449493|FG001|Overall Study|Withdrawal by Subject|0|||
161016756|NCT03692611|581449494|FG000|Overall Study|Found to be ineligible postrandomization|3|||
161016757|NCT03692611|581449495|FG001|Overall Study|Found to be ineligible postrandomization|0|||
161016758|NCT06311084|581449496|FG000|Overall Study|Lost to Follow-up|14|||
161016759|NCT03988634|581449497|FG000|Double-Blind|Adverse Event|4|||
161016760|NCT03988634|581449498|FG001|Double-Blind|Adverse Event|0|||
161016761|NCT03988634|581449499|FG002|Double-Blind|Adverse Event|0|||
161016762|NCT03988634|581449497|FG000|Double-Blind|Death|18|||
161016763|NCT03988634|581449498|FG001|Double-Blind|Death|26|||
161016764|NCT03988634|581449499|FG002|Double-Blind|Death|0|||
161016765|NCT03988634|581449497|FG000|Double-Blind|Lost to Follow-up|6|||
161016766|NCT03988634|581449498|FG001|Double-Blind|Lost to Follow-up|7|||
161016767|NCT03988634|581449499|FG002|Double-Blind|Lost to Follow-up|0|||
161016768|NCT03988634|581449497|FG000|Double-Blind|Physician Decision|9|||
161016769|NCT03988634|581449498|FG001|Double-Blind|Physician Decision|5|||
161016770|NCT03988634|581449499|FG002|Double-Blind|Physician Decision|0|||
161016771|NCT03988634|581449497|FG000|Double-Blind|Subject decision|24|||
161016772|NCT03988634|581449498|FG001|Double-Blind|Subject decision|13|||
161016773|NCT03988634|581449499|FG002|Double-Blind|Subject decision|0|||
161016774|NCT03988634|581449497|FG000|Open-Label|Adverse Event|0|||
161016775|NCT03988634|581449498|FG001|Open-Label|Adverse Event|0|||
161016776|NCT03988634|581449499|FG002|Open-Label|Adverse Event|7|||
161016777|NCT03988634|581449497|FG000|Open-Label|Physician Decision|0|||
161016778|NCT03988634|581449498|FG001|Open-Label|Physician Decision|0|||
161016779|NCT03988634|581449499|FG002|Open-Label|Physician Decision|1|||
161016780|NCT03988634|581449497|FG000|Open-Label|Technical problems|0|||
161016781|NCT03988634|581449498|FG001|Open-Label|Technical problems|0|||
161016782|NCT03988634|581449499|FG002|Open-Label|Technical problems|1|||
161016783|NCT04725240|581449500|FG000|Overall Study|Adverse Event|2|||
161016784|NCT04083235|581449519|FG000|Overall Study|Death|252|||
161016785|NCT04083235|581449520|FG001|Overall Study|Death|277|||
161016786|NCT04083235|581449519|FG000|Overall Study|Withdrawal by Subject|13|||
161016787|NCT04083235|581449520|FG001|Overall Study|Withdrawal by Subject|17|||
161016788|NCT04083235|581449519|FG000|Overall Study|Lost to Follow-up|1|||
161016789|NCT04083235|581449520|FG001|Overall Study|Lost to Follow-up|1|||
161016790|NCT04083235|581449519|FG000|Overall Study|Does not meet entry criteria|1|||
161016791|NCT04083235|581449520|FG001|Overall Study|Does not meet entry criteria|0|||
161016792|NCT04083235|581449519|FG000|Overall Study|Did not receive treatment|13|||
161016793|NCT04083235|581449520|FG001|Overall Study|Did not receive treatment|8|||
161016794|NCT04083235|581449519|FG000|Overall Study|Ongoing at the time of DCO|44|||
161016795|NCT04083235|581449520|FG001|Overall Study|Ongoing at the time of DCO|7|||
161016796|NCT03016169|581449523|FG000|Overall Study|Lost to Follow-up|4|||
161016797|NCT03016169|581449523|FG000|Overall Study|Death|54|||
161016798|NCT03016169|581449523|FG000|Overall Study|Device Explant|11|||
161016799|NCT03016169|581449523|FG000|Overall Study|Withdrawal by Subject|19|||
161016800|NCT03016169|581449523|FG000|Overall Study|Other Reasons|1|||
161016801|NCT04060355|581449524|FG000|Overall Study|Lost to Follow-up|41|||
161272732|NCT01305044|582379515|FG000|Overall Study|Withdrawal by Subject|3|||
161272733|NCT01305044|582379516|FG001|Overall Study|Withdrawal by Subject|6|||
161272734|NCT00492024|582379517|FG000|Treatment|Adverse Event|3|||
161272735|NCT00492024|582379518|FG001|Treatment|Adverse Event|1|||
161272736|NCT00492024|582379517|FG000|Treatment|Lack of Efficacy|21|||
161272737|NCT00492024|582379518|FG001|Treatment|Lack of Efficacy|20|||
161272738|NCT00492024|582379517|FG000|Treatment|Lost to Follow-up|3|||
161272739|NCT00492024|582379518|FG001|Treatment|Lost to Follow-up|1|||
161272740|NCT00492024|582379517|FG000|Treatment|Withdrawal by Subject|2|||
161272741|NCT00492024|582379518|FG001|Treatment|Withdrawal by Subject|0|||
161272742|NCT00492024|582379517|FG000|Follow up|Lack of Efficacy|0|||
161272743|NCT00492024|582379518|FG001|Follow up|Lack of Efficacy|1|||
161272744|NCT00492024|582379517|FG000|Follow up|Lost to Follow-up|1|||
161272745|NCT00492024|582379518|FG001|Follow up|Lost to Follow-up|1|||
161272746|NCT02861014|582379519|FG000|Primary Analysis|Adverse Event|7|||
161272747|NCT02861014|582379519|FG000|Primary Analysis|Death|1|||
161272748|NCT02861014|582379519|FG000|Primary Analysis|Lack of Efficacy|3|||
161272749|NCT02861014|582379519|FG000|Primary Analysis|Physician Decision|2|||
161272750|NCT02861014|582379519|FG000|Primary Analysis|Pregnancy|4|||
161272751|NCT02861014|582379519|FG000|Primary Analysis|Protocol Violation|2|||
161272752|NCT02861014|582379519|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
161272753|NCT02861014|582379519|FG000|Primary Analysis|Withdrawal by Subject|14|||
161272754|NCT02861014|582379519|FG000|Primary Analysis|Commercial ocrelizumab|3|||
161272755|NCT02861014|582379519|FG000|Safety Follow-up|Adverse Event|1|||
161272756|NCT02861014|582379519|FG000|Safety Follow-up|Pregnancy|1|||
161272757|NCT02861014|582379519|FG000|Safety Follow-up|Withdrawal by Subject|9|||
160968834|NCT00279201|581273407|FG004|Intensification Addendum|Lack of Efficacy|1|||
160968835|NCT00279201|581273408|FG005|Intensification Addendum|Lack of Efficacy|0|||
160968836|NCT00279201|581273403|FG000|Intensification Addendum|Death|0|||
160968837|NCT00279201|581273404|FG001|Intensification Addendum|Death|0|||
160968838|NCT00279201|581273405|FG002|Intensification Addendum|Death|0|||
160968839|NCT00279201|581273406|FG003|Intensification Addendum|Death|0|||
160968840|NCT00279201|581273407|FG004|Intensification Addendum|Death|1|||
160968841|NCT00279201|581273408|FG005|Intensification Addendum|Death|0|||
160968842|NCT00696384|581273419|FG000|Open Label Phase|Adverse Event|27|||
160968843|NCT00696384|581273420|FG001|Open Label Phase|Adverse Event|0|||
160968844|NCT00696384|581273421|FG002|Open Label Phase|Adverse Event|0|||
160968845|NCT00696384|581273419|FG000|Open Label Phase|Protocol Violation|18|||
160968846|NCT00696384|581273420|FG001|Open Label Phase|Protocol Violation|0|||
160968847|NCT00696384|581273421|FG002|Open Label Phase|Protocol Violation|0|||
160968848|NCT00696384|581273419|FG000|Open Label Phase|Lost to Follow-up|24|||
160968849|NCT00696384|581273420|FG001|Open Label Phase|Lost to Follow-up|0|||
160968850|NCT00696384|581273421|FG002|Open Label Phase|Lost to Follow-up|0|||
160968851|NCT00696384|581273419|FG000|Open Label Phase|Withdrawal by Subject|37|||
160968852|NCT00696384|581273420|FG001|Open Label Phase|Withdrawal by Subject|0|||
160968853|NCT00696384|581273421|FG002|Open Label Phase|Withdrawal by Subject|0|||
160968854|NCT00696384|581273419|FG000|Open Label Phase|Other|6|||
160968855|NCT00696384|581273420|FG001|Open Label Phase|Other|0|||
160968856|NCT00696384|581273421|FG002|Open Label Phase|Other|0|||
160968857|NCT00696384|581273419|FG000|Open Label Phase|Lack of Efficacy|3|||
160968858|NCT00696384|581273420|FG001|Open Label Phase|Lack of Efficacy|0|||
160968859|NCT00696384|581273421|FG002|Open Label Phase|Lack of Efficacy|0|||
160968860|NCT00696384|581273419|FG000|Open Label Phase|Physician Decision|4|||
160968861|NCT00696384|581273420|FG001|Open Label Phase|Physician Decision|0|||
160968862|NCT00696384|581273421|FG002|Open Label Phase|Physician Decision|0|||
160968863|NCT00696384|581273419|FG000|Double Blind Phase|Adverse Event|0|||
160968864|NCT00696384|581273420|FG001|Double Blind Phase|Adverse Event|2|||
160968865|NCT00696384|581273421|FG002|Double Blind Phase|Adverse Event|2|||
160968866|NCT00696384|581273419|FG000|Double Blind Phase|Lost to Follow-up|0|||
160968867|NCT00696384|581273420|FG001|Double Blind Phase|Lost to Follow-up|2|||
160968868|NCT00696384|581273421|FG002|Double Blind Phase|Lost to Follow-up|1|||
160968869|NCT00696384|581273419|FG000|Double Blind Phase|Withdrawal by Subject|0|||
160968870|NCT00696384|581273420|FG001|Double Blind Phase|Withdrawal by Subject|4|||
160968871|NCT00696384|581273421|FG002|Double Blind Phase|Withdrawal by Subject|3|||
160968872|NCT00696384|581273419|FG000|Double Blind Phase|Lack of Efficacy|0|||
160968873|NCT00696384|581273420|FG001|Double Blind Phase|Lack of Efficacy|1|||
160968874|NCT00696384|581273421|FG002|Double Blind Phase|Lack of Efficacy|0|||
160968875|NCT00696384|581273419|FG000|Double Blind Phase|Physician Decision|0|||
160968876|NCT00696384|581273420|FG001|Double Blind Phase|Physician Decision|2|||
160968877|NCT00696384|581273421|FG002|Double Blind Phase|Physician Decision|0|||
160968878|NCT03995784|581273425|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
160968879|NCT01489189|581273426|FG000|Overall Study|Withdrawal by Subject|20|||
160968880|NCT01489189|581273427|FG001|Overall Study|Withdrawal by Subject|23|||
161272758|NCT02861014|582379519|FG000|Safety Follow-up|Study terminated by sponsor|1|||
161272759|NCT02861014|582379519|FG000|Safety Follow-up|Physician Decision|1|||
161272760|NCT02861014|582379519|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
161272761|NCT02861014|582379519|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
161016802|NCT04421378|581449529|FG000|Overall Study|Adverse Event|2|||
161016803|NCT04421378|581449530|FG001|Overall Study|Adverse Event|7|||
161016804|NCT04421378|581449531|FG002|Overall Study|Adverse Event|0|||
161016805|NCT04421378|581449532|FG003|Overall Study|Adverse Event|1|||
161016806|NCT04421378|581449533|FG004|Overall Study|Adverse Event|0|||
161016807|NCT04421378|581449529|FG000|Overall Study|Physician Decision|1|||
161016808|NCT04421378|581449530|FG001|Overall Study|Physician Decision|2|||
161016809|NCT04421378|581449531|FG002|Overall Study|Physician Decision|0|||
161016810|NCT04421378|581449532|FG003|Overall Study|Physician Decision|0|||
161016811|NCT04421378|581449533|FG004|Overall Study|Physician Decision|0|||
161016812|NCT04421378|581449529|FG000|Overall Study|Progressive Disease|16|||
161016813|NCT04421378|581449530|FG001|Overall Study|Progressive Disease|4|||
161016814|NCT04421378|581449531|FG002|Overall Study|Progressive Disease|18|||
161016815|NCT04421378|581449532|FG003|Overall Study|Progressive Disease|11|||
161016816|NCT04421378|581449533|FG004|Overall Study|Progressive Disease|3|||
161016817|NCT04421378|581449529|FG000|Overall Study|Study Terminated by Sponsor|0|||
161016818|NCT04421378|581449530|FG001|Overall Study|Study Terminated by Sponsor|1|||
161016819|NCT04421378|581449531|FG002|Overall Study|Study Terminated by Sponsor|1|||
161016820|NCT04421378|581449532|FG003|Overall Study|Study Terminated by Sponsor|0|||
161016821|NCT04421378|581449533|FG004|Overall Study|Study Terminated by Sponsor|0|||
161016822|NCT04421378|581449529|FG000|Overall Study|Withdrawal by Subject|3|||
161016823|NCT04421378|581449530|FG001|Overall Study|Withdrawal by Subject|1|||
161016824|NCT04421378|581449531|FG002|Overall Study|Withdrawal by Subject|0|||
161016825|NCT04421378|581449532|FG003|Overall Study|Withdrawal by Subject|2|||
161016826|NCT04421378|581449533|FG004|Overall Study|Withdrawal by Subject|0|||
161016827|NCT04421378|581449529|FG000|Overall Study|Other|1|||
161016828|NCT04421378|581449530|FG001|Overall Study|Other|0|||
161016829|NCT04421378|581449531|FG002|Overall Study|Other|0|||
161016830|NCT04421378|581449532|FG003|Overall Study|Other|0|||
161016831|NCT04421378|581449533|FG004|Overall Study|Other|0|||
161016832|NCT03090152|581449534|FG000|Overall Study|Withdrawal by Subject|0|||
161016833|NCT03090152|581449535|FG001|Overall Study|Withdrawal by Subject|2|||
161016834|NCT03090152|581449536|FG002|Overall Study|Withdrawal by Subject|1|||
161016835|NCT03090152|581449534|FG000|Overall Study|Surgery Canceled|1|||
161016836|NCT03090152|581449535|FG001|Overall Study|Surgery Canceled|0|||
161016837|NCT03090152|581449536|FG002|Overall Study|Surgery Canceled|0|||
161016838|NCT03090152|581449534|FG000|Overall Study|Epidural catheter could not be placed|0|||
161016839|NCT03090152|581449535|FG001|Overall Study|Epidural catheter could not be placed|2|||
161016840|NCT03090152|581449536|FG002|Overall Study|Epidural catheter could not be placed|0|||
161016841|NCT04673929|581449537|FG000|Overall Study|Death|73|||
161016842|NCT04673929|581449537|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
161016843|NCT05082909|581449541|FG000|Overall Study|Protocol Violation|0|||
161016844|NCT05082909|581449542|FG001|Overall Study|Protocol Violation|0|||
161016845|NCT05082909|581449543|FG002|Overall Study|Protocol Violation|1|||
161016846|NCT05082909|581449544|FG003|Overall Study|Protocol Violation|0|||
161016847|NCT05082909|581449545|FG004|Overall Study|Protocol Violation|0|||
161016848|NCT05082909|581449546|FG005|Overall Study|Protocol Violation|0|||
161016849|NCT04088630|581449547|FG000|Overall Study|Lost to Follow-up|3|||
161016850|NCT04088630|581449548|FG001|Overall Study|Lost to Follow-up|2|||
161016851|NCT04088630|581449549|FG002|Overall Study|Lost to Follow-up|6|||
161016852|NCT04088630|581449547|FG000|Overall Study|Death|3|||
161016853|NCT04088630|581449548|FG001|Overall Study|Death|1|||
161016854|NCT04088630|581449549|FG002|Overall Study|Death|1|||
161016855|NCT04088630|581449547|FG000|Overall Study|Physician Decision|0|||
161016856|NCT04088630|581449548|FG001|Overall Study|Physician Decision|1|||
161016857|NCT04088630|581449549|FG002|Overall Study|Physician Decision|1|||
161016858|NCT03175029|581449550|FG000|Overall Study|Withdrawal by Subject|2|||
161016859|NCT03175029|581449551|FG001|Overall Study|Withdrawal by Subject|1|||
161272762|NCT03247816|582379520|FG000|Overall Study|Adverse Event|12|||
161272763|NCT03247816|582379520|FG000|Overall Study|Physician Decision|3|||
161272764|NCT03247816|582379520|FG000|Overall Study|Lack of Efficacy|1|||
161272765|NCT03247816|582379520|FG000|Overall Study|Lost to Follow-up|10|||
161272766|NCT03247816|582379520|FG000|Overall Study|Missing Feraccru stop date|3|||
161016860|NCT03175029|581449550|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
161016861|NCT03175029|581449551|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
161016862|NCT04024813|581449557|FG000|Overall Study|Study terminated by Sponsor|1|||
161016863|NCT03047928|581449558|FG000|Overall Study|Adverse Event|0|||
161016864|NCT03047928|581449559|FG001|Overall Study|Adverse Event|2|||
161016865|NCT03047928|581449560|FG002|Overall Study|Adverse Event|0|||
161016866|NCT03047928|581449558|FG000|Overall Study|Protocol Violation|0|||
161016867|NCT03047928|581449559|FG001|Overall Study|Protocol Violation|1|||
161016868|NCT03047928|581449560|FG002|Overall Study|Protocol Violation|0|||
161016869|NCT03047928|581449558|FG000|Overall Study|included in another protocol|0|||
161016870|NCT03047928|581449559|FG001|Overall Study|included in another protocol|1|||
161148060|NCT00972244|581924489|FG003|Overall Study|Death|0|||
161272767|NCT01439009|582379523|FG000|Overall Study|Physician Decision|5|||
161272768|NCT01439009|582379524|FG001|Overall Study|Physician Decision|3|||
161272769|NCT01439009|582379523|FG000|Overall Study|Protocol Violation|2|||
161272770|NCT01439009|582379524|FG001|Overall Study|Protocol Violation|0|||
161272771|NCT01439009|582379523|FG000|Overall Study|Deviation of exclusion criteria|1|||
161272772|NCT01439009|582379524|FG001|Overall Study|Deviation of exclusion criteria|0|||
161272773|NCT00926783|582379525|FG000|Overall Study|Incomplete CFAE Procedures|3|||
161016871|NCT03047928|581449560|FG002|Overall Study|included in another protocol|0|||
161016872|NCT02729311|581449561|FG000|Overall Study|Withdrawal by Subject|8|||
161016873|NCT02729311|581449562|FG001|Overall Study|Withdrawal by Subject|2|||
161016874|NCT05324124|581449563|FG000|Period 1|Withdrawal by Subject|1|||
161016875|NCT05324124|581449564|FG001|Period 1|Withdrawal by Subject|0|||
161016876|NCT05324124|581449563|FG000|Period 1|Physician Decision|0|||
161016877|NCT05324124|581449564|FG001|Period 1|Physician Decision|1|||
161016878|NCT04950660|581449565|FG000|Overall Study|Protocol Violation|4|||
161016879|NCT04950660|581449566|FG001|Overall Study|Protocol Violation|2|||
161016880|NCT04950660|581449565|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
161016881|NCT04950660|581449566|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
161016882|NCT04950660|581449565|FG000|Overall Study|Withdrawal by Subject|0|||
161016883|NCT04950660|581449566|FG001|Overall Study|Withdrawal by Subject|1|||
161016884|NCT04950660|581449565|FG000|Overall Study|Hypotension|1|||
161016885|NCT04950660|581449566|FG001|Overall Study|Hypotension|0|||
161016886|NCT04783935|581449569|FG000|Overall Study|Withdrawal by Subject|6|||
161016887|NCT04783935|581449569|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
161016888|NCT04783935|581449569|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
161016889|NCT04783935|581449569|FG000|Overall Study|Lost to Follow-up|3|||
161016890|NCT04783935|581449569|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
161016891|NCT02437318|581449570|FG000|Overall Study|Progressive disease|207|||
161016892|NCT02437318|581449571|FG001|Overall Study|Progressive disease|240|||
161016893|NCT02437318|581449570|FG000|Overall Study|Subject/guardian decision|24|||
161016894|NCT02437318|581449571|FG001|Overall Study|Subject/guardian decision|11|||
161016895|NCT02437318|581449570|FG000|Overall Study|Physician Decision|29|||
161016896|NCT02437318|581449571|FG001|Overall Study|Physician Decision|22|||
161016897|NCT02437318|581449570|FG000|Overall Study|Adverse Event|14|||
161016898|NCT02437318|581449571|FG001|Overall Study|Adverse Event|4|||
161016899|NCT02437318|581449570|FG000|Overall Study|Death|4|||
161016900|NCT02437318|581449571|FG001|Overall Study|Death|4|||
161016901|NCT02437318|581449570|FG000|Overall Study|Protocol deviation|5|||
161016902|NCT02437318|581449571|FG001|Overall Study|Protocol deviation|7|||
161016903|NCT02437318|581449570|FG000|Overall Study|Sponsor decision|1|||
161016904|NCT02437318|581449571|FG001|Overall Study|Sponsor decision|0|||
161016905|NCT00920621|581449575|FG000|Overall Study|Lost to Follow-up|16|||
161016906|NCT00920621|581449576|FG001|Overall Study|Lost to Follow-up|17|||
161016907|NCT00920621|581449577|FG002|Overall Study|Lost to Follow-up|19|||
161016908|NCT00920621|581449578|FG003|Overall Study|Lost to Follow-up|21|||
161016909|NCT00920621|581449575|FG000|Overall Study|Fetal/neonatal deaths|16|||
161016910|NCT00920621|581449576|FG001|Overall Study|Fetal/neonatal deaths|14|||
161016911|NCT00920621|581449577|FG002|Overall Study|Fetal/neonatal deaths|16|||
161016912|NCT00920621|581449578|FG003|Overall Study|Fetal/neonatal deaths|14|||
161016913|NCT00920621|581449575|FG000|Overall Study|Blood sample not collected|22|||
161016914|NCT00920621|581449576|FG001|Overall Study|Blood sample not collected|14|||
161016915|NCT00920621|581449577|FG002|Overall Study|Blood sample not collected|0|||
161016916|NCT00920621|581449578|FG003|Overall Study|Blood sample not collected|0|||
161016917|NCT06074523|581449579|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
161016918|NCT06074523|581449579|FG000|Overall Study|Withdrawal by Subject|1|||
161016919|NCT01195831|581450918|FG000|Overall Study|Lost to Follow-up|2|||
161016920|NCT01195831|581450919|FG001|Overall Study|Lost to Follow-up|4|||
161016921|NCT01195831|581450918|FG000|Overall Study|Withdrawal by Subject|2|||
161016922|NCT01195831|581450919|FG001|Overall Study|Withdrawal by Subject|2|||
161016923|NCT01195831|581450918|FG000|Overall Study|Adverse Event|4|||
161016924|NCT01195831|581450919|FG001|Overall Study|Adverse Event|2|||
161016925|NCT01195831|581450918|FG000|Overall Study|Protocol Violation|0|||
161016926|NCT01195831|581450919|FG001|Overall Study|Protocol Violation|2|||
161016927|NCT04490915|581450921|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161016928|NCT04490915|581450922|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
161016929|NCT04490915|581450921|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161016930|NCT04490915|581450922|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161016931|NCT04490915|581450921|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161016932|NCT04490915|581450922|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
161016933|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
161016934|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
161016935|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
161016936|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
161016937|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
161016938|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
161016939|NCT04490915|581450921|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
161016940|NCT04490915|581450922|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
161016941|NCT02287610|581450924|FG000|Overall Study|Lost to Follow-up|3|||
161016942|NCT02287610|581450924|FG000|Overall Study|Withdrawal by Subject|8|||
161016943|NCT02287610|581450924|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
161016944|NCT01426425|581450925|FG000|Overall Study|Exited prior to EP study|22|||
161016945|NCT01426425|581450925|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
161016946|NCT01426425|581450925|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
161016947|NCT03281291|581450931|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
161016948|NCT03281291|581450932|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
161016949|NCT03281291|581450933|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
161016950|NCT03281291|581450934|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
161016951|NCT03281291|581450935|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
161016952|NCT03281291|581450931|FG000|Overall Study|Protocol Deviation|2|||
161016953|NCT03281291|581450932|FG001|Overall Study|Protocol Deviation|0|||
161016954|NCT03281291|581450933|FG002|Overall Study|Protocol Deviation|1|||
161016955|NCT03281291|581450934|FG003|Overall Study|Protocol Deviation|2|||
161016956|NCT03281291|581450935|FG004|Overall Study|Protocol Deviation|1|||
161016957|NCT03281291|581450931|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
161016958|NCT03281291|581450932|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161016959|NCT03281291|581450933|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
161016960|NCT03281291|581450934|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
161016961|NCT03281291|581450935|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
161016962|NCT03281291|581450931|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
161016963|NCT03281291|581450932|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
161016964|NCT03281291|581450933|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
161016965|NCT03281291|581450934|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
161016966|NCT03281291|581450935|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
161016967|NCT03281291|581450931|FG000|Overall Study|Lost to Follow-up|10|||
161016968|NCT03281291|581450932|FG001|Overall Study|Lost to Follow-up|10|||
161016969|NCT03281291|581450933|FG002|Overall Study|Lost to Follow-up|4|||
161016970|NCT03281291|581450934|FG003|Overall Study|Lost to Follow-up|6|||
161016971|NCT03281291|581450935|FG004|Overall Study|Lost to Follow-up|10|||
161016972|NCT03281291|581450931|FG000|Overall Study|Other|0|||
161016973|NCT03281291|581450932|FG001|Overall Study|Other|2|||
161016974|NCT03281291|581450933|FG002|Overall Study|Other|0|||
161016975|NCT03281291|581450934|FG003|Overall Study|Other|2|||
161016976|NCT03281291|581450935|FG004|Overall Study|Other|1|||
161016977|NCT00512070|581450936|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
161016978|NCT00512070|581450937|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
161016979|NCT00512070|581450938|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
161016980|NCT00512070|581450936|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
161016981|NCT00512070|581450937|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
161016982|NCT00512070|581450938|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
161016983|NCT04956861|581450939|FG000|Overall Study|Withdrawal by Subject|4|||
161016984|NCT04956861|581450940|FG001|Overall Study|Withdrawal by Subject|4|||
161016985|NCT04956861|581450941|FG002|Overall Study|Withdrawal by Subject|2|||
161016986|NCT04956861|581450939|FG000|Overall Study|Physician Decision|4|||
161016987|NCT04956861|581450940|FG001|Overall Study|Physician Decision|5|||
161016988|NCT04956861|581450941|FG002|Overall Study|Physician Decision|1|||
161016989|NCT00961571|581450942|FG000|Overall Study|Physician Decision|39|||
161016990|NCT05862870|581450946|FG000|Overall Study|Lost to Follow-up|3|||
161016991|NCT02900924|581450947|FG000|Overall Study|Death|52|||
161016992|NCT02900924|581450947|FG000|Overall Study|Lost to Follow-up|4|||
161016993|NCT02900924|581450947|FG000|Overall Study|Withdrawal by Subject|20|||
161016994|NCT02900924|581450947|FG000|Overall Study|Missed Visit|33|||
161016995|NCT03143153|581450950|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
161016996|NCT03143153|581450951|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
161016997|NCT03143153|581450952|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
161016998|NCT03143153|581450950|FG000|Pre-Treatment|Participant withdrew consent|0|||
161148061|NCT00972244|581924490|FG004|Overall Study|Death|0|||
161148062|NCT00972244|581924486|FG000|Overall Study|Various|0|||
161016999|NCT03143153|581450951|FG001|Pre-Treatment|Participant withdrew consent|1|||
161017000|NCT03143153|581450952|FG002|Pre-Treatment|Participant withdrew consent|12|||
161017001|NCT03143153|581450950|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
161017002|NCT03143153|581450951|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
161017003|NCT03143153|581450952|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
161017004|NCT03143153|581450950|FG000|Pre-Treatment|Other Reasons|1|||
161017005|NCT03143153|581450951|FG001|Pre-Treatment|Other Reasons|2|||
161017006|NCT03143153|581450952|FG002|Pre-Treatment|Other Reasons|1|||
161017007|NCT03143153|581450950|FG000|Pre-Treatment|Disease Progression|1|||
161017008|NCT03143153|581450951|FG001|Pre-Treatment|Disease Progression|1|||
161017009|NCT03143153|581450952|FG002|Pre-Treatment|Disease Progression|2|||
161148063|NCT00972244|581924487|FG001|Overall Study|Various|0|||
161272774|NCT00926783|582379526|FG001|Overall Study|Incomplete CFAE Procedures|3|||
161017010|NCT03143153|581450950|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161017011|NCT03143153|581450951|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
161017012|NCT03143153|581450952|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
161017013|NCT03143153|581450950|FG000|Treatment|Disease progression|174|||
161017014|NCT03143153|581450951|FG001|Treatment|Disease progression|184|||
161017015|NCT03143153|581450952|FG002|Treatment|Disease progression|193|||
161017016|NCT03143153|581450950|FG000|Treatment|Study drug toxicity|59|||
161017017|NCT03143153|581450951|FG001|Treatment|Study drug toxicity|33|||
161017018|NCT03143153|581450952|FG002|Treatment|Study drug toxicity|40|||
161017019|NCT03143153|581450950|FG000|Treatment|Death|5|||
161017020|NCT03143153|581450951|FG001|Treatment|Death|3|||
161017021|NCT03143153|581450952|FG002|Treatment|Death|4|||
161017022|NCT03143153|581450950|FG000|Treatment|Adverse event unrelated to study drug|19|||
161017023|NCT03143153|581450951|FG001|Treatment|Adverse event unrelated to study drug|28|||
161017024|NCT03143153|581450952|FG002|Treatment|Adverse event unrelated to study drug|12|||
161017025|NCT03143153|581450950|FG000|Treatment|Participant request to discontinue study treatment|13|||
161017026|NCT03143153|581450951|FG001|Treatment|Participant request to discontinue study treatment|15|||
161017027|NCT03143153|581450952|FG002|Treatment|Participant request to discontinue study treatment|20|||
161017028|NCT03143153|581450950|FG000|Treatment|Participant withdrew consent|3|||
161017029|NCT03143153|581450951|FG001|Treatment|Participant withdrew consent|4|||
161017030|NCT03143153|581450952|FG002|Treatment|Participant withdrew consent|12|||
161017031|NCT03143153|581450950|FG000|Treatment|Pregnancy|1|||
161017032|NCT03143153|581450951|FG001|Treatment|Pregnancy|0|||
161017033|NCT03143153|581450952|FG002|Treatment|Pregnancy|0|||
161017034|NCT03143153|581450950|FG000|Treatment|Maximum clinical benefit|1|||
161017035|NCT03143153|581450951|FG001|Treatment|Maximum clinical benefit|3|||
161017036|NCT03143153|581450952|FG002|Treatment|Maximum clinical benefit|4|||
161017037|NCT03143153|581450950|FG000|Treatment|Completed treatment as per Protocol|13|||
161017038|NCT03143153|581450951|FG001|Treatment|Completed treatment as per Protocol|8|||
161017039|NCT03143153|581450952|FG002|Treatment|Completed treatment as per Protocol|0|||
161017040|NCT03143153|581450950|FG000|Treatment|Other reasons|12|||
161017041|NCT03143153|581450951|FG001|Treatment|Other reasons|7|||
161017042|NCT03143153|581450952|FG002|Treatment|Other reasons|15|||
161017043|NCT03143153|581450950|FG000|Treatment|Not reported|1|||
161017044|NCT03143153|581450951|FG001|Treatment|Not reported|0|||
161017045|NCT03143153|581450952|FG002|Treatment|Not reported|0|||
161017046|NCT02736409|581450953|FG000|Overall Study|Withdrawal by Subject|4|||
161017047|NCT02736409|581450954|FG001|Overall Study|Withdrawal by Subject|2|||
161017048|NCT02736409|581450955|FG002|Overall Study|Withdrawal by Subject|17|||
161017049|NCT02736409|581450956|FG003|Overall Study|Withdrawal by Subject|3|||
161017050|NCT02736409|581450953|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161017051|NCT02736409|581450954|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161017052|NCT02736409|581450955|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161017053|NCT02736409|581450956|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161017054|NCT02736409|581450953|FG000|Overall Study|Adverse Event|0|||
161017055|NCT02736409|581450954|FG001|Overall Study|Adverse Event|1|||
161017056|NCT02736409|581450955|FG002|Overall Study|Adverse Event|5|||
161017057|NCT02736409|581450956|FG003|Overall Study|Adverse Event|4|||
161017058|NCT02736409|581450953|FG000|Overall Study|Other|0|||
161017059|NCT02736409|581450954|FG001|Overall Study|Other|0|||
161017060|NCT02736409|581450955|FG002|Overall Study|Other|1|||
161017061|NCT02736409|581450956|FG003|Overall Study|Other|1|||
161017062|NCT02736409|581450953|FG000|Overall Study|Pregnancy|0|||
161017063|NCT02736409|581450954|FG001|Overall Study|Pregnancy|0|||
161017064|NCT02736409|581450955|FG002|Overall Study|Pregnancy|1|||
161017065|NCT02736409|581450956|FG003|Overall Study|Pregnancy|0|||
161017066|NCT02736409|581450953|FG000|Overall Study|Lost to Follow-up|0|||
161017067|NCT02736409|581450954|FG001|Overall Study|Lost to Follow-up|0|||
161017068|NCT02736409|581450955|FG002|Overall Study|Lost to Follow-up|2|||
161017069|NCT02736409|581450956|FG003|Overall Study|Lost to Follow-up|1|||
161017070|NCT02736409|581450953|FG000|Overall Study|Physician Decision|0|||
161017071|NCT02736409|581450954|FG001|Overall Study|Physician Decision|0|||
161017072|NCT02736409|581450955|FG002|Overall Study|Physician Decision|0|||
161017073|NCT02736409|581450956|FG003|Overall Study|Physician Decision|2|||
161017074|NCT01415154|581450957|FG000|Overall Study|Lack of Efficacy|4|||
161017075|NCT01415154|581450958|FG001|Overall Study|Lack of Efficacy|5|||
161017076|NCT01415154|581450957|FG000|Overall Study|Withdrawal by Subject|7|||
161017077|NCT01415154|581450958|FG001|Overall Study|Withdrawal by Subject|8|||
161017078|NCT01415154|581450957|FG000|Overall Study|Lost to Follow-up|1|||
161017079|NCT01415154|581450958|FG001|Overall Study|Lost to Follow-up|4|||
161017080|NCT01415154|581450957|FG000|Overall Study|Protocol Violation|0|||
161017081|NCT01415154|581450958|FG001|Overall Study|Protocol Violation|1|||
161017082|NCT01415154|581450957|FG000|Overall Study|Satisfactory Response|0|||
161017083|NCT01415154|581450958|FG001|Overall Study|Satisfactory Response|1|||
161017084|NCT01415154|581450957|FG000|Overall Study|Adverse Event|1|||
161017085|NCT01415154|581450958|FG001|Overall Study|Adverse Event|1|||
161017086|NCT03763708|581450962|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
161017087|NCT03763708|581450963|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017088|NCT03763708|581450964|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017089|NCT03763708|581450965|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017090|NCT03763708|581450966|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017091|NCT03763708|581450967|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017092|NCT03763708|581450968|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017093|NCT03763708|581450969|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017094|NCT03763708|581450970|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
161017095|NCT03763708|581450962|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017096|NCT03763708|581450963|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017097|NCT03763708|581450964|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
161017098|NCT03763708|581450965|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017099|NCT03763708|581450966|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017100|NCT03763708|581450967|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017101|NCT03763708|581450968|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017102|NCT03763708|581450969|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017103|NCT03763708|581450970|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
161017104|NCT03763708|581450962|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017105|NCT03763708|581450963|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017106|NCT03763708|581450964|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017107|NCT03763708|581450965|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
161017108|NCT03763708|581450966|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017109|NCT03763708|581450967|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017110|NCT03763708|581450968|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017111|NCT03763708|581450969|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017112|NCT03763708|581450970|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
161017113|NCT03763708|581450962|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017114|NCT03763708|581450963|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017115|NCT03763708|581450964|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017116|NCT03763708|581450965|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017117|NCT03763708|581450966|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
161017118|NCT03763708|581450967|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017119|NCT03763708|581450968|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017120|NCT03763708|581450969|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017121|NCT03763708|581450970|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
161017122|NCT03763708|581450962|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017123|NCT03763708|581450963|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017124|NCT03763708|581450964|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017125|NCT03763708|581450965|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017126|NCT03763708|581450966|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017127|NCT03763708|581450967|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
161017128|NCT03763708|581450968|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017129|NCT03763708|581450969|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017130|NCT03763708|581450970|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
161017131|NCT03763708|581450962|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017132|NCT03763708|581450963|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017133|NCT03763708|581450964|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017134|NCT03763708|581450965|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017135|NCT03763708|581450966|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017136|NCT03763708|581450967|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017137|NCT03763708|581450968|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
161017138|NCT03763708|581450969|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017139|NCT03763708|581450970|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
161017140|NCT03763708|581450962|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
161017141|NCT03763708|581450963|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
161017142|NCT03763708|581450964|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
161017143|NCT03763708|581450965|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
161017144|NCT03763708|581450966|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
161017145|NCT03763708|581450967|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
161017146|NCT03763708|581450968|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
161017147|NCT03763708|581450969|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
161017148|NCT03763708|581450970|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
161017149|NCT03763708|581450962|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
161017150|NCT03763708|581450963|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
161148064|NCT00972244|581924488|FG002|Overall Study|Various|0|||
161148065|NCT00972244|581924489|FG003|Overall Study|Various|0|||
161148066|NCT00972244|581924490|FG004|Overall Study|Various|2|||
161017151|NCT03763708|581450964|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
161017152|NCT03763708|581450965|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
161148067|NCT00090285|581924491|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
161272775|NCT00696787|582379528|FG000|Overall Study|Adverse Event|1|||
161272776|NCT00696787|582379529|FG001|Overall Study|Adverse Event|0|||
161272777|NCT00696787|582379530|FG002|Overall Study|Adverse Event|6|||
161272778|NCT00696787|582379528|FG000|Overall Study|Discontinuation by Sponsor|9|||
161272779|NCT00696787|582379529|FG001|Overall Study|Discontinuation by Sponsor|13|||
161272780|NCT00696787|582379530|FG002|Overall Study|Discontinuation by Sponsor|14|||
161017153|NCT03763708|581450966|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
161017154|NCT03763708|581450967|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
161017155|NCT03763708|581450968|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
161017156|NCT03763708|581450969|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
161017157|NCT03763708|581450970|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
161017158|NCT03763708|581450962|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
161017159|NCT03763708|581450963|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
161017160|NCT03763708|581450964|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
161017161|NCT03763708|581450965|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
161017162|NCT03763708|581450966|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
161017163|NCT03763708|581450967|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
161017164|NCT03763708|581450968|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
161017165|NCT03763708|581450969|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
161017166|NCT03763708|581450970|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
161017167|NCT04382404|581450973|FG000|Overall Study|Adverse Event|1|||
161017168|NCT04382404|581450973|FG000|Overall Study|Lost to Follow-up|2|||
161017169|NCT05687916|581450977|FG000|Overall Study|Adverse Event|1|||
161017170|NCT05687916|581450978|FG001|Overall Study|Adverse Event|2|||
161017171|NCT05687916|581450979|FG002|Overall Study|Adverse Event|0|||
161017172|NCT05687916|581450977|FG000|Overall Study|Withdrawal by Subject|1|||
161017173|NCT05687916|581450978|FG001|Overall Study|Withdrawal by Subject|0|||
161017174|NCT05687916|581450979|FG002|Overall Study|Withdrawal by Subject|1|||
161017175|NCT05687916|581450977|FG000|Overall Study|Protocol Violation|0|||
161017176|NCT05687916|581450978|FG001|Overall Study|Protocol Violation|2|||
161017177|NCT05687916|581450979|FG002|Overall Study|Protocol Violation|1|||
161017178|NCT05687916|581450977|FG000|Overall Study|Reason not Specified|1|||
161017179|NCT05687916|581450978|FG001|Overall Study|Reason not Specified|0|||
161017180|NCT05687916|581450979|FG002|Overall Study|Reason not Specified|0|||
161017181|NCT03406871|581450987|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
161017182|NCT03406871|581450988|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
161017183|NCT03406871|581450989|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
161017184|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
161017185|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
161017186|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
161017187|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
161017188|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
161017189|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
161017190|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
161017191|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
161017192|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
161017193|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Death|0|||
161017194|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Death|1|||
161017195|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Death|0|||
161017196|NCT03406871|581450987|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
161017197|NCT03406871|581450988|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
161017198|NCT03406871|581450989|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
161017199|NCT02243709|581451000|FG000|Phase 1|Lost to Follow-up|0|||
161017200|NCT02243709|581451001|FG001|Phase 1|Lost to Follow-up|1|||
161017201|NCT02243709|581451000|FG000|Phase 1|Withdrawal by Subject|1|||
161017202|NCT02243709|581451001|FG001|Phase 1|Withdrawal by Subject|0|||
161017203|NCT02243709|581451000|FG000|Phase 1|Protocol Violation|0|||
161017204|NCT02243709|581451001|FG001|Phase 1|Protocol Violation|1|||
161017205|NCT02243709|581451000|FG000|Phase 1|Adverse Event|0|||
161017206|NCT02243709|581451001|FG001|Phase 1|Adverse Event|1|||
161017207|NCT04177823|581451002|FG000|Overall Study|Physician Decision|1|||
161017208|NCT04177823|581451002|FG000|Overall Study|Withdrawal by Subject|1|||
161017209|NCT01748448|581451004|FG000|Treatment Period|Consent withdrawn by subject|1|||
161017210|NCT01748448|581451005|FG001|Treatment Period|Consent withdrawn by subject|0|||
161017211|NCT01748448|581451004|FG000|Treatment Period|Adverse Event|1|||
161017212|NCT01748448|581451005|FG001|Treatment Period|Adverse Event|0|||
161017213|NCT01748448|581451004|FG000|Treatment Period|Personal|0|||
161017214|NCT01748448|581451005|FG001|Treatment Period|Personal|1|||
161017215|NCT02913872|581451006|FG000|Overall Study|Withdrawal by Subject|1|||
161017216|NCT03110315|581451009|FG000|Overall Study|Withdrawal by Subject|1|||
161017217|NCT03110315|581451010|FG001|Overall Study|Withdrawal by Subject|0|||
161017218|NCT03978871|581451011|FG000|Overall Study|Lost to Follow-up|11|||
161017219|NCT03978871|581451012|FG001|Overall Study|Lost to Follow-up|12|||
161017220|NCT05710107|581451013|FG000|Overall Study|Withdrawal by Subject|1|||
161017221|NCT05710107|581451014|FG001|Overall Study|Withdrawal by Subject|1|||
161017222|NCT05710107|581451013|FG000|Overall Study|Lost to Follow-up|8|||
161017223|NCT05710107|581451014|FG001|Overall Study|Lost to Follow-up|9|||
161017224|NCT05710107|581451013|FG000|Overall Study|Unable to place assigned block|2|||
161017225|NCT05710107|581451014|FG001|Overall Study|Unable to place assigned block|0|||
161017226|NCT05710107|581451013|FG000|Overall Study|Withdrawn by study team|0|||
161017227|NCT05710107|581451014|FG001|Overall Study|Withdrawn by study team|1|||
161017228|NCT04166773|581451015|FG000|Overall Study|Adverse Event|2|||
161017229|NCT04166773|581451016|FG001|Overall Study|Adverse Event|0|||
161017230|NCT04166773|581451017|FG002|Overall Study|Adverse Event|2|||
161017231|NCT04166773|581451018|FG003|Overall Study|Adverse Event|1|||
161017232|NCT04166773|581451015|FG000|Overall Study|Lost to Follow-up|4|||
161017233|NCT04166773|581451016|FG001|Overall Study|Lost to Follow-up|2|||
161017234|NCT04166773|581451017|FG002|Overall Study|Lost to Follow-up|1|||
161017235|NCT04166773|581451018|FG003|Overall Study|Lost to Follow-up|3|||
161272781|NCT00696787|582379528|FG000|Overall Study|Lack of Efficacy|0|||
161272782|NCT00696787|582379529|FG001|Overall Study|Lack of Efficacy|1|||
161272783|NCT00696787|582379530|FG002|Overall Study|Lack of Efficacy|0|||
161272784|NCT00696787|582379528|FG000|Overall Study|Lost to Follow-up|4|||
161272785|NCT00696787|582379529|FG001|Overall Study|Lost to Follow-up|0|||
161272786|NCT00696787|582379530|FG002|Overall Study|Lost to Follow-up|3|||
161017236|NCT04166773|581451015|FG000|Overall Study|Physician Decision|0|||
161017237|NCT04166773|581451016|FG001|Overall Study|Physician Decision|0|||
161017238|NCT04166773|581451017|FG002|Overall Study|Physician Decision|0|||
161017239|NCT04166773|581451018|FG003|Overall Study|Physician Decision|1|||
161017240|NCT04166773|581451015|FG000|Overall Study|Withdrawal by Subject|1|||
161017241|NCT04166773|581451016|FG001|Overall Study|Withdrawal by Subject|1|||
161017242|NCT04166773|581451017|FG002|Overall Study|Withdrawal by Subject|2|||
161017243|NCT04166773|581451018|FG003|Overall Study|Withdrawal by Subject|5|||
161017244|NCT04072822|581451019|FG000|Treatment|Adverse Event|9|||
161017245|NCT04072822|581451020|FG001|Treatment|Adverse Event|5|||
161017246|NCT04072822|581451019|FG000|Treatment|Met Stopping Criteria|13|||
161017247|NCT04072822|581451020|FG001|Treatment|Met Stopping Criteria|24|||
161017248|NCT04072822|581451019|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
161017249|NCT04072822|581451020|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
161017250|NCT04072822|581451019|FG000|Treatment|Withdrawal by Subject|0|||
161017251|NCT04072822|581451020|FG001|Treatment|Withdrawal by Subject|2|||
161017252|NCT04072822|581451019|FG000|Treatment|Death|0|||
161017253|NCT04072822|581451020|FG001|Treatment|Death|2|||
161017254|NCT04072822|581451019|FG000|Treatment|Lost to Follow-up|11|||
161017255|NCT04072822|581451020|FG001|Treatment|Lost to Follow-up|3|||
161017256|NCT04072822|581451019|FG000|Treatment|Physician Decision|1|||
161017257|NCT04072822|581451020|FG001|Treatment|Physician Decision|0|||
161017258|NCT04072822|581451019|FG000|Treatment|Other|7|||
161017259|NCT04072822|581451020|FG001|Treatment|Other|9|||
161017260|NCT04072822|581451019|FG000|Follow-up|Withdrawal by Subject|1|||
161017261|NCT04072822|581451020|FG001|Follow-up|Withdrawal by Subject|0|||
161017262|NCT04072822|581451019|FG000|Follow-up|Lost to Follow-up|5|||
161017263|NCT04072822|581451020|FG001|Follow-up|Lost to Follow-up|4|||
161017264|NCT03033576|581451021|FG000|Overall Study|Ineligible|1|||
161017265|NCT03033576|581451022|FG001|Overall Study|Ineligible|1|||
161017266|NCT03033576|581451021|FG000|Overall Study|Adverse Event|4|||
161017267|NCT03033576|581451022|FG001|Overall Study|Adverse Event|20|||
161017268|NCT03033576|581451021|FG000|Overall Study|Progression/relapse|9|||
161017269|NCT03033576|581451022|FG001|Overall Study|Progression/relapse|36|||
161017270|NCT03033576|581451021|FG000|Overall Study|Death|1|||
161017271|NCT03033576|581451022|FG001|Overall Study|Death|1|||
161017272|NCT03033576|581451021|FG000|Overall Study|Patient refusal|1|||
161017273|NCT03033576|581451022|FG001|Overall Study|Patient refusal|6|||
161017274|NCT03033576|581451021|FG000|Overall Study|Other, unspecified reasons|0|||
161017275|NCT03033576|581451022|FG001|Overall Study|Other, unspecified reasons|4|||
161017276|NCT03033576|581451021|FG000|Overall Study|Currently on protocol therapy|0|||
161017277|NCT03033576|581451022|FG001|Overall Study|Currently on protocol therapy|2|||
161017278|NCT01214616|581451023|FG000|Overall Study|Progressive disease|2|||
161017279|NCT01214616|581451024|FG001|Overall Study|Progressive disease|2|||
161017280|NCT01214616|581451025|FG002|Overall Study|Progressive disease|2|||
161017281|NCT01214616|581451026|FG003|Overall Study|Progressive disease|4|||
161017282|NCT01214616|581451023|FG000|Overall Study|Dose limiting toxicity|0|||
161017283|NCT01214616|581451024|FG001|Overall Study|Dose limiting toxicity|2|||
161017284|NCT01214616|581451025|FG002|Overall Study|Dose limiting toxicity|0|||
161017285|NCT01214616|581451026|FG003|Overall Study|Dose limiting toxicity|0|||
161017286|NCT01214616|581451023|FG000|Overall Study|Other adverse events|0|||
161017287|NCT01214616|581451024|FG001|Overall Study|Other adverse events|1|||
161017288|NCT01214616|581451025|FG002|Overall Study|Other adverse events|1|||
161017289|NCT01214616|581451026|FG003|Overall Study|Other adverse events|1|||
161017290|NCT01214616|581451023|FG000|Overall Study|Withdrawal by Subject|1|||
161017291|NCT01214616|581451024|FG001|Overall Study|Withdrawal by Subject|0|||
161017292|NCT01214616|581451025|FG002|Overall Study|Withdrawal by Subject|0|||
161017293|NCT01214616|581451026|FG003|Overall Study|Withdrawal by Subject|1|||
161017294|NCT02949362|581451027|FG000|Retrospective Period|Inform consent not signed by participant|4|||
161017295|NCT02949362|581451028|FG001|Retrospective Period|Inform consent not signed by participant|1|||
161017296|NCT02949362|581451029|FG002|Retrospective Period|Inform consent not signed by participant|0|||
161017297|NCT02949362|581451030|FG003|Retrospective Period|Inform consent not signed by participant|0|||
161017298|NCT02949362|581451027|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161017299|NCT02949362|581451028|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161017300|NCT02949362|581451029|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
161017301|NCT02949362|581451030|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
161017302|NCT02949362|581451027|FG000|Prospective Period|Other|0|||
161017303|NCT02949362|581451028|FG001|Prospective Period|Other|0|||
161017304|NCT02949362|581451029|FG002|Prospective Period|Other|0|||
161017305|NCT02949362|581451030|FG003|Prospective Period|Other|4|||
161017306|NCT05268302|581451031|FG000|Overall Study|Death|0|||
161017307|NCT05268302|581451032|FG001|Overall Study|Death|1|||
161017308|NCT02811679|581451033|FG000|Overall Study|Adverse Event|1|||
161017309|NCT02811679|581451033|FG000|Overall Study|Lack of Efficacy|6|||
161017310|NCT02811679|581451033|FG000|Overall Study|Early study closure due to slow accrual|3|||
161017311|NCT05319860|581451034|FG000|Overall Study|Death|1|||
161017312|NCT05319860|581451035|FG001|Overall Study|Death|1|||
161017313|NCT05319860|581451034|FG000|Overall Study|Lost to Follow-up|3|||
161017314|NCT05319860|581451035|FG001|Overall Study|Lost to Follow-up|1|||
161017315|NCT05319860|581451034|FG000|Overall Study|Withdrawal by Subject|1|||
161017316|NCT05319860|581451035|FG001|Overall Study|Withdrawal by Subject|7|||
161017317|NCT04314895|581451036|FG000|Overall Study|Lost to Follow-up|1|||
161017318|NCT04314895|581451036|FG000|Overall Study|Death|10|||
161017319|NCT04314895|581451036|FG000|Overall Study|Physician Decision|2|||
161017320|NCT01361711|581451037|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
161017321|NCT01361711|581451037|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
161017322|NCT01361711|581451037|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
161017323|NCT01361711|581451037|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
161017324|NCT01361711|581451037|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
161017325|NCT01361711|581451037|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
161017326|NCT01361711|581451037|FG000|Completed Week 18 of Treatment|Other|9|||
161017327|NCT01361711|581451037|FG000|10 Year Follow-up|Still in follow-up|22|||
161017328|NCT01361711|581451037|FG000|10 Year Follow-up|Death|7|||
161017329|NCT01361711|581451037|FG000|10 Year Follow-up|Developed new cancer|1|||
161017330|NCT01361711|581451037|FG000|10 Year Follow-up|Lost to Follow-up|2|||
161017331|NCT01361711|581451037|FG000|10 Year Follow-up|New treatment started|6|||
161017332|NCT01361711|581451037|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
161017333|NCT01361711|581451037|FG000|10 Year Follow-up|Progressive Disease|1|||
161017334|NCT02187003|581453098|FG000|Overall Study|Adverse Event|2|||
161017335|NCT02187003|581453099|FG001|Overall Study|Adverse Event|0|||
161017336|NCT02187003|581453098|FG000|Overall Study|Lost to Follow-up|14|||
161017337|NCT02187003|581453099|FG001|Overall Study|Lost to Follow-up|10|||
161017338|NCT02187003|581453098|FG000|Overall Study|Withdrawal by Subject|3|||
161017339|NCT02187003|581453099|FG001|Overall Study|Withdrawal by Subject|7|||
161017340|NCT02187003|581453098|FG000|Overall Study|Protocol Violation|2|||
161017341|NCT02187003|581453099|FG001|Overall Study|Protocol Violation|4|||
161017342|NCT02187003|581453098|FG000|Overall Study|Other|5|||
161017343|NCT02187003|581453099|FG001|Overall Study|Other|5|||
161017344|NCT02187003|581453098|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161017345|NCT02187003|581453099|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
161017346|NCT05816551|581453100|FG000|Overall Study|Withdrawal by Subject|0|||
161017347|NCT05816551|581453101|FG001|Overall Study|Withdrawal by Subject|1|||
161017348|NCT05816551|581453100|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
161017349|NCT05816551|581453101|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
161017350|NCT04593472|581453104|FG000|Overall Study|Death|31|||
161017351|NCT04593472|581453105|FG001|Overall Study|Death|27|||
161017352|NCT04593472|581453104|FG000|Overall Study|Withdrawal by Subject|12|||
161017353|NCT04593472|581453105|FG001|Overall Study|Withdrawal by Subject|12|||
161017354|NCT04593472|581453104|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
161017355|NCT04593472|581453105|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
161017356|NCT04593472|581453104|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
161017357|NCT04593472|581453105|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
161017358|NCT04593472|581453104|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
161017359|NCT04593472|581453105|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
161017360|NCT04593472|581453104|FG000|Overall Study|Lost to Follow-up|0|||
161017361|NCT04593472|581453105|FG001|Overall Study|Lost to Follow-up|2|||
161017362|NCT04593472|581453104|FG000|Overall Study|Still collecting 24-month assessment|17|||
161017363|NCT04593472|581453105|FG001|Overall Study|Still collecting 24-month assessment|10|||
161017364|NCT03648840|581453108|FG000|First IV Infusion Session|Adverse Event|0|||
161017365|NCT03648840|581453109|FG001|First IV Infusion Session|Adverse Event|2|||
161017366|NCT03648840|581453108|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
161017367|NCT03648840|581453109|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
161017368|NCT03648840|581453108|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
161017369|NCT03648840|581453109|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
161017370|NCT03648840|581453108|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
161017371|NCT03648840|581453109|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
161017372|NCT05382936|581453110|FG000|Overall Study|Progressive Disease|3|||
161017373|NCT05382936|581453111|FG001|Overall Study|Progressive Disease|5|||
161017374|NCT05382936|581453112|FG002|Overall Study|Progressive Disease|2|||
161017375|NCT05382936|581453113|FG003|Overall Study|Progressive Disease|5|||
161017376|NCT05382936|581453110|FG000|Overall Study|Adverse Event|0|||
161017377|NCT05382936|581453111|FG001|Overall Study|Adverse Event|1|||
161017378|NCT05382936|581453112|FG002|Overall Study|Adverse Event|1|||
161017379|NCT05382936|581453113|FG003|Overall Study|Adverse Event|0|||
161017380|NCT05382936|581453110|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161017381|NCT05382936|581453111|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
161017382|NCT05382936|581453112|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161017383|NCT05382936|581453113|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
161017384|NCT05382936|581453110|FG000|Overall Study|Withdrawal by Subject|0|||
161017385|NCT05382936|581453111|FG001|Overall Study|Withdrawal by Subject|0|||
161017386|NCT05382936|581453112|FG002|Overall Study|Withdrawal by Subject|1|||
161017387|NCT05382936|581453113|FG003|Overall Study|Withdrawal by Subject|1|||
161017388|NCT05063994|581453114|FG000|Cortef Run-In|Withdrawal of Consent|1|||
161017389|NCT05063994|581453115|FG001|Cortef Run-In|Withdrawal of Consent|0|||
161017390|NCT05063994|581453116|FG002|Cortef Run-In|Withdrawal of Consent|0|||
161017391|NCT05063994|581453114|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
161017392|NCT05063994|581453115|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
161017393|NCT05063994|581453116|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
161017394|NCT05063994|581453114|FG000|Treatment|Physician Decision|0|||
161017395|NCT05063994|581453115|FG001|Treatment|Physician Decision|0|||
161017396|NCT05063994|581453116|FG002|Treatment|Physician Decision|1|||
161017397|NCT05063994|581453114|FG000|Treatment|Withdrawal by Subject|0|||
161017398|NCT05063994|581453115|FG001|Treatment|Withdrawal by Subject|0|||
161017399|NCT05063994|581453116|FG002|Treatment|Withdrawal by Subject|1|||
161017400|NCT05063994|581453114|FG000|Treatment|Withdrawal of Consent|0|||
161017401|NCT05063994|581453115|FG001|Treatment|Withdrawal of Consent|0|||
161017402|NCT05063994|581453116|FG002|Treatment|Withdrawal of Consent|1|||
161017403|NCT00667251|581453120|FG000|Overall Study|Disease progression|232|||
161017404|NCT00667251|581453121|FG001|Overall Study|Disease progression|203|||
161017405|NCT00667251|581453120|FG000|Overall Study|Toxicity|44|||
161017406|NCT00667251|581453121|FG001|Overall Study|Toxicity|23|||
161017407|NCT00667251|581453120|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
161017408|NCT00667251|581453121|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
161017409|NCT00667251|581453120|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
161017410|NCT00667251|581453121|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
161017411|NCT00667251|581453120|FG000|Overall Study|Symptomatic progression|8|||
161017412|NCT00667251|581453121|FG001|Overall Study|Symptomatic progression|4|||
161017413|NCT00667251|581453120|FG000|Overall Study|Death|6|||
161017414|NCT00667251|581453121|FG001|Overall Study|Death|11|||
161017415|NCT00667251|581453120|FG000|Overall Study|Intercurrent illness|5|||
161017416|NCT00667251|581453121|FG001|Overall Study|Intercurrent illness|6|||
161017417|NCT00667251|581453120|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
161017418|NCT00667251|581453121|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
161017419|NCT00667251|581453120|FG000|Overall Study|Randomized not Treated|4|||
161017420|NCT00667251|581453121|FG001|Overall Study|Randomized not Treated|1|||
161017421|NCT02995434|581453122|FG000|Overall Study|Adverse Event|1|||
161017422|NCT02995434|581453123|FG001|Overall Study|Adverse Event|0|||
161017423|NCT02995434|581453122|FG000|Overall Study|Withdrawal by Subject|6|||
161017424|NCT02995434|581453123|FG001|Overall Study|Withdrawal by Subject|3|||
161017425|NCT04150718|581453129|FG000|Overall Study|Withdrawal by Subject|2|||
161017426|NCT04150718|581453130|FG001|Overall Study|Withdrawal by Subject|7|||
161148068|NCT00090285|581924492|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
161272787|NCT00696787|582379528|FG000|Overall Study|Withdrawal by Subject|0|||
161272788|NCT00696787|582379529|FG001|Overall Study|Withdrawal by Subject|3|||
161272789|NCT00696787|582379530|FG002|Overall Study|Withdrawal by Subject|2|||
161272790|NCT00696787|582379528|FG000|Overall Study|Failed to return|1|||
161272791|NCT00696787|582379529|FG001|Overall Study|Failed to return|3|||
161017427|NCT04150718|581453131|FG002|Overall Study|Withdrawal by Subject|1|||
161017428|NCT04150718|581453129|FG000|Overall Study|Lost to Follow-up|1|||
161272792|NCT00696787|582379530|FG002|Overall Study|Failed to return|1|||
161272793|NCT00867503|582379532|FG000|Overall Study|Withdrawal by Subject|1|||
161272794|NCT02704403|582379533|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
161343572|NCT03034967|582644412|FG000|Overall Study|Liver function test abnormality|0|||
161343573|NCT03034967|582644413|FG001|Overall Study|Liver function test abnormality|0|||
161343574|NCT03034967|582644414|FG002|Overall Study|Liver function test abnormality|1|||
161017429|NCT04150718|581453130|FG001|Overall Study|Lost to Follow-up|2|||
161017430|NCT04150718|581453131|FG002|Overall Study|Lost to Follow-up|0|||
161017431|NCT04150718|581453129|FG000|Overall Study|Ineligible|1|||
161017432|NCT04150718|581453130|FG001|Overall Study|Ineligible|0|||
161017433|NCT04150718|581453131|FG002|Overall Study|Ineligible|10|||
161017434|NCT04034251|581453132|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
161017435|NCT04034251|581453133|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
161017436|NCT04034251|581453134|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
161017437|NCT05034952|581453135|FG000|Overall Study|Adverse Event|1|||
161017438|NCT05034952|581453136|FG001|Overall Study|Adverse Event|0|||
161017439|NCT05034952|581453137|FG002|Overall Study|Adverse Event|0|||
161017440|NCT05034952|581453138|FG003|Overall Study|Adverse Event|0|||
161017441|NCT05034952|581453135|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
161017442|NCT05034952|581453136|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
161017443|NCT05034952|581453137|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
161017444|NCT05034952|581453138|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
161017445|NCT05034952|581453135|FG000|Overall Study|Lost to Follow-up|1|||
161017446|NCT05034952|581453136|FG001|Overall Study|Lost to Follow-up|4|||
161148069|NCT00090285|581924493|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161148070|NCT00090285|581924494|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161148071|NCT00090285|581924495|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161148072|NCT00090285|581924496|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161148073|NCT00090285|581924491|FG000|Base Study Vaccination Period|Adverse Event|2|||
161148074|NCT00090285|581924492|FG001|Base Study Vaccination Period|Adverse Event|4|||
161148075|NCT00090285|581924493|FG002|Base Study Vaccination Period|Adverse Event|0|||
161148076|NCT00090285|581924494|FG003|Base Study Vaccination Period|Adverse Event|0|||
161148077|NCT00090285|581924495|FG004|Base Study Vaccination Period|Adverse Event|0|||
161148078|NCT00090285|581924496|FG005|Base Study Vaccination Period|Adverse Event|0|||
161148079|NCT00090285|581924491|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
161148080|NCT00090285|581924492|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
161148081|NCT00090285|581924493|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161148082|NCT00090285|581924494|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161148083|NCT00090285|581924495|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161148084|NCT00090285|581924496|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
161148085|NCT00090285|581924491|FG000|Base Study Vaccination Period|Protocol Violation|2|||
161148086|NCT00090285|581924492|FG001|Base Study Vaccination Period|Protocol Violation|3|||
161148087|NCT00090285|581924493|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161148088|NCT00090285|581924494|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161148089|NCT00090285|581924495|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161148090|NCT00090285|581924496|FG005|Base Study Vaccination Period|Protocol Violation|0|||
161148091|NCT00090285|581924491|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
161148092|NCT00090285|581924492|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
161148093|NCT00090285|581924493|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161148094|NCT00090285|581924494|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161148095|NCT00090285|581924495|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161148096|NCT00090285|581924496|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
160968881|NCT01489189|581273426|FG000|Overall Study|Death|10|||
160968882|NCT01489189|581273427|FG001|Overall Study|Death|8|||
160968883|NCT01489189|581273426|FG000|Overall Study|Missed Visit|1|||
160968884|NCT01489189|581273427|FG001|Overall Study|Missed Visit|4|||
160968885|NCT04225988|581273428|FG000|Overall Study|Withdrawal by Subject|2|||
160968886|NCT04225988|581273429|FG001|Overall Study|Withdrawal by Subject|0|||
160968887|NCT00112580|581273430|FG000|Overall Study|Adverse Event|1|||
160968888|NCT00112580|581273431|FG001|Overall Study|Adverse Event|2|||
160968889|NCT00112580|581273430|FG000|Overall Study|Disease progression|5|||
160968890|NCT00112580|581273431|FG001|Overall Study|Disease progression|16|||
160968891|NCT00112580|581273430|FG000|Overall Study|Participant withdrew consent|2|||
160968892|NCT00112580|581273431|FG001|Overall Study|Participant withdrew consent|1|||
160968893|NCT05619003|581273434|FG000|Overall Study|Adverse Event|1|||
160968894|NCT07018999|581273439|FG000|Overall Study|Protocol Violation|0|||
160968895|NCT07018999|581273440|FG001|Overall Study|Protocol Violation|1|||
160968896|NCT07018999|581273439|FG000|Overall Study|Incomplete data entry|4|||
160968897|NCT07018999|581273440|FG001|Overall Study|Incomplete data entry|7|||
160968898|NCT04739761|581273442|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
160968899|NCT04739761|581273443|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
160968900|NCT04739761|581273442|FG000|Overall Study|By complete response from the participant|1|||
160968901|NCT04739761|581273443|FG001|Overall Study|By complete response from the participant|0|||
160968902|NCT04739761|581273442|FG000|Overall Study|Lost to Follow-up|3|||
160968903|NCT04739761|581273443|FG001|Overall Study|Lost to Follow-up|3|||
160968904|NCT04739761|581273442|FG000|Overall Study|Death|13|||
160968905|NCT04739761|581273443|FG001|Overall Study|Death|13|||
161272795|NCT02704403|582379534|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
161272796|NCT02704403|582379533|FG000|Overall Study|Administrative reasons by sponsor|1251|||
161272797|NCT02704403|582379534|FG001|Overall Study|Administrative reasons by sponsor|616|||
161272798|NCT02704403|582379533|FG000|Overall Study|Death|4|||
161272799|NCT02704403|582379534|FG001|Overall Study|Death|3|||
161272800|NCT02704403|582379533|FG000|Overall Study|Endpoint event|52|||
161272801|NCT02704403|582379534|FG001|Overall Study|Endpoint event|24|||
161272802|NCT02704403|582379533|FG000|Overall Study|Lost to Follow-up|22|||
161272803|NCT02704403|582379534|FG001|Overall Study|Lost to Follow-up|11|||
161272804|NCT02704403|582379533|FG000|Overall Study|Protocol Violation|15|||
161272805|NCT02704403|582379534|FG001|Overall Study|Protocol Violation|15|||
161272806|NCT02704403|582379533|FG000|Overall Study|Adverse Event|2|||
161272807|NCT02704403|582379534|FG001|Overall Study|Adverse Event|0|||
161272808|NCT02704403|582379533|FG000|Overall Study|Withdrawal by Subject|85|||
161272809|NCT02704403|582379534|FG001|Overall Study|Withdrawal by Subject|45|||
161272810|NCT02704403|582379533|FG000|Overall Study|Investigator decision|1|||
161272811|NCT02704403|582379534|FG001|Overall Study|Investigator decision|1|||
161272812|NCT02704403|582379533|FG000|Overall Study|Follow-up not possible|1|||
161272813|NCT02704403|582379534|FG001|Overall Study|Follow-up not possible|2|||
161272814|NCT00927394|582379543|FG000|Overall Study|Adverse Event|14|||
161272815|NCT00927394|582379544|FG001|Overall Study|Adverse Event|9|||
161272816|NCT00927394|582379543|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
161272817|NCT00927394|582379544|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
161272818|NCT00927394|582379543|FG000|Overall Study|Withdrawal by Subject|20|||
161272819|NCT00927394|582379544|FG001|Overall Study|Withdrawal by Subject|24|||
161272820|NCT00927394|582379543|FG000|Overall Study|Lost to Follow-up|8|||
161272821|NCT00927394|582379544|FG001|Overall Study|Lost to Follow-up|14|||
161272822|NCT00927394|582379543|FG000|Overall Study|Administrative Problem|1|||
160968906|NCT04739761|581273442|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
160968907|NCT04739761|581273443|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
160968908|NCT04739761|581273442|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
160968909|NCT04739761|581273443|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
160968910|NCT04739761|581273442|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
160968911|NCT04739761|581273443|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
160968912|NCT04739761|581273442|FG000|Overall Study|Adverse Event|0|||
160968913|NCT04739761|581273443|FG001|Overall Study|Adverse Event|3|||
160968914|NCT04739761|581273442|FG000|Overall Study|Participant decision|1|||
160968915|NCT04739761|581273443|FG001|Overall Study|Participant decision|0|||
160968916|NCT04739761|581273442|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
160968917|NCT04739761|581273443|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
160968918|NCT04739761|581273442|FG000|Overall Study|Participant immediately started next line of treatment|1|||
160968919|NCT04739761|581273443|FG001|Overall Study|Participant immediately started next line of treatment|0|||
160968920|NCT04739761|581273442|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
160968921|NCT04739761|581273443|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
160968922|NCT04739761|581273442|FG000|Overall Study|Lack of clinical benefit|1|||
160968923|NCT04739761|581273443|FG001|Overall Study|Lack of clinical benefit|0|||
160968924|NCT04739761|581273442|FG000|Overall Study|Disease progression|5|||
160968925|NCT04739761|581273443|FG001|Overall Study|Disease progression|5|||
160968926|NCT04739761|581273442|FG000|Overall Study|Withdrawal by Subject|14|||
160968927|NCT04739761|581273443|FG001|Overall Study|Withdrawal by Subject|13|||
160968928|NCT04739761|581273442|FG000|Overall Study|Protocol Violation|1|||
160968929|NCT04739761|581273443|FG001|Overall Study|Protocol Violation|0|||
160968930|NCT04739761|581273442|FG000|Overall Study|Physician Decision|2|||
160968931|NCT04739761|581273443|FG001|Overall Study|Physician Decision|0|||
160968932|NCT03881696|581273447|FG000|Overall Study|Adverse Event|2|||
160968933|NCT03881696|581273448|FG001|Overall Study|Adverse Event|0|||
160968934|NCT03881696|581273447|FG000|Overall Study|Withdrawal by Subject|2|||
160968935|NCT03881696|581273448|FG001|Overall Study|Withdrawal by Subject|0|||
160968936|NCT03881696|581273447|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
160968937|NCT03881696|581273448|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
160968938|NCT03881696|581273447|FG000|Overall Study|Failure to meet continuation criteria|1|||
160968939|NCT03881696|581273448|FG001|Overall Study|Failure to meet continuation criteria|0|||
160968940|NCT00856167|581273450|FG000|Period 1|Withdrawal by Subject|1|||
160968941|NCT00856167|581273451|FG001|Period 1|Withdrawal by Subject|4|||
160968942|NCT00856167|581273452|FG002|Period 1|Withdrawal by Subject|0|||
160968943|NCT00856167|581273453|FG003|Period 1|Withdrawal by Subject|0|||
161017447|NCT05034952|581453137|FG002|Overall Study|Lost to Follow-up|3|||
161272823|NCT00927394|582379544|FG001|Overall Study|Administrative Problem|0|||
160968944|NCT00856167|581273450|FG000|Period 1|Lost to Follow-up|2|||
160968945|NCT00856167|581273451|FG001|Period 1|Lost to Follow-up|1|||
160968946|NCT00856167|581273452|FG002|Period 1|Lost to Follow-up|0|||
161272824|NCT00927394|582379543|FG000|Overall Study|Death|1|||
161272825|NCT00927394|582379544|FG001|Overall Study|Death|1|||
161272826|NCT00927394|582379543|FG000|Overall Study|Protocol deviation|16|||
161272827|NCT00927394|582379544|FG001|Overall Study|Protocol deviation|13|||
161272828|NCT00927394|582379543|FG000|Overall Study|Randomized in error|0|||
161272829|NCT00927394|582379544|FG001|Overall Study|Randomized in error|1|||
161272830|NCT04623086|582379545|FG000|Overall Study|Withdrawal by Subject|0|||
161272831|NCT04623086|582379546|FG001|Overall Study|Withdrawal by Subject|0|||
161272832|NCT04623086|582379547|FG002|Overall Study|Withdrawal by Subject|10|||
161272833|NCT03464630|582379548|FG000|Overall Study|Lost to Follow-up|62|||
161272834|NCT03464630|582379549|FG001|Overall Study|Lost to Follow-up|52|||
161272835|NCT03464630|582379548|FG000|Overall Study|Withdrawal by Subject|16|||
161272836|NCT03464630|582379549|FG001|Overall Study|Withdrawal by Subject|10|||
161272837|NCT03464630|582379548|FG000|Overall Study|Passive Disengagement|8|||
161272838|NCT03464630|582379549|FG001|Overall Study|Passive Disengagement|4|||
161272839|NCT00715624|582379550|FG000|Overall Study|Adverse Event|12|||
161272840|NCT00715624|582379551|FG001|Overall Study|Adverse Event|37|||
161272841|NCT00715624|582379550|FG000|Overall Study|Lack of Efficacy|11|||
161272842|NCT00715624|582379551|FG001|Overall Study|Lack of Efficacy|11|||
161272843|NCT00715624|582379550|FG000|Overall Study|Lost to Follow-up|1|||
161272844|NCT00715624|582379551|FG001|Overall Study|Lost to Follow-up|2|||
161272845|NCT00715624|582379550|FG000|Overall Study|Protocol Violation|1|||
161272846|NCT00715624|582379551|FG001|Overall Study|Protocol Violation|0|||
161272847|NCT00715624|582379550|FG000|Overall Study|Withdrawal by Subject|11|||
161272848|NCT00715624|582379551|FG001|Overall Study|Withdrawal by Subject|25|||
161272849|NCT00715624|582379550|FG000|Overall Study|Familial and personal reasons|10|||
161272850|NCT00715624|582379551|FG001|Overall Study|Familial and personal reasons|22|||
161272851|NCT00715624|582379550|FG000|Overall Study|Poor compliance|6|||
161272852|NCT00715624|582379551|FG001|Overall Study|Poor compliance|13|||
161272853|NCT00715624|582379550|FG000|Overall Study|Sponsor decision|0|||
161272854|NCT00715624|582379551|FG001|Overall Study|Sponsor decision|4|||
161272855|NCT00715624|582379550|FG000|Overall Study|Incorrect randomization (not treated)|0|||
161272856|NCT00715624|582379551|FG001|Overall Study|Incorrect randomization (not treated)|1|||
161272857|NCT00715624|582379550|FG000|Overall Study|Other|0|||
161272858|NCT00715624|582379551|FG001|Overall Study|Other|1|||
161272859|NCT04524364|582379555|FG000|Overall Study|Physician Decision|3|||
161272860|NCT04524364|582379556|FG001|Overall Study|Physician Decision|6|||
161272861|NCT04524364|582379555|FG000|Overall Study|Adverse Event|0|||
161272862|NCT04524364|582379556|FG001|Overall Study|Adverse Event|1|||
161272863|NCT04524364|582379555|FG000|Overall Study|Investigational device deficiency|0|||
161272864|NCT04524364|582379556|FG001|Overall Study|Investigational device deficiency|1|||
161272865|NCT04524364|582379555|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
161272866|NCT04524364|582379556|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
161272867|NCT04524364|582379555|FG000|Overall Study|Device unavailability|0|||
161272868|NCT04524364|582379556|FG001|Overall Study|Device unavailability|2|||
161272869|NCT04524364|582379555|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
161272870|NCT04524364|582379556|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
161272871|NCT04524364|582379555|FG000|Overall Study|Low International normalized ratio (INR)|1|||
161272872|NCT04524364|582379556|FG001|Overall Study|Low International normalized ratio (INR)|0|||
161272873|NCT00229723|582379557|FG000|Concomitant Phase|Adverse Event|4|||
160968947|NCT00856167|581273453|FG003|Period 1|Lost to Follow-up|0|||
160968948|NCT00856167|581273450|FG000|Period 2|Lost to Follow-up|0|||
160968949|NCT00856167|581273451|FG001|Period 2|Lost to Follow-up|0|||
160968950|NCT00856167|581273452|FG002|Period 2|Lost to Follow-up|3|||
160968951|NCT00856167|581273453|FG003|Period 2|Lost to Follow-up|1|||
160968952|NCT00856167|581273450|FG000|Period 2|Withdrawal by Subject|0|||
160968953|NCT00856167|581273451|FG001|Period 2|Withdrawal by Subject|0|||
160968954|NCT00856167|581273452|FG002|Period 2|Withdrawal by Subject|2|||
160968955|NCT00856167|581273453|FG003|Period 2|Withdrawal by Subject|4|||
160968956|NCT01061333|581273454|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
160968957|NCT01061333|581273455|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
160968958|NCT01816763|581275061|FG000|Overall Study|The main reason for an incomplete survey|4|||
160968959|NCT01816763|581275062|FG001|Overall Study|The main reason for an incomplete survey|15|||
160968960|NCT01816763|581275063|FG002|Overall Study|The main reason for an incomplete survey|11|||
160968961|NCT01186328|581275068|FG000|Overall Study|Death|1|||
160968962|NCT01186328|581275069|FG001|Overall Study|Death|0|||
161272874|NCT00229723|582379558|FG001|Concomitant Phase|Adverse Event|2|||
161272875|NCT00229723|582379559|FG002|Concomitant Phase|Adverse Event|5|||
161272876|NCT00229723|582379560|FG003|Concomitant Phase|Adverse Event|2|||
161272877|NCT00229723|582379561|FG004|Concomitant Phase|Adverse Event|0|||
161272878|NCT00229723|582379562|FG005|Concomitant Phase|Adverse Event|1|||
160968963|NCT01186328|581275070|FG002|Overall Study|Death|0|||
160968964|NCT02202434|581275071|FG000|Overall Study|Death|70|||
161272879|NCT00229723|582379563|FG006|Concomitant Phase|Adverse Event|2|||
161272880|NCT00229723|582379557|FG000|Concomitant Phase|Objective disease progression|0|||
160968965|NCT02202434|581275072|FG001|Overall Study|Death|39|||
161272881|NCT00229723|582379558|FG001|Concomitant Phase|Objective disease progression|0|||
161272882|NCT00229723|582379559|FG002|Concomitant Phase|Objective disease progression|0|||
161017448|NCT05034952|581453138|FG003|Overall Study|Lost to Follow-up|3|||
161017449|NCT05034952|581453135|FG000|Overall Study|Other|0|||
161017450|NCT05034952|581453136|FG001|Overall Study|Other|0|||
161017451|NCT05034952|581453137|FG002|Overall Study|Other|0|||
161017452|NCT05034952|581453138|FG003|Overall Study|Other|1|||
161017453|NCT05273749|581453145|FG000|Overall Study|Adverse Event|14|||
161017454|NCT05273749|581453146|FG001|Overall Study|Adverse Event|8|||
161017455|NCT05273749|581453145|FG000|Overall Study|Lack of Efficacy|2|||
161017456|NCT05273749|581453146|FG001|Overall Study|Lack of Efficacy|8|||
161017457|NCT05273749|581453145|FG000|Overall Study|Physician Decision|0|||
161017458|NCT05273749|581453146|FG001|Overall Study|Physician Decision|2|||
161017459|NCT05273749|581453145|FG000|Overall Study|Withdrawal by Subject|14|||
161017460|NCT05273749|581453146|FG001|Overall Study|Withdrawal by Subject|16|||
161017461|NCT05273749|581453145|FG000|Overall Study|Lost to Follow-up|10|||
161017462|NCT05273749|581453146|FG001|Overall Study|Lost to Follow-up|10|||
161017463|NCT05273749|581453145|FG000|Overall Study|Pregnancy|1|||
161017464|NCT05273749|581453146|FG001|Overall Study|Pregnancy|0|||
161017465|NCT05273749|581453145|FG000|Overall Study|Non-Compliance|3|||
161017466|NCT05273749|581453146|FG001|Overall Study|Non-Compliance|2|||
161017467|NCT05273749|581453145|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
161017468|NCT05273749|581453146|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
161017469|NCT02543281|581453153|FG000|Overall Study|Lost to Follow-up|0|||
161017470|NCT02543281|581453154|FG001|Overall Study|Lost to Follow-up|0|||
161017471|NCT02543281|581453155|FG002|Overall Study|Lost to Follow-up|1|||
161017472|NCT02530671|581453156|FG000|Overall Study|Lost to Follow-up|2|||
161017473|NCT02530671|581453157|FG001|Overall Study|Lost to Follow-up|0|||
161017474|NCT02530671|581453156|FG000|Overall Study|Withdrawal by Subject|1|||
161017475|NCT02530671|581453157|FG001|Overall Study|Withdrawal by Subject|0|||
161017476|NCT05247489|581453158|FG000|Overall Study|Lost to Follow-up|5|||
161017477|NCT05247489|581453159|FG001|Overall Study|Lost to Follow-up|1|||
161017478|NCT05247489|581453158|FG000|Overall Study|Withdrawal by Subject|6|||
161017479|NCT05247489|581453159|FG001|Overall Study|Withdrawal by Subject|7|||
161017480|NCT05247489|581453158|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
161017481|NCT05247489|581453159|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
161017482|NCT05247489|581453158|FG000|Overall Study|Left Country|1|||
161017483|NCT05247489|581453159|FG001|Overall Study|Left Country|0|||
161017484|NCT05247489|581453158|FG000|Overall Study|Noncompliance with Investigational Product|1|||
161017485|NCT05247489|581453159|FG001|Overall Study|Noncompliance with Investigational Product|0|||
161017486|NCT05247489|581453158|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
161017487|NCT05247489|581453159|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
161017488|NCT03126019|581453160|FG000|Overall Study|Death|5|||
161017489|NCT03126019|581453161|FG001|Overall Study|Death|27|||
161017490|NCT03126019|581453160|FG000|Overall Study|Lost to Follow-up|2|||
161017491|NCT03126019|581453161|FG001|Overall Study|Lost to Follow-up|4|||
161017492|NCT03126019|581453160|FG000|Overall Study|Withdrawal by Subject|1|||
161017493|NCT03126019|581453161|FG001|Overall Study|Withdrawal by Subject|9|||
161017494|NCT03126019|581453160|FG000|Overall Study|Physician Decision|1|||
161017495|NCT03126019|581453161|FG001|Overall Study|Physician Decision|0|||
161017496|NCT03126019|581453160|FG000|Overall Study|Transitioned to Rollover Study|0|||
161017497|NCT03126019|581453161|FG001|Overall Study|Transitioned to Rollover Study|11|||
161017498|NCT03126019|581453160|FG000|Overall Study|Did Not Return to Site for Care|0|||
161272883|NCT00229723|582379560|FG003|Concomitant Phase|Objective disease progression|0|||
161272884|NCT00229723|582379561|FG004|Concomitant Phase|Objective disease progression|0|||
161272885|NCT00229723|582379562|FG005|Concomitant Phase|Objective disease progression|0|||
161272886|NCT00229723|582379563|FG006|Concomitant Phase|Objective disease progression|0|||
161272887|NCT00229723|582379557|FG000|Concomitant Phase|Clinical progression|0|||
161272888|NCT00229723|582379558|FG001|Concomitant Phase|Clinical progression|0|||
161272889|NCT00229723|582379559|FG002|Concomitant Phase|Clinical progression|0|||
161017499|NCT03126019|581453161|FG001|Overall Study|Did Not Return to Site for Care|1|||
161017500|NCT03126019|581453160|FG000|Overall Study|Site Closed|0|||
161017501|NCT03126019|581453161|FG001|Overall Study|Site Closed|1|||
161017502|NCT00170573|581453165|FG000|Overall Study|Violation of inclusion criteria|13|||
161017503|NCT05563246|581453211|FG000|Overall Study|Withdrawal by Subject|1|||
161017504|NCT05563246|581453212|FG001|Overall Study|Withdrawal by Subject|2|||
161017505|NCT05563246|581453213|FG002|Overall Study|Withdrawal by Subject|0|||
161017506|NCT05563246|581453214|FG003|Overall Study|Withdrawal by Subject|0|||
161017507|NCT05563246|581453211|FG000|Overall Study|Protocol Deviation|0|||
161017508|NCT05563246|581453212|FG001|Overall Study|Protocol Deviation|1|||
161017509|NCT05563246|581453213|FG002|Overall Study|Protocol Deviation|0|||
161017510|NCT05563246|581453214|FG003|Overall Study|Protocol Deviation|0|||
161017511|NCT05563246|581453211|FG000|Overall Study|Physician Decision|0|||
161017512|NCT05563246|581453212|FG001|Overall Study|Physician Decision|1|||
161017513|NCT05563246|581453213|FG002|Overall Study|Physician Decision|0|||
161017514|NCT05563246|581453214|FG003|Overall Study|Physician Decision|0|||
161272890|NCT00229723|582379560|FG003|Concomitant Phase|Clinical progression|0|||
161017515|NCT05563246|581453211|FG000|Overall Study|Adverse Event|0|||
161017516|NCT05563246|581453212|FG001|Overall Study|Adverse Event|0|||
161017517|NCT05563246|581453213|FG002|Overall Study|Adverse Event|2|||
161017518|NCT05563246|581453214|FG003|Overall Study|Adverse Event|0|||
161017519|NCT05563246|581453211|FG000|Overall Study|Lost to Follow-up|0|||
161017520|NCT05563246|581453212|FG001|Overall Study|Lost to Follow-up|0|||
161017521|NCT05563246|581453213|FG002|Overall Study|Lost to Follow-up|1|||
161017522|NCT05563246|581453214|FG003|Overall Study|Lost to Follow-up|0|||
161017523|NCT03332017|581453216|FG000|Overall Study|Lost to Follow-up|1|||
161017524|NCT03332017|581453217|FG001|Overall Study|Lost to Follow-up|2|||
161017525|NCT03332017|581453216|FG000|Overall Study|Death|17|||
161017526|NCT03332017|581453217|FG001|Overall Study|Death|16|||
161017527|NCT03332017|581453216|FG000|Overall Study|Withdrawal by Subject|6|||
161017528|NCT03332017|581453217|FG001|Overall Study|Withdrawal by Subject|14|||
161017529|NCT03332017|581453216|FG000|Overall Study|Other|1|||
161017530|NCT03332017|581453217|FG001|Overall Study|Other|3|||
161017531|NCT03332017|581453216|FG000|Overall Study|Remained in Study (Ongoing)|47|||
161017532|NCT03332017|581453217|FG001|Overall Study|Remained in Study (Ongoing)|110|||
161017533|NCT01580488|581453218|FG000|Overall Study|Withdrawal by Subject|1|||
161017534|NCT03699709|581453222|FG000|Overall Study|Death|1|||
161017535|NCT03699709|581453223|FG001|Overall Study|Death|2|||
161017536|NCT03699709|581453222|FG000|Overall Study|Lost to Follow-up|10|||
161017537|NCT03699709|581453223|FG001|Overall Study|Lost to Follow-up|3|||
161017538|NCT03699709|581453222|FG000|Overall Study|Withdrawal by Subject|5|||
161017539|NCT03699709|581453223|FG001|Overall Study|Withdrawal by Subject|0|||
161017540|NCT03699709|581453222|FG000|Overall Study|incarcerated|1|||
161017541|NCT03699709|581453223|FG001|Overall Study|incarcerated|0|||
161017542|NCT03699709|581453222|FG000|Overall Study|scheduled, but no show|0|||
161017543|NCT03699709|581453223|FG001|Overall Study|scheduled, but no show|1|||
161017544|NCT02907099|581453224|FG000|Overall Study|Adverse Event|1|||
161017545|NCT02907099|581453224|FG000|Overall Study|Withdrawal by Subject|2|||
161017546|NCT02907099|581453224|FG000|Overall Study|Screen Fail|2|||
161017547|NCT05784662|581453225|FG000|Overall Study|Lost to Follow-up|21|||
161017548|NCT05784662|581453226|FG001|Overall Study|Lost to Follow-up|17|||
161017549|NCT04831216|581453230|FG000|Overall Study|Lost to Follow-up|32|||
161017550|NCT04739956|581453237|FG000|Overall Study|Withdrawal by Subject|1|||
161017551|NCT04739956|581453238|FG001|Overall Study|Withdrawal by Subject|1|||
161017552|NCT03920111|581453239|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
161017553|NCT03920111|581453240|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
161017554|NCT03920111|581453241|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
161017555|NCT03519581|581453242|FG000|Overall Study|Lost to Follow-up|3|||
161017556|NCT03519581|581453243|FG001|Overall Study|Lost to Follow-up|2|||
161017557|NCT03519581|581453242|FG000|Overall Study|Adverse Event|5|||
161017558|NCT03519581|581453243|FG001|Overall Study|Adverse Event|2|||
161017559|NCT03519581|581453242|FG000|Overall Study|Withdrawal by Subject|2|||
161017560|NCT03519581|581453243|FG001|Overall Study|Withdrawal by Subject|0|||
161017561|NCT03519581|581453242|FG000|Overall Study|Change to insurance|2|||
161017562|NCT03519581|581453243|FG001|Overall Study|Change to insurance|1|||
161017563|NCT03519581|581453242|FG000|Overall Study|Other|2|||
161017564|NCT03519581|581453243|FG001|Overall Study|Other|4|||
161017565|NCT05177848|581453244|FG000|Overall Study|Lost to Follow-up|1|||
161017566|NCT05177848|581453245|FG001|Overall Study|Lost to Follow-up|4|||
161017567|NCT05177848|581453244|FG000|Overall Study|Discontinued|2|||
161017568|NCT05177848|581453245|FG001|Overall Study|Discontinued|1|||
161017569|NCT06414213|581453246|FG000|Overall Study|Lost to Follow-up|1|||
161017570|NCT06414213|581453247|FG001|Overall Study|Lost to Follow-up|1|||
161017571|NCT06414213|581453248|FG002|Overall Study|Lost to Follow-up|3|||
161017572|NCT03720795|581453254|FG000|Phase 1|Lost to Follow-up|4|||
161017573|NCT03720795|581453254|FG000|Phase 1|Withdrawal by Subject|6|||
161017574|NCT03720795|581453254|FG000|Phase 1|Protocol Violation|1|||
161017575|NCT03720795|581453254|FG000|Phase 1|Other|1|||
161017576|NCT03720795|581453254|FG000|Phase 2|Lost to Follow-up|5|||
161017577|NCT03720795|581453254|FG000|Phase 2|Withdrawal by Subject|10|||
161017578|NCT03720795|581453254|FG000|Phase 2|Protocol Violation|2|||
161017579|NCT03720795|581453254|FG000|3 Month Follow Up|Lost to Follow-up|2|||
161017580|NCT04322643|581453255|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
161017581|NCT05486078|581453258|FG000|Overall Study|4 drop out and one withdrawn|5|||
161017582|NCT05134233|581453259|FG000|Overall Study|Pregnancy|1|||
161017583|NCT05134233|581453259|FG000|Overall Study|MEP value too low|2|||
161017584|NCT05134233|581453259|FG000|Overall Study|Lost to Follow-up|1|||
161017585|NCT04763265|581453262|FG000|Overall Study|Adverse Event|1|||
161017586|NCT04763265|581453263|FG001|Overall Study|Adverse Event|0|||
161017587|NCT04763265|581453262|FG000|Overall Study|Lost to Follow-up|2|||
161017588|NCT04763265|581453263|FG001|Overall Study|Lost to Follow-up|4|||
161017589|NCT04763265|581453262|FG000|Overall Study|Withdrawal by Subject|0|||
161017590|NCT04763265|581453263|FG001|Overall Study|Withdrawal by Subject|1|||
161017591|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Other|0|||
161017592|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Other|0|||
161017593|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Other|0|||
161017594|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Other|0|||
161017595|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Other|0|||
161017596|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Other|0|||
161017597|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Other|0|||
161017598|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Other|0|||
161017599|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Other|0|||
161017600|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Other|0|||
161017601|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Other|1|||
161017602|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Other|1|||
161017603|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Other|1|||
161017604|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Other|0|||
161017605|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Other|3|||
161017606|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Other|1|||
161017607|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Other|1|||
161017608|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Other|0|||
161017609|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017610|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017611|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017612|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017613|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017614|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017615|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
161017616|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017617|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
161017618|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017619|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017620|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017621|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
161017622|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017623|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017624|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017625|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017626|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
161017627|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017628|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017629|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017630|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017631|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017632|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017633|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017634|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
161017635|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017636|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017637|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017638|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017639|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017640|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017641|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017642|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017643|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017644|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
161017645|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017646|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017647|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017648|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017649|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017650|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017651|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017652|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017653|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017654|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
161017655|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017656|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017657|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017658|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017659|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017660|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017661|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017662|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
161017663|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Death|0|||
161017664|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Death|0|||
161272891|NCT00229723|582379561|FG004|Concomitant Phase|Clinical progression|0|||
161272892|NCT00229723|582379562|FG005|Concomitant Phase|Clinical progression|0|||
161272893|NCT00229723|582379563|FG006|Concomitant Phase|Clinical progression|1|||
161272894|NCT00229723|582379557|FG000|Concomitant Phase|Lost to Follow-up|0|||
161272895|NCT00229723|582379558|FG001|Concomitant Phase|Lost to Follow-up|0|||
161272896|NCT00229723|582379559|FG002|Concomitant Phase|Lost to Follow-up|0|||
161272897|NCT00229723|582379560|FG003|Concomitant Phase|Lost to Follow-up|0|||
161272898|NCT00229723|582379561|FG004|Concomitant Phase|Lost to Follow-up|1|||
161272899|NCT00229723|582379562|FG005|Concomitant Phase|Lost to Follow-up|0|||
161272900|NCT00229723|582379563|FG006|Concomitant Phase|Lost to Follow-up|0|||
161272901|NCT00229723|582379557|FG000|Concomitant Phase|Informed consent withdrawn|3|||
161272902|NCT00229723|582379558|FG001|Concomitant Phase|Informed consent withdrawn|2|||
161272903|NCT00229723|582379559|FG002|Concomitant Phase|Informed consent withdrawn|0|||
161272904|NCT00229723|582379560|FG003|Concomitant Phase|Informed consent withdrawn|2|||
161272905|NCT00229723|582379561|FG004|Concomitant Phase|Informed consent withdrawn|0|||
161272906|NCT00229723|582379562|FG005|Concomitant Phase|Informed consent withdrawn|0|||
161272907|NCT00229723|582379563|FG006|Concomitant Phase|Informed consent withdrawn|0|||
161272908|NCT00229723|582379557|FG000|Concomitant Phase|Severe non-compliance|0|||
161272909|NCT00229723|582379558|FG001|Concomitant Phase|Severe non-compliance|1|||
161272910|NCT00229723|582379559|FG002|Concomitant Phase|Severe non-compliance|0|||
161272911|NCT00229723|582379560|FG003|Concomitant Phase|Severe non-compliance|0|||
161272912|NCT00229723|582379561|FG004|Concomitant Phase|Severe non-compliance|1|||
161272913|NCT00229723|582379562|FG005|Concomitant Phase|Severe non-compliance|0|||
161272914|NCT00229723|582379563|FG006|Concomitant Phase|Severe non-compliance|0|||
161272915|NCT00229723|582379557|FG000|Concomitant Phase|Other|3|||
161272916|NCT00229723|582379558|FG001|Concomitant Phase|Other|0|||
161272917|NCT00229723|582379559|FG002|Concomitant Phase|Other|1|||
160968966|NCT02202434|581275073|FG002|Overall Study|Death|13|||
160968967|NCT02202434|581275074|FG003|Overall Study|Death|27|||
160968968|NCT02202434|581275071|FG000|Overall Study|Lost to Follow-up|1|||
160968969|NCT02202434|581275072|FG001|Overall Study|Lost to Follow-up|1|||
160968970|NCT02202434|581275073|FG002|Overall Study|Lost to Follow-up|1|||
160968971|NCT02202434|581275074|FG003|Overall Study|Lost to Follow-up|0|||
160968972|NCT02202434|581275071|FG000|Overall Study|Physician Decision|2|||
160968973|NCT02202434|581275072|FG001|Overall Study|Physician Decision|3|||
160968974|NCT02202434|581275073|FG002|Overall Study|Physician Decision|0|||
160968975|NCT02202434|581275074|FG003|Overall Study|Physician Decision|0|||
160968976|NCT02202434|581275071|FG000|Overall Study|Withdrawal by Subject|13|||
160968977|NCT02202434|581275072|FG001|Overall Study|Withdrawal by Subject|14|||
160968978|NCT02202434|581275073|FG002|Overall Study|Withdrawal by Subject|1|||
160968979|NCT02202434|581275074|FG003|Overall Study|Withdrawal by Subject|4|||
160968980|NCT02202434|581275071|FG000|Overall Study|Completed Study|1|||
160968981|NCT02202434|581275072|FG001|Overall Study|Completed Study|0|||
160968982|NCT02202434|581275073|FG002|Overall Study|Completed Study|0|||
160968983|NCT02202434|581275074|FG003|Overall Study|Completed Study|0|||
160968984|NCT02202434|581275071|FG000|Overall Study|Visit Missed|21|||
160968985|NCT02202434|581275072|FG001|Overall Study|Visit Missed|12|||
160968986|NCT02202434|581275073|FG002|Overall Study|Visit Missed|0|||
160968987|NCT02202434|581275074|FG003|Overall Study|Visit Missed|5|||
160968988|NCT02202434|581275071|FG000|Overall Study|Other|1|||
160968989|NCT02202434|581275072|FG001|Overall Study|Other|0|||
160968990|NCT02202434|581275073|FG002|Overall Study|Other|0|||
160968991|NCT02202434|581275074|FG003|Overall Study|Other|1|||
160968992|NCT03237858|581275075|FG000|Overall Study|Death|19|||
160968993|NCT03237858|581275075|FG000|Overall Study|Withdrawal by Subject|37|||
160968994|NCT00332332|581275076|FG000|Overall Study|Adverse Event|13|||
160968995|NCT00332332|581275076|FG000|Overall Study|Death|1|||
160968996|NCT00332332|581275076|FG000|Overall Study|Withdrawal by Subject|8|||
160968997|NCT00332332|581275076|FG000|Overall Study|Physician Decision|1|||
160968998|NCT00332332|581275076|FG000|Overall Study|Lost to Follow-up|3|||
160968999|NCT00332332|581275076|FG000|Overall Study|Protocol deviation|4|||
160969000|NCT00332332|581275076|FG000|Overall Study|Noncompliance|2|||
160969001|NCT00332332|581275076|FG000|Overall Study|Disease progression|2|||
160969002|NCT00332332|581275076|FG000|Overall Study|Other|18|||
160969003|NCT00332332|581275076|FG000|Overall Study|Did not receive study treatment|16|||
160969004|NCT01108458|581275077|FG000|Overall Study|Withdrawal by Subject|1|||
160969005|NCT03075501|581275079|FG000|Overall Study|Scheduling difficulties|15|||
160969006|NCT03075501|581275080|FG001|Overall Study|Scheduling difficulties|9|||
161272918|NCT00229723|582379560|FG003|Concomitant Phase|Other|1|||
160969007|NCT03610737|581275085|FG000|Overall Study|Withdrawal by Subject|1|||
160969008|NCT03610737|581275086|FG001|Overall Study|Withdrawal by Subject|5|||
160969009|NCT03610737|581275085|FG000|Overall Study|Death|1|||
160969010|NCT03610737|581275086|FG001|Overall Study|Death|0|||
161272919|NCT00229723|582379561|FG004|Concomitant Phase|Other|0|||
161272920|NCT00229723|582379562|FG005|Concomitant Phase|Other|2|||
161272921|NCT00229723|582379563|FG006|Concomitant Phase|Other|0|||
161272922|NCT00229723|582379557|FG000|Maintenance Phase|Adverse Event|7|||
160969011|NCT03610737|581275085|FG000|Overall Study|Not treated|5|||
161272923|NCT00229723|582379558|FG001|Maintenance Phase|Adverse Event|2|||
161272924|NCT00229723|582379559|FG002|Maintenance Phase|Adverse Event|1|||
161272925|NCT00229723|582379560|FG003|Maintenance Phase|Adverse Event|4|||
161272926|NCT00229723|582379561|FG004|Maintenance Phase|Adverse Event|7|||
161017665|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Death|0|||
161017666|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Death|0|||
161017667|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Death|0|||
161017668|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Death|0|||
161017669|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Death|0|||
161017670|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Death|0|||
161017671|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Death|0|||
161017672|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Death|1|||
161017673|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Death|0|||
161017674|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Death|1|||
161017675|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Death|0|||
161017676|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Death|1|||
161017677|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Death|0|||
161017678|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Death|0|||
161017679|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Death|2|||
161017680|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Death|0|||
161017681|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
161017682|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
161017683|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
161017684|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
161017685|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
161017686|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
161017687|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
161017688|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
161017689|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
161017690|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
161017691|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
161017692|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
161017693|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
161017694|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
161017695|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
161017696|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
161017697|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
161017698|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
161017699|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Adverse Event|0|||
161017700|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Adverse Event|0|||
161017701|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Adverse Event|0|||
161017702|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Adverse Event|0|||
161017703|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Adverse Event|0|||
161017704|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Adverse Event|0|||
161017705|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Adverse Event|2|||
161017706|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Adverse Event|0|||
161017707|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Adverse Event|0|||
161017708|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Adverse Event|0|||
161017709|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Adverse Event|1|||
161017710|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Adverse Event|2|||
161017711|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Adverse Event|0|||
161017712|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Adverse Event|1|||
161017713|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Adverse Event|0|||
161017714|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Adverse Event|0|||
161017715|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Adverse Event|1|||
161017716|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Adverse Event|0|||
161017717|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
161017718|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
161272927|NCT00229723|582379562|FG005|Maintenance Phase|Adverse Event|5|||
161272928|NCT00229723|582379563|FG006|Maintenance Phase|Adverse Event|2|||
161272929|NCT00229723|582379557|FG000|Maintenance Phase|Objective disease progression|5|||
161017719|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
161017720|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
161017721|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
161017722|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
161017723|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
161017724|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
161017725|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
161017726|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
161017727|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
161017728|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
161272930|NCT00229723|582379558|FG001|Maintenance Phase|Objective disease progression|5|||
161017729|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
161272931|NCT00229723|582379559|FG002|Maintenance Phase|Objective disease progression|3|||
161272932|NCT00229723|582379560|FG003|Maintenance Phase|Objective disease progression|6|||
161017730|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
161017731|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
161017732|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
161017733|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
161017734|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
161017735|NCT03269136|581453266|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017736|NCT03269136|581453267|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017737|NCT03269136|581453268|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017738|NCT03269136|581453269|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017739|NCT03269136|581453270|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017740|NCT03269136|581453271|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017741|NCT03269136|581453272|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017742|NCT03269136|581453273|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017743|NCT03269136|581453274|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017744|NCT03269136|581453275|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017745|NCT03269136|581453276|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017746|NCT03269136|581453277|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017747|NCT03269136|581453278|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161017748|NCT03269136|581453279|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161017749|NCT03269136|581453280|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161017750|NCT03269136|581453281|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017751|NCT03269136|581453282|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161017752|NCT03269136|581453283|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161017753|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Other|0|||
161017754|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Other|0|||
161017755|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Other|0|||
161017756|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Other|0|||
161017757|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Other|0|||
161017758|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Other|0|||
161017759|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Other|0|||
161017760|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Other|0|||
161017761|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Other|0|||
161017762|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Other|0|||
161017763|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Other|0|||
161017764|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Other|0|||
161017765|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Other|0|||
161017766|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Other|0|||
161017767|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Other|0|||
161017768|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Other|0|||
161017769|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Other|0|||
161017770|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Other|1|||
161017771|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017772|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017773|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017774|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017775|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017776|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017777|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017778|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017779|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017780|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017781|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017782|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017783|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017784|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017785|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017786|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017787|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
161017788|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
161017789|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
161017790|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
161017791|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
161148097|NCT00090285|581924491|FG000|Base Study Vaccination Period|Uncooperative|2|||
161272933|NCT00229723|582379561|FG004|Maintenance Phase|Objective disease progression|2|||
161272934|NCT00229723|582379562|FG005|Maintenance Phase|Objective disease progression|9|||
161272935|NCT00229723|582379563|FG006|Maintenance Phase|Objective disease progression|5|||
161272936|NCT00229723|582379557|FG000|Maintenance Phase|Clinical progression|4|||
161272937|NCT00229723|582379558|FG001|Maintenance Phase|Clinical progression|1|||
161017792|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
161017793|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
161017794|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
161017795|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
161272938|NCT00229723|582379559|FG002|Maintenance Phase|Clinical progression|2|||
161272939|NCT00229723|582379560|FG003|Maintenance Phase|Clinical progression|2|||
161017796|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
161017797|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
161017798|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
161017799|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
161017800|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
161017801|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
161017802|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
161017803|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
161017804|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
161017805|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
161017806|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
161017807|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
161017808|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
161017809|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
161017810|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
161017811|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
161017812|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
161017813|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
161017814|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
161017815|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
161017816|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
161017817|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
161017818|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
161017819|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
161017820|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
161017821|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
161017822|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
161017823|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
161017824|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
161017825|NCT03269136|581453266|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
161017826|NCT03269136|581453267|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
161017827|NCT03269136|581453268|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
161017828|NCT03269136|581453269|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
161017829|NCT03269136|581453270|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
161017830|NCT03269136|581453271|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
161017831|NCT03269136|581453272|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
161017832|NCT03269136|581453273|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
161017833|NCT03269136|581453274|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
161017834|NCT03269136|581453275|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
161017835|NCT03269136|581453276|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
161017836|NCT03269136|581453277|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
161017837|NCT03269136|581453278|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
161017838|NCT03269136|581453279|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
161017839|NCT03269136|581453280|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
161017840|NCT03269136|581453281|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
161017841|NCT03269136|581453282|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
161017842|NCT03269136|581453283|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
161017843|NCT04856163|581453290|FG000|Overall Study|Lost to Follow-up|97|||
161017844|NCT04856163|581453291|FG001|Overall Study|Lost to Follow-up|100|||
161017845|NCT03468218|581453294|FG000|Overall Study|Adverse Event|5|||
161017846|NCT03468218|581453294|FG000|Overall Study|Progressive Disease|16|||
161017847|NCT03468218|581453294|FG000|Overall Study|Death|1|||
161272940|NCT00229723|582379561|FG004|Maintenance Phase|Clinical progression|1|||
161272941|NCT00229723|582379562|FG005|Maintenance Phase|Clinical progression|1|||
161272942|NCT00229723|582379563|FG006|Maintenance Phase|Clinical progression|1|||
161272943|NCT00229723|582379557|FG000|Maintenance Phase|Lost to Follow-up|0|||
161272944|NCT00229723|582379558|FG001|Maintenance Phase|Lost to Follow-up|1|||
161272945|NCT00229723|582379559|FG002|Maintenance Phase|Lost to Follow-up|2|||
161272946|NCT00229723|582379560|FG003|Maintenance Phase|Lost to Follow-up|2|||
161272947|NCT00229723|582379561|FG004|Maintenance Phase|Lost to Follow-up|0|||
161272948|NCT00229723|582379562|FG005|Maintenance Phase|Lost to Follow-up|0|||
161272949|NCT00229723|582379563|FG006|Maintenance Phase|Lost to Follow-up|1|||
161343575|NCT03034967|582644415|FG003|Overall Study|Liver function test abnormality|0|||
161343576|NCT03034967|582644416|FG004|Overall Study|Liver function test abnormality|0|||
161017848|NCT03468218|581453294|FG000|Overall Study|Alternate therapy|1|||
161017849|NCT03468218|581453294|FG000|Overall Study|Withdrawal by Subject|2|||
161017850|NCT03719443|581453295|FG000|Overall Study|Lost to Follow-up|0|||
161017851|NCT03719443|581453296|FG001|Overall Study|Lost to Follow-up|0|||
161017852|NCT03719443|581453297|FG002|Overall Study|Lost to Follow-up|1|||
161017853|NCT03719443|581453298|FG003|Overall Study|Lost to Follow-up|0|||
161017854|NCT03719443|581453299|FG004|Overall Study|Lost to Follow-up|1|||
161017855|NCT03719443|581453300|FG005|Overall Study|Lost to Follow-up|0|||
161017856|NCT03719443|581453301|FG006|Overall Study|Lost to Follow-up|1|||
161017857|NCT03719443|581453295|FG000|Overall Study|Withdrawal by Subject|0|||
161017858|NCT03719443|581453296|FG001|Overall Study|Withdrawal by Subject|0|||
161272950|NCT00229723|582379557|FG000|Maintenance Phase|Informed consent withdrawn|1|||
161272951|NCT00229723|582379558|FG001|Maintenance Phase|Informed consent withdrawn|0|||
161272952|NCT00229723|582379559|FG002|Maintenance Phase|Informed consent withdrawn|0|||
161272953|NCT00229723|582379560|FG003|Maintenance Phase|Informed consent withdrawn|1|||
161272954|NCT00229723|582379561|FG004|Maintenance Phase|Informed consent withdrawn|1|||
161017859|NCT03719443|581453297|FG002|Overall Study|Withdrawal by Subject|1|||
161017860|NCT03719443|581453298|FG003|Overall Study|Withdrawal by Subject|0|||
161017861|NCT03719443|581453299|FG004|Overall Study|Withdrawal by Subject|0|||
161017862|NCT03719443|581453300|FG005|Overall Study|Withdrawal by Subject|0|||
161017863|NCT03719443|581453301|FG006|Overall Study|Withdrawal by Subject|0|||
161017864|NCT03447470|581453306|FG000|Overall Study|Death|0|||
161017865|NCT03447470|581453307|FG001|Overall Study|Death|1|||
161017866|NCT03447470|581453308|FG002|Overall Study|Death|3|||
161017867|NCT03447470|581453309|FG003|Overall Study|Death|0|||
161017868|NCT03447470|581453310|FG004|Overall Study|Death|1|||
161017869|NCT03447470|581453311|FG005|Overall Study|Death|0|||
161017870|NCT03447470|581453312|FG006|Overall Study|Death|3|||
161017871|NCT03447470|581453313|FG007|Overall Study|Death|3|||
161017872|NCT03447470|581453314|FG008|Overall Study|Death|1|||
161017873|NCT03447470|581453306|FG000|Overall Study|Withdrawal by Subject|1|||
161017874|NCT03447470|581453307|FG001|Overall Study|Withdrawal by Subject|0|||
161017875|NCT03447470|581453308|FG002|Overall Study|Withdrawal by Subject|0|||
161017876|NCT03447470|581453309|FG003|Overall Study|Withdrawal by Subject|0|||
161017877|NCT03447470|581453310|FG004|Overall Study|Withdrawal by Subject|1|||
161017878|NCT03447470|581453311|FG005|Overall Study|Withdrawal by Subject|0|||
161017879|NCT03447470|581453312|FG006|Overall Study|Withdrawal by Subject|1|||
161017880|NCT03447470|581453313|FG007|Overall Study|Withdrawal by Subject|1|||
161017881|NCT03447470|581453314|FG008|Overall Study|Withdrawal by Subject|3|||
161017882|NCT03447470|581453306|FG000|Overall Study|Treatment discontinued|3|||
161017883|NCT03447470|581453307|FG001|Overall Study|Treatment discontinued|2|||
161017884|NCT03447470|581453308|FG002|Overall Study|Treatment discontinued|4|||
161017885|NCT03447470|581453309|FG003|Overall Study|Treatment discontinued|6|||
161017886|NCT03447470|581453310|FG004|Overall Study|Treatment discontinued|2|||
161017887|NCT03447470|581453311|FG005|Overall Study|Treatment discontinued|1|||
161017888|NCT03447470|581453312|FG006|Overall Study|Treatment discontinued|2|||
161017889|NCT03447470|581453313|FG007|Overall Study|Treatment discontinued|4|||
161017890|NCT03447470|581453314|FG008|Overall Study|Treatment discontinued|3|||
161017891|NCT02471638|581453323|FG000|Overall Study|Early Term Withdrawal|10|||
161148098|NCT00090285|581924492|FG001|Base Study Vaccination Period|Uncooperative|2|||
161148099|NCT00090285|581924493|FG002|Base Study Vaccination Period|Uncooperative|0|||
161148100|NCT00090285|581924494|FG003|Base Study Vaccination Period|Uncooperative|0|||
161148101|NCT00090285|581924495|FG004|Base Study Vaccination Period|Uncooperative|0|||
161148102|NCT00090285|581924496|FG005|Base Study Vaccination Period|Uncooperative|0|||
161148103|NCT00090285|581924491|FG000|Base Study Vaccination Period|Moved|20|||
161148104|NCT00090285|581924492|FG001|Base Study Vaccination Period|Moved|21|||
161148105|NCT00090285|581924493|FG002|Base Study Vaccination Period|Moved|0|||
161148106|NCT00090285|581924494|FG003|Base Study Vaccination Period|Moved|0|||
161148107|NCT00090285|581924495|FG004|Base Study Vaccination Period|Moved|0|||
161148108|NCT00090285|581924496|FG005|Base Study Vaccination Period|Moved|0|||
161148109|NCT00090285|581924491|FG000|Base Study Vaccination Period|Site Terminated|1|||
161148110|NCT00090285|581924492|FG001|Base Study Vaccination Period|Site Terminated|0|||
161148111|NCT00090285|581924493|FG002|Base Study Vaccination Period|Site Terminated|0|||
161148112|NCT00090285|581924494|FG003|Base Study Vaccination Period|Site Terminated|0|||
161148113|NCT00090285|581924495|FG004|Base Study Vaccination Period|Site Terminated|0|||
161148114|NCT00090285|581924496|FG005|Base Study Vaccination Period|Site Terminated|0|||
161148115|NCT00090285|581924491|FG000|Base Study Vaccination Period|Other|2|||
161272955|NCT00229723|582379562|FG005|Maintenance Phase|Informed consent withdrawn|1|||
161272956|NCT00229723|582379563|FG006|Maintenance Phase|Informed consent withdrawn|0|||
161272957|NCT00229723|582379557|FG000|Maintenance Phase|Severe non-compliance|3|||
160969012|NCT03610737|581275086|FG001|Overall Study|Not treated|2|||
160969013|NCT03610737|581275085|FG000|Overall Study|Missed Visit|1|||
160969014|NCT03610737|581275086|FG001|Overall Study|Missed Visit|2|||
160969015|NCT00710606|581275093|FG000|Overall Study|Adverse Event|0|||
160969016|NCT00710606|581275094|FG001|Overall Study|Adverse Event|2|||
160969017|NCT02670538|581275099|FG000|Overall Study|Withdrawal of Consent|8|||
160969018|NCT02670538|581275100|FG001|Overall Study|Withdrawal of Consent|6|||
160969019|NCT02670538|581275101|FG002|Overall Study|Withdrawal of Consent|5|||
160969020|NCT02670538|581275099|FG000|Overall Study|Lost to Follow-up|8|||
161017892|NCT04353661|581455735|FG000|Overall Study|Protocol Violation|0|||
161272958|NCT00229723|582379558|FG001|Maintenance Phase|Severe non-compliance|1|||
161017893|NCT04353661|581455736|FG001|Overall Study|Protocol Violation|0|||
161017894|NCT04353661|581455737|FG002|Overall Study|Protocol Violation|1|||
161017895|NCT04353661|581455735|FG000|Overall Study|Study termination by the Sponsor|1|||
161017896|NCT04353661|581455736|FG001|Overall Study|Study termination by the Sponsor|1|||
161017897|NCT04353661|581455737|FG002|Overall Study|Study termination by the Sponsor|1|||
161017898|NCT03376321|581455743|FG000|Overall Study|Other|5|||
161017899|NCT03376321|581455744|FG001|Overall Study|Other|1|||
161017900|NCT03376321|581455743|FG000|Overall Study|Withdrawal by Subject|8|||
161017901|NCT03376321|581455744|FG001|Overall Study|Withdrawal by Subject|14|||
161017902|NCT03376321|581455743|FG000|Overall Study|Lost to Follow-up|1|||
161017903|NCT03376321|581455744|FG001|Overall Study|Lost to Follow-up|7|||
161017904|NCT03376321|581455743|FG000|Overall Study|Death|4|||
161017905|NCT03376321|581455744|FG001|Overall Study|Death|0|||
161017906|NCT03376321|581455743|FG000|Overall Study|Randomized, not treated|5|||
161017907|NCT03376321|581455744|FG001|Overall Study|Randomized, not treated|3|||
161017908|NCT02671903|581455745|FG000|Period 0 (Run-In)|Death|0|||
161272959|NCT00229723|582379559|FG002|Maintenance Phase|Severe non-compliance|0|||
161017909|NCT02671903|581455746|FG001|Period 0 (Run-In)|Death|0|||
161017910|NCT02671903|581455747|FG002|Period 0 (Run-In)|Death|3|||
161017911|NCT02671903|581455745|FG000|Period 0 (Run-In)|Physician Decision|0|||
161017912|NCT02671903|581455746|FG001|Period 0 (Run-In)|Physician Decision|0|||
161017913|NCT02671903|581455747|FG002|Period 0 (Run-In)|Physician Decision|4|||
161017914|NCT02671903|581455745|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
161017915|NCT02671903|581455746|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
161017916|NCT02671903|581455747|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
161017917|NCT02671903|581455745|FG000|Period 0 (Run-In)|Protocol Violation|0|||
161017918|NCT02671903|581455746|FG001|Period 0 (Run-In)|Protocol Violation|0|||
161017919|NCT02671903|581455747|FG002|Period 0 (Run-In)|Protocol Violation|1|||
161017920|NCT02671903|581455745|FG000|Period 0 (Run-In)|Adverse Event|0|||
161017921|NCT02671903|581455746|FG001|Period 0 (Run-In)|Adverse Event|0|||
161017922|NCT02671903|581455747|FG002|Period 0 (Run-In)|Adverse Event|1|||
161017923|NCT02671903|581455745|FG000|Period 0 (Run-In)|Implantation Failure|0|||
161017924|NCT02671903|581455746|FG001|Period 0 (Run-In)|Implantation Failure|0|||
161017925|NCT02671903|581455747|FG002|Period 0 (Run-In)|Implantation Failure|2|||
161017926|NCT02671903|581455745|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
161017927|NCT02671903|581455746|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
161017928|NCT02671903|581455747|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
161017929|NCT03673111|581455767|FG000|Overall Study|Protocol Violation|0|||
161017930|NCT03673111|581455768|FG001|Overall Study|Protocol Violation|0|||
161017931|NCT03673111|581455769|FG002|Overall Study|Protocol Violation|0|||
161017932|NCT03673111|581455770|FG003|Overall Study|Protocol Violation|0|||
161017933|NCT03673111|581455771|FG004|Overall Study|Protocol Violation|0|||
161017934|NCT03673111|581455772|FG005|Overall Study|Protocol Violation|0|||
161017935|NCT03673111|581455773|FG006|Overall Study|Protocol Violation|0|||
161017936|NCT03673111|581455774|FG007|Overall Study|Protocol Violation|0|||
161017937|NCT03673111|581455775|FG008|Overall Study|Protocol Violation|0|||
161017938|NCT03673111|581455776|FG009|Overall Study|Protocol Violation|0|||
161017939|NCT03673111|581455777|FG010|Overall Study|Protocol Violation|1|||
161017940|NCT03673111|581455778|FG011|Overall Study|Protocol Violation|0|||
161017941|NCT03673111|581455779|FG012|Overall Study|Protocol Violation|0|||
161017942|NCT03673111|581455780|FG013|Overall Study|Protocol Violation|0|||
161017943|NCT03673111|581455767|FG000|Overall Study|Adverse Event|1|||
161017944|NCT03673111|581455768|FG001|Overall Study|Adverse Event|0|||
161017945|NCT03673111|581455769|FG002|Overall Study|Adverse Event|0|||
161017946|NCT03673111|581455770|FG003|Overall Study|Adverse Event|0|||
161017947|NCT03673111|581455771|FG004|Overall Study|Adverse Event|0|||
161017948|NCT03673111|581455772|FG005|Overall Study|Adverse Event|0|||
161017949|NCT03673111|581455773|FG006|Overall Study|Adverse Event|0|||
161017950|NCT03673111|581455774|FG007|Overall Study|Adverse Event|0|||
161272960|NCT00229723|582379560|FG003|Maintenance Phase|Severe non-compliance|0|||
161272961|NCT00229723|582379561|FG004|Maintenance Phase|Severe non-compliance|1|||
161017951|NCT03673111|581455775|FG008|Overall Study|Adverse Event|0|||
161017952|NCT03673111|581455776|FG009|Overall Study|Adverse Event|0|||
161017953|NCT03673111|581455777|FG010|Overall Study|Adverse Event|0|||
161017954|NCT03673111|581455778|FG011|Overall Study|Adverse Event|0|||
161017955|NCT03673111|581455779|FG012|Overall Study|Adverse Event|0|||
161272962|NCT00229723|582379562|FG005|Maintenance Phase|Severe non-compliance|0|||
161272963|NCT00229723|582379563|FG006|Maintenance Phase|Severe non-compliance|0|||
161272964|NCT00229723|582379557|FG000|Maintenance Phase|Other|5|||
161017956|NCT03673111|581455780|FG013|Overall Study|Adverse Event|0|||
161272965|NCT00229723|582379558|FG001|Maintenance Phase|Other|4|||
161017957|NCT04485039|581455784|FG000|TPOXX Only|Adverse Event|2|||
161017958|NCT04485039|581455784|FG000|TPOXX Only|Physician Decision|1|||
161017959|NCT04485039|581455784|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
161017960|NCT04485039|581455784|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
161017961|NCT04005716|581455788|FG000|Overall Study|Death|175|||
161272966|NCT00229723|582379559|FG002|Maintenance Phase|Other|1|||
161272967|NCT00229723|582379560|FG003|Maintenance Phase|Other|2|||
161017962|NCT04005716|581455789|FG001|Overall Study|Death|196|||
161017963|NCT04005716|581455788|FG000|Overall Study|Withdrawal by Subject|1|||
161017964|NCT04005716|581455789|FG001|Overall Study|Withdrawal by Subject|6|||
161017965|NCT04005716|581455788|FG000|Overall Study|Lost to Follow-up|2|||
161017966|NCT04005716|581455789|FG001|Overall Study|Lost to Follow-up|2|||
161272968|NCT00229723|582379561|FG004|Maintenance Phase|Other|3|||
161272969|NCT00229723|582379562|FG005|Maintenance Phase|Other|3|||
161272970|NCT00229723|582379563|FG006|Maintenance Phase|Other|1|||
161272971|NCT02309138|582379564|FG000|Overall Study|Withdrawal by Subject|44|||
161272972|NCT02309138|582379565|FG001|Overall Study|Withdrawal by Subject|15|||
161272973|NCT02309138|582379564|FG000|Overall Study|Protocol Violation|4|||
161272974|NCT02309138|582379565|FG001|Overall Study|Protocol Violation|2|||
161272975|NCT02309138|582379564|FG000|Overall Study|delivered before visit 2|0|||
161272976|NCT02309138|582379565|FG001|Overall Study|delivered before visit 2|1|||
161272977|NCT00735397|582379571|FG000|Overall Study|Adverse Event|194|||
161272978|NCT00735397|582379571|FG000|Overall Study|Lost to Follow-up|33|||
161272979|NCT00735397|582379571|FG000|Overall Study|Participant choice|252|||
161272980|NCT00735397|582379571|FG000|Overall Study|Inadequate therapeutic effect|202|||
161272981|NCT00735397|582379571|FG000|Overall Study|Administrative/Other|502|||
161272982|NCT00380744|582379572|FG000|Overall Study|Death|0|||
161272983|NCT00380744|582379573|FG001|Overall Study|Death|0|||
161272984|NCT00380744|582379574|FG002|Overall Study|Death|0|||
161272985|NCT00380744|582379575|FG003|Overall Study|Death|0|||
161272986|NCT00380744|582379576|FG004|Overall Study|Death|0|||
161272987|NCT00380744|582379577|FG005|Overall Study|Death|0|||
161272988|NCT00380744|582379578|FG006|Overall Study|Death|1|||
161272989|NCT00380744|582379572|FG000|Overall Study|Withdrawal by Subject|1|||
161272990|NCT00380744|582379573|FG001|Overall Study|Withdrawal by Subject|0|||
161272991|NCT00380744|582379574|FG002|Overall Study|Withdrawal by Subject|0|||
161272992|NCT00380744|582379575|FG003|Overall Study|Withdrawal by Subject|0|||
161272993|NCT00380744|582379576|FG004|Overall Study|Withdrawal by Subject|0|||
161272994|NCT00380744|582379577|FG005|Overall Study|Withdrawal by Subject|0|||
161272995|NCT00380744|582379578|FG006|Overall Study|Withdrawal by Subject|0|||
161272996|NCT01338870|582379583|FG000|Overall Study|Lost to Follow-up|0|||
161017967|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017968|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017969|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017970|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017971|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017972|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017973|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
161017974|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017975|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017976|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017977|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017978|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017979|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017980|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017981|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017982|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017983|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017984|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017985|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017986|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017987|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017988|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017989|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017990|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017991|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017992|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017993|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
161017994|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017995|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017996|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017997|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
161272997|NCT01338870|582379584|FG001|Overall Study|Lost to Follow-up|0|||
161272998|NCT01338870|582379585|FG002|Overall Study|Lost to Follow-up|1|||
161017998|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161017999|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018000|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161272999|NCT01338870|582379586|FG003|Overall Study|Lost to Follow-up|0|||
161273000|NCT01338870|582379587|FG004|Overall Study|Lost to Follow-up|1|||
161273001|NCT01338870|582379588|FG005|Overall Study|Lost to Follow-up|0|||
161273002|NCT01338870|582379583|FG000|Overall Study|Withdrawal by Subject|2|||
161273003|NCT01338870|582379584|FG001|Overall Study|Withdrawal by Subject|3|||
161273004|NCT01338870|582379585|FG002|Overall Study|Withdrawal by Subject|4|||
161273005|NCT01338870|582379586|FG003|Overall Study|Withdrawal by Subject|0|||
161273006|NCT01338870|582379587|FG004|Overall Study|Withdrawal by Subject|0|||
161273007|NCT01338870|582379588|FG005|Overall Study|Withdrawal by Subject|2|||
161273008|NCT01338870|582379583|FG000|Overall Study|Other|3|||
161018001|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018002|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018003|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018004|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018005|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018006|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018007|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018008|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018009|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018010|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018011|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018012|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018013|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018014|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018015|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018016|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018017|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018018|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018019|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018020|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
161018021|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
161018022|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
161018023|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
161018024|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
161018025|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
161018026|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
161018027|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
161018028|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
161018029|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
161018030|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
161018031|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
161018032|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
161018033|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
161273009|NCT01338870|582379584|FG001|Overall Study|Other|3|||
161273010|NCT01338870|582379585|FG002|Overall Study|Other|3|||
161273011|NCT01338870|582379586|FG003|Overall Study|Other|2|||
161273012|NCT01338870|582379587|FG004|Overall Study|Other|0|||
161273013|NCT01338870|582379588|FG005|Overall Study|Other|2|||
161273014|NCT01338870|582379583|FG000|Overall Study|Protocol Violation|0|||
161273015|NCT01338870|582379584|FG001|Overall Study|Protocol Violation|2|||
161273016|NCT01338870|582379585|FG002|Overall Study|Protocol Violation|2|||
161273017|NCT01338870|582379586|FG003|Overall Study|Protocol Violation|2|||
161273018|NCT01338870|582379587|FG004|Overall Study|Protocol Violation|1|||
161273019|NCT01338870|582379588|FG005|Overall Study|Protocol Violation|1|||
161343577|NCT03034967|582644417|FG005|Overall Study|Liver function test abnormality|0|||
161343578|NCT03034967|582644412|FG000|Overall Study|Protocol Violation|1|||
160969021|NCT02670538|581275100|FG001|Overall Study|Lost to Follow-up|12|||
160969022|NCT02670538|581275101|FG002|Overall Study|Lost to Follow-up|7|||
160969023|NCT02670538|581275099|FG000|Overall Study|Adverse Event|5|||
160969024|NCT02670538|581275100|FG001|Overall Study|Adverse Event|5|||
160969025|NCT02670538|581275101|FG002|Overall Study|Adverse Event|11|||
160969026|NCT02670538|581275099|FG000|Overall Study|Lack of Efficacy|7|||
160969027|NCT02670538|581275100|FG001|Overall Study|Lack of Efficacy|1|||
160969028|NCT02670538|581275101|FG002|Overall Study|Lack of Efficacy|2|||
160969029|NCT02670538|581275099|FG000|Overall Study|Protocol Violation|3|||
160969030|NCT02670538|581275100|FG001|Overall Study|Protocol Violation|4|||
160969031|NCT02670538|581275101|FG002|Overall Study|Protocol Violation|1|||
160969032|NCT02670538|581275099|FG000|Overall Study|Noncompliance with Study Drug|1|||
160969033|NCT02670538|581275100|FG001|Overall Study|Noncompliance with Study Drug|3|||
160969034|NCT02670538|581275101|FG002|Overall Study|Noncompliance with Study Drug|2|||
160969035|NCT02670538|581275099|FG000|Overall Study|Other Miscellaneous Reasons|0|||
160969036|NCT02670538|581275100|FG001|Overall Study|Other Miscellaneous Reasons|1|||
160969037|NCT02670538|581275101|FG002|Overall Study|Other Miscellaneous Reasons|2|||
160969038|NCT02243202|581275102|FG000|Overall Study|Adverse Event|5|||
160969039|NCT02243202|581275103|FG001|Overall Study|Adverse Event|6|||
160969040|NCT02243202|581275104|FG002|Overall Study|Adverse Event|10|||
160969041|NCT02243202|581275105|FG003|Overall Study|Adverse Event|4|||
160969042|NCT02243202|581275102|FG000|Overall Study|Lost to Follow-up|9|||
160969043|NCT02243202|581275103|FG001|Overall Study|Lost to Follow-up|9|||
160969044|NCT02243202|581275104|FG002|Overall Study|Lost to Follow-up|14|||
160969045|NCT02243202|581275105|FG003|Overall Study|Lost to Follow-up|11|||
160969046|NCT02243202|581275102|FG000|Overall Study|Protocol Violation|3|||
160969047|NCT02243202|581275103|FG001|Overall Study|Protocol Violation|1|||
160969048|NCT02243202|581275104|FG002|Overall Study|Protocol Violation|2|||
161018034|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
161018035|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
161018036|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
161018037|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
161018038|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
161018039|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
161018040|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
161018041|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
161018042|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
161018043|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
161018044|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
161018045|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
161018046|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
161018047|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
161018048|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018049|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018050|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018051|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018052|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018053|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018054|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
161018055|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018056|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018057|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018058|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018059|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018060|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
161018061|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018062|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018063|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018064|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018065|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018066|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018067|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018068|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018069|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018070|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018071|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018072|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018073|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018074|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
161018075|NCT02783300|581455790|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018076|NCT02783300|581455791|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018077|NCT02783300|581455792|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018078|NCT02783300|581455793|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018079|NCT02783300|581455794|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161018080|NCT02783300|581455795|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018081|NCT02783300|581455796|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161018082|NCT02783300|581455797|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018083|NCT02783300|581455798|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018084|NCT02783300|581455799|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
161018085|NCT02783300|581455800|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018086|NCT02783300|581455801|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018087|NCT02783300|581455802|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
161018088|NCT02783300|581455803|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018089|NCT02783300|581455804|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018090|NCT02783300|581455805|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018091|NCT02783300|581455806|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018092|NCT02783300|581455807|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018093|NCT02783300|581455808|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018094|NCT02783300|581455809|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161148116|NCT00090285|581924492|FG001|Base Study Vaccination Period|Other|2|||
161018095|NCT02783300|581455810|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018096|NCT02783300|581455811|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161148117|NCT00090285|581924493|FG002|Base Study Vaccination Period|Other|0|||
161273020|NCT01338870|582379583|FG000|Overall Study|Adverse Event|4|||
161273021|NCT01338870|582379584|FG001|Overall Study|Adverse Event|4|||
161018097|NCT02783300|581455812|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018098|NCT02783300|581455813|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018099|NCT02783300|581455814|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018100|NCT02783300|581455815|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018101|NCT02783300|581455816|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
161018102|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018103|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018104|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018105|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018106|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018107|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018108|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018109|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018110|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018111|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018112|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018113|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018114|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018115|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018116|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018117|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161018118|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018119|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
161018120|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
161018121|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161018122|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018123|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018124|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018125|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018126|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
161018127|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018128|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
161018129|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018130|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018131|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018132|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018133|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018134|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018135|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018136|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018137|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018138|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018139|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018140|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018141|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018142|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018143|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018144|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018145|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
161018146|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018147|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
161018148|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
161018149|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018150|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161273022|NCT01338870|582379585|FG002|Overall Study|Adverse Event|1|||
161273023|NCT01338870|582379586|FG003|Overall Study|Adverse Event|5|||
161273024|NCT01338870|582379587|FG004|Overall Study|Adverse Event|4|||
161273025|NCT01338870|582379588|FG005|Overall Study|Adverse Event|1|||
161273026|NCT01955083|582379591|FG000|Overall Study|Lost to Follow-up|1|||
161273027|NCT01955083|582379592|FG001|Overall Study|Lost to Follow-up|1|||
161273028|NCT01559389|582379601|FG000|Overall Study|Withdrawal by Subject|20|||
161273029|NCT01559389|582379602|FG001|Overall Study|Withdrawal by Subject|20|||
161018151|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018152|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018153|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018154|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018155|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
161018156|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018157|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018158|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018159|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018160|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018161|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018162|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018163|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018164|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018165|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018166|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018167|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018168|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018169|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018170|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018171|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018172|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161018173|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018174|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161018175|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
161018176|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
161018177|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018178|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018179|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018180|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018181|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018182|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
161018183|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018184|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018185|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018186|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018187|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018188|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018189|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018190|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018191|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018192|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018193|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018194|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018195|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018196|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018197|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018198|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
161018199|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018200|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018201|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018202|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018203|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018204|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018205|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
161018206|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018207|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018208|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018209|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
161018210|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018211|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018212|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018213|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018214|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018215|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018216|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018217|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018218|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018219|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018220|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018221|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018222|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018223|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
161018224|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
161018225|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
161018226|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
161018227|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018228|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
161018229|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
161018230|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018231|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018232|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018233|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018234|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018235|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018236|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
161018237|NCT02783300|581455790|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018238|NCT02783300|581455791|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018239|NCT02783300|581455792|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018240|NCT02783300|581455793|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018241|NCT02783300|581455794|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018242|NCT02783300|581455795|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018243|NCT02783300|581455796|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018244|NCT02783300|581455797|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018245|NCT02783300|581455798|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018246|NCT02783300|581455799|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018247|NCT02783300|581455800|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018248|NCT02783300|581455801|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018249|NCT02783300|581455802|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018250|NCT02783300|581455803|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
161018251|NCT02783300|581455804|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018252|NCT02783300|581455805|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018253|NCT02783300|581455806|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018254|NCT02783300|581455807|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018255|NCT02783300|581455808|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018256|NCT02783300|581455809|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
161018257|NCT02783300|581455810|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018258|NCT02783300|581455811|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018259|NCT02783300|581455812|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
161018260|NCT02783300|581455813|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
161018261|NCT02783300|581455814|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
161018262|NCT02783300|581455815|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
161018263|NCT02783300|581455816|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
161018264|NCT02783300|581455790|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018265|NCT02783300|581455791|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018266|NCT02783300|581455792|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018267|NCT02783300|581455793|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018268|NCT02783300|581455794|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018269|NCT02783300|581455795|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018270|NCT02783300|581455796|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161148118|NCT00090285|581924494|FG003|Base Study Vaccination Period|Other|0|||
161273030|NCT02871492|582379603|FG000|Overall Study|Lost to Follow-up|6|||
161273031|NCT02871492|582379604|FG001|Overall Study|Lost to Follow-up|3|||
161273032|NCT02871492|582379605|FG002|Overall Study|Lost to Follow-up|5|||
161273033|NCT02871492|582379603|FG000|Overall Study|Withdrawal by Subject|0|||
161273034|NCT02871492|582379604|FG001|Overall Study|Withdrawal by Subject|0|||
161018271|NCT02783300|581455797|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018272|NCT02783300|581455798|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018273|NCT02783300|581455799|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018274|NCT02783300|581455800|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018275|NCT02783300|581455801|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018276|NCT02783300|581455802|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018277|NCT02783300|581455803|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018278|NCT02783300|581455804|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018279|NCT02783300|581455805|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018280|NCT02783300|581455806|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018281|NCT02783300|581455807|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018282|NCT02783300|581455808|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018283|NCT02783300|581455809|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018284|NCT02783300|581455810|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018285|NCT02783300|581455811|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018286|NCT02783300|581455812|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018287|NCT02783300|581455813|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018288|NCT02783300|581455814|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018289|NCT02783300|581455815|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
161018290|NCT02783300|581455816|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
161018291|NCT02783300|581455790|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018292|NCT02783300|581455791|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018293|NCT02783300|581455792|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018294|NCT02783300|581455793|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018295|NCT02783300|581455794|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018296|NCT02783300|581455795|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018297|NCT02783300|581455796|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018298|NCT02783300|581455797|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018299|NCT02783300|581455798|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018300|NCT02783300|581455799|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018301|NCT02783300|581455800|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018302|NCT02783300|581455801|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018303|NCT02783300|581455802|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018304|NCT02783300|581455803|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018305|NCT02783300|581455804|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018306|NCT02783300|581455805|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018307|NCT02783300|581455806|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018308|NCT02783300|581455807|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018309|NCT02783300|581455808|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018310|NCT02783300|581455809|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018311|NCT02783300|581455810|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018312|NCT02783300|581455811|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018313|NCT02783300|581455812|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018314|NCT02783300|581455813|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018315|NCT02783300|581455814|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018316|NCT02783300|581455815|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
161018317|NCT02783300|581455816|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
161018318|NCT03535272|581455817|FG000|Overall Study|Lost to Follow-up|71|||
161018319|NCT03535272|581455818|FG001|Overall Study|Lost to Follow-up|73|||
161018320|NCT01744782|581455819|FG000|Overall Study|Death|1|||
161018321|NCT00378105|581455820|FG000|Overall Study|Adverse Event|3|||
161018322|NCT00378105|581455821|FG001|Overall Study|Adverse Event|1|||
161018323|NCT00378105|581455820|FG000|Overall Study|Withdrawal by Subject|3|||
161018324|NCT00378105|581455821|FG001|Overall Study|Withdrawal by Subject|3|||
161018325|NCT00378105|581455820|FG000|Overall Study|Death|1|||
161018326|NCT00378105|581455821|FG001|Overall Study|Death|0|||
161018327|NCT00378105|581455820|FG000|Overall Study|Going to transplant|7|||
161018328|NCT00378105|581455821|FG001|Overall Study|Going to transplant|8|||
161018329|NCT00378105|581455820|FG000|Overall Study|Progressive disease|3|||
161018330|NCT00378105|581455821|FG001|Overall Study|Progressive disease|3|||
161018331|NCT00378105|581455820|FG000|Overall Study|remain on study|3|||
161018332|NCT00378105|581455821|FG001|Overall Study|remain on study|11|||
161018333|NCT00378105|581455820|FG000|Overall Study|Physician Decision|0|||
161018334|NCT00378105|581455821|FG001|Overall Study|Physician Decision|2|||
161018335|NCT00378105|581455820|FG000|Overall Study|Going non-protocol therapy|0|||
161018336|NCT00378105|581455821|FG001|Overall Study|Going non-protocol therapy|1|||
161018337|NCT00378105|581455820|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
161018338|NCT00378105|581455821|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
161018339|NCT03623321|581455822|FG000|Overall Study|Adverse Event|32|||
161273035|NCT02871492|582379605|FG002|Overall Study|Withdrawal by Subject|1|||
161273036|NCT04546724|582379606|FG000|Overall Study|Withdrawal by Subject|145|||
161273037|NCT04546724|582379607|FG001|Overall Study|Withdrawal by Subject|41|||
161273038|NCT04546724|582379606|FG000|Overall Study|Adverse Event|1|||
161018340|NCT03623321|581455822|FG000|Overall Study|Death|9|||
161018341|NCT03623321|581455822|FG000|Overall Study|Lack of Efficacy|9|||
161018342|NCT03623321|581455822|FG000|Overall Study|Lost to Follow-up|6|||
161273039|NCT04546724|582379607|FG001|Overall Study|Adverse Event|1|||
161273040|NCT04546724|582379606|FG000|Overall Study|Lost to Follow-up|186|||
161273041|NCT04546724|582379607|FG001|Overall Study|Lost to Follow-up|63|||
161273042|NCT04546724|582379606|FG000|Overall Study|Physician Decision|8|||
161273043|NCT04546724|582379607|FG001|Overall Study|Physician Decision|2|||
161273044|NCT04546724|582379606|FG000|Overall Study|Death|2|||
161273045|NCT04546724|582379607|FG001|Overall Study|Death|1|||
161273046|NCT04546724|582379606|FG000|Overall Study|subject has been out of town|1|||
161273047|NCT04546724|582379607|FG001|Overall Study|subject has been out of town|0|||
161273048|NCT04546724|582379606|FG000|Overall Study|subject is incarcerated|2|||
161273049|NCT04546724|582379607|FG001|Overall Study|subject is incarcerated|0|||
161273050|NCT04546724|582379606|FG000|Overall Study|subject is relocating|12|||
161273051|NCT04546724|582379607|FG001|Overall Study|subject is relocating|4|||
161273052|NCT04546724|582379606|FG000|Overall Study|Subject in another study|1|||
161273053|NCT04546724|582379607|FG001|Overall Study|Subject in another study|1|||
161273054|NCT03583086|582379608|FG000|Overall Study|Death|2|||
161273055|NCT03583086|582379609|FG001|Overall Study|Death|6|||
161273056|NCT03583086|582379610|FG002|Overall Study|Death|12|||
161273057|NCT03583086|582379611|FG003|Overall Study|Death|10|||
161273058|NCT03583086|582379612|FG004|Overall Study|Death|14|||
161273059|NCT03583086|582379613|FG005|Overall Study|Death|14|||
161273060|NCT03583086|582379614|FG006|Overall Study|Death|4|||
161273061|NCT03583086|582379608|FG000|Overall Study|Withdrawal by Subject|0|||
161273062|NCT03583086|582379609|FG001|Overall Study|Withdrawal by Subject|0|||
161273063|NCT03583086|582379610|FG002|Overall Study|Withdrawal by Subject|1|||
161273064|NCT03583086|582379611|FG003|Overall Study|Withdrawal by Subject|0|||
161273065|NCT03583086|582379612|FG004|Overall Study|Withdrawal by Subject|0|||
161273066|NCT03583086|582379613|FG005|Overall Study|Withdrawal by Subject|0|||
161273067|NCT03583086|582379614|FG006|Overall Study|Withdrawal by Subject|1|||
161273068|NCT03583086|582379608|FG000|Overall Study|Refused follow-up|0|||
161273069|NCT03583086|582379609|FG001|Overall Study|Refused follow-up|0|||
161273070|NCT03583086|582379610|FG002|Overall Study|Refused follow-up|1|||
161273071|NCT03583086|582379611|FG003|Overall Study|Refused follow-up|0|||
161273072|NCT03583086|582379612|FG004|Overall Study|Refused follow-up|1|||
161273073|NCT03583086|582379613|FG005|Overall Study|Refused follow-up|0|||
161273074|NCT03583086|582379614|FG006|Overall Study|Refused follow-up|0|||
161273075|NCT03583086|582379608|FG000|Overall Study|Declining Performance Status|0|||
161273076|NCT03583086|582379609|FG001|Overall Study|Declining Performance Status|0|||
161273077|NCT03583086|582379610|FG002|Overall Study|Declining Performance Status|1|||
161273078|NCT03583086|582379611|FG003|Overall Study|Declining Performance Status|0|||
161273079|NCT03583086|582379612|FG004|Overall Study|Declining Performance Status|0|||
160969049|NCT02243202|581275105|FG003|Overall Study|Protocol Violation|1|||
160969050|NCT02243202|581275102|FG000|Overall Study|Withdrawal by Subject|7|||
160969051|NCT02243202|581275103|FG001|Overall Study|Withdrawal by Subject|6|||
160969052|NCT02243202|581275104|FG002|Overall Study|Withdrawal by Subject|4|||
160969053|NCT02243202|581275105|FG003|Overall Study|Withdrawal by Subject|4|||
160969054|NCT02243202|581275102|FG000|Overall Study|Other|1|||
160969055|NCT02243202|581275103|FG001|Overall Study|Other|3|||
160969056|NCT02243202|581275104|FG002|Overall Study|Other|1|||
160969057|NCT02243202|581275105|FG003|Overall Study|Other|2|||
160969058|NCT02243202|581275102|FG000|Overall Study|Randomized but not received treatment|0|||
160969059|NCT02243202|581275103|FG001|Overall Study|Randomized but not received treatment|0|||
160969060|NCT02243202|581275104|FG002|Overall Study|Randomized but not received treatment|0|||
160969061|NCT02243202|581275105|FG003|Overall Study|Randomized but not received treatment|1|||
160969062|NCT02801669|581275108|FG000|Overall Study|Death|66|||
160969063|NCT02801669|581275109|FG001|Overall Study|Death|69|||
160969064|NCT02801669|581275108|FG000|Overall Study|Withdrawal by Subject|81|||
160969065|NCT02801669|581275109|FG001|Overall Study|Withdrawal by Subject|77|||
160969066|NCT02801669|581275108|FG000|Overall Study|Other|4|||
160969067|NCT02801669|581275109|FG001|Overall Study|Other|6|||
160969068|NCT00615264|581275110|FG000|Overall Study|Withdrawal by Subject|17|||
160969069|NCT00615264|581275111|FG001|Overall Study|Withdrawal by Subject|19|||
160969070|NCT00615264|581275110|FG000|Overall Study|Lost to Follow-up|6|||
160969071|NCT00615264|581275111|FG001|Overall Study|Lost to Follow-up|13|||
161018343|NCT03623321|581455822|FG000|Overall Study|Noncompliance with study drug|6|||
161273080|NCT03583086|582379613|FG005|Overall Study|Declining Performance Status|0|||
161273081|NCT03583086|582379614|FG006|Overall Study|Declining Performance Status|0|||
161273082|NCT03583086|582379608|FG000|Overall Study|Still on study|0|||
161273083|NCT03583086|582379609|FG001|Overall Study|Still on study|0|||
161018344|NCT03623321|581455822|FG000|Overall Study|Use of prohibited medication|3|||
160969072|NCT00615264|581275110|FG000|Overall Study|Adverse Event|8|||
161273084|NCT03583086|582379610|FG002|Overall Study|Still on study|0|||
161273085|NCT03583086|582379611|FG003|Overall Study|Still on study|1|||
161273086|NCT03583086|582379612|FG004|Overall Study|Still on study|0|||
161018345|NCT03623321|581455822|FG000|Overall Study|Physician Decision|5|||
161018346|NCT03623321|581455822|FG000|Overall Study|Protocol Violation|1|||
161018347|NCT03623321|581455822|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
161018348|NCT03623321|581455822|FG000|Overall Study|Not further specified|43|||
161018349|NCT04241068|581455825|FG000|Core Treatment Period|Adverse Event|91|||
161018350|NCT04241068|581455825|FG000|Core Treatment Period|Change of Treatment|4|||
161018351|NCT04241068|581455825|FG000|Core Treatment Period|Consent Withdrawn|143|||
161018352|NCT04241068|581455825|FG000|Core Treatment Period|Death|26|||
161018353|NCT04241068|581455825|FG000|Core Treatment Period|Disease Progression|67|||
161018354|NCT04241068|581455825|FG000|Core Treatment Period|Investigator Decision|40|||
161018355|NCT04241068|581455825|FG000|Core Treatment Period|Loss of Capacity|9|||
161018356|NCT04241068|581455825|FG000|Core Treatment Period|Lost to Follow-up|11|||
161018357|NCT04241068|581455825|FG000|Core Treatment Period|Relocation|4|||
161018358|NCT04241068|581455825|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
161018359|NCT04241068|581455825|FG000|Core Treatment Period|Study Visit Burden|40|||
161018360|NCT04241068|581455825|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
161018361|NCT04241068|581455825|FG000|Core Treatment Period|Missing|2|||
161018362|NCT04241068|581455825|FG000|Core Treatment Period|Reason Not Specified|41|||
161018363|NCT04241068|581455825|FG000|LTE Period|Adverse Event|19|||
161018364|NCT04241068|581455825|FG000|LTE Period|Change of Treatment|1|||
161018365|NCT04241068|581455825|FG000|LTE Period|Consent Withdrawn|71|||
161018366|NCT04241068|581455825|FG000|LTE Period|Death|8|||
161018367|NCT04241068|581455825|FG000|LTE Period|Disease Progression|11|||
161018368|NCT04241068|581455825|FG000|LTE Period|Investigator Decision|12|||
161018369|NCT04241068|581455825|FG000|LTE Period|Loss of Capacity|2|||
161018370|NCT04241068|581455825|FG000|LTE Period|Lost to Follow-up|7|||
161018371|NCT04241068|581455825|FG000|LTE Period|Relocation|6|||
161018372|NCT04241068|581455825|FG000|LTE Period|Site Terminated by Sponsor|26|||
161018373|NCT04241068|581455825|FG000|LTE Period|Study Terminated by Sponsor|276|||
161018374|NCT04241068|581455825|FG000|LTE Period|Study Visit Burden|10|||
161018375|NCT04241068|581455825|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
161018376|NCT04241068|581455825|FG000|LTE Period|Reason Not Specified|65|||
161018377|NCT04229992|581455835|FG000|Overall Study|Withdrawal by Subject|0|||
161018378|NCT04229992|581455836|FG001|Overall Study|Withdrawal by Subject|2|||
161018379|NCT04229992|581455837|FG002|Overall Study|Withdrawal by Subject|1|||
161018380|NCT04229992|581455838|FG003|Overall Study|Withdrawal by Subject|1|||
161018381|NCT04229992|581455835|FG000|Overall Study|Adverse Event|1|||
161018382|NCT04229992|581455836|FG001|Overall Study|Adverse Event|1|||
161018383|NCT04229992|581455837|FG002|Overall Study|Adverse Event|3|||
161018384|NCT04229992|581455838|FG003|Overall Study|Adverse Event|1|||
161018385|NCT04229992|581455835|FG000|Overall Study|Lost to Follow-up|0|||
161018386|NCT04229992|581455836|FG001|Overall Study|Lost to Follow-up|0|||
161018387|NCT04229992|581455837|FG002|Overall Study|Lost to Follow-up|0|||
161018388|NCT04229992|581455838|FG003|Overall Study|Lost to Follow-up|1|||
161018389|NCT05178316|581455839|FG000|Overall Study|Adverse Event|5|||
161018390|NCT05178316|581455840|FG001|Overall Study|Adverse Event|4|||
161018391|NCT05178316|581455841|FG002|Overall Study|Adverse Event|9|||
161018392|NCT05178316|581455839|FG000|Overall Study|Enrolled in Error|1|||
161018393|NCT05178316|581455840|FG001|Overall Study|Enrolled in Error|2|||
161018394|NCT05178316|581455841|FG002|Overall Study|Enrolled in Error|1|||
161273087|NCT03583086|582379613|FG005|Overall Study|Still on study|0|||
161273088|NCT03583086|582379614|FG006|Overall Study|Still on study|1|||
161018395|NCT05178316|581455839|FG000|Overall Study|Lost to Follow-up|3|||
161018396|NCT05178316|581455840|FG001|Overall Study|Lost to Follow-up|15|||
161018397|NCT05178316|581455841|FG002|Overall Study|Lost to Follow-up|11|||
161273089|NCT03583086|582379608|FG000|Overall Study|Disease progression|0|||
161273090|NCT03583086|582379609|FG001|Overall Study|Disease progression|0|||
161273091|NCT03583086|582379610|FG002|Overall Study|Disease progression|0|||
161018398|NCT05178316|581455839|FG000|Overall Study|Noncompliance|1|||
161018399|NCT05178316|581455840|FG001|Overall Study|Noncompliance|3|||
161018400|NCT05178316|581455841|FG002|Overall Study|Noncompliance|1|||
161018401|NCT05178316|581455839|FG000|Overall Study|Other|0|||
161018402|NCT05178316|581455840|FG001|Overall Study|Other|1|||
161018403|NCT05178316|581455841|FG002|Overall Study|Other|0|||
161018404|NCT05178316|581455839|FG000|Overall Study|Physician Decision|0|||
161018405|NCT05178316|581455840|FG001|Overall Study|Physician Decision|3|||
161018406|NCT05178316|581455841|FG002|Overall Study|Physician Decision|2|||
161018407|NCT05178316|581455839|FG000|Overall Study|Protocol deviation|1|||
161018408|NCT05178316|581455840|FG001|Overall Study|Protocol deviation|0|||
161018409|NCT05178316|581455841|FG002|Overall Study|Protocol deviation|1|||
161018410|NCT05178316|581455839|FG000|Overall Study|Sponsor decision|1|||
161273092|NCT03583086|582379611|FG003|Overall Study|Disease progression|0|||
161018411|NCT05178316|581455840|FG001|Overall Study|Sponsor decision|0|||
161018412|NCT05178316|581455841|FG002|Overall Study|Sponsor decision|1|||
161018413|NCT05178316|581455839|FG000|Overall Study|Withdrawal by Subject|5|||
161273093|NCT03583086|582379612|FG004|Overall Study|Disease progression|0|||
161018414|NCT05178316|581455840|FG001|Overall Study|Withdrawal by Subject|11|||
161018415|NCT05178316|581455841|FG002|Overall Study|Withdrawal by Subject|5|||
161018416|NCT04347161|581455842|FG000|Overall Study|Death|0|||
161018417|NCT04347161|581455843|FG001|Overall Study|Death|2|||
161018418|NCT04347161|581455842|FG000|Overall Study|Withdrawal by Subject|1|||
161018419|NCT04347161|581455843|FG001|Overall Study|Withdrawal by Subject|0|||
161018420|NCT04347161|581455842|FG000|Overall Study|Lost to Follow-up|0|||
161018421|NCT04347161|581455843|FG001|Overall Study|Lost to Follow-up|1|||
161018422|NCT04347161|581455842|FG000|Overall Study|No longer on study medication|1|||
161018423|NCT04347161|581455843|FG001|Overall Study|No longer on study medication|1|||
161018424|NCT04169373|581455844|FG000|Week 1 to Week 14|Adverse Event|1|||
161018425|NCT04169373|581455845|FG001|Week 1 to Week 14|Adverse Event|0|||
161018426|NCT04169373|581455846|FG002|Week 1 to Week 14|Adverse Event|1|||
161018427|NCT04169373|581455847|FG003|Week 1 to Week 14|Adverse Event|2|||
161018428|NCT04169373|581455844|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
161018429|NCT04169373|581455845|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
161018430|NCT04169373|581455846|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
161018431|NCT04169373|581455847|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
161018432|NCT04169373|581455844|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
161018433|NCT04169373|581455845|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
161018434|NCT04169373|581455846|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
161018435|NCT04169373|581455847|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
161018436|NCT04169373|581455844|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161018437|NCT04169373|581455845|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
161018438|NCT04169373|581455846|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161018439|NCT04169373|581455847|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
161018440|NCT04169373|581455844|FG000|Week 1 to Week 14|Other|1|||
161273094|NCT03583086|582379613|FG005|Overall Study|Disease progression|0|||
161273095|NCT03583086|582379614|FG006|Overall Study|Disease progression|1|||
161273096|NCT03583086|582379608|FG000|Overall Study|Undergoing radiation therapy|0|||
161273097|NCT03583086|582379609|FG001|Overall Study|Undergoing radiation therapy|0|||
161018441|NCT04169373|581455845|FG001|Week 1 to Week 14|Other|3|||
161018442|NCT04169373|581455846|FG002|Week 1 to Week 14|Other|3|||
161018443|NCT04169373|581455847|FG003|Week 1 to Week 14|Other|5|||
161018444|NCT04169373|581455844|FG000|Week 14 to Week 52|Adverse Event|1|||
161018445|NCT04169373|581455845|FG001|Week 14 to Week 52|Adverse Event|0|||
161018446|NCT04169373|581455846|FG002|Week 14 to Week 52|Adverse Event|0|||
161018447|NCT04169373|581455847|FG003|Week 14 to Week 52|Adverse Event|1|||
161018448|NCT04169373|581455844|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
161018449|NCT04169373|581455845|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
161018450|NCT04169373|581455846|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
161018451|NCT04169373|581455847|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
161018452|NCT04169373|581455844|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
161018453|NCT04169373|581455845|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
161018454|NCT04169373|581455846|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
161018455|NCT04169373|581455847|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
161018456|NCT04169373|581455844|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
161018457|NCT04169373|581455845|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161018458|NCT04169373|581455846|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161018459|NCT04169373|581455847|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
161018460|NCT04169373|581455844|FG000|Week 14 to Week 52|Other|4|||
161018461|NCT04169373|581455845|FG001|Week 14 to Week 52|Other|5|||
161018462|NCT04169373|581455846|FG002|Week 14 to Week 52|Other|4|||
161018463|NCT04169373|581455847|FG003|Week 14 to Week 52|Other|5|||
161018464|NCT04169373|581455844|FG000|Week 14 to Week 52|Ongoing|0|||
161018465|NCT04169373|581455845|FG001|Week 14 to Week 52|Ongoing|1|||
161018466|NCT04169373|581455846|FG002|Week 14 to Week 52|Ongoing|0|||
161018467|NCT04169373|581455847|FG003|Week 14 to Week 52|Ongoing|0|||
161018468|NCT04610892|581455848|FG000|Overall Study|Adverse Event|1|||
161018469|NCT04610892|581455849|FG001|Overall Study|Adverse Event|0|||
161018470|NCT04610892|581455850|FG002|Overall Study|Adverse Event|0|||
161018471|NCT04610892|581455851|FG003|Overall Study|Adverse Event|1|||
161018472|NCT04610892|581455852|FG004|Overall Study|Adverse Event|3|||
161148119|NCT00090285|581924495|FG004|Base Study Vaccination Period|Other|0|||
161148120|NCT00090285|581924496|FG005|Base Study Vaccination Period|Other|0|||
161018473|NCT04610892|581455848|FG000|Overall Study|Death|0|||
161018474|NCT04610892|581455849|FG001|Overall Study|Death|1|||
161018475|NCT04610892|581455850|FG002|Overall Study|Death|0|||
161018476|NCT04610892|581455851|FG003|Overall Study|Death|1|||
161018477|NCT04610892|581455852|FG004|Overall Study|Death|0|||
161018478|NCT04610892|581455848|FG000|Overall Study|Withdrawal by Subject|3|||
161018479|NCT04610892|581455849|FG001|Overall Study|Withdrawal by Subject|2|||
161018480|NCT04610892|581455850|FG002|Overall Study|Withdrawal by Subject|0|||
161018481|NCT04610892|581455851|FG003|Overall Study|Withdrawal by Subject|6|||
161018482|NCT04610892|581455852|FG004|Overall Study|Withdrawal by Subject|6|||
161018483|NCT04610892|581455848|FG000|Overall Study|Subjects who did not receive treatment|1|||
161273098|NCT03583086|582379610|FG002|Overall Study|Undergoing radiation therapy|0|||
161273099|NCT03583086|582379611|FG003|Overall Study|Undergoing radiation therapy|0|||
161273100|NCT03583086|582379612|FG004|Overall Study|Undergoing radiation therapy|0|||
161273101|NCT03583086|582379613|FG005|Overall Study|Undergoing radiation therapy|0|||
161273102|NCT03583086|582379614|FG006|Overall Study|Undergoing radiation therapy|1|||
161273103|NCT03583086|582379608|FG000|Overall Study|Lost to Follow-up|0|||
161273104|NCT03583086|582379609|FG001|Overall Study|Lost to Follow-up|0|||
161273105|NCT03583086|582379610|FG002|Overall Study|Lost to Follow-up|0|||
161273106|NCT03583086|582379611|FG003|Overall Study|Lost to Follow-up|0|||
161273107|NCT03583086|582379612|FG004|Overall Study|Lost to Follow-up|0|||
161273108|NCT03583086|582379613|FG005|Overall Study|Lost to Follow-up|1|||
161273109|NCT03583086|582379614|FG006|Overall Study|Lost to Follow-up|0|||
161273110|NCT03583086|582379608|FG000|Overall Study|Adverse Event|0|||
161273111|NCT03583086|582379609|FG001|Overall Study|Adverse Event|0|||
161273112|NCT03583086|582379610|FG002|Overall Study|Adverse Event|0|||
161273113|NCT03583086|582379611|FG003|Overall Study|Adverse Event|0|||
160969073|NCT00615264|581275111|FG001|Overall Study|Adverse Event|5|||
160969074|NCT00615264|581275110|FG000|Overall Study|Death|1|||
160969075|NCT00615264|581275111|FG001|Overall Study|Death|1|||
160969076|NCT00615264|581275110|FG000|Overall Study|Protocol Violation|11|||
160969077|NCT00615264|581275111|FG001|Overall Study|Protocol Violation|7|||
160969078|NCT00615264|581275110|FG000|Overall Study|Not defined|7|||
160969079|NCT00615264|581275111|FG001|Overall Study|Not defined|4|||
160969080|NCT00615264|581275110|FG000|Overall Study|Dermal Hypersensitivity|0|||
160969081|NCT00615264|581275111|FG001|Overall Study|Dermal Hypersensitivity|3|||
160969082|NCT00633932|581275112|FG000|Overall Study|Adverse Event|1|||
160969083|NCT00633932|581275113|FG001|Overall Study|Adverse Event|3|||
160969084|NCT00633932|581275114|FG002|Overall Study|Adverse Event|4|||
160969085|NCT00633932|581275112|FG000|Overall Study|Withdrawal by Subject|3|||
160969086|NCT00633932|581275113|FG001|Overall Study|Withdrawal by Subject|9|||
160969087|NCT00633932|581275114|FG002|Overall Study|Withdrawal by Subject|1|||
160969088|NCT00633932|581275112|FG000|Overall Study|Lost to Follow-up|1|||
160969089|NCT00633932|581275113|FG001|Overall Study|Lost to Follow-up|0|||
160969090|NCT00633932|581275114|FG002|Overall Study|Lost to Follow-up|2|||
160969091|NCT00633932|581275112|FG000|Overall Study|Protocol Violation|5|||
160969092|NCT00633932|581275113|FG001|Overall Study|Protocol Violation|2|||
160969093|NCT00633932|581275114|FG002|Overall Study|Protocol Violation|3|||
160969094|NCT00633932|581275112|FG000|Overall Study|Physician Decision|0|||
160969095|NCT00633932|581275113|FG001|Overall Study|Physician Decision|0|||
160969096|NCT00633932|581275114|FG002|Overall Study|Physician Decision|1|||
160969097|NCT00633932|581275112|FG000|Overall Study|Doctor's judgement|1|||
160969098|NCT00633932|581275113|FG001|Overall Study|Doctor's judgement|0|||
160969099|NCT00633932|581275114|FG002|Overall Study|Doctor's judgement|0|||
160969100|NCT00633932|581275112|FG000|Overall Study|Moved Away|1|||
160969101|NCT00633932|581275113|FG001|Overall Study|Moved Away|0|||
160969102|NCT00633932|581275114|FG002|Overall Study|Moved Away|0|||
160969103|NCT04836858|581275115|FG000|Overall Study|Adverse Event|0|||
160969104|NCT04836858|581275116|FG001|Overall Study|Adverse Event|0|||
160969105|NCT04836858|581275117|FG002|Overall Study|Adverse Event|0|||
160969106|NCT04836858|581275118|FG003|Overall Study|Adverse Event|1|||
160969107|NCT04836858|581275115|FG000|Overall Study|Lost to Follow-up|1|||
160969108|NCT04836858|581275116|FG001|Overall Study|Lost to Follow-up|0|||
160969109|NCT04836858|581275117|FG002|Overall Study|Lost to Follow-up|0|||
160969110|NCT04836858|581275118|FG003|Overall Study|Lost to Follow-up|0|||
160969111|NCT04836858|581275115|FG000|Overall Study|Subject/Guardian decision|3|||
160969112|NCT04836858|581275116|FG001|Overall Study|Subject/Guardian decision|0|||
160969113|NCT04836858|581275117|FG002|Overall Study|Subject/Guardian decision|0|||
160969114|NCT04836858|581275118|FG003|Overall Study|Subject/Guardian decision|1|||
160969115|NCT04836858|581275115|FG000|Overall Study|Randomized but not treated|4|||
160969116|NCT04836858|581275116|FG001|Overall Study|Randomized but not treated|0|||
160969117|NCT04836858|581275117|FG002|Overall Study|Randomized but not treated|0|||
160969118|NCT04836858|581275118|FG003|Overall Study|Randomized but not treated|0|||
160969119|NCT00708435|581275120|FG000|Overall Study|Death / Serious Adverse Event|10|||
160969120|NCT00708435|581275121|FG001|Overall Study|Death / Serious Adverse Event|5|||
160969121|NCT00708435|581275120|FG000|Overall Study|Lost to Follow-up|9|||
160969122|NCT00708435|581275121|FG001|Overall Study|Lost to Follow-up|4|||
160969123|NCT00708435|581275120|FG000|Overall Study|Withdrawal by Subject|3|||
161273114|NCT03583086|582379612|FG004|Overall Study|Adverse Event|0|||
161273115|NCT03583086|582379613|FG005|Overall Study|Adverse Event|1|||
161273116|NCT03583086|582379614|FG006|Overall Study|Adverse Event|0|||
160969124|NCT00708435|581275121|FG001|Overall Study|Withdrawal by Subject|7|||
160969125|NCT00708435|581275120|FG000|Overall Study|Adverse Event|1|||
160969126|NCT00708435|581275121|FG001|Overall Study|Adverse Event|0|||
160969127|NCT00708435|581275120|FG000|Overall Study|Protocol Violation|0|||
160969128|NCT00708435|581275121|FG001|Overall Study|Protocol Violation|1|||
160969129|NCT00708435|581275120|FG000|Overall Study|Intervention by primary care physician|1|||
160969130|NCT00708435|581275121|FG001|Overall Study|Intervention by primary care physician|0|||
161273117|NCT00396812|582379618|FG000|Overall Study|Physician Decision|1|||
161273118|NCT03201445|582379620|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
161273119|NCT03201445|582379621|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
161273120|NCT03201445|582379620|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
161273121|NCT03201445|582379621|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
161273122|NCT03201445|582379620|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
161273123|NCT03201445|582379621|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
161273124|NCT03201445|582379620|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
161273125|NCT03201445|582379621|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
161273126|NCT03201445|582379620|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
161273127|NCT03201445|582379621|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
161273128|NCT03201445|582379620|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
161273129|NCT03201445|582379621|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
161273130|NCT03201445|582379620|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
161273131|NCT03201445|582379621|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
160969131|NCT00708435|581275120|FG000|Overall Study|Refused hospitalization|1|||
160969132|NCT00708435|581275121|FG001|Overall Study|Refused hospitalization|0|||
160969133|NCT04766086|581275124|FG000|Overall Study|Lost to Follow-up|3|||
160969134|NCT04766086|581275125|FG001|Overall Study|Lost to Follow-up|5|||
160969135|NCT04766086|581275126|FG002|Overall Study|Lost to Follow-up|3|||
160969136|NCT04766086|581275124|FG000|Overall Study|Withdrawal by Subject|1|||
160969137|NCT04766086|581275125|FG001|Overall Study|Withdrawal by Subject|1|||
160969138|NCT04766086|581275126|FG002|Overall Study|Withdrawal by Subject|2|||
160969139|NCT04766086|581275124|FG000|Overall Study|Other|0|||
160969140|NCT04766086|581275125|FG001|Overall Study|Other|0|||
160969141|NCT04766086|581275126|FG002|Overall Study|Other|1|||
160969142|NCT01691521|581275127|FG000|Overall Study|Adverse Event|4|||
160969143|NCT01691521|581275128|FG001|Overall Study|Adverse Event|0|||
160969144|NCT01691521|581275129|FG002|Overall Study|Adverse Event|1|||
160969145|NCT01691521|581275127|FG000|Overall Study|Lack of Efficacy|1|||
160969146|NCT01691521|581275128|FG001|Overall Study|Lack of Efficacy|1|||
160969147|NCT01691521|581275129|FG002|Overall Study|Lack of Efficacy|2|||
160969148|NCT01691521|581275127|FG000|Overall Study|Protocol Violation|0|||
160969149|NCT01691521|581275128|FG001|Overall Study|Protocol Violation|3|||
160969150|NCT01691521|581275129|FG002|Overall Study|Protocol Violation|0|||
160969151|NCT01691521|581275127|FG000|Overall Study|Lost to Follow-up|0|||
160969152|NCT01691521|581275128|FG001|Overall Study|Lost to Follow-up|2|||
160969153|NCT01691521|581275129|FG002|Overall Study|Lost to Follow-up|2|||
160969154|NCT01691521|581275127|FG000|Overall Study|Physician Decision|2|||
160969155|NCT01691521|581275128|FG001|Overall Study|Physician Decision|1|||
160969156|NCT01691521|581275129|FG002|Overall Study|Physician Decision|0|||
160969157|NCT01691521|581275127|FG000|Overall Study|Withdrawal by Subject|5|||
160969158|NCT01691521|581275128|FG001|Overall Study|Withdrawal by Subject|9|||
160969159|NCT01691521|581275129|FG002|Overall Study|Withdrawal by Subject|4|||
160969160|NCT02343003|581275130|FG000|Overall Study|Withdrawal by Subject|9|||
160969161|NCT02343003|581275131|FG001|Overall Study|Withdrawal by Subject|4|||
160969162|NCT02343003|581275130|FG000|Overall Study|Lost to Follow-up|5|||
160969163|NCT02343003|581275131|FG001|Overall Study|Lost to Follow-up|1|||
160969164|NCT02343003|581275130|FG000|Overall Study|Protocol Violation|1|||
160969165|NCT02343003|581275131|FG001|Overall Study|Protocol Violation|0|||
160969166|NCT02343003|581275130|FG000|Overall Study|Death|0|||
160969167|NCT02343003|581275131|FG001|Overall Study|Death|1|||
160969168|NCT02343003|581275130|FG000|Overall Study|exclusion criteria met|1|||
160969169|NCT02343003|581275131|FG001|Overall Study|exclusion criteria met|1|||
160969170|NCT02343003|581275130|FG000|Overall Study|terminated by sponsor|2|||
160969171|NCT02343003|581275131|FG001|Overall Study|terminated by sponsor|0|||
160969172|NCT02635724|581275134|FG000|Overall Study|Withdrawal by Subject|0|||
160969173|NCT02635724|581275135|FG001|Overall Study|Withdrawal by Subject|1|||
160969174|NCT02635724|581275136|FG002|Overall Study|Withdrawal by Subject|0|||
160969175|NCT03579290|581275139|FG000|Overall Study|Lost to Follow-up|9|||
160969176|NCT00622713|581275140|FG000|Overall Study|Adverse Event|35|||
160969177|NCT00622713|581275140|FG000|Overall Study|Administrative problems|4|||
160969178|NCT00622713|581275140|FG000|Overall Study|Withdrawal by Subject|11|||
160969179|NCT00622713|581275140|FG000|Overall Study|Lost to Follow-up|5|||
160969180|NCT00622713|581275140|FG000|Overall Study|Death|2|||
160969181|NCT00622713|581275140|FG000|Overall Study|Subject no longer required study drug|1|||
160969182|NCT00622713|581275140|FG000|Overall Study|Did not meet eligibility criteria|1|||
160969183|NCT04404478|581275141|FG000|Overall Study|Withdrawal by Subject|1|||
160969184|NCT04404478|581275142|FG001|Overall Study|Withdrawal by Subject|3|||
160969185|NCT01725386|581275155|FG000|Overall Study|Death|84|||
160969186|NCT01725386|581275156|FG001|Overall Study|Death|40|||
160969187|NCT01725386|581275155|FG000|Overall Study|Lost to Follow-up|81|||
160969188|NCT01725386|581275156|FG001|Overall Study|Lost to Follow-up|6|||
160969189|NCT01725386|581275155|FG000|Overall Study|Withdrawal by Subject|10|||
160969190|NCT01725386|581275156|FG001|Overall Study|Withdrawal by Subject|0|||
160969191|NCT00879996|581275160|FG000|Overall Study|Lost to Follow-up|7|||
160969192|NCT00879996|581275161|FG001|Overall Study|Lost to Follow-up|6|||
160969193|NCT00879996|581275160|FG000|Overall Study|non-compliance|6|||
161273132|NCT03201445|582379620|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
161018484|NCT04610892|581455849|FG001|Overall Study|Subjects who did not receive treatment|0|||
161018485|NCT04610892|581455850|FG002|Overall Study|Subjects who did not receive treatment|0|||
161018486|NCT04610892|581455851|FG003|Overall Study|Subjects who did not receive treatment|0|||
161018487|NCT04610892|581455852|FG004|Overall Study|Subjects who did not receive treatment|2|||
161018488|NCT01413100|581455853|FG000|Overall Study|Withdrawal by Subject|1|||
161018489|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
161018490|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
161018491|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
161018492|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
161018493|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
161018494|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
161018495|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
161018496|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
161018497|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
161018498|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
161018499|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
161018500|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
161018501|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
161018502|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
161018503|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
161018504|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
161018505|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
161018506|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
161018507|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
161148121|NCT00090285|581924491|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
161148122|NCT00090285|581924492|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
161148123|NCT00090285|581924493|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
161148124|NCT00090285|581924494|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
161148125|NCT00090285|581924495|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
161148126|NCT00090285|581924496|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
161148127|NCT00090285|581924491|FG000|Base Study Vaccination Period|HIV positive|1|||
161148128|NCT00090285|581924492|FG001|Base Study Vaccination Period|HIV positive|1|||
161148129|NCT00090285|581924493|FG002|Base Study Vaccination Period|HIV positive|0|||
161148130|NCT00090285|581924494|FG003|Base Study Vaccination Period|HIV positive|0|||
161148131|NCT00090285|581924495|FG004|Base Study Vaccination Period|HIV positive|0|||
161148132|NCT00090285|581924496|FG005|Base Study Vaccination Period|HIV positive|0|||
161148133|NCT00090285|581924491|FG000|Base Study Follow-up Period|Adverse Event|3|||
161148134|NCT00090285|581924492|FG001|Base Study Follow-up Period|Adverse Event|10|||
161148135|NCT00090285|581924493|FG002|Base Study Follow-up Period|Adverse Event|0|||
161148136|NCT00090285|581924494|FG003|Base Study Follow-up Period|Adverse Event|0|||
161148137|NCT00090285|581924495|FG004|Base Study Follow-up Period|Adverse Event|0|||
161148138|NCT00090285|581924496|FG005|Base Study Follow-up Period|Adverse Event|0|||
161148139|NCT00090285|581924491|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
161148140|NCT00090285|581924492|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
161148141|NCT00090285|581924493|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
161148142|NCT00090285|581924494|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
161148143|NCT00090285|581924495|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161148144|NCT00090285|581924496|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
161148145|NCT00090285|581924491|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
161148146|NCT00090285|581924492|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
161148147|NCT00090285|581924493|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161148148|NCT00090285|581924494|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161148149|NCT00090285|581924495|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161148150|NCT00090285|581924496|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
161148151|NCT00090285|581924491|FG000|Base Study Follow-up Period|Moved|41|||
161148152|NCT00090285|581924492|FG001|Base Study Follow-up Period|Moved|36|||
161148153|NCT00090285|581924493|FG002|Base Study Follow-up Period|Moved|0|||
161148154|NCT00090285|581924494|FG003|Base Study Follow-up Period|Moved|0|||
161148155|NCT00090285|581924495|FG004|Base Study Follow-up Period|Moved|0|||
161148156|NCT00090285|581924496|FG005|Base Study Follow-up Period|Moved|0|||
161148157|NCT00090285|581924491|FG000|Base Study Follow-up Period|Other|2|||
161148158|NCT00090285|581924492|FG001|Base Study Follow-up Period|Other|0|||
161148159|NCT00090285|581924493|FG002|Base Study Follow-up Period|Other|0|||
161148160|NCT00090285|581924494|FG003|Base Study Follow-up Period|Other|0|||
161148161|NCT00090285|581924495|FG004|Base Study Follow-up Period|Other|0|||
161148162|NCT00090285|581924496|FG005|Base Study Follow-up Period|Other|0|||
161148163|NCT00090285|581924491|FG000|Base Study Follow-up Period|Protocol Violation|1|||
161148164|NCT00090285|581924492|FG001|Base Study Follow-up Period|Protocol Violation|0|||
161273133|NCT03201445|582379621|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
161343579|NCT03034967|582644413|FG001|Overall Study|Protocol Violation|0|||
161018508|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
161018509|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
161018510|NCT05369403|581455854|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
161018511|NCT05369403|581455855|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
161018512|NCT05369403|581455856|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
161018513|NCT05369403|581455854|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
161018514|NCT05369403|581455855|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
161018515|NCT05369403|581455856|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
161018516|NCT05369403|581455854|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
161018517|NCT05369403|581455855|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
161018518|NCT05369403|581455856|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
161018519|NCT05369403|581455854|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
161018520|NCT05369403|581455855|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
161018521|NCT05369403|581455856|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
161018522|NCT03792256|581455857|FG000|Overall Study|Death|0|||
161018523|NCT03792256|581455858|FG001|Overall Study|Death|1|||
161018524|NCT03792256|581455857|FG000|Overall Study|Lack of Efficacy|0|||
161018525|NCT03792256|581455858|FG001|Overall Study|Lack of Efficacy|1|||
161018526|NCT03792256|581455857|FG000|Overall Study|Withdrawal by Subject|0|||
161018527|NCT03792256|581455858|FG001|Overall Study|Withdrawal by Subject|1|||
161018528|NCT04760678|581455861|FG000|Overall Study|Death|13|||
161018529|NCT04760678|581455861|FG000|Overall Study|Lost to Follow-up|48|||
161018530|NCT04760678|581455861|FG000|Overall Study|Withdrawal by Subject|1|||
161018531|NCT01997840|581455870|FG000|Overall Study|Lost to Follow-up|0|||
161018532|NCT01997840|581455871|FG001|Overall Study|Lost to Follow-up|0|||
161018533|NCT01997840|581455872|FG002|Overall Study|Lost to Follow-up|1|||
161018534|NCT01997840|581455873|FG003|Overall Study|Lost to Follow-up|0|||
161018535|NCT01997840|581455870|FG000|Overall Study|Withdrawal by participant|0|||
161018536|NCT01997840|581455871|FG001|Overall Study|Withdrawal by participant|0|||
161018537|NCT01997840|581455872|FG002|Overall Study|Withdrawal by participant|8|||
161018538|NCT01997840|581455873|FG003|Overall Study|Withdrawal by participant|1|||
161018539|NCT01997840|581455870|FG000|Overall Study|Physician Decision|0|||
161018540|NCT01997840|581455871|FG001|Overall Study|Physician Decision|0|||
161018541|NCT01997840|581455872|FG002|Overall Study|Physician Decision|3|||
161018542|NCT01997840|581455873|FG003|Overall Study|Physician Decision|0|||
161018543|NCT01997840|581455870|FG000|Overall Study|Progressive disease|3|||
161018544|NCT01997840|581455871|FG001|Overall Study|Progressive disease|4|||
161018545|NCT01997840|581455872|FG002|Overall Study|Progressive disease|57|||
161018546|NCT01997840|581455873|FG003|Overall Study|Progressive disease|8|||
161148165|NCT00090285|581924493|FG002|Base Study Follow-up Period|Protocol Violation|0|||
161148166|NCT00090285|581924494|FG003|Base Study Follow-up Period|Protocol Violation|0|||
161148167|NCT00090285|581924495|FG004|Base Study Follow-up Period|Protocol Violation|0|||
161018547|NCT01997840|581455870|FG000|Overall Study|Other reasons|0|||
161018548|NCT01997840|581455871|FG001|Overall Study|Other reasons|0|||
161018549|NCT01997840|581455872|FG002|Overall Study|Other reasons|1|||
161018550|NCT01997840|581455873|FG003|Overall Study|Other reasons|0|||
161018551|NCT01997840|581455870|FG000|Overall Study|Adverse Event|0|||
161018552|NCT01997840|581455871|FG001|Overall Study|Adverse Event|0|||
161018553|NCT01997840|581455872|FG002|Overall Study|Adverse Event|15|||
161018554|NCT01997840|581455873|FG003|Overall Study|Adverse Event|2|||
161018555|NCT01573442|581455878|FG000|Overall Study|Cancels|9|||
161018556|NCT01573442|581455879|FG001|Overall Study|Cancels|10|||
161148168|NCT00090285|581924496|FG005|Base Study Follow-up Period|Protocol Violation|0|||
161148169|NCT00090285|581924491|FG000|Base Study Follow-up Period|Uncooperative|3|||
161148170|NCT00090285|581924492|FG001|Base Study Follow-up Period|Uncooperative|4|||
161148171|NCT00090285|581924493|FG002|Base Study Follow-up Period|Uncooperative|0|||
161148172|NCT00090285|581924494|FG003|Base Study Follow-up Period|Uncooperative|0|||
161148173|NCT00090285|581924495|FG004|Base Study Follow-up Period|Uncooperative|0|||
161273134|NCT03201445|582379620|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
161018557|NCT04952909|581455890|FG000|Overall Study|Death|3|||
161018558|NCT05308004|581455891|FG000|Overall Study|Not seen by Palliative Care NP|0|||
161018559|NCT05308004|581455892|FG001|Overall Study|Not seen by Palliative Care NP|1|||
161018560|NCT04552223|581455893|FG000|Overall Study|Withdrawal by Subject|1|||
161018561|NCT00881621|581455896|FG000|Overall Study|Physician Decision|34|||
161018562|NCT04359108|581455900|FG000|Overall Study|Withdrawal by Subject|1|||
161018563|NCT04359108|581455901|FG001|Overall Study|Withdrawal by Subject|0|||
161018564|NCT04359108|581455900|FG000|Overall Study|Unable or too feeble to walk independently|0|||
161018565|NCT04359108|581455901|FG001|Overall Study|Unable or too feeble to walk independently|2|||
161018566|NCT04359108|581455900|FG000|Overall Study|Argus II system stopped functioning|0|||
161018567|NCT04359108|581455901|FG001|Overall Study|Argus II system stopped functioning|1|||
161148174|NCT00090285|581924496|FG005|Base Study Follow-up Period|Uncooperative|0|||
161273135|NCT03201445|582379621|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
161018568|NCT04359108|581455900|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
161018569|NCT04359108|581455901|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
161018570|NCT02515773|581455902|FG000|Overall Study|Withdrawal by Subject|12|||
161018571|NCT02515773|581455903|FG001|Overall Study|Withdrawal by Subject|2|||
161018572|NCT02515773|581455902|FG000|Overall Study|Lost to Follow-up|119|||
161018573|NCT02515773|581455903|FG001|Overall Study|Lost to Follow-up|126|||
161018574|NCT02515773|581455902|FG000|Overall Study|Discharged from Clinic Services|53|||
161018575|NCT02515773|581455903|FG001|Overall Study|Discharged from Clinic Services|84|||
161018576|NCT02515773|581455902|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
161018577|NCT02515773|581455903|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
161018578|NCT02515773|581455902|FG000|Overall Study|Follow-up at non-study site|8|||
161018579|NCT02515773|581455903|FG001|Overall Study|Follow-up at non-study site|16|||
161018580|NCT02515773|581455902|FG000|Overall Study|Moved from area|9|||
161018581|NCT02515773|581455903|FG001|Overall Study|Moved from area|14|||
161018582|NCT04176965|581455904|FG000|Overall Study|Death|1|||
161018583|NCT04176965|581455905|FG001|Overall Study|Death|2|||
161018584|NCT04176965|581455904|FG000|Overall Study|Lost to Follow-up|10|||
161018585|NCT04176965|581455905|FG001|Overall Study|Lost to Follow-up|2|||
161018586|NCT04176965|581455904|FG000|Overall Study|Withdrawal by Subject|6|||
161018587|NCT04176965|581455905|FG001|Overall Study|Withdrawal by Subject|1|||
161018588|NCT05434078|581455907|FG000|Overall Study|Lost to Follow-up|2|||
161148175|NCT00090285|581924491|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
161148176|NCT00090285|581924492|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
161148177|NCT00090285|581924493|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
161148178|NCT00090285|581924494|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
161148179|NCT00090285|581924495|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
161148180|NCT00090285|581924496|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
161148181|NCT00090285|581924491|FG000|Extension 1|Adverse Event|0|||
161148182|NCT00090285|581924492|FG001|Extension 1|Adverse Event|0|||
161148183|NCT00090285|581924493|FG002|Extension 1|Adverse Event|2|||
161148184|NCT00090285|581924494|FG003|Extension 1|Adverse Event|0|||
161148185|NCT00090285|581924495|FG004|Extension 1|Adverse Event|0|||
161148186|NCT00090285|581924496|FG005|Extension 1|Adverse Event|0|||
161148187|NCT00090285|581924491|FG000|Extension 1|Lost to Follow-up|0|||
161148188|NCT00090285|581924492|FG001|Extension 1|Lost to Follow-up|0|||
161148189|NCT00090285|581924493|FG002|Extension 1|Lost to Follow-up|35|||
161148190|NCT00090285|581924494|FG003|Extension 1|Lost to Follow-up|0|||
161148191|NCT00090285|581924495|FG004|Extension 1|Lost to Follow-up|0|||
161148192|NCT00090285|581924496|FG005|Extension 1|Lost to Follow-up|0|||
161148193|NCT00090285|581924491|FG000|Extension 1|Withdrawal by Subject|0|||
161148194|NCT00090285|581924492|FG001|Extension 1|Withdrawal by Subject|0|||
161148195|NCT00090285|581924493|FG002|Extension 1|Withdrawal by Subject|13|||
161148196|NCT00090285|581924494|FG003|Extension 1|Withdrawal by Subject|1|||
161148197|NCT00090285|581924495|FG004|Extension 1|Withdrawal by Subject|0|||
161148198|NCT00090285|581924496|FG005|Extension 1|Withdrawal by Subject|0|||
161148199|NCT00090285|581924491|FG000|Extension 1|Other|0|||
161148200|NCT00090285|581924492|FG001|Extension 1|Other|0|||
161148201|NCT00090285|581924493|FG002|Extension 1|Other|4|||
161148202|NCT00090285|581924494|FG003|Extension 1|Other|0|||
161148203|NCT00090285|581924495|FG004|Extension 1|Other|0|||
161148204|NCT00090285|581924496|FG005|Extension 1|Other|0|||
161148205|NCT00090285|581924491|FG000|Extension 1|Moved|0|||
161148206|NCT00090285|581924492|FG001|Extension 1|Moved|0|||
161148207|NCT00090285|581924493|FG002|Extension 1|Moved|3|||
161148208|NCT00090285|581924494|FG003|Extension 1|Moved|0|||
161148209|NCT00090285|581924495|FG004|Extension 1|Moved|0|||
161148210|NCT00090285|581924496|FG005|Extension 1|Moved|0|||
161148211|NCT00090285|581924491|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
161148212|NCT00090285|581924492|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
161148213|NCT00090285|581924493|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
161148214|NCT00090285|581924494|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
161148215|NCT00090285|581924495|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
161148216|NCT00090285|581924496|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
161148217|NCT00090285|581924491|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161148218|NCT00090285|581924492|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161018589|NCT05434078|581455908|FG001|Overall Study|Lost to Follow-up|1|||
161018590|NCT05434078|581455907|FG000|Overall Study|Withdrawal by Subject|1|||
161018591|NCT05434078|581455908|FG001|Overall Study|Withdrawal by Subject|0|||
161148219|NCT00090285|581924493|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161148220|NCT00090285|581924494|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161148221|NCT00090285|581924495|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
161148222|NCT00090285|581924496|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
161018592|NCT03652688|581455909|FG000|Baseline|Withdrawal by Subject|0|||
161018593|NCT03652688|581455910|FG001|Baseline|Withdrawal by Subject|3|||
161018594|NCT03652688|581455909|FG000|Follow-up|Lost to Follow-up|56|||
161148223|NCT00090285|581924491|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161148224|NCT00090285|581924492|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161148225|NCT00090285|581924493|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161018595|NCT03652688|581455910|FG001|Follow-up|Lost to Follow-up|54|||
161018596|NCT04072380|581455911|FG000|Overall Study|Adverse Event|4|||
161018597|NCT04072380|581455912|FG001|Overall Study|Adverse Event|6|||
161018598|NCT04072380|581455913|FG002|Overall Study|Adverse Event|0|||
161018599|NCT04072380|581455911|FG000|Overall Study|Withdrawal by Subject|3|||
161018600|NCT04072380|581455912|FG001|Overall Study|Withdrawal by Subject|1|||
161018601|NCT04072380|581455913|FG002|Overall Study|Withdrawal by Subject|1|||
161018602|NCT04072380|581455911|FG000|Overall Study|Physician Decision|2|||
161018603|NCT04072380|581455912|FG001|Overall Study|Physician Decision|0|||
161018604|NCT04072380|581455913|FG002|Overall Study|Physician Decision|0|||
161018605|NCT04072380|581455911|FG000|Overall Study|Protocol Violation|0|||
161018606|NCT04072380|581455912|FG001|Overall Study|Protocol Violation|2|||
161018607|NCT04072380|581455913|FG002|Overall Study|Protocol Violation|3|||
161018608|NCT04072380|581455911|FG000|Overall Study|Intercurrent Illness and Others|3|||
161018609|NCT04072380|581455912|FG001|Overall Study|Intercurrent Illness and Others|5|||
161018610|NCT04072380|581455913|FG002|Overall Study|Intercurrent Illness and Others|6|||
161018611|NCT00554788|581455919|FG000|Overall Study|Adverse Event|0|||
161018612|NCT00554788|581455920|FG001|Overall Study|Adverse Event|1|||
161018613|NCT00554788|581455921|FG002|Overall Study|Adverse Event|2|||
161018614|NCT00554788|581455919|FG000|Overall Study|Lost to Follow-up|4|||
161018615|NCT00554788|581455920|FG001|Overall Study|Lost to Follow-up|3|||
161018616|NCT00554788|581455921|FG002|Overall Study|Lost to Follow-up|3|||
161018617|NCT00554788|581455919|FG000|Overall Study|Physician Decision|1|||
161018618|NCT00554788|581455920|FG001|Overall Study|Physician Decision|1|||
161018619|NCT00554788|581455921|FG002|Overall Study|Physician Decision|3|||
161018620|NCT00554788|581455919|FG000|Overall Study|Withdrawal by Subject|0|||
161018621|NCT00554788|581455920|FG001|Overall Study|Withdrawal by Subject|0|||
161018622|NCT00554788|581455921|FG002|Overall Study|Withdrawal by Subject|1|||
161018623|NCT00554788|581455919|FG000|Overall Study|Refusal of further protocol therapy|0|||
161018624|NCT00554788|581455920|FG001|Overall Study|Refusal of further protocol therapy|1|||
161018625|NCT00554788|581455921|FG002|Overall Study|Refusal of further protocol therapy|1|||
161018626|NCT00554788|581455919|FG000|Overall Study|Progressive disease|0|||
161018627|NCT00554788|581455920|FG001|Overall Study|Progressive disease|0|||
161018628|NCT00554788|581455921|FG002|Overall Study|Progressive disease|3|||
161018629|NCT00554788|581455919|FG000|Overall Study|Ineligible|2|||
161018630|NCT00554788|581455920|FG001|Overall Study|Ineligible|0|||
161018631|NCT00554788|581455921|FG002|Overall Study|Ineligible|1|||
161018632|NCT03640312|581455932|FG000|Overall Study|Lost to Follow-up|3|||
161018633|NCT03640312|581455933|FG001|Overall Study|Lost to Follow-up|6|||
161018634|NCT05008835|581455937|FG000|Overall Study|Adverse Event|5|||
161018635|NCT05008835|581455938|FG001|Overall Study|Adverse Event|2|||
161018636|NCT05008835|581455939|FG002|Overall Study|Adverse Event|1|||
161018637|NCT05008835|581455937|FG000|Overall Study|Lack of Efficacy|0|||
161018638|NCT05008835|581455938|FG001|Overall Study|Lack of Efficacy|0|||
161018639|NCT05008835|581455939|FG002|Overall Study|Lack of Efficacy|1|||
161018640|NCT05008835|581455937|FG000|Overall Study|Study terminated by sponsor|0|||
161148226|NCT00090285|581924494|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161148227|NCT00090285|581924495|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
161148228|NCT00090285|581924496|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
161148229|NCT00090285|581924491|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
161148230|NCT00090285|581924492|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
161148231|NCT00090285|581924493|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
161148232|NCT00090285|581924494|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
161148233|NCT00090285|581924495|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
161148234|NCT00090285|581924496|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
161148235|NCT03554005|581924497|FG000|Overall Study|Not in participant's best interest|0|||
161148236|NCT03554005|581924498|FG001|Overall Study|Not in participant's best interest|0|||
161148237|NCT03554005|581924499|FG002|Overall Study|Not in participant's best interest|0|||
161148238|NCT03554005|581924500|FG003|Overall Study|Not in participant's best interest|0|||
161148239|NCT03554005|581924501|FG004|Overall Study|Not in participant's best interest|0|||
161148240|NCT03554005|581924502|FG005|Overall Study|Not in participant's best interest|1|||
161148241|NCT03554005|581924497|FG000|Overall Study|Disease Progression|1|||
161148242|NCT03554005|581924498|FG001|Overall Study|Disease Progression|1|||
161148243|NCT03554005|581924499|FG002|Overall Study|Disease Progression|1|||
161018641|NCT05008835|581455938|FG001|Overall Study|Study terminated by sponsor|0|||
161018642|NCT05008835|581455939|FG002|Overall Study|Study terminated by sponsor|1|||
161018643|NCT05008835|581455937|FG000|Overall Study|Not further specified|3|||
161018644|NCT05008835|581455938|FG001|Overall Study|Not further specified|2|||
161018645|NCT05008835|581455939|FG002|Overall Study|Not further specified|1|||
161018646|NCT04876118|581455940|FG000|Overall Study|Pregnancy|1|||
161148244|NCT03554005|581924500|FG003|Overall Study|Disease Progression|1|||
161148245|NCT03554005|581924501|FG004|Overall Study|Disease Progression|5|||
161148246|NCT03554005|581924502|FG005|Overall Study|Disease Progression|6|||
161018647|NCT04876118|581455940|FG000|Overall Study|Withdrawal by Subject|14|||
161018648|NCT05089734|581455941|FG000|Overall Study|Still on study|122|||
161018649|NCT05089734|581455942|FG001|Overall Study|Still on study|101|||
161018650|NCT05089734|581455941|FG000|Overall Study|Death|161|||
161018651|NCT05089734|581455942|FG001|Overall Study|Death|179|||
161018652|NCT05089734|581455941|FG000|Overall Study|Withdrew consent|11|||
161018653|NCT05089734|581455942|FG001|Overall Study|Withdrew consent|24|||
161018654|NCT05089734|581455941|FG000|Overall Study|Lost to Follow-up|5|||
161018655|NCT05089734|581455942|FG001|Overall Study|Lost to Follow-up|0|||
161018656|NCT05215314|581457686|FG000|Overall Study|Lost to Follow-up|2|||
161018657|NCT05215314|581457687|FG001|Overall Study|Lost to Follow-up|2|||
161018658|NCT05215314|581457686|FG000|Overall Study|Withdrawal by Subject|2|||
161018659|NCT05215314|581457687|FG001|Overall Study|Withdrawal by Subject|0|||
161018660|NCT05215314|581457686|FG000|Overall Study|Physician Decision|1|||
161018661|NCT05215314|581457687|FG001|Overall Study|Physician Decision|0|||
161018662|NCT04179500|581457688|FG000|Treatment|Withdrawal by Subject|1|||
161018663|NCT04179500|581457688|FG000|Treatment|Adverse Event|2|||
161018664|NCT04179500|581457688|FG000|Treatment|pyrazinamide resistance|1|||
161018665|NCT03792555|581457691|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
161018666|NCT03792555|581457692|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
161018667|NCT03792555|581457693|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
161018668|NCT03792555|581457691|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
161018669|NCT03792555|581457692|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
161018670|NCT03792555|581457693|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
161018671|NCT03792555|581457691|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
161018672|NCT03792555|581457692|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
161018673|NCT03792555|581457693|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
161018674|NCT04492007|581457694|FG000|Overall Study|Lost to Follow-up|1|||
161018675|NCT04492007|581457695|FG001|Overall Study|Lost to Follow-up|1|||
161018676|NCT04492007|581457696|FG002|Overall Study|Lost to Follow-up|2|||
161018677|NCT04492007|581457697|FG003|Overall Study|Lost to Follow-up|2|||
161018678|NCT04492007|581457694|FG000|Overall Study|Protocol Violation|1|||
161018679|NCT04492007|581457695|FG001|Overall Study|Protocol Violation|1|||
161018680|NCT04492007|581457696|FG002|Overall Study|Protocol Violation|1|||
161018681|NCT04492007|581457697|FG003|Overall Study|Protocol Violation|1|||
161018682|NCT04492007|581457694|FG000|Overall Study|Withdrawal by Subject|0|||
161018683|NCT04492007|581457695|FG001|Overall Study|Withdrawal by Subject|0|||
161018684|NCT04492007|581457696|FG002|Overall Study|Withdrawal by Subject|1|||
161018685|NCT04492007|581457697|FG003|Overall Study|Withdrawal by Subject|1|||
161018686|NCT03457142|581457702|FG000|Overall Study|Death|1|||
161018687|NCT03770273|581457703|FG000|Overall Study|Adverse Event|2|||
161018688|NCT03770273|581457704|FG001|Overall Study|Adverse Event|0|||
161018689|NCT03770273|581457703|FG000|Overall Study|Lost to Follow-up|1|||
161018690|NCT03770273|581457704|FG001|Overall Study|Lost to Follow-up|1|||
161018691|NCT00418886|581457705|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
161018692|NCT00418886|581457706|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
161018693|NCT00418886|581457705|FG000|Randomized Period|Death|122|||
161018694|NCT00418886|581457706|FG001|Randomized Period|Death|147|||
161018695|NCT00418886|581457705|FG000|Randomized Period|Withdrawal by Subject|9|||
161018696|NCT00418886|581457706|FG001|Randomized Period|Withdrawal by Subject|10|||
161018697|NCT00418886|581457705|FG000|Randomized Period|Lost to Follow-up|4|||
161018698|NCT00418886|581457706|FG001|Randomized Period|Lost to Follow-up|6|||
161018699|NCT00418886|581457705|FG000|Randomized Period|withdrawn due to other reason|1|||
161018700|NCT00418886|581457706|FG001|Randomized Period|withdrawn due to other reason|0|||
161018701|NCT00418886|581457705|FG000|Randomized Period|randomised but no treatment received|0|||
161018702|NCT00418886|581457706|FG001|Randomized Period|randomised but no treatment received|1|||
161018703|NCT04060654|581457707|FG000|Overall Study|Withdrawal by Subject|1|||
161018704|NCT04060654|581457707|FG000|Overall Study|Lost to Follow-up|5|||
161018705|NCT03707951|581457708|FG000|Overall Study|Lost to Follow-up|8|||
161018706|NCT03707951|581457709|FG001|Overall Study|Lost to Follow-up|17|||
161018707|NCT03707951|581457708|FG000|Overall Study|Withdrawal by Subject|6|||
161018708|NCT03707951|581457709|FG001|Overall Study|Withdrawal by Subject|6|||
161018709|NCT04887129|581457710|FG000|Overall Study|Lost to Follow-up|0|||
161018710|NCT04887129|581457711|FG001|Overall Study|Lost to Follow-up|24|||
161018711|NCT04887129|581457710|FG000|Overall Study|Withdrawal by Subject|9|||
161018712|NCT04887129|581457711|FG001|Overall Study|Withdrawal by Subject|57|||
161018713|NCT04887129|581457710|FG000|Overall Study|Other|2|||
161018714|NCT04887129|581457711|FG001|Overall Study|Other|9|||
161018715|NCT04533347|581457713|FG000|Overall Study|Adverse Event|1|||
161018716|NCT04533347|581457714|FG001|Overall Study|Adverse Event|2|||
161018717|NCT04533347|581457713|FG000|Overall Study|Lost to Follow-up|2|||
161018718|NCT04533347|581457714|FG001|Overall Study|Lost to Follow-up|0|||
161018719|NCT04533347|581457713|FG000|Overall Study|Withdrawal by Subject|1|||
161018720|NCT04533347|581457714|FG001|Overall Study|Withdrawal by Subject|0|||
161018721|NCT05520190|581457715|FG000|Overall Study|Lost to Follow-up|7|||
161018722|NCT05520190|581457715|FG000|Overall Study|Withdrawal by Subject|2|||
161018723|NCT01999075|581457716|FG000|Overall Study|Lost to Follow-up|0|||
161018724|NCT01999075|581457717|FG001|Overall Study|Lost to Follow-up|2|||
161018725|NCT01999075|581457716|FG000|Overall Study|Withdrawal by Subject|2|||
161018726|NCT01999075|581457717|FG001|Overall Study|Withdrawal by Subject|7|||
161018727|NCT01999075|581457716|FG000|Overall Study|Enrolled in drug trial|3|||
161018728|NCT01999075|581457717|FG001|Overall Study|Enrolled in drug trial|1|||
161018729|NCT01999075|581457716|FG000|Overall Study|Became ineligible|0|||
161018730|NCT01999075|581457717|FG001|Overall Study|Became ineligible|2|||
161018731|NCT03907397|581457720|FG000|Overall Study|Lost to Follow-up|0|||
161018732|NCT03907397|581457721|FG001|Overall Study|Lost to Follow-up|1|||
161018733|NCT03907397|581457720|FG000|Overall Study|Physician Decision|2|||
161018734|NCT03907397|581457721|FG001|Overall Study|Physician Decision|1|||
161018735|NCT03907397|581457720|FG000|Overall Study|Withdrawal by Subject|5|||
161018736|NCT03907397|581457721|FG001|Overall Study|Withdrawal by Subject|4|||
161018737|NCT03907397|581457720|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
161018738|NCT03907397|581457721|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
161018739|NCT04896476|581457733|FG000|Overall Study|Withdrawal by Subject|1|||
161018740|NCT04896476|581457733|FG000|Overall Study|Lost to Follow-up|2|||
161018741|NCT03476187|581457734|FG000|Overall Study|Protocol Violation|7|||
161018742|NCT03476187|581457734|FG000|Overall Study|Physician Decision|5|||
161018743|NCT05948670|581457736|FG000|Overall Study|Protocol Violation|6|||
161018744|NCT05948670|581457737|FG001|Overall Study|Protocol Violation|8|||
161018745|NCT05948670|581457736|FG000|Overall Study|Withdrawal by Subject|0|||
161018746|NCT05948670|581457737|FG001|Overall Study|Withdrawal by Subject|1|||
161018747|NCT04562649|581457739|FG000|Overall Study|Withdrawal by Subject|11|||
161018748|NCT04562649|581457740|FG001|Overall Study|Withdrawal by Subject|8|||
161018749|NCT04562649|581457739|FG000|Overall Study|Lost to Follow-up|26|||
161018750|NCT04562649|581457740|FG001|Overall Study|Lost to Follow-up|20|||
161018751|NCT05368103|581457741|FG000|Overall Study|Withdrawal by Subject|4|||
161018752|NCT05368103|581457741|FG000|Overall Study|Lost to Follow-up|1|||
161018753|NCT05368103|581457741|FG000|Overall Study|Lack of Efficacy|3|||
161018754|NCT03675282|581457744|FG000|Overall Study|Lost to Follow-up|4|||
161018755|NCT03675282|581457745|FG001|Overall Study|Lost to Follow-up|8|||
161018756|NCT03675282|581457746|FG002|Overall Study|Lost to Follow-up|1|||
161018757|NCT03675282|581457747|FG003|Overall Study|Lost to Follow-up|0|||
161018758|NCT03675282|581457748|FG004|Overall Study|Lost to Follow-up|2|||
161018759|NCT03675282|581457749|FG005|Overall Study|Lost to Follow-up|7|||
161018760|NCT03675282|581457744|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
161018761|NCT03675282|581457745|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
161018762|NCT03675282|581457746|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
161018763|NCT03675282|581457747|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
161018764|NCT03675282|581457748|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
161018765|NCT03675282|581457749|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
161018766|NCT03675282|581457744|FG000|Overall Study|Physician Decision|1|||
161018767|NCT03675282|581457745|FG001|Overall Study|Physician Decision|0|||
161018768|NCT03675282|581457746|FG002|Overall Study|Physician Decision|0|||
161018769|NCT03675282|581457747|FG003|Overall Study|Physician Decision|0|||
161018770|NCT03675282|581457748|FG004|Overall Study|Physician Decision|0|||
161018771|NCT03675282|581457749|FG005|Overall Study|Physician Decision|0|||
161018772|NCT03056040|581457750|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
161018773|NCT03056040|581457751|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
161018774|NCT03056040|581457750|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
161018775|NCT03056040|581457751|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
161018776|NCT03056040|581457750|FG000|Primary Evaluation Period|Pregnancy|0|||
161018777|NCT03056040|581457751|FG001|Primary Evaluation Period|Pregnancy|1|||
161018778|NCT03056040|581457750|FG000|Primary Evaluation Period|Randomized, not treated|1|||
161018779|NCT03056040|581457751|FG001|Primary Evaluation Period|Randomized, not treated|1|||
161018780|NCT03056040|581457750|FG000|Extension Period|Physician Decision|3|||
161018781|NCT03056040|581457751|FG001|Extension Period|Physician Decision|3|||
161018782|NCT03056040|581457750|FG000|Extension Period|Lost to Follow-up|0|||
161273136|NCT03201445|582379620|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
161273137|NCT03201445|582379621|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
161018783|NCT03056040|581457751|FG001|Extension Period|Lost to Follow-up|1|||
161018784|NCT03056040|581457750|FG000|Extension Period|Death|0|||
161018785|NCT03056040|581457751|FG001|Extension Period|Death|3|||
161018786|NCT03056040|581457750|FG000|Extension Period|Withdrawal by Subject|1|||
161018787|NCT03056040|581457751|FG001|Extension Period|Withdrawal by Subject|0|||
161018788|NCT03232138|581457757|FG000|Overall Study|Physician Decision|1|||
161018789|NCT03232138|581457758|FG001|Overall Study|Physician Decision|0|||
161273138|NCT03201445|582379620|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
161018790|NCT03232138|581457757|FG000|Overall Study|Adverse Event|2|||
161018791|NCT03232138|581457758|FG001|Overall Study|Adverse Event|0|||
161018792|NCT03232138|581457757|FG000|Overall Study|Withdrawal by Subject|1|||
161018793|NCT03232138|581457758|FG001|Overall Study|Withdrawal by Subject|2|||
161018794|NCT03853746|581457760|FG000|Overall Study|Withdrawal by Subject|1|||
161018795|NCT05028634|581457761|FG000|Overall Study|Withdrawal by Subject|0|||
161018796|NCT05028634|581457762|FG001|Overall Study|Withdrawal by Subject|1|||
161018797|NCT03850678|581457763|FG000|Overall Study|Withdrawal by Subject|3|||
161018798|NCT03850678|581457764|FG001|Overall Study|Withdrawal by Subject|0|||
161018799|NCT03850678|581457763|FG000|Overall Study|Experimenter Error|1|||
161018800|NCT03850678|581457764|FG001|Overall Study|Experimenter Error|1|||
161018801|NCT03850678|581457763|FG000|Overall Study|Did Not Condition To Experiment|7|||
161018802|NCT03850678|581457764|FG001|Overall Study|Did Not Condition To Experiment|2|||
161018803|NCT02724631|581457772|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
161018804|NCT02908477|581457773|FG000|Overall Study|Withdrawal by Subject|8|||
161018805|NCT02908477|581457774|FG001|Overall Study|Withdrawal by Subject|28|||
161018806|NCT03766009|581457779|FG000|Usual Care|Death|0|||
161018807|NCT03766009|581457780|FG001|Usual Care|Death|0|||
161018808|NCT03766009|581457781|FG002|Usual Care|Death|0|||
161018809|NCT03766009|581457782|FG003|Usual Care|Death|1|||
161018810|NCT03766009|581457783|FG004|Usual Care|Death|0|||
161018811|NCT03766009|581457784|FG005|Usual Care|Death|0|||
161018812|NCT03766009|581457779|FG000|Usual Care|Lost to Follow-up|0|||
161018813|NCT03766009|581457780|FG001|Usual Care|Lost to Follow-up|0|||
161018814|NCT03766009|581457781|FG002|Usual Care|Lost to Follow-up|0|||
161018815|NCT03766009|581457782|FG003|Usual Care|Lost to Follow-up|1|||
161018816|NCT03766009|581457783|FG004|Usual Care|Lost to Follow-up|0|||
161018817|NCT03766009|581457784|FG005|Usual Care|Lost to Follow-up|0|||
161018818|NCT03766009|581457779|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
161018819|NCT03766009|581457780|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
161018820|NCT03766009|581457781|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
161018821|NCT03766009|581457782|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
161148247|NCT03554005|581924497|FG000|Overall Study|Adverse Event|0|||
161148248|NCT03554005|581924498|FG001|Overall Study|Adverse Event|0|||
161148249|NCT03554005|581924499|FG002|Overall Study|Adverse Event|0|||
161148250|NCT03554005|581924500|FG003|Overall Study|Adverse Event|0|||
161148251|NCT03554005|581924501|FG004|Overall Study|Adverse Event|0|||
161148252|NCT03554005|581924502|FG005|Overall Study|Adverse Event|3|||
161148253|NCT03554005|581924497|FG000|Overall Study|Physician Decision|0|||
161148254|NCT03554005|581924498|FG001|Overall Study|Physician Decision|0|||
161148255|NCT03554005|581924499|FG002|Overall Study|Physician Decision|0|||
161148256|NCT03554005|581924500|FG003|Overall Study|Physician Decision|0|||
161148257|NCT03554005|581924501|FG004|Overall Study|Physician Decision|1|||
161148258|NCT03554005|581924502|FG005|Overall Study|Physician Decision|0|||
161148259|NCT03554005|581924497|FG000|Overall Study|Other|0|||
161148260|NCT03554005|581924498|FG001|Overall Study|Other|0|||
161148261|NCT03554005|581924499|FG002|Overall Study|Other|0|||
161148262|NCT03554005|581924500|FG003|Overall Study|Other|0|||
161148263|NCT03554005|581924501|FG004|Overall Study|Other|0|||
161148264|NCT03554005|581924502|FG005|Overall Study|Other|1|||
161018822|NCT03766009|581457783|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
161018823|NCT03766009|581457784|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
161018824|NCT03766009|581457779|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018825|NCT03766009|581457780|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161018826|NCT03766009|581457781|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018827|NCT03766009|581457782|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
161018828|NCT03766009|581457783|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018829|NCT03766009|581457784|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
161018830|NCT03766009|581457779|FG000|Usual Care|No treatment or declined surgery|0|||
161018831|NCT03766009|581457780|FG001|Usual Care|No treatment or declined surgery|0|||
161018832|NCT03766009|581457781|FG002|Usual Care|No treatment or declined surgery|0|||
161018833|NCT03766009|581457782|FG003|Usual Care|No treatment or declined surgery|2|||
161018834|NCT03766009|581457783|FG004|Usual Care|No treatment or declined surgery|0|||
161018835|NCT03766009|581457784|FG005|Usual Care|No treatment or declined surgery|0|||
161018836|NCT03766009|581457779|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
161018837|NCT03766009|581457780|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
161018838|NCT03766009|581457781|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
161148265|NCT00631488|581924506|FG000|Overall Study|Adverse Event|1|||
161148266|NCT00631488|581924507|FG001|Overall Study|Adverse Event|0|||
161148267|NCT00631488|581924508|FG002|Overall Study|Adverse Event|0|||
161148268|NCT00631488|581924506|FG000|Overall Study|Lost to Follow-up|2|||
161148269|NCT00631488|581924507|FG001|Overall Study|Lost to Follow-up|2|||
161148270|NCT00631488|581924508|FG002|Overall Study|Lost to Follow-up|0|||
161018839|NCT03766009|581457782|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
161018840|NCT03766009|581457783|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
161148271|NCT00631488|581924506|FG000|Overall Study|Physician Decision|1|||
161148272|NCT00631488|581924507|FG001|Overall Study|Physician Decision|0|||
161148273|NCT00631488|581924508|FG002|Overall Study|Physician Decision|1|||
161148274|NCT00631488|581924506|FG000|Overall Study|Protocol Violation|0|||
161148275|NCT00631488|581924507|FG001|Overall Study|Protocol Violation|0|||
161273139|NCT03201445|582379621|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
161018841|NCT03766009|581457784|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
161018842|NCT03766009|581457779|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018843|NCT03766009|581457780|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
161018844|NCT03766009|581457781|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018845|NCT03766009|581457782|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018846|NCT03766009|581457783|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018847|NCT03766009|581457784|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
161018848|NCT03766009|581457779|FG000|Usual Care|Ineligible|0|||
161018849|NCT03766009|581457780|FG001|Usual Care|Ineligible|1|||
161018850|NCT03766009|581457781|FG002|Usual Care|Ineligible|0|||
161018851|NCT03766009|581457782|FG003|Usual Care|Ineligible|0|||
161018852|NCT03766009|581457783|FG004|Usual Care|Ineligible|0|||
161018853|NCT03766009|581457784|FG005|Usual Care|Ineligible|0|||
161018854|NCT03766009|581457779|FG000|Usual Care|Other: Staff turnover|0|||
161018855|NCT03766009|581457780|FG001|Usual Care|Other: Staff turnover|0|||
161018856|NCT03766009|581457781|FG002|Usual Care|Other: Staff turnover|0|||
161018857|NCT03766009|581457782|FG003|Usual Care|Other: Staff turnover|0|||
161148276|NCT00631488|581924508|FG002|Overall Study|Protocol Violation|1|||
161148277|NCT02855411|581924509|FG000|Overall Study|Study terminated by sponsor|21|||
161148278|NCT02855411|581924509|FG000|Overall Study|Does not meet entrance criteria|14|||
161148279|NCT03988751|581924510|FG000|Overall Study|Withdrawal by Subject|1|||
161148280|NCT03988751|581924511|FG001|Overall Study|Withdrawal by Subject|0|||
161148281|NCT03988751|581924510|FG000|Overall Study|Protocol Violation|0|||
161148282|NCT03988751|581924511|FG001|Overall Study|Protocol Violation|1|||
161148283|NCT00844883|581924512|FG000|Overall Study|Bridged to liver transplant|3|||
161148284|NCT00844883|581924512|FG000|Overall Study|Bridged to resection|1|||
161148285|NCT02927171|581924517|FG000|Overall Study|Lost to Follow-up|0|||
161148286|NCT02927171|581924518|FG001|Overall Study|Lost to Follow-up|1|||
161148287|NCT02240628|581924521|FG000|Overall Study|Physician Decision|6|||
161148288|NCT02240628|581924522|FG001|Overall Study|Physician Decision|5|||
161148289|NCT04530825|581924525|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
161148290|NCT04530825|581924526|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
161148291|NCT04530825|581924527|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
161148292|NCT04530825|581924528|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
161148293|NCT04530825|581924525|FG000|Overall Study|Did not complete follow-up|3|||
161148294|NCT04530825|581924526|FG001|Overall Study|Did not complete follow-up|0|||
161148295|NCT04530825|581924527|FG002|Overall Study|Did not complete follow-up|0|||
161148296|NCT04530825|581924528|FG003|Overall Study|Did not complete follow-up|0|||
161148297|NCT04101422|581924530|FG000|Overall Study|Ineligible|1|||
161148298|NCT04101422|581924531|FG001|Overall Study|Ineligible|0|||
161148299|NCT04101422|581924532|FG002|Overall Study|Ineligible|9|||
161148300|NCT04101422|581924533|FG003|Overall Study|Ineligible|0|||
161148301|NCT04101422|581924530|FG000|Overall Study|Withdrawal by Subject|0|||
161148302|NCT04101422|581924531|FG001|Overall Study|Withdrawal by Subject|0|||
161148303|NCT04101422|581924532|FG002|Overall Study|Withdrawal by Subject|1|||
161148304|NCT04101422|581924533|FG003|Overall Study|Withdrawal by Subject|0|||
161148305|NCT04101422|581924530|FG000|Overall Study|Not attending to the stimuli|0|||
161148306|NCT04101422|581924531|FG001|Overall Study|Not attending to the stimuli|0|||
161148307|NCT04101422|581924532|FG002|Overall Study|Not attending to the stimuli|4|||
161148308|NCT04101422|581924533|FG003|Overall Study|Not attending to the stimuli|0|||
161148309|NCT04101422|581924530|FG000|Overall Study|Did not download app|0|||
161148310|NCT04101422|581924531|FG001|Overall Study|Did not download app|0|||
161148311|NCT04101422|581924532|FG002|Overall Study|Did not download app|0|||
161148312|NCT04101422|581924533|FG003|Overall Study|Did not download app|17|||
161148313|NCT04101422|581924530|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161148314|NCT04101422|581924531|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161148315|NCT04101422|581924532|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
161148316|NCT04101422|581924533|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
161148317|NCT00850499|581924534|FG000|Overall Study|Adverse Event|3|||
161148318|NCT00850499|581924535|FG001|Overall Study|Adverse Event|1|||
161018858|NCT03766009|581457783|FG004|Usual Care|Other: Staff turnover|0|||
161018859|NCT03766009|581457784|FG005|Usual Care|Other: Staff turnover|2|||
161148319|NCT00850499|581924534|FG000|Overall Study|Lack of Efficacy|0|||
161148320|NCT00850499|581924535|FG001|Overall Study|Lack of Efficacy|1|||
161148321|NCT00552305|581924536|FG000|Overall Study|Adverse Event|43|||
161148322|NCT00552305|581924536|FG000|Overall Study|Lack of Efficacy|120|||
161148323|NCT00552305|581924536|FG000|Overall Study|Lost to Follow-up|4|||
161148324|NCT00552305|581924536|FG000|Overall Study|Protocol Violation|3|||
161148325|NCT00552305|581924536|FG000|Overall Study|Withdrawal by Subject|44|||
161148326|NCT00552305|581924536|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
161148327|NCT00552305|581924536|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
161018860|NCT05071807|581457788|FG000|Overall Study|Withdrawal by Subject|4|||
161018861|NCT05071807|581457789|FG001|Overall Study|Withdrawal by Subject|0|||
161148328|NCT00552305|581924536|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
161148329|NCT00552305|581924536|FG000|Overall Study|Unsatisfactory compliance|11|||
161148330|NCT00552305|581924536|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
161148331|NCT00552305|581924536|FG000|Overall Study|AE/Other: prohibited drug required|1|||
161148332|NCT00552305|581924536|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
161148333|NCT00552305|581924536|FG000|Overall Study|Other: Site closed|4|||
161148334|NCT00552305|581924536|FG000|Overall Study|Other: Personal problems|1|||
161148335|NCT00552305|581924536|FG000|Overall Study|Other: Unable to attend visits|1|||
161148336|NCT00552305|581924536|FG000|Overall Study|Other: Subject underwent surgery|4|||
161148337|NCT00552305|581924536|FG000|Overall Study|Other: Subject became pregnant|1|||
161148338|NCT00552305|581924536|FG000|Overall Study|Other: Health problems, not drug related|1|||
161148339|NCT00552305|581924536|FG000|Overall Study|Other: Subject moved from area|2|||
161148340|NCT00552305|581924536|FG000|Overall Study|Other: Subject incarcerated|1|||
161148341|NCT00552305|581924536|FG000|Overall Study|Other: Subject went to rehab|1|||
161148342|NCT00718861|581924539|FG000|Overall Study|Withdrawal by Subject|15|||
161148343|NCT00718861|581924540|FG001|Overall Study|Withdrawal by Subject|10|||
161148344|NCT00718861|581924539|FG000|Overall Study|Adverse Event|2|||
161148345|NCT00718861|581924540|FG001|Overall Study|Adverse Event|1|||
161148346|NCT00718861|581924539|FG000|Overall Study|Lost to Follow-up|2|||
161148347|NCT00718861|581924540|FG001|Overall Study|Lost to Follow-up|1|||
161148348|NCT00718861|581924539|FG000|Overall Study|Administrative Problems|1|||
161148349|NCT00718861|581924540|FG001|Overall Study|Administrative Problems|1|||
161148350|NCT00718861|581924539|FG000|Overall Study|Death|1|||
161148351|NCT00718861|581924540|FG001|Overall Study|Death|5|||
161148352|NCT01703819|581924541|FG000|Overall Study|Adverse Event|0|||
161148353|NCT01703819|581924542|FG001|Overall Study|Adverse Event|1|||
161148354|NCT01703819|581924541|FG000|Overall Study|Withdrawal by Subject|0|||
161148355|NCT01703819|581924542|FG001|Overall Study|Withdrawal by Subject|1|||
161148356|NCT04230486|581924549|FG000|Overall Study|Screen Failure|1|||
161148357|NCT01302041|581924550|FG000|Overall Study|Death|5|||
161148358|NCT01302041|581924550|FG000|Overall Study|Withdrawal by Subject|4|||
161148359|NCT01302041|581924550|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
161148360|NCT01302041|581924550|FG000|Overall Study|Other-Miscellaneous Reason|2|||
161148361|NCT01839188|581924551|FG000|Overall Study|Withdrawal by Subject|1|||
161148362|NCT04983901|581924552|FG000|Overall Study|Death|1|||
161148363|NCT04983901|581924553|FG001|Overall Study|Death|4|||
161148364|NCT04983901|581924552|FG000|Overall Study|Lost to Follow-up|3|||
161148365|NCT04983901|581924553|FG001|Overall Study|Lost to Follow-up|0|||
161148366|NCT04983901|581924552|FG000|Overall Study|Protocol Violation|1|||
161148367|NCT04983901|581924553|FG001|Overall Study|Protocol Violation|0|||
161018862|NCT05071807|581457788|FG000|Overall Study|Unrelated medical issues|3|||
161018863|NCT05071807|581457789|FG001|Overall Study|Unrelated medical issues|0|||
161018864|NCT05071807|581457788|FG000|Overall Study|Relocated|0|||
161018865|NCT05071807|581457789|FG001|Overall Study|Relocated|1|||
161018866|NCT03903146|581457794|FG000|Overall Study|Lost to Follow-up|6|||
161018867|NCT03903146|581457795|FG001|Overall Study|Lost to Follow-up|4|||
161018868|NCT03903146|581457794|FG000|Overall Study|Withdrawal by Subject|0|||
161018869|NCT03903146|581457795|FG001|Overall Study|Withdrawal by Subject|1|||
161018870|NCT05551637|581457796|FG000|Overall Study|Lack of Efficacy|0|||
161018871|NCT05551637|581457797|FG001|Overall Study|Lack of Efficacy|6|||
161018872|NCT05551637|581457796|FG000|Overall Study|Lost to Follow-up|1|||
161018873|NCT05551637|581457797|FG001|Overall Study|Lost to Follow-up|1|||
161018874|NCT05179837|581457800|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
161018875|NCT05179837|581457800|FG000|Overall Study|Device malfunctioned|1|||
161018876|NCT05179837|581457800|FG000|Overall Study|Image quality too low|2|||
161018877|NCT04924660|581457801|FG000|United States|Death|29|||
161018878|NCT04924660|581457802|FG001|United States|Death|32|||
161018879|NCT04924660|581457803|FG002|United States|Death|34|||
161018880|NCT04924660|581457804|FG003|United States|Death|25|||
161018881|NCT04924660|581457805|FG004|United States|Death|26|||
161148368|NCT04983901|581924552|FG000|Overall Study|Withdrawal by Subject|1|||
161148369|NCT04983901|581924553|FG001|Overall Study|Withdrawal by Subject|2|||
161148370|NCT01174784|581924554|FG000|Overall Study|Screen fails|4|||
161148371|NCT01671488|581924561|FG000|Overall Study|Withdrawal by Subject|1|||
161018882|NCT04924660|581457806|FG005|United States|Death|23|||
161018883|NCT04924660|581457801|FG000|United States|Lost to Follow-up|15|||
161018884|NCT04924660|581457802|FG001|United States|Lost to Follow-up|10|||
161018885|NCT04924660|581457803|FG002|United States|Lost to Follow-up|13|||
161148372|NCT01022853|581924562|FG000|Overall Study|Progressive disease|2|||
161148373|NCT01022853|581924563|FG001|Overall Study|Progressive disease|3|||
161148374|NCT01022853|581924564|FG002|Overall Study|Progressive disease|11|||
161273140|NCT03201445|582379620|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
161018886|NCT04924660|581457804|FG003|United States|Lost to Follow-up|5|||
161018887|NCT04924660|581457805|FG004|United States|Lost to Follow-up|19|||
161018888|NCT04924660|581457806|FG005|United States|Lost to Follow-up|20|||
161018889|NCT04924660|581457801|FG000|United States|Withdrawal by Subject|8|||
161148375|NCT01022853|581924565|FG003|Overall Study|Progressive disease|7|||
161343580|NCT03034967|582644414|FG002|Overall Study|Protocol Violation|0|||
161018890|NCT04924660|581457802|FG001|United States|Withdrawal by Subject|3|||
161018891|NCT04924660|581457803|FG002|United States|Withdrawal by Subject|3|||
161018892|NCT04924660|581457804|FG003|United States|Withdrawal by Subject|3|||
161018893|NCT04924660|581457805|FG004|United States|Withdrawal by Subject|8|||
161018894|NCT04924660|581457806|FG005|United States|Withdrawal by Subject|4|||
161018895|NCT04924660|581457801|FG000|Spain|Death|0|||
161018896|NCT04924660|581457802|FG001|Spain|Death|0|||
161018897|NCT04924660|581457803|FG002|Spain|Death|0|||
161018898|NCT04924660|581457804|FG003|Spain|Death|0|||
161018899|NCT04924660|581457805|FG004|Spain|Death|0|||
161018900|NCT04924660|581457806|FG005|Spain|Death|2|||
161018901|NCT04924660|581457801|FG000|Spain|Lost to Follow-up|0|||
161148376|NCT01022853|581924566|FG004|Overall Study|Progressive disease|1|||
161148377|NCT01022853|581924562|FG000|Overall Study|Dose-limiting toxicity|0|||
161148378|NCT01022853|581924563|FG001|Overall Study|Dose-limiting toxicity|0|||
161148379|NCT01022853|581924564|FG002|Overall Study|Dose-limiting toxicity|0|||
161148380|NCT01022853|581924565|FG003|Overall Study|Dose-limiting toxicity|0|||
161148381|NCT01022853|581924566|FG004|Overall Study|Dose-limiting toxicity|1|||
161148382|NCT01022853|581924562|FG000|Overall Study|Withdrawal by Subject|0|||
161148383|NCT01022853|581924563|FG001|Overall Study|Withdrawal by Subject|1|||
161148384|NCT01022853|581924564|FG002|Overall Study|Withdrawal by Subject|1|||
161148385|NCT01022853|581924565|FG003|Overall Study|Withdrawal by Subject|1|||
161148386|NCT01022853|581924566|FG004|Overall Study|Withdrawal by Subject|0|||
161148387|NCT01022853|581924562|FG000|Overall Study|Other not stated above|1|||
161148388|NCT01022853|581924563|FG001|Overall Study|Other not stated above|0|||
161148389|NCT01022853|581924564|FG002|Overall Study|Other not stated above|1|||
161148390|NCT01022853|581924565|FG003|Overall Study|Other not stated above|0|||
161148391|NCT01022853|581924566|FG004|Overall Study|Other not stated above|0|||
161148392|NCT02416908|581924567|FG000|Dose Escalation Phase|Adverse Event|0|||
161148393|NCT02416908|581924568|FG001|Dose Escalation Phase|Adverse Event|0|||
161148394|NCT02416908|581924569|FG002|Dose Escalation Phase|Adverse Event|3|||
161273141|NCT03201445|582379621|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
161273142|NCT03201445|582379620|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
161273143|NCT03201445|582379621|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
161273144|NCT03201445|582379620|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
161273145|NCT03201445|582379621|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
161273146|NCT03201445|582379620|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
161273147|NCT03201445|582379621|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
160969194|NCT00879996|581275161|FG001|Overall Study|non-compliance|4|||
160969195|NCT00879996|581275160|FG000|Overall Study|Physician Decision|1|||
160969196|NCT00879996|581275161|FG001|Overall Study|Physician Decision|2|||
160969197|NCT00879996|581275160|FG000|Overall Study|psychiatric problem|0|||
160969198|NCT00879996|581275161|FG001|Overall Study|psychiatric problem|1|||
160969199|NCT00879996|581275160|FG000|Overall Study|put on parole|1|||
160969200|NCT00879996|581275161|FG001|Overall Study|put on parole|0|||
160969201|NCT01216163|581275166|FG000|Overall Study|Withdrawal by Subject|1|||
160969202|NCT01216163|581275167|FG001|Overall Study|Withdrawal by Subject|1|||
160969203|NCT01216163|581275168|FG002|Overall Study|Withdrawal by Subject|0|||
160969204|NCT02914314|581275169|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
160969205|NCT02914314|581275170|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
160969206|NCT02914314|581275171|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
160969207|NCT02914314|581275172|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
160969208|NCT02914314|581275169|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
160969209|NCT02914314|581275170|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
160969210|NCT02914314|581275171|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
160969211|NCT02914314|581275172|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
160969212|NCT02914314|581275169|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
160969213|NCT02914314|581275170|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
160969214|NCT02914314|581275171|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
160969215|NCT02914314|581275172|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
160969216|NCT02914314|581275169|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
160969217|NCT02914314|581275170|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
160969218|NCT02914314|581275171|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
161018902|NCT04924660|581457802|FG001|Spain|Lost to Follow-up|0|||
161018903|NCT04924660|581457803|FG002|Spain|Lost to Follow-up|0|||
161018904|NCT04924660|581457804|FG003|Spain|Lost to Follow-up|0|||
161148395|NCT02416908|581924570|FG003|Dose Escalation Phase|Adverse Event|0|||
161148396|NCT02416908|581924567|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
160969219|NCT02914314|581275172|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
160969220|NCT02914314|581275169|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
161018905|NCT04924660|581457805|FG004|Spain|Lost to Follow-up|1|||
161018906|NCT04924660|581457806|FG005|Spain|Lost to Follow-up|0|||
161018907|NCT04924660|581457801|FG000|Brazil|Death|0|||
161148397|NCT02416908|581924568|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161148398|NCT02416908|581924569|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
161148399|NCT02416908|581924570|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161148400|NCT00532883|581924571|FG000|Overall Study|Adverse Event|1|||
161148401|NCT00532883|581924572|FG001|Overall Study|Adverse Event|0|||
161148402|NCT00532883|581924573|FG002|Overall Study|Adverse Event|0|||
161148403|NCT00532883|581924574|FG003|Overall Study|Adverse Event|1|||
161148404|NCT00532883|581924571|FG000|Overall Study|Lost to Follow-up|1|||
161148405|NCT00532883|581924572|FG001|Overall Study|Lost to Follow-up|1|||
161148406|NCT00532883|581924573|FG002|Overall Study|Lost to Follow-up|1|||
161148407|NCT00532883|581924574|FG003|Overall Study|Lost to Follow-up|0|||
161148408|NCT00532883|581924571|FG000|Overall Study|Withdrawal by Subject|0|||
161148409|NCT00532883|581924572|FG001|Overall Study|Withdrawal by Subject|1|||
161148410|NCT00532883|581924573|FG002|Overall Study|Withdrawal by Subject|1|||
161148411|NCT00532883|581924574|FG003|Overall Study|Withdrawal by Subject|0|||
161148412|NCT00532883|581924571|FG000|Overall Study|Subject was Nonadherent|0|||
161148413|NCT00532883|581924572|FG001|Overall Study|Subject was Nonadherent|1|||
161148414|NCT00532883|581924573|FG002|Overall Study|Subject was Nonadherent|1|||
161148415|NCT00532883|581924574|FG003|Overall Study|Subject was Nonadherent|0|||
161148416|NCT00532883|581924571|FG000|Overall Study|Early Study Termination|4|||
161148417|NCT00532883|581924572|FG001|Overall Study|Early Study Termination|4|||
161148418|NCT00532883|581924573|FG002|Overall Study|Early Study Termination|1|||
161148419|NCT00532883|581924574|FG003|Overall Study|Early Study Termination|4|||
161148420|NCT01651052|581924575|FG000|Overall Study|Death|21|||
161148421|NCT01651052|581924575|FG000|Overall Study|Explant|1|||
161148422|NCT01651052|581924575|FG000|Overall Study|Withdrawal by Subject|1|||
161148423|NCT01651052|581924575|FG000|Overall Study|Lost to Follow-up|3|||
161148424|NCT03503773|581924576|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
161148425|NCT03503773|581924577|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
161148426|NCT03503773|581924576|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
161148427|NCT03503773|581924577|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
161148428|NCT03503773|581924576|FG000|Overall Study|Not completing the primary ABPM|3|||
161148429|NCT03503773|581924577|FG001|Overall Study|Not completing the primary ABPM|1|||
161148430|NCT03503773|581924576|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161148431|NCT03503773|581924577|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161148432|NCT02285010|581924581|FG000|Overall Study|not abdominal hysterectomy|2|||
161148433|NCT02285010|581924582|FG001|Overall Study|not abdominal hysterectomy|0|||
161148434|NCT02285010|581924581|FG000|Overall Study|Not spinal anesthesia|3|||
161148435|NCT02285010|581924582|FG001|Overall Study|Not spinal anesthesia|1|||
161148436|NCT01478347|581924583|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
161018908|NCT04924660|581457802|FG001|Brazil|Death|0|||
161018909|NCT04924660|581457803|FG002|Brazil|Death|0|||
161018910|NCT04924660|581457804|FG003|Brazil|Death|0|||
161018911|NCT04924660|581457805|FG004|Brazil|Death|1|||
161018912|NCT04924660|581457806|FG005|Brazil|Death|0|||
161018913|NCT04924660|581457801|FG000|Italy|Lost to Follow-up|0|||
161018914|NCT04924660|581457802|FG001|Italy|Lost to Follow-up|0|||
161018915|NCT04924660|581457803|FG002|Italy|Lost to Follow-up|0|||
161018916|NCT04924660|581457804|FG003|Italy|Lost to Follow-up|0|||
161018917|NCT04924660|581457805|FG004|Italy|Lost to Follow-up|0|||
161018918|NCT04924660|581457806|FG005|Italy|Lost to Follow-up|1|||
161018919|NCT04924660|581457801|FG000|South Africa|Death|0|||
161018920|NCT04924660|581457802|FG001|South Africa|Death|0|||
161018921|NCT04924660|581457803|FG002|South Africa|Death|0|||
161018922|NCT04924660|581457804|FG003|South Africa|Death|0|||
161018923|NCT04924660|581457805|FG004|South Africa|Death|0|||
161018924|NCT04924660|581457806|FG005|South Africa|Death|1|||
161018925|NCT04924660|581457801|FG000|South Africa|Lost to Follow-up|0|||
161018926|NCT04924660|581457802|FG001|South Africa|Lost to Follow-up|0|||
161018927|NCT04924660|581457803|FG002|South Africa|Lost to Follow-up|0|||
161018928|NCT04924660|581457804|FG003|South Africa|Lost to Follow-up|0|||
161018929|NCT04924660|581457805|FG004|South Africa|Lost to Follow-up|0|||
161018930|NCT04924660|581457806|FG005|South Africa|Lost to Follow-up|1|||
161148437|NCT01478347|581924583|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
161018931|NCT03557697|581457807|FG000|Overall Study|Withdrawal by Subject|2|||
161018932|NCT03557697|581457808|FG001|Overall Study|Withdrawal by Subject|4|||
161148438|NCT01478347|581924583|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
161018933|NCT03197662|581457809|FG000|Overall Study|Withdrawn by family|0|||
161148439|NCT01645930|581924584|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
161148440|NCT01645930|581924584|FG000|Overall Study|Progressive Disease|12|||
161148441|NCT01645930|581924584|FG000|Overall Study|Adverse Event|4|||
161273148|NCT03201445|582379620|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
161018934|NCT03197662|581457810|FG001|Overall Study|Withdrawn by family|2|||
161018935|NCT03721952|581457811|FG000|Overall Study|Lost to Follow-up|0|||
161018936|NCT03721952|581457812|FG001|Overall Study|Lost to Follow-up|0|||
161018937|NCT03721952|581457813|FG002|Overall Study|Lost to Follow-up|2|||
161018938|NCT03721952|581457814|FG003|Overall Study|Lost to Follow-up|0|||
161018939|NCT03721952|581457815|FG004|Overall Study|Lost to Follow-up|0|||
161018940|NCT03721952|581457811|FG000|Overall Study|Protocol Violation|0|||
161273149|NCT03201445|582379621|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
161273150|NCT03201445|582379620|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
161273151|NCT03201445|582379621|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
161273152|NCT03201445|582379620|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
161273153|NCT03201445|582379621|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
161273154|NCT03201445|582379620|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
161273155|NCT03201445|582379621|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
161273156|NCT03201445|582379620|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
161273157|NCT03201445|582379621|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
161273158|NCT03201445|582379620|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
161273159|NCT03201445|582379621|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
161273160|NCT01228019|582379622|FG000|Overall Study|Dose Violation|70|||
161273161|NCT01228019|582379622|FG000|Overall Study|Duplicate enrollment|1|||
161273162|NCT01228019|582379622|FG000|Overall Study|Missing pre-treatment data|72|||
161273163|NCT01228019|582379622|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
161273164|NCT01228019|582379622|FG000|Overall Study|Violation of Entry Criterion|9|||
161273165|NCT01346293|582379625|FG000|Overall Study|Protocol Violation|30|||
161273166|NCT01346293|582379626|FG001|Overall Study|Protocol Violation|9|||
161273167|NCT01346293|582379625|FG000|Overall Study|Lost to Follow-up|21|||
161273168|NCT01346293|582379626|FG001|Overall Study|Lost to Follow-up|8|||
161273169|NCT01346293|582379625|FG000|Overall Study|Withdrawal by Subject|15|||
161273170|NCT01346293|582379626|FG001|Overall Study|Withdrawal by Subject|4|||
161273171|NCT01346293|582379625|FG000|Overall Study|Other|1|||
161273172|NCT01346293|582379626|FG001|Overall Study|Other|0|||
161273173|NCT01844505|582379630|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
161273174|NCT01844505|582379631|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
161273175|NCT01844505|582379632|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
161273176|NCT01844505|582379630|FG000|Treatment Period|Other Reasons|120|||
161273177|NCT01844505|582379631|FG001|Treatment Period|Other Reasons|136|||
161273178|NCT01844505|582379632|FG002|Treatment Period|Other Reasons|58|||
161273179|NCT01844505|582379630|FG000|Treatment Period|Lost to Follow-up|9|||
161273180|NCT01844505|582379631|FG001|Treatment Period|Lost to Follow-up|11|||
161273181|NCT01844505|582379632|FG002|Treatment Period|Lost to Follow-up|6|||
161273182|NCT01844505|582379630|FG000|Treatment Period|Death|175|||
161273183|NCT01844505|582379631|FG001|Treatment Period|Death|154|||
161273184|NCT01844505|582379632|FG002|Treatment Period|Death|228|||
161273185|NCT00128830|582379633|FG000|Overall Study|Adverse Event|10|||
161273186|NCT00128830|582379633|FG000|Overall Study|Withdrawal by Subject|14|||
161273187|NCT00128830|582379633|FG000|Overall Study|Lost to Follow-up|4|||
161273188|NCT00128830|582379633|FG000|Overall Study|Reached a virologic endpoint|29|||
161273189|NCT00128830|582379633|FG000|Overall Study|Non-compliant|4|||
161273190|NCT00128830|582379633|FG000|Overall Study|Discontinued or ineligible for study|2|||
161273191|NCT00128830|582379633|FG000|Overall Study|Other|9|||
161273192|NCT00311402|582379634|FG000|Overall Study|Adverse Event|118|||
161273193|NCT00311402|582379635|FG001|Overall Study|Adverse Event|105|||
161273194|NCT00311402|582379634|FG000|Overall Study|Lost to Follow-up|0|||
161273195|NCT00311402|582379635|FG001|Overall Study|Lost to Follow-up|3|||
161273196|NCT00311402|582379634|FG000|Overall Study|Withdrawal by Subject|17|||
161273197|NCT00311402|582379635|FG001|Overall Study|Withdrawal by Subject|18|||
161273198|NCT00311402|582379634|FG000|Overall Study|Lack of Efficacy|58|||
161273199|NCT00311402|582379635|FG001|Overall Study|Lack of Efficacy|42|||
161273200|NCT00311402|582379634|FG000|Overall Study|Protocol Violation|7|||
161273201|NCT00311402|582379635|FG001|Overall Study|Protocol Violation|6|||
161273202|NCT00311402|582379634|FG000|Overall Study|IRB's rejection etc.|10|||
161273203|NCT00311402|582379635|FG001|Overall Study|IRB's rejection etc.|3|||
161273204|NCT02640053|582379636|FG000|Overall Study|Withdrawal by Subject|2|||
161273205|NCT02640053|582379637|FG001|Overall Study|Withdrawal by Subject|1|||
161273206|NCT02640053|582379636|FG000|Overall Study|Adverse Event|1|||
161273207|NCT02640053|582379637|FG001|Overall Study|Adverse Event|1|||
161273208|NCT02640053|582379636|FG000|Overall Study|Alternative Therapy|1|||
161273209|NCT02640053|582379637|FG001|Overall Study|Alternative Therapy|1|||
161273210|NCT02640053|582379636|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
161273211|NCT02640053|582379637|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
161273212|NCT02754856|582379639|FG000|Overall Study|Withdrawal by Subject|1|||
161273213|NCT00530218|582379640|FG000|Overall Study|CMV Not Detected|13|||
161273214|NCT00530218|582379640|FG000|Overall Study|Death|12|||
160969221|NCT02914314|581275170|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
160969222|NCT02914314|581275171|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
160969223|NCT02914314|581275172|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
160969224|NCT01148862|581275177|FG000|Second Intervention|Withdrawal by Subject|0|||
160969225|NCT01148862|581275178|FG001|Second Intervention|Withdrawal by Subject|2|||
160969226|NCT03056534|581275179|FG000|Overall Study|Participant withdrew consent|8|||
160969227|NCT03056534|581275179|FG000|Overall Study|Participant not able to return|6|||
160969228|NCT03056534|581275179|FG000|Overall Study|Lost to Follow-up|37|||
161018941|NCT03721952|581457812|FG001|Overall Study|Protocol Violation|1|||
161018942|NCT03721952|581457813|FG002|Overall Study|Protocol Violation|0|||
161018943|NCT03721952|581457814|FG003|Overall Study|Protocol Violation|0|||
161018944|NCT03721952|581457815|FG004|Overall Study|Protocol Violation|0|||
161018945|NCT03721952|581457811|FG000|Overall Study|Withdrawal by Subject|1|||
161018946|NCT03721952|581457812|FG001|Overall Study|Withdrawal by Subject|0|||
161018947|NCT03721952|581457813|FG002|Overall Study|Withdrawal by Subject|40|||
161018948|NCT03721952|581457814|FG003|Overall Study|Withdrawal by Subject|28|||
161018949|NCT03721952|581457815|FG004|Overall Study|Withdrawal by Subject|0|||
161018950|NCT03364647|581457816|FG000|Overall Study|Withdrawal by Subject|3|||
161018951|NCT03364647|581457817|FG001|Overall Study|Withdrawal by Subject|1|||
161018952|NCT03476460|581457818|FG000|Overall Study|Withdrawal by Subject|3|||
161018953|NCT03476460|581457819|FG001|Overall Study|Withdrawal by Subject|2|||
161018954|NCT03476460|581457818|FG000|Overall Study|Non-compliance with treatment|3|||
161018955|NCT03476460|581457819|FG001|Overall Study|Non-compliance with treatment|0|||
161018956|NCT03476460|581457818|FG000|Overall Study|Missing laboratory tests|5|||
161018957|NCT03476460|581457819|FG001|Overall Study|Missing laboratory tests|5|||
161018958|NCT03476460|581457818|FG000|Overall Study|Adverse Event|0|||
161018959|NCT03476460|581457819|FG001|Overall Study|Adverse Event|1|||
161018960|NCT04624633|581457823|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
161018961|NCT04624633|581457824|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
161018962|NCT04624633|581457823|FG000|Overall Study|Death|1|||
161018963|NCT04624633|581457824|FG001|Overall Study|Death|0|||
161018964|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
161018965|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018966|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018967|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018968|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018969|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
161018970|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
161018971|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018972|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018973|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018974|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018975|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
161018976|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018977|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
161018978|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018979|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018980|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018981|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
161018982|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018983|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
161018984|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018985|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018986|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018987|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
161018988|NCT01902173|581457825|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018989|NCT01902173|581457826|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
161018990|NCT01902173|581457827|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018991|NCT01902173|581457828|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018992|NCT01902173|581457829|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018993|NCT01902173|581457830|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
161018994|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018995|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018996|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
161018997|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018998|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161018999|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
161019000|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019001|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019002|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
161019003|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161148442|NCT01645930|581924584|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
161148443|NCT01645930|581924584|FG000|Overall Study|Withdrawal by Participant|2|||
161019004|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019005|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
161019006|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019007|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019008|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
160969229|NCT03056534|581275179|FG000|Overall Study|Investigator judgment|1|||
160969230|NCT03056534|581275179|FG000|Overall Study|Death|4|||
160969231|NCT03056534|581275179|FG000|Overall Study|Adverse Event|1|||
160969232|NCT03056534|581275179|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
160969233|NCT05398796|581275182|FG000|Overall Study|Participant moved from the area|0|||
160969234|NCT05398796|581275183|FG001|Overall Study|Participant moved from the area|1|||
160969235|NCT05398796|581275184|FG002|Overall Study|Participant moved from the area|0|||
160969236|NCT05398796|581275185|FG003|Overall Study|Participant moved from the area|0|||
160969237|NCT05004688|581275186|FG000|Overall Study|Protocol Violation|7|||
160969238|NCT05004688|581275186|FG000|Overall Study|Physician Decision|2|||
160969239|NCT05004688|581275186|FG000|Overall Study|Withdrawal by Subject|2|||
160969240|NCT02134925|581275187|FG000|Overall Study|Withdrawal by Subject|1|||
160969241|NCT02134925|581275188|FG001|Overall Study|Withdrawal by Subject|0|||
160969242|NCT02134925|581275187|FG000|Overall Study|Cancel|1|||
160969243|NCT02134925|581275188|FG001|Overall Study|Cancel|6|||
160969244|NCT02158884|581275189|FG000|Baseline Assessment|Missed performance assessment|3|||
160969245|NCT02158884|581275189|FG000|Baseline Assessment|Missed SMFA|1|||
160969246|NCT02158884|581275189|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
160969247|NCT02158884|581275189|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
160969248|NCT02158884|581275189|FG000|6 Month Assessment|Missed SMFA|20|||
160969249|NCT02158884|581275189|FG000|12 Month Assessment|Missed SMFA|17|||
160969250|NCT05158296|581275190|FG000|Overall Study|Sponsor Decision|2|||
160969251|NCT05158296|581275191|FG001|Overall Study|Sponsor Decision|3|||
160969252|NCT05158296|581275192|FG002|Overall Study|Sponsor Decision|2|||
160969253|NCT02552238|581275193|FG000|Overall Study|Withdrawal by Subject|2|||
160969254|NCT02552238|581275193|FG000|Overall Study|Adverse Event|2|||
160969255|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
160969256|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969257|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969258|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969259|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969260|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969261|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
160969262|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
160969263|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969264|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969265|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969266|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969267|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969268|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
160969269|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
160969270|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969271|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969272|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969273|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969274|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969275|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
160969276|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
160969277|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969278|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969279|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969280|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969281|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969282|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
160969283|NCT01576718|581275196|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
160969284|NCT01576718|581275197|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969285|NCT01576718|581275198|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969286|NCT01576718|581275199|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969287|NCT01576718|581275200|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969288|NCT01576718|581275201|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
161273215|NCT03477903|582379645|FG000|Overall Study|Study Terminated by Sponsor|1|||
160969289|NCT01576718|581275202|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
160969290|NCT01576718|581275196|FG000|Treatment Period|Adverse Event|0|||
160969291|NCT01576718|581275197|FG001|Treatment Period|Adverse Event|1|||
160969292|NCT01576718|581275198|FG002|Treatment Period|Adverse Event|1|||
160969293|NCT01576718|581275199|FG003|Treatment Period|Adverse Event|1|||
160969294|NCT01576718|581275200|FG004|Treatment Period|Adverse Event|1|||
160969295|NCT01576718|581275201|FG005|Treatment Period|Adverse Event|1|||
161273216|NCT00474266|582379646|FG000|Overall Study|Withdrawal by Subject|7|||
161019009|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
161019010|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019011|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
161019012|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019013|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019014|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019015|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
161019016|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019017|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
161019018|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019019|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019020|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019021|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019022|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
161019023|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
161019024|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019025|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019026|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019027|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019028|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
161019029|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
161019030|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019031|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019032|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019033|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019034|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
161019035|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
161019036|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019037|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019038|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019039|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019040|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
161019041|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
161019042|NCT01902173|581457825|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019043|NCT01902173|581457826|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019044|NCT01902173|581457827|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019045|NCT01902173|581457828|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019046|NCT01902173|581457829|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
161019047|NCT01902173|581457830|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
161019048|NCT03536754|581457833|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
161019049|NCT03536754|581457834|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
161019050|NCT03536754|581457835|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
161019051|NCT03536754|581457836|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
161019052|NCT03536754|581457837|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
161019053|NCT03536754|581457833|FG000|Open Label Extension|Other|0|||
161019054|NCT03536754|581457834|FG001|Open Label Extension|Other|0|||
161019055|NCT03536754|581457835|FG002|Open Label Extension|Other|0|||
161019056|NCT03536754|581457836|FG003|Open Label Extension|Other|0|||
161019057|NCT03536754|581457837|FG004|Open Label Extension|Other|1|||
161019058|NCT03382652|581457840|FG000|Overall Study|Lost to Follow-up|6|||
161019059|NCT03382652|581457840|FG000|Overall Study|Death|4|||
161019060|NCT03382652|581457840|FG000|Overall Study|Revision|5|||
161019061|NCT03382652|581457840|FG000|Overall Study|Patient withdrew|3|||
161019062|NCT03382652|581457840|FG000|Overall Study|Other reasons|21|||
161019063|NCT04806594|581459595|FG000|Overall Study|Withdrawal by Subject|2|||
161273217|NCT00474266|582379647|FG001|Overall Study|Withdrawal by Subject|20|||
161273218|NCT00474266|582379648|FG002|Overall Study|Withdrawal by Subject|4|||
161273219|NCT00474266|582379649|FG003|Overall Study|Withdrawal by Subject|7|||
161273220|NCT02329847|582379650|FG000|Overall Study|Death|4|||
161273221|NCT02329847|582379651|FG001|Overall Study|Death|4|||
161273222|NCT02329847|582379652|FG002|Overall Study|Death|22|||
161273223|NCT02329847|582379653|FG003|Overall Study|Death|12|||
161273224|NCT02329847|582379654|FG004|Overall Study|Death|20|||
161019064|NCT04806594|581459595|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
161019065|NCT04390048|581459596|FG000|Overall Study|Withdrawal by Subject|1|||
161273225|NCT02329847|582379655|FG005|Overall Study|Death|13|||
161273226|NCT02329847|582379650|FG000|Overall Study|Lost to Follow-up|0|||
161019066|NCT04390048|581459597|FG001|Overall Study|Withdrawal by Subject|3|||
161019067|NCT06283173|581459598|FG000|Overall Study|Did not show for first visit|10|||
161019068|NCT06283173|581459598|FG000|Overall Study|Lost to Follow-up|12|||
161019069|NCT06283173|581459598|FG000|Overall Study|Physician Decision|7|||
161273227|NCT02329847|582379651|FG001|Overall Study|Lost to Follow-up|0|||
161019070|NCT03138512|581459599|FG000|Randomization|Participants withdrew consent|0|||
161019071|NCT03138512|581459600|FG001|Randomization|Participants withdrew consent|1|||
161019072|NCT03138512|581459601|FG002|Randomization|Participants withdrew consent|1|||
161019073|NCT03138512|581459602|FG003|Randomization|Participants withdrew consent|0|||
161019074|NCT03138512|581459603|FG004|Randomization|Participants withdrew consent|0|||
161019075|NCT03138512|581459599|FG000|Randomization|Participant no longer meets study criteria|0|||
161019076|NCT03138512|581459600|FG001|Randomization|Participant no longer meets study criteria|3|||
161019077|NCT03138512|581459601|FG002|Randomization|Participant no longer meets study criteria|1|||
161019078|NCT03138512|581459602|FG003|Randomization|Participant no longer meets study criteria|1|||
161019079|NCT03138512|581459603|FG004|Randomization|Participant no longer meets study criteria|3|||
161019080|NCT03138512|581459599|FG000|Randomization|Other reasons|1|||
161019081|NCT03138512|581459600|FG001|Randomization|Other reasons|0|||
161019082|NCT03138512|581459601|FG002|Randomization|Other reasons|0|||
161019083|NCT03138512|581459602|FG003|Randomization|Other reasons|0|||
161019084|NCT03138512|581459603|FG004|Randomization|Other reasons|0|||
161019085|NCT03138512|581459599|FG000|Treatment Part A|Disease recurrence|10|||
161019086|NCT03138512|581459600|FG001|Treatment Part A|Disease recurrence|20|||
161019087|NCT03138512|581459601|FG002|Treatment Part A|Disease recurrence|0|||
161019088|NCT03138512|581459602|FG003|Treatment Part A|Disease recurrence|0|||
161019089|NCT03138512|581459603|FG004|Treatment Part A|Disease recurrence|0|||
161019090|NCT03138512|581459599|FG000|Treatment Part A|Study Drug Toxicity|132|||
161019091|NCT03138512|581459600|FG001|Treatment Part A|Study Drug Toxicity|5|||
161019092|NCT03138512|581459601|FG002|Treatment Part A|Study Drug Toxicity|0|||
161019093|NCT03138512|581459602|FG003|Treatment Part A|Study Drug Toxicity|0|||
161019094|NCT03138512|581459603|FG004|Treatment Part A|Study Drug Toxicity|0|||
161019095|NCT03138512|581459599|FG000|Treatment Part A|Death|1|||
161019096|NCT03138512|581459600|FG001|Treatment Part A|Death|0|||
161019097|NCT03138512|581459601|FG002|Treatment Part A|Death|0|||
161019098|NCT03138512|581459602|FG003|Treatment Part A|Death|0|||
161019099|NCT03138512|581459603|FG004|Treatment Part A|Death|0|||
161019100|NCT03138512|581459599|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
161148444|NCT01645930|581924584|FG000|Overall Study|Reason not Defined|1|||
161148445|NCT03245814|581924585|FG000|Overall Study|Lost to Follow-up|5|||
161148446|NCT03245814|581924586|FG001|Overall Study|Lost to Follow-up|8|||
161148447|NCT03245814|581924585|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
161148448|NCT03245814|581924586|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
161148449|NCT02263365|581924591|FG000|Overall Study|Physician Decision|22|||
161148450|NCT02263365|581924592|FG001|Overall Study|Physician Decision|18|||
161148451|NCT01004146|581924595|FG000|Overall Study|Withdrawal by Subject|4|||
161148452|NCT01004146|581924596|FG001|Overall Study|Withdrawal by Subject|5|||
161148453|NCT00465738|581924605|FG000|Overall Study|Lost to Follow-up|2|||
161019101|NCT03138512|581459600|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
161019102|NCT03138512|581459601|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
161019103|NCT03138512|581459602|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
161019104|NCT03138512|581459603|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
161019105|NCT03138512|581459599|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
161019106|NCT03138512|581459600|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
161019107|NCT03138512|581459601|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
161019108|NCT03138512|581459602|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
161019109|NCT03138512|581459603|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
161019110|NCT03138512|581459599|FG000|Treatment Part A|Participant withdrew consent|2|||
161019111|NCT03138512|581459600|FG001|Treatment Part A|Participant withdrew consent|4|||
161019112|NCT03138512|581459601|FG002|Treatment Part A|Participant withdrew consent|0|||
161019113|NCT03138512|581459602|FG003|Treatment Part A|Participant withdrew consent|0|||
161019114|NCT03138512|581459603|FG004|Treatment Part A|Participant withdrew consent|0|||
161019115|NCT03138512|581459599|FG000|Treatment Part A|Lost to Follow-up|0|||
161019116|NCT03138512|581459600|FG001|Treatment Part A|Lost to Follow-up|1|||
161019117|NCT03138512|581459601|FG002|Treatment Part A|Lost to Follow-up|0|||
161019118|NCT03138512|581459602|FG003|Treatment Part A|Lost to Follow-up|0|||
161019119|NCT03138512|581459603|FG004|Treatment Part A|Lost to Follow-up|0|||
161019120|NCT03138512|581459599|FG000|Treatment Part A|Poor/non-compliance|1|||
161019121|NCT03138512|581459600|FG001|Treatment Part A|Poor/non-compliance|0|||
161019122|NCT03138512|581459601|FG002|Treatment Part A|Poor/non-compliance|0|||
161019123|NCT03138512|581459602|FG003|Treatment Part A|Poor/non-compliance|0|||
161019124|NCT03138512|581459603|FG004|Treatment Part A|Poor/non-compliance|0|||
161019125|NCT03138512|581459599|FG000|Treatment Part A|Pregnancy|0|||
161148454|NCT00465738|581924606|FG001|Overall Study|Lost to Follow-up|0|||
161019126|NCT03138512|581459600|FG001|Treatment Part A|Pregnancy|1|||
161019127|NCT03138512|581459601|FG002|Treatment Part A|Pregnancy|0|||
161019128|NCT03138512|581459602|FG003|Treatment Part A|Pregnancy|0|||
161019129|NCT03138512|581459603|FG004|Treatment Part A|Pregnancy|0|||
161148455|NCT00465738|581924605|FG000|Overall Study|Adverse Event|0|||
161148456|NCT00465738|581924606|FG001|Overall Study|Adverse Event|1|||
161148457|NCT00465738|581924605|FG000|Overall Study|Withdrawal by Subject|2|||
161019130|NCT03138512|581459599|FG000|Treatment Part A|Other reasons|11|||
161019131|NCT03138512|581459600|FG001|Treatment Part A|Other reasons|8|||
161019132|NCT03138512|581459601|FG002|Treatment Part A|Other reasons|0|||
161019133|NCT03138512|581459602|FG003|Treatment Part A|Other reasons|0|||
161019134|NCT03138512|581459603|FG004|Treatment Part A|Other reasons|0|||
161019135|NCT03138512|581459599|FG000|Treatment Part B|Disease recurrence|0|||
161019136|NCT03138512|581459600|FG001|Treatment Part B|Disease recurrence|0|||
161019137|NCT03138512|581459601|FG002|Treatment Part B|Disease recurrence|6|||
161019138|NCT03138512|581459602|FG003|Treatment Part B|Disease recurrence|12|||
161019139|NCT03138512|581459603|FG004|Treatment Part B|Disease recurrence|10|||
161019140|NCT03138512|581459599|FG000|Treatment Part B|Study drug toxicity|0|||
161019141|NCT03138512|581459600|FG001|Treatment Part B|Study drug toxicity|0|||
161019142|NCT03138512|581459601|FG002|Treatment Part B|Study drug toxicity|63|||
161019143|NCT03138512|581459602|FG003|Treatment Part B|Study drug toxicity|3|||
161019144|NCT03138512|581459603|FG004|Treatment Part B|Study drug toxicity|45|||
161019145|NCT03138512|581459599|FG000|Treatment Part B|Death|0|||
161019146|NCT03138512|581459600|FG001|Treatment Part B|Death|0|||
161019147|NCT03138512|581459601|FG002|Treatment Part B|Death|1|||
161019148|NCT03138512|581459602|FG003|Treatment Part B|Death|0|||
161019149|NCT03138512|581459603|FG004|Treatment Part B|Death|0|||
161019150|NCT03138512|581459599|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
161019151|NCT03138512|581459600|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
161019152|NCT03138512|581459601|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
161019153|NCT03138512|581459602|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
161019154|NCT03138512|581459603|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
161019155|NCT03138512|581459599|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
161019156|NCT03138512|581459600|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
161019157|NCT03138512|581459601|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
161019158|NCT03138512|581459602|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
161019159|NCT03138512|581459603|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
161019160|NCT03138512|581459599|FG000|Treatment Part B|Participant withdrew consent|0|||
161019161|NCT03138512|581459600|FG001|Treatment Part B|Participant withdrew consent|0|||
161019162|NCT03138512|581459601|FG002|Treatment Part B|Participant withdrew consent|1|||
161019163|NCT03138512|581459602|FG003|Treatment Part B|Participant withdrew consent|1|||
161019164|NCT03138512|581459603|FG004|Treatment Part B|Participant withdrew consent|2|||
161019165|NCT03138512|581459599|FG000|Treatment Part B|Lost to Follow-up|0|||
161019166|NCT03138512|581459600|FG001|Treatment Part B|Lost to Follow-up|0|||
161019167|NCT03138512|581459601|FG002|Treatment Part B|Lost to Follow-up|0|||
161019168|NCT03138512|581459602|FG003|Treatment Part B|Lost to Follow-up|1|||
161019169|NCT03138512|581459603|FG004|Treatment Part B|Lost to Follow-up|0|||
161019170|NCT03138512|581459599|FG000|Treatment Part B|Poor/non-compliance|0|||
161019171|NCT03138512|581459600|FG001|Treatment Part B|Poor/non-compliance|0|||
161019172|NCT03138512|581459601|FG002|Treatment Part B|Poor/non-compliance|1|||
161019173|NCT03138512|581459602|FG003|Treatment Part B|Poor/non-compliance|1|||
161019174|NCT03138512|581459603|FG004|Treatment Part B|Poor/non-compliance|1|||
161019175|NCT03138512|581459599|FG000|Treatment Part B|Other reasons|0|||
161019176|NCT03138512|581459600|FG001|Treatment Part B|Other reasons|0|||
161019177|NCT03138512|581459601|FG002|Treatment Part B|Other reasons|3|||
161019178|NCT03138512|581459602|FG003|Treatment Part B|Other reasons|1|||
161019179|NCT03138512|581459603|FG004|Treatment Part B|Other reasons|5|||
161019180|NCT02120456|581459608|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019181|NCT02120456|581459609|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019182|NCT02120456|581459610|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019183|NCT02120456|581459611|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019184|NCT02120456|581459612|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019185|NCT02120456|581459613|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019186|NCT02120456|581459614|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
161019187|NCT02120456|581459615|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019188|NCT02120456|581459616|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
161019189|NCT02120456|581459608|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019190|NCT02120456|581459609|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019191|NCT02120456|581459610|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019192|NCT02120456|581459611|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019193|NCT02120456|581459612|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019194|NCT02120456|581459613|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019195|NCT02120456|581459614|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
161019196|NCT02120456|581459615|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019197|NCT02120456|581459616|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
161019198|NCT02120456|581459608|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161273228|NCT02329847|582379652|FG002|Overall Study|Lost to Follow-up|2|||
161273229|NCT02329847|582379653|FG003|Overall Study|Lost to Follow-up|3|||
161273230|NCT02329847|582379654|FG004|Overall Study|Lost to Follow-up|0|||
161273231|NCT02329847|582379655|FG005|Overall Study|Lost to Follow-up|1|||
161019199|NCT02120456|581459609|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019200|NCT02120456|581459610|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019201|NCT02120456|581459611|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019202|NCT02120456|581459612|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019203|NCT02120456|581459613|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019204|NCT02120456|581459614|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019205|NCT02120456|581459615|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
161019206|NCT02120456|581459616|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
161019207|NCT05192200|581459617|FG000|Treatment Period|Other|1|||
161019208|NCT05192200|581459617|FG000|Treatment Period|Lack of Efficacy|1|||
161019209|NCT05192200|581459617|FG000|Treatment Period|Withdrawal by Subject|1|||
161019210|NCT05192200|581459617|FG000|Follow-up|Withdrawal by Subject|1|||
161019211|NCT03443323|581459620|FG000|Overall Study|Lost to Follow-up|2|||
161019212|NCT03443323|581459621|FG001|Overall Study|Lost to Follow-up|2|||
161019213|NCT03443323|581459620|FG000|Overall Study|PI withdrawal|1|||
161019214|NCT03443323|581459621|FG001|Overall Study|PI withdrawal|0|||
161019215|NCT02921230|581459622|FG000|Overall Study|Withdrawal by Subject|20|||
161019216|NCT02921230|581459623|FG001|Overall Study|Withdrawal by Subject|8|||
161019217|NCT02921230|581459622|FG000|Overall Study|Death|12|||
161019218|NCT02921230|581459623|FG001|Overall Study|Death|3|||
161019219|NCT02921230|581459622|FG000|Overall Study|Protocol Violation|17|||
161019220|NCT02921230|581459623|FG001|Overall Study|Protocol Violation|6|||
161019221|NCT02921230|581459622|FG000|Overall Study|Early completion|5|||
161019222|NCT02921230|581459623|FG001|Overall Study|Early completion|1|||
161019223|NCT02921230|581459622|FG000|Overall Study|Pending data entry|1|||
161019224|NCT02921230|581459623|FG001|Overall Study|Pending data entry|0|||
161019225|NCT04274764|581459624|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
161019226|NCT04274764|581459625|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
161019227|NCT04142788|581459630|FG000|Overall Study|Trial terminated prematurely|2|||
161019228|NCT04142788|581459631|FG001|Overall Study|Trial terminated prematurely|2|||
161019229|NCT05268393|581459635|FG000|Overall Study|Withdrawal by Subject|2|||
161019230|NCT05268393|581459636|FG001|Overall Study|Withdrawal by Subject|1|||
161019231|NCT03396926|581459637|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
161019232|NCT03396926|581459638|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
161019233|NCT02035787|581459639|FG000|Overall Study- 12 Months|Adverse Event|3|||
161019234|NCT02035787|581459640|FG001|Overall Study- 12 Months|Adverse Event|0|||
161019235|NCT02035787|581459639|FG000|Overall Study- 12 Months|Complete response|4|||
161019236|NCT02035787|581459640|FG001|Overall Study- 12 Months|Complete response|1|||
161019237|NCT02035787|581459639|FG000|Overall Study- 12 Months|Protocol Violation|1|||
161019238|NCT02035787|581459640|FG001|Overall Study- 12 Months|Protocol Violation|1|||
161019239|NCT01396278|581459642|FG000|Overall Study|Adverse Event|0|||
161019240|NCT01396278|581459643|FG001|Overall Study|Adverse Event|0|||
161019241|NCT01396278|581459644|FG002|Overall Study|Adverse Event|0|||
161019242|NCT01396278|581459645|FG003|Overall Study|Adverse Event|2|||
161019243|NCT01396278|581459646|FG004|Overall Study|Adverse Event|0|||
161019244|NCT01396278|581459642|FG000|Overall Study|Withdraw due to trial termination|2|||
161019245|NCT01396278|581459643|FG001|Overall Study|Withdraw due to trial termination|1|||
161019246|NCT01396278|581459644|FG002|Overall Study|Withdraw due to trial termination|1|||
161019247|NCT01396278|581459645|FG003|Overall Study|Withdraw due to trial termination|0|||
161019248|NCT01396278|581459646|FG004|Overall Study|Withdraw due to trial termination|2|||
161019249|NCT00450658|581459647|FG000|Overall Study|Adverse Event|24|||
161019250|NCT00450658|581459648|FG001|Overall Study|Adverse Event|15|||
161019251|NCT00450658|581459647|FG000|Overall Study|Withdrawal by Subject|43|||
161019252|NCT00450658|581459648|FG001|Overall Study|Withdrawal by Subject|26|||
161019253|NCT00450658|581459647|FG000|Overall Study|Lost to Follow-up|22|||
161019254|NCT00450658|581459648|FG001|Overall Study|Lost to Follow-up|5|||
161019255|NCT00450658|581459647|FG000|Overall Study|UGI ulcer|33|||
161019256|NCT00450658|581459648|FG001|Overall Study|UGI ulcer|34|||
161019257|NCT00450658|581459647|FG000|Overall Study|misc|21|||
161019258|NCT00450658|581459648|FG001|Overall Study|misc|10|||
161019259|NCT04727554|581459650|FG000|Overall Study|Lost to Follow-up|0|||
161019260|NCT04727554|581459651|FG001|Overall Study|Lost to Follow-up|1|||
161019261|NCT04727554|581459650|FG000|Overall Study|Death|2|||
161019262|NCT04727554|581459651|FG001|Overall Study|Death|6|||
161019263|NCT04727554|581459650|FG000|Overall Study|Withdrawal by Subject|1|||
161019264|NCT04727554|581459651|FG001|Overall Study|Withdrawal by Subject|0|||
161019265|NCT05763823|581459652|FG000|Overall Study|Death|6|||
161019266|NCT05763823|581459652|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161019267|NCT05763823|581459652|FG000|Overall Study|Withdrawal by Subject|6|||
161019268|NCT00999804|581459655|FG000|Overall Study|Lack of Efficacy|9|||
161019269|NCT00999804|581459656|FG001|Overall Study|Lack of Efficacy|2|||
161019270|NCT00999804|581459655|FG000|Overall Study|Adverse Event|4|||
161019271|NCT00999804|581459656|FG001|Overall Study|Adverse Event|3|||
161019272|NCT00999804|581459655|FG000|Overall Study|Withdrawal by Subject|4|||
161019273|NCT00999804|581459656|FG001|Overall Study|Withdrawal by Subject|0|||
161019274|NCT00999804|581459655|FG000|Overall Study|Death|1|||
161019275|NCT00999804|581459656|FG001|Overall Study|Death|0|||
161019276|NCT00999804|581459655|FG000|Overall Study|Ineligible|3|||
161019277|NCT00999804|581459656|FG001|Overall Study|Ineligible|0|||
161019278|NCT05311384|581459667|FG000|Overall Study|Uncontrolled health conditions|2|||
161019279|NCT05311384|581459667|FG000|Overall Study|Withdrawal by Subject|1|||
161019280|NCT05076708|581459668|FG000|Overall Study|Withdrawal by Subject|4|||
161019281|NCT05076708|581459668|FG000|Overall Study|Lost to study during switch phase|8|||
161019282|NCT05590403|581459669|FG000|Overall Study|Lost to Follow-up|13|||
161019283|NCT05590403|581459670|FG001|Overall Study|Lost to Follow-up|1|||
161019284|NCT05590403|581459671|FG002|Overall Study|Lost to Follow-up|7|||
161019285|NCT05590403|581459672|FG003|Overall Study|Lost to Follow-up|3|||
161019286|NCT05590403|581459673|FG004|Overall Study|Lost to Follow-up|4|||
161019287|NCT05590403|581459669|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
161019288|NCT05590403|581459670|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
161019289|NCT05590403|581459671|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
161019290|NCT05590403|581459672|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
161019291|NCT05590403|581459673|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
161019292|NCT05590403|581459669|FG000|Overall Study|Other|2|||
161019293|NCT05590403|581459670|FG001|Overall Study|Other|0|||
161019294|NCT05590403|581459671|FG002|Overall Study|Other|2|||
161019295|NCT05590403|581459672|FG003|Overall Study|Other|2|||
161019296|NCT05590403|581459673|FG004|Overall Study|Other|0|||
161019297|NCT05590403|581459669|FG000|Overall Study|Migrated / moved from the study area|1|||
161019298|NCT05590403|581459670|FG001|Overall Study|Migrated / moved from the study area|1|||
161019299|NCT05590403|581459671|FG002|Overall Study|Migrated / moved from the study area|0|||
161019300|NCT05590403|581459672|FG003|Overall Study|Migrated / moved from the study area|3|||
161019301|NCT05590403|581459673|FG004|Overall Study|Migrated / moved from the study area|1|||
161019302|NCT05590403|581459669|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
161019303|NCT05590403|581459670|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
161019304|NCT05590403|581459671|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
161019305|NCT05590403|581459672|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
161019306|NCT05590403|581459673|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
161019307|NCT04717492|581459674|FG000|Overall Study|Withdrawal by Subject|2|||
161019308|NCT04717492|581459675|FG001|Overall Study|Withdrawal by Subject|13|||
161019309|NCT04717492|581459674|FG000|Overall Study|Lost to Follow-up|2|||
161019310|NCT04717492|581459675|FG001|Overall Study|Lost to Follow-up|9|||
161019311|NCT02924272|581459676|FG000|Overall Study|Site Terminated by Sponsor|4|||
161019312|NCT02924272|581459677|FG001|Overall Study|Site Terminated by Sponsor|1|||
161019313|NCT02924272|581459676|FG000|Overall Study|Withdrawal by Subject|2|||
161019314|NCT02924272|581459677|FG001|Overall Study|Withdrawal by Subject|0|||
161019315|NCT02924272|581459676|FG000|Overall Study|Adverse Event|3|||
161019316|NCT02924272|581459677|FG001|Overall Study|Adverse Event|0|||
161019317|NCT02924272|581459676|FG000|Overall Study|Progressive Disease|11|||
161019318|NCT02924272|581459677|FG001|Overall Study|Progressive Disease|8|||
161019319|NCT02924272|581459676|FG000|Overall Study|Clinical Deterioration|1|||
161019320|NCT02924272|581459677|FG001|Overall Study|Clinical Deterioration|0|||
161148458|NCT00465738|581924606|FG001|Overall Study|Withdrawal by Subject|0|||
161148459|NCT00465738|581924605|FG000|Overall Study|Other|2|||
161148460|NCT00465738|581924606|FG001|Overall Study|Other|5|||
161148461|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Adverse Event|37|||
161148462|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Adverse Event|0|||
161148463|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Adverse Event|0|||
161148464|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Adverse Event|0|||
161148465|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Death|2|||
161148466|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Death|0|||
161148467|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Death|0|||
161148468|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Death|0|||
161148469|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
161148470|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
161148471|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
161148472|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
161148473|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
161148474|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
161148475|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
161148476|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
161148477|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
161148478|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
161148479|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
161148480|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
161148481|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
161148482|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161148483|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161019321|NCT02924272|581459676|FG000|Overall Study|Death|1|||
161019322|NCT02924272|581459677|FG001|Overall Study|Death|0|||
161019323|NCT02924272|581459676|FG000|Overall Study|Reason Not Specified|1|||
161019324|NCT02924272|581459677|FG001|Overall Study|Reason Not Specified|0|||
161019325|NCT03575897|581459680|FG000|Overall Study|Lost to Follow-up|12|||
161019326|NCT03575897|581459681|FG001|Overall Study|Lost to Follow-up|13|||
161019327|NCT03150810|581459683|FG000|Overall Study|Death|4|||
161019328|NCT03150810|581459684|FG001|Overall Study|Death|8|||
161019329|NCT03150810|581459685|FG002|Overall Study|Death|7|||
161019330|NCT03150810|581459686|FG003|Overall Study|Death|2|||
161019331|NCT03150810|581459687|FG004|Overall Study|Death|2|||
161019332|NCT03150810|581459688|FG005|Overall Study|Death|10|||
161019333|NCT03150810|581459689|FG006|Overall Study|Death|8|||
161019334|NCT03150810|581459690|FG007|Overall Study|Death|6|||
161019335|NCT03150810|581459691|FG008|Overall Study|Death|18|||
161019336|NCT03150810|581459692|FG009|Overall Study|Death|3|||
161019337|NCT03150810|581459693|FG010|Overall Study|Death|19|||
161019338|NCT03150810|581459694|FG011|Overall Study|Death|1|||
161019339|NCT03150810|581459695|FG012|Overall Study|Death|19|||
161019340|NCT03150810|581459683|FG000|Overall Study|Withdrawal by Subject|0|||
161019341|NCT03150810|581459684|FG001|Overall Study|Withdrawal by Subject|1|||
161019342|NCT03150810|581459685|FG002|Overall Study|Withdrawal by Subject|1|||
161019343|NCT03150810|581459686|FG003|Overall Study|Withdrawal by Subject|1|||
161019344|NCT03150810|581459687|FG004|Overall Study|Withdrawal by Subject|0|||
161019345|NCT03150810|581459688|FG005|Overall Study|Withdrawal by Subject|0|||
161019346|NCT03150810|581459689|FG006|Overall Study|Withdrawal by Subject|2|||
161019347|NCT03150810|581459690|FG007|Overall Study|Withdrawal by Subject|0|||
161019348|NCT03150810|581459691|FG008|Overall Study|Withdrawal by Subject|2|||
161019349|NCT03150810|581459692|FG009|Overall Study|Withdrawal by Subject|0|||
161019350|NCT03150810|581459693|FG010|Overall Study|Withdrawal by Subject|1|||
161019351|NCT03150810|581459694|FG011|Overall Study|Withdrawal by Subject|0|||
161019352|NCT03150810|581459695|FG012|Overall Study|Withdrawal by Subject|1|||
161019353|NCT03150810|581459683|FG000|Overall Study|Sponsor Decision|0|||
161019354|NCT03150810|581459684|FG001|Overall Study|Sponsor Decision|2|||
161019355|NCT03150810|581459685|FG002|Overall Study|Sponsor Decision|0|||
161019356|NCT03150810|581459686|FG003|Overall Study|Sponsor Decision|0|||
161019357|NCT03150810|581459687|FG004|Overall Study|Sponsor Decision|1|||
161019358|NCT03150810|581459688|FG005|Overall Study|Sponsor Decision|1|||
161019359|NCT03150810|581459689|FG006|Overall Study|Sponsor Decision|0|||
161019360|NCT03150810|581459690|FG007|Overall Study|Sponsor Decision|0|||
161019361|NCT03150810|581459691|FG008|Overall Study|Sponsor Decision|1|||
161019362|NCT03150810|581459692|FG009|Overall Study|Sponsor Decision|0|||
161019363|NCT03150810|581459693|FG010|Overall Study|Sponsor Decision|0|||
161019364|NCT03150810|581459694|FG011|Overall Study|Sponsor Decision|0|||
161019365|NCT03150810|581459695|FG012|Overall Study|Sponsor Decision|5|||
161019366|NCT03150810|581459683|FG000|Overall Study|Lost to Follow-up|0|||
161019367|NCT03150810|581459684|FG001|Overall Study|Lost to Follow-up|1|||
161019368|NCT03150810|581459685|FG002|Overall Study|Lost to Follow-up|1|||
161019369|NCT03150810|581459686|FG003|Overall Study|Lost to Follow-up|0|||
161019370|NCT03150810|581459687|FG004|Overall Study|Lost to Follow-up|0|||
161019371|NCT03150810|581459688|FG005|Overall Study|Lost to Follow-up|0|||
161019372|NCT03150810|581459689|FG006|Overall Study|Lost to Follow-up|1|||
161019373|NCT03150810|581459690|FG007|Overall Study|Lost to Follow-up|0|||
161019374|NCT03150810|581459691|FG008|Overall Study|Lost to Follow-up|0|||
161019375|NCT03150810|581459692|FG009|Overall Study|Lost to Follow-up|0|||
161019376|NCT03150810|581459693|FG010|Overall Study|Lost to Follow-up|1|||
161019377|NCT03150810|581459694|FG011|Overall Study|Lost to Follow-up|0|||
161019378|NCT03150810|581459695|FG012|Overall Study|Lost to Follow-up|0|||
161019379|NCT03150810|581459683|FG000|Overall Study|Physician Decision|0|||
161148484|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
161148485|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Physician Decision|4|||
161148486|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Physician Decision|0|||
161148487|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Physician Decision|0|||
161148488|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Physician Decision|0|||
161148489|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Pregnancy|1|||
161148490|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Pregnancy|0|||
161148491|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Pregnancy|0|||
161019380|NCT03150810|581459684|FG001|Overall Study|Physician Decision|0|||
161019381|NCT03150810|581459685|FG002|Overall Study|Physician Decision|0|||
161019382|NCT03150810|581459686|FG003|Overall Study|Physician Decision|0|||
161148492|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Pregnancy|0|||
161019383|NCT03150810|581459687|FG004|Overall Study|Physician Decision|0|||
161148493|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
161148494|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
161273232|NCT02329847|582379650|FG000|Overall Study|Physician Decision|0|||
161019384|NCT03150810|581459688|FG005|Overall Study|Physician Decision|1|||
161019385|NCT03150810|581459689|FG006|Overall Study|Physician Decision|1|||
161019386|NCT03150810|581459690|FG007|Overall Study|Physician Decision|0|||
161019387|NCT03150810|581459691|FG008|Overall Study|Physician Decision|0|||
161019388|NCT03150810|581459692|FG009|Overall Study|Physician Decision|0|||
161019389|NCT03150810|581459693|FG010|Overall Study|Physician Decision|0|||
161019390|NCT03150810|581459694|FG011|Overall Study|Physician Decision|0|||
161019391|NCT03150810|581459695|FG012|Overall Study|Physician Decision|0|||
161019392|NCT03150810|581459683|FG000|Overall Study|Site withdrawal from study|0|||
161019393|NCT03150810|581459684|FG001|Overall Study|Site withdrawal from study|1|||
161019394|NCT03150810|581459685|FG002|Overall Study|Site withdrawal from study|0|||
161019395|NCT03150810|581459686|FG003|Overall Study|Site withdrawal from study|0|||
161019396|NCT03150810|581459687|FG004|Overall Study|Site withdrawal from study|0|||
161019397|NCT03150810|581459688|FG005|Overall Study|Site withdrawal from study|0|||
161019398|NCT03150810|581459689|FG006|Overall Study|Site withdrawal from study|0|||
161019399|NCT03150810|581459690|FG007|Overall Study|Site withdrawal from study|0|||
161019400|NCT03150810|581459691|FG008|Overall Study|Site withdrawal from study|0|||
161019401|NCT03150810|581459692|FG009|Overall Study|Site withdrawal from study|1|||
161019402|NCT03150810|581459693|FG010|Overall Study|Site withdrawal from study|1|||
161019403|NCT03150810|581459694|FG011|Overall Study|Site withdrawal from study|0|||
161019404|NCT03150810|581459695|FG012|Overall Study|Site withdrawal from study|0|||
161019405|NCT03150810|581459683|FG000|Overall Study|Hospice|0|||
161019406|NCT03150810|581459684|FG001|Overall Study|Hospice|0|||
161019407|NCT03150810|581459685|FG002|Overall Study|Hospice|0|||
161019408|NCT03150810|581459686|FG003|Overall Study|Hospice|0|||
161019409|NCT03150810|581459687|FG004|Overall Study|Hospice|0|||
161019410|NCT03150810|581459688|FG005|Overall Study|Hospice|1|||
161019411|NCT03150810|581459689|FG006|Overall Study|Hospice|0|||
161019412|NCT03150810|581459690|FG007|Overall Study|Hospice|0|||
161019413|NCT03150810|581459691|FG008|Overall Study|Hospice|0|||
161019414|NCT03150810|581459692|FG009|Overall Study|Hospice|0|||
161019415|NCT03150810|581459693|FG010|Overall Study|Hospice|0|||
161019416|NCT03150810|581459694|FG011|Overall Study|Hospice|0|||
161019417|NCT03150810|581459695|FG012|Overall Study|Hospice|0|||
161019418|NCT03150810|581459683|FG000|Overall Study|Participant relocated abroad.|0|||
161019419|NCT03150810|581459684|FG001|Overall Study|Participant relocated abroad.|0|||
161019420|NCT03150810|581459685|FG002|Overall Study|Participant relocated abroad.|0|||
161019421|NCT03150810|581459686|FG003|Overall Study|Participant relocated abroad.|0|||
161019422|NCT03150810|581459687|FG004|Overall Study|Participant relocated abroad.|0|||
161019423|NCT03150810|581459688|FG005|Overall Study|Participant relocated abroad.|1|||
161019424|NCT03150810|581459689|FG006|Overall Study|Participant relocated abroad.|0|||
161019425|NCT03150810|581459690|FG007|Overall Study|Participant relocated abroad.|0|||
161019426|NCT03150810|581459691|FG008|Overall Study|Participant relocated abroad.|0|||
161019427|NCT03150810|581459692|FG009|Overall Study|Participant relocated abroad.|0|||
161019428|NCT03150810|581459693|FG010|Overall Study|Participant relocated abroad.|0|||
161019429|NCT03150810|581459694|FG011|Overall Study|Participant relocated abroad.|0|||
161019430|NCT03150810|581459695|FG012|Overall Study|Participant relocated abroad.|0|||
161019431|NCT03150810|581459683|FG000|Overall Study|Transferred care to oncologist|0|||
161019432|NCT03150810|581459684|FG001|Overall Study|Transferred care to oncologist|0|||
161019433|NCT03150810|581459685|FG002|Overall Study|Transferred care to oncologist|0|||
161019434|NCT03150810|581459686|FG003|Overall Study|Transferred care to oncologist|0|||
161019435|NCT03150810|581459687|FG004|Overall Study|Transferred care to oncologist|0|||
161019436|NCT03150810|581459688|FG005|Overall Study|Transferred care to oncologist|0|||
161019437|NCT03150810|581459689|FG006|Overall Study|Transferred care to oncologist|2|||
161019438|NCT03150810|581459690|FG007|Overall Study|Transferred care to oncologist|0|||
161019439|NCT03150810|581459691|FG008|Overall Study|Transferred care to oncologist|0|||
161019440|NCT03150810|581459692|FG009|Overall Study|Transferred care to oncologist|0|||
161019441|NCT03150810|581459693|FG010|Overall Study|Transferred care to oncologist|0|||
161019442|NCT03150810|581459694|FG011|Overall Study|Transferred care to oncologist|0|||
161019443|NCT03150810|581459695|FG012|Overall Study|Transferred care to oncologist|0|||
161019444|NCT04526704|581459696|FG000|Overall Study|Adverse Event|1|||
161019445|NCT04526704|581459697|FG001|Overall Study|Adverse Event|0|||
161019446|NCT04526704|581459696|FG000|Overall Study|Physician Decision|1|||
161019447|NCT04526704|581459697|FG001|Overall Study|Physician Decision|0|||
161019448|NCT04526704|581459696|FG000|Overall Study|Withdrawal by Subject|2|||
161019449|NCT04526704|581459697|FG001|Overall Study|Withdrawal by Subject|0|||
161019450|NCT03936322|581459698|FG000|Overall Study|Lost to Follow-up|1|||
161019451|NCT03936322|581459698|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
161019452|NCT06393088|581459699|FG000|Overall Study|Withdrawal by Subject|0|||
161019453|NCT06393088|581459700|FG001|Overall Study|Withdrawal by Subject|2|||
161273233|NCT02329847|582379651|FG001|Overall Study|Physician Decision|0|||
161019454|NCT05051124|581459701|FG000|Overall Study|Lost to Follow-up|2|||
161019455|NCT05051124|581459701|FG000|Overall Study|Withdrawal by Subject|1|||
161019456|NCT05051124|581459701|FG000|Overall Study|Residential relocation|2|||
161019457|NCT05051124|581459701|FG000|Overall Study|Death|1|||
161019458|NCT04782973|581459702|FG000|Overall Study|Withdrawal by Subject|5|||
161019459|NCT04782973|581459702|FG000|Overall Study|Protocol Violation|6|||
161019460|NCT04782973|581459702|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
161019461|NCT04495894|581459718|FG000|Overall Study|Withdrawal by Subject|2|||
161273234|NCT02329847|582379652|FG002|Overall Study|Physician Decision|0|||
161273235|NCT02329847|582379653|FG003|Overall Study|Physician Decision|0|||
161019462|NCT04495894|581459719|FG001|Overall Study|Withdrawal by Subject|0|||
161019463|NCT04495894|581459720|FG002|Overall Study|Withdrawal by Subject|2|||
161019464|NCT04495894|581459721|FG003|Overall Study|Withdrawal by Subject|3|||
161019465|NCT04495894|581459718|FG000|Overall Study|Early termination|0|||
161019466|NCT04495894|581459719|FG001|Overall Study|Early termination|0|||
161019467|NCT04495894|581459720|FG002|Overall Study|Early termination|3|||
161019468|NCT04495894|581459721|FG003|Overall Study|Early termination|0|||
161019469|NCT01000961|581459722|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161019470|NCT01000961|581459723|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161019471|NCT01000961|581459722|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
161019472|NCT01000961|581459723|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
161019473|NCT05746455|581459726|FG000|Overall Study|Discharged from Clinical Service|1|||
161019474|NCT05746455|581459726|FG000|Overall Study|Lost to Follow-up|1|||
161019475|NCT02023866|581459727|FG000|Overall Study|Non-compliance|2|||
161019476|NCT02023866|581459727|FG000|Overall Study|Adverse Event|3|||
161019477|NCT02023866|581459727|FG000|Overall Study|Withdrawal by Subject|1|||
161019478|NCT03307343|581459728|FG000|Overall Study|Withdrawal by Subject|1|||
161019479|NCT03307343|581459729|FG001|Overall Study|Withdrawal by Subject|2|||
161019480|NCT03307343|581459728|FG000|Overall Study|Pregnancy|0|||
161019481|NCT03307343|581459729|FG001|Overall Study|Pregnancy|2|||
161019482|NCT03307343|581459728|FG000|Overall Study|Physician Decision|1|||
161019483|NCT03307343|581459729|FG001|Overall Study|Physician Decision|0|||
161019484|NCT03307343|581459728|FG000|Overall Study|Lost to Follow-up|0|||
161019485|NCT03307343|581459729|FG001|Overall Study|Lost to Follow-up|2|||
161019486|NCT04683744|581459731|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
161019487|NCT04683744|581459732|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
161019488|NCT04683744|581459733|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
161019489|NCT05184192|581459736|FG000|Overall Study|Lost to Follow-up|4|||
161019490|NCT05184192|581459737|FG001|Overall Study|Lost to Follow-up|7|||
161019491|NCT05184192|581459736|FG000|Overall Study|Adverse Event|1|||
161019492|NCT05184192|581459737|FG001|Overall Study|Adverse Event|4|||
161019493|NCT05184192|581459736|FG000|Overall Study|PI withdrawal|1|||
161019494|NCT05184192|581459737|FG001|Overall Study|PI withdrawal|2|||
161019495|NCT05184192|581459736|FG000|Overall Study|Withdrew due to adverse effect|1|||
161019496|NCT05184192|581459737|FG001|Overall Study|Withdrew due to adverse effect|0|||
161019497|NCT05184192|581459736|FG000|Overall Study|Medication schedule|1|||
161019498|NCT05184192|581459737|FG001|Overall Study|Medication schedule|0|||
161019499|NCT05184192|581459736|FG000|Overall Study|Concern for adverse effects|0|||
161019500|NCT05184192|581459737|FG001|Overall Study|Concern for adverse effects|4|||
161019501|NCT01824394|581459743|FG000|Overall Study|Early Termination|1|||
161019502|NCT01824394|581459744|FG001|Overall Study|Early Termination|1|||
161019503|NCT01824394|581459745|FG002|Overall Study|Early Termination|3|||
161019504|NCT01824394|581459743|FG000|Overall Study|Withdrawn due to Study Termination|91|||
161019505|NCT01824394|581459744|FG001|Overall Study|Withdrawn due to Study Termination|83|||
161019506|NCT01824394|581459745|FG002|Overall Study|Withdrawn due to Study Termination|41|||
161019507|NCT01824394|581459743|FG000|Overall Study|Lost to Follow-up|0|||
161019508|NCT01824394|581459744|FG001|Overall Study|Lost to Follow-up|9|||
161019509|NCT01824394|581459745|FG002|Overall Study|Lost to Follow-up|3|||
161148495|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
161148496|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
161148497|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
161148498|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
161148499|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
161148500|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
161148501|NCT01855789|581924607|FG000|1) Baseline up to Week 24|Other|4|||
161148502|NCT01855789|581924608|FG001|1) Baseline up to Week 24|Other|0|||
161148503|NCT01855789|581924609|FG002|1) Baseline up to Week 24|Other|0|||
161148504|NCT01855789|581924610|FG003|1) Baseline up to Week 24|Other|0|||
161148505|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
161148506|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
161148507|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
161148508|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
161148509|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161148510|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161148511|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
161019510|NCT01824394|581459743|FG000|Overall Study|Death|3|||
161019511|NCT01824394|581459744|FG001|Overall Study|Death|2|||
161019512|NCT01824394|581459745|FG002|Overall Study|Death|4|||
161019513|NCT01824394|581459743|FG000|Overall Study|Discontinued Subjects|1|||
161019514|NCT01824394|581459744|FG001|Overall Study|Discontinued Subjects|1|||
161019515|NCT01824394|581459745|FG002|Overall Study|Discontinued Subjects|2|||
161019516|NCT01824394|581459743|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
161019517|NCT01824394|581459744|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
161019518|NCT01824394|581459745|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
161273236|NCT02329847|582379654|FG004|Overall Study|Physician Decision|1|||
161019519|NCT05364671|581459747|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
161019520|NCT05364671|581459748|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
161019521|NCT05364671|581459747|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
161019522|NCT05364671|581459748|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
161019523|NCT05364671|581459747|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
161019524|NCT05364671|581459748|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
161019525|NCT05364671|581459747|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
161019526|NCT05364671|581459748|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
161019527|NCT05364671|581459747|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
161019528|NCT05364671|581459748|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
161019529|NCT04015167|581459749|FG000|Overall Study|Lost to Follow-up|40|||
161019530|NCT04015167|581459749|FG000|Overall Study|Adverse Event|5|||
161019531|NCT04015167|581459749|FG000|Overall Study|Withdrawal by Subject|2|||
161019532|NCT04015167|581459749|FG000|Overall Study|Subject went to jail|1|||
161019533|NCT04810650|581459751|FG000|Overall Study|Disenrolled in error|0|||
161019534|NCT04810650|581459752|FG001|Overall Study|Disenrolled in error|0|||
161019535|NCT04810650|581459753|FG002|Overall Study|Disenrolled in error|0|||
161019536|NCT04810650|581459754|FG003|Overall Study|Disenrolled in error|0|||
161019537|NCT04810650|581459755|FG004|Overall Study|Disenrolled in error|0|||
161019538|NCT04810650|581459756|FG005|Overall Study|Disenrolled in error|0|||
161019539|NCT04810650|581459757|FG006|Overall Study|Disenrolled in error|0|||
161019540|NCT04810650|581459758|FG007|Overall Study|Disenrolled in error|0|||
161019541|NCT04810650|581459759|FG008|Overall Study|Disenrolled in error|1|||
161019542|NCT04810650|581459760|FG009|Overall Study|Disenrolled in error|0|||
161019543|NCT04810650|581459761|FG010|Overall Study|Disenrolled in error|0|||
161019544|NCT04810650|581459762|FG011|Overall Study|Disenrolled in error|0|||
161019545|NCT04810650|581459763|FG012|Overall Study|Disenrolled in error|0|||
161273237|NCT02329847|582379655|FG005|Overall Study|Physician Decision|0|||
161273238|NCT02329847|582379650|FG000|Overall Study|Withdrawal by Subject|2|||
161273239|NCT02329847|582379651|FG001|Overall Study|Withdrawal by Subject|1|||
161273240|NCT02329847|582379652|FG002|Overall Study|Withdrawal by Subject|5|||
161273241|NCT02329847|582379653|FG003|Overall Study|Withdrawal by Subject|7|||
161273242|NCT02329847|582379654|FG004|Overall Study|Withdrawal by Subject|8|||
161273243|NCT02329847|582379655|FG005|Overall Study|Withdrawal by Subject|3|||
161273244|NCT02329847|582379650|FG000|Overall Study|Other|1|||
161273245|NCT02329847|582379651|FG001|Overall Study|Other|2|||
161273246|NCT02329847|582379652|FG002|Overall Study|Other|6|||
161273247|NCT02329847|582379653|FG003|Overall Study|Other|13|||
161273248|NCT02329847|582379654|FG004|Overall Study|Other|10|||
161273249|NCT02329847|582379655|FG005|Overall Study|Other|3|||
161273250|NCT05330468|582379656|FG000|Overall Study|Death|6|||
161273251|NCT05330468|582379656|FG000|Overall Study|Withdrawal by Subject|4|||
161273252|NCT05330468|582379656|FG000|Overall Study|Lost to Follow-up|4|||
161273253|NCT02828241|582379659|FG000|Overall Study|Adverse Event|7|||
161273254|NCT02828241|582379660|FG001|Overall Study|Adverse Event|2|||
161273255|NCT02828241|582379659|FG000|Overall Study|Protocol Violation|1|||
161273256|NCT02828241|582379660|FG001|Overall Study|Protocol Violation|0|||
161273257|NCT04572893|582379661|FG000|Part A|Adverse Event|1|||
161273258|NCT04572893|582379662|FG001|Part A|Adverse Event|0|||
161273259|NCT04572893|582379663|FG002|Part A|Adverse Event|0|||
161273260|NCT04572893|582379664|FG003|Part A|Adverse Event|0|||
161273261|NCT04572893|582379665|FG004|Part A|Adverse Event|0|||
161273262|NCT04572893|582379666|FG005|Part A|Adverse Event|0|||
161019546|NCT04810650|581459764|FG013|Overall Study|Disenrolled in error|0|||
161019547|NCT04810650|581459751|FG000|Overall Study|Death|0|||
161019548|NCT04810650|581459752|FG001|Overall Study|Death|0|||
161019549|NCT04810650|581459753|FG002|Overall Study|Death|0|||
161019550|NCT04810650|581459754|FG003|Overall Study|Death|0|||
161019551|NCT04810650|581459755|FG004|Overall Study|Death|0|||
161019552|NCT04810650|581459756|FG005|Overall Study|Death|0|||
161019553|NCT04810650|581459757|FG006|Overall Study|Death|2|||
161273263|NCT04572893|582379667|FG006|Part A|Adverse Event|0|||
161273264|NCT04572893|582379661|FG000|Part B|Withdrawal by Subject|0|||
161273265|NCT04572893|582379662|FG001|Part B|Withdrawal by Subject|0|||
161273266|NCT04572893|582379663|FG002|Part B|Withdrawal by Subject|0|||
161019554|NCT04810650|581459758|FG007|Overall Study|Death|2|||
161019555|NCT04810650|581459759|FG008|Overall Study|Death|0|||
161019556|NCT04810650|581459760|FG009|Overall Study|Death|1|||
161019557|NCT04810650|581459761|FG010|Overall Study|Death|0|||
161019558|NCT04810650|581459762|FG011|Overall Study|Death|0|||
161019559|NCT04810650|581459763|FG012|Overall Study|Death|2|||
161273267|NCT04572893|582379664|FG003|Part B|Withdrawal by Subject|0|||
161273268|NCT04572893|582379665|FG004|Part B|Withdrawal by Subject|0|||
161273269|NCT04572893|582379666|FG005|Part B|Withdrawal by Subject|1|||
161273270|NCT04572893|582379667|FG006|Part B|Withdrawal by Subject|0|||
161273271|NCT04572893|582379661|FG000|Part B|Study terminated by sponsor|0|||
161019560|NCT04810650|581459764|FG013|Overall Study|Death|1|||
161019561|NCT04810650|581459751|FG000|Overall Study|Moved/transferred care|0|||
161019562|NCT04810650|581459752|FG001|Overall Study|Moved/transferred care|0|||
161019563|NCT04810650|581459753|FG002|Overall Study|Moved/transferred care|0|||
161019564|NCT04810650|581459754|FG003|Overall Study|Moved/transferred care|0|||
161019565|NCT04810650|581459755|FG004|Overall Study|Moved/transferred care|0|||
161019566|NCT04810650|581459756|FG005|Overall Study|Moved/transferred care|0|||
161019567|NCT04810650|581459757|FG006|Overall Study|Moved/transferred care|0|||
161019568|NCT04810650|581459758|FG007|Overall Study|Moved/transferred care|1|||
161273272|NCT04572893|582379662|FG001|Part B|Study terminated by sponsor|0|||
161273273|NCT04572893|582379663|FG002|Part B|Study terminated by sponsor|0|||
161273274|NCT04572893|582379664|FG003|Part B|Study terminated by sponsor|0|||
161273275|NCT04572893|582379665|FG004|Part B|Study terminated by sponsor|7|||
161273276|NCT04572893|582379666|FG005|Part B|Study terminated by sponsor|5|||
161273277|NCT04572893|582379667|FG006|Part B|Study terminated by sponsor|3|||
161273278|NCT04572893|582379661|FG000|Part B|Lost to Follow-up|0|||
161273279|NCT04572893|582379662|FG001|Part B|Lost to Follow-up|0|||
161273280|NCT04572893|582379663|FG002|Part B|Lost to Follow-up|0|||
161273281|NCT04572893|582379664|FG003|Part B|Lost to Follow-up|0|||
161273282|NCT04572893|582379665|FG004|Part B|Lost to Follow-up|0|||
161273283|NCT04572893|582379666|FG005|Part B|Lost to Follow-up|0|||
161273284|NCT04572893|582379667|FG006|Part B|Lost to Follow-up|1|||
161273285|NCT04572893|582379661|FG000|Part B|Adverse Event|0|||
161273286|NCT04572893|582379662|FG001|Part B|Adverse Event|0|||
161019569|NCT04810650|581459759|FG008|Overall Study|Moved/transferred care|12|||
161019570|NCT04810650|581459760|FG009|Overall Study|Moved/transferred care|10|||
161019571|NCT04810650|581459761|FG010|Overall Study|Moved/transferred care|0|||
161019572|NCT04810650|581459762|FG011|Overall Study|Moved/transferred care|0|||
161019573|NCT04810650|581459763|FG012|Overall Study|Moved/transferred care|0|||
161019574|NCT04810650|581459764|FG013|Overall Study|Moved/transferred care|0|||
161019575|NCT04810650|581459751|FG000|Overall Study|Lost to Follow-up|15|||
161019576|NCT04810650|581459752|FG001|Overall Study|Lost to Follow-up|12|||
161019577|NCT04810650|581459753|FG002|Overall Study|Lost to Follow-up|7|||
161019578|NCT04810650|581459754|FG003|Overall Study|Lost to Follow-up|9|||
161019579|NCT04810650|581459755|FG004|Overall Study|Lost to Follow-up|10|||
161019580|NCT04810650|581459756|FG005|Overall Study|Lost to Follow-up|6|||
161019581|NCT04810650|581459757|FG006|Overall Study|Lost to Follow-up|0|||
161019582|NCT04810650|581459758|FG007|Overall Study|Lost to Follow-up|0|||
161019583|NCT04810650|581459759|FG008|Overall Study|Lost to Follow-up|0|||
161019584|NCT04810650|581459760|FG009|Overall Study|Lost to Follow-up|0|||
161019585|NCT04810650|581459761|FG010|Overall Study|Lost to Follow-up|1|||
161019586|NCT04810650|581459762|FG011|Overall Study|Lost to Follow-up|0|||
161019587|NCT04810650|581459763|FG012|Overall Study|Lost to Follow-up|3|||
161019588|NCT04810650|581459764|FG013|Overall Study|Lost to Follow-up|9|||
161019589|NCT04810650|581459751|FG000|Overall Study|Participant declined|0|||
161019590|NCT04810650|581459752|FG001|Overall Study|Participant declined|0|||
161019591|NCT04810650|581459753|FG002|Overall Study|Participant declined|0|||
161019592|NCT04810650|581459754|FG003|Overall Study|Participant declined|0|||
161019593|NCT04810650|581459755|FG004|Overall Study|Participant declined|0|||
161019594|NCT04810650|581459756|FG005|Overall Study|Participant declined|0|||
161019595|NCT04810650|581459757|FG006|Overall Study|Participant declined|0|||
161019596|NCT04810650|581459758|FG007|Overall Study|Participant declined|0|||
161019597|NCT04810650|581459759|FG008|Overall Study|Participant declined|0|||
161019598|NCT04810650|581459760|FG009|Overall Study|Participant declined|0|||
161019599|NCT04810650|581459761|FG010|Overall Study|Participant declined|2|||
161019600|NCT04810650|581459762|FG011|Overall Study|Participant declined|0|||
161019601|NCT04810650|581459763|FG012|Overall Study|Participant declined|0|||
161019602|NCT04810650|581459764|FG013|Overall Study|Participant declined|0|||
161019603|NCT05794243|581459765|FG000|Overall Study|Withdrawal by Subject|1|||
161019604|NCT05794243|581459766|FG001|Overall Study|Withdrawal by Subject|0|||
161273287|NCT04572893|582379663|FG002|Part B|Adverse Event|0|||
161273288|NCT04572893|582379664|FG003|Part B|Adverse Event|0|||
161019605|NCT05794243|581459767|FG002|Overall Study|Withdrawal by Subject|1|||
161273289|NCT04572893|582379665|FG004|Part B|Adverse Event|1|||
161273290|NCT04572893|582379666|FG005|Part B|Adverse Event|1|||
161019606|NCT05794243|581459765|FG000|Overall Study|Physician Decision|0|||
161019607|NCT05794243|581459766|FG001|Overall Study|Physician Decision|3|||
161019608|NCT05794243|581459767|FG002|Overall Study|Physician Decision|1|||
161019609|NCT02761057|581459771|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
161019610|NCT02761057|581459772|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
161019611|NCT02761057|581459773|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
161019612|NCT02761057|581459774|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
161019613|NCT02761057|581459771|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
161273291|NCT04572893|582379667|FG006|Part B|Adverse Event|0|||
161273292|NCT03276780|582379675|FG000|Overall Study|Withdrawal by Subject|5|||
161273293|NCT03276780|582379676|FG001|Overall Study|Withdrawal by Subject|3|||
161273294|NCT03276780|582379675|FG000|Overall Study|Lost to Follow-up|3|||
161273295|NCT03276780|582379676|FG001|Overall Study|Lost to Follow-up|5|||
161273296|NCT03276780|582379675|FG000|Overall Study|Moved out of state|1|||
161273297|NCT03276780|582379676|FG001|Overall Study|Moved out of state|1|||
161273298|NCT03276780|582379675|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
161019614|NCT02761057|581459772|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
161019615|NCT02761057|581459773|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
161019616|NCT02761057|581459774|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
161019617|NCT02761057|581459771|FG000|Overall Study|Currently On Study Treatment|0|||
161019618|NCT02761057|581459772|FG001|Overall Study|Currently On Study Treatment|3|||
161019619|NCT02761057|581459773|FG002|Overall Study|Currently On Study Treatment|0|||
161019620|NCT02761057|581459774|FG003|Overall Study|Currently On Study Treatment|0|||
161019621|NCT02761057|581459771|FG000|Overall Study|Adverse Event|11|||
161273299|NCT03276780|582379676|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
161273300|NCT03276780|582379675|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
161273301|NCT03276780|582379676|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
161273302|NCT01372774|582379677|FG000|Overall Study|Withdrawal prior to treatment|4|||
161273303|NCT01372774|582379678|FG001|Overall Study|Withdrawal prior to treatment|5|||
161273308|NCT00070499|582380896|FG000|Overall Study|Adverse Event|6|||
161273309|NCT00070499|582380897|FG001|Overall Study|Adverse Event|6|||
161019622|NCT02761057|581459772|FG001|Overall Study|Adverse Event|9|||
161019623|NCT02761057|581459773|FG002|Overall Study|Adverse Event|5|||
161019624|NCT02761057|581459774|FG003|Overall Study|Adverse Event|3|||
161019625|NCT02761057|581459771|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
161019626|NCT02761057|581459772|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
161019627|NCT02761057|581459773|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
161019628|NCT02761057|581459774|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
161019629|NCT02761057|581459771|FG000|Overall Study|Progression/Relapse|29|||
161273310|NCT00070499|582380898|FG002|Overall Study|Adverse Event|19|||
161273311|NCT00070499|582380899|FG003|Overall Study|Adverse Event|15|||
161273312|NCT00070499|582380896|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
161273313|NCT00070499|582380897|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
161273314|NCT00070499|582380898|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
161273315|NCT00070499|582380899|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
161273316|NCT00070499|582380896|FG000|Overall Study|Progression/relapse|4|||
161273317|NCT00070499|582380897|FG001|Overall Study|Progression/relapse|2|||
161273318|NCT00070499|582380898|FG002|Overall Study|Progression/relapse|1|||
161273319|NCT00070499|582380899|FG003|Overall Study|Progression/relapse|4|||
161273320|NCT00070499|582380896|FG000|Overall Study|Death|1|||
161273321|NCT00070499|582380897|FG001|Overall Study|Death|1|||
161273322|NCT00070499|582380898|FG002|Overall Study|Death|1|||
161273323|NCT00070499|582380899|FG003|Overall Study|Death|2|||
161273324|NCT00070499|582380896|FG000|Overall Study|Other - not protocol specified|7|||
161273325|NCT00070499|582380897|FG001|Overall Study|Other - not protocol specified|3|||
161273326|NCT00070499|582380898|FG002|Overall Study|Other - not protocol specified|12|||
161273327|NCT00070499|582380899|FG003|Overall Study|Other - not protocol specified|20|||
161273328|NCT00070499|582380896|FG000|Overall Study|Still on protocol treatment|10|||
161273329|NCT00070499|582380897|FG001|Overall Study|Still on protocol treatment|4|||
161273330|NCT00070499|582380898|FG002|Overall Study|Still on protocol treatment|79|||
161273331|NCT00070499|582380899|FG003|Overall Study|Still on protocol treatment|57|||
161273332|NCT00070499|582380896|FG000|Overall Study|Did not start treatment|1|||
161273333|NCT00070499|582380897|FG001|Overall Study|Did not start treatment|0|||
161273334|NCT00070499|582380898|FG002|Overall Study|Did not start treatment|0|||
161273335|NCT00070499|582380899|FG003|Overall Study|Did not start treatment|2|||
161019630|NCT02761057|581459772|FG001|Overall Study|Progression/Relapse|27|||
161148512|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
161273336|NCT00070499|582380896|FG000|Overall Study|Not eligible|2|||
161273337|NCT00070499|582380897|FG001|Overall Study|Not eligible|5|||
161273338|NCT00070499|582380898|FG002|Overall Study|Not eligible|3|||
161273339|NCT00070499|582380899|FG003|Overall Study|Not eligible|2|||
161273340|NCT00805467|582380900|FG000|Overall Study|Lack of Efficacy|0|||
161273341|NCT00805467|582380901|FG001|Overall Study|Lack of Efficacy|8|||
161273342|NCT00805467|582380902|FG002|Overall Study|Lack of Efficacy|13|||
161273343|NCT00805467|582380903|FG003|Overall Study|Lack of Efficacy|86|||
161273344|NCT00805467|582380900|FG000|Overall Study|Lost to Follow-up|0|||
161273345|NCT00805467|582380901|FG001|Overall Study|Lost to Follow-up|1|||
161273346|NCT00805467|582380902|FG002|Overall Study|Lost to Follow-up|7|||
161273347|NCT00805467|582380903|FG003|Overall Study|Lost to Follow-up|21|||
161019631|NCT02761057|581459773|FG002|Overall Study|Progression/Relapse|20|||
161019632|NCT02761057|581459774|FG003|Overall Study|Progression/Relapse|23|||
161019633|NCT02761057|581459771|FG000|Overall Study|Death|2|||
161019634|NCT02761057|581459772|FG001|Overall Study|Death|2|||
161019635|NCT02761057|581459773|FG002|Overall Study|Death|1|||
161019636|NCT02761057|581459774|FG003|Overall Study|Death|1|||
161019637|NCT02761057|581459771|FG000|Overall Study|Other - Not Protocol Specified|2|||
161019638|NCT02761057|581459772|FG001|Overall Study|Other - Not Protocol Specified|1|||
161019639|NCT02761057|581459773|FG002|Overall Study|Other - Not Protocol Specified|2|||
161019640|NCT02761057|581459774|FG003|Overall Study|Other - Not Protocol Specified|0|||
161019641|NCT05609760|581459781|FG000|Overall Study|Lost to Follow-up|0|||
161019642|NCT05609760|581459782|FG001|Overall Study|Lost to Follow-up|1|||
161019643|NCT05609760|581459781|FG000|Overall Study|Withdrawal by Subject|1|||
161019644|NCT05609760|581459782|FG001|Overall Study|Withdrawal by Subject|0|||
161019645|NCT05179395|581459783|FG000|Overall Study|Lack of Efficacy|1|||
161019646|NCT00812461|581459785|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
161019647|NCT00812461|581459786|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
161019648|NCT00812461|581459785|FG000|All Treated Patients|Adverse Event|8|||
161019649|NCT00812461|581459786|FG001|All Treated Patients|Adverse Event|15|||
161019650|NCT00812461|581459785|FG000|All Treated Patients|Lack of Efficacy|13|||
161019651|NCT00812461|581459786|FG001|All Treated Patients|Lack of Efficacy|7|||
161019652|NCT00812461|581459785|FG000|All Treated Patients|Non-compliance|6|||
161019653|NCT00812461|581459786|FG001|All Treated Patients|Non-compliance|9|||
161019654|NCT00812461|581459785|FG000|All Treated Patients|Protocol Violation|36|||
161019655|NCT00812461|581459786|FG001|All Treated Patients|Protocol Violation|27|||
161019656|NCT00812461|581459785|FG000|All Treated Patients|Withdrawal by Subject|45|||
161019657|NCT00812461|581459786|FG001|All Treated Patients|Withdrawal by Subject|54|||
161019658|NCT00812461|581459785|FG000|All Treated Patients|Lost to Follow-up|11|||
161019659|NCT00812461|581459786|FG001|All Treated Patients|Lost to Follow-up|14|||
161019660|NCT00812461|581459785|FG000|All Treated Patients|Other Reason|13|||
161019661|NCT00812461|581459786|FG001|All Treated Patients|Other Reason|21|||
161019662|NCT05093829|581459788|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019663|NCT05093829|581459789|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019664|NCT05093829|581459790|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
161019665|NCT05093829|581459791|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019666|NCT05093829|581459792|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
161019667|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Physician Decision|1|||
161019668|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Physician Decision|0|||
161019669|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
161019670|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
161019671|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
161019672|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
161019673|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Pregnancy|0|||
161019674|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Pregnancy|2|||
161019675|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
161019676|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
161019677|NCT01785719|581461609|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
161019678|NCT01785719|581461610|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
161019679|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
161019680|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
161019681|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
161019682|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
161019683|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
161019684|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
161019685|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
161019686|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
161019687|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
161019688|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
161019689|NCT01785719|581461609|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
161019690|NCT01785719|581461610|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
161019691|NCT01785719|581461609|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
161019692|NCT01785719|581461610|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
161019693|NCT01785719|581461609|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
161019694|NCT01785719|581461610|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
161019695|NCT01785719|581461609|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
161019696|NCT01785719|581461610|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
161019697|NCT04977947|581461611|FG000|Overall Study|Lost to Follow-up|1|||
161019698|NCT04977947|581461612|FG001|Overall Study|Lost to Follow-up|1|||
161019699|NCT03445988|581461613|FG000|Overall Study|Lost to Follow-up|14|||
161019700|NCT03445988|581461614|FG001|Overall Study|Lost to Follow-up|26|||
161019701|NCT03445988|581461615|FG002|Overall Study|Lost to Follow-up|27|||
161019702|NCT03445988|581461616|FG003|Overall Study|Lost to Follow-up|66|||
161019703|NCT03445988|581461613|FG000|Overall Study|Withdrawal by Subject|7|||
161019704|NCT03445988|581461614|FG001|Overall Study|Withdrawal by Subject|4|||
161019705|NCT03445988|581461615|FG002|Overall Study|Withdrawal by Subject|3|||
161019706|NCT03445988|581461616|FG003|Overall Study|Withdrawal by Subject|5|||
161019707|NCT03445988|581461613|FG000|Overall Study|Death (unrelated to study)|5|||
161019708|NCT03445988|581461614|FG001|Overall Study|Death (unrelated to study)|1|||
161019709|NCT03445988|581461615|FG002|Overall Study|Death (unrelated to study)|2|||
161019710|NCT03445988|581461616|FG003|Overall Study|Death (unrelated to study)|4|||
161019711|NCT05875142|581461617|FG000|Overall Study|Lost to Follow-up|0|||
161019712|NCT05875142|581461618|FG001|Overall Study|Lost to Follow-up|1|||
161019713|NCT05875142|581461619|FG002|Overall Study|Lost to Follow-up|1|||
161019714|NCT02677298|581461630|FG000|Double Blind Phase|Adverse Event|2|||
161019715|NCT02677298|581461631|FG001|Double Blind Phase|Adverse Event|1|||
161019716|NCT02677298|581461632|FG002|Double Blind Phase|Adverse Event|0|||
161019717|NCT02677298|581461630|FG000|Double Blind Phase|Physician Decision|5|||
161019718|NCT02677298|581461631|FG001|Double Blind Phase|Physician Decision|0|||
161019719|NCT02677298|581461632|FG002|Double Blind Phase|Physician Decision|0|||
161019720|NCT02677298|581461630|FG000|Double Blind Phase|Lost to Follow-up|11|||
161019721|NCT02677298|581461631|FG001|Double Blind Phase|Lost to Follow-up|7|||
161019722|NCT02677298|581461632|FG002|Double Blind Phase|Lost to Follow-up|0|||
161019723|NCT02677298|581461630|FG000|Double Blind Phase|Withdrawal by Subject|11|||
161019724|NCT02677298|581461631|FG001|Double Blind Phase|Withdrawal by Subject|8|||
161019725|NCT02677298|581461632|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161019726|NCT02677298|581461630|FG000|Double Blind Phase|No study drug available at site|0|||
161019727|NCT02677298|581461631|FG001|Double Blind Phase|No study drug available at site|1|||
161019728|NCT02677298|581461632|FG002|Double Blind Phase|No study drug available at site|0|||
161019729|NCT02677298|581461630|FG000|Open Label Phase|Adverse Event|0|||
161019730|NCT02677298|581461631|FG001|Open Label Phase|Adverse Event|0|||
161019731|NCT02677298|581461632|FG002|Open Label Phase|Adverse Event|4|||
161019732|NCT02677298|581461630|FG000|Open Label Phase|Physician Decision|0|||
161019733|NCT02677298|581461631|FG001|Open Label Phase|Physician Decision|0|||
161019734|NCT02677298|581461632|FG002|Open Label Phase|Physician Decision|1|||
161019735|NCT02677298|581461630|FG000|Open Label Phase|Lost to Follow-up|0|||
161019736|NCT02677298|581461631|FG001|Open Label Phase|Lost to Follow-up|0|||
161019737|NCT02677298|581461632|FG002|Open Label Phase|Lost to Follow-up|17|||
161019738|NCT02677298|581461630|FG000|Open Label Phase|Withdrawal by Subject|0|||
161019739|NCT02677298|581461631|FG001|Open Label Phase|Withdrawal by Subject|0|||
161019740|NCT02677298|581461632|FG002|Open Label Phase|Withdrawal by Subject|38|||
161019741|NCT03611621|581461633|FG000|Overall Study|Graft loss|3|||
161019742|NCT03611621|581461633|FG000|Overall Study|Death|3|||
161019743|NCT03611621|581461633|FG000|Overall Study|Lost to Follow-up|1|||
161019744|NCT05653427|581461636|FG000|Overall Study|Study Terminated by Sponsor|13|||
161019745|NCT03891667|581461639|FG000|Overall Study|Physician Decision|1|||
161019746|NCT03891667|581461640|FG001|Overall Study|Physician Decision|1|||
161019747|NCT03891667|581461639|FG000|Overall Study|COVID related pause|1|||
161019748|NCT03891667|581461640|FG001|Overall Study|COVID related pause|0|||
161019749|NCT03891667|581461639|FG000|Overall Study|Withdrawal by Subject|0|||
161019750|NCT03891667|581461640|FG001|Overall Study|Withdrawal by Subject|1|||
161019751|NCT03891667|581461639|FG000|Overall Study|Adverse Event|0|||
161019752|NCT03891667|581461640|FG001|Overall Study|Adverse Event|1|||
161019753|NCT05659537|581461641|FG000|Overall Study|Adverse Event|5|||
161019754|NCT05659537|581461641|FG000|Overall Study|Lost to Follow-up|4|||
161019755|NCT05659537|581461641|FG000|Overall Study|Withdrawal by Subject|13|||
161019756|NCT05659537|581461641|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
161019757|NCT05659537|581461641|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
161019758|NCT05659537|581461641|FG000|Overall Study|Participant was suffering from anaemia|1|||
161019759|NCT04971395|581461642|FG000|Overall Study|Withdrawal by Subject|0|||
161019760|NCT04971395|581461643|FG001|Overall Study|Withdrawal by Subject|1|||
161019761|NCT04971395|581461644|FG002|Overall Study|Withdrawal by Subject|0|||
161019762|NCT00506519|581461651|FG000|Overall Study|Death|4|||
161019763|NCT00506519|581461652|FG001|Overall Study|Death|6|||
161019764|NCT00506519|581461653|FG002|Overall Study|Death|0|||
161019765|NCT00506519|581461651|FG000|Overall Study|Adverse Event|1|||
161019766|NCT00506519|581461652|FG001|Overall Study|Adverse Event|0|||
161019767|NCT00506519|581461653|FG002|Overall Study|Adverse Event|0|||
161019768|NCT02975882|581461654|FG000|Overall Study|Adverse Event|1|||
161019769|NCT02975882|581461655|FG001|Overall Study|Adverse Event|2|||
161019770|NCT02975882|581461656|FG002|Overall Study|Adverse Event|1|||
161019771|NCT02975882|581461657|FG003|Overall Study|Adverse Event|1|||
161019772|NCT02975882|581461654|FG000|Overall Study|Death|0|||
161019773|NCT02975882|581461655|FG001|Overall Study|Death|1|||
161019774|NCT02975882|581461656|FG002|Overall Study|Death|0|||
161019775|NCT02975882|581461657|FG003|Overall Study|Death|0|||
161019776|NCT02975882|581461654|FG000|Overall Study|Lack of Efficacy|3|||
161019777|NCT02975882|581461655|FG001|Overall Study|Lack of Efficacy|7|||
161019778|NCT02975882|581461656|FG002|Overall Study|Lack of Efficacy|4|||
161019779|NCT02975882|581461657|FG003|Overall Study|Lack of Efficacy|3|||
161019780|NCT02975882|581461654|FG000|Overall Study|Physician Decision|0|||
161019781|NCT02975882|581461655|FG001|Overall Study|Physician Decision|2|||
161019782|NCT02975882|581461656|FG002|Overall Study|Physician Decision|4|||
161019783|NCT02975882|581461657|FG003|Overall Study|Physician Decision|2|||
161019784|NCT02975882|581461654|FG000|Overall Study|Ineligible|0|||
161019785|NCT02975882|581461655|FG001|Overall Study|Ineligible|1|||
161019786|NCT02975882|581461656|FG002|Overall Study|Ineligible|0|||
161019787|NCT02975882|581461657|FG003|Overall Study|Ineligible|0|||
161019788|NCT05116787|581461658|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
161019789|NCT05116787|581461659|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
161019790|NCT05116787|581461658|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
161019791|NCT05116787|581461659|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
161019792|NCT05116787|581461658|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
161019793|NCT05116787|581461659|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
161019794|NCT05116787|581461658|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
161019795|NCT05116787|581461659|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
161019796|NCT02737436|581461660|FG000|Washout Period|Lost to Follow-up|5|||
161019797|NCT02737436|581461661|FG001|Washout Period|Lost to Follow-up|11|||
161019798|NCT02737436|581461660|FG000|Data Analysis|Scanning data problems|5|||
161019799|NCT02737436|581461661|FG001|Data Analysis|Scanning data problems|8|||
161019800|NCT02919683|581461662|FG000|Post-Surgery Follow-Up|Death|2|||
161019801|NCT02919683|581461663|FG001|Post-Surgery Follow-Up|Death|2|||
161019802|NCT02919683|581461662|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
161019803|NCT02919683|581461663|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
161019804|NCT01160211|581461665|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
161019805|NCT01160211|581461666|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
161019806|NCT01160211|581461667|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
161019807|NCT01160211|581461665|FG000|Overall Study|Lost to Follow-up|4|||
161019808|NCT01160211|581461666|FG001|Overall Study|Lost to Follow-up|8|||
161019809|NCT01160211|581461667|FG002|Overall Study|Lost to Follow-up|4|||
161019810|NCT01160211|581461665|FG000|Overall Study|Physician Decision|1|||
161019811|NCT01160211|581461666|FG001|Overall Study|Physician Decision|0|||
161019812|NCT01160211|581461667|FG002|Overall Study|Physician Decision|0|||
161019813|NCT01160211|581461665|FG000|Overall Study|Withdrawal by Subject|4|||
161019814|NCT01160211|581461666|FG001|Overall Study|Withdrawal by Subject|2|||
161019815|NCT01160211|581461667|FG002|Overall Study|Withdrawal by Subject|2|||
161019816|NCT01160211|581461665|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
161019817|NCT01160211|581461666|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
161019818|NCT01160211|581461667|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
161019819|NCT02734290|581461668|FG000|Overall Study|Adverse Event|1|||
161019820|NCT02734290|581461669|FG001|Overall Study|Adverse Event|0|||
161019821|NCT02734290|581461668|FG000|Overall Study|Death|1|||
161019822|NCT02734290|581461669|FG001|Overall Study|Death|0|||
161019823|NCT03829410|581461671|FG000|Overall Study|Adverse Event|1|||
161019824|NCT03829410|581461672|FG001|Overall Study|Adverse Event|0|||
161019825|NCT03829410|581461673|FG002|Overall Study|Adverse Event|1|||
161019826|NCT03829410|581461674|FG003|Overall Study|Adverse Event|4|||
161019827|NCT03829410|581461671|FG000|Overall Study|Physician Decision|0|||
161019828|NCT03829410|581461672|FG001|Overall Study|Physician Decision|0|||
161019829|NCT03829410|581461673|FG002|Overall Study|Physician Decision|0|||
161019830|NCT03829410|581461674|FG003|Overall Study|Physician Decision|2|||
161019831|NCT03829410|581461671|FG000|Overall Study|Disease Progressing|3|||
161019832|NCT03829410|581461672|FG001|Overall Study|Disease Progressing|4|||
161019833|NCT03829410|581461673|FG002|Overall Study|Disease Progressing|2|||
161019834|NCT03829410|581461674|FG003|Overall Study|Disease Progressing|31|||
161019835|NCT03829410|581461671|FG000|Overall Study|Miscellaneous|2|||
161019836|NCT03829410|581461672|FG001|Overall Study|Miscellaneous|4|||
161019837|NCT03829410|581461673|FG002|Overall Study|Miscellaneous|3|||
161019838|NCT03829410|581461674|FG003|Overall Study|Miscellaneous|10|||
161019839|NCT03158129|581461675|FG000|Overall Study|Adverse Event|0|||
161019840|NCT03158129|581461676|FG001|Overall Study|Adverse Event|1|||
161019841|NCT03158129|581461677|FG002|Overall Study|Adverse Event|0|||
161019842|NCT03158129|581461678|FG003|Overall Study|Adverse Event|0|||
161019843|NCT03158129|581461675|FG000|Overall Study|Death|0|||
161019844|NCT03158129|581461676|FG001|Overall Study|Death|0|||
161019845|NCT03158129|581461677|FG002|Overall Study|Death|0|||
161019846|NCT03158129|581461678|FG003|Overall Study|Death|1|||
161019847|NCT03158129|581461675|FG000|Overall Study|High surgical risk|1|||
161019848|NCT03158129|581461676|FG001|Overall Study|High surgical risk|1|||
161019849|NCT03158129|581461677|FG002|Overall Study|High surgical risk|0|||
161019850|NCT03158129|581461678|FG003|Overall Study|High surgical risk|0|||
161019851|NCT03158129|581461675|FG000|Overall Study|Progression|1|||
161019852|NCT03158129|581461676|FG001|Overall Study|Progression|1|||
161019853|NCT03158129|581461677|FG002|Overall Study|Progression|0|||
161019854|NCT03158129|581461678|FG003|Overall Study|Progression|0|||
161019855|NCT03158129|581461675|FG000|Overall Study|Lack of resectability|0|||
161019856|NCT03158129|581461676|FG001|Overall Study|Lack of resectability|1|||
161019857|NCT03158129|581461677|FG002|Overall Study|Lack of resectability|0|||
161019858|NCT03158129|581461678|FG003|Overall Study|Lack of resectability|0|||
161019859|NCT03158129|581461675|FG000|Overall Study|Declined surgery|0|||
161019860|NCT03158129|581461676|FG001|Overall Study|Declined surgery|1|||
161019861|NCT03158129|581461677|FG002|Overall Study|Declined surgery|0|||
161019862|NCT03158129|581461678|FG003|Overall Study|Declined surgery|0|||
161019863|NCT03158129|581461675|FG000|Overall Study|No longer surgical candidate|0|||
161019864|NCT03158129|581461676|FG001|Overall Study|No longer surgical candidate|0|||
161019865|NCT03158129|581461677|FG002|Overall Study|No longer surgical candidate|0|||
161019866|NCT03158129|581461678|FG003|Overall Study|No longer surgical candidate|1|||
161019867|NCT02105766|581461683|FG000|Overall Study|Physician Decision|1|||
161019868|NCT02105766|581461684|FG001|Overall Study|Physician Decision|1|||
161019869|NCT02105766|581461685|FG002|Overall Study|Physician Decision|0|||
161019870|NCT02105766|581461683|FG000|Overall Study|Lost to Follow-up|2|||
161019871|NCT02105766|581461684|FG001|Overall Study|Lost to Follow-up|0|||
161019872|NCT02105766|581461685|FG002|Overall Study|Lost to Follow-up|0|||
161019873|NCT02105766|581461683|FG000|Overall Study|Death|1|||
161019874|NCT02105766|581461684|FG001|Overall Study|Death|1|||
161019875|NCT02105766|581461685|FG002|Overall Study|Death|0|||
161019876|NCT06205407|581461686|FG000|Period 2|Withdrawal by Subject|0|||
161019877|NCT06205407|581461687|FG001|Period 2|Withdrawal by Subject|1|||
161019878|NCT06205407|581461686|FG000|Period 2|Adverse Event|2|||
161019879|NCT06205407|581461687|FG001|Period 2|Adverse Event|1|||
161019880|NCT06491433|581461688|FG000|Overall Study|Protocol Violation|51|||
161019881|NCT06491433|581461688|FG000|Overall Study|consent withdrawal|2|||
161019882|NCT06491433|581461688|FG000|Overall Study|screen failure|1|||
161019883|NCT04676022|581461692|FG000|Overall Study|Screen Failure/|1|||
161019884|NCT04676022|581461693|FG001|Overall Study|Screen Failure/|1|||
161019885|NCT04676022|581461694|FG002|Overall Study|Screen Failure/|85|||
161019886|NCT04676022|581461692|FG000|Overall Study|Lost to Follow-up|1|||
161019887|NCT04676022|581461693|FG001|Overall Study|Lost to Follow-up|1|||
161019888|NCT04676022|581461694|FG002|Overall Study|Lost to Follow-up|0|||
161019889|NCT04676022|581461692|FG000|Overall Study|Adverse Event|2|||
161019890|NCT04676022|581461693|FG001|Overall Study|Adverse Event|0|||
161019891|NCT04676022|581461694|FG002|Overall Study|Adverse Event|1|||
161019892|NCT04676022|581461692|FG000|Overall Study|Physician Decision|2|||
161019893|NCT04676022|581461693|FG001|Overall Study|Physician Decision|0|||
161019894|NCT04676022|581461694|FG002|Overall Study|Physician Decision|1|||
161019895|NCT04676022|581461692|FG000|Overall Study|Withdrawal by Subject|3|||
161019896|NCT04676022|581461693|FG001|Overall Study|Withdrawal by Subject|1|||
161019897|NCT04676022|581461694|FG002|Overall Study|Withdrawal by Subject|6|||
161019898|NCT04676022|581461692|FG000|Overall Study|Will not move forward with permanent implant|6|||
161019899|NCT04676022|581461693|FG001|Overall Study|Will not move forward with permanent implant|0|||
161019900|NCT04676022|581461694|FG002|Overall Study|Will not move forward with permanent implant|0|||
161019901|NCT04676022|581461692|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
161019902|NCT04676022|581461693|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
161019903|NCT04676022|581461694|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
161019904|NCT05409183|581461709|FG000|Complete Study|Adverse Event|1|||
161019905|NCT05409183|581461710|FG001|Complete Study|Adverse Event|2|||
161019906|NCT05409183|581461709|FG000|Complete Study|Withdrawal by Subject|3|||
161019907|NCT05409183|581461710|FG001|Complete Study|Withdrawal by Subject|0|||
161019908|NCT02274662|581461711|FG000|Overall Study|Death|1|||
161019909|NCT02274662|581461711|FG000|Overall Study|Lost to Follow-up|3|||
161019910|NCT04806451|581461712|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
161019911|NCT04806451|581461713|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
161019912|NCT04806451|581461712|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
161019913|NCT04806451|581461713|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
161019914|NCT04806451|581461712|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
161019915|NCT04806451|581461713|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
161019916|NCT02936752|581461714|FG000|Overall Study|Death|2|||
161019917|NCT02936752|581461715|FG001|Overall Study|Death|1|||
161019918|NCT02936752|581461714|FG000|Overall Study|Physician Decision|4|||
161019919|NCT02936752|581461715|FG001|Overall Study|Physician Decision|0|||
161019920|NCT02936752|581461714|FG000|Overall Study|Withdrawal by Subject|0|||
161019921|NCT02936752|581461715|FG001|Overall Study|Withdrawal by Subject|2|||
161019922|NCT05292365|581461720|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
161019923|NCT05292365|581461721|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
161019924|NCT05292365|581461722|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
161019925|NCT05292365|581461723|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
161019926|NCT05282173|581461724|FG000|Overall Study|Missed|3|||
161019927|NCT05282173|581461725|FG001|Overall Study|Missed|2|||
161019928|NCT05282173|581461726|FG002|Overall Study|Missed|4|||
161019929|NCT03134196|581461731|FG000|Overall Study|Death|2|||
161019930|NCT03134196|581461732|FG001|Overall Study|Death|1|||
161019931|NCT03134196|581461731|FG000|Overall Study|Lost to Follow-up|13|||
161019932|NCT03134196|581461732|FG001|Overall Study|Lost to Follow-up|15|||
161019933|NCT03134196|581461731|FG000|Overall Study|Physician Decision|0|||
161019934|NCT03134196|581461732|FG001|Overall Study|Physician Decision|1|||
161019935|NCT03134196|581461731|FG000|Overall Study|Withdrawal by Subject|19|||
161019936|NCT03134196|581461732|FG001|Overall Study|Withdrawal by Subject|12|||
161019937|NCT03134196|581461731|FG000|Overall Study|Site Unable to Contact Participant|2|||
161019938|NCT03134196|581461732|FG001|Overall Study|Site Unable to Contact Participant|0|||
161019939|NCT03134196|581461731|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
161019940|NCT03134196|581461732|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
161019941|NCT03134196|581461731|FG000|Overall Study|Scheduling Conflict|1|||
161019942|NCT03134196|581461732|FG001|Overall Study|Scheduling Conflict|0|||
161019943|NCT01798498|581461745|FG000|Overall Study|Lost to Follow-up|1|||
161019944|NCT04592549|581461750|FG000|Overall Study|Withdrawal by Subject|0|||
161019945|NCT04592549|581461751|FG001|Overall Study|Withdrawal by Subject|1|||
161019946|NCT04592549|581461752|FG002|Overall Study|Withdrawal by Subject|0|||
161019947|NCT04592549|581461753|FG003|Overall Study|Withdrawal by Subject|1|||
161019948|NCT04592549|581461754|FG004|Overall Study|Withdrawal by Subject|1|||
161019949|NCT04592549|581461755|FG005|Overall Study|Withdrawal by Subject|0|||
161019950|NCT04592549|581461750|FG000|Overall Study|Lost to Follow-up|2|||
161019951|NCT04592549|581461751|FG001|Overall Study|Lost to Follow-up|0|||
161019952|NCT04592549|581461752|FG002|Overall Study|Lost to Follow-up|0|||
161019953|NCT04592549|581461753|FG003|Overall Study|Lost to Follow-up|1|||
161019954|NCT04592549|581461754|FG004|Overall Study|Lost to Follow-up|1|||
161019955|NCT04592549|581461755|FG005|Overall Study|Lost to Follow-up|1|||
161019956|NCT04295798|581461758|FG000|Overall Study|Lost to Follow-up|1|||
161019957|NCT04625283|581461762|FG000|Overall Study|post randomization exclusion|28|||
161019958|NCT04625283|581461763|FG001|Overall Study|post randomization exclusion|20|||
161019959|NCT04137289|581461766|FG000|Overall Study|Death|0|||
161019960|NCT04137289|581461767|FG001|Overall Study|Death|0|||
161019961|NCT04137289|581461768|FG002|Overall Study|Death|0|||
161019962|NCT04137289|581461769|FG003|Overall Study|Death|0|||
161019963|NCT04137289|581461770|FG004|Overall Study|Death|0|||
161019964|NCT04137289|581461771|FG005|Overall Study|Death|0|||
161019965|NCT04137289|581461772|FG006|Overall Study|Death|1|||
161019966|NCT04137289|581461773|FG007|Overall Study|Death|0|||
161019967|NCT04137289|581461774|FG008|Overall Study|Death|0|||
161019968|NCT04137289|581461766|FG000|Overall Study|Clinical disease progression|0|||
161019969|NCT04137289|581461767|FG001|Overall Study|Clinical disease progression|0|||
161019970|NCT04137289|581461768|FG002|Overall Study|Clinical disease progression|0|||
161019971|NCT04137289|581461769|FG003|Overall Study|Clinical disease progression|4|||
161019972|NCT04137289|581461770|FG004|Overall Study|Clinical disease progression|4|||
161019973|NCT04137289|581461771|FG005|Overall Study|Clinical disease progression|2|||
161019974|NCT04137289|581461772|FG006|Overall Study|Clinical disease progression|5|||
161019975|NCT04137289|581461773|FG007|Overall Study|Clinical disease progression|1|||
161019976|NCT04137289|581461774|FG008|Overall Study|Clinical disease progression|0|||
161019977|NCT04137289|581461766|FG000|Overall Study|Lost to Follow-up|0|||
161019978|NCT04137289|581461767|FG001|Overall Study|Lost to Follow-up|0|||
161019979|NCT04137289|581461768|FG002|Overall Study|Lost to Follow-up|0|||
161019980|NCT04137289|581461769|FG003|Overall Study|Lost to Follow-up|1|||
161019981|NCT04137289|581461770|FG004|Overall Study|Lost to Follow-up|0|||
161019982|NCT04137289|581461771|FG005|Overall Study|Lost to Follow-up|0|||
161019983|NCT04137289|581461772|FG006|Overall Study|Lost to Follow-up|0|||
161019984|NCT04137289|581461773|FG007|Overall Study|Lost to Follow-up|0|||
161019985|NCT04137289|581461774|FG008|Overall Study|Lost to Follow-up|0|||
161019986|NCT04137289|581461766|FG000|Overall Study|Adverse Event|0|||
161019987|NCT04137289|581461767|FG001|Overall Study|Adverse Event|0|||
161019988|NCT04137289|581461768|FG002|Overall Study|Adverse Event|1|||
161019989|NCT04137289|581461769|FG003|Overall Study|Adverse Event|0|||
161019990|NCT04137289|581461770|FG004|Overall Study|Adverse Event|0|||
161273348|NCT00805467|582380900|FG000|Overall Study|Withdrawal by Subject|0|||
161273349|NCT00805467|582380901|FG001|Overall Study|Withdrawal by Subject|6|||
161273350|NCT00805467|582380902|FG002|Overall Study|Withdrawal by Subject|45|||
161273351|NCT00805467|582380903|FG003|Overall Study|Withdrawal by Subject|50|||
161273352|NCT00805467|582380900|FG000|Overall Study|Protocol Violation|0|||
161019991|NCT04137289|581461771|FG005|Overall Study|Adverse Event|1|||
161019992|NCT04137289|581461772|FG006|Overall Study|Adverse Event|0|||
161019993|NCT04137289|581461773|FG007|Overall Study|Adverse Event|0|||
161019994|NCT04137289|581461774|FG008|Overall Study|Adverse Event|0|||
161019995|NCT04137289|581461766|FG000|Overall Study|Lack of clinical benefit|0|||
161019996|NCT04137289|581461767|FG001|Overall Study|Lack of clinical benefit|0|||
161019997|NCT04137289|581461768|FG002|Overall Study|Lack of clinical benefit|0|||
161019998|NCT04137289|581461769|FG003|Overall Study|Lack of clinical benefit|0|||
161019999|NCT04137289|581461770|FG004|Overall Study|Lack of clinical benefit|0|||
161020000|NCT04137289|581461771|FG005|Overall Study|Lack of clinical benefit|0|||
161020001|NCT04137289|581461772|FG006|Overall Study|Lack of clinical benefit|0|||
161020002|NCT04137289|581461773|FG007|Overall Study|Lack of clinical benefit|0|||
161020003|NCT04137289|581461774|FG008|Overall Study|Lack of clinical benefit|1|||
161273353|NCT00805467|582380901|FG001|Overall Study|Protocol Violation|3|||
161020004|NCT04137289|581461766|FG000|Overall Study|Objective disease progression|1|||
161020005|NCT04137289|581461767|FG001|Overall Study|Objective disease progression|1|||
161020006|NCT04137289|581461768|FG002|Overall Study|Objective disease progression|6|||
161020007|NCT04137289|581461769|FG003|Overall Study|Objective disease progression|18|||
161020008|NCT04137289|581461770|FG004|Overall Study|Objective disease progression|12|||
161020009|NCT04137289|581461771|FG005|Overall Study|Objective disease progression|20|||
161020010|NCT04137289|581461772|FG006|Overall Study|Objective disease progression|18|||
161020011|NCT04137289|581461773|FG007|Overall Study|Objective disease progression|7|||
161020012|NCT04137289|581461774|FG008|Overall Study|Objective disease progression|6|||
161020013|NCT03396588|581461775|FG000|Overall Study|Physician Decision|2|||
161020014|NCT03396588|581461776|FG001|Overall Study|Physician Decision|3|||
161020015|NCT02727699|581463376|FG000|Overall Study|Adverse Event|2|||
161020016|NCT02727699|581463377|FG001|Overall Study|Adverse Event|0|||
161020017|NCT02727699|581463376|FG000|Overall Study|Withdrawal by Subject|5|||
161020018|NCT02727699|581463377|FG001|Overall Study|Withdrawal by Subject|3|||
161020019|NCT02727699|581463376|FG000|Overall Study|Protocol Violation|0|||
161020020|NCT02727699|581463377|FG001|Overall Study|Protocol Violation|1|||
161020021|NCT02727699|581463376|FG000|Overall Study|Physician Decision|0|||
161020022|NCT02727699|581463377|FG001|Overall Study|Physician Decision|1|||
161020023|NCT02727699|581463376|FG000|Overall Study|Lost to Follow-up|1|||
161020024|NCT02727699|581463377|FG001|Overall Study|Lost to Follow-up|0|||
161020025|NCT02727699|581463376|FG000|Overall Study|Sponsor Decision|1|||
161020026|NCT02727699|581463377|FG001|Overall Study|Sponsor Decision|0|||
161020027|NCT04318548|581463386|FG000|Overall Study|Adverse Event|0|||
161020028|NCT04318548|581463387|FG001|Overall Study|Adverse Event|0|||
161020029|NCT04318548|581463388|FG002|Overall Study|Adverse Event|1|||
161020030|NCT04318548|581463386|FG000|Overall Study|Lost to Follow-up|6|||
161020031|NCT04318548|581463387|FG001|Overall Study|Lost to Follow-up|13|||
161020032|NCT04318548|581463388|FG002|Overall Study|Lost to Follow-up|9|||
161020033|NCT04318548|581463386|FG000|Overall Study|Protocol Violation|1|||
161020034|NCT04318548|581463387|FG001|Overall Study|Protocol Violation|0|||
161020035|NCT04318548|581463388|FG002|Overall Study|Protocol Violation|2|||
161020036|NCT04318548|581463386|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
161020037|NCT04318548|581463387|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
161020038|NCT04318548|581463388|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
161020039|NCT04318548|581463386|FG000|Overall Study|Migrated / moved from the study area|0|||
161020040|NCT04318548|581463387|FG001|Overall Study|Migrated / moved from the study area|0|||
161020041|NCT04318548|581463388|FG002|Overall Study|Migrated / moved from the study area|1|||
161020042|NCT04318548|581463386|FG000|Overall Study|Other|1|||
161020043|NCT04318548|581463387|FG001|Overall Study|Other|2|||
161020044|NCT04318548|581463388|FG002|Overall Study|Other|3|||
161020045|NCT03366649|581463389|FG000|Overall Study|Failed preoperative screening|4|||
161020046|NCT03366649|581463390|FG001|Overall Study|Failed preoperative screening|0|||
161020047|NCT03366649|581463391|FG002|Overall Study|Failed preoperative screening|0|||
161020048|NCT03366649|581463389|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
161020049|NCT03366649|581463390|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
161020050|NCT03366649|581463391|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
161020051|NCT04029688|581463401|FG000|Overall Study|Death|8|||
161020052|NCT04029688|581463402|FG001|Overall Study|Death|3|||
161020053|NCT04029688|581463403|FG002|Overall Study|Death|6|||
161020054|NCT04029688|581463404|FG003|Overall Study|Death|2|||
161020055|NCT04029688|581463405|FG004|Overall Study|Death|5|||
161020056|NCT04029688|581463406|FG005|Overall Study|Death|0|||
161020057|NCT04029688|581463407|FG006|Overall Study|Death|2|||
161020058|NCT04029688|581463408|FG007|Overall Study|Death|3|||
161020059|NCT04029688|581463401|FG000|Overall Study|Study Terminated by Sponsor|0|||
161020060|NCT04029688|581463402|FG001|Overall Study|Study Terminated by Sponsor|0|||
161020061|NCT04029688|581463403|FG002|Overall Study|Study Terminated by Sponsor|0|||
161020062|NCT04029688|581463404|FG003|Overall Study|Study Terminated by Sponsor|0|||
161020063|NCT04029688|581463405|FG004|Overall Study|Study Terminated by Sponsor|1|||
161020064|NCT04029688|581463406|FG005|Overall Study|Study Terminated by Sponsor|3|||
161020065|NCT04029688|581463407|FG006|Overall Study|Study Terminated by Sponsor|1|||
161020066|NCT04029688|581463408|FG007|Overall Study|Study Terminated by Sponsor|3|||
161020067|NCT04029688|581463401|FG000|Overall Study|Withdrawal by Subject|0|||
161020068|NCT04029688|581463402|FG001|Overall Study|Withdrawal by Subject|0|||
161020069|NCT04029688|581463403|FG002|Overall Study|Withdrawal by Subject|0|||
161020070|NCT04029688|581463404|FG003|Overall Study|Withdrawal by Subject|1|||
161020071|NCT04029688|581463405|FG004|Overall Study|Withdrawal by Subject|0|||
161020072|NCT04029688|581463406|FG005|Overall Study|Withdrawal by Subject|0|||
161020073|NCT04029688|581463407|FG006|Overall Study|Withdrawal by Subject|0|||
161020074|NCT04029688|581463408|FG007|Overall Study|Withdrawal by Subject|0|||
161020075|NCT03436290|581463409|FG000|Overall Study|Post-randomization Exclusion|1|||
161020076|NCT03436290|581463410|FG001|Overall Study|Post-randomization Exclusion|0|||
161020077|NCT03436290|581463409|FG000|Overall Study|Death|6|||
161020078|NCT03436290|581463410|FG001|Overall Study|Death|0|||
160969296|NCT01576718|581275202|FG006|Treatment Period|Adverse Event|0|||
160969297|NCT01576718|581275196|FG000|Treatment Period|Withdrawal by Subject|0|||
160969298|NCT01576718|581275197|FG001|Treatment Period|Withdrawal by Subject|1|||
160969299|NCT01576718|581275198|FG002|Treatment Period|Withdrawal by Subject|1|||
160969300|NCT01576718|581275199|FG003|Treatment Period|Withdrawal by Subject|0|||
160969301|NCT01576718|581275200|FG004|Treatment Period|Withdrawal by Subject|2|||
160969302|NCT01576718|581275201|FG005|Treatment Period|Withdrawal by Subject|4|||
160969303|NCT01576718|581275202|FG006|Treatment Period|Withdrawal by Subject|2|||
160969304|NCT01576718|581275196|FG000|Treatment Period|Physician Decision|0|||
160969305|NCT01576718|581275197|FG001|Treatment Period|Physician Decision|1|||
160969306|NCT01576718|581275198|FG002|Treatment Period|Physician Decision|1|||
160969307|NCT01576718|581275199|FG003|Treatment Period|Physician Decision|1|||
160969308|NCT01576718|581275200|FG004|Treatment Period|Physician Decision|1|||
160969309|NCT01576718|581275201|FG005|Treatment Period|Physician Decision|0|||
160969310|NCT01576718|581275202|FG006|Treatment Period|Physician Decision|0|||
160969311|NCT01576718|581275196|FG000|Treatment Period|Protocol Violation|0|||
160969312|NCT01576718|581275197|FG001|Treatment Period|Protocol Violation|5|||
160969313|NCT01576718|581275198|FG002|Treatment Period|Protocol Violation|4|||
160969314|NCT01576718|581275199|FG003|Treatment Period|Protocol Violation|10|||
160969315|NCT01576718|581275200|FG004|Treatment Period|Protocol Violation|6|||
160969316|NCT01576718|581275201|FG005|Treatment Period|Protocol Violation|8|||
160969317|NCT01576718|581275202|FG006|Treatment Period|Protocol Violation|12|||
160969318|NCT01576718|581275196|FG000|Treatment Period|Sponsor request|0|||
160969319|NCT01576718|581275197|FG001|Treatment Period|Sponsor request|1|||
160969320|NCT01576718|581275198|FG002|Treatment Period|Sponsor request|0|||
160969321|NCT01576718|581275199|FG003|Treatment Period|Sponsor request|0|||
160969322|NCT01576718|581275200|FG004|Treatment Period|Sponsor request|0|||
160969323|NCT01576718|581275201|FG005|Treatment Period|Sponsor request|1|||
160969324|NCT01576718|581275202|FG006|Treatment Period|Sponsor request|0|||
160969325|NCT01576718|581275196|FG000|Treatment Period|Met stopping criteria|0|||
160969326|NCT01576718|581275197|FG001|Treatment Period|Met stopping criteria|16|||
160969327|NCT01576718|581275198|FG002|Treatment Period|Met stopping criteria|13|||
160969328|NCT01576718|581275199|FG003|Treatment Period|Met stopping criteria|19|||
160969329|NCT01576718|581275200|FG004|Treatment Period|Met stopping criteria|16|||
160969330|NCT01576718|581275201|FG005|Treatment Period|Met stopping criteria|33|||
160969331|NCT01576718|581275202|FG006|Treatment Period|Met stopping criteria|15|||
160969332|NCT01576718|581275196|FG000|Treatment Period|Lost to Follow-up|0|||
160969333|NCT01576718|581275197|FG001|Treatment Period|Lost to Follow-up|0|||
160969334|NCT01576718|581275198|FG002|Treatment Period|Lost to Follow-up|0|||
160969335|NCT01576718|581275199|FG003|Treatment Period|Lost to Follow-up|0|||
160969336|NCT01576718|581275200|FG004|Treatment Period|Lost to Follow-up|1|||
160969337|NCT01576718|581275201|FG005|Treatment Period|Lost to Follow-up|0|||
160969338|NCT01576718|581275202|FG006|Treatment Period|Lost to Follow-up|0|||
160969339|NCT01576718|581275196|FG000|Treatment Period|Noncompliance to study medication|0|||
160969340|NCT01576718|581275197|FG001|Treatment Period|Noncompliance to study medication|0|||
160969341|NCT01576718|581275198|FG002|Treatment Period|Noncompliance to study medication|0|||
160969342|NCT01576718|581275199|FG003|Treatment Period|Noncompliance to study medication|0|||
160969343|NCT01576718|581275200|FG004|Treatment Period|Noncompliance to study medication|0|||
160969344|NCT01576718|581275201|FG005|Treatment Period|Noncompliance to study medication|1|||
160969345|NCT01576718|581275202|FG006|Treatment Period|Noncompliance to study medication|1|||
160969346|NCT02070484|581275203|FG000|Overall Study|Withdrawal by Subject|1|||
160969347|NCT02070484|581275204|FG001|Overall Study|Withdrawal by Subject|0|||
160969348|NCT02821819|581275209|FG000|Overall Study|Protocol Violation|1|||
160969349|NCT01669798|581275210|FG000|Overall Study|Physician Decision|5|||
160969350|NCT02272725|581275218|FG000|Overall Study|equipment malfunction|2|||
160969351|NCT02272725|581275219|FG001|Overall Study|equipment malfunction|0|||
160969352|NCT02764775|581276761|FG000|Overall Study|Death|1|||
160969353|NCT02764775|581276761|FG000|Overall Study|Lost to Follow-up|2|||
160969354|NCT02764775|581276761|FG000|Overall Study|Withdrawal by Subject|3|||
160969355|NCT05056870|581276762|FG000|Period 1|Site COVID-19 Related|3|||
160969356|NCT05056870|581276763|FG001|Period 1|Site COVID-19 Related|3|||
160969357|NCT05056870|581276762|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
160969358|NCT05056870|581276763|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
160969359|NCT05056870|581276762|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
160969360|NCT05056870|581276763|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
160969361|NCT05056870|581276762|FG000|Period 2|COVID-19 Related|1|||
160969362|NCT05056870|581276763|FG001|Period 2|COVID-19 Related|0|||
160969363|NCT05056870|581276762|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
160969364|NCT05056870|581276763|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
160969365|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Adverse Event|0|||
160969366|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Adverse Event|0|||
160969367|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Adverse Event|0|||
160969368|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Adverse Event|0|||
160969369|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Adverse Event|0|||
161020079|NCT03436290|581463409|FG000|Overall Study|Withdrawal by Subject|4|||
161020080|NCT03436290|581463410|FG001|Overall Study|Withdrawal by Subject|0|||
161020081|NCT03436290|581463409|FG000|Overall Study|Protocol Violation|30|||
161020082|NCT03436290|581463410|FG001|Overall Study|Protocol Violation|0|||
161020083|NCT03812679|581463432|FG000|Overall Study|Adverse Event|2|||
161020084|NCT03812679|581463432|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
161020085|NCT03812679|581463432|FG000|Overall Study|Renal transplant|1|||
161020086|NCT03812679|581463432|FG000|Overall Study|Withdrawal by Subject|1|||
161020087|NCT03812679|581463432|FG000|Overall Study|Termination of study|2|||
161020088|NCT03812679|581463432|FG000|Overall Study|Water device replacement|1|||
161020089|NCT02140554|581463444|FG000|Overall Study|Withdrawal of consent|1|||
161020090|NCT02140554|581463445|FG001|Overall Study|Withdrawal of consent|0|||
161020091|NCT02140554|581463446|FG002|Overall Study|Withdrawal of consent|4|||
161020092|NCT02140554|581463444|FG000|Overall Study|Physician Decision|1|||
161020093|NCT02140554|581463445|FG001|Overall Study|Physician Decision|0|||
161020094|NCT02140554|581463446|FG002|Overall Study|Physician Decision|2|||
161020095|NCT02140554|581463444|FG000|Overall Study|Death|0|||
161020096|NCT02140554|581463445|FG001|Overall Study|Death|0|||
161020097|NCT02140554|581463446|FG002|Overall Study|Death|1|||
161020098|NCT02140554|581463444|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
161020099|NCT02140554|581463445|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
161020100|NCT02140554|581463446|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
161020101|NCT03953508|581463448|FG000|Baseline|Lost to Follow-up|3|||
161020102|NCT03953508|581463449|FG001|Baseline|Lost to Follow-up|2|||
161020103|NCT03953508|581463448|FG000|6-month Follow-up|Lost to Follow-up|62|||
161020104|NCT03953508|581463449|FG001|6-month Follow-up|Lost to Follow-up|70|||
161020105|NCT03771417|581463450|FG000|Overall Study|Withdrawal by Subject|1|||
161020106|NCT03771417|581463451|FG001|Overall Study|Withdrawal by Subject|0|||
161020107|NCT03771417|581463452|FG002|Overall Study|Withdrawal by Subject|0|||
161020108|NCT03771417|581463450|FG000|Overall Study|Covid-19 Shutdown|0|||
161020109|NCT03771417|581463451|FG001|Overall Study|Covid-19 Shutdown|1|||
161020110|NCT03771417|581463452|FG002|Overall Study|Covid-19 Shutdown|0|||
161020111|NCT04456517|581463453|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
161020112|NCT04456517|581463454|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
161020113|NCT02100813|581463455|FG000|Overall Study|Adverse Event|0|||
161020114|NCT02100813|581463456|FG001|Overall Study|Adverse Event|0|||
161148513|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
161148514|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
161148515|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
161148516|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
161148517|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
161148518|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
161148519|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
161148520|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
161273354|NCT00805467|582380902|FG002|Overall Study|Protocol Violation|0|||
161273355|NCT00805467|582380903|FG003|Overall Study|Protocol Violation|5|||
161273356|NCT00805467|582380900|FG000|Overall Study|Adverse Event|0|||
161273357|NCT00805467|582380901|FG001|Overall Study|Adverse Event|13|||
161273358|NCT00805467|582380902|FG002|Overall Study|Adverse Event|26|||
161273359|NCT00805467|582380903|FG003|Overall Study|Adverse Event|57|||
161273360|NCT00805467|582380900|FG000|Overall Study|Death|0|||
161273361|NCT00805467|582380901|FG001|Overall Study|Death|2|||
161273362|NCT00805467|582380902|FG002|Overall Study|Death|7|||
161273363|NCT00805467|582380903|FG003|Overall Study|Death|5|||
161273364|NCT00805467|582380900|FG000|Overall Study|Physician Decision|0|||
161273365|NCT00805467|582380901|FG001|Overall Study|Physician Decision|1|||
161020115|NCT02100813|581463457|FG002|Overall Study|Adverse Event|0|||
161020116|NCT02100813|581463458|FG003|Overall Study|Adverse Event|0|||
161020117|NCT02100813|581463459|FG004|Overall Study|Adverse Event|0|||
161020118|NCT02100813|581463460|FG005|Overall Study|Adverse Event|0|||
161020119|NCT02100813|581463461|FG006|Overall Study|Adverse Event|0|||
161020120|NCT02100813|581463462|FG007|Overall Study|Adverse Event|1|||
161020121|NCT01186367|581463463|FG000|Overall Study|Lost to Follow-up|7|||
161020122|NCT01186367|581463464|FG001|Overall Study|Lost to Follow-up|4|||
161148521|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
161273366|NCT00805467|582380902|FG002|Overall Study|Physician Decision|2|||
161273367|NCT00805467|582380903|FG003|Overall Study|Physician Decision|6|||
161273368|NCT00805467|582380900|FG000|Overall Study|Not reported|0|||
161273369|NCT00805467|582380901|FG001|Overall Study|Not reported|0|||
161273370|NCT00805467|582380902|FG002|Overall Study|Not reported|3|||
161020123|NCT01186367|581463465|FG002|Overall Study|Lost to Follow-up|7|||
161020124|NCT01186367|581463463|FG000|Overall Study|Did not receive study treatment|0|||
161020125|NCT01186367|581463464|FG001|Overall Study|Did not receive study treatment|1|||
161020126|NCT01186367|581463465|FG002|Overall Study|Did not receive study treatment|0|||
161020127|NCT03867500|581463467|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
161020128|NCT04749615|581463468|FG000|Overall Study|Lost to Follow-up|6|||
161020129|NCT04749615|581463469|FG001|Overall Study|Lost to Follow-up|10|||
161020130|NCT03611491|581463470|FG000|Overall Study|Lost to Follow-up|1|||
161020131|NCT05894577|581463471|FG000|Overall Study|No receipt of study drug|14|||
161020132|NCT05894577|581463472|FG001|Overall Study|No receipt of study drug|13|||
161020133|NCT05894577|581463471|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
161020134|NCT05894577|581463472|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
161020135|NCT05894577|581463471|FG000|Overall Study|Screen Fail|2|||
161020136|NCT05894577|581463472|FG001|Overall Study|Screen Fail|0|||
161020137|NCT05894577|581463471|FG000|Overall Study|Study drug recall|86|||
161020138|NCT05894577|581463472|FG001|Overall Study|Study drug recall|63|||
161020139|NCT04064164|581463475|FG000|Overall Study|Withdrawal by Subject|8|||
161020140|NCT04064164|581463476|FG001|Overall Study|Withdrawal by Subject|8|||
161020141|NCT04650269|581463484|FG000|Overall Study|Death|3|||
161020142|NCT04650269|581463484|FG000|Overall Study|Lost to Follow-up|6|||
161020143|NCT04091750|581463485|FG000|Overall Study|Adverse Event|4|||
161020144|NCT04091750|581463485|FG000|Overall Study|Withdrawal by Subject|1|||
161020145|NCT02619838|581463486|FG000|Overall Study|Lost to Follow-up|9|||
161020146|NCT02619838|581463486|FG000|Overall Study|Withdrawal by Subject|15|||
161020147|NCT05020249|581463487|FG000|Overall Study|Protocol Violation|1|||
161020148|NCT05020249|581463488|FG001|Overall Study|Protocol Violation|0|||
161020149|NCT04971681|581463499|FG000|Followup|Lost to Follow-up|1|||
161020150|NCT04971681|581463500|FG001|Followup|Lost to Follow-up|0|||
161020151|NCT00686335|581463501|FG000|Run-in Period|Adverse Event|1|||
161020152|NCT00686335|581463501|FG000|Run-in Period|asthma exacerbation|1|||
161020153|NCT00686335|581463501|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
161020154|NCT04376502|581463502|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
161020155|NCT05603143|581463503|FG000|Overall Study|Withdrew consent|6|||
161020156|NCT05603143|581463504|FG001|Overall Study|Withdrew consent|2|||
161020157|NCT05603143|581463503|FG000|Overall Study|Randomized but never treated|0|||
161020158|NCT05603143|581463504|FG001|Overall Study|Randomized but never treated|3|||
161020159|NCT05603143|581463503|FG000|Overall Study|Adverse Event|2|||
161020160|NCT05603143|581463504|FG001|Overall Study|Adverse Event|0|||
161020161|NCT05603143|581463503|FG000|Overall Study|Death|0|||
161020162|NCT05603143|581463504|FG001|Overall Study|Death|1|||
161020163|NCT05603143|581463503|FG000|Overall Study|Investigator's discretion|1|||
161020164|NCT05603143|581463504|FG001|Overall Study|Investigator's discretion|0|||
161020165|NCT05603143|581463503|FG000|Overall Study|Lost to Follow-up|0|||
161020166|NCT05603143|581463504|FG001|Overall Study|Lost to Follow-up|1|||
161020167|NCT05603143|581463503|FG000|Overall Study|Protocol Violation|0|||
161020168|NCT05603143|581463504|FG001|Overall Study|Protocol Violation|1|||
161020169|NCT04171999|581463505|FG000|Overall Study|deemed ineligible after randomization|2|||
160969370|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Adverse Event|1|||
160969371|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Adverse Event|0|||
160969372|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Adverse Event|1|||
160969373|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Adverse Event|0|||
160969374|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Adverse Event|0|||
160969375|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969376|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969377|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969378|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
160969379|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
160969380|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
160969381|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969382|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969383|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969384|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
160969385|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Physician Decision|0|||
160969386|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Physician Decision|0|||
160969387|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Physician Decision|0|||
160969388|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Physician Decision|0|||
160969389|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Physician Decision|0|||
160969390|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Physician Decision|0|||
160969391|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Physician Decision|1|||
160969392|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Physician Decision|0|||
160969393|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Physician Decision|0|||
160969394|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Physician Decision|0|||
160969395|NCT05044325|581276766|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969396|NCT05044325|581276767|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969397|NCT05044325|581276768|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
160969398|NCT05044325|581276769|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969399|NCT05044325|581276770|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969400|NCT05044325|581276771|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969401|NCT05044325|581276772|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
161020170|NCT04171999|581463506|FG001|Overall Study|deemed ineligible after randomization|1|||
161148522|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
161148523|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
161148524|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
161148525|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
161148526|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
161148527|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
161148528|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
161148529|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
161148530|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
161273371|NCT00805467|582380903|FG003|Overall Study|Not reported|7|||
160969402|NCT05044325|581276773|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969403|NCT05044325|581276774|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969404|NCT05044325|581276775|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
160969405|NCT05044325|581276766|FG000|Part A:Treatment Period 2|Adverse Event|0|||
160969406|NCT05044325|581276767|FG001|Part A:Treatment Period 2|Adverse Event|1|||
160969407|NCT05044325|581276768|FG002|Part A:Treatment Period 2|Adverse Event|0|||
160969408|NCT05044325|581276769|FG003|Part A:Treatment Period 2|Adverse Event|0|||
160969409|NCT05044325|581276770|FG004|Part A:Treatment Period 2|Adverse Event|1|||
160969410|NCT05044325|581276771|FG005|Part A:Treatment Period 2|Adverse Event|1|||
160969411|NCT05044325|581276772|FG006|Part A:Treatment Period 2|Adverse Event|0|||
160969412|NCT05044325|581276773|FG007|Part A:Treatment Period 2|Adverse Event|0|||
160969413|NCT05044325|581276774|FG008|Part A:Treatment Period 2|Adverse Event|0|||
160969414|NCT05044325|581276775|FG009|Part A:Treatment Period 2|Adverse Event|0|||
160969415|NCT05044325|581276766|FG000|Part A:Treatment Period 2|Physician Decision|0|||
160969416|NCT05044325|581276767|FG001|Part A:Treatment Period 2|Physician Decision|0|||
160969417|NCT05044325|581276768|FG002|Part A:Treatment Period 2|Physician Decision|0|||
160969418|NCT05044325|581276769|FG003|Part A:Treatment Period 2|Physician Decision|0|||
160969419|NCT05044325|581276770|FG004|Part A:Treatment Period 2|Physician Decision|0|||
160969420|NCT05044325|581276771|FG005|Part A:Treatment Period 2|Physician Decision|1|||
160969421|NCT05044325|581276772|FG006|Part A:Treatment Period 2|Physician Decision|0|||
160969422|NCT05044325|581276773|FG007|Part A:Treatment Period 2|Physician Decision|0|||
160969423|NCT05044325|581276774|FG008|Part A:Treatment Period 2|Physician Decision|0|||
160969424|NCT05044325|581276775|FG009|Part A:Treatment Period 2|Physician Decision|0|||
160969425|NCT05044325|581276766|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969426|NCT05044325|581276767|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969427|NCT05044325|581276768|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969428|NCT05044325|581276769|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
160969429|NCT05044325|581276770|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
160969430|NCT05044325|581276771|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969431|NCT05044325|581276772|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969432|NCT05044325|581276773|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969433|NCT05044325|581276774|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969434|NCT05044325|581276775|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
160969435|NCT01373931|581276778|FG000|Lead-in Period|Adverse Event|2|||
160969436|NCT01373931|581276779|FG001|Lead-in Period|Adverse Event|0|||
160969437|NCT01373931|581276778|FG000|Period 1|Adverse Event|2|||
160969438|NCT01373931|581276779|FG001|Period 1|Adverse Event|0|||
160969439|NCT01373931|581276778|FG000|Period 1|Withdrawal by Subject|0|||
160969440|NCT01373931|581276779|FG001|Period 1|Withdrawal by Subject|2|||
160969441|NCT00674323|581276780|FG000|Overall Study|Adverse Event|0|||
160969442|NCT00674323|581276781|FG001|Overall Study|Adverse Event|1|||
160969443|NCT00674323|581276782|FG002|Overall Study|Adverse Event|0|||
160969444|NCT00674323|581276780|FG000|Overall Study|Protocol Violation|1|||
160969445|NCT00674323|581276781|FG001|Overall Study|Protocol Violation|0|||
160969446|NCT00674323|581276782|FG002|Overall Study|Protocol Violation|0|||
160969447|NCT00742079|581276783|FG000|Overall Study|Lost to Follow-up|0|||
160969448|NCT00742079|581276784|FG001|Overall Study|Lost to Follow-up|1|||
160969449|NCT01114204|581276793|FG000|Overall Study|Adverse Event|3|||
160969450|NCT01114204|581276794|FG001|Overall Study|Adverse Event|2|||
160969451|NCT01114204|581276793|FG000|Overall Study|Lost to Follow-up|1|||
160969452|NCT01114204|581276794|FG001|Overall Study|Lost to Follow-up|0|||
160969453|NCT01114204|581276793|FG000|Overall Study|Withdrawal by Subject|10|||
160969454|NCT01114204|581276794|FG001|Overall Study|Withdrawal by Subject|6|||
160969455|NCT01114204|581276793|FG000|Overall Study|Death|1|||
160969456|NCT01114204|581276794|FG001|Overall Study|Death|0|||
160969457|NCT01114204|581276793|FG000|Overall Study|Other-Personal reasons|2|||
160969458|NCT01114204|581276794|FG001|Overall Study|Other-Personal reasons|0|||
160969459|NCT01114204|581276793|FG000|Overall Study|Other-Medical monitor request|1|||
160969460|NCT01114204|581276794|FG001|Overall Study|Other-Medical monitor request|0|||
160969461|NCT01114204|581276793|FG000|Overall Study|Other-Participant request|2|||
160969462|NCT01114204|581276794|FG001|Overall Study|Other-Participant request|0|||
160969463|NCT01114204|581276793|FG000|Overall Study|Other-Protocol Violation|1|||
160969464|NCT01114204|581276794|FG001|Overall Study|Other-Protocol Violation|0|||
161148531|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
161148532|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
161343581|NCT03034967|582644415|FG003|Overall Study|Protocol Violation|0|||
161343582|NCT03034967|582644416|FG004|Overall Study|Protocol Violation|0|||
160969465|NCT00991341|581276799|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
160969466|NCT00991341|581276800|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
160969467|NCT00991341|581276799|FG000|Overall Study|Death|3|||
160969468|NCT00991341|581276800|FG001|Overall Study|Death|0|||
160969469|NCT00991341|581276799|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
160969470|NCT00991341|581276800|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
160969471|NCT00991341|581276799|FG000|Overall Study|Physician Decision|1|||
160969472|NCT00991341|581276800|FG001|Overall Study|Physician Decision|2|||
160969473|NCT00991341|581276799|FG000|Overall Study|Withdrawal by Subject|3|||
160969474|NCT00991341|581276800|FG001|Overall Study|Withdrawal by Subject|4|||
160969475|NCT02207725|581276812|FG000|Overall Study|Did Not Receive Treatment|0|||
160969476|NCT02207725|581276813|FG001|Overall Study|Did Not Receive Treatment|1|||
160969477|NCT02207725|581276814|FG002|Overall Study|Did Not Receive Treatment|1|||
160969478|NCT02207725|581276815|FG003|Overall Study|Did Not Receive Treatment|1|||
160969479|NCT02799472|581276818|FG000|Overall Study|Withdrawal by Subject|2|||
160969480|NCT02799472|581276819|FG001|Overall Study|Withdrawal by Subject|4|||
160969481|NCT02799472|581276818|FG000|Overall Study|Lack of Efficacy|2|||
160969482|NCT02799472|581276819|FG001|Overall Study|Lack of Efficacy|0|||
160969483|NCT02799472|581276818|FG000|Overall Study|Lost to Follow-up|0|||
160969484|NCT02799472|581276819|FG001|Overall Study|Lost to Follow-up|1|||
160969485|NCT04461795|581276820|FG000|Overall Study|Lost to Follow-up|2|||
160969486|NCT04461795|581276820|FG000|Overall Study|Withdrawal by Subject|2|||
160969487|NCT04461795|581276820|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
160969488|NCT00058422|581276822|FG000|Overall Study|Not treated|2|||
160969489|NCT00185640|581276823|FG000|Overall Study|Not Eligible|4|||
160969490|NCT00185640|581276823|FG000|Overall Study|Withdrawal by Subject|3|||
160969491|NCT00185640|581276823|FG000|Overall Study|Death|138|||
160969492|NCT01982435|581276826|FG000|Overall Study|Adverse Event|1|||
160969493|NCT01982435|581276827|FG001|Overall Study|Adverse Event|0|||
160969494|NCT03954743|581276828|FG000|Overall Study|Adverse Event|1|||
160969495|NCT03954743|581276829|FG001|Overall Study|Adverse Event|0|||
160969496|NCT03954743|581276828|FG000|Overall Study|Lost to Follow-up|6|||
160969497|NCT03954743|581276829|FG001|Overall Study|Lost to Follow-up|4|||
160969498|NCT03954743|581276828|FG000|Overall Study|Protocol Violation|1|||
160969499|NCT03954743|581276829|FG001|Overall Study|Protocol Violation|0|||
160969500|NCT03954743|581276828|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
160969501|NCT03954743|581276829|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
160969502|NCT03954743|581276828|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
160969503|NCT03954743|581276829|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
160969504|NCT03541044|581276830|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
160969505|NCT03541044|581276831|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
160969506|NCT03541044|581276830|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
160969507|NCT03541044|581276831|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
160969508|NCT01153269|581276832|FG000|Overall Study|Withdrawal by Subject|1|||
160969509|NCT01153269|581276832|FG000|Overall Study|Antiretroviral therapy break|1|||
160969510|NCT00860067|581276843|FG000|Overall Study|Lost to Follow-up|46|||
160969511|NCT00860067|581276844|FG001|Overall Study|Lost to Follow-up|9|||
160969512|NCT00860067|581276845|FG002|Overall Study|Lost to Follow-up|9|||
160969513|NCT00860067|581276843|FG000|Overall Study|Withdrawal by Subject|4|||
160969514|NCT00860067|581276844|FG001|Overall Study|Withdrawal by Subject|0|||
160969515|NCT00860067|581276845|FG002|Overall Study|Withdrawal by Subject|0|||
160969516|NCT00860067|581276843|FG000|Overall Study|Pregnancy|1|||
160969517|NCT00860067|581276844|FG001|Overall Study|Pregnancy|0|||
160969518|NCT00860067|581276845|FG002|Overall Study|Pregnancy|0|||
160969519|NCT02387996|581276846|FG000|Overall Study|Disease Progression|167|||
160969520|NCT02387996|581276846|FG000|Overall Study|Study Drug Toxicity|31|||
160969521|NCT02387996|581276846|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
160969522|NCT02387996|581276846|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
160969523|NCT02387996|581276846|FG000|Overall Study|Subject Withdrew Consent|5|||
160969524|NCT02387996|581276846|FG000|Overall Study|Lost to Follow-up|1|||
160969525|NCT02387996|581276846|FG000|Overall Study|Poor/Non-Compliance|1|||
160969526|NCT02387996|581276846|FG000|Overall Study|Other Reasons|5|||
160969527|NCT02387996|581276846|FG000|Overall Study|Death|1|||
160969528|NCT00770432|581276847|FG000|Overall Study|Other|4|||
160969529|NCT00770432|581276848|FG001|Overall Study|Other|6|||
160969530|NCT00770432|581276847|FG000|Overall Study|Non-compliance|0|||
160969531|NCT00770432|581276848|FG001|Overall Study|Non-compliance|1|||
160969532|NCT00312702|581276849|FG000|Immunization Phase|Lost to Follow-up|0|||
160969533|NCT00312702|581276850|FG001|Immunization Phase|Lost to Follow-up|1|||
160969534|NCT00312702|581276851|FG002|Immunization Phase|Lost to Follow-up|0|||
160969535|NCT03592277|581276853|FG000|Overall Study|Withdrawal by Subject|6|||
160969536|NCT03592277|581276854|FG001|Overall Study|Withdrawal by Subject|8|||
160969537|NCT03787680|581276864|FG000|Overall Study|Physician Decision|2|||
161020171|NCT04505904|581463507|FG000|Overall Study|Withdrawal by Subject|1|||
161020172|NCT04505904|581463508|FG001|Overall Study|Withdrawal by Subject|2|||
161020173|NCT04505904|581463509|FG002|Overall Study|Withdrawal by Subject|0|||
161020174|NCT04505904|581463510|FG003|Overall Study|Withdrawal by Subject|0|||
161020175|NCT04505904|581463507|FG000|Overall Study|Physician Decision|1|||
161020176|NCT04505904|581463508|FG001|Overall Study|Physician Decision|0|||
161020177|NCT04505904|581463509|FG002|Overall Study|Physician Decision|0|||
161020178|NCT04505904|581463510|FG003|Overall Study|Physician Decision|0|||
161020179|NCT04505904|581463507|FG000|Overall Study|Adverse Event|0|||
161020180|NCT04505904|581463508|FG001|Overall Study|Adverse Event|1|||
161020181|NCT04505904|581463509|FG002|Overall Study|Adverse Event|0|||
161020182|NCT04505904|581463510|FG003|Overall Study|Adverse Event|0|||
161020183|NCT04277442|581463513|FG000|Overall Study|Death|1|||
161020184|NCT03092518|581463514|FG000|Overall Study|Ineligible|2|||
161020185|NCT01824537|581463515|FG000|Overall Study|Lost to Follow-up|78|||
161020186|NCT01824537|581463516|FG001|Overall Study|Lost to Follow-up|87|||
161020187|NCT02547987|581463517|FG000|Overall Study|Withdrawal by Subject|1|||
161020188|NCT02547987|581463517|FG000|Overall Study|Adverse Event|2|||
161020189|NCT04938492|581463529|FG000|Overall Study|Lost to Follow-up|17|||
161020190|NCT04938492|581463530|FG001|Overall Study|Lost to Follow-up|18|||
161020191|NCT03865498|581463531|FG000|Overall Study|Lack of Efficacy|12|||
161020192|NCT03865498|581463532|FG001|Overall Study|Lack of Efficacy|11|||
161020193|NCT03865498|581463531|FG000|Overall Study|Lost to Follow-up|125|||
161020194|NCT03865498|581463532|FG001|Overall Study|Lost to Follow-up|133|||
161020195|NCT03865498|581463531|FG000|Overall Study|Withdrawal by Subject|2|||
161020196|NCT03865498|581463532|FG001|Overall Study|Withdrawal by Subject|4|||
161020197|NCT01648023|581463533|FG000|Overall Study|Screen Fail Post Randomization|1|||
161020198|NCT01648023|581463534|FG001|Overall Study|Screen Fail Post Randomization|2|||
161020199|NCT05084508|581463535|FG000|Overall Study|Lost to Follow-up|6|||
161020200|NCT05084508|581463536|FG001|Overall Study|Lost to Follow-up|3|||
161020201|NCT05084508|581463537|FG002|Overall Study|Lost to Follow-up|7|||
161020202|NCT05084508|581463538|FG003|Overall Study|Lost to Follow-up|3|||
161020203|NCT05084508|581463535|FG000|Overall Study|Withdrawal by Subject|0|||
161020204|NCT05084508|581463536|FG001|Overall Study|Withdrawal by Subject|2|||
161020205|NCT05084508|581463537|FG002|Overall Study|Withdrawal by Subject|3|||
161020206|NCT05084508|581463538|FG003|Overall Study|Withdrawal by Subject|1|||
161020207|NCT05084508|581463535|FG000|Overall Study|Other|0|||
161020208|NCT05084508|581463536|FG001|Overall Study|Other|0|||
161020209|NCT05084508|581463537|FG002|Overall Study|Other|0|||
161020210|NCT05084508|581463538|FG003|Overall Study|Other|1|||
161020211|NCT05296525|581463539|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161020212|NCT05296525|581463540|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161020213|NCT05296525|581463541|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
161020214|NCT05296525|581463542|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
161020215|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161020216|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161020217|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
161020218|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
161148533|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
161148534|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
161148535|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
161148536|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
161148537|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
161148538|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
161148539|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
161148540|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
161148541|NCT01855789|581924607|FG000|2) Week 24 up to End of Study|Other|0|||
161148542|NCT01855789|581924608|FG001|2) Week 24 up to End of Study|Other|0|||
161148543|NCT01855789|581924609|FG002|2) Week 24 up to End of Study|Other|0|||
161148544|NCT01855789|581924610|FG003|2) Week 24 up to End of Study|Other|1|||
161148545|NCT01863758|581924611|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
161343583|NCT03034967|582644417|FG005|Overall Study|Protocol Violation|2|||
161020219|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161020220|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161020221|NCT02547363|581463549|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
161020222|NCT02547363|581463550|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
161020223|NCT02547363|581463549|FG000|12-month Follow-up|Withdrawal by Subject|4|||
161020224|NCT02547363|581463550|FG001|12-month Follow-up|Withdrawal by Subject|3|||
161020225|NCT02547363|581463549|FG000|12-month Follow-up|Lost to Follow-up|4|||
161020226|NCT02547363|581463550|FG001|12-month Follow-up|Lost to Follow-up|1|||
161020227|NCT02547363|581463549|FG000|12-month Follow-up|Lack of Efficacy|1|||
161020228|NCT02547363|581463550|FG001|12-month Follow-up|Lack of Efficacy|1|||
161020229|NCT02547363|581463549|FG000|12-month Follow-up|Other|1|||
161020230|NCT02547363|581463550|FG001|12-month Follow-up|Other|0|||
161020231|NCT03931174|581463551|FG000|Providers|Staff left organization|26|||
161020232|NCT03931174|581463552|FG001|Providers|Staff left organization|25|||
161020233|NCT03931174|581463551|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
161020234|NCT03931174|581463552|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
161020235|NCT03931174|581463551|FG000|Providers|Lost to Follow-up|4|||
161020236|NCT03931174|581463552|FG001|Providers|Lost to Follow-up|4|||
161020237|NCT03931174|581463551|FG000|Patients|Post-consent screening failure|1|||
161020238|NCT03931174|581463552|FG001|Patients|Post-consent screening failure|1|||
161020239|NCT03931174|581463551|FG000|Patients|Death|1|||
161020240|NCT03931174|581463552|FG001|Patients|Death|1|||
161020241|NCT03931174|581463551|FG000|Patients|Lost to Follow-up|60|||
161020242|NCT03931174|581463552|FG001|Patients|Lost to Follow-up|89|||
161020243|NCT05386030|581463553|FG000|Overall Study|Death|1|||
161020244|NCT05386030|581463554|FG001|Overall Study|Death|0|||
161020245|NCT05386030|581463553|FG000|Overall Study|Physician Decision|2|||
161020246|NCT05386030|581463554|FG001|Overall Study|Physician Decision|1|||
161020247|NCT05386030|581463553|FG000|Overall Study|Lost to Follow-up|19|||
161020248|NCT05386030|581463554|FG001|Overall Study|Lost to Follow-up|7|||
161020249|NCT05386030|581463553|FG000|Overall Study|Withdrawal by Subject|20|||
161020250|NCT05386030|581463554|FG001|Overall Study|Withdrawal by Subject|10|||
161020251|NCT05386030|581463553|FG000|Overall Study|Eligibility criteria violation|1|||
161020252|NCT05386030|581463554|FG001|Overall Study|Eligibility criteria violation|1|||
161020253|NCT05386030|581463553|FG000|Overall Study|Personal Reasons|1|||
161020254|NCT05386030|581463554|FG001|Overall Study|Personal Reasons|0|||
161020255|NCT03213691|581463555|FG000|Overall Study|Adverse Event|2|||
161020256|NCT03213691|581463555|FG000|Overall Study|Death|3|||
161020257|NCT03213691|581463555|FG000|Overall Study|Physician Decision|1|||
161020258|NCT03213691|581463555|FG000|Overall Study|Progressive Disease|14|||
161020259|NCT03213691|581463555|FG000|Overall Study|Ineligible|1|||
161020260|NCT03161028|581463558|FG000|Overall Study|Withdrawal by Subject|6|||
161020261|NCT03161028|581463559|FG001|Overall Study|Withdrawal by Subject|4|||
161020262|NCT03161028|581463558|FG000|Overall Study|Adverse Event|5|||
161020263|NCT03161028|581463559|FG001|Overall Study|Adverse Event|1|||
161020264|NCT03161028|581463558|FG000|Overall Study|Study drug side effects|2|||
161020265|NCT03161028|581463559|FG001|Overall Study|Study drug side effects|2|||
161020266|NCT03161028|581463558|FG000|Overall Study|Administrative PD/UP|4|||
161020267|NCT03161028|581463559|FG001|Overall Study|Administrative PD/UP|2|||
161020268|NCT03161028|581463558|FG000|Overall Study|Lost to Follow-up|2|||
161020269|NCT03161028|581463559|FG001|Overall Study|Lost to Follow-up|0|||
161020270|NCT03161028|581463558|FG000|Overall Study|Unable to comply with procedures|1|||
161020271|NCT03161028|581463559|FG001|Overall Study|Unable to comply with procedures|1|||
161020272|NCT00736723|581463560|FG000|Overall Study|Withdrawal by Subject|4|||
161020273|NCT00736723|581463561|FG001|Overall Study|Withdrawal by Subject|3|||
161020274|NCT03492216|581463562|FG000|Overall Study|Death|1|||
161020275|NCT03492216|581463563|FG001|Overall Study|Death|0|||
161020276|NCT03492216|581463564|FG002|Overall Study|Death|4|||
161020277|NCT03492216|581463565|FG003|Overall Study|Death|0|||
161020278|NCT03492216|581463562|FG000|Overall Study|Withdrawal by Subject|5|||
161020279|NCT03492216|581463563|FG001|Overall Study|Withdrawal by Subject|3|||
161020280|NCT03492216|581463564|FG002|Overall Study|Withdrawal by Subject|1|||
161020281|NCT03492216|581463565|FG003|Overall Study|Withdrawal by Subject|1|||
161020282|NCT03492216|581463562|FG000|Overall Study|Lost to Follow-up|9|||
161020283|NCT03492216|581463563|FG001|Overall Study|Lost to Follow-up|2|||
161020284|NCT03492216|581463564|FG002|Overall Study|Lost to Follow-up|7|||
161020285|NCT03492216|581463565|FG003|Overall Study|Lost to Follow-up|8|||
161020286|NCT03492216|581463562|FG000|Overall Study|Moved|5|||
161020287|NCT03492216|581463563|FG001|Overall Study|Moved|3|||
161020288|NCT03492216|581463564|FG002|Overall Study|Moved|3|||
161020289|NCT03492216|581463565|FG003|Overall Study|Moved|5|||
161020290|NCT03492216|581463562|FG000|Overall Study|Too ill|0|||
161020291|NCT03492216|581463563|FG001|Overall Study|Too ill|1|||
161020292|NCT03492216|581463564|FG002|Overall Study|Too ill|0|||
161020293|NCT03492216|581463565|FG003|Overall Study|Too ill|0|||
161148546|NCT01863758|581924611|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
161020294|NCT03492216|581463562|FG000|Overall Study|Incarcerated|0|||
161020295|NCT03492216|581463563|FG001|Overall Study|Incarcerated|0|||
161020296|NCT03492216|581463564|FG002|Overall Study|Incarcerated|2|||
161020297|NCT03492216|581463565|FG003|Overall Study|Incarcerated|0|||
161020298|NCT05351554|581463566|FG000|Overall Study|Study terminated by sponsor|1|||
161020299|NCT05030233|581463567|FG000|Overall Study|withdrawn for transfer|1|||
161020300|NCT05030233|581463568|FG001|Overall Study|withdrawn for transfer|0|||
161020301|NCT04256941|581465536|FG000|Overall Study|Withdrawal by Subject|0|||
161020302|NCT04256941|581465537|FG001|Overall Study|Withdrawal by Subject|1|||
161020303|NCT04256941|581465536|FG000|Overall Study|Death|1|||
161020304|NCT04256941|581465537|FG001|Overall Study|Death|0|||
161148547|NCT02369510|581924612|FG000|Overall Study|Spilled Medication|1|||
161020305|NCT04256941|581465536|FG000|Overall Study|Disease Progession|0|||
161020306|NCT04256941|581465537|FG001|Overall Study|Disease Progession|2|||
161020307|NCT04185298|581465543|FG000|Overall Study|Lost to Follow-up|1|||
161020308|NCT04185298|581465544|FG001|Overall Study|Lost to Follow-up|3|||
161020309|NCT04185298|581465543|FG000|Overall Study|Withdrawal by Subject|0|||
161273372|NCT04240392|582380905|FG000|Overall Study|Withdrawal by Subject|13|||
161273373|NCT04240392|582380906|FG001|Overall Study|Withdrawal by Subject|4|||
161273374|NCT04240392|582380905|FG000|Overall Study|Lost to Follow-up|11|||
161273375|NCT04240392|582380906|FG001|Overall Study|Lost to Follow-up|12|||
161273376|NCT04345601|582380919|FG000|Overall Study|Death|0|||
161273377|NCT04345601|582380920|FG001|Overall Study|Death|3|||
161273378|NCT04345601|582380921|FG002|Overall Study|Death|2|||
161273379|NCT04345601|582380919|FG000|Overall Study|Lost to Follow-up|0|||
161148548|NCT02369510|581924613|FG001|Overall Study|Spilled Medication|2|||
161148549|NCT02369510|581924614|FG002|Overall Study|Spilled Medication|1|||
161148550|NCT02369510|581924612|FG000|Overall Study|Epidural Activation|1|||
161148551|NCT02369510|581924613|FG001|Overall Study|Epidural Activation|1|||
161148552|NCT02369510|581924614|FG002|Overall Study|Epidural Activation|5|||
161148553|NCT02658656|581924617|FG000|Screening|Failed eligibility criteria|0|||
161148554|NCT02658656|581924618|FG001|Screening|Failed eligibility criteria|0|||
161273380|NCT04345601|582380920|FG001|Overall Study|Lost to Follow-up|0|||
161273381|NCT04345601|582380921|FG002|Overall Study|Lost to Follow-up|2|||
160969538|NCT03787680|581276865|FG001|Overall Study|Physician Decision|3|||
160969539|NCT03787680|581276864|FG000|Overall Study|Adverse Event|7|||
160969540|NCT03787680|581276865|FG001|Overall Study|Adverse Event|3|||
160969541|NCT03787680|581276864|FG000|Overall Study|Withdrawal by Subject|2|||
160969542|NCT03787680|581276865|FG001|Overall Study|Withdrawal by Subject|1|||
160969543|NCT05454410|581276868|FG000|Overall Study|Withdrawal by Subject|0|||
160969544|NCT05454410|581276869|FG001|Overall Study|Withdrawal by Subject|0|||
160969545|NCT05454410|581276870|FG002|Overall Study|Withdrawal by Subject|1|||
160969546|NCT05454410|581276871|FG003|Overall Study|Withdrawal by Subject|1|||
160969547|NCT00895622|581276872|FG000|Overall Study|Protocol Violation|5|||
160969548|NCT00895622|581276873|FG001|Overall Study|Protocol Violation|4|||
160969549|NCT00895622|581276874|FG002|Overall Study|Protocol Violation|4|||
160969550|NCT00532155|581276882|FG000|Overall Study|Adverse Event|66|||
160969551|NCT00532155|581276883|FG001|Overall Study|Adverse Event|123|||
160969552|NCT00532155|581276882|FG000|Overall Study|Lack of Efficacy|332|||
160969553|NCT00532155|581276883|FG001|Overall Study|Lack of Efficacy|255|||
160969554|NCT00532155|581276882|FG000|Overall Study|Protocol Violation|1|||
160969555|NCT00532155|581276883|FG001|Overall Study|Protocol Violation|3|||
160969556|NCT00532155|581276882|FG000|Overall Study|Lost to Follow-up|2|||
160969557|NCT00532155|581276883|FG001|Overall Study|Lost to Follow-up|0|||
160969558|NCT00532155|581276882|FG000|Overall Study|Physician Decision|16|||
160969559|NCT00532155|581276883|FG001|Overall Study|Physician Decision|15|||
160969560|NCT00532155|581276882|FG000|Overall Study|Withdrawal by Subject|23|||
160969561|NCT00532155|581276883|FG001|Overall Study|Withdrawal by Subject|44|||
160969562|NCT00532155|581276882|FG000|Overall Study|Consent withdrawn|5|||
160969563|NCT00532155|581276883|FG001|Overall Study|Consent withdrawn|7|||
160969564|NCT00532155|581276882|FG000|Overall Study|Moved|1|||
160969565|NCT00532155|581276883|FG001|Overall Study|Moved|0|||
160969566|NCT00532155|581276882|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
160969567|NCT00532155|581276883|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
160969568|NCT00532155|581276882|FG000|Overall Study|Occurence of a second cancer|0|||
160969569|NCT00532155|581276883|FG001|Overall Study|Occurence of a second cancer|1|||
160969570|NCT00532155|581276882|FG000|Overall Study|Occurence of a secondary cancer|0|||
160969571|NCT00532155|581276883|FG001|Overall Study|Occurence of a secondary cancer|1|||
160969572|NCT00532155|581276882|FG000|Overall Study|Promotor ended study|1|||
160969573|NCT00532155|581276883|FG001|Overall Study|Promotor ended study|0|||
160969574|NCT00532155|581276882|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
160969575|NCT00532155|581276883|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
160969576|NCT00532155|581276882|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
160969577|NCT00532155|581276883|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
160969578|NCT00532155|581276882|FG000|Overall Study|Study stopped|1|||
160969579|NCT00532155|581276883|FG001|Overall Study|Study stopped|0|||
160969580|NCT00532155|581276882|FG000|Overall Study|Study terminated by sponsor|1|||
160969581|NCT00532155|581276883|FG001|Overall Study|Study terminated by sponsor|0|||
160969582|NCT00532155|581276882|FG000|Overall Study|Study termination stop further treatment|4|||
160969583|NCT00532155|581276883|FG001|Overall Study|Study termination stop further treatment|0|||
160969584|NCT00532155|581276882|FG000|Overall Study|Did not receive study medication|2|||
160969585|NCT00532155|581276883|FG001|Overall Study|Did not receive study medication|6|||
160969586|NCT03483038|581276884|FG000|Overall Study|Subjects still in follow-up|18|||
160969587|NCT03635489|581276885|FG000|Overall Study|Death|19|||
160969588|NCT03635489|581276886|FG001|Overall Study|Death|13|||
160969589|NCT03635489|581276885|FG000|Overall Study|Lost to Follow-up|1|||
160969590|NCT03635489|581276886|FG001|Overall Study|Lost to Follow-up|2|||
160969591|NCT03635489|581276885|FG000|Overall Study|Withdrawal by Subject|1|||
160969592|NCT03635489|581276886|FG001|Overall Study|Withdrawal by Subject|2|||
160969593|NCT03635489|581276885|FG000|Overall Study|Study Ended by Sponsor|28|||
160969594|NCT03635489|581276886|FG001|Overall Study|Study Ended by Sponsor|34|||
160969595|NCT01368900|581276887|FG000|Overall Study|Lost to Follow-up|7|||
160969596|NCT04027348|581276892|FG000|Overall Study|Adverse Event|2|||
161273382|NCT02152605|582380927|FG000|Overall Study|Adverse Event|6|||
161020310|NCT04185298|581465544|FG001|Overall Study|Withdrawal by Subject|3|||
161020311|NCT03896789|581465545|FG000|Baseline|Lost to Follow-up|1|||
161020312|NCT03896789|581465546|FG001|Baseline|Lost to Follow-up|2|||
161020313|NCT03896789|581465545|FG000|Baseline|Death|3|||
161020314|NCT03896789|581465546|FG001|Baseline|Death|6|||
161020315|NCT03896789|581465545|FG000|Post-Randomization|Lost to Follow-up|12|||
161020316|NCT03896789|581465546|FG001|Post-Randomization|Lost to Follow-up|11|||
161020317|NCT03896789|581465545|FG000|Post-Randomization|Death|12|||
161020318|NCT03896789|581465546|FG001|Post-Randomization|Death|13|||
161020319|NCT01606215|581465547|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
161020320|NCT01606215|581465548|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
161020321|NCT03524118|581465550|FG000|Overall Study|Lost to Follow-up|0|||
161020322|NCT03524118|581465551|FG001|Overall Study|Lost to Follow-up|0|||
161020323|NCT03524118|581465552|FG002|Overall Study|Lost to Follow-up|0|||
161020324|NCT03524118|581465553|FG003|Overall Study|Lost to Follow-up|0|||
161020325|NCT03524118|581465554|FG004|Overall Study|Lost to Follow-up|1|||
161020326|NCT03524118|581465555|FG005|Overall Study|Lost to Follow-up|0|||
161020327|NCT03524118|581465550|FG000|Overall Study|Other|0|||
161020328|NCT03524118|581465551|FG001|Overall Study|Other|1|||
161020329|NCT03524118|581465552|FG002|Overall Study|Other|0|||
161020330|NCT03524118|581465553|FG003|Overall Study|Other|0|||
161020331|NCT03524118|581465554|FG004|Overall Study|Other|1|||
161020332|NCT03524118|581465555|FG005|Overall Study|Other|1|||
161020333|NCT03524118|581465550|FG000|Overall Study|Physician Decision|0|||
161020334|NCT03524118|581465551|FG001|Overall Study|Physician Decision|0|||
161020335|NCT03524118|581465552|FG002|Overall Study|Physician Decision|0|||
161020336|NCT03524118|581465553|FG003|Overall Study|Physician Decision|0|||
161020337|NCT03524118|581465554|FG004|Overall Study|Physician Decision|1|||
161020338|NCT03524118|581465555|FG005|Overall Study|Physician Decision|0|||
161020339|NCT03524118|581465550|FG000|Overall Study|Protocol Violation|0|||
161020340|NCT03524118|581465551|FG001|Overall Study|Protocol Violation|0|||
161020341|NCT03524118|581465552|FG002|Overall Study|Protocol Violation|1|||
161020342|NCT03524118|581465553|FG003|Overall Study|Protocol Violation|0|||
161020343|NCT03524118|581465554|FG004|Overall Study|Protocol Violation|1|||
161020344|NCT03524118|581465555|FG005|Overall Study|Protocol Violation|0|||
161020345|NCT03524118|581465550|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161020346|NCT03524118|581465551|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161020347|NCT03524118|581465552|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161020348|NCT03524118|581465553|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
161020349|NCT03524118|581465554|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
161020350|NCT03524118|581465555|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161020351|NCT01437709|581465558|FG000|Overall Study|Adverse Event|0|||
161020352|NCT01437709|581465559|FG001|Overall Study|Adverse Event|1|||
161020353|NCT01437709|581465560|FG002|Overall Study|Adverse Event|0|||
161020354|NCT01437709|581465558|FG000|Overall Study|Pt trasnferred care|0|||
161020355|NCT01437709|581465559|FG001|Overall Study|Pt trasnferred care|1|||
161020356|NCT01437709|581465560|FG002|Overall Study|Pt trasnferred care|0|||
161020357|NCT01842542|581465561|FG000|Overall Study|Withdrawal by Subject|2|||
161020358|NCT01842542|581465561|FG000|Overall Study|Lack of Efficacy|1|||
161020359|NCT01842542|581465561|FG000|Overall Study|Protocol Non-compliance|2|||
161020360|NCT01842542|581465561|FG000|Overall Study|Lost to Follow-up|1|||
161020361|NCT02919306|581465562|FG000|Overall Study|Withdrawal by Subject|1|||
161020362|NCT02919306|581465563|FG001|Overall Study|Withdrawal by Subject|0|||
161020363|NCT02919306|581465562|FG000|Overall Study|Protocol Violation|1|||
161020364|NCT02919306|581465563|FG001|Overall Study|Protocol Violation|0|||
161020365|NCT04293055|581465564|FG000|Overall Study|Lost to Follow-up|1|||
161020366|NCT04293055|581465565|FG001|Overall Study|Lost to Follow-up|1|||
161020367|NCT04293055|581465564|FG000|Overall Study|Did not trigger randomization|6|||
161020368|NCT04293055|581465565|FG001|Overall Study|Did not trigger randomization|5|||
161020369|NCT02262728|581465566|FG000|Follow-up Phase (3 Years)|Death|0|||
161020370|NCT02262728|581465567|FG001|Follow-up Phase (3 Years)|Death|1|||
161020371|NCT02262728|581465566|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
161020372|NCT02262728|581465567|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
161020373|NCT02262728|581465566|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
161020374|NCT02262728|581465567|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
161020375|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
161020376|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
161020377|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
161020378|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
161020379|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
161020380|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
161020381|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
161020382|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
161020383|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
161020384|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
161273383|NCT02152605|582380928|FG001|Overall Study|Adverse Event|8|||
161273384|NCT02152605|582380927|FG000|Overall Study|Lack of Efficacy|7|||
161273385|NCT02152605|582380928|FG001|Overall Study|Lack of Efficacy|4|||
161273386|NCT02152605|582380927|FG000|Overall Study|Protocol deviation|1|||
161020385|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
161020386|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
161020387|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
161020388|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
161020389|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
161020390|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
161020391|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
161020392|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
161020393|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
161020394|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
161020395|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
161020396|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
161020397|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
161020398|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
161020399|NCT01715285|581465568|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
161020400|NCT01715285|581465569|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
161020401|NCT01715285|581465570|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
161020402|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
161020403|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
161020404|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
161020405|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
161020406|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
161020407|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
161020408|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
161020409|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
161020410|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
161020411|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
161020412|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
161020413|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
161020414|NCT01715285|581465568|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
161020415|NCT01715285|581465569|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
161020416|NCT01715285|581465570|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
161020417|NCT02573493|581465581|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
161020418|NCT02573493|581465582|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
161020419|NCT02573493|581465583|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
161020420|NCT02573493|581465584|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
161020421|NCT04149704|581465588|FG000|Three Month Follow-up|Death|2|||
161020422|NCT04149704|581465589|FG001|Three Month Follow-up|Death|0|||
161020423|NCT04149704|581465590|FG002|Three Month Follow-up|Death|0|||
161020424|NCT04149704|581465591|FG003|Three Month Follow-up|Death|0|||
161020425|NCT04149704|581465588|FG000|Three Month Follow-up|Lost to Follow-up|1|||
161020426|NCT04149704|581465589|FG001|Three Month Follow-up|Lost to Follow-up|4|||
161020427|NCT04149704|581465590|FG002|Three Month Follow-up|Lost to Follow-up|5|||
161020428|NCT04149704|581465591|FG003|Three Month Follow-up|Lost to Follow-up|5|||
161020429|NCT04149704|581465588|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
161020430|NCT04149704|581465589|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
161020431|NCT04149704|581465590|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
161020432|NCT04149704|581465591|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
161020433|NCT04149704|581465588|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
161020434|NCT04149704|581465589|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
161020435|NCT04149704|581465590|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
161020436|NCT04149704|581465591|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
161273387|NCT02152605|582380928|FG001|Overall Study|Protocol deviation|4|||
161273388|NCT02152605|582380927|FG000|Overall Study|Lost to Follow-up|1|||
161273389|NCT02152605|582380928|FG001|Overall Study|Lost to Follow-up|0|||
161273390|NCT02152605|582380927|FG000|Overall Study|Withdrew consent|4|||
161020437|NCT04332926|581465592|FG000|Overall Study|Withdrawal by Subject|6|||
161020438|NCT04332926|581465592|FG000|Overall Study|Physician Decision|6|||
161020439|NCT04632992|581465602|FG000|Overall Study|Adverse Event|0|||
161020440|NCT04632992|581465603|FG001|Overall Study|Adverse Event|0|||
161273391|NCT02152605|582380928|FG001|Overall Study|Withdrew consent|2|||
161273392|NCT00537303|582380935|FG000|Overall Study|Adverse Event|1|||
161273393|NCT00537303|582380936|FG001|Overall Study|Adverse Event|4|||
161273394|NCT00537303|582380935|FG000|Overall Study|Lack of Efficacy|6|||
161020441|NCT04632992|581465604|FG002|Overall Study|Adverse Event|0|||
161020442|NCT04632992|581465605|FG003|Overall Study|Adverse Event|0|||
161020443|NCT04632992|581465606|FG004|Overall Study|Adverse Event|0|||
161020444|NCT04632992|581465607|FG005|Overall Study|Adverse Event|0|||
161020445|NCT04632992|581465608|FG006|Overall Study|Adverse Event|0|||
161020446|NCT04632992|581465609|FG007|Overall Study|Adverse Event|0|||
161020447|NCT04632992|581465610|FG008|Overall Study|Adverse Event|0|||
161020448|NCT04632992|581465611|FG009|Overall Study|Adverse Event|0|||
161020449|NCT04632992|581465612|FG010|Overall Study|Adverse Event|0|||
161020450|NCT04632992|581465613|FG011|Overall Study|Adverse Event|0|||
161020451|NCT04632992|581465614|FG012|Overall Study|Adverse Event|1|||
161020452|NCT04632992|581465615|FG013|Overall Study|Adverse Event|0|||
161020453|NCT04632992|581465602|FG000|Overall Study|Death|17|||
161020454|NCT04632992|581465603|FG001|Overall Study|Death|1|||
161020455|NCT04632992|581465604|FG002|Overall Study|Death|14|||
161020456|NCT04632992|581465605|FG003|Overall Study|Death|14|||
161020457|NCT04632992|581465606|FG004|Overall Study|Death|13|||
161020458|NCT04632992|581465607|FG005|Overall Study|Death|6|||
161020459|NCT04632992|581465608|FG006|Overall Study|Death|7|||
161020460|NCT04632992|581465609|FG007|Overall Study|Death|12|||
161020461|NCT04632992|581465610|FG008|Overall Study|Death|15|||
161020462|NCT04632992|581465611|FG009|Overall Study|Death|20|||
161020463|NCT04632992|581465612|FG010|Overall Study|Death|8|||
161020464|NCT04632992|581465613|FG011|Overall Study|Death|2|||
161020465|NCT04632992|581465614|FG012|Overall Study|Death|10|||
161020466|NCT04632992|581465615|FG013|Overall Study|Death|1|||
161020467|NCT04632992|581465602|FG000|Overall Study|Lost to Follow-up|1|||
161020468|NCT04632992|581465603|FG001|Overall Study|Lost to Follow-up|0|||
161020469|NCT04632992|581465604|FG002|Overall Study|Lost to Follow-up|1|||
161020470|NCT04632992|581465605|FG003|Overall Study|Lost to Follow-up|0|||
161020471|NCT04632992|581465606|FG004|Overall Study|Lost to Follow-up|2|||
161020472|NCT04632992|581465607|FG005|Overall Study|Lost to Follow-up|0|||
161020473|NCT04632992|581465608|FG006|Overall Study|Lost to Follow-up|1|||
161020474|NCT04632992|581465609|FG007|Overall Study|Lost to Follow-up|1|||
161020475|NCT04632992|581465610|FG008|Overall Study|Lost to Follow-up|1|||
161020476|NCT04632992|581465611|FG009|Overall Study|Lost to Follow-up|1|||
161020477|NCT04632992|581465612|FG010|Overall Study|Lost to Follow-up|2|||
161020478|NCT04632992|581465613|FG011|Overall Study|Lost to Follow-up|0|||
161020479|NCT04632992|581465614|FG012|Overall Study|Lost to Follow-up|0|||
161020480|NCT04632992|581465615|FG013|Overall Study|Lost to Follow-up|0|||
161020481|NCT04632992|581465602|FG000|Overall Study|Reason not Specified|2|||
161020482|NCT04632992|581465603|FG001|Overall Study|Reason not Specified|0|||
161273395|NCT00537303|582380936|FG001|Overall Study|Lack of Efficacy|7|||
161020483|NCT04632992|581465604|FG002|Overall Study|Reason not Specified|1|||
161020484|NCT04632992|581465605|FG003|Overall Study|Reason not Specified|1|||
161020485|NCT04632992|581465606|FG004|Overall Study|Reason not Specified|0|||
161020486|NCT04632992|581465607|FG005|Overall Study|Reason not Specified|0|||
161020487|NCT04632992|581465608|FG006|Overall Study|Reason not Specified|0|||
161020488|NCT04632992|581465609|FG007|Overall Study|Reason not Specified|0|||
161020489|NCT04632992|581465610|FG008|Overall Study|Reason not Specified|0|||
161020490|NCT04632992|581465611|FG009|Overall Study|Reason not Specified|0|||
161020491|NCT04632992|581465612|FG010|Overall Study|Reason not Specified|1|||
161020492|NCT04632992|581465613|FG011|Overall Study|Reason not Specified|0|||
161020493|NCT04632992|581465614|FG012|Overall Study|Reason not Specified|0|||
161020494|NCT04632992|581465615|FG013|Overall Study|Reason not Specified|0|||
161020495|NCT04632992|581465602|FG000|Overall Study|Physician Decision|0|||
161020496|NCT04632992|581465603|FG001|Overall Study|Physician Decision|0|||
161020497|NCT04632992|581465604|FG002|Overall Study|Physician Decision|0|||
161273396|NCT00537303|582380935|FG000|Overall Study|Protocol Violation|8|||
161020498|NCT04632992|581465605|FG003|Overall Study|Physician Decision|2|||
161020499|NCT04632992|581465606|FG004|Overall Study|Physician Decision|1|||
161020500|NCT04632992|581465607|FG005|Overall Study|Physician Decision|0|||
161020501|NCT04632992|581465608|FG006|Overall Study|Physician Decision|0|||
161273397|NCT00537303|582380936|FG001|Overall Study|Protocol Violation|4|||
161020502|NCT04632992|581465609|FG007|Overall Study|Physician Decision|0|||
161020503|NCT04632992|581465610|FG008|Overall Study|Physician Decision|0|||
161020504|NCT04632992|581465611|FG009|Overall Study|Physician Decision|0|||
161020505|NCT04632992|581465612|FG010|Overall Study|Physician Decision|0|||
161020506|NCT04632992|581465613|FG011|Overall Study|Physician Decision|0|||
161020507|NCT04632992|581465614|FG012|Overall Study|Physician Decision|3|||
161020508|NCT04632992|581465615|FG013|Overall Study|Physician Decision|0|||
161020509|NCT04632992|581465602|FG000|Overall Study|Progressive Disease|0|||
161020510|NCT04632992|581465603|FG001|Overall Study|Progressive Disease|0|||
161020511|NCT04632992|581465604|FG002|Overall Study|Progressive Disease|0|||
161273398|NCT00537303|582380935|FG000|Overall Study|Withdrawal criteria|3|||
161020512|NCT04632992|581465605|FG003|Overall Study|Progressive Disease|0|||
161020513|NCT04632992|581465606|FG004|Overall Study|Progressive Disease|1|||
161020514|NCT04632992|581465607|FG005|Overall Study|Progressive Disease|0|||
161020515|NCT04632992|581465608|FG006|Overall Study|Progressive Disease|0|||
161020516|NCT04632992|581465609|FG007|Overall Study|Progressive Disease|0|||
161020517|NCT04632992|581465610|FG008|Overall Study|Progressive Disease|0|||
161020518|NCT04632992|581465611|FG009|Overall Study|Progressive Disease|1|||
161020519|NCT04632992|581465612|FG010|Overall Study|Progressive Disease|1|||
161020520|NCT04632992|581465613|FG011|Overall Study|Progressive Disease|0|||
161020521|NCT04632992|581465614|FG012|Overall Study|Progressive Disease|2|||
161020522|NCT04632992|581465615|FG013|Overall Study|Progressive Disease|0|||
161020523|NCT04632992|581465602|FG000|Overall Study|Withdrawal by Subject|4|||
161020524|NCT04632992|581465603|FG001|Overall Study|Withdrawal by Subject|1|||
161020525|NCT04632992|581465604|FG002|Overall Study|Withdrawal by Subject|5|||
161020526|NCT04632992|581465605|FG003|Overall Study|Withdrawal by Subject|4|||
161020527|NCT04632992|581465606|FG004|Overall Study|Withdrawal by Subject|3|||
161020528|NCT04632992|581465607|FG005|Overall Study|Withdrawal by Subject|3|||
161020529|NCT04632992|581465608|FG006|Overall Study|Withdrawal by Subject|0|||
161020530|NCT04632992|581465609|FG007|Overall Study|Withdrawal by Subject|5|||
161020531|NCT04632992|581465610|FG008|Overall Study|Withdrawal by Subject|0|||
161020532|NCT04632992|581465611|FG009|Overall Study|Withdrawal by Subject|2|||
161020533|NCT04632992|581465612|FG010|Overall Study|Withdrawal by Subject|8|||
161020534|NCT04632992|581465613|FG011|Overall Study|Withdrawal by Subject|0|||
161020535|NCT04632992|581465614|FG012|Overall Study|Withdrawal by Subject|1|||
161020536|NCT04632992|581465615|FG013|Overall Study|Withdrawal by Subject|1|||
161020537|NCT02677805|581465616|FG000|Double Blind Phase|Lost to Follow-up|8|||
161020538|NCT02677805|581465617|FG001|Double Blind Phase|Lost to Follow-up|3|||
161020539|NCT02677805|581465618|FG002|Double Blind Phase|Lost to Follow-up|0|||
161020540|NCT02677805|581465616|FG000|Double Blind Phase|Withdrawal by Subject|5|||
161020541|NCT02677805|581465617|FG001|Double Blind Phase|Withdrawal by Subject|2|||
161020542|NCT02677805|581465618|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161020543|NCT02677805|581465616|FG000|Open Label Phase|Lost to Follow-up|0|||
161020544|NCT02677805|581465617|FG001|Open Label Phase|Lost to Follow-up|0|||
161020545|NCT02677805|581465618|FG002|Open Label Phase|Lost to Follow-up|10|||
161020546|NCT02677805|581465616|FG000|Open Label Phase|Withdrawal by Subject|0|||
161020547|NCT02677805|581465617|FG001|Open Label Phase|Withdrawal by Subject|0|||
161020548|NCT02677805|581465618|FG002|Open Label Phase|Withdrawal by Subject|6|||
161020549|NCT04111536|581465623|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161020550|NCT04111536|581465624|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161020551|NCT04111536|581465623|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
161020552|NCT04111536|581465624|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
161020553|NCT04111536|581465623|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
161020554|NCT04111536|581465624|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161020555|NCT04111536|581465623|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
161020556|NCT04111536|581465624|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
161020557|NCT04350463|581465625|FG000|Overall Study|Other reason|0|||
161020558|NCT04350463|581465626|FG001|Overall Study|Other reason|0|||
161020559|NCT04350463|581465627|FG002|Overall Study|Other reason|0|||
161020560|NCT04350463|581465628|FG003|Overall Study|Other reason|1|||
161020561|NCT04350463|581465625|FG000|Overall Study|Lost to Follow-up|0|||
161020562|NCT04350463|581465626|FG001|Overall Study|Lost to Follow-up|0|||
161020563|NCT04350463|581465627|FG002|Overall Study|Lost to Follow-up|0|||
161020564|NCT04350463|581465628|FG003|Overall Study|Lost to Follow-up|2|||
161020565|NCT04350463|581465625|FG000|Overall Study|Withdrawal by Subject|4|||
161020566|NCT04350463|581465626|FG001|Overall Study|Withdrawal by Subject|0|||
161020567|NCT04350463|581465627|FG002|Overall Study|Withdrawal by Subject|1|||
161020568|NCT04350463|581465628|FG003|Overall Study|Withdrawal by Subject|4|||
161020569|NCT04350463|581465625|FG000|Overall Study|Adverse Event|0|||
161020570|NCT04350463|581465626|FG001|Overall Study|Adverse Event|0|||
161020571|NCT04350463|581465627|FG002|Overall Study|Adverse Event|0|||
161020572|NCT04350463|581465628|FG003|Overall Study|Adverse Event|2|||
161020573|NCT04350463|581465625|FG000|Overall Study|Death|27|||
161020574|NCT04350463|581465626|FG001|Overall Study|Death|2|||
161020575|NCT04350463|581465627|FG002|Overall Study|Death|13|||
161020576|NCT04350463|581465628|FG003|Overall Study|Death|26|||
161020577|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
161020578|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
161020579|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
161020580|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
161148555|NCT02658656|581924619|FG002|Screening|Failed eligibility criteria|263|||
161020581|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
161020582|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
161020583|NCT04652700|581465629|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
161148556|NCT02658656|581924617|FG000|Randomization|Withdrawal by Subject|8|||
161148557|NCT02658656|581924618|FG001|Randomization|Withdrawal by Subject|7|||
161020584|NCT04652700|581465630|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
161020585|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
161020586|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
161148558|NCT02658656|581924619|FG002|Randomization|Withdrawal by Subject|0|||
161273399|NCT00537303|582380936|FG001|Overall Study|Withdrawal criteria|3|||
161020587|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
161020588|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
161020589|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
161020590|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
161020591|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
161020592|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
161020593|NCT04652700|581465629|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
161020594|NCT04652700|581465630|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
161020595|NCT04187833|581465631|FG000|Overall Study|Withdrawal by Subject|1|||
161020596|NCT06037369|581465635|FG000|Overall Study|Lost to Follow-up|0|||
161020597|NCT06037369|581465636|FG001|Overall Study|Lost to Follow-up|1|||
161020598|NCT04209465|581465637|FG000|Overall Study|Adverse Event|0|||
161020599|NCT04209465|581465638|FG001|Overall Study|Adverse Event|0|||
161020600|NCT04209465|581465639|FG002|Overall Study|Adverse Event|0|||
161020601|NCT04209465|581465640|FG003|Overall Study|Adverse Event|0|||
161020602|NCT04209465|581465641|FG004|Overall Study|Adverse Event|0|||
161020603|NCT04209465|581465642|FG005|Overall Study|Adverse Event|1|||
161020604|NCT04209465|581465643|FG006|Overall Study|Adverse Event|0|||
161020605|NCT04209465|581465644|FG007|Overall Study|Adverse Event|0|||
161020606|NCT04209465|581465645|FG008|Overall Study|Adverse Event|1|||
161020607|NCT04209465|581465646|FG009|Overall Study|Adverse Event|0|||
161020608|NCT04209465|581465647|FG010|Overall Study|Adverse Event|2|||
161020609|NCT04209465|581465648|FG011|Overall Study|Adverse Event|1|||
161020610|NCT04209465|581465649|FG012|Overall Study|Adverse Event|1|||
161020611|NCT04209465|581465637|FG000|Overall Study|Death|1|||
161020612|NCT04209465|581465638|FG001|Overall Study|Death|0|||
161020613|NCT04209465|581465639|FG002|Overall Study|Death|0|||
161020614|NCT04209465|581465640|FG003|Overall Study|Death|0|||
161020615|NCT04209465|581465641|FG004|Overall Study|Death|2|||
161020616|NCT04209465|581465642|FG005|Overall Study|Death|7|||
161020617|NCT04209465|581465643|FG006|Overall Study|Death|2|||
161020618|NCT04209465|581465644|FG007|Overall Study|Death|2|||
161020619|NCT04209465|581465645|FG008|Overall Study|Death|1|||
161020620|NCT04209465|581465646|FG009|Overall Study|Death|1|||
161020621|NCT04209465|581465647|FG010|Overall Study|Death|1|||
161020622|NCT04209465|581465648|FG011|Overall Study|Death|0|||
161020623|NCT04209465|581465649|FG012|Overall Study|Death|10|||
161020624|NCT04209465|581465637|FG000|Overall Study|Physician Decision|0|||
161020625|NCT04209465|581465638|FG001|Overall Study|Physician Decision|1|||
161020626|NCT04209465|581465639|FG002|Overall Study|Physician Decision|0|||
161020627|NCT04209465|581465640|FG003|Overall Study|Physician Decision|0|||
161020628|NCT04209465|581465641|FG004|Overall Study|Physician Decision|0|||
161020629|NCT04209465|581465642|FG005|Overall Study|Physician Decision|0|||
161020630|NCT04209465|581465643|FG006|Overall Study|Physician Decision|0|||
161020631|NCT04209465|581465644|FG007|Overall Study|Physician Decision|0|||
161020632|NCT04209465|581465645|FG008|Overall Study|Physician Decision|0|||
161020633|NCT04209465|581465646|FG009|Overall Study|Physician Decision|0|||
161020634|NCT04209465|581465647|FG010|Overall Study|Physician Decision|0|||
161020635|NCT04209465|581465648|FG011|Overall Study|Physician Decision|0|||
161020636|NCT04209465|581465649|FG012|Overall Study|Physician Decision|0|||
161020637|NCT04209465|581465637|FG000|Overall Study|Progressive Disease|0|||
161020638|NCT04209465|581465638|FG001|Overall Study|Progressive Disease|0|||
161020639|NCT04209465|581465639|FG002|Overall Study|Progressive Disease|1|||
161020640|NCT04209465|581465640|FG003|Overall Study|Progressive Disease|2|||
161020641|NCT04209465|581465641|FG004|Overall Study|Progressive Disease|8|||
161020642|NCT04209465|581465642|FG005|Overall Study|Progressive Disease|5|||
161020643|NCT04209465|581465643|FG006|Overall Study|Progressive Disease|3|||
161020644|NCT04209465|581465644|FG007|Overall Study|Progressive Disease|4|||
161020645|NCT04209465|581465645|FG008|Overall Study|Progressive Disease|1|||
161020646|NCT04209465|581465646|FG009|Overall Study|Progressive Disease|3|||
161020647|NCT04209465|581465647|FG010|Overall Study|Progressive Disease|2|||
161020648|NCT04209465|581465648|FG011|Overall Study|Progressive Disease|1|||
161020649|NCT04209465|581465649|FG012|Overall Study|Progressive Disease|0|||
161273400|NCT00537303|582380935|FG000|Overall Study|Unclassified|8|||
161273401|NCT00537303|582380936|FG001|Overall Study|Unclassified|7|||
161273402|NCT01735955|582380937|FG000|Overall Study|Administrative problems|1|||
161020650|NCT04209465|581465637|FG000|Overall Study|Withdrawal by Subject|0|||
161020651|NCT04209465|581465638|FG001|Overall Study|Withdrawal by Subject|0|||
161020652|NCT04209465|581465639|FG002|Overall Study|Withdrawal by Subject|0|||
161020653|NCT04209465|581465640|FG003|Overall Study|Withdrawal by Subject|0|||
161020654|NCT04209465|581465641|FG004|Overall Study|Withdrawal by Subject|0|||
161020655|NCT04209465|581465642|FG005|Overall Study|Withdrawal by Subject|1|||
161273403|NCT01735955|582380937|FG000|Overall Study|Patient/guardian decision|1|||
161273404|NCT01735955|582380937|FG000|Overall Study|Patient withdrew consent|2|||
161020656|NCT04209465|581465643|FG006|Overall Study|Withdrawal by Subject|2|||
161273405|NCT01735955|582380937|FG000|Overall Study|Physician Decision|4|||
161020657|NCT04209465|581465644|FG007|Overall Study|Withdrawal by Subject|0|||
161020658|NCT04209465|581465645|FG008|Overall Study|Withdrawal by Subject|1|||
161020659|NCT04209465|581465646|FG009|Overall Study|Withdrawal by Subject|0|||
161020660|NCT04209465|581465647|FG010|Overall Study|Withdrawal by Subject|0|||
161020661|NCT04209465|581465648|FG011|Overall Study|Withdrawal by Subject|2|||
161020662|NCT04209465|581465649|FG012|Overall Study|Withdrawal by Subject|2|||
161020663|NCT04209465|581465637|FG000|Overall Study|Lost to Follow-up|0|||
161020664|NCT04209465|581465638|FG001|Overall Study|Lost to Follow-up|0|||
161020665|NCT04209465|581465639|FG002|Overall Study|Lost to Follow-up|0|||
161020666|NCT04209465|581465640|FG003|Overall Study|Lost to Follow-up|0|||
161020667|NCT04209465|581465641|FG004|Overall Study|Lost to Follow-up|0|||
161020668|NCT04209465|581465642|FG005|Overall Study|Lost to Follow-up|1|||
161020669|NCT04209465|581465643|FG006|Overall Study|Lost to Follow-up|0|||
161020670|NCT04209465|581465644|FG007|Overall Study|Lost to Follow-up|0|||
161020671|NCT04209465|581465645|FG008|Overall Study|Lost to Follow-up|1|||
161020672|NCT04209465|581465646|FG009|Overall Study|Lost to Follow-up|0|||
161020673|NCT04209465|581465647|FG010|Overall Study|Lost to Follow-up|0|||
161020674|NCT04209465|581465648|FG011|Overall Study|Lost to Follow-up|1|||
161020675|NCT04209465|581465649|FG012|Overall Study|Lost to Follow-up|0|||
161020676|NCT04209465|581465637|FG000|Overall Study|Started new therapy|0|||
161020677|NCT04209465|581465638|FG001|Overall Study|Started new therapy|0|||
161020678|NCT04209465|581465639|FG002|Overall Study|Started new therapy|0|||
161020679|NCT04209465|581465640|FG003|Overall Study|Started new therapy|0|||
161020680|NCT04209465|581465641|FG004|Overall Study|Started new therapy|0|||
161020681|NCT04209465|581465642|FG005|Overall Study|Started new therapy|1|||
161020682|NCT04209465|581465643|FG006|Overall Study|Started new therapy|0|||
161020683|NCT04209465|581465644|FG007|Overall Study|Started new therapy|0|||
161020684|NCT04209465|581465645|FG008|Overall Study|Started new therapy|0|||
161020685|NCT04209465|581465646|FG009|Overall Study|Started new therapy|0|||
161020686|NCT04209465|581465647|FG010|Overall Study|Started new therapy|0|||
161020687|NCT04209465|581465648|FG011|Overall Study|Started new therapy|0|||
161020688|NCT04209465|581465649|FG012|Overall Study|Started new therapy|0|||
161020689|NCT04209465|581465637|FG000|Overall Study|Study terminated early by sponsor|0|||
161020690|NCT04209465|581465638|FG001|Overall Study|Study terminated early by sponsor|0|||
161020691|NCT04209465|581465639|FG002|Overall Study|Study terminated early by sponsor|0|||
161020692|NCT04209465|581465640|FG003|Overall Study|Study terminated early by sponsor|0|||
161020693|NCT04209465|581465641|FG004|Overall Study|Study terminated early by sponsor|0|||
161020694|NCT04209465|581465642|FG005|Overall Study|Study terminated early by sponsor|0|||
161020695|NCT04209465|581465643|FG006|Overall Study|Study terminated early by sponsor|3|||
161020696|NCT04209465|581465644|FG007|Overall Study|Study terminated early by sponsor|0|||
161020697|NCT04209465|581465645|FG008|Overall Study|Study terminated early by sponsor|0|||
161020698|NCT04209465|581465646|FG009|Overall Study|Study terminated early by sponsor|0|||
161020699|NCT04209465|581465647|FG010|Overall Study|Study terminated early by sponsor|0|||
161020700|NCT04209465|581465648|FG011|Overall Study|Study terminated early by sponsor|0|||
161020701|NCT04209465|581465649|FG012|Overall Study|Study terminated early by sponsor|3|||
161020702|NCT04209465|581465637|FG000|Overall Study|Other|0|||
161020703|NCT04209465|581465638|FG001|Overall Study|Other|0|||
161020704|NCT04209465|581465639|FG002|Overall Study|Other|0|||
161020705|NCT04209465|581465640|FG003|Overall Study|Other|0|||
161020706|NCT04209465|581465641|FG004|Overall Study|Other|0|||
161020707|NCT04209465|581465642|FG005|Overall Study|Other|0|||
161020708|NCT04209465|581465643|FG006|Overall Study|Other|0|||
161020709|NCT04209465|581465644|FG007|Overall Study|Other|0|||
161020710|NCT04209465|581465645|FG008|Overall Study|Other|1|||
161020711|NCT04209465|581465646|FG009|Overall Study|Other|0|||
161020712|NCT04209465|581465647|FG010|Overall Study|Other|0|||
161020713|NCT04209465|581465648|FG011|Overall Study|Other|0|||
161020714|NCT04209465|581465649|FG012|Overall Study|Other|0|||
161020715|NCT03097549|581465650|FG000|Overall Study|Withdrawal by Subject|1|||
161020716|NCT03097549|581465651|FG001|Overall Study|Withdrawal by Subject|0|||
161020717|NCT03097549|581465650|FG000|Overall Study|Lost to Follow-up|1|||
161020718|NCT03097549|581465651|FG001|Overall Study|Lost to Follow-up|0|||
161020719|NCT05783102|581465652|FG000|Overall Study|Lost to Follow-up|1|||
161020720|NCT05783102|581465652|FG000|Overall Study|Withdrawal by Subject|2|||
161020721|NCT05647304|581465653|FG000|Overall Study|Withdrawal by Subject|1|||
161020722|NCT05647304|581465654|FG001|Overall Study|Withdrawal by Subject|0|||
161020723|NCT04282148|581465657|FG000|Overall Study|Death|7|||
161273406|NCT01735955|582380937|FG000|Overall Study|Disease progression|24|||
161020724|NCT04282148|581465657|FG000|Overall Study|Withdrawal by Subject|1|||
161020725|NCT04282148|581465657|FG000|Overall Study|Physician Decision|1|||
161020726|NCT02146378|581465658|FG000|Overall Study|No information of administration|2|||
161020727|NCT06215521|581465659|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020728|NCT06215521|581465660|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
161020729|NCT06215521|581465661|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020730|NCT06215521|581465662|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020731|NCT06215521|581465663|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020732|NCT06215521|581465664|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
161020733|NCT04096040|581465665|FG000|Overall Study|Protocol Violation|12|||
161020734|NCT04096040|581465665|FG000|Overall Study|Non-compliant site|4|||
161020735|NCT04973254|581465666|FG000|Overall Study|Not adherent|0|||
161020736|NCT04973254|581465667|FG001|Overall Study|Not adherent|1|||
161020737|NCT04973254|581465668|FG002|Overall Study|Not adherent|0|||
161273407|NCT01735955|582380937|FG000|Overall Study|Adverse Event|5|||
161273408|NCT01724489|582380938|FG000|Overall Study|Adverse Event|8|||
161273409|NCT01724489|582380939|FG001|Overall Study|Adverse Event|3|||
161273410|NCT01724489|582380938|FG000|Overall Study|Surgery, medication|1|||
161273411|NCT01724489|582380939|FG001|Overall Study|Surgery, medication|1|||
161273412|NCT01724489|582380938|FG000|Overall Study|Lost to Follow-up|1|||
161273413|NCT01724489|582380939|FG001|Overall Study|Lost to Follow-up|2|||
161273414|NCT01724489|582380938|FG000|Overall Study|Withdrawal by Subject|6|||
161273415|NCT01724489|582380939|FG001|Overall Study|Withdrawal by Subject|6|||
161273416|NCT01473524|582380940|FG000|DB Phase|Adverse Event|4|||
161273417|NCT01473524|582380941|FG001|DB Phase|Adverse Event|8|||
161273418|NCT01473524|582380942|FG002|DB Phase|Adverse Event|2|||
161273419|NCT01473524|582380943|FG003|DB Phase|Adverse Event|0|||
161273420|NCT01473524|582380944|FG004|DB Phase|Adverse Event|0|||
161273421|NCT01473524|582380945|FG005|DB Phase|Adverse Event|0|||
161273422|NCT01473524|582380940|FG000|DB Phase|Death|1|||
161273423|NCT01473524|582380941|FG001|DB Phase|Death|0|||
161273424|NCT01473524|582380942|FG002|DB Phase|Death|0|||
161273425|NCT01473524|582380943|FG003|DB Phase|Death|0|||
161273426|NCT01473524|582380944|FG004|DB Phase|Death|0|||
161273427|NCT01473524|582380945|FG005|DB Phase|Death|0|||
161273428|NCT01473524|582380940|FG000|DB Phase|Withdrawal by Subject|2|||
161273429|NCT01473524|582380941|FG001|DB Phase|Withdrawal by Subject|1|||
161273430|NCT01473524|582380942|FG002|DB Phase|Withdrawal by Subject|1|||
161273431|NCT01473524|582380943|FG003|DB Phase|Withdrawal by Subject|0|||
161273432|NCT01473524|582380944|FG004|DB Phase|Withdrawal by Subject|0|||
161273433|NCT01473524|582380945|FG005|DB Phase|Withdrawal by Subject|0|||
161273434|NCT01473524|582380940|FG000|LTSE Phase|Withdrawal by Subject|0|||
161273435|NCT01473524|582380941|FG001|LTSE Phase|Withdrawal by Subject|0|||
161273436|NCT01473524|582380942|FG002|LTSE Phase|Withdrawal by Subject|0|||
161273437|NCT01473524|582380943|FG003|LTSE Phase|Withdrawal by Subject|3|||
161273438|NCT01473524|582380944|FG004|LTSE Phase|Withdrawal by Subject|3|||
161273439|NCT01473524|582380945|FG005|LTSE Phase|Withdrawal by Subject|6|||
161273440|NCT01473524|582380940|FG000|LTSE Phase|Death|0|||
161273441|NCT01473524|582380941|FG001|LTSE Phase|Death|0|||
161273442|NCT01473524|582380942|FG002|LTSE Phase|Death|0|||
161273443|NCT01473524|582380943|FG003|LTSE Phase|Death|0|||
161273444|NCT01473524|582380944|FG004|LTSE Phase|Death|1|||
161273445|NCT01473524|582380945|FG005|LTSE Phase|Death|0|||
161273446|NCT01473524|582380940|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
161273447|NCT01473524|582380941|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
161020738|NCT04044768|581465669|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
161020739|NCT04044768|581465670|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
161020740|NCT05089019|581465671|FG000|Period 1|Withdrawal by Subject|0|||
161020741|NCT05089019|581465672|FG001|Period 1|Withdrawal by Subject|1|||
161020742|NCT05089019|581465671|FG000|Washout Period|Adverse Event|3|||
161020743|NCT05089019|581465672|FG001|Washout Period|Adverse Event|4|||
161020744|NCT05089019|581465671|FG000|Washout Period|Lost to Follow-up|1|||
161020745|NCT05089019|581465672|FG001|Washout Period|Lost to Follow-up|0|||
161020746|NCT05089019|581465671|FG000|Washout Period|Physician Decision|2|||
161020747|NCT05089019|581465672|FG001|Washout Period|Physician Decision|0|||
161020748|NCT05089019|581465671|FG000|Washout Period|Withdrawal by Subject|6|||
161020749|NCT05089019|581465672|FG001|Washout Period|Withdrawal by Subject|3|||
161020750|NCT05089019|581465671|FG000|Period 2|Adverse Event|4|||
161020751|NCT05089019|581465672|FG001|Period 2|Adverse Event|2|||
161020752|NCT05089019|581465671|FG000|Period 2|Lost to Follow-up|1|||
161020753|NCT05089019|581465672|FG001|Period 2|Lost to Follow-up|0|||
161020754|NCT05089019|581465671|FG000|Period 2|Withdrawal by Subject|0|||
161020755|NCT05089019|581465672|FG001|Period 2|Withdrawal by Subject|1|||
161020756|NCT05170009|581465673|FG000|Overall Study|Physician Decision|0|||
161020757|NCT05170009|581465674|FG001|Overall Study|Physician Decision|1|||
161020758|NCT04925986|581465675|FG000|Overall Study|Death|0|||
161273448|NCT01473524|582380942|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
161020759|NCT04925986|581465676|FG001|Overall Study|Death|0|||
161020760|NCT04925986|581465677|FG002|Overall Study|Death|2|||
161273449|NCT01473524|582380943|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
161273450|NCT01473524|582380944|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
161273451|NCT01473524|582380945|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
161273452|NCT01473524|582380940|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161273453|NCT01473524|582380941|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161273454|NCT01473524|582380942|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
161020761|NCT04925986|581465678|FG003|Overall Study|Death|0|||
161273455|NCT01473524|582380943|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
161020762|NCT04925986|581465675|FG000|Overall Study|Lack of Efficacy|1|||
161020763|NCT04925986|581465676|FG001|Overall Study|Lack of Efficacy|2|||
161020764|NCT04925986|581465677|FG002|Overall Study|Lack of Efficacy|0|||
161273456|NCT01473524|582380944|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
161273457|NCT01473524|582380945|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
161273458|NCT01473524|582380940|FG000|LTSE Phase|Lost to Follow-up|0|||
161273459|NCT01473524|582380941|FG001|LTSE Phase|Lost to Follow-up|0|||
161273460|NCT01473524|582380942|FG002|LTSE Phase|Lost to Follow-up|0|||
161273461|NCT01473524|582380943|FG003|LTSE Phase|Lost to Follow-up|1|||
161273462|NCT01473524|582380944|FG004|LTSE Phase|Lost to Follow-up|3|||
161273463|NCT01473524|582380945|FG005|LTSE Phase|Lost to Follow-up|2|||
161273464|NCT01473524|582380940|FG000|LTSE Phase|Principal Investigator Decision|0|||
161273465|NCT01473524|582380941|FG001|LTSE Phase|Principal Investigator Decision|0|||
161273466|NCT01473524|582380942|FG002|LTSE Phase|Principal Investigator Decision|0|||
161273467|NCT01473524|582380943|FG003|LTSE Phase|Principal Investigator Decision|1|||
161273468|NCT01473524|582380944|FG004|LTSE Phase|Principal Investigator Decision|1|||
161273469|NCT01473524|582380945|FG005|LTSE Phase|Principal Investigator Decision|3|||
161273470|NCT01473524|582380940|FG000|LTSE Phase|Liver Transplantation|0|||
161273471|NCT01473524|582380941|FG001|LTSE Phase|Liver Transplantation|0|||
161273472|NCT01473524|582380942|FG002|LTSE Phase|Liver Transplantation|0|||
161273473|NCT01473524|582380943|FG003|LTSE Phase|Liver Transplantation|0|||
161273474|NCT01473524|582380944|FG004|LTSE Phase|Liver Transplantation|0|||
161273475|NCT01473524|582380945|FG005|LTSE Phase|Liver Transplantation|1|||
161273476|NCT01473524|582380940|FG000|LTSE Phase|Pregnancy|0|||
161273477|NCT01473524|582380941|FG001|LTSE Phase|Pregnancy|0|||
161273478|NCT01473524|582380942|FG002|LTSE Phase|Pregnancy|0|||
161273479|NCT01473524|582380943|FG003|LTSE Phase|Pregnancy|1|||
161273480|NCT01473524|582380944|FG004|LTSE Phase|Pregnancy|0|||
161273481|NCT01473524|582380945|FG005|LTSE Phase|Pregnancy|0|||
161273482|NCT01473524|582380940|FG000|LTSE Phase|Protocol Violation|0|||
161273483|NCT01473524|582380941|FG001|LTSE Phase|Protocol Violation|0|||
161273484|NCT01473524|582380942|FG002|LTSE Phase|Protocol Violation|0|||
161273485|NCT01473524|582380943|FG003|LTSE Phase|Protocol Violation|0|||
161273486|NCT01473524|582380944|FG004|LTSE Phase|Protocol Violation|0|||
161273487|NCT01473524|582380945|FG005|LTSE Phase|Protocol Violation|1|||
161273488|NCT01544179|582380946|FG000|Overall Study|Death|50|||
161273489|NCT01544179|582380947|FG001|Overall Study|Death|37|||
161273490|NCT01544179|582380946|FG000|Overall Study|Lost to Follow-up|0|||
161273491|NCT01544179|582380947|FG001|Overall Study|Lost to Follow-up|1|||
161273492|NCT01544179|582380946|FG000|Overall Study|Adverse Event|0|||
161273493|NCT01544179|582380947|FG001|Overall Study|Adverse Event|1|||
161273494|NCT01544179|582380946|FG000|Overall Study|Withdrawal by Subject|12|||
161273495|NCT01544179|582380947|FG001|Overall Study|Withdrawal by Subject|7|||
161020765|NCT04925986|581465678|FG003|Overall Study|Lack of Efficacy|1|||
161020766|NCT04925986|581465675|FG000|Overall Study|Withdrawal by Subject|0|||
161020767|NCT04925986|581465676|FG001|Overall Study|Withdrawal by Subject|0|||
161020768|NCT04925986|581465677|FG002|Overall Study|Withdrawal by Subject|1|||
161020769|NCT04925986|581465678|FG003|Overall Study|Withdrawal by Subject|2|||
161020770|NCT03858634|581465679|FG000|Overall Study|Withdrawal by Subject|1|||
161020771|NCT03858634|581465680|FG001|Overall Study|Withdrawal by Subject|0|||
161020772|NCT03858634|581465679|FG000|Overall Study|Adverse Event|1|||
161020773|NCT03858634|581465680|FG001|Overall Study|Adverse Event|0|||
161020774|NCT03858634|581465679|FG000|Overall Study|Lost to Follow-up|0|||
161020775|NCT03858634|581465680|FG001|Overall Study|Lost to Follow-up|1|||
161020776|NCT03858634|581465679|FG000|Overall Study|Other, Not Specified|1|||
161020777|NCT03858634|581465680|FG001|Overall Study|Other, Not Specified|1|||
161020778|NCT03808818|581465681|FG000|Overall Study|Death|6|||
161020779|NCT03808818|581465682|FG001|Overall Study|Death|6|||
161020780|NCT03808818|581465681|FG000|Overall Study|Withdrawal by Subject|7|||
161020781|NCT03808818|581465682|FG001|Overall Study|Withdrawal by Subject|18|||
161020782|NCT03808818|581465681|FG000|Overall Study|Lost to Follow-up|31|||
161020783|NCT03808818|581465682|FG001|Overall Study|Lost to Follow-up|33|||
161020784|NCT06181760|581465683|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
161020785|NCT06181760|581465684|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
161020786|NCT06181760|581465685|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
161020787|NCT06181760|581465686|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
161020788|NCT05415722|581465688|FG000|Overall Study|Lost to Follow-up|0|||
161020789|NCT05415722|581465689|FG001|Overall Study|Lost to Follow-up|2|||
161020790|NCT05415722|581465690|FG002|Overall Study|Lost to Follow-up|0|||
161273496|NCT01544179|582380946|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
161020791|NCT05415722|581465691|FG003|Overall Study|Lost to Follow-up|1|||
161020792|NCT05415722|581465692|FG004|Overall Study|Lost to Follow-up|0|||
161020793|NCT05415722|581465693|FG005|Overall Study|Lost to Follow-up|0|||
161020794|NCT05415722|581465694|FG006|Overall Study|Lost to Follow-up|1|||
161020795|NCT05415722|581465688|FG000|Overall Study|Physician Decision|0|||
161020796|NCT05415722|581465689|FG001|Overall Study|Physician Decision|0|||
161273497|NCT01544179|582380947|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161020797|NCT05415722|581465690|FG002|Overall Study|Physician Decision|0|||
161020798|NCT05415722|581465691|FG003|Overall Study|Physician Decision|1|||
161020799|NCT05415722|581465692|FG004|Overall Study|Physician Decision|0|||
161020800|NCT05415722|581465693|FG005|Overall Study|Physician Decision|0|||
161273498|NCT03146962|582380950|FG000|Overall Study|Lost to Follow-up|1|||
161273499|NCT03146962|582380951|FG001|Overall Study|Lost to Follow-up|1|||
161273500|NCT03146962|582380952|FG002|Overall Study|Lost to Follow-up|0|||
161273501|NCT03146962|582380953|FG003|Overall Study|Lost to Follow-up|0|||
161273502|NCT03146962|582380954|FG004|Overall Study|Lost to Follow-up|0|||
161273503|NCT03146962|582380955|FG005|Overall Study|Lost to Follow-up|0|||
161020801|NCT05415722|581465694|FG006|Overall Study|Physician Decision|1|||
161020802|NCT05415722|581465688|FG000|Overall Study|Protocol Violation|0|||
161020803|NCT05415722|581465689|FG001|Overall Study|Protocol Violation|0|||
161020804|NCT05415722|581465690|FG002|Overall Study|Protocol Violation|0|||
161020805|NCT05415722|581465691|FG003|Overall Study|Protocol Violation|1|||
161020806|NCT05415722|581465692|FG004|Overall Study|Protocol Violation|0|||
161020807|NCT05415722|581465693|FG005|Overall Study|Protocol Violation|0|||
161020808|NCT05415722|581465694|FG006|Overall Study|Protocol Violation|0|||
161020809|NCT05415722|581465688|FG000|Overall Study|Sponsor Discretion|0|||
161020810|NCT05415722|581465689|FG001|Overall Study|Sponsor Discretion|0|||
161020811|NCT05415722|581465690|FG002|Overall Study|Sponsor Discretion|0|||
161020812|NCT05415722|581465691|FG003|Overall Study|Sponsor Discretion|0|||
161020813|NCT05415722|581465692|FG004|Overall Study|Sponsor Discretion|1|||
161020814|NCT05415722|581465693|FG005|Overall Study|Sponsor Discretion|1|||
161020815|NCT05415722|581465694|FG006|Overall Study|Sponsor Discretion|0|||
161020816|NCT05415722|581465688|FG000|Overall Study|Withdrawal by Subject|0|||
161020817|NCT05415722|581465689|FG001|Overall Study|Withdrawal by Subject|1|||
161020818|NCT05415722|581465690|FG002|Overall Study|Withdrawal by Subject|0|||
161020819|NCT05415722|581465691|FG003|Overall Study|Withdrawal by Subject|1|||
161020820|NCT05415722|581465692|FG004|Overall Study|Withdrawal by Subject|1|||
161020821|NCT05415722|581465693|FG005|Overall Study|Withdrawal by Subject|0|||
161020822|NCT05415722|581465694|FG006|Overall Study|Withdrawal by Subject|1|||
161020823|NCT04629716|581465695|FG000|Overall Study|Lost to Follow-up|7|||
161020824|NCT04629716|581465696|FG001|Overall Study|Lost to Follow-up|3|||
161020825|NCT03524612|581465697|FG000|Overall Study|Lack of Efficacy|10|||
161020826|NCT03524612|581465697|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
161020827|NCT03524612|581465697|FG000|Overall Study|Adverse Event|10|||
161020828|NCT03524612|581465697|FG000|Overall Study|Withdrawal by Subject|7|||
161020829|NCT03524612|581465697|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
161020830|NCT03524612|581465697|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
161020831|NCT03524612|581465697|FG000|Overall Study|New therapy for study indication|6|||
161020832|NCT03524612|581465697|FG000|Overall Study|Death|3|||
161020833|NCT03524612|581465697|FG000|Overall Study|Lost to Follow-up|2|||
161020834|NCT03524612|581465697|FG000|Overall Study|Protocol Violation|1|||
161020835|NCT04537715|581465699|FG000|Overall Study|Death|3|||
161020836|NCT04537715|581465700|FG001|Overall Study|Death|1|||
161020837|NCT04537715|581465699|FG000|Overall Study|Withdrawal by Subject|3|||
161020838|NCT04537715|581465700|FG001|Overall Study|Withdrawal by Subject|1|||
161020839|NCT04537715|581465699|FG000|Overall Study|Other|4|||
161020840|NCT04537715|581465700|FG001|Overall Study|Other|3|||
161020841|NCT04537715|581465699|FG000|Overall Study|Progressive disease|1|||
161020842|NCT04537715|581465700|FG001|Overall Study|Progressive disease|0|||
161020843|NCT05457647|581465702|FG000|Overall Study|Lost to Follow-up|3|||
161020844|NCT03448107|581465703|FG000|Overall Study|Lost to Follow-up|229|||
161020845|NCT03448107|581465704|FG001|Overall Study|Lost to Follow-up|258|||
161020846|NCT03115476|581465705|FG000|LP0084-1369|Death|1|||
161020847|NCT03115476|581465706|FG001|LP0084-1369|Death|0|||
161020848|NCT03115476|581465707|FG002|LP0084-1369|Death|2|||
161020849|NCT03115476|581465705|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
161020850|NCT03115476|581465706|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
161020851|NCT03115476|581465707|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
161020852|NCT05228457|581465711|FG000|Overall Study|Withdrawal by Subject|1|||
161020853|NCT05228457|581465712|FG001|Overall Study|Withdrawal by Subject|1|||
161020854|NCT05302596|581465728|FG000|Overall Study|Withdrawal by Subject|1|||
161020855|NCT05302596|581465729|FG001|Overall Study|Withdrawal by Subject|1|||
161020856|NCT03287817|581468040|FG000|Overall Study|Progressive disease|4|||
161020857|NCT03287817|581468041|FG001|Overall Study|Progressive disease|2|||
161020858|NCT03287817|581468042|FG002|Overall Study|Progressive disease|3|||
161020859|NCT03287817|581468043|FG003|Overall Study|Progressive disease|10|||
161020860|NCT03287817|581468044|FG004|Overall Study|Progressive disease|8|||
161020861|NCT03287817|581468040|FG000|Overall Study|Death|0|||
161020862|NCT03287817|581468041|FG001|Overall Study|Death|0|||
161020863|NCT03287817|581468042|FG002|Overall Study|Death|2|||
161020864|NCT03287817|581468043|FG003|Overall Study|Death|3|||
161020865|NCT03287817|581468044|FG004|Overall Study|Death|4|||
161020866|NCT03287817|581468040|FG000|Overall Study|Physician Decision|0|||
161020867|NCT03287817|581468041|FG001|Overall Study|Physician Decision|0|||
161020868|NCT03287817|581468042|FG002|Overall Study|Physician Decision|0|||
161148559|NCT02658656|581924617|FG000|Randomization|Lost to Follow-up|1|||
161148560|NCT02658656|581924618|FG001|Randomization|Lost to Follow-up|3|||
161148561|NCT02658656|581924619|FG002|Randomization|Lost to Follow-up|0|||
161148562|NCT02658656|581924617|FG000|Randomization|Adverse Event|4|||
161020869|NCT03287817|581468043|FG003|Overall Study|Physician Decision|1|||
161020870|NCT03287817|581468044|FG004|Overall Study|Physician Decision|0|||
161020871|NCT03287817|581468040|FG000|Overall Study|Withdrawal by Subject|0|||
161020872|NCT03287817|581468041|FG001|Overall Study|Withdrawal by Subject|0|||
161020873|NCT03287817|581468042|FG002|Overall Study|Withdrawal by Subject|0|||
161020874|NCT03287817|581468043|FG003|Overall Study|Withdrawal by Subject|0|||
161020875|NCT03287817|581468044|FG004|Overall Study|Withdrawal by Subject|4|||
161148563|NCT02658656|581924618|FG001|Randomization|Adverse Event|0|||
161273504|NCT03146962|582380956|FG006|Overall Study|Lost to Follow-up|0|||
161273505|NCT03146962|582380957|FG007|Overall Study|Lost to Follow-up|0|||
161273506|NCT03146962|582380958|FG008|Overall Study|Lost to Follow-up|0|||
161273507|NCT03146962|582380959|FG009|Overall Study|Lost to Follow-up|0|||
161273508|NCT03146962|582380950|FG000|Overall Study|Adverse Event|0|||
161273509|NCT03146962|582380951|FG001|Overall Study|Adverse Event|3|||
161273510|NCT03146962|582380952|FG002|Overall Study|Adverse Event|0|||
161273511|NCT03146962|582380953|FG003|Overall Study|Adverse Event|0|||
161273512|NCT03146962|582380954|FG004|Overall Study|Adverse Event|0|||
161273513|NCT03146962|582380955|FG005|Overall Study|Adverse Event|0|||
161273514|NCT03146962|582380956|FG006|Overall Study|Adverse Event|0|||
161273515|NCT03146962|582380957|FG007|Overall Study|Adverse Event|1|||
161273516|NCT03146962|582380958|FG008|Overall Study|Adverse Event|0|||
161273517|NCT03146962|582380959|FG009|Overall Study|Adverse Event|0|||
161273518|NCT03146962|582380950|FG000|Overall Study|Withdrawal by Subject|0|||
161273519|NCT03146962|582380951|FG001|Overall Study|Withdrawal by Subject|0|||
161273520|NCT03146962|582380952|FG002|Overall Study|Withdrawal by Subject|0|||
161273521|NCT03146962|582380953|FG003|Overall Study|Withdrawal by Subject|0|||
161273522|NCT03146962|582380954|FG004|Overall Study|Withdrawal by Subject|1|||
161273523|NCT03146962|582380955|FG005|Overall Study|Withdrawal by Subject|0|||
160969597|NCT02487472|581276893|FG000|Overall Study|Did not complete telephonic interviews|9|||
160969598|NCT02487472|581276893|FG000|Overall Study|Other|2|||
160969599|NCT01313286|581276894|FG000|Period 1|Withdrawal by Subject|2|||
160969600|NCT01313286|581276895|FG001|Period 1|Withdrawal by Subject|0|||
160969601|NCT00654901|581276896|FG000|Overall Study|Lost to Follow-up|1|||
160969602|NCT00654901|581276897|FG001|Overall Study|Lost to Follow-up|0|||
160969603|NCT00654901|581276898|FG002|Overall Study|Lost to Follow-up|1|||
160969604|NCT00654901|581276899|FG003|Overall Study|Lost to Follow-up|0|||
160969605|NCT00654901|581276896|FG000|Overall Study|Withdrawal by Subject|3|||
160969606|NCT00654901|581276897|FG001|Overall Study|Withdrawal by Subject|0|||
160969607|NCT00654901|581276898|FG002|Overall Study|Withdrawal by Subject|1|||
160969608|NCT00654901|581276899|FG003|Overall Study|Withdrawal by Subject|0|||
160969609|NCT04843930|581276901|FG000|Randomization|Withdrawal by Subject|6|||
160969610|NCT04843930|581276902|FG001|Randomization|Withdrawal by Subject|6|||
160969611|NCT04843930|581276903|FG002|Randomization|Withdrawal by Subject|0|||
160969612|NCT04843930|581276904|FG003|Randomization|Withdrawal by Subject|0|||
160969613|NCT04843930|581276901|FG000|Week 6 Assessment|Adverse Event|3|||
160969614|NCT04843930|581276902|FG001|Week 6 Assessment|Adverse Event|0|||
160969615|NCT04843930|581276903|FG002|Week 6 Assessment|Adverse Event|0|||
160969616|NCT04843930|581276904|FG003|Week 6 Assessment|Adverse Event|0|||
160969617|NCT04843930|581276901|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
160969618|NCT04843930|581276902|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
160969619|NCT04843930|581276903|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
160969620|NCT04843930|581276904|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
160969621|NCT04843930|581276901|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
160969622|NCT04843930|581276902|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
160969623|NCT04843930|581276903|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
160969624|NCT04843930|581276904|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
160969625|NCT04631705|581276905|FG000|Overall Study|Withdrawal by Subject|0|||
160969626|NCT04631705|581276906|FG001|Overall Study|Withdrawal by Subject|0|||
160969627|NCT04631705|581276907|FG002|Overall Study|Withdrawal by Subject|0|||
160969628|NCT04631705|581276908|FG003|Overall Study|Withdrawal by Subject|0|||
160969629|NCT04631705|581276909|FG004|Overall Study|Withdrawal by Subject|0|||
160969630|NCT04631705|581276910|FG005|Overall Study|Withdrawal by Subject|0|||
160969631|NCT04631705|581276911|FG006|Overall Study|Withdrawal by Subject|1|||
160969632|NCT04631705|581276912|FG007|Overall Study|Withdrawal by Subject|0|||
160969633|NCT04631705|581276913|FG008|Overall Study|Withdrawal by Subject|0|||
160969634|NCT01521884|581276915|FG000|Overall Study|Non Responders|10|||
160969635|NCT01521884|581276915|FG000|Overall Study|Adverse Event|5|||
160969636|NCT01521884|581276915|FG000|Overall Study|Pregnancy|1|||
160969637|NCT01521884|581276915|FG000|Overall Study|Withdrawal by Subject|1|||
160969638|NCT01521884|581276915|FG000|Overall Study|Physician Decision|2|||
160969639|NCT01521884|581276915|FG000|Overall Study|Protocol Violation|3|||
160969640|NCT01521884|581276915|FG000|Overall Study|Participant non-eligible|1|||
160969641|NCT01521884|581276915|FG000|Overall Study|Lost to Follow-up|4|||
160969642|NCT04241094|581276916|FG000|Overall Study|Dropped out of treatment|4|||
160969643|NCT04241094|581276916|FG000|Overall Study|Ineligible after clinical assessment|2|||
160969644|NCT04241094|581276916|FG000|Overall Study|Lost to Follow-up|2|||
160969645|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
160969646|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
160969647|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
160969648|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
160969649|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
160969650|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
160969651|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
160969652|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
160969653|NCT02332590|581276917|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
160969654|NCT02332590|581276918|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
160969655|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
160969656|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
160969657|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
160969658|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
160969659|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
160969660|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
161020876|NCT05251909|581468049|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
161020877|NCT05251909|581468050|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
161020878|NCT04130438|581468051|FG000|Overall Study|Lost to Follow-up|0|||
161020879|NCT04130438|581468052|FG001|Overall Study|Lost to Follow-up|0|||
161020880|NCT04130438|581468053|FG002|Overall Study|Lost to Follow-up|1|||
161020881|NCT03338933|581468055|FG000|Screening Visit|Lost to Follow-up|1|||
161020882|NCT03338933|581468056|FG001|Screening Visit|Lost to Follow-up|3|||
161020883|NCT03338933|581468057|FG002|Screening Visit|Lost to Follow-up|1|||
161020884|NCT03338933|581468058|FG003|Screening Visit|Lost to Follow-up|4|||
161020885|NCT03338933|581468055|FG000|Screening Visit|Screen fail after consent|2|||
161020886|NCT03338933|581468056|FG001|Screening Visit|Screen fail after consent|7|||
161020887|NCT03338933|581468057|FG002|Screening Visit|Screen fail after consent|1|||
161020888|NCT03338933|581468058|FG003|Screening Visit|Screen fail after consent|4|||
161020889|NCT03338933|581468055|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
161020890|NCT03338933|581468056|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
161020891|NCT03338933|581468057|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
161020892|NCT03338933|581468058|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
161020893|NCT03338933|581468055|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
161020894|NCT03338933|581468056|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
161020895|NCT03338933|581468057|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
161020896|NCT03338933|581468058|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
161020897|NCT03338933|581468055|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
161020898|NCT03338933|581468056|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
161020899|NCT03338933|581468057|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
161020900|NCT03338933|581468058|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
161020901|NCT04764448|581468059|FG000|Overall Study|Study terminated by sponsor|2|||
161020902|NCT04764448|581468060|FG001|Overall Study|Study terminated by sponsor|2|||
161020903|NCT04764448|581468061|FG002|Overall Study|Study terminated by sponsor|5|||
161020904|NCT04764448|581468059|FG000|Overall Study|Withdrawal by Subject|3|||
161020905|NCT04764448|581468060|FG001|Overall Study|Withdrawal by Subject|3|||
161020906|NCT04764448|581468061|FG002|Overall Study|Withdrawal by Subject|1|||
161020907|NCT01084876|581468062|FG000|Main Study Treatment Period|Adverse Event|12|||
161020908|NCT01084876|581468063|FG001|Main Study Treatment Period|Adverse Event|7|||
161020909|NCT01084876|581468062|FG000|Main Study Treatment Period|Disease Progression|41|||
161020910|NCT01084876|581468063|FG001|Main Study Treatment Period|Disease Progression|24|||
161020911|NCT01084876|581468062|FG000|Main Study Treatment Period|Physician Decision|2|||
161020912|NCT01084876|581468063|FG001|Main Study Treatment Period|Physician Decision|0|||
161020913|NCT01084876|581468062|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
161020914|NCT01084876|581468063|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
161273524|NCT03146962|582380956|FG006|Overall Study|Withdrawal by Subject|0|||
161273525|NCT03146962|582380957|FG007|Overall Study|Withdrawal by Subject|0|||
161273526|NCT03146962|582380958|FG008|Overall Study|Withdrawal by Subject|0|||
161273527|NCT03146962|582380959|FG009|Overall Study|Withdrawal by Subject|0|||
161273528|NCT03146962|582380950|FG000|Overall Study|Death|0|||
161273529|NCT03146962|582380951|FG001|Overall Study|Death|1|||
161273530|NCT03146962|582380952|FG002|Overall Study|Death|0|||
161020915|NCT01084876|581468062|FG000|Main Study Treatment Period|Other Reason|0|||
161020916|NCT01084876|581468063|FG001|Main Study Treatment Period|Other Reason|1|||
161020917|NCT01084876|581468062|FG000|Main Study Treatment Period|Other|0|||
161020918|NCT01084876|581468063|FG001|Main Study Treatment Period|Other|1|||
161020919|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
161020920|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
161020921|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
161020922|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
161020923|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
161148564|NCT02658656|581924619|FG002|Randomization|Adverse Event|0|||
161273531|NCT03146962|582380953|FG003|Overall Study|Death|0|||
161020924|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
161148565|NCT02658656|581924617|FG000|Randomization|Administrative Termination|3|||
161020925|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
161020926|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
161020927|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
161020928|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
161020929|NCT01084876|581468062|FG000|Treatment Period Beyond Cycle 8|Other|6|||
161020930|NCT01084876|581468063|FG001|Treatment Period Beyond Cycle 8|Other|9|||
161020931|NCT04515576|581468064|FG000|Overall Study|Withdrawal by Subject|0|||
161020932|NCT04515576|581468065|FG001|Overall Study|Withdrawal by Subject|0|||
161020933|NCT04515576|581468066|FG002|Overall Study|Withdrawal by Subject|0|||
161020934|NCT04515576|581468067|FG003|Overall Study|Withdrawal by Subject|0|||
161020935|NCT04515576|581468068|FG004|Overall Study|Withdrawal by Subject|0|||
161020936|NCT04515576|581468069|FG005|Overall Study|Withdrawal by Subject|1|||
161020937|NCT02577835|581468070|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
161020938|NCT04342494|581468071|FG000|Overall Study|Questionnaire partially completed|1|||
161020939|NCT04342494|581468072|FG001|Overall Study|Questionnaire partially completed|0|||
161020940|NCT04342494|581468073|FG002|Overall Study|Questionnaire partially completed|2|||
161020941|NCT04342494|581468074|FG003|Overall Study|Questionnaire partially completed|0|||
161020942|NCT04342494|581468075|FG004|Overall Study|Questionnaire partially completed|1|||
161020943|NCT04342494|581468071|FG000|Overall Study|Lost to Follow-up|49|||
161020944|NCT04342494|581468072|FG001|Overall Study|Lost to Follow-up|38|||
161020945|NCT04342494|581468073|FG002|Overall Study|Lost to Follow-up|34|||
161020946|NCT04342494|581468074|FG003|Overall Study|Lost to Follow-up|34|||
161020947|NCT04342494|581468075|FG004|Overall Study|Lost to Follow-up|35|||
161020948|NCT05119023|581468077|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
161020949|NCT05119023|581468077|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
161020950|NCT05119023|581468077|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
161020951|NCT03194217|581468078|FG000|Overall Study|Adverse Event|0|||
161020952|NCT03194217|581468079|FG001|Overall Study|Adverse Event|2|||
161020953|NCT03194217|581468080|FG002|Overall Study|Adverse Event|3|||
161020954|NCT03194217|581468081|FG003|Overall Study|Adverse Event|3|||
161020955|NCT03194217|581468078|FG000|Overall Study|Failure to meet randomisation criteria|0|||
161020956|NCT03194217|581468079|FG001|Overall Study|Failure to meet randomisation criteria|0|||
161020957|NCT03194217|581468080|FG002|Overall Study|Failure to meet randomisation criteria|0|||
161020958|NCT03194217|581468081|FG003|Overall Study|Failure to meet randomisation criteria|1|||
161020959|NCT03194217|581468078|FG000|Overall Study|Other|0|||
161020960|NCT03194217|581468079|FG001|Overall Study|Other|1|||
161020961|NCT03194217|581468080|FG002|Overall Study|Other|1|||
161020962|NCT03194217|581468081|FG003|Overall Study|Other|0|||
161020963|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
161020964|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
161020965|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
161020966|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020967|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020968|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020969|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
161020970|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020971|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
161020972|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020973|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020974|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020975|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020976|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
161020977|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020978|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
161020979|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
161020980|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020981|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020982|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020983|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
161020984|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
161020985|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020986|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020987|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020988|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020989|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161020990|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
161091132|NCT02581631|581723821|FG003|Overall Study|Request to discontinue|0|||
161020991|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020992|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
161020993|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020994|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020995|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020996|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020997|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
161020998|NCT02962895|581468082|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161020999|NCT02962895|581468083|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021000|NCT02962895|581468084|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021001|NCT02962895|581468085|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
161021002|NCT02962895|581468086|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021003|NCT02962895|581468087|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021004|NCT02962895|581468088|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
161021005|NCT02962895|581468082|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021006|NCT02962895|581468083|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021007|NCT02962895|581468084|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021008|NCT02962895|581468085|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021009|NCT02962895|581468086|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021010|NCT02962895|581468087|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
161021011|NCT02962895|581468088|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
161021012|NCT02962895|581468082|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021013|NCT02962895|581468083|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021014|NCT02962895|581468084|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021015|NCT02962895|581468085|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021016|NCT02962895|581468086|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
161021017|NCT02962895|581468087|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
161021018|NCT02962895|581468088|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
161021019|NCT02962895|581468082|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021020|NCT02962895|581468083|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021021|NCT02962895|581468084|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021022|NCT02962895|581468085|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021023|NCT02962895|581468086|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021024|NCT02962895|581468087|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
161021025|NCT02962895|581468088|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
161021026|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021027|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
161021028|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021029|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021030|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021031|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021032|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
161021033|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021034|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021035|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021036|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021037|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
161021038|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021039|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
161021040|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021041|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021042|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021043|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021044|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
161021045|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021046|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
161021047|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161021048|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
161021049|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
161021050|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
161021051|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161021052|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161148566|NCT02658656|581924618|FG001|Randomization|Administrative Termination|1|||
161148567|NCT02658656|581924619|FG002|Randomization|Administrative Termination|0|||
161273532|NCT03146962|582380954|FG004|Overall Study|Death|0|||
161021053|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
161021054|NCT02962895|581468082|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
161021055|NCT02962895|581468083|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161021056|NCT02962895|581468084|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
161021057|NCT02962895|581468085|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
161021058|NCT02962895|581468086|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161021059|NCT02962895|581468087|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
161021060|NCT02962895|581468088|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
161021061|NCT04509674|581468091|FG000|Overall Study|Not treated|33|||
161021062|NCT04509674|581468092|FG001|Overall Study|Not treated|26|||
161021063|NCT04509674|581468091|FG000|Overall Study|Protocol Violation|9|||
161021064|NCT04509674|581468092|FG001|Overall Study|Protocol Violation|10|||
161021065|NCT04509674|581468091|FG000|Overall Study|Lost to Follow-up|31|||
161021066|NCT04509674|581468092|FG001|Overall Study|Lost to Follow-up|39|||
161021067|NCT04509674|581468091|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
161021068|NCT04509674|581468092|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
161021069|NCT04509674|581468091|FG000|Overall Study|Adverse event, serious fatal event|11|||
161021070|NCT04509674|581468092|FG001|Overall Study|Adverse event, serious fatal event|4|||
161021071|NCT04509674|581468091|FG000|Overall Study|Adverse event, non-fatal event|107|||
161021072|NCT04509674|581468092|FG001|Overall Study|Adverse event, non-fatal event|118|||
161021073|NCT04509674|581468091|FG000|Overall Study|Other reason than listed|106|||
161021074|NCT04509674|581468092|FG001|Overall Study|Other reason than listed|95|||
161021075|NCT06190691|581468102|FG000|Overall Study|Adverse Event|2|||
161021076|NCT06190691|581468103|FG001|Overall Study|Adverse Event|0|||
161021077|NCT06190691|581468104|FG002|Overall Study|Adverse Event|0|||
161021078|NCT06190691|581468105|FG003|Overall Study|Adverse Event|0|||
161021079|NCT03016754|581468107|FG000|Overall Study|Death|5|||
161021080|NCT03016754|581468108|FG001|Overall Study|Death|4|||
161021081|NCT03016754|581468109|FG002|Overall Study|Death|5|||
161148568|NCT02658656|581924617|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
161148569|NCT02658656|581924618|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
161273533|NCT03146962|582380955|FG005|Overall Study|Death|0|||
161273534|NCT03146962|582380956|FG006|Overall Study|Death|0|||
161273535|NCT03146962|582380957|FG007|Overall Study|Death|0|||
161273536|NCT03146962|582380958|FG008|Overall Study|Death|0|||
161273537|NCT03146962|582380959|FG009|Overall Study|Death|0|||
161273538|NCT03146962|582380950|FG000|Overall Study|COVID Precautions|1|||
161273539|NCT03146962|582380951|FG001|Overall Study|COVID Precautions|0|||
161273540|NCT03146962|582380952|FG002|Overall Study|COVID Precautions|0|||
161273541|NCT03146962|582380953|FG003|Overall Study|COVID Precautions|0|||
161273542|NCT03146962|582380954|FG004|Overall Study|COVID Precautions|0|||
161273543|NCT03146962|582380955|FG005|Overall Study|COVID Precautions|0|||
161273544|NCT03146962|582380956|FG006|Overall Study|COVID Precautions|0|||
161273545|NCT03146962|582380957|FG007|Overall Study|COVID Precautions|0|||
161273546|NCT03146962|582380958|FG008|Overall Study|COVID Precautions|0|||
161273547|NCT03146962|582380959|FG009|Overall Study|COVID Precautions|0|||
161273548|NCT03146962|582380950|FG000|Overall Study|Physician Decision|0|||
161273549|NCT03146962|582380951|FG001|Overall Study|Physician Decision|0|||
161273550|NCT03146962|582380952|FG002|Overall Study|Physician Decision|0|||
161273551|NCT03146962|582380953|FG003|Overall Study|Physician Decision|0|||
161273552|NCT03146962|582380954|FG004|Overall Study|Physician Decision|0|||
161273553|NCT03146962|582380955|FG005|Overall Study|Physician Decision|0|||
161273554|NCT03146962|582380956|FG006|Overall Study|Physician Decision|0|||
161273555|NCT03146962|582380957|FG007|Overall Study|Physician Decision|0|||
161273556|NCT03146962|582380958|FG008|Overall Study|Physician Decision|0|||
161273557|NCT03146962|582380959|FG009|Overall Study|Physician Decision|1|||
161273558|NCT03146962|582380950|FG000|Overall Study|Started New Treatment|0|||
161273559|NCT03146962|582380951|FG001|Overall Study|Started New Treatment|1|||
161273560|NCT03146962|582380952|FG002|Overall Study|Started New Treatment|0|||
161343584|NCT03034967|582644412|FG000|Overall Study|Lack of Efficacy|0|||
161021082|NCT03016754|581468110|FG003|Overall Study|Death|1|||
161021083|NCT03016754|581468107|FG000|Overall Study|Lost to Follow-up|23|||
161148570|NCT02658656|581924619|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
161273561|NCT03146962|582380953|FG003|Overall Study|Started New Treatment|0|||
161273562|NCT03146962|582380954|FG004|Overall Study|Started New Treatment|0|||
161343585|NCT03034967|582644413|FG001|Overall Study|Lack of Efficacy|1|||
161273563|NCT03146962|582380955|FG005|Overall Study|Started New Treatment|0|||
161273564|NCT03146962|582380956|FG006|Overall Study|Started New Treatment|0|||
161273565|NCT03146962|582380957|FG007|Overall Study|Started New Treatment|0|||
161273566|NCT03146962|582380958|FG008|Overall Study|Started New Treatment|0|||
161273567|NCT03146962|582380959|FG009|Overall Study|Started New Treatment|0|||
161273568|NCT01635283|582380962|FG000|Overall Study|Tumor Progression|3|||
161273569|NCT01635283|582380962|FG000|Overall Study|Lost to Follow-up|1|||
161343586|NCT03034967|582644414|FG002|Overall Study|Lack of Efficacy|2|||
161021084|NCT03016754|581468108|FG001|Overall Study|Lost to Follow-up|17|||
161021085|NCT03016754|581468109|FG002|Overall Study|Lost to Follow-up|4|||
161021086|NCT03016754|581468110|FG003|Overall Study|Lost to Follow-up|2|||
161021087|NCT03016754|581468107|FG000|Overall Study|Withdrawal by Subject|6|||
161021088|NCT03016754|581468108|FG001|Overall Study|Withdrawal by Subject|6|||
161021089|NCT03016754|581468109|FG002|Overall Study|Withdrawal by Subject|2|||
161021090|NCT03016754|581468110|FG003|Overall Study|Withdrawal by Subject|2|||
161021091|NCT03016754|581468107|FG000|Overall Study|Other/Unknown|2|||
161021092|NCT03016754|581468108|FG001|Overall Study|Other/Unknown|4|||
161021093|NCT03016754|581468109|FG002|Overall Study|Other/Unknown|2|||
161021094|NCT03016754|581468110|FG003|Overall Study|Other/Unknown|1|||
161021095|NCT03016754|581468107|FG000|Overall Study|Protocol Violation|0|||
161021096|NCT03016754|581468108|FG001|Overall Study|Protocol Violation|0|||
161021097|NCT03016754|581468109|FG002|Overall Study|Protocol Violation|0|||
161021098|NCT03016754|581468110|FG003|Overall Study|Protocol Violation|4|||
161021099|NCT04019873|581468111|FG000|Overall Study|Discontinued from the treatment|1|||
161021100|NCT04019873|581468112|FG001|Overall Study|Discontinued from the treatment|39|||
161021101|NCT04019873|581468113|FG002|Overall Study|Discontinued from the treatment|2|||
161021102|NCT04316871|581468124|FG000|Overall Study|Protocol Violation|2|||
161021103|NCT04316871|581468125|FG001|Overall Study|Protocol Violation|2|||
161021104|NCT04316871|581468126|FG002|Overall Study|Protocol Violation|2|||
161021105|NCT04316871|581468127|FG003|Overall Study|Protocol Violation|2|||
161021106|NCT05087992|581468128|FG000|Overall Study|Adverse Event|0|||
161021107|NCT05087992|581468129|FG001|Overall Study|Adverse Event|1|||
161021108|NCT05087992|581468130|FG002|Overall Study|Adverse Event|0|||
161021109|NCT05087992|581468128|FG000|Overall Study|Withdrawal by Subject|2|||
161021110|NCT05087992|581468129|FG001|Overall Study|Withdrawal by Subject|0|||
161021111|NCT05087992|581468130|FG002|Overall Study|Withdrawal by Subject|0|||
161021112|NCT05087992|581468128|FG000|Overall Study|clinical disease progression|3|||
161021113|NCT05087992|581468129|FG001|Overall Study|clinical disease progression|1|||
161021114|NCT05087992|581468130|FG002|Overall Study|clinical disease progression|0|||
161021115|NCT05087992|581468128|FG000|Overall Study|objective disease progression|4|||
161021116|NCT05087992|581468129|FG001|Overall Study|objective disease progression|1|||
161021117|NCT05087992|581468130|FG002|Overall Study|objective disease progression|0|||
161021118|NCT04473222|581468131|FG000|Overall Study|Lost to Follow-up|13|||
161021119|NCT04473222|581468132|FG001|Overall Study|Lost to Follow-up|13|||
161021120|NCT04473222|581468131|FG000|Overall Study|Withdrawal by Subject|0|||
161021121|NCT04473222|581468132|FG001|Overall Study|Withdrawal by Subject|1|||
161021122|NCT04473222|581468131|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
161021123|NCT04473222|581468132|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
161021124|NCT01098812|581468141|FG000|Overall Study|Death|2|||
161021125|NCT01098812|581468142|FG001|Overall Study|Death|0|||
161021126|NCT01098812|581468143|FG002|Overall Study|Death|1|||
161021127|NCT01098812|581468141|FG000|Overall Study|Lost to Follow-up|0|||
161021128|NCT01098812|581468142|FG001|Overall Study|Lost to Follow-up|1|||
161021129|NCT01098812|581468143|FG002|Overall Study|Lost to Follow-up|0|||
161021130|NCT02319759|581468144|FG000|Week 0 - 16|Lack of Efficacy|1|||
161021131|NCT02319759|581468145|FG001|Week 0 - 16|Lack of Efficacy|0|||
161021132|NCT02319759|581468146|FG002|Week 0 - 16|Lack of Efficacy|0|||
161021133|NCT02319759|581468147|FG003|Week 0 - 16|Lack of Efficacy|0|||
161021134|NCT02319759|581468148|FG004|Week 0 - 16|Lack of Efficacy|0|||
161021135|NCT02319759|581468144|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021136|NCT02319759|581468145|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021137|NCT02319759|581468146|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
161021138|NCT02319759|581468147|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021139|NCT02319759|581468148|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
161021140|NCT02319759|581468144|FG000|Week 16 - 24|Lack of Efficacy|1|||
161021141|NCT02319759|581468145|FG001|Week 16 - 24|Lack of Efficacy|0|||
161021142|NCT02319759|581468146|FG002|Week 16 - 24|Lack of Efficacy|1|||
161021143|NCT02319759|581468147|FG003|Week 16 - 24|Lack of Efficacy|0|||
161021144|NCT02319759|581468148|FG004|Week 16 - 24|Lack of Efficacy|0|||
161021145|NCT02319759|581468144|FG000|Week 16 - 24|Lost to Follow-up|1|||
161021146|NCT02319759|581468145|FG001|Week 16 - 24|Lost to Follow-up|0|||
161021147|NCT02319759|581468146|FG002|Week 16 - 24|Lost to Follow-up|0|||
161021148|NCT02319759|581468147|FG003|Week 16 - 24|Lost to Follow-up|0|||
161021149|NCT02319759|581468148|FG004|Week 16 - 24|Lost to Follow-up|0|||
161021150|NCT02319759|581468144|FG000|Week 16 - 24|Withdrawal by Subject|0|||
161021151|NCT02319759|581468145|FG001|Week 16 - 24|Withdrawal by Subject|0|||
161021152|NCT02319759|581468146|FG002|Week 16 - 24|Withdrawal by Subject|2|||
161021153|NCT02319759|581468147|FG003|Week 16 - 24|Withdrawal by Subject|0|||
161021154|NCT02319759|581468148|FG004|Week 16 - 24|Withdrawal by Subject|0|||
161021155|NCT02319759|581468144|FG000|Week 24 - 56|Adverse Event|0|||
161273570|NCT04516759|582380963|FG000|Overall Study|Withdrawal by Subject|1|||
161273571|NCT04516759|582380964|FG001|Overall Study|Withdrawal by Subject|1|||
161273572|NCT04516759|582380963|FG000|Overall Study|Other|0|||
161273573|NCT04516759|582380964|FG001|Overall Study|Other|1|||
161273574|NCT01268501|582380972|FG000|Overall Study|Lost to Follow-up|1|||
161273575|NCT01268501|582380972|FG000|Overall Study|Withdrawal by Subject|3|||
161273576|NCT01268501|582380972|FG000|Overall Study|Unacceptable Subjective Vision|3|||
161021156|NCT02319759|581468145|FG001|Week 24 - 56|Adverse Event|0|||
161021157|NCT02319759|581468146|FG002|Week 24 - 56|Adverse Event|2|||
161021158|NCT02319759|581468147|FG003|Week 24 - 56|Adverse Event|0|||
161021159|NCT02319759|581468148|FG004|Week 24 - 56|Adverse Event|0|||
161021160|NCT02319759|581468144|FG000|Week 24 - 56|Lack of Efficacy|0|||
161021161|NCT02319759|581468145|FG001|Week 24 - 56|Lack of Efficacy|0|||
161021162|NCT02319759|581468146|FG002|Week 24 - 56|Lack of Efficacy|0|||
161021163|NCT02319759|581468147|FG003|Week 24 - 56|Lack of Efficacy|2|||
161021164|NCT02319759|581468148|FG004|Week 24 - 56|Lack of Efficacy|1|||
161021165|NCT02319759|581468144|FG000|Week 24 - 56|Withdrawal by Subject|0|||
161021166|NCT02319759|581468145|FG001|Week 24 - 56|Withdrawal by Subject|1|||
161021167|NCT02319759|581468146|FG002|Week 24 - 56|Withdrawal by Subject|0|||
161021168|NCT02319759|581468147|FG003|Week 24 - 56|Withdrawal by Subject|0|||
161021169|NCT02319759|581468148|FG004|Week 24 - 56|Withdrawal by Subject|0|||
161021170|NCT02319759|581468144|FG000|Week 24 - 56|Lost to Follow-up|0|||
161021171|NCT02319759|581468145|FG001|Week 24 - 56|Lost to Follow-up|0|||
161021172|NCT02319759|581468146|FG002|Week 24 - 56|Lost to Follow-up|0|||
161021173|NCT02319759|581468147|FG003|Week 24 - 56|Lost to Follow-up|0|||
161021174|NCT02319759|581468148|FG004|Week 24 - 56|Lost to Follow-up|1|||
161021175|NCT03452579|581468151|FG000|Overall Study|Death|0|||
161021176|NCT03452579|581468152|FG001|Overall Study|Death|1|||
161021177|NCT03452579|581468151|FG000|Overall Study|Withdrawal by Subject|2|||
161021178|NCT03452579|581468152|FG001|Overall Study|Withdrawal by Subject|0|||
161021179|NCT03452579|581468151|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
161021180|NCT03452579|581468152|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
161021181|NCT03452579|581468151|FG000|Overall Study|Physician Decision|1|||
161021182|NCT03452579|581468152|FG001|Overall Study|Physician Decision|1|||
161021183|NCT03452579|581468151|FG000|Overall Study|Adverse Event|1|||
161021184|NCT03452579|581468152|FG001|Overall Study|Adverse Event|4|||
161021185|NCT04858321|581468153|FG000|Overall Study|Withdrawal by Subject|3|||
161021186|NCT05006872|581468156|FG000|Overall Study|Lost to Follow-up|37|||
161021187|NCT05006872|581468157|FG001|Overall Study|Lost to Follow-up|31|||
161021188|NCT04025554|581468158|FG000|Overall Study|Adverse Event|3|||
161021189|NCT04700163|581468159|FG000|Overall Study|Lost to Follow-up|0|||
161021190|NCT04700163|581468160|FG001|Overall Study|Lost to Follow-up|0|||
161021191|NCT04700163|581468161|FG002|Overall Study|Lost to Follow-up|0|||
161021192|NCT04700163|581468162|FG003|Overall Study|Lost to Follow-up|0|||
161021193|NCT04700163|581468163|FG004|Overall Study|Lost to Follow-up|0|||
161021194|NCT04700163|581468164|FG005|Overall Study|Lost to Follow-up|1|||
161021195|NCT03848065|581468167|FG000|Overall Study|Death|0|||
161021196|NCT03848065|581468168|FG001|Overall Study|Death|1|||
161021197|NCT03848065|581468169|FG002|Overall Study|Death|0|||
161021198|NCT03848065|581468167|FG000|Overall Study|Lost to Follow-up|0|||
161021199|NCT03848065|581468168|FG001|Overall Study|Lost to Follow-up|0|||
161021200|NCT03848065|581468169|FG002|Overall Study|Lost to Follow-up|1|||
161021201|NCT03848065|581468167|FG000|Overall Study|Physician Decision|0|||
161021202|NCT03848065|581468168|FG001|Overall Study|Physician Decision|0|||
161021203|NCT03848065|581468169|FG002|Overall Study|Physician Decision|1|||
161021204|NCT05543629|581468172|FG000|Overall Study|Death|1|||
161021205|NCT05543629|581468173|FG001|Overall Study|Death|0|||
161021206|NCT05543629|581468174|FG002|Overall Study|Death|1|||
161021207|NCT05543629|581468175|FG003|Overall Study|Death|0|||
161021208|NCT05543629|581468176|FG004|Overall Study|Death|0|||
161021209|NCT05543629|581468177|FG005|Overall Study|Death|1|||
161273577|NCT01268501|582380972|FG000|Overall Study|Handling Difficulties|2|||
161273578|NCT00724048|582380973|FG000|Overall Study|Adverse Event|1|||
161273579|NCT00724048|582380974|FG001|Overall Study|Adverse Event|1|||
161273580|NCT00724048|582380975|FG002|Overall Study|Adverse Event|1|||
161021210|NCT05543629|581468178|FG006|Overall Study|Death|2|||
161021211|NCT05543629|581468179|FG007|Overall Study|Death|2|||
161021212|NCT05543629|581468172|FG000|Overall Study|Other Reasons|0|||
161021213|NCT05543629|581468173|FG001|Overall Study|Other Reasons|0|||
161021214|NCT05543629|581468174|FG002|Overall Study|Other Reasons|0|||
161021215|NCT05543629|581468175|FG003|Overall Study|Other Reasons|0|||
161021216|NCT05543629|581468176|FG004|Overall Study|Other Reasons|1|||
161021217|NCT05543629|581468177|FG005|Overall Study|Other Reasons|0|||
161021218|NCT05543629|581468178|FG006|Overall Study|Other Reasons|0|||
161021219|NCT05543629|581468179|FG007|Overall Study|Other Reasons|0|||
161148571|NCT02658656|581924617|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
161273581|NCT00724048|582380976|FG003|Overall Study|Adverse Event|0|||
161273582|NCT00724048|582380973|FG000|Overall Study|Lost to Follow-up|0|||
161021220|NCT05543629|581468172|FG000|Overall Study|Physician Decision|0|||
161021221|NCT05543629|581468173|FG001|Overall Study|Physician Decision|0|||
161021222|NCT05543629|581468174|FG002|Overall Study|Physician Decision|3|||
161021223|NCT05543629|581468175|FG003|Overall Study|Physician Decision|0|||
161021224|NCT05543629|581468176|FG004|Overall Study|Physician Decision|0|||
161021225|NCT05543629|581468177|FG005|Overall Study|Physician Decision|0|||
161021226|NCT05543629|581468178|FG006|Overall Study|Physician Decision|1|||
161021227|NCT05543629|581468179|FG007|Overall Study|Physician Decision|0|||
161021228|NCT05543629|581468172|FG000|Overall Study|Study terminated by Sponsor|1|||
161021229|NCT05543629|581468173|FG001|Overall Study|Study terminated by Sponsor|0|||
161021230|NCT05543629|581468174|FG002|Overall Study|Study terminated by Sponsor|0|||
161021231|NCT05543629|581468175|FG003|Overall Study|Study terminated by Sponsor|1|||
161021232|NCT05543629|581468176|FG004|Overall Study|Study terminated by Sponsor|0|||
161021233|NCT05543629|581468177|FG005|Overall Study|Study terminated by Sponsor|4|||
161021234|NCT05543629|581468178|FG006|Overall Study|Study terminated by Sponsor|1|||
161021235|NCT05543629|581468179|FG007|Overall Study|Study terminated by Sponsor|0|||
161021236|NCT05543629|581468172|FG000|Overall Study|Withdrawal by Subject|1|||
161021237|NCT05543629|581468173|FG001|Overall Study|Withdrawal by Subject|1|||
161021238|NCT05543629|581468174|FG002|Overall Study|Withdrawal by Subject|0|||
161021239|NCT05543629|581468175|FG003|Overall Study|Withdrawal by Subject|2|||
161021240|NCT05543629|581468176|FG004|Overall Study|Withdrawal by Subject|1|||
161021241|NCT05543629|581468177|FG005|Overall Study|Withdrawal by Subject|1|||
161021242|NCT05543629|581468178|FG006|Overall Study|Withdrawal by Subject|1|||
161021243|NCT05543629|581468179|FG007|Overall Study|Withdrawal by Subject|1|||
161021244|NCT05543629|581468172|FG000|Overall Study|Not Reported|2|||
161021245|NCT05543629|581468173|FG001|Overall Study|Not Reported|2|||
161021246|NCT05543629|581468174|FG002|Overall Study|Not Reported|0|||
161021247|NCT05543629|581468175|FG003|Overall Study|Not Reported|0|||
161021248|NCT05543629|581468176|FG004|Overall Study|Not Reported|1|||
161021249|NCT05543629|581468177|FG005|Overall Study|Not Reported|1|||
161021250|NCT05543629|581468178|FG006|Overall Study|Not Reported|3|||
161021251|NCT05543629|581468179|FG007|Overall Study|Not Reported|0|||
161021252|NCT04568603|581468180|FG000|Overall Study|Physician Decision|1|||
161021253|NCT03270501|581468181|FG000|Overall Study|Screen failure|6|||
161021254|NCT03270501|581468181|FG000|Overall Study|Lost to Follow-up|2|||
161021255|NCT03270501|581468181|FG000|Overall Study|Adverse Event|1|||
161021256|NCT00764751|581468186|FG000|Overall Study|Adverse Event|1|||
161021257|NCT00764751|581468187|FG001|Overall Study|Adverse Event|1|||
161021258|NCT00764751|581468186|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
161021259|NCT00764751|581468187|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
161021260|NCT05270408|581468196|FG000|Started Treatment|Withdrawal by Subject|0|||
161021261|NCT05270408|581468197|FG001|Started Treatment|Withdrawal by Subject|0|||
161021262|NCT05270408|581468198|FG002|Started Treatment|Withdrawal by Subject|3|||
161021263|NCT05270408|581468196|FG000|Started Treatment|Adverse Event|0|||
161021264|NCT05270408|581468197|FG001|Started Treatment|Adverse Event|0|||
161021265|NCT05270408|581468198|FG002|Started Treatment|Adverse Event|1|||
161021266|NCT05270408|581468196|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
161021267|NCT05270408|581468197|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
161021268|NCT05270408|581468198|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
161021269|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
161021270|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
161021271|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
161021272|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
161021273|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
161021274|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
161021275|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
161021276|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
161021277|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
161021278|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
161021279|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
161021280|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
161021281|NCT04338061|581468199|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
161021282|NCT04338061|581468200|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
161021283|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
161021284|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
161021285|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
161021286|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
161021287|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161021288|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
161021289|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
161021290|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
161021291|NCT04338061|581468199|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
161021292|NCT04338061|581468200|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
161021293|NCT04074759|581468201|FG000|Overall Study|Withdrawal by Subject|0|||
161021294|NCT04074759|581468202|FG001|Overall Study|Withdrawal by Subject|0|||
161021295|NCT04074759|581468203|FG002|Overall Study|Withdrawal by Subject|0|||
161021296|NCT04074759|581468204|FG003|Overall Study|Withdrawal by Subject|0|||
161207085|NCT05004181|582138119|FG010|Overall Study|Withdrawal by Subject|3|||
161207086|NCT05004181|582138120|FG011|Overall Study|Withdrawal by Subject|2|||
161207087|NCT05004181|582138109|FG000|Overall Study|Protocol Violation|2|||
161207088|NCT05004181|582138110|FG001|Overall Study|Protocol Violation|3|||
161273583|NCT00724048|582380974|FG001|Overall Study|Lost to Follow-up|1|||
161021297|NCT04074759|581468205|FG004|Overall Study|Withdrawal by Subject|0|||
161021298|NCT04074759|581468206|FG005|Overall Study|Withdrawal by Subject|2|||
161021299|NCT04074759|581468207|FG006|Overall Study|Withdrawal by Subject|0|||
161021300|NCT04074759|581468208|FG007|Overall Study|Withdrawal by Subject|2|||
161021301|NCT04074759|581468209|FG008|Overall Study|Withdrawal by Subject|1|||
161021302|NCT04074759|581468210|FG009|Overall Study|Withdrawal by Subject|2|||
161021303|NCT04074759|581468211|FG010|Overall Study|Withdrawal by Subject|9|||
161021304|NCT04074759|581468212|FG011|Overall Study|Withdrawal by Subject|2|||
161021305|NCT04074759|581468213|FG012|Overall Study|Withdrawal by Subject|1|||
161021306|NCT04074759|581468214|FG013|Overall Study|Withdrawal by Subject|3|||
161021307|NCT04074759|581468215|FG014|Overall Study|Withdrawal by Subject|2|||
161021308|NCT04074759|581468216|FG015|Overall Study|Withdrawal by Subject|0|||
161021309|NCT04074759|581468217|FG016|Overall Study|Withdrawal by Subject|0|||
161021310|NCT04074759|581468218|FG017|Overall Study|Withdrawal by Subject|3|||
161021311|NCT04074759|581468219|FG018|Overall Study|Withdrawal by Subject|1|||
161021312|NCT04074759|581468201|FG000|Overall Study|Death|1|||
161021313|NCT04074759|581468202|FG001|Overall Study|Death|0|||
161021314|NCT04074759|581468203|FG002|Overall Study|Death|1|||
161021315|NCT04074759|581468204|FG003|Overall Study|Death|1|||
161021316|NCT04074759|581468205|FG004|Overall Study|Death|2|||
161021317|NCT04074759|581468206|FG005|Overall Study|Death|0|||
161021318|NCT04074759|581468207|FG006|Overall Study|Death|1|||
161021319|NCT04074759|581468208|FG007|Overall Study|Death|0|||
161021320|NCT04074759|581468209|FG008|Overall Study|Death|3|||
161021321|NCT04074759|581468210|FG009|Overall Study|Death|2|||
161021322|NCT04074759|581468211|FG010|Overall Study|Death|4|||
161021323|NCT04074759|581468212|FG011|Overall Study|Death|1|||
161021324|NCT04074759|581468213|FG012|Overall Study|Death|0|||
161021325|NCT04074759|581468214|FG013|Overall Study|Death|2|||
161021326|NCT04074759|581468215|FG014|Overall Study|Death|1|||
161021327|NCT04074759|581468216|FG015|Overall Study|Death|0|||
161021328|NCT04074759|581468217|FG016|Overall Study|Death|1|||
161021329|NCT04074759|581468218|FG017|Overall Study|Death|0|||
161021330|NCT04074759|581468219|FG018|Overall Study|Death|1|||
161021331|NCT04074759|581468201|FG000|Overall Study|Lost to Follow-up|0|||
161021332|NCT04074759|581468202|FG001|Overall Study|Lost to Follow-up|0|||
161021333|NCT04074759|581468203|FG002|Overall Study|Lost to Follow-up|0|||
161021334|NCT04074759|581468204|FG003|Overall Study|Lost to Follow-up|0|||
161021335|NCT04074759|581468205|FG004|Overall Study|Lost to Follow-up|0|||
161021336|NCT04074759|581468206|FG005|Overall Study|Lost to Follow-up|0|||
161021337|NCT04074759|581468207|FG006|Overall Study|Lost to Follow-up|0|||
161021338|NCT04074759|581468208|FG007|Overall Study|Lost to Follow-up|0|||
161021339|NCT04074759|581468209|FG008|Overall Study|Lost to Follow-up|0|||
161021340|NCT04074759|581468210|FG009|Overall Study|Lost to Follow-up|0|||
161021341|NCT04074759|581468211|FG010|Overall Study|Lost to Follow-up|1|||
161021342|NCT04074759|581468212|FG011|Overall Study|Lost to Follow-up|0|||
161021343|NCT04074759|581468213|FG012|Overall Study|Lost to Follow-up|0|||
161021344|NCT04074759|581468214|FG013|Overall Study|Lost to Follow-up|0|||
161021345|NCT04074759|581468215|FG014|Overall Study|Lost to Follow-up|0|||
161021346|NCT04074759|581468216|FG015|Overall Study|Lost to Follow-up|0|||
161021347|NCT04074759|581468217|FG016|Overall Study|Lost to Follow-up|1|||
161021348|NCT04074759|581468218|FG017|Overall Study|Lost to Follow-up|0|||
161021349|NCT04074759|581468219|FG018|Overall Study|Lost to Follow-up|1|||
161021350|NCT04074759|581468201|FG000|Overall Study|Other|0|||
161021351|NCT04074759|581468202|FG001|Overall Study|Other|1|||
161021352|NCT04074759|581468203|FG002|Overall Study|Other|1|||
161021353|NCT04074759|581468204|FG003|Overall Study|Other|0|||
161021354|NCT04074759|581468205|FG004|Overall Study|Other|2|||
161021355|NCT04074759|581468206|FG005|Overall Study|Other|1|||
161021356|NCT04074759|581468207|FG006|Overall Study|Other|2|||
161021357|NCT04074759|581468208|FG007|Overall Study|Other|1|||
161021358|NCT04074759|581468209|FG008|Overall Study|Other|1|||
161021359|NCT04074759|581468210|FG009|Overall Study|Other|4|||
161021360|NCT04074759|581468211|FG010|Overall Study|Other|4|||
161021361|NCT04074759|581468212|FG011|Overall Study|Other|2|||
161021362|NCT04074759|581468213|FG012|Overall Study|Other|0|||
161021363|NCT04074759|581468214|FG013|Overall Study|Other|0|||
161021364|NCT04074759|581468215|FG014|Overall Study|Other|0|||
161021365|NCT04074759|581468216|FG015|Overall Study|Other|1|||
161021366|NCT04074759|581468217|FG016|Overall Study|Other|0|||
161021367|NCT04074759|581468218|FG017|Overall Study|Other|0|||
161021368|NCT04074759|581468219|FG018|Overall Study|Other|0|||
161021369|NCT04074759|581468201|FG000|Overall Study|Missing end of study status|0|||
161021370|NCT04074759|581468202|FG001|Overall Study|Missing end of study status|0|||
161021371|NCT04074759|581468203|FG002|Overall Study|Missing end of study status|0|||
161021372|NCT04074759|581468204|FG003|Overall Study|Missing end of study status|0|||
161021373|NCT04074759|581468205|FG004|Overall Study|Missing end of study status|0|||
161021374|NCT04074759|581468206|FG005|Overall Study|Missing end of study status|0|||
161021375|NCT04074759|581468207|FG006|Overall Study|Missing end of study status|0|||
161021376|NCT04074759|581468208|FG007|Overall Study|Missing end of study status|0|||
161021377|NCT04074759|581468209|FG008|Overall Study|Missing end of study status|0|||
161021378|NCT04074759|581468210|FG009|Overall Study|Missing end of study status|0|||
161021379|NCT04074759|581468211|FG010|Overall Study|Missing end of study status|2|||
161021380|NCT04074759|581468212|FG011|Overall Study|Missing end of study status|0|||
161021381|NCT04074759|581468213|FG012|Overall Study|Missing end of study status|0|||
161021382|NCT04074759|581468214|FG013|Overall Study|Missing end of study status|0|||
161021383|NCT04074759|581468215|FG014|Overall Study|Missing end of study status|0|||
161021384|NCT04074759|581468216|FG015|Overall Study|Missing end of study status|0|||
161021385|NCT04074759|581468217|FG016|Overall Study|Missing end of study status|1|||
161021386|NCT04074759|581468218|FG017|Overall Study|Missing end of study status|0|||
161021387|NCT04074759|581468219|FG018|Overall Study|Missing end of study status|0|||
161021388|NCT03631784|581468220|FG000|Overall Study|Participants Ongoing|1|||
161021389|NCT03631784|581468221|FG001|Overall Study|Participants Ongoing|0|||
161021390|NCT03631784|581468220|FG000|Overall Study|Withdrawal by Subject|3|||
161021391|NCT03631784|581468221|FG001|Overall Study|Withdrawal by Subject|3|||
161021392|NCT03631784|581468220|FG000|Overall Study|Sponsor's Decision|36|||
161021393|NCT03631784|581468221|FG001|Overall Study|Sponsor's Decision|52|||
161021394|NCT03631784|581468220|FG000|Overall Study|Lost to Follow-up|1|||
161021395|NCT03631784|581468221|FG001|Overall Study|Lost to Follow-up|0|||
161021396|NCT03631784|581468220|FG000|Overall Study|Death|71|||
161021397|NCT03631784|581468221|FG001|Overall Study|Death|49|||
161021398|NCT02465268|581468223|FG000|Overall Study|Withdrawal by Subject|4|||
161021399|NCT02465268|581468224|FG001|Overall Study|Withdrawal by Subject|3|||
161021400|NCT02465268|581468225|FG002|Overall Study|Withdrawal by Subject|1|||
161021401|NCT02465268|581468223|FG000|Overall Study|Not evaluable per protocol criteria|3|||
161021402|NCT02465268|581468224|FG001|Overall Study|Not evaluable per protocol criteria|2|||
161021403|NCT02465268|581468225|FG002|Overall Study|Not evaluable per protocol criteria|1|||
161021404|NCT02465268|581468223|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
161021405|NCT02465268|581468224|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
161021406|NCT02465268|581468225|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
161021407|NCT02465268|581468223|FG000|Overall Study|Study drug did not pass QA/QC|1|||
161021408|NCT02465268|581468224|FG001|Overall Study|Study drug did not pass QA/QC|0|||
161021409|NCT02465268|581468225|FG002|Overall Study|Study drug did not pass QA/QC|0|||
161021410|NCT02465268|581468223|FG000|Overall Study|Adverse Event|0|||
161021411|NCT02465268|581468224|FG001|Overall Study|Adverse Event|1|||
161021412|NCT02465268|581468225|FG002|Overall Study|Adverse Event|0|||
161021413|NCT02465268|581468223|FG000|Overall Study|Physician Decision|0|||
161021414|NCT02465268|581468224|FG001|Overall Study|Physician Decision|1|||
161021415|NCT02465268|581468225|FG002|Overall Study|Physician Decision|0|||
161021416|NCT03322267|581468227|FG000|Overall Study|Lack of Efficacy|11|||
161021417|NCT03322267|581468227|FG000|Overall Study|Adverse Event|1|||
161021418|NCT03322267|581468227|FG000|Overall Study|Withdrawal by Subject|2|||
161021419|NCT04719832|581468231|FG000|Overall Study|Adverse Event|2|||
161021420|NCT04719832|581468232|FG001|Overall Study|Adverse Event|0|||
161021421|NCT04719832|581468231|FG000|Overall Study|Lack of Efficacy|2|||
161021422|NCT04719832|581468232|FG001|Overall Study|Lack of Efficacy|4|||
161021423|NCT04719832|581468231|FG000|Overall Study|Lost to Follow-up|0|||
161021424|NCT04719832|581468232|FG001|Overall Study|Lost to Follow-up|2|||
161021425|NCT04719832|581468231|FG000|Overall Study|Physician Decision|0|||
161021426|NCT04719832|581468232|FG001|Overall Study|Physician Decision|1|||
161021427|NCT04719832|581468231|FG000|Overall Study|Pregnancy|1|||
161021428|NCT04719832|581468232|FG001|Overall Study|Pregnancy|1|||
161021429|NCT04719832|581468231|FG000|Overall Study|Withdrawal by Subject|5|||
161021430|NCT04719832|581468232|FG001|Overall Study|Withdrawal by Subject|5|||
161148572|NCT02658656|581924618|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
161148573|NCT02658656|581924619|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
161148574|NCT02658656|581924617|FG000|Randomization|Not eligible for Randomization|1|||
161148575|NCT02658656|581924618|FG001|Randomization|Not eligible for Randomization|0|||
161148576|NCT02658656|581924619|FG002|Randomization|Not eligible for Randomization|0|||
161148577|NCT02658656|581924617|FG000|Randomization|Protocol Violation|1|||
161273584|NCT00724048|582380975|FG002|Overall Study|Lost to Follow-up|0|||
161273585|NCT00724048|582380976|FG003|Overall Study|Lost to Follow-up|0|||
161021431|NCT04719832|581468231|FG000|Overall Study|Randomized, not treated|0|||
161021432|NCT04719832|581468232|FG001|Overall Study|Randomized, not treated|2|||
161021433|NCT04719832|581468231|FG000|Overall Study|GCP violations|4|||
161021434|NCT04719832|581468232|FG001|Overall Study|GCP violations|7|||
161021435|NCT01799265|581468237|FG000|Overall Study|Lost to Follow-up|1|||
161021436|NCT01799265|581468238|FG001|Overall Study|Lost to Follow-up|0|||
161021437|NCT01799265|581468237|FG000|Overall Study|Protocol Violation|2|||
161021438|NCT01799265|581468238|FG001|Overall Study|Protocol Violation|1|||
161021439|NCT01799265|581468237|FG000|Overall Study|inadequate sleep study|0|||
161021440|NCT01799265|581468238|FG001|Overall Study|inadequate sleep study|2|||
161021441|NCT03084536|581468242|FG000|Overall Study|Determined to be ineligible|0|||
161021442|NCT03084536|581468243|FG001|Overall Study|Determined to be ineligible|0|||
161021443|NCT03084536|581468244|FG002|Overall Study|Determined to be ineligible|16|||
161021444|NCT03084536|581468242|FG000|Overall Study|Withdrawal by Subject|0|||
161021445|NCT03084536|581468243|FG001|Overall Study|Withdrawal by Subject|0|||
161021446|NCT03084536|581468244|FG002|Overall Study|Withdrawal by Subject|4|||
161021447|NCT03084536|581468242|FG000|Overall Study|Physician Decision|0|||
161021448|NCT03084536|581468243|FG001|Overall Study|Physician Decision|0|||
161021449|NCT03084536|581468244|FG002|Overall Study|Physician Decision|3|||
161021450|NCT03084536|581468242|FG000|Overall Study|Death|0|||
161021451|NCT03084536|581468243|FG001|Overall Study|Death|0|||
161021452|NCT03084536|581468244|FG002|Overall Study|Death|1|||
161021453|NCT03084536|581468242|FG000|Overall Study|Lost to Follow-up|0|||
161021454|NCT03084536|581468243|FG001|Overall Study|Lost to Follow-up|0|||
161021455|NCT03084536|581468244|FG002|Overall Study|Lost to Follow-up|1|||
161021456|NCT03084536|581468242|FG000|Overall Study|Protocol Violation|0|||
161021457|NCT03084536|581468243|FG001|Overall Study|Protocol Violation|0|||
161021458|NCT03084536|581468244|FG002|Overall Study|Protocol Violation|1|||
161021459|NCT03084536|581468242|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
161021460|NCT03084536|581468243|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
161021461|NCT03084536|581468244|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
161021462|NCT05704543|581468245|FG000|Overall Study|Withdrawal by Subject|1|||
161021463|NCT05704543|581468246|FG001|Overall Study|Withdrawal by Subject|1|||
161021464|NCT05704543|581468247|FG002|Overall Study|Withdrawal by Subject|0|||
161021465|NCT05704543|581468248|FG003|Overall Study|Withdrawal by Subject|2|||
161021466|NCT05704543|581468245|FG000|Overall Study|Lost to Follow-up|1|||
161021467|NCT05704543|581468246|FG001|Overall Study|Lost to Follow-up|2|||
161021468|NCT05704543|581468247|FG002|Overall Study|Lost to Follow-up|0|||
161021469|NCT05704543|581468248|FG003|Overall Study|Lost to Follow-up|0|||
161021470|NCT04830800|581468252|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
161021471|NCT04830800|581468253|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
161021472|NCT04830800|581468254|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
161021473|NCT04830800|581468255|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
161021474|NCT04830800|581468256|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
161021475|NCT05192109|581468261|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161021476|NCT05192109|581468262|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161021477|NCT05192109|581468263|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021478|NCT05192109|581468264|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021479|NCT05192109|581468261|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161021480|NCT05192109|581468262|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161021481|NCT05192109|581468263|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021482|NCT05192109|581468264|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161021483|NCT04728347|581470718|FG000|Overall Study|Sponsor decision|0|||
161021484|NCT04728347|581470719|FG001|Overall Study|Sponsor decision|0|||
161021485|NCT04728347|581470720|FG002|Overall Study|Sponsor decision|1|||
161021486|NCT04728347|581470721|FG003|Overall Study|Sponsor decision|0|||
161021487|NCT03869866|581470724|FG000|Overall Study|Protocol Violation|1|||
161021488|NCT03869866|581470724|FG000|Overall Study|Withdrawal by Subject|3|||
161021489|NCT06181227|581470725|FG000|Overall Study|Study terminated by sponsor|7|||
161021490|NCT06181227|581470726|FG001|Overall Study|Study terminated by sponsor|9|||
161021491|NCT05543915|581470727|FG000|Overall Study|Lost to Follow-up|0|||
161021492|NCT05543915|581470728|FG001|Overall Study|Lost to Follow-up|1|||
161021493|NCT06516705|581470733|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
161021494|NCT06516705|581470734|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
161021495|NCT06516705|581470733|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
161021496|NCT06516705|581470734|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
161021497|NCT06516705|581470733|FG000|T3 ( 3 Month After Education)|covid-19|1|||
161021498|NCT06516705|581470734|FG001|T3 ( 3 Month After Education)|covid-19|2|||
161021499|NCT06516705|581470733|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
161021500|NCT06516705|581470734|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
161021501|NCT06516705|581470733|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
161021502|NCT06516705|581470734|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
161021503|NCT06516705|581470733|FG000|T4 ( 6 Month After Education)|covid-19|3|||
161021504|NCT06516705|581470734|FG001|T4 ( 6 Month After Education)|covid-19|2|||
161021505|NCT06516705|581470733|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
161021506|NCT06516705|581470734|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
161021507|NCT04292223|581470736|FG000|Overall Study|Adverse Event|1|||
161021508|NCT04292223|581470736|FG000|Overall Study|Lost to Follow-up|1|||
161021509|NCT04292223|581470736|FG000|Overall Study|Noncompliance with study drug|2|||
161021510|NCT04292223|581470736|FG000|Overall Study|Patient moved out of the state|1|||
161021511|NCT04719390|581470737|FG000|Overall Study|Withdrawal by Subject|1|||
161021512|NCT04633122|581470738|FG000|Overall Study|Remained on treatment|19|||
161021513|NCT04633122|581470739|FG001|Overall Study|Remained on treatment|14|||
161021514|NCT04633122|581470738|FG000|Overall Study|Survival follow-up stopped|22|||
161021515|NCT04633122|581470739|FG001|Overall Study|Survival follow-up stopped|25|||
161021516|NCT02561247|581470740|FG000|Overall Study|Protocol Violation|1|||
161021517|NCT02561247|581470740|FG000|Overall Study|Withdrawal by Subject|1|||
161021518|NCT02561247|581470740|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
161021519|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
161021520|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
161021521|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
161021522|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
161021523|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161021524|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
161021525|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161021526|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
161021527|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
161021528|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161021529|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161021530|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
161021531|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
161021532|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161021533|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161021534|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
161021535|NCT04963270|581470741|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161021536|NCT04963270|581470742|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
161021537|NCT04963270|581470743|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161021538|NCT04963270|581470744|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
161021539|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161021540|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161021541|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
161021542|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
161021543|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161021544|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161021545|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
161021546|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
161021547|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
161021548|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
161021549|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
161021550|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
161021551|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
161021552|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
161021553|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
161021554|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
161021555|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161021556|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161021557|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
161021558|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
161021559|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
161021560|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
161021561|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
161021562|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
161021563|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161021564|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161021565|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
161021566|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
161021567|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161021568|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161021569|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
161021570|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
161021571|NCT04963270|581470741|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161021572|NCT04963270|581470742|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161021573|NCT04963270|581470743|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
161021574|NCT04963270|581470744|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
161273586|NCT00724048|582380973|FG000|Overall Study|Withdrawal by Subject|1|||
161021575|NCT03560609|581470745|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
161021576|NCT03560609|581470746|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
161021577|NCT04908722|581470749|FG000|Overall Study|Protocol deviation|1|||
161021578|NCT04908722|581470750|FG001|Overall Study|Protocol deviation|0|||
161021579|NCT04908722|581470751|FG002|Overall Study|Protocol deviation|0|||
161021580|NCT04908722|581470752|FG003|Overall Study|Protocol deviation|0|||
161021581|NCT04908722|581470753|FG004|Overall Study|Protocol deviation|0|||
161021582|NCT04908722|581470754|FG005|Overall Study|Protocol deviation|1|||
161021583|NCT04908722|581470749|FG000|Overall Study|Lost to Follow-up|33|||
161021584|NCT04908722|581470750|FG001|Overall Study|Lost to Follow-up|33|||
161021585|NCT04908722|581470751|FG002|Overall Study|Lost to Follow-up|36|||
161021586|NCT04908722|581470752|FG003|Overall Study|Lost to Follow-up|30|||
161021587|NCT04908722|581470753|FG004|Overall Study|Lost to Follow-up|32|||
161021588|NCT04908722|581470754|FG005|Overall Study|Lost to Follow-up|34|||
161343587|NCT03034967|582644415|FG003|Overall Study|Lack of Efficacy|1|||
161021589|NCT04908722|581470749|FG000|Overall Study|Physician Decision|1|||
161021590|NCT04908722|581470750|FG001|Overall Study|Physician Decision|1|||
161021591|NCT04908722|581470751|FG002|Overall Study|Physician Decision|1|||
161021592|NCT04908722|581470752|FG003|Overall Study|Physician Decision|2|||
161021593|NCT04908722|581470753|FG004|Overall Study|Physician Decision|0|||
161021594|NCT04908722|581470754|FG005|Overall Study|Physician Decision|0|||
161021595|NCT04908722|581470749|FG000|Overall Study|Death|1|||
161021596|NCT04908722|581470750|FG001|Overall Study|Death|0|||
161021597|NCT04908722|581470751|FG002|Overall Study|Death|0|||
161021598|NCT04908722|581470752|FG003|Overall Study|Death|0|||
161021599|NCT04908722|581470753|FG004|Overall Study|Death|0|||
161021600|NCT04908722|581470754|FG005|Overall Study|Death|1|||
161021601|NCT04908722|581470749|FG000|Overall Study|Withdrawal by Subject|12|||
161021602|NCT04908722|581470750|FG001|Overall Study|Withdrawal by Subject|8|||
161021603|NCT04908722|581470751|FG002|Overall Study|Withdrawal by Subject|7|||
161021604|NCT04908722|581470752|FG003|Overall Study|Withdrawal by Subject|6|||
161021605|NCT04908722|581470753|FG004|Overall Study|Withdrawal by Subject|12|||
161021606|NCT04908722|581470754|FG005|Overall Study|Withdrawal by Subject|14|||
161021607|NCT04908722|581470749|FG000|Overall Study|Other|3|||
161021608|NCT04908722|581470750|FG001|Overall Study|Other|1|||
161021609|NCT04908722|581470751|FG002|Overall Study|Other|3|||
161021610|NCT04908722|581470752|FG003|Overall Study|Other|2|||
161021611|NCT04908722|581470753|FG004|Overall Study|Other|4|||
161021612|NCT04908722|581470754|FG005|Overall Study|Other|1|||
161021613|NCT04908722|581470749|FG000|Overall Study|Initiated prohibited medication|0|||
161021614|NCT04908722|581470750|FG001|Overall Study|Initiated prohibited medication|0|||
161021615|NCT04908722|581470751|FG002|Overall Study|Initiated prohibited medication|0|||
161021616|NCT04908722|581470752|FG003|Overall Study|Initiated prohibited medication|1|||
161021617|NCT04908722|581470753|FG004|Overall Study|Initiated prohibited medication|0|||
161021618|NCT04908722|581470754|FG005|Overall Study|Initiated prohibited medication|1|||
161021619|NCT04908722|581470749|FG000|Overall Study|Randomized but not vaccinated|3|||
161021620|NCT04908722|581470750|FG001|Overall Study|Randomized but not vaccinated|1|||
161021621|NCT04908722|581470751|FG002|Overall Study|Randomized but not vaccinated|2|||
161021622|NCT04908722|581470752|FG003|Overall Study|Randomized but not vaccinated|2|||
161021623|NCT04908722|581470753|FG004|Overall Study|Randomized but not vaccinated|3|||
161021624|NCT04908722|581470754|FG005|Overall Study|Randomized but not vaccinated|4|||
161021625|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
161021626|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
161021627|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
161021628|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
161021629|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
161021630|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
161021631|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161021632|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161021633|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
161021634|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161021635|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
161021636|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161021637|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
161021638|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
161021639|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
161021640|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161021641|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161021642|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
161021643|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021644|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
161021645|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
161021646|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021647|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021648|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
161021649|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021650|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161148578|NCT02658656|581924618|FG001|Randomization|Protocol Violation|0|||
161021651|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
161021652|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
161021653|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021654|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
161021655|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
161021656|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
161021657|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
161021658|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021659|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021660|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
161021661|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
161021662|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
161021663|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
161021664|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
161021665|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
161021666|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
161021667|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161021668|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161021669|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
161021670|NCT01369355|581470759|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
161021671|NCT01369355|581470760|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
161021672|NCT01369355|581470761|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
161021673|NCT01369355|581470762|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
161021674|NCT01369355|581470763|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
161021675|NCT01369355|581470764|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
161021676|NCT01369355|581470765|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
161021677|NCT01369355|581470766|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
161021678|NCT01369355|581470767|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
161021679|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021680|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021681|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021682|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021683|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021684|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
161021685|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
161021686|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
161021687|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
161021688|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Death|0|||
161021689|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Death|0|||
161021690|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Death|0|||
161021691|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Death|0|||
161021692|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Death|0|||
161021693|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Death|0|||
161021694|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Death|0|||
161021695|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Death|1|||
161021696|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Death|3|||
161021697|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021698|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021699|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021700|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021701|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021702|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
161021703|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
161021704|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
161021705|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
161021706|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021707|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021708|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021709|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161273587|NCT00724048|582380974|FG001|Overall Study|Withdrawal by Subject|2|||
161273588|NCT00724048|582380975|FG002|Overall Study|Withdrawal by Subject|1|||
161021710|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021711|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021712|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
161021713|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
161021714|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
161021715|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021716|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021717|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
161273589|NCT00724048|582380976|FG003|Overall Study|Withdrawal by Subject|2|||
161273590|NCT00724048|582380973|FG000|Overall Study|Investigator decision|0|||
161273591|NCT00724048|582380974|FG001|Overall Study|Investigator decision|0|||
161273592|NCT00724048|582380975|FG002|Overall Study|Investigator decision|1|||
161021718|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021719|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021720|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
161021721|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
161021722|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
161021723|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
161021724|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021725|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021726|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021727|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021728|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021729|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
161021730|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
161021731|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
161021732|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
161021733|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021734|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021735|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021736|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021737|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021738|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
161021739|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
161021740|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
161021741|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
161021742|NCT01369355|581470759|FG000|Long-term Extension (Week 44-272)|Other|0|||
161021743|NCT01369355|581470760|FG001|Long-term Extension (Week 44-272)|Other|0|||
161021744|NCT01369355|581470761|FG002|Long-term Extension (Week 44-272)|Other|0|||
161021745|NCT01369355|581470762|FG003|Long-term Extension (Week 44-272)|Other|0|||
161021746|NCT01369355|581470763|FG004|Long-term Extension (Week 44-272)|Other|0|||
161021747|NCT01369355|581470764|FG005|Long-term Extension (Week 44-272)|Other|0|||
161021748|NCT01369355|581470765|FG006|Long-term Extension (Week 44-272)|Other|110|||
161021749|NCT01369355|581470766|FG007|Long-term Extension (Week 44-272)|Other|9|||
161021750|NCT01369355|581470767|FG008|Long-term Extension (Week 44-272)|Other|17|||
161021751|NCT06424236|581470770|FG000|Overall Study|Adverse Event|0|||
161021752|NCT06424236|581470771|FG001|Overall Study|Adverse Event|1|||
161021753|NCT06424236|581470772|FG002|Overall Study|Adverse Event|0|||
161021754|NCT06424236|581470770|FG000|Overall Study|Withdrawal by Subject|3|||
161021755|NCT06424236|581470771|FG001|Overall Study|Withdrawal by Subject|1|||
161021756|NCT06424236|581470772|FG002|Overall Study|Withdrawal by Subject|2|||
161021757|NCT06424236|581470770|FG000|Overall Study|Physician Decision|0|||
161021758|NCT06424236|581470771|FG001|Overall Study|Physician Decision|1|||
161021759|NCT06424236|581470772|FG002|Overall Study|Physician Decision|0|||
161021760|NCT06424236|581470770|FG000|Overall Study|Study Terminated by Sponsor|11|||
161021761|NCT06424236|581470771|FG001|Overall Study|Study Terminated by Sponsor|20|||
161021762|NCT06424236|581470772|FG002|Overall Study|Study Terminated by Sponsor|16|||
161021763|NCT06424236|581470770|FG000|Overall Study|Lost to Follow-up|0|||
161021764|NCT06424236|581470771|FG001|Overall Study|Lost to Follow-up|1|||
161021765|NCT06424236|581470772|FG002|Overall Study|Lost to Follow-up|0|||
161021766|NCT06424236|581470770|FG000|Overall Study|Disease Progression|0|||
161021767|NCT06424236|581470771|FG001|Overall Study|Disease Progression|1|||
161021768|NCT06424236|581470772|FG002|Overall Study|Disease Progression|2|||
161021769|NCT06424236|581470770|FG000|Overall Study|Other|0|||
161021770|NCT06424236|581470771|FG001|Overall Study|Other|0|||
161021771|NCT06424236|581470772|FG002|Overall Study|Other|1|||
161021772|NCT01959425|581470776|FG000|Overall Study|Withdrawal by Subject|5|||
161021773|NCT01959425|581470777|FG001|Overall Study|Withdrawal by Subject|4|||
161021774|NCT01959425|581470776|FG000|Overall Study|Lost to Follow-up|1|||
161021775|NCT01959425|581470777|FG001|Overall Study|Lost to Follow-up|0|||
161021776|NCT01959425|581470776|FG000|Overall Study|Discontinued Subjects|6|||
161021777|NCT01959425|581470777|FG001|Overall Study|Discontinued Subjects|4|||
161021778|NCT00227344|581470779|FG000|Overall Study|study terminated early|12|||
161021779|NCT00227344|581470780|FG001|Overall Study|study terminated early|5|||
161021780|NCT01987895|581470781|FG000|Overall Study|Withdrawal by Subject|12|||
161021781|NCT01987895|581470782|FG001|Overall Study|Withdrawal by Subject|7|||
161021782|NCT01987895|581470781|FG000|Overall Study|Physician Decision|8|||
161021783|NCT01987895|581470782|FG001|Overall Study|Physician Decision|10|||
161021784|NCT01987895|581470781|FG000|Overall Study|Death|7|||
161273593|NCT00724048|582380976|FG003|Overall Study|Investigator decision|0|||
161273594|NCT00724048|582380973|FG000|Overall Study|Did not tolerate study drug|0|||
161273595|NCT00724048|582380974|FG001|Overall Study|Did not tolerate study drug|0|||
161021785|NCT01987895|581470782|FG001|Overall Study|Death|7|||
161021786|NCT01987895|581470781|FG000|Overall Study|Lost to Follow-up|3|||
161021787|NCT01987895|581470782|FG001|Overall Study|Lost to Follow-up|5|||
161021788|NCT01987895|581470781|FG000|Overall Study|randomized before giving IC|0|||
161273596|NCT00724048|582380975|FG002|Overall Study|Did not tolerate study drug|0|||
161273597|NCT00724048|582380976|FG003|Overall Study|Did not tolerate study drug|1|||
161021789|NCT01987895|581470782|FG001|Overall Study|randomized before giving IC|1|||
161021790|NCT02979327|581470783|FG000|First Intervention|Protocol Violation|1|||
161021791|NCT02979327|581470784|FG001|First Intervention|Protocol Violation|0|||
161021792|NCT01073566|581470790|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
161021793|NCT01073566|581470791|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
161021794|NCT05780437|581470792|FG000|Overall Study|Withdrawal by Subject|22|||
161021795|NCT05780437|581470793|FG001|Overall Study|Withdrawal by Subject|16|||
161021796|NCT03474679|581470802|FG000|Overall Study|Death|7|||
161021797|NCT03474679|581470802|FG000|Overall Study|Withdrawal by Subject|1|||
161021798|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
161021799|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161021800|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
161021801|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
161021802|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
161021803|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
161021804|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Death|6|||
161021805|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Death|0|||
161021806|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Death|0|||
161021807|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
161021808|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
161021809|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
161021810|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
161021811|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
161021812|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
161021813|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
161021814|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
161021815|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
161021816|NCT01539083|581470806|FG000|Before Randomization (VCD Induction)|Other|5|||
161021817|NCT01539083|581470807|FG001|Before Randomization (VCD Induction)|Other|0|||
161021818|NCT01539083|581470808|FG002|Before Randomization (VCD Induction)|Other|0|||
161021819|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
161021820|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
161021821|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
161021822|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Other|0|||
161021823|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Other|1|||
161021824|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Other|1|||
161021825|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
161021826|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
161021827|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
161021828|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
161021829|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
161021830|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
161021831|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
161021832|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
161021833|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
161021834|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
161021835|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
161021836|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
161021837|NCT01539083|581470806|FG000|After Randomization (TP and VTP)|Death|0|||
161021838|NCT01539083|581470807|FG001|After Randomization (TP and VTP)|Death|6|||
161021839|NCT01539083|581470808|FG002|After Randomization (TP and VTP)|Death|11|||
161021840|NCT05499377|581470813|FG000|Overall Study|Withdrawal by Subject|2|||
161021841|NCT05499377|581470814|FG001|Overall Study|Withdrawal by Subject|0|||
161021842|NCT05499377|581470813|FG000|Overall Study|Physician Decision|1|||
161021843|NCT05499377|581470814|FG001|Overall Study|Physician Decision|0|||
161021844|NCT03544281|581470817|FG000|Main Study Phase|Death|3|||
161021845|NCT03544281|581470818|FG001|Main Study Phase|Death|2|||
161273598|NCT00724048|582380973|FG000|Overall Study|Other than specified|1|||
161273599|NCT00724048|582380974|FG001|Overall Study|Other than specified|1|||
161273600|NCT00724048|582380975|FG002|Overall Study|Other than specified|0|||
161273601|NCT00724048|582380976|FG003|Overall Study|Other than specified|0|||
161273602|NCT04874155|582380977|FG000|Overall Study|Lost to Follow-up|1|||
161021846|NCT03544281|581470819|FG002|Main Study Phase|Death|6|||
161021847|NCT03544281|581470820|FG003|Main Study Phase|Death|8|||
161021848|NCT03544281|581470821|FG004|Main Study Phase|Death|4|||
161021849|NCT03544281|581470822|FG005|Main Study Phase|Death|2|||
161021850|NCT03544281|581470823|FG006|Main Study Phase|Death|4|||
161021851|NCT03544281|581470824|FG007|Main Study Phase|Death|5|||
161021852|NCT03544281|581470825|FG008|Main Study Phase|Death|5|||
161021853|NCT03544281|581470826|FG009|Main Study Phase|Death|8|||
161021854|NCT03544281|581470827|FG010|Main Study Phase|Death|6|||
161021855|NCT03544281|581470828|FG011|Main Study Phase|Death|4|||
161021856|NCT03544281|581470829|FG012|Main Study Phase|Death|0|||
161021857|NCT03544281|581470830|FG013|Main Study Phase|Death|0|||
161021858|NCT03544281|581470831|FG014|Main Study Phase|Death|0|||
161021859|NCT03544281|581470832|FG015|Main Study Phase|Death|0|||
161021860|NCT03544281|581470833|FG016|Main Study Phase|Death|0|||
161021861|NCT03544281|581470834|FG017|Main Study Phase|Death|0|||
161021862|NCT03544281|581470835|FG018|Main Study Phase|Death|0|||
161021863|NCT03544281|581470836|FG019|Main Study Phase|Death|0|||
161021864|NCT03544281|581470837|FG020|Main Study Phase|Death|0|||
161021865|NCT03544281|581470838|FG021|Main Study Phase|Death|0|||
161021866|NCT03544281|581470817|FG000|Main Study Phase|Lost to Follow-up|0|||
161021867|NCT03544281|581470818|FG001|Main Study Phase|Lost to Follow-up|0|||
161021868|NCT03544281|581470819|FG002|Main Study Phase|Lost to Follow-up|0|||
161021869|NCT03544281|581470820|FG003|Main Study Phase|Lost to Follow-up|0|||
161021870|NCT03544281|581470821|FG004|Main Study Phase|Lost to Follow-up|0|||
161021871|NCT03544281|581470822|FG005|Main Study Phase|Lost to Follow-up|0|||
161021872|NCT03544281|581470823|FG006|Main Study Phase|Lost to Follow-up|0|||
161021873|NCT03544281|581470824|FG007|Main Study Phase|Lost to Follow-up|0|||
161021874|NCT03544281|581470825|FG008|Main Study Phase|Lost to Follow-up|0|||
161021875|NCT03544281|581470826|FG009|Main Study Phase|Lost to Follow-up|0|||
161021876|NCT03544281|581470827|FG010|Main Study Phase|Lost to Follow-up|1|||
161021877|NCT03544281|581470828|FG011|Main Study Phase|Lost to Follow-up|0|||
161021878|NCT03544281|581470829|FG012|Main Study Phase|Lost to Follow-up|0|||
161021879|NCT03544281|581470830|FG013|Main Study Phase|Lost to Follow-up|0|||
161021880|NCT03544281|581470831|FG014|Main Study Phase|Lost to Follow-up|0|||
161021881|NCT03544281|581470832|FG015|Main Study Phase|Lost to Follow-up|0|||
161021882|NCT03544281|581470833|FG016|Main Study Phase|Lost to Follow-up|0|||
161021883|NCT03544281|581470834|FG017|Main Study Phase|Lost to Follow-up|0|||
161021884|NCT03544281|581470835|FG018|Main Study Phase|Lost to Follow-up|0|||
161021885|NCT03544281|581470836|FG019|Main Study Phase|Lost to Follow-up|0|||
161021886|NCT03544281|581470837|FG020|Main Study Phase|Lost to Follow-up|0|||
161021887|NCT03544281|581470838|FG021|Main Study Phase|Lost to Follow-up|0|||
161021888|NCT03544281|581470817|FG000|Main Study Phase|Physician Decision|0|||
161021889|NCT03544281|581470818|FG001|Main Study Phase|Physician Decision|0|||
161021890|NCT03544281|581470819|FG002|Main Study Phase|Physician Decision|0|||
161021891|NCT03544281|581470820|FG003|Main Study Phase|Physician Decision|0|||
161021892|NCT03544281|581470821|FG004|Main Study Phase|Physician Decision|0|||
161021893|NCT03544281|581470822|FG005|Main Study Phase|Physician Decision|0|||
161021894|NCT03544281|581470823|FG006|Main Study Phase|Physician Decision|0|||
161021895|NCT03544281|581470824|FG007|Main Study Phase|Physician Decision|1|||
161021896|NCT03544281|581470825|FG008|Main Study Phase|Physician Decision|0|||
161021897|NCT03544281|581470826|FG009|Main Study Phase|Physician Decision|0|||
161021898|NCT03544281|581470827|FG010|Main Study Phase|Physician Decision|0|||
161021899|NCT03544281|581470828|FG011|Main Study Phase|Physician Decision|0|||
161021900|NCT03544281|581470829|FG012|Main Study Phase|Physician Decision|0|||
161021901|NCT03544281|581470830|FG013|Main Study Phase|Physician Decision|0|||
161021902|NCT03544281|581470831|FG014|Main Study Phase|Physician Decision|0|||
161021903|NCT03544281|581470832|FG015|Main Study Phase|Physician Decision|0|||
161021904|NCT03544281|581470833|FG016|Main Study Phase|Physician Decision|0|||
161021905|NCT03544281|581470834|FG017|Main Study Phase|Physician Decision|0|||
161021906|NCT03544281|581470835|FG018|Main Study Phase|Physician Decision|0|||
161021907|NCT03544281|581470836|FG019|Main Study Phase|Physician Decision|0|||
161021908|NCT03544281|581470837|FG020|Main Study Phase|Physician Decision|0|||
161021909|NCT03544281|581470838|FG021|Main Study Phase|Physician Decision|0|||
161021910|NCT03544281|581470817|FG000|Main Study Phase|Withdrawal by Subject|2|||
161021911|NCT03544281|581470818|FG001|Main Study Phase|Withdrawal by Subject|0|||
161021912|NCT03544281|581470819|FG002|Main Study Phase|Withdrawal by Subject|1|||
161021913|NCT03544281|581470820|FG003|Main Study Phase|Withdrawal by Subject|2|||
161021914|NCT03544281|581470821|FG004|Main Study Phase|Withdrawal by Subject|0|||
161021915|NCT03544281|581470822|FG005|Main Study Phase|Withdrawal by Subject|0|||
161021916|NCT03544281|581470823|FG006|Main Study Phase|Withdrawal by Subject|0|||
161021917|NCT03544281|581470824|FG007|Main Study Phase|Withdrawal by Subject|0|||
161021918|NCT03544281|581470825|FG008|Main Study Phase|Withdrawal by Subject|2|||
161021919|NCT03544281|581470826|FG009|Main Study Phase|Withdrawal by Subject|3|||
161021920|NCT03544281|581470827|FG010|Main Study Phase|Withdrawal by Subject|0|||
161021921|NCT03544281|581470828|FG011|Main Study Phase|Withdrawal by Subject|4|||
161021922|NCT03544281|581470829|FG012|Main Study Phase|Withdrawal by Subject|0|||
161021923|NCT03544281|581470830|FG013|Main Study Phase|Withdrawal by Subject|0|||
161021924|NCT03544281|581470831|FG014|Main Study Phase|Withdrawal by Subject|0|||
161021925|NCT03544281|581470832|FG015|Main Study Phase|Withdrawal by Subject|0|||
161021926|NCT03544281|581470833|FG016|Main Study Phase|Withdrawal by Subject|0|||
161021927|NCT03544281|581470834|FG017|Main Study Phase|Withdrawal by Subject|0|||
161021928|NCT03544281|581470835|FG018|Main Study Phase|Withdrawal by Subject|0|||
161021929|NCT03544281|581470836|FG019|Main Study Phase|Withdrawal by Subject|0|||
161021930|NCT03544281|581470837|FG020|Main Study Phase|Withdrawal by Subject|0|||
161021931|NCT03544281|581470838|FG021|Main Study Phase|Withdrawal by Subject|0|||
161021932|NCT03544281|581470817|FG000|Main Study Phase|Ongoing|3|||
161021933|NCT03544281|581470818|FG001|Main Study Phase|Ongoing|1|||
161021934|NCT03544281|581470819|FG002|Main Study Phase|Ongoing|2|||
161021935|NCT03544281|581470820|FG003|Main Study Phase|Ongoing|4|||
161021936|NCT03544281|581470821|FG004|Main Study Phase|Ongoing|2|||
161021937|NCT03544281|581470822|FG005|Main Study Phase|Ongoing|4|||
161021938|NCT03544281|581470823|FG006|Main Study Phase|Ongoing|4|||
161021939|NCT03544281|581470824|FG007|Main Study Phase|Ongoing|0|||
161021940|NCT03544281|581470825|FG008|Main Study Phase|Ongoing|2|||
161021941|NCT03544281|581470826|FG009|Main Study Phase|Ongoing|2|||
161021942|NCT03544281|581470827|FG010|Main Study Phase|Ongoing|1|||
161021943|NCT03544281|581470828|FG011|Main Study Phase|Ongoing|0|||
161021944|NCT03544281|581470829|FG012|Main Study Phase|Ongoing|0|||
161021945|NCT03544281|581470830|FG013|Main Study Phase|Ongoing|0|||
161021946|NCT03544281|581470831|FG014|Main Study Phase|Ongoing|0|||
161021947|NCT03544281|581470832|FG015|Main Study Phase|Ongoing|0|||
161021948|NCT03544281|581470833|FG016|Main Study Phase|Ongoing|0|||
161021949|NCT03544281|581470834|FG017|Main Study Phase|Ongoing|0|||
161021950|NCT03544281|581470835|FG018|Main Study Phase|Ongoing|0|||
161021951|NCT03544281|581470836|FG019|Main Study Phase|Ongoing|0|||
161021952|NCT03544281|581470837|FG020|Main Study Phase|Ongoing|0|||
161021953|NCT03544281|581470838|FG021|Main Study Phase|Ongoing|0|||
161021954|NCT03544281|581470817|FG000|Main Study Phase|Investigator Site Closed|0|||
161021955|NCT03544281|581470818|FG001|Main Study Phase|Investigator Site Closed|0|||
161021956|NCT03544281|581470819|FG002|Main Study Phase|Investigator Site Closed|0|||
161021957|NCT03544281|581470820|FG003|Main Study Phase|Investigator Site Closed|0|||
161021958|NCT03544281|581470821|FG004|Main Study Phase|Investigator Site Closed|0|||
161021959|NCT03544281|581470822|FG005|Main Study Phase|Investigator Site Closed|0|||
161021960|NCT03544281|581470823|FG006|Main Study Phase|Investigator Site Closed|0|||
161021961|NCT03544281|581470824|FG007|Main Study Phase|Investigator Site Closed|0|||
161021962|NCT03544281|581470825|FG008|Main Study Phase|Investigator Site Closed|0|||
161021963|NCT03544281|581470826|FG009|Main Study Phase|Investigator Site Closed|1|||
161021964|NCT03544281|581470827|FG010|Main Study Phase|Investigator Site Closed|0|||
161021965|NCT03544281|581470828|FG011|Main Study Phase|Investigator Site Closed|0|||
161021966|NCT03544281|581470829|FG012|Main Study Phase|Investigator Site Closed|0|||
161021967|NCT03544281|581470830|FG013|Main Study Phase|Investigator Site Closed|0|||
161021968|NCT03544281|581470831|FG014|Main Study Phase|Investigator Site Closed|0|||
161021969|NCT03544281|581470832|FG015|Main Study Phase|Investigator Site Closed|0|||
161021970|NCT03544281|581470833|FG016|Main Study Phase|Investigator Site Closed|0|||
161021971|NCT03544281|581470834|FG017|Main Study Phase|Investigator Site Closed|0|||
161021972|NCT03544281|581470835|FG018|Main Study Phase|Investigator Site Closed|0|||
161021973|NCT03544281|581470836|FG019|Main Study Phase|Investigator Site Closed|0|||
161021974|NCT03544281|581470837|FG020|Main Study Phase|Investigator Site Closed|0|||
161021975|NCT03544281|581470838|FG021|Main Study Phase|Investigator Site Closed|0|||
161021976|NCT03544281|581470817|FG000|Main Study Phase|Did not receive study treatment|0|||
161021977|NCT03544281|581470818|FG001|Main Study Phase|Did not receive study treatment|0|||
161021978|NCT03544281|581470819|FG002|Main Study Phase|Did not receive study treatment|0|||
161021979|NCT03544281|581470820|FG003|Main Study Phase|Did not receive study treatment|0|||
161021980|NCT03544281|581470821|FG004|Main Study Phase|Did not receive study treatment|0|||
161021981|NCT03544281|581470822|FG005|Main Study Phase|Did not receive study treatment|0|||
161021982|NCT03544281|581470823|FG006|Main Study Phase|Did not receive study treatment|1|||
161021983|NCT03544281|581470824|FG007|Main Study Phase|Did not receive study treatment|0|||
161021984|NCT03544281|581470825|FG008|Main Study Phase|Did not receive study treatment|0|||
161021985|NCT03544281|581470826|FG009|Main Study Phase|Did not receive study treatment|0|||
161021986|NCT03544281|581470827|FG010|Main Study Phase|Did not receive study treatment|0|||
161021987|NCT03544281|581470828|FG011|Main Study Phase|Did not receive study treatment|0|||
161021988|NCT03544281|581470829|FG012|Main Study Phase|Did not receive study treatment|0|||
161021989|NCT03544281|581470830|FG013|Main Study Phase|Did not receive study treatment|0|||
161021990|NCT03544281|581470831|FG014|Main Study Phase|Did not receive study treatment|0|||
161021991|NCT03544281|581470832|FG015|Main Study Phase|Did not receive study treatment|0|||
161021992|NCT03544281|581470833|FG016|Main Study Phase|Did not receive study treatment|0|||
161021993|NCT03544281|581470834|FG017|Main Study Phase|Did not receive study treatment|0|||
161021994|NCT03544281|581470835|FG018|Main Study Phase|Did not receive study treatment|0|||
161021995|NCT03544281|581470836|FG019|Main Study Phase|Did not receive study treatment|0|||
161021996|NCT03544281|581470837|FG020|Main Study Phase|Did not receive study treatment|0|||
161021997|NCT03544281|581470838|FG021|Main Study Phase|Did not receive study treatment|0|||
161021998|NCT03544281|581470817|FG000|PACT Phase|Adverse Event|0|||
161021999|NCT03544281|581470818|FG001|PACT Phase|Adverse Event|0|||
161022000|NCT03544281|581470819|FG002|PACT Phase|Adverse Event|0|||
161022001|NCT03544281|581470820|FG003|PACT Phase|Adverse Event|0|||
161022002|NCT03544281|581470821|FG004|PACT Phase|Adverse Event|0|||
161022003|NCT03544281|581470822|FG005|PACT Phase|Adverse Event|0|||
161022004|NCT03544281|581470823|FG006|PACT Phase|Adverse Event|0|||
161022005|NCT03544281|581470824|FG007|PACT Phase|Adverse Event|0|||
161022006|NCT03544281|581470825|FG008|PACT Phase|Adverse Event|0|||
161022007|NCT03544281|581470826|FG009|PACT Phase|Adverse Event|0|||
161022008|NCT03544281|581470827|FG010|PACT Phase|Adverse Event|0|||
161022009|NCT03544281|581470828|FG011|PACT Phase|Adverse Event|0|||
161148579|NCT02658656|581924619|FG002|Randomization|Protocol Violation|0|||
161148580|NCT00710034|581926118|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
161022010|NCT03544281|581470829|FG012|PACT Phase|Adverse Event|1|||
161022011|NCT03544281|581470830|FG013|PACT Phase|Adverse Event|0|||
161022012|NCT03544281|581470831|FG014|PACT Phase|Adverse Event|0|||
161022013|NCT03544281|581470832|FG015|PACT Phase|Adverse Event|0|||
161022014|NCT03544281|581470833|FG016|PACT Phase|Adverse Event|0|||
161022015|NCT03544281|581470834|FG017|PACT Phase|Adverse Event|1|||
161022016|NCT03544281|581470835|FG018|PACT Phase|Adverse Event|1|||
161022017|NCT03544281|581470836|FG019|PACT Phase|Adverse Event|0|||
161022018|NCT03544281|581470837|FG020|PACT Phase|Adverse Event|0|||
161022019|NCT03544281|581470838|FG021|PACT Phase|Adverse Event|0|||
161022020|NCT06019559|581470839|FG000|Overall Study|Withdrawal by Subject|7|||
161022021|NCT06019559|581470840|FG001|Overall Study|Withdrawal by Subject|6|||
161022022|NCT06019559|581470841|FG002|Overall Study|Withdrawal by Subject|5|||
161022023|NCT06019559|581470839|FG000|Overall Study|Lost to Follow-up|2|||
161022024|NCT06019559|581470840|FG001|Overall Study|Lost to Follow-up|0|||
161022025|NCT06019559|581470841|FG002|Overall Study|Lost to Follow-up|3|||
161022026|NCT04623671|581470847|FG000|Overall Study|Adverse Event|0|||
161022027|NCT04623671|581470848|FG001|Overall Study|Adverse Event|1|||
161022028|NCT04623671|581470847|FG000|Overall Study|Lost to Follow-up|2|||
161022029|NCT04623671|581470848|FG001|Overall Study|Lost to Follow-up|1|||
161022030|NCT04623671|581470847|FG000|Overall Study|Death|5|||
161022031|NCT04623671|581470848|FG001|Overall Study|Death|5|||
161022032|NCT01802788|581470852|FG000|Overall Study|Withdrawal by Subject|102|||
161022033|NCT01802788|581470853|FG001|Overall Study|Withdrawal by Subject|5|||
161022034|NCT01802788|581470852|FG000|Overall Study|Death|382|||
161022035|NCT01802788|581470853|FG001|Overall Study|Death|18|||
161022036|NCT01802788|581470852|FG000|Overall Study|Lost to Follow-up|31|||
161022037|NCT01802788|581470853|FG001|Overall Study|Lost to Follow-up|2|||
161022038|NCT01802788|581470852|FG000|Overall Study|Physician Decision|3|||
161022039|NCT01802788|581470853|FG001|Overall Study|Physician Decision|0|||
161022040|NCT01802788|581470852|FG000|Overall Study|Patient Non-Compliance|1|||
161022041|NCT01802788|581470853|FG001|Overall Study|Patient Non-Compliance|0|||
161022042|NCT01802788|581470852|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
161022043|NCT01802788|581470853|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
161022044|NCT01802788|581470852|FG000|Overall Study|Other Reasons|19|||
161022045|NCT01802788|581470853|FG001|Overall Study|Other Reasons|0|||
161022046|NCT05257486|581470854|FG000|Overall Study|Protocol Violation|3|||
161022047|NCT04542317|581470855|FG000|Overall Study|Care recipients passed away|18|||
161022048|NCT04542317|581470856|FG001|Overall Study|Care recipients passed away|13|||
161022049|NCT04542317|581470855|FG000|Overall Study|No longer a primary caregiver|5|||
161022050|NCT04542317|581470856|FG001|Overall Study|No longer a primary caregiver|1|||
161022051|NCT04542317|581470855|FG000|Overall Study|Withdrawal by Subject|4|||
161022052|NCT04542317|581470856|FG001|Overall Study|Withdrawal by Subject|2|||
161022053|NCT04542317|581470855|FG000|Overall Study|Caregivers passed away|0|||
161022054|NCT04542317|581470856|FG001|Overall Study|Caregivers passed away|2|||
161022055|NCT04564742|581470861|FG000|Overall Study|Lost to Follow-up|1|||
161022056|NCT04564742|581470862|FG001|Overall Study|Lost to Follow-up|0|||
161022057|NCT04564742|581470861|FG000|Overall Study|Consent Withdrawal|4|||
161022058|NCT04564742|581470862|FG001|Overall Study|Consent Withdrawal|4|||
161022059|NCT03313076|581470866|FG000|Overall Study|Withdrawal by Subject|2|||
161022060|NCT03313076|581470867|FG001|Overall Study|Withdrawal by Subject|0|||
161022061|NCT03313076|581470868|FG002|Overall Study|Withdrawal by Subject|0|||
161022062|NCT03313076|581470869|FG003|Overall Study|Withdrawal by Subject|0|||
161022063|NCT03313076|581470866|FG000|Overall Study|Lost to Follow-up|0|||
161022064|NCT03313076|581470867|FG001|Overall Study|Lost to Follow-up|2|||
161022065|NCT03313076|581470868|FG002|Overall Study|Lost to Follow-up|2|||
161022066|NCT03313076|581470869|FG003|Overall Study|Lost to Follow-up|2|||
161022067|NCT05869383|581470870|FG000|Overall Study|Withdrawal by Subject|2|||
161022068|NCT05869383|581470871|FG001|Overall Study|Withdrawal by Subject|0|||
161022069|NCT04137367|581470880|FG000|Overall Study|Lost to Follow-up|8|||
161148581|NCT00710034|581926119|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
161148582|NCT00710034|581926118|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
161148583|NCT00710034|581926119|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
161148584|NCT00710034|581926118|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
161148585|NCT00710034|581926119|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
161148586|NCT00710034|581926118|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
161022070|NCT04137367|581470881|FG001|Overall Study|Lost to Follow-up|6|||
161022071|NCT04137367|581470882|FG002|Overall Study|Lost to Follow-up|4|||
161022072|NCT05144009|581470883|FG000|Overall Study|Lost to Follow-up|0|||
161022073|NCT05144009|581470884|FG001|Overall Study|Lost to Follow-up|1|||
161022074|NCT05144009|581470883|FG000|Overall Study|Study Termination by the Sponsor|11|||
161022075|NCT05144009|581470884|FG001|Overall Study|Study Termination by the Sponsor|11|||
161022076|NCT05144009|581470883|FG000|Overall Study|Disease Progression|1|||
161022077|NCT05144009|581470884|FG001|Overall Study|Disease Progression|0|||
161022078|NCT05144009|581470883|FG000|Overall Study|Participant Decision|0|||
161148587|NCT00710034|581926119|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
161022079|NCT05144009|581470884|FG001|Overall Study|Participant Decision|2|||
161022080|NCT05144009|581470883|FG000|Overall Study|Death|5|||
161022081|NCT05144009|581470884|FG001|Overall Study|Death|10|||
161022082|NCT04065841|581470885|FG000|Overall Study|Adverse Event|4|||
161022083|NCT04065841|581470886|FG001|Overall Study|Adverse Event|2|||
161022084|NCT04065841|581470887|FG002|Overall Study|Adverse Event|10|||
161022085|NCT04065841|581470888|FG003|Overall Study|Adverse Event|1|||
161022086|NCT04065841|581470885|FG000|Overall Study|Lost to Follow-up|1|||
161022087|NCT04065841|581470886|FG001|Overall Study|Lost to Follow-up|2|||
161022088|NCT04065841|581470887|FG002|Overall Study|Lost to Follow-up|2|||
161022089|NCT04065841|581470888|FG003|Overall Study|Lost to Follow-up|2|||
161022090|NCT04065841|581470885|FG000|Overall Study|Physician Decision|1|||
161022091|NCT04065841|581470886|FG001|Overall Study|Physician Decision|0|||
161022092|NCT04065841|581470887|FG002|Overall Study|Physician Decision|0|||
161022093|NCT04065841|581470888|FG003|Overall Study|Physician Decision|0|||
161022094|NCT04065841|581470885|FG000|Overall Study|Protocol Violation|0|||
161022095|NCT04065841|581470886|FG001|Overall Study|Protocol Violation|1|||
161022096|NCT04065841|581470887|FG002|Overall Study|Protocol Violation|0|||
161022097|NCT04065841|581470888|FG003|Overall Study|Protocol Violation|0|||
161022098|NCT04065841|581470885|FG000|Overall Study|Study terminated by Sponsor|22|||
161022099|NCT04065841|581470886|FG001|Overall Study|Study terminated by Sponsor|16|||
161022100|NCT04065841|581470887|FG002|Overall Study|Study terminated by Sponsor|28|||
161022101|NCT04065841|581470888|FG003|Overall Study|Study terminated by Sponsor|17|||
161022102|NCT04065841|581470885|FG000|Overall Study|Withdrawal by Subject|1|||
161022103|NCT04065841|581470886|FG001|Overall Study|Withdrawal by Subject|1|||
161022104|NCT04065841|581470887|FG002|Overall Study|Withdrawal by Subject|2|||
161022105|NCT04065841|581470888|FG003|Overall Study|Withdrawal by Subject|0|||
161022106|NCT01420237|581470891|FG000|Overall Study|Death|13|||
161022107|NCT01420237|581470891|FG000|Overall Study|Withdrawal by Subject|41|||
161022108|NCT01420237|581470891|FG000|Overall Study|Lost to Follow-up|32|||
161022109|NCT01420237|581470891|FG000|Overall Study|Adverse Event|10|||
161022110|NCT01420237|581470891|FG000|Overall Study|Investigative Site Termination|43|||
161022111|NCT01420237|581470891|FG000|Overall Study|Censored because study device not implanted|21|||
161022112|NCT01420237|581470891|FG000|Overall Study|Censored because surgery not performed|2|||
161022113|NCT01420237|581470891|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
161022114|NCT01420237|581470891|FG000|Overall Study|Sponsor terminated study early|127|||
161022115|NCT05269667|581470892|FG000|Overall Study|Study Terminated by Sponsor|4|||
161022116|NCT02815566|581470895|FG000|Overall Study|Adverse Event|1|||
161022117|NCT02815566|581470896|FG001|Overall Study|Adverse Event|1|||
161022118|NCT02815566|581470895|FG000|Overall Study|Withdrawal by Subject|1|||
161022119|NCT02815566|581470896|FG001|Overall Study|Withdrawal by Subject|0|||
161022120|NCT02815566|581470895|FG000|Overall Study|Lost to Follow-up|0|||
161022121|NCT02815566|581470896|FG001|Overall Study|Lost to Follow-up|1|||
161022122|NCT04492722|581470898|FG000|Overall Study|Adverse Event|7|||
161022123|NCT04492722|581470899|FG001|Overall Study|Adverse Event|2|||
161022124|NCT04492722|581470900|FG002|Overall Study|Adverse Event|3|||
161022125|NCT04492722|581470901|FG003|Overall Study|Adverse Event|0|||
161022126|NCT04492722|581470898|FG000|Overall Study|Death|0|||
161022127|NCT04492722|581470899|FG001|Overall Study|Death|0|||
161022128|NCT04492722|581470900|FG002|Overall Study|Death|0|||
161022129|NCT04492722|581470901|FG003|Overall Study|Death|1|||
161022130|NCT04492722|581470898|FG000|Overall Study|Lost to Follow-up|0|||
161022131|NCT04492722|581470899|FG001|Overall Study|Lost to Follow-up|1|||
161022132|NCT04492722|581470900|FG002|Overall Study|Lost to Follow-up|0|||
161022133|NCT04492722|581470901|FG003|Overall Study|Lost to Follow-up|1|||
161022134|NCT04492722|581470898|FG000|Overall Study|Physician Decision|0|||
161022135|NCT04492722|581470899|FG001|Overall Study|Physician Decision|3|||
161022136|NCT04492722|581470900|FG002|Overall Study|Physician Decision|1|||
161022137|NCT04492722|581470901|FG003|Overall Study|Physician Decision|1|||
161022138|NCT04492722|581470898|FG000|Overall Study|Withdrawal by Subject|6|||
161022139|NCT04492722|581470899|FG001|Overall Study|Withdrawal by Subject|6|||
161022140|NCT04492722|581470900|FG002|Overall Study|Withdrawal by Subject|0|||
161022141|NCT04492722|581470901|FG003|Overall Study|Withdrawal by Subject|3|||
161022142|NCT04492722|581470898|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
161022143|NCT04492722|581470899|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
161022144|NCT04492722|581470900|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
161022145|NCT04492722|581470901|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
161207089|NCT05004181|582138111|FG002|Overall Study|Protocol Violation|0|||
161207090|NCT05004181|582138112|FG003|Overall Study|Protocol Violation|0|||
161207091|NCT05004181|582138113|FG004|Overall Study|Protocol Violation|1|||
161207092|NCT05004181|582138114|FG005|Overall Study|Protocol Violation|0|||
161207093|NCT05004181|582138115|FG006|Overall Study|Protocol Violation|16|||
161207094|NCT05004181|582138116|FG007|Overall Study|Protocol Violation|18|||
161207095|NCT05004181|582138117|FG008|Overall Study|Protocol Violation|2|||
161207096|NCT05004181|582138118|FG009|Overall Study|Protocol Violation|2|||
161207097|NCT05004181|582138119|FG010|Overall Study|Protocol Violation|2|||
161207098|NCT05004181|582138120|FG011|Overall Study|Protocol Violation|1|||
161207099|NCT05004181|582138109|FG000|Overall Study|Not further specified|1|||
161022146|NCT04492722|581470898|FG000|Overall Study|Due to Covid-19 pandemic|7|||
161022147|NCT04492722|581470899|FG001|Overall Study|Due to Covid-19 pandemic|3|||
161022148|NCT04492722|581470900|FG002|Overall Study|Due to Covid-19 pandemic|7|||
161022149|NCT04492722|581470901|FG003|Overall Study|Due to Covid-19 pandemic|6|||
161022150|NCT04492722|581470898|FG000|Overall Study|Failure to meet randomisation criteria|2|||
161022151|NCT04492722|581470899|FG001|Overall Study|Failure to meet randomisation criteria|3|||
161022152|NCT04492722|581470900|FG002|Overall Study|Failure to meet randomisation criteria|4|||
161022153|NCT04492722|581470901|FG003|Overall Study|Failure to meet randomisation criteria|2|||
161022154|NCT04492722|581470898|FG000|Overall Study|Early termination from the study|54|||
161022155|NCT04492722|581470899|FG001|Overall Study|Early termination from the study|51|||
161022156|NCT04492722|581470900|FG002|Overall Study|Early termination from the study|50|||
161022157|NCT04492722|581470901|FG003|Overall Study|Early termination from the study|50|||
161022158|NCT04492722|581470898|FG000|Overall Study|Missing|3|||
161022159|NCT04492722|581470899|FG001|Overall Study|Missing|0|||
161022160|NCT04492722|581470900|FG002|Overall Study|Missing|0|||
161022161|NCT04492722|581470901|FG003|Overall Study|Missing|5|||
161022162|NCT04492722|581470898|FG000|Overall Study|Participants who did not receive treatment|0|||
161022163|NCT04492722|581470899|FG001|Overall Study|Participants who did not receive treatment|1|||
161022164|NCT04492722|581470900|FG002|Overall Study|Participants who did not receive treatment|4|||
161022165|NCT04492722|581470901|FG003|Overall Study|Participants who did not receive treatment|0|||
161022166|NCT05329220|581470905|FG000|Active Trial Period|Adverse Event|0|||
161022167|NCT05329220|581470906|FG001|Active Trial Period|Adverse Event|0|||
161022168|NCT05329220|581470907|FG002|Active Trial Period|Adverse Event|0|||
161022169|NCT05329220|581470908|FG003|Active Trial Period|Adverse Event|0|||
161022170|NCT05329220|581470909|FG004|Active Trial Period|Adverse Event|1|||
161022171|NCT05329220|581470910|FG005|Active Trial Period|Adverse Event|0|||
161022172|NCT05329220|581470905|FG000|Active Trial Period|Lost to Follow-up|0|||
161022173|NCT05329220|581470906|FG001|Active Trial Period|Lost to Follow-up|0|||
161022174|NCT05329220|581470907|FG002|Active Trial Period|Lost to Follow-up|0|||
161022175|NCT05329220|581470908|FG003|Active Trial Period|Lost to Follow-up|0|||
161022176|NCT05329220|581470909|FG004|Active Trial Period|Lost to Follow-up|32|||
161022177|NCT05329220|581470910|FG005|Active Trial Period|Lost to Follow-up|28|||
161022178|NCT05329220|581470905|FG000|Active Trial Period|Physician Decision|0|||
161022179|NCT05329220|581470906|FG001|Active Trial Period|Physician Decision|0|||
161022180|NCT05329220|581470907|FG002|Active Trial Period|Physician Decision|0|||
161022181|NCT05329220|581470908|FG003|Active Trial Period|Physician Decision|0|||
161022182|NCT05329220|581470909|FG004|Active Trial Period|Physician Decision|2|||
161022183|NCT05329220|581470910|FG005|Active Trial Period|Physician Decision|0|||
161022184|NCT05329220|581470905|FG000|Active Trial Period|Protocol Violation|0|||
161022185|NCT05329220|581470906|FG001|Active Trial Period|Protocol Violation|0|||
161022186|NCT05329220|581470907|FG002|Active Trial Period|Protocol Violation|0|||
161022187|NCT05329220|581470908|FG003|Active Trial Period|Protocol Violation|0|||
161022188|NCT05329220|581470909|FG004|Active Trial Period|Protocol Violation|1|||
161022189|NCT05329220|581470910|FG005|Active Trial Period|Protocol Violation|3|||
161022190|NCT05329220|581470905|FG000|Active Trial Period|Withdrawal by Subject|0|||
161022191|NCT05329220|581470906|FG001|Active Trial Period|Withdrawal by Subject|0|||
161022192|NCT05329220|581470907|FG002|Active Trial Period|Withdrawal by Subject|0|||
161022193|NCT05329220|581470908|FG003|Active Trial Period|Withdrawal by Subject|1|||
161022194|NCT05329220|581470909|FG004|Active Trial Period|Withdrawal by Subject|12|||
161022195|NCT05329220|581470910|FG005|Active Trial Period|Withdrawal by Subject|13|||
161022196|NCT05329220|581470905|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022197|NCT05329220|581470906|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022198|NCT05329220|581470907|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022199|NCT05329220|581470908|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022200|NCT05329220|581470909|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
161022201|NCT05329220|581470910|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
161022202|NCT05329220|581470905|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022203|NCT05329220|581470906|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022204|NCT05329220|581470907|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022205|NCT05329220|581470908|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022206|NCT05329220|581470909|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
161022207|NCT05329220|581470910|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
161022208|NCT05329220|581470905|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
161022209|NCT05329220|581470906|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
161273603|NCT04874155|582380978|FG001|Overall Study|Lost to Follow-up|1|||
161273604|NCT04874155|582380977|FG000|Overall Study|Withdrawal by Subject|2|||
161273605|NCT04874155|582380978|FG001|Overall Study|Withdrawal by Subject|2|||
161022210|NCT05329220|581470907|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
161022211|NCT05329220|581470908|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
161022212|NCT05329220|581470909|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
161022213|NCT05329220|581470910|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
161022214|NCT05329220|581470905|FG000|Follow-up Period|Adverse Event|0|||
161022215|NCT05329220|581470906|FG001|Follow-up Period|Adverse Event|0|||
161022216|NCT05329220|581470907|FG002|Follow-up Period|Adverse Event|0|||
161022217|NCT05329220|581470908|FG003|Follow-up Period|Adverse Event|0|||
161022218|NCT05329220|581470909|FG004|Follow-up Period|Adverse Event|2|||
161022219|NCT05329220|581470910|FG005|Follow-up Period|Adverse Event|1|||
161022220|NCT05329220|581470905|FG000|Follow-up Period|Death|0|||
161022221|NCT05329220|581470906|FG001|Follow-up Period|Death|0|||
161022222|NCT05329220|581470907|FG002|Follow-up Period|Death|1|||
161022223|NCT05329220|581470908|FG003|Follow-up Period|Death|1|||
161022224|NCT05329220|581470909|FG004|Follow-up Period|Death|0|||
161022225|NCT05329220|581470910|FG005|Follow-up Period|Death|1|||
161022226|NCT05329220|581470905|FG000|Follow-up Period|Lost to Follow-up|0|||
161022227|NCT05329220|581470906|FG001|Follow-up Period|Lost to Follow-up|1|||
161022228|NCT05329220|581470907|FG002|Follow-up Period|Lost to Follow-up|2|||
161022229|NCT05329220|581470908|FG003|Follow-up Period|Lost to Follow-up|2|||
161022230|NCT05329220|581470909|FG004|Follow-up Period|Lost to Follow-up|113|||
161022231|NCT05329220|581470910|FG005|Follow-up Period|Lost to Follow-up|89|||
161022232|NCT05329220|581470905|FG000|Follow-up Period|Physician Decision|0|||
161022233|NCT05329220|581470906|FG001|Follow-up Period|Physician Decision|0|||
161022234|NCT05329220|581470907|FG002|Follow-up Period|Physician Decision|0|||
161022235|NCT05329220|581470908|FG003|Follow-up Period|Physician Decision|0|||
161022236|NCT05329220|581470909|FG004|Follow-up Period|Physician Decision|2|||
161022237|NCT05329220|581470910|FG005|Follow-up Period|Physician Decision|2|||
161022238|NCT05329220|581470905|FG000|Follow-up Period|Protocol Violation|0|||
161022239|NCT05329220|581470906|FG001|Follow-up Period|Protocol Violation|0|||
161022240|NCT05329220|581470907|FG002|Follow-up Period|Protocol Violation|0|||
161022241|NCT05329220|581470908|FG003|Follow-up Period|Protocol Violation|0|||
161022242|NCT05329220|581470909|FG004|Follow-up Period|Protocol Violation|0|||
161022243|NCT05329220|581470910|FG005|Follow-up Period|Protocol Violation|1|||
161022244|NCT05329220|581470905|FG000|Follow-up Period|Withdrawal by Subject|0|||
161022245|NCT05329220|581470906|FG001|Follow-up Period|Withdrawal by Subject|0|||
161022246|NCT05329220|581470907|FG002|Follow-up Period|Withdrawal by Subject|1|||
161022247|NCT05329220|581470908|FG003|Follow-up Period|Withdrawal by Subject|1|||
161022248|NCT05329220|581470909|FG004|Follow-up Period|Withdrawal by Subject|34|||
161022249|NCT05329220|581470910|FG005|Follow-up Period|Withdrawal by Subject|35|||
161022250|NCT05329220|581470905|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022251|NCT05329220|581470906|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022252|NCT05329220|581470907|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
161022253|NCT05329220|581470908|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022254|NCT05329220|581470909|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022255|NCT05329220|581470910|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
161022256|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022257|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022258|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022259|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022260|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
161022261|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
161022262|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022263|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022264|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022265|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022266|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
161022267|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
161022268|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022269|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022270|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022271|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022272|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
161022273|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
161022274|NCT05329220|581470905|FG000|Follow-up Period|EARLY TERMINATION|0|||
161022275|NCT05329220|581470906|FG001|Follow-up Period|EARLY TERMINATION|0|||
161022276|NCT05329220|581470907|FG002|Follow-up Period|EARLY TERMINATION|0|||
161022277|NCT05329220|581470908|FG003|Follow-up Period|EARLY TERMINATION|0|||
161022278|NCT05329220|581470909|FG004|Follow-up Period|EARLY TERMINATION|0|||
161022279|NCT05329220|581470910|FG005|Follow-up Period|EARLY TERMINATION|1|||
161022280|NCT05329220|581470905|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161091133|NCT02581631|581723822|FG004|Overall Study|Request to discontinue|1|||
161022281|NCT05329220|581470906|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022282|NCT05329220|581470907|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022283|NCT05329220|581470908|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022284|NCT05329220|581470909|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
161022285|NCT05329220|581470910|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
161022286|NCT05329220|581470905|FG000|Follow-up Period|DROPPED|0|||
161022287|NCT05329220|581470906|FG001|Follow-up Period|DROPPED|0|||
161022288|NCT05329220|581470907|FG002|Follow-up Period|DROPPED|0|||
161022289|NCT05329220|581470908|FG003|Follow-up Period|DROPPED|0|||
161022290|NCT05329220|581470909|FG004|Follow-up Period|DROPPED|0|||
161022291|NCT05329220|581470910|FG005|Follow-up Period|DROPPED|1|||
161022292|NCT05329220|581470905|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022293|NCT05329220|581470906|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022294|NCT05329220|581470907|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022295|NCT05329220|581470908|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022296|NCT05329220|581470909|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
161022297|NCT05329220|581470910|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
161022298|NCT05835336|581472788|FG000|Overall Study|Withdrawal by Subject|5|||
161022299|NCT05835336|581472788|FG000|Overall Study|Did not complete the personalization process|3|||
161022300|NCT04489771|581472789|FG000|Overall Study|Death|27|||
161022301|NCT04489771|581472790|FG001|Overall Study|Death|25|||
161022302|NCT04489771|581472789|FG000|Overall Study|Withdrawal by Subject|1|||
161022303|NCT04489771|581472790|FG001|Overall Study|Withdrawal by Subject|0|||
161022304|NCT04489771|581472789|FG000|Overall Study|Participants Ongoing in Study|50|||
161022305|NCT04489771|581472790|FG001|Overall Study|Participants Ongoing in Study|51|||
161022306|NCT04059484|581472796|FG000|Overall Study|Adverse Event|2|||
161022307|NCT04059484|581472797|FG001|Overall Study|Adverse Event|5|||
161022308|NCT04059484|581472796|FG000|Overall Study|Withdrawal by Subject|5|||
161022309|NCT04059484|581472797|FG001|Overall Study|Withdrawal by Subject|3|||
161022310|NCT04059484|581472796|FG000|Overall Study|Progressive disease|112|||
161022311|NCT04059484|581472797|FG001|Overall Study|Progressive disease|112|||
161022312|NCT04059484|581472796|FG000|Overall Study|Other|8|||
161022313|NCT04059484|581472797|FG001|Overall Study|Other|3|||
161022314|NCT04059484|581472796|FG000|Overall Study|Ongoing|20|||
161022315|NCT04059484|581472797|FG001|Overall Study|Ongoing|20|||
161022316|NCT00753545|581472798|FG000|Overall Study|Death|98|||
161022317|NCT00753545|581472799|FG001|Overall Study|Death|112|||
161022318|NCT00753545|581472798|FG000|Overall Study|Lost to Follow-up|2|||
161022319|NCT00753545|581472799|FG001|Overall Study|Lost to Follow-up|3|||
161022320|NCT00753545|581472798|FG000|Overall Study|Protocol Violation|1|||
161022321|NCT00753545|581472799|FG001|Overall Study|Protocol Violation|0|||
161022322|NCT00753545|581472798|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
161022323|NCT00753545|581472799|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
161022324|NCT05453773|581472800|FG000|Overall Study|Withdrawal by Subject|3|||
161022325|NCT05453773|581472800|FG000|Overall Study|Lost to Follow-up|3|||
161022326|NCT05453773|581472800|FG000|Overall Study|Difficult Blood Draw|3|||
161022327|NCT02485938|581472803|FG000|Overall Study|Withdrawal of consent|2|||
161022328|NCT02485938|581472804|FG001|Overall Study|Withdrawal of consent|0|||
161022329|NCT03839940|581472805|FG000|Overall Study|Withdrawal by Subject|3|||
161022330|NCT03839940|581472806|FG001|Overall Study|Withdrawal by Subject|0|||
161022331|NCT03839940|581472805|FG000|Overall Study|Protocol Violation|0|||
161022332|NCT03839940|581472806|FG001|Overall Study|Protocol Violation|1|||
161022333|NCT03839940|581472805|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
161022334|NCT03839940|581472806|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
161022335|NCT03241745|581472807|FG000|Overall Study|Adverse Event|7|||
161022336|NCT03241745|581472807|FG000|Overall Study|Death|1|||
161022337|NCT03241745|581472807|FG000|Overall Study|Withdrawal by Subject|5|||
161022338|NCT03241745|581472807|FG000|Overall Study|Treatment delay >28 days|2|||
161022339|NCT03241745|581472807|FG000|Overall Study|Lack of Efficacy|14|||
161022340|NCT00470704|581472808|FG000|Overall Study|Withdrawal by Subject|4|||
161022341|NCT00470704|581472809|FG001|Overall Study|Withdrawal by Subject|3|||
161022342|NCT00470704|581472808|FG000|Overall Study|Relapse/Progression|37|||
161022343|NCT00470704|581472809|FG001|Overall Study|Relapse/Progression|42|||
161022344|NCT00470704|581472808|FG000|Overall Study|toxicity|0|||
161022345|NCT00470704|581472809|FG001|Overall Study|toxicity|1|||
161022346|NCT04802967|581472811|FG000|Part B|Withdrawal by Subject|0|||
161022347|NCT04802967|581472812|FG001|Part B|Withdrawal by Subject|0|||
161022348|NCT04802967|581472813|FG002|Part B|Withdrawal by Subject|0|||
161022349|NCT04802967|581472814|FG003|Part B|Withdrawal by Subject|0|||
161022350|NCT04802967|581472815|FG004|Part B|Withdrawal by Subject|0|||
161022351|NCT04802967|581472816|FG005|Part B|Withdrawal by Subject|1|||
161022352|NCT04802967|581472817|FG006|Part B|Withdrawal by Subject|0|||
161022353|NCT04802967|581472818|FG007|Part B|Withdrawal by Subject|0|||
161022354|NCT04802967|581472819|FG008|Part B|Withdrawal by Subject|0|||
161022355|NCT04802967|581472820|FG009|Part B|Withdrawal by Subject|0|||
161022356|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161022357|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161022358|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
161022359|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
161022360|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
161022361|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
161022362|NCT02547233|581472826|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
161022363|NCT02547233|581472827|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
161022364|NCT02547233|581472826|FG000|12-month Follow-up|Withdrawal by Subject|10|||
161022365|NCT02547233|581472827|FG001|12-month Follow-up|Withdrawal by Subject|10|||
161022366|NCT02547233|581472826|FG000|12-month Follow-up|Lost to Follow-up|3|||
161022367|NCT02547233|581472827|FG001|12-month Follow-up|Lost to Follow-up|3|||
161022368|NCT02547233|581472826|FG000|12-month Follow-up|Lack of Efficacy|1|||
161022369|NCT02547233|581472827|FG001|12-month Follow-up|Lack of Efficacy|2|||
161022370|NCT02547233|581472826|FG000|12-month Follow-up|Protocol Violation|0|||
161022371|NCT02547233|581472827|FG001|12-month Follow-up|Protocol Violation|1|||
161022372|NCT02547233|581472826|FG000|12-month Follow-up|Other|0|||
161022373|NCT02547233|581472827|FG001|12-month Follow-up|Other|1|||
161022374|NCT05362487|581472829|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
161022375|NCT03603600|581472831|FG000|Overall Study|Withdrawal by Subject|5|||
161022376|NCT03603600|581472832|FG001|Overall Study|Withdrawal by Subject|7|||
161022377|NCT03603600|581472831|FG000|Overall Study|Lost to Follow-up|2|||
161022378|NCT03603600|581472832|FG001|Overall Study|Lost to Follow-up|3|||
161022379|NCT03603600|581472831|FG000|Overall Study|Death|3|||
161022380|NCT03603600|581472832|FG001|Overall Study|Death|1|||
161022381|NCT03603600|581472831|FG000|Overall Study|Physician Decision|2|||
161022382|NCT03603600|581472832|FG001|Overall Study|Physician Decision|1|||
161022383|NCT03603600|581472831|FG000|Overall Study|Other reason|1|||
161022384|NCT03603600|581472832|FG001|Overall Study|Other reason|0|||
161022385|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
161022386|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
161022387|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
161022388|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
161022389|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
161022390|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
161022391|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
161022392|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
161022393|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
161022394|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
161022395|NCT03461276|581472833|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
161022396|NCT03461276|581472834|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
161022397|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
161022398|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
161022399|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
161022400|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
161022401|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
161022402|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
161022403|NCT03461276|581472833|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
161022404|NCT03461276|581472834|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
161022405|NCT01943409|581472838|FG000|Overall Study|resumed oral/entral|24|||
161022406|NCT01943409|581472839|FG001|Overall Study|resumed oral/entral|20|||
161022407|NCT01943409|581472838|FG000|Overall Study|Protocol Violation|14|||
161022408|NCT01943409|581472839|FG001|Overall Study|Protocol Violation|24|||
161022409|NCT01943409|581472838|FG000|Overall Study|Death|3|||
161022410|NCT01943409|581472839|FG001|Overall Study|Death|1|||
161022411|NCT01943409|581472838|FG000|Overall Study|Withdrawal by Subject|4|||
161022412|NCT01943409|581472839|FG001|Overall Study|Withdrawal by Subject|3|||
161273606|NCT02774642|582380981|FG000|Overall Study|Lost to Follow-up|9|||
161273607|NCT02774642|582380982|FG001|Overall Study|Lost to Follow-up|7|||
161273608|NCT00477295|582380983|FG000|Overall Study|Adverse Event|31|||
161273609|NCT00477295|582380984|FG001|Overall Study|Adverse Event|35|||
161022413|NCT02310646|581472840|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
161273610|NCT00477295|582380983|FG000|Overall Study|Withdrawal by Subject|35|||
161273611|NCT00477295|582380984|FG001|Overall Study|Withdrawal by Subject|24|||
161022414|NCT02310646|581472841|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
161022415|NCT02310646|581472840|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
161022416|NCT02310646|581472841|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
161022417|NCT00613106|581472848|FG000|Overall Study|Adverse Event|3|||
161022418|NCT00613106|581472849|FG001|Overall Study|Adverse Event|1|||
161273612|NCT00477295|582380983|FG000|Overall Study|Lack of Efficacy|23|||
161273613|NCT00477295|582380984|FG001|Overall Study|Lack of Efficacy|23|||
161022419|NCT00613106|581472848|FG000|Overall Study|Withdrawal by Subject|6|||
161022420|NCT00613106|581472849|FG001|Overall Study|Withdrawal by Subject|3|||
161022421|NCT00613106|581472848|FG000|Overall Study|Lost to Follow-up|7|||
161022422|NCT00613106|581472849|FG001|Overall Study|Lost to Follow-up|2|||
161022423|NCT00613106|581472848|FG000|Overall Study|misc|4|||
161022424|NCT00613106|581472849|FG001|Overall Study|misc|3|||
161022425|NCT03496168|581472850|FG000|Overall Study|Other Reasons|1|||
161022426|NCT03496168|581472850|FG000|Overall Study|Adverse Event|1|||
161022427|NCT02043678|581472855|FG000|Overall Study|Never treated|11|||
161022428|NCT02043678|581472856|FG001|Overall Study|Never treated|9|||
161022429|NCT02043678|581472855|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
161022430|NCT02043678|581472856|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
161022431|NCT02043678|581472855|FG000|Overall Study|AE without clinical PD|54|||
161022432|NCT02043678|581472856|FG001|Overall Study|AE without clinical PD|36|||
161022433|NCT02043678|581472855|FG000|Overall Study|Lost to Follow-up|1|||
161022434|NCT02043678|581472856|FG001|Overall Study|Lost to Follow-up|1|||
161022435|NCT02043678|581472855|FG000|Overall Study|Other|10|||
161022436|NCT02043678|581472856|FG001|Overall Study|Other|14|||
161022437|NCT02043678|581472855|FG000|Overall Study|Clinical PD|114|||
161022438|NCT02043678|581472856|FG001|Overall Study|Clinical PD|148|||
161022439|NCT02043678|581472855|FG000|Overall Study|Radiological PD|100|||
161022440|NCT02043678|581472856|FG001|Overall Study|Radiological PD|90|||
161022441|NCT02043678|581472855|FG000|Overall Study|Protocol-driven decision point|59|||
161022442|NCT02043678|581472856|FG001|Overall Study|Protocol-driven decision point|58|||
161022443|NCT02043678|581472855|FG000|Overall Study|Withdrawal by Subject|16|||
161022444|NCT02043678|581472856|FG001|Overall Study|Withdrawal by Subject|20|||
161022445|NCT02043678|581472855|FG000|Overall Study|Protocol Violation|1|||
161022446|NCT02043678|581472856|FG001|Overall Study|Protocol Violation|0|||
161022447|NCT02043678|581472855|FG000|Overall Study|Deterioration of general conditions|1|||
161022448|NCT02043678|581472856|FG001|Overall Study|Deterioration of general conditions|1|||
161022449|NCT02043678|581472855|FG000|Overall Study|Logistical difficulties|2|||
161022450|NCT02043678|581472856|FG001|Overall Study|Logistical difficulties|0|||
161022451|NCT02043678|581472855|FG000|Overall Study|Non-compliance with study drug|3|||
161022452|NCT02043678|581472856|FG001|Overall Study|Non-compliance with study drug|1|||
161022453|NCT02043678|581472855|FG000|Overall Study|Physician Decision|4|||
161022454|NCT02043678|581472856|FG001|Overall Study|Physician Decision|3|||
161022455|NCT02043678|581472855|FG000|Overall Study|Subject decision|0|||
161022456|NCT02043678|581472856|FG001|Overall Study|Subject decision|1|||
161022457|NCT02043678|581472855|FG000|Overall Study|Switching to other therapy|3|||
161022458|NCT02043678|581472856|FG001|Overall Study|Switching to other therapy|2|||
161022459|NCT02043678|581472855|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
161022460|NCT02043678|581472856|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
161022461|NCT02043678|581472855|FG000|Overall Study|Missing|1|||
161022462|NCT02043678|581472856|FG001|Overall Study|Missing|0|||
161022463|NCT02043678|581472855|FG000|Overall Study|Adverse Event|0|||
161022464|NCT02043678|581472856|FG001|Overall Study|Adverse Event|1|||
161022465|NCT05126433|581472857|FG000|Overall Study|Withdrawal by Subject|3|||
161022466|NCT05126433|581472858|FG001|Overall Study|Withdrawal by Subject|0|||
161022467|NCT05126433|581472859|FG002|Overall Study|Withdrawal by Subject|4|||
161022468|NCT05126433|581472857|FG000|Overall Study|Death|9|||
161022469|NCT05126433|581472858|FG001|Overall Study|Death|3|||
161022470|NCT05126433|581472859|FG002|Overall Study|Death|5|||
161022471|NCT05126433|581472857|FG000|Overall Study|Study Terminated by sponsor|0|||
161022472|NCT05126433|581472858|FG001|Overall Study|Study Terminated by sponsor|1|||
161022473|NCT05126433|581472859|FG002|Overall Study|Study Terminated by sponsor|2|||
161022474|NCT05126433|581472857|FG000|Overall Study|Progressive Disease|1|||
161022475|NCT05126433|581472858|FG001|Overall Study|Progressive Disease|4|||
161022476|NCT05126433|581472859|FG002|Overall Study|Progressive Disease|3|||
161022477|NCT05126433|581472857|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
161022478|NCT05126433|581472858|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
161022479|NCT05126433|581472859|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
161022480|NCT03907878|581472860|FG000|Treatment Period|Withdrawal by Subject|5|||
161022481|NCT03907878|581472860|FG000|Treatment Period|Adverse Event|4|||
161022482|NCT03907878|581472860|FG000|Treatment Period|Lack of Efficacy|1|||
161022483|NCT03907878|581472860|FG000|Treatment Period|Protocol Violation|1|||
161022484|NCT03907878|581472860|FG000|Follow-up Period|Adverse Event|3|||
161022485|NCT03907878|581472860|FG000|Follow-up Period|Withdrawal by Subject|3|||
161022486|NCT04307355|581472869|FG000|Overall Study|Non-Compliance|3|||
161022487|NCT04307355|581472870|FG001|Overall Study|Non-Compliance|3|||
161022488|NCT04307355|581472871|FG002|Overall Study|Non-Compliance|0|||
161022489|NCT04313972|581472876|FG000|Overall Study|Withdrawal by Subject|0|||
161022490|NCT04313972|581472877|FG001|Overall Study|Withdrawal by Subject|1|||
161022491|NCT05201079|581472891|FG000|Overall Study|Adverse Event|7|||
161022492|NCT05201079|581472892|FG001|Overall Study|Adverse Event|11|||
161148588|NCT00710034|581926118|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
161343588|NCT03034967|582644416|FG004|Overall Study|Lack of Efficacy|1|||
161022493|NCT05201079|581472891|FG000|Overall Study|Death|1|||
161022494|NCT05201079|581472892|FG001|Overall Study|Death|1|||
161022495|NCT05201079|581472891|FG000|Overall Study|Lack of Efficacy|0|||
161022496|NCT05201079|581472892|FG001|Overall Study|Lack of Efficacy|2|||
161022497|NCT05201079|581472891|FG000|Overall Study|Lost to Follow-up|0|||
161022498|NCT05201079|581472892|FG001|Overall Study|Lost to Follow-up|1|||
161022499|NCT05201079|581472891|FG000|Overall Study|Physician Decision|1|||
161022500|NCT05201079|581472892|FG001|Overall Study|Physician Decision|1|||
161022501|NCT05201079|581472891|FG000|Overall Study|Protocol Violation|1|||
161022502|NCT05201079|581472892|FG001|Overall Study|Protocol Violation|0|||
161022503|NCT05201079|581472891|FG000|Overall Study|Withdrawal by Subject|1|||
161022504|NCT05201079|581472892|FG001|Overall Study|Withdrawal by Subject|0|||
161022505|NCT05201079|581472891|FG000|Overall Study|Forbidden medication|9|||
161022506|NCT05201079|581472892|FG001|Overall Study|Forbidden medication|5|||
161148589|NCT00710034|581926119|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
161148590|NCT00710034|581926118|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
161148591|NCT00710034|581926119|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
161148592|NCT00710034|581926118|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
161148593|NCT00710034|581926119|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
161148594|NCT00710034|581926118|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
161148595|NCT00710034|581926119|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
161148596|NCT00710034|581926118|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
161148597|NCT00710034|581926119|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
161148598|NCT00710034|581926118|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
161148599|NCT00710034|581926119|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
161148600|NCT00710034|581926118|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
161148601|NCT00710034|581926119|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
161148602|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
161148603|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
161148604|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
161148605|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
161148606|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Death|8|||
161148607|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Death|3|||
161148608|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
161148609|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
161148610|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
161148611|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
161148612|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
161148613|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
161148614|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
161148615|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
161148616|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
161148617|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
161148618|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
161148619|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
161148620|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
161148621|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
161148622|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
161148623|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
161148624|NCT00494871|581926120|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
161148625|NCT00494871|581926121|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
161148626|NCT00494871|581926120|FG000|Follow-up (FU) Period|Adverse Event|1|||
161148627|NCT00494871|581926121|FG001|Follow-up (FU) Period|Adverse Event|1|||
161148628|NCT00494871|581926120|FG000|Follow-up (FU) Period|Death|13|||
161148629|NCT00494871|581926121|FG001|Follow-up (FU) Period|Death|12|||
161148630|NCT00494871|581926120|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
161148631|NCT00494871|581926121|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
161148632|NCT00494871|581926120|FG000|Follow-up (FU) Period|Physician Decision|0|||
161148633|NCT00494871|581926121|FG001|Follow-up (FU) Period|Physician Decision|1|||
161148634|NCT00494871|581926120|FG000|Follow-up (FU) Period|Protocol Violation|1|||
161148635|NCT00494871|581926121|FG001|Follow-up (FU) Period|Protocol Violation|0|||
161148636|NCT00494871|581926120|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
161148637|NCT00494871|581926121|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
161148638|NCT00494871|581926120|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
161148639|NCT00494871|581926121|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
161148640|NCT03270085|581926122|FG000|Overall Study|Withdrawal by Subject|1|||
161148641|NCT03270085|581926123|FG001|Overall Study|Withdrawal by Subject|0|||
161022507|NCT05201079|581472891|FG000|Overall Study|Transfer to another hospital|0|||
161022508|NCT05201079|581472892|FG001|Overall Study|Transfer to another hospital|1|||
161022509|NCT05201079|581472891|FG000|Overall Study|Clinical condition|1|||
161022510|NCT05201079|581472892|FG001|Overall Study|Clinical condition|0|||
161022511|NCT05201079|581472891|FG000|Overall Study|SAE and sepsis|1|||
161022512|NCT05201079|581472892|FG001|Overall Study|SAE and sepsis|0|||
161022513|NCT05281562|581472899|FG000|Overall Study|Ineligible patient|1|||
161022514|NCT05281562|581472900|FG001|Overall Study|Ineligible patient|0|||
161022515|NCT05792085|581472901|FG000|Overall Study|Death|0|||
161022516|NCT05792085|581472902|FG001|Overall Study|Death|0|||
161022517|NCT05792085|581472903|FG002|Overall Study|Death|0|||
161022518|NCT05792085|581472904|FG003|Overall Study|Death|0|||
161022519|NCT05792085|581472905|FG004|Overall Study|Death|1|||
161022520|NCT05977530|581472912|FG000|Overall Study|Withdrawal by Subject|1|||
161022521|NCT05977530|581472912|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
161273614|NCT00477295|582380983|FG000|Overall Study|Protocol Violation|3|||
161022522|NCT04524442|581472915|FG000|Overall Study|Subject Decision|1|||
161022523|NCT04898673|581472918|FG000|Overall Study|Screenfail|1|||
161022524|NCT04898673|581472919|FG001|Overall Study|Screenfail|0|||
161022525|NCT04797897|581472920|FG000|Overall Study|Study Termination by Sponsor|1|||
161022526|NCT04797897|581472921|FG001|Overall Study|Study Termination by Sponsor|1|||
161022527|NCT05526430|581472926|FG000|Overall Study|Withdrawal by Subject|0|||
161022528|NCT05526430|581472927|FG001|Overall Study|Withdrawal by Subject|2|||
161022529|NCT05526430|581472928|FG002|Overall Study|Withdrawal by Subject|0|||
161022530|NCT05526430|581472929|FG003|Overall Study|Withdrawal by Subject|0|||
161022531|NCT02601313|581472930|FG000|Overall Study|Death|2|||
161022532|NCT02601313|581472931|FG001|Overall Study|Death|41|||
161022533|NCT02601313|581472932|FG002|Overall Study|Death|6|||
161022534|NCT02601313|581472930|FG000|Overall Study|Enrolled but never treated|0|||
161022535|NCT02601313|581472931|FG001|Overall Study|Enrolled but never treated|6|||
161022536|NCT02601313|581472932|FG002|Overall Study|Enrolled but never treated|3|||
161022537|NCT02601313|581472930|FG000|Overall Study|Enrolled, did not initiate AC|4|||
161022538|NCT02601313|581472931|FG001|Overall Study|Enrolled, did not initiate AC|0|||
161022539|NCT02601313|581472932|FG002|Overall Study|Enrolled, did not initiate AC|0|||
161022540|NCT02601313|581472930|FG000|Overall Study|Full consent withdrawal|0|||
161022541|NCT02601313|581472931|FG001|Overall Study|Full consent withdrawal|3|||
161022542|NCT02601313|581472932|FG002|Overall Study|Full consent withdrawal|2|||
161022543|NCT02601313|581472930|FG000|Overall Study|Lost to Follow-up|0|||
161022544|NCT02601313|581472931|FG001|Overall Study|Lost to Follow-up|1|||
161022545|NCT02601313|581472932|FG002|Overall Study|Lost to Follow-up|1|||
161022546|NCT03701763|581472938|FG000|Placebo-controlled Phase|Adverse Event|1|||
161022547|NCT03701763|581472939|FG001|Placebo-controlled Phase|Adverse Event|5|||
161022548|NCT03701763|581472940|FG002|Placebo-controlled Phase|Adverse Event|0|||
161022549|NCT03701763|581472941|FG003|Placebo-controlled Phase|Adverse Event|0|||
161022550|NCT03701763|581472938|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
161022551|NCT03701763|581472939|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
161273615|NCT00477295|582380984|FG001|Overall Study|Protocol Violation|8|||
161273616|NCT00477295|582380983|FG000|Overall Study|Physician Decision|4|||
161273617|NCT00477295|582380984|FG001|Overall Study|Physician Decision|5|||
161273618|NCT00477295|582380983|FG000|Overall Study|Lost to Follow-up|21|||
161273619|NCT00477295|582380984|FG001|Overall Study|Lost to Follow-up|11|||
161273620|NCT00477295|582380983|FG000|Overall Study|Other|4|||
161273621|NCT00477295|582380984|FG001|Overall Study|Other|3|||
161273622|NCT01425723|582380987|FG000|Overall Study|Lack of Efficacy|0|||
161273623|NCT01425723|582380988|FG001|Overall Study|Lack of Efficacy|1|||
161273624|NCT01425723|582380987|FG000|Overall Study|Withdrawal by Subject|1|||
161273625|NCT01425723|582380988|FG001|Overall Study|Withdrawal by Subject|4|||
161273626|NCT01425723|582380987|FG000|Overall Study|Lost to Follow-up|0|||
161273627|NCT01425723|582380988|FG001|Overall Study|Lost to Follow-up|3|||
161273628|NCT01425723|582380987|FG000|Overall Study|Physician Decision|2|||
161273629|NCT01425723|582380988|FG001|Overall Study|Physician Decision|0|||
161273630|NCT01425723|582380987|FG000|Overall Study|Other|1|||
161273631|NCT01425723|582380988|FG001|Overall Study|Other|10|||
161273632|NCT03835221|582380989|FG000|Methafilcon A|Withdrawal by Subject|1|||
161273633|NCT00861198|582380990|FG000|Overall Study|SpyGlass Failed|5|||
161022552|NCT03701763|581472940|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161022553|NCT03701763|581472941|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
161022554|NCT03701763|581472938|FG000|Placebo-controlled Phase|Miscellaneous|2|||
161022555|NCT03701763|581472939|FG001|Placebo-controlled Phase|Miscellaneous|0|||
161022556|NCT03701763|581472940|FG002|Placebo-controlled Phase|Miscellaneous|0|||
161022557|NCT03701763|581472941|FG003|Placebo-controlled Phase|Miscellaneous|0|||
161022558|NCT03701763|581472938|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
161022559|NCT03701763|581472939|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
161022560|NCT03701763|581472940|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
161022561|NCT03701763|581472941|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
161273634|NCT02288182|582380991|FG000|Overall Study|Adverse Event|0|||
161273635|NCT02288182|582380992|FG001|Overall Study|Adverse Event|1|||
161273636|NCT02288182|582380991|FG000|Overall Study|Lost to Follow-up|0|||
161273637|NCT02288182|582380992|FG001|Overall Study|Lost to Follow-up|1|||
161022562|NCT03701763|581472938|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
161273638|NCT04619992|582380994|FG000|Overall Study|Withdrawal by Subject|1|||
161022563|NCT03701763|581472939|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
161022564|NCT03701763|581472940|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161022565|NCT03701763|581472941|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
161022566|NCT03701763|581472938|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
161022567|NCT03701763|581472939|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
161022568|NCT03701763|581472940|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161022569|NCT03701763|581472941|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
161022570|NCT03701763|581472938|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161022571|NCT03701763|581472939|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161022572|NCT03701763|581472940|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
161022573|NCT03701763|581472941|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
161022574|NCT03701763|581472938|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161022575|NCT03701763|581472939|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161022576|NCT03701763|581472940|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
161022577|NCT03701763|581472941|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
161022578|NCT03701763|581472938|FG000|Apremilast Extension Phase|Adverse Event|0|||
161022579|NCT03701763|581472939|FG001|Apremilast Extension Phase|Adverse Event|0|||
161022580|NCT03701763|581472940|FG002|Apremilast Extension Phase|Adverse Event|3|||
161022581|NCT03701763|581472941|FG003|Apremilast Extension Phase|Adverse Event|1|||
161022582|NCT03701763|581472938|FG000|Apremilast Extension Phase|Miscellaneous|0|||
161022583|NCT03701763|581472939|FG001|Apremilast Extension Phase|Miscellaneous|0|||
161022584|NCT03701763|581472940|FG002|Apremilast Extension Phase|Miscellaneous|2|||
161022585|NCT03701763|581472941|FG003|Apremilast Extension Phase|Miscellaneous|1|||
161022586|NCT03701763|581472938|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
161022587|NCT03701763|581472939|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
161022588|NCT03701763|581472940|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
161022589|NCT03701763|581472941|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
161022590|NCT03701763|581472938|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161022591|NCT03701763|581472939|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161022592|NCT03701763|581472940|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
161022593|NCT03701763|581472941|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
161022594|NCT03701763|581472938|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
161022595|NCT03701763|581472939|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
161022596|NCT03701763|581472940|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
161022597|NCT03701763|581472941|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
161022598|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161022599|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161022600|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
161022601|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
161022602|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
161022603|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
161022604|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
161022605|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
161022606|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Other|0|||
161022607|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Other|0|||
161022608|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Other|1|||
161022609|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Other|0|||
161022610|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161022611|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161022612|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
161022613|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
161022614|NCT03701763|581472938|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161022615|NCT03701763|581472939|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161022616|NCT03701763|581472940|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
161022617|NCT03701763|581472941|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
161022618|NCT03365882|581472948|FG000|Randomization|Still Receiving Protocol Treatment|2|||
161022619|NCT03365882|581472949|FG001|Randomization|Still Receiving Protocol Treatment|0|||
161022620|NCT03365882|581472948|FG000|Randomization|Adverse Event|1|||
161022621|NCT03365882|581472949|FG001|Randomization|Adverse Event|2|||
161273639|NCT04619992|582380995|FG001|Overall Study|Withdrawal by Subject|0|||
161273640|NCT01197755|582380996|FG000|Overall Study|Adverse Event|8|||
161273641|NCT01197755|582380997|FG001|Overall Study|Adverse Event|10|||
161273642|NCT01197755|582380998|FG002|Overall Study|Adverse Event|10|||
161273643|NCT01197755|582380996|FG000|Overall Study|Study-specific discontinuation criteria|2|||
161022622|NCT03365882|581472948|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
161148642|NCT03825042|581926124|FG000|Overall Study|Adverse Event|1|||
161148643|NCT03825042|581926125|FG001|Overall Study|Adverse Event|0|||
161148644|NCT03825042|581926124|FG000|Overall Study|Withdrawal by Subject|1|||
161273644|NCT01197755|582380997|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161022623|NCT03365882|581472949|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
161022624|NCT03365882|581472948|FG000|Randomization|Progression/Relapse|21|||
161022625|NCT03365882|581472949|FG001|Randomization|Progression/Relapse|3|||
161022626|NCT03365882|581472948|FG000|Randomization|Death|1|||
161022627|NCT03365882|581472949|FG001|Randomization|Death|0|||
161022628|NCT03365882|581472948|FG000|Randomization|Other - Not Protocol Specified|1|||
161022629|NCT03365882|581472949|FG001|Randomization|Other - Not Protocol Specified|1|||
161022630|NCT03365882|581472948|FG000|Randomization|Major Protocol Deviation|0|||
161022631|NCT03365882|581472949|FG001|Randomization|Major Protocol Deviation|1|||
161022632|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
161022633|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
161022634|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
161022635|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
161022636|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
161022637|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
161022638|NCT03365882|581472948|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
161022639|NCT03365882|581472949|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
161022640|NCT04437615|581472950|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
161022641|NCT04828005|581472951|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
161022642|NCT04828005|581472952|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161022643|NCT04828005|581472953|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161022644|NCT04828005|581472954|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
161022645|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
161022646|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
161022647|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
161022648|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
161022649|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161022650|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161022651|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
161022652|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
161022653|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161022654|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
161022655|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
161022656|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
161022657|NCT04828005|581472951|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161022658|NCT04828005|581472952|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161022659|NCT04828005|581472953|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
161022660|NCT04828005|581472954|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
161022661|NCT04828005|581472951|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161022662|NCT04828005|581472952|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161022663|NCT04828005|581472953|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
161022664|NCT04828005|581472954|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
161022665|NCT04828005|581472951|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
161022666|NCT04828005|581472952|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
161022667|NCT04828005|581472953|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
161022668|NCT04828005|581472954|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
161022669|NCT04828005|581472951|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161022670|NCT04828005|581472952|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161022671|NCT04828005|581472953|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
161022672|NCT04828005|581472954|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
161022673|NCT04828005|581472951|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161022674|NCT04828005|581472952|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161022675|NCT04828005|581472953|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
161022676|NCT04828005|581472954|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
161022677|NCT05579899|581474495|FG000|Overall Study|Lost to Follow-up|3|||
161022678|NCT05579899|581474496|FG001|Overall Study|Lost to Follow-up|1|||
161022679|NCT05579899|581474495|FG000|Overall Study|Adverse Event|0|||
161022680|NCT05579899|581474496|FG001|Overall Study|Adverse Event|3|||
161022681|NCT05579899|581474495|FG000|Overall Study|Pregnancy|0|||
161022682|NCT05579899|581474496|FG001|Overall Study|Pregnancy|1|||
161022683|NCT05579899|581474495|FG000|Overall Study|Withdrawal by Subject|0|||
161022684|NCT05579899|581474496|FG001|Overall Study|Withdrawal by Subject|3|||
161022685|NCT04799899|581474497|FG000|Overall Study|Lost to Follow-up|2|||
161022686|NCT04799899|581474498|FG001|Overall Study|Lost to Follow-up|4|||
161022687|NCT03339713|581474502|FG000|Overall Study|Lost to Follow-up|2|||
161022688|NCT03339713|581474503|FG001|Overall Study|Lost to Follow-up|1|||
161022689|NCT03339713|581474502|FG000|Overall Study|Protocol Violation|1|||
161022690|NCT03339713|581474503|FG001|Overall Study|Protocol Violation|0|||
161022691|NCT03339713|581474502|FG000|Overall Study|Withdrawal by Subject|1|||
161022692|NCT03339713|581474503|FG001|Overall Study|Withdrawal by Subject|1|||
161022693|NCT05540665|581474504|FG000|Overall Study|Study terminated by sponsor|6|||
161022694|NCT05540665|581474505|FG001|Overall Study|Study terminated by sponsor|6|||
161022695|NCT05540665|581474506|FG002|Overall Study|Study terminated by sponsor|7|||
161022696|NCT03462030|581474507|FG000|Overall Study|Withdrawal by Subject|1|||
161022697|NCT03462030|581474508|FG001|Overall Study|Withdrawal by Subject|1|||
161022698|NCT03381196|581474509|FG000|Overall Study|Withdrawal by Subject|7|||
161273645|NCT01197755|582380998|FG002|Overall Study|Study-specific discontinuation criteria|0|||
161273646|NCT01197755|582380996|FG000|Overall Study|Entered the long-term extension study|18|||
161273647|NCT01197755|582380997|FG001|Overall Study|Entered the long-term extension study|21|||
161273648|NCT01197755|582380998|FG002|Overall Study|Entered the long-term extension study|35|||
161022699|NCT03381196|581474510|FG001|Overall Study|Withdrawal by Subject|7|||
161022700|NCT03381196|581474509|FG000|Overall Study|Other|0|||
161022701|NCT03381196|581474510|FG001|Overall Study|Other|1|||
161022702|NCT03381196|581474509|FG000|Overall Study|Lost to Follow-up|5|||
161022703|NCT03381196|581474510|FG001|Overall Study|Lost to Follow-up|4|||
161022704|NCT03381196|581474509|FG000|Overall Study|Death|0|||
161022705|NCT03381196|581474510|FG001|Overall Study|Death|1|||
161022706|NCT03381196|581474509|FG000|Overall Study|Adverse Event|1|||
161022707|NCT03381196|581474510|FG001|Overall Study|Adverse Event|0|||
161022708|NCT03381196|581474509|FG000|Overall Study|Randomized, not treated|3|||
161022709|NCT03381196|581474510|FG001|Overall Study|Randomized, not treated|6|||
161022710|NCT02675751|581474511|FG000|Overall Study|Lost to Follow-up|16|||
161022711|NCT03371381|581474512|FG000|Overall Study|Death|5|||
161022712|NCT03371381|581474512|FG000|Overall Study|Study terminated by sponsor|3|||
161022713|NCT03371381|581474512|FG000|Overall Study|Other|4|||
161022714|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
161022715|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022716|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022717|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022718|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022719|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022720|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
161022721|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022722|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022723|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
161022724|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022725|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022726|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022727|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
161022728|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
161022729|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
161022730|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
161022731|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022732|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022733|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022734|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
161022735|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022736|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
161022737|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022738|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022739|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022740|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022741|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161022742|NCT03628924|581474514|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
161022743|NCT03628924|581474515|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022744|NCT03628924|581474516|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
161022745|NCT03628924|581474517|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022746|NCT03628924|581474518|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022747|NCT03628924|581474519|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022748|NCT03628924|581474520|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
161022749|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161022750|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161022751|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
161022752|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161022753|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161273649|NCT01197755|582380996|FG000|Overall Study|Lack of therapeutic response|0|||
161022754|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
161022755|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
161022756|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022757|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022758|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022759|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
161022760|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
161022761|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
161022762|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
161022763|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022764|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022765|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022766|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161022767|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161022768|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
161022769|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
161022770|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161022771|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161022772|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
161022773|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
161022774|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
161022775|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
161022776|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
161022777|NCT03628924|581474514|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022778|NCT03628924|581474515|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022779|NCT03628924|581474516|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022780|NCT03628924|581474517|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
161022781|NCT03628924|581474518|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
161022782|NCT03628924|581474519|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
161022783|NCT03628924|581474520|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
161022784|NCT02268253|581474521|FG000|Stage 1|Withdrawal by Subject|1|||
161022785|NCT02268253|581474522|FG001|Stage 1|Withdrawal by Subject|0|||
161022786|NCT02268253|581474523|FG002|Stage 1|Withdrawal by Subject|0|||
161022787|NCT02268253|581474524|FG003|Stage 1|Withdrawal by Subject|0|||
161022788|NCT02268253|581474525|FG004|Stage 1|Withdrawal by Subject|0|||
161022789|NCT02268253|581474526|FG005|Stage 1|Withdrawal by Subject|0|||
161022790|NCT02268253|581474527|FG006|Stage 1|Withdrawal by Subject|0|||
161022791|NCT02268253|581474521|FG000|Stage 1|Death|0|||
161022792|NCT02268253|581474522|FG001|Stage 1|Death|2|||
161022793|NCT02268253|581474523|FG002|Stage 1|Death|2|||
161022794|NCT02268253|581474524|FG003|Stage 1|Death|2|||
161022795|NCT02268253|581474525|FG004|Stage 1|Death|1|||
161022796|NCT02268253|581474526|FG005|Stage 1|Death|1|||
161022797|NCT02268253|581474527|FG006|Stage 1|Death|0|||
161022798|NCT02268253|581474521|FG000|Stage 2|Disease Recurrence/ Progression|0|||
161022799|NCT02268253|581474522|FG001|Stage 2|Disease Recurrence/ Progression|0|||
161022800|NCT02268253|581474523|FG002|Stage 2|Disease Recurrence/ Progression|1|||
161022801|NCT02268253|581474524|FG003|Stage 2|Disease Recurrence/ Progression|0|||
161022802|NCT02268253|581474525|FG004|Stage 2|Disease Recurrence/ Progression|0|||
161022803|NCT02268253|581474526|FG005|Stage 2|Disease Recurrence/ Progression|0|||
161022804|NCT02268253|581474527|FG006|Stage 2|Disease Recurrence/ Progression|0|||
161022805|NCT02268253|581474521|FG000|Stage 2|Withdrawal by Subject|0|||
161022806|NCT02268253|581474522|FG001|Stage 2|Withdrawal by Subject|0|||
161022807|NCT02268253|581474523|FG002|Stage 2|Withdrawal by Subject|2|||
161022808|NCT02268253|581474524|FG003|Stage 2|Withdrawal by Subject|0|||
161022809|NCT02268253|581474525|FG004|Stage 2|Withdrawal by Subject|0|||
161022810|NCT02268253|581474526|FG005|Stage 2|Withdrawal by Subject|2|||
161022811|NCT02268253|581474527|FG006|Stage 2|Withdrawal by Subject|0|||
161022812|NCT02268253|581474521|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161273650|NCT01197755|582380997|FG001|Overall Study|Lack of therapeutic response|7|||
161022813|NCT02268253|581474522|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022814|NCT02268253|581474523|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
161022815|NCT02268253|581474524|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022816|NCT02268253|581474525|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022817|NCT02268253|581474526|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
161022818|NCT02268253|581474527|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
161022819|NCT02268253|581474521|FG000|Stage 2|Death|0|||
161273651|NCT01197755|582380998|FG002|Overall Study|Lack of therapeutic response|4|||
161273652|NCT01197755|582380996|FG000|Overall Study|Severe non-compliance to the protocol|2|||
161022820|NCT02268253|581474522|FG001|Stage 2|Death|0|||
161022821|NCT02268253|581474523|FG002|Stage 2|Death|19|||
161022822|NCT02268253|581474524|FG003|Stage 2|Death|0|||
161022823|NCT02268253|581474525|FG004|Stage 2|Death|0|||
161022824|NCT02268253|581474526|FG005|Stage 2|Death|20|||
161022825|NCT02268253|581474527|FG006|Stage 2|Death|1|||
161022826|NCT02268253|581474521|FG000|Stage 2|Lost to Follow-up|0|||
161022827|NCT02268253|581474522|FG001|Stage 2|Lost to Follow-up|0|||
161273653|NCT01197755|582380997|FG001|Overall Study|Severe non-compliance to the protocol|1|||
161022828|NCT02268253|581474523|FG002|Stage 2|Lost to Follow-up|0|||
161022829|NCT02268253|581474524|FG003|Stage 2|Lost to Follow-up|0|||
161022830|NCT02268253|581474525|FG004|Stage 2|Lost to Follow-up|0|||
161022831|NCT02268253|581474526|FG005|Stage 2|Lost to Follow-up|4|||
161022832|NCT02268253|581474527|FG006|Stage 2|Lost to Follow-up|0|||
161022833|NCT02268253|581474521|FG000|Stage 2|Transferred to Hospice|0|||
161022834|NCT02268253|581474522|FG001|Stage 2|Transferred to Hospice|0|||
161022835|NCT02268253|581474523|FG002|Stage 2|Transferred to Hospice|0|||
161022836|NCT02268253|581474524|FG003|Stage 2|Transferred to Hospice|0|||
161022837|NCT02268253|581474525|FG004|Stage 2|Transferred to Hospice|0|||
161022838|NCT02268253|581474526|FG005|Stage 2|Transferred to Hospice|2|||
161022839|NCT02268253|581474527|FG006|Stage 2|Transferred to Hospice|0|||
161022840|NCT02268253|581474521|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
161022841|NCT02268253|581474522|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
161022842|NCT02268253|581474523|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
161022843|NCT02268253|581474524|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
161022844|NCT02268253|581474525|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
161022845|NCT02268253|581474526|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
161022846|NCT02268253|581474527|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
161022847|NCT02268253|581474521|FG000|Stage 3A|Withdrawal by Subject|0|||
161022848|NCT02268253|581474522|FG001|Stage 3A|Withdrawal by Subject|0|||
161022849|NCT02268253|581474523|FG002|Stage 3A|Withdrawal by Subject|2|||
161022850|NCT02268253|581474524|FG003|Stage 3A|Withdrawal by Subject|0|||
161022851|NCT02268253|581474525|FG004|Stage 3A|Withdrawal by Subject|0|||
161022852|NCT02268253|581474526|FG005|Stage 3A|Withdrawal by Subject|0|||
161022853|NCT02268253|581474527|FG006|Stage 3A|Withdrawal by Subject|0|||
161022854|NCT02268253|581474521|FG000|Stage 3A|Physician Decision|0|||
161022855|NCT02268253|581474522|FG001|Stage 3A|Physician Decision|0|||
161022856|NCT02268253|581474523|FG002|Stage 3A|Physician Decision|2|||
161022857|NCT02268253|581474524|FG003|Stage 3A|Physician Decision|0|||
161022858|NCT02268253|581474525|FG004|Stage 3A|Physician Decision|0|||
161022859|NCT02268253|581474526|FG005|Stage 3A|Physician Decision|0|||
161022860|NCT02268253|581474527|FG006|Stage 3A|Physician Decision|0|||
161022861|NCT02268253|581474521|FG000|Stage 3A|Study Terminated by Sponsor|0|||
161022862|NCT02268253|581474522|FG001|Stage 3A|Study Terminated by Sponsor|0|||
161022863|NCT02268253|581474523|FG002|Stage 3A|Study Terminated by Sponsor|2|||
161022864|NCT02268253|581474524|FG003|Stage 3A|Study Terminated by Sponsor|0|||
161022865|NCT02268253|581474525|FG004|Stage 3A|Study Terminated by Sponsor|0|||
161022866|NCT02268253|581474526|FG005|Stage 3A|Study Terminated by Sponsor|0|||
161022867|NCT02268253|581474527|FG006|Stage 3A|Study Terminated by Sponsor|0|||
161022868|NCT02268253|581474521|FG000|Stage 3A|Lost to Follow-up|0|||
161022869|NCT02268253|581474522|FG001|Stage 3A|Lost to Follow-up|0|||
161022870|NCT02268253|581474523|FG002|Stage 3A|Lost to Follow-up|1|||
161022871|NCT02268253|581474524|FG003|Stage 3A|Lost to Follow-up|0|||
161022872|NCT02268253|581474525|FG004|Stage 3A|Lost to Follow-up|0|||
161022873|NCT02268253|581474526|FG005|Stage 3A|Lost to Follow-up|0|||
161022874|NCT02268253|581474527|FG006|Stage 3A|Lost to Follow-up|0|||
161022875|NCT02268253|581474521|FG000|Stage 3A|Death|0|||
161022876|NCT02268253|581474522|FG001|Stage 3A|Death|0|||
161022877|NCT02268253|581474523|FG002|Stage 3A|Death|5|||
161022878|NCT02268253|581474524|FG003|Stage 3A|Death|0|||
161022879|NCT02268253|581474525|FG004|Stage 3A|Death|0|||
161022880|NCT02268253|581474526|FG005|Stage 3A|Death|0|||
161022881|NCT02268253|581474527|FG006|Stage 3A|Death|0|||
161022882|NCT05714761|581474528|FG000|Overall Study|Lost to Follow-up|3|||
161022883|NCT05714761|581474528|FG000|Overall Study|Withdrawal by Subject|3|||
161022884|NCT05714761|581474528|FG000|Overall Study|unblinding of sensor data|1|||
161022885|NCT05714761|581474528|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
161022886|NCT05714761|581474528|FG000|Overall Study|did not return second CGM sensor|4|||
161022887|NCT05672069|581474529|FG000|Overall Study|Implant removal|1|||
161022888|NCT05672069|581474529|FG000|Overall Study|Lost to Follow-up|2|||
161022889|NCT05949788|581474530|FG000|Overall Study|severe birth deformity|2|||
161022890|NCT05949788|581474531|FG001|Overall Study|severe birth deformity|7|||
161022891|NCT05949788|581474530|FG000|Overall Study|twin-twin transfusion syndrome|2|||
161022892|NCT05949788|581474531|FG001|Overall Study|twin-twin transfusion syndrome|7|||
161022893|NCT05949788|581474530|FG000|Overall Study|neonatal hemolytic disease|3|||
161022894|NCT05949788|581474531|FG001|Overall Study|neonatal hemolytic disease|8|||
161022895|NCT05949788|581474530|FG000|Overall Study|death within 14 days after birth|2|||
161022896|NCT05949788|581474531|FG001|Overall Study|death within 14 days after birth|6|||
161022897|NCT05949788|581474530|FG000|Overall Study|transfer to another hospital|2|||
161022898|NCT05949788|581474531|FG001|Overall Study|transfer to another hospital|6|||
161022899|NCT05213390|581474532|FG000|Overall Study|Withdrawal by Subject|2|||
161022900|NCT05213390|581474532|FG000|Overall Study|Lost to Follow-up|12|||
161022901|NCT05213390|581474532|FG000|Overall Study|Protocol Violation|9|||
161022902|NCT02191618|581474540|FG000|Overall Study|Withdrawal by Subject|3|||
161022903|NCT02191618|581474540|FG000|Overall Study|Missed Visit|4|||
161022904|NCT03031470|581474542|FG000|Overall Study|Adverse Event|3|||
161022905|NCT03031470|581474543|FG001|Overall Study|Adverse Event|0|||
161022906|NCT03031470|581474542|FG000|Overall Study|Death|3|||
161022907|NCT03031470|581474543|FG001|Overall Study|Death|1|||
161022908|NCT03031470|581474542|FG000|Overall Study|Lost to Follow-up|1|||
161022909|NCT03031470|581474543|FG001|Overall Study|Lost to Follow-up|1|||
161022910|NCT03031470|581474542|FG000|Overall Study|Withdrawal by Subject|1|||
161022911|NCT03031470|581474543|FG001|Overall Study|Withdrawal by Subject|0|||
161022912|NCT03031470|581474542|FG000|Overall Study|Protocol entry criteria not met|0|||
161022913|NCT03031470|581474543|FG001|Overall Study|Protocol entry criteria not met|1|||
161022914|NCT03031470|581474542|FG000|Overall Study|Cancel the operation|0|||
161022915|NCT03031470|581474543|FG001|Overall Study|Cancel the operation|1|||
161022916|NCT01593917|581474544|FG000|Overall Study|Death|67|||
161022917|NCT01593917|581474544|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
161022918|NCT01593917|581474544|FG000|Overall Study|Withdrawal by Subject|23|||
161022919|NCT01593917|581474544|FG000|Overall Study|Lost to Follow-up|12|||
161022920|NCT01593917|581474544|FG000|Overall Study|Protocol Violation|5|||
161022921|NCT01593917|581474544|FG000|Overall Study|Physician Decision|3|||
161022922|NCT03021096|581474546|FG000|Overall Study|Lost to Follow-up|4|||
161022923|NCT03021096|581474546|FG000|Overall Study|Protocol Violation|2|||
161022924|NCT03216057|581474547|FG000|Overall Study|Lost to Follow-up|2|||
161022925|NCT03216057|581474548|FG001|Overall Study|Lost to Follow-up|2|||
161022926|NCT03768505|581474549|FG000|Overall Study|sponsor decision|76|||
161022927|NCT03768505|581474549|FG000|Overall Study|Death|35|||
161022928|NCT03768505|581474549|FG000|Overall Study|Other -Various|30|||
161022929|NCT03768505|581474549|FG000|Overall Study|Withdrawal by Subject|22|||
161022930|NCT03768505|581474549|FG000|Overall Study|Lost to Follow-up|6|||
161022931|NCT02861300|581474553|FG000|Overall Study|Death|0|||
161022932|NCT02861300|581474554|FG001|Overall Study|Death|0|||
161022933|NCT02861300|581474555|FG002|Overall Study|Death|0|||
161022934|NCT02861300|581474556|FG003|Overall Study|Death|0|||
161022935|NCT02861300|581474557|FG004|Overall Study|Death|0|||
161022936|NCT02861300|581474558|FG005|Overall Study|Death|0|||
161022937|NCT02861300|581474559|FG006|Overall Study|Death|24|||
161022938|NCT02861300|581474553|FG000|Overall Study|Delay in treatment|0|||
161022939|NCT02861300|581474554|FG001|Overall Study|Delay in treatment|0|||
161022940|NCT02861300|581474555|FG002|Overall Study|Delay in treatment|0|||
161022941|NCT02861300|581474556|FG003|Overall Study|Delay in treatment|0|||
161022942|NCT02861300|581474557|FG004|Overall Study|Delay in treatment|0|||
161022943|NCT02861300|581474558|FG005|Overall Study|Delay in treatment|1|||
161022944|NCT02861300|581474559|FG006|Overall Study|Delay in treatment|0|||
161022945|NCT02861300|581474553|FG000|Overall Study|Disease Progression|0|||
161022946|NCT02861300|581474554|FG001|Overall Study|Disease Progression|1|||
161022947|NCT02861300|581474555|FG002|Overall Study|Disease Progression|0|||
161022948|NCT02861300|581474556|FG003|Overall Study|Disease Progression|0|||
161022949|NCT02861300|581474557|FG004|Overall Study|Disease Progression|0|||
161022950|NCT02861300|581474558|FG005|Overall Study|Disease Progression|0|||
161022951|NCT02861300|581474559|FG006|Overall Study|Disease Progression|2|||
161022952|NCT02861300|581474553|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
161022953|NCT02861300|581474554|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
161022954|NCT02861300|581474555|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
161022955|NCT02861300|581474556|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
161022956|NCT02861300|581474557|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
161022957|NCT02861300|581474558|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
161022958|NCT02861300|581474559|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
161022959|NCT02861300|581474553|FG000|Overall Study|Clinical Complications|0|||
161022960|NCT02861300|581474554|FG001|Overall Study|Clinical Complications|0|||
161022961|NCT02861300|581474555|FG002|Overall Study|Clinical Complications|0|||
161022962|NCT02861300|581474556|FG003|Overall Study|Clinical Complications|0|||
161022963|NCT02861300|581474557|FG004|Overall Study|Clinical Complications|0|||
161022964|NCT02861300|581474558|FG005|Overall Study|Clinical Complications|0|||
161022965|NCT02861300|581474559|FG006|Overall Study|Clinical Complications|1|||
161022966|NCT03133546|581474566|FG000|Overall Study|Death|46|||
161022967|NCT03133546|581474567|FG001|Overall Study|Death|43|||
161022968|NCT03133546|581474566|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
161022969|NCT03133546|581474567|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
161022970|NCT02993159|581474569|FG000|Overall Study|Withdrawal by Subject|1|||
161022971|NCT02993159|581474570|FG001|Overall Study|Withdrawal by Subject|3|||
161022972|NCT02993159|581474569|FG000|Overall Study|Protocol Violation|1|||
161022973|NCT02993159|581474570|FG001|Overall Study|Protocol Violation|0|||
161022974|NCT02993159|581474569|FG000|Overall Study|Opted out of surgery|2|||
161022975|NCT02993159|581474570|FG001|Overall Study|Opted out of surgery|0|||
161022976|NCT02993159|581474569|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161022977|NCT02993159|581474570|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
161022978|NCT02993159|581474569|FG000|Overall Study|Physician Decision|0|||
161022979|NCT02993159|581474570|FG001|Overall Study|Physician Decision|1|||
161022980|NCT05034328|581474571|FG000|Overall Study|Protocol Violation|1|||
161022981|NCT05034328|581474572|FG001|Overall Study|Protocol Violation|0|||
161022982|NCT05034328|581474571|FG000|Overall Study|Lost to Follow-up|0|||
161022983|NCT05034328|581474572|FG001|Overall Study|Lost to Follow-up|10|||
161022984|NCT05399459|581474575|FG000|Overall Study|Randomized but not treated|29|||
161022985|NCT05399459|581474576|FG001|Overall Study|Randomized but not treated|30|||
161022986|NCT05399459|581474577|FG002|Overall Study|Randomized but not treated|38|||
161022987|NCT05399459|581474575|FG000|Overall Study|Lost to Follow-up|1|||
161022988|NCT05399459|581474576|FG001|Overall Study|Lost to Follow-up|0|||
161022989|NCT05399459|581474577|FG002|Overall Study|Lost to Follow-up|0|||
161022990|NCT04992520|581474578|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
161022991|NCT04992520|581474579|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
161022992|NCT04992520|581474580|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
161022993|NCT04992520|581474581|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
161022994|NCT04992520|581474582|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
161022995|NCT04992520|581474583|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
161022996|NCT04992520|581474578|FG000|Part A: First Challenge|Non-compliance|0|||
161022997|NCT04992520|581474579|FG001|Part A: First Challenge|Non-compliance|0|||
161022998|NCT04992520|581474580|FG002|Part A: First Challenge|Non-compliance|0|||
161022999|NCT04992520|581474581|FG003|Part A: First Challenge|Non-compliance|1|||
161023000|NCT04992520|581474582|FG004|Part A: First Challenge|Non-compliance|0|||
161023001|NCT04992520|581474583|FG005|Part A: First Challenge|Non-compliance|0|||
161023002|NCT04992520|581474578|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023003|NCT04992520|581474579|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023004|NCT04992520|581474580|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
161023005|NCT04992520|581474581|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023006|NCT04992520|581474582|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
161023007|NCT04992520|581474583|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
161023008|NCT04992520|581474578|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023009|NCT04992520|581474579|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023010|NCT04992520|581474580|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
161023011|NCT04992520|581474581|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023012|NCT04992520|581474582|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023013|NCT04992520|581474583|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
161023014|NCT03625167|581474585|FG000|Overall Study|Protocol Violation|5|||
161023015|NCT02231164|581474586|FG000|Overall Study|Adverse Event|1|||
161023016|NCT02231164|581474587|FG001|Overall Study|Adverse Event|1|||
161023017|NCT02231164|581474586|FG000|Overall Study|Lack of Efficacy|4|||
161023018|NCT02231164|581474587|FG001|Overall Study|Lack of Efficacy|3|||
161023019|NCT02231164|581474586|FG000|Overall Study|Withdrawal by Subject|1|||
161023020|NCT02231164|581474587|FG001|Overall Study|Withdrawal by Subject|2|||
161023021|NCT06103188|581474588|FG000|Overall Study|Lost to Follow-up|1|||
161023022|NCT06103188|581474589|FG001|Overall Study|Lost to Follow-up|6|||
161023023|NCT06103188|581474590|FG002|Overall Study|Lost to Follow-up|4|||
161023024|NCT02969707|581474593|FG000|Overall Study|Withdrawal by Subject|6|||
161023025|NCT02969707|581474594|FG001|Overall Study|Withdrawal by Subject|5|||
161023026|NCT02969707|581474593|FG000|Overall Study|Severe anxiety|0|||
161023027|NCT02969707|581474594|FG001|Overall Study|Severe anxiety|1|||
161023028|NCT02969707|581474593|FG000|Overall Study|Positive toxicology screen|0|||
161023029|NCT02969707|581474594|FG001|Overall Study|Positive toxicology screen|2|||
161023030|NCT02969707|581474593|FG000|Overall Study|Claustrophobia|2|||
161023031|NCT02969707|581474594|FG001|Overall Study|Claustrophobia|2|||
161023032|NCT02969707|581474593|FG000|Overall Study|Non-compliance|1|||
161023033|NCT02969707|581474594|FG001|Overall Study|Non-compliance|2|||
161023034|NCT01175356|581474595|FG000|Overall Study|Death|1|||
161023035|NCT01175356|581474595|FG000|Overall Study|Lack of Efficacy|12|||
161023036|NCT01175356|581474595|FG000|Overall Study|Lost to Follow-up|1|||
161023037|NCT01175356|581474595|FG000|Overall Study|Physician Decision|23|||
161023038|NCT01175356|581474595|FG000|Overall Study|Ineligible|1|||
161023039|NCT01175356|581474595|FG000|Overall Study|Treatment Slot Not Available|18|||
161023040|NCT01175356|581474595|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
161023041|NCT01175356|581474595|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
161023042|NCT01175356|581474595|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
161023043|NCT01175356|581474595|FG000|Overall Study|Inadequate stem cell for transplant|1|||
161023044|NCT01175356|581474595|FG000|Overall Study|Initiation other tx prior to completion|9|||
161023045|NCT03020199|581474602|FG000|Treatment Period|Adverse Event|0|||
161023046|NCT03020199|581474603|FG001|Treatment Period|Adverse Event|2|||
161023047|NCT03020199|581474602|FG000|Treatment Period|Lack of Efficacy|1|||
161023048|NCT03020199|581474603|FG001|Treatment Period|Lack of Efficacy|6|||
161023049|NCT03020199|581474602|FG000|Treatment Period|Lost to Follow-up|1|||
161023050|NCT03020199|581474603|FG001|Treatment Period|Lost to Follow-up|6|||
161023051|NCT03020199|581474602|FG000|Treatment Period|Physician Decision|0|||
161023052|NCT03020199|581474603|FG001|Treatment Period|Physician Decision|1|||
161023053|NCT03020199|581474602|FG000|Treatment Period|Subject/guardian decision|8|||
161023054|NCT03020199|581474603|FG001|Treatment Period|Subject/guardian decision|15|||
161023055|NCT03020199|581474602|FG000|Treatment Period|Subjects not treated|3|||
161023056|NCT03020199|581474603|FG001|Treatment Period|Subjects not treated|4|||
161023057|NCT03020199|581474602|FG000|Follow-up Period|Disease relapse|32|||
161023058|NCT03020199|581474603|FG001|Follow-up Period|Disease relapse|7|||
161023059|NCT03020199|581474602|FG000|Follow-up Period|Lack of Efficacy|1|||
161023060|NCT03020199|581474603|FG001|Follow-up Period|Lack of Efficacy|2|||
161023061|NCT03020199|581474602|FG000|Follow-up Period|Lost to Follow-up|4|||
161023062|NCT03020199|581474603|FG001|Follow-up Period|Lost to Follow-up|6|||
161273654|NCT01197755|582380998|FG002|Overall Study|Severe non-compliance to the protocol|2|||
161273655|NCT01197755|582380996|FG000|Overall Study|Withdrawal by Subject|1|||
161273656|NCT01197755|582380997|FG001|Overall Study|Withdrawal by Subject|0|||
161273657|NCT01197755|582380998|FG002|Overall Study|Withdrawal by Subject|0|||
161273658|NCT01197755|582380996|FG000|Overall Study|Lost to Follow-up|0|||
161273659|NCT01197755|582380997|FG001|Overall Study|Lost to Follow-up|0|||
161273660|NCT01197755|582380998|FG002|Overall Study|Lost to Follow-up|1|||
161273661|NCT01197755|582380996|FG000|Overall Study|eg, change in circumstances|7|||
161273662|NCT01197755|582380997|FG001|Overall Study|eg, change in circumstances|3|||
161273663|NCT01197755|582380998|FG002|Overall Study|eg, change in circumstances|2|||
161273664|NCT03365011|582380999|FG000|Overall Study|Withdrawal by Subject|1|||
161273665|NCT03365011|582381000|FG001|Overall Study|Withdrawal by Subject|2|||
161273666|NCT00499174|582381001|FG000|Overall Study|Physician Decision|78|||
161273667|NCT00499174|582381002|FG001|Overall Study|Physician Decision|9|||
161273668|NCT03582826|582381003|FG000|Overall Study|Lost to Follow-up|39|||
161273669|NCT03582826|582381004|FG001|Overall Study|Lost to Follow-up|0|||
161273670|NCT03582826|582381003|FG000|Overall Study|Withdrawal by Subject|2|||
161273671|NCT03582826|582381004|FG001|Overall Study|Withdrawal by Subject|0|||
161273672|NCT01214915|582381008|FG000|Overall Study|Adverse Event|8|||
161273673|NCT01214915|582381008|FG000|Overall Study|Lack of Efficacy|3|||
161273674|NCT00574912|582381009|FG000|Overall Study|Could not place IV lines.|3|||
161273675|NCT00574912|582381009|FG000|Overall Study|scheduling conflicts|3|||
161273676|NCT00574912|582381009|FG000|Overall Study|Physician Decision|2|||
161273677|NCT04730349|582381018|FG000|Overall Study|Participant withdrew consent|1|||
161273678|NCT04730349|582381019|FG001|Overall Study|Participant withdrew consent|0|||
161273679|NCT04730349|582381018|FG000|Overall Study|Disease progression|6|||
161273680|NCT04730349|582381019|FG001|Overall Study|Disease progression|4|||
161273681|NCT04730349|582381018|FG000|Overall Study|Study drug toxicity|0|||
161273682|NCT04730349|582381019|FG001|Overall Study|Study drug toxicity|1|||
161273683|NCT00638027|582381020|FG000|Overall Study|Adverse Event|0|||
161273684|NCT00638027|582381021|FG001|Overall Study|Adverse Event|2|||
161273685|NCT00371397|582381022|FG000|Session 1|Withdrawal by Subject|1|||
161023063|NCT03020199|581474602|FG000|Follow-up Period|Physician Decision|2|||
161023064|NCT03020199|581474603|FG001|Follow-up Period|Physician Decision|2|||
161023065|NCT03020199|581474602|FG000|Follow-up Period|Protocol Violation|1|||
161023066|NCT03020199|581474603|FG001|Follow-up Period|Protocol Violation|2|||
161023067|NCT03020199|581474602|FG000|Follow-up Period|Study terminated by Sponsor|6|||
161023068|NCT03020199|581474603|FG001|Follow-up Period|Study terminated by Sponsor|3|||
161023069|NCT03020199|581474602|FG000|Follow-up Period|Subject/guardian decision|14|||
161023070|NCT03020199|581474603|FG001|Follow-up Period|Subject/guardian decision|9|||
161023071|NCT05583578|581474604|FG000|Overall Study|Withdrawal by Subject|2|||
161023072|NCT05583578|581474605|FG001|Overall Study|Withdrawal by Subject|0|||
161023073|NCT00248287|581474608|FG000|Overall Study|Adverse Event|11|||
161023074|NCT00248287|581474609|FG001|Overall Study|Adverse Event|10|||
161023075|NCT00248287|581474608|FG000|Overall Study|Death|1|||
161023076|NCT00248287|581474609|FG001|Overall Study|Death|0|||
161023077|NCT00248287|581474608|FG000|Overall Study|Lost to Follow-up|0|||
161023078|NCT00248287|581474609|FG001|Overall Study|Lost to Follow-up|1|||
161023079|NCT00248287|581474608|FG000|Overall Study|Investigator Request|4|||
161023080|NCT00248287|581474609|FG001|Overall Study|Investigator Request|3|||
161023081|NCT00248287|581474608|FG000|Overall Study|Patient Request|5|||
161023082|NCT00248287|581474609|FG001|Overall Study|Patient Request|3|||
161023083|NCT00248287|581474608|FG000|Overall Study|Other|3|||
161023084|NCT00248287|581474609|FG001|Overall Study|Other|2|||
161273686|NCT00371397|582381023|FG001|Session 1|Withdrawal by Subject|0|||
161273687|NCT00371397|582381024|FG002|Session 1|Withdrawal by Subject|0|||
161023085|NCT02714257|581474610|FG000|Overall Study|Withdrawal by Subject|6|||
161023086|NCT02714257|581474611|FG001|Overall Study|Withdrawal by Subject|11|||
161023087|NCT02714257|581474610|FG000|Overall Study|Death|3|||
161023088|NCT02714257|581474611|FG001|Overall Study|Death|4|||
161023089|NCT02714257|581474610|FG000|Overall Study|Lost to Follow-up|1|||
161023090|NCT02714257|581474611|FG001|Overall Study|Lost to Follow-up|6|||
161023091|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
161023092|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
161023093|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
161023094|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
161273688|NCT00371397|582381025|FG003|Session 1|Withdrawal by Subject|0|||
161273689|NCT00371397|582381026|FG004|Session 1|Withdrawal by Subject|0|||
161023095|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
161023096|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
161023097|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
161273690|NCT00371397|582381027|FG005|Session 1|Withdrawal by Subject|0|||
161273691|NCT00371397|582381028|FG006|Session 1|Withdrawal by Subject|0|||
161273692|NCT00371397|582381029|FG007|Session 1|Withdrawal by Subject|1|||
161023098|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
161023099|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
161023100|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
161023101|NCT04103580|581474612|FG000|Phase 1 Active Caregiving|Other|3|||
161023102|NCT04103580|581474613|FG001|Phase 1 Active Caregiving|Other|3|||
161023103|NCT04103580|581474612|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
161023104|NCT04103580|581474613|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
161023105|NCT04103580|581474612|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
161023106|NCT04103580|581474613|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
161023107|NCT04103580|581474612|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
161023108|NCT04103580|581474613|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
161023109|NCT04103580|581474612|FG000|Phase 2 Bereavement|Other|8|||
161023110|NCT04103580|581474613|FG001|Phase 2 Bereavement|Other|6|||
161023111|NCT04568486|581474614|FG000|Overall Study|Withdrawal by Subject|26|||
161023112|NCT04568486|581474614|FG000|Overall Study|Lost to Follow-up|7|||
161023113|NCT04042233|581474615|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
161023114|NCT04042233|581474616|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
161023115|NCT04042233|581474615|FG000|Overall Study|Protocol Violation|0|||
161023116|NCT04042233|581474616|FG001|Overall Study|Protocol Violation|2|||
161023117|NCT01210807|581474626|FG000|Overall Study|Lost to Follow-up|1|||
161023118|NCT01210807|581474627|FG001|Overall Study|Lost to Follow-up|2|||
161023119|NCT01210807|581474626|FG000|Overall Study|Not implanted bilaterally|2|||
161023120|NCT01210807|581474627|FG001|Overall Study|Not implanted bilaterally|1|||
161023121|NCT00324805|581474633|FG000|Overall Study|Adverse Event|62|||
161023122|NCT00324805|581474634|FG001|Overall Study|Adverse Event|203|||
161023123|NCT00324805|581474633|FG000|Overall Study|Progression|7|||
161023124|NCT00324805|581474634|FG001|Overall Study|Progression|35|||
161023125|NCT00324805|581474633|FG000|Overall Study|Withdrawal by Subject|51|||
161023126|NCT00324805|581474634|FG001|Overall Study|Withdrawal by Subject|174|||
161023127|NCT00324805|581474633|FG000|Overall Study|Death|6|||
161023128|NCT00324805|581474634|FG001|Overall Study|Death|9|||
161023129|NCT00324805|581474633|FG000|Overall Study|Alternative therapy|4|||
161023130|NCT00324805|581474634|FG001|Overall Study|Alternative therapy|8|||
161023131|NCT00324805|581474633|FG000|Overall Study|Other complicating disease|1|||
161023132|NCT00324805|581474634|FG001|Overall Study|Other complicating disease|9|||
161023133|NCT00324805|581474633|FG000|Overall Study|Other reasons|7|||
161023134|NCT00324805|581474634|FG001|Overall Study|Other reasons|26|||
161023135|NCT00324805|581474633|FG000|Overall Study|Other|0|||
161023136|NCT00324805|581474634|FG001|Overall Study|Other|2|||
161023137|NCT00324805|581474633|FG000|Overall Study|Did not start therapy|12|||
161023138|NCT00324805|581474634|FG001|Overall Study|Did not start therapy|17|||
161023139|NCT05496231|581474636|FG000|Overall Study|Adverse Event|1|||
161023140|NCT05496231|581474637|FG001|Overall Study|Adverse Event|1|||
161023141|NCT05496231|581474638|FG002|Overall Study|Adverse Event|0|||
161023142|NCT05496231|581474639|FG003|Overall Study|Adverse Event|4|||
161023143|NCT05496231|581474636|FG000|Overall Study|Withdrawal by Subject|5|||
161023144|NCT05496231|581474637|FG001|Overall Study|Withdrawal by Subject|5|||
161023145|NCT05496231|581474638|FG002|Overall Study|Withdrawal by Subject|4|||
161023146|NCT05496231|581474639|FG003|Overall Study|Withdrawal by Subject|11|||
161023147|NCT05496231|581474636|FG000|Overall Study|Migrated/moved from the study area|3|||
161023148|NCT05496231|581474637|FG001|Overall Study|Migrated/moved from the study area|5|||
161023149|NCT05496231|581474638|FG002|Overall Study|Migrated/moved from the study area|3|||
161023150|NCT05496231|581474639|FG003|Overall Study|Migrated/moved from the study area|3|||
161023151|NCT05496231|581474636|FG000|Overall Study|Lost to Follow-up|13|||
161023152|NCT05496231|581474637|FG001|Overall Study|Lost to Follow-up|6|||
161023153|NCT05496231|581474638|FG002|Overall Study|Lost to Follow-up|11|||
161023154|NCT05496231|581474639|FG003|Overall Study|Lost to Follow-up|6|||
161023155|NCT05496231|581474636|FG000|Overall Study|Other|9|||
161023156|NCT05496231|581474637|FG001|Overall Study|Other|7|||
161023157|NCT05496231|581474638|FG002|Overall Study|Other|7|||
161023158|NCT05496231|581474639|FG003|Overall Study|Other|8|||
161023159|NCT03085810|581474654|FG000|Main Study|Withdrawal by Subject|77|||
161023160|NCT03085810|581474655|FG001|Main Study|Withdrawal by Subject|0|||
161023161|NCT03085810|581474656|FG002|Main Study|Withdrawal by Subject|0|||
161023162|NCT03085810|581474654|FG000|Main Study|Terminated By Sponsor|14|||
161023163|NCT03085810|581474655|FG001|Main Study|Terminated By Sponsor|0|||
161023164|NCT03085810|581474656|FG002|Main Study|Terminated By Sponsor|0|||
161023165|NCT03085810|581474654|FG000|Main Study|Protocol Violation|15|||
161023166|NCT03085810|581474655|FG001|Main Study|Protocol Violation|0|||
161023167|NCT03085810|581474656|FG002|Main Study|Protocol Violation|0|||
161023168|NCT03085810|581474654|FG000|Main Study|Physician Decision|13|||
161023169|NCT03085810|581474655|FG001|Main Study|Physician Decision|0|||
161023170|NCT03085810|581474656|FG002|Main Study|Physician Decision|0|||
161023171|NCT03085810|581474654|FG000|Main Study|Lost to Follow-up|17|||
161023172|NCT03085810|581474655|FG001|Main Study|Lost to Follow-up|0|||
161023173|NCT03085810|581474656|FG002|Main Study|Lost to Follow-up|0|||
161023174|NCT03085810|581474654|FG000|Main Study|Adverse Event|25|||
161023175|NCT03085810|581474655|FG001|Main Study|Adverse Event|0|||
161023176|NCT03085810|581474656|FG002|Main Study|Adverse Event|0|||
161023177|NCT03085810|581474654|FG000|Main Study|Pregnancy|7|||
161023178|NCT03085810|581474655|FG001|Main Study|Pregnancy|0|||
161023179|NCT03085810|581474656|FG002|Main Study|Pregnancy|0|||
161023180|NCT03085810|581474654|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
161023181|NCT03085810|581474655|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
161023182|NCT03085810|581474656|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
161023183|NCT03085810|581474654|FG000|Main Study|Lack of Efficacy|10|||
161023184|NCT03085810|581474655|FG001|Main Study|Lack of Efficacy|0|||
161023185|NCT03085810|581474656|FG002|Main Study|Lack of Efficacy|0|||
161023186|NCT03085810|581474654|FG000|Main Study|Death|12|||
161023187|NCT03085810|581474655|FG001|Main Study|Death|0|||
161023188|NCT03085810|581474656|FG002|Main Study|Death|0|||
161023189|NCT03085810|581474654|FG000|Main Study|Disease progression|1|||
161023190|NCT03085810|581474655|FG001|Main Study|Disease progression|0|||
161023191|NCT03085810|581474656|FG002|Main Study|Disease progression|0|||
161023192|NCT03085810|581474654|FG000|Main Study|Site Closure|3|||
161023193|NCT03085810|581474655|FG001|Main Study|Site Closure|0|||
161023194|NCT03085810|581474656|FG002|Main Study|Site Closure|0|||
161023195|NCT03085810|581474654|FG000|Main Study|Planned pregnancy|17|||
161023196|NCT03085810|581474655|FG001|Main Study|Planned pregnancy|0|||
161023197|NCT03085810|581474656|FG002|Main Study|Planned pregnancy|0|||
161023198|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
161023199|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
161023200|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
161023201|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
161023202|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
161023203|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
161023204|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
161023205|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
161023206|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
161023207|NCT03085810|581474654|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
161023208|NCT03085810|581474655|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
161023209|NCT03085810|581474656|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
161023210|NCT05239455|581474657|FG000|Overall Study|Adverse Event|1|||
161023211|NCT05239455|581474657|FG000|Overall Study|Sponsor Decision|5|||
161023212|NCT05239455|581474657|FG000|Overall Study|Incomplete Blood Collection|1|||
161023213|NCT03023410|581477188|FG000|Overall Study|study termination|0|||
161023214|NCT03023410|581477189|FG001|Overall Study|study termination|1|||
161023215|NCT04987320|581477195|FG000|Overall Study|Withdrawal by Subject|0|||
161023216|NCT04987320|581477196|FG001|Overall Study|Withdrawal by Subject|1|||
161023217|NCT00085735|581477197|FG000|Overall Study|Adverse Event|1|||
161023218|NCT00085735|581477198|FG001|Overall Study|Adverse Event|0|||
161023219|NCT00085735|581477199|FG002|Overall Study|Adverse Event|0|||
161023220|NCT00085735|581477200|FG003|Overall Study|Adverse Event|0|||
161023221|NCT00085735|581477201|FG004|Overall Study|Adverse Event|0|||
161023222|NCT00085735|581477202|FG005|Overall Study|Adverse Event|0|||
161023223|NCT00085735|581477197|FG000|Overall Study|Lack of Efficacy|2|||
161023224|NCT00085735|581477198|FG001|Overall Study|Lack of Efficacy|4|||
161023225|NCT00085735|581477199|FG002|Overall Study|Lack of Efficacy|6|||
161023226|NCT00085735|581477200|FG003|Overall Study|Lack of Efficacy|3|||
161023227|NCT00085735|581477201|FG004|Overall Study|Lack of Efficacy|4|||
161023228|NCT00085735|581477202|FG005|Overall Study|Lack of Efficacy|3|||
161023229|NCT00085735|581477197|FG000|Overall Study|Lost to Follow-up|0|||
161023230|NCT00085735|581477198|FG001|Overall Study|Lost to Follow-up|1|||
161148645|NCT03825042|581926125|FG001|Overall Study|Withdrawal by Subject|0|||
161148646|NCT04003155|581926127|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
161148647|NCT04003155|581926128|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
161148648|NCT04003155|581926129|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
161023231|NCT00085735|581477199|FG002|Overall Study|Lost to Follow-up|0|||
161023232|NCT00085735|581477200|FG003|Overall Study|Lost to Follow-up|0|||
161023233|NCT00085735|581477201|FG004|Overall Study|Lost to Follow-up|1|||
161023234|NCT00085735|581477202|FG005|Overall Study|Lost to Follow-up|0|||
161023235|NCT00085735|581477197|FG000|Overall Study|Physician Decision|2|||
161023236|NCT00085735|581477198|FG001|Overall Study|Physician Decision|3|||
161148649|NCT04003155|581926130|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
161148650|NCT04003155|581926131|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
161148651|NCT04003155|581926127|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
161273693|NCT00371397|582381030|FG008|Session 1|Withdrawal by Subject|0|||
161023237|NCT00085735|581477199|FG002|Overall Study|Physician Decision|2|||
161023238|NCT00085735|581477200|FG003|Overall Study|Physician Decision|3|||
161023239|NCT00085735|581477201|FG004|Overall Study|Physician Decision|11|||
161023240|NCT00085735|581477202|FG005|Overall Study|Physician Decision|8|||
161023241|NCT00085735|581477197|FG000|Overall Study|Protocol Violation|1|||
161023242|NCT00085735|581477198|FG001|Overall Study|Protocol Violation|0|||
161023243|NCT00085735|581477199|FG002|Overall Study|Protocol Violation|0|||
161023244|NCT00085735|581477200|FG003|Overall Study|Protocol Violation|0|||
161023245|NCT00085735|581477201|FG004|Overall Study|Protocol Violation|0|||
161023246|NCT00085735|581477202|FG005|Overall Study|Protocol Violation|0|||
161023247|NCT00085735|581477197|FG000|Overall Study|Withdrawal by Subject|1|||
161023248|NCT00085735|581477198|FG001|Overall Study|Withdrawal by Subject|0|||
161023249|NCT00085735|581477199|FG002|Overall Study|Withdrawal by Subject|4|||
161023250|NCT00085735|581477200|FG003|Overall Study|Withdrawal by Subject|5|||
161023251|NCT00085735|581477201|FG004|Overall Study|Withdrawal by Subject|7|||
161023252|NCT00085735|581477202|FG005|Overall Study|Withdrawal by Subject|8|||
161023253|NCT00085735|581477197|FG000|Overall Study|Patient ineligible|1|||
161023254|NCT00085735|581477198|FG001|Overall Study|Patient ineligible|0|||
161023255|NCT00085735|581477199|FG002|Overall Study|Patient ineligible|3|||
161273694|NCT00371397|582381031|FG009|Session 1|Withdrawal by Subject|0|||
161273695|NCT00371397|582381032|FG010|Session 1|Withdrawal by Subject|0|||
161273696|NCT00371397|582381033|FG011|Session 1|Withdrawal by Subject|0|||
161273697|NCT01104779|582381034|FG000|Overall Study|Protocol Violation|1|||
161273698|NCT01104779|582381035|FG001|Overall Study|Protocol Violation|2|||
161273699|NCT01104779|582381036|FG002|Overall Study|Protocol Violation|2|||
161273700|NCT01104779|582381034|FG000|Overall Study|Lack of Efficacy|26|||
161273701|NCT01104779|582381035|FG001|Overall Study|Lack of Efficacy|12|||
161273702|NCT01104779|582381036|FG002|Overall Study|Lack of Efficacy|13|||
161273703|NCT01104779|582381034|FG000|Overall Study|Adverse Event|13|||
161273704|NCT01104779|582381035|FG001|Overall Study|Adverse Event|14|||
161273705|NCT01104779|582381036|FG002|Overall Study|Adverse Event|13|||
161273706|NCT01104779|582381034|FG000|Overall Study|Did not meet inc/exc criteria|1|||
161273707|NCT01104779|582381035|FG001|Overall Study|Did not meet inc/exc criteria|1|||
161273708|NCT01104779|582381036|FG002|Overall Study|Did not meet inc/exc criteria|1|||
161273709|NCT01104779|582381034|FG000|Overall Study|Other reasons|0|||
161273710|NCT01104779|582381035|FG001|Overall Study|Other reasons|1|||
161273711|NCT01104779|582381036|FG002|Overall Study|Other reasons|0|||
161273712|NCT01104779|582381034|FG000|Overall Study|Lost to Follow-up|2|||
161273713|NCT01104779|582381035|FG001|Overall Study|Lost to Follow-up|0|||
161273714|NCT01104779|582381036|FG002|Overall Study|Lost to Follow-up|1|||
161273715|NCT01104779|582381034|FG000|Overall Study|Withdrawal by Subject|16|||
161273716|NCT01104779|582381035|FG001|Overall Study|Withdrawal by Subject|25|||
161273717|NCT01104779|582381036|FG002|Overall Study|Withdrawal by Subject|32|||
161273718|NCT03753763|582381037|FG000|Overall Study|Adverse Event|2|||
161273719|NCT03753763|582381038|FG001|Overall Study|Adverse Event|0|||
161273720|NCT03753763|582381037|FG000|Overall Study|Withdrawal by Subject|3|||
161273721|NCT03753763|582381038|FG001|Overall Study|Withdrawal by Subject|1|||
161273722|NCT03753763|582381037|FG000|Overall Study|clinical deterioration|1|||
161273723|NCT03753763|582381038|FG001|Overall Study|clinical deterioration|0|||
161273724|NCT02342639|582381045|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
161273725|NCT02342639|582381046|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
161273726|NCT02342639|582381045|FG000|Overall Study|Protocol Violation|0|||
161273727|NCT02342639|582381046|FG001|Overall Study|Protocol Violation|2|||
161273728|NCT00871741|582381051|FG000|Overall Study|Premature study termination|9|||
161273729|NCT00871741|582381052|FG001|Overall Study|Premature study termination|7|||
161023256|NCT00085735|581477200|FG003|Overall Study|Patient ineligible|7|||
161023257|NCT00085735|581477201|FG004|Overall Study|Patient ineligible|17|||
161023258|NCT00085735|581477202|FG005|Overall Study|Patient ineligible|8|||
161023259|NCT00085735|581477197|FG000|Overall Study|Excess residual disease|2|||
161023260|NCT00085735|581477198|FG001|Overall Study|Excess residual disease|2|||
161023261|NCT00085735|581477199|FG002|Overall Study|Excess residual disease|1|||
161023262|NCT00085735|581477200|FG003|Overall Study|Excess residual disease|1|||
161023263|NCT00085735|581477201|FG004|Overall Study|Excess residual disease|1|||
161273730|NCT01565850|582381053|FG000|Overall Study|Adverse Event|0|||
161273731|NCT01565850|582381054|FG001|Overall Study|Adverse Event|1|||
161023264|NCT00085735|581477202|FG005|Overall Study|Excess residual disease|4|||
161023265|NCT00085735|581477197|FG000|Overall Study|Reason not documented|1|||
161023266|NCT00085735|581477198|FG001|Overall Study|Reason not documented|0|||
161023267|NCT00085735|581477199|FG002|Overall Study|Reason not documented|1|||
161023268|NCT00085735|581477200|FG003|Overall Study|Reason not documented|0|||
161023269|NCT00085735|581477201|FG004|Overall Study|Reason not documented|1|||
161273732|NCT01565850|582381053|FG000|Overall Study|Lost to Follow-up|12|||
161273733|NCT01565850|582381054|FG001|Overall Study|Lost to Follow-up|4|||
161273734|NCT01565850|582381053|FG000|Overall Study|Investigator's Discretion|2|||
161023270|NCT00085735|581477202|FG005|Overall Study|Reason not documented|0|||
161023271|NCT00085735|581477197|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
161023272|NCT00085735|581477198|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
161023273|NCT00085735|581477199|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
161273735|NCT01565850|582381054|FG001|Overall Study|Investigator's Discretion|1|||
161273736|NCT01565850|582381053|FG000|Overall Study|Participant noncompliance|2|||
161273737|NCT01565850|582381054|FG001|Overall Study|Participant noncompliance|0|||
161273738|NCT01565850|582381053|FG000|Overall Study|Withdrew Consent|4|||
161273739|NCT01565850|582381054|FG001|Overall Study|Withdrew Consent|2|||
161023274|NCT00085735|581477200|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
161023275|NCT00085735|581477201|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
161023276|NCT00085735|581477202|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
161023277|NCT01824875|581477203|FG000|Overall Study|Disease progression|22|||
161023278|NCT01824875|581477204|FG001|Overall Study|Disease progression|15|||
161023279|NCT01824875|581477203|FG000|Overall Study|Withdrawal by Subject|5|||
161023280|NCT01824875|581477204|FG001|Overall Study|Withdrawal by Subject|4|||
161023281|NCT01824875|581477203|FG000|Overall Study|Adverse Event|4|||
161023282|NCT01824875|581477204|FG001|Overall Study|Adverse Event|10|||
161023283|NCT01824875|581477203|FG000|Overall Study|Alternative therapy|3|||
161023284|NCT01824875|581477204|FG001|Overall Study|Alternative therapy|0|||
161023285|NCT01824875|581477203|FG000|Overall Study|Complicating disease|1|||
161023286|NCT01824875|581477204|FG001|Overall Study|Complicating disease|0|||
161023287|NCT01824875|581477203|FG000|Overall Study|Physician Decision|0|||
161023288|NCT01824875|581477204|FG001|Overall Study|Physician Decision|1|||
161023289|NCT01824875|581477203|FG000|Overall Study|Non-compliance|1|||
161023290|NCT01824875|581477204|FG001|Overall Study|Non-compliance|1|||
161023291|NCT01824875|581477203|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
161023292|NCT01824875|581477204|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
161023293|NCT01824875|581477203|FG000|Overall Study|Administrative issues|0|||
161023294|NCT01824875|581477204|FG001|Overall Study|Administrative issues|2|||
161023295|NCT01824875|581477203|FG000|Overall Study|Ineligible or never started treatment|9|||
161023296|NCT01824875|581477204|FG001|Overall Study|Ineligible or never started treatment|5|||
161023297|NCT01824875|581477203|FG000|Overall Study|Other|0|||
161023298|NCT01824875|581477204|FG001|Overall Study|Other|2|||
161023299|NCT04195698|581477207|FG000|Overall Study|Adverse Event|4|||
161023300|NCT04195698|581477208|FG001|Overall Study|Adverse Event|11|||
161023301|NCT04195698|581477207|FG000|Overall Study|Withdrawal by Subject|9|||
161023302|NCT04195698|581477208|FG001|Overall Study|Withdrawal by Subject|10|||
161023303|NCT04195698|581477207|FG000|Overall Study|Lost to Follow-up|5|||
161023304|NCT04195698|581477208|FG001|Overall Study|Lost to Follow-up|4|||
161023305|NCT04195698|581477207|FG000|Overall Study|Lack of Efficacy|2|||
161023306|NCT04195698|581477208|FG001|Overall Study|Lack of Efficacy|10|||
161023307|NCT04195698|581477207|FG000|Overall Study|Other|5|||
161023308|NCT04195698|581477208|FG001|Overall Study|Other|4|||
161023309|NCT00433329|581477209|FG000|Overall Study|Adverse Event|9|||
161023310|NCT00433329|581477209|FG000|Overall Study|Death|4|||
161023311|NCT00433329|581477209|FG000|Overall Study|Withdrew consent|3|||
161023312|NCT00433329|581477209|FG000|Overall Study|Discontinued sildenafil|2|||
161023313|NCT00433329|581477209|FG000|Overall Study|Moved out of state|1|||
161023314|NCT00433329|581477209|FG000|Overall Study|Lost to Follow-up|1|||
161023315|NCT00433329|581477209|FG000|Overall Study|Physician Decision|1|||
161023316|NCT05459688|581477210|FG000|Overall Study|Lost to Follow-up|6|||
161023317|NCT05459688|581477210|FG000|Overall Study|Physician Decision|1|||
161023318|NCT05459688|581477210|FG000|Overall Study|Withdrawal by Subject|19|||
161023319|NCT05459688|581477210|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
161023320|NCT01129102|581477211|FG000|Overall Study|No study drug treatment|2|||
161023321|NCT01129102|581477212|FG001|Overall Study|No study drug treatment|3|||
161023322|NCT01129102|581477213|FG002|Overall Study|No study drug treatment|1|||
161023323|NCT01129102|581477211|FG000|Overall Study|Withdrawal by Subject|2|||
161023324|NCT01129102|581477212|FG001|Overall Study|Withdrawal by Subject|0|||
161023325|NCT01129102|581477213|FG002|Overall Study|Withdrawal by Subject|3|||
161023326|NCT01129102|581477211|FG000|Overall Study|Protocol Violation|0|||
161023327|NCT01129102|581477212|FG001|Overall Study|Protocol Violation|1|||
161023328|NCT01129102|581477213|FG002|Overall Study|Protocol Violation|1|||
161023329|NCT01129102|581477211|FG000|Overall Study|Pregnancy|0|||
161023330|NCT01129102|581477212|FG001|Overall Study|Pregnancy|0|||
161023331|NCT01129102|581477213|FG002|Overall Study|Pregnancy|1|||
161023332|NCT01129102|581477211|FG000|Overall Study|Adverse Event|2|||
161023333|NCT01129102|581477212|FG001|Overall Study|Adverse Event|2|||
161023334|NCT01129102|581477213|FG002|Overall Study|Adverse Event|1|||
161023335|NCT01129102|581477211|FG000|Overall Study|Lost to Follow-up|2|||
161023336|NCT01129102|581477212|FG001|Overall Study|Lost to Follow-up|0|||
161023337|NCT01129102|581477213|FG002|Overall Study|Lost to Follow-up|0|||
161023338|NCT03379675|581477216|FG000|Overall Study|Lost to Follow-up|0|||
161023339|NCT03379675|581477217|FG001|Overall Study|Lost to Follow-up|1|||
161023340|NCT03379675|581477218|FG002|Overall Study|Lost to Follow-up|0|||
161023341|NCT03379675|581477216|FG000|Overall Study|Adverse Event|2|||
161023342|NCT03379675|581477217|FG001|Overall Study|Adverse Event|0|||
161023343|NCT03379675|581477218|FG002|Overall Study|Adverse Event|0|||
161023344|NCT03379675|581477216|FG000|Overall Study|Withdrawal by Subject|2|||
161023345|NCT03379675|581477217|FG001|Overall Study|Withdrawal by Subject|1|||
161023346|NCT03379675|581477218|FG002|Overall Study|Withdrawal by Subject|2|||
161023347|NCT02817776|581477219|FG000|Overall Study|Excluded|33|||
161023348|NCT02817776|581477219|FG000|Overall Study|Lost to Follow-up|20|||
161148652|NCT04003155|581926128|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
161023349|NCT02817776|581477219|FG000|Overall Study|Withdrawal by Subject|33|||
161023350|NCT02817776|581477219|FG000|Overall Study|Death|2|||
161023351|NCT02359890|581477220|FG000|Overall Study|Not meeting eligibility|4|||
161023352|NCT02359890|581477220|FG000|Overall Study|Never treated with study catheter|6|||
161023353|NCT02683447|581477225|FG000|Overall Study|Lost to Follow-up|2|||
161023354|NCT04663737|581477226|FG000|Overall Study|Withdrawal by Subject|2|||
161023355|NCT04663737|581477227|FG001|Overall Study|Withdrawal by Subject|0|||
161023356|NCT04016662|581477228|FG000|Run-In Phase|Death|1|||
161023357|NCT04016662|581477228|FG000|Run-In Phase|Withdrawal by Subject|11|||
161023358|NCT04016662|581477228|FG000|Run-In Phase|Not meeting screening eligibility|9|||
161023359|NCT04016662|581477228|FG000|Run-In Phase|Physician Decision|3|||
161023360|NCT04016662|581477228|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
161023361|NCT04016662|581477228|FG000|PLGS (12 Weeks)|Death|1|||
161023362|NCT04016662|581477228|FG000|SAP (12 Weeks)|Death|1|||
161023363|NCT02489903|581477232|FG000|Screening|Screen Failure|24|||
161023364|NCT02489903|581477233|FG001|Screening|Screen Failure|0|||
161023365|NCT02489903|581477234|FG002|Screening|Screen Failure|0|||
161023366|NCT02489903|581477235|FG003|Screening|Screen Failure|8|||
161023367|NCT02489903|581477232|FG000|Randomized and Received Treatment|Protocol Violation|0|||
161023368|NCT02489903|581477233|FG001|Randomized and Received Treatment|Protocol Violation|1|||
161023369|NCT02489903|581477234|FG002|Randomized and Received Treatment|Protocol Violation|0|||
161023370|NCT02489903|581477235|FG003|Randomized and Received Treatment|Protocol Violation|0|||
161023371|NCT02489903|581477232|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
161023372|NCT02489903|581477233|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
161023373|NCT02489903|581477234|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
161023374|NCT02489903|581477235|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
161023375|NCT02489903|581477232|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
161023376|NCT02489903|581477233|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
161023377|NCT02489903|581477234|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
161023378|NCT02489903|581477235|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
161023379|NCT02489903|581477232|FG000|Randomized and Received Treatment|Death|10|||
161023380|NCT02489903|581477233|FG001|Randomized and Received Treatment|Death|1|||
161023381|NCT02489903|581477234|FG002|Randomized and Received Treatment|Death|0|||
161023382|NCT02489903|581477235|FG003|Randomized and Received Treatment|Death|0|||
161023383|NCT03904147|581477240|FG000|Overall Study|Death|15|||
161023384|NCT03904147|581477241|FG001|Overall Study|Death|13|||
161023385|NCT03904147|581477242|FG002|Overall Study|Death|15|||
161023386|NCT03904147|581477240|FG000|Overall Study|Withdrawal by Subject|7|||
161023387|NCT03904147|581477241|FG001|Overall Study|Withdrawal by Subject|12|||
161023388|NCT03904147|581477242|FG002|Overall Study|Withdrawal by Subject|1|||
161023389|NCT03904147|581477240|FG000|Overall Study|1Y visit completed after 365 days|1|||
161023390|NCT03904147|581477241|FG001|Overall Study|1Y visit completed after 365 days|1|||
161023391|NCT03904147|581477242|FG002|Overall Study|1Y visit completed after 365 days|0|||
161023392|NCT04413708|581477243|FG000|Overall Study|Lost to Follow-up|1|||
161023393|NCT04413708|581477244|FG001|Overall Study|Lost to Follow-up|2|||
161023394|NCT04948697|581477245|FG000|Overall Study|Progressive disease|27|||
161023395|NCT04948697|581477246|FG001|Overall Study|Progressive disease|18|||
161023396|NCT04948697|581477245|FG000|Overall Study|Adverse Event|14|||
161023397|NCT04948697|581477246|FG001|Overall Study|Adverse Event|4|||
161023398|NCT04948697|581477245|FG000|Overall Study|Participant moved to long term extension study|7|||
161023399|NCT04948697|581477246|FG001|Overall Study|Participant moved to long term extension study|4|||
161023400|NCT04948697|581477245|FG000|Overall Study|Withdrawal by Subject|10|||
161023401|NCT04948697|581477246|FG001|Overall Study|Withdrawal by Subject|0|||
161023402|NCT04948697|581477245|FG000|Overall Study|Closed by Sponsor|3|||
161023403|NCT04948697|581477246|FG001|Overall Study|Closed by Sponsor|2|||
161023404|NCT04948697|581477245|FG000|Overall Study|Physician Decision|0|||
161023405|NCT04948697|581477246|FG001|Overall Study|Physician Decision|2|||
161023406|NCT04948697|581477245|FG000|Overall Study|Lost to Follow-up|0|||
161023407|NCT04948697|581477246|FG001|Overall Study|Lost to Follow-up|1|||
161023408|NCT04948697|581477245|FG000|Overall Study|Other-Miscellaneous|1|||
161273740|NCT03395405|582382422|FG000|Overall Study|Death|0|||
161023409|NCT04948697|581477246|FG001|Overall Study|Other-Miscellaneous|0|||
161023410|NCT04948697|581477245|FG000|Overall Study|Randomized but not treated|0|||
161023411|NCT04948697|581477246|FG001|Overall Study|Randomized but not treated|1|||
161023412|NCT04599062|581477247|FG000|Overall Study|Physician Decision|1|||
161148653|NCT04003155|581926129|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161023413|NCT04599062|581477248|FG001|Overall Study|Physician Decision|0|||
161023414|NCT04032704|581477249|FG000|Part A|Withdrawal by Subject|0|||
161023415|NCT04032704|581477250|FG001|Part A|Withdrawal by Subject|0|||
161023416|NCT04032704|581477251|FG002|Part A|Withdrawal by Subject|3|||
161023417|NCT04032704|581477252|FG003|Part A|Withdrawal by Subject|0|||
161023418|NCT04032704|581477253|FG004|Part A|Withdrawal by Subject|1|||
161023419|NCT04032704|581477254|FG005|Part A|Withdrawal by Subject|7|||
161023420|NCT04032704|581477255|FG006|Part A|Withdrawal by Subject|0|||
161023421|NCT04032704|581477256|FG007|Part A|Withdrawal by Subject|0|||
161273741|NCT03395405|582382423|FG001|Overall Study|Death|2|||
161023422|NCT04032704|581477257|FG008|Part A|Withdrawal by Subject|0|||
161023423|NCT04032704|581477258|FG009|Part A|Withdrawal by Subject|0|||
161023424|NCT04032704|581477259|FG010|Part A|Withdrawal by Subject|0|||
161023425|NCT04032704|581477260|FG011|Part A|Withdrawal by Subject|0|||
161023426|NCT04032704|581477261|FG012|Part A|Withdrawal by Subject|0|||
161023427|NCT04032704|581477262|FG013|Part A|Withdrawal by Subject|0|||
161023428|NCT04032704|581477263|FG014|Part A|Withdrawal by Subject|0|||
161023429|NCT04032704|581477264|FG015|Part A|Withdrawal by Subject|0|||
161023430|NCT04032704|581477265|FG016|Part A|Withdrawal by Subject|0|||
161023431|NCT04032704|581477266|FG017|Part A|Withdrawal by Subject|0|||
161023432|NCT04032704|581477249|FG000|Part A|Lost to Follow-up|1|||
161023433|NCT04032704|581477250|FG001|Part A|Lost to Follow-up|0|||
161023434|NCT04032704|581477251|FG002|Part A|Lost to Follow-up|0|||
161023435|NCT04032704|581477252|FG003|Part A|Lost to Follow-up|0|||
161023436|NCT04032704|581477253|FG004|Part A|Lost to Follow-up|0|||
161023437|NCT04032704|581477254|FG005|Part A|Lost to Follow-up|0|||
161023438|NCT04032704|581477255|FG006|Part A|Lost to Follow-up|0|||
161023439|NCT04032704|581477256|FG007|Part A|Lost to Follow-up|0|||
161023440|NCT04032704|581477257|FG008|Part A|Lost to Follow-up|0|||
161023441|NCT04032704|581477258|FG009|Part A|Lost to Follow-up|0|||
161023442|NCT04032704|581477259|FG010|Part A|Lost to Follow-up|0|||
161023443|NCT04032704|581477260|FG011|Part A|Lost to Follow-up|0|||
161023444|NCT04032704|581477261|FG012|Part A|Lost to Follow-up|0|||
161023445|NCT04032704|581477262|FG013|Part A|Lost to Follow-up|0|||
161023446|NCT04032704|581477263|FG014|Part A|Lost to Follow-up|0|||
161023447|NCT04032704|581477264|FG015|Part A|Lost to Follow-up|0|||
161023448|NCT04032704|581477265|FG016|Part A|Lost to Follow-up|0|||
161023449|NCT04032704|581477266|FG017|Part A|Lost to Follow-up|0|||
161023450|NCT04032704|581477249|FG000|Part A|Death|9|||
161023451|NCT04032704|581477250|FG001|Part A|Death|2|||
161023452|NCT04032704|581477251|FG002|Part A|Death|10|||
161023453|NCT04032704|581477252|FG003|Part A|Death|7|||
161148654|NCT04003155|581926130|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161148655|NCT04003155|581926131|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
161023454|NCT04032704|581477253|FG004|Part A|Death|4|||
161023455|NCT04032704|581477254|FG005|Part A|Death|5|||
161023456|NCT04032704|581477255|FG006|Part A|Death|0|||
161023457|NCT04032704|581477256|FG007|Part A|Death|0|||
161023458|NCT04032704|581477257|FG008|Part A|Death|0|||
161023459|NCT04032704|581477258|FG009|Part A|Death|0|||
161023460|NCT04032704|581477259|FG010|Part A|Death|0|||
161023461|NCT04032704|581477260|FG011|Part A|Death|0|||
161023462|NCT04032704|581477261|FG012|Part A|Death|0|||
161023463|NCT04032704|581477262|FG013|Part A|Death|0|||
161023464|NCT04032704|581477263|FG014|Part A|Death|0|||
161023465|NCT04032704|581477264|FG015|Part A|Death|0|||
161023466|NCT04032704|581477265|FG016|Part A|Death|0|||
161023467|NCT04032704|581477266|FG017|Part A|Death|0|||
161023468|NCT04032704|581477249|FG000|Part B|Other|0|||
161023469|NCT04032704|581477250|FG001|Part B|Other|0|||
161273742|NCT03395405|582382422|FG000|Overall Study|Lost to Follow-up|0|||
161273743|NCT03395405|582382423|FG001|Overall Study|Lost to Follow-up|1|||
161273744|NCT03395405|582382422|FG000|Overall Study|Protocol Violation|0|||
161273745|NCT03395405|582382423|FG001|Overall Study|Protocol Violation|1|||
161273746|NCT03395405|582382422|FG000|Overall Study|Withdrawal by Subject|3|||
161273747|NCT03395405|582382423|FG001|Overall Study|Withdrawal by Subject|1|||
161148656|NCT04003155|581926127|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
161148657|NCT04003155|581926128|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
161148658|NCT04003155|581926129|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
161148659|NCT04003155|581926130|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
161273748|NCT03395405|582382422|FG000|Overall Study|COVID-19 Pandemic|1|||
161273749|NCT03395405|582382423|FG001|Overall Study|COVID-19 Pandemic|0|||
161148660|NCT04003155|581926131|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
161148661|NCT04003155|581926127|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
161273750|NCT04324073|582382424|FG000|Overall Study|withdrew consent|0|||
161273751|NCT04324073|582382425|FG001|Overall Study|withdrew consent|4|||
161273752|NCT04324073|582382426|FG002|Overall Study|withdrew consent|2|||
161023470|NCT04032704|581477251|FG002|Part B|Other|0|||
161023471|NCT04032704|581477252|FG003|Part B|Other|0|||
161023472|NCT04032704|581477253|FG004|Part B|Other|0|||
161023473|NCT04032704|581477254|FG005|Part B|Other|0|||
161023474|NCT04032704|581477255|FG006|Part B|Other|0|||
161023475|NCT04032704|581477256|FG007|Part B|Other|1|||
161023476|NCT04032704|581477257|FG008|Part B|Other|2|||
161023477|NCT04032704|581477258|FG009|Part B|Other|1|||
161023478|NCT04032704|581477259|FG010|Part B|Other|1|||
161023479|NCT04032704|581477260|FG011|Part B|Other|1|||
161023480|NCT04032704|581477261|FG012|Part B|Other|5|||
161023481|NCT04032704|581477262|FG013|Part B|Other|13|||
161023482|NCT04032704|581477263|FG014|Part B|Other|0|||
161023483|NCT04032704|581477264|FG015|Part B|Other|0|||
161023484|NCT04032704|581477265|FG016|Part B|Other|0|||
161023485|NCT04032704|581477266|FG017|Part B|Other|0|||
161023486|NCT04032704|581477249|FG000|Part B|Study termination by Sponsor|0|||
161023487|NCT04032704|581477250|FG001|Part B|Study termination by Sponsor|0|||
161023488|NCT04032704|581477251|FG002|Part B|Study termination by Sponsor|0|||
161023489|NCT04032704|581477252|FG003|Part B|Study termination by Sponsor|0|||
161023490|NCT04032704|581477253|FG004|Part B|Study termination by Sponsor|0|||
161023491|NCT04032704|581477254|FG005|Part B|Study termination by Sponsor|0|||
161023492|NCT04032704|581477255|FG006|Part B|Study termination by Sponsor|0|||
161023493|NCT04032704|581477256|FG007|Part B|Study termination by Sponsor|0|||
161023494|NCT04032704|581477257|FG008|Part B|Study termination by Sponsor|1|||
161023495|NCT04032704|581477258|FG009|Part B|Study termination by Sponsor|0|||
161023496|NCT04032704|581477259|FG010|Part B|Study termination by Sponsor|0|||
161023497|NCT04032704|581477260|FG011|Part B|Study termination by Sponsor|0|||
161023498|NCT04032704|581477261|FG012|Part B|Study termination by Sponsor|0|||
161023499|NCT04032704|581477262|FG013|Part B|Study termination by Sponsor|0|||
161023500|NCT04032704|581477263|FG014|Part B|Study termination by Sponsor|0|||
161023501|NCT04032704|581477264|FG015|Part B|Study termination by Sponsor|0|||
161023502|NCT04032704|581477265|FG016|Part B|Study termination by Sponsor|0|||
161023503|NCT04032704|581477266|FG017|Part B|Study termination by Sponsor|0|||
161023504|NCT04032704|581477249|FG000|Part B|Withdrawal by Subject|0|||
161023505|NCT04032704|581477250|FG001|Part B|Withdrawal by Subject|0|||
161023506|NCT04032704|581477251|FG002|Part B|Withdrawal by Subject|0|||
161023507|NCT04032704|581477252|FG003|Part B|Withdrawal by Subject|0|||
161023508|NCT04032704|581477253|FG004|Part B|Withdrawal by Subject|0|||
161023509|NCT04032704|581477254|FG005|Part B|Withdrawal by Subject|0|||
161023510|NCT04032704|581477255|FG006|Part B|Withdrawal by Subject|3|||
161023511|NCT04032704|581477256|FG007|Part B|Withdrawal by Subject|2|||
161023512|NCT04032704|581477257|FG008|Part B|Withdrawal by Subject|2|||
161023513|NCT04032704|581477258|FG009|Part B|Withdrawal by Subject|1|||
161023514|NCT04032704|581477259|FG010|Part B|Withdrawal by Subject|4|||
161023515|NCT04032704|581477260|FG011|Part B|Withdrawal by Subject|6|||
161023516|NCT04032704|581477261|FG012|Part B|Withdrawal by Subject|2|||
161023517|NCT04032704|581477262|FG013|Part B|Withdrawal by Subject|1|||
161023518|NCT04032704|581477263|FG014|Part B|Withdrawal by Subject|0|||
161023519|NCT04032704|581477264|FG015|Part B|Withdrawal by Subject|1|||
161023520|NCT04032704|581477265|FG016|Part B|Withdrawal by Subject|0|||
161023521|NCT04032704|581477266|FG017|Part B|Withdrawal by Subject|0|||
161023522|NCT04032704|581477249|FG000|Part B|Lost to Follow-up|0|||
161023523|NCT04032704|581477250|FG001|Part B|Lost to Follow-up|0|||
161023524|NCT04032704|581477251|FG002|Part B|Lost to Follow-up|0|||
161023525|NCT04032704|581477252|FG003|Part B|Lost to Follow-up|0|||
161023526|NCT04032704|581477253|FG004|Part B|Lost to Follow-up|0|||
161023527|NCT04032704|581477254|FG005|Part B|Lost to Follow-up|0|||
161023528|NCT04032704|581477255|FG006|Part B|Lost to Follow-up|0|||
161023529|NCT04032704|581477256|FG007|Part B|Lost to Follow-up|0|||
161023530|NCT04032704|581477257|FG008|Part B|Lost to Follow-up|0|||
161023531|NCT04032704|581477258|FG009|Part B|Lost to Follow-up|0|||
161023532|NCT04032704|581477259|FG010|Part B|Lost to Follow-up|0|||
161023533|NCT04032704|581477260|FG011|Part B|Lost to Follow-up|1|||
161023534|NCT04032704|581477261|FG012|Part B|Lost to Follow-up|0|||
161023535|NCT04032704|581477262|FG013|Part B|Lost to Follow-up|0|||
161023536|NCT04032704|581477263|FG014|Part B|Lost to Follow-up|0|||
161023537|NCT04032704|581477264|FG015|Part B|Lost to Follow-up|0|||
161023538|NCT04032704|581477265|FG016|Part B|Lost to Follow-up|0|||
161023539|NCT04032704|581477266|FG017|Part B|Lost to Follow-up|0|||
161023540|NCT04032704|581477249|FG000|Part B|Death|0|||
161023541|NCT04032704|581477250|FG001|Part B|Death|0|||
161023542|NCT04032704|581477251|FG002|Part B|Death|0|||
161023543|NCT04032704|581477252|FG003|Part B|Death|0|||
161023544|NCT04032704|581477253|FG004|Part B|Death|0|||
161023545|NCT04032704|581477254|FG005|Part B|Death|0|||
161023546|NCT04032704|581477255|FG006|Part B|Death|13|||
161023547|NCT04032704|581477256|FG007|Part B|Death|13|||
161023548|NCT04032704|581477257|FG008|Part B|Death|14|||
161023549|NCT04032704|581477258|FG009|Part B|Death|12|||
161023550|NCT04032704|581477259|FG010|Part B|Death|12|||
161023551|NCT04032704|581477260|FG011|Part B|Death|13|||
161023552|NCT04032704|581477261|FG012|Part B|Death|7|||
161023553|NCT04032704|581477262|FG013|Part B|Death|17|||
161023554|NCT04032704|581477263|FG014|Part B|Death|2|||
161023555|NCT04032704|581477264|FG015|Part B|Death|1|||
161023556|NCT04032704|581477265|FG016|Part B|Death|2|||
161023557|NCT04032704|581477266|FG017|Part B|Death|2|||
161023558|NCT05877976|581477267|FG000|Overall Study|Lost to Follow-up|31|||
161023559|NCT04145440|581477268|FG000|Overall Study|Physician Decision|3|||
161023560|NCT04145440|581477269|FG001|Overall Study|Physician Decision|0|||
161023561|NCT04145440|581477268|FG000|Overall Study|Use of prohibited therapy|2|||
161023562|NCT04145440|581477269|FG001|Overall Study|Use of prohibited therapy|3|||
161023563|NCT05808257|581477274|FG000|Overall Study|Lost to Follow-up|8|||
161023564|NCT05808257|581477275|FG001|Overall Study|Lost to Follow-up|8|||
161023565|NCT04907851|581477278|FG000|Overall Study|Consent withdrawn|1|||
161023566|NCT04907851|581477279|FG001|Overall Study|Consent withdrawn|2|||
161023567|NCT04907851|581477280|FG002|Overall Study|Consent withdrawn|0|||
161023568|NCT04907851|581477278|FG000|Overall Study|Death|5|||
161023569|NCT04907851|581477279|FG001|Overall Study|Death|15|||
161023570|NCT04907851|581477280|FG002|Overall Study|Death|10|||
161023571|NCT04248725|581477283|FG000|Post-Treatment|Lost to Follow-up|6|||
161023572|NCT04248725|581477284|FG001|Post-Treatment|Lost to Follow-up|5|||
161023573|NCT04248725|581477283|FG000|6-Month Follow Up|Lost to Follow-up|9|||
161023574|NCT04248725|581477284|FG001|6-Month Follow Up|Lost to Follow-up|8|||
161023575|NCT04436276|581477294|FG000|Overall Study|Adverse Event|0|||
161023576|NCT04436276|581477295|FG001|Overall Study|Adverse Event|0|||
161023577|NCT04436276|581477296|FG002|Overall Study|Adverse Event|0|||
161023578|NCT04436276|581477297|FG003|Overall Study|Adverse Event|0|||
161023579|NCT04436276|581477298|FG004|Overall Study|Adverse Event|0|||
161023580|NCT04436276|581477299|FG005|Overall Study|Adverse Event|0|||
161023581|NCT04436276|581477300|FG006|Overall Study|Adverse Event|0|||
161023582|NCT04436276|581477301|FG007|Overall Study|Adverse Event|0|||
161023583|NCT04436276|581477302|FG008|Overall Study|Adverse Event|0|||
161023584|NCT04436276|581477303|FG009|Overall Study|Adverse Event|0|||
161023585|NCT04436276|581477304|FG010|Overall Study|Adverse Event|0|||
161023586|NCT04436276|581477305|FG011|Overall Study|Adverse Event|0|||
161023587|NCT04436276|581477306|FG012|Overall Study|Adverse Event|0|||
161023588|NCT04436276|581477307|FG013|Overall Study|Adverse Event|0|||
161023589|NCT04436276|581477308|FG014|Overall Study|Adverse Event|0|||
161023590|NCT04436276|581477309|FG015|Overall Study|Adverse Event|0|||
161023591|NCT04436276|581477310|FG016|Overall Study|Adverse Event|1|||
161023592|NCT04436276|581477311|FG017|Overall Study|Adverse Event|0|||
161023593|NCT04436276|581477312|FG018|Overall Study|Adverse Event|0|||
161023594|NCT04436276|581477313|FG019|Overall Study|Adverse Event|0|||
161023595|NCT04436276|581477314|FG020|Overall Study|Adverse Event|0|||
161023596|NCT04436276|581477315|FG021|Overall Study|Adverse Event|0|||
161023597|NCT04436276|581477316|FG022|Overall Study|Adverse Event|0|||
161023598|NCT04436276|581477294|FG000|Overall Study|Death|0|||
161023599|NCT04436276|581477295|FG001|Overall Study|Death|0|||
161023600|NCT04436276|581477296|FG002|Overall Study|Death|0|||
161023601|NCT04436276|581477297|FG003|Overall Study|Death|0|||
161023602|NCT04436276|581477298|FG004|Overall Study|Death|0|||
161023603|NCT04436276|581477299|FG005|Overall Study|Death|0|||
161023604|NCT04436276|581477300|FG006|Overall Study|Death|0|||
161023605|NCT04436276|581477301|FG007|Overall Study|Death|0|||
161023606|NCT04436276|581477302|FG008|Overall Study|Death|0|||
161023607|NCT04436276|581477303|FG009|Overall Study|Death|0|||
161023608|NCT04436276|581477304|FG010|Overall Study|Death|0|||
161023609|NCT04436276|581477305|FG011|Overall Study|Death|0|||
161023610|NCT04436276|581477306|FG012|Overall Study|Death|1|||
161023611|NCT04436276|581477307|FG013|Overall Study|Death|0|||
161023612|NCT04436276|581477308|FG014|Overall Study|Death|1|||
161023613|NCT04436276|581477309|FG015|Overall Study|Death|0|||
161023614|NCT04436276|581477310|FG016|Overall Study|Death|0|||
161023615|NCT04436276|581477311|FG017|Overall Study|Death|0|||
161023616|NCT04436276|581477312|FG018|Overall Study|Death|0|||
161023617|NCT04436276|581477313|FG019|Overall Study|Death|2|||
161023618|NCT04436276|581477314|FG020|Overall Study|Death|0|||
161023619|NCT04436276|581477315|FG021|Overall Study|Death|1|||
161023620|NCT04436276|581477316|FG022|Overall Study|Death|0|||
161023621|NCT04436276|581477294|FG000|Overall Study|Lost to Follow-up|0|||
161023622|NCT04436276|581477295|FG001|Overall Study|Lost to Follow-up|2|||
161023623|NCT04436276|581477296|FG002|Overall Study|Lost to Follow-up|2|||
161023624|NCT04436276|581477297|FG003|Overall Study|Lost to Follow-up|1|||
161023625|NCT04436276|581477298|FG004|Overall Study|Lost to Follow-up|4|||
161023626|NCT04436276|581477299|FG005|Overall Study|Lost to Follow-up|1|||
161023627|NCT04436276|581477300|FG006|Overall Study|Lost to Follow-up|0|||
161023628|NCT04436276|581477301|FG007|Overall Study|Lost to Follow-up|0|||
161023629|NCT04436276|581477302|FG008|Overall Study|Lost to Follow-up|1|||
161023630|NCT04436276|581477303|FG009|Overall Study|Lost to Follow-up|0|||
161023631|NCT04436276|581477304|FG010|Overall Study|Lost to Follow-up|5|||
161023632|NCT04436276|581477305|FG011|Overall Study|Lost to Follow-up|5|||
161023633|NCT04436276|581477306|FG012|Overall Study|Lost to Follow-up|4|||
161023634|NCT04436276|581477307|FG013|Overall Study|Lost to Follow-up|1|||
161023635|NCT04436276|581477308|FG014|Overall Study|Lost to Follow-up|7|||
161023636|NCT04436276|581477309|FG015|Overall Study|Lost to Follow-up|7|||
161023637|NCT04436276|581477310|FG016|Overall Study|Lost to Follow-up|1|||
161023638|NCT04436276|581477311|FG017|Overall Study|Lost to Follow-up|0|||
161023639|NCT04436276|581477312|FG018|Overall Study|Lost to Follow-up|1|||
161023640|NCT04436276|581477313|FG019|Overall Study|Lost to Follow-up|1|||
161023641|NCT04436276|581477314|FG020|Overall Study|Lost to Follow-up|2|||
161023642|NCT04436276|581477315|FG021|Overall Study|Lost to Follow-up|1|||
161023643|NCT04436276|581477316|FG022|Overall Study|Lost to Follow-up|1|||
161023644|NCT04436276|581477294|FG000|Overall Study|Physician Decision|1|||
161023645|NCT04436276|581477295|FG001|Overall Study|Physician Decision|0|||
161023646|NCT04436276|581477296|FG002|Overall Study|Physician Decision|2|||
161023647|NCT04436276|581477297|FG003|Overall Study|Physician Decision|1|||
161023648|NCT04436276|581477298|FG004|Overall Study|Physician Decision|0|||
161148662|NCT04003155|581926128|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
161023649|NCT04436276|581477299|FG005|Overall Study|Physician Decision|0|||
161023650|NCT04436276|581477300|FG006|Overall Study|Physician Decision|0|||
161023651|NCT04436276|581477301|FG007|Overall Study|Physician Decision|0|||
161023652|NCT04436276|581477302|FG008|Overall Study|Physician Decision|0|||
161023653|NCT04436276|581477303|FG009|Overall Study|Physician Decision|0|||
161023654|NCT04436276|581477304|FG010|Overall Study|Physician Decision|0|||
161023655|NCT04436276|581477305|FG011|Overall Study|Physician Decision|1|||
161023656|NCT04436276|581477306|FG012|Overall Study|Physician Decision|2|||
161273753|NCT04324073|582382427|FG003|Overall Study|withdrew consent|8|||
161273754|NCT01200069|582382433|FG000|Overall Study|Withdrawal by Subject|0|||
161273755|NCT01200069|582382434|FG001|Overall Study|Withdrawal by Subject|1|||
161273756|NCT03665441|582382437|FG000|Overall Study|survival follow up ongoing|23|||
161273757|NCT03665441|582382438|FG001|Overall Study|survival follow up ongoing|0|||
161273758|NCT03665441|582382437|FG000|Overall Study|Patients ongoing on treatment|9|||
161273759|NCT03665441|582382438|FG001|Overall Study|Patients ongoing on treatment|6|||
161273760|NCT03665441|582382437|FG000|Overall Study|Randomized but not treated|7|||
161273761|NCT03665441|582382438|FG001|Overall Study|Randomized but not treated|11|||
161273762|NCT05307510|582382439|FG000|Overall Study|Lost to Follow-up|3|||
161273763|NCT05307510|582382440|FG001|Overall Study|Lost to Follow-up|6|||
161273764|NCT05307510|582382439|FG000|Overall Study|Withdrawal by Subject|0|||
161273765|NCT05307510|582382440|FG001|Overall Study|Withdrawal by Subject|1|||
161273766|NCT03610516|582382441|FG000|Treatment Epoch|Adverse Event|3|||
161273767|NCT03610516|582382442|FG001|Treatment Epoch|Adverse Event|1|||
161273768|NCT03610516|582382441|FG000|Treatment Epoch|Death|1|||
161273769|NCT03610516|582382442|FG001|Treatment Epoch|Death|0|||
161273770|NCT03610516|582382441|FG000|Treatment Epoch|Lack of Efficacy|0|||
161273771|NCT03610516|582382442|FG001|Treatment Epoch|Lack of Efficacy|1|||
161273772|NCT03610516|582382441|FG000|Treatment Epoch|No longer requires treatment|1|||
161273773|NCT03610516|582382442|FG001|Treatment Epoch|No longer requires treatment|0|||
161273774|NCT03610516|582382441|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
161273775|NCT03610516|582382442|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
161273776|NCT03610516|582382441|FG000|Treatment Epoch|Physician Decision|8|||
161273777|NCT03610516|582382442|FG001|Treatment Epoch|Physician Decision|5|||
161273778|NCT03610516|582382441|FG000|Treatment Epoch|Protocol Deviation|1|||
161273779|NCT03610516|582382442|FG001|Treatment Epoch|Protocol Deviation|0|||
161273780|NCT03610516|582382441|FG000|Treatment Epoch|Withdrawal by Subject|3|||
161273781|NCT03610516|582382442|FG001|Treatment Epoch|Withdrawal by Subject|1|||
161273782|NCT03610516|582382441|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
161273783|NCT03610516|582382442|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
161273784|NCT03610516|582382441|FG000|Post-Treatment Follow-up|Death|1|||
161273785|NCT03610516|582382442|FG001|Post-Treatment Follow-up|Death|0|||
161273786|NCT01908907|582382443|FG000|Overall Study|Physician Decision|1|||
161273787|NCT01908907|582382444|FG001|Overall Study|Physician Decision|0|||
161023657|NCT04436276|581477307|FG013|Overall Study|Physician Decision|0|||
161023658|NCT04436276|581477308|FG014|Overall Study|Physician Decision|0|||
161023659|NCT04436276|581477309|FG015|Overall Study|Physician Decision|0|||
161023660|NCT04436276|581477310|FG016|Overall Study|Physician Decision|0|||
161023661|NCT04436276|581477311|FG017|Overall Study|Physician Decision|0|||
161023662|NCT04436276|581477312|FG018|Overall Study|Physician Decision|0|||
161023663|NCT04436276|581477313|FG019|Overall Study|Physician Decision|0|||
161023664|NCT04436276|581477314|FG020|Overall Study|Physician Decision|1|||
161023665|NCT04436276|581477315|FG021|Overall Study|Physician Decision|2|||
161023666|NCT04436276|581477316|FG022|Overall Study|Physician Decision|0|||
161023667|NCT04436276|581477294|FG000|Overall Study|Protocol Violation|0|||
161023668|NCT04436276|581477295|FG001|Overall Study|Protocol Violation|0|||
161023669|NCT04436276|581477296|FG002|Overall Study|Protocol Violation|0|||
161023670|NCT04436276|581477297|FG003|Overall Study|Protocol Violation|0|||
161023671|NCT04436276|581477298|FG004|Overall Study|Protocol Violation|0|||
161023672|NCT04436276|581477299|FG005|Overall Study|Protocol Violation|0|||
161023673|NCT04436276|581477300|FG006|Overall Study|Protocol Violation|0|||
161023674|NCT04436276|581477301|FG007|Overall Study|Protocol Violation|0|||
161023675|NCT04436276|581477302|FG008|Overall Study|Protocol Violation|0|||
161023676|NCT04436276|581477303|FG009|Overall Study|Protocol Violation|0|||
161023677|NCT04436276|581477304|FG010|Overall Study|Protocol Violation|0|||
161023678|NCT04436276|581477305|FG011|Overall Study|Protocol Violation|0|||
161023679|NCT04436276|581477306|FG012|Overall Study|Protocol Violation|0|||
161023680|NCT04436276|581477307|FG013|Overall Study|Protocol Violation|1|||
161023681|NCT04436276|581477308|FG014|Overall Study|Protocol Violation|0|||
161273788|NCT01908907|582382443|FG000|Overall Study|Protocol Violation|1|||
161273789|NCT01908907|582382444|FG001|Overall Study|Protocol Violation|0|||
161023682|NCT04436276|581477309|FG015|Overall Study|Protocol Violation|1|||
161023683|NCT04436276|581477310|FG016|Overall Study|Protocol Violation|0|||
161273790|NCT00660907|582382445|FG000|Overall Study|Incorrect Enrollment|1|||
161273791|NCT00660907|582382446|FG001|Overall Study|Incorrect Enrollment|1|||
161273792|NCT00660907|582382445|FG000|Overall Study|Adverse Event|33|||
161343589|NCT03034967|582644417|FG005|Overall Study|Lack of Efficacy|0|||
161273793|NCT00660907|582382446|FG001|Overall Study|Adverse Event|19|||
161273794|NCT00660907|582382445|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
161273795|NCT00660907|582382446|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
161273796|NCT00660907|582382445|FG000|Overall Study|Withdrawal by Subject|23|||
161273797|NCT00660907|582382446|FG001|Overall Study|Withdrawal by Subject|32|||
161273798|NCT00660907|582382445|FG000|Overall Study|Lost to Follow-up|3|||
161023684|NCT04436276|581477311|FG017|Overall Study|Protocol Violation|0|||
161023685|NCT04436276|581477312|FG018|Overall Study|Protocol Violation|0|||
161023686|NCT04436276|581477313|FG019|Overall Study|Protocol Violation|0|||
161023687|NCT04436276|581477314|FG020|Overall Study|Protocol Violation|0|||
161273799|NCT00660907|582382446|FG001|Overall Study|Lost to Follow-up|3|||
161273800|NCT00660907|582382445|FG000|Overall Study|Poor/Non-Compliance|5|||
161273801|NCT00660907|582382446|FG001|Overall Study|Poor/Non-Compliance|1|||
161273802|NCT00660907|582382445|FG000|Overall Study|Safety|1|||
161273803|NCT00660907|582382446|FG001|Overall Study|Safety|0|||
161273804|NCT00660907|582382445|FG000|Overall Study|Death|1|||
161273805|NCT00660907|582382446|FG001|Overall Study|Death|3|||
161273806|NCT00660907|582382445|FG000|Overall Study|Various|11|||
161273807|NCT00660907|582382446|FG001|Overall Study|Various|8|||
161273808|NCT04975191|582382447|FG000|Overall Study|Protocol Violation|1|||
161273809|NCT04975191|582382448|FG001|Overall Study|Protocol Violation|2|||
161273810|NCT04975191|582382449|FG002|Overall Study|Protocol Violation|2|||
161273811|NCT04975191|582382450|FG003|Overall Study|Protocol Violation|2|||
161273812|NCT04975191|582382447|FG000|Overall Study|Lost to Follow-up|13|||
161273813|NCT04975191|582382448|FG001|Overall Study|Lost to Follow-up|3|||
161273814|NCT04975191|582382449|FG002|Overall Study|Lost to Follow-up|8|||
161273815|NCT04975191|582382450|FG003|Overall Study|Lost to Follow-up|8|||
161273816|NCT00761657|582382453|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
161273817|NCT00761657|582382454|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
161273818|NCT00761657|582382455|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
161273819|NCT00761657|582382456|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
161273820|NCT00761657|582382457|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
161023688|NCT04436276|581477315|FG021|Overall Study|Protocol Violation|0|||
161023689|NCT04436276|581477316|FG022|Overall Study|Protocol Violation|0|||
161023690|NCT04436276|581477294|FG000|Overall Study|Withdrawal by Subject|25|||
161023691|NCT04436276|581477295|FG001|Overall Study|Withdrawal by Subject|22|||
161023692|NCT04436276|581477296|FG002|Overall Study|Withdrawal by Subject|24|||
161023693|NCT04436276|581477297|FG003|Overall Study|Withdrawal by Subject|23|||
161023694|NCT04436276|581477298|FG004|Overall Study|Withdrawal by Subject|14|||
161023695|NCT04436276|581477299|FG005|Overall Study|Withdrawal by Subject|0|||
161023696|NCT04436276|581477300|FG006|Overall Study|Withdrawal by Subject|0|||
161023697|NCT04436276|581477301|FG007|Overall Study|Withdrawal by Subject|1|||
161023698|NCT04436276|581477302|FG008|Overall Study|Withdrawal by Subject|0|||
161023699|NCT04436276|581477303|FG009|Overall Study|Withdrawal by Subject|1|||
161023700|NCT04436276|581477304|FG010|Overall Study|Withdrawal by Subject|17|||
161023701|NCT04436276|581477305|FG011|Overall Study|Withdrawal by Subject|7|||
161023702|NCT04436276|581477306|FG012|Overall Study|Withdrawal by Subject|10|||
161023703|NCT04436276|581477307|FG013|Overall Study|Withdrawal by Subject|6|||
161023704|NCT04436276|581477308|FG014|Overall Study|Withdrawal by Subject|20|||
161023705|NCT04436276|581477309|FG015|Overall Study|Withdrawal by Subject|6|||
161023706|NCT04436276|581477310|FG016|Overall Study|Withdrawal by Subject|11|||
161023707|NCT04436276|581477311|FG017|Overall Study|Withdrawal by Subject|4|||
161023708|NCT04436276|581477312|FG018|Overall Study|Withdrawal by Subject|14|||
161023709|NCT04436276|581477313|FG019|Overall Study|Withdrawal by Subject|24|||
161023710|NCT04436276|581477314|FG020|Overall Study|Withdrawal by Subject|24|||
161023711|NCT04436276|581477315|FG021|Overall Study|Withdrawal by Subject|16|||
161023712|NCT04436276|581477316|FG022|Overall Study|Withdrawal by Subject|14|||
161023713|NCT04436276|581477294|FG000|Overall Study|Other|3|||
161023714|NCT04436276|581477295|FG001|Overall Study|Other|2|||
161023715|NCT04436276|581477296|FG002|Overall Study|Other|5|||
161023716|NCT04436276|581477297|FG003|Overall Study|Other|9|||
161023717|NCT04436276|581477298|FG004|Overall Study|Other|23|||
161023718|NCT04436276|581477299|FG005|Overall Study|Other|1|||
161023719|NCT04436276|581477300|FG006|Overall Study|Other|0|||
161023720|NCT04436276|581477301|FG007|Overall Study|Other|0|||
161023721|NCT04436276|581477302|FG008|Overall Study|Other|0|||
161023722|NCT04436276|581477303|FG009|Overall Study|Other|0|||
161023723|NCT04436276|581477304|FG010|Overall Study|Other|3|||
161273821|NCT00761657|582382458|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
161273822|NCT00761657|582382459|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
161273823|NCT00761657|582382460|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
161023724|NCT04436276|581477305|FG011|Overall Study|Other|1|||
161023725|NCT04436276|581477306|FG012|Overall Study|Other|1|||
161273824|NCT00761657|582382461|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
161273825|NCT00761657|582382453|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273826|NCT00761657|582382454|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273827|NCT00761657|582382455|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
161023726|NCT04436276|581477307|FG013|Overall Study|Other|2|||
161023727|NCT04436276|581477308|FG014|Overall Study|Other|3|||
161023728|NCT04436276|581477309|FG015|Overall Study|Other|0|||
161023729|NCT04436276|581477310|FG016|Overall Study|Other|0|||
161023730|NCT04436276|581477311|FG017|Overall Study|Other|6|||
161023731|NCT04436276|581477312|FG018|Overall Study|Other|1|||
161023732|NCT04436276|581477313|FG019|Overall Study|Other|0|||
161023733|NCT04436276|581477314|FG020|Overall Study|Other|2|||
161023734|NCT04436276|581477315|FG021|Overall Study|Other|2|||
161023735|NCT04436276|581477316|FG022|Overall Study|Other|60|||
161273828|NCT00761657|582382456|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
161273829|NCT00761657|582382457|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273830|NCT00761657|582382458|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273831|NCT00761657|582382459|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273832|NCT00761657|582382460|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273833|NCT00761657|582382461|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
161273834|NCT00761657|582382453|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
161273835|NCT00761657|582382454|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
161273836|NCT00761657|582382455|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
161273837|NCT00761657|582382456|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
161273838|NCT00761657|582382457|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
161273839|NCT00761657|582382458|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
161273840|NCT00761657|582382459|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
161343590|NCT03034967|582644412|FG000|Overall Study|Adverse Event, non-fatal|3|||
161343591|NCT03034967|582644413|FG001|Overall Study|Adverse Event, non-fatal|1|||
161023736|NCT03656510|581477318|FG000|Overall Study|Lost to Follow-up|1|||
161023737|NCT03656510|581477319|FG001|Overall Study|Lost to Follow-up|0|||
161023738|NCT03656510|581477320|FG002|Overall Study|Lost to Follow-up|0|||
161023739|NCT03656510|581477321|FG003|Overall Study|Lost to Follow-up|0|||
161343592|NCT03034967|582644414|FG002|Overall Study|Adverse Event, non-fatal|2|||
161023740|NCT03656510|581477322|FG004|Overall Study|Lost to Follow-up|0|||
161023741|NCT03656510|581477323|FG005|Overall Study|Lost to Follow-up|0|||
161023742|NCT03656510|581477318|FG000|Overall Study|Withdrawal by Subject|1|||
161023743|NCT03656510|581477319|FG001|Overall Study|Withdrawal by Subject|1|||
161023744|NCT03656510|581477320|FG002|Overall Study|Withdrawal by Subject|0|||
161343593|NCT03034967|582644415|FG003|Overall Study|Adverse Event, non-fatal|0|||
161343594|NCT03034967|582644416|FG004|Overall Study|Adverse Event, non-fatal|2|||
161343595|NCT03034967|582644417|FG005|Overall Study|Adverse Event, non-fatal|8|||
161343596|NCT03034967|582644412|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
161343597|NCT03034967|582644413|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
161343598|NCT03034967|582644414|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
161023745|NCT03656510|581477321|FG003|Overall Study|Withdrawal by Subject|1|||
161023746|NCT03656510|581477322|FG004|Overall Study|Withdrawal by Subject|0|||
161023747|NCT03656510|581477323|FG005|Overall Study|Withdrawal by Subject|0|||
161023748|NCT06457802|581477329|FG000|Overall Study|Early termination of study prior to participant completion|2|||
161023749|NCT06457802|581477330|FG001|Overall Study|Early termination of study prior to participant completion|2|||
161023750|NCT03819153|581477333|FG000|Overall Study|Withdrawal by Subject|20|||
161023751|NCT03819153|581477334|FG001|Overall Study|Withdrawal by Subject|28|||
161023752|NCT03819153|581477333|FG000|Overall Study|Lost to Follow-up|23|||
161023753|NCT03819153|581477334|FG001|Overall Study|Lost to Follow-up|30|||
161023754|NCT03974178|581477335|FG000|Overall Study|Death|0|||
161023755|NCT03974178|581477336|FG001|Overall Study|Death|1|||
161023756|NCT03899259|581477337|FG000|Overall Study|Adverse Event|5|||
161023757|NCT03899259|581477338|FG001|Overall Study|Adverse Event|4|||
161023758|NCT03899259|581477339|FG002|Overall Study|Adverse Event|6|||
161023759|NCT03899259|581477337|FG000|Overall Study|Lack of Efficacy|5|||
161023760|NCT03899259|581477338|FG001|Overall Study|Lack of Efficacy|0|||
161023761|NCT03899259|581477339|FG002|Overall Study|Lack of Efficacy|2|||
161023762|NCT03899259|581477337|FG000|Overall Study|Pregnancy|3|||
161023763|NCT03899259|581477338|FG001|Overall Study|Pregnancy|0|||
161023764|NCT03899259|581477339|FG002|Overall Study|Pregnancy|1|||
161023765|NCT03899259|581477337|FG000|Overall Study|Physician Decision|0|||
161023766|NCT03899259|581477338|FG001|Overall Study|Physician Decision|1|||
161023767|NCT03899259|581477339|FG002|Overall Study|Physician Decision|0|||
161023768|NCT03899259|581477337|FG000|Overall Study|Protocol Deviation|1|||
161023769|NCT03899259|581477338|FG001|Overall Study|Protocol Deviation|1|||
161023770|NCT03899259|581477339|FG002|Overall Study|Protocol Deviation|1|||
161023771|NCT03899259|581477337|FG000|Overall Study|Withdrawal by Subject|8|||
161023772|NCT03899259|581477338|FG001|Overall Study|Withdrawal by Subject|10|||
161023773|NCT03899259|581477339|FG002|Overall Study|Withdrawal by Subject|12|||
161023774|NCT03899259|581477337|FG000|Overall Study|Lost to Follow-up|5|||
161023775|NCT03899259|581477338|FG001|Overall Study|Lost to Follow-up|6|||
161023776|NCT03899259|581477339|FG002|Overall Study|Lost to Follow-up|2|||
161023777|NCT03899259|581477337|FG000|Overall Study|Lack of Adherence|1|||
161023778|NCT03899259|581477338|FG001|Overall Study|Lack of Adherence|0|||
161023779|NCT03899259|581477339|FG002|Overall Study|Lack of Adherence|0|||
161023780|NCT03899259|581477337|FG000|Overall Study|Screen Failure|1|||
161023781|NCT03899259|581477338|FG001|Overall Study|Screen Failure|0|||
161023782|NCT03899259|581477339|FG002|Overall Study|Screen Failure|0|||
161023783|NCT03899259|581477337|FG000|Overall Study|Ongoing Study Participation|127|||
161023784|NCT03899259|581477338|FG001|Overall Study|Ongoing Study Participation|134|||
161023785|NCT03899259|581477339|FG002|Overall Study|Ongoing Study Participation|210|||
161023786|NCT01152450|581477340|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
161273841|NCT00761657|582382460|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
161273842|NCT00761657|582382461|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
161023787|NCT01152450|581477341|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
161023788|NCT01152450|581477342|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
161023789|NCT01152450|581477343|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
161273843|NCT00761657|582382453|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
161273844|NCT00761657|582382454|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
161023790|NCT01152450|581477344|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
161023791|NCT01152450|581477345|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
161023792|NCT01152450|581477340|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
161023793|NCT01152450|581477341|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
161023794|NCT01152450|581477342|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
161023795|NCT01152450|581477343|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
161023796|NCT01152450|581477344|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
161023797|NCT01152450|581477345|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
161023798|NCT01152450|581477340|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023799|NCT01152450|581477341|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161023800|NCT01152450|581477342|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161023801|NCT01152450|581477343|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023802|NCT01152450|581477344|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023803|NCT01152450|581477345|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161023804|NCT01544114|581477350|FG000|Overall Study|Withdrawal by Subject|0|||
161023805|NCT01544114|581477351|FG001|Overall Study|Withdrawal by Subject|0|||
161023806|NCT01544114|581477352|FG002|Overall Study|Withdrawal by Subject|3|||
161023807|NCT01544114|581477350|FG000|Overall Study|Lost to Follow-up|0|||
161023808|NCT01544114|581477351|FG001|Overall Study|Lost to Follow-up|2|||
161023809|NCT01544114|581477352|FG002|Overall Study|Lost to Follow-up|0|||
161023810|NCT01544114|581477350|FG000|Overall Study|Adverse Event|1|||
161023811|NCT01544114|581477351|FG001|Overall Study|Adverse Event|1|||
161023812|NCT01544114|581477352|FG002|Overall Study|Adverse Event|2|||
161023813|NCT01544114|581477350|FG000|Overall Study|Protocol Violation|0|||
161023814|NCT01544114|581477351|FG001|Overall Study|Protocol Violation|1|||
161023815|NCT01544114|581477352|FG002|Overall Study|Protocol Violation|0|||
161023816|NCT04508309|581477358|FG000|Overall Study|Death|0|||
161023817|NCT04508309|581477359|FG001|Overall Study|Death|0|||
161023818|NCT04508309|581477360|FG002|Overall Study|Death|0|||
161023819|NCT04508309|581477361|FG003|Overall Study|Death|0|||
161023820|NCT04508309|581477362|FG004|Overall Study|Death|1|||
161023821|NCT04508309|581477358|FG000|Overall Study|Lost to Follow-up|0|||
161023822|NCT04508309|581477359|FG001|Overall Study|Lost to Follow-up|0|||
161023823|NCT04508309|581477360|FG002|Overall Study|Lost to Follow-up|1|||
161023824|NCT04508309|581477361|FG003|Overall Study|Lost to Follow-up|1|||
161023825|NCT04508309|581477362|FG004|Overall Study|Lost to Follow-up|0|||
161023826|NCT04508309|581477358|FG000|Overall Study|Withdrawal by Subject|0|||
161023827|NCT04508309|581477359|FG001|Overall Study|Withdrawal by Subject|0|||
161023828|NCT04508309|581477360|FG002|Overall Study|Withdrawal by Subject|0|||
161023829|NCT04508309|581477361|FG003|Overall Study|Withdrawal by Subject|0|||
161023830|NCT04508309|581477362|FG004|Overall Study|Withdrawal by Subject|1|||
161023831|NCT03058289|581477363|FG000|Overall Study|Radiographic Deterioration|0|||
161023832|NCT03058289|581477364|FG001|Overall Study|Radiographic Deterioration|3|||
161023833|NCT03058289|581477365|FG002|Overall Study|Radiographic Deterioration|1|||
161023834|NCT03058289|581477366|FG003|Overall Study|Radiographic Deterioration|2|||
161023835|NCT03058289|581477367|FG004|Overall Study|Radiographic Deterioration|6|||
161023836|NCT03058289|581477368|FG005|Overall Study|Radiographic Deterioration|3|||
161023837|NCT03058289|581477369|FG006|Overall Study|Radiographic Deterioration|0|||
161023838|NCT03058289|581477370|FG007|Overall Study|Radiographic Deterioration|4|||
161023839|NCT03058289|581477371|FG008|Overall Study|Radiographic Deterioration|2|||
161023840|NCT03058289|581477363|FG000|Overall Study|Adverse Event|2|||
161023841|NCT03058289|581477364|FG001|Overall Study|Adverse Event|0|||
161023842|NCT03058289|581477365|FG002|Overall Study|Adverse Event|1|||
161023843|NCT03058289|581477366|FG003|Overall Study|Adverse Event|3|||
161023844|NCT03058289|581477367|FG004|Overall Study|Adverse Event|1|||
161023845|NCT03058289|581477368|FG005|Overall Study|Adverse Event|0|||
161023846|NCT03058289|581477369|FG006|Overall Study|Adverse Event|1|||
161023847|NCT03058289|581477370|FG007|Overall Study|Adverse Event|3|||
161023848|NCT03058289|581477371|FG008|Overall Study|Adverse Event|0|||
161023849|NCT03058289|581477363|FG000|Overall Study|Withdrawal by Subject|0|||
161023850|NCT03058289|581477364|FG001|Overall Study|Withdrawal by Subject|0|||
161023851|NCT03058289|581477365|FG002|Overall Study|Withdrawal by Subject|0|||
161023852|NCT03058289|581477366|FG003|Overall Study|Withdrawal by Subject|2|||
161023853|NCT03058289|581477367|FG004|Overall Study|Withdrawal by Subject|0|||
161023854|NCT03058289|581477368|FG005|Overall Study|Withdrawal by Subject|2|||
161023855|NCT03058289|581477369|FG006|Overall Study|Withdrawal by Subject|0|||
161023856|NCT03058289|581477370|FG007|Overall Study|Withdrawal by Subject|4|||
161023857|NCT03058289|581477371|FG008|Overall Study|Withdrawal by Subject|1|||
161023858|NCT03058289|581477363|FG000|Overall Study|Physician Decision|1|||
161023859|NCT03058289|581477364|FG001|Overall Study|Physician Decision|0|||
161023860|NCT03058289|581477365|FG002|Overall Study|Physician Decision|0|||
161023861|NCT03058289|581477366|FG003|Overall Study|Physician Decision|2|||
161023862|NCT03058289|581477367|FG004|Overall Study|Physician Decision|1|||
161023863|NCT03058289|581477368|FG005|Overall Study|Physician Decision|0|||
161023864|NCT03058289|581477369|FG006|Overall Study|Physician Decision|2|||
161023865|NCT03058289|581477370|FG007|Overall Study|Physician Decision|3|||
161023866|NCT03058289|581477371|FG008|Overall Study|Physician Decision|0|||
161023867|NCT03058289|581477363|FG000|Overall Study|Clinical Deterioration|2|||
161023868|NCT03058289|581477364|FG001|Overall Study|Clinical Deterioration|0|||
160969661|NCT02332590|581276917|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
160969662|NCT02332590|581276918|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
160969663|NCT01806584|581276919|FG000|Overall Study|Adverse Event|2|||
160969664|NCT01806584|581276920|FG001|Overall Study|Adverse Event|1|||
160969665|NCT01806584|581276919|FG000|Overall Study|Death|1|||
160969666|NCT01806584|581276920|FG001|Overall Study|Death|0|||
160969667|NCT01806584|581276919|FG000|Overall Study|Lost to Follow-up|0|||
160969668|NCT01806584|581276920|FG001|Overall Study|Lost to Follow-up|2|||
160969669|NCT01806584|581276919|FG000|Overall Study|Study terminated by sponsor|9|||
160969670|NCT01806584|581276920|FG001|Overall Study|Study terminated by sponsor|14|||
160969671|NCT01806584|581276919|FG000|Overall Study|Withdrawal by Subject|1|||
160969672|NCT01806584|581276920|FG001|Overall Study|Withdrawal by Subject|1|||
160969673|NCT01806584|581276919|FG000|Overall Study|Other unspecified|1|||
160969674|NCT01806584|581276920|FG001|Overall Study|Other unspecified|0|||
160969675|NCT00976703|581278767|FG000|Overall Study|Physician Decision|1|||
160969676|NCT00976703|581278768|FG001|Overall Study|Physician Decision|1|||
160969677|NCT00976703|581278767|FG000|Overall Study|ineligible for study|2|||
160969678|NCT00976703|581278768|FG001|Overall Study|ineligible for study|2|||
160969679|NCT00975221|581278771|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
160969680|NCT00975221|581278772|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
160969681|NCT00975221|581278771|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
160969682|NCT00975221|581278772|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
160969683|NCT00975221|581278771|FG000|Titration Phase (Weeks 1-12)|Other|0|||
160969684|NCT00975221|581278772|FG001|Titration Phase (Weeks 1-12)|Other|1|||
160969685|NCT00975221|581278771|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
160969686|NCT00975221|581278772|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
160969687|NCT00975221|581278771|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
160969688|NCT00975221|581278772|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
160969689|NCT00975221|581278771|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
160969690|NCT00975221|581278772|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
160969691|NCT02243631|581278773|FG000|Overall Study|no synovial fluid on second aspirate|0|||
160969692|NCT02243631|581278774|FG001|Overall Study|no synovial fluid on second aspirate|1|||
160969693|NCT01992549|581278777|FG000|Overall Study|Lost to Follow-up|2|||
160969694|NCT01992549|581278777|FG000|Overall Study|Serious Adverse Event|1|||
160969695|NCT01992549|581278777|FG000|Overall Study|Product Switch to Extend Half Life|1|||
160969696|NCT01590771|581278778|FG000|Overall Study|Other Protocol Specified Criteria|5|||
160969697|NCT01590771|581278779|FG001|Overall Study|Other Protocol Specified Criteria|14|||
160969698|NCT01590771|581278778|FG000|Overall Study|Withdrawal by Subject|8|||
160969699|NCT01590771|581278779|FG001|Overall Study|Withdrawal by Subject|15|||
160969700|NCT01590771|581278778|FG000|Overall Study|Protocol Violation|1|||
160969701|NCT01590771|581278779|FG001|Overall Study|Protocol Violation|2|||
160969702|NCT01590771|581278778|FG000|Overall Study|Lost to Follow-up|1|||
160969703|NCT01590771|581278779|FG001|Overall Study|Lost to Follow-up|1|||
160969704|NCT01590771|581278778|FG000|Overall Study|Lack of Efficacy|1|||
160969705|NCT01590771|581278779|FG001|Overall Study|Lack of Efficacy|0|||
160969706|NCT01590771|581278778|FG000|Overall Study|Adverse Event|3|||
160969707|NCT01590771|581278779|FG001|Overall Study|Adverse Event|7|||
160969708|NCT01785628|581278780|FG000|Overall Study|Lost to Follow-up|2|||
160969709|NCT01785628|581278781|FG001|Overall Study|Lost to Follow-up|3|||
160969710|NCT04022889|581278782|FG000|Stage 1: Period 1|Adverse Event|1|||
160969711|NCT04022889|581278783|FG001|Stage 1: Period 1|Adverse Event|0|||
160969712|NCT04022889|581278784|FG002|Stage 1: Period 1|Adverse Event|0|||
160969713|NCT04022889|581278782|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
160969714|NCT04022889|581278783|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
161273845|NCT00761657|582382455|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
160969715|NCT04022889|581278784|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
160969716|NCT04022889|581278782|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
160969717|NCT04022889|581278783|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
161023869|NCT03058289|581477365|FG002|Overall Study|Clinical Deterioration|0|||
161273846|NCT00761657|582382456|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
161273847|NCT00761657|582382457|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
160969718|NCT04022889|581278784|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
160969719|NCT04022889|581278782|FG000|Stage 2|Screen Failure|0|||
160969720|NCT04022889|581278783|FG001|Stage 2|Screen Failure|0|||
160969721|NCT04022889|581278784|FG002|Stage 2|Screen Failure|3|||
161023870|NCT03058289|581477366|FG003|Overall Study|Clinical Deterioration|2|||
160969722|NCT04022889|581278782|FG000|Stage 2|Ineligible for apheresis donation|0|||
160969723|NCT04022889|581278783|FG001|Stage 2|Ineligible for apheresis donation|0|||
160969724|NCT04022889|581278784|FG002|Stage 2|Ineligible for apheresis donation|2|||
160969725|NCT04022889|581278782|FG000|Stage 2|Adverse Event|0|||
160969726|NCT04022889|581278783|FG001|Stage 2|Adverse Event|0|||
160969727|NCT04022889|581278784|FG002|Stage 2|Adverse Event|2|||
160969728|NCT04022889|581278782|FG000|Stage 2|Protocol Violation|0|||
160969729|NCT04022889|581278783|FG001|Stage 2|Protocol Violation|0|||
160969730|NCT04022889|581278784|FG002|Stage 2|Protocol Violation|1|||
160969731|NCT04022889|581278782|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
160969732|NCT04022889|581278783|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
160969733|NCT04022889|581278784|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
160969734|NCT03015116|581278785|FG000|Overall Study|Lost to Follow-up|3|||
160969735|NCT03015116|581278786|FG001|Overall Study|Lost to Follow-up|0|||
160969736|NCT03015116|581278787|FG002|Overall Study|Lost to Follow-up|2|||
160969737|NCT03015116|581278785|FG000|Overall Study|Withdrawal by Subject|3|||
160969738|NCT03015116|581278786|FG001|Overall Study|Withdrawal by Subject|1|||
160969739|NCT03015116|581278787|FG002|Overall Study|Withdrawal by Subject|0|||
160969740|NCT03015116|581278785|FG000|Overall Study|Subject has New Medical Status|1|||
160969741|NCT03015116|581278786|FG001|Overall Study|Subject has New Medical Status|0|||
160969742|NCT03015116|581278787|FG002|Overall Study|Subject has New Medical Status|0|||
160969743|NCT03015116|581278785|FG000|Overall Study|Physician Decision|0|||
160969744|NCT03015116|581278786|FG001|Overall Study|Physician Decision|1|||
160969745|NCT03015116|581278787|FG002|Overall Study|Physician Decision|0|||
160969746|NCT01862991|581278788|FG000|Overall Study|Lost to Follow-up|2|||
160969747|NCT01862991|581278789|FG001|Overall Study|Lost to Follow-up|1|||
160969748|NCT01862991|581278790|FG002|Overall Study|Lost to Follow-up|1|||
160969749|NCT01862991|581278788|FG000|Overall Study|Protocol Violation|1|||
160969750|NCT01862991|581278789|FG001|Overall Study|Protocol Violation|0|||
160969751|NCT01862991|581278790|FG002|Overall Study|Protocol Violation|0|||
160969752|NCT04858802|581278791|FG000|Overall Study|Lost to Follow-up|1|||
160969753|NCT04858802|581278792|FG001|Overall Study|Lost to Follow-up|1|||
160969754|NCT04858802|581278791|FG000|Overall Study|Withdrawal by Subject|1|||
160969755|NCT04858802|581278792|FG001|Overall Study|Withdrawal by Subject|1|||
160969756|NCT00857805|581278793|FG000|Overall Study|Withdrawal by Subject|1|||
160969757|NCT00857805|581278794|FG001|Overall Study|Withdrawal by Subject|1|||
160969758|NCT01289041|581278795|FG000|Overall Study|Adverse Event|24|||
161148663|NCT04003155|581926129|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
161148664|NCT04003155|581926130|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
161148665|NCT04003155|581926131|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
160969759|NCT01289041|581278795|FG000|Overall Study|Physician Decision|1|||
160969760|NCT01289041|581278795|FG000|Overall Study|Progressive Disease|41|||
160969761|NCT01289041|581278795|FG000|Overall Study|Withdrawal by Subject|3|||
160969762|NCT01289041|581278795|FG000|Overall Study|Death|1|||
160969763|NCT02714868|581278800|FG000|Overall Study|Withdrawal by Subject|3|||
160969764|NCT02714868|581278801|FG001|Overall Study|Withdrawal by Subject|0|||
160969765|NCT02714868|581278800|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
160969766|NCT02714868|581278801|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
160969767|NCT02714868|581278800|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
160969768|NCT02714868|581278801|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
160969769|NCT02013388|581278806|FG000|Overall Study|work emergency|1|||
160969770|NCT02013388|581278807|FG001|Overall Study|work emergency|0|||
160969771|NCT02013388|581278808|FG002|Overall Study|work emergency|0|||
160969772|NCT02013388|581278809|FG003|Overall Study|work emergency|0|||
160969773|NCT02013388|581278810|FG004|Overall Study|work emergency|1|||
160969774|NCT02013388|581278811|FG005|Overall Study|work emergency|0|||
160969775|NCT02013388|581278812|FG006|Overall Study|work emergency|0|||
160969776|NCT02013388|581278813|FG007|Overall Study|work emergency|0|||
160969777|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
160969778|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
160969779|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
160969780|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
160969781|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
160969782|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
160969783|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
160969784|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
160969785|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
160969786|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
160969787|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
160969788|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
160969789|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
160969790|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
160969791|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
160969792|NCT03145766|581278814|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
160969793|NCT03145766|581278815|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
160969794|NCT03145766|581278816|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
160969795|NCT03145766|581278817|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
160969796|NCT03145766|581278818|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
160969797|NCT03145766|581278814|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
160969798|NCT03145766|581278815|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
160969799|NCT03145766|581278816|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
160969800|NCT03145766|581278817|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
160969801|NCT03145766|581278818|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
160969802|NCT03145766|581278814|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
160969803|NCT03145766|581278815|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
160969804|NCT03145766|581278816|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
160969805|NCT03145766|581278817|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
160969806|NCT03145766|581278818|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
160969807|NCT03145766|581278814|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
160969808|NCT03145766|581278815|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
160969809|NCT03145766|581278816|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
160969810|NCT03145766|581278817|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
160969811|NCT03145766|581278818|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
160969812|NCT01932294|581278825|FG000|Overall Study|Death|43|||
160969813|NCT01932294|581278825|FG000|Overall Study|Lost to Follow-up|8|||
160969814|NCT01932294|581278825|FG000|Overall Study|VAD Implantation|20|||
160969815|NCT01932294|581278825|FG000|Overall Study|Heart Transplantation|16|||
160969816|NCT01932294|581278825|FG000|Overall Study|Transferred to other hospitals|12|||
160969817|NCT00409786|581278826|FG000|Overall Study|Withdrawal by Subject|3|||
161273848|NCT00761657|582382458|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
160969818|NCT03075904|581278829|FG000|Overall Study|Physician Decision|3|||
161273849|NCT00761657|582382459|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
161273850|NCT00761657|582382460|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
161273851|NCT00761657|582382461|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
161273852|NCT00478244|582382470|FG000|Overall Study|Did not receive transplant|1|||
161273853|NCT01396512|582382473|FG000|Overall Study|Withdrawal by Subject|0|||
161273854|NCT01396512|582382474|FG001|Overall Study|Withdrawal by Subject|1|||
161273855|NCT01564537|582382475|FG000|Overall Study|Site Terminated by Sponsor|1|||
161273856|NCT01564537|582382476|FG001|Overall Study|Site Terminated by Sponsor|0|||
161273857|NCT01564537|582382475|FG000|Overall Study|Withdrawal by Subject|12|||
161273858|NCT01564537|582382476|FG001|Overall Study|Withdrawal by Subject|14|||
161273859|NCT01564537|582382475|FG000|Overall Study|Lost to Follow-up|7|||
161273860|NCT01564537|582382476|FG001|Overall Study|Lost to Follow-up|3|||
161273861|NCT01564537|582382475|FG000|Overall Study|Reason not specified|81|||
160969819|NCT03075904|581278829|FG000|Overall Study|Need for Medication not Permitted|1|||
160969820|NCT00597714|581278830|FG000|Overall Study|Death|56|||
160969821|NCT00597714|581278831|FG001|Overall Study|Death|46|||
160969822|NCT00597714|581278832|FG002|Overall Study|Death|0|||
161273862|NCT01564537|582382476|FG001|Overall Study|Reason not specified|82|||
161273863|NCT05776862|582382478|FG000|Overall Study|Adverse Event|0|||
161273864|NCT05776862|582382479|FG001|Overall Study|Adverse Event|1|||
160969823|NCT00597714|581278830|FG000|Overall Study|Recipient death|0|||
160969824|NCT00597714|581278831|FG001|Overall Study|Recipient death|0|||
160969825|NCT00597714|581278832|FG002|Overall Study|Recipient death|10|||
160969826|NCT02228395|581278833|FG000|First Intervention Period|No longer willing to participate|1|||
160969827|NCT02228395|581278834|FG001|First Intervention Period|No longer willing to participate|0|||
160969828|NCT02228395|581278835|FG002|First Intervention Period|No longer willing to participate|0|||
160969829|NCT02228395|581278833|FG000|First Intervention Period|Unable to comply with study dates|0|||
160969830|NCT02228395|581278834|FG001|First Intervention Period|Unable to comply with study dates|1|||
160969831|NCT02228395|581278835|FG002|First Intervention Period|Unable to comply with study dates|1|||
160969832|NCT02281760|581278838|FG000|Overall Study|Withdrawal by Subject|1|||
160969833|NCT00100932|581278843|FG000|Overall Study|Adverse Event|11|||
160969834|NCT00100932|581278844|FG001|Overall Study|Adverse Event|2|||
160969835|NCT00100932|581278843|FG000|Overall Study|Withdrawal by Subject|6|||
160969836|NCT00100932|581278844|FG001|Overall Study|Withdrawal by Subject|0|||
161273865|NCT05776862|582382478|FG000|Overall Study|non-compliance|1|||
160969837|NCT00100932|581278843|FG000|Overall Study|Progressive Disease|44|||
161148666|NCT04003155|581926127|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
161273866|NCT05776862|582382479|FG001|Overall Study|non-compliance|0|||
161273867|NCT02448706|582382480|FG000|Overall Study|Withdrawal by Subject|4|||
161273868|NCT02448706|582382481|FG001|Overall Study|Withdrawal by Subject|3|||
160969838|NCT00100932|581278844|FG001|Overall Study|Progressive Disease|18|||
160969839|NCT00100932|581278843|FG000|Overall Study|Physician Decision|7|||
160969840|NCT00100932|581278844|FG001|Overall Study|Physician Decision|5|||
160969841|NCT00100932|581278843|FG000|Overall Study|Other|5|||
161273869|NCT02448706|582382480|FG000|Overall Study|Protocol Violation|1|||
161273870|NCT02448706|582382481|FG001|Overall Study|Protocol Violation|1|||
161273871|NCT01664130|582382488|FG000|Overall Study|competing secondary disease|2|||
161273872|NCT02679235|582382489|FG000|Overall Study|Withdrawal by Subject|3|||
161273873|NCT02679235|582382489|FG000|Overall Study|Adverse Event|1|||
161273874|NCT00923273|582382490|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161273875|NCT00923273|582382491|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161273876|NCT00923273|582382492|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161273877|NCT00923273|582382493|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
161273878|NCT00923273|582382494|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
161273879|NCT00923273|582382490|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161273880|NCT00923273|582382491|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
160969842|NCT00100932|581278844|FG001|Overall Study|Other|2|||
160969843|NCT02424591|581278849|FG000|Overall Study|Protocol Violation|2|||
160969844|NCT02424591|581278850|FG001|Overall Study|Protocol Violation|3|||
160969845|NCT00988221|581278853|FG000|Part I|Adverse Event|0|||
160969846|NCT00988221|581278854|FG001|Part I|Adverse Event|1|||
160969847|NCT00988221|581278855|FG002|Part I|Adverse Event|2|||
160969848|NCT00988221|581278856|FG003|Part I|Adverse Event|0|||
160969849|NCT00988221|581278853|FG000|Part I|Insufficient Therapeutic Response|4|||
160969850|NCT00988221|581278854|FG001|Part I|Insufficient Therapeutic Response|6|||
160969851|NCT00988221|581278855|FG002|Part I|Insufficient Therapeutic Response|5|||
160969852|NCT00988221|581278856|FG003|Part I|Insufficient Therapeutic Response|0|||
160969853|NCT00988221|581278853|FG000|Part I|Refused Treatment|0|||
160969854|NCT00988221|581278854|FG001|Part I|Refused Treatment|2|||
160969855|NCT00988221|581278855|FG002|Part I|Refused Treatment|1|||
160969856|NCT00988221|581278856|FG003|Part I|Refused Treatment|0|||
160969857|NCT00988221|581278853|FG000|Part I|Lost to Follow-up|0|||
160969858|NCT00988221|581278854|FG001|Part I|Lost to Follow-up|1|||
160969859|NCT00988221|581278855|FG002|Part I|Lost to Follow-up|0|||
160969860|NCT00988221|581278856|FG003|Part I|Lost to Follow-up|0|||
160969861|NCT00988221|581278853|FG000|Part II|Adverse Event|1|||
160969862|NCT00988221|581278854|FG001|Part II|Adverse Event|0|||
160969863|NCT00988221|581278855|FG002|Part II|Adverse Event|0|||
160969864|NCT00988221|581278856|FG003|Part II|Adverse Event|1|||
160969865|NCT00988221|581278853|FG000|Part II|Withdrawal by Subject|0|||
160969866|NCT00988221|581278854|FG001|Part II|Withdrawal by Subject|0|||
160969867|NCT00988221|581278855|FG002|Part II|Withdrawal by Subject|2|||
160969868|NCT00988221|581278856|FG003|Part II|Withdrawal by Subject|2|||
160969869|NCT00988221|581278853|FG000|Part II|Reason not Specified|0|||
160969870|NCT00988221|581278854|FG001|Part II|Reason not Specified|0|||
160969871|NCT00988221|581278855|FG002|Part II|Reason not Specified|1|||
160969872|NCT00988221|581278856|FG003|Part II|Reason not Specified|0|||
160969873|NCT00988221|581278853|FG000|Part III|Adverse Event|1|||
160969874|NCT00988221|581278854|FG001|Part III|Adverse Event|0|||
160969875|NCT00988221|581278855|FG002|Part III|Adverse Event|1|||
160969876|NCT00988221|581278856|FG003|Part III|Adverse Event|0|||
160969877|NCT00988221|581278853|FG000|Part III|Insufficient Therapeutic Response|0|||
160969878|NCT00988221|581278854|FG001|Part III|Insufficient Therapeutic Response|1|||
160969879|NCT00988221|581278855|FG002|Part III|Insufficient Therapeutic Response|1|||
160969880|NCT00988221|581278856|FG003|Part III|Insufficient Therapeutic Response|0|||
160969881|NCT00988221|581278853|FG000|Part III|Refused Treatment|0|||
160969882|NCT00988221|581278854|FG001|Part III|Refused Treatment|0|||
160969883|NCT00988221|581278855|FG002|Part III|Refused Treatment|1|||
160969884|NCT00988221|581278856|FG003|Part III|Refused Treatment|0|||
160969885|NCT01453348|581278857|FG000|Overall Study|Death|0|||
160969886|NCT01453348|581278858|FG001|Overall Study|Death|0|||
160969887|NCT01453348|581278859|FG002|Overall Study|Death|1|||
160969888|NCT01453348|581278857|FG000|Overall Study|Withdrawal by Subject|0|||
160969889|NCT01453348|581278858|FG001|Overall Study|Withdrawal by Subject|1|||
160969890|NCT01453348|581278859|FG002|Overall Study|Withdrawal by Subject|0|||
160969891|NCT01453348|581278857|FG000|Overall Study|Protocol Violation|1|||
160969892|NCT01453348|581278858|FG001|Overall Study|Protocol Violation|0|||
160969893|NCT01453348|581278859|FG002|Overall Study|Protocol Violation|0|||
160969894|NCT02756832|581278862|FG000|Overall Study|Lost for Observation after Baseline|6|||
160969895|NCT02756832|581278862|FG000|Overall Study|Lost for Observation|13|||
160969896|NCT02756832|581278862|FG000|Overall Study|Patient's Unwillingness|12|||
160969897|NCT02756832|581278862|FG000|Overall Study|Insufficient Efficacy|2|||
160969898|NCT02756832|581278862|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
161148667|NCT04003155|581926128|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
161273881|NCT00923273|582382492|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
160969899|NCT02756832|581278862|FG000|Overall Study|Reason not Specified|9|||
161148668|NCT04003155|581926129|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
160969900|NCT02756832|581278862|FG000|Overall Study|Protocol Deviation|10|||
160969901|NCT01498822|581278863|FG000|Overall Study|Protocol Violation|8|||
160969902|NCT01498822|581278864|FG001|Overall Study|Protocol Violation|4|||
160969903|NCT01498822|581278863|FG000|Overall Study|Other Reason|5|||
160969904|NCT01498822|581278864|FG001|Overall Study|Other Reason|2|||
160969905|NCT01498822|581278863|FG000|Overall Study|Lack of Efficacy|7|||
160969906|NCT01498822|581278864|FG001|Overall Study|Lack of Efficacy|2|||
160969907|NCT01498822|581278863|FG000|Overall Study|AE, non-serious non-fatal|8|||
160969908|NCT01498822|581278864|FG001|Overall Study|AE, non-serious non-fatal|17|||
160969909|NCT01498822|581278863|FG000|Overall Study|SAE, non-fatal|2|||
160969910|NCT01498822|581278864|FG001|Overall Study|SAE, non-fatal|2|||
160969911|NCT01498822|581278863|FG000|Overall Study|Adverse Event, serious fatal|1|||
160969912|NCT01498822|581278864|FG001|Overall Study|Adverse Event, serious fatal|1|||
160969913|NCT01498822|581278863|FG000|Overall Study|Withdrawal by Subject|15|||
160969914|NCT01498822|581278864|FG001|Overall Study|Withdrawal by Subject|25|||
160969915|NCT01498822|581278863|FG000|Overall Study|Lost to Follow-up|8|||
160969916|NCT01498822|581278864|FG001|Overall Study|Lost to Follow-up|3|||
160969917|NCT02917265|581278869|FG000|Overall Study|Physician Decision|1|||
160969918|NCT02917265|581278870|FG001|Overall Study|Physician Decision|0|||
160969919|NCT02917265|581278869|FG000|Overall Study|Withdrawal by Subject|1|||
160969920|NCT02917265|581278870|FG001|Overall Study|Withdrawal by Subject|0|||
160969921|NCT00979602|581278883|FG000|Overall Study|Serious Adverse Event|5|||
160969922|NCT00979602|581278884|FG001|Overall Study|Serious Adverse Event|3|||
160969923|NCT00979602|581278883|FG000|Overall Study|Protocol Violation|3|||
160969924|NCT00979602|581278884|FG001|Overall Study|Protocol Violation|0|||
160969925|NCT00979602|581278883|FG000|Overall Study|Withdrawal by Subject|31|||
160969926|NCT00979602|581278884|FG001|Overall Study|Withdrawal by Subject|25|||
160969927|NCT00979602|581278883|FG000|Overall Study|Lost to Follow-up|100|||
160969928|NCT00979602|581278884|FG001|Overall Study|Lost to Follow-up|96|||
160969929|NCT00979602|581278883|FG000|Overall Study|Migrated/moved from study area|3|||
160969930|NCT00979602|581278884|FG001|Overall Study|Migrated/moved from study area|6|||
160969931|NCT00979602|581278883|FG000|Overall Study|Others|3|||
160969932|NCT00979602|581278884|FG001|Overall Study|Others|3|||
160969933|NCT02712398|581278888|FG000|Overall Study|Withdrawal by Subject|6|||
160969934|NCT02712398|581278888|FG000|Overall Study|Lost to Follow-up|6|||
160969935|NCT02712398|581278888|FG000|Overall Study|Sponsor Decision|1|||
160969936|NCT02712398|581278888|FG000|Overall Study|Physician Decision|1|||
160969937|NCT02712398|581278888|FG000|Overall Study|Death|2|||
160969938|NCT02712398|581278888|FG000|Overall Study|Re-operation|21|||
160969939|NCT01719237|581278889|FG000|Overall Study|Physician Decision|0|||
160969940|NCT01719237|581278890|FG001|Overall Study|Physician Decision|1|||
160969941|NCT02002182|581278897|FG000|Overall Study|Withdraw from study|3|||
160969942|NCT02002182|581278898|FG001|Overall Study|Withdraw from study|1|||
160969943|NCT02002182|581278897|FG000|Overall Study|Health Reasons|1|||
160969944|NCT02002182|581278898|FG001|Overall Study|Health Reasons|0|||
160969945|NCT02002182|581278897|FG000|Overall Study|Death|1|||
160969946|NCT02002182|581278898|FG001|Overall Study|Death|0|||
160969947|NCT04772053|581278906|FG000|Overall Study|Physician Decision|2|||
160969948|NCT04772053|581278906|FG000|Overall Study|Withdrawal by Subject|3|||
160969949|NCT04772053|581278906|FG000|Overall Study|Study Terminated by Sponsor|1|||
160969950|NCT04146896|581278911|FG000|Overall Study|Adverse Event|5|||
160969951|NCT04146896|581278912|FG001|Overall Study|Adverse Event|8|||
160969952|NCT04146896|581278911|FG000|Overall Study|Lack of Efficacy|3|||
160969953|NCT04146896|581278912|FG001|Overall Study|Lack of Efficacy|2|||
160969954|NCT04146896|581278911|FG000|Overall Study|Lost to Follow-up|0|||
160969955|NCT04146896|581278912|FG001|Overall Study|Lost to Follow-up|1|||
160969956|NCT04146896|581278911|FG000|Overall Study|Non-compliance|5|||
160969957|NCT04146896|581278912|FG001|Overall Study|Non-compliance|4|||
160969958|NCT04146896|581278911|FG000|Overall Study|Withdrawal by Subject|3|||
160969959|NCT04146896|581278912|FG001|Overall Study|Withdrawal by Subject|5|||
160969960|NCT04146896|581278911|FG000|Overall Study|Randomized in error|1|||
160969961|NCT04146896|581278912|FG001|Overall Study|Randomized in error|2|||
160969962|NCT03107377|581278913|FG000|Overall Study|Adverse Event|3|||
160969963|NCT03107377|581278914|FG001|Overall Study|Adverse Event|3|||
160969964|NCT03107377|581278913|FG000|Overall Study|Protocol Violation|9|||
160969965|NCT03107377|581278914|FG001|Overall Study|Protocol Violation|12|||
160969966|NCT03107377|581278913|FG000|Overall Study|Physician Decision|3|||
160969967|NCT03107377|581278914|FG001|Overall Study|Physician Decision|6|||
160969968|NCT03107377|581278913|FG000|Overall Study|Pregnancy|7|||
160969969|NCT03107377|581278914|FG001|Overall Study|Pregnancy|7|||
160969970|NCT03107377|581278913|FG000|Overall Study|Withdrawal by Subject|16|||
160969971|NCT03107377|581278914|FG001|Overall Study|Withdrawal by Subject|22|||
160969972|NCT03107377|581278913|FG000|Overall Study|Lost to Follow-up|37|||
160969973|NCT03107377|581278914|FG001|Overall Study|Lost to Follow-up|34|||
160969974|NCT03107377|581278913|FG000|Overall Study|Other reason not specified|16|||
160969975|NCT03107377|581278914|FG001|Overall Study|Other reason not specified|15|||
160969976|NCT01597505|581278915|FG000|Overall Study|Physician Decision|5|||
160969977|NCT01597505|581278916|FG001|Overall Study|Physician Decision|0|||
160969978|NCT01597505|581278915|FG000|Overall Study|Adverse Event|19|||
160969979|NCT01597505|581278916|FG001|Overall Study|Adverse Event|7|||
160969980|NCT01597505|581278915|FG000|Overall Study|Lost to Follow-up|4|||
161023871|NCT03058289|581477367|FG004|Overall Study|Clinical Deterioration|1|||
160969981|NCT01597505|581278916|FG001|Overall Study|Lost to Follow-up|2|||
160969982|NCT01597505|581278915|FG000|Overall Study|Withdrawal by Subject|10|||
160969983|NCT01597505|581278916|FG001|Overall Study|Withdrawal by Subject|18|||
160969984|NCT01597505|581278915|FG000|Overall Study|Other|5|||
160969985|NCT01597505|581278916|FG001|Overall Study|Other|6|||
160969986|NCT01597505|581278915|FG000|Overall Study|Missing|1|||
160969987|NCT01597505|581278916|FG001|Overall Study|Missing|0|||
161273882|NCT00923273|582382493|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
161273883|NCT00923273|582382494|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
161273884|NCT02383810|582382497|FG000|Overall Study|Physician Decision|1|||
160969988|NCT02675465|581278918|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969989|NCT02675465|581278919|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969990|NCT02675465|581278920|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
160969991|NCT02675465|581278921|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
160969992|NCT02675465|581278922|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969993|NCT02675465|581278923|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
160969994|NCT02675465|581278918|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969995|NCT02675465|581278919|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969996|NCT02675465|581278920|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
160969997|NCT02675465|581278921|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969998|NCT02675465|581278922|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160969999|NCT02675465|581278923|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
160970000|NCT02675465|581278918|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
160970001|NCT02675465|581278919|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
160970002|NCT02675465|581278920|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
160970003|NCT02675465|581278921|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
160970004|NCT02675465|581278922|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
160970005|NCT02675465|581278923|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
160970006|NCT02675465|581278918|FG000|Stage 4: Long Term Extension|Death|0|||
160970007|NCT02675465|581278919|FG001|Stage 4: Long Term Extension|Death|0|||
160970008|NCT02675465|581278920|FG002|Stage 4: Long Term Extension|Death|0|||
160970009|NCT02675465|581278921|FG003|Stage 4: Long Term Extension|Death|1|||
160970010|NCT02675465|581278922|FG004|Stage 4: Long Term Extension|Death|0|||
160970011|NCT02675465|581278923|FG005|Stage 4: Long Term Extension|Death|0|||
160970012|NCT00453102|581278924|FG000|Overall Study|Withdrawal by Subject|2|||
160970013|NCT05031078|581278925|FG000|Overall Study|Withdrawal by Subject|0|||
160970014|NCT05031078|581278926|FG001|Overall Study|Withdrawal by Subject|1|||
160970015|NCT05031078|581278927|FG002|Overall Study|Withdrawal by Subject|0|||
160970016|NCT03728972|581278928|FG000|Overall Study|Death|1|||
160970017|NCT03728972|581278929|FG001|Overall Study|Death|0|||
160970018|NCT03728972|581278928|FG000|Overall Study|Lack of Efficacy|1|||
160970019|NCT03728972|581278929|FG001|Overall Study|Lack of Efficacy|0|||
160970020|NCT03728972|581278928|FG000|Overall Study|Physician Decision|3|||
160970021|NCT03728972|581278929|FG001|Overall Study|Physician Decision|0|||
160970022|NCT03728972|581278928|FG000|Overall Study|Disease progression|4|||
160970023|NCT03728972|581278929|FG001|Overall Study|Disease progression|3|||
160970024|NCT01490125|581278934|FG000|Period I|Adverse Event|4|||
160970025|NCT01490125|581278935|FG001|Period I|Adverse Event|1|||
160970026|NCT01490125|581278936|FG002|Period I|Adverse Event|1|||
160970027|NCT01490125|581278937|FG003|Period I|Adverse Event|3|||
160970028|NCT01490125|581278938|FG004|Period I|Adverse Event|2|||
160970029|NCT01490125|581278939|FG005|Period I|Adverse Event|4|||
160970030|NCT01490125|581278934|FG000|Period I|Protocol Violation|1|||
160970031|NCT01490125|581278935|FG001|Period I|Protocol Violation|1|||
160970032|NCT01490125|581278936|FG002|Period I|Protocol Violation|1|||
160970033|NCT01490125|581278937|FG003|Period I|Protocol Violation|1|||
160970034|NCT01490125|581278938|FG004|Period I|Protocol Violation|0|||
160970035|NCT01490125|581278939|FG005|Period I|Protocol Violation|0|||
160970036|NCT01490125|581278934|FG000|Period I|Withdrawal by Subject|1|||
160970037|NCT01490125|581278935|FG001|Period I|Withdrawal by Subject|3|||
160970038|NCT01490125|581278936|FG002|Period I|Withdrawal by Subject|2|||
160970039|NCT01490125|581278937|FG003|Period I|Withdrawal by Subject|1|||
160970040|NCT01490125|581278938|FG004|Period I|Withdrawal by Subject|2|||
160970041|NCT01490125|581278939|FG005|Period I|Withdrawal by Subject|1|||
160970042|NCT01490125|581278934|FG000|Period II|Adverse Event|2|||
160970043|NCT01490125|581278935|FG001|Period II|Adverse Event|3|||
160970044|NCT01490125|581278936|FG002|Period II|Adverse Event|2|||
160970045|NCT01490125|581278937|FG003|Period II|Adverse Event|2|||
160970046|NCT01490125|581278938|FG004|Period II|Adverse Event|4|||
161273885|NCT02383810|582382498|FG001|Overall Study|Physician Decision|1|||
160970047|NCT01490125|581278939|FG005|Period II|Adverse Event|2|||
160970048|NCT01490125|581278934|FG000|Period II|Protocol Violation|0|||
160970049|NCT01490125|581278935|FG001|Period II|Protocol Violation|0|||
161273886|NCT02383810|582382499|FG002|Overall Study|Physician Decision|0|||
160970050|NCT01490125|581278936|FG002|Period II|Protocol Violation|1|||
160970051|NCT01490125|581278937|FG003|Period II|Protocol Violation|1|||
160970052|NCT01490125|581278938|FG004|Period II|Protocol Violation|0|||
160970053|NCT01490125|581278939|FG005|Period II|Protocol Violation|0|||
160970054|NCT01490125|581278934|FG000|Period II|Lost to Follow-up|0|||
160970055|NCT01490125|581278935|FG001|Period II|Lost to Follow-up|1|||
160970056|NCT01490125|581278936|FG002|Period II|Lost to Follow-up|0|||
160970057|NCT01490125|581278937|FG003|Period II|Lost to Follow-up|0|||
160970058|NCT01490125|581278938|FG004|Period II|Lost to Follow-up|0|||
160970059|NCT01490125|581278939|FG005|Period II|Lost to Follow-up|0|||
160970060|NCT01490125|581278934|FG000|Period II|Withdrawal by Subject|1|||
160970061|NCT01490125|581278935|FG001|Period II|Withdrawal by Subject|0|||
160970062|NCT01490125|581278936|FG002|Period II|Withdrawal by Subject|0|||
160970063|NCT01490125|581278937|FG003|Period II|Withdrawal by Subject|0|||
160970064|NCT01490125|581278938|FG004|Period II|Withdrawal by Subject|0|||
160970065|NCT01490125|581278939|FG005|Period II|Withdrawal by Subject|0|||
160970066|NCT01490125|581278934|FG000|Period III|Adverse Event|3|||
160970067|NCT01490125|581278935|FG001|Period III|Adverse Event|1|||
160970068|NCT01490125|581278936|FG002|Period III|Adverse Event|0|||
160970069|NCT01490125|581278937|FG003|Period III|Adverse Event|1|||
160970070|NCT01490125|581278938|FG004|Period III|Adverse Event|0|||
160970071|NCT01490125|581278939|FG005|Period III|Adverse Event|0|||
160970072|NCT01490125|581278934|FG000|Period III|Death|0|||
160970073|NCT01490125|581278935|FG001|Period III|Death|0|||
160970074|NCT01490125|581278936|FG002|Period III|Death|0|||
160970075|NCT01490125|581278937|FG003|Period III|Death|1|||
160970076|NCT01490125|581278938|FG004|Period III|Death|0|||
160970077|NCT01490125|581278939|FG005|Period III|Death|0|||
160970078|NCT01490125|581278934|FG000|Period III|Lack of Efficacy|0|||
160970079|NCT01490125|581278935|FG001|Period III|Lack of Efficacy|0|||
160970080|NCT01490125|581278936|FG002|Period III|Lack of Efficacy|0|||
160970081|NCT01490125|581278937|FG003|Period III|Lack of Efficacy|0|||
160970082|NCT01490125|581278938|FG004|Period III|Lack of Efficacy|1|||
160970083|NCT01490125|581278939|FG005|Period III|Lack of Efficacy|0|||
160970084|NCT01320943|581278940|FG000|Overall Study|Lost to Follow-up|1|||
160970085|NCT01320943|581278941|FG001|Overall Study|Lost to Follow-up|0|||
160970086|NCT01320943|581278940|FG000|Overall Study|Physician Decision|0|||
160970087|NCT01320943|581278941|FG001|Overall Study|Physician Decision|1|||
160970088|NCT01320943|581278940|FG000|Overall Study|Randomized but not Treated|0|||
160970089|NCT01320943|581278941|FG001|Overall Study|Randomized but not Treated|1|||
160970090|NCT00311155|581281225|FG000|Overall Study|Adverse Event|21|||
160970091|NCT00311155|581281225|FG000|Overall Study|Withdrawal by Subject|17|||
160970092|NCT00311155|581281225|FG000|Overall Study|Did not meet entry criteria|55|||
160970093|NCT00429494|581281228|FG000|Overall Study|Withdrawal by Subject|9|||
160970094|NCT00429494|581281228|FG000|Overall Study|Death|6|||
160970095|NCT03285295|581281243|FG000|Alinity s HBsAg|Protocol Violation|11|||
160970096|NCT03285295|581281244|FG001|Alinity s HBsAg|Protocol Violation|0|||
160970097|NCT03285295|581281245|FG002|Alinity s HBsAg|Protocol Violation|0|||
160970098|NCT03285295|581281246|FG003|Alinity s HBsAg|Protocol Violation|0|||
160970099|NCT03285295|581281247|FG004|Alinity s HBsAg|Protocol Violation|0|||
160970100|NCT03285295|581281243|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
160970101|NCT03285295|581281244|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970102|NCT03285295|581281245|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970103|NCT03285295|581281246|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970104|NCT03285295|581281247|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
160970105|NCT03285295|581281243|FG000|Alinity s HBsAg|No Results Generated|74|||
160970106|NCT03285295|581281244|FG001|Alinity s HBsAg|No Results Generated|6|||
160970107|NCT03285295|581281245|FG002|Alinity s HBsAg|No Results Generated|0|||
160970108|NCT03285295|581281246|FG003|Alinity s HBsAg|No Results Generated|0|||
160970109|NCT03285295|581281247|FG004|Alinity s HBsAg|No Results Generated|0|||
160970110|NCT03285295|581281243|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
160970111|NCT03285295|581281244|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
160970112|NCT03285295|581281245|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
160970113|NCT03285295|581281246|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
160970114|NCT03285295|581281247|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
160970115|NCT03285295|581281243|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
160970116|NCT03285295|581281244|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970117|NCT03285295|581281245|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970118|NCT03285295|581281246|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970119|NCT03285295|581281247|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
160970120|NCT03285295|581281243|FG000|Alinity s HTLV I/II|No Results Generated|70|||
160970121|NCT03285295|581281244|FG001|Alinity s HTLV I/II|No Results Generated|0|||
160970122|NCT03285295|581281245|FG002|Alinity s HTLV I/II|No Results Generated|0|||
160970123|NCT03285295|581281246|FG003|Alinity s HTLV I/II|No Results Generated|0|||
160970124|NCT03285295|581281247|FG004|Alinity s HTLV I/II|No Results Generated|0|||
160970125|NCT03285295|581281243|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
160970126|NCT03285295|581281244|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970127|NCT03285295|581281245|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970128|NCT03285295|581281246|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970129|NCT03285295|581281247|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
160970130|NCT03285295|581281243|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
160970131|NCT03285295|581281244|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
160970132|NCT03285295|581281245|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
160970133|NCT03285295|581281246|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
160970134|NCT03285295|581281247|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
160970135|NCT03285295|581281243|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
160970136|NCT03285295|581281244|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970137|NCT03285295|581281245|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970138|NCT03285295|581281246|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970139|NCT03285295|581281247|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
160970140|NCT03285295|581281243|FG000|Alinity s Anti-HCV|No Results Generated|71|||
160970141|NCT03285295|581281244|FG001|Alinity s Anti-HCV|No Results Generated|0|||
160970142|NCT03285295|581281245|FG002|Alinity s Anti-HCV|No Results Generated|0|||
160970143|NCT03285295|581281246|FG003|Alinity s Anti-HCV|No Results Generated|0|||
160970144|NCT03285295|581281247|FG004|Alinity s Anti-HCV|No Results Generated|0|||
160970145|NCT03285295|581281243|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
160970146|NCT03285295|581281244|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970147|NCT03285295|581281245|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970148|NCT03285295|581281246|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970149|NCT03285295|581281247|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
160970150|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
160970151|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970152|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970153|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970154|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
160970155|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
160970156|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970157|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970158|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970159|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
160970160|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
160970161|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970162|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970163|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970164|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
160970165|NCT03285295|581281243|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
160970166|NCT03285295|581281244|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970167|NCT03285295|581281245|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970168|NCT03285295|581281246|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970169|NCT03285295|581281247|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
160970170|NCT03285295|581281243|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
160970171|NCT03285295|581281244|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
160970172|NCT03285295|581281245|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
160970173|NCT03285295|581281246|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
160970174|NCT03285295|581281247|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
160970175|NCT03285295|581281243|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
160970176|NCT03285295|581281244|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
160970177|NCT03285295|581281245|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
160970178|NCT03285295|581281246|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
160970179|NCT03285295|581281247|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
160970180|NCT03285295|581281243|FG000|Alinity s Anti-HBc|No Results Generated|70|||
160970181|NCT03285295|581281244|FG001|Alinity s Anti-HBc|No Results Generated|0|||
160970182|NCT03285295|581281245|FG002|Alinity s Anti-HBc|No Results Generated|0|||
160970183|NCT03285295|581281246|FG003|Alinity s Anti-HBc|No Results Generated|0|||
160970184|NCT03285295|581281247|FG004|Alinity s Anti-HBc|No Results Generated|0|||
160970185|NCT03285295|581281243|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
160970186|NCT03285295|581281244|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970187|NCT03285295|581281245|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970188|NCT03285295|581281246|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970189|NCT03285295|581281247|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
160970190|NCT03285295|581281243|FG000|Alinity s Chagas|Protocol Violation|76|||
160970191|NCT03285295|581281244|FG001|Alinity s Chagas|Protocol Violation|0|||
160970192|NCT03285295|581281245|FG002|Alinity s Chagas|Protocol Violation|0|||
160970193|NCT03285295|581281246|FG003|Alinity s Chagas|Protocol Violation|0|||
160970194|NCT03285295|581281247|FG004|Alinity s Chagas|Protocol Violation|0|||
160970195|NCT03285295|581281243|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
161023872|NCT03058289|581477368|FG005|Overall Study|Clinical Deterioration|1|||
161273887|NCT02383810|582382500|FG003|Overall Study|Physician Decision|0|||
161273888|NCT02383810|582382501|FG004|Overall Study|Physician Decision|0|||
161273889|NCT02383810|582382502|FG005|Overall Study|Physician Decision|0|||
161273890|NCT02383810|582382503|FG006|Overall Study|Physician Decision|0|||
160970196|NCT03285295|581281244|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
160970197|NCT03285295|581281245|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
160970198|NCT03285295|581281246|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
160970199|NCT03285295|581281247|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
160970200|NCT03285295|581281243|FG000|Alinity s Chagas|No Results Generated|105|||
161273891|NCT02383810|582382504|FG007|Overall Study|Physician Decision|0|||
161273892|NCT02383810|582382497|FG000|Overall Study|Withdrawal by Subject|2|||
160970201|NCT03285295|581281244|FG001|Alinity s Chagas|No Results Generated|0|||
160970202|NCT03285295|581281245|FG002|Alinity s Chagas|No Results Generated|0|||
160970203|NCT03285295|581281246|FG003|Alinity s Chagas|No Results Generated|0|||
160970204|NCT03285295|581281247|FG004|Alinity s Chagas|No Results Generated|0|||
160970205|NCT03285295|581281243|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
160970206|NCT03285295|581281244|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970207|NCT03285295|581281245|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970208|NCT03285295|581281246|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970209|NCT03285295|581281247|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
160970210|NCT02200939|581281251|FG000|Overall Study|Participant withdrew consent|0|||
160970211|NCT02200939|581281252|FG001|Overall Study|Participant withdrew consent|1|||
160970212|NCT02200939|581281251|FG000|Overall Study|Lost to Follow-up|2|||
160970213|NCT02200939|581281252|FG001|Overall Study|Lost to Follow-up|9|||
160970214|NCT02200939|581281251|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
160970215|NCT02200939|581281252|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
160970216|NCT04567693|581281253|FG000|Overall Study|Death|0|||
160970217|NCT04567693|581281254|FG001|Overall Study|Death|0|||
160970218|NCT04567693|581281255|FG002|Overall Study|Death|2|||
160970219|NCT04567693|581281253|FG000|Overall Study|Lost to Follow-up|1|||
160970220|NCT04567693|581281254|FG001|Overall Study|Lost to Follow-up|0|||
160970221|NCT04567693|581281255|FG002|Overall Study|Lost to Follow-up|2|||
160970222|NCT04567693|581281253|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
160970223|NCT04567693|581281254|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
160970224|NCT04567693|581281255|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
160970225|NCT04867785|581281260|FG000|Overall Study|Adverse Event|1|||
160970226|NCT04867785|581281261|FG001|Overall Study|Adverse Event|0|||
160970227|NCT04867785|581281262|FG002|Overall Study|Adverse Event|1|||
160970228|NCT04867785|581281263|FG003|Overall Study|Adverse Event|0|||
160970229|NCT04867785|581281264|FG004|Overall Study|Adverse Event|0|||
160970230|NCT04867785|581281265|FG005|Overall Study|Adverse Event|0|||
160970231|NCT04867785|581281266|FG006|Overall Study|Adverse Event|0|||
160970232|NCT04867785|581281267|FG007|Overall Study|Adverse Event|2|||
160970233|NCT04867785|581281260|FG000|Overall Study|Lost to Follow-up|4|||
160970234|NCT04867785|581281261|FG001|Overall Study|Lost to Follow-up|4|||
160970235|NCT04867785|581281262|FG002|Overall Study|Lost to Follow-up|3|||
160970236|NCT04867785|581281263|FG003|Overall Study|Lost to Follow-up|2|||
160970237|NCT04867785|581281264|FG004|Overall Study|Lost to Follow-up|0|||
160970238|NCT04867785|581281265|FG005|Overall Study|Lost to Follow-up|1|||
160970239|NCT04867785|581281266|FG006|Overall Study|Lost to Follow-up|0|||
160970240|NCT04867785|581281267|FG007|Overall Study|Lost to Follow-up|1|||
160970241|NCT04867785|581281260|FG000|Overall Study|Withdrawal by Subject|6|||
160970242|NCT04867785|581281261|FG001|Overall Study|Withdrawal by Subject|2|||
160970243|NCT04867785|581281262|FG002|Overall Study|Withdrawal by Subject|2|||
160970244|NCT04867785|581281263|FG003|Overall Study|Withdrawal by Subject|1|||
160970245|NCT04867785|581281264|FG004|Overall Study|Withdrawal by Subject|2|||
160970246|NCT04867785|581281265|FG005|Overall Study|Withdrawal by Subject|0|||
161148669|NCT04003155|581926130|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
161148670|NCT04003155|581926131|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
161148671|NCT04003155|581926127|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
161148672|NCT04003155|581926128|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
161148673|NCT04003155|581926129|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
161148674|NCT04003155|581926130|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
161148675|NCT04003155|581926131|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
161148676|NCT04003155|581926127|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
161148677|NCT04003155|581926128|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161148678|NCT04003155|581926129|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
161148679|NCT04003155|581926130|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161148680|NCT04003155|581926131|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
161148681|NCT04003155|581926127|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
161148682|NCT04003155|581926128|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
161148683|NCT04003155|581926129|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
161148684|NCT04003155|581926130|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
161148685|NCT04003155|581926131|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
161148686|NCT04003155|581926127|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
161148687|NCT04003155|581926128|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
161148688|NCT04003155|581926129|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
160970247|NCT04867785|581281266|FG006|Overall Study|Withdrawal by Subject|2|||
160970248|NCT04867785|581281267|FG007|Overall Study|Withdrawal by Subject|5|||
160970249|NCT04867785|581281260|FG000|Overall Study|Physician Decision|0|||
160970250|NCT04867785|581281261|FG001|Overall Study|Physician Decision|0|||
160970251|NCT04867785|581281262|FG002|Overall Study|Physician Decision|0|||
160970252|NCT04867785|581281263|FG003|Overall Study|Physician Decision|0|||
160970253|NCT04867785|581281264|FG004|Overall Study|Physician Decision|0|||
160970254|NCT04867785|581281265|FG005|Overall Study|Physician Decision|0|||
161273893|NCT02383810|582382498|FG001|Overall Study|Withdrawal by Subject|3|||
161273894|NCT02383810|582382499|FG002|Overall Study|Withdrawal by Subject|3|||
161273895|NCT02383810|582382500|FG003|Overall Study|Withdrawal by Subject|3|||
160970255|NCT04867785|581281266|FG006|Overall Study|Physician Decision|0|||
160970256|NCT04867785|581281267|FG007|Overall Study|Physician Decision|1|||
160970257|NCT04867785|581281260|FG000|Overall Study|Inadvertent Enrollment|0|||
160970258|NCT04867785|581281261|FG001|Overall Study|Inadvertent Enrollment|0|||
160970259|NCT04867785|581281262|FG002|Overall Study|Inadvertent Enrollment|0|||
160970260|NCT04867785|581281263|FG003|Overall Study|Inadvertent Enrollment|1|||
160970261|NCT04867785|581281264|FG004|Overall Study|Inadvertent Enrollment|1|||
160970262|NCT04867785|581281265|FG005|Overall Study|Inadvertent Enrollment|0|||
160970263|NCT04867785|581281266|FG006|Overall Study|Inadvertent Enrollment|0|||
160970264|NCT04867785|581281267|FG007|Overall Study|Inadvertent Enrollment|1|||
160970265|NCT04867785|581281260|FG000|Overall Study|Eligibility Criteria Not Met|0|||
160970266|NCT04867785|581281261|FG001|Overall Study|Eligibility Criteria Not Met|0|||
160970267|NCT04867785|581281262|FG002|Overall Study|Eligibility Criteria Not Met|0|||
160970268|NCT04867785|581281263|FG003|Overall Study|Eligibility Criteria Not Met|0|||
160970269|NCT04867785|581281264|FG004|Overall Study|Eligibility Criteria Not Met|0|||
160970270|NCT04867785|581281265|FG005|Overall Study|Eligibility Criteria Not Met|0|||
160970271|NCT04867785|581281266|FG006|Overall Study|Eligibility Criteria Not Met|0|||
160970272|NCT04867785|581281267|FG007|Overall Study|Eligibility Criteria Not Met|1|||
160970273|NCT00553202|581281280|FG000|Overall Study|Death|16|||
160970274|NCT00553202|581281280|FG000|Overall Study|Lost to Follow-up|1|||
160970275|NCT00553202|581281280|FG000|Overall Study|Physician Decision|28|||
160970276|NCT00553202|581281280|FG000|Overall Study|Withdrawal by Subject|1|||
160970277|NCT00553202|581281280|FG000|Overall Study|No donor identified|16|||
160970278|NCT00553202|581281280|FG000|Overall Study|Fails to meet organ function|6|||
160970279|NCT00369681|581281281|FG000|Overall Study|Death|1|||
160970280|NCT03239873|581281284|FG000|Overall Study|Lost to Follow-up|15|||
160970281|NCT03239873|581281285|FG001|Overall Study|Lost to Follow-up|16|||
160970282|NCT03239873|581281284|FG000|Overall Study|Physician Decision|1|||
160970283|NCT03239873|581281285|FG001|Overall Study|Physician Decision|0|||
160970284|NCT03239873|581281284|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
160970285|NCT03239873|581281285|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
160970286|NCT03239873|581281284|FG000|Overall Study|Withdrawal by Subject|2|||
160970287|NCT03239873|581281285|FG001|Overall Study|Withdrawal by Subject|0|||
160970288|NCT03239873|581281284|FG000|Overall Study|Contraindication to study medication|1|||
160970289|NCT03239873|581281285|FG001|Overall Study|Contraindication to study medication|0|||
160970290|NCT03239873|581281284|FG000|Overall Study|Protocol Violation|1|||
160970291|NCT03239873|581281285|FG001|Overall Study|Protocol Violation|0|||
160970292|NCT01250119|581281294|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
160970293|NCT01250119|581281295|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
160970294|NCT01250119|581281294|FG000|Diagnostic Phase|Participants Not Tested|44|||
160970295|NCT01250119|581281295|FG001|Diagnostic Phase|Participants Not Tested|0|||
160970296|NCT01250119|581281294|FG000|Treatment Phase|Progressive Disease|0|||
160970297|NCT01250119|581281295|FG001|Treatment Phase|Progressive Disease|32|||
160970298|NCT01250119|581281294|FG000|Treatment Phase|Death|0|||
160970299|NCT01250119|581281295|FG001|Treatment Phase|Death|2|||
160970300|NCT01250119|581281294|FG000|Treatment Phase|Withdrawal by Subject|0|||
160970301|NCT01250119|581281295|FG001|Treatment Phase|Withdrawal by Subject|1|||
160970302|NCT01250119|581281294|FG000|Treatment Phase|Adverse Event|0|||
160970303|NCT01250119|581281295|FG001|Treatment Phase|Adverse Event|2|||
160970304|NCT01250119|581281294|FG000|Treatment Phase|Unknown reason|0|||
160970305|NCT01250119|581281295|FG001|Treatment Phase|Unknown reason|4|||
160970306|NCT02045433|581281301|FG000|Overall Study|Withdrawal by Subject|1|||
160970307|NCT01559454|581281302|FG000|Overall Study|Lost to Follow-up|3|||
160970308|NCT01559454|581281303|FG001|Overall Study|Lost to Follow-up|2|||
160970309|NCT01559454|581281302|FG000|Overall Study|Withdrawal by Subject|0|||
160970310|NCT01559454|581281303|FG001|Overall Study|Withdrawal by Subject|1|||
160970311|NCT01559454|581281302|FG000|Overall Study|Physician Decision|0|||
160970312|NCT01559454|581281303|FG001|Overall Study|Physician Decision|1|||
161273896|NCT02383810|582382501|FG004|Overall Study|Withdrawal by Subject|0|||
161273897|NCT02383810|582382502|FG005|Overall Study|Withdrawal by Subject|0|||
160970313|NCT01559454|581281302|FG000|Overall Study|Protocol Violation|0|||
161273898|NCT02383810|582382503|FG006|Overall Study|Withdrawal by Subject|0|||
160970314|NCT01559454|581281303|FG001|Overall Study|Protocol Violation|1|||
161273899|NCT02383810|582382504|FG007|Overall Study|Withdrawal by Subject|0|||
160970315|NCT01559454|581281302|FG000|Overall Study|Lack of Efficacy|0|||
160970316|NCT01559454|581281303|FG001|Overall Study|Lack of Efficacy|1|||
161273900|NCT02383810|582382497|FG000|Overall Study|Adverse Event|0|||
160970317|NCT00462670|581281308|FG000|Overall Study|Adverse Event|3|||
160970318|NCT00462670|581281309|FG001|Overall Study|Adverse Event|5|||
160970319|NCT00462670|581281308|FG000|Overall Study|Lack of Efficacy|1|||
160970320|NCT00462670|581281309|FG001|Overall Study|Lack of Efficacy|0|||
160970321|NCT00462670|581281308|FG000|Overall Study|Protocol Violation|1|||
160970322|NCT00462670|581281309|FG001|Overall Study|Protocol Violation|0|||
161273901|NCT02383810|582382498|FG001|Overall Study|Adverse Event|2|||
160970323|NCT00462670|581281308|FG000|Overall Study|Resolution of signs and symptoms|0|||
160970324|NCT00462670|581281309|FG001|Overall Study|Resolution of signs and symptoms|2|||
161273902|NCT02383810|582382499|FG002|Overall Study|Adverse Event|4|||
161273903|NCT02383810|582382500|FG003|Overall Study|Adverse Event|5|||
160970325|NCT00482274|581281312|FG000|Overall Study|Adverse Event|1|||
160970326|NCT02396537|581281313|FG000|Overall Study|Protocol Violation|0|||
160970327|NCT02396537|581281314|FG001|Overall Study|Protocol Violation|1|||
160970328|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
160970329|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
160970330|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Adverse Event|2|||
160970331|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Adverse Event|5|||
160970332|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
160970333|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
160970334|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
160970335|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
160970336|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Randomized by error|0|||
160970337|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Randomized by error|5|||
160970338|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
160970339|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
160970340|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
160970341|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
160970342|NCT02948959|581281315|FG000|52 Weeks Treatment Period|Change of residence location|0|||
160970343|NCT02948959|581281316|FG001|52 Weeks Treatment Period|Change of residence location|1|||
160970344|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
160970345|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
160970346|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
160970347|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
160970348|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
160970349|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
160970350|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
160970351|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
160970352|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
160970353|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
160970354|NCT02948959|581281315|FG000|12 Weeks Follow-up Period|Study site closure|1|||
160970355|NCT02948959|581281316|FG001|12 Weeks Follow-up Period|Study site closure|0|||
160970356|NCT00787319|581281317|FG000|Overall Study|Lost to Follow-up|2|||
160970357|NCT00787319|581281317|FG000|Overall Study|Withdrawal by Subject|15|||
160970358|NCT00787319|581281317|FG000|Overall Study|Adverse Event|3|||
160970359|NCT00787319|581281317|FG000|Overall Study|Objective progression or relapse|30|||
160970360|NCT00787319|581281317|FG000|Overall Study|Lack of Efficacy|1|||
160970361|NCT00787319|581281317|FG000|Overall Study|Budget exhausted/exceeded|1|||
160970362|NCT00787319|581281317|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
160970363|NCT00787319|581281317|FG000|Overall Study|No health insurance reimbursement|2|||
160970364|NCT00787319|581281317|FG000|Overall Study|Stabilized disease findings|3|||
160970365|NCT00787319|581281317|FG000|Overall Study|Inactive disease|5|||
160970366|NCT04522180|581281325|FG000|Overall Study|Investigator judgement|3|||
160970367|NCT04522180|581281326|FG001|Overall Study|Investigator judgement|4|||
160970368|NCT04522180|581281325|FG000|Overall Study|Voluntary withdrawal|1|||
160970369|NCT04522180|581281326|FG001|Overall Study|Voluntary withdrawal|0|||
160970370|NCT04522180|581281325|FG000|Overall Study|Pregnancy|0|||
160970371|NCT04522180|581281326|FG001|Overall Study|Pregnancy|1|||
160970372|NCT04522180|581281325|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
160970373|NCT04522180|581281326|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
160970374|NCT04522180|581281325|FG000|Overall Study|Reason not specified|8|||
160970375|NCT04522180|581281326|FG001|Overall Study|Reason not specified|5|||
160970376|NCT05807919|581281327|FG000|Overall Study|Received antibiotics - excluded|0|||
160970377|NCT05807919|581281328|FG001|Overall Study|Received antibiotics - excluded|1|||
160970378|NCT05807919|581281327|FG000|Overall Study|Withdrawal by Subject|0|||
160970379|NCT05807919|581281328|FG001|Overall Study|Withdrawal by Subject|3|||
160970380|NCT05807919|581281327|FG000|Overall Study|Adverse Event|1|||
160970381|NCT05807919|581281328|FG001|Overall Study|Adverse Event|1|||
160970382|NCT00747123|581281329|FG000|Overall Study|Investigator's request|0|||
160970383|NCT00747123|581281330|FG001|Overall Study|Investigator's request|0|||
160970384|NCT00747123|581281331|FG002|Overall Study|Investigator's request|1|||
160970385|NCT00747123|581281332|FG003|Overall Study|Investigator's request|0|||
160970386|NCT00747123|581281329|FG000|Overall Study|Withdrew consent|0|||
160970387|NCT00747123|581281330|FG001|Overall Study|Withdrew consent|1|||
160970388|NCT00747123|581281331|FG002|Overall Study|Withdrew consent|0|||
160970389|NCT00747123|581281332|FG003|Overall Study|Withdrew consent|0|||
161273904|NCT02383810|582382501|FG004|Overall Study|Adverse Event|0|||
161273905|NCT02383810|582382502|FG005|Overall Study|Adverse Event|1|||
161273906|NCT02383810|582382503|FG006|Overall Study|Adverse Event|1|||
161273907|NCT02383810|582382504|FG007|Overall Study|Adverse Event|0|||
161273908|NCT02383810|582382497|FG000|Overall Study|Lost to Follow-up|0|||
161273909|NCT02383810|582382498|FG001|Overall Study|Lost to Follow-up|1|||
161273910|NCT02383810|582382499|FG002|Overall Study|Lost to Follow-up|0|||
161273911|NCT02383810|582382500|FG003|Overall Study|Lost to Follow-up|1|||
161273912|NCT02383810|582382501|FG004|Overall Study|Lost to Follow-up|0|||
161273913|NCT02383810|582382502|FG005|Overall Study|Lost to Follow-up|0|||
161273914|NCT02383810|582382503|FG006|Overall Study|Lost to Follow-up|0|||
161273915|NCT02383810|582382504|FG007|Overall Study|Lost to Follow-up|0|||
161273916|NCT02383810|582382497|FG000|Overall Study|other|0|||
160970390|NCT00747123|581281329|FG000|Overall Study|Adverse Event|0|||
160970391|NCT00747123|581281330|FG001|Overall Study|Adverse Event|1|||
160970392|NCT00747123|581281331|FG002|Overall Study|Adverse Event|0|||
160970393|NCT00747123|581281332|FG003|Overall Study|Adverse Event|1|||
160970394|NCT02277743|581281343|FG000|Overall Study|Protocol Violation|1|||
160970395|NCT02277743|581281344|FG001|Overall Study|Protocol Violation|1|||
160970396|NCT02277743|581281345|FG002|Overall Study|Protocol Violation|1|||
160970397|NCT02277743|581281343|FG000|Overall Study|Adverse Event|10|||
160970398|NCT02277743|581281344|FG001|Overall Study|Adverse Event|6|||
160970399|NCT02277743|581281345|FG002|Overall Study|Adverse Event|6|||
160970400|NCT02277743|581281343|FG000|Overall Study|Lack of Efficacy|11|||
160970401|NCT02277743|581281344|FG001|Overall Study|Lack of Efficacy|4|||
160970402|NCT02277743|581281345|FG002|Overall Study|Lack of Efficacy|3|||
160970403|NCT02277743|581281343|FG000|Overall Study|Other than specified above|18|||
160970404|NCT02277743|581281344|FG001|Overall Study|Other than specified above|5|||
160970405|NCT02277743|581281345|FG002|Overall Study|Other than specified above|16|||
160970406|NCT01224158|581281346|FG000|Overall Study|Withdrawal by Subject|1|||
160970407|NCT01224158|581281347|FG001|Overall Study|Withdrawal by Subject|0|||
160970408|NCT03976466|581281350|FG000|Overall Study|Lost to Follow-up|1|||
160970409|NCT03976466|581281351|FG001|Overall Study|Lost to Follow-up|3|||
160970410|NCT02055157|581281352|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
160970411|NCT02055157|581281353|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
160970412|NCT02055157|581281354|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
160970413|NCT02055157|581281355|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
160970414|NCT02055157|581281352|FG000|Initial 6 Months|Adverse Event|0|||
160970415|NCT02055157|581281353|FG001|Initial 6 Months|Adverse Event|0|||
160970416|NCT02055157|581281354|FG002|Initial 6 Months|Adverse Event|0|||
160970417|NCT02055157|581281355|FG003|Initial 6 Months|Adverse Event|1|||
160970418|NCT02055157|581281352|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
161273917|NCT02383810|582382498|FG001|Overall Study|other|0|||
161273918|NCT02383810|582382499|FG002|Overall Study|other|0|||
161273919|NCT02383810|582382500|FG003|Overall Study|other|2|||
161273920|NCT02383810|582382501|FG004|Overall Study|other|0|||
161273921|NCT02383810|582382502|FG005|Overall Study|other|0|||
161273922|NCT02383810|582382503|FG006|Overall Study|other|0|||
161273923|NCT02383810|582382504|FG007|Overall Study|other|0|||
161273924|NCT02383810|582382497|FG000|Overall Study|subject did not receive study treatment|0|||
161273925|NCT02383810|582382498|FG001|Overall Study|subject did not receive study treatment|1|||
161273926|NCT02383810|582382499|FG002|Overall Study|subject did not receive study treatment|0|||
161273927|NCT02383810|582382500|FG003|Overall Study|subject did not receive study treatment|0|||
161273928|NCT02383810|582382501|FG004|Overall Study|subject did not receive study treatment|0|||
161273929|NCT02383810|582382502|FG005|Overall Study|subject did not receive study treatment|0|||
161273930|NCT02383810|582382503|FG006|Overall Study|subject did not receive study treatment|0|||
161273931|NCT02383810|582382504|FG007|Overall Study|subject did not receive study treatment|0|||
161273932|NCT01438996|582382507|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
161273933|NCT01438996|582382508|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
161273934|NCT01438996|582382509|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
161273935|NCT02246114|582382510|FG000|Overall Study|miscarriage|1|||
160970419|NCT02055157|581281353|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
161273936|NCT02246114|582382511|FG001|Overall Study|miscarriage|0|||
161273937|NCT02278055|582382518|FG000|Overall Study|Adverse Event|1|||
161273938|NCT02278055|582382518|FG000|Overall Study|Lost to Follow-up|1|||
160970420|NCT02055157|581281354|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
160970421|NCT02055157|581281355|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
160970422|NCT02055157|581281352|FG000|18-month Extension|Investigator decision|0|||
160970423|NCT02055157|581281353|FG001|18-month Extension|Investigator decision|1|||
161273939|NCT02278055|582382518|FG000|Overall Study|Withdrawal by Subject|2|||
161273940|NCT02278055|582382518|FG000|Overall Study|Progressive Disease|4|||
160970424|NCT02055157|581281354|FG002|18-month Extension|Investigator decision|0|||
160970425|NCT02055157|581281355|FG003|18-month Extension|Investigator decision|0|||
160970426|NCT02055157|581281352|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
160970427|NCT02055157|581281353|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
161273941|NCT01934335|582382519|FG000|Overall Study|Withdrawal by Subject|1|||
161273942|NCT01934335|582382520|FG001|Overall Study|Withdrawal by Subject|1|||
161273943|NCT01111825|582382521|FG000|Overall Study|Withdrawal by Subject|0|||
161273944|NCT01111825|582382522|FG001|Overall Study|Withdrawal by Subject|0|||
160970428|NCT02055157|581281354|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
160970429|NCT02055157|581281355|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
160970430|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
160970431|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
160970432|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
160970433|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
160970434|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
160970435|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
160970436|NCT02034708|581281356|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
160970437|NCT02034708|581281357|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
160970438|NCT00733499|581281360|FG000|Pre-operative|Protocol Violation|0|||
160970439|NCT00733499|581281361|FG001|Pre-operative|Protocol Violation|1|||
160970440|NCT00733499|581281360|FG000|3 Months Follow-up|Death|1|||
160970441|NCT00733499|581281361|FG001|3 Months Follow-up|Death|2|||
160970442|NCT00733499|581281360|FG000|6 Months Follow-up|Death|0|||
160970443|NCT00733499|581281361|FG001|6 Months Follow-up|Death|2|||
160970444|NCT00733499|581281360|FG000|6 Months Follow-up|Adverse Event|0|||
160970445|NCT00733499|581281361|FG001|6 Months Follow-up|Adverse Event|1|||
160970446|NCT00733499|581281360|FG000|12 Months Follow-up|Death|2|||
160970447|NCT00733499|581281361|FG001|12 Months Follow-up|Death|1|||
160970448|NCT00733499|581281360|FG000|24 Months Follow-up|Death|0|||
160970449|NCT00733499|581281361|FG001|24 Months Follow-up|Death|1|||
160970450|NCT00733499|581281360|FG000|5 Year Followup|Adverse Event|2|||
160970451|NCT00733499|581281361|FG001|5 Year Followup|Adverse Event|2|||
160970452|NCT00733499|581281360|FG000|5 Year Followup|Non device related AE|0|||
160970453|NCT00733499|581281361|FG001|5 Year Followup|Non device related AE|1|||
160970454|NCT00733499|581281360|FG000|5 Year Followup|Revision of Study Implant|0|||
160970455|NCT00733499|581281361|FG001|5 Year Followup|Revision of Study Implant|1|||
160970456|NCT00733499|581281360|FG000|5 Year Followup|Lost to Follow-up|2|||
160970457|NCT00733499|581281361|FG001|5 Year Followup|Lost to Follow-up|0|||
160970458|NCT00733499|581281360|FG000|5 Year Followup|Death|13|||
160970459|NCT00733499|581281361|FG001|5 Year Followup|Death|19|||
160970460|NCT00733499|581281360|FG000|5 Year Followup|missing, unable to locate|0|||
160970461|NCT00733499|581281361|FG001|5 Year Followup|missing, unable to locate|1|||
160970462|NCT00733499|581281360|FG000|5 Year Followup|Withdrawal by Subject|4|||
160970463|NCT00733499|581281361|FG001|5 Year Followup|Withdrawal by Subject|1|||
160970464|NCT00733499|581281360|FG000|10 Year Followup|Death|9|||
160970465|NCT00733499|581281361|FG001|10 Year Followup|Death|7|||
160970466|NCT00733499|581281360|FG000|10 Year Followup|Adverse Event|3|||
160970467|NCT00733499|581281361|FG001|10 Year Followup|Adverse Event|3|||
160970468|NCT00733499|581281360|FG000|10 Year Followup|Lost to Follow-up|3|||
160970469|NCT00733499|581281361|FG001|10 Year Followup|Lost to Follow-up|2|||
160970470|NCT00733499|581281360|FG000|10 Year Followup|Withdrawal by Subject|5|||
160970471|NCT00733499|581281361|FG001|10 Year Followup|Withdrawal by Subject|5|||
160970472|NCT00733499|581281360|FG000|10 Year Followup|missing, unable to locate|0|||
160970473|NCT00733499|581281361|FG001|10 Year Followup|missing, unable to locate|2|||
160970474|NCT02010632|581281365|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
160970475|NCT02010632|581281366|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
160970476|NCT02404389|581281367|FG000|Overall Study|Adverse Event|1|||
160970477|NCT02404389|581281368|FG001|Overall Study|Adverse Event|0|||
160970478|NCT02404389|581281369|FG002|Overall Study|Adverse Event|1|||
160970479|NCT02404389|581281370|FG003|Overall Study|Adverse Event|0|||
160970480|NCT02404389|581281371|FG004|Overall Study|Adverse Event|2|||
160970481|NCT02404389|581281367|FG000|Overall Study|Subject/guardian decision|1|||
160970482|NCT02404389|581281368|FG001|Overall Study|Subject/guardian decision|0|||
160970483|NCT02404389|581281369|FG002|Overall Study|Subject/guardian decision|0|||
160970484|NCT02404389|581281370|FG003|Overall Study|Subject/guardian decision|1|||
160970485|NCT02404389|581281371|FG004|Overall Study|Subject/guardian decision|1|||
160970486|NCT05076149|581281377|FG000|Overall Study|Adverse Event|3|||
160970487|NCT05076149|581281378|FG001|Overall Study|Adverse Event|9|||
160970488|NCT05076149|581281377|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
160970489|NCT05076149|581281378|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
160970490|NCT05076149|581281377|FG000|Overall Study|Lost to Follow-up|0|||
160970491|NCT05076149|581281378|FG001|Overall Study|Lost to Follow-up|1|||
160970492|NCT05076149|581281377|FG000|Overall Study|Commercial drug is available for participant|0|||
160970493|NCT05076149|581281378|FG001|Overall Study|Commercial drug is available for participant|1|||
160970494|NCT05076149|581281377|FG000|Overall Study|Other non compliance|1|||
160970495|NCT05076149|581281378|FG001|Overall Study|Other non compliance|1|||
160970496|NCT05076149|581281377|FG000|Overall Study|Physician Decision|0|||
160970497|NCT05076149|581281378|FG001|Overall Study|Physician Decision|1|||
160970498|NCT05076149|581281377|FG000|Overall Study|Other|5|||
160970499|NCT05076149|581281378|FG001|Overall Study|Other|4|||
160970500|NCT00782496|581281379|FG000|Overall Study|Lost to Follow-up|14|||
160970501|NCT00782496|581281380|FG001|Overall Study|Lost to Follow-up|15|||
160970502|NCT02087501|581281381|FG000|Overall Study|Death|7|||
160970503|NCT02087501|581281381|FG000|Overall Study|Open repair of aneurysm|1|||
160970504|NCT02087501|581281381|FG000|Overall Study|Lost to Follow-up|2|||
160970505|NCT00094328|581281382|FG000|Overall Study|Lost to Follow-up|1|||
161023873|NCT03058289|581477369|FG006|Overall Study|Clinical Deterioration|0|||
161023874|NCT03058289|581477370|FG007|Overall Study|Clinical Deterioration|3|||
161023875|NCT03058289|581477371|FG008|Overall Study|Clinical Deterioration|2|||
161023876|NCT03058289|581477363|FG000|Overall Study|Lost to Follow-up|0|||
161023877|NCT03058289|581477364|FG001|Overall Study|Lost to Follow-up|0|||
161023878|NCT03058289|581477365|FG002|Overall Study|Lost to Follow-up|0|||
161023879|NCT03058289|581477366|FG003|Overall Study|Lost to Follow-up|0|||
161023880|NCT03058289|581477367|FG004|Overall Study|Lost to Follow-up|1|||
161023881|NCT03058289|581477368|FG005|Overall Study|Lost to Follow-up|0|||
161023882|NCT03058289|581477369|FG006|Overall Study|Lost to Follow-up|0|||
161023883|NCT03058289|581477370|FG007|Overall Study|Lost to Follow-up|0|||
161023884|NCT03058289|581477371|FG008|Overall Study|Lost to Follow-up|0|||
161023885|NCT03058289|581477363|FG000|Overall Study|Refused Further Treatment|0|||
161023886|NCT03058289|581477364|FG001|Overall Study|Refused Further Treatment|0|||
161023887|NCT03058289|581477365|FG002|Overall Study|Refused Further Treatment|1|||
161023888|NCT03058289|581477366|FG003|Overall Study|Refused Further Treatment|0|||
161023889|NCT03058289|581477367|FG004|Overall Study|Refused Further Treatment|1|||
161023890|NCT03058289|581477368|FG005|Overall Study|Refused Further Treatment|0|||
161023891|NCT03058289|581477369|FG006|Overall Study|Refused Further Treatment|0|||
161023892|NCT03058289|581477370|FG007|Overall Study|Refused Further Treatment|0|||
161023893|NCT03058289|581477371|FG008|Overall Study|Refused Further Treatment|0|||
161023894|NCT03058289|581477363|FG000|Overall Study|Rapid Progression of Disease|0|||
161023895|NCT03058289|581477364|FG001|Overall Study|Rapid Progression of Disease|0|||
161023896|NCT03058289|581477365|FG002|Overall Study|Rapid Progression of Disease|0|||
161023897|NCT03058289|581477366|FG003|Overall Study|Rapid Progression of Disease|1|||
161023898|NCT03058289|581477367|FG004|Overall Study|Rapid Progression of Disease|0|||
161023899|NCT03058289|581477368|FG005|Overall Study|Rapid Progression of Disease|0|||
161023900|NCT03058289|581477369|FG006|Overall Study|Rapid Progression of Disease|0|||
161273945|NCT01111825|582382523|FG002|Overall Study|Withdrawal by Subject|1|||
161273946|NCT01111825|582382524|FG003|Overall Study|Withdrawal by Subject|0|||
161273947|NCT01111825|582382521|FG000|Overall Study|Lost to Follow-up|0|||
161273948|NCT01111825|582382522|FG001|Overall Study|Lost to Follow-up|0|||
161273949|NCT01111825|582382523|FG002|Overall Study|Lost to Follow-up|3|||
161273950|NCT01111825|582382524|FG003|Overall Study|Lost to Follow-up|1|||
160970506|NCT03682705|581281385|FG000|Overall Study|Adverse Event|1|||
160970507|NCT03682705|581281386|FG001|Overall Study|Adverse Event|1|||
160970508|NCT03682705|581281387|FG002|Overall Study|Adverse Event|1|||
160970509|NCT03682705|581281388|FG003|Overall Study|Adverse Event|0|||
160970510|NCT03682705|581281389|FG004|Overall Study|Adverse Event|1|||
160970511|NCT03682705|581281390|FG005|Overall Study|Adverse Event|1|||
160970512|NCT03682705|581281385|FG000|Overall Study|Withdrawal by Subject|1|||
160970513|NCT03682705|581281386|FG001|Overall Study|Withdrawal by Subject|3|||
160970514|NCT03682705|581281387|FG002|Overall Study|Withdrawal by Subject|2|||
160970515|NCT03682705|581281388|FG003|Overall Study|Withdrawal by Subject|4|||
160970516|NCT03682705|581281389|FG004|Overall Study|Withdrawal by Subject|0|||
160970517|NCT03682705|581281390|FG005|Overall Study|Withdrawal by Subject|1|||
160970518|NCT03682705|581281385|FG000|Overall Study|Other, not specified|0|||
160970519|NCT03682705|581281386|FG001|Overall Study|Other, not specified|0|||
160970520|NCT03682705|581281387|FG002|Overall Study|Other, not specified|0|||
160970521|NCT03682705|581281388|FG003|Overall Study|Other, not specified|1|||
160970522|NCT03682705|581281389|FG004|Overall Study|Other, not specified|2|||
160970523|NCT03682705|581281390|FG005|Overall Study|Other, not specified|0|||
160970524|NCT03682705|581281385|FG000|Overall Study|Lost to Follow-up|0|||
160970525|NCT03682705|581281386|FG001|Overall Study|Lost to Follow-up|0|||
160970526|NCT03682705|581281387|FG002|Overall Study|Lost to Follow-up|0|||
160970527|NCT03682705|581281388|FG003|Overall Study|Lost to Follow-up|0|||
160970528|NCT03682705|581281389|FG004|Overall Study|Lost to Follow-up|3|||
160970529|NCT03682705|581281390|FG005|Overall Study|Lost to Follow-up|0|||
160970530|NCT00117156|581281391|FG000|Overall Study|Adverse Event|9|||
160970531|NCT00117156|581281391|FG000|Overall Study|Physician Decision|1|||
160970532|NCT00117156|581281391|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
160970533|NCT01919970|581281392|FG000|Overall Study|Withdrawal by Subject|3|||
160970534|NCT01919970|581281393|FG001|Overall Study|Withdrawal by Subject|0|||
160970535|NCT00990340|581281394|FG000|First 14-day Treatment|Not Compliant|2|||
160970536|NCT00990340|581281395|FG001|First 14-day Treatment|Not Compliant|1|||
160970537|NCT00990340|581281394|FG000|First 14-day Treatment|Lost to Follow-up|2|||
161023901|NCT03058289|581477370|FG007|Overall Study|Rapid Progression of Disease|0|||
161023902|NCT03058289|581477371|FG008|Overall Study|Rapid Progression of Disease|0|||
161023903|NCT05940194|581477372|FG000|Overall Study|Adverse Event|0|||
161023904|NCT05940194|581477373|FG001|Overall Study|Adverse Event|1|||
161023905|NCT05940194|581477374|FG002|Overall Study|Adverse Event|0|||
160970538|NCT00990340|581281395|FG001|First 14-day Treatment|Lost to Follow-up|1|||
160970539|NCT00990340|581281394|FG000|First 14-day Treatment|Protocol Violation|2|||
161023906|NCT05940194|581477372|FG000|Overall Study|Migrated/Moved from the study area|2|||
161023907|NCT05940194|581477373|FG001|Overall Study|Migrated/Moved from the study area|2|||
161273951|NCT01111825|582382521|FG000|Overall Study|Adverse Event|2|||
161273952|NCT01111825|582382522|FG001|Overall Study|Adverse Event|1|||
161343599|NCT03034967|582644415|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
160970540|NCT00990340|581281395|FG001|First 14-day Treatment|Protocol Violation|2|||
160970541|NCT04615182|581281396|FG000|Overall Study|Re-transplanted|2|||
160970542|NCT04615182|581281396|FG000|Overall Study|Protocol Violation|6|||
160970543|NCT04615182|581281396|FG000|Overall Study|Death|6|||
160970544|NCT04615182|581281396|FG000|Overall Study|Death and protocol violation|1|||
160970545|NCT01126060|581281397|FG000|Overall Study|Protocol Violation|0|||
160970546|NCT01126060|581281398|FG001|Overall Study|Protocol Violation|2|||
160970547|NCT03565068|581281399|FG000|Overall Study|Protocol Violation|0|||
160970548|NCT03565068|581281400|FG001|Overall Study|Protocol Violation|0|||
160970549|NCT03565068|581281401|FG002|Overall Study|Protocol Violation|0|||
160970550|NCT03565068|581281402|FG003|Overall Study|Protocol Violation|0|||
160970551|NCT03565068|581281403|FG004|Overall Study|Protocol Violation|1|||
160970552|NCT03565068|581281404|FG005|Overall Study|Protocol Violation|0|||
160970553|NCT03565068|581281405|FG006|Overall Study|Protocol Violation|0|||
160970554|NCT03565068|581281406|FG007|Overall Study|Protocol Violation|1|||
160970555|NCT03565068|581281407|FG008|Overall Study|Protocol Violation|0|||
160970556|NCT03565068|581281399|FG000|Overall Study|Sponsor decision|0|||
160970557|NCT03565068|581281400|FG001|Overall Study|Sponsor decision|0|||
160970558|NCT03565068|581281401|FG002|Overall Study|Sponsor decision|0|||
160970559|NCT03565068|581281402|FG003|Overall Study|Sponsor decision|0|||
160970560|NCT03565068|581281403|FG004|Overall Study|Sponsor decision|1|||
160970561|NCT03565068|581281404|FG005|Overall Study|Sponsor decision|1|||
160970562|NCT03565068|581281405|FG006|Overall Study|Sponsor decision|0|||
160970563|NCT03565068|581281406|FG007|Overall Study|Sponsor decision|0|||
160970564|NCT03565068|581281407|FG008|Overall Study|Sponsor decision|0|||
160970565|NCT03565068|581281399|FG000|Overall Study|Withdrawal by Subject|0|||
160970566|NCT03565068|581281400|FG001|Overall Study|Withdrawal by Subject|0|||
160970567|NCT03565068|581281401|FG002|Overall Study|Withdrawal by Subject|1|||
160970568|NCT03565068|581281402|FG003|Overall Study|Withdrawal by Subject|0|||
160970569|NCT03565068|581281403|FG004|Overall Study|Withdrawal by Subject|2|||
160970570|NCT03565068|581281404|FG005|Overall Study|Withdrawal by Subject|0|||
160970571|NCT03565068|581281405|FG006|Overall Study|Withdrawal by Subject|1|||
160970572|NCT03565068|581281406|FG007|Overall Study|Withdrawal by Subject|5|||
160970573|NCT03565068|581281407|FG008|Overall Study|Withdrawal by Subject|1|||
160970574|NCT03565068|581281399|FG000|Overall Study|Physician Decision|0|||
160970575|NCT03565068|581281400|FG001|Overall Study|Physician Decision|0|||
160970576|NCT03565068|581281401|FG002|Overall Study|Physician Decision|0|||
160970577|NCT03565068|581281402|FG003|Overall Study|Physician Decision|0|||
160970578|NCT03565068|581281403|FG004|Overall Study|Physician Decision|0|||
160970579|NCT03565068|581281404|FG005|Overall Study|Physician Decision|0|||
160970580|NCT03565068|581281405|FG006|Overall Study|Physician Decision|0|||
160970581|NCT03565068|581281406|FG007|Overall Study|Physician Decision|1|||
160970582|NCT03565068|581281407|FG008|Overall Study|Physician Decision|0|||
160970583|NCT03565068|581281399|FG000|Overall Study|Lost to Follow-up|0|||
160970584|NCT03565068|581281400|FG001|Overall Study|Lost to Follow-up|0|||
160970585|NCT03565068|581281401|FG002|Overall Study|Lost to Follow-up|0|||
160970586|NCT03565068|581281402|FG003|Overall Study|Lost to Follow-up|0|||
160970587|NCT03565068|581281403|FG004|Overall Study|Lost to Follow-up|0|||
160970588|NCT03565068|581281404|FG005|Overall Study|Lost to Follow-up|0|||
160970589|NCT03565068|581281405|FG006|Overall Study|Lost to Follow-up|0|||
160970590|NCT03565068|581281406|FG007|Overall Study|Lost to Follow-up|1|||
160970591|NCT03565068|581281407|FG008|Overall Study|Lost to Follow-up|0|||
160970592|NCT01654601|581281418|FG000|1st Administration|Withdrawal by Subject|2|||
160970593|NCT01654601|581281419|FG001|1st Administration|Withdrawal by Subject|0|||
160970594|NCT01654601|581281418|FG000|1st Administration|Protocol Violation|0|||
160970595|NCT01654601|581281419|FG001|1st Administration|Protocol Violation|2|||
160970596|NCT01654601|581281418|FG000|2nd Administration|Adverse Event|1|||
160970597|NCT01654601|581281419|FG001|2nd Administration|Adverse Event|0|||
160970598|NCT01654601|581281418|FG000|2nd Administration|Protocol Violation|0|||
160970599|NCT01654601|581281419|FG001|2nd Administration|Protocol Violation|1|||
160970600|NCT02636270|581281420|FG000|Overall Study|Adverse Event|1|||
160970601|NCT02636270|581281421|FG001|Overall Study|Adverse Event|0|||
160970602|NCT02636270|581281422|FG002|Overall Study|Adverse Event|0|||
160970603|NCT02636270|581281420|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
160970604|NCT02636270|581281421|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
160970605|NCT02636270|581281422|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
160970606|NCT03722264|581283519|FG000|Overall Study|Physician Decision|3|||
160970607|NCT00957931|581283520|FG000|Overall Study|Death|4|||
160970608|NCT01486758|581283521|FG000|Overall Study|Lost to Follow-up|0|||
160970609|NCT01486758|581283522|FG001|Overall Study|Lost to Follow-up|1|||
160970610|NCT01062763|581283523|FG000|Overall Study|Adverse Event|3|||
160970611|NCT01062763|581283524|FG001|Overall Study|Adverse Event|4|||
160970612|NCT02494921|581283525|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
160970613|NCT02494921|581283526|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
160970614|NCT02494921|581283527|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
160970615|NCT02494921|581283528|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
161273953|NCT01111825|582382523|FG002|Overall Study|Adverse Event|4|||
161273954|NCT01111825|582382524|FG003|Overall Study|Adverse Event|0|||
161273955|NCT01111825|582382521|FG000|Overall Study|Disease Progression|1|||
161273956|NCT01111825|582382522|FG001|Overall Study|Disease Progression|0|||
160970616|NCT02494921|581283529|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
160970617|NCT02494921|581283525|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
160970618|NCT02494921|581283526|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
160970619|NCT02494921|581283527|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
160970620|NCT02494921|581283528|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
160970621|NCT02494921|581283529|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
160970622|NCT02494921|581283525|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970623|NCT02494921|581283526|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970624|NCT02494921|581283527|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
160970625|NCT02494921|581283528|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970626|NCT02494921|581283529|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
160970627|NCT02392611|581283530|FG000|Overall Study|Adverse Event|0|||
160970628|NCT02392611|581283531|FG001|Overall Study|Adverse Event|0|||
160970629|NCT02392611|581283532|FG002|Overall Study|Adverse Event|0|||
160970630|NCT02392611|581283533|FG003|Overall Study|Adverse Event|1|||
160970631|NCT02392611|581283534|FG004|Overall Study|Adverse Event|0|||
160970632|NCT02392611|581283535|FG005|Overall Study|Adverse Event|0|||
160970633|NCT02392611|581283536|FG006|Overall Study|Adverse Event|0|||
160970634|NCT02392611|581283537|FG007|Overall Study|Adverse Event|0|||
160970635|NCT02392611|581283538|FG008|Overall Study|Adverse Event|0|||
160970636|NCT02392611|581283530|FG000|Overall Study|Progressive disease|0|||
160970637|NCT02392611|581283531|FG001|Overall Study|Progressive disease|0|||
160970638|NCT02392611|581283532|FG002|Overall Study|Progressive disease|0|||
160970639|NCT02392611|581283533|FG003|Overall Study|Progressive disease|2|||
160970640|NCT02392611|581283534|FG004|Overall Study|Progressive disease|1|||
160970641|NCT02392611|581283535|FG005|Overall Study|Progressive disease|0|||
160970642|NCT02392611|581283536|FG006|Overall Study|Progressive disease|0|||
160970643|NCT02392611|581283537|FG007|Overall Study|Progressive disease|0|||
160970644|NCT02392611|581283538|FG008|Overall Study|Progressive disease|0|||
160970645|NCT02392611|581283530|FG000|Overall Study|Death|1|||
160970646|NCT02392611|581283531|FG001|Overall Study|Death|0|||
160970647|NCT02392611|581283532|FG002|Overall Study|Death|0|||
160970648|NCT02392611|581283533|FG003|Overall Study|Death|0|||
160970649|NCT02392611|581283534|FG004|Overall Study|Death|0|||
160970650|NCT02392611|581283535|FG005|Overall Study|Death|1|||
160970651|NCT02392611|581283536|FG006|Overall Study|Death|0|||
160970652|NCT02392611|581283537|FG007|Overall Study|Death|0|||
160970653|NCT02392611|581283538|FG008|Overall Study|Death|0|||
160970654|NCT02392611|581283530|FG000|Overall Study|Withdrawal by Subject|0|||
160970655|NCT02392611|581283531|FG001|Overall Study|Withdrawal by Subject|0|||
160970656|NCT02392611|581283532|FG002|Overall Study|Withdrawal by Subject|0|||
160970657|NCT02392611|581283533|FG003|Overall Study|Withdrawal by Subject|1|||
160970658|NCT02392611|581283534|FG004|Overall Study|Withdrawal by Subject|0|||
160970659|NCT02392611|581283535|FG005|Overall Study|Withdrawal by Subject|0|||
160970660|NCT02392611|581283536|FG006|Overall Study|Withdrawal by Subject|0|||
160970661|NCT02392611|581283537|FG007|Overall Study|Withdrawal by Subject|0|||
160970662|NCT02392611|581283538|FG008|Overall Study|Withdrawal by Subject|0|||
160970663|NCT02392611|581283530|FG000|Overall Study|Lost to Follow-up|0|||
160970664|NCT02392611|581283531|FG001|Overall Study|Lost to Follow-up|0|||
160970665|NCT02392611|581283532|FG002|Overall Study|Lost to Follow-up|0|||
160970666|NCT02392611|581283533|FG003|Overall Study|Lost to Follow-up|0|||
160970667|NCT02392611|581283534|FG004|Overall Study|Lost to Follow-up|0|||
160970668|NCT02392611|581283535|FG005|Overall Study|Lost to Follow-up|0|||
160970669|NCT02392611|581283536|FG006|Overall Study|Lost to Follow-up|1|||
160970670|NCT02392611|581283537|FG007|Overall Study|Lost to Follow-up|0|||
160970671|NCT02392611|581283538|FG008|Overall Study|Lost to Follow-up|0|||
160970672|NCT02392611|581283530|FG000|Overall Study|Enrolled, not treated|0|||
160970673|NCT02392611|581283531|FG001|Overall Study|Enrolled, not treated|0|||
160970674|NCT02392611|581283532|FG002|Overall Study|Enrolled, not treated|0|||
160970675|NCT02392611|581283533|FG003|Overall Study|Enrolled, not treated|2|||
160970676|NCT02392611|581283534|FG004|Overall Study|Enrolled, not treated|0|||
161273957|NCT01111825|582382523|FG002|Overall Study|Disease Progression|0|||
161273958|NCT01111825|582382524|FG003|Overall Study|Disease Progression|0|||
161273959|NCT01111825|582382521|FG000|Overall Study|Discontinuation by Sponsor|0|||
161273960|NCT01111825|582382522|FG001|Overall Study|Discontinuation by Sponsor|0|||
160970677|NCT02392611|581283535|FG005|Overall Study|Enrolled, not treated|0|||
160970678|NCT02392611|581283536|FG006|Overall Study|Enrolled, not treated|0|||
160970679|NCT02392611|581283537|FG007|Overall Study|Enrolled, not treated|0|||
160970680|NCT02392611|581283538|FG008|Overall Study|Enrolled, not treated|0|||
160970681|NCT02991482|581283539|FG000|Overall Study|Disease progression|56|||
160970682|NCT02991482|581283540|FG001|Overall Study|Disease progression|47|||
160970683|NCT02991482|581283539|FG000|Overall Study|Death|4|||
161273961|NCT01111825|582382523|FG002|Overall Study|Discontinuation by Sponsor|0|||
161273962|NCT01111825|582382524|FG003|Overall Study|Discontinuation by Sponsor|20|||
160970684|NCT02991482|581283540|FG001|Overall Study|Death|4|||
160970685|NCT02991482|581283539|FG000|Overall Study|Adverse Event|1|||
160970686|NCT02991482|581283540|FG001|Overall Study|Adverse Event|6|||
160970687|NCT02991482|581283539|FG000|Overall Study|Patient decision|1|||
160970688|NCT02991482|581283540|FG001|Overall Study|Patient decision|1|||
160970689|NCT02991482|581283539|FG000|Overall Study|Physician Decision|0|||
160970690|NCT02991482|581283540|FG001|Overall Study|Physician Decision|6|||
160970691|NCT02991482|581283539|FG000|Overall Study|Clinical deterioration|1|||
160970692|NCT02991482|581283540|FG001|Overall Study|Clinical deterioration|0|||
160970693|NCT02991482|581283539|FG000|Overall Study|Patient feeling too unwell|1|||
160970694|NCT02991482|581283540|FG001|Overall Study|Patient feeling too unwell|0|||
160970695|NCT02991482|581283539|FG000|Overall Study|Worsening of performance status|0|||
160970696|NCT02991482|581283540|FG001|Overall Study|Worsening of performance status|1|||
160970697|NCT02991482|581283539|FG000|Overall Study|Death prior to study drug initiation|1|||
160970698|NCT02991482|581283540|FG001|Overall Study|Death prior to study drug initiation|0|||
160970699|NCT02991482|581283539|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
160970700|NCT02991482|581283540|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
160970701|NCT02887989|581283549|FG000|Overall Study|Withdrawal by Subject|8|||
160970702|NCT02887989|581283550|FG001|Overall Study|Withdrawal by Subject|11|||
160970703|NCT02887989|581283549|FG000|Overall Study|Death|1|||
160970704|NCT02887989|581283550|FG001|Overall Study|Death|0|||
160970705|NCT05648357|581283551|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
160970706|NCT00768430|581283552|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
160970707|NCT00768430|581283553|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
160970708|NCT03585296|581283556|FG000|Overall Study|Adverse Event|1|||
160970709|NCT03585296|581283556|FG000|Overall Study|Lost to Follow-up|2|||
160970710|NCT03585296|581283556|FG000|Overall Study|Withdrawal by Subject|2|||
160970711|NCT00041756|581283557|FG000|Overall Study|Adverse Event|4|||
161273963|NCT00469144|582382525|FG000|Overall Study|Death|0|||
161273964|NCT00469144|582382526|FG001|Overall Study|Death|1|||
160970712|NCT00041756|581283558|FG001|Overall Study|Adverse Event|10|||
160970713|NCT00041756|581283559|FG002|Overall Study|Adverse Event|6|||
160970714|NCT00041756|581283560|FG003|Overall Study|Adverse Event|11|||
160970715|NCT00041756|581283561|FG004|Overall Study|Adverse Event|34|||
160970716|NCT00041756|581283557|FG000|Overall Study|Protocol Violation|1|||
160970717|NCT00041756|581283558|FG001|Overall Study|Protocol Violation|1|||
160970718|NCT00041756|581283559|FG002|Overall Study|Protocol Violation|2|||
160970719|NCT00041756|581283560|FG003|Overall Study|Protocol Violation|2|||
160970720|NCT00041756|581283561|FG004|Overall Study|Protocol Violation|1|||
160970721|NCT00041756|581283557|FG000|Overall Study|Withdrawal by Subject|3|||
160970722|NCT00041756|581283558|FG001|Overall Study|Withdrawal by Subject|3|||
160970723|NCT00041756|581283559|FG002|Overall Study|Withdrawal by Subject|4|||
160970724|NCT00041756|581283560|FG003|Overall Study|Withdrawal by Subject|2|||
160970725|NCT00041756|581283561|FG004|Overall Study|Withdrawal by Subject|3|||
160970726|NCT00041756|581283557|FG000|Overall Study|Lost to Follow-up|0|||
160970727|NCT00041756|581283558|FG001|Overall Study|Lost to Follow-up|1|||
160970728|NCT00041756|581283559|FG002|Overall Study|Lost to Follow-up|0|||
160970729|NCT00041756|581283560|FG003|Overall Study|Lost to Follow-up|1|||
160970730|NCT00041756|581283561|FG004|Overall Study|Lost to Follow-up|0|||
160970731|NCT00041756|581283557|FG000|Overall Study|Unable to meet protocol criteria|0|||
160970732|NCT00041756|581283558|FG001|Overall Study|Unable to meet protocol criteria|0|||
160970733|NCT00041756|581283559|FG002|Overall Study|Unable to meet protocol criteria|1|||
161273965|NCT00469144|582382525|FG000|Overall Study|No Response|5|||
161273966|NCT00469144|582382526|FG001|Overall Study|No Response|5|||
161273967|NCT00469144|582382525|FG000|Overall Study|Progressive Disease|1|||
161273968|NCT00469144|582382526|FG001|Overall Study|Progressive Disease|0|||
161273969|NCT01994291|582382527|FG000|Overall Study|Adverse Event|4|||
161273970|NCT01994291|582382528|FG001|Overall Study|Adverse Event|1|||
161273971|NCT01994291|582382529|FG002|Overall Study|Adverse Event|3|||
161273972|NCT01994291|582382527|FG000|Overall Study|Lost to Follow-up|1|||
161273973|NCT01994291|582382528|FG001|Overall Study|Lost to Follow-up|1|||
161273974|NCT01994291|582382529|FG002|Overall Study|Lost to Follow-up|0|||
161273975|NCT01994291|582382527|FG000|Overall Study|Does not meet entrance criteria|1|||
161273976|NCT01994291|582382528|FG001|Overall Study|Does not meet entrance criteria|0|||
161273977|NCT01994291|582382529|FG002|Overall Study|Does not meet entrance criteria|0|||
161273978|NCT01994291|582382527|FG000|Overall Study|Medication error without associated AE|1|||
160970734|NCT00041756|581283560|FG003|Overall Study|Unable to meet protocol criteria|0|||
160970735|NCT00041756|581283561|FG004|Overall Study|Unable to meet protocol criteria|1|||
160970736|NCT00041756|581283557|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
160970737|NCT00041756|581283558|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
160970738|NCT00041756|581283559|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
160970739|NCT00041756|581283560|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
160970740|NCT00041756|581283561|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
160970741|NCT02110732|581283562|FG000|Overall Study|Physician Decision|5|||
160970742|NCT02110732|581283563|FG001|Overall Study|Physician Decision|2|||
160970743|NCT02110732|581283562|FG000|Overall Study|Lost to Follow-up|1|||
160970744|NCT02110732|581283563|FG001|Overall Study|Lost to Follow-up|1|||
160970745|NCT04887948|581283567|FG000|Overall Study|Death|1|||
160970746|NCT04887948|581283568|FG001|Overall Study|Death|0|||
160970747|NCT04887948|581283569|FG002|Overall Study|Death|0|||
160970748|NCT04887948|581283567|FG000|Overall Study|Lost to Follow-up|1|||
160970749|NCT04887948|581283568|FG001|Overall Study|Lost to Follow-up|0|||
160970750|NCT04887948|581283569|FG002|Overall Study|Lost to Follow-up|3|||
160970751|NCT04887948|581283567|FG000|Overall Study|Physician Decision|0|||
161273979|NCT01994291|582382528|FG001|Overall Study|Medication error without associated AE|0|||
161273980|NCT01994291|582382529|FG002|Overall Study|Medication error without associated AE|1|||
161273981|NCT01994291|582382527|FG000|Overall Study|Protocol Violation|1|||
160970752|NCT04887948|581283568|FG001|Overall Study|Physician Decision|4|||
160970753|NCT04887948|581283569|FG002|Overall Study|Physician Decision|1|||
160970754|NCT04887948|581283567|FG000|Overall Study|Protocol Violation|1|||
160970755|NCT04887948|581283568|FG001|Overall Study|Protocol Violation|1|||
160970756|NCT04887948|581283569|FG002|Overall Study|Protocol Violation|0|||
160970757|NCT04887948|581283567|FG000|Overall Study|Withdrawal by Subject|0|||
160970758|NCT04887948|581283568|FG001|Overall Study|Withdrawal by Subject|6|||
160970759|NCT04887948|581283569|FG002|Overall Study|Withdrawal by Subject|1|||
160970760|NCT04887948|581283567|FG000|Overall Study|No longer met eligibility criteria|1|||
160970761|NCT04887948|581283568|FG001|Overall Study|No longer met eligibility criteria|2|||
160970762|NCT04887948|581283569|FG002|Overall Study|No longer met eligibility criteria|1|||
160970763|NCT04887948|581283567|FG000|Overall Study|Other|2|||
160970764|NCT04887948|581283568|FG001|Overall Study|Other|1|||
160970765|NCT04887948|581283569|FG002|Overall Study|Other|1|||
160970766|NCT02312856|581283570|FG000|Overall Study|Death|1|||
160970767|NCT02312856|581283570|FG000|Overall Study|Lost to Follow-up|3|||
160970768|NCT04415151|581283571|FG000|Overall Study|Death|1|||
160970769|NCT04415151|581283572|FG001|Overall Study|Death|1|||
160970770|NCT04415151|581283571|FG000|Overall Study|Withdrawal by Subject|1|||
160970771|NCT04415151|581283572|FG001|Overall Study|Withdrawal by Subject|0|||
161273982|NCT01994291|582382528|FG001|Overall Study|Protocol Violation|0|||
161273983|NCT01994291|582382529|FG002|Overall Study|Protocol Violation|0|||
161273984|NCT01994291|582382527|FG000|Overall Study|Withdrawal by Subject|6|||
160970772|NCT00638235|581283573|FG000|Overall Study|Lost to Follow-up|31|||
160970773|NCT00638235|581283574|FG001|Overall Study|Lost to Follow-up|3|||
160970774|NCT00638235|581283575|FG002|Overall Study|Lost to Follow-up|18|||
160970775|NCT00638235|581283576|FG003|Overall Study|Lost to Follow-up|10|||
160970776|NCT00638235|581283577|FG004|Overall Study|Lost to Follow-up|13|||
160970777|NCT00638235|581283578|FG005|Overall Study|Lost to Follow-up|26|||
160970778|NCT00638235|581283579|FG006|Overall Study|Lost to Follow-up|0|||
160970779|NCT00638235|581283580|FG007|Overall Study|Lost to Follow-up|1|||
160970780|NCT00638235|581283581|FG008|Overall Study|Lost to Follow-up|18|||
160970781|NCT01588990|581283582|FG000|Phase A|Withdrawal by Subject|5|||
160970782|NCT01588990|581283582|FG000|Phase A|Physician Decision|11|||
160970783|NCT01588990|581283582|FG000|Phase A|Other|14|||
160970784|NCT01588990|581283582|FG000|Phase A|Lost to Follow-up|1|||
160970785|NCT01588990|581283582|FG000|Phase A|Death|5|||
160970786|NCT01588990|581283582|FG000|Phase A|Adverse Event|28|||
160970787|NCT01588990|581283582|FG000|Phase A|Still on therapy at end of study|6|||
160970788|NCT01588990|581283582|FG000|Phase B|Adverse Event|2|||
160970789|NCT01588990|581283582|FG000|Phase B|Still on therapy at end of study|5|||
160970790|NCT01588990|581283582|FG000|Phase B|Withdrawal by Subject|3|||
160970791|NCT01588990|581283582|FG000|Phase B|Physician Decision|4|||
160970792|NCT01588990|581283582|FG000|Phase B|Other|2|||
160970793|NCT02367716|581283585|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
160970794|NCT01473381|581283586|FG000|Overall Study|Adverse Event|8|||
160970795|NCT01473381|581283587|FG001|Overall Study|Adverse Event|20|||
160970796|NCT01473381|581283588|FG002|Overall Study|Adverse Event|25|||
160970797|NCT01473381|581283589|FG003|Overall Study|Adverse Event|17|||
161273985|NCT01994291|582382528|FG001|Overall Study|Withdrawal by Subject|3|||
160970798|NCT01473381|581283586|FG000|Overall Study|Insufficient Therapeutic Response|10|||
160970799|NCT01473381|581283587|FG001|Overall Study|Insufficient Therapeutic Response|1|||
160970800|NCT01473381|581283588|FG002|Overall Study|Insufficient Therapeutic Response|2|||
160970801|NCT01473381|581283589|FG003|Overall Study|Insufficient Therapeutic Response|3|||
160970802|NCT01473381|581283586|FG000|Overall Study|Protocol Violation|17|||
160970803|NCT01473381|581283587|FG001|Overall Study|Protocol Violation|23|||
160970804|NCT01473381|581283588|FG002|Overall Study|Protocol Violation|19|||
160970805|NCT01473381|581283589|FG003|Overall Study|Protocol Violation|17|||
160970806|NCT01473381|581283586|FG000|Overall Study|Withdrawal of Consent|20|||
160970807|NCT01473381|581283587|FG001|Overall Study|Withdrawal of Consent|21|||
160970808|NCT01473381|581283588|FG002|Overall Study|Withdrawal of Consent|20|||
160970809|NCT01473381|581283589|FG003|Overall Study|Withdrawal of Consent|26|||
160970810|NCT01473381|581283586|FG000|Overall Study|Lost to Follow-up|25|||
160970811|NCT01473381|581283587|FG001|Overall Study|Lost to Follow-up|28|||
160970812|NCT01473381|581283588|FG002|Overall Study|Lost to Follow-up|35|||
160970813|NCT01473381|581283589|FG003|Overall Study|Lost to Follow-up|23|||
160970814|NCT01473381|581283586|FG000|Overall Study|Other Reasons|0|||
160970815|NCT01473381|581283587|FG001|Overall Study|Other Reasons|0|||
161273986|NCT01994291|582382529|FG002|Overall Study|Withdrawal by Subject|5|||
160970816|NCT01473381|581283588|FG002|Overall Study|Other Reasons|1|||
161273987|NCT01994291|582382527|FG000|Overall Study|Other|1|||
161273988|NCT01994291|582382528|FG001|Overall Study|Other|2|||
161273989|NCT01994291|582382529|FG002|Overall Study|Other|0|||
161273990|NCT01147107|582382539|FG000|Overall Study|Lack of Efficacy|5|||
161273991|NCT01147107|582382540|FG001|Overall Study|Lack of Efficacy|0|||
161273992|NCT01147107|582382539|FG000|Overall Study|Withdrawal by Subject|1|||
161273993|NCT01147107|582382540|FG001|Overall Study|Withdrawal by Subject|1|||
161273994|NCT04435184|582382541|FG000|Overall Study|follow-up blood draws missing|3|||
161273995|NCT04435184|582382542|FG001|Overall Study|follow-up blood draws missing|5|||
161273996|NCT00369317|582382545|FG000|Overall Study|Adverse Event|3|||
161343600|NCT03034967|582644416|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
161343601|NCT03034967|582644417|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
161343602|NCT03806296|582644418|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
161343603|NCT03806296|582644419|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
161343604|NCT03806296|582644420|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
161343605|NCT03806296|582644418|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
161343606|NCT03806296|582644419|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
161343607|NCT03806296|582644420|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
161343608|NCT03806296|582644418|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
161343609|NCT03806296|582644419|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
161343610|NCT03806296|582644420|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
161343611|NCT02763566|582644428|FG000|Overall Study|Lost to Follow-up|1|||
161343612|NCT02763566|582644429|FG001|Overall Study|Lost to Follow-up|4|||
161343613|NCT02763566|582644430|FG002|Overall Study|Lost to Follow-up|0|||
161343614|NCT02763566|582644431|FG003|Overall Study|Lost to Follow-up|1|||
161343615|NCT02763566|582644428|FG000|Overall Study|On study treatment at study conclusion|114|||
161343616|NCT02763566|582644429|FG001|Overall Study|On study treatment at study conclusion|34|||
161343617|NCT02763566|582644430|FG002|Overall Study|On study treatment at study conclusion|54|||
161343618|NCT02763566|582644431|FG003|Overall Study|On study treatment at study conclusion|13|||
161343619|NCT02763566|582644428|FG000|Overall Study|Withdrawal by Subject|3|||
161343620|NCT02763566|582644429|FG001|Overall Study|Withdrawal by Subject|1|||
161343621|NCT02763566|582644430|FG002|Overall Study|Withdrawal by Subject|0|||
161343622|NCT02763566|582644431|FG003|Overall Study|Withdrawal by Subject|0|||
161343623|NCT04896385|582644432|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
161343624|NCT04896385|582644433|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
160970817|NCT01473381|581283589|FG003|Overall Study|Other Reasons|3|||
160970818|NCT00539643|581283590|FG000|Overall Study|Adverse Event|1|||
160970819|NCT00539643|581283591|FG001|Overall Study|Adverse Event|0|||
160970820|NCT00539643|581283590|FG000|Overall Study|Death|2|||
160970821|NCT00539643|581283591|FG001|Overall Study|Death|1|||
160970822|NCT00539643|581283590|FG000|Overall Study|Physician Decision|3|||
160970823|NCT00539643|581283591|FG001|Overall Study|Physician Decision|1|||
161343625|NCT04896385|582644434|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
160970824|NCT00539643|581283590|FG000|Overall Study|Withdrawal by Subject|0|||
160970825|NCT00539643|581283591|FG001|Overall Study|Withdrawal by Subject|1|||
160970826|NCT01641926|581283594|FG000|Overall Study|Adverse Event|5|||
160970827|NCT01641926|581283595|FG001|Overall Study|Adverse Event|2|||
160970828|NCT01641926|581283596|FG002|Overall Study|Adverse Event|3|||
160970829|NCT01641926|581283597|FG003|Overall Study|Adverse Event|1|||
160970830|NCT01641926|581283594|FG000|Overall Study|Lost to Follow-up|2|||
160970831|NCT01641926|581283595|FG001|Overall Study|Lost to Follow-up|2|||
160970832|NCT01641926|581283596|FG002|Overall Study|Lost to Follow-up|1|||
160970833|NCT01641926|581283597|FG003|Overall Study|Lost to Follow-up|0|||
160970834|NCT01641926|581283594|FG000|Overall Study|Physician Decision|6|||
160970835|NCT01641926|581283595|FG001|Overall Study|Physician Decision|5|||
160970836|NCT01641926|581283596|FG002|Overall Study|Physician Decision|0|||
160970837|NCT01641926|581283597|FG003|Overall Study|Physician Decision|1|||
160970838|NCT01641926|581283594|FG000|Overall Study|Protocol Violation|1|||
160970839|NCT01641926|581283595|FG001|Overall Study|Protocol Violation|0|||
160970840|NCT01641926|581283596|FG002|Overall Study|Protocol Violation|0|||
160970841|NCT01641926|581283597|FG003|Overall Study|Protocol Violation|1|||
161273997|NCT00369317|582382545|FG000|Overall Study|Death|1|||
161273998|NCT00369317|582382545|FG000|Overall Study|Lack of Efficacy|5|||
161343626|NCT04896385|582644435|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
161343627|NCT04896385|582644432|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
161343628|NCT04896385|582644433|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
161273999|NCT00369317|582382545|FG000|Overall Study|Physician Decision|2|||
160970842|NCT01641926|581283594|FG000|Overall Study|Withdrawal by Subject|13|||
160970843|NCT01641926|581283595|FG001|Overall Study|Withdrawal by Subject|5|||
160970844|NCT01641926|581283596|FG002|Overall Study|Withdrawal by Subject|6|||
160970845|NCT01641926|581283597|FG003|Overall Study|Withdrawal by Subject|1|||
160970846|NCT01641926|581283594|FG000|Overall Study|Not Treated|1|||
161274000|NCT00369317|582382545|FG000|Overall Study|Withdrawal by Subject|8|||
161274001|NCT00369317|582382545|FG000|Overall Study|Ineligible|1|||
160970847|NCT01641926|581283595|FG001|Overall Study|Not Treated|1|||
160970848|NCT01641926|581283596|FG002|Overall Study|Not Treated|1|||
160970849|NCT01641926|581283597|FG003|Overall Study|Not Treated|0|||
160970850|NCT01800201|581283598|FG000|Overall Study|Withdrawal by Subject|2|||
160970851|NCT01800201|581283599|FG001|Overall Study|Withdrawal by Subject|0|||
160970852|NCT01800201|581283598|FG000|Overall Study|patient privacy concerns|1|||
160970853|NCT01800201|581283599|FG001|Overall Study|patient privacy concerns|1|||
160970854|NCT01800201|581283598|FG000|Overall Study|did not want to use device|0|||
160970855|NCT01800201|581283599|FG001|Overall Study|did not want to use device|1|||
160970856|NCT01800201|581283598|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
160970857|NCT01800201|581283599|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
160970858|NCT01480596|581283600|FG000|Overall Study|Adverse Event|3|||
160970859|NCT01480596|581283601|FG001|Overall Study|Adverse Event|0|||
160970860|NCT01480596|581283600|FG000|Overall Study|MG exacerbation or change in medication|2|||
160970861|NCT01480596|581283601|FG001|Overall Study|MG exacerbation or change in medication|2|||
160970862|NCT02904902|581283602|FG000|Overall Study|Withdrawal by Subject|1|||
160970863|NCT05400746|581283607|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
160970864|NCT05400746|581283608|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
160970865|NCT05400746|581283609|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
160970866|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
160970867|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
160970868|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
161274002|NCT02365558|582382546|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
161274003|NCT02365558|582382547|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
161274004|NCT02365558|582382546|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
161274005|NCT02365558|582382547|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
161274006|NCT02722148|582382551|FG000|Overall Study|Lost to Follow-up|2|||
161274007|NCT02722148|582382551|FG000|Overall Study|Non compliant with treatment regimen|3|||
161274008|NCT00073021|582382552|FG000|Overall Study|Protocol Violation|2|||
161274009|NCT00073021|582382553|FG001|Overall Study|Protocol Violation|1|||
161274010|NCT00073021|582382552|FG000|Overall Study|Adverse Event|4|||
161274011|NCT00073021|582382553|FG001|Overall Study|Adverse Event|4|||
161274012|NCT00073021|582382552|FG000|Overall Study|Withdrawal by Subject|6|||
161274013|NCT00073021|582382553|FG001|Overall Study|Withdrawal by Subject|5|||
161274014|NCT00073021|582382552|FG000|Overall Study|Physician Decision|3|||
161274015|NCT00073021|582382553|FG001|Overall Study|Physician Decision|1|||
161274016|NCT00073021|582382552|FG000|Overall Study|Lack of Efficacy|11|||
161274017|NCT00073021|582382553|FG001|Overall Study|Lack of Efficacy|5|||
161274018|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
161274019|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
161274020|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274021|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274022|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274023|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274024|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274025|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274026|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274027|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274028|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274029|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274030|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274031|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
161274032|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
161274033|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
161274034|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274035|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274036|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274037|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274038|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274039|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160970869|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
160970870|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
161148689|NCT04003155|581926130|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
161148690|NCT04003155|581926131|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
161274040|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274041|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274042|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274043|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
160970871|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
160970872|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
161148691|NCT01912872|581926132|FG000|Overall Study|Lost to Follow-up|2|||
160970873|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Physician Decision|4|||
160970874|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Physician Decision|1|||
160970875|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Physician Decision|3|||
160970876|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Physician Decision|0|||
160970877|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Physician Decision|0|||
160970878|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Physician Decision|1|||
160970879|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Physician Decision|0|||
160970880|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Other|0|||
160970881|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Other|1|||
160970882|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Other|0|||
160970883|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Other|0|||
160970884|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Other|0|||
160970885|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Other|0|||
160970886|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Other|0|||
160970887|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970888|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970889|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970890|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970891|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970892|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
160970893|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
160970894|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
160970895|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
160970896|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
160970897|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
160970898|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
160970899|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
160970900|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
160970901|NCT05375955|581283610|FG000|Treatment (12 Weeks)|Pregnancy|0|||
160970902|NCT05375955|581283611|FG001|Treatment (12 Weeks)|Pregnancy|0|||
160970903|NCT05375955|581283612|FG002|Treatment (12 Weeks)|Pregnancy|1|||
160970904|NCT05375955|581283613|FG003|Treatment (12 Weeks)|Pregnancy|0|||
160970905|NCT05375955|581283614|FG004|Treatment (12 Weeks)|Pregnancy|0|||
160970906|NCT05375955|581283615|FG005|Treatment (12 Weeks)|Pregnancy|0|||
160970907|NCT05375955|581283616|FG006|Treatment (12 Weeks)|Pregnancy|0|||
160970908|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970909|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970910|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
160970911|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970912|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970913|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970914|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
160970915|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
160970916|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970917|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
160970918|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970919|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970920|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
160970921|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
160970922|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Other|0|||
160970923|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Other|1|||
160970924|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Other|0|||
160970925|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Other|0|||
160970926|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Other|0|||
160970927|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Other|0|||
160970928|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Other|0|||
160970929|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
160970930|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970931|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
160970932|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970933|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970934|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970935|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
160970936|NCT05375955|581283610|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161023908|NCT05940194|581477374|FG002|Overall Study|Migrated/Moved from the study area|4|||
161023909|NCT03800654|581477376|FG000|Overall Study|Time constraints|3|||
161023910|NCT03800654|581477377|FG001|Overall Study|Time constraints|3|||
160970937|NCT05375955|581283611|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
160970938|NCT05375955|581283612|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
160970939|NCT05375955|581283613|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
160970940|NCT05375955|581283614|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
160970941|NCT05375955|581283615|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
161023911|NCT03800654|581477378|FG002|Overall Study|Time constraints|3|||
160970942|NCT05375955|581283616|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
160970943|NCT03879408|581283626|FG000|Overall Study|Lost to Follow-up|0|||
160970944|NCT03879408|581283627|FG001|Overall Study|Lost to Follow-up|3|||
160970945|NCT03879408|581283628|FG002|Overall Study|Lost to Follow-up|2|||
160970946|NCT03879408|581283629|FG003|Overall Study|Lost to Follow-up|1|||
160970947|NCT03879408|581283630|FG004|Overall Study|Lost to Follow-up|0|||
160970948|NCT03879408|581283626|FG000|Overall Study|Withdrawal by Subject|2|||
160970949|NCT03879408|581283627|FG001|Overall Study|Withdrawal by Subject|1|||
160970950|NCT03879408|581283628|FG002|Overall Study|Withdrawal by Subject|1|||
160970951|NCT03879408|581283629|FG003|Overall Study|Withdrawal by Subject|0|||
160970952|NCT03879408|581283630|FG004|Overall Study|Withdrawal by Subject|1|||
160970953|NCT05458024|581283631|FG000|Overall Study|Withdrawal by Subject|1|||
160970954|NCT05458024|581283632|FG001|Overall Study|Withdrawal by Subject|1|||
160970955|NCT00943306|581283634|FG000|Overall Study|Physician Decision|1|||
160970956|NCT00943306|581283634|FG000|Overall Study|Death|1|||
160970957|NCT00943306|581283634|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
160970958|NCT00733980|581283635|FG000|Overall Study|Adverse Event|5|||
160970959|NCT00733980|581283636|FG001|Overall Study|Adverse Event|2|||
160970960|NCT00733980|581283635|FG000|Overall Study|Lack of Efficacy|0|||
160970961|NCT00733980|581283636|FG001|Overall Study|Lack of Efficacy|1|||
160970962|NCT00733980|581283635|FG000|Overall Study|Protocol Violation|2|||
160970963|NCT00733980|581283636|FG001|Overall Study|Protocol Violation|1|||
160970964|NCT00733980|581283635|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
160970965|NCT00733980|581283636|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
160970966|NCT00733980|581283635|FG000|Overall Study|Lost to Follow-up|6|||
160970967|NCT00733980|581283636|FG001|Overall Study|Lost to Follow-up|11|||
160970968|NCT00733980|581283635|FG000|Overall Study|Physician Decision|2|||
160970969|NCT00733980|581283636|FG001|Overall Study|Physician Decision|3|||
160970970|NCT00733980|581283635|FG000|Overall Study|Withdrawal by Subject|6|||
160970971|NCT00733980|581283636|FG001|Overall Study|Withdrawal by Subject|2|||
160970972|NCT02739347|581283637|FG000|Overall Study|Adverse Event|3|||
160970973|NCT02739347|581283638|FG001|Overall Study|Adverse Event|0|||
160970974|NCT02739347|581283637|FG000|Overall Study|Protocol Violation|0|||
160970975|NCT02739347|581283638|FG001|Overall Study|Protocol Violation|1|||
160970976|NCT02739347|581283637|FG000|Overall Study|Lost to Follow-up|0|||
160970977|NCT02739347|581283638|FG001|Overall Study|Lost to Follow-up|2|||
160970978|NCT01552954|581283639|FG000|Overall Study|Adverse Event|1|||
160970979|NCT01552954|581283640|FG001|Overall Study|Adverse Event|2|||
160970980|NCT01552954|581283639|FG000|Overall Study|Lost to Follow-up|1|||
160970981|NCT01552954|581283640|FG001|Overall Study|Lost to Follow-up|1|||
160970982|NCT01552954|581283639|FG000|Overall Study|Withdrawal by Subject|1|||
160970983|NCT01552954|581283640|FG001|Overall Study|Withdrawal by Subject|1|||
160970984|NCT01552954|581283639|FG000|Overall Study|Protocol Violation|1|||
160970985|NCT01552954|581283640|FG001|Overall Study|Protocol Violation|2|||
160970986|NCT01552954|581283639|FG000|Overall Study|diagnosed DM|1|||
160970987|NCT01552954|581283640|FG001|Overall Study|diagnosed DM|0|||
160970988|NCT01931735|581283641|FG000|Randomized Phase|Lost to Follow-up|2|||
160970989|NCT01931735|581283642|FG001|Randomized Phase|Lost to Follow-up|2|||
160970990|NCT01931735|581283643|FG002|Randomized Phase|Lost to Follow-up|5|||
160970991|NCT01931735|581283644|FG003|Randomized Phase|Lost to Follow-up|0|||
160970992|NCT01931735|581283641|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
160970993|NCT01931735|581283642|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
160970994|NCT01931735|581283643|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
160970995|NCT01931735|581283644|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
160970996|NCT01931735|581283641|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
161274044|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274045|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
161274046|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
160970997|NCT01931735|581283642|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
160970998|NCT01931735|581283643|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
160970999|NCT01931735|581283644|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
160971000|NCT02719990|581283645|FG000|Overall Study|Physician Decision|2|||
160971001|NCT02719990|581283645|FG000|Overall Study|Withdrawal by Subject|2|||
160971002|NCT02719990|581283645|FG000|Overall Study|Study Terminated By Sponsor|32|||
160971003|NCT00652938|581283646|FG000|Overall Study|Adverse Event|1|||
160971004|NCT00652938|581283647|FG001|Overall Study|Adverse Event|0|||
160971005|NCT00652938|581283648|FG002|Overall Study|Adverse Event|2|||
160971006|NCT00652938|581283646|FG000|Overall Study|Withdrawal by Subject|0|||
160971007|NCT00652938|581283647|FG001|Overall Study|Withdrawal by Subject|6|||
160971008|NCT00652938|581283648|FG002|Overall Study|Withdrawal by Subject|1|||
160971009|NCT00652938|581283646|FG000|Overall Study|Lost to Follow-up|0|||
160971010|NCT00652938|581283647|FG001|Overall Study|Lost to Follow-up|0|||
160971011|NCT00652938|581283648|FG002|Overall Study|Lost to Follow-up|2|||
160971012|NCT00652938|581283646|FG000|Overall Study|fear of blood sampling|0|||
160971013|NCT00652938|581283647|FG001|Overall Study|fear of blood sampling|1|||
160971014|NCT00652938|581283648|FG002|Overall Study|fear of blood sampling|0|||
160971015|NCT03324880|581283649|FG000|Overall Study|Adverse Event|0|||
160971016|NCT03324880|581283650|FG001|Overall Study|Adverse Event|2|||
160971017|NCT03324880|581283649|FG000|Overall Study|Withdrawal by Subject|2|||
160971018|NCT03324880|581283650|FG001|Overall Study|Withdrawal by Subject|2|||
160971019|NCT03324880|581283649|FG000|Overall Study|Lost to Follow-up|0|||
160971020|NCT03324880|581283650|FG001|Overall Study|Lost to Follow-up|1|||
160971021|NCT03324880|581283649|FG000|Overall Study|Product Recall|0|||
160971022|NCT03324880|581283650|FG001|Overall Study|Product Recall|1|||
160971023|NCT01412801|581283654|FG000|Overall Study|Death|0|||
160971024|NCT01412801|581283655|FG001|Overall Study|Death|1|||
160971025|NCT01412801|581283656|FG002|Overall Study|Death|0|||
160971026|NCT01412801|581283657|FG003|Overall Study|Death|4|||
160971027|NCT01412801|581283658|FG004|Overall Study|Death|2|||
160971028|NCT01412801|581283659|FG005|Overall Study|Death|2|||
160971029|NCT01412801|581283654|FG000|Overall Study|Lost to Follow-up|1|||
160971030|NCT01412801|581283655|FG001|Overall Study|Lost to Follow-up|2|||
160971031|NCT01412801|581283656|FG002|Overall Study|Lost to Follow-up|4|||
160971032|NCT01412801|581283657|FG003|Overall Study|Lost to Follow-up|0|||
160971033|NCT01412801|581283658|FG004|Overall Study|Lost to Follow-up|1|||
160971034|NCT01412801|581283659|FG005|Overall Study|Lost to Follow-up|1|||
160971035|NCT01412801|581283654|FG000|Overall Study|Withdrawal by Subject|3|||
160971036|NCT01412801|581283655|FG001|Overall Study|Withdrawal by Subject|2|||
160971037|NCT01412801|581283656|FG002|Overall Study|Withdrawal by Subject|1|||
160971038|NCT01412801|581283657|FG003|Overall Study|Withdrawal by Subject|0|||
160971039|NCT01412801|581283658|FG004|Overall Study|Withdrawal by Subject|0|||
160971040|NCT01412801|581283659|FG005|Overall Study|Withdrawal by Subject|0|||
160971041|NCT01412801|581283654|FG000|Overall Study|Relocated to another area|0|||
160971042|NCT01412801|581283655|FG001|Overall Study|Relocated to another area|0|||
160971043|NCT01412801|581283656|FG002|Overall Study|Relocated to another area|2|||
160971044|NCT01412801|581283657|FG003|Overall Study|Relocated to another area|0|||
160971045|NCT01412801|581283658|FG004|Overall Study|Relocated to another area|0|||
160971046|NCT01412801|581283659|FG005|Overall Study|Relocated to another area|0|||
160971047|NCT01235403|581283660|FG000|Overall Study|Adverse Event|14|||
160971048|NCT01235403|581283660|FG000|Overall Study|Lost to Follow-up|2|||
160971049|NCT01235403|581283660|FG000|Overall Study|Withdrawal by Subject|4|||
160971050|NCT01235403|581283660|FG000|Overall Study|Lack of Efficacy|2|||
160971051|NCT01235403|581283660|FG000|Overall Study|Other reasons for premature termination|4|||
160971052|NCT01547299|581283661|FG000|Overall Study|Withdrawal by Subject|2|||
160971053|NCT01547299|581283662|FG001|Overall Study|Withdrawal by Subject|2|||
160971054|NCT00717314|581283664|FG000|Overall Study|Adverse Event|3|||
160971055|NCT00717314|581283665|FG001|Overall Study|Adverse Event|2|||
160971056|NCT00717314|581283664|FG000|Overall Study|Protocol Violation|1|||
160971057|NCT00717314|581283665|FG001|Overall Study|Protocol Violation|0|||
160971058|NCT00717314|581283664|FG000|Overall Study|Lost to Follow-up|1|||
160971059|NCT00717314|581283665|FG001|Overall Study|Lost to Follow-up|5|||
160971060|NCT00717314|581283664|FG000|Overall Study|Withdrawal by Subject|1|||
160971061|NCT00717314|581283665|FG001|Overall Study|Withdrawal by Subject|3|||
160971062|NCT05096208|581283666|FG000|Overall Study|Lost to Follow-up|3|||
160971063|NCT05096208|581283667|FG001|Overall Study|Lost to Follow-up|5|||
160971064|NCT05096208|581283668|FG002|Overall Study|Lost to Follow-up|5|||
160971065|NCT05096208|581283669|FG003|Overall Study|Lost to Follow-up|2|||
160971066|NCT05096208|581283666|FG000|Overall Study|Withdrawal by Subject|0|||
160971067|NCT05096208|581283667|FG001|Overall Study|Withdrawal by Subject|1|||
160971068|NCT05096208|581283668|FG002|Overall Study|Withdrawal by Subject|2|||
161023912|NCT03800654|581477376|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
161274047|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
161274048|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274049|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161023913|NCT03800654|581477377|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
161023914|NCT03800654|581477378|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
161023915|NCT03800654|581477376|FG000|Overall Study|Lost to Follow-up|2|||
161148692|NCT01912872|581926133|FG001|Overall Study|Lost to Follow-up|3|||
161148693|NCT01912872|581926134|FG002|Overall Study|Lost to Follow-up|5|||
160971069|NCT05096208|581283669|FG003|Overall Study|Withdrawal by Subject|3|||
160971070|NCT05096208|581283666|FG000|Overall Study|No longer met eligibility criteria|1|||
160971071|NCT05096208|581283667|FG001|Overall Study|No longer met eligibility criteria|0|||
160971072|NCT05096208|581283668|FG002|Overall Study|No longer met eligibility criteria|0|||
160971073|NCT05096208|581283669|FG003|Overall Study|No longer met eligibility criteria|0|||
160971074|NCT05096208|581283666|FG000|Overall Study|Other|0|||
160971075|NCT05096208|581283667|FG001|Overall Study|Other|0|||
160971076|NCT05096208|581283668|FG002|Overall Study|Other|1|||
160971077|NCT05096208|581283669|FG003|Overall Study|Other|0|||
161148694|NCT01912872|581926135|FG003|Overall Study|Lost to Follow-up|5|||
160971078|NCT01483937|581283671|FG000|Overall Study|Withdrawal by Subject|4|||
160971079|NCT01483937|581283672|FG001|Overall Study|Withdrawal by Subject|3|||
160971080|NCT02213328|581283673|FG000|Overall Study|Withdrawal by Subject|10|||
160971081|NCT02213328|581283673|FG000|Overall Study|Physician Decision|2|||
160971082|NCT02213328|581283673|FG000|Overall Study|Lost to Follow-up|16|||
161274050|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274051|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274052|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274053|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274054|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274055|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274056|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274057|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274058|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274059|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
161274060|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
161274061|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
161274062|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274063|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274064|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274065|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274066|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274067|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274068|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274069|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274070|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274071|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274072|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274073|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
161274074|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
161274075|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
161274076|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274077|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274078|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274079|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274080|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274081|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274082|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274083|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274084|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274085|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274086|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161343629|NCT04896385|582644434|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
160971083|NCT04043962|581283674|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
160971084|NCT04043962|581283674|FG000|Post-Treatment|Withdrawal by Subject|5|||
160971085|NCT04043962|581283674|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
160971086|NCT01874145|581283675|FG000|Core Period|Non-compliance|1|||
160971087|NCT01874145|581283676|FG001|Core Period|Non-compliance|0|||
160971088|NCT01874145|581283675|FG000|Core Period|Protocol Violation|1|||
160971089|NCT01874145|581283676|FG001|Core Period|Protocol Violation|1|||
160971090|NCT01874145|581283675|FG000|Core Period|Physician Decision|1|||
160971091|NCT01874145|581283676|FG001|Core Period|Physician Decision|1|||
160971092|NCT01874145|581283675|FG000|Core Period|Adverse Event|0|||
160971093|NCT01874145|581283676|FG001|Core Period|Adverse Event|1|||
160971094|NCT01874145|581283675|FG000|Core Period|Withdrawal by Subject|0|||
160971095|NCT01874145|581283676|FG001|Core Period|Withdrawal by Subject|4|||
160971096|NCT01874145|581283675|FG000|Extension Period|Adverse Event|3|||
160971097|NCT01874145|581283676|FG001|Extension Period|Adverse Event|2|||
160971098|NCT01874145|581283675|FG000|Extension Period|Withdrawal by Subject|2|||
160971099|NCT01874145|581283676|FG001|Extension Period|Withdrawal by Subject|1|||
160971100|NCT01874145|581283675|FG000|Extension Period|Lost to Follow-up|1|||
160971101|NCT01874145|581283676|FG001|Extension Period|Lost to Follow-up|1|||
160971102|NCT00402337|581283677|FG000|Overall Study|Adverse Event|0|||
160971103|NCT00402337|581283678|FG001|Overall Study|Adverse Event|2|||
160971104|NCT00402337|581283679|FG002|Overall Study|Adverse Event|2|||
160971105|NCT00402337|581283680|FG003|Overall Study|Adverse Event|3|||
160971106|NCT00402337|581283681|FG004|Overall Study|Adverse Event|2|||
160971107|NCT00402337|581283677|FG000|Overall Study|Noncompliance|0|||
160971108|NCT00402337|581283678|FG001|Overall Study|Noncompliance|0|||
160971109|NCT00402337|581283679|FG002|Overall Study|Noncompliance|0|||
160971110|NCT00402337|581283680|FG003|Overall Study|Noncompliance|0|||
160971111|NCT00402337|581283681|FG004|Overall Study|Noncompliance|2|||
160971112|NCT00402337|581283677|FG000|Overall Study|Withdrawal by Subject|5|||
161148695|NCT01912872|581926132|FG000|Overall Study|Other unspecified|3|||
160971113|NCT00402337|581283678|FG001|Overall Study|Withdrawal by Subject|3|||
160971114|NCT00402337|581283679|FG002|Overall Study|Withdrawal by Subject|1|||
161023916|NCT03800654|581477377|FG001|Overall Study|Lost to Follow-up|1|||
161023917|NCT03800654|581477378|FG002|Overall Study|Lost to Follow-up|6|||
161023918|NCT03800654|581477376|FG000|Overall Study|Medical Health Issue|0|||
161023919|NCT03800654|581477377|FG001|Overall Study|Medical Health Issue|0|||
161023920|NCT03800654|581477378|FG002|Overall Study|Medical Health Issue|1|||
161023921|NCT03800654|581477376|FG000|Overall Study|Personal Issues|0|||
161023922|NCT03800654|581477377|FG001|Overall Study|Personal Issues|2|||
161023923|NCT03800654|581477378|FG002|Overall Study|Personal Issues|0|||
161023924|NCT03800654|581477376|FG000|Overall Study|Protocol Violation|0|||
161023925|NCT03800654|581477377|FG001|Overall Study|Protocol Violation|1|||
161023926|NCT03800654|581477378|FG002|Overall Study|Protocol Violation|0|||
161274087|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
161274088|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
161274089|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
161274090|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274091|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274092|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160971115|NCT00402337|581283680|FG003|Overall Study|Withdrawal by Subject|6|||
160971116|NCT00402337|581283681|FG004|Overall Study|Withdrawal by Subject|4|||
160971117|NCT00402337|581283677|FG000|Overall Study|Lost to Follow-up|0|||
160971118|NCT00402337|581283678|FG001|Overall Study|Lost to Follow-up|0|||
160971119|NCT00402337|581283679|FG002|Overall Study|Lost to Follow-up|1|||
160971120|NCT00402337|581283680|FG003|Overall Study|Lost to Follow-up|2|||
160971121|NCT00402337|581283681|FG004|Overall Study|Lost to Follow-up|0|||
160971122|NCT00402337|581283677|FG000|Overall Study|Physician Decision|0|||
160971123|NCT00402337|581283678|FG001|Overall Study|Physician Decision|0|||
160971124|NCT00402337|581283679|FG002|Overall Study|Physician Decision|0|||
160971125|NCT00402337|581283680|FG003|Overall Study|Physician Decision|1|||
160971126|NCT00402337|581283681|FG004|Overall Study|Physician Decision|0|||
160971127|NCT00402337|581283677|FG000|Overall Study|Other Reason|0|||
160971128|NCT00402337|581283678|FG001|Overall Study|Other Reason|1|||
160971129|NCT00402337|581283679|FG002|Overall Study|Other Reason|0|||
160971130|NCT00402337|581283680|FG003|Overall Study|Other Reason|0|||
160971131|NCT00402337|581283681|FG004|Overall Study|Other Reason|0|||
160971132|NCT01833143|581283682|FG000|Overall Study|Not Treated|1|||
160971133|NCT00767104|581285490|FG000|Overall Study|Lost to Follow-up|1|||
160971134|NCT00767104|581285491|FG001|Overall Study|Lost to Follow-up|2|||
160971135|NCT00840996|581285492|FG000|Overall Study|Withdrawal by Subject|1|||
160971136|NCT00840996|581285493|FG001|Overall Study|Withdrawal by Subject|0|||
160971137|NCT02762981|581285494|FG000|Overall Study|Adverse Event|2|||
160971138|NCT02762981|581285495|FG001|Overall Study|Adverse Event|3|||
160971139|NCT02762981|581285496|FG002|Overall Study|Adverse Event|1|||
160971140|NCT02762981|581285497|FG003|Overall Study|Adverse Event|1|||
160971141|NCT02762981|581285498|FG004|Overall Study|Adverse Event|3|||
160971142|NCT02762981|581285494|FG000|Overall Study|Physician Decision|0|||
160971143|NCT02762981|581285495|FG001|Overall Study|Physician Decision|1|||
160971144|NCT02762981|581285496|FG002|Overall Study|Physician Decision|0|||
160971145|NCT02762981|581285497|FG003|Overall Study|Physician Decision|0|||
160971146|NCT02762981|581285498|FG004|Overall Study|Physician Decision|1|||
160971147|NCT02762981|581285494|FG000|Overall Study|Disease progression|11|||
160971148|NCT02762981|581285495|FG001|Overall Study|Disease progression|23|||
160971149|NCT02762981|581285496|FG002|Overall Study|Disease progression|4|||
160971150|NCT02762981|581285497|FG003|Overall Study|Disease progression|10|||
160971151|NCT02762981|581285498|FG004|Overall Study|Disease progression|1|||
160971152|NCT02762981|581285494|FG000|Overall Study|Enrolled not treated|1|||
160971153|NCT02762981|581285495|FG001|Overall Study|Enrolled not treated|5|||
160971154|NCT02762981|581285496|FG002|Overall Study|Enrolled not treated|0|||
160971155|NCT02762981|581285497|FG003|Overall Study|Enrolled not treated|2|||
160971156|NCT02762981|581285498|FG004|Overall Study|Enrolled not treated|0|||
160971157|NCT02762981|581285494|FG000|Overall Study|Other|2|||
160971158|NCT02762981|581285495|FG001|Overall Study|Other|3|||
160971159|NCT02762981|581285496|FG002|Overall Study|Other|1|||
160971160|NCT02762981|581285497|FG003|Overall Study|Other|0|||
160971161|NCT02762981|581285498|FG004|Overall Study|Other|0|||
160971162|NCT02762981|581285494|FG000|Overall Study|Missing|1|||
160971163|NCT02762981|581285495|FG001|Overall Study|Missing|0|||
160971164|NCT02762981|581285496|FG002|Overall Study|Missing|0|||
160971165|NCT02762981|581285497|FG003|Overall Study|Missing|0|||
160971166|NCT02762981|581285498|FG004|Overall Study|Missing|0|||
161023927|NCT03459729|581477379|FG000|Overall Study|Physician Decision|2|||
161023928|NCT06182033|581477380|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
161274093|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160971167|NCT02762981|581285494|FG000|Overall Study|Withdrawal by Subject|0|||
160971168|NCT02762981|581285495|FG001|Overall Study|Withdrawal by Subject|5|||
160971169|NCT02762981|581285496|FG002|Overall Study|Withdrawal by Subject|1|||
160971170|NCT02762981|581285497|FG003|Overall Study|Withdrawal by Subject|3|||
160971171|NCT02762981|581285498|FG004|Overall Study|Withdrawal by Subject|0|||
160971172|NCT02145078|581285499|FG000|Overall Study|Death|1|||
160971173|NCT02145078|581285499|FG000|Overall Study|Reason not given|3|||
160971174|NCT01350141|581285500|FG000|Overall Study|Lost to Follow-up|1|||
160971175|NCT01350141|581285501|FG001|Overall Study|Lost to Follow-up|0|||
160971176|NCT01350141|581285502|FG002|Overall Study|Lost to Follow-up|1|||
160971177|NCT01350141|581285500|FG000|Overall Study|Withdrawal by Subject|1|||
160971178|NCT01350141|581285501|FG001|Overall Study|Withdrawal by Subject|0|||
160971179|NCT01350141|581285502|FG002|Overall Study|Withdrawal by Subject|0|||
160971180|NCT01350141|581285500|FG000|Overall Study|Randomized but not treated|1|||
160971181|NCT01350141|581285501|FG001|Overall Study|Randomized but not treated|0|||
160971182|NCT01350141|581285502|FG002|Overall Study|Randomized but not treated|0|||
160971183|NCT01616771|581285508|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
160971184|NCT04399356|581285513|FG000|Overall Study|Lost to Follow-up|1|||
160971185|NCT04399356|581285514|FG001|Overall Study|Lost to Follow-up|1|||
160971186|NCT04399356|581285513|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
160971187|NCT04399356|581285514|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
160971188|NCT04399356|581285513|FG000|Overall Study|Withdrawal by Subject|1|||
160971189|NCT04399356|581285514|FG001|Overall Study|Withdrawal by Subject|0|||
160971190|NCT04359771|581285515|FG000|Overall Study|Lack of Efficacy|2|||
160971191|NCT04359771|581285516|FG001|Overall Study|Lack of Efficacy|2|||
160971192|NCT04041440|581285518|FG000|Overall Study|Withdrawal by Subject|0|||
160971193|NCT04041440|581285519|FG001|Overall Study|Withdrawal by Subject|1|||
160971194|NCT04041440|581285518|FG000|Overall Study|Lost to Follow-up|0|||
160971195|NCT04041440|581285519|FG001|Overall Study|Lost to Follow-up|1|||
160971196|NCT02306265|581285520|FG000|Overall Study|Withdrawal by Subject|1|||
160971197|NCT02247804|581285525|FG000|Treatment Period 1|Adverse Event|9|||
160971198|NCT02247804|581285526|FG001|Treatment Period 1|Adverse Event|2|||
160971199|NCT02247804|581285527|FG002|Treatment Period 1|Adverse Event|0|||
160971200|NCT02247804|581285525|FG000|Treatment Period 1|Lack of Efficacy|0|||
160971201|NCT02247804|581285526|FG001|Treatment Period 1|Lack of Efficacy|0|||
160971202|NCT02247804|581285527|FG002|Treatment Period 1|Lack of Efficacy|2|||
160971203|NCT02247804|581285525|FG000|Treatment Period 1|Lost to Follow-up|1|||
160971204|NCT02247804|581285526|FG001|Treatment Period 1|Lost to Follow-up|0|||
160971205|NCT02247804|581285527|FG002|Treatment Period 1|Lost to Follow-up|2|||
160971206|NCT02247804|581285525|FG000|Treatment Period 1|Personal Reasons|7|||
160971207|NCT02247804|581285526|FG001|Treatment Period 1|Personal Reasons|1|||
160971208|NCT02247804|581285527|FG002|Treatment Period 1|Personal Reasons|2|||
160971209|NCT02247804|581285525|FG000|Treatment Period 1|Protocol Deviation|0|||
160971210|NCT02247804|581285526|FG001|Treatment Period 1|Protocol Deviation|0|||
160971211|NCT02247804|581285527|FG002|Treatment Period 1|Protocol Deviation|1|||
160971212|NCT02247804|581285525|FG000|Treatment Period 1|Randomized but not Treated|5|||
160971213|NCT02247804|581285526|FG001|Treatment Period 1|Randomized but not Treated|1|||
160971214|NCT02247804|581285527|FG002|Treatment Period 1|Randomized but not Treated|1|||
160971215|NCT02247804|581285525|FG000|Treatment Period 2|Adverse Event|6|||
160971216|NCT02247804|581285526|FG001|Treatment Period 2|Adverse Event|3|||
160971217|NCT02247804|581285527|FG002|Treatment Period 2|Adverse Event|3|||
160971218|NCT02247804|581285525|FG000|Treatment Period 2|Lack of Efficacy|0|||
160971219|NCT02247804|581285526|FG001|Treatment Period 2|Lack of Efficacy|0|||
160971220|NCT02247804|581285527|FG002|Treatment Period 2|Lack of Efficacy|1|||
161274094|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274095|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274096|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274097|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274098|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274099|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274100|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
160971221|NCT02247804|581285525|FG000|Treatment Period 2|Lost to Follow-up|0|||
160971222|NCT02247804|581285526|FG001|Treatment Period 2|Lost to Follow-up|1|||
160971223|NCT02247804|581285527|FG002|Treatment Period 2|Lost to Follow-up|1|||
160971224|NCT02247804|581285525|FG000|Treatment Period 2|Personal Reasons|2|||
160971225|NCT02247804|581285526|FG001|Treatment Period 2|Personal Reasons|1|||
160971226|NCT02247804|581285527|FG002|Treatment Period 2|Personal Reasons|1|||
160971227|NCT02247804|581285525|FG000|Treatment Period 2|Reason not Specified|0|||
161023929|NCT06182033|581477381|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
161343630|NCT04896385|582644435|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
160971228|NCT02247804|581285526|FG001|Treatment Period 2|Reason not Specified|0|||
160971229|NCT02247804|581285527|FG002|Treatment Period 2|Reason not Specified|2|||
160971230|NCT02247804|581285525|FG000|Treatment Period 3|Adverse Event|4|||
160971231|NCT02247804|581285526|FG001|Treatment Period 3|Adverse Event|3|||
160971232|NCT02247804|581285527|FG002|Treatment Period 3|Adverse Event|3|||
160971233|NCT02247804|581285525|FG000|Treatment Period 3|Lack of Efficacy|0|||
160971234|NCT02247804|581285526|FG001|Treatment Period 3|Lack of Efficacy|1|||
160971235|NCT02247804|581285527|FG002|Treatment Period 3|Lack of Efficacy|0|||
160971236|NCT02247804|581285525|FG000|Treatment Period 3|Lost to Follow-up|1|||
160971237|NCT02247804|581285526|FG001|Treatment Period 3|Lost to Follow-up|2|||
160971238|NCT02247804|581285527|FG002|Treatment Period 3|Lost to Follow-up|2|||
161274101|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
161274102|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
161274103|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
161274104|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274105|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274106|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274107|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274108|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274109|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274110|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274111|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274112|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274113|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
161274114|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160971239|NCT02247804|581285525|FG000|Treatment Period 3|Personal Reasons|4|||
160971240|NCT02247804|581285526|FG001|Treatment Period 3|Personal Reasons|3|||
160971241|NCT02247804|581285527|FG002|Treatment Period 3|Personal Reasons|2|||
161274115|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
160971242|NCT02247804|581285525|FG000|Treatment Period 3|Reason not Specified|2|||
160971243|NCT02247804|581285526|FG001|Treatment Period 3|Reason not Specified|1|||
160971244|NCT02247804|581285527|FG002|Treatment Period 3|Reason not Specified|3|||
160971245|NCT01346514|581285530|FG000|Overall Study|Lost to Follow-up|19|||
160971246|NCT01346514|581285531|FG001|Overall Study|Lost to Follow-up|30|||
160971247|NCT01346514|581285530|FG000|Overall Study|Withdrawal by Subject|7|||
160971248|NCT01346514|581285531|FG001|Overall Study|Withdrawal by Subject|3|||
160971249|NCT01346514|581285530|FG000|Overall Study|Death|3|||
160971250|NCT01346514|581285531|FG001|Overall Study|Death|4|||
160971251|NCT00909480|581285532|FG000|Overall Study|Adverse Event|5|||
160971252|NCT00909480|581285533|FG001|Overall Study|Adverse Event|3|||
160971253|NCT00909480|581285532|FG000|Overall Study|Protocol Violation|6|||
160971254|NCT00909480|581285533|FG001|Overall Study|Protocol Violation|8|||
160971255|NCT00909480|581285532|FG000|Overall Study|Withdrawal criteria|9|||
160971256|NCT00909480|581285533|FG001|Overall Study|Withdrawal criteria|11|||
160971257|NCT00909480|581285532|FG000|Overall Study|Unclassified|18|||
160971258|NCT00909480|581285533|FG001|Overall Study|Unclassified|19|||
160971259|NCT03002038|581285537|FG000|Overall Study|Adverse Event|3|||
160971260|NCT03002038|581285538|FG001|Overall Study|Adverse Event|1|||
160971261|NCT03002038|581285537|FG000|Overall Study|Withdrawal by Subject|8|||
160971262|NCT03002038|581285538|FG001|Overall Study|Withdrawal by Subject|4|||
160971263|NCT03002038|581285537|FG000|Overall Study|Immigration to another region|0|||
160971264|NCT03002038|581285538|FG001|Overall Study|Immigration to another region|2|||
160971265|NCT01054573|581285539|FG000|Overall Study|Adverse Event|1|||
160971266|NCT01054573|581285540|FG001|Overall Study|Adverse Event|0|||
160971267|NCT01054573|581285541|FG002|Overall Study|Adverse Event|1|||
160971268|NCT01054573|581285542|FG003|Overall Study|Adverse Event|1|||
160971269|NCT01054573|581285539|FG000|Overall Study|Lost to Follow-up|0|||
160971270|NCT01054573|581285540|FG001|Overall Study|Lost to Follow-up|2|||
160971271|NCT01054573|581285541|FG002|Overall Study|Lost to Follow-up|0|||
160971272|NCT01054573|581285542|FG003|Overall Study|Lost to Follow-up|0|||
160971273|NCT01054573|581285539|FG000|Overall Study|Withdrawal by Subject|0|||
160971274|NCT01054573|581285540|FG001|Overall Study|Withdrawal by Subject|2|||
160971275|NCT01054573|581285541|FG002|Overall Study|Withdrawal by Subject|2|||
160971276|NCT01054573|581285542|FG003|Overall Study|Withdrawal by Subject|1|||
160971277|NCT03812536|581285543|FG000|Overall Study|Protocol Violation|2|||
160971278|NCT03812536|581285544|FG001|Overall Study|Protocol Violation|0|||
160971279|NCT03812536|581285543|FG000|Overall Study|Withdrawal by Subject|1|||
160971280|NCT03812536|581285544|FG001|Overall Study|Withdrawal by Subject|1|||
160971281|NCT00152009|581285545|FG000|Overall Study|Adverse Event|9|||
160971282|NCT00152009|581285546|FG001|Overall Study|Adverse Event|13|||
160971283|NCT00152009|581285547|FG002|Overall Study|Adverse Event|20|||
160971284|NCT00152009|581285548|FG003|Overall Study|Adverse Event|1|||
160971285|NCT00152009|581285545|FG000|Overall Study|Protocol Violation|3|||
160971286|NCT00152009|581285546|FG001|Overall Study|Protocol Violation|0|||
160971287|NCT00152009|581285547|FG002|Overall Study|Protocol Violation|0|||
160971288|NCT00152009|581285548|FG003|Overall Study|Protocol Violation|1|||
160971289|NCT00152009|581285545|FG000|Overall Study|Withdrawal by Subject|2|||
160971290|NCT00152009|581285546|FG001|Overall Study|Withdrawal by Subject|3|||
160971291|NCT00152009|581285547|FG002|Overall Study|Withdrawal by Subject|4|||
160971292|NCT00152009|581285548|FG003|Overall Study|Withdrawal by Subject|9|||
160971293|NCT00152009|581285545|FG000|Overall Study|Lost to Follow-up|2|||
160971294|NCT00152009|581285546|FG001|Overall Study|Lost to Follow-up|4|||
160971295|NCT00152009|581285547|FG002|Overall Study|Lost to Follow-up|3|||
160971296|NCT00152009|581285548|FG003|Overall Study|Lost to Follow-up|3|||
160971297|NCT00152009|581285545|FG000|Overall Study|Lack of Efficacy|8|||
160971298|NCT00152009|581285546|FG001|Overall Study|Lack of Efficacy|6|||
160971299|NCT00152009|581285547|FG002|Overall Study|Lack of Efficacy|7|||
160971300|NCT00152009|581285548|FG003|Overall Study|Lack of Efficacy|15|||
160971301|NCT00152009|581285545|FG000|Overall Study|ECG abnormalities|2|||
160971302|NCT00152009|581285546|FG001|Overall Study|ECG abnormalities|2|||
160971303|NCT00152009|581285547|FG002|Overall Study|ECG abnormalities|2|||
160971304|NCT00152009|581285548|FG003|Overall Study|ECG abnormalities|1|||
160971305|NCT00152009|581285545|FG000|Overall Study|Sponsor's decision|3|||
160971306|NCT00152009|581285546|FG001|Overall Study|Sponsor's decision|3|||
160971307|NCT00152009|581285547|FG002|Overall Study|Sponsor's decision|1|||
160971308|NCT00152009|581285548|FG003|Overall Study|Sponsor's decision|3|||
160971309|NCT01306201|581285549|FG000|Overall Study|Arrhythmia|4|||
160971310|NCT01306201|581285549|FG000|Overall Study|Files could not be processed|3|||
160971311|NCT01306201|581285549|FG000|Overall Study|Files unreadable|3|||
160971312|NCT00393523|581285550|FG000|Overall Study|Lost to Follow-up|0|||
160971313|NCT00393523|581285551|FG001|Overall Study|Lost to Follow-up|0|||
160971314|NCT00393523|581285552|FG002|Overall Study|Lost to Follow-up|0|||
160971315|NCT00393523|581285553|FG003|Overall Study|Lost to Follow-up|2|||
160971316|NCT00393523|581285554|FG004|Overall Study|Lost to Follow-up|1|||
160971317|NCT00393523|581285550|FG000|Overall Study|Protocol Violation|6|||
160971318|NCT00393523|581285551|FG001|Overall Study|Protocol Violation|2|||
160971319|NCT00393523|581285552|FG002|Overall Study|Protocol Violation|0|||
160971320|NCT00393523|581285553|FG003|Overall Study|Protocol Violation|1|||
160971321|NCT00393523|581285554|FG004|Overall Study|Protocol Violation|0|||
160971322|NCT00393523|581285550|FG000|Overall Study|Withdrawal by Subject|6|||
160971323|NCT00393523|581285551|FG001|Overall Study|Withdrawal by Subject|7|||
160971324|NCT00393523|581285552|FG002|Overall Study|Withdrawal by Subject|2|||
160971325|NCT00393523|581285553|FG003|Overall Study|Withdrawal by Subject|3|||
160971326|NCT00393523|581285554|FG004|Overall Study|Withdrawal by Subject|0|||
160971327|NCT00393523|581285550|FG000|Overall Study|Difficulties in specimen collection|0|||
160971328|NCT00393523|581285551|FG001|Overall Study|Difficulties in specimen collection|0|||
160971329|NCT00393523|581285552|FG002|Overall Study|Difficulties in specimen collection|1|||
160971330|NCT00393523|581285553|FG003|Overall Study|Difficulties in specimen collection|0|||
160971331|NCT00393523|581285554|FG004|Overall Study|Difficulties in specimen collection|0|||
160971332|NCT00393523|581285550|FG000|Overall Study|Vaccine supply issue|0|||
160971333|NCT00393523|581285551|FG001|Overall Study|Vaccine supply issue|0|||
160971334|NCT00393523|581285552|FG002|Overall Study|Vaccine supply issue|1|||
160971335|NCT00393523|581285553|FG003|Overall Study|Vaccine supply issue|0|||
160971336|NCT00393523|581285554|FG004|Overall Study|Vaccine supply issue|0|||
160971337|NCT01735396|581285560|FG000|Overall Study|not evaluable|1|||
160971338|NCT00980005|581285563|FG000|Overall Study|Withdrawal by Subject|6|||
160971339|NCT00980005|581285564|FG001|Overall Study|Withdrawal by Subject|17|||
160971340|NCT00980005|581285563|FG000|Overall Study|Lost to Follow-up|37|||
160971341|NCT00980005|581285564|FG001|Overall Study|Lost to Follow-up|43|||
160971342|NCT00980005|581285563|FG000|Overall Study|Other|4|||
160971343|NCT00980005|581285564|FG001|Overall Study|Other|3|||
160971344|NCT00572624|581285565|FG000|Overall Study|Lost to Follow-up|10|||
160971345|NCT00572624|581285566|FG001|Overall Study|Lost to Follow-up|4|||
160971346|NCT00572624|581285565|FG000|Overall Study|Wanted to do a different diet program|1|||
160971347|NCT00572624|581285566|FG001|Overall Study|Wanted to do a different diet program|0|||
160971348|NCT00572624|581285565|FG000|Overall Study|Medication change|1|||
160971349|NCT00572624|581285566|FG001|Overall Study|Medication change|0|||
160971350|NCT00572624|581285565|FG000|Overall Study|Started a new job-- no time for study|1|||
160971351|NCT00572624|581285566|FG001|Overall Study|Started a new job-- no time for study|0|||
160971352|NCT00572624|581285565|FG000|Overall Study|Admitted to being a smoker|1|||
161023930|NCT06182033|581477380|FG000|Overall Study|Target child relocation|1|||
161023931|NCT06182033|581477381|FG001|Overall Study|Target child relocation|1|||
161023932|NCT06182033|581477380|FG000|Overall Study|Withdrawal by Subject|1|||
161274116|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
161274117|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
161274118|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274119|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274120|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161023933|NCT06182033|581477381|FG001|Overall Study|Withdrawal by Subject|0|||
161023934|NCT02626533|581477383|FG000|Overall Study|Protocol Violation|14|||
161023935|NCT02626533|581477383|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
161023936|NCT02626533|581477383|FG000|Overall Study|Withdrawal by Subject|1|||
161023937|NCT05576155|581477386|FG000|Overall Study|Withdrawal by Subject|1|||
161023938|NCT05576155|581477387|FG001|Overall Study|Withdrawal by Subject|1|||
161274121|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274122|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160971353|NCT00572624|581285566|FG001|Overall Study|Admitted to being a smoker|0|||
160971354|NCT00572624|581285565|FG000|Overall Study|Refused to do the stress test|1|||
160971355|NCT00572624|581285566|FG001|Overall Study|Refused to do the stress test|0|||
160971356|NCT00572624|581285565|FG000|Overall Study|Problem with vascular access|1|||
161023939|NCT04515849|581477388|FG000|Overall Study|Adverse Event|0|||
161023940|NCT04515849|581477389|FG001|Overall Study|Adverse Event|0|||
161023941|NCT04515849|581477390|FG002|Overall Study|Adverse Event|0|||
161023942|NCT04515849|581477391|FG003|Overall Study|Adverse Event|1|||
161023943|NCT04515849|581477392|FG004|Overall Study|Adverse Event|2|||
161023944|NCT04515849|581477388|FG000|Overall Study|Death|2|||
161023945|NCT04515849|581477389|FG001|Overall Study|Death|0|||
161023946|NCT04515849|581477390|FG002|Overall Study|Death|0|||
161023947|NCT04515849|581477391|FG003|Overall Study|Death|0|||
160971357|NCT00572624|581285566|FG001|Overall Study|Problem with vascular access|0|||
160971358|NCT00572624|581285565|FG000|Overall Study|Health issues unrelated to the study|1|||
160971359|NCT00572624|581285566|FG001|Overall Study|Health issues unrelated to the study|0|||
160971360|NCT00098254|581285571|FG000|Overall Study|Adverse Event|2|||
160971361|NCT00098254|581285571|FG000|Overall Study|Death|1|||
160971362|NCT02118337|581285572|FG000|Overall Study|Other|1|||
160971363|NCT02118337|581285573|FG001|Overall Study|Other|0|||
160971364|NCT02118337|581285574|FG002|Overall Study|Other|0|||
160971365|NCT02118337|581285575|FG003|Overall Study|Other|0|||
160971366|NCT02118337|581285576|FG004|Overall Study|Other|2|||
160971367|NCT02118337|581285577|FG005|Overall Study|Other|3|||
160971368|NCT02118337|581285578|FG006|Overall Study|Other|1|||
160971369|NCT02118337|581285579|FG007|Overall Study|Other|28|||
160971370|NCT02118337|581285580|FG008|Overall Study|Other|15|||
160971371|NCT02118337|581285572|FG000|Overall Study|Lost to Follow-up|0|||
160971372|NCT02118337|581285573|FG001|Overall Study|Lost to Follow-up|0|||
160971373|NCT02118337|581285574|FG002|Overall Study|Lost to Follow-up|0|||
160971374|NCT02118337|581285575|FG003|Overall Study|Lost to Follow-up|0|||
160971375|NCT02118337|581285576|FG004|Overall Study|Lost to Follow-up|0|||
160971376|NCT02118337|581285577|FG005|Overall Study|Lost to Follow-up|0|||
160971377|NCT02118337|581285578|FG006|Overall Study|Lost to Follow-up|0|||
160971378|NCT02118337|581285579|FG007|Overall Study|Lost to Follow-up|1|||
160971379|NCT02118337|581285580|FG008|Overall Study|Lost to Follow-up|0|||
160971380|NCT02118337|581285572|FG000|Overall Study|Withdrawal by Subject|1|||
160971381|NCT02118337|581285573|FG001|Overall Study|Withdrawal by Subject|3|||
160971382|NCT02118337|581285574|FG002|Overall Study|Withdrawal by Subject|2|||
160971383|NCT02118337|581285575|FG003|Overall Study|Withdrawal by Subject|1|||
160971384|NCT02118337|581285576|FG004|Overall Study|Withdrawal by Subject|2|||
160971385|NCT02118337|581285577|FG005|Overall Study|Withdrawal by Subject|2|||
160971386|NCT02118337|581285578|FG006|Overall Study|Withdrawal by Subject|1|||
160971387|NCT02118337|581285579|FG007|Overall Study|Withdrawal by Subject|4|||
160971388|NCT02118337|581285580|FG008|Overall Study|Withdrawal by Subject|2|||
160971389|NCT02118337|581285572|FG000|Overall Study|Death|2|||
160971390|NCT02118337|581285573|FG001|Overall Study|Death|2|||
160971391|NCT02118337|581285574|FG002|Overall Study|Death|1|||
160971392|NCT02118337|581285575|FG003|Overall Study|Death|2|||
160971393|NCT02118337|581285576|FG004|Overall Study|Death|5|||
160971394|NCT02118337|581285577|FG005|Overall Study|Death|1|||
160971395|NCT02118337|581285578|FG006|Overall Study|Death|2|||
160971396|NCT02118337|581285579|FG007|Overall Study|Death|9|||
160971397|NCT02118337|581285580|FG008|Overall Study|Death|4|||
160971398|NCT00130793|581285582|FG000|Overall Study|Lost to Follow-up|1|||
160971399|NCT00130793|581285583|FG001|Overall Study|Lost to Follow-up|4|||
160971400|NCT00130793|581285582|FG000|Overall Study|Withdrew consent|2|||
160971401|NCT00130793|581285583|FG001|Overall Study|Withdrew consent|0|||
160971402|NCT00211237|581285584|FG000|Baseline|Withdrew|1|||
160971403|NCT00211237|581285585|FG001|Baseline|Withdrew|3|||
160971404|NCT00211237|581285586|FG002|Baseline|Withdrew|0|||
160971405|NCT00211237|581285584|FG000|Baseline|Refused random assignment|1|||
160971406|NCT00211237|581285585|FG001|Baseline|Refused random assignment|0|||
160971407|NCT00211237|581285586|FG002|Baseline|Refused random assignment|0|||
160971408|NCT00211237|581285584|FG000|1 Month|Death|2|||
160971409|NCT00211237|581285585|FG001|1 Month|Death|1|||
160971410|NCT00211237|581285586|FG002|1 Month|Death|0|||
160971411|NCT00211237|581285584|FG000|1 Month|Lost to Follow-up|0|||
160971412|NCT00211237|581285585|FG001|1 Month|Lost to Follow-up|2|||
160971413|NCT00211237|581285586|FG002|1 Month|Lost to Follow-up|0|||
160971414|NCT00211237|581285584|FG000|1 Month|Withdrew|0|||
160971415|NCT00211237|581285585|FG001|1 Month|Withdrew|4|||
160971416|NCT00211237|581285586|FG002|1 Month|Withdrew|0|||
160971417|NCT00211237|581285584|FG000|1 Month|Additional surgery needed|1|||
160971418|NCT00211237|581285585|FG001|1 Month|Additional surgery needed|0|||
160971419|NCT00211237|581285586|FG002|1 Month|Additional surgery needed|0|||
160971420|NCT00211237|581285584|FG000|1 Month|Non-medical problem|0|||
161023948|NCT04515849|581477392|FG004|Overall Study|Death|0|||
161023949|NCT04515849|581477388|FG000|Overall Study|Other:family emergency|0|||
161148696|NCT01912872|581926133|FG001|Overall Study|Other unspecified|1|||
160971421|NCT00211237|581285585|FG001|1 Month|Non-medical problem|2|||
160971422|NCT00211237|581285586|FG002|1 Month|Non-medical problem|0|||
160971423|NCT00211237|581285584|FG000|3 Months|Death|7|||
160971424|NCT00211237|581285585|FG001|3 Months|Death|3|||
160971425|NCT00211237|581285586|FG002|3 Months|Death|0|||
160971426|NCT00211237|581285584|FG000|3 Months|Could not comply with protocol|1|||
160971427|NCT00211237|581285585|FG001|3 Months|Could not comply with protocol|0|||
160971428|NCT00211237|581285586|FG002|3 Months|Could not comply with protocol|0|||
160971429|NCT00211237|581285584|FG000|3 Months|Withdrew|0|||
160971430|NCT00211237|581285585|FG001|3 Months|Withdrew|1|||
160971431|NCT00211237|581285586|FG002|3 Months|Withdrew|0|||
160971432|NCT00211237|581285584|FG000|3 Months|Non-medical problem|0|||
160971433|NCT00211237|581285585|FG001|3 Months|Non-medical problem|0|||
160971434|NCT00211237|581285586|FG002|3 Months|Non-medical problem|1|||
160971435|NCT00211237|581285584|FG000|6 Months|Death|6|||
160971436|NCT00211237|581285585|FG001|6 Months|Death|0|||
160971437|NCT00211237|581285586|FG002|6 Months|Death|3|||
160971438|NCT00211237|581285584|FG000|6 Months|Lost to Follow-up|2|||
160971439|NCT00211237|581285585|FG001|6 Months|Lost to Follow-up|0|||
160971440|NCT00211237|581285586|FG002|6 Months|Lost to Follow-up|0|||
160971441|NCT00211237|581285584|FG000|6 Months|Could not comply with protocol|0|||
160971442|NCT00211237|581285585|FG001|6 Months|Could not comply with protocol|2|||
160971443|NCT00211237|581285586|FG002|6 Months|Could not comply with protocol|0|||
160971444|NCT00211237|581285584|FG000|12 Months|Death|8|||
160971445|NCT00211237|581285585|FG001|12 Months|Death|2|||
160971446|NCT00211237|581285586|FG002|12 Months|Death|3|||
160971447|NCT00211237|581285584|FG000|12 Months|Lost to Follow-up|1|||
160971448|NCT00211237|581285585|FG001|12 Months|Lost to Follow-up|0|||
160971449|NCT00211237|581285586|FG002|12 Months|Lost to Follow-up|1|||
160971450|NCT00211237|581285584|FG000|12 Months|Withdrew|0|||
160971451|NCT00211237|581285585|FG001|12 Months|Withdrew|0|||
160971452|NCT00211237|581285586|FG002|12 Months|Withdrew|1|||
160971453|NCT00211237|581285584|FG000|12 Months|unrelated medical problem|0|||
160971454|NCT00211237|581285585|FG001|12 Months|unrelated medical problem|0|||
160971455|NCT00211237|581285586|FG002|12 Months|unrelated medical problem|1|||
160971456|NCT01003639|581285589|FG000|Overall Study|Lost to Follow-up|6|||
160971457|NCT01003639|581285590|FG001|Overall Study|Lost to Follow-up|9|||
160971458|NCT01003639|581285589|FG000|Overall Study|Withdrawal by Subject|9|||
160971459|NCT01003639|581285590|FG001|Overall Study|Withdrawal by Subject|5|||
160971460|NCT01003639|581285589|FG000|Overall Study|Lack of Efficacy|1|||
160971461|NCT01003639|581285590|FG001|Overall Study|Lack of Efficacy|6|||
160971462|NCT01003639|581285589|FG000|Overall Study|Adverse Event|0|||
160971463|NCT01003639|581285590|FG001|Overall Study|Adverse Event|1|||
160971464|NCT01003639|581285589|FG000|Overall Study|Protocol Violation|0|||
160971465|NCT01003639|581285590|FG001|Overall Study|Protocol Violation|1|||
160971466|NCT01003639|581285589|FG000|Overall Study|Physician Decision|1|||
160971467|NCT01003639|581285590|FG001|Overall Study|Physician Decision|0|||
160971468|NCT03724396|581285591|FG000|Overall Study|Lost to Follow-up|1|||
160971469|NCT03724396|581285592|FG001|Overall Study|Lost to Follow-up|1|||
160971470|NCT03724396|581285591|FG000|Overall Study|Withdrawal by Subject|1|||
160971471|NCT03724396|581285592|FG001|Overall Study|Withdrawal by Subject|0|||
160971472|NCT02237508|581285594|FG000|Overall Study|Withdrawal by Subject|0|||
160971473|NCT02237508|581285595|FG001|Overall Study|Withdrawal by Subject|2|||
160971474|NCT02237508|581285596|FG002|Overall Study|Withdrawal by Subject|0|||
160971475|NCT02237508|581285597|FG003|Overall Study|Withdrawal by Subject|1|||
160971476|NCT02237508|581285598|FG004|Overall Study|Withdrawal by Subject|0|||
160971477|NCT02237508|581285599|FG005|Overall Study|Withdrawal by Subject|1|||
160971478|NCT02237508|581285600|FG006|Overall Study|Withdrawal by Subject|1|||
160971479|NCT02237508|581285601|FG007|Overall Study|Withdrawal by Subject|0|||
160971480|NCT02237508|581285602|FG008|Overall Study|Withdrawal by Subject|1|||
160971481|NCT02237508|581285603|FG009|Overall Study|Withdrawal by Subject|0|||
160971482|NCT02237508|581285594|FG000|Overall Study|Physician Decision|0|||
160971483|NCT02237508|581285595|FG001|Overall Study|Physician Decision|1|||
160971484|NCT02237508|581285596|FG002|Overall Study|Physician Decision|0|||
160971485|NCT02237508|581285597|FG003|Overall Study|Physician Decision|0|||
160971486|NCT02237508|581285598|FG004|Overall Study|Physician Decision|0|||
160971487|NCT02237508|581285599|FG005|Overall Study|Physician Decision|0|||
160971488|NCT02237508|581285600|FG006|Overall Study|Physician Decision|0|||
160971489|NCT02237508|581285601|FG007|Overall Study|Physician Decision|0|||
160971490|NCT02237508|581285602|FG008|Overall Study|Physician Decision|0|||
160971491|NCT02237508|581285603|FG009|Overall Study|Physician Decision|0|||
160971492|NCT02237508|581285594|FG000|Overall Study|Protocol Violation|0|||
160971493|NCT02237508|581285595|FG001|Overall Study|Protocol Violation|0|||
160971494|NCT02237508|581285596|FG002|Overall Study|Protocol Violation|1|||
160971495|NCT02237508|581285597|FG003|Overall Study|Protocol Violation|0|||
160971496|NCT02237508|581285598|FG004|Overall Study|Protocol Violation|0|||
160971497|NCT02237508|581285599|FG005|Overall Study|Protocol Violation|0|||
160971498|NCT02237508|581285600|FG006|Overall Study|Protocol Violation|0|||
160971499|NCT02237508|581285601|FG007|Overall Study|Protocol Violation|0|||
160971500|NCT02237508|581285602|FG008|Overall Study|Protocol Violation|0|||
160971501|NCT02237508|581285603|FG009|Overall Study|Protocol Violation|0|||
160971502|NCT01650519|581285604|FG000|Overall Study|Withdrawal by Subject|1|||
160971503|NCT01650519|581285605|FG001|Overall Study|Withdrawal by Subject|0|||
160971504|NCT04000594|581285607|FG000|Overall Study|Withdrawal by Subject|1|||
160971505|NCT04000594|581285608|FG001|Overall Study|Withdrawal by Subject|0|||
160971506|NCT04000594|581285609|FG002|Overall Study|Withdrawal by Subject|0|||
160971507|NCT03489057|581285610|FG000|Overall Study|Lost to Follow-up|16|||
160971508|NCT03489057|581285611|FG001|Overall Study|Lost to Follow-up|16|||
160971509|NCT03489057|581285612|FG002|Overall Study|Lost to Follow-up|14|||
160971510|NCT03489057|581285613|FG003|Overall Study|Lost to Follow-up|14|||
160971511|NCT03489057|581285610|FG000|Overall Study|Withdrawal by Subject|12|||
160971512|NCT03489057|581285611|FG001|Overall Study|Withdrawal by Subject|12|||
160971513|NCT03489057|581285612|FG002|Overall Study|Withdrawal by Subject|8|||
160971514|NCT03489057|581285613|FG003|Overall Study|Withdrawal by Subject|8|||
160971515|NCT03489057|581285610|FG000|Overall Study|Protocol Violation|7|||
160971516|NCT03489057|581285611|FG001|Overall Study|Protocol Violation|7|||
160971517|NCT03489057|581285612|FG002|Overall Study|Protocol Violation|2|||
160971518|NCT03489057|581285613|FG003|Overall Study|Protocol Violation|2|||
160971519|NCT00779779|581285616|FG000|Overall Study|Adverse Event|1|||
160971520|NCT00779779|581285616|FG000|Overall Study|Protocol Violation|14|||
160971521|NCT00779779|581285616|FG000|Overall Study|Withdrawal by Subject|4|||
160971522|NCT00779779|581285616|FG000|Overall Study|Lost to Follow-up|5|||
160971523|NCT01395823|581285617|FG000|Overall Study|Death|4|||
160971524|NCT01395823|581285618|FG001|Overall Study|Death|4|||
160971525|NCT01395823|581285617|FG000|Overall Study|Physician Decision|3|||
160971526|NCT01395823|581285618|FG001|Overall Study|Physician Decision|1|||
160971527|NCT01395823|581285617|FG000|Overall Study|Lost to Follow-up|1|||
160971528|NCT01395823|581285618|FG001|Overall Study|Lost to Follow-up|0|||
160971529|NCT01395823|581285617|FG000|Overall Study|Transplant|1|||
160971530|NCT01395823|581285618|FG001|Overall Study|Transplant|0|||
160971531|NCT01395823|581285617|FG000|Overall Study|GI symptoms|1|||
160971532|NCT01395823|581285618|FG001|Overall Study|GI symptoms|0|||
160971533|NCT01395823|581285617|FG000|Overall Study|Withdrawal by Subject|5|||
160971534|NCT01395823|581285618|FG001|Overall Study|Withdrawal by Subject|4|||
160971535|NCT01778556|581285619|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
160971536|NCT01778556|581285620|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
160971537|NCT01778556|581285619|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
160971538|NCT01778556|581285620|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
160971539|NCT01778556|581285619|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
160971540|NCT01778556|581285620|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
160971541|NCT01778556|581285619|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
160971542|NCT01778556|581285620|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
160971543|NCT03300570|581285622|FG000|Overall Study|Adverse Event|0|||
160971544|NCT03300570|581285623|FG001|Overall Study|Adverse Event|1|||
160971545|NCT03300570|581285622|FG000|Overall Study|Withdrawal by Subject|1|||
160971546|NCT03300570|581285623|FG001|Overall Study|Withdrawal by Subject|0|||
160971547|NCT03300570|581285622|FG000|Overall Study|Inadequate bowel prep|1|||
160971548|NCT03300570|581285623|FG001|Overall Study|Inadequate bowel prep|0|||
160971549|NCT00116272|581285624|FG000|Overall Study|Lost to Follow-up|11|||
160971550|NCT00116272|581285625|FG001|Overall Study|Lost to Follow-up|6|||
160971551|NCT00576732|581285626|FG000|DOUBLE BLIND|Adverse Event|0|||
160971552|NCT00576732|581285627|FG001|DOUBLE BLIND|Adverse Event|0|||
160971553|NCT00576732|581285628|FG002|DOUBLE BLIND|Adverse Event|1|||
160971554|NCT00576732|581285629|FG003|DOUBLE BLIND|Adverse Event|0|||
160971555|NCT00576732|581285630|FG004|DOUBLE BLIND|Adverse Event|0|||
160971556|NCT00576732|581285631|FG005|DOUBLE BLIND|Adverse Event|0|||
160971557|NCT00576732|581285626|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
160971558|NCT00576732|581285627|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
160971559|NCT00576732|581285628|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
160971560|NCT00576732|581285629|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
160971561|NCT00576732|581285630|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
160971562|NCT00576732|581285631|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
161023950|NCT04515849|581477389|FG001|Overall Study|Other:family emergency|0|||
161023951|NCT04515849|581477390|FG002|Overall Study|Other:family emergency|0|||
161023952|NCT04515849|581477391|FG003|Overall Study|Other:family emergency|1|||
161023953|NCT04515849|581477392|FG004|Overall Study|Other:family emergency|0|||
161023954|NCT04515849|581477388|FG000|Overall Study|Other:randomised by error|0|||
161023955|NCT04515849|581477389|FG001|Overall Study|Other:randomised by error|1|||
161023956|NCT04515849|581477390|FG002|Overall Study|Other:randomised by error|0|||
161023957|NCT04515849|581477391|FG003|Overall Study|Other:randomised by error|0|||
161023958|NCT04515849|581477392|FG004|Overall Study|Other:randomised by error|0|||
161023959|NCT04515849|581477388|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161023960|NCT04515849|581477389|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161023961|NCT04515849|581477390|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
161023962|NCT04515849|581477391|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
161023963|NCT04515849|581477392|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
160971563|NCT00576732|581285626|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
160971564|NCT00576732|581285627|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
160971565|NCT00576732|581285628|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
160971566|NCT00576732|581285629|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
160971567|NCT00576732|581285630|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
160971568|NCT00576732|581285631|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
160971569|NCT00576732|581285626|FG000|DOUBLE BLIND|OTHER|0|||
161023964|NCT04515849|581477388|FG000|Overall Study|Physician Decision|0|||
160971570|NCT00576732|581285627|FG001|DOUBLE BLIND|OTHER|2|||
160971571|NCT00576732|581285628|FG002|DOUBLE BLIND|OTHER|1|||
160971572|NCT00576732|581285629|FG003|DOUBLE BLIND|OTHER|0|||
160971573|NCT00576732|581285630|FG004|DOUBLE BLIND|OTHER|0|||
160971574|NCT00576732|581285631|FG005|DOUBLE BLIND|OTHER|0|||
160971575|NCT00576732|581285626|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
160971576|NCT00576732|581285627|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
160971577|NCT00576732|581285628|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
160971578|NCT00576732|581285629|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
160971579|NCT00576732|581285630|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
160971580|NCT00576732|581285631|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
160971581|NCT00576732|581285626|FG000|DOUBLE BLIND|Protocol Violation|1|||
160971582|NCT00576732|581285627|FG001|DOUBLE BLIND|Protocol Violation|0|||
160971583|NCT00576732|581285628|FG002|DOUBLE BLIND|Protocol Violation|0|||
160971584|NCT00576732|581285629|FG003|DOUBLE BLIND|Protocol Violation|0|||
160971585|NCT00576732|581285630|FG004|DOUBLE BLIND|Protocol Violation|0|||
160971586|NCT00576732|581285631|FG005|DOUBLE BLIND|Protocol Violation|0|||
160971587|NCT00576732|581285626|FG000|OPEN LABEL|Adverse Event|0|||
160971588|NCT00576732|581285627|FG001|OPEN LABEL|Adverse Event|0|||
160971589|NCT00576732|581285628|FG002|OPEN LABEL|Adverse Event|0|||
160971590|NCT00576732|581285629|FG003|OPEN LABEL|Adverse Event|4|||
160971591|NCT00576732|581285630|FG004|OPEN LABEL|Adverse Event|0|||
160971592|NCT00576732|581285631|FG005|OPEN LABEL|Adverse Event|1|||
160971593|NCT00576732|581285626|FG000|OPEN LABEL|Lost to Follow-up|0|||
160971594|NCT00576732|581285627|FG001|OPEN LABEL|Lost to Follow-up|0|||
160971595|NCT00576732|581285628|FG002|OPEN LABEL|Lost to Follow-up|0|||
160971596|NCT00576732|581285629|FG003|OPEN LABEL|Lost to Follow-up|2|||
160971597|NCT00576732|581285630|FG004|OPEN LABEL|Lost to Follow-up|1|||
160971598|NCT00576732|581285631|FG005|OPEN LABEL|Lost to Follow-up|1|||
160971599|NCT00576732|581285626|FG000|OPEN LABEL|Withdrawal by Subject|0|||
160971600|NCT00576732|581285627|FG001|OPEN LABEL|Withdrawal by Subject|0|||
160971601|NCT00576732|581285628|FG002|OPEN LABEL|Withdrawal by Subject|0|||
160971602|NCT00576732|581285629|FG003|OPEN LABEL|Withdrawal by Subject|1|||
160971603|NCT00576732|581285630|FG004|OPEN LABEL|Withdrawal by Subject|0|||
160971604|NCT00576732|581285631|FG005|OPEN LABEL|Withdrawal by Subject|1|||
160971605|NCT00576732|581285626|FG000|OPEN LABEL|OTHER|0|||
160971606|NCT00576732|581285627|FG001|OPEN LABEL|OTHER|0|||
160971607|NCT00576732|581285628|FG002|OPEN LABEL|OTHER|0|||
160971608|NCT00576732|581285629|FG003|OPEN LABEL|OTHER|0|||
160971609|NCT00576732|581285630|FG004|OPEN LABEL|OTHER|0|||
160971610|NCT00576732|581285631|FG005|OPEN LABEL|OTHER|2|||
160971611|NCT00576732|581285626|FG000|OPEN LABEL|Lack of Efficacy|0|||
160971612|NCT00576732|581285627|FG001|OPEN LABEL|Lack of Efficacy|0|||
160971613|NCT00576732|581285628|FG002|OPEN LABEL|Lack of Efficacy|0|||
160971614|NCT00576732|581285629|FG003|OPEN LABEL|Lack of Efficacy|2|||
160971615|NCT00576732|581285630|FG004|OPEN LABEL|Lack of Efficacy|2|||
160971616|NCT00576732|581285631|FG005|OPEN LABEL|Lack of Efficacy|3|||
160971617|NCT00576732|581285626|FG000|OPEN LABEL|Protocol Violation|0|||
160971618|NCT00576732|581285627|FG001|OPEN LABEL|Protocol Violation|0|||
160971619|NCT00576732|581285628|FG002|OPEN LABEL|Protocol Violation|0|||
160971620|NCT00576732|581285629|FG003|OPEN LABEL|Protocol Violation|2|||
160971621|NCT00576732|581285630|FG004|OPEN LABEL|Protocol Violation|1|||
160971622|NCT00576732|581285631|FG005|OPEN LABEL|Protocol Violation|0|||
160971623|NCT03188120|581285633|FG000|Overall Study|Adverse Event|4|||
160971624|NCT03188120|581285633|FG000|Overall Study|Insufficient Effectiveness|8|||
160971625|NCT03188120|581285633|FG000|Overall Study|Improved|12|||
160971626|NCT03188120|581285633|FG000|Overall Study|Lost to Follow-up|7|||
160971627|NCT03188120|581285633|FG000|Overall Study|Other than specified|3|||
160971628|NCT03188120|581285633|FG000|Overall Study|No visit after the first visit|13|||
160971629|NCT02296190|581285634|FG000|Overall Study|Lost to Follow-up|0|||
160971630|NCT02296190|581285635|FG001|Overall Study|Lost to Follow-up|0|||
160971631|NCT02296190|581285636|FG002|Overall Study|Lost to Follow-up|0|||
160971632|NCT02296190|581285637|FG003|Overall Study|Lost to Follow-up|0|||
161023965|NCT04515849|581477389|FG001|Overall Study|Physician Decision|1|||
161023966|NCT04515849|581477390|FG002|Overall Study|Physician Decision|0|||
160971633|NCT02296190|581285638|FG004|Overall Study|Lost to Follow-up|1|||
160971634|NCT02296190|581285639|FG005|Overall Study|Lost to Follow-up|0|||
160971635|NCT02296190|581285634|FG000|Overall Study|Failure to induce PSVT|6|||
160971636|NCT02296190|581285635|FG001|Overall Study|Failure to induce PSVT|10|||
160971637|NCT02296190|581285636|FG002|Overall Study|Failure to induce PSVT|5|||
161274123|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274124|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
160971638|NCT02296190|581285637|FG003|Overall Study|Failure to induce PSVT|13|||
160971639|NCT02296190|581285638|FG004|Overall Study|Failure to induce PSVT|8|||
160971640|NCT02296190|581285639|FG005|Overall Study|Failure to induce PSVT|0|||
160971641|NCT02296190|581285634|FG000|Overall Study|Physician Decision|1|||
160971642|NCT02296190|581285635|FG001|Overall Study|Physician Decision|1|||
160971643|NCT02296190|581285636|FG002|Overall Study|Physician Decision|0|||
160971644|NCT02296190|581285637|FG003|Overall Study|Physician Decision|1|||
160971645|NCT02296190|581285638|FG004|Overall Study|Physician Decision|2|||
160971646|NCT02296190|581285639|FG005|Overall Study|Physician Decision|0|||
160971647|NCT02296190|581285634|FG000|Overall Study|Withdrawal by Subject|0|||
160971648|NCT02296190|581285635|FG001|Overall Study|Withdrawal by Subject|1|||
160971649|NCT02296190|581285636|FG002|Overall Study|Withdrawal by Subject|0|||
160971650|NCT02296190|581285637|FG003|Overall Study|Withdrawal by Subject|0|||
160971651|NCT02296190|581285638|FG004|Overall Study|Withdrawal by Subject|0|||
160971652|NCT02296190|581285639|FG005|Overall Study|Withdrawal by Subject|0|||
160971653|NCT02296190|581285634|FG000|Overall Study|PSVT < 5 minutes|5|||
160971654|NCT02296190|581285635|FG001|Overall Study|PSVT < 5 minutes|6|||
160971655|NCT02296190|581285636|FG002|Overall Study|PSVT < 5 minutes|6|||
160971656|NCT02296190|581285637|FG003|Overall Study|PSVT < 5 minutes|6|||
160971657|NCT02296190|581285638|FG004|Overall Study|PSVT < 5 minutes|5|||
160971658|NCT02296190|581285639|FG005|Overall Study|PSVT < 5 minutes|0|||
160971659|NCT02296190|581285634|FG000|Overall Study|Patient was given Propofol|0|||
160971660|NCT02296190|581285635|FG001|Overall Study|Patient was given Propofol|1|||
161274125|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274126|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274127|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274128|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274129|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
161274130|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
161274131|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
161274132|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274133|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274134|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274135|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274136|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274137|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274138|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274139|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274140|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274141|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274142|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274143|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
161274144|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
161274145|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
161274146|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274147|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274148|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274149|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274150|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274151|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274152|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274153|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274154|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274155|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274156|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274157|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
161274158|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
161274159|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
161274160|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274161|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274162|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274163|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274164|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274165|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274166|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274167|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274168|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161343631|NCT04896385|582644432|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
160971661|NCT02296190|581285636|FG002|Overall Study|Patient was given Propofol|0|||
160971662|NCT02296190|581285637|FG003|Overall Study|Patient was given Propofol|1|||
160971663|NCT02296190|581285638|FG004|Overall Study|Patient was given Propofol|0|||
160971664|NCT02296190|581285639|FG005|Overall Study|Patient was given Propofol|0|||
160971665|NCT02296190|581285634|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
160971666|NCT02296190|581285635|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
160971667|NCT02296190|581285636|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
160971668|NCT02296190|581285637|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
160971669|NCT02296190|581285638|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
160971670|NCT02296190|581285639|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
160971671|NCT02296190|581285634|FG000|Overall Study|Blood pressure <100 after sedation|0|||
160971672|NCT02296190|581285635|FG001|Overall Study|Blood pressure <100 after sedation|0|||
160971673|NCT02296190|581285636|FG002|Overall Study|Blood pressure <100 after sedation|0|||
160971674|NCT02296190|581285637|FG003|Overall Study|Blood pressure <100 after sedation|1|||
160971675|NCT02296190|581285638|FG004|Overall Study|Blood pressure <100 after sedation|0|||
160971676|NCT02296190|581285639|FG005|Overall Study|Blood pressure <100 after sedation|0|||
160971677|NCT02296190|581285634|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971678|NCT02296190|581285635|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
160971679|NCT02296190|581285636|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
160971680|NCT02296190|581285637|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971681|NCT02296190|581285638|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971682|NCT02296190|581285639|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
160971683|NCT02296190|581285634|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
160971684|NCT02296190|581285635|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
160971685|NCT02296190|581285636|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
160971686|NCT02296190|581285637|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
160971687|NCT02296190|581285638|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
160971688|NCT02296190|581285639|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
160971689|NCT02296190|581285634|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971690|NCT02296190|581285635|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
160971691|NCT02296190|581285636|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971692|NCT02296190|581285637|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971693|NCT02296190|581285638|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971694|NCT02296190|581285639|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
160971695|NCT02296190|581285634|FG000|Overall Study|Lab result not available in time|1|||
160971696|NCT02296190|581285635|FG001|Overall Study|Lab result not available in time|0|||
160971697|NCT02296190|581285636|FG002|Overall Study|Lab result not available in time|0|||
160971698|NCT02296190|581285637|FG003|Overall Study|Lab result not available in time|0|||
160971699|NCT02296190|581285638|FG004|Overall Study|Lab result not available in time|0|||
160971700|NCT02296190|581285639|FG005|Overall Study|Lab result not available in time|0|||
160971701|NCT00265330|581285640|FG000|Overall Study|Adverse Event|41|||
160971702|NCT00265330|581285640|FG000|Overall Study|Lost to Follow-up|8|||
160971703|NCT00265330|581285640|FG000|Overall Study|Withdrawal by Subject|34|||
160971704|NCT00265330|581285640|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
160971705|NCT00265330|581285640|FG000|Overall Study|Lack of Efficacy|4|||
160971706|NCT00265330|581285640|FG000|Overall Study|Family Scheduling Conflicts|1|||
160971707|NCT00265330|581285640|FG000|Overall Study|Began Taking Formulary Geodon|1|||
160971708|NCT00265330|581285640|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
160971709|NCT00265330|581285640|FG000|Overall Study|Site Closed by Sponsor|1|||
160971710|NCT00265330|581285640|FG000|Overall Study|Principal Investigators Request|1|||
160971711|NCT00265330|581285640|FG000|Overall Study|Withdrew Consent|1|||
160971712|NCT00265330|581285640|FG000|Overall Study|Protocol Violation|1|||
160971713|NCT02178566|581285649|FG000|Overall Study|patient did not complete due to noncompliance|0|||
160971714|NCT02178566|581285650|FG001|Overall Study|patient did not complete due to noncompliance|1|||
160971715|NCT02658630|581285651|FG000|Overall Study|Withdrawal by Subject|4|||
160971716|NCT00682643|581285652|FG000|Overall Study|Adverse Event|12|||
160971717|NCT00682643|581285653|FG001|Overall Study|Adverse Event|23|||
160971718|NCT00682643|581285652|FG000|Overall Study|Lack of Efficacy|2|||
160971719|NCT00682643|581285653|FG001|Overall Study|Lack of Efficacy|0|||
160971720|NCT00682643|581285652|FG000|Overall Study|Protocol Violation|38|||
160971721|NCT00682643|581285653|FG001|Overall Study|Protocol Violation|76|||
160971722|NCT00682643|581285652|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
160971723|NCT00682643|581285653|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
160971724|NCT00682643|581285652|FG000|Overall Study|Lost to Follow-up|1|||
160971725|NCT00682643|581285653|FG001|Overall Study|Lost to Follow-up|6|||
160971726|NCT00682643|581285652|FG000|Overall Study|Physician Decision|2|||
160971727|NCT00682643|581285653|FG001|Overall Study|Physician Decision|6|||
160971728|NCT00682643|581285652|FG000|Overall Study|Withdrawal by Subject|19|||
160971729|NCT00682643|581285653|FG001|Overall Study|Withdrawal by Subject|53|||
160971730|NCT00682643|581285652|FG000|Overall Study|Did Not Receive Study Drug|1|||
160971731|NCT00682643|581285653|FG001|Overall Study|Did Not Receive Study Drug|1|||
160971732|NCT01875185|581285654|FG000|Overall Study|study was terminated|52|||
160971733|NCT01875185|581285655|FG001|Overall Study|study was terminated|48|||
160971734|NCT00085202|581285656|FG000|Overall Study|Still on therapy|2|||
160971735|NCT00085202|581285657|FG001|Overall Study|Still on therapy|0|||
160971736|NCT00085202|581285656|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
160971737|NCT00085202|581285657|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
160971738|NCT00085202|581285656|FG000|Overall Study|Excessive toxicity|6|||
160971739|NCT00085202|581285657|FG001|Overall Study|Excessive toxicity|5|||
160971740|NCT00085202|581285656|FG000|Overall Study|Non-specified|3|||
160971741|NCT00085202|581285657|FG001|Overall Study|Non-specified|5|||
161023967|NCT04515849|581477391|FG003|Overall Study|Physician Decision|0|||
160971742|NCT00085202|581285656|FG000|Overall Study|Withdrawal by Subject|2|||
160971743|NCT00085202|581285657|FG001|Overall Study|Withdrawal by Subject|1|||
160971744|NCT00085202|581285656|FG000|Overall Study|Physician Decision|4|||
160971745|NCT00085202|581285657|FG001|Overall Study|Physician Decision|1|||
160971746|NCT00085202|581285656|FG000|Overall Study|Progressive disease|1|||
160971747|NCT00085202|581285657|FG001|Overall Study|Progressive disease|11|||
160971748|NCT03238300|581285658|FG000|Baseline (Before Intervention)|Physician Decision|0|||
160971749|NCT03238300|581285659|FG001|Baseline (Before Intervention)|Physician Decision|1|||
160971750|NCT03238300|581285658|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
160971751|NCT03238300|581285659|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
160971752|NCT03238300|581285658|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
160971753|NCT03238300|581285659|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
160971754|NCT03238300|581285658|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
160971755|NCT03238300|581285659|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
160971756|NCT00386308|581287539|FG000|Overall Study|Adverse Event|3|||
160971757|NCT00386308|581287540|FG001|Overall Study|Adverse Event|3|||
160971758|NCT00386308|581287539|FG000|Overall Study|Protocol Violation|2|||
160971759|NCT00386308|581287540|FG001|Overall Study|Protocol Violation|5|||
160971760|NCT00386308|581287539|FG000|Overall Study|Lack of Efficacy|0|||
160971761|NCT00386308|581287540|FG001|Overall Study|Lack of Efficacy|2|||
161023968|NCT04515849|581477392|FG004|Overall Study|Physician Decision|0|||
161023969|NCT04515849|581477388|FG000|Overall Study|Withdrawal by Subject|1|||
161023970|NCT04515849|581477389|FG001|Overall Study|Withdrawal by Subject|2|||
161023971|NCT04515849|581477390|FG002|Overall Study|Withdrawal by Subject|1|||
161023972|NCT04515849|581477391|FG003|Overall Study|Withdrawal by Subject|0|||
161023973|NCT04515849|581477392|FG004|Overall Study|Withdrawal by Subject|0|||
161023974|NCT04049643|581477394|FG000|Overall Study|Lack of Efficacy|1|||
161274169|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274170|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274171|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
161274172|NCT03982199|582382554|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
161274173|NCT03982199|582382555|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
161274174|NCT03982199|582382556|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274175|NCT03982199|582382557|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274176|NCT03982199|582382558|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274177|NCT03982199|582382559|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274178|NCT03982199|582382560|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274179|NCT03982199|582382561|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274180|NCT03982199|582382562|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274181|NCT03982199|582382563|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274182|NCT03982199|582382564|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274183|NCT03982199|582382565|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274184|NCT03982199|582382566|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274185|NCT03982199|582382567|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
161274186|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274187|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274188|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274189|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
161274190|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274191|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274192|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274193|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274194|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274195|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274196|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274197|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274198|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274199|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
161274200|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274201|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274202|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
161274203|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160971762|NCT00386308|581287539|FG000|Overall Study|Lost to Follow-up|10|||
160971763|NCT00386308|581287540|FG001|Overall Study|Lost to Follow-up|6|||
160971764|NCT00386308|581287539|FG000|Overall Study|Withdrawal by Subject|6|||
160971765|NCT00386308|581287540|FG001|Overall Study|Withdrawal by Subject|2|||
161023975|NCT04049643|581477395|FG001|Overall Study|Lack of Efficacy|1|||
161023976|NCT04049643|581477396|FG002|Overall Study|Lack of Efficacy|0|||
161023977|NCT04049643|581477394|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161023978|NCT04049643|581477395|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
161023979|NCT04049643|581477396|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
161023980|NCT04081103|581477397|FG000|Overall Study|Adverse Event|1|||
161023981|NCT04081103|581477398|FG001|Overall Study|Adverse Event|1|||
161023982|NCT04081103|581477399|FG002|Overall Study|Adverse Event|1|||
161023983|NCT04081103|581477397|FG000|Overall Study|Physician Decision|0|||
161023984|NCT04081103|581477398|FG001|Overall Study|Physician Decision|0|||
161023985|NCT04081103|581477399|FG002|Overall Study|Physician Decision|1|||
161023986|NCT05623228|581477400|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
160971766|NCT00386308|581287539|FG000|Overall Study|Other Event|8|||
160971767|NCT00386308|581287540|FG001|Overall Study|Other Event|1|||
160971768|NCT03518658|581287541|FG000|Overall Study|Other|51|||
160971769|NCT03518658|581287542|FG001|Overall Study|Other|0|||
160971770|NCT00649389|581287543|FG000|Overall Study|Adverse Event|22|||
160971771|NCT00649389|581287544|FG001|Overall Study|Adverse Event|46|||
160971772|NCT00649389|581287545|FG002|Overall Study|Adverse Event|38|||
160971773|NCT00649389|581287546|FG003|Overall Study|Adverse Event|48|||
160971774|NCT00649389|581287543|FG000|Overall Study|Lost to Follow-up|15|||
160971775|NCT00649389|581287544|FG001|Overall Study|Lost to Follow-up|17|||
160971776|NCT00649389|581287545|FG002|Overall Study|Lost to Follow-up|21|||
160971777|NCT00649389|581287546|FG003|Overall Study|Lost to Follow-up|26|||
160971778|NCT00649389|581287543|FG000|Overall Study|Protocol Violation|11|||
160971779|NCT00649389|581287544|FG001|Overall Study|Protocol Violation|13|||
160971780|NCT00649389|581287545|FG002|Overall Study|Protocol Violation|9|||
160971781|NCT00649389|581287546|FG003|Overall Study|Protocol Violation|8|||
160971782|NCT00649389|581287543|FG000|Overall Study|Withdrawal by Subject|20|||
160971783|NCT00649389|581287544|FG001|Overall Study|Withdrawal by Subject|21|||
160971784|NCT00649389|581287545|FG002|Overall Study|Withdrawal by Subject|19|||
160971785|NCT00649389|581287546|FG003|Overall Study|Withdrawal by Subject|23|||
160971786|NCT00649389|581287543|FG000|Overall Study|Other|3|||
160971787|NCT00649389|581287544|FG001|Overall Study|Other|9|||
160971788|NCT00649389|581287545|FG002|Overall Study|Other|1|||
160971789|NCT00649389|581287546|FG003|Overall Study|Other|6|||
160971790|NCT02746575|581287549|FG000|Overall Study|Surgery cancelled or time chaned|13|||
160971791|NCT02746575|581287549|FG000|Overall Study|Received epidural|10|||
160971792|NCT02746575|581287549|FG000|Overall Study|Withdrawal by Subject|3|||
160971793|NCT02746575|581287549|FG000|Overall Study|Bradycardia/hypotension|9|||
160971794|NCT02746575|581287549|FG000|Overall Study|Study paused|8|||
160971795|NCT02746575|581287549|FG000|Overall Study|put on beta-blocker|3|||
160971796|NCT02746575|581287549|FG000|Overall Study|type of surgery|1|||
160971797|NCT02746575|581287549|FG000|Overall Study|typ of surgery|1|||
160971798|NCT02746575|581287549|FG000|Overall Study|PI unavailable|1|||
160971799|NCT02746575|581287549|FG000|Overall Study|Unknown history of CVA|1|||
160971800|NCT00976482|581287550|FG000|Overall Study|Death|208|||
160971801|NCT00976482|581287550|FG000|Overall Study|Withdrawal by Subject|45|||
160971802|NCT00976482|581287550|FG000|Overall Study|Center terminated|1|||
160971803|NCT00976482|581287550|FG000|Overall Study|Protocol Violation|5|||
160971804|NCT02959671|581287551|FG000|Overall Study|Adverse Event|2|||
160971805|NCT02959671|581287551|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
160971806|NCT00605319|581287557|FG000|Overall Study|Adverse Event|6|||
160971807|NCT00432835|581287560|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
160971808|NCT00432835|581287561|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
160971809|NCT02002884|581287563|FG000|Main Period (MP)|Other|0|||
160971810|NCT02002884|581287564|FG001|Main Period (MP)|Other|3|||
160971811|NCT02002884|581287565|FG002|Main Period (MP)|Other|3|||
160971812|NCT02002884|581287566|FG003|Main Period (MP)|Other|0|||
160971813|NCT02002884|581287563|FG000|Main Period (MP)|Adverse Event|0|||
160971814|NCT02002884|581287564|FG001|Main Period (MP)|Adverse Event|1|||
160971815|NCT02002884|581287565|FG002|Main Period (MP)|Adverse Event|1|||
160971816|NCT02002884|581287566|FG003|Main Period (MP)|Adverse Event|0|||
160971817|NCT02002884|581287563|FG000|Main Period (MP)|Withdrawal by Subject|6|||
160971818|NCT02002884|581287564|FG001|Main Period (MP)|Withdrawal by Subject|2|||
160971819|NCT02002884|581287565|FG002|Main Period (MP)|Withdrawal by Subject|2|||
160971820|NCT02002884|581287566|FG003|Main Period (MP)|Withdrawal by Subject|0|||
160971821|NCT02002884|581287563|FG000|Main Period (MP)|Lost to Follow-up|0|||
161023987|NCT05623228|581477401|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161274204|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274205|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161319369|NCT01410240|582555290|FG001|Overall Study|Missed week 6 assessments|1|||
160971822|NCT02002884|581287564|FG001|Main Period (MP)|Lost to Follow-up|0|||
160971823|NCT02002884|581287565|FG002|Main Period (MP)|Lost to Follow-up|2|||
160971824|NCT02002884|581287566|FG003|Main Period (MP)|Lost to Follow-up|0|||
161023988|NCT05623228|581477402|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
160971825|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Other|0|||
160971826|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Other|0|||
160971827|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Other|0|||
161148697|NCT01912872|581926134|FG002|Overall Study|Other unspecified|3|||
161148698|NCT01912872|581926135|FG003|Overall Study|Other unspecified|0|||
161148699|NCT01912872|581926132|FG000|Overall Study|Informed consent withdrawn|0|||
161148700|NCT01912872|581926133|FG001|Overall Study|Informed consent withdrawn|0|||
161148701|NCT01912872|581926134|FG002|Overall Study|Informed consent withdrawn|1|||
161148702|NCT01912872|581926135|FG003|Overall Study|Informed consent withdrawn|1|||
161148703|NCT01912872|581926132|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
161148704|NCT01912872|581926133|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
161148705|NCT01912872|581926134|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
161148706|NCT01912872|581926135|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
161148707|NCT01912872|581926132|FG000|Overall Study|Protocol Violation|0|||
161148708|NCT01912872|581926133|FG001|Overall Study|Protocol Violation|0|||
160971828|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Other|24|||
160971829|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
160971830|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
160971831|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
160971832|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
160971833|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
160971834|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
160971835|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
160971836|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
160971837|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
160971838|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
160971839|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
160971840|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
160971841|NCT02002884|581287563|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
160971842|NCT02002884|581287564|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
160971843|NCT02002884|581287565|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
160971844|NCT02002884|581287566|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
160971845|NCT00810082|581287570|FG000|Overall Study|Lost to Follow-up|0|||
160971846|NCT00810082|581287571|FG001|Overall Study|Lost to Follow-up|4|||
160971847|NCT01454830|581287574|FG000|Overall Study|Withdrawal by Subject|4|||
160971848|NCT01454830|581287575|FG001|Overall Study|Withdrawal by Subject|4|||
160971849|NCT01454830|581287574|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
160971850|NCT01454830|581287575|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
160971851|NCT01454830|581287574|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
160971852|NCT01454830|581287575|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
160971853|NCT01454830|581287574|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
160971854|NCT01454830|581287575|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
160971855|NCT01454830|581287574|FG000|Overall Study|Withdrawal - no polysomnography|3|||
160971856|NCT01454830|581287575|FG001|Overall Study|Withdrawal - no polysomnography|2|||
160971857|NCT00584805|581287576|FG000|Overall Study|No longer at risk of exposure|39|||
160971858|NCT00584805|581287576|FG000|Overall Study|Relocation|36|||
160971859|NCT00584805|581287576|FG000|Overall Study|Withdrawal by Subject|18|||
160971860|NCT00584805|581287576|FG000|Overall Study|Non-compliance|1|||
160971861|NCT00584805|581287576|FG000|Overall Study|Lost to follow up|3|||
160971862|NCT00584805|581287576|FG000|Overall Study|Screen failures|2|||
160971863|NCT02341456|581287577|FG000|Overall Study|Disease progression|2|||
160971864|NCT02341456|581287578|FG001|Overall Study|Disease progression|3|||
160971865|NCT02341456|581287579|FG002|Overall Study|Disease progression|1|||
160971866|NCT02341456|581287577|FG000|Overall Study|Death|1|||
160971867|NCT02341456|581287578|FG001|Overall Study|Death|1|||
160971868|NCT02341456|581287579|FG002|Overall Study|Death|1|||
160971869|NCT02341456|581287577|FG000|Overall Study|Withdrawal by Subject|0|||
160971870|NCT02341456|581287578|FG001|Overall Study|Withdrawal by Subject|1|||
160971871|NCT02341456|581287579|FG002|Overall Study|Withdrawal by Subject|1|||
160971872|NCT02341456|581287577|FG000|Overall Study|Moved to local access programme.|0|||
161148709|NCT01912872|581926134|FG002|Overall Study|Protocol Violation|1|||
161148710|NCT01912872|581926135|FG003|Overall Study|Protocol Violation|0|||
161148711|NCT01912872|581926132|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161148712|NCT01912872|581926133|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161148713|NCT01912872|581926134|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161148714|NCT01912872|581926135|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161148715|NCT01912872|581926132|FG000|Overall Study|Withdrawal of study medication|0|||
161148716|NCT01912872|581926133|FG001|Overall Study|Withdrawal of study medication|0|||
161148717|NCT01912872|581926134|FG002|Overall Study|Withdrawal of study medication|0|||
161148718|NCT01912872|581926135|FG003|Overall Study|Withdrawal of study medication|2|||
161319370|NCT01410240|582555291|FG002|Overall Study|Missed week 6 assessments|1|||
160971873|NCT02341456|581287578|FG001|Overall Study|Moved to local access programme.|1|||
160971874|NCT02341456|581287579|FG002|Overall Study|Moved to local access programme.|1|||
160971875|NCT02341456|581287577|FG000|Overall Study|Physician Decision|1|||
160971876|NCT02341456|581287578|FG001|Overall Study|Physician Decision|0|||
161148719|NCT01912872|581926132|FG000|Overall Study|Missing|0|||
160971877|NCT02341456|581287579|FG002|Overall Study|Physician Decision|0|||
160971878|NCT01077362|581287580|FG000|Overall Study|Lack of Efficacy|13|||
160971879|NCT01077362|581287581|FG001|Overall Study|Lack of Efficacy|8|||
160971880|NCT01077362|581287582|FG002|Overall Study|Lack of Efficacy|10|||
160971881|NCT01077362|581287580|FG000|Overall Study|Lost to Follow-up|1|||
160971882|NCT01077362|581287581|FG001|Overall Study|Lost to Follow-up|0|||
160971883|NCT01077362|581287582|FG002|Overall Study|Lost to Follow-up|3|||
160971884|NCT01077362|581287580|FG000|Overall Study|Adverse Event|12|||
160971885|NCT01077362|581287581|FG001|Overall Study|Adverse Event|7|||
160971886|NCT01077362|581287582|FG002|Overall Study|Adverse Event|4|||
160971887|NCT01077362|581287580|FG000|Overall Study|Withdrawal by Subject|5|||
160971888|NCT01077362|581287581|FG001|Overall Study|Withdrawal by Subject|3|||
160971889|NCT01077362|581287582|FG002|Overall Study|Withdrawal by Subject|5|||
160971890|NCT01077362|581287580|FG000|Overall Study|Other|0|||
160971891|NCT01077362|581287581|FG001|Overall Study|Other|1|||
160971892|NCT01077362|581287582|FG002|Overall Study|Other|2|||
160971893|NCT02508532|581287586|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971894|NCT02508532|581287587|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971895|NCT02508532|581287588|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971896|NCT02508532|581287589|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971897|NCT02508532|581287590|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971898|NCT02508532|581287591|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
161023989|NCT05623228|581477403|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023990|NCT05623228|581477404|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023991|NCT05623228|581477405|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023992|NCT05623228|581477406|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023993|NCT05623228|581477407|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
161023994|NCT05623228|581477400|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
161343632|NCT04896385|582644433|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
160971899|NCT02508532|581287592|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
160971900|NCT02508532|581287593|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971901|NCT02508532|581287594|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
160971902|NCT02508532|581287586|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971903|NCT02508532|581287587|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971904|NCT02508532|581287588|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971905|NCT02508532|581287589|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971906|NCT02508532|581287590|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971907|NCT02508532|581287591|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971908|NCT02508532|581287592|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971909|NCT02508532|581287593|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
160971910|NCT02508532|581287594|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
160971911|NCT02508532|581287586|FG000|Part 2 - Treatment|Disease Progression|0|||
160971912|NCT02508532|581287587|FG001|Part 2 - Treatment|Disease Progression|0|||
160971913|NCT02508532|581287588|FG002|Part 2 - Treatment|Disease Progression|0|||
160971914|NCT02508532|581287589|FG003|Part 2 - Treatment|Disease Progression|0|||
160971915|NCT02508532|581287590|FG004|Part 2 - Treatment|Disease Progression|0|||
160971916|NCT02508532|581287591|FG005|Part 2 - Treatment|Disease Progression|0|||
160971917|NCT02508532|581287592|FG006|Part 2 - Treatment|Disease Progression|0|||
160971918|NCT02508532|581287593|FG007|Part 2 - Treatment|Disease Progression|0|||
160971919|NCT02508532|581287594|FG008|Part 2 - Treatment|Disease Progression|118|||
160971920|NCT02508532|581287586|FG000|Part 2 - Treatment|Adverse Event|0|||
160971921|NCT02508532|581287587|FG001|Part 2 - Treatment|Adverse Event|0|||
160971922|NCT02508532|581287588|FG002|Part 2 - Treatment|Adverse Event|0|||
160971923|NCT02508532|581287589|FG003|Part 2 - Treatment|Adverse Event|0|||
160971924|NCT02508532|581287590|FG004|Part 2 - Treatment|Adverse Event|0|||
160971925|NCT02508532|581287591|FG005|Part 2 - Treatment|Adverse Event|0|||
160971926|NCT02508532|581287592|FG006|Part 2 - Treatment|Adverse Event|0|||
160971927|NCT02508532|581287593|FG007|Part 2 - Treatment|Adverse Event|0|||
160971928|NCT02508532|581287594|FG008|Part 2 - Treatment|Adverse Event|49|||
160971929|NCT02508532|581287586|FG000|Part 2 - Treatment|Physician Decision|0|||
160971930|NCT02508532|581287587|FG001|Part 2 - Treatment|Physician Decision|0|||
160971931|NCT02508532|581287588|FG002|Part 2 - Treatment|Physician Decision|0|||
160971932|NCT02508532|581287589|FG003|Part 2 - Treatment|Physician Decision|0|||
160971933|NCT02508532|581287590|FG004|Part 2 - Treatment|Physician Decision|0|||
160971934|NCT02508532|581287591|FG005|Part 2 - Treatment|Physician Decision|0|||
160971935|NCT02508532|581287592|FG006|Part 2 - Treatment|Physician Decision|0|||
160971936|NCT02508532|581287593|FG007|Part 2 - Treatment|Physician Decision|0|||
160971937|NCT02508532|581287594|FG008|Part 2 - Treatment|Physician Decision|12|||
160971938|NCT02508532|581287586|FG000|Part 2 - Treatment|Administrative|0|||
161023995|NCT05623228|581477401|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161148720|NCT01912872|581926133|FG001|Overall Study|Missing|0|||
161343633|NCT04896385|582644434|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
160971939|NCT02508532|581287587|FG001|Part 2 - Treatment|Administrative|0|||
160971940|NCT02508532|581287588|FG002|Part 2 - Treatment|Administrative|0|||
160971941|NCT02508532|581287589|FG003|Part 2 - Treatment|Administrative|0|||
160971942|NCT02508532|581287590|FG004|Part 2 - Treatment|Administrative|0|||
160971943|NCT02508532|581287591|FG005|Part 2 - Treatment|Administrative|0|||
160971944|NCT02508532|581287592|FG006|Part 2 - Treatment|Administrative|0|||
160971945|NCT02508532|581287593|FG007|Part 2 - Treatment|Administrative|0|||
160971946|NCT02508532|581287594|FG008|Part 2 - Treatment|Administrative|3|||
160971947|NCT02508532|581287586|FG000|Part 2 - Treatment|Sponsor Decision|0|||
160971948|NCT02508532|581287587|FG001|Part 2 - Treatment|Sponsor Decision|0|||
160971949|NCT02508532|581287588|FG002|Part 2 - Treatment|Sponsor Decision|0|||
160971950|NCT02508532|581287589|FG003|Part 2 - Treatment|Sponsor Decision|0|||
160971951|NCT02508532|581287590|FG004|Part 2 - Treatment|Sponsor Decision|0|||
160971952|NCT02508532|581287591|FG005|Part 2 - Treatment|Sponsor Decision|0|||
160971953|NCT02508532|581287592|FG006|Part 2 - Treatment|Sponsor Decision|0|||
160971954|NCT02508532|581287593|FG007|Part 2 - Treatment|Sponsor Decision|0|||
160971955|NCT02508532|581287594|FG008|Part 2 - Treatment|Sponsor Decision|28|||
160971956|NCT02508532|581287586|FG000|Part 2 - Treatment|Death|0|||
160971957|NCT02508532|581287587|FG001|Part 2 - Treatment|Death|0|||
160971958|NCT02508532|581287588|FG002|Part 2 - Treatment|Death|0|||
160971959|NCT02508532|581287589|FG003|Part 2 - Treatment|Death|0|||
160971960|NCT02508532|581287590|FG004|Part 2 - Treatment|Death|0|||
160971961|NCT02508532|581287591|FG005|Part 2 - Treatment|Death|0|||
160971962|NCT02508532|581287592|FG006|Part 2 - Treatment|Death|0|||
160971963|NCT02508532|581287593|FG007|Part 2 - Treatment|Death|0|||
160971964|NCT02508532|581287594|FG008|Part 2 - Treatment|Death|1|||
160971965|NCT02508532|581287586|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
160971966|NCT02508532|581287587|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
160971967|NCT02508532|581287588|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
160971968|NCT02508532|581287589|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
160971969|NCT02508532|581287590|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
160971970|NCT02508532|581287591|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
160971971|NCT02508532|581287592|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
160971972|NCT02508532|581287593|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
160971973|NCT02508532|581287594|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
160971974|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
160971975|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971976|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971977|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971978|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971979|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971980|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
160971981|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
160971982|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
160971983|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
160971984|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971985|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
160971986|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971987|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971988|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971989|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971990|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
160971991|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
160971992|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Death|0|||
160971993|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Death|4|||
160971994|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Death|2|||
160971995|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Death|4|||
160971996|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Death|3|||
160971997|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Death|0|||
160971998|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Death|0|||
160971999|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Death|1|||
160972000|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Death|111|||
160972001|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
160972002|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
160972003|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
160972004|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972005|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972006|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972007|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972008|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
160972009|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
160972010|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972011|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972012|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972013|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972014|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972015|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972016|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972017|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
160972018|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
160972019|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972020|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972021|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
160972022|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972023|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
160972024|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972025|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972026|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
160972027|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
160972028|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972029|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972030|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972031|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972032|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972033|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972034|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972035|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
160972036|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
160972037|NCT02508532|581287586|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
160972038|NCT02508532|581287587|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
160972039|NCT02508532|581287588|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
160972040|NCT02508532|581287589|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
160972041|NCT02508532|581287590|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
160972042|NCT02508532|581287591|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
160972043|NCT02508532|581287592|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
160972044|NCT02508532|581287593|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
160972045|NCT02508532|581287594|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
160972046|NCT01111838|581287598|FG000|Overall Study|Patient Ineligible|2|||
160972047|NCT01111838|581287598|FG000|Overall Study|Not Treated|3|||
160972048|NCT01111838|581287598|FG000|Overall Study|Clinical deterioration|1|||
160972049|NCT01111838|581287598|FG000|Overall Study|Other Complicating Disease|1|||
160972050|NCT01287520|581287599|FG000|Overall Study|Adverse Event|2|||
160972051|NCT01287520|581287600|FG001|Overall Study|Adverse Event|2|||
160972052|NCT01287520|581287601|FG002|Overall Study|Adverse Event|2|||
160972053|NCT01287520|581287602|FG003|Overall Study|Adverse Event|1|||
160972054|NCT01287520|581287603|FG004|Overall Study|Adverse Event|1|||
160972055|NCT01287520|581287604|FG005|Overall Study|Adverse Event|2|||
160972056|NCT01287520|581287605|FG006|Overall Study|Adverse Event|0|||
160972057|NCT01287520|581287606|FG007|Overall Study|Adverse Event|2|||
160972058|NCT01287520|581287607|FG008|Overall Study|Adverse Event|0|||
160972059|NCT01287520|581287599|FG000|Overall Study|Physician Decision|1|||
160972060|NCT01287520|581287600|FG001|Overall Study|Physician Decision|1|||
160972061|NCT01287520|581287601|FG002|Overall Study|Physician Decision|2|||
160972062|NCT01287520|581287602|FG003|Overall Study|Physician Decision|0|||
160972063|NCT01287520|581287603|FG004|Overall Study|Physician Decision|1|||
160972064|NCT01287520|581287604|FG005|Overall Study|Physician Decision|1|||
160972065|NCT01287520|581287605|FG006|Overall Study|Physician Decision|0|||
160972066|NCT01287520|581287606|FG007|Overall Study|Physician Decision|1|||
160972067|NCT01287520|581287607|FG008|Overall Study|Physician Decision|0|||
160972068|NCT01287520|581287599|FG000|Overall Study|Progressive disease|0|||
160972069|NCT01287520|581287600|FG001|Overall Study|Progressive disease|4|||
161274206|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274207|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274208|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274209|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274210|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274211|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161343634|NCT04896385|582644435|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
161343635|NCT04896385|582644432|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
160972070|NCT01287520|581287601|FG002|Overall Study|Progressive disease|1|||
161148721|NCT01912872|581926134|FG002|Overall Study|Missing|0|||
160972071|NCT01287520|581287602|FG003|Overall Study|Progressive disease|6|||
160972072|NCT01287520|581287603|FG004|Overall Study|Progressive disease|1|||
160972073|NCT01287520|581287604|FG005|Overall Study|Progressive disease|0|||
160972074|NCT01287520|581287605|FG006|Overall Study|Progressive disease|2|||
160972075|NCT01287520|581287606|FG007|Overall Study|Progressive disease|2|||
161148722|NCT01912872|581926135|FG003|Overall Study|Missing|1|||
161274212|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
160972076|NCT01287520|581287607|FG008|Overall Study|Progressive disease|4|||
160972077|NCT01287520|581287599|FG000|Overall Study|Withdrawal by Subject|0|||
160972078|NCT01287520|581287600|FG001|Overall Study|Withdrawal by Subject|0|||
160972079|NCT01287520|581287601|FG002|Overall Study|Withdrawal by Subject|0|||
160972080|NCT01287520|581287602|FG003|Overall Study|Withdrawal by Subject|0|||
160972081|NCT01287520|581287603|FG004|Overall Study|Withdrawal by Subject|0|||
160972082|NCT01287520|581287604|FG005|Overall Study|Withdrawal by Subject|1|||
160972083|NCT01287520|581287605|FG006|Overall Study|Withdrawal by Subject|0|||
160972084|NCT01287520|581287606|FG007|Overall Study|Withdrawal by Subject|0|||
160972085|NCT01287520|581287607|FG008|Overall Study|Withdrawal by Subject|1|||
160972086|NCT03587142|581287608|FG000|Overall Study|Lost to Follow-up|5|||
160972087|NCT03587142|581287609|FG001|Overall Study|Lost to Follow-up|3|||
160972088|NCT03587142|581287608|FG000|Overall Study|Did not complete the f4 visit|3|||
160972089|NCT03587142|581287609|FG001|Overall Study|Did not complete the f4 visit|7|||
160972090|NCT03673462|581287610|FG000|Overall Study|Adverse Event|11|||
160972091|NCT03673462|581287611|FG001|Overall Study|Adverse Event|1|||
160972092|NCT03673462|581287610|FG000|Overall Study|Protocol Violation|25|||
160972093|NCT03673462|581287611|FG001|Overall Study|Protocol Violation|11|||
160972094|NCT03673462|581287610|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
160972095|NCT03673462|581287611|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
160972096|NCT03673462|581287610|FG000|Overall Study|Lost to Follow-up|102|||
160972097|NCT03673462|581287611|FG001|Overall Study|Lost to Follow-up|19|||
160972098|NCT02768662|581287612|FG000|Overall Study|Adverse Event|1|||
160972099|NCT02768662|581287612|FG000|Overall Study|Lost to Follow-up|4|||
160972100|NCT02768662|581287612|FG000|Overall Study|Withdrawal by Subject|3|||
160972101|NCT02768662|581287612|FG000|Overall Study|Study terminated by Sponsor|78|||
160972102|NCT04503096|581287620|FG000|Overall Study|Withdrawal by Subject|3|||
160972103|NCT00744328|581287621|FG000|Overall Study|Lost to Follow-up|2|||
160972104|NCT00744328|581287622|FG001|Overall Study|Lost to Follow-up|5|||
160972105|NCT00744328|581287623|FG002|Overall Study|Lost to Follow-up|3|||
160972106|NCT00744328|581287621|FG000|Overall Study|Withdrawal by Subject|5|||
160972107|NCT00744328|581287622|FG001|Overall Study|Withdrawal by Subject|3|||
160972108|NCT00744328|581287623|FG002|Overall Study|Withdrawal by Subject|4|||
160972109|NCT00744328|581287621|FG000|Overall Study|Found ineligible after randomization|0|||
160972110|NCT00744328|581287622|FG001|Overall Study|Found ineligible after randomization|0|||
160972111|NCT00744328|581287623|FG002|Overall Study|Found ineligible after randomization|1|||
160972112|NCT01576367|581287624|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
160972113|NCT01576367|581287624|FG000|Overall Study|Moved to commercial use after 6 months|1|||
160972114|NCT02387216|581287625|FG000|Overall Study|Progressive disease|2|||
160972115|NCT02387216|581287626|FG001|Overall Study|Progressive disease|0|||
160972116|NCT02387216|581287625|FG000|Overall Study|Withdrawal by Subject|3|||
160972117|NCT02387216|581287626|FG001|Overall Study|Withdrawal by Subject|5|||
160972118|NCT02387216|581287625|FG000|Overall Study|Physician Decision|2|||
160972119|NCT02387216|581287626|FG001|Overall Study|Physician Decision|0|||
160972120|NCT02387216|581287625|FG000|Overall Study|Sponsor Decision|28|||
160972121|NCT02387216|581287626|FG001|Overall Study|Sponsor Decision|12|||
160972122|NCT02387216|581287625|FG000|Overall Study|Death|60|||
160972123|NCT02387216|581287626|FG001|Overall Study|Death|23|||
160972124|NCT02387216|581287625|FG000|Overall Study|Other|5|||
160972125|NCT02387216|581287626|FG001|Overall Study|Other|4|||
160972126|NCT02387216|581287625|FG000|Overall Study|Lost to Follow-up|0|||
160972127|NCT02387216|581287626|FG001|Overall Study|Lost to Follow-up|3|||
161148723|NCT04760314|581926139|FG000|Induction Period|Withdrawal by Subject|0|||
161274213|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
161274214|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274215|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274216|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
161274217|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274218|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274219|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274220|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274221|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160972128|NCT02091739|581287627|FG000|MP: 16 Weeks|Adverse Event|1|||
160972129|NCT02091739|581287628|FG001|MP: 16 Weeks|Adverse Event|1|||
160972130|NCT02091739|581287629|FG002|MP: 16 Weeks|Adverse Event|1|||
160972131|NCT02091739|581287630|FG003|MP: 16 Weeks|Adverse Event|0|||
161274222|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274223|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
160972132|NCT02091739|581287631|FG004|MP: 16 Weeks|Adverse Event|0|||
161319371|NCT00496587|582555292|FG000|Overall Study|Adverse Event|2|||
160972133|NCT02091739|581287627|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
160972134|NCT02091739|581287628|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
160972135|NCT02091739|581287629|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
161023996|NCT05623228|581477402|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
160972136|NCT02091739|581287630|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
160972137|NCT02091739|581287631|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
160972138|NCT02091739|581287627|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
160972139|NCT02091739|581287628|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
160972140|NCT02091739|581287629|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
160972141|NCT02091739|581287630|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
160972142|NCT02091739|581287631|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
160972143|NCT02091739|581287627|FG000|EP: 48 Weeks|Other|0|||
160972144|NCT02091739|581287628|FG001|EP: 48 Weeks|Other|0|||
160972145|NCT02091739|581287629|FG002|EP: 48 Weeks|Other|0|||
160972146|NCT02091739|581287630|FG003|EP: 48 Weeks|Other|1|||
160972147|NCT02091739|581287631|FG004|EP: 48 Weeks|Other|0|||
160972148|NCT02091739|581287627|FG000|EP: 48 Weeks|Death|0|||
160972149|NCT02091739|581287628|FG001|EP: 48 Weeks|Death|0|||
160972150|NCT02091739|581287629|FG002|EP: 48 Weeks|Death|0|||
160972151|NCT02091739|581287630|FG003|EP: 48 Weeks|Death|3|||
160972152|NCT02091739|581287631|FG004|EP: 48 Weeks|Death|2|||
160972153|NCT02091739|581287627|FG000|EP: 48 Weeks|Adverse Event|0|||
160972154|NCT02091739|581287628|FG001|EP: 48 Weeks|Adverse Event|0|||
160972155|NCT02091739|581287629|FG002|EP: 48 Weeks|Adverse Event|0|||
160972156|NCT02091739|581287630|FG003|EP: 48 Weeks|Adverse Event|2|||
160972157|NCT02091739|581287631|FG004|EP: 48 Weeks|Adverse Event|6|||
160972158|NCT02091739|581287627|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
160972159|NCT02091739|581287628|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
160972160|NCT02091739|581287629|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
160972161|NCT02091739|581287630|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
160972162|NCT02091739|581287631|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
160972163|NCT03528174|581287632|FG000|Overall Study|Adverse Event|1|||
160972164|NCT03528174|581287632|FG000|Overall Study|sensors dislodged|1|||
160972165|NCT04251065|581287633|FG000|Overall Study|Death|2|||
160972166|NCT04251065|581287633|FG000|Overall Study|Lack of Efficacy|3|||
160972167|NCT04251065|581287633|FG000|Overall Study|Death|1|||
160972168|NCT01436201|581287634|FG000|Overall Study|Adverse Event|2|||
160972169|NCT01436201|581287634|FG000|Overall Study|Withdrawal by Subject|1|||
160972170|NCT01436201|581287634|FG000|Overall Study|Protocol Violation|1|||
160972171|NCT00110890|581287635|FG000|Overall Study|Adverse Event|30|||
160972172|NCT00110890|581287636|FG001|Overall Study|Adverse Event|7|||
160972173|NCT00110890|581287635|FG000|Overall Study|Death|16|||
160972174|NCT00110890|581287636|FG001|Overall Study|Death|9|||
160972175|NCT00110890|581287635|FG000|Overall Study|Lost to Follow-up|3|||
160972176|NCT00110890|581287636|FG001|Overall Study|Lost to Follow-up|1|||
160972177|NCT00110890|581287635|FG000|Overall Study|Physician Decision|4|||
160972178|NCT00110890|581287636|FG001|Overall Study|Physician Decision|5|||
160972179|NCT00110890|581287635|FG000|Overall Study|Withdrawal by Subject|17|||
160972180|NCT00110890|581287636|FG001|Overall Study|Withdrawal by Subject|5|||
161148724|NCT04760314|581926140|FG001|Induction Period|Withdrawal by Subject|1|||
161148725|NCT04760314|581926141|FG002|Induction Period|Withdrawal by Subject|1|||
161148726|NCT04760314|581926142|FG003|Induction Period|Withdrawal by Subject|0|||
161148727|NCT04760314|581926143|FG004|Induction Period|Withdrawal by Subject|0|||
161148728|NCT04760314|581926144|FG005|Induction Period|Withdrawal by Subject|0|||
161148729|NCT04760314|581926145|FG006|Induction Period|Withdrawal by Subject|0|||
161148730|NCT04760314|581926146|FG007|Induction Period|Withdrawal by Subject|0|||
161148731|NCT04760314|581926147|FG008|Induction Period|Withdrawal by Subject|0|||
161148732|NCT04760314|581926148|FG009|Induction Period|Withdrawal by Subject|0|||
161148733|NCT04760314|581926149|FG010|Induction Period|Withdrawal by Subject|0|||
161148734|NCT04760314|581926139|FG000|Induction Period|Adverse Event|0|||
161148735|NCT04760314|581926140|FG001|Induction Period|Adverse Event|0|||
161148736|NCT04760314|581926141|FG002|Induction Period|Adverse Event|2|||
161148737|NCT04760314|581926142|FG003|Induction Period|Adverse Event|0|||
161148738|NCT04760314|581926143|FG004|Induction Period|Adverse Event|0|||
160972181|NCT00110890|581287635|FG000|Overall Study|Protocol Deviation|1|||
160972182|NCT00110890|581287636|FG001|Overall Study|Protocol Deviation|0|||
160972183|NCT00110890|581287635|FG000|Overall Study|Noncompliance|10|||
161148739|NCT04760314|581926144|FG005|Induction Period|Adverse Event|0|||
161148740|NCT04760314|581926145|FG006|Induction Period|Adverse Event|0|||
161148741|NCT04760314|581926146|FG007|Induction Period|Adverse Event|0|||
160972184|NCT00110890|581287636|FG001|Overall Study|Noncompliance|0|||
160972185|NCT00110890|581287635|FG000|Overall Study|Kidney Transplant|16|||
160972186|NCT00110890|581287636|FG001|Overall Study|Kidney Transplant|12|||
160972187|NCT00110890|581287635|FG000|Overall Study|Invest. Product Commercially Available|217|||
161148742|NCT04760314|581926147|FG008|Induction Period|Adverse Event|0|||
161148743|NCT04760314|581926148|FG009|Induction Period|Adverse Event|0|||
161148744|NCT04760314|581926149|FG010|Induction Period|Adverse Event|0|||
160972188|NCT00110890|581287636|FG001|Overall Study|Invest. Product Commercially Available|110|||
160972189|NCT00110890|581287635|FG000|Overall Study|Other|34|||
160972190|NCT00110890|581287636|FG001|Overall Study|Other|23|||
160972191|NCT00110890|581287635|FG000|Overall Study|Ineligibility determined|3|||
160972192|NCT00110890|581287636|FG001|Overall Study|Ineligibility determined|0|||
160972193|NCT00110890|581287635|FG000|Overall Study|Requirement for alternative therapy|0|||
161148745|NCT04760314|581926139|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
160972194|NCT00110890|581287636|FG001|Overall Study|Requirement for alternative therapy|1|||
160972195|NCT00110890|581287635|FG000|Overall Study|Disease progression|0|||
160972196|NCT00110890|581287636|FG001|Overall Study|Disease progression|1|||
160972197|NCT00110890|581287635|FG000|Overall Study|Parathyroidectomy|0|||
160972198|NCT00110890|581287636|FG001|Overall Study|Parathyroidectomy|1|||
160972199|NCT00110890|581287635|FG000|Overall Study|Did not enter follow-up phase|10|||
160972200|NCT00110890|581287636|FG001|Overall Study|Did not enter follow-up phase|4|||
160972201|NCT01686581|581287637|FG000|Overall Study|Side-effects or Health Problems|15|||
160972202|NCT01686581|581287637|FG000|Overall Study|Lack of Efficacy|90|||
160972203|NCT01686581|581287637|FG000|Overall Study|Participant Concerned about Risks|6|||
160972204|NCT01686581|581287637|FG000|Overall Study|Thinks Injections Too Painful|8|||
160972205|NCT01686581|581287637|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
160972206|NCT01686581|581287637|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
160972207|NCT01686581|581287637|FG000|Overall Study|Thinks it is Inconvenient|17|||
160972208|NCT01686581|581287637|FG000|Overall Study|Other Miscellaneous Reasons|36|||
160972209|NCT01686581|581287637|FG000|Overall Study|Reason Missing|1|||
160972210|NCT01975220|581287638|FG000|Test Period 1|Not treated|0|||
160972211|NCT01975220|581287639|FG001|Test Period 1|Not treated|1|||
160972212|NCT01975220|581287640|FG002|Test Period 1|Not treated|0|||
160972213|NCT01975220|581287641|FG003|Test Period 1|Not treated|0|||
160972214|NCT01975220|581287642|FG004|Test Period 1|Not treated|0|||
160972215|NCT01975220|581287643|FG005|Test Period 1|Not treated|0|||
160972216|NCT00263328|581287646|FG000|Overall Study|Death|0|||
161148746|NCT04760314|581926140|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
161148747|NCT04760314|581926141|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
161274224|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274225|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274226|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274227|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
161274228|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274229|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274230|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
161274231|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
161274232|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274233|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274234|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274235|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274236|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274237|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274238|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274239|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274240|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274241|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
161274242|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274243|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274244|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274245|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
161274246|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274247|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274248|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274249|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274250|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274251|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274252|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274253|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274254|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161319372|NCT00496587|582555292|FG000|Overall Study|Progressive Disease|24|||
160972217|NCT00263328|581287647|FG001|Overall Study|Death|0|||
160972218|NCT00263328|581287648|FG002|Overall Study|Death|1|||
160972219|NCT00263328|581287646|FG000|Overall Study|Lost to Follow-up|1|||
160972220|NCT00263328|581287647|FG001|Overall Study|Lost to Follow-up|1|||
160972221|NCT00263328|581287648|FG002|Overall Study|Lost to Follow-up|0|||
160972222|NCT00263328|581287646|FG000|Overall Study|Withdrawal by Subject|3|||
160972223|NCT00263328|581287647|FG001|Overall Study|Withdrawal by Subject|0|||
161319373|NCT00496587|582555292|FG000|Overall Study|Withdrawal by Subject|2|||
160972224|NCT00263328|581287648|FG002|Overall Study|Withdrawal by Subject|1|||
160972225|NCT00263328|581287646|FG000|Overall Study|Other|3|||
160972226|NCT00263328|581287647|FG001|Overall Study|Other|0|||
160972227|NCT00263328|581287648|FG002|Overall Study|Other|1|||
160972228|NCT00263328|581287646|FG000|Overall Study|Adverse Event|1|||
160972229|NCT00263328|581287647|FG001|Overall Study|Adverse Event|1|||
161148748|NCT04760314|581926142|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
161148749|NCT04760314|581926143|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
161148750|NCT04760314|581926144|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
161148751|NCT04760314|581926145|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
161148752|NCT04760314|581926146|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
161148753|NCT04760314|581926147|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
161148754|NCT04760314|581926148|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
160972230|NCT00263328|581287648|FG002|Overall Study|Adverse Event|4|||
160972231|NCT01008475|581287653|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
160972232|NCT01008475|581287654|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
160972233|NCT01008475|581287655|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
160972234|NCT01008475|581287656|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
160972235|NCT01008475|581287657|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
160972236|NCT01008475|581287658|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
160972237|NCT01008475|581287659|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
160972238|NCT01301274|581287660|FG000|Overall Study|Physician Decision|2|||
160972239|NCT01301274|581287661|FG001|Overall Study|Physician Decision|1|||
160972240|NCT00661661|581287662|FG000|Overall Study|Adverse Event|99|||
160972241|NCT00661661|581287663|FG001|Overall Study|Adverse Event|24|||
160972242|NCT00661661|581287662|FG000|Overall Study|Lack of Efficacy|3|||
160972243|NCT00661661|581287663|FG001|Overall Study|Lack of Efficacy|2|||
160972244|NCT00661661|581287662|FG000|Overall Study|Lost to Follow-up|0|||
160972245|NCT00661661|581287663|FG001|Overall Study|Lost to Follow-up|1|||
160972246|NCT00661661|581287662|FG000|Overall Study|Withdrawal by Subject|15|||
160972247|NCT00661661|581287663|FG001|Overall Study|Withdrawal by Subject|5|||
160972248|NCT00661661|581287662|FG000|Overall Study|Other|22|||
160972249|NCT00661661|581287663|FG001|Overall Study|Other|7|||
160972250|NCT00661661|581287662|FG000|Overall Study|Not assigned treatment|1|||
160972251|NCT00661661|581287663|FG001|Overall Study|Not assigned treatment|0|||
160972252|NCT01893827|581287664|FG000|Overall Study|Lost to Follow-up|19|||
160972253|NCT01893827|581287665|FG001|Overall Study|Lost to Follow-up|26|||
160972254|NCT02917941|581287666|FG000|Treatment Period|Adverse Event|11|||
160972255|NCT02917941|581287666|FG000|Treatment Period|Progressive Disease|11|||
160972256|NCT02917941|581287666|FG000|Treatment Period|Reason not Specified|2|||
160972257|NCT02917941|581287666|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
160972258|NCT02917941|581287666|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
160972259|NCT00399763|581287667|FG000|Overall Study|Lost to Follow-up|2|||
160972260|NCT00399763|581287668|FG001|Overall Study|Lost to Follow-up|3|||
160972261|NCT03389477|581287671|FG000|Step 1|Withdrawal by Subject|1|||
160972262|NCT03389477|581287672|FG001|Step 1|Withdrawal by Subject|0|||
160972263|NCT03389477|581287671|FG000|Step 2|Withdrawal by Subject|1|||
160972264|NCT03389477|581287672|FG001|Step 2|Withdrawal by Subject|2|||
160972265|NCT03389477|581287671|FG000|Step 2|Disease progression|1|||
160972266|NCT03389477|581287672|FG001|Step 2|Disease progression|0|||
160972267|NCT03389477|581287671|FG000|Step 2|Death|0|||
160972268|NCT03389477|581287672|FG001|Step 2|Death|1|||
160972269|NCT03389477|581287671|FG000|Step 2|Poor performance status and nutrition|0|||
160972270|NCT03389477|581287672|FG001|Step 2|Poor performance status and nutrition|1|||
160972271|NCT03389477|581287671|FG000|Step 3|Withdrawal after 3 cycles|0|||
160972272|NCT03389477|581287672|FG001|Step 3|Withdrawal after 3 cycles|1|||
160972273|NCT03389477|581287671|FG000|Step 3|Still receiving active treatment|4|||
160972274|NCT03389477|581287672|FG001|Step 3|Still receiving active treatment|0|||
160972275|NCT03389477|581287671|FG000|Step 3|Progressive disease after 2 cycles|1|||
160972276|NCT03389477|581287672|FG001|Step 3|Progressive disease after 2 cycles|0|||
160972277|NCT04512066|581287675|FG000|Double-blind Treatment Period|Adverse Event|6|||
160972278|NCT04512066|581287676|FG001|Double-blind Treatment Period|Adverse Event|4|||
161148755|NCT04760314|581926149|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
161148756|NCT04760314|581926139|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161148757|NCT04760314|581926140|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161148758|NCT04760314|581926141|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161274255|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
161274256|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274257|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
160972279|NCT04512066|581287677|FG002|Double-blind Treatment Period|Adverse Event|5|||
160972280|NCT04512066|581287678|FG003|Double-blind Treatment Period|Adverse Event|1|||
160972281|NCT04512066|581287679|FG004|Double-blind Treatment Period|Adverse Event|0|||
160972282|NCT04512066|581287680|FG005|Double-blind Treatment Period|Adverse Event|0|||
160972283|NCT04512066|581287675|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
160972284|NCT04512066|581287676|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
160972285|NCT04512066|581287677|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
160972286|NCT04512066|581287678|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
160972287|NCT04512066|581287679|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
161148759|NCT04760314|581926142|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
161148760|NCT04760314|581926143|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
160972288|NCT04512066|581287680|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
160972289|NCT04512066|581287675|FG000|Double-blind Treatment Period|Physician Decision|1|||
160972290|NCT04512066|581287676|FG001|Double-blind Treatment Period|Physician Decision|0|||
160972291|NCT04512066|581287677|FG002|Double-blind Treatment Period|Physician Decision|1|||
160972292|NCT04512066|581287678|FG003|Double-blind Treatment Period|Physician Decision|0|||
160972293|NCT04512066|581287679|FG004|Double-blind Treatment Period|Physician Decision|0|||
160972294|NCT04512066|581287680|FG005|Double-blind Treatment Period|Physician Decision|0|||
160972295|NCT04512066|581287675|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
160972296|NCT04512066|581287676|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
160972297|NCT04512066|581287677|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
160972298|NCT04512066|581287678|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
160972299|NCT04512066|581287679|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
160972300|NCT04512066|581287680|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
160972301|NCT04512066|581287675|FG000|Extension Period|Adverse Event|0|||
160972302|NCT04512066|581287676|FG001|Extension Period|Adverse Event|1|||
160972303|NCT04512066|581287677|FG002|Extension Period|Adverse Event|4|||
160972304|NCT04512066|581287678|FG003|Extension Period|Adverse Event|3|||
160972305|NCT04512066|581287679|FG004|Extension Period|Adverse Event|1|||
160972306|NCT04512066|581287680|FG005|Extension Period|Adverse Event|3|||
160972307|NCT04512066|581287675|FG000|Extension Period|Death|0|||
160972308|NCT04512066|581287676|FG001|Extension Period|Death|0|||
161023997|NCT05623228|581477403|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
161023998|NCT05623228|581477404|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161023999|NCT05623228|581477405|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161274258|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
161274259|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
161274260|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274261|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274262|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274263|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274264|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274265|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274266|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274267|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274268|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274269|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
161274270|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274271|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274272|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274273|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274274|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274275|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274276|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274277|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274278|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
161274279|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274280|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274281|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274282|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274283|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
161274284|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274285|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274286|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274287|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274288|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274289|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274290|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274291|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274292|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
161274293|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274294|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274295|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274296|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
161274297|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
160972309|NCT04512066|581287677|FG002|Extension Period|Death|0|||
160972310|NCT04512066|581287678|FG003|Extension Period|Death|0|||
160972311|NCT04512066|581287679|FG004|Extension Period|Death|0|||
160972312|NCT04512066|581287680|FG005|Extension Period|Death|1|||
160972313|NCT04512066|581287675|FG000|Extension Period|Lack of Efficacy|0|||
160972314|NCT04512066|581287676|FG001|Extension Period|Lack of Efficacy|4|||
160972315|NCT04512066|581287677|FG002|Extension Period|Lack of Efficacy|4|||
160972316|NCT04512066|581287678|FG003|Extension Period|Lack of Efficacy|1|||
160972317|NCT04512066|581287679|FG004|Extension Period|Lack of Efficacy|3|||
160972318|NCT04512066|581287680|FG005|Extension Period|Lack of Efficacy|3|||
160972319|NCT04512066|581287675|FG000|Extension Period|Lost to Follow-up|0|||
160972320|NCT04512066|581287676|FG001|Extension Period|Lost to Follow-up|1|||
160972321|NCT04512066|581287677|FG002|Extension Period|Lost to Follow-up|5|||
160972322|NCT04512066|581287678|FG003|Extension Period|Lost to Follow-up|2|||
160972323|NCT04512066|581287679|FG004|Extension Period|Lost to Follow-up|3|||
160972324|NCT04512066|581287680|FG005|Extension Period|Lost to Follow-up|2|||
160972325|NCT04512066|581287675|FG000|Extension Period|Non-compliance with study drug|0|||
160972326|NCT04512066|581287676|FG001|Extension Period|Non-compliance with study drug|1|||
160972327|NCT04512066|581287677|FG002|Extension Period|Non-compliance with study drug|0|||
160972328|NCT04512066|581287678|FG003|Extension Period|Non-compliance with study drug|0|||
160972329|NCT04512066|581287679|FG004|Extension Period|Non-compliance with study drug|0|||
160972330|NCT04512066|581287680|FG005|Extension Period|Non-compliance with study drug|1|||
160972331|NCT04512066|581287675|FG000|Extension Period|Other|0|||
160972332|NCT04512066|581287676|FG001|Extension Period|Other|2|||
160972333|NCT04512066|581287677|FG002|Extension Period|Other|0|||
160972334|NCT04512066|581287678|FG003|Extension Period|Other|0|||
160972335|NCT04512066|581287679|FG004|Extension Period|Other|0|||
160972336|NCT04512066|581287680|FG005|Extension Period|Other|0|||
160972337|NCT04512066|581287675|FG000|Extension Period|Physician Decision|0|||
160972338|NCT04512066|581287676|FG001|Extension Period|Physician Decision|2|||
160972339|NCT04512066|581287677|FG002|Extension Period|Physician Decision|0|||
160972340|NCT04512066|581287678|FG003|Extension Period|Physician Decision|1|||
160972341|NCT04512066|581287679|FG004|Extension Period|Physician Decision|1|||
160972342|NCT04512066|581287680|FG005|Extension Period|Physician Decision|0|||
160972343|NCT04512066|581287675|FG000|Extension Period|Withdrawal by Subject|0|||
160972344|NCT04512066|581287676|FG001|Extension Period|Withdrawal by Subject|3|||
160972345|NCT04512066|581287677|FG002|Extension Period|Withdrawal by Subject|7|||
160972346|NCT04512066|581287678|FG003|Extension Period|Withdrawal by Subject|11|||
160972347|NCT04512066|581287679|FG004|Extension Period|Withdrawal by Subject|8|||
160972348|NCT04512066|581287680|FG005|Extension Period|Withdrawal by Subject|4|||
160972349|NCT03403426|581287682|FG000|Overall Study|Death|1|||
160972350|NCT03403426|581287682|FG000|Overall Study|Lost to Follow-up|2|||
160972351|NCT01657266|581287686|FG000|Overall Study|Lost to Follow-up|2|||
160972352|NCT01657266|581287687|FG001|Overall Study|Lost to Follow-up|2|||
160972353|NCT01657266|581287686|FG000|Overall Study|Adverse Event|2|||
160972354|NCT01657266|581287687|FG001|Overall Study|Adverse Event|3|||
160972355|NCT03520400|581287688|FG000|Overall Study|Physician Decision|15|||
160972356|NCT03520400|581287689|FG001|Overall Study|Physician Decision|7|||
160972357|NCT00445679|581287692|FG000|Overall Study|Adverse Event|22|||
160972358|NCT00445679|581287693|FG001|Overall Study|Adverse Event|12|||
160972359|NCT00445679|581287694|FG002|Overall Study|Adverse Event|30|||
160972360|NCT00445679|581287695|FG003|Overall Study|Adverse Event|19|||
160972361|NCT00445679|581287692|FG000|Overall Study|Failed to return|1|||
160972362|NCT00445679|581287693|FG001|Overall Study|Failed to return|3|||
160972363|NCT00445679|581287694|FG002|Overall Study|Failed to return|2|||
160972364|NCT00445679|581287695|FG003|Overall Study|Failed to return|2|||
160972365|NCT00445679|581287692|FG000|Overall Study|Physician Decision|0|||
160972366|NCT00445679|581287693|FG001|Overall Study|Physician Decision|0|||
160972367|NCT00445679|581287694|FG002|Overall Study|Physician Decision|1|||
160972368|NCT00445679|581287695|FG003|Overall Study|Physician Decision|0|||
160972369|NCT00445679|581287692|FG000|Overall Study|Lost to Follow-up|10|||
160972370|NCT00445679|581287693|FG001|Overall Study|Lost to Follow-up|6|||
160972371|NCT00445679|581287694|FG002|Overall Study|Lost to Follow-up|6|||
160972372|NCT00445679|581287695|FG003|Overall Study|Lost to Follow-up|5|||
160972373|NCT00445679|581287692|FG000|Overall Study|Compliance|3|||
160972374|NCT00445679|581287693|FG001|Overall Study|Compliance|2|||
160972375|NCT00445679|581287694|FG002|Overall Study|Compliance|1|||
160972376|NCT00445679|581287695|FG003|Overall Study|Compliance|2|||
160972377|NCT00445679|581287692|FG000|Overall Study|Withdrawal of Informed Consent|0|||
160972378|NCT00445679|581287693|FG001|Overall Study|Withdrawal of Informed Consent|0|||
160972379|NCT00445679|581287694|FG002|Overall Study|Withdrawal of Informed Consent|1|||
160972380|NCT00445679|581287695|FG003|Overall Study|Withdrawal of Informed Consent|0|||
160972381|NCT00445679|581287692|FG000|Overall Study|Protocol Violation|2|||
160972382|NCT00445679|581287693|FG001|Overall Study|Protocol Violation|3|||
160972383|NCT00445679|581287694|FG002|Overall Study|Protocol Violation|3|||
160972384|NCT00445679|581287695|FG003|Overall Study|Protocol Violation|1|||
160972385|NCT00445679|581287692|FG000|Overall Study|Withdrawal by Subject|8|||
160972386|NCT00445679|581287693|FG001|Overall Study|Withdrawal by Subject|14|||
160972387|NCT00445679|581287694|FG002|Overall Study|Withdrawal by Subject|20|||
160972388|NCT00445679|581287695|FG003|Overall Study|Withdrawal by Subject|18|||
160972389|NCT00445679|581287692|FG000|Overall Study|Lack of Efficacy|2|||
160972390|NCT00445679|581287693|FG001|Overall Study|Lack of Efficacy|6|||
161343636|NCT04896385|582644433|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161343637|NCT04896385|582644434|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
161343638|NCT04896385|582644435|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
161343639|NCT04896385|582644432|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
161343640|NCT04896385|582644433|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
161343641|NCT04896385|582644434|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
161343642|NCT04896385|582644435|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
161343643|NCT04896385|582644432|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
161343644|NCT04896385|582644433|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
161343645|NCT04896385|582644434|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
161343646|NCT04896385|582644435|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
161343647|NCT05291689|582644438|FG000|Overall Study|Adverse Event|3|||
161343648|NCT05291689|582644438|FG000|Overall Study|Lack of Efficacy|10|||
161343649|NCT05291689|582644438|FG000|Overall Study|Withdrawal by Subject|4|||
161343650|NCT01931098|582644439|FG000|Overall Study|Withdrawal by Subject|0|||
161343651|NCT01931098|582644440|FG001|Overall Study|Withdrawal by Subject|1|||
161343652|NCT01931098|582644439|FG000|Overall Study|Enrolled in different protocol|0|||
161343653|NCT01931098|582644440|FG001|Overall Study|Enrolled in different protocol|1|||
161343654|NCT01931098|582644439|FG000|Overall Study|Unable to begin trmt:active infection|0|||
161343655|NCT01931098|582644440|FG001|Overall Study|Unable to begin trmt:active infection|1|||
161343656|NCT01931098|582644439|FG000|Overall Study|Refused further treatment|0|||
161343657|NCT01931098|582644440|FG001|Overall Study|Refused further treatment|1|||
161343658|NCT02612155|582644441|FG000|Overall Study|Death|1|||
161343659|NCT02612155|582644442|FG001|Overall Study|Death|1|||
161343660|NCT02612155|582644441|FG000|Overall Study|Lost to Follow-up|2|||
161343661|NCT02612155|582644442|FG001|Overall Study|Lost to Follow-up|2|||
161343662|NCT04235374|582644443|FG000|Overall Study|Death|91|||
161343663|NCT04235374|582644444|FG001|Overall Study|Death|91|||
161343664|NCT04235374|582644443|FG000|Overall Study|Refused|2|||
161343665|NCT04235374|582644444|FG001|Overall Study|Refused|2|||
161343666|NCT04235374|582644443|FG000|Overall Study|Unavailable|12|||
161343667|NCT04235374|582644444|FG001|Overall Study|Unavailable|3|||
161343668|NCT04235374|582644443|FG000|Overall Study|Withdrawal by Subject|0|||
161343669|NCT04235374|582644444|FG001|Overall Study|Withdrawal by Subject|1|||
161343670|NCT04235374|582644443|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
161343671|NCT04235374|582644444|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
161343672|NCT01551173|582644445|FG000|Overall Study|Withdrawal by Subject|11|||
161343673|NCT01551173|582644446|FG001|Overall Study|Withdrawal by Subject|16|||
161343674|NCT01551173|582644445|FG000|Overall Study|Adverse Event|7|||
161343675|NCT01551173|582644446|FG001|Overall Study|Adverse Event|6|||
161343676|NCT01551173|582644445|FG000|Overall Study|Lost to Follow-up|5|||
161343677|NCT01551173|582644446|FG001|Overall Study|Lost to Follow-up|7|||
161343678|NCT01551173|582644445|FG000|Overall Study|Other|5|||
161343679|NCT01551173|582644446|FG001|Overall Study|Other|3|||
161343680|NCT01394276|582644447|FG000|Overall Study|Related Adverse event (AEs)|15|||
161343681|NCT01394276|582644447|FG000|Overall Study|Not related AEs|9|||
161343682|NCT01394276|582644447|FG000|Overall Study|Remission of disease|2|||
160972391|NCT00445679|581287694|FG002|Overall Study|Lack of Efficacy|2|||
160972392|NCT00445679|581287695|FG003|Overall Study|Lack of Efficacy|0|||
160972393|NCT00909428|581287699|FG000|Overall Study|Lost to Follow-up|13|||
160972394|NCT00909428|581287700|FG001|Overall Study|Lost to Follow-up|10|||
160972395|NCT00909428|581287701|FG002|Overall Study|Lost to Follow-up|9|||
160972396|NCT03021668|581287702|FG000|Overall Study|Physician Decision|0|||
161343683|NCT01394276|582644447|FG000|Overall Study|Insufficient therapeutic effect|17|||
161343684|NCT01394276|582644447|FG000|Overall Study|Insufficient compliance|9|||
161343685|NCT01394276|582644447|FG000|Overall Study|Lost to Follow-up|5|||
161343686|NCT01394276|582644447|FG000|Overall Study|Participant moved to another site|1|||
161343687|NCT01394276|582644447|FG000|Overall Study|Pregnancy|1|||
160972397|NCT03021668|581287703|FG001|Overall Study|Physician Decision|1|||
160972398|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
160972399|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
160972400|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
160972401|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
161024000|NCT05623228|581477406|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161024001|NCT05623228|581477407|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
161024002|NCT05256017|581479571|FG000|Treatment Period|Withdrawal by Subject|1|||
160972402|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
161024003|NCT05256017|581479572|FG001|Treatment Period|Withdrawal by Subject|1|||
161024004|NCT05256017|581479571|FG000|Follow-up|Lost to Follow-up|7|||
161343688|NCT01394276|582644447|FG000|Overall Study|unavailability of drug at the Hospital|2|||
161343689|NCT01394276|582644447|FG000|Overall Study|Symptoms of concurrent diseases|1|||
161343690|NCT04530344|582644448|FG000|Overall Study|Lost to Follow-up|3|||
161343691|NCT04530344|582644449|FG001|Overall Study|Lost to Follow-up|3|||
161343692|NCT04530344|582644450|FG002|Overall Study|Lost to Follow-up|3|||
160972403|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
160972404|NCT00116844|581287706|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
160972405|NCT00116844|581287707|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
160972406|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
160972407|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
160972408|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
160972409|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
160972410|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
160972411|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
160972412|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
160972413|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
160972414|NCT00116844|581287706|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
160972415|NCT00116844|581287707|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
160972416|NCT01933880|581287708|FG000|Overall Study|Withdrawal by Subject|5|||
160972417|NCT01933880|581287709|FG001|Overall Study|Withdrawal by Subject|0|||
160972418|NCT01933880|581287708|FG000|Overall Study|Lack of Efficacy|1|||
160972419|NCT01933880|581287709|FG001|Overall Study|Lack of Efficacy|0|||
160972420|NCT01933880|581287708|FG000|Overall Study|Concomitant medication Interference|0|||
160972421|NCT01933880|581287709|FG001|Overall Study|Concomitant medication Interference|1|||
160972422|NCT01933880|581287708|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
160972423|NCT01933880|581287709|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
160972424|NCT01933880|581287708|FG000|Overall Study|Other|4|||
160972425|NCT01933880|581287709|FG001|Overall Study|Other|0|||
160972426|NCT01933880|581287708|FG000|Overall Study|Protocol Violation|1|||
160972427|NCT01933880|581287709|FG001|Overall Study|Protocol Violation|0|||
160972428|NCT01125722|581287710|FG000|Overall Study|Withdrawal by Subject|2|||
160972429|NCT01125722|581287711|FG001|Overall Study|Withdrawal by Subject|1|||
160972430|NCT01125722|581287710|FG000|Overall Study|Lost to Follow-up|1|||
160972431|NCT01125722|581287711|FG001|Overall Study|Lost to Follow-up|0|||
160972432|NCT03474549|581287712|FG000|Overall Study|Death|31|||
160972433|NCT03474549|581287712|FG000|Overall Study|Lost to Follow-up|4|||
160972434|NCT03474549|581287712|FG000|Overall Study|Withdrawal by Subject|2|||
160972435|NCT00069784|581287713|FG000|Overall Study|Adverse Event|105|||
160972436|NCT00069784|581287714|FG001|Overall Study|Adverse Event|0|||
160972437|NCT00069784|581287713|FG000|Overall Study|Withdrawal by Subject|1090|||
160972438|NCT00069784|581287714|FG001|Overall Study|Withdrawal by Subject|0|||
160972439|NCT00069784|581287713|FG000|Overall Study|Other|17|||
160972440|NCT00069784|581287714|FG001|Overall Study|Other|0|||
160972441|NCT00926003|581287717|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
160972442|NCT00926003|581287718|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
160972443|NCT00926003|581287719|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
160972444|NCT00926003|581287717|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
160972445|NCT00926003|581287718|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
160972446|NCT00926003|581287719|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
160972447|NCT00709059|581287721|FG000|Overall Study|Lost to Follow-up|34|||
160972448|NCT00709059|581287721|FG000|Overall Study|Withdrawal by Subject|19|||
160972449|NCT00709059|581287721|FG000|Overall Study|Physician Decision|7|||
160972450|NCT00709059|581287721|FG000|Overall Study|Disease complication|3|||
160972451|NCT00709059|581287721|FG000|Overall Study|Side effects|20|||
160972452|NCT00709059|581287721|FG000|Overall Study|Serious side effects|11|||
160972453|NCT01786330|581287722|FG000|Overall Study|Withdrawal by Subject|0|||
160972454|NCT01786330|581287723|FG001|Overall Study|Withdrawal by Subject|1|||
160972455|NCT01786330|581287722|FG000|Overall Study|Lost to Follow-up|0|||
160972456|NCT01786330|581287723|FG001|Overall Study|Lost to Follow-up|1|||
160972457|NCT01786330|581287722|FG000|Overall Study|Excluded intraoperatively|0|||
160972458|NCT01786330|581287723|FG001|Overall Study|Excluded intraoperatively|1|||
160972459|NCT01786330|581287722|FG000|Overall Study|Protocol Violation|1|||
160972460|NCT01786330|581287723|FG001|Overall Study|Protocol Violation|0|||
160972461|NCT01167179|581289115|FG000|Overall Study|disease recurrence|4|||
160972462|NCT01167179|581289116|FG001|Overall Study|disease recurrence|4|||
160972463|NCT01167179|581289115|FG000|Overall Study|Death|4|||
160972464|NCT01167179|581289116|FG001|Overall Study|Death|10|||
160972465|NCT01167179|581289115|FG000|Overall Study|Withdrawal by Subject|1|||
160972466|NCT01167179|581289116|FG001|Overall Study|Withdrawal by Subject|2|||
160972467|NCT01167179|581289115|FG000|Overall Study|diverse|6|||
160972468|NCT01167179|581289116|FG001|Overall Study|diverse|5|||
160972469|NCT03017235|581289117|FG000|Overall Study|Withdrawal by Subject|4|||
160972470|NCT03017235|581289118|FG001|Overall Study|Withdrawal by Subject|3|||
160972471|NCT03017235|581289117|FG000|Overall Study|Lost to Follow-up|2|||
160972472|NCT03017235|581289118|FG001|Overall Study|Lost to Follow-up|7|||
160972473|NCT03017235|581289117|FG000|Overall Study|Adverse Event|0|||
160972474|NCT03017235|581289118|FG001|Overall Study|Adverse Event|1|||
160972475|NCT03017235|581289117|FG000|Overall Study|Protocol Violation|2|||
160972476|NCT03017235|581289118|FG001|Overall Study|Protocol Violation|1|||
160972477|NCT03017235|581289117|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
161148761|NCT04760314|581926144|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
161148762|NCT04760314|581926145|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
161148763|NCT04760314|581926146|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161148764|NCT04760314|581926147|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161148765|NCT04760314|581926148|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161148766|NCT04760314|581926149|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
161148767|NCT04760314|581926139|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148768|NCT04760314|581926140|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148769|NCT04760314|581926141|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148770|NCT04760314|581926142|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148771|NCT04760314|581926143|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
161148772|NCT04760314|581926144|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148773|NCT04760314|581926145|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148774|NCT04760314|581926146|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148775|NCT04760314|581926147|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148776|NCT04760314|581926148|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148777|NCT04760314|581926149|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
161148778|NCT04760314|581926139|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
161148779|NCT04760314|581926140|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
161148780|NCT04760314|581926141|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
161148781|NCT04760314|581926142|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
161148782|NCT04760314|581926143|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
161148783|NCT04760314|581926144|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
161148784|NCT04760314|581926145|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
161148785|NCT04760314|581926146|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
161148786|NCT04760314|581926147|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
161148787|NCT04760314|581926148|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
161148788|NCT04760314|581926149|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
161148789|NCT04760314|581926139|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161148790|NCT04760314|581926140|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161148791|NCT04760314|581926141|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161148792|NCT04760314|581926142|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161148793|NCT04760314|581926143|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161148794|NCT04760314|581926144|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161274298|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274299|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274300|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274301|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274302|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161024005|NCT05256017|581479572|FG001|Follow-up|Lost to Follow-up|1|||
161024006|NCT05256017|581479571|FG000|Follow-up|Withdrawal by Subject|1|||
161024007|NCT05256017|581479572|FG001|Follow-up|Withdrawal by Subject|0|||
161024008|NCT05256017|581479571|FG000|Follow-up|Death|0|||
161024009|NCT05256017|581479572|FG001|Follow-up|Death|1|||
161024010|NCT03854227|581479573|FG000|Overall Study|Adverse Event|0|||
161024011|NCT03854227|581479574|FG001|Overall Study|Adverse Event|0|||
161024012|NCT03854227|581479575|FG002|Overall Study|Adverse Event|0|||
161024013|NCT03854227|581479576|FG003|Overall Study|Adverse Event|1|||
161024014|NCT03854227|581479577|FG004|Overall Study|Adverse Event|0|||
161024015|NCT03854227|581479578|FG005|Overall Study|Adverse Event|0|||
161024016|NCT03854227|581479579|FG006|Overall Study|Adverse Event|1|||
161024017|NCT03854227|581479580|FG007|Overall Study|Adverse Event|0|||
161024018|NCT03854227|581479581|FG008|Overall Study|Adverse Event|0|||
161024019|NCT03854227|581479582|FG009|Overall Study|Adverse Event|3|||
161274303|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274304|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274305|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274306|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
161274307|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274308|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274309|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274310|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161024020|NCT03854227|581479583|FG010|Overall Study|Adverse Event|0|||
161148795|NCT04760314|581926145|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161148796|NCT04760314|581926146|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161148797|NCT04760314|581926147|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
161024021|NCT03854227|581479584|FG011|Overall Study|Adverse Event|1|||
161024022|NCT03854227|581479573|FG000|Overall Study|Death|0|||
161274311|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
161274312|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274313|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274314|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274315|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274316|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274317|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274318|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274319|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274320|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
161274321|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274322|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274323|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274324|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274325|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
161274326|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274327|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274328|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274329|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274330|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274331|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274332|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274333|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274334|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
161274335|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274336|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274337|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274338|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274339|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
161274340|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274341|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274342|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274343|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274344|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274345|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
161274346|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274347|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
161274348|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
161274349|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274350|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274351|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274352|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274353|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
161274354|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274355|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274356|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274357|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274358|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274359|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274360|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274361|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274362|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
161274363|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274364|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161024023|NCT03854227|581479574|FG001|Overall Study|Death|0|||
161024024|NCT03854227|581479575|FG002|Overall Study|Death|0|||
161274365|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274366|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161274367|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
161343693|NCT04530344|582644451|FG003|Overall Study|Lost to Follow-up|10|||
161024025|NCT03854227|581479576|FG003|Overall Study|Death|0|||
161024026|NCT03854227|581479577|FG004|Overall Study|Death|0|||
161024027|NCT03854227|581479578|FG005|Overall Study|Death|1|||
161024028|NCT03854227|581479579|FG006|Overall Study|Death|0|||
161024029|NCT03854227|581479580|FG007|Overall Study|Death|0|||
161024030|NCT03854227|581479581|FG008|Overall Study|Death|0|||
161024031|NCT03854227|581479582|FG009|Overall Study|Death|1|||
161024032|NCT03854227|581479583|FG010|Overall Study|Death|0|||
161024033|NCT03854227|581479584|FG011|Overall Study|Death|1|||
161343694|NCT04530344|582644448|FG000|Overall Study|Withdrawal by Subject|14|||
161343695|NCT04530344|582644449|FG001|Overall Study|Withdrawal by Subject|5|||
161343696|NCT04530344|582644450|FG002|Overall Study|Withdrawal by Subject|18|||
161343697|NCT04530344|582644451|FG003|Overall Study|Withdrawal by Subject|33|||
161343698|NCT04530344|582644448|FG000|Overall Study|Adverse Event|0|||
161343699|NCT04530344|582644449|FG001|Overall Study|Adverse Event|0|||
161343700|NCT04530344|582644450|FG002|Overall Study|Adverse Event|0|||
161343701|NCT04530344|582644451|FG003|Overall Study|Adverse Event|1|||
161343702|NCT04530344|582644448|FG000|Overall Study|Lack of Efficacy|0|||
161343703|NCT04530344|582644449|FG001|Overall Study|Lack of Efficacy|0|||
161343704|NCT04530344|582644450|FG002|Overall Study|Lack of Efficacy|0|||
161343705|NCT04530344|582644451|FG003|Overall Study|Lack of Efficacy|1|||
161343706|NCT04530344|582644448|FG000|Overall Study|Physician Decision|0|||
161343707|NCT04530344|582644449|FG001|Overall Study|Physician Decision|0|||
161343708|NCT04530344|582644450|FG002|Overall Study|Physician Decision|1|||
161343709|NCT04530344|582644451|FG003|Overall Study|Physician Decision|1|||
161343710|NCT04530344|582644448|FG000|Overall Study|Pregnancy|0|||
161343711|NCT04530344|582644449|FG001|Overall Study|Pregnancy|0|||
161343712|NCT04530344|582644450|FG002|Overall Study|Pregnancy|2|||
161024034|NCT03854227|581479573|FG000|Overall Study|Physician Decision|0|||
161024035|NCT03854227|581479574|FG001|Overall Study|Physician Decision|0|||
161024036|NCT03854227|581479575|FG002|Overall Study|Physician Decision|0|||
161024037|NCT03854227|581479576|FG003|Overall Study|Physician Decision|0|||
161024038|NCT03854227|581479577|FG004|Overall Study|Physician Decision|0|||
161024039|NCT03854227|581479578|FG005|Overall Study|Physician Decision|1|||
161024040|NCT03854227|581479579|FG006|Overall Study|Physician Decision|0|||
161024041|NCT03854227|581479580|FG007|Overall Study|Physician Decision|0|||
161274368|NCT03982199|582382554|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274369|NCT03982199|582382555|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274370|NCT03982199|582382556|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274371|NCT03982199|582382557|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274372|NCT03982199|582382558|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274373|NCT03982199|582382559|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
161274374|NCT03982199|582382560|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274375|NCT03982199|582382561|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
161274376|NCT03982199|582382562|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
161274377|NCT03982199|582382563|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274378|NCT03982199|582382564|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274379|NCT03982199|582382565|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274380|NCT03982199|582382566|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274381|NCT03982199|582382567|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
161274382|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274383|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274384|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274385|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274386|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274387|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274388|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274389|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274390|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
161274391|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
161274392|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
161274393|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
161274394|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
161274395|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
161343713|NCT04530344|582644451|FG003|Overall Study|Pregnancy|1|||
161343714|NCT04530344|582644448|FG000|Overall Study|Protocol Violation|0|||
161343715|NCT04530344|582644449|FG001|Overall Study|Protocol Violation|0|||
161024042|NCT03854227|581479581|FG008|Overall Study|Physician Decision|1|||
161024043|NCT03854227|581479582|FG009|Overall Study|Physician Decision|1|||
161343716|NCT04530344|582644450|FG002|Overall Study|Protocol Violation|0|||
161343717|NCT04530344|582644451|FG003|Overall Study|Protocol Violation|1|||
161024044|NCT03854227|581479583|FG010|Overall Study|Physician Decision|0|||
161024045|NCT03854227|581479584|FG011|Overall Study|Physician Decision|1|||
161024046|NCT03854227|581479573|FG000|Overall Study|Progressive disease|1|||
161024047|NCT03854227|581479574|FG001|Overall Study|Progressive disease|1|||
161024048|NCT03854227|581479575|FG002|Overall Study|Progressive disease|1|||
161024049|NCT03854227|581479576|FG003|Overall Study|Progressive disease|2|||
161343718|NCT04530344|582644448|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
161343719|NCT04530344|582644449|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
161343720|NCT04530344|582644450|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
161343721|NCT04530344|582644451|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
161343722|NCT04530344|582644448|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161343723|NCT04530344|582644449|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161343724|NCT04530344|582644450|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
161343725|NCT04530344|582644451|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
161343726|NCT04530344|582644448|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
161343727|NCT04530344|582644449|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
161343728|NCT04530344|582644450|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
161343729|NCT04530344|582644451|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
161343730|NCT04530344|582644448|FG000|Overall Study|Personal Reasons|0|||
161343731|NCT04530344|582644449|FG001|Overall Study|Personal Reasons|0|||
161343732|NCT04530344|582644450|FG002|Overall Study|Personal Reasons|0|||
161343733|NCT04530344|582644451|FG003|Overall Study|Personal Reasons|1|||
161343734|NCT04530344|582644448|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161343735|NCT04530344|582644449|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161343736|NCT04530344|582644450|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
161343737|NCT04530344|582644451|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
161343738|NCT01402700|582644452|FG000|Overall Study|Death|3|||
161343739|NCT01402700|582644452|FG000|Overall Study|Withdrawal by Subject|3|||
161343740|NCT01402700|582644452|FG000|Overall Study|Missed Visit|1|||
161343741|NCT05352399|582644466|FG000|Overall Study|Discontinued intervention|6|||
161343742|NCT04058717|582644467|FG000|Randomization Period|Lost to Follow-up|2|||
161343743|NCT04058717|582644468|FG001|Randomization Period|Lost to Follow-up|3|||
161343744|NCT04058717|582644469|FG002|Randomization Period|Lost to Follow-up|4|||
161343745|NCT04058717|582644470|FG003|Randomization Period|Lost to Follow-up|4|||
161343746|NCT04058717|582644467|FG000|Randomization Period|Withdrawal by Subject|1|||
161343747|NCT04058717|582644468|FG001|Randomization Period|Withdrawal by Subject|3|||
161343748|NCT04058717|582644469|FG002|Randomization Period|Withdrawal by Subject|3|||
161343749|NCT04058717|582644470|FG003|Randomization Period|Withdrawal by Subject|3|||
161343750|NCT04058717|582644467|FG000|Randomization Period|PI decision|0|||
161343751|NCT04058717|582644468|FG001|Randomization Period|PI decision|1|||
161343752|NCT04058717|582644469|FG002|Randomization Period|PI decision|0|||
161343753|NCT04058717|582644470|FG003|Randomization Period|PI decision|0|||
161343754|NCT04809974|582645949|FG000|Lead-in Phase|Withdrawal by Subject|3|||
161343755|NCT04809974|582645950|FG001|Lead-in Phase|Withdrawal by Subject|0|||
161343756|NCT04809974|582645951|FG002|Lead-in Phase|Withdrawal by Subject|0|||
161343757|NCT04809974|582645949|FG000|Lead-in Phase|No longer eligible|11|||
161343758|NCT04809974|582645950|FG001|Lead-in Phase|No longer eligible|0|||
161343759|NCT04809974|582645951|FG002|Lead-in Phase|No longer eligible|0|||
161343760|NCT04809974|582645949|FG000|Randomized Phase|Lost to Follow-up|0|||
161343761|NCT04809974|582645950|FG001|Randomized Phase|Lost to Follow-up|1|||
161343762|NCT04809974|582645951|FG002|Randomized Phase|Lost to Follow-up|5|||
161343763|NCT04809974|582645949|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
161343764|NCT04809974|582645950|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
161343765|NCT04809974|582645951|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
161343766|NCT04809974|582645949|FG000|Randomized Phase|Adverse Event|0|||
161343767|NCT04809974|582645950|FG001|Randomized Phase|Adverse Event|1|||
161343768|NCT04809974|582645951|FG002|Randomized Phase|Adverse Event|4|||
161343769|NCT04809974|582645949|FG000|Randomized Phase|Withdrawal by Subject|0|||
161343770|NCT04809974|582645950|FG001|Randomized Phase|Withdrawal by Subject|0|||
161343771|NCT04809974|582645951|FG002|Randomized Phase|Withdrawal by Subject|5|||
161343772|NCT00549055|582645952|FG000|Overall Study|Adverse Event|4|||
161343773|NCT00549055|582645952|FG000|Overall Study|Lack of Efficacy|18|||
161343774|NCT00549055|582645952|FG000|Overall Study|Stabilization|5|||
161343775|NCT00549055|582645952|FG000|Overall Study|Progression to fibrosis|2|||
160972478|NCT03017235|581289118|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
160972479|NCT02254408|581289123|FG000|Overall Study|Randomized But Not Treated|1|||
160972480|NCT02254408|581289124|FG001|Overall Study|Randomized But Not Treated|3|||
160972481|NCT02254408|581289123|FG000|Overall Study|Adverse Event|1|||
160972482|NCT02254408|581289124|FG001|Overall Study|Adverse Event|0|||
160972483|NCT02254408|581289123|FG000|Overall Study|Death|2|||
160972484|NCT02254408|581289124|FG001|Overall Study|Death|3|||
160972485|NCT02254408|581289123|FG000|Overall Study|Investigator's Discretion|0|||
161343776|NCT00549055|582645952|FG000|Overall Study|Decrease of size|1|||
161343777|NCT00549055|582645952|FG000|Overall Study|Active choroidal neovascula increased|1|||
161343778|NCT00549055|582645952|FG000|Overall Study|Vitreous hemorrhage|1|||
161343779|NCT00549055|582645952|FG000|Overall Study|Growth choroidal neovascularisation|1|||
161343780|NCT00549055|582645952|FG000|Overall Study|Choroidal neovascularization|1|||
160972486|NCT02254408|581289124|FG001|Overall Study|Investigator's Discretion|1|||
161148798|NCT04760314|581926148|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161148799|NCT04760314|581926149|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
161148800|NCT04760314|581926139|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148801|NCT04760314|581926140|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148802|NCT04760314|581926141|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148803|NCT04760314|581926142|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148804|NCT04760314|581926143|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148805|NCT04760314|581926144|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148806|NCT04760314|581926145|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148807|NCT04760314|581926146|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
161148808|NCT04760314|581926147|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
161148809|NCT04760314|581926148|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
161148810|NCT04760314|581926149|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
161148811|NCT04760314|581926139|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148812|NCT04760314|581926140|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148813|NCT04760314|581926141|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148814|NCT04760314|581926142|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148815|NCT04760314|581926143|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148816|NCT04760314|581926144|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148817|NCT04760314|581926145|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148818|NCT04760314|581926146|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
161148819|NCT04760314|581926147|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148820|NCT04760314|581926148|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148821|NCT04760314|581926149|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
161148822|NCT04760314|581926139|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
161148823|NCT04760314|581926140|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
161148824|NCT04760314|581926141|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
161148825|NCT04760314|581926142|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
160972487|NCT02254408|581289123|FG000|Overall Study|Withdrawal by Subject|3|||
160972488|NCT02254408|581289124|FG001|Overall Study|Withdrawal by Subject|3|||
160972489|NCT02254408|581289123|FG000|Overall Study|Lost to Follow-up|1|||
160972490|NCT02254408|581289124|FG001|Overall Study|Lost to Follow-up|0|||
160972491|NCT00917267|581289125|FG000|Overall Study|Adverse Event|15|||
160972492|NCT00917267|581289126|FG001|Overall Study|Adverse Event|36|||
160972493|NCT00917267|581289125|FG000|Overall Study|Physician Decision|2|||
160972494|NCT00917267|581289126|FG001|Overall Study|Physician Decision|4|||
160972495|NCT00917267|581289125|FG000|Overall Study|Protocol Violation|9|||
160972496|NCT00917267|581289126|FG001|Overall Study|Protocol Violation|18|||
160972497|NCT00917267|581289125|FG000|Overall Study|Withdrawal by Subject|5|||
160972498|NCT00917267|581289126|FG001|Overall Study|Withdrawal by Subject|12|||
160972499|NCT00917267|581289125|FG000|Overall Study|Lost to follow up|0|||
160972500|NCT00917267|581289126|FG001|Overall Study|Lost to follow up|2|||
160972501|NCT00917267|581289125|FG000|Overall Study|Entry Criteria Not Met|1|||
160972502|NCT00917267|581289126|FG001|Overall Study|Entry Criteria Not Met|0|||
160972503|NCT00917267|581289125|FG000|Overall Study|Sponsor Decision|5|||
160972504|NCT00917267|581289126|FG001|Overall Study|Sponsor Decision|5|||
161024050|NCT03854227|581479577|FG004|Overall Study|Progressive disease|3|||
161024051|NCT03854227|581479578|FG005|Overall Study|Progressive disease|1|||
161024052|NCT03854227|581479579|FG006|Overall Study|Progressive disease|2|||
161024053|NCT03854227|581479580|FG007|Overall Study|Progressive disease|5|||
161024054|NCT03854227|581479581|FG008|Overall Study|Progressive disease|2|||
161024055|NCT03854227|581479582|FG009|Overall Study|Progressive disease|5|||
161024056|NCT03854227|581479583|FG010|Overall Study|Progressive disease|1|||
161024057|NCT03854227|581479584|FG011|Overall Study|Progressive disease|6|||
161024058|NCT03854227|581479573|FG000|Overall Study|Study terminated by sponsor|0|||
161024059|NCT03854227|581479574|FG001|Overall Study|Study terminated by sponsor|0|||
161024060|NCT03854227|581479575|FG002|Overall Study|Study terminated by sponsor|0|||
161024061|NCT03854227|581479576|FG003|Overall Study|Study terminated by sponsor|0|||
161024062|NCT03854227|581479577|FG004|Overall Study|Study terminated by sponsor|0|||
161024063|NCT03854227|581479578|FG005|Overall Study|Study terminated by sponsor|0|||
161024064|NCT03854227|581479579|FG006|Overall Study|Study terminated by sponsor|0|||
161024065|NCT03854227|581479580|FG007|Overall Study|Study terminated by sponsor|0|||
161024066|NCT03854227|581479581|FG008|Overall Study|Study terminated by sponsor|0|||
161024067|NCT03854227|581479582|FG009|Overall Study|Study terminated by sponsor|1|||
161024068|NCT03854227|581479583|FG010|Overall Study|Study terminated by sponsor|0|||
161024069|NCT03854227|581479584|FG011|Overall Study|Study terminated by sponsor|0|||
161024070|NCT03854227|581479573|FG000|Overall Study|Withdrawal by Subject|0|||
161274396|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
160972505|NCT00917267|581289125|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
161024071|NCT03854227|581479574|FG001|Overall Study|Withdrawal by Subject|0|||
161024072|NCT03854227|581479575|FG002|Overall Study|Withdrawal by Subject|1|||
161024073|NCT03854227|581479576|FG003|Overall Study|Withdrawal by Subject|0|||
160972506|NCT00917267|581289126|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
160972507|NCT01478113|581289129|FG000|Overall Study|Withdrawal by Subject|0|||
160972508|NCT01478113|581289130|FG001|Overall Study|Withdrawal by Subject|1|||
160972509|NCT01478113|581289129|FG000|Overall Study|Physician Decision|1|||
160972510|NCT01478113|581289130|FG001|Overall Study|Physician Decision|0|||
160972511|NCT00289770|581289131|FG000|Year 15|Withdrawal by Subject|1|||
160972512|NCT00423293|581289132|FG000|Overall Study|Ineligible / No protocol treatment|11|||
160972513|NCT02966002|581289139|FG000|Overall Study|Withdrawal by Subject|2|||
160972514|NCT02966002|581289139|FG000|Overall Study|Adverse Event|1|||
160972515|NCT02966002|581289139|FG000|Overall Study|Lost to Follow-up|1|||
160972516|NCT00067990|581289141|FG000|Overall Study|Death|5|||
160972517|NCT00067990|581289142|FG001|Overall Study|Death|7|||
160972518|NCT00067990|581289141|FG000|Overall Study|ESRD, Non IF/TA|1|||
160972519|NCT00067990|581289142|FG001|Overall Study|ESRD, Non IF/TA|3|||
160972520|NCT00067990|581289141|FG000|Overall Study|Withdrawal by Subject|4|||
160972521|NCT00067990|581289142|FG001|Overall Study|Withdrawal by Subject|12|||
160972522|NCT02291432|581289143|FG000|Overall Study|Withdrawal by Subject|2|||
160972523|NCT00519896|581289144|FG000|Overall Study|Protocol Violation|1|||
160972524|NCT00519896|581289144|FG000|Overall Study|Adverse Event|1|||
160972525|NCT03327402|581289145|FG000|Overall Study|Withdrawal by Subject|1|||
160972526|NCT03327402|581289145|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
160972527|NCT03810313|581289146|FG000|Overall Study|Study terminated by sponsor|164|||
160972528|NCT03810313|581289147|FG001|Overall Study|Study terminated by sponsor|159|||
160972529|NCT03810313|581289146|FG000|Overall Study|Subject decision|10|||
160972530|NCT03810313|581289147|FG001|Overall Study|Subject decision|11|||
161274397|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274398|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274399|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274400|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274401|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274402|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274403|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274404|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274405|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
161274406|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274407|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274408|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274409|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
161274410|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274411|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274412|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274413|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274414|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274415|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274416|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274417|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274418|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274419|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274420|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274421|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274422|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
161274423|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
161274424|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274425|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274426|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274427|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274428|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274429|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274430|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274431|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274432|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274433|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274434|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
161274435|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
161274436|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
160972531|NCT03810313|581289146|FG000|Overall Study|Lost to Follow-up|3|||
160972532|NCT03810313|581289147|FG001|Overall Study|Lost to Follow-up|3|||
160972533|NCT03810313|581289146|FG000|Overall Study|Adverse Event|2|||
161343781|NCT00549055|582645952|FG000|Overall Study|Very low visual acuity (VA)|1|||
161343782|NCT00770809|582645953|FG000|Overall Study|Adverse Event|9|||
161343783|NCT00770809|582645954|FG001|Overall Study|Adverse Event|1|||
161343784|NCT00770809|582645955|FG002|Overall Study|Adverse Event|12|||
161343785|NCT00770809|582645953|FG000|Overall Study|Death|1|||
161024074|NCT03854227|581479577|FG004|Overall Study|Withdrawal by Subject|0|||
161024075|NCT03854227|581479578|FG005|Overall Study|Withdrawal by Subject|0|||
161024076|NCT03854227|581479579|FG006|Overall Study|Withdrawal by Subject|0|||
161274437|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
161274438|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274439|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274440|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274441|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274442|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274443|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274444|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274445|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274446|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274447|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274448|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274449|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274450|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
161274451|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
161274452|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274453|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274454|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274455|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274456|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274457|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274458|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274459|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274460|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274461|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274462|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274463|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
161274464|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
161274465|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
161274466|NCT03982199|582382554|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274467|NCT03982199|582382555|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274468|NCT03982199|582382556|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274469|NCT03982199|582382557|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274470|NCT03982199|582382558|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274471|NCT03982199|582382559|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274472|NCT03982199|582382560|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274473|NCT03982199|582382561|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274474|NCT03982199|582382562|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274475|NCT03982199|582382563|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274476|NCT03982199|582382564|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274477|NCT03982199|582382565|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274478|NCT03982199|582382566|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
161274479|NCT03982199|582382567|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
161274480|NCT03433755|582382568|FG000|Overall Study|Lost to Follow-up|1|||
161274481|NCT03433755|582382569|FG001|Overall Study|Lost to Follow-up|0|||
161274482|NCT03433755|582382570|FG002|Overall Study|Lost to Follow-up|0|||
161274483|NCT03433755|582382571|FG003|Overall Study|Lost to Follow-up|0|||
161274484|NCT03433755|582382568|FG000|Overall Study|Decision by Sponsor|1|||
161274485|NCT03433755|582382569|FG001|Overall Study|Decision by Sponsor|0|||
161274486|NCT03433755|582382570|FG002|Overall Study|Decision by Sponsor|0|||
161274487|NCT03433755|582382571|FG003|Overall Study|Decision by Sponsor|0|||
161274488|NCT05065567|582382573|FG000|Overall Study|Lost to Follow-up|10|||
161274489|NCT05065567|582382574|FG001|Overall Study|Lost to Follow-up|9|||
161274490|NCT05065567|582382575|FG002|Overall Study|Lost to Follow-up|6|||
161274491|NCT05323123|582382576|FG000|Overall Study|Withdrawal by Subject|2|||
161274492|NCT05323123|582382577|FG001|Overall Study|Withdrawal by Subject|1|||
161274493|NCT05323123|582382576|FG000|Overall Study|Lost to Follow-up|4|||
161343786|NCT00770809|582645954|FG001|Overall Study|Death|0|||
161343787|NCT00770809|582645955|FG002|Overall Study|Death|0|||
161343788|NCT00770809|582645953|FG000|Overall Study|Withdrawal by Subject|3|||
161024077|NCT03854227|581479580|FG007|Overall Study|Withdrawal by Subject|0|||
161274494|NCT05323123|582382577|FG001|Overall Study|Lost to Follow-up|2|||
161274495|NCT05323123|582382576|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
161274496|NCT05323123|582382577|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
161274497|NCT05529472|582382578|FG000|Overall Study|Withdrawal by Subject|1|||
160972534|NCT03810313|581289147|FG001|Overall Study|Adverse Event|1|||
160972535|NCT03810313|581289146|FG000|Overall Study|Death|2|||
160972536|NCT03810313|581289147|FG001|Overall Study|Death|1|||
160972537|NCT03810313|581289146|FG000|Overall Study|Physician Decision|0|||
160972538|NCT03810313|581289147|FG001|Overall Study|Physician Decision|1|||
160972539|NCT00301080|581289153|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
160972540|NCT00301080|581289154|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972541|NCT00301080|581289155|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972542|NCT00301080|581289156|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972543|NCT00301080|581289157|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
160972544|NCT02567825|581289160|FG000|Overall Study|No follow-up post-randomization|5|||
160972545|NCT02567825|581289161|FG001|Overall Study|No follow-up post-randomization|1|||
160972546|NCT02567825|581289160|FG000|Overall Study|Follow-up less than 23 months|16|||
160972547|NCT02567825|581289161|FG001|Overall Study|Follow-up less than 23 months|20|||
160972548|NCT03097861|581289166|FG000|Overall Study|Adverse Event|3|||
160972549|NCT03097861|581289167|FG001|Overall Study|Adverse Event|8|||
160972550|NCT03097861|581289168|FG002|Overall Study|Adverse Event|4|||
160972551|NCT03097861|581289166|FG000|Overall Study|Investigator Decision|0|||
160972552|NCT03097861|581289167|FG001|Overall Study|Investigator Decision|1|||
160972553|NCT03097861|581289168|FG002|Overall Study|Investigator Decision|0|||
160972554|NCT03097861|581289166|FG000|Overall Study|Lost to Follow-up|0|||
160972555|NCT03097861|581289167|FG001|Overall Study|Lost to Follow-up|7|||
160972556|NCT03097861|581289168|FG002|Overall Study|Lost to Follow-up|1|||
160972557|NCT03097861|581289166|FG000|Overall Study|Withdrawal by Subject|1|||
160972558|NCT03097861|581289167|FG001|Overall Study|Withdrawal by Subject|5|||
160972559|NCT03097861|581289168|FG002|Overall Study|Withdrawal by Subject|3|||
160972560|NCT03097861|581289166|FG000|Overall Study|Reason not provided|3|||
160972561|NCT03097861|581289167|FG001|Overall Study|Reason not provided|1|||
160972562|NCT03097861|581289168|FG002|Overall Study|Reason not provided|1|||
160972563|NCT05061537|581289172|FG000|Treatment Phase|Progressive disease|0|||
160972564|NCT05061537|581289173|FG001|Treatment Phase|Progressive disease|1|||
160972565|NCT05061537|581289174|FG002|Treatment Phase|Progressive disease|2|||
160972566|NCT05061537|581289175|FG003|Treatment Phase|Progressive disease|0|||
160972567|NCT05061537|581289176|FG004|Treatment Phase|Progressive disease|0|||
160972568|NCT05061537|581289172|FG000|Treatment Phase|Adverse Event|0|||
160972569|NCT05061537|581289173|FG001|Treatment Phase|Adverse Event|0|||
160972570|NCT05061537|581289174|FG002|Treatment Phase|Adverse Event|2|||
160972571|NCT05061537|581289175|FG003|Treatment Phase|Adverse Event|0|||
160972572|NCT05061537|581289176|FG004|Treatment Phase|Adverse Event|0|||
160972573|NCT05061537|581289172|FG000|Treatment Phase|Global deterioration of health status|0|||
160972574|NCT05061537|581289173|FG001|Treatment Phase|Global deterioration of health status|1|||
160972575|NCT05061537|581289174|FG002|Treatment Phase|Global deterioration of health status|0|||
160972576|NCT05061537|581289175|FG003|Treatment Phase|Global deterioration of health status|0|||
160972577|NCT05061537|581289176|FG004|Treatment Phase|Global deterioration of health status|0|||
160972578|NCT05061537|581289172|FG000|Follow up|Other|2|||
160972579|NCT05061537|581289173|FG001|Follow up|Other|0|||
160972580|NCT05061537|581289174|FG002|Follow up|Other|2|||
160972581|NCT05061537|581289175|FG003|Follow up|Other|0|||
160972582|NCT05061537|581289176|FG004|Follow up|Other|0|||
160972583|NCT05061537|581289172|FG000|Follow up|Study terminated by sponsor|0|||
160972584|NCT05061537|581289173|FG001|Follow up|Study terminated by sponsor|0|||
160972585|NCT05061537|581289174|FG002|Follow up|Study terminated by sponsor|2|||
160972586|NCT05061537|581289175|FG003|Follow up|Study terminated by sponsor|0|||
160972587|NCT05061537|581289176|FG004|Follow up|Study terminated by sponsor|0|||
160972588|NCT05061537|581289172|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
160972589|NCT05061537|581289173|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
160972590|NCT05061537|581289174|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
160972591|NCT05061537|581289175|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
160972592|NCT05061537|581289176|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
160972593|NCT05061537|581289172|FG000|Long-term Follow-up|Death|0|||
160972594|NCT05061537|581289173|FG001|Long-term Follow-up|Death|1|||
160972595|NCT05061537|581289174|FG002|Long-term Follow-up|Death|0|||
160972596|NCT05061537|581289175|FG003|Long-term Follow-up|Death|0|||
160972597|NCT05061537|581289176|FG004|Long-term Follow-up|Death|0|||
160972598|NCT03502616|581289177|FG000|Up to Week 16|Withdrawal by Subject|1|||
160972599|NCT03502616|581289178|FG001|Up to Week 16|Withdrawal by Subject|2|||
160972600|NCT03502616|581289177|FG000|Up to Week 16|Lost to Follow-up|0|||
160972601|NCT03502616|581289178|FG001|Up to Week 16|Lost to Follow-up|1|||
160972602|NCT03502616|581289177|FG000|Up to Week 16|Randomized, but not treated|1|||
160972603|NCT03502616|581289178|FG001|Up to Week 16|Randomized, but not treated|0|||
160972604|NCT03502616|581289177|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
160972605|NCT03502616|581289178|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
160972606|NCT03502616|581289177|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
160972607|NCT03502616|581289178|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
160972608|NCT01785563|581289179|FG000|Overall Study|Physician Decision|10|||
160972609|NCT01785563|581289179|FG000|Overall Study|Withdrawal by Subject|1|||
160972610|NCT01785563|581289179|FG000|Overall Study|Protocol Violation|2|||
160972611|NCT01872910|581289181|FG000|Overall Study|Lost to Follow-up|2|||
160972612|NCT01872910|581289182|FG001|Overall Study|Lost to Follow-up|0|||
160972613|NCT01872910|581289183|FG002|Overall Study|Lost to Follow-up|2|||
160972614|NCT01872910|581289184|FG003|Overall Study|Lost to Follow-up|0|||
160972615|NCT01872910|581289185|FG004|Overall Study|Lost to Follow-up|0|||
160972616|NCT01872910|581289186|FG005|Overall Study|Lost to Follow-up|0|||
160972617|NCT01540565|581289192|FG000|Overall Study|Ineligible|2|||
160972618|NCT03469349|581289193|FG000|Overall Study|Withdrawal by Subject|1|||
160972619|NCT03469349|581289194|FG001|Overall Study|Withdrawal by Subject|3|||
160972620|NCT03469349|581289193|FG000|Overall Study|Progressive Disease|0|||
160972621|NCT03469349|581289194|FG001|Overall Study|Progressive Disease|1|||
160972622|NCT03469349|581289193|FG000|Overall Study|Lost to Follow-up|2|||
160972623|NCT03469349|581289194|FG001|Overall Study|Lost to Follow-up|2|||
160972624|NCT03469349|581289193|FG000|Overall Study|Adverse Event|2|||
160972625|NCT03469349|581289194|FG001|Overall Study|Adverse Event|4|||
160972626|NCT01225822|581289211|FG000|Overall Study|Adverse Event|13|||
160972627|NCT01225822|581289212|FG001|Overall Study|Adverse Event|31|||
160972628|NCT01225822|581289213|FG002|Overall Study|Adverse Event|18|||
160972629|NCT01225822|581289214|FG003|Overall Study|Adverse Event|23|||
160972630|NCT01225822|581289215|FG004|Overall Study|Adverse Event|14|||
160972631|NCT01225822|581289211|FG000|Overall Study|Protocol Violation|6|||
160972632|NCT01225822|581289212|FG001|Overall Study|Protocol Violation|8|||
160972633|NCT01225822|581289213|FG002|Overall Study|Protocol Violation|6|||
160972634|NCT01225822|581289214|FG003|Overall Study|Protocol Violation|7|||
160972635|NCT01225822|581289215|FG004|Overall Study|Protocol Violation|4|||
160972636|NCT01225822|581289211|FG000|Overall Study|Lost to Follow-up|0|||
160972637|NCT01225822|581289212|FG001|Overall Study|Lost to Follow-up|0|||
160972638|NCT01225822|581289213|FG002|Overall Study|Lost to Follow-up|0|||
160972639|NCT01225822|581289214|FG003|Overall Study|Lost to Follow-up|1|||
160972640|NCT01225822|581289215|FG004|Overall Study|Lost to Follow-up|0|||
160972641|NCT01225822|581289211|FG000|Overall Study|Withdrawal by Subject|6|||
160972642|NCT01225822|581289212|FG001|Overall Study|Withdrawal by Subject|7|||
160972643|NCT01225822|581289213|FG002|Overall Study|Withdrawal by Subject|7|||
160972644|NCT01225822|581289214|FG003|Overall Study|Withdrawal by Subject|11|||
160972645|NCT01225822|581289215|FG004|Overall Study|Withdrawal by Subject|6|||
160972646|NCT01225822|581289211|FG000|Overall Study|Other|13|||
160972647|NCT01225822|581289212|FG001|Overall Study|Other|10|||
160972648|NCT01225822|581289213|FG002|Overall Study|Other|7|||
160972649|NCT01225822|581289214|FG003|Overall Study|Other|10|||
160972650|NCT01225822|581289215|FG004|Overall Study|Other|7|||
160972651|NCT04078035|581289218|FG000|Session 2|Lost to Follow-up|3|||
160972652|NCT04078035|581289219|FG001|Session 2|Lost to Follow-up|1|||
160972653|NCT04078035|581289218|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
160972654|NCT04078035|581289219|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
160972655|NCT04296890|581289220|FG000|Overall Study|Withdrawal by Subject|1|||
160972656|NCT04296890|581289220|FG000|Overall Study|Death|62|||
160972657|NCT04296890|581289220|FG000|Overall Study|Lost to Follow-up|3|||
160972658|NCT04296890|581289220|FG000|Overall Study|Other than specified|2|||
160972659|NCT02978443|581289222|FG000|Overall Study|Withdrawal by Subject|1|||
160972660|NCT02978443|581289222|FG000|Overall Study|Adverse Event|3|||
161024078|NCT03854227|581479581|FG008|Overall Study|Withdrawal by Subject|0|||
161024079|NCT03854227|581479582|FG009|Overall Study|Withdrawal by Subject|1|||
161024080|NCT03854227|581479583|FG010|Overall Study|Withdrawal by Subject|1|||
161024081|NCT03854227|581479584|FG011|Overall Study|Withdrawal by Subject|0|||
161024082|NCT03854227|581479573|FG000|Overall Study|Disease relapse|0|||
161024083|NCT03854227|581479574|FG001|Overall Study|Disease relapse|0|||
161024084|NCT03854227|581479575|FG002|Overall Study|Disease relapse|0|||
160972661|NCT02978443|581289222|FG000|Overall Study|Disease Progression on study|6|||
161024085|NCT03854227|581479576|FG003|Overall Study|Disease relapse|0|||
161024086|NCT03854227|581479577|FG004|Overall Study|Disease relapse|0|||
161024087|NCT03854227|581479578|FG005|Overall Study|Disease relapse|0|||
161024088|NCT03854227|581479579|FG006|Overall Study|Disease relapse|0|||
161024089|NCT03854227|581479580|FG007|Overall Study|Disease relapse|0|||
161024090|NCT03854227|581479581|FG008|Overall Study|Disease relapse|1|||
161024091|NCT03854227|581479582|FG009|Overall Study|Disease relapse|0|||
161024092|NCT03854227|581479583|FG010|Overall Study|Disease relapse|0|||
161024093|NCT03854227|581479584|FG011|Overall Study|Disease relapse|0|||
161024094|NCT03854227|581479573|FG000|Overall Study|Global deterioration of health status|0|||
161024095|NCT03854227|581479574|FG001|Overall Study|Global deterioration of health status|0|||
161024096|NCT03854227|581479575|FG002|Overall Study|Global deterioration of health status|0|||
160972662|NCT02978443|581289222|FG000|Overall Study|Death|1|||
161024097|NCT03854227|581479576|FG003|Overall Study|Global deterioration of health status|0|||
161024098|NCT03854227|581479577|FG004|Overall Study|Global deterioration of health status|0|||
160972663|NCT02978443|581289222|FG000|Overall Study|Physician Decision|1|||
160972664|NCT02978443|581289222|FG000|Overall Study|Switch to alternative therapy|1|||
160972665|NCT02978443|581289222|FG000|Overall Study|Refused further treatment|1|||
160972666|NCT01279343|581289224|FG000|Overall Study|Did not receive treatment|2|||
160972667|NCT01279343|581289225|FG001|Overall Study|Did not receive treatment|6|||
160972668|NCT03287414|581289226|FG000|Treatment Epoch|Adverse Event|0|||
160972669|NCT03287414|581289227|FG001|Treatment Epoch|Adverse Event|1|||
160972670|NCT03287414|581289226|FG000|Treatment Epoch|Study terminated by sponsor|2|||
160972671|NCT03287414|581289227|FG001|Treatment Epoch|Study terminated by sponsor|2|||
160972672|NCT03287414|581289226|FG000|Treatment Epoch|Subject/Guardian decision|4|||
160972673|NCT03287414|581289227|FG001|Treatment Epoch|Subject/Guardian decision|0|||
160972674|NCT03287414|581289226|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
160972675|NCT03287414|581289227|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
160972676|NCT03287414|581289226|FG000|Treatment Epoch|Withdrawal by Subject|1|||
160972677|NCT03287414|581289227|FG001|Treatment Epoch|Withdrawal by Subject|0|||
160972678|NCT03287414|581289226|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
160972679|NCT03287414|581289227|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
160972680|NCT03287414|581289226|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
160972681|NCT03287414|581289227|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
160972682|NCT02613221|581289230|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
160972683|NCT02613221|581289230|FG000|Overall Study|Adverse Event|2|||
160972684|NCT02613221|581289230|FG000|Overall Study|Voluntary Discontinuation|1|||
160972685|NCT02613221|581289230|FG000|Overall Study|Delayed Treatment|1|||
160972686|NCT02613221|581289230|FG000|Overall Study|Enrolled but Not Treated|1|||
160972687|NCT01353222|581289235|FG000|Overall Study|Death|30|||
160972688|NCT01353222|581289236|FG001|Overall Study|Death|30|||
160972689|NCT01353222|581289235|FG000|Overall Study|Withdrawal by Subject|8|||
160972690|NCT01353222|581289236|FG001|Overall Study|Withdrawal by Subject|5|||
160972691|NCT01353222|581289235|FG000|Overall Study|Study Terminated|31|||
160972692|NCT01353222|581289236|FG001|Overall Study|Study Terminated|37|||
160972693|NCT01353222|581289235|FG000|Overall Study|Site closed research department|1|||
160972694|NCT01353222|581289236|FG001|Overall Study|Site closed research department|0|||
160972695|NCT01119898|581289237|FG000|Overall Study|Adverse Event|4|||
160972696|NCT01119898|581289238|FG001|Overall Study|Adverse Event|5|||
160972697|NCT01119898|581289237|FG000|Overall Study|Withdrawal by Subject|1|||
160972698|NCT01119898|581289238|FG001|Overall Study|Withdrawal by Subject|4|||
160972699|NCT01119898|581289237|FG000|Overall Study|Lack of Efficacy|0|||
160972700|NCT01119898|581289238|FG001|Overall Study|Lack of Efficacy|2|||
160972701|NCT01119898|581289237|FG000|Overall Study|Protocol Violation|1|||
160972702|NCT01119898|581289238|FG001|Overall Study|Protocol Violation|1|||
160972703|NCT01119898|581289237|FG000|Overall Study|Medical procedure|1|||
160972704|NCT01119898|581289238|FG001|Overall Study|Medical procedure|0|||
160972705|NCT01119898|581289237|FG000|Overall Study|Randomized in error did not participate|1|||
160972706|NCT01119898|581289238|FG001|Overall Study|Randomized in error did not participate|0|||
160972707|NCT01807650|581289241|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
160972708|NCT01807650|581289241|FG000|Overall Study|Adverse Event|5|||
160972709|NCT01807650|581289241|FG000|Overall Study|Other|2|||
160972710|NCT02217280|581289242|FG000|Overall Study|Withdrawal by Subject|2|||
160972711|NCT02217280|581289242|FG000|Overall Study|Post-consent sceen fail|2|||
160972712|NCT03573908|581289248|FG000|Treatment Period|Adverse Event|4|||
160972713|NCT03573908|581289249|FG001|Treatment Period|Adverse Event|9|||
160972714|NCT03573908|581289250|FG002|Treatment Period|Adverse Event|0|||
160972715|NCT03573908|581289251|FG003|Treatment Period|Adverse Event|0|||
160972716|NCT03573908|581289252|FG004|Treatment Period|Adverse Event|0|||
160972717|NCT03573908|581289248|FG000|Treatment Period|Protocol Violation|1|||
160972718|NCT03573908|581289249|FG001|Treatment Period|Protocol Violation|0|||
160972719|NCT03573908|581289250|FG002|Treatment Period|Protocol Violation|0|||
160972720|NCT03573908|581289251|FG003|Treatment Period|Protocol Violation|0|||
160972721|NCT03573908|581289252|FG004|Treatment Period|Protocol Violation|0|||
160972722|NCT03573908|581289248|FG000|Treatment Period|Withdrawal by Subject|7|||
160972723|NCT03573908|581289249|FG001|Treatment Period|Withdrawal by Subject|5|||
160972724|NCT03573908|581289250|FG002|Treatment Period|Withdrawal by Subject|0|||
160972725|NCT03573908|581289251|FG003|Treatment Period|Withdrawal by Subject|0|||
160972726|NCT03573908|581289252|FG004|Treatment Period|Withdrawal by Subject|0|||
160972727|NCT03573908|581289248|FG000|Treatment Period|Lost to Follow-up|7|||
160972728|NCT03573908|581289249|FG001|Treatment Period|Lost to Follow-up|6|||
160972729|NCT03573908|581289250|FG002|Treatment Period|Lost to Follow-up|0|||
160972730|NCT03573908|581289251|FG003|Treatment Period|Lost to Follow-up|0|||
160972731|NCT03573908|581289252|FG004|Treatment Period|Lost to Follow-up|0|||
160972732|NCT03573908|581289248|FG000|Treatment Period|Pregnancy|1|||
160972733|NCT03573908|581289249|FG001|Treatment Period|Pregnancy|0|||
160972734|NCT03573908|581289250|FG002|Treatment Period|Pregnancy|0|||
160972735|NCT03573908|581289251|FG003|Treatment Period|Pregnancy|0|||
161274498|NCT05529472|582382579|FG001|Overall Study|Withdrawal by Subject|1|||
161274499|NCT02886624|582384662|FG000|12-week Post Treatment Follow-up|Death|1|||
161274500|NCT02886624|582384662|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
161274501|NCT00359801|582384667|FG000|Overall Study|Lost to Follow-up|72|||
161274502|NCT00359801|582384668|FG001|Overall Study|Lost to Follow-up|58|||
161274503|NCT00359801|582384667|FG000|Overall Study|Withdrawal by Subject|143|||
161274504|NCT00359801|582384668|FG001|Overall Study|Withdrawal by Subject|96|||
161274505|NCT00359801|582384667|FG000|Overall Study|Other|66|||
161274506|NCT00359801|582384668|FG001|Overall Study|Other|46|||
161274507|NCT00359801|582384667|FG000|Overall Study|Final Status Unknown: missing data|7|||
161274508|NCT00359801|582384668|FG001|Overall Study|Final Status Unknown: missing data|4|||
161274509|NCT00359801|582384667|FG000|Overall Study|Sponsor Decision|17|||
161274510|NCT00359801|582384668|FG001|Overall Study|Sponsor Decision|16|||
161274511|NCT02929056|582384674|FG000|Overall Study|Lost to Follow-up|0|||
161274512|NCT02929056|582384675|FG001|Overall Study|Lost to Follow-up|1|||
161274513|NCT02245412|582384681|FG000|Treatment Period|Death|1|||
161274514|NCT02245412|582384682|FG001|Treatment Period|Death|1|||
161274515|NCT02245412|582384683|FG002|Treatment Period|Death|0|||
161274516|NCT02245412|582384681|FG000|Treatment Period|Physician Decision|1|||
161274517|NCT02245412|582384682|FG001|Treatment Period|Physician Decision|1|||
161274518|NCT02245412|582384683|FG002|Treatment Period|Physician Decision|0|||
161274519|NCT02245412|582384681|FG000|Treatment Period|Withdrawal by Subject|2|||
161274520|NCT02245412|582384682|FG001|Treatment Period|Withdrawal by Subject|1|||
161274521|NCT02245412|582384683|FG002|Treatment Period|Withdrawal by Subject|0|||
161274522|NCT02245412|582384681|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
161274523|NCT02245412|582384682|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
161274524|NCT02245412|582384683|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
161274525|NCT02245412|582384681|FG000|Follow-Up Period|Death|4|||
161274526|NCT02245412|582384682|FG001|Follow-Up Period|Death|2|||
161274527|NCT02245412|582384683|FG002|Follow-Up Period|Death|1|||
161274528|NCT02245412|582384681|FG000|Follow-Up Period|Physician Decision|1|||
161274529|NCT02245412|582384682|FG001|Follow-Up Period|Physician Decision|0|||
161274530|NCT02245412|582384683|FG002|Follow-Up Period|Physician Decision|0|||
161343789|NCT00770809|582645954|FG001|Overall Study|Withdrawal by Subject|3|||
161343790|NCT00770809|582645955|FG002|Overall Study|Withdrawal by Subject|7|||
161343791|NCT00770809|582645953|FG000|Overall Study|Progression|2|||
160972736|NCT03573908|581289252|FG004|Treatment Period|Pregnancy|0|||
160972737|NCT03573908|581289248|FG000|Treatment Period|Other, Not Specified|4|||
160972738|NCT03573908|581289249|FG001|Treatment Period|Other, Not Specified|6|||
160972739|NCT03573908|581289250|FG002|Treatment Period|Other, Not Specified|0|||
160972740|NCT03573908|581289251|FG003|Treatment Period|Other, Not Specified|0|||
160972741|NCT03573908|581289252|FG004|Treatment Period|Other, Not Specified|0|||
160972742|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Adverse Event|0|||
160972743|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Adverse Event|0|||
160972744|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Adverse Event|3|||
160972745|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Adverse Event|0|||
160972746|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Adverse Event|0|||
160972747|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972748|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972749|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972750|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
160972751|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
160972752|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972753|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972754|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
160972755|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972756|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
160972757|NCT03573908|581289248|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
160972758|NCT03573908|581289249|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
160972759|NCT03573908|581289250|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
160972760|NCT03573908|581289251|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
160972761|NCT03573908|581289252|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
160972762|NCT04006925|581289253|FG000|Overall Study|Side effects|2|||
160972763|NCT04006925|581289254|FG001|Overall Study|Side effects|0|||
160972764|NCT02906683|581291016|FG000|Overall Study|Adverse Event|0|||
160972765|NCT02906683|581291017|FG001|Overall Study|Adverse Event|1|||
160972766|NCT02906683|581291018|FG002|Overall Study|Adverse Event|0|||
160972767|NCT02906683|581291016|FG000|Overall Study|Physician Decision|0|||
160972768|NCT02906683|581291017|FG001|Overall Study|Physician Decision|1|||
160972769|NCT02906683|581291018|FG002|Overall Study|Physician Decision|1|||
160972770|NCT02906683|581291016|FG000|Overall Study|Withdrawal by Subject|0|||
160972771|NCT02906683|581291017|FG001|Overall Study|Withdrawal by Subject|2|||
160972772|NCT02906683|581291018|FG002|Overall Study|Withdrawal by Subject|1|||
161274531|NCT02245412|582384681|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
161274532|NCT02245412|582384682|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
161024099|NCT03854227|581479578|FG005|Overall Study|Global deterioration of health status|1|||
161024100|NCT03854227|581479579|FG006|Overall Study|Global deterioration of health status|0|||
161024101|NCT03854227|581479580|FG007|Overall Study|Global deterioration of health status|1|||
161024102|NCT03854227|581479581|FG008|Overall Study|Global deterioration of health status|0|||
161024103|NCT03854227|581479582|FG009|Overall Study|Global deterioration of health status|0|||
161024104|NCT03854227|581479583|FG010|Overall Study|Global deterioration of health status|0|||
161024105|NCT03854227|581479584|FG011|Overall Study|Global deterioration of health status|0|||
161024106|NCT03854227|581479573|FG000|Overall Study|Refused further treatment|0|||
161024107|NCT03854227|581479574|FG001|Overall Study|Refused further treatment|0|||
161024108|NCT03854227|581479575|FG002|Overall Study|Refused further treatment|0|||
161024109|NCT03854227|581479576|FG003|Overall Study|Refused further treatment|0|||
161024110|NCT03854227|581479577|FG004|Overall Study|Refused further treatment|0|||
161024111|NCT03854227|581479578|FG005|Overall Study|Refused further treatment|0|||
161024112|NCT03854227|581479579|FG006|Overall Study|Refused further treatment|0|||
161024113|NCT03854227|581479580|FG007|Overall Study|Refused further treatment|0|||
161024114|NCT03854227|581479581|FG008|Overall Study|Refused further treatment|0|||
161024115|NCT03854227|581479582|FG009|Overall Study|Refused further treatment|1|||
161024116|NCT03854227|581479583|FG010|Overall Study|Refused further treatment|0|||
161024117|NCT03854227|581479584|FG011|Overall Study|Refused further treatment|1|||
161024118|NCT03854227|581479573|FG000|Overall Study|Other|0|||
161024119|NCT03854227|581479574|FG001|Overall Study|Other|0|||
161024120|NCT03854227|581479575|FG002|Overall Study|Other|0|||
161024121|NCT03854227|581479576|FG003|Overall Study|Other|0|||
161024122|NCT03854227|581479577|FG004|Overall Study|Other|0|||
161024123|NCT03854227|581479578|FG005|Overall Study|Other|0|||
161024124|NCT03854227|581479579|FG006|Overall Study|Other|0|||
161024125|NCT03854227|581479580|FG007|Overall Study|Other|0|||
161024126|NCT03854227|581479581|FG008|Overall Study|Other|1|||
161024127|NCT03854227|581479582|FG009|Overall Study|Other|1|||
161024128|NCT03854227|581479583|FG010|Overall Study|Other|0|||
161024129|NCT03854227|581479584|FG011|Overall Study|Other|0|||
161024130|NCT01574274|581479585|FG000|Overall Study|Ineligible|0|||
161024131|NCT01574274|581479586|FG001|Overall Study|Ineligible|1|||
161024132|NCT01574274|581479585|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
161024133|NCT01574274|581479586|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
161024134|NCT01574274|581479585|FG000|Overall Study|Ph+ B-ALL|3|||
161024135|NCT01574274|581479586|FG001|Overall Study|Ph+ B-ALL|4|||
161024136|NCT01574274|581479585|FG000|Overall Study|Induction Death|2|||
161024137|NCT01574274|581479586|FG001|Overall Study|Induction Death|0|||
161024138|NCT01574274|581479585|FG000|Overall Study|Induction Failure|4|||
161024139|NCT01574274|581479586|FG001|Overall Study|Induction Failure|1|||
161024140|NCT01574274|581479585|FG000|Overall Study|Adverse Event|16|||
161024141|NCT01574274|581479586|FG001|Overall Study|Adverse Event|13|||
161024142|NCT01574274|581479585|FG000|Overall Study|Remission Death|1|||
161024143|NCT01574274|581479586|FG001|Overall Study|Remission Death|0|||
161024144|NCT01574274|581479585|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
161024145|NCT01574274|581479586|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
161024146|NCT01574274|581479585|FG000|Overall Study|Other, unknown|3|||
161024147|NCT01574274|581479586|FG001|Overall Study|Other, unknown|2|||
161024148|NCT04314713|581479593|FG000|Overall Study|Lost to Follow-up|0|||
161024149|NCT04314713|581479594|FG001|Overall Study|Lost to Follow-up|0|||
161024150|NCT04314713|581479595|FG002|Overall Study|Lost to Follow-up|0|||
161024151|NCT04314713|581479596|FG003|Overall Study|Lost to Follow-up|1|||
161024152|NCT04314713|581479597|FG004|Overall Study|Lost to Follow-up|0|||
161024153|NCT04314713|581479598|FG005|Overall Study|Lost to Follow-up|0|||
161024154|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
161024155|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
161024156|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
161024157|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
161024158|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
161024159|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161024160|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
161024161|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
161024162|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161024163|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
161024164|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
161024165|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
161024166|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
161024167|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
161024168|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
161024169|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
161024170|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161024171|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
161024172|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161024173|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
161343792|NCT00770809|582645954|FG001|Overall Study|Progression|2|||
161343793|NCT00770809|582645955|FG002|Overall Study|Progression|0|||
161343794|NCT00770809|582645953|FG000|Overall Study|Complicating illness|0|||
161343795|NCT00770809|582645954|FG001|Overall Study|Complicating illness|0|||
161343796|NCT00770809|582645955|FG002|Overall Study|Complicating illness|1|||
161343797|NCT00770809|582645953|FG000|Overall Study|Other Medical Reasons|2|||
161343798|NCT00770809|582645954|FG001|Overall Study|Other Medical Reasons|4|||
161024174|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024175|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
161024176|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024177|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024178|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
161024179|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
161024180|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
161024181|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
161024182|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
161024183|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
161274533|NCT02245412|582384683|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
161274534|NCT00459043|582384684|FG000|Overall Study|Withdrawal by Subject|1|||
161274535|NCT00459043|582384685|FG001|Overall Study|Withdrawal by Subject|0|||
161274536|NCT00450801|582384688|FG000|Overall Study|Death|1|||
161274537|NCT00324649|582384689|FG000|Overall Study|Adverse Event|1|||
161274538|NCT00324649|582384690|FG001|Overall Study|Adverse Event|4|||
161274539|NCT00324649|582384689|FG000|Overall Study|Withdrawal by Subject|0|||
161274540|NCT00324649|582384690|FG001|Overall Study|Withdrawal by Subject|1|||
161274541|NCT00324649|582384689|FG000|Overall Study|Noncompliance|1|||
161274542|NCT00324649|582384690|FG001|Overall Study|Noncompliance|0|||
161274543|NCT02618759|582384691|FG000|Overall Study|Lost to Follow-up|0|||
161274544|NCT02618759|582384692|FG001|Overall Study|Lost to Follow-up|1|||
161274545|NCT02618759|582384691|FG000|Overall Study|Withdrawal by Subject|1|||
161274546|NCT02618759|582384692|FG001|Overall Study|Withdrawal by Subject|0|||
161274547|NCT02618759|582384691|FG000|Overall Study|Other Reasons|1|||
161274548|NCT02618759|582384692|FG001|Overall Study|Other Reasons|4|||
161274549|NCT02500043|582384699|FG000|Overall Study|Randomized, but not Treated|2|||
161274550|NCT02500043|582384700|FG001|Overall Study|Randomized, but not Treated|2|||
161274551|NCT02500043|582384699|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
161274552|NCT02500043|582384700|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
161274553|NCT02500043|582384699|FG000|Overall Study|Adverse Event|33|||
161274554|NCT02500043|582384700|FG001|Overall Study|Adverse Event|11|||
161274555|NCT02500043|582384699|FG000|Overall Study|Clinical Progression|54|||
161274556|NCT02500043|582384700|FG001|Overall Study|Clinical Progression|35|||
161274557|NCT02500043|582384699|FG000|Overall Study|Radiological Progression|192|||
161274558|NCT02500043|582384700|FG001|Overall Study|Radiological Progression|110|||
161274559|NCT02500043|582384699|FG000|Overall Study|Physician's Decision|11|||
161274560|NCT02500043|582384700|FG001|Overall Study|Physician's Decision|3|||
161274561|NCT02500043|582384699|FG000|Overall Study|Withdrawal by Subject|14|||
161274562|NCT02500043|582384700|FG001|Overall Study|Withdrawal by Subject|4|||
161274563|NCT02500043|582384699|FG000|Overall Study|Death|11|||
161274564|NCT02500043|582384700|FG001|Overall Study|Death|2|||
161274565|NCT02500043|582384699|FG000|Overall Study|Protocol Deviation|1|||
161274566|NCT02500043|582384700|FG001|Overall Study|Protocol Deviation|0|||
161274567|NCT00580788|582384701|FG000|Overall Study|Adverse Event|0|||
161274568|NCT00580788|582384702|FG001|Overall Study|Adverse Event|0|||
161274569|NCT00580788|582384703|FG002|Overall Study|Adverse Event|0|||
161274570|NCT00580788|582384704|FG003|Overall Study|Adverse Event|1|||
161274571|NCT03301649|582384705|FG000|Overall Study|Need alternate therapy due to live lice|17|||
161274572|NCT03301649|582384706|FG001|Overall Study|Need alternate therapy due to live lice|25|||
161274573|NCT03301649|582384707|FG002|Overall Study|Need alternate therapy due to live lice|81|||
161274574|NCT03301649|582384705|FG000|Overall Study|Lost to Follow-up|11|||
161274575|NCT03301649|582384706|FG001|Overall Study|Lost to Follow-up|11|||
161274576|NCT03301649|582384707|FG002|Overall Study|Lost to Follow-up|3|||
161274577|NCT03301649|582384705|FG000|Overall Study|Protocol Violation|0|||
161274578|NCT03301649|582384706|FG001|Overall Study|Protocol Violation|1|||
161274579|NCT03301649|582384707|FG002|Overall Study|Protocol Violation|1|||
161274580|NCT03301649|582384705|FG000|Overall Study|Withdrawal by Subject|10|||
161024184|NCT03852472|581479603|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
161274581|NCT03301649|582384706|FG001|Overall Study|Withdrawal by Subject|4|||
161274582|NCT03301649|582384707|FG002|Overall Study|Withdrawal by Subject|0|||
161343799|NCT00770809|582645955|FG002|Overall Study|Other Medical Reasons|3|||
161274583|NCT03301649|582384705|FG000|Overall Study|Other than specified|5|||
161274584|NCT03301649|582384706|FG001|Overall Study|Other than specified|3|||
161274585|NCT03301649|582384707|FG002|Overall Study|Other than specified|0|||
161274586|NCT01403051|582384708|FG000|Overall Study|Protocol Violation|2|||
161274587|NCT01403051|582384709|FG001|Overall Study|Protocol Violation|0|||
161274588|NCT01403051|582384708|FG000|Overall Study|Death|1|||
161343800|NCT00764517|582645960|FG000|Overall Study|Adverse Event|9|||
161343801|NCT00764517|582645961|FG001|Overall Study|Adverse Event|3|||
161343802|NCT00764517|582645960|FG000|Overall Study|Death|3|||
161343803|NCT00764517|582645961|FG001|Overall Study|Death|11|||
161024185|NCT03852472|581479604|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
161274589|NCT01403051|582384709|FG001|Overall Study|Death|0|||
161274590|NCT01403051|582384708|FG000|Overall Study|Withdrawal by Subject|2|||
161274591|NCT01403051|582384709|FG001|Overall Study|Withdrawal by Subject|1|||
161274592|NCT01403051|582384708|FG000|Overall Study|Lost to Follow-up|5|||
161274593|NCT01403051|582384709|FG001|Overall Study|Lost to Follow-up|5|||
161274594|NCT02932306|582384722|FG000|Overall Study|Withdrawal by Subject|16|||
161274595|NCT02932306|582384723|FG001|Overall Study|Withdrawal by Subject|25|||
161274596|NCT02932306|582384722|FG000|Overall Study|Adverse Event|3|||
161274597|NCT02932306|582384723|FG001|Overall Study|Adverse Event|0|||
161274598|NCT02932306|582384722|FG000|Overall Study|Pregnancy|2|||
161274599|NCT02932306|582384723|FG001|Overall Study|Pregnancy|0|||
161274600|NCT02932306|582384722|FG000|Overall Study|Protocol Violation|1|||
161274601|NCT02932306|582384723|FG001|Overall Study|Protocol Violation|1|||
161274602|NCT02932306|582384722|FG000|Overall Study|Noncompliance with Study Drug|1|||
161274603|NCT02932306|582384723|FG001|Overall Study|Noncompliance with Study Drug|1|||
161274604|NCT02932306|582384722|FG000|Overall Study|Lost to Follow-up|36|||
161274605|NCT02932306|582384723|FG001|Overall Study|Lost to Follow-up|40|||
161274606|NCT02932306|582384722|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
161274607|NCT02932306|582384723|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
161274608|NCT02932306|582384722|FG000|Overall Study|Lack of Efficacy|0|||
161274609|NCT02932306|582384723|FG001|Overall Study|Lack of Efficacy|2|||
161274610|NCT02932306|582384722|FG000|Overall Study|Worsening condition|2|||
161274611|NCT02932306|582384723|FG001|Overall Study|Worsening condition|0|||
161274612|NCT02932306|582384722|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
161274613|NCT02932306|582384723|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
161274614|NCT02065700|582384734|FG000|Overall Study|Adverse Event|165|||
161274615|NCT02065700|582384735|FG001|Overall Study|Adverse Event|101|||
161274616|NCT02065700|582384734|FG000|Overall Study|Withdrawal by Subject|90|||
161274617|NCT02065700|582384735|FG001|Overall Study|Withdrawal by Subject|29|||
161274618|NCT02065700|582384734|FG000|Overall Study|Lost to Follow-up|12|||
161343804|NCT00764517|582645960|FG000|Overall Study|Physician Decision|3|||
161343805|NCT00764517|582645961|FG001|Overall Study|Physician Decision|0|||
161343806|NCT00770367|582645962|FG000|First Intervention|Withdrawal by Subject|0|||
161343807|NCT00770367|582645963|FG001|First Intervention|Withdrawal by Subject|2|||
161343808|NCT00770367|582645962|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
161343809|NCT00770367|582645963|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
161343810|NCT00770367|582645962|FG000|Second Intervention|Lost to Follow-up|2|||
161343811|NCT00770367|582645963|FG001|Second Intervention|Lost to Follow-up|0|||
161343812|NCT00435942|582645964|FG000|Overall Study|Death|17|||
161343813|NCT00435942|582645965|FG001|Overall Study|Death|10|||
161343814|NCT00435942|582645964|FG000|Overall Study|Withdrawal by Subject|2|||
161343815|NCT00435942|582645965|FG001|Overall Study|Withdrawal by Subject|0|||
161343816|NCT00435942|582645964|FG000|Overall Study|Lost to Follow-up|0|||
161343817|NCT00435942|582645965|FG001|Overall Study|Lost to Follow-up|16|||
161343818|NCT00435942|582645964|FG000|Overall Study|Conversion to Open Repair|1|||
161343819|NCT00435942|582645965|FG001|Overall Study|Conversion to Open Repair|0|||
161343820|NCT00435942|582645964|FG000|Overall Study|Technical Failure|3|||
161343821|NCT00435942|582645965|FG001|Overall Study|Technical Failure|0|||
161343822|NCT00435942|582645964|FG000|Overall Study|Other|0|||
161343823|NCT00435942|582645965|FG001|Overall Study|Other|1|||
161343824|NCT01898130|582645966|FG000|Treatment|Withdrawal by Subject|2|||
161343825|NCT01898130|582645966|FG000|Treatment|Progressive Disease|4|||
161343826|NCT01898130|582645966|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
161343827|NCT04115059|582645970|FG000|Overall Study|Withdrawal by Subject|1|||
161343828|NCT04115059|582645970|FG000|Overall Study|Lack of Efficacy|2|||
161343829|NCT04491994|582645971|FG000|Overall Study|Withdrawal by Subject|10|||
161343830|NCT04491994|582645972|FG001|Overall Study|Withdrawal by Subject|5|||
161343831|NCT04491994|582645971|FG000|Overall Study|developed fever > 3 days|4|||
161343832|NCT04491994|582645972|FG001|Overall Study|developed fever > 3 days|1|||
161343833|NCT04491994|582645971|FG000|Overall Study|Protocol Violation|11|||
161343834|NCT04491994|582645972|FG001|Overall Study|Protocol Violation|2|||
161343835|NCT04491994|582645971|FG000|Overall Study|Lost to Follow-up|4|||
161343836|NCT04491994|582645972|FG001|Overall Study|Lost to Follow-up|3|||
161343837|NCT03517137|582645980|FG000|Overall Study|Lack of Efficacy|1|||
161343838|NCT03517137|582645980|FG000|Overall Study|Adverse Event|2|||
161343839|NCT03517137|582645980|FG000|Overall Study|Withdrawal by Subject|2|||
161274619|NCT02065700|582384735|FG001|Overall Study|Lost to Follow-up|9|||
161274620|NCT02065700|582384734|FG000|Overall Study|Physician Decision|2|||
161274621|NCT02065700|582384735|FG001|Overall Study|Physician Decision|0|||
161274622|NCT02065700|582384734|FG000|Overall Study|Sponsor Request|38|||
161343840|NCT03517137|582645980|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
161343841|NCT03575364|582645981|FG000|Overall Study|Death|45|||
161274623|NCT02065700|582384735|FG001|Overall Study|Sponsor Request|15|||
161343842|NCT03575364|582645981|FG000|Overall Study|Lost to Follow-up|114|||
161024186|NCT03852472|581479605|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
161024187|NCT03852472|581479606|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
161024188|NCT03852472|581479607|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
161024189|NCT03852472|581479603|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
161024190|NCT03852472|581479604|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
161024191|NCT03852472|581479605|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
161024192|NCT03852472|581479606|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
161024193|NCT03852472|581479607|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
161024194|NCT03852472|581479603|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
161024195|NCT03852472|581479604|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
161024196|NCT03852472|581479605|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
161024197|NCT03852472|581479606|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
161024198|NCT03852472|581479607|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
161024199|NCT03852472|581479603|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
161024200|NCT03852472|581479604|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
161024201|NCT03852472|581479605|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
161024202|NCT03852472|581479606|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
161024203|NCT03852472|581479607|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
161024204|NCT03852472|581479603|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
161024205|NCT03852472|581479604|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
161024206|NCT03852472|581479605|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
161024207|NCT03852472|581479606|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
161024208|NCT03852472|581479607|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
161024209|NCT03852472|581479603|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
161024210|NCT03852472|581479604|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
161024211|NCT03852472|581479605|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
161024212|NCT03852472|581479606|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
161024213|NCT03852472|581479607|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
161024214|NCT03852472|581479603|FG000|Period 2 - Week 44|Adverse Event|0|||
161024215|NCT03852472|581479604|FG001|Period 2 - Week 44|Adverse Event|3|||
160972773|NCT02906683|581291016|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
160972774|NCT02906683|581291017|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
160972775|NCT02906683|581291018|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
160972776|NCT02906683|581291016|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
160972777|NCT02906683|581291017|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
160972778|NCT02906683|581291018|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
160972779|NCT01158378|581291019|FG000|Overall Study|Death|4|||
160972780|NCT01158378|581291020|FG001|Overall Study|Death|5|||
160972781|NCT01158378|581291019|FG000|Overall Study|Lost to Follow-up|2|||
160972782|NCT01158378|581291020|FG001|Overall Study|Lost to Follow-up|4|||
160972783|NCT01158378|581291019|FG000|Overall Study|Withdrawal by Subject|4|||
160972784|NCT01158378|581291020|FG001|Overall Study|Withdrawal by Subject|0|||
160972785|NCT02769065|581291021|FG000|Overall Study|Voluntary Withdrawal|1|||
160972786|NCT02769065|581291022|FG001|Overall Study|Voluntary Withdrawal|0|||
160972787|NCT02769065|581291023|FG002|Overall Study|Voluntary Withdrawal|0|||
160972788|NCT02769065|581291024|FG003|Overall Study|Voluntary Withdrawal|0|||
160972789|NCT02769065|581291025|FG004|Overall Study|Voluntary Withdrawal|0|||
160972790|NCT02769065|581291026|FG005|Overall Study|Voluntary Withdrawal|0|||
160972791|NCT02769065|581291027|FG006|Overall Study|Voluntary Withdrawal|0|||
160972792|NCT02769065|581291028|FG007|Overall Study|Voluntary Withdrawal|0|||
160972793|NCT02769065|581291029|FG008|Overall Study|Voluntary Withdrawal|0|||
160972794|NCT02769065|581291030|FG009|Overall Study|Voluntary Withdrawal|0|||
160972795|NCT02769065|581291031|FG010|Overall Study|Voluntary Withdrawal|0|||
160972796|NCT02769065|581291032|FG011|Overall Study|Voluntary Withdrawal|0|||
160972797|NCT02769065|581291033|FG012|Overall Study|Voluntary Withdrawal|0|||
160972798|NCT02769065|581291034|FG013|Overall Study|Voluntary Withdrawal|0|||
160972799|NCT02769065|581291035|FG014|Overall Study|Voluntary Withdrawal|0|||
160972800|NCT02769065|581291036|FG015|Overall Study|Voluntary Withdrawal|0|||
160972801|NCT02769065|581291037|FG016|Overall Study|Voluntary Withdrawal|0|||
160972802|NCT02769065|581291038|FG017|Overall Study|Voluntary Withdrawal|0|||
160972803|NCT02769065|581291039|FG018|Overall Study|Voluntary Withdrawal|0|||
160972804|NCT02769065|581291040|FG019|Overall Study|Voluntary Withdrawal|0|||
161274624|NCT02065700|582384734|FG000|Overall Study|Treatment Failure|3|||
161274625|NCT02065700|582384735|FG001|Overall Study|Treatment Failure|2|||
160972805|NCT02769065|581291041|FG020|Overall Study|Voluntary Withdrawal|0|||
161024216|NCT03852472|581479605|FG002|Period 2 - Week 44|Adverse Event|1|||
161024217|NCT03852472|581479606|FG003|Period 2 - Week 44|Adverse Event|2|||
161274626|NCT02065700|582384734|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
161024218|NCT03852472|581479607|FG004|Period 2 - Week 44|Adverse Event|2|||
160972806|NCT02769065|581291042|FG021|Overall Study|Voluntary Withdrawal|0|||
161274627|NCT02065700|582384735|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
161274628|NCT02065700|582384734|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
161274629|NCT02065700|582384735|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
161274630|NCT02065700|582384734|FG000|Overall Study|Non-compliance with Study Procedures|2|||
161274631|NCT02065700|582384735|FG001|Overall Study|Non-compliance with Study Procedures|0|||
161274632|NCT02065700|582384734|FG000|Overall Study|Not Defined|21|||
161024219|NCT03852472|581479603|FG000|Period 2 - Week 44|COVID-19 Related|0|||
161024220|NCT03852472|581479604|FG001|Period 2 - Week 44|COVID-19 Related|0|||
161024221|NCT03852472|581479605|FG002|Period 2 - Week 44|COVID-19 Related|0|||
161024222|NCT03852472|581479606|FG003|Period 2 - Week 44|COVID-19 Related|1|||
161024223|NCT03852472|581479607|FG004|Period 2 - Week 44|COVID-19 Related|0|||
161024224|NCT03852472|581479603|FG000|Period 2 - Week 44|Reason not stated|0|||
161024225|NCT03852472|581479604|FG001|Period 2 - Week 44|Reason not stated|0|||
161024226|NCT03852472|581479605|FG002|Period 2 - Week 44|Reason not stated|0|||
160972807|NCT02769065|581291043|FG022|Overall Study|Voluntary Withdrawal|0|||
160972808|NCT02769065|581291044|FG023|Overall Study|Voluntary Withdrawal|0|||
160972809|NCT02769065|581291045|FG024|Overall Study|Voluntary Withdrawal|0|||
160972810|NCT02769065|581291046|FG025|Overall Study|Voluntary Withdrawal|0|||
160972811|NCT02769065|581291047|FG026|Overall Study|Voluntary Withdrawal|0|||
160972812|NCT02769065|581291048|FG027|Overall Study|Voluntary Withdrawal|0|||
160972813|NCT02769065|581291049|FG028|Overall Study|Voluntary Withdrawal|0|||
160972814|NCT02769065|581291050|FG029|Overall Study|Voluntary Withdrawal|0|||
160972815|NCT02769065|581291021|FG000|Overall Study|Reason Not Specified|0|||
160972816|NCT02769065|581291022|FG001|Overall Study|Reason Not Specified|0|||
160972817|NCT02769065|581291023|FG002|Overall Study|Reason Not Specified|0|||
160972818|NCT02769065|581291024|FG003|Overall Study|Reason Not Specified|0|||
160972819|NCT02769065|581291025|FG004|Overall Study|Reason Not Specified|0|||
160972820|NCT02769065|581291026|FG005|Overall Study|Reason Not Specified|0|||
160972821|NCT02769065|581291027|FG006|Overall Study|Reason Not Specified|1|||
160972822|NCT02769065|581291028|FG007|Overall Study|Reason Not Specified|0|||
160972823|NCT02769065|581291029|FG008|Overall Study|Reason Not Specified|0|||
160972824|NCT02769065|581291030|FG009|Overall Study|Reason Not Specified|0|||
160972825|NCT02769065|581291031|FG010|Overall Study|Reason Not Specified|0|||
160972826|NCT02769065|581291032|FG011|Overall Study|Reason Not Specified|0|||
160972827|NCT02769065|581291033|FG012|Overall Study|Reason Not Specified|0|||
160972828|NCT02769065|581291034|FG013|Overall Study|Reason Not Specified|0|||
160972829|NCT02769065|581291035|FG014|Overall Study|Reason Not Specified|0|||
160972830|NCT02769065|581291036|FG015|Overall Study|Reason Not Specified|0|||
160972831|NCT02769065|581291037|FG016|Overall Study|Reason Not Specified|0|||
160972832|NCT02769065|581291038|FG017|Overall Study|Reason Not Specified|0|||
160972833|NCT02769065|581291039|FG018|Overall Study|Reason Not Specified|0|||
160972834|NCT02769065|581291040|FG019|Overall Study|Reason Not Specified|0|||
160972835|NCT02769065|581291041|FG020|Overall Study|Reason Not Specified|0|||
160972836|NCT02769065|581291042|FG021|Overall Study|Reason Not Specified|0|||
160972837|NCT02769065|581291043|FG022|Overall Study|Reason Not Specified|0|||
160972838|NCT02769065|581291044|FG023|Overall Study|Reason Not Specified|0|||
160972839|NCT02769065|581291045|FG024|Overall Study|Reason Not Specified|0|||
160972840|NCT02769065|581291046|FG025|Overall Study|Reason Not Specified|0|||
160972841|NCT02769065|581291047|FG026|Overall Study|Reason Not Specified|0|||
160972842|NCT02769065|581291048|FG027|Overall Study|Reason Not Specified|0|||
160972843|NCT02769065|581291049|FG028|Overall Study|Reason Not Specified|0|||
160972844|NCT02769065|581291050|FG029|Overall Study|Reason Not Specified|0|||
160972845|NCT02769065|581291021|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972846|NCT02769065|581291022|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972847|NCT02769065|581291023|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972848|NCT02769065|581291024|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972849|NCT02769065|581291025|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
161274633|NCT02065700|582384735|FG001|Overall Study|Not Defined|3|||
161274634|NCT02315196|582384736|FG000|Overall Study|Withdrew consent|9|||
161274635|NCT01635218|582384737|FG000|Overall Study|Lost to Follow-up|3|||
161274636|NCT01635218|582384738|FG001|Overall Study|Lost to Follow-up|7|||
161274637|NCT01635218|582384739|FG002|Overall Study|Lost to Follow-up|6|||
161274638|NCT03559400|582384740|FG000|Overall Study|Lost to Follow-up|9|||
161274639|NCT03559400|582384741|FG001|Overall Study|Lost to Follow-up|7|||
161274640|NCT03559400|582384740|FG000|Overall Study|Death|0|||
160972850|NCT02769065|581291026|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972851|NCT02769065|581291027|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972852|NCT02769065|581291028|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972853|NCT02769065|581291029|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
161274641|NCT03559400|582384741|FG001|Overall Study|Death|2|||
161274642|NCT03262038|582384742|FG000|Overall Study|Withdrawal by Subject|0|||
161274643|NCT03262038|582384743|FG001|Overall Study|Withdrawal by Subject|1|||
160972854|NCT02769065|581291030|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
161024227|NCT03852472|581479606|FG003|Period 2 - Week 44|Reason not stated|0|||
161024228|NCT03852472|581479607|FG004|Period 2 - Week 44|Reason not stated|1|||
161024229|NCT04880863|581479610|FG000|Overall Study|Adverse Event|1|||
161024230|NCT04880863|581479610|FG000|Overall Study|Patient decision|2|||
161024231|NCT04880863|581479610|FG000|Overall Study|Confirmed Disease Progression|15|||
161024232|NCT04880863|581479610|FG000|Overall Study|Death|3|||
161024233|NCT04880863|581479610|FG000|Overall Study|Physician Decision|4|||
161024234|NCT04880863|581479610|FG000|Overall Study|Unconfirmed Disease Progression|4|||
161024235|NCT04880863|581479610|FG000|Overall Study|Withdrawal by Subject|2|||
161024236|NCT04880863|581479610|FG000|Overall Study|Study discontinuation by the sponsor|4|||
161024237|NCT04880863|581479610|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
161024238|NCT04880863|581479610|FG000|Overall Study|Not received study drug NAP|2|||
161024239|NCT05670587|581479611|FG000|Overall Study|Withdrawal by Subject|3|||
161024240|NCT02305888|581479621|FG000|Overall Study|Lost to Follow-up|0|||
161024241|NCT02305888|581479622|FG001|Overall Study|Lost to Follow-up|0|||
161024242|NCT02305888|581479623|FG002|Overall Study|Lost to Follow-up|1|||
161024243|NCT02305888|581479621|FG000|Overall Study|Adverse Event|0|||
161024244|NCT02305888|581479622|FG001|Overall Study|Adverse Event|1|||
161024245|NCT02305888|581479623|FG002|Overall Study|Adverse Event|0|||
161024246|NCT05139810|581479624|FG000|Overall Study|Voluntary Withdrawal|2|||
161024247|NCT05139810|581479625|FG001|Overall Study|Voluntary Withdrawal|1|||
161024248|NCT05139810|581479626|FG002|Overall Study|Voluntary Withdrawal|0|||
161024249|NCT05139810|581479624|FG000|Overall Study|Pregnancy|1|||
161024250|NCT05139810|581479625|FG001|Overall Study|Pregnancy|0|||
161024251|NCT05139810|581479626|FG002|Overall Study|Pregnancy|0|||
161024252|NCT05139810|581479624|FG000|Overall Study|Roll Over to CS7|19|||
161024253|NCT05139810|581479625|FG001|Overall Study|Roll Over to CS7|44|||
161024254|NCT05139810|581479626|FG002|Overall Study|Roll Over to CS7|20|||
161024255|NCT03240016|581479633|FG000|Overall Study|Adverse Event|9|||
161024256|NCT03240016|581479633|FG000|Overall Study|Withdrawal by Subject|7|||
161024257|NCT03240016|581479633|FG000|Overall Study|Death|1|||
161024258|NCT03240016|581479633|FG000|Overall Study|Physician Decision|2|||
161024259|NCT05200403|581479634|FG000|Overall Study|Withdrawal by Subject|4|||
161024260|NCT05200403|581479635|FG001|Overall Study|Withdrawal by Subject|2|||
161024261|NCT05200403|581479636|FG002|Overall Study|Withdrawal by Subject|6|||
161024262|NCT05546411|581479637|FG000|Overall Study|Progressive Disease|1|||
161024263|NCT05546411|581479638|FG001|Overall Study|Progressive Disease|0|||
161024264|NCT05546411|581479637|FG000|Overall Study|Adverse Event|0|||
161024265|NCT05546411|581479638|FG001|Overall Study|Adverse Event|1|||
161024266|NCT05546411|581479637|FG000|Overall Study|Metastatic disease|1|||
161024267|NCT05546411|581479638|FG001|Overall Study|Metastatic disease|0|||
161024268|NCT04068181|581479646|FG000|Overall Study|Death|17|||
161024269|NCT04068181|581479647|FG001|Overall Study|Death|12|||
161024270|NCT04068181|581479648|FG002|Overall Study|Death|4|||
161024271|NCT04068181|581479649|FG003|Overall Study|Death|7|||
161024272|NCT04068181|581479646|FG000|Overall Study|Lost to Follow-up|1|||
161024273|NCT04068181|581479647|FG001|Overall Study|Lost to Follow-up|0|||
161024274|NCT04068181|581479648|FG002|Overall Study|Lost to Follow-up|0|||
161024275|NCT04068181|581479649|FG003|Overall Study|Lost to Follow-up|0|||
161024276|NCT04068181|581479646|FG000|Overall Study|Withdrawal of consent from study|3|||
161024277|NCT04068181|581479647|FG001|Overall Study|Withdrawal of consent from study|0|||
161024278|NCT04068181|581479648|FG002|Overall Study|Withdrawal of consent from study|0|||
161024279|NCT04068181|581479649|FG003|Overall Study|Withdrawal of consent from study|0|||
161024280|NCT03785964|581479652|FG000|Overall Study|Adverse Event|14|||
161024281|NCT03785964|581479653|FG001|Overall Study|Adverse Event|1|||
161024282|NCT03785964|581479652|FG000|Overall Study|Unqualified Clinical Progression|1|||
161024283|NCT03785964|581479653|FG001|Overall Study|Unqualified Clinical Progression|1|||
161024284|NCT03785964|581479652|FG000|Overall Study|Participant non-compliance|1|||
161024285|NCT03785964|581479653|FG001|Overall Study|Participant non-compliance|1|||
161024286|NCT03785964|581479652|FG000|Overall Study|Not treated|1|||
161024287|NCT03785964|581479653|FG001|Overall Study|Not treated|0|||
161024288|NCT03785964|581479652|FG000|Overall Study|Other reason|5|||
161024289|NCT03785964|581479653|FG001|Overall Study|Other reason|11|||
161024290|NCT03785964|581479652|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
161024291|NCT03785964|581479653|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
161024292|NCT02723591|581479654|FG000|Overall Study|Adverse Event|48|||
161024293|NCT02723591|581479655|FG001|Overall Study|Adverse Event|40|||
161024294|NCT02723591|581479654|FG000|Overall Study|Death|2|||
161024295|NCT02723591|581479655|FG001|Overall Study|Death|2|||
161024296|NCT02723591|581479654|FG000|Overall Study|Lack of Efficacy|4|||
161024297|NCT02723591|581479655|FG001|Overall Study|Lack of Efficacy|3|||
161024298|NCT02723591|581479654|FG000|Overall Study|Lost to Follow-up|1|||
161024299|NCT02723591|581479655|FG001|Overall Study|Lost to Follow-up|7|||
161024300|NCT02723591|581479654|FG000|Overall Study|Protocol Violation|20|||
161024301|NCT02723591|581479655|FG001|Overall Study|Protocol Violation|23|||
161024302|NCT02723591|581479654|FG000|Overall Study|Withdrawal by Subject|4|||
161024303|NCT02723591|581479655|FG001|Overall Study|Withdrawal by Subject|8|||
161024304|NCT02723591|581479654|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
161343843|NCT03575364|582645981|FG000|Overall Study|Withdrawal by Subject|21|||
161343844|NCT03575364|582645981|FG000|Overall Study|Physician Decision|11|||
161343845|NCT03575364|582645981|FG000|Overall Study|Subject Refused Follow-up|13|||
161343846|NCT03575364|582645981|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
161343847|NCT03575364|582645981|FG000|Overall Study|Patient moved out of the state|1|||
161343848|NCT03575364|582645981|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
161343849|NCT03575364|582645981|FG000|Overall Study|Patient is lost to follow up|1|||
161343850|NCT03575364|582645981|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
161343851|NCT01186770|582645982|FG000|Overall Study|Ineligibility|0|||
161343852|NCT01186770|582645983|FG001|Overall Study|Ineligibility|0|||
161343853|NCT01186770|582645984|FG002|Overall Study|Ineligibility|2|||
161343854|NCT01186770|582645985|FG003|Overall Study|Ineligibility|0|||
161343855|NCT01186770|582645982|FG000|Overall Study|Protocol Violation|7|||
161343856|NCT01186770|582645983|FG001|Overall Study|Protocol Violation|9|||
161343857|NCT01186770|582645984|FG002|Overall Study|Protocol Violation|12|||
161343858|NCT01186770|582645985|FG003|Overall Study|Protocol Violation|14|||
161343859|NCT01186770|582645982|FG000|Overall Study|Adverse Event|2|||
161343860|NCT01186770|582645983|FG001|Overall Study|Adverse Event|9|||
161343861|NCT01186770|582645984|FG002|Overall Study|Adverse Event|7|||
161343862|NCT01186770|582645985|FG003|Overall Study|Adverse Event|9|||
160972855|NCT02769065|581291031|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
160972856|NCT02769065|581291032|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972857|NCT02769065|581291033|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972858|NCT02769065|581291034|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972859|NCT02769065|581291035|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972860|NCT02769065|581291036|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972861|NCT02769065|581291037|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972862|NCT02769065|581291038|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972863|NCT02769065|581291039|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972864|NCT02769065|581291040|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972865|NCT02769065|581291041|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972866|NCT02769065|581291042|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972867|NCT02769065|581291043|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972868|NCT02769065|581291044|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972869|NCT02769065|581291045|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972870|NCT02769065|581291046|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972871|NCT02769065|581291047|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972872|NCT02769065|581291048|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972873|NCT02769065|581291049|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972874|NCT02769065|581291050|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
160972875|NCT02531295|581291055|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972876|NCT02531295|581291056|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972877|NCT02531295|581291057|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972878|NCT02531295|581291058|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972879|NCT02531295|581291059|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
160972880|NCT02531295|581291060|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
160972881|NCT00453310|581291061|FG000|Overall Study|Progression of Disease|10|||
160972882|NCT01806740|581291062|FG000|Overall Study|Withdrawal by Subject|4|||
160972883|NCT01806740|581291062|FG000|Overall Study|Physician Decision|1|||
160972884|NCT01806740|581291062|FG000|Overall Study|Patient's refusal of treatment|1|||
160972885|NCT04666922|581291063|FG000|Overall Study|Withdrawal by Subject|1|||
160972886|NCT04666922|581291064|FG001|Overall Study|Withdrawal by Subject|0|||
160972887|NCT04666922|581291065|FG002|Overall Study|Withdrawal by Subject|0|||
160972888|NCT04666922|581291066|FG003|Overall Study|Withdrawal by Subject|0|||
160972889|NCT04666922|581291067|FG004|Overall Study|Withdrawal by Subject|0|||
160972890|NCT04666922|581291068|FG005|Overall Study|Withdrawal by Subject|0|||
160972891|NCT04666922|581291069|FG006|Overall Study|Withdrawal by Subject|0|||
160972892|NCT01382940|581291072|FG000|Overall Study|Adverse Event|19|||
160972893|NCT01382940|581291072|FG000|Overall Study|Lost to Follow-up|4|||
160972894|NCT01382940|581291072|FG000|Overall Study|Physician Decision|7|||
160972895|NCT01382940|581291072|FG000|Overall Study|Withdrawal by Subject|23|||
160972896|NCT01382940|581291072|FG000|Overall Study|Protocol Violation|20|||
160972897|NCT02105636|581291073|FG000|Pre-Treatment|Disease Progression|1|||
160972898|NCT02105636|581291074|FG001|Pre-Treatment|Disease Progression|0|||
160972899|NCT02105636|581291073|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
160972900|NCT02105636|581291074|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
160972901|NCT02105636|581291073|FG000|Pre-Treatment|Participant withdrew consent|0|||
160972902|NCT02105636|581291074|FG001|Pre-Treatment|Participant withdrew consent|6|||
160972903|NCT02105636|581291073|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
160972904|NCT02105636|581291074|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
161024305|NCT02723591|581479655|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
161024306|NCT02723591|581479654|FG000|Overall Study|Miscellaneous|5|||
161024307|NCT02723591|581479655|FG001|Overall Study|Miscellaneous|6|||
161024308|NCT05070728|581479656|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
161024309|NCT05070728|581479657|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
161024310|NCT04811040|581479658|FG000|Overall Study|Lost to Follow-up|2|||
161024311|NCT04811040|581479659|FG001|Overall Study|Lost to Follow-up|0|||
161274644|NCT04933968|582384744|FG000|Overall Study|Adverse Event|0|||
161274645|NCT04933968|582384745|FG001|Overall Study|Adverse Event|0|||
161274646|NCT04933968|582384746|FG002|Overall Study|Adverse Event|1|||
161274647|NCT04933968|582384747|FG003|Overall Study|Adverse Event|1|||
161274648|NCT04933968|582384748|FG004|Overall Study|Adverse Event|0|||
161274649|NCT04933968|582384749|FG005|Overall Study|Adverse Event|0|||
161274650|NCT04933968|582384744|FG000|Overall Study|Lost to Follow-up|1|||
161274651|NCT04933968|582384745|FG001|Overall Study|Lost to Follow-up|0|||
161274652|NCT04933968|582384746|FG002|Overall Study|Lost to Follow-up|1|||
161274653|NCT04933968|582384747|FG003|Overall Study|Lost to Follow-up|0|||
161274654|NCT04933968|582384748|FG004|Overall Study|Lost to Follow-up|0|||
161274655|NCT04933968|582384749|FG005|Overall Study|Lost to Follow-up|0|||
161274656|NCT04933968|582384744|FG000|Overall Study|Randomized not treated|1|||
161274657|NCT04933968|582384745|FG001|Overall Study|Randomized not treated|0|||
161274658|NCT04933968|582384746|FG002|Overall Study|Randomized not treated|0|||
161274659|NCT04933968|582384747|FG003|Overall Study|Randomized not treated|0|||
161274660|NCT04933968|582384748|FG004|Overall Study|Randomized not treated|0|||
161274661|NCT04933968|582384749|FG005|Overall Study|Randomized not treated|0|||
161274662|NCT04933968|582384744|FG000|Overall Study|Sponsor terminated study|0|||
161274663|NCT04933968|582384745|FG001|Overall Study|Sponsor terminated study|0|||
161274664|NCT04933968|582384746|FG002|Overall Study|Sponsor terminated study|0|||
161274665|NCT04933968|582384747|FG003|Overall Study|Sponsor terminated study|1|||
161274666|NCT04933968|582384748|FG004|Overall Study|Sponsor terminated study|2|||
161274667|NCT04933968|582384749|FG005|Overall Study|Sponsor terminated study|0|||
161274668|NCT04933968|582384744|FG000|Overall Study|Other|0|||
161274669|NCT04933968|582384745|FG001|Overall Study|Other|0|||
161274670|NCT04933968|582384746|FG002|Overall Study|Other|0|||
161274671|NCT04933968|582384747|FG003|Overall Study|Other|1|||
161024312|NCT04811040|581479660|FG002|Overall Study|Lost to Follow-up|0|||
161024313|NCT04811040|581479661|FG003|Overall Study|Lost to Follow-up|0|||
161024314|NCT04811040|581479658|FG000|Overall Study|Withdrew consent|1|||
161024315|NCT04811040|581479659|FG001|Overall Study|Withdrew consent|1|||
161024316|NCT04811040|581479660|FG002|Overall Study|Withdrew consent|0|||
161024317|NCT04811040|581479661|FG003|Overall Study|Withdrew consent|0|||
161024318|NCT02151981|581479664|FG000|Overall Study|Death|184|||
161024319|NCT02151981|581479665|FG001|Overall Study|Death|88|||
161024320|NCT02151981|581479664|FG000|Overall Study|Lost to Follow-up|7|||
161024321|NCT02151981|581479665|FG001|Overall Study|Lost to Follow-up|1|||
161024322|NCT02151981|581479664|FG000|Overall Study|Withdrawal by Subject|27|||
161024323|NCT02151981|581479665|FG001|Overall Study|Withdrawal by Subject|21|||
161024324|NCT02151981|581479664|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161274672|NCT04933968|582384748|FG004|Overall Study|Other|0|||
161274673|NCT04933968|582384749|FG005|Overall Study|Other|0|||
161274674|NCT04933968|582384744|FG000|Overall Study|Missing|1|||
161274675|NCT04933968|582384745|FG001|Overall Study|Missing|3|||
161274676|NCT04933968|582384746|FG002|Overall Study|Missing|2|||
161274677|NCT04933968|582384747|FG003|Overall Study|Missing|1|||
161274678|NCT04933968|582384748|FG004|Overall Study|Missing|1|||
161274679|NCT04933968|582384749|FG005|Overall Study|Missing|0|||
161274680|NCT03323437|582384752|FG000|Overall Study|Withdrawal by Subject|0|||
161274681|NCT03323437|582384753|FG001|Overall Study|Withdrawal by Subject|4|||
161274682|NCT01377987|582384756|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
161274683|NCT01377987|582384757|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161274684|NCT00168818|582384758|FG000|Overall Study|Adverse Event|23|||
161274685|NCT00168818|582384759|FG001|Overall Study|Adverse Event|29|||
161274686|NCT00168818|582384760|FG002|Overall Study|Adverse Event|31|||
161274687|NCT00168818|582384758|FG000|Overall Study|Protocol Violation|16|||
161274688|NCT00168818|582384759|FG001|Overall Study|Protocol Violation|11|||
161274689|NCT00168818|582384760|FG002|Overall Study|Protocol Violation|11|||
161274690|NCT00168818|582384758|FG000|Overall Study|Lost to Follow-up|13|||
161274691|NCT00168818|582384759|FG001|Overall Study|Lost to Follow-up|4|||
161024325|NCT02151981|581479665|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161024326|NCT02151981|581479664|FG000|Overall Study|Other reasons|1|||
161024327|NCT02151981|581479665|FG001|Overall Study|Other reasons|2|||
161024328|NCT05934942|581479671|FG000|Run-in Period|Not treated|1|||
161274692|NCT00168818|582384760|FG002|Overall Study|Lost to Follow-up|15|||
161274693|NCT00168818|582384758|FG000|Overall Study|Withdrawal by Subject|43|||
161274694|NCT00168818|582384759|FG001|Overall Study|Withdrawal by Subject|41|||
161274695|NCT00168818|582384760|FG002|Overall Study|Withdrawal by Subject|37|||
161274696|NCT00168818|582384758|FG000|Overall Study|Other|22|||
161274697|NCT00168818|582384759|FG001|Overall Study|Other|24|||
161274698|NCT00168818|582384760|FG002|Overall Study|Other|30|||
161274699|NCT00168818|582384758|FG000|Treatment|Adverse Event|77|||
161274700|NCT00168818|582384759|FG001|Treatment|Adverse Event|89|||
161274701|NCT00168818|582384760|FG002|Treatment|Adverse Event|68|||
161274702|NCT00168818|582384758|FG000|Treatment|Protocol Violation|8|||
161274703|NCT00168818|582384759|FG001|Treatment|Protocol Violation|11|||
161274704|NCT00168818|582384760|FG002|Treatment|Protocol Violation|11|||
161274705|NCT00168818|582384758|FG000|Treatment|Lost to Follow-up|0|||
161274706|NCT00168818|582384759|FG001|Treatment|Lost to Follow-up|2|||
161274707|NCT00168818|582384760|FG002|Treatment|Lost to Follow-up|1|||
161274708|NCT00168818|582384758|FG000|Treatment|Withdrawal by Subject|25|||
161274709|NCT00168818|582384759|FG001|Treatment|Withdrawal by Subject|20|||
161274710|NCT00168818|582384760|FG002|Treatment|Withdrawal by Subject|22|||
161274711|NCT00168818|582384758|FG000|Treatment|Other|23|||
161274712|NCT00168818|582384759|FG001|Treatment|Other|29|||
161274713|NCT00168818|582384760|FG002|Treatment|Other|31|||
161274714|NCT01775189|582384761|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161274715|NCT01775189|582384762|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
161274716|NCT01775189|582384763|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161274717|NCT01775189|582384764|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161274718|NCT01775189|582384765|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161274719|NCT01775189|582384766|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161274720|NCT01775189|582384767|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
161274721|NCT01775189|582384761|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161274722|NCT01775189|582384762|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
161274723|NCT01775189|582384763|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161274724|NCT01775189|582384764|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161274725|NCT01775189|582384765|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161274726|NCT01775189|582384766|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161274727|NCT01775189|582384767|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
161274728|NCT01775189|582384761|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161274729|NCT01775189|582384762|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
161274730|NCT01775189|582384763|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
160972905|NCT02105636|581291073|FG000|Treatment|Study Drug Toxicity|14|||
160972906|NCT02105636|581291074|FG001|Treatment|Study Drug Toxicity|10|||
160972907|NCT02105636|581291073|FG000|Treatment|Adverse event unrelated to study drug|19|||
160972908|NCT02105636|581291074|FG001|Treatment|Adverse event unrelated to study drug|3|||
160972909|NCT02105636|581291073|FG000|Treatment|Participant request to discontinue study treatment|8|||
160972910|NCT02105636|581291074|FG001|Treatment|Participant request to discontinue study treatment|6|||
160972911|NCT02105636|581291073|FG000|Treatment|Participant withdrew consent|5|||
160972912|NCT02105636|581291074|FG001|Treatment|Participant withdrew consent|1|||
160972913|NCT02105636|581291073|FG000|Treatment|Lost to Follow-up|1|||
160972914|NCT02105636|581291074|FG001|Treatment|Lost to Follow-up|0|||
160972915|NCT02105636|581291073|FG000|Treatment|Maximum Clinical Benefit|1|||
160972916|NCT02105636|581291074|FG001|Treatment|Maximum Clinical Benefit|3|||
160972917|NCT02105636|581291073|FG000|Treatment|Poor/Non-compliance|0|||
160972918|NCT02105636|581291074|FG001|Treatment|Poor/Non-compliance|1|||
160972919|NCT02105636|581291073|FG000|Treatment|Participant no longer meets study criteria|1|||
160972920|NCT02105636|581291074|FG001|Treatment|Participant no longer meets study criteria|0|||
160972921|NCT02105636|581291073|FG000|Treatment|Other reasons|1|||
160972922|NCT02105636|581291074|FG001|Treatment|Other reasons|0|||
160972923|NCT02105636|581291073|FG000|Treatment|Disease Progression|185|||
160972924|NCT02105636|581291074|FG001|Treatment|Disease Progression|87|||
160972925|NCT00720902|581291075|FG000|Overall Study|Withdrawal by Subject|1|||
160972926|NCT00720902|581291076|FG001|Overall Study|Withdrawal by Subject|0|||
160972927|NCT00720902|581291075|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
160972928|NCT00720902|581291076|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
160972929|NCT01993017|581291078|FG000|Overall Study|Death|23|||
160972930|NCT01993017|581291079|FG001|Overall Study|Death|26|||
160972931|NCT01993017|581291080|FG002|Overall Study|Death|18|||
160972932|NCT01993017|581291078|FG000|Overall Study|Could not be contacted|43|||
160972933|NCT01993017|581291079|FG001|Overall Study|Could not be contacted|42|||
160972934|NCT01993017|581291080|FG002|Overall Study|Could not be contacted|38|||
160972935|NCT01993017|581291078|FG000|Overall Study|Dropped out|19|||
160972936|NCT01993017|581291079|FG001|Overall Study|Dropped out|6|||
160972937|NCT01993017|581291080|FG002|Overall Study|Dropped out|11|||
160972938|NCT01993017|581291078|FG000|Overall Study|Other reasons|17|||
160972939|NCT01993017|581291079|FG001|Overall Study|Other reasons|11|||
160972940|NCT01993017|581291080|FG002|Overall Study|Other reasons|7|||
160972941|NCT01993017|581291078|FG000|Overall Study|Ineligible after randomization|4|||
160972942|NCT01993017|581291079|FG001|Overall Study|Ineligible after randomization|5|||
160972943|NCT01993017|581291080|FG002|Overall Study|Ineligible after randomization|5|||
160972944|NCT00003511|581291081|FG000|Overall Study|Not evaluable|4|||
160972945|NCT03638635|581291082|FG000|Initial Hospitalization|Study terminated prematurely|0|||
160972946|NCT03638635|581291083|FG001|Initial Hospitalization|Study terminated prematurely|1|||
160972947|NCT03638635|581291082|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
160972948|NCT03638635|581291083|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
161274731|NCT01775189|582384764|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161274732|NCT01775189|582384765|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161274733|NCT01775189|582384766|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161274734|NCT01775189|582384767|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
161274735|NCT01775189|582384761|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161274736|NCT01775189|582384762|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161274737|NCT01775189|582384763|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161274738|NCT01775189|582384764|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161274739|NCT01775189|582384765|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161274740|NCT01775189|582384766|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
161274741|NCT01775189|582384767|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
161274742|NCT01775189|582384761|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161274743|NCT01775189|582384762|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161274744|NCT01775189|582384763|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161274745|NCT01775189|582384764|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
161274746|NCT01775189|582384765|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161274747|NCT01775189|582384766|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161274748|NCT01775189|582384767|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
161274749|NCT01775189|582384761|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161274750|NCT01775189|582384762|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161274751|NCT01775189|582384763|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161274752|NCT01775189|582384764|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
161274753|NCT01775189|582384765|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161274754|NCT01775189|582384766|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
161274755|NCT01775189|582384767|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
161274756|NCT02227446|582384768|FG000|Overall Study|not eligible post randomization|18|||
161274757|NCT02227446|582384769|FG001|Overall Study|not eligible post randomization|29|||
161274758|NCT02227446|582384768|FG000|Overall Study|Withdrawal by Subject|4|||
161274759|NCT02227446|582384769|FG001|Overall Study|Withdrawal by Subject|5|||
161274760|NCT03016975|582384777|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
161274761|NCT03016975|582384778|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
161274762|NCT03016975|582384779|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
161274763|NCT03016975|582384777|FG000|At 6 Months Follow-up|Death|2|||
161274764|NCT03016975|582384778|FG001|At 6 Months Follow-up|Death|0|||
161274765|NCT03016975|582384779|FG002|At 6 Months Follow-up|Death|0|||
161274766|NCT03016975|582384777|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
161274767|NCT03016975|582384778|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
161274768|NCT03016975|582384779|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
161274769|NCT03016975|582384777|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
161274770|NCT03016975|582384778|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
161024329|NCT05934942|581479671|FG000|Run-in Period|Withdrawal by Subject|1|||
161024330|NCT05645757|581479686|FG000|Overall Study|Enrolled but treatment not administered|0|||
161024331|NCT05645757|581479687|FG001|Overall Study|Enrolled but treatment not administered|0|||
161024332|NCT05645757|581479688|FG002|Overall Study|Enrolled but treatment not administered|0|||
161024333|NCT05645757|581479689|FG003|Overall Study|Enrolled but treatment not administered|0|||
161024334|NCT05645757|581479690|FG004|Overall Study|Enrolled but treatment not administered|1|||
161024335|NCT05645757|581479691|FG005|Overall Study|Enrolled but treatment not administered|1|||
161024336|NCT05645757|581479692|FG006|Overall Study|Enrolled but treatment not administered|0|||
161024337|NCT05645757|581479693|FG007|Overall Study|Enrolled but treatment not administered|0|||
161024338|NCT04568434|581479698|FG000|Overall Study|Voluntary Withdrawal|0|||
161024339|NCT04568434|581479699|FG001|Overall Study|Voluntary Withdrawal|1|||
161024340|NCT04568434|581479700|FG002|Overall Study|Voluntary Withdrawal|1|||
161024341|NCT04568434|581479698|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
161024342|NCT04568434|581479699|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
161024343|NCT04568434|581479700|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
161024344|NCT04568434|581479698|FG000|Overall Study|Investigator Judgement|1|||
161024345|NCT04568434|581479699|FG001|Overall Study|Investigator Judgement|0|||
161024346|NCT04568434|581479700|FG002|Overall Study|Investigator Judgement|0|||
161024347|NCT05469464|581479701|FG000|Overall Study|Withdrawal by Subject|8|||
161024348|NCT05469464|581479702|FG001|Overall Study|Withdrawal by Subject|7|||
161024349|NCT05469464|581479703|FG002|Overall Study|Withdrawal by Subject|4|||
161274771|NCT03016975|582384779|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
161274772|NCT03016975|582384777|FG000|At 6 Months Follow-up|Aborted implant|1|||
161274773|NCT03016975|582384778|FG001|At 6 Months Follow-up|Aborted implant|0|||
161024350|NCT05469464|581479704|FG003|Overall Study|Withdrawal by Subject|5|||
161024351|NCT05469464|581479701|FG000|Overall Study|Adverse Event|8|||
161024352|NCT05469464|581479702|FG001|Overall Study|Adverse Event|14|||
161024353|NCT05469464|581479703|FG002|Overall Study|Adverse Event|13|||
161024354|NCT05469464|581479704|FG003|Overall Study|Adverse Event|2|||
161274774|NCT03016975|582384779|FG002|At 6 Months Follow-up|Aborted implant|0|||
161274775|NCT03016975|582384777|FG000|At 2 Year Follow-up|Death|1|||
161274776|NCT03016975|582384778|FG001|At 2 Year Follow-up|Death|0|||
161274777|NCT03016975|582384779|FG002|At 2 Year Follow-up|Death|0|||
161274778|NCT03016975|582384777|FG000|At 3 Year Follow-up|Death|1|||
161274779|NCT03016975|582384778|FG001|At 3 Year Follow-up|Death|0|||
161274780|NCT03016975|582384779|FG002|At 3 Year Follow-up|Death|0|||
161274781|NCT03016975|582384777|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
161274782|NCT03016975|582384778|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
161274783|NCT03016975|582384779|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
161274784|NCT03016975|582384777|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
161274785|NCT03016975|582384778|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
161274786|NCT03016975|582384779|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
161274787|NCT02901548|582384780|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
161274788|NCT04893018|582384781|FG000|Overall Study|Lost to Follow-up|1|||
161274789|NCT04893018|582384782|FG001|Overall Study|Lost to Follow-up|0|||
161274790|NCT04893018|582384781|FG000|Overall Study|Withdrawal by Subject|2|||
161274791|NCT04893018|582384782|FG001|Overall Study|Withdrawal by Subject|0|||
161274792|NCT04893018|582384781|FG000|Overall Study|Study Terminated|1|||
161274793|NCT04893018|582384782|FG001|Overall Study|Study Terminated|2|||
161274794|NCT03336528|582384783|FG000|Overall Study|Protocol Violation|1|||
161274795|NCT03336528|582384784|FG001|Overall Study|Protocol Violation|1|||
161274796|NCT03336528|582384783|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
161274797|NCT03336528|582384784|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
161274798|NCT03336528|582384783|FG000|Overall Study|Did not receive study medication|1|||
161274799|NCT03336528|582384784|FG001|Overall Study|Did not receive study medication|2|||
161274800|NCT00811928|582384785|FG000|Overall Study|AEs and SAEs Including Death|7|||
161274801|NCT00811928|582384786|FG001|Overall Study|AEs and SAEs Including Death|11|||
161274802|NCT00811928|582384785|FG000|Overall Study|Withdrawal by Subject|18|||
161274803|NCT00811928|582384786|FG001|Overall Study|Withdrawal by Subject|12|||
161274804|NCT00811928|582384785|FG000|Overall Study|Did Not Take Study Drug|3|||
161274805|NCT00811928|582384786|FG001|Overall Study|Did Not Take Study Drug|0|||
161274806|NCT00811928|582384785|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
161274807|NCT00811928|582384786|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
161274808|NCT00811928|582384785|FG000|Overall Study|Investigator Decision|2|||
161274809|NCT00811928|582384786|FG001|Overall Study|Investigator Decision|1|||
161274810|NCT00811928|582384785|FG000|Overall Study|Poor Compliance|2|||
161274811|NCT00811928|582384786|FG001|Overall Study|Poor Compliance|5|||
161274812|NCT01085357|582384787|FG000|Overall Study|Adverse Event|1|||
161274813|NCT01085357|582384788|FG001|Overall Study|Adverse Event|1|||
161274814|NCT01085357|582384787|FG000|Overall Study|Subject Decision|4|||
161274815|NCT01085357|582384788|FG001|Overall Study|Subject Decision|3|||
161274816|NCT01085357|582384787|FG000|Overall Study|Investigator Decision|1|||
161274817|NCT01085357|582384788|FG001|Overall Study|Investigator Decision|1|||
161274818|NCT01085357|582384787|FG000|Overall Study|Death|11|||
161274819|NCT01085357|582384788|FG001|Overall Study|Death|1|||
161274820|NCT01085357|582384787|FG000|Overall Study|Lost to Follow-up|2|||
161274821|NCT01085357|582384788|FG001|Overall Study|Lost to Follow-up|0|||
161274822|NCT00314951|582384791|FG000|Treatment|Didn't meet criteria for mITT population|16|||
161274823|NCT00314951|582384792|FG001|Treatment|Didn't meet criteria for mITT population|11|||
161274824|NCT00314951|582384791|FG000|Follow-up|mITT failure|44|||
161274825|NCT00314951|582384792|FG001|Follow-up|mITT failure|34|||
161343863|NCT01186770|582645982|FG000|Overall Study|Withdrawal by Subject|15|||
161343864|NCT01186770|582645983|FG001|Overall Study|Withdrawal by Subject|13|||
161274826|NCT02910011|582384793|FG000|Overall Study|Physician Decision|2|||
161274827|NCT00920790|582384794|FG000|Overall Study|aggravation of general condition|14|||
161274828|NCT00838435|582384795|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
161274829|NCT00838435|582384795|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
161274830|NCT00838435|582384795|FG000|Part 2 (7 Years)|Adverse Event|2|||
161274831|NCT00838435|582384795|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
161274832|NCT00838435|582384795|FG000|Part 2 (7 Years)|Physician Decision|1|||
161274833|NCT00838435|582384795|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
161274834|NCT00838435|582384795|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
161343865|NCT01186770|582645984|FG002|Overall Study|Withdrawal by Subject|11|||
161343866|NCT01186770|582645985|FG003|Overall Study|Withdrawal by Subject|17|||
161343867|NCT01186770|582645982|FG000|Overall Study|Lost to Follow-up|10|||
161274835|NCT02348723|582384796|FG000|Overall Study|No ablation|21|||
161274836|NCT02348723|582384797|FG001|Overall Study|No ablation|20|||
161274837|NCT02348723|582384796|FG000|Overall Study|Non-compliant with Protocol|1|||
161274838|NCT02348723|582384797|FG001|Overall Study|Non-compliant with Protocol|0|||
161274839|NCT02348723|582384796|FG000|Overall Study|Lost to Follow-up|1|||
161274840|NCT02348723|582384797|FG001|Overall Study|Lost to Follow-up|1|||
161274841|NCT02348723|582384796|FG000|Overall Study|Consent withdrawn|1|||
161274842|NCT02348723|582384797|FG001|Overall Study|Consent withdrawn|3|||
161274843|NCT02348723|582384796|FG000|Overall Study|Reason other than specified|1|||
161274844|NCT02348723|582384797|FG001|Overall Study|Reason other than specified|1|||
161024355|NCT05469464|581479701|FG000|Overall Study|Lost to Follow-up|2|||
161024356|NCT05469464|581479702|FG001|Overall Study|Lost to Follow-up|5|||
161024357|NCT05469464|581479703|FG002|Overall Study|Lost to Follow-up|3|||
161024358|NCT05469464|581479704|FG003|Overall Study|Lost to Follow-up|3|||
161024359|NCT05469464|581479701|FG000|Overall Study|Lack of Efficacy|4|||
161024360|NCT05469464|581479702|FG001|Overall Study|Lack of Efficacy|1|||
161024361|NCT05469464|581479703|FG002|Overall Study|Lack of Efficacy|2|||
161024362|NCT05469464|581479704|FG003|Overall Study|Lack of Efficacy|2|||
161024363|NCT05469464|581479701|FG000|Overall Study|Physician Decision|0|||
161024364|NCT05469464|581479702|FG001|Overall Study|Physician Decision|0|||
161024365|NCT05469464|581479703|FG002|Overall Study|Physician Decision|0|||
161024366|NCT05469464|581479704|FG003|Overall Study|Physician Decision|1|||
161024367|NCT03905798|581479705|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
161024368|NCT05374798|581479708|FG000|Overall Study|Lost to Follow-up|2|||
161024369|NCT05374798|581479708|FG000|Overall Study|Withdrawal by Subject|2|||
161024370|NCT05374798|581479708|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
161024371|NCT03463044|581479709|FG000|Overall Study|Lost to Follow-up|0|||
161024372|NCT03463044|581479710|FG001|Overall Study|Lost to Follow-up|0|||
161024373|NCT03463044|581479711|FG002|Overall Study|Lost to Follow-up|0|||
161024374|NCT03463044|581479712|FG003|Overall Study|Lost to Follow-up|0|||
161024375|NCT03463044|581479713|FG004|Overall Study|Lost to Follow-up|0|||
161024376|NCT03463044|581479714|FG005|Overall Study|Lost to Follow-up|0|||
161024377|NCT03463044|581479715|FG006|Overall Study|Lost to Follow-up|0|||
161024378|NCT03463044|581479716|FG007|Overall Study|Lost to Follow-up|1|||
161024379|NCT03463044|581479717|FG008|Overall Study|Lost to Follow-up|0|||
161024380|NCT03334630|581479718|FG000|Overall Study|Withdrawal by Subject|7|||
161024381|NCT03334630|581479719|FG001|Overall Study|Withdrawal by Subject|7|||
161024382|NCT03334630|581479718|FG000|Overall Study|Lost to Follow-up|3|||
161024383|NCT03334630|581479719|FG001|Overall Study|Lost to Follow-up|1|||
161024384|NCT03334630|581479718|FG000|Overall Study|Adverse Event|0|||
161024385|NCT03334630|581479719|FG001|Overall Study|Adverse Event|1|||
161024386|NCT03334630|581479718|FG000|Overall Study|Physician Decision|1|||
161024387|NCT03334630|581479719|FG001|Overall Study|Physician Decision|1|||
161024388|NCT03334630|581479718|FG000|Overall Study|Enrollment closed|2|||
161024389|NCT03334630|581479719|FG001|Overall Study|Enrollment closed|1|||
161024390|NCT03334630|581479718|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
161024391|NCT03334630|581479719|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
161024392|NCT03334630|581479718|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
161024393|NCT03334630|581479719|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
161274845|NCT02348723|582384796|FG000|Overall Study|Adverse Event|3|||
161274846|NCT02348723|582384797|FG001|Overall Study|Adverse Event|1|||
161274847|NCT00678886|582384798|FG000|Overall Study|Withdrawal by Subject|0|||
161274848|NCT00678886|582384799|FG001|Overall Study|Withdrawal by Subject|0|||
161274849|NCT00678886|582384800|FG002|Overall Study|Withdrawal by Subject|4|||
161274850|NCT00678886|582384801|FG003|Overall Study|Withdrawal by Subject|6|||
161274851|NCT00678886|582384798|FG000|Overall Study|Physician Decision|0|||
161024431|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
161024432|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
161024433|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
161024434|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
161024435|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
161024436|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
161024437|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
161024438|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
161024439|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
161024440|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
161024441|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
161024442|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161024443|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161024444|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
161024445|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
161024446|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
161024447|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
161024448|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
161024449|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161024450|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161024451|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
161024452|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
161024453|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
161024454|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024455|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024456|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024457|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161024458|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
161274852|NCT00678886|582384799|FG001|Overall Study|Physician Decision|0|||
161274853|NCT00678886|582384800|FG002|Overall Study|Physician Decision|1|||
161274854|NCT00678886|582384801|FG003|Overall Study|Physician Decision|1|||
161274855|NCT00678886|582384798|FG000|Overall Study|Lost to Follow-up|0|||
161274856|NCT00678886|582384799|FG001|Overall Study|Lost to Follow-up|0|||
161274857|NCT00678886|582384800|FG002|Overall Study|Lost to Follow-up|3|||
161274858|NCT00678886|582384801|FG003|Overall Study|Lost to Follow-up|2|||
161274859|NCT00678886|582384798|FG000|Overall Study|Other|0|||
161274860|NCT00678886|582384799|FG001|Overall Study|Other|0|||
161274861|NCT00678886|582384800|FG002|Overall Study|Other|1|||
161274862|NCT00678886|582384801|FG003|Overall Study|Other|0|||
161274863|NCT02290223|582384802|FG000|6 Months|Lost to Follow-up|9|||
161274864|NCT02290223|582384803|FG001|6 Months|Lost to Follow-up|6|||
161274865|NCT02290223|582384802|FG000|6 Months|Withdrawal by Subject|5|||
161274866|NCT02290223|582384803|FG001|6 Months|Withdrawal by Subject|0|||
161274867|NCT02290223|582384802|FG000|6 Months|deceased (not related to study)|2|||
161274868|NCT02290223|582384803|FG001|6 Months|deceased (not related to study)|0|||
161274869|NCT02290223|582384802|FG000|12 Months|Lost to Follow-up|16|||
161274870|NCT02290223|582384803|FG001|12 Months|Lost to Follow-up|10|||
161274871|NCT02290223|582384802|FG000|12 Months|Refusal|0|||
161274872|NCT02290223|582384803|FG001|12 Months|Refusal|1|||
161274873|NCT05293639|582384804|FG000|Overall Study|Withdrawal by Subject|1|||
161274874|NCT05293639|582384805|FG001|Overall Study|Withdrawal by Subject|1|||
161274875|NCT05293639|582384806|FG002|Overall Study|Withdrawal by Subject|2|||
161274876|NCT05293639|582384804|FG000|Overall Study|Death|0|||
161274877|NCT05293639|582384805|FG001|Overall Study|Death|1|||
161274878|NCT05293639|582384806|FG002|Overall Study|Death|0|||
161274879|NCT05293639|582384804|FG000|Overall Study|Lost to Follow-up|0|||
161274880|NCT05293639|582384805|FG001|Overall Study|Lost to Follow-up|0|||
161274881|NCT05293639|582384806|FG002|Overall Study|Lost to Follow-up|5|||
161274882|NCT05293639|582384804|FG000|Overall Study|Other|0|||
161274883|NCT05293639|582384805|FG001|Overall Study|Other|0|||
161274884|NCT05293639|582384806|FG002|Overall Study|Other|1|||
161274885|NCT01671332|582384813|FG000|Overall Study|Withdrawal by Subject|1|||
161274886|NCT01671332|582384814|FG001|Overall Study|Withdrawal by Subject|1|||
161024459|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161024460|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
161274887|NCT01458106|582384820|FG000|Overall Study|Withdrawal by Subject|2|||
161274888|NCT01458106|582384821|FG001|Overall Study|Withdrawal by Subject|0|||
161274889|NCT01458106|582384820|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
161274890|NCT01458106|582384821|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
160972949|NCT03638635|581291082|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
161024461|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161024462|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
161024463|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161024464|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161024465|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
161024466|NCT05693935|581483641|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
161024467|NCT05693935|581483642|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
161024468|NCT05693935|581483643|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
161024469|NCT05693935|581483644|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
161024470|NCT05693935|581483645|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161024471|NCT05693935|581483646|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161024472|NCT05693935|581483647|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
161024473|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
160972950|NCT03638635|581291083|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
160972951|NCT03980184|581291085|FG000|Overall Study|Dropped out before treatment|2|||
161024474|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
161024475|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
161024476|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
161024477|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
161024478|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
160972952|NCT03980184|581291086|FG001|Overall Study|Dropped out before treatment|2|||
160972953|NCT03980184|581291085|FG000|Overall Study|Lost to Follow-up|11|||
161024479|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
161024480|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
161024481|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
161024482|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
161024483|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
161024484|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
161024485|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
161024486|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
161024487|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024488|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
161024489|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
161024490|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
161024491|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024492|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024493|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
161024494|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
161024495|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
161024496|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
161024497|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
161024498|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
161024499|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
161024500|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
160972954|NCT03980184|581291086|FG001|Overall Study|Lost to Follow-up|13|||
160972955|NCT01129336|581291092|FG000|Overall Study|Protocol Violation|1|||
160972956|NCT01129336|581291093|FG001|Overall Study|Protocol Violation|0|||
160972957|NCT01129336|581291092|FG000|Overall Study|Disease Progression|1|||
160972958|NCT01129336|581291093|FG001|Overall Study|Disease Progression|4|||
160972959|NCT01129336|581291092|FG000|Overall Study|Lost to Follow-up|1|||
160972960|NCT01129336|581291093|FG001|Overall Study|Lost to Follow-up|0|||
160972961|NCT01129336|581291092|FG000|Overall Study|Withdrawal by Subject|7|||
160972962|NCT01129336|581291093|FG001|Overall Study|Withdrawal by Subject|4|||
160972963|NCT01129336|581291092|FG000|Overall Study|Adverse Event|0|||
160972964|NCT01129336|581291093|FG001|Overall Study|Adverse Event|1|||
160972965|NCT01129336|581291092|FG000|Overall Study|Missing Study Completion Status|2|||
160972966|NCT01129336|581291093|FG001|Overall Study|Missing Study Completion Status|3|||
160972967|NCT01129336|581291092|FG000|Overall Study|Death|0|||
160972968|NCT01129336|581291093|FG001|Overall Study|Death|4|||
160972969|NCT00467142|581291096|FG000|Overall Study|Withdrawal by Subject|1|||
160972970|NCT00467142|581291096|FG000|Overall Study|Adverse Event|1|||
160972971|NCT00467142|581291096|FG000|Overall Study|Protocol Violation|1|||
161024501|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
161024502|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161024503|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
161024504|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161024505|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
161024506|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
161024507|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
161024508|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024509|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024510|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
161024511|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024512|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024513|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024514|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
161024515|NCT05693935|581483641|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
161024516|NCT05693935|581483642|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
161024517|NCT05693935|581483643|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
161024518|NCT05693935|581483644|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
161024519|NCT05693935|581483645|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
161024520|NCT05693935|581483646|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
161024521|NCT05693935|581483647|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
160972972|NCT00154310|581291097|FG000|Overall Study|Adverse Event|19|||
160972973|NCT00154310|581291098|FG001|Overall Study|Adverse Event|9|||
160972974|NCT00154310|581291097|FG000|Overall Study|Lack of Efficacy|5|||
160972975|NCT00154310|581291098|FG001|Overall Study|Lack of Efficacy|4|||
160972976|NCT00154310|581291097|FG000|Overall Study|Protocol Violation|4|||
160972977|NCT00154310|581291098|FG001|Overall Study|Protocol Violation|2|||
160972978|NCT00154310|581291097|FG000|Overall Study|Withdrawal by Subject|9|||
160972979|NCT00154310|581291098|FG001|Overall Study|Withdrawal by Subject|3|||
160972980|NCT00154310|581291097|FG000|Overall Study|Lost to Follow-up|0|||
160972981|NCT00154310|581291098|FG001|Overall Study|Lost to Follow-up|8|||
160972982|NCT00154310|581291097|FG000|Overall Study|Administrative problems|0|||
160972983|NCT00154310|581291098|FG001|Overall Study|Administrative problems|1|||
160972984|NCT00154310|581291097|FG000|Overall Study|Death|0|||
160972985|NCT00154310|581291098|FG001|Overall Study|Death|1|||
160972986|NCT02086162|581291100|FG000|Overall Study|Withdrawal by Subject|4|||
160972987|NCT02086162|581291101|FG001|Overall Study|Withdrawal by Subject|4|||
160972988|NCT02086162|581291100|FG000|Overall Study|moved|1|||
160972989|NCT02086162|581291101|FG001|Overall Study|moved|1|||
160972990|NCT02086162|581291100|FG000|Overall Study|Lost to Follow-up|4|||
160972991|NCT02086162|581291101|FG001|Overall Study|Lost to Follow-up|2|||
160972992|NCT02086162|581291100|FG000|Overall Study|Death|1|||
160972993|NCT02086162|581291101|FG001|Overall Study|Death|0|||
160972994|NCT03447730|581291102|FG000|Overall Study|Adverse Event|0|||
160972995|NCT03447730|581291103|FG001|Overall Study|Adverse Event|2|||
160972996|NCT03447730|581291104|FG002|Overall Study|Adverse Event|0|||
160972997|NCT01248962|581291108|FG000|Overall Study|Withdrawal by Subject|1|||
160972998|NCT01248962|581291109|FG001|Overall Study|Withdrawal by Subject|1|||
160972999|NCT01248962|581291108|FG000|Overall Study|Adverse Event|2|||
160973000|NCT01248962|581291109|FG001|Overall Study|Adverse Event|1|||
160973001|NCT01248962|581291108|FG000|Overall Study|Complete Response after 4 Cycles|1|||
160973002|NCT01248962|581291109|FG001|Overall Study|Complete Response after 4 Cycles|0|||
160973003|NCT01248962|581291108|FG000|Overall Study|Complete Response after 3 Cycles|0|||
160973004|NCT01248962|581291109|FG001|Overall Study|Complete Response after 3 Cycles|1|||
160973005|NCT01248962|581291108|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
160973006|NCT01248962|581291109|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
160973007|NCT01827254|581291111|FG000|Overall Study|Death|10|||
160973008|NCT01827254|581291111|FG000|Overall Study|Case report form not completed|4|||
160973009|NCT01827254|581291111|FG000|Overall Study|Invalidated centre|3|||
160973010|NCT01827254|581291111|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
160973011|NCT01827254|581291111|FG000|Overall Study|Did not complete re-challenge|1|||
160973012|NCT01827254|581291111|FG000|Overall Study|Disease progression|36|||
160973013|NCT01827254|581291111|FG000|Overall Study|Intolerance to treatment|4|||
160973014|NCT01350505|581291112|FG000|Overall Study|Lost to Follow-up|4|||
160973015|NCT01834222|581291113|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
160973016|NCT04702568|581291114|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
160973017|NCT04702568|581291115|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
160973018|NCT04702568|581291114|FG000|Overall Study|Pregnancy|1|||
160973019|NCT04702568|581291115|FG001|Overall Study|Pregnancy|0|||
160973020|NCT04702568|581291114|FG000|Overall Study|Bone marrow transplant|1|||
160973021|NCT04702568|581291115|FG001|Overall Study|Bone marrow transplant|0|||
160973022|NCT04702568|581291114|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
160973023|NCT04702568|581291115|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
160973024|NCT04702568|581291114|FG000|Overall Study|Withdrawal by Subject|0|||
160973025|NCT04702568|581291115|FG001|Overall Study|Withdrawal by Subject|2|||
160973026|NCT00423852|581291118|FG000|Overall Study|Removed pior to the high-dose portion|3|||
160973027|NCT04145037|581291121|FG000|Overall Study|Study terminated|2|||
160973028|NCT04145037|581291122|FG001|Overall Study|Study terminated|0|||
160973029|NCT04145037|581291121|FG000|Overall Study|Withdrawal by Subject|1|||
160973030|NCT04145037|581291122|FG001|Overall Study|Withdrawal by Subject|0|||
160973031|NCT04145037|581291121|FG000|Overall Study|Lost to Follow-up|1|||
160973032|NCT04145037|581291122|FG001|Overall Study|Lost to Follow-up|0|||
160973033|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
160973034|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
160973035|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
161274891|NCT01458106|582384820|FG000|Overall Study|Withdrawn Per Protocol|0|||
161274892|NCT01458106|582384821|FG001|Overall Study|Withdrawn Per Protocol|1|||
161274893|NCT01056289|582386686|FG000|Open-label Phase|Adverse Event|29|||
161274894|NCT01056289|582386687|FG001|Open-label Phase|Adverse Event|0|||
161274895|NCT01056289|582386688|FG002|Open-label Phase|Adverse Event|0|||
161274896|NCT01056289|582386689|FG003|Open-label Phase|Adverse Event|0|||
161274897|NCT01056289|582386686|FG000|Open-label Phase|Lost to Follow-up|30|||
161274898|NCT01056289|582386687|FG001|Open-label Phase|Lost to Follow-up|0|||
161274899|NCT01056289|582386688|FG002|Open-label Phase|Lost to Follow-up|0|||
161274900|NCT01056289|582386689|FG003|Open-label Phase|Lost to Follow-up|0|||
161274901|NCT01056289|582386686|FG000|Open-label Phase|Other|9|||
161274902|NCT01056289|582386687|FG001|Open-label Phase|Other|0|||
161274903|NCT01056289|582386688|FG002|Open-label Phase|Other|0|||
161274904|NCT01056289|582386689|FG003|Open-label Phase|Other|0|||
161274905|NCT01056289|582386686|FG000|Open-label Phase|Protocol Violation|6|||
161274906|NCT01056289|582386687|FG001|Open-label Phase|Protocol Violation|0|||
161274907|NCT01056289|582386688|FG002|Open-label Phase|Protocol Violation|0|||
161274908|NCT01056289|582386689|FG003|Open-label Phase|Protocol Violation|0|||
161274909|NCT01056289|582386686|FG000|Open-label Phase|Withdrawal by Subject|26|||
161274910|NCT01056289|582386687|FG001|Open-label Phase|Withdrawal by Subject|0|||
161274911|NCT01056289|582386688|FG002|Open-label Phase|Withdrawal by Subject|0|||
161274912|NCT01056289|582386689|FG003|Open-label Phase|Withdrawal by Subject|0|||
161274913|NCT01056289|582386686|FG000|Open-label Phase|Lack of Efficacy|18|||
161274914|NCT01056289|582386687|FG001|Open-label Phase|Lack of Efficacy|0|||
161274915|NCT01056289|582386688|FG002|Open-label Phase|Lack of Efficacy|0|||
161274916|NCT01056289|582386689|FG003|Open-label Phase|Lack of Efficacy|0|||
161274917|NCT01056289|582386686|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
161274918|NCT01056289|582386687|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
161091134|NCT02581631|581723818|FG000|Overall Study|participant withdrew consent|3|||
161319374|NCT00496587|582555292|FG000|Overall Study|Death|1|||
161274919|NCT01056289|582386688|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
161274920|NCT01056289|582386689|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
161274921|NCT01056289|582386686|FG000|Double-blind Phase|Adverse Event|0|||
161274922|NCT01056289|582386687|FG001|Double-blind Phase|Adverse Event|1|||
161274923|NCT01056289|582386688|FG002|Double-blind Phase|Adverse Event|2|||
161274924|NCT01056289|582386689|FG003|Double-blind Phase|Adverse Event|1|||
161274925|NCT01056289|582386686|FG000|Double-blind Phase|Lost to Follow-up|0|||
161274926|NCT01056289|582386687|FG001|Double-blind Phase|Lost to Follow-up|2|||
161274927|NCT01056289|582386688|FG002|Double-blind Phase|Lost to Follow-up|2|||
161274928|NCT01056289|582386689|FG003|Double-blind Phase|Lost to Follow-up|2|||
161274929|NCT01056289|582386686|FG000|Double-blind Phase|Other|0|||
161274930|NCT01056289|582386687|FG001|Double-blind Phase|Other|0|||
161274931|NCT01056289|582386688|FG002|Double-blind Phase|Other|1|||
161274932|NCT01056289|582386689|FG003|Double-blind Phase|Other|2|||
161274933|NCT01056289|582386686|FG000|Double-blind Phase|Protocol Violation|0|||
161274934|NCT01056289|582386687|FG001|Double-blind Phase|Protocol Violation|0|||
161274935|NCT01056289|582386688|FG002|Double-blind Phase|Protocol Violation|1|||
161274936|NCT01056289|582386689|FG003|Double-blind Phase|Protocol Violation|1|||
161274937|NCT01056289|582386686|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161274938|NCT01056289|582386687|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161274939|NCT01056289|582386688|FG002|Double-blind Phase|Withdrawal by Subject|4|||
161274940|NCT01056289|582386689|FG003|Double-blind Phase|Withdrawal by Subject|2|||
161274941|NCT01056289|582386686|FG000|Double-blind Phase|Discontinuation symptom|0|||
161274942|NCT01056289|582386687|FG001|Double-blind Phase|Discontinuation symptom|1|||
161274943|NCT01056289|582386688|FG002|Double-blind Phase|Discontinuation symptom|2|||
161274944|NCT01056289|582386689|FG003|Double-blind Phase|Discontinuation symptom|2|||
161274945|NCT01056289|582386686|FG000|Double-blind Phase|Physician Decision|0|||
161274946|NCT01056289|582386687|FG001|Double-blind Phase|Physician Decision|0|||
161274947|NCT01056289|582386688|FG002|Double-blind Phase|Physician Decision|1|||
161274948|NCT01056289|582386689|FG003|Double-blind Phase|Physician Decision|0|||
161274949|NCT00270855|582386696|FG000|Overall Study|Withdrawal by Subject|8|||
161274950|NCT00270855|582386697|FG001|Overall Study|Withdrawal by Subject|8|||
161274951|NCT03156504|582386703|FG000|Overall Study|Withdrawal by Subject|1|||
161274952|NCT05048329|582386704|FG000|Overall Study|Withdrawal by Subject|1|||
161274953|NCT05048329|582386704|FG000|Overall Study|Screenfail|1|||
161274954|NCT03257865|582386708|FG000|Overall Study|Adverse Event|4|||
161274955|NCT03257865|582386709|FG001|Overall Study|Adverse Event|8|||
161274956|NCT03257865|582386708|FG000|Overall Study|Lack of Efficacy|1|||
161274957|NCT03257865|582386709|FG001|Overall Study|Lack of Efficacy|2|||
161274958|NCT03257865|582386708|FG000|Overall Study|Non-compliance with Study Drug|0|||
161274959|NCT03257865|582386709|FG001|Overall Study|Non-compliance with Study Drug|2|||
161274960|NCT03257865|582386708|FG000|Overall Study|Withdrawal by Subject|23|||
161274961|NCT03257865|582386709|FG001|Overall Study|Withdrawal by Subject|17|||
161274962|NCT03257865|582386708|FG000|Overall Study|Physician Decision|3|||
161274963|NCT03257865|582386709|FG001|Overall Study|Physician Decision|1|||
161274964|NCT03257865|582386708|FG000|Overall Study|Other|0|||
161274965|NCT03257865|582386709|FG001|Overall Study|Other|1|||
161274966|NCT03257865|582386708|FG000|Overall Study|Lost to Follow-up|4|||
161274967|NCT03257865|582386709|FG001|Overall Study|Lost to Follow-up|4|||
161274968|NCT02549027|582386710|FG000|Washout After Period 4|Withdrawal by Subject|0|||
161274969|NCT02549027|582386711|FG001|Washout After Period 4|Withdrawal by Subject|1|||
161274970|NCT02549027|582386712|FG002|Washout After Period 4|Withdrawal by Subject|1|||
161274971|NCT02549027|582386713|FG003|Washout After Period 4|Withdrawal by Subject|1|||
161274972|NCT02549027|582386714|FG004|Washout After Period 4|Withdrawal by Subject|0|||
161274973|NCT02549027|582386715|FG005|Washout After Period 4|Withdrawal by Subject|0|||
161274974|NCT02549027|582386710|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161274975|NCT02549027|582386711|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161274976|NCT02549027|582386712|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161274977|NCT02549027|582386713|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161274978|NCT02549027|582386714|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
161274979|NCT02549027|582386715|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
161274980|NCT01421511|582386721|FG000|Overall Study|Lost to Follow-up|11|||
161274981|NCT01421511|582386722|FG001|Overall Study|Lost to Follow-up|14|||
161274982|NCT01421511|582386721|FG000|Overall Study|Randomized but didn't receive study drug|1|||
161274983|NCT01421511|582386722|FG001|Overall Study|Randomized but didn't receive study drug|7|||
161274984|NCT01421511|582386721|FG000|Overall Study|Physician Decision|0|||
161274985|NCT01421511|582386722|FG001|Overall Study|Physician Decision|1|||
161274986|NCT01421511|582386721|FG000|Overall Study|Withdrawal by Subject|6|||
161274987|NCT01421511|582386722|FG001|Overall Study|Withdrawal by Subject|5|||
161274988|NCT01421511|582386721|FG000|Overall Study|Death|1|||
161274989|NCT01421511|582386722|FG001|Overall Study|Death|1|||
161274990|NCT05384171|582386723|FG000|Overall Study|Lost to Follow-up|9|||
161274991|NCT05384171|582386724|FG001|Overall Study|Lost to Follow-up|9|||
161274992|NCT05384171|582386723|FG000|Overall Study|Withdrawal by Subject|3|||
161274993|NCT05384171|582386724|FG001|Overall Study|Withdrawal by Subject|0|||
161274994|NCT02242045|582386725|FG000|Overall Study|Investigator's Discretion|1|||
161274995|NCT02242045|582386725|FG000|Overall Study|Progressive Disease|2|||
161274996|NCT02242045|582386725|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
161274997|NCT02242045|582386725|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
161274998|NCT00749892|582386726|FG000|Overall Study|Withdrawal by Subject|3|||
161274999|NCT00106964|582386728|FG000|Overall Study|Lost to Follow-up|8|||
161275000|NCT00106964|582386729|FG001|Overall Study|Lost to Follow-up|6|||
161275001|NCT00106964|582386730|FG002|Overall Study|Lost to Follow-up|2|||
161275002|NCT00106964|582386728|FG000|Overall Study|Pregnancy|2|||
161275003|NCT00106964|582386729|FG001|Overall Study|Pregnancy|3|||
161275004|NCT00106964|582386730|FG002|Overall Study|Pregnancy|2|||
161275005|NCT00106964|582386728|FG000|Overall Study|Death|1|||
161275006|NCT00106964|582386729|FG001|Overall Study|Death|1|||
161275007|NCT00106964|582386730|FG002|Overall Study|Death|0|||
161275008|NCT00106964|582386728|FG000|Overall Study|Incarceration|0|||
161275009|NCT00106964|582386729|FG001|Overall Study|Incarceration|1|||
161275010|NCT00106964|582386730|FG002|Overall Study|Incarceration|0|||
161275011|NCT00106964|582386728|FG000|Overall Study|Site Funding Terminated|0|||
161275012|NCT00106964|582386729|FG001|Overall Study|Site Funding Terminated|1|||
161275013|NCT00106964|582386730|FG002|Overall Study|Site Funding Terminated|1|||
161275014|NCT00106964|582386728|FG000|Overall Study|Failure to adhere|2|||
161275015|NCT00106964|582386729|FG001|Overall Study|Failure to adhere|0|||
161275016|NCT00106964|582386730|FG002|Overall Study|Failure to adhere|0|||
161275017|NCT00106964|582386728|FG000|Overall Study|Did not meet eligibility criteria|0|||
161275018|NCT00106964|582386729|FG001|Overall Study|Did not meet eligibility criteria|2|||
161275019|NCT00106964|582386730|FG002|Overall Study|Did not meet eligibility criteria|2|||
161275020|NCT00106964|582386728|FG000|Overall Study|Required disallowed medication|0|||
161275021|NCT00106964|582386729|FG001|Overall Study|Required disallowed medication|1|||
161275022|NCT00106964|582386730|FG002|Overall Study|Required disallowed medication|0|||
161275023|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
161275024|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
161275025|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
161275026|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
161275027|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
161275028|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
161275029|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
161275030|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
161275031|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
161275032|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
161275033|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
161275034|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
161275035|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
161275036|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
161275037|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
161275038|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
161275039|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
161275040|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
161275041|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
161275042|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
161275043|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
161275044|NCT04040192|582386731|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
161275045|NCT04040192|582386732|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
161275046|NCT04040192|582386733|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
161275047|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
161275048|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
161275049|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
161275050|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
161275051|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
161275052|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
161275053|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
161275054|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
160973036|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
160973037|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
160973038|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
160973039|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
160973040|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
160973041|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
160973042|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
160973043|NCT02307513|581291123|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
160973044|NCT02307513|581291124|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
160973045|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
160973046|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
160973047|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
160973048|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
160973049|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
160973050|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
160973051|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
160973052|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
160973053|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
160973054|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
160973055|NCT02307513|581291123|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
160973056|NCT02307513|581291124|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
160973057|NCT02307513|581291123|FG000|Long-term Extension|Physician Decision|1|||
160973058|NCT02307513|581291124|FG001|Long-term Extension|Physician Decision|0|||
160973059|NCT00525265|581291132|FG000|Overall Study|Protocol Violation|1|||
160973060|NCT00525265|581291133|FG001|Overall Study|Protocol Violation|0|||
160973061|NCT01107743|581291134|FG000|Overall Study|Protocol Violation|46|||
160973062|NCT00308737|581291135|FG000|Overall Study|Adverse Event|104|||
160973063|NCT00308737|581291136|FG001|Overall Study|Adverse Event|9|||
160973064|NCT00308737|581291137|FG002|Overall Study|Adverse Event|0|||
160973065|NCT00308737|581291135|FG000|Overall Study|Death|4|||
160973066|NCT00308737|581291136|FG001|Overall Study|Death|3|||
160973067|NCT00308737|581291137|FG002|Overall Study|Death|0|||
160973068|NCT00308737|581291135|FG000|Overall Study|Lost to Follow-up|56|||
160973069|NCT00308737|581291136|FG001|Overall Study|Lost to Follow-up|80|||
160973070|NCT00308737|581291137|FG002|Overall Study|Lost to Follow-up|5|||
160973071|NCT00308737|581291135|FG000|Overall Study|Physician Decision|15|||
160973072|NCT00308737|581291136|FG001|Overall Study|Physician Decision|2|||
160973073|NCT00308737|581291137|FG002|Overall Study|Physician Decision|1|||
160973074|NCT00308737|581291135|FG000|Overall Study|Protocol Violation|34|||
160973075|NCT00308737|581291136|FG001|Overall Study|Protocol Violation|9|||
160973076|NCT00308737|581291137|FG002|Overall Study|Protocol Violation|5|||
160973077|NCT00308737|581291135|FG000|Overall Study|Withdrawal by Subject|218|||
160973078|NCT00308737|581291136|FG001|Overall Study|Withdrawal by Subject|166|||
160973079|NCT00308737|581291137|FG002|Overall Study|Withdrawal by Subject|18|||
160973080|NCT00308737|581291135|FG000|Overall Study|Various|32|||
160973081|NCT00308737|581291136|FG001|Overall Study|Various|20|||
160973082|NCT00308737|581291137|FG002|Overall Study|Various|8|||
160973083|NCT00744263|581291140|FG000|Overall Study|Death|3006|||
160973084|NCT00744263|581291141|FG001|Overall Study|Death|3005|||
160973085|NCT00744263|581291140|FG000|Overall Study|Lost to Follow-up|2038|||
160973086|NCT00744263|581291141|FG001|Overall Study|Lost to Follow-up|2135|||
160973087|NCT00744263|581291140|FG000|Overall Study|Withdrawal by Subject|166|||
160973088|NCT00744263|581291141|FG001|Overall Study|Withdrawal by Subject|150|||
161275055|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
160973089|NCT00744263|581291140|FG000|Overall Study|Physician Decision|20|||
160973090|NCT00744263|581291141|FG001|Overall Study|Physician Decision|23|||
160973091|NCT00744263|581291140|FG000|Overall Study|Protocol Violation|3|||
160973092|NCT00744263|581291141|FG001|Overall Study|Protocol Violation|5|||
160973093|NCT00744263|581291140|FG000|Overall Study|Adverse Event|1|||
160973094|NCT00744263|581291141|FG001|Overall Study|Adverse Event|0|||
160973095|NCT00744263|581291140|FG000|Overall Study|Other|2|||
160973096|NCT00744263|581291141|FG001|Overall Study|Other|2|||
160973097|NCT01913639|581291142|FG000|Overall Study|Not Eligible|3|||
160973098|NCT01290822|581291143|FG000|Overall Study|Withdrawal by Subject|1|||
160973099|NCT01290822|581291143|FG000|Overall Study|Physician Decision|10|||
161275056|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
160973100|NCT02100722|581291146|FG000|Overall Study|Withdrawal pre-procedure|4|||
160973101|NCT02100722|581291147|FG001|Overall Study|Withdrawal pre-procedure|9|||
160973102|NCT02100722|581291146|FG000|Overall Study|Withdrawal post-procedure|0|||
160973103|NCT02100722|581291147|FG001|Overall Study|Withdrawal post-procedure|3|||
160973104|NCT02100722|581291146|FG000|Overall Study|Lost to Follow-up|2|||
160973105|NCT02100722|581291147|FG001|Overall Study|Lost to Follow-up|2|||
160973106|NCT02100722|581291146|FG000|Overall Study|Continuing on study|751|||
160973107|NCT02100722|581291147|FG001|Overall Study|Continuing on study|729|||
160973108|NCT04986982|581291148|FG000|Overall Study|Withdrawal by Subject|3|||
161275057|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
161275058|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
161275059|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161275060|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
161275061|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
161343868|NCT01186770|582645983|FG001|Overall Study|Lost to Follow-up|6|||
161275062|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
161275063|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
161275064|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
161275065|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
161275066|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
161275067|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
161275068|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
161275069|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
161275070|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
161275071|NCT04040192|582386731|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
161275072|NCT04040192|582386732|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
161275073|NCT04040192|582386733|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
161275074|NCT03207243|582386734|FG000|Overall Study|Adverse Event|2|||
161275075|NCT03207243|582386735|FG001|Overall Study|Adverse Event|2|||
161275076|NCT03207243|582386734|FG000|Overall Study|Loss of Asthma Control|47|||
161275077|NCT03207243|582386735|FG001|Overall Study|Loss of Asthma Control|31|||
161275078|NCT03207243|582386734|FG000|Overall Study|Withdrawal by Subject|2|||
161275079|NCT03207243|582386735|FG001|Overall Study|Withdrawal by Subject|4|||
161275080|NCT03207243|582386734|FG000|Overall Study|Physician Decision|1|||
161275081|NCT03207243|582386735|FG001|Overall Study|Physician Decision|1|||
161275082|NCT03207243|582386734|FG000|Overall Study|Lost to Follow-up|0|||
161275083|NCT03207243|582386735|FG001|Overall Study|Lost to Follow-up|1|||
161275084|NCT03207243|582386734|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
161275085|NCT03207243|582386735|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
161275086|NCT03207243|582386734|FG000|Overall Study|Protocol Violation|0|||
161275087|NCT03207243|582386735|FG001|Overall Study|Protocol Violation|3|||
161275088|NCT04411914|582386742|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
161275089|NCT04411914|582386743|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
161275090|NCT04106661|582386747|FG000|Overall Study|Protocol Violation|3|||
161275091|NCT04106661|582386748|FG001|Overall Study|Protocol Violation|0|||
161275092|NCT04106661|582386747|FG000|Overall Study|Scheduling difficulties|1|||
161275093|NCT04106661|582386748|FG001|Overall Study|Scheduling difficulties|1|||
161275094|NCT00233402|582386749|FG000|Overall Study|No pathology data|12|||
161275095|NCT00233402|582386750|FG001|Overall Study|No pathology data|9|||
161275096|NCT00233402|582386749|FG000|Overall Study|No Ta/T1|89|||
161275097|NCT00233402|582386750|FG001|Overall Study|No Ta/T1|94|||
161275098|NCT00233402|582386749|FG000|Overall Study|Lost to follow up etc|3|||
161275099|NCT00233402|582386750|FG001|Overall Study|Lost to follow up etc|21|||
161275100|NCT03280381|582386751|FG000|Overall Study|Physician Decision|0|||
161275101|NCT03280381|582386752|FG001|Overall Study|Physician Decision|2|||
161275102|NCT03503864|582386753|FG000|Overall Study|Protocol Violation|6|||
161275103|NCT03503864|582386753|FG000|Overall Study|Withdrawal by Subject|7|||
161275104|NCT00423319|582386754|FG000|Overall Study|Death|2|||
161275105|NCT00423319|582386755|FG001|Overall Study|Death|0|||
161275106|NCT00423319|582386754|FG000|Overall Study|Adverse Event|93|||
161275107|NCT00423319|582386755|FG001|Overall Study|Adverse Event|112|||
161275108|NCT00423319|582386754|FG000|Overall Study|Withdrawal by Subject|86|||
161275109|NCT00423319|582386755|FG001|Overall Study|Withdrawal by Subject|99|||
161275110|NCT00423319|582386754|FG000|Overall Study|Lost to Follow-up|4|||
161275111|NCT00423319|582386755|FG001|Overall Study|Lost to Follow-up|3|||
161275112|NCT00423319|582386754|FG000|Overall Study|Poor compliance or noncompliance|1|||
161275113|NCT00423319|582386755|FG001|Overall Study|Poor compliance or noncompliance|1|||
161275114|NCT00423319|582386754|FG000|Overall Study|No longer meets study criteria|15|||
160973109|NCT04986982|581291149|FG001|Overall Study|Withdrawal by Subject|1|||
161275115|NCT00423319|582386755|FG001|Overall Study|No longer meets study criteria|15|||
161275116|NCT00423319|582386754|FG000|Overall Study|Other|23|||
161275117|NCT00423319|582386755|FG001|Overall Study|Other|22|||
161275118|NCT02639052|582386756|FG000|Overall Study|Lost to Follow-up|1|||
161275119|NCT02655666|582386759|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
161275120|NCT00895414|582386760|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
161275121|NCT00895414|582386761|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
161275122|NCT00895414|582386760|FG000|First Intervention (14 Days)|Physician Decision|0|||
161275123|NCT00895414|582386761|FG001|First Intervention (14 Days)|Physician Decision|1|||
161275124|NCT02087189|582386762|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
161343869|NCT01186770|582645984|FG002|Overall Study|Lost to Follow-up|14|||
161275125|NCT00478426|582386767|FG000|Overall Study|Withdrawal by Subject|1|||
161275126|NCT00789737|582386768|FG000|Overall Study|Withdrawal by Subject|13|||
161275127|NCT00789737|582386769|FG001|Overall Study|Withdrawal by Subject|22|||
161343870|NCT01186770|582645985|FG003|Overall Study|Lost to Follow-up|9|||
161343871|NCT01186770|582645982|FG000|Overall Study|Insufficient response to treatment|7|||
160973110|NCT04986982|581291148|FG000|Overall Study|Lack of Efficacy|0|||
160973111|NCT04986982|581291149|FG001|Overall Study|Lack of Efficacy|2|||
160973112|NCT04986982|581291148|FG000|Overall Study|Ineligibility|3|||
160973113|NCT04986982|581291149|FG001|Overall Study|Ineligibility|0|||
161275128|NCT00789737|582386768|FG000|Overall Study|Lost to Follow-up|10|||
161275129|NCT00789737|582386769|FG001|Overall Study|Lost to Follow-up|14|||
161275130|NCT00789737|582386768|FG000|Overall Study|Adverse Event|8|||
161275131|NCT00789737|582386769|FG001|Overall Study|Adverse Event|8|||
161275132|NCT00789737|582386768|FG000|Overall Study|Protocol Violation|3|||
161275133|NCT00789737|582386769|FG001|Overall Study|Protocol Violation|0|||
161275134|NCT00789737|582386768|FG000|Overall Study|Lack of Efficacy|3|||
161275135|NCT00789737|582386769|FG001|Overall Study|Lack of Efficacy|0|||
161275136|NCT00789737|582386768|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
161275137|NCT00789737|582386769|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
161275138|NCT00789737|582386768|FG000|Overall Study|Other|11|||
161275139|NCT00789737|582386769|FG001|Overall Study|Other|7|||
161275140|NCT01189487|582386770|FG000|Overall Study|Lack of Efficacy|2|||
161275141|NCT01189487|582386770|FG000|Overall Study|Adverse Event|1|||
161275142|NCT04630158|582386771|FG000|Overall Study|Adverse Event|1|||
161275143|NCT04630158|582386772|FG001|Overall Study|Adverse Event|1|||
161275144|NCT04630158|582386773|FG002|Overall Study|Adverse Event|1|||
161275145|NCT04630158|582386771|FG000|Overall Study|Physician Decision|0|||
161275146|NCT04630158|582386772|FG001|Overall Study|Physician Decision|2|||
161275147|NCT04630158|582386773|FG002|Overall Study|Physician Decision|0|||
161275148|NCT04630158|582386771|FG000|Overall Study|Protocol Violation|1|||
161275149|NCT04630158|582386772|FG001|Overall Study|Protocol Violation|0|||
161275150|NCT04630158|582386773|FG002|Overall Study|Protocol Violation|1|||
161275151|NCT04630158|582386771|FG000|Overall Study|Withdrawal by Subject|2|||
161275152|NCT04630158|582386772|FG001|Overall Study|Withdrawal by Subject|1|||
161275153|NCT04630158|582386773|FG002|Overall Study|Withdrawal by Subject|2|||
161275154|NCT03136965|582386776|FG000|Overall Study|Lost to Follow-up|0|||
161275155|NCT03136965|582386777|FG001|Overall Study|Lost to Follow-up|1|||
161275156|NCT03136965|582386778|FG002|Overall Study|Lost to Follow-up|0|||
161275157|NCT01210612|582386781|FG000|Overall Study|Withdrawal by Subject|0|||
161275158|NCT01210612|582386782|FG001|Overall Study|Withdrawal by Subject|2|||
161275159|NCT02458287|582386783|FG000|Overall Study|Adverse Event|0|||
161275160|NCT02458287|582386784|FG001|Overall Study|Adverse Event|0|||
161275161|NCT02458287|582386785|FG002|Overall Study|Adverse Event|0|||
161275162|NCT02458287|582386786|FG003|Overall Study|Adverse Event|1|||
161275163|NCT02458287|582386783|FG000|Overall Study|Lost to Follow-up|0|||
161275164|NCT02458287|582386784|FG001|Overall Study|Lost to Follow-up|1|||
161275165|NCT02458287|582386785|FG002|Overall Study|Lost to Follow-up|1|||
161275166|NCT02458287|582386786|FG003|Overall Study|Lost to Follow-up|0|||
161275167|NCT02458287|582386783|FG000|Overall Study|Protocol Violation|0|||
161275168|NCT02458287|582386784|FG001|Overall Study|Protocol Violation|1|||
161275169|NCT02458287|582386785|FG002|Overall Study|Protocol Violation|0|||
161275170|NCT02458287|582386786|FG003|Overall Study|Protocol Violation|0|||
160973114|NCT04986982|581291148|FG000|Overall Study|Adverse Event|4|||
160973115|NCT04986982|581291149|FG001|Overall Study|Adverse Event|4|||
160973116|NCT04986982|581291148|FG000|Overall Study|Lost to Follow-up|0|||
160973117|NCT04986982|581291149|FG001|Overall Study|Lost to Follow-up|1|||
160973118|NCT04986982|581291148|FG000|Overall Study|Sponsor's discretion|1|||
160973119|NCT04986982|581291149|FG001|Overall Study|Sponsor's discretion|0|||
160973120|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
160973121|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
160973122|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
160973123|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
160973124|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
160973125|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
160973126|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
160973127|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
160973128|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
160973129|NCT03500640|581291150|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
160973130|NCT03500640|581291151|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
160973131|NCT03500640|581291152|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
160973132|NCT03500640|581291150|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
160973133|NCT03500640|581291151|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
160973134|NCT03500640|581291152|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
160973135|NCT03500640|581291150|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
160973136|NCT03500640|581291151|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
160973137|NCT03500640|581291152|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
160973138|NCT03500640|581291150|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
160973139|NCT03500640|581291151|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
160973140|NCT03500640|581291152|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
160973141|NCT03500640|581291150|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
161275171|NCT02458287|582386783|FG000|Overall Study|Withdrawal by Subject|0|||
161275172|NCT02458287|582386784|FG001|Overall Study|Withdrawal by Subject|2|||
161275173|NCT02458287|582386785|FG002|Overall Study|Withdrawal by Subject|2|||
161275174|NCT02458287|582386786|FG003|Overall Study|Withdrawal by Subject|1|||
161275175|NCT02458287|582386783|FG000|Overall Study|Relocated Out of State|0|||
161275176|NCT02458287|582386784|FG001|Overall Study|Relocated Out of State|0|||
161275177|NCT02458287|582386785|FG002|Overall Study|Relocated Out of State|0|||
161275178|NCT02458287|582386786|FG003|Overall Study|Relocated Out of State|1|||
161275179|NCT02752087|582386787|FG000|Washout|Physician Decision|1|||
161275180|NCT02752087|582386788|FG001|Washout|Physician Decision|0|||
161275181|NCT00843635|582386789|FG000|Overall Study|Adverse Event|2|||
161275182|NCT00843635|582386790|FG001|Overall Study|Adverse Event|2|||
161275183|NCT00843635|582386791|FG002|Overall Study|Adverse Event|0|||
161275184|NCT04693416|582386792|FG000|Overall Study|Lost to Follow-up|13|||
161275185|NCT04693416|582386793|FG001|Overall Study|Lost to Follow-up|0|||
161275186|NCT00813800|582386796|FG000|Overall Study|Screen Failure after Consent|2|||
161275187|NCT00813800|582386796|FG000|Overall Study|Adverse Event|1|||
161275188|NCT00813800|582386796|FG000|Overall Study|Worsening of depression|2|||
161275189|NCT00813800|582386796|FG000|Overall Study|Physician Decision|1|||
161275190|NCT01860677|582386797|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
161275191|NCT01860677|582386798|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
161275192|NCT00418821|582386805|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
161275193|NCT02823652|582386806|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
161275194|NCT02823652|582386807|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
161275195|NCT02823652|582386808|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
161275196|NCT02823652|582386806|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
161275197|NCT02823652|582386807|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
161275198|NCT02823652|582386808|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
161275199|NCT02823652|582386806|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
161275200|NCT02823652|582386807|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
161275201|NCT02823652|582386808|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
161275202|NCT02823652|582386806|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
161275203|NCT02823652|582386807|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
161275204|NCT02823652|582386808|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
161275205|NCT04428333|582386809|FG000|Overall Study|Physician Decision|5|||
161275206|NCT04428333|582386810|FG001|Overall Study|Physician Decision|6|||
161275207|NCT04428333|582386809|FG000|Overall Study|Withdrawal by Subject|1|||
161275208|NCT04428333|582386810|FG001|Overall Study|Withdrawal by Subject|3|||
161275209|NCT04428333|582386809|FG000|Overall Study|Study Terminated By Sponsor|14|||
161275210|NCT04428333|582386810|FG001|Overall Study|Study Terminated By Sponsor|16|||
161275211|NCT04853992|582386811|FG000|Treatment Period A|Adverse Event|0|||
161275212|NCT04853992|582386812|FG001|Treatment Period A|Adverse Event|1|||
161275213|NCT04853992|582386811|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
161275214|NCT04853992|582386812|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
161275215|NCT02269163|582386813|FG000|Overall Study|Lost to Follow-up|1|||
161275216|NCT02269163|582386814|FG001|Overall Study|Lost to Follow-up|0|||
161275217|NCT02269163|582386813|FG000|Overall Study|Major protocol violation|0|||
161275218|NCT02269163|582386814|FG001|Overall Study|Major protocol violation|1|||
161275219|NCT02269163|582386813|FG000|Overall Study|Other|2|||
161275220|NCT02269163|582386814|FG001|Overall Study|Other|2|||
161275221|NCT02269163|582386813|FG000|Overall Study|Withdrawal by Subject|0|||
161275222|NCT02269163|582386814|FG001|Overall Study|Withdrawal by Subject|3|||
161275223|NCT02269163|582386813|FG000|Overall Study|Physician Decision|0|||
161275224|NCT02269163|582386814|FG001|Overall Study|Physician Decision|1|||
161275225|NCT02351960|582386815|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
161275226|NCT02351960|582386816|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161275227|NCT02351960|582386815|FG000|Overall Study|Voluntary Withdrawal|5|||
161275228|NCT02351960|582386816|FG001|Overall Study|Voluntary Withdrawal|4|||
161275229|NCT02351960|582386815|FG000|Overall Study|Significant Protocol Deviation|0|||
161275230|NCT02351960|582386816|FG001|Overall Study|Significant Protocol Deviation|5|||
161275231|NCT03866902|582386819|FG000|Overall Study|Lost to Follow-up|98|||
161275232|NCT03866902|582386820|FG001|Overall Study|Lost to Follow-up|82|||
161275233|NCT03866902|582386819|FG000|Overall Study|Pregnancy|18|||
161275234|NCT03866902|582386820|FG001|Overall Study|Pregnancy|24|||
161275235|NCT02092467|582386822|FG000|Overall Study|Death|49|||
161275236|NCT02092467|582386823|FG001|Overall Study|Death|66|||
161275237|NCT02092467|582386824|FG002|Overall Study|Death|38|||
161275238|NCT02092467|582386822|FG000|Overall Study|Lost to Follow-up|38|||
161275239|NCT02092467|582386823|FG001|Overall Study|Lost to Follow-up|35|||
161275240|NCT02092467|582386824|FG002|Overall Study|Lost to Follow-up|40|||
161275241|NCT02092467|582386822|FG000|Overall Study|Global Deterioration of Health Status|1|||
161275242|NCT02092467|582386823|FG001|Overall Study|Global Deterioration of Health Status|0|||
161275243|NCT02092467|582386824|FG002|Overall Study|Global Deterioration of Health Status|0|||
161275244|NCT02092467|582386822|FG000|Overall Study|Other|32|||
161275245|NCT02092467|582386823|FG001|Overall Study|Other|30|||
161275246|NCT02092467|582386824|FG002|Overall Study|Other|24|||
161275247|NCT02092467|582386822|FG000|Overall Study|Withdrawal by Subject|282|||
161275248|NCT02092467|582386823|FG001|Overall Study|Withdrawal by Subject|327|||
161275249|NCT02092467|582386824|FG002|Overall Study|Withdrawal by Subject|289|||
161275250|NCT02092467|582386822|FG000|Overall Study|Randomized but not treated|2|||
161275251|NCT02092467|582386823|FG001|Overall Study|Randomized but not treated|1|||
161275252|NCT02092467|582386824|FG002|Overall Study|Randomized but not treated|7|||
161275253|NCT01284621|582386825|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161275254|NCT01284621|582386826|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161275255|NCT01284621|582386827|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161275256|NCT01284621|582386828|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161275257|NCT01284621|582386829|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
161275258|NCT01284621|582386830|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
161275259|NCT02377427|582386833|FG000|Part A (Up to Week 20)|Physician Decision|1|||
161275260|NCT02377427|582386834|FG001|Part A (Up to Week 20)|Physician Decision|0|||
161275261|NCT02377427|582386835|FG002|Part A (Up to Week 20)|Physician Decision|0|||
161275262|NCT02377427|582386836|FG003|Part A (Up to Week 20)|Physician Decision|0|||
161275263|NCT02377427|582386837|FG004|Part A (Up to Week 20)|Physician Decision|0|||
161275264|NCT02377427|582386833|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
161275265|NCT02377427|582386834|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161275266|NCT02377427|582386835|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161275267|NCT02377427|582386836|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161275268|NCT02377427|582386837|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
161275269|NCT02377427|582386833|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
161275270|NCT02377427|582386834|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161275271|NCT02377427|582386835|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161275272|NCT02377427|582386836|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161275273|NCT02377427|582386837|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
161275274|NCT02377427|582386833|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161275275|NCT02377427|582386834|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161275276|NCT02377427|582386835|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
161275277|NCT02377427|582386836|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161275278|NCT02377427|582386837|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
161275279|NCT02293863|582386838|FG000|Overall Study|Death|4|||
161275280|NCT02293863|582386839|FG001|Overall Study|Death|6|||
161343872|NCT01186770|582645983|FG001|Overall Study|Insufficient response to treatment|8|||
161343873|NCT01186770|582645984|FG002|Overall Study|Insufficient response to treatment|5|||
161343874|NCT01186770|582645985|FG003|Overall Study|Insufficient response to treatment|7|||
161343875|NCT01186770|582645982|FG000|Overall Study|Other than specified|0|||
161343876|NCT01186770|582645983|FG001|Overall Study|Other than specified|1|||
161275281|NCT02293863|582386840|FG002|Overall Study|Death|4|||
161275282|NCT02293863|582386838|FG000|Overall Study|Lost to Follow-up|2|||
161343877|NCT01186770|582645984|FG002|Overall Study|Other than specified|1|||
161024810|NCT04304820|581483687|FG000|Overall Study|Death|1|||
161024811|NCT04304820|581483687|FG000|Overall Study|Lost to Follow-up|1|||
161024812|NCT04304820|581483687|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
161024813|NCT04304820|581483687|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
161024814|NCT04304820|581483687|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
161275283|NCT02293863|582386839|FG001|Overall Study|Lost to Follow-up|2|||
161275284|NCT02293863|582386840|FG002|Overall Study|Lost to Follow-up|2|||
161275285|NCT02293863|582386838|FG000|Overall Study|Withdrawal by Subject|3|||
161275286|NCT02293863|582386839|FG001|Overall Study|Withdrawal by Subject|3|||
161275287|NCT02293863|582386840|FG002|Overall Study|Withdrawal by Subject|1|||
161275288|NCT02293863|582386838|FG000|Overall Study|Reason Not Specified|0|||
161275289|NCT02293863|582386839|FG001|Overall Study|Reason Not Specified|2|||
161275290|NCT02293863|582386840|FG002|Overall Study|Reason Not Specified|2|||
161275291|NCT03155945|582386841|FG000|Overall Study|Lost to Follow-up|0|||
161275292|NCT03155945|582386842|FG001|Overall Study|Lost to Follow-up|1|||
161275293|NCT03155945|582386841|FG000|Overall Study|Withdrawal by Subject|0|||
161275294|NCT03155945|582386842|FG001|Overall Study|Withdrawal by Subject|1|||
161275295|NCT03155945|582386841|FG000|Overall Study|Other Reason|0|||
161275296|NCT03155945|582386842|FG001|Overall Study|Other Reason|1|||
161275297|NCT00416884|582386845|FG000|Overall Study|Study terminated due to low accrual|1|||
161275298|NCT03408639|582389097|FG000|Overall Study|Death|5|||
161275299|NCT03408639|582389098|FG001|Overall Study|Death|5|||
161275300|NCT03408639|582389097|FG000|Overall Study|Lost to Follow-up|1|||
161275301|NCT03408639|582389098|FG001|Overall Study|Lost to Follow-up|4|||
161275302|NCT03408639|582389097|FG000|Overall Study|Withdrawal by Subject|2|||
161275303|NCT03408639|582389098|FG001|Overall Study|Withdrawal by Subject|7|||
161275304|NCT03408639|582389097|FG000|Overall Study|Physician Decision|3|||
161275305|NCT03408639|582389098|FG001|Overall Study|Physician Decision|6|||
161275306|NCT00213135|582389108|FG000|Overall Study|Adverse Event|9|||
161275307|NCT00213135|582389109|FG001|Overall Study|Adverse Event|5|||
161275308|NCT00213135|582389110|FG002|Overall Study|Adverse Event|5|||
161275309|NCT00213135|582389108|FG000|Overall Study|Lost to Follow-up|11|||
161275310|NCT00213135|582389109|FG001|Overall Study|Lost to Follow-up|8|||
161275311|NCT00213135|582389110|FG002|Overall Study|Lost to Follow-up|4|||
161275312|NCT00213135|582389108|FG000|Overall Study|Protocol Violation|4|||
161275313|NCT00213135|582389109|FG001|Overall Study|Protocol Violation|4|||
161275314|NCT00213135|582389110|FG002|Overall Study|Protocol Violation|10|||
161275315|NCT00213135|582389108|FG000|Overall Study|Death|1|||
161275316|NCT00213135|582389109|FG001|Overall Study|Death|1|||
161275317|NCT00213135|582389110|FG002|Overall Study|Death|2|||
161275318|NCT00213135|582389108|FG000|Overall Study|Disease progression|4|||
161275319|NCT00213135|582389109|FG001|Overall Study|Disease progression|5|||
161275320|NCT00213135|582389110|FG002|Overall Study|Disease progression|21|||
161275321|NCT00213135|582389108|FG000|Overall Study|Other|21|||
161275322|NCT00213135|582389109|FG001|Overall Study|Other|12|||
161275323|NCT00213135|582389110|FG002|Overall Study|Other|15|||
161275324|NCT01924754|582389115|FG000|Overall Study|Lost to Follow-up|1|||
161275325|NCT01924754|582389116|FG001|Overall Study|Lost to Follow-up|2|||
161275326|NCT01924754|582389117|FG002|Overall Study|Lost to Follow-up|1|||
161275327|NCT01924754|582389115|FG000|Overall Study|Pregnancy|0|||
161275328|NCT01924754|582389116|FG001|Overall Study|Pregnancy|1|||
161275329|NCT01924754|582389117|FG002|Overall Study|Pregnancy|2|||
161275330|NCT03132155|582389118|FG000|Overall Study|Lack of Efficacy|6|||
161275331|NCT03132155|582389118|FG000|Overall Study|Lost to Follow-up|1|||
161275332|NCT03132155|582389118|FG000|Overall Study|Withdrawal by Subject|1|||
161275333|NCT02925403|582389124|FG000|Overall Study|Lost to Follow-up|0|||
161275334|NCT02925403|582389125|FG001|Overall Study|Lost to Follow-up|1|||
161275335|NCT00402116|582389126|FG000|Overall Study|Jaw infection after surgery-other|1|||
161275336|NCT00402116|582389127|FG001|Overall Study|Jaw infection after surgery-other|0|||
161275337|NCT00402116|582389128|FG002|Overall Study|Jaw infection after surgery-other|0|||
161275338|NCT00402116|582389126|FG000|Overall Study|Withdrawal by Subject|1|||
161275339|NCT00402116|582389127|FG001|Overall Study|Withdrawal by Subject|0|||
161275340|NCT00402116|582389128|FG002|Overall Study|Withdrawal by Subject|5|||
161275341|NCT00402116|582389126|FG000|Overall Study|Treatment completed per protocol|1|||
161275342|NCT00402116|582389127|FG001|Overall Study|Treatment completed per protocol|1|||
161275343|NCT00402116|582389128|FG002|Overall Study|Treatment completed per protocol|2|||
161275344|NCT00402116|582389126|FG000|Overall Study|other complicating disease|0|||
161275345|NCT00402116|582389127|FG001|Overall Study|other complicating disease|0|||
161275346|NCT00402116|582389128|FG002|Overall Study|other complicating disease|2|||
161275347|NCT00402116|582389126|FG000|Overall Study|Disease Progression|0|||
161275348|NCT00402116|582389127|FG001|Overall Study|Disease Progression|4|||
161275349|NCT00402116|582389128|FG002|Overall Study|Disease Progression|38|||
161275350|NCT00402116|582389126|FG000|Overall Study|mistaken thrombocytopenia|0|||
161275351|NCT00402116|582389127|FG001|Overall Study|mistaken thrombocytopenia|0|||
161275352|NCT00402116|582389128|FG002|Overall Study|mistaken thrombocytopenia|1|||
161275353|NCT00402116|582389126|FG000|Overall Study|decline related hyponatremia/tumor|0|||
161275354|NCT00402116|582389127|FG001|Overall Study|decline related hyponatremia/tumor|0|||
161275355|NCT00402116|582389128|FG002|Overall Study|decline related hyponatremia/tumor|1|||
161275356|NCT00402116|582389126|FG000|Overall Study|Adverse Event|0|||
161275357|NCT00402116|582389127|FG001|Overall Study|Adverse Event|1|||
161275358|NCT00402116|582389128|FG002|Overall Study|Adverse Event|6|||
161275359|NCT02899195|582389129|FG000|Concurrent Durvalumab|Adverse Event|4|||
161275360|NCT02899195|582389129|FG000|Concurrent Durvalumab|Physician Decision|1|||
161275361|NCT02899195|582389129|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
161275362|NCT02899195|582389129|FG000|Concurrent Durvalumab|Progressive Disease|5|||
161275363|NCT02899195|582389129|FG000|Maintenance Durvalumab|Adverse Event|1|||
161275364|NCT02899195|582389129|FG000|Maintenance Durvalumab|Physician Decision|1|||
161275365|NCT02899195|582389129|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
161275366|NCT02899195|582389129|FG000|Maintenance Durvalumab|Progressive Disease|31|||
161275367|NCT04778904|582389130|FG000|Overall Study|Protocol Violation|1|||
161275368|NCT04778904|582389131|FG001|Overall Study|Protocol Violation|0|||
161275369|NCT04778904|582389132|FG002|Overall Study|Protocol Violation|0|||
161275370|NCT04778904|582389133|FG003|Overall Study|Protocol Violation|0|||
161275371|NCT04778904|582389130|FG000|Overall Study|Withdrawal by Subject|0|||
161275372|NCT04778904|582389131|FG001|Overall Study|Withdrawal by Subject|0|||
161275373|NCT04778904|582389132|FG002|Overall Study|Withdrawal by Subject|1|||
161275374|NCT04778904|582389133|FG003|Overall Study|Withdrawal by Subject|0|||
161275375|NCT03452137|582389134|FG000|Overall Study|Death|67|||
161275376|NCT03452137|582389135|FG001|Overall Study|Death|70|||
161275377|NCT03452137|582389134|FG000|Overall Study|Lost to Follow-up|4|||
161275378|NCT03452137|582389135|FG001|Overall Study|Lost to Follow-up|2|||
161275379|NCT03452137|582389134|FG000|Overall Study|Physician Decision|0|||
161275380|NCT03452137|582389135|FG001|Overall Study|Physician Decision|1|||
161275381|NCT03452137|582389134|FG000|Overall Study|Study Terminated by Sponsor|120|||
161275382|NCT03452137|582389135|FG001|Overall Study|Study Terminated by Sponsor|121|||
161275383|NCT03452137|582389134|FG000|Overall Study|Withdrawal by Subject|12|||
161275384|NCT03452137|582389135|FG001|Overall Study|Withdrawal by Subject|9|||
161275385|NCT03772717|582389136|FG000|Overall Study|Withdrawal by Subject|2|||
161275386|NCT04138043|582389137|FG000|Overall Study|Withdrawal by Subject|0|||
161275387|NCT04138043|582389138|FG001|Overall Study|Withdrawal by Subject|1|||
161275388|NCT02856802|582389139|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161275389|NCT02856802|582389140|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
161275390|NCT02856802|582389139|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
161275391|NCT02856802|582389140|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
161275392|NCT02856802|582389139|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
161275393|NCT02856802|582389140|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
161275394|NCT02856802|582389139|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
161275395|NCT02856802|582389140|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
161275396|NCT02856802|582389139|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
161275397|NCT02856802|582389140|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
161275398|NCT02856802|582389139|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
161275399|NCT02856802|582389140|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
161275400|NCT00587860|582389141|FG000|Overall Study|Lost to Follow-up|2|||
161275401|NCT00587860|582389142|FG001|Overall Study|Lost to Follow-up|2|||
161275402|NCT00587860|582389141|FG000|Overall Study|Withdrawal by Subject|3|||
161275403|NCT00587860|582389142|FG001|Overall Study|Withdrawal by Subject|3|||
161024825|NCT03873818|581483698|FG000|Overall Study|Death|9|||
161024826|NCT03873818|581483699|FG001|Overall Study|Death|3|||
161024827|NCT03873818|581483698|FG000|Overall Study|Lost to Follow-up|1|||
161024828|NCT03873818|581483699|FG001|Overall Study|Lost to Follow-up|0|||
161275404|NCT01659125|582389143|FG000|Overall Study|Withdrawal by Subject|2|||
161275405|NCT01659125|582389143|FG000|Overall Study|Lost to Follow-up|7|||
161275406|NCT01659125|582389143|FG000|Overall Study|Technical Problem|1|||
161275407|NCT01659125|582389143|FG000|Overall Study|Time Constraints|2|||
161275408|NCT01659125|582389143|FG000|Overall Study|Failed to Start Treatment|2|||
161275409|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
161275410|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
161275411|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
161275412|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
161275413|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
161275414|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
161275415|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
161275416|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
161275417|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
161275418|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
161275419|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
161275420|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
161275421|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
161275422|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
161275423|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
161275424|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
161275425|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
161275426|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
161275427|NCT00261443|582389144|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
161275428|NCT00261443|582389145|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
161275429|NCT00261443|582389146|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
161275430|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
161275431|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
161275432|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
161275433|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
161275434|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
161275435|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
161275436|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
161275437|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
161275438|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
161275439|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
161275440|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
161275441|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
161275442|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
161275443|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
161275444|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
161275445|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
161275446|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
161275447|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
161275448|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
160973142|NCT03500640|581291151|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
160973143|NCT03500640|581291152|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
160973144|NCT03500640|581291150|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
160973145|NCT03500640|581291151|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
160973146|NCT03500640|581291152|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
160973147|NCT03500640|581291150|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
160973148|NCT03500640|581291151|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
160973149|NCT03500640|581291152|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
160973150|NCT01535274|581291153|FG000|Overall Study|Determined to be ineligible|0|||
160973151|NCT01535274|581291154|FG001|Overall Study|Determined to be ineligible|1|||
160973152|NCT01535274|581291153|FG000|Overall Study|Misallocated to propofol intervention|0|||
160973153|NCT01535274|581291154|FG001|Overall Study|Misallocated to propofol intervention|1|||
160973154|NCT02954458|581291157|FG000|Overall Study|Adverse Event|0|||
160973155|NCT02954458|581291158|FG001|Overall Study|Adverse Event|0|||
160973156|NCT02954458|581291159|FG002|Overall Study|Adverse Event|0|||
160973157|NCT02954458|581291160|FG003|Overall Study|Adverse Event|1|||
160973158|NCT02954458|581291157|FG000|Overall Study|Withdrawal by Subject|0|||
160973159|NCT02954458|581291158|FG001|Overall Study|Withdrawal by Subject|0|||
160973160|NCT02954458|581291159|FG002|Overall Study|Withdrawal by Subject|0|||
160973161|NCT02954458|581291160|FG003|Overall Study|Withdrawal by Subject|1|||
160973162|NCT02954458|581291157|FG000|Overall Study|Physician Decision|0|||
160973163|NCT02954458|581291158|FG001|Overall Study|Physician Decision|0|||
160973164|NCT02954458|581291159|FG002|Overall Study|Physician Decision|1|||
160973165|NCT02954458|581291160|FG003|Overall Study|Physician Decision|1|||
160973166|NCT02954458|581291157|FG000|Overall Study|Lost to Follow-up|1|||
160973167|NCT02954458|581291158|FG001|Overall Study|Lost to Follow-up|0|||
160973168|NCT02954458|581291159|FG002|Overall Study|Lost to Follow-up|0|||
160973169|NCT02954458|581291160|FG003|Overall Study|Lost to Follow-up|1|||
160973170|NCT02954458|581291157|FG000|Overall Study|Death|0|||
160973171|NCT02954458|581291158|FG001|Overall Study|Death|0|||
160973172|NCT02954458|581291159|FG002|Overall Study|Death|0|||
161275449|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
161275450|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
161275451|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
161275452|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
161275453|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
161275454|NCT00261443|582389144|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
161275455|NCT00261443|582389145|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
161275456|NCT00261443|582389146|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
161275457|NCT00261443|582389144|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
161275458|NCT00261443|582389145|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
161275459|NCT00261443|582389146|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
161275460|NCT00261443|582389144|FG000|3: Assessment of Relapse|Adverse Event|0|||
161275461|NCT00261443|582389145|FG001|3: Assessment of Relapse|Adverse Event|15|||
161275462|NCT00261443|582389146|FG002|3: Assessment of Relapse|Adverse Event|19|||
161275463|NCT00261443|582389144|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
161275464|NCT00261443|582389145|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
161275465|NCT00261443|582389146|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
161275466|NCT00261443|582389144|FG000|3: Assessment of Relapse|Death|0|||
161275467|NCT00261443|582389145|FG001|3: Assessment of Relapse|Death|0|||
161275468|NCT00261443|582389146|FG002|3: Assessment of Relapse|Death|1|||
161275469|NCT00261443|582389144|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
161275470|NCT00261443|582389145|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
161275471|NCT00261443|582389146|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
161275472|NCT00261443|582389144|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
161275473|NCT00261443|582389145|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
161275474|NCT00261443|582389146|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
161275475|NCT00261443|582389144|FG000|3: Assessment of Relapse|Pregnancy|0|||
161343878|NCT01186770|582645985|FG003|Overall Study|Other than specified|2|||
161343879|NCT02567188|582645986|FG000|Overall Study|Death|10|||
161343880|NCT02567188|582645986|FG000|Overall Study|Terminated Mircera Treatment|9|||
161343881|NCT02567188|582645986|FG000|Overall Study|Lost to Follow-up|5|||
161343882|NCT02567188|582645986|FG000|Overall Study|Adverse Event|1|||
161343883|NCT02567188|582645986|FG000|Overall Study|Withdrawal by Subject|1|||
161024851|NCT03474107|581483724|FG000|Overall Study|Adverse Event|42|||
161024852|NCT03474107|581483725|FG001|Overall Study|Adverse Event|46|||
161024853|NCT03474107|581483724|FG000|Overall Study|Death|2|||
161024854|NCT03474107|581483725|FG001|Overall Study|Death|2|||
161024855|NCT03474107|581483724|FG000|Overall Study|Lost to Follow-up|0|||
161024856|NCT03474107|581483725|FG001|Overall Study|Lost to Follow-up|1|||
161024857|NCT03474107|581483724|FG000|Overall Study|Progressive Disease|177|||
161024858|NCT03474107|581483725|FG001|Overall Study|Progressive Disease|180|||
161024859|NCT03474107|581483724|FG000|Overall Study|Protocol Violation|1|||
161024860|NCT03474107|581483725|FG001|Overall Study|Protocol Violation|1|||
161024861|NCT03474107|581483724|FG000|Overall Study|Withdrawal by Subject|15|||
161024862|NCT03474107|581483725|FG001|Overall Study|Withdrawal by Subject|27|||
161024863|NCT03474107|581483724|FG000|Overall Study|Physician Decision|7|||
161275476|NCT00261443|582389145|FG001|3: Assessment of Relapse|Pregnancy|2|||
161275477|NCT00261443|582389146|FG002|3: Assessment of Relapse|Pregnancy|1|||
161343884|NCT02567188|582645986|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
161343885|NCT02567188|582645986|FG000|Overall Study|Moved and Changed Clinic|1|||
161024864|NCT03474107|581483725|FG001|Overall Study|Physician Decision|22|||
161024865|NCT03474107|581483724|FG000|Overall Study|Miscellaneous|1|||
161024866|NCT03474107|581483725|FG001|Overall Study|Miscellaneous|6|||
161275478|NCT00261443|582389144|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
161275479|NCT00261443|582389145|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
161275480|NCT00261443|582389146|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
161275481|NCT00261443|582389144|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
161275482|NCT00261443|582389145|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
161275483|NCT00261443|582389146|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
161275484|NCT00261443|582389144|FG000|3: Assessment of Relapse|Other Reasons|0|||
161275485|NCT00261443|582389145|FG001|3: Assessment of Relapse|Other Reasons|4|||
161275486|NCT00261443|582389146|FG002|3: Assessment of Relapse|Other Reasons|3|||
161275487|NCT00261443|582389144|FG000|4: Extension Phase|Adverse Event|0|||
161275488|NCT00261443|582389145|FG001|4: Extension Phase|Adverse Event|1|||
161024902|NCT05171855|581483735|FG000|Overall Study|Death|1|||
161024903|NCT05171855|581483736|FG001|Overall Study|Death|0|||
161024904|NCT05171855|581483737|FG002|Overall Study|Death|0|||
161024905|NCT05171855|581483735|FG000|Overall Study|Withdrawal by Subject|2|||
161024906|NCT05171855|581483736|FG001|Overall Study|Withdrawal by Subject|0|||
161024907|NCT05171855|581483737|FG002|Overall Study|Withdrawal by Subject|5|||
161024908|NCT05171855|581483735|FG000|Overall Study|Physician Decision|1|||
161024909|NCT05171855|581483736|FG001|Overall Study|Physician Decision|0|||
161024910|NCT05171855|581483737|FG002|Overall Study|Physician Decision|0|||
161024911|NCT05171855|581483735|FG000|Overall Study|Adverse Event|2|||
161024912|NCT05171855|581483736|FG001|Overall Study|Adverse Event|4|||
161024913|NCT05171855|581483737|FG002|Overall Study|Adverse Event|2|||
161024914|NCT05171855|581483735|FG000|Overall Study|Other|0|||
161024915|NCT05171855|581483736|FG001|Overall Study|Other|0|||
161024916|NCT05171855|581483737|FG002|Overall Study|Other|1|||
161024917|NCT05041257|581483738|FG000|Overall Study|Death|37|||
161024918|NCT05041257|581483738|FG000|Overall Study|Lost to Follow-up|3|||
161024919|NCT05041257|581483738|FG000|Overall Study|Sponsor decision|39|||
161275489|NCT00261443|582389146|FG002|4: Extension Phase|Adverse Event|0|||
161275490|NCT00261443|582389144|FG000|4: Extension Phase|Withdrawal by Subject|0|||
161275491|NCT00261443|582389145|FG001|4: Extension Phase|Withdrawal by Subject|1|||
161275492|NCT00261443|582389146|FG002|4: Extension Phase|Withdrawal by Subject|2|||
161275493|NCT00261443|582389144|FG000|4: Extension Phase|Lost to Follow-up|0|||
161275494|NCT00261443|582389145|FG001|4: Extension Phase|Lost to Follow-up|1|||
161275495|NCT00261443|582389146|FG002|4: Extension Phase|Lost to Follow-up|0|||
161275496|NCT02755649|582389147|FG000|Overall Study|Transitioned into OLE study|99|||
161275497|NCT02755649|582389148|FG001|Overall Study|Transitioned into OLE study|98|||
161275498|NCT02755649|582389149|FG002|Overall Study|Transitioned into OLE study|100|||
161275499|NCT02755649|582389147|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
161025001|NCT03067480|581483772|FG000|Overall Study|Lost to Follow-up|2|||
161025002|NCT03067480|581483773|FG001|Overall Study|Lost to Follow-up|4|||
161025003|NCT03067480|581483772|FG000|Overall Study|started insulin|1|||
161025004|NCT03067480|581483773|FG001|Overall Study|started insulin|1|||
161275500|NCT02755649|582389148|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
161275501|NCT02755649|582389149|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
161275502|NCT02755649|582389147|FG000|Overall Study|Physician Decision|0|||
161275503|NCT02755649|582389148|FG001|Overall Study|Physician Decision|0|||
161275504|NCT02755649|582389149|FG002|Overall Study|Physician Decision|2|||
161275505|NCT02755649|582389147|FG000|Overall Study|Withdrawal by Subject|0|||
161275506|NCT02755649|582389148|FG001|Overall Study|Withdrawal by Subject|1|||
161275507|NCT02755649|582389149|FG002|Overall Study|Withdrawal by Subject|0|||
161275508|NCT02755649|582389147|FG000|Overall Study|Undecided|1|||
161275509|NCT02755649|582389148|FG001|Overall Study|Undecided|0|||
161275510|NCT02755649|582389149|FG002|Overall Study|Undecided|0|||
161275511|NCT01286753|582389150|FG000|Overall Study|Adverse Event|7|||
161275512|NCT01286753|582389151|FG001|Overall Study|Adverse Event|6|||
161275513|NCT01286753|582389150|FG000|Overall Study|Progression|11|||
161275514|NCT01286753|582389151|FG001|Overall Study|Progression|13|||
161275515|NCT01286753|582389150|FG000|Overall Study|Refused Treatment|1|||
161275516|NCT01286753|582389151|FG001|Overall Study|Refused Treatment|0|||
161275517|NCT01286753|582389150|FG000|Overall Study|Withdrawal of Consent|0|||
161275518|NCT01286753|582389151|FG001|Overall Study|Withdrawal of Consent|2|||
161275519|NCT01286753|582389150|FG000|Overall Study|Discontinued to Join Extension Study|6|||
161275520|NCT01286753|582389151|FG001|Overall Study|Discontinued to Join Extension Study|4|||
161275521|NCT01286753|582389150|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
161275522|NCT01286753|582389151|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
161275523|NCT02126826|582389155|FG000|Overall Study|Withdrawal by Subject|0|||
161275524|NCT02126826|582389156|FG001|Overall Study|Withdrawal by Subject|0|||
161275525|NCT02126826|582389157|FG002|Overall Study|Withdrawal by Subject|0|||
161275526|NCT02126826|582389158|FG003|Overall Study|Withdrawal by Subject|1|||
161275527|NCT02126826|582389159|FG004|Overall Study|Withdrawal by Subject|0|||
161275528|NCT02126826|582389160|FG005|Overall Study|Withdrawal by Subject|0|||
161275529|NCT02126826|582389161|FG006|Overall Study|Withdrawal by Subject|0|||
161275530|NCT00887289|582389162|FG000|Overall Study|Lack of Efficacy|14|||
161275531|NCT00887289|582389162|FG000|Overall Study|Adverse Event|27|||
161275532|NCT00887289|582389162|FG000|Overall Study|Withdrawal by Subject|26|||
161275533|NCT00887289|582389162|FG000|Overall Study|Lost to Follow-up|8|||
161275534|NCT00887289|582389162|FG000|Overall Study|Other|20|||
161275535|NCT00591773|582389163|FG000|Overall Study|Adverse Event|9|||
161275536|NCT00591773|582389164|FG001|Overall Study|Adverse Event|9|||
161275537|NCT00591773|582389165|FG002|Overall Study|Adverse Event|6|||
161275538|NCT00591773|582389163|FG000|Overall Study|Protocol Violation|2|||
161275539|NCT00591773|582389164|FG001|Overall Study|Protocol Violation|3|||
161275540|NCT00591773|582389165|FG002|Overall Study|Protocol Violation|0|||
161275541|NCT00591773|582389163|FG000|Overall Study|Lost to Follow-up|1|||
161275542|NCT00591773|582389164|FG001|Overall Study|Lost to Follow-up|4|||
161275543|NCT00591773|582389165|FG002|Overall Study|Lost to Follow-up|1|||
161275544|NCT00591773|582389163|FG000|Overall Study|Withdrawal by Subject|2|||
161275545|NCT00591773|582389164|FG001|Overall Study|Withdrawal by Subject|5|||
161275546|NCT00591773|582389165|FG002|Overall Study|Withdrawal by Subject|3|||
161275547|NCT00591773|582389163|FG000|Overall Study|Lack of Efficacy|1|||
161275548|NCT00591773|582389164|FG001|Overall Study|Lack of Efficacy|2|||
161275549|NCT00591773|582389165|FG002|Overall Study|Lack of Efficacy|2|||
161275550|NCT00591773|582389163|FG000|Overall Study|Other|1|||
161275551|NCT00591773|582389164|FG001|Overall Study|Other|1|||
161275552|NCT00591773|582389165|FG002|Overall Study|Other|4|||
161275553|NCT02135614|582389166|FG000|Overall Study|Randomized but Not Treated|2|||
161275554|NCT02135614|582389167|FG001|Overall Study|Randomized but Not Treated|1|||
161275555|NCT02135614|582389166|FG000|Overall Study|Adverse Event|0|||
161275556|NCT02135614|582389167|FG001|Overall Study|Adverse Event|1|||
161275557|NCT02135614|582389166|FG000|Overall Study|Death|1|||
161275558|NCT02135614|582389167|FG001|Overall Study|Death|0|||
161275559|NCT02135614|582389166|FG000|Overall Study|Investigator's Discretion|0|||
161275560|NCT02135614|582389167|FG001|Overall Study|Investigator's Discretion|1|||
161275561|NCT02135614|582389166|FG000|Overall Study|Withdrew Consent|2|||
161275562|NCT02135614|582389167|FG001|Overall Study|Withdrew Consent|2|||
161275563|NCT02135614|582389166|FG000|Overall Study|Lost to Follow-up|3|||
161275564|NCT02135614|582389167|FG001|Overall Study|Lost to Follow-up|0|||
161275565|NCT03022084|582389168|FG000|Overall Study|Lost to Follow-up|2|||
161275566|NCT03022084|582389169|FG001|Overall Study|Lost to Follow-up|3|||
161275567|NCT00554606|582389170|FG000|Overall Study|Adverse Event|3|||
161275568|NCT00554606|582389170|FG000|Overall Study|Abnormal laboratory values|1|||
161275569|NCT00554606|582389170|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
161275570|NCT00554606|582389170|FG000|Overall Study|Subject withdrew consent|2|||
161275571|NCT00554606|582389170|FG000|Overall Study|Lost to Follow-up|2|||
161275572|NCT00554606|582389170|FG000|Overall Study|Administrative problems|60|||
161275573|NCT00554606|582389170|FG000|Overall Study|Death|1|||
161275574|NCT00554606|582389170|FG000|Overall Study|Protocol deviation|2|||
161275575|NCT00605540|582389172|FG000|Overall Study|Death|15|||
161275576|NCT00605540|582389172|FG000|Overall Study|Lost to Follow-up|23|||
161275577|NCT00509366|582389173|FG000|Overall Study|Not Treated (Screen Failure)|1|||
161275578|NCT00509366|582389174|FG001|Overall Study|Not Treated (Screen Failure)|1|||
161275579|NCT00509366|582389175|FG002|Overall Study|Not Treated (Screen Failure)|1|||
161275580|NCT00509366|582389176|FG003|Overall Study|Not Treated (Screen Failure)|0|||
161275581|NCT00509366|582389177|FG004|Overall Study|Not Treated (Screen Failure)|0|||
161275582|NCT02119819|582389180|FG000|Overall Study|Adverse Event|3|||
161275583|NCT02119819|582389181|FG001|Overall Study|Adverse Event|1|||
161275584|NCT02119819|582389182|FG002|Overall Study|Adverse Event|2|||
161275585|NCT02119819|582389183|FG003|Overall Study|Adverse Event|3|||
161275586|NCT02119819|582389184|FG004|Overall Study|Adverse Event|0|||
161275587|NCT02119819|582389185|FG005|Overall Study|Adverse Event|1|||
161275588|NCT02119819|582389180|FG000|Overall Study|Lack of Efficacy|0|||
161275589|NCT02119819|582389181|FG001|Overall Study|Lack of Efficacy|0|||
161275590|NCT02119819|582389182|FG002|Overall Study|Lack of Efficacy|0|||
161275591|NCT02119819|582389183|FG003|Overall Study|Lack of Efficacy|0|||
161275592|NCT02119819|582389184|FG004|Overall Study|Lack of Efficacy|0|||
161275593|NCT02119819|582389185|FG005|Overall Study|Lack of Efficacy|1|||
161275594|NCT02119819|582389180|FG000|Overall Study|Lost to Follow-up|0|||
161275595|NCT02119819|582389181|FG001|Overall Study|Lost to Follow-up|0|||
160973173|NCT02954458|581291160|FG003|Overall Study|Death|1|||
160973174|NCT02954458|581291157|FG000|Overall Study|Other|0|||
160973175|NCT02954458|581291158|FG001|Overall Study|Other|0|||
160973176|NCT02954458|581291159|FG002|Overall Study|Other|0|||
160973177|NCT02954458|581291160|FG003|Overall Study|Other|7|||
160973178|NCT02690077|581291163|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
160973179|NCT02690077|581291164|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
160973180|NCT02690077|581291163|FG000|Overall Study|Withdrawal by Subject|0|||
160973181|NCT02690077|581291164|FG001|Overall Study|Withdrawal by Subject|5|||
160973182|NCT02690077|581291163|FG000|Overall Study|Excluded by IRB|0|||
160973183|NCT02690077|581291164|FG001|Overall Study|Excluded by IRB|2|||
160973184|NCT01845974|581291165|FG000|Overall Study|screen failure|1|||
160973185|NCT01845974|581291166|FG001|Overall Study|screen failure|0|||
160973186|NCT00612534|581291168|FG000|Overall Study|Adverse Event|0|||
160973187|NCT00612534|581291169|FG001|Overall Study|Adverse Event|4|||
160973188|NCT00612534|581291170|FG002|Overall Study|Adverse Event|2|||
160973189|NCT00612534|581291171|FG003|Overall Study|Adverse Event|1|||
160973190|NCT00612534|581291168|FG000|Overall Study|Lack of Efficacy|13|||
160973191|NCT00612534|581291169|FG001|Overall Study|Lack of Efficacy|12|||
160973192|NCT00612534|581291170|FG002|Overall Study|Lack of Efficacy|5|||
160973193|NCT00612534|581291171|FG003|Overall Study|Lack of Efficacy|16|||
160973194|NCT00612534|581291168|FG000|Overall Study|Other Reason|0|||
160973195|NCT00612534|581291169|FG001|Overall Study|Other Reason|1|||
160973196|NCT00612534|581291170|FG002|Overall Study|Other Reason|0|||
160973197|NCT00612534|581291171|FG003|Overall Study|Other Reason|0|||
160973198|NCT01435655|581291173|FG000|Overall Study|Death|2|||
160973199|NCT01435655|581291173|FG000|Overall Study|Other|1|||
160973200|NCT02839343|581291176|FG000|Overall Study|Withdrawal by Subject|3|||
160973201|NCT02839343|581291177|FG001|Overall Study|Withdrawal by Subject|1|||
160973202|NCT02839343|581291176|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
160973203|NCT02839343|581291177|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
160973204|NCT02839343|581291176|FG000|Overall Study|Adverse Event|1|||
160973205|NCT02839343|581291177|FG001|Overall Study|Adverse Event|0|||
160973206|NCT01852058|581291178|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
160973207|NCT01852058|581291179|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973208|NCT01852058|581291180|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973209|NCT01852058|581291181|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973210|NCT01852058|581291182|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973211|NCT01852058|581291183|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973212|NCT01852058|581291184|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973213|NCT01852058|581291185|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973214|NCT01852058|581291186|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973215|NCT01852058|581291187|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973216|NCT01852058|581291188|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973217|NCT01852058|581291189|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
160973218|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973219|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973220|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973221|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973222|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
160973223|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973224|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973225|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973226|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973227|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973228|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973229|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
160973230|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973231|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973232|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973233|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973234|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
160973235|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
160973236|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973237|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973238|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973239|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973240|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973241|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
160973242|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
161275596|NCT02119819|582389182|FG002|Overall Study|Lost to Follow-up|1|||
161275597|NCT02119819|582389183|FG003|Overall Study|Lost to Follow-up|2|||
161275598|NCT02119819|582389184|FG004|Overall Study|Lost to Follow-up|1|||
161275599|NCT02119819|582389185|FG005|Overall Study|Lost to Follow-up|2|||
161275600|NCT02119819|582389180|FG000|Overall Study|Physician Decision|1|||
161275601|NCT02119819|582389181|FG001|Overall Study|Physician Decision|1|||
161275602|NCT02119819|582389182|FG002|Overall Study|Physician Decision|0|||
161275603|NCT02119819|582389183|FG003|Overall Study|Physician Decision|0|||
161275604|NCT02119819|582389184|FG004|Overall Study|Physician Decision|0|||
161275605|NCT02119819|582389185|FG005|Overall Study|Physician Decision|1|||
161275606|NCT02119819|582389180|FG000|Overall Study|Withdrawal by Subject|5|||
161275607|NCT02119819|582389181|FG001|Overall Study|Withdrawal by Subject|3|||
161275608|NCT02119819|582389182|FG002|Overall Study|Withdrawal by Subject|0|||
161275609|NCT02119819|582389183|FG003|Overall Study|Withdrawal by Subject|0|||
161275610|NCT02119819|582389184|FG004|Overall Study|Withdrawal by Subject|6|||
161275611|NCT02119819|582389185|FG005|Overall Study|Withdrawal by Subject|10|||
161275612|NCT02119819|582389180|FG000|Overall Study|Jury Duty|0|||
161275613|NCT02119819|582389181|FG001|Overall Study|Jury Duty|0|||
161275614|NCT02119819|582389182|FG002|Overall Study|Jury Duty|1|||
161275615|NCT02119819|582389183|FG003|Overall Study|Jury Duty|0|||
161275616|NCT02119819|582389184|FG004|Overall Study|Jury Duty|0|||
161275617|NCT02119819|582389185|FG005|Overall Study|Jury Duty|0|||
161275618|NCT02119819|582389180|FG000|Overall Study|Protocol Violation|0|||
161275619|NCT02119819|582389181|FG001|Overall Study|Protocol Violation|0|||
161275620|NCT02119819|582389182|FG002|Overall Study|Protocol Violation|0|||
161275621|NCT02119819|582389183|FG003|Overall Study|Protocol Violation|1|||
161275622|NCT02119819|582389184|FG004|Overall Study|Protocol Violation|0|||
161275623|NCT02119819|582389185|FG005|Overall Study|Protocol Violation|0|||
161275624|NCT02119819|582389180|FG000|Overall Study|Left the city to get a job|0|||
161275625|NCT02119819|582389181|FG001|Overall Study|Left the city to get a job|0|||
161275626|NCT02119819|582389182|FG002|Overall Study|Left the city to get a job|0|||
161275627|NCT02119819|582389183|FG003|Overall Study|Left the city to get a job|1|||
161275628|NCT02119819|582389184|FG004|Overall Study|Left the city to get a job|0|||
161275629|NCT02119819|582389185|FG005|Overall Study|Left the city to get a job|0|||
161275630|NCT00282919|582389186|FG000|Overall Study|Lack of Efficacy|4|||
161275631|NCT00282919|582389186|FG000|Overall Study|Withdrawal by Subject|1|||
161275632|NCT00282919|582389186|FG000|Overall Study|Asymptomatic Parasitemia|2|||
161275633|NCT04497948|582389191|FG000|Overall Study|Death|2|||
161275634|NCT00603837|582389195|FG000|Overall Study|Physician Decision|3|||
161275635|NCT00603837|582389196|FG001|Overall Study|Physician Decision|0|||
161275636|NCT04611529|582389197|FG000|2-day Follow up|Lost to Follow-up|5|||
161275637|NCT04611529|582389198|FG001|2-day Follow up|Lost to Follow-up|6|||
161275638|NCT04611529|582389199|FG002|2-day Follow up|Lost to Follow-up|3|||
161275639|NCT00856375|582389260|FG000|Overall Study|Other|0|||
161275640|NCT00856375|582389261|FG001|Overall Study|Other|1|||
161275641|NCT00856375|582389260|FG000|Overall Study|Death|32|||
161275642|NCT00856375|582389261|FG001|Overall Study|Death|30|||
161275643|NCT00856375|582389260|FG000|Overall Study|Sponsor Terminated Study|7|||
161275644|NCT00856375|582389261|FG001|Overall Study|Sponsor Terminated Study|7|||
161275645|NCT00856375|582389260|FG000|Overall Study|Withdrawal by Subject|2|||
161275646|NCT00856375|582389261|FG001|Overall Study|Withdrawal by Subject|1|||
161275647|NCT00856375|582389260|FG000|Overall Study|Lost to Follow-up|1|||
161343886|NCT02567188|582645986|FG000|Overall Study|Started Hemodialysis|2|||
161343887|NCT02567188|582645986|FG000|Overall Study|Protocol Violation|5|||
161343888|NCT02441283|582645987|FG000|Overall Study|Withdrew consent|15|||
161343889|NCT02441283|582645987|FG000|Overall Study|Lost to Follow-up|42|||
161343890|NCT02441283|582645987|FG000|Overall Study|Death|1|||
161275648|NCT00856375|582389261|FG001|Overall Study|Lost to Follow-up|2|||
161275649|NCT02121392|582389264|FG000|Prior to Intervention|Protocol Violation|40|||
161275650|NCT02121392|582389265|FG001|Prior to Intervention|Protocol Violation|35|||
161275651|NCT02121392|582389264|FG000|Prior to Intervention|Withdrawal by Subject|8|||
161275652|NCT02121392|582389265|FG001|Prior to Intervention|Withdrawal by Subject|6|||
161275653|NCT02121392|582389264|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
161275654|NCT02121392|582389265|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
161275655|NCT02121392|582389264|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
161275656|NCT02121392|582389265|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
161275657|NCT01352416|582389266|FG000|Overall Study|Physician Decision|1|||
161275658|NCT01352416|582389267|FG001|Overall Study|Physician Decision|2|||
161275659|NCT01352416|582389268|FG002|Overall Study|Physician Decision|2|||
161275660|NCT01352416|582389269|FG003|Overall Study|Physician Decision|1|||
161275661|NCT01851330|582389270|FG000|Overall Study|Lack of Efficacy|10|||
161275662|NCT01851330|582389271|FG001|Overall Study|Lack of Efficacy|9|||
161275663|NCT01851330|582389272|FG002|Overall Study|Lack of Efficacy|2|||
161275664|NCT01851330|582389270|FG000|Overall Study|Lost to Follow-up|1|||
161275665|NCT01851330|582389271|FG001|Overall Study|Lost to Follow-up|6|||
161275666|NCT01851330|582389272|FG002|Overall Study|Lost to Follow-up|9|||
161275667|NCT01851330|582389270|FG000|Overall Study|Withdrew Consent|2|||
161275668|NCT01851330|582389271|FG001|Overall Study|Withdrew Consent|1|||
161343891|NCT02441283|582645987|FG000|Overall Study|Other, not specified|32|||
161275669|NCT01851330|582389272|FG002|Overall Study|Withdrew Consent|0|||
161275670|NCT01851330|582389270|FG000|Overall Study|Investigator's Discretion|0|||
161275671|NCT01851330|582389271|FG001|Overall Study|Investigator's Discretion|0|||
161275672|NCT01851330|582389272|FG002|Overall Study|Investigator's Discretion|1|||
161275673|NCT02648932|582389273|FG000|Overall Study|No transplant|3|||
161275674|NCT02648932|582389274|FG001|Overall Study|No transplant|1|||
161275675|NCT01199016|582389275|FG000|Overall Study|No longer meets eligibility criteria|4|||
161275676|NCT01199016|582389275|FG000|Overall Study|Entrance criteria|5|||
161275677|NCT01199016|582389275|FG000|Overall Study|Protocol Violation|9|||
161275678|NCT01199016|582389275|FG000|Overall Study|Other|13|||
161275679|NCT01199016|582389275|FG000|Overall Study|Withdrawal by Subject|21|||
161275680|NCT01199016|582389275|FG000|Overall Study|Lost to Follow-up|25|||
161275681|NCT02960490|582389284|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
161275682|NCT02960490|582389285|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
161275683|NCT02960490|582389286|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275684|NCT02960490|582389287|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275685|NCT02960490|582389288|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275686|NCT02960490|582389289|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275687|NCT02960490|582389290|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275688|NCT02960490|582389291|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275689|NCT02960490|582389292|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275690|NCT02960490|582389293|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
161275691|NCT02960490|582389284|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275692|NCT02960490|582389285|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
161275693|NCT02960490|582389286|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275694|NCT02960490|582389287|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275695|NCT02960490|582389288|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275696|NCT02960490|582389289|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275697|NCT02960490|582389290|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275698|NCT02960490|582389291|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275699|NCT02960490|582389292|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275700|NCT02960490|582389293|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
161275701|NCT02960490|582389284|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
161275702|NCT02960490|582389285|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
161275703|NCT02960490|582389286|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275704|NCT02960490|582389287|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275705|NCT02960490|582389288|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275706|NCT02960490|582389289|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275707|NCT02960490|582389290|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275708|NCT02960490|582389291|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275709|NCT02960490|582389292|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275710|NCT02960490|582389293|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
161275711|NCT02960490|582389284|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
161275712|NCT02960490|582389285|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
161275713|NCT02960490|582389286|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275714|NCT02960490|582389287|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275715|NCT02960490|582389288|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275716|NCT02960490|582389289|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275717|NCT02960490|582389290|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275718|NCT02960490|582389291|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275719|NCT02960490|582389292|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275720|NCT02960490|582389293|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
161275721|NCT02960490|582389284|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275722|NCT02960490|582389285|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275723|NCT02960490|582389286|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
161275724|NCT02960490|582389287|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
161275725|NCT02960490|582389288|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275726|NCT02960490|582389289|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
161275727|NCT02960490|582389290|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275728|NCT02960490|582389291|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275729|NCT02960490|582389292|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275730|NCT02960490|582389293|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
161275731|NCT02960490|582389284|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161275732|NCT02960490|582389285|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161343892|NCT01033136|582645988|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
161343893|NCT01033136|582645989|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
161343894|NCT00630292|582645990|FG000|Overall Study|Withdrawal by Subject|1|||
161343895|NCT05383209|582645991|FG000|Overall Study|Adverse Event: Non-ocular|0|||
161343896|NCT05383209|582645992|FG001|Overall Study|Adverse Event: Non-ocular|1|||
161343897|NCT05383209|582645993|FG002|Overall Study|Adverse Event: Non-ocular|0|||
161343898|NCT05383209|582645991|FG000|Overall Study|Lost to Follow-up|2|||
161343899|NCT05383209|582645992|FG001|Overall Study|Lost to Follow-up|1|||
161343900|NCT05383209|582645993|FG002|Overall Study|Lost to Follow-up|4|||
161343901|NCT05383209|582645991|FG000|Overall Study|Withdrawal by Subject|2|||
161343902|NCT05383209|582645992|FG001|Overall Study|Withdrawal by Subject|0|||
161343903|NCT05383209|582645993|FG002|Overall Study|Withdrawal by Subject|1|||
161343904|NCT05383209|582645991|FG000|Overall Study|Death|1|||
161343905|NCT05383209|582645992|FG001|Overall Study|Death|0|||
161343906|NCT05383209|582645993|FG002|Overall Study|Death|0|||
161343907|NCT05383209|582645991|FG000|Overall Study|Other|0|||
161343908|NCT05383209|582645992|FG001|Overall Study|Other|1|||
161343909|NCT05383209|582645993|FG002|Overall Study|Other|0|||
161343910|NCT00717886|582645995|FG000|Overall Study|Withdrawal by Subject|3|||
161343911|NCT00717886|582645995|FG000|Overall Study|Treatment Failure|1|||
161343912|NCT01553851|582645996|FG000|Overall Study|Adverse Event|2|||
161343913|NCT01553851|582645996|FG000|Overall Study|constipation|1|||
161343914|NCT02472353|582645999|FG000|Overall Study|Lost to Follow-up|1|||
161343915|NCT02472353|582646000|FG001|Overall Study|Lost to Follow-up|1|||
161343916|NCT02472353|582645999|FG000|Overall Study|Withdrawal by Subject|2|||
161343917|NCT02472353|582646000|FG001|Overall Study|Withdrawal by Subject|1|||
161343918|NCT02472353|582645999|FG000|Overall Study|Study Termination|1|||
161343919|NCT02472353|582646000|FG001|Overall Study|Study Termination|4|||
161343920|NCT02101294|582646001|FG000|Overall Study|Withdrawal by Subject|5|||
161343921|NCT02101294|582646001|FG000|Overall Study|Lost to Follow-up|6|||
161343922|NCT00933933|582646005|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
161343923|NCT00933933|582646006|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
161343924|NCT00933933|582646007|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
160973243|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973244|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973245|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973246|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
160973247|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973248|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973249|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973250|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973251|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973252|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973253|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
160973254|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973255|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973256|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973257|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973258|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
160973259|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
160973260|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973261|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973262|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973263|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973264|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973265|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
160973266|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973267|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973268|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973269|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
160973270|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973271|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973272|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973273|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973274|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973275|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973276|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
160973277|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
161343925|NCT00933933|582646005|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
160973278|NCT01852058|581291178|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973279|NCT01852058|581291179|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973280|NCT01852058|581291180|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973281|NCT01852058|581291181|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973282|NCT01852058|581291182|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
160973283|NCT01852058|581291183|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
160973284|NCT01852058|581291184|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973285|NCT01852058|581291185|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973286|NCT01852058|581291186|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973287|NCT01852058|581291187|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973288|NCT01852058|581291188|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973289|NCT01852058|581291189|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
160973290|NCT01852058|581291178|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973291|NCT01852058|581291179|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973292|NCT01852058|581291180|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973293|NCT01852058|581291181|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973294|NCT01852058|581291182|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973295|NCT01852058|581291183|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973296|NCT01852058|581291184|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973297|NCT01852058|581291185|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
160973298|NCT01852058|581291186|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973299|NCT01852058|581291187|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973300|NCT01852058|581291188|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973301|NCT01852058|581291189|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
160973302|NCT01852058|581291178|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973303|NCT01852058|581291179|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973304|NCT01852058|581291180|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973305|NCT01852058|581291181|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973306|NCT01852058|581291182|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973307|NCT01852058|581291183|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973308|NCT01852058|581291184|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973309|NCT01852058|581291185|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973310|NCT01852058|581291186|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
160973311|NCT01852058|581291187|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973312|NCT01852058|581291188|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973313|NCT01852058|581291189|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
160973314|NCT00738101|581291193|FG000|Overall Study|Physician Decision|5|||
160973315|NCT00738101|581291193|FG000|Overall Study|Death|1|||
160973316|NCT00738101|581291193|FG000|Overall Study|Repeat enrollment|1|||
160973317|NCT01396317|581291194|FG000|Overall Study|Adverse Event|1|||
160973318|NCT01396317|581291195|FG001|Overall Study|Adverse Event|0|||
160973319|NCT03661996|581293354|FG000|Overall Study|Adverse Event|0|||
160973320|NCT03661996|581293355|FG001|Overall Study|Adverse Event|0|||
160973321|NCT03661996|581293356|FG002|Overall Study|Adverse Event|1|||
160973322|NCT03661996|581293357|FG003|Overall Study|Adverse Event|1|||
160973323|NCT03661996|581293358|FG004|Overall Study|Adverse Event|0|||
160973324|NCT03661996|581293354|FG000|Overall Study|Lost to Follow-up|5|||
160973325|NCT03661996|581293355|FG001|Overall Study|Lost to Follow-up|1|||
160973326|NCT03661996|581293356|FG002|Overall Study|Lost to Follow-up|2|||
160973327|NCT03661996|581293357|FG003|Overall Study|Lost to Follow-up|2|||
160973328|NCT03661996|581293358|FG004|Overall Study|Lost to Follow-up|6|||
160973329|NCT03661996|581293354|FG000|Overall Study|Physician Decision|1|||
161275733|NCT02960490|582389286|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
161275734|NCT02960490|582389287|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161275735|NCT02960490|582389288|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
161275736|NCT02960490|582389289|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161275737|NCT02960490|582389290|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161275738|NCT02960490|582389291|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161275739|NCT02960490|582389292|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161275740|NCT02960490|582389293|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
161343926|NCT00933933|582646006|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
161275741|NCT02960490|582389284|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
161275742|NCT02960490|582389285|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
161343927|NCT00933933|582646007|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
161343928|NCT00844519|582646010|FG000|Overall Study|Withdrawal by Subject|1|||
161343929|NCT00844519|582646011|FG001|Overall Study|Withdrawal by Subject|1|||
161343930|NCT00844519|582646010|FG000|Overall Study|Adverse Event|1|||
161275743|NCT02960490|582389286|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
161275744|NCT02960490|582389287|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
161275745|NCT02960490|582389288|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
161275746|NCT02960490|582389289|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
161275747|NCT02960490|582389290|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
161275748|NCT02960490|582389291|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
161275749|NCT02960490|582389292|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
161275750|NCT02960490|582389293|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
161025091|NCT05782816|581483807|FG000|Overall Study|Withdrawal by Subject|1|||
161025092|NCT05782816|581483808|FG001|Overall Study|Withdrawal by Subject|0|||
161025093|NCT04221490|581483809|FG000|At 30 Days Follow-up|Death|7|||
161025094|NCT04221490|581483809|FG000|At 30 Days Follow-up|Physician Decision|1|||
161025095|NCT04221490|581483809|FG000|At 30 Days Follow-up|Missed Visit|4|||
161025096|NCT04221490|581483809|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
161025097|NCT04221490|581483809|FG000|At 6 Months Follow-up|Death|9|||
161025098|NCT04221490|581483809|FG000|At 6 Months Follow-up|Missed Visit|8|||
161025099|NCT04221490|581483809|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
161025100|NCT04221490|581483809|FG000|At 1 Year Follow-up|Death|7|||
161025101|NCT04221490|581483809|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
161025102|NCT04221490|581483809|FG000|At 1 Year Follow-up|Missed Visit|9|||
161025103|NCT04221490|581483809|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
161275751|NCT02960490|582389284|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275752|NCT02960490|582389285|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275753|NCT02960490|582389286|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275754|NCT02960490|582389287|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275755|NCT02960490|582389288|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275756|NCT02960490|582389289|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275757|NCT02960490|582389290|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
161275758|NCT02960490|582389291|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
161275759|NCT02960490|582389292|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
161275760|NCT02960490|582389293|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
161275761|NCT02960490|582389284|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161343931|NCT00844519|582646011|FG001|Overall Study|Adverse Event|0|||
161275762|NCT02960490|582389285|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275763|NCT02960490|582389286|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275764|NCT02960490|582389287|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275765|NCT02960490|582389288|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275766|NCT02960490|582389289|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275767|NCT02960490|582389290|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275768|NCT02960490|582389291|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
161275769|NCT02960490|582389292|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275770|NCT02960490|582389293|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
161275771|NCT02960490|582389284|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161275772|NCT02960490|582389285|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161275773|NCT02960490|582389286|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161275774|NCT02960490|582389287|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161275775|NCT02960490|582389288|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161275776|NCT02960490|582389289|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
161275777|NCT02960490|582389290|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
161275778|NCT02960490|582389291|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
161275779|NCT02960490|582389292|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
161275780|NCT02960490|582389293|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
161275781|NCT02960490|582389284|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275782|NCT02960490|582389285|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275783|NCT02960490|582389286|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275784|NCT02960490|582389287|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275785|NCT02960490|582389288|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275786|NCT02960490|582389289|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
160973330|NCT03661996|581293355|FG001|Overall Study|Physician Decision|1|||
160973331|NCT03661996|581293356|FG002|Overall Study|Physician Decision|1|||
160973332|NCT03661996|581293357|FG003|Overall Study|Physician Decision|2|||
160973333|NCT03661996|581293358|FG004|Overall Study|Physician Decision|0|||
160973334|NCT03661996|581293354|FG000|Overall Study|Protocol Violation|0|||
160973335|NCT03661996|581293355|FG001|Overall Study|Protocol Violation|0|||
160973336|NCT03661996|581293356|FG002|Overall Study|Protocol Violation|0|||
160973337|NCT03661996|581293357|FG003|Overall Study|Protocol Violation|0|||
160973338|NCT03661996|581293358|FG004|Overall Study|Protocol Violation|1|||
160973339|NCT03661996|581293354|FG000|Overall Study|Withdrawal by Subject|3|||
160973340|NCT03661996|581293355|FG001|Overall Study|Withdrawal by Subject|5|||
160973341|NCT03661996|581293356|FG002|Overall Study|Withdrawal by Subject|1|||
160973342|NCT03661996|581293357|FG003|Overall Study|Withdrawal by Subject|7|||
160973343|NCT03661996|581293358|FG004|Overall Study|Withdrawal by Subject|7|||
160973344|NCT03661996|581293354|FG000|Overall Study|Sponsors Decision|2|||
160973345|NCT03661996|581293355|FG001|Overall Study|Sponsors Decision|0|||
160973346|NCT03661996|581293356|FG002|Overall Study|Sponsors Decision|0|||
160973347|NCT03661996|581293357|FG003|Overall Study|Sponsors Decision|0|||
160973348|NCT03661996|581293358|FG004|Overall Study|Sponsors Decision|0|||
160973349|NCT03661996|581293354|FG000|Overall Study|Other|1|||
160973350|NCT03661996|581293355|FG001|Overall Study|Other|1|||
160973351|NCT03661996|581293356|FG002|Overall Study|Other|1|||
160973352|NCT03661996|581293357|FG003|Overall Study|Other|1|||
160973353|NCT03661996|581293358|FG004|Overall Study|Other|0|||
160973354|NCT03321513|581293359|FG000|Overall Study|Death|11|||
160973355|NCT03321513|581293360|FG001|Overall Study|Death|5|||
160973356|NCT03321513|581293359|FG000|Overall Study|Withdrawal by Subject|5|||
160973357|NCT03321513|581293360|FG001|Overall Study|Withdrawal by Subject|10|||
161343932|NCT01303419|582646012|FG000|Overall Study|Discontinuation of study|60|||
161343933|NCT01303419|582646012|FG000|Overall Study|Did not complete both imaging methods|5|||
161343934|NCT01303419|582646012|FG000|Overall Study|Did not meet all I/E after screening|31|||
161343935|NCT03329001|582646013|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161343936|NCT03329001|582646014|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161343937|NCT03329001|582646015|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
161343938|NCT03329001|582646016|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
161343939|NCT03329001|582646017|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161343940|NCT03329001|582646018|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161343941|NCT03329001|582646019|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161343942|NCT03329001|582646020|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
161343943|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343944|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343945|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343946|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
161343947|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343948|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343949|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343950|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
161343951|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343952|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343953|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343954|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
161343955|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343956|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343957|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343958|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
161343959|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343960|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343961|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343962|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
161343963|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343964|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343965|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343966|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
161343967|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343968|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343969|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
161343970|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343971|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343972|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343973|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343974|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
161343975|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161343976|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161343977|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
161343978|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161343979|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
160973358|NCT03321513|581293359|FG000|Overall Study|Lost to Follow-up|10|||
160973359|NCT03321513|581293360|FG001|Overall Study|Lost to Follow-up|11|||
160973360|NCT01161472|581293361|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
160973361|NCT01161472|581293362|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
160973362|NCT01161472|581293363|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
160973363|NCT01161472|581293364|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
160973364|NCT02176421|581293384|FG000|Overall Study|Lost to Follow-up|4|||
160973365|NCT02176421|581293384|FG000|Overall Study|Adverse Event|1|||
160973366|NCT04848662|581293385|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
161025239|NCT05082025|581483836|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
161025240|NCT02442349|581483839|FG000|Overall Study|Death|95|||
161025241|NCT02442349|581483839|FG000|Overall Study|Withdrawal by Subject|27|||
161025242|NCT02442349|581483839|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
161025243|NCT02442349|581483839|FG000|Overall Study|Lost to Follow-up|1|||
161025271|NCT06504862|581483851|FG000|Transition period|Adverse Event|1|||
161025272|NCT06504862|581483852|FG001|Transition period|Adverse Event|0|||
161025300|NCT02296125|581483869|FG000|Overall Study|Withdrawal by Subject|18|||
161025301|NCT02296125|581483870|FG001|Overall Study|Withdrawal by Subject|8|||
161025302|NCT02296125|581483871|FG002|Overall Study|Withdrawal by Subject|6|||
161025303|NCT02296125|581483872|FG003|Overall Study|Withdrawal by Subject|2|||
161025304|NCT02296125|581483869|FG000|Overall Study|Adverse Event|41|||
161025305|NCT02296125|581483870|FG001|Overall Study|Adverse Event|52|||
161025306|NCT02296125|581483871|FG002|Overall Study|Adverse Event|9|||
161025307|NCT02296125|581483872|FG003|Overall Study|Adverse Event|4|||
161025308|NCT02296125|581483869|FG000|Overall Study|Severe non-compliance to protocol|0|||
161025309|NCT02296125|581483870|FG001|Overall Study|Severe non-compliance to protocol|1|||
161025310|NCT02296125|581483871|FG002|Overall Study|Severe non-compliance to protocol|0|||
161025311|NCT02296125|581483872|FG003|Overall Study|Severe non-compliance to protocol|0|||
161025312|NCT02296125|581483869|FG000|Overall Study|Condition under investigation worsened|153|||
161025313|NCT02296125|581483870|FG001|Overall Study|Condition under investigation worsened|199|||
161025314|NCT02296125|581483871|FG002|Overall Study|Condition under investigation worsened|39|||
161025315|NCT02296125|581483872|FG003|Overall Study|Condition under investigation worsened|56|||
161025316|NCT02296125|581483869|FG000|Overall Study|Any reason not specifically recorded|6|||
161025317|NCT02296125|581483870|FG001|Overall Study|Any reason not specifically recorded|4|||
161025318|NCT02296125|581483871|FG002|Overall Study|Any reason not specifically recorded|2|||
161025319|NCT02296125|581483872|FG003|Overall Study|Any reason not specifically recorded|0|||
161025341|NCT04192266|581483891|FG000|Overall Study|Withdrawal by Subject|3|||
161025342|NCT04192266|581483892|FG001|Overall Study|Withdrawal by Subject|2|||
161025355|NCT04870515|581483896|FG000|Overall Study|Lost to Follow-up|0|||
161025356|NCT04870515|581483897|FG001|Overall Study|Lost to Follow-up|2|||
161275787|NCT02960490|582389290|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
161275788|NCT02960490|582389291|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161025357|NCT04870515|581483896|FG000|Overall Study|Withdrawal by Subject|0|||
161025358|NCT04870515|581483897|FG001|Overall Study|Withdrawal by Subject|1|||
161025359|NCT04870515|581483896|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
161025360|NCT04870515|581483897|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
161275789|NCT02960490|582389292|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275790|NCT02960490|582389293|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
161275791|NCT02960490|582389284|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275792|NCT02960490|582389285|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275793|NCT02960490|582389286|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275794|NCT02960490|582389287|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275795|NCT02960490|582389288|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275796|NCT02960490|582389289|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275797|NCT02960490|582389290|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275798|NCT02960490|582389291|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
161275799|NCT02960490|582389292|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275800|NCT02960490|582389293|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
161275801|NCT02368314|582389296|FG000|Overall Study|Withdrawal by Subject|2|||
161275802|NCT02368314|582389297|FG001|Overall Study|Withdrawal by Subject|1|||
161275803|NCT02368314|582389296|FG000|Overall Study|Adverse Event|1|||
161275804|NCT02368314|582389297|FG001|Overall Study|Adverse Event|2|||
161275805|NCT01266031|582389298|FG000|Overall Study|Not treated|0|||
161275806|NCT01266031|582389299|FG001|Overall Study|Not treated|3|||
161275807|NCT01266031|582389300|FG002|Overall Study|Not treated|2|||
161275808|NCT02842073|582389305|FG000|Overall Study|Withdrawal by Subject|1|||
161275809|NCT00195338|582389306|FG000|Overall Study|Lost to Follow-up|2|||
161275810|NCT00195338|582389306|FG000|Overall Study|Adverse Event|5|||
161275811|NCT00195338|582389306|FG000|Overall Study|Lack of Efficacy|1|||
161275812|NCT00195338|582389306|FG000|Overall Study|Early closure of the site|4|||
161275813|NCT02047734|582389309|FG000|Overall Study|Adverse Event|18|||
161275814|NCT02047734|582389310|FG001|Overall Study|Adverse Event|13|||
161275815|NCT02047734|582389311|FG002|Overall Study|Adverse Event|13|||
161275816|NCT02047734|582389309|FG000|Overall Study|Lack of Efficacy|4|||
161275817|NCT02047734|582389310|FG001|Overall Study|Lack of Efficacy|5|||
161275818|NCT02047734|582389311|FG002|Overall Study|Lack of Efficacy|1|||
161275819|NCT02047734|582389309|FG000|Overall Study|Protocol Violation|3|||
161275820|NCT02047734|582389310|FG001|Overall Study|Protocol Violation|1|||
161275821|NCT02047734|582389311|FG002|Overall Study|Protocol Violation|1|||
161275822|NCT02047734|582389309|FG000|Overall Study|Lost to Follow-up|1|||
161275823|NCT02047734|582389310|FG001|Overall Study|Lost to Follow-up|4|||
161275824|NCT02047734|582389311|FG002|Overall Study|Lost to Follow-up|0|||
161275825|NCT02047734|582389309|FG000|Overall Study|Death|0|||
161275826|NCT02047734|582389310|FG001|Overall Study|Death|1|||
161275827|NCT02047734|582389311|FG002|Overall Study|Death|0|||
161275828|NCT02047734|582389309|FG000|Overall Study|Withdrawal by Subject|30|||
161275829|NCT02047734|582389310|FG001|Overall Study|Withdrawal by Subject|31|||
161275830|NCT02047734|582389311|FG002|Overall Study|Withdrawal by Subject|19|||
161275831|NCT02047734|582389309|FG000|Overall Study|Physician Decision|7|||
161275832|NCT02047734|582389310|FG001|Overall Study|Physician Decision|6|||
161275833|NCT02047734|582389311|FG002|Overall Study|Physician Decision|5|||
161275834|NCT02047734|582389309|FG000|Overall Study|Miscellaneous|2|||
161275835|NCT02047734|582389310|FG001|Overall Study|Miscellaneous|4|||
161275836|NCT02047734|582389311|FG002|Overall Study|Miscellaneous|6|||
161275837|NCT02047734|582389309|FG000|Overall Study|Did Not Receive Study Drug|2|||
161275838|NCT02047734|582389310|FG001|Overall Study|Did Not Receive Study Drug|4|||
161275839|NCT02047734|582389311|FG002|Overall Study|Did Not Receive Study Drug|1|||
161275840|NCT01333397|582389312|FG000|Overall Study|Lost to Follow-up|1|||
161275841|NCT01333397|582389313|FG001|Overall Study|Lost to Follow-up|0|||
161275842|NCT01333397|582389314|FG002|Overall Study|Lost to Follow-up|0|||
161275843|NCT01333397|582389315|FG003|Overall Study|Lost to Follow-up|1|||
161275844|NCT01333397|582389316|FG004|Overall Study|Lost to Follow-up|0|||
161275845|NCT01994850|582389322|FG000|Overall Study|Physician Decision|1|||
161275846|NCT01994850|582389322|FG000|Overall Study|Withdrawal by Subject|1|||
161275847|NCT00182325|582389328|FG000|Overall Study|Lost to Follow-up|7|||
161275848|NCT00182325|582389329|FG001|Overall Study|Lost to Follow-up|7|||
161275849|NCT00182325|582389328|FG000|Overall Study|Miscarriage|5|||
161275850|NCT00182325|582389329|FG001|Overall Study|Miscarriage|3|||
161275851|NCT00182325|582389328|FG000|Overall Study|Did not complete survey|22|||
161275852|NCT00182325|582389329|FG001|Overall Study|Did not complete survey|43|||
161275853|NCT02015065|582389333|FG000|Overall Study|Death on study|1|||
161275854|NCT02015065|582389334|FG001|Overall Study|Death on study|2|||
161275855|NCT02015065|582389335|FG002|Overall Study|Death on study|1|||
161275856|NCT01420965|582389336|FG000|Overall Study|Withdrawal by Subject|1|||
161275857|NCT01420965|582389337|FG001|Overall Study|Withdrawal by Subject|0|||
161275858|NCT01420965|582389338|FG002|Overall Study|Withdrawal by Subject|0|||
161275859|NCT01420965|582389336|FG000|Overall Study|Adverse Event|0|||
160973367|NCT04848662|581293386|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
160973368|NCT02912468|581293387|FG000|Overall Study|Adverse Event|3|||
160973369|NCT02912468|581293388|FG001|Overall Study|Adverse Event|2|||
160973370|NCT02912468|581293387|FG000|Overall Study|Withdrawal by Subject|6|||
160973371|NCT02912468|581293388|FG001|Overall Study|Withdrawal by Subject|2|||
160973372|NCT02912468|581293387|FG000|Overall Study|Randomized and not treated|0|||
160973373|NCT02912468|581293388|FG001|Overall Study|Randomized and not treated|1|||
160973374|NCT00089895|581293389|FG000|Overall Study|Consent Withdrawn|11|||
160973375|NCT00089895|581293390|FG001|Overall Study|Consent Withdrawn|14|||
160973376|NCT00089895|581293389|FG000|Overall Study|Technical reason|7|||
160973377|NCT00089895|581293390|FG001|Overall Study|Technical reason|2|||
160973378|NCT00089895|581293389|FG000|Overall Study|Surgery|0|||
160973379|NCT00089895|581293390|FG001|Overall Study|Surgery|1|||
160973380|NCT00089895|581293389|FG000|Overall Study|Bleeding|0|||
160973381|NCT00089895|581293390|FG001|Overall Study|Bleeding|2|||
160973382|NCT00089895|581293389|FG000|Overall Study|Physician Decision|3|||
160973383|NCT00089895|581293390|FG001|Overall Study|Physician Decision|7|||
160973384|NCT00089895|581293389|FG000|Overall Study|Exclusion criteria met|6|||
160973385|NCT00089895|581293390|FG001|Overall Study|Exclusion criteria met|6|||
160973386|NCT00089895|581293389|FG000|Overall Study|Not otherwise specified|4|||
160973387|NCT00089895|581293390|FG001|Overall Study|Not otherwise specified|8|||
160973388|NCT00089895|581293389|FG000|Overall Study|Missing|4|||
160973389|NCT00089895|581293390|FG001|Overall Study|Missing|2|||
160973390|NCT05644353|581293391|FG000|Overall Study|Physician Decision|1|||
160973391|NCT05644353|581293392|FG001|Overall Study|Physician Decision|0|||
160973392|NCT05644353|581293393|FG002|Overall Study|Physician Decision|0|||
160973393|NCT05644353|581293394|FG003|Overall Study|Physician Decision|0|||
160973394|NCT05644353|581293395|FG004|Overall Study|Physician Decision|0|||
160973395|NCT05644353|581293396|FG005|Overall Study|Physician Decision|0|||
160973396|NCT05644353|581293391|FG000|Overall Study|Protocol Violation|1|||
160973397|NCT05644353|581293392|FG001|Overall Study|Protocol Violation|0|||
160973398|NCT05644353|581293393|FG002|Overall Study|Protocol Violation|0|||
160973399|NCT05644353|581293394|FG003|Overall Study|Protocol Violation|0|||
160973400|NCT05644353|581293395|FG004|Overall Study|Protocol Violation|0|||
160973401|NCT05644353|581293396|FG005|Overall Study|Protocol Violation|0|||
160973402|NCT05644353|581293391|FG000|Overall Study|Withdrawal by Subject|0|||
160973403|NCT05644353|581293392|FG001|Overall Study|Withdrawal by Subject|2|||
160973404|NCT05644353|581293393|FG002|Overall Study|Withdrawal by Subject|0|||
160973405|NCT05644353|581293394|FG003|Overall Study|Withdrawal by Subject|0|||
160973406|NCT05644353|581293395|FG004|Overall Study|Withdrawal by Subject|1|||
160973407|NCT05644353|581293396|FG005|Overall Study|Withdrawal by Subject|0|||
160973408|NCT05644353|581293391|FG000|Overall Study|Lost to Follow-up|0|||
160973409|NCT05644353|581293392|FG001|Overall Study|Lost to Follow-up|0|||
160973410|NCT05644353|581293393|FG002|Overall Study|Lost to Follow-up|1|||
160973411|NCT05644353|581293394|FG003|Overall Study|Lost to Follow-up|0|||
160973412|NCT05644353|581293395|FG004|Overall Study|Lost to Follow-up|0|||
160973413|NCT05644353|581293396|FG005|Overall Study|Lost to Follow-up|0|||
160973414|NCT02667886|581293397|FG000|Dose Escalation (Part A)|Adverse Event|1|||
160973415|NCT02667886|581293398|FG001|Dose Escalation (Part A)|Adverse Event|3|||
160973416|NCT02667886|581293399|FG002|Dose Escalation (Part A)|Adverse Event|1|||
160973417|NCT02667886|581293400|FG003|Dose Escalation (Part A)|Adverse Event|0|||
160973418|NCT02667886|581293401|FG004|Dose Escalation (Part A)|Adverse Event|0|||
160973419|NCT02667886|581293397|FG000|Dose Escalation (Part A)|Disease Progression|1|||
160973420|NCT02667886|581293398|FG001|Dose Escalation (Part A)|Disease Progression|4|||
160973421|NCT02667886|581293399|FG002|Dose Escalation (Part A)|Disease Progression|3|||
160973422|NCT02667886|581293400|FG003|Dose Escalation (Part A)|Disease Progression|0|||
160973423|NCT02667886|581293401|FG004|Dose Escalation (Part A)|Disease Progression|0|||
160973424|NCT02667886|581293397|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973425|NCT02667886|581293398|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973426|NCT02667886|581293399|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
160973427|NCT02667886|581293400|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973428|NCT02667886|581293401|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
160973429|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Adverse Event|0|||
160973430|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Adverse Event|0|||
160973431|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Adverse Event|0|||
160973432|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Adverse Event|9|||
160973433|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Adverse Event|0|||
160973434|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973435|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973436|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973437|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
160973438|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
160973439|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Disease Progression|0|||
160973440|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Disease Progression|0|||
160973441|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Disease Progression|0|||
160973442|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Disease Progression|38|||
161025379|NCT02838420|581483913|FG000|Overall Study|Ongoing in Study|113|||
161025380|NCT02838420|581483914|FG001|Overall Study|Ongoing in Study|45|||
161025381|NCT02838420|581483913|FG000|Overall Study|Lost to Follow-up|1|||
161025382|NCT02838420|581483914|FG001|Overall Study|Lost to Follow-up|0|||
161025383|NCT02838420|581483913|FG000|Overall Study|Withdrawal by Subject|3|||
161025384|NCT02838420|581483914|FG001|Overall Study|Withdrawal by Subject|4|||
161025385|NCT02838420|581483913|FG000|Overall Study|Death|8|||
161025386|NCT02838420|581483914|FG001|Overall Study|Death|13|||
161275860|NCT01420965|582389337|FG001|Overall Study|Adverse Event|1|||
161275861|NCT01420965|582389338|FG002|Overall Study|Adverse Event|0|||
161275862|NCT01292226|582389375|FG000|Overall Study|Adverse Event|5|||
161275863|NCT01292226|582389375|FG000|Overall Study|Death|1|||
161275864|NCT01292226|582389375|FG000|Overall Study|Graft loss|1|||
161275865|NCT01292226|582389375|FG000|Overall Study|Protocol Violation|3|||
161275866|NCT01292226|582389375|FG000|Overall Study|Withdrawal by Subject|1|||
161275867|NCT01292226|582389375|FG000|Overall Study|Other|2|||
161275868|NCT00468650|582389378|FG000|Overall Study|Lost to Follow-up|4|||
161275869|NCT00468650|582389378|FG000|Overall Study|Withdrawal by Subject|2|||
161275870|NCT00468650|582389378|FG000|Overall Study|Protocol Violation|1|||
161275871|NCT01094886|582389379|FG000|Overall Study|Adverse Event|2|||
161275872|NCT01094886|582389379|FG000|Overall Study|Withdrawal by Subject|5|||
161275873|NCT02013674|582389380|FG000|Overall Study|Death|0|||
161275874|NCT02013674|582389381|FG001|Overall Study|Death|1|||
161275875|NCT02013674|582389380|FG000|Overall Study|Lost to Follow-up|1|||
160973443|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Disease Progression|0|||
160973444|NCT02667886|581293397|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973445|NCT02667886|581293398|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973446|NCT02667886|581293399|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973447|NCT02667886|581293400|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
160973448|NCT02667886|581293401|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
160973449|NCT02667886|581293397|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973450|NCT02667886|581293398|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973451|NCT02667886|581293399|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973452|NCT02667886|581293400|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
160973453|NCT02667886|581293401|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
160973454|NCT02667886|581293397|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
160973455|NCT02667886|581293398|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
160973456|NCT02667886|581293399|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
160973457|NCT02667886|581293400|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
160973458|NCT02667886|581293401|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
160973459|NCT01905046|581293402|FG000|Months 13-24|Withdrawal by Subject|10|||
160973460|NCT01905046|581293403|FG001|Months 13-24|Withdrawal by Subject|10|||
160973461|NCT01905046|581293402|FG000|Months 13-24|Adverse Event|3|||
160973462|NCT01905046|581293403|FG001|Months 13-24|Adverse Event|2|||
160973463|NCT01905046|581293402|FG000|Months 13-24|Protocol Violation|3|||
160973464|NCT01905046|581293403|FG001|Months 13-24|Protocol Violation|3|||
160973465|NCT01905046|581293402|FG000|Months 13-24|Physician Decision|1|||
160973466|NCT01905046|581293403|FG001|Months 13-24|Physician Decision|0|||
160973467|NCT05672680|581293404|FG000|Overall Study|Patient Did Not Complete the Form|5|||
160973468|NCT05672680|581293405|FG001|Overall Study|Patient Did Not Complete the Form|4|||
160973469|NCT05672680|581293404|FG000|Overall Study|Procedure Aborted|1|||
160973470|NCT05672680|581293405|FG001|Overall Study|Procedure Aborted|0|||
160973471|NCT03929562|581293406|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
160973472|NCT03929562|581293407|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
160973473|NCT03929562|581293406|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
160973474|NCT03929562|581293407|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
161275876|NCT02013674|582389381|FG001|Overall Study|Lost to Follow-up|0|||
161275877|NCT05013008|582391546|FG000|Overall Study|Exclusion from mBFAS|5|||
161275878|NCT05013008|582391547|FG001|Overall Study|Exclusion from mBFAS|25|||
161275879|NCT02094417|582391551|FG000|Overall Study|Adverse Event|0|||
161275880|NCT02094417|582391552|FG001|Overall Study|Adverse Event|0|||
161275881|NCT02094417|582391553|FG002|Overall Study|Adverse Event|0|||
161275882|NCT02094417|582391554|FG003|Overall Study|Adverse Event|1|||
161275883|NCT02094417|582391551|FG000|Overall Study|Eligibility criteria|0|||
161275884|NCT02094417|582391552|FG001|Overall Study|Eligibility criteria|1|||
161275885|NCT02094417|582391553|FG002|Overall Study|Eligibility criteria|0|||
161275886|NCT02094417|582391554|FG003|Overall Study|Eligibility criteria|0|||
161275887|NCT02094417|582391551|FG000|Overall Study|No responder|4|||
161275888|NCT02094417|582391552|FG001|Overall Study|No responder|4|||
161275889|NCT02094417|582391553|FG002|Overall Study|No responder|4|||
161275890|NCT02094417|582391554|FG003|Overall Study|No responder|3|||
161275891|NCT02094417|582391551|FG000|Overall Study|Unable to conduct observations or assess|0|||
161275892|NCT02094417|582391552|FG001|Overall Study|Unable to conduct observations or assess|1|||
161275893|NCT02094417|582391553|FG002|Overall Study|Unable to conduct observations or assess|0|||
161275894|NCT02094417|582391554|FG003|Overall Study|Unable to conduct observations or assess|0|||
161025535|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
161025536|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
161025537|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
161025538|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
161025539|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
161025540|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
161025541|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
161025542|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Death|0|||
161025543|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Death|2|||
161025544|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Death|0|||
161025545|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Death|0|||
160973475|NCT03929562|581293406|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
161025546|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Death|0|||
160973476|NCT03929562|581293407|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
160973477|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
160973478|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
160973479|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
160973480|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
160973481|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
160973482|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
160973483|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
160973484|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
160973485|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
160973486|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
160973487|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
160973488|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
160973489|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973490|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973491|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973492|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973493|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
160973494|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
160973495|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
160973496|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973497|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973498|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973499|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
160973500|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
160973501|NCT02778399|581293415|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973502|NCT02778399|581293416|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973503|NCT02778399|581293417|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973504|NCT02778399|581293418|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
160973505|NCT02778399|581293419|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
160973506|NCT02778399|581293420|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
160973507|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
160973508|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
160973509|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
160973510|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
160973511|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
160973512|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
160973513|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
160973514|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
160973515|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
160973516|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
160973517|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
160973518|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
160973519|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973520|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
160973521|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973522|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973523|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973524|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
160973525|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
161025547|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Death|0|||
161025548|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Death|0|||
161025549|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
161025550|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025551|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025552|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025553|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025554|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025555|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
161025556|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025557|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
161025558|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025559|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025560|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025561|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025562|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
161025563|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
161025564|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
161025565|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
161025566|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
161025567|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
161025568|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
161025569|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
161025570|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
161025571|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
161025572|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025573|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025574|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025575|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025576|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
161025577|NCT04585815|581485660|FG000|Sub-study A- Treatment Phase|Other|1|||
161025578|NCT04585815|581485661|FG001|Sub-study A- Treatment Phase|Other|0|||
161025579|NCT04585815|581485662|FG002|Sub-study A- Treatment Phase|Other|0|||
161025580|NCT04585815|581485663|FG003|Sub-study A- Treatment Phase|Other|0|||
161025581|NCT04585815|581485664|FG004|Sub-study A- Treatment Phase|Other|0|||
161025582|NCT04585815|581485665|FG005|Sub-study A- Treatment Phase|Other|0|||
161025583|NCT04585815|581485666|FG006|Sub-study A- Treatment Phase|Other|0|||
161025584|NCT04585815|581485660|FG000|Sub-study A- Follow-up Phase|Death|0|||
161025585|NCT04585815|581485661|FG001|Sub-study A- Follow-up Phase|Death|1|||
161025586|NCT04585815|581485662|FG002|Sub-study A- Follow-up Phase|Death|0|||
161025587|NCT04585815|581485663|FG003|Sub-study A- Follow-up Phase|Death|0|||
161025588|NCT04585815|581485664|FG004|Sub-study A- Follow-up Phase|Death|0|||
161025589|NCT04585815|581485665|FG005|Sub-study A- Follow-up Phase|Death|0|||
161025590|NCT04585815|581485666|FG006|Sub-study A- Follow-up Phase|Death|0|||
161025591|NCT04585815|581485660|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
161025592|NCT04585815|581485661|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
161025593|NCT04585815|581485662|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025594|NCT04585815|581485663|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025595|NCT04585815|581485664|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025596|NCT04585815|581485665|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161275895|NCT02094417|582391551|FG000|Overall Study|Withdrawal by Subject|1|||
161275896|NCT02094417|582391552|FG001|Overall Study|Withdrawal by Subject|2|||
161275897|NCT02094417|582391553|FG002|Overall Study|Withdrawal by Subject|1|||
161275898|NCT02094417|582391554|FG003|Overall Study|Withdrawal by Subject|3|||
161275899|NCT04971187|582391555|FG000|Overall Study|Screen failures|2|||
161275900|NCT01443728|582391558|FG000|Overall Study|Lost to Follow-up|2|||
161275901|NCT01443728|582391559|FG001|Overall Study|Lost to Follow-up|0|||
161275902|NCT01443728|582391558|FG000|Overall Study|Withdrawal by Subject|1|||
161275903|NCT01443728|582391559|FG001|Overall Study|Withdrawal by Subject|1|||
161275904|NCT01443728|582391558|FG000|Overall Study|Adverse Event|0|||
161275905|NCT01443728|582391559|FG001|Overall Study|Adverse Event|2|||
161275906|NCT04981717|582391565|FG000|Overall Study|Protocol Violation|0|||
161275907|NCT04981717|582391566|FG001|Overall Study|Protocol Violation|3|||
161275908|NCT04981717|582391565|FG000|Overall Study|Adverse Event|1|||
161275909|NCT04981717|582391566|FG001|Overall Study|Adverse Event|3|||
161275910|NCT04981717|582391565|FG000|Overall Study|Pregnancy|1|||
161275911|NCT04981717|582391566|FG001|Overall Study|Pregnancy|0|||
161343980|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161025597|NCT04585815|581485666|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
161025598|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
161025599|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
161025600|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
161275912|NCT04981717|582391565|FG000|Overall Study|Physician Decision|1|||
161275913|NCT04981717|582391566|FG001|Overall Study|Physician Decision|0|||
161275914|NCT04981717|582391565|FG000|Overall Study|Sponsor Request|157|||
161275915|NCT04981717|582391566|FG001|Overall Study|Sponsor Request|172|||
161025601|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
161025602|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
161025603|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
161025604|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
161025605|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Death|0|||
161025606|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Death|0|||
161025607|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Death|0|||
161025608|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Death|1|||
161025609|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Death|0|||
161025610|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Death|0|||
161025611|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Death|0|||
161025612|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
161025613|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
161025614|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
161025615|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
161025616|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
161025617|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
161025618|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
161025619|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025620|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025621|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025622|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
161025623|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025624|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
161025625|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
161025626|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025627|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025628|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025629|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
161025630|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025631|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025632|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
161025633|NCT04585815|581485660|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
161025634|NCT04585815|581485661|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
161025635|NCT04585815|581485662|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
161025636|NCT04585815|581485663|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
161025637|NCT04585815|581485664|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
161025638|NCT04585815|581485665|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
161025639|NCT04585815|581485666|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
161025640|NCT04585815|581485660|FG000|Sub-study B- Follow-up Phase|Death|0|||
161025641|NCT04585815|581485661|FG001|Sub-study B- Follow-up Phase|Death|0|||
161025642|NCT04585815|581485662|FG002|Sub-study B- Follow-up Phase|Death|1|||
161025643|NCT04585815|581485663|FG003|Sub-study B- Follow-up Phase|Death|3|||
161025644|NCT04585815|581485664|FG004|Sub-study B- Follow-up Phase|Death|1|||
161025645|NCT04585815|581485665|FG005|Sub-study B- Follow-up Phase|Death|0|||
161025646|NCT04585815|581485666|FG006|Sub-study B- Follow-up Phase|Death|3|||
161025647|NCT04585815|581485660|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025648|NCT04585815|581485661|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025649|NCT04585815|581485662|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025650|NCT04585815|581485663|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025651|NCT04585815|581485664|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161025652|NCT04585815|581485665|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
161025653|NCT04585815|581485666|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
161275916|NCT04981717|582391565|FG000|Overall Study|Lost to Follow-up|4|||
161275917|NCT04981717|582391566|FG001|Overall Study|Lost to Follow-up|5|||
161275918|NCT04981717|582391565|FG000|Overall Study|Withdrawal by Subject|50|||
161275919|NCT04981717|582391566|FG001|Overall Study|Withdrawal by Subject|37|||
161275920|NCT02207634|582391567|FG000|Overall Study|Withdrawal by Subject|21|||
161275921|NCT02207634|582391568|FG001|Overall Study|Withdrawal by Subject|31|||
161275922|NCT02207634|582391567|FG000|Overall Study|Lost to Follow-up|1|||
161025688|NCT01854775|581485672|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
161025689|NCT01854775|581485673|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
161025690|NCT01854775|581485674|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
161025691|NCT01854775|581485672|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
161025692|NCT01854775|581485673|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
161025693|NCT01854775|581485674|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
161025694|NCT01854775|581485672|FG000|Extension Phase|Pregnancy|1|||
161025695|NCT01854775|581485673|FG001|Extension Phase|Pregnancy|0|||
161025696|NCT01854775|581485674|FG002|Extension Phase|Pregnancy|0|||
161025697|NCT01854775|581485672|FG000|Extension Phase|Investigator's Discretion|1|||
161025698|NCT01854775|581485673|FG001|Extension Phase|Investigator's Discretion|0|||
161025699|NCT01854775|581485674|FG002|Extension Phase|Investigator's Discretion|0|||
161025700|NCT01854775|581485672|FG000|Extension Phase|Non-Compliance with study drug|1|||
161025701|NCT01854775|581485673|FG001|Extension Phase|Non-Compliance with study drug|0|||
161025702|NCT01854775|581485674|FG002|Extension Phase|Non-Compliance with study drug|0|||
161025703|NCT01854775|581485672|FG000|Extension Phase|Lost to Follow-up|1|||
161025704|NCT01854775|581485673|FG001|Extension Phase|Lost to Follow-up|0|||
161025705|NCT01854775|581485674|FG002|Extension Phase|Lost to Follow-up|0|||
161025706|NCT01854775|581485672|FG000|Extension Phase|Withdrew consent|0|||
161025707|NCT01854775|581485673|FG001|Extension Phase|Withdrew consent|1|||
161275923|NCT02207634|582391568|FG001|Overall Study|Lost to Follow-up|0|||
161275924|NCT01207583|582391571|FG000|Overall Study|Withdrawal by Subject|0|||
161275925|NCT01207583|582391572|FG001|Overall Study|Withdrawal by Subject|3|||
161275926|NCT01207583|582391573|FG002|Overall Study|Withdrawal by Subject|1|||
161275927|NCT01207583|582391571|FG000|Overall Study|Participant failed to return|1|||
161275928|NCT01207583|582391572|FG001|Overall Study|Participant failed to return|0|||
161275929|NCT01207583|582391573|FG002|Overall Study|Participant failed to return|0|||
161275930|NCT01207583|582391571|FG000|Overall Study|Lost to Follow-up|0|||
161275931|NCT01207583|582391572|FG001|Overall Study|Lost to Follow-up|2|||
161275932|NCT01207583|582391573|FG002|Overall Study|Lost to Follow-up|0|||
161275933|NCT01433549|582391575|FG000|Phase 2: Second Study Product|Adverse Event|0|||
161275934|NCT01433549|582391576|FG001|Phase 2: Second Study Product|Adverse Event|1|||
161275935|NCT01696058|582391578|FG000|Overall Study|Adverse Event|21|||
161275936|NCT01696058|582391579|FG001|Overall Study|Adverse Event|11|||
161275937|NCT01696058|582391578|FG000|Overall Study|Lack of Efficacy|2|||
161343981|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161025708|NCT01854775|581485674|FG002|Extension Phase|Withdrew consent|0|||
161025709|NCT04068311|581485675|FG000|Overall Study|Death|3|||
161025710|NCT04068311|581485676|FG001|Overall Study|Death|3|||
161025711|NCT04068311|581485675|FG000|Overall Study|Lost to Follow-up|24|||
161025712|NCT04068311|581485676|FG001|Overall Study|Lost to Follow-up|68|||
161025713|NCT04068311|581485675|FG000|Overall Study|Withdrawal by Subject|5|||
161025714|NCT04068311|581485676|FG001|Overall Study|Withdrawal by Subject|0|||
161275938|NCT01696058|582391579|FG001|Overall Study|Lack of Efficacy|3|||
161275939|NCT01696058|582391578|FG000|Overall Study|Protocol Violation|9|||
161275940|NCT01696058|582391579|FG001|Overall Study|Protocol Violation|3|||
161275941|NCT01696058|582391578|FG000|Overall Study|Lost to Follow-up|2|||
160973526|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
160973527|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
160973528|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
160973529|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
160973530|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
160973531|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
160973532|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973533|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
160973534|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973535|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973536|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
160973537|NCT02778399|581293415|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
160973538|NCT02778399|581293416|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
160973539|NCT02778399|581293417|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
160973540|NCT02778399|581293418|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
160973541|NCT02778399|581293419|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
160973542|NCT02778399|581293420|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
160973543|NCT00405639|581293422|FG000|Overall Study|Withdrawal by Subject|1|||
160973544|NCT00405639|581293423|FG001|Overall Study|Withdrawal by Subject|0|||
160973545|NCT00405639|581293422|FG000|Overall Study|Adverse Event|1|||
160973546|NCT00405639|581293423|FG001|Overall Study|Adverse Event|0|||
160973547|NCT00405639|581293422|FG000|Overall Study|Seizure prior to receiving BNP|1|||
160973548|NCT00405639|581293423|FG001|Overall Study|Seizure prior to receiving BNP|0|||
161275942|NCT01696058|582391579|FG001|Overall Study|Lost to Follow-up|5|||
161275943|NCT01696058|582391578|FG000|Overall Study|Withdrawal by Subject|4|||
161275944|NCT01696058|582391579|FG001|Overall Study|Withdrawal by Subject|6|||
161275945|NCT01696058|582391578|FG000|Overall Study|Other reason prematurely discontinued|5|||
161275946|NCT01696058|582391579|FG001|Overall Study|Other reason prematurely discontinued|3|||
160973549|NCT02130284|581293432|FG000|Overall Study|Withdrawal by Subject|3|||
161275947|NCT02186834|582391581|FG000|Dose Escalation|Death|0|||
161275948|NCT02186834|582391582|FG001|Dose Escalation|Death|0|||
161275949|NCT02186834|582391583|FG002|Dose Escalation|Death|0|||
161275950|NCT02186834|582391584|FG003|Dose Escalation|Death|1|||
161275951|NCT02186834|582391585|FG004|Dose Escalation|Death|0|||
161275952|NCT02186834|582391586|FG005|Dose Escalation|Death|0|||
161275953|NCT02186834|582391581|FG000|Treatment at RP2D|Died prior to treatment|0|||
161275954|NCT02186834|582391582|FG001|Treatment at RP2D|Died prior to treatment|0|||
161275955|NCT02186834|582391583|FG002|Treatment at RP2D|Died prior to treatment|0|||
160973550|NCT02130284|581293432|FG000|Overall Study|Subject Withdrew Consent|1|||
160973551|NCT02130284|581293432|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
160973552|NCT02130284|581293432|FG000|Overall Study|Subject was screened as backup for study|3|||
160973553|NCT02130284|581293432|FG000|Overall Study|Screen Failure|1|||
160973554|NCT05778526|581293435|FG000|Overall Study|Lost to Follow-up|0|||
160973555|NCT05778526|581293436|FG001|Overall Study|Lost to Follow-up|1|||
160973556|NCT05778526|581293437|FG002|Overall Study|Lost to Follow-up|3|||
160973557|NCT05778526|581293435|FG000|Overall Study|Protocol Violation|0|||
160973558|NCT05778526|581293436|FG001|Overall Study|Protocol Violation|0|||
160973559|NCT05778526|581293437|FG002|Overall Study|Protocol Violation|8|||
160973560|NCT03108157|581293440|FG000|Overall Study|Protocol Violation|15|||
160973561|NCT03108157|581293441|FG001|Overall Study|Protocol Violation|4|||
160973562|NCT02223754|581293442|FG000|Period 1|Adverse Event|1|||
160973563|NCT02223754|581293443|FG001|Period 1|Adverse Event|0|||
160973564|NCT02223754|581293442|FG000|Period 1|Lost to Follow-up|0|||
160973565|NCT02223754|581293443|FG001|Period 1|Lost to Follow-up|1|||
160973566|NCT02223754|581293442|FG000|Period 1|Protocol Violation|2|||
160973567|NCT02223754|581293443|FG001|Period 1|Protocol Violation|4|||
160973568|NCT02223754|581293442|FG000|Period 1|Withdrawal by Subject|0|||
160973569|NCT02223754|581293443|FG001|Period 1|Withdrawal by Subject|4|||
160973570|NCT02223754|581293442|FG000|Period 1|Test Article No Longer Available|1|||
160973571|NCT02223754|581293443|FG001|Period 1|Test Article No Longer Available|5|||
160973572|NCT02223754|581293442|FG000|Period 1|Unsatisfactory Visual Response|0|||
160973573|NCT02223754|581293443|FG001|Period 1|Unsatisfactory Visual Response|1|||
160973574|NCT02223754|581293442|FG000|Period 2|Adverse Event|0|||
160973575|NCT02223754|581293443|FG001|Period 2|Adverse Event|1|||
160973576|NCT02223754|581293442|FG000|Period 2|Protocol Violation|1|||
160973577|NCT02223754|581293443|FG001|Period 2|Protocol Violation|0|||
160973578|NCT02223754|581293442|FG000|Period 2|Lens Discomfort|1|||
160973579|NCT02223754|581293443|FG001|Period 2|Lens Discomfort|1|||
160973580|NCT02223754|581293442|FG000|Period 2|Lost to Follow-up|1|||
160973581|NCT02223754|581293443|FG001|Period 2|Lost to Follow-up|0|||
160973582|NCT02223754|581293442|FG000|Period 2|Test Article No Longer Available|0|||
160973583|NCT02223754|581293443|FG001|Period 2|Test Article No Longer Available|1|||
160973584|NCT04395183|581293445|FG000|Overall Study|Withdrawal by Subject|1|||
160973585|NCT04395183|581293446|FG001|Overall Study|Withdrawal by Subject|0|||
160973586|NCT04395183|581293447|FG002|Overall Study|Withdrawal by Subject|2|||
160973587|NCT04395183|581293448|FG003|Overall Study|Withdrawal by Subject|2|||
160973588|NCT02668016|581293449|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
160973589|NCT02668016|581293449|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
160973590|NCT02668016|581293449|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
160973591|NCT02668016|581293449|FG000|Month 4|Withdrawal due to severe symptoms|1|||
160973592|NCT02668016|581293449|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
160973593|NCT02668016|581293449|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
160973594|NCT02668016|581293449|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
160973595|NCT02668016|581293449|FG000|Month 6|Withdrawal due to severe symptoms|2|||
160973596|NCT02668016|581293449|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
160973597|NCT02668016|581293449|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
160973598|NCT02668016|581293449|FG000|Month 8|Withdrawal due to severe symptoms|1|||
160973599|NCT02668016|581293449|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
160973600|NCT02668016|581293449|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
160973601|NCT02668016|581293449|FG000|Month 10|Withdrawal due to severe symptoms|1|||
160973602|NCT02668016|581293449|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
160973603|NCT01122381|581293454|FG000|Overall Study|study terminated early|0|||
160973604|NCT01122381|581293455|FG001|Overall Study|study terminated early|1|||
160973605|NCT00736489|581293456|FG000|Period 1|Lost to Follow-up|1|||
160973606|NCT00736489|581293457|FG001|Period 1|Lost to Follow-up|0|||
160973607|NCT00736489|581293458|FG002|Period 1|Lost to Follow-up|0|||
160973608|NCT00736489|581293459|FG003|Period 1|Lost to Follow-up|0|||
160973609|NCT00736489|581293460|FG004|Period 1|Lost to Follow-up|0|||
160973610|NCT00736489|581293461|FG005|Period 1|Lost to Follow-up|0|||
160973611|NCT00736489|581293456|FG000|Period 1|Withdrawal by Subject|0|||
160973612|NCT00736489|581293457|FG001|Period 1|Withdrawal by Subject|0|||
160973613|NCT00736489|581293458|FG002|Period 1|Withdrawal by Subject|0|||
160973614|NCT00736489|581293459|FG003|Period 1|Withdrawal by Subject|0|||
160973615|NCT00736489|581293460|FG004|Period 1|Withdrawal by Subject|0|||
160973616|NCT00736489|581293461|FG005|Period 1|Withdrawal by Subject|1|||
161275956|NCT02186834|582391584|FG003|Treatment at RP2D|Died prior to treatment|0|||
161275957|NCT02186834|582391585|FG004|Treatment at RP2D|Died prior to treatment|0|||
161275958|NCT02186834|582391586|FG005|Treatment at RP2D|Died prior to treatment|1|||
161275959|NCT04581369|582391587|FG000|Overall Study|Death|7|||
161275960|NCT04581369|582391588|FG001|Overall Study|Death|6|||
161275961|NCT04581369|582391589|FG002|Overall Study|Death|0|||
160973617|NCT02395133|581293462|FG000|Overall Study|Adverse Event|4|||
160973618|NCT02395133|581293463|FG001|Overall Study|Adverse Event|1|||
160973619|NCT02395133|581293464|FG002|Overall Study|Adverse Event|3|||
160973620|NCT02395133|581293465|FG003|Overall Study|Adverse Event|0|||
160973621|NCT02395133|581293462|FG000|Overall Study|Lack of Efficacy|1|||
160973622|NCT02395133|581293463|FG001|Overall Study|Lack of Efficacy|0|||
160973623|NCT02395133|581293464|FG002|Overall Study|Lack of Efficacy|1|||
160973624|NCT02395133|581293465|FG003|Overall Study|Lack of Efficacy|1|||
160973625|NCT02395133|581293462|FG000|Overall Study|Protocol Violation|1|||
160973626|NCT02395133|581293463|FG001|Overall Study|Protocol Violation|1|||
160973627|NCT02395133|581293464|FG002|Overall Study|Protocol Violation|0|||
160973628|NCT02395133|581293465|FG003|Overall Study|Protocol Violation|3|||
160973629|NCT02395133|581293462|FG000|Overall Study|Lost to Follow-up|0|||
160973630|NCT02395133|581293463|FG001|Overall Study|Lost to Follow-up|1|||
160973631|NCT02395133|581293464|FG002|Overall Study|Lost to Follow-up|1|||
160973632|NCT02395133|581293465|FG003|Overall Study|Lost to Follow-up|0|||
160973633|NCT02395133|581293462|FG000|Overall Study|Pregnancy|0|||
160973634|NCT02395133|581293463|FG001|Overall Study|Pregnancy|0|||
160973635|NCT02395133|581293464|FG002|Overall Study|Pregnancy|3|||
160973636|NCT02395133|581293465|FG003|Overall Study|Pregnancy|0|||
160973637|NCT02395133|581293462|FG000|Overall Study|Consent withdrawn with no reason given|1|||
160973638|NCT02395133|581293463|FG001|Overall Study|Consent withdrawn with no reason given|3|||
160973639|NCT02395133|581293464|FG002|Overall Study|Consent withdrawn with no reason given|0|||
160973640|NCT02395133|581293465|FG003|Overall Study|Consent withdrawn with no reason given|2|||
160973641|NCT02395133|581293462|FG000|Overall Study|Consent withdrawn with personal reason|0|||
160973642|NCT02395133|581293463|FG001|Overall Study|Consent withdrawn with personal reason|1|||
160973643|NCT02395133|581293464|FG002|Overall Study|Consent withdrawn with personal reason|0|||
160973644|NCT02395133|581293465|FG003|Overall Study|Consent withdrawn with personal reason|3|||
160973645|NCT02395133|581293462|FG000|Overall Study|Sponsor decision|2|||
160973646|NCT02395133|581293463|FG001|Overall Study|Sponsor decision|0|||
160973647|NCT02395133|581293464|FG002|Overall Study|Sponsor decision|0|||
160973648|NCT02395133|581293465|FG003|Overall Study|Sponsor decision|1|||
160973649|NCT02395133|581293462|FG000|Overall Study|Other than specified above|5|||
160973650|NCT02395133|581293463|FG001|Overall Study|Other than specified above|2|||
160973651|NCT02395133|581293464|FG002|Overall Study|Other than specified above|2|||
160973652|NCT02395133|581293465|FG003|Overall Study|Other than specified above|4|||
160973653|NCT02234063|581293468|FG000|Overall Study|Lost to Follow-up|235|||
160973654|NCT02234063|581293469|FG001|Overall Study|Lost to Follow-up|42|||
160973655|NCT02234063|581293468|FG000|Overall Study|Withdrawal by Subject|20|||
160973656|NCT02234063|581293469|FG001|Overall Study|Withdrawal by Subject|1|||
160973657|NCT00510458|581293470|FG000|Overall Study|5 year not evaluable/missed|21|||
160973658|NCT00510458|581293470|FG000|Overall Study|Death|1|||
160973659|NCT00510458|581293470|FG000|Overall Study|Terminated|14|||
160973660|NCT00510458|581293470|FG000|Overall Study|Lost to Follow-up|6|||
160973661|NCT00510458|581293470|FG000|Overall Study|Withdrawal by Subject|3|||
160973662|NCT00510458|581293470|FG000|Overall Study|Revision|2|||
160973663|NCT02569710|581293471|FG000|Overall Study|Adverse Event|1|||
160973664|NCT02569710|581293472|FG001|Overall Study|Adverse Event|0|||
160973665|NCT02569710|581293473|FG002|Overall Study|Adverse Event|0|||
160973666|NCT02569710|581293474|FG003|Overall Study|Adverse Event|0|||
160973667|NCT02569710|581293475|FG004|Overall Study|Adverse Event|0|||
160973668|NCT02569710|581293476|FG005|Overall Study|Adverse Event|0|||
160973669|NCT02569710|581293477|FG006|Overall Study|Adverse Event|0|||
160973670|NCT02569710|581293478|FG007|Overall Study|Adverse Event|0|||
160973671|NCT02569710|581293479|FG008|Overall Study|Adverse Event|0|||
160973672|NCT02569710|581293480|FG009|Overall Study|Adverse Event|0|||
160973673|NCT02569710|581293471|FG000|Overall Study|Lost to Follow-up|0|||
160973674|NCT02569710|581293472|FG001|Overall Study|Lost to Follow-up|0|||
160973675|NCT02569710|581293473|FG002|Overall Study|Lost to Follow-up|0|||
160973676|NCT02569710|581293474|FG003|Overall Study|Lost to Follow-up|0|||
160973677|NCT02569710|581293475|FG004|Overall Study|Lost to Follow-up|0|||
160973678|NCT02569710|581293476|FG005|Overall Study|Lost to Follow-up|0|||
160973679|NCT02569710|581293477|FG006|Overall Study|Lost to Follow-up|1|||
160973680|NCT02569710|581293478|FG007|Overall Study|Lost to Follow-up|0|||
160973681|NCT02569710|581293479|FG008|Overall Study|Lost to Follow-up|1|||
160973682|NCT02569710|581293480|FG009|Overall Study|Lost to Follow-up|0|||
160973683|NCT02569710|581293471|FG000|Overall Study|Virologic failure|0|||
160973684|NCT02569710|581293472|FG001|Overall Study|Virologic failure|0|||
160973685|NCT02569710|581293473|FG002|Overall Study|Virologic failure|0|||
160973686|NCT02569710|581293474|FG003|Overall Study|Virologic failure|0|||
160973687|NCT02569710|581293475|FG004|Overall Study|Virologic failure|1|||
161275962|NCT04581369|582391587|FG000|Overall Study|Lost to Follow-up|7|||
161275963|NCT04581369|582391588|FG001|Overall Study|Lost to Follow-up|3|||
160973688|NCT02569710|581293476|FG005|Overall Study|Virologic failure|0|||
160973689|NCT02569710|581293477|FG006|Overall Study|Virologic failure|1|||
160973690|NCT02569710|581293478|FG007|Overall Study|Virologic failure|0|||
160973691|NCT02569710|581293479|FG008|Overall Study|Virologic failure|0|||
160973692|NCT02569710|581293480|FG009|Overall Study|Virologic failure|0|||
160973693|NCT02569710|581293471|FG000|Overall Study|Withdrawal by Subject|0|||
160973694|NCT02569710|581293472|FG001|Overall Study|Withdrawal by Subject|0|||
160973695|NCT02569710|581293473|FG002|Overall Study|Withdrawal by Subject|0|||
160973696|NCT02569710|581293474|FG003|Overall Study|Withdrawal by Subject|0|||
160973697|NCT02569710|581293475|FG004|Overall Study|Withdrawal by Subject|0|||
160973698|NCT02569710|581293476|FG005|Overall Study|Withdrawal by Subject|1|||
160973699|NCT02569710|581293477|FG006|Overall Study|Withdrawal by Subject|0|||
160973700|NCT02569710|581293478|FG007|Overall Study|Withdrawal by Subject|0|||
160973701|NCT02569710|581293479|FG008|Overall Study|Withdrawal by Subject|0|||
160973702|NCT02569710|581293480|FG009|Overall Study|Withdrawal by Subject|0|||
160973703|NCT02946918|581293481|FG000|Overall Study|Patient unblinded himself|1|||
160973704|NCT02946918|581293482|FG001|Overall Study|Patient unblinded himself|0|||
160973705|NCT02946918|581293481|FG000|Overall Study|Physician Decision|0|||
160973706|NCT02946918|581293482|FG001|Overall Study|Physician Decision|2|||
160973707|NCT02946918|581293481|FG000|Overall Study|Ran out of study medication|0|||
160973708|NCT02946918|581293482|FG001|Overall Study|Ran out of study medication|1|||
160973709|NCT02669095|581293483|FG000|Overall Study|Adverse Event|1|||
160973710|NCT02669095|581293484|FG001|Overall Study|Adverse Event|0|||
160973711|NCT02669095|581293483|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
160973712|NCT02669095|581293484|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
160973713|NCT02669095|581293483|FG000|Overall Study|Torn Lens|0|||
160973714|NCT02669095|581293484|FG001|Overall Study|Torn Lens|1|||
160973715|NCT02669095|581293483|FG000|Overall Study|Visit 5 assessments not completed|0|||
160973716|NCT02669095|581293484|FG001|Overall Study|Visit 5 assessments not completed|1|||
160973717|NCT01555164|581293490|FG000|Overall Study|Adverse Event|5|||
160973718|NCT01555164|581293491|FG001|Overall Study|Adverse Event|7|||
160973719|NCT01555164|581293490|FG000|Overall Study|Hyperglycemia|0|||
160973720|NCT01555164|581293491|FG001|Overall Study|Hyperglycemia|1|||
160973721|NCT01555164|581293490|FG000|Overall Study|Investigator's Discretion|2|||
160973722|NCT01555164|581293491|FG001|Overall Study|Investigator's Discretion|2|||
160973723|NCT01555164|581293490|FG000|Overall Study|Lost to Follow-up|4|||
160973724|NCT01555164|581293491|FG001|Overall Study|Lost to Follow-up|3|||
160973725|NCT01555164|581293490|FG000|Overall Study|Protocol Violation|9|||
160973726|NCT01555164|581293491|FG001|Overall Study|Protocol Violation|5|||
160973727|NCT01555164|581293490|FG000|Overall Study|Subject Non-compliance|14|||
160973728|NCT01555164|581293491|FG001|Overall Study|Subject Non-compliance|6|||
160973729|NCT01555164|581293490|FG000|Overall Study|Subject Withdrew Consent|6|||
160973730|NCT01555164|581293491|FG001|Overall Study|Subject Withdrew Consent|11|||
160973731|NCT03203694|581293492|FG000|Overall Study|Withdrawal by Subject|2|||
160973732|NCT03203694|581293493|FG001|Overall Study|Withdrawal by Subject|0|||
160973733|NCT03203694|581293494|FG002|Overall Study|Withdrawal by Subject|0|||
160973734|NCT03203694|581293495|FG003|Overall Study|Withdrawal by Subject|0|||
160973735|NCT03203694|581293496|FG004|Overall Study|Withdrawal by Subject|0|||
160973736|NCT03203694|581293497|FG005|Overall Study|Withdrawal by Subject|0|||
160973737|NCT02969525|581293504|FG000|Double-Blind Period|Adverse Event|0|||
160973738|NCT02969525|581293505|FG001|Double-Blind Period|Adverse Event|0|||
160973739|NCT02969525|581293506|FG002|Double-Blind Period|Adverse Event|1|||
160973740|NCT02969525|581293507|FG003|Double-Blind Period|Adverse Event|1|||
160973741|NCT02969525|581293508|FG004|Double-Blind Period|Adverse Event|0|||
160973742|NCT02969525|581293509|FG005|Double-Blind Period|Adverse Event|0|||
160973743|NCT02969525|581293510|FG006|Double-Blind Period|Adverse Event|0|||
160973744|NCT02969525|581293511|FG007|Double-Blind Period|Adverse Event|0|||
160973745|NCT02969525|581293512|FG008|Double-Blind Period|Adverse Event|0|||
160973746|NCT02969525|581293513|FG009|Double-Blind Period|Adverse Event|0|||
160973747|NCT02969525|581293514|FG010|Double-Blind Period|Adverse Event|0|||
160973748|NCT02969525|581293515|FG011|Double-Blind Period|Adverse Event|0|||
160973749|NCT02969525|581293504|FG000|Double-Blind Period|LOW EGFR|0|||
160973750|NCT02969525|581293505|FG001|Double-Blind Period|LOW EGFR|0|||
160973751|NCT02969525|581293506|FG002|Double-Blind Period|LOW EGFR|0|||
160973752|NCT02969525|581293507|FG003|Double-Blind Period|LOW EGFR|1|||
160973753|NCT02969525|581293508|FG004|Double-Blind Period|LOW EGFR|0|||
160973754|NCT02969525|581293509|FG005|Double-Blind Period|LOW EGFR|0|||
160973755|NCT02969525|581293510|FG006|Double-Blind Period|LOW EGFR|0|||
160973756|NCT02969525|581293511|FG007|Double-Blind Period|LOW EGFR|0|||
160973757|NCT02969525|581293512|FG008|Double-Blind Period|LOW EGFR|0|||
160973758|NCT02969525|581293513|FG009|Double-Blind Period|LOW EGFR|0|||
160973759|NCT02969525|581293514|FG010|Double-Blind Period|LOW EGFR|0|||
160973760|NCT02969525|581293515|FG011|Double-Blind Period|LOW EGFR|0|||
160973761|NCT02969525|581293504|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
160973762|NCT02969525|581293505|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973763|NCT02969525|581293506|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973764|NCT02969525|581293507|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
161275964|NCT04581369|582391589|FG002|Overall Study|Lost to Follow-up|0|||
161275965|NCT04581369|582391587|FG000|Overall Study|liver transplant|2|||
161275966|NCT04581369|582391588|FG001|Overall Study|liver transplant|2|||
161275967|NCT04581369|582391589|FG002|Overall Study|liver transplant|0|||
161275968|NCT04581369|582391587|FG000|Overall Study|transitioned to hospice care|0|||
161275969|NCT04581369|582391588|FG001|Overall Study|transitioned to hospice care|5|||
161275970|NCT04581369|582391589|FG002|Overall Study|transitioned to hospice care|0|||
161275971|NCT04746794|582391592|FG000|Overall Study|Did not complete any study assessment|50303|||
161275972|NCT04746794|582391593|FG001|Overall Study|Did not complete any study assessment|44997|||
161275973|NCT02538965|582391594|FG000|Treatment Period|Other = Death due to disease progression|1|||
161275974|NCT02538965|582391594|FG000|Treatment Period|Adverse Event|2|||
161275975|NCT02538965|582391594|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
161275976|NCT02538965|582391594|FG000|Treatment Period|Treatment Failure|9|||
161275977|NCT02538965|582391594|FG000|Treatment Period|Disease Progression|1|||
161275978|NCT02538965|582391594|FG000|Treatment Period|Physician Decision|2|||
161275979|NCT02538965|582391594|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
161275980|NCT02538965|582391594|FG000|Follow-Up Period|Withdrawal by Parent|4|||
161275981|NCT00875797|582391595|FG000|Overall Study|Protocol Violation|6|||
161275982|NCT00875797|582391596|FG001|Overall Study|Protocol Violation|3|||
161275983|NCT00253448|582391599|FG000|Overall Study|Withdrawal by Subject|1|||
161275984|NCT02564887|582391601|FG000|Overall Study|Lost to Follow-up|6|||
161275985|NCT02564887|582391602|FG001|Overall Study|Lost to Follow-up|0|||
161275986|NCT02052011|582391605|FG000|Overall Study|Lost to Follow-up|3|||
161275987|NCT02052011|582391606|FG001|Overall Study|Lost to Follow-up|0|||
161275988|NCT02052011|582391605|FG000|Overall Study|Withdrawal by Subject|1|||
161275989|NCT02052011|582391606|FG001|Overall Study|Withdrawal by Subject|2|||
161275990|NCT00000620|582391607|FG000|Overall Study|Death|86|||
160973765|NCT02969525|581293508|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973766|NCT02969525|581293509|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973767|NCT02969525|581293510|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973768|NCT02969525|581293511|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973769|NCT02969525|581293512|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973770|NCT02969525|581293513|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973771|NCT02969525|581293514|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973772|NCT02969525|581293515|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
160973773|NCT02969525|581293504|FG000|Dose-Blind Period|Adverse Event|0|||
160973774|NCT02969525|581293505|FG001|Dose-Blind Period|Adverse Event|0|||
160973775|NCT02969525|581293506|FG002|Dose-Blind Period|Adverse Event|0|||
160973776|NCT02969525|581293507|FG003|Dose-Blind Period|Adverse Event|0|||
160973777|NCT02969525|581293508|FG004|Dose-Blind Period|Adverse Event|0|||
160973778|NCT02969525|581293509|FG005|Dose-Blind Period|Adverse Event|0|||
160973779|NCT02969525|581293510|FG006|Dose-Blind Period|Adverse Event|0|||
160973780|NCT02969525|581293511|FG007|Dose-Blind Period|Adverse Event|0|||
160973781|NCT02969525|581293512|FG008|Dose-Blind Period|Adverse Event|0|||
160973782|NCT02969525|581293513|FG009|Dose-Blind Period|Adverse Event|1|||
160973783|NCT02969525|581293514|FG010|Dose-Blind Period|Adverse Event|1|||
160973784|NCT02969525|581293515|FG011|Dose-Blind Period|Adverse Event|1|||
160973785|NCT02969525|581293504|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
160973786|NCT02969525|581293505|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
160973787|NCT02969525|581293506|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
160973788|NCT02969525|581293507|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
160973789|NCT02969525|581293508|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
160973790|NCT02969525|581293509|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
160973791|NCT02969525|581293510|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
160973792|NCT02969525|581293511|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
160973793|NCT02969525|581293512|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
160973794|NCT02969525|581293513|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
160973795|NCT02969525|581293514|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
160973796|NCT02969525|581293515|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
160973797|NCT02969525|581293504|FG000|Dose-Blind Period|Non-cooperating patient|0|||
160973798|NCT02969525|581293505|FG001|Dose-Blind Period|Non-cooperating patient|0|||
160973799|NCT02969525|581293506|FG002|Dose-Blind Period|Non-cooperating patient|0|||
160973800|NCT02969525|581293507|FG003|Dose-Blind Period|Non-cooperating patient|0|||
160973801|NCT02969525|581293508|FG004|Dose-Blind Period|Non-cooperating patient|0|||
160973802|NCT02969525|581293509|FG005|Dose-Blind Period|Non-cooperating patient|0|||
160973803|NCT02969525|581293510|FG006|Dose-Blind Period|Non-cooperating patient|0|||
160973804|NCT02969525|581293511|FG007|Dose-Blind Period|Non-cooperating patient|0|||
160973805|NCT02969525|581293512|FG008|Dose-Blind Period|Non-cooperating patient|0|||
160973806|NCT02969525|581293513|FG009|Dose-Blind Period|Non-cooperating patient|0|||
160973807|NCT02969525|581293514|FG010|Dose-Blind Period|Non-cooperating patient|0|||
160973808|NCT02969525|581293515|FG011|Dose-Blind Period|Non-cooperating patient|1|||
160973809|NCT02969525|581293504|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973810|NCT02969525|581293505|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973811|NCT02969525|581293506|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973812|NCT02969525|581293507|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
161275991|NCT00000620|582391608|FG001|Overall Study|Death|67|||
161025839|NCT02068885|581485698|FG000|Overall Study|Withdrew|3|||
161025840|NCT02068885|581485699|FG001|Overall Study|Withdrew|5|||
161025841|NCT02068885|581485700|FG002|Overall Study|Withdrew|8|||
161025879|NCT03100149|581485732|FG000|Overall Study|Adverse Event|0|||
161025880|NCT03100149|581485733|FG001|Overall Study|Adverse Event|1|||
161025881|NCT03100149|581485734|FG002|Overall Study|Adverse Event|0|||
161025882|NCT03100149|581485732|FG000|Overall Study|Participant Moved out of Country|0|||
161025883|NCT03100149|581485733|FG001|Overall Study|Participant Moved out of Country|0|||
161025884|NCT03100149|581485734|FG002|Overall Study|Participant Moved out of Country|1|||
161025885|NCT03100149|581485732|FG000|Overall Study|Withdrawal by Subject|0|||
161025886|NCT03100149|581485733|FG001|Overall Study|Withdrawal by Subject|3|||
161025887|NCT03100149|581485734|FG002|Overall Study|Withdrawal by Subject|1|||
161025888|NCT03697876|581485735|FG000|Overall Study|Lost to Follow-up|0|||
161025889|NCT03697876|581485736|FG001|Overall Study|Lost to Follow-up|1|||
161025890|NCT03697876|581485735|FG000|Overall Study|Adverse Event|1|||
161025891|NCT03697876|581485736|FG001|Overall Study|Adverse Event|0|||
161025892|NCT04721977|581485737|FG000|Overall Study|Death|15|||
161025893|NCT04721977|581485737|FG000|Overall Study|Ongoing|51|||
161025894|NCT02670525|581485738|FG000|Overall Study|Death|94|||
161025895|NCT02670525|581485739|FG001|Overall Study|Death|14|||
161025896|NCT02670525|581485738|FG000|Overall Study|Lost to Follow-up|4|||
161025897|NCT02670525|581485739|FG001|Overall Study|Lost to Follow-up|1|||
161025898|NCT02670525|581485738|FG000|Overall Study|Subject withdrew consent|1|||
161025899|NCT02670525|581485739|FG001|Overall Study|Subject withdrew consent|0|||
161025900|NCT02670525|581485738|FG000|Overall Study|Unknown, data entry delayed|123|||
161025901|NCT02670525|581485739|FG001|Overall Study|Unknown, data entry delayed|78|||
161025902|NCT04622046|581486197|FG000|Intervention Period|Adverse Event|1|||
161025903|NCT04622046|581486197|FG000|Intervention Period|Withdrawal by Subject|2|||
161025904|NCT04622046|581486197|FG000|Extension Period|Ongoing in the Extension Period|21|||
161025977|NCT05321082|581486208|FG000|Overall Study|Other than listed|40|||
161275992|NCT00000620|582391609|FG002|Overall Study|Death|112|||
161275993|NCT00000620|582391610|FG003|Overall Study|Death|126|||
161275994|NCT00000620|582391611|FG004|Overall Study|Death|64|||
161275995|NCT00000620|582391612|FG005|Overall Study|Death|77|||
161025978|NCT05321082|581486209|FG001|Overall Study|Other than listed|26|||
161025979|NCT05321082|581486210|FG002|Overall Study|Other than listed|27|||
161025980|NCT05321082|581486208|FG000|Overall Study|Lost to Follow-up|0|||
161025981|NCT05321082|581486209|FG001|Overall Study|Lost to Follow-up|1|||
161275996|NCT00000620|582391613|FG006|Overall Study|Death|91|||
161275997|NCT00000620|582391614|FG007|Overall Study|Death|95|||
161025982|NCT05321082|581486210|FG002|Overall Study|Lost to Follow-up|0|||
161275998|NCT00000620|582391607|FG000|Overall Study|Lost to Follow-up|14|||
161025983|NCT05321082|581486208|FG000|Overall Study|Withdrawal by Subject|30|||
161025984|NCT05321082|581486209|FG001|Overall Study|Withdrawal by Subject|34|||
161025985|NCT05321082|581486210|FG002|Overall Study|Withdrawal by Subject|42|||
161025986|NCT05321082|581486208|FG000|Overall Study|Protocol Violation|0|||
161025987|NCT05321082|581486209|FG001|Overall Study|Protocol Violation|0|||
161025988|NCT05321082|581486210|FG002|Overall Study|Protocol Violation|1|||
161025989|NCT05321082|581486208|FG000|Overall Study|Adverse Event|49|||
161025990|NCT05321082|581486209|FG001|Overall Study|Adverse Event|49|||
161025991|NCT05321082|581486210|FG002|Overall Study|Adverse Event|48|||
161025992|NCT05321082|581486208|FG000|Overall Study|Lack of Efficacy|2|||
161025993|NCT05321082|581486209|FG001|Overall Study|Lack of Efficacy|0|||
161025994|NCT05321082|581486210|FG002|Overall Study|Lack of Efficacy|1|||
161025995|NCT05321082|581486208|FG000|Overall Study|Not treated|1|||
161025996|NCT05321082|581486209|FG001|Overall Study|Not treated|0|||
161025997|NCT05321082|581486210|FG002|Overall Study|Not treated|1|||
161026015|NCT07147257|581486360|FG000|Overall Study|Pregnancy|1|||
161026016|NCT07147257|581486361|FG001|Overall Study|Pregnancy|0|||
161026017|NCT07147257|581486360|FG000|Overall Study|Physician Decision|0|||
161026018|NCT07147257|581486361|FG001|Overall Study|Physician Decision|1|||
161026019|NCT07147257|581486360|FG000|Overall Study|Withdrawal by Subject|0|||
161026020|NCT07147257|581486361|FG001|Overall Study|Withdrawal by Subject|1|||
161026021|NCT07147257|581486360|FG000|Overall Study|Drug administration failure|0|||
161026022|NCT07147257|581486361|FG001|Overall Study|Drug administration failure|1|||
161091135|NCT02581631|581723819|FG001|Overall Study|participant withdrew consent|0|||
161091136|NCT02581631|581723820|FG002|Overall Study|participant withdrew consent|1|||
161091137|NCT02581631|581723821|FG003|Overall Study|participant withdrew consent|0|||
161091138|NCT02581631|581723822|FG004|Overall Study|participant withdrew consent|0|||
161091139|NCT02581631|581723818|FG000|Overall Study|Maximum clinical benefit|1|||
161091140|NCT02581631|581723819|FG001|Overall Study|Maximum clinical benefit|7|||
161091141|NCT02581631|581723820|FG002|Overall Study|Maximum clinical benefit|1|||
161091142|NCT02581631|581723821|FG003|Overall Study|Maximum clinical benefit|3|||
161091143|NCT02581631|581723822|FG004|Overall Study|Maximum clinical benefit|13|||
161091144|NCT02581631|581723818|FG000|Overall Study|Other Reasons|1|||
161091145|NCT02581631|581723819|FG001|Overall Study|Other Reasons|0|||
161091146|NCT02581631|581723820|FG002|Overall Study|Other Reasons|2|||
161091147|NCT02581631|581723821|FG003|Overall Study|Other Reasons|2|||
161091148|NCT02581631|581723822|FG004|Overall Study|Other Reasons|3|||
161091149|NCT02581631|581723818|FG000|Overall Study|Poor/Non-Compliance|0|||
161091150|NCT02581631|581723819|FG001|Overall Study|Poor/Non-Compliance|0|||
161091151|NCT02581631|581723820|FG002|Overall Study|Poor/Non-Compliance|1|||
161091152|NCT02581631|581723821|FG003|Overall Study|Poor/Non-Compliance|0|||
161091153|NCT02581631|581723822|FG004|Overall Study|Poor/Non-Compliance|0|||
161091154|NCT01759368|581723823|FG000|Overall Study|Lost to Follow-up|1|||
161091155|NCT01759368|581723824|FG001|Overall Study|Lost to Follow-up|0|||
161091156|NCT01191268|581723825|FG000|Overall Study|Withdrawal by Subject|19|||
161091157|NCT01191268|581723826|FG001|Overall Study|Withdrawal by Subject|25|||
161091158|NCT01191268|581723827|FG002|Overall Study|Withdrawal by Subject|21|||
161091159|NCT01191268|581723825|FG000|Overall Study|Adverse Event|21|||
161091160|NCT01191268|581723826|FG001|Overall Study|Adverse Event|13|||
161091161|NCT01191268|581723827|FG002|Overall Study|Adverse Event|8|||
161091162|NCT01191268|581723825|FG000|Overall Study|Physician Decision|6|||
161091163|NCT01191268|581723826|FG001|Overall Study|Physician Decision|8|||
161091164|NCT01191268|581723827|FG002|Overall Study|Physician Decision|9|||
161091165|NCT01191268|581723825|FG000|Overall Study|Lost to Follow-up|8|||
161091166|NCT01191268|581723826|FG001|Overall Study|Lost to Follow-up|5|||
161091167|NCT01191268|581723827|FG002|Overall Study|Lost to Follow-up|9|||
161091168|NCT01191268|581723825|FG000|Overall Study|Entry Criteria Not Met|3|||
161343982|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
161343983|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343984|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343985|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
161343986|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343987|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343988|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343989|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343990|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
161343991|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161343992|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161343993|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
161343994|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161343995|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161343996|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161343997|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161343998|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
161026024|NCT03748953|581488551|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
161026025|NCT03748953|581488552|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
160973813|NCT02969525|581293508|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973814|NCT02969525|581293509|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973815|NCT02969525|581293510|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973816|NCT02969525|581293511|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973817|NCT02969525|581293512|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973818|NCT02969525|581293513|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973819|NCT02969525|581293514|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
160973820|NCT02969525|581293515|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
160973821|NCT02172625|581293516|FG000|Overall Study|Adverse Event|0|||
160973822|NCT02172625|581293517|FG001|Overall Study|Adverse Event|1|||
160973823|NCT02172625|581293516|FG000|Overall Study|Pregnancy|0|||
160973824|NCT02172625|581293517|FG001|Overall Study|Pregnancy|1|||
160973825|NCT02172625|581293516|FG000|Overall Study|car accident|0|||
160973826|NCT02172625|581293517|FG001|Overall Study|car accident|1|||
160973827|NCT03445065|581293518|FG000|Overall Study|Withdrawal by Subject|3|||
160973828|NCT03445065|581293519|FG001|Overall Study|Withdrawal by Subject|6|||
160973829|NCT03445065|581293520|FG002|Overall Study|Withdrawal by Subject|2|||
160973830|NCT03445065|581293521|FG003|Overall Study|Withdrawal by Subject|2|||
160973831|NCT03445065|581293518|FG000|Overall Study|Other|4|||
160973832|NCT03445065|581293519|FG001|Overall Study|Other|3|||
160973833|NCT03445065|581293520|FG002|Overall Study|Other|3|||
160973834|NCT03445065|581293521|FG003|Overall Study|Other|1|||
160973835|NCT00524030|581293522|FG000|Overall Study|Lack of Efficacy|10|||
160973836|NCT00524030|581293523|FG001|Overall Study|Lack of Efficacy|24|||
160973837|NCT00524030|581293522|FG000|Overall Study|Lost to Follow-up|0|||
160973838|NCT00524030|581293523|FG001|Overall Study|Lost to Follow-up|2|||
160973839|NCT00524030|581293522|FG000|Overall Study|Withdrawal by Subject|3|||
160973840|NCT00524030|581293523|FG001|Overall Study|Withdrawal by Subject|8|||
160973841|NCT00524030|581293522|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
160973842|NCT00524030|581293523|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
160973843|NCT00524030|581293522|FG000|Overall Study|Protocol Violation|0|||
160973844|NCT00524030|581293523|FG001|Overall Study|Protocol Violation|1|||
160973845|NCT00524030|581293522|FG000|Overall Study|Pregnancy|1|||
160973846|NCT00524030|581293523|FG001|Overall Study|Pregnancy|0|||
160973847|NCT00524030|581293522|FG000|Overall Study|Adverse Event|3|||
160973848|NCT00524030|581293523|FG001|Overall Study|Adverse Event|21|||
160973849|NCT00524030|581293522|FG000|Overall Study|Death|0|||
160973850|NCT00524030|581293523|FG001|Overall Study|Death|1|||
160973851|NCT03315130|581293524|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
160973852|NCT03315130|581293525|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
160973853|NCT03315130|581293526|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
160973854|NCT03315130|581293527|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
160973855|NCT03315130|581293524|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
160973856|NCT03315130|581293525|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
160973857|NCT03315130|581293526|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
160973858|NCT03315130|581293527|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
160973859|NCT03315130|581293524|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
160973860|NCT03315130|581293525|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
160973861|NCT03315130|581293526|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
160973862|NCT03315130|581293527|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
160973863|NCT03315130|581293524|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
160973864|NCT03315130|581293525|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
160973865|NCT03315130|581293526|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
160973866|NCT03315130|581293527|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
160973867|NCT03315130|581293524|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
160973868|NCT03315130|581293525|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
160973869|NCT03315130|581293526|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
160973870|NCT03315130|581293527|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
160973871|NCT03315130|581293524|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
160973872|NCT03315130|581293525|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
160973873|NCT03315130|581293526|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
160973874|NCT03315130|581293527|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
160973875|NCT02944656|581293528|FG000|Overall Study|No longer eligible|3|||
160973876|NCT02944656|581293529|FG001|Overall Study|No longer eligible|0|||
160973877|NCT02944656|581293528|FG000|Overall Study|Lost to Follow-up|7|||
160973878|NCT02944656|581293529|FG001|Overall Study|Lost to Follow-up|10|||
160973879|NCT04398537|581293530|FG000|Overall Study|Physician Decision|10|||
160973880|NCT04398537|581293531|FG001|Overall Study|Physician Decision|15|||
160973881|NCT03535337|581293532|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
160973882|NCT03535337|581293533|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
160973883|NCT03535337|581293534|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
160973884|NCT03535337|581293535|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
160973885|NCT03535337|581293536|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
160973886|NCT03535337|581293537|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
160973887|NCT03535337|581293538|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
160973888|NCT03535337|581293539|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
160973889|NCT03535337|581293540|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
160973890|NCT03535337|581293541|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
160973891|NCT05879198|581293542|FG000|Overall Study|Lost to Follow-up|1|||
160973892|NCT01598298|581293543|FG000|Overall Study|Not eligible|5|||
160973893|NCT01598298|581293544|FG001|Overall Study|Not eligible|5|||
160973894|NCT01598298|581293543|FG000|Overall Study|Adverse Event|21|||
160973895|NCT01598298|581293544|FG001|Overall Study|Adverse Event|19|||
160973896|NCT01598298|581293543|FG000|Overall Study|Progression/relapse|0|||
160973897|NCT01598298|581293544|FG001|Overall Study|Progression/relapse|2|||
160973898|NCT01598298|581293543|FG000|Overall Study|Withdrawal by Subject|10|||
160973899|NCT01598298|581293544|FG001|Overall Study|Withdrawal by Subject|15|||
160973900|NCT01598298|581293543|FG000|Overall Study|Other reason (not protocol specified)|4|||
160973901|NCT01598298|581293544|FG001|Overall Study|Other reason (not protocol specified)|0|||
160973902|NCT00663117|581295273|FG000|Overall Study|Lack of Efficacy|1|||
160973903|NCT00663117|581295274|FG001|Overall Study|Lack of Efficacy|0|||
160973904|NCT02781506|581295275|FG000|Overall Study|Adverse Event|5|||
160973905|NCT02593539|581295276|FG000|Overall Study|Adverse Event|1|||
160973906|NCT00437125|581295279|FG000|Overall Study|Adverse Event|12|||
160973907|NCT00437125|581295279|FG000|Overall Study|Death|1|||
160973908|NCT00437125|581295279|FG000|Overall Study|Clinical Relapse|1|||
160973909|NCT00437125|581295279|FG000|Overall Study|Lack of Efficacy|1|||
160973910|NCT00437125|581295279|FG000|Overall Study|Lost to Follow-up|1|||
160973911|NCT00437125|581295279|FG000|Overall Study|Withdrawal by Subject|13|||
160973912|NCT00437125|581295279|FG000|Overall Study|Withdrawal by Caregiver|2|||
160973913|NCT00437125|581295279|FG000|Overall Study|Physician Decision|1|||
160973914|NCT02248961|581295280|FG000|Overall Study|Adverse Event|1|||
160973915|NCT02248961|581295281|FG001|Overall Study|Adverse Event|0|||
160973916|NCT02248961|581295280|FG000|Overall Study|Withdrawal by Subject|1|||
160973917|NCT02248961|581295281|FG001|Overall Study|Withdrawal by Subject|2|||
160973918|NCT02248961|581295280|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
160973919|NCT02248961|581295281|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
160973920|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
160973921|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973922|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973923|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973924|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
160973925|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
160973926|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973927|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973928|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973929|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
160973930|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
160973931|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973932|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973933|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973934|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
160973935|NCT00244374|581295288|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
160973936|NCT00244374|581295289|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973937|NCT00244374|581295290|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973938|NCT00244374|581295291|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973939|NCT00244374|581295292|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
160973940|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
160973941|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973942|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973943|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973944|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
160973945|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
160973946|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973947|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973948|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973949|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
160973950|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
160973951|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973952|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973953|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973954|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
160973955|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
160973956|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973957|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973958|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973959|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
160973960|NCT00244374|581295288|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
160973961|NCT00244374|581295289|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973962|NCT00244374|581295290|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973963|NCT00244374|581295291|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973964|NCT00244374|581295292|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
160973965|NCT03462706|581295294|FG000|Overall Study|Polyp was pedunculated|1|||
160973966|NCT03462706|581295295|FG001|Overall Study|Polyp was pedunculated|0|||
160973967|NCT03462706|581295296|FG002|Overall Study|Polyp was pedunculated|1|||
160973968|NCT03462706|581295297|FG003|Overall Study|Polyp was pedunculated|0|||
160973969|NCT03462706|581295294|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
160973970|NCT03462706|581295295|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
160973971|NCT03462706|581295296|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
160973972|NCT03462706|581295297|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
160973973|NCT04105972|581295307|FG000|Overall Study|Adverse Event|2|||
160973974|NCT04105972|581295308|FG001|Overall Study|Adverse Event|1|||
160973975|NCT02802319|581295309|FG000|Overall Study|Physician Decision|2|||
160973976|NCT02802319|581295310|FG001|Overall Study|Physician Decision|1|||
160973977|NCT02802319|581295309|FG000|Overall Study|Lost to Follow-up|0|||
160973978|NCT02802319|581295310|FG001|Overall Study|Lost to Follow-up|4|||
160973979|NCT04651114|581295311|FG000|Overall Study|Withdrawal by Subject|8|||
160973980|NCT01923896|581295316|FG000|Overall Study|Adverse Event|1|||
160973981|NCT01923896|581295317|FG001|Overall Study|Adverse Event|0|||
160973982|NCT03545113|581295320|FG000|Overall Study|Surgery Cancelled|1|||
160973983|NCT03545113|581295321|FG001|Overall Study|Surgery Cancelled|0|||
160973984|NCT03545113|581295320|FG000|Overall Study|Death|1|||
160973985|NCT03545113|581295321|FG001|Overall Study|Death|0|||
160973986|NCT03545113|581295320|FG000|Overall Study|Adverse Event|2|||
160973987|NCT03545113|581295321|FG001|Overall Study|Adverse Event|0|||
160973988|NCT03545113|581295320|FG000|Overall Study|Received different surgery|1|||
160973989|NCT03545113|581295321|FG001|Overall Study|Received different surgery|0|||
160973990|NCT00235443|581295322|FG000|Overall Study|Adverse Event|4|||
160973991|NCT00235443|581295323|FG001|Overall Study|Adverse Event|12|||
160973992|NCT00235443|581295324|FG002|Overall Study|Adverse Event|17|||
160973993|NCT00235443|581295325|FG003|Overall Study|Adverse Event|44|||
160973994|NCT00235443|581295326|FG004|Overall Study|Adverse Event|10|||
160973995|NCT00235443|581295327|FG005|Overall Study|Adverse Event|15|||
161026026|NCT03748953|581488551|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
161026027|NCT03748953|581488552|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
161026028|NCT03748953|581488551|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
161026029|NCT03748953|581488552|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
161026030|NCT03748953|581488551|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
161026031|NCT03748953|581488552|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
161026032|NCT03748953|581488551|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
161026033|NCT03748953|581488552|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
161026034|NCT04676763|581488553|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
161026035|NCT04676763|581488554|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
161026036|NCT04676763|581488555|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
161026037|NCT04676763|581488553|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
161026038|NCT04676763|581488554|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
161026039|NCT04676763|581488555|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
161026040|NCT04676763|581488553|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
161026041|NCT04676763|581488554|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
161026042|NCT04676763|581488555|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
161026043|NCT04858451|581488556|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
161026044|NCT04858451|581488557|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026045|NCT04858451|581488558|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026046|NCT04858451|581488559|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026047|NCT04858451|581488560|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026048|NCT04858451|581488561|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026049|NCT04858451|581488562|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026050|NCT04858451|581488563|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026051|NCT04858451|581488564|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
161026052|NCT04858451|581488556|FG000|Part 2|Discontinued|0|||
161026053|NCT04858451|581488557|FG001|Part 2|Discontinued|0|||
161026054|NCT04858451|581488558|FG002|Part 2|Discontinued|0|||
161026055|NCT04858451|581488559|FG003|Part 2|Discontinued|0|||
161026056|NCT04858451|581488560|FG004|Part 2|Discontinued|0|||
161026057|NCT04858451|581488561|FG005|Part 2|Discontinued|0|||
161026058|NCT04858451|581488562|FG006|Part 2|Discontinued|0|||
161026059|NCT04858451|581488563|FG007|Part 2|Discontinued|0|||
161026060|NCT04858451|581488564|FG008|Part 2|Discontinued|63|||
161026061|NCT04119843|581488565|FG000|Overall Study|Adverse Event|3|||
161026062|NCT04119843|581488565|FG000|Overall Study|Death|1|||
161026063|NCT02998268|581488567|FG000|Overall Study|Adverse Event|0|||
161026064|NCT02998268|581488568|FG001|Overall Study|Adverse Event|2|||
161026065|NCT02998268|581488567|FG000|Overall Study|Withdrawal by Subject|0|||
161026066|NCT02998268|581488568|FG001|Overall Study|Withdrawal by Subject|1|||
161026067|NCT04225273|581488569|FG000|Overall Study|Lost to Follow-up|3|||
161026068|NCT03652389|581488570|FG000|Overall Study|Lost to Follow-up|1|||
161026069|NCT03652389|581488571|FG001|Overall Study|Lost to Follow-up|5|||
161026070|NCT03652389|581488570|FG000|Overall Study|Withdrawal by Subject|5|||
161026071|NCT03652389|581488571|FG001|Overall Study|Withdrawal by Subject|1|||
161026072|NCT03652389|581488570|FG000|Overall Study|New diagnosis|2|||
161026073|NCT03652389|581488571|FG001|Overall Study|New diagnosis|0|||
161026074|NCT04231149|581488572|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161026075|NCT04231149|581488573|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
161026076|NCT04231149|581488574|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161275999|NCT00000620|582391608|FG001|Overall Study|Lost to Follow-up|14|||
161276000|NCT00000620|582391609|FG002|Overall Study|Lost to Follow-up|14|||
161276001|NCT00000620|582391610|FG003|Overall Study|Lost to Follow-up|14|||
161276002|NCT00000620|582391611|FG004|Overall Study|Lost to Follow-up|15|||
161276003|NCT00000620|582391612|FG005|Overall Study|Lost to Follow-up|15|||
161276004|NCT00000620|582391613|FG006|Overall Study|Lost to Follow-up|13|||
161276005|NCT00000620|582391614|FG007|Overall Study|Lost to Follow-up|14|||
161276006|NCT00000620|582391607|FG000|Overall Study|Withdrawal by Subject|40|||
161276007|NCT00000620|582391608|FG001|Overall Study|Withdrawal by Subject|27|||
161276008|NCT00000620|582391609|FG002|Overall Study|Withdrawal by Subject|28|||
161276009|NCT00000620|582391610|FG003|Overall Study|Withdrawal by Subject|27|||
161276010|NCT00000620|582391611|FG004|Overall Study|Withdrawal by Subject|30|||
161276011|NCT00000620|582391612|FG005|Overall Study|Withdrawal by Subject|32|||
161026077|NCT04231149|581488575|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161026078|NCT04231149|581488576|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
161026079|NCT03252847|581488577|FG000|Overall Study|Withdrawal by Subject|0|||
161026080|NCT03252847|581488578|FG001|Overall Study|Withdrawal by Subject|0|||
161026081|NCT03252847|581488579|FG002|Overall Study|Withdrawal by Subject|1|||
161026082|NCT03252847|581488580|FG003|Overall Study|Withdrawal by Subject|0|||
161276012|NCT00000620|582391613|FG006|Overall Study|Withdrawal by Subject|32|||
161276013|NCT00000620|582391614|FG007|Overall Study|Withdrawal by Subject|21|||
161026083|NCT03252847|581488581|FG004|Overall Study|Withdrawal by Subject|0|||
161026084|NCT03252847|581488582|FG005|Overall Study|Withdrawal by Subject|0|||
161026085|NCT03252847|581488583|FG006|Overall Study|Withdrawal by Subject|0|||
161026086|NCT03252847|581488577|FG000|Overall Study|Other: Patient decision|0|||
161026087|NCT03252847|581488578|FG001|Overall Study|Other: Patient decision|0|||
161026088|NCT03252847|581488579|FG002|Overall Study|Other: Patient decision|0|||
161026089|NCT03252847|581488580|FG003|Overall Study|Other: Patient decision|0|||
161026090|NCT03252847|581488581|FG004|Overall Study|Other: Patient decision|1|||
161026091|NCT03252847|581488582|FG005|Overall Study|Other: Patient decision|0|||
161026092|NCT03252847|581488583|FG006|Overall Study|Other: Patient decision|0|||
161026093|NCT01501955|581488586|FG000|Overall Study|Withdrawal by Subject|1|||
161026094|NCT01501955|581488587|FG001|Overall Study|Withdrawal by Subject|0|||
161026095|NCT01501955|581488586|FG000|Overall Study|Adverse Event|1|||
161026096|NCT01501955|581488587|FG001|Overall Study|Adverse Event|3|||
161026097|NCT04298983|581488590|FG000|Overall Study|Adverse Event|4|||
161026098|NCT04298983|581488590|FG000|Overall Study|Lack of Efficacy|3|||
161026099|NCT05477186|581488591|FG000|Overall Study|Vaccine not administered|0|||
161026100|NCT05477186|581488592|FG001|Overall Study|Vaccine not administered|2|||
161026101|NCT05477186|581488593|FG002|Overall Study|Vaccine not administered|1|||
161026102|NCT05477186|581488594|FG003|Overall Study|Vaccine not administered|0|||
161026103|NCT05477186|581488595|FG004|Overall Study|Vaccine not administered|1|||
161026104|NCT05477186|581488596|FG005|Overall Study|Vaccine not administered|0|||
161026105|NCT05477186|581488597|FG006|Overall Study|Vaccine not administered|0|||
161026106|NCT05477186|581488591|FG000|Overall Study|Withdrawal by Subject|1|||
161026107|NCT05477186|581488592|FG001|Overall Study|Withdrawal by Subject|0|||
161026108|NCT05477186|581488593|FG002|Overall Study|Withdrawal by Subject|0|||
161026109|NCT05477186|581488594|FG003|Overall Study|Withdrawal by Subject|0|||
161026110|NCT05477186|581488595|FG004|Overall Study|Withdrawal by Subject|0|||
161026111|NCT05477186|581488596|FG005|Overall Study|Withdrawal by Subject|1|||
161026112|NCT05477186|581488597|FG006|Overall Study|Withdrawal by Subject|0|||
161026113|NCT05477186|581488591|FG000|Overall Study|Lost to Follow-up|1|||
161026114|NCT05477186|581488592|FG001|Overall Study|Lost to Follow-up|0|||
161026115|NCT05477186|581488593|FG002|Overall Study|Lost to Follow-up|2|||
161026116|NCT05477186|581488594|FG003|Overall Study|Lost to Follow-up|1|||
161026117|NCT05477186|581488595|FG004|Overall Study|Lost to Follow-up|1|||
161026118|NCT05477186|581488596|FG005|Overall Study|Lost to Follow-up|0|||
161026119|NCT05477186|581488597|FG006|Overall Study|Lost to Follow-up|2|||
161026120|NCT01919554|581488599|FG000|Overall Study|Withdrawal by Subject|0|||
161026121|NCT01919554|581488600|FG001|Overall Study|Withdrawal by Subject|0|||
161026122|NCT01919554|581488601|FG002|Overall Study|Withdrawal by Subject|1|||
161026123|NCT01919554|581488602|FG003|Overall Study|Withdrawal by Subject|1|||
161026124|NCT01733316|581488603|FG000|RP103 Phase|Non-compliance|1|||
161026125|NCT01733316|581488603|FG000|Long Term Extension Phase|Adverse Event|1|||
161026126|NCT01733316|581488603|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
161026127|NCT01733316|581488603|FG000|Long Term Extension Phase|Sponsor Decision|2|||
161026128|NCT04914676|581488604|FG000|Overall Study|Study termination|3|||
161026129|NCT04914676|581488605|FG001|Overall Study|Study termination|0|||
161026130|NCT03024437|581488606|FG000|Overall Study|Adverse Event|0|||
161026131|NCT03024437|581488607|FG001|Overall Study|Adverse Event|1|||
161026132|NCT03024437|581488608|FG002|Overall Study|Adverse Event|3|||
161026133|NCT03024437|581488609|FG003|Overall Study|Adverse Event|5|||
161026134|NCT03024437|581488610|FG004|Overall Study|Adverse Event|0|||
161026135|NCT03024437|581488606|FG000|Overall Study|Physician Decision|1|||
161026136|NCT03024437|581488607|FG001|Overall Study|Physician Decision|0|||
161026137|NCT03024437|581488608|FG002|Overall Study|Physician Decision|0|||
161026138|NCT03024437|581488609|FG003|Overall Study|Physician Decision|1|||
161026139|NCT03024437|581488610|FG004|Overall Study|Physician Decision|0|||
161026140|NCT03024437|581488606|FG000|Overall Study|Disease progression, relapse|1|||
161026141|NCT03024437|581488607|FG001|Overall Study|Disease progression, relapse|0|||
161026142|NCT03024437|581488608|FG002|Overall Study|Disease progression, relapse|0|||
161026143|NCT03024437|581488609|FG003|Overall Study|Disease progression, relapse|3|||
161026144|NCT03024437|581488610|FG004|Overall Study|Disease progression, relapse|0|||
161026145|NCT03024437|581488606|FG000|Overall Study|Disease progression, refractory disease|4|||
161026146|NCT03024437|581488607|FG001|Overall Study|Disease progression, refractory disease|4|||
161026147|NCT03024437|581488608|FG002|Overall Study|Disease progression, refractory disease|2|||
161026148|NCT03024437|581488609|FG003|Overall Study|Disease progression, refractory disease|2|||
161026149|NCT03024437|581488610|FG004|Overall Study|Disease progression, refractory disease|1|||
161026150|NCT03024437|581488606|FG000|Overall Study|Newly diagnosed cancer|0|||
161026151|NCT03024437|581488607|FG001|Overall Study|Newly diagnosed cancer|0|||
161026152|NCT03024437|581488608|FG002|Overall Study|Newly diagnosed cancer|0|||
161026153|NCT03024437|581488609|FG003|Overall Study|Newly diagnosed cancer|1|||
161026154|NCT03024437|581488610|FG004|Overall Study|Newly diagnosed cancer|0|||
161026155|NCT03024437|581488606|FG000|Overall Study|Moved out of state|0|||
161026156|NCT03024437|581488607|FG001|Overall Study|Moved out of state|1|||
161026157|NCT03024437|581488608|FG002|Overall Study|Moved out of state|0|||
161026158|NCT03024437|581488609|FG003|Overall Study|Moved out of state|0|||
161026159|NCT03024437|581488610|FG004|Overall Study|Moved out of state|0|||
161026160|NCT03024437|581488606|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161026161|NCT03024437|581488607|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161343999|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161344000|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161344001|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
161344002|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
161344003|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161344004|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161344005|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161344006|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
161344007|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344008|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344009|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
161344010|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344011|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344012|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344013|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344014|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
161344015|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161344016|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161026162|NCT03024437|581488608|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
161026163|NCT03024437|581488609|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161026164|NCT03024437|581488610|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
161026165|NCT02606422|581488611|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
161026166|NCT02606422|581488612|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
161026167|NCT02606422|581488611|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
161026168|NCT02606422|581488612|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
161026169|NCT02606422|581488611|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
161026170|NCT02606422|581488612|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
161026171|NCT02606422|581488611|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
161026172|NCT02606422|581488612|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
161026173|NCT04625465|581488613|FG000|Overall Study|Lost to Follow-up|2|||
161026174|NCT04625465|581488614|FG001|Overall Study|Lost to Follow-up|2|||
161026175|NCT04625465|581488615|FG002|Overall Study|Lost to Follow-up|1|||
161026176|NCT04625465|581488616|FG003|Overall Study|Lost to Follow-up|0|||
161026177|NCT04625465|581488617|FG004|Overall Study|Lost to Follow-up|0|||
161026178|NCT04625465|581488618|FG005|Overall Study|Lost to Follow-up|2|||
161026179|NCT04625465|581488619|FG006|Overall Study|Lost to Follow-up|0|||
161026180|NCT04625465|581488620|FG007|Overall Study|Lost to Follow-up|0|||
161026181|NCT04625465|581488613|FG000|Overall Study|Death|1|||
161026182|NCT04625465|581488614|FG001|Overall Study|Death|0|||
161026183|NCT04625465|581488615|FG002|Overall Study|Death|0|||
161026184|NCT04625465|581488616|FG003|Overall Study|Death|0|||
161026185|NCT04625465|581488617|FG004|Overall Study|Death|0|||
161026186|NCT04625465|581488618|FG005|Overall Study|Death|0|||
161026187|NCT04625465|581488619|FG006|Overall Study|Death|0|||
161026188|NCT04625465|581488620|FG007|Overall Study|Death|0|||
160973996|NCT00235443|581295322|FG000|Overall Study|Lack of Efficacy|0|||
160973997|NCT00235443|581295323|FG001|Overall Study|Lack of Efficacy|1|||
160973998|NCT00235443|581295324|FG002|Overall Study|Lack of Efficacy|5|||
160973999|NCT00235443|581295325|FG003|Overall Study|Lack of Efficacy|12|||
160974000|NCT00235443|581295326|FG004|Overall Study|Lack of Efficacy|2|||
160974001|NCT00235443|581295327|FG005|Overall Study|Lack of Efficacy|9|||
160974002|NCT00235443|581295322|FG000|Overall Study|Withdrawal by Subject|3|||
160974003|NCT00235443|581295323|FG001|Overall Study|Withdrawal by Subject|9|||
160974004|NCT00235443|581295324|FG002|Overall Study|Withdrawal by Subject|25|||
160974005|NCT00235443|581295325|FG003|Overall Study|Withdrawal by Subject|24|||
160974006|NCT00235443|581295326|FG004|Overall Study|Withdrawal by Subject|10|||
160974007|NCT00235443|581295327|FG005|Overall Study|Withdrawal by Subject|12|||
160974008|NCT00235443|581295322|FG000|Overall Study|Lost to Follow-up|0|||
160974009|NCT00235443|581295323|FG001|Overall Study|Lost to Follow-up|8|||
160974010|NCT00235443|581295324|FG002|Overall Study|Lost to Follow-up|6|||
160974011|NCT00235443|581295325|FG003|Overall Study|Lost to Follow-up|6|||
160974012|NCT00235443|581295326|FG004|Overall Study|Lost to Follow-up|4|||
160974013|NCT00235443|581295327|FG005|Overall Study|Lost to Follow-up|3|||
161026189|NCT04625465|581488613|FG000|Overall Study|Withdrawal by Subject|1|||
161026190|NCT04625465|581488614|FG001|Overall Study|Withdrawal by Subject|0|||
161026191|NCT04625465|581488615|FG002|Overall Study|Withdrawal by Subject|4|||
161026192|NCT04625465|581488616|FG003|Overall Study|Withdrawal by Subject|4|||
161026193|NCT04625465|581488617|FG004|Overall Study|Withdrawal by Subject|4|||
161276014|NCT00000620|582391607|FG000|Overall Study|missed closeout visit|22|||
161276015|NCT00000620|582391608|FG001|Overall Study|missed closeout visit|28|||
161276016|NCT00000620|582391609|FG002|Overall Study|missed closeout visit|16|||
161276017|NCT00000620|582391610|FG003|Overall Study|missed closeout visit|11|||
161276018|NCT00000620|582391611|FG004|Overall Study|missed closeout visit|26|||
161276019|NCT00000620|582391612|FG005|Overall Study|missed closeout visit|28|||
161276020|NCT00000620|582391613|FG006|Overall Study|missed closeout visit|13|||
161276021|NCT00000620|582391614|FG007|Overall Study|missed closeout visit|16|||
161276022|NCT01590797|582391615|FG000|Overall Study|Adverse Event|4|||
161276023|NCT01590797|582391616|FG001|Overall Study|Adverse Event|3|||
161276024|NCT01590797|582391615|FG000|Overall Study|Lack of Efficacy|0|||
161276025|NCT01590797|582391616|FG001|Overall Study|Lack of Efficacy|2|||
161276026|NCT01590797|582391615|FG000|Overall Study|Lost to Follow-up|0|||
161276027|NCT01590797|582391616|FG001|Overall Study|Lost to Follow-up|1|||
161276028|NCT01590797|582391615|FG000|Overall Study|Protocol Violation|4|||
161276029|NCT01590797|582391616|FG001|Overall Study|Protocol Violation|1|||
161276030|NCT01590797|582391615|FG000|Overall Study|Withdrawal by Subject|7|||
161276031|NCT01590797|582391616|FG001|Overall Study|Withdrawal by Subject|5|||
161276032|NCT01590797|582391615|FG000|Overall Study|Other Protocol Specified Criteria|2|||
161276033|NCT01590797|582391616|FG001|Overall Study|Other Protocol Specified Criteria|4|||
161276034|NCT03106987|582391617|FG000|Overall Study|Death|37|||
161276035|NCT03106987|582391618|FG001|Overall Study|Death|22|||
160974014|NCT00235443|581295322|FG000|Overall Study|Unsatisfactory compliance|0|||
161276036|NCT03106987|582391619|FG002|Overall Study|Death|12|||
161276037|NCT03106987|582391620|FG003|Overall Study|Death|8|||
161276038|NCT03106987|582391617|FG000|Overall Study|Lost to Follow-up|2|||
161276039|NCT03106987|582391618|FG001|Overall Study|Lost to Follow-up|0|||
161276040|NCT03106987|582391619|FG002|Overall Study|Lost to Follow-up|2|||
161276041|NCT03106987|582391620|FG003|Overall Study|Lost to Follow-up|2|||
161276042|NCT03106987|582391617|FG000|Overall Study|Withdrawal by Subject|5|||
161276043|NCT03106987|582391618|FG001|Overall Study|Withdrawal by Subject|1|||
161276044|NCT03106987|582391619|FG002|Overall Study|Withdrawal by Subject|4|||
161276045|NCT03106987|582391620|FG003|Overall Study|Withdrawal by Subject|1|||
161276046|NCT01307111|582391621|FG000|IUD Insertion|Lost to Follow-up|2|||
161276047|NCT01307111|582391622|FG001|IUD Insertion|Lost to Follow-up|0|||
160974015|NCT00235443|581295323|FG001|Overall Study|Unsatisfactory compliance|2|||
160974016|NCT00235443|581295324|FG002|Overall Study|Unsatisfactory compliance|3|||
160974017|NCT00235443|581295325|FG003|Overall Study|Unsatisfactory compliance|4|||
160974018|NCT00235443|581295326|FG004|Overall Study|Unsatisfactory compliance|1|||
160974019|NCT00235443|581295327|FG005|Overall Study|Unsatisfactory compliance|0|||
160974020|NCT00235443|581295322|FG000|Overall Study|Other reasons for premature termination|1|||
160974021|NCT00235443|581295323|FG001|Overall Study|Other reasons for premature termination|6|||
160974022|NCT00235443|581295324|FG002|Overall Study|Other reasons for premature termination|6|||
160974023|NCT00235443|581295325|FG003|Overall Study|Other reasons for premature termination|7|||
160974024|NCT00235443|581295326|FG004|Overall Study|Other reasons for premature termination|3|||
160974025|NCT00235443|581295327|FG005|Overall Study|Other reasons for premature termination|6|||
160974026|NCT00474929|581295331|FG000|Overall Study|Withdrawal by Subject|0|||
160974027|NCT00474929|581295332|FG001|Overall Study|Withdrawal by Subject|1|||
160974028|NCT00474929|581295333|FG002|Overall Study|Withdrawal by Subject|0|||
160974029|NCT00474929|581295334|FG003|Overall Study|Withdrawal by Subject|0|||
160974030|NCT00474929|581295335|FG004|Overall Study|Withdrawal by Subject|0|||
160974031|NCT00474929|581295331|FG000|Overall Study|Unrelated medical condition|0|||
160974032|NCT00474929|581295332|FG001|Overall Study|Unrelated medical condition|0|||
160974033|NCT00474929|581295333|FG002|Overall Study|Unrelated medical condition|1|||
160974034|NCT00474929|581295334|FG003|Overall Study|Unrelated medical condition|0|||
160974035|NCT00474929|581295335|FG004|Overall Study|Unrelated medical condition|0|||
160974036|NCT00474929|581295331|FG000|Overall Study|Physician Decision|0|||
160974037|NCT00474929|581295332|FG001|Overall Study|Physician Decision|0|||
160974038|NCT00474929|581295333|FG002|Overall Study|Physician Decision|1|||
160974039|NCT00474929|581295334|FG003|Overall Study|Physician Decision|2|||
160974040|NCT00474929|581295335|FG004|Overall Study|Physician Decision|0|||
160974041|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
160974042|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
160974043|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
160974044|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
160974045|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
160974046|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
160974047|NCT03029247|581295338|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
160974048|NCT03029247|581295339|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
160974049|NCT02593305|581295340|FG000|Post 1|Comparison only group. No intervention.|0|||
160974050|NCT02593305|581295341|FG001|Post 1|Comparison only group. No intervention.|0|||
160974051|NCT02593305|581295342|FG002|Post 1|Comparison only group. No intervention.|10|||
160974052|NCT02757521|581295343|FG000|Overall Study|Adverse Event|1|||
161276048|NCT01307111|582391621|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
160974053|NCT02757521|581295344|FG001|Overall Study|Adverse Event|0|||
160974054|NCT00999661|581295349|FG000|Overall Study|Lost to Follow-up|59|||
160974055|NCT00999661|581295349|FG000|Overall Study|Adverse Event|1|||
160974056|NCT00999661|581295349|FG000|Overall Study|Withdrawal by Subject|1|||
160974057|NCT00999661|581295349|FG000|Overall Study|Not meeting eligibility criteria|9|||
160974058|NCT00312858|581295350|FG000|Overall Study|Adverse Event|0|||
160974059|NCT00312858|581295351|FG001|Overall Study|Adverse Event|1|||
160974060|NCT00312858|581295350|FG000|Overall Study|Lost to Follow-up|25|||
160974061|NCT00312858|581295351|FG001|Overall Study|Lost to Follow-up|42|||
160974062|NCT00312858|581295350|FG000|Overall Study|Protocol Violation|3|||
160974063|NCT00312858|581295351|FG001|Overall Study|Protocol Violation|8|||
160974064|NCT00312858|581295350|FG000|Overall Study|Withdraw by Participant|20|||
160974065|NCT00312858|581295351|FG001|Overall Study|Withdraw by Participant|20|||
160974066|NCT00312858|581295350|FG000|Overall Study|Participant Moved|11|||
160974067|NCT00312858|581295351|FG001|Overall Study|Participant Moved|10|||
160974068|NCT00312858|581295350|FG000|Overall Study|Other|9|||
160974069|NCT00312858|581295351|FG001|Overall Study|Other|12|||
160974070|NCT01622348|581295356|FG000|Overall Study|Withdrawal by Subject|1|||
160974071|NCT01622348|581295357|FG001|Overall Study|Withdrawal by Subject|0|||
160974072|NCT01622348|581295358|FG002|Overall Study|Withdrawal by Subject|1|||
160974073|NCT00422799|581295359|FG000|Overall Study|Withdrawal by Subject|6|||
160974074|NCT00422799|581295359|FG000|Overall Study|Adverse Event|7|||
160974075|NCT01965158|581295360|FG000|Overall Study|Adverse Event|14|||
160974076|NCT01965158|581295361|FG001|Overall Study|Adverse Event|5|||
160974077|NCT01965158|581295360|FG000|Overall Study|Withdrawal by Subject|16|||
160974078|NCT01965158|581295361|FG001|Overall Study|Withdrawal by Subject|24|||
160974079|NCT01965158|581295360|FG000|Overall Study|Lost to Follow-up|7|||
160974080|NCT01965158|581295361|FG001|Overall Study|Lost to Follow-up|5|||
160974081|NCT01965158|581295360|FG000|Overall Study|Protocol Violation|1|||
160974082|NCT01965158|581295361|FG001|Overall Study|Protocol Violation|1|||
160974083|NCT01965158|581295360|FG000|Overall Study|Other - Miscellaneous|3|||
160974084|NCT01965158|581295361|FG001|Overall Study|Other - Miscellaneous|0|||
160974085|NCT04537897|581295362|FG000|Overall Study|Other than listed|0|||
160974086|NCT04537897|581295363|FG001|Overall Study|Other than listed|0|||
160974087|NCT04537897|581295364|FG002|Overall Study|Other than listed|0|||
160974088|NCT04537897|581295365|FG003|Overall Study|Other than listed|0|||
160974089|NCT04537897|581295366|FG004|Overall Study|Other than listed|0|||
160974090|NCT04537897|581295367|FG005|Overall Study|Other than listed|0|||
160974091|NCT04537897|581295368|FG006|Overall Study|Other than listed|1|||
160974092|NCT04537897|581295369|FG007|Overall Study|Other than listed|0|||
161026194|NCT04625465|581488618|FG005|Overall Study|Withdrawal by Subject|0|||
161026195|NCT04625465|581488619|FG006|Overall Study|Withdrawal by Subject|0|||
161026196|NCT04625465|581488620|FG007|Overall Study|Withdrawal by Subject|0|||
161026197|NCT05566639|581488624|FG000|Overall Study|Adverse Event|1|||
161026198|NCT05566639|581488625|FG001|Overall Study|Adverse Event|1|||
161026199|NCT05566639|581488624|FG000|Overall Study|Serious Adverse Event|1|||
161026200|NCT05566639|581488625|FG001|Overall Study|Serious Adverse Event|3|||
161026201|NCT05566639|581488624|FG000|Overall Study|Death|44|||
161026202|NCT05566639|581488625|FG001|Overall Study|Death|45|||
161026203|NCT05566639|581488624|FG000|Overall Study|Lost to Follow-up|467|||
161026204|NCT05566639|581488625|FG001|Overall Study|Lost to Follow-up|461|||
161026205|NCT05566639|581488624|FG000|Overall Study|Physician Decision|45|||
161026206|NCT05566639|581488625|FG001|Overall Study|Physician Decision|44|||
161026207|NCT05566639|581488624|FG000|Overall Study|Protocol Deviation|4|||
161026208|NCT05566639|581488625|FG001|Overall Study|Protocol Deviation|4|||
161026209|NCT05566639|581488624|FG000|Overall Study|Withdrawal by Subject|277|||
160974093|NCT04537897|581295370|FG008|Overall Study|Other than listed|0|||
160974094|NCT04537897|581295362|FG000|Overall Study|Adverse Event|0|||
161026210|NCT05566639|581488625|FG001|Overall Study|Withdrawal by Subject|271|||
161026211|NCT05566639|581488624|FG000|Overall Study|Other Than Specified|52|||
160974095|NCT04537897|581295363|FG001|Overall Study|Adverse Event|0|||
160974096|NCT04537897|581295364|FG002|Overall Study|Adverse Event|0|||
160974097|NCT04537897|581295365|FG003|Overall Study|Adverse Event|1|||
160974098|NCT04537897|581295366|FG004|Overall Study|Adverse Event|0|||
160974099|NCT04537897|581295367|FG005|Overall Study|Adverse Event|0|||
160974100|NCT04537897|581295368|FG006|Overall Study|Adverse Event|0|||
160974101|NCT04537897|581295369|FG007|Overall Study|Adverse Event|0|||
161026212|NCT05566639|581488625|FG001|Overall Study|Other Than Specified|64|||
161026213|NCT04054193|581488633|FG000|Cycle 1|Physician Decision|1|||
161026214|NCT04054193|581488633|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
161026215|NCT04054193|581488633|FG000|Cycle 1|Allocated but not treated|3|||
161026216|NCT04054193|581488633|FG000|Cycles 2-3|Physician Decision|2|||
161026217|NCT04054193|581488633|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
161026218|NCT04054193|581488633|FG000|Cycles 2-3|Various reasons|17|||
160974102|NCT04537897|581295370|FG008|Overall Study|Adverse Event|0|||
160974103|NCT04537897|581295362|FG000|Overall Study|Withdrawal by Subject|0|||
161276049|NCT01307111|582391622|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
160974104|NCT04537897|581295363|FG001|Overall Study|Withdrawal by Subject|1|||
160974105|NCT04537897|581295364|FG002|Overall Study|Withdrawal by Subject|0|||
161026219|NCT02966873|581488634|FG000|Overall Study|Lost to Follow-up|16|||
161026220|NCT02966873|581488635|FG001|Overall Study|Lost to Follow-up|15|||
161026221|NCT03235544|581488637|FG000|Overall Study|Death|11|||
161026222|NCT03235544|581488638|FG001|Overall Study|Death|31|||
161026223|NCT03235544|581488639|FG002|Overall Study|Death|19|||
161026224|NCT03235544|581488640|FG003|Overall Study|Death|34|||
161026225|NCT03235544|581488637|FG000|Overall Study|Lost to Follow-up|0|||
161026226|NCT03235544|581488638|FG001|Overall Study|Lost to Follow-up|1|||
161026227|NCT03235544|581488639|FG002|Overall Study|Lost to Follow-up|1|||
161026228|NCT03235544|581488640|FG003|Overall Study|Lost to Follow-up|1|||
161026229|NCT03235544|581488637|FG000|Overall Study|Withdrawal by Subject|0|||
161026230|NCT03235544|581488638|FG001|Overall Study|Withdrawal by Subject|3|||
161026231|NCT03235544|581488639|FG002|Overall Study|Withdrawal by Subject|1|||
161026232|NCT03235544|581488640|FG003|Overall Study|Withdrawal by Subject|5|||
161026233|NCT03235544|581488637|FG000|Overall Study|Disease Progression|0|||
161026234|NCT03235544|581488638|FG001|Overall Study|Disease Progression|1|||
161026235|NCT03235544|581488639|FG002|Overall Study|Disease Progression|0|||
161026236|NCT03235544|581488640|FG003|Overall Study|Disease Progression|2|||
161026237|NCT03235544|581488637|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
161026238|NCT03235544|581488638|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
161026239|NCT03235544|581488639|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
161026240|NCT03235544|581488640|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
161026241|NCT03235544|581488637|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
161026242|NCT03235544|581488638|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
161026243|NCT03235544|581488639|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
161026244|NCT03235544|581488640|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
161026245|NCT00950742|581488641|FG000|Overall Study|Other Adverse Event|1|||
161026246|NCT00950742|581488642|FG001|Overall Study|Other Adverse Event|0|||
161026247|NCT00950742|581488641|FG000|Overall Study|Withdrawal by Subject|3|||
161026248|NCT00950742|581488642|FG001|Overall Study|Withdrawal by Subject|0|||
161026249|NCT00950742|581488641|FG000|Overall Study|Progressive Disease|6|||
161026250|NCT00950742|581488642|FG001|Overall Study|Progressive Disease|2|||
161026251|NCT00950742|581488641|FG000|Overall Study|Dose limiting toxicity|6|||
161026252|NCT00950742|581488642|FG001|Overall Study|Dose limiting toxicity|0|||
161026253|NCT05436262|581488644|FG000|Pre-Randomization|Withdrawal by Subject|1|||
161026254|NCT05436262|581488645|FG001|Pre-Randomization|Withdrawal by Subject|0|||
161026255|NCT05436262|581488646|FG002|Pre-Randomization|Withdrawal by Subject|0|||
161026256|NCT05436262|581488644|FG000|Randomization|Withdrawal by Subject|0|||
161026257|NCT05436262|581488645|FG001|Randomization|Withdrawal by Subject|1|||
161026258|NCT05436262|581488646|FG002|Randomization|Withdrawal by Subject|0|||
161026259|NCT01456949|581488647|FG000|Enrollment|PI death- incomplete data|6|||
161026260|NCT01456949|581488647|FG000|Enrollment|Death|1|||
161026261|NCT01456949|581488647|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
161026262|NCT01456949|581488647|FG000|Enrollment|Physician Decision|10|||
161026263|NCT01456949|581488647|FG000|Enrollment|Withdrawal by Subject|7|||
161026264|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
161026265|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
161026266|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
161026267|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
161026268|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
161026269|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
161026270|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
161026271|NCT01456949|581488647|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
161026272|NCT04753697|581488648|FG000|Induction Phase|Withdrawal by Subject|12|||
161026273|NCT04753697|581488649|FG001|Induction Phase|Withdrawal by Subject|5|||
161026274|NCT04753697|581488650|FG002|Induction Phase|Withdrawal by Subject|6|||
161026275|NCT04753697|581488648|FG000|Induction Phase|Physician Decision|1|||
161026276|NCT04753697|581488649|FG001|Induction Phase|Physician Decision|0|||
161026277|NCT04753697|581488650|FG002|Induction Phase|Physician Decision|0|||
161026278|NCT04753697|581488648|FG000|Induction Phase|Lost to Follow-up|2|||
161026279|NCT04753697|581488649|FG001|Induction Phase|Lost to Follow-up|2|||
161344017|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
161026280|NCT04753697|581488650|FG002|Induction Phase|Lost to Follow-up|1|||
161026281|NCT04753697|581488648|FG000|Induction Phase|Lack of Efficacy|1|||
161026282|NCT04753697|581488649|FG001|Induction Phase|Lack of Efficacy|0|||
161026283|NCT04753697|581488650|FG002|Induction Phase|Lack of Efficacy|0|||
161026284|NCT04753697|581488648|FG000|Maintenance Phase|Physician Decision|0|||
161026285|NCT04753697|581488649|FG001|Maintenance Phase|Physician Decision|0|||
161026286|NCT04753697|581488650|FG002|Maintenance Phase|Physician Decision|1|||
161026287|NCT04753697|581488648|FG000|Maintenance Phase|Withdrawal by Subject|3|||
161026288|NCT04753697|581488649|FG001|Maintenance Phase|Withdrawal by Subject|4|||
161026289|NCT04753697|581488650|FG002|Maintenance Phase|Withdrawal by Subject|6|||
161026290|NCT04753697|581488648|FG000|Maintenance Phase|Lost to Follow-up|2|||
161026291|NCT04753697|581488649|FG001|Maintenance Phase|Lost to Follow-up|2|||
161026292|NCT04753697|581488650|FG002|Maintenance Phase|Lost to Follow-up|0|||
161026293|NCT04753697|581488648|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
161026294|NCT04753697|581488649|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
161026295|NCT04753697|581488650|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
161026296|NCT04753697|581488648|FG000|Maintenance Phase|Adverse Event|0|||
161026297|NCT04753697|581488649|FG001|Maintenance Phase|Adverse Event|1|||
161026298|NCT04753697|581488650|FG002|Maintenance Phase|Adverse Event|1|||
161026299|NCT04753697|581488648|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
161026300|NCT04753697|581488649|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
161026301|NCT04753697|581488650|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
161026302|NCT04200456|581488653|FG000|Overall Study|Physician Decision|0|||
161026303|NCT04200456|581488654|FG001|Overall Study|Physician Decision|1|||
161026304|NCT04200456|581488653|FG000|Overall Study|Withdrawal by Subject|2|||
161026305|NCT04200456|581488654|FG001|Overall Study|Withdrawal by Subject|2|||
161026306|NCT04200456|581488653|FG000|Overall Study|Lack of Efficacy|1|||
161026307|NCT04200456|581488654|FG001|Overall Study|Lack of Efficacy|1|||
161026308|NCT04200456|581488653|FG000|Overall Study|Adverse event, non-fatal|0|||
161026309|NCT04200456|581488654|FG001|Overall Study|Adverse event, non-fatal|1|||
161026310|NCT04200456|581488653|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
161026311|NCT04200456|581488654|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
161026312|NCT05002088|581488656|FG000|Overall Study|Withdrawal by Subject|9|||
161026313|NCT05002088|581488657|FG001|Overall Study|Withdrawal by Subject|0|||
161026314|NCT05002088|581488656|FG000|Overall Study|Lost to Follow-up|0|||
161026315|NCT05002088|581488657|FG001|Overall Study|Lost to Follow-up|1|||
161026316|NCT05002088|581488656|FG000|Overall Study|Death|16|||
161026317|NCT05002088|581488657|FG001|Overall Study|Death|2|||
161026318|NCT05002088|581488656|FG000|Overall Study|Protocol Violation|25|||
161026319|NCT05002088|581488657|FG001|Overall Study|Protocol Violation|7|||
161026320|NCT04770402|581488658|FG000|Overall Study|Lost to Follow-up|1|||
161026321|NCT04770402|581488659|FG001|Overall Study|Lost to Follow-up|2|||
161026322|NCT04770402|581488658|FG000|Overall Study|Non-compliance|1|||
161026323|NCT04770402|581488659|FG001|Overall Study|Non-compliance|0|||
161026324|NCT04770402|581488658|FG000|Overall Study|Withdrawal by Subject|0|||
161026325|NCT04770402|581488659|FG001|Overall Study|Withdrawal by Subject|1|||
161026326|NCT03599661|581488660|FG000|Overall Study|Lost to Follow-up|9|||
161026327|NCT05446168|581488661|FG000|Overall Study|Physician Decision|0|||
161026328|NCT05446168|581488662|FG001|Overall Study|Physician Decision|1|||
161026329|NCT01828099|581488663|FG000|Treatment Period|Adverse Event|24|||
161026330|NCT01828099|581488664|FG001|Treatment Period|Adverse Event|23|||
161026331|NCT01828099|581488663|FG000|Treatment Period|Death|10|||
161026332|NCT01828099|581488664|FG001|Treatment Period|Death|12|||
161026333|NCT01828099|581488663|FG000|Treatment Period|Lost to Follow-up|2|||
161026334|NCT01828099|581488664|FG001|Treatment Period|Lost to Follow-up|1|||
161026335|NCT01828099|581488663|FG000|Treatment Period|Non-compliance with study treatment|1|||
161026336|NCT01828099|581488664|FG001|Treatment Period|Non-compliance with study treatment|0|||
161026337|NCT01828099|581488663|FG000|Treatment Period|Physician Decision|17|||
161026338|NCT01828099|581488664|FG001|Treatment Period|Physician Decision|16|||
161026339|NCT01828099|581488663|FG000|Treatment Period|Progressive disease|99|||
161026340|NCT01828099|581488664|FG001|Treatment Period|Progressive disease|107|||
161026341|NCT01828099|581488663|FG000|Treatment Period|Subject/guardian decision|22|||
161026342|NCT01828099|581488664|FG001|Treatment Period|Subject/guardian decision|26|||
161026343|NCT01828099|581488663|FG000|Treatment Period|Study terminated by Sponsor|13|||
161026344|NCT01828099|581488664|FG001|Treatment Period|Study terminated by Sponsor|1|||
161026345|NCT01828099|581488663|FG000|Treatment Period|Protocol deviation|1|||
161026346|NCT01828099|581488664|FG001|Treatment Period|Protocol deviation|0|||
161026347|NCT01828099|581488663|FG000|Treatment Period|No longer requires treatment|0|||
161026348|NCT01828099|581488664|FG001|Treatment Period|No longer requires treatment|1|||
161026349|NCT01828099|581488663|FG000|Extension-treatment Phase|Adverse Event|0|||
161026350|NCT01828099|581488664|FG001|Extension-treatment Phase|Adverse Event|17|||
161026351|NCT01828099|581488663|FG000|Extension-treatment Phase|Death|0|||
161026352|NCT01828099|581488664|FG001|Extension-treatment Phase|Death|11|||
161026353|NCT01828099|581488663|FG000|Extension-treatment Phase|Physician Decision|0|||
161026354|NCT01828099|581488664|FG001|Extension-treatment Phase|Physician Decision|5|||
161026355|NCT01828099|581488663|FG000|Extension-treatment Phase|Progressive disease|0|||
161276050|NCT02114385|582391628|FG000|Overall Study|Withdrawal by Subject|3|||
161026356|NCT01828099|581488664|FG001|Extension-treatment Phase|Progressive disease|54|||
161026357|NCT01828099|581488663|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
161026358|NCT01828099|581488664|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
161026359|NCT01828099|581488663|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
161026360|NCT01828099|581488664|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
161026361|NCT03924635|581488667|FG000|Overall Study|Withdrawal by Subject|2|||
161026362|NCT03924635|581488668|FG001|Overall Study|Withdrawal by Subject|4|||
161026363|NCT04471246|581488669|FG000|Overall Study|Lost to Follow-up|2|||
161026364|NCT04471246|581488670|FG001|Overall Study|Lost to Follow-up|2|||
161026365|NCT04826471|581488671|FG000|Overall Study|Lost to Follow-up|2|||
161026366|NCT04826471|581488671|FG000|Overall Study|Protocol Violation|3|||
161026367|NCT04826471|581488671|FG000|Overall Study|Withdrawal by Subject|1|||
161026368|NCT05764525|581488672|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
161026369|NCT05764525|581488673|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
161026370|NCT05764525|581488672|FG000|Overall Study|Withdrawal by Subject|4|||
161026371|NCT05764525|581488673|FG001|Overall Study|Withdrawal by Subject|8|||
161026372|NCT05764525|581488672|FG000|Overall Study|Physician Decision|1|||
161026373|NCT05764525|581488673|FG001|Overall Study|Physician Decision|0|||
161026374|NCT04079218|581488674|FG000|Overall Study|Death|1|||
161026375|NCT04079218|581488675|FG001|Overall Study|Death|0|||
161026376|NCT04079218|581488674|FG000|Overall Study|Withdrawal by Subject|3|||
161026377|NCT04079218|581488675|FG001|Overall Study|Withdrawal by Subject|0|||
161026378|NCT04079218|581488674|FG000|Overall Study|Physician Decision|4|||
161026379|NCT04079218|581488675|FG001|Overall Study|Physician Decision|0|||
161026380|NCT04079218|581488674|FG000|Overall Study|Lost to Follow-up|0|||
161026381|NCT04079218|581488675|FG001|Overall Study|Lost to Follow-up|1|||
161026382|NCT05907174|581488681|FG000|3-Month Assessment|Withdrawal by Subject|0|||
161026383|NCT05907174|581488682|FG001|3-Month Assessment|Withdrawal by Subject|0|||
161026384|NCT05907174|581488683|FG002|3-Month Assessment|Withdrawal by Subject|0|||
161026385|NCT05907174|581488684|FG003|3-Month Assessment|Withdrawal by Subject|1|||
161026386|NCT05907174|581488681|FG000|3-Month Assessment|Lost to Follow-up|1|||
161026387|NCT05907174|581488682|FG001|3-Month Assessment|Lost to Follow-up|1|||
161026388|NCT05907174|581488683|FG002|3-Month Assessment|Lost to Follow-up|1|||
161026389|NCT05907174|581488684|FG003|3-Month Assessment|Lost to Follow-up|1|||
161026390|NCT05907174|581488681|FG000|6-Month Assessment|Death|0|||
161026391|NCT05907174|581488682|FG001|6-Month Assessment|Death|0|||
161026392|NCT05907174|581488683|FG002|6-Month Assessment|Death|3|||
161026393|NCT05907174|581488684|FG003|6-Month Assessment|Death|0|||
161026394|NCT05907174|581488681|FG000|6-Month Assessment|Withdrawal by Subject|0|||
161026395|NCT05907174|581488682|FG001|6-Month Assessment|Withdrawal by Subject|0|||
161026396|NCT05907174|581488683|FG002|6-Month Assessment|Withdrawal by Subject|1|||
161026397|NCT05907174|581488684|FG003|6-Month Assessment|Withdrawal by Subject|1|||
161026398|NCT05907174|581488681|FG000|6-Month Assessment|Lost to Follow-up|0|||
161026399|NCT05907174|581488682|FG001|6-Month Assessment|Lost to Follow-up|1|||
161026400|NCT05907174|581488683|FG002|6-Month Assessment|Lost to Follow-up|1|||
161026401|NCT05907174|581488684|FG003|6-Month Assessment|Lost to Follow-up|1|||
161026402|NCT04498390|581488685|FG000|Overall Study|Adverse Event|0|||
161026403|NCT04498390|581488686|FG001|Overall Study|Adverse Event|0|||
161026404|NCT04498390|581488687|FG002|Overall Study|Adverse Event|1|||
161026405|NCT04498390|581488688|FG003|Overall Study|Adverse Event|0|||
161026406|NCT04498390|581488689|FG004|Overall Study|Adverse Event|0|||
161026407|NCT04498390|581488685|FG000|Overall Study|Withdrawal by Subject|0|||
161026408|NCT04498390|581488686|FG001|Overall Study|Withdrawal by Subject|0|||
161026409|NCT04498390|581488687|FG002|Overall Study|Withdrawal by Subject|0|||
161026410|NCT04498390|581488688|FG003|Overall Study|Withdrawal by Subject|1|||
161026411|NCT04498390|581488689|FG004|Overall Study|Withdrawal by Subject|0|||
161026412|NCT05093842|581488692|FG000|Overall Study|Pregnancy loss|1|||
161026413|NCT05093842|581488693|FG001|Overall Study|Pregnancy loss|1|||
161026414|NCT05093842|581488692|FG000|Overall Study|Lost to Follow-up|6|||
161026415|NCT05093842|581488693|FG001|Overall Study|Lost to Follow-up|0|||
161026416|NCT05093842|581488692|FG000|Overall Study|Physician Decision|0|||
161026417|NCT05093842|581488693|FG001|Overall Study|Physician Decision|1|||
161026418|NCT03910478|581488699|FG000|Overall Study|Death|13|||
161026419|NCT03910478|581488700|FG001|Overall Study|Death|6|||
161026420|NCT03910478|581488699|FG000|Overall Study|Withdrawal by Subject|23|||
161026421|NCT03910478|581488700|FG001|Overall Study|Withdrawal by Subject|2|||
161026422|NCT03910478|581488699|FG000|Overall Study|Physician Decision|5|||
161026423|NCT03910478|581488700|FG001|Overall Study|Physician Decision|0|||
161026424|NCT03910478|581488699|FG000|Overall Study|Protocol Violation|1|||
161026425|NCT03910478|581488700|FG001|Overall Study|Protocol Violation|0|||
161026426|NCT03910478|581488699|FG000|Overall Study|Failure to meet continuation criteria|2|||
161026427|NCT03910478|581488700|FG001|Overall Study|Failure to meet continuation criteria|0|||
161026428|NCT03910478|581488699|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
161026429|NCT03910478|581488700|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
161026430|NCT01275677|581488704|FG000|Overall Study|Not at risk for recurrence.|1|||
161026431|NCT01275677|581488705|FG001|Overall Study|Not at risk for recurrence.|1|||
161026432|NCT01275677|581488704|FG000|Overall Study|No follow-up|26|||
161026433|NCT01275677|581488705|FG001|Overall Study|No follow-up|37|||
161026434|NCT01275677|581488704|FG000|Overall Study|No clinical follow up.|1|||
161026435|NCT01275677|581488705|FG001|Overall Study|No clinical follow up.|4|||
161026436|NCT03478956|581488706|FG000|Randomized Treatment Period|Adverse Event|1|||
161026437|NCT03478956|581488707|FG001|Randomized Treatment Period|Adverse Event|0|||
161026438|NCT03478956|581488708|FG002|Randomized Treatment Period|Adverse Event|0|||
161026439|NCT03478956|581488709|FG003|Randomized Treatment Period|Adverse Event|0|||
161026440|NCT03478956|581488706|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
161026441|NCT03478956|581488707|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
161026442|NCT03478956|581488708|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
161026443|NCT03478956|581488709|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
161026444|NCT03478956|581488706|FG000|Open Label Extension Period|Adverse Event|0|||
161026445|NCT03478956|581488707|FG001|Open Label Extension Period|Adverse Event|0|||
161026446|NCT03478956|581488708|FG002|Open Label Extension Period|Adverse Event|4|||
161026447|NCT03478956|581488709|FG003|Open Label Extension Period|Adverse Event|0|||
161026448|NCT03478956|581488706|FG000|Open Label Extension Period|Lack of Efficacy|0|||
161026449|NCT03478956|581488707|FG001|Open Label Extension Period|Lack of Efficacy|0|||
161026450|NCT03478956|581488708|FG002|Open Label Extension Period|Lack of Efficacy|8|||
161026451|NCT03478956|581488709|FG003|Open Label Extension Period|Lack of Efficacy|0|||
161026452|NCT03478956|581488706|FG000|Open Label Extension Period|Reason Not Provided|0|||
161026453|NCT03478956|581488707|FG001|Open Label Extension Period|Reason Not Provided|0|||
161026454|NCT03478956|581488708|FG002|Open Label Extension Period|Reason Not Provided|1|||
161026455|NCT03478956|581488709|FG003|Open Label Extension Period|Reason Not Provided|0|||
161026456|NCT03478956|581488706|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
161026457|NCT03478956|581488707|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
161026458|NCT03478956|581488708|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
161026459|NCT03478956|581488709|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
161026460|NCT03478956|581488706|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
161026461|NCT03478956|581488707|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
161026462|NCT03478956|581488708|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
161026463|NCT03478956|581488709|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
161026464|NCT03478956|581488706|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161026465|NCT03478956|581488707|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161026466|NCT03478956|581488708|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
161026467|NCT03478956|581488709|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
161026468|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
161026469|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
161026470|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
161026471|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
161026472|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
161026473|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
161026474|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
161026475|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
161026476|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
161026477|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
161026478|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
161026479|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
161026480|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
161026481|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
161026482|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
161026483|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
161026484|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
161026485|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
161026486|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
161026487|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
161026488|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
161026489|NCT04800211|581488710|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
161026490|NCT04800211|581488711|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
161026491|NCT04800211|581488712|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
161026492|NCT04800211|581488710|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
161026493|NCT04800211|581488711|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
161026494|NCT04800211|581488712|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
161026495|NCT04800211|581488710|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
161026496|NCT04800211|581488711|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
161276051|NCT02114385|582391629|FG001|Overall Study|Withdrawal by Subject|2|||
161276052|NCT02114385|582391628|FG000|Overall Study|Lost to Follow-up|0|||
161276053|NCT02114385|582391629|FG001|Overall Study|Lost to Follow-up|6|||
161276054|NCT02460679|582391630|FG000|Overall Study|Investigator Decision|1|||
161276055|NCT02460679|582391630|FG000|Overall Study|Withdrawal by Subject|4|||
161276056|NCT00339144|582391639|FG000|Overall Study|Disease progression|5|||
161276057|NCT00339144|582391640|FG001|Overall Study|Disease progression|2|||
161276058|NCT00339144|582391641|FG002|Overall Study|Disease progression|2|||
161026497|NCT04800211|581488712|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
161026498|NCT04800211|581488710|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
161026499|NCT04800211|581488711|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
161026500|NCT04800211|581488712|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
161026501|NCT05170841|581488713|FG000|Single Dose Phase|Adverse Event|1|||
161026502|NCT05170841|581488714|FG001|Single Dose Phase|Adverse Event|2|||
160974106|NCT04537897|581295365|FG003|Overall Study|Withdrawal by Subject|0|||
160974107|NCT04537897|581295366|FG004|Overall Study|Withdrawal by Subject|0|||
160974108|NCT04537897|581295367|FG005|Overall Study|Withdrawal by Subject|0|||
160974109|NCT04537897|581295368|FG006|Overall Study|Withdrawal by Subject|0|||
160974110|NCT04537897|581295369|FG007|Overall Study|Withdrawal by Subject|0|||
160974111|NCT04537897|581295370|FG008|Overall Study|Withdrawal by Subject|0|||
160974112|NCT00197028|581295374|FG000|Overall Study|Adverse Event|2|||
160974113|NCT00197028|581295375|FG001|Overall Study|Adverse Event|2|||
160974114|NCT00197028|581295374|FG000|Overall Study|Protocol Violation|2|||
160974115|NCT00197028|581295375|FG001|Overall Study|Protocol Violation|1|||
160974116|NCT00197028|581295374|FG000|Overall Study|Withdrawal by Subject|8|||
160974117|NCT00197028|581295375|FG001|Overall Study|Withdrawal by Subject|12|||
160974118|NCT00197028|581295374|FG000|Overall Study|Lost to Follow-up|1|||
160974119|NCT00197028|581295375|FG001|Overall Study|Lost to Follow-up|0|||
160974120|NCT00197028|581295374|FG000|Overall Study|Other|3|||
160974121|NCT00197028|581295375|FG001|Overall Study|Other|6|||
160974122|NCT03893825|581295376|FG000|Overall Study|Death|2|||
160974123|NCT03893825|581295377|FG001|Overall Study|Death|1|||
160974124|NCT03893825|581295376|FG000|Overall Study|Adverse Event|0|||
160974125|NCT03893825|581295377|FG001|Overall Study|Adverse Event|2|||
160974126|NCT03893825|581295376|FG000|Overall Study|Withdrawal by Subject|19|||
160974127|NCT03893825|581295377|FG001|Overall Study|Withdrawal by Subject|21|||
160974128|NCT03893825|581295376|FG000|Overall Study|Protocol deviation|1|||
160974129|NCT03893825|581295377|FG001|Overall Study|Protocol deviation|0|||
160974130|NCT03893825|581295376|FG000|Overall Study|Lost to Follow-up|10|||
160974131|NCT03893825|581295377|FG001|Overall Study|Lost to Follow-up|10|||
160974132|NCT03893825|581295376|FG000|Overall Study|Other than specified|7|||
160974133|NCT03893825|581295377|FG001|Overall Study|Other than specified|6|||
160974134|NCT00692406|581295378|FG000|Overall Study|PI dropped, bad data|57|||
160974135|NCT01617005|581295379|FG000|Overall Study|Pregnancy|1|||
160974136|NCT01617005|581295379|FG000|Overall Study|Lack of motivation for treatment|1|||
160974137|NCT01515189|581295380|FG000|Induction|Disease Progression|109|||
160974138|NCT01515189|581295381|FG001|Induction|Disease Progression|155|||
160974139|NCT01515189|581295380|FG000|Induction|Study drug toxicity|86|||
160974140|NCT01515189|581295381|FG001|Induction|Study drug toxicity|36|||
160974141|NCT01515189|581295380|FG000|Induction|Death|24|||
160974142|NCT01515189|581295381|FG001|Induction|Death|17|||
160974143|NCT01515189|581295380|FG000|Induction|Adverse Event|14|||
160974144|NCT01515189|581295381|FG001|Induction|Adverse Event|9|||
160974145|NCT01515189|581295380|FG000|Induction|Withdrawal by Subject|3|||
160974146|NCT01515189|581295381|FG001|Induction|Withdrawal by Subject|9|||
160974147|NCT01515189|581295380|FG000|Induction|No longer meets study criteria|0|||
160974148|NCT01515189|581295381|FG001|Induction|No longer meets study criteria|2|||
160974149|NCT01515189|581295380|FG000|Induction|Lost to Follow-up|1|||
160974150|NCT01515189|581295381|FG001|Induction|Lost to Follow-up|0|||
160974151|NCT01515189|581295380|FG000|Induction|Other|0|||
160974152|NCT01515189|581295381|FG001|Induction|Other|4|||
160974153|NCT01515189|581295380|FG000|First Re-Induction Phase|Disease progression|6|||
160974154|NCT01515189|581295381|FG001|First Re-Induction Phase|Disease progression|14|||
160974155|NCT01515189|581295380|FG000|First Re-Induction Phase|Study drug toxicity|5|||
160974156|NCT01515189|581295381|FG001|First Re-Induction Phase|Study drug toxicity|0|||
160974157|NCT01515189|581295380|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
160974158|NCT01515189|581295381|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
160974159|NCT01515189|581295380|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
160974160|NCT01515189|581295381|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
160974161|NCT01515189|581295380|FG000|First Re-Induction Phase|Other|1|||
160974162|NCT01515189|581295381|FG001|First Re-Induction Phase|Other|0|||
160974163|NCT00284089|581295384|FG000|Multiple Dose Phase|Adverse Event|1|||
160974164|NCT00284089|581295385|FG001|Multiple Dose Phase|Adverse Event|0|||
160974165|NCT00284089|581295386|FG002|Multiple Dose Phase|Adverse Event|1|||
160974166|NCT00284089|581295387|FG003|Multiple Dose Phase|Adverse Event|1|||
160974167|NCT00284089|581295384|FG000|Multiple Dose Phase|Protocol Violation|0|||
160974168|NCT00284089|581295385|FG001|Multiple Dose Phase|Protocol Violation|0|||
160974169|NCT00284089|581295386|FG002|Multiple Dose Phase|Protocol Violation|1|||
160974170|NCT00284089|581295387|FG003|Multiple Dose Phase|Protocol Violation|0|||
160974171|NCT00284089|581295384|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
160974172|NCT00284089|581295385|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
160974173|NCT00284089|581295386|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
160974174|NCT00284089|581295387|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
160974175|NCT00284089|581295384|FG000|Multiple Dose Phase|Death|0|||
160974176|NCT00284089|581295385|FG001|Multiple Dose Phase|Death|0|||
160974177|NCT00284089|581295386|FG002|Multiple Dose Phase|Death|1|||
160974178|NCT00284089|581295387|FG003|Multiple Dose Phase|Death|1|||
160974179|NCT00284089|581295384|FG000|Extension Phase|Adverse Event|0|||
160974180|NCT00284089|581295385|FG001|Extension Phase|Adverse Event|0|||
160974181|NCT00284089|581295386|FG002|Extension Phase|Adverse Event|2|||
160974182|NCT00284089|581295387|FG003|Extension Phase|Adverse Event|2|||
160974183|NCT00284089|581295384|FG000|Extension Phase|condition no longer requires study drug|2|||
161344018|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
161344019|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161344020|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161344021|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161344022|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
161344023|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161344024|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161344025|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
161344026|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
161344027|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161344028|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161344029|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161344030|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
161344031|NCT03329001|582646013|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161344032|NCT03329001|582646014|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161344033|NCT03329001|582646015|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
161344034|NCT03329001|582646016|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
161344035|NCT03329001|582646017|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161344036|NCT03329001|582646018|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161344037|NCT03329001|582646019|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161344038|NCT03329001|582646020|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
161344039|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344040|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344041|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344042|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
161344043|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344044|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344045|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344046|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
161344047|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344048|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344049|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344050|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
161344051|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344052|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344053|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344054|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
161344055|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344056|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344057|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
161344058|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344059|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344060|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344061|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344062|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
161344063|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161344064|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161344065|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
161344066|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
161344067|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161344068|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161344069|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161344070|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
161344071|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344072|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344073|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
161026503|NCT05170841|581488715|FG002|Single Dose Phase|Adverse Event|0|||
161026504|NCT05170841|581488716|FG003|Single Dose Phase|Adverse Event|2|||
161026505|NCT05170841|581488713|FG000|Multiple Dose Phase|Adverse Event|1|||
161026506|NCT05170841|581488714|FG001|Multiple Dose Phase|Adverse Event|2|||
161026507|NCT05170841|581488715|FG002|Multiple Dose Phase|Adverse Event|1|||
161026508|NCT05170841|581488716|FG003|Multiple Dose Phase|Adverse Event|4|||
161026509|NCT05170841|581488713|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
161026510|NCT05170841|581488714|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
161026511|NCT05170841|581488715|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
161026512|NCT05170841|581488716|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
161026513|NCT03734679|581488726|FG000|Overall Study|Missed Visit|1|||
161026514|NCT03088878|581488744|FG000|Overall Study|Adverse Event|0|||
161026515|NCT03088878|581488745|FG001|Overall Study|Adverse Event|0|||
161026516|NCT03088878|581488746|FG002|Overall Study|Adverse Event|0|||
161026517|NCT03088878|581488747|FG003|Overall Study|Adverse Event|0|||
161026518|NCT03088878|581488748|FG004|Overall Study|Adverse Event|4|||
161026519|NCT03088878|581488749|FG005|Overall Study|Adverse Event|2|||
161026520|NCT03088878|581488750|FG006|Overall Study|Adverse Event|1|||
161026521|NCT03088878|581488751|FG007|Overall Study|Adverse Event|0|||
161026522|NCT03088878|581488752|FG008|Overall Study|Adverse Event|0|||
161026523|NCT03088878|581488753|FG009|Overall Study|Adverse Event|0|||
161026524|NCT03088878|581488754|FG010|Overall Study|Adverse Event|0|||
161026525|NCT03088878|581488755|FG011|Overall Study|Adverse Event|0|||
161026526|NCT03088878|581488756|FG012|Overall Study|Adverse Event|5|||
161026527|NCT03088878|581488757|FG013|Overall Study|Adverse Event|3|||
161026528|NCT03088878|581488744|FG000|Overall Study|Clinical Progression|0|||
161026529|NCT03088878|581488745|FG001|Overall Study|Clinical Progression|0|||
161026530|NCT03088878|581488746|FG002|Overall Study|Clinical Progression|0|||
161026531|NCT03088878|581488747|FG003|Overall Study|Clinical Progression|0|||
161026532|NCT03088878|581488748|FG004|Overall Study|Clinical Progression|2|||
161026533|NCT03088878|581488749|FG005|Overall Study|Clinical Progression|0|||
161026534|NCT03088878|581488750|FG006|Overall Study|Clinical Progression|0|||
161026535|NCT03088878|581488751|FG007|Overall Study|Clinical Progression|0|||
161026536|NCT03088878|581488752|FG008|Overall Study|Clinical Progression|0|||
161026537|NCT03088878|581488753|FG009|Overall Study|Clinical Progression|0|||
161026538|NCT03088878|581488754|FG010|Overall Study|Clinical Progression|0|||
161026539|NCT03088878|581488755|FG011|Overall Study|Clinical Progression|0|||
161026540|NCT03088878|581488756|FG012|Overall Study|Clinical Progression|0|||
161026541|NCT03088878|581488757|FG013|Overall Study|Clinical Progression|0|||
161026542|NCT03088878|581488744|FG000|Overall Study|Death|0|||
161026543|NCT03088878|581488745|FG001|Overall Study|Death|0|||
161026544|NCT03088878|581488746|FG002|Overall Study|Death|0|||
161026545|NCT03088878|581488747|FG003|Overall Study|Death|0|||
161026546|NCT03088878|581488748|FG004|Overall Study|Death|2|||
161026547|NCT03088878|581488749|FG005|Overall Study|Death|0|||
161026548|NCT03088878|581488750|FG006|Overall Study|Death|0|||
161026549|NCT03088878|581488751|FG007|Overall Study|Death|0|||
161026550|NCT03088878|581488752|FG008|Overall Study|Death|0|||
161026551|NCT03088878|581488753|FG009|Overall Study|Death|0|||
161026552|NCT03088878|581488754|FG010|Overall Study|Death|0|||
161026553|NCT03088878|581488755|FG011|Overall Study|Death|1|||
161026554|NCT03088878|581488756|FG012|Overall Study|Death|0|||
161026555|NCT03088878|581488757|FG013|Overall Study|Death|0|||
161026556|NCT03088878|581488744|FG000|Overall Study|Disease Progression|1|||
161026557|NCT03088878|581488745|FG001|Overall Study|Disease Progression|2|||
161026558|NCT03088878|581488746|FG002|Overall Study|Disease Progression|3|||
161026559|NCT03088878|581488747|FG003|Overall Study|Disease Progression|0|||
161026560|NCT03088878|581488748|FG004|Overall Study|Disease Progression|3|||
161026561|NCT03088878|581488749|FG005|Overall Study|Disease Progression|0|||
161026562|NCT03088878|581488750|FG006|Overall Study|Disease Progression|0|||
161026563|NCT03088878|581488751|FG007|Overall Study|Disease Progression|0|||
161026564|NCT03088878|581488752|FG008|Overall Study|Disease Progression|0|||
161026565|NCT03088878|581488753|FG009|Overall Study|Disease Progression|0|||
161026566|NCT03088878|581488754|FG010|Overall Study|Disease Progression|0|||
161026567|NCT03088878|581488755|FG011|Overall Study|Disease Progression|0|||
161026568|NCT03088878|581488756|FG012|Overall Study|Disease Progression|1|||
161026569|NCT03088878|581488757|FG013|Overall Study|Disease Progression|1|||
161026570|NCT03088878|581488744|FG000|Overall Study|Initiation of Alternative Treatment|0|||
161026571|NCT03088878|581488745|FG001|Overall Study|Initiation of Alternative Treatment|0|||
161026572|NCT03088878|581488746|FG002|Overall Study|Initiation of Alternative Treatment|0|||
161026573|NCT03088878|581488747|FG003|Overall Study|Initiation of Alternative Treatment|1|||
161026574|NCT03088878|581488748|FG004|Overall Study|Initiation of Alternative Treatment|0|||
161026575|NCT03088878|581488749|FG005|Overall Study|Initiation of Alternative Treatment|0|||
161026576|NCT03088878|581488750|FG006|Overall Study|Initiation of Alternative Treatment|0|||
161026577|NCT03088878|581488751|FG007|Overall Study|Initiation of Alternative Treatment|1|||
161276059|NCT00339144|582391639|FG000|Overall Study|Study drug toxicity|3|||
161026578|NCT03088878|581488752|FG008|Overall Study|Initiation of Alternative Treatment|1|||
161026579|NCT03088878|581488753|FG009|Overall Study|Initiation of Alternative Treatment|0|||
161026580|NCT03088878|581488754|FG010|Overall Study|Initiation of Alternative Treatment|0|||
161026581|NCT03088878|581488755|FG011|Overall Study|Initiation of Alternative Treatment|0|||
161026582|NCT03088878|581488756|FG012|Overall Study|Initiation of Alternative Treatment|0|||
161026583|NCT03088878|581488757|FG013|Overall Study|Initiation of Alternative Treatment|0|||
161026584|NCT03088878|581488744|FG000|Overall Study|Withdrawal by Subject|0|||
161026585|NCT03088878|581488745|FG001|Overall Study|Withdrawal by Subject|0|||
161026586|NCT03088878|581488746|FG002|Overall Study|Withdrawal by Subject|0|||
161026587|NCT03088878|581488747|FG003|Overall Study|Withdrawal by Subject|1|||
161026588|NCT03088878|581488748|FG004|Overall Study|Withdrawal by Subject|4|||
161026589|NCT03088878|581488749|FG005|Overall Study|Withdrawal by Subject|1|||
161026590|NCT03088878|581488750|FG006|Overall Study|Withdrawal by Subject|1|||
161026591|NCT03088878|581488751|FG007|Overall Study|Withdrawal by Subject|0|||
161026592|NCT03088878|581488752|FG008|Overall Study|Withdrawal by Subject|1|||
161026593|NCT03088878|581488753|FG009|Overall Study|Withdrawal by Subject|2|||
161026594|NCT03088878|581488754|FG010|Overall Study|Withdrawal by Subject|0|||
161026595|NCT03088878|581488755|FG011|Overall Study|Withdrawal by Subject|2|||
161026596|NCT03088878|581488756|FG012|Overall Study|Withdrawal by Subject|1|||
161026597|NCT03088878|581488757|FG013|Overall Study|Withdrawal by Subject|0|||
161026598|NCT03088878|581488744|FG000|Overall Study|Terminated by Sponsor|2|||
161026599|NCT03088878|581488745|FG001|Overall Study|Terminated by Sponsor|1|||
161026600|NCT03088878|581488746|FG002|Overall Study|Terminated by Sponsor|0|||
161026601|NCT03088878|581488747|FG003|Overall Study|Terminated by Sponsor|1|||
161026602|NCT03088878|581488748|FG004|Overall Study|Terminated by Sponsor|6|||
161026603|NCT03088878|581488749|FG005|Overall Study|Terminated by Sponsor|0|||
161026604|NCT03088878|581488750|FG006|Overall Study|Terminated by Sponsor|0|||
161026605|NCT03088878|581488751|FG007|Overall Study|Terminated by Sponsor|0|||
161026606|NCT03088878|581488752|FG008|Overall Study|Terminated by Sponsor|0|||
161026607|NCT03088878|581488753|FG009|Overall Study|Terminated by Sponsor|0|||
161026608|NCT03088878|581488754|FG010|Overall Study|Terminated by Sponsor|3|||
161026609|NCT03088878|581488755|FG011|Overall Study|Terminated by Sponsor|13|||
161026610|NCT03088878|581488756|FG012|Overall Study|Terminated by Sponsor|2|||
161026611|NCT03088878|581488757|FG013|Overall Study|Terminated by Sponsor|1|||
161026612|NCT03088878|581488744|FG000|Overall Study|Completed 2 years of Treatment|0|||
161026613|NCT03088878|581488745|FG001|Overall Study|Completed 2 years of Treatment|0|||
161026614|NCT03088878|581488746|FG002|Overall Study|Completed 2 years of Treatment|0|||
161026615|NCT03088878|581488747|FG003|Overall Study|Completed 2 years of Treatment|0|||
161026616|NCT03088878|581488748|FG004|Overall Study|Completed 2 years of Treatment|0|||
161026617|NCT03088878|581488749|FG005|Overall Study|Completed 2 years of Treatment|0|||
161026618|NCT03088878|581488750|FG006|Overall Study|Completed 2 years of Treatment|1|||
161026619|NCT03088878|581488751|FG007|Overall Study|Completed 2 years of Treatment|0|||
161026620|NCT03088878|581488752|FG008|Overall Study|Completed 2 years of Treatment|0|||
161026621|NCT03088878|581488753|FG009|Overall Study|Completed 2 years of Treatment|1|||
161026622|NCT03088878|581488754|FG010|Overall Study|Completed 2 years of Treatment|0|||
161026623|NCT03088878|581488755|FG011|Overall Study|Completed 2 years of Treatment|0|||
161026624|NCT03088878|581488756|FG012|Overall Study|Completed 2 years of Treatment|8|||
161026625|NCT03088878|581488757|FG013|Overall Study|Completed 2 years of Treatment|3|||
161026626|NCT03088878|581488744|FG000|Overall Study|Physician Decision|0|||
161026627|NCT03088878|581488745|FG001|Overall Study|Physician Decision|0|||
161026628|NCT03088878|581488746|FG002|Overall Study|Physician Decision|0|||
161026629|NCT03088878|581488747|FG003|Overall Study|Physician Decision|0|||
161026630|NCT03088878|581488748|FG004|Overall Study|Physician Decision|0|||
161026631|NCT03088878|581488749|FG005|Overall Study|Physician Decision|0|||
161026632|NCT03088878|581488750|FG006|Overall Study|Physician Decision|0|||
161276060|NCT00339144|582391640|FG001|Overall Study|Study drug toxicity|1|||
161276061|NCT00339144|582391641|FG002|Overall Study|Study drug toxicity|1|||
161276062|NCT00339144|582391639|FG000|Overall Study|Participant's request to discontinuation|1|||
161276063|NCT00339144|582391640|FG001|Overall Study|Participant's request to discontinuation|0|||
161276064|NCT00339144|582391641|FG002|Overall Study|Participant's request to discontinuation|1|||
161276065|NCT01267994|582391645|FG000|Overall Study|Adverse Event|2|||
161276066|NCT00642278|582391650|FG000|Overall Study|Adverse Event|2|||
161026633|NCT03088878|581488751|FG007|Overall Study|Physician Decision|2|||
161026634|NCT03088878|581488752|FG008|Overall Study|Physician Decision|1|||
161026635|NCT03088878|581488753|FG009|Overall Study|Physician Decision|0|||
161026636|NCT03088878|581488754|FG010|Overall Study|Physician Decision|0|||
161026637|NCT03088878|581488755|FG011|Overall Study|Physician Decision|0|||
161026638|NCT03088878|581488756|FG012|Overall Study|Physician Decision|0|||
161026639|NCT03088878|581488757|FG013|Overall Study|Physician Decision|1|||
161026640|NCT03088878|581488744|FG000|Overall Study|COVID Related noncompliance|0|||
161026641|NCT03088878|581488745|FG001|Overall Study|COVID Related noncompliance|0|||
161026642|NCT03088878|581488746|FG002|Overall Study|COVID Related noncompliance|0|||
161026643|NCT03088878|581488747|FG003|Overall Study|COVID Related noncompliance|0|||
161026644|NCT03088878|581488748|FG004|Overall Study|COVID Related noncompliance|0|||
161026645|NCT03088878|581488749|FG005|Overall Study|COVID Related noncompliance|0|||
161026646|NCT03088878|581488750|FG006|Overall Study|COVID Related noncompliance|0|||
161026647|NCT03088878|581488751|FG007|Overall Study|COVID Related noncompliance|0|||
161026648|NCT03088878|581488752|FG008|Overall Study|COVID Related noncompliance|0|||
161026649|NCT03088878|581488753|FG009|Overall Study|COVID Related noncompliance|0|||
161026650|NCT03088878|581488754|FG010|Overall Study|COVID Related noncompliance|0|||
161026651|NCT03088878|581488755|FG011|Overall Study|COVID Related noncompliance|0|||
161026652|NCT03088878|581488756|FG012|Overall Study|COVID Related noncompliance|0|||
161026653|NCT03088878|581488757|FG013|Overall Study|COVID Related noncompliance|1|||
161026654|NCT03088878|581488744|FG000|Overall Study|Drug or Study Noncompliance|0|||
161026655|NCT03088878|581488745|FG001|Overall Study|Drug or Study Noncompliance|0|||
161026656|NCT03088878|581488746|FG002|Overall Study|Drug or Study Noncompliance|0|||
161026657|NCT03088878|581488747|FG003|Overall Study|Drug or Study Noncompliance|0|||
161026658|NCT03088878|581488748|FG004|Overall Study|Drug or Study Noncompliance|0|||
161026659|NCT03088878|581488749|FG005|Overall Study|Drug or Study Noncompliance|0|||
161026660|NCT03088878|581488750|FG006|Overall Study|Drug or Study Noncompliance|0|||
161026661|NCT03088878|581488751|FG007|Overall Study|Drug or Study Noncompliance|0|||
161026662|NCT03088878|581488752|FG008|Overall Study|Drug or Study Noncompliance|0|||
161026663|NCT03088878|581488753|FG009|Overall Study|Drug or Study Noncompliance|0|||
161026664|NCT03088878|581488754|FG010|Overall Study|Drug or Study Noncompliance|0|||
161026665|NCT03088878|581488755|FG011|Overall Study|Drug or Study Noncompliance|0|||
161026666|NCT03088878|581488756|FG012|Overall Study|Drug or Study Noncompliance|1|||
161026667|NCT03088878|581488757|FG013|Overall Study|Drug or Study Noncompliance|0|||
161026668|NCT02823145|581488761|FG000|Enrollment|Other|1|||
161026669|NCT02823145|581488762|FG001|Enrollment|Other|0|||
161026670|NCT02823145|581488761|FG000|Treatment|Adverse Event|0|||
161026671|NCT02823145|581488762|FG001|Treatment|Adverse Event|11|||
161026672|NCT02823145|581488761|FG000|Treatment|Death|0|||
161026673|NCT02823145|581488762|FG001|Treatment|Death|3|||
161026674|NCT02823145|581488761|FG000|Treatment|Family Decision|0|||
161026675|NCT02823145|581488762|FG001|Treatment|Family Decision|1|||
161026676|NCT02823145|581488761|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
161026677|NCT02823145|581488762|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
161026678|NCT02823145|581488761|FG000|Treatment|Lack of Efficacy|0|||
161026679|NCT02823145|581488762|FG001|Treatment|Lack of Efficacy|48|||
161026680|NCT02823145|581488761|FG000|Treatment|Non-Compliance With E-Diary|0|||
161026681|NCT02823145|581488762|FG001|Treatment|Non-Compliance With E-Diary|1|||
161026682|NCT02823145|581488761|FG000|Treatment|Physician Decision|0|||
161026683|NCT02823145|581488762|FG001|Treatment|Physician Decision|2|||
161026684|NCT02823145|581488761|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
161026685|NCT02823145|581488762|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
161026686|NCT02823145|581488761|FG000|Treatment|Subject needed to take prohibited medication|0|||
161026687|NCT02823145|581488762|FG001|Treatment|Subject needed to take prohibited medication|1|||
161026688|NCT02823145|581488761|FG000|Treatment|Subject transferred to direct access programme|0|||
161026689|NCT02823145|581488762|FG001|Treatment|Subject transferred to direct access programme|1|||
161026690|NCT02823145|581488761|FG000|Treatment|Switching to commercially available drug|0|||
161026691|NCT02823145|581488762|FG001|Treatment|Switching to commercially available drug|11|||
161026692|NCT02823145|581488761|FG000|Treatment|Transitioned to commercial supply of medication|0|||
161026693|NCT02823145|581488762|FG001|Treatment|Transitioned to commercial supply of medication|1|||
161026694|NCT02823145|581488761|FG000|Treatment|Withdrawal By Caregiver|0|||
161026695|NCT02823145|581488762|FG001|Treatment|Withdrawal By Caregiver|1|||
161026696|NCT02823145|581488761|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
161026697|NCT02823145|581488762|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
161026698|NCT02823145|581488761|FG000|Treatment|Withdrawal by Subject|0|||
161026699|NCT02823145|581488762|FG001|Treatment|Withdrawal by Subject|16|||
161026700|NCT02823145|581488761|FG000|Treatment|Reason unknown|0|||
161026701|NCT02823145|581488762|FG001|Treatment|Reason unknown|1|||
161026702|NCT04233216|581490492|FG000|Overall Study|Lost to Follow-up|1|||
161026703|NCT04233216|581490493|FG001|Overall Study|Lost to Follow-up|0|||
161026704|NCT04233216|581490494|FG002|Overall Study|Lost to Follow-up|2|||
161026705|NCT04233216|581490495|FG003|Overall Study|Lost to Follow-up|0|||
161026706|NCT04233216|581490492|FG000|Overall Study|Physician Decision|0|||
161026707|NCT04233216|581490493|FG001|Overall Study|Physician Decision|3|||
161026708|NCT04233216|581490494|FG002|Overall Study|Physician Decision|0|||
161026709|NCT04233216|581490495|FG003|Overall Study|Physician Decision|2|||
161026710|NCT04233216|581490492|FG000|Overall Study|Withdrawal by Subject|0|||
161026711|NCT04233216|581490493|FG001|Overall Study|Withdrawal by Subject|2|||
161026712|NCT04233216|581490494|FG002|Overall Study|Withdrawal by Subject|1|||
161026713|NCT04233216|581490495|FG003|Overall Study|Withdrawal by Subject|0|||
161026714|NCT02927236|581490498|FG000|Characterization Phase|Physician Decision|0|||
161026715|NCT02927236|581490499|FG001|Characterization Phase|Physician Decision|3|||
161026716|NCT02927236|581490500|FG002|Characterization Phase|Physician Decision|0|||
161026717|NCT02927236|581490501|FG003|Characterization Phase|Physician Decision|2|||
161026718|NCT02927236|581490498|FG000|Characterization Phase|Lost to Follow-up|0|||
161026719|NCT02927236|581490499|FG001|Characterization Phase|Lost to Follow-up|0|||
161026720|NCT02927236|581490500|FG002|Characterization Phase|Lost to Follow-up|0|||
161026721|NCT02927236|581490501|FG003|Characterization Phase|Lost to Follow-up|3|||
161026722|NCT02927236|581490498|FG000|Characterization Phase|Withdrawal by Subject|1|||
161276067|NCT00642278|582391651|FG001|Overall Study|Adverse Event|1|||
161276068|NCT00642278|582391652|FG002|Overall Study|Adverse Event|3|||
161276069|NCT00642278|582391653|FG003|Overall Study|Adverse Event|1|||
161276070|NCT00642278|582391654|FG004|Overall Study|Adverse Event|2|||
161276071|NCT00642278|582391655|FG005|Overall Study|Adverse Event|2|||
161276072|NCT00642278|582391656|FG006|Overall Study|Adverse Event|0|||
161276073|NCT00642278|582391650|FG000|Overall Study|Lack of Efficacy|0|||
161026723|NCT02927236|581490499|FG001|Characterization Phase|Withdrawal by Subject|0|||
161026724|NCT02927236|581490500|FG002|Characterization Phase|Withdrawal by Subject|0|||
161026725|NCT02927236|581490501|FG003|Characterization Phase|Withdrawal by Subject|1|||
161026726|NCT02927236|581490498|FG000|Treatment Phase|Adverse Event|1|||
161026727|NCT02927236|581490499|FG001|Treatment Phase|Adverse Event|0|||
161026728|NCT02927236|581490500|FG002|Treatment Phase|Adverse Event|1|||
161026729|NCT02927236|581490501|FG003|Treatment Phase|Adverse Event|1|||
161026730|NCT02927236|581490498|FG000|Treatment Phase|Protocol Violation|3|||
161026731|NCT02927236|581490499|FG001|Treatment Phase|Protocol Violation|0|||
161026732|NCT02927236|581490500|FG002|Treatment Phase|Protocol Violation|0|||
161026733|NCT02927236|581490501|FG003|Treatment Phase|Protocol Violation|1|||
161026734|NCT02927236|581490498|FG000|Treatment Phase|Lost to Follow-up|1|||
161026735|NCT02927236|581490499|FG001|Treatment Phase|Lost to Follow-up|0|||
161026736|NCT02927236|581490500|FG002|Treatment Phase|Lost to Follow-up|0|||
161026737|NCT02927236|581490501|FG003|Treatment Phase|Lost to Follow-up|0|||
161026738|NCT02927236|581490498|FG000|Follow-up Phase|Lost to Follow-up|1|||
161026739|NCT02927236|581490499|FG001|Follow-up Phase|Lost to Follow-up|0|||
161026740|NCT02927236|581490500|FG002|Follow-up Phase|Lost to Follow-up|1|||
161026741|NCT02927236|581490501|FG003|Follow-up Phase|Lost to Follow-up|0|||
161026742|NCT05297565|581490502|FG000|Overall Study|Other Reasons|0|||
161026743|NCT05297565|581490503|FG001|Overall Study|Other Reasons|1|||
161026744|NCT05297565|581490502|FG000|Overall Study|Physician Decision|0|||
161026745|NCT05297565|581490503|FG001|Overall Study|Physician Decision|1|||
161026746|NCT05297565|581490502|FG000|Overall Study|Disease recurrence|1|||
161026747|NCT05297565|581490503|FG001|Overall Study|Disease recurrence|0|||
161026748|NCT01959607|581490504|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161026749|NCT01959607|581490505|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
161026750|NCT01959607|581490506|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161026751|NCT01959607|581490507|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161026752|NCT03913442|581490508|FG000|Overall Study|Adverse Event|0|||
161026753|NCT03913442|581490509|FG001|Overall Study|Adverse Event|3|||
161026754|NCT03913442|581490508|FG000|Overall Study|Withdrawal by Subject|5|||
161026755|NCT03913442|581490509|FG001|Overall Study|Withdrawal by Subject|5|||
161026756|NCT03913442|581490508|FG000|Overall Study|Terminations|2|||
161026757|NCT03913442|581490509|FG001|Overall Study|Terminations|1|||
161026758|NCT03913442|581490508|FG000|Overall Study|Lost to Follow-up|2|||
161026759|NCT03913442|581490509|FG001|Overall Study|Lost to Follow-up|2|||
161026760|NCT02433379|581490513|FG000|Overall Study|Screen Failures|55|||
161026761|NCT02433379|581490513|FG000|Overall Study|Death|57|||
161026762|NCT02433379|581490513|FG000|Overall Study|Total Withdrawals|209|||
161026763|NCT05299073|581490514|FG000|Overall Study|Withdrawal by Subject|0|||
161026764|NCT05299073|581490515|FG001|Overall Study|Withdrawal by Subject|0|||
161026765|NCT05299073|581490516|FG002|Overall Study|Withdrawal by Subject|1|||
161026766|NCT05299073|581490514|FG000|Overall Study|Adverse Event|0|||
161026767|NCT05299073|581490515|FG001|Overall Study|Adverse Event|1|||
161026768|NCT05299073|581490516|FG002|Overall Study|Adverse Event|0|||
161026769|NCT05299073|581490514|FG000|Overall Study|Lost to Follow-up|0|||
161026770|NCT05299073|581490515|FG001|Overall Study|Lost to Follow-up|1|||
161026771|NCT05299073|581490516|FG002|Overall Study|Lost to Follow-up|0|||
161026772|NCT03952338|581490517|FG000|Overall Study|Lost to Follow-up|11|||
161026773|NCT03952338|581490518|FG001|Overall Study|Lost to Follow-up|17|||
161026774|NCT03952338|581490517|FG000|Overall Study|Withdrawal by Subject|1|||
161026775|NCT03952338|581490518|FG001|Overall Study|Withdrawal by Subject|1|||
161026776|NCT03952338|581490517|FG000|Overall Study|Protocol Violation|1|||
161026777|NCT03952338|581490518|FG001|Overall Study|Protocol Violation|0|||
161026778|NCT03710603|581490519|FG000|Overall Study|Adverse Event|1|||
161026779|NCT03710603|581490520|FG001|Overall Study|Adverse Event|0|||
161026780|NCT03710603|581490519|FG000|Overall Study|Death|44|||
161026781|NCT03710603|581490520|FG001|Overall Study|Death|34|||
161026782|NCT03710603|581490519|FG000|Overall Study|Lost to Follow-up|3|||
161026783|NCT03710603|581490520|FG001|Overall Study|Lost to Follow-up|5|||
161026784|NCT03710603|581490519|FG000|Overall Study|Withdrawal by Subject|11|||
161026785|NCT03710603|581490520|FG001|Overall Study|Withdrawal by Subject|10|||
161026786|NCT00592852|581490521|FG000|Overall Study|Non-compliance|1|||
161026787|NCT00592852|581490521|FG000|Overall Study|Adverse Event|3|||
161026788|NCT00592852|581490521|FG000|Overall Study|Found ineligible|1|||
161026789|NCT00592852|581490521|FG000|Overall Study|Withdrawal by Subject|1|||
161026790|NCT02589795|581490525|FG000|Overall Study|Lost to Follow-up|1|||
161026791|NCT02589795|581490526|FG001|Overall Study|Lost to Follow-up|0|||
161026792|NCT02589795|581490527|FG002|Overall Study|Lost to Follow-up|0|||
161026793|NCT02589795|581490525|FG000|Overall Study|Withdrawal by Subject|0|||
161026794|NCT02589795|581490526|FG001|Overall Study|Withdrawal by Subject|0|||
161026795|NCT02589795|581490527|FG002|Overall Study|Withdrawal by Subject|2|||
161026796|NCT02589795|581490525|FG000|Overall Study|Protocol Violation|0|||
161026797|NCT02589795|581490526|FG001|Overall Study|Protocol Violation|0|||
161026798|NCT02589795|581490527|FG002|Overall Study|Protocol Violation|1|||
161026799|NCT02505984|581490529|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
161091169|NCT01191268|581723826|FG001|Overall Study|Entry Criteria Not Met|1|||
161276074|NCT00642278|582391651|FG001|Overall Study|Lack of Efficacy|1|||
160974184|NCT00284089|581295385|FG001|Extension Phase|condition no longer requires study drug|0|||
160974185|NCT00284089|581295386|FG002|Extension Phase|condition no longer requires study drug|2|||
160974186|NCT00284089|581295387|FG003|Extension Phase|condition no longer requires study drug|7|||
160974187|NCT00284089|581295384|FG000|Extension Phase|Protocol Violation|0|||
160974188|NCT00284089|581295385|FG001|Extension Phase|Protocol Violation|0|||
160974189|NCT00284089|581295386|FG002|Extension Phase|Protocol Violation|1|||
160974190|NCT00284089|581295387|FG003|Extension Phase|Protocol Violation|0|||
160974191|NCT00284089|581295384|FG000|Extension Phase|Withdrawal by Subject|0|||
160974192|NCT00284089|581295385|FG001|Extension Phase|Withdrawal by Subject|0|||
160974193|NCT00284089|581295386|FG002|Extension Phase|Withdrawal by Subject|1|||
160974194|NCT00284089|581295387|FG003|Extension Phase|Withdrawal by Subject|3|||
160974195|NCT02541383|581295388|FG000|Overall Study|Death|50|||
160974196|NCT02541383|581295389|FG001|Overall Study|Death|37|||
160974197|NCT02541383|581295390|FG002|Overall Study|Death|48|||
160974198|NCT02541383|581295391|FG003|Overall Study|Death|41|||
160974199|NCT02541383|581295392|FG004|Overall Study|Death|21|||
160974200|NCT02541383|581295393|FG005|Overall Study|Death|25|||
160974201|NCT02541383|581295388|FG000|Overall Study|Lost to Follow-up|5|||
160974202|NCT02541383|581295389|FG001|Overall Study|Lost to Follow-up|3|||
160974203|NCT02541383|581295390|FG002|Overall Study|Lost to Follow-up|1|||
160974204|NCT02541383|581295391|FG003|Overall Study|Lost to Follow-up|1|||
160974205|NCT02541383|581295392|FG004|Overall Study|Lost to Follow-up|3|||
160974206|NCT02541383|581295393|FG005|Overall Study|Lost to Follow-up|0|||
160974207|NCT02541383|581295388|FG000|Overall Study|Consent withdrawn|5|||
160974208|NCT02541383|581295389|FG001|Overall Study|Consent withdrawn|6|||
160974209|NCT02541383|581295390|FG002|Overall Study|Consent withdrawn|1|||
160974210|NCT02541383|581295391|FG003|Overall Study|Consent withdrawn|1|||
160974211|NCT02541383|581295392|FG004|Overall Study|Consent withdrawn|0|||
160974212|NCT02541383|581295393|FG005|Overall Study|Consent withdrawn|0|||
160974213|NCT02541383|581295388|FG000|Overall Study|Sponsor's decision|1|||
160974214|NCT02541383|581295389|FG001|Overall Study|Sponsor's decision|1|||
160974215|NCT02541383|581295390|FG002|Overall Study|Sponsor's decision|0|||
160974216|NCT02541383|581295391|FG003|Overall Study|Sponsor's decision|0|||
160974217|NCT02541383|581295392|FG004|Overall Study|Sponsor's decision|0|||
160974218|NCT02541383|581295393|FG005|Overall Study|Sponsor's decision|0|||
160974219|NCT05796518|581295394|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
160974220|NCT00594217|581295395|FG000|Overall Study|Withdrawal by Subject|1|||
160974221|NCT00594217|581295396|FG001|Overall Study|Withdrawal by Subject|3|||
160974222|NCT04186403|581295397|FG000|Overall Study|Adverse Event|1|||
160974223|NCT04186403|581295398|FG001|Overall Study|Adverse Event|8|||
160974224|NCT04186403|581295397|FG000|Overall Study|Lost to Follow-up|7|||
160974225|NCT04186403|581295398|FG001|Overall Study|Lost to Follow-up|3|||
160974226|NCT04186403|581295397|FG000|Overall Study|Physician Decision|1|||
160974227|NCT04186403|581295398|FG001|Overall Study|Physician Decision|0|||
160974228|NCT04186403|581295397|FG000|Overall Study|Withdrawal by Subject|7|||
160974229|NCT04186403|581295398|FG001|Overall Study|Withdrawal by Subject|8|||
160974230|NCT04186403|581295397|FG000|Overall Study|Other: Not Related to Covid-19|3|||
160974231|NCT04186403|581295398|FG001|Overall Study|Other: Not Related to Covid-19|0|||
160974232|NCT01407354|581295403|FG000|First Intervention|Withdrawal by Subject|0|||
160974233|NCT01407354|581295404|FG001|First Intervention|Withdrawal by Subject|2|||
160974234|NCT01407354|581295403|FG000|First Intervention|Adverse Event|1|||
160974235|NCT01407354|581295404|FG001|First Intervention|Adverse Event|0|||
160974236|NCT01407354|581295403|FG000|First Intervention|Physician Decision|1|||
160974237|NCT01407354|581295404|FG001|First Intervention|Physician Decision|0|||
160974238|NCT01036022|581295405|FG000|Overall Study|Adverse Event|1|||
160974239|NCT01036022|581295406|FG001|Overall Study|Adverse Event|3|||
160974240|NCT01036022|581295407|FG002|Overall Study|Adverse Event|2|||
160974241|NCT01036022|581295408|FG003|Overall Study|Adverse Event|1|||
160974242|NCT01036022|581295409|FG004|Overall Study|Adverse Event|0|||
160974243|NCT01036022|581295410|FG005|Overall Study|Adverse Event|2|||
160974244|NCT01036022|581295405|FG000|Overall Study|Lack of Efficacy|1|||
160974245|NCT01036022|581295406|FG001|Overall Study|Lack of Efficacy|1|||
160974246|NCT01036022|581295407|FG002|Overall Study|Lack of Efficacy|1|||
160974247|NCT01036022|581295408|FG003|Overall Study|Lack of Efficacy|0|||
160974248|NCT01036022|581295409|FG004|Overall Study|Lack of Efficacy|1|||
160974249|NCT01036022|581295410|FG005|Overall Study|Lack of Efficacy|1|||
160974250|NCT01036022|581295405|FG000|Overall Study|Physician Decision|0|||
160974251|NCT01036022|581295406|FG001|Overall Study|Physician Decision|0|||
160974252|NCT01036022|581295407|FG002|Overall Study|Physician Decision|1|||
160974253|NCT01036022|581295408|FG003|Overall Study|Physician Decision|0|||
160974254|NCT01036022|581295409|FG004|Overall Study|Physician Decision|0|||
160974255|NCT01036022|581295410|FG005|Overall Study|Physician Decision|0|||
160974256|NCT01036022|581295405|FG000|Overall Study|Withdrawal by Subject|0|||
160974257|NCT01036022|581295406|FG001|Overall Study|Withdrawal by Subject|0|||
160974258|NCT01036022|581295407|FG002|Overall Study|Withdrawal by Subject|0|||
160974259|NCT01036022|581295408|FG003|Overall Study|Withdrawal by Subject|1|||
160974260|NCT01036022|581295409|FG004|Overall Study|Withdrawal by Subject|2|||
160974261|NCT01036022|581295410|FG005|Overall Study|Withdrawal by Subject|0|||
161026800|NCT02505984|581490530|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
161026801|NCT02505984|581490529|FG000|Overall Study|Unreliable self-report data|1|||
161026802|NCT02505984|581490530|FG001|Overall Study|Unreliable self-report data|0|||
161026803|NCT02505984|581490529|FG000|Overall Study|Study blind opened during assessment|0|||
161026804|NCT02505984|581490530|FG001|Overall Study|Study blind opened during assessment|1|||
161026805|NCT02505984|581490529|FG000|Overall Study|Noncompliance with study protocol|0|||
161026806|NCT02505984|581490530|FG001|Overall Study|Noncompliance with study protocol|1|||
161026807|NCT03691935|581490535|FG000|Overall Study|Physician Decision|2|||
161026808|NCT03691935|581490536|FG001|Overall Study|Physician Decision|1|||
161026809|NCT03691935|581490535|FG000|Overall Study|Adverse Event|3|||
161026810|NCT03691935|581490536|FG001|Overall Study|Adverse Event|0|||
161026811|NCT03511664|581490548|FG000|Overall Study|Death|457|||
161026812|NCT03511664|581490549|FG001|Overall Study|Death|201|||
161026813|NCT03511664|581490550|FG002|Overall Study|Death|21|||
161026814|NCT03511664|581490548|FG000|Overall Study|Withdrew consent|40|||
161026815|NCT03511664|581490549|FG001|Overall Study|Withdrew consent|63|||
161026816|NCT03511664|581490550|FG002|Overall Study|Withdrew consent|3|||
161026817|NCT03511664|581490548|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
161026818|NCT03511664|581490549|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
161026819|NCT03511664|581490550|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
161026820|NCT03511664|581490548|FG000|Overall Study|Lost to Follow-up|8|||
161026821|NCT03511664|581490549|FG001|Overall Study|Lost to Follow-up|5|||
161026822|NCT03511664|581490550|FG002|Overall Study|Lost to Follow-up|0|||
161026823|NCT03511664|581490548|FG000|Overall Study|Physician Decision|2|||
161026824|NCT03511664|581490549|FG001|Overall Study|Physician Decision|1|||
161026825|NCT03511664|581490550|FG002|Overall Study|Physician Decision|0|||
161026826|NCT03511664|581490548|FG000|Overall Study|Patient non-compliance|1|||
161026827|NCT03511664|581490549|FG001|Overall Study|Patient non-compliance|0|||
161026828|NCT03511664|581490550|FG002|Overall Study|Patient non-compliance|0|||
161026829|NCT01946789|581490551|FG000|Overall Study|Death|0|||
161026830|NCT01946789|581490552|FG001|Overall Study|Death|2|||
161026831|NCT01946789|581490553|FG002|Overall Study|Death|1|||
161026832|NCT01946789|581490554|FG003|Overall Study|Death|1|||
161026833|NCT01946789|581490555|FG004|Overall Study|Death|1|||
161026834|NCT01946789|581490556|FG005|Overall Study|Death|1|||
161026835|NCT01946789|581490557|FG006|Overall Study|Death|3|||
161026836|NCT01946789|581490558|FG007|Overall Study|Death|1|||
161026837|NCT01946789|581490559|FG008|Overall Study|Death|2|||
161026838|NCT01946789|581490551|FG000|Overall Study|Progressive Disease|0|||
161026839|NCT01946789|581490552|FG001|Overall Study|Progressive Disease|0|||
161026840|NCT01946789|581490553|FG002|Overall Study|Progressive Disease|1|||
161026841|NCT01946789|581490554|FG003|Overall Study|Progressive Disease|0|||
161026842|NCT01946789|581490555|FG004|Overall Study|Progressive Disease|0|||
161026843|NCT01946789|581490556|FG005|Overall Study|Progressive Disease|2|||
161026844|NCT01946789|581490557|FG006|Overall Study|Progressive Disease|0|||
161026845|NCT01946789|581490558|FG007|Overall Study|Progressive Disease|0|||
161026846|NCT01946789|581490559|FG008|Overall Study|Progressive Disease|0|||
161026847|NCT01946789|581490551|FG000|Overall Study|Withdrawal by Subject|0|||
161026848|NCT01946789|581490552|FG001|Overall Study|Withdrawal by Subject|0|||
161026849|NCT01946789|581490553|FG002|Overall Study|Withdrawal by Subject|0|||
161026850|NCT01946789|581490554|FG003|Overall Study|Withdrawal by Subject|2|||
161026851|NCT01946789|581490555|FG004|Overall Study|Withdrawal by Subject|1|||
161026852|NCT01946789|581490556|FG005|Overall Study|Withdrawal by Subject|0|||
161026853|NCT01946789|581490557|FG006|Overall Study|Withdrawal by Subject|1|||
161026854|NCT01946789|581490558|FG007|Overall Study|Withdrawal by Subject|0|||
161026855|NCT01946789|581490559|FG008|Overall Study|Withdrawal by Subject|0|||
161026856|NCT06473662|581490560|FG000|Overall Study|Withdrawal by Subject|1|||
161026857|NCT06473662|581490561|FG001|Overall Study|Withdrawal by Subject|6|||
161026858|NCT06473662|581490562|FG002|Overall Study|Withdrawal by Subject|5|||
161026859|NCT06473662|581490560|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
161026860|NCT06473662|581490561|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
161026861|NCT06473662|581490562|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
161026862|NCT06473662|581490560|FG000|Overall Study|Starting HbA1c below 7%|0|||
161026863|NCT06473662|581490561|FG001|Overall Study|Starting HbA1c below 7%|1|||
161026864|NCT06473662|581490562|FG002|Overall Study|Starting HbA1c below 7%|1|||
161026865|NCT06473662|581490560|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
161026866|NCT06473662|581490561|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
161026867|NCT06473662|581490562|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
161026868|NCT06473662|581490560|FG000|Overall Study|Did not take medication|2|||
161026869|NCT06473662|581490561|FG001|Overall Study|Did not take medication|3|||
161026870|NCT06473662|581490562|FG002|Overall Study|Did not take medication|2|||
161026871|NCT04299464|581490565|FG000|Overall Study|Adverse Event|1|||
161026872|NCT04299464|581490566|FG001|Overall Study|Adverse Event|0|||
161026873|NCT04299464|581490567|FG002|Overall Study|Adverse Event|2|||
161026874|NCT04299464|581490565|FG000|Overall Study|Non-compliance with Study Drug|1|||
161026875|NCT04299464|581490566|FG001|Overall Study|Non-compliance with Study Drug|0|||
161344074|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344075|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344076|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344077|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344078|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
161344079|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344080|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344081|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
161344082|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344083|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344084|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344085|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344086|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
161344087|NCT03329001|582646013|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344088|NCT03329001|582646014|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344089|NCT03329001|582646015|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344090|NCT03329001|582646016|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
161344091|NCT03329001|582646017|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344092|NCT03329001|582646018|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344093|NCT03329001|582646019|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344094|NCT03329001|582646020|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
161344095|NCT03329001|582646013|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344096|NCT03329001|582646014|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344097|NCT03329001|582646015|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344098|NCT03329001|582646016|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344099|NCT03329001|582646017|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344100|NCT03329001|582646018|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
161344101|NCT03329001|582646019|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344102|NCT03329001|582646020|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
161344103|NCT03329001|582646013|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344104|NCT03329001|582646014|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344105|NCT03329001|582646015|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344106|NCT03329001|582646016|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344107|NCT03329001|582646017|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
161344108|NCT03329001|582646018|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344109|NCT03329001|582646019|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344110|NCT03329001|582646020|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
161344111|NCT03329001|582646013|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161344112|NCT03329001|582646014|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161344113|NCT03329001|582646015|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
160974262|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
160974263|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
160974264|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
160974265|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
160974266|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
160974267|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
160974268|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
160974269|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
160974270|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
160974271|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
160974272|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
160974273|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
160974274|NCT04534114|581295412|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
160974275|NCT04534114|581295413|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
160974276|NCT04534114|581295414|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
160974277|NCT04534114|581295415|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
160974278|NCT04534114|581295412|FG000|Main Treatment Period|Physician Decision|0|||
160974279|NCT04534114|581295413|FG001|Main Treatment Period|Physician Decision|0|||
160974280|NCT04534114|581295414|FG002|Main Treatment Period|Physician Decision|0|||
160974281|NCT04534114|581295415|FG003|Main Treatment Period|Physician Decision|1|||
160974282|NCT04534114|581295412|FG000|Main Treatment Period|Death|1|||
160974283|NCT04534114|581295413|FG001|Main Treatment Period|Death|0|||
161026876|NCT04299464|581490567|FG002|Overall Study|Non-compliance with Study Drug|0|||
161026877|NCT04299464|581490565|FG000|Overall Study|Reason not Specified|0|||
161026878|NCT04299464|581490566|FG001|Overall Study|Reason not Specified|1|||
161026879|NCT04299464|581490567|FG002|Overall Study|Reason not Specified|3|||
161026880|NCT04299464|581490565|FG000|Overall Study|Physician Decision|0|||
161026881|NCT04299464|581490566|FG001|Overall Study|Physician Decision|1|||
161026882|NCT04299464|581490567|FG002|Overall Study|Physician Decision|1|||
161026883|NCT04299464|581490565|FG000|Overall Study|Withdrawal by Subject|0|||
161026884|NCT04299464|581490566|FG001|Overall Study|Withdrawal by Subject|2|||
161026885|NCT04299464|581490567|FG002|Overall Study|Withdrawal by Subject|1|||
161026886|NCT05293171|581490574|FG000|Washout 5 to 7 Days|Adverse Event|1|||
161026887|NCT05293171|581490575|FG001|Washout 5 to 7 Days|Adverse Event|1|||
161026888|NCT05293171|581490576|FG002|Washout 5 to 7 Days|Adverse Event|0|||
161026889|NCT05293171|581490577|FG003|Washout 5 to 7 Days|Adverse Event|0|||
161026890|NCT05293171|581490578|FG004|Washout 5 to 7 Days|Adverse Event|0|||
161026891|NCT05293171|581490579|FG005|Washout 5 to 7 Days|Adverse Event|0|||
161026892|NCT05293171|581490580|FG006|Washout 5 to 7 Days|Adverse Event|0|||
160974284|NCT04534114|581295414|FG002|Main Treatment Period|Death|0|||
160974285|NCT04534114|581295415|FG003|Main Treatment Period|Death|1|||
160974286|NCT04534114|581295412|FG000|Main Treatment Period|Other reason|1|||
160974287|NCT04534114|581295413|FG001|Main Treatment Period|Other reason|1|||
160974288|NCT04534114|581295414|FG002|Main Treatment Period|Other reason|0|||
160974289|NCT04534114|581295415|FG003|Main Treatment Period|Other reason|0|||
160974290|NCT04534114|581295412|FG000|Main Treatment Period|Participant decision|1|||
160974291|NCT04534114|581295413|FG001|Main Treatment Period|Participant decision|3|||
160974292|NCT04534114|581295414|FG002|Main Treatment Period|Participant decision|3|||
160974293|NCT04534114|581295415|FG003|Main Treatment Period|Participant decision|1|||
161026893|NCT05293171|581490581|FG007|Washout 5 to 7 Days|Adverse Event|0|||
161026894|NCT05293171|581490582|FG008|Washout 5 to 7 Days|Adverse Event|0|||
161026895|NCT05293171|581490583|FG009|Washout 5 to 7 Days|Adverse Event|0|||
161026896|NCT05293171|581490584|FG010|Washout 5 to 7 Days|Adverse Event|0|||
160974294|NCT04534114|581295412|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
160974295|NCT04534114|581295413|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
161026897|NCT05293171|581490585|FG011|Washout 5 to 7 Days|Adverse Event|0|||
161026898|NCT05293171|581490574|FG000|Washout 5 to 7 Days|Adverse Event|0|||
161026899|NCT05293171|581490575|FG001|Washout 5 to 7 Days|Adverse Event|0|||
161026900|NCT05293171|581490576|FG002|Washout 5 to 7 Days|Adverse Event|0|||
161026901|NCT05293171|581490577|FG003|Washout 5 to 7 Days|Adverse Event|0|||
161026902|NCT05293171|581490578|FG004|Washout 5 to 7 Days|Adverse Event|0|||
161026903|NCT05293171|581490579|FG005|Washout 5 to 7 Days|Adverse Event|1|||
161026904|NCT05293171|581490580|FG006|Washout 5 to 7 Days|Adverse Event|0|||
161026905|NCT05293171|581490581|FG007|Washout 5 to 7 Days|Adverse Event|0|||
161026906|NCT05293171|581490582|FG008|Washout 5 to 7 Days|Adverse Event|0|||
161026907|NCT05293171|581490583|FG009|Washout 5 to 7 Days|Adverse Event|0|||
161026908|NCT05293171|581490584|FG010|Washout 5 to 7 Days|Adverse Event|0|||
161026909|NCT05293171|581490585|FG011|Washout 5 to 7 Days|Adverse Event|0|||
161026910|NCT04066205|581490586|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
161026911|NCT04066205|581490587|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
161026912|NCT04066205|581490586|FG000|T2 Immediate Post-Intervention|did not respond|5|||
161026913|NCT04066205|581490587|FG001|T2 Immediate Post-Intervention|did not respond|3|||
161026914|NCT02052882|581490588|FG000|Overall Study|Not treated|11|||
161026915|NCT02052882|581490588|FG000|Overall Study|Protocol Violation|1|||
161026916|NCT02052882|581490588|FG000|Overall Study|Inadequate testing|1|||
160974296|NCT04534114|581295414|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
160974297|NCT04534114|581295415|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
160974298|NCT04534114|581295412|FG000|Main Treatment Period|Adverse Event|4|||
160974299|NCT04534114|581295413|FG001|Main Treatment Period|Adverse Event|2|||
160974300|NCT04534114|581295414|FG002|Main Treatment Period|Adverse Event|1|||
160974301|NCT04534114|581295415|FG003|Main Treatment Period|Adverse Event|2|||
160974302|NCT04534114|581295412|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
160974303|NCT04534114|581295413|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
160974304|NCT04534114|581295414|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
161026917|NCT05123586|581490596|FG000|Overall Study|Physician Decision|1|||
161026918|NCT05123586|581490597|FG001|Overall Study|Physician Decision|1|||
160974305|NCT04534114|581295415|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
160974306|NCT04534114|581295412|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
160974307|NCT04534114|581295413|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
160974308|NCT04534114|581295414|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
161026919|NCT05123586|581490596|FG000|Overall Study|Withdrawal by Subject|0|||
161026920|NCT05123586|581490597|FG001|Overall Study|Withdrawal by Subject|3|||
161026921|NCT02733159|581490609|FG000|Overall Study|Adverse Event|1|||
161026922|NCT02733159|581490609|FG000|Overall Study|Lack of disease progression|1|||
161026923|NCT06122194|581490612|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
161026924|NCT06122194|581490613|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
161276075|NCT00642278|582391652|FG002|Overall Study|Lack of Efficacy|0|||
161026925|NCT06122194|581490614|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
161026926|NCT06122194|581490615|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
161026927|NCT05218096|581490616|FG000|Primary Evaluation|Withdrawal by Subject|0|||
161026928|NCT05218096|581490617|FG001|Primary Evaluation|Withdrawal by Subject|0|||
161026929|NCT05218096|581490618|FG002|Primary Evaluation|Withdrawal by Subject|2|||
161026930|NCT05218096|581490619|FG003|Primary Evaluation|Withdrawal by Subject|0|||
161026931|NCT05218096|581490620|FG004|Primary Evaluation|Withdrawal by Subject|0|||
161026932|NCT05218096|581490616|FG000|Primary Evaluation|Physician Decision|1|||
161026933|NCT05218096|581490617|FG001|Primary Evaluation|Physician Decision|0|||
161026934|NCT05218096|581490618|FG002|Primary Evaluation|Physician Decision|0|||
161026935|NCT05218096|581490619|FG003|Primary Evaluation|Physician Decision|0|||
161276076|NCT00642278|582391653|FG003|Overall Study|Lack of Efficacy|0|||
161276077|NCT00642278|582391654|FG004|Overall Study|Lack of Efficacy|0|||
161276078|NCT00642278|582391655|FG005|Overall Study|Lack of Efficacy|0|||
161276079|NCT00642278|582391656|FG006|Overall Study|Lack of Efficacy|0|||
161276080|NCT00642278|582391650|FG000|Overall Study|Lost to Follow-up|5|||
161276081|NCT00642278|582391651|FG001|Overall Study|Lost to Follow-up|1|||
161276082|NCT00642278|582391652|FG002|Overall Study|Lost to Follow-up|0|||
161276083|NCT00642278|582391653|FG003|Overall Study|Lost to Follow-up|1|||
161276084|NCT00642278|582391654|FG004|Overall Study|Lost to Follow-up|0|||
161276085|NCT00642278|582391655|FG005|Overall Study|Lost to Follow-up|1|||
161276086|NCT00642278|582391656|FG006|Overall Study|Lost to Follow-up|1|||
161276087|NCT00642278|582391650|FG000|Overall Study|Physician Decision|0|||
161276088|NCT00642278|582391651|FG001|Overall Study|Physician Decision|0|||
161276089|NCT00642278|582391652|FG002|Overall Study|Physician Decision|0|||
161276090|NCT00642278|582391653|FG003|Overall Study|Physician Decision|1|||
161276091|NCT00642278|582391654|FG004|Overall Study|Physician Decision|0|||
161276092|NCT00642278|582391655|FG005|Overall Study|Physician Decision|0|||
161276093|NCT00642278|582391656|FG006|Overall Study|Physician Decision|0|||
161276094|NCT00642278|582391650|FG000|Overall Study|Protocol Violation|0|||
161276095|NCT00642278|582391651|FG001|Overall Study|Protocol Violation|0|||
161276096|NCT00642278|582391652|FG002|Overall Study|Protocol Violation|1|||
161276097|NCT00642278|582391653|FG003|Overall Study|Protocol Violation|1|||
161276098|NCT00642278|582391654|FG004|Overall Study|Protocol Violation|0|||
161276099|NCT00642278|582391655|FG005|Overall Study|Protocol Violation|1|||
161276100|NCT00642278|582391656|FG006|Overall Study|Protocol Violation|2|||
161276101|NCT00642278|582391650|FG000|Overall Study|Withdrawal by Subject|1|||
161276102|NCT00642278|582391651|FG001|Overall Study|Withdrawal by Subject|1|||
161276103|NCT00642278|582391652|FG002|Overall Study|Withdrawal by Subject|1|||
161276104|NCT00642278|582391653|FG003|Overall Study|Withdrawal by Subject|3|||
161276105|NCT00642278|582391654|FG004|Overall Study|Withdrawal by Subject|6|||
161276106|NCT00642278|582391655|FG005|Overall Study|Withdrawal by Subject|2|||
161276107|NCT00642278|582391656|FG006|Overall Study|Withdrawal by Subject|2|||
161276108|NCT00642278|582391650|FG000|Overall Study|Noncompliance with study drug regimen|0|||
161276109|NCT00642278|582391651|FG001|Overall Study|Noncompliance with study drug regimen|0|||
161276110|NCT00642278|582391652|FG002|Overall Study|Noncompliance with study drug regimen|0|||
161276111|NCT00642278|582391653|FG003|Overall Study|Noncompliance with study drug regimen|1|||
161276112|NCT00642278|582391654|FG004|Overall Study|Noncompliance with study drug regimen|0|||
161276113|NCT00642278|582391655|FG005|Overall Study|Noncompliance with study drug regimen|0|||
161276114|NCT00642278|582391656|FG006|Overall Study|Noncompliance with study drug regimen|0|||
161276115|NCT00642278|582391650|FG000|Overall Study|Other|2|||
161276116|NCT00642278|582391651|FG001|Overall Study|Other|1|||
161276117|NCT00642278|582391652|FG002|Overall Study|Other|0|||
161276118|NCT00642278|582391653|FG003|Overall Study|Other|1|||
161276119|NCT00642278|582391654|FG004|Overall Study|Other|0|||
161276120|NCT00642278|582391655|FG005|Overall Study|Other|1|||
161276121|NCT00642278|582391656|FG006|Overall Study|Other|0|||
161276122|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161026936|NCT05218096|581490620|FG004|Primary Evaluation|Physician Decision|0|||
161276123|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161276124|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
161276125|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161276126|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161276127|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
161276128|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161276129|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161276130|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161276131|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161276132|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161276133|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161276134|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
161026937|NCT05218096|581490616|FG000|Extended Treatment|Clinical Deterioration|1|||
161026938|NCT05218096|581490617|FG001|Extended Treatment|Clinical Deterioration|1|||
161026939|NCT05218096|581490618|FG002|Extended Treatment|Clinical Deterioration|0|||
161026940|NCT05218096|581490619|FG003|Extended Treatment|Clinical Deterioration|0|||
161026941|NCT05218096|581490620|FG004|Extended Treatment|Clinical Deterioration|0|||
161026942|NCT05218096|581490616|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
161026943|NCT05218096|581490617|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
161026944|NCT05218096|581490618|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
161026945|NCT05218096|581490619|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
161026946|NCT05218096|581490620|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
161026947|NCT05218096|581490616|FG000|Extended Treatment|Withdrawal by Subject|1|||
161026948|NCT05218096|581490617|FG001|Extended Treatment|Withdrawal by Subject|3|||
161026949|NCT05218096|581490618|FG002|Extended Treatment|Withdrawal by Subject|0|||
161026950|NCT05218096|581490619|FG003|Extended Treatment|Withdrawal by Subject|2|||
161026951|NCT05218096|581490620|FG004|Extended Treatment|Withdrawal by Subject|2|||
161026952|NCT05218096|581490616|FG000|Extended Treatment|Lack of Efficacy|3|||
161026953|NCT05218096|581490617|FG001|Extended Treatment|Lack of Efficacy|0|||
161026954|NCT05218096|581490618|FG002|Extended Treatment|Lack of Efficacy|0|||
161026955|NCT05218096|581490619|FG003|Extended Treatment|Lack of Efficacy|0|||
161026956|NCT05218096|581490620|FG004|Extended Treatment|Lack of Efficacy|0|||
161026957|NCT05218096|581490616|FG000|Extended Treatment|Physician Decision|0|||
161026958|NCT05218096|581490617|FG001|Extended Treatment|Physician Decision|1|||
161026959|NCT05218096|581490618|FG002|Extended Treatment|Physician Decision|0|||
161026960|NCT05218096|581490619|FG003|Extended Treatment|Physician Decision|0|||
161026961|NCT05218096|581490620|FG004|Extended Treatment|Physician Decision|0|||
161026962|NCT05218096|581490616|FG000|Open-label Extension|Adverse Event|1|||
161026963|NCT05218096|581490617|FG001|Open-label Extension|Adverse Event|0|||
161026964|NCT05218096|581490618|FG002|Open-label Extension|Adverse Event|0|||
161026965|NCT05218096|581490619|FG003|Open-label Extension|Adverse Event|0|||
161026966|NCT05218096|581490620|FG004|Open-label Extension|Adverse Event|1|||
161026967|NCT05218096|581490616|FG000|Open-label Extension|Pregnancy|0|||
161026968|NCT05218096|581490617|FG001|Open-label Extension|Pregnancy|0|||
161026969|NCT05218096|581490618|FG002|Open-label Extension|Pregnancy|0|||
161026970|NCT05218096|581490619|FG003|Open-label Extension|Pregnancy|0|||
161026971|NCT05218096|581490620|FG004|Open-label Extension|Pregnancy|1|||
161026972|NCT05218096|581490616|FG000|Open-label Extension|Lack of Efficacy|1|||
161026973|NCT05218096|581490617|FG001|Open-label Extension|Lack of Efficacy|2|||
161026974|NCT05218096|581490618|FG002|Open-label Extension|Lack of Efficacy|0|||
161026975|NCT05218096|581490619|FG003|Open-label Extension|Lack of Efficacy|0|||
161026976|NCT05218096|581490620|FG004|Open-label Extension|Lack of Efficacy|0|||
161026977|NCT05218096|581490616|FG000|Open-label Extension|Lost to Follow-up|1|||
160974309|NCT04534114|581295415|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
160974310|NCT04534114|581295412|FG000|Extension Treatment Period|Other reason|0|||
160974311|NCT04534114|581295413|FG001|Extension Treatment Period|Other reason|1|||
160974312|NCT04534114|581295414|FG002|Extension Treatment Period|Other reason|0|||
160974313|NCT04534114|581295415|FG003|Extension Treatment Period|Other reason|0|||
160974314|NCT04534114|581295412|FG000|Extension Treatment Period|Death|0|||
160974315|NCT04534114|581295413|FG001|Extension Treatment Period|Death|0|||
160974316|NCT04534114|581295414|FG002|Extension Treatment Period|Death|1|||
160974317|NCT04534114|581295415|FG003|Extension Treatment Period|Death|2|||
160974318|NCT04534114|581295412|FG000|Extension Treatment Period|Adverse Event|0|||
160974319|NCT04534114|581295413|FG001|Extension Treatment Period|Adverse Event|1|||
160974320|NCT04534114|581295414|FG002|Extension Treatment Period|Adverse Event|0|||
160974321|NCT04534114|581295415|FG003|Extension Treatment Period|Adverse Event|1|||
160974322|NCT04534114|581295412|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
160974323|NCT04534114|581295413|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
160974324|NCT04534114|581295414|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
160974325|NCT04534114|581295415|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
160974326|NCT02759185|581295416|FG000|Stage 1|Adverse Event|0|||
160974327|NCT02759185|581295417|FG001|Stage 1|Adverse Event|1|||
160974328|NCT02759185|581295418|FG002|Stage 1|Adverse Event|3|||
160974329|NCT02759185|581295419|FG003|Stage 1|Adverse Event|0|||
160974330|NCT02759185|581295420|FG004|Stage 1|Adverse Event|0|||
160974331|NCT02759185|581295421|FG005|Stage 1|Adverse Event|0|||
160974332|NCT02759185|581295422|FG006|Stage 1|Adverse Event|0|||
160974333|NCT02759185|581295416|FG000|Stage 1|Withdrawal by Subject|1|||
160974334|NCT02759185|581295417|FG001|Stage 1|Withdrawal by Subject|0|||
160974335|NCT02759185|581295418|FG002|Stage 1|Withdrawal by Subject|0|||
160974336|NCT02759185|581295419|FG003|Stage 1|Withdrawal by Subject|0|||
160974337|NCT02759185|581295420|FG004|Stage 1|Withdrawal by Subject|0|||
160974338|NCT02759185|581295421|FG005|Stage 1|Withdrawal by Subject|0|||
161026978|NCT05218096|581490617|FG001|Open-label Extension|Lost to Follow-up|0|||
161026979|NCT05218096|581490618|FG002|Open-label Extension|Lost to Follow-up|0|||
161026980|NCT05218096|581490619|FG003|Open-label Extension|Lost to Follow-up|0|||
161026981|NCT05218096|581490620|FG004|Open-label Extension|Lost to Follow-up|0|||
160974339|NCT02759185|581295422|FG006|Stage 1|Withdrawal by Subject|0|||
161026982|NCT05218096|581490616|FG000|Open-label Extension|Death|0|||
161026983|NCT05218096|581490617|FG001|Open-label Extension|Death|0|||
160974340|NCT02759185|581295416|FG000|Stage 2|Adverse Event|0|||
160974341|NCT02759185|581295417|FG001|Stage 2|Adverse Event|0|||
160974342|NCT02759185|581295418|FG002|Stage 2|Adverse Event|0|||
160974343|NCT02759185|581295419|FG003|Stage 2|Adverse Event|0|||
160974344|NCT02759185|581295420|FG004|Stage 2|Adverse Event|1|||
160974345|NCT02759185|581295421|FG005|Stage 2|Adverse Event|2|||
160974346|NCT02759185|581295422|FG006|Stage 2|Adverse Event|0|||
160974347|NCT02759185|581295416|FG000|Stage 2|Withdrawal by Subject|0|||
160974348|NCT02759185|581295417|FG001|Stage 2|Withdrawal by Subject|0|||
160974349|NCT02759185|581295418|FG002|Stage 2|Withdrawal by Subject|0|||
160974350|NCT02759185|581295419|FG003|Stage 2|Withdrawal by Subject|0|||
160974351|NCT02759185|581295420|FG004|Stage 2|Withdrawal by Subject|1|||
160974352|NCT02759185|581295421|FG005|Stage 2|Withdrawal by Subject|1|||
160974353|NCT02759185|581295422|FG006|Stage 2|Withdrawal by Subject|1|||
160974354|NCT00962247|581295427|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
160974355|NCT00962247|581295427|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
160974356|NCT00886639|581295439|FG000|Overall Study|acute exacerbation|14|||
160974357|NCT00886639|581295439|FG000|Overall Study|non-compliance|2|||
160974358|NCT01871558|581295440|FG000|Overall Study|Other reason|0|||
160974359|NCT01871558|581295441|FG001|Overall Study|Other reason|1|||
160974360|NCT01871558|581295440|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
160974361|NCT01871558|581295441|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
160974362|NCT01871558|581295440|FG000|Overall Study|Withdrawal by Subject|2|||
160974363|NCT01871558|581295441|FG001|Overall Study|Withdrawal by Subject|0|||
160974364|NCT01709305|581295442|FG000|Phase 1|Clinical Adverse Event|80|||
160974365|NCT01709305|581295443|FG001|Phase 1|Clinical Adverse Event|0|||
160974366|NCT01709305|581295444|FG002|Phase 1|Clinical Adverse Event|0|||
160974367|NCT01709305|581295445|FG003|Phase 1|Clinical Adverse Event|0|||
160974368|NCT01709305|581295446|FG004|Phase 1|Clinical Adverse Event|0|||
160974369|NCT01709305|581295442|FG000|Phase 1|Death|2|||
160974370|NCT01709305|581295443|FG001|Phase 1|Death|0|||
160974371|NCT01709305|581295444|FG002|Phase 1|Death|0|||
160974372|NCT01709305|581295445|FG003|Phase 1|Death|0|||
160974373|NCT01709305|581295446|FG004|Phase 1|Death|0|||
160974374|NCT01709305|581295442|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
160974375|NCT01709305|581295443|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974376|NCT01709305|581295444|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974377|NCT01709305|581295445|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974378|NCT01709305|581295446|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
160974379|NCT01709305|581295442|FG000|Phase 1|Laboratory Adverse Event|16|||
160974380|NCT01709305|581295443|FG001|Phase 1|Laboratory Adverse Event|0|||
160974381|NCT01709305|581295444|FG002|Phase 1|Laboratory Adverse Event|0|||
160974382|NCT01709305|581295445|FG003|Phase 1|Laboratory Adverse Event|0|||
160974383|NCT01709305|581295446|FG004|Phase 1|Laboratory Adverse Event|0|||
160974384|NCT01709305|581295442|FG000|Phase 1|Lost to Follow-up|147|||
160974385|NCT01709305|581295443|FG001|Phase 1|Lost to Follow-up|0|||
160974386|NCT01709305|581295444|FG002|Phase 1|Lost to Follow-up|0|||
160974387|NCT01709305|581295445|FG003|Phase 1|Lost to Follow-up|0|||
160974388|NCT01709305|581295446|FG004|Phase 1|Lost to Follow-up|0|||
160974389|NCT01709305|581295442|FG000|Phase 1|Travel, moving, etc.|30|||
160974390|NCT01709305|581295443|FG001|Phase 1|Travel, moving, etc.|0|||
160974391|NCT01709305|581295444|FG002|Phase 1|Travel, moving, etc.|0|||
160974392|NCT01709305|581295445|FG003|Phase 1|Travel, moving, etc.|0|||
160974393|NCT01709305|581295446|FG004|Phase 1|Travel, moving, etc.|0|||
160974394|NCT01709305|581295442|FG000|Phase 1|Physician Decision|13|||
160974395|NCT01709305|581295443|FG001|Phase 1|Physician Decision|0|||
160974396|NCT01709305|581295444|FG002|Phase 1|Physician Decision|0|||
160974397|NCT01709305|581295445|FG003|Phase 1|Physician Decision|0|||
160974398|NCT01709305|581295446|FG004|Phase 1|Physician Decision|0|||
160974399|NCT01709305|581295442|FG000|Phase 1|Protocol Violation|118|||
160974400|NCT01709305|581295443|FG001|Phase 1|Protocol Violation|0|||
160974401|NCT01709305|581295444|FG002|Phase 1|Protocol Violation|0|||
160974402|NCT01709305|581295445|FG003|Phase 1|Protocol Violation|0|||
160974403|NCT01709305|581295446|FG004|Phase 1|Protocol Violation|0|||
160974404|NCT01709305|581295442|FG000|Phase 1|Withdrawal by Subject|218|||
160974405|NCT01709305|581295443|FG001|Phase 1|Withdrawal by Subject|0|||
160974406|NCT01709305|581295444|FG002|Phase 1|Withdrawal by Subject|0|||
160974407|NCT01709305|581295445|FG003|Phase 1|Withdrawal by Subject|0|||
160974408|NCT01709305|581295446|FG004|Phase 1|Withdrawal by Subject|0|||
160974409|NCT01709305|581295442|FG000|Phase 2|Clinical Adverse Event|0|||
160974410|NCT01709305|581295443|FG001|Phase 2|Clinical Adverse Event|10|||
160974411|NCT01709305|581295444|FG002|Phase 2|Clinical Adverse Event|10|||
160974412|NCT01709305|581295445|FG003|Phase 2|Clinical Adverse Event|6|||
160974413|NCT01709305|581295446|FG004|Phase 2|Clinical Adverse Event|11|||
160974414|NCT01709305|581295442|FG000|Phase 2|Death|0|||
160974415|NCT01709305|581295443|FG001|Phase 2|Death|0|||
160974416|NCT01709305|581295444|FG002|Phase 2|Death|1|||
160974417|NCT01709305|581295445|FG003|Phase 2|Death|0|||
160974418|NCT01709305|581295446|FG004|Phase 2|Death|0|||
160974419|NCT01709305|581295442|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160974420|NCT01709305|581295443|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160974421|NCT01709305|581295444|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
160974422|NCT01709305|581295445|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
161344114|NCT03329001|582646016|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161344115|NCT03329001|582646017|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
161344116|NCT03329001|582646018|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
161344117|NCT03329001|582646019|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161344118|NCT03329001|582646020|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
161344119|NCT03329001|582646013|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344120|NCT03329001|582646014|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344121|NCT03329001|582646015|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344122|NCT03329001|582646016|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344123|NCT03329001|582646017|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
161344124|NCT03329001|582646018|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344125|NCT03329001|582646019|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344126|NCT03329001|582646020|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
161344127|NCT03329001|582646013|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161344128|NCT03329001|582646014|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161344129|NCT03329001|582646015|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161344130|NCT03329001|582646016|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161344131|NCT03329001|582646017|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
161344132|NCT03329001|582646018|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
161344133|NCT03329001|582646019|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161344134|NCT03329001|582646020|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
161344135|NCT03329001|582646013|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161344136|NCT03329001|582646014|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161344137|NCT03329001|582646015|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161344138|NCT03329001|582646016|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161344139|NCT03329001|582646017|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161344140|NCT03329001|582646018|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
161344141|NCT03329001|582646019|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
161344142|NCT03329001|582646020|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
161344143|NCT03329001|582646013|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161344144|NCT03329001|582646014|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161026984|NCT05218096|581490618|FG002|Open-label Extension|Death|0|||
161026985|NCT05218096|581490619|FG003|Open-label Extension|Death|1|||
161026986|NCT05218096|581490620|FG004|Open-label Extension|Death|0|||
161026987|NCT05218096|581490616|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
161026988|NCT05218096|581490617|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
161026989|NCT05218096|581490618|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
161026990|NCT05218096|581490619|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
161026991|NCT05218096|581490620|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
161026992|NCT04690582|581490626|FG000|Overall Study|Withdrawal by Subject|6|||
161026993|NCT04690582|581490627|FG001|Overall Study|Withdrawal by Subject|4|||
161026994|NCT04032847|581490638|FG000|Overall Study|Study termination by sponsor|8|||
161026995|NCT04032847|581490639|FG001|Overall Study|Study termination by sponsor|0|||
161026996|NCT04032847|581490640|FG002|Overall Study|Study termination by sponsor|4|||
161026997|NCT04032847|581490638|FG000|Overall Study|Death|12|||
161026998|NCT04032847|581490639|FG001|Overall Study|Death|0|||
161026999|NCT04032847|581490640|FG002|Overall Study|Death|0|||
161027000|NCT04032847|581490638|FG000|Overall Study|Progressive disease|2|||
161027001|NCT04032847|581490639|FG001|Overall Study|Progressive disease|0|||
161027002|NCT04032847|581490640|FG002|Overall Study|Progressive disease|1|||
161027003|NCT03056573|581490641|FG000|Overall Study|Death|2|||
161027004|NCT03056573|581490642|FG001|Overall Study|Death|4|||
161027005|NCT03056573|581490641|FG000|Overall Study|Withdrawal by Subject|2|||
161027006|NCT03056573|581490642|FG001|Overall Study|Withdrawal by Subject|0|||
161027007|NCT03056573|581490641|FG000|Overall Study|Lost to Follow-up|1|||
161027008|NCT03056573|581490642|FG001|Overall Study|Lost to Follow-up|1|||
161027009|NCT05104463|581490643|FG000|Overall Study|Adverse Event|1|||
161027010|NCT05104463|581490644|FG001|Overall Study|Adverse Event|1|||
161027011|NCT05104463|581490643|FG000|Overall Study|Lost to Follow-up|1|||
161027012|NCT05104463|581490644|FG001|Overall Study|Lost to Follow-up|1|||
161027013|NCT05104463|581490643|FG000|Overall Study|Physician Decision|1|||
161027014|NCT05104463|581490644|FG001|Overall Study|Physician Decision|0|||
161027015|NCT05104463|581490643|FG000|Overall Study|Protocol Violation|0|||
161027016|NCT05104463|581490644|FG001|Overall Study|Protocol Violation|2|||
161027017|NCT05104463|581490643|FG000|Overall Study|Withdrawal by Subject|1|||
161027018|NCT05104463|581490644|FG001|Overall Study|Withdrawal by Subject|1|||
161027019|NCT05267470|581490645|FG000|Overall Study|Decision by sponsor|0|||
161027020|NCT05267470|581490646|FG001|Overall Study|Decision by sponsor|3|||
161027021|NCT05267470|581490647|FG002|Overall Study|Decision by sponsor|19|||
161027022|NCT05267470|581490648|FG003|Overall Study|Decision by sponsor|7|||
161027023|NCT05267470|581490649|FG004|Overall Study|Decision by sponsor|3|||
161027024|NCT05267470|581490645|FG000|Overall Study|Withdrawal by Subject|1|||
161027025|NCT05267470|581490646|FG001|Overall Study|Withdrawal by Subject|1|||
161027026|NCT05267470|581490647|FG002|Overall Study|Withdrawal by Subject|2|||
161027027|NCT05267470|581490648|FG003|Overall Study|Withdrawal by Subject|2|||
161027028|NCT05267470|581490649|FG004|Overall Study|Withdrawal by Subject|0|||
161027029|NCT05267470|581490645|FG000|Overall Study|Death|3|||
161027030|NCT05267470|581490646|FG001|Overall Study|Death|5|||
161027031|NCT05267470|581490647|FG002|Overall Study|Death|8|||
161027032|NCT05267470|581490648|FG003|Overall Study|Death|18|||
161027033|NCT05267470|581490649|FG004|Overall Study|Death|1|||
161027034|NCT05267470|581490645|FG000|Overall Study|Lost to Follow-up|0|||
161027035|NCT05267470|581490646|FG001|Overall Study|Lost to Follow-up|0|||
161027036|NCT05267470|581490647|FG002|Overall Study|Lost to Follow-up|0|||
161027037|NCT05267470|581490648|FG003|Overall Study|Lost to Follow-up|1|||
161027038|NCT05267470|581490649|FG004|Overall Study|Lost to Follow-up|0|||
161027039|NCT04428203|581490650|FG000|Overall Study|Adverse Event|1|||
161027040|NCT04428203|581490651|FG001|Overall Study|Adverse Event|0|||
161027041|NCT04428203|581490652|FG002|Overall Study|Adverse Event|0|||
161027042|NCT04428203|581490650|FG000|Overall Study|Withdrawal by Subject|1|||
161027043|NCT04428203|581490651|FG001|Overall Study|Withdrawal by Subject|0|||
161027044|NCT04428203|581490652|FG002|Overall Study|Withdrawal by Subject|1|||
161027045|NCT04741776|581490653|FG000|Overall Study|Withdrawal by Subject|7|||
161027046|NCT04741776|581490654|FG001|Overall Study|Withdrawal by Subject|10|||
161027047|NCT04741776|581490655|FG002|Overall Study|Withdrawal by Subject|10|||
161027048|NCT04741776|581490656|FG003|Overall Study|Withdrawal by Subject|17|||
161027049|NCT04741776|581490653|FG000|Overall Study|Death|0|||
161027050|NCT04741776|581490654|FG001|Overall Study|Death|0|||
161027051|NCT04741776|581490655|FG002|Overall Study|Death|1|||
161027052|NCT04741776|581490656|FG003|Overall Study|Death|0|||
161027053|NCT02852655|581490672|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
161027054|NCT02852655|581490673|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
161027055|NCT02852655|581490674|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
161027056|NCT02852655|581490672|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
161027057|NCT02852655|581490673|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
161027058|NCT02852655|581490674|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
161027059|NCT02852655|581490672|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
161027060|NCT02852655|581490673|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
161027061|NCT02852655|581490674|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
161027062|NCT02852655|581490672|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
161027063|NCT02852655|581490673|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
161027064|NCT02852655|581490674|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
161027065|NCT02852655|581490672|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
161027066|NCT02852655|581490673|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
161027067|NCT02852655|581490674|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
161027068|NCT02852655|581490672|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
161027069|NCT02852655|581490673|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
161027070|NCT02852655|581490674|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
161027071|NCT02852655|581490672|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
161027072|NCT02852655|581490673|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
161027073|NCT02852655|581490674|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
161027074|NCT02852655|581490672|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
161027075|NCT02852655|581490673|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
161027076|NCT02852655|581490674|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
161027077|NCT02852655|581490672|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
161027078|NCT02852655|581490673|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
161027079|NCT02852655|581490674|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
161027080|NCT03257410|581492802|FG000|Overall Study|Adverse Event|2|||
161276135|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
161276136|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
161276137|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161276138|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161027081|NCT03257410|581492803|FG001|Overall Study|Adverse Event|3|||
161276139|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161027082|NCT03257410|581492802|FG000|Overall Study|Protocol Violation|1|||
161276140|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161027083|NCT03257410|581492803|FG001|Overall Study|Protocol Violation|2|||
161027084|NCT03257410|581492802|FG000|Overall Study|Lost to Follow-up|1|||
161027085|NCT03257410|581492803|FG001|Overall Study|Lost to Follow-up|0|||
161027086|NCT03257410|581492802|FG000|Overall Study|Withdrawal by Subject|1|||
161027087|NCT03257410|581492803|FG001|Overall Study|Withdrawal by Subject|2|||
161027088|NCT03257410|581492802|FG000|Overall Study|Physician Decision|1|||
161027089|NCT03257410|581492803|FG001|Overall Study|Physician Decision|1|||
161027090|NCT03257410|581492802|FG000|Overall Study|Renal transplantation|2|||
161027091|NCT03257410|581492803|FG001|Overall Study|Renal transplantation|0|||
161027092|NCT03257410|581492802|FG000|Overall Study|Switch to peritoneal dialysis|1|||
161027093|NCT03257410|581492803|FG001|Overall Study|Switch to peritoneal dialysis|0|||
161027094|NCT03257410|581492802|FG000|Overall Study|Death|3|||
161027095|NCT03257410|581492803|FG001|Overall Study|Death|2|||
161027096|NCT03257410|581492802|FG000|Overall Study|Change to another dialysis center|2|||
161027097|NCT03257410|581492803|FG001|Overall Study|Change to another dialysis center|2|||
161027098|NCT03257410|581492802|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
161027099|NCT03257410|581492803|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
161027100|NCT03257410|581492802|FG000|Overall Study|Miscellaneous|2|||
161027101|NCT03257410|581492803|FG001|Overall Study|Miscellaneous|2|||
161027102|NCT03257410|581492802|FG000|Overall Study|Other|0|||
161027103|NCT03257410|581492803|FG001|Overall Study|Other|1|||
161027104|NCT02598388|581492804|FG000|Overall Study|Lost to Follow-up|1|||
161027105|NCT02598388|581492805|FG001|Overall Study|Lost to Follow-up|0|||
161027106|NCT02598388|581492806|FG002|Overall Study|Lost to Follow-up|1|||
161027107|NCT02598388|581492807|FG003|Overall Study|Lost to Follow-up|0|||
161027108|NCT02598388|581492808|FG004|Overall Study|Lost to Follow-up|5|||
161027109|NCT02598388|581492809|FG005|Overall Study|Lost to Follow-up|1|||
161027110|NCT02598388|581492810|FG006|Overall Study|Lost to Follow-up|2|||
161027111|NCT02598388|581492811|FG007|Overall Study|Lost to Follow-up|1|||
161027112|NCT02598388|581492812|FG008|Overall Study|Lost to Follow-up|0|||
161027113|NCT02598388|581492813|FG009|Overall Study|Lost to Follow-up|0|||
161027114|NCT02598388|581492814|FG010|Overall Study|Lost to Follow-up|1|||
161027115|NCT02598388|581492815|FG011|Overall Study|Lost to Follow-up|0|||
161027116|NCT02598388|581492804|FG000|Overall Study|Withdrawal by Subject|0|||
161027117|NCT02598388|581492805|FG001|Overall Study|Withdrawal by Subject|0|||
161027118|NCT02598388|581492806|FG002|Overall Study|Withdrawal by Subject|0|||
161027119|NCT02598388|581492807|FG003|Overall Study|Withdrawal by Subject|0|||
161027120|NCT02598388|581492808|FG004|Overall Study|Withdrawal by Subject|2|||
161027121|NCT02598388|581492809|FG005|Overall Study|Withdrawal by Subject|0|||
161027122|NCT02598388|581492810|FG006|Overall Study|Withdrawal by Subject|2|||
161027123|NCT02598388|581492811|FG007|Overall Study|Withdrawal by Subject|0|||
161027124|NCT02598388|581492812|FG008|Overall Study|Withdrawal by Subject|0|||
161027125|NCT02598388|581492813|FG009|Overall Study|Withdrawal by Subject|1|||
161027126|NCT02598388|581492814|FG010|Overall Study|Withdrawal by Subject|0|||
161027127|NCT02598388|581492815|FG011|Overall Study|Withdrawal by Subject|0|||
161027128|NCT02598388|581492804|FG000|Overall Study|Other|0|||
161027129|NCT02598388|581492805|FG001|Overall Study|Other|0|||
161027130|NCT02598388|581492806|FG002|Overall Study|Other|1|||
161027131|NCT02598388|581492807|FG003|Overall Study|Other|0|||
161027132|NCT02598388|581492808|FG004|Overall Study|Other|3|||
161027133|NCT02598388|581492809|FG005|Overall Study|Other|0|||
161027134|NCT02598388|581492810|FG006|Overall Study|Other|1|||
161027135|NCT02598388|581492811|FG007|Overall Study|Other|0|||
161027136|NCT02598388|581492812|FG008|Overall Study|Other|0|||
161027137|NCT02598388|581492813|FG009|Overall Study|Other|0|||
161027138|NCT02598388|581492814|FG010|Overall Study|Other|0|||
161027139|NCT02598388|581492815|FG011|Overall Study|Other|0|||
161027140|NCT03668236|581492818|FG000|90-day Follow-up|Withdrawal by Subject|3|||
161027141|NCT03668236|581492819|FG001|90-day Follow-up|Withdrawal by Subject|2|||
161027142|NCT03668236|581492818|FG000|90-day Follow-up|Lost to Follow-up|3|||
161027143|NCT03668236|581492819|FG001|90-day Follow-up|Lost to Follow-up|1|||
161027144|NCT03668236|581492818|FG000|Baseline Characteristics|Lost to Follow-up|9|||
161027145|NCT03668236|581492819|FG001|Baseline Characteristics|Lost to Follow-up|5|||
161027146|NCT03668236|581492818|FG000|1-year Follow-up|Withdrawal by Subject|17|||
161027147|NCT03668236|581492819|FG001|1-year Follow-up|Withdrawal by Subject|15|||
161027148|NCT06132282|581492820|FG000|Overall Study|Lost to Follow-up|31|||
161027149|NCT04171141|581492821|FG000|Overall Study|Adverse Event|0|||
161027150|NCT04171141|581492822|FG001|Overall Study|Adverse Event|0|||
161027151|NCT04171141|581492823|FG002|Overall Study|Adverse Event|2|||
161027152|NCT04171141|581492824|FG003|Overall Study|Adverse Event|0|||
161027153|NCT04171141|581492825|FG004|Overall Study|Adverse Event|0|||
161027154|NCT04171141|581492826|FG005|Overall Study|Adverse Event|0|||
161027155|NCT04171141|581492827|FG006|Overall Study|Adverse Event|0|||
161027156|NCT04171141|581492828|FG007|Overall Study|Adverse Event|0|||
161027157|NCT04171141|581492829|FG008|Overall Study|Adverse Event|0|||
161027158|NCT04171141|581492830|FG009|Overall Study|Adverse Event|0|||
161027159|NCT04171141|581492831|FG010|Overall Study|Adverse Event|0|||
161027160|NCT04171141|581492832|FG011|Overall Study|Adverse Event|0|||
161027161|NCT04171141|581492833|FG012|Overall Study|Adverse Event|0|||
161027162|NCT04171141|581492834|FG013|Overall Study|Adverse Event|2|||
161027163|NCT04171141|581492835|FG014|Overall Study|Adverse Event|0|||
160974423|NCT01709305|581295446|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
160974424|NCT01709305|581295442|FG000|Phase 2|Laboratory Adverse Event|0|||
160974425|NCT01709305|581295443|FG001|Phase 2|Laboratory Adverse Event|1|||
160974426|NCT01709305|581295444|FG002|Phase 2|Laboratory Adverse Event|0|||
160974427|NCT01709305|581295445|FG003|Phase 2|Laboratory Adverse Event|1|||
160974428|NCT01709305|581295446|FG004|Phase 2|Laboratory Adverse Event|1|||
160974429|NCT01709305|581295442|FG000|Phase 2|Lost to Follow-up|0|||
160974430|NCT01709305|581295443|FG001|Phase 2|Lost to Follow-up|10|||
160974431|NCT01709305|581295444|FG002|Phase 2|Lost to Follow-up|6|||
160974432|NCT01709305|581295445|FG003|Phase 2|Lost to Follow-up|9|||
160974433|NCT01709305|581295446|FG004|Phase 2|Lost to Follow-up|5|||
160974434|NCT01709305|581295442|FG000|Phase 2|Travel, moving, etc.|0|||
160974435|NCT01709305|581295443|FG001|Phase 2|Travel, moving, etc.|2|||
160974436|NCT01709305|581295444|FG002|Phase 2|Travel, moving, etc.|3|||
160974437|NCT01709305|581295445|FG003|Phase 2|Travel, moving, etc.|3|||
160974438|NCT01709305|581295446|FG004|Phase 2|Travel, moving, etc.|5|||
160974439|NCT01709305|581295442|FG000|Phase 2|Physician Decision|0|||
160974440|NCT01709305|581295443|FG001|Phase 2|Physician Decision|2|||
160974441|NCT01709305|581295444|FG002|Phase 2|Physician Decision|0|||
160974442|NCT01709305|581295445|FG003|Phase 2|Physician Decision|1|||
160974443|NCT01709305|581295446|FG004|Phase 2|Physician Decision|2|||
160974444|NCT01709305|581295442|FG000|Phase 2|Protocol Violation|0|||
160974445|NCT01709305|581295443|FG001|Phase 2|Protocol Violation|19|||
160974446|NCT01709305|581295444|FG002|Phase 2|Protocol Violation|19|||
160974447|NCT01709305|581295445|FG003|Phase 2|Protocol Violation|13|||
160974448|NCT01709305|581295446|FG004|Phase 2|Protocol Violation|9|||
160974449|NCT01709305|581295442|FG000|Phase 2|Withdrawal by Subject|0|||
160974450|NCT01709305|581295443|FG001|Phase 2|Withdrawal by Subject|8|||
160974451|NCT01709305|581295444|FG002|Phase 2|Withdrawal by Subject|6|||
160974452|NCT01709305|581295445|FG003|Phase 2|Withdrawal by Subject|15|||
160974453|NCT01709305|581295446|FG004|Phase 2|Withdrawal by Subject|12|||
160974454|NCT03443713|581295449|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
160974455|NCT03443713|581295450|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
160974456|NCT03443713|581295451|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
160974457|NCT00118898|581295452|FG000|Overall Study|Death|6|||
160974458|NCT00118898|581295453|FG001|Overall Study|Death|11|||
160974459|NCT00118898|581295454|FG002|Overall Study|Death|6|||
160974460|NCT00118898|581295455|FG003|Overall Study|Death|8|||
160974461|NCT00118898|581295452|FG000|Overall Study|Lost to Follow-up|26|||
160974462|NCT00118898|581295453|FG001|Overall Study|Lost to Follow-up|34|||
160974463|NCT00118898|581295454|FG002|Overall Study|Lost to Follow-up|33|||
160974464|NCT00118898|581295455|FG003|Overall Study|Lost to Follow-up|33|||
160974465|NCT00118898|581295452|FG000|Overall Study|Withdrawal by Subject|10|||
160974466|NCT00118898|581295453|FG001|Overall Study|Withdrawal by Subject|5|||
160974467|NCT00118898|581295454|FG002|Overall Study|Withdrawal by Subject|8|||
160974468|NCT00118898|581295455|FG003|Overall Study|Withdrawal by Subject|8|||
160974469|NCT00118898|581295452|FG000|Overall Study|Site Closure|33|||
160974470|NCT00118898|581295453|FG001|Overall Study|Site Closure|31|||
160974471|NCT00118898|581295454|FG002|Overall Study|Site Closure|28|||
160974472|NCT00118898|581295455|FG003|Overall Study|Site Closure|37|||
160974473|NCT00118898|581295452|FG000|Overall Study|Severe debilitation|1|||
160974474|NCT00118898|581295453|FG001|Overall Study|Severe debilitation|4|||
160974475|NCT00118898|581295454|FG002|Overall Study|Severe debilitation|6|||
160974476|NCT00118898|581295455|FG003|Overall Study|Severe debilitation|4|||
160974477|NCT00118898|581295452|FG000|Overall Study|Not compliant with requirements|11|||
160974478|NCT00118898|581295453|FG001|Overall Study|Not compliant with requirements|13|||
160974479|NCT00118898|581295454|FG002|Overall Study|Not compliant with requirements|11|||
160974480|NCT00118898|581295455|FG003|Overall Study|Not compliant with requirements|11|||
160974481|NCT00118898|581295452|FG000|Overall Study|Not able to get to clinic|34|||
160974482|NCT00118898|581295453|FG001|Overall Study|Not able to get to clinic|43|||
160974483|NCT00118898|581295454|FG002|Overall Study|Not able to get to clinic|31|||
160974484|NCT00118898|581295455|FG003|Overall Study|Not able to get to clinic|40|||
160974485|NCT02714205|581295456|FG000|Overall Study|Cannot tolerate medication|1|||
160974486|NCT02714205|581295457|FG001|Overall Study|Cannot tolerate medication|0|||
160974487|NCT02714205|581295456|FG000|Overall Study|Adverse Event|2|||
160974488|NCT02714205|581295457|FG001|Overall Study|Adverse Event|0|||
160974489|NCT02714205|581295456|FG000|Overall Study|Too busy|1|||
160974490|NCT02714205|581295457|FG001|Overall Study|Too busy|0|||
160974491|NCT02714205|581295456|FG000|Overall Study|Incomplete outcome data|0|||
160974492|NCT02714205|581295457|FG001|Overall Study|Incomplete outcome data|1|||
160974493|NCT02073097|581295458|FG000|Overall Study|Adverse Event|0|||
160974494|NCT02073097|581295459|FG001|Overall Study|Adverse Event|0|||
160974495|NCT02073097|581295460|FG002|Overall Study|Adverse Event|0|||
160974496|NCT02073097|581295461|FG003|Overall Study|Adverse Event|0|||
160974497|NCT02073097|581295462|FG004|Overall Study|Adverse Event|0|||
160974498|NCT02073097|581295463|FG005|Overall Study|Adverse Event|0|||
160974499|NCT02073097|581295464|FG006|Overall Study|Adverse Event|0|||
160974500|NCT02073097|581295465|FG007|Overall Study|Adverse Event|2|||
160974501|NCT02073097|581295458|FG000|Overall Study|Withdrawal by Subject|0|||
160974502|NCT02073097|581295459|FG001|Overall Study|Withdrawal by Subject|0|||
161027164|NCT04171141|581492836|FG015|Overall Study|Adverse Event|0|||
161027165|NCT04171141|581492821|FG000|Overall Study|Physician Decision|0|||
161027166|NCT04171141|581492822|FG001|Overall Study|Physician Decision|0|||
161027167|NCT04171141|581492823|FG002|Overall Study|Physician Decision|0|||
161027168|NCT04171141|581492824|FG003|Overall Study|Physician Decision|0|||
161027169|NCT04171141|581492825|FG004|Overall Study|Physician Decision|1|||
161027170|NCT04171141|581492826|FG005|Overall Study|Physician Decision|0|||
161027171|NCT04171141|581492827|FG006|Overall Study|Physician Decision|0|||
161027172|NCT04171141|581492828|FG007|Overall Study|Physician Decision|0|||
161027173|NCT04171141|581492829|FG008|Overall Study|Physician Decision|0|||
161027174|NCT04171141|581492830|FG009|Overall Study|Physician Decision|0|||
161027175|NCT04171141|581492831|FG010|Overall Study|Physician Decision|0|||
161027176|NCT04171141|581492832|FG011|Overall Study|Physician Decision|0|||
161027177|NCT04171141|581492833|FG012|Overall Study|Physician Decision|0|||
161027178|NCT04171141|581492834|FG013|Overall Study|Physician Decision|0|||
161027179|NCT04171141|581492835|FG014|Overall Study|Physician Decision|0|||
161027180|NCT04171141|581492836|FG015|Overall Study|Physician Decision|1|||
161027181|NCT04171141|581492821|FG000|Overall Study|Progressive disease|2|||
161027182|NCT04171141|581492822|FG001|Overall Study|Progressive disease|3|||
161027183|NCT04171141|581492823|FG002|Overall Study|Progressive disease|4|||
161027184|NCT04171141|581492824|FG003|Overall Study|Progressive disease|7|||
161027185|NCT04171141|581492825|FG004|Overall Study|Progressive disease|1|||
161027186|NCT04171141|581492826|FG005|Overall Study|Progressive disease|8|||
161027187|NCT04171141|581492827|FG006|Overall Study|Progressive disease|4|||
161027188|NCT04171141|581492828|FG007|Overall Study|Progressive disease|6|||
161027189|NCT04171141|581492829|FG008|Overall Study|Progressive disease|7|||
161027190|NCT04171141|581492830|FG009|Overall Study|Progressive disease|3|||
161027191|NCT04171141|581492831|FG010|Overall Study|Progressive disease|4|||
161027192|NCT04171141|581492832|FG011|Overall Study|Progressive disease|3|||
161027193|NCT04171141|581492833|FG012|Overall Study|Progressive disease|4|||
161027194|NCT04171141|581492834|FG013|Overall Study|Progressive disease|2|||
161027195|NCT04171141|581492835|FG014|Overall Study|Progressive disease|4|||
161027196|NCT04171141|581492836|FG015|Overall Study|Progressive disease|1|||
161027197|NCT04171141|581492821|FG000|Overall Study|Withdrawal by Subject|0|||
161027198|NCT04171141|581492822|FG001|Overall Study|Withdrawal by Subject|0|||
161027199|NCT04171141|581492823|FG002|Overall Study|Withdrawal by Subject|0|||
161027200|NCT04171141|581492824|FG003|Overall Study|Withdrawal by Subject|1|||
161027201|NCT04171141|581492825|FG004|Overall Study|Withdrawal by Subject|0|||
161027202|NCT04171141|581492826|FG005|Overall Study|Withdrawal by Subject|0|||
161027203|NCT04171141|581492827|FG006|Overall Study|Withdrawal by Subject|1|||
161027204|NCT04171141|581492828|FG007|Overall Study|Withdrawal by Subject|0|||
161027205|NCT04171141|581492829|FG008|Overall Study|Withdrawal by Subject|0|||
161027206|NCT04171141|581492830|FG009|Overall Study|Withdrawal by Subject|1|||
161027207|NCT04171141|581492831|FG010|Overall Study|Withdrawal by Subject|0|||
161027208|NCT04171141|581492832|FG011|Overall Study|Withdrawal by Subject|0|||
161027209|NCT04171141|581492833|FG012|Overall Study|Withdrawal by Subject|0|||
161027210|NCT04171141|581492834|FG013|Overall Study|Withdrawal by Subject|0|||
161027211|NCT04171141|581492835|FG014|Overall Study|Withdrawal by Subject|0|||
161027212|NCT04171141|581492836|FG015|Overall Study|Withdrawal by Subject|0|||
161027213|NCT04171141|581492821|FG000|Overall Study|Global deterioration of health status|0|||
161027214|NCT04171141|581492822|FG001|Overall Study|Global deterioration of health status|0|||
161027215|NCT04171141|581492823|FG002|Overall Study|Global deterioration of health status|0|||
161027216|NCT04171141|581492824|FG003|Overall Study|Global deterioration of health status|1|||
161027217|NCT04171141|581492825|FG004|Overall Study|Global deterioration of health status|0|||
161027218|NCT04171141|581492826|FG005|Overall Study|Global deterioration of health status|2|||
161027219|NCT04171141|581492827|FG006|Overall Study|Global deterioration of health status|1|||
161027220|NCT04171141|581492828|FG007|Overall Study|Global deterioration of health status|0|||
161027221|NCT04171141|581492829|FG008|Overall Study|Global deterioration of health status|1|||
161027222|NCT04171141|581492830|FG009|Overall Study|Global deterioration of health status|0|||
161027223|NCT04171141|581492831|FG010|Overall Study|Global deterioration of health status|0|||
161027224|NCT04171141|581492832|FG011|Overall Study|Global deterioration of health status|0|||
161027225|NCT04171141|581492833|FG012|Overall Study|Global deterioration of health status|0|||
161027226|NCT04171141|581492834|FG013|Overall Study|Global deterioration of health status|0|||
161027227|NCT04171141|581492835|FG014|Overall Study|Global deterioration of health status|1|||
161027228|NCT04171141|581492836|FG015|Overall Study|Global deterioration of health status|1|||
161027229|NCT03314454|581492837|FG000|Overall Study|Protocol Violation|1|||
161027230|NCT02841579|581492838|FG000|Overall Study|Death|1|||
161027231|NCT02841579|581492838|FG000|Overall Study|Adverse Event|1|||
161027232|NCT02841579|581492838|FG000|Overall Study|Lack of Efficacy|9|||
161027233|NCT04979442|581492839|FG000|Overall Study|Death|43|||
161027234|NCT04979442|581492840|FG001|Overall Study|Death|30|||
161027235|NCT04979442|581492839|FG000|Overall Study|Withdrawal by Subject|8|||
161027236|NCT04979442|581492840|FG001|Overall Study|Withdrawal by Subject|13|||
161027237|NCT04979442|581492839|FG000|Overall Study|Physician Decision|1|||
161027238|NCT04979442|581492840|FG001|Overall Study|Physician Decision|1|||
161027239|NCT04979442|581492839|FG000|Overall Study|Lost to Follow-up|0|||
161344145|NCT03329001|582646015|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161344146|NCT03329001|582646016|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161344147|NCT03329001|582646017|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161344148|NCT03329001|582646018|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161344149|NCT03329001|582646019|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
161344150|NCT03329001|582646020|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
161344151|NCT03329001|582646013|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161344152|NCT03329001|582646014|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161344153|NCT03329001|582646015|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161344154|NCT03329001|582646016|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161344155|NCT03329001|582646017|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161344156|NCT03329001|582646018|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
161344157|NCT03329001|582646019|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
161344158|NCT03329001|582646020|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
161344159|NCT03329001|582646013|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161344160|NCT03329001|582646014|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161344161|NCT03329001|582646015|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161344162|NCT03329001|582646016|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161344163|NCT03329001|582646017|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161344164|NCT03329001|582646018|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
161344165|NCT03329001|582646019|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
161344166|NCT03329001|582646020|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
161344167|NCT05233761|582646027|FG000|Treatment Period A|Withdrawal by Subject|12|||
161344168|NCT05233761|582646028|FG001|Treatment Period A|Withdrawal by Subject|10|||
160974503|NCT02073097|581295460|FG002|Overall Study|Withdrawal by Subject|0|||
160974504|NCT02073097|581295461|FG003|Overall Study|Withdrawal by Subject|0|||
160974505|NCT02073097|581295462|FG004|Overall Study|Withdrawal by Subject|0|||
160974506|NCT02073097|581295463|FG005|Overall Study|Withdrawal by Subject|0|||
160974507|NCT02073097|581295464|FG006|Overall Study|Withdrawal by Subject|0|||
160974508|NCT02073097|581295465|FG007|Overall Study|Withdrawal by Subject|2|||
160974509|NCT02073097|581295458|FG000|Overall Study|Death|0|||
160974510|NCT02073097|581295459|FG001|Overall Study|Death|0|||
160974511|NCT02073097|581295460|FG002|Overall Study|Death|0|||
160974512|NCT02073097|581295461|FG003|Overall Study|Death|0|||
160974513|NCT02073097|581295462|FG004|Overall Study|Death|0|||
160974514|NCT02073097|581295463|FG005|Overall Study|Death|0|||
160974515|NCT02073097|581295464|FG006|Overall Study|Death|0|||
160974516|NCT02073097|581295465|FG007|Overall Study|Death|1|||
160974517|NCT02073097|581295458|FG000|Overall Study|Physician Decision|0|||
160974518|NCT02073097|581295459|FG001|Overall Study|Physician Decision|0|||
160974519|NCT02073097|581295460|FG002|Overall Study|Physician Decision|0|||
160974520|NCT02073097|581295461|FG003|Overall Study|Physician Decision|0|||
160974521|NCT02073097|581295462|FG004|Overall Study|Physician Decision|0|||
160974522|NCT02073097|581295463|FG005|Overall Study|Physician Decision|0|||
160974523|NCT02073097|581295464|FG006|Overall Study|Physician Decision|0|||
160974524|NCT02073097|581295465|FG007|Overall Study|Physician Decision|1|||
160974525|NCT01693692|581295468|FG000|Overall Study|Withdrawal by Subject|12|||
160974526|NCT01693692|581295469|FG001|Overall Study|Withdrawal by Subject|10|||
160974527|NCT01693692|581295470|FG002|Overall Study|Withdrawal by Subject|11|||
160974528|NCT01693692|581295468|FG000|Overall Study|Adverse Event|7|||
160974529|NCT01693692|581295469|FG001|Overall Study|Adverse Event|14|||
160974530|NCT01693692|581295470|FG002|Overall Study|Adverse Event|9|||
160974531|NCT01693692|581295468|FG000|Overall Study|Physician Decision|0|||
160974532|NCT01693692|581295469|FG001|Overall Study|Physician Decision|0|||
160974533|NCT01693692|581295470|FG002|Overall Study|Physician Decision|1|||
160974534|NCT01693692|581295468|FG000|Overall Study|Protocol Violation|5|||
160974535|NCT01693692|581295469|FG001|Overall Study|Protocol Violation|4|||
160974536|NCT01693692|581295470|FG002|Overall Study|Protocol Violation|6|||
160974537|NCT01693692|581295468|FG000|Overall Study|Lost to Follow-up|2|||
160974538|NCT01693692|581295469|FG001|Overall Study|Lost to Follow-up|2|||
160974539|NCT01693692|581295470|FG002|Overall Study|Lost to Follow-up|3|||
160974540|NCT01693692|581295468|FG000|Overall Study|Other|4|||
160974541|NCT01693692|581295469|FG001|Overall Study|Other|4|||
160974542|NCT01693692|581295470|FG002|Overall Study|Other|6|||
160974543|NCT04424290|581297484|FG000|Overall Study|Not treated|0|||
160974544|NCT04424290|581297485|FG001|Overall Study|Not treated|0|||
160974545|NCT04424290|581297486|FG002|Overall Study|Not treated|1|||
160974546|NCT04424290|581297487|FG003|Overall Study|Not treated|0|||
160974547|NCT04424290|581297488|FG004|Overall Study|Not treated|1|||
160974548|NCT04424290|581297484|FG000|Overall Study|Adverse Event|0|||
160974549|NCT04424290|581297485|FG001|Overall Study|Adverse Event|0|||
160974550|NCT04424290|581297486|FG002|Overall Study|Adverse Event|0|||
160974551|NCT04424290|581297487|FG003|Overall Study|Adverse Event|2|||
160974552|NCT04424290|581297488|FG004|Overall Study|Adverse Event|0|||
160974553|NCT04424290|581297484|FG000|Overall Study|Withdrawal by Subject|0|||
160974554|NCT04424290|581297485|FG001|Overall Study|Withdrawal by Subject|0|||
161027240|NCT04979442|581492840|FG001|Overall Study|Lost to Follow-up|2|||
161027241|NCT04979442|581492839|FG000|Overall Study|do not want to continue|0|||
161027242|NCT04979442|581492840|FG001|Overall Study|do not want to continue|1|||
161027243|NCT04005794|581492842|FG000|Overall Study|Lost to Follow-up|0|||
161027244|NCT04005794|581492843|FG001|Overall Study|Lost to Follow-up|4|||
161027245|NCT04005794|581492844|FG002|Overall Study|Lost to Follow-up|0|||
161027246|NCT00104676|581492848|FG000|Overall Study|Death|3|||
161027247|NCT00104676|581492849|FG001|Overall Study|Death|2|||
161027248|NCT00104676|581492848|FG000|Overall Study|Withdrawal by Subject|0|||
161027249|NCT00104676|581492849|FG001|Overall Study|Withdrawal by Subject|2|||
161027250|NCT00104676|581492848|FG000|Overall Study|treatment interruption|4|||
161027251|NCT00104676|581492849|FG001|Overall Study|treatment interruption|10|||
161027252|NCT05622812|581492850|FG000|Overall Study|Withdrawal by Subject|1|||
161027253|NCT05622812|581492851|FG001|Overall Study|Withdrawal by Subject|4|||
161027254|NCT05622812|581492850|FG000|Overall Study|Lost to Follow-up|2|||
161027255|NCT05622812|581492851|FG001|Overall Study|Lost to Follow-up|1|||
161027256|NCT03916185|581492852|FG000|Overall Study|Lost to Follow-up|0|||
161027257|NCT03916185|581492853|FG001|Overall Study|Lost to Follow-up|1|||
161027258|NCT03916185|581492854|FG002|Overall Study|Lost to Follow-up|0|||
161027259|NCT03916185|581492855|FG003|Overall Study|Lost to Follow-up|0|||
161027260|NCT03916185|581492852|FG000|Overall Study|Moved|1|||
161027261|NCT03916185|581492853|FG001|Overall Study|Moved|0|||
161027262|NCT03916185|581492854|FG002|Overall Study|Moved|0|||
161027263|NCT03916185|581492855|FG003|Overall Study|Moved|1|||
161027264|NCT03916185|581492852|FG000|Overall Study|Not Able to Get to Clinic|1|||
161027265|NCT03916185|581492853|FG001|Overall Study|Not Able to Get to Clinic|0|||
161027266|NCT03916185|581492854|FG002|Overall Study|Not Able to Get to Clinic|0|||
161027267|NCT03916185|581492855|FG003|Overall Study|Not Able to Get to Clinic|0|||
161027268|NCT03766685|581492856|FG000|Overall Study|Lost to Follow-up|1|||
161027269|NCT03766685|581492857|FG001|Overall Study|Lost to Follow-up|1|||
161027270|NCT03766685|581492858|FG002|Overall Study|Lost to Follow-up|0|||
161027271|NCT03766685|581492859|FG003|Overall Study|Lost to Follow-up|0|||
161027272|NCT03766685|581492856|FG000|Overall Study|Adverse Event, not fatal|0|||
161027273|NCT03766685|581492857|FG001|Overall Study|Adverse Event, not fatal|1|||
161027274|NCT03766685|581492858|FG002|Overall Study|Adverse Event, not fatal|0|||
161027275|NCT03766685|581492859|FG003|Overall Study|Adverse Event, not fatal|1|||
161027276|NCT03766685|581492856|FG000|Overall Study|Withdrawal by Subject|0|||
161027277|NCT03766685|581492857|FG001|Overall Study|Withdrawal by Subject|2|||
161027278|NCT03766685|581492858|FG002|Overall Study|Withdrawal by Subject|0|||
161027279|NCT03766685|581492859|FG003|Overall Study|Withdrawal by Subject|0|||
161027280|NCT03766685|581492856|FG000|Overall Study|Protocol Violation|0|||
161027281|NCT03766685|581492857|FG001|Overall Study|Protocol Violation|1|||
161027282|NCT03766685|581492858|FG002|Overall Study|Protocol Violation|0|||
161027283|NCT03766685|581492859|FG003|Overall Study|Protocol Violation|0|||
161027284|NCT03766685|581492856|FG000|Overall Study|Non-compliance|0|||
161027285|NCT03766685|581492857|FG001|Overall Study|Non-compliance|2|||
161027286|NCT03766685|581492858|FG002|Overall Study|Non-compliance|0|||
161027287|NCT03766685|581492859|FG003|Overall Study|Non-compliance|0|||
161027288|NCT02116530|581492860|FG000|Overall Study|Withdrawal by Subject|1|||
161027289|NCT02116530|581492861|FG001|Overall Study|Withdrawal by Subject|2|||
161027290|NCT02116530|581492860|FG000|Overall Study|Adverse Event|4|||
161027291|NCT02116530|581492861|FG001|Overall Study|Adverse Event|0|||
161027292|NCT02116530|581492860|FG000|Overall Study|Physician Decision|1|||
161027293|NCT02116530|581492861|FG001|Overall Study|Physician Decision|0|||
161027294|NCT02116530|581492860|FG000|Overall Study|Lost to Follow-up|1|||
161027295|NCT02116530|581492861|FG001|Overall Study|Lost to Follow-up|0|||
161027296|NCT02116530|581492860|FG000|Overall Study|Other Medical Problems|2|||
161027297|NCT02116530|581492861|FG001|Overall Study|Other Medical Problems|2|||
161027298|NCT02844465|581492864|FG000|Overall Study|Screen Failure|36|||
161027299|NCT02844465|581492864|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
161027300|NCT02844465|581492864|FG000|Overall Study|Withdrawal by Subject|5|||
161027301|NCT02844465|581492864|FG000|Overall Study|Lost to Follow-up|1|||
161027302|NCT02844465|581492864|FG000|Overall Study|Retreatment|1|||
161027303|NCT05029622|581492865|FG000|Overall Study|Lost to Follow-up|1|||
161027304|NCT05671653|581492866|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
161027305|NCT05671653|581492867|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
161027306|NCT05671653|581492868|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
161027307|NCT05671653|581492869|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
161027308|NCT05671653|581492870|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
161027309|NCT05671653|581492871|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
161027310|NCT05671653|581492872|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
161027311|NCT05671653|581492873|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
161027312|NCT05671653|581492874|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
161027313|NCT05671653|581492875|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
161027314|NCT05671653|581492876|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
161027315|NCT05671653|581492877|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
161027316|NCT05671653|581492878|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
161027317|NCT05671653|581492866|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027318|NCT05671653|581492867|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027319|NCT05671653|581492868|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027320|NCT05671653|581492869|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027321|NCT05671653|581492870|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027322|NCT05671653|581492871|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
161027323|NCT05671653|581492872|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027324|NCT05671653|581492873|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027325|NCT05671653|581492874|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027326|NCT05671653|581492875|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027327|NCT05671653|581492876|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027328|NCT05671653|581492877|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027329|NCT05671653|581492878|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
161027330|NCT05671653|581492866|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027331|NCT05671653|581492867|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027332|NCT05671653|581492868|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027333|NCT05671653|581492869|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027334|NCT05671653|581492870|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027335|NCT05671653|581492871|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
161027336|NCT05671653|581492872|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027337|NCT05671653|581492873|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027338|NCT05671653|581492874|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027339|NCT05671653|581492875|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027340|NCT05671653|581492876|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027341|NCT05671653|581492877|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027342|NCT05671653|581492878|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
161027343|NCT05671653|581492866|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027344|NCT05671653|581492867|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027345|NCT05671653|581492868|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027346|NCT05671653|581492869|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027347|NCT05671653|581492870|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027348|NCT05671653|581492871|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027349|NCT05671653|581492872|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027350|NCT05671653|581492873|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027351|NCT05671653|581492874|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
161027352|NCT05671653|581492875|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027353|NCT05671653|581492876|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027354|NCT05671653|581492877|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027355|NCT05671653|581492878|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
161027356|NCT05671653|581492866|FG000|Cohort 2 Period 2|Adverse Event|0|||
161027357|NCT05671653|581492867|FG001|Cohort 2 Period 2|Adverse Event|0|||
161027358|NCT05671653|581492868|FG002|Cohort 2 Period 2|Adverse Event|0|||
161027359|NCT05671653|581492869|FG003|Cohort 2 Period 2|Adverse Event|0|||
161027360|NCT05671653|581492870|FG004|Cohort 2 Period 2|Adverse Event|0|||
161027361|NCT05671653|581492871|FG005|Cohort 2 Period 2|Adverse Event|0|||
161027362|NCT05671653|581492872|FG006|Cohort 2 Period 2|Adverse Event|0|||
161027363|NCT05671653|581492873|FG007|Cohort 2 Period 2|Adverse Event|0|||
161027364|NCT05671653|581492874|FG008|Cohort 2 Period 2|Adverse Event|0|||
161027365|NCT05671653|581492875|FG009|Cohort 2 Period 2|Adverse Event|0|||
161027366|NCT05671653|581492876|FG010|Cohort 2 Period 2|Adverse Event|1|||
161027367|NCT05671653|581492877|FG011|Cohort 2 Period 2|Adverse Event|0|||
161027368|NCT05671653|581492878|FG012|Cohort 2 Period 2|Adverse Event|0|||
161027369|NCT05671653|581492866|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
161027370|NCT05671653|581492867|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
161027371|NCT05671653|581492868|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
161027372|NCT05671653|581492869|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
161276141|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161276142|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
161276143|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
161276144|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
161276145|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161027373|NCT05671653|581492870|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
161276146|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161027374|NCT05671653|581492871|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
161027375|NCT05671653|581492872|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
161027376|NCT05671653|581492873|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
161027377|NCT05671653|581492874|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
161027378|NCT05671653|581492875|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
161027379|NCT05671653|581492876|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
161027380|NCT05671653|581492877|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
161027381|NCT05671653|581492878|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
161027382|NCT05671653|581492866|FG000|Cohort 2 Period 2|Pregnancy|0|||
161027383|NCT05671653|581492867|FG001|Cohort 2 Period 2|Pregnancy|0|||
161027384|NCT05671653|581492868|FG002|Cohort 2 Period 2|Pregnancy|0|||
161027385|NCT05671653|581492869|FG003|Cohort 2 Period 2|Pregnancy|0|||
161027386|NCT05671653|581492870|FG004|Cohort 2 Period 2|Pregnancy|0|||
161027387|NCT05671653|581492871|FG005|Cohort 2 Period 2|Pregnancy|0|||
161027388|NCT05671653|581492872|FG006|Cohort 2 Period 2|Pregnancy|0|||
161027389|NCT05671653|581492873|FG007|Cohort 2 Period 2|Pregnancy|0|||
161027390|NCT05671653|581492874|FG008|Cohort 2 Period 2|Pregnancy|0|||
161027391|NCT05671653|581492875|FG009|Cohort 2 Period 2|Pregnancy|0|||
161027392|NCT05671653|581492876|FG010|Cohort 2 Period 2|Pregnancy|1|||
161027393|NCT05671653|581492877|FG011|Cohort 2 Period 2|Pregnancy|0|||
161027394|NCT05671653|581492878|FG012|Cohort 2 Period 2|Pregnancy|0|||
161027395|NCT05671653|581492866|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027396|NCT05671653|581492867|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027397|NCT05671653|581492868|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027398|NCT05671653|581492869|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027399|NCT05671653|581492870|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027400|NCT05671653|581492871|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027401|NCT05671653|581492872|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027402|NCT05671653|581492873|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027403|NCT05671653|581492874|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027404|NCT05671653|581492875|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027405|NCT05671653|581492876|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
161027406|NCT05671653|581492877|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027407|NCT05671653|581492878|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
161027408|NCT05671653|581492866|FG000|Cohort 2 Period 2|Other|0|||
161027409|NCT05671653|581492867|FG001|Cohort 2 Period 2|Other|0|||
161027410|NCT05671653|581492868|FG002|Cohort 2 Period 2|Other|0|||
161027411|NCT05671653|581492869|FG003|Cohort 2 Period 2|Other|0|||
161027412|NCT05671653|581492870|FG004|Cohort 2 Period 2|Other|0|||
161027413|NCT05671653|581492871|FG005|Cohort 2 Period 2|Other|0|||
161027414|NCT05671653|581492872|FG006|Cohort 2 Period 2|Other|0|||
161027415|NCT05671653|581492873|FG007|Cohort 2 Period 2|Other|0|||
161027416|NCT05671653|581492874|FG008|Cohort 2 Period 2|Other|0|||
161027417|NCT05671653|581492875|FG009|Cohort 2 Period 2|Other|0|||
161027418|NCT05671653|581492876|FG010|Cohort 2 Period 2|Other|1|||
161027419|NCT05671653|581492877|FG011|Cohort 2 Period 2|Other|0|||
161027420|NCT05671653|581492878|FG012|Cohort 2 Period 2|Other|0|||
161027421|NCT05671653|581492866|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027422|NCT05671653|581492867|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027423|NCT05671653|581492868|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027424|NCT05671653|581492869|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027425|NCT05671653|581492870|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027426|NCT05671653|581492871|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027427|NCT05671653|581492872|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027428|NCT05671653|581492873|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027429|NCT05671653|581492874|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027430|NCT05671653|581492875|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027431|NCT05671653|581492876|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027432|NCT05671653|581492877|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
161027433|NCT05671653|581492878|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
161027434|NCT06232590|581492882|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
161027435|NCT06232590|581492883|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
161027436|NCT02460458|581492884|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
161027437|NCT02460458|581492884|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
161027438|NCT02460458|581492884|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
161027439|NCT02460458|581492884|FG000|First Prospective Phase|Lost to Follow-up|84|||
161027440|NCT02460458|581492884|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
161027441|NCT04362254|581492890|FG000|Overall Study|Adverse Event|1|||
161027442|NCT04362254|581492890|FG000|Overall Study|Protocol Violation|1|||
161027443|NCT04362254|581492890|FG000|Overall Study|Due to early termination of the trial|10|||
161027444|NCT04076618|581492891|FG000|Overall Study|Lost to Follow-up|2|||
161027445|NCT04076618|581492892|FG001|Overall Study|Lost to Follow-up|1|||
161027446|NCT04076618|581492893|FG002|Overall Study|Lost to Follow-up|3|||
161027447|NCT04076618|581492891|FG000|Overall Study|Withdrawal by Subject|3|||
161027448|NCT04076618|581492892|FG001|Overall Study|Withdrawal by Subject|1|||
161027449|NCT04076618|581492893|FG002|Overall Study|Withdrawal by Subject|2|||
161027450|NCT04076618|581492891|FG000|Overall Study|Relocated out of state|0|||
161027451|NCT04076618|581492892|FG001|Overall Study|Relocated out of state|2|||
161027452|NCT04076618|581492893|FG002|Overall Study|Relocated out of state|0|||
161027453|NCT04076618|581492891|FG000|Overall Study|COVID concerns|0|||
161027454|NCT04076618|581492892|FG001|Overall Study|COVID concerns|1|||
161027455|NCT04076618|581492893|FG002|Overall Study|COVID concerns|0|||
161027456|NCT04076618|581492891|FG000|Overall Study|Adverse Event|0|||
161027457|NCT04076618|581492892|FG001|Overall Study|Adverse Event|0|||
161027458|NCT04076618|581492893|FG002|Overall Study|Adverse Event|2|||
161027459|NCT01928394|581492894|FG000|Treatment Period|Disease progression|17|||
160974555|NCT04424290|581297486|FG002|Overall Study|Withdrawal by Subject|0|||
161027460|NCT01928394|581492895|FG001|Treatment Period|Disease progression|2|||
161027461|NCT01928394|581492896|FG002|Treatment Period|Disease progression|12|||
161027462|NCT01928394|581492897|FG003|Treatment Period|Disease progression|48|||
161027463|NCT01928394|581492898|FG004|Treatment Period|Disease progression|3|||
161027464|NCT01928394|581492899|FG005|Treatment Period|Disease progression|25|||
161027465|NCT01928394|581492900|FG006|Treatment Period|Disease progression|38|||
161027466|NCT01928394|581492901|FG007|Treatment Period|Disease progression|16|||
161027467|NCT01928394|581492902|FG008|Treatment Period|Disease progression|3|||
161027468|NCT01928394|581492903|FG009|Treatment Period|Disease progression|11|||
161027469|NCT01928394|581492904|FG010|Treatment Period|Disease progression|22|||
161027470|NCT01928394|581492905|FG011|Treatment Period|Disease progression|73|||
161027471|NCT01928394|581492906|FG012|Treatment Period|Disease progression|38|||
161027472|NCT01928394|581492907|FG013|Treatment Period|Disease progression|118|||
161027473|NCT01928394|581492908|FG014|Treatment Period|Disease progression|59|||
161027474|NCT01928394|581492909|FG015|Treatment Period|Disease progression|1|||
161027475|NCT01928394|581492910|FG016|Treatment Period|Disease progression|43|||
161027476|NCT01928394|581492911|FG017|Treatment Period|Disease progression|56|||
161027477|NCT01928394|581492912|FG018|Treatment Period|Disease progression|50|||
161027478|NCT01928394|581492913|FG019|Treatment Period|Disease progression|71|||
161027479|NCT01928394|581492914|FG020|Treatment Period|Disease progression|30|||
161027480|NCT01928394|581492915|FG021|Treatment Period|Disease progression|31|||
161027481|NCT01928394|581492916|FG022|Treatment Period|Disease progression|31|||
161027482|NCT01928394|581492894|FG000|Treatment Period|Study drug toxicity|1|||
161027483|NCT01928394|581492895|FG001|Treatment Period|Study drug toxicity|1|||
161027484|NCT01928394|581492896|FG002|Treatment Period|Study drug toxicity|3|||
161027485|NCT01928394|581492897|FG003|Treatment Period|Study drug toxicity|3|||
161027486|NCT01928394|581492898|FG004|Treatment Period|Study drug toxicity|0|||
161027487|NCT01928394|581492899|FG005|Treatment Period|Study drug toxicity|9|||
161027488|NCT01928394|581492900|FG006|Treatment Period|Study drug toxicity|7|||
161027489|NCT01928394|581492901|FG007|Treatment Period|Study drug toxicity|1|||
161027490|NCT01928394|581492902|FG008|Treatment Period|Study drug toxicity|0|||
161027491|NCT01928394|581492903|FG009|Treatment Period|Study drug toxicity|5|||
161027492|NCT01928394|581492904|FG010|Treatment Period|Study drug toxicity|2|||
161027493|NCT01928394|581492905|FG011|Treatment Period|Study drug toxicity|3|||
161027494|NCT01928394|581492906|FG012|Treatment Period|Study drug toxicity|7|||
161027495|NCT01928394|581492907|FG013|Treatment Period|Study drug toxicity|5|||
161027496|NCT01928394|581492908|FG014|Treatment Period|Study drug toxicity|12|||
161027497|NCT01928394|581492909|FG015|Treatment Period|Study drug toxicity|0|||
161027498|NCT01928394|581492910|FG016|Treatment Period|Study drug toxicity|3|||
161027499|NCT01928394|581492911|FG017|Treatment Period|Study drug toxicity|3|||
161027500|NCT01928394|581492912|FG018|Treatment Period|Study drug toxicity|12|||
161027501|NCT01928394|581492913|FG019|Treatment Period|Study drug toxicity|15|||
160974556|NCT04424290|581297487|FG003|Overall Study|Withdrawal by Subject|0|||
160974557|NCT04424290|581297488|FG004|Overall Study|Withdrawal by Subject|1|||
160974558|NCT04424290|581297484|FG000|Overall Study|Other than listed|0|||
160974559|NCT04424290|581297485|FG001|Overall Study|Other than listed|0|||
160974560|NCT04424290|581297486|FG002|Overall Study|Other than listed|0|||
160974561|NCT04424290|581297487|FG003|Overall Study|Other than listed|1|||
160974562|NCT04424290|581297488|FG004|Overall Study|Other than listed|0|||
160974563|NCT02914184|581297492|FG000|Overall Study|Lost to Follow-up|7|||
160974564|NCT02914184|581297493|FG001|Overall Study|Lost to Follow-up|10|||
160974565|NCT02914184|581297494|FG002|Overall Study|Lost to Follow-up|8|||
160974566|NCT02914184|581297495|FG003|Overall Study|Lost to Follow-up|7|||
160974567|NCT02914184|581297492|FG000|Overall Study|Withdrawal by Subject|4|||
160974568|NCT02914184|581297493|FG001|Overall Study|Withdrawal by Subject|2|||
160974569|NCT02914184|581297494|FG002|Overall Study|Withdrawal by Subject|7|||
160974570|NCT02914184|581297495|FG003|Overall Study|Withdrawal by Subject|3|||
160974571|NCT02914184|581297492|FG000|Overall Study|Other|1|||
160974572|NCT02914184|581297493|FG001|Overall Study|Other|0|||
160974573|NCT02914184|581297494|FG002|Overall Study|Other|0|||
160974574|NCT02914184|581297495|FG003|Overall Study|Other|0|||
160974575|NCT02914184|581297492|FG000|Overall Study|Migrated/moved from the study area|2|||
160974576|NCT02914184|581297493|FG001|Overall Study|Migrated/moved from the study area|1|||
160974577|NCT02914184|581297494|FG002|Overall Study|Migrated/moved from the study area|2|||
160974578|NCT02914184|581297495|FG003|Overall Study|Migrated/moved from the study area|1|||
160974579|NCT00798174|581297496|FG000|Overall Study|inability to implant azygos coil|3|||
160974580|NCT00798174|581297497|FG001|Overall Study|inability to implant azygos coil|3|||
160974581|NCT00798174|581297496|FG000|Overall Study|Inability to sedate for DFT testing|1|||
160974582|NCT00798174|581297497|FG001|Overall Study|Inability to sedate for DFT testing|0|||
161027502|NCT01928394|581492914|FG020|Treatment Period|Study drug toxicity|4|||
161027503|NCT01928394|581492915|FG021|Treatment Period|Study drug toxicity|7|||
161027504|NCT01928394|581492916|FG022|Treatment Period|Study drug toxicity|4|||
161027505|NCT01928394|581492894|FG000|Treatment Period|AE unrelated to study drug|0|||
161027506|NCT01928394|581492895|FG001|Treatment Period|AE unrelated to study drug|0|||
161027507|NCT01928394|581492896|FG002|Treatment Period|AE unrelated to study drug|2|||
161276147|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161027508|NCT01928394|581492897|FG003|Treatment Period|AE unrelated to study drug|3|||
161027509|NCT01928394|581492898|FG004|Treatment Period|AE unrelated to study drug|0|||
161027510|NCT01928394|581492899|FG005|Treatment Period|AE unrelated to study drug|5|||
161027511|NCT01928394|581492900|FG006|Treatment Period|AE unrelated to study drug|1|||
161027512|NCT01928394|581492901|FG007|Treatment Period|AE unrelated to study drug|0|||
161027513|NCT01928394|581492902|FG008|Treatment Period|AE unrelated to study drug|0|||
161027514|NCT01928394|581492903|FG009|Treatment Period|AE unrelated to study drug|2|||
161027515|NCT01928394|581492904|FG010|Treatment Period|AE unrelated to study drug|0|||
161027516|NCT01928394|581492905|FG011|Treatment Period|AE unrelated to study drug|12|||
161027517|NCT01928394|581492906|FG012|Treatment Period|AE unrelated to study drug|6|||
161027518|NCT01928394|581492907|FG013|Treatment Period|AE unrelated to study drug|13|||
161027519|NCT01928394|581492908|FG014|Treatment Period|AE unrelated to study drug|6|||
161027520|NCT01928394|581492909|FG015|Treatment Period|AE unrelated to study drug|1|||
161027521|NCT01928394|581492910|FG016|Treatment Period|AE unrelated to study drug|1|||
161027522|NCT01928394|581492911|FG017|Treatment Period|AE unrelated to study drug|6|||
161027523|NCT01928394|581492912|FG018|Treatment Period|AE unrelated to study drug|3|||
161027524|NCT01928394|581492913|FG019|Treatment Period|AE unrelated to study drug|5|||
161027525|NCT01928394|581492914|FG020|Treatment Period|AE unrelated to study drug|1|||
161027526|NCT01928394|581492915|FG021|Treatment Period|AE unrelated to study drug|1|||
161027527|NCT01928394|581492916|FG022|Treatment Period|AE unrelated to study drug|0|||
161027528|NCT01928394|581492894|FG000|Treatment Period|Participant request to stop therapy|0|||
161027529|NCT01928394|581492895|FG001|Treatment Period|Participant request to stop therapy|0|||
161027530|NCT01928394|581492896|FG002|Treatment Period|Participant request to stop therapy|0|||
161027531|NCT01928394|581492897|FG003|Treatment Period|Participant request to stop therapy|0|||
161027532|NCT01928394|581492898|FG004|Treatment Period|Participant request to stop therapy|0|||
161027533|NCT01928394|581492899|FG005|Treatment Period|Participant request to stop therapy|3|||
161027534|NCT01928394|581492900|FG006|Treatment Period|Participant request to stop therapy|3|||
161027535|NCT01928394|581492901|FG007|Treatment Period|Participant request to stop therapy|0|||
161027536|NCT01928394|581492902|FG008|Treatment Period|Participant request to stop therapy|0|||
161027537|NCT01928394|581492903|FG009|Treatment Period|Participant request to stop therapy|0|||
161027538|NCT01928394|581492904|FG010|Treatment Period|Participant request to stop therapy|3|||
161027539|NCT01928394|581492905|FG011|Treatment Period|Participant request to stop therapy|2|||
161027540|NCT01928394|581492906|FG012|Treatment Period|Participant request to stop therapy|1|||
161027541|NCT01928394|581492907|FG013|Treatment Period|Participant request to stop therapy|2|||
161027542|NCT01928394|581492908|FG014|Treatment Period|Participant request to stop therapy|4|||
161027543|NCT01928394|581492909|FG015|Treatment Period|Participant request to stop therapy|0|||
161027544|NCT01928394|581492910|FG016|Treatment Period|Participant request to stop therapy|1|||
161027545|NCT01928394|581492911|FG017|Treatment Period|Participant request to stop therapy|3|||
161027546|NCT01928394|581492912|FG018|Treatment Period|Participant request to stop therapy|1|||
161027547|NCT01928394|581492913|FG019|Treatment Period|Participant request to stop therapy|1|||
161027548|NCT01928394|581492914|FG020|Treatment Period|Participant request to stop therapy|3|||
161027549|NCT01928394|581492915|FG021|Treatment Period|Participant request to stop therapy|1|||
161027550|NCT01928394|581492916|FG022|Treatment Period|Participant request to stop therapy|3|||
161027551|NCT01928394|581492894|FG000|Treatment Period|Participant withdrew consent|0|||
161027552|NCT01928394|581492895|FG001|Treatment Period|Participant withdrew consent|0|||
161027553|NCT01928394|581492896|FG002|Treatment Period|Participant withdrew consent|1|||
161027554|NCT01928394|581492897|FG003|Treatment Period|Participant withdrew consent|1|||
161027555|NCT01928394|581492898|FG004|Treatment Period|Participant withdrew consent|0|||
161027556|NCT01928394|581492899|FG005|Treatment Period|Participant withdrew consent|1|||
161027557|NCT01928394|581492900|FG006|Treatment Period|Participant withdrew consent|0|||
161027558|NCT01928394|581492901|FG007|Treatment Period|Participant withdrew consent|1|||
161027559|NCT01928394|581492902|FG008|Treatment Period|Participant withdrew consent|0|||
161027560|NCT01928394|581492903|FG009|Treatment Period|Participant withdrew consent|0|||
161027561|NCT01928394|581492904|FG010|Treatment Period|Participant withdrew consent|1|||
161027562|NCT01928394|581492905|FG011|Treatment Period|Participant withdrew consent|1|||
161027563|NCT01928394|581492906|FG012|Treatment Period|Participant withdrew consent|1|||
161027564|NCT01928394|581492907|FG013|Treatment Period|Participant withdrew consent|0|||
161027565|NCT01928394|581492908|FG014|Treatment Period|Participant withdrew consent|2|||
161027566|NCT01928394|581492909|FG015|Treatment Period|Participant withdrew consent|0|||
161027567|NCT01928394|581492910|FG016|Treatment Period|Participant withdrew consent|2|||
161276148|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
161276149|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
161027568|NCT01928394|581492911|FG017|Treatment Period|Participant withdrew consent|1|||
161027569|NCT01928394|581492912|FG018|Treatment Period|Participant withdrew consent|1|||
161027570|NCT01928394|581492913|FG019|Treatment Period|Participant withdrew consent|1|||
161027571|NCT01928394|581492914|FG020|Treatment Period|Participant withdrew consent|0|||
161027572|NCT01928394|581492915|FG021|Treatment Period|Participant withdrew consent|2|||
161027573|NCT01928394|581492916|FG022|Treatment Period|Participant withdrew consent|0|||
161027574|NCT01928394|581492894|FG000|Treatment Period|Poor/non-compliance|0|||
161027575|NCT01928394|581492895|FG001|Treatment Period|Poor/non-compliance|0|||
161027576|NCT01928394|581492896|FG002|Treatment Period|Poor/non-compliance|0|||
161027577|NCT01928394|581492897|FG003|Treatment Period|Poor/non-compliance|1|||
161027578|NCT01928394|581492898|FG004|Treatment Period|Poor/non-compliance|0|||
161027579|NCT01928394|581492899|FG005|Treatment Period|Poor/non-compliance|0|||
161027580|NCT01928394|581492900|FG006|Treatment Period|Poor/non-compliance|0|||
161027581|NCT01928394|581492901|FG007|Treatment Period|Poor/non-compliance|0|||
161027582|NCT01928394|581492902|FG008|Treatment Period|Poor/non-compliance|0|||
161027583|NCT01928394|581492903|FG009|Treatment Period|Poor/non-compliance|0|||
161027584|NCT01928394|581492904|FG010|Treatment Period|Poor/non-compliance|0|||
161027585|NCT01928394|581492905|FG011|Treatment Period|Poor/non-compliance|0|||
161027586|NCT01928394|581492906|FG012|Treatment Period|Poor/non-compliance|1|||
161027587|NCT01928394|581492907|FG013|Treatment Period|Poor/non-compliance|0|||
161027588|NCT01928394|581492908|FG014|Treatment Period|Poor/non-compliance|1|||
161027589|NCT01928394|581492909|FG015|Treatment Period|Poor/non-compliance|0|||
161027590|NCT01928394|581492910|FG016|Treatment Period|Poor/non-compliance|0|||
161027591|NCT01928394|581492911|FG017|Treatment Period|Poor/non-compliance|1|||
161027592|NCT01928394|581492912|FG018|Treatment Period|Poor/non-compliance|0|||
161027593|NCT01928394|581492913|FG019|Treatment Period|Poor/non-compliance|1|||
161027594|NCT01928394|581492914|FG020|Treatment Period|Poor/non-compliance|0|||
161027595|NCT01928394|581492915|FG021|Treatment Period|Poor/non-compliance|0|||
161027596|NCT01928394|581492916|FG022|Treatment Period|Poor/non-compliance|0|||
161027597|NCT01928394|581492894|FG000|Treatment Period|other reason|0|||
161027598|NCT01928394|581492895|FG001|Treatment Period|other reason|0|||
161027599|NCT01928394|581492896|FG002|Treatment Period|other reason|0|||
161027600|NCT01928394|581492897|FG003|Treatment Period|other reason|0|||
161027601|NCT01928394|581492898|FG004|Treatment Period|other reason|0|||
161027602|NCT01928394|581492899|FG005|Treatment Period|other reason|0|||
161027603|NCT01928394|581492900|FG006|Treatment Period|other reason|0|||
161027604|NCT01928394|581492901|FG007|Treatment Period|other reason|0|||
161027605|NCT01928394|581492902|FG008|Treatment Period|other reason|0|||
161027606|NCT01928394|581492903|FG009|Treatment Period|other reason|0|||
161027607|NCT01928394|581492904|FG010|Treatment Period|other reason|1|||
161027608|NCT01928394|581492905|FG011|Treatment Period|other reason|1|||
161027609|NCT01928394|581492906|FG012|Treatment Period|other reason|1|||
161027610|NCT01928394|581492907|FG013|Treatment Period|other reason|0|||
161027611|NCT01928394|581492908|FG014|Treatment Period|other reason|1|||
161027612|NCT01928394|581492909|FG015|Treatment Period|other reason|0|||
161027613|NCT01928394|581492910|FG016|Treatment Period|other reason|0|||
161027614|NCT01928394|581492911|FG017|Treatment Period|other reason|0|||
161027615|NCT01928394|581492912|FG018|Treatment Period|other reason|2|||
161027616|NCT01928394|581492913|FG019|Treatment Period|other reason|2|||
161027617|NCT01928394|581492914|FG020|Treatment Period|other reason|0|||
161027618|NCT01928394|581492915|FG021|Treatment Period|other reason|0|||
161027619|NCT01928394|581492916|FG022|Treatment Period|other reason|0|||
161027620|NCT01928394|581492894|FG000|Treatment Period|Maximum clinical benefit|0|||
160974583|NCT01683994|581297499|FG000|Overall Study|Withdrawal by Subject|1|||
160974584|NCT01683994|581297500|FG001|Overall Study|Withdrawal by Subject|0|||
160974585|NCT01683994|581297501|FG002|Overall Study|Withdrawal by Subject|0|||
160974586|NCT01683994|581297502|FG003|Overall Study|Withdrawal by Subject|1|||
160974587|NCT01683994|581297503|FG004|Overall Study|Withdrawal by Subject|0|||
160974588|NCT01683994|581297499|FG000|Overall Study|Intercurrent illness|0|||
160974589|NCT01683994|581297500|FG001|Overall Study|Intercurrent illness|0|||
160974590|NCT01683994|581297501|FG002|Overall Study|Intercurrent illness|0|||
160974591|NCT01683994|581297502|FG003|Overall Study|Intercurrent illness|2|||
160974592|NCT01683994|581297503|FG004|Overall Study|Intercurrent illness|1|||
160974593|NCT02318719|581297509|FG000|Double-blind Phase|Adverse Event|7|||
160974594|NCT02318719|581297510|FG001|Double-blind Phase|Adverse Event|6|||
160974595|NCT02318719|581297511|FG002|Double-blind Phase|Adverse Event|12|||
161276150|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
160974596|NCT02318719|581297512|FG003|Double-blind Phase|Adverse Event|4|||
160974597|NCT02318719|581297513|FG004|Double-blind Phase|Adverse Event|0|||
161027621|NCT01928394|581492895|FG001|Treatment Period|Maximum clinical benefit|0|||
161027622|NCT01928394|581492896|FG002|Treatment Period|Maximum clinical benefit|0|||
161027623|NCT01928394|581492897|FG003|Treatment Period|Maximum clinical benefit|0|||
161027624|NCT01928394|581492898|FG004|Treatment Period|Maximum clinical benefit|0|||
161027625|NCT01928394|581492899|FG005|Treatment Period|Maximum clinical benefit|0|||
161027626|NCT01928394|581492900|FG006|Treatment Period|Maximum clinical benefit|0|||
161276151|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
160974598|NCT02318719|581297509|FG000|Double-blind Phase|Lack of Efficacy|5|||
161027627|NCT01928394|581492901|FG007|Treatment Period|Maximum clinical benefit|0|||
161027628|NCT01928394|581492902|FG008|Treatment Period|Maximum clinical benefit|0|||
161027629|NCT01928394|581492903|FG009|Treatment Period|Maximum clinical benefit|0|||
160974599|NCT02318719|581297510|FG001|Double-blind Phase|Lack of Efficacy|0|||
160974600|NCT02318719|581297511|FG002|Double-blind Phase|Lack of Efficacy|1|||
161276152|NCT03713619|582391657|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
161276153|NCT03713619|582391658|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
161027630|NCT01928394|581492904|FG010|Treatment Period|Maximum clinical benefit|1|||
161027631|NCT01928394|581492905|FG011|Treatment Period|Maximum clinical benefit|1|||
161027632|NCT01928394|581492906|FG012|Treatment Period|Maximum clinical benefit|0|||
161027633|NCT01928394|581492907|FG013|Treatment Period|Maximum clinical benefit|0|||
161027634|NCT01928394|581492908|FG014|Treatment Period|Maximum clinical benefit|1|||
161027635|NCT01928394|581492909|FG015|Treatment Period|Maximum clinical benefit|0|||
161027636|NCT01928394|581492910|FG016|Treatment Period|Maximum clinical benefit|0|||
161027637|NCT01928394|581492911|FG017|Treatment Period|Maximum clinical benefit|1|||
161027638|NCT01928394|581492912|FG018|Treatment Period|Maximum clinical benefit|1|||
161027639|NCT01928394|581492913|FG019|Treatment Period|Maximum clinical benefit|0|||
161027640|NCT01928394|581492914|FG020|Treatment Period|Maximum clinical benefit|2|||
161027641|NCT01928394|581492915|FG021|Treatment Period|Maximum clinical benefit|0|||
161027642|NCT01928394|581492916|FG022|Treatment Period|Maximum clinical benefit|0|||
161027643|NCT01928394|581492894|FG000|Treatment Period|Lost to Follow-up|0|||
161027644|NCT01928394|581492895|FG001|Treatment Period|Lost to Follow-up|0|||
161027645|NCT01928394|581492896|FG002|Treatment Period|Lost to Follow-up|0|||
161027646|NCT01928394|581492897|FG003|Treatment Period|Lost to Follow-up|0|||
161027647|NCT01928394|581492898|FG004|Treatment Period|Lost to Follow-up|0|||
161027648|NCT01928394|581492899|FG005|Treatment Period|Lost to Follow-up|0|||
161027649|NCT01928394|581492900|FG006|Treatment Period|Lost to Follow-up|0|||
161027650|NCT01928394|581492901|FG007|Treatment Period|Lost to Follow-up|0|||
161027651|NCT01928394|581492902|FG008|Treatment Period|Lost to Follow-up|0|||
161027652|NCT01928394|581492903|FG009|Treatment Period|Lost to Follow-up|0|||
161027653|NCT01928394|581492904|FG010|Treatment Period|Lost to Follow-up|0|||
161027654|NCT01928394|581492905|FG011|Treatment Period|Lost to Follow-up|0|||
161027655|NCT01928394|581492906|FG012|Treatment Period|Lost to Follow-up|0|||
161027656|NCT01928394|581492907|FG013|Treatment Period|Lost to Follow-up|0|||
161027657|NCT01928394|581492908|FG014|Treatment Period|Lost to Follow-up|0|||
161027658|NCT01928394|581492909|FG015|Treatment Period|Lost to Follow-up|0|||
161027659|NCT01928394|581492910|FG016|Treatment Period|Lost to Follow-up|0|||
161027660|NCT01928394|581492911|FG017|Treatment Period|Lost to Follow-up|0|||
161027661|NCT01928394|581492912|FG018|Treatment Period|Lost to Follow-up|0|||
161027662|NCT01928394|581492913|FG019|Treatment Period|Lost to Follow-up|0|||
161027663|NCT01928394|581492914|FG020|Treatment Period|Lost to Follow-up|0|||
161027664|NCT01928394|581492915|FG021|Treatment Period|Lost to Follow-up|0|||
161027665|NCT01928394|581492916|FG022|Treatment Period|Lost to Follow-up|1|||
161027666|NCT01928394|581492894|FG000|Treatment Period|Death|0|||
161027667|NCT01928394|581492895|FG001|Treatment Period|Death|0|||
161027668|NCT01928394|581492896|FG002|Treatment Period|Death|0|||
161027669|NCT01928394|581492897|FG003|Treatment Period|Death|0|||
161027670|NCT01928394|581492898|FG004|Treatment Period|Death|0|||
161027671|NCT01928394|581492899|FG005|Treatment Period|Death|0|||
161027672|NCT01928394|581492900|FG006|Treatment Period|Death|0|||
161027673|NCT01928394|581492901|FG007|Treatment Period|Death|0|||
161027674|NCT01928394|581492902|FG008|Treatment Period|Death|0|||
161027675|NCT01928394|581492903|FG009|Treatment Period|Death|0|||
161027676|NCT01928394|581492904|FG010|Treatment Period|Death|0|||
161027677|NCT01928394|581492905|FG011|Treatment Period|Death|0|||
161027678|NCT01928394|581492906|FG012|Treatment Period|Death|0|||
161027679|NCT01928394|581492907|FG013|Treatment Period|Death|1|||
161027680|NCT01928394|581492908|FG014|Treatment Period|Death|2|||
161027681|NCT01928394|581492909|FG015|Treatment Period|Death|0|||
161027682|NCT01928394|581492910|FG016|Treatment Period|Death|0|||
161027683|NCT01928394|581492911|FG017|Treatment Period|Death|0|||
161027684|NCT01928394|581492912|FG018|Treatment Period|Death|0|||
161027685|NCT01928394|581492913|FG019|Treatment Period|Death|0|||
161027686|NCT01928394|581492914|FG020|Treatment Period|Death|0|||
161027687|NCT01928394|581492915|FG021|Treatment Period|Death|0|||
161027688|NCT01928394|581492916|FG022|Treatment Period|Death|0|||
161027689|NCT01928394|581492894|FG000|Follow-up Period|Participant withdrew consent|3|||
161027690|NCT01928394|581492895|FG001|Follow-up Period|Participant withdrew consent|0|||
161027691|NCT01928394|581492896|FG002|Follow-up Period|Participant withdrew consent|1|||
161027692|NCT01928394|581492897|FG003|Follow-up Period|Participant withdrew consent|4|||
161027693|NCT01928394|581492898|FG004|Follow-up Period|Participant withdrew consent|0|||
161027694|NCT01928394|581492899|FG005|Follow-up Period|Participant withdrew consent|2|||
161027695|NCT01928394|581492900|FG006|Follow-up Period|Participant withdrew consent|5|||
161027696|NCT01928394|581492901|FG007|Follow-up Period|Participant withdrew consent|1|||
161027697|NCT01928394|581492902|FG008|Follow-up Period|Participant withdrew consent|0|||
161027698|NCT01928394|581492903|FG009|Follow-up Period|Participant withdrew consent|0|||
161027699|NCT01928394|581492904|FG010|Follow-up Period|Participant withdrew consent|5|||
161027700|NCT01928394|581492905|FG011|Follow-up Period|Participant withdrew consent|8|||
161027701|NCT01928394|581492906|FG012|Follow-up Period|Participant withdrew consent|2|||
161027702|NCT01928394|581492907|FG013|Follow-up Period|Participant withdrew consent|12|||
161027703|NCT01928394|581492908|FG014|Follow-up Period|Participant withdrew consent|7|||
161027704|NCT01928394|581492909|FG015|Follow-up Period|Participant withdrew consent|0|||
161027705|NCT01928394|581492910|FG016|Follow-up Period|Participant withdrew consent|5|||
161027706|NCT01928394|581492911|FG017|Follow-up Period|Participant withdrew consent|3|||
161027707|NCT01928394|581492912|FG018|Follow-up Period|Participant withdrew consent|2|||
161027708|NCT01928394|581492913|FG019|Follow-up Period|Participant withdrew consent|7|||
161027709|NCT01928394|581492914|FG020|Follow-up Period|Participant withdrew consent|4|||
161027710|NCT01928394|581492915|FG021|Follow-up Period|Participant withdrew consent|6|||
161027711|NCT01928394|581492916|FG022|Follow-up Period|Participant withdrew consent|2|||
161027712|NCT01928394|581492894|FG000|Follow-up Period|Death|0|||
161027713|NCT01928394|581492895|FG001|Follow-up Period|Death|0|||
161027714|NCT01928394|581492896|FG002|Follow-up Period|Death|2|||
161027715|NCT01928394|581492897|FG003|Follow-up Period|Death|6|||
161027716|NCT01928394|581492898|FG004|Follow-up Period|Death|0|||
161027717|NCT01928394|581492899|FG005|Follow-up Period|Death|6|||
161027718|NCT01928394|581492900|FG006|Follow-up Period|Death|6|||
161027719|NCT01928394|581492901|FG007|Follow-up Period|Death|2|||
161027720|NCT01928394|581492902|FG008|Follow-up Period|Death|1|||
161027721|NCT01928394|581492903|FG009|Follow-up Period|Death|2|||
161276154|NCT03713619|582391659|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161276155|NCT03713619|582391660|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161276156|NCT03713619|582391661|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
161276157|NCT03713619|582391657|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
161276158|NCT03713619|582391658|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
161276159|NCT03713619|582391659|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
161276160|NCT03713619|582391660|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
161276161|NCT03713619|582391661|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
161276162|NCT03713619|582391657|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161276163|NCT03713619|582391658|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161276164|NCT03713619|582391659|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161276165|NCT03713619|582391660|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161276166|NCT03713619|582391661|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161276167|NCT03713619|582391657|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
161276168|NCT03713619|582391658|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
161276169|NCT03713619|582391659|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
161276170|NCT03713619|582391660|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
161276171|NCT03713619|582391661|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
161276172|NCT03713619|582391657|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
161276173|NCT03713619|582391658|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
161276174|NCT03713619|582391659|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
161276175|NCT03713619|582391660|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
161276176|NCT03713619|582391661|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
161276177|NCT03713619|582391657|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
161276178|NCT03713619|582391658|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
161276179|NCT03713619|582391659|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161276180|NCT03713619|582391660|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
161276181|NCT03713619|582391661|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
161276182|NCT03713619|582391657|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161276183|NCT03713619|582391658|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161276184|NCT03713619|582391659|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161276185|NCT03713619|582391660|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161276186|NCT03713619|582391661|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161276187|NCT04642365|582391665|FG000|Overall Study|Death|3|||
161276188|NCT04642365|582391666|FG001|Overall Study|Death|2|||
161276189|NCT04642365|582391667|FG002|Overall Study|Death|4|||
161276190|NCT04642365|582391668|FG003|Overall Study|Death|5|||
161276191|NCT04642365|582391669|FG004|Overall Study|Death|5|||
161276192|NCT04642365|582391670|FG005|Overall Study|Death|3|||
161276193|NCT04642365|582391671|FG006|Overall Study|Death|2|||
161276194|NCT04642365|582391672|FG007|Overall Study|Death|1|||
161276195|NCT04642365|582391665|FG000|Overall Study|Physician Decision|1|||
161276196|NCT04642365|582391666|FG001|Overall Study|Physician Decision|0|||
161276197|NCT04642365|582391667|FG002|Overall Study|Physician Decision|0|||
161276198|NCT04642365|582391668|FG003|Overall Study|Physician Decision|0|||
161276199|NCT04642365|582391669|FG004|Overall Study|Physician Decision|0|||
161276200|NCT04642365|582391670|FG005|Overall Study|Physician Decision|0|||
161276201|NCT04642365|582391671|FG006|Overall Study|Physician Decision|0|||
161276202|NCT04642365|582391672|FG007|Overall Study|Physician Decision|0|||
161276203|NCT04642365|582391665|FG000|Overall Study|Progressive Disease|1|||
161276204|NCT04642365|582391666|FG001|Overall Study|Progressive Disease|1|||
161276205|NCT04642365|582391667|FG002|Overall Study|Progressive Disease|1|||
161276206|NCT04642365|582391668|FG003|Overall Study|Progressive Disease|0|||
161027722|NCT01928394|581492904|FG010|Follow-up Period|Death|4|||
161027723|NCT01928394|581492905|FG011|Follow-up Period|Death|12|||
161027724|NCT01928394|581492906|FG012|Follow-up Period|Death|11|||
161027725|NCT01928394|581492907|FG013|Follow-up Period|Death|25|||
161027726|NCT01928394|581492908|FG014|Follow-up Period|Death|18|||
161027727|NCT01928394|581492909|FG015|Follow-up Period|Death|0|||
161027728|NCT01928394|581492910|FG016|Follow-up Period|Death|6|||
161027729|NCT01928394|581492911|FG017|Follow-up Period|Death|5|||
161027730|NCT01928394|581492912|FG018|Follow-up Period|Death|13|||
161027731|NCT01928394|581492913|FG019|Follow-up Period|Death|13|||
161027732|NCT01928394|581492914|FG020|Follow-up Period|Death|5|||
161027733|NCT01928394|581492915|FG021|Follow-up Period|Death|3|||
161027734|NCT01928394|581492916|FG022|Follow-up Period|Death|2|||
161027735|NCT01928394|581492894|FG000|Follow-up Period|other reason|0|||
161027736|NCT01928394|581492895|FG001|Follow-up Period|other reason|0|||
161027737|NCT01928394|581492896|FG002|Follow-up Period|other reason|0|||
161027738|NCT01928394|581492897|FG003|Follow-up Period|other reason|0|||
161027739|NCT01928394|581492898|FG004|Follow-up Period|other reason|0|||
160974601|NCT02318719|581297512|FG003|Double-blind Phase|Lack of Efficacy|1|||
160974602|NCT02318719|581297513|FG004|Double-blind Phase|Lack of Efficacy|0|||
160974603|NCT02318719|581297509|FG000|Double-blind Phase|Protocol Violation|0|||
160974604|NCT02318719|581297510|FG001|Double-blind Phase|Protocol Violation|1|||
160974605|NCT02318719|581297511|FG002|Double-blind Phase|Protocol Violation|3|||
160974606|NCT02318719|581297512|FG003|Double-blind Phase|Protocol Violation|0|||
160974607|NCT02318719|581297513|FG004|Double-blind Phase|Protocol Violation|0|||
160974608|NCT02318719|581297509|FG000|Double-blind Phase|Withdrawal by Subject|25|||
160974609|NCT02318719|581297510|FG001|Double-blind Phase|Withdrawal by Subject|7|||
160974610|NCT02318719|581297511|FG002|Double-blind Phase|Withdrawal by Subject|9|||
160974611|NCT02318719|581297512|FG003|Double-blind Phase|Withdrawal by Subject|10|||
160974612|NCT02318719|581297513|FG004|Double-blind Phase|Withdrawal by Subject|0|||
160974613|NCT02318719|581297509|FG000|Double-blind Phase|Other|1|||
160974614|NCT02318719|581297510|FG001|Double-blind Phase|Other|2|||
160974615|NCT02318719|581297511|FG002|Double-blind Phase|Other|0|||
160974616|NCT02318719|581297512|FG003|Double-blind Phase|Other|0|||
160974617|NCT02318719|581297513|FG004|Double-blind Phase|Other|0|||
160974618|NCT02318719|581297509|FG000|Open-label Extension Phase|Adverse Event|0|||
160974619|NCT02318719|581297510|FG001|Open-label Extension Phase|Adverse Event|0|||
160974620|NCT02318719|581297511|FG002|Open-label Extension Phase|Adverse Event|0|||
160974621|NCT02318719|581297512|FG003|Open-label Extension Phase|Adverse Event|0|||
160974622|NCT02318719|581297513|FG004|Open-label Extension Phase|Adverse Event|15|||
160974623|NCT02318719|581297509|FG000|Open-label Extension Phase|Death|0|||
160974624|NCT02318719|581297510|FG001|Open-label Extension Phase|Death|0|||
160974625|NCT02318719|581297511|FG002|Open-label Extension Phase|Death|0|||
160974626|NCT02318719|581297512|FG003|Open-label Extension Phase|Death|0|||
160974627|NCT02318719|581297513|FG004|Open-label Extension Phase|Death|1|||
160974628|NCT02318719|581297509|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
160974629|NCT02318719|581297510|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
160974630|NCT02318719|581297511|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
160974631|NCT02318719|581297512|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
160974632|NCT02318719|581297513|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
160974633|NCT02318719|581297509|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
160974634|NCT02318719|581297510|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
160974635|NCT02318719|581297511|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
160974636|NCT02318719|581297512|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
160974637|NCT02318719|581297513|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
160974638|NCT02318719|581297509|FG000|Open-label Extension Phase|Other|0|||
160974639|NCT02318719|581297510|FG001|Open-label Extension Phase|Other|0|||
160974640|NCT02318719|581297511|FG002|Open-label Extension Phase|Other|0|||
160974641|NCT02318719|581297512|FG003|Open-label Extension Phase|Other|0|||
160974642|NCT02318719|581297513|FG004|Open-label Extension Phase|Other|7|||
160974643|NCT00802659|581297514|FG000|Overall Study|Physician Decision|0|||
160974644|NCT00802659|581297515|FG001|Overall Study|Physician Decision|1|||
160974645|NCT00802659|581297516|FG002|Overall Study|Physician Decision|0|||
160974646|NCT00802659|581297517|FG003|Overall Study|Physician Decision|0|||
160974647|NCT00806624|581297518|FG000|Overall Study|Adverse Event|2|||
160974648|NCT00806624|581297519|FG001|Overall Study|Adverse Event|8|||
160974649|NCT00806624|581297520|FG002|Overall Study|Adverse Event|0|||
160974650|NCT00806624|581297518|FG000|Overall Study|Death|0|||
160974651|NCT00806624|581297519|FG001|Overall Study|Death|1|||
160974652|NCT00806624|581297520|FG002|Overall Study|Death|1|||
161027740|NCT01928394|581492899|FG005|Follow-up Period|other reason|0|||
160974653|NCT00806624|581297518|FG000|Overall Study|Lost to Follow-up|1|||
160974654|NCT00806624|581297519|FG001|Overall Study|Lost to Follow-up|0|||
160974655|NCT00806624|581297520|FG002|Overall Study|Lost to Follow-up|1|||
160974656|NCT00806624|581297518|FG000|Overall Study|Withdrawal by Subject|6|||
160974657|NCT00806624|581297519|FG001|Overall Study|Withdrawal by Subject|3|||
160974658|NCT00806624|581297520|FG002|Overall Study|Withdrawal by Subject|3|||
160974659|NCT00806624|581297518|FG000|Overall Study|discontinued before start of treatment|0|||
160974660|NCT00806624|581297519|FG001|Overall Study|discontinued before start of treatment|0|||
160974661|NCT00806624|581297520|FG002|Overall Study|discontinued before start of treatment|1|||
160974662|NCT03093428|581297521|FG000|Overall Study|Not eligible for treatment|2|||
161027741|NCT01928394|581492900|FG006|Follow-up Period|other reason|1|||
161027742|NCT01928394|581492901|FG007|Follow-up Period|other reason|3|||
161027743|NCT01928394|581492902|FG008|Follow-up Period|other reason|0|||
161276207|NCT04642365|582391669|FG004|Overall Study|Progressive Disease|0|||
161276208|NCT04642365|582391670|FG005|Overall Study|Progressive Disease|0|||
161276209|NCT04642365|582391671|FG006|Overall Study|Progressive Disease|1|||
161276210|NCT04642365|582391672|FG007|Overall Study|Progressive Disease|0|||
161276211|NCT04642365|582391665|FG000|Overall Study|Study Terminated By Sponsor|0|||
161276212|NCT04642365|582391666|FG001|Overall Study|Study Terminated By Sponsor|2|||
161276213|NCT04642365|582391667|FG002|Overall Study|Study Terminated By Sponsor|1|||
161276214|NCT04642365|582391668|FG003|Overall Study|Study Terminated By Sponsor|1|||
161027744|NCT01928394|581492903|FG009|Follow-up Period|other reason|0|||
161027745|NCT01928394|581492904|FG010|Follow-up Period|other reason|2|||
161027746|NCT01928394|581492905|FG011|Follow-up Period|other reason|1|||
161027747|NCT01928394|581492906|FG012|Follow-up Period|other reason|0|||
161027748|NCT01928394|581492907|FG013|Follow-up Period|other reason|1|||
161027749|NCT01928394|581492908|FG014|Follow-up Period|other reason|4|||
161027750|NCT01928394|581492909|FG015|Follow-up Period|other reason|0|||
161027751|NCT01928394|581492910|FG016|Follow-up Period|other reason|2|||
161027752|NCT01928394|581492911|FG017|Follow-up Period|other reason|0|||
161027753|NCT01928394|581492912|FG018|Follow-up Period|other reason|1|||
161027754|NCT01928394|581492913|FG019|Follow-up Period|other reason|1|||
161027755|NCT01928394|581492914|FG020|Follow-up Period|other reason|0|||
161027756|NCT01928394|581492915|FG021|Follow-up Period|other reason|0|||
161276215|NCT04642365|582391669|FG004|Overall Study|Study Terminated By Sponsor|1|||
161276216|NCT04642365|582391670|FG005|Overall Study|Study Terminated By Sponsor|2|||
161276217|NCT04642365|582391671|FG006|Overall Study|Study Terminated By Sponsor|2|||
161276218|NCT04642365|582391672|FG007|Overall Study|Study Terminated By Sponsor|1|||
161276219|NCT04642365|582391665|FG000|Overall Study|Symptomatic Deterioration|1|||
161276220|NCT04642365|582391666|FG001|Overall Study|Symptomatic Deterioration|1|||
161276221|NCT04642365|582391667|FG002|Overall Study|Symptomatic Deterioration|0|||
161276222|NCT04642365|582391668|FG003|Overall Study|Symptomatic Deterioration|0|||
161276223|NCT04642365|582391669|FG004|Overall Study|Symptomatic Deterioration|0|||
161276224|NCT04642365|582391670|FG005|Overall Study|Symptomatic Deterioration|1|||
161276225|NCT04642365|582391671|FG006|Overall Study|Symptomatic Deterioration|0|||
161276226|NCT04642365|582391672|FG007|Overall Study|Symptomatic Deterioration|0|||
161276227|NCT04642365|582391665|FG000|Overall Study|Withdrawal by Subject|0|||
161276228|NCT04642365|582391666|FG001|Overall Study|Withdrawal by Subject|0|||
161276229|NCT04642365|582391667|FG002|Overall Study|Withdrawal by Subject|1|||
161276230|NCT04642365|582391668|FG003|Overall Study|Withdrawal by Subject|1|||
161276231|NCT04642365|582391669|FG004|Overall Study|Withdrawal by Subject|0|||
161276232|NCT04642365|582391670|FG005|Overall Study|Withdrawal by Subject|0|||
161276233|NCT04642365|582391671|FG006|Overall Study|Withdrawal by Subject|2|||
161276234|NCT04642365|582391672|FG007|Overall Study|Withdrawal by Subject|0|||
161276235|NCT04642365|582391665|FG000|Overall Study|Adverse Event|0|||
161276236|NCT04642365|582391666|FG001|Overall Study|Adverse Event|0|||
161276237|NCT04642365|582391667|FG002|Overall Study|Adverse Event|0|||
161276238|NCT04642365|582391668|FG003|Overall Study|Adverse Event|0|||
161276239|NCT04642365|582391669|FG004|Overall Study|Adverse Event|0|||
161027757|NCT01928394|581492916|FG022|Follow-up Period|other reason|1|||
161027758|NCT01928394|581492894|FG000|Follow-up Period|Lost to Follow-up|0|||
161027759|NCT01928394|581492895|FG001|Follow-up Period|Lost to Follow-up|0|||
161027760|NCT01928394|581492896|FG002|Follow-up Period|Lost to Follow-up|0|||
161027761|NCT01928394|581492897|FG003|Follow-up Period|Lost to Follow-up|0|||
161027762|NCT01928394|581492898|FG004|Follow-up Period|Lost to Follow-up|0|||
161027763|NCT01928394|581492899|FG005|Follow-up Period|Lost to Follow-up|0|||
161027764|NCT01928394|581492900|FG006|Follow-up Period|Lost to Follow-up|0|||
161027765|NCT01928394|581492901|FG007|Follow-up Period|Lost to Follow-up|0|||
161027766|NCT01928394|581492902|FG008|Follow-up Period|Lost to Follow-up|0|||
161027767|NCT01928394|581492903|FG009|Follow-up Period|Lost to Follow-up|0|||
161027768|NCT01928394|581492904|FG010|Follow-up Period|Lost to Follow-up|0|||
161027769|NCT01928394|581492905|FG011|Follow-up Period|Lost to Follow-up|1|||
161027770|NCT01928394|581492906|FG012|Follow-up Period|Lost to Follow-up|1|||
161027771|NCT01928394|581492907|FG013|Follow-up Period|Lost to Follow-up|0|||
161027772|NCT01928394|581492908|FG014|Follow-up Period|Lost to Follow-up|1|||
161027773|NCT01928394|581492909|FG015|Follow-up Period|Lost to Follow-up|0|||
161276240|NCT04642365|582391670|FG005|Overall Study|Adverse Event|0|||
161276241|NCT04642365|582391671|FG006|Overall Study|Adverse Event|0|||
161276242|NCT04642365|582391672|FG007|Overall Study|Adverse Event|1|||
161276243|NCT01144715|582391673|FG000|Overall Study|Lost to Follow-up|2|||
161276244|NCT01144715|582391674|FG001|Overall Study|Lost to Follow-up|1|||
161276245|NCT01144715|582391673|FG000|Overall Study|Withdrawal by Subject|2|||
161027774|NCT01928394|581492910|FG016|Follow-up Period|Lost to Follow-up|1|||
161027775|NCT01928394|581492911|FG017|Follow-up Period|Lost to Follow-up|0|||
161027776|NCT01928394|581492912|FG018|Follow-up Period|Lost to Follow-up|0|||
161027777|NCT01928394|581492913|FG019|Follow-up Period|Lost to Follow-up|0|||
161027778|NCT01928394|581492914|FG020|Follow-up Period|Lost to Follow-up|0|||
161027779|NCT01928394|581492915|FG021|Follow-up Period|Lost to Follow-up|0|||
161027780|NCT01928394|581492916|FG022|Follow-up Period|Lost to Follow-up|1|||
161276246|NCT01144715|582391674|FG001|Overall Study|Withdrawal by Subject|1|||
161276247|NCT01144715|582391673|FG000|Overall Study|Adverse Event|0|||
161276248|NCT01144715|582391674|FG001|Overall Study|Adverse Event|1|||
161276249|NCT03553576|582391675|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
161276250|NCT03553576|582391676|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
161276251|NCT03553576|582391675|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
161276252|NCT03553576|582391676|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
161276253|NCT03553576|582391675|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
161276254|NCT03553576|582391676|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
161276255|NCT03553576|582391675|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
161276256|NCT03553576|582391676|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
161276257|NCT03553576|582391675|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
161276258|NCT03553576|582391676|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
161276259|NCT03553576|582391675|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
161276260|NCT03553576|582391676|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
161276261|NCT03553576|582391675|FG000|Overall Study|Physician Decision|2|||
161276262|NCT03553576|582391676|FG001|Overall Study|Physician Decision|5|||
161276263|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
161276264|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
161276265|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
161276266|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
161276267|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
161276268|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
161276269|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
161276270|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
161276271|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
161276272|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
161276273|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
161276274|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
161276275|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
161276276|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
161276277|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
161276278|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
161276279|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
161276280|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
161276281|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
161276282|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
161276283|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
161276284|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
161276285|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
161276286|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
161276287|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
161276288|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
161276289|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
161276290|NCT02552212|582391677|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
161276291|NCT02552212|582391678|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
161276292|NCT02552212|582391679|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
161276293|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
161276294|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
161276295|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
161276296|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
161276297|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
160974663|NCT03093428|581297522|FG001|Overall Study|Not eligible for treatment|1|||
160974664|NCT03093428|581297521|FG000|Overall Study|Progression|14|||
160974665|NCT03093428|581297522|FG001|Overall Study|Progression|4|||
160974666|NCT03093428|581297521|FG000|Overall Study|Death|1|||
160974667|NCT03093428|581297522|FG001|Overall Study|Death|0|||
160974668|NCT03093428|581297521|FG000|Overall Study|Adverse Event|1|||
160974669|NCT03093428|581297522|FG001|Overall Study|Adverse Event|0|||
160974670|NCT03093428|581297521|FG000|Overall Study|Withdrawal by Subject|1|||
160974671|NCT03093428|581297522|FG001|Overall Study|Withdrawal by Subject|1|||
160974672|NCT01336634|581297526|FG000|Overall Study|Study closed/terminated|5|||
160974673|NCT01336634|581297527|FG001|Overall Study|Study closed/terminated|6|||
160974674|NCT01336634|581297528|FG002|Overall Study|Study closed/terminated|6|||
160974675|NCT01336634|581297526|FG000|Overall Study|Lost to Follow-up|2|||
160974676|NCT01336634|581297527|FG001|Overall Study|Lost to Follow-up|1|||
161344169|NCT05233761|582646027|FG000|Treatment Period A|Lost to Follow-up|6|||
161344170|NCT05233761|582646028|FG001|Treatment Period A|Lost to Follow-up|12|||
161344171|NCT05233761|582646027|FG000|Treatment Period A|Protocol Violation|8|||
161344172|NCT05233761|582646028|FG001|Treatment Period A|Protocol Violation|15|||
161344173|NCT01933594|582646029|FG000|Overall Study|Lost to Follow-up|1|||
161344174|NCT01933594|582646030|FG001|Overall Study|Lost to Follow-up|0|||
161344175|NCT01933594|582646031|FG002|Overall Study|Lost to Follow-up|0|||
161344176|NCT01933594|582646032|FG003|Overall Study|Lost to Follow-up|0|||
161344177|NCT01933594|582646033|FG004|Overall Study|Lost to Follow-up|1|||
161344178|NCT01933594|582646034|FG005|Overall Study|Lost to Follow-up|0|||
161344179|NCT01933594|582646029|FG000|Overall Study|Ineligible for subsequent study step|0|||
161344180|NCT01933594|582646030|FG001|Overall Study|Ineligible for subsequent study step|0|||
161344181|NCT01933594|582646031|FG002|Overall Study|Ineligible for subsequent study step|0|||
161344182|NCT01933594|582646032|FG003|Overall Study|Ineligible for subsequent study step|0|||
161344183|NCT01933594|582646033|FG004|Overall Study|Ineligible for subsequent study step|1|||
161344184|NCT01933594|582646034|FG005|Overall Study|Ineligible for subsequent study step|0|||
161344185|NCT01654276|582646035|FG000|Overall Study|Lack of Efficacy|1|||
161344186|NCT01654276|582646035|FG000|Overall Study|Lost to Follow-up|4|||
161344187|NCT01654276|582646035|FG000|Overall Study|Withdrawal by Subject|1|||
161344188|NCT02657551|582646036|FG000|Overall Study|Adverse Event|2|||
161344189|NCT02657551|582646036|FG000|Overall Study|Withdrawal by Subject|1|||
161344190|NCT02657551|582646036|FG000|Overall Study|Non-Compliance|1|||
161344191|NCT02657551|582646036|FG000|Overall Study|Progression / Relapse|4|||
161344192|NCT04478266|582646037|FG000|Overall Study|Adverse Event|20|||
161344193|NCT04478266|582646038|FG001|Overall Study|Adverse Event|21|||
161344194|NCT04478266|582646037|FG000|Overall Study|Progressive disease|146|||
161344195|NCT04478266|582646038|FG001|Overall Study|Progressive disease|168|||
161344196|NCT04478266|582646037|FG000|Overall Study|Poor compliance to protocol|1|||
161344197|NCT04478266|582646038|FG001|Overall Study|Poor compliance to protocol|0|||
161344198|NCT04478266|582646037|FG000|Overall Study|Withdrawal by Subject|19|||
161344199|NCT04478266|582646038|FG001|Overall Study|Withdrawal by Subject|16|||
161344200|NCT04478266|582646037|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
161344201|NCT04478266|582646038|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
161344202|NCT04478266|582646037|FG000|Overall Study|Study terminated by sponsor|33|||
161344203|NCT04478266|582646038|FG001|Overall Study|Study terminated by sponsor|35|||
161344204|NCT04478266|582646037|FG000|Overall Study|Other: unspecified|5|||
161344205|NCT04478266|582646038|FG001|Overall Study|Other: unspecified|7|||
161344206|NCT04478266|582646037|FG000|Overall Study|Randomized but not treated|1|||
161344207|NCT04478266|582646038|FG001|Overall Study|Randomized but not treated|1|||
161344208|NCT04770779|582646039|FG000|Overall Study|Randomized, never treated|0|||
161344209|NCT04770779|582646040|FG001|Overall Study|Randomized, never treated|1|||
161344210|NCT04770779|582646039|FG000|Overall Study|Adverse Event|9|||
161344211|NCT04770779|582646040|FG001|Overall Study|Adverse Event|1|||
161344212|NCT04770779|582646039|FG000|Overall Study|Withdrawal by Subject|7|||
161344213|NCT04770779|582646040|FG001|Overall Study|Withdrawal by Subject|1|||
161344214|NCT04770779|582646039|FG000|Overall Study|Pregnancy|0|||
161344215|NCT04770779|582646040|FG001|Overall Study|Pregnancy|1|||
161344216|NCT02799602|582646041|FG000|Overall Study|Protocol Violation|1|||
161344217|NCT02799602|582646042|FG001|Overall Study|Protocol Violation|0|||
161344218|NCT02799602|582646041|FG000|Overall Study|Physician Decision|5|||
161344219|NCT02799602|582646042|FG001|Overall Study|Physician Decision|6|||
161344220|NCT02799602|582646041|FG000|Overall Study|Lost to Follow-up|4|||
161344221|NCT02799602|582646042|FG001|Overall Study|Lost to Follow-up|2|||
161027781|NCT04707625|581492917|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
161027782|NCT00321048|581492918|FG000|Overall Study|Withdrawal by Subject|6|||
161027783|NCT00321048|581492919|FG001|Overall Study|Withdrawal by Subject|8|||
161344222|NCT02799602|582646041|FG000|Overall Study|Additional primary malignancy|11|||
161027784|NCT02038777|581492920|FG000|Overall Study|Death|0|||
161027785|NCT02038777|581492921|FG001|Overall Study|Death|2|||
161027786|NCT02038777|581492922|FG002|Overall Study|Death|0|||
161027787|NCT02038777|581492923|FG003|Overall Study|Death|1|||
161027788|NCT02038777|581492924|FG004|Overall Study|Death|2|||
161027789|NCT02038777|581492925|FG005|Overall Study|Death|4|||
161027790|NCT02038777|581492926|FG006|Overall Study|Death|0|||
161027791|NCT02038777|581492927|FG007|Overall Study|Death|11|||
161027792|NCT02038777|581492920|FG000|Overall Study|Lost to Follow-up|0|||
161027793|NCT02038777|581492921|FG001|Overall Study|Lost to Follow-up|0|||
161344223|NCT02799602|582646042|FG001|Overall Study|Additional primary malignancy|6|||
161344224|NCT02799602|582646041|FG000|Overall Study|Non-compliance with study drug|14|||
161344225|NCT02799602|582646042|FG001|Overall Study|Non-compliance with study drug|12|||
161344226|NCT02799602|582646041|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
161344227|NCT02799602|582646042|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
161344228|NCT02799602|582646041|FG000|Overall Study|Withdrawal by Subject|26|||
161027794|NCT02038777|581492922|FG002|Overall Study|Lost to Follow-up|0|||
161027795|NCT02038777|581492923|FG003|Overall Study|Lost to Follow-up|1|||
161027796|NCT02038777|581492924|FG004|Overall Study|Lost to Follow-up|0|||
161344229|NCT02799602|582646042|FG001|Overall Study|Withdrawal by Subject|40|||
161344230|NCT02799602|582646041|FG000|Overall Study|Progressive disease - clinical progression|131|||
161344231|NCT02799602|582646042|FG001|Overall Study|Progressive disease - clinical progression|276|||
161344232|NCT02799602|582646041|FG000|Overall Study|Progressive disease - radiological progression|90|||
161344233|NCT02799602|582646042|FG001|Overall Study|Progressive disease - radiological progression|133|||
161344234|NCT02799602|582646041|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
161344235|NCT02799602|582646042|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
161344236|NCT02799602|582646041|FG000|Overall Study|Death|9|||
161344237|NCT02799602|582646042|FG001|Overall Study|Death|5|||
161344238|NCT02799602|582646041|FG000|Overall Study|Other|287|||
161344239|NCT02799602|582646042|FG001|Overall Study|Other|118|||
161344240|NCT02799602|582646041|FG000|Overall Study|Study drug never administered|0|||
161344241|NCT02799602|582646042|FG001|Overall Study|Study drug never administered|3|||
161344242|NCT01192178|582646048|FG000|Overall Study|Withdrawal by Subject|6|||
161344243|NCT01192178|582646049|FG001|Overall Study|Withdrawal by Subject|10|||
161344244|NCT01192178|582646048|FG000|Overall Study|Protocol Violation|10|||
161344245|NCT01192178|582646049|FG001|Overall Study|Protocol Violation|3|||
161344246|NCT01192178|582646048|FG000|Overall Study|Physician Decision|2|||
161344247|NCT01192178|582646049|FG001|Overall Study|Physician Decision|4|||
161344248|NCT01192178|582646048|FG000|Overall Study|Lost to Follow-up|3|||
161344249|NCT01192178|582646049|FG001|Overall Study|Lost to Follow-up|3|||
161344250|NCT01192178|582646048|FG000|Overall Study|Adverse Event|2|||
161344251|NCT01192178|582646049|FG001|Overall Study|Adverse Event|1|||
161027797|NCT02038777|581492925|FG005|Overall Study|Lost to Follow-up|0|||
161027798|NCT02038777|581492926|FG006|Overall Study|Lost to Follow-up|0|||
161027799|NCT02038777|581492927|FG007|Overall Study|Lost to Follow-up|0|||
161027800|NCT02038777|581492920|FG000|Overall Study|Other|0|||
161027801|NCT02038777|581492921|FG001|Overall Study|Other|1|||
161027802|NCT02038777|581492922|FG002|Overall Study|Other|0|||
161027803|NCT02038777|581492923|FG003|Overall Study|Other|2|||
161027804|NCT02038777|581492924|FG004|Overall Study|Other|1|||
161027805|NCT02038777|581492925|FG005|Overall Study|Other|0|||
161027806|NCT02038777|581492926|FG006|Overall Study|Other|0|||
161027807|NCT02038777|581492927|FG007|Overall Study|Other|0|||
161027808|NCT02038777|581492920|FG000|Overall Study|Randomized but not treated|0|||
161027809|NCT02038777|581492921|FG001|Overall Study|Randomized but not treated|1|||
161027810|NCT02038777|581492922|FG002|Overall Study|Randomized but not treated|0|||
161027811|NCT02038777|581492923|FG003|Overall Study|Randomized but not treated|0|||
161027812|NCT02038777|581492924|FG004|Overall Study|Randomized but not treated|0|||
161027813|NCT02038777|581492925|FG005|Overall Study|Randomized but not treated|0|||
161027814|NCT02038777|581492926|FG006|Overall Study|Randomized but not treated|0|||
161027815|NCT02038777|581492927|FG007|Overall Study|Randomized but not treated|0|||
161027816|NCT02038777|581492920|FG000|Overall Study|Started Chemotherapy|1|||
161027817|NCT02038777|581492921|FG001|Overall Study|Started Chemotherapy|0|||
161027818|NCT02038777|581492922|FG002|Overall Study|Started Chemotherapy|3|||
161027819|NCT02038777|581492923|FG003|Overall Study|Started Chemotherapy|0|||
161027820|NCT02038777|581492924|FG004|Overall Study|Started Chemotherapy|0|||
161027821|NCT02038777|581492925|FG005|Overall Study|Started Chemotherapy|0|||
161027822|NCT02038777|581492926|FG006|Overall Study|Started Chemotherapy|0|||
161027823|NCT02038777|581492927|FG007|Overall Study|Started Chemotherapy|0|||
161027824|NCT02038777|581492920|FG000|Overall Study|participation terminated by sponsor|0|||
161027825|NCT02038777|581492921|FG001|Overall Study|participation terminated by sponsor|0|||
161027826|NCT02038777|581492922|FG002|Overall Study|participation terminated by sponsor|0|||
161027827|NCT02038777|581492923|FG003|Overall Study|participation terminated by sponsor|0|||
161027828|NCT02038777|581492924|FG004|Overall Study|participation terminated by sponsor|0|||
161027829|NCT02038777|581492925|FG005|Overall Study|participation terminated by sponsor|0|||
161027830|NCT02038777|581492926|FG006|Overall Study|participation terminated by sponsor|1|||
161027831|NCT02038777|581492927|FG007|Overall Study|participation terminated by sponsor|1|||
161027832|NCT03209973|581492935|FG000|Overall Study|Withdrawal by Subject|7|||
161027833|NCT03209973|581492935|FG000|Overall Study|Lost to Follow-up|2|||
161027834|NCT03209973|581492935|FG000|Overall Study|Death|8|||
161027835|NCT03209973|581492935|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
161344252|NCT01192178|582646048|FG000|Overall Study|Lack of Efficacy|1|||
161344253|NCT01192178|582646049|FG001|Overall Study|Lack of Efficacy|2|||
161027836|NCT03209973|581492935|FG000|Overall Study|Sponsor Decision|18|||
161027837|NCT03209973|581492935|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
161027838|NCT03209973|581492935|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
161027839|NCT03987022|581492938|FG000|Overall Study|Lost to Follow-up|2|||
161027840|NCT03987022|581492939|FG001|Overall Study|Lost to Follow-up|2|||
161027841|NCT03987022|581492938|FG000|Overall Study|Withdrawal by Subject|1|||
161027842|NCT03987022|581492939|FG001|Overall Study|Withdrawal by Subject|0|||
161344254|NCT00296517|582646050|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
161027843|NCT05863156|581492942|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
161027844|NCT05863156|581492943|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
161027845|NCT05863156|581492944|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
161027846|NCT01346540|581492945|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
161027847|NCT01346540|581492946|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
161027848|NCT01346540|581492945|FG000|Overall Study|Adverse Event|0|||
161027849|NCT01346540|581492946|FG001|Overall Study|Adverse Event|4|||
161027850|NCT03362476|581492947|FG000|Overall Study|Withdrawal by Subject|0|||
161027851|NCT03362476|581492948|FG001|Overall Study|Withdrawal by Subject|1|||
161027852|NCT05216406|581492949|FG000|Overall Study|Lost to Follow-up|8|||
161027853|NCT05216406|581492950|FG001|Overall Study|Lost to Follow-up|9|||
161027854|NCT04270942|581492953|FG000|Overall Study|Death|1|||
161027855|NCT04797195|581492959|FG000|Overall Study|Death|8|||
161027856|NCT04797195|581492960|FG001|Overall Study|Death|15|||
161027857|NCT04797195|581492959|FG000|Overall Study|Change from PD|15|||
161027858|NCT04797195|581492960|FG001|Overall Study|Change from PD|15|||
161027859|NCT04797195|581492959|FG000|Overall Study|Withdrawal by Subject|3|||
161027860|NCT04797195|581492960|FG001|Overall Study|Withdrawal by Subject|2|||
161027861|NCT01236781|581492961|FG000|Overall Study|Ineligible|2|||
161027862|NCT01236781|581492962|FG001|Overall Study|Ineligible|1|||
161027863|NCT01236781|581492961|FG000|Overall Study|Did not complete study imaging|5|||
161027864|NCT01236781|581492962|FG001|Overall Study|Did not complete study imaging|0|||
161027865|NCT04862416|581492965|FG000|Overall Study|Withdrawal by Subject|0|||
161027866|NCT04862416|581492966|FG001|Overall Study|Withdrawal by Subject|1|||
161027867|NCT04862416|581492967|FG002|Overall Study|Withdrawal by Subject|0|||
161027868|NCT04862416|581492968|FG003|Overall Study|Withdrawal by Subject|1|||
161027869|NCT04862416|581492969|FG004|Overall Study|Withdrawal by Subject|0|||
161027870|NCT04862416|581492970|FG005|Overall Study|Withdrawal by Subject|0|||
161027871|NCT04862416|581492971|FG006|Overall Study|Withdrawal by Subject|0|||
161027872|NCT04862416|581492972|FG007|Overall Study|Withdrawal by Subject|0|||
161027873|NCT04059185|581492975|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
161027874|NCT04059185|581492976|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
161027875|NCT04059185|581492977|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
161027876|NCT04059185|581492975|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
161027877|NCT04059185|581492976|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
161027878|NCT04059185|581492977|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
161027879|NCT04059185|581492975|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
161027880|NCT04059185|581492976|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
161027881|NCT04059185|581492977|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
161027882|NCT04059185|581492975|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
161027883|NCT04059185|581492976|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
161027884|NCT04059185|581492977|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
161027885|NCT04059185|581492975|FG000|Longitudinal Assessment-Adults Only|Death|4|||
161027886|NCT04059185|581492976|FG001|Longitudinal Assessment-Adults Only|Death|4|||
161027887|NCT04059185|581492977|FG002|Longitudinal Assessment-Adults Only|Death|3|||
161027888|NCT04587453|581492991|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
161027889|NCT04587453|581492992|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
161027890|NCT03571581|581492993|FG000|Overall Study|Death|2|||
161027891|NCT03571581|581492993|FG000|Overall Study|Withdrawal by Subject|2|||
161027892|NCT01309672|581492994|FG000|Overall Study|Lack of Efficacy|20|||
161027893|NCT01309672|581492994|FG000|Overall Study|Other|9|||
161027894|NCT01309672|581492994|FG000|Overall Study|Adverse Event|5|||
161027895|NCT01309672|581492994|FG000|Overall Study|Withdrawal by Subject|3|||
161027896|NCT04737330|581492997|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
161027897|NCT04737330|581492998|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
161027898|NCT04737330|581492997|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
161027899|NCT04737330|581492998|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
161027900|NCT04737330|581492997|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
161027901|NCT04737330|581492998|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
161027902|NCT04737330|581492997|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
160974677|NCT01336634|581297528|FG002|Overall Study|Lost to Follow-up|1|||
160974678|NCT01336634|581297526|FG000|Overall Study|Physician Decision|1|||
160974679|NCT01336634|581297527|FG001|Overall Study|Physician Decision|1|||
160974680|NCT01336634|581297528|FG002|Overall Study|Physician Decision|0|||
160974681|NCT01336634|581297526|FG000|Overall Study|Withdrawal by Subject|6|||
160974682|NCT01336634|581297527|FG001|Overall Study|Withdrawal by Subject|0|||
160974683|NCT01336634|581297528|FG002|Overall Study|Withdrawal by Subject|2|||
160974684|NCT01973491|581297529|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
160974685|NCT01973491|581297529|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
160974686|NCT01973491|581297529|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
160974687|NCT01863043|581297530|FG000|Overall Study|Death|6|||
160974688|NCT01863043|581297531|FG001|Overall Study|Death|1|||
160974689|NCT01863043|581297530|FG000|Overall Study|Withdrawal by Subject|0|||
161027903|NCT04737330|581492998|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
161027904|NCT04737330|581492997|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
161027905|NCT04737330|581492998|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
161027906|NCT04737330|581492997|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
161027907|NCT04737330|581492998|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
161027908|NCT04499924|581494462|FG000|Overall Study|Study termination by sponsor|4|||
161027909|NCT04499924|581494463|FG001|Overall Study|Study termination by sponsor|6|||
161027910|NCT04499924|581494462|FG000|Overall Study|Withdrawal by Subject|1|||
161027911|NCT04499924|581494463|FG001|Overall Study|Withdrawal by Subject|3|||
161027912|NCT03011333|581494464|FG000|Overall Study|Lost to Follow-up|0|||
161027913|NCT03011333|581494465|FG001|Overall Study|Lost to Follow-up|1|||
161027914|NCT03011333|581494466|FG002|Overall Study|Lost to Follow-up|0|||
161027915|NCT03011333|581494467|FG003|Overall Study|Lost to Follow-up|1|||
161027916|NCT03011333|581494468|FG004|Overall Study|Lost to Follow-up|4|||
161027917|NCT03011333|581494469|FG005|Overall Study|Lost to Follow-up|4|||
161027918|NCT03011333|581494470|FG006|Overall Study|Lost to Follow-up|5|||
161027919|NCT03663569|581494471|FG000|Overall Study|Discontinuation of study|11|||
161027920|NCT03663569|581494471|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
161027921|NCT03663569|581494471|FG000|Overall Study|Deceased patient|6|||
161027922|NCT03663569|581494471|FG000|Overall Study|Lost to Follow-up|18|||
161027923|NCT03663569|581494471|FG000|Overall Study|Withdrawal of consent|5|||
161027924|NCT03663569|581494471|FG000|Overall Study|Patient's request|11|||
161027925|NCT03663569|581494471|FG000|Overall Study|Adverse Event|4|||
161027926|NCT03663569|581494471|FG000|Overall Study|Not come to second visit|3|||
161027927|NCT03663569|581494471|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
161027928|NCT03663569|581494471|FG000|Overall Study|Serious adverse event|1|||
161027929|NCT01197378|581494479|FG000|Overall Study|Adverse Event|3|||
161027930|NCT01197378|581494479|FG000|Overall Study|Withdrawal by Subject|1|||
161027931|NCT01197378|581494479|FG000|Overall Study|Physician Decision|1|||
161027932|NCT01197378|581494479|FG000|Overall Study|Other|2|||
161027933|NCT05299723|581494483|FG000|Overall Study|Withdrawal by Subject|0|||
161027934|NCT05299723|581494484|FG001|Overall Study|Withdrawal by Subject|2|||
161027935|NCT05299723|581494485|FG002|Overall Study|Withdrawal by Subject|0|||
161027936|NCT00696111|581494486|FG000|Overall Study|Withdrawal by Subject|17|||
161027937|NCT05274074|581494489|FG000|Overall Study|Lost to Follow-up|2|||
161027938|NCT05274074|581494490|FG001|Overall Study|Lost to Follow-up|3|||
161027939|NCT05274074|581494489|FG000|Overall Study|Withdrawal by Subject|1|||
161027940|NCT05274074|581494490|FG001|Overall Study|Withdrawal by Subject|2|||
161027941|NCT04117347|581494491|FG000|Overall Study|Adverse Event|0|||
161027942|NCT04117347|581494492|FG001|Overall Study|Adverse Event|0|||
161027943|NCT04117347|581494493|FG002|Overall Study|Adverse Event|1|||
161027944|NCT04117347|581494491|FG000|Overall Study|No time for study|0|||
161027945|NCT04117347|581494492|FG001|Overall Study|No time for study|2|||
161027946|NCT04117347|581494493|FG002|Overall Study|No time for study|0|||
161027947|NCT04117347|581494491|FG000|Overall Study|Family emergency|1|||
161027948|NCT04117347|581494492|FG001|Overall Study|Family emergency|0|||
161027949|NCT04117347|581494493|FG002|Overall Study|Family emergency|0|||
161027950|NCT05194956|581494494|FG000|Washout Period|Withdrawal by Subject|0|||
161027951|NCT05194956|581494495|FG001|Washout Period|Withdrawal by Subject|2|||
161027952|NCT03687086|581494496|FG000|Overall Study|Withdrawal by Subject|3|||
161027953|NCT03687086|581494497|FG001|Overall Study|Withdrawal by Subject|4|||
161027954|NCT03687086|581494496|FG000|Overall Study|Lost to Follow-up|1|||
161027955|NCT03687086|581494497|FG001|Overall Study|Lost to Follow-up|1|||
161027956|NCT03687086|581494496|FG000|Overall Study|Death|1|||
161027957|NCT03687086|581494497|FG001|Overall Study|Death|0|||
161027958|NCT03687086|581494496|FG000|Overall Study|Incomplete assessment|0|||
161027959|NCT03687086|581494497|FG001|Overall Study|Incomplete assessment|2|||
161027960|NCT05485779|581494500|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027961|NCT05485779|581494501|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027962|NCT05485779|581494502|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027963|NCT05485779|581494503|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027964|NCT05485779|581494504|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027965|NCT05485779|581494505|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027966|NCT05485779|581494506|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027967|NCT05485779|581494507|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
161344255|NCT00296517|582646051|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
161027968|NCT05485779|581494508|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
161027969|NCT05485779|581494509|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027970|NCT05485779|581494510|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
161027971|NCT05485779|581494500|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027972|NCT05485779|581494501|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027973|NCT05485779|581494502|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027974|NCT05485779|581494503|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027975|NCT05485779|581494504|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027976|NCT05485779|581494505|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027977|NCT05485779|581494506|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027978|NCT05485779|581494507|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027979|NCT05485779|581494508|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027980|NCT05485779|581494509|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
161027981|NCT05485779|581494510|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
161027982|NCT05485779|581494500|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027983|NCT05485779|581494501|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027984|NCT05485779|581494502|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027985|NCT05485779|581494503|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
161027986|NCT05485779|581494504|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027987|NCT05485779|581494505|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027988|NCT05485779|581494506|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027989|NCT05485779|581494507|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027990|NCT05485779|581494508|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027991|NCT05485779|581494509|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027992|NCT05485779|581494510|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
161027993|NCT03676192|581494511|FG000|Induction Study Period|Adverse Event|21|||
161027994|NCT03676192|581494512|FG001|Induction Study Period|Adverse Event|20|||
161027995|NCT03676192|581494511|FG000|Induction Study Period|Death|23|||
161027996|NCT03676192|581494512|FG001|Induction Study Period|Death|20|||
161027997|NCT03676192|581494511|FG000|Induction Study Period|Lost to Follow-up|3|||
161276298|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
161276299|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
161276300|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
161276301|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
161276302|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
161276303|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
161276304|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
161276305|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
161276306|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
161276307|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
161276308|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
161276309|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
161276310|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
161276311|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
161276312|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
161276313|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
161276314|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
161276315|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
161276316|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
161276317|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
161276318|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
161276319|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
161276320|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
161276321|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
161276322|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
161276323|NCT02552212|582391677|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
161276324|NCT02552212|582391678|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
161276325|NCT02552212|582391679|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
161276326|NCT02728843|582391681|FG000|Overall Study|Adverse Event|0|||
161276327|NCT02728843|582391682|FG001|Overall Study|Adverse Event|2|||
161276328|NCT02728843|582391683|FG002|Overall Study|Adverse Event|3|||
161276329|NCT02728843|582391684|FG003|Overall Study|Adverse Event|1|||
161276330|NCT02728843|582391685|FG004|Overall Study|Adverse Event|2|||
161276331|NCT02728843|582391681|FG000|Overall Study|Lack of Efficacy|0|||
161276332|NCT02728843|582391682|FG001|Overall Study|Lack of Efficacy|1|||
161276333|NCT02728843|582391683|FG002|Overall Study|Lack of Efficacy|1|||
161276334|NCT02728843|582391684|FG003|Overall Study|Lack of Efficacy|0|||
161276335|NCT02728843|582391685|FG004|Overall Study|Lack of Efficacy|0|||
161276336|NCT02728843|582391681|FG000|Overall Study|Protocol Violation|2|||
161276337|NCT02728843|582391682|FG001|Overall Study|Protocol Violation|0|||
161276338|NCT02728843|582391683|FG002|Overall Study|Protocol Violation|4|||
161276339|NCT02728843|582391684|FG003|Overall Study|Protocol Violation|2|||
161027998|NCT03676192|581494512|FG001|Induction Study Period|Lost to Follow-up|3|||
161027999|NCT03676192|581494511|FG000|Induction Study Period|Physician Decision|6|||
161028000|NCT03676192|581494512|FG001|Induction Study Period|Physician Decision|3|||
161028001|NCT03676192|581494511|FG000|Induction Study Period|Progressive Disease|32|||
161028002|NCT03676192|581494512|FG001|Induction Study Period|Progressive Disease|21|||
161028003|NCT03676192|581494511|FG000|Induction Study Period|Protocol Violation|1|||
161028004|NCT03676192|581494512|FG001|Induction Study Period|Protocol Violation|2|||
161028005|NCT03676192|581494511|FG000|Induction Study Period|Withdrawal by Subject|20|||
161028006|NCT03676192|581494512|FG001|Induction Study Period|Withdrawal by Subject|15|||
161028007|NCT03386578|581494513|FG000|PK Component|Lost to Follow-up|0|||
161028008|NCT03386578|581494514|FG001|PK Component|Lost to Follow-up|1|||
161028009|NCT03386578|581494515|FG002|PK Component|Lost to Follow-up|0|||
161028010|NCT03386578|581494516|FG003|PK Component|Lost to Follow-up|0|||
161028011|NCT03386578|581494517|FG004|PK Component|Lost to Follow-up|0|||
161028012|NCT03386578|581494518|FG005|PK Component|Lost to Follow-up|0|||
161028013|NCT03386578|581494519|FG006|PK Component|Lost to Follow-up|1|||
161028014|NCT03386578|581494520|FG007|PK Component|Lost to Follow-up|0|||
161028015|NCT03386578|581494521|FG008|PK Component|Lost to Follow-up|0|||
161028016|NCT03386578|581494522|FG009|PK Component|Lost to Follow-up|0|||
161028017|NCT03386578|581494513|FG000|PK Component|Stillbirth/Abortion|0|||
161028018|NCT03386578|581494514|FG001|PK Component|Stillbirth/Abortion|0|||
161028019|NCT03386578|581494515|FG002|PK Component|Stillbirth/Abortion|0|||
161028020|NCT03386578|581494516|FG003|PK Component|Stillbirth/Abortion|0|||
161028021|NCT03386578|581494517|FG004|PK Component|Stillbirth/Abortion|0|||
161028022|NCT03386578|581494518|FG005|PK Component|Stillbirth/Abortion|2|||
161028023|NCT03386578|581494519|FG006|PK Component|Stillbirth/Abortion|0|||
161028024|NCT03386578|581494520|FG007|PK Component|Stillbirth/Abortion|0|||
161028025|NCT03386578|581494521|FG008|PK Component|Stillbirth/Abortion|0|||
161028026|NCT03386578|581494522|FG009|PK Component|Stillbirth/Abortion|0|||
161028027|NCT03386578|581494513|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161028028|NCT03386578|581494514|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161028029|NCT03386578|581494515|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
161028030|NCT03386578|581494516|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
161028031|NCT03386578|581494517|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161028032|NCT03386578|581494518|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161028033|NCT03386578|581494519|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161028034|NCT03386578|581494520|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
161028035|NCT03386578|581494521|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
161028036|NCT03386578|581494522|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
161028037|NCT03386578|581494513|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161028038|NCT03386578|581494514|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161028039|NCT03386578|581494515|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
161028040|NCT03386578|581494516|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
161028041|NCT03386578|581494517|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161028042|NCT03386578|581494518|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161028043|NCT03386578|581494519|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161028044|NCT03386578|581494520|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
161028045|NCT03386578|581494521|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
161028046|NCT03386578|581494522|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
161028047|NCT03386578|581494513|FG000|PrEP Comparison Component Step 1|Death|0|||
161028048|NCT03386578|581494514|FG001|PrEP Comparison Component Step 1|Death|0|||
161028049|NCT03386578|581494515|FG002|PrEP Comparison Component Step 1|Death|1|||
161028050|NCT03386578|581494516|FG003|PrEP Comparison Component Step 1|Death|0|||
161028051|NCT03386578|581494517|FG004|PrEP Comparison Component Step 1|Death|0|||
161028052|NCT03386578|581494518|FG005|PrEP Comparison Component Step 1|Death|0|||
161028053|NCT03386578|581494519|FG006|PrEP Comparison Component Step 1|Death|0|||
161028054|NCT03386578|581494520|FG007|PrEP Comparison Component Step 1|Death|9|||
161344256|NCT00296517|582646050|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
161344257|NCT00296517|582646051|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
161344258|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
161344259|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
161344260|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
161344261|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
161344262|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
161344263|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
161028055|NCT03386578|581494521|FG008|PrEP Comparison Component Step 1|Death|5|||
161028056|NCT03386578|581494522|FG009|PrEP Comparison Component Step 1|Death|0|||
161028057|NCT03386578|581494513|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028058|NCT03386578|581494514|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028059|NCT03386578|581494515|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028060|NCT03386578|581494516|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
161028061|NCT03386578|581494517|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028062|NCT03386578|581494518|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028063|NCT03386578|581494519|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028064|NCT03386578|581494520|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028065|NCT03386578|581494521|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
161028066|NCT03386578|581494522|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
161028067|NCT03386578|581494513|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028068|NCT03386578|581494514|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028069|NCT03386578|581494515|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028070|NCT03386578|581494516|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028071|NCT03386578|581494517|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028072|NCT03386578|581494518|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028073|NCT03386578|581494519|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028074|NCT03386578|581494520|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
161028075|NCT03386578|581494521|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
161028076|NCT03386578|581494522|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
161028077|NCT03386578|581494513|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028078|NCT03386578|581494514|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028079|NCT03386578|581494515|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028080|NCT03386578|581494516|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028081|NCT03386578|581494517|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028082|NCT03386578|581494518|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028083|NCT03386578|581494519|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028084|NCT03386578|581494520|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
161028085|NCT03386578|581494521|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
161028086|NCT03386578|581494522|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
161028087|NCT01627574|581494526|FG000|Overall Study|Withdrawal by Subject|8|||
161028088|NCT01627574|581494527|FG001|Overall Study|Withdrawal by Subject|5|||
161028089|NCT01627574|581494526|FG000|Overall Study|Lost to Follow-up|13|||
161028090|NCT01627574|581494527|FG001|Overall Study|Lost to Follow-up|13|||
161028091|NCT04730739|581494528|FG000|Overall Study|Death|1|||
161028092|NCT03308877|581494530|FG000|Overall Study|Lost to Follow-up|32|||
161028093|NCT03308877|581494531|FG001|Overall Study|Lost to Follow-up|28|||
161028094|NCT03249090|581494541|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
161028095|NCT03249090|581494542|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
161028096|NCT03249090|581494541|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
161028097|NCT03249090|581494542|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
161028098|NCT03249090|581494541|FG000|3 Month Time Point|Voluntary withdrawal|6|||
161028099|NCT03249090|581494542|FG001|3 Month Time Point|Voluntary withdrawal|3|||
161028100|NCT03249090|581494541|FG000|3 Month Time Point|Changed oncology practice|4|||
161028101|NCT03249090|581494542|FG001|3 Month Time Point|Changed oncology practice|2|||
161028102|NCT03249090|581494541|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
161028103|NCT03249090|581494542|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
161028104|NCT03249090|581494541|FG000|12 Month Time Point|Voluntary withdrawal|35|||
161028105|NCT03249090|581494542|FG001|12 Month Time Point|Voluntary withdrawal|4|||
161028106|NCT03249090|581494541|FG000|12 Month Time Point|Changed oncology practice|20|||
161028107|NCT03249090|581494542|FG001|12 Month Time Point|Changed oncology practice|9|||
161028108|NCT05646355|581494551|FG000|Overall Study|Lost to Follow-up|1|||
161028109|NCT05646355|581494552|FG001|Overall Study|Lost to Follow-up|0|||
161028110|NCT05646355|581494551|FG000|Overall Study|translated materials not available for pilot|2|||
161028111|NCT05646355|581494552|FG001|Overall Study|translated materials not available for pilot|0|||
161028112|NCT05646355|581494551|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
161028113|NCT05646355|581494552|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
161028114|NCT04577963|581494553|FG000|Part 2|Death|0|||
161028115|NCT04577963|581494554|FG001|Part 2|Death|1|||
161028116|NCT04577963|581494555|FG002|Part 2|Death|8|||
161028117|NCT04577963|581494556|FG003|Part 2|Death|0|||
161028118|NCT04577963|581494557|FG004|Part 2|Death|20|||
161028119|NCT04577963|581494553|FG000|Part 2|Lost to Follow-up|0|||
161028120|NCT04577963|581494554|FG001|Part 2|Lost to Follow-up|0|||
161028121|NCT04577963|581494555|FG002|Part 2|Lost to Follow-up|0|||
161028122|NCT04577963|581494556|FG003|Part 2|Lost to Follow-up|0|||
161028123|NCT04577963|581494557|FG004|Part 2|Lost to Follow-up|2|||
161028124|NCT04577963|581494553|FG000|Part 2|Withdrawal by Subject|0|||
161028125|NCT04577963|581494554|FG001|Part 2|Withdrawal by Subject|0|||
161028126|NCT04577963|581494555|FG002|Part 2|Withdrawal by Subject|0|||
161028127|NCT04577963|581494556|FG003|Part 2|Withdrawal by Subject|0|||
161028128|NCT04577963|581494557|FG004|Part 2|Withdrawal by Subject|10|||
161028129|NCT04577963|581494553|FG000|Part 2|Progressive disease|0|||
161028130|NCT04577963|581494554|FG001|Part 2|Progressive disease|0|||
161028131|NCT04577963|581494555|FG002|Part 2|Progressive disease|0|||
161028132|NCT04577963|581494556|FG003|Part 2|Progressive disease|0|||
161028133|NCT04577963|581494557|FG004|Part 2|Progressive disease|2|||
161028134|NCT04577963|581494553|FG000|Part 2|Investigator decision|0|||
161028135|NCT04577963|581494554|FG001|Part 2|Investigator decision|0|||
161028136|NCT04577963|581494555|FG002|Part 2|Investigator decision|0|||
161028137|NCT04577963|581494556|FG003|Part 2|Investigator decision|0|||
161028138|NCT04577963|581494557|FG004|Part 2|Investigator decision|1|||
161028139|NCT04577963|581494553|FG000|Part 2|Sponsor terminated study|0|||
161028140|NCT04577963|581494554|FG001|Part 2|Sponsor terminated study|0|||
161028141|NCT04577963|581494555|FG002|Part 2|Sponsor terminated study|3|||
161028142|NCT04577963|581494556|FG003|Part 2|Sponsor terminated study|1|||
161028143|NCT04577963|581494557|FG004|Part 2|Sponsor terminated study|4|||
161028144|NCT02709161|581494560|FG000|Overall Study|Withdrawal by Subject|1|||
161028145|NCT02709161|581494561|FG001|Overall Study|Withdrawal by Subject|0|||
161028146|NCT00746096|581494565|FG000|Overall Study|Adverse Event|1|||
161028147|NCT00746096|581494566|FG001|Overall Study|Adverse Event|0|||
161028148|NCT00746096|581494565|FG000|Overall Study|Withdrawal by Subject|5|||
161028149|NCT00746096|581494566|FG001|Overall Study|Withdrawal by Subject|1|||
161028150|NCT00746096|581494565|FG000|Overall Study|Lost to Follow-up|2|||
161028151|NCT00746096|581494566|FG001|Overall Study|Lost to Follow-up|1|||
161028152|NCT00746096|581494565|FG000|Overall Study|Protocol Violation|1|||
161028153|NCT00746096|581494566|FG001|Overall Study|Protocol Violation|0|||
161028154|NCT00746096|581494565|FG000|Overall Study|No study drug treatment|1|||
161028155|NCT00746096|581494566|FG001|Overall Study|No study drug treatment|1|||
161028156|NCT01254864|581494572|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
161028157|NCT01254864|581494573|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
161028158|NCT01254864|581494574|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
161028159|NCT01254864|581494572|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
161028160|NCT01254864|581494573|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
161028161|NCT01254864|581494574|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
161028162|NCT01254864|581494572|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
161028163|NCT01254864|581494573|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
161028164|NCT01254864|581494574|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
161028165|NCT01254864|581494572|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
161028166|NCT01254864|581494573|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
161028167|NCT01254864|581494574|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
161028168|NCT01254864|581494572|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
161028169|NCT01254864|581494573|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
161028170|NCT01254864|581494574|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
161028171|NCT01254864|581494572|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
161028172|NCT01254864|581494573|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
161028173|NCT01254864|581494574|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
161028174|NCT01254864|581494572|FG000|Randomization Phase|Adverse Event|0|||
161028175|NCT01254864|581494573|FG001|Randomization Phase|Adverse Event|5|||
161028176|NCT01254864|581494574|FG002|Randomization Phase|Adverse Event|17|||
161028177|NCT01254864|581494572|FG000|Randomization Phase|Death|0|||
161028178|NCT01254864|581494573|FG001|Randomization Phase|Death|1|||
161028179|NCT01254864|581494574|FG002|Randomization Phase|Death|0|||
161028180|NCT01254864|581494572|FG000|Randomization Phase|Lost to Follow-up|0|||
161028181|NCT01254864|581494573|FG001|Randomization Phase|Lost to Follow-up|0|||
161028182|NCT01254864|581494574|FG002|Randomization Phase|Lost to Follow-up|1|||
161028183|NCT01254864|581494572|FG000|Randomization Phase|Physician Decision|0|||
161028184|NCT01254864|581494573|FG001|Randomization Phase|Physician Decision|20|||
161028185|NCT01254864|581494574|FG002|Randomization Phase|Physician Decision|25|||
161028186|NCT01254864|581494572|FG000|Randomization Phase|Withdrawal by Subject|0|||
161028187|NCT01254864|581494573|FG001|Randomization Phase|Withdrawal by Subject|4|||
161028188|NCT01254864|581494574|FG002|Randomization Phase|Withdrawal by Subject|2|||
161028189|NCT01254864|581494572|FG000|Randomization Phase|Non-Compliance|0|||
161028190|NCT01254864|581494573|FG001|Randomization Phase|Non-Compliance|1|||
161028191|NCT01254864|581494574|FG002|Randomization Phase|Non-Compliance|0|||
161028192|NCT01254864|581494572|FG000|Randomization Phase|Comorbidities|0|||
161028193|NCT01254864|581494573|FG001|Randomization Phase|Comorbidities|2|||
161028194|NCT01254864|581494574|FG002|Randomization Phase|Comorbidities|1|||
161028195|NCT04141891|581494576|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
161028196|NCT04141891|581494577|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
161028197|NCT04141891|581494576|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
161028198|NCT04141891|581494577|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
161028199|NCT04141891|581494576|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
161028200|NCT04141891|581494577|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
161028201|NCT04141891|581494576|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
161028202|NCT04141891|581494577|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
161028203|NCT04141891|581494576|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
161028204|NCT04141891|581494577|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
161028205|NCT04141891|581494576|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
161028206|NCT04141891|581494577|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
161028207|NCT04141891|581494576|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
161028208|NCT04141891|581494577|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
161028209|NCT04141891|581494576|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
161028210|NCT04141891|581494577|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
161028211|NCT04141891|581494576|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
161028212|NCT04141891|581494577|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
161028213|NCT04141891|581494576|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
161028214|NCT04141891|581494577|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
161028215|NCT04141891|581494576|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
161028216|NCT04141891|581494577|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
161028217|NCT04141891|581494576|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
161028218|NCT04141891|581494577|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
161028219|NCT04141891|581494576|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
161028220|NCT04141891|581494577|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
161028221|NCT04141891|581494576|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
161028222|NCT04141891|581494577|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
161028223|NCT03295721|581494578|FG000|Overall Study|Adverse Event|1|||
161028224|NCT03295721|581494579|FG001|Overall Study|Adverse Event|0|||
161028225|NCT03295721|581494580|FG002|Overall Study|Adverse Event|0|||
161028226|NCT03295721|581494578|FG000|Overall Study|Lost to Follow-up|1|||
161028227|NCT03295721|581494579|FG001|Overall Study|Lost to Follow-up|1|||
161028228|NCT03295721|581494580|FG002|Overall Study|Lost to Follow-up|1|||
161028229|NCT03295721|581494578|FG000|Overall Study|Withdrawal by Subject|1|||
161028230|NCT03295721|581494579|FG001|Overall Study|Withdrawal by Subject|0|||
161028231|NCT03295721|581494580|FG002|Overall Study|Withdrawal by Subject|1|||
161028232|NCT03295721|581494578|FG000|Overall Study|Death|0|||
161028233|NCT03295721|581494579|FG001|Overall Study|Death|0|||
161028234|NCT03295721|581494580|FG002|Overall Study|Death|1|||
161028235|NCT01651403|581494586|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
161028236|NCT01651403|581494587|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
161028237|NCT01651403|581494586|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
161028238|NCT01651403|581494587|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
161028239|NCT01651403|581494586|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
161028240|NCT01651403|581494587|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
161028241|NCT01651403|581494586|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
161028242|NCT01651403|581494587|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
161028243|NCT01651403|581494586|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
161028244|NCT01651403|581494587|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
161028245|NCT01651403|581494586|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
161028246|NCT01651403|581494587|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
161028247|NCT05090683|581494588|FG000|Overall Study|Lost to Follow-up|10|||
161028248|NCT05090683|581494589|FG001|Overall Study|Lost to Follow-up|2|||
161028249|NCT05090683|581494588|FG000|Overall Study|Withdrawal by Subject|15|||
161028250|NCT05090683|581494589|FG001|Overall Study|Withdrawal by Subject|0|||
161028251|NCT03213665|581494590|FG000|Overall Study|Adverse Event|1|||
161028252|NCT03213665|581494590|FG000|Overall Study|Physician Decision|2|||
161028253|NCT03213665|581494590|FG000|Overall Study|Withdrawal by Subject|3|||
161028254|NCT03213665|581494590|FG000|Overall Study|Progressive Disease|13|||
161028255|NCT03325985|581494591|FG000|Overall Study|Lost to Follow-up|122|||
161028256|NCT03325985|581494592|FG001|Overall Study|Lost to Follow-up|26|||
161028257|NCT03325985|581494593|FG002|Overall Study|Lost to Follow-up|141|||
161028258|NCT03325985|581494594|FG003|Overall Study|Lost to Follow-up|28|||
161028259|NCT03325985|581494591|FG000|Overall Study|Death|99|||
161028260|NCT03325985|581494592|FG001|Overall Study|Death|36|||
161028261|NCT03325985|581494593|FG002|Overall Study|Death|94|||
161028262|NCT03325985|581494594|FG003|Overall Study|Death|32|||
161028263|NCT03034356|581494595|FG000|Baseline|Lost to Follow-up|2|||
161028264|NCT03034356|581494596|FG001|Baseline|Lost to Follow-up|4|||
161028265|NCT03034356|581494595|FG000|Baseline|Withdrawal by Subject|2|||
161028266|NCT03034356|581494596|FG001|Baseline|Withdrawal by Subject|0|||
161028267|NCT03034356|581494595|FG000|Baseline|Physician Decision|0|||
161028268|NCT03034356|581494596|FG001|Baseline|Physician Decision|1|||
161276340|NCT02728843|582391685|FG004|Overall Study|Protocol Violation|2|||
161028269|NCT03034356|581494595|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
161028270|NCT03034356|581494596|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
161276341|NCT02728843|582391681|FG000|Overall Study|Withdrawal by Subject|1|||
161276342|NCT02728843|582391682|FG001|Overall Study|Withdrawal by Subject|0|||
161276343|NCT02728843|582391683|FG002|Overall Study|Withdrawal by Subject|0|||
161276344|NCT02728843|582391684|FG003|Overall Study|Withdrawal by Subject|1|||
161276345|NCT02728843|582391685|FG004|Overall Study|Withdrawal by Subject|0|||
161344264|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
161028271|NCT03034356|581494595|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
161028272|NCT03034356|581494596|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
161028273|NCT03034356|581494595|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
161028274|NCT03034356|581494596|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
161028275|NCT03034356|581494595|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
161028276|NCT03034356|581494596|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
161028277|NCT02684227|581494597|FG000|Overall Study|Adverse Event|1|||
161028278|NCT02684227|581494598|FG001|Overall Study|Adverse Event|7|||
161028279|NCT02684227|581494597|FG000|Overall Study|Death|0|||
161028280|NCT02684227|581494598|FG001|Overall Study|Death|2|||
161028281|NCT02684227|581494597|FG000|Overall Study|Withdrawal by Subject|0|||
161028282|NCT02684227|581494598|FG001|Overall Study|Withdrawal by Subject|1|||
161028283|NCT02684227|581494597|FG000|Overall Study|Progressive Disease|0|||
161028284|NCT02684227|581494598|FG001|Overall Study|Progressive Disease|2|||
161028285|NCT04571619|581494601|FG000|Phase 1|Death|22|||
161028286|NCT04571619|581494602|FG001|Phase 1|Death|18|||
161028287|NCT04571619|581494601|FG000|Phase 1|Withdrawal by Subject|7|||
161028288|NCT04571619|581494602|FG001|Phase 1|Withdrawal by Subject|2|||
161028289|NCT04571619|581494601|FG000|Phase 2|Death|13|||
161028290|NCT04571619|581494602|FG001|Phase 2|Death|16|||
161028291|NCT04571619|581494601|FG000|Phase 2|Withdrawal by Subject|6|||
161028292|NCT04571619|581494602|FG001|Phase 2|Withdrawal by Subject|4|||
161028293|NCT04479761|581494605|FG000|Overall Study|could not perform the balance tasks|1|||
161028294|NCT04479761|581494606|FG001|Overall Study|could not perform the balance tasks|0|||
161028295|NCT04479761|581494607|FG002|Overall Study|could not perform the balance tasks|0|||
161028296|NCT04479761|581494605|FG000|Overall Study|Adverse Event|1|||
161028297|NCT04479761|581494606|FG001|Overall Study|Adverse Event|0|||
161028298|NCT04479761|581494607|FG002|Overall Study|Adverse Event|0|||
161028299|NCT04479761|581494605|FG000|Overall Study|one control did not meet screening criteria|0|||
161028300|NCT04479761|581494606|FG001|Overall Study|one control did not meet screening criteria|0|||
161028301|NCT04479761|581494607|FG002|Overall Study|one control did not meet screening criteria|1|||
161028302|NCT04479761|581494605|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
161028303|NCT04479761|581494606|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
161028304|NCT04479761|581494607|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
161028305|NCT05309291|581494608|FG000|Overall Study|Adverse Event|0|||
161028306|NCT05309291|581494609|FG001|Overall Study|Adverse Event|1|||
161028307|NCT04183283|581496505|FG000|Period 1|Withdrawal by Subject|0|||
161028308|NCT04183283|581496506|FG001|Period 1|Withdrawal by Subject|1|||
161028309|NCT04183283|581496507|FG002|Period 1|Withdrawal by Subject|0|||
161028310|NCT04183283|581496508|FG003|Period 1|Withdrawal by Subject|0|||
161028311|NCT04183283|581496505|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
161028312|NCT04183283|581496506|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
161028313|NCT04183283|581496507|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
161028314|NCT04183283|581496508|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
161028315|NCT04909801|581496518|FG000|Overall Study|Lack of Efficacy|2|||
161028316|NCT04909801|581496519|FG001|Overall Study|Lack of Efficacy|1|||
161028317|NCT04909801|581496518|FG000|Overall Study|Adverse Event|1|||
161028318|NCT04909801|581496519|FG001|Overall Study|Adverse Event|2|||
160974690|NCT01863043|581297531|FG001|Overall Study|Withdrawal by Subject|2|||
160974691|NCT01863043|581297530|FG000|Overall Study|Adverse Event|7|||
160974692|NCT01863043|581297531|FG001|Overall Study|Adverse Event|8|||
160974693|NCT01863043|581297530|FG000|Overall Study|exclusion criteria found after enrollment|0|||
160974694|NCT01863043|581297531|FG001|Overall Study|exclusion criteria found after enrollment|1|||
160974695|NCT01987596|581297532|FG000|Overall Study|Physician Decision|1|||
160974696|NCT01987596|581297533|FG001|Overall Study|Physician Decision|0|||
160974697|NCT01987596|581297532|FG000|Overall Study|Progressive Disease; missing all period|0|||
160974698|NCT01987596|581297533|FG001|Overall Study|Progressive Disease; missing all period|1|||
160974699|NCT02632786|581297536|FG000|Overall Study|Adverse Event|2|||
160974700|NCT02632786|581297537|FG001|Overall Study|Adverse Event|1|||
160974701|NCT02632786|581297536|FG000|Overall Study|Death|3|||
160974702|NCT02632786|581297537|FG001|Overall Study|Death|2|||
160974703|NCT02632786|581297536|FG000|Overall Study|Physician Decision|5|||
160974704|NCT02632786|581297537|FG001|Overall Study|Physician Decision|4|||
160974705|NCT02632786|581297536|FG000|Overall Study|Withdrawal by Subject|1|||
160974706|NCT02632786|581297537|FG001|Overall Study|Withdrawal by Subject|0|||
160974707|NCT00854295|581297538|FG000|Overall Study|Death|7|||
160974708|NCT00854295|581297539|FG001|Overall Study|Death|0|||
160974709|NCT00854295|581297540|FG002|Overall Study|Death|1|||
160974710|NCT00854295|581297541|FG003|Overall Study|Death|1|||
160974711|NCT00854295|581297538|FG000|Overall Study|Adverse Event|6|||
160974712|NCT00854295|581297539|FG001|Overall Study|Adverse Event|1|||
160974713|NCT00854295|581297540|FG002|Overall Study|Adverse Event|1|||
160974714|NCT00854295|581297541|FG003|Overall Study|Adverse Event|3|||
161028319|NCT04909801|581496518|FG000|Overall Study|Participant request to discontinue study treatment|1|||
161276346|NCT02728843|582391681|FG000|Overall Study|Use of rescue medication|0|||
161028320|NCT04909801|581496519|FG001|Overall Study|Participant request to discontinue study treatment|2|||
161028321|NCT04909801|581496518|FG000|Overall Study|Withdrawal by Subject|2|||
161028322|NCT04909801|581496519|FG001|Overall Study|Withdrawal by Subject|1|||
161028323|NCT04909801|581496518|FG000|Overall Study|other reasons|1|||
161028324|NCT04909801|581496519|FG001|Overall Study|other reasons|1|||
161028325|NCT02694822|581496521|FG000|Phase 1|Death|2|||
161028326|NCT02694822|581496522|FG001|Phase 1|Death|1|||
161028327|NCT02694822|581496523|FG002|Phase 1|Death|6|||
161028328|NCT02694822|581496524|FG003|Phase 1|Death|6|||
161028329|NCT02694822|581496525|FG004|Phase 1|Death|3|||
161028330|NCT02694822|581496526|FG005|Phase 1|Death|0|||
161028331|NCT02694822|581496521|FG000|Phase 1|Withdrawal by Subject|2|||
161028332|NCT02694822|581496522|FG001|Phase 1|Withdrawal by Subject|2|||
161028333|NCT02694822|581496523|FG002|Phase 1|Withdrawal by Subject|4|||
161028334|NCT02694822|581496524|FG003|Phase 1|Withdrawal by Subject|8|||
161028335|NCT02694822|581496525|FG004|Phase 1|Withdrawal by Subject|1|||
161028336|NCT02694822|581496526|FG005|Phase 1|Withdrawal by Subject|0|||
161028337|NCT02694822|581496521|FG000|Phase 2|Death|0|||
161028338|NCT02694822|581496522|FG001|Phase 2|Death|0|||
161028339|NCT02694822|581496523|FG002|Phase 2|Death|0|||
161028340|NCT02694822|581496524|FG003|Phase 2|Death|0|||
161028341|NCT02694822|581496525|FG004|Phase 2|Death|0|||
161028342|NCT02694822|581496526|FG005|Phase 2|Death|26|||
161028343|NCT02694822|581496521|FG000|Phase 2|Withdrawal by Subject|0|||
161028344|NCT02694822|581496522|FG001|Phase 2|Withdrawal by Subject|0|||
161028345|NCT02694822|581496523|FG002|Phase 2|Withdrawal by Subject|0|||
161028346|NCT02694822|581496524|FG003|Phase 2|Withdrawal by Subject|0|||
161028347|NCT02694822|581496525|FG004|Phase 2|Withdrawal by Subject|0|||
161028348|NCT02694822|581496526|FG005|Phase 2|Withdrawal by Subject|13|||
161028349|NCT02694822|581496521|FG000|Phase 2|Administrative Study Closure|0|||
161028350|NCT02694822|581496522|FG001|Phase 2|Administrative Study Closure|0|||
161028351|NCT02694822|581496523|FG002|Phase 2|Administrative Study Closure|0|||
161028352|NCT02694822|581496524|FG003|Phase 2|Administrative Study Closure|0|||
161028353|NCT02694822|581496525|FG004|Phase 2|Administrative Study Closure|0|||
161028354|NCT02694822|581496526|FG005|Phase 2|Administrative Study Closure|2|||
161028355|NCT02694822|581496521|FG000|Phase 2|Lost to Follow-up|0|||
161028356|NCT02694822|581496522|FG001|Phase 2|Lost to Follow-up|0|||
161028357|NCT02694822|581496523|FG002|Phase 2|Lost to Follow-up|0|||
161028358|NCT02694822|581496524|FG003|Phase 2|Lost to Follow-up|0|||
161028359|NCT02694822|581496525|FG004|Phase 2|Lost to Follow-up|0|||
161276347|NCT02728843|582391682|FG001|Overall Study|Use of rescue medication|2|||
161276348|NCT02728843|582391683|FG002|Overall Study|Use of rescue medication|0|||
161276349|NCT02728843|582391684|FG003|Overall Study|Use of rescue medication|2|||
161276350|NCT02728843|582391685|FG004|Overall Study|Use of rescue medication|1|||
161276351|NCT00205803|582391689|FG000|Infant Series|Lost to Follow-up|10|||
161276352|NCT00205803|582391690|FG001|Infant Series|Lost to Follow-up|4|||
161276353|NCT00205803|582391689|FG000|Infant Series|Withdrawal by Subject|2|||
161276354|NCT00205803|582391690|FG001|Infant Series|Withdrawal by Subject|5|||
161276355|NCT00205803|582391689|FG000|Infant Series|Physician Decision|3|||
161276356|NCT00205803|582391690|FG001|Infant Series|Physician Decision|1|||
161276357|NCT00205803|582391689|FG000|Infant Series|Protocol Violation|1|||
161276358|NCT00205803|582391690|FG001|Infant Series|Protocol Violation|0|||
161276359|NCT00205803|582391689|FG000|Infant Series|Lost Kaiser coverage|0|||
161276360|NCT00205803|582391690|FG001|Infant Series|Lost Kaiser coverage|1|||
161276361|NCT00205803|582391689|FG000|Infant Series|Non-compliant|1|||
161276362|NCT00205803|582391690|FG001|Infant Series|Non-compliant|0|||
161276363|NCT00205803|582391689|FG000|Infant Series|Sponsor request|1|||
161276364|NCT00205803|582391690|FG001|Infant Series|Sponsor request|0|||
161028360|NCT02694822|581496526|FG005|Phase 2|Lost to Follow-up|1|||
161028361|NCT02694822|581496521|FG000|Phase 2|Participant Transferred to Another Site|0|||
161028362|NCT02694822|581496522|FG001|Phase 2|Participant Transferred to Another Site|0|||
161028363|NCT02694822|581496523|FG002|Phase 2|Participant Transferred to Another Site|0|||
161028364|NCT02694822|581496524|FG003|Phase 2|Participant Transferred to Another Site|0|||
161028365|NCT02694822|581496525|FG004|Phase 2|Participant Transferred to Another Site|0|||
161276365|NCT00205803|582391689|FG000|After Infant Series|Adverse Event|1|||
161276366|NCT00205803|582391690|FG001|After Infant Series|Adverse Event|1|||
161028366|NCT02694822|581496526|FG005|Phase 2|Participant Transferred to Another Site|1|||
161028367|NCT01868997|581496527|FG000|Overall Study|Adverse Event|2|||
161028368|NCT01868997|581496528|FG001|Overall Study|Adverse Event|5|||
161028369|NCT01868997|581496527|FG000|Overall Study|Lack of Efficacy|2|||
161028370|NCT01868997|581496528|FG001|Overall Study|Lack of Efficacy|0|||
161028371|NCT01868997|581496527|FG000|Overall Study|Other|3|||
161028372|NCT01868997|581496528|FG001|Overall Study|Other|1|||
161028373|NCT05370040|581496529|FG000|Overall Study|Lost to Follow-up|0|||
161028374|NCT05370040|581496530|FG001|Overall Study|Lost to Follow-up|0|||
161028375|NCT05370040|581496531|FG002|Overall Study|Lost to Follow-up|1|||
161028376|NCT05370040|581496532|FG003|Overall Study|Lost to Follow-up|0|||
161028377|NCT05370040|581496533|FG004|Overall Study|Lost to Follow-up|1|||
161028378|NCT05370040|581496534|FG005|Overall Study|Lost to Follow-up|0|||
161276367|NCT00205803|582391689|FG000|After Infant Series|Protocol Violation|1|||
161344265|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
161344266|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
161344267|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
161344268|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
161344269|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
161344270|NCT00296517|582646050|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
161344271|NCT00296517|582646051|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
161344272|NCT02164916|582646052|FG000|Overall Study|Adverse Event|3|||
161344273|NCT02164916|582646053|FG001|Overall Study|Adverse Event|8|||
161344274|NCT02164916|582646052|FG000|Overall Study|Death|1|||
161344275|NCT02164916|582646053|FG001|Overall Study|Death|1|||
161344276|NCT02164916|582646052|FG000|Overall Study|Refusal unrelated to adverse event|3|||
161344277|NCT02164916|582646053|FG001|Overall Study|Refusal unrelated to adverse event|7|||
161344278|NCT02164916|582646052|FG000|Overall Study|Progression|37|||
161344279|NCT02164916|582646053|FG001|Overall Study|Progression|26|||
161344280|NCT02164916|582646052|FG000|Overall Study|Not protocol specified|5|||
161344281|NCT02164916|582646053|FG001|Overall Study|Not protocol specified|1|||
161344282|NCT02164916|582646052|FG000|Overall Study|Reason under review|1|||
161344283|NCT02164916|582646053|FG001|Overall Study|Reason under review|6|||
161344284|NCT02164916|582646052|FG000|Overall Study|Not eligible|2|||
161344285|NCT02164916|582646053|FG001|Overall Study|Not eligible|5|||
161344286|NCT00964782|582646056|FG000|Overall Study|Lost to Follow-up|1|||
161344287|NCT00964782|582646057|FG001|Overall Study|Lost to Follow-up|0|||
161344288|NCT00596635|582646063|FG000|Overall Study|Lost to Follow-up|0|||
161344289|NCT00596635|582646064|FG001|Overall Study|Lost to Follow-up|2|||
161344290|NCT00596635|582646065|FG002|Overall Study|Lost to Follow-up|0|||
161344291|NCT00596635|582646063|FG000|Overall Study|Treatment for symptomatic UTI|4|||
161344292|NCT00596635|582646064|FG001|Overall Study|Treatment for symptomatic UTI|6|||
161344293|NCT00596635|582646065|FG002|Overall Study|Treatment for symptomatic UTI|3|||
161344294|NCT00596635|582646063|FG000|Overall Study|Hip fracture|2|||
161344295|NCT00596635|582646064|FG001|Overall Study|Hip fracture|3|||
161344296|NCT00596635|582646065|FG002|Overall Study|Hip fracture|3|||
161344297|NCT00596635|582646063|FG000|Overall Study|Could not provide urine specimen|1|||
161344298|NCT00596635|582646064|FG001|Overall Study|Could not provide urine specimen|2|||
161344299|NCT00596635|582646065|FG002|Overall Study|Could not provide urine specimen|2|||
161344300|NCT01143324|582646066|FG000|Overall Study|Lost to Follow-up|11|||
161344301|NCT01143324|582646066|FG000|Overall Study|Withdrawal by Subject|4|||
161344302|NCT01143324|582646066|FG000|Overall Study|Explant of the device|4|||
161344303|NCT01101178|582646069|FG000|Period 1|Withdrawal by Subject|1|||
161344304|NCT01101178|582646070|FG001|Period 1|Withdrawal by Subject|2|||
161344305|NCT01101178|582646069|FG000|Period 1|Positive drug screen|1|||
161344306|NCT01101178|582646070|FG001|Period 1|Positive drug screen|1|||
161344307|NCT01101178|582646069|FG000|Period 1|Adverse Event|2|||
161344308|NCT01101178|582646070|FG001|Period 1|Adverse Event|1|||
161344309|NCT01101178|582646069|FG000|Period 2|Withdrawal by Subject|0|||
161344310|NCT01101178|582646070|FG001|Period 2|Withdrawal by Subject|1|||
161344311|NCT01850641|582646071|FG000|Overall Study|Physician Decision|1|||
161344312|NCT01850641|582646071|FG000|Overall Study|Decrease in serum phosphorus|1|||
161344313|NCT01850641|582646071|FG000|Overall Study|Decrease in serum calcium|2|||
160974715|NCT00854295|581297538|FG000|Overall Study|Lost to Follow-up|18|||
160974716|NCT00854295|581297539|FG001|Overall Study|Lost to Follow-up|5|||
160974717|NCT00854295|581297540|FG002|Overall Study|Lost to Follow-up|21|||
160974718|NCT00854295|581297541|FG003|Overall Study|Lost to Follow-up|21|||
160974719|NCT00854295|581297538|FG000|Overall Study|Physician Decision|10|||
160974720|NCT00854295|581297539|FG001|Overall Study|Physician Decision|0|||
160974721|NCT00854295|581297540|FG002|Overall Study|Physician Decision|0|||
160974722|NCT00854295|581297541|FG003|Overall Study|Physician Decision|0|||
160974723|NCT00709592|581297542|FG000|Overall Study|Unable to proceed to transplant|0|||
160974724|NCT00709592|581297543|FG001|Overall Study|Unable to proceed to transplant|1|||
160974725|NCT03154359|581297547|FG000|Overall Study|Adverse Event|1|||
160974726|NCT03154359|581297547|FG000|Overall Study|Lack of Efficacy|2|||
160974727|NCT03154359|581297547|FG000|Overall Study|Lost to Follow-up|3|||
160974728|NCT03154359|581297547|FG000|Overall Study|Physician Decision|3|||
160974729|NCT03154359|581297547|FG000|Overall Study|Protocol Violation|4|||
160974730|NCT03154359|581297547|FG000|Overall Study|Withdrawal by Subject|5|||
160974731|NCT03154359|581297547|FG000|Overall Study|Disruption of study due to COVID-19|4|||
160974732|NCT02440594|581297548|FG000|Overall Study|Lost to Follow-up|34|||
160974733|NCT02440594|581297549|FG001|Overall Study|Lost to Follow-up|33|||
160974734|NCT02440594|581297550|FG002|Overall Study|Lost to Follow-up|54|||
160974735|NCT02440594|581297551|FG003|Overall Study|Lost to Follow-up|47|||
160974736|NCT02440594|581297552|FG004|Overall Study|Lost to Follow-up|5|||
160974737|NCT02440594|581297553|FG005|Overall Study|Lost to Follow-up|4|||
160974738|NCT02440594|581297554|FG006|Overall Study|Lost to Follow-up|28|||
160974739|NCT02440594|581297555|FG007|Overall Study|Lost to Follow-up|48|||
160974740|NCT02440594|581297548|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
160974741|NCT02440594|581297549|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
161344314|NCT01850641|582646071|FG000|Overall Study|Increase in serum ferritin|1|||
161344315|NCT00141817|582646072|FG000|Overall Study|Protocol Violation|0|||
161028379|NCT04971109|581496535|FG000|Overall Study|Adverse Event|4|||
161028380|NCT04971109|581496536|FG001|Overall Study|Adverse Event|3|||
161028381|NCT04971109|581496535|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
161028382|NCT04971109|581496536|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
161028383|NCT04971109|581496535|FG000|Overall Study|Lost to Follow-up|8|||
161028384|NCT04971109|581496536|FG001|Overall Study|Lost to Follow-up|2|||
161028385|NCT04971109|581496535|FG000|Overall Study|Physician Decision|5|||
161028386|NCT04971109|581496536|FG001|Overall Study|Physician Decision|0|||
161028387|NCT04971109|581496535|FG000|Overall Study|Protocol Violation|0|||
161028388|NCT04971109|581496536|FG001|Overall Study|Protocol Violation|1|||
161028389|NCT04971109|581496535|FG000|Overall Study|Withdrawal by Subject|18|||
161028390|NCT04971109|581496536|FG001|Overall Study|Withdrawal by Subject|3|||
161028391|NCT04971109|581496535|FG000|Overall Study|Subject was randomized in error|1|||
161028392|NCT04971109|581496536|FG001|Overall Study|Subject was randomized in error|0|||
161028393|NCT04778397|581496539|FG000|Overall Study|Death|59|||
161028394|NCT04778397|581496540|FG001|Overall Study|Death|54|||
161028395|NCT04778397|581496541|FG002|Overall Study|Death|11|||
161028396|NCT04778397|581496542|FG003|Overall Study|Death|9|||
161028397|NCT04778397|581496539|FG000|Overall Study|Study Terminated by Sponsor|34|||
161028398|NCT04778397|581496540|FG001|Overall Study|Study Terminated by Sponsor|42|||
161028399|NCT04778397|581496541|FG002|Overall Study|Study Terminated by Sponsor|15|||
161028400|NCT04778397|581496542|FG003|Overall Study|Study Terminated by Sponsor|12|||
161028401|NCT04778397|581496539|FG000|Overall Study|Withdrew Consent|5|||
161028402|NCT04778397|581496540|FG001|Overall Study|Withdrew Consent|4|||
161028403|NCT04778397|581496541|FG002|Overall Study|Withdrew Consent|1|||
161028404|NCT04778397|581496542|FG003|Overall Study|Withdrew Consent|1|||
161028405|NCT04778397|581496539|FG000|Overall Study|Reason Not Specified|1|||
161028406|NCT04778397|581496540|FG001|Overall Study|Reason Not Specified|3|||
160974742|NCT02440594|581297550|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
160974743|NCT02440594|581297551|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
160974744|NCT02440594|581297552|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
160974745|NCT02440594|581297553|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
160974746|NCT02440594|581297554|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
160974747|NCT02440594|581297555|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
161276368|NCT00205803|582391690|FG001|After Infant Series|Protocol Violation|1|||
161276369|NCT00205803|582391689|FG000|After Infant Series|Lost to Follow-up|2|||
161276370|NCT00205803|582391690|FG001|After Infant Series|Lost to Follow-up|1|||
161276371|NCT00205803|582391689|FG000|After Infant Series|Physician Decision|3|||
161276372|NCT00205803|582391690|FG001|After Infant Series|Physician Decision|2|||
161276373|NCT00205803|582391689|FG000|After Infant Series|Withdrawal by Subject|1|||
161276374|NCT00205803|582391690|FG001|After Infant Series|Withdrawal by Subject|4|||
161276375|NCT00205803|582391689|FG000|After Infant Series|Other|10|||
161276376|NCT00205803|582391690|FG001|After Infant Series|Other|4|||
161276377|NCT00205803|582391689|FG000|Toddler Dose|Lost to Follow-up|2|||
161276378|NCT00205803|582391690|FG001|Toddler Dose|Lost to Follow-up|3|||
161276379|NCT00197496|582391694|FG000|Baseline to Discharge|not interested|1|||
161276380|NCT00197496|582391695|FG001|Baseline to Discharge|not interested|0|||
161276381|NCT00197496|582391694|FG000|Baseline to Discharge|MRSA|1|||
161276382|NCT00197496|582391695|FG001|Baseline to Discharge|MRSA|0|||
161276383|NCT00197496|582391694|FG000|Baseline to Discharge|Physician Decision|0|||
161276384|NCT00197496|582391695|FG001|Baseline to Discharge|Physician Decision|1|||
161276385|NCT00197496|582391694|FG000|Baseline to Discharge|Protocol Violation|0|||
161276386|NCT00197496|582391695|FG001|Baseline to Discharge|Protocol Violation|1|||
161276387|NCT00197496|582391694|FG000|Follow-up|Lost to Follow-up|2|||
161276388|NCT00197496|582391695|FG001|Follow-up|Lost to Follow-up|1|||
161276389|NCT00857584|582391698|FG000|Overall Study|Lack of Efficacy|1|||
161276390|NCT00857584|582391699|FG001|Overall Study|Lack of Efficacy|2|||
161276391|NCT00857584|582391698|FG000|Overall Study|Adverse Event|2|||
161276392|NCT00857584|582391699|FG001|Overall Study|Adverse Event|2|||
161276393|NCT00857584|582391698|FG000|Overall Study|Physician Decision|1|||
161276394|NCT00857584|582391699|FG001|Overall Study|Physician Decision|1|||
161276395|NCT02533375|582391700|FG000|Overall Study|Lack of Efficacy|3|||
161276396|NCT02533375|582391700|FG000|Overall Study|Adverse Event|2|||
161276397|NCT00673387|582391701|FG000|Overall Study|Withdrawal by Subject|15|||
161276398|NCT00673387|582391702|FG001|Overall Study|Withdrawal by Subject|16|||
161276399|NCT00673387|582391703|FG002|Overall Study|Withdrawal by Subject|20|||
161276400|NCT00673387|582391704|FG003|Overall Study|Withdrawal by Subject|16|||
161276401|NCT00673387|582391705|FG004|Overall Study|Withdrawal by Subject|18|||
160974748|NCT02440594|581297548|FG000|Overall Study|Withdrawal by Subject|81|||
161028407|NCT04778397|581496541|FG002|Overall Study|Reason Not Specified|0|||
161028408|NCT04778397|581496542|FG003|Overall Study|Reason Not Specified|2|||
161028409|NCT04778397|581496539|FG000|Overall Study|Lost to Follow-up|2|||
160974749|NCT02440594|581297549|FG001|Overall Study|Withdrawal by Subject|67|||
161028410|NCT04778397|581496540|FG001|Overall Study|Lost to Follow-up|1|||
161276402|NCT00673387|582391706|FG005|Overall Study|Withdrawal by Subject|21|||
161276403|NCT00673387|582391707|FG006|Overall Study|Withdrawal by Subject|15|||
161276404|NCT00673387|582391708|FG007|Overall Study|Withdrawal by Subject|21|||
161028411|NCT04778397|581496541|FG002|Overall Study|Lost to Follow-up|0|||
161028412|NCT04778397|581496542|FG003|Overall Study|Lost to Follow-up|1|||
161028413|NCT04294641|581496543|FG000|Overall Study|Screen failure|4|||
161028414|NCT05906784|581496545|FG000|Overall Study|Lost to Follow-up|2|||
161028415|NCT05906784|581496546|FG001|Overall Study|Lost to Follow-up|1|||
161028416|NCT05906784|581496547|FG002|Overall Study|Lost to Follow-up|1|||
161028417|NCT05906784|581496548|FG003|Overall Study|Lost to Follow-up|1|||
161028418|NCT04314778|581496552|FG000|Overall Study|Lost to Follow-up|5|||
161028419|NCT04314778|581496553|FG001|Overall Study|Lost to Follow-up|3|||
161028420|NCT03523572|581496554|FG000|Dose Escalation|Progressive disease|1|||
161028421|NCT03523572|581496555|FG001|Dose Escalation|Progressive disease|0|||
161028422|NCT03523572|581496556|FG002|Dose Escalation|Progressive disease|0|||
161028423|NCT03523572|581496557|FG003|Dose Escalation|Progressive disease|0|||
161028424|NCT03523572|581496558|FG004|Dose Escalation|Progressive disease|0|||
161028425|NCT03523572|581496559|FG005|Dose Escalation|Progressive disease|0|||
161028426|NCT03523572|581496554|FG000|Dose Escalation|Clinical Progression|0|||
161028427|NCT03523572|581496555|FG001|Dose Escalation|Clinical Progression|1|||
161028428|NCT03523572|581496556|FG002|Dose Escalation|Clinical Progression|0|||
161028429|NCT03523572|581496557|FG003|Dose Escalation|Clinical Progression|0|||
161028430|NCT03523572|581496558|FG004|Dose Escalation|Clinical Progression|0|||
161028431|NCT03523572|581496559|FG005|Dose Escalation|Clinical Progression|0|||
161028432|NCT03523572|581496554|FG000|Dose Escalation|Adverse Event|2|||
161028433|NCT03523572|581496555|FG001|Dose Escalation|Adverse Event|0|||
161028434|NCT03523572|581496556|FG002|Dose Escalation|Adverse Event|0|||
161028435|NCT03523572|581496557|FG003|Dose Escalation|Adverse Event|0|||
161028436|NCT03523572|581496558|FG004|Dose Escalation|Adverse Event|0|||
161028437|NCT03523572|581496559|FG005|Dose Escalation|Adverse Event|0|||
161028438|NCT03523572|581496554|FG000|Dose Escalation|Physician Decision|1|||
161028439|NCT03523572|581496555|FG001|Dose Escalation|Physician Decision|1|||
161028440|NCT03523572|581496556|FG002|Dose Escalation|Physician Decision|0|||
161028441|NCT03523572|581496557|FG003|Dose Escalation|Physician Decision|0|||
161028442|NCT03523572|581496558|FG004|Dose Escalation|Physician Decision|0|||
161028443|NCT03523572|581496559|FG005|Dose Escalation|Physician Decision|0|||
161028444|NCT03523572|581496554|FG000|Dose Expansion|Progressive Disease|0|||
161028445|NCT03523572|581496555|FG001|Dose Expansion|Progressive Disease|0|||
161028446|NCT03523572|581496556|FG002|Dose Expansion|Progressive Disease|9|||
161028447|NCT03523572|581496557|FG003|Dose Expansion|Progressive Disease|11|||
161028448|NCT03523572|581496558|FG004|Dose Expansion|Progressive Disease|15|||
161028449|NCT03523572|581496559|FG005|Dose Expansion|Progressive Disease|2|||
161028450|NCT03523572|581496554|FG000|Dose Expansion|Clinical Progression|0|||
161028451|NCT03523572|581496555|FG001|Dose Expansion|Clinical Progression|0|||
161028452|NCT03523572|581496556|FG002|Dose Expansion|Clinical Progression|2|||
161028453|NCT03523572|581496557|FG003|Dose Expansion|Clinical Progression|2|||
161028454|NCT03523572|581496558|FG004|Dose Expansion|Clinical Progression|2|||
161028455|NCT03523572|581496559|FG005|Dose Expansion|Clinical Progression|0|||
161028456|NCT03523572|581496554|FG000|Dose Expansion|Adverse Event|0|||
161028457|NCT03523572|581496555|FG001|Dose Expansion|Adverse Event|0|||
161028458|NCT03523572|581496556|FG002|Dose Expansion|Adverse Event|10|||
161028459|NCT03523572|581496557|FG003|Dose Expansion|Adverse Event|1|||
161028460|NCT03523572|581496558|FG004|Dose Expansion|Adverse Event|5|||
161028461|NCT03523572|581496559|FG005|Dose Expansion|Adverse Event|2|||
161028462|NCT03523572|581496554|FG000|Dose Expansion|Withdrawal by Subject|0|||
161028463|NCT03523572|581496555|FG001|Dose Expansion|Withdrawal by Subject|0|||
161028464|NCT03523572|581496556|FG002|Dose Expansion|Withdrawal by Subject|1|||
161028465|NCT03523572|581496557|FG003|Dose Expansion|Withdrawal by Subject|1|||
161028466|NCT03523572|581496558|FG004|Dose Expansion|Withdrawal by Subject|0|||
161028467|NCT03523572|581496559|FG005|Dose Expansion|Withdrawal by Subject|0|||
161028468|NCT03523572|581496554|FG000|Dose Expansion|Physician Decision|0|||
161028469|NCT03523572|581496555|FG001|Dose Expansion|Physician Decision|0|||
161028470|NCT03523572|581496556|FG002|Dose Expansion|Physician Decision|1|||
161028471|NCT03523572|581496557|FG003|Dose Expansion|Physician Decision|0|||
161028472|NCT03523572|581496558|FG004|Dose Expansion|Physician Decision|1|||
161028473|NCT03523572|581496559|FG005|Dose Expansion|Physician Decision|0|||
161028474|NCT03523572|581496554|FG000|Dose Expansion|Miscellaneous|0|||
161028475|NCT03523572|581496555|FG001|Dose Expansion|Miscellaneous|0|||
161028476|NCT03523572|581496556|FG002|Dose Expansion|Miscellaneous|0|||
161028477|NCT03523572|581496557|FG003|Dose Expansion|Miscellaneous|0|||
161028478|NCT03523572|581496558|FG004|Dose Expansion|Miscellaneous|3|||
161028479|NCT03523572|581496559|FG005|Dose Expansion|Miscellaneous|0|||
161028480|NCT04685135|581496565|FG000|Overall Study|Death|126|||
161028481|NCT04685135|581496566|FG001|Overall Study|Death|53|||
161028482|NCT04685135|581496565|FG000|Overall Study|Withdrawal by Subject|12|||
161028483|NCT04685135|581496566|FG001|Overall Study|Withdrawal by Subject|16|||
161028484|NCT02315703|581496567|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161028485|NCT02315703|581496568|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161028486|NCT02315703|581496569|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161028487|NCT02315703|581496570|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
161028488|NCT02315703|581496571|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
161028489|NCT02315703|581496572|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161028490|NCT02315703|581496573|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
161028491|NCT02315703|581496574|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
161028492|NCT02315703|581496567|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
161028493|NCT02315703|581496568|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
161028494|NCT02315703|581496569|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
161028495|NCT02315703|581496570|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
161028496|NCT02315703|581496571|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
161028497|NCT02315703|581496572|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
161028498|NCT02315703|581496573|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
161028499|NCT02315703|581496574|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
161028500|NCT02315703|581496567|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161028501|NCT02315703|581496568|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161028502|NCT02315703|581496569|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161028503|NCT02315703|581496570|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161028504|NCT02315703|581496571|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161028505|NCT02315703|581496572|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
161028506|NCT02315703|581496573|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
161028507|NCT02315703|581496574|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
161028508|NCT02315703|581496567|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028509|NCT02315703|581496568|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028510|NCT02315703|581496569|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028511|NCT02315703|581496570|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028512|NCT02315703|581496571|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028513|NCT02315703|581496572|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028514|NCT02315703|581496573|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
161028515|NCT02315703|581496574|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
161028516|NCT02315703|581496567|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
161028517|NCT02315703|581496568|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
161028518|NCT02315703|581496569|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
161028519|NCT02315703|581496570|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
161028520|NCT02315703|581496571|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
161028521|NCT02315703|581496572|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
161028522|NCT02315703|581496573|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
161028523|NCT02315703|581496574|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
161028524|NCT02315703|581496567|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
161028525|NCT02315703|581496568|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
161028526|NCT02315703|581496569|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
161028527|NCT02315703|581496570|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
161028528|NCT02315703|581496571|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
161028529|NCT02315703|581496572|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
161028530|NCT02315703|581496573|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
161028531|NCT02315703|581496574|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
161028532|NCT02315703|581496567|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
161028533|NCT02315703|581496568|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
161028534|NCT02315703|581496569|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161028535|NCT02315703|581496570|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161028536|NCT02315703|581496571|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161028537|NCT02315703|581496572|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161028538|NCT02315703|581496573|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161028539|NCT02315703|581496574|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
161028540|NCT02315703|581496567|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161028541|NCT02315703|581496568|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
161028542|NCT02315703|581496569|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161028543|NCT02315703|581496570|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161028544|NCT02315703|581496571|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161028545|NCT02315703|581496572|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161028546|NCT02315703|581496573|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161028547|NCT02315703|581496574|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
161276405|NCT00673387|582391701|FG000|Overall Study|Adverse Event|3|||
161276406|NCT00673387|582391702|FG001|Overall Study|Adverse Event|1|||
161276407|NCT00673387|582391703|FG002|Overall Study|Adverse Event|5|||
161276408|NCT00673387|582391704|FG003|Overall Study|Adverse Event|2|||
161028548|NCT02315703|581496567|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
161276409|NCT00673387|582391705|FG004|Overall Study|Adverse Event|6|||
161028549|NCT02315703|581496568|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
161344316|NCT00141817|582646073|FG001|Overall Study|Protocol Violation|0|||
161344317|NCT00141817|582646074|FG002|Overall Study|Protocol Violation|1|||
161344318|NCT00141817|582646075|FG003|Overall Study|Protocol Violation|0|||
161344319|NCT00141817|582646072|FG000|Overall Study|Parent request|1|||
161344320|NCT00141817|582646073|FG001|Overall Study|Parent request|0|||
161344321|NCT00141817|582646074|FG002|Overall Study|Parent request|0|||
161344322|NCT00141817|582646075|FG003|Overall Study|Parent request|0|||
161028550|NCT02315703|581496569|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
161028551|NCT02315703|581496570|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
161028552|NCT02315703|581496571|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
161028553|NCT02315703|581496572|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
161028554|NCT02315703|581496573|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
161028555|NCT02315703|581496574|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
161028556|NCT02240238|581496577|FG000|Phase 1|Adverse Event|0|||
161028557|NCT02240238|581496578|FG001|Phase 1|Adverse Event|0|||
161028558|NCT02240238|581496579|FG002|Phase 1|Adverse Event|0|||
161028559|NCT02240238|581496580|FG003|Phase 1|Adverse Event|0|||
161028560|NCT02240238|581496581|FG004|Phase 1|Adverse Event|0|||
161028561|NCT02240238|581496582|FG005|Phase 1|Adverse Event|0|||
161028562|NCT02240238|581496583|FG006|Phase 1|Adverse Event|3|||
161028563|NCT02240238|581496584|FG007|Phase 1|Adverse Event|1|||
161028564|NCT02240238|581496585|FG008|Phase 1|Adverse Event|0|||
161028565|NCT02240238|581496586|FG009|Phase 1|Adverse Event|0|||
161028566|NCT02240238|581496587|FG010|Phase 1|Adverse Event|0|||
161028567|NCT02240238|581496588|FG011|Phase 1|Adverse Event|0|||
161028568|NCT02240238|581496577|FG000|Phase 1|Death|0|||
161028569|NCT02240238|581496578|FG001|Phase 1|Death|0|||
161028570|NCT02240238|581496579|FG002|Phase 1|Death|0|||
161028571|NCT02240238|581496580|FG003|Phase 1|Death|0|||
161028572|NCT02240238|581496581|FG004|Phase 1|Death|0|||
161028573|NCT02240238|581496582|FG005|Phase 1|Death|1|||
161028574|NCT02240238|581496583|FG006|Phase 1|Death|0|||
161028575|NCT02240238|581496584|FG007|Phase 1|Death|0|||
161028576|NCT02240238|581496585|FG008|Phase 1|Death|0|||
161028577|NCT02240238|581496586|FG009|Phase 1|Death|0|||
161028578|NCT02240238|581496587|FG010|Phase 1|Death|0|||
161028579|NCT02240238|581496588|FG011|Phase 1|Death|0|||
161028580|NCT02240238|581496577|FG000|Phase 1|Sponsor termination|0|||
161028581|NCT02240238|581496578|FG001|Phase 1|Sponsor termination|0|||
161028582|NCT02240238|581496579|FG002|Phase 1|Sponsor termination|0|||
161028583|NCT02240238|581496580|FG003|Phase 1|Sponsor termination|0|||
161028584|NCT02240238|581496581|FG004|Phase 1|Sponsor termination|0|||
161028585|NCT02240238|581496582|FG005|Phase 1|Sponsor termination|1|||
161028586|NCT02240238|581496583|FG006|Phase 1|Sponsor termination|0|||
161028587|NCT02240238|581496584|FG007|Phase 1|Sponsor termination|0|||
161028588|NCT02240238|581496585|FG008|Phase 1|Sponsor termination|0|||
161028589|NCT02240238|581496586|FG009|Phase 1|Sponsor termination|0|||
161028590|NCT02240238|581496587|FG010|Phase 1|Sponsor termination|0|||
161028591|NCT02240238|581496588|FG011|Phase 1|Sponsor termination|0|||
161028592|NCT02240238|581496577|FG000|Phase 1|Withdrawal by Subject|0|||
161028593|NCT02240238|581496578|FG001|Phase 1|Withdrawal by Subject|0|||
161028594|NCT02240238|581496579|FG002|Phase 1|Withdrawal by Subject|0|||
161028595|NCT02240238|581496580|FG003|Phase 1|Withdrawal by Subject|0|||
161028596|NCT02240238|581496581|FG004|Phase 1|Withdrawal by Subject|0|||
161028597|NCT02240238|581496582|FG005|Phase 1|Withdrawal by Subject|2|||
161028598|NCT02240238|581496583|FG006|Phase 1|Withdrawal by Subject|0|||
161028599|NCT02240238|581496584|FG007|Phase 1|Withdrawal by Subject|0|||
161028600|NCT02240238|581496585|FG008|Phase 1|Withdrawal by Subject|0|||
161028601|NCT02240238|581496586|FG009|Phase 1|Withdrawal by Subject|0|||
161028602|NCT02240238|581496587|FG010|Phase 1|Withdrawal by Subject|0|||
161344323|NCT00127803|582646078|FG000|Overall Study|Adverse Event|2|||
161344324|NCT00127803|582646079|FG001|Overall Study|Adverse Event|0|||
161344325|NCT00127803|582646080|FG002|Overall Study|Adverse Event|0|||
161344326|NCT00127803|582646081|FG003|Overall Study|Adverse Event|0|||
161028603|NCT02240238|581496588|FG011|Phase 1|Withdrawal by Subject|0|||
161028604|NCT02240238|581496577|FG000|Phase 1|Physician Decision|0|||
161028605|NCT02240238|581496578|FG001|Phase 1|Physician Decision|0|||
161028606|NCT02240238|581496579|FG002|Phase 1|Physician Decision|0|||
161028607|NCT02240238|581496580|FG003|Phase 1|Physician Decision|0|||
161028608|NCT02240238|581496581|FG004|Phase 1|Physician Decision|0|||
161028609|NCT02240238|581496582|FG005|Phase 1|Physician Decision|2|||
161028610|NCT02240238|581496583|FG006|Phase 1|Physician Decision|0|||
161028611|NCT02240238|581496584|FG007|Phase 1|Physician Decision|0|||
161028612|NCT02240238|581496585|FG008|Phase 1|Physician Decision|0|||
161028613|NCT02240238|581496586|FG009|Phase 1|Physician Decision|0|||
161028614|NCT02240238|581496587|FG010|Phase 1|Physician Decision|0|||
161028615|NCT02240238|581496588|FG011|Phase 1|Physician Decision|0|||
161028616|NCT02240238|581496577|FG000|Phase 2|Adverse Event|0|||
161028617|NCT02240238|581496578|FG001|Phase 2|Adverse Event|0|||
161028618|NCT02240238|581496579|FG002|Phase 2|Adverse Event|0|||
161028619|NCT02240238|581496580|FG003|Phase 2|Adverse Event|0|||
161028620|NCT02240238|581496581|FG004|Phase 2|Adverse Event|0|||
161028621|NCT02240238|581496582|FG005|Phase 2|Adverse Event|0|||
161028622|NCT02240238|581496583|FG006|Phase 2|Adverse Event|0|||
161028623|NCT02240238|581496584|FG007|Phase 2|Adverse Event|0|||
161028624|NCT02240238|581496585|FG008|Phase 2|Adverse Event|0|||
161028625|NCT02240238|581496586|FG009|Phase 2|Adverse Event|7|||
161028626|NCT02240238|581496587|FG010|Phase 2|Adverse Event|14|||
161028627|NCT02240238|581496588|FG011|Phase 2|Adverse Event|2|||
161028628|NCT02240238|581496577|FG000|Phase 2|Death|0|||
161276410|NCT00673387|582391706|FG005|Overall Study|Adverse Event|2|||
161276411|NCT00673387|582391707|FG006|Overall Study|Adverse Event|5|||
161276412|NCT00673387|582391708|FG007|Overall Study|Adverse Event|5|||
161276413|NCT00673387|582391701|FG000|Overall Study|Physician Decision|0|||
161276414|NCT00673387|582391702|FG001|Overall Study|Physician Decision|0|||
161276415|NCT00673387|582391703|FG002|Overall Study|Physician Decision|0|||
161276416|NCT00673387|582391704|FG003|Overall Study|Physician Decision|0|||
161276417|NCT00673387|582391705|FG004|Overall Study|Physician Decision|0|||
161276418|NCT00673387|582391706|FG005|Overall Study|Physician Decision|5|||
161276419|NCT00673387|582391707|FG006|Overall Study|Physician Decision|1|||
161276420|NCT00673387|582391708|FG007|Overall Study|Physician Decision|1|||
161276421|NCT00673387|582391701|FG000|Overall Study|Protocol Violation|3|||
161276422|NCT00673387|582391702|FG001|Overall Study|Protocol Violation|0|||
161276423|NCT00673387|582391703|FG002|Overall Study|Protocol Violation|1|||
161276424|NCT00673387|582391704|FG003|Overall Study|Protocol Violation|2|||
161276425|NCT00673387|582391705|FG004|Overall Study|Protocol Violation|0|||
161276426|NCT00673387|582391706|FG005|Overall Study|Protocol Violation|1|||
161276427|NCT00673387|582391707|FG006|Overall Study|Protocol Violation|1|||
161276428|NCT00673387|582391708|FG007|Overall Study|Protocol Violation|3|||
161276429|NCT00673387|582391701|FG000|Overall Study|Lost to Follow-up|8|||
161276430|NCT00673387|582391702|FG001|Overall Study|Lost to Follow-up|6|||
161276431|NCT00673387|582391703|FG002|Overall Study|Lost to Follow-up|5|||
161276432|NCT00673387|582391704|FG003|Overall Study|Lost to Follow-up|6|||
161276433|NCT00673387|582391705|FG004|Overall Study|Lost to Follow-up|6|||
161276434|NCT00673387|582391706|FG005|Overall Study|Lost to Follow-up|5|||
161276435|NCT00673387|582391707|FG006|Overall Study|Lost to Follow-up|8|||
161276436|NCT00673387|582391708|FG007|Overall Study|Lost to Follow-up|5|||
161276437|NCT00960115|582391709|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
161028629|NCT02240238|581496578|FG001|Phase 2|Death|0|||
161028630|NCT02240238|581496579|FG002|Phase 2|Death|0|||
161028631|NCT02240238|581496580|FG003|Phase 2|Death|0|||
161028632|NCT02240238|581496581|FG004|Phase 2|Death|0|||
161028633|NCT02240238|581496582|FG005|Phase 2|Death|0|||
161028634|NCT02240238|581496583|FG006|Phase 2|Death|0|||
161028635|NCT02240238|581496584|FG007|Phase 2|Death|0|||
161028636|NCT02240238|581496585|FG008|Phase 2|Death|0|||
161028637|NCT02240238|581496586|FG009|Phase 2|Death|3|||
161028638|NCT02240238|581496587|FG010|Phase 2|Death|2|||
161028639|NCT02240238|581496588|FG011|Phase 2|Death|1|||
161028640|NCT02240238|581496577|FG000|Phase 2|Disease progression|0|||
161028641|NCT02240238|581496578|FG001|Phase 2|Disease progression|0|||
161028642|NCT02240238|581496579|FG002|Phase 2|Disease progression|0|||
161028643|NCT02240238|581496580|FG003|Phase 2|Disease progression|0|||
161028644|NCT02240238|581496581|FG004|Phase 2|Disease progression|0|||
161028645|NCT02240238|581496582|FG005|Phase 2|Disease progression|0|||
161028646|NCT02240238|581496583|FG006|Phase 2|Disease progression|0|||
161028647|NCT02240238|581496584|FG007|Phase 2|Disease progression|0|||
161028648|NCT02240238|581496585|FG008|Phase 2|Disease progression|0|||
161028649|NCT02240238|581496586|FG009|Phase 2|Disease progression|5|||
161028650|NCT02240238|581496587|FG010|Phase 2|Disease progression|11|||
161028651|NCT02240238|581496588|FG011|Phase 2|Disease progression|1|||
161028652|NCT02240238|581496577|FG000|Phase 2|Withdrawal by Subject|0|||
161028653|NCT02240238|581496578|FG001|Phase 2|Withdrawal by Subject|0|||
161028654|NCT02240238|581496579|FG002|Phase 2|Withdrawal by Subject|0|||
161028655|NCT02240238|581496580|FG003|Phase 2|Withdrawal by Subject|0|||
161028656|NCT02240238|581496581|FG004|Phase 2|Withdrawal by Subject|0|||
161028657|NCT02240238|581496582|FG005|Phase 2|Withdrawal by Subject|0|||
161028658|NCT02240238|581496583|FG006|Phase 2|Withdrawal by Subject|0|||
161028659|NCT02240238|581496584|FG007|Phase 2|Withdrawal by Subject|0|||
161028660|NCT02240238|581496585|FG008|Phase 2|Withdrawal by Subject|0|||
161028661|NCT02240238|581496586|FG009|Phase 2|Withdrawal by Subject|1|||
161028662|NCT02240238|581496587|FG010|Phase 2|Withdrawal by Subject|1|||
161028663|NCT02240238|581496588|FG011|Phase 2|Withdrawal by Subject|0|||
161028664|NCT02240238|581496577|FG000|Phase 2|Physician Decision|0|||
161028665|NCT02240238|581496578|FG001|Phase 2|Physician Decision|0|||
161028666|NCT02240238|581496579|FG002|Phase 2|Physician Decision|0|||
161028667|NCT02240238|581496580|FG003|Phase 2|Physician Decision|0|||
161028668|NCT02240238|581496581|FG004|Phase 2|Physician Decision|0|||
161028669|NCT02240238|581496582|FG005|Phase 2|Physician Decision|0|||
161028670|NCT02240238|581496583|FG006|Phase 2|Physician Decision|0|||
161028671|NCT02240238|581496584|FG007|Phase 2|Physician Decision|0|||
161028672|NCT02240238|581496585|FG008|Phase 2|Physician Decision|0|||
161276438|NCT00960115|582391710|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
161276439|NCT01102374|582391711|FG000|Overall Study|Death|9|||
161276440|NCT01102374|582391712|FG001|Overall Study|Death|13|||
161276441|NCT01102374|582391711|FG000|Overall Study|Lost to Follow-up|7|||
161276442|NCT01102374|582391712|FG001|Overall Study|Lost to Follow-up|6|||
161276443|NCT02952898|582391713|FG000|Overall Study|Withdrawal by Subject|10|||
161276444|NCT02952898|582391714|FG001|Overall Study|Withdrawal by Subject|8|||
161276445|NCT02952898|582391715|FG002|Overall Study|Withdrawal by Subject|8|||
161276446|NCT02952898|582391713|FG000|Overall Study|Adverse Event|8|||
161276447|NCT02952898|582391714|FG001|Overall Study|Adverse Event|8|||
161276448|NCT02952898|582391715|FG002|Overall Study|Adverse Event|3|||
161276449|NCT02952898|582391713|FG000|Overall Study|Lost to Follow-up|3|||
161276450|NCT02952898|582391714|FG001|Overall Study|Lost to Follow-up|2|||
161276451|NCT02952898|582391715|FG002|Overall Study|Lost to Follow-up|2|||
161276452|NCT02952898|582391713|FG000|Overall Study|Non-compliance with study drug|1|||
161276453|NCT02952898|582391714|FG001|Overall Study|Non-compliance with study drug|1|||
161276454|NCT02952898|582391715|FG002|Overall Study|Non-compliance with study drug|2|||
161276455|NCT00477633|582391716|FG000|Overall Study|Did not receive treatment|23|||
161276456|NCT00477633|582391716|FG000|Overall Study|Adverse Event|143|||
161276457|NCT00477633|582391716|FG000|Overall Study|Pregnancy|23|||
161276458|NCT00477633|582391716|FG000|Overall Study|Lost to Follow-up|271|||
161344327|NCT00127803|582646078|FG000|Overall Study|Withdrawal by Subject|1|||
161344328|NCT00127803|582646079|FG001|Overall Study|Withdrawal by Subject|0|||
161028673|NCT02240238|581496586|FG009|Phase 2|Physician Decision|1|||
161028674|NCT02240238|581496587|FG010|Phase 2|Physician Decision|3|||
161028675|NCT02240238|581496588|FG011|Phase 2|Physician Decision|0|||
161028676|NCT02240238|581496577|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028677|NCT02240238|581496578|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028678|NCT02240238|581496579|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028679|NCT02240238|581496580|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028680|NCT02240238|581496581|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028681|NCT02240238|581496582|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028682|NCT02240238|581496583|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028683|NCT02240238|581496584|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028684|NCT02240238|581496585|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028685|NCT02240238|581496586|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
161028686|NCT02240238|581496587|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028687|NCT02240238|581496588|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
161028688|NCT02240238|581496577|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028689|NCT02240238|581496578|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028690|NCT02240238|581496579|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028691|NCT02240238|581496580|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028692|NCT02240238|581496581|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028693|NCT02240238|581496582|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028694|NCT02240238|581496583|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028695|NCT02240238|581496584|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028696|NCT02240238|581496585|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028697|NCT02240238|581496586|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
161028698|NCT02240238|581496587|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028699|NCT02240238|581496588|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
161028700|NCT02240238|581496577|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028701|NCT02240238|581496578|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028702|NCT02240238|581496579|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028703|NCT02240238|581496580|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028704|NCT02240238|581496581|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028705|NCT02240238|581496582|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028706|NCT02240238|581496583|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028707|NCT02240238|581496584|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028708|NCT02240238|581496585|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028709|NCT02240238|581496586|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028710|NCT02240238|581496587|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
161028711|NCT02240238|581496588|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
161028712|NCT02240238|581496577|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028713|NCT02240238|581496578|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028714|NCT02240238|581496579|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028715|NCT02240238|581496580|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028716|NCT02240238|581496581|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028717|NCT02240238|581496582|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161276459|NCT00477633|582391716|FG000|Overall Study|Withdrawal by Subject|149|||
161276460|NCT00477633|582391716|FG000|Overall Study|Protocol Violation|25|||
161028718|NCT02240238|581496583|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028719|NCT02240238|581496584|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028720|NCT02240238|581496585|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028721|NCT02240238|581496586|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028722|NCT02240238|581496587|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
161028723|NCT02240238|581496588|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
161028724|NCT02240238|581496577|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028725|NCT02240238|581496578|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028726|NCT02240238|581496579|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028727|NCT02240238|581496580|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028728|NCT02240238|581496581|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028729|NCT02240238|581496582|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028730|NCT02240238|581496583|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028731|NCT02240238|581496584|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028732|NCT02240238|581496585|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028733|NCT02240238|581496586|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028734|NCT02240238|581496587|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
161028735|NCT02240238|581496588|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
161028736|NCT02240238|581496577|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028737|NCT02240238|581496578|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028738|NCT02240238|581496579|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028739|NCT02240238|581496580|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028740|NCT02240238|581496581|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028741|NCT02240238|581496582|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028742|NCT02240238|581496583|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028743|NCT02240238|581496584|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028744|NCT02240238|581496585|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028745|NCT02240238|581496586|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028746|NCT02240238|581496587|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
161028747|NCT02240238|581496588|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
161028748|NCT02240238|581496577|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028749|NCT02240238|581496578|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028750|NCT02240238|581496579|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028751|NCT02240238|581496580|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028752|NCT02240238|581496581|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028753|NCT02240238|581496582|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028754|NCT02240238|581496583|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028755|NCT02240238|581496584|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028756|NCT02240238|581496585|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028757|NCT02240238|581496586|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028758|NCT02240238|581496587|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
161028759|NCT02240238|581496588|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
161028760|NCT02240238|581496577|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028761|NCT02240238|581496578|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028762|NCT02240238|581496579|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028763|NCT02240238|581496580|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028764|NCT02240238|581496581|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028765|NCT02240238|581496582|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028766|NCT02240238|581496583|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028767|NCT02240238|581496584|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028768|NCT02240238|581496585|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028769|NCT02240238|581496586|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028770|NCT02240238|581496587|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
161028771|NCT02240238|581496588|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
161028772|NCT02724969|581496601|FG000|Overall Study|Lost to Follow-up|12|||
161028773|NCT02724969|581496602|FG001|Overall Study|Lost to Follow-up|6|||
161028774|NCT02724969|581496601|FG000|Overall Study|Withdrawal by Subject|3|||
161028775|NCT02724969|581496602|FG001|Overall Study|Withdrawal by Subject|3|||
161028776|NCT02724969|581496601|FG000|Overall Study|Infant demise|0|||
161028777|NCT02724969|581496602|FG001|Overall Study|Infant demise|2|||
161028778|NCT05147116|581496605|FG000|Overall Study|Withdrawal by Subject|0|||
161028779|NCT05147116|581496606|FG001|Overall Study|Withdrawal by Subject|1|||
161028780|NCT03625115|581496607|FG000|Overall Study|Withdrawal by Subject|4|||
161028781|NCT03625115|581496608|FG001|Overall Study|Withdrawal by Subject|7|||
161028782|NCT03625115|581496607|FG000|Overall Study|Lost to Follow-up|17|||
161028783|NCT03625115|581496608|FG001|Overall Study|Lost to Follow-up|24|||
161028784|NCT03672916|581496609|FG000|Overall Study|Death|6|||
161028785|NCT03672916|581496609|FG000|Overall Study|Lost to Follow-up|29|||
161028786|NCT03672916|581496609|FG000|Overall Study|Adverse Event|6|||
161028787|NCT03672916|581496609|FG000|Overall Study|Withdrawal by Subject|11|||
161028788|NCT04197336|581496610|FG000|Overall Study|Withdrawal by Subject|1|||
161028789|NCT05868382|581496612|FG000|Overall Study|Lost to Follow-up|5|||
161028790|NCT05868382|581496613|FG001|Overall Study|Lost to Follow-up|0|||
161028791|NCT05868382|581496614|FG002|Overall Study|Lost to Follow-up|6|||
161028792|NCT05868382|581496615|FG003|Overall Study|Lost to Follow-up|4|||
161028793|NCT05868382|581496616|FG004|Overall Study|Lost to Follow-up|2|||
161028794|NCT05868382|581496617|FG005|Overall Study|Lost to Follow-up|6|||
161028795|NCT05868382|581496612|FG000|Overall Study|Withdrawal by Subject|1|||
161028796|NCT05868382|581496613|FG001|Overall Study|Withdrawal by Subject|0|||
161028797|NCT05868382|581496614|FG002|Overall Study|Withdrawal by Subject|0|||
161028798|NCT05868382|581496615|FG003|Overall Study|Withdrawal by Subject|0|||
161028799|NCT05868382|581496616|FG004|Overall Study|Withdrawal by Subject|1|||
161028800|NCT05868382|581496617|FG005|Overall Study|Withdrawal by Subject|0|||
161028801|NCT03655028|581496620|FG000|12-weeks Follow up|Death|1|||
161028802|NCT03655028|581496621|FG001|12-weeks Follow up|Death|0|||
161028803|NCT03655028|581496620|FG000|12-weeks Follow up|Physician Decision|3|||
161028804|NCT03655028|581496621|FG001|12-weeks Follow up|Physician Decision|3|||
161028805|NCT03655028|581496620|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
161028806|NCT03655028|581496621|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
161028807|NCT03655028|581496620|FG000|12-weeks Follow up|Lost to Follow-up|4|||
161028808|NCT03655028|581496621|FG001|12-weeks Follow up|Lost to Follow-up|4|||
161028809|NCT03655028|581496620|FG000|24-weeks|Lost to Follow-up|1|||
161028810|NCT03655028|581496621|FG001|24-weeks|Lost to Follow-up|1|||
161028811|NCT03655028|581496620|FG000|24-weeks|Death|0|||
161028812|NCT03655028|581496621|FG001|24-weeks|Death|1|||
161028813|NCT03513302|581496622|FG000|First Intervention (14 Days)|Screen failure|15|||
161028814|NCT03513302|581496623|FG001|First Intervention (14 Days)|Screen failure|16|||
161028815|NCT05256654|581496624|FG000|Overall Study|Adverse Event|0|||
161028816|NCT05256654|581496625|FG001|Overall Study|Adverse Event|0|||
161028817|NCT05256654|581496626|FG002|Overall Study|Adverse Event|1|||
161028818|NCT05256654|581496627|FG003|Overall Study|Adverse Event|0|||
161028819|NCT05256654|581496624|FG000|Overall Study|Lost to Follow-up|0|||
161028820|NCT05256654|581496625|FG001|Overall Study|Lost to Follow-up|0|||
161028821|NCT05256654|581496626|FG002|Overall Study|Lost to Follow-up|0|||
161028822|NCT05256654|581496627|FG003|Overall Study|Lost to Follow-up|1|||
161028823|NCT05256654|581496624|FG000|Overall Study|Withdrawal by Subject|1|||
161028824|NCT05256654|581496625|FG001|Overall Study|Withdrawal by Subject|2|||
161028825|NCT05256654|581496626|FG002|Overall Study|Withdrawal by Subject|1|||
161028826|NCT05256654|581496627|FG003|Overall Study|Withdrawal by Subject|3|||
161028827|NCT05256654|581496624|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
161028828|NCT05256654|581496625|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
161028829|NCT05256654|581496626|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
161028830|NCT05256654|581496627|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
161028831|NCT05256654|581496624|FG000|Overall Study|Other|0|||
161028832|NCT05256654|581496625|FG001|Overall Study|Other|0|||
161028833|NCT05256654|581496626|FG002|Overall Study|Other|0|||
161028834|NCT05256654|581496627|FG003|Overall Study|Other|1|||
161028835|NCT05167864|581496636|FG000|Overall Study|Lost to Follow-up|7|||
161028836|NCT05167864|581496637|FG001|Overall Study|Lost to Follow-up|6|||
161028837|NCT05167864|581496638|FG002|Overall Study|Lost to Follow-up|7|||
161028838|NCT05167864|581496639|FG003|Overall Study|Lost to Follow-up|9|||
161028839|NCT05204654|581496640|FG000|Overall Study|Study terminated due to time restraint|2|||
161028840|NCT05204654|581496641|FG001|Overall Study|Study terminated due to time restraint|2|||
161028841|NCT01221948|581496642|FG000|Overall Study|Physician Decision|5|||
161028842|NCT01221948|581496642|FG000|Overall Study|Withdrawal by Subject|2|||
161148826|NCT04760314|581926143|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
161028843|NCT01221948|581496642|FG000|Overall Study|not disclosed|2|||
161028844|NCT01221948|581496642|FG000|Overall Study|Death|1|||
161028845|NCT01221948|581496642|FG000|Overall Study|Protocol Violation|4|||
161148827|NCT04760314|581926144|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
161148828|NCT04760314|581926145|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
161028846|NCT03756662|581496643|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
161028847|NCT04295512|581496646|FG000|Overall Study|Lack of family response to schedule assessment|0|||
161028848|NCT04295512|581496647|FG001|Overall Study|Lack of family response to schedule assessment|0|||
161028849|NCT04295512|581496648|FG002|Overall Study|Lack of family response to schedule assessment|0|||
161028850|NCT04295512|581496649|FG003|Overall Study|Lack of family response to schedule assessment|2|||
161028851|NCT04295512|581496646|FG000|Overall Study|Therapist did not refer eligible family|7|||
161276461|NCT00477633|582391716|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
161276462|NCT02968849|582391717|FG000|Overall Study|Death|8|||
161276463|NCT02968849|582391718|FG001|Overall Study|Death|10|||
161276464|NCT02968849|582391717|FG000|Overall Study|Lost to Follow-up|31|||
161276465|NCT02968849|582391718|FG001|Overall Study|Lost to Follow-up|29|||
161276466|NCT02968849|582391717|FG000|Overall Study|Withdrawal by Subject|73|||
161276467|NCT02968849|582391718|FG001|Overall Study|Withdrawal by Subject|64|||
161276468|NCT02968849|582391717|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
161276469|NCT02968849|582391718|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
161276470|NCT02968849|582391717|FG000|Overall Study|Physician Decision|6|||
161276471|NCT02968849|582391718|FG001|Overall Study|Physician Decision|9|||
161276472|NCT02968849|582391717|FG000|Overall Study|Other|16|||
161276473|NCT02968849|582391718|FG001|Overall Study|Other|10|||
161276474|NCT02203331|582391721|FG000|Overall Study|Pregnancy|1|||
161276475|NCT02203331|582391722|FG001|Overall Study|Pregnancy|0|||
161276476|NCT02203331|582391723|FG002|Overall Study|Pregnancy|0|||
161276477|NCT02203331|582391724|FG003|Overall Study|Pregnancy|0|||
161276478|NCT02203331|582391725|FG004|Overall Study|Pregnancy|2|||
161276479|NCT02203331|582391726|FG005|Overall Study|Pregnancy|0|||
161276480|NCT02203331|582391721|FG000|Overall Study|Withdrawal by Subject|1|||
161276481|NCT02203331|582391722|FG001|Overall Study|Withdrawal by Subject|0|||
161028852|NCT04295512|581496647|FG001|Overall Study|Therapist did not refer eligible family|7|||
161028853|NCT04295512|581496648|FG002|Overall Study|Therapist did not refer eligible family|0|||
161028854|NCT04295512|581496649|FG003|Overall Study|Therapist did not refer eligible family|0|||
161028855|NCT05207956|581496653|FG000|Overall Study|Lost to follow up|1|||
161028856|NCT05207956|581496654|FG001|Overall Study|Lost to follow up|2|||
161028857|NCT01009788|581496655|FG000|Overall Study|Withdrawal by Subject|1|||
161028858|NCT01009788|581496656|FG001|Overall Study|Withdrawal by Subject|0|||
161028859|NCT03626220|581496660|FG000|Overall Study|Withdrawal by Subject|2|||
161028860|NCT03626220|581496661|FG001|Overall Study|Withdrawal by Subject|0|||
161028861|NCT04625725|581496662|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
161028862|NCT04625725|581496663|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161028863|NCT04625725|581496664|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161028864|NCT04625725|581496665|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161028865|NCT04625725|581496666|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161028866|NCT04625725|581496667|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
161028867|NCT04625725|581496662|FG000|Provent Main Study|Withdrawal by Subject|242|||
161028868|NCT04625725|581496663|FG001|Provent Main Study|Withdrawal by Subject|144|||
161028869|NCT04625725|581496664|FG002|Provent Main Study|Withdrawal by Subject|0|||
161028870|NCT04625725|581496665|FG003|Provent Main Study|Withdrawal by Subject|0|||
161028871|NCT04625725|581496666|FG004|Provent Main Study|Withdrawal by Subject|0|||
161028872|NCT04625725|581496667|FG005|Provent Main Study|Withdrawal by Subject|0|||
161028873|NCT04625725|581496662|FG000|Provent Main Study|Physician Decision|5|||
161028874|NCT04625725|581496663|FG001|Provent Main Study|Physician Decision|0|||
161028875|NCT04625725|581496664|FG002|Provent Main Study|Physician Decision|0|||
161028876|NCT04625725|581496665|FG003|Provent Main Study|Physician Decision|0|||
161028877|NCT04625725|581496666|FG004|Provent Main Study|Physician Decision|0|||
161028878|NCT04625725|581496667|FG005|Provent Main Study|Physician Decision|0|||
161028879|NCT04625725|581496662|FG000|Provent Main Study|Protocol Violation|1|||
161028880|NCT04625725|581496663|FG001|Provent Main Study|Protocol Violation|0|||
161028881|NCT04625725|581496664|FG002|Provent Main Study|Protocol Violation|0|||
161028882|NCT04625725|581496665|FG003|Provent Main Study|Protocol Violation|0|||
161028883|NCT04625725|581496666|FG004|Provent Main Study|Protocol Violation|0|||
161028884|NCT04625725|581496667|FG005|Provent Main Study|Protocol Violation|0|||
161028885|NCT04625725|581496662|FG000|Provent Main Study|Lost to Follow-up|357|||
161028886|NCT04625725|581496663|FG001|Provent Main Study|Lost to Follow-up|200|||
161028887|NCT04625725|581496664|FG002|Provent Main Study|Lost to Follow-up|0|||
161028888|NCT04625725|581496665|FG003|Provent Main Study|Lost to Follow-up|0|||
161028889|NCT04625725|581496666|FG004|Provent Main Study|Lost to Follow-up|0|||
161028890|NCT04625725|581496667|FG005|Provent Main Study|Lost to Follow-up|0|||
161028891|NCT04625725|581496662|FG000|Provent Main Study|Death|22|||
161028892|NCT04625725|581496663|FG001|Provent Main Study|Death|10|||
161028893|NCT04625725|581496664|FG002|Provent Main Study|Death|0|||
161028894|NCT04625725|581496665|FG003|Provent Main Study|Death|0|||
161028895|NCT04625725|581496666|FG004|Provent Main Study|Death|0|||
161028896|NCT04625725|581496667|FG005|Provent Main Study|Death|0|||
161028897|NCT04625725|581496662|FG000|Provent Main Study|Adverse Event|2|||
161028898|NCT04625725|581496663|FG001|Provent Main Study|Adverse Event|1|||
161276482|NCT02203331|582391723|FG002|Overall Study|Withdrawal by Subject|1|||
161276483|NCT02203331|582391724|FG003|Overall Study|Withdrawal by Subject|0|||
161276484|NCT02203331|582391725|FG004|Overall Study|Withdrawal by Subject|0|||
161276485|NCT02203331|582391726|FG005|Overall Study|Withdrawal by Subject|3|||
161276486|NCT02203331|582391721|FG000|Overall Study|Adverse Event|4|||
161276487|NCT02203331|582391722|FG001|Overall Study|Adverse Event|8|||
161276488|NCT02203331|582391723|FG002|Overall Study|Adverse Event|3|||
161028899|NCT04625725|581496664|FG002|Provent Main Study|Adverse Event|0|||
161028900|NCT04625725|581496665|FG003|Provent Main Study|Adverse Event|0|||
161028901|NCT04625725|581496666|FG004|Provent Main Study|Adverse Event|0|||
160974750|NCT02440594|581297550|FG002|Overall Study|Withdrawal by Subject|59|||
160974751|NCT02440594|581297551|FG003|Overall Study|Withdrawal by Subject|38|||
160974752|NCT02440594|581297552|FG004|Overall Study|Withdrawal by Subject|2|||
161028902|NCT04625725|581496667|FG005|Provent Main Study|Adverse Event|0|||
161028903|NCT04625725|581496662|FG000|Provent Main Study|Participants dosed in sub-study|310|||
161028904|NCT04625725|581496663|FG001|Provent Main Study|Participants dosed in sub-study|193|||
161028905|NCT04625725|581496664|FG002|Provent Main Study|Participants dosed in sub-study|0|||
161028906|NCT04625725|581496665|FG003|Provent Main Study|Participants dosed in sub-study|0|||
160974753|NCT02440594|581297553|FG005|Overall Study|Withdrawal by Subject|2|||
160974754|NCT02440594|581297554|FG006|Overall Study|Withdrawal by Subject|7|||
160974755|NCT02440594|581297555|FG007|Overall Study|Withdrawal by Subject|7|||
160974756|NCT02440594|581297548|FG000|Overall Study|Administratively w/drawn|3|||
160974757|NCT02440594|581297549|FG001|Overall Study|Administratively w/drawn|2|||
160974758|NCT02440594|581297550|FG002|Overall Study|Administratively w/drawn|0|||
160974759|NCT02440594|581297551|FG003|Overall Study|Administratively w/drawn|0|||
160974760|NCT02440594|581297552|FG004|Overall Study|Administratively w/drawn|0|||
160974761|NCT02440594|581297553|FG005|Overall Study|Administratively w/drawn|0|||
160974762|NCT02440594|581297554|FG006|Overall Study|Administratively w/drawn|2|||
160974763|NCT02440594|581297555|FG007|Overall Study|Administratively w/drawn|1|||
160974764|NCT04250337|581297556|FG000|Overall Study|Adverse Event|0|||
160974765|NCT04250337|581297557|FG001|Overall Study|Adverse Event|3|||
160974766|NCT04250337|581297556|FG000|Overall Study|Lack of Efficacy|1|||
160974767|NCT04250337|581297557|FG001|Overall Study|Lack of Efficacy|3|||
160974768|NCT04250337|581297556|FG000|Overall Study|Physician Decision|1|||
160974769|NCT04250337|581297557|FG001|Overall Study|Physician Decision|0|||
160974770|NCT04250337|581297556|FG000|Overall Study|Protocol Deviation|2|||
160974771|NCT04250337|581297557|FG001|Overall Study|Protocol Deviation|2|||
160974772|NCT04250337|581297556|FG000|Overall Study|Withdrawal by Subject|4|||
160974773|NCT04250337|581297557|FG001|Overall Study|Withdrawal by Subject|3|||
160974774|NCT00152763|581297558|FG000|Overall Study|Death|4|||
160974775|NCT00152763|581297559|FG001|Overall Study|Death|1|||
160974776|NCT00152763|581297560|FG002|Overall Study|Death|2|||
160974777|NCT00152763|581297561|FG003|Overall Study|Death|1|||
160974778|NCT00152763|581297558|FG000|Overall Study|Lost to Follow-up|6|||
160974779|NCT00152763|581297559|FG001|Overall Study|Lost to Follow-up|4|||
160974780|NCT00152763|581297560|FG002|Overall Study|Lost to Follow-up|2|||
160974781|NCT00152763|581297561|FG003|Overall Study|Lost to Follow-up|13|||
160974782|NCT04668989|581297564|FG000|First Intervention|Covid-19 related self-isolation|0|||
160974783|NCT04668989|581297565|FG001|First Intervention|Covid-19 related self-isolation|1|||
160974784|NCT04668989|581297564|FG000|Second Intervention|Adverse Event|0|||
160974785|NCT04668989|581297565|FG001|Second Intervention|Adverse Event|1|||
160974786|NCT00569803|581297566|FG000|Overall Study|Lost to Follow-up|1|||
160974787|NCT00569803|581297567|FG001|Overall Study|Lost to Follow-up|0|||
160974788|NCT00569803|581297568|FG002|Overall Study|Lost to Follow-up|0|||
160974789|NCT00569803|581297569|FG003|Overall Study|Lost to Follow-up|0|||
160974790|NCT00569803|581297570|FG004|Overall Study|Lost to Follow-up|0|||
160974791|NCT00569803|581297571|FG005|Overall Study|Lost to Follow-up|0|||
160974792|NCT00569803|581297572|FG006|Overall Study|Lost to Follow-up|0|||
160974793|NCT00569803|581297573|FG007|Overall Study|Lost to Follow-up|0|||
160974794|NCT00569803|581297566|FG000|Overall Study|injection syringe leaked during dosing|0|||
160974795|NCT00569803|581297567|FG001|Overall Study|injection syringe leaked during dosing|0|||
160974796|NCT00569803|581297568|FG002|Overall Study|injection syringe leaked during dosing|0|||
160974797|NCT00569803|581297569|FG003|Overall Study|injection syringe leaked during dosing|1|||
160974798|NCT00569803|581297570|FG004|Overall Study|injection syringe leaked during dosing|0|||
160974799|NCT00569803|581297571|FG005|Overall Study|injection syringe leaked during dosing|0|||
160974800|NCT00569803|581297572|FG006|Overall Study|injection syringe leaked during dosing|0|||
160974801|NCT00569803|581297573|FG007|Overall Study|injection syringe leaked during dosing|0|||
160974802|NCT00569803|581297566|FG000|Overall Study|Withdrawal by Subject|0|||
160974803|NCT00569803|581297567|FG001|Overall Study|Withdrawal by Subject|0|||
160974804|NCT00569803|581297568|FG002|Overall Study|Withdrawal by Subject|0|||
161028907|NCT04625725|581496666|FG004|Provent Main Study|Participants dosed in sub-study|0|||
160974805|NCT00569803|581297569|FG003|Overall Study|Withdrawal by Subject|0|||
160974806|NCT00569803|581297570|FG004|Overall Study|Withdrawal by Subject|0|||
160974807|NCT00569803|581297571|FG005|Overall Study|Withdrawal by Subject|0|||
160974808|NCT00569803|581297572|FG006|Overall Study|Withdrawal by Subject|0|||
160974809|NCT00569803|581297573|FG007|Overall Study|Withdrawal by Subject|1|||
160974810|NCT01993823|581297574|FG000|Overall Study|Requested by the patient|6|||
160974811|NCT01993823|581297575|FG001|Overall Study|Requested by the patient|11|||
160974812|NCT01993823|581297574|FG000|Overall Study|Protocol Violation|0|||
160974813|NCT01993823|581297575|FG001|Overall Study|Protocol Violation|1|||
160974814|NCT01993823|581297574|FG000|Overall Study|Lost to Follow-up|1|||
160974815|NCT01993823|581297575|FG001|Overall Study|Lost to Follow-up|4|||
160974816|NCT00791921|581297582|FG000|Overall Study|Protocol planed|24|||
161276489|NCT02203331|582391724|FG003|Overall Study|Adverse Event|4|||
161276490|NCT02203331|582391725|FG004|Overall Study|Adverse Event|3|||
161276491|NCT02203331|582391726|FG005|Overall Study|Adverse Event|3|||
161276492|NCT02203331|582391721|FG000|Overall Study|Other Reasons|1|||
161276493|NCT02203331|582391722|FG001|Overall Study|Other Reasons|2|||
161276494|NCT02203331|582391723|FG002|Overall Study|Other Reasons|0|||
161276495|NCT02203331|582391724|FG003|Overall Study|Other Reasons|2|||
161276496|NCT02203331|582391725|FG004|Overall Study|Other Reasons|0|||
161276497|NCT02203331|582391726|FG005|Overall Study|Other Reasons|0|||
161276498|NCT02203331|582391721|FG000|Overall Study|Lack of Efficacy|0|||
161276499|NCT02203331|582391722|FG001|Overall Study|Lack of Efficacy|2|||
161276500|NCT02203331|582391723|FG002|Overall Study|Lack of Efficacy|1|||
161276501|NCT02203331|582391724|FG003|Overall Study|Lack of Efficacy|0|||
161276502|NCT02203331|582391725|FG004|Overall Study|Lack of Efficacy|0|||
161276503|NCT02203331|582391726|FG005|Overall Study|Lack of Efficacy|1|||
161276504|NCT02203331|582391721|FG000|Overall Study|Protocol Violation|0|||
161276505|NCT02203331|582391722|FG001|Overall Study|Protocol Violation|2|||
161276506|NCT02203331|582391723|FG002|Overall Study|Protocol Violation|0|||
161276507|NCT02203331|582391724|FG003|Overall Study|Protocol Violation|1|||
161276508|NCT02203331|582391725|FG004|Overall Study|Protocol Violation|1|||
161276509|NCT02203331|582391726|FG005|Overall Study|Protocol Violation|0|||
161276510|NCT02203331|582391721|FG000|Overall Study|Lost to Follow-up|0|||
161276511|NCT02203331|582391722|FG001|Overall Study|Lost to Follow-up|0|||
161276512|NCT02203331|582391723|FG002|Overall Study|Lost to Follow-up|0|||
161276513|NCT02203331|582391724|FG003|Overall Study|Lost to Follow-up|0|||
161276514|NCT02203331|582391725|FG004|Overall Study|Lost to Follow-up|1|||
161276515|NCT02203331|582391726|FG005|Overall Study|Lost to Follow-up|0|||
161276516|NCT02542605|582391727|FG000|Part B: Challenge Phase|Sponsor decision|1|||
161276517|NCT02542605|582391728|FG001|Part B: Challenge Phase|Sponsor decision|0|||
161276518|NCT02542605|582391729|FG002|Part B: Challenge Phase|Sponsor decision|0|||
161276519|NCT02542605|582391727|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
161276520|NCT02542605|582391728|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
161276521|NCT02542605|582391729|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
161276522|NCT00278889|582391731|FG000|Overall Study|Withdrawal by Subject|0|||
161276523|NCT00278889|582391732|FG001|Overall Study|Withdrawal by Subject|5|||
161276524|NCT00278889|582391733|FG002|Overall Study|Withdrawal by Subject|3|||
161276525|NCT00278889|582391731|FG000|Overall Study|Lost to Follow-up|1|||
161276526|NCT00278889|582391732|FG001|Overall Study|Lost to Follow-up|1|||
161276527|NCT00278889|582391733|FG002|Overall Study|Lost to Follow-up|0|||
161276528|NCT00278889|582391731|FG000|Overall Study|Death|24|||
161276529|NCT00278889|582391732|FG001|Overall Study|Death|21|||
160974817|NCT00791921|581297583|FG001|Overall Study|Protocol planed|88|||
160974818|NCT00791921|581297582|FG000|Overall Study|Withdrawal by Subject|1|||
160974819|NCT00791921|581297583|FG001|Overall Study|Withdrawal by Subject|2|||
160974820|NCT00791921|581297582|FG000|Overall Study|Adverse Event|8|||
160974821|NCT00791921|581297583|FG001|Overall Study|Adverse Event|2|||
160974822|NCT00791921|581297582|FG000|Overall Study|Lack of Efficacy|0|||
160974823|NCT00791921|581297583|FG001|Overall Study|Lack of Efficacy|2|||
160974824|NCT00791921|581297582|FG000|Overall Study|Lack of study drug administration|1|||
160974825|NCT00791921|581297583|FG001|Overall Study|Lack of study drug administration|1|||
160974826|NCT00791921|581297582|FG000|Overall Study|Reason other than those above|0|||
160974827|NCT00791921|581297583|FG001|Overall Study|Reason other than those above|1|||
160974828|NCT01592695|581297587|FG000|Overall Study|Lost to Follow-up|8|||
160974829|NCT01592695|581297588|FG001|Overall Study|Lost to Follow-up|4|||
160974830|NCT00474175|581297589|FG000|Overall Study|Lack of Efficacy|0|||
160974831|NCT00474175|581297590|FG001|Overall Study|Lack of Efficacy|0|||
160974832|NCT00474175|581297591|FG002|Overall Study|Lack of Efficacy|1|||
160974833|NCT00474175|581297589|FG000|Overall Study|Withdrawal by Subject|0|||
160974834|NCT00474175|581297590|FG001|Overall Study|Withdrawal by Subject|1|||
160974835|NCT00474175|581297591|FG002|Overall Study|Withdrawal by Subject|1|||
160974836|NCT00474175|581297589|FG000|Overall Study|Ineligible|1|||
160974837|NCT00474175|581297590|FG001|Overall Study|Ineligible|3|||
160974838|NCT00474175|581297591|FG002|Overall Study|Ineligible|1|||
160974839|NCT00474175|581297589|FG000|Overall Study|Protocol Violation|0|||
160974840|NCT00474175|581297590|FG001|Overall Study|Protocol Violation|2|||
160974841|NCT00474175|581297591|FG002|Overall Study|Protocol Violation|1|||
160974842|NCT00474175|581297589|FG000|Overall Study|Administrative|0|||
160974843|NCT00474175|581297590|FG001|Overall Study|Administrative|1|||
161276530|NCT00278889|582391733|FG002|Overall Study|Death|17|||
161276531|NCT00704730|582391734|FG000|Overall Study|Adverse Event|35|||
161276532|NCT00704730|582391735|FG001|Overall Study|Adverse Event|9|||
161276533|NCT00704730|582391734|FG000|Overall Study|Death|11|||
161276534|NCT00704730|582391735|FG001|Overall Study|Death|5|||
161276535|NCT00704730|582391734|FG000|Overall Study|Physician Decision|2|||
161276536|NCT00704730|582391735|FG001|Overall Study|Physician Decision|0|||
161276537|NCT00704730|582391734|FG000|Overall Study|Did not receive drug|5|||
161276538|NCT00704730|582391735|FG001|Overall Study|Did not receive drug|2|||
161276539|NCT00704730|582391734|FG000|Overall Study|Disease progression per PI|58|||
161276540|NCT00704730|582391735|FG001|Overall Study|Disease progression per PI|67|||
161276541|NCT00704730|582391734|FG000|Overall Study|data unavailable|1|||
161344329|NCT00127803|582646080|FG002|Overall Study|Withdrawal by Subject|0|||
161344330|NCT00127803|582646081|FG003|Overall Study|Withdrawal by Subject|0|||
161344331|NCT00127803|582646078|FG000|Overall Study|Lost to Follow-up|0|||
160974844|NCT00474175|581297591|FG002|Overall Study|Administrative|0|||
160974845|NCT01619787|581297592|FG000|Overall Study|Lost to Follow-up|5|||
160974846|NCT03029780|581297596|FG000|Overall Study|Disease Progression|20|||
160974847|NCT03029780|581297597|FG001|Overall Study|Disease Progression|22|||
160974848|NCT03029780|581297596|FG000|Overall Study|Study Drug Toxicity|15|||
160974849|NCT03029780|581297597|FG001|Overall Study|Study Drug Toxicity|11|||
160974850|NCT03029780|581297596|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
160974851|NCT03029780|581297597|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
160974852|NCT03029780|581297596|FG000|Overall Study|Participant request to discontinue study treatment|4|||
160974853|NCT03029780|581297597|FG001|Overall Study|Participant request to discontinue study treatment|1|||
160974854|NCT03029780|581297596|FG000|Overall Study|Maximum clinical benefit|1|||
160974855|NCT03029780|581297597|FG001|Overall Study|Maximum clinical benefit|0|||
160974856|NCT03029780|581297596|FG000|Overall Study|Participant no longer meets study criteria|0|||
160974857|NCT03029780|581297597|FG001|Overall Study|Participant no longer meets study criteria|1|||
160974858|NCT03029780|581297596|FG000|Overall Study|Other reasons|6|||
160974859|NCT03029780|581297597|FG001|Overall Study|Other reasons|6|||
160974860|NCT03029780|581297596|FG000|Overall Study|Not reported|1|||
160974861|NCT03029780|581297597|FG001|Overall Study|Not reported|1|||
160974862|NCT03029780|581297596|FG000|Overall Study|Death|2|||
160974863|NCT03029780|581297597|FG001|Overall Study|Death|6|||
160974864|NCT00178256|581297598|FG000|Overall Study|Adverse Event|2|||
160974865|NCT00178256|581297599|FG001|Overall Study|Adverse Event|0|||
160974866|NCT00178256|581297600|FG002|Overall Study|Adverse Event|0|||
160974867|NCT00178256|581297601|FG003|Overall Study|Adverse Event|0|||
160974868|NCT00178256|581297598|FG000|Overall Study|Death|0|||
160974869|NCT00178256|581297599|FG001|Overall Study|Death|1|||
160974870|NCT00178256|581297600|FG002|Overall Study|Death|0|||
160974871|NCT00178256|581297601|FG003|Overall Study|Death|1|||
160974872|NCT00178256|581297598|FG000|Overall Study|Cancer progression|2|||
160974873|NCT00178256|581297599|FG001|Overall Study|Cancer progression|0|||
160974874|NCT00178256|581297600|FG002|Overall Study|Cancer progression|0|||
160974875|NCT00178256|581297601|FG003|Overall Study|Cancer progression|1|||
160974876|NCT01763788|581297602|FG000|Overall Study|Lost to Follow-up|0|||
160974877|NCT01763788|581297603|FG001|Overall Study|Lost to Follow-up|0|||
160974878|NCT01763788|581297604|FG002|Overall Study|Lost to Follow-up|1|||
160974879|NCT01763788|581297605|FG003|Overall Study|Lost to Follow-up|0|||
160974880|NCT03303469|581297606|FG000|Overall Study|Lost to Follow-up|2|||
160974881|NCT03560258|581297607|FG000|Overall Study|Lost to Follow-up|3|||
160974882|NCT03560258|581297608|FG001|Overall Study|Lost to Follow-up|0|||
160974883|NCT03560258|581297609|FG002|Overall Study|Lost to Follow-up|0|||
160974884|NCT03560258|581297607|FG000|Overall Study|Protocol Violation|0|||
160974885|NCT03560258|581297608|FG001|Overall Study|Protocol Violation|1|||
160974886|NCT03560258|581297609|FG002|Overall Study|Protocol Violation|0|||
160974887|NCT03560258|581297607|FG000|Overall Study|Withdrawal by Subject|0|||
160974888|NCT03560258|581297608|FG001|Overall Study|Withdrawal by Subject|0|||
160974889|NCT03560258|581297609|FG002|Overall Study|Withdrawal by Subject|1|||
160974890|NCT01460160|581297610|FG000|Treatment Phase|Lack of Efficacy|3|||
160974891|NCT01460160|581297610|FG000|Treatment Phase|Study Drug Toxicity|2|||
160974892|NCT01460160|581297610|FG000|Treatment Phase|Adverse Event|8|||
160974893|NCT01460160|581297610|FG000|Treatment Phase|Withdrawal by Subject|4|||
160974894|NCT01460160|581297610|FG000|Treatment Phase|Death|2|||
160974895|NCT01460160|581297610|FG000|Treatment Phase|Other reasons|9|||
160974896|NCT01460160|581297610|FG000|Follow-up Phase|Withdrawal by Subject|4|||
160974897|NCT01460160|581297610|FG000|Follow-up Phase|Death|14|||
160974898|NCT01460160|581297610|FG000|Follow-up Phase|Lost to Follow-up|7|||
160974899|NCT01460160|581297610|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
160974900|NCT01460160|581297610|FG000|Follow-up Phase|Other and not reported reasons|5|||
160974901|NCT04488003|581297613|FG000|Assessed for Eligibility|Screen Failure|24|||
160974902|NCT04488003|581297614|FG001|Assessed for Eligibility|Screen Failure|0|||
160974903|NCT04488003|581297615|FG002|Assessed for Eligibility|Screen Failure|0|||
160974904|NCT04488003|581297613|FG000|Assessed for Eligibility|Adverse Event|1|||
160974905|NCT04488003|581297614|FG001|Assessed for Eligibility|Adverse Event|0|||
160974906|NCT04488003|581297615|FG002|Assessed for Eligibility|Adverse Event|0|||
160974907|NCT04488003|581297613|FG000|Assessed for Eligibility|Death|1|||
160974908|NCT04488003|581297614|FG001|Assessed for Eligibility|Death|0|||
160974909|NCT04488003|581297615|FG002|Assessed for Eligibility|Death|0|||
160974910|NCT04488003|581297613|FG000|Assessed for Eligibility|Physician Decision|1|||
160974911|NCT04488003|581297614|FG001|Assessed for Eligibility|Physician Decision|0|||
160974912|NCT04488003|581297615|FG002|Assessed for Eligibility|Physician Decision|0|||
160974913|NCT04488003|581297613|FG000|Allocated to Treatment|Progressive Disease|51|||
160974914|NCT04488003|581297614|FG001|Allocated to Treatment|Progressive Disease|0|||
160974915|NCT04488003|581297615|FG002|Allocated to Treatment|Progressive Disease|0|||
160974916|NCT04488003|581297613|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
160974917|NCT04488003|581297614|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
160974918|NCT04488003|581297615|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
160974919|NCT04488003|581297613|FG000|Allocated to Treatment|Adverse Event|6|||
160974920|NCT04488003|581297614|FG001|Allocated to Treatment|Adverse Event|0|||
161276542|NCT00704730|582391735|FG001|Overall Study|data unavailable|0|||
160974921|NCT04488003|581297615|FG002|Allocated to Treatment|Adverse Event|0|||
161276543|NCT00704730|582391734|FG000|Overall Study|Withdrawal by Subject|9|||
161276544|NCT00704730|582391735|FG001|Overall Study|Withdrawal by Subject|13|||
161276545|NCT05833139|582393278|FG000|Study Period 2|Adverse Event|1|||
161276546|NCT03996447|582393279|FG000|First MRI Examination|Adverse Event|2|||
161276547|NCT03996447|582393280|FG001|First MRI Examination|Adverse Event|0|||
161276548|NCT03996447|582393279|FG000|First MRI Examination|Withdrawal by Subject|1|||
161276549|NCT03996447|582393280|FG001|First MRI Examination|Withdrawal by Subject|2|||
161276550|NCT03996447|582393279|FG000|First MRI Examination|Protocol Violation|0|||
161276551|NCT03996447|582393280|FG001|First MRI Examination|Protocol Violation|1|||
161276552|NCT03996447|582393279|FG000|Washout|Adverse Event|2|||
161276553|NCT03996447|582393280|FG001|Washout|Adverse Event|0|||
161276554|NCT03996447|582393279|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
161276555|NCT03996447|582393280|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
161276556|NCT03996447|582393279|FG000|Washout|Withdrawal by Subject|0|||
161276557|NCT03996447|582393280|FG001|Washout|Withdrawal by Subject|1|||
161276558|NCT03996447|582393279|FG000|Washout|Other reason|1|||
161276559|NCT03996447|582393280|FG001|Washout|Other reason|1|||
161276560|NCT00369486|582393282|FG000|4-Week Visit|Missed visit|2|||
161276561|NCT00369486|582393283|FG001|4-Week Visit|Missed visit|2|||
161276562|NCT00369486|582393284|FG002|4-Week Visit|Missed visit|0|||
161276563|NCT00369486|582393285|FG003|4-Week Visit|Missed visit|2|||
161276564|NCT00369486|582393286|FG004|4-Week Visit|Missed visit|1|||
161276565|NCT00369486|582393282|FG000|4-Week Visit|Dropped|0|||
161276566|NCT00369486|582393283|FG001|4-Week Visit|Dropped|0|||
161276567|NCT00369486|582393284|FG002|4-Week Visit|Dropped|1|||
161276568|NCT00369486|582393285|FG003|4-Week Visit|Dropped|0|||
161276569|NCT00369486|582393286|FG004|4-Week Visit|Dropped|0|||
161276570|NCT00369486|582393282|FG000|8-Week Visit|Missed visit|0|||
161276571|NCT00369486|582393283|FG001|8-Week Visit|Missed visit|1|||
161276572|NCT00369486|582393284|FG002|8-Week Visit|Missed visit|0|||
161276573|NCT00369486|582393285|FG003|8-Week Visit|Missed visit|0|||
161276574|NCT00369486|582393286|FG004|8-Week Visit|Missed visit|1|||
161276575|NCT00369486|582393282|FG000|8-Week Visit|Dropped|0|||
161276576|NCT00369486|582393283|FG001|8-Week Visit|Dropped|0|||
161276577|NCT00369486|582393284|FG002|8-Week Visit|Dropped|0|||
161276578|NCT00369486|582393285|FG003|8-Week Visit|Dropped|1|||
161276579|NCT00369486|582393286|FG004|8-Week Visit|Dropped|0|||
161276580|NCT00369486|582393282|FG000|17-Week Visit|Missed visit|0|||
161276581|NCT00369486|582393283|FG001|17-Week Visit|Missed visit|0|||
161276582|NCT00369486|582393284|FG002|17-Week Visit|Missed visit|1|||
161276583|NCT00369486|582393285|FG003|17-Week Visit|Missed visit|1|||
161276584|NCT00369486|582393286|FG004|17-Week Visit|Missed visit|1|||
161276585|NCT00369486|582393282|FG000|34-Week Visit|Dropped|0|||
161276586|NCT00369486|582393283|FG001|34-Week Visit|Dropped|1|||
161276587|NCT00369486|582393284|FG002|34-Week Visit|Dropped|1|||
161276588|NCT00369486|582393285|FG003|34-Week Visit|Dropped|3|||
161276589|NCT00369486|582393286|FG004|34-Week Visit|Dropped|3|||
161276590|NCT01810302|582393293|FG000|Overall Study|Death|1|||
161276591|NCT01810302|582393294|FG001|Overall Study|Death|0|||
161276592|NCT01810302|582393293|FG000|Overall Study|Physician Decision|0|||
161276593|NCT01810302|582393294|FG001|Overall Study|Physician Decision|1|||
161276594|NCT01371747|582393295|FG000|Overall Study|Adverse Event|4|||
161276595|NCT01371747|582393296|FG001|Overall Study|Adverse Event|2|||
161276596|NCT01371747|582393297|FG002|Overall Study|Adverse Event|7|||
161276597|NCT01371747|582393298|FG003|Overall Study|Adverse Event|2|||
161276598|NCT01371747|582393299|FG004|Overall Study|Adverse Event|2|||
161276599|NCT01371747|582393300|FG005|Overall Study|Adverse Event|2|||
161276600|NCT01371747|582393295|FG000|Overall Study|Death|1|||
161276601|NCT01371747|582393296|FG001|Overall Study|Death|0|||
161276602|NCT01371747|582393297|FG002|Overall Study|Death|4|||
161276603|NCT01371747|582393298|FG003|Overall Study|Death|1|||
161276604|NCT01371747|582393299|FG004|Overall Study|Death|2|||
161276605|NCT01371747|582393300|FG005|Overall Study|Death|0|||
161276606|NCT01371747|582393295|FG000|Overall Study|Abnormal Renal Function|0|||
161276607|NCT01371747|582393296|FG001|Overall Study|Abnormal Renal Function|2|||
161276608|NCT01371747|582393297|FG002|Overall Study|Abnormal Renal Function|0|||
161276609|NCT01371747|582393298|FG003|Overall Study|Abnormal Renal Function|1|||
161276610|NCT01371747|582393299|FG004|Overall Study|Abnormal Renal Function|0|||
161276611|NCT01371747|582393300|FG005|Overall Study|Abnormal Renal Function|1|||
161276612|NCT01371747|582393295|FG000|Overall Study|High Serum Potassium Results|1|||
161276613|NCT01371747|582393296|FG001|Overall Study|High Serum Potassium Results|1|||
160974922|NCT04488003|581297613|FG000|Allocated to Treatment|Other|5|||
160974923|NCT04488003|581297614|FG001|Allocated to Treatment|Other|0|||
160974924|NCT04488003|581297615|FG002|Allocated to Treatment|Other|0|||
160974925|NCT04488003|581297613|FG000|Allocated to Treatment|Physician Decision|4|||
160974926|NCT04488003|581297614|FG001|Allocated to Treatment|Physician Decision|0|||
160974927|NCT04488003|581297615|FG002|Allocated to Treatment|Physician Decision|0|||
160974928|NCT04488003|581297613|FG000|Allocated to Treatment|Death|4|||
160974929|NCT04488003|581297614|FG001|Allocated to Treatment|Death|0|||
160974930|NCT04488003|581297615|FG002|Allocated to Treatment|Death|0|||
160974931|NCT01737996|581297619|FG000|Overall Study|Adverse Event|0|||
160974932|NCT01737996|581297620|FG001|Overall Study|Adverse Event|1|||
160974933|NCT01737996|581297621|FG002|Overall Study|Adverse Event|1|||
160974934|NCT01737996|581297619|FG000|Overall Study|Withdrawal by Subject|0|||
160974935|NCT01737996|581297620|FG001|Overall Study|Withdrawal by Subject|0|||
160974936|NCT01737996|581297621|FG002|Overall Study|Withdrawal by Subject|1|||
160974937|NCT01003184|581297624|FG000|Overall Study|Adverse Event|12|||
160974938|NCT01003184|581297625|FG001|Overall Study|Adverse Event|5|||
160974939|NCT01003184|581297624|FG000|Overall Study|Lost to Follow-up|1|||
160974940|NCT01003184|581297625|FG001|Overall Study|Lost to Follow-up|0|||
160974941|NCT01003184|581297624|FG000|Overall Study|Loss of glucose control|1|||
160974942|NCT01003184|581297625|FG001|Overall Study|Loss of glucose control|1|||
160974943|NCT01003184|581297624|FG000|Overall Study|Protocol Violation|3|||
160974944|NCT01003184|581297625|FG001|Overall Study|Protocol Violation|0|||
160974945|NCT01003184|581297624|FG000|Overall Study|Withdrawal by Subject|1|||
160974946|NCT01003184|581297625|FG001|Overall Study|Withdrawal by Subject|6|||
160974947|NCT01003184|581297624|FG000|Overall Study|Physician Decision|1|||
160974948|NCT01003184|581297625|FG001|Overall Study|Physician Decision|0|||
160974949|NCT00557622|581297626|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
160974950|NCT00557622|581297627|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
160974951|NCT00557622|581297626|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
160974952|NCT00557622|581297627|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
160974953|NCT00557622|581297626|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
160974954|NCT00557622|581297627|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
160974955|NCT01468922|581297628|FG000|Overall Study|Screening failure|0|||
160974956|NCT01468922|581297629|FG001|Overall Study|Screening failure|0|||
160974957|NCT01468922|581297630|FG002|Overall Study|Screening failure|0|||
160974958|NCT01468922|581297631|FG003|Overall Study|Screening failure|0|||
160974959|NCT01468922|581297632|FG004|Overall Study|Screening failure|0|||
160974960|NCT01468922|581297633|FG005|Overall Study|Screening failure|0|||
160974961|NCT01468922|581297634|FG006|Overall Study|Screening failure|0|||
160974962|NCT01468922|581297635|FG007|Overall Study|Screening failure|0|||
160974963|NCT01468922|581297636|FG008|Overall Study|Screening failure|1|||
160974964|NCT01468922|581297628|FG000|Overall Study|Per patient choice|1|||
160974965|NCT01468922|581297629|FG001|Overall Study|Per patient choice|0|||
160974966|NCT01468922|581297630|FG002|Overall Study|Per patient choice|0|||
160974967|NCT01468922|581297631|FG003|Overall Study|Per patient choice|0|||
160974968|NCT01468922|581297632|FG004|Overall Study|Per patient choice|0|||
160974969|NCT01468922|581297633|FG005|Overall Study|Per patient choice|0|||
160974970|NCT01468922|581297634|FG006|Overall Study|Per patient choice|0|||
160974971|NCT01468922|581297635|FG007|Overall Study|Per patient choice|0|||
160974972|NCT01468922|581297636|FG008|Overall Study|Per patient choice|0|||
160974973|NCT01468922|581297628|FG000|Overall Study|Switched to alternative treatment|1|||
160974974|NCT01468922|581297629|FG001|Overall Study|Switched to alternative treatment|0|||
160974975|NCT01468922|581297630|FG002|Overall Study|Switched to alternative treatment|0|||
160974976|NCT01468922|581297631|FG003|Overall Study|Switched to alternative treatment|0|||
160974977|NCT01468922|581297632|FG004|Overall Study|Switched to alternative treatment|1|||
160974978|NCT01468922|581297633|FG005|Overall Study|Switched to alternative treatment|0|||
160974979|NCT01468922|581297634|FG006|Overall Study|Switched to alternative treatment|0|||
160974980|NCT01468922|581297635|FG007|Overall Study|Switched to alternative treatment|0|||
160974981|NCT01468922|581297636|FG008|Overall Study|Switched to alternative treatment|0|||
160974982|NCT01468922|581297628|FG000|Overall Study|Enrolled on new protocol|0|||
160974983|NCT01468922|581297629|FG001|Overall Study|Enrolled on new protocol|0|||
160974984|NCT01468922|581297630|FG002|Overall Study|Enrolled on new protocol|0|||
160974985|NCT01468922|581297631|FG003|Overall Study|Enrolled on new protocol|0|||
161276614|NCT01371747|582393297|FG002|Overall Study|High Serum Potassium Results|1|||
160974986|NCT01468922|581297632|FG004|Overall Study|Enrolled on new protocol|1|||
160974987|NCT01468922|581297633|FG005|Overall Study|Enrolled on new protocol|0|||
160974988|NCT01468922|581297634|FG006|Overall Study|Enrolled on new protocol|0|||
160974989|NCT01468922|581297635|FG007|Overall Study|Enrolled on new protocol|0|||
160974990|NCT01468922|581297636|FG008|Overall Study|Enrolled on new protocol|0|||
160974991|NCT01468922|581297628|FG000|Overall Study|Adverse Event|0|||
160974992|NCT01468922|581297629|FG001|Overall Study|Adverse Event|0|||
160974993|NCT01468922|581297630|FG002|Overall Study|Adverse Event|0|||
160974994|NCT01468922|581297631|FG003|Overall Study|Adverse Event|0|||
160974995|NCT01468922|581297632|FG004|Overall Study|Adverse Event|0|||
160974996|NCT01468922|581297633|FG005|Overall Study|Adverse Event|0|||
160974997|NCT01468922|581297634|FG006|Overall Study|Adverse Event|0|||
160974998|NCT01468922|581297635|FG007|Overall Study|Adverse Event|1|||
160974999|NCT01468922|581297636|FG008|Overall Study|Adverse Event|0|||
160975000|NCT01468922|581297628|FG000|Overall Study|Infection of blood|0|||
160975001|NCT01468922|581297629|FG001|Overall Study|Infection of blood|0|||
160975002|NCT01468922|581297630|FG002|Overall Study|Infection of blood|0|||
160975003|NCT01468922|581297631|FG003|Overall Study|Infection of blood|0|||
160975004|NCT01468922|581297632|FG004|Overall Study|Infection of blood|0|||
160975005|NCT01468922|581297633|FG005|Overall Study|Infection of blood|0|||
160975006|NCT01468922|581297634|FG006|Overall Study|Infection of blood|0|||
160975007|NCT01468922|581297635|FG007|Overall Study|Infection of blood|1|||
160975008|NCT01468922|581297636|FG008|Overall Study|Infection of blood|0|||
160975009|NCT01468922|581297628|FG000|Overall Study|Patient choice - surgery|0|||
160975010|NCT01468922|581297629|FG001|Overall Study|Patient choice - surgery|0|||
160975011|NCT01468922|581297630|FG002|Overall Study|Patient choice - surgery|0|||
160975012|NCT01468922|581297631|FG003|Overall Study|Patient choice - surgery|0|||
160975013|NCT01468922|581297632|FG004|Overall Study|Patient choice - surgery|0|||
160975014|NCT01468922|581297633|FG005|Overall Study|Patient choice - surgery|0|||
160975015|NCT01468922|581297634|FG006|Overall Study|Patient choice - surgery|0|||
160975016|NCT01468922|581297635|FG007|Overall Study|Patient choice - surgery|1|||
160975017|NCT01468922|581297636|FG008|Overall Study|Patient choice - surgery|0|||
160975018|NCT01468922|581297628|FG000|Overall Study|Refused further treatment|0|||
160975019|NCT01468922|581297629|FG001|Overall Study|Refused further treatment|0|||
160975020|NCT01468922|581297630|FG002|Overall Study|Refused further treatment|0|||
160975021|NCT01468922|581297631|FG003|Overall Study|Refused further treatment|0|||
160975022|NCT01468922|581297632|FG004|Overall Study|Refused further treatment|0|||
161028908|NCT04625725|581496667|FG005|Provent Main Study|Participants dosed in sub-study|0|||
161028909|NCT04625725|581496662|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
161028910|NCT04625725|581496663|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
161028911|NCT04625725|581496664|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161028912|NCT04625725|581496665|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161028913|NCT04625725|581496666|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161028914|NCT04625725|581496667|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
161028915|NCT04625725|581496662|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
161028916|NCT04625725|581496663|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
161028917|NCT04625725|581496664|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161028918|NCT04625725|581496665|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161028919|NCT04625725|581496666|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161028920|NCT04625725|581496667|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
161028921|NCT04625725|581496662|FG000|Provent Main Study|INCARCERATION|3|||
161028922|NCT04625725|581496663|FG001|Provent Main Study|INCARCERATION|0|||
161028923|NCT04625725|581496664|FG002|Provent Main Study|INCARCERATION|0|||
161028924|NCT04625725|581496665|FG003|Provent Main Study|INCARCERATION|0|||
161028925|NCT04625725|581496666|FG004|Provent Main Study|INCARCERATION|0|||
161028926|NCT04625725|581496667|FG005|Provent Main Study|INCARCERATION|0|||
161028927|NCT04625725|581496662|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
161028928|NCT04625725|581496663|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
161028929|NCT04625725|581496664|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161028930|NCT04625725|581496665|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161028931|NCT04625725|581496666|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161028932|NCT04625725|581496667|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
161028933|NCT04625725|581496662|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
161028934|NCT04625725|581496663|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
161028935|NCT04625725|581496664|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161028936|NCT04625725|581496665|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161028937|NCT04625725|581496666|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161028938|NCT04625725|581496667|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
161028939|NCT04625725|581496662|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
161028940|NCT04625725|581496663|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
161028941|NCT04625725|581496664|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161028942|NCT04625725|581496665|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161028943|NCT04625725|581496666|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
160975023|NCT01468922|581297633|FG005|Overall Study|Refused further treatment|0|||
160975024|NCT01468922|581297634|FG006|Overall Study|Refused further treatment|0|||
160975025|NCT01468922|581297635|FG007|Overall Study|Refused further treatment|1|||
160975026|NCT01468922|581297636|FG008|Overall Study|Refused further treatment|0|||
160975027|NCT01923389|581297637|FG000|Overall Study|Protocol Violation|1|||
160975028|NCT01923389|581297638|FG001|Overall Study|Protocol Violation|0|||
160975029|NCT03237013|581297641|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
161028944|NCT04625725|581496667|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
161028945|NCT04625725|581496662|FG000|Provent Main Study|MISSING REASON|0|||
161028946|NCT04625725|581496663|FG001|Provent Main Study|MISSING REASON|1|||
161028947|NCT04625725|581496664|FG002|Provent Main Study|MISSING REASON|0|||
161028948|NCT04625725|581496665|FG003|Provent Main Study|MISSING REASON|0|||
161028949|NCT04625725|581496666|FG004|Provent Main Study|MISSING REASON|0|||
161028950|NCT04625725|581496667|FG005|Provent Main Study|MISSING REASON|0|||
161028951|NCT04625725|581496662|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161028952|NCT04625725|581496663|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161028953|NCT04625725|581496664|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161028954|NCT04625725|581496665|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
161028955|NCT04625725|581496666|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161028956|NCT04625725|581496667|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
161028957|NCT04625725|581496662|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161028958|NCT04625725|581496663|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161028959|NCT04625725|581496664|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
161028960|NCT04625725|581496665|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161028961|NCT04625725|581496666|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161028962|NCT04625725|581496667|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
161028963|NCT04625725|581496662|FG000|Provent Sub Study|Lost to Follow-up|0|||
161028964|NCT04625725|581496663|FG001|Provent Sub Study|Lost to Follow-up|0|||
161028965|NCT04625725|581496664|FG002|Provent Sub Study|Lost to Follow-up|20|||
161028966|NCT04625725|581496665|FG003|Provent Sub Study|Lost to Follow-up|10|||
161028967|NCT04625725|581496666|FG004|Provent Sub Study|Lost to Follow-up|6|||
161028968|NCT04625725|581496667|FG005|Provent Sub Study|Lost to Follow-up|4|||
161028969|NCT04625725|581496662|FG000|Provent Sub Study|Death|0|||
161028970|NCT04625725|581496663|FG001|Provent Sub Study|Death|0|||
161028971|NCT04625725|581496664|FG002|Provent Sub Study|Death|8|||
161028972|NCT04625725|581496665|FG003|Provent Sub Study|Death|5|||
161028973|NCT04625725|581496666|FG004|Provent Sub Study|Death|0|||
161028974|NCT04625725|581496667|FG005|Provent Sub Study|Death|1|||
161028975|NCT04625725|581496662|FG000|Provent Sub Study|Adverse Event|0|||
161028976|NCT04625725|581496663|FG001|Provent Sub Study|Adverse Event|0|||
161028977|NCT04625725|581496664|FG002|Provent Sub Study|Adverse Event|0|||
161028978|NCT04625725|581496665|FG003|Provent Sub Study|Adverse Event|0|||
161028979|NCT04625725|581496666|FG004|Provent Sub Study|Adverse Event|0|||
161028980|NCT04625725|581496667|FG005|Provent Sub Study|Adverse Event|1|||
161028981|NCT04625725|581496662|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161028982|NCT04625725|581496663|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161028983|NCT04625725|581496664|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161028984|NCT04625725|581496665|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161028985|NCT04625725|581496666|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
161148829|NCT04760314|581926146|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
161344332|NCT00127803|582646079|FG001|Overall Study|Lost to Follow-up|0|||
160975030|NCT03237013|581297642|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
160975031|NCT03237013|581297643|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
160975032|NCT00007475|581297644|FG000|Overall Study|Withdrawal by Subject|1|||
160975033|NCT00007475|581297645|FG001|Overall Study|Withdrawal by Subject|0|||
160975034|NCT00007475|581297646|FG002|Overall Study|Withdrawal by Subject|0|||
160975035|NCT00007475|581297647|FG003|Overall Study|Withdrawal by Subject|0|||
160975036|NCT00007475|581297644|FG000|Overall Study|Adverse Event|3|||
160975037|NCT00007475|581297645|FG001|Overall Study|Adverse Event|0|||
160975038|NCT00007475|581297646|FG002|Overall Study|Adverse Event|0|||
160975039|NCT00007475|581297647|FG003|Overall Study|Adverse Event|0|||
160975040|NCT01719224|581297648|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
160975041|NCT01719224|581297649|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
160975042|NCT00258440|581297650|FG000|Overall Study|Withdrawal by Subject|0|||
160975043|NCT00258440|581297651|FG001|Overall Study|Withdrawal by Subject|0|||
160975044|NCT00258440|581297652|FG002|Overall Study|Withdrawal by Subject|1|||
160975045|NCT00737061|581297653|FG000|Waiting Period|Lost to Follow-up|6|||
160975046|NCT00737061|581297653|FG000|Waiting Period|Withdrawal by Subject|1|||
160975047|NCT00737061|581297653|FG000|Waiting Period|Bilateral placement failure|34|||
160975048|NCT00737061|581297653|FG000|Waiting Period|Deemed patent following HSG|26|||
160975049|NCT00737061|581297653|FG000|Waiting Period|Alternative contraception failure|3|||
160975050|NCT00737061|581297653|FG000|Waiting Period|Elected surgical tubal ligation|5|||
160975051|NCT00737061|581297653|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
160975052|NCT00737061|581297653|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
160975053|NCT00737061|581297653|FG000|1 Year Wearing Period|Discontinued reilance|3|||
160975054|NCT00737061|581297653|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
160975055|NCT03000673|581297654|FG000|Overall Study|Withdrawal by Subject|1|||
160975056|NCT03000673|581297655|FG001|Overall Study|Withdrawal by Subject|0|||
160975057|NCT03000673|581297656|FG002|Overall Study|Withdrawal by Subject|0|||
160975058|NCT03000673|581297657|FG003|Overall Study|Withdrawal by Subject|0|||
160975059|NCT02597933|581297658|FG000|Overall Study|Withdrawal by Subject|7|||
160975060|NCT02597933|581297659|FG001|Overall Study|Withdrawal by Subject|5|||
160975061|NCT02597933|581297658|FG000|Overall Study|Protocol Violation|2|||
161028986|NCT04625725|581496667|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
161028987|NCT04625725|581496662|FG000|Provent Sub Study|Withdrawal by Subject|0|||
161028988|NCT04625725|581496663|FG001|Provent Sub Study|Withdrawal by Subject|0|||
161344333|NCT00127803|582646080|FG002|Overall Study|Lost to Follow-up|0|||
160975062|NCT02597933|581297659|FG001|Overall Study|Protocol Violation|2|||
160975063|NCT02597933|581297658|FG000|Overall Study|Adverse Event|20|||
160975064|NCT02597933|581297659|FG001|Overall Study|Adverse Event|28|||
160975065|NCT02597933|581297658|FG000|Overall Study|Not treated|2|||
160975066|NCT02597933|581297659|FG001|Overall Study|Not treated|2|||
160975067|NCT02597933|581297658|FG000|Overall Study|Other than stated above|7|||
160975068|NCT02597933|581297659|FG001|Overall Study|Other than stated above|14|||
160975069|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
160975070|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
160975071|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
160975072|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
160975073|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
160975074|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
160975075|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
160975076|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
160975077|NCT01336621|581297666|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
160975078|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
160975079|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
160975080|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
160975081|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
160975082|NCT01336621|581297666|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
160975083|NCT02487095|581297667|FG000|Dose Expansion|Unable to scan/restage participant|0|||
160975084|NCT02487095|581297668|FG001|Dose Expansion|Unable to scan/restage participant|0|||
160975085|NCT02487095|581297669|FG002|Dose Expansion|Unable to scan/restage participant|0|||
160975086|NCT02487095|581297670|FG003|Dose Expansion|Unable to scan/restage participant|0|||
160975087|NCT02487095|581297671|FG004|Dose Expansion|Unable to scan/restage participant|1|||
160975088|NCT01672853|581297678|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
160975089|NCT01672853|581297679|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
160975090|NCT01672853|581297680|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
160975091|NCT01672853|581297678|FG000|Overall Study|Pregnancy|0|||
160975092|NCT01672853|581297679|FG001|Overall Study|Pregnancy|1|||
160975093|NCT01672853|581297680|FG002|Overall Study|Pregnancy|0|||
160975094|NCT01672853|581297678|FG000|Overall Study|Investigator's Discretion|1|||
160975095|NCT01672853|581297679|FG001|Overall Study|Investigator's Discretion|0|||
160975096|NCT01672853|581297680|FG002|Overall Study|Investigator's Discretion|0|||
160975097|NCT01672853|581297678|FG000|Overall Study|Withdrew Consent|5|||
160975098|NCT01672853|581297679|FG001|Overall Study|Withdrew Consent|5|||
160975099|NCT01672853|581297680|FG002|Overall Study|Withdrew Consent|5|||
160975100|NCT01672853|581297678|FG000|Overall Study|Adverse Event|4|||
160975101|NCT01672853|581297679|FG001|Overall Study|Adverse Event|6|||
160975102|NCT01672853|581297680|FG002|Overall Study|Adverse Event|8|||
160975103|NCT01672853|581297678|FG000|Overall Study|Lost to Follow-up|0|||
160975104|NCT01672853|581297679|FG001|Overall Study|Lost to Follow-up|1|||
160975105|NCT01672853|581297680|FG002|Overall Study|Lost to Follow-up|0|||
160975106|NCT01672853|581297678|FG000|Overall Study|Randomized but Never Treated|0|||
160975107|NCT01672853|581297679|FG001|Overall Study|Randomized but Never Treated|0|||
160975108|NCT01672853|581297680|FG002|Overall Study|Randomized but Never Treated|1|||
160975109|NCT03813147|581297683|FG000|Overall Study|Lack of Efficacy|4|||
160975110|NCT03813147|581297684|FG001|Overall Study|Lack of Efficacy|4|||
160975111|NCT03813147|581297683|FG000|Overall Study|Physician Decision|2|||
160975112|NCT03813147|581297684|FG001|Overall Study|Physician Decision|1|||
160975113|NCT01811563|581299234|FG000|Overall Study|Lost to Follow-up|5|||
160975114|NCT01811563|581299235|FG001|Overall Study|Lost to Follow-up|2|||
160975115|NCT01811563|581299234|FG000|Overall Study|Incorrect Randomization procedure|0|||
160975116|NCT01811563|581299235|FG001|Overall Study|Incorrect Randomization procedure|1|||
160975117|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
160975118|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
160975119|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
160975120|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
160975121|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
160975122|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
160975123|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Death|0|||
160975124|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Death|1|||
160975125|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Adverse Event|11|||
160975126|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Adverse Event|11|||
160975127|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
160975128|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
160975129|NCT02936037|581299236|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161028989|NCT04625725|581496664|FG002|Provent Sub Study|Withdrawal by Subject|11|||
161028990|NCT04625725|581496665|FG003|Provent Sub Study|Withdrawal by Subject|13|||
161028991|NCT04625725|581496666|FG004|Provent Sub Study|Withdrawal by Subject|5|||
161028992|NCT04625725|581496667|FG005|Provent Sub Study|Withdrawal by Subject|6|||
161028993|NCT04625725|581496662|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161028994|NCT04625725|581496663|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161028995|NCT04625725|581496664|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161028996|NCT04625725|581496665|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161028997|NCT04625725|581496666|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
161028998|NCT04625725|581496667|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
161028999|NCT04308681|581496674|FG000|Pre-Treatment|Not reported|1|||
161029000|NCT04308681|581496675|FG001|Pre-Treatment|Not reported|1|||
161029001|NCT04308681|581496676|FG002|Pre-Treatment|Not reported|0|||
161029002|NCT04308681|581496677|FG003|Pre-Treatment|Not reported|0|||
161029003|NCT04308681|581496678|FG004|Pre-Treatment|Not reported|0|||
161029004|NCT04308681|581496679|FG005|Pre-Treatment|Not reported|2|||
161029005|NCT04308681|581496680|FG006|Pre-Treatment|Not reported|0|||
161029006|NCT04308681|581496681|FG007|Pre-Treatment|Not reported|0|||
161029007|NCT04308681|581496674|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
161029008|NCT04308681|581496675|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
161029009|NCT04308681|581496676|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
161029010|NCT04308681|581496677|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
161029011|NCT04308681|581496678|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
161029012|NCT04308681|581496679|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
161029013|NCT04308681|581496680|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
161029014|NCT04308681|581496681|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
161029015|NCT04308681|581496674|FG000|Treatment up to Week 26|Other reasons|2|||
161029016|NCT04308681|581496675|FG001|Treatment up to Week 26|Other reasons|0|||
161029017|NCT04308681|581496676|FG002|Treatment up to Week 26|Other reasons|0|||
161029018|NCT04308681|581496677|FG003|Treatment up to Week 26|Other reasons|0|||
161029019|NCT04308681|581496678|FG004|Treatment up to Week 26|Other reasons|1|||
161029020|NCT04308681|581496679|FG005|Treatment up to Week 26|Other reasons|1|||
161029021|NCT04308681|581496680|FG006|Treatment up to Week 26|Other reasons|0|||
161029022|NCT04308681|581496681|FG007|Treatment up to Week 26|Other reasons|0|||
161029023|NCT04308681|581496674|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161029024|NCT04308681|581496675|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
161029025|NCT04308681|581496676|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
161029026|NCT04308681|581496677|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161029027|NCT04308681|581496678|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
161029028|NCT04308681|581496679|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161029029|NCT04308681|581496680|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
161029030|NCT04308681|581496681|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
161029031|NCT04308681|581496674|FG000|Treatment up to Week 26|Adverse Event|6|||
161029032|NCT04308681|581496675|FG001|Treatment up to Week 26|Adverse Event|5|||
161029033|NCT04308681|581496676|FG002|Treatment up to Week 26|Adverse Event|5|||
161029034|NCT04308681|581496677|FG003|Treatment up to Week 26|Adverse Event|0|||
161029035|NCT04308681|581496678|FG004|Treatment up to Week 26|Adverse Event|6|||
161029036|NCT04308681|581496679|FG005|Treatment up to Week 26|Adverse Event|1|||
161029037|NCT04308681|581496680|FG006|Treatment up to Week 26|Adverse Event|0|||
161029038|NCT04308681|581496681|FG007|Treatment up to Week 26|Adverse Event|0|||
161029039|NCT04308681|581496674|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161029040|NCT04308681|581496675|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
161029041|NCT04308681|581496676|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
161029042|NCT04308681|581496677|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161029043|NCT04308681|581496678|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161029044|NCT04308681|581496679|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161029045|NCT04308681|581496680|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161029046|NCT04308681|581496681|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
161029047|NCT04308681|581496674|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
161029048|NCT04308681|581496675|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
161029049|NCT04308681|581496676|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
161029050|NCT04308681|581496677|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
161029051|NCT04308681|581496678|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
161029052|NCT04308681|581496679|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
161029053|NCT04308681|581496680|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
161148830|NCT04760314|581926147|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
161029054|NCT04308681|581496681|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
161029055|NCT04308681|581496674|FG000|OTE - 26 Weeks|Death|0|||
161029056|NCT04308681|581496675|FG001|OTE - 26 Weeks|Death|1|||
161029057|NCT04308681|581496676|FG002|OTE - 26 Weeks|Death|0|||
161029058|NCT04308681|581496677|FG003|OTE - 26 Weeks|Death|0|||
161344334|NCT00127803|582646081|FG003|Overall Study|Lost to Follow-up|1|||
161344335|NCT00858988|582646084|FG000|Analysis|Lactulose unable to be detected in urine|2|||
161344336|NCT00858988|582646085|FG001|Analysis|Lactulose unable to be detected in urine|1|||
161344337|NCT00846365|582646088|FG000|Overall Study|Adverse Event|20|||
161344338|NCT00846365|582646089|FG001|Overall Study|Adverse Event|30|||
161344339|NCT00846365|582646090|FG002|Overall Study|Adverse Event|11|||
161344340|NCT00846365|582646088|FG000|Overall Study|Protocol Violation|5|||
161344341|NCT00846365|582646089|FG001|Overall Study|Protocol Violation|4|||
161344342|NCT00846365|582646090|FG002|Overall Study|Protocol Violation|0|||
161344343|NCT00846365|582646088|FG000|Overall Study|Lost to Follow-up|8|||
161344344|NCT00846365|582646089|FG001|Overall Study|Lost to Follow-up|2|||
161344345|NCT00846365|582646090|FG002|Overall Study|Lost to Follow-up|5|||
161344346|NCT00846365|582646088|FG000|Overall Study|Withdrawal by Subject|11|||
161344347|NCT00846365|582646089|FG001|Overall Study|Withdrawal by Subject|11|||
161344348|NCT00846365|582646090|FG002|Overall Study|Withdrawal by Subject|9|||
161344349|NCT00846365|582646088|FG000|Overall Study|Pregnancy|1|||
161344350|NCT00846365|582646089|FG001|Overall Study|Pregnancy|0|||
161029059|NCT04308681|581496678|FG004|OTE - 26 Weeks|Death|0|||
161029060|NCT04308681|581496679|FG005|OTE - 26 Weeks|Death|0|||
161029061|NCT04308681|581496680|FG006|OTE - 26 Weeks|Death|1|||
161029062|NCT04308681|581496681|FG007|OTE - 26 Weeks|Death|0|||
161029063|NCT04308681|581496674|FG000|OTE - 26 Weeks|Adverse Event|0|||
161029064|NCT04308681|581496675|FG001|OTE - 26 Weeks|Adverse Event|2|||
161029065|NCT04308681|581496676|FG002|OTE - 26 Weeks|Adverse Event|8|||
161029066|NCT04308681|581496677|FG003|OTE - 26 Weeks|Adverse Event|3|||
161029067|NCT04308681|581496678|FG004|OTE - 26 Weeks|Adverse Event|0|||
161029068|NCT04308681|581496679|FG005|OTE - 26 Weeks|Adverse Event|1|||
161029069|NCT04308681|581496680|FG006|OTE - 26 Weeks|Adverse Event|2|||
161029070|NCT04308681|581496681|FG007|OTE - 26 Weeks|Adverse Event|0|||
161029071|NCT04308681|581496674|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161029072|NCT04308681|581496675|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
161029073|NCT04308681|581496676|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
161029074|NCT04308681|581496677|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161029075|NCT04308681|581496678|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161029076|NCT04308681|581496679|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
161029077|NCT04308681|581496680|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161029078|NCT04308681|581496681|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
161029079|NCT02631746|581496687|FG000|Overall Study|Lack of Efficacy|3|||
161029080|NCT02361216|581496688|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
161029081|NCT02361216|581496689|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
161029082|NCT02361216|581496688|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
161029083|NCT02361216|581496689|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
161029084|NCT02361216|581496688|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
161029085|NCT02361216|581496689|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
161029086|NCT02361216|581496688|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
161029087|NCT02361216|581496689|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
161029088|NCT02361216|581496688|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
161029089|NCT02361216|581496689|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
161029090|NCT02361216|581496688|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
161029091|NCT02361216|581496689|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
161029092|NCT04086121|581496694|FG000|Overall Study|Other than listed|8|||
161029093|NCT04086121|581496694|FG000|Overall Study|Withdrawal by Subject|3|||
161029094|NCT04086121|581496694|FG000|Overall Study|Lost to Follow-up|2|||
161029095|NCT04086121|581496694|FG000|Overall Study|Adverse Event|1|||
161029096|NCT04167553|581496695|FG000|Overall Study|Withdrawal by Subject|1|||
161029097|NCT04167553|581496696|FG001|Overall Study|Withdrawal by Subject|0|||
161029098|NCT04167553|581496697|FG002|Overall Study|Withdrawal by Subject|1|||
161029099|NCT04167553|581496698|FG003|Overall Study|Withdrawal by Subject|2|||
161029100|NCT04167553|581496699|FG004|Overall Study|Withdrawal by Subject|1|||
161344351|NCT00846365|582646090|FG002|Overall Study|Pregnancy|0|||
161344352|NCT00846365|582646088|FG000|Overall Study|Lack of Efficacy|1|||
161029101|NCT04167553|581496700|FG005|Overall Study|Withdrawal by Subject|0|||
161029102|NCT04167553|581496701|FG006|Overall Study|Withdrawal by Subject|0|||
161029103|NCT04167553|581496695|FG000|Overall Study|Physician Decision|0|||
161148831|NCT04760314|581926148|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
161344353|NCT00846365|582646089|FG001|Overall Study|Lack of Efficacy|1|||
161344354|NCT00846365|582646090|FG002|Overall Study|Lack of Efficacy|2|||
161344355|NCT00846365|582646088|FG000|Overall Study|Other|9|||
161344356|NCT00846365|582646089|FG001|Overall Study|Other|1|||
161344357|NCT00846365|582646090|FG002|Overall Study|Other|6|||
161344358|NCT01277861|582646098|FG000|Overall Study|Physician Decision|2|||
161029104|NCT04167553|581496696|FG001|Overall Study|Physician Decision|0|||
161029105|NCT04167553|581496697|FG002|Overall Study|Physician Decision|0|||
161029106|NCT04167553|581496698|FG003|Overall Study|Physician Decision|0|||
161344359|NCT01277861|582646099|FG001|Overall Study|Physician Decision|2|||
161276615|NCT01371747|582393298|FG003|Overall Study|High Serum Potassium Results|2|||
161276616|NCT01371747|582393299|FG004|Overall Study|High Serum Potassium Results|0|||
161276617|NCT01371747|582393300|FG005|Overall Study|High Serum Potassium Results|2|||
161276618|NCT01371747|582393295|FG000|Overall Study|Low Serum Potassium Results|1|||
161276619|NCT01371747|582393296|FG001|Overall Study|Low Serum Potassium Results|1|||
161276620|NCT01371747|582393297|FG002|Overall Study|Low Serum Potassium Results|1|||
161276621|NCT01371747|582393298|FG003|Overall Study|Low Serum Potassium Results|1|||
161276622|NCT01371747|582393299|FG004|Overall Study|Low Serum Potassium Results|0|||
161276623|NCT01371747|582393300|FG005|Overall Study|Low Serum Potassium Results|3|||
161276624|NCT01371747|582393295|FG000|Overall Study|Protocol Violation|0|||
161276625|NCT01371747|582393296|FG001|Overall Study|Protocol Violation|0|||
161276626|NCT01371747|582393297|FG002|Overall Study|Protocol Violation|1|||
161276627|NCT01371747|582393298|FG003|Overall Study|Protocol Violation|0|||
161344360|NCT05032196|582646100|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161029107|NCT04167553|581496699|FG004|Overall Study|Physician Decision|2|||
161029108|NCT04167553|581496700|FG005|Overall Study|Physician Decision|2|||
161029109|NCT04167553|581496701|FG006|Overall Study|Physician Decision|0|||
161029110|NCT04167553|581496695|FG000|Overall Study|Lost to Follow-up|0|||
161029111|NCT04167553|581496696|FG001|Overall Study|Lost to Follow-up|0|||
161029112|NCT04167553|581496697|FG002|Overall Study|Lost to Follow-up|2|||
161029113|NCT04167553|581496698|FG003|Overall Study|Lost to Follow-up|0|||
161029114|NCT04167553|581496699|FG004|Overall Study|Lost to Follow-up|0|||
161029115|NCT04167553|581496700|FG005|Overall Study|Lost to Follow-up|0|||
161029116|NCT04167553|581496701|FG006|Overall Study|Lost to Follow-up|0|||
161029117|NCT05285137|581496704|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161029118|NCT05285137|581496705|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161029119|NCT05285137|581496706|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
161029120|NCT05285137|581496707|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
161029121|NCT05285137|581496708|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
161029122|NCT05285137|581496709|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
161029123|NCT05285137|581496710|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
161029124|NCT05285137|581496711|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
161029125|NCT05285137|581496712|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
161029126|NCT05285137|581496704|FG000|Overall Study|Lost to Follow-up|0|||
161029127|NCT05285137|581496705|FG001|Overall Study|Lost to Follow-up|0|||
161029128|NCT05285137|581496706|FG002|Overall Study|Lost to Follow-up|1|||
161029129|NCT05285137|581496707|FG003|Overall Study|Lost to Follow-up|3|||
161029130|NCT05285137|581496708|FG004|Overall Study|Lost to Follow-up|0|||
161029131|NCT05285137|581496709|FG005|Overall Study|Lost to Follow-up|0|||
161029132|NCT05285137|581496710|FG006|Overall Study|Lost to Follow-up|1|||
161029133|NCT05285137|581496711|FG007|Overall Study|Lost to Follow-up|0|||
161029134|NCT05285137|581496712|FG008|Overall Study|Lost to Follow-up|0|||
161029135|NCT05285137|581496704|FG000|Overall Study|Physician Decision|0|||
161029136|NCT05285137|581496705|FG001|Overall Study|Physician Decision|1|||
161029137|NCT05285137|581496706|FG002|Overall Study|Physician Decision|0|||
161029138|NCT05285137|581496707|FG003|Overall Study|Physician Decision|0|||
161029139|NCT05285137|581496708|FG004|Overall Study|Physician Decision|0|||
161029140|NCT05285137|581496709|FG005|Overall Study|Physician Decision|0|||
161029141|NCT05285137|581496710|FG006|Overall Study|Physician Decision|0|||
161029142|NCT05285137|581496711|FG007|Overall Study|Physician Decision|0|||
161029143|NCT05285137|581496712|FG008|Overall Study|Physician Decision|0|||
161029144|NCT05285137|581496704|FG000|Overall Study|Pregnancy|0|||
161029145|NCT05285137|581496705|FG001|Overall Study|Pregnancy|0|||
161029146|NCT05285137|581496706|FG002|Overall Study|Pregnancy|0|||
161029147|NCT05285137|581496707|FG003|Overall Study|Pregnancy|0|||
161029148|NCT05285137|581496708|FG004|Overall Study|Pregnancy|0|||
161029149|NCT05285137|581496709|FG005|Overall Study|Pregnancy|0|||
161029150|NCT05285137|581496710|FG006|Overall Study|Pregnancy|1|||
161029151|NCT05285137|581496711|FG007|Overall Study|Pregnancy|0|||
161029152|NCT05285137|581496712|FG008|Overall Study|Pregnancy|0|||
161029153|NCT05285137|581496704|FG000|Overall Study|Withdrawal by Subject|0|||
161344361|NCT05032196|582646101|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
161344362|NCT05032196|582646102|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161029154|NCT05285137|581496705|FG001|Overall Study|Withdrawal by Subject|1|||
161029155|NCT05285137|581496706|FG002|Overall Study|Withdrawal by Subject|2|||
161029156|NCT05285137|581496707|FG003|Overall Study|Withdrawal by Subject|1|||
161029157|NCT05285137|581496708|FG004|Overall Study|Withdrawal by Subject|0|||
161029158|NCT05285137|581496709|FG005|Overall Study|Withdrawal by Subject|0|||
161029159|NCT05285137|581496710|FG006|Overall Study|Withdrawal by Subject|0|||
161029160|NCT05285137|581496711|FG007|Overall Study|Withdrawal by Subject|0|||
161029161|NCT05285137|581496712|FG008|Overall Study|Withdrawal by Subject|1|||
161029162|NCT05209152|581496713|FG000|Overall Study|Sponsor decision|1|||
161029163|NCT05209152|581496714|FG001|Overall Study|Sponsor decision|2|||
161029164|NCT05209152|581496713|FG000|Overall Study|Death|3|||
161276628|NCT01371747|582393299|FG004|Overall Study|Protocol Violation|0|||
161276629|NCT01371747|582393300|FG005|Overall Study|Protocol Violation|0|||
161276630|NCT01371747|582393295|FG000|Overall Study|Non-Compliance|3|||
161029165|NCT05209152|581496714|FG001|Overall Study|Death|1|||
161029166|NCT03221426|581496715|FG000|Overall Study|Ongoing in study|212|||
161029167|NCT03221426|581496716|FG001|Overall Study|Ongoing in study|193|||
161029168|NCT03221426|581496717|FG002|Overall Study|Ongoing in study|61|||
161276631|NCT01371747|582393296|FG001|Overall Study|Non-Compliance|4|||
161276632|NCT01371747|582393297|FG002|Overall Study|Non-Compliance|3|||
161276633|NCT01371747|582393298|FG003|Overall Study|Non-Compliance|0|||
161276634|NCT01371747|582393299|FG004|Overall Study|Non-Compliance|0|||
161276635|NCT01371747|582393300|FG005|Overall Study|Non-Compliance|1|||
161276636|NCT01371747|582393295|FG000|Overall Study|Physician Decision|0|||
161276637|NCT01371747|582393296|FG001|Overall Study|Physician Decision|0|||
161276638|NCT01371747|582393297|FG002|Overall Study|Physician Decision|0|||
161276639|NCT01371747|582393298|FG003|Overall Study|Physician Decision|0|||
161276640|NCT01371747|582393299|FG004|Overall Study|Physician Decision|1|||
161276641|NCT01371747|582393300|FG005|Overall Study|Physician Decision|0|||
161276642|NCT01371747|582393295|FG000|Overall Study|Withdrawal by Subject|6|||
161276643|NCT01371747|582393296|FG001|Overall Study|Withdrawal by Subject|12|||
161276644|NCT01371747|582393297|FG002|Overall Study|Withdrawal by Subject|5|||
161276645|NCT01371747|582393298|FG003|Overall Study|Withdrawal by Subject|2|||
161276646|NCT01371747|582393299|FG004|Overall Study|Withdrawal by Subject|2|||
161276647|NCT01371747|582393300|FG005|Overall Study|Withdrawal by Subject|4|||
161276648|NCT01371747|582393295|FG000|Overall Study|Other Reasons|2|||
161276649|NCT01371747|582393296|FG001|Overall Study|Other Reasons|1|||
161276650|NCT01371747|582393297|FG002|Overall Study|Other Reasons|2|||
161276651|NCT01371747|582393298|FG003|Overall Study|Other Reasons|0|||
161276652|NCT01371747|582393299|FG004|Overall Study|Other Reasons|0|||
161276653|NCT01371747|582393300|FG005|Overall Study|Other Reasons|1|||
161276654|NCT03092219|582393301|FG000|Overall Study|Protocol Violation|7|||
161276655|NCT03092219|582393302|FG001|Overall Study|Protocol Violation|4|||
161276656|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #1|24|||
161276657|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #1|0|||
161276658|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
161276659|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
161276660|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276661|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276662|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
161276663|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
161276664|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
161276665|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
161276666|NCT03888066|582393305|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276667|NCT03888066|582393306|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276668|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276669|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276670|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
161276671|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
161276672|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276673|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276674|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
161276675|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276676|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #2|5|||
161276677|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #2|0|||
161276678|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
161276679|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
161276680|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
161276681|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
161276682|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
161276683|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
161276684|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #3|11|||
161276685|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #3|0|||
161276686|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
161276687|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
161276688|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
161276689|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161276690|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276691|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276692|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #4|3|||
161276693|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #4|0|||
161029169|NCT03221426|581496718|FG003|Overall Study|Ongoing in study|55|||
161029170|NCT03221426|581496715|FG000|Overall Study|Withdrawal by Subject|12|||
161029171|NCT03221426|581496716|FG001|Overall Study|Withdrawal by Subject|4|||
161029172|NCT03221426|581496717|FG002|Overall Study|Withdrawal by Subject|2|||
161029173|NCT03221426|581496718|FG003|Overall Study|Withdrawal by Subject|3|||
161029174|NCT03221426|581496715|FG000|Overall Study|Lost to Follow-up|4|||
161029175|NCT03221426|581496716|FG001|Overall Study|Lost to Follow-up|1|||
161029176|NCT03221426|581496717|FG002|Overall Study|Lost to Follow-up|1|||
161029177|NCT03221426|581496718|FG003|Overall Study|Lost to Follow-up|0|||
161029178|NCT03221426|581496715|FG000|Overall Study|Death|174|||
161029179|NCT03221426|581496716|FG001|Overall Study|Death|204|||
161029180|NCT03221426|581496717|FG002|Overall Study|Death|36|||
161029181|NCT03221426|581496718|FG003|Overall Study|Death|45|||
161029182|NCT05809453|581498109|FG000|Overall Study|Withdrawal by Subject|1|||
161029183|NCT05809453|581498110|FG001|Overall Study|Withdrawal by Subject|0|||
161029184|NCT05809453|581498111|FG002|Overall Study|Withdrawal by Subject|0|||
161029185|NCT05809453|581498112|FG003|Overall Study|Withdrawal by Subject|0|||
161029186|NCT04850898|581498114|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
161029187|NCT04850898|581498115|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
161029188|NCT04550221|581498122|FG000|Overall Study|Lost to Follow-up|0|||
161029189|NCT04550221|581498123|FG001|Overall Study|Lost to Follow-up|4|||
161029190|NCT04550221|581498122|FG000|Overall Study|Withdrawn|3|||
161029191|NCT04550221|581498123|FG001|Overall Study|Withdrawn|0|||
161029192|NCT04550221|581498122|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
161029193|NCT04550221|581498123|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
161029194|NCT02593773|581498124|FG000|Overall Study|Voluntary Withdrawal|3|||
161029195|NCT02593773|581498124|FG000|Overall Study|Study Terminated by Sponsor|31|||
161029196|NCT02593773|581498124|FG000|Overall Study|Death|1|||
161029197|NCT05452460|581498125|FG000|Overall Study|Lost to Follow-up|3|||
161029198|NCT05452460|581498126|FG001|Overall Study|Lost to Follow-up|3|||
161029199|NCT05452460|581498125|FG000|Overall Study|Did not receive intervention|1|||
161029200|NCT05452460|581498126|FG001|Overall Study|Did not receive intervention|0|||
161029201|NCT04447040|581498128|FG000|Overall Study|Lost to Follow-up|2|||
161029202|NCT04447040|581498129|FG001|Overall Study|Lost to Follow-up|1|||
161029203|NCT04447040|581498130|FG002|Overall Study|Lost to Follow-up|3|||
161029204|NCT04447040|581498131|FG003|Overall Study|Lost to Follow-up|3|||
161029205|NCT04447040|581498132|FG004|Overall Study|Lost to Follow-up|1|||
161029206|NCT04447040|581498133|FG005|Overall Study|Lost to Follow-up|3|||
161029207|NCT04447040|581498128|FG000|Overall Study|Withdrawal by Subject|0|||
161029208|NCT04447040|581498129|FG001|Overall Study|Withdrawal by Subject|1|||
161029209|NCT04447040|581498130|FG002|Overall Study|Withdrawal by Subject|1|||
161029210|NCT04447040|581498131|FG003|Overall Study|Withdrawal by Subject|1|||
161029211|NCT04447040|581498132|FG004|Overall Study|Withdrawal by Subject|0|||
161029212|NCT04447040|581498133|FG005|Overall Study|Withdrawal by Subject|0|||
161029213|NCT01208662|581498134|FG000|Induction and Consolidation|Disease Progression|23|||
161029214|NCT01208662|581498135|FG001|Induction and Consolidation|Disease Progression|13|||
161029215|NCT01208662|581498136|FG002|Induction and Consolidation|Disease Progression|0|||
161029216|NCT01208662|581498134|FG000|Induction and Consolidation|Adverse Event|16|||
161029217|NCT01208662|581498135|FG001|Induction and Consolidation|Adverse Event|18|||
161029218|NCT01208662|581498136|FG002|Induction and Consolidation|Adverse Event|2|||
161029219|NCT01208662|581498134|FG000|Induction and Consolidation|MD or Participant Decision|16|||
161029220|NCT01208662|581498135|FG001|Induction and Consolidation|MD or Participant Decision|34|||
161029221|NCT01208662|581498136|FG002|Induction and Consolidation|MD or Participant Decision|4|||
161029222|NCT01208662|581498134|FG000|Induction and Consolidation|Death|1|||
161029223|NCT01208662|581498135|FG001|Induction and Consolidation|Death|3|||
161029224|NCT01208662|581498136|FG002|Induction and Consolidation|Death|1|||
161029225|NCT01208662|581498134|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
161029226|NCT01208662|581498135|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
161029227|NCT01208662|581498136|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
161029228|NCT01208662|581498134|FG000|Maintenance|Disease Progression|156|||
161029229|NCT01208662|581498135|FG001|Maintenance|Disease Progression|102|||
161029230|NCT01208662|581498136|FG002|Maintenance|Disease Progression|0|||
161029231|NCT01208662|581498134|FG000|Maintenance|Adverse Event|12|||
161029232|NCT01208662|581498135|FG001|Maintenance|Adverse Event|28|||
161029233|NCT01208662|581498136|FG002|Maintenance|Adverse Event|0|||
161029234|NCT01208662|581498134|FG000|Maintenance|MD or Participant Decision|24|||
161029235|NCT01208662|581498135|FG001|Maintenance|MD or Participant Decision|36|||
161029236|NCT01208662|581498136|FG002|Maintenance|MD or Participant Decision|0|||
161029237|NCT01208662|581498134|FG000|Maintenance|Death|0|||
161029238|NCT01208662|581498135|FG001|Maintenance|Death|3|||
161029239|NCT01208662|581498136|FG002|Maintenance|Death|0|||
161029240|NCT01208662|581498134|FG000|Maintenance|Discontinued for other reasons|21|||
161029241|NCT01208662|581498135|FG001|Maintenance|Discontinued for other reasons|31|||
161029242|NCT01208662|581498136|FG002|Maintenance|Discontinued for other reasons|0|||
161029243|NCT01208662|581498134|FG000|Maintenance|Still on Treatment|78|||
161029244|NCT01208662|581498135|FG001|Maintenance|Still on Treatment|89|||
161029245|NCT01208662|581498136|FG002|Maintenance|Still on Treatment|0|||
161029246|NCT04433208|581498137|FG000|Overall Study|Withdrawal by Subject|0|||
161029247|NCT04433208|581498138|FG001|Overall Study|Withdrawal by Subject|1|||
161029248|NCT04433208|581498139|FG002|Overall Study|Withdrawal by Subject|1|||
161029249|NCT04433208|581498140|FG003|Overall Study|Withdrawal by Subject|0|||
161029250|NCT04433208|581498141|FG004|Overall Study|Withdrawal by Subject|2|||
161029251|NCT04433208|581498142|FG005|Overall Study|Withdrawal by Subject|1|||
161029252|NCT04433208|581498137|FG000|Overall Study|Lost to Follow-up|0|||
161029253|NCT04433208|581498138|FG001|Overall Study|Lost to Follow-up|0|||
161029254|NCT04433208|581498139|FG002|Overall Study|Lost to Follow-up|0|||
161029255|NCT04433208|581498140|FG003|Overall Study|Lost to Follow-up|0|||
161029256|NCT04433208|581498141|FG004|Overall Study|Lost to Follow-up|0|||
161029257|NCT04433208|581498142|FG005|Overall Study|Lost to Follow-up|1|||
161029258|NCT02424617|581498145|FG000|Overall Study|Adverse Event|0|||
161029259|NCT02424617|581498146|FG001|Overall Study|Adverse Event|1|||
161029260|NCT02424617|581498147|FG002|Overall Study|Adverse Event|0|||
161029261|NCT02424617|581498148|FG003|Overall Study|Adverse Event|0|||
161029262|NCT02424617|581498145|FG000|Overall Study|Investigator Decision|0|||
161029263|NCT02424617|581498146|FG001|Overall Study|Investigator Decision|0|||
161029264|NCT02424617|581498147|FG002|Overall Study|Investigator Decision|0|||
161029265|NCT02424617|581498148|FG003|Overall Study|Investigator Decision|1|||
161029266|NCT02424617|581498145|FG000|Overall Study|Withdrawal by Subject|1|||
161029267|NCT02424617|581498146|FG001|Overall Study|Withdrawal by Subject|1|||
161029268|NCT02424617|581498147|FG002|Overall Study|Withdrawal by Subject|0|||
161029269|NCT02424617|581498148|FG003|Overall Study|Withdrawal by Subject|1|||
161029270|NCT02424617|581498145|FG000|Overall Study|Progressive Disease|7|||
161029271|NCT02424617|581498146|FG001|Overall Study|Progressive Disease|6|||
161029272|NCT02424617|581498147|FG002|Overall Study|Progressive Disease|11|||
161029273|NCT02424617|581498148|FG003|Overall Study|Progressive Disease|10|||
161029274|NCT02424617|581498145|FG000|Overall Study|Other|0|||
161029275|NCT02424617|581498146|FG001|Overall Study|Other|0|||
161029276|NCT02424617|581498147|FG002|Overall Study|Other|0|||
161029277|NCT02424617|581498148|FG003|Overall Study|Other|1|||
161029278|NCT05269966|581498152|FG000|Overall Study|Adverse Event|4|||
161029279|NCT05269966|581498152|FG000|Overall Study|Withdrawal by Subject|1|||
161029280|NCT05269966|581498152|FG000|Overall Study|Lost to Follow-up|4|||
161029281|NCT05269966|581498152|FG000|Overall Study|Physician Decision|1|||
161029282|NCT06262347|581498155|FG000|Overall Study|Lost to Follow-up|4|||
161029283|NCT06262347|581498156|FG001|Overall Study|Lost to Follow-up|3|||
161029284|NCT06262347|581498155|FG000|Overall Study|Withdrawal by Subject|0|||
161029285|NCT06262347|581498156|FG001|Overall Study|Withdrawal by Subject|1|||
161029286|NCT03476343|581498157|FG000|Overall Study|Clinical exam moved to another scanner|7|||
161029287|NCT03476343|581498157|FG000|Overall Study|Clinical order cancelled|4|||
161029288|NCT03476343|581498157|FG000|Overall Study|Neonate did not settle down for the scan|1|||
161029289|NCT05974501|581498158|FG000|Overall Study|Physician Decision|0|||
161029290|NCT05974501|581498159|FG001|Overall Study|Physician Decision|1|||
161029291|NCT04304144|581498160|FG000|DLT Observation Period|Physician Decision|0|||
161029292|NCT04304144|581498161|FG001|DLT Observation Period|Physician Decision|1|||
161029293|NCT04304144|581498162|FG002|DLT Observation Period|Physician Decision|0|||
161029294|NCT04304144|581498163|FG003|DLT Observation Period|Physician Decision|0|||
161029295|NCT04304144|581498160|FG000|Continued Treatment Period|Adverse Event|0|||
161029296|NCT04304144|581498161|FG001|Continued Treatment Period|Adverse Event|1|||
161029297|NCT04304144|581498162|FG002|Continued Treatment Period|Adverse Event|0|||
161029298|NCT04304144|581498163|FG003|Continued Treatment Period|Adverse Event|0|||
161029299|NCT04304144|581498160|FG000|Continued Treatment Period|Death|0|||
161029300|NCT04304144|581498161|FG001|Continued Treatment Period|Death|0|||
160975130|NCT02936037|581299237|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
160975131|NCT02936037|581299236|FG000|Open Label Extension|Adverse Event|0|||
160975132|NCT02936037|581299237|FG001|Open Label Extension|Adverse Event|3|||
160975133|NCT02936037|581299236|FG000|Open Label Extension|Other|0|||
160975134|NCT02936037|581299237|FG001|Open Label Extension|Other|3|||
160975135|NCT02936037|581299236|FG000|Open Label Extension|Withdrawal by Subject|0|||
160975136|NCT02936037|581299237|FG001|Open Label Extension|Withdrawal by Subject|4|||
160975137|NCT01267825|581299238|FG000|Overall Study|study terminated. no data collected.|1|||
160975138|NCT01267825|581299239|FG001|Overall Study|study terminated. no data collected.|0|||
160975139|NCT04249336|581299240|FG000|Overall Study|Lost to Follow-up|3|||
161029301|NCT04304144|581498162|FG002|Continued Treatment Period|Death|1|||
161029302|NCT04304144|581498163|FG003|Continued Treatment Period|Death|2|||
161029303|NCT04304144|581498160|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
161029304|NCT04304144|581498161|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
161029305|NCT04304144|581498162|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
161029306|NCT04304144|581498163|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
161029307|NCT04304144|581498160|FG000|Continued Treatment Period|Other than specified|2|||
161029308|NCT04304144|581498161|FG001|Continued Treatment Period|Other than specified|0|||
161029309|NCT04304144|581498162|FG002|Continued Treatment Period|Other than specified|1|||
161029310|NCT04304144|581498163|FG003|Continued Treatment Period|Other than specified|1|||
161029311|NCT04101357|581498164|FG000|Overall Study|Death|1|||
161029312|NCT04101357|581498165|FG001|Overall Study|Death|1|||
161029313|NCT04101357|581498166|FG002|Overall Study|Death|1|||
161029314|NCT04101357|581498167|FG003|Overall Study|Death|2|||
161029315|NCT04101357|581498168|FG004|Overall Study|Death|4|||
161029316|NCT04101357|581498169|FG005|Overall Study|Death|11|||
161029317|NCT04101357|581498170|FG006|Overall Study|Death|4|||
161029318|NCT04101357|581498171|FG007|Overall Study|Death|4|||
161029319|NCT04101357|581498172|FG008|Overall Study|Death|5|||
161029320|NCT04101357|581498173|FG009|Overall Study|Death|2|||
161029321|NCT04101357|581498174|FG010|Overall Study|Death|3|||
161029322|NCT04101357|581498164|FG000|Overall Study|Trial closure|0|||
161029323|NCT04101357|581498165|FG001|Overall Study|Trial closure|0|||
161029324|NCT04101357|581498166|FG002|Overall Study|Trial closure|0|||
161029325|NCT04101357|581498167|FG003|Overall Study|Trial closure|0|||
161029326|NCT04101357|581498168|FG004|Overall Study|Trial closure|0|||
161029327|NCT04101357|581498169|FG005|Overall Study|Trial closure|2|||
161029328|NCT04101357|581498170|FG006|Overall Study|Trial closure|2|||
161029329|NCT04101357|581498171|FG007|Overall Study|Trial closure|0|||
161029330|NCT04101357|581498172|FG008|Overall Study|Trial closure|0|||
161029331|NCT04101357|581498173|FG009|Overall Study|Trial closure|0|||
161029332|NCT04101357|581498174|FG010|Overall Study|Trial closure|1|||
161029333|NCT04101357|581498164|FG000|Overall Study|Lost to Follow-up|0|||
161029334|NCT04101357|581498165|FG001|Overall Study|Lost to Follow-up|0|||
161029335|NCT04101357|581498166|FG002|Overall Study|Lost to Follow-up|0|||
161029336|NCT04101357|581498167|FG003|Overall Study|Lost to Follow-up|1|||
161029337|NCT04101357|581498168|FG004|Overall Study|Lost to Follow-up|0|||
161029338|NCT04101357|581498169|FG005|Overall Study|Lost to Follow-up|0|||
161029339|NCT04101357|581498170|FG006|Overall Study|Lost to Follow-up|0|||
161029340|NCT04101357|581498171|FG007|Overall Study|Lost to Follow-up|1|||
161029341|NCT04101357|581498172|FG008|Overall Study|Lost to Follow-up|0|||
161029342|NCT04101357|581498173|FG009|Overall Study|Lost to Follow-up|0|||
161029343|NCT04101357|581498174|FG010|Overall Study|Lost to Follow-up|0|||
161029344|NCT04101357|581498164|FG000|Overall Study|Withdrawal by Subject|1|||
161029345|NCT04101357|581498165|FG001|Overall Study|Withdrawal by Subject|0|||
161029346|NCT04101357|581498166|FG002|Overall Study|Withdrawal by Subject|0|||
161029347|NCT04101357|581498167|FG003|Overall Study|Withdrawal by Subject|0|||
161029348|NCT04101357|581498168|FG004|Overall Study|Withdrawal by Subject|0|||
161029349|NCT04101357|581498169|FG005|Overall Study|Withdrawal by Subject|0|||
161029350|NCT04101357|581498170|FG006|Overall Study|Withdrawal by Subject|0|||
161029351|NCT04101357|581498171|FG007|Overall Study|Withdrawal by Subject|0|||
161029352|NCT04101357|581498172|FG008|Overall Study|Withdrawal by Subject|1|||
161029353|NCT04101357|581498173|FG009|Overall Study|Withdrawal by Subject|1|||
161029354|NCT04101357|581498174|FG010|Overall Study|Withdrawal by Subject|0|||
161029355|NCT04101357|581498164|FG000|Overall Study|Other|0|||
161029356|NCT04101357|581498165|FG001|Overall Study|Other|0|||
161029357|NCT04101357|581498166|FG002|Overall Study|Other|0|||
161029358|NCT04101357|581498167|FG003|Overall Study|Other|0|||
161029359|NCT04101357|581498168|FG004|Overall Study|Other|0|||
161029360|NCT04101357|581498169|FG005|Overall Study|Other|1|||
161029361|NCT04101357|581498170|FG006|Overall Study|Other|2|||
161029362|NCT04101357|581498171|FG007|Overall Study|Other|1|||
161029363|NCT04101357|581498172|FG008|Overall Study|Other|0|||
161029364|NCT04101357|581498173|FG009|Overall Study|Other|0|||
161029365|NCT04101357|581498174|FG010|Overall Study|Other|0|||
161029366|NCT04101357|581498164|FG000|Overall Study|Enrolled but not treated|0|||
161029367|NCT04101357|581498165|FG001|Overall Study|Enrolled but not treated|0|||
161029368|NCT04101357|581498166|FG002|Overall Study|Enrolled but not treated|0|||
161029369|NCT04101357|581498167|FG003|Overall Study|Enrolled but not treated|0|||
161029370|NCT04101357|581498168|FG004|Overall Study|Enrolled but not treated|0|||
161276694|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
161276695|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
161276696|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
161276697|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
161276698|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
161276699|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161276700|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
161029371|NCT04101357|581498169|FG005|Overall Study|Enrolled but not treated|1|||
161029372|NCT04101357|581498170|FG006|Overall Study|Enrolled but not treated|1|||
161029373|NCT04101357|581498171|FG007|Overall Study|Enrolled but not treated|0|||
161029374|NCT04101357|581498172|FG008|Overall Study|Enrolled but not treated|0|||
161029375|NCT04101357|581498173|FG009|Overall Study|Enrolled but not treated|0|||
161029376|NCT04101357|581498174|FG010|Overall Study|Enrolled but not treated|0|||
161029377|NCT02497950|581498177|FG000|Overall Study|Death|209|||
161029378|NCT02497950|581498177|FG000|Overall Study|Transplanted|85|||
161029379|NCT02497950|581498177|FG000|Overall Study|Explanted|8|||
161029380|NCT02497950|581498177|FG000|Overall Study|Device Permanently Deactivated|4|||
161029381|NCT02497950|581498177|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
161029382|NCT02497950|581498177|FG000|Overall Study|Lost to Follow-up|6|||
161029383|NCT02497950|581498177|FG000|Overall Study|Withdrawal by Subject|2|||
161344363|NCT05032196|582646103|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
160975140|NCT04249336|581299241|FG001|Overall Study|Lost to Follow-up|3|||
160975141|NCT04249336|581299242|FG002|Overall Study|Lost to Follow-up|3|||
160975142|NCT04249336|581299243|FG003|Overall Study|Lost to Follow-up|3|||
160975144|NCT01189890|581299248|FG000|Overall Study|Adverse Event|3|||
160975145|NCT01189890|581299249|FG001|Overall Study|Adverse Event|4|||
160975146|NCT01189890|581299248|FG000|Overall Study|Lack of Efficacy|7|||
160975147|NCT01189890|581299249|FG001|Overall Study|Lack of Efficacy|2|||
160975148|NCT01189890|581299248|FG000|Overall Study|Lost to Follow-up|1|||
160975149|NCT01189890|581299249|FG001|Overall Study|Lost to Follow-up|7|||
160975150|NCT01189890|581299248|FG000|Overall Study|Protocol Violation|1|||
160975151|NCT01189890|581299249|FG001|Overall Study|Protocol Violation|5|||
160975152|NCT01189890|581299248|FG000|Overall Study|Withdrawal by Subject|15|||
160975153|NCT01189890|581299249|FG001|Overall Study|Withdrawal by Subject|11|||
160975154|NCT01189890|581299248|FG000|Overall Study|Non Compliance|0|||
160975155|NCT01189890|581299249|FG001|Overall Study|Non Compliance|1|||
160975156|NCT01189890|581299248|FG000|Overall Study|Physician Decision|5|||
160975157|NCT01189890|581299249|FG001|Overall Study|Physician Decision|4|||
160975158|NCT01189890|581299248|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
160975159|NCT01189890|581299249|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
160975160|NCT00077636|581299250|FG000|Overall Study|Refused Treatment|9|||
160975161|NCT00077636|581299251|FG001|Overall Study|Refused Treatment|31|||
160975162|NCT00077636|581299250|FG000|Overall Study|Admin|3|||
160975163|NCT00077636|581299251|FG001|Overall Study|Admin|3|||
160975164|NCT00077636|581299250|FG000|Overall Study|Withdrawal by Subject|2|||
160975165|NCT00077636|581299251|FG001|Overall Study|Withdrawal by Subject|2|||
160975166|NCT00077636|581299250|FG000|Overall Study|Adverse Event|17|||
160975167|NCT00077636|581299251|FG001|Overall Study|Adverse Event|34|||
160975168|NCT00077636|581299250|FG000|Overall Study|Protocol Violation|0|||
160975169|NCT00077636|581299251|FG001|Overall Study|Protocol Violation|2|||
160975170|NCT00077636|581299250|FG000|Overall Study|Lost to Follow-up|10|||
160975171|NCT00077636|581299251|FG001|Overall Study|Lost to Follow-up|18|||
160975172|NCT00077636|581299250|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
160975173|NCT00077636|581299251|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
160975174|NCT00068380|581299252|FG000|Overall Study|Withdrawal by Subject|3|||
160975175|NCT00068380|581299252|FG000|Overall Study|Adverse Event|2|||
160975176|NCT01976364|581299253|FG000|Main Study (36 Months)|Adverse Event|63|||
160975177|NCT01976364|581299254|FG001|Main Study (36 Months)|Adverse Event|0|||
160975178|NCT01976364|581299255|FG002|Main Study (36 Months)|Adverse Event|0|||
160975179|NCT01976364|581299253|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
160975180|NCT01976364|581299254|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
160975181|NCT01976364|581299255|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
160975182|NCT01976364|581299253|FG000|Main Study (36 Months)|Other|13|||
160975183|NCT01976364|581299254|FG001|Main Study (36 Months)|Other|0|||
160975184|NCT01976364|581299255|FG002|Main Study (36 Months)|Other|0|||
160975185|NCT01976364|581299253|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
160975186|NCT01976364|581299254|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
160975187|NCT01976364|581299255|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
160975188|NCT01976364|581299253|FG000|Main Study (36 Months)|Medication error|1|||
160975189|NCT01976364|581299254|FG001|Main Study (36 Months)|Medication error|0|||
160975190|NCT01976364|581299255|FG002|Main Study (36 Months)|Medication error|0|||
160975191|NCT01976364|581299253|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
160975192|NCT01976364|581299254|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
160975193|NCT01976364|581299255|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
160975194|NCT01976364|581299253|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
160975195|NCT01976364|581299254|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
160975196|NCT01976364|581299255|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
160975197|NCT01976364|581299253|FG000|Main Study (36 Months)|Protocol Violation|13|||
160975198|NCT01976364|581299254|FG001|Main Study (36 Months)|Protocol Violation|0|||
160975199|NCT01976364|581299255|FG002|Main Study (36 Months)|Protocol Violation|0|||
160975200|NCT01976364|581299253|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
160975201|NCT01976364|581299254|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
160975202|NCT01976364|581299255|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
160975203|NCT01976364|581299253|FG000|Main Study (36 Months)|Death|5|||
160975204|NCT01976364|581299254|FG001|Main Study (36 Months)|Death|0|||
160975205|NCT01976364|581299255|FG002|Main Study (36 Months)|Death|0|||
160975206|NCT01976364|581299253|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
160975207|NCT01976364|581299254|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
160975208|NCT01976364|581299255|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
160975209|NCT01976364|581299253|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
160975210|NCT01976364|581299254|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
160975211|NCT01976364|581299255|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
160975212|NCT01976364|581299253|FG000|Sub-study (12 Months)|Protocol Violation|0|||
160975213|NCT01976364|581299254|FG001|Sub-study (12 Months)|Protocol Violation|1|||
161029384|NCT02497950|581498177|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
161276701|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
161276702|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
161276703|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276704|NCT03888066|582393305|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
161276705|NCT03888066|582393306|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161276706|NCT03888066|582393305|FG000|Run-in Phase|AE (Adverse Event)|17|||
161276707|NCT03888066|582393306|FG001|Run-in Phase|AE (Adverse Event)|0|||
161276708|NCT03888066|582393305|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
161276709|NCT03888066|582393306|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
161276710|NCT03888066|582393305|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276711|NCT03888066|582393306|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276712|NCT03888066|582393305|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
161276713|NCT03888066|582393306|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276714|NCT03888066|582393305|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
161276715|NCT03888066|582393306|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161276716|NCT03888066|582393305|FG000|Run-in Phase|Withdrawal by Subject|43|||
161276717|NCT03888066|582393306|FG001|Run-in Phase|Withdrawal by Subject|0|||
161276718|NCT03888066|582393305|FG000|Run-in Phase|AE; Physician Decision|1|||
161276719|NCT03888066|582393306|FG001|Run-in Phase|AE; Physician Decision|0|||
161276720|NCT03888066|582393305|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
161276721|NCT03888066|582393306|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
161276722|NCT03888066|582393305|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
161276723|NCT03888066|582393306|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
161276724|NCT03888066|582393305|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
161276725|NCT03888066|582393306|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
161276726|NCT03888066|582393305|FG000|Run-in Phase|Death|1|||
161276727|NCT03888066|582393306|FG001|Run-in Phase|Death|0|||
161276728|NCT03888066|582393305|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
161276729|NCT03888066|582393306|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
161276730|NCT03888066|582393305|FG000|Run-in Phase|Physician Decision|1|||
161276731|NCT03888066|582393306|FG001|Run-in Phase|Physician Decision|0|||
161276732|NCT03888066|582393305|FG000|Run-in Phase|Protocol Violation|13|||
161276733|NCT03888066|582393306|FG001|Run-in Phase|Protocol Violation|0|||
161276734|NCT03888066|582393305|FG000|Run-in Phase|Sponsor Request|34|||
161276735|NCT03888066|582393306|FG001|Run-in Phase|Sponsor Request|0|||
161276736|NCT03888066|582393305|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
161276737|NCT03888066|582393306|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
161276738|NCT03888066|582393305|FG000|Run-in Phase|Withdrawal Of Consent|1|||
161276739|NCT03888066|582393306|FG001|Run-in Phase|Withdrawal Of Consent|0|||
161276740|NCT03888066|582393305|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
161276741|NCT03888066|582393306|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
161276742|NCT03888066|582393305|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
161276743|NCT03888066|582393306|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
161276744|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
161276745|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
161276746|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
161276747|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
161029385|NCT02497950|581498177|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
161029386|NCT04660539|581498178|FG000|Overall Study|Adverse Event|10|||
161029387|NCT04660539|581498178|FG000|Overall Study|Lack of Efficacy|4|||
161029388|NCT04660539|581498178|FG000|Overall Study|Lost to Follow-up|5|||
161029389|NCT04660539|581498178|FG000|Overall Study|Non-Compliance With Study Drug|3|||
161029390|NCT04660539|581498178|FG000|Overall Study|Reason not Specified|12|||
161029391|NCT04660539|581498178|FG000|Overall Study|Pregnancy|2|||
161029392|NCT04660539|581498178|FG000|Overall Study|Protocol Violation|2|||
161029393|NCT04660539|581498178|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
161029394|NCT04660539|581498178|FG000|Overall Study|Withdrawal by Subject|21|||
161029395|NCT03852550|581498181|FG000|Overall Study|Lost to Follow-up|4|||
161029396|NCT03852550|581498182|FG001|Overall Study|Lost to Follow-up|3|||
161029397|NCT03852550|581498181|FG000|Overall Study|Only parent outcomes completed|0|||
161029398|NCT03852550|581498182|FG001|Overall Study|Only parent outcomes completed|1|||
161029399|NCT03852550|581498181|FG000|Overall Study|Withdrawal by Subject|1|||
161029400|NCT03852550|581498182|FG001|Overall Study|Withdrawal by Subject|0|||
161276748|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
161276749|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
161276750|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
161029401|NCT00429364|581498195|FG000|Overall Study|Withdrawal by Subject|11|||
161029402|NCT00429364|581498196|FG001|Overall Study|Withdrawal by Subject|5|||
161029403|NCT00429364|581498195|FG000|Overall Study|Physician Decision|4|||
161276751|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
161276752|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
161276753|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
161276754|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
160975214|NCT01976364|581299255|FG002|Sub-study (12 Months)|Protocol Violation|1|||
160975215|NCT01976364|581299253|FG000|Sub-study (12 Months)|Adverse Event|0|||
160975216|NCT01976364|581299254|FG001|Sub-study (12 Months)|Adverse Event|4|||
160975217|NCT01976364|581299255|FG002|Sub-study (12 Months)|Adverse Event|3|||
160975218|NCT01190215|581299256|FG000|Up to Month 6|Lost to Follow-up|2|||
160975219|NCT01190215|581299257|FG001|Up to Month 6|Lost to Follow-up|0|||
160975220|NCT02960763|581299258|FG000|Step 1|Withdrawal by Subject|10|||
160975221|NCT02960763|581299259|FG001|Step 1|Withdrawal by Subject|8|||
160975222|NCT02960763|581299260|FG002|Step 1|Withdrawal by Subject|13|||
160975223|NCT02960763|581299261|FG003|Step 1|Withdrawal by Subject|0|||
160975224|NCT02960763|581299262|FG004|Step 1|Withdrawal by Subject|0|||
160975225|NCT02960763|581299258|FG000|Step 1|Lost to Follow-up|7|||
160975226|NCT02960763|581299259|FG001|Step 1|Lost to Follow-up|9|||
160975227|NCT02960763|581299260|FG002|Step 1|Lost to Follow-up|12|||
160975228|NCT02960763|581299261|FG003|Step 1|Lost to Follow-up|0|||
160975229|NCT02960763|581299262|FG004|Step 1|Lost to Follow-up|0|||
160975230|NCT02960763|581299258|FG000|Step 1|Death|1|||
160975231|NCT02960763|581299259|FG001|Step 1|Death|1|||
160975232|NCT02960763|581299260|FG002|Step 1|Death|1|||
160975233|NCT02960763|581299261|FG003|Step 1|Death|0|||
160975234|NCT02960763|581299262|FG004|Step 1|Death|0|||
160975235|NCT02960763|581299258|FG000|Step 1|Investigator discretion|1|||
160975236|NCT02960763|581299259|FG001|Step 1|Investigator discretion|0|||
160975237|NCT02960763|581299260|FG002|Step 1|Investigator discretion|1|||
160975238|NCT02960763|581299261|FG003|Step 1|Investigator discretion|0|||
160975239|NCT02960763|581299262|FG004|Step 1|Investigator discretion|0|||
160975240|NCT02960763|581299258|FG000|Step 1|Other|0|||
160975241|NCT02960763|581299259|FG001|Step 1|Other|0|||
160975242|NCT02960763|581299260|FG002|Step 1|Other|1|||
160975243|NCT02960763|581299261|FG003|Step 1|Other|0|||
160975244|NCT02960763|581299262|FG004|Step 1|Other|0|||
160975245|NCT02960763|581299258|FG000|Step 2|Withdrawal by Subject|0|||
160975246|NCT02960763|581299259|FG001|Step 2|Withdrawal by Subject|0|||
160975247|NCT02960763|581299260|FG002|Step 2|Withdrawal by Subject|0|||
160975248|NCT02960763|581299261|FG003|Step 2|Withdrawal by Subject|7|||
160975249|NCT02960763|581299262|FG004|Step 2|Withdrawal by Subject|3|||
160975250|NCT02960763|581299258|FG000|Step 2|Lost to Follow-up|0|||
160975251|NCT02960763|581299259|FG001|Step 2|Lost to Follow-up|0|||
160975252|NCT02960763|581299260|FG002|Step 2|Lost to Follow-up|0|||
160975253|NCT02960763|581299261|FG003|Step 2|Lost to Follow-up|4|||
160975254|NCT02960763|581299262|FG004|Step 2|Lost to Follow-up|1|||
160975255|NCT02960763|581299258|FG000|Step 2|Investigator discretion|0|||
160975256|NCT02960763|581299259|FG001|Step 2|Investigator discretion|0|||
160975257|NCT02960763|581299260|FG002|Step 2|Investigator discretion|0|||
160975258|NCT02960763|581299261|FG003|Step 2|Investigator discretion|0|||
160975259|NCT02960763|581299262|FG004|Step 2|Investigator discretion|1|||
160975260|NCT05340751|581299263|FG000|Overall Study|Physician Decision|3|||
160975261|NCT01014975|581299276|FG000|Overall Study|Withdrawal by Subject|1|||
160975262|NCT01014975|581299277|FG001|Overall Study|Withdrawal by Subject|0|||
160975263|NCT01014975|581299278|FG002|Overall Study|Withdrawal by Subject|1|||
160975264|NCT01014975|581299276|FG000|Overall Study|Death|3|||
160975265|NCT01014975|581299277|FG001|Overall Study|Death|3|||
160975266|NCT01014975|581299278|FG002|Overall Study|Death|4|||
160975267|NCT01014975|581299276|FG000|Overall Study|Lost to Follow-up|0|||
160975268|NCT01014975|581299277|FG001|Overall Study|Lost to Follow-up|0|||
160975269|NCT01014975|581299278|FG002|Overall Study|Lost to Follow-up|1|||
160975270|NCT00313911|581299282|FG000|Overall Study|Serious adverse event|6|||
160975271|NCT00313911|581299283|FG001|Overall Study|Serious adverse event|1|||
160975272|NCT00313911|581299282|FG000|Overall Study|Adverse Event|2|||
160975273|NCT00313911|581299283|FG001|Overall Study|Adverse Event|3|||
160975274|NCT00313911|581299282|FG000|Overall Study|Protocol Violation|19|||
160975275|NCT00313911|581299283|FG001|Overall Study|Protocol Violation|10|||
160975276|NCT00313911|581299282|FG000|Overall Study|Lost to Follow-up|27|||
160975277|NCT00313911|581299283|FG001|Overall Study|Lost to Follow-up|14|||
160975278|NCT00313911|581299282|FG000|Overall Study|Withdrawal by Subject|39|||
160975279|NCT00313911|581299283|FG001|Overall Study|Withdrawal by Subject|12|||
160975280|NCT00313911|581299282|FG000|Overall Study|Did not meet age criteria|1|||
160975281|NCT00313911|581299283|FG001|Overall Study|Did not meet age criteria|1|||
160975282|NCT00451217|581299284|FG000|Overall Study|Lost to Follow-up|0|||
160975283|NCT00451217|581299285|FG001|Overall Study|Lost to Follow-up|1|||
160975284|NCT00451217|581299286|FG002|Overall Study|Lost to Follow-up|1|||
160975285|NCT00451217|581299287|FG003|Overall Study|Lost to Follow-up|1|||
160975286|NCT00451217|581299284|FG000|Overall Study|Withdrawal by Subject|1|||
160975287|NCT00451217|581299285|FG001|Overall Study|Withdrawal by Subject|0|||
160975288|NCT00451217|581299286|FG002|Overall Study|Withdrawal by Subject|0|||
160975289|NCT00451217|581299287|FG003|Overall Study|Withdrawal by Subject|0|||
160975290|NCT00451217|581299284|FG000|Overall Study|Not Treated|1|||
161029404|NCT00429364|581498196|FG001|Overall Study|Physician Decision|2|||
161029405|NCT00429364|581498195|FG000|Overall Study|Lost to Follow-up|7|||
161029406|NCT00429364|581498196|FG001|Overall Study|Lost to Follow-up|6|||
161029407|NCT00429364|581498195|FG000|Overall Study|Death|0|||
161029408|NCT00429364|581498196|FG001|Overall Study|Death|1|||
161029409|NCT00429364|581498195|FG000|Overall Study|Underwent aortic root surgery|10|||
161029410|NCT00429364|581498196|FG001|Overall Study|Underwent aortic root surgery|18|||
161029411|NCT00429364|581498195|FG000|Overall Study|Pregnancy|0|||
161029412|NCT00429364|581498196|FG001|Overall Study|Pregnancy|1|||
161029413|NCT05425420|581498198|FG000|Overall Study|Physician Decision|1|||
161029414|NCT05425420|581498198|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
161029415|NCT03505008|581498199|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
161029416|NCT03505008|581498200|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
161029417|NCT03505008|581498201|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
161029418|NCT03505008|581498202|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
161029419|NCT03505008|581498199|FG000|Before Week 24 Randomization|Adverse Event|10|||
161029420|NCT03505008|581498200|FG001|Before Week 24 Randomization|Adverse Event|0|||
161029421|NCT03505008|581498201|FG002|Before Week 24 Randomization|Adverse Event|0|||
161029422|NCT03505008|581498202|FG003|Before Week 24 Randomization|Adverse Event|0|||
161029423|NCT03505008|581498199|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
161029424|NCT03505008|581498200|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
161029425|NCT03505008|581498201|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
161029426|NCT03505008|581498202|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
161029427|NCT03505008|581498199|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
161029428|NCT03505008|581498200|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
161029429|NCT03505008|581498201|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
161029430|NCT03505008|581498202|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
161029431|NCT03505008|581498199|FG000|Before Week 24 Randomization|Physician Decision|2|||
161029432|NCT03505008|581498200|FG001|Before Week 24 Randomization|Physician Decision|0|||
161029433|NCT03505008|581498201|FG002|Before Week 24 Randomization|Physician Decision|0|||
161029434|NCT03505008|581498202|FG003|Before Week 24 Randomization|Physician Decision|0|||
161029435|NCT03505008|581498199|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
161029436|NCT03505008|581498200|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
161029437|NCT03505008|581498201|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
161029438|NCT03505008|581498202|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
161029439|NCT03505008|581498199|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
161029440|NCT03505008|581498200|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
161029441|NCT03505008|581498201|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
161029442|NCT03505008|581498202|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
161029443|NCT03505008|581498199|FG000|Before Week 24 Randomization|Complication|1|||
161029444|NCT03505008|581498200|FG001|Before Week 24 Randomization|Complication|0|||
161029445|NCT03505008|581498201|FG002|Before Week 24 Randomization|Complication|0|||
161029446|NCT03505008|581498202|FG003|Before Week 24 Randomization|Complication|0|||
161029447|NCT03505008|581498199|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
161029448|NCT03505008|581498200|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
161029449|NCT03505008|581498201|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
161029450|NCT03505008|581498202|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
161029451|NCT03505008|581498199|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
161029452|NCT03505008|581498200|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
161029453|NCT03505008|581498201|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
161029454|NCT03505008|581498202|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
161029455|NCT03505008|581498199|FG000|After Week 24 Randomization|Adverse Event|0|||
161029456|NCT03505008|581498200|FG001|After Week 24 Randomization|Adverse Event|1|||
161029457|NCT03505008|581498201|FG002|After Week 24 Randomization|Adverse Event|2|||
161029458|NCT03505008|581498202|FG003|After Week 24 Randomization|Adverse Event|2|||
161029459|NCT03505008|581498199|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
161029460|NCT03505008|581498200|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
161029461|NCT03505008|581498201|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
161029462|NCT03505008|581498202|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
161029463|NCT03505008|581498199|FG000|After Week 24 Randomization|Protocol Violation|0|||
161276755|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
161276756|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
161029464|NCT03505008|581498200|FG001|After Week 24 Randomization|Protocol Violation|0|||
161029465|NCT03505008|581498201|FG002|After Week 24 Randomization|Protocol Violation|1|||
161029466|NCT03505008|581498202|FG003|After Week 24 Randomization|Protocol Violation|0|||
161029467|NCT02437136|581498203|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
161029468|NCT02437136|581498204|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161276757|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
161029469|NCT02437136|581498205|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161029470|NCT02437136|581498206|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161276758|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
161276759|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
161276760|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
161029471|NCT02437136|581498207|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161029472|NCT02437136|581498208|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161029473|NCT02437136|581498209|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
161029474|NCT02437136|581498203|FG000|Expansion (Phase 2)|Death|0|||
161029475|NCT02437136|581498204|FG001|Expansion (Phase 2)|Death|0|||
161029476|NCT02437136|581498205|FG002|Expansion (Phase 2)|Death|0|||
161029477|NCT02437136|581498206|FG003|Expansion (Phase 2)|Death|6|||
161029478|NCT02437136|581498207|FG004|Expansion (Phase 2)|Death|37|||
161029479|NCT02437136|581498208|FG005|Expansion (Phase 2)|Death|29|||
161029480|NCT02437136|581498209|FG006|Expansion (Phase 2)|Death|24|||
161029481|NCT02437136|581498203|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
161029482|NCT02437136|581498204|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
161029483|NCT02437136|581498205|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
161029484|NCT02437136|581498206|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
161029485|NCT02437136|581498207|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
161029486|NCT02437136|581498208|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
161029487|NCT02437136|581498209|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
161029488|NCT02437136|581498203|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
161029489|NCT02437136|581498204|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
161029490|NCT02437136|581498205|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
161029491|NCT02437136|581498206|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
161029492|NCT02437136|581498207|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
161029493|NCT02437136|581498208|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
161029494|NCT02437136|581498209|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
161029495|NCT02056834|581498210|FG000|Overall Study|Lost to Follow-up|7|||
161029496|NCT00323856|581498213|FG000|Overall Study|Withdrawal by Subject|1|||
161029497|NCT00323856|581498213|FG000|Overall Study|Was uncooperative and noncompliant|1|||
161029498|NCT00323856|581498213|FG000|Overall Study|Reason not specified|1|||
161029499|NCT00323856|581498213|FG000|Overall Study|Missing|2|||
161029500|NCT04580914|581498214|FG000|Overall Study|Withdrawal by Subject|6|||
161029501|NCT04580914|581498214|FG000|Overall Study|Lost to Follow-up|2|||
161029502|NCT02828358|581498218|FG000|Overall Study|Physician Decision|7|||
161029503|NCT02828358|581498219|FG001|Overall Study|Physician Decision|1|||
161029504|NCT02828358|581498218|FG000|Overall Study|Treatment Failure|6|||
161029505|NCT02828358|581498219|FG001|Overall Study|Treatment Failure|0|||
161029506|NCT02828358|581498218|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
161029507|NCT02828358|581498219|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
161029508|NCT02828358|581498218|FG000|Overall Study|Refusal of further protocol therapy|2|||
161029509|NCT02828358|581498219|FG001|Overall Study|Refusal of further protocol therapy|0|||
161029510|NCT02828358|581498218|FG000|Overall Study|Relapse|25|||
161029511|NCT02828358|581498219|FG001|Overall Study|Relapse|0|||
161029512|NCT02828358|581498218|FG000|Overall Study|Still on therapy|5|||
161029513|NCT02828358|581498219|FG001|Overall Study|Still on therapy|0|||
161029514|NCT03993392|581498233|FG000|Overall Study|Withdrawal by Subject|3|||
161029515|NCT03993392|581498233|FG000|Overall Study|Lost to Follow-up|2|||
161029516|NCT03993392|581498233|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
161029517|NCT05292391|581498236|FG000|Overall Study|Lost to Follow-up|0|||
161029518|NCT05292391|581498237|FG001|Overall Study|Lost to Follow-up|0|||
161029519|NCT05292391|581498238|FG002|Overall Study|Lost to Follow-up|0|||
161029520|NCT05292391|581498239|FG003|Overall Study|Lost to Follow-up|1|||
161029521|NCT05292391|581498240|FG004|Overall Study|Lost to Follow-up|0|||
161029522|NCT04857723|581498243|FG000|Overall Study|Withdrawal by Subject|2|||
161029523|NCT06262477|581500014|FG000|Overall Study|Withdrawal by Subject|1|||
161029524|NCT06262477|581500015|FG001|Overall Study|Withdrawal by Subject|0|||
161029525|NCT06262477|581500014|FG000|Overall Study|Adverse Event|0|||
161029526|NCT06262477|581500015|FG001|Overall Study|Adverse Event|1|||
161029527|NCT06262477|581500014|FG000|Overall Study|Lost to Follow-up|0|||
161029528|NCT06262477|581500015|FG001|Overall Study|Lost to Follow-up|1|||
161029529|NCT01064440|581500016|FG000|Overall Study|Lost to Follow-up|1|||
161029530|NCT01064440|581500017|FG001|Overall Study|Lost to Follow-up|1|||
161029531|NCT01064440|581500018|FG002|Overall Study|Lost to Follow-up|1|||
161029532|NCT01064440|581500016|FG000|Overall Study|Non-compliance|0|||
161029533|NCT01064440|581500017|FG001|Overall Study|Non-compliance|1|||
161029534|NCT01064440|581500018|FG002|Overall Study|Non-compliance|0|||
161276761|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
161029535|NCT01064440|581500016|FG000|Overall Study|Death|1|||
161029536|NCT01064440|581500017|FG001|Overall Study|Death|0|||
161029537|NCT01064440|581500018|FG002|Overall Study|Death|1|||
161029538|NCT01064440|581500016|FG000|Overall Study|Withdrawal by Subject|0|||
161029539|NCT01064440|581500017|FG001|Overall Study|Withdrawal by Subject|1|||
161029540|NCT01064440|581500018|FG002|Overall Study|Withdrawal by Subject|1|||
161029541|NCT01064440|581500016|FG000|Overall Study|Other: amputation|1|||
161029542|NCT01064440|581500017|FG001|Overall Study|Other: amputation|0|||
161029543|NCT01064440|581500018|FG002|Overall Study|Other: amputation|0|||
161029544|NCT03220035|581500022|FG000|Overall Study|Adverse Event|1|||
161029545|NCT03220035|581500022|FG000|Overall Study|Protocol Violation|1|||
161029546|NCT03220035|581500022|FG000|Overall Study|Progressive Disease|2|||
161029547|NCT04024020|581500025|FG000|Overall Study|Withdrawal by Subject|2|||
161029548|NCT04024020|581500026|FG001|Overall Study|Withdrawal by Subject|2|||
161029549|NCT05618587|581500039|FG000|Overall Study|Lost to Follow-up|2|||
161029550|NCT05618587|581500040|FG001|Overall Study|Lost to Follow-up|0|||
161029551|NCT01828112|581500043|FG000|Treatment Phase|Adverse Event|7|||
161029552|NCT01828112|581500044|FG001|Treatment Phase|Adverse Event|8|||
161029553|NCT01828112|581500045|FG002|Treatment Phase|Adverse Event|0|||
161029554|NCT01828112|581500043|FG000|Treatment Phase|Death|9|||
161029555|NCT01828112|581500044|FG001|Treatment Phase|Death|5|||
161029556|NCT01828112|581500045|FG002|Treatment Phase|Death|0|||
161029557|NCT01828112|581500043|FG000|Treatment Phase|No longer required treatment|0|||
161029558|NCT01828112|581500044|FG001|Treatment Phase|No longer required treatment|1|||
161029559|NCT01828112|581500045|FG002|Treatment Phase|No longer required treatment|0|||
161029560|NCT01828112|581500043|FG000|Treatment Phase|Physician Decision|6|||
161029561|NCT01828112|581500044|FG001|Treatment Phase|Physician Decision|7|||
161029562|NCT01828112|581500045|FG002|Treatment Phase|Physician Decision|0|||
161029563|NCT01828112|581500043|FG000|Treatment Phase|Pregnancy|1|||
161029564|NCT01828112|581500044|FG001|Treatment Phase|Pregnancy|0|||
161029565|NCT01828112|581500045|FG002|Treatment Phase|Pregnancy|0|||
161029566|NCT01828112|581500043|FG000|Treatment Phase|Progressive disease|79|||
161029567|NCT01828112|581500044|FG001|Treatment Phase|Progressive disease|87|||
161029568|NCT01828112|581500045|FG002|Treatment Phase|Progressive disease|0|||
161029569|NCT01828112|581500043|FG000|Treatment Phase|Study terminated by sponsor|1|||
161029570|NCT01828112|581500044|FG001|Treatment Phase|Study terminated by sponsor|0|||
161029571|NCT01828112|581500045|FG002|Treatment Phase|Study terminated by sponsor|0|||
161029572|NCT01828112|581500043|FG000|Treatment Phase|Subject/guardian decision|12|||
161276762|NCT03888066|582393305|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
161276763|NCT03888066|582393306|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
161276764|NCT03278626|582393307|FG000|Overall Study|Death|2|||
161276765|NCT03278626|582393307|FG000|Overall Study|Toxicity|1|||
161276766|NCT03278626|582393307|FG000|Overall Study|Disease Progression|2|||
161276767|NCT02856555|582393309|FG000|Overall Study|Adverse Event|1|||
161276768|NCT02856555|582393310|FG001|Overall Study|Adverse Event|0|||
161276769|NCT02856555|582393311|FG002|Overall Study|Adverse Event|0|||
161276770|NCT02856555|582393309|FG000|Overall Study|Lost to Follow-up|1|||
161276771|NCT02856555|582393310|FG001|Overall Study|Lost to Follow-up|3|||
161276772|NCT02856555|582393311|FG002|Overall Study|Lost to Follow-up|0|||
161276773|NCT02856555|582393309|FG000|Overall Study|Withdrawal by Subject|3|||
161276774|NCT02856555|582393310|FG001|Overall Study|Withdrawal by Subject|0|||
161276775|NCT02856555|582393311|FG002|Overall Study|Withdrawal by Subject|0|||
161276776|NCT02856555|582393309|FG000|Overall Study|Randomized but Never Treated|0|||
161276777|NCT02856555|582393310|FG001|Overall Study|Randomized but Never Treated|1|||
161276778|NCT02856555|582393311|FG002|Overall Study|Randomized but Never Treated|0|||
161276779|NCT03333941|582393312|FG000|Overall Study|Lost to Follow-up|10|||
161276780|NCT03333941|582393312|FG000|Overall Study|Death|2|||
161276781|NCT03333941|582393312|FG000|Overall Study|Adverse Event|1|||
161276782|NCT02077140|582393313|FG000|Overall Study|Lost to Follow-up|4|||
161276783|NCT02077140|582393314|FG001|Overall Study|Lost to Follow-up|1|||
161276784|NCT02077140|582393315|FG002|Overall Study|Lost to Follow-up|2|||
161276785|NCT02077140|582393316|FG003|Overall Study|Lost to Follow-up|2|||
161276786|NCT02077140|582393317|FG004|Overall Study|Lost to Follow-up|3|||
161276787|NCT02077140|582393313|FG000|Overall Study|Withdrawal by Subject|0|||
161276788|NCT02077140|582393314|FG001|Overall Study|Withdrawal by Subject|1|||
161276789|NCT02077140|582393315|FG002|Overall Study|Withdrawal by Subject|0|||
161276790|NCT02077140|582393316|FG003|Overall Study|Withdrawal by Subject|2|||
161276791|NCT02077140|582393317|FG004|Overall Study|Withdrawal by Subject|2|||
161276792|NCT00974922|582393318|FG000|Overall Study|study terminated|24|||
161276793|NCT01762800|582393320|FG000|Overall Study|Adverse Event|8|||
161276794|NCT01762800|582393321|FG001|Overall Study|Adverse Event|13|||
161276795|NCT01762800|582393320|FG000|Overall Study|Lack of Efficacy|3|||
161276796|NCT01762800|582393321|FG001|Overall Study|Lack of Efficacy|2|||
161276797|NCT01762800|582393320|FG000|Overall Study|Study Closed/Terminated|0|||
161276798|NCT01762800|582393321|FG001|Overall Study|Study Closed/Terminated|1|||
161276799|NCT01762800|582393320|FG000|Overall Study|Physician Decision|1|||
161276800|NCT01762800|582393321|FG001|Overall Study|Physician Decision|1|||
161276801|NCT01762800|582393320|FG000|Overall Study|Withdrawal by Subject|7|||
161029573|NCT01828112|581500044|FG001|Treatment Phase|Subject/guardian decision|8|||
161029574|NCT01828112|581500045|FG002|Treatment Phase|Subject/guardian decision|0|||
161029575|NCT01828112|581500043|FG000|Extension Treatment Phase|Adverse Event|0|||
161029576|NCT01828112|581500044|FG001|Extension Treatment Phase|Adverse Event|0|||
161029577|NCT01828112|581500045|FG002|Extension Treatment Phase|Adverse Event|6|||
161029578|NCT01828112|581500043|FG000|Extension Treatment Phase|Death|0|||
161276802|NCT01762800|582393321|FG001|Overall Study|Withdrawal by Subject|4|||
161276803|NCT02640482|582393322|FG000|Overall Study|Lost to Follow-up|3|||
161276804|NCT02640482|582393323|FG001|Overall Study|Lost to Follow-up|0|||
161029579|NCT01828112|581500044|FG001|Extension Treatment Phase|Death|0|||
161029580|NCT01828112|581500045|FG002|Extension Treatment Phase|Death|17|||
161029581|NCT01828112|581500043|FG000|Extension Treatment Phase|Physician Decision|0|||
161029582|NCT01828112|581500044|FG001|Extension Treatment Phase|Physician Decision|0|||
161029583|NCT01828112|581500045|FG002|Extension Treatment Phase|Physician Decision|5|||
161029584|NCT01828112|581500043|FG000|Extension Treatment Phase|Progressive disease|0|||
161029585|NCT01828112|581500044|FG001|Extension Treatment Phase|Progressive disease|0|||
161029586|NCT01828112|581500045|FG002|Extension Treatment Phase|Progressive disease|46|||
161029587|NCT01828112|581500043|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
161029588|NCT01828112|581500044|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
161029589|NCT01828112|581500045|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
161029590|NCT01828112|581500043|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
161029591|NCT01828112|581500044|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
161029592|NCT01828112|581500045|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
161029593|NCT05565820|581500046|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
161029594|NCT05565820|581500047|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
161029595|NCT05565820|581500046|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
161029596|NCT05565820|581500047|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
161029597|NCT04871529|581500051|FG000|Overall Study|Withdrawal by Subject|0|||
161029598|NCT04871529|581500052|FG001|Overall Study|Withdrawal by Subject|1|||
161029599|NCT04871529|581500051|FG000|Overall Study|Death|0|||
161029600|NCT04871529|581500052|FG001|Overall Study|Death|1|||
161029601|NCT04871529|581500051|FG000|Overall Study|Not protocol specified|0|||
161029602|NCT04871529|581500052|FG001|Overall Study|Not protocol specified|1|||
161029603|NCT05184452|581500053|FG000|Overall Study|Lost to Follow-up|0|||
161029604|NCT05184452|581500054|FG001|Overall Study|Lost to Follow-up|0|||
161029605|NCT05184452|581500055|FG002|Overall Study|Lost to Follow-up|0|||
161029606|NCT05184452|581500056|FG003|Overall Study|Lost to Follow-up|0|||
161029607|NCT05184452|581500057|FG004|Overall Study|Lost to Follow-up|0|||
161029608|NCT05184452|581500058|FG005|Overall Study|Lost to Follow-up|2|||
161029609|NCT05184452|581500059|FG006|Overall Study|Lost to Follow-up|0|||
161029610|NCT05184452|581500060|FG007|Overall Study|Lost to Follow-up|0|||
161029611|NCT05184452|581500061|FG008|Overall Study|Lost to Follow-up|0|||
161029612|NCT05184452|581500062|FG009|Overall Study|Lost to Follow-up|1|||
161029613|NCT05184452|581500053|FG000|Overall Study|Withdrawal by Subject|0|||
161029614|NCT05184452|581500054|FG001|Overall Study|Withdrawal by Subject|0|||
161029615|NCT05184452|581500055|FG002|Overall Study|Withdrawal by Subject|0|||
161029616|NCT05184452|581500056|FG003|Overall Study|Withdrawal by Subject|0|||
161029617|NCT05184452|581500057|FG004|Overall Study|Withdrawal by Subject|0|||
161029618|NCT05184452|581500058|FG005|Overall Study|Withdrawal by Subject|1|||
161029619|NCT05184452|581500059|FG006|Overall Study|Withdrawal by Subject|0|||
161029620|NCT05184452|581500060|FG007|Overall Study|Withdrawal by Subject|0|||
161029621|NCT05184452|581500061|FG008|Overall Study|Withdrawal by Subject|0|||
161029622|NCT05184452|581500062|FG009|Overall Study|Withdrawal by Subject|1|||
161029623|NCT05586490|581500063|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161029624|NCT05586490|581500064|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161029625|NCT05586490|581500065|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
161029626|NCT05586490|581500066|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161029627|NCT05586490|581500067|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
161029628|NCT05586490|581500063|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
161029629|NCT05586490|581500064|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161029630|NCT05586490|581500065|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161029631|NCT05586490|581500066|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161029632|NCT05586490|581500067|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
161029633|NCT05586490|581500063|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
161029634|NCT05586490|581500064|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161029635|NCT05586490|581500065|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161029636|NCT05586490|581500066|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161029637|NCT05586490|581500067|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
161029638|NCT05873556|581500068|FG000|Overall Study|Lost to Follow-up|4|||
161029639|NCT05873556|581500069|FG001|Overall Study|Lost to Follow-up|1|||
161029640|NCT03606408|581500071|FG000|Overall Study|Adverse Event|13|||
161029641|NCT03606408|581500071|FG000|Overall Study|Withdrawal by Subject|7|||
161029642|NCT03606408|581500071|FG000|Overall Study|Physician Decision|4|||
161276805|NCT00113763|582393324|FG000|Overall Study|Adverse Event|5|||
161276806|NCT00113763|582393325|FG001|Overall Study|Adverse Event|2|||
161029643|NCT03606408|581500071|FG000|Overall Study|Lack of Efficacy|2|||
161029644|NCT03606408|581500071|FG000|Overall Study|Death|1|||
161029645|NCT03606408|581500071|FG000|Overall Study|new therapy for study indication|1|||
161029646|NCT04689256|581500072|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
161276807|NCT00113763|582393324|FG000|Overall Study|Disease Progression|28|||
161276808|NCT00113763|582393325|FG001|Overall Study|Disease Progression|14|||
161029647|NCT04689256|581500073|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
161276809|NCT00113763|582393324|FG000|Overall Study|Lost to Follow-up|10|||
161276810|NCT00113763|582393325|FG001|Overall Study|Lost to Follow-up|0|||
161276811|NCT00113763|582393324|FG000|Overall Study|Withdrawal by Subject|1|||
161276812|NCT00113763|582393325|FG001|Overall Study|Withdrawal by Subject|4|||
161276813|NCT00113763|582393324|FG000|Overall Study|Other|27|||
161276814|NCT00113763|582393325|FG001|Overall Study|Other|6|||
161276815|NCT00113763|582393324|FG000|Overall Study|Non-compliance|1|||
161276816|NCT00113763|582393325|FG001|Overall Study|Non-compliance|0|||
161276817|NCT00113763|582393324|FG000|Overall Study|Ongoing|1|||
161276818|NCT00113763|582393325|FG001|Overall Study|Ongoing|0|||
161276819|NCT00517881|582393326|FG000|Overall Study|Protocol Violation|2|||
161276820|NCT00517881|582393326|FG000|Overall Study|Adverse Event|1|||
161276821|NCT00517881|582393326|FG000|Overall Study|Renal transplantation|2|||
161276822|NCT03743415|582393327|FG000|Overall Study|Death|5|||
161276823|NCT03743415|582393328|FG001|Overall Study|Death|3|||
161276824|NCT03743415|582393329|FG002|Overall Study|Death|1|||
161276825|NCT03743415|582393330|FG003|Overall Study|Death|4|||
161276826|NCT03743415|582393331|FG004|Overall Study|Death|0|||
161276827|NCT03743415|582393332|FG005|Overall Study|Death|0|||
161276828|NCT03743415|582393333|FG006|Overall Study|Death|0|||
161276829|NCT03743415|582393334|FG007|Overall Study|Death|0|||
161276830|NCT03743415|582393335|FG008|Overall Study|Death|1|||
161276831|NCT03743415|582393336|FG009|Overall Study|Death|0|||
161276832|NCT03743415|582393327|FG000|Overall Study|Withdrawal by Subject|1|||
161276833|NCT03743415|582393328|FG001|Overall Study|Withdrawal by Subject|0|||
161276834|NCT03743415|582393329|FG002|Overall Study|Withdrawal by Subject|4|||
161276835|NCT03743415|582393330|FG003|Overall Study|Withdrawal by Subject|5|||
161276836|NCT03743415|582393331|FG004|Overall Study|Withdrawal by Subject|5|||
161029648|NCT04862234|581500076|FG000|Overall Study|Surgery cancellation|1|||
161029649|NCT04862234|581500077|FG001|Overall Study|Surgery cancellation|2|||
161029650|NCT04862234|581500076|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
161029651|NCT04862234|581500077|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
161029652|NCT04862234|581500076|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
161029653|NCT04862234|581500077|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
161029654|NCT05828017|581500086|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
161029655|NCT05012163|581500090|FG000|Overall Study|Protocol Violation|0|||
161029656|NCT05012163|581500091|FG001|Overall Study|Protocol Violation|0|||
161029657|NCT05012163|581500092|FG002|Overall Study|Protocol Violation|1|||
161029658|NCT05012163|581500093|FG003|Overall Study|Protocol Violation|1|||
161029659|NCT04132518|581500101|FG000|Overall Study|Prematurely withdrawn from the study|0|||
161029660|NCT04132518|581500102|FG001|Overall Study|Prematurely withdrawn from the study|9|||
161029661|NCT04132518|581500103|FG002|Overall Study|Prematurely withdrawn from the study|1|||
161029662|NCT03381586|581500104|FG000|Overall Study|Adverse Event|1|||
161029663|NCT03381586|581500105|FG001|Overall Study|Adverse Event|1|||
161029664|NCT03381586|581500104|FG000|Overall Study|Protocol Violation|1|||
161029665|NCT03381586|581500105|FG001|Overall Study|Protocol Violation|0|||
161029666|NCT03381586|581500104|FG000|Overall Study|Withdrawal by Subject|1|||
161029667|NCT03381586|581500105|FG001|Overall Study|Withdrawal by Subject|2|||
161029668|NCT03673501|581500108|FG000|Overall Study|Participants ongoing.|36|||
161029669|NCT03673501|581500109|FG001|Overall Study|Participants ongoing.|24|||
161029670|NCT05838027|581500110|FG000|Overall Study|Lost to Follow-up|5|||
161029671|NCT05838027|581500111|FG001|Overall Study|Lost to Follow-up|1|||
161029672|NCT05838027|581500110|FG000|Overall Study|Withdrawal by Subject|1|||
161029673|NCT05838027|581500111|FG001|Overall Study|Withdrawal by Subject|0|||
161029674|NCT05237284|581500112|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
161029675|NCT05237284|581500113|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
161029676|NCT05237284|581500114|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
161029677|NCT05237284|581500115|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
161029678|NCT05237284|581500112|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
161029679|NCT05237284|581500113|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
161029680|NCT05237284|581500114|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
161029681|NCT05237284|581500115|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
161029682|NCT05237284|581500112|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
161029683|NCT05237284|581500113|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
161029684|NCT05237284|581500114|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
161029685|NCT05237284|581500115|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
161276837|NCT03743415|582393332|FG005|Overall Study|Withdrawal by Subject|2|||
161276838|NCT03743415|582393333|FG006|Overall Study|Withdrawal by Subject|2|||
161276839|NCT03743415|582393334|FG007|Overall Study|Withdrawal by Subject|5|||
161276840|NCT03743415|582393335|FG008|Overall Study|Withdrawal by Subject|9|||
161276841|NCT03743415|582393336|FG009|Overall Study|Withdrawal by Subject|10|||
161276842|NCT03743415|582393327|FG000|Overall Study|Lost to Follow-up|2|||
161276843|NCT03743415|582393328|FG001|Overall Study|Lost to Follow-up|0|||
161029686|NCT05237284|581500112|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
161029687|NCT05237284|581500113|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
161029688|NCT05237284|581500114|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
161029689|NCT05237284|581500115|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
161029690|NCT05237284|581500112|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
161029691|NCT05237284|581500113|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
161029692|NCT05237284|581500114|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
161029693|NCT05237284|581500115|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
161029694|NCT05237284|581500112|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
161029695|NCT05237284|581500113|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
161029696|NCT05237284|581500114|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
161029697|NCT05237284|581500115|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
161029698|NCT05237284|581500112|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
161029699|NCT05237284|581500113|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
161029700|NCT05237284|581500114|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
161029701|NCT05237284|581500115|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
161029702|NCT05237284|581500112|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
161029703|NCT05237284|581500113|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
161029704|NCT05237284|581500114|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
161029705|NCT05237284|581500115|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
161029706|NCT05237284|581500112|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
161029707|NCT05237284|581500113|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
161029708|NCT05237284|581500114|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
161029709|NCT05237284|581500115|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
161029710|NCT04599634|581500116|FG000|Overall Study|Dose limiting toxicity|0|||
161029711|NCT04599634|581500117|FG001|Overall Study|Dose limiting toxicity|0|||
161029712|NCT04599634|581500118|FG002|Overall Study|Dose limiting toxicity|2|||
161029713|NCT04599634|581500119|FG003|Overall Study|Dose limiting toxicity|0|||
161029714|NCT03714815|581500120|FG000|Overall Study|Physician Decision|2|||
161029715|NCT03714815|581500120|FG000|Overall Study|Withdrawal by Subject|2|||
161029716|NCT03714815|581500120|FG000|Overall Study|Death|11|||
161029717|NCT04056611|581500128|FG000|Overall Study|Physician Decision|1|||
161029718|NCT03733925|581500129|FG000|Overall Study|Lost to Follow-up|1|||
161029719|NCT03733925|581500129|FG000|Overall Study|Withdrawal by Subject|2|||
161029720|NCT03733925|581500129|FG000|Overall Study|Adverse Event|2|||
161029721|NCT03733925|581500129|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161029722|NCT03213873|581500130|FG000|Overall Study|Withdrawal by Subject|8|||
161029723|NCT03213873|581500131|FG001|Overall Study|Withdrawal by Subject|9|||
161029724|NCT03213873|581500130|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
161029725|NCT03213873|581500131|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
161029726|NCT03213873|581500130|FG000|Overall Study|Lost to Follow-up|0|||
161029727|NCT03213873|581500131|FG001|Overall Study|Lost to Follow-up|2|||
161029728|NCT05683340|581500133|FG000|Overall Study|Adverse Event|1|||
161029729|NCT05683340|581500134|FG001|Overall Study|Adverse Event|1|||
161029730|NCT05683340|581500133|FG000|Overall Study|Protocol Violation|1|||
161029731|NCT05683340|581500134|FG001|Overall Study|Protocol Violation|0|||
161029732|NCT05683340|581500133|FG000|Overall Study|Withdrawal by Subject|0|||
161029733|NCT05683340|581500134|FG001|Overall Study|Withdrawal by Subject|2|||
161029734|NCT02224144|581500138|FG000|Overall Study|Lost to Follow-up|3|||
161029735|NCT02224144|581500139|FG001|Overall Study|Lost to Follow-up|1|||
161029736|NCT02224144|581500138|FG000|Overall Study|Death|2|||
161029737|NCT02224144|581500139|FG001|Overall Study|Death|0|||
161029738|NCT02224144|581500138|FG000|Overall Study|Withdrawal by Subject|0|||
161029739|NCT02224144|581500139|FG001|Overall Study|Withdrawal by Subject|1|||
161029740|NCT02780700|581500142|FG000|Overall Study|Progressive disease|1|||
161029741|NCT03824366|581500157|FG000|Overall Study|Death|1|||
161029742|NCT03824366|581500157|FG000|Overall Study|Previously unidentified metal artifact|1|||
161029743|NCT03824366|581500157|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
161029744|NCT03824366|581500157|FG000|Overall Study|Withdrawal by Subject|1|||
161029745|NCT05533190|581500163|FG000|Overall Study|Lost to Follow-up|19|||
161029746|NCT05533190|581500164|FG001|Overall Study|Lost to Follow-up|7|||
161029747|NCT05533190|581500163|FG000|Overall Study|Failed to download app|1|||
161029748|NCT05533190|581500164|FG001|Overall Study|Failed to download app|0|||
161029749|NCT05533190|581500163|FG000|Overall Study|Thought app was a scam|1|||
161029750|NCT05533190|581500164|FG001|Overall Study|Thought app was a scam|0|||
161029751|NCT05533190|581500163|FG000|Overall Study|Withdrawal by Subject|2|||
161029752|NCT05533190|581500164|FG001|Overall Study|Withdrawal by Subject|0|||
161029753|NCT01199133|581500171|FG000|Year 1|Adverse Event|16|||
161029754|NCT01199133|581500172|FG001|Year 1|Adverse Event|4|||
161029755|NCT01199133|581500171|FG000|Year 1|Withdrawal by Subject|8|||
161029756|NCT01199133|581500172|FG001|Year 1|Withdrawal by Subject|4|||
161029757|NCT01199133|581500171|FG000|Year 1|Any other reason not above-mentioned|6|||
161029758|NCT01199133|581500172|FG001|Year 1|Any other reason not above-mentioned|7|||
161029759|NCT01199133|581500171|FG000|Year 2|Adverse Event|1|||
161029760|NCT01199133|581500172|FG001|Year 2|Adverse Event|0|||
161029761|NCT01199133|581500171|FG000|Year 2|Withdrawal by Subject|1|||
161029762|NCT01199133|581500172|FG001|Year 2|Withdrawal by Subject|1|||
161029763|NCT01199133|581500171|FG000|Year 2|Any other reason not above-mentioned|1|||
161029764|NCT01199133|581500172|FG001|Year 2|Any other reason not above-mentioned|2|||
161029765|NCT02575950|581500173|FG000|Overall Study|Withdrawal by Subject|0|||
161029766|NCT02575950|581500174|FG001|Overall Study|Withdrawal by Subject|0|||
161029767|NCT02575950|581500175|FG002|Overall Study|Withdrawal by Subject|0|||
161029768|NCT02575950|581500176|FG003|Overall Study|Withdrawal by Subject|2|||
161029769|NCT02575950|581500173|FG000|Overall Study|Lost to Follow-up|0|||
161029770|NCT02575950|581500174|FG001|Overall Study|Lost to Follow-up|1|||
161029771|NCT02575950|581500175|FG002|Overall Study|Lost to Follow-up|0|||
161029772|NCT02575950|581500176|FG003|Overall Study|Lost to Follow-up|3|||
161029773|NCT02446236|581501467|FG000|Overall Study|Screen Failure|1|||
161029774|NCT02446236|581501468|FG001|Overall Study|Screen Failure|0|||
161029775|NCT02446236|581501469|FG002|Overall Study|Screen Failure|1|||
161029776|NCT02446236|581501467|FG000|Overall Study|Actively Receiving Therapy|0|||
161029777|NCT02446236|581501468|FG001|Overall Study|Actively Receiving Therapy|0|||
161029778|NCT02446236|581501469|FG002|Overall Study|Actively Receiving Therapy|1|||
161029779|NCT04136912|581501472|FG000|Overall Study|Operational reasons|0|||
161029780|NCT04136912|581501473|FG001|Overall Study|Operational reasons|0|||
161029781|NCT04136912|581501474|FG002|Overall Study|Operational reasons|2|||
161029782|NCT03556293|581501475|FG000|Overall Study|Ineligible for analysis|1904|||
161029783|NCT03556293|581501476|FG001|Overall Study|Ineligible for analysis|1471|||
161029784|NCT03556293|581501477|FG002|Overall Study|Ineligible for analysis|1091|||
161029785|NCT03556293|581501478|FG003|Overall Study|Ineligible for analysis|1269|||
161029786|NCT03292484|581501484|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
161029787|NCT03292484|581501484|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
161029788|NCT03292484|581501484|FG000|Overall Study|Protocol Violation|2|||
161029789|NCT03292484|581501484|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
161029790|NCT03292484|581501484|FG000|Overall Study|Sponsor decision|349|||
161029791|NCT03292484|581501484|FG000|Overall Study|Lost to Follow-up|7|||
161029792|NCT03292484|581501484|FG000|Overall Study|Coronavirus Disease 2019|1|||
161029793|NCT03292484|581501484|FG000|Overall Study|Other|20|||
161029794|NCT05290493|581501485|FG000|Overall Study|Withdrawal by Subject|2|||
161029795|NCT05290493|581501486|FG001|Overall Study|Withdrawal by Subject|2|||
161029796|NCT05290493|581501485|FG000|Overall Study|Adverse Event|1|||
161029797|NCT05290493|581501486|FG001|Overall Study|Adverse Event|0|||
161029798|NCT05524402|581501489|FG000|Overall Study|Withdrawal by Subject|3|||
161029799|NCT05524402|581501490|FG001|Overall Study|Withdrawal by Subject|1|||
161029800|NCT05524402|581501489|FG000|Overall Study|Lost to Follow-up|2|||
161029801|NCT05524402|581501490|FG001|Overall Study|Lost to Follow-up|1|||
161276844|NCT03743415|582393329|FG002|Overall Study|Lost to Follow-up|2|||
161276845|NCT03743415|582393330|FG003|Overall Study|Lost to Follow-up|1|||
160975291|NCT00451217|581299285|FG001|Overall Study|Not Treated|1|||
160975292|NCT00451217|581299286|FG002|Overall Study|Not Treated|3|||
160975293|NCT00451217|581299287|FG003|Overall Study|Not Treated|4|||
160975294|NCT03066622|581299288|FG000|Overall Study|Lost to Follow-up|24|||
160975295|NCT03066622|581299289|FG001|Overall Study|Lost to Follow-up|25|||
160975296|NCT03066622|581299288|FG000|Overall Study|Withdrawal by Subject|2|||
160975297|NCT03066622|581299289|FG001|Overall Study|Withdrawal by Subject|1|||
160975298|NCT00641719|581299290|FG000|Overall Study|Lack of Efficacy|1|||
160975299|NCT00641719|581299291|FG001|Overall Study|Lack of Efficacy|2|||
160975300|NCT00641719|581299290|FG000|Overall Study|Adverse Event|24|||
160975301|NCT00641719|581299291|FG001|Overall Study|Adverse Event|29|||
160975302|NCT00641719|581299290|FG000|Overall Study|Withdrawal by Subject|4|||
160975303|NCT00641719|581299291|FG001|Overall Study|Withdrawal by Subject|4|||
160975304|NCT00641719|581299290|FG000|Overall Study|Reason Not Specified|1|||
160975305|NCT00641719|581299291|FG001|Overall Study|Reason Not Specified|2|||
160975306|NCT03321006|581299292|FG000|Overall Study|Death|1|||
160975307|NCT03321006|581299293|FG001|Overall Study|Death|0|||
160975308|NCT03321006|581299292|FG000|Overall Study|Lack of Efficacy|1|||
160975309|NCT03321006|581299293|FG001|Overall Study|Lack of Efficacy|0|||
160975310|NCT00885352|581299296|FG000|Overall Study|Adverse Event|2|||
160975311|NCT00885352|581299297|FG001|Overall Study|Adverse Event|3|||
160975312|NCT00885352|581299296|FG000|Overall Study|Lost to Follow-up|2|||
160975313|NCT00885352|581299297|FG001|Overall Study|Lost to Follow-up|2|||
160975314|NCT00885352|581299296|FG000|Overall Study|Physician Decision|0|||
160975315|NCT00885352|581299297|FG001|Overall Study|Physician Decision|3|||
160975316|NCT00885352|581299296|FG000|Overall Study|Protocol Violation|0|||
160975317|NCT00885352|581299297|FG001|Overall Study|Protocol Violation|2|||
161029802|NCT05976334|581501491|FG000|Part B|Death|0|||
161029803|NCT05976334|581501492|FG001|Part B|Death|1|||
161029804|NCT05976334|581501491|FG000|Part B|Study Terminated by Sponsor|0|||
161276846|NCT03743415|582393331|FG004|Overall Study|Lost to Follow-up|1|||
160975318|NCT00885352|581299296|FG000|Overall Study|Withdrawal by Subject|1|||
160975319|NCT00885352|581299297|FG001|Overall Study|Withdrawal by Subject|5|||
161029805|NCT05976334|581501492|FG001|Part B|Study Terminated by Sponsor|1|||
161029806|NCT05976334|581501491|FG000|Part B|Reason Not Specified|0|||
161029807|NCT05976334|581501492|FG001|Part B|Reason Not Specified|1|||
161029808|NCT05280574|581501498|FG000|Overall Study|Withdrawal by Subject|0|||
161029809|NCT05280574|581501499|FG001|Overall Study|Withdrawal by Subject|2|||
161029810|NCT05280574|581501500|FG002|Overall Study|Withdrawal by Subject|0|||
161029811|NCT05363163|581501501|FG000|Overall Study|Withdrawal by Subject|13|||
161029812|NCT04999111|581501505|FG000|Overall Study|Lost to Follow-up|21|||
161029813|NCT04999111|581501506|FG001|Overall Study|Lost to Follow-up|16|||
161029814|NCT04999111|581501507|FG002|Overall Study|Lost to Follow-up|2|||
161029815|NCT04999111|581501508|FG003|Overall Study|Lost to Follow-up|26|||
161029816|NCT04999111|581501509|FG004|Overall Study|Lost to Follow-up|30|||
161029817|NCT04999111|581501510|FG005|Overall Study|Lost to Follow-up|6|||
161029818|NCT04999111|581501505|FG000|Overall Study|Physician Decision|1|||
161276847|NCT03743415|582393332|FG005|Overall Study|Lost to Follow-up|0|||
160975320|NCT00885352|581299296|FG000|Overall Study|Contradiction to study medication|0|||
160975321|NCT00885352|581299297|FG001|Overall Study|Contradiction to study medication|2|||
160975322|NCT00885352|581299296|FG000|Overall Study|Excluded medication|2|||
160975323|NCT00885352|581299297|FG001|Overall Study|Excluded medication|2|||
160975324|NCT00885352|581299296|FG000|Overall Study|Lab abnormalities|1|||
160975325|NCT00885352|581299297|FG001|Overall Study|Lab abnormalities|1|||
160975326|NCT02006121|581299298|FG000|Double Blind Phase|Adverse Event|6|||
160975327|NCT02006121|581299299|FG001|Double Blind Phase|Adverse Event|0|||
160975328|NCT02006121|581299298|FG000|Double Blind Phase|Lack of Efficacy|1|||
160975329|NCT02006121|581299299|FG001|Double Blind Phase|Lack of Efficacy|16|||
160975330|NCT02006121|581299298|FG000|Double Blind Phase|Withdrawal by Subject|3|||
160975331|NCT02006121|581299299|FG001|Double Blind Phase|Withdrawal by Subject|4|||
160975332|NCT02006121|581299298|FG000|Double Blind Phase|Non-compliance with study drug|1|||
160975333|NCT02006121|581299299|FG001|Double Blind Phase|Non-compliance with study drug|3|||
160975334|NCT02006121|581299298|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
160975335|NCT02006121|581299299|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
160975336|NCT02006121|581299298|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
160975337|NCT02006121|581299299|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
160975338|NCT02006121|581299298|FG000|Open Label Phase|Adverse Event|15|||
160975339|NCT02006121|581299299|FG001|Open Label Phase|Adverse Event|0|||
160975340|NCT02006121|581299298|FG000|Open Label Phase|Lack of Efficacy|2|||
160975341|NCT02006121|581299299|FG001|Open Label Phase|Lack of Efficacy|0|||
160975342|NCT02006121|581299298|FG000|Open Label Phase|Protocol Violation|2|||
160975343|NCT02006121|581299299|FG001|Open Label Phase|Protocol Violation|0|||
160975344|NCT02006121|581299298|FG000|Open Label Phase|Withdrawal by Subject|3|||
160975345|NCT02006121|581299299|FG001|Open Label Phase|Withdrawal by Subject|0|||
160975346|NCT02006121|581299298|FG000|Open Label Phase|Non-compliance with study drug|3|||
160975347|NCT02006121|581299299|FG001|Open Label Phase|Non-compliance with study drug|0|||
160975348|NCT04498247|581299303|FG000|Overall Study|Lost to Follow-up|0|||
160975349|NCT04498247|581299304|FG001|Overall Study|Lost to Follow-up|0|||
160975350|NCT04498247|581299305|FG002|Overall Study|Lost to Follow-up|0|||
160975351|NCT04498247|581299306|FG003|Overall Study|Lost to Follow-up|1|||
160975352|NCT04498247|581299307|FG004|Overall Study|Lost to Follow-up|0|||
160975353|NCT04498247|581299308|FG005|Overall Study|Lost to Follow-up|0|||
160975354|NCT04498247|581299309|FG006|Overall Study|Lost to Follow-up|0|||
160975355|NCT04498247|581299310|FG007|Overall Study|Lost to Follow-up|0|||
160975356|NCT04498247|581299303|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
160975357|NCT04498247|581299304|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975358|NCT04498247|581299305|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975359|NCT04498247|581299306|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975360|NCT04498247|581299307|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975361|NCT04498247|581299308|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975362|NCT04498247|581299309|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975363|NCT04498247|581299310|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
160975364|NCT04498247|581299303|FG000|Overall Study|Withdrawal by Subject|0|||
160975365|NCT04498247|581299304|FG001|Overall Study|Withdrawal by Subject|8|||
160975366|NCT04498247|581299305|FG002|Overall Study|Withdrawal by Subject|0|||
160975367|NCT04498247|581299306|FG003|Overall Study|Withdrawal by Subject|7|||
160975368|NCT04498247|581299307|FG004|Overall Study|Withdrawal by Subject|0|||
160975369|NCT04498247|581299308|FG005|Overall Study|Withdrawal by Subject|0|||
160975370|NCT04498247|581299309|FG006|Overall Study|Withdrawal by Subject|1|||
160975371|NCT04498247|581299310|FG007|Overall Study|Withdrawal by Subject|0|||
160975372|NCT04498247|581299303|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975373|NCT04498247|581299304|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
160975374|NCT04498247|581299305|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975375|NCT04498247|581299306|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
160975376|NCT04498247|581299307|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975377|NCT04498247|581299308|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975378|NCT04498247|581299309|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
161029819|NCT04999111|581501506|FG001|Overall Study|Physician Decision|3|||
161276848|NCT03743415|582393333|FG006|Overall Study|Lost to Follow-up|1|||
161276849|NCT03743415|582393334|FG007|Overall Study|Lost to Follow-up|4|||
161276850|NCT03743415|582393335|FG008|Overall Study|Lost to Follow-up|13|||
161276851|NCT03743415|582393336|FG009|Overall Study|Lost to Follow-up|13|||
161276852|NCT01422187|582393337|FG000|Overall Study|Personal reason|1|||
161276853|NCT01422187|582393338|FG001|Overall Study|Personal reason|0|||
161276854|NCT01422187|582393339|FG002|Overall Study|Personal reason|0|||
161276855|NCT01422187|582393337|FG000|Overall Study|Lost to Follow-up|0|||
161276856|NCT01422187|582393338|FG001|Overall Study|Lost to Follow-up|1|||
161276857|NCT01422187|582393339|FG002|Overall Study|Lost to Follow-up|0|||
161276858|NCT00741286|582393343|FG000|Overall Study|Lost to Follow-up|15|||
161276859|NCT00741286|582393344|FG001|Overall Study|Lost to Follow-up|10|||
161276860|NCT00741286|582393343|FG000|Overall Study|Adverse Event|1|||
161276861|NCT00741286|582393344|FG001|Overall Study|Adverse Event|6|||
161276862|NCT00741286|582393343|FG000|Overall Study|Protocol Violation|3|||
161276863|NCT00741286|582393344|FG001|Overall Study|Protocol Violation|2|||
161276864|NCT00741286|582393343|FG000|Overall Study|Primary Outcome|1|||
161276865|NCT00741286|582393344|FG001|Overall Study|Primary Outcome|1|||
161276866|NCT00582010|582393348|FG000|Overall Study|Death|0|||
161276867|NCT00582010|582393349|FG001|Overall Study|Death|1|||
161276868|NCT05320887|582393352|FG000|Overall Study|Lost to Follow-up|0|||
161276869|NCT05320887|582393353|FG001|Overall Study|Lost to Follow-up|3|||
161276870|NCT05320887|582393354|FG002|Overall Study|Lost to Follow-up|0|||
161276871|NCT05320887|582393355|FG003|Overall Study|Lost to Follow-up|0|||
161276872|NCT02463357|582393356|FG000|Overall Study|Withdrawal by Subject|1|||
161276873|NCT02463357|582393357|FG001|Overall Study|Withdrawal by Subject|0|||
161276874|NCT02463357|582393358|FG002|Overall Study|Withdrawal by Subject|0|||
161276875|NCT02463357|582393359|FG003|Overall Study|Withdrawal by Subject|0|||
161276876|NCT02463357|582393360|FG004|Overall Study|Withdrawal by Subject|0|||
161276877|NCT02463357|582393356|FG000|Overall Study|Withdrawal by Subject|0|||
161276878|NCT02463357|582393357|FG001|Overall Study|Withdrawal by Subject|0|||
161276879|NCT02463357|582393358|FG002|Overall Study|Withdrawal by Subject|0|||
161276880|NCT02463357|582393359|FG003|Overall Study|Withdrawal by Subject|0|||
161276881|NCT02463357|582393360|FG004|Overall Study|Withdrawal by Subject|1|||
161276882|NCT00378573|582393362|FG000|Treatment Period|Adverse Event|9|||
161276883|NCT00378573|582393362|FG000|Treatment Period|Physician Decision|1|||
161276884|NCT00378573|582393362|FG000|Treatment Period|Withdrawal by Subject|2|||
161276885|NCT00378573|582393362|FG000|Treatment Period|Disease Progression|4|||
161276886|NCT00378573|582393362|FG000|Treatment Period|Sponsor decision to close study|1|||
161276887|NCT00378573|582393362|FG000|Follow-up|Death|12|||
161276888|NCT00378573|582393362|FG000|Follow-up|Lost to Follow-up|1|||
161276889|NCT00378573|582393362|FG000|Follow-up|Withdrawal by Subject|1|||
161276890|NCT00252239|582393368|FG000|Overall Study|Withdrawal by Subject|1|||
161276891|NCT00252239|582393369|FG001|Overall Study|Withdrawal by Subject|0|||
161276892|NCT00252239|582393370|FG002|Overall Study|Withdrawal by Subject|0|||
161276893|NCT00252239|582393371|FG003|Overall Study|Withdrawal by Subject|1|||
161276894|NCT00252239|582393368|FG000|Overall Study|Lost to Follow-up|0|||
161276895|NCT00252239|582393369|FG001|Overall Study|Lost to Follow-up|0|||
161276896|NCT00252239|582393370|FG002|Overall Study|Lost to Follow-up|2|||
161276897|NCT00252239|582393371|FG003|Overall Study|Lost to Follow-up|0|||
161276898|NCT02181790|582393376|FG000|Overall Study|study terminated|2|||
161276899|NCT02181790|582393377|FG001|Overall Study|study terminated|0|||
161276900|NCT03276078|582393378|FG000|Overall Study|Adverse Event|1|||
161276901|NCT02785952|582393379|FG000|Overall Study|Adverse Event|31|||
161276902|NCT02785952|582393380|FG001|Overall Study|Adverse Event|19|||
161276903|NCT02785952|582393379|FG000|Overall Study|Refusal unrelated to adverse events|10|||
161276904|NCT02785952|582393380|FG001|Overall Study|Refusal unrelated to adverse events|5|||
161276905|NCT02785952|582393379|FG000|Overall Study|Disease progression/relapse|61|||
161276906|NCT02785952|582393380|FG001|Overall Study|Disease progression/relapse|89|||
161276907|NCT02785952|582393379|FG000|Overall Study|Death|11|||
161276908|NCT02785952|582393380|FG001|Overall Study|Death|7|||
161276909|NCT02785952|582393379|FG000|Overall Study|Other- not protocol specified|6|||
161276910|NCT02785952|582393380|FG001|Overall Study|Other- not protocol specified|4|||
161276911|NCT02785952|582393379|FG000|Overall Study|On protocol treatment|6|||
161276912|NCT02785952|582393380|FG001|Overall Study|On protocol treatment|3|||
161276913|NCT00090363|582393381|FG000|Overall Study|Lost to Follow-up|1|||
161276914|NCT00090363|582393382|FG001|Overall Study|Lost to Follow-up|2|||
161276915|NCT00090363|582393383|FG002|Overall Study|Lost to Follow-up|1|||
161276916|NCT00090363|582393381|FG000|Overall Study|Withdrawal by Subject|7|||
161276917|NCT00090363|582393382|FG001|Overall Study|Withdrawal by Subject|7|||
161276918|NCT00090363|582393383|FG002|Overall Study|Withdrawal by Subject|6|||
161344364|NCT05032196|582646104|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161276919|NCT00090363|582393381|FG000|Overall Study|Study-specific discontinuation criteria|75|||
161276920|NCT00090363|582393382|FG001|Overall Study|Study-specific discontinuation criteria|74|||
161276921|NCT00090363|582393383|FG002|Overall Study|Study-specific discontinuation criteria|62|||
161276922|NCT00090363|582393381|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161276923|NCT00090363|582393382|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161344365|NCT05032196|582646105|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
161344366|NCT05032196|582646100|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161344367|NCT05032196|582646101|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161344368|NCT05032196|582646102|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161344369|NCT05032196|582646103|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
161344370|NCT05032196|582646104|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161344371|NCT05032196|582646105|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
161344372|NCT05032196|582646100|FG000|Period 2 (Multidose)|Physician Decision|0|||
161344373|NCT05032196|582646101|FG001|Period 2 (Multidose)|Physician Decision|0|||
161344374|NCT05032196|582646102|FG002|Period 2 (Multidose)|Physician Decision|0|||
161344375|NCT05032196|582646103|FG003|Period 2 (Multidose)|Physician Decision|0|||
161344376|NCT05032196|582646104|FG004|Period 2 (Multidose)|Physician Decision|1|||
161344377|NCT05032196|582646105|FG005|Period 2 (Multidose)|Physician Decision|0|||
161344378|NCT00857389|582646106|FG000|Overall Study|Did not proceed to transplant|2|||
161344379|NCT04338581|582647193|FG000|Overall Study|Lack of Efficacy|1|||
161344380|NCT04338581|582647194|FG001|Overall Study|Lack of Efficacy|0|||
161344381|NCT04338581|582647193|FG000|Overall Study|Withdrawal by Subject|4|||
161344382|NCT04338581|582647194|FG001|Overall Study|Withdrawal by Subject|4|||
161344383|NCT04338581|582647193|FG000|Overall Study|Prohibited Medication|1|||
161344384|NCT04338581|582647194|FG001|Overall Study|Prohibited Medication|0|||
161344385|NCT00460798|582647197|FG000|Overall Study|Death|59|||
161344386|NCT00460798|582647197|FG000|Overall Study|Adverse Event|27|||
161344387|NCT00460798|582647197|FG000|Overall Study|Lost to Follow-up|19|||
161344388|NCT00460798|582647197|FG000|Overall Study|Progressive Disease|99|||
161344389|NCT00460798|582647197|FG000|Overall Study|Other|27|||
161344390|NCT00460798|582647197|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
161344391|NCT00460798|582647197|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
161344392|NCT01369433|582647198|FG000|Overall Study|Adverse Event|31|||
161344393|NCT01369433|582647199|FG001|Overall Study|Adverse Event|1|||
161344394|NCT01369433|582647198|FG000|Overall Study|Required significant surgical procedure|1|||
161344395|NCT01369433|582647199|FG001|Overall Study|Required significant surgical procedure|0|||
161344396|NCT01369433|582647198|FG000|Overall Study|Non-compliance|1|||
161344397|NCT01369433|582647199|FG001|Overall Study|Non-compliance|0|||
161344398|NCT01369433|582647198|FG000|Overall Study|Withdrawal by Subject|5|||
161344399|NCT01369433|582647199|FG001|Overall Study|Withdrawal by Subject|2|||
161344400|NCT01369433|582647198|FG000|Overall Study|Study terminated by Sponsor|67|||
160975379|NCT04498247|581299310|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
160975380|NCT00669903|581299311|FG000|Overall Study|Adverse Event|0|||
160975381|NCT00669903|581299312|FG001|Overall Study|Adverse Event|1|||
160975382|NCT00669903|581299313|FG002|Overall Study|Adverse Event|3|||
160975383|NCT00669903|581299314|FG003|Overall Study|Adverse Event|1|||
160975384|NCT00669903|581299311|FG000|Overall Study|Withdrawal by Subject|0|||
160975385|NCT00669903|581299312|FG001|Overall Study|Withdrawal by Subject|2|||
160975386|NCT00669903|581299313|FG002|Overall Study|Withdrawal by Subject|2|||
160975387|NCT00669903|581299314|FG003|Overall Study|Withdrawal by Subject|2|||
160975388|NCT00669903|581299311|FG000|Overall Study|Lost to Follow-up|1|||
160975389|NCT00669903|581299312|FG001|Overall Study|Lost to Follow-up|1|||
160975390|NCT00669903|581299313|FG002|Overall Study|Lost to Follow-up|0|||
160975391|NCT00669903|581299314|FG003|Overall Study|Lost to Follow-up|1|||
160975392|NCT00669903|581299311|FG000|Overall Study|Protocol Violation|0|||
160975393|NCT00669903|581299312|FG001|Overall Study|Protocol Violation|1|||
160975394|NCT00669903|581299313|FG002|Overall Study|Protocol Violation|0|||
160975395|NCT00669903|581299314|FG003|Overall Study|Protocol Violation|0|||
160975396|NCT00251927|581299315|FG000|Overall Study|Adverse Event|3|||
160975397|NCT00251927|581299316|FG001|Overall Study|Adverse Event|15|||
160975398|NCT00251927|581299315|FG000|Overall Study|Lack of Efficacy|22|||
160975399|NCT00251927|581299316|FG001|Overall Study|Lack of Efficacy|16|||
160975400|NCT00251927|581299315|FG000|Overall Study|Lost to Follow-up|22|||
160975401|NCT00251927|581299316|FG001|Overall Study|Lost to Follow-up|8|||
160975402|NCT00251927|581299315|FG000|Overall Study|Protocol Violation|1|||
160975403|NCT00251927|581299316|FG001|Overall Study|Protocol Violation|2|||
160975404|NCT00251927|581299315|FG000|Overall Study|Pregnancy|2|||
160975405|NCT00251927|581299316|FG001|Overall Study|Pregnancy|0|||
160975406|NCT00251927|581299315|FG000|Overall Study|Withdrawal by Subject|40|||
160975407|NCT00251927|581299316|FG001|Overall Study|Withdrawal by Subject|25|||
160975408|NCT00251927|581299315|FG000|Overall Study|Study-specific discont. achieved|13|||
160975409|NCT00251927|581299316|FG001|Overall Study|Study-specific discont. achieved|2|||
160975410|NCT00251927|581299315|FG000|Overall Study|Study procedure non-compliance|5|||
160975411|NCT00251927|581299316|FG001|Overall Study|Study procedure non-compliance|6|||
160975412|NCT01678820|581299317|FG000|Overall Study|Study Terminated by Sponsor|45|||
160975413|NCT01678820|581299318|FG001|Overall Study|Study Terminated by Sponsor|43|||
160975414|NCT01678820|581299319|FG002|Overall Study|Study Terminated by Sponsor|43|||
160975415|NCT01678820|581299317|FG000|Overall Study|Withdrawal by Subject|2|||
160975416|NCT01678820|581299318|FG001|Overall Study|Withdrawal by Subject|5|||
160975417|NCT01678820|581299319|FG002|Overall Study|Withdrawal by Subject|2|||
161029820|NCT04999111|581501507|FG002|Overall Study|Physician Decision|0|||
161029821|NCT04999111|581501508|FG003|Overall Study|Physician Decision|1|||
161029822|NCT04999111|581501509|FG004|Overall Study|Physician Decision|2|||
161029823|NCT04999111|581501510|FG005|Overall Study|Physician Decision|0|||
161029824|NCT04999111|581501505|FG000|Overall Study|Withdrawal by Subject|23|||
161029825|NCT04999111|581501506|FG001|Overall Study|Withdrawal by Subject|29|||
161029826|NCT04999111|581501507|FG002|Overall Study|Withdrawal by Subject|15|||
161029827|NCT04999111|581501508|FG003|Overall Study|Withdrawal by Subject|30|||
161276924|NCT00090363|582393383|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161276925|NCT00090363|582393381|FG000|Overall Study|Consent expired|7|||
161276926|NCT00090363|582393382|FG001|Overall Study|Consent expired|10|||
161276927|NCT00090363|582393383|FG002|Overall Study|Consent expired|9|||
161276928|NCT00090363|582393381|FG000|Overall Study|Reasons not specified|2|||
161276929|NCT00090363|582393382|FG001|Overall Study|Reasons not specified|1|||
161276930|NCT00090363|582393383|FG002|Overall Study|Reasons not specified|1|||
161276931|NCT00090363|582393381|FG000|Overall Study|Continuing on study off treatment|14|||
161276932|NCT00090363|582393382|FG001|Overall Study|Continuing on study off treatment|13|||
161276933|NCT00090363|582393383|FG002|Overall Study|Continuing on study off treatment|16|||
161276934|NCT05038800|582393385|FG000|Overall Study|Death|1|||
161276935|NCT05038800|582393386|FG001|Overall Study|Death|1|||
161276936|NCT05038800|582393387|FG002|Overall Study|Death|5|||
161276937|NCT05038800|582393388|FG003|Overall Study|Death|3|||
161276938|NCT05038800|582393389|FG004|Overall Study|Death|1|||
161276939|NCT05038800|582393385|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161276940|NCT05038800|582393386|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161276941|NCT05038800|582393387|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161276942|NCT05038800|582393388|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
161276943|NCT05038800|582393389|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
161276944|NCT05038800|582393385|FG000|Overall Study|Lack of Efficacy|0|||
161276945|NCT05038800|582393386|FG001|Overall Study|Lack of Efficacy|0|||
161276946|NCT05038800|582393387|FG002|Overall Study|Lack of Efficacy|0|||
161276947|NCT05038800|582393388|FG003|Overall Study|Lack of Efficacy|0|||
161276948|NCT05038800|582393389|FG004|Overall Study|Lack of Efficacy|1|||
161276949|NCT00121134|582393390|FG000|Overall Study|Progression of Disease|5|||
161276950|NCT00121134|582393391|FG001|Overall Study|Progression of Disease|3|||
161276951|NCT00121134|582393392|FG002|Overall Study|Progression of Disease|4|||
161276952|NCT00121134|582393393|FG003|Overall Study|Progression of Disease|2|||
161276953|NCT00121134|582393390|FG000|Overall Study|Toxicity|4|||
161276954|NCT00121134|582393391|FG001|Overall Study|Toxicity|7|||
161276955|NCT00121134|582393392|FG002|Overall Study|Toxicity|13|||
161276956|NCT00121134|582393393|FG003|Overall Study|Toxicity|5|||
161276957|NCT00121134|582393390|FG000|Overall Study|Physician Decision|6|||
161276958|NCT00121134|582393391|FG001|Overall Study|Physician Decision|4|||
161276959|NCT00121134|582393392|FG002|Overall Study|Physician Decision|4|||
161276960|NCT00121134|582393393|FG003|Overall Study|Physician Decision|1|||
161276961|NCT00121134|582393390|FG000|Overall Study|Treatment Delay|1|||
161276962|NCT00121134|582393391|FG001|Overall Study|Treatment Delay|0|||
161276963|NCT00121134|582393392|FG002|Overall Study|Treatment Delay|0|||
161276964|NCT00121134|582393393|FG003|Overall Study|Treatment Delay|0|||
161276965|NCT00121134|582393390|FG000|Overall Study|Intercurrent Illness|0|||
161276966|NCT00121134|582393391|FG001|Overall Study|Intercurrent Illness|0|||
161276967|NCT00121134|582393392|FG002|Overall Study|Intercurrent Illness|0|||
161276968|NCT00121134|582393393|FG003|Overall Study|Intercurrent Illness|1|||
161276969|NCT00121134|582393390|FG000|Overall Study|Patient Personal Reasons|0|||
161276970|NCT00121134|582393391|FG001|Overall Study|Patient Personal Reasons|1|||
161276971|NCT00121134|582393392|FG002|Overall Study|Patient Personal Reasons|0|||
161276972|NCT00121134|582393393|FG003|Overall Study|Patient Personal Reasons|0|||
161276973|NCT02478320|582393399|FG000|Overall Study|Adverse Event|2|||
161276974|NCT02478320|582393400|FG001|Overall Study|Adverse Event|0|||
161276975|NCT02478320|582393399|FG000|Overall Study|Death|1|||
161276976|NCT02478320|582393400|FG001|Overall Study|Death|0|||
161276977|NCT02478320|582393399|FG000|Overall Study|Lack of Efficacy|4|||
161276978|NCT02478320|582393400|FG001|Overall Study|Lack of Efficacy|0|||
161276979|NCT02478320|582393399|FG000|Overall Study|Withdrawal by Subject|2|||
161276980|NCT02478320|582393400|FG001|Overall Study|Withdrawal by Subject|0|||
161276981|NCT02478320|582393399|FG000|Overall Study|Screen Failure|3|||
161276982|NCT02478320|582393400|FG001|Overall Study|Screen Failure|0|||
161276983|NCT03185013|582393401|FG000|Overall Study|Withdrawal by Subject|5|||
161276984|NCT03185013|582393402|FG001|Overall Study|Withdrawal by Subject|3|||
161276985|NCT03185013|582393401|FG000|Overall Study|Adverse Event|1|||
161029828|NCT04999111|581501509|FG004|Overall Study|Withdrawal by Subject|35|||
161276986|NCT03185013|582393402|FG001|Overall Study|Adverse Event|0|||
161276987|NCT03185013|582393401|FG000|Overall Study|Progressive Disease|1|||
161276988|NCT03185013|582393402|FG001|Overall Study|Progressive Disease|0|||
161276989|NCT03185013|582393401|FG000|Overall Study|Lost to Follow-up|8|||
161276990|NCT03185013|582393402|FG001|Overall Study|Lost to Follow-up|2|||
161276991|NCT03185013|582393401|FG000|Overall Study|Physician Decision|1|||
161276992|NCT03185013|582393402|FG001|Overall Study|Physician Decision|0|||
161276993|NCT03185013|582393401|FG000|Overall Study|Protocol Deviation|2|||
161029829|NCT04999111|581501510|FG005|Overall Study|Withdrawal by Subject|10|||
161029830|NCT04999111|581501505|FG000|Overall Study|Other|6|||
161029831|NCT04999111|581501506|FG001|Overall Study|Other|6|||
161029832|NCT04999111|581501507|FG002|Overall Study|Other|3|||
161276994|NCT03185013|582393402|FG001|Overall Study|Protocol Deviation|0|||
161276995|NCT03185013|582393401|FG000|Overall Study|Reason not Specified|3|||
161276996|NCT03185013|582393402|FG001|Overall Study|Reason not Specified|2|||
161276997|NCT03185013|582393401|FG000|Overall Study|Death|1|||
161276998|NCT03185013|582393402|FG001|Overall Study|Death|0|||
161276999|NCT01104792|582393406|FG000|Overall Study|Adverse Event|77|||
161277000|NCT01104792|582393406|FG000|Overall Study|Insufficient Therapeutic Response|22|||
161277001|NCT01104792|582393406|FG000|Overall Study|Protocol Violation|45|||
161277002|NCT01104792|582393406|FG000|Overall Study|Withdrawal of Consent|179|||
161277003|NCT01104792|582393406|FG000|Overall Study|Lost to Follow-up|43|||
161277004|NCT01104792|582393406|FG000|Overall Study|Reasons Not Specified|27|||
161277005|NCT01104792|582393406|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
161277006|NCT02071849|582393408|FG000|6-month Primary Endpoint|Did not receive device|4|||
161277007|NCT02071849|582393408|FG000|6-month Primary Endpoint|Adverse Event|1|||
161277008|NCT02071849|582393408|FG000|2-year Extended Follow-up|Adverse Event|1|||
161277009|NCT03255655|582393409|FG000|Overall Study|Lost to Follow-up|7|||
161277010|NCT03255655|582393410|FG001|Overall Study|Lost to Follow-up|4|||
161277011|NCT02056392|582393416|FG000|Overall Study|Lost to Follow-up|0|||
161277012|NCT02056392|582393417|FG001|Overall Study|Lost to Follow-up|1|||
161277013|NCT02056392|582393418|FG002|Overall Study|Lost to Follow-up|2|||
161277014|NCT02056392|582393419|FG003|Overall Study|Lost to Follow-up|0|||
161277015|NCT02056392|582393420|FG004|Overall Study|Lost to Follow-up|0|||
161277016|NCT02056392|582393421|FG005|Overall Study|Lost to Follow-up|0|||
161277017|NCT02056392|582393416|FG000|Overall Study|Protocol Violation|1|||
161277018|NCT02056392|582393417|FG001|Overall Study|Protocol Violation|0|||
161277019|NCT02056392|582393418|FG002|Overall Study|Protocol Violation|1|||
161277020|NCT02056392|582393419|FG003|Overall Study|Protocol Violation|0|||
161277021|NCT02056392|582393420|FG004|Overall Study|Protocol Violation|0|||
161277022|NCT02056392|582393421|FG005|Overall Study|Protocol Violation|0|||
161277023|NCT02056392|582393416|FG000|Overall Study|Withdrawal by Subject|1|||
161277024|NCT02056392|582393417|FG001|Overall Study|Withdrawal by Subject|0|||
161277025|NCT02056392|582393418|FG002|Overall Study|Withdrawal by Subject|0|||
161277026|NCT02056392|582393419|FG003|Overall Study|Withdrawal by Subject|0|||
161277027|NCT02056392|582393420|FG004|Overall Study|Withdrawal by Subject|1|||
161277028|NCT02056392|582393421|FG005|Overall Study|Withdrawal by Subject|0|||
161277029|NCT00103610|582393422|FG000|Overall Study|Entered Rescue Procedure|10|||
161277030|NCT00103610|582393423|FG001|Overall Study|Entered Rescue Procedure|52|||
161277031|NCT00103610|582393422|FG000|Overall Study|Death|16|||
161277032|NCT00103610|582393423|FG001|Overall Study|Death|12|||
161277033|NCT00103610|582393422|FG000|Overall Study|Elective Withdrawal|4|||
161277034|NCT00103610|582393423|FG001|Overall Study|Elective Withdrawal|0|||
161277035|NCT00103610|582393422|FG000|Overall Study|Lost to Follow-up|3|||
161277036|NCT00103610|582393423|FG001|Overall Study|Lost to Follow-up|1|||
161277037|NCT00103610|582393422|FG000|Overall Study|Adverse Event|2|||
161277038|NCT00103610|582393423|FG001|Overall Study|Adverse Event|2|||
161277039|NCT00103610|582393422|FG000|Overall Study|Other|2|||
161277040|NCT00103610|582393423|FG001|Overall Study|Other|7|||
161277041|NCT00103610|582393422|FG000|Overall Study|Failed mobilization|1|||
161277042|NCT00103610|582393423|FG001|Overall Study|Failed mobilization|5|||
161277043|NCT00103610|582393422|FG000|Overall Study|Noncompliance|0|||
161277044|NCT00103610|582393423|FG001|Overall Study|Noncompliance|1|||
161277045|NCT00658021|582393424|FG000|28-Week Treatment Period|Adverse Event|3|||
161277046|NCT00658021|582393425|FG001|28-Week Treatment Period|Adverse Event|1|||
161029833|NCT04999111|581501508|FG003|Overall Study|Other|8|||
161029834|NCT04999111|581501509|FG004|Overall Study|Other|8|||
161029835|NCT04999111|581501510|FG005|Overall Study|Other|5|||
161029836|NCT04999111|581501505|FG000|Overall Study|Non-compliance with study schedule|1|||
161277047|NCT00658021|582393426|FG002|28-Week Treatment Period|Adverse Event|0|||
161277048|NCT00658021|582393424|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
161277049|NCT00658021|582393425|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
161277050|NCT00658021|582393426|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
161277051|NCT00658021|582393424|FG000|28-Week Treatment Period|Protocol Violation|0|||
161277052|NCT00658021|582393425|FG001|28-Week Treatment Period|Protocol Violation|2|||
161277053|NCT00658021|582393426|FG002|28-Week Treatment Period|Protocol Violation|1|||
161277054|NCT00658021|582393424|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
161277055|NCT00658021|582393425|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
161277056|NCT00658021|582393426|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
161277057|NCT00658021|582393424|FG000|28-Week Treatment Period|Physician Decision|1|||
161277058|NCT00658021|582393425|FG001|28-Week Treatment Period|Physician Decision|2|||
161277059|NCT00658021|582393426|FG002|28-Week Treatment Period|Physician Decision|1|||
161277060|NCT00658021|582393424|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161029837|NCT04999111|581501506|FG001|Overall Study|Non-compliance with study schedule|0|||
161029838|NCT04999111|581501507|FG002|Overall Study|Non-compliance with study schedule|0|||
161029839|NCT04999111|581501508|FG003|Overall Study|Non-compliance with study schedule|1|||
161029840|NCT04999111|581501509|FG004|Overall Study|Non-compliance with study schedule|1|||
161029841|NCT04999111|581501510|FG005|Overall Study|Non-compliance with study schedule|1|||
161029842|NCT04999111|581501505|FG000|Overall Study|Randomized but not vaccinated|1|||
161029843|NCT04999111|581501506|FG001|Overall Study|Randomized but not vaccinated|2|||
161029844|NCT04999111|581501507|FG002|Overall Study|Randomized but not vaccinated|0|||
161029845|NCT04999111|581501508|FG003|Overall Study|Randomized but not vaccinated|3|||
161029846|NCT04999111|581501509|FG004|Overall Study|Randomized but not vaccinated|3|||
161029847|NCT04999111|581501510|FG005|Overall Study|Randomized but not vaccinated|0|||
161029848|NCT04999111|581501505|FG000|Overall Study|Adverse Event|1|||
161029849|NCT04999111|581501506|FG001|Overall Study|Adverse Event|1|||
161029850|NCT04999111|581501507|FG002|Overall Study|Adverse Event|0|||
161029851|NCT04999111|581501508|FG003|Overall Study|Adverse Event|0|||
161029852|NCT04999111|581501509|FG004|Overall Study|Adverse Event|0|||
161029853|NCT04999111|581501510|FG005|Overall Study|Adverse Event|0|||
161029854|NCT04999111|581501505|FG000|Overall Study|Initiated prohibited medication|0|||
161029855|NCT04999111|581501506|FG001|Overall Study|Initiated prohibited medication|0|||
161029856|NCT04999111|581501507|FG002|Overall Study|Initiated prohibited medication|0|||
161029857|NCT04999111|581501508|FG003|Overall Study|Initiated prohibited medication|0|||
161029858|NCT04999111|581501509|FG004|Overall Study|Initiated prohibited medication|1|||
161029859|NCT04999111|581501510|FG005|Overall Study|Initiated prohibited medication|0|||
161029860|NCT04709419|581501512|FG000|Overall Study|Physician Decision|1|||
161029861|NCT04709419|581501513|FG001|Overall Study|Physician Decision|0|||
161029862|NCT04526886|581501515|FG000|Overall Study|Physician Decision|4|||
161029863|NCT03276676|581501518|FG000|Overall Study|Withdrawal by Subject|2|||
161029864|NCT03276676|581501519|FG001|Overall Study|Withdrawal by Subject|1|||
161029865|NCT02962076|581501521|FG000|Overall Study|MHED tracer not available|5|||
161029866|NCT02962076|581501521|FG000|Overall Study|Protocol Violation|1|||
161029867|NCT02962076|581501521|FG000|Overall Study|Physician Decision|1|||
161029868|NCT03926130|581501533|FG000|Overall Study|Adverse Event|9|||
161029869|NCT03926130|581501534|FG001|Overall Study|Adverse Event|11|||
161029870|NCT03926130|581501535|FG002|Overall Study|Adverse Event|2|||
161029871|NCT03926130|581501536|FG003|Overall Study|Adverse Event|0|||
161029872|NCT03926130|581501533|FG000|Overall Study|Death|2|||
161029873|NCT03926130|581501534|FG001|Overall Study|Death|0|||
161029874|NCT03926130|581501535|FG002|Overall Study|Death|1|||
161029875|NCT03926130|581501536|FG003|Overall Study|Death|0|||
161029876|NCT03926130|581501533|FG000|Overall Study|Lack of Efficacy|14|||
161029877|NCT03926130|581501534|FG001|Overall Study|Lack of Efficacy|11|||
161029878|NCT03926130|581501535|FG002|Overall Study|Lack of Efficacy|7|||
161029879|NCT03926130|581501536|FG003|Overall Study|Lack of Efficacy|1|||
161029880|NCT03926130|581501533|FG000|Overall Study|Lost to Follow-up|0|||
161029881|NCT03926130|581501534|FG001|Overall Study|Lost to Follow-up|7|||
161029882|NCT03926130|581501535|FG002|Overall Study|Lost to Follow-up|1|||
161029883|NCT03926130|581501536|FG003|Overall Study|Lost to Follow-up|0|||
161029884|NCT03926130|581501533|FG000|Overall Study|As Reported by Investigator|2|||
161029885|NCT03926130|581501534|FG001|Overall Study|As Reported by Investigator|6|||
161029886|NCT03926130|581501535|FG002|Overall Study|As Reported by Investigator|6|||
161029887|NCT03926130|581501536|FG003|Overall Study|As Reported by Investigator|0|||
161029888|NCT03926130|581501533|FG000|Overall Study|Physician Decision|3|||
161029889|NCT03926130|581501534|FG001|Overall Study|Physician Decision|2|||
161029890|NCT03926130|581501535|FG002|Overall Study|Physician Decision|1|||
161029891|NCT03926130|581501536|FG003|Overall Study|Physician Decision|0|||
161029892|NCT03926130|581501533|FG000|Overall Study|Pregnancy|2|||
161029893|NCT03926130|581501534|FG001|Overall Study|Pregnancy|2|||
161029894|NCT03926130|581501535|FG002|Overall Study|Pregnancy|1|||
161029895|NCT03926130|581501536|FG003|Overall Study|Pregnancy|0|||
160975418|NCT01678820|581299317|FG000|Overall Study|Protocol Specified Criteria|2|||
160975419|NCT01678820|581299318|FG001|Overall Study|Protocol Specified Criteria|3|||
160975420|NCT01678820|581299319|FG002|Overall Study|Protocol Specified Criteria|1|||
160975421|NCT01678820|581299317|FG000|Overall Study|Adverse Event|2|||
160975422|NCT01678820|581299318|FG001|Overall Study|Adverse Event|2|||
160975423|NCT01678820|581299319|FG002|Overall Study|Adverse Event|2|||
160975424|NCT01678820|581299317|FG000|Overall Study|Lost to Follow-up|7|||
160975425|NCT01678820|581299318|FG001|Overall Study|Lost to Follow-up|2|||
160975426|NCT01678820|581299319|FG002|Overall Study|Lost to Follow-up|2|||
160975427|NCT01678820|581299317|FG000|Overall Study|Non-compliance with study drug|0|||
160975428|NCT01678820|581299318|FG001|Overall Study|Non-compliance with study drug|1|||
160975429|NCT01678820|581299319|FG002|Overall Study|Non-compliance with study drug|0|||
160975430|NCT01678820|581299317|FG000|Overall Study|Physician Decision|0|||
160975431|NCT01678820|581299318|FG001|Overall Study|Physician Decision|0|||
161029896|NCT03926130|581501533|FG000|Overall Study|Withdrawal by Subject|20|||
161029897|NCT03926130|581501534|FG001|Overall Study|Withdrawal by Subject|28|||
161029898|NCT03926130|581501535|FG002|Overall Study|Withdrawal by Subject|18|||
161029899|NCT03926130|581501536|FG003|Overall Study|Withdrawal by Subject|1|||
161029900|NCT03926130|581501533|FG000|Overall Study|Non-Compliance|1|||
161029901|NCT03926130|581501534|FG001|Overall Study|Non-Compliance|1|||
161029902|NCT03926130|581501535|FG002|Overall Study|Non-Compliance|0|||
161277061|NCT00658021|582393425|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161277062|NCT00658021|582393426|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
161277063|NCT00658021|582393424|FG000|28-Week Treatment Period|Loss of glucose control|1|||
161277064|NCT00658021|582393425|FG001|28-Week Treatment Period|Loss of glucose control|1|||
161277065|NCT00658021|582393426|FG002|28-Week Treatment Period|Loss of glucose control|10|||
161277066|NCT00658021|582393424|FG000|28-Week Treatment Period|Other|2|||
161277067|NCT00658021|582393425|FG001|28-Week Treatment Period|Other|3|||
161277068|NCT00658021|582393426|FG002|28-Week Treatment Period|Other|1|||
161277069|NCT00658021|582393424|FG000|28-Week Treatment Period|Did not receive treatment|2|||
161277070|NCT00658021|582393425|FG001|28-Week Treatment Period|Did not receive treatment|0|||
161277071|NCT00658021|582393426|FG002|28-Week Treatment Period|Did not receive treatment|0|||
161277072|NCT00658021|582393424|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
161277073|NCT00658021|582393425|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
161277074|NCT00658021|582393426|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
161277075|NCT00658021|582393424|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
161277076|NCT00658021|582393425|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
161277077|NCT00658021|582393426|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
161277078|NCT01806506|582393427|FG000|Overall Study|Lost to Follow-up|2|||
161277079|NCT01806506|582393428|FG001|Overall Study|Lost to Follow-up|1|||
161277080|NCT05819203|582393435|FG000|Overall Study|Protocol Violation|1|||
161277081|NCT05819203|582393436|FG001|Overall Study|Protocol Violation|2|||
161277082|NCT05819203|582393435|FG000|Overall Study|Withdrawal by Subject|1|||
160975432|NCT01678820|581299319|FG002|Overall Study|Physician Decision|1|||
160975433|NCT01678820|581299317|FG000|Overall Study|Protocol Violation|4|||
160975434|NCT01678820|581299318|FG001|Overall Study|Protocol Violation|5|||
160975435|NCT01678820|581299319|FG002|Overall Study|Protocol Violation|4|||
160975436|NCT01678820|581299317|FG000|Overall Study|Not treated with double-blind study drug|0|||
160975437|NCT01678820|581299318|FG001|Overall Study|Not treated with double-blind study drug|2|||
160975438|NCT01678820|581299319|FG002|Overall Study|Not treated with double-blind study drug|2|||
160975439|NCT00245856|581299320|FG000|Period Two|Withdrawal by Subject|0|||
160975440|NCT00245856|581299321|FG001|Period Two|Withdrawal by Subject|1|||
160975441|NCT02765490|581299322|FG000|Overall Study|Lost to Follow-up|1|||
160975442|NCT02765490|581299323|FG001|Overall Study|Lost to Follow-up|1|||
160975443|NCT02765490|581299322|FG000|Overall Study|Other|0|||
160975444|NCT02765490|581299323|FG001|Overall Study|Other|1|||
160975445|NCT02765490|581299322|FG000|Overall Study|Death|0|||
160975446|NCT02765490|581299323|FG001|Overall Study|Death|1|||
160975447|NCT03662997|581299328|FG000|Overall Study|Adverse Event|0|||
160975448|NCT03662997|581299329|FG001|Overall Study|Adverse Event|2|||
160975449|NCT03662997|581299330|FG002|Overall Study|Adverse Event|0|||
160975450|NCT03662997|581299331|FG003|Overall Study|Adverse Event|0|||
160975451|NCT05266963|581299334|FG000|Drug Period A|Withdrawal by Subject|0|||
160975452|NCT05266963|581299335|FG001|Drug Period A|Withdrawal by Subject|1|||
160975453|NCT00152971|581299336|FG000|Overall Study|Adverse Event|12|||
160975454|NCT00152971|581299337|FG001|Overall Study|Adverse Event|10|||
160975455|NCT00152971|581299338|FG002|Overall Study|Adverse Event|9|||
160975456|NCT00152971|581299336|FG000|Overall Study|Protocol Violation|10|||
160975457|NCT00152971|581299337|FG001|Overall Study|Protocol Violation|11|||
160975458|NCT00152971|581299338|FG002|Overall Study|Protocol Violation|8|||
160975459|NCT00152971|581299336|FG000|Overall Study|Lost to Follow-up|17|||
160975460|NCT00152971|581299337|FG001|Overall Study|Lost to Follow-up|14|||
160975461|NCT00152971|581299338|FG002|Overall Study|Lost to Follow-up|13|||
160975462|NCT00152971|581299336|FG000|Overall Study|Withdrawal by Subject|9|||
160975463|NCT00152971|581299337|FG001|Overall Study|Withdrawal by Subject|8|||
160975464|NCT00152971|581299338|FG002|Overall Study|Withdrawal by Subject|14|||
160975465|NCT00152971|581299336|FG000|Overall Study|Other|3|||
160975466|NCT00152971|581299337|FG001|Overall Study|Other|5|||
160975467|NCT00152971|581299338|FG002|Overall Study|Other|5|||
160975468|NCT00152971|581299336|FG000|Treatment|Adverse Event|49|||
160975469|NCT00152971|581299337|FG001|Treatment|Adverse Event|40|||
160975470|NCT00152971|581299338|FG002|Treatment|Adverse Event|54|||
160975471|NCT00152971|581299336|FG000|Treatment|Protocol Violation|8|||
160975472|NCT00152971|581299337|FG001|Treatment|Protocol Violation|6|||
160975473|NCT00152971|581299338|FG002|Treatment|Protocol Violation|10|||
160975474|NCT00152971|581299336|FG000|Treatment|Lost to Follow-up|1|||
160975475|NCT00152971|581299337|FG001|Treatment|Lost to Follow-up|2|||
160975476|NCT00152971|581299338|FG002|Treatment|Lost to Follow-up|1|||
160975477|NCT00152971|581299336|FG000|Treatment|Withdrawal by Subject|4|||
160975478|NCT00152971|581299337|FG001|Treatment|Withdrawal by Subject|4|||
160975479|NCT00152971|581299338|FG002|Treatment|Withdrawal by Subject|5|||
160975480|NCT00152971|581299336|FG000|Treatment|Other|9|||
160975481|NCT00152971|581299337|FG001|Treatment|Other|11|||
160975482|NCT00152971|581299338|FG002|Treatment|Other|10|||
160975483|NCT04091360|581299339|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975484|NCT04091360|581299340|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975485|NCT04091360|581299341|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975486|NCT04091360|581299342|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
161029903|NCT03926130|581501536|FG003|Overall Study|Non-Compliance|0|||
161029904|NCT03926130|581501533|FG000|Overall Study|Disposition Not Captured|0|||
161029905|NCT03926130|581501534|FG001|Overall Study|Disposition Not Captured|2|||
161029906|NCT03926130|581501535|FG002|Overall Study|Disposition Not Captured|1|||
161029907|NCT03926130|581501536|FG003|Overall Study|Disposition Not Captured|0|||
161029908|NCT03583333|581501537|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
161029909|NCT03583333|581501538|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
161029910|NCT03583333|581501537|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
161029911|NCT03583333|581501538|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
161029912|NCT03583333|581501537|FG000|Overall Study|Withdrawal by Subject|9|||
161277083|NCT05819203|582393436|FG001|Overall Study|Withdrawal by Subject|0|||
161277084|NCT04844762|582393439|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277085|NCT04844762|582393440|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277086|NCT04844762|582393441|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
161029913|NCT03583333|581501538|FG001|Overall Study|Withdrawal by Subject|5|||
161029914|NCT03583333|581501537|FG000|Overall Study|Physician Decision|3|||
161029915|NCT03583333|581501538|FG001|Overall Study|Physician Decision|2|||
161029916|NCT03583333|581501537|FG000|Overall Study|Death|12|||
161029917|NCT03583333|581501538|FG001|Overall Study|Death|7|||
161029918|NCT05069896|581501546|FG000|Overall Study|Adverse Event|0|||
161029919|NCT05069896|581501547|FG001|Overall Study|Adverse Event|1|||
161029920|NCT05069896|581501548|FG002|Overall Study|Adverse Event|1|||
161029921|NCT05069896|581501549|FG003|Overall Study|Adverse Event|0|||
161029922|NCT05069896|581501550|FG004|Overall Study|Adverse Event|0|||
161029923|NCT05069896|581501551|FG005|Overall Study|Adverse Event|0|||
161029924|NCT05069896|581501546|FG000|Overall Study|Lost to Follow-up|0|||
161029925|NCT05069896|581501547|FG001|Overall Study|Lost to Follow-up|0|||
161029926|NCT05069896|581501548|FG002|Overall Study|Lost to Follow-up|1|||
161029927|NCT05069896|581501549|FG003|Overall Study|Lost to Follow-up|0|||
161029928|NCT05069896|581501550|FG004|Overall Study|Lost to Follow-up|1|||
161029929|NCT05069896|581501551|FG005|Overall Study|Lost to Follow-up|2|||
161029930|NCT04068831|581501552|FG000|Overall Study|Disease Progression|10|||
161029931|NCT04068831|581501553|FG001|Overall Study|Disease Progression|8|||
161029932|NCT03580356|581501557|FG000|Treatment Period|Withdrawal by Subject|13|||
161029933|NCT03580356|581501558|FG001|Treatment Period|Withdrawal by Subject|0|||
161029934|NCT03580356|581501559|FG002|Treatment Period|Withdrawal by Subject|13|||
161029935|NCT03580356|581501560|FG003|Treatment Period|Withdrawal by Subject|1|||
161029936|NCT03580356|581501561|FG004|Treatment Period|Withdrawal by Subject|17|||
161029937|NCT03580356|581501562|FG005|Treatment Period|Withdrawal by Subject|0|||
161029938|NCT03580356|581501563|FG006|Treatment Period|Withdrawal by Subject|5|||
161029939|NCT03580356|581501564|FG007|Treatment Period|Withdrawal by Subject|0|||
161029940|NCT03580356|581501557|FG000|Treatment Period|Adverse Event|10|||
161029941|NCT03580356|581501558|FG001|Treatment Period|Adverse Event|0|||
161029942|NCT03580356|581501559|FG002|Treatment Period|Adverse Event|13|||
161029943|NCT03580356|581501560|FG003|Treatment Period|Adverse Event|0|||
161029944|NCT03580356|581501561|FG004|Treatment Period|Adverse Event|5|||
161029945|NCT03580356|581501562|FG005|Treatment Period|Adverse Event|0|||
161029946|NCT03580356|581501563|FG006|Treatment Period|Adverse Event|8|||
161029947|NCT03580356|581501564|FG007|Treatment Period|Adverse Event|0|||
161277087|NCT04844762|582393442|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277088|NCT04844762|582393443|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277089|NCT04844762|582393444|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277090|NCT04844762|582393439|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161277091|NCT04844762|582393440|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161277092|NCT04844762|582393441|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161277093|NCT04844762|582393442|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161277094|NCT04844762|582393443|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
161277095|NCT04844762|582393444|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
161277096|NCT04844762|582393439|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277097|NCT04844762|582393440|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161029948|NCT03580356|581501557|FG000|Treatment Period|Protocol Violation|5|||
161029949|NCT03580356|581501558|FG001|Treatment Period|Protocol Violation|0|||
161029950|NCT03580356|581501559|FG002|Treatment Period|Protocol Violation|6|||
161029951|NCT03580356|581501560|FG003|Treatment Period|Protocol Violation|1|||
161029952|NCT03580356|581501561|FG004|Treatment Period|Protocol Violation|9|||
161029953|NCT03580356|581501562|FG005|Treatment Period|Protocol Violation|1|||
161029954|NCT03580356|581501563|FG006|Treatment Period|Protocol Violation|1|||
161029955|NCT03580356|581501564|FG007|Treatment Period|Protocol Violation|0|||
161029956|NCT03580356|581501557|FG000|Treatment Period|Lack of Efficacy|6|||
161029957|NCT03580356|581501558|FG001|Treatment Period|Lack of Efficacy|0|||
161029958|NCT03580356|581501559|FG002|Treatment Period|Lack of Efficacy|2|||
161277098|NCT04844762|582393441|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161029959|NCT03580356|581501560|FG003|Treatment Period|Lack of Efficacy|0|||
161029960|NCT03580356|581501561|FG004|Treatment Period|Lack of Efficacy|3|||
161029961|NCT03580356|581501562|FG005|Treatment Period|Lack of Efficacy|0|||
161029962|NCT03580356|581501563|FG006|Treatment Period|Lack of Efficacy|3|||
161029963|NCT03580356|581501564|FG007|Treatment Period|Lack of Efficacy|0|||
161029964|NCT03580356|581501557|FG000|Treatment Period|Pregnancy|1|||
161029965|NCT03580356|581501558|FG001|Treatment Period|Pregnancy|0|||
161277099|NCT04844762|582393442|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
161277100|NCT04844762|582393443|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277101|NCT04844762|582393444|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161277102|NCT04844762|582393439|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277103|NCT04844762|582393440|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277104|NCT04844762|582393441|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161277105|NCT04844762|582393442|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161277106|NCT04844762|582393443|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
161277107|NCT04844762|582393444|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277108|NCT04844762|582393439|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
161277109|NCT04844762|582393440|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
161277110|NCT04844762|582393441|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277111|NCT04844762|582393442|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277112|NCT04844762|582393443|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277113|NCT04844762|582393444|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277114|NCT04844762|582393439|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161277115|NCT04844762|582393440|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277116|NCT04844762|582393441|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277117|NCT04844762|582393442|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277118|NCT04844762|582393443|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277119|NCT04844762|582393444|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277120|NCT04844762|582393439|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277121|NCT04844762|582393440|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277122|NCT04844762|582393441|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277123|NCT04844762|582393442|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277124|NCT04844762|582393443|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
161277125|NCT04844762|582393444|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
161277126|NCT04844762|582393439|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
161277127|NCT04844762|582393440|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277128|NCT04844762|582393441|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277129|NCT04844762|582393442|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277130|NCT04844762|582393443|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277131|NCT04844762|582393444|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
161277132|NCT04844762|582393439|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161277133|NCT04844762|582393440|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277134|NCT04844762|582393441|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277135|NCT04844762|582393442|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277136|NCT04844762|582393443|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
161277137|NCT04844762|582393444|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
161277138|NCT04844762|582393439|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161277139|NCT04844762|582393440|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
161277140|NCT04844762|582393441|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161277141|NCT04844762|582393442|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161277142|NCT04844762|582393443|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161277143|NCT04844762|582393444|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
161277144|NCT04844762|582393439|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161277145|NCT04844762|582393440|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161277146|NCT04844762|582393441|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161277147|NCT04844762|582393442|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
161277148|NCT04844762|582393443|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161277149|NCT04844762|582393444|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
161029966|NCT03580356|581501559|FG002|Treatment Period|Pregnancy|7|||
161029967|NCT03580356|581501560|FG003|Treatment Period|Pregnancy|0|||
161029968|NCT03580356|581501561|FG004|Treatment Period|Pregnancy|2|||
161277150|NCT02099682|582393445|FG000|Overall Study|Data Not Available|51|||
161277151|NCT02099682|582393445|FG000|Overall Study|Lost to Follow-up|31|||
161277152|NCT02099682|582393445|FG000|Overall Study|Other|29|||
161277153|NCT02802631|582393446|FG000|Overall Study|Withdrawal by Subject|1|||
161277154|NCT02802631|582393447|FG001|Overall Study|Withdrawal by Subject|0|||
161029969|NCT03580356|581501562|FG005|Treatment Period|Pregnancy|0|||
161029970|NCT03580356|581501563|FG006|Treatment Period|Pregnancy|1|||
161277155|NCT02802631|582393448|FG002|Overall Study|Withdrawal by Subject|0|||
161029971|NCT03580356|581501564|FG007|Treatment Period|Pregnancy|0|||
161029972|NCT03580356|581501557|FG000|Treatment Period|Physician Decision|2|||
161029973|NCT03580356|581501558|FG001|Treatment Period|Physician Decision|0|||
161029974|NCT03580356|581501559|FG002|Treatment Period|Physician Decision|1|||
161029975|NCT03580356|581501560|FG003|Treatment Period|Physician Decision|0|||
161029976|NCT03580356|581501561|FG004|Treatment Period|Physician Decision|4|||
161029977|NCT03580356|581501562|FG005|Treatment Period|Physician Decision|0|||
161029978|NCT03580356|581501563|FG006|Treatment Period|Physician Decision|2|||
161029979|NCT03580356|581501564|FG007|Treatment Period|Physician Decision|0|||
161029980|NCT03580356|581501557|FG000|Treatment Period|Lost to Follow-up|1|||
161029981|NCT03580356|581501558|FG001|Treatment Period|Lost to Follow-up|1|||
161029982|NCT03580356|581501559|FG002|Treatment Period|Lost to Follow-up|1|||
161029983|NCT03580356|581501560|FG003|Treatment Period|Lost to Follow-up|0|||
161029984|NCT03580356|581501561|FG004|Treatment Period|Lost to Follow-up|3|||
161029985|NCT03580356|581501562|FG005|Treatment Period|Lost to Follow-up|0|||
161029986|NCT03580356|581501563|FG006|Treatment Period|Lost to Follow-up|1|||
161029987|NCT03580356|581501564|FG007|Treatment Period|Lost to Follow-up|0|||
161029988|NCT03580356|581501557|FG000|Treatment Period|Death|0|||
161029989|NCT03580356|581501558|FG001|Treatment Period|Death|0|||
161029990|NCT03580356|581501559|FG002|Treatment Period|Death|1|||
161029991|NCT03580356|581501560|FG003|Treatment Period|Death|0|||
161029992|NCT03580356|581501561|FG004|Treatment Period|Death|0|||
161029993|NCT03580356|581501562|FG005|Treatment Period|Death|0|||
161029994|NCT03580356|581501563|FG006|Treatment Period|Death|0|||
161029995|NCT03580356|581501564|FG007|Treatment Period|Death|0|||
161029996|NCT03580356|581501557|FG000|Treatment Period|Technical problems|0|||
161029997|NCT03580356|581501558|FG001|Treatment Period|Technical problems|0|||
161029998|NCT03580356|581501559|FG002|Treatment Period|Technical problems|0|||
161029999|NCT03580356|581501560|FG003|Treatment Period|Technical problems|0|||
161030000|NCT03580356|581501561|FG004|Treatment Period|Technical problems|1|||
161030001|NCT03580356|581501562|FG005|Treatment Period|Technical problems|0|||
161030002|NCT03580356|581501563|FG006|Treatment Period|Technical problems|0|||
161030003|NCT03580356|581501564|FG007|Treatment Period|Technical problems|0|||
161030004|NCT03580356|581501557|FG000|Treatment Period|Misrandomized, no treatment|0|||
161030005|NCT03580356|581501558|FG001|Treatment Period|Misrandomized, no treatment|0|||
161030006|NCT03580356|581501559|FG002|Treatment Period|Misrandomized, no treatment|1|||
161030007|NCT03580356|581501560|FG003|Treatment Period|Misrandomized, no treatment|0|||
161030008|NCT03580356|581501561|FG004|Treatment Period|Misrandomized, no treatment|2|||
161030009|NCT03580356|581501562|FG005|Treatment Period|Misrandomized, no treatment|0|||
161030010|NCT03580356|581501563|FG006|Treatment Period|Misrandomized, no treatment|0|||
161030011|NCT03580356|581501564|FG007|Treatment Period|Misrandomized, no treatment|0|||
161030012|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
161030013|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
161030014|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
161030015|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
161030016|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
161030017|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
161030018|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
161030019|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
161030020|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
161030021|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161030022|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
161030023|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161030024|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
161030025|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161030026|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161030027|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
161030028|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
161030029|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
161030030|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
161030031|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
161030032|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
161030033|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
161030034|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
161030035|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
161030036|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161030037|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161030038|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
161030039|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161030040|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
161030041|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161030042|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161030043|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
161030044|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
161277156|NCT02802631|582393449|FG003|Overall Study|Withdrawal by Subject|0|||
161277157|NCT02802631|582393450|FG004|Overall Study|Withdrawal by Subject|0|||
161277158|NCT02802631|582393451|FG005|Overall Study|Withdrawal by Subject|0|||
161277159|NCT02802631|582393452|FG006|Overall Study|Withdrawal by Subject|0|||
161277160|NCT02802631|582393453|FG007|Overall Study|Withdrawal by Subject|0|||
161277161|NCT02802631|582393446|FG000|Overall Study|Physician Decision|1|||
161277162|NCT02802631|582393447|FG001|Overall Study|Physician Decision|0|||
161277163|NCT02802631|582393448|FG002|Overall Study|Physician Decision|0|||
161277164|NCT02802631|582393449|FG003|Overall Study|Physician Decision|0|||
161277165|NCT02802631|582393450|FG004|Overall Study|Physician Decision|0|||
161277166|NCT02802631|582393451|FG005|Overall Study|Physician Decision|0|||
161277167|NCT02802631|582393452|FG006|Overall Study|Physician Decision|1|||
161277168|NCT02802631|582393453|FG007|Overall Study|Physician Decision|0|||
161277169|NCT02802631|582393446|FG000|Overall Study|Adverse Event|0|||
161277170|NCT02802631|582393447|FG001|Overall Study|Adverse Event|2|||
161277171|NCT02802631|582393448|FG002|Overall Study|Adverse Event|0|||
161277172|NCT02802631|582393449|FG003|Overall Study|Adverse Event|1|||
161277173|NCT02802631|582393450|FG004|Overall Study|Adverse Event|6|||
161277174|NCT02802631|582393451|FG005|Overall Study|Adverse Event|1|||
161277175|NCT02802631|582393452|FG006|Overall Study|Adverse Event|4|||
161277176|NCT02802631|582393453|FG007|Overall Study|Adverse Event|0|||
161277177|NCT02802631|582393446|FG000|Overall Study|Sponsor Decision|0|||
161277178|NCT02802631|582393447|FG001|Overall Study|Sponsor Decision|0|||
161277179|NCT02802631|582393448|FG002|Overall Study|Sponsor Decision|6|||
161344401|NCT01369433|582647199|FG001|Overall Study|Study terminated by Sponsor|0|||
160975487|NCT04091360|581299343|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975488|NCT04091360|581299344|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975489|NCT04091360|581299345|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975490|NCT04091360|581299346|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
160975491|NCT04091360|581299347|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
160975492|NCT04091360|581299348|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
160975493|NCT04091360|581299339|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975494|NCT04091360|581299340|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975495|NCT04091360|581299341|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975496|NCT04091360|581299342|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975497|NCT04091360|581299343|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975498|NCT04091360|581299344|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975499|NCT04091360|581299345|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
160975500|NCT04091360|581299346|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
160975501|NCT04091360|581299347|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975502|NCT04091360|581299348|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
160975503|NCT04091360|581299339|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975504|NCT04091360|581299340|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975505|NCT04091360|581299341|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975506|NCT04091360|581299342|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975507|NCT04091360|581299343|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975508|NCT04091360|581299344|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975509|NCT04091360|581299345|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
160975510|NCT04091360|581299346|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975511|NCT04091360|581299347|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
160975512|NCT04091360|581299348|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
160975513|NCT01320735|581299349|FG000|Overall Study|Adverse Event|3|||
160975514|NCT01320735|581299349|FG000|Overall Study|Withdrawal by Subject|3|||
160975515|NCT01320735|581299349|FG000|Overall Study|Lost to Follow-up|13|||
160975516|NCT01320735|581299349|FG000|Overall Study|Administrative Reason|6|||
160975517|NCT01320735|581299349|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
160975518|NCT01320735|581299349|FG000|Overall Study|Protocol Violation|1|||
160975519|NCT01320735|581299349|FG000|Overall Study|Other|1|||
160975520|NCT01320735|581299349|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
160975521|NCT01320735|581299349|FG000|Overall Study|Investigator Unable to be Contacted|17|||
160975522|NCT04599101|581299350|FG000|Overall Study|Lost to Follow-up|5|||
160975523|NCT04599101|581299351|FG001|Overall Study|Lost to Follow-up|5|||
160975524|NCT05952297|581299352|FG000|Overall Study|Withdrawal by Subject|1|||
160975525|NCT05952297|581299353|FG001|Overall Study|Withdrawal by Subject|0|||
160975526|NCT03556358|581299354|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
160975527|NCT03556358|581299355|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
160975528|NCT03556358|581299354|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
160975529|NCT03556358|581299355|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
160975530|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
161277180|NCT02802631|582393449|FG003|Overall Study|Sponsor Decision|0|||
161277181|NCT02802631|582393450|FG004|Overall Study|Sponsor Decision|2|||
161277182|NCT02802631|582393451|FG005|Overall Study|Sponsor Decision|0|||
161277183|NCT02802631|582393452|FG006|Overall Study|Sponsor Decision|0|||
160975531|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
160975532|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
160975533|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
160975534|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
160975535|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
160975536|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
160975537|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
160975538|NCT03556358|581299354|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
160975539|NCT03556358|581299355|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
160975540|NCT05067933|581299362|FG000|Overall Study|Withdrawal by Subject|2|||
160975541|NCT05067933|581299363|FG001|Overall Study|Withdrawal by Subject|0|||
160975542|NCT05067933|581299364|FG002|Overall Study|Withdrawal by Subject|0|||
160975543|NCT05067933|581299365|FG003|Overall Study|Withdrawal by Subject|0|||
160975544|NCT05067933|581299366|FG004|Overall Study|Withdrawal by Subject|0|||
160975545|NCT05067933|581299367|FG005|Overall Study|Withdrawal by Subject|0|||
160975546|NCT05067933|581299362|FG000|Overall Study|Lost to Follow-up|1|||
160975547|NCT05067933|581299363|FG001|Overall Study|Lost to Follow-up|1|||
160975548|NCT05067933|581299364|FG002|Overall Study|Lost to Follow-up|1|||
160975549|NCT05067933|581299365|FG003|Overall Study|Lost to Follow-up|2|||
160975550|NCT05067933|581299366|FG004|Overall Study|Lost to Follow-up|1|||
160975551|NCT05067933|581299367|FG005|Overall Study|Lost to Follow-up|0|||
160975552|NCT05067933|581299362|FG000|Overall Study|Miscellaneous|1|||
160975553|NCT05067933|581299363|FG001|Overall Study|Miscellaneous|0|||
160975554|NCT05067933|581299364|FG002|Overall Study|Miscellaneous|0|||
160975555|NCT05067933|581299365|FG003|Overall Study|Miscellaneous|0|||
160975556|NCT05067933|581299366|FG004|Overall Study|Miscellaneous|0|||
160975557|NCT05067933|581299367|FG005|Overall Study|Miscellaneous|0|||
160975558|NCT05067933|581299362|FG000|Overall Study|Death|0|||
160975559|NCT05067933|581299363|FG001|Overall Study|Death|0|||
160975560|NCT05067933|581299364|FG002|Overall Study|Death|0|||
160975561|NCT05067933|581299365|FG003|Overall Study|Death|1|||
160975562|NCT05067933|581299366|FG004|Overall Study|Death|0|||
160975563|NCT05067933|581299367|FG005|Overall Study|Death|0|||
160975564|NCT01065350|581299368|FG000|Overall Study|Received incorrect drug allocation|0|||
160975565|NCT01065350|581299369|FG001|Overall Study|Received incorrect drug allocation|1|||
160975566|NCT02716038|581299376|FG000|Overall Study|Not evaluable|1|||
160975567|NCT02716038|581299376|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
160975568|NCT02716038|581299376|FG000|Overall Study|Unresectable|3|||
160975569|NCT00550550|581299377|FG000|Overall Study|Adverse Event|13|||
160975570|NCT00550550|581299378|FG001|Overall Study|Adverse Event|5|||
160975571|NCT00550550|581299377|FG000|Overall Study|Treatment Failure|0|||
160975572|NCT00550550|581299378|FG001|Overall Study|Treatment Failure|1|||
160975573|NCT00550550|581299377|FG000|Overall Study|Lost to Follow-up|4|||
160975574|NCT00550550|581299378|FG001|Overall Study|Lost to Follow-up|0|||
160975575|NCT00550550|581299377|FG000|Overall Study|Withdrawal by Subject|10|||
160975576|NCT00550550|581299378|FG001|Overall Study|Withdrawal by Subject|8|||
160975577|NCT00550550|581299377|FG000|Overall Study|Protocol Violation|5|||
160975578|NCT00550550|581299378|FG001|Overall Study|Protocol Violation|14|||
160975579|NCT00550550|581299377|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
160975580|NCT00550550|581299378|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
160975581|NCT00550550|581299377|FG000|Overall Study|Randomized But Not Treated|1|||
160975582|NCT00550550|581299378|FG001|Overall Study|Randomized But Not Treated|0|||
160975583|NCT00118092|581299379|FG000|Overall Study|Withdrawal by Subject|1|||
160975584|NCT00118092|581299379|FG000|Overall Study|Protocol Violation|1|||
160975585|NCT00591864|581299380|FG000|Overall Study|Incomplete Imaging|5|||
160975586|NCT02459093|581299385|FG000|Overall Study|Protocol Violation|6|||
160975587|NCT02459093|581299386|FG001|Overall Study|Protocol Violation|11|||
160975588|NCT02459093|581299385|FG000|Overall Study|Lost to Follow-up|6|||
160975589|NCT02459093|581299386|FG001|Overall Study|Lost to Follow-up|7|||
160975590|NCT01103960|581299389|FG000|Overall Study|Adverse Event|2|||
160975591|NCT01103960|581299390|FG001|Overall Study|Adverse Event|1|||
160975592|NCT01103960|581299389|FG000|Overall Study|Withdrawal by Subject|2|||
160975593|NCT01103960|581299390|FG001|Overall Study|Withdrawal by Subject|1|||
160975594|NCT01103960|581299389|FG000|Overall Study|Other|1|||
160975595|NCT01103960|581299390|FG001|Overall Study|Other|0|||
160975596|NCT02875834|581299391|FG000|Open-label Phase|Withdrawal by Subject|3|||
160975597|NCT02875834|581299392|FG001|Open-label Phase|Withdrawal by Subject|0|||
160975598|NCT02875834|581299393|FG002|Open-label Phase|Withdrawal by Subject|0|||
160975599|NCT02875834|581299394|FG003|Open-label Phase|Withdrawal by Subject|0|||
160975600|NCT02875834|581299391|FG000|Open-label Phase|(Not collected)|4|||
160975601|NCT02875834|581299392|FG001|Open-label Phase|(Not collected)|0|||
161277184|NCT02802631|582393453|FG007|Overall Study|Sponsor Decision|4|||
160975602|NCT02875834|581299393|FG002|Open-label Phase|(Not collected)|0|||
161030045|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
161030046|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
161030047|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
161030048|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
161030049|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
161030050|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
161030051|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
161030052|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
161030053|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
161030054|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
161030055|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
161030056|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
161030057|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
161030058|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
161030059|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
161030060|NCT03580356|581501557|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
161030061|NCT03580356|581501558|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
161030062|NCT03580356|581501559|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
161030063|NCT03580356|581501560|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
161030064|NCT03580356|581501561|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
161030065|NCT03580356|581501562|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
161030066|NCT03580356|581501563|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
161030067|NCT03580356|581501564|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
161030068|NCT05715528|581501565|FG000|Overall Study|Randomized but never treated|11|||
161030069|NCT05715528|581501566|FG001|Overall Study|Randomized but never treated|13|||
161030070|NCT05715528|581501565|FG000|Overall Study|Withdrew consent|7|||
161030071|NCT05715528|581501566|FG001|Overall Study|Withdrew consent|15|||
161030072|NCT05715528|581501565|FG000|Overall Study|Lost to Follow-up|5|||
161030073|NCT05715528|581501566|FG001|Overall Study|Lost to Follow-up|13|||
161030074|NCT05715528|581501565|FG000|Overall Study|Investigator's discretion|3|||
161030075|NCT05715528|581501566|FG001|Overall Study|Investigator's discretion|1|||
161030076|NCT05715528|581501565|FG000|Overall Study|Protocol Violation|2|||
161030077|NCT05715528|581501566|FG001|Overall Study|Protocol Violation|0|||
161030078|NCT05715528|581501565|FG000|Overall Study|Non-compliance with study drug|0|||
161030079|NCT05715528|581501566|FG001|Overall Study|Non-compliance with study drug|1|||
161030080|NCT02834390|581501567|FG000|Induction Phase|Progressive disease|0|||
161030081|NCT02834390|581501568|FG001|Induction Phase|Progressive disease|1|||
161030082|NCT02834390|581501567|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
161030083|NCT02834390|581501568|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
161030084|NCT02834390|581501567|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
161030085|NCT02834390|581501568|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
161030086|NCT02834390|581501567|FG000|Consolidation Phase|Physician Decision|1|||
161030087|NCT02834390|581501568|FG001|Consolidation Phase|Physician Decision|1|||
161030088|NCT03118518|581501569|FG000|Overall Study|Early Exit after treatment|2|||
161030089|NCT03118518|581501570|FG001|Overall Study|Early Exit after treatment|8|||
161030090|NCT03118518|581501569|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
161030091|NCT03118518|581501570|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
161030092|NCT03485729|581501578|FG000|Overall Study|Withdrawal by Subject|0|||
161030093|NCT03485729|581501579|FG001|Overall Study|Withdrawal by Subject|0|||
161277185|NCT03316547|582393455|FG000|Overall Study|Death|3|||
161277186|NCT03316547|582393456|FG001|Overall Study|Death|1|||
161277187|NCT03316547|582393455|FG000|Overall Study|Lost to Follow-up|6|||
161277188|NCT03316547|582393456|FG001|Overall Study|Lost to Follow-up|6|||
161277189|NCT03316547|582393455|FG000|Overall Study|Withdrawal by Subject|3|||
161277190|NCT03316547|582393456|FG001|Overall Study|Withdrawal by Subject|2|||
161277191|NCT03316547|582393455|FG000|Overall Study|Transfer to another hospital|6|||
160975603|NCT02875834|581299394|FG003|Open-label Phase|(Not collected)|0|||
160975604|NCT02875834|581299391|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
160975605|NCT02875834|581299392|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
160975606|NCT02875834|581299393|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
160975607|NCT02875834|581299394|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
160975608|NCT02875834|581299391|FG000|Randomized Treatment Phase|Protocol Violation|0|||
160975609|NCT02875834|581299392|FG001|Randomized Treatment Phase|Protocol Violation|2|||
160975610|NCT02875834|581299393|FG002|Randomized Treatment Phase|Protocol Violation|0|||
160975611|NCT02875834|581299394|FG003|Randomized Treatment Phase|Protocol Violation|0|||
160975612|NCT02875834|581299391|FG000|Randomized Treatment Phase|(Not collected)|0|||
160975613|NCT02875834|581299392|FG001|Randomized Treatment Phase|(Not collected)|9|||
160975614|NCT02875834|581299393|FG002|Randomized Treatment Phase|(Not collected)|10|||
160975615|NCT02875834|581299394|FG003|Randomized Treatment Phase|(Not collected)|9|||
160975616|NCT01302938|581299395|FG000|Overall Study|Withdrawal by Subject|1|||
160975617|NCT01302938|581299396|FG001|Overall Study|Withdrawal by Subject|0|||
161030094|NCT03485729|581501580|FG002|Overall Study|Withdrawal by Subject|1|||
161030095|NCT03485729|581501578|FG000|Overall Study|Disease progression|8|||
161030096|NCT03485729|581501579|FG001|Overall Study|Disease progression|13|||
161030097|NCT03485729|581501580|FG002|Overall Study|Disease progression|1|||
161030098|NCT03485729|581501578|FG000|Overall Study|Hospice care|1|||
161030099|NCT03485729|581501579|FG001|Overall Study|Hospice care|0|||
161030100|NCT03485729|581501580|FG002|Overall Study|Hospice care|0|||
161030101|NCT03485729|581501578|FG000|Overall Study|Poor performance status|1|||
161030102|NCT03485729|581501579|FG001|Overall Study|Poor performance status|0|||
161030103|NCT03485729|581501580|FG002|Overall Study|Poor performance status|0|||
161030104|NCT03485729|581501578|FG000|Overall Study|Illness|0|||
161030105|NCT03485729|581501579|FG001|Overall Study|Illness|1|||
161030106|NCT03485729|581501580|FG002|Overall Study|Illness|0|||
161030107|NCT05035654|581501581|FG000|Overall Study|Physician Decision|0|||
161030108|NCT05035654|581501582|FG001|Overall Study|Physician Decision|1|||
161030109|NCT05035654|581501583|FG002|Overall Study|Physician Decision|0|||
161030110|NCT05035654|581501581|FG000|Overall Study|Adverse Event|0|||
161030111|NCT05035654|581501582|FG001|Overall Study|Adverse Event|1|||
161030112|NCT05035654|581501583|FG002|Overall Study|Adverse Event|0|||
161030113|NCT05035654|581501581|FG000|Overall Study|Withdrawal by Subject|0|||
161030114|NCT05035654|581501582|FG001|Overall Study|Withdrawal by Subject|0|||
161030115|NCT05035654|581501583|FG002|Overall Study|Withdrawal by Subject|4|||
161030116|NCT05035654|581501581|FG000|Overall Study|Bilateral Dislodgement|1|||
161030117|NCT05035654|581501582|FG001|Overall Study|Bilateral Dislodgement|0|||
161030118|NCT05035654|581501583|FG002|Overall Study|Bilateral Dislodgement|0|||
161030119|NCT05552508|581501584|FG000|Overall Study|Adverse Event|3|||
161030120|NCT04632225|581501585|FG000|Overall Study|Withdrawal by Subject|2|||
161030121|NCT04632225|581501586|FG001|Overall Study|Withdrawal by Subject|2|||
161030122|NCT05660434|581501587|FG000|Overall Study|Never obtained study materials|2|||
161030123|NCT05660434|581501588|FG001|Overall Study|Never obtained study materials|1|||
161030124|NCT03213678|581501592|FG000|Overall Study|Death|1|||
161030125|NCT03213678|581501592|FG000|Overall Study|Physician Decision|1|||
161030126|NCT03213678|581501592|FG000|Overall Study|Progressive disease|16|||
161030127|NCT02413489|581501593|FG000|Overall Study|Death|11|||
161030128|NCT02413489|581501594|FG001|Overall Study|Death|3|||
161030129|NCT02413489|581501595|FG002|Overall Study|Death|4|||
161030130|NCT02413489|581501593|FG000|Overall Study|Withdrawal by Subject|2|||
161030131|NCT02413489|581501594|FG001|Overall Study|Withdrawal by Subject|0|||
161030132|NCT02413489|581501595|FG002|Overall Study|Withdrawal by Subject|0|||
161030133|NCT02413489|581501593|FG000|Overall Study|Study Terminated By Sponsor|2|||
161030134|NCT02413489|581501594|FG001|Overall Study|Study Terminated By Sponsor|13|||
161030135|NCT02413489|581501595|FG002|Overall Study|Study Terminated By Sponsor|1|||
161030136|NCT03717935|581501596|FG000|Overall Study|Withdrawal by Subject|0|||
161030137|NCT03717935|581501597|FG001|Overall Study|Withdrawal by Subject|2|||
161030138|NCT04456296|581501598|FG000|Overall Study|Withdrawal by Subject|14|||
161030139|NCT04456296|581501599|FG001|Overall Study|Withdrawal by Subject|21|||
161030140|NCT04456296|581501600|FG002|Overall Study|Withdrawal by Subject|21|||
161030141|NCT04456296|581501598|FG000|Overall Study|Adverse Event|2|||
161030142|NCT04456296|581501599|FG001|Overall Study|Adverse Event|2|||
161030143|NCT04456296|581501600|FG002|Overall Study|Adverse Event|2|||
161030144|NCT04456296|581501598|FG000|Overall Study|Death|1|||
161030145|NCT04456296|581501599|FG001|Overall Study|Death|0|||
161030146|NCT04456296|581501600|FG002|Overall Study|Death|0|||
161030147|NCT04456296|581501598|FG000|Overall Study|Lost to Follow-up|3|||
161030148|NCT04456296|581501599|FG001|Overall Study|Lost to Follow-up|5|||
161030149|NCT04456296|581501600|FG002|Overall Study|Lost to Follow-up|6|||
161030150|NCT04456296|581501598|FG000|Overall Study|Other than specified|0|||
161030151|NCT04456296|581501599|FG001|Overall Study|Other than specified|1|||
161030152|NCT04456296|581501600|FG002|Overall Study|Other than specified|4|||
161030153|NCT04456296|581501598|FG000|Overall Study|Randomized, not treated|2|||
161030154|NCT04456296|581501599|FG001|Overall Study|Randomized, not treated|1|||
161030155|NCT04456296|581501600|FG002|Overall Study|Randomized, not treated|0|||
161030156|NCT05736458|581501601|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
161030157|NCT05736458|581501602|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
161030158|NCT05736458|581501603|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
161030159|NCT05736458|581501601|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
161030160|NCT05736458|581501602|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
161030161|NCT05736458|581501603|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
161030162|NCT05736458|581501601|FG000|TMS/fMRI #1|Physician Decision|0|||
161277192|NCT03316547|582393456|FG001|Overall Study|Transfer to another hospital|4|||
161277193|NCT05292183|582395045|FG000|Overall Study|Adverse Event|1|||
161030163|NCT05736458|581501602|FG001|TMS/fMRI #1|Physician Decision|0|||
161030164|NCT05736458|581501603|FG002|TMS/fMRI #1|Physician Decision|2|||
161030165|NCT05736458|581501601|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
161030166|NCT05736458|581501602|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
161030167|NCT05736458|581501603|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
161030168|NCT05654662|581501613|FG000|Overall Study|Withdrawal by Subject|1|||
161030169|NCT05654662|581501614|FG001|Overall Study|Withdrawal by Subject|0|||
161030170|NCT05654662|581501613|FG000|Overall Study|A death in the family|1|||
161030171|NCT05654662|581501614|FG001|Overall Study|A death in the family|0|||
161030172|NCT04230681|581501615|FG000|Overall Study|Physician Decision|2|||
161030173|NCT04230681|581501616|FG001|Overall Study|Physician Decision|3|||
161030174|NCT04230681|581501615|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
161030175|NCT04230681|581501616|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
161030176|NCT04230681|581501615|FG000|Overall Study|IV inadvertently removed|0|||
161030177|NCT04230681|581501616|FG001|Overall Study|IV inadvertently removed|1|||
161030178|NCT03106740|581503051|FG000|Overall Study|Lost to Follow-up|2|||
161030179|NCT03106740|581503052|FG001|Overall Study|Lost to Follow-up|2|||
161030180|NCT03106740|581503051|FG000|Overall Study|Withdrawal by Subject|2|||
161030181|NCT03106740|581503052|FG001|Overall Study|Withdrawal by Subject|4|||
161030182|NCT03106740|581503051|FG000|Overall Study|Physician Decision|0|||
161030183|NCT03106740|581503052|FG001|Overall Study|Physician Decision|1|||
161030184|NCT03106740|581503051|FG000|Overall Study|Partial data|1|||
161030185|NCT03106740|581503052|FG001|Overall Study|Partial data|0|||
161030186|NCT04565990|581503053|FG000|Overall Study|Death|5|||
161030187|NCT04565990|581503053|FG000|Overall Study|Lost to Follow-up|1|||
161030188|NCT04565990|581503053|FG000|Overall Study|Withdrawal by Subject|1|||
161030189|NCT04797858|581503054|FG000|Overall Study|Withdrawal by Subject|0|||
161030190|NCT04797858|581503055|FG001|Overall Study|Withdrawal by Subject|1|||
161030191|NCT04797858|581503054|FG000|Overall Study|Excluded due to administrative error|7|||
161030192|NCT04797858|581503055|FG001|Overall Study|Excluded due to administrative error|8|||
161030193|NCT01880515|581503061|FG000|Overall Study|Lost to Follow-up|3|||
161030194|NCT01880515|581503062|FG001|Overall Study|Lost to Follow-up|2|||
161030195|NCT01880515|581503061|FG000|Overall Study|Disease Progression|5|||
161030196|NCT01880515|581503062|FG001|Overall Study|Disease Progression|7|||
161030197|NCT03505710|581503063|FG000|Overall Study|Progressive Disease|24|||
161030198|NCT03505710|581503064|FG001|Overall Study|Progressive Disease|17|||
161030199|NCT03505710|581503065|FG002|Overall Study|Progressive Disease|43|||
161030200|NCT03505710|581503063|FG000|Overall Study|Clinical Progression|6|||
161030201|NCT03505710|581503064|FG001|Overall Study|Clinical Progression|8|||
161030202|NCT03505710|581503065|FG002|Overall Study|Clinical Progression|3|||
160975618|NCT01302938|581299395|FG000|Overall Study|Adverse Event|1|||
160975619|NCT01302938|581299396|FG001|Overall Study|Adverse Event|0|||
160975620|NCT00539279|581299398|FG000|Treatment|Withdrawal by Subject|10|||
160975621|NCT00539279|581299399|FG001|Treatment|Withdrawal by Subject|8|||
160975622|NCT00539279|581299398|FG000|Treatment|Death|1|||
160975623|NCT00539279|581299399|FG001|Treatment|Death|0|||
160975624|NCT00539279|581299398|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
160975625|NCT00539279|581299399|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
160975626|NCT00539279|581299398|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
160975627|NCT00539279|581299399|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
160975628|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975629|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
160975630|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
160975631|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975632|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975633|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975634|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
160975635|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
160975636|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975637|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975638|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975639|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975640|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975641|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
160975642|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
160975643|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
160975644|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
160975645|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975646|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975647|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975648|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
160975649|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975650|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
160975651|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
160975652|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975653|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975654|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975655|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
160975656|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975657|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
161344402|NCT01369433|582647198|FG000|Overall Study|Lost to Follow-up|1|||
161344403|NCT01369433|582647199|FG001|Overall Study|Lost to Follow-up|0|||
161344404|NCT01369433|582647198|FG000|Overall Study|Death|5|||
161344405|NCT01369433|582647199|FG001|Overall Study|Death|0|||
161344406|NCT01369433|582647198|FG000|Overall Study|Investigator discretion|6|||
161344407|NCT01369433|582647199|FG001|Overall Study|Investigator discretion|1|||
161344408|NCT01369433|582647198|FG000|Overall Study|Progressive Disease|92|||
161344409|NCT01369433|582647199|FG001|Overall Study|Progressive Disease|12|||
161344410|NCT00688597|582647200|FG000|Overall Study|Adverse Event|2|||
161344411|NCT00688597|582647201|FG001|Overall Study|Adverse Event|0|||
161344412|NCT00688597|582647202|FG002|Overall Study|Adverse Event|0|||
161344413|NCT00688597|582647200|FG000|Overall Study|Physician Decision|1|||
161344414|NCT00688597|582647201|FG001|Overall Study|Physician Decision|0|||
161344415|NCT00688597|582647202|FG002|Overall Study|Physician Decision|0|||
161344416|NCT01995201|582647205|FG000|From Baseline Until Week 24|Adverse Event|4|||
161344417|NCT01995201|582647206|FG001|From Baseline Until Week 24|Adverse Event|15|||
161344418|NCT01995201|582647207|FG002|From Baseline Until Week 24|Adverse Event|0|||
161344419|NCT01995201|582647208|FG003|From Baseline Until Week 24|Adverse Event|0|||
161344420|NCT01995201|582647209|FG004|From Baseline Until Week 24|Adverse Event|0|||
161344421|NCT01995201|582647210|FG005|From Baseline Until Week 24|Adverse Event|0|||
161344422|NCT01995201|582647211|FG006|From Baseline Until Week 24|Adverse Event|0|||
161344423|NCT01995201|582647205|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161344424|NCT01995201|582647206|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
161344425|NCT01995201|582647207|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161344426|NCT01995201|582647208|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161344427|NCT01995201|582647209|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161344428|NCT01995201|582647210|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161344429|NCT01995201|582647211|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
161344430|NCT01995201|582647205|FG000|From Baseline Until Week 24|Death|0|||
161344431|NCT01995201|582647206|FG001|From Baseline Until Week 24|Death|1|||
161344432|NCT01995201|582647207|FG002|From Baseline Until Week 24|Death|0|||
161344433|NCT01995201|582647208|FG003|From Baseline Until Week 24|Death|0|||
161344434|NCT01995201|582647209|FG004|From Baseline Until Week 24|Death|0|||
161344435|NCT01995201|582647210|FG005|From Baseline Until Week 24|Death|0|||
161344436|NCT01995201|582647211|FG006|From Baseline Until Week 24|Death|0|||
161344437|NCT01995201|582647205|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
161344438|NCT01995201|582647206|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
161344439|NCT01995201|582647207|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
161344440|NCT01995201|582647208|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
161344441|NCT01995201|582647209|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
161344442|NCT01995201|582647210|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
161344443|NCT01995201|582647211|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
161344444|NCT01995201|582647205|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
161344445|NCT01995201|582647206|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
161344446|NCT01995201|582647207|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
161344447|NCT01995201|582647208|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
161344448|NCT01995201|582647209|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
161344449|NCT01995201|582647210|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
161277194|NCT02017015|582395050|FG000|Overall Study|Adverse Event|9|||
161277195|NCT02017015|582395050|FG000|Overall Study|Withdrawal by Subject|21|||
161277196|NCT02017015|582395050|FG000|Overall Study|Death|4|||
161277197|NCT02017015|582395050|FG000|Overall Study|Progressive Disease|31|||
161277198|NCT02017015|582395050|FG000|Overall Study|Non-compliance with study drug|2|||
161277199|NCT02017015|582395050|FG000|Overall Study|Physician Decision|2|||
161277200|NCT01277601|582395053|FG000|Overall Study|Adverse Event|5|||
161277201|NCT01277601|582395054|FG001|Overall Study|Adverse Event|3|||
161277202|NCT01277601|582395055|FG002|Overall Study|Adverse Event|0|||
161277203|NCT01277601|582395056|FG003|Overall Study|Adverse Event|7|||
161277204|NCT01277601|582395053|FG000|Overall Study|Withdrawal by Subject|18|||
161344450|NCT01995201|582647211|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
161344451|NCT01995201|582647205|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
161277205|NCT01277601|582395054|FG001|Overall Study|Withdrawal by Subject|21|||
161344452|NCT01995201|582647206|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
161344453|NCT01995201|582647207|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
161344454|NCT01995201|582647208|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
161344455|NCT01995201|582647209|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
161344456|NCT01995201|582647210|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
161344457|NCT01995201|582647211|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
161344458|NCT01995201|582647205|FG000|From Baseline Until Week 24|Physician Decision|0|||
161030203|NCT03505710|581503063|FG000|Overall Study|Adverse Event|12|||
161030204|NCT03505710|581503064|FG001|Overall Study|Adverse Event|6|||
161277206|NCT01277601|582395055|FG002|Overall Study|Withdrawal by Subject|8|||
161277207|NCT01277601|582395056|FG003|Overall Study|Withdrawal by Subject|17|||
161344459|NCT01995201|582647206|FG001|From Baseline Until Week 24|Physician Decision|2|||
161030205|NCT03505710|581503065|FG002|Overall Study|Adverse Event|28|||
161030206|NCT03505710|581503063|FG000|Overall Study|Withdrawal by Subject|1|||
161030207|NCT03505710|581503064|FG001|Overall Study|Withdrawal by Subject|3|||
161030208|NCT03505710|581503065|FG002|Overall Study|Withdrawal by Subject|7|||
161030209|NCT03505710|581503063|FG000|Overall Study|Physician Decision|1|||
161030210|NCT03505710|581503064|FG001|Overall Study|Physician Decision|1|||
161030211|NCT03505710|581503065|FG002|Overall Study|Physician Decision|2|||
161030212|NCT03505710|581503063|FG000|Overall Study|Death|4|||
161030213|NCT03505710|581503064|FG001|Overall Study|Death|5|||
161030214|NCT03505710|581503065|FG002|Overall Study|Death|6|||
161030215|NCT03505710|581503063|FG000|Overall Study|Other Reasons|1|||
161030216|NCT03505710|581503064|FG001|Overall Study|Other Reasons|1|||
161030217|NCT03505710|581503065|FG002|Overall Study|Other Reasons|1|||
161030218|NCT03505710|581503063|FG000|Overall Study|Study Terminated by Sponsor|0|||
161030219|NCT03505710|581503064|FG001|Overall Study|Study Terminated by Sponsor|0|||
161030220|NCT03505710|581503065|FG002|Overall Study|Study Terminated by Sponsor|1|||
161030221|NCT04414722|581503066|FG000|Overall Study|Lost to Follow-up|3|||
161030222|NCT04414722|581503067|FG001|Overall Study|Lost to Follow-up|4|||
161030223|NCT04414722|581503068|FG002|Overall Study|Lost to Follow-up|3|||
161030224|NCT04414722|581503069|FG003|Overall Study|Lost to Follow-up|2|||
161030225|NCT04414722|581503070|FG004|Overall Study|Lost to Follow-up|3|||
161030226|NCT04414722|581503066|FG000|Overall Study|Withdrawal by Subject|6|||
161030227|NCT04414722|581503067|FG001|Overall Study|Withdrawal by Subject|3|||
161030228|NCT04414722|581503068|FG002|Overall Study|Withdrawal by Subject|1|||
161030229|NCT04414722|581503069|FG003|Overall Study|Withdrawal by Subject|5|||
161030230|NCT04414722|581503070|FG004|Overall Study|Withdrawal by Subject|1|||
161030231|NCT04414722|581503066|FG000|Overall Study|Physician Decision|0|||
161030232|NCT04414722|581503067|FG001|Overall Study|Physician Decision|1|||
161030233|NCT04414722|581503068|FG002|Overall Study|Physician Decision|2|||
161030234|NCT04414722|581503069|FG003|Overall Study|Physician Decision|0|||
161030235|NCT04414722|581503070|FG004|Overall Study|Physician Decision|0|||
161030236|NCT04414722|581503066|FG000|Overall Study|Non-participatory|0|||
161030237|NCT04414722|581503067|FG001|Overall Study|Non-participatory|1|||
161030238|NCT04414722|581503068|FG002|Overall Study|Non-participatory|1|||
161030239|NCT04414722|581503069|FG003|Overall Study|Non-participatory|0|||
161030240|NCT04414722|581503070|FG004|Overall Study|Non-participatory|0|||
161030241|NCT04766892|581503071|FG000|Overall Study|Withdrawal by Subject|1|||
161030242|NCT04766892|581503071|FG000|Overall Study|Lost to Follow-up|1|||
161030243|NCT04766892|581503071|FG000|Overall Study|Adverse Event|3|||
161030244|NCT04766892|581503071|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
161030245|NCT04359654|581503072|FG000|Overall Study|Withdrawal by Subject|1|||
161030246|NCT04359654|581503073|FG001|Overall Study|Withdrawal by Subject|0|||
161030247|NCT04359654|581503072|FG000|Overall Study|Adverse Event|0|||
161030248|NCT04359654|581503073|FG001|Overall Study|Adverse Event|1|||
161030249|NCT03711474|581503076|FG000|Overall Study|Physician Decision|2|||
161030250|NCT03711474|581503077|FG001|Overall Study|Physician Decision|0|||
161030251|NCT03677141|581503080|FG000|Overall Study|Death|2|||
161030252|NCT03677141|581503081|FG001|Overall Study|Death|1|||
161030253|NCT03677141|581503082|FG002|Overall Study|Death|6|||
161030254|NCT03677141|581503083|FG003|Overall Study|Death|9|||
161030255|NCT03677141|581503084|FG004|Overall Study|Death|5|||
161030256|NCT03677141|581503085|FG005|Overall Study|Death|3|||
161030257|NCT03677141|581503080|FG000|Overall Study|Lost to Follow-up|0|||
161030258|NCT03677141|581503081|FG001|Overall Study|Lost to Follow-up|0|||
161030259|NCT03677141|581503082|FG002|Overall Study|Lost to Follow-up|0|||
161030260|NCT03677141|581503083|FG003|Overall Study|Lost to Follow-up|2|||
161030261|NCT03677141|581503084|FG004|Overall Study|Lost to Follow-up|0|||
161030262|NCT03677141|581503085|FG005|Overall Study|Lost to Follow-up|0|||
161030263|NCT03677141|581503080|FG000|Overall Study|Screen failure or enrolled in error|0|||
161030264|NCT03677141|581503081|FG001|Overall Study|Screen failure or enrolled in error|0|||
161030265|NCT03677141|581503082|FG002|Overall Study|Screen failure or enrolled in error|0|||
161030266|NCT03677141|581503083|FG003|Overall Study|Screen failure or enrolled in error|0|||
161030267|NCT03677141|581503084|FG004|Overall Study|Screen failure or enrolled in error|2|||
161030268|NCT03677141|581503085|FG005|Overall Study|Screen failure or enrolled in error|0|||
161030269|NCT03677141|581503080|FG000|Overall Study|Physician Decision|0|||
161030270|NCT03677141|581503081|FG001|Overall Study|Physician Decision|0|||
161030271|NCT03677141|581503082|FG002|Overall Study|Physician Decision|0|||
161030272|NCT03677141|581503083|FG003|Overall Study|Physician Decision|0|||
161148832|NCT04760314|581926149|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
161148833|NCT03238248|581926155|FG000|Overall Study|Death|5|||
161030273|NCT03677141|581503084|FG004|Overall Study|Physician Decision|1|||
161030274|NCT03677141|581503085|FG005|Overall Study|Physician Decision|0|||
161030275|NCT03677141|581503080|FG000|Overall Study|Withdrawal by Subject|0|||
161030276|NCT03677141|581503081|FG001|Overall Study|Withdrawal by Subject|0|||
161030277|NCT03677141|581503082|FG002|Overall Study|Withdrawal by Subject|1|||
161030278|NCT03677141|581503083|FG003|Overall Study|Withdrawal by Subject|1|||
161030279|NCT03677141|581503084|FG004|Overall Study|Withdrawal by Subject|1|||
161030280|NCT03677141|581503085|FG005|Overall Study|Withdrawal by Subject|0|||
161030281|NCT04003246|581503089|FG000|Overall Study|Death|9|||
161277208|NCT01277601|582395053|FG000|Overall Study|Lost to Follow-up|7|||
161277209|NCT01277601|582395054|FG001|Overall Study|Lost to Follow-up|9|||
161277210|NCT01277601|582395055|FG002|Overall Study|Lost to Follow-up|4|||
161277211|NCT01277601|582395056|FG003|Overall Study|Lost to Follow-up|2|||
161277212|NCT01277601|582395053|FG000|Overall Study|Physician Decision|3|||
161277213|NCT01277601|582395054|FG001|Overall Study|Physician Decision|5|||
161277214|NCT01277601|582395055|FG002|Overall Study|Physician Decision|1|||
161277215|NCT01277601|582395056|FG003|Overall Study|Physician Decision|6|||
161277216|NCT01277601|582395053|FG000|Overall Study|Pregnancy|2|||
161277217|NCT01277601|582395054|FG001|Overall Study|Pregnancy|2|||
161277218|NCT01277601|582395055|FG002|Overall Study|Pregnancy|4|||
161277219|NCT01277601|582395056|FG003|Overall Study|Pregnancy|1|||
161277220|NCT01277601|582395053|FG000|Overall Study|Noncompliance with Study Drug|1|||
161277221|NCT01277601|582395054|FG001|Overall Study|Noncompliance with Study Drug|3|||
161277222|NCT01277601|582395055|FG002|Overall Study|Noncompliance with Study Drug|2|||
161277223|NCT01277601|582395056|FG003|Overall Study|Noncompliance with Study Drug|0|||
161277224|NCT01277601|582395053|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
161277225|NCT01277601|582395054|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
161277226|NCT01277601|582395055|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
161277227|NCT01277601|582395056|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
161277228|NCT01277601|582395053|FG000|Overall Study|Protocol Violation|0|||
161277229|NCT01277601|582395054|FG001|Overall Study|Protocol Violation|2|||
161277230|NCT01277601|582395055|FG002|Overall Study|Protocol Violation|5|||
161277231|NCT01277601|582395056|FG003|Overall Study|Protocol Violation|0|||
161277232|NCT01277601|582395053|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
161277233|NCT01277601|582395054|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
161277234|NCT01277601|582395055|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
161277235|NCT01277601|582395056|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
161277236|NCT02260570|582395058|FG000|Overall Study|Withdrawal by Subject|2|||
161277237|NCT02260570|582395059|FG001|Overall Study|Withdrawal by Subject|1|||
161277238|NCT02260570|582395058|FG000|Overall Study|Physician Decision|1|||
161277239|NCT02260570|582395059|FG001|Overall Study|Physician Decision|1|||
161277240|NCT04034927|582395060|FG000|Overall Study|Adverse Event|4|||
161277241|NCT04034927|582395061|FG001|Overall Study|Adverse Event|9|||
161277242|NCT04034927|582395060|FG000|Overall Study|Death|0|||
161277243|NCT04034927|582395061|FG001|Overall Study|Death|1|||
161277244|NCT04034927|582395060|FG000|Overall Study|Withdrawal by Subject|0|||
161277245|NCT04034927|582395061|FG001|Overall Study|Withdrawal by Subject|3|||
161277246|NCT04034927|582395060|FG000|Overall Study|Still on Treatment|2|||
161277247|NCT04034927|582395061|FG001|Overall Study|Still on Treatment|1|||
161277248|NCT04034927|582395060|FG000|Overall Study|Other|1|||
161277249|NCT04034927|582395061|FG001|Overall Study|Other|1|||
161277250|NCT00287586|582395064|FG000|Overall Study|Withdrew Consent|19|||
161277251|NCT00287586|582395065|FG001|Overall Study|Withdrew Consent|30|||
161277252|NCT00287586|582395064|FG000|Overall Study|Lost to Follow-up|5|||
161277253|NCT00287586|582395065|FG001|Overall Study|Lost to Follow-up|4|||
161277254|NCT00287586|582395064|FG000|Overall Study|Death|2|||
161277255|NCT00287586|582395065|FG001|Overall Study|Death|3|||
161277256|NCT00287586|582395064|FG000|Overall Study|Elevated Hematocrit|3|||
161277257|NCT00287586|582395065|FG001|Overall Study|Elevated Hematocrit|0|||
161277258|NCT00287586|582395064|FG000|Overall Study|Rash|3|||
161277259|NCT00287586|582395065|FG001|Overall Study|Rash|0|||
161277260|NCT00287586|582395064|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
161277261|NCT00287586|582395065|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
161277262|NCT00287586|582395064|FG000|Overall Study|Stroke|2|||
161277263|NCT00287586|582395065|FG001|Overall Study|Stroke|0|||
161277264|NCT00287586|582395064|FG000|Overall Study|Myocardial Infarction|1|||
161277265|NCT00287586|582395065|FG001|Overall Study|Myocardial Infarction|0|||
161277266|NCT00287586|582395064|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
161277267|NCT00287586|582395065|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
161277268|NCT00287586|582395064|FG000|Overall Study|Cognitive Impairment|1|||
161030282|NCT04451772|581503115|FG000|Overall Study|Adverse Event|1|||
161030283|NCT04451772|581503116|FG001|Overall Study|Adverse Event|0|||
161030284|NCT04451772|581503117|FG002|Overall Study|Adverse Event|1|||
161277269|NCT00287586|582395065|FG001|Overall Study|Cognitive Impairment|0|||
161277270|NCT00287586|582395064|FG000|Overall Study|Pancreatic Cancer|1|||
161277271|NCT00287586|582395065|FG001|Overall Study|Pancreatic Cancer|3|||
161277272|NCT00287586|582395064|FG000|Overall Study|Sleep Apnea|1|||
161277273|NCT00287586|582395065|FG001|Overall Study|Sleep Apnea|0|||
161277274|NCT00287586|582395064|FG000|Overall Study|Shoulder Pain|1|||
161277275|NCT00287586|582395065|FG001|Overall Study|Shoulder Pain|0|||
161277276|NCT00287586|582395064|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
161277277|NCT00287586|582395065|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
161277278|NCT00287586|582395064|FG000|Overall Study|Nonadherence|1|||
161277279|NCT00287586|582395065|FG001|Overall Study|Nonadherence|1|||
161277280|NCT00287586|582395064|FG000|Overall Study|Enrolled in Another Study|1|||
161277281|NCT00287586|582395065|FG001|Overall Study|Enrolled in Another Study|0|||
161030285|NCT04451772|581503118|FG003|Overall Study|Adverse Event|1|||
161277282|NCT00287586|582395064|FG000|Overall Study|Major Depression|0|||
161277283|NCT00287586|582395065|FG001|Overall Study|Major Depression|2|||
161277284|NCT00287586|582395064|FG000|Overall Study|Lung Cancer|0|||
161277285|NCT00287586|582395065|FG001|Overall Study|Lung Cancer|2|||
161277286|NCT00287586|582395064|FG000|Overall Study|Elevated IPSS Score|0|||
161277287|NCT00287586|582395065|FG001|Overall Study|Elevated IPSS Score|1|||
161277288|NCT00287586|582395064|FG000|Overall Study|Retroperitoneal Cancer|0|||
161277289|NCT00287586|582395065|FG001|Overall Study|Retroperitoneal Cancer|1|||
161277290|NCT00287586|582395064|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
161277291|NCT00287586|582395065|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
161277292|NCT00287586|582395064|FG000|Overall Study|Mood Swings and Irritability|0|||
161277293|NCT00287586|582395065|FG001|Overall Study|Mood Swings and Irritability|1|||
161277294|NCT00287586|582395064|FG000|Overall Study|Bradycardia|0|||
161277295|NCT00287586|582395065|FG001|Overall Study|Bradycardia|1|||
161277296|NCT00287586|582395064|FG000|Overall Study|Itchy Swollen Eyes|0|||
161277297|NCT00287586|582395065|FG001|Overall Study|Itchy Swollen Eyes|1|||
161277298|NCT00287586|582395064|FG000|Overall Study|Recurrent Melanoma|0|||
161277299|NCT00287586|582395065|FG001|Overall Study|Recurrent Melanoma|1|||
161277300|NCT00264550|582395066|FG000|Overall Study|Death|0|||
161277301|NCT00264550|582395067|FG001|Overall Study|Death|3|||
161277302|NCT00264550|582395068|FG002|Overall Study|Death|0|||
161277303|NCT00264550|582395069|FG003|Overall Study|Death|0|||
161277304|NCT00264550|582395066|FG000|Overall Study|Lost to Follow-up|3|||
161277305|NCT00264550|582395067|FG001|Overall Study|Lost to Follow-up|1|||
161277306|NCT00264550|582395068|FG002|Overall Study|Lost to Follow-up|1|||
161277307|NCT00264550|582395069|FG003|Overall Study|Lost to Follow-up|1|||
161277308|NCT00264550|582395066|FG000|Overall Study|Adverse Event|23|||
161277309|NCT00264550|582395067|FG001|Overall Study|Adverse Event|18|||
161277310|NCT00264550|582395068|FG002|Overall Study|Adverse Event|9|||
161277311|NCT00264550|582395069|FG003|Overall Study|Adverse Event|14|||
161277312|NCT00264550|582395066|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161277313|NCT00264550|582395067|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
161277314|NCT00264550|582395068|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
161277315|NCT00264550|582395069|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
161277316|NCT00264550|582395066|FG000|Overall Study|Discontinued oral study agent|0|||
161277317|NCT00264550|582395067|FG001|Overall Study|Discontinued oral study agent|1|||
161277318|NCT00264550|582395068|FG002|Overall Study|Discontinued oral study agent|0|||
161277319|NCT00264550|582395069|FG003|Overall Study|Discontinued oral study agent|0|||
161277320|NCT00264550|582395066|FG000|Overall Study|Other|13|||
161277321|NCT00264550|582395067|FG001|Overall Study|Other|7|||
161277322|NCT00264550|582395068|FG002|Overall Study|Other|3|||
161277323|NCT00264550|582395069|FG003|Overall Study|Other|9|||
161277324|NCT02129608|582395070|FG000|Overall Study|Lost to Follow-up|0|||
161030286|NCT04451772|581503119|FG004|Overall Study|Adverse Event|0|||
161030287|NCT04451772|581503120|FG005|Overall Study|Adverse Event|3|||
161030288|NCT04451772|581503115|FG000|Overall Study|Withdrawal by Subject|2|||
161030289|NCT04451772|581503116|FG001|Overall Study|Withdrawal by Subject|7|||
161030290|NCT04451772|581503117|FG002|Overall Study|Withdrawal by Subject|2|||
161030291|NCT04451772|581503118|FG003|Overall Study|Withdrawal by Subject|1|||
161030292|NCT04451772|581503119|FG004|Overall Study|Withdrawal by Subject|1|||
161030293|NCT04451772|581503120|FG005|Overall Study|Withdrawal by Subject|0|||
161030294|NCT04451772|581503115|FG000|Overall Study|Other, not specified|1|||
161030295|NCT04451772|581503116|FG001|Overall Study|Other, not specified|2|||
161030296|NCT04451772|581503117|FG002|Overall Study|Other, not specified|1|||
161030297|NCT04451772|581503118|FG003|Overall Study|Other, not specified|0|||
161030298|NCT04451772|581503119|FG004|Overall Study|Other, not specified|0|||
161030299|NCT04451772|581503120|FG005|Overall Study|Other, not specified|1|||
161030300|NCT04451772|581503115|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
161030301|NCT04451772|581503116|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
161030302|NCT04451772|581503117|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
161030303|NCT04451772|581503118|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
161030304|NCT04451772|581503119|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
161030305|NCT04451772|581503120|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
161277325|NCT02129608|582395071|FG001|Overall Study|Lost to Follow-up|1|||
161277326|NCT02129608|582395072|FG002|Overall Study|Lost to Follow-up|1|||
161277327|NCT02129608|582395070|FG000|Overall Study|Withdrawal by Subject|0|||
161277328|NCT02129608|582395071|FG001|Overall Study|Withdrawal by Subject|0|||
161277329|NCT02129608|582395072|FG002|Overall Study|Withdrawal by Subject|2|||
161277330|NCT00425373|582395081|FG000|Overall Study|Adverse Event|2|||
161277331|NCT00425373|582395082|FG001|Overall Study|Adverse Event|2|||
161277332|NCT00425373|582395083|FG002|Overall Study|Adverse Event|0|||
161277333|NCT00425373|582395084|FG003|Overall Study|Adverse Event|1|||
161277334|NCT00425373|582395085|FG004|Overall Study|Adverse Event|4|||
161277335|NCT00425373|582395086|FG005|Overall Study|Adverse Event|6|||
161277336|NCT00425373|582395087|FG006|Overall Study|Adverse Event|2|||
161277337|NCT00425373|582395088|FG007|Overall Study|Adverse Event|3|||
161277338|NCT00425373|582395089|FG008|Overall Study|Adverse Event|8|||
161277339|NCT00425373|582395081|FG000|Overall Study|Lost to Follow-up|0|||
161277340|NCT00425373|582395082|FG001|Overall Study|Lost to Follow-up|1|||
161277341|NCT00425373|582395083|FG002|Overall Study|Lost to Follow-up|0|||
161277342|NCT00425373|582395084|FG003|Overall Study|Lost to Follow-up|0|||
161277343|NCT00425373|582395085|FG004|Overall Study|Lost to Follow-up|1|||
161277344|NCT00425373|582395086|FG005|Overall Study|Lost to Follow-up|0|||
161277345|NCT00425373|582395087|FG006|Overall Study|Lost to Follow-up|0|||
161277346|NCT00425373|582395088|FG007|Overall Study|Lost to Follow-up|0|||
161277347|NCT00425373|582395089|FG008|Overall Study|Lost to Follow-up|0|||
161277348|NCT00425373|582395081|FG000|Overall Study|Protocol Violation|1|||
161277349|NCT00425373|582395082|FG001|Overall Study|Protocol Violation|0|||
161277350|NCT00425373|582395083|FG002|Overall Study|Protocol Violation|1|||
161277351|NCT00425373|582395084|FG003|Overall Study|Protocol Violation|0|||
161277352|NCT00425373|582395085|FG004|Overall Study|Protocol Violation|0|||
161277353|NCT00425373|582395086|FG005|Overall Study|Protocol Violation|0|||
161277354|NCT00425373|582395087|FG006|Overall Study|Protocol Violation|0|||
161277355|NCT00425373|582395088|FG007|Overall Study|Protocol Violation|5|||
161277356|NCT00425373|582395089|FG008|Overall Study|Protocol Violation|3|||
161277357|NCT00425373|582395081|FG000|Overall Study|Withdrawal by Subject|2|||
161277358|NCT00425373|582395082|FG001|Overall Study|Withdrawal by Subject|0|||
161277359|NCT00425373|582395083|FG002|Overall Study|Withdrawal by Subject|2|||
161277360|NCT00425373|582395084|FG003|Overall Study|Withdrawal by Subject|1|||
161277361|NCT00425373|582395085|FG004|Overall Study|Withdrawal by Subject|4|||
161277362|NCT00425373|582395086|FG005|Overall Study|Withdrawal by Subject|0|||
161277363|NCT00425373|582395087|FG006|Overall Study|Withdrawal by Subject|2|||
161277364|NCT00425373|582395088|FG007|Overall Study|Withdrawal by Subject|2|||
161277365|NCT00425373|582395089|FG008|Overall Study|Withdrawal by Subject|2|||
161277366|NCT00425373|582395081|FG000|Overall Study|Lack of Efficacy|0|||
161277367|NCT00425373|582395082|FG001|Overall Study|Lack of Efficacy|0|||
161277368|NCT00425373|582395083|FG002|Overall Study|Lack of Efficacy|0|||
161277369|NCT00425373|582395084|FG003|Overall Study|Lack of Efficacy|0|||
161277370|NCT00425373|582395085|FG004|Overall Study|Lack of Efficacy|1|||
161277371|NCT00425373|582395086|FG005|Overall Study|Lack of Efficacy|3|||
161277372|NCT00425373|582395087|FG006|Overall Study|Lack of Efficacy|3|||
161277373|NCT00425373|582395088|FG007|Overall Study|Lack of Efficacy|0|||
161277374|NCT00425373|582395089|FG008|Overall Study|Lack of Efficacy|5|||
161277375|NCT02620579|582395097|FG000|Overall Study|Physician Decision|0|||
161277376|NCT02620579|582395098|FG001|Overall Study|Physician Decision|0|||
161277377|NCT02620579|582395099|FG002|Overall Study|Physician Decision|0|||
161277378|NCT02620579|582395100|FG003|Overall Study|Physician Decision|1|||
161277379|NCT02620579|582395097|FG000|Overall Study|Withdrawal by Subject|0|||
161277380|NCT02620579|582395098|FG001|Overall Study|Withdrawal by Subject|1|||
161277381|NCT02620579|582395099|FG002|Overall Study|Withdrawal by Subject|1|||
161277382|NCT02620579|582395100|FG003|Overall Study|Withdrawal by Subject|0|||
161277383|NCT01721317|582395101|FG000|Overall Study|Study Closed / Terminated|2|||
161277384|NCT01721317|582395102|FG001|Overall Study|Study Closed / Terminated|2|||
161277385|NCT01721317|582395101|FG000|Overall Study|Physician Decision|0|||
161277386|NCT01721317|582395102|FG001|Overall Study|Physician Decision|1|||
161277387|NCT01721317|582395101|FG000|Overall Study|Withdrawal by Subject|0|||
161277388|NCT01721317|582395102|FG001|Overall Study|Withdrawal by Subject|1|||
161030306|NCT04311632|581503121|FG000|Overall Study|Withdrawal by Subject|0|||
161030307|NCT04311632|581503122|FG001|Overall Study|Withdrawal by Subject|0|||
161030308|NCT04311632|581503123|FG002|Overall Study|Withdrawal by Subject|1|||
161030309|NCT05856435|581503124|FG000|Overall Study|Lost to Follow-up|6|||
161030310|NCT05970861|581503126|FG000|Overall Study|Physician Decision|4|||
161030311|NCT05970861|581503127|FG001|Overall Study|Physician Decision|4|||
161030312|NCT05970861|581503126|FG000|Overall Study|Lost to Follow-up|4|||
161030313|NCT05970861|581503127|FG001|Overall Study|Lost to Follow-up|3|||
161030314|NCT02990338|581503128|FG000|Overall Study|Randomized and not treated|4|||
161277389|NCT02661217|582395107|FG000|Overall Study|Physician Decision|12|||
161277390|NCT02661217|582395108|FG001|Overall Study|Physician Decision|15|||
161277391|NCT02661217|582395107|FG000|Overall Study|Lost to Follow-up|1|||
161277392|NCT02661217|582395108|FG001|Overall Study|Lost to Follow-up|4|||
161277393|NCT02661217|582395107|FG000|Overall Study|Protocol Deviation|0|||
161277394|NCT02661217|582395108|FG001|Overall Study|Protocol Deviation|4|||
161277395|NCT02661217|582395107|FG000|Overall Study|Non-compliance with study treatment|5|||
161277396|NCT02661217|582395108|FG001|Overall Study|Non-compliance with study treatment|5|||
161277397|NCT02661217|582395107|FG000|Overall Study|Death|21|||
161277398|NCT02661217|582395108|FG001|Overall Study|Death|15|||
161277399|NCT02661217|582395107|FG000|Overall Study|Adverse Event|10|||
161277400|NCT02661217|582395108|FG001|Overall Study|Adverse Event|8|||
161277401|NCT02661217|582395107|FG000|Overall Study|Withdrawal by Subject|15|||
161277402|NCT02661217|582395108|FG001|Overall Study|Withdrawal by Subject|19|||
161277403|NCT02661217|582395107|FG000|Overall Study|Did not enter follow-up epoch|7|||
161277404|NCT02661217|582395108|FG001|Overall Study|Did not enter follow-up epoch|10|||
161277405|NCT02661217|582395107|FG000|Overall Study|Death - no study drug received|1|||
161277406|NCT02661217|582395108|FG001|Overall Study|Death - no study drug received|2|||
161277407|NCT02661217|582395107|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
161030315|NCT02990338|581503129|FG001|Overall Study|Randomized and not treated|2|||
161030316|NCT02990338|581503128|FG000|Overall Study|Adverse Event|23|||
161030317|NCT02990338|581503129|FG001|Overall Study|Adverse Event|22|||
161030318|NCT02990338|581503128|FG000|Overall Study|Progressive disease|118|||
161030319|NCT02990338|581503129|FG001|Overall Study|Progressive disease|107|||
161030320|NCT02990338|581503128|FG000|Overall Study|Poor compliance to protocol|0|||
161030321|NCT02990338|581503129|FG001|Overall Study|Poor compliance to protocol|1|||
161030322|NCT02990338|581503128|FG000|Overall Study|Withdrawal by Subject|6|||
161030323|NCT02990338|581503129|FG001|Overall Study|Withdrawal by Subject|8|||
161030324|NCT02990338|581503128|FG000|Overall Study|Physician's decision|2|||
161030325|NCT02990338|581503129|FG001|Overall Study|Physician's decision|6|||
161030326|NCT02990338|581503128|FG000|Overall Study|Treatment extension study|0|||
161030327|NCT02990338|581503129|FG001|Overall Study|Treatment extension study|6|||
161030328|NCT02990338|581503128|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
161030329|NCT02990338|581503129|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
161030330|NCT02990338|581503128|FG000|Overall Study|Continue with therapy available commercially|0|||
161030331|NCT02990338|581503129|FG001|Overall Study|Continue with therapy available commercially|1|||
161030332|NCT05100628|581503131|FG000|Overall Study|Progressive Disease|1|||
161030333|NCT05100628|581503132|FG001|Overall Study|Progressive Disease|0|||
161030334|NCT05100628|581503133|FG002|Overall Study|Progressive Disease|0|||
161030335|NCT05100628|581503134|FG003|Overall Study|Progressive Disease|0|||
161030336|NCT05100628|581503131|FG000|Overall Study|Study Terminated by Sponsor|0|||
161030337|NCT05100628|581503132|FG001|Overall Study|Study Terminated by Sponsor|0|||
161030338|NCT05100628|581503133|FG002|Overall Study|Study Terminated by Sponsor|3|||
161030339|NCT05100628|581503134|FG003|Overall Study|Study Terminated by Sponsor|0|||
161030340|NCT05100628|581503131|FG000|Overall Study|unkown|0|||
161030341|NCT05100628|581503132|FG001|Overall Study|unkown|1|||
161030342|NCT05100628|581503133|FG002|Overall Study|unkown|0|||
161030343|NCT05100628|581503134|FG003|Overall Study|unkown|0|||
161030344|NCT03914469|581503135|FG000|Overall Study|Lost to Follow-up|1|||
161030345|NCT03914469|581503136|FG001|Overall Study|Lost to Follow-up|4|||
161030346|NCT00677365|581503141|FG000|Overall Study|Adverse Event|2|||
161030347|NCT00677365|581503142|FG001|Overall Study|Adverse Event|1|||
161030348|NCT00677365|581503143|FG002|Overall Study|Adverse Event|1|||
161030349|NCT00677365|581503144|FG003|Overall Study|Adverse Event|2|||
161030350|NCT00677365|581503141|FG000|Overall Study|Withdrawal by Subject|0|||
161030351|NCT00677365|581503142|FG001|Overall Study|Withdrawal by Subject|0|||
161030352|NCT00677365|581503143|FG002|Overall Study|Withdrawal by Subject|1|||
161030353|NCT00677365|581503144|FG003|Overall Study|Withdrawal by Subject|0|||
161030354|NCT00677365|581503141|FG000|Overall Study|Other reason|0|||
161030355|NCT00677365|581503142|FG001|Overall Study|Other reason|0|||
161030356|NCT00677365|581503143|FG002|Overall Study|Other reason|0|||
161030357|NCT00677365|581503144|FG003|Overall Study|Other reason|1|||
161030358|NCT05900154|581503145|FG000|Follow-Up Period|Lost to Follow-up|1|||
161030359|NCT05900154|581503146|FG001|Follow-Up Period|Lost to Follow-up|2|||
161030360|NCT05900154|581503147|FG002|Follow-Up Period|Lost to Follow-up|1|||
161030361|NCT05900154|581503148|FG003|Follow-Up Period|Lost to Follow-up|0|||
161030362|NCT05900154|581503149|FG004|Follow-Up Period|Lost to Follow-up|1|||
161030363|NCT05900154|581503150|FG005|Follow-Up Period|Lost to Follow-up|1|||
161030364|NCT04102111|581503153|FG000|Overall Study|Withdrawal by Subject|2|||
161030365|NCT04102111|581503154|FG001|Overall Study|Withdrawal by Subject|3|||
161030366|NCT04102111|581503153|FG000|Overall Study|Adverse Event|1|||
161030367|NCT04102111|581503154|FG001|Overall Study|Adverse Event|1|||
161030368|NCT04102111|581503153|FG000|Overall Study|Study terminated by sponsor|1|||
161030369|NCT04102111|581503154|FG001|Overall Study|Study terminated by sponsor|3|||
161030370|NCT03334695|581503155|FG000|Overall Study|Lost to Follow-up|3|||
161030371|NCT03334695|581503156|FG001|Overall Study|Lost to Follow-up|3|||
161030372|NCT03334695|581503155|FG000|Overall Study|Physician Decision|1|||
161030373|NCT03334695|581503156|FG001|Overall Study|Physician Decision|2|||
161030374|NCT03334695|581503155|FG000|Overall Study|Protocol Violation|0|||
161030375|NCT03334695|581503156|FG001|Overall Study|Protocol Violation|1|||
161030376|NCT02641730|581503157|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
161030377|NCT02641730|581503158|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161030378|NCT02641730|581503159|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
161030379|NCT02641730|581503160|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
161030380|NCT02641730|581503161|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
161030381|NCT02641730|581503157|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
161030382|NCT02641730|581503158|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161030383|NCT02641730|581503159|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
161030384|NCT02641730|581503160|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
161030385|NCT02641730|581503161|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
161030386|NCT02641730|581503157|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
161030387|NCT02641730|581503158|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
161030388|NCT02641730|581503159|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
161030389|NCT02641730|581503160|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
161277408|NCT02661217|582395108|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
161277409|NCT00958893|582395109|FG000|Overall Study|Study prematurely terminated|4|||
161277410|NCT02892149|582395113|FG000|Overall Study|Death|262|||
161277411|NCT02892149|582395114|FG001|Overall Study|Death|278|||
161277412|NCT02892149|582395113|FG000|Overall Study|Withdrawal by Subject|53|||
161277413|NCT02892149|582395114|FG001|Overall Study|Withdrawal by Subject|47|||
161277414|NCT02892149|582395113|FG000|Overall Study|Lost to Follow-up|37|||
161277415|NCT02892149|582395114|FG001|Overall Study|Lost to Follow-up|31|||
161277416|NCT02165735|582395119|FG000|Overall Study|Lost to Follow-up|12|||
161277417|NCT02165735|582395120|FG001|Overall Study|Lost to Follow-up|10|||
161277418|NCT02165735|582395119|FG000|Overall Study|Withdrawal by Subject|3|||
161277419|NCT02165735|582395120|FG001|Overall Study|Withdrawal by Subject|0|||
161277420|NCT02165735|582395119|FG000|Overall Study|Participant indicated lack of time|1|||
161277421|NCT02165735|582395120|FG001|Overall Study|Participant indicated lack of time|3|||
161277422|NCT02165735|582395119|FG000|Overall Study|Protocol Violation|0|||
161277423|NCT02165735|582395120|FG001|Overall Study|Protocol Violation|1|||
161277424|NCT03066258|582395121|FG000|Overall Study|Death|1|||
161277425|NCT03066258|582395122|FG001|Overall Study|Death|0|||
161277426|NCT03066258|582395123|FG002|Overall Study|Death|0|||
161277427|NCT03066258|582395124|FG003|Overall Study|Death|0|||
161277428|NCT03066258|582395125|FG004|Overall Study|Death|1|||
161277429|NCT02784795|582395126|FG000|Overall Study|Progressive Disease|2|||
161277430|NCT02784795|582395127|FG001|Overall Study|Progressive Disease|1|||
161277431|NCT02784795|582395128|FG002|Overall Study|Progressive Disease|1|||
161277432|NCT02784795|582395129|FG003|Overall Study|Progressive Disease|0|||
161277433|NCT02784795|582395130|FG004|Overall Study|Progressive Disease|2|||
161277434|NCT02784795|582395131|FG005|Overall Study|Progressive Disease|0|||
161277435|NCT02784795|582395132|FG006|Overall Study|Progressive Disease|2|||
161277436|NCT02784795|582395133|FG007|Overall Study|Progressive Disease|0|||
161277437|NCT02784795|582395134|FG008|Overall Study|Progressive Disease|0|||
161277438|NCT02784795|582395135|FG009|Overall Study|Progressive Disease|0|||
161277439|NCT02784795|582395136|FG010|Overall Study|Progressive Disease|1|||
161277440|NCT02784795|582395137|FG011|Overall Study|Progressive Disease|0|||
161277441|NCT02784795|582395126|FG000|Overall Study|Adverse Event|1|||
161277442|NCT02784795|582395127|FG001|Overall Study|Adverse Event|0|||
161277443|NCT02784795|582395128|FG002|Overall Study|Adverse Event|0|||
161277444|NCT02784795|582395129|FG003|Overall Study|Adverse Event|1|||
161277445|NCT02784795|582395130|FG004|Overall Study|Adverse Event|0|||
161277446|NCT02784795|582395131|FG005|Overall Study|Adverse Event|0|||
161277447|NCT02784795|582395132|FG006|Overall Study|Adverse Event|1|||
161277448|NCT02784795|582395133|FG007|Overall Study|Adverse Event|0|||
161277449|NCT02784795|582395134|FG008|Overall Study|Adverse Event|0|||
161277450|NCT02784795|582395135|FG009|Overall Study|Adverse Event|0|||
161277451|NCT02784795|582395136|FG010|Overall Study|Adverse Event|0|||
161277452|NCT02784795|582395137|FG011|Overall Study|Adverse Event|2|||
161277453|NCT02784795|582395126|FG000|Overall Study|Withdrawal by Subject|1|||
161277454|NCT02784795|582395127|FG001|Overall Study|Withdrawal by Subject|0|||
161277455|NCT02784795|582395128|FG002|Overall Study|Withdrawal by Subject|2|||
161277456|NCT02784795|582395129|FG003|Overall Study|Withdrawal by Subject|1|||
161277457|NCT02784795|582395130|FG004|Overall Study|Withdrawal by Subject|3|||
161277458|NCT02784795|582395131|FG005|Overall Study|Withdrawal by Subject|0|||
161277459|NCT02784795|582395132|FG006|Overall Study|Withdrawal by Subject|0|||
161277460|NCT02784795|582395133|FG007|Overall Study|Withdrawal by Subject|1|||
161277461|NCT02784795|582395134|FG008|Overall Study|Withdrawal by Subject|0|||
161277462|NCT02784795|582395135|FG009|Overall Study|Withdrawal by Subject|0|||
161277463|NCT02784795|582395136|FG010|Overall Study|Withdrawal by Subject|0|||
160975658|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
161277464|NCT02784795|582395137|FG011|Overall Study|Withdrawal by Subject|2|||
161277465|NCT02784795|582395126|FG000|Overall Study|Death|0|||
161277466|NCT02784795|582395127|FG001|Overall Study|Death|0|||
161277467|NCT02784795|582395128|FG002|Overall Study|Death|0|||
161277468|NCT02784795|582395129|FG003|Overall Study|Death|0|||
161277469|NCT02784795|582395130|FG004|Overall Study|Death|1|||
161277470|NCT02784795|582395131|FG005|Overall Study|Death|0|||
161277471|NCT02784795|582395132|FG006|Overall Study|Death|0|||
161277472|NCT02784795|582395133|FG007|Overall Study|Death|0|||
161277473|NCT02784795|582395134|FG008|Overall Study|Death|0|||
161277474|NCT02784795|582395135|FG009|Overall Study|Death|0|||
161277475|NCT02784795|582395136|FG010|Overall Study|Death|0|||
161277476|NCT02784795|582395137|FG011|Overall Study|Death|0|||
161277477|NCT02784795|582395126|FG000|Overall Study|Physician Decision|0|||
161277478|NCT02784795|582395127|FG001|Overall Study|Physician Decision|0|||
160975659|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975660|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975661|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975662|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
160975663|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
160975664|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
160975665|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
161277479|NCT02784795|582395128|FG002|Overall Study|Physician Decision|0|||
161277480|NCT02784795|582395129|FG003|Overall Study|Physician Decision|0|||
161277481|NCT02784795|582395130|FG004|Overall Study|Physician Decision|0|||
161277482|NCT02784795|582395131|FG005|Overall Study|Physician Decision|0|||
161277483|NCT02784795|582395132|FG006|Overall Study|Physician Decision|1|||
161277484|NCT02784795|582395133|FG007|Overall Study|Physician Decision|0|||
161277485|NCT02784795|582395134|FG008|Overall Study|Physician Decision|0|||
161277486|NCT02784795|582395135|FG009|Overall Study|Physician Decision|0|||
161277487|NCT02784795|582395136|FG010|Overall Study|Physician Decision|0|||
161277488|NCT02784795|582395137|FG011|Overall Study|Physician Decision|0|||
161277489|NCT00101283|582395138|FG000|Overall Study|Withdrawal by Subject|0|||
161277490|NCT00101283|582395139|FG001|Overall Study|Withdrawal by Subject|1|||
161277491|NCT00101283|582395138|FG000|Overall Study|Insurance Refusal|0|||
161277492|NCT00101283|582395139|FG001|Overall Study|Insurance Refusal|1|||
161277493|NCT00101283|582395138|FG000|Overall Study|Prostate Cancer Recurrence|0|||
161277494|NCT00101283|582395139|FG001|Overall Study|Prostate Cancer Recurrence|1|||
161277495|NCT00595309|582395140|FG000|Overall Study|Lost to Follow-up|1|||
161277496|NCT00595309|582395140|FG000|Overall Study|planned vaccination against yellow fever|1|||
161277497|NCT00595309|582395140|FG000|Overall Study|acute infection after V0|1|||
161277498|NCT00595309|582395140|FG000|Overall Study|personal reason|1|||
161030390|NCT02641730|581503161|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
161030391|NCT02641730|581503157|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161030392|NCT02641730|581503158|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161030393|NCT02641730|581503159|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
161030394|NCT02641730|581503160|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161030395|NCT02641730|581503161|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
161030396|NCT02641730|581503157|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
161030397|NCT02641730|581503158|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
161030398|NCT02641730|581503159|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
161030399|NCT02641730|581503160|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
161030400|NCT02641730|581503161|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
161030401|NCT02641730|581503157|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
161030402|NCT02641730|581503158|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
161030403|NCT02641730|581503159|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
161030404|NCT02641730|581503160|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
161030405|NCT02641730|581503161|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
161030406|NCT05460871|581503162|FG000|Overall Study|Withdrawal by Subject|1|||
161030407|NCT05460871|581503163|FG001|Overall Study|Withdrawal by Subject|2|||
161030408|NCT02938923|581503164|FG000|Overall Study|Death|1|||
161030409|NCT02938923|581503165|FG001|Overall Study|Death|0|||
161030410|NCT02938923|581503166|FG002|Overall Study|Death|0|||
161030411|NCT02938923|581503164|FG000|Overall Study|Physician Decision|0|||
161030412|NCT02938923|581503165|FG001|Overall Study|Physician Decision|2|||
161030413|NCT02938923|581503166|FG002|Overall Study|Physician Decision|0|||
161030414|NCT02938923|581503164|FG000|Overall Study|Withdrawal by Subject|0|||
161030415|NCT02938923|581503165|FG001|Overall Study|Withdrawal by Subject|1|||
161030416|NCT02938923|581503166|FG002|Overall Study|Withdrawal by Subject|1|||
161030417|NCT00721149|581503167|FG000|Overall Study|Physician Decision|1|||
161030418|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
161030419|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
161030420|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
161030421|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
161030422|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
161030423|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
161030424|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
161030425|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
161030426|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
161030427|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
161030428|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
161030429|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
161030430|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
161030431|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
161030432|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
161277499|NCT02756208|582395143|FG000|Overall Study|Withdrawal by Subject|1|||
161277500|NCT02756208|582395144|FG001|Overall Study|Withdrawal by Subject|0|||
161030433|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
161030434|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
161277501|NCT02756208|582395145|FG002|Overall Study|Withdrawal by Subject|1|||
161277502|NCT02756208|582395146|FG003|Overall Study|Withdrawal by Subject|3|||
161277503|NCT02756208|582395143|FG000|Overall Study|Lost to Follow-up|3|||
161277504|NCT02756208|582395144|FG001|Overall Study|Lost to Follow-up|1|||
161277505|NCT02756208|582395145|FG002|Overall Study|Lost to Follow-up|1|||
161277506|NCT02756208|582395146|FG003|Overall Study|Lost to Follow-up|1|||
161277507|NCT02756208|582395143|FG000|Overall Study|Physician Decision|1|||
161030435|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
161030436|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
161030437|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
161030438|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
161030439|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
161030440|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
161030441|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
161030442|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
161030443|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
161030444|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
161030445|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
161030446|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
161030447|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
161030448|NCT04614948|581503170|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
161030449|NCT04614948|581503171|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
161030450|NCT04614948|581503172|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
161030451|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
161030452|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
161030453|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
161030454|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
161030455|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
161030456|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
161030457|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
161030458|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
161030459|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
161030460|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
161030461|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
161030462|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
161030463|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
161030464|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
161030465|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
161030466|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
161030467|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
161030468|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
161030469|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
161030470|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
161030471|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
161030472|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
161030473|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
161030474|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
161030475|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
161030476|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
161030477|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
161030478|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
161030479|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
161030480|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
161030481|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
161030482|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
161030483|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
161030484|NCT04614948|581503170|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
161030485|NCT04614948|581503171|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
161030486|NCT04614948|581503172|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
161030487|NCT04271046|581503173|FG000|Overall Study|Death|0|||
161030488|NCT04271046|581503174|FG001|Overall Study|Death|2|||
161030489|NCT04271046|581503175|FG002|Overall Study|Death|0|||
161030490|NCT04271046|581503176|FG003|Overall Study|Death|2|||
161030491|NCT04271046|581503173|FG000|Overall Study|Lost to Follow-up|12|||
161030492|NCT04271046|581503174|FG001|Overall Study|Lost to Follow-up|12|||
161030493|NCT04271046|581503175|FG002|Overall Study|Lost to Follow-up|11|||
161030494|NCT04271046|581503176|FG003|Overall Study|Lost to Follow-up|11|||
161030495|NCT04271046|581503173|FG000|Overall Study|Patient with Dementia Died|2|||
161148834|NCT03238248|581926155|FG000|Overall Study|Withdrawal by Subject|7|||
161148835|NCT03238248|581926155|FG000|Overall Study|Participant proceeding to transplant|10|||
161148836|NCT03238248|581926155|FG000|Overall Study|Lack of Efficacy|4|||
161148837|NCT03238248|581926155|FG000|Overall Study|Physician Decision|3|||
161148838|NCT03238248|581926155|FG000|Overall Study|Transitioning to another study|1|||
161030496|NCT04271046|581503174|FG001|Overall Study|Patient with Dementia Died|0|||
161030497|NCT04271046|581503175|FG002|Overall Study|Patient with Dementia Died|2|||
161030498|NCT04271046|581503176|FG003|Overall Study|Patient with Dementia Died|0|||
161030499|NCT04271046|581503173|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
161030500|NCT04271046|581503174|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
161030501|NCT04271046|581503175|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
161030502|NCT04271046|581503176|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
161030503|NCT04129554|581503177|FG000|Overall Study|Withdrawal by Subject|4|||
161030504|NCT04129554|581503178|FG001|Overall Study|Withdrawal by Subject|3|||
161030505|NCT04129554|581503177|FG000|Overall Study|Other|0|||
161030506|NCT04129554|581503178|FG001|Overall Study|Other|2|||
161030507|NCT01570361|581503179|FG000|Overall Study|Subject discontinued|1|||
161030508|NCT01570361|581503180|FG001|Overall Study|Subject discontinued|2|||
161030509|NCT01570361|581503179|FG000|Overall Study|Sponsor closing the study|51|||
161030510|NCT01570361|581503180|FG001|Overall Study|Sponsor closing the study|50|||
161030511|NCT01570361|581503179|FG000|Overall Study|Subject excluded|5|||
161030512|NCT01570361|581503180|FG001|Overall Study|Subject excluded|3|||
161030513|NCT01570361|581503179|FG000|Overall Study|Subject withdrew consent|14|||
161030514|NCT01570361|581503180|FG001|Overall Study|Subject withdrew consent|9|||
161030515|NCT01570361|581503179|FG000|Overall Study|Adverse Event|2|||
161030516|NCT01570361|581503180|FG001|Overall Study|Adverse Event|1|||
161030517|NCT01570361|581503179|FG000|Overall Study|Lost to Follow-up|4|||
161030518|NCT01570361|581503180|FG001|Overall Study|Lost to Follow-up|4|||
161030519|NCT01570361|581503179|FG000|Overall Study|Death|5|||
161030520|NCT01570361|581503180|FG001|Overall Study|Death|4|||
161030521|NCT01570361|581503179|FG000|Overall Study|Other|0|||
161030522|NCT01570361|581503180|FG001|Overall Study|Other|2|||
161030523|NCT05158504|581503181|FG000|Overall Study|Lost to Follow-up|2|||
161030524|NCT05158504|581503182|FG001|Overall Study|Lost to Follow-up|3|||
161030525|NCT03606512|581503183|FG000|Overall Study|Lost to Follow-up|0|||
161030526|NCT03606512|581503184|FG001|Overall Study|Lost to Follow-up|1|||
161030527|NCT03606512|581503183|FG000|Overall Study|'moved from study area|0|||
161030528|NCT03606512|581503184|FG001|Overall Study|'moved from study area|1|||
161030529|NCT05513937|581503185|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
161030530|NCT05513937|581503186|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
161030531|NCT05513937|581503187|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
161030532|NCT05513937|581503188|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
161030533|NCT05513937|581503185|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
161030534|NCT05513937|581503186|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
161030535|NCT05513937|581503187|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
161030536|NCT05513937|581503188|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
161030537|NCT05513937|581503185|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
161030538|NCT05513937|581503186|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
161030539|NCT05513937|581503187|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
161030540|NCT05513937|581503188|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
161030541|NCT05513937|581503185|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
161030542|NCT05513937|581503186|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161030543|NCT05513937|581503187|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161030544|NCT05513937|581503188|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
161030545|NCT05513937|581503185|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
161030546|NCT05513937|581503186|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
161030547|NCT05513937|581503187|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
161030548|NCT05513937|581503188|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
161030549|NCT05513937|581503185|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161030550|NCT05513937|581503186|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161030551|NCT05513937|581503187|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
161030552|NCT05513937|581503188|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
161030553|NCT02846545|581503189|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
161030554|NCT02846545|581503190|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
161030555|NCT02846545|581503189|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
161030556|NCT02846545|581503190|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
161030557|NCT02846545|581503189|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
161030558|NCT02846545|581503190|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
161030559|NCT02846545|581503189|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
161030560|NCT02846545|581503190|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
161030561|NCT02846545|581503189|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
161030562|NCT02846545|581503190|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
161030563|NCT03663205|581503193|FG000|Overall Study|Death|144|||
161030564|NCT03663205|581503194|FG001|Overall Study|Death|69|||
161277508|NCT02756208|582395144|FG001|Overall Study|Physician Decision|0|||
161277509|NCT02756208|582395145|FG002|Overall Study|Physician Decision|0|||
161277510|NCT02756208|582395146|FG003|Overall Study|Physician Decision|0|||
161277511|NCT02756208|582395143|FG000|Overall Study|Protocol Violation|0|||
161277512|NCT02756208|582395144|FG001|Overall Study|Protocol Violation|1|||
161277513|NCT02756208|582395145|FG002|Overall Study|Protocol Violation|0|||
161277514|NCT02756208|582395146|FG003|Overall Study|Protocol Violation|0|||
161277515|NCT03485365|582395147|FG000|Overall Study|Protocol Violation|0|||
161277516|NCT03485365|582395148|FG001|Overall Study|Protocol Violation|0|||
161277517|NCT03485365|582395149|FG002|Overall Study|Protocol Violation|0|||
161277518|NCT03485365|582395150|FG003|Overall Study|Protocol Violation|1|||
161277519|NCT03485365|582395151|FG004|Overall Study|Protocol Violation|0|||
161277520|NCT03485365|582395152|FG005|Overall Study|Protocol Violation|0|||
161277521|NCT03485365|582395153|FG006|Overall Study|Protocol Violation|1|||
161277522|NCT03485365|582395154|FG007|Overall Study|Protocol Violation|0|||
161277523|NCT03485365|582395155|FG008|Overall Study|Protocol Violation|0|||
161277524|NCT01275430|582395161|FG000|Overall Study|Adverse Event|1|||
161277525|NCT01275430|582395161|FG000|Overall Study|No Contrast Injection|6|||
161277526|NCT01275430|582395161|FG000|Overall Study|Device Malfunction|1|||
161277527|NCT01275430|582395161|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
161277528|NCT04988087|582395162|FG000|Overall Study|Adverse Event|4|||
161277529|NCT04988087|582395163|FG001|Overall Study|Adverse Event|0|||
161277530|NCT04988087|582395164|FG002|Overall Study|Adverse Event|0|||
161277531|NCT04988087|582395165|FG003|Overall Study|Adverse Event|0|||
161277532|NCT04988087|582395162|FG000|Overall Study|Withdrawal by Subject|1|||
161277533|NCT04988087|582395163|FG001|Overall Study|Withdrawal by Subject|1|||
161277534|NCT04988087|582395164|FG002|Overall Study|Withdrawal by Subject|0|||
161277535|NCT04988087|582395165|FG003|Overall Study|Withdrawal by Subject|0|||
161277536|NCT04988087|582395162|FG000|Overall Study|Technical problems|7|||
161277537|NCT04988087|582395163|FG001|Overall Study|Technical problems|9|||
161277538|NCT04988087|582395164|FG002|Overall Study|Technical problems|1|||
161277539|NCT04988087|582395165|FG003|Overall Study|Technical problems|2|||
161277540|NCT02613182|582395166|FG000|Overall Study|Death|6|||
161277541|NCT02613182|582395166|FG000|Overall Study|Physician Decision|1|||
161277542|NCT02613182|582395166|FG000|Overall Study|Study Terminated by Sponsor|21|||
161030565|NCT03663205|581503193|FG000|Overall Study|Sponsor decision|53|||
161030566|NCT03663205|581503194|FG001|Overall Study|Sponsor decision|19|||
161030567|NCT03663205|581503193|FG000|Overall Study|Withdrawal by Subject|8|||
161030568|NCT03663205|581503194|FG001|Overall Study|Withdrawal by Subject|11|||
161030569|NCT03663205|581503193|FG000|Overall Study|Lost to Follow-up|7|||
161030570|NCT03663205|581503194|FG001|Overall Study|Lost to Follow-up|9|||
161030571|NCT03663205|581503193|FG000|Overall Study|Transferred to long term extension study|11|||
161030572|NCT03663205|581503194|FG001|Overall Study|Transferred to long term extension study|3|||
161030573|NCT04505410|581503195|FG000|Overall Study|Adverse Event|2|||
161030574|NCT04505410|581503196|FG001|Overall Study|Adverse Event|0|||
161030575|NCT04505410|581503195|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
161030576|NCT04505410|581503196|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
161030577|NCT04505410|581503195|FG000|Overall Study|did not want to follow diet|1|||
161030578|NCT04505410|581503196|FG001|Overall Study|did not want to follow diet|0|||
161030579|NCT04505410|581503195|FG000|Overall Study|flare up of ulcerative colitis|0|||
161030580|NCT04505410|581503196|FG001|Overall Study|flare up of ulcerative colitis|1|||
161030581|NCT04505410|581503195|FG000|Overall Study|Lost to Follow-up|0|||
161030582|NCT04505410|581503196|FG001|Overall Study|Lost to Follow-up|2|||
161030583|NCT04505410|581503195|FG000|Overall Study|Lost to Follow-up|1|||
161030584|NCT04505410|581503196|FG001|Overall Study|Lost to Follow-up|0|||
161030585|NCT04505410|581503195|FG000|Overall Study|initiated another diet on their own|0|||
161030586|NCT04505410|581503196|FG001|Overall Study|initiated another diet on their own|2|||
161030587|NCT05962814|581503197|FG000|Overall Study|failed eligibility|1|||
161030588|NCT03057054|581503198|FG000|Overall Study|Death|4|||
161030589|NCT03057054|581503199|FG001|Overall Study|Death|4|||
161030590|NCT03057054|581503198|FG000|Overall Study|Withdrawal by Subject|6|||
161030591|NCT03057054|581503199|FG001|Overall Study|Withdrawal by Subject|3|||
161030592|NCT03057054|581503198|FG000|Overall Study|Ineligible|1|||
161277543|NCT02613182|582395166|FG000|Overall Study|Withdrawal by Subject|6|||
161277544|NCT03968978|582395167|FG000|Overall Study|Adverse Event|1|||
161277545|NCT03968978|582395168|FG001|Overall Study|Adverse Event|0|||
161277546|NCT00863772|582395169|FG000|Overall Study|Adverse Event|1|||
161277547|NCT00863772|582395170|FG001|Overall Study|Adverse Event|4|||
161277548|NCT00863772|582395171|FG002|Overall Study|Adverse Event|0|||
161277549|NCT00863772|582395169|FG000|Overall Study|Lack of Efficacy|4|||
161277550|NCT00863772|582395170|FG001|Overall Study|Lack of Efficacy|2|||
161030593|NCT03057054|581503199|FG001|Overall Study|Ineligible|1|||
161277551|NCT00863772|582395171|FG002|Overall Study|Lack of Efficacy|4|||
161277552|NCT00863772|582395169|FG000|Overall Study|Lost to Follow-up|5|||
161277553|NCT00863772|582395170|FG001|Overall Study|Lost to Follow-up|1|||
161277554|NCT00863772|582395171|FG002|Overall Study|Lost to Follow-up|1|||
161277555|NCT00863772|582395169|FG000|Overall Study|Protocol Violation|2|||
161277556|NCT00863772|582395170|FG001|Overall Study|Protocol Violation|0|||
161030594|NCT05507333|581504754|FG000|Overall Study|Protocol Violation|1|||
161030595|NCT05311176|581504757|FG000|Overall Study|Death|6|||
161030596|NCT05311176|581504757|FG000|Overall Study|Sponsor discontinued the study|1|||
161030597|NCT05247034|581504758|FG000|Overall Study|Lost to Follow-up|3|||
161030598|NCT05247034|581504759|FG001|Overall Study|Lost to Follow-up|2|||
161030599|NCT05247034|581504758|FG000|Overall Study|Organizational problems when attending appointments|1|||
161030600|NCT05247034|581504759|FG001|Overall Study|Organizational problems when attending appointments|0|||
161030601|NCT01960452|581504762|FG000|Overall Study|Withdrawal by Subject|2|||
161030602|NCT01960452|581504763|FG001|Overall Study|Withdrawal by Subject|1|||
161030603|NCT01960452|581504762|FG000|Overall Study|Sleep apnea in Night 1|1|||
161030604|NCT01960452|581504763|FG001|Overall Study|Sleep apnea in Night 1|0|||
161030605|NCT01960452|581504762|FG000|Overall Study|Poor Sleep in Night 1|0|||
161030606|NCT01960452|581504763|FG001|Overall Study|Poor Sleep in Night 1|2|||
161030607|NCT01960452|581504762|FG000|Overall Study|No Sex/Age Match Night 1|1|||
161030608|NCT01960452|581504763|FG001|Overall Study|No Sex/Age Match Night 1|0|||
161030609|NCT01960452|581504762|FG000|Overall Study|No Sex/Age Match Night 2|0|||
161030610|NCT01960452|581504763|FG001|Overall Study|No Sex/Age Match Night 2|2|||
161030611|NCT01960452|581504762|FG000|Overall Study|Technical Difficulties Night 2|2|||
161030612|NCT01960452|581504763|FG001|Overall Study|Technical Difficulties Night 2|0|||
161030613|NCT02668692|581504764|FG000|Overall Study|Adverse Event|1|||
161030614|NCT02668692|581504765|FG001|Overall Study|Adverse Event|0|||
161030615|NCT03981926|581504766|FG000|Overall Study|Lost to Follow-up|5|||
161030616|NCT03981926|581504767|FG001|Overall Study|Lost to Follow-up|9|||
161030617|NCT04615273|581504774|FG000|Overall Study|Withdrawal by Subject|3|||
161030618|NCT04615273|581504775|FG001|Overall Study|Withdrawal by Subject|1|||
161030619|NCT04615273|581504776|FG002|Overall Study|Withdrawal by Subject|2|||
161030620|NCT04615273|581504774|FG000|Overall Study|Adverse Event|1|||
161030621|NCT04615273|581504775|FG001|Overall Study|Adverse Event|0|||
161030622|NCT04615273|581504776|FG002|Overall Study|Adverse Event|1|||
161030623|NCT04615273|581504774|FG000|Overall Study|Lost to Follow-up|0|||
161030624|NCT04615273|581504775|FG001|Overall Study|Lost to Follow-up|1|||
161030625|NCT04615273|581504776|FG002|Overall Study|Lost to Follow-up|0|||
161030626|NCT04615273|581504774|FG000|Overall Study|Physician Decision|0|||
161030627|NCT04615273|581504775|FG001|Overall Study|Physician Decision|0|||
161030628|NCT04615273|581504776|FG002|Overall Study|Physician Decision|1|||
161030629|NCT04615273|581504774|FG000|Overall Study|Other|0|||
161030630|NCT04615273|581504775|FG001|Overall Study|Other|1|||
161030631|NCT04615273|581504776|FG002|Overall Study|Other|0|||
161030632|NCT04615273|581504774|FG000|Overall Study|Randomized but not treated|1|||
161030633|NCT04615273|581504775|FG001|Overall Study|Randomized but not treated|3|||
161030634|NCT04615273|581504776|FG002|Overall Study|Randomized but not treated|1|||
161030635|NCT01314105|581504781|FG000|Overall Study|Progressive Disease|6|||
161030636|NCT01314105|581504782|FG001|Overall Study|Progressive Disease|10|||
161030637|NCT01314105|581504781|FG000|Overall Study|Refused to continue taking medication|0|||
161030638|NCT01314105|581504782|FG001|Overall Study|Refused to continue taking medication|1|||
161030639|NCT01314105|581504781|FG000|Overall Study|Other Adverse Event|1|||
161030640|NCT01314105|581504782|FG001|Overall Study|Other Adverse Event|1|||
161030641|NCT04820322|581504783|FG000|Overall Study|Adverse Event|1|||
161030642|NCT04820322|581504784|FG001|Overall Study|Adverse Event|0|||
161030643|NCT03156465|581504785|FG000|Overall Study|Withdrawal by Subject|2|||
161030644|NCT03640286|581504786|FG000|Overall Study|Adverse Event|6|||
161030645|NCT03640286|581504787|FG001|Overall Study|Adverse Event|6|||
161030646|NCT03640286|581504786|FG000|Overall Study|Lost to Follow-up|3|||
161030647|NCT03640286|581504787|FG001|Overall Study|Lost to Follow-up|6|||
161030648|NCT03640286|581504786|FG000|Overall Study|Pregnancy|1|||
161030649|NCT03640286|581504787|FG001|Overall Study|Pregnancy|0|||
161030650|NCT03640286|581504786|FG000|Overall Study|Withdrawal by Subject|10|||
161030651|NCT03640286|581504787|FG001|Overall Study|Withdrawal by Subject|10|||
161030652|NCT03640286|581504786|FG000|Overall Study|Non-compliance|4|||
161030653|NCT03640286|581504787|FG001|Overall Study|Non-compliance|10|||
161030654|NCT03640286|581504786|FG000|Overall Study|Medication change|1|||
161277557|NCT00863772|582395171|FG002|Overall Study|Protocol Violation|2|||
161030655|NCT03640286|581504787|FG001|Overall Study|Medication change|0|||
161030656|NCT03640286|581504786|FG000|Overall Study|Other|1|||
161030657|NCT03640286|581504787|FG001|Overall Study|Other|2|||
161030658|NCT03640286|581504786|FG000|Overall Study|Joined another lifestyle program|0|||
161030659|NCT03640286|581504787|FG001|Overall Study|Joined another lifestyle program|1|||
161030660|NCT03181516|581504788|FG000|Overall Study|Withdrawal by Subject|14|||
161030661|NCT03181516|581504789|FG001|Overall Study|Withdrawal by Subject|7|||
161030662|NCT03181516|581504788|FG000|Overall Study|Lost to Follow-up|2|||
161030663|NCT03181516|581504789|FG001|Overall Study|Lost to Follow-up|2|||
161030664|NCT04544007|581504793|FG000|Overall Study|Withdrawal by Subject|1|||
161030665|NCT04544007|581504793|FG000|Overall Study|Confirmed Progressive Disease|1|||
161030666|NCT05405985|581504796|FG000|Overall Study|Withdrawal by Subject|1|||
161030667|NCT05405985|581504797|FG001|Overall Study|Withdrawal by Subject|0|||
161030668|NCT02839265|581504800|FG000|Overall Study|Screen Failure|2|||
161148839|NCT03238248|581926155|FG000|Overall Study|No longer benefiting|1|||
161030669|NCT02839265|581504800|FG000|Overall Study|Death|1|||
161344460|NCT01995201|582647207|FG002|From Baseline Until Week 24|Physician Decision|0|||
161344461|NCT01995201|582647208|FG003|From Baseline Until Week 24|Physician Decision|0|||
161344462|NCT01995201|582647209|FG004|From Baseline Until Week 24|Physician Decision|0|||
161344463|NCT01995201|582647210|FG005|From Baseline Until Week 24|Physician Decision|0|||
161344464|NCT01995201|582647211|FG006|From Baseline Until Week 24|Physician Decision|0|||
161344465|NCT01995201|582647205|FG000|From Baseline Until Week 24|Protocol Violation|0|||
161344466|NCT01995201|582647206|FG001|From Baseline Until Week 24|Protocol Violation|9|||
161344467|NCT01995201|582647207|FG002|From Baseline Until Week 24|Protocol Violation|0|||
161344468|NCT01995201|582647208|FG003|From Baseline Until Week 24|Protocol Violation|0|||
161344469|NCT01995201|582647209|FG004|From Baseline Until Week 24|Protocol Violation|0|||
161344470|NCT01995201|582647210|FG005|From Baseline Until Week 24|Protocol Violation|0|||
161344471|NCT01995201|582647211|FG006|From Baseline Until Week 24|Protocol Violation|0|||
161344472|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Adverse Event|0|||
161344473|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Adverse Event|0|||
161344474|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Adverse Event|2|||
161344475|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Adverse Event|1|||
161344476|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Adverse Event|1|||
161344477|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Adverse Event|3|||
161344478|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Adverse Event|1|||
161344479|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Death|0|||
161344480|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Death|0|||
161344481|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Death|0|||
161344482|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Death|0|||
161344483|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Death|0|||
161344484|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Death|2|||
161344485|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Death|0|||
161344486|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
161344487|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
161344488|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
161344489|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
161344490|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
161344491|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
161344492|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
161344493|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
161344494|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
161344495|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
161344496|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
161344497|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
161344498|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
161344499|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
161344500|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161344501|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161344502|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
161344503|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161344504|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
161344505|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161344506|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
161344507|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Physician Decision|0|||
161344508|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Physician Decision|0|||
161344509|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Physician Decision|0|||
161344510|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Physician Decision|0|||
161344511|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Physician Decision|1|||
161344512|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Physician Decision|0|||
161344513|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Physician Decision|0|||
161344514|NCT01995201|582647205|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
161344515|NCT01995201|582647206|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
161344516|NCT01995201|582647207|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
161344517|NCT01995201|582647208|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
161344518|NCT01995201|582647209|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
161344519|NCT01995201|582647210|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
161344520|NCT01995201|582647211|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
161344521|NCT01138046|582647212|FG000|Overall Study|Withdrawal due to death|6|||
161344522|NCT01136915|582647213|FG000|Overall Study|Lost to Follow-up|2|||
161344523|NCT01136915|582647214|FG001|Overall Study|Lost to Follow-up|0|||
161344524|NCT01136915|582647213|FG000|Overall Study|Exclusion criterion met|0|||
161344525|NCT01136915|582647214|FG001|Overall Study|Exclusion criterion met|1|||
160975666|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161344526|NCT04797169|582647215|FG000|Overall Study|Lost to Follow-up|84|||
161344527|NCT04797169|582647216|FG001|Overall Study|Lost to Follow-up|67|||
161344528|NCT04797169|582647215|FG000|Overall Study|Pregnancy|1|||
160975667|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161344529|NCT04797169|582647216|FG001|Overall Study|Pregnancy|3|||
161344530|NCT04797169|582647215|FG000|Overall Study|Withdrawal by Subject|27|||
161030670|NCT02839265|581504800|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
161030671|NCT04605159|581504804|FG000|Overall Study|Adverse Event|6|||
161030672|NCT04605159|581504805|FG001|Overall Study|Adverse Event|3|||
161030673|NCT04605159|581504806|FG002|Overall Study|Adverse Event|21|||
161030674|NCT04605159|581504807|FG003|Overall Study|Adverse Event|4|||
161030675|NCT04605159|581504804|FG000|Overall Study|Lost to Follow-up|74|||
161030676|NCT04605159|581504805|FG001|Overall Study|Lost to Follow-up|45|||
161030677|NCT04605159|581504806|FG002|Overall Study|Lost to Follow-up|119|||
161030678|NCT04605159|581504807|FG003|Overall Study|Lost to Follow-up|80|||
161030679|NCT04605159|581504804|FG000|Overall Study|Protocol Violation|4|||
161030680|NCT04605159|581504805|FG001|Overall Study|Protocol Violation|5|||
161030681|NCT04605159|581504806|FG002|Overall Study|Protocol Violation|2|||
161030682|NCT04605159|581504807|FG003|Overall Study|Protocol Violation|0|||
161030683|NCT04605159|581504804|FG000|Overall Study|Withdrawal by Subject|66|||
161030684|NCT04605159|581504805|FG001|Overall Study|Withdrawal by Subject|37|||
161030685|NCT04605159|581504806|FG002|Overall Study|Withdrawal by Subject|68|||
161030686|NCT04605159|581504807|FG003|Overall Study|Withdrawal by Subject|50|||
161030687|NCT04605159|581504804|FG000|Overall Study|Migrated / moved from the study area|32|||
160975668|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160975669|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
160975670|NCT04921969|581299405|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
160975671|NCT04921969|581299406|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
160975672|NCT04921969|581299407|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975673|NCT04921969|581299408|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975674|NCT04921969|581299409|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975675|NCT04921969|581299410|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975676|NCT04921969|581299411|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
160975677|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975678|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975679|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975680|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975681|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975682|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
160975683|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
160975684|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975685|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975686|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975687|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
160975688|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
160975689|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
160975690|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
160975691|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160975692|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160975693|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
160975694|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
160975695|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
160975696|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
160975697|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
160975698|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975699|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975700|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975701|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
160975702|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
160975703|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
160975704|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
160975705|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160975706|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160975707|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
160975708|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
160975709|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
160975710|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
160975711|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
160975712|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975713|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975714|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
160975715|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
160975716|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
161030688|NCT04605159|581504805|FG001|Overall Study|Migrated / moved from the study area|22|||
161030689|NCT04605159|581504806|FG002|Overall Study|Migrated / moved from the study area|41|||
161030690|NCT04605159|581504807|FG003|Overall Study|Migrated / moved from the study area|21|||
161030691|NCT04605159|581504804|FG000|Overall Study|Other|1|||
161030692|NCT04605159|581504805|FG001|Overall Study|Other|2|||
161030693|NCT04605159|581504806|FG002|Overall Study|Other|7|||
161030694|NCT04605159|581504807|FG003|Overall Study|Other|3|||
161030695|NCT02323880|581504808|FG000|Overall Study|Adverse Event|2|||
161030696|NCT02323880|581504809|FG001|Overall Study|Adverse Event|0|||
161030697|NCT02323880|581504810|FG002|Overall Study|Adverse Event|1|||
161030698|NCT02323880|581504811|FG003|Overall Study|Adverse Event|1|||
161030699|NCT02323880|581504812|FG004|Overall Study|Adverse Event|1|||
161030700|NCT02323880|581504813|FG005|Overall Study|Adverse Event|0|||
161030701|NCT02323880|581504814|FG006|Overall Study|Adverse Event|1|||
161030702|NCT02323880|581504815|FG007|Overall Study|Adverse Event|0|||
161030703|NCT02323880|581504808|FG000|Overall Study|Death|0|||
161030704|NCT02323880|581504809|FG001|Overall Study|Death|0|||
161030705|NCT02323880|581504810|FG002|Overall Study|Death|0|||
161030706|NCT02323880|581504811|FG003|Overall Study|Death|0|||
161030707|NCT02323880|581504812|FG004|Overall Study|Death|0|||
161030708|NCT02323880|581504813|FG005|Overall Study|Death|1|||
161030709|NCT02323880|581504814|FG006|Overall Study|Death|0|||
161030710|NCT02323880|581504815|FG007|Overall Study|Death|0|||
161030711|NCT02323880|581504808|FG000|Overall Study|Lack of Efficacy|4|||
161030712|NCT02323880|581504809|FG001|Overall Study|Lack of Efficacy|11|||
161030713|NCT02323880|581504810|FG002|Overall Study|Lack of Efficacy|5|||
161030714|NCT02323880|581504811|FG003|Overall Study|Lack of Efficacy|5|||
161030715|NCT02323880|581504812|FG004|Overall Study|Lack of Efficacy|4|||
161030716|NCT02323880|581504813|FG005|Overall Study|Lack of Efficacy|8|||
161030717|NCT02323880|581504814|FG006|Overall Study|Lack of Efficacy|4|||
161030718|NCT02323880|581504815|FG007|Overall Study|Lack of Efficacy|6|||
161030719|NCT02323880|581504808|FG000|Overall Study|Physician Decision|0|||
161030720|NCT02323880|581504809|FG001|Overall Study|Physician Decision|0|||
161030721|NCT02323880|581504810|FG002|Overall Study|Physician Decision|0|||
161030722|NCT02323880|581504811|FG003|Overall Study|Physician Decision|0|||
161030723|NCT02323880|581504812|FG004|Overall Study|Physician Decision|1|||
161030724|NCT02323880|581504813|FG005|Overall Study|Physician Decision|1|||
161030725|NCT02323880|581504814|FG006|Overall Study|Physician Decision|1|||
161030726|NCT02323880|581504815|FG007|Overall Study|Physician Decision|0|||
161030727|NCT02323880|581504808|FG000|Overall Study|Withdrawal by Subject|0|||
161030728|NCT02323880|581504809|FG001|Overall Study|Withdrawal by Subject|2|||
161030729|NCT02323880|581504810|FG002|Overall Study|Withdrawal by Subject|0|||
161030730|NCT02323880|581504811|FG003|Overall Study|Withdrawal by Subject|0|||
161030731|NCT02323880|581504812|FG004|Overall Study|Withdrawal by Subject|0|||
161030732|NCT02323880|581504813|FG005|Overall Study|Withdrawal by Subject|0|||
161030733|NCT02323880|581504814|FG006|Overall Study|Withdrawal by Subject|0|||
161030734|NCT02323880|581504815|FG007|Overall Study|Withdrawal by Subject|0|||
161030735|NCT04934072|581504817|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
161030736|NCT04934072|581504818|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
161030737|NCT04934072|581504819|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
161030738|NCT04934072|581504820|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
161030739|NCT04934072|581504821|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
161030740|NCT04934072|581504817|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
161030741|NCT04934072|581504818|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
161030742|NCT04934072|581504819|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
161030743|NCT04934072|581504820|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
161030744|NCT04934072|581504821|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
160975717|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
160975718|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
160975719|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975720|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975721|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975722|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
160975723|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975724|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
160975725|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
160975726|NCT04921969|581299405|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
161030745|NCT04934072|581504817|FG000|Day 0 to Week 52|Other|3|||
161030746|NCT04934072|581504818|FG001|Day 0 to Week 52|Other|1|||
161030747|NCT04934072|581504819|FG002|Day 0 to Week 52|Other|0|||
161030748|NCT04934072|581504820|FG003|Day 0 to Week 52|Other|0|||
161030749|NCT04934072|581504821|FG004|Day 0 to Week 52|Other|0|||
161030750|NCT04934072|581504817|FG000|Day 0 to Week 52|Adverse Event|1|||
161030751|NCT04934072|581504818|FG001|Day 0 to Week 52|Adverse Event|3|||
161030752|NCT04934072|581504819|FG002|Day 0 to Week 52|Adverse Event|0|||
161030753|NCT04934072|581504820|FG003|Day 0 to Week 52|Adverse Event|0|||
161030754|NCT04934072|581504821|FG004|Day 0 to Week 52|Adverse Event|0|||
161030755|NCT04934072|581504817|FG000|Week 52 to Week 78|Adverse Event|0|||
161030756|NCT04934072|581504818|FG001|Week 52 to Week 78|Adverse Event|0|||
161277558|NCT00863772|582395169|FG000|Overall Study|Withdrawal by Subject|4|||
161277559|NCT00863772|582395170|FG001|Overall Study|Withdrawal by Subject|7|||
161277560|NCT00863772|582395171|FG002|Overall Study|Withdrawal by Subject|5|||
161277561|NCT00863772|582395169|FG000|Overall Study|Study terminated by sponsor|44|||
161277562|NCT00863772|582395170|FG001|Overall Study|Study terminated by sponsor|45|||
161277563|NCT00863772|582395171|FG002|Overall Study|Study terminated by sponsor|36|||
161277564|NCT00863772|582395169|FG000|Overall Study|Entered extension study|6|||
161277565|NCT00863772|582395170|FG001|Overall Study|Entered extension study|4|||
161277566|NCT00863772|582395171|FG002|Overall Study|Entered extension study|9|||
161277567|NCT00863772|582395169|FG000|Overall Study|Other|1|||
161277568|NCT00863772|582395170|FG001|Overall Study|Other|2|||
161277569|NCT00863772|582395171|FG002|Overall Study|Other|4|||
161277570|NCT00863772|582395169|FG000|Overall Study|Randomized but not Treated|1|||
161277571|NCT00863772|582395170|FG001|Overall Study|Randomized but not Treated|0|||
161277572|NCT00863772|582395171|FG002|Overall Study|Randomized but not Treated|0|||
161277573|NCT03014180|582395176|FG000|Overall Study|Protocol Violation|2|||
161277574|NCT04400682|582395177|FG000|Period 1|Withdrawal by Subject|1|||
161277575|NCT04400682|582395178|FG001|Period 1|Withdrawal by Subject|4|||
161277576|NCT04784533|582395179|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
161277577|NCT04784533|582395180|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
161277578|NCT04784533|582395181|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277579|NCT04784533|582395182|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277580|NCT04784533|582395183|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277581|NCT04784533|582395184|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277582|NCT04784533|582395185|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277583|NCT04784533|582395186|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277584|NCT04784533|582395187|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277585|NCT04784533|582395188|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
161277586|NCT04784533|582395179|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
161277587|NCT04784533|582395180|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
161277588|NCT04784533|582395181|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161277589|NCT04784533|582395182|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161344531|NCT04797169|582647216|FG001|Overall Study|Withdrawal by Subject|35|||
161148840|NCT03238248|581926155|FG000|Overall Study|Other complicating disease|1|||
160975727|NCT04921969|581299406|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975728|NCT04921969|581299407|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975729|NCT04921969|581299408|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975730|NCT04921969|581299409|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
160975731|NCT04921969|581299410|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
160975732|NCT04921969|581299411|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
160975733|NCT04287868|581299412|FG000|Overall Study|Screening fail|1|||
160975734|NCT04287868|581299413|FG001|Overall Study|Screening fail|0|||
160975735|NCT02961881|581300592|FG000|Overall Study|Adverse Event|1|||
160975736|NCT02961881|581300593|FG001|Overall Study|Adverse Event|2|||
160975737|NCT02961881|581300594|FG002|Overall Study|Adverse Event|2|||
160975738|NCT02961881|581300595|FG003|Overall Study|Adverse Event|0|||
160975739|NCT02961881|581300596|FG004|Overall Study|Adverse Event|1|||
160975740|NCT02961881|581300592|FG000|Overall Study|Participant request|0|||
160975741|NCT02961881|581300593|FG001|Overall Study|Participant request|2|||
160975742|NCT02961881|581300594|FG002|Overall Study|Participant request|0|||
160975743|NCT02961881|581300595|FG003|Overall Study|Participant request|0|||
160975744|NCT02961881|581300596|FG004|Overall Study|Participant request|0|||
160975745|NCT02961881|581300592|FG000|Overall Study|Disease progression|1|||
160975746|NCT02961881|581300593|FG001|Overall Study|Disease progression|0|||
160975747|NCT02961881|581300594|FG002|Overall Study|Disease progression|1|||
160975748|NCT02961881|581300595|FG003|Overall Study|Disease progression|0|||
160975749|NCT02961881|581300596|FG004|Overall Study|Disease progression|0|||
160975750|NCT00636792|581300597|FG000|Overall Study|Adverse Event|16|||
160975751|NCT00636792|581300597|FG000|Overall Study|Physician Decision|7|||
160975752|NCT00636792|581300597|FG000|Overall Study|Progressive Disease|4|||
160975753|NCT00636792|581300597|FG000|Overall Study|Withdrawal by Subject|3|||
160975754|NCT00636792|581300597|FG000|Overall Study|Other|3|||
160975755|NCT01928225|581300598|FG000|Overall Study|Pregnancy|1|||
160975756|NCT01928225|581300599|FG001|Overall Study|Pregnancy|0|||
160975757|NCT01928225|581300598|FG000|Overall Study|basaloid cervical cancer|1|||
160975758|NCT01928225|581300599|FG001|Overall Study|basaloid cervical cancer|0|||
160975759|NCT01928225|581300598|FG000|Overall Study|Lost to Follow-up|1|||
160975760|NCT01928225|581300599|FG001|Overall Study|Lost to Follow-up|3|||
160975761|NCT03101241|581300601|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
160975762|NCT03101241|581300602|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
160975763|NCT03101241|581300601|FG000|Overall Study|Participant withdrew consent|3|||
161030757|NCT04934072|581504819|FG002|Week 52 to Week 78|Adverse Event|0|||
161030758|NCT04934072|581504820|FG003|Week 52 to Week 78|Adverse Event|1|||
161030759|NCT04934072|581504821|FG004|Week 52 to Week 78|Adverse Event|1|||
160975764|NCT03101241|581300602|FG001|Overall Study|Participant withdrew consent|1|||
160975765|NCT03101241|581300601|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
160975766|NCT03101241|581300602|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
160975767|NCT03101241|581300601|FG000|Overall Study|Lost to Follow-up|2|||
160975768|NCT03101241|581300602|FG001|Overall Study|Lost to Follow-up|0|||
160975769|NCT03101241|581300601|FG000|Overall Study|Lack of Efficacy|0|||
160975770|NCT03101241|581300602|FG001|Overall Study|Lack of Efficacy|1|||
160975771|NCT03101241|581300601|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
160975772|NCT03101241|581300602|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
160975773|NCT03283696|581300603|FG000|Overall Study|Physician Decision|5|||
160975774|NCT03283696|581300604|FG001|Overall Study|Physician Decision|6|||
160975775|NCT03283696|581300603|FG000|Overall Study|Withdrawal by Subject|2|||
160975776|NCT03283696|581300604|FG001|Overall Study|Withdrawal by Subject|0|||
160975777|NCT01512745|581300606|FG000|Overall Study|Adverse Event|22|||
161030760|NCT04934072|581504817|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
161030761|NCT04934072|581504818|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
161030762|NCT04934072|581504819|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
161030763|NCT04934072|581504820|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
161030764|NCT04934072|581504821|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
161030765|NCT04934072|581504817|FG000|Week 52 to Week 78|Other|0|||
161030766|NCT04934072|581504818|FG001|Week 52 to Week 78|Other|0|||
161030767|NCT04934072|581504819|FG002|Week 52 to Week 78|Other|1|||
161030768|NCT04934072|581504820|FG003|Week 52 to Week 78|Other|0|||
161030769|NCT04934072|581504821|FG004|Week 52 to Week 78|Other|0|||
161030770|NCT05424380|581504826|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
161030771|NCT05424380|581504827|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161030772|NCT05424380|581504828|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161030773|NCT05424380|581504829|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161030774|NCT05424380|581504830|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161030775|NCT05424380|581504831|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
161030776|NCT05424380|581504826|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
161030777|NCT05424380|581504827|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161030778|NCT05424380|581504828|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161030779|NCT05424380|581504829|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161030780|NCT05424380|581504830|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161030781|NCT05424380|581504831|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
161030782|NCT05424380|581504826|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
161030783|NCT05424380|581504827|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161030784|NCT05424380|581504828|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161030785|NCT05424380|581504829|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161030786|NCT05424380|581504830|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161030787|NCT05424380|581504831|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
161030788|NCT05424380|581504826|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161030789|NCT05424380|581504827|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
161030790|NCT05424380|581504828|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161030791|NCT05424380|581504829|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161030792|NCT05424380|581504830|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161030793|NCT05424380|581504831|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
161030794|NCT05424380|581504826|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161030795|NCT05424380|581504827|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
161030796|NCT05424380|581504828|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161030797|NCT05424380|581504829|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161030798|NCT05424380|581504830|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161030799|NCT05424380|581504831|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
161030800|NCT05424380|581504826|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161030801|NCT05424380|581504827|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161030802|NCT05424380|581504828|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
161030803|NCT05424380|581504829|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161030804|NCT05424380|581504830|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161030805|NCT05424380|581504831|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
161030806|NCT05424380|581504826|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161030807|NCT05424380|581504827|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161030808|NCT05424380|581504828|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
161030809|NCT05424380|581504829|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161030810|NCT05424380|581504830|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161030811|NCT05424380|581504831|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
161030812|NCT05424380|581504826|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161030813|NCT05424380|581504827|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161030814|NCT05424380|581504828|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
161277590|NCT04784533|582395183|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161030815|NCT05424380|581504829|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161030816|NCT05424380|581504830|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161030817|NCT05424380|581504831|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
161030818|NCT05424380|581504826|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161148841|NCT03238248|581926155|FG000|Overall Study|Adverse Event|5|||
161277591|NCT04784533|582395184|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161277592|NCT04784533|582395185|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161277593|NCT04784533|582395186|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161277594|NCT04784533|582395187|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161277595|NCT04784533|582395188|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
161277596|NCT04784533|582395179|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277597|NCT04784533|582395180|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
161277598|NCT04784533|582395181|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277599|NCT04784533|582395182|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277600|NCT04784533|582395183|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277601|NCT04784533|582395184|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277602|NCT04784533|582395185|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277603|NCT04784533|582395186|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277604|NCT04784533|582395187|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277605|NCT04784533|582395188|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
161277606|NCT04784533|582395179|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
161277607|NCT04784533|582395180|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
160975778|NCT01512745|581300607|FG001|Overall Study|Adverse Event|3|||
160975779|NCT01512745|581300606|FG000|Overall Study|Death|9|||
160975780|NCT01512745|581300607|FG001|Overall Study|Death|13|||
160975781|NCT01512745|581300606|FG000|Overall Study|Withdrawal by Subject|2|||
160975782|NCT01512745|581300607|FG001|Overall Study|Withdrawal by Subject|2|||
160975783|NCT01512745|581300606|FG000|Overall Study|Lost to Follow-up|4|||
160975784|NCT01512745|581300607|FG001|Overall Study|Lost to Follow-up|0|||
160975785|NCT01512745|581300606|FG000|Overall Study|Lack of Efficacy|2|||
160975786|NCT01512745|581300607|FG001|Overall Study|Lack of Efficacy|2|||
160975787|NCT01512745|581300606|FG000|Overall Study|Protocol Violation|1|||
160975788|NCT01512745|581300607|FG001|Overall Study|Protocol Violation|0|||
160975789|NCT02357810|581300608|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
160975790|NCT02357810|581300608|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
160975791|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Adverse Event|5|||
160975792|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
160975793|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
160975794|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
160975795|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Death|1|||
160975796|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Physician Decision|1|||
160975797|NCT02357810|581300608|FG000|Reached 12 Weeks Response|Other|1|||
160975798|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
160975799|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
160975800|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
160975801|NCT02357810|581300608|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
160975802|NCT02357810|581300608|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
160975803|NCT02357810|581300608|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
160975804|NCT00562978|581300609|FG000|Overall Study|Patient had imaging dose only|1|||
160975805|NCT00562978|581300610|FG001|Overall Study|Patient had imaging dose only|11|||
160975806|NCT00675506|581300612|FG000|Overall Study|Lost to Follow-up|1|||
160975807|NCT00675506|581300613|FG001|Overall Study|Lost to Follow-up|5|||
160975808|NCT00675506|581300612|FG000|Overall Study|Lost interest|3|||
160975809|NCT00675506|581300613|FG001|Overall Study|Lost interest|5|||
160975810|NCT00675506|581300612|FG000|Overall Study|Elevated fasting glucose|2|||
160975811|NCT00675506|581300613|FG001|Overall Study|Elevated fasting glucose|1|||
160975812|NCT00675506|581300612|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
160975813|NCT00675506|581300613|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
160975814|NCT00675506|581300612|FG000|Overall Study|Elevated IGF-1|2|||
160975815|NCT00675506|581300613|FG001|Overall Study|Elevated IGF-1|0|||
160975816|NCT00675506|581300612|FG000|Overall Study|Hypersensitivity Reaction|1|||
160975817|NCT00675506|581300613|FG001|Overall Study|Hypersensitivity Reaction|0|||
160975818|NCT00675506|581300612|FG000|Overall Study|Disclosed history of cancer|1|||
160975819|NCT00675506|581300613|FG001|Overall Study|Disclosed history of cancer|0|||
160975820|NCT00675506|581300612|FG000|Overall Study|Declined participation|1|||
160975821|NCT00675506|581300613|FG001|Overall Study|Declined participation|0|||
160975822|NCT00675506|581300612|FG000|Overall Study|Schedule conflict|0|||
160975823|NCT00675506|581300613|FG001|Overall Study|Schedule conflict|1|||
161277608|NCT04784533|582395181|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277609|NCT04784533|582395182|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277610|NCT04784533|582395183|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277611|NCT04784533|582395184|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277612|NCT04784533|582395185|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277613|NCT04784533|582395186|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277614|NCT04784533|582395187|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277615|NCT04784533|582395188|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
161277616|NCT04784533|582395179|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
161277617|NCT04784533|582395180|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
161277618|NCT04784533|582395181|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277619|NCT04784533|582395182|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277620|NCT04784533|582395183|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277621|NCT04784533|582395184|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277622|NCT04784533|582395185|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277623|NCT04784533|582395186|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277624|NCT04784533|582395187|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277625|NCT04784533|582395188|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
161277626|NCT04784533|582395179|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
161277627|NCT04784533|582395180|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
161277628|NCT04784533|582395181|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277629|NCT04784533|582395182|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277630|NCT04784533|582395183|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277631|NCT04784533|582395184|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277632|NCT04784533|582395185|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277633|NCT04784533|582395186|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277634|NCT04784533|582395187|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277635|NCT04784533|582395188|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
161277636|NCT04784533|582395179|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277637|NCT04784533|582395180|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277638|NCT04784533|582395181|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
161277639|NCT04784533|582395182|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277640|NCT04784533|582395183|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277641|NCT04784533|582395184|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277642|NCT04784533|582395185|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277643|NCT04784533|582395186|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277644|NCT04784533|582395187|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277645|NCT04784533|582395188|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
161277646|NCT04784533|582395179|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277647|NCT04784533|582395180|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277648|NCT04784533|582395181|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277649|NCT04784533|582395182|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277650|NCT04784533|582395183|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277651|NCT04784533|582395184|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161030819|NCT05424380|581504827|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030820|NCT05424380|581504828|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030821|NCT05424380|581504829|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
161030822|NCT05424380|581504830|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030823|NCT05424380|581504831|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030824|NCT05424380|581504826|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161030825|NCT05424380|581504827|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161030826|NCT05424380|581504828|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161030827|NCT05424380|581504829|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
161030828|NCT05424380|581504830|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161030829|NCT05424380|581504831|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
161030830|NCT05424380|581504826|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161030831|NCT05424380|581504827|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161030832|NCT05424380|581504828|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161030833|NCT05424380|581504829|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
161030834|NCT05424380|581504830|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161030835|NCT05424380|581504831|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
161030836|NCT05424380|581504826|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161030837|NCT05424380|581504827|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161277652|NCT04784533|582395185|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277653|NCT04784533|582395186|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277654|NCT04784533|582395187|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
161030838|NCT05424380|581504828|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161030839|NCT05424380|581504829|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161030840|NCT05424380|581504830|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
161030841|NCT05424380|581504831|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
161030842|NCT05424380|581504826|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030843|NCT05424380|581504827|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030844|NCT05424380|581504828|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030845|NCT05424380|581504829|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030846|NCT05424380|581504830|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
161030847|NCT05424380|581504831|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
161030848|NCT05424380|581504826|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161030849|NCT05424380|581504827|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161030850|NCT05424380|581504828|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161030851|NCT05424380|581504829|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161030852|NCT05424380|581504830|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
161030853|NCT05424380|581504831|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
161030854|NCT04218851|581504838|FG000|Overall Study|Death|1|||
161030855|NCT04218851|581504839|FG001|Overall Study|Death|3|||
161030856|NCT00844415|581504840|FG000|Overall Study|Withdrawal by Subject|1|||
161030857|NCT01820611|581504847|FG000|Overall Study|Death|8|||
161030858|NCT01820611|581504847|FG000|Overall Study|Adverse Event|1|||
161030859|NCT01820611|581504847|FG000|Overall Study|Withdrawal by Subject|9|||
161030860|NCT03015532|581504848|FG000|Overall Study|Adverse Event|0|||
161030861|NCT03015532|581504849|FG001|Overall Study|Adverse Event|0|||
161030862|NCT03015532|581504850|FG002|Overall Study|Adverse Event|0|||
161030863|NCT03015532|581504851|FG003|Overall Study|Adverse Event|0|||
161030864|NCT03015532|581504852|FG004|Overall Study|Adverse Event|0|||
161030865|NCT03015532|581504853|FG005|Overall Study|Adverse Event|2|||
161030866|NCT03015532|581504854|FG006|Overall Study|Adverse Event|1|||
161030867|NCT03015532|581504855|FG007|Overall Study|Adverse Event|0|||
161030868|NCT03015532|581504848|FG000|Overall Study|Withdrawal by Subject|0|||
161030869|NCT03015532|581504849|FG001|Overall Study|Withdrawal by Subject|0|||
161030870|NCT03015532|581504850|FG002|Overall Study|Withdrawal by Subject|0|||
161030871|NCT03015532|581504851|FG003|Overall Study|Withdrawal by Subject|0|||
161030872|NCT03015532|581504852|FG004|Overall Study|Withdrawal by Subject|0|||
161030873|NCT03015532|581504853|FG005|Overall Study|Withdrawal by Subject|0|||
161030874|NCT03015532|581504854|FG006|Overall Study|Withdrawal by Subject|1|||
161030875|NCT03015532|581504855|FG007|Overall Study|Withdrawal by Subject|0|||
161030876|NCT03484819|581504856|FG000|Overall Study|Death|2|||
161030877|NCT03484819|581504856|FG000|Overall Study|Adverse Event|2|||
161030878|NCT03484819|581504856|FG000|Overall Study|Physician Decision|1|||
161030879|NCT03484819|581504856|FG000|Overall Study|Withdrawal by Subject|2|||
161030880|NCT03484819|581504856|FG000|Overall Study|Disease Progression|4|||
161030881|NCT03484819|581504856|FG000|Overall Study|Complicating Condition|1|||
161030882|NCT04186819|581504857|FG000|Overall Study|Adverse Event|1|||
161030883|NCT04186819|581504857|FG000|Overall Study|Lost to Follow-up|1|||
161030884|NCT04186819|581504857|FG000|Overall Study|Opted for EBRT|1|||
161030885|NCT04186819|581504857|FG000|Overall Study|Opted SBRT|1|||
161030886|NCT04186819|581504857|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
161030887|NCT04186819|581504857|FG000|Overall Study|Physician Decision|1|||
161030888|NCT04186819|581504857|FG000|Overall Study|RP Delayed|1|||
161030889|NCT04186819|581504857|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
161030890|NCT04186819|581504857|FG000|Overall Study|Subject declined for financial reasons|1|||
161030891|NCT04186819|581504857|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
161030892|NCT04186819|581504857|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
161030893|NCT04186819|581504857|FG000|Overall Study|The subject opted for other treatment option|2|||
161030894|NCT04186819|581504857|FG000|Overall Study|The subject opted for other treatment options|1|||
161030895|NCT04186819|581504857|FG000|Overall Study|Withdrawal by Subject|3|||
161030896|NCT04186819|581504857|FG000|Overall Study|Reason not specified|1|||
161030897|NCT05013385|581504861|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
161030898|NCT01447719|581504862|FG000|Overall Study|Image acquisition failure|2|||
161030899|NCT01447719|581504862|FG000|Overall Study|Invalid image or not imaged|3|||
161030900|NCT01447719|581504862|FG000|Overall Study|Subject still living at end of study|79|||
161030901|NCT01447719|581504862|FG000|Overall Study|Withdrawal by Subject|2|||
161030902|NCT01447719|581504862|FG000|Overall Study|Family withdrew autopsy consent|7|||
161030903|NCT03252288|581504863|FG000|Overall Study|Death|1|||
161030904|NCT03252288|581504864|FG001|Overall Study|Death|0|||
161030905|NCT03252288|581504865|FG002|Overall Study|Death|0|||
161030906|NCT03252288|581504863|FG000|Overall Study|Death|11|||
161030907|NCT03252288|581504864|FG001|Overall Study|Death|0|||
161030908|NCT03252288|581504865|FG002|Overall Study|Death|0|||
161030909|NCT03252288|581504863|FG000|Overall Study|Withdrawal by Subject|2|||
161030910|NCT03252288|581504864|FG001|Overall Study|Withdrawal by Subject|0|||
161030911|NCT03252288|581504865|FG002|Overall Study|Withdrawal by Subject|0|||
161030912|NCT03252288|581504863|FG000|Overall Study|Lost to Follow-up|79|||
161030913|NCT03252288|581504864|FG001|Overall Study|Lost to Follow-up|0|||
161030914|NCT03252288|581504865|FG002|Overall Study|Lost to Follow-up|0|||
161030915|NCT03252288|581504863|FG000|Overall Study|Loss of baseline data on tablets|6|||
161030916|NCT03252288|581504864|FG001|Overall Study|Loss of baseline data on tablets|0|||
161030917|NCT03252288|581504865|FG002|Overall Study|Loss of baseline data on tablets|0|||
161030918|NCT02326974|581504875|FG000|Overall Study|Withdrawal by Subject|2|||
161030919|NCT02326974|581504875|FG000|Overall Study|failed heterogenity evaluation|5|||
161030920|NCT04924400|581504876|FG000|Overall Study|Lost to Follow-up|3|||
161030921|NCT04924400|581504877|FG001|Overall Study|Lost to Follow-up|0|||
161030922|NCT04633538|581504878|FG000|Overall Study|Death|1|||
161030923|NCT04633538|581504878|FG000|Overall Study|Lost to Follow-up|3|||
161030924|NCT04633538|581504878|FG000|Overall Study|Withdrawal by Subject|1|||
161030925|NCT03582033|581504879|FG000|Part A|Other|0|||
161030926|NCT03582033|581504880|FG001|Part A|Other|0|||
161030927|NCT03582033|581504881|FG002|Part A|Other|0|||
161030928|NCT03582033|581504882|FG003|Part A|Other|0|||
161030929|NCT03582033|581504883|FG004|Part A|Other|2|||
161030930|NCT03582033|581504884|FG005|Part A|Other|0|||
161030931|NCT03582033|581504885|FG006|Part A|Other|0|||
161030932|NCT03582033|581504886|FG007|Part A|Other|0|||
161030933|NCT03582033|581504887|FG008|Part A|Other|0|||
161030934|NCT03582033|581504888|FG009|Part A|Other|0|||
161030935|NCT03582033|581504879|FG000|Part A|Death|1|||
161030936|NCT03582033|581504880|FG001|Part A|Death|1|||
161030937|NCT03582033|581504881|FG002|Part A|Death|2|||
161030938|NCT03582033|581504882|FG003|Part A|Death|4|||
161030939|NCT03582033|581504883|FG004|Part A|Death|11|||
161030940|NCT03582033|581504884|FG005|Part A|Death|0|||
161030941|NCT03582033|581504885|FG006|Part A|Death|0|||
161030942|NCT03582033|581504886|FG007|Part A|Death|0|||
161030943|NCT03582033|581504887|FG008|Part A|Death|0|||
161030944|NCT03582033|581504888|FG009|Part A|Death|0|||
161030945|NCT03582033|581504879|FG000|Part A|Lost to Follow-up|0|||
161277655|NCT04784533|582395188|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
161277656|NCT04784533|582395179|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161277657|NCT04784533|582395180|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161030946|NCT03582033|581504880|FG001|Part A|Lost to Follow-up|0|||
161030947|NCT03582033|581504881|FG002|Part A|Lost to Follow-up|0|||
161277658|NCT04784533|582395181|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161277659|NCT04784533|582395182|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161030948|NCT03582033|581504882|FG003|Part A|Lost to Follow-up|0|||
161030949|NCT03582033|581504883|FG004|Part A|Lost to Follow-up|1|||
161030950|NCT03582033|581504884|FG005|Part A|Lost to Follow-up|0|||
161030951|NCT03582033|581504885|FG006|Part A|Lost to Follow-up|0|||
161030952|NCT03582033|581504886|FG007|Part A|Lost to Follow-up|0|||
161030953|NCT03582033|581504887|FG008|Part A|Lost to Follow-up|0|||
161030954|NCT03582033|581504888|FG009|Part A|Lost to Follow-up|0|||
161030955|NCT03582033|581504879|FG000|Part A|Study terminated by sponsor|0|||
161030956|NCT03582033|581504880|FG001|Part A|Study terminated by sponsor|0|||
161030957|NCT03582033|581504881|FG002|Part A|Study terminated by sponsor|0|||
161030958|NCT03582033|581504882|FG003|Part A|Study terminated by sponsor|2|||
161030959|NCT03582033|581504883|FG004|Part A|Study terminated by sponsor|1|||
161030960|NCT03582033|581504884|FG005|Part A|Study terminated by sponsor|0|||
161277660|NCT04784533|582395183|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161277661|NCT04784533|582395184|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161277662|NCT04784533|582395185|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161277663|NCT04784533|582395186|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
161277664|NCT04784533|582395187|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
161277665|NCT04784533|582395188|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
161277666|NCT02105974|582395189|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
161277667|NCT02105974|582395190|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
161277668|NCT02105974|582395191|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
161344532|NCT03916926|582647217|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
161344533|NCT03916926|582647218|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
161030961|NCT03582033|581504885|FG006|Part A|Study terminated by sponsor|0|||
161030962|NCT03582033|581504886|FG007|Part A|Study terminated by sponsor|0|||
161030963|NCT03582033|581504887|FG008|Part A|Study terminated by sponsor|0|||
161030964|NCT03582033|581504888|FG009|Part A|Study terminated by sponsor|0|||
161030965|NCT03582033|581504879|FG000|Part A|Withdrawal by Subject|1|||
161030966|NCT03582033|581504880|FG001|Part A|Withdrawal by Subject|1|||
161030967|NCT03582033|581504881|FG002|Part A|Withdrawal by Subject|0|||
161030968|NCT03582033|581504882|FG003|Part A|Withdrawal by Subject|1|||
161030969|NCT03582033|581504883|FG004|Part A|Withdrawal by Subject|7|||
161030970|NCT03582033|581504884|FG005|Part A|Withdrawal by Subject|0|||
161030971|NCT03582033|581504885|FG006|Part A|Withdrawal by Subject|0|||
161030972|NCT03582033|581504886|FG007|Part A|Withdrawal by Subject|0|||
161030973|NCT03582033|581504887|FG008|Part A|Withdrawal by Subject|0|||
161030974|NCT03582033|581504888|FG009|Part A|Withdrawal by Subject|0|||
161030975|NCT03582033|581504879|FG000|Part B|Death|0|||
161030976|NCT03582033|581504880|FG001|Part B|Death|0|||
161030977|NCT03582033|581504881|FG002|Part B|Death|0|||
161030978|NCT03582033|581504882|FG003|Part B|Death|0|||
161030979|NCT03582033|581504883|FG004|Part B|Death|0|||
161030980|NCT03582033|581504884|FG005|Part B|Death|2|||
161030981|NCT03582033|581504885|FG006|Part B|Death|0|||
161030982|NCT03582033|581504886|FG007|Part B|Death|0|||
161030983|NCT03582033|581504887|FG008|Part B|Death|0|||
161030984|NCT03582033|581504888|FG009|Part B|Death|0|||
161030985|NCT03582033|581504879|FG000|Part B|Study terminated by sponsor|0|||
161030986|NCT03582033|581504880|FG001|Part B|Study terminated by sponsor|0|||
161030987|NCT03582033|581504881|FG002|Part B|Study terminated by sponsor|0|||
161030988|NCT03582033|581504882|FG003|Part B|Study terminated by sponsor|0|||
161030989|NCT03582033|581504883|FG004|Part B|Study terminated by sponsor|0|||
161030990|NCT03582033|581504884|FG005|Part B|Study terminated by sponsor|12|||
161030991|NCT03582033|581504885|FG006|Part B|Study terminated by sponsor|0|||
161030992|NCT03582033|581504886|FG007|Part B|Study terminated by sponsor|0|||
161030993|NCT03582033|581504887|FG008|Part B|Study terminated by sponsor|0|||
161030994|NCT03582033|581504888|FG009|Part B|Study terminated by sponsor|0|||
161030995|NCT03582033|581504879|FG000|Part B|Withdrawal by Subject|0|||
161030996|NCT03582033|581504880|FG001|Part B|Withdrawal by Subject|0|||
161030997|NCT03582033|581504881|FG002|Part B|Withdrawal by Subject|0|||
161030998|NCT03582033|581504882|FG003|Part B|Withdrawal by Subject|0|||
161030999|NCT03582033|581504883|FG004|Part B|Withdrawal by Subject|0|||
161031000|NCT03582033|581504884|FG005|Part B|Withdrawal by Subject|6|||
161031001|NCT03582033|581504885|FG006|Part B|Withdrawal by Subject|0|||
161031002|NCT03582033|581504886|FG007|Part B|Withdrawal by Subject|0|||
161031003|NCT03582033|581504887|FG008|Part B|Withdrawal by Subject|0|||
161031004|NCT03582033|581504888|FG009|Part B|Withdrawal by Subject|0|||
161031005|NCT03582033|581504879|FG000|Part C|Other|0|||
161031006|NCT03582033|581504880|FG001|Part C|Other|0|||
161031007|NCT03582033|581504881|FG002|Part C|Other|0|||
161031008|NCT03582033|581504882|FG003|Part C|Other|0|||
161031009|NCT03582033|581504883|FG004|Part C|Other|0|||
161031010|NCT03582033|581504884|FG005|Part C|Other|0|||
161031011|NCT03582033|581504885|FG006|Part C|Other|2|||
161031012|NCT03582033|581504886|FG007|Part C|Other|0|||
161031013|NCT03582033|581504887|FG008|Part C|Other|0|||
161031014|NCT03582033|581504888|FG009|Part C|Other|0|||
161031015|NCT03582033|581504879|FG000|Part C|Death|0|||
161031016|NCT03582033|581504880|FG001|Part C|Death|0|||
161031017|NCT03582033|581504881|FG002|Part C|Death|0|||
161031018|NCT03582033|581504882|FG003|Part C|Death|0|||
161031019|NCT03582033|581504883|FG004|Part C|Death|0|||
161031020|NCT03582033|581504884|FG005|Part C|Death|0|||
161031021|NCT03582033|581504885|FG006|Part C|Death|6|||
161031022|NCT03582033|581504886|FG007|Part C|Death|1|||
161031023|NCT03582033|581504887|FG008|Part C|Death|2|||
161031024|NCT03582033|581504888|FG009|Part C|Death|0|||
161031025|NCT03582033|581504879|FG000|Part C|Study terminated by sponsor|0|||
161031026|NCT03582033|581504880|FG001|Part C|Study terminated by sponsor|0|||
161031027|NCT03582033|581504881|FG002|Part C|Study terminated by sponsor|0|||
161031028|NCT03582033|581504882|FG003|Part C|Study terminated by sponsor|0|||
161031029|NCT03582033|581504883|FG004|Part C|Study terminated by sponsor|0|||
161031030|NCT03582033|581504884|FG005|Part C|Study terminated by sponsor|0|||
161031031|NCT03582033|581504885|FG006|Part C|Study terminated by sponsor|3|||
160975824|NCT06173570|581300614|FG000|Overall Study|Adverse Event|1|||
160975825|NCT06173570|581300615|FG001|Overall Study|Adverse Event|0|||
160975826|NCT06173570|581300616|FG002|Overall Study|Adverse Event|0|||
160975827|NCT06173570|581300617|FG003|Overall Study|Adverse Event|2|||
160975828|NCT06173570|581300618|FG004|Overall Study|Adverse Event|0|||
160975829|NCT06173570|581300614|FG000|Overall Study|Lost to Follow-up|1|||
160975830|NCT06173570|581300615|FG001|Overall Study|Lost to Follow-up|0|||
161031032|NCT03582033|581504886|FG007|Part C|Study terminated by sponsor|3|||
161031033|NCT03582033|581504887|FG008|Part C|Study terminated by sponsor|2|||
161031034|NCT03582033|581504888|FG009|Part C|Study terminated by sponsor|0|||
161031035|NCT03582033|581504879|FG000|Part C|Withdrawal by Subject|0|||
161031036|NCT03582033|581504880|FG001|Part C|Withdrawal by Subject|0|||
161031037|NCT03582033|581504881|FG002|Part C|Withdrawal by Subject|0|||
161031038|NCT03582033|581504882|FG003|Part C|Withdrawal by Subject|0|||
161031039|NCT03582033|581504883|FG004|Part C|Withdrawal by Subject|0|||
161031040|NCT03582033|581504884|FG005|Part C|Withdrawal by Subject|0|||
161031041|NCT03582033|581504885|FG006|Part C|Withdrawal by Subject|1|||
161031042|NCT03582033|581504886|FG007|Part C|Withdrawal by Subject|2|||
160975831|NCT06173570|581300616|FG002|Overall Study|Lost to Follow-up|0|||
160975832|NCT06173570|581300617|FG003|Overall Study|Lost to Follow-up|0|||
161031043|NCT03582033|581504887|FG008|Part C|Withdrawal by Subject|1|||
161031044|NCT03582033|581504888|FG009|Part C|Withdrawal by Subject|0|||
161031045|NCT03582033|581504879|FG000|Part D|Death|0|||
161031046|NCT03582033|581504880|FG001|Part D|Death|0|||
161031047|NCT03582033|581504881|FG002|Part D|Death|0|||
161031048|NCT03582033|581504882|FG003|Part D|Death|0|||
161031049|NCT03582033|581504883|FG004|Part D|Death|0|||
161031050|NCT03582033|581504884|FG005|Part D|Death|0|||
161031051|NCT03582033|581504885|FG006|Part D|Death|0|||
161031052|NCT03582033|581504886|FG007|Part D|Death|0|||
161277669|NCT02105974|582395189|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
161277670|NCT02105974|582395190|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
161277671|NCT02105974|582395191|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
161277672|NCT02105974|582395189|FG000|2 Week Run-in Period|Adverse Event|6|||
161277673|NCT02105974|582395190|FG001|2 Week Run-in Period|Adverse Event|0|||
161277674|NCT02105974|582395191|FG002|2 Week Run-in Period|Adverse Event|0|||
161277675|NCT02105974|582395189|FG000|2 Week Run-in Period|Study closed/terminated|1|||
161277676|NCT02105974|582395190|FG001|2 Week Run-in Period|Study closed/terminated|0|||
161277677|NCT02105974|582395191|FG002|2 Week Run-in Period|Study closed/terminated|0|||
161277678|NCT02105974|582395189|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
161277679|NCT02105974|582395190|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
161277680|NCT02105974|582395191|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
161277681|NCT02105974|582395189|FG000|2 Week Run-in Period|Withdrew consent|23|||
161277682|NCT02105974|582395190|FG001|2 Week Run-in Period|Withdrew consent|0|||
161277683|NCT02105974|582395191|FG002|2 Week Run-in Period|Withdrew consent|0|||
161031053|NCT03582033|581504887|FG008|Part D|Death|0|||
161031054|NCT03582033|581504888|FG009|Part D|Death|1|||
161031055|NCT03582033|581504879|FG000|Part D|Study terminated by sponsor|0|||
161031056|NCT03582033|581504880|FG001|Part D|Study terminated by sponsor|0|||
161031057|NCT03582033|581504881|FG002|Part D|Study terminated by sponsor|0|||
161031058|NCT03582033|581504882|FG003|Part D|Study terminated by sponsor|0|||
161031059|NCT03582033|581504883|FG004|Part D|Study terminated by sponsor|0|||
161031060|NCT03582033|581504884|FG005|Part D|Study terminated by sponsor|0|||
161031061|NCT03582033|581504885|FG006|Part D|Study terminated by sponsor|0|||
161031062|NCT03582033|581504886|FG007|Part D|Study terminated by sponsor|0|||
161031063|NCT03582033|581504887|FG008|Part D|Study terminated by sponsor|0|||
161031064|NCT03582033|581504888|FG009|Part D|Study terminated by sponsor|4|||
161031065|NCT06010836|581504889|FG000|Overall Study|Lost to Follow-up|2|||
161031066|NCT06010836|581504890|FG001|Overall Study|Lost to Follow-up|2|||
161031067|NCT06010836|581504889|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
161031068|NCT06010836|581504890|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
161031069|NCT06010836|581504889|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
161031070|NCT06010836|581504890|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
161031071|NCT06010836|581504889|FG000|Overall Study|Did not receive intervention discussion|0|||
161031072|NCT06010836|581504890|FG001|Overall Study|Did not receive intervention discussion|4|||
161031073|NCT03972150|581505827|FG000|Overall Study|Adverse Event|0|||
161031074|NCT03972150|581505828|FG001|Overall Study|Adverse Event|1|||
161031075|NCT03972150|581505829|FG002|Overall Study|Adverse Event|1|||
161031076|NCT03972150|581505830|FG003|Overall Study|Adverse Event|0|||
161031077|NCT03972150|581505831|FG004|Overall Study|Adverse Event|0|||
161031078|NCT03972150|581505827|FG000|Overall Study|Progressive disease|3|||
161031079|NCT03972150|581505828|FG001|Overall Study|Progressive disease|5|||
161031080|NCT03972150|581505829|FG002|Overall Study|Progressive disease|2|||
161031081|NCT03972150|581505830|FG003|Overall Study|Progressive disease|2|||
161031082|NCT03972150|581505831|FG004|Overall Study|Progressive disease|3|||
161031083|NCT05464069|581505834|FG000|Overall Study|Protocol Violation|3|||
161277684|NCT02105974|582395189|FG000|2 Week Run-in Period|Investigator discretion|8|||
161277685|NCT02105974|582395190|FG001|2 Week Run-in Period|Investigator discretion|0|||
161277686|NCT02105974|582395191|FG002|2 Week Run-in Period|Investigator discretion|0|||
161031084|NCT05464069|581505835|FG001|Overall Study|Protocol Violation|2|||
161031085|NCT03442309|581505836|FG000|Overall Study|Lost to Follow-up|1676|||
161031086|NCT03442309|581505837|FG001|Overall Study|Lost to Follow-up|1642|||
161031087|NCT03174275|581505840|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
161031088|NCT03174275|581505840|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
161031089|NCT03174275|581505840|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
161031090|NCT03174275|581505840|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
161031091|NCT03174275|581505840|FG000|Adjuvant Chemotherapy|Progression|1|||
161031092|NCT03174275|581505840|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
161031093|NCT03174275|581505840|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
161031094|NCT03174275|581505840|FG000|Adjuvant Durvalumab|Progression|1|||
161031095|NCT03174275|581505840|FG000|Adjuvant Durvalumab|Adverse Event|3|||
161031096|NCT03174275|581505840|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
161031097|NCT03174275|581505840|FG000|Adjuvant Radiotherapy|Progression|1|||
161031098|NCT03174275|581505840|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
161031099|NCT03988621|581505841|FG000|Overall Study|Lost to Follow-up|16|||
161031100|NCT03988621|581505842|FG001|Overall Study|Lost to Follow-up|17|||
161031101|NCT03988621|581505841|FG000|Overall Study|Withdrawal by Subject|14|||
161031102|NCT03988621|581505842|FG001|Overall Study|Withdrawal by Subject|7|||
161148842|NCT03238248|581926155|FG000|Overall Study|Disease progression|26|||
161277687|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
161277688|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
161031103|NCT03988621|581505841|FG000|Overall Study|Patient Lost to Follow Up|15|||
161031104|NCT03988621|581505842|FG001|Overall Study|Patient Lost to Follow Up|15|||
161031105|NCT03988621|581505841|FG000|Overall Study|Patient death|1|||
160975833|NCT06173570|581300618|FG004|Overall Study|Lost to Follow-up|2|||
160975834|NCT06173570|581300614|FG000|Overall Study|Protocol Violation|0|||
160975835|NCT06173570|581300615|FG001|Overall Study|Protocol Violation|2|||
160975836|NCT06173570|581300616|FG002|Overall Study|Protocol Violation|0|||
160975837|NCT06173570|581300617|FG003|Overall Study|Protocol Violation|0|||
160975838|NCT06173570|581300618|FG004|Overall Study|Protocol Violation|1|||
160975839|NCT06173570|581300614|FG000|Overall Study|Withdrawal by Subject|0|||
160975840|NCT06173570|581300615|FG001|Overall Study|Withdrawal by Subject|1|||
160975841|NCT06173570|581300616|FG002|Overall Study|Withdrawal by Subject|1|||
160975842|NCT06173570|581300617|FG003|Overall Study|Withdrawal by Subject|1|||
160975843|NCT06173570|581300618|FG004|Overall Study|Withdrawal by Subject|1|||
160975844|NCT06173570|581300614|FG000|Overall Study|Non-compliance with Study Drug|1|||
160975845|NCT06173570|581300615|FG001|Overall Study|Non-compliance with Study Drug|0|||
160975846|NCT06173570|581300616|FG002|Overall Study|Non-compliance with Study Drug|0|||
160975847|NCT06173570|581300617|FG003|Overall Study|Non-compliance with Study Drug|0|||
160975848|NCT06173570|581300618|FG004|Overall Study|Non-compliance with Study Drug|0|||
160975849|NCT06173570|581300614|FG000|Overall Study|Screen Failure|0|||
160975850|NCT06173570|581300615|FG001|Overall Study|Screen Failure|0|||
160975851|NCT06173570|581300616|FG002|Overall Study|Screen Failure|0|||
160975852|NCT06173570|581300617|FG003|Overall Study|Screen Failure|0|||
160975853|NCT06173570|581300618|FG004|Overall Study|Screen Failure|1|||
160975854|NCT06173570|581300614|FG000|Overall Study|Other|2|||
160975855|NCT06173570|581300615|FG001|Overall Study|Other|1|||
160975856|NCT06173570|581300616|FG002|Overall Study|Other|0|||
160975857|NCT06173570|581300617|FG003|Overall Study|Other|2|||
160975858|NCT06173570|581300618|FG004|Overall Study|Other|0|||
160975859|NCT03820323|581300619|FG000|Overall Study|Lost to Follow-up|2|||
160975860|NCT03820323|581300620|FG001|Overall Study|Lost to Follow-up|1|||
160975861|NCT03820323|581300619|FG000|Overall Study|Missed 12-month visit|22|||
160975862|NCT03820323|581300620|FG001|Overall Study|Missed 12-month visit|14|||
160975863|NCT03820323|581300619|FG000|Overall Study|Death|2|||
160975864|NCT03820323|581300620|FG001|Overall Study|Death|1|||
160975865|NCT03820323|581300619|FG000|Overall Study|Transferred out|13|||
160975866|NCT03820323|581300620|FG001|Overall Study|Transferred out|11|||
160975867|NCT03820323|581300619|FG000|Overall Study|Terminated|0|||
160975868|NCT03820323|581300620|FG001|Overall Study|Terminated|3|||
160975869|NCT03820323|581300619|FG000|Overall Study|Withdrawal by Subject|1|||
160975870|NCT03820323|581300620|FG001|Overall Study|Withdrawal by Subject|6|||
161031106|NCT03988621|581505842|FG001|Overall Study|Patient death|5|||
161031107|NCT02944968|581505843|FG000|Overall Study|Subject excluded before study procedure|1|||
161031108|NCT02944968|581505843|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
161031109|NCT02905331|581505844|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
161031110|NCT02905331|581505845|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
161031111|NCT02905331|581505846|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
161031112|NCT02905331|581505844|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
161031113|NCT02905331|581505845|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
161031114|NCT02905331|581505846|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
161031115|NCT02905331|581505844|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
161031116|NCT02905331|581505845|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
161031117|NCT02905331|581505846|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
161031118|NCT02905331|581505844|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
161031119|NCT02905331|581505845|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
161031120|NCT02905331|581505846|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
161031121|NCT02905331|581505844|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
161031122|NCT02905331|581505845|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
161031123|NCT02905331|581505846|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
161031124|NCT02542631|581505847|FG000|Overall Study|Adverse Event|1|||
161031125|NCT02542631|581505848|FG001|Overall Study|Adverse Event|1|||
161031126|NCT02542631|581505847|FG000|Overall Study|Sponsor Termination|1|||
161031127|NCT02542631|581505848|FG001|Overall Study|Sponsor Termination|0|||
161031128|NCT02542631|581505847|FG000|Overall Study|Withdrawal by Subject|11|||
161031129|NCT02542631|581505848|FG001|Overall Study|Withdrawal by Subject|16|||
160975871|NCT03151395|581300621|FG000|Overall Study|Adverse Event|2|||
160975872|NCT03151395|581300621|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
160975873|NCT03151395|581300621|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
160975874|NCT03151395|581300621|FG000|Overall Study|Unspecified reason|4|||
160975875|NCT00366301|581300622|FG000|Overall Study|Lost to Follow-up|4|||
160975876|NCT00366301|581300623|FG001|Overall Study|Lost to Follow-up|4|||
160975877|NCT00366301|581300624|FG002|Overall Study|Lost to Follow-up|3|||
160975878|NCT00366301|581300625|FG003|Overall Study|Lost to Follow-up|7|||
160975879|NCT00366301|581300622|FG000|Overall Study|Withdrawal by Subject|4|||
160975880|NCT00366301|581300623|FG001|Overall Study|Withdrawal by Subject|2|||
160975881|NCT00366301|581300624|FG002|Overall Study|Withdrawal by Subject|1|||
160975882|NCT00366301|581300625|FG003|Overall Study|Withdrawal by Subject|1|||
161031130|NCT02542631|581505847|FG000|Overall Study|Protocol Violation|1|||
161031131|NCT02542631|581505848|FG001|Overall Study|Protocol Violation|1|||
161031132|NCT02542631|581505847|FG000|Overall Study|Physician Decision|6|||
161031133|NCT02542631|581505848|FG001|Overall Study|Physician Decision|4|||
161031134|NCT02542631|581505847|FG000|Overall Study|Lost to Follow-up|6|||
161031135|NCT02542631|581505848|FG001|Overall Study|Lost to Follow-up|5|||
161031136|NCT02542631|581505847|FG000|Overall Study|Death|1|||
161031137|NCT02542631|581505848|FG001|Overall Study|Death|2|||
161031138|NCT02542631|581505847|FG000|Overall Study|Other|2|||
161031139|NCT02542631|581505848|FG001|Overall Study|Other|1|||
161031140|NCT02542631|581505847|FG000|Overall Study|Used Prohibited Medication|2|||
161031141|NCT02542631|581505848|FG001|Overall Study|Used Prohibited Medication|1|||
161031142|NCT04424316|581505854|FG000|Overall Study|Adverse Event|0|||
161031143|NCT04424316|581505855|FG001|Overall Study|Adverse Event|1|||
161031144|NCT04424316|581505856|FG002|Overall Study|Adverse Event|0|||
161031145|NCT04424316|581505857|FG003|Overall Study|Adverse Event|0|||
161031146|NCT04424316|581505854|FG000|Overall Study|Death|1|||
161031147|NCT04424316|581505855|FG001|Overall Study|Death|0|||
161031148|NCT04424316|581505856|FG002|Overall Study|Death|8|||
161031149|NCT04424316|581505857|FG003|Overall Study|Death|14|||
161031150|NCT04424316|581505854|FG000|Overall Study|Lost to Follow-up|93|||
161031151|NCT04424316|581505855|FG001|Overall Study|Lost to Follow-up|88|||
161031152|NCT04424316|581505856|FG002|Overall Study|Lost to Follow-up|224|||
161031153|NCT04424316|581505857|FG003|Overall Study|Lost to Follow-up|211|||
161031154|NCT04424316|581505854|FG000|Overall Study|No longer met eligibility criteria|1|||
161031155|NCT04424316|581505855|FG001|Overall Study|No longer met eligibility criteria|0|||
161031156|NCT04424316|581505856|FG002|Overall Study|No longer met eligibility criteria|0|||
161031157|NCT04424316|581505857|FG003|Overall Study|No longer met eligibility criteria|0|||
161031158|NCT04424316|581505854|FG000|Overall Study|Other|15|||
161031159|NCT04424316|581505855|FG001|Overall Study|Other|11|||
161031160|NCT04424316|581505856|FG002|Overall Study|Other|34|||
161031161|NCT04424316|581505857|FG003|Overall Study|Other|45|||
161031162|NCT04424316|581505854|FG000|Overall Study|Physician Decision|1|||
161031163|NCT04424316|581505855|FG001|Overall Study|Physician Decision|0|||
161031164|NCT04424316|581505856|FG002|Overall Study|Physician Decision|1|||
161031165|NCT04424316|581505857|FG003|Overall Study|Physician Decision|1|||
161031166|NCT04424316|581505854|FG000|Overall Study|Protocol Violation|0|||
161031167|NCT04424316|581505855|FG001|Overall Study|Protocol Violation|1|||
161031168|NCT04424316|581505856|FG002|Overall Study|Protocol Violation|0|||
161031169|NCT04424316|581505857|FG003|Overall Study|Protocol Violation|0|||
161031170|NCT04424316|581505854|FG000|Overall Study|Withdrawal by Subject|71|||
161031171|NCT04424316|581505855|FG001|Overall Study|Withdrawal by Subject|77|||
161031172|NCT04424316|581505856|FG002|Overall Study|Withdrawal by Subject|0|||
161031173|NCT04424316|581505857|FG003|Overall Study|Withdrawal by Subject|0|||
161031174|NCT04424316|581505854|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161031175|NCT04424316|581505855|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161031176|NCT04424316|581505856|FG002|Overall Study|Withdrawal by parent/guardian|74|||
161031177|NCT04424316|581505857|FG003|Overall Study|Withdrawal by parent/guardian|81|||
161031178|NCT04424316|581505854|FG000|Overall Study|Randomized but not vaccinated|13|||
161031179|NCT04424316|581505855|FG001|Overall Study|Randomized but not vaccinated|21|||
161031180|NCT04424316|581505856|FG002|Overall Study|Randomized but not vaccinated|0|||
161031181|NCT04424316|581505857|FG003|Overall Study|Randomized but not vaccinated|0|||
161031182|NCT04424316|581505854|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
161031183|NCT04424316|581505855|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
161031184|NCT04424316|581505856|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
161031185|NCT04424316|581505857|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
161031186|NCT03812614|581505859|FG000|Intervention|Withdrawal by Subject|7|||
161031187|NCT03812614|581505860|FG001|Intervention|Withdrawal by Subject|2|||
161031188|NCT03812614|581505861|FG002|Intervention|Withdrawal by Subject|7|||
161031189|NCT03812614|581505862|FG003|Intervention|Withdrawal by Subject|2|||
161277689|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
161277690|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
161277691|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
161277692|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
161277693|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
161277694|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
161277695|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
161277696|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
161277697|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
161277698|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
161277699|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
161277700|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
161031190|NCT03812614|581505859|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
161091170|NCT01191268|581723827|FG002|Overall Study|Entry Criteria Not Met|1|||
161031191|NCT03812614|581505860|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
161031192|NCT03812614|581505861|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
161031193|NCT03812614|581505862|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
161031194|NCT03812614|581505859|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
161031195|NCT03812614|581505860|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
161031196|NCT03812614|581505861|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
161031197|NCT03812614|581505862|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
161031198|NCT03812614|581505859|FG000|6-month Follow-up|Lost to Follow-up|0|||
161031199|NCT03812614|581505860|FG001|6-month Follow-up|Lost to Follow-up|0|||
161031200|NCT03812614|581505861|FG002|6-month Follow-up|Lost to Follow-up|12|||
161031201|NCT03812614|581505862|FG003|6-month Follow-up|Lost to Follow-up|8|||
161031202|NCT03812614|581505859|FG000|12-month Follow-up|Lost to Follow-up|18|||
161031203|NCT03812614|581505860|FG001|12-month Follow-up|Lost to Follow-up|17|||
161031204|NCT03812614|581505861|FG002|12-month Follow-up|Lost to Follow-up|5|||
161031205|NCT03812614|581505862|FG003|12-month Follow-up|Lost to Follow-up|2|||
161031206|NCT05652010|581505863|FG000|First Intervention|Withdrawal by Subject|0|||
161031207|NCT05652010|581505864|FG001|First Intervention|Withdrawal by Subject|1|||
161031208|NCT05652010|581505863|FG000|Second Intervention|Withdrawal by Subject|1|||
161031209|NCT05652010|581505864|FG001|Second Intervention|Withdrawal by Subject|0|||
161031210|NCT05451693|581505865|FG000|Overall Study|Withdrawal by Subject|1|||
161031211|NCT05451693|581505866|FG001|Overall Study|Withdrawal by Subject|1|||
161031212|NCT03372057|581505871|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
161031213|NCT03372057|581505872|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
161031214|NCT03372057|581505873|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
161031215|NCT03372057|581505871|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
161031216|NCT03372057|581505872|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
161031217|NCT03372057|581505873|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
161031218|NCT03372057|581505871|FG000|Dose Optimization Phase|Death|16|||
161031219|NCT03372057|581505872|FG001|Dose Optimization Phase|Death|11|||
161031220|NCT03372057|581505873|FG002|Dose Optimization Phase|Death|0|||
161031221|NCT03372057|581505871|FG000|Expansion Phase|Withdrawal by Subject|0|||
161031222|NCT03372057|581505872|FG001|Expansion Phase|Withdrawal by Subject|0|||
161031223|NCT03372057|581505873|FG002|Expansion Phase|Withdrawal by Subject|4|||
161031224|NCT03372057|581505871|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
161031225|NCT03372057|581505872|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
161031226|NCT03372057|581505873|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
161031227|NCT03372057|581505871|FG000|Expansion Phase|Death|0|||
161031228|NCT03372057|581505872|FG001|Expansion Phase|Death|0|||
161031229|NCT03372057|581505873|FG002|Expansion Phase|Death|78|||
161031230|NCT03372057|581505871|FG000|Expansion Phase|Progressive Disease|0|||
161031231|NCT03372057|581505872|FG001|Expansion Phase|Progressive Disease|0|||
161031232|NCT03372057|581505873|FG002|Expansion Phase|Progressive Disease|1|||
161031233|NCT03372057|581505871|FG000|Expansion Phase|Adverse Event|0|||
161031234|NCT03372057|581505872|FG001|Expansion Phase|Adverse Event|0|||
161031235|NCT03372057|581505873|FG002|Expansion Phase|Adverse Event|1|||
161031236|NCT02518048|581505874|FG000|Overall Study|Withdrawal by Subject|1|||
161031237|NCT05890105|581505875|FG000|Overall Study|Adverse Event|1|||
161031238|NCT05890105|581505876|FG001|Overall Study|Adverse Event|0|||
161031239|NCT05890105|581505877|FG002|Overall Study|Adverse Event|0|||
161031240|NCT05890105|581505875|FG000|Overall Study|Other|1|||
161031241|NCT05890105|581505876|FG001|Overall Study|Other|2|||
161031242|NCT05890105|581505877|FG002|Overall Study|Other|0|||
161031243|NCT05123027|581505879|FG000|Overall Study|Lost to Follow-up|17|||
161031244|NCT05123027|581505880|FG001|Overall Study|Lost to Follow-up|22|||
161031245|NCT05123027|581505879|FG000|Overall Study|Incarceration|3|||
161031246|NCT05123027|581505880|FG001|Overall Study|Incarceration|4|||
161031247|NCT05123027|581505879|FG000|Overall Study|Death|2|||
161031248|NCT05123027|581505880|FG001|Overall Study|Death|2|||
161031249|NCT05123027|581505879|FG000|Overall Study|Other|2|||
161031250|NCT05123027|581505880|FG001|Overall Study|Other|0|||
161031251|NCT04330040|581505881|FG000|Overall Study|Other: Adverse event|5|||
161031252|NCT04330040|581505882|FG001|Overall Study|Other: Adverse event|0|||
161031253|NCT04330040|581505883|FG002|Overall Study|Other: Adverse event|0|||
161031254|NCT04330040|581505881|FG000|Overall Study|Disease progression|38|||
161031255|NCT04330040|581505882|FG001|Overall Study|Disease progression|10|||
161031256|NCT04330040|581505883|FG002|Overall Study|Disease progression|0|||
161031257|NCT04330040|581505881|FG000|Overall Study|Physician Decision|5|||
161031258|NCT04330040|581505882|FG001|Overall Study|Physician Decision|3|||
161031259|NCT04330040|581505883|FG002|Overall Study|Physician Decision|0|||
161031260|NCT04330040|581505881|FG000|Overall Study|Lost to Follow-up|1|||
161031261|NCT04330040|581505882|FG001|Overall Study|Lost to Follow-up|1|||
161031262|NCT04330040|581505883|FG002|Overall Study|Lost to Follow-up|0|||
161031263|NCT04330040|581505881|FG000|Overall Study|Death|2|||
161031264|NCT04330040|581505882|FG001|Overall Study|Death|1|||
161031265|NCT04330040|581505883|FG002|Overall Study|Death|0|||
161031266|NCT04330040|581505881|FG000|Overall Study|Withdrawal by Subject|3|||
161031267|NCT04330040|581505882|FG001|Overall Study|Withdrawal by Subject|3|||
161031268|NCT04330040|581505883|FG002|Overall Study|Withdrawal by Subject|0|||
161031269|NCT04330040|581505881|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
161031270|NCT04330040|581505882|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
161031271|NCT04330040|581505883|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
161031272|NCT04330040|581505881|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
161031273|NCT04330040|581505882|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
161031274|NCT04330040|581505883|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
161031275|NCT04330040|581505881|FG000|Overall Study|Other: Disease progression|1|||
161031276|NCT04330040|581505882|FG001|Overall Study|Other: Disease progression|0|||
161031277|NCT04330040|581505883|FG002|Overall Study|Other: Disease progression|0|||
161031278|NCT04330040|581505881|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
161031279|NCT04330040|581505882|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
161031280|NCT04330040|581505883|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
161031281|NCT04330040|581505881|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
161031282|NCT04330040|581505882|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
161031283|NCT04330040|581505883|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
161031284|NCT04330040|581505881|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
161031285|NCT04330040|581505882|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
161031286|NCT04330040|581505883|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
161031287|NCT04761198|581505886|FG000|Overall Study|Progressive Disease|1|||
161031288|NCT04761198|581505887|FG001|Overall Study|Progressive Disease|0|||
161031289|NCT04761198|581505888|FG002|Overall Study|Progressive Disease|0|||
161031290|NCT04761198|581505889|FG003|Overall Study|Progressive Disease|1|||
161031291|NCT04761198|581505890|FG004|Overall Study|Progressive Disease|4|||
161031292|NCT04761198|581505891|FG005|Overall Study|Progressive Disease|1|||
161031293|NCT04761198|581505892|FG006|Overall Study|Progressive Disease|2|||
161031294|NCT04761198|581505886|FG000|Overall Study|Protocol Violation|0|||
161031295|NCT04761198|581505887|FG001|Overall Study|Protocol Violation|0|||
161031296|NCT04761198|581505888|FG002|Overall Study|Protocol Violation|0|||
161031297|NCT04761198|581505889|FG003|Overall Study|Protocol Violation|0|||
161031298|NCT04761198|581505890|FG004|Overall Study|Protocol Violation|1|||
161031299|NCT04761198|581505891|FG005|Overall Study|Protocol Violation|0|||
161031300|NCT04761198|581505892|FG006|Overall Study|Protocol Violation|0|||
161031301|NCT04761198|581505886|FG000|Overall Study|Death|2|||
161031302|NCT04761198|581505887|FG001|Overall Study|Death|1|||
161031303|NCT04761198|581505888|FG002|Overall Study|Death|2|||
161031304|NCT04761198|581505889|FG003|Overall Study|Death|5|||
161031305|NCT04761198|581505890|FG004|Overall Study|Death|14|||
161031306|NCT04761198|581505891|FG005|Overall Study|Death|2|||
161031307|NCT04761198|581505892|FG006|Overall Study|Death|5|||
161031308|NCT04761198|581505886|FG000|Overall Study|Lost to Follow-up|0|||
161031309|NCT04761198|581505887|FG001|Overall Study|Lost to Follow-up|0|||
161031310|NCT04761198|581505888|FG002|Overall Study|Lost to Follow-up|0|||
161031311|NCT04761198|581505889|FG003|Overall Study|Lost to Follow-up|0|||
161031312|NCT04761198|581505890|FG004|Overall Study|Lost to Follow-up|1|||
161031313|NCT04761198|581505891|FG005|Overall Study|Lost to Follow-up|0|||
161031314|NCT04761198|581505892|FG006|Overall Study|Lost to Follow-up|0|||
161031315|NCT04761198|581505886|FG000|Overall Study|Withdrawal by Subject|2|||
161031316|NCT04761198|581505887|FG001|Overall Study|Withdrawal by Subject|0|||
161031317|NCT04761198|581505888|FG002|Overall Study|Withdrawal by Subject|1|||
161031318|NCT04761198|581505889|FG003|Overall Study|Withdrawal by Subject|0|||
161031319|NCT04761198|581505890|FG004|Overall Study|Withdrawal by Subject|2|||
161031320|NCT04761198|581505891|FG005|Overall Study|Withdrawal by Subject|0|||
161031321|NCT04761198|581505892|FG006|Overall Study|Withdrawal by Subject|1|||
161031322|NCT04761198|581505886|FG000|Overall Study|Study Terminated by Sponsor|6|||
161031323|NCT04761198|581505887|FG001|Overall Study|Study Terminated by Sponsor|0|||
161031324|NCT04761198|581505888|FG002|Overall Study|Study Terminated by Sponsor|5|||
161031325|NCT04761198|581505889|FG003|Overall Study|Study Terminated by Sponsor|3|||
161277701|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
161031326|NCT04761198|581505890|FG004|Overall Study|Study Terminated by Sponsor|10|||
161031327|NCT04761198|581505891|FG005|Overall Study|Study Terminated by Sponsor|1|||
161031328|NCT04761198|581505892|FG006|Overall Study|Study Terminated by Sponsor|2|||
161031329|NCT02994927|581505893|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161031330|NCT02994927|581505894|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161031331|NCT02994927|581505893|FG000|Overall Study|Did not meet eligibility criteria|0|||
161031332|NCT02994927|581505894|FG001|Overall Study|Did not meet eligibility criteria|1|||
161031333|NCT02994927|581505893|FG000|Overall Study|Physician Decision|4|||
161277702|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
161344534|NCT03916926|582647217|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
161031334|NCT02994927|581505894|FG001|Overall Study|Physician Decision|3|||
161031335|NCT02994927|581505893|FG000|Overall Study|Death|4|||
161031336|NCT02994927|581505894|FG001|Overall Study|Death|2|||
161031337|NCT02994927|581505893|FG000|Overall Study|Adverse Event|2|||
161031338|NCT02994927|581505894|FG001|Overall Study|Adverse Event|1|||
161031339|NCT02994927|581505893|FG000|Overall Study|Withdrawal by Subject|3|||
161031340|NCT02994927|581505894|FG001|Overall Study|Withdrawal by Subject|6|||
161031341|NCT02994927|581505893|FG000|Overall Study|Lost to Follow-up|2|||
161031342|NCT02994927|581505894|FG001|Overall Study|Lost to Follow-up|1|||
161031343|NCT03533257|581505895|FG000|Overall Study|Adverse Event|4|||
161031344|NCT03533257|581505896|FG001|Overall Study|Adverse Event|2|||
161031345|NCT03533257|581505895|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
161031346|NCT03533257|581505896|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
161031347|NCT05525104|581505898|FG000|Overall Study|Failed caudal analgesia|1|||
161031348|NCT05525104|581505899|FG001|Overall Study|Failed caudal analgesia|3|||
161031349|NCT05525104|581505898|FG000|Overall Study|Premedication needed|0|||
161031350|NCT05525104|581505899|FG001|Overall Study|Premedication needed|1|||
161031351|NCT05525104|581505898|FG000|Overall Study|Protocol Violation|10|||
161031352|NCT05525104|581505899|FG001|Overall Study|Protocol Violation|0|||
161031353|NCT05525104|581505898|FG000|Overall Study|Cancelled operation|1|||
161031354|NCT05525104|581505899|FG001|Overall Study|Cancelled operation|0|||
161031355|NCT02039401|581505900|FG000|Overall Study|Adverse Event|0|||
161031356|NCT02039401|581505901|FG001|Overall Study|Adverse Event|1|||
161031357|NCT04427007|581507343|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
161031358|NCT04427007|581507344|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
161031359|NCT06106022|581507345|FG000|Overall Study|Lost to Follow-up|1|||
161031360|NCT06106022|581507346|FG001|Overall Study|Lost to Follow-up|0|||
161031361|NCT06106022|581507345|FG000|Overall Study|Voluntary Withdrawal|0|||
161031362|NCT06106022|581507346|FG001|Overall Study|Voluntary Withdrawal|2|||
161031363|NCT05524116|581507353|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
161031364|NCT05524116|581507354|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
161031365|NCT05524116|581507353|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
161031366|NCT05524116|581507354|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
161031367|NCT05524116|581507353|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
161031368|NCT05524116|581507354|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
161031369|NCT05524116|581507353|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
161031370|NCT05524116|581507354|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
161031371|NCT05524116|581507353|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
161031372|NCT05524116|581507354|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
161031373|NCT04389957|581507362|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
161031374|NCT04389957|581507363|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
161031375|NCT04389957|581507364|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
161031376|NCT04389957|581507365|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
161031377|NCT04389957|581507366|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
161031378|NCT04247802|581507370|FG000|Overall Study|Withdrawal by Subject|1|||
161031379|NCT04247802|581507371|FG001|Overall Study|Withdrawal by Subject|3|||
161031380|NCT04247802|581507370|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
161031381|NCT04247802|581507371|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
161031382|NCT01385202|581507383|FG000|Overall Study|Lost to Follow-up|6|||
161031383|NCT01385202|581507383|FG000|Overall Study|Not Eligible|11|||
161031384|NCT01385202|581507383|FG000|Overall Study|Withdrawn|1|||
161031385|NCT03691298|581507390|FG000|Overall Study|Lost to Follow-up|8|||
161031386|NCT03691298|581507390|FG000|Overall Study|Sponsor terminated study|2|||
161031387|NCT02577354|581507391|FG000|Overall Study|Lack of Efficacy|4|||
161031388|NCT02577354|581507392|FG001|Overall Study|Lack of Efficacy|4|||
161031389|NCT02577354|581507391|FG000|Overall Study|Lost to Follow-up|3|||
161031390|NCT02577354|581507392|FG001|Overall Study|Lost to Follow-up|1|||
161031391|NCT02577354|581507391|FG000|Overall Study|Missed Visit|4|||
161031392|NCT02577354|581507392|FG001|Overall Study|Missed Visit|3|||
161031393|NCT02577354|581507391|FG000|Overall Study|Adverse Event|4|||
161031394|NCT02577354|581507392|FG001|Overall Study|Adverse Event|5|||
161031395|NCT05070741|581507397|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
161031396|NCT03245840|581507398|FG000|Overall Study|Adverse Event|6|||
161031397|NCT03245840|581507399|FG001|Overall Study|Adverse Event|0|||
161031398|NCT03245840|581507398|FG000|Overall Study|Death|2|||
161031399|NCT03245840|581507399|FG001|Overall Study|Death|0|||
161031400|NCT03245840|581507398|FG000|Overall Study|Withdrawal by Subject|31|||
161031401|NCT03245840|581507399|FG001|Overall Study|Withdrawal by Subject|1|||
161031402|NCT03245840|581507398|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161091171|NCT01191268|581723825|FG000|Overall Study|Death|0|||
161344535|NCT03916926|582647218|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
161031403|NCT03245840|581507399|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161031404|NCT03245840|581507398|FG000|Overall Study|Physician Decision|4|||
161031405|NCT03245840|581507399|FG001|Overall Study|Physician Decision|1|||
161031406|NCT03245840|581507398|FG000|Overall Study|Study Terminated by Sponsor|56|||
161031407|NCT03245840|581507399|FG001|Overall Study|Study Terminated by Sponsor|6|||
161031408|NCT03245840|581507398|FG000|Overall Study|Site Terminated by Sponsor|4|||
161031409|NCT03245840|581507399|FG001|Overall Study|Site Terminated by Sponsor|0|||
161031410|NCT03245840|581507398|FG000|Overall Study|Lost to Follow-up|12|||
161031411|NCT03245840|581507399|FG001|Overall Study|Lost to Follow-up|2|||
161031412|NCT03245840|581507398|FG000|Overall Study|Pregnancy|2|||
161031413|NCT03245840|581507399|FG001|Overall Study|Pregnancy|0|||
161031414|NCT03245840|581507398|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161031415|NCT03245840|581507399|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161031416|NCT03245840|581507398|FG000|Overall Study|Not treated|1|||
161031417|NCT03245840|581507399|FG001|Overall Study|Not treated|1|||
161031418|NCT05741294|581507405|FG000|Overall Study|Lost to Follow-up|3|||
161031419|NCT05741294|581507405|FG000|Overall Study|Protocol deviation|3|||
161031420|NCT05741294|581507405|FG000|Overall Study|Withdrawal by Subject|1|||
161031421|NCT04707768|581507408|FG000|Overall Study|Adverse Event|9|||
161031422|NCT04707768|581507409|FG001|Overall Study|Adverse Event|18|||
161031423|NCT04707768|581507410|FG002|Overall Study|Adverse Event|3|||
161031424|NCT04707768|581507408|FG000|Overall Study|Investigator's Discretion|8|||
161031425|NCT04707768|581507409|FG001|Overall Study|Investigator's Discretion|4|||
161031426|NCT04707768|581507410|FG002|Overall Study|Investigator's Discretion|3|||
161031427|NCT04707768|581507408|FG000|Overall Study|Withdrawal by Subject|6|||
161031428|NCT04707768|581507409|FG001|Overall Study|Withdrawal by Subject|8|||
161031429|NCT04707768|581507410|FG002|Overall Study|Withdrawal by Subject|2|||
161031430|NCT04707768|581507408|FG000|Overall Study|Lack of Efficacy|1|||
161031431|NCT04707768|581507409|FG001|Overall Study|Lack of Efficacy|3|||
161031432|NCT04707768|581507410|FG002|Overall Study|Lack of Efficacy|0|||
161031433|NCT04707768|581507408|FG000|Overall Study|Lost to Follow-up|0|||
161031434|NCT04707768|581507409|FG001|Overall Study|Lost to Follow-up|0|||
161031435|NCT04707768|581507410|FG002|Overall Study|Lost to Follow-up|3|||
161031436|NCT04707768|581507408|FG000|Overall Study|Death|13|||
161031437|NCT04707768|581507409|FG001|Overall Study|Death|11|||
161031438|NCT04707768|581507410|FG002|Overall Study|Death|13|||
161031439|NCT04707768|581507408|FG000|Overall Study|Protocol Violation|2|||
161031440|NCT04707768|581507409|FG001|Overall Study|Protocol Violation|1|||
161031441|NCT04707768|581507410|FG002|Overall Study|Protocol Violation|0|||
161031442|NCT04707768|581507408|FG000|Overall Study|Non Compliance with Study Drug|1|||
161031443|NCT04707768|581507409|FG001|Overall Study|Non Compliance with Study Drug|0|||
161031444|NCT04707768|581507410|FG002|Overall Study|Non Compliance with Study Drug|0|||
161031445|NCT04707768|581507408|FG000|Overall Study|Transplant|4|||
161031446|NCT04707768|581507409|FG001|Overall Study|Transplant|4|||
161031447|NCT04707768|581507410|FG002|Overall Study|Transplant|8|||
161031448|NCT04707768|581507408|FG000|Overall Study|Other|9|||
161031449|NCT04707768|581507409|FG001|Overall Study|Other|5|||
161031450|NCT04707768|581507410|FG002|Overall Study|Other|2|||
161031451|NCT04490109|581507411|FG000|Overall Study|Lost to Follow-up|3|||
161031452|NCT04490109|581507412|FG001|Overall Study|Lost to Follow-up|10|||
161031453|NCT04490109|581507413|FG002|Overall Study|Lost to Follow-up|4|||
161031454|NCT04490109|581507411|FG000|Overall Study|Withdrawal by Subject|8|||
161031455|NCT04490109|581507412|FG001|Overall Study|Withdrawal by Subject|6|||
161031456|NCT04490109|581507413|FG002|Overall Study|Withdrawal by Subject|9|||
161031457|NCT04490109|581507411|FG000|Overall Study|Physician Decision|0|||
161031458|NCT04490109|581507412|FG001|Overall Study|Physician Decision|2|||
161031459|NCT04490109|581507413|FG002|Overall Study|Physician Decision|3|||
161031460|NCT04490109|581507411|FG000|Overall Study|Adverse Event|2|||
161031461|NCT04490109|581507412|FG001|Overall Study|Adverse Event|1|||
161277703|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
161277704|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
161277705|NCT02105974|582395189|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
161277706|NCT02105974|582395190|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
161277707|NCT02105974|582395191|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
161277708|NCT03597464|582395199|FG000|Overall Study|Withdrawal by Subject|4|||
161277709|NCT03597464|582395200|FG001|Overall Study|Withdrawal by Subject|5|||
161277710|NCT03597464|582395199|FG000|Overall Study|Lost to Follow-up|3|||
161277711|NCT03597464|582395200|FG001|Overall Study|Lost to Follow-up|1|||
161031462|NCT04490109|581507413|FG002|Overall Study|Adverse Event|0|||
161277712|NCT03597464|582395199|FG000|Overall Study|Pregnancy|3|||
161277713|NCT03597464|582395200|FG001|Overall Study|Pregnancy|1|||
161344536|NCT03916926|582647217|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
161031463|NCT04490109|581507411|FG000|Overall Study|Significant Non-Compliance|2|||
161031464|NCT04490109|581507412|FG001|Overall Study|Significant Non-Compliance|4|||
161031465|NCT04490109|581507413|FG002|Overall Study|Significant Non-Compliance|4|||
161031466|NCT04490109|581507411|FG000|Overall Study|Significant Clinical Event|0|||
161031467|NCT04490109|581507412|FG001|Overall Study|Significant Clinical Event|1|||
161031468|NCT04490109|581507413|FG002|Overall Study|Significant Clinical Event|0|||
161031469|NCT04490109|581507411|FG000|Overall Study|Other Reason|4|||
161031470|NCT04490109|581507412|FG001|Overall Study|Other Reason|1|||
161031471|NCT04490109|581507413|FG002|Overall Study|Other Reason|1|||
161031472|NCT04163991|581507414|FG000|Overall Study|Adverse Event|0|||
161031473|NCT04163991|581507415|FG001|Overall Study|Adverse Event|0|||
161031474|NCT04163991|581507416|FG002|Overall Study|Adverse Event|0|||
161031475|NCT04163991|581507417|FG003|Overall Study|Adverse Event|1|||
161031476|NCT04163991|581507418|FG004|Overall Study|Adverse Event|0|||
161031477|NCT04163991|581507414|FG000|Overall Study|Death|0|||
161031478|NCT04163991|581507415|FG001|Overall Study|Death|0|||
161031479|NCT04163991|581507416|FG002|Overall Study|Death|1|||
161031480|NCT04163991|581507417|FG003|Overall Study|Death|0|||
161031481|NCT04163991|581507418|FG004|Overall Study|Death|0|||
161031482|NCT04163991|581507414|FG000|Overall Study|Lost to Follow-up|0|||
161031483|NCT04163991|581507415|FG001|Overall Study|Lost to Follow-up|1|||
161031484|NCT04163991|581507416|FG002|Overall Study|Lost to Follow-up|0|||
161031485|NCT04163991|581507417|FG003|Overall Study|Lost to Follow-up|0|||
161031486|NCT04163991|581507418|FG004|Overall Study|Lost to Follow-up|0|||
161031487|NCT04163991|581507414|FG000|Overall Study|Withdrawal by Subject|1|||
161031488|NCT04163991|581507415|FG001|Overall Study|Withdrawal by Subject|1|||
161031489|NCT04163991|581507416|FG002|Overall Study|Withdrawal by Subject|3|||
161031490|NCT04163991|581507417|FG003|Overall Study|Withdrawal by Subject|1|||
161031491|NCT04163991|581507418|FG004|Overall Study|Withdrawal by Subject|1|||
161031492|NCT04163991|581507414|FG000|Overall Study|Other, Not Specified|0|||
161031493|NCT04163991|581507415|FG001|Overall Study|Other, Not Specified|1|||
161031494|NCT04163991|581507416|FG002|Overall Study|Other, Not Specified|1|||
161031495|NCT04163991|581507417|FG003|Overall Study|Other, Not Specified|1|||
161031496|NCT04163991|581507418|FG004|Overall Study|Other, Not Specified|0|||
161031497|NCT04206787|581507420|FG000|Overall Study|Other than listed|2|||
161031498|NCT04206787|581507420|FG000|Overall Study|Investigator decision|1|||
160975883|NCT01348776|581300626|FG000|Overall Study|Lost to Follow-up|3|||
160975884|NCT01372605|581300627|FG000|Overall Study|Death|1|||
160975885|NCT01372605|581300628|FG001|Overall Study|Death|2|||
160975886|NCT01372605|581300627|FG000|Overall Study|Lost to Follow-up|2|||
160975887|NCT01372605|581300628|FG001|Overall Study|Lost to Follow-up|1|||
160975888|NCT01372605|581300627|FG000|Overall Study|Withdrawal by Subject|4|||
160975889|NCT01372605|581300628|FG001|Overall Study|Withdrawal by Subject|7|||
160975890|NCT01372605|581300627|FG000|Overall Study|Moved|3|||
160975891|NCT01372605|581300628|FG001|Overall Study|Moved|0|||
161277714|NCT03597464|582395199|FG000|Overall Study|Lack of Efficacy|2|||
161031499|NCT04206787|581507420|FG000|Overall Study|Death|25|||
161031500|NCT04206787|581507420|FG000|Overall Study|Lost to Follow-up|9|||
161031501|NCT04206787|581507420|FG000|Overall Study|Withdrawal of consent|9|||
161031502|NCT03011034|581507425|FG000|Overall Study|Adverse Event|1|||
161031503|NCT03011034|581507426|FG001|Overall Study|Adverse Event|0|||
161031504|NCT03735979|581507435|FG000|Overall Study|Lost to Follow-up|1|||
161031505|NCT03735979|581507436|FG001|Overall Study|Lost to Follow-up|12|||
161031506|NCT03735979|581507437|FG002|Overall Study|Lost to Follow-up|14|||
161031507|NCT03735979|581507435|FG000|Overall Study|Withdrawal by Subject|1|||
161031508|NCT03735979|581507436|FG001|Overall Study|Withdrawal by Subject|5|||
161031509|NCT03735979|581507437|FG002|Overall Study|Withdrawal by Subject|2|||
161031510|NCT03735979|581507435|FG000|Overall Study|Not due to the above reasons|1|||
161031511|NCT03735979|581507436|FG001|Overall Study|Not due to the above reasons|0|||
161031512|NCT03735979|581507437|FG002|Overall Study|Not due to the above reasons|0|||
161031513|NCT00319111|581507440|FG000|Overall Study|Adverse Event|20|||
161031514|NCT00319111|581507440|FG000|Overall Study|Withdrawal of consent|11|||
161031515|NCT00319111|581507440|FG000|Overall Study|Death|9|||
161031516|NCT00319111|581507440|FG000|Overall Study|Lack of clinical improvement|4|||
161031517|NCT00319111|581507440|FG000|Overall Study|Administrative|2|||
161031518|NCT00319111|581507440|FG000|Overall Study|Treatment failure|1|||
161031519|NCT01475786|581507441|FG000|Overall Study|Adverse Event|0|||
161031520|NCT01475786|581507442|FG001|Overall Study|Adverse Event|1|||
161031521|NCT01475786|581507443|FG002|Overall Study|Adverse Event|0|||
161031522|NCT01475786|581507441|FG000|Overall Study|Lost to Follow-up|1|||
161031523|NCT01475786|581507442|FG001|Overall Study|Lost to Follow-up|2|||
161277715|NCT03597464|582395200|FG001|Overall Study|Lack of Efficacy|0|||
160975892|NCT01372605|581300627|FG000|Overall Study|Changed medical home|2|||
160975893|NCT01372605|581300628|FG001|Overall Study|Changed medical home|0|||
160975894|NCT00210119|581300629|FG000|Overall Study|Protocol Violation|1|||
160975895|NCT00210119|581300629|FG000|Overall Study|Withdrawal by Subject|1|||
160975896|NCT00951509|581300630|FG000|Overall Study|Withdrawal by Subject|2|||
161031524|NCT01475786|581507443|FG002|Overall Study|Lost to Follow-up|1|||
161031525|NCT01475786|581507441|FG000|Overall Study|Withdrawal by Subject|0|||
161031526|NCT01475786|581507442|FG001|Overall Study|Withdrawal by Subject|1|||
161031527|NCT01475786|581507443|FG002|Overall Study|Withdrawal by Subject|1|||
161031528|NCT01475786|581507441|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
161277716|NCT03597464|582395199|FG000|Overall Study|Physician Decision|2|||
161031529|NCT01475786|581507442|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
161091172|NCT01191268|581723826|FG001|Overall Study|Death|1|||
161031530|NCT01475786|581507443|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
161031531|NCT02865538|581507445|FG000|Overall Study|Withdrawal by Subject|0|||
161031532|NCT02865538|581507446|FG001|Overall Study|Withdrawal by Subject|0|||
161031533|NCT02865538|581507447|FG002|Overall Study|Withdrawal by Subject|1|||
161031534|NCT02865538|581507448|FG003|Overall Study|Withdrawal by Subject|0|||
161031535|NCT02865538|581507449|FG004|Overall Study|Withdrawal by Subject|0|||
161031536|NCT02865538|581507445|FG000|Overall Study|Lost to Follow-up|1|||
161031537|NCT02865538|581507446|FG001|Overall Study|Lost to Follow-up|0|||
161031538|NCT02865538|581507447|FG002|Overall Study|Lost to Follow-up|0|||
161031539|NCT02865538|581507448|FG003|Overall Study|Lost to Follow-up|0|||
161031540|NCT02865538|581507449|FG004|Overall Study|Lost to Follow-up|0|||
161031541|NCT04108130|581509323|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
161031542|NCT04108130|581509324|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
161031543|NCT04108130|581509323|FG000|Overall Study|Consent Withdrawn|9|||
161031544|NCT04108130|581509324|FG001|Overall Study|Consent Withdrawn|6|||
161031545|NCT04108130|581509323|FG000|Overall Study|Surgery Cancelled|4|||
161031546|NCT04108130|581509324|FG001|Overall Study|Surgery Cancelled|4|||
161031547|NCT04108130|581509323|FG000|Overall Study|Found Ineligible for Study|4|||
161031548|NCT04108130|581509324|FG001|Overall Study|Found Ineligible for Study|3|||
161031549|NCT04108130|581509323|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
161031550|NCT04108130|581509324|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
161031551|NCT04108130|581509323|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
161031552|NCT04108130|581509324|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
161031553|NCT04244175|581509325|FG000|Overall Study|Adverse Event|3|||
161031554|NCT04244175|581509326|FG001|Overall Study|Adverse Event|2|||
161031555|NCT04244175|581509327|FG002|Overall Study|Adverse Event|5|||
161031556|NCT04244175|581509325|FG000|Overall Study|Lack of Efficacy|1|||
161031557|NCT04244175|581509326|FG001|Overall Study|Lack of Efficacy|0|||
161031558|NCT04244175|581509327|FG002|Overall Study|Lack of Efficacy|1|||
161031559|NCT04244175|581509325|FG000|Overall Study|Lost to Follow-up|1|||
161031560|NCT04244175|581509326|FG001|Overall Study|Lost to Follow-up|0|||
161031561|NCT04244175|581509327|FG002|Overall Study|Lost to Follow-up|0|||
161031562|NCT04244175|581509325|FG000|Overall Study|Non-compliance with study drug|1|||
161031563|NCT04244175|581509326|FG001|Overall Study|Non-compliance with study drug|0|||
161031564|NCT04244175|581509327|FG002|Overall Study|Non-compliance with study drug|1|||
161031565|NCT04244175|581509325|FG000|Overall Study|Protocol deviation|0|||
161031566|NCT04244175|581509326|FG001|Overall Study|Protocol deviation|1|||
161031567|NCT04244175|581509327|FG002|Overall Study|Protocol deviation|0|||
161031568|NCT04244175|581509325|FG000|Overall Study|Withdrawal by Subject|1|||
161031569|NCT04244175|581509326|FG001|Overall Study|Withdrawal by Subject|3|||
161031570|NCT04244175|581509327|FG002|Overall Study|Withdrawal by Subject|1|||
161031571|NCT04244175|581509325|FG000|Overall Study|Other, not specified|0|||
161031572|NCT04244175|581509326|FG001|Overall Study|Other, not specified|1|||
161031573|NCT04244175|581509327|FG002|Overall Study|Other, not specified|2|||
161031574|NCT03417284|581509328|FG000|Overall Study|Inadequate supply on study drug|1|||
161031575|NCT03417284|581509329|FG001|Overall Study|Inadequate supply on study drug|0|||
161031576|NCT03417284|581509330|FG002|Overall Study|Inadequate supply on study drug|0|||
161031577|NCT03417284|581509331|FG003|Overall Study|Inadequate supply on study drug|0|||
161344537|NCT03916926|582647218|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
161344538|NCT03916926|582647217|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
161344539|NCT03916926|582647218|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
161344540|NCT03188822|582647223|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
161344541|NCT03188822|582647223|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
161344542|NCT03314935|582647238|FG000|Phase 1|Death|4|||
161344543|NCT03314935|582647239|FG001|Phase 1|Death|2|||
161344544|NCT03314935|582647240|FG002|Phase 1|Death|5|||
161344545|NCT03314935|582647241|FG003|Phase 1|Death|4|||
161344546|NCT03314935|582647242|FG004|Phase 1|Death|3|||
161344547|NCT03314935|582647243|FG005|Phase 1|Death|4|||
161344548|NCT03314935|582647244|FG006|Phase 1|Death|5|||
161344549|NCT03314935|582647245|FG007|Phase 1|Death|4|||
161344550|NCT03314935|582647246|FG008|Phase 1|Death|3|||
161344551|NCT03314935|582647247|FG009|Phase 1|Death|0|||
161344552|NCT03314935|582647248|FG010|Phase 1|Death|0|||
161344553|NCT03314935|582647249|FG011|Phase 1|Death|0|||
161344554|NCT03314935|582647250|FG012|Phase 1|Death|0|||
161031578|NCT03417284|581509328|FG000|Overall Study|Disease Progression|0|||
161031579|NCT03417284|581509329|FG001|Overall Study|Disease Progression|0|||
161031580|NCT03417284|581509330|FG002|Overall Study|Disease Progression|1|||
161031581|NCT03417284|581509331|FG003|Overall Study|Disease Progression|0|||
161031582|NCT04089865|581509338|FG000|Overall Study|Withdrawal by Subject|2|||
161031583|NCT04089865|581509339|FG001|Overall Study|Withdrawal by Subject|2|||
161031584|NCT04089865|581509340|FG002|Overall Study|Withdrawal by Subject|7|||
161031585|NCT04089865|581509341|FG003|Overall Study|Withdrawal by Subject|2|||
161031586|NCT04282980|581509344|FG000|Overall Study|Remained on treatment|6|||
161031587|NCT04282980|581509344|FG000|Overall Study|Survival follow-up|11|||
161344555|NCT03314935|582647251|FG013|Phase 1|Death|0|||
161344556|NCT03314935|582647252|FG014|Phase 1|Death|0|||
161031588|NCT04282980|581509344|FG000|Overall Study|Withdrawal of informed consent|1|||
161031589|NCT04282980|581509344|FG000|Overall Study|Lost to Follow-up|1|||
161031590|NCT01917084|581509346|FG000|Overall Study|Withdrawal by Subject|1|||
161031591|NCT03571386|581509347|FG000|Overall Study|scheduling conflict|4|||
161031592|NCT03571386|581509348|FG001|Overall Study|scheduling conflict|0|||
161031593|NCT03571386|581509347|FG000|Overall Study|Withdrawal by Subject|15|||
161031594|NCT03571386|581509348|FG001|Overall Study|Withdrawal by Subject|5|||
161031595|NCT02909686|581509356|FG000|Overall Study|Physician Decision|3|||
161031596|NCT02909686|581509356|FG000|Overall Study|Withdrawal by Subject|2|||
161031597|NCT03858517|581509357|FG000|Overall Study|Adverse Event|1|||
161031598|NCT03858517|581509357|FG000|Overall Study|Lost to Follow-up|1|||
161031599|NCT03858517|581509357|FG000|Overall Study|removed for being incarcerated|1|||
161031600|NCT03858517|581509357|FG000|Overall Study|Sponsor Closure|48|||
161031601|NCT06037668|581509358|FG000|Overall Study|Lost to Follow-up|1|||
161031602|NCT06037668|581509359|FG001|Overall Study|Lost to Follow-up|1|||
161031603|NCT06037668|581509358|FG000|Overall Study|Protocol Violation|1|||
161031604|NCT06037668|581509359|FG001|Overall Study|Protocol Violation|0|||
161031605|NCT06037668|581509358|FG000|Overall Study|Withdrawal by Subject|1|||
161031606|NCT06037668|581509359|FG001|Overall Study|Withdrawal by Subject|0|||
161031607|NCT06037668|581509358|FG000|Overall Study|Other Study Discontinuation Reason|1|||
161031608|NCT06037668|581509359|FG001|Overall Study|Other Study Discontinuation Reason|0|||
161031609|NCT04804540|581509360|FG000|Overall Study|Adverse Event|26|||
161031610|NCT04804540|581509361|FG001|Overall Study|Adverse Event|13|||
161031611|NCT05172232|581509362|FG000|Overall Study|Lost to Follow-up|3|||
161031612|NCT02473445|581509363|FG000|Overall Study|Withdrawal by Subject|2|||
161031613|NCT02473445|581509363|FG000|Overall Study|Sponsor Decision|20|||
161031614|NCT04881461|581509364|FG000|Overall Study|Adverse Event|2|||
161031615|NCT04881461|581509365|FG001|Overall Study|Adverse Event|4|||
161031616|NCT04881461|581509364|FG000|Overall Study|Withdrawal by Subject|19|||
161031617|NCT04881461|581509365|FG001|Overall Study|Withdrawal by Subject|19|||
161031618|NCT04881461|581509364|FG000|Overall Study|Lost to Follow-up|4|||
161031619|NCT04881461|581509365|FG001|Overall Study|Lost to Follow-up|4|||
161031620|NCT04881461|581509364|FG000|Overall Study|Lack of Efficacy|1|||
161031621|NCT04881461|581509365|FG001|Overall Study|Lack of Efficacy|0|||
161031622|NCT04881461|581509364|FG000|Overall Study|"Reason stated as other in CRF"|1|||
161031623|NCT04881461|581509365|FG001|Overall Study|"Reason stated as other in CRF"|2|||
161031624|NCT04629339|581509369|FG000|Overall Study|Death|1|||
161031625|NCT04629339|581509370|FG001|Overall Study|Death|0|||
161031626|NCT04629339|581509371|FG002|Overall Study|Death|2|||
161031627|NCT04629339|581509372|FG003|Overall Study|Death|2|||
161031628|NCT04629339|581509373|FG004|Overall Study|Death|0|||
161031629|NCT04629339|581509369|FG000|Overall Study|Disease Progression|0|||
161031630|NCT04629339|581509370|FG001|Overall Study|Disease Progression|0|||
161031631|NCT04629339|581509371|FG002|Overall Study|Disease Progression|1|||
161031632|NCT04629339|581509372|FG003|Overall Study|Disease Progression|1|||
161031633|NCT04629339|581509373|FG004|Overall Study|Disease Progression|0|||
161031634|NCT04629339|581509369|FG000|Overall Study|Lost to Follow-up|0|||
161031635|NCT04629339|581509370|FG001|Overall Study|Lost to Follow-up|0|||
161031636|NCT04629339|581509371|FG002|Overall Study|Lost to Follow-up|0|||
161031637|NCT04629339|581509372|FG003|Overall Study|Lost to Follow-up|1|||
161031638|NCT04629339|581509373|FG004|Overall Study|Lost to Follow-up|0|||
161031639|NCT04629339|581509369|FG000|Overall Study|Physician Decision|0|||
161031640|NCT04629339|581509370|FG001|Overall Study|Physician Decision|1|||
161031641|NCT04629339|581509371|FG002|Overall Study|Physician Decision|0|||
161031642|NCT04629339|581509372|FG003|Overall Study|Physician Decision|0|||
161031643|NCT04629339|581509373|FG004|Overall Study|Physician Decision|0|||
161031644|NCT04629339|581509369|FG000|Overall Study|Study Terminated by Sponsor|0|||
161031645|NCT04629339|581509370|FG001|Overall Study|Study Terminated by Sponsor|0|||
161031646|NCT04629339|581509371|FG002|Overall Study|Study Terminated by Sponsor|0|||
161031647|NCT04629339|581509372|FG003|Overall Study|Study Terminated by Sponsor|1|||
161031648|NCT04629339|581509373|FG004|Overall Study|Study Terminated by Sponsor|0|||
161031649|NCT04629339|581509369|FG000|Overall Study|Withdrawal by Subject|0|||
161031650|NCT04629339|581509370|FG001|Overall Study|Withdrawal by Subject|0|||
161031651|NCT04629339|581509371|FG002|Overall Study|Withdrawal by Subject|2|||
161031652|NCT04629339|581509372|FG003|Overall Study|Withdrawal by Subject|2|||
161031653|NCT04629339|581509373|FG004|Overall Study|Withdrawal by Subject|0|||
161031654|NCT04158739|581509376|FG000|Overall Study|Adverse Event|1|||
161031655|NCT04158739|581509377|FG001|Overall Study|Adverse Event|0|||
161031656|NCT04158739|581509376|FG000|Overall Study|Death|0|||
161277717|NCT03597464|582395200|FG001|Overall Study|Physician Decision|2|||
161031657|NCT04158739|581509377|FG001|Overall Study|Death|1|||
161031658|NCT04158739|581509376|FG000|Overall Study|Lack of Efficacy|3|||
161031659|NCT04158739|581509377|FG001|Overall Study|Lack of Efficacy|7|||
161277718|NCT03597464|582395199|FG000|Overall Study|Protocol Violation|1|||
161277719|NCT03597464|582395200|FG001|Overall Study|Protocol Violation|1|||
161031660|NCT04158739|581509376|FG000|Overall Study|Physician Decision|0|||
161031661|NCT04158739|581509377|FG001|Overall Study|Physician Decision|1|||
161031662|NCT04158739|581509376|FG000|Overall Study|Withdrawal by Subject|3|||
161091173|NCT01191268|581723827|FG002|Overall Study|Death|3|||
161031663|NCT04158739|581509377|FG001|Overall Study|Withdrawal by Subject|0|||
161031664|NCT04778410|581509378|FG000|Safety Run-in Period|Death|5|||
161031665|NCT04778410|581509379|FG001|Safety Run-in Period|Death|6|||
161031666|NCT04778410|581509380|FG002|Safety Run-in Period|Death|0|||
161031667|NCT04778410|581509381|FG003|Safety Run-in Period|Death|0|||
161031668|NCT04778410|581509382|FG004|Safety Run-in Period|Death|0|||
161031669|NCT04778410|581509383|FG005|Safety Run-in Period|Death|0|||
161031670|NCT04778410|581509378|FG000|Phase 2 Period|Death|0|||
161031671|NCT04778410|581509379|FG001|Phase 2 Period|Death|0|||
161031672|NCT04778410|581509380|FG002|Phase 2 Period|Death|0|||
161031673|NCT04778410|581509381|FG003|Phase 2 Period|Death|5|||
161031674|NCT04778410|581509382|FG004|Phase 2 Period|Death|18|||
161031675|NCT04778410|581509383|FG005|Phase 2 Period|Death|0|||
161031676|NCT04778410|581509378|FG000|Phase 2 Period|Lost to Follow-up|0|||
161031677|NCT04778410|581509379|FG001|Phase 2 Period|Lost to Follow-up|0|||
161031678|NCT04778410|581509380|FG002|Phase 2 Period|Lost to Follow-up|0|||
161031679|NCT04778410|581509381|FG003|Phase 2 Period|Lost to Follow-up|1|||
161031680|NCT04778410|581509382|FG004|Phase 2 Period|Lost to Follow-up|1|||
161031681|NCT04778410|581509383|FG005|Phase 2 Period|Lost to Follow-up|0|||
161031682|NCT04778410|581509378|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
161031683|NCT04778410|581509379|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
161031684|NCT04778410|581509380|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
161031685|NCT04778410|581509381|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
161031686|NCT04778410|581509382|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
161031687|NCT04778410|581509383|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
161031688|NCT04778410|581509378|FG000|Phase 2 Period|Withdrew Consent|0|||
161031689|NCT04778410|581509379|FG001|Phase 2 Period|Withdrew Consent|0|||
161031690|NCT04778410|581509380|FG002|Phase 2 Period|Withdrew Consent|0|||
161031691|NCT04778410|581509381|FG003|Phase 2 Period|Withdrew Consent|0|||
161031692|NCT04778410|581509382|FG004|Phase 2 Period|Withdrew Consent|2|||
161031693|NCT04778410|581509383|FG005|Phase 2 Period|Withdrew Consent|0|||
161031694|NCT05422885|581509390|FG000|Overall Study|Lost to Follow-up|1|||
161031695|NCT05422885|581509390|FG000|Overall Study|Withdrawal by Subject|2|||
161031696|NCT04084574|581509391|FG000|Overall Study|Lost to Follow-up|1|||
161031697|NCT04084574|581509392|FG001|Overall Study|Lost to Follow-up|0|||
161031698|NCT04084574|581509391|FG000|Overall Study|Physician Decision|1|||
161031699|NCT04084574|581509392|FG001|Overall Study|Physician Decision|0|||
161031700|NCT04084574|581509391|FG000|Overall Study|Relocated out of state|1|||
161031701|NCT04084574|581509392|FG001|Overall Study|Relocated out of state|0|||
161031702|NCT00942877|581509393|FG000|Overall Study|Refused further treatment|1|||
161031703|NCT00942877|581509394|FG001|Overall Study|Refused further treatment|1|||
161031704|NCT00942877|581509393|FG000|Overall Study|Patient was not treated|1|||
161031705|NCT00942877|581509394|FG001|Overall Study|Patient was not treated|0|||
161031706|NCT00942877|581509393|FG000|Overall Study|Adverse Event|1|||
161031707|NCT00942877|581509394|FG001|Overall Study|Adverse Event|0|||
161031708|NCT00942877|581509393|FG000|Overall Study|Progressive disease|42|||
161031709|NCT00942877|581509394|FG001|Overall Study|Progressive disease|3|||
161031710|NCT03681262|581509397|FG000|Overall Study|Continuing on study|3|||
161031711|NCT03681262|581509398|FG001|Overall Study|Continuing on study|3|||
161031712|NCT03681262|581509397|FG000|Overall Study|Lost to Follow-up|1|||
161031713|NCT03681262|581509398|FG001|Overall Study|Lost to Follow-up|0|||
161031714|NCT02095691|581509399|FG000|Overall Study|Physician Decision|1|||
161031715|NCT00887198|581509401|FG000|Randomized Period|Ongoing|42|||
161031716|NCT00887198|581509402|FG001|Randomized Period|Ongoing|0|||
161031717|NCT00887198|581509403|FG002|Randomized Period|Ongoing|0|||
161031718|NCT00887198|581509401|FG000|Randomized Period|Adverse Event|50|||
161031719|NCT00887198|581509402|FG001|Randomized Period|Adverse Event|33|||
161031720|NCT00887198|581509403|FG002|Randomized Period|Adverse Event|0|||
161031721|NCT00887198|581509401|FG000|Randomized Period|Lost to Follow-up|1|||
161031722|NCT00887198|581509402|FG001|Randomized Period|Lost to Follow-up|0|||
161031723|NCT00887198|581509403|FG002|Randomized Period|Lost to Follow-up|0|||
161031724|NCT00887198|581509401|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
161031725|NCT00887198|581509402|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
161031726|NCT00887198|581509403|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
161031727|NCT00887198|581509401|FG000|Randomized Period|Withdrawal by Subject|41|||
161031728|NCT00887198|581509402|FG001|Randomized Period|Withdrawal by Subject|56|||
161277720|NCT03597464|582395199|FG000|Overall Study|Adverse Event|0|||
161031729|NCT00887198|581509403|FG002|Randomized Period|Withdrawal by Subject|0|||
161031730|NCT00887198|581509401|FG000|Randomized Period|Progressive disease|366|||
161031731|NCT00887198|581509402|FG001|Randomized Period|Progressive disease|370|||
161031732|NCT00887198|581509403|FG002|Randomized Period|Progressive disease|0|||
161031733|NCT00887198|581509401|FG000|Randomized Period|Other|42|||
161031734|NCT00887198|581509402|FG001|Randomized Period|Other|30|||
161031735|NCT00887198|581509403|FG002|Randomized Period|Other|0|||
161031736|NCT00887198|581509401|FG000|Randomized Period|Randomized, Not treated|4|||
161031737|NCT00887198|581509402|FG001|Randomized Period|Randomized, Not treated|2|||
161031738|NCT00887198|581509403|FG002|Randomized Period|Randomized, Not treated|0|||
161091174|NCT01191268|581723825|FG000|Overall Study|Protocol Violation|1|||
161091175|NCT01191268|581723826|FG001|Overall Study|Protocol Violation|0|||
161344557|NCT03314935|582647238|FG000|Phase 1|Withdrawal by Subject|2|||
161344558|NCT03314935|582647239|FG001|Phase 1|Withdrawal by Subject|1|||
161344559|NCT03314935|582647240|FG002|Phase 1|Withdrawal by Subject|1|||
161344560|NCT03314935|582647241|FG003|Phase 1|Withdrawal by Subject|2|||
161344561|NCT03314935|582647242|FG004|Phase 1|Withdrawal by Subject|1|||
161344562|NCT03314935|582647243|FG005|Phase 1|Withdrawal by Subject|0|||
161031739|NCT00887198|581509401|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
161031740|NCT00887198|581509402|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
161031741|NCT00887198|581509403|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
161031742|NCT00887198|581509401|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
161031743|NCT00887198|581509402|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
161031744|NCT00887198|581509403|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
161031745|NCT00887198|581509401|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
161031746|NCT00887198|581509402|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
161031747|NCT00887198|581509403|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
161031748|NCT00887198|581509401|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
161031749|NCT00887198|581509402|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
161031750|NCT00887198|581509403|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
161031751|NCT00887198|581509401|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
161031752|NCT00887198|581509402|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
161031753|NCT00887198|581509403|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
161031754|NCT00887198|581509401|FG000|Cross Over (Placebo to AA)|Other|0|||
161031755|NCT00887198|581509402|FG001|Cross Over (Placebo to AA)|Other|0|||
161031756|NCT00887198|581509403|FG002|Cross Over (Placebo to AA)|Other|19|||
161031757|NCT02782676|581509404|FG000|Overall Study|Lost to Follow-up|0|||
161148843|NCT03238248|581926155|FG000|Overall Study|N/A participant is still on treatment|1|||
161148844|NCT03238248|581926155|FG000|Overall Study|Decline in condition|1|||
161148845|NCT03238248|581926155|FG000|Overall Study|Alternative therapy|2|||
161148846|NCT02241512|581926162|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
160975897|NCT01830881|581300635|FG000|Overall Study|Changed decision to have an abortion|0|||
160975898|NCT01830881|581300636|FG001|Overall Study|Changed decision to have an abortion|1|||
160975899|NCT03125941|581300637|FG000|Overall Study|did not receive intervention|1|||
160975900|NCT03125941|581300638|FG001|Overall Study|did not receive intervention|2|||
160975901|NCT00734214|581300639|FG000|Overall Study|Withdrawal by Subject|3|||
160975902|NCT00734214|581300640|FG001|Overall Study|Withdrawal by Subject|4|||
160975903|NCT00734214|581300639|FG000|Overall Study|MD withdrawal|1|||
160975904|NCT00734214|581300640|FG001|Overall Study|MD withdrawal|0|||
160975905|NCT00406419|581300647|FG000|Overall Study|Death|3|||
160975906|NCT00406419|581300648|FG001|Overall Study|Death|1|||
160975907|NCT00406419|581300649|FG002|Overall Study|Death|4|||
160975908|NCT00406419|581300647|FG000|Overall Study|Protocol Violation|6|||
160975909|NCT00406419|581300648|FG001|Overall Study|Protocol Violation|2|||
160975910|NCT00406419|581300649|FG002|Overall Study|Protocol Violation|5|||
160975911|NCT00406419|581300647|FG000|Overall Study|Study Terminated by Sponsor|260|||
160975912|NCT00406419|581300648|FG001|Overall Study|Study Terminated by Sponsor|288|||
160975913|NCT00406419|581300649|FG002|Overall Study|Study Terminated by Sponsor|282|||
160975914|NCT00406419|581300647|FG000|Overall Study|Withdrawal by Subject|17|||
160975915|NCT00406419|581300648|FG001|Overall Study|Withdrawal by Subject|24|||
160975916|NCT00406419|581300649|FG002|Overall Study|Withdrawal by Subject|26|||
160975917|NCT00406419|581300647|FG000|Overall Study|Lack of Efficacy|12|||
160975918|NCT00406419|581300648|FG001|Overall Study|Lack of Efficacy|1|||
160975919|NCT00406419|581300649|FG002|Overall Study|Lack of Efficacy|6|||
160975920|NCT00406419|581300647|FG000|Overall Study|Non-Compliance with Study Drug|5|||
160975921|NCT00406419|581300648|FG001|Overall Study|Non-Compliance with Study Drug|6|||
160975922|NCT00406419|581300649|FG002|Overall Study|Non-Compliance with Study Drug|3|||
160975923|NCT00406419|581300647|FG000|Overall Study|Adverse Event|10|||
160975924|NCT00406419|581300648|FG001|Overall Study|Adverse Event|12|||
161344563|NCT03314935|582647244|FG006|Phase 1|Withdrawal by Subject|1|||
161344564|NCT03314935|582647245|FG007|Phase 1|Withdrawal by Subject|0|||
161344565|NCT03314935|582647246|FG008|Phase 1|Withdrawal by Subject|1|||
160975925|NCT00406419|581300649|FG002|Overall Study|Adverse Event|16|||
160975926|NCT00406419|581300647|FG000|Overall Study|Lost to Follow-up|11|||
160975927|NCT00406419|581300648|FG001|Overall Study|Lost to Follow-up|10|||
160975928|NCT00406419|581300649|FG002|Overall Study|Lost to Follow-up|5|||
161031758|NCT02782676|581509405|FG001|Overall Study|Lost to Follow-up|1|||
161031759|NCT05007080|581509406|FG000|Overall Study|Lost to Follow-up|0|||
161148847|NCT02241512|581926163|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
161148848|NCT04275310|581926164|FG000|Overall Study|Non-randomized due to running out of funding|4|||
161148849|NCT04275310|581926165|FG001|Overall Study|Non-randomized due to running out of funding|0|||
161148850|NCT03088605|581926168|FG000|Overall Study|Withdrawal by Subject|1|||
161148851|NCT03088605|581926169|FG001|Overall Study|Withdrawal by Subject|0|||
161148852|NCT02345161|581926170|FG000|Overall Study|Withdrawal by Subject|25|||
161148853|NCT02345161|581926171|FG001|Overall Study|Withdrawal by Subject|33|||
161148854|NCT02345161|581926170|FG000|Overall Study|Adverse Event|16|||
161344566|NCT03314935|582647247|FG009|Phase 1|Withdrawal by Subject|0|||
160975929|NCT01115491|581300652|FG000|Overall Study|Death|22|||
160975930|NCT01115491|581300652|FG000|Overall Study|Adverse Event|3|||
160975931|NCT01115491|581300652|FG000|Overall Study|Lost to Follow-up|3|||
160975932|NCT01115491|581300652|FG000|Overall Study|Withdrawal by Subject|1|||
160975933|NCT01115491|581300652|FG000|Overall Study|Physician Decision|1|||
160975934|NCT03856996|581300653|FG000|Overall Study|Withdrawal by Subject|1|||
160975935|NCT03856996|581300654|FG001|Overall Study|Withdrawal by Subject|0|||
160975936|NCT03856996|581300653|FG000|Overall Study|Lost to Follow-up|0|||
160975937|NCT03856996|581300654|FG001|Overall Study|Lost to Follow-up|1|||
160975938|NCT03856996|581300653|FG000|Overall Study|Adverse Event|1|||
160975939|NCT03856996|581300654|FG001|Overall Study|Adverse Event|1|||
160975940|NCT03856996|581300653|FG000|Overall Study|Other|1|||
160975941|NCT03856996|581300654|FG001|Overall Study|Other|0|||
160975942|NCT04362137|581300657|FG000|Overall Study|Death|9|||
160975943|NCT04362137|581300658|FG001|Overall Study|Death|3|||
160975944|NCT04362137|581300657|FG000|Overall Study|Patient decision|6|||
160975945|NCT04362137|581300658|FG001|Overall Study|Patient decision|3|||
160975946|NCT04362137|581300657|FG000|Overall Study|Adverse Event|1|||
160975947|NCT04362137|581300658|FG001|Overall Study|Adverse Event|0|||
160975948|NCT04362137|581300657|FG000|Overall Study|Lost to Follow-up|1|||
160975949|NCT04362137|581300658|FG001|Overall Study|Lost to Follow-up|0|||
160975950|NCT04362137|581300657|FG000|Overall Study|Protocol deviation|1|||
160975951|NCT04362137|581300658|FG001|Overall Study|Protocol deviation|0|||
160975952|NCT01821898|581300662|FG000|Overall Study|Withdrawal by Subject|2|||
160975953|NCT01821898|581300663|FG001|Overall Study|Withdrawal by Subject|1|||
160975954|NCT03679767|581300666|FG000|Overall Study|Death|16|||
160975955|NCT03679767|581300667|FG001|Overall Study|Death|11|||
160975956|NCT03679767|581300668|FG002|Overall Study|Death|17|||
160975957|NCT03679767|581300669|FG003|Overall Study|Death|10|||
160975958|NCT03679767|581300666|FG000|Overall Study|Lost to Follow-up|1|||
160975959|NCT03679767|581300667|FG001|Overall Study|Lost to Follow-up|1|||
161031760|NCT05007080|581509407|FG001|Overall Study|Lost to Follow-up|1|||
161031761|NCT05007080|581509408|FG002|Overall Study|Lost to Follow-up|0|||
161031762|NCT05007080|581509409|FG003|Overall Study|Lost to Follow-up|1|||
161031763|NCT05007080|581509410|FG004|Overall Study|Lost to Follow-up|1|||
161031764|NCT05007080|581509411|FG005|Overall Study|Lost to Follow-up|1|||
161031765|NCT05007080|581509406|FG000|Overall Study|Death|0|||
161031766|NCT05007080|581509407|FG001|Overall Study|Death|1|||
161031767|NCT05007080|581509408|FG002|Overall Study|Death|0|||
161031768|NCT05007080|581509409|FG003|Overall Study|Death|0|||
161031769|NCT05007080|581509410|FG004|Overall Study|Death|0|||
161031770|NCT05007080|581509411|FG005|Overall Study|Death|0|||
161031771|NCT05007080|581509406|FG000|Overall Study|Withdrawal by Subject|1|||
161031772|NCT05007080|581509407|FG001|Overall Study|Withdrawal by Subject|2|||
161031773|NCT05007080|581509408|FG002|Overall Study|Withdrawal by Subject|0|||
161031774|NCT05007080|581509409|FG003|Overall Study|Withdrawal by Subject|2|||
161031775|NCT05007080|581509410|FG004|Overall Study|Withdrawal by Subject|1|||
161031776|NCT05007080|581509411|FG005|Overall Study|Withdrawal by Subject|1|||
161031777|NCT05007080|581509406|FG000|Overall Study|Other|1|||
161031778|NCT05007080|581509407|FG001|Overall Study|Other|0|||
161031779|NCT05007080|581509408|FG002|Overall Study|Other|1|||
161031780|NCT05007080|581509409|FG003|Overall Study|Other|1|||
161031781|NCT05007080|581509410|FG004|Overall Study|Other|0|||
161031782|NCT05007080|581509411|FG005|Overall Study|Other|2|||
160975960|NCT03679767|581300668|FG002|Overall Study|Lost to Follow-up|1|||
160975961|NCT03679767|581300669|FG003|Overall Study|Lost to Follow-up|1|||
160975962|NCT03679767|581300666|FG000|Overall Study|Withdrawal by Subject|0|||
160975963|NCT03679767|581300667|FG001|Overall Study|Withdrawal by Subject|0|||
160975964|NCT03679767|581300668|FG002|Overall Study|Withdrawal by Subject|0|||
160975965|NCT03679767|581300669|FG003|Overall Study|Withdrawal by Subject|1|||
160975966|NCT03679767|581300666|FG000|Overall Study|Follow-up Completed|18|||
160975967|NCT03679767|581300667|FG001|Overall Study|Follow-up Completed|11|||
160975968|NCT03679767|581300668|FG002|Overall Study|Follow-up Completed|11|||
160975969|NCT03679767|581300669|FG003|Overall Study|Follow-up Completed|20|||
161031783|NCT05007080|581509406|FG000|Overall Study|Randomized not vaccinated|0|||
160975970|NCT03679767|581300666|FG000|Overall Study|Entered Hospice Care|0|||
160975971|NCT03679767|581300667|FG001|Overall Study|Entered Hospice Care|0|||
160975972|NCT03679767|581300668|FG002|Overall Study|Entered Hospice Care|0|||
160975973|NCT03679767|581300669|FG003|Overall Study|Entered Hospice Care|1|||
161031784|NCT05007080|581509407|FG001|Overall Study|Randomized not vaccinated|0|||
161031785|NCT05007080|581509408|FG002|Overall Study|Randomized not vaccinated|0|||
161031786|NCT05007080|581509409|FG003|Overall Study|Randomized not vaccinated|0|||
161148855|NCT02345161|581926171|FG001|Overall Study|Adverse Event|19|||
160975974|NCT03679767|581300666|FG000|Overall Study|Progressive Disease|0|||
160975975|NCT03679767|581300667|FG001|Overall Study|Progressive Disease|0|||
160975976|NCT03679767|581300668|FG002|Overall Study|Progressive Disease|0|||
160975977|NCT03679767|581300669|FG003|Overall Study|Progressive Disease|1|||
160975978|NCT00180713|581300676|FG000|Overall Study|Withdrawal by Subject|2|||
160975979|NCT00180713|581300677|FG001|Overall Study|Withdrawal by Subject|0|||
160975980|NCT00180713|581300676|FG000|Overall Study|Adverse Event|3|||
161031787|NCT05007080|581509410|FG004|Overall Study|Randomized not vaccinated|0|||
161031788|NCT05007080|581509411|FG005|Overall Study|Randomized not vaccinated|1|||
161031789|NCT02874742|581509413|FG000|Overall Study|Death|0|||
161031790|NCT02874742|581509414|FG001|Overall Study|Death|1|||
161031791|NCT02874742|581509415|FG002|Overall Study|Death|0|||
161031792|NCT02874742|581509413|FG000|Overall Study|Lost to Follow-up|5|||
161031793|NCT02874742|581509414|FG001|Overall Study|Lost to Follow-up|4|||
161031794|NCT02874742|581509415|FG002|Overall Study|Lost to Follow-up|1|||
161031795|NCT02874742|581509413|FG000|Overall Study|Withdrawal by Subject|17|||
161031796|NCT02874742|581509414|FG001|Overall Study|Withdrawal by Subject|8|||
161031797|NCT02874742|581509415|FG002|Overall Study|Withdrawal by Subject|0|||
161031798|NCT02874742|581509413|FG000|Overall Study|Other|4|||
161031799|NCT02874742|581509414|FG001|Overall Study|Other|1|||
161031800|NCT02874742|581509415|FG002|Overall Study|Other|0|||
161031801|NCT02874742|581509413|FG000|Overall Study|Progressive Disease|1|||
161031802|NCT02874742|581509414|FG001|Overall Study|Progressive Disease|0|||
161031803|NCT02874742|581509415|FG002|Overall Study|Progressive Disease|0|||
161031804|NCT02874742|581509413|FG000|Overall Study|Screen Failure|0|||
161031805|NCT02874742|581509414|FG001|Overall Study|Screen Failure|2|||
161031806|NCT02874742|581509415|FG002|Overall Study|Screen Failure|0|||
161031807|NCT00964392|581509418|FG000|Overall Study|Withdrawal by Subject|4|||
161031808|NCT00964392|581509419|FG001|Overall Study|Withdrawal by Subject|6|||
161031809|NCT00964392|581509418|FG000|Overall Study|Lost to Follow-up|4|||
161031810|NCT00964392|581509419|FG001|Overall Study|Lost to Follow-up|10|||
161031811|NCT00964392|581509418|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
161031812|NCT00964392|581509419|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
161031813|NCT00964392|581509418|FG000|Overall Study|Not completed|44|||
161031814|NCT00964392|581509419|FG001|Overall Study|Not completed|168|||
161031815|NCT04173247|581509423|FG000|Overall Study|Withdrawal by Subject|0|||
161031816|NCT04173247|581509424|FG001|Overall Study|Withdrawal by Subject|2|||
161031817|NCT04173247|581509423|FG000|Overall Study|Death|1|||
161031818|NCT04173247|581509424|FG001|Overall Study|Death|0|||
161031819|NCT04173247|581509423|FG000|Overall Study|Physician Decision|1|||
161031820|NCT04173247|581509424|FG001|Overall Study|Physician Decision|0|||
161031821|NCT04214834|581509432|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
161031822|NCT04214834|581509433|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
161031823|NCT04109066|581509438|FG000|Pre-treatment|Participant withdrew consent|2|||
161031824|NCT04109066|581509439|FG001|Pre-treatment|Participant withdrew consent|0|||
161031825|NCT04109066|581509438|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
161031826|NCT04109066|581509439|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
161031827|NCT04109066|581509438|FG000|Treatment|Lack of Efficacy|2|||
161031828|NCT04109066|581509439|FG001|Treatment|Lack of Efficacy|4|||
161031829|NCT04109066|581509438|FG000|Treatment|Adverse Event|23|||
161031830|NCT04109066|581509439|FG001|Treatment|Adverse Event|7|||
161031831|NCT04109066|581509438|FG000|Treatment|Participant request to discontinue Study treatment|15|||
161031832|NCT04109066|581509439|FG001|Treatment|Participant request to discontinue Study treatment|14|||
161031833|NCT04109066|581509438|FG000|Treatment|Withdrawal by Subject|8|||
161031834|NCT04109066|581509439|FG001|Treatment|Withdrawal by Subject|8|||
161031835|NCT04109066|581509438|FG000|Treatment|Death|3|||
161031836|NCT04109066|581509439|FG001|Treatment|Death|0|||
161031837|NCT04109066|581509438|FG000|Treatment|Participant no longer meets study criteria|2|||
161031838|NCT04109066|581509439|FG001|Treatment|Participant no longer meets study criteria|2|||
161031839|NCT04109066|581509438|FG000|Treatment|Administrative reasons by sponsor|2|||
161031840|NCT04109066|581509439|FG001|Treatment|Administrative reasons by sponsor|3|||
161031841|NCT04109066|581509438|FG000|Treatment|Other reasons|17|||
161031842|NCT04109066|581509439|FG001|Treatment|Other reasons|23|||
161031843|NCT04109066|581509438|FG000|Treatment|Disease Progression|4|||
161031844|NCT04109066|581509439|FG001|Treatment|Disease Progression|7|||
161031845|NCT04109066|581509438|FG000|Treatment|Study drug toxicity|12|||
161031846|NCT04109066|581509439|FG001|Treatment|Study drug toxicity|5|||
161031847|NCT04109066|581509438|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
161031848|NCT04109066|581509439|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
161031849|NCT04109066|581509438|FG000|Treatment|Disease Recurrence|0|||
161031850|NCT04109066|581509439|FG001|Treatment|Disease Recurrence|2|||
161031851|NCT04109066|581509438|FG000|Treatment|Not reported|4|||
161031852|NCT04109066|581509439|FG001|Treatment|Not reported|8|||
161031853|NCT05205161|581509440|FG000|Overall Study|Study terminated by sponsor|3|||
161031854|NCT05205161|581509441|FG001|Overall Study|Study terminated by sponsor|3|||
161031855|NCT05205161|581509442|FG002|Overall Study|Study terminated by sponsor|1|||
161031856|NCT04369911|581509444|FG000|Overall Study|Lost to Follow-up|3|||
161031857|NCT04369911|581509445|FG001|Overall Study|Lost to Follow-up|3|||
161031858|NCT04369911|581509444|FG000|Overall Study|Withdrawal by Subject|1|||
161031859|NCT04369911|581509445|FG001|Overall Study|Withdrawal by Subject|2|||
161031860|NCT05953740|581509448|FG000|Period 1|Physician Decision|0|||
161031861|NCT05953740|581509449|FG001|Period 1|Physician Decision|1|||
161031862|NCT05953740|581509450|FG002|Period 1|Physician Decision|0|||
161031863|NCT05953740|581509451|FG003|Period 1|Physician Decision|0|||
161031864|NCT05953740|581509452|FG004|Period 1|Physician Decision|0|||
161031865|NCT05953740|581509453|FG005|Period 1|Physician Decision|0|||
161031866|NCT05953740|581509454|FG006|Period 1|Physician Decision|0|||
161031867|NCT05953740|581509455|FG007|Period 1|Physician Decision|0|||
161031868|NCT05953740|581509448|FG000|Period 2|Withdrawal by Subject|0|||
161031869|NCT05953740|581509449|FG001|Period 2|Withdrawal by Subject|1|||
161031870|NCT05953740|581509450|FG002|Period 2|Withdrawal by Subject|1|||
161031871|NCT05953740|581509451|FG003|Period 2|Withdrawal by Subject|0|||
161031872|NCT05953740|581509452|FG004|Period 2|Withdrawal by Subject|0|||
161031873|NCT05953740|581509453|FG005|Period 2|Withdrawal by Subject|0|||
161031874|NCT05953740|581509454|FG006|Period 2|Withdrawal by Subject|0|||
161031875|NCT05953740|581509455|FG007|Period 2|Withdrawal by Subject|0|||
161031876|NCT03880955|581509456|FG000|Overall Study|Adverse Event|1|||
161031877|NCT03880955|581509456|FG000|Overall Study|Death|1|||
161031878|NCT03880955|581509456|FG000|Overall Study|Lost to Follow-up|12|||
161031879|NCT03880955|581509456|FG000|Overall Study|Withdrawal by Subject|4|||
161031880|NCT03880955|581509456|FG000|Overall Study|Missing- Study Site Closed|27|||
161031881|NCT03817983|581509457|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
161031882|NCT03817983|581509458|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
161031883|NCT03817983|581509459|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
161031884|NCT03744676|581509460|FG000|Pre-Treatment Phase|Disease related complications|2|||
161031885|NCT03744676|581509460|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
161031886|NCT03744676|581509460|FG000|Pre-Treatment Phase|Death|7|||
161031887|NCT03744676|581509460|FG000|Pre-Treatment Phase|Other Reasons|7|||
161031888|NCT03744676|581509460|FG000|Treatment Phase|Participant withdrew consent|8|||
161031889|NCT03744676|581509460|FG000|Treatment Phase|Death|33|||
161031890|NCT03744676|581509460|FG000|Treatment Phase|other reasons|6|||
161031891|NCT02510235|581509461|FG000|Overall Study|Withdrawal by Subject|1|||
161031892|NCT02510235|581509462|FG001|Overall Study|Withdrawal by Subject|0|||
161031893|NCT00450216|581509463|FG000|Overall Study|Adverse Event|38|||
161031894|NCT00450216|581509464|FG001|Overall Study|Adverse Event|23|||
161031895|NCT00450216|581509463|FG000|Overall Study|Withdrawal by Subject|48|||
161031896|NCT00450216|581509464|FG001|Overall Study|Withdrawal by Subject|26|||
161031897|NCT00450216|581509463|FG000|Overall Study|Lost to Follow-up|16|||
161031898|NCT00450216|581509464|FG001|Overall Study|Lost to Follow-up|9|||
161031899|NCT00450216|581509463|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
161031900|NCT00450216|581509464|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
161031901|NCT00450216|581509463|FG000|Overall Study|misc|21|||
161031902|NCT00450216|581509464|FG001|Overall Study|misc|20|||
161031903|NCT05008055|581509467|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
161031904|NCT05008055|581509468|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
161031905|NCT05008055|581509469|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
161031906|NCT03165955|581509473|FG000|Treatment|Withdrawal by Subject|3|||
161031907|NCT03165955|581509473|FG000|Treatment|Death|1|||
161031908|NCT03165955|581509473|FG000|Treatment|Adverse Event|1|||
161031909|NCT03165955|581509473|FG000|Treatment|Progressive disease|3|||
161031910|NCT03636490|581510306|FG000|Overall Study|Dropped out or incomplete data|141|||
161031911|NCT02585323|581510307|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
161031912|NCT02585323|581510308|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
161031913|NCT02585323|581510307|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
161031914|NCT02585323|581510308|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
161031915|NCT02585323|581510307|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
161031916|NCT02585323|581510308|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
161031917|NCT02585323|581510307|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
161031918|NCT02585323|581510308|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
161031919|NCT01130883|581510309|FG000|Overall Study|Patient Noncompliance|6|||
161031920|NCT01130883|581510309|FG000|Overall Study|Reason Unknown|1|||
161031921|NCT01130883|581510309|FG000|Overall Study|Adverse Event|3|||
161031922|NCT04165213|581510319|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
161031923|NCT04165213|581510320|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
161031924|NCT04165213|581510319|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
161031925|NCT04165213|581510320|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
161031926|NCT04165213|581510319|FG000|Clinician Enrollment|Termination from site|0|||
161031927|NCT04165213|581510320|FG001|Clinician Enrollment|Termination from site|1|||
161031928|NCT04165213|581510319|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
161031929|NCT04165213|581510320|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
161031930|NCT04165213|581510319|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
161031931|NCT04165213|581510320|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
161031932|NCT04165213|581510319|FG000|Caregiver Enrollment|Physician Decision|1|||
161031933|NCT04165213|581510320|FG001|Caregiver Enrollment|Physician Decision|0|||
161031934|NCT04165213|581510319|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
161031935|NCT04165213|581510320|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
161031936|NCT04165213|581510319|FG000|Caregiver Enrollment|PLWD death|2|||
161031937|NCT04165213|581510320|FG001|Caregiver Enrollment|PLWD death|0|||
161031938|NCT04165213|581510319|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
161031939|NCT04165213|581510320|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
161031940|NCT04165213|581510319|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
161031941|NCT04165213|581510320|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
161031942|NCT04165213|581510319|FG000|PLWD Enrollment|Lost to Follow-up|1|||
161031943|NCT04165213|581510320|FG001|PLWD Enrollment|Lost to Follow-up|1|||
161031944|NCT04165213|581510319|FG000|PLWD Enrollment|Physician Decision|1|||
161031945|NCT04165213|581510320|FG001|PLWD Enrollment|Physician Decision|0|||
161031946|NCT04165213|581510319|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
161031947|NCT04165213|581510320|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
161031948|NCT04165213|581510319|FG000|PLWD Enrollment|Death|2|||
161031949|NCT04165213|581510320|FG001|PLWD Enrollment|Death|0|||
161031950|NCT04165213|581510319|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
161031951|NCT04165213|581510320|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
161031952|NCT02997202|581510321|FG000|Overall Study|Miscellaneous|2|||
161031953|NCT02997202|581510322|FG001|Overall Study|Miscellaneous|2|||
161031954|NCT02997202|581510321|FG000|Overall Study|Withdrawal by Subject|8|||
161031955|NCT02997202|581510322|FG001|Overall Study|Withdrawal by Subject|12|||
161031956|NCT02997202|581510321|FG000|Overall Study|Lost to Follow-up|5|||
161031957|NCT02997202|581510322|FG001|Overall Study|Lost to Follow-up|3|||
161031958|NCT02997202|581510321|FG000|Overall Study|Death|41|||
161031959|NCT02997202|581510322|FG001|Overall Study|Death|45|||
161031960|NCT01121588|581510323|FG000|Overall Study|Death|5|||
161031961|NCT01121588|581510324|FG001|Overall Study|Death|3|||
161031962|NCT01121588|581510325|FG002|Overall Study|Death|13|||
161031963|NCT01121588|581510323|FG000|Overall Study|Study Terminated by Sponsor|1|||
161031964|NCT01121588|581510324|FG001|Overall Study|Study Terminated by Sponsor|1|||
161031965|NCT01121588|581510325|FG002|Overall Study|Study Terminated by Sponsor|0|||
161031966|NCT01121588|581510323|FG000|Overall Study|Participant Refused Further Followup|2|||
161031967|NCT01121588|581510324|FG001|Overall Study|Participant Refused Further Followup|0|||
161031968|NCT01121588|581510325|FG002|Overall Study|Participant Refused Further Followup|2|||
161031969|NCT01121588|581510323|FG000|Overall Study|Lost to Follow-up|0|||
161031970|NCT01121588|581510324|FG001|Overall Study|Lost to Follow-up|1|||
161031971|NCT01121588|581510325|FG002|Overall Study|Lost to Follow-up|1|||
161031972|NCT01121588|581510323|FG000|Overall Study|Non-Specified Reasons|9|||
161031973|NCT01121588|581510324|FG001|Overall Study|Non-Specified Reasons|4|||
161031974|NCT01121588|581510325|FG002|Overall Study|Non-Specified Reasons|2|||
161031975|NCT04583280|581510329|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
161031976|NCT04583280|581510330|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
161031977|NCT00631475|581510331|FG000|Overall Study|Death|18|||
161031978|NCT00631475|581510331|FG000|Overall Study|Adverse Event|14|||
161031979|NCT00631475|581510331|FG000|Overall Study|Withdrew consent|5|||
161031980|NCT00631475|581510331|FG000|Overall Study|Preparation for lung transplant|8|||
161031981|NCT00303459|581510332|FG000|Overall Study|Death|33|||
161031982|NCT00303459|581510333|FG001|Overall Study|Death|44|||
161031983|NCT00303459|581510332|FG000|Overall Study|Withdrawal of consent|32|||
161031984|NCT00303459|581510333|FG001|Overall Study|Withdrawal of consent|26|||
161031985|NCT00303459|581510332|FG000|Overall Study|Lost to Follow-up|5|||
161031986|NCT00303459|581510333|FG001|Overall Study|Lost to Follow-up|4|||
161031987|NCT00303459|581510332|FG000|Overall Study|Administrative reason|7|||
161031988|NCT00303459|581510333|FG001|Overall Study|Administrative reason|7|||
161031989|NCT00303459|581510332|FG000|Overall Study|Decision by the investigator|5|||
161031990|NCT00303459|581510333|FG001|Overall Study|Decision by the investigator|7|||
161031991|NCT00303459|581510332|FG000|Overall Study|Lung transplantation|1|||
161031992|NCT00303459|581510333|FG001|Overall Study|Lung transplantation|1|||
161031993|NCT04055012|581510334|FG000|Overall Study|Withdrawal by Subject|1|||
161031994|NCT04055012|581510335|FG001|Overall Study|Withdrawal by Subject|3|||
161031995|NCT04055012|581510336|FG002|Overall Study|Withdrawal by Subject|1|||
161031996|NCT04055012|581510337|FG003|Overall Study|Withdrawal by Subject|0|||
161031997|NCT04055012|581510334|FG000|Overall Study|Metformin Recall|1|||
161031998|NCT04055012|581510335|FG001|Overall Study|Metformin Recall|1|||
161031999|NCT04055012|581510336|FG002|Overall Study|Metformin Recall|1|||
161032000|NCT04055012|581510337|FG003|Overall Study|Metformin Recall|0|||
161032001|NCT02492711|581510340|FG000|Overall Study|Adverse Event|9|||
161032002|NCT02492711|581510341|FG001|Overall Study|Adverse Event|9|||
161032003|NCT02492711|581510342|FG002|Overall Study|Adverse Event|2|||
161032004|NCT02492711|581510340|FG000|Overall Study|Death|3|||
161032005|NCT02492711|581510341|FG001|Overall Study|Death|3|||
161032006|NCT02492711|581510342|FG002|Overall Study|Death|0|||
161032007|NCT02492711|581510340|FG000|Overall Study|Withdrawal by Subject|10|||
161032008|NCT02492711|581510341|FG001|Overall Study|Withdrawal by Subject|16|||
161032009|NCT02492711|581510342|FG002|Overall Study|Withdrawal by Subject|5|||
161032010|NCT02492711|581510340|FG000|Overall Study|Physician Decision|10|||
161032011|NCT02492711|581510341|FG001|Overall Study|Physician Decision|6|||
161032012|NCT02492711|581510342|FG002|Overall Study|Physician Decision|4|||
161032013|NCT02492711|581510340|FG000|Overall Study|Lost to Follow-up|0|||
161032014|NCT02492711|581510341|FG001|Overall Study|Lost to Follow-up|0|||
161032015|NCT02492711|581510342|FG002|Overall Study|Lost to Follow-up|1|||
161032016|NCT02492711|581510340|FG000|Overall Study|study treatment delay|2|||
160975981|NCT00180713|581300677|FG001|Overall Study|Adverse Event|3|||
160975982|NCT05295732|581300678|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
160975983|NCT05295732|581300679|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
160975984|NCT05295732|581300680|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
160975985|NCT05295732|581300681|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
160975986|NCT05295732|581300682|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
160975987|NCT05295732|581300678|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
160975988|NCT05295732|581300679|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
160975989|NCT05295732|581300680|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
160975990|NCT05295732|581300681|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
160975991|NCT05295732|581300682|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
160975992|NCT03311230|581300685|FG000|Overall Study|Withdrawal by Subject|1|||
160975993|NCT03311230|581300686|FG001|Overall Study|Withdrawal by Subject|4|||
160975994|NCT03311230|581300687|FG002|Overall Study|Withdrawal by Subject|2|||
160975995|NCT03311230|581300688|FG003|Overall Study|Withdrawal by Subject|7|||
160975996|NCT03311230|581300685|FG000|Overall Study|Unrelated injury|0|||
160975997|NCT03311230|581300686|FG001|Overall Study|Unrelated injury|1|||
160975998|NCT03311230|581300687|FG002|Overall Study|Unrelated injury|0|||
160975999|NCT03311230|581300688|FG003|Overall Study|Unrelated injury|0|||
160976000|NCT05200936|581300690|FG000|Overall Study|Withdrawal by Subject|2|||
160976001|NCT05200936|581300691|FG001|Overall Study|Withdrawal by Subject|2|||
160976002|NCT05200936|581300690|FG000|Overall Study|Lost to Follow-up|2|||
160976003|NCT05200936|581300691|FG001|Overall Study|Lost to Follow-up|0|||
160976004|NCT05200936|581300690|FG000|Overall Study|Pregnancy|0|||
160976005|NCT05200936|581300691|FG001|Overall Study|Pregnancy|1|||
160976006|NCT01338012|581300692|FG000|Overall Study|Death|4|||
160976007|NCT01338012|581300692|FG000|Overall Study|Study terminated|4|||
160976008|NCT02089230|581300693|FG000|Overall Study|Death|0|||
160976009|NCT02089230|581300694|FG001|Overall Study|Death|0|||
160976010|NCT02089230|581300695|FG002|Overall Study|Death|2|||
160976011|NCT02089230|581300693|FG000|Overall Study|Seeking Alternative Therapy|0|||
160976012|NCT02089230|581300694|FG001|Overall Study|Seeking Alternative Therapy|0|||
160976013|NCT02089230|581300695|FG002|Overall Study|Seeking Alternative Therapy|4|||
160976014|NCT02791490|581302145|FG000|Overall Study|Lost to Follow-up|1|||
160976015|NCT02791490|581302146|FG001|Overall Study|Lost to Follow-up|2|||
160976016|NCT02791490|581302145|FG000|Overall Study|Withdrawal by Subject|2|||
160976017|NCT02791490|581302146|FG001|Overall Study|Withdrawal by Subject|6|||
160976018|NCT01235975|581302151|FG000|Overall Study|Serious Adverse Event|0|||
160976019|NCT01235975|581302152|FG001|Overall Study|Serious Adverse Event|1|||
160976020|NCT01235975|581302151|FG000|Overall Study|Withdrawal by Subject|8|||
160976021|NCT01235975|581302152|FG001|Overall Study|Withdrawal by Subject|2|||
160976022|NCT01235975|581302151|FG000|Overall Study|Migrated/moved from study area|2|||
160976023|NCT01235975|581302152|FG001|Overall Study|Migrated/moved from study area|1|||
160976024|NCT01235975|581302151|FG000|Overall Study|Lost to Follow-up|7|||
160976025|NCT01235975|581302152|FG001|Overall Study|Lost to Follow-up|3|||
160976026|NCT00919893|581302155|FG000|Overall Study|Protocol Violation|19|||
160976027|NCT00919893|581302156|FG001|Overall Study|Protocol Violation|9|||
160976028|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
160976029|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
160976030|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
160976031|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
160976032|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
160976033|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
160976034|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
160976035|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
160976036|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
161277721|NCT03597464|582395200|FG001|Overall Study|Adverse Event|2|||
161277722|NCT03597464|582395199|FG000|Overall Study|Death|0|||
161277723|NCT03597464|582395200|FG001|Overall Study|Death|3|||
161277724|NCT02847260|582396534|FG000|Overall Study|Adverse Event|3|||
161277725|NCT02847260|582396534|FG000|Overall Study|Withdrawal by Subject|2|||
161277726|NCT02847260|582396534|FG000|Overall Study|Clinical Deterioration|1|||
160976037|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
160976038|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
160976039|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
160976040|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
160976041|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
160976042|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
160976043|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
161277727|NCT02847260|582396534|FG000|Overall Study|Physician Decision|1|||
161277728|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
160976044|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
160976045|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
160976046|NCT00365378|581302163|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
161344567|NCT03314935|582647248|FG010|Phase 1|Withdrawal by Subject|0|||
161032017|NCT02492711|581510341|FG001|Overall Study|study treatment delay|1|||
161032018|NCT02492711|581510342|FG002|Overall Study|study treatment delay|0|||
161032019|NCT02492711|581510340|FG000|Overall Study|change in chemotherapy|0|||
161032020|NCT02492711|581510341|FG001|Overall Study|change in chemotherapy|1|||
161032021|NCT02492711|581510342|FG002|Overall Study|change in chemotherapy|0|||
161032022|NCT02492711|581510340|FG000|Overall Study|never treated|2|||
161032023|NCT02492711|581510341|FG001|Overall Study|never treated|4|||
161032024|NCT02492711|581510342|FG002|Overall Study|never treated|0|||
161032025|NCT02492711|581510340|FG000|Overall Study|Other|0|||
161032026|NCT02492711|581510341|FG001|Overall Study|Other|0|||
161032027|NCT02492711|581510342|FG002|Overall Study|Other|1|||
161032028|NCT05830799|581510346|FG000|Overall Study|Withdrawal by Subject|1|||
161032029|NCT03652272|581510347|FG000|3 Month|Withdrawal by Subject|1|||
161032030|NCT03652272|581510348|FG001|3 Month|Withdrawal by Subject|1|||
161344568|NCT03314935|582647249|FG011|Phase 1|Withdrawal by Subject|0|||
161344569|NCT03314935|582647250|FG012|Phase 1|Withdrawal by Subject|0|||
161344570|NCT03314935|582647251|FG013|Phase 1|Withdrawal by Subject|0|||
161344571|NCT03314935|582647252|FG014|Phase 1|Withdrawal by Subject|0|||
161344572|NCT03314935|582647238|FG000|Phase 1|Progressive Disease|2|||
161344573|NCT03314935|582647239|FG001|Phase 1|Progressive Disease|0|||
161344574|NCT03314935|582647240|FG002|Phase 1|Progressive Disease|0|||
161344575|NCT03314935|582647241|FG003|Phase 1|Progressive Disease|1|||
161344576|NCT03314935|582647242|FG004|Phase 1|Progressive Disease|0|||
161344577|NCT03314935|582647243|FG005|Phase 1|Progressive Disease|0|||
161344578|NCT03314935|582647244|FG006|Phase 1|Progressive Disease|0|||
161344579|NCT03314935|582647245|FG007|Phase 1|Progressive Disease|0|||
161344580|NCT03314935|582647246|FG008|Phase 1|Progressive Disease|0|||
161344581|NCT03314935|582647247|FG009|Phase 1|Progressive Disease|0|||
161344582|NCT03314935|582647248|FG010|Phase 1|Progressive Disease|0|||
161344583|NCT03314935|582647249|FG011|Phase 1|Progressive Disease|0|||
161344584|NCT03314935|582647250|FG012|Phase 1|Progressive Disease|0|||
161344585|NCT03314935|582647251|FG013|Phase 1|Progressive Disease|0|||
161344586|NCT03314935|582647252|FG014|Phase 1|Progressive Disease|0|||
161032031|NCT03652272|581510347|FG000|3 Month|Lost to Follow-up|16|||
161032032|NCT03652272|581510348|FG001|3 Month|Lost to Follow-up|14|||
161032033|NCT04967599|581510353|FG000|Overall Study|Lost to Follow-up|35|||
161032034|NCT04967599|581510354|FG001|Overall Study|Lost to Follow-up|19|||
161032035|NCT04967599|581510355|FG002|Overall Study|Lost to Follow-up|23|||
161032036|NCT02919917|581510359|FG000|Overall Study|Withdrawal by Subject|4|||
161032037|NCT02919917|581510360|FG001|Overall Study|Withdrawal by Subject|8|||
161032038|NCT03418740|581510361|FG000|Overall Study|Lost to Follow-up|13|||
161032039|NCT03418740|581510361|FG000|Overall Study|Scheduling Issues|7|||
161032040|NCT03418740|581510361|FG000|Overall Study|Withdrawal by Subject|2|||
161032041|NCT03418740|581510361|FG000|Overall Study|Unable to Continue Consent|1|||
161344587|NCT03314935|582647238|FG000|Phase 1|Study Terminated by Sponsor|0|||
161344588|NCT03314935|582647239|FG001|Phase 1|Study Terminated by Sponsor|1|||
160976047|NCT00365378|581302164|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
160976048|NCT00365378|581302165|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
160976049|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
160976050|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
160976051|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
160976052|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
160976053|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
160976054|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
160976055|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
160976056|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
160976057|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
160976058|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
160976059|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
160976060|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
160976061|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
160976062|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
160976063|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
160976064|NCT00365378|581302163|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
160976065|NCT00365378|581302164|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
160976066|NCT00365378|581302165|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
161344589|NCT03314935|582647240|FG002|Phase 1|Study Terminated by Sponsor|0|||
161344590|NCT03314935|582647241|FG003|Phase 1|Study Terminated by Sponsor|0|||
161344591|NCT03314935|582647242|FG004|Phase 1|Study Terminated by Sponsor|0|||
160976067|NCT00365378|581302163|FG000|Extension|Adverse Event|0|||
160976068|NCT00365378|581302164|FG001|Extension|Adverse Event|0|||
160976069|NCT00365378|581302165|FG002|Extension|Adverse Event|1|||
161032042|NCT04743973|581510362|FG000|Overall Study|Withdrawal by Subject|5|||
161032043|NCT02461134|581510367|FG000|Overall Study|Adverse Event|1|||
161344592|NCT03314935|582647243|FG005|Phase 1|Study Terminated by Sponsor|0|||
161091176|NCT01191268|581723827|FG002|Overall Study|Protocol Violation|1|||
161277729|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
160976070|NCT00365378|581302163|FG000|Extension|Moved|0|||
160976071|NCT00365378|581302164|FG001|Extension|Moved|0|||
160976072|NCT00365378|581302165|FG002|Extension|Moved|8|||
160976073|NCT00365378|581302163|FG000|Extension|Lost to Follow-up|0|||
160976074|NCT00365378|581302164|FG001|Extension|Lost to Follow-up|0|||
160976075|NCT00365378|581302165|FG002|Extension|Lost to Follow-up|57|||
160976076|NCT00365378|581302163|FG000|Extension|Protocol Violation|0|||
160976077|NCT00365378|581302164|FG001|Extension|Protocol Violation|0|||
160976078|NCT00365378|581302165|FG002|Extension|Protocol Violation|2|||
160976079|NCT00365378|581302163|FG000|Extension|Withdrawal by Subject|0|||
160976080|NCT00365378|581302164|FG001|Extension|Withdrawal by Subject|0|||
160976081|NCT00365378|581302165|FG002|Extension|Withdrawal by Subject|98|||
160976082|NCT00365378|581302163|FG000|Extension|Other|0|||
160976083|NCT00365378|581302164|FG001|Extension|Other|0|||
160976084|NCT00365378|581302165|FG002|Extension|Other|31|||
160976085|NCT04741802|581302166|FG000|Overall Study|Death|1|||
160976086|NCT04741802|581302166|FG000|Overall Study|Lost to Follow-up|11|||
160976087|NCT01381874|581302177|FG000|Overall Study|Lost to Follow-up|1|||
160976088|NCT01381874|581302178|FG001|Overall Study|Lost to Follow-up|1|||
160976089|NCT01381874|581302179|FG002|Overall Study|Lost to Follow-up|0|||
160976090|NCT01381874|581302177|FG000|Overall Study|Withdrawal by Subject|9|||
160976091|NCT01381874|581302178|FG001|Overall Study|Withdrawal by Subject|10|||
160976092|NCT01381874|581302179|FG002|Overall Study|Withdrawal by Subject|9|||
160976093|NCT01381874|581302177|FG000|Overall Study|Other|67|||
160976094|NCT01381874|581302178|FG001|Overall Study|Other|52|||
160976095|NCT01381874|581302179|FG002|Overall Study|Other|67|||
160976096|NCT00452413|581302182|FG000|Overall Study|Progressive Disease|4|||
160976097|NCT00452413|581302183|FG001|Overall Study|Progressive Disease|11|||
160976098|NCT00452413|581302184|FG002|Overall Study|Progressive Disease|30|||
160976099|NCT00452413|581302182|FG000|Overall Study|Withdrawal by Subject|0|||
160976100|NCT00452413|581302183|FG001|Overall Study|Withdrawal by Subject|1|||
160976101|NCT00452413|581302184|FG002|Overall Study|Withdrawal by Subject|4|||
160976102|NCT00452413|581302182|FG000|Overall Study|Adverse Event|0|||
160976103|NCT00452413|581302183|FG001|Overall Study|Adverse Event|0|||
160976104|NCT00452413|581302184|FG002|Overall Study|Adverse Event|5|||
160976105|NCT00452413|581302182|FG000|Overall Study|Physician Decision|0|||
160976106|NCT00452413|581302183|FG001|Overall Study|Physician Decision|0|||
160976107|NCT00452413|581302184|FG002|Overall Study|Physician Decision|4|||
160976108|NCT00452413|581302182|FG000|Overall Study|Death due to study disease|0|||
160976109|NCT00452413|581302183|FG001|Overall Study|Death due to study disease|0|||
160976110|NCT00452413|581302184|FG002|Overall Study|Death due to study disease|2|||
160976111|NCT00452413|581302182|FG000|Overall Study|Death due to adverse event (AE)|0|||
160976112|NCT00452413|581302183|FG001|Overall Study|Death due to adverse event (AE)|0|||
160976113|NCT00452413|581302184|FG002|Overall Study|Death due to adverse event (AE)|1|||
160976114|NCT00452413|581302182|FG000|Overall Study|On treatment|0|||
160976115|NCT00452413|581302183|FG001|Overall Study|On treatment|0|||
160976116|NCT00452413|581302184|FG002|Overall Study|On treatment|3|||
160976117|NCT03119610|581302186|FG000|Overall Study|Adverse Event|1|||
160976118|NCT03119610|581302187|FG001|Overall Study|Adverse Event|0|||
160976119|NCT03119610|581302186|FG000|Overall Study|Lost to Follow-up|0|||
160976120|NCT03119610|581302187|FG001|Overall Study|Lost to Follow-up|1|||
160976121|NCT00114634|581302188|FG000|Overall Study|failure to return forms|3|||
160976122|NCT00684762|581302191|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
160976123|NCT00684762|581302192|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
160976124|NCT02310126|581302204|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
160976125|NCT02310126|581302205|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
160976126|NCT02310126|581302204|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
160976127|NCT02310126|581302205|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
160976128|NCT01539863|581302208|FG000|Overall Study|Lost to Follow-up|5|||
160976129|NCT01539863|581302209|FG001|Overall Study|Lost to Follow-up|4|||
160976130|NCT02693834|581302213|FG000|Baseline Measurement|Withdrawal by Subject|1|||
160976131|NCT02693834|581302214|FG001|Baseline Measurement|Withdrawal by Subject|0|||
160976132|NCT02693834|581302213|FG000|Baseline Measurement|Adverse Event|1|||
160976133|NCT02693834|581302214|FG001|Baseline Measurement|Adverse Event|0|||
160976134|NCT02693834|581302213|FG000|Week 2 Practice|Adverse Event|0|||
160976135|NCT02693834|581302214|FG001|Week 2 Practice|Adverse Event|1|||
160976136|NCT02111213|581302217|FG000|Overall Study|Withdrawal by Subject|3|||
160976137|NCT02111213|581302218|FG001|Overall Study|Withdrawal by Subject|2|||
160976138|NCT02111213|581302217|FG000|Overall Study|Lost to Follow-up|3|||
160976139|NCT02111213|581302218|FG001|Overall Study|Lost to Follow-up|4|||
160976140|NCT02226172|581302223|FG000|Overall Study|Participant refused further follow-up|4|||
160976141|NCT02226172|581302223|FG000|Overall Study|Other|5|||
160976142|NCT02226172|581302223|FG000|Overall Study|Death|1|||
160976143|NCT02226172|581302223|FG000|Overall Study|Study terminated by sponsor|1|||
160976144|NCT02226172|581302223|FG000|Overall Study|Adverse Event|6|||
160976145|NCT00439179|581302227|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
160976146|NCT00439179|581302228|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
160976147|NCT00439179|581302229|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
161344593|NCT03314935|582647244|FG006|Phase 1|Study Terminated by Sponsor|0|||
161344594|NCT03314935|582647245|FG007|Phase 1|Study Terminated by Sponsor|0|||
161344595|NCT03314935|582647246|FG008|Phase 1|Study Terminated by Sponsor|1|||
161344596|NCT03314935|582647247|FG009|Phase 1|Study Terminated by Sponsor|0|||
161344597|NCT03314935|582647248|FG010|Phase 1|Study Terminated by Sponsor|0|||
161344598|NCT03314935|582647249|FG011|Phase 1|Study Terminated by Sponsor|0|||
161344599|NCT03314935|582647250|FG012|Phase 1|Study Terminated by Sponsor|0|||
161344600|NCT03314935|582647251|FG013|Phase 1|Study Terminated by Sponsor|0|||
161344601|NCT03314935|582647252|FG014|Phase 1|Study Terminated by Sponsor|0|||
161344602|NCT03314935|582647238|FG000|Phase 1|"Captured as Other in Database"|0|||
161344603|NCT03314935|582647239|FG001|Phase 1|"Captured as Other in Database"|2|||
161344604|NCT03314935|582647240|FG002|Phase 1|"Captured as Other in Database"|0|||
161344605|NCT03314935|582647241|FG003|Phase 1|"Captured as Other in Database"|0|||
161344606|NCT03314935|582647242|FG004|Phase 1|"Captured as Other in Database"|0|||
161344607|NCT03314935|582647243|FG005|Phase 1|"Captured as Other in Database"|0|||
161344608|NCT03314935|582647244|FG006|Phase 1|"Captured as Other in Database"|1|||
161344609|NCT03314935|582647245|FG007|Phase 1|"Captured as Other in Database"|1|||
161344610|NCT03314935|582647246|FG008|Phase 1|"Captured as Other in Database"|1|||
161344611|NCT03314935|582647247|FG009|Phase 1|"Captured as Other in Database"|0|||
161344612|NCT03314935|582647248|FG010|Phase 1|"Captured as Other in Database"|0|||
161344613|NCT03314935|582647249|FG011|Phase 1|"Captured as Other in Database"|0|||
161344614|NCT03314935|582647250|FG012|Phase 1|"Captured as Other in Database"|0|||
161344615|NCT03314935|582647251|FG013|Phase 1|"Captured as Other in Database"|0|||
161032044|NCT00626795|581510368|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
161032045|NCT00626795|581510369|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
161032046|NCT00626795|581510370|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
161032047|NCT00626795|581510368|FG000|Blinded Treatment|Lack of Efficacy|2|||
161277730|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
161277731|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
161277732|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
161277733|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
161277734|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
161277735|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
161277736|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
161277737|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
161277738|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
161277739|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
161277740|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
161277741|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
161277742|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
161277743|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161277744|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161277745|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161277746|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161277747|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
161277748|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
161277749|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
161277750|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
161277751|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
161277752|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
161277753|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161277754|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161277755|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161277756|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161277757|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
161277758|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
161277759|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
161277760|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
161277761|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
161344616|NCT03314935|582647252|FG014|Phase 1|"Captured as Other in Database"|0|||
161344617|NCT03314935|582647238|FG000|Phase 1|Lost to Follow-up|0|||
161344618|NCT03314935|582647239|FG001|Phase 1|Lost to Follow-up|0|||
161032048|NCT00626795|581510369|FG001|Blinded Treatment|Lack of Efficacy|0|||
161032049|NCT00626795|581510370|FG002|Blinded Treatment|Lack of Efficacy|0|||
161032050|NCT00626795|581510368|FG000|Blinded Treatment|Unacceptable adverse event|0|||
161277762|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
161277763|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161344619|NCT03314935|582647240|FG002|Phase 1|Lost to Follow-up|0|||
161344620|NCT03314935|582647241|FG003|Phase 1|Lost to Follow-up|0|||
161032051|NCT00626795|581510369|FG001|Blinded Treatment|Unacceptable adverse event|0|||
161344621|NCT03314935|582647242|FG004|Phase 1|Lost to Follow-up|0|||
161344622|NCT03314935|582647243|FG005|Phase 1|Lost to Follow-up|0|||
161277764|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161277765|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161277766|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161344623|NCT03314935|582647244|FG006|Phase 1|Lost to Follow-up|0|||
161344624|NCT03314935|582647245|FG007|Phase 1|Lost to Follow-up|0|||
161344625|NCT03314935|582647246|FG008|Phase 1|Lost to Follow-up|1|||
161344626|NCT03314935|582647247|FG009|Phase 1|Lost to Follow-up|0|||
161344627|NCT03314935|582647248|FG010|Phase 1|Lost to Follow-up|0|||
161344628|NCT03314935|582647249|FG011|Phase 1|Lost to Follow-up|0|||
160976148|NCT00439179|581302230|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
160976149|NCT02761629|581302231|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
160976150|NCT02761629|581302232|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
160976151|NCT02761629|581302231|FG000|Overall Study|Insufficient Therapeutic Response|2|||
160976152|NCT02761629|581302232|FG001|Overall Study|Insufficient Therapeutic Response|7|||
160976153|NCT02761629|581302231|FG000|Overall Study|Failure to Return|2|||
160976154|NCT02761629|581302232|FG001|Overall Study|Failure to Return|4|||
160976155|NCT02761629|581302231|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
160976156|NCT02761629|581302232|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
160976157|NCT02761629|581302231|FG000|Overall Study|Protocol Violation|2|||
160976158|NCT02761629|581302232|FG001|Overall Study|Protocol Violation|2|||
160976159|NCT02761629|581302231|FG000|Overall Study|Withdrawal by Subject|0|||
160976160|NCT02761629|581302232|FG001|Overall Study|Withdrawal by Subject|3|||
160976161|NCT02761629|581302231|FG000|Overall Study|Other|0|||
160976162|NCT02761629|581302232|FG001|Overall Study|Other|2|||
160976163|NCT02761629|581302231|FG000|Overall Study|Lost to Follow-up|4|||
160976164|NCT02761629|581302232|FG001|Overall Study|Lost to Follow-up|1|||
160976165|NCT02761629|581302231|FG000|Overall Study|Randomized But Not Treated|8|||
160976166|NCT02761629|581302232|FG001|Overall Study|Randomized But Not Treated|4|||
160976167|NCT00936221|581302239|FG000|Overall Study|Withdrawal by Subject|1|||
160976168|NCT00936221|581302240|FG001|Overall Study|Withdrawal by Subject|1|||
160976169|NCT01844115|581302243|FG000|Overall Study|Adverse Event|4|||
160976170|NCT01844115|581302244|FG001|Overall Study|Adverse Event|22|||
160976171|NCT01844115|581302243|FG000|Overall Study|Lack of Efficacy|1|||
160976172|NCT01844115|581302244|FG001|Overall Study|Lack of Efficacy|4|||
160976173|NCT01844115|581302243|FG000|Overall Study|Protocol Violation|12|||
160976174|NCT01844115|581302244|FG001|Overall Study|Protocol Violation|10|||
160976175|NCT01844115|581302243|FG000|Overall Study|Withdrawal by Subject|11|||
160976176|NCT01844115|581302244|FG001|Overall Study|Withdrawal by Subject|11|||
160976177|NCT01844115|581302243|FG000|Overall Study|Lost to Follow-up|11|||
160976178|NCT01844115|581302244|FG001|Overall Study|Lost to Follow-up|10|||
160976179|NCT01844115|581302243|FG000|Overall Study|Pregnancy|0|||
160976180|NCT01844115|581302244|FG001|Overall Study|Pregnancy|1|||
160976181|NCT00545363|581302245|FG000|Overall Study|Adverse Event|6|||
160976182|NCT00545363|581302246|FG001|Overall Study|Adverse Event|7|||
160976183|NCT00545363|581302245|FG000|Overall Study|Withdrawal by Subject|6|||
160976184|NCT00545363|581302246|FG001|Overall Study|Withdrawal by Subject|5|||
160976185|NCT00545363|581302245|FG000|Overall Study|Non-compliance|3|||
160976186|NCT00545363|581302246|FG001|Overall Study|Non-compliance|1|||
160976187|NCT00545363|581302245|FG000|Overall Study|Did not meet entry criteria|1|||
160976188|NCT00545363|581302246|FG001|Overall Study|Did not meet entry criteria|1|||
160976189|NCT00545363|581302245|FG000|Overall Study|Lost to Follow-up|2|||
160976190|NCT00545363|581302246|FG001|Overall Study|Lost to Follow-up|0|||
160976191|NCT00545363|581302245|FG000|Overall Study|Other|1|||
160976192|NCT00545363|581302246|FG001|Overall Study|Other|1|||
160976193|NCT02153359|581302247|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
160976194|NCT02153359|581302248|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
160976195|NCT01775930|581302249|FG000|Overall Study|Futility stopping boundary met|1|||
160976196|NCT01208415|581302250|FG000|Overall Study|Death|1|||
160976197|NCT01208415|581302250|FG000|Overall Study|Lost to Follow-up|2|||
160976198|NCT01208415|581302250|FG000|Overall Study|Withdrawal by Subject|3|||
160976199|NCT01208415|581302250|FG000|Overall Study|Device not placed|1|||
160976200|NCT01208415|581302250|FG000|Overall Study|Still be eligible for follow-up|33|||
160976201|NCT02340520|581302251|FG000|Overall Study|Lost to Follow-up|1|||
160976202|NCT02340520|581302251|FG000|Overall Study|Patient did not take drug as specified|1|||
160976203|NCT02340520|581302251|FG000|Overall Study|Withdrawal by Subject|1|||
160976204|NCT01586338|581302253|FG000|Overall Study|Adverse Event|3|||
160976205|NCT01586338|581302253|FG000|Overall Study|Lost to Follow-up|1|||
160976206|NCT01586338|581302253|FG000|Overall Study|Withdrawal by participant|3|||
160976207|NCT01586338|581302253|FG000|Overall Study|Other|1|||
160976208|NCT01868074|581302258|FG000|Overall Study|Lost to Follow-up|3|||
160976209|NCT01868074|581302259|FG001|Overall Study|Lost to Follow-up|2|||
160976210|NCT01868074|581302258|FG000|Overall Study|Withdrawal by Subject|4|||
160976211|NCT01868074|581302259|FG001|Overall Study|Withdrawal by Subject|2|||
160976212|NCT03306043|581302260|FG000|Overall Study|Adverse Event|1|||
160976213|NCT03306043|581302260|FG000|Overall Study|Lost to Follow-up|1|||
160976214|NCT03306043|581302260|FG000|Overall Study|Withdrawal by Subject|2|||
160976215|NCT02494206|581302261|FG000|Overall Study|Adverse Event|1|||
160976216|NCT02494206|581302261|FG000|Overall Study|Disease Progression|1|||
160976217|NCT01013792|581302262|FG000|Overall Study|Study suspended|2|||
160976218|NCT01013792|581302263|FG001|Overall Study|Study suspended|1|||
160976219|NCT01013792|581302262|FG000|Overall Study|Adverse Event|0|||
161344629|NCT03314935|582647250|FG012|Phase 1|Lost to Follow-up|0|||
161032052|NCT00626795|581510370|FG002|Blinded Treatment|Unacceptable adverse event|1|||
161032053|NCT00626795|581510368|FG000|Blinded Treatment|Protocol Violation|0|||
161032054|NCT00626795|581510369|FG001|Blinded Treatment|Protocol Violation|1|||
161032055|NCT00626795|581510370|FG002|Blinded Treatment|Protocol Violation|1|||
161032056|NCT00626795|581510368|FG000|Blinded Treatment|Withdrawal by Subject|1|||
161032057|NCT00626795|581510369|FG001|Blinded Treatment|Withdrawal by Subject|1|||
161032058|NCT00626795|581510370|FG002|Blinded Treatment|Withdrawal by Subject|0|||
161032059|NCT00626795|581510368|FG000|Blinded Treatment|Other reasons|2|||
161032060|NCT00626795|581510369|FG001|Blinded Treatment|Other reasons|0|||
161032061|NCT00626795|581510370|FG002|Blinded Treatment|Other reasons|2|||
161032062|NCT00626795|581510368|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
161032063|NCT00626795|581510369|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
161032064|NCT00626795|581510370|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
161032065|NCT04499521|581510371|FG000|Overall Study|Disease Progression|1|||
161032066|NCT04499521|581510372|FG001|Overall Study|Disease Progression|0|||
161032067|NCT05412004|581511084|FG000|Overall Study|Adverse Event|0|||
161032068|NCT05412004|581511085|FG001|Overall Study|Adverse Event|2|||
161032069|NCT05412004|581511086|FG002|Overall Study|Adverse Event|1|||
161032070|NCT05412004|581511087|FG003|Overall Study|Adverse Event|5|||
161032071|NCT05412004|581511084|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161032072|NCT05412004|581511085|FG001|Overall Study|Assigned Treatment by Mistake|10|||
161032073|NCT05412004|581511086|FG002|Overall Study|Assigned Treatment by Mistake|2|||
161032074|NCT05412004|581511087|FG003|Overall Study|Assigned Treatment by Mistake|5|||
161032075|NCT05412004|581511084|FG000|Overall Study|Lost to Follow-up|3|||
161032076|NCT05412004|581511085|FG001|Overall Study|Lost to Follow-up|0|||
161032077|NCT05412004|581511086|FG002|Overall Study|Lost to Follow-up|0|||
161032078|NCT05412004|581511087|FG003|Overall Study|Lost to Follow-up|0|||
161032079|NCT05412004|581511084|FG000|Overall Study|Patient could not travel to site|0|||
161032080|NCT05412004|581511085|FG001|Overall Study|Patient could not travel to site|1|||
161032081|NCT05412004|581511086|FG002|Overall Study|Patient could not travel to site|0|||
161032082|NCT05412004|581511087|FG003|Overall Study|Patient could not travel to site|0|||
161032083|NCT05412004|581511084|FG000|Overall Study|Physician Decision|0|||
161032084|NCT05412004|581511085|FG001|Overall Study|Physician Decision|1|||
161032085|NCT05412004|581511086|FG002|Overall Study|Physician Decision|0|||
161032086|NCT05412004|581511087|FG003|Overall Study|Physician Decision|0|||
161032087|NCT05412004|581511084|FG000|Overall Study|Pregnancy|0|||
161032088|NCT05412004|581511085|FG001|Overall Study|Pregnancy|1|||
161032089|NCT05412004|581511086|FG002|Overall Study|Pregnancy|0|||
161032090|NCT05412004|581511087|FG003|Overall Study|Pregnancy|0|||
161032091|NCT05412004|581511084|FG000|Overall Study|Protocol Violation|1|||
161032092|NCT05412004|581511085|FG001|Overall Study|Protocol Violation|0|||
161032093|NCT05412004|581511086|FG002|Overall Study|Protocol Violation|0|||
161032094|NCT05412004|581511087|FG003|Overall Study|Protocol Violation|0|||
161032095|NCT05412004|581511084|FG000|Overall Study|Withdrawal by Subject|4|||
161032096|NCT05412004|581511085|FG001|Overall Study|Withdrawal by Subject|19|||
161032097|NCT05412004|581511086|FG002|Overall Study|Withdrawal by Subject|4|||
161032098|NCT05412004|581511087|FG003|Overall Study|Withdrawal by Subject|14|||
161032099|NCT05412004|581511084|FG000|Overall Study|Screen Failure|0|||
161032100|NCT05412004|581511085|FG001|Overall Study|Screen Failure|0|||
161032101|NCT05412004|581511086|FG002|Overall Study|Screen Failure|0|||
161032102|NCT05412004|581511087|FG003|Overall Study|Screen Failure|1|||
161032103|NCT05412004|581511084|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
161032104|NCT05412004|581511085|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
161032105|NCT05412004|581511086|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
161032106|NCT05412004|581511087|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
161032107|NCT03781089|581511088|FG000|Overall Study|Constipation|1|||
161032108|NCT03781089|581511089|FG001|Overall Study|Constipation|0|||
161032109|NCT03781089|581511088|FG000|Overall Study|Positive pregnancy test|0|||
161032110|NCT03781089|581511089|FG001|Overall Study|Positive pregnancy test|1|||
161032111|NCT04644029|581511090|FG000|Overall Study|Death|1|||
161032112|NCT04644029|581511091|FG001|Overall Study|Death|0|||
161032113|NCT04644029|581511090|FG000|Overall Study|Physician Decision|1|||
161032114|NCT04644029|581511091|FG001|Overall Study|Physician Decision|2|||
161032115|NCT04644029|581511090|FG000|Overall Study|Withdrawal by Subject|21|||
161032116|NCT04644029|581511091|FG001|Overall Study|Withdrawal by Subject|19|||
161148856|NCT02345161|581926170|FG000|Overall Study|Physician Decision|4|||
161032117|NCT04644029|581511090|FG000|Overall Study|Lost to Follow-up|31|||
161032118|NCT04644029|581511091|FG001|Overall Study|Lost to Follow-up|34|||
161032119|NCT04644029|581511090|FG000|Overall Study|Study Terminated by Sponsor|308|||
161032120|NCT04644029|581511091|FG001|Overall Study|Study Terminated by Sponsor|309|||
161032121|NCT04644029|581511090|FG000|Overall Study|Randomized in Error|2|||
161032122|NCT04644029|581511091|FG001|Overall Study|Randomized in Error|1|||
161032123|NCT04644029|581511090|FG000|Overall Study|Other|0|||
161032124|NCT04644029|581511091|FG001|Overall Study|Other|1|||
161032125|NCT02246127|581511092|FG000|First Course Treatment|Adverse Event|9|||
161277767|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
161277768|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277769|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277770|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
160976220|NCT01013792|581302263|FG001|Overall Study|Adverse Event|3|||
160976221|NCT01013792|581302262|FG000|Overall Study|Lost to Follow-up|0|||
160976222|NCT01013792|581302263|FG001|Overall Study|Lost to Follow-up|1|||
160976223|NCT01234649|581302264|FG000|Overall Study|Withdrawal by Subject|32|||
160976224|NCT01234649|581302265|FG001|Overall Study|Withdrawal by Subject|26|||
160976225|NCT01234649|581302264|FG000|Overall Study|Pregnancy|6|||
160976226|NCT01234649|581302265|FG001|Overall Study|Pregnancy|6|||
160976227|NCT01234649|581302264|FG000|Overall Study|intolerant to side effects|4|||
160976228|NCT01234649|581302265|FG001|Overall Study|intolerant to side effects|3|||
160976229|NCT01234649|581302264|FG000|Overall Study|Allergic reaction|1|||
160976230|NCT01234649|581302265|FG001|Overall Study|Allergic reaction|0|||
161277771|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
161277772|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161032126|NCT02246127|581511093|FG001|First Course Treatment|Adverse Event|7|||
161032127|NCT02246127|581511092|FG000|First Course Treatment|Withdrawal by Subject|6|||
161032128|NCT02246127|581511093|FG001|First Course Treatment|Withdrawal by Subject|7|||
161032129|NCT02246127|581511092|FG000|First Course Treatment|Physician Decision|9|||
161032130|NCT02246127|581511093|FG001|First Course Treatment|Physician Decision|9|||
161032131|NCT02246127|581511092|FG000|First Course Treatment|Death|3|||
161032132|NCT02246127|581511093|FG001|First Course Treatment|Death|3|||
161032133|NCT02246127|581511092|FG000|First Course Treatment|Not reported reasons|6|||
161032134|NCT02246127|581511093|FG001|First Course Treatment|Not reported reasons|7|||
161032135|NCT02246127|581511092|FG000|First Course Treatment|Not treated|3|||
161032136|NCT02246127|581511093|FG001|First Course Treatment|Not treated|3|||
161032137|NCT05157841|581511094|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
161032138|NCT05157841|581511095|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
161032139|NCT05157841|581511096|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
161032140|NCT05157841|581511094|FG000|Part A (14 Days)|Adverse Event|1|||
161032141|NCT05157841|581511095|FG001|Part A (14 Days)|Adverse Event|0|||
161032142|NCT05157841|581511096|FG002|Part A (14 Days)|Adverse Event|0|||
161032143|NCT05157841|581511094|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
161032144|NCT05157841|581511095|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
161032145|NCT05157841|581511096|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
161032146|NCT04464564|581511098|FG000|Period A (Placebo lead-in)|Other|5|||
161032147|NCT04464564|581511099|FG001|Period A (Placebo lead-in)|Other|0|||
161032148|NCT04464564|581511100|FG002|Period A (Placebo lead-in)|Other|0|||
161032149|NCT04464564|581511101|FG003|Period A (Placebo lead-in)|Other|0|||
161032150|NCT04464564|581511098|FG000|Period B (Randomization Period)|Adverse Event|0|||
161032151|NCT04464564|581511099|FG001|Period B (Randomization Period)|Adverse Event|1|||
161032152|NCT04464564|581511100|FG002|Period B (Randomization Period)|Adverse Event|2|||
161032153|NCT04464564|581511101|FG003|Period B (Randomization Period)|Adverse Event|8|||
161032154|NCT04464564|581511098|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
161032155|NCT04464564|581511099|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
161032156|NCT04464564|581511100|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
161277773|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277774|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277775|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277776|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277777|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
161277778|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
161277779|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
161277780|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
161277781|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
161277782|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
161277783|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
161277784|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
161277785|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
161277786|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
161344630|NCT03314935|582647251|FG013|Phase 1|Lost to Follow-up|0|||
161344631|NCT03314935|582647252|FG014|Phase 1|Lost to Follow-up|0|||
161032157|NCT04464564|581511101|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
161032158|NCT04464564|581511098|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
161032159|NCT04464564|581511099|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
161032160|NCT04464564|581511100|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
160976231|NCT01234649|581302264|FG000|Overall Study|Lack of Efficacy|0|||
160976232|NCT01234649|581302265|FG001|Overall Study|Lack of Efficacy|3|||
160976233|NCT01461993|581302266|FG000|Overall Study|Withdrawal by Subject|60|||
161032161|NCT04464564|581511101|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
161032162|NCT04464564|581511098|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
161032163|NCT04464564|581511099|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
161032164|NCT04464564|581511100|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
161032165|NCT04464564|581511101|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
161032166|NCT04464564|581511098|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
161032167|NCT04464564|581511099|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
161032168|NCT04464564|581511100|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
161032169|NCT04464564|581511101|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
161032170|NCT04464564|581511098|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
161032171|NCT04464564|581511099|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
161032172|NCT04464564|581511100|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
161032173|NCT04464564|581511101|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
161032174|NCT04464564|581511098|FG000|Period B (Randomization Period)|Reason not Specified|0|||
161032175|NCT04464564|581511099|FG001|Period B (Randomization Period)|Reason not Specified|3|||
161032176|NCT04464564|581511100|FG002|Period B (Randomization Period)|Reason not Specified|3|||
161032177|NCT04464564|581511101|FG003|Period B (Randomization Period)|Reason not Specified|3|||
161032178|NCT02278211|581511106|FG000|Overall Study|Unable to analyse PET scan|2|||
161032179|NCT01828021|581511109|FG000|Overall Study|Adverse Event|5|||
161032180|NCT01828021|581511109|FG000|Overall Study|Lack of Efficacy|17|||
161032181|NCT01828021|581511109|FG000|Overall Study|Withdrawal by Subject|2|||
161032182|NCT01828021|581511109|FG000|Overall Study|Ileal obstruction, unrelated|1|||
161032183|NCT03884101|581511121|FG000|Overall Study|Participant Ongoing in Study|202|||
161032184|NCT03884101|581511122|FG001|Overall Study|Participant Ongoing in Study|186|||
161032185|NCT03884101|581511121|FG000|Overall Study|Death|212|||
161032186|NCT03884101|581511122|FG001|Overall Study|Death|224|||
161032187|NCT03884101|581511121|FG000|Overall Study|Lost to Follow-up|0|||
161032188|NCT03884101|581511122|FG001|Overall Study|Lost to Follow-up|1|||
161032189|NCT03884101|581511121|FG000|Overall Study|Withdrawal by Subject|6|||
161032190|NCT03884101|581511122|FG001|Overall Study|Withdrawal by Subject|11|||
161032191|NCT04631016|581511123|FG000|Overall Study|Adverse Event|3|||
161032192|NCT04631016|581511124|FG001|Overall Study|Adverse Event|0|||
161032193|NCT04631016|581511123|FG000|Overall Study|Withdrawal by Subject|5|||
161032194|NCT04631016|581511124|FG001|Overall Study|Withdrawal by Subject|4|||
161032195|NCT04631016|581511123|FG000|Overall Study|Reason unspecified|1|||
161032196|NCT04631016|581511124|FG001|Overall Study|Reason unspecified|0|||
161032197|NCT04631016|581511123|FG000|Overall Study|Failure to meet randomization criteria|2|||
161032198|NCT04631016|581511124|FG001|Overall Study|Failure to meet randomization criteria|1|||
161032199|NCT05112900|581511127|FG000|Overall Study|Withdrawal by Subject|960|||
161032200|NCT05112900|581511128|FG001|Overall Study|Withdrawal by Subject|921|||
161032201|NCT05112900|581511129|FG002|Overall Study|Withdrawal by Subject|968|||
161032202|NCT05541484|581511130|FG000|Overall Study|Withdrawal by Subject|1|||
161032203|NCT05541484|581511131|FG001|Overall Study|Withdrawal by Subject|0|||
161032204|NCT01438853|581511137|FG000|Overall Study|Death|0|||
161032205|NCT01438853|581511138|FG001|Overall Study|Death|0|||
161032206|NCT01438853|581511139|FG002|Overall Study|Death|0|||
161032207|NCT01438853|581511140|FG003|Overall Study|Death|1|||
161277787|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
161277788|NCT03104400|582396535|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277789|NCT03104400|582396536|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277790|NCT03104400|582396537|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277791|NCT03104400|582396538|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
161277792|NCT03104400|582396539|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277793|NCT03104400|582396540|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277794|NCT03104400|582396541|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277795|NCT03104400|582396542|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277796|NCT03104400|582396543|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277797|NCT03104400|582396544|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
161277798|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
161277799|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
161277800|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
161277801|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
161277802|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
161277803|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
161277804|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
161277805|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
161277806|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
161032208|NCT01438853|581511137|FG000|Overall Study|Withdrawal by Subject|0|||
161032209|NCT01438853|581511138|FG001|Overall Study|Withdrawal by Subject|0|||
161032210|NCT01438853|581511139|FG002|Overall Study|Withdrawal by Subject|1|||
161032211|NCT01438853|581511140|FG003|Overall Study|Withdrawal by Subject|0|||
161032212|NCT03279978|581511142|FG000|Overall Study|Withdrawal by Subject|0|||
161277807|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
161032213|NCT03279978|581511143|FG001|Overall Study|Withdrawal by Subject|1|||
161277808|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161277809|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161277810|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161277811|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161277812|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
161277813|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
161277814|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
161277815|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
161277816|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
161277817|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
161277818|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161277819|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161277820|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161277821|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161277822|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
161277823|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
161277824|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
161277825|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
161277826|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
161277827|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
161277828|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161277829|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161277830|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161277831|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161277832|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
161277833|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
161277834|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
161277835|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
161277836|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
161277837|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
161277838|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277839|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277840|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277841|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277842|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277843|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277844|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
161277845|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
161277846|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
161277847|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
161277848|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277849|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277850|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277851|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277852|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277853|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277854|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277855|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
161277856|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
161277857|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
161277858|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
161277859|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
161277860|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
161277861|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
161277862|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
161277863|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
161277864|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
161277865|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
161277866|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
161277867|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
161277868|NCT03104400|582396535|FG000|Period 2 Week 56 - 260)|Other|0|||
161277869|NCT03104400|582396536|FG001|Period 2 Week 56 - 260)|Other|0|||
161277870|NCT03104400|582396537|FG002|Period 2 Week 56 - 260)|Other|0|||
161277871|NCT03104400|582396538|FG003|Period 2 Week 56 - 260)|Other|0|||
161277872|NCT03104400|582396539|FG004|Period 2 Week 56 - 260)|Other|0|||
161277873|NCT03104400|582396540|FG005|Period 2 Week 56 - 260)|Other|0|||
161277874|NCT03104400|582396541|FG006|Period 2 Week 56 - 260)|Other|0|||
161277875|NCT03104400|582396542|FG007|Period 2 Week 56 - 260)|Other|0|||
161277876|NCT03104400|582396543|FG008|Period 2 Week 56 - 260)|Other|1|||
161277877|NCT03104400|582396544|FG009|Period 2 Week 56 - 260)|Other|1|||
161277878|NCT00094861|582396547|FG000|Overall Study|Adverse Event|5|||
161277879|NCT00094861|582396548|FG001|Overall Study|Adverse Event|2|||
161032214|NCT03279978|581511144|FG002|Overall Study|Withdrawal by Subject|0|||
161032215|NCT03279978|581511145|FG003|Overall Study|Withdrawal by Subject|0|||
161032216|NCT03279978|581511146|FG004|Overall Study|Withdrawal by Subject|0|||
161032217|NCT03279978|581511147|FG005|Overall Study|Withdrawal by Subject|0|||
161032218|NCT03279978|581511148|FG006|Overall Study|Withdrawal by Subject|0|||
161032219|NCT03279978|581511149|FG007|Overall Study|Withdrawal by Subject|0|||
161032220|NCT03279978|581511150|FG008|Overall Study|Withdrawal by Subject|0|||
161032221|NCT03279978|581511151|FG009|Overall Study|Withdrawal by Subject|1|||
161032222|NCT03279978|581511142|FG000|Overall Study|Lost to Follow-up|1|||
161032223|NCT03279978|581511143|FG001|Overall Study|Lost to Follow-up|0|||
161032224|NCT03279978|581511144|FG002|Overall Study|Lost to Follow-up|1|||
161032225|NCT03279978|581511145|FG003|Overall Study|Lost to Follow-up|0|||
161277880|NCT00094861|582396547|FG000|Overall Study|Withdrawal by Subject|5|||
161277881|NCT00094861|582396548|FG001|Overall Study|Withdrawal by Subject|3|||
161277882|NCT00094861|582396547|FG000|Overall Study|Physician Decision|1|||
161277883|NCT00094861|582396548|FG001|Overall Study|Physician Decision|1|||
161277884|NCT00094861|582396547|FG000|Overall Study|Lost to Follow-up|0|||
161277885|NCT00094861|582396548|FG001|Overall Study|Lost to Follow-up|1|||
161277886|NCT00094861|582396547|FG000|Overall Study|Death|4|||
161277887|NCT00094861|582396548|FG001|Overall Study|Death|2|||
161277888|NCT00094861|582396547|FG000|Overall Study|Other|3|||
161277889|NCT00094861|582396548|FG001|Overall Study|Other|0|||
161032226|NCT03279978|581511146|FG004|Overall Study|Lost to Follow-up|0|||
161032227|NCT03279978|581511147|FG005|Overall Study|Lost to Follow-up|0|||
161032228|NCT03279978|581511148|FG006|Overall Study|Lost to Follow-up|0|||
161032229|NCT03279978|581511149|FG007|Overall Study|Lost to Follow-up|0|||
161277890|NCT00129389|582396549|FG000|Overall Study|Adverse Event|19|||
161277891|NCT00129389|582396550|FG001|Overall Study|Adverse Event|87|||
161277892|NCT00129389|582396549|FG000|Overall Study|Death|0|||
161277893|NCT00129389|582396550|FG001|Overall Study|Death|1|||
161277894|NCT00129389|582396549|FG000|Overall Study|Lost to Follow-up|2|||
161277895|NCT00129389|582396550|FG001|Overall Study|Lost to Follow-up|1|||
161032230|NCT03279978|581511150|FG008|Overall Study|Lost to Follow-up|0|||
161032231|NCT03279978|581511151|FG009|Overall Study|Lost to Follow-up|0|||
161277896|NCT00129389|582396549|FG000|Overall Study|Physician Decision|0|||
161277897|NCT00129389|582396550|FG001|Overall Study|Physician Decision|4|||
161277898|NCT00129389|582396549|FG000|Overall Study|Protocol Violation|0|||
161277899|NCT00129389|582396550|FG001|Overall Study|Protocol Violation|6|||
161277900|NCT00129389|582396549|FG000|Overall Study|Withdrawal by Subject|9|||
161032232|NCT03279978|581511142|FG000|Overall Study|Other than stated above|0|||
161032233|NCT03279978|581511143|FG001|Overall Study|Other than stated above|0|||
161032234|NCT03279978|581511144|FG002|Overall Study|Other than stated above|0|||
161032235|NCT03279978|581511145|FG003|Overall Study|Other than stated above|0|||
161032236|NCT03279978|581511146|FG004|Overall Study|Other than stated above|0|||
161032237|NCT03279978|581511147|FG005|Overall Study|Other than stated above|0|||
161032238|NCT03279978|581511148|FG006|Overall Study|Other than stated above|1|||
161032239|NCT03279978|581511149|FG007|Overall Study|Other than stated above|0|||
161277901|NCT00129389|582396550|FG001|Overall Study|Withdrawal by Subject|23|||
161277902|NCT00129389|582396549|FG000|Overall Study|Relapse|1|||
161277903|NCT00129389|582396550|FG001|Overall Study|Relapse|0|||
161277904|NCT00129389|582396549|FG000|Overall Study|Not eligible|1|||
161032240|NCT03279978|581511150|FG008|Overall Study|Other than stated above|0|||
161032241|NCT03279978|581511151|FG009|Overall Study|Other than stated above|0|||
161032242|NCT04159519|581511152|FG000|Overall Study|Adverse Event|1|||
161032243|NCT04159519|581511153|FG001|Overall Study|Adverse Event|1|||
161032244|NCT04159519|581511152|FG000|Overall Study|Lack of Efficacy|1|||
161032245|NCT04159519|581511153|FG001|Overall Study|Lack of Efficacy|0|||
161032246|NCT04159519|581511152|FG000|Overall Study|Discontinued from study|1|||
161032247|NCT04159519|581511153|FG001|Overall Study|Discontinued from study|0|||
161032248|NCT04159519|581511152|FG000|Overall Study|Protocol Violation|1|||
161032249|NCT04159519|581511153|FG001|Overall Study|Protocol Violation|1|||
161032250|NCT04159519|581511152|FG000|Overall Study|Withdrawal by Subject|4|||
161032251|NCT04159519|581511153|FG001|Overall Study|Withdrawal by Subject|4|||
161277905|NCT00129389|582396550|FG001|Overall Study|Not eligible|2|||
161277906|NCT00129389|582396549|FG000|Overall Study|Crossed to the other arm|1|||
161277907|NCT00129389|582396550|FG001|Overall Study|Crossed to the other arm|16|||
161277908|NCT00451204|582396551|FG000|Overall Study|Adverse Event|4|||
161277909|NCT00451204|582396552|FG001|Overall Study|Adverse Event|6|||
161277910|NCT00451204|582396551|FG000|Overall Study|Lack of Efficacy|4|||
161032252|NCT03493542|581511156|FG000|Base Study|Withdrawal by Subject|0|||
161032253|NCT03493542|581511157|FG001|Base Study|Withdrawal by Subject|4|||
161032254|NCT03493542|581511158|FG002|Base Study|Withdrawal by Subject|0|||
161032255|NCT03493542|581511156|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
161032256|NCT03493542|581511157|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
161032257|NCT03493542|581511158|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
161148857|NCT02345161|581926171|FG001|Overall Study|Physician Decision|4|||
161277911|NCT00451204|582396552|FG001|Overall Study|Lack of Efficacy|4|||
161277912|NCT00451204|582396551|FG000|Overall Study|Lost to Follow-up|4|||
161277913|NCT00451204|582396552|FG001|Overall Study|Lost to Follow-up|4|||
161277914|NCT00451204|582396551|FG000|Overall Study|Protocol Violation|1|||
161277915|NCT00451204|582396552|FG001|Overall Study|Protocol Violation|0|||
161277916|NCT00451204|582396551|FG000|Overall Study|Patient refusal|8|||
161277917|NCT00451204|582396552|FG001|Overall Study|Patient refusal|4|||
161277918|NCT00451204|582396551|FG000|Overall Study|Other|1|||
161277919|NCT00451204|582396552|FG001|Overall Study|Other|2|||
161277920|NCT01191944|582396556|FG000|Overall Study|Adverse Event|11|||
161277921|NCT01191944|582396557|FG001|Overall Study|Adverse Event|12|||
161277922|NCT01191944|582396556|FG000|Overall Study|Protocol Violation|1|||
161277923|NCT01191944|582396557|FG001|Overall Study|Protocol Violation|2|||
161277924|NCT01191944|582396556|FG000|Overall Study|Withdrawal by Subject|4|||
161277925|NCT01191944|582396557|FG001|Overall Study|Withdrawal by Subject|2|||
161277926|NCT01191944|582396556|FG000|Overall Study|Other|1|||
161277927|NCT01191944|582396557|FG001|Overall Study|Other|3|||
161277928|NCT04602546|582396564|FG000|Overall Study|Training|2|||
161277929|NCT04602546|582396565|FG001|Overall Study|Training|2|||
161277930|NCT04602546|582396566|FG002|Overall Study|Training|1|||
161277931|NCT04602546|582396567|FG003|Overall Study|Training|2|||
161277932|NCT04602546|582396568|FG004|Overall Study|Training|0|||
161277933|NCT04602546|582396564|FG000|Overall Study|Randomized with disqualified data|2|||
161277934|NCT04602546|582396565|FG001|Overall Study|Randomized with disqualified data|0|||
161277935|NCT04602546|582396566|FG002|Overall Study|Randomized with disqualified data|2|||
161277936|NCT04602546|582396567|FG003|Overall Study|Randomized with disqualified data|5|||
161277937|NCT04602546|582396568|FG004|Overall Study|Randomized with disqualified data|3|||
161277938|NCT02794246|582396569|FG000|Overall Study|Withdrawal by Subject|2|||
161277939|NCT02794246|582396569|FG000|Overall Study|Physician Decision|4|||
161277940|NCT01831258|582396573|FG000|Overall Study|Withdrawal by Subject|2|||
161277941|NCT01831258|582396574|FG001|Overall Study|Withdrawal by Subject|1|||
161277942|NCT01831258|582396573|FG000|Overall Study|Lost to Follow-up|3|||
161277943|NCT01831258|582396574|FG001|Overall Study|Lost to Follow-up|2|||
161277944|NCT01753297|582396579|FG000|Overall Study|Lost to Follow-up|7|||
161277945|NCT01753297|582396580|FG001|Overall Study|Lost to Follow-up|2|||
161277946|NCT01753297|582396579|FG000|Overall Study|Withdrawal by Subject|26|||
161277947|NCT01753297|582396580|FG001|Overall Study|Withdrawal by Subject|23|||
161277948|NCT01753297|582396579|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
161277949|NCT01753297|582396580|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
161277950|NCT01753297|582396579|FG000|Overall Study|Death|0|||
161277951|NCT01753297|582396580|FG001|Overall Study|Death|2|||
161277952|NCT01753297|582396579|FG000|Overall Study|Did not attend end of study visit|7|||
161277953|NCT01753297|582396580|FG001|Overall Study|Did not attend end of study visit|8|||
161277954|NCT02533180|582396581|FG000|Overall Study|Death|0|||
161277955|NCT02533180|582396582|FG001|Overall Study|Death|2|||
161277956|NCT02533180|582396581|FG000|Overall Study|Lost to Follow-up|0|||
161277957|NCT02533180|582396582|FG001|Overall Study|Lost to Follow-up|1|||
161277958|NCT02533180|582396581|FG000|Overall Study|Physician Decision|0|||
161277959|NCT02533180|582396582|FG001|Overall Study|Physician Decision|1|||
161277960|NCT02533180|582396581|FG000|Overall Study|Withdrawal by Subject|2|||
161277961|NCT02533180|582396582|FG001|Overall Study|Withdrawal by Subject|5|||
161277962|NCT02533180|582396581|FG000|Overall Study|Screen Failure|37|||
161277963|NCT02533180|582396582|FG001|Overall Study|Screen Failure|0|||
161277964|NCT02533180|582396581|FG000|Overall Study|Protocol Deviation|0|||
161277965|NCT02533180|582396582|FG001|Overall Study|Protocol Deviation|1|||
161277966|NCT02533180|582396581|FG000|Overall Study|Non-compliance|0|||
161277967|NCT02533180|582396582|FG001|Overall Study|Non-compliance|1|||
161277968|NCT01174043|582396583|FG000|Overall Study|Disease progression|5|||
161277969|NCT01174043|582396583|FG000|Overall Study|Adverse Event|3|||
161277970|NCT01174043|582396583|FG000|Overall Study|Death|1|||
161277971|NCT01174043|582396583|FG000|Overall Study|Withdrawal by Subject|2|||
161277972|NCT00794339|582396589|FG000|Overall Study|Withdrawal by Subject|3|||
161277973|NCT00794339|582396589|FG000|Overall Study|Ineligible|4|||
161277974|NCT00794339|582396589|FG000|Overall Study|Tx prior to ATSM|3|||
161277975|NCT00794339|582396589|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
161277976|NCT00794339|582396589|FG000|Overall Study|Tx not per protocol|1|||
161277977|NCT01371539|582396596|FG000|Period One: One Week|Lost to Follow-up|0|||
161277978|NCT01371539|582396597|FG001|Period One: One Week|Lost to Follow-up|1|||
161277979|NCT01371539|582396596|FG000|Period Two: One Week|Lost to Follow-up|0|||
161277980|NCT01371539|582396597|FG001|Period Two: One Week|Lost to Follow-up|1|||
161277981|NCT01371539|582396596|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
161277982|NCT01371539|582396597|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
161277983|NCT01371539|582396596|FG000|Period Two: One Week|Time/job conflict|0|||
161277984|NCT01371539|582396597|FG001|Period Two: One Week|Time/job conflict|1|||
161277985|NCT00704132|582396600|FG000|Overall Study|Clinical Adverse Experience|1|||
161277986|NCT00704132|582396601|FG001|Overall Study|Clinical Adverse Experience|0|||
161277987|NCT00704132|582396600|FG000|Overall Study|Lack of Efficacy|0|||
161277988|NCT00704132|582396601|FG001|Overall Study|Lack of Efficacy|1|||
161277989|NCT00704132|582396600|FG000|Overall Study|Withdrawal by Subject|0|||
161277990|NCT00704132|582396601|FG001|Overall Study|Withdrawal by Subject|1|||
161277991|NCT00442962|582396602|FG000|Overall Study|Pregnancy|1|||
161277992|NCT00442962|582396602|FG000|Overall Study|Lost to Follow-up|7|||
161344632|NCT03314935|582647238|FG000|Phase 2|Death|0|||
161344633|NCT03314935|582647239|FG001|Phase 2|Death|0|||
161344634|NCT03314935|582647240|FG002|Phase 2|Death|0|||
161344635|NCT03314935|582647241|FG003|Phase 2|Death|0|||
161344636|NCT03314935|582647242|FG004|Phase 2|Death|0|||
161344637|NCT03314935|582647243|FG005|Phase 2|Death|0|||
161344638|NCT03314935|582647244|FG006|Phase 2|Death|0|||
161344639|NCT03314935|582647245|FG007|Phase 2|Death|0|||
161344640|NCT03314935|582647246|FG008|Phase 2|Death|0|||
161344641|NCT03314935|582647247|FG009|Phase 2|Death|5|||
161344642|NCT03314935|582647248|FG010|Phase 2|Death|20|||
161344643|NCT03314935|582647249|FG011|Phase 2|Death|6|||
161344644|NCT03314935|582647250|FG012|Phase 2|Death|7|||
161344645|NCT03314935|582647251|FG013|Phase 2|Death|6|||
161344646|NCT03314935|582647252|FG014|Phase 2|Death|17|||
161344647|NCT03314935|582647238|FG000|Phase 2|Withdrawal by Subject|0|||
161344648|NCT03314935|582647239|FG001|Phase 2|Withdrawal by Subject|0|||
161344649|NCT03314935|582647240|FG002|Phase 2|Withdrawal by Subject|0|||
161344650|NCT03314935|582647241|FG003|Phase 2|Withdrawal by Subject|0|||
161344651|NCT03314935|582647242|FG004|Phase 2|Withdrawal by Subject|0|||
161344652|NCT03314935|582647243|FG005|Phase 2|Withdrawal by Subject|0|||
161344653|NCT03314935|582647244|FG006|Phase 2|Withdrawal by Subject|0|||
161344654|NCT03314935|582647245|FG007|Phase 2|Withdrawal by Subject|0|||
161344655|NCT03314935|582647246|FG008|Phase 2|Withdrawal by Subject|0|||
161344656|NCT03314935|582647247|FG009|Phase 2|Withdrawal by Subject|1|||
161344657|NCT03314935|582647248|FG010|Phase 2|Withdrawal by Subject|4|||
161344658|NCT03314935|582647249|FG011|Phase 2|Withdrawal by Subject|0|||
161344659|NCT03314935|582647250|FG012|Phase 2|Withdrawal by Subject|1|||
161344660|NCT03314935|582647251|FG013|Phase 2|Withdrawal by Subject|0|||
161344661|NCT03314935|582647252|FG014|Phase 2|Withdrawal by Subject|1|||
161344662|NCT03314935|582647238|FG000|Phase 2|Progressive Disease|0|||
161344663|NCT03314935|582647239|FG001|Phase 2|Progressive Disease|0|||
161344664|NCT03314935|582647240|FG002|Phase 2|Progressive Disease|0|||
161344665|NCT03314935|582647241|FG003|Phase 2|Progressive Disease|0|||
161344666|NCT03314935|582647242|FG004|Phase 2|Progressive Disease|0|||
161344667|NCT03314935|582647243|FG005|Phase 2|Progressive Disease|0|||
161344668|NCT03314935|582647244|FG006|Phase 2|Progressive Disease|0|||
161344669|NCT03314935|582647245|FG007|Phase 2|Progressive Disease|0|||
161344670|NCT03314935|582647246|FG008|Phase 2|Progressive Disease|0|||
161344671|NCT03314935|582647247|FG009|Phase 2|Progressive Disease|1|||
161344672|NCT03314935|582647248|FG010|Phase 2|Progressive Disease|1|||
161344673|NCT03314935|582647249|FG011|Phase 2|Progressive Disease|1|||
161344674|NCT03314935|582647250|FG012|Phase 2|Progressive Disease|2|||
161344675|NCT03314935|582647251|FG013|Phase 2|Progressive Disease|0|||
161344676|NCT03314935|582647252|FG014|Phase 2|Progressive Disease|1|||
161344677|NCT03314935|582647238|FG000|Phase 2|Study Terminated by Sponsor|0|||
161344678|NCT03314935|582647239|FG001|Phase 2|Study Terminated by Sponsor|0|||
161344679|NCT03314935|582647240|FG002|Phase 2|Study Terminated by Sponsor|0|||
161277993|NCT04238650|582396603|FG000|Overall Study|Withdrawal by Subject|0|||
161277994|NCT04238650|582396604|FG001|Overall Study|Withdrawal by Subject|1|||
161277995|NCT03348163|582396605|FG000|Overall Study|Withdrawal by Subject|2|||
161277996|NCT03348163|582396606|FG001|Overall Study|Withdrawal by Subject|0|||
161277997|NCT02585778|582396607|FG000|Overall Study|Adverse Event|17|||
161277998|NCT02585778|582396608|FG001|Overall Study|Adverse Event|4|||
161277999|NCT02585778|582396607|FG000|Overall Study|Participant did not wish to continue|9|||
161278000|NCT02585778|582396608|FG001|Overall Study|Participant did not wish to continue|4|||
161278001|NCT02585778|582396607|FG000|Overall Study|Poor compliance to study protocol|0|||
161344680|NCT03314935|582647241|FG003|Phase 2|Study Terminated by Sponsor|0|||
161344681|NCT03314935|582647242|FG004|Phase 2|Study Terminated by Sponsor|0|||
161344682|NCT03314935|582647243|FG005|Phase 2|Study Terminated by Sponsor|0|||
161344683|NCT03314935|582647244|FG006|Phase 2|Study Terminated by Sponsor|0|||
161344684|NCT03314935|582647245|FG007|Phase 2|Study Terminated by Sponsor|0|||
161032258|NCT03493542|581511156|FG000|Extension Study|Withdrawal by Subject|0|||
161278002|NCT02585778|582396608|FG001|Overall Study|Poor compliance to study protocol|2|||
161278003|NCT02585778|582396607|FG000|Overall Study|Death|0|||
161278004|NCT02585778|582396608|FG001|Overall Study|Death|1|||
161278005|NCT02585778|582396607|FG000|Overall Study|Randomized but not treated|1|||
161278006|NCT02585778|582396608|FG001|Overall Study|Randomized but not treated|2|||
161344685|NCT03314935|582647246|FG008|Phase 2|Study Terminated by Sponsor|0|||
161344686|NCT03314935|582647247|FG009|Phase 2|Study Terminated by Sponsor|0|||
161344687|NCT03314935|582647248|FG010|Phase 2|Study Terminated by Sponsor|7|||
161344688|NCT03314935|582647249|FG011|Phase 2|Study Terminated by Sponsor|2|||
161344689|NCT03314935|582647250|FG012|Phase 2|Study Terminated by Sponsor|1|||
161344690|NCT03314935|582647251|FG013|Phase 2|Study Terminated by Sponsor|4|||
161344691|NCT03314935|582647252|FG014|Phase 2|Study Terminated by Sponsor|4|||
161344692|NCT03314935|582647238|FG000|Phase 2|Lost to Follow-up|0|||
161344693|NCT03314935|582647239|FG001|Phase 2|Lost to Follow-up|0|||
161344694|NCT03314935|582647240|FG002|Phase 2|Lost to Follow-up|0|||
161278007|NCT02585778|582396607|FG000|Overall Study|Other than specified above|6|||
161344695|NCT03314935|582647241|FG003|Phase 2|Lost to Follow-up|0|||
161344696|NCT03314935|582647242|FG004|Phase 2|Lost to Follow-up|0|||
161344697|NCT03314935|582647243|FG005|Phase 2|Lost to Follow-up|0|||
161032259|NCT03493542|581511157|FG001|Extension Study|Withdrawal by Subject|0|||
161032260|NCT03493542|581511158|FG002|Extension Study|Withdrawal by Subject|25|||
161032261|NCT01651000|581511162|FG000|Overall Study|Adverse Event|2|||
161032262|NCT01651000|581511163|FG001|Overall Study|Adverse Event|8|||
161032263|NCT01651000|581511162|FG000|Overall Study|Lost to Follow-up|3|||
161032264|NCT01651000|581511163|FG001|Overall Study|Lost to Follow-up|2|||
161032265|NCT01651000|581511162|FG000|Overall Study|Protocol Violation|0|||
161032266|NCT01651000|581511163|FG001|Overall Study|Protocol Violation|3|||
161032267|NCT01651000|581511162|FG000|Overall Study|Withdrawal by Subject|2|||
161032268|NCT01651000|581511163|FG001|Overall Study|Withdrawal by Subject|10|||
161032269|NCT01651000|581511162|FG000|Overall Study|Subject noncompliance|0|||
161032270|NCT01651000|581511163|FG001|Overall Study|Subject noncompliance|3|||
161032271|NCT01651000|581511162|FG000|Overall Study|Lack of Efficacy|1|||
161032272|NCT01651000|581511163|FG001|Overall Study|Lack of Efficacy|1|||
161032273|NCT01651000|581511162|FG000|Overall Study|Physician Decision|1|||
161032274|NCT01651000|581511163|FG001|Overall Study|Physician Decision|0|||
161032275|NCT01651000|581511162|FG000|Overall Study|Administrative reason|1|||
161032276|NCT01651000|581511163|FG001|Overall Study|Administrative reason|0|||
161032277|NCT01651000|581511162|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
161032278|NCT01651000|581511163|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
161032279|NCT05132400|581511804|FG000|Overall Study|Withdrawal by Subject|14|||
161032280|NCT05132400|581511805|FG001|Overall Study|Withdrawal by Subject|8|||
161032281|NCT05132400|581511804|FG000|Overall Study|Lost to Follow-up|132|||
161032282|NCT05132400|581511805|FG001|Overall Study|Lost to Follow-up|121|||
161032283|NCT03934931|581511806|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
161032284|NCT03934931|581511807|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
161032285|NCT03934931|581511808|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
161032286|NCT03635567|581511811|FG000|Overall Study|Lost to Follow-up|4|||
161032287|NCT03635567|581511812|FG001|Overall Study|Lost to Follow-up|1|||
161032288|NCT03635567|581511811|FG000|Overall Study|Withdrawal by Subject|11|||
161032289|NCT03635567|581511812|FG001|Overall Study|Withdrawal by Subject|16|||
161032290|NCT03635567|581511811|FG000|Overall Study|Sponsor Decision|99|||
161032291|NCT03635567|581511812|FG001|Overall Study|Sponsor Decision|57|||
161032292|NCT03635567|581511811|FG000|Overall Study|Death|194|||
161032293|NCT03635567|581511812|FG001|Overall Study|Death|235|||
161032294|NCT00739908|581511813|FG000|Overall Study|Adverse Event|5|||
161032295|NCT00739908|581511814|FG001|Overall Study|Adverse Event|6|||
161032296|NCT00739908|581511813|FG000|Overall Study|Withdrawal by Subject|4|||
161032297|NCT00739908|581511814|FG001|Overall Study|Withdrawal by Subject|2|||
161032298|NCT00739908|581511813|FG000|Overall Study|Lost to Follow-up|14|||
161032299|NCT00739908|581511814|FG001|Overall Study|Lost to Follow-up|9|||
161032300|NCT00739908|581511813|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
161032301|NCT00739908|581511814|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
161032302|NCT00739908|581511813|FG000|Overall Study|Non-Compliance With Study Medication|0|||
161032303|NCT00739908|581511814|FG001|Overall Study|Non-Compliance With Study Medication|3|||
161032304|NCT00739908|581511813|FG000|Overall Study|Lack of Efficacy|0|||
161032305|NCT00739908|581511814|FG001|Overall Study|Lack of Efficacy|1|||
161032306|NCT00739908|581511813|FG000|Overall Study|Relocation|0|||
161032307|NCT00739908|581511814|FG001|Overall Study|Relocation|1|||
161032308|NCT02076009|581511815|FG000|Overall Study|Death|172|||
161032309|NCT02076009|581511816|FG001|Overall Study|Death|153|||
161032310|NCT02076009|581511815|FG000|Overall Study|Withdrawal by Subject|16|||
161032311|NCT02076009|581511816|FG001|Overall Study|Withdrawal by Subject|12|||
161032312|NCT02076009|581511815|FG000|Overall Study|Lost to Follow-up|4|||
161032313|NCT02076009|581511816|FG001|Overall Study|Lost to Follow-up|2|||
161032314|NCT02076009|581511815|FG000|Overall Study|Progressive Disease|1|||
161032315|NCT02076009|581511816|FG001|Overall Study|Progressive Disease|0|||
161032316|NCT02076009|581511815|FG000|Overall Study|Physician Decision|0|||
161032317|NCT02076009|581511816|FG001|Overall Study|Physician Decision|1|||
161032318|NCT02076009|581511815|FG000|Overall Study|End of data collection|90|||
161032319|NCT02076009|581511816|FG001|Overall Study|End of data collection|118|||
161032320|NCT03786926|581511819|FG000|Overall Study|Adverse Event|0|||
161032321|NCT03786926|581511820|FG001|Overall Study|Adverse Event|0|||
161032322|NCT03786926|581511821|FG002|Overall Study|Adverse Event|0|||
161032323|NCT03786926|581511822|FG003|Overall Study|Adverse Event|0|||
161032324|NCT03786926|581511823|FG004|Overall Study|Adverse Event|0|||
161032325|NCT03786926|581511824|FG005|Overall Study|Adverse Event|0|||
161032326|NCT03786926|581511825|FG006|Overall Study|Adverse Event|0|||
161032327|NCT03786926|581511826|FG007|Overall Study|Adverse Event|1|||
161032328|NCT03786926|581511827|FG008|Overall Study|Adverse Event|1|||
161032329|NCT03786926|581511828|FG009|Overall Study|Adverse Event|0|||
161032330|NCT03786926|581511829|FG010|Overall Study|Adverse Event|1|||
161032331|NCT03786926|581511819|FG000|Overall Study|Progressive disease|3|||
161032332|NCT03786926|581511820|FG001|Overall Study|Progressive disease|0|||
161032333|NCT03786926|581511821|FG002|Overall Study|Progressive disease|3|||
161032334|NCT03786926|581511822|FG003|Overall Study|Progressive disease|1|||
161032335|NCT03786926|581511823|FG004|Overall Study|Progressive disease|2|||
161032336|NCT03786926|581511824|FG005|Overall Study|Progressive disease|2|||
161032337|NCT03786926|581511825|FG006|Overall Study|Progressive disease|1|||
161032338|NCT03786926|581511826|FG007|Overall Study|Progressive disease|6|||
161032339|NCT03786926|581511827|FG008|Overall Study|Progressive disease|1|||
161032340|NCT03786926|581511828|FG009|Overall Study|Progressive disease|1|||
161032341|NCT03786926|581511829|FG010|Overall Study|Progressive disease|1|||
161032342|NCT03786926|581511819|FG000|Overall Study|Death|0|||
161032343|NCT03786926|581511820|FG001|Overall Study|Death|1|||
161032344|NCT03786926|581511821|FG002|Overall Study|Death|1|||
161032345|NCT03786926|581511822|FG003|Overall Study|Death|0|||
161032346|NCT03786926|581511823|FG004|Overall Study|Death|0|||
161032347|NCT03786926|581511824|FG005|Overall Study|Death|0|||
161032348|NCT03786926|581511825|FG006|Overall Study|Death|0|||
161032349|NCT03786926|581511826|FG007|Overall Study|Death|0|||
161032350|NCT03786926|581511827|FG008|Overall Study|Death|0|||
161032351|NCT03786926|581511828|FG009|Overall Study|Death|1|||
161032352|NCT03786926|581511829|FG010|Overall Study|Death|2|||
161032353|NCT03786926|581511819|FG000|Overall Study|Physician Decision|0|||
161032354|NCT03786926|581511820|FG001|Overall Study|Physician Decision|1|||
161032355|NCT03786926|581511821|FG002|Overall Study|Physician Decision|0|||
161032356|NCT03786926|581511822|FG003|Overall Study|Physician Decision|1|||
161032357|NCT03786926|581511823|FG004|Overall Study|Physician Decision|2|||
161032358|NCT03786926|581511824|FG005|Overall Study|Physician Decision|0|||
161032359|NCT03786926|581511825|FG006|Overall Study|Physician Decision|0|||
161032360|NCT03786926|581511826|FG007|Overall Study|Physician Decision|2|||
161032361|NCT03786926|581511827|FG008|Overall Study|Physician Decision|1|||
161032362|NCT03786926|581511828|FG009|Overall Study|Physician Decision|1|||
161032363|NCT03786926|581511829|FG010|Overall Study|Physician Decision|0|||
161032364|NCT03786926|581511819|FG000|Overall Study|Withdrawal by Subject|0|||
161032365|NCT03786926|581511820|FG001|Overall Study|Withdrawal by Subject|1|||
161032366|NCT03786926|581511821|FG002|Overall Study|Withdrawal by Subject|1|||
161032367|NCT03786926|581511822|FG003|Overall Study|Withdrawal by Subject|0|||
161032368|NCT03786926|581511823|FG004|Overall Study|Withdrawal by Subject|0|||
161032369|NCT03786926|581511824|FG005|Overall Study|Withdrawal by Subject|0|||
161032370|NCT03786926|581511825|FG006|Overall Study|Withdrawal by Subject|1|||
161032371|NCT03786926|581511826|FG007|Overall Study|Withdrawal by Subject|0|||
161032372|NCT03786926|581511827|FG008|Overall Study|Withdrawal by Subject|1|||
161032373|NCT03786926|581511828|FG009|Overall Study|Withdrawal by Subject|0|||
161032374|NCT03786926|581511829|FG010|Overall Study|Withdrawal by Subject|1|||
161032375|NCT03786926|581511819|FG000|Overall Study|Study terminated by Sponsor|0|||
161032376|NCT03786926|581511820|FG001|Overall Study|Study terminated by Sponsor|0|||
161032377|NCT03786926|581511821|FG002|Overall Study|Study terminated by Sponsor|0|||
161032378|NCT03786926|581511822|FG003|Overall Study|Study terminated by Sponsor|0|||
161032379|NCT03786926|581511823|FG004|Overall Study|Study terminated by Sponsor|1|||
161032380|NCT03786926|581511824|FG005|Overall Study|Study terminated by Sponsor|0|||
161032381|NCT03786926|581511825|FG006|Overall Study|Study terminated by Sponsor|0|||
161032382|NCT03786926|581511826|FG007|Overall Study|Study terminated by Sponsor|4|||
161032383|NCT03786926|581511827|FG008|Overall Study|Study terminated by Sponsor|0|||
161032384|NCT03786926|581511828|FG009|Overall Study|Study terminated by Sponsor|0|||
161032385|NCT03786926|581511829|FG010|Overall Study|Study terminated by Sponsor|0|||
161032386|NCT03786926|581511819|FG000|Overall Study|Anti-neoplasm treatment|0|||
161032387|NCT03786926|581511820|FG001|Overall Study|Anti-neoplasm treatment|0|||
161032388|NCT03786926|581511821|FG002|Overall Study|Anti-neoplasm treatment|0|||
161032389|NCT03786926|581511822|FG003|Overall Study|Anti-neoplasm treatment|0|||
161032390|NCT03786926|581511823|FG004|Overall Study|Anti-neoplasm treatment|1|||
161032391|NCT03786926|581511824|FG005|Overall Study|Anti-neoplasm treatment|0|||
161032392|NCT03786926|581511825|FG006|Overall Study|Anti-neoplasm treatment|1|||
161278008|NCT02585778|582396608|FG001|Overall Study|Other than specified above|2|||
161278009|NCT03682107|582396609|FG000|Overall Study|Withdrawal by Subject|0|||
161278010|NCT03682107|582396610|FG001|Overall Study|Withdrawal by Subject|1|||
161278011|NCT03682107|582396611|FG002|Overall Study|Withdrawal by Subject|0|||
161278012|NCT03682107|582396612|FG003|Overall Study|Withdrawal by Subject|0|||
161278013|NCT03682107|582396613|FG004|Overall Study|Withdrawal by Subject|0|||
161278014|NCT05211726|582396614|FG000|Overall Study|Withdrawal by Subject|2|||
161032393|NCT03786926|581511826|FG007|Overall Study|Anti-neoplasm treatment|0|||
161032394|NCT03786926|581511827|FG008|Overall Study|Anti-neoplasm treatment|0|||
161032395|NCT03786926|581511828|FG009|Overall Study|Anti-neoplasm treatment|0|||
161278015|NCT05211726|582396615|FG001|Overall Study|Withdrawal by Subject|3|||
161032396|NCT03786926|581511829|FG010|Overall Study|Anti-neoplasm treatment|0|||
161032397|NCT03786926|581511819|FG000|Overall Study|Other|0|||
161032398|NCT03786926|581511820|FG001|Overall Study|Other|0|||
161032399|NCT03786926|581511821|FG002|Overall Study|Other|0|||
161032400|NCT03786926|581511822|FG003|Overall Study|Other|1|||
161032401|NCT03786926|581511823|FG004|Overall Study|Other|0|||
161032402|NCT03786926|581511824|FG005|Overall Study|Other|1|||
161278016|NCT05211726|582396614|FG000|Overall Study|Protocol Violation|0|||
161032403|NCT03786926|581511825|FG006|Overall Study|Other|0|||
161032404|NCT03786926|581511826|FG007|Overall Study|Other|0|||
161032405|NCT03786926|581511827|FG008|Overall Study|Other|2|||
161032406|NCT03786926|581511828|FG009|Overall Study|Other|0|||
161032407|NCT03786926|581511829|FG010|Overall Study|Other|0|||
161278017|NCT05211726|582396615|FG001|Overall Study|Protocol Violation|1|||
161278018|NCT01038297|582396616|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
161278019|NCT01038297|582396617|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
161278020|NCT01038297|582396618|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
161278021|NCT02714426|582396621|FG000|Overall Study|Withdrawal by Subject|2|||
161278022|NCT02714426|582396622|FG001|Overall Study|Withdrawal by Subject|2|||
161278023|NCT00908310|582396628|FG000|Overall Study|Death|37|||
161278024|NCT00908310|582396628|FG000|Overall Study|Withdrawal by Subject|7|||
161278025|NCT00908310|582396628|FG000|Overall Study|Lost to Follow-up|7|||
161278026|NCT00908310|582396628|FG000|Overall Study|Screening failure|5|||
161278027|NCT00908310|582396628|FG000|Overall Study|Other reasons|4|||
161278028|NCT00725205|582396631|FG000|Overall Study|Adverse Event|22|||
161278029|NCT00725205|582396631|FG000|Overall Study|Investigator Discontinued|1|||
161278030|NCT00725205|582396631|FG000|Overall Study|Non-compliance With Protocol|14|||
161278031|NCT00725205|582396631|FG000|Overall Study|Other|8|||
161278032|NCT00725205|582396631|FG000|Overall Study|Protocol Defined Clinical Event|1|||
161278033|NCT00725205|582396631|FG000|Overall Study|Treatment Failure|41|||
161278034|NCT02212379|582396635|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
161278035|NCT02212379|582396635|FG000|From Baseline to Week 48|Adverse Event|7|||
161278036|NCT02212379|582396635|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
161278037|NCT02212379|582396635|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
161278038|NCT02212379|582396635|FG000|From Week 48 to Week 96|Adverse Event|1|||
161278039|NCT02212379|582396635|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
161278040|NCT03462459|582396637|FG000|Overall Study|Death|1|||
161278041|NCT03462459|582396638|FG001|Overall Study|Death|0|||
161278042|NCT03462459|582396637|FG000|Overall Study|Lack of Efficacy|2|||
161278043|NCT03462459|582396638|FG001|Overall Study|Lack of Efficacy|4|||
161278044|NCT03462459|582396637|FG000|Overall Study|Lost to Follow-up|1|||
161278045|NCT03462459|582396638|FG001|Overall Study|Lost to Follow-up|3|||
161278046|NCT03462459|582396637|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
161278047|NCT03462459|582396638|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
161278048|NCT03462459|582396637|FG000|Overall Study|Withdrawal by Subject|3|||
161278049|NCT03462459|582396638|FG001|Overall Study|Withdrawal by Subject|2|||
161278050|NCT03462459|582396637|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
161278051|NCT03462459|582396638|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
161278052|NCT01243775|582396639|FG000|Overall Study|Withdrawal by Subject|2|||
161278053|NCT01177059|582396640|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
161278054|NCT01177059|582396640|FG000|Overall Study|Withdrew consent|2|||
161278055|NCT01177059|582396640|FG000|Overall Study|Lost to Follow-up|18|||
161278056|NCT04051619|582396641|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
161278057|NCT04051619|582396642|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
161278058|NCT04051619|582396641|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
161278059|NCT04051619|582396642|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
161032408|NCT05988398|581511833|FG000|Overall Study|Lack of time|21|||
161032409|NCT05988398|581511834|FG001|Overall Study|Lack of time|0|||
161032410|NCT05988398|581511833|FG000|Overall Study|Absent from school|0|||
161032411|NCT05988398|581511834|FG001|Overall Study|Absent from school|38|||
161032412|NCT05988398|581511833|FG000|Overall Study|Chose not to participate|0|||
161032413|NCT05988398|581511834|FG001|Overall Study|Chose not to participate|42|||
161032414|NCT05988398|581511833|FG000|Overall Study|Other commitments (e.g., sports)|0|||
161032415|NCT05988398|581511834|FG001|Overall Study|Other commitments (e.g., sports)|25|||
161032416|NCT00942734|581511836|FG000|Overall Study|Adverse Event|2|||
161032417|NCT00942734|581511836|FG000|Overall Study|Protocol Violation|3|||
161032418|NCT00942734|581511836|FG000|Overall Study|Disease Progression|2|||
161032419|NCT00942734|581511836|FG000|Overall Study|Physician Decision|1|||
161032420|NCT05147584|581511837|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
161032421|NCT02163694|581511843|FG000|Overall Study|Adverse event- related to progression|4|||
161278060|NCT05938621|582398362|FG000|Overall Study|Lost to Follow-up|1|||
161032422|NCT02163694|581511844|FG001|Overall Study|Adverse event- related to progression|10|||
161278061|NCT05938621|582398363|FG001|Overall Study|Lost to Follow-up|5|||
161278062|NCT05938621|582398364|FG002|Overall Study|Lost to Follow-up|2|||
161278063|NCT05938621|582398365|FG003|Overall Study|Lost to Follow-up|2|||
161278064|NCT03922529|582398370|FG000|Overall Study|Withdrawal by Subject|13|||
161278065|NCT03922529|582398371|FG001|Overall Study|Withdrawal by Subject|12|||
161278066|NCT03922529|582398370|FG000|Overall Study|Death|7|||
161278067|NCT03922529|582398371|FG001|Overall Study|Death|12|||
161278068|NCT03922529|582398370|FG000|Overall Study|Lost to Follow-up|12|||
161032423|NCT02163694|581511843|FG000|Overall Study|Adverse event- not related to progression|7|||
161032424|NCT02163694|581511844|FG001|Overall Study|Adverse event- not related to progression|22|||
161278069|NCT03922529|582398371|FG001|Overall Study|Lost to Follow-up|19|||
161278070|NCT03922529|582398370|FG000|Overall Study|Adverse Event|1|||
161278071|NCT03922529|582398371|FG001|Overall Study|Adverse Event|0|||
161278072|NCT03922529|582398370|FG000|Overall Study|Death after withdrawal|1|||
161278073|NCT03922529|582398371|FG001|Overall Study|Death after withdrawal|0|||
161344698|NCT03314935|582647244|FG006|Phase 2|Lost to Follow-up|0|||
161032425|NCT02163694|581511843|FG000|Overall Study|Withdrew consent|13|||
161278074|NCT03922529|582398370|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
161278075|NCT03922529|582398371|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
161278076|NCT03922529|582398370|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
161278077|NCT03922529|582398371|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
161278078|NCT02731638|582398372|FG000|Overall Study|Lost to Follow-up|6|||
161278079|NCT02731638|582398373|FG001|Overall Study|Lost to Follow-up|9|||
161278080|NCT04158245|582398374|FG000|Overall Study|Lost to Follow-up|1|||
161278081|NCT01275729|582398375|FG000|Overall Study|Death|3|||
161278082|NCT01275729|582398375|FG000|Overall Study|Withdrawal by Subject|1|||
161278083|NCT00447876|582398378|FG000|Overall Study|Withdrawal by Subject|1|||
161278084|NCT00447876|582398379|FG001|Overall Study|Withdrawal by Subject|4|||
161278085|NCT00447876|582398378|FG000|Overall Study|Lost to Follow-up|1|||
161278086|NCT00447876|582398379|FG001|Overall Study|Lost to Follow-up|0|||
161278087|NCT00447876|582398378|FG000|Overall Study|Deterioration of symptomology|1|||
161278088|NCT00447876|582398379|FG001|Overall Study|Deterioration of symptomology|0|||
161278089|NCT04172597|582398380|FG000|Overall Study|Disease Progression|0|||
161278090|NCT04172597|582398381|FG001|Overall Study|Disease Progression|0|||
161278091|NCT04172597|582398382|FG002|Overall Study|Disease Progression|0|||
161278092|NCT04172597|582398383|FG003|Overall Study|Disease Progression|0|||
161278093|NCT04172597|582398384|FG004|Overall Study|Disease Progression|1|||
161278094|NCT02952586|582398388|FG000|Lead-In Phase (7 Days)|Death|0|||
161278095|NCT02952586|582398389|FG001|Lead-In Phase (7 Days)|Death|1|||
161278096|NCT02952586|582398388|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
161278097|NCT02952586|582398389|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
161278098|NCT02952586|582398388|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
161278099|NCT02952586|582398389|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
161032426|NCT02163694|581511844|FG001|Overall Study|Withdrew consent|28|||
161032427|NCT02163694|581511843|FG000|Overall Study|Lost to Follow-up|2|||
161032428|NCT02163694|581511844|FG001|Overall Study|Lost to Follow-up|2|||
161032429|NCT02163694|581511843|FG000|Overall Study|Sponsor discontinued study|3|||
161032430|NCT02163694|581511844|FG001|Overall Study|Sponsor discontinued study|29|||
161032431|NCT02163694|581511843|FG000|Overall Study|Progressive disease per protocol|125|||
161032432|NCT02163694|581511844|FG001|Overall Study|Progressive disease per protocol|224|||
161032433|NCT02163694|581511843|FG000|Overall Study|Other, not specified|17|||
161032434|NCT02163694|581511844|FG001|Overall Study|Other, not specified|22|||
161032435|NCT02163694|581511843|FG000|Overall Study|Randomized but Not Treated|1|||
161032436|NCT02163694|581511844|FG001|Overall Study|Randomized but Not Treated|0|||
161032437|NCT02163694|581511843|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
161032438|NCT02163694|581511844|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
161032439|NCT03370913|581511845|FG000|Overall Study|Death|1|||
161032440|NCT03370913|581511845|FG000|Overall Study|Lost to Follow-up|1|||
161032441|NCT04560179|581511848|FG000|Overall Study|Physician Decision|1|||
161032442|NCT04560179|581511849|FG001|Overall Study|Physician Decision|0|||
161032443|NCT04560179|581511850|FG002|Overall Study|Physician Decision|0|||
161032444|NCT04560179|581511851|FG003|Overall Study|Physician Decision|0|||
161278100|NCT02952586|582398388|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
161278101|NCT02952586|582398389|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
161278102|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
160976234|NCT01461993|581302267|FG001|Overall Study|Withdrawal by Subject|53|||
161278103|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
161278104|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
161278105|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
161278106|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
161278107|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
161319375|NCT00496587|582555292|FG000|Overall Study|Complications unrelated|2|||
161319376|NCT00482170|582555294|FG000|Overall Study|Adverse Event|5|||
161319377|NCT00482170|582555295|FG001|Overall Study|Adverse Event|14|||
161319378|NCT00482170|582555294|FG000|Overall Study|Withdrawal by Subject|6|||
160976235|NCT01461993|581302268|FG002|Overall Study|Withdrawal by Subject|16|||
161319379|NCT00482170|582555295|FG001|Overall Study|Withdrawal by Subject|1|||
161319380|NCT00482170|582555294|FG000|Overall Study|Protocol Violation|2|||
160976236|NCT01461993|581302266|FG000|Overall Study|Lost to Follow-up|44|||
160976237|NCT01461993|581302267|FG001|Overall Study|Lost to Follow-up|48|||
160976238|NCT01461993|581302268|FG002|Overall Study|Lost to Follow-up|22|||
160976239|NCT01461993|581302266|FG000|Overall Study|Protocol Violation|10|||
160976240|NCT01461993|581302267|FG001|Overall Study|Protocol Violation|9|||
160976241|NCT01461993|581302268|FG002|Overall Study|Protocol Violation|7|||
161319381|NCT00482170|582555295|FG001|Overall Study|Protocol Violation|3|||
161319382|NCT00482170|582555294|FG000|Overall Study|Lost to Follow-up|2|||
161319383|NCT00482170|582555295|FG001|Overall Study|Lost to Follow-up|0|||
161319384|NCT00482170|582555294|FG000|Overall Study|Unspecified reason|0|||
161319385|NCT00482170|582555295|FG001|Overall Study|Unspecified reason|2|||
161344699|NCT03314935|582647245|FG007|Phase 2|Lost to Follow-up|0|||
161344700|NCT03314935|582647246|FG008|Phase 2|Lost to Follow-up|0|||
161344701|NCT03314935|582647247|FG009|Phase 2|Lost to Follow-up|1|||
161344702|NCT03314935|582647248|FG010|Phase 2|Lost to Follow-up|0|||
161344703|NCT03314935|582647249|FG011|Phase 2|Lost to Follow-up|0|||
161344704|NCT03314935|582647250|FG012|Phase 2|Lost to Follow-up|0|||
161344705|NCT03314935|582647251|FG013|Phase 2|Lost to Follow-up|0|||
161344706|NCT03314935|582647252|FG014|Phase 2|Lost to Follow-up|1|||
161344707|NCT03314935|582647238|FG000|Phase 2|Physician Decision|0|||
161344708|NCT03314935|582647239|FG001|Phase 2|Physician Decision|0|||
161344709|NCT03314935|582647240|FG002|Phase 2|Physician Decision|0|||
161344710|NCT03314935|582647241|FG003|Phase 2|Physician Decision|0|||
161344711|NCT03314935|582647242|FG004|Phase 2|Physician Decision|0|||
161344712|NCT03314935|582647243|FG005|Phase 2|Physician Decision|0|||
161344713|NCT03314935|582647244|FG006|Phase 2|Physician Decision|0|||
161344714|NCT03314935|582647245|FG007|Phase 2|Physician Decision|0|||
161344715|NCT03314935|582647246|FG008|Phase 2|Physician Decision|0|||
161344716|NCT03314935|582647247|FG009|Phase 2|Physician Decision|0|||
161344717|NCT03314935|582647248|FG010|Phase 2|Physician Decision|1|||
161344718|NCT03314935|582647249|FG011|Phase 2|Physician Decision|0|||
161344719|NCT03314935|582647250|FG012|Phase 2|Physician Decision|0|||
161344720|NCT03314935|582647251|FG013|Phase 2|Physician Decision|0|||
161344721|NCT03314935|582647252|FG014|Phase 2|Physician Decision|0|||
161344722|NCT05252702|582647253|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
161344723|NCT05252702|582647253|FG000|Overall Study|Death|16|||
161344724|NCT05252702|582647253|FG000|Overall Study|System explant|5|||
161344725|NCT05252702|582647253|FG000|Overall Study|Lost to Follow-up|1|||
161344726|NCT05252702|582647253|FG000|Overall Study|Withdrawn by investigator|1|||
161344727|NCT05252702|582647253|FG000|Overall Study|Visit not due|306|||
161344728|NCT05252702|582647253|FG000|Overall Study|Visit within window but not completed|92|||
161344729|NCT05252702|582647253|FG000|Overall Study|Unsuccessful implant|1|||
161344730|NCT04153864|582647254|FG000|Overall Study|Withdrawal by Subject|21|||
161344731|NCT04153864|582647255|FG001|Overall Study|Withdrawal by Subject|7|||
161344732|NCT04153864|582647256|FG002|Overall Study|Withdrawal by Subject|23|||
161344733|NCT04153864|582647257|FG003|Overall Study|Withdrawal by Subject|2|||
161344734|NCT04153864|582647254|FG000|Overall Study|Lost to Follow-up|4|||
161344735|NCT04153864|582647255|FG001|Overall Study|Lost to Follow-up|0|||
161344736|NCT04153864|582647256|FG002|Overall Study|Lost to Follow-up|3|||
161344737|NCT04153864|582647257|FG003|Overall Study|Lost to Follow-up|0|||
161344738|NCT04153864|582647254|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
161344739|NCT04153864|582647255|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
161344740|NCT04153864|582647256|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
160976242|NCT01461993|581302266|FG000|Overall Study|Adverse Event|9|||
160976243|NCT01461993|581302267|FG001|Overall Study|Adverse Event|11|||
160976244|NCT01461993|581302268|FG002|Overall Study|Adverse Event|3|||
160976245|NCT01461993|581302266|FG000|Overall Study|No longer met eligibility criteria|13|||
160976246|NCT01461993|581302267|FG001|Overall Study|No longer met eligibility criteria|18|||
160976247|NCT01461993|581302268|FG002|Overall Study|No longer met eligibility criteria|10|||
160976248|NCT01461993|581302266|FG000|Overall Study|Did not meet entrance criteria|2|||
160976249|NCT01461993|581302267|FG001|Overall Study|Did not meet entrance criteria|3|||
160976250|NCT01461993|581302268|FG002|Overall Study|Did not meet entrance criteria|0|||
160976251|NCT01461993|581302266|FG000|Overall Study|Other|13|||
160976252|NCT01461993|581302267|FG001|Overall Study|Other|15|||
160976253|NCT01461993|581302268|FG002|Overall Study|Other|6|||
160976254|NCT01121484|581302270|FG000|Overall Study|Adverse Event|12|||
160976255|NCT01121484|581302271|FG001|Overall Study|Adverse Event|5|||
160976256|NCT01121484|581302270|FG000|Overall Study|Lack of Efficacy|3|||
160976257|NCT01121484|581302271|FG001|Overall Study|Lack of Efficacy|11|||
160976258|NCT01121484|581302270|FG000|Overall Study|Lost to Follow-up|5|||
160976259|NCT01121484|581302271|FG001|Overall Study|Lost to Follow-up|9|||
160976260|NCT01121484|581302270|FG000|Overall Study|Physician Decision|0|||
160976261|NCT01121484|581302271|FG001|Overall Study|Physician Decision|3|||
160976262|NCT01121484|581302270|FG000|Overall Study|Protocol Violation|1|||
160976263|NCT01121484|581302271|FG001|Overall Study|Protocol Violation|0|||
160976264|NCT01121484|581302270|FG000|Overall Study|Withdrawal by Subject|8|||
160976265|NCT01121484|581302271|FG001|Overall Study|Withdrawal by Subject|7|||
160976266|NCT01121484|581302270|FG000|Overall Study|Discontinuation of study by sponsor|0|||
160976267|NCT01121484|581302271|FG001|Overall Study|Discontinuation of study by sponsor|1|||
160976268|NCT01121484|581302270|FG000|Overall Study|Other|3|||
160976269|NCT01121484|581302271|FG001|Overall Study|Other|3|||
160976270|NCT01121484|581302270|FG000|Overall Study|Randomized, not treated|1|||
160976271|NCT01121484|581302271|FG001|Overall Study|Randomized, not treated|4|||
160976272|NCT06390826|581302272|FG000|Overall Study|Never Start Protocol Therapy|1|||
160976273|NCT06390826|581302272|FG000|Overall Study|Adverse Event|1|||
160976274|NCT06390826|581302272|FG000|Overall Study|Disease Progression|8|||
160976275|NCT05229653|581302273|FG000|Overall Study|Lost to Follow-up|1|||
161344741|NCT04153864|582647257|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
161032445|NCT04560179|581511852|FG004|Overall Study|Physician Decision|0|||
161032446|NCT04560179|581511848|FG000|Overall Study|Adverse Event|0|||
161032447|NCT04560179|581511849|FG001|Overall Study|Adverse Event|0|||
161032448|NCT04560179|581511850|FG002|Overall Study|Adverse Event|0|||
161032449|NCT04560179|581511851|FG003|Overall Study|Adverse Event|1|||
161032450|NCT04560179|581511852|FG004|Overall Study|Adverse Event|0|||
161032451|NCT05454514|581511853|FG000|Overall Study|Withdrawal by Subject|4|||
161032452|NCT02624050|581511854|FG000|Overall Study|Physician Decision|4|||
161032453|NCT02624050|581511855|FG001|Overall Study|Physician Decision|0|||
161278108|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
161278109|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
161278110|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
161278111|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
161278112|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
161278113|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
161278114|NCT02952586|582398388|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
161278115|NCT02952586|582398389|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
161278116|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Death|3|||
161278117|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Death|8|||
161278118|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
161278119|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
161278120|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
161278121|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
161278122|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
161278123|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
161278124|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
161278125|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
161278126|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
161032454|NCT02624050|581511854|FG000|Overall Study|Protocol Violation|2|||
161032455|NCT02624050|581511855|FG001|Overall Study|Protocol Violation|0|||
161032456|NCT04795245|581511856|FG000|Overall Study|Unkown reason|7|||
161032457|NCT04795245|581511856|FG000|Overall Study|Death|17|||
161032458|NCT04795245|581511856|FG000|Overall Study|Other than listed|19|||
161032459|NCT04795245|581511856|FG000|Overall Study|Adverse Event|143|||
161032460|NCT04795245|581511856|FG000|Overall Study|Progressive disease|512|||
161032461|NCT04795245|581511856|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
161032462|NCT01756300|581511857|FG000|Overall Study|Death|1|||
161032463|NCT01756300|581511857|FG000|Overall Study|Withdrawal by Subject|1|||
161032464|NCT03734029|581511858|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
161032465|NCT03734029|581511859|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
161032466|NCT03734029|581511858|FG000|Overall Study|Adverse Event|60|||
161032467|NCT03734029|581511859|FG001|Overall Study|Adverse Event|14|||
161032468|NCT03734029|581511858|FG000|Overall Study|Withdrawal by Subject|12|||
161032469|NCT03734029|581511859|FG001|Overall Study|Withdrawal by Subject|11|||
161032470|NCT03734029|581511858|FG000|Overall Study|Clinical progression by investigator|10|||
161032471|NCT03734029|581511859|FG001|Overall Study|Clinical progression by investigator|8|||
161032472|NCT03734029|581511858|FG000|Overall Study|Death|5|||
161032473|NCT03734029|581511859|FG001|Overall Study|Death|2|||
161032474|NCT03734029|581511858|FG000|Overall Study|Physician Decision|4|||
161032475|NCT03734029|581511859|FG001|Overall Study|Physician Decision|3|||
161032476|NCT03734029|581511858|FG000|Overall Study|Other|2|||
161032477|NCT03734029|581511859|FG001|Overall Study|Other|0|||
161032478|NCT03734029|581511858|FG000|Overall Study|Lost to Follow-up|0|||
161032479|NCT03734029|581511859|FG001|Overall Study|Lost to Follow-up|1|||
161032480|NCT03734029|581511858|FG000|Overall Study|Randomized, but not treated|2|||
161032481|NCT03734029|581511859|FG001|Overall Study|Randomized, but not treated|12|||
161032482|NCT04595331|581512571|FG000|Overall Study|Withdrawal by Subject|0|||
161032483|NCT04595331|581512572|FG001|Overall Study|Withdrawal by Subject|1|||
161032484|NCT04595331|581512571|FG000|Overall Study|Lost to Follow-up|0|||
161032485|NCT04595331|581512572|FG001|Overall Study|Lost to Follow-up|5|||
161278127|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
161278128|NCT02952586|582398388|FG000|CRT for Cisplatin (63 Days)|Other|1|||
161278129|NCT02952586|582398389|FG001|CRT for Cisplatin (63 Days)|Other|1|||
161278130|NCT02952586|582398388|FG000|CRT for IMRT (63 Days)|Death|5|||
161278131|NCT02952586|582398389|FG001|CRT for IMRT (63 Days)|Death|8|||
161032486|NCT04595331|581512571|FG000|Overall Study|Medical reason|0|||
161032487|NCT04595331|581512572|FG001|Overall Study|Medical reason|1|||
161032488|NCT02611687|581512577|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
161032489|NCT02611687|581512578|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
161032490|NCT02075554|581512579|FG000|Overall Study|Lost to Follow-up|7|||
161032491|NCT02075554|581512579|FG000|Overall Study|Withdrawal by Subject|5|||
161032492|NCT02075554|581512579|FG000|Overall Study|Physician Decision|3|||
161032493|NCT04933474|581512585|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
161278132|NCT02952586|582398388|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
161032494|NCT04933474|581512586|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
161032495|NCT04933474|581512585|FG000|Overall Study|Lost to Follow-up|19|||
161032496|NCT04933474|581512586|FG001|Overall Study|Lost to Follow-up|9|||
161032497|NCT04933474|581512585|FG000|Overall Study|Life Burden - unable to participate|6|||
161032498|NCT04933474|581512586|FG001|Overall Study|Life Burden - unable to participate|2|||
161032499|NCT04933474|581512585|FG000|Overall Study|Disease Burden - unable to participate|4|||
161032500|NCT04933474|581512586|FG001|Overall Study|Disease Burden - unable to participate|1|||
161032501|NCT04933474|581512585|FG000|Overall Study|Surgery/Hospitalization|1|||
161032502|NCT04933474|581512586|FG001|Overall Study|Surgery/Hospitalization|2|||
161032503|NCT04933474|581512585|FG000|Overall Study|Dissatisfied with Intervention|1|||
161032504|NCT04933474|581512586|FG001|Overall Study|Dissatisfied with Intervention|1|||
161032505|NCT04933474|581512585|FG000|Overall Study|Withdrew interest in participation|1|||
161032506|NCT04933474|581512586|FG001|Overall Study|Withdrew interest in participation|0|||
161032507|NCT04933474|581512585|FG000|Overall Study|Had previously enrolled in the study|0|||
161032508|NCT04933474|581512586|FG001|Overall Study|Had previously enrolled in the study|1|||
161032509|NCT04757753|581512589|FG000|Overall Study|Lost to Follow-up|7|||
161032510|NCT04757753|581512590|FG001|Overall Study|Lost to Follow-up|7|||
161032511|NCT04757753|581512589|FG000|Overall Study|Withdrawal by Subject|0|||
161032512|NCT04757753|581512590|FG001|Overall Study|Withdrawal by Subject|3|||
161032513|NCT04757753|581512589|FG000|Overall Study|Endodontic treatment failure|1|||
161032514|NCT04757753|581512590|FG001|Overall Study|Endodontic treatment failure|2|||
161032515|NCT04757753|581512589|FG000|Overall Study|Tooth fracture/extraction|3|||
161032516|NCT04757753|581512590|FG001|Overall Study|Tooth fracture/extraction|0|||
161032517|NCT03733626|581512595|FG000|Overall Study|Physician Decision|4|||
161032518|NCT03733626|581512596|FG001|Overall Study|Physician Decision|4|||
161032519|NCT00319046|581512597|FG000|Overall Study|withdrawal of subject's consent|7|||
161032520|NCT00319046|581512597|FG000|Overall Study|administrative reason|1|||
161032521|NCT03816397|581512600|FG000|Overall Study|Censored at interim analysis date.|13|||
161032522|NCT03816397|581512601|FG001|Overall Study|Censored at interim analysis date.|6|||
161032523|NCT03816397|581512600|FG000|Overall Study|Withdrawal by Subject|1|||
161032524|NCT03816397|581512601|FG001|Overall Study|Withdrawal by Subject|1|||
161032525|NCT04214418|581512602|FG000|Overall Study|Withdrawal by Subject|1|||
161032526|NCT04214418|581512603|FG001|Overall Study|Withdrawal by Subject|0|||
161032527|NCT04214418|581512604|FG002|Overall Study|Withdrawal by Subject|0|||
161032528|NCT04214418|581512605|FG003|Overall Study|Withdrawal by Subject|0|||
161032529|NCT04214418|581512606|FG004|Overall Study|Withdrawal by Subject|0|||
161032530|NCT04214418|581512607|FG005|Overall Study|Withdrawal by Subject|0|||
161032531|NCT04214418|581512602|FG000|Overall Study|Adverse Event|0|||
161032532|NCT04214418|581512603|FG001|Overall Study|Adverse Event|2|||
161032533|NCT04214418|581512604|FG002|Overall Study|Adverse Event|0|||
161148858|NCT02345161|581926170|FG000|Overall Study|Lost to Follow-up|0|||
161148859|NCT02345161|581926171|FG001|Overall Study|Lost to Follow-up|1|||
161148860|NCT02639182|581926172|FG000|Overall Study|Disease Progression|50|||
161148861|NCT02639182|581926173|FG001|Overall Study|Disease Progression|49|||
161148862|NCT02639182|581926172|FG000|Overall Study|Adverse Event|7|||
161148863|NCT02639182|581926173|FG001|Overall Study|Adverse Event|5|||
161148864|NCT02639182|581926172|FG000|Overall Study|Physician Decision|3|||
161148865|NCT02639182|581926173|FG001|Overall Study|Physician Decision|3|||
161148866|NCT02639182|581926172|FG000|Overall Study|Withdrew Consent|5|||
161148867|NCT02639182|581926173|FG001|Overall Study|Withdrew Consent|4|||
161148868|NCT02639182|581926172|FG000|Overall Study|Lost to Follow-up|0|||
161148869|NCT02639182|581926173|FG001|Overall Study|Lost to Follow-up|1|||
161148870|NCT02639182|581926172|FG000|Overall Study|Study Closure|1|||
161148871|NCT02639182|581926173|FG001|Overall Study|Study Closure|2|||
161148872|NCT02639182|581926172|FG000|Overall Study|Sponsor Ended Study|0|||
161148873|NCT02639182|581926173|FG001|Overall Study|Sponsor Ended Study|1|||
161278133|NCT02952586|582398389|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
161278134|NCT02952586|582398388|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
161278135|NCT02952586|582398389|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
161278136|NCT02952586|582398388|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
161278137|NCT02952586|582398389|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
161278138|NCT02952586|582398388|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
161278139|NCT02952586|582398389|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
161278140|NCT02952586|582398388|FG000|CRT for IMRT (63 Days)|Other|1|||
161278141|NCT02952586|582398389|FG001|CRT for IMRT (63 Days)|Other|0|||
161278142|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Death|17|||
161278143|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Death|11|||
161278144|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
161278145|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
161278146|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
161278147|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
161278148|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
161278149|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
161278150|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
160976276|NCT05229653|581302274|FG001|Overall Study|Lost to Follow-up|0|||
160976277|NCT03915951|581302275|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
160976278|NCT03915951|581302276|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
160976279|NCT03915951|581302275|FG000|Overall Study|Adverse Event|12|||
160976280|NCT03915951|581302276|FG001|Overall Study|Adverse Event|6|||
160976281|NCT03915951|581302275|FG000|Overall Study|Disease progression (radiological)|17|||
160976282|NCT03915951|581302276|FG001|Overall Study|Disease progression (radiological)|15|||
160976283|NCT03915951|581302275|FG000|Overall Study|Disease progression (clinical)|4|||
160976284|NCT03915951|581302276|FG001|Overall Study|Disease progression (clinical)|1|||
160976285|NCT03915951|581302275|FG000|Overall Study|Patient decision|0|||
160976286|NCT03915951|581302276|FG001|Overall Study|Patient decision|4|||
160976287|NCT03915951|581302275|FG000|Overall Study|Investigator decision|0|||
160976288|NCT03915951|581302276|FG001|Overall Study|Investigator decision|1|||
160976289|NCT03915951|581302275|FG000|Overall Study|Consent withdrawn|1|||
160976290|NCT03915951|581302276|FG001|Overall Study|Consent withdrawn|1|||
160976291|NCT03915951|581302275|FG000|Overall Study|Death|0|||
160976292|NCT03915951|581302276|FG001|Overall Study|Death|3|||
160976293|NCT05408468|581302277|FG000|Overall Study|Lost to Follow-up|3|||
160976294|NCT05408468|581302278|FG001|Overall Study|Lost to Follow-up|1|||
160976295|NCT05408468|581302277|FG000|Overall Study|Physician Decision|1|||
160976296|NCT05408468|581302278|FG001|Overall Study|Physician Decision|0|||
160976297|NCT05408468|581302277|FG000|Overall Study|Overwhelmed by clinical situation|3|||
160976298|NCT05408468|581302278|FG001|Overall Study|Overwhelmed by clinical situation|0|||
160976299|NCT05408468|581302277|FG000|Overall Study|Personal illness precluding participation|1|||
160976300|NCT05408468|581302278|FG001|Overall Study|Personal illness precluding participation|0|||
160976301|NCT05408468|581302277|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
160976302|NCT05408468|581302278|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
160976303|NCT02204579|581302283|FG000|Overall Study|Screen failures|2|||
160976304|NCT01396395|581302284|FG000|Overall Study|Withdrawal by Subject|10|||
160976305|NCT01396395|581302285|FG001|Overall Study|Withdrawal by Subject|12|||
160976306|NCT01396395|581302284|FG000|Overall Study|Protocol Violation|3|||
160976307|NCT01396395|581302285|FG001|Overall Study|Protocol Violation|1|||
160976308|NCT01396395|581302284|FG000|Overall Study|Adverse Event|10|||
160976309|NCT01396395|581302285|FG001|Overall Study|Adverse Event|2|||
160976310|NCT01396395|581302284|FG000|Overall Study|Lost to Follow-up|17|||
160976311|NCT01396395|581302285|FG001|Overall Study|Lost to Follow-up|11|||
160976312|NCT01396395|581302284|FG000|Overall Study|Other|0|||
160976313|NCT01396395|581302285|FG001|Overall Study|Other|1|||
160976314|NCT03691948|581302286|FG000|Overall Study|Lost to Follow-up|1|||
160976315|NCT03691948|581302287|FG001|Overall Study|Lost to Follow-up|3|||
160976316|NCT01370005|581302288|FG000|Overall Study|Not treated|1|||
160976317|NCT01370005|581302289|FG001|Overall Study|Not treated|0|||
160976318|NCT01370005|581302290|FG002|Overall Study|Not treated|0|||
160976319|NCT01370005|581302288|FG000|Overall Study|Adverse Event|5|||
160976320|NCT01370005|581302289|FG001|Overall Study|Adverse Event|5|||
160976321|NCT01370005|581302290|FG002|Overall Study|Adverse Event|6|||
160976322|NCT01370005|581302288|FG000|Overall Study|Lack of Efficacy|1|||
160976323|NCT01370005|581302289|FG001|Overall Study|Lack of Efficacy|0|||
160976324|NCT01370005|581302290|FG002|Overall Study|Lack of Efficacy|0|||
160976325|NCT01370005|581302288|FG000|Overall Study|Non compliant with protocol|0|||
160976326|NCT01370005|581302289|FG001|Overall Study|Non compliant with protocol|1|||
160976327|NCT01370005|581302290|FG002|Overall Study|Non compliant with protocol|2|||
160976328|NCT01370005|581302288|FG000|Overall Study|Lost to Follow-up|1|||
160976329|NCT01370005|581302289|FG001|Overall Study|Lost to Follow-up|1|||
160976330|NCT01370005|581302290|FG002|Overall Study|Lost to Follow-up|1|||
160976331|NCT01370005|581302288|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
160976332|NCT01370005|581302289|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
160976333|NCT01370005|581302290|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
160976334|NCT01370005|581302288|FG000|Overall Study|Other reason not defined above|3|||
160976335|NCT01370005|581302289|FG001|Overall Study|Other reason not defined above|0|||
160976336|NCT01370005|581302290|FG002|Overall Study|Other reason not defined above|2|||
160976337|NCT02009696|581302291|FG000|Overall Study|Withdrawal by Subject|2|||
160976338|NCT02344537|581302293|FG000|Overall Study|Protocol Violation|1|||
160976339|NCT02344537|581302294|FG001|Overall Study|Protocol Violation|1|||
160976340|NCT02344537|581302293|FG000|Overall Study|Subject started another treatment after wk 6|1|||
160976341|NCT02344537|581302294|FG001|Overall Study|Subject started another treatment after wk 6|0|||
160976342|NCT02344537|581302293|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
160976343|NCT02344537|581302294|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
160976344|NCT05490329|581302297|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
160976345|NCT05490329|581302298|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
160976346|NCT05490329|581302297|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
160976347|NCT05490329|581302298|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
160976348|NCT05490329|581302297|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
161032534|NCT04214418|581512605|FG003|Overall Study|Adverse Event|0|||
161032535|NCT04214418|581512606|FG004|Overall Study|Adverse Event|0|||
161032536|NCT04214418|581512607|FG005|Overall Study|Adverse Event|0|||
161032537|NCT04214418|581512602|FG000|Overall Study|Death|1|||
161032538|NCT04214418|581512603|FG001|Overall Study|Death|0|||
161032539|NCT04214418|581512604|FG002|Overall Study|Death|0|||
161032540|NCT04214418|581512605|FG003|Overall Study|Death|0|||
161032541|NCT04214418|581512606|FG004|Overall Study|Death|0|||
161032542|NCT04214418|581512607|FG005|Overall Study|Death|0|||
161032543|NCT04078152|581512608|FG000|Overall Study|Other|83|||
161032544|NCT04078152|581512609|FG001|Overall Study|Other|22|||
161032545|NCT04078152|581512610|FG002|Overall Study|Other|25|||
161032546|NCT04078152|581512608|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
161032547|NCT04078152|581512609|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
161032548|NCT04078152|581512610|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
161032549|NCT04078152|581512608|FG000|Overall Study|Withdrawal by Subject|5|||
161032550|NCT04078152|581512609|FG001|Overall Study|Withdrawal by Subject|0|||
161032551|NCT04078152|581512610|FG002|Overall Study|Withdrawal by Subject|1|||
161032552|NCT04078152|581512608|FG000|Overall Study|Death|10|||
161032553|NCT04078152|581512609|FG001|Overall Study|Death|2|||
161032554|NCT04078152|581512610|FG002|Overall Study|Death|12|||
161032555|NCT04078152|581512608|FG000|Overall Study|Adverse Event|1|||
161032556|NCT04078152|581512609|FG001|Overall Study|Adverse Event|0|||
161032557|NCT04078152|581512610|FG002|Overall Study|Adverse Event|0|||
161032558|NCT04908930|581512614|FG000|Overall Study|Lost to Follow-up|1|||
161032559|NCT04908930|581512615|FG001|Overall Study|Lost to Follow-up|1|||
161032560|NCT04908930|581512616|FG002|Overall Study|Lost to Follow-up|0|||
161032561|NCT04908930|581512617|FG003|Overall Study|Lost to Follow-up|0|||
161032562|NCT04908930|581512618|FG004|Overall Study|Lost to Follow-up|0|||
161032563|NCT04908930|581512614|FG000|Overall Study|hardware in mouth|1|||
161032564|NCT04908930|581512615|FG001|Overall Study|hardware in mouth|1|||
161032565|NCT04908930|581512616|FG002|Overall Study|hardware in mouth|0|||
161032566|NCT04908930|581512617|FG003|Overall Study|hardware in mouth|0|||
161032567|NCT04908930|581512618|FG004|Overall Study|hardware in mouth|0|||
161032568|NCT04908930|581512614|FG000|Overall Study|wrong team|1|||
161032569|NCT04908930|581512615|FG001|Overall Study|wrong team|0|||
161032570|NCT04908930|581512616|FG002|Overall Study|wrong team|0|||
161032571|NCT04908930|581512617|FG003|Overall Study|wrong team|0|||
161032572|NCT04908930|581512618|FG004|Overall Study|wrong team|0|||
161032573|NCT04908930|581512614|FG000|Overall Study|quit team|2|||
161032574|NCT04908930|581512615|FG001|Overall Study|quit team|4|||
161032575|NCT04908930|581512616|FG002|Overall Study|quit team|0|||
161032576|NCT04908930|581512617|FG003|Overall Study|quit team|0|||
161032577|NCT04908930|581512618|FG004|Overall Study|quit team|0|||
161032578|NCT04908930|581512614|FG000|Overall Study|Withdrawal by Subject|1|||
161032579|NCT04908930|581512615|FG001|Overall Study|Withdrawal by Subject|2|||
161032580|NCT04908930|581512616|FG002|Overall Study|Withdrawal by Subject|0|||
160976349|NCT05490329|581302298|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
160976350|NCT02120664|581302299|FG000|Overall Study|Withdrawal by Subject|0|||
160976351|NCT02120664|581302300|FG001|Overall Study|Withdrawal by Subject|0|||
160976352|NCT02120664|581302301|FG002|Overall Study|Withdrawal by Subject|0|||
160976353|NCT02120664|581302302|FG003|Overall Study|Withdrawal by Subject|1|||
160976354|NCT02120664|581302303|FG004|Overall Study|Withdrawal by Subject|0|||
160976355|NCT03916744|581302304|FG000|Overall Study|Withdrawal by Subject|0|||
160976356|NCT03916744|581302305|FG001|Overall Study|Withdrawal by Subject|1|||
160976357|NCT03916744|581302306|FG002|Overall Study|Withdrawal by Subject|2|||
160976358|NCT02460263|581302307|FG000|Transition Period|Withdrawal by Subject|1|||
160976359|NCT02460263|581302307|FG000|Transition Period|Death|1|||
160976360|NCT03176238|581302310|FG000|Overall Study|Unacceptable AEs|15|||
161032581|NCT04908930|581512617|FG003|Overall Study|Withdrawal by Subject|0|||
161032582|NCT04908930|581512618|FG004|Overall Study|Withdrawal by Subject|0|||
160976361|NCT03176238|581302311|FG001|Overall Study|Unacceptable AEs|8|||
161344742|NCT04717557|582647261|FG000|Overall Study|Withdrawal by Subject|2|||
161344743|NCT04717557|582647262|FG001|Overall Study|Withdrawal by Subject|0|||
161032583|NCT04908930|581512614|FG000|Overall Study|parent not liking program|0|||
161032584|NCT04908930|581512615|FG001|Overall Study|parent not liking program|1|||
161032585|NCT04908930|581512616|FG002|Overall Study|parent not liking program|0|||
161032586|NCT04908930|581512617|FG003|Overall Study|parent not liking program|0|||
161032587|NCT04908930|581512618|FG004|Overall Study|parent not liking program|0|||
161344744|NCT04717557|582647261|FG000|Overall Study|Death|1|||
160976362|NCT03176238|581302310|FG000|Overall Study|Abnormal lab value(s)|2|||
161032588|NCT04679389|581512619|FG000|Overall Study|Adverse Event|1|||
161032589|NCT04679389|581512620|FG001|Overall Study|Adverse Event|0|||
161032590|NCT04679389|581512619|FG000|Overall Study|Protocol Violation|2|||
161032591|NCT04679389|581512620|FG001|Overall Study|Protocol Violation|0|||
160976363|NCT03176238|581302311|FG001|Overall Study|Abnormal lab value(s)|0|||
160976364|NCT03176238|581302310|FG000|Overall Study|Inter-current illness|0|||
161032592|NCT04679389|581512619|FG000|Overall Study|Physician Decision|3|||
161032593|NCT04679389|581512620|FG001|Overall Study|Physician Decision|5|||
161091177|NCT01191268|581723825|FG000|Overall Study|Sponsor Decision|0|||
161032594|NCT04679389|581512619|FG000|Overall Study|Withdrawal by Subject|5|||
161032595|NCT04679389|581512620|FG001|Overall Study|Withdrawal by Subject|7|||
161032596|NCT03904576|581512639|FG000|Washout Period|Protocol Violation|1|||
161032597|NCT03904576|581512640|FG001|Washout Period|Protocol Violation|1|||
161032598|NCT04780581|581512643|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
161032599|NCT04780581|581512644|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
161032600|NCT04780581|581512643|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
161032601|NCT04780581|581512644|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
161032602|NCT02765412|581512645|FG000|Overall Study|Death|482|||
161032603|NCT02765412|581512646|FG001|Overall Study|Death|855|||
161032604|NCT03990883|581512647|FG000|Blinded Treatment Phase|Adverse Event|1|||
161032605|NCT03990883|581512648|FG001|Blinded Treatment Phase|Adverse Event|1|||
161032606|NCT03990883|581512649|FG002|Blinded Treatment Phase|Adverse Event|0|||
161032607|NCT03990883|581512647|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
161032608|NCT03990883|581512648|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
161032609|NCT03990883|581512649|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
161032610|NCT03990883|581512647|FG000|Blinded Treatment Phase|Physician Decision|1|||
161032611|NCT03990883|581512648|FG001|Blinded Treatment Phase|Physician Decision|0|||
161032612|NCT03990883|581512649|FG002|Blinded Treatment Phase|Physician Decision|0|||
161032613|NCT03990883|581512647|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
161032614|NCT03990883|581512648|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
161032615|NCT03990883|581512649|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
161032616|NCT03990883|581512647|FG000|Blinded Treatment Phase|COVID-19|3|||
161032617|NCT03990883|581512648|FG001|Blinded Treatment Phase|COVID-19|2|||
161032618|NCT03990883|581512649|FG002|Blinded Treatment Phase|COVID-19|0|||
161032619|NCT03990883|581512647|FG000|Blinded Treatment Phase|Personal Reasons|6|||
161032620|NCT03990883|581512648|FG001|Blinded Treatment Phase|Personal Reasons|3|||
161032621|NCT03990883|581512649|FG002|Blinded Treatment Phase|Personal Reasons|0|||
161032622|NCT03990883|581512647|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
161032623|NCT03990883|581512648|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
161032624|NCT03990883|581512649|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
161032625|NCT03990883|581512647|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
161032626|NCT03990883|581512648|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
161032627|NCT03990883|581512649|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
161032628|NCT03990883|581512647|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
161032629|NCT03990883|581512648|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
161032630|NCT03990883|581512649|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
161032631|NCT04678856|581512650|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
161032632|NCT04678856|581512651|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
161032633|NCT04678856|581512650|FG000|Overall Study|Withdrawal by Subject|5|||
161032634|NCT04678856|581512651|FG001|Overall Study|Withdrawal by Subject|1|||
161032635|NCT05020353|581513411|FG000|Overall Study|Protocol Violation|7|||
161032636|NCT05020353|581513411|FG000|Overall Study|Withdrawal by Subject|33|||
161032637|NCT06655818|581513418|FG000|Overall Study|Withdrawal by Subject|1|||
161032638|NCT04496752|581513423|FG000|Second Assessment|Lost to Follow-up|3|||
161032639|NCT04496752|581513424|FG001|Second Assessment|Lost to Follow-up|3|||
161032640|NCT04496752|581513423|FG000|Second Assessment|Adverse Event|2|||
161032641|NCT04496752|581513424|FG001|Second Assessment|Adverse Event|0|||
161032642|NCT05836012|581513429|FG000|Overall Study|Lost to Follow-up|1|||
161032643|NCT05836012|581513430|FG001|Overall Study|Lost to Follow-up|0|||
161032644|NCT05836012|581513429|FG000|Overall Study|Withdrawal by Subject|1|||
161032645|NCT05836012|581513430|FG001|Overall Study|Withdrawal by Subject|3|||
161032646|NCT05836012|581513429|FG000|Overall Study|Reason not included in pre-specified categories|2|||
161032647|NCT05836012|581513430|FG001|Overall Study|Reason not included in pre-specified categories|1|||
161032648|NCT02777593|581513435|FG000|Overall Study|Still in study|1|||
161032649|NCT02777593|581513436|FG001|Overall Study|Still in study|32|||
161032650|NCT02777593|581513437|FG002|Overall Study|Still in study|3|||
161032651|NCT02777593|581513438|FG003|Overall Study|Still in study|6|||
161032652|NCT02777593|581513439|FG004|Overall Study|Still in study|5|||
161032653|NCT02777593|581513435|FG000|Overall Study|Death|21|||
161032654|NCT02777593|581513436|FG001|Overall Study|Death|28|||
161032655|NCT02777593|581513437|FG002|Overall Study|Death|0|||
161032656|NCT02777593|581513438|FG003|Overall Study|Death|5|||
161032657|NCT02777593|581513439|FG004|Overall Study|Death|0|||
161032658|NCT02777593|581513435|FG000|Overall Study|Withdrawal by Subject|8|||
161032659|NCT02777593|581513436|FG001|Overall Study|Withdrawal by Subject|4|||
161032660|NCT02777593|581513437|FG002|Overall Study|Withdrawal by Subject|1|||
161032661|NCT02777593|581513438|FG003|Overall Study|Withdrawal by Subject|1|||
161032662|NCT02777593|581513439|FG004|Overall Study|Withdrawal by Subject|0|||
161032663|NCT02777593|581513435|FG000|Overall Study|Lost to Follow-up|8|||
161032664|NCT02777593|581513436|FG001|Overall Study|Lost to Follow-up|16|||
161032665|NCT02777593|581513437|FG002|Overall Study|Lost to Follow-up|5|||
161032666|NCT02777593|581513438|FG003|Overall Study|Lost to Follow-up|0|||
161032667|NCT02777593|581513439|FG004|Overall Study|Lost to Follow-up|1|||
161032668|NCT02777593|581513435|FG000|Overall Study|Physician Decision|2|||
161032669|NCT02777593|581513436|FG001|Overall Study|Physician Decision|2|||
161032670|NCT02777593|581513437|FG002|Overall Study|Physician Decision|0|||
161032671|NCT02777593|581513438|FG003|Overall Study|Physician Decision|0|||
161032672|NCT02777593|581513439|FG004|Overall Study|Physician Decision|0|||
161032673|NCT02777593|581513435|FG000|Overall Study|Discontinued due to Other|1|||
161032674|NCT02777593|581513436|FG001|Overall Study|Discontinued due to Other|0|||
161032675|NCT02777593|581513437|FG002|Overall Study|Discontinued due to Other|0|||
161032676|NCT02777593|581513438|FG003|Overall Study|Discontinued due to Other|0|||
161032677|NCT02777593|581513439|FG004|Overall Study|Discontinued due to Other|0|||
161032678|NCT05785130|581513440|FG000|Overall Study|Withdrawal by Subject|1|||
161032679|NCT05785130|581513441|FG001|Overall Study|Withdrawal by Subject|0|||
161032680|NCT05785130|581513440|FG000|Overall Study|Lack of Efficacy|0|||
161032681|NCT05785130|581513441|FG001|Overall Study|Lack of Efficacy|1|||
161032682|NCT03547271|581513442|FG000|Overall Study|Adverse Event|1|||
161032683|NCT03547271|581513443|FG001|Overall Study|Adverse Event|1|||
161032684|NCT03547271|581513444|FG002|Overall Study|Adverse Event|0|||
161032685|NCT03547271|581513445|FG003|Overall Study|Adverse Event|0|||
161032686|NCT03547271|581513442|FG000|Overall Study|Protocol deviation|5|||
161032687|NCT03547271|581513443|FG001|Overall Study|Protocol deviation|7|||
161032688|NCT03547271|581513444|FG002|Overall Study|Protocol deviation|3|||
161032689|NCT03547271|581513445|FG003|Overall Study|Protocol deviation|0|||
161032690|NCT03547271|581513442|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
161032691|NCT03547271|581513443|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
161032692|NCT03547271|581513444|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161032693|NCT03547271|581513445|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
161032694|NCT03547271|581513442|FG000|Overall Study|Lost to Follow-up|3|||
161032695|NCT03547271|581513443|FG001|Overall Study|Lost to Follow-up|3|||
161032696|NCT03547271|581513444|FG002|Overall Study|Lost to Follow-up|1|||
161032697|NCT03547271|581513445|FG003|Overall Study|Lost to Follow-up|0|||
161032698|NCT05718687|581513448|FG000|Overall Study|Withdrawal by Subject|3|||
161032699|NCT05215054|581513451|FG000|Overall Study|Lost to Follow-up|1|||
161032700|NCT05215054|581513452|FG001|Overall Study|Lost to Follow-up|1|||
161032701|NCT05215054|581513451|FG000|Overall Study|Protocol Violation|1|||
161032702|NCT05215054|581513452|FG001|Overall Study|Protocol Violation|1|||
161032703|NCT05215054|581513451|FG000|Overall Study|Withdrawal by Subject|4|||
161032704|NCT05215054|581513452|FG001|Overall Study|Withdrawal by Subject|4|||
161032705|NCT01897441|581513453|FG000|Overall Study|Lost to Follow-up|0|||
161032706|NCT01897441|581513454|FG001|Overall Study|Lost to Follow-up|0|||
161032707|NCT01897441|581513455|FG002|Overall Study|Lost to Follow-up|1|||
161032708|NCT01897441|581513456|FG003|Overall Study|Lost to Follow-up|0|||
161032709|NCT01897441|581513457|FG004|Overall Study|Lost to Follow-up|0|||
161032710|NCT01897441|581513458|FG005|Overall Study|Lost to Follow-up|0|||
161032711|NCT01897441|581513453|FG000|Overall Study|Withdrawal by Subject|0|||
161032712|NCT01897441|581513454|FG001|Overall Study|Withdrawal by Subject|0|||
161032713|NCT01897441|581513455|FG002|Overall Study|Withdrawal by Subject|0|||
161032714|NCT01897441|581513456|FG003|Overall Study|Withdrawal by Subject|0|||
161032715|NCT01897441|581513457|FG004|Overall Study|Withdrawal by Subject|1|||
161032716|NCT01897441|581513458|FG005|Overall Study|Withdrawal by Subject|0|||
161032717|NCT01897441|581513453|FG000|Overall Study|Withdrawn by Provider|0|||
161032718|NCT01897441|581513454|FG001|Overall Study|Withdrawn by Provider|2|||
161032719|NCT01897441|581513455|FG002|Overall Study|Withdrawn by Provider|0|||
161032720|NCT01897441|581513456|FG003|Overall Study|Withdrawn by Provider|0|||
161032721|NCT01897441|581513457|FG004|Overall Study|Withdrawn by Provider|0|||
161032722|NCT01897441|581513458|FG005|Overall Study|Withdrawn by Provider|0|||
161032723|NCT02933489|581513459|FG000|Overall Study|Ineligible|3|||
161032724|NCT02933489|581513460|FG001|Overall Study|Ineligible|3|||
161032725|NCT02933489|581513459|FG000|Overall Study|Withdrawal by Subject|27|||
161032726|NCT02933489|581513460|FG001|Overall Study|Withdrawal by Subject|18|||
161032727|NCT02933489|581513459|FG000|Overall Study|Unable to complete exams (other)|14|||
161032728|NCT02933489|581513460|FG001|Overall Study|Unable to complete exams (other)|7|||
161032729|NCT05485935|581513461|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
161032730|NCT05485935|581513462|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
161032731|NCT05485935|581513461|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
161032732|NCT05485935|581513462|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
161032733|NCT05485935|581513461|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
161032734|NCT05485935|581513462|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
161032735|NCT05485935|581513461|FG000|Period 2 (T2 and V3)|loss of contact|0|||
161032736|NCT05485935|581513462|FG001|Period 2 (T2 and V3)|loss of contact|1|||
161032737|NCT04093869|581513463|FG000|Overall Study|Death|0|||
161032738|NCT04093869|581513464|FG001|Overall Study|Death|1|||
161032739|NCT04093869|581513463|FG000|Overall Study|Withdrawal by Subject|1|||
161032740|NCT04093869|581513464|FG001|Overall Study|Withdrawal by Subject|0|||
161032741|NCT03250676|581513465|FG000|Overall Study|Adverse Event|0|||
161032742|NCT03250676|581513466|FG001|Overall Study|Adverse Event|0|||
161032743|NCT03250676|581513467|FG002|Overall Study|Adverse Event|0|||
161032744|NCT03250676|581513468|FG003|Overall Study|Adverse Event|1|||
161032745|NCT03250676|581513469|FG004|Overall Study|Adverse Event|2|||
161032746|NCT03250676|581513470|FG005|Overall Study|Adverse Event|9|||
161032747|NCT03250676|581513465|FG000|Overall Study|Withdrawal by Subject|1|||
161032748|NCT03250676|581513466|FG001|Overall Study|Withdrawal by Subject|0|||
161032749|NCT03250676|581513467|FG002|Overall Study|Withdrawal by Subject|0|||
161032750|NCT03250676|581513468|FG003|Overall Study|Withdrawal by Subject|1|||
161032751|NCT03250676|581513469|FG004|Overall Study|Withdrawal by Subject|1|||
161032752|NCT03250676|581513470|FG005|Overall Study|Withdrawal by Subject|2|||
161032753|NCT03250676|581513465|FG000|Overall Study|Physician Decision|0|||
161032754|NCT03250676|581513466|FG001|Overall Study|Physician Decision|0|||
161032755|NCT03250676|581513467|FG002|Overall Study|Physician Decision|0|||
161032756|NCT03250676|581513468|FG003|Overall Study|Physician Decision|2|||
161278151|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
161278152|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
161278153|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
161278154|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
161278155|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
161278156|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
161278157|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
161278158|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Other|2|||
161278159|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Other|1|||
161278160|NCT02952586|582398388|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
161278161|NCT02952586|582398389|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
161278162|NCT02952586|582398388|FG000|Follow-Up Phase (90 Days)|Death|12|||
161278163|NCT02952586|582398389|FG001|Follow-Up Phase (90 Days)|Death|10|||
161278164|NCT02952586|582398388|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
161278165|NCT02952586|582398389|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
161278166|NCT02952586|582398388|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
161278167|NCT02952586|582398389|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
161278168|NCT02952586|582398388|FG000|Follow-Up Phase (90 Days)|Other|7|||
161278169|NCT02952586|582398389|FG001|Follow-Up Phase (90 Days)|Other|5|||
161278170|NCT02952586|582398388|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
161278171|NCT02952586|582398389|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
161278172|NCT02952586|582398388|FG000|LT Follow-up (up to 45 Months)|Death|51|||
161278173|NCT02952586|582398389|FG001|LT Follow-up (up to 45 Months)|Death|31|||
161278174|NCT02952586|582398388|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
161278175|NCT02952586|582398389|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
161278176|NCT02952586|582398388|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
161278177|NCT02952586|582398389|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
161278178|NCT02952586|582398388|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
161278179|NCT02952586|582398389|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
161278180|NCT00492778|582398390|FG000|Overall Study|Ineligible by Pathology Review|8|||
161278181|NCT00492778|582398391|FG001|Overall Study|Ineligible by Pathology Review|1|||
161278182|NCT03717012|582398408|FG000|Overall Study|Due to trial termination|1|||
161278183|NCT03717012|582398409|FG001|Overall Study|Due to trial termination|2|||
161278184|NCT03717012|582398408|FG000|Overall Study|Protocol Violation|0|||
161278185|NCT03717012|582398409|FG001|Overall Study|Protocol Violation|2|||
161278186|NCT03717012|582398408|FG000|Overall Study|Adverse Event|0|||
161278187|NCT03717012|582398409|FG001|Overall Study|Adverse Event|1|||
161278188|NCT03717012|582398408|FG000|Overall Study|Lung transplant|0|||
161278189|NCT03717012|582398409|FG001|Overall Study|Lung transplant|1|||
161278190|NCT00789035|582398410|FG000|Overall Study|Adverse Event|0|||
161278191|NCT00789035|582398411|FG001|Overall Study|Adverse Event|2|||
161278192|NCT00789035|582398412|FG002|Overall Study|Adverse Event|0|||
161278193|NCT00789035|582398413|FG003|Overall Study|Adverse Event|1|||
161278194|NCT00789035|582398414|FG004|Overall Study|Adverse Event|3|||
161278195|NCT00789035|582398410|FG000|Overall Study|Lack of Efficacy|3|||
161278196|NCT00789035|582398411|FG001|Overall Study|Lack of Efficacy|0|||
161278197|NCT00789035|582398412|FG002|Overall Study|Lack of Efficacy|0|||
161278198|NCT00789035|582398413|FG003|Overall Study|Lack of Efficacy|0|||
161278199|NCT00789035|582398414|FG004|Overall Study|Lack of Efficacy|2|||
161278200|NCT00789035|582398410|FG000|Overall Study|Protocol Violation|1|||
161344745|NCT04717557|582647262|FG001|Overall Study|Death|0|||
161344746|NCT06354257|582647263|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161344747|NCT06354257|582647263|FG000|Treatment Period 2|Adverse Event|1|||
161032757|NCT03250676|581513469|FG004|Overall Study|Physician Decision|0|||
161278201|NCT00789035|582398411|FG001|Overall Study|Protocol Violation|0|||
161344748|NCT02401230|582647264|FG000|Overall Study|Adverse Event|3|||
161032758|NCT03250676|581513470|FG005|Overall Study|Physician Decision|3|||
161032759|NCT03250676|581513465|FG000|Overall Study|Withdrawal of consent|0|||
161278202|NCT00789035|582398412|FG002|Overall Study|Protocol Violation|0|||
161278203|NCT00789035|582398413|FG003|Overall Study|Protocol Violation|0|||
161278204|NCT00789035|582398414|FG004|Overall Study|Protocol Violation|0|||
161278205|NCT00789035|582398410|FG000|Overall Study|Withdrawal by Subject|0|||
161032760|NCT03250676|581513466|FG001|Overall Study|Withdrawal of consent|0|||
161344749|NCT02401230|582647265|FG001|Overall Study|Adverse Event|2|||
160976365|NCT03176238|581302311|FG001|Overall Study|Inter-current illness|1|||
160976366|NCT03176238|581302310|FG000|Overall Study|Consent withdrawal|14|||
160976367|NCT03176238|581302311|FG001|Overall Study|Consent withdrawal|2|||
160976368|NCT03176238|581302310|FG000|Overall Study|Lost to Follow-up|3|||
160976369|NCT03176238|581302311|FG001|Overall Study|Lost to Follow-up|0|||
160976370|NCT03176238|581302310|FG000|Overall Study|Administrative problems|1|||
160976371|NCT03176238|581302311|FG001|Overall Study|Administrative problems|0|||
160976372|NCT03176238|581302310|FG000|Overall Study|Death|3|||
160976373|NCT03176238|581302311|FG001|Overall Study|Death|0|||
160976374|NCT03176238|581302310|FG000|Overall Study|Disease Progression|133|||
160976375|NCT03176238|581302311|FG001|Overall Study|Disease Progression|22|||
160976376|NCT03176238|581302310|FG000|Overall Study|Tx duration completed per EAP|0|||
160976377|NCT03176238|581302311|FG001|Overall Study|Tx duration completed per EAP|1|||
160976378|NCT03176238|581302310|FG000|Overall Study|Patient is switched to commercial drug|16|||
160976379|NCT03176238|581302311|FG001|Overall Study|Patient is switched to commercial drug|1|||
160976380|NCT03176238|581302310|FG000|Overall Study|Protocol Violation|1|||
160976381|NCT03176238|581302311|FG001|Overall Study|Protocol Violation|0|||
160976382|NCT03176238|581302310|FG000|Overall Study|Changes in the patient's condition|2|||
160976383|NCT03176238|581302311|FG001|Overall Study|Changes in the patient's condition|1|||
160976384|NCT03176238|581302310|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
160976385|NCT03176238|581302311|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
160976386|NCT04524598|581302312|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
160976387|NCT04524598|581302313|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
160976388|NCT04524598|581302314|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
160976389|NCT04524598|581302315|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
160976390|NCT04524598|581302316|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
160976391|NCT04524598|581302312|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
160976392|NCT04524598|581302313|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
160976393|NCT04524598|581302314|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976394|NCT04524598|581302315|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976395|NCT04524598|581302316|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976396|NCT04524598|581302312|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
160976397|NCT04524598|581302313|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
160976398|NCT04524598|581302314|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
160976399|NCT04524598|581302315|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
160976400|NCT04524598|581302316|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
160976401|NCT04524598|581302312|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
160976402|NCT04524598|581302313|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
160976403|NCT04524598|581302314|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
160976404|NCT04524598|581302315|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
160976405|NCT04524598|581302316|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
160976406|NCT04524598|581302312|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976407|NCT04524598|581302313|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976408|NCT04524598|581302314|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
160976409|NCT04524598|581302315|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
160976410|NCT04524598|581302316|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976411|NCT04524598|581302312|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
160976412|NCT04524598|581302313|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
160976413|NCT04524598|581302314|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
160976414|NCT04524598|581302315|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
160976415|NCT04524598|581302316|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
160976416|NCT04524598|581302312|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976417|NCT04524598|581302313|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976418|NCT04524598|581302314|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976419|NCT04524598|581302315|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
160976420|NCT04524598|581302316|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
160976421|NCT01351025|581302317|FG000|Week 0 - 20|Lost to Follow-up|2|||
160976422|NCT01351025|581302318|FG001|Week 0 - 20|Lost to Follow-up|1|||
160976423|NCT01351025|581302317|FG000|Week 0 - 20|Withdrawal by Subject|1|||
160976424|NCT01351025|581302318|FG001|Week 0 - 20|Withdrawal by Subject|0|||
160976425|NCT01351025|581302317|FG000|Week 24 - 44|Lost to Follow-up|0|||
160976426|NCT01351025|581302318|FG001|Week 24 - 44|Lost to Follow-up|2|||
160976427|NCT01351025|581302317|FG000|Week 24 - 44|Site closed|0|||
160976428|NCT01351025|581302318|FG001|Week 24 - 44|Site closed|1|||
160976429|NCT01351025|581302317|FG000|Week 24 - 44|unable to get to clinic|1|||
160976430|NCT01351025|581302318|FG001|Week 24 - 44|unable to get to clinic|1|||
160976431|NCT01242176|581304566|FG000|Washout Period of 7 Days|Adverse Event|0|||
160976432|NCT01242176|581304567|FG001|Washout Period of 7 Days|Adverse Event|2|||
161091178|NCT01191268|581723826|FG001|Overall Study|Sponsor Decision|2|||
161278206|NCT00789035|582398411|FG001|Overall Study|Withdrawal by Subject|2|||
161278207|NCT00789035|582398412|FG002|Overall Study|Withdrawal by Subject|0|||
161278208|NCT00789035|582398413|FG003|Overall Study|Withdrawal by Subject|0|||
161278209|NCT00789035|582398414|FG004|Overall Study|Withdrawal by Subject|0|||
161278210|NCT00789035|582398410|FG000|Overall Study|Other reason not defined above|2|||
161278211|NCT00789035|582398411|FG001|Overall Study|Other reason not defined above|3|||
161278212|NCT00789035|582398412|FG002|Overall Study|Other reason not defined above|1|||
161278213|NCT00789035|582398413|FG003|Overall Study|Other reason not defined above|0|||
161278214|NCT00789035|582398414|FG004|Overall Study|Other reason not defined above|1|||
161278215|NCT00362336|582398415|FG000|Overall Study|Serious Adverse Event|1|||
161278216|NCT00362336|582398416|FG001|Overall Study|Serious Adverse Event|0|||
161278217|NCT00362336|582398417|FG002|Overall Study|Serious Adverse Event|1|||
161278218|NCT00362336|582398415|FG000|Overall Study|Protocol Violation|0|||
161278219|NCT00362336|582398416|FG001|Overall Study|Protocol Violation|0|||
161278220|NCT00362336|582398417|FG002|Overall Study|Protocol Violation|1|||
161278221|NCT00362336|582398415|FG000|Overall Study|Lost to Follow-up|6|||
161278222|NCT00362336|582398416|FG001|Overall Study|Lost to Follow-up|4|||
161278223|NCT00362336|582398417|FG002|Overall Study|Lost to Follow-up|0|||
161278224|NCT00362336|582398415|FG000|Overall Study|Withdrawal by Subject|3|||
161278225|NCT00362336|582398416|FG001|Overall Study|Withdrawal by Subject|3|||
161278226|NCT00362336|582398417|FG002|Overall Study|Withdrawal by Subject|1|||
161278227|NCT04414618|582398418|FG000|Overall Study|Death|3|||
161278228|NCT04414618|582398419|FG001|Overall Study|Death|3|||
161278229|NCT04414618|582398418|FG000|Overall Study|Withdrawal by Subject|2|||
161278230|NCT04414618|582398419|FG001|Overall Study|Withdrawal by Subject|1|||
161278231|NCT04414618|582398418|FG000|Overall Study|Lost to Follow-up|2|||
161278232|NCT04414618|582398419|FG001|Overall Study|Lost to Follow-up|3|||
161278233|NCT04414618|582398418|FG000|Overall Study|Physician Decision|1|||
161278234|NCT04414618|582398419|FG001|Overall Study|Physician Decision|0|||
161278235|NCT00658879|582398420|FG000|Overall Study|Protocol Violation|1|||
161278236|NCT02640690|582398421|FG000|Overall Study|Lost to Follow-up|7|||
161278237|NCT02640690|582398422|FG001|Overall Study|Lost to Follow-up|7|||
161278238|NCT02640690|582398421|FG000|Overall Study|Withdrawal by Subject|16|||
161278239|NCT02640690|582398422|FG001|Overall Study|Withdrawal by Subject|20|||
161278240|NCT02640690|582398421|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
161278241|NCT02640690|582398422|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
161278242|NCT01520870|582398423|FG000|Overall Study|Withdrawal by Subject|2|||
161278243|NCT01118975|582398424|FG000|Overall Study|Adverse Event|0|||
161278244|NCT01118975|582398425|FG001|Overall Study|Adverse Event|1|||
161278245|NCT01645787|582398426|FG000|Washout (2 Weeks)|Adverse Event|1|||
161278246|NCT01645787|582398427|FG001|Washout (2 Weeks)|Adverse Event|0|||
161278247|NCT02289456|582398428|FG000|Induction Period|Death|2|||
161278248|NCT02289456|582398428|FG000|Induction Period|Adverse Event|11|||
161278249|NCT02289456|582398428|FG000|Induction Period|Progressive Disease (PD)|4|||
161278250|NCT02289456|582398428|FG000|Induction Period|Symptomatic Deterioration|4|||
161278251|NCT02289456|582398428|FG000|Induction Period|Withdrawal by Subject|2|||
161278252|NCT02289456|582398428|FG000|Induction Period|Miscellaneous|1|||
161278253|NCT02289456|582398428|FG000|Monotherapy Period|Death|1|||
161278254|NCT02289456|582398428|FG000|Monotherapy Period|Adverse Event|1|||
161344750|NCT02401230|582647266|FG002|Overall Study|Adverse Event|0|||
161344751|NCT02401230|582647264|FG000|Overall Study|Withdrawal by Subject|2|||
161344752|NCT02401230|582647265|FG001|Overall Study|Withdrawal by Subject|1|||
161344753|NCT02401230|582647266|FG002|Overall Study|Withdrawal by Subject|1|||
161344754|NCT02401230|582647264|FG000|Overall Study|Lost to Follow-up|1|||
161344755|NCT02401230|582647265|FG001|Overall Study|Lost to Follow-up|3|||
161344756|NCT02401230|582647266|FG002|Overall Study|Lost to Follow-up|3|||
161344757|NCT00720759|582647271|FG000|Overall Study|Lost to Follow-up|0|||
161278255|NCT02289456|582398428|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
161278256|NCT02289456|582398428|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
161278257|NCT02289456|582398428|FG000|Monotherapy Period|Withdrawal by Subject|2|||
161278258|NCT02289456|582398428|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
161344758|NCT00720759|582647272|FG001|Overall Study|Lost to Follow-up|1|||
161278259|NCT02289456|582398428|FG000|Monotherapy Period|Miscellaneous|1|||
161344759|NCT00720759|582647273|FG002|Overall Study|Lost to Follow-up|1|||
161278260|NCT01399658|582398429|FG000|Overall Study|Ineligible|1|||
161278261|NCT01399658|582398429|FG000|Overall Study|Machine Technical Issue|3|||
161278262|NCT01399658|582398429|FG000|Overall Study|Alternative therapy|1|||
161278263|NCT01399658|582398429|FG000|Overall Study|No reason given|1|||
161278264|NCT04315506|582398431|FG000|Overall Study|Lost to Follow-up|74|||
161278265|NCT04315506|582398432|FG001|Overall Study|Lost to Follow-up|82|||
161344760|NCT00720759|582647274|FG003|Overall Study|Lost to Follow-up|0|||
161344761|NCT02318940|582647275|FG000|Overall Study|lost the record|1|||
160976433|NCT01242176|581304566|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
161278266|NCT04315506|582398431|FG000|Overall Study|Withdrawal by Subject|8|||
161278267|NCT04315506|582398432|FG001|Overall Study|Withdrawal by Subject|8|||
161278268|NCT04315506|582398431|FG000|Overall Study|Physician Decision|0|||
161278269|NCT04315506|582398432|FG001|Overall Study|Physician Decision|1|||
161344762|NCT02318940|582647276|FG001|Overall Study|lost the record|0|||
160976434|NCT01242176|581304567|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
160976435|NCT00358215|581304568|FG000|Overall Study|Ineligibility determined|4|||
160976436|NCT00358215|581304569|FG001|Overall Study|Ineligibility determined|3|||
160976437|NCT00358215|581304568|FG000|Overall Study|Adverse Event|83|||
160976438|NCT00358215|581304569|FG001|Overall Study|Adverse Event|65|||
160976439|NCT00358215|581304568|FG000|Overall Study|Withdrawal by Subject|111|||
160976440|NCT00358215|581304569|FG001|Overall Study|Withdrawal by Subject|102|||
160976441|NCT00358215|581304568|FG000|Overall Study|Participant request|65|||
160976442|NCT00358215|581304569|FG001|Overall Study|Participant request|64|||
160976443|NCT00358215|581304568|FG000|Overall Study|Physician Decision|47|||
160976444|NCT00358215|581304569|FG001|Overall Study|Physician Decision|39|||
160976445|NCT00358215|581304568|FG000|Overall Study|Lost to Follow-up|16|||
160976446|NCT00358215|581304569|FG001|Overall Study|Lost to Follow-up|22|||
161032761|NCT03250676|581513467|FG002|Overall Study|Withdrawal of consent|2|||
161032762|NCT03250676|581513468|FG003|Overall Study|Withdrawal of consent|0|||
161032763|NCT03250676|581513469|FG004|Overall Study|Withdrawal of consent|0|||
161032764|NCT03250676|581513470|FG005|Overall Study|Withdrawal of consent|2|||
161032765|NCT03250676|581513465|FG000|Overall Study|Other|1|||
161032766|NCT03250676|581513466|FG001|Overall Study|Other|0|||
161032767|NCT03250676|581513467|FG002|Overall Study|Other|0|||
161032768|NCT03250676|581513468|FG003|Overall Study|Other|0|||
161032769|NCT03250676|581513469|FG004|Overall Study|Other|0|||
161032770|NCT03250676|581513470|FG005|Overall Study|Other|0|||
161032771|NCT03250676|581513465|FG000|Overall Study|Disease progression|4|||
161032772|NCT03250676|581513466|FG001|Overall Study|Disease progression|12|||
161032773|NCT03250676|581513467|FG002|Overall Study|Disease progression|9|||
161032774|NCT03250676|581513468|FG003|Overall Study|Disease progression|7|||
161032775|NCT03250676|581513469|FG004|Overall Study|Disease progression|4|||
161032776|NCT03250676|581513470|FG005|Overall Study|Disease progression|88|||
161032777|NCT01499368|581513471|FG000|Overall Study|Did not meet I/E criteria|8|||
161032778|NCT01499368|581513472|FG001|Overall Study|Did not meet I/E criteria|4|||
161032779|NCT01499368|581513473|FG002|Overall Study|Did not meet I/E criteria|4|||
161032780|NCT01499368|581513471|FG000|Overall Study|Prohibited Concomitant medication|1|||
161032781|NCT01499368|581513472|FG001|Overall Study|Prohibited Concomitant medication|1|||
161032782|NCT01499368|581513473|FG002|Overall Study|Prohibited Concomitant medication|0|||
161032783|NCT01499368|581513471|FG000|Overall Study|Withdrawal by Subject|11|||
161032784|NCT01499368|581513472|FG001|Overall Study|Withdrawal by Subject|10|||
161032785|NCT01499368|581513473|FG002|Overall Study|Withdrawal by Subject|8|||
161032786|NCT01499368|581513471|FG000|Overall Study|Lost to Follow-up|3|||
161032787|NCT01499368|581513472|FG001|Overall Study|Lost to Follow-up|2|||
161032788|NCT01499368|581513473|FG002|Overall Study|Lost to Follow-up|5|||
161032789|NCT01499368|581513471|FG000|Overall Study|Adverse Event|4|||
161032790|NCT01499368|581513472|FG001|Overall Study|Adverse Event|0|||
161032791|NCT01499368|581513473|FG002|Overall Study|Adverse Event|2|||
161032792|NCT01499368|581513471|FG000|Overall Study|Physician Decision|0|||
161032793|NCT01499368|581513472|FG001|Overall Study|Physician Decision|1|||
161032794|NCT01499368|581513473|FG002|Overall Study|Physician Decision|0|||
161032795|NCT01499368|581513471|FG000|Overall Study|Deviation from visit window|0|||
161032796|NCT01499368|581513472|FG001|Overall Study|Deviation from visit window|0|||
161032797|NCT01499368|581513473|FG002|Overall Study|Deviation from visit window|1|||
161032798|NCT01499368|581513471|FG000|Overall Study|Error of Prescriptions|0|||
161032799|NCT01499368|581513472|FG001|Overall Study|Error of Prescriptions|0|||
161032800|NCT01499368|581513473|FG002|Overall Study|Error of Prescriptions|1|||
161032801|NCT03092674|581513474|FG000|Overall Study|Adverse Event or Side Effects|1|||
161032802|NCT03092674|581513475|FG001|Overall Study|Adverse Event or Side Effects|4|||
161032803|NCT03092674|581513476|FG002|Overall Study|Adverse Event or Side Effects|4|||
161032804|NCT03092674|581513474|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
161032805|NCT03092674|581513475|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
161032806|NCT03092674|581513476|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
161032807|NCT03092674|581513474|FG000|Overall Study|Progression/Relapse|5|||
161032808|NCT03092674|581513475|FG001|Overall Study|Progression/Relapse|4|||
161032809|NCT03092674|581513476|FG002|Overall Study|Progression/Relapse|8|||
161032810|NCT03092674|581513474|FG000|Overall Study|Death|4|||
161032811|NCT03092674|581513475|FG001|Overall Study|Death|8|||
161032812|NCT03092674|581513476|FG002|Overall Study|Death|2|||
161032813|NCT03092674|581513474|FG000|Overall Study|Other - Not Protocol Specified|11|||
161032814|NCT03092674|581513475|FG001|Overall Study|Other - Not Protocol Specified|8|||
161032815|NCT03092674|581513476|FG002|Overall Study|Other - Not Protocol Specified|8|||
161032816|NCT02325154|581513477|FG000|Overall Study|Physician Decision|1|||
161032817|NCT04633278|581514357|FG000|Overall Study|Adverse Event|1|||
161032818|NCT04633278|581514358|FG001|Overall Study|Adverse Event|0|||
161032819|NCT04633278|581514357|FG000|Overall Study|Withdrawal by Subject|1|||
161032820|NCT04633278|581514358|FG001|Overall Study|Withdrawal by Subject|0|||
161032821|NCT04633278|581514357|FG000|Overall Study|Death|11|||
161032822|NCT04633278|581514358|FG001|Overall Study|Death|7|||
161032823|NCT04633278|581514357|FG000|Overall Study|Sponsor Decision|3|||
161032824|NCT04633278|581514358|FG001|Overall Study|Sponsor Decision|0|||
160976447|NCT00358215|581304568|FG000|Overall Study|Death|265|||
161278270|NCT02806024|582398435|FG000|Overall Study|Night Delivery|1|||
161278271|NCT02806024|582398436|FG001|Overall Study|Night Delivery|1|||
161278272|NCT02806024|582398435|FG000|Overall Study|DVT during antepartum admission|0|||
161278273|NCT02806024|582398436|FG001|Overall Study|DVT during antepartum admission|1|||
161278274|NCT01098474|582398437|FG000|Active Phase|Other|0|||
161278275|NCT01098474|582398438|FG001|Active Phase|Other|0|||
161278276|NCT01098474|582398439|FG002|Active Phase|Other|3|||
161278277|NCT01098474|582398440|FG003|Active Phase|Other|0|||
161278278|NCT01098474|582398441|FG004|Active Phase|Other|0|||
161278279|NCT01098474|582398442|FG005|Active Phase|Other|0|||
160976448|NCT00358215|581304569|FG001|Overall Study|Death|281|||
160976449|NCT00358215|581304568|FG000|Overall Study|Protocol Violation|64|||
160976450|NCT00358215|581304569|FG001|Overall Study|Protocol Violation|59|||
160976451|NCT00358215|581304568|FG000|Overall Study|Pregnancy|1|||
160976452|NCT00358215|581304569|FG001|Overall Study|Pregnancy|0|||
160976453|NCT00358215|581304568|FG000|Overall Study|Other|21|||
160976454|NCT00358215|581304569|FG001|Overall Study|Other|14|||
160976455|NCT00358215|581304568|FG000|Overall Study|Did not receive investigational product|2|||
160976456|NCT00358215|581304569|FG001|Overall Study|Did not receive investigational product|3|||
160976457|NCT00871351|581304570|FG000|Overall Study|Withdrawal by Subject|1|||
160976458|NCT00871351|581304571|FG001|Overall Study|Withdrawal by Subject|0|||
160976459|NCT00871351|581304572|FG002|Overall Study|Withdrawal by Subject|0|||
160976460|NCT00871351|581304570|FG000|Overall Study|Adverse Event|3|||
160976461|NCT00871351|581304571|FG001|Overall Study|Adverse Event|1|||
160976462|NCT00871351|581304572|FG002|Overall Study|Adverse Event|0|||
160976463|NCT00744237|581304573|FG000|Overall Study|Lack of Efficacy|1|||
160976464|NCT00744237|581304574|FG001|Overall Study|Lack of Efficacy|1|||
160976465|NCT00744237|581304575|FG002|Overall Study|Lack of Efficacy|0|||
160976466|NCT00744237|581304573|FG000|Overall Study|Withdrawal by Subject|9|||
160976467|NCT00744237|581304574|FG001|Overall Study|Withdrawal by Subject|5|||
160976468|NCT00744237|581304575|FG002|Overall Study|Withdrawal by Subject|3|||
160976469|NCT00744237|581304573|FG000|Overall Study|Lost to Follow-up|1|||
160976470|NCT00744237|581304574|FG001|Overall Study|Lost to Follow-up|1|||
160976471|NCT00744237|581304575|FG002|Overall Study|Lost to Follow-up|1|||
160976472|NCT00744237|581304573|FG000|Overall Study|Protocol Violation|3|||
160976473|NCT00744237|581304574|FG001|Overall Study|Protocol Violation|4|||
160976474|NCT00744237|581304575|FG002|Overall Study|Protocol Violation|3|||
160976475|NCT00744237|581304573|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
160976476|NCT00744237|581304574|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
160976477|NCT00744237|581304575|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
160976478|NCT00744237|581304573|FG000|Overall Study|Dosing Error|1|||
160976479|NCT00744237|581304574|FG001|Overall Study|Dosing Error|0|||
160976480|NCT00744237|581304575|FG002|Overall Study|Dosing Error|1|||
160976481|NCT00744237|581304573|FG000|Overall Study|Study Drug Error|1|||
160976482|NCT00744237|581304574|FG001|Overall Study|Study Drug Error|0|||
160976483|NCT00744237|581304575|FG002|Overall Study|Study Drug Error|0|||
160976484|NCT00744237|581304573|FG000|Overall Study|Prohibited Concomitant Medication|0|||
160976485|NCT00744237|581304574|FG001|Overall Study|Prohibited Concomitant Medication|0|||
160976486|NCT00744237|581304575|FG002|Overall Study|Prohibited Concomitant Medication|1|||
160976487|NCT00744237|581304573|FG000|Overall Study|Poor Compliance|0|||
160976488|NCT00744237|581304574|FG001|Overall Study|Poor Compliance|2|||
160976489|NCT00744237|581304575|FG002|Overall Study|Poor Compliance|0|||
160976490|NCT00744237|581304573|FG000|Overall Study|Administrative. Site Closed|1|||
160976491|NCT00744237|581304574|FG001|Overall Study|Administrative. Site Closed|1|||
160976492|NCT00744237|581304575|FG002|Overall Study|Administrative. Site Closed|1|||
160976493|NCT00744237|581304573|FG000|Overall Study|Adverse Event|9|||
160976494|NCT00744237|581304574|FG001|Overall Study|Adverse Event|13|||
160976495|NCT00744237|581304575|FG002|Overall Study|Adverse Event|5|||
160976496|NCT02032173|581304578|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
160976497|NCT02291289|581304582|FG000|Induction Treatment|Withdrawal by Subject|0|||
160976498|NCT02291289|581304583|FG001|Induction Treatment|Withdrawal by Subject|0|||
160976499|NCT02291289|581304584|FG002|Induction Treatment|Withdrawal by Subject|0|||
160976500|NCT02291289|581304585|FG003|Induction Treatment|Withdrawal by Subject|24|||
160976501|NCT02291289|581304586|FG004|Induction Treatment|Withdrawal by Subject|0|||
160976502|NCT02291289|581304587|FG005|Induction Treatment|Withdrawal by Subject|0|||
160976503|NCT02291289|581304588|FG006|Induction Treatment|Withdrawal by Subject|0|||
160976504|NCT02291289|581304589|FG007|Induction Treatment|Withdrawal by Subject|0|||
160976505|NCT02291289|581304590|FG008|Induction Treatment|Withdrawal by Subject|0|||
160976506|NCT02291289|581304591|FG009|Induction Treatment|Withdrawal by Subject|18|||
160976507|NCT02291289|581304592|FG010|Induction Treatment|Withdrawal by Subject|0|||
160976508|NCT02291289|581304593|FG011|Induction Treatment|Withdrawal by Subject|0|||
160976509|NCT02291289|581304594|FG012|Induction Treatment|Withdrawal by Subject|0|||
160976510|NCT02291289|581304582|FG000|Induction Treatment|Adverse Event|0|||
160976511|NCT02291289|581304583|FG001|Induction Treatment|Adverse Event|0|||
160976512|NCT02291289|581304584|FG002|Induction Treatment|Adverse Event|0|||
160976513|NCT02291289|581304585|FG003|Induction Treatment|Adverse Event|3|||
160976514|NCT02291289|581304586|FG004|Induction Treatment|Adverse Event|0|||
161278280|NCT01098474|582398437|FG000|Active Phase|Withdrawal by Subject|1|||
161278281|NCT01098474|582398438|FG001|Active Phase|Withdrawal by Subject|1|||
161278282|NCT01098474|582398439|FG002|Active Phase|Withdrawal by Subject|2|||
161278283|NCT01098474|582398440|FG003|Active Phase|Withdrawal by Subject|0|||
161278284|NCT01098474|582398441|FG004|Active Phase|Withdrawal by Subject|0|||
161278285|NCT01098474|582398442|FG005|Active Phase|Withdrawal by Subject|0|||
161278286|NCT01098474|582398437|FG000|Active Phase|Lost to Follow-up|1|||
161278287|NCT01098474|582398438|FG001|Active Phase|Lost to Follow-up|0|||
161278288|NCT01098474|582398439|FG002|Active Phase|Lost to Follow-up|0|||
161278289|NCT01098474|582398440|FG003|Active Phase|Lost to Follow-up|0|||
161278290|NCT01098474|582398441|FG004|Active Phase|Lost to Follow-up|0|||
161278291|NCT01098474|582398442|FG005|Active Phase|Lost to Follow-up|0|||
161278292|NCT01098474|582398437|FG000|Follow Up Phase|Travelled out of study area|0|||
161278293|NCT01098474|582398438|FG001|Follow Up Phase|Travelled out of study area|0|||
161278294|NCT01098474|582398439|FG002|Follow Up Phase|Travelled out of study area|0|||
161278295|NCT01098474|582398440|FG003|Follow Up Phase|Travelled out of study area|0|||
161278296|NCT01098474|582398441|FG004|Follow Up Phase|Travelled out of study area|1|||
161278297|NCT01098474|582398442|FG005|Follow Up Phase|Travelled out of study area|0|||
161278298|NCT01098474|582398437|FG000|Follow Up Phase|Other|0|||
161278299|NCT01098474|582398438|FG001|Follow Up Phase|Other|0|||
161278300|NCT01098474|582398439|FG002|Follow Up Phase|Other|0|||
161278301|NCT01098474|582398440|FG003|Follow Up Phase|Other|0|||
161278302|NCT01098474|582398441|FG004|Follow Up Phase|Other|0|||
161278303|NCT01098474|582398442|FG005|Follow Up Phase|Other|4|||
161278304|NCT01098474|582398437|FG000|Follow Up Phase|Withdrawal by Subject|0|||
161278305|NCT01098474|582398438|FG001|Follow Up Phase|Withdrawal by Subject|0|||
161278306|NCT01098474|582398439|FG002|Follow Up Phase|Withdrawal by Subject|0|||
161278307|NCT01098474|582398440|FG003|Follow Up Phase|Withdrawal by Subject|2|||
161278308|NCT01098474|582398441|FG004|Follow Up Phase|Withdrawal by Subject|0|||
161278309|NCT01098474|582398442|FG005|Follow Up Phase|Withdrawal by Subject|1|||
161278310|NCT01098474|582398437|FG000|Follow Up Phase|Lost to Follow-up|0|||
161278311|NCT01098474|582398438|FG001|Follow Up Phase|Lost to Follow-up|0|||
161278312|NCT01098474|582398439|FG002|Follow Up Phase|Lost to Follow-up|0|||
161278313|NCT01098474|582398440|FG003|Follow Up Phase|Lost to Follow-up|0|||
161278314|NCT01098474|582398441|FG004|Follow Up Phase|Lost to Follow-up|1|||
161278315|NCT01098474|582398442|FG005|Follow Up Phase|Lost to Follow-up|0|||
161278316|NCT00626561|582398443|FG000|Overall Study|Withdrawal by Subject|2|||
161278317|NCT00626561|582398443|FG000|Overall Study|Disease Progression|2|||
161278318|NCT02797171|582398446|FG000|Overall Study|Lost to Follow-up|2|||
161278319|NCT02797171|582398447|FG001|Overall Study|Lost to Follow-up|0|||
161278320|NCT02797171|582398448|FG002|Overall Study|Lost to Follow-up|2|||
161278321|NCT02797171|582398449|FG003|Overall Study|Lost to Follow-up|1|||
161278322|NCT02797171|582398450|FG004|Overall Study|Lost to Follow-up|2|||
161278323|NCT02797171|582398451|FG005|Overall Study|Lost to Follow-up|0|||
161278324|NCT02797171|582398446|FG000|Overall Study|Withdrawal by Subject|1|||
161278325|NCT02797171|582398447|FG001|Overall Study|Withdrawal by Subject|1|||
161278326|NCT02797171|582398448|FG002|Overall Study|Withdrawal by Subject|0|||
161278327|NCT02797171|582398449|FG003|Overall Study|Withdrawal by Subject|0|||
161278328|NCT02797171|582398450|FG004|Overall Study|Withdrawal by Subject|0|||
161278329|NCT02797171|582398451|FG005|Overall Study|Withdrawal by Subject|0|||
161278330|NCT02797171|582398446|FG000|Overall Study|Protocol Violation|1|||
161278331|NCT02797171|582398447|FG001|Overall Study|Protocol Violation|0|||
161278332|NCT02797171|582398448|FG002|Overall Study|Protocol Violation|0|||
161278333|NCT02797171|582398449|FG003|Overall Study|Protocol Violation|0|||
161278334|NCT02797171|582398450|FG004|Overall Study|Protocol Violation|0|||
161278335|NCT02797171|582398451|FG005|Overall Study|Protocol Violation|0|||
160976515|NCT02291289|581304587|FG005|Induction Treatment|Adverse Event|0|||
160976516|NCT02291289|581304588|FG006|Induction Treatment|Adverse Event|0|||
160976517|NCT02291289|581304589|FG007|Induction Treatment|Adverse Event|0|||
160976518|NCT02291289|581304590|FG008|Induction Treatment|Adverse Event|0|||
160976519|NCT02291289|581304591|FG009|Induction Treatment|Adverse Event|1|||
160976520|NCT02291289|581304592|FG010|Induction Treatment|Adverse Event|0|||
160976521|NCT02291289|581304593|FG011|Induction Treatment|Adverse Event|0|||
160976522|NCT02291289|581304594|FG012|Induction Treatment|Adverse Event|0|||
160976523|NCT02291289|581304582|FG000|Induction Treatment|Death|25|||
160976524|NCT02291289|581304583|FG001|Induction Treatment|Death|0|||
160976525|NCT02291289|581304584|FG002|Induction Treatment|Death|0|||
160976526|NCT02291289|581304585|FG003|Induction Treatment|Death|111|||
160976527|NCT02291289|581304586|FG004|Induction Treatment|Death|0|||
160976528|NCT02291289|581304587|FG005|Induction Treatment|Death|0|||
160976529|NCT02291289|581304588|FG006|Induction Treatment|Death|1|||
160976530|NCT02291289|581304589|FG007|Induction Treatment|Death|0|||
160976531|NCT02291289|581304590|FG008|Induction Treatment|Death|0|||
160976532|NCT02291289|581304591|FG009|Induction Treatment|Death|82|||
160976533|NCT02291289|581304592|FG010|Induction Treatment|Death|0|||
160976534|NCT02291289|581304593|FG011|Induction Treatment|Death|0|||
160976535|NCT02291289|581304594|FG012|Induction Treatment|Death|0|||
161278336|NCT02797171|582398446|FG000|Overall Study|Participant unable to adhere|0|||
161278337|NCT02797171|582398447|FG001|Overall Study|Participant unable to adhere|1|||
161278338|NCT02797171|582398448|FG002|Overall Study|Participant unable to adhere|0|||
161278339|NCT02797171|582398449|FG003|Overall Study|Participant unable to adhere|0|||
161278340|NCT02797171|582398450|FG004|Overall Study|Participant unable to adhere|0|||
161278341|NCT02797171|582398451|FG005|Overall Study|Participant unable to adhere|0|||
160976536|NCT02291289|581304582|FG000|Induction Treatment|Lost to Follow-up|1|||
160976537|NCT02291289|581304583|FG001|Induction Treatment|Lost to Follow-up|0|||
160976538|NCT02291289|581304584|FG002|Induction Treatment|Lost to Follow-up|0|||
160976539|NCT02291289|581304585|FG003|Induction Treatment|Lost to Follow-up|12|||
160976540|NCT02291289|581304586|FG004|Induction Treatment|Lost to Follow-up|0|||
160976541|NCT02291289|581304587|FG005|Induction Treatment|Lost to Follow-up|0|||
160976542|NCT02291289|581304588|FG006|Induction Treatment|Lost to Follow-up|0|||
160976543|NCT02291289|581304589|FG007|Induction Treatment|Lost to Follow-up|0|||
160976544|NCT02291289|581304590|FG008|Induction Treatment|Lost to Follow-up|0|||
160976545|NCT02291289|581304591|FG009|Induction Treatment|Lost to Follow-up|9|||
160976546|NCT02291289|581304592|FG010|Induction Treatment|Lost to Follow-up|0|||
160976547|NCT02291289|581304593|FG011|Induction Treatment|Lost to Follow-up|0|||
160976548|NCT02291289|581304594|FG012|Induction Treatment|Lost to Follow-up|0|||
160976549|NCT02291289|581304582|FG000|Induction Treatment|Non-Compliance|0|||
160976550|NCT02291289|581304583|FG001|Induction Treatment|Non-Compliance|0|||
160976551|NCT02291289|581304584|FG002|Induction Treatment|Non-Compliance|0|||
160976552|NCT02291289|581304585|FG003|Induction Treatment|Non-Compliance|1|||
160976553|NCT02291289|581304586|FG004|Induction Treatment|Non-Compliance|0|||
160976554|NCT02291289|581304587|FG005|Induction Treatment|Non-Compliance|0|||
160976555|NCT02291289|581304588|FG006|Induction Treatment|Non-Compliance|0|||
160976556|NCT02291289|581304589|FG007|Induction Treatment|Non-Compliance|0|||
160976557|NCT02291289|581304590|FG008|Induction Treatment|Non-Compliance|0|||
160976558|NCT02291289|581304591|FG009|Induction Treatment|Non-Compliance|1|||
160976559|NCT02291289|581304592|FG010|Induction Treatment|Non-Compliance|0|||
160976560|NCT02291289|581304593|FG011|Induction Treatment|Non-Compliance|0|||
160976561|NCT02291289|581304594|FG012|Induction Treatment|Non-Compliance|0|||
160976562|NCT02291289|581304582|FG000|Induction Treatment|Reason Not Specified|0|||
160976563|NCT02291289|581304583|FG001|Induction Treatment|Reason Not Specified|0|||
160976564|NCT02291289|581304584|FG002|Induction Treatment|Reason Not Specified|0|||
160976565|NCT02291289|581304585|FG003|Induction Treatment|Reason Not Specified|4|||
160976566|NCT02291289|581304586|FG004|Induction Treatment|Reason Not Specified|0|||
160976567|NCT02291289|581304587|FG005|Induction Treatment|Reason Not Specified|0|||
160976568|NCT02291289|581304588|FG006|Induction Treatment|Reason Not Specified|0|||
160976569|NCT02291289|581304589|FG007|Induction Treatment|Reason Not Specified|0|||
160976570|NCT02291289|581304590|FG008|Induction Treatment|Reason Not Specified|0|||
160976571|NCT02291289|581304591|FG009|Induction Treatment|Reason Not Specified|7|||
160976572|NCT02291289|581304592|FG010|Induction Treatment|Reason Not Specified|0|||
160976573|NCT02291289|581304593|FG011|Induction Treatment|Reason Not Specified|0|||
160976574|NCT02291289|581304594|FG012|Induction Treatment|Reason Not Specified|0|||
160976575|NCT02291289|581304582|FG000|Induction Treatment|Physician Decision|0|||
160976576|NCT02291289|581304583|FG001|Induction Treatment|Physician Decision|0|||
160976577|NCT02291289|581304584|FG002|Induction Treatment|Physician Decision|0|||
160976578|NCT02291289|581304585|FG003|Induction Treatment|Physician Decision|3|||
160976579|NCT02291289|581304586|FG004|Induction Treatment|Physician Decision|0|||
160976580|NCT02291289|581304587|FG005|Induction Treatment|Physician Decision|0|||
160976581|NCT02291289|581304588|FG006|Induction Treatment|Physician Decision|0|||
160976582|NCT02291289|581304589|FG007|Induction Treatment|Physician Decision|0|||
160976583|NCT02291289|581304590|FG008|Induction Treatment|Physician Decision|0|||
160976584|NCT02291289|581304591|FG009|Induction Treatment|Physician Decision|1|||
160976585|NCT02291289|581304592|FG010|Induction Treatment|Physician Decision|0|||
160976586|NCT02291289|581304593|FG011|Induction Treatment|Physician Decision|0|||
160976587|NCT02291289|581304594|FG012|Induction Treatment|Physician Decision|0|||
160976588|NCT02291289|581304582|FG000|Induction Treatment|Protocol Violation|0|||
160976589|NCT02291289|581304583|FG001|Induction Treatment|Protocol Violation|0|||
160976590|NCT02291289|581304584|FG002|Induction Treatment|Protocol Violation|0|||
160976591|NCT02291289|581304585|FG003|Induction Treatment|Protocol Violation|3|||
160976592|NCT02291289|581304586|FG004|Induction Treatment|Protocol Violation|0|||
160976593|NCT02291289|581304587|FG005|Induction Treatment|Protocol Violation|0|||
160976594|NCT02291289|581304588|FG006|Induction Treatment|Protocol Violation|0|||
160976595|NCT02291289|581304589|FG007|Induction Treatment|Protocol Violation|0|||
160976596|NCT02291289|581304590|FG008|Induction Treatment|Protocol Violation|0|||
160976597|NCT02291289|581304591|FG009|Induction Treatment|Protocol Violation|2|||
160976598|NCT02291289|581304592|FG010|Induction Treatment|Protocol Violation|0|||
160976599|NCT02291289|581304593|FG011|Induction Treatment|Protocol Violation|0|||
160976600|NCT02291289|581304594|FG012|Induction Treatment|Protocol Violation|0|||
160976601|NCT02291289|581304582|FG000|Induction Treatment|Missing|4|||
160976602|NCT02291289|581304583|FG001|Induction Treatment|Missing|0|||
160976603|NCT02291289|581304584|FG002|Induction Treatment|Missing|0|||
160976604|NCT02291289|581304585|FG003|Induction Treatment|Missing|14|||
160976605|NCT02291289|581304586|FG004|Induction Treatment|Missing|0|||
160976606|NCT02291289|581304587|FG005|Induction Treatment|Missing|0|||
160976607|NCT02291289|581304588|FG006|Induction Treatment|Missing|0|||
161032825|NCT04633278|581514357|FG000|Overall Study|Not Listed|1|||
161032826|NCT04633278|581514358|FG001|Overall Study|Not Listed|0|||
161032827|NCT03705793|581514362|FG000|Overall Study|Lost to Follow-up|3|||
161278342|NCT02797171|582398446|FG000|Overall Study|Not Randomized|0|||
161278343|NCT02797171|582398447|FG001|Overall Study|Not Randomized|0|||
161278344|NCT02797171|582398448|FG002|Overall Study|Not Randomized|0|||
161278345|NCT02797171|582398449|FG003|Overall Study|Not Randomized|0|||
161278346|NCT02797171|582398450|FG004|Overall Study|Not Randomized|0|||
161278347|NCT02797171|582398451|FG005|Overall Study|Not Randomized|1|||
161278348|NCT01372748|582398454|FG000|Overall Study|Lost to Follow-up|16|||
161278349|NCT01372748|582398455|FG001|Overall Study|Lost to Follow-up|34|||
161278350|NCT01372748|582398454|FG000|Overall Study|Withdrawal by Subject|7|||
161278351|NCT01372748|582398455|FG001|Overall Study|Withdrawal by Subject|5|||
161278352|NCT00134901|582398456|FG000|Overall Study|Lost to Follow-up|5|||
161278353|NCT00134901|582398457|FG001|Overall Study|Lost to Follow-up|5|||
161278354|NCT00134901|582398456|FG000|Overall Study|discontinued intervention|12|||
161278355|NCT00134901|582398457|FG001|Overall Study|discontinued intervention|10|||
161278356|NCT00606632|582398458|FG000|Overall Study|Withdrawal by Subject|13|||
161278357|NCT00606632|582398458|FG000|Overall Study|Miscellaneous reasons|9|||
161278358|NCT00711880|582398459|FG000|Overall Study|Adverse Event|11|||
161278359|NCT00711880|582398460|FG001|Overall Study|Adverse Event|2|||
161278360|NCT00711880|582398459|FG000|Overall Study|Patient non-compliance|1|||
161278361|NCT00711880|582398460|FG001|Overall Study|Patient non-compliance|0|||
161278362|NCT00711880|582398459|FG000|Overall Study|Lack of Efficacy|1|||
161278363|NCT00711880|582398460|FG001|Overall Study|Lack of Efficacy|5|||
161278364|NCT03908437|582398461|FG000|Overall Study|Death|0|||
161278365|NCT03908437|582398462|FG001|Overall Study|Death|1|||
161278366|NCT03908437|582398461|FG000|Overall Study|Lost to Follow-up|31|||
161278367|NCT03908437|582398462|FG001|Overall Study|Lost to Follow-up|24|||
161278368|NCT03633825|582398463|FG000|Enrollment|Did not post on network|5066|||
161278369|NCT03633825|582398464|FG001|Enrollment|Did not post on network|5080|||
161278370|NCT03633825|582398463|FG000|Enrollment|Post not classified as crisis|13967|||
161278371|NCT03633825|582398464|FG001|Enrollment|Post not classified as crisis|13757|||
161278372|NCT03633825|582398463|FG000|Follow up|Lost to Follow-up|478|||
161278373|NCT03633825|582398464|FG001|Follow up|Lost to Follow-up|450|||
161278374|NCT04841577|582398465|FG000|Overall Study|Adverse Event|5|||
161278375|NCT04841577|582398466|FG001|Overall Study|Adverse Event|10|||
161278376|NCT04841577|582398465|FG000|Overall Study|Lost to Follow-up|8|||
161278377|NCT04841577|582398466|FG001|Overall Study|Lost to Follow-up|7|||
161278378|NCT04841577|582398465|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161278379|NCT04841577|582398466|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
161278380|NCT04841577|582398465|FG000|Overall Study|Other|0|||
161278381|NCT04841577|582398466|FG001|Overall Study|Other|1|||
161278382|NCT05246670|582398469|FG000|Overall Study|Withdrawal by Subject|2|||
161278383|NCT05246670|582398470|FG001|Overall Study|Withdrawal by Subject|3|||
161278384|NCT05246670|582398471|FG002|Overall Study|Withdrawal by Subject|0|||
161278385|NCT05246670|582398472|FG003|Overall Study|Withdrawal by Subject|1|||
161278386|NCT05246670|582398469|FG000|Overall Study|Adverse Event|0|||
161278387|NCT05246670|582398470|FG001|Overall Study|Adverse Event|0|||
161278388|NCT05246670|582398471|FG002|Overall Study|Adverse Event|1|||
161278389|NCT05246670|582398472|FG003|Overall Study|Adverse Event|0|||
161278390|NCT05246670|582398469|FG000|Overall Study|Physician Decision|1|||
161278391|NCT05246670|582398470|FG001|Overall Study|Physician Decision|0|||
161278392|NCT05246670|582398471|FG002|Overall Study|Physician Decision|0|||
161278393|NCT05246670|582398472|FG003|Overall Study|Physician Decision|0|||
161278394|NCT05246670|582398469|FG000|Overall Study|Protocol Violation|1|||
161278395|NCT05246670|582398470|FG001|Overall Study|Protocol Violation|0|||
161278396|NCT05246670|582398471|FG002|Overall Study|Protocol Violation|0|||
161278397|NCT05246670|582398472|FG003|Overall Study|Protocol Violation|0|||
161278398|NCT00356525|582398473|FG000|Overall Study|Progressive Disease|8|||
161278399|NCT00356525|582398474|FG001|Overall Study|Progressive Disease|5|||
161032828|NCT03705793|581514363|FG001|Overall Study|Lost to Follow-up|4|||
161032829|NCT03705793|581514362|FG000|Overall Study|Withdrawal by Subject|2|||
161032830|NCT03705793|581514363|FG001|Overall Study|Withdrawal by Subject|1|||
161278400|NCT00356525|582398475|FG002|Overall Study|Progressive Disease|4|||
161278401|NCT00356525|582398476|FG003|Overall Study|Progressive Disease|2|||
161278402|NCT00356525|582398473|FG000|Overall Study|Adverse Event|1|||
161278403|NCT00356525|582398474|FG001|Overall Study|Adverse Event|3|||
161278404|NCT00356525|582398475|FG002|Overall Study|Adverse Event|1|||
161278405|NCT00356525|582398476|FG003|Overall Study|Adverse Event|1|||
161278406|NCT00356525|582398473|FG000|Overall Study|Lost to Follow-up|1|||
161278407|NCT00356525|582398474|FG001|Overall Study|Lost to Follow-up|0|||
161278408|NCT00356525|582398475|FG002|Overall Study|Lost to Follow-up|0|||
161032831|NCT00447980|581514364|FG000|Overall Study|Withdrawal by Subject|1|||
161278409|NCT00356525|582398476|FG003|Overall Study|Lost to Follow-up|0|||
161278410|NCT00356525|582398473|FG000|Overall Study|Physician Decision|2|||
161278411|NCT00356525|582398474|FG001|Overall Study|Physician Decision|2|||
161278412|NCT00356525|582398475|FG002|Overall Study|Physician Decision|2|||
161278413|NCT00356525|582398476|FG003|Overall Study|Physician Decision|1|||
161278414|NCT00356525|582398473|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
160976608|NCT02291289|581304589|FG007|Induction Treatment|Missing|0|||
161032832|NCT00447980|581514365|FG001|Overall Study|Withdrawal by Subject|1|||
161032833|NCT00447980|581514366|FG002|Overall Study|Withdrawal by Subject|4|||
161032834|NCT00447980|581514367|FG003|Overall Study|Withdrawal by Subject|4|||
161032835|NCT00447980|581514364|FG000|Overall Study|Lost to Follow-up|1|||
161032836|NCT00447980|581514365|FG001|Overall Study|Lost to Follow-up|1|||
161032837|NCT00447980|581514366|FG002|Overall Study|Lost to Follow-up|0|||
161032838|NCT00447980|581514367|FG003|Overall Study|Lost to Follow-up|0|||
161032839|NCT00447980|581514364|FG000|Overall Study|Did not proceed with surgery|3|||
161032840|NCT00447980|581514365|FG001|Overall Study|Did not proceed with surgery|3|||
161032841|NCT00447980|581514366|FG002|Overall Study|Did not proceed with surgery|2|||
161032842|NCT00447980|581514367|FG003|Overall Study|Did not proceed with surgery|2|||
161032843|NCT02720068|581514368|FG000|Overall Study|Adverse Event|0|||
161032844|NCT02720068|581514369|FG001|Overall Study|Adverse Event|0|||
161032845|NCT02720068|581514370|FG002|Overall Study|Adverse Event|0|||
161032846|NCT02720068|581514371|FG003|Overall Study|Adverse Event|0|||
161032847|NCT02720068|581514372|FG004|Overall Study|Adverse Event|0|||
161032848|NCT02720068|581514373|FG005|Overall Study|Adverse Event|0|||
161032849|NCT02720068|581514374|FG006|Overall Study|Adverse Event|0|||
161032850|NCT02720068|581514375|FG007|Overall Study|Adverse Event|0|||
161032851|NCT02720068|581514376|FG008|Overall Study|Adverse Event|0|||
161032852|NCT02720068|581514377|FG009|Overall Study|Adverse Event|0|||
161032853|NCT02720068|581514378|FG010|Overall Study|Adverse Event|0|||
161032854|NCT02720068|581514379|FG011|Overall Study|Adverse Event|1|||
161032855|NCT02720068|581514380|FG012|Overall Study|Adverse Event|0|||
161032856|NCT02720068|581514381|FG013|Overall Study|Adverse Event|0|||
161032857|NCT02720068|581514382|FG014|Overall Study|Adverse Event|0|||
161032858|NCT02720068|581514383|FG015|Overall Study|Adverse Event|0|||
161032859|NCT02720068|581514384|FG016|Overall Study|Adverse Event|0|||
160976609|NCT02291289|581304590|FG008|Induction Treatment|Missing|0|||
160976610|NCT02291289|581304591|FG009|Induction Treatment|Missing|54|||
160976611|NCT02291289|581304592|FG010|Induction Treatment|Missing|0|||
160976612|NCT02291289|581304593|FG011|Induction Treatment|Missing|0|||
161278415|NCT00356525|582398474|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
161278416|NCT00356525|582398475|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
161278417|NCT00356525|582398476|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
161278418|NCT00356525|582398473|FG000|Overall Study|Withdrawal by Subject|1|||
161278419|NCT00356525|582398474|FG001|Overall Study|Withdrawal by Subject|1|||
161278420|NCT00356525|582398475|FG002|Overall Study|Withdrawal by Subject|0|||
161278421|NCT00356525|582398476|FG003|Overall Study|Withdrawal by Subject|3|||
161278422|NCT00356525|582398473|FG000|Overall Study|Death|0|||
161278423|NCT00356525|582398474|FG001|Overall Study|Death|0|||
161278424|NCT00356525|582398475|FG002|Overall Study|Death|0|||
161278425|NCT00356525|582398476|FG003|Overall Study|Death|1|||
161278426|NCT00356525|582398473|FG000|Overall Study|Sponsor Decision|0|||
161278427|NCT00356525|582398474|FG001|Overall Study|Sponsor Decision|0|||
161278428|NCT00356525|582398475|FG002|Overall Study|Sponsor Decision|0|||
161278429|NCT00356525|582398476|FG003|Overall Study|Sponsor Decision|1|||
161278430|NCT00652340|582398482|FG000|Overall Study|Had not progressed.|4|||
161278431|NCT00652340|582398483|FG001|Overall Study|Had not progressed.|3|||
161278432|NCT00214383|582398486|FG000|Overall Study|Lost to Follow-up|16|||
161278433|NCT00214383|582398487|FG001|Overall Study|Lost to Follow-up|26|||
161278434|NCT04152291|582398488|FG000|Overall Study|Covid-19 restrictions|27|||
161278435|NCT04152291|582398488|FG000|Overall Study|Withdrawal by Subject|3|||
161278436|NCT03597295|582398489|FG000|Overall Study|Death|70|||
161278437|NCT03597295|582398489|FG000|Overall Study|Lost to Follow-up|7|||
161278438|NCT00879411|582398490|FG000|Overall Study|lost to follow-up (non-AE)|162|||
161278439|NCT05124691|582398491|FG000|Phase II|Eligibility criteria|0|||
161278440|NCT05124691|582398492|FG001|Phase II|Eligibility criteria|1|||
161278441|NCT05124691|582398493|FG002|Phase II|Eligibility criteria|0|||
161278442|NCT05124691|582398491|FG000|Phase II|Withdrawal by Subject|6|||
161278443|NCT05124691|582398492|FG001|Phase II|Withdrawal by Subject|2|||
161278444|NCT05124691|582398493|FG002|Phase II|Withdrawal by Subject|3|||
161032860|NCT02720068|581514385|FG017|Overall Study|Adverse Event|0|||
161032861|NCT02720068|581514368|FG000|Overall Study|Death|1|||
161032862|NCT02720068|581514369|FG001|Overall Study|Death|3|||
161032863|NCT02720068|581514370|FG002|Overall Study|Death|2|||
161032864|NCT02720068|581514371|FG003|Overall Study|Death|1|||
160976613|NCT02291289|581304594|FG012|Induction Treatment|Missing|0|||
160976614|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161278445|NCT05124691|582398491|FG000|Phase III|Withdrawal by Subject|6|||
160976615|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
161278446|NCT05124691|582398492|FG001|Phase III|Withdrawal by Subject|4|||
161278447|NCT05124691|582398493|FG002|Phase III|Withdrawal by Subject|4|||
161278448|NCT05124691|582398491|FG000|Phase III|Lost to Follow-up|1|||
161278449|NCT05124691|582398492|FG001|Phase III|Lost to Follow-up|0|||
161278450|NCT05124691|582398493|FG002|Phase III|Lost to Follow-up|0|||
161278451|NCT00428116|582398494|FG000|Overall Study|Death|1|||
161032865|NCT02720068|581514372|FG004|Overall Study|Death|2|||
161278452|NCT00428116|582398495|FG001|Overall Study|Death|0|||
161032866|NCT02720068|581514373|FG005|Overall Study|Death|1|||
161032867|NCT02720068|581514374|FG006|Overall Study|Death|2|||
161032868|NCT02720068|581514375|FG007|Overall Study|Death|2|||
161032869|NCT02720068|581514376|FG008|Overall Study|Death|3|||
161032870|NCT02720068|581514377|FG009|Overall Study|Death|1|||
161032871|NCT02720068|581514378|FG010|Overall Study|Death|20|||
161032872|NCT02720068|581514379|FG011|Overall Study|Death|166|||
161032873|NCT02720068|581514380|FG012|Overall Study|Death|34|||
161032874|NCT02720068|581514381|FG013|Overall Study|Death|30|||
161032875|NCT02720068|581514382|FG014|Overall Study|Death|45|||
161032876|NCT02720068|581514383|FG015|Overall Study|Death|16|||
161032877|NCT02720068|581514384|FG016|Overall Study|Death|20|||
161032878|NCT02720068|581514385|FG017|Overall Study|Death|28|||
161032879|NCT02720068|581514368|FG000|Overall Study|Lost to Follow-up|0|||
161032880|NCT02720068|581514369|FG001|Overall Study|Lost to Follow-up|0|||
161032881|NCT02720068|581514370|FG002|Overall Study|Lost to Follow-up|0|||
161032882|NCT02720068|581514371|FG003|Overall Study|Lost to Follow-up|0|||
161032883|NCT02720068|581514372|FG004|Overall Study|Lost to Follow-up|0|||
161032884|NCT02720068|581514373|FG005|Overall Study|Lost to Follow-up|0|||
161032885|NCT02720068|581514374|FG006|Overall Study|Lost to Follow-up|0|||
161032886|NCT02720068|581514375|FG007|Overall Study|Lost to Follow-up|0|||
161032887|NCT02720068|581514376|FG008|Overall Study|Lost to Follow-up|0|||
161032888|NCT02720068|581514377|FG009|Overall Study|Lost to Follow-up|0|||
161032889|NCT02720068|581514378|FG010|Overall Study|Lost to Follow-up|0|||
161032890|NCT02720068|581514379|FG011|Overall Study|Lost to Follow-up|1|||
161032891|NCT02720068|581514380|FG012|Overall Study|Lost to Follow-up|0|||
161032892|NCT02720068|581514381|FG013|Overall Study|Lost to Follow-up|1|||
161032893|NCT02720068|581514382|FG014|Overall Study|Lost to Follow-up|2|||
161032894|NCT02720068|581514383|FG015|Overall Study|Lost to Follow-up|0|||
161032895|NCT02720068|581514384|FG016|Overall Study|Lost to Follow-up|0|||
161032896|NCT02720068|581514385|FG017|Overall Study|Lost to Follow-up|1|||
161032897|NCT02720068|581514368|FG000|Overall Study|Physician Decision|0|||
161032898|NCT02720068|581514369|FG001|Overall Study|Physician Decision|0|||
161032899|NCT02720068|581514370|FG002|Overall Study|Physician Decision|0|||
161032900|NCT02720068|581514371|FG003|Overall Study|Physician Decision|1|||
161032901|NCT02720068|581514372|FG004|Overall Study|Physician Decision|0|||
161032902|NCT02720068|581514373|FG005|Overall Study|Physician Decision|0|||
161032903|NCT02720068|581514374|FG006|Overall Study|Physician Decision|0|||
161032904|NCT02720068|581514375|FG007|Overall Study|Physician Decision|0|||
161032905|NCT02720068|581514376|FG008|Overall Study|Physician Decision|0|||
161032906|NCT02720068|581514377|FG009|Overall Study|Physician Decision|0|||
161032907|NCT02720068|581514378|FG010|Overall Study|Physician Decision|0|||
161032908|NCT02720068|581514379|FG011|Overall Study|Physician Decision|1|||
161032909|NCT02720068|581514380|FG012|Overall Study|Physician Decision|0|||
161278453|NCT00428116|582398494|FG000|Overall Study|Withdrawal by Subject|1|||
161278454|NCT00428116|582398495|FG001|Overall Study|Withdrawal by Subject|0|||
161278455|NCT00428116|582398494|FG000|Overall Study|Lost to Follow-up|1|||
161278456|NCT00428116|582398495|FG001|Overall Study|Lost to Follow-up|0|||
161278457|NCT02257385|582398501|FG000|Overall Study|Adverse Event|12|||
161278458|NCT02257385|582398502|FG001|Overall Study|Adverse Event|8|||
161278459|NCT02257385|582398501|FG000|Overall Study|Lack of Efficacy|1|||
161278460|NCT02257385|582398502|FG001|Overall Study|Lack of Efficacy|2|||
161278461|NCT02257385|582398501|FG000|Overall Study|Protocol Violation|5|||
161278462|NCT02257385|582398502|FG001|Overall Study|Protocol Violation|7|||
161278463|NCT02257385|582398501|FG000|Overall Study|Lost to Follow-up|0|||
161278464|NCT02257385|582398502|FG001|Overall Study|Lost to Follow-up|1|||
161278465|NCT02257385|582398501|FG000|Overall Study|Withdrawal by Subject|4|||
161278466|NCT02257385|582398502|FG001|Overall Study|Withdrawal by Subject|4|||
161278467|NCT00086281|582398509|FG000|Phase 1|Adverse Event|0|||
161278468|NCT00086281|582398510|FG001|Phase 1|Adverse Event|0|||
161032910|NCT02720068|581514381|FG013|Overall Study|Physician Decision|0|||
161032911|NCT02720068|581514382|FG014|Overall Study|Physician Decision|0|||
161344763|NCT01047319|582647277|FG000|Overall Study|Teva requested participant withdrawal|3|||
161344764|NCT01047319|582647278|FG001|Overall Study|Teva requested participant withdrawal|0|||
161344765|NCT01047319|582647279|FG002|Overall Study|Teva requested participant withdrawal|1|||
161344766|NCT01047319|582647277|FG000|Overall Study|Protocol Violation|3|||
161032912|NCT02720068|581514383|FG015|Overall Study|Physician Decision|0|||
161032913|NCT02720068|581514384|FG016|Overall Study|Physician Decision|0|||
161032914|NCT02720068|581514385|FG017|Overall Study|Physician Decision|1|||
161278469|NCT00086281|582398511|FG002|Phase 1|Adverse Event|0|||
161278470|NCT00086281|582398512|FG003|Phase 1|Adverse Event|0|||
161032915|NCT02720068|581514368|FG000|Overall Study|Progressive Disease|2|||
161278471|NCT00086281|582398513|FG004|Phase 1|Adverse Event|0|||
161032916|NCT02720068|581514369|FG001|Overall Study|Progressive Disease|3|||
161032917|NCT02720068|581514370|FG002|Overall Study|Progressive Disease|1|||
161032918|NCT02720068|581514371|FG003|Overall Study|Progressive Disease|1|||
161278472|NCT00086281|582398514|FG005|Phase 1|Adverse Event|0|||
161278473|NCT00086281|582398515|FG006|Phase 1|Adverse Event|0|||
161032919|NCT02720068|581514372|FG004|Overall Study|Progressive Disease|1|||
161032920|NCT02720068|581514373|FG005|Overall Study|Progressive Disease|2|||
161032921|NCT02720068|581514374|FG006|Overall Study|Progressive Disease|1|||
161278474|NCT00086281|582398516|FG007|Phase 1|Adverse Event|0|||
161032922|NCT02720068|581514375|FG007|Overall Study|Progressive Disease|1|||
161032923|NCT02720068|581514376|FG008|Overall Study|Progressive Disease|0|||
161032924|NCT02720068|581514377|FG009|Overall Study|Progressive Disease|1|||
161032925|NCT02720068|581514378|FG010|Overall Study|Progressive Disease|0|||
161032926|NCT02720068|581514379|FG011|Overall Study|Progressive Disease|4|||
161032927|NCT02720068|581514380|FG012|Overall Study|Progressive Disease|1|||
161032928|NCT02720068|581514381|FG013|Overall Study|Progressive Disease|0|||
161032929|NCT02720068|581514382|FG014|Overall Study|Progressive Disease|0|||
161032930|NCT02720068|581514383|FG015|Overall Study|Progressive Disease|0|||
161032931|NCT02720068|581514384|FG016|Overall Study|Progressive Disease|0|||
161032932|NCT02720068|581514385|FG017|Overall Study|Progressive Disease|0|||
161032933|NCT02720068|581514368|FG000|Overall Study|Sponsor Decision|0|||
161032934|NCT02720068|581514369|FG001|Overall Study|Sponsor Decision|0|||
161032935|NCT02720068|581514370|FG002|Overall Study|Sponsor Decision|0|||
161032936|NCT02720068|581514371|FG003|Overall Study|Sponsor Decision|0|||
161032937|NCT02720068|581514372|FG004|Overall Study|Sponsor Decision|0|||
161032938|NCT02720068|581514373|FG005|Overall Study|Sponsor Decision|0|||
161032939|NCT02720068|581514374|FG006|Overall Study|Sponsor Decision|0|||
161032940|NCT02720068|581514375|FG007|Overall Study|Sponsor Decision|0|||
161032941|NCT02720068|581514376|FG008|Overall Study|Sponsor Decision|0|||
161032942|NCT02720068|581514377|FG009|Overall Study|Sponsor Decision|0|||
161032943|NCT02720068|581514378|FG010|Overall Study|Sponsor Decision|0|||
161032944|NCT02720068|581514379|FG011|Overall Study|Sponsor Decision|6|||
161032945|NCT02720068|581514380|FG012|Overall Study|Sponsor Decision|3|||
161032946|NCT02720068|581514381|FG013|Overall Study|Sponsor Decision|2|||
161032947|NCT02720068|581514382|FG014|Overall Study|Sponsor Decision|4|||
161032948|NCT02720068|581514383|FG015|Overall Study|Sponsor Decision|4|||
161032949|NCT02720068|581514384|FG016|Overall Study|Sponsor Decision|0|||
161032950|NCT02720068|581514385|FG017|Overall Study|Sponsor Decision|8|||
161032951|NCT02720068|581514368|FG000|Overall Study|Withdrawal by Subject|0|||
161032952|NCT02720068|581514369|FG001|Overall Study|Withdrawal by Subject|0|||
161032953|NCT02720068|581514370|FG002|Overall Study|Withdrawal by Subject|0|||
161032954|NCT02720068|581514371|FG003|Overall Study|Withdrawal by Subject|0|||
161032955|NCT02720068|581514372|FG004|Overall Study|Withdrawal by Subject|0|||
161032956|NCT02720068|581514373|FG005|Overall Study|Withdrawal by Subject|0|||
161032957|NCT02720068|581514374|FG006|Overall Study|Withdrawal by Subject|0|||
161032958|NCT02720068|581514375|FG007|Overall Study|Withdrawal by Subject|0|||
161032959|NCT02720068|581514376|FG008|Overall Study|Withdrawal by Subject|0|||
161032960|NCT02720068|581514377|FG009|Overall Study|Withdrawal by Subject|1|||
161032961|NCT02720068|581514378|FG010|Overall Study|Withdrawal by Subject|0|||
161032962|NCT02720068|581514379|FG011|Overall Study|Withdrawal by Subject|27|||
161032963|NCT02720068|581514380|FG012|Overall Study|Withdrawal by Subject|2|||
161032964|NCT02720068|581514381|FG013|Overall Study|Withdrawal by Subject|8|||
161032965|NCT02720068|581514382|FG014|Overall Study|Withdrawal by Subject|7|||
161032966|NCT02720068|581514383|FG015|Overall Study|Withdrawal by Subject|0|||
161032967|NCT02720068|581514384|FG016|Overall Study|Withdrawal by Subject|0|||
161032968|NCT02720068|581514385|FG017|Overall Study|Withdrawal by Subject|2|||
161032969|NCT02720068|581514368|FG000|Overall Study|Protocol Violation|0|||
161032970|NCT02720068|581514369|FG001|Overall Study|Protocol Violation|0|||
161032971|NCT02720068|581514370|FG002|Overall Study|Protocol Violation|0|||
161032972|NCT02720068|581514371|FG003|Overall Study|Protocol Violation|0|||
161032973|NCT02720068|581514372|FG004|Overall Study|Protocol Violation|0|||
161032974|NCT02720068|581514373|FG005|Overall Study|Protocol Violation|0|||
161032975|NCT02720068|581514374|FG006|Overall Study|Protocol Violation|0|||
161032976|NCT02720068|581514375|FG007|Overall Study|Protocol Violation|0|||
161032977|NCT02720068|581514376|FG008|Overall Study|Protocol Violation|0|||
161032978|NCT02720068|581514377|FG009|Overall Study|Protocol Violation|0|||
161032979|NCT02720068|581514378|FG010|Overall Study|Protocol Violation|1|||
161032980|NCT02720068|581514379|FG011|Overall Study|Protocol Violation|0|||
161032981|NCT02720068|581514380|FG012|Overall Study|Protocol Violation|0|||
161032982|NCT02720068|581514381|FG013|Overall Study|Protocol Violation|0|||
161032983|NCT02720068|581514382|FG014|Overall Study|Protocol Violation|1|||
161032984|NCT02720068|581514383|FG015|Overall Study|Protocol Violation|0|||
161032985|NCT02720068|581514384|FG016|Overall Study|Protocol Violation|1|||
161032986|NCT02720068|581514385|FG017|Overall Study|Protocol Violation|0|||
161032987|NCT01773993|581514389|FG000|Overall Study|No Visit After Treatment|35|||
161032988|NCT04664881|581514390|FG000|Overall Study|Withdrawal by Subject|1|||
161032989|NCT04664881|581514391|FG001|Overall Study|Withdrawal by Subject|8|||
161032990|NCT04664881|581514390|FG000|Overall Study|Physician Decision|0|||
161032991|NCT04664881|581514391|FG001|Overall Study|Physician Decision|5|||
161032992|NCT04664881|581514390|FG000|Overall Study|Lost to Follow-up|1|||
161032993|NCT04664881|581514391|FG001|Overall Study|Lost to Follow-up|0|||
161032994|NCT04408755|581514410|FG000|Period A (Placebo lead-in)|Other|11|||
161032995|NCT04408755|581514411|FG001|Period A (Placebo lead-in)|Other|0|||
161032996|NCT04408755|581514412|FG002|Period A (Placebo lead-in)|Other|0|||
161032997|NCT04408755|581514413|FG003|Period A (Placebo lead-in)|Other|0|||
161032998|NCT04408755|581514410|FG000|Period B (Randomization Period)|Adverse Event|0|||
161032999|NCT04408755|581514411|FG001|Period B (Randomization Period)|Adverse Event|3|||
161033000|NCT04408755|581514412|FG002|Period B (Randomization Period)|Adverse Event|0|||
161278475|NCT00086281|582398517|FG008|Phase 1|Adverse Event|0|||
161278476|NCT00086281|582398518|FG009|Phase 1|Adverse Event|1|||
161278477|NCT00086281|582398519|FG010|Phase 1|Adverse Event|2|||
161278478|NCT00086281|582398520|FG011|Phase 1|Adverse Event|1|||
161278479|NCT00086281|582398521|FG012|Phase 1|Adverse Event|1|||
161278480|NCT00086281|582398522|FG013|Phase 1|Adverse Event|1|||
161278481|NCT00086281|582398523|FG014|Phase 1|Adverse Event|2|||
161278482|NCT00086281|582398509|FG000|Phase 1|Protocol Violation|0|||
161278483|NCT00086281|582398510|FG001|Phase 1|Protocol Violation|0|||
161278484|NCT00086281|582398511|FG002|Phase 1|Protocol Violation|0|||
161278485|NCT00086281|582398512|FG003|Phase 1|Protocol Violation|0|||
161278486|NCT00086281|582398513|FG004|Phase 1|Protocol Violation|0|||
161278487|NCT00086281|582398514|FG005|Phase 1|Protocol Violation|0|||
161278488|NCT00086281|582398515|FG006|Phase 1|Protocol Violation|0|||
161278489|NCT00086281|582398516|FG007|Phase 1|Protocol Violation|0|||
161278490|NCT00086281|582398517|FG008|Phase 1|Protocol Violation|0|||
161278491|NCT00086281|582398518|FG009|Phase 1|Protocol Violation|0|||
161278492|NCT00086281|582398519|FG010|Phase 1|Protocol Violation|1|||
161278493|NCT00086281|582398520|FG011|Phase 1|Protocol Violation|0|||
161278494|NCT00086281|582398521|FG012|Phase 1|Protocol Violation|0|||
161278495|NCT00086281|582398522|FG013|Phase 1|Protocol Violation|0|||
161278496|NCT00086281|582398523|FG014|Phase 1|Protocol Violation|0|||
161278497|NCT00086281|582398509|FG000|Phase 1|Serious Adverse Event|0|||
161278498|NCT00086281|582398510|FG001|Phase 1|Serious Adverse Event|0|||
161278499|NCT00086281|582398511|FG002|Phase 1|Serious Adverse Event|0|||
161278500|NCT00086281|582398512|FG003|Phase 1|Serious Adverse Event|0|||
161278501|NCT00086281|582398513|FG004|Phase 1|Serious Adverse Event|0|||
161278502|NCT00086281|582398514|FG005|Phase 1|Serious Adverse Event|0|||
161278503|NCT00086281|582398515|FG006|Phase 1|Serious Adverse Event|0|||
161278504|NCT00086281|582398516|FG007|Phase 1|Serious Adverse Event|0|||
161278505|NCT00086281|582398517|FG008|Phase 1|Serious Adverse Event|0|||
161278506|NCT00086281|582398518|FG009|Phase 1|Serious Adverse Event|0|||
161278507|NCT00086281|582398519|FG010|Phase 1|Serious Adverse Event|0|||
161278508|NCT00086281|582398520|FG011|Phase 1|Serious Adverse Event|0|||
161278509|NCT00086281|582398521|FG012|Phase 1|Serious Adverse Event|0|||
161278510|NCT00086281|582398522|FG013|Phase 1|Serious Adverse Event|0|||
161278511|NCT00086281|582398523|FG014|Phase 1|Serious Adverse Event|1|||
161278512|NCT00086281|582398509|FG000|Phase 2|Adverse Event|0|||
161278513|NCT00086281|582398510|FG001|Phase 2|Adverse Event|0|||
161278514|NCT00086281|582398511|FG002|Phase 2|Adverse Event|0|||
161278515|NCT00086281|582398512|FG003|Phase 2|Adverse Event|0|||
161278516|NCT00086281|582398513|FG004|Phase 2|Adverse Event|0|||
161278517|NCT00086281|582398514|FG005|Phase 2|Adverse Event|0|||
160976616|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976617|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976618|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
160976619|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
160976620|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976621|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976622|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976623|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976624|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
160976625|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
160976626|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
160976627|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Death|0|||
160976628|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Death|29|||
160976629|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Death|16|||
160976630|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Death|0|||
160976631|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Death|188|||
160976632|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Death|107|||
160976633|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Death|0|||
160976634|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Death|1|||
160976635|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Death|1|||
160976636|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Death|0|||
160976637|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Death|46|||
160976638|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Death|19|||
160976639|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Death|0|||
160976640|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Adverse Event|0|||
160976641|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Adverse Event|0|||
160976642|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Adverse Event|0|||
160976643|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Adverse Event|0|||
160976644|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Adverse Event|1|||
160976645|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Adverse Event|1|||
160976646|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Adverse Event|0|||
160976647|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Adverse Event|0|||
160976648|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Adverse Event|0|||
160976649|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Adverse Event|0|||
160976650|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Adverse Event|0|||
161091179|NCT01191268|581723827|FG002|Overall Study|Sponsor Decision|0|||
161278518|NCT00086281|582398515|FG006|Phase 2|Adverse Event|0|||
161278519|NCT00086281|582398516|FG007|Phase 2|Adverse Event|0|||
161278520|NCT00086281|582398517|FG008|Phase 2|Adverse Event|0|||
161278521|NCT00086281|582398518|FG009|Phase 2|Adverse Event|0|||
161278522|NCT00086281|582398519|FG010|Phase 2|Adverse Event|0|||
161278523|NCT00086281|582398520|FG011|Phase 2|Adverse Event|0|||
161278524|NCT00086281|582398521|FG012|Phase 2|Adverse Event|1|||
161278525|NCT00086281|582398522|FG013|Phase 2|Adverse Event|1|||
161278526|NCT00086281|582398523|FG014|Phase 2|Adverse Event|0|||
161278527|NCT03456453|582398526|FG000|Overall Study|Withdrawal by Subject|2|||
161278528|NCT03456453|582398527|FG001|Overall Study|Withdrawal by Subject|0|||
161278529|NCT03456453|582398526|FG000|Overall Study|Not released to community|1|||
161278530|NCT03456453|582398527|FG001|Overall Study|Not released to community|5|||
161278531|NCT03456453|582398526|FG000|Overall Study|Lost to Follow-up|0|||
161278532|NCT03456453|582398527|FG001|Overall Study|Lost to Follow-up|2|||
161278533|NCT00896480|582398528|FG000|Overall Study|Disease progression/recurrence|21|||
161278534|NCT00351533|582398529|FG000|Overall Study|Extubated before first BAL|1|||
161278535|NCT00351533|582398530|FG001|Overall Study|Extubated before first BAL|0|||
161278536|NCT00351533|582398529|FG000|Overall Study|Lost to Follow-up|1|||
161278537|NCT00351533|582398530|FG001|Overall Study|Lost to Follow-up|3|||
161278538|NCT00351533|582398529|FG000|Overall Study|Physician Decision|0|||
161278539|NCT00351533|582398530|FG001|Overall Study|Physician Decision|1|||
161278540|NCT00351533|582398529|FG000|Overall Study|Withdrawal by Subject|0|||
161278541|NCT00351533|582398530|FG001|Overall Study|Withdrawal by Subject|1|||
161278542|NCT00315731|582398533|FG000|Overall Study|Lost to Follow-up|1|||
161278543|NCT00315731|582398533|FG000|Overall Study|Death|5|||
161278544|NCT01680497|582398535|FG000|Overall Study|Lost to Follow-up|2|||
161278545|NCT04123561|582398537|FG000|Overall Study|Lost to Follow-up|20|||
161278546|NCT04123561|582398538|FG001|Overall Study|Lost to Follow-up|12|||
161278547|NCT04123561|582398539|FG002|Overall Study|Lost to Follow-up|5|||
161278548|NCT04123561|582398537|FG000|Overall Study|Withdrawal by Subject|9|||
161278549|NCT04123561|582398538|FG001|Overall Study|Withdrawal by Subject|7|||
161278550|NCT04123561|582398539|FG002|Overall Study|Withdrawal by Subject|9|||
161278551|NCT04123561|582398537|FG000|Overall Study|Lack of Efficacy|7|||
161278552|NCT04123561|582398538|FG001|Overall Study|Lack of Efficacy|8|||
161278553|NCT04123561|582398539|FG002|Overall Study|Lack of Efficacy|6|||
161278554|NCT04123561|582398537|FG000|Overall Study|Adverse Event|5|||
161278555|NCT04123561|582398538|FG001|Overall Study|Adverse Event|2|||
161278556|NCT04123561|582398539|FG002|Overall Study|Adverse Event|3|||
161278557|NCT04123561|582398537|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
161278558|NCT04123561|582398538|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
161278559|NCT04123561|582398539|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
161278560|NCT04123561|582398537|FG000|Overall Study|Death|0|||
161278561|NCT04123561|582398538|FG001|Overall Study|Death|0|||
161278562|NCT04123561|582398539|FG002|Overall Study|Death|1|||
161278563|NCT04123561|582398537|FG000|Overall Study|Protocol Violation|0|||
161278564|NCT04123561|582398538|FG001|Overall Study|Protocol Violation|1|||
161278565|NCT04123561|582398539|FG002|Overall Study|Protocol Violation|0|||
161278566|NCT02682927|582398549|FG000|Overall Study|Adverse Event|0|||
161278567|NCT02682927|582398550|FG001|Overall Study|Adverse Event|0|||
161278568|NCT02682927|582398551|FG002|Overall Study|Adverse Event|5|||
161278569|NCT02682927|582398552|FG003|Overall Study|Adverse Event|1|||
161278570|NCT02682927|582398553|FG004|Overall Study|Adverse Event|0|||
161278571|NCT02682927|582398554|FG005|Overall Study|Adverse Event|2|||
161278572|NCT02682927|582398549|FG000|Overall Study|Death|0|||
161278573|NCT02682927|582398550|FG001|Overall Study|Death|0|||
161278574|NCT02682927|582398551|FG002|Overall Study|Death|0|||
161278575|NCT02682927|582398552|FG003|Overall Study|Death|1|||
161278576|NCT02682927|582398553|FG004|Overall Study|Death|0|||
161278577|NCT02682927|582398554|FG005|Overall Study|Death|0|||
161278578|NCT02682927|582398549|FG000|Overall Study|Lack of Efficacy|1|||
161278579|NCT02682927|582398550|FG001|Overall Study|Lack of Efficacy|0|||
160976651|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Adverse Event|0|||
160976652|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Adverse Event|0|||
161278580|NCT02682927|582398551|FG002|Overall Study|Lack of Efficacy|0|||
161278581|NCT02682927|582398552|FG003|Overall Study|Lack of Efficacy|1|||
161344767|NCT01047319|582647278|FG001|Overall Study|Protocol Violation|2|||
161344768|NCT01047319|582647279|FG002|Overall Study|Protocol Violation|4|||
161344769|NCT01047319|582647277|FG000|Overall Study|Lack of Efficacy|4|||
161344770|NCT01047319|582647278|FG001|Overall Study|Lack of Efficacy|3|||
161278582|NCT02682927|582398553|FG004|Overall Study|Lack of Efficacy|0|||
161278583|NCT02682927|582398554|FG005|Overall Study|Lack of Efficacy|0|||
161278584|NCT02682927|582398549|FG000|Overall Study|Other|0|||
161278585|NCT02682927|582398550|FG001|Overall Study|Other|0|||
161278586|NCT02682927|582398551|FG002|Overall Study|Other|0|||
161278587|NCT02682927|582398552|FG003|Overall Study|Other|2|||
161278588|NCT02682927|582398553|FG004|Overall Study|Other|0|||
161278589|NCT02682927|582398554|FG005|Overall Study|Other|0|||
161278590|NCT02682927|582398549|FG000|Overall Study|Withdrawal by Subject|2|||
161278591|NCT02682927|582398550|FG001|Overall Study|Withdrawal by Subject|0|||
161278592|NCT02682927|582398551|FG002|Overall Study|Withdrawal by Subject|1|||
161033001|NCT04408755|581514413|FG003|Period B (Randomization Period)|Adverse Event|1|||
161033002|NCT04408755|581514410|FG000|Period B (Randomization Period)|Death|0|||
161033003|NCT04408755|581514411|FG001|Period B (Randomization Period)|Death|0|||
161033004|NCT04408755|581514412|FG002|Period B (Randomization Period)|Death|1|||
161033005|NCT04408755|581514413|FG003|Period B (Randomization Period)|Death|0|||
161033006|NCT04408755|581514410|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
161033007|NCT04408755|581514411|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
161033008|NCT04408755|581514412|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
161033009|NCT04408755|581514413|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
161033010|NCT04408755|581514410|FG000|Period B (Randomization Period)|Physician Decision|0|||
161033011|NCT04408755|581514411|FG001|Period B (Randomization Period)|Physician Decision|0|||
161278593|NCT02682927|582398552|FG003|Overall Study|Withdrawal by Subject|0|||
161278594|NCT02682927|582398553|FG004|Overall Study|Withdrawal by Subject|1|||
161278595|NCT02682927|582398554|FG005|Overall Study|Withdrawal by Subject|1|||
161278596|NCT02540850|582400258|FG000|Overall Study|Lost to Follow-up|69|||
161278597|NCT02540850|582400259|FG001|Overall Study|Lost to Follow-up|66|||
161278598|NCT02540850|582400260|FG002|Overall Study|Lost to Follow-up|34|||
161278599|NCT03760185|582400271|FG000|Overall Study|Lost to Follow-up|1|||
161278600|NCT03760185|582400272|FG001|Overall Study|Lost to Follow-up|1|||
161278601|NCT02473523|582400273|FG000|Overall Study|Death|1|||
161278602|NCT02473523|582400273|FG000|Overall Study|Lost to Follow-up|1|||
161278603|NCT02111603|582400276|FG000|Overall Study|Withdrawal by Subject|1|||
161278604|NCT00976911|582400277|FG000|Overall Study|Withdrawal by Subject|4|||
161278605|NCT00976911|582400278|FG001|Overall Study|Withdrawal by Subject|6|||
161278606|NCT00976911|582400277|FG000|Overall Study|Death|138|||
161278607|NCT00976911|582400278|FG001|Overall Study|Death|126|||
161278608|NCT00976911|582400277|FG000|Overall Study|Adverse Event|0|||
161278609|NCT00976911|582400278|FG001|Overall Study|Adverse Event|1|||
161278610|NCT00976911|582400277|FG000|Overall Study|Protocol Violation|2|||
161278611|NCT00976911|582400278|FG001|Overall Study|Protocol Violation|0|||
161278612|NCT00976911|582400277|FG000|Overall Study|Other|8|||
161278613|NCT00976911|582400278|FG001|Overall Study|Other|9|||
161278614|NCT00976911|582400277|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
161278615|NCT00976911|582400278|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
161278616|NCT02954991|582400279|FG000|Overall Study|Death|92|||
161278617|NCT02954991|582400280|FG001|Overall Study|Death|11|||
161278618|NCT02954991|582400281|FG002|Overall Study|Death|2|||
161278619|NCT02954991|582400279|FG000|Overall Study|Lost to Follow-up|3|||
161033012|NCT04408755|581514412|FG002|Period B (Randomization Period)|Physician Decision|1|||
161033013|NCT04408755|581514413|FG003|Period B (Randomization Period)|Physician Decision|0|||
161033014|NCT04408755|581514410|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
161278620|NCT02954991|582400280|FG001|Overall Study|Lost to Follow-up|2|||
161278621|NCT02954991|582400281|FG002|Overall Study|Lost to Follow-up|0|||
161278622|NCT02954991|582400279|FG000|Overall Study|Withdrawal by Subject|9|||
161278623|NCT02954991|582400280|FG001|Overall Study|Withdrawal by Subject|8|||
161278624|NCT02954991|582400281|FG002|Overall Study|Withdrawal by Subject|1|||
161278625|NCT02954991|582400279|FG000|Overall Study|Study Terminated by Sponsor|18|||
161278626|NCT02954991|582400280|FG001|Overall Study|Study Terminated by Sponsor|10|||
161033015|NCT04408755|581514411|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
161033016|NCT04408755|581514412|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
161033017|NCT04408755|581514413|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
161033018|NCT04408755|581514410|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
161033019|NCT04408755|581514411|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
161033020|NCT04408755|581514412|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
161033021|NCT04408755|581514413|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
161033022|NCT04408755|581514410|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
161033023|NCT04408755|581514411|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
161278627|NCT02954991|582400281|FG002|Overall Study|Study Terminated by Sponsor|1|||
161278628|NCT02954991|582400279|FG000|Overall Study|Miscellaneous|2|||
161278629|NCT02954991|582400280|FG001|Overall Study|Miscellaneous|1|||
161278630|NCT02954991|582400281|FG002|Overall Study|Miscellaneous|1|||
161278631|NCT00576316|582400282|FG000|Overall Study|Adverse Event|9|||
161344771|NCT01047319|582647279|FG002|Overall Study|Lack of Efficacy|3|||
161033024|NCT04408755|581514412|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
161033025|NCT04408755|581514413|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
161033026|NCT04408755|581514410|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
161278632|NCT00576316|582400282|FG000|Overall Study|Withdrawal by Subject|2|||
161278633|NCT00576316|582400282|FG000|Overall Study|Protocol Violation|9|||
161278634|NCT02552303|582400285|FG000|Allocation|Withdrawal by Subject|2|||
161278635|NCT02552303|582400286|FG001|Allocation|Withdrawal by Subject|1|||
161278636|NCT02552303|582400287|FG002|Allocation|Withdrawal by Subject|1|||
161278637|NCT02552303|582400288|FG003|Allocation|Withdrawal by Subject|1|||
161278638|NCT02552303|582400285|FG000|Allocation|ineligible|1|||
161278639|NCT02552303|582400286|FG001|Allocation|ineligible|1|||
161278640|NCT02552303|582400287|FG002|Allocation|ineligible|0|||
161278641|NCT02552303|582400288|FG003|Allocation|ineligible|0|||
161278642|NCT02552303|582400285|FG000|Follow-Up|Lost to Follow-up|0|||
161278643|NCT02552303|582400286|FG001|Follow-Up|Lost to Follow-up|0|||
161278644|NCT02552303|582400287|FG002|Follow-Up|Lost to Follow-up|1|||
161278645|NCT02552303|582400288|FG003|Follow-Up|Lost to Follow-up|0|||
161278646|NCT02552303|582400285|FG000|Follow-Up|ineligible|0|||
161278647|NCT02552303|582400286|FG001|Follow-Up|ineligible|2|||
161278648|NCT02552303|582400287|FG002|Follow-Up|ineligible|0|||
161344772|NCT01047319|582647277|FG000|Overall Study|Death|5|||
160976653|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976654|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
160976655|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976656|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976657|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
160976658|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
160976659|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976660|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
160976661|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976662|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976663|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
160976664|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
160976665|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
160976666|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
160976667|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
160976668|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
160976669|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
160976670|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
160976671|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
160976672|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
160976673|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
160976674|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
160976675|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
160976676|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
160976677|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
160976678|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
160976679|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Physician Decision|0|||
160976680|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Physician Decision|2|||
160976681|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Physician Decision|0|||
160976682|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Physician Decision|0|||
160976683|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Physician Decision|3|||
160976684|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Physician Decision|0|||
160976685|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Physician Decision|0|||
160976686|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Physician Decision|0|||
160976687|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Physician Decision|0|||
160976688|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Physician Decision|0|||
160976689|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Physician Decision|1|||
160976690|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Physician Decision|3|||
160976691|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Physician Decision|0|||
160976692|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Not Treated|0|||
160976693|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Not Treated|0|||
160976694|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Not Treated|2|||
160976695|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Not Treated|0|||
160976696|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Not Treated|0|||
160976697|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Not Treated|0|||
160976698|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Not Treated|0|||
160976699|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Not Treated|0|||
160976700|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Not Treated|0|||
160976701|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Not Treated|0|||
160976702|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Not Treated|0|||
160976703|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Not Treated|0|||
160976704|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Not Treated|0|||
160976705|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976706|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
160976707|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976708|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976709|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976710|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976711|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976712|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976713|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
161278649|NCT02552303|582400288|FG003|Follow-Up|ineligible|0|||
161033027|NCT04408755|581514411|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
161033028|NCT04408755|581514412|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
161033029|NCT04408755|581514413|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
161033030|NCT04408755|581514410|FG000|Period B (Randomization Period)|Reason not Specified|0|||
161033031|NCT04408755|581514411|FG001|Period B (Randomization Period)|Reason not Specified|1|||
161033032|NCT04408755|581514412|FG002|Period B (Randomization Period)|Reason not Specified|0|||
161033033|NCT04408755|581514413|FG003|Period B (Randomization Period)|Reason not Specified|2|||
161033034|NCT00308997|581514414|FG000|Overall Study|Subject feigned clinical data|0|||
161033035|NCT00308997|581514415|FG001|Overall Study|Subject feigned clinical data|1|||
161033036|NCT00308997|581514414|FG000|Overall Study|Unable to tolerate intervention|1|||
161033037|NCT00308997|581514415|FG001|Overall Study|Unable to tolerate intervention|0|||
161033038|NCT00412607|581514418|FG000|Overall Study|Withdrawal by Subject|9|||
161033039|NCT00412607|581514418|FG000|Overall Study|Lost to Follow-up|19|||
161033040|NCT00412607|581514418|FG000|Overall Study|Death|61|||
161033041|NCT00412607|581514418|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
161033042|NCT03662022|581514419|FG000|Year 1 2019|prevalent case|83|||
161033043|NCT03662022|581514420|FG001|Year 1 2019|prevalent case|116|||
161033044|NCT03662022|581514421|FG002|Year 1 2019|prevalent case|158|||
161033045|NCT03662022|581514422|FG003|Year 1 2019|prevalent case|99|||
161033046|NCT03662022|581514419|FG000|Year 2 2020|incident case|18|||
161033047|NCT03662022|581514420|FG001|Year 2 2020|incident case|18|||
161033048|NCT03662022|581514421|FG002|Year 2 2020|incident case|16|||
161033049|NCT03662022|581514422|FG003|Year 2 2020|incident case|26|||
161033050|NCT03662022|581514419|FG000|Year 2 2020|other case|18|||
161033051|NCT03662022|581514420|FG001|Year 2 2020|other case|16|||
161033052|NCT03662022|581514421|FG002|Year 2 2020|other case|16|||
161033053|NCT03662022|581514422|FG003|Year 2 2020|other case|24|||
161033054|NCT03662022|581514419|FG000|Year 2 2020|Lost to Follow-up|1633|||
161033055|NCT03662022|581514420|FG001|Year 2 2020|Lost to Follow-up|1183|||
161033056|NCT03662022|581514421|FG002|Year 2 2020|Lost to Follow-up|1381|||
161033057|NCT03662022|581514422|FG003|Year 2 2020|Lost to Follow-up|2858|||
161033058|NCT03662022|581514419|FG000|Year 3 2021|incident case|24|||
161033059|NCT03662022|581514420|FG001|Year 3 2021|incident case|27|||
161033060|NCT03662022|581514421|FG002|Year 3 2021|incident case|24|||
161033061|NCT03662022|581514422|FG003|Year 3 2021|incident case|11|||
161033062|NCT03662022|581514419|FG000|Year 3 2021|other case|4|||
161033063|NCT03662022|581514420|FG001|Year 3 2021|other case|15|||
161033064|NCT03662022|581514421|FG002|Year 3 2021|other case|10|||
161033065|NCT03662022|581514422|FG003|Year 3 2021|other case|14|||
161033066|NCT03662022|581514419|FG000|Year 3 2021|Lost to Follow-up|179|||
161033067|NCT03662022|581514420|FG001|Year 3 2021|Lost to Follow-up|244|||
161033068|NCT03662022|581514421|FG002|Year 3 2021|Lost to Follow-up|480|||
161033069|NCT03662022|581514422|FG003|Year 3 2021|Lost to Follow-up|477|||
161033070|NCT03662022|581514419|FG000|Year 4 2022|incident case|25|||
161033071|NCT03662022|581514420|FG001|Year 4 2022|incident case|41|||
161033072|NCT03662022|581514421|FG002|Year 4 2022|incident case|28|||
161033073|NCT03662022|581514422|FG003|Year 4 2022|incident case|7|||
161033074|NCT03662022|581514419|FG000|Year 4 2022|other case|8|||
161033075|NCT03662022|581514420|FG001|Year 4 2022|other case|19|||
161033076|NCT03662022|581514421|FG002|Year 4 2022|other case|13|||
161033077|NCT03662022|581514422|FG003|Year 4 2022|other case|7|||
161033078|NCT03662022|581514419|FG000|Year 4 2022|Lost to Follow-up|986|||
161033079|NCT03662022|581514420|FG001|Year 4 2022|Lost to Follow-up|1079|||
161033080|NCT03662022|581514421|FG002|Year 4 2022|Lost to Follow-up|1236|||
161033081|NCT03662022|581514422|FG003|Year 4 2022|Lost to Follow-up|1826|||
161033082|NCT03248479|581514423|FG000|Overall Study|Death|12|||
161033083|NCT03248479|581514424|FG001|Overall Study|Death|44|||
160976714|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976715|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976716|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976717|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
160976718|NCT02291289|581304582|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
160976719|NCT02291289|581304583|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
160976720|NCT02291289|581304584|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
161033084|NCT03248479|581514425|FG002|Overall Study|Death|1|||
161033085|NCT03248479|581514426|FG003|Overall Study|Death|72|||
161033086|NCT03248479|581514427|FG004|Overall Study|Death|17|||
161033087|NCT03248479|581514428|FG005|Overall Study|Death|6|||
161033088|NCT03248479|581514429|FG006|Overall Study|Death|1|||
161033089|NCT03248479|581514430|FG007|Overall Study|Death|14|||
161033090|NCT03248479|581514431|FG008|Overall Study|Death|3|||
160976721|NCT02291289|581304585|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
160976722|NCT02291289|581304586|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
161033091|NCT03248479|581514432|FG009|Overall Study|Death|7|||
161033092|NCT03248479|581514433|FG010|Overall Study|Death|3|||
161033093|NCT03248479|581514434|FG011|Overall Study|Death|1|||
161033094|NCT03248479|581514435|FG012|Overall Study|Death|1|||
161033095|NCT03248479|581514423|FG000|Overall Study|Study terminated by sponsor|12|||
161033096|NCT03248479|581514424|FG001|Overall Study|Study terminated by sponsor|15|||
161033097|NCT03248479|581514425|FG002|Overall Study|Study terminated by sponsor|0|||
161278650|NCT01582152|582400289|FG000|Overall Study|Disease Progression|4|||
161278651|NCT01582152|582400290|FG001|Overall Study|Disease Progression|5|||
161278652|NCT01582152|582400289|FG000|Overall Study|Adverse Event|2|||
161278653|NCT01582152|582400290|FG001|Overall Study|Adverse Event|1|||
161278654|NCT00230178|582400293|FG000|Overall Study|Adverse Event|1|||
161278655|NCT00230178|582400294|FG001|Overall Study|Adverse Event|5|||
161278656|NCT00230178|582400295|FG002|Overall Study|Adverse Event|2|||
161278657|NCT00230178|582400293|FG000|Overall Study|Withdrawal by Subject|0|||
161278658|NCT00230178|582400294|FG001|Overall Study|Withdrawal by Subject|0|||
161278659|NCT00230178|582400295|FG002|Overall Study|Withdrawal by Subject|1|||
161278660|NCT00230178|582400293|FG000|Overall Study|Various other reasons|3|||
161278661|NCT00230178|582400294|FG001|Overall Study|Various other reasons|2|||
161278662|NCT00230178|582400295|FG002|Overall Study|Various other reasons|4|||
161278663|NCT02252406|582400302|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
161278664|NCT02252406|582400303|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
161278665|NCT02252406|582400302|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
161278666|NCT02252406|582400303|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
161278667|NCT02252406|582400302|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
161278668|NCT02252406|582400303|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
161278669|NCT02252406|582400302|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
161278670|NCT02252406|582400303|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
161278671|NCT02252406|582400302|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
161278672|NCT02252406|582400303|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
161278673|NCT00005957|582400304|FG000|Overall Study|No treated|3|||
161278674|NCT00005957|582400305|FG001|Overall Study|No treated|9|||
161278675|NCT00005957|582400304|FG000|Overall Study|Crossover to the other arm|5|||
161278676|NCT00005957|582400305|FG001|Overall Study|Crossover to the other arm|19|||
161278677|NCT01609023|582400306|FG000|Overall Study|Lack of Efficacy|3|||
161278678|NCT01609023|582400306|FG000|Overall Study|Withdrawal by Subject|4|||
161278679|NCT01609023|582400306|FG000|Overall Study|Lost to Follow-up|8|||
161278680|NCT01609023|582400306|FG000|Overall Study|Toxicity|3|||
161278681|NCT01609023|582400306|FG000|Overall Study|Disease progression|10|||
161278682|NCT01609023|582400306|FG000|Overall Study|Physician Decision|2|||
161278683|NCT01609023|582400306|FG000|Overall Study|Death|2|||
161278684|NCT01609023|582400306|FG000|Overall Study|Personal reasons|1|||
161278685|NCT00799825|582400307|FG000|Overall Study|Adverse Event|1|||
161278686|NCT00799825|582400307|FG000|Overall Study|Withdrawal by Subject|6|||
161278687|NCT00799825|582400307|FG000|Overall Study|Lost to Follow-up|38|||
161278688|NCT00799825|582400307|FG000|Overall Study|Pregnancy|3|||
161278689|NCT04974749|582400308|FG000|Overall Study|Withdrawal by Subject|2|||
161278690|NCT04974749|582400308|FG000|Overall Study|Gestation|1|||
161278691|NCT00796107|582400314|FG000|Overall Study|Lack of Efficacy|1|||
161278692|NCT00796107|582400314|FG000|Overall Study|Progressive Disease|5|||
161278693|NCT02681510|582400322|FG000|Overall Study|Withdrawal by Subject|1|||
161278694|NCT02681510|582400322|FG000|Overall Study|Lost to Follow-up|9|||
161278695|NCT02075515|582400323|FG000|Overall Study|Serious Adverse Event|1|||
161278696|NCT02075515|582400324|FG001|Overall Study|Serious Adverse Event|1|||
161033098|NCT03248479|581514426|FG003|Overall Study|Study terminated by sponsor|5|||
161033099|NCT03248479|581514427|FG004|Overall Study|Study terminated by sponsor|0|||
161033100|NCT03248479|581514428|FG005|Overall Study|Study terminated by sponsor|0|||
161033101|NCT03248479|581514429|FG006|Overall Study|Study terminated by sponsor|0|||
161033102|NCT03248479|581514430|FG007|Overall Study|Study terminated by sponsor|1|||
161033103|NCT03248479|581514431|FG008|Overall Study|Study terminated by sponsor|1|||
161033104|NCT03248479|581514432|FG009|Overall Study|Study terminated by sponsor|0|||
161033105|NCT03248479|581514433|FG010|Overall Study|Study terminated by sponsor|5|||
161033106|NCT03248479|581514434|FG011|Overall Study|Study terminated by sponsor|4|||
161033107|NCT03248479|581514435|FG012|Overall Study|Study terminated by sponsor|0|||
161033108|NCT03248479|581514423|FG000|Overall Study|Consent withdrawn|6|||
161033109|NCT03248479|581514424|FG001|Overall Study|Consent withdrawn|3|||
161033110|NCT03248479|581514425|FG002|Overall Study|Consent withdrawn|0|||
161278697|NCT02075515|582400325|FG002|Overall Study|Serious Adverse Event|1|||
161278698|NCT02075515|582400323|FG000|Overall Study|Non-Serious Adverse Event|0|||
161278699|NCT02075515|582400324|FG001|Overall Study|Non-Serious Adverse Event|1|||
161278700|NCT02075515|582400325|FG002|Overall Study|Non-Serious Adverse Event|0|||
161278701|NCT02075515|582400323|FG000|Overall Study|Withdrawal by Subject|2|||
161033111|NCT03248479|581514426|FG003|Overall Study|Consent withdrawn|9|||
161033112|NCT03248479|581514427|FG004|Overall Study|Consent withdrawn|1|||
161033113|NCT03248479|581514428|FG005|Overall Study|Consent withdrawn|0|||
161278702|NCT02075515|582400324|FG001|Overall Study|Withdrawal by Subject|0|||
161278703|NCT02075515|582400325|FG002|Overall Study|Withdrawal by Subject|1|||
161278704|NCT02075515|582400323|FG000|Overall Study|Lost to Follow-up|1|||
161278705|NCT02075515|582400324|FG001|Overall Study|Lost to Follow-up|3|||
161278706|NCT02075515|582400325|FG002|Overall Study|Lost to Follow-up|6|||
161278707|NCT00741338|582400336|FG000|Overall Study|Adverse Event|0|||
161278708|NCT00741338|582400337|FG001|Overall Study|Adverse Event|1|||
161278709|NCT03593395|582400338|FG000|Overall Study|Lost to Follow-up|48|||
161278710|NCT03593395|582400339|FG001|Overall Study|Lost to Follow-up|3|||
161033114|NCT03248479|581514429|FG006|Overall Study|Consent withdrawn|0|||
161033115|NCT03248479|581514430|FG007|Overall Study|Consent withdrawn|1|||
161033116|NCT03248479|581514431|FG008|Overall Study|Consent withdrawn|0|||
161033117|NCT03248479|581514432|FG009|Overall Study|Consent withdrawn|3|||
161033118|NCT03248479|581514433|FG010|Overall Study|Consent withdrawn|1|||
161033119|NCT03248479|581514434|FG011|Overall Study|Consent withdrawn|0|||
161033120|NCT03248479|581514435|FG012|Overall Study|Consent withdrawn|1|||
161033121|NCT03248479|581514423|FG000|Overall Study|Lost to Follow-up|2|||
161033122|NCT03248479|581514424|FG001|Overall Study|Lost to Follow-up|1|||
161033123|NCT03248479|581514425|FG002|Overall Study|Lost to Follow-up|0|||
161033124|NCT03248479|581514426|FG003|Overall Study|Lost to Follow-up|0|||
161033125|NCT03248479|581514427|FG004|Overall Study|Lost to Follow-up|0|||
161033126|NCT03248479|581514428|FG005|Overall Study|Lost to Follow-up|0|||
161033127|NCT03248479|581514429|FG006|Overall Study|Lost to Follow-up|0|||
161033128|NCT03248479|581514430|FG007|Overall Study|Lost to Follow-up|0|||
161033129|NCT03248479|581514431|FG008|Overall Study|Lost to Follow-up|0|||
161033130|NCT03248479|581514432|FG009|Overall Study|Lost to Follow-up|0|||
161033131|NCT03248479|581514433|FG010|Overall Study|Lost to Follow-up|0|||
161033132|NCT03248479|581514434|FG011|Overall Study|Lost to Follow-up|0|||
161033133|NCT03248479|581514435|FG012|Overall Study|Lost to Follow-up|1|||
161033134|NCT03248479|581514423|FG000|Overall Study|Not reported|0|||
161033135|NCT03248479|581514424|FG001|Overall Study|Not reported|0|||
161033136|NCT03248479|581514425|FG002|Overall Study|Not reported|0|||
161033137|NCT03248479|581514426|FG003|Overall Study|Not reported|1|||
161033138|NCT03248479|581514427|FG004|Overall Study|Not reported|1|||
161033139|NCT03248479|581514428|FG005|Overall Study|Not reported|0|||
161033140|NCT03248479|581514429|FG006|Overall Study|Not reported|0|||
161033141|NCT03248479|581514430|FG007|Overall Study|Not reported|1|||
161033142|NCT03248479|581514431|FG008|Overall Study|Not reported|1|||
161033143|NCT03248479|581514432|FG009|Overall Study|Not reported|0|||
161033144|NCT03248479|581514433|FG010|Overall Study|Not reported|0|||
161033145|NCT03248479|581514434|FG011|Overall Study|Not reported|0|||
161033146|NCT03248479|581514435|FG012|Overall Study|Not reported|0|||
161033147|NCT06065735|581514442|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
161033148|NCT06065735|581514443|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
161033149|NCT06065735|581514444|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
161033150|NCT06065735|581514442|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
161033151|NCT06065735|581514443|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
161033152|NCT06065735|581514444|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
161033153|NCT06065735|581514442|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
161033154|NCT06065735|581514443|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
161033155|NCT06065735|581514444|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
161033156|NCT06065735|581514442|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
161033157|NCT06065735|581514443|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
161033158|NCT06065735|581514444|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
161033159|NCT06065735|581514442|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
161033160|NCT06065735|581514443|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
161033161|NCT06065735|581514444|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
161033162|NCT03522298|581514445|FG000|Overall Study|Adverse Event|1|||
161278711|NCT03593395|582400338|FG000|Overall Study|Withdrawal by Subject|5|||
161278712|NCT03593395|582400339|FG001|Overall Study|Withdrawal by Subject|24|||
161278713|NCT03593395|582400338|FG000|Overall Study|Death|2|||
161278714|NCT03593395|582400339|FG001|Overall Study|Death|3|||
161033163|NCT03522298|581514446|FG001|Overall Study|Adverse Event|0|||
161033164|NCT03522298|581514447|FG002|Overall Study|Adverse Event|0|||
161033165|NCT03522298|581514448|FG003|Overall Study|Adverse Event|1|||
161033166|NCT03522298|581514445|FG000|Overall Study|Death|2|||
161033167|NCT03522298|581514446|FG001|Overall Study|Death|4|||
161033168|NCT03522298|581514447|FG002|Overall Study|Death|8|||
161033169|NCT03522298|581514448|FG003|Overall Study|Death|8|||
161033170|NCT03522298|581514445|FG000|Overall Study|Patient decision|0|||
161033171|NCT03522298|581514446|FG001|Overall Study|Patient decision|2|||
161033172|NCT03522298|581514447|FG002|Overall Study|Patient decision|2|||
161278715|NCT03593395|582400338|FG000|Overall Study|Physician Decision|0|||
161278716|NCT03593395|582400339|FG001|Overall Study|Physician Decision|6|||
161033173|NCT03522298|581514448|FG003|Overall Study|Patient decision|2|||
161033174|NCT02806726|581514453|FG000|Overall Study|Lost to Follow-up|1|||
161033175|NCT01527188|581514454|FG000|Overall Study|Adverse Event|5|||
161033176|NCT01527188|581514455|FG001|Overall Study|Adverse Event|5|||
161033177|NCT01527188|581514456|FG002|Overall Study|Adverse Event|11|||
161033178|NCT01527188|581514457|FG003|Overall Study|Adverse Event|0|||
161033179|NCT01527188|581514454|FG000|Overall Study|Withdrawal by Subject|3|||
161278717|NCT03593395|582400338|FG000|Overall Study|Participant Relocated|19|||
161033180|NCT01527188|581514455|FG001|Overall Study|Withdrawal by Subject|6|||
161033181|NCT01527188|581514456|FG002|Overall Study|Withdrawal by Subject|4|||
161033182|NCT01527188|581514457|FG003|Overall Study|Withdrawal by Subject|4|||
161278718|NCT03593395|582400339|FG001|Overall Study|Participant Relocated|3|||
161033183|NCT01527188|581514454|FG000|Overall Study|Any other reason not above-mentioned|6|||
161033184|NCT01527188|581514455|FG001|Overall Study|Any other reason not above-mentioned|7|||
161033185|NCT01527188|581514456|FG002|Overall Study|Any other reason not above-mentioned|8|||
161033186|NCT01527188|581514457|FG003|Overall Study|Any other reason not above-mentioned|8|||
161033187|NCT04626427|581514458|FG000|Overall Study|Death|1|||
161033188|NCT04626427|581514458|FG000|Overall Study|Withdrawal by Subject|1|||
161033189|NCT04626427|581514458|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
161033190|NCT04626427|581514458|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
161278719|NCT03593395|582400338|FG000|Overall Study|No Information|1|||
161278720|NCT03593395|582400339|FG001|Overall Study|No Information|7|||
161278721|NCT02370238|582400346|FG000|Overall Study|Death|42|||
161278722|NCT02370238|582400347|FG001|Overall Study|Death|35|||
161278723|NCT02370238|582400346|FG000|Overall Study|Lost to Follow-up|1|||
161278724|NCT02370238|582400347|FG001|Overall Study|Lost to Follow-up|3|||
161278725|NCT02370238|582400346|FG000|Overall Study|Withdrawal by Subject|2|||
161278726|NCT02370238|582400347|FG001|Overall Study|Withdrawal by Subject|6|||
161278727|NCT02370238|582400346|FG000|Overall Study|Other|2|||
161278728|NCT02370238|582400347|FG001|Overall Study|Other|1|||
161278729|NCT01890434|582400348|FG000|Overall Study|Adverse Event|8|||
161278730|NCT01890434|582400348|FG000|Overall Study|PCI at external hospital|1|||
161278731|NCT01890434|582400348|FG000|Overall Study|Assessment discrepancy|1|||
161278732|NCT01890434|582400348|FG000|Overall Study|CRC didn't contact participant for FU|1|||
161278733|NCT01890434|582400348|FG000|Overall Study|Could not get whole set of images|1|||
161278734|NCT01890434|582400348|FG000|Overall Study|Decline to return for GSPECT|1|||
161278735|NCT01890434|582400348|FG000|Overall Study|GSPECT at rest was not done|1|||
161278736|NCT01890434|582400348|FG000|Overall Study|Participant didn't complete MRI|1|||
161278737|NCT01890434|582400348|FG000|Overall Study|Uncontactable by phone|1|||
161278738|NCT01890434|582400348|FG000|Overall Study|Moved out of position|1|||
161278739|NCT01890434|582400348|FG000|Overall Study|Unable to contact|1|||
161278740|NCT01890434|582400348|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
161278741|NCT03837743|582400354|FG000|Overall Study|Adverse Event|1|||
161278742|NCT03837743|582400354|FG000|Overall Study|Withdrawal by Subject|2|||
161278743|NCT01449370|582400357|FG000|Overall Study|Disease Progression|5|||
161278744|NCT01449370|582400358|FG001|Overall Study|Disease Progression|4|||
161278745|NCT01449370|582400359|FG002|Overall Study|Disease Progression|8|||
161278746|NCT01449370|582400360|FG003|Overall Study|Disease Progression|3|||
161278747|NCT01449370|582400361|FG004|Overall Study|Disease Progression|3|||
161278748|NCT01449370|582400362|FG005|Overall Study|Disease Progression|3|||
161278749|NCT01449370|582400363|FG006|Overall Study|Disease Progression|3|||
161278750|NCT01449370|582400364|FG007|Overall Study|Disease Progression|2|||
161278751|NCT01449370|582400365|FG008|Overall Study|Disease Progression|9|||
161278752|NCT01449370|582400366|FG009|Overall Study|Disease Progression|1|||
161278753|NCT01449370|582400367|FG010|Overall Study|Disease Progression|3|||
161278754|NCT01449370|582400368|FG011|Overall Study|Disease Progression|3|||
161278755|NCT01449370|582400369|FG012|Overall Study|Disease Progression|2|||
161278756|NCT01449370|582400370|FG013|Overall Study|Disease Progression|8|||
161278757|NCT01449370|582400371|FG014|Overall Study|Disease Progression|3|||
161278758|NCT01449370|582400372|FG015|Overall Study|Disease Progression|1|||
161278759|NCT01449370|582400373|FG016|Overall Study|Disease Progression|4|||
161278760|NCT01449370|582400374|FG017|Overall Study|Disease Progression|3|||
161278761|NCT01449370|582400375|FG018|Overall Study|Disease Progression|1|||
161278762|NCT01449370|582400376|FG019|Overall Study|Disease Progression|2|||
161278763|NCT01449370|582400377|FG020|Overall Study|Disease Progression|5|||
161278764|NCT01449370|582400378|FG021|Overall Study|Disease Progression|2|||
161278765|NCT01449370|582400379|FG022|Overall Study|Disease Progression|3|||
161278766|NCT01449370|582400380|FG023|Overall Study|Disease Progression|7|||
161278767|NCT01449370|582400381|FG024|Overall Study|Disease Progression|3|||
161278768|NCT01449370|582400357|FG000|Overall Study|Adverse Event|1|||
161278769|NCT01449370|582400358|FG001|Overall Study|Adverse Event|2|||
161033191|NCT01265537|581514459|FG000|Overall Study|Adverse Event|2|||
161278770|NCT01449370|582400359|FG002|Overall Study|Adverse Event|0|||
161278771|NCT01449370|582400360|FG003|Overall Study|Adverse Event|1|||
161278772|NCT01449370|582400361|FG004|Overall Study|Adverse Event|0|||
161033192|NCT01265537|581514460|FG001|Overall Study|Adverse Event|1|||
161033193|NCT01265537|581514459|FG000|Overall Study|Physician Decision|0|||
161278773|NCT01449370|582400362|FG005|Overall Study|Adverse Event|0|||
161278774|NCT01449370|582400363|FG006|Overall Study|Adverse Event|0|||
161278775|NCT01449370|582400364|FG007|Overall Study|Adverse Event|0|||
161278776|NCT01449370|582400365|FG008|Overall Study|Adverse Event|1|||
161278777|NCT01449370|582400366|FG009|Overall Study|Adverse Event|1|||
161278778|NCT01449370|582400367|FG010|Overall Study|Adverse Event|0|||
161278779|NCT01449370|582400368|FG011|Overall Study|Adverse Event|0|||
161278780|NCT01449370|582400369|FG012|Overall Study|Adverse Event|0|||
161278781|NCT01449370|582400370|FG013|Overall Study|Adverse Event|2|||
161278782|NCT01449370|582400371|FG014|Overall Study|Adverse Event|0|||
161278783|NCT01449370|582400372|FG015|Overall Study|Adverse Event|1|||
161278784|NCT01449370|582400373|FG016|Overall Study|Adverse Event|0|||
161278785|NCT01449370|582400374|FG017|Overall Study|Adverse Event|0|||
161278786|NCT01449370|582400375|FG018|Overall Study|Adverse Event|1|||
161278787|NCT01449370|582400376|FG019|Overall Study|Adverse Event|1|||
161278788|NCT01449370|582400377|FG020|Overall Study|Adverse Event|0|||
161278789|NCT01449370|582400378|FG021|Overall Study|Adverse Event|1|||
161033194|NCT01265537|581514460|FG001|Overall Study|Physician Decision|1|||
161033195|NCT04518943|581515326|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
161033196|NCT04518943|581515327|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
161033197|NCT04518943|581515328|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
161033198|NCT04518943|581515329|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
161033199|NCT04518943|581515330|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
161033200|NCT04518943|581515331|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
161033201|NCT04518943|581515332|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
161033202|NCT04518943|581515333|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
161033203|NCT04518943|581515334|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
161033204|NCT04518943|581515335|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
161033205|NCT04518943|581515336|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
161033206|NCT04518943|581515337|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
161033207|NCT04518943|581515338|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
161033208|NCT04518943|581515339|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
161033209|NCT04518943|581515340|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
161033210|NCT04518943|581515341|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
161033211|NCT06408870|581515342|FG000|Washout period|Withdrawal by Subject|1|||
161033212|NCT06408870|581515343|FG001|Washout period|Withdrawal by Subject|0|||
161033213|NCT06408870|581515342|FG000|Washout period|Adverse Event|2|||
161033214|NCT06408870|581515343|FG001|Washout period|Adverse Event|0|||
161033215|NCT04174170|581515347|FG000|Placebo Run-in Period|Not Randomized|38|||
161033216|NCT04174170|581515348|FG001|Placebo Run-in Period|Not Randomized|0|||
161033217|NCT04174170|581515349|FG002|Placebo Run-in Period|Not Randomized|0|||
161033218|NCT04174170|581515350|FG003|Placebo Run-in Period|Not Randomized|0|||
161033219|NCT04174170|581515347|FG000|Double Blind Treatment Period|Adverse Event|0|||
161033220|NCT04174170|581515348|FG001|Double Blind Treatment Period|Adverse Event|9|||
161033221|NCT04174170|581515349|FG002|Double Blind Treatment Period|Adverse Event|9|||
161033222|NCT04174170|581515350|FG003|Double Blind Treatment Period|Adverse Event|8|||
161033223|NCT04174170|581515347|FG000|Double Blind Treatment Period|Death|0|||
161033224|NCT04174170|581515348|FG001|Double Blind Treatment Period|Death|1|||
161033225|NCT04174170|581515349|FG002|Double Blind Treatment Period|Death|0|||
161033226|NCT04174170|581515350|FG003|Double Blind Treatment Period|Death|0|||
161033227|NCT04174170|581515347|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
161033228|NCT04174170|581515348|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
161033229|NCT04174170|581515349|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
161033230|NCT04174170|581515350|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
161033231|NCT04174170|581515347|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
161033232|NCT04174170|581515348|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
161033233|NCT04174170|581515349|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
161033234|NCT04174170|581515350|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
161033235|NCT04174170|581515347|FG000|Double Blind Treatment Period|Physician Decision|0|||
161033236|NCT04174170|581515348|FG001|Double Blind Treatment Period|Physician Decision|1|||
161033237|NCT04174170|581515349|FG002|Double Blind Treatment Period|Physician Decision|0|||
161033238|NCT04174170|581515350|FG003|Double Blind Treatment Period|Physician Decision|1|||
161033239|NCT04174170|581515347|FG000|Double Blind Treatment Period|Pregnancy|0|||
161033240|NCT04174170|581515348|FG001|Double Blind Treatment Period|Pregnancy|1|||
161033241|NCT04174170|581515349|FG002|Double Blind Treatment Period|Pregnancy|0|||
161033242|NCT04174170|581515350|FG003|Double Blind Treatment Period|Pregnancy|1|||
161033243|NCT04174170|581515347|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
161033244|NCT04174170|581515348|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
161033245|NCT04174170|581515349|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
161033246|NCT04174170|581515350|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
161278790|NCT01449370|582400379|FG022|Overall Study|Adverse Event|0|||
161278791|NCT01449370|582400380|FG023|Overall Study|Adverse Event|1|||
161278792|NCT01449370|582400381|FG024|Overall Study|Adverse Event|3|||
161278793|NCT01449370|582400357|FG000|Overall Study|Participant Decision|0|||
161278794|NCT01449370|582400358|FG001|Overall Study|Participant Decision|0|||
161278795|NCT01449370|582400359|FG002|Overall Study|Participant Decision|0|||
161278796|NCT01449370|582400360|FG003|Overall Study|Participant Decision|0|||
161033247|NCT04174170|581515347|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
161033248|NCT04174170|581515348|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
161033249|NCT04174170|581515349|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
161033250|NCT04174170|581515350|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
161033251|NCT04174170|581515347|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
161033252|NCT04174170|581515348|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
161278797|NCT01449370|582400361|FG004|Overall Study|Participant Decision|0|||
161278798|NCT01449370|582400362|FG005|Overall Study|Participant Decision|0|||
161278799|NCT01449370|582400363|FG006|Overall Study|Participant Decision|0|||
160976723|NCT02291289|581304587|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
160976724|NCT02291289|581304588|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
160976725|NCT02291289|581304589|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
160976726|NCT02291289|581304590|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
160976727|NCT02291289|581304591|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
160976728|NCT02291289|581304592|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
160976729|NCT02291289|581304593|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
160976730|NCT02291289|581304594|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
160976731|NCT02291289|581304582|FG000|Early Disease Progression|Death|0|||
160976732|NCT02291289|581304583|FG001|Early Disease Progression|Death|0|||
160976733|NCT02291289|581304584|FG002|Early Disease Progression|Death|0|||
160976734|NCT02291289|581304585|FG003|Early Disease Progression|Death|0|||
160976735|NCT02291289|581304586|FG004|Early Disease Progression|Death|0|||
160976736|NCT02291289|581304587|FG005|Early Disease Progression|Death|0|||
160976737|NCT02291289|581304588|FG006|Early Disease Progression|Death|0|||
160976738|NCT02291289|581304589|FG007|Early Disease Progression|Death|0|||
160976739|NCT02291289|581304590|FG008|Early Disease Progression|Death|0|||
160976740|NCT02291289|581304591|FG009|Early Disease Progression|Death|0|||
160976741|NCT02291289|581304592|FG010|Early Disease Progression|Death|0|||
160976742|NCT02291289|581304593|FG011|Early Disease Progression|Death|0|||
160976743|NCT02291289|581304594|FG012|Early Disease Progression|Death|10|||
160976744|NCT02291289|581304582|FG000|Early Disease Progression|Lost to Follow-up|0|||
160976745|NCT02291289|581304583|FG001|Early Disease Progression|Lost to Follow-up|0|||
160976746|NCT02291289|581304584|FG002|Early Disease Progression|Lost to Follow-up|0|||
160976747|NCT02291289|581304585|FG003|Early Disease Progression|Lost to Follow-up|0|||
160976748|NCT02291289|581304586|FG004|Early Disease Progression|Lost to Follow-up|0|||
160976749|NCT02291289|581304587|FG005|Early Disease Progression|Lost to Follow-up|0|||
160976750|NCT02291289|581304588|FG006|Early Disease Progression|Lost to Follow-up|0|||
160976751|NCT02291289|581304589|FG007|Early Disease Progression|Lost to Follow-up|0|||
160976752|NCT02291289|581304590|FG008|Early Disease Progression|Lost to Follow-up|0|||
160976753|NCT02291289|581304591|FG009|Early Disease Progression|Lost to Follow-up|0|||
160976754|NCT02291289|581304592|FG010|Early Disease Progression|Lost to Follow-up|0|||
160976755|NCT02291289|581304593|FG011|Early Disease Progression|Lost to Follow-up|0|||
160976756|NCT02291289|581304594|FG012|Early Disease Progression|Lost to Follow-up|1|||
160976757|NCT01017120|581304598|FG000|Overall Study|Adverse Event|9|||
160976758|NCT01017120|581304599|FG001|Overall Study|Adverse Event|0|||
160976759|NCT01017120|581304598|FG000|Overall Study|Lost to Follow-up|13|||
160976760|NCT01017120|581304599|FG001|Overall Study|Lost to Follow-up|11|||
160976761|NCT01017120|581304598|FG000|Overall Study|Lack of Efficacy|1|||
160976762|NCT01017120|581304599|FG001|Overall Study|Lack of Efficacy|0|||
160976763|NCT01017120|581304598|FG000|Overall Study|Withdrawal by Subject|39|||
160976764|NCT01017120|581304599|FG001|Overall Study|Withdrawal by Subject|21|||
160976765|NCT01017120|581304598|FG000|Overall Study|Pregnancy|1|||
160976766|NCT01017120|581304599|FG001|Overall Study|Pregnancy|1|||
160976767|NCT01017120|581304598|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
160976768|NCT01017120|581304599|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
160976769|NCT01017120|581304598|FG000|Overall Study|Relocated Out of Town|0|||
160976770|NCT01017120|581304599|FG001|Overall Study|Relocated Out of Town|2|||
160976771|NCT01017120|581304598|FG000|Overall Study|Protocol Violation|1|||
160976772|NCT01017120|581304599|FG001|Overall Study|Protocol Violation|0|||
160976773|NCT01017120|581304598|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
160976774|NCT01017120|581304599|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
160976775|NCT04399551|581304600|FG000|Overall Study|Adverse Event|15|||
160976776|NCT04399551|581304600|FG000|Overall Study|Withdrawal by Subject|6|||
160976777|NCT04399551|581304600|FG000|Overall Study|Physician Decision|3|||
160976778|NCT04399551|581304600|FG000|Overall Study|Lost to Follow-up|2|||
160976779|NCT04399551|581304600|FG000|Overall Study|Protocol Deviation|2|||
160976780|NCT01642602|581304604|FG000|Overall Study|Adverse Event|2|||
160976781|NCT01112514|581304605|FG000|Overall Study|Lost to Follow-up|1|||
160976782|NCT01024959|581304606|FG000|Overall Study|ineligible|12|||
160976783|NCT01024959|581304606|FG000|Overall Study|results not evaluable|12|||
160976784|NCT01024959|581304606|FG000|Overall Study|missing results required for analysis|17|||
160976785|NCT01118455|581304607|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
160976786|NCT01118455|581304608|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
160976787|NCT01912781|581304616|FG000|Overall Study|Withdrawal by Subject|2|||
160976788|NCT01912781|581304617|FG001|Overall Study|Withdrawal by Subject|0|||
160976789|NCT03377790|581304620|FG000|Overall Study|Withdrawal by Subject|1|||
160976790|NCT03377790|581304621|FG001|Overall Study|Withdrawal by Subject|0|||
160976791|NCT03377790|581304620|FG000|Overall Study|Adverse Event|1|||
160976792|NCT03377790|581304621|FG001|Overall Study|Adverse Event|0|||
160976793|NCT03377790|581304620|FG000|Overall Study|Lost to Follow-up|0|||
160976794|NCT03377790|581304621|FG001|Overall Study|Lost to Follow-up|2|||
160976795|NCT03377790|581304620|FG000|Overall Study|Randomized but not treated|1|||
160976796|NCT03377790|581304621|FG001|Overall Study|Randomized but not treated|0|||
161033253|NCT04174170|581515349|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
161033254|NCT04174170|581515350|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
161033255|NCT05875701|581515364|FG000|Overall Study|Lost to Follow-up|2|||
161033256|NCT05875701|581515365|FG001|Overall Study|Lost to Follow-up|0|||
161033257|NCT05875701|581515364|FG000|Overall Study|Withdrawal by Subject|1|||
161033258|NCT05875701|581515365|FG001|Overall Study|Withdrawal by Subject|1|||
161033259|NCT02656706|581515367|FG000|Overall Study|Insurance Denial|1|||
161033260|NCT04490356|581515371|FG000|Overall Study|Lost to Follow-up|1|||
161033261|NCT03201939|581515379|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
161033262|NCT03201939|581515380|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
161033263|NCT03884439|581515381|FG000|Overall Study|No informed consent for publication of study results|38|||
161033264|NCT03884439|581515381|FG000|Overall Study|Contract violation/deficiency|7|||
161033265|NCT05129501|581515384|FG000|Overall Study|Lost to Follow-up|54|||
161033266|NCT05129501|581515385|FG001|Overall Study|Lost to Follow-up|41|||
161033267|NCT03142009|581515388|FG000|Overall Study|Lost to Follow-up|45|||
161033268|NCT03142009|581515389|FG001|Overall Study|Lost to Follow-up|30|||
161033269|NCT03982186|581515390|FG000|Overall Study|Lost to Follow-up|0|||
161033270|NCT03982186|581515391|FG001|Overall Study|Lost to Follow-up|1|||
161033271|NCT03982186|581515392|FG002|Overall Study|Lost to Follow-up|2|||
161033272|NCT03982186|581515393|FG003|Overall Study|Lost to Follow-up|1|||
161033273|NCT03982186|581515394|FG004|Overall Study|Lost to Follow-up|1|||
161033274|NCT03982186|581515395|FG005|Overall Study|Lost to Follow-up|0|||
161033275|NCT03982186|581515390|FG000|Overall Study|Physician Decision|0|||
161033276|NCT03982186|581515391|FG001|Overall Study|Physician Decision|1|||
161033277|NCT03982186|581515392|FG002|Overall Study|Physician Decision|0|||
161033278|NCT03982186|581515393|FG003|Overall Study|Physician Decision|0|||
161033279|NCT03982186|581515394|FG004|Overall Study|Physician Decision|0|||
161033280|NCT03982186|581515395|FG005|Overall Study|Physician Decision|0|||
161033281|NCT03982186|581515390|FG000|Overall Study|Withdrawal by Subject|3|||
161033282|NCT03982186|581515391|FG001|Overall Study|Withdrawal by Subject|4|||
161033283|NCT03982186|581515392|FG002|Overall Study|Withdrawal by Subject|1|||
161033284|NCT03982186|581515393|FG003|Overall Study|Withdrawal by Subject|7|||
161033285|NCT03982186|581515394|FG004|Overall Study|Withdrawal by Subject|2|||
161033286|NCT03982186|581515395|FG005|Overall Study|Withdrawal by Subject|0|||
161033287|NCT03982186|581515390|FG000|Overall Study|Randomized and not treated|0|||
161033288|NCT03982186|581515391|FG001|Overall Study|Randomized and not treated|0|||
161033289|NCT03982186|581515392|FG002|Overall Study|Randomized and not treated|0|||
161033290|NCT03982186|581515393|FG003|Overall Study|Randomized and not treated|1|||
161033291|NCT03982186|581515394|FG004|Overall Study|Randomized and not treated|0|||
161033292|NCT03982186|581515395|FG005|Overall Study|Randomized and not treated|0|||
161033293|NCT01553149|581515396|FG000|Overall Study|Adverse Event|0|||
161033294|NCT01553149|581515397|FG001|Overall Study|Adverse Event|9|||
161033295|NCT01553149|581515396|FG000|Overall Study|Physician Decision|5|||
161033296|NCT01553149|581515397|FG001|Overall Study|Physician Decision|10|||
161033297|NCT01553149|581515396|FG000|Overall Study|Ineligible|0|||
161033298|NCT01553149|581515397|FG001|Overall Study|Ineligible|1|||
161033299|NCT05267639|581516066|FG000|Overall Study|Withdrawal by Subject|1|||
161033300|NCT05267639|581516067|FG001|Overall Study|Withdrawal by Subject|0|||
161033301|NCT03512301|581516069|FG000|Overall Study|Protocol Violation|2|||
161033302|NCT03512301|581516069|FG000|Overall Study|Did Not Qualify|3|||
161033303|NCT03512301|581516069|FG000|Overall Study|Age-ineligible|1|||
161033304|NCT03512301|581516069|FG000|Overall Study|Inadequate fluency with the English language|3|||
161033305|NCT00113360|581516070|FG000|Overall Study|Adverse Event|3|||
161033306|NCT00113360|581516070|FG000|Overall Study|Subject required surgery|1|||
161033307|NCT00113360|581516070|FG000|Overall Study|Did not meet eligibility criteria|3|||
161033308|NCT04993677|581516077|FG000|Overall Study|Lost to Follow-up|1|||
161033309|NCT04993677|581516078|FG001|Overall Study|Lost to Follow-up|0|||
161033310|NCT04993677|581516079|FG002|Overall Study|Lost to Follow-up|0|||
161033311|NCT04993677|581516080|FG003|Overall Study|Lost to Follow-up|0|||
161033312|NCT04993677|581516077|FG000|Overall Study|Death|11|||
161033313|NCT04993677|581516078|FG001|Overall Study|Death|8|||
161033314|NCT04993677|581516079|FG002|Overall Study|Death|3|||
161033315|NCT04993677|581516080|FG003|Overall Study|Death|1|||
161033316|NCT04993677|581516077|FG000|Overall Study|Subject withdrawal of consent|4|||
161033317|NCT04993677|581516078|FG001|Overall Study|Subject withdrawal of consent|3|||
161033318|NCT04993677|581516079|FG002|Overall Study|Subject withdrawal of consent|0|||
161033319|NCT04993677|581516080|FG003|Overall Study|Subject withdrawal of consent|2|||
161033320|NCT04993677|581516077|FG000|Overall Study|Study termination by sponsor|3|||
161033321|NCT04993677|581516078|FG001|Overall Study|Study termination by sponsor|25|||
161033322|NCT04993677|581516079|FG002|Overall Study|Study termination by sponsor|3|||
161033323|NCT04993677|581516080|FG003|Overall Study|Study termination by sponsor|3|||
161033324|NCT04993677|581516077|FG000|Overall Study|Other|2|||
161033325|NCT04993677|581516078|FG001|Overall Study|Other|3|||
161033326|NCT04993677|581516079|FG002|Overall Study|Other|3|||
161033327|NCT04993677|581516080|FG003|Overall Study|Other|2|||
161033328|NCT02231749|581516082|FG000|Overall Study|Disease progression|229|||
161033329|NCT02231749|581516083|FG001|Overall Study|Disease progression|297|||
161278800|NCT01449370|582400364|FG007|Overall Study|Participant Decision|1|||
161278801|NCT01449370|582400365|FG008|Overall Study|Participant Decision|1|||
161278802|NCT01449370|582400366|FG009|Overall Study|Participant Decision|0|||
161278803|NCT01449370|582400367|FG010|Overall Study|Participant Decision|0|||
161278804|NCT01449370|582400368|FG011|Overall Study|Participant Decision|0|||
161278805|NCT01449370|582400369|FG012|Overall Study|Participant Decision|1|||
161278806|NCT01449370|582400370|FG013|Overall Study|Participant Decision|1|||
161278807|NCT01449370|582400371|FG014|Overall Study|Participant Decision|0|||
161278808|NCT01449370|582400372|FG015|Overall Study|Participant Decision|1|||
161278809|NCT01449370|582400373|FG016|Overall Study|Participant Decision|3|||
161278810|NCT01449370|582400374|FG017|Overall Study|Participant Decision|0|||
161278811|NCT01449370|582400375|FG018|Overall Study|Participant Decision|1|||
161278812|NCT01449370|582400376|FG019|Overall Study|Participant Decision|0|||
161033330|NCT02231749|581516082|FG000|Overall Study|Study Drug Toxicity|134|||
161033331|NCT02231749|581516083|FG001|Overall Study|Study Drug Toxicity|63|||
161033332|NCT02231749|581516082|FG000|Overall Study|Death|1|||
161033333|NCT02231749|581516083|FG001|Overall Study|Death|1|||
161033334|NCT02231749|581516082|FG000|Overall Study|AE unrelated to Study drug|32|||
161033335|NCT02231749|581516083|FG001|Overall Study|AE unrelated to Study drug|31|||
161033336|NCT02231749|581516082|FG000|Overall Study|Participant's request to discontinue|10|||
161033337|NCT02231749|581516083|FG001|Overall Study|Participant's request to discontinue|21|||
161033338|NCT02231749|581516082|FG000|Overall Study|Participant withdrew Consent|8|||
161033339|NCT02231749|581516083|FG001|Overall Study|Participant withdrew Consent|15|||
161033340|NCT02231749|581516082|FG000|Overall Study|Lost to Follow-up|1|||
161033341|NCT02231749|581516083|FG001|Overall Study|Lost to Follow-up|2|||
161033342|NCT02231749|581516082|FG000|Overall Study|Maximum Clinical Benefit|5|||
161033343|NCT02231749|581516083|FG001|Overall Study|Maximum Clinical Benefit|8|||
161033344|NCT02231749|581516082|FG000|Overall Study|Poor/Non-Compliance|0|||
161033345|NCT02231749|581516083|FG001|Overall Study|Poor/Non-Compliance|3|||
161033346|NCT02231749|581516082|FG000|Overall Study|Pregnancy|1|||
161033347|NCT02231749|581516083|FG001|Overall Study|Pregnancy|0|||
161033348|NCT02231749|581516082|FG000|Overall Study|other|0|||
161033349|NCT02231749|581516083|FG001|Overall Study|other|8|||
161033350|NCT02231749|581516082|FG000|Overall Study|No longer meets Study Criteria|1|||
161033351|NCT02231749|581516083|FG001|Overall Study|No longer meets Study Criteria|0|||
161033352|NCT04772534|581516084|FG000|Overall Study|Physician Decision|1|||
161033353|NCT04772534|581516085|FG001|Overall Study|Physician Decision|0|||
161033354|NCT04772534|581516086|FG002|Overall Study|Physician Decision|0|||
161033355|NCT04772534|581516084|FG000|Overall Study|Withdrawal by Subject|3|||
161033356|NCT04772534|581516085|FG001|Overall Study|Withdrawal by Subject|0|||
161033357|NCT04772534|581516086|FG002|Overall Study|Withdrawal by Subject|1|||
161033358|NCT04194450|581516087|FG000|Overall Study|not eligible|1|||
161033359|NCT04194450|581516088|FG001|Overall Study|not eligible|0|||
161033360|NCT04675034|581516099|FG000|Overall Study|Lost to Follow-up|1|||
161033361|NCT04675034|581516100|FG001|Overall Study|Lost to Follow-up|1|||
161033362|NCT04675034|581516101|FG002|Overall Study|Lost to Follow-up|0|||
161033363|NCT04675034|581516102|FG003|Overall Study|Lost to Follow-up|2|||
161033364|NCT04675034|581516103|FG004|Overall Study|Lost to Follow-up|0|||
161033365|NCT04675034|581516099|FG000|Overall Study|Protocol Violation|1|||
161033366|NCT04675034|581516100|FG001|Overall Study|Protocol Violation|0|||
161033367|NCT04675034|581516101|FG002|Overall Study|Protocol Violation|0|||
161033368|NCT04675034|581516102|FG003|Overall Study|Protocol Violation|1|||
161033369|NCT04675034|581516103|FG004|Overall Study|Protocol Violation|3|||
161278813|NCT01449370|582400377|FG020|Overall Study|Participant Decision|0|||
161278814|NCT01449370|582400378|FG021|Overall Study|Participant Decision|1|||
161033370|NCT04675034|581516099|FG000|Overall Study|Withdrawal by Subject|9|||
161033371|NCT04675034|581516100|FG001|Overall Study|Withdrawal by Subject|3|||
161033372|NCT04675034|581516101|FG002|Overall Study|Withdrawal by Subject|4|||
161033373|NCT04675034|581516102|FG003|Overall Study|Withdrawal by Subject|8|||
161033374|NCT04675034|581516103|FG004|Overall Study|Withdrawal by Subject|6|||
161033375|NCT02532621|581516108|FG000|Overall Study|Death|3|||
161033376|NCT02532621|581516108|FG000|Overall Study|Lost to Follow-up|3|||
161033377|NCT02532621|581516108|FG000|Overall Study|Withdrawal by Subject|6|||
161033378|NCT02532621|581516108|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
161033379|NCT02532621|581516108|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
161033380|NCT04281498|581516113|FG000|Overall Study|Progression of disease|1|||
161033381|NCT04281498|581516113|FG000|Overall Study|Planned SCT|1|||
161278815|NCT01449370|582400379|FG022|Overall Study|Participant Decision|0|||
161278816|NCT01449370|582400380|FG023|Overall Study|Participant Decision|0|||
161278817|NCT01449370|582400381|FG024|Overall Study|Participant Decision|1|||
161033382|NCT04281498|581516113|FG000|Overall Study|Alternative Treatment|1|||
161278818|NCT01449370|582400357|FG000|Overall Study|Lost to Follow-up|0|||
161278819|NCT01449370|582400358|FG001|Overall Study|Lost to Follow-up|0|||
161033383|NCT01220531|581516114|FG000|Overall Study|Death|7|||
161033384|NCT01220531|581516114|FG000|Overall Study|Lost to Follow-up|1|||
161033385|NCT03008382|581516116|FG000|Overall Study|Withdrawal by Subject|2|||
161091180|NCT00336895|581723828|FG000|Overall Study|diarrhea|1|||
161278820|NCT01449370|582400359|FG002|Overall Study|Lost to Follow-up|0|||
161278821|NCT01449370|582400360|FG003|Overall Study|Lost to Follow-up|0|||
161278822|NCT01449370|582400361|FG004|Overall Study|Lost to Follow-up|0|||
161278823|NCT01449370|582400362|FG005|Overall Study|Lost to Follow-up|0|||
161278824|NCT01449370|582400363|FG006|Overall Study|Lost to Follow-up|0|||
161278825|NCT01449370|582400364|FG007|Overall Study|Lost to Follow-up|0|||
161278826|NCT01449370|582400365|FG008|Overall Study|Lost to Follow-up|0|||
161278827|NCT01449370|582400366|FG009|Overall Study|Lost to Follow-up|0|||
161278828|NCT01449370|582400367|FG010|Overall Study|Lost to Follow-up|0|||
161278829|NCT01449370|582400368|FG011|Overall Study|Lost to Follow-up|0|||
161278830|NCT01449370|582400369|FG012|Overall Study|Lost to Follow-up|0|||
161278831|NCT01449370|582400370|FG013|Overall Study|Lost to Follow-up|0|||
161278832|NCT01449370|582400371|FG014|Overall Study|Lost to Follow-up|0|||
161278833|NCT01449370|582400372|FG015|Overall Study|Lost to Follow-up|0|||
161278834|NCT01449370|582400373|FG016|Overall Study|Lost to Follow-up|0|||
161278835|NCT01449370|582400374|FG017|Overall Study|Lost to Follow-up|0|||
161278836|NCT01449370|582400375|FG018|Overall Study|Lost to Follow-up|0|||
161278837|NCT01449370|582400376|FG019|Overall Study|Lost to Follow-up|0|||
161278838|NCT01449370|582400377|FG020|Overall Study|Lost to Follow-up|1|||
161278839|NCT01449370|582400378|FG021|Overall Study|Lost to Follow-up|0|||
161278840|NCT01449370|582400379|FG022|Overall Study|Lost to Follow-up|0|||
161278841|NCT01449370|582400380|FG023|Overall Study|Lost to Follow-up|0|||
161278842|NCT01449370|582400381|FG024|Overall Study|Lost to Follow-up|0|||
161278843|NCT01449370|582400357|FG000|Overall Study|Other|0|||
161278844|NCT01449370|582400358|FG001|Overall Study|Other|0|||
161278845|NCT01449370|582400359|FG002|Overall Study|Other|0|||
161278846|NCT01449370|582400360|FG003|Overall Study|Other|0|||
161278847|NCT01449370|582400361|FG004|Overall Study|Other|0|||
161278848|NCT01449370|582400362|FG005|Overall Study|Other|0|||
161278849|NCT01449370|582400363|FG006|Overall Study|Other|0|||
161278850|NCT01449370|582400364|FG007|Overall Study|Other|0|||
161278851|NCT01449370|582400365|FG008|Overall Study|Other|1|||
161278852|NCT01449370|582400366|FG009|Overall Study|Other|1|||
161278853|NCT01449370|582400367|FG010|Overall Study|Other|0|||
161278854|NCT01449370|582400368|FG011|Overall Study|Other|0|||
161278855|NCT01449370|582400369|FG012|Overall Study|Other|0|||
161278856|NCT01449370|582400370|FG013|Overall Study|Other|0|||
161278857|NCT01449370|582400371|FG014|Overall Study|Other|0|||
161278858|NCT01449370|582400372|FG015|Overall Study|Other|0|||
161278859|NCT01449370|582400373|FG016|Overall Study|Other|0|||
161278860|NCT01449370|582400374|FG017|Overall Study|Other|0|||
161278861|NCT01449370|582400375|FG018|Overall Study|Other|0|||
161278862|NCT01449370|582400376|FG019|Overall Study|Other|0|||
161278863|NCT01449370|582400377|FG020|Overall Study|Other|0|||
161278864|NCT01449370|582400378|FG021|Overall Study|Other|0|||
161278865|NCT01449370|582400379|FG022|Overall Study|Other|1|||
161278866|NCT01449370|582400380|FG023|Overall Study|Other|1|||
161344773|NCT01047319|582647278|FG001|Overall Study|Death|1|||
160976797|NCT03377790|581304620|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
160976798|NCT03377790|581304621|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
160976799|NCT01533714|581304622|FG000|Overall Study|Adverse Event|0|||
160976800|NCT01533714|581304623|FG001|Overall Study|Adverse Event|1|||
160976801|NCT01533714|581304624|FG002|Overall Study|Adverse Event|2|||
160976802|NCT01533714|581304625|FG003|Overall Study|Adverse Event|2|||
160976803|NCT01533714|581304626|FG004|Overall Study|Adverse Event|2|||
160976804|NCT01533714|581304627|FG005|Overall Study|Adverse Event|1|||
160976805|NCT01533714|581304622|FG000|Overall Study|Lack of Efficacy|0|||
160976806|NCT01533714|581304623|FG001|Overall Study|Lack of Efficacy|0|||
160976807|NCT01533714|581304624|FG002|Overall Study|Lack of Efficacy|0|||
160976808|NCT01533714|581304625|FG003|Overall Study|Lack of Efficacy|0|||
160976809|NCT01533714|581304626|FG004|Overall Study|Lack of Efficacy|0|||
160976810|NCT01533714|581304627|FG005|Overall Study|Lack of Efficacy|1|||
160976811|NCT01533714|581304622|FG000|Overall Study|Withdrawal by Subject|0|||
160976812|NCT01533714|581304623|FG001|Overall Study|Withdrawal by Subject|1|||
160976813|NCT01533714|581304624|FG002|Overall Study|Withdrawal by Subject|0|||
160976814|NCT01533714|581304625|FG003|Overall Study|Withdrawal by Subject|1|||
160976815|NCT01533714|581304626|FG004|Overall Study|Withdrawal by Subject|1|||
160976816|NCT01533714|581304627|FG005|Overall Study|Withdrawal by Subject|0|||
160976817|NCT01533714|581304622|FG000|Overall Study|Exclusion criteria|0|||
160976818|NCT01533714|581304623|FG001|Overall Study|Exclusion criteria|1|||
160976819|NCT01533714|581304624|FG002|Overall Study|Exclusion criteria|0|||
161278867|NCT01449370|582400381|FG024|Overall Study|Other|0|||
161278868|NCT01449370|582400357|FG000|Overall Study|Medication Prohibited by Protocol|0|||
161278869|NCT01449370|582400358|FG001|Overall Study|Medication Prohibited by Protocol|0|||
161278870|NCT01449370|582400359|FG002|Overall Study|Medication Prohibited by Protocol|0|||
161278871|NCT01449370|582400360|FG003|Overall Study|Medication Prohibited by Protocol|0|||
160976820|NCT01533714|581304625|FG003|Overall Study|Exclusion criteria|0|||
160976821|NCT01533714|581304626|FG004|Overall Study|Exclusion criteria|0|||
160976822|NCT01533714|581304627|FG005|Overall Study|Exclusion criteria|0|||
161278872|NCT01449370|582400361|FG004|Overall Study|Medication Prohibited by Protocol|0|||
161278873|NCT01449370|582400362|FG005|Overall Study|Medication Prohibited by Protocol|0|||
161344774|NCT01047319|582647279|FG002|Overall Study|Death|5|||
161033386|NCT03008382|581516117|FG001|Overall Study|Withdrawal by Subject|5|||
161033387|NCT03008382|581516118|FG002|Overall Study|Withdrawal by Subject|2|||
161033388|NCT03008382|581516119|FG003|Overall Study|Withdrawal by Subject|0|||
161033389|NCT03008382|581516116|FG000|Overall Study|Protocol Violation|1|||
161033390|NCT03008382|581516117|FG001|Overall Study|Protocol Violation|0|||
161033391|NCT03008382|581516118|FG002|Overall Study|Protocol Violation|0|||
161033392|NCT03008382|581516119|FG003|Overall Study|Protocol Violation|0|||
161033393|NCT03008382|581516116|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
161033394|NCT03008382|581516117|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
161033395|NCT03008382|581516118|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
161033396|NCT03008382|581516119|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
161033397|NCT03008382|581516116|FG000|Overall Study|Lost to Follow-up|0|||
161033398|NCT03008382|581516117|FG001|Overall Study|Lost to Follow-up|0|||
161033399|NCT03008382|581516118|FG002|Overall Study|Lost to Follow-up|1|||
161033400|NCT03008382|581516119|FG003|Overall Study|Lost to Follow-up|0|||
161033401|NCT03008382|581516116|FG000|Overall Study|Screenfail|0|||
161033402|NCT03008382|581516117|FG001|Overall Study|Screenfail|0|||
161033403|NCT03008382|581516118|FG002|Overall Study|Screenfail|2|||
161033404|NCT03008382|581516119|FG003|Overall Study|Screenfail|0|||
161033405|NCT04732871|581516892|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
161033406|NCT04732871|581516893|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
161033407|NCT04732871|581516894|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
161033408|NCT04732871|581516892|FG000|Overall Study|Lost to Follow-up|7|||
161033409|NCT04732871|581516893|FG001|Overall Study|Lost to Follow-up|4|||
161033410|NCT04732871|581516894|FG002|Overall Study|Lost to Follow-up|3|||
161033411|NCT04732871|581516892|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
161033412|NCT04732871|581516893|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
161033413|NCT04732871|581516894|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
161033414|NCT04732871|581516892|FG000|Overall Study|Migrated / moved from the study area|5|||
161033415|NCT04732871|581516893|FG001|Overall Study|Migrated / moved from the study area|0|||
161033416|NCT04732871|581516894|FG002|Overall Study|Migrated / moved from the study area|0|||
161033417|NCT04732871|581516892|FG000|Overall Study|Other|1|||
161033418|NCT04732871|581516893|FG001|Overall Study|Other|0|||
161033419|NCT04732871|581516894|FG002|Overall Study|Other|1|||
161033420|NCT04732871|581516892|FG000|Overall Study|Ongoing|6|||
161033421|NCT04732871|581516893|FG001|Overall Study|Ongoing|0|||
161033422|NCT04732871|581516894|FG002|Overall Study|Ongoing|1|||
161033423|NCT04732871|581516892|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
161033424|NCT04732871|581516893|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
161033425|NCT04732871|581516894|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
161033426|NCT05180539|581516904|FG000|Overall Study|Lost to Follow-up|27|||
161033427|NCT05180539|581516905|FG001|Overall Study|Lost to Follow-up|30|||
161033428|NCT01976936|581516906|FG000|Overall Study|Did not receive at least 9 doses|9|||
161033429|NCT01976936|581516907|FG001|Overall Study|Did not receive at least 9 doses|4|||
161033430|NCT02467270|581516908|FG000|Overall Study|Participants Never Treated|0|||
161033431|NCT02467270|581516909|FG001|Overall Study|Participants Never Treated|1|||
161033432|NCT02467270|581516910|FG002|Overall Study|Participants Never Treated|0|||
161033433|NCT02467270|581516908|FG000|Overall Study|Ongoing|50|||
161033434|NCT02467270|581516909|FG001|Overall Study|Ongoing|41|||
161033435|NCT02467270|581516910|FG002|Overall Study|Ongoing|43|||
161033436|NCT02467270|581516908|FG000|Overall Study|Adverse Event|16|||
161033437|NCT02467270|581516909|FG001|Overall Study|Adverse Event|15|||
161033438|NCT02467270|581516910|FG002|Overall Study|Adverse Event|14|||
161033439|NCT02467270|581516908|FG000|Overall Study|Progressive Disease|7|||
161033440|NCT02467270|581516909|FG001|Overall Study|Progressive Disease|7|||
161033441|NCT02467270|581516910|FG002|Overall Study|Progressive Disease|4|||
161033442|NCT02467270|581516908|FG000|Overall Study|Death|2|||
161033443|NCT02467270|581516909|FG001|Overall Study|Death|0|||
161033444|NCT02467270|581516910|FG002|Overall Study|Death|2|||
161033445|NCT02467270|581516908|FG000|Overall Study|Lack of Efficacy|12|||
161033446|NCT02467270|581516909|FG001|Overall Study|Lack of Efficacy|18|||
161033447|NCT02467270|581516910|FG002|Overall Study|Lack of Efficacy|23|||
161033448|NCT02467270|581516908|FG000|Overall Study|Non-compliance With Study Drug|0|||
161033449|NCT02467270|581516909|FG001|Overall Study|Non-compliance With Study Drug|2|||
161033450|NCT02467270|581516910|FG002|Overall Study|Non-compliance With Study Drug|1|||
161033451|NCT02467270|581516908|FG000|Overall Study|Lost to Follow-up|2|||
161033452|NCT02467270|581516909|FG001|Overall Study|Lost to Follow-up|1|||
161033453|NCT02467270|581516910|FG002|Overall Study|Lost to Follow-up|0|||
161033454|NCT02467270|581516908|FG000|Overall Study|Pregnancy|0|||
161033455|NCT02467270|581516909|FG001|Overall Study|Pregnancy|1|||
161033456|NCT02467270|581516910|FG002|Overall Study|Pregnancy|0|||
161033457|NCT02467270|581516908|FG000|Overall Study|Physician Decision|0|||
161033458|NCT02467270|581516909|FG001|Overall Study|Physician Decision|4|||
161033459|NCT02467270|581516910|FG002|Overall Study|Physician Decision|1|||
161033460|NCT02467270|581516908|FG000|Overall Study|Withdrawal by Subject|4|||
161033461|NCT02467270|581516909|FG001|Overall Study|Withdrawal by Subject|3|||
161033462|NCT02467270|581516910|FG002|Overall Study|Withdrawal by Subject|5|||
161033463|NCT02467270|581516908|FG000|Overall Study|Reason not Specified|1|||
161033464|NCT02467270|581516909|FG001|Overall Study|Reason not Specified|2|||
161033465|NCT02467270|581516910|FG002|Overall Study|Reason not Specified|1|||
161033466|NCT00495677|581516911|FG000|Stage 1 (25 Days)|Adverse Event|0|||
161033467|NCT00495677|581516912|FG001|Stage 1 (25 Days)|Adverse Event|0|||
161033468|NCT00495677|581516913|FG002|Stage 1 (25 Days)|Adverse Event|1|||
161033469|NCT00495677|581516914|FG003|Stage 1 (25 Days)|Adverse Event|0|||
161033470|NCT00495677|581516915|FG004|Stage 1 (25 Days)|Adverse Event|0|||
161033471|NCT00495677|581516916|FG005|Stage 1 (25 Days)|Adverse Event|0|||
161033472|NCT00495677|581516917|FG006|Stage 1 (25 Days)|Adverse Event|0|||
161033473|NCT05162586|581516919|FG000|Overall Study|Other|0|||
161033474|NCT05162586|581516920|FG001|Overall Study|Other|0|||
161033475|NCT05162586|581516921|FG002|Overall Study|Other|0|||
161033476|NCT05162586|581516922|FG003|Overall Study|Other|0|||
161033477|NCT05162586|581516923|FG004|Overall Study|Other|1|||
161033478|NCT05162586|581516924|FG005|Overall Study|Other|0|||
161033479|NCT05162586|581516925|FG006|Overall Study|Other|2|||
161033480|NCT05162586|581516926|FG007|Overall Study|Other|2|||
161033481|NCT05162586|581516919|FG000|Overall Study|Lack of Efficacy|0|||
161033482|NCT05162586|581516920|FG001|Overall Study|Lack of Efficacy|0|||
161033483|NCT05162586|581516921|FG002|Overall Study|Lack of Efficacy|0|||
161033484|NCT05162586|581516922|FG003|Overall Study|Lack of Efficacy|0|||
161033485|NCT05162586|581516923|FG004|Overall Study|Lack of Efficacy|1|||
161033486|NCT05162586|581516924|FG005|Overall Study|Lack of Efficacy|0|||
161033487|NCT05162586|581516925|FG006|Overall Study|Lack of Efficacy|0|||
161033488|NCT05162586|581516926|FG007|Overall Study|Lack of Efficacy|1|||
161033489|NCT05162586|581516919|FG000|Overall Study|Lost to Follow-up|0|||
161033490|NCT05162586|581516920|FG001|Overall Study|Lost to Follow-up|0|||
161033491|NCT05162586|581516921|FG002|Overall Study|Lost to Follow-up|0|||
161033492|NCT05162586|581516922|FG003|Overall Study|Lost to Follow-up|0|||
161033493|NCT05162586|581516923|FG004|Overall Study|Lost to Follow-up|2|||
161033494|NCT05162586|581516924|FG005|Overall Study|Lost to Follow-up|0|||
161033495|NCT05162586|581516925|FG006|Overall Study|Lost to Follow-up|0|||
161033496|NCT05162586|581516926|FG007|Overall Study|Lost to Follow-up|2|||
161033497|NCT05162586|581516919|FG000|Overall Study|Non-Compliance|0|||
161033498|NCT05162586|581516920|FG001|Overall Study|Non-Compliance|1|||
161033499|NCT05162586|581516921|FG002|Overall Study|Non-Compliance|0|||
161033500|NCT05162586|581516922|FG003|Overall Study|Non-Compliance|0|||
161033501|NCT05162586|581516923|FG004|Overall Study|Non-Compliance|1|||
161033502|NCT05162586|581516924|FG005|Overall Study|Non-Compliance|0|||
161033503|NCT05162586|581516925|FG006|Overall Study|Non-Compliance|0|||
161033504|NCT05162586|581516926|FG007|Overall Study|Non-Compliance|1|||
161033505|NCT05162586|581516919|FG000|Overall Study|Withdrawal by Subject|2|||
161033506|NCT05162586|581516920|FG001|Overall Study|Withdrawal by Subject|0|||
161033507|NCT05162586|581516921|FG002|Overall Study|Withdrawal by Subject|0|||
161033508|NCT05162586|581516922|FG003|Overall Study|Withdrawal by Subject|0|||
161033509|NCT05162586|581516923|FG004|Overall Study|Withdrawal by Subject|7|||
161033510|NCT05162586|581516924|FG005|Overall Study|Withdrawal by Subject|6|||
161033511|NCT05162586|581516925|FG006|Overall Study|Withdrawal by Subject|2|||
161033512|NCT05162586|581516926|FG007|Overall Study|Withdrawal by Subject|2|||
161033513|NCT05162586|581516919|FG000|Overall Study|Adverse Event|2|||
161033514|NCT05162586|581516920|FG001|Overall Study|Adverse Event|0|||
161033515|NCT05162586|581516921|FG002|Overall Study|Adverse Event|1|||
161033516|NCT05162586|581516922|FG003|Overall Study|Adverse Event|2|||
161033517|NCT05162586|581516923|FG004|Overall Study|Adverse Event|4|||
161033518|NCT05162586|581516924|FG005|Overall Study|Adverse Event|1|||
161033519|NCT05162586|581516925|FG006|Overall Study|Adverse Event|5|||
161033520|NCT05162586|581516926|FG007|Overall Study|Adverse Event|2|||
161033521|NCT00357682|581516929|FG000|Overall Study|Did not receive allocated Treatment|10|||
161033522|NCT00357682|581516930|FG001|Overall Study|Did not receive allocated Treatment|9|||
161033523|NCT00357682|581516931|FG002|Overall Study|Did not receive allocated Treatment|9|||
161033524|NCT00357682|581516932|FG003|Overall Study|Did not receive allocated Treatment|10|||
161033525|NCT00357682|581516929|FG000|Overall Study|Withdrew consent|6|||
161033526|NCT00357682|581516930|FG001|Overall Study|Withdrew consent|6|||
161033527|NCT00357682|581516931|FG002|Overall Study|Withdrew consent|5|||
161033528|NCT00357682|581516932|FG003|Overall Study|Withdrew consent|5|||
161033529|NCT00357682|581516929|FG000|Overall Study|Lost to Follow-up|39|||
161033530|NCT00357682|581516930|FG001|Overall Study|Lost to Follow-up|33|||
161033531|NCT00357682|581516931|FG002|Overall Study|Lost to Follow-up|26|||
161033532|NCT00357682|581516932|FG003|Overall Study|Lost to Follow-up|35|||
161033533|NCT00357682|581516929|FG000|Overall Study|Adverse Event|24|||
161033534|NCT00357682|581516930|FG001|Overall Study|Adverse Event|32|||
161033535|NCT00357682|581516931|FG002|Overall Study|Adverse Event|22|||
161033536|NCT00357682|581516932|FG003|Overall Study|Adverse Event|27|||
161033537|NCT00357682|581516929|FG000|Overall Study|Physician Decision|32|||
161033538|NCT00357682|581516930|FG001|Overall Study|Physician Decision|20|||
161033539|NCT00357682|581516931|FG002|Overall Study|Physician Decision|24|||
161033540|NCT00357682|581516932|FG003|Overall Study|Physician Decision|30|||
161033541|NCT00357682|581516929|FG000|Overall Study|Patient decision|73|||
161033542|NCT00357682|581516930|FG001|Overall Study|Patient decision|80|||
161033543|NCT00357682|581516931|FG002|Overall Study|Patient decision|51|||
161033544|NCT00357682|581516932|FG003|Overall Study|Patient decision|59|||
161033545|NCT00357682|581516929|FG000|Overall Study|Other reason|157|||
161033546|NCT00357682|581516930|FG001|Overall Study|Other reason|130|||
161033547|NCT00357682|581516931|FG002|Overall Study|Other reason|114|||
161033548|NCT00357682|581516932|FG003|Overall Study|Other reason|99|||
161033549|NCT05424718|581516937|FG000|Overall Study|Lost to Follow-up|5|||
161033550|NCT05424718|581516938|FG001|Overall Study|Lost to Follow-up|4|||
161033551|NCT04046549|581516939|FG000|Overall Study|Adverse Event|1|||
161033552|NCT04046549|581516939|FG000|Overall Study|Physician Decision|1|||
161033553|NCT04046549|581516939|FG000|Overall Study|Withdrawal by Subject|3|||
161033554|NCT04046549|581516939|FG000|Overall Study|Other, Not Specified|5|||
161033555|NCT06059443|581516940|FG000|Overall Study|Withdrawal by Subject|2|||
161033556|NCT06059443|581516941|FG001|Overall Study|Withdrawal by Subject|0|||
161033557|NCT06059443|581516940|FG000|Overall Study|Lost to Follow-up|2|||
161033558|NCT06059443|581516941|FG001|Overall Study|Lost to Follow-up|2|||
161033559|NCT03587805|581516943|FG000|Overall Study|Adverse Event|72|||
161344775|NCT01047319|582647277|FG000|Overall Study|Pregnancy|13|||
161344776|NCT01047319|582647278|FG001|Overall Study|Pregnancy|8|||
161344777|NCT01047319|582647279|FG002|Overall Study|Pregnancy|8|||
161344778|NCT01047319|582647277|FG000|Overall Study|Physician Decision|12|||
160976823|NCT01533714|581304622|FG000|Overall Study|Positive for purified protein derivative|0|||
160976824|NCT01533714|581304623|FG001|Overall Study|Positive for purified protein derivative|0|||
160976825|NCT01533714|581304624|FG002|Overall Study|Positive for purified protein derivative|1|||
160976826|NCT01533714|581304625|FG003|Overall Study|Positive for purified protein derivative|0|||
160976827|NCT01533714|581304626|FG004|Overall Study|Positive for purified protein derivative|1|||
160976828|NCT01533714|581304627|FG005|Overall Study|Positive for purified protein derivative|0|||
160976829|NCT01533714|581304622|FG000|Overall Study|Withdrawal criteria|0|||
160976830|NCT01533714|581304623|FG001|Overall Study|Withdrawal criteria|0|||
160976831|NCT01533714|581304624|FG002|Overall Study|Withdrawal criteria|1|||
160976832|NCT01533714|581304625|FG003|Overall Study|Withdrawal criteria|0|||
160976833|NCT01533714|581304626|FG004|Overall Study|Withdrawal criteria|3|||
160976834|NCT01533714|581304627|FG005|Overall Study|Withdrawal criteria|1|||
160976835|NCT01533714|581304622|FG000|Overall Study|Ineligibility reason|0|||
160976836|NCT01533714|581304623|FG001|Overall Study|Ineligibility reason|0|||
160976837|NCT01533714|581304624|FG002|Overall Study|Ineligibility reason|0|||
160976838|NCT01533714|581304625|FG003|Overall Study|Ineligibility reason|1|||
160976839|NCT01533714|581304626|FG004|Overall Study|Ineligibility reason|0|||
160976840|NCT01533714|581304627|FG005|Overall Study|Ineligibility reason|0|||
160976841|NCT05033743|581304628|FG000|Overall Study|Lost to Follow-up|1|||
160976842|NCT05033743|581304628|FG000|Overall Study|Protocol Violation|2|||
160976843|NCT05033743|581304628|FG000|Overall Study|Withdrawal by Subject|1|||
160976844|NCT02564055|581304629|FG000|Overall Study|Adverse Event|1|||
160976845|NCT02564055|581304630|FG001|Overall Study|Adverse Event|0|||
160976846|NCT02564055|581304631|FG002|Overall Study|Adverse Event|4|||
160976847|NCT02564055|581304632|FG003|Overall Study|Adverse Event|1|||
160976848|NCT02564055|581304633|FG004|Overall Study|Adverse Event|4|||
160976849|NCT02564055|581304634|FG005|Overall Study|Adverse Event|1|||
160976850|NCT02564055|581304629|FG000|Overall Study|Protocol Violation|1|||
160976851|NCT02564055|581304630|FG001|Overall Study|Protocol Violation|0|||
160976852|NCT02564055|581304631|FG002|Overall Study|Protocol Violation|0|||
160976853|NCT02564055|581304632|FG003|Overall Study|Protocol Violation|0|||
160976854|NCT02564055|581304633|FG004|Overall Study|Protocol Violation|0|||
160976855|NCT02564055|581304634|FG005|Overall Study|Protocol Violation|0|||
160976856|NCT02564055|581304629|FG000|Overall Study|Reached stopping criteria|0|||
160976857|NCT02564055|581304630|FG001|Overall Study|Reached stopping criteria|0|||
160976858|NCT02564055|581304631|FG002|Overall Study|Reached stopping criteria|0|||
160976859|NCT02564055|581304632|FG003|Overall Study|Reached stopping criteria|0|||
160976860|NCT02564055|581304633|FG004|Overall Study|Reached stopping criteria|0|||
160976861|NCT02564055|581304634|FG005|Overall Study|Reached stopping criteria|1|||
160976862|NCT02564055|581304629|FG000|Overall Study|Lost to Follow-up|0|||
160976863|NCT02564055|581304630|FG001|Overall Study|Lost to Follow-up|1|||
160976864|NCT02564055|581304631|FG002|Overall Study|Lost to Follow-up|4|||
160976865|NCT02564055|581304632|FG003|Overall Study|Lost to Follow-up|2|||
160976866|NCT02564055|581304633|FG004|Overall Study|Lost to Follow-up|1|||
160976867|NCT02564055|581304634|FG005|Overall Study|Lost to Follow-up|0|||
160976868|NCT02564055|581304629|FG000|Overall Study|Physician Decision|0|||
160976869|NCT02564055|581304630|FG001|Overall Study|Physician Decision|0|||
160976870|NCT02564055|581304631|FG002|Overall Study|Physician Decision|1|||
160976871|NCT02564055|581304632|FG003|Overall Study|Physician Decision|0|||
160976872|NCT02564055|581304633|FG004|Overall Study|Physician Decision|0|||
160976873|NCT02564055|581304634|FG005|Overall Study|Physician Decision|0|||
160976874|NCT02564055|581304629|FG000|Overall Study|Withdrawal by Subject|4|||
160976875|NCT02564055|581304630|FG001|Overall Study|Withdrawal by Subject|4|||
161033560|NCT03587805|581516943|FG000|Overall Study|Death|1|||
161033561|NCT03587805|581516943|FG000|Overall Study|Lost to Follow-up|78|||
161033562|NCT03587805|581516943|FG000|Overall Study|Withdrawal by Subject|105|||
161033563|NCT03587805|581516943|FG000|Overall Study|Lack of Efficacy|119|||
161033564|NCT03587805|581516943|FG000|Overall Study|Reason unknown|26|||
161033565|NCT03587805|581516943|FG000|Overall Study|COVID_19 pandemic|4|||
161033566|NCT03587805|581516943|FG000|Overall Study|Various reasons|121|||
161033567|NCT03587805|581516943|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161033568|NCT05771467|581516945|FG000|Overall Study|Lost to Follow-up|6|||
161033569|NCT05771467|581516946|FG001|Overall Study|Lost to Follow-up|3|||
161033570|NCT05866926|581516953|FG000|Overall Study|Death|16|||
161033571|NCT05866926|581516954|FG001|Overall Study|Death|9|||
161033572|NCT05866926|581516953|FG000|Overall Study|Lost to Follow-up|0|||
161033573|NCT05866926|581516954|FG001|Overall Study|Lost to Follow-up|1|||
161033574|NCT05866926|581516953|FG000|Overall Study|Adverse Event|1|||
161033575|NCT05866926|581516954|FG001|Overall Study|Adverse Event|0|||
161033576|NCT05866926|581516953|FG000|Overall Study|Withdrawal by Subject|5|||
161033577|NCT05866926|581516954|FG001|Overall Study|Withdrawal by Subject|1|||
161033578|NCT05866926|581516953|FG000|Overall Study|Disease progression|1|||
161033579|NCT05866926|581516954|FG001|Overall Study|Disease progression|0|||
161033580|NCT05866926|581516953|FG000|Overall Study|other causes|2|||
161033581|NCT05866926|581516954|FG001|Overall Study|other causes|1|||
161033582|NCT00709956|581516955|FG000|Overall Study|Withdrawal by Subject|1|||
161033583|NCT00709956|581516956|FG001|Overall Study|Withdrawal by Subject|1|||
161033584|NCT00709956|581516955|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
161033585|NCT00709956|581516956|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
161033586|NCT01105091|581516957|FG000|Overall Study|Death|2|||
161033587|NCT01105091|581516958|FG001|Overall Study|Death|0|||
161033588|NCT04940624|581516961|FG000|Overall Study|Adverse Event|4|||
161033589|NCT04940624|581516962|FG001|Overall Study|Adverse Event|11|||
161033590|NCT04940624|581516961|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161033591|NCT04940624|581516962|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161033592|NCT04940624|581516961|FG000|Overall Study|Physician Decision|1|||
161033593|NCT04940624|581516962|FG001|Overall Study|Physician Decision|0|||
161033594|NCT04940624|581516961|FG000|Overall Study|Lost to Follow-up|1|||
161033595|NCT04940624|581516962|FG001|Overall Study|Lost to Follow-up|0|||
161033596|NCT04940624|581516961|FG000|Overall Study|Reason Not Specified|1|||
161033597|NCT04940624|581516962|FG001|Overall Study|Reason Not Specified|0|||
161033598|NCT04479787|581516963|FG000|Through 6 Months|Withdrawal by Subject|16|||
161033599|NCT04479787|581516964|FG001|Through 6 Months|Withdrawal by Subject|14|||
161033600|NCT04479787|581516963|FG000|Through 6 Months|Unsuccessful Trial|17|||
161033601|NCT04479787|581516964|FG001|Through 6 Months|Unsuccessful Trial|0|||
161033602|NCT04479787|581516963|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
161033603|NCT04479787|581516964|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
161033604|NCT04479787|581516963|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
161033605|NCT04479787|581516964|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
161033606|NCT04479787|581516963|FG000|Through 6 Months|Lost to Follow-up|3|||
161033607|NCT04479787|581516964|FG001|Through 6 Months|Lost to Follow-up|2|||
161033608|NCT04479787|581516963|FG000|Through 6 Months|Death|3|||
161033609|NCT04479787|581516964|FG001|Through 6 Months|Death|0|||
161033610|NCT04479787|581516963|FG000|Through 6 Months|Inclusion/Exclusion|2|||
161033611|NCT04479787|581516964|FG001|Through 6 Months|Inclusion/Exclusion|1|||
161033612|NCT04479787|581516963|FG000|Through 6 Months|Subject Became Pregnant|1|||
161033613|NCT04479787|581516964|FG001|Through 6 Months|Subject Became Pregnant|1|||
161033614|NCT04479787|581516963|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
161033615|NCT04479787|581516964|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
161033616|NCT04479787|581516963|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
161033617|NCT04479787|581516964|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
161033618|NCT04479787|581516963|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
161033619|NCT04479787|581516964|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
161033620|NCT04479787|581516963|FG000|After 6 Months|Withdrawal by Subject|3|||
161033621|NCT04479787|581516964|FG001|After 6 Months|Withdrawal by Subject|13|||
161033622|NCT04479787|581516963|FG000|After 6 Months|Unsuccessful Trial|0|||
161278874|NCT01449370|582400363|FG006|Overall Study|Medication Prohibited by Protocol|0|||
161278875|NCT01449370|582400364|FG007|Overall Study|Medication Prohibited by Protocol|0|||
161278876|NCT01449370|582400365|FG008|Overall Study|Medication Prohibited by Protocol|0|||
161033623|NCT04479787|581516964|FG001|After 6 Months|Unsuccessful Trial|7|||
161033624|NCT04479787|581516963|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
161033625|NCT04479787|581516964|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
161033626|NCT04479787|581516963|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
161033627|NCT04479787|581516964|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
161033628|NCT04479787|581516963|FG000|After 6 Months|Death|2|||
161033629|NCT04479787|581516964|FG001|After 6 Months|Death|0|||
161033630|NCT04479787|581516963|FG000|After 6 Months|Lost to Follow-up|1|||
161033631|NCT04479787|581516964|FG001|After 6 Months|Lost to Follow-up|1|||
161033632|NCT04479787|581516963|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
161278877|NCT01449370|582400366|FG009|Overall Study|Medication Prohibited by Protocol|0|||
160976876|NCT02564055|581304631|FG002|Overall Study|Withdrawal by Subject|3|||
160976877|NCT02564055|581304632|FG003|Overall Study|Withdrawal by Subject|3|||
160976878|NCT02564055|581304633|FG004|Overall Study|Withdrawal by Subject|10|||
160976879|NCT02564055|581304634|FG005|Overall Study|Withdrawal by Subject|10|||
160976880|NCT04161807|581304636|FG000|Overall Study|Withdrawal by Subject|2|||
160976881|NCT04161807|581304636|FG000|Overall Study|Performed only 1 treatment|2|||
160976882|NCT00708305|581304643|FG000|Period 1|Protocol Violation|1|||
160976883|NCT00708305|581304644|FG001|Period 1|Protocol Violation|0|||
160976884|NCT00708305|581304645|FG002|Period 1|Protocol Violation|1|||
160976885|NCT00708305|581304646|FG003|Period 1|Protocol Violation|0|||
160976886|NCT00708305|581304643|FG000|Period 1|Other Reason|0|||
160976887|NCT00708305|581304644|FG001|Period 1|Other Reason|0|||
160976888|NCT00708305|581304645|FG002|Period 1|Other Reason|0|||
160976889|NCT00708305|581304646|FG003|Period 1|Other Reason|2|||
160976890|NCT00708305|581304643|FG000|Period 2|Lost to Follow-up|0|||
160976891|NCT00708305|581304644|FG001|Period 2|Lost to Follow-up|1|||
160976892|NCT00708305|581304645|FG002|Period 2|Lost to Follow-up|0|||
160976893|NCT00708305|581304646|FG003|Period 2|Lost to Follow-up|0|||
160976894|NCT00708305|581304643|FG000|Period 2|Protocol Violation|0|||
160976895|NCT00708305|581304644|FG001|Period 2|Protocol Violation|1|||
160976896|NCT00708305|581304645|FG002|Period 2|Protocol Violation|0|||
160976897|NCT00708305|581304646|FG003|Period 2|Protocol Violation|0|||
160976898|NCT00708305|581304643|FG000|Period 2|Other Reason|1|||
160976899|NCT00708305|581304644|FG001|Period 2|Other Reason|0|||
160976900|NCT00708305|581304645|FG002|Period 2|Other Reason|0|||
160976901|NCT00708305|581304646|FG003|Period 2|Other Reason|1|||
160976902|NCT00708305|581304643|FG000|Period 3|Protocol Violation|0|||
160976903|NCT00708305|581304644|FG001|Period 3|Protocol Violation|2|||
160976904|NCT00708305|581304645|FG002|Period 3|Protocol Violation|0|||
160976905|NCT00708305|581304646|FG003|Period 3|Protocol Violation|0|||
160976906|NCT00708305|581304643|FG000|Period 3|Other Reason|1|||
160976907|NCT00708305|581304644|FG001|Period 3|Other Reason|0|||
160976908|NCT00708305|581304645|FG002|Period 3|Other Reason|0|||
160976909|NCT00708305|581304646|FG003|Period 3|Other Reason|0|||
160976910|NCT00192023|581304651|FG000|Period III - Double-Blind|Adverse Event|3|||
160976911|NCT00192023|581304652|FG001|Period III - Double-Blind|Adverse Event|0|||
160976912|NCT00192023|581304651|FG000|Period III - Double-Blind|Physician Decision|2|||
160976913|NCT00192023|581304652|FG001|Period III - Double-Blind|Physician Decision|0|||
160976914|NCT00192023|581304651|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
160976915|NCT00192023|581304652|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
160976916|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
160976917|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
160976918|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
160976919|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
160976920|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
160976921|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
160976922|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
160976923|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
160976924|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
160976925|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
160976926|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
160976927|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
160976928|NCT00192023|581304651|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
160976929|NCT00192023|581304652|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
160976930|NCT02572817|581304678|FG000|Overall Study|Death|6|||
160976931|NCT02572817|581304679|FG001|Overall Study|Death|3|||
160976932|NCT02572817|581304678|FG000|Overall Study|Lost to Follow-up|3|||
160976933|NCT02572817|581304679|FG001|Overall Study|Lost to Follow-up|3|||
160976934|NCT00758160|581304684|FG000|Overall Study|No Longer Requires Study Medication|4|||
160976935|NCT00758160|581304684|FG000|Overall Study|Administration Problems|3|||
160976936|NCT00758160|581304684|FG000|Overall Study|Adverse Event|15|||
160976937|NCT00758160|581304684|FG000|Overall Study|Lack of Efficacy|10|||
160976938|NCT00758160|581304684|FG000|Overall Study|Lost to Follow-up|14|||
160976939|NCT00758160|581304684|FG000|Overall Study|Protocol Violation|12|||
160976940|NCT00758160|581304684|FG000|Overall Study|Withdrawal by Subject|8|||
160976941|NCT01108510|581304688|FG000|Overall Study|Randomized but Not Treated|5|||
160976942|NCT01108510|581304689|FG001|Overall Study|Randomized but Not Treated|1|||
160976943|NCT01108510|581304688|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
160976944|NCT01108510|581304689|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
160976945|NCT01108510|581304688|FG000|Overall Study|Adverse Event|26|||
160976946|NCT01108510|581304689|FG001|Overall Study|Adverse Event|19|||
160976947|NCT01108510|581304688|FG000|Overall Study|Lost to Follow-up|20|||
160976948|NCT01108510|581304689|FG001|Overall Study|Lost to Follow-up|17|||
160976949|NCT01108510|581304688|FG000|Overall Study|Withdrew Consent|21|||
161033633|NCT04479787|581516964|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
161033634|NCT04479787|581516963|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
161033635|NCT04479787|581516964|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
161033636|NCT04479787|581516963|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
161033637|NCT04479787|581516964|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
161033638|NCT04479787|581516963|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
161033639|NCT04479787|581516964|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
161033640|NCT04039113|581516966|FG000|Overall Study|Withdrawal by Subject|8|||
161033641|NCT04039113|581516967|FG001|Overall Study|Withdrawal by Subject|11|||
161033642|NCT04039113|581516966|FG000|Overall Study|Lost to Follow-up|1|||
161033643|NCT04039113|581516967|FG001|Overall Study|Lost to Follow-up|1|||
161033644|NCT04039113|581516966|FG000|Overall Study|Adverse Event|2|||
161033645|NCT04039113|581516967|FG001|Overall Study|Adverse Event|2|||
161033646|NCT04039113|581516966|FG000|Overall Study|Death|2|||
161033647|NCT04039113|581516967|FG001|Overall Study|Death|4|||
161033648|NCT04039113|581516966|FG000|Overall Study|Site Closure|6|||
161033649|NCT04039113|581516967|FG001|Overall Study|Site Closure|0|||
161033650|NCT04039113|581516966|FG000|Overall Study|Failure to meet randomisation criteria|4|||
161033651|NCT04039113|581516967|FG001|Overall Study|Failure to meet randomisation criteria|0|||
161033652|NCT00968149|581517707|FG000|Overall Study|Adverse Event|5|||
161033653|NCT00968149|581517708|FG001|Overall Study|Adverse Event|1|||
161033654|NCT00968149|581517707|FG000|Overall Study|Lack of Efficacy|0|||
161033655|NCT00968149|581517708|FG001|Overall Study|Lack of Efficacy|4|||
161033656|NCT00968149|581517707|FG000|Overall Study|Lost to Follow-up|0|||
161033657|NCT00968149|581517708|FG001|Overall Study|Lost to Follow-up|1|||
161033658|NCT00968149|581517707|FG000|Overall Study|Protocol Violation|4|||
161033659|NCT00968149|581517708|FG001|Overall Study|Protocol Violation|0|||
161033660|NCT00968149|581517707|FG000|Overall Study|Withdrawal by Subject|2|||
161033661|NCT00968149|581517708|FG001|Overall Study|Withdrawal by Subject|0|||
161033662|NCT02502266|581517709|FG000|Overall Study|Adverse Event|0|||
161033663|NCT02502266|581517710|FG001|Overall Study|Adverse Event|0|||
161033664|NCT02502266|581517711|FG002|Overall Study|Adverse Event|0|||
161033665|NCT02502266|581517712|FG003|Overall Study|Adverse Event|0|||
161033666|NCT02502266|581517713|FG004|Overall Study|Adverse Event|1|||
161033667|NCT02502266|581517714|FG005|Overall Study|Adverse Event|1|||
161033668|NCT02502266|581517715|FG006|Overall Study|Adverse Event|1|||
161033669|NCT02502266|581517709|FG000|Overall Study|Withdrawal by Subject|30|||
161033670|NCT02502266|581517710|FG001|Overall Study|Withdrawal by Subject|15|||
161033671|NCT02502266|581517711|FG002|Overall Study|Withdrawal by Subject|16|||
161033672|NCT02502266|581517712|FG003|Overall Study|Withdrawal by Subject|0|||
161033673|NCT02502266|581517713|FG004|Overall Study|Withdrawal by Subject|0|||
161033674|NCT02502266|581517714|FG005|Overall Study|Withdrawal by Subject|0|||
161033675|NCT02502266|581517715|FG006|Overall Study|Withdrawal by Subject|0|||
161033676|NCT02502266|581517709|FG000|Overall Study|Still on Treatment|0|||
161033677|NCT02502266|581517710|FG001|Overall Study|Still on Treatment|0|||
161033678|NCT02502266|581517711|FG002|Overall Study|Still on Treatment|1|||
161033679|NCT02502266|581517712|FG003|Overall Study|Still on Treatment|0|||
161033680|NCT02502266|581517713|FG004|Overall Study|Still on Treatment|0|||
161033681|NCT02502266|581517714|FG005|Overall Study|Still on Treatment|0|||
161033682|NCT02502266|581517715|FG006|Overall Study|Still on Treatment|0|||
161033683|NCT02502266|581517709|FG000|Overall Study|Other Reasons|19|||
161033684|NCT02502266|581517710|FG001|Overall Study|Other Reasons|6|||
161033685|NCT02502266|581517711|FG002|Overall Study|Other Reasons|14|||
161033686|NCT02502266|581517712|FG003|Overall Study|Other Reasons|0|||
161278878|NCT01449370|582400367|FG010|Overall Study|Medication Prohibited by Protocol|0|||
161278879|NCT01449370|582400368|FG011|Overall Study|Medication Prohibited by Protocol|0|||
161278880|NCT01449370|582400369|FG012|Overall Study|Medication Prohibited by Protocol|0|||
161033687|NCT02502266|581517713|FG004|Overall Study|Other Reasons|1|||
161033688|NCT02502266|581517714|FG005|Overall Study|Other Reasons|1|||
161033689|NCT02502266|581517715|FG006|Overall Study|Other Reasons|0|||
161033690|NCT02502266|581517709|FG000|Overall Study|Arm 4 Discontinued|0|||
161033691|NCT02502266|581517710|FG001|Overall Study|Arm 4 Discontinued|0|||
161033692|NCT02502266|581517711|FG002|Overall Study|Arm 4 Discontinued|0|||
161033693|NCT02502266|581517712|FG003|Overall Study|Arm 4 Discontinued|52|||
161033694|NCT02502266|581517713|FG004|Overall Study|Arm 4 Discontinued|0|||
161033695|NCT02502266|581517714|FG005|Overall Study|Arm 4 Discontinued|0|||
161033696|NCT02502266|581517715|FG006|Overall Study|Arm 4 Discontinued|0|||
161033697|NCT02502266|581517709|FG000|Overall Study|Never treated|0|||
161033698|NCT02502266|581517710|FG001|Overall Study|Never treated|0|||
161033699|NCT02502266|581517711|FG002|Overall Study|Never treated|0|||
161033700|NCT02502266|581517712|FG003|Overall Study|Never treated|0|||
161033701|NCT02502266|581517713|FG004|Overall Study|Never treated|0|||
161033702|NCT02502266|581517714|FG005|Overall Study|Never treated|1|||
161033703|NCT02502266|581517715|FG006|Overall Study|Never treated|0|||
161033704|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|Other|0|||
161033705|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|Other|2|||
161033706|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|Other|1|||
161033707|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|Other|2|||
161033708|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|Other|2|||
161033709|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|Other|0|||
161033710|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|Other|0|||
161033711|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|Other|0|||
161033712|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|Other|0|||
161033713|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|Other|0|||
161033714|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|Other|0|||
161033715|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|Other|0|||
161033716|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|Other|0|||
161033717|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|Other|0|||
161033718|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|Other|0|||
161033719|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|Other|0|||
161033720|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|Other|0|||
161033721|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
161033722|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
161033723|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
161033724|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
161033725|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
161033726|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
161033727|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033728|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033729|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033730|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033731|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033732|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033733|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033734|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033735|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033736|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033737|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
161033738|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033739|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
161033740|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
161033741|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033742|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
161033743|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
161033744|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033745|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033746|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033747|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033748|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033749|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033750|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033751|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033752|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
160976950|NCT01108510|581304689|FG001|Overall Study|Withdrew Consent|15|||
160976951|NCT01108510|581304688|FG000|Overall Study|Investigator's Discretion|12|||
160976952|NCT01108510|581304689|FG001|Overall Study|Investigator's Discretion|10|||
160976953|NCT01108510|581304688|FG000|Overall Study|Participant Noncompliance|5|||
160976954|NCT01108510|581304689|FG001|Overall Study|Participant Noncompliance|7|||
160976955|NCT01108510|581304688|FG000|Overall Study|Lack of Efficacy|3|||
160976956|NCT01108510|581304689|FG001|Overall Study|Lack of Efficacy|0|||
161033753|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033754|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
161033755|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|Death|2|||
161033756|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|Death|1|||
161033757|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|Death|1|||
161033758|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|Death|0|||
161033759|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|Death|0|||
161033760|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|Death|0|||
161033761|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|Death|0|||
161033762|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|Death|0|||
161033763|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|Death|0|||
161033764|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|Death|0|||
160976957|NCT01108510|581304688|FG000|Overall Study|Pregnancy|0|||
160976958|NCT01108510|581304689|FG001|Overall Study|Pregnancy|3|||
160976959|NCT01108510|581304688|FG000|Overall Study|Death|1|||
160976960|NCT01108510|581304689|FG001|Overall Study|Death|1|||
161033765|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|Death|0|||
161033766|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|Death|0|||
161033767|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|Death|0|||
160976961|NCT01258660|581304690|FG000|Overall Study|Adverse Event|2|||
160976962|NCT01258660|581304691|FG001|Overall Study|Adverse Event|4|||
161033768|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|Death|0|||
161033769|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|Death|0|||
161033770|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|Death|0|||
160976963|NCT01258660|581304690|FG000|Overall Study|Withdrawal by Subject|3|||
160976964|NCT01258660|581304691|FG001|Overall Study|Withdrawal by Subject|0|||
160976965|NCT01258660|581304690|FG000|Overall Study|due to relocation|2|||
160976966|NCT01258660|581304691|FG001|Overall Study|due to relocation|0|||
160976967|NCT01258660|581304690|FG000|Overall Study|Protocol Violation|0|||
160976968|NCT01258660|581304691|FG001|Overall Study|Protocol Violation|1|||
160976969|NCT01258660|581304690|FG000|Overall Study|Invalid for primary analysis data set|4|||
160976970|NCT01258660|581304691|FG001|Overall Study|Invalid for primary analysis data set|6|||
160976971|NCT00582491|581304692|FG000|Overall Study|Withdrawal by Subject|1|||
160976972|NCT00582491|581304693|FG001|Overall Study|Withdrawal by Subject|0|||
160976973|NCT04192630|581304696|FG000|Overall Study|Discontinued before surgery|2|||
160976974|NCT04192630|581304697|FG001|Overall Study|Discontinued before surgery|0|||
160976975|NCT04192630|581304696|FG000|Overall Study|Discontinued after surgery|5|||
160976976|NCT04192630|581304697|FG001|Overall Study|Discontinued after surgery|3|||
160976977|NCT01193582|581304698|FG000|Vaccination Series|Withdrawal by Subject|11|||
161278881|NCT01449370|582400370|FG013|Overall Study|Medication Prohibited by Protocol|0|||
161278882|NCT01449370|582400371|FG014|Overall Study|Medication Prohibited by Protocol|0|||
161278883|NCT01449370|582400372|FG015|Overall Study|Medication Prohibited by Protocol|0|||
161278884|NCT01449370|582400373|FG016|Overall Study|Medication Prohibited by Protocol|0|||
161278885|NCT01449370|582400374|FG017|Overall Study|Medication Prohibited by Protocol|0|||
161278886|NCT01449370|582400375|FG018|Overall Study|Medication Prohibited by Protocol|0|||
161278887|NCT01449370|582400376|FG019|Overall Study|Medication Prohibited by Protocol|0|||
161278888|NCT01449370|582400377|FG020|Overall Study|Medication Prohibited by Protocol|0|||
161278889|NCT01449370|582400378|FG021|Overall Study|Medication Prohibited by Protocol|0|||
161278890|NCT01449370|582400379|FG022|Overall Study|Medication Prohibited by Protocol|0|||
161278891|NCT01449370|582400380|FG023|Overall Study|Medication Prohibited by Protocol|1|||
161278892|NCT01449370|582400381|FG024|Overall Study|Medication Prohibited by Protocol|0|||
161278893|NCT01449370|582400357|FG000|Overall Study|Death|0|||
161278894|NCT01449370|582400358|FG001|Overall Study|Death|0|||
161278895|NCT01449370|582400359|FG002|Overall Study|Death|0|||
161278896|NCT01449370|582400360|FG003|Overall Study|Death|0|||
161278897|NCT01449370|582400361|FG004|Overall Study|Death|0|||
161278898|NCT01449370|582400362|FG005|Overall Study|Death|0|||
161033771|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|Death|0|||
161033772|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033773|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
161033774|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033775|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033776|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
161033777|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
161033778|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033779|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033780|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033781|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033782|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033783|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033784|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033785|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033786|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033787|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033788|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
161033789|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033790|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033791|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033792|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033793|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
161033794|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
161033795|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033796|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
160976978|NCT01193582|581304699|FG001|Vaccination Series|Withdrawal by Subject|13|||
160976979|NCT01193582|581304700|FG002|Vaccination Series|Withdrawal by Subject|8|||
160976980|NCT01193582|581304701|FG003|Vaccination Series|Withdrawal by Subject|3|||
160976981|NCT01193582|581304698|FG000|12 Month Follow-up|Death|0|||
161278899|NCT01449370|582400363|FG006|Overall Study|Death|0|||
161278900|NCT01449370|582400364|FG007|Overall Study|Death|0|||
161278901|NCT01449370|582400365|FG008|Overall Study|Death|0|||
161278902|NCT01449370|582400366|FG009|Overall Study|Death|0|||
161278903|NCT01449370|582400367|FG010|Overall Study|Death|0|||
161278904|NCT01449370|582400368|FG011|Overall Study|Death|0|||
161278905|NCT01449370|582400369|FG012|Overall Study|Death|0|||
161278906|NCT01449370|582400370|FG013|Overall Study|Death|0|||
161278907|NCT01449370|582400371|FG014|Overall Study|Death|0|||
161278908|NCT01449370|582400372|FG015|Overall Study|Death|0|||
161278909|NCT01449370|582400373|FG016|Overall Study|Death|0|||
161278910|NCT01449370|582400374|FG017|Overall Study|Death|0|||
160976982|NCT01193582|581304699|FG001|12 Month Follow-up|Death|0|||
160976983|NCT01193582|581304700|FG002|12 Month Follow-up|Death|1|||
161033797|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033798|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033799|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033800|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033801|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033802|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033803|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033804|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033805|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
161033806|NCT02719574|581517716|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033807|NCT02719574|581517717|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033808|NCT02719574|581517718|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
161033809|NCT02719574|581517719|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033810|NCT02719574|581517720|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033811|NCT02719574|581517721|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033812|NCT02719574|581517722|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033813|NCT02719574|581517723|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033814|NCT02719574|581517724|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033815|NCT02719574|581517725|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033816|NCT02719574|581517726|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033817|NCT02719574|581517727|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033818|NCT02719574|581517728|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161278911|NCT01449370|582400375|FG018|Overall Study|Death|0|||
161278912|NCT01449370|582400376|FG019|Overall Study|Death|0|||
161278913|NCT01449370|582400377|FG020|Overall Study|Death|0|||
161278914|NCT01449370|582400378|FG021|Overall Study|Death|0|||
161278915|NCT01449370|582400379|FG022|Overall Study|Death|0|||
161278916|NCT01449370|582400380|FG023|Overall Study|Death|0|||
161278917|NCT01449370|582400381|FG024|Overall Study|Death|1|||
160976984|NCT01193582|581304701|FG003|12 Month Follow-up|Death|0|||
161033819|NCT02719574|581517729|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033820|NCT02719574|581517730|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033821|NCT02719574|581517731|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033822|NCT02719574|581517732|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
161033823|NCT02719574|581517716|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033824|NCT02719574|581517717|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033825|NCT02719574|581517718|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033826|NCT02719574|581517719|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033827|NCT02719574|581517720|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033828|NCT02719574|581517721|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033829|NCT02719574|581517722|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
161033830|NCT02719574|581517723|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
161033831|NCT02719574|581517724|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
161033832|NCT02719574|581517725|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033833|NCT02719574|581517726|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033834|NCT02719574|581517727|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033835|NCT02719574|581517728|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033836|NCT02719574|581517729|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033837|NCT02719574|581517730|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
160976985|NCT01193582|581304698|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
160976986|NCT01193582|581304699|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
160976987|NCT01193582|581304700|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
160976988|NCT01193582|581304701|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
160976989|NCT00779584|581304702|FG000|Overall Study|Protocol Violation|0|||
160976990|NCT00779584|581304703|FG001|Overall Study|Protocol Violation|0|||
160976991|NCT00779584|581304704|FG002|Overall Study|Protocol Violation|0|||
160976992|NCT00779584|581304705|FG003|Overall Study|Protocol Violation|0|||
160976993|NCT00779584|581304706|FG004|Overall Study|Protocol Violation|0|||
160976994|NCT00779584|581304707|FG005|Overall Study|Protocol Violation|1|||
160976995|NCT00779584|581304708|FG006|Overall Study|Protocol Violation|0|||
160976996|NCT00779584|581304709|FG007|Overall Study|Protocol Violation|0|||
160976997|NCT00779584|581304710|FG008|Overall Study|Protocol Violation|0|||
160976998|NCT00779584|581304702|FG000|Overall Study|Withdrawal by Subject|1|||
160976999|NCT00779584|581304703|FG001|Overall Study|Withdrawal by Subject|1|||
160977000|NCT00779584|581304704|FG002|Overall Study|Withdrawal by Subject|2|||
160977001|NCT00779584|581304705|FG003|Overall Study|Withdrawal by Subject|0|||
160977002|NCT00779584|581304706|FG004|Overall Study|Withdrawal by Subject|0|||
161033838|NCT02719574|581517731|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033839|NCT02719574|581517732|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
161033840|NCT02719574|581517716|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161278918|NCT01685840|582400382|FG000|Overall Study|Death|77|||
161278919|NCT01685840|582400383|FG001|Overall Study|Death|66|||
161278920|NCT01685840|582400382|FG000|Overall Study|Lost to Follow-up|27|||
160977003|NCT00779584|581304707|FG005|Overall Study|Withdrawal by Subject|2|||
161278921|NCT01685840|582400383|FG001|Overall Study|Lost to Follow-up|25|||
161278922|NCT01685840|582400382|FG000|Overall Study|Physician Decision|3|||
161278923|NCT01685840|582400383|FG001|Overall Study|Physician Decision|7|||
161278924|NCT01685840|582400382|FG000|Overall Study|Withdrawal by Subject|14|||
161278925|NCT01685840|582400383|FG001|Overall Study|Withdrawal by Subject|17|||
161278926|NCT01685840|582400382|FG000|Overall Study|Futility|197|||
161278927|NCT01685840|582400383|FG001|Overall Study|Futility|200|||
161278928|NCT01685840|582400382|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
161278929|NCT01685840|582400383|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
161278930|NCT00710866|582400384|FG000|Overall Study|Protocol Violation|5|||
161278931|NCT00710866|582400385|FG001|Overall Study|Protocol Violation|4|||
161278932|NCT00710866|582400384|FG000|Overall Study|Withdrawal by Subject|2|||
161278933|NCT00710866|582400385|FG001|Overall Study|Withdrawal by Subject|1|||
161278934|NCT00710866|582400384|FG000|Overall Study|Lost to Follow-up|1|||
161278935|NCT00710866|582400385|FG001|Overall Study|Lost to Follow-up|0|||
161278936|NCT00710866|582400384|FG000|Overall Study|Failed to meet eligibility|1|||
161278937|NCT00710866|582400385|FG001|Overall Study|Failed to meet eligibility|1|||
161278938|NCT01004003|582400389|FG000|Overall Study|Progressive disease|2|||
161278939|NCT01004003|582400390|FG001|Overall Study|Progressive disease|1|||
161278940|NCT01004003|582400391|FG002|Overall Study|Progressive disease|1|||
161278941|NCT01004003|582400392|FG003|Overall Study|Progressive disease|0|||
161278942|NCT01004003|582400393|FG004|Overall Study|Progressive disease|2|||
161278943|NCT01004003|582400394|FG005|Overall Study|Progressive disease|1|||
161278944|NCT01004003|582400395|FG006|Overall Study|Progressive disease|1|||
161278945|NCT01004003|582400396|FG007|Overall Study|Progressive disease|39|||
161278946|NCT01004003|582400397|FG008|Overall Study|Progressive disease|22|||
161278947|NCT01004003|582400389|FG000|Overall Study|Adverse Event|4|||
161278948|NCT01004003|582400390|FG001|Overall Study|Adverse Event|2|||
161278949|NCT01004003|582400391|FG002|Overall Study|Adverse Event|3|||
161278950|NCT01004003|582400392|FG003|Overall Study|Adverse Event|3|||
161278951|NCT01004003|582400393|FG004|Overall Study|Adverse Event|2|||
161278952|NCT01004003|582400394|FG005|Overall Study|Adverse Event|2|||
161278953|NCT01004003|582400395|FG006|Overall Study|Adverse Event|7|||
161278954|NCT01004003|582400396|FG007|Overall Study|Adverse Event|21|||
161278955|NCT01004003|582400397|FG008|Overall Study|Adverse Event|6|||
161278956|NCT01004003|582400389|FG000|Overall Study|Refused to continue taking trial med.|0|||
161278957|NCT01004003|582400390|FG001|Overall Study|Refused to continue taking trial med.|0|||
161278958|NCT01004003|582400391|FG002|Overall Study|Refused to continue taking trial med.|0|||
161278959|NCT01004003|582400392|FG003|Overall Study|Refused to continue taking trial med.|0|||
161278960|NCT01004003|582400393|FG004|Overall Study|Refused to continue taking trial med.|0|||
161033841|NCT02719574|581517717|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033842|NCT02719574|581517718|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033843|NCT02719574|581517719|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033844|NCT02719574|581517720|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033845|NCT02719574|581517721|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033846|NCT02719574|581517722|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
161033847|NCT02719574|581517723|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
161033848|NCT02719574|581517724|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033849|NCT02719574|581517725|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033850|NCT02719574|581517726|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033851|NCT02719574|581517727|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033852|NCT02719574|581517728|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033853|NCT02719574|581517729|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033854|NCT02719574|581517730|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161278961|NCT01004003|582400394|FG005|Overall Study|Refused to continue taking trial med.|0|||
161278962|NCT01004003|582400395|FG006|Overall Study|Refused to continue taking trial med.|0|||
161278963|NCT01004003|582400396|FG007|Overall Study|Refused to continue taking trial med.|0|||
161278964|NCT01004003|582400397|FG008|Overall Study|Refused to continue taking trial med.|2|||
161278965|NCT01004003|582400389|FG000|Overall Study|Other|0|||
161278966|NCT01004003|582400390|FG001|Overall Study|Other|0|||
161278967|NCT01004003|582400391|FG002|Overall Study|Other|0|||
161278968|NCT01004003|582400392|FG003|Overall Study|Other|0|||
161278969|NCT01004003|582400393|FG004|Overall Study|Other|0|||
161278970|NCT01004003|582400394|FG005|Overall Study|Other|1|||
161278971|NCT01004003|582400395|FG006|Overall Study|Other|0|||
161344779|NCT01047319|582647278|FG001|Overall Study|Physician Decision|9|||
161033855|NCT02719574|581517731|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161278972|NCT01004003|582400396|FG007|Overall Study|Other|0|||
161278973|NCT01004003|582400397|FG008|Overall Study|Other|0|||
161278974|NCT03371459|582400403|FG000|Washout|Lost to Follow-up|0|||
161278975|NCT03371459|582400404|FG001|Washout|Lost to Follow-up|1|||
161278976|NCT01885195|582400407|FG000|Overall Study|Adverse Event|29|||
161278977|NCT01885195|582400407|FG000|Overall Study|Death|1|||
161278978|NCT01885195|582400407|FG000|Overall Study|Disease Progression|67|||
161278979|NCT01885195|582400407|FG000|Overall Study|Protocol Deviation|2|||
161033856|NCT02719574|581517732|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
161033857|NCT02719574|581517716|FG000|Phase 1 (Dose Expansion)|Death|0|||
161033858|NCT02719574|581517717|FG001|Phase 1 (Dose Expansion)|Death|0|||
161033859|NCT02719574|581517718|FG002|Phase 1 (Dose Expansion)|Death|0|||
161033860|NCT02719574|581517719|FG003|Phase 1 (Dose Expansion)|Death|0|||
161033861|NCT02719574|581517720|FG004|Phase 1 (Dose Expansion)|Death|0|||
161033862|NCT02719574|581517721|FG005|Phase 1 (Dose Expansion)|Death|0|||
161033863|NCT02719574|581517722|FG006|Phase 1 (Dose Expansion)|Death|1|||
161033864|NCT02719574|581517723|FG007|Phase 1 (Dose Expansion)|Death|6|||
161033865|NCT02719574|581517724|FG008|Phase 1 (Dose Expansion)|Death|0|||
161033866|NCT02719574|581517725|FG009|Phase 1 (Dose Expansion)|Death|0|||
161033867|NCT02719574|581517726|FG010|Phase 1 (Dose Expansion)|Death|0|||
161033868|NCT02719574|581517727|FG011|Phase 1 (Dose Expansion)|Death|0|||
161033869|NCT02719574|581517728|FG012|Phase 1 (Dose Expansion)|Death|0|||
161033870|NCT02719574|581517729|FG013|Phase 1 (Dose Expansion)|Death|0|||
161033871|NCT02719574|581517730|FG014|Phase 1 (Dose Expansion)|Death|0|||
161033872|NCT02719574|581517731|FG015|Phase 1 (Dose Expansion)|Death|0|||
161033873|NCT02719574|581517732|FG016|Phase 1 (Dose Expansion)|Death|0|||
161033874|NCT02719574|581517716|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033875|NCT02719574|581517717|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
161278980|NCT01885195|582400407|FG000|Overall Study|Physician Decision|3|||
161278981|NCT01885195|582400407|FG000|Overall Study|Patient/guardian decision|8|||
161278982|NCT01589497|582400408|FG000|Overall Study|Withdrawal by Subject|0|||
161278983|NCT01589497|582400409|FG001|Overall Study|Withdrawal by Subject|1|||
161278984|NCT01589497|582400410|FG002|Overall Study|Withdrawal by Subject|0|||
161278985|NCT01589497|582400411|FG003|Overall Study|Withdrawal by Subject|1|||
161278986|NCT01589497|582400408|FG000|Overall Study|Death|1|||
161278987|NCT01589497|582400409|FG001|Overall Study|Death|0|||
161278988|NCT01589497|582400410|FG002|Overall Study|Death|0|||
161278989|NCT01589497|582400411|FG003|Overall Study|Death|0|||
161278990|NCT01589497|582400408|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161278991|NCT01589497|582400409|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161278992|NCT01589497|582400410|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
161278993|NCT01589497|582400411|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
161278994|NCT03390426|582400412|FG000|Overall Study|Protocol Violation|0|||
161278995|NCT03390426|582400413|FG001|Overall Study|Protocol Violation|1|||
161278996|NCT00259272|582400414|FG000|Overall Study|Adverse Event|2|||
161278997|NCT00259272|582400415|FG001|Overall Study|Adverse Event|1|||
161278998|NCT00259272|582400416|FG002|Overall Study|Adverse Event|0|||
161278999|NCT00259272|582400417|FG003|Overall Study|Adverse Event|3|||
161279000|NCT00259272|582400414|FG000|Overall Study|Lack of Efficacy|5|||
161279001|NCT00259272|582400415|FG001|Overall Study|Lack of Efficacy|1|||
161279002|NCT00259272|582400416|FG002|Overall Study|Lack of Efficacy|2|||
161279003|NCT00259272|582400417|FG003|Overall Study|Lack of Efficacy|6|||
161279004|NCT00259272|582400414|FG000|Overall Study|Physician Decision|1|||
161279005|NCT00259272|582400415|FG001|Overall Study|Physician Decision|2|||
161279006|NCT00259272|582400416|FG002|Overall Study|Physician Decision|1|||
161279007|NCT00259272|582400417|FG003|Overall Study|Physician Decision|3|||
161279008|NCT00259272|582400414|FG000|Overall Study|Protocol Violation|2|||
161279009|NCT00259272|582400415|FG001|Overall Study|Protocol Violation|0|||
161279010|NCT00259272|582400416|FG002|Overall Study|Protocol Violation|0|||
161279011|NCT00259272|582400417|FG003|Overall Study|Protocol Violation|1|||
161279012|NCT00259272|582400414|FG000|Overall Study|Sponsor Decision|0|||
161279013|NCT00259272|582400415|FG001|Overall Study|Sponsor Decision|1|||
161279014|NCT00259272|582400416|FG002|Overall Study|Sponsor Decision|0|||
161279015|NCT00259272|582400417|FG003|Overall Study|Sponsor Decision|0|||
161279016|NCT00259272|582400414|FG000|Overall Study|Withdrawal by Subject|4|||
161279017|NCT00259272|582400415|FG001|Overall Study|Withdrawal by Subject|2|||
161279018|NCT00259272|582400416|FG002|Overall Study|Withdrawal by Subject|2|||
161279019|NCT00259272|582400417|FG003|Overall Study|Withdrawal by Subject|7|||
161279020|NCT00259272|582400414|FG000|Overall Study|Lost to Follow-up|1|||
161033876|NCT02719574|581517718|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
161279021|NCT00259272|582400415|FG001|Overall Study|Lost to Follow-up|0|||
161279022|NCT00259272|582400416|FG002|Overall Study|Lost to Follow-up|0|||
161279023|NCT00259272|582400417|FG003|Overall Study|Lost to Follow-up|1|||
161279024|NCT01290302|582402327|FG000|Overall Study|Adverse Event|2|||
161279025|NCT01290302|582402328|FG001|Overall Study|Adverse Event|0|||
161033877|NCT02719574|581517719|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033878|NCT02719574|581517720|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033879|NCT02719574|581517721|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
161279026|NCT01290302|582402327|FG000|Overall Study|Withdrawal by Subject|1|||
161279027|NCT01290302|582402328|FG001|Overall Study|Withdrawal by Subject|0|||
161344780|NCT01047319|582647279|FG002|Overall Study|Physician Decision|10|||
161279028|NCT01290302|582402327|FG000|Overall Study|Physician Decision|0|||
161033880|NCT02719574|581517722|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
161033881|NCT02719574|581517723|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
161279029|NCT01290302|582402328|FG001|Overall Study|Physician Decision|2|||
161279030|NCT01290302|582402327|FG000|Overall Study|Expiration of time for screening window|1|||
161033882|NCT02719574|581517724|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
161279031|NCT01290302|582402328|FG001|Overall Study|Expiration of time for screening window|0|||
161344781|NCT01047319|582647277|FG000|Overall Study|Lost to Follow-up|14|||
161344782|NCT01047319|582647278|FG001|Overall Study|Lost to Follow-up|10|||
161279032|NCT03816878|582402331|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
161033883|NCT02719574|581517725|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033884|NCT02719574|581517726|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033885|NCT02719574|581517727|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033886|NCT02719574|581517728|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033887|NCT02719574|581517729|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033888|NCT02719574|581517730|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033889|NCT02719574|581517731|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033890|NCT02719574|581517732|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
161033891|NCT02719574|581517716|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033892|NCT02719574|581517717|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033893|NCT02719574|581517718|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033894|NCT02719574|581517719|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033895|NCT02719574|581517720|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033896|NCT02719574|581517721|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033897|NCT02719574|581517722|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
161033898|NCT02719574|581517723|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
161033899|NCT02719574|581517724|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033900|NCT02719574|581517725|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033901|NCT02719574|581517726|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033902|NCT02719574|581517727|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033903|NCT02719574|581517728|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033904|NCT02719574|581517729|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033905|NCT02719574|581517730|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033906|NCT02719574|581517731|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033907|NCT02719574|581517732|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
161033908|NCT02719574|581517716|FG000|Phase 1 (Dose Expansion)|Other|0|||
161033909|NCT02719574|581517717|FG001|Phase 1 (Dose Expansion)|Other|0|||
161033910|NCT02719574|581517718|FG002|Phase 1 (Dose Expansion)|Other|0|||
161033911|NCT02719574|581517719|FG003|Phase 1 (Dose Expansion)|Other|0|||
161033912|NCT02719574|581517720|FG004|Phase 1 (Dose Expansion)|Other|0|||
161033913|NCT02719574|581517721|FG005|Phase 1 (Dose Expansion)|Other|0|||
161033914|NCT02719574|581517722|FG006|Phase 1 (Dose Expansion)|Other|1|||
161033915|NCT02719574|581517723|FG007|Phase 1 (Dose Expansion)|Other|7|||
161033916|NCT02719574|581517724|FG008|Phase 1 (Dose Expansion)|Other|0|||
161033917|NCT02719574|581517725|FG009|Phase 1 (Dose Expansion)|Other|0|||
161033918|NCT02719574|581517726|FG010|Phase 1 (Dose Expansion)|Other|0|||
161033919|NCT02719574|581517727|FG011|Phase 1 (Dose Expansion)|Other|0|||
161033920|NCT02719574|581517728|FG012|Phase 1 (Dose Expansion)|Other|0|||
161033921|NCT02719574|581517729|FG013|Phase 1 (Dose Expansion)|Other|0|||
161033922|NCT02719574|581517730|FG014|Phase 1 (Dose Expansion)|Other|0|||
161033923|NCT02719574|581517731|FG015|Phase 1 (Dose Expansion)|Other|0|||
161033924|NCT02719574|581517732|FG016|Phase 1 (Dose Expansion)|Other|0|||
161033925|NCT02719574|581517716|FG000|Phase 2|Protocol Defined Disease Progression|0|||
161033926|NCT02719574|581517717|FG001|Phase 2|Protocol Defined Disease Progression|0|||
161033927|NCT02719574|581517718|FG002|Phase 2|Protocol Defined Disease Progression|0|||
161033928|NCT02719574|581517719|FG003|Phase 2|Protocol Defined Disease Progression|0|||
161033929|NCT02719574|581517720|FG004|Phase 2|Protocol Defined Disease Progression|0|||
161033930|NCT02719574|581517721|FG005|Phase 2|Protocol Defined Disease Progression|0|||
161033931|NCT02719574|581517722|FG006|Phase 2|Protocol Defined Disease Progression|0|||
161033932|NCT02719574|581517723|FG007|Phase 2|Protocol Defined Disease Progression|0|||
161033933|NCT02719574|581517724|FG008|Phase 2|Protocol Defined Disease Progression|0|||
161033934|NCT02719574|581517725|FG009|Phase 2|Protocol Defined Disease Progression|65|||
161033935|NCT02719574|581517726|FG010|Phase 2|Protocol Defined Disease Progression|8|||
161033936|NCT02719574|581517727|FG011|Phase 2|Protocol Defined Disease Progression|2|||
161033937|NCT02719574|581517728|FG012|Phase 2|Protocol Defined Disease Progression|4|||
161033938|NCT02719574|581517729|FG013|Phase 2|Protocol Defined Disease Progression|9|||
161279033|NCT03816878|582402332|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
161279034|NCT03816878|582402331|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
161279035|NCT03816878|582402332|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
161279036|NCT03355469|582402333|FG000|Overall Study|COVID-19|3|||
161279037|NCT03355469|582402334|FG001|Overall Study|COVID-19|2|||
161279038|NCT03355469|582402335|FG002|Overall Study|COVID-19|3|||
161279039|NCT03355469|582402336|FG003|Overall Study|COVID-19|3|||
161033939|NCT02719574|581517730|FG014|Phase 2|Protocol Defined Disease Progression|11|||
161033940|NCT02719574|581517731|FG015|Phase 2|Protocol Defined Disease Progression|3|||
161033941|NCT02719574|581517732|FG016|Phase 2|Protocol Defined Disease Progression|4|||
161033942|NCT02719574|581517716|FG000|Phase 2|Adverse Event|0|||
161033943|NCT02719574|581517717|FG001|Phase 2|Adverse Event|0|||
161033944|NCT02719574|581517718|FG002|Phase 2|Adverse Event|0|||
161033945|NCT02719574|581517719|FG003|Phase 2|Adverse Event|0|||
161033946|NCT02719574|581517720|FG004|Phase 2|Adverse Event|0|||
161033947|NCT02719574|581517721|FG005|Phase 2|Adverse Event|0|||
161279040|NCT03355469|582402333|FG000|Overall Study|Lost to Follow-up|1|||
161033948|NCT02719574|581517722|FG006|Phase 2|Adverse Event|0|||
161033949|NCT02719574|581517723|FG007|Phase 2|Adverse Event|0|||
161033950|NCT02719574|581517724|FG008|Phase 2|Adverse Event|0|||
161033951|NCT02719574|581517725|FG009|Phase 2|Adverse Event|27|||
161033952|NCT02719574|581517726|FG010|Phase 2|Adverse Event|0|||
161033953|NCT02719574|581517727|FG011|Phase 2|Adverse Event|1|||
161033954|NCT02719574|581517728|FG012|Phase 2|Adverse Event|1|||
161033955|NCT02719574|581517729|FG013|Phase 2|Adverse Event|1|||
161033956|NCT02719574|581517730|FG014|Phase 2|Adverse Event|2|||
161033957|NCT02719574|581517731|FG015|Phase 2|Adverse Event|2|||
161033958|NCT02719574|581517732|FG016|Phase 2|Adverse Event|3|||
161033959|NCT02719574|581517716|FG000|Phase 2|Other|0|||
161033960|NCT02719574|581517717|FG001|Phase 2|Other|0|||
161033961|NCT02719574|581517718|FG002|Phase 2|Other|0|||
161033962|NCT02719574|581517719|FG003|Phase 2|Other|0|||
161033963|NCT02719574|581517720|FG004|Phase 2|Other|0|||
161033964|NCT02719574|581517721|FG005|Phase 2|Other|0|||
161033965|NCT02719574|581517722|FG006|Phase 2|Other|0|||
161033966|NCT02719574|581517723|FG007|Phase 2|Other|0|||
161033967|NCT02719574|581517724|FG008|Phase 2|Other|0|||
161033968|NCT02719574|581517725|FG009|Phase 2|Other|20|||
161033969|NCT02719574|581517726|FG010|Phase 2|Other|7|||
161033970|NCT02719574|581517727|FG011|Phase 2|Other|0|||
161033971|NCT02719574|581517728|FG012|Phase 2|Other|5|||
161033972|NCT02719574|581517729|FG013|Phase 2|Other|7|||
161033973|NCT02719574|581517730|FG014|Phase 2|Other|0|||
161033974|NCT02719574|581517731|FG015|Phase 2|Other|1|||
161033975|NCT02719574|581517732|FG016|Phase 2|Other|4|||
161033976|NCT02719574|581517716|FG000|Phase 2|Transplant|0|||
161033977|NCT02719574|581517717|FG001|Phase 2|Transplant|0|||
161033978|NCT02719574|581517718|FG002|Phase 2|Transplant|0|||
161033979|NCT02719574|581517719|FG003|Phase 2|Transplant|0|||
161033980|NCT02719574|581517720|FG004|Phase 2|Transplant|0|||
161033981|NCT02719574|581517721|FG005|Phase 2|Transplant|0|||
161033982|NCT02719574|581517722|FG006|Phase 2|Transplant|0|||
161033983|NCT02719574|581517723|FG007|Phase 2|Transplant|0|||
161033984|NCT02719574|581517724|FG008|Phase 2|Transplant|0|||
161033985|NCT02719574|581517725|FG009|Phase 2|Transplant|15|||
161033986|NCT02719574|581517726|FG010|Phase 2|Transplant|2|||
161033987|NCT02719574|581517727|FG011|Phase 2|Transplant|0|||
161033988|NCT02719574|581517728|FG012|Phase 2|Transplant|6|||
161033989|NCT02719574|581517729|FG013|Phase 2|Transplant|1|||
161033990|NCT02719574|581517730|FG014|Phase 2|Transplant|1|||
161033991|NCT02719574|581517731|FG015|Phase 2|Transplant|0|||
161033992|NCT02719574|581517732|FG016|Phase 2|Transplant|0|||
161033993|NCT02719574|581517716|FG000|Phase 2|Death|0|||
161033994|NCT02719574|581517717|FG001|Phase 2|Death|0|||
161033995|NCT02719574|581517718|FG002|Phase 2|Death|0|||
161033996|NCT02719574|581517719|FG003|Phase 2|Death|0|||
161033997|NCT02719574|581517720|FG004|Phase 2|Death|0|||
161033998|NCT02719574|581517721|FG005|Phase 2|Death|0|||
161033999|NCT02719574|581517722|FG006|Phase 2|Death|0|||
161034000|NCT02719574|581517723|FG007|Phase 2|Death|0|||
161034001|NCT02719574|581517724|FG008|Phase 2|Death|0|||
161034002|NCT02719574|581517725|FG009|Phase 2|Death|14|||
161034003|NCT02719574|581517726|FG010|Phase 2|Death|0|||
161034004|NCT02719574|581517727|FG011|Phase 2|Death|0|||
161034005|NCT02719574|581517728|FG012|Phase 2|Death|1|||
161034006|NCT02719574|581517729|FG013|Phase 2|Death|1|||
161034007|NCT02719574|581517730|FG014|Phase 2|Death|2|||
161034008|NCT02719574|581517731|FG015|Phase 2|Death|0|||
161034009|NCT02719574|581517732|FG016|Phase 2|Death|0|||
161034010|NCT02719574|581517716|FG000|Phase 2|Investigator Decision|0|||
161034011|NCT02719574|581517717|FG001|Phase 2|Investigator Decision|0|||
161034012|NCT02719574|581517718|FG002|Phase 2|Investigator Decision|0|||
161034013|NCT02719574|581517719|FG003|Phase 2|Investigator Decision|0|||
161034014|NCT02719574|581517720|FG004|Phase 2|Investigator Decision|0|||
161034015|NCT02719574|581517721|FG005|Phase 2|Investigator Decision|0|||
161034016|NCT02719574|581517722|FG006|Phase 2|Investigator Decision|0|||
161034017|NCT02719574|581517723|FG007|Phase 2|Investigator Decision|0|||
161034018|NCT02719574|581517724|FG008|Phase 2|Investigator Decision|0|||
161034019|NCT02719574|581517725|FG009|Phase 2|Investigator Decision|6|||
161034020|NCT02719574|581517726|FG010|Phase 2|Investigator Decision|1|||
161034021|NCT02719574|581517727|FG011|Phase 2|Investigator Decision|2|||
161034022|NCT02719574|581517728|FG012|Phase 2|Investigator Decision|3|||
161034023|NCT02719574|581517729|FG013|Phase 2|Investigator Decision|1|||
161034024|NCT02719574|581517730|FG014|Phase 2|Investigator Decision|3|||
161034025|NCT02719574|581517731|FG015|Phase 2|Investigator Decision|2|||
161034026|NCT02719574|581517732|FG016|Phase 2|Investigator Decision|0|||
161034027|NCT02719574|581517716|FG000|Phase 2|Withdrawal by Subject|0|||
161034028|NCT02719574|581517717|FG001|Phase 2|Withdrawal by Subject|0|||
161034029|NCT02719574|581517718|FG002|Phase 2|Withdrawal by Subject|0|||
161034030|NCT02719574|581517719|FG003|Phase 2|Withdrawal by Subject|0|||
161034031|NCT02719574|581517720|FG004|Phase 2|Withdrawal by Subject|0|||
161034032|NCT02719574|581517721|FG005|Phase 2|Withdrawal by Subject|0|||
161034033|NCT02719574|581517722|FG006|Phase 2|Withdrawal by Subject|0|||
161034034|NCT02719574|581517723|FG007|Phase 2|Withdrawal by Subject|0|||
161034035|NCT02719574|581517724|FG008|Phase 2|Withdrawal by Subject|0|||
161034036|NCT02719574|581517725|FG009|Phase 2|Withdrawal by Subject|5|||
161034037|NCT02719574|581517726|FG010|Phase 2|Withdrawal by Subject|0|||
161034038|NCT02719574|581517727|FG011|Phase 2|Withdrawal by Subject|0|||
161034039|NCT02719574|581517728|FG012|Phase 2|Withdrawal by Subject|0|||
161034040|NCT02719574|581517729|FG013|Phase 2|Withdrawal by Subject|1|||
161034041|NCT02719574|581517730|FG014|Phase 2|Withdrawal by Subject|1|||
161034042|NCT02719574|581517731|FG015|Phase 2|Withdrawal by Subject|2|||
161034043|NCT02719574|581517732|FG016|Phase 2|Withdrawal by Subject|0|||
161034044|NCT02719574|581517716|FG000|Phase 2|Protocol Violation|0|||
161034045|NCT02719574|581517717|FG001|Phase 2|Protocol Violation|0|||
161034046|NCT02719574|581517718|FG002|Phase 2|Protocol Violation|0|||
161034047|NCT02719574|581517719|FG003|Phase 2|Protocol Violation|0|||
161034048|NCT02719574|581517720|FG004|Phase 2|Protocol Violation|0|||
161034049|NCT02719574|581517721|FG005|Phase 2|Protocol Violation|0|||
161034050|NCT02719574|581517722|FG006|Phase 2|Protocol Violation|0|||
161034051|NCT02719574|581517723|FG007|Phase 2|Protocol Violation|0|||
161034052|NCT02719574|581517724|FG008|Phase 2|Protocol Violation|0|||
161034053|NCT02719574|581517725|FG009|Phase 2|Protocol Violation|1|||
161034054|NCT02719574|581517726|FG010|Phase 2|Protocol Violation|0|||
161034055|NCT02719574|581517727|FG011|Phase 2|Protocol Violation|0|||
161034056|NCT02719574|581517728|FG012|Phase 2|Protocol Violation|0|||
161034057|NCT02719574|581517729|FG013|Phase 2|Protocol Violation|0|||
161279041|NCT03355469|582402334|FG001|Overall Study|Lost to Follow-up|0|||
161279042|NCT03355469|582402335|FG002|Overall Study|Lost to Follow-up|1|||
160977004|NCT00779584|581304708|FG006|Overall Study|Withdrawal by Subject|1|||
160977005|NCT00779584|581304709|FG007|Overall Study|Withdrawal by Subject|0|||
160977006|NCT00779584|581304710|FG008|Overall Study|Withdrawal by Subject|0|||
160977007|NCT00779584|581304702|FG000|Overall Study|Lost to Follow-up|0|||
160977008|NCT00779584|581304703|FG001|Overall Study|Lost to Follow-up|0|||
160977009|NCT00779584|581304704|FG002|Overall Study|Lost to Follow-up|0|||
160977010|NCT00779584|581304705|FG003|Overall Study|Lost to Follow-up|0|||
160977011|NCT00779584|581304706|FG004|Overall Study|Lost to Follow-up|1|||
160977012|NCT00779584|581304707|FG005|Overall Study|Lost to Follow-up|0|||
160977013|NCT00779584|581304708|FG006|Overall Study|Lost to Follow-up|0|||
160977014|NCT00779584|581304709|FG007|Overall Study|Lost to Follow-up|0|||
160977015|NCT00779584|581304710|FG008|Overall Study|Lost to Follow-up|0|||
160977016|NCT00779584|581304702|FG000|Overall Study|Progression of Disease|0|||
160977017|NCT00779584|581304703|FG001|Overall Study|Progression of Disease|1|||
160977018|NCT00779584|581304704|FG002|Overall Study|Progression of Disease|2|||
160977019|NCT00779584|581304705|FG003|Overall Study|Progression of Disease|6|||
160977020|NCT00779584|581304706|FG004|Overall Study|Progression of Disease|5|||
160977021|NCT00779584|581304707|FG005|Overall Study|Progression of Disease|1|||
160977022|NCT00779584|581304708|FG006|Overall Study|Progression of Disease|4|||
160977023|NCT00779584|581304709|FG007|Overall Study|Progression of Disease|2|||
160977024|NCT00779584|581304710|FG008|Overall Study|Progression of Disease|1|||
160977025|NCT00779584|581304702|FG000|Overall Study|Adverse Event|1|||
160977026|NCT00779584|581304703|FG001|Overall Study|Adverse Event|0|||
160977027|NCT00779584|581304704|FG002|Overall Study|Adverse Event|2|||
160977028|NCT00779584|581304705|FG003|Overall Study|Adverse Event|0|||
160977029|NCT00779584|581304706|FG004|Overall Study|Adverse Event|0|||
160977030|NCT00779584|581304707|FG005|Overall Study|Adverse Event|0|||
160977031|NCT00779584|581304708|FG006|Overall Study|Adverse Event|2|||
160977032|NCT00779584|581304709|FG007|Overall Study|Adverse Event|1|||
160977033|NCT00779584|581304710|FG008|Overall Study|Adverse Event|1|||
160977034|NCT00779584|581304702|FG000|Overall Study|Symptomatic Deterioration|1|||
160977035|NCT00779584|581304703|FG001|Overall Study|Symptomatic Deterioration|1|||
160977036|NCT00779584|581304704|FG002|Overall Study|Symptomatic Deterioration|1|||
160977037|NCT00779584|581304705|FG003|Overall Study|Symptomatic Deterioration|0|||
160977038|NCT00779584|581304706|FG004|Overall Study|Symptomatic Deterioration|0|||
160977039|NCT00779584|581304707|FG005|Overall Study|Symptomatic Deterioration|1|||
160977040|NCT00779584|581304708|FG006|Overall Study|Symptomatic Deterioration|1|||
160977041|NCT00779584|581304709|FG007|Overall Study|Symptomatic Deterioration|0|||
160977042|NCT00779584|581304710|FG008|Overall Study|Symptomatic Deterioration|0|||
160977043|NCT00779584|581304702|FG000|Overall Study|Ongoing in Study|0|||
160977044|NCT00779584|581304703|FG001|Overall Study|Ongoing in Study|0|||
160977045|NCT00779584|581304704|FG002|Overall Study|Ongoing in Study|0|||
160977046|NCT00779584|581304705|FG003|Overall Study|Ongoing in Study|0|||
160977047|NCT00779584|581304706|FG004|Overall Study|Ongoing in Study|1|||
160977048|NCT00779584|581304707|FG005|Overall Study|Ongoing in Study|1|||
160977049|NCT00779584|581304708|FG006|Overall Study|Ongoing in Study|0|||
160977050|NCT00779584|581304709|FG007|Overall Study|Ongoing in Study|0|||
160977051|NCT00779584|581304710|FG008|Overall Study|Ongoing in Study|0|||
160977052|NCT01544491|581304716|FG000|Overall Study|Withdrawal by Subject|3|||
161034058|NCT02719574|581517730|FG014|Phase 2|Protocol Violation|0|||
161034059|NCT02719574|581517731|FG015|Phase 2|Protocol Violation|0|||
161034060|NCT02719574|581517732|FG016|Phase 2|Protocol Violation|0|||
160977053|NCT01544491|581304717|FG001|Overall Study|Withdrawal by Subject|2|||
160977054|NCT01544491|581304716|FG000|Overall Study|Lost to Follow-up|0|||
161034061|NCT02306161|581517745|FG000|Overall Study|Death|1|||
161034062|NCT02306161|581517746|FG001|Overall Study|Death|3|||
161034063|NCT02306161|581517745|FG000|Overall Study|Lack of Efficacy|20|||
161034064|NCT02306161|581517746|FG001|Overall Study|Lack of Efficacy|43|||
161034065|NCT02306161|581517745|FG000|Overall Study|Physician Decision|30|||
161034066|NCT02306161|581517746|FG001|Overall Study|Physician Decision|18|||
161034067|NCT02306161|581517745|FG000|Overall Study|Withdrawal by Subject|4|||
161034068|NCT02306161|581517746|FG001|Overall Study|Withdrawal by Subject|0|||
161034069|NCT02306161|581517745|FG000|Overall Study|Ineligible|9|||
161034070|NCT02306161|581517746|FG001|Overall Study|Ineligible|5|||
161034071|NCT03983382|581517747|FG000|Overall Study|Death|1|||
161034072|NCT03983382|581517747|FG000|Overall Study|Lost to Follow-up|3|||
161034073|NCT03983382|581517747|FG000|Overall Study|Physician Decision|2|||
161034074|NCT03983382|581517747|FG000|Overall Study|Withdrawal by Subject|10|||
161034075|NCT03983382|581517747|FG000|Overall Study|Change in cancer treatment|2|||
161034076|NCT02567435|581517754|FG000|Overall Study|Death|1|||
161034077|NCT02567435|581517755|FG001|Overall Study|Death|1|||
161279043|NCT03355469|582402336|FG003|Overall Study|Lost to Follow-up|0|||
161279044|NCT03355469|582402333|FG000|Overall Study|Withdrawal by Subject|2|||
161279045|NCT03355469|582402334|FG001|Overall Study|Withdrawal by Subject|1|||
161279046|NCT03355469|582402335|FG002|Overall Study|Withdrawal by Subject|0|||
161279047|NCT03355469|582402336|FG003|Overall Study|Withdrawal by Subject|3|||
161279048|NCT02291510|582402337|FG000|Overall Study|Adverse Event|0|||
161279049|NCT02291510|582402338|FG001|Overall Study|Adverse Event|0|||
161279050|NCT02291510|582402339|FG002|Overall Study|Adverse Event|0|||
161279051|NCT02291510|582402340|FG003|Overall Study|Adverse Event|1|||
161279052|NCT02454608|582402341|FG000|Double-Blind Period|Lack of Efficacy|0|||
161279053|NCT02454608|582402342|FG001|Double-Blind Period|Lack of Efficacy|2|||
161279054|NCT02454608|582402343|FG002|Double-Blind Period|Lack of Efficacy|0|||
161279055|NCT02454608|582402341|FG000|Open Label Period|Lost to Follow-up|0|||
161279056|NCT02454608|582402342|FG001|Open Label Period|Lost to Follow-up|0|||
161279057|NCT02454608|582402343|FG002|Open Label Period|Lost to Follow-up|11|||
161279058|NCT02454608|582402341|FG000|Open Label Period|Withdrawal by Subject|0|||
161279059|NCT02454608|582402342|FG001|Open Label Period|Withdrawal by Subject|0|||
161279060|NCT02454608|582402343|FG002|Open Label Period|Withdrawal by Subject|8|||
161279061|NCT04856930|582402348|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
161344783|NCT01047319|582647279|FG002|Overall Study|Lost to Follow-up|10|||
160977055|NCT01544491|581304717|FG001|Overall Study|Lost to Follow-up|1|||
160977056|NCT01544491|581304716|FG000|Overall Study|administrative problems|2|||
160977057|NCT01544491|581304717|FG001|Overall Study|administrative problems|0|||
160977058|NCT00896454|581304731|FG000|Overall Study|Death|10|||
160977059|NCT00896454|581304731|FG000|Overall Study|Adverse Event|8|||
160977060|NCT00896454|581304731|FG000|Overall Study|Disease Progression|5|||
160977061|NCT00896454|581304731|FG000|Overall Study|Other|4|||
160977062|NCT00896454|581304731|FG000|Overall Study|Requirement for alternative therapy|3|||
160977063|NCT00896454|581304731|FG000|Overall Study|Ongoing in study|2|||
160977064|NCT00896454|581304731|FG000|Overall Study|Withdrawal by Subject|1|||
160977065|NCT00680056|581304735|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
160977066|NCT00680056|581304736|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
160977067|NCT00680056|581304735|FG000|Second Intervention|Protocol Violation|3|||
160977068|NCT00680056|581304736|FG001|Second Intervention|Protocol Violation|1|||
160977069|NCT03688711|581304742|FG000|Overall Study|Withdrawal by Subject|0|||
160977070|NCT03688711|581304743|FG001|Overall Study|Withdrawal by Subject|1|||
160977071|NCT01018563|581304744|FG000|Overall Study|Termination of the study by Sponsor|2|||
160977072|NCT01018563|581304745|FG001|Overall Study|Termination of the study by Sponsor|1|||
160977073|NCT02306122|581304746|FG000|Initial Physician Randomization|Physician Decision|0|||
160977074|NCT02306122|581304747|FG001|Initial Physician Randomization|Physician Decision|0|||
160977075|NCT02306122|581304748|FG002|Initial Physician Randomization|Physician Decision|0|||
160977076|NCT02306122|581304749|FG003|Initial Physician Randomization|Physician Decision|0|||
160977077|NCT02306122|581304750|FG004|Initial Physician Randomization|Physician Decision|0|||
160977078|NCT02306122|581304751|FG005|Initial Physician Randomization|Physician Decision|0|||
160977079|NCT02306122|581304752|FG006|Initial Physician Randomization|Physician Decision|0|||
160977080|NCT02306122|581304753|FG007|Initial Physician Randomization|Physician Decision|0|||
160977081|NCT02306122|581304754|FG008|Initial Physician Randomization|Physician Decision|1|||
160977082|NCT02306122|581304755|FG009|Initial Physician Randomization|Physician Decision|0|||
160977083|NCT02306122|581304756|FG010|Initial Physician Randomization|Physician Decision|0|||
160977084|NCT02322814|581304757|FG000|Overall Study|Death|7|||
160977085|NCT02322814|581304758|FG001|Overall Study|Death|29|||
160977086|NCT02322814|581304759|FG002|Overall Study|Death|32|||
160977087|NCT02322814|581304760|FG003|Overall Study|Death|23|||
160977088|NCT02322814|581304761|FG004|Overall Study|Death|14|||
160977089|NCT02322814|581304757|FG000|Overall Study|Lost to Follow-up|1|||
160977090|NCT02322814|581304758|FG001|Overall Study|Lost to Follow-up|3|||
160977091|NCT02322814|581304759|FG002|Overall Study|Lost to Follow-up|3|||
160977092|NCT02322814|581304760|FG003|Overall Study|Lost to Follow-up|1|||
160977093|NCT02322814|581304761|FG004|Overall Study|Lost to Follow-up|0|||
160977094|NCT02322814|581304757|FG000|Overall Study|Various Reasons|2|||
161034078|NCT02567435|581517756|FG002|Overall Study|Death|0|||
161034079|NCT02567435|581517757|FG003|Overall Study|Death|0|||
161034080|NCT02567435|581517754|FG000|Overall Study|Ineligible|1|||
161034081|NCT02567435|581517755|FG001|Overall Study|Ineligible|3|||
161034082|NCT02567435|581517756|FG002|Overall Study|Ineligible|0|||
161034083|NCT02567435|581517757|FG003|Overall Study|Ineligible|0|||
161034084|NCT02567435|581517754|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
161034085|NCT02567435|581517755|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
161034086|NCT02567435|581517756|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
161034087|NCT02567435|581517757|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
161034088|NCT02166463|581517758|FG000|Overall Study|Lost to Follow-up|0|||
161034089|NCT02166463|581517759|FG001|Overall Study|Lost to Follow-up|1|||
161034090|NCT02166463|581517758|FG000|Overall Study|Physician Decision|10|||
161034091|NCT02166463|581517759|FG001|Overall Study|Physician Decision|10|||
161034092|NCT02166463|581517758|FG000|Overall Study|Ineligible|11|||
161034093|NCT02166463|581517759|FG001|Overall Study|Ineligible|2|||
161034094|NCT02166463|581517758|FG000|Overall Study|Progressive Disease|9|||
161034095|NCT02166463|581517759|FG001|Overall Study|Progressive Disease|6|||
161034096|NCT02166463|581517758|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
161034097|NCT02166463|581517759|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
161034098|NCT02166463|581517758|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
161034099|NCT02166463|581517759|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
161034100|NCT02166463|581517758|FG000|Overall Study|Refusal of further protocol therapy|5|||
161034101|NCT02166463|581517759|FG001|Overall Study|Refusal of further protocol therapy|6|||
161034102|NCT00982644|581517762|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
161034103|NCT00982644|581517763|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
161034104|NCT00982644|581517762|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
161034105|NCT00982644|581517763|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
161034106|NCT00982644|581517762|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
161034107|NCT00982644|581517763|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
161034108|NCT00982644|581517762|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
161034109|NCT00982644|581517763|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
161034110|NCT00982644|581517762|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
161034111|NCT00982644|581517763|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
161034112|NCT00982644|581517762|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
161034113|NCT00982644|581517763|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
161034114|NCT00982644|581517762|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
161034115|NCT00982644|581517763|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
161034116|NCT00982644|581517762|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
161034117|NCT00982644|581517763|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
161034118|NCT00982644|581517762|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
161034119|NCT00982644|581517763|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
161034120|NCT00982644|581517762|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
161034121|NCT00982644|581517763|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
161034122|NCT03767335|581517770|FG000|Overall Study|Physician Decision|1|||
161034123|NCT03767335|581517771|FG001|Overall Study|Physician Decision|1|||
161034124|NCT03767335|581517772|FG002|Overall Study|Physician Decision|0|||
161034125|NCT03767335|581517770|FG000|Overall Study|Withdrawal by Subject|0|||
161034126|NCT03767335|581517771|FG001|Overall Study|Withdrawal by Subject|0|||
161034127|NCT03767335|581517772|FG002|Overall Study|Withdrawal by Subject|6|||
161034128|NCT03767335|581517770|FG000|Overall Study|Participant excluded from efficacy population|0|||
161034129|NCT03767335|581517771|FG001|Overall Study|Participant excluded from efficacy population|0|||
161034130|NCT03767335|581517772|FG002|Overall Study|Participant excluded from efficacy population|1|||
161034131|NCT03767335|581517770|FG000|Overall Study|Death|0|||
161034132|NCT03767335|581517771|FG001|Overall Study|Death|0|||
161034133|NCT03767335|581517772|FG002|Overall Study|Death|2|||
161034134|NCT03767335|581517770|FG000|Overall Study|Progressive Disease|2|||
161034135|NCT03767335|581517771|FG001|Overall Study|Progressive Disease|2|||
161034136|NCT03767335|581517772|FG002|Overall Study|Progressive Disease|2|||
161034137|NCT03767335|581517770|FG000|Overall Study|Disease progression needing additional medication|0|||
161034138|NCT03767335|581517771|FG001|Overall Study|Disease progression needing additional medication|0|||
161034139|NCT03767335|581517772|FG002|Overall Study|Disease progression needing additional medication|17|||
161034140|NCT03767335|581517770|FG000|Overall Study|Sponsor decision|0|||
161034141|NCT03767335|581517771|FG001|Overall Study|Sponsor decision|0|||
161034142|NCT03767335|581517772|FG002|Overall Study|Sponsor decision|2|||
161034143|NCT03767335|581517770|FG000|Overall Study|Other Medical Reasons|0|||
161034144|NCT03767335|581517771|FG001|Overall Study|Other Medical Reasons|0|||
161034145|NCT03767335|581517772|FG002|Overall Study|Other Medical Reasons|3|||
161034146|NCT03705390|581517773|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
161034147|NCT03705390|581517773|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
161279062|NCT04856930|582402349|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
161344784|NCT01047319|582647277|FG000|Overall Study|Adverse Event|16|||
161034148|NCT02989662|581517778|FG000|Overall Study|Lost to Follow-up|0|||
161034149|NCT02989662|581517779|FG001|Overall Study|Lost to Follow-up|0|||
161034150|NCT02989662|581517780|FG002|Overall Study|Lost to Follow-up|0|||
161034151|NCT02989662|581517781|FG003|Overall Study|Lost to Follow-up|2|||
161034152|NCT02989662|581517778|FG000|Overall Study|Physician Decision|3|||
161034153|NCT02989662|581517779|FG001|Overall Study|Physician Decision|0|||
161034154|NCT02989662|581517780|FG002|Overall Study|Physician Decision|0|||
161034155|NCT02989662|581517781|FG003|Overall Study|Physician Decision|0|||
161034156|NCT02989662|581517778|FG000|Overall Study|Withdrawal by Subject|1|||
161034157|NCT02989662|581517779|FG001|Overall Study|Withdrawal by Subject|0|||
161034158|NCT02989662|581517780|FG002|Overall Study|Withdrawal by Subject|0|||
161034159|NCT02989662|581517781|FG003|Overall Study|Withdrawal by Subject|0|||
161034160|NCT02726386|581517782|FG000|Overall Study|Adverse Event|17|||
161034161|NCT02726386|581517783|FG001|Overall Study|Adverse Event|20|||
161034162|NCT02726386|581517782|FG000|Overall Study|Withdrawal by Subject|14|||
161034163|NCT02726386|581517783|FG001|Overall Study|Withdrawal by Subject|28|||
161034164|NCT02726386|581517782|FG000|Overall Study|Other reasons|7|||
161034165|NCT02726386|581517783|FG001|Overall Study|Other reasons|8|||
161034166|NCT00353496|581517796|FG000|Overall Study|Adverse Event|1|||
161034167|NCT00353496|581517797|FG001|Overall Study|Adverse Event|0|||
161034168|NCT00353496|581517796|FG000|Overall Study|Protocol Violation|2|||
161034169|NCT00353496|581517797|FG001|Overall Study|Protocol Violation|2|||
161034170|NCT00353496|581517796|FG000|Overall Study|Withdrawal by Subject|3|||
161034171|NCT00353496|581517797|FG001|Overall Study|Withdrawal by Subject|4|||
161034172|NCT00353496|581517796|FG000|Overall Study|Physician Decision|6|||
161034173|NCT00353496|581517797|FG001|Overall Study|Physician Decision|9|||
161034174|NCT00353496|581517796|FG000|Overall Study|Not otherwise specified|4|||
161034175|NCT00353496|581517797|FG001|Overall Study|Not otherwise specified|2|||
161034176|NCT02180867|581517798|FG000|Overall Study|Adverse Event|3|||
161034177|NCT02180867|581517799|FG001|Overall Study|Adverse Event|4|||
161034178|NCT02180867|581517800|FG002|Overall Study|Adverse Event|1|||
161034179|NCT02180867|581517801|FG003|Overall Study|Adverse Event|5|||
161034180|NCT02180867|581517802|FG004|Overall Study|Adverse Event|0|||
161034181|NCT02180867|581517803|FG005|Overall Study|Adverse Event|0|||
161034182|NCT02180867|581517804|FG006|Overall Study|Adverse Event|0|||
161034183|NCT02180867|581517798|FG000|Overall Study|Death|0|||
161034184|NCT02180867|581517799|FG001|Overall Study|Death|0|||
161034185|NCT02180867|581517800|FG002|Overall Study|Death|0|||
161034186|NCT02180867|581517801|FG003|Overall Study|Death|0|||
161034187|NCT02180867|581517802|FG004|Overall Study|Death|1|||
161034188|NCT02180867|581517803|FG005|Overall Study|Death|0|||
161034189|NCT02180867|581517804|FG006|Overall Study|Death|0|||
161034190|NCT02180867|581517798|FG000|Overall Study|Lack of Efficacy|0|||
161034191|NCT02180867|581517799|FG001|Overall Study|Lack of Efficacy|2|||
161034192|NCT02180867|581517800|FG002|Overall Study|Lack of Efficacy|0|||
161034193|NCT02180867|581517801|FG003|Overall Study|Lack of Efficacy|1|||
161034194|NCT02180867|581517802|FG004|Overall Study|Lack of Efficacy|6|||
161034195|NCT02180867|581517803|FG005|Overall Study|Lack of Efficacy|0|||
161034196|NCT02180867|581517804|FG006|Overall Study|Lack of Efficacy|1|||
161034197|NCT02180867|581517798|FG000|Overall Study|Physician Decision|1|||
161034198|NCT02180867|581517799|FG001|Overall Study|Physician Decision|3|||
161034199|NCT02180867|581517800|FG002|Overall Study|Physician Decision|1|||
161034200|NCT02180867|581517801|FG003|Overall Study|Physician Decision|10|||
161034201|NCT02180867|581517802|FG004|Overall Study|Physician Decision|9|||
161034202|NCT02180867|581517803|FG005|Overall Study|Physician Decision|3|||
161034203|NCT02180867|581517804|FG006|Overall Study|Physician Decision|4|||
161034204|NCT02180867|581517798|FG000|Overall Study|Withdrawal by Subject|0|||
161034205|NCT02180867|581517799|FG001|Overall Study|Withdrawal by Subject|0|||
161034206|NCT02180867|581517800|FG002|Overall Study|Withdrawal by Subject|0|||
161034207|NCT02180867|581517801|FG003|Overall Study|Withdrawal by Subject|1|||
161034208|NCT02180867|581517802|FG004|Overall Study|Withdrawal by Subject|1|||
161034209|NCT02180867|581517803|FG005|Overall Study|Withdrawal by Subject|0|||
161034210|NCT02180867|581517804|FG006|Overall Study|Withdrawal by Subject|0|||
161034211|NCT02180867|581517798|FG000|Overall Study|Ineligible|1|||
161034212|NCT02180867|581517799|FG001|Overall Study|Ineligible|2|||
161034213|NCT02180867|581517800|FG002|Overall Study|Ineligible|0|||
161034214|NCT02180867|581517801|FG003|Overall Study|Ineligible|3|||
161034215|NCT02180867|581517802|FG004|Overall Study|Ineligible|5|||
161034216|NCT02180867|581517803|FG005|Overall Study|Ineligible|0|||
161034217|NCT02180867|581517804|FG006|Overall Study|Ineligible|0|||
161034218|NCT02180867|581517798|FG000|Overall Study|Repeat Eligibility Studies|0|||
161034219|NCT02180867|581517799|FG001|Overall Study|Repeat Eligibility Studies|0|||
161034220|NCT02180867|581517800|FG002|Overall Study|Repeat Eligibility Studies|0|||
161034221|NCT02180867|581517801|FG003|Overall Study|Repeat Eligibility Studies|0|||
161034222|NCT02180867|581517802|FG004|Overall Study|Repeat Eligibility Studies|1|||
161034223|NCT02180867|581517803|FG005|Overall Study|Repeat Eligibility Studies|0|||
161034224|NCT02180867|581517804|FG006|Overall Study|Repeat Eligibility Studies|0|||
161034225|NCT02180867|581517798|FG000|Overall Study|Refusal of further protocol therapy|1|||
161034226|NCT02180867|581517799|FG001|Overall Study|Refusal of further protocol therapy|0|||
161034227|NCT02180867|581517800|FG002|Overall Study|Refusal of further protocol therapy|2|||
161034228|NCT02180867|581517801|FG003|Overall Study|Refusal of further protocol therapy|6|||
161034229|NCT02180867|581517802|FG004|Overall Study|Refusal of further protocol therapy|4|||
161034230|NCT02180867|581517803|FG005|Overall Study|Refusal of further protocol therapy|0|||
161034231|NCT02180867|581517804|FG006|Overall Study|Refusal of further protocol therapy|0|||
161034232|NCT00945724|581517805|FG000|Overall Study|Withdrawal by Subject|2|||
161034233|NCT00945724|581517805|FG000|Overall Study|Physician Decision|1|||
161034234|NCT00945724|581517805|FG000|Overall Study|Adverse Event|5|||
161279063|NCT04856930|582402350|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
161279064|NCT04856930|582402348|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
161279065|NCT04856930|582402349|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
161279066|NCT04856930|582402350|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
161034235|NCT00945724|581517805|FG000|Overall Study|Second malignancy|1|||
161034236|NCT00557492|581518471|FG000|Overall Study|Change in health insurance|1|||
161034237|NCT01260896|581518481|FG000|First Intervention|Withdrawn Due to Emesis|2|||
161034238|NCT01260896|581518482|FG001|First Intervention|Withdrawn Due to Emesis|0|||
161034239|NCT05030584|581518488|FG000|Overall Study|Adverse Event|17|||
161034240|NCT05030584|581518489|FG001|Overall Study|Adverse Event|2|||
161034241|NCT05030584|581518488|FG000|Overall Study|Lack of Efficacy|0|||
161034242|NCT05030584|581518489|FG001|Overall Study|Lack of Efficacy|6|||
161034243|NCT05030584|581518488|FG000|Overall Study|Lost to Follow-up|5|||
161034244|NCT05030584|581518489|FG001|Overall Study|Lost to Follow-up|2|||
161034245|NCT05030584|581518488|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161034246|NCT05030584|581518489|FG001|Overall Study|Non-Compliance with Study Drug|3|||
161034247|NCT05030584|581518488|FG000|Overall Study|Other reason|4|||
161034248|NCT05030584|581518489|FG001|Overall Study|Other reason|3|||
161034249|NCT05030584|581518488|FG000|Overall Study|Physician Decision|1|||
161034250|NCT05030584|581518489|FG001|Overall Study|Physician Decision|4|||
161034251|NCT05030584|581518488|FG000|Overall Study|Protocol Violation|0|||
161034252|NCT05030584|581518489|FG001|Overall Study|Protocol Violation|2|||
161034253|NCT05030584|581518488|FG000|Overall Study|Randomized by Mistake|0|||
161034254|NCT05030584|581518489|FG001|Overall Study|Randomized by Mistake|2|||
161034255|NCT05030584|581518488|FG000|Overall Study|Withdrawal by Subject|21|||
161034256|NCT05030584|581518489|FG001|Overall Study|Withdrawal by Subject|28|||
161034257|NCT05030584|581518488|FG000|Overall Study|Technical Problems|0|||
161034258|NCT05030584|581518489|FG001|Overall Study|Technical Problems|1|||
161034259|NCT05030584|581518488|FG000|Overall Study|Completed post-treatment/FU visits|41|||
161034260|NCT05030584|581518489|FG001|Overall Study|Completed post-treatment/FU visits|31|||
161034261|NCT03047213|581518490|FG000|Overall Study|Withdrawal by Subject|2|||
161034262|NCT03047213|581518491|FG001|Overall Study|Withdrawal by Subject|0|||
161034263|NCT03047213|581518490|FG000|Overall Study|Adverse Event|2|||
161034264|NCT03047213|581518491|FG001|Overall Study|Adverse Event|0|||
161034265|NCT06393127|581518493|FG000|Washout period|Withdrawal by Subject|1|||
161034266|NCT06393127|581518494|FG001|Washout period|Withdrawal by Subject|0|||
161034267|NCT06393127|581518493|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
161034268|NCT06393127|581518494|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
161034269|NCT02446600|581518495|FG000|Overall Study|Never treated|20|||
161034270|NCT02446600|581518496|FG001|Overall Study|Never treated|2|||
161034271|NCT02446600|581518497|FG002|Overall Study|Never treated|6|||
161034272|NCT02446600|581518498|FG003|Overall Study|Never treated|0|||
161279067|NCT04856930|582402348|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
161279068|NCT04856930|582402349|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
161279069|NCT04856930|582402350|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
161279070|NCT04856930|582402348|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
161279071|NCT04856930|582402349|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
161279072|NCT04856930|582402350|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
161279073|NCT04856930|582402348|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
161034273|NCT02446600|581518495|FG000|Overall Study|Withdrawal by Subject|19|||
161279074|NCT04856930|582402349|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
161279075|NCT04856930|582402350|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
161279076|NCT04856930|582402348|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161279077|NCT04856930|582402349|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
161034274|NCT02446600|581518496|FG001|Overall Study|Withdrawal by Subject|5|||
161034275|NCT02446600|581518497|FG002|Overall Study|Withdrawal by Subject|17|||
161034276|NCT02446600|581518498|FG003|Overall Study|Withdrawal by Subject|0|||
161034277|NCT02446600|581518495|FG000|Overall Study|Ineligible|1|||
161279078|NCT04856930|582402350|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161034278|NCT02446600|581518496|FG001|Overall Study|Ineligible|4|||
161034279|NCT02446600|581518497|FG002|Overall Study|Ineligible|4|||
161034280|NCT02446600|581518498|FG003|Overall Study|Ineligible|1|||
161034281|NCT02446600|581518495|FG000|Overall Study|Duplicate Enrollment|0|||
161034282|NCT02446600|581518496|FG001|Overall Study|Duplicate Enrollment|1|||
161034283|NCT02446600|581518497|FG002|Overall Study|Duplicate Enrollment|0|||
161034284|NCT02446600|581518498|FG003|Overall Study|Duplicate Enrollment|0|||
161034285|NCT00328783|581518499|FG000|Overall Study|Could not tolerate ABC|21|||
161034286|NCT00328783|581518499|FG000|Overall Study|No heart in RT field|4|||
161034287|NCT00328783|581518499|FG000|Overall Study|Withdrawal by Subject|1|||
161034288|NCT03660930|581518500|FG000|Overall Study|Adverse Event|0|||
161034289|NCT03660930|581518501|FG001|Overall Study|Adverse Event|0|||
161034290|NCT03660930|581518502|FG002|Overall Study|Adverse Event|0|||
161034291|NCT03660930|581518503|FG003|Overall Study|Adverse Event|2|||
161034292|NCT03660930|581518504|FG004|Overall Study|Adverse Event|0|||
161034293|NCT03660930|581518505|FG005|Overall Study|Adverse Event|1|||
161034294|NCT03660930|581518506|FG006|Overall Study|Adverse Event|0|||
161034295|NCT03660930|581518507|FG007|Overall Study|Adverse Event|0|||
161034296|NCT03660930|581518500|FG000|Overall Study|Withdrawal by Subject|0|||
161034297|NCT03660930|581518501|FG001|Overall Study|Withdrawal by Subject|0|||
161034298|NCT03660930|581518502|FG002|Overall Study|Withdrawal by Subject|0|||
161034299|NCT03660930|581518503|FG003|Overall Study|Withdrawal by Subject|0|||
161034300|NCT03660930|581518504|FG004|Overall Study|Withdrawal by Subject|0|||
161034301|NCT03660930|581518505|FG005|Overall Study|Withdrawal by Subject|1|||
161034302|NCT03660930|581518506|FG006|Overall Study|Withdrawal by Subject|0|||
161034303|NCT03660930|581518507|FG007|Overall Study|Withdrawal by Subject|0|||
161034304|NCT03725332|581518508|FG000|Overall Study|Adverse Event|5|||
161034305|NCT03725332|581518509|FG001|Overall Study|Adverse Event|10|||
161034306|NCT03725332|581518508|FG000|Overall Study|Death|1|||
161034307|NCT03725332|581518509|FG001|Overall Study|Death|3|||
161034308|NCT03725332|581518508|FG000|Overall Study|Lost to Follow-up|43|||
161034309|NCT03725332|581518509|FG001|Overall Study|Lost to Follow-up|122|||
161034310|NCT03725332|581518508|FG000|Overall Study|Withdrawal by Subject|0|||
161034311|NCT03725332|581518509|FG001|Overall Study|Withdrawal by Subject|1|||
161034312|NCT03725332|581518508|FG000|Overall Study|Duplicate enrollment|0|||
161034313|NCT03725332|581518509|FG001|Overall Study|Duplicate enrollment|1|||
161034314|NCT03725332|581518508|FG000|Overall Study|Did not consent|0|||
161034315|NCT03725332|581518509|FG001|Overall Study|Did not consent|1|||
161034316|NCT03242915|581518516|FG000|Overall Study|Adverse Event|5|||
161034317|NCT03242915|581518517|FG001|Overall Study|Adverse Event|1|||
161034318|NCT03242915|581518516|FG000|Overall Study|Withdrawal by Subject|0|||
161034319|NCT03242915|581518517|FG001|Overall Study|Withdrawal by Subject|2|||
161034320|NCT03242915|581518516|FG000|Overall Study|Physician Decision|4|||
161034321|NCT03242915|581518517|FG001|Overall Study|Physician Decision|1|||
161034322|NCT02112916|581518520|FG000|Overall Study|Adverse Event|6|||
161034323|NCT02112916|581518521|FG001|Overall Study|Adverse Event|9|||
161034324|NCT02112916|581518522|FG002|Overall Study|Adverse Event|3|||
161034325|NCT02112916|581518523|FG003|Overall Study|Adverse Event|2|||
161034326|NCT02112916|581518520|FG000|Overall Study|Death|9|||
161034327|NCT02112916|581518521|FG001|Overall Study|Death|9|||
161034328|NCT02112916|581518522|FG002|Overall Study|Death|3|||
161034329|NCT02112916|581518523|FG003|Overall Study|Death|4|||
161034330|NCT02112916|581518520|FG000|Overall Study|Lost to Follow-up|1|||
161034331|NCT02112916|581518521|FG001|Overall Study|Lost to Follow-up|0|||
161034332|NCT02112916|581518522|FG002|Overall Study|Lost to Follow-up|0|||
161034333|NCT02112916|581518523|FG003|Overall Study|Lost to Follow-up|0|||
161034334|NCT02112916|581518520|FG000|Overall Study|Physician Decision|94|||
161034335|NCT02112916|581518521|FG001|Overall Study|Physician Decision|72|||
161034336|NCT02112916|581518522|FG002|Overall Study|Physician Decision|24|||
161034337|NCT02112916|581518523|FG003|Overall Study|Physician Decision|15|||
161034338|NCT02112916|581518520|FG000|Overall Study|Withdrawal by Subject|5|||
161034339|NCT02112916|581518521|FG001|Overall Study|Withdrawal by Subject|3|||
161034340|NCT02112916|581518522|FG002|Overall Study|Withdrawal by Subject|1|||
161034341|NCT02112916|581518523|FG003|Overall Study|Withdrawal by Subject|1|||
161034342|NCT02112916|581518520|FG000|Overall Study|Ineligible|4|||
161034343|NCT02112916|581518521|FG001|Overall Study|Ineligible|8|||
161034344|NCT02112916|581518522|FG002|Overall Study|Ineligible|3|||
161034345|NCT02112916|581518523|FG003|Overall Study|Ineligible|8|||
161034346|NCT02112916|581518520|FG000|Overall Study|Inevaluable|6|||
161034347|NCT02112916|581518521|FG001|Overall Study|Inevaluable|4|||
161034348|NCT02112916|581518522|FG002|Overall Study|Inevaluable|5|||
161034349|NCT02112916|581518523|FG003|Overall Study|Inevaluable|5|||
161034350|NCT02112916|581518520|FG000|Overall Study|Refusal of further protocol therapy|19|||
161034351|NCT02112916|581518521|FG001|Overall Study|Refusal of further protocol therapy|16|||
161279079|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
161034352|NCT02112916|581518522|FG002|Overall Study|Refusal of further protocol therapy|1|||
161034353|NCT02112916|581518523|FG003|Overall Study|Refusal of further protocol therapy|7|||
161034354|NCT02112916|581518520|FG000|Overall Study|Development of SMN|1|||
161034355|NCT02112916|581518521|FG001|Overall Study|Development of SMN|0|||
161034356|NCT02112916|581518522|FG002|Overall Study|Development of SMN|0|||
161279080|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
161034357|NCT02112916|581518523|FG003|Overall Study|Development of SMN|1|||
161034358|NCT02112916|581518520|FG000|Overall Study|Relapse/Progression|10|||
161034359|NCT02112916|581518521|FG001|Overall Study|Relapse/Progression|18|||
161034360|NCT02112916|581518522|FG002|Overall Study|Relapse/Progression|15|||
161034361|NCT02112916|581518523|FG003|Overall Study|Relapse/Progression|2|||
161091181|NCT00336895|581723828|FG000|Overall Study|nausea and upset stomach|1|||
161034362|NCT02112916|581518520|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
161034363|NCT02112916|581518521|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
161034364|NCT02112916|581518522|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
161034365|NCT02112916|581518523|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
161034366|NCT02112916|581518520|FG000|Overall Study|Still on Therapy|44|||
161034367|NCT02112916|581518521|FG001|Overall Study|Still on Therapy|47|||
161034368|NCT02112916|581518522|FG002|Overall Study|Still on Therapy|3|||
161034369|NCT02112916|581518523|FG003|Overall Study|Still on Therapy|2|||
161034370|NCT02112916|581518520|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
161034371|NCT02112916|581518521|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
161034372|NCT02112916|581518522|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
161034373|NCT02112916|581518523|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
161034374|NCT02112916|581518520|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
161034375|NCT02112916|581518521|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
161034376|NCT02112916|581518522|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
161034377|NCT02112916|581518523|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
161034378|NCT03333915|581518525|FG000|Overall Study|Lost to Follow-up|0|||
161034379|NCT03333915|581518526|FG001|Overall Study|Lost to Follow-up|0|||
161034380|NCT03333915|581518527|FG002|Overall Study|Lost to Follow-up|1|||
161034381|NCT03333915|581518528|FG003|Overall Study|Lost to Follow-up|0|||
161034382|NCT03333915|581518529|FG004|Overall Study|Lost to Follow-up|0|||
161034383|NCT03333915|581518525|FG000|Overall Study|Disease Progression|0|||
161034384|NCT03333915|581518526|FG001|Overall Study|Disease Progression|1|||
161034385|NCT03333915|581518527|FG002|Overall Study|Disease Progression|0|||
161034386|NCT03333915|581518528|FG003|Overall Study|Disease Progression|0|||
161034387|NCT03333915|581518529|FG004|Overall Study|Disease Progression|0|||
161034388|NCT03333915|581518525|FG000|Overall Study|Death|0|||
161034389|NCT03333915|581518526|FG001|Overall Study|Death|0|||
161034390|NCT03333915|581518527|FG002|Overall Study|Death|0|||
161034391|NCT03333915|581518528|FG003|Overall Study|Death|37|||
161034392|NCT03333915|581518529|FG004|Overall Study|Death|18|||
161034393|NCT03333915|581518525|FG000|Overall Study|Sponsor's Decision|0|||
161034394|NCT03333915|581518526|FG001|Overall Study|Sponsor's Decision|0|||
161034395|NCT03333915|581518527|FG002|Overall Study|Sponsor's Decision|0|||
161034396|NCT03333915|581518528|FG003|Overall Study|Sponsor's Decision|48|||
161034397|NCT03333915|581518529|FG004|Overall Study|Sponsor's Decision|4|||
161034398|NCT03333915|581518525|FG000|Overall Study|Withdrawal by Subject|0|||
161034399|NCT03333915|581518526|FG001|Overall Study|Withdrawal by Subject|0|||
161034400|NCT03333915|581518527|FG002|Overall Study|Withdrawal by Subject|0|||
161034401|NCT03333915|581518528|FG003|Overall Study|Withdrawal by Subject|5|||
161034402|NCT03333915|581518529|FG004|Overall Study|Withdrawal by Subject|1|||
161034403|NCT02206828|581518543|FG000|Overall Study|Lost to Follow-up|7|||
161034404|NCT05039021|581519052|FG000|Overall Study|Death|1|||
161034405|NCT05039021|581519052|FG000|Overall Study|Lost to Follow-up|3|||
161034406|NCT00994643|581519053|FG000|Overall Study|Withdrawal by Subject|1|||
161034407|NCT02566889|581519054|FG000|Overall Study|Withdrawal by Subject|3|||
161034408|NCT02566889|581519055|FG001|Overall Study|Withdrawal by Subject|1|||
161034409|NCT02566889|581519054|FG000|Overall Study|Adverse Event|4|||
161034410|NCT02566889|581519055|FG001|Overall Study|Adverse Event|2|||
161034411|NCT02566889|581519054|FG000|Overall Study|Other|6|||
161034412|NCT02566889|581519055|FG001|Overall Study|Other|2|||
161034413|NCT03391466|581519057|FG000|Overall Study|Death|84|||
161034414|NCT03391466|581519058|FG001|Overall Study|Death|91|||
161034415|NCT03391466|581519057|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
161034416|NCT03391466|581519058|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
161034417|NCT03391466|581519057|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
161034418|NCT03391466|581519058|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
161034419|NCT03391466|581519057|FG000|Overall Study|Lost to Follow-up|9|||
161034420|NCT03391466|581519058|FG001|Overall Study|Lost to Follow-up|5|||
161034421|NCT03391466|581519057|FG000|Overall Study|Reason Not Specified|2|||
161034422|NCT03391466|581519058|FG001|Overall Study|Reason Not Specified|2|||
161034423|NCT03391466|581519057|FG000|Overall Study|Investigator Decision|0|||
161034424|NCT03391466|581519058|FG001|Overall Study|Investigator Decision|1|||
161034425|NCT03140670|581519059|FG000|Overall Study|Withdrawal by Subject|2|||
161034426|NCT03140670|581519059|FG000|Overall Study|Lost to Follow-up|1|||
161034427|NCT03140670|581519059|FG000|Overall Study|Physician Decision|1|||
161344785|NCT01047319|582647278|FG001|Overall Study|Adverse Event|27|||
161034428|NCT03699163|581519060|FG000|Overall Study|Physician Decision|12|||
161034429|NCT03699163|581519061|FG001|Overall Study|Physician Decision|0|||
161034430|NCT03699163|581519060|FG000|Overall Study|failed QC measures|205|||
161034431|NCT03699163|581519061|FG001|Overall Study|failed QC measures|206|||
161034432|NCT04121546|581519067|FG000|Overall Study|Lost to Follow-up|1|||
161034433|NCT04121546|581519068|FG001|Overall Study|Lost to Follow-up|3|||
161034434|NCT04129164|581519069|FG000|Overall Study|Non-compliance with procedures|0|||
161034435|NCT04129164|581519070|FG001|Overall Study|Non-compliance with procedures|0|||
161279081|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
161279082|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
161279083|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
161279084|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
161279085|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
161279086|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
161279087|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
161279088|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
161279089|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
161279090|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
161279091|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
161279092|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161279093|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
161279094|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
161279095|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
161279096|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
161279097|NCT04856930|582402348|FG000|Extension Period (16 Weeks)|Other than specified|0|||
161279098|NCT04856930|582402349|FG001|Extension Period (16 Weeks)|Other than specified|0|||
161279099|NCT04856930|582402350|FG002|Extension Period (16 Weeks)|Other than specified|1|||
161279100|NCT04856930|582402348|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161279101|NCT04856930|582402349|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161279102|NCT04856930|582402350|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
161279103|NCT04856930|582402348|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
161279104|NCT04856930|582402349|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
161279105|NCT04856930|582402350|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
161279106|NCT04856930|582402348|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
161279107|NCT04856930|582402349|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161279108|NCT04856930|582402350|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
161279109|NCT04856930|582402348|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
161279110|NCT04856930|582402349|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
161279111|NCT04856930|582402350|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
160977095|NCT02322814|581304758|FG001|Overall Study|Various Reasons|0|||
160977096|NCT02322814|581304759|FG002|Overall Study|Various Reasons|1|||
160977097|NCT02322814|581304760|FG003|Overall Study|Various Reasons|1|||
160977098|NCT02322814|581304761|FG004|Overall Study|Various Reasons|0|||
160977099|NCT02322814|581304757|FG000|Overall Study|Progressive Disease|0|||
160977100|NCT02322814|581304758|FG001|Overall Study|Progressive Disease|0|||
161279112|NCT02465398|582402352|FG000|Overall Study|Death|7|||
161279113|NCT02465398|582402352|FG000|Overall Study|Revision|7|||
161279114|NCT02465398|582402352|FG000|Overall Study|did not receive study device|1|||
161279115|NCT02465398|582402352|FG000|Overall Study|Withdrawal by Subject|1|||
161279116|NCT02465398|582402352|FG000|Overall Study|Lost to Follow-up|14|||
161279117|NCT01009814|582402355|FG000|Overall Study|No longer met study criteria|1|||
161279118|NCT01009814|582402356|FG001|Overall Study|No longer met study criteria|1|||
161279119|NCT01009814|582402357|FG002|Overall Study|No longer met study criteria|0|||
161279120|NCT01009814|582402358|FG003|Overall Study|No longer met study criteria|0|||
161279121|NCT01009814|582402359|FG004|Overall Study|No longer met study criteria|0|||
161279122|NCT01173120|582402360|FG000|Overall Study|Lack of Efficacy|2|||
161279123|NCT01173120|582402360|FG000|Overall Study|Lost to Follow-up|1|||
161279124|NCT01173120|582402360|FG000|Overall Study|Participant Decision|2|||
161279125|NCT01173120|582402360|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
161279126|NCT01173120|582402360|FG000|Overall Study|Switch-Participant Decision|12|||
161279127|NCT01173120|582402360|FG000|Overall Study|Switch-Difficulty With Device|12|||
161279128|NCT01383707|582402364|FG000|Overall Study|Consent withdrawal|6|||
161279129|NCT01383707|582402364|FG000|Overall Study|Death|19|||
161279130|NCT01383707|582402364|FG000|Overall Study|Other|8|||
161279131|NCT01383707|582402364|FG000|Overall Study|Sponsor's decision|2|||
161344786|NCT01047319|582647279|FG002|Overall Study|Adverse Event|21|||
160977101|NCT02322814|581304759|FG002|Overall Study|Progressive Disease|0|||
160977102|NCT02322814|581304760|FG003|Overall Study|Progressive Disease|1|||
160977103|NCT02322814|581304761|FG004|Overall Study|Progressive Disease|1|||
160977104|NCT02322814|581304757|FG000|Overall Study|Protocol Violation|1|||
160977105|NCT02322814|581304758|FG001|Overall Study|Protocol Violation|0|||
161279132|NCT01383707|582402364|FG000|Overall Study|Adverse Event|14|||
161279133|NCT01383707|582402364|FG000|Overall Study|Progressive disease|23|||
161279134|NCT01977417|582402368|FG000|Overall Study|Adverse Event|1|||
161279135|NCT01977417|582402369|FG001|Overall Study|Adverse Event|0|||
161279136|NCT01977417|582402368|FG000|Overall Study|Withdrawal by Subject|2|||
161279137|NCT01977417|582402369|FG001|Overall Study|Withdrawal by Subject|4|||
161279138|NCT01977417|582402368|FG000|Overall Study|Female enrollment goal met|0|||
161279139|NCT01977417|582402369|FG001|Overall Study|Female enrollment goal met|2|||
161279140|NCT02906358|582402370|FG000|Overall Study|Withdrawal by Subject|10|||
160977106|NCT02322814|581304759|FG002|Overall Study|Protocol Violation|0|||
161279141|NCT02906358|582402371|FG001|Overall Study|Withdrawal by Subject|7|||
161279142|NCT02906358|582402370|FG000|Overall Study|Lost to Follow-up|12|||
161279143|NCT02906358|582402371|FG001|Overall Study|Lost to Follow-up|15|||
161279144|NCT02699684|582402372|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
161279145|NCT02699684|582402373|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
161279146|NCT03055624|582402379|FG000|Overall Study|Study closed|9|||
161279147|NCT02437903|582402380|FG000|Overall Study|Adverse Event|1|||
161279148|NCT02437903|582402380|FG000|Overall Study|Withdrawal by Subject|1|||
161279149|NCT02437903|582402380|FG000|Overall Study|Lost to Follow-up|3|||
161279150|NCT01625988|582402382|FG000|Overall Study|Lost to Follow-up|5|||
161279151|NCT01625988|582402383|FG001|Overall Study|Lost to Follow-up|6|||
161279152|NCT01625988|582402382|FG000|Overall Study|Withdrawal by Subject|8|||
161279153|NCT01625988|582402383|FG001|Overall Study|Withdrawal by Subject|3|||
161279154|NCT01625988|582402382|FG000|Overall Study|Adverse Event|0|||
161279155|NCT01625988|582402383|FG001|Overall Study|Adverse Event|1|||
161279156|NCT01625988|582402382|FG000|Overall Study|Lack of Efficacy|0|||
161279157|NCT01625988|582402383|FG001|Overall Study|Lack of Efficacy|1|||
161279158|NCT01625988|582402382|FG000|Overall Study|Randomized Inappropriately|1|||
161279159|NCT01625988|582402383|FG001|Overall Study|Randomized Inappropriately|0|||
161279160|NCT01625988|582402382|FG000|Overall Study|Protocol Violation|0|||
161279161|NCT01625988|582402383|FG001|Overall Study|Protocol Violation|2|||
161279162|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
161279163|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
161279164|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
161279165|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161279166|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
161279167|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
161279168|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161279169|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
161279170|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161279171|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
161279172|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
160977107|NCT02322814|581304760|FG003|Overall Study|Protocol Violation|0|||
160977108|NCT02322814|581304761|FG004|Overall Study|Protocol Violation|0|||
160977109|NCT02322814|581304757|FG000|Overall Study|Study Terminated by Sponsor|0|||
160977110|NCT02322814|581304758|FG001|Overall Study|Study Terminated by Sponsor|7|||
160977111|NCT02322814|581304759|FG002|Overall Study|Study Terminated by Sponsor|9|||
160977112|NCT02322814|581304760|FG003|Overall Study|Study Terminated by Sponsor|5|||
160977113|NCT02322814|581304761|FG004|Overall Study|Study Terminated by Sponsor|13|||
160977114|NCT02322814|581304757|FG000|Overall Study|Withdrawal by Subject|5|||
160977115|NCT02322814|581304758|FG001|Overall Study|Withdrawal by Subject|4|||
160977116|NCT02322814|581304759|FG002|Overall Study|Withdrawal by Subject|2|||
160977117|NCT02322814|581304760|FG003|Overall Study|Withdrawal by Subject|1|||
160977118|NCT02322814|581304761|FG004|Overall Study|Withdrawal by Subject|3|||
160977119|NCT02998021|581304767|FG000|Overall Study|Withdrawal by Subject|3|||
160977120|NCT02998021|581304768|FG001|Overall Study|Withdrawal by Subject|1|||
160977121|NCT02998021|581304767|FG000|Overall Study|unsafe home|0|||
160977122|NCT02998021|581304768|FG001|Overall Study|unsafe home|1|||
160977123|NCT03342053|581304769|FG000|Overall Study|Adverse Event|2|||
160977124|NCT03342053|581304770|FG001|Overall Study|Adverse Event|0|||
160977125|NCT03342053|581304769|FG000|Overall Study|Withdrawal by Subject|0|||
160977126|NCT03342053|581304770|FG001|Overall Study|Withdrawal by Subject|1|||
160977127|NCT02294474|581304771|FG000|Overall Study|Adverse Event|7|||
160977128|NCT02294474|581304772|FG001|Overall Study|Adverse Event|7|||
160977129|NCT02294474|581304771|FG000|Overall Study|Lack of Efficacy|2|||
160977130|NCT02294474|581304772|FG001|Overall Study|Lack of Efficacy|1|||
160977131|NCT02294474|581304771|FG000|Overall Study|Protocol Violation|4|||
160977132|NCT02294474|581304772|FG001|Overall Study|Protocol Violation|2|||
160977133|NCT02294474|581304771|FG000|Overall Study|Other than specified above|12|||
160977134|NCT02294474|581304772|FG001|Overall Study|Other than specified above|12|||
160977135|NCT02961374|581304773|FG000|Overall Study|Adverse Event|4|||
160977136|NCT00171873|581304776|FG000|Overall Study|Withdrawal by Subject|4|||
160977137|NCT00171873|581304777|FG001|Overall Study|Withdrawal by Subject|2|||
160977138|NCT00171873|581304776|FG000|Overall Study|Adverse Event|5|||
160977139|NCT00171873|581304777|FG001|Overall Study|Adverse Event|0|||
160977140|NCT00171873|581304776|FG000|Overall Study|Switched to Octreotide|0|||
160977141|NCT00171873|581304777|FG001|Overall Study|Switched to Octreotide|1|||
160977142|NCT02041923|581304778|FG000|Overall Study|Lost to Follow-up|26|||
160977143|NCT02041923|581304779|FG001|Overall Study|Lost to Follow-up|30|||
160977144|NCT00309608|581304782|FG000|Overall Study|Adverse Event|1|||
160977145|NCT00309608|581304783|FG001|Overall Study|Adverse Event|5|||
160977146|NCT00309608|581304784|FG002|Overall Study|Adverse Event|3|||
160977147|NCT00309608|581304785|FG003|Overall Study|Adverse Event|2|||
160977148|NCT00309608|581304786|FG004|Overall Study|Adverse Event|3|||
160977149|NCT00309608|581304782|FG000|Overall Study|Protocol Violation|2|||
160977150|NCT00309608|581304783|FG001|Overall Study|Protocol Violation|0|||
161034436|NCT04129164|581519071|FG002|Overall Study|Non-compliance with procedures|2|||
161034437|NCT04129164|581519072|FG003|Overall Study|Non-compliance with procedures|0|||
161034438|NCT04129164|581519069|FG000|Overall Study|Adverse Event|0|||
161034439|NCT04129164|581519070|FG001|Overall Study|Adverse Event|0|||
161034440|NCT04129164|581519071|FG002|Overall Study|Adverse Event|2|||
161034441|NCT04129164|581519072|FG003|Overall Study|Adverse Event|0|||
161034442|NCT04129164|581519069|FG000|Overall Study|Pregnancy|0|||
161034443|NCT04129164|581519070|FG001|Overall Study|Pregnancy|0|||
161034444|NCT04129164|581519071|FG002|Overall Study|Pregnancy|0|||
161034445|NCT04129164|581519072|FG003|Overall Study|Pregnancy|1|||
161034446|NCT04129164|581519069|FG000|Overall Study|Withdrawal by Subject|3|||
161034447|NCT04129164|581519070|FG001|Overall Study|Withdrawal by Subject|2|||
161034448|NCT04129164|581519071|FG002|Overall Study|Withdrawal by Subject|4|||
161034449|NCT04129164|581519072|FG003|Overall Study|Withdrawal by Subject|6|||
161034450|NCT04129164|581519069|FG000|Overall Study|Death|0|||
161034451|NCT04129164|581519070|FG001|Overall Study|Death|1|||
161034452|NCT04129164|581519071|FG002|Overall Study|Death|0|||
161034453|NCT04129164|581519072|FG003|Overall Study|Death|0|||
161034454|NCT04129164|581519069|FG000|Overall Study|Lost to Follow-up|0|||
161034455|NCT04129164|581519070|FG001|Overall Study|Lost to Follow-up|1|||
161279173|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161279174|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
161279175|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161279176|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
161279177|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
161279178|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161279179|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
161279180|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161279181|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
161279182|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161279183|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161279184|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
161279185|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161279186|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
161279187|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161279188|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161279189|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
161279190|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161279191|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
161279192|NCT03713632|582402386|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
161279193|NCT03713632|582402387|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161279194|NCT03713632|582402388|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161279195|NCT03713632|582402389|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161279196|NCT03713632|582402390|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
161279197|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
161279198|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
161279199|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
161344787|NCT01047319|582647277|FG000|Overall Study|Withdrawal by Subject|77|||
160977151|NCT00309608|581304784|FG002|Overall Study|Protocol Violation|0|||
160977152|NCT00309608|581304785|FG003|Overall Study|Protocol Violation|0|||
160977153|NCT00309608|581304786|FG004|Overall Study|Protocol Violation|0|||
160977154|NCT00309608|581304782|FG000|Overall Study|Lost to Follow-up|0|||
160977155|NCT00309608|581304783|FG001|Overall Study|Lost to Follow-up|0|||
160977156|NCT00309608|581304784|FG002|Overall Study|Lost to Follow-up|2|||
160977157|NCT00309608|581304785|FG003|Overall Study|Lost to Follow-up|0|||
160977158|NCT00309608|581304786|FG004|Overall Study|Lost to Follow-up|1|||
160977159|NCT00309608|581304782|FG000|Overall Study|Withdrawal by Subject|1|||
160977160|NCT00309608|581304783|FG001|Overall Study|Withdrawal by Subject|4|||
160977161|NCT00309608|581304784|FG002|Overall Study|Withdrawal by Subject|2|||
160977162|NCT00309608|581304785|FG003|Overall Study|Withdrawal by Subject|0|||
160977163|NCT00309608|581304786|FG004|Overall Study|Withdrawal by Subject|0|||
160977164|NCT00309608|581304782|FG000|Overall Study|Other incl. Lack of efficacy|10|||
160977165|NCT00309608|581304783|FG001|Overall Study|Other incl. Lack of efficacy|4|||
160977166|NCT00309608|581304784|FG002|Overall Study|Other incl. Lack of efficacy|3|||
160977167|NCT00309608|581304785|FG003|Overall Study|Other incl. Lack of efficacy|4|||
160977168|NCT00309608|581304786|FG004|Overall Study|Other incl. Lack of efficacy|0|||
160977169|NCT00127413|581304787|FG000|Overall Study|Lost to Follow-up|6|||
160977170|NCT00127413|581304788|FG001|Overall Study|Lost to Follow-up|4|||
160977171|NCT00127413|581304789|FG002|Overall Study|Lost to Follow-up|8|||
160977172|NCT00127413|581304790|FG003|Overall Study|Lost to Follow-up|2|||
160977173|NCT03713021|581304793|FG000|Overall Study|Did not have CT sim scan available|6|||
160977174|NCT03713021|581304793|FG000|Overall Study|Not eligible|4|||
161034456|NCT04129164|581519071|FG002|Overall Study|Lost to Follow-up|0|||
161034457|NCT04129164|581519072|FG003|Overall Study|Lost to Follow-up|0|||
161034458|NCT03653364|581519073|FG000|Overall Study|Withdrawal by Subject|1|||
161034459|NCT03653364|581519073|FG000|Overall Study|Enrolled in Error|1|||
161034460|NCT03653364|581519073|FG000|Overall Study|Death|1|||
161034461|NCT02466971|581519078|FG000|Overall Study|eligible and never treated|14|||
161034462|NCT02466971|581519079|FG001|Overall Study|eligible and never treated|20|||
161034463|NCT02466971|581519078|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
161034464|NCT02466971|581519079|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
161034465|NCT02466971|581519078|FG000|Overall Study|ineligible and treated|1|||
161034466|NCT02466971|581519079|FG001|Overall Study|ineligible and treated|0|||
161034467|NCT02466971|581519078|FG000|Overall Study|ineligible and never treated|0|||
161034468|NCT02466971|581519079|FG001|Overall Study|ineligible and never treated|1|||
161034469|NCT02754596|581519080|FG000|Overall Study|Withdrawal by Subject|3|||
161034470|NCT02754596|581519081|FG001|Overall Study|Withdrawal by Subject|4|||
161034471|NCT02754596|581519082|FG002|Overall Study|Withdrawal by Subject|0|||
161034472|NCT02754596|581519080|FG000|Overall Study|Physician Decision|1|||
161034473|NCT02754596|581519081|FG001|Overall Study|Physician Decision|1|||
161034474|NCT02754596|581519082|FG002|Overall Study|Physician Decision|1|||
161034475|NCT02754596|581519080|FG000|Overall Study|Lost to Follow-up|1|||
161034476|NCT02754596|581519081|FG001|Overall Study|Lost to Follow-up|1|||
161034477|NCT02754596|581519082|FG002|Overall Study|Lost to Follow-up|2|||
161034478|NCT02754596|581519080|FG000|Overall Study|Death|0|||
161034479|NCT02754596|581519081|FG001|Overall Study|Death|2|||
161034480|NCT02754596|581519082|FG002|Overall Study|Death|0|||
161034481|NCT02754596|581519080|FG000|Overall Study|Adverse Event|1|||
161034482|NCT02754596|581519081|FG001|Overall Study|Adverse Event|0|||
161034483|NCT02754596|581519082|FG002|Overall Study|Adverse Event|1|||
161034484|NCT02754596|581519080|FG000|Overall Study|Other|1|||
161034485|NCT02754596|581519081|FG001|Overall Study|Other|0|||
161034486|NCT02754596|581519082|FG002|Overall Study|Other|0|||
161034487|NCT02101853|581519083|FG000|Block 1 Induction|Adverse Event|11|||
161034488|NCT02101853|581519084|FG001|Block 1 Induction|Adverse Event|0|||
161034489|NCT02101853|581519085|FG002|Block 1 Induction|Adverse Event|0|||
161034490|NCT02101853|581519086|FG003|Block 1 Induction|Adverse Event|0|||
161034491|NCT02101853|581519087|FG004|Block 1 Induction|Adverse Event|0|||
161034492|NCT02101853|581519088|FG005|Block 1 Induction|Adverse Event|0|||
161034493|NCT02101853|581519083|FG000|Block 1 Induction|Death|20|||
161034494|NCT02101853|581519084|FG001|Block 1 Induction|Death|0|||
161034495|NCT02101853|581519085|FG002|Block 1 Induction|Death|0|||
161034496|NCT02101853|581519086|FG003|Block 1 Induction|Death|0|||
161034497|NCT02101853|581519087|FG004|Block 1 Induction|Death|0|||
161034498|NCT02101853|581519088|FG005|Block 1 Induction|Death|0|||
161034499|NCT02101853|581519083|FG000|Block 1 Induction|Lack of Efficacy|6|||
161034500|NCT02101853|581519084|FG001|Block 1 Induction|Lack of Efficacy|0|||
161034501|NCT02101853|581519085|FG002|Block 1 Induction|Lack of Efficacy|0|||
161034502|NCT02101853|581519086|FG003|Block 1 Induction|Lack of Efficacy|0|||
161034503|NCT02101853|581519087|FG004|Block 1 Induction|Lack of Efficacy|0|||
161034504|NCT02101853|581519088|FG005|Block 1 Induction|Lack of Efficacy|0|||
161034505|NCT02101853|581519083|FG000|Block 1 Induction|Physician Decision|61|||
161034506|NCT02101853|581519084|FG001|Block 1 Induction|Physician Decision|0|||
161034507|NCT02101853|581519085|FG002|Block 1 Induction|Physician Decision|0|||
161034508|NCT02101853|581519086|FG003|Block 1 Induction|Physician Decision|0|||
161034509|NCT02101853|581519087|FG004|Block 1 Induction|Physician Decision|0|||
161034510|NCT02101853|581519088|FG005|Block 1 Induction|Physician Decision|0|||
161034511|NCT02101853|581519083|FG000|Block 1 Induction|Protocol Violation|2|||
161034512|NCT02101853|581519084|FG001|Block 1 Induction|Protocol Violation|0|||
161034513|NCT02101853|581519085|FG002|Block 1 Induction|Protocol Violation|0|||
161034514|NCT02101853|581519086|FG003|Block 1 Induction|Protocol Violation|0|||
161034515|NCT02101853|581519087|FG004|Block 1 Induction|Protocol Violation|0|||
161034516|NCT02101853|581519088|FG005|Block 1 Induction|Protocol Violation|0|||
161034517|NCT02101853|581519083|FG000|Block 1 Induction|Withdrawal by Subject|65|||
161034518|NCT02101853|581519084|FG001|Block 1 Induction|Withdrawal by Subject|0|||
161034519|NCT02101853|581519085|FG002|Block 1 Induction|Withdrawal by Subject|0|||
161034520|NCT02101853|581519086|FG003|Block 1 Induction|Withdrawal by Subject|0|||
161034521|NCT02101853|581519087|FG004|Block 1 Induction|Withdrawal by Subject|0|||
161034522|NCT02101853|581519088|FG005|Block 1 Induction|Withdrawal by Subject|0|||
161034523|NCT02101853|581519083|FG000|Block 1 Induction|Ineligible|8|||
161034524|NCT02101853|581519084|FG001|Block 1 Induction|Ineligible|0|||
161034525|NCT02101853|581519085|FG002|Block 1 Induction|Ineligible|0|||
161034526|NCT02101853|581519086|FG003|Block 1 Induction|Ineligible|0|||
161034527|NCT02101853|581519087|FG004|Block 1 Induction|Ineligible|0|||
161034528|NCT02101853|581519088|FG005|Block 1 Induction|Ineligible|0|||
161034529|NCT02101853|581519083|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
161034530|NCT02101853|581519084|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161034531|NCT02101853|581519085|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161034532|NCT02101853|581519086|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
160977175|NCT03713021|581304793|FG000|Overall Study|Issues with TraceIT markers|5|||
160977176|NCT01340482|581306405|FG000|Overall Study|Adverse Event|2|||
160977177|NCT01340482|581306406|FG001|Overall Study|Adverse Event|0|||
160977178|NCT01340482|581306407|FG002|Overall Study|Adverse Event|0|||
160977179|NCT01282476|581306408|FG000|Overall Study|Death|11|||
160977180|NCT00592319|581306411|FG000|Overall Study|Lost to Follow-up|0|||
160977181|NCT00592319|581306412|FG001|Overall Study|Lost to Follow-up|3|||
160977182|NCT01087723|581306414|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
160977183|NCT01087723|581306415|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
160977184|NCT01087723|581306414|FG000|Overall Study|Withdrawal by Subject|10|||
160977185|NCT01087723|581306415|FG001|Overall Study|Withdrawal by Subject|13|||
160977186|NCT01087723|581306414|FG000|Overall Study|Physician Decision|2|||
160977187|NCT01087723|581306415|FG001|Overall Study|Physician Decision|0|||
160977188|NCT01087723|581306414|FG000|Overall Study|Lost to Follow-up|1|||
160977189|NCT01087723|581306415|FG001|Overall Study|Lost to Follow-up|4|||
160977190|NCT01087723|581306414|FG000|Overall Study|Reason Not Specified|1|||
160977191|NCT01087723|581306415|FG001|Overall Study|Reason Not Specified|2|||
160977192|NCT01868035|581306416|FG000|Overall Study|Lost to Follow-up|3|||
160977193|NCT01868035|581306416|FG000|Overall Study|Withdrawal by Subject|1|||
160977194|NCT01868035|581306416|FG000|Overall Study|Progressive Disease|2|||
160977195|NCT01868035|581306416|FG000|Overall Study|Non-compliance|1|||
160977196|NCT01757665|581306421|FG000|Overall Study|Still on Study - Visit Completed|240|||
160977197|NCT01757665|581306422|FG001|Overall Study|Still on Study - Visit Completed|30|||
161034533|NCT02101853|581519087|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161034534|NCT02101853|581519088|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
161034535|NCT02101853|581519083|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
161034536|NCT02101853|581519084|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034537|NCT02101853|581519085|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034538|NCT02101853|581519086|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034539|NCT02101853|581519087|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034540|NCT02101853|581519088|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034541|NCT02101853|581519083|FG000|Post Induction Randomization|Adverse Event|0|||
161034542|NCT02101853|581519084|FG001|Post Induction Randomization|Adverse Event|3|||
161034543|NCT02101853|581519085|FG002|Post Induction Randomization|Adverse Event|8|||
161034544|NCT02101853|581519086|FG003|Post Induction Randomization|Adverse Event|4|||
161034545|NCT02101853|581519087|FG004|Post Induction Randomization|Adverse Event|4|||
161034546|NCT02101853|581519088|FG005|Post Induction Randomization|Adverse Event|0|||
161034547|NCT02101853|581519083|FG000|Post Induction Randomization|Death|0|||
161034548|NCT02101853|581519084|FG001|Post Induction Randomization|Death|9|||
161034549|NCT02101853|581519085|FG002|Post Induction Randomization|Death|2|||
161034550|NCT02101853|581519086|FG003|Post Induction Randomization|Death|2|||
161034551|NCT02101853|581519087|FG004|Post Induction Randomization|Death|0|||
161034552|NCT02101853|581519088|FG005|Post Induction Randomization|Death|0|||
161034553|NCT02101853|581519083|FG000|Post Induction Randomization|Lack of Efficacy|0|||
161034554|NCT02101853|581519084|FG001|Post Induction Randomization|Lack of Efficacy|14|||
161034555|NCT02101853|581519085|FG002|Post Induction Randomization|Lack of Efficacy|23|||
161034556|NCT02101853|581519086|FG003|Post Induction Randomization|Lack of Efficacy|18|||
161034557|NCT02101853|581519087|FG004|Post Induction Randomization|Lack of Efficacy|21|||
161034558|NCT02101853|581519088|FG005|Post Induction Randomization|Lack of Efficacy|0|||
161034559|NCT02101853|581519083|FG000|Post Induction Randomization|Physician Decision|0|||
161034560|NCT02101853|581519084|FG001|Post Induction Randomization|Physician Decision|43|||
161034561|NCT02101853|581519085|FG002|Post Induction Randomization|Physician Decision|23|||
161034562|NCT02101853|581519086|FG003|Post Induction Randomization|Physician Decision|14|||
161034563|NCT02101853|581519087|FG004|Post Induction Randomization|Physician Decision|14|||
161034564|NCT02101853|581519088|FG005|Post Induction Randomization|Physician Decision|0|||
161034565|NCT02101853|581519083|FG000|Post Induction Randomization|Protocol Violation|0|||
161034566|NCT02101853|581519084|FG001|Post Induction Randomization|Protocol Violation|3|||
161034567|NCT02101853|581519085|FG002|Post Induction Randomization|Protocol Violation|0|||
161034568|NCT02101853|581519086|FG003|Post Induction Randomization|Protocol Violation|0|||
161034569|NCT02101853|581519087|FG004|Post Induction Randomization|Protocol Violation|0|||
160977198|NCT01757665|581306421|FG000|Overall Study|Still on Study - Visit Pending|398|||
160977199|NCT01757665|581306422|FG001|Overall Study|Still on Study - Visit Pending|40|||
160977200|NCT01757665|581306421|FG000|Overall Study|Still on Study - Missed Visit|14|||
160977201|NCT01757665|581306422|FG001|Overall Study|Still on Study - Missed Visit|1|||
160977202|NCT01757665|581306421|FG000|Overall Study|Death|25|||
161279200|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
161279201|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
160977203|NCT01757665|581306422|FG001|Overall Study|Death|8|||
161034570|NCT02101853|581519088|FG005|Post Induction Randomization|Protocol Violation|0|||
161279202|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
161279203|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
161279204|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
161279205|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
161279206|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
161034571|NCT02101853|581519083|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
161034572|NCT02101853|581519084|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
161034573|NCT02101853|581519085|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
161034574|NCT02101853|581519086|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
161034575|NCT02101853|581519087|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
161034576|NCT02101853|581519088|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
161034577|NCT02101853|581519083|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034578|NCT02101853|581519084|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034579|NCT02101853|581519085|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034580|NCT02101853|581519086|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
161034581|NCT02101853|581519087|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034582|NCT02101853|581519088|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
161034583|NCT02101853|581519083|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161034584|NCT02101853|581519084|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
161034585|NCT02101853|581519085|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
161034586|NCT02101853|581519086|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161034587|NCT02101853|581519087|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161034588|NCT02101853|581519088|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
161034589|NCT02101853|581519083|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161034590|NCT02101853|581519084|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
161034591|NCT02101853|581519085|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161034592|NCT02101853|581519086|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161034593|NCT02101853|581519087|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161034594|NCT02101853|581519088|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
161034595|NCT02101853|581519083|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161034596|NCT02101853|581519084|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161034597|NCT02101853|581519085|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161034598|NCT02101853|581519086|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
161034599|NCT02101853|581519087|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
161034600|NCT02101853|581519088|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
161034601|NCT02101853|581519083|FG000|Blinatumomab Salvage Therapy|Death|0|||
161034602|NCT02101853|581519084|FG001|Blinatumomab Salvage Therapy|Death|0|||
161034603|NCT02101853|581519085|FG002|Blinatumomab Salvage Therapy|Death|0|||
161034604|NCT02101853|581519086|FG003|Blinatumomab Salvage Therapy|Death|0|||
161034605|NCT02101853|581519087|FG004|Blinatumomab Salvage Therapy|Death|0|||
161034606|NCT02101853|581519088|FG005|Blinatumomab Salvage Therapy|Death|2|||
161034607|NCT02101853|581519083|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161034608|NCT02101853|581519084|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161034609|NCT02101853|581519085|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161034610|NCT02101853|581519086|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161034611|NCT02101853|581519087|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
161034612|NCT02101853|581519088|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
161034613|NCT02101853|581519083|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
161034614|NCT02101853|581519084|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
161034615|NCT02101853|581519085|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
161034616|NCT02101853|581519086|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
161034617|NCT02101853|581519087|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
161034618|NCT02101853|581519088|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
161034619|NCT02101853|581519083|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161034620|NCT02101853|581519084|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161034621|NCT02101853|581519085|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161034622|NCT02101853|581519086|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161034623|NCT02101853|581519087|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
161034624|NCT02101853|581519088|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
161034625|NCT05707351|581519092|FG000|Overall Study|Withdrawal by Subject|2|||
161034626|NCT05707351|581519092|FG000|Overall Study|Reason Not Specified|1|||
161034627|NCT04174560|581519096|FG000|Overall Study|Lost to Follow-up|1|||
161034628|NCT04174560|581519097|FG001|Overall Study|Lost to Follow-up|0|||
161279207|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
161279208|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
161279209|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
161279210|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
161279211|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
161279212|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
161279213|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
161279214|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161279215|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
161279216|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
161279217|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
161279218|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161279219|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161279220|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
161279221|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
161279222|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
161279223|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161034629|NCT04174560|581519098|FG002|Overall Study|Lost to Follow-up|0|||
161034630|NCT04174560|581519099|FG003|Overall Study|Lost to Follow-up|0|||
161034631|NCT04174560|581519096|FG000|Overall Study|Withdrawal by Subject|0|||
161034632|NCT04174560|581519097|FG001|Overall Study|Withdrawal by Subject|0|||
161034633|NCT04174560|581519098|FG002|Overall Study|Withdrawal by Subject|2|||
161034634|NCT04174560|581519099|FG003|Overall Study|Withdrawal by Subject|0|||
161034635|NCT03782116|581519106|FG000|Completed Intervetion|Lost to Follow-up|11|||
161034636|NCT03782116|581519107|FG001|Completed Intervetion|Lost to Follow-up|7|||
161034637|NCT03782116|581519106|FG000|Completed Intervetion|Withdrawal by Subject|6|||
161034638|NCT03782116|581519107|FG001|Completed Intervetion|Withdrawal by Subject|5|||
161034639|NCT03782116|581519106|FG000|Included in Analysis|Protocol Violation|5|||
161034640|NCT03782116|581519107|FG001|Included in Analysis|Protocol Violation|5|||
161034641|NCT04908514|581519108|FG000|Overall Study|Lost to Follow-up|2|||
161034642|NCT04908514|581519108|FG000|Overall Study|Withdrawal by Subject|1|||
161034643|NCT02890355|581519109|FG000|Overall Study|Adverse Event|5|||
161034644|NCT02890355|581519110|FG001|Overall Study|Adverse Event|5|||
161034645|NCT02890355|581519109|FG000|Overall Study|Refusal unrelated to adverse event|5|||
161034646|NCT02890355|581519110|FG001|Overall Study|Refusal unrelated to adverse event|10|||
161034647|NCT02890355|581519109|FG000|Overall Study|Progression/relapse|46|||
161034648|NCT02890355|581519110|FG001|Overall Study|Progression/relapse|39|||
161034649|NCT02890355|581519109|FG000|Overall Study|Not protocol specified|3|||
161034650|NCT02890355|581519110|FG001|Overall Study|Not protocol specified|4|||
161034651|NCT04129450|581519112|FG000|Overall Study|Lost to Follow-up|20|||
161034652|NCT04129450|581519113|FG001|Overall Study|Lost to Follow-up|10|||
161034653|NCT04129450|581519112|FG000|Overall Study|Withdrawal by Subject|9|||
161034654|NCT04129450|581519113|FG001|Overall Study|Withdrawal by Subject|5|||
161034655|NCT04129450|581519112|FG000|Overall Study|Work Family Obligations|2|||
161034656|NCT04129450|581519113|FG001|Overall Study|Work Family Obligations|0|||
161034657|NCT04129450|581519112|FG000|Overall Study|Other|3|||
161034658|NCT04129450|581519113|FG001|Overall Study|Other|0|||
161034659|NCT00220805|581519809|FG000|Overall Study|Adverse Event|1|||
161034660|NCT00220805|581519810|FG001|Overall Study|Adverse Event|3|||
161034661|NCT00220805|581519809|FG000|Overall Study|Withdrawal by Subject|3|||
161034662|NCT00220805|581519810|FG001|Overall Study|Withdrawal by Subject|0|||
161034663|NCT00220805|581519809|FG000|Overall Study|Lack of Efficacy|1|||
161034664|NCT00220805|581519810|FG001|Overall Study|Lack of Efficacy|0|||
161034665|NCT00220805|581519809|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
161034666|NCT00220805|581519810|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
161034667|NCT02325466|581519811|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
161034668|NCT02325466|581519812|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
161034669|NCT02325466|581519813|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
161034670|NCT02325466|581519811|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
161034671|NCT02325466|581519812|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
161279224|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161279225|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161279226|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
161279227|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Death|0|||
161279228|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Death|1|||
161279229|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Death|0|||
161279230|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Death|0|||
161034672|NCT02325466|581519813|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
161034673|NCT02325466|581519811|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
161034674|NCT02325466|581519812|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
161034675|NCT02325466|581519813|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
161034676|NCT02325466|581519811|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
161279231|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Death|0|||
161279232|NCT03713632|582402386|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161279233|NCT03713632|582402387|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
161034677|NCT02325466|581519812|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
161034678|NCT02325466|581519813|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
161034679|NCT02325466|581519811|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
161034680|NCT02325466|581519812|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
161034681|NCT02325466|581519813|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
161034682|NCT02325466|581519811|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
161034683|NCT02325466|581519812|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
161034684|NCT02325466|581519813|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
161034685|NCT02325466|581519811|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
161034686|NCT02325466|581519812|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
161034687|NCT02325466|581519813|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
161034688|NCT02325466|581519811|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
161034689|NCT02325466|581519812|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
161034690|NCT02325466|581519813|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
161034691|NCT02325466|581519811|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
161034692|NCT02325466|581519812|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
161034693|NCT02325466|581519813|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
161034694|NCT01596972|581519829|FG000|Overall Study|Physician Decision|1|||
161034695|NCT01596972|581519830|FG001|Overall Study|Physician Decision|9|||
161034696|NCT01596972|581519829|FG000|Overall Study|Lost to Follow-up|0|||
161034697|NCT01596972|581519830|FG001|Overall Study|Lost to Follow-up|4|||
161034698|NCT01596972|581519829|FG000|Overall Study|Withdrawal by Subject|0|||
161034699|NCT01596972|581519830|FG001|Overall Study|Withdrawal by Subject|1|||
161034700|NCT01639131|581519831|FG000|Overall Study|Disease Progression|6|||
161034701|NCT03286114|581519835|FG000|Overall Study|Adverse Event|6|||
161034702|NCT03286114|581519835|FG000|Overall Study|Death|3|||
161034703|NCT00943917|581519847|FG000|Stage I|Adverse Event|1|||
161034704|NCT00943917|581519848|FG001|Stage I|Adverse Event|2|||
161034705|NCT00943917|581519849|FG002|Stage I|Adverse Event|2|||
161034706|NCT00943917|581519850|FG003|Stage I|Adverse Event|0|||
161034707|NCT00943917|581519851|FG004|Stage I|Adverse Event|0|||
161034708|NCT00943917|581519852|FG005|Stage I|Adverse Event|0|||
161034709|NCT00943917|581519853|FG006|Stage I|Adverse Event|0|||
161034710|NCT00943917|581519854|FG007|Stage I|Adverse Event|0|||
161034711|NCT00943917|581519855|FG008|Stage I|Adverse Event|0|||
161034712|NCT00943917|581519856|FG009|Stage I|Adverse Event|0|||
161034713|NCT00943917|581519857|FG010|Stage I|Adverse Event|0|||
161034714|NCT00943917|581519858|FG011|Stage I|Adverse Event|0|||
161034715|NCT00943917|581519859|FG012|Stage I|Adverse Event|0|||
161034716|NCT00943917|581519860|FG013|Stage I|Adverse Event|0|||
161034717|NCT00943917|581519861|FG014|Stage I|Adverse Event|0|||
161034718|NCT00943917|581519847|FG000|Stage I|Lost to Follow-up|0|||
161034719|NCT00943917|581519848|FG001|Stage I|Lost to Follow-up|0|||
161034720|NCT00943917|581519849|FG002|Stage I|Lost to Follow-up|1|||
161034721|NCT00943917|581519850|FG003|Stage I|Lost to Follow-up|0|||
161034722|NCT00943917|581519851|FG004|Stage I|Lost to Follow-up|0|||
161034723|NCT00943917|581519852|FG005|Stage I|Lost to Follow-up|0|||
161034724|NCT00943917|581519853|FG006|Stage I|Lost to Follow-up|0|||
161034725|NCT00943917|581519854|FG007|Stage I|Lost to Follow-up|0|||
161034726|NCT00943917|581519855|FG008|Stage I|Lost to Follow-up|0|||
161034727|NCT00943917|581519856|FG009|Stage I|Lost to Follow-up|0|||
161034728|NCT00943917|581519857|FG010|Stage I|Lost to Follow-up|0|||
161034729|NCT00943917|581519858|FG011|Stage I|Lost to Follow-up|0|||
161034730|NCT00943917|581519859|FG012|Stage I|Lost to Follow-up|0|||
161034731|NCT00943917|581519860|FG013|Stage I|Lost to Follow-up|0|||
161034732|NCT00943917|581519861|FG014|Stage I|Lost to Follow-up|0|||
161034733|NCT00943917|581519847|FG000|Stage I|hyperglycemia|0|||
161034734|NCT00943917|581519848|FG001|Stage I|hyperglycemia|0|||
161279234|NCT03713632|582402388|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161279235|NCT03713632|582402389|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161279236|NCT03713632|582402390|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
161034735|NCT00943917|581519849|FG002|Stage I|hyperglycemia|1|||
161034736|NCT00943917|581519850|FG003|Stage I|hyperglycemia|0|||
161034737|NCT00943917|581519851|FG004|Stage I|hyperglycemia|0|||
161034738|NCT00943917|581519852|FG005|Stage I|hyperglycemia|0|||
161034739|NCT00943917|581519853|FG006|Stage I|hyperglycemia|0|||
161034740|NCT00943917|581519854|FG007|Stage I|hyperglycemia|0|||
161034741|NCT00943917|581519855|FG008|Stage I|hyperglycemia|0|||
161034742|NCT00943917|581519856|FG009|Stage I|hyperglycemia|0|||
161034743|NCT00943917|581519857|FG010|Stage I|hyperglycemia|0|||
161034744|NCT00943917|581519858|FG011|Stage I|hyperglycemia|0|||
161034745|NCT00943917|581519859|FG012|Stage I|hyperglycemia|0|||
161034746|NCT00943917|581519860|FG013|Stage I|hyperglycemia|0|||
161034747|NCT00943917|581519861|FG014|Stage I|hyperglycemia|0|||
161034748|NCT00943917|581519847|FG000|Stage I|A1C elevation|1|||
161279237|NCT01524978|582402391|FG000|Overall Study|Other|16|||
161279238|NCT01524978|582402392|FG001|Overall Study|Other|2|||
161279239|NCT01524978|582402393|FG002|Overall Study|Other|1|||
161279240|NCT01524978|582402394|FG003|Overall Study|Other|2|||
161279241|NCT01524978|582402395|FG004|Overall Study|Other|1|||
161279242|NCT01524978|582402396|FG005|Overall Study|Other|3|||
161279243|NCT01524978|582402397|FG006|Overall Study|Other|17|||
161279244|NCT01524978|582402398|FG007|Overall Study|Other|1|||
161279245|NCT01524978|582402399|FG008|Overall Study|Other|2|||
161279246|NCT01524978|582402400|FG009|Overall Study|Other|2|||
161279247|NCT01524978|582402401|FG010|Overall Study|Other|5|||
161279248|NCT01524978|582402391|FG000|Overall Study|Withdrawal by Subject|12|||
161279249|NCT01524978|582402392|FG001|Overall Study|Withdrawal by Subject|0|||
161279250|NCT01524978|582402393|FG002|Overall Study|Withdrawal by Subject|1|||
161279251|NCT01524978|582402394|FG003|Overall Study|Withdrawal by Subject|1|||
161279252|NCT01524978|582402395|FG004|Overall Study|Withdrawal by Subject|3|||
161279253|NCT01524978|582402396|FG005|Overall Study|Withdrawal by Subject|1|||
161279254|NCT01524978|582402397|FG006|Overall Study|Withdrawal by Subject|6|||
161279255|NCT01524978|582402398|FG007|Overall Study|Withdrawal by Subject|2|||
161279256|NCT01524978|582402399|FG008|Overall Study|Withdrawal by Subject|4|||
161279257|NCT01524978|582402400|FG009|Overall Study|Withdrawal by Subject|0|||
161279258|NCT01524978|582402401|FG010|Overall Study|Withdrawal by Subject|5|||
161279259|NCT01524978|582402391|FG000|Overall Study|Lost to Follow-up|0|||
161279260|NCT01524978|582402392|FG001|Overall Study|Lost to Follow-up|0|||
161279261|NCT01524978|582402393|FG002|Overall Study|Lost to Follow-up|3|||
161279262|NCT01524978|582402394|FG003|Overall Study|Lost to Follow-up|0|||
161279263|NCT01524978|582402395|FG004|Overall Study|Lost to Follow-up|1|||
161279264|NCT01524978|582402396|FG005|Overall Study|Lost to Follow-up|1|||
161279265|NCT01524978|582402397|FG006|Overall Study|Lost to Follow-up|2|||
161279266|NCT01524978|582402398|FG007|Overall Study|Lost to Follow-up|0|||
161279267|NCT01524978|582402399|FG008|Overall Study|Lost to Follow-up|1|||
161279268|NCT01524978|582402400|FG009|Overall Study|Lost to Follow-up|1|||
161279269|NCT01524978|582402401|FG010|Overall Study|Lost to Follow-up|1|||
161279270|NCT01524978|582402391|FG000|Overall Study|Death|34|||
161279271|NCT01524978|582402392|FG001|Overall Study|Death|2|||
161279272|NCT01524978|582402393|FG002|Overall Study|Death|5|||
161279273|NCT01524978|582402394|FG003|Overall Study|Death|24|||
161279274|NCT01524978|582402395|FG004|Overall Study|Death|4|||
161279275|NCT01524978|582402396|FG005|Overall Study|Death|4|||
161279276|NCT01524978|582402397|FG006|Overall Study|Death|1|||
160977204|NCT01757665|581306421|FG000|Overall Study|Explant|1|||
160977205|NCT01757665|581306422|FG001|Overall Study|Explant|2|||
160977206|NCT01757665|581306421|FG000|Overall Study|Withdrawal by Subject|10|||
160977207|NCT01757665|581306422|FG001|Overall Study|Withdrawal by Subject|0|||
160977208|NCT01757665|581306421|FG000|Overall Study|Lost to Follow-up|1|||
160977209|NCT01757665|581306422|FG001|Overall Study|Lost to Follow-up|1|||
160977210|NCT01757665|581306421|FG000|Overall Study|Not Implanted with Device|5|||
160977211|NCT01757665|581306422|FG001|Overall Study|Not Implanted with Device|1|||
160977212|NCT00154063|581306425|FG000|Overall Study|Adverse Event|4|||
160977213|NCT00154063|581306426|FG001|Overall Study|Adverse Event|8|||
160977214|NCT00154063|581306425|FG000|Overall Study|Protocol Violation|1|||
160977215|NCT00154063|581306426|FG001|Overall Study|Protocol Violation|1|||
160977216|NCT00154063|581306425|FG000|Overall Study|Investigator or Sponsor Request|0|||
160977217|NCT00154063|581306426|FG001|Overall Study|Investigator or Sponsor Request|1|||
160977218|NCT00154063|581306425|FG000|Overall Study|Withdrawal by Subject|4|||
160977219|NCT00154063|581306426|FG001|Overall Study|Withdrawal by Subject|9|||
160977220|NCT00154063|581306425|FG000|Overall Study|Other|3|||
160977221|NCT00154063|581306426|FG001|Overall Study|Other|3|||
160977222|NCT01912222|581306427|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
160977223|NCT01912222|581306428|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
160977224|NCT01912222|581306429|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
160977225|NCT01912222|581306427|FG000|Part B: Treatment Period|Progressive disease|10|||
160977226|NCT01912222|581306428|FG001|Part B: Treatment Period|Progressive disease|12|||
160977227|NCT01912222|581306429|FG002|Part B: Treatment Period|Progressive disease|15|||
160977228|NCT01912222|581306427|FG000|Part B: Treatment Period|Adverse Event|1|||
160977229|NCT01912222|581306428|FG001|Part B: Treatment Period|Adverse Event|2|||
160977230|NCT01912222|581306429|FG002|Part B: Treatment Period|Adverse Event|3|||
160977231|NCT01912222|581306427|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
160977232|NCT01912222|581306428|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
160977233|NCT01912222|581306429|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
161279277|NCT01524978|582402398|FG007|Overall Study|Death|9|||
161279278|NCT01524978|582402399|FG008|Overall Study|Death|5|||
161279279|NCT01524978|582402400|FG009|Overall Study|Death|6|||
161279280|NCT01524978|582402401|FG010|Overall Study|Death|17|||
161279281|NCT03971474|582402402|FG000|Overall Study|Adverse Event|11|||
161279282|NCT03971474|582402403|FG001|Overall Study|Adverse Event|7|||
161279283|NCT03971474|582402402|FG000|Overall Study|Refusal unrelated to adverse event|5|||
161279284|NCT03971474|582402403|FG001|Overall Study|Refusal unrelated to adverse event|1|||
161279285|NCT03971474|582402402|FG000|Overall Study|Progression/relapse|40|||
161279286|NCT03971474|582402403|FG001|Overall Study|Progression/relapse|47|||
161279287|NCT03971474|582402402|FG000|Overall Study|Death|6|||
160977234|NCT01804673|581306430|FG000|Overall Study|Adverse Event|4|||
160977235|NCT01804673|581306430|FG000|Overall Study|Withdrawal by Subject|1|||
160977236|NCT01804673|581306430|FG000|Overall Study|Lack of Efficacy|9|||
160977237|NCT01804673|581306430|FG000|Overall Study|Change to Oral Therapy|37|||
160977238|NCT01804673|581306430|FG000|Overall Study|No Further Therapy Required|84|||
160977239|NCT01804673|581306430|FG000|Overall Study|Use of Prohibited Medication|1|||
160977240|NCT01804673|581306430|FG000|Overall Study|Other|4|||
160977241|NCT01857934|581306438|FG000|Overall Study|Relapse or progression|2|||
160977242|NCT01857934|581306438|FG000|Overall Study|Unacceptable toxicity|3|||
160977243|NCT01857934|581306438|FG000|Overall Study|Unwillingness or inability to comply|2|||
160977244|NCT01857934|581306438|FG000|Overall Study|Physician Decision|3|||
160977245|NCT00603265|581306439|FG000|Overall Study|Adverse Event|2|||
160977246|NCT00603265|581306440|FG001|Overall Study|Adverse Event|11|||
160977247|NCT00603265|581306441|FG002|Overall Study|Adverse Event|1|||
160977248|NCT00603265|581306439|FG000|Overall Study|Withdrawal by Subject|1|||
160977249|NCT00603265|581306440|FG001|Overall Study|Withdrawal by Subject|2|||
160977250|NCT00603265|581306441|FG002|Overall Study|Withdrawal by Subject|1|||
160977251|NCT00603265|581306439|FG000|Overall Study|Lack of Efficacy|3|||
160977252|NCT00603265|581306440|FG001|Overall Study|Lack of Efficacy|0|||
160977253|NCT00603265|581306441|FG002|Overall Study|Lack of Efficacy|3|||
160977254|NCT00603265|581306439|FG000|Overall Study|Lost to Follow-up|0|||
160977255|NCT00603265|581306440|FG001|Overall Study|Lost to Follow-up|1|||
160977256|NCT00603265|581306441|FG002|Overall Study|Lost to Follow-up|0|||
160977257|NCT00603265|581306439|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
160977258|NCT00603265|581306440|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
160977259|NCT00603265|581306441|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
160977260|NCT00603265|581306439|FG000|Overall Study|Participant Left Country, No Responses|0|||
160977261|NCT00603265|581306440|FG001|Overall Study|Participant Left Country, No Responses|1|||
160977262|NCT00603265|581306441|FG002|Overall Study|Participant Left Country, No Responses|0|||
160977263|NCT00603265|581306439|FG000|Overall Study|Protocol Violation|1|||
160977264|NCT00603265|581306440|FG001|Overall Study|Protocol Violation|0|||
160977265|NCT00603265|581306441|FG002|Overall Study|Protocol Violation|0|||
160977266|NCT01375959|581306442|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
160977267|NCT01375959|581306443|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
160977268|NCT01375959|581306442|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
160977269|NCT01375959|581306443|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
160977270|NCT01375959|581306442|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
160977271|NCT01375959|581306443|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
160977272|NCT04012814|581306450|FG000|Overall Study|Lost to Follow-up|4|||
160977273|NCT04012814|581306450|FG000|Overall Study|Withdrawal by Subject|2|||
160977274|NCT04012814|581306450|FG000|Overall Study|Protocol Violation|1|||
160977275|NCT04012814|581306450|FG000|Overall Study|Adverse Event|1|||
160977276|NCT04789577|581306451|FG000|Overall Study|Withdrawal by Subject|1|||
160977277|NCT04789577|581306452|FG001|Overall Study|Withdrawal by Subject|1|||
160977278|NCT04789577|581306453|FG002|Overall Study|Withdrawal by Subject|1|||
160977279|NCT04789577|581306454|FG003|Overall Study|Withdrawal by Subject|3|||
160977280|NCT04789577|581306455|FG004|Overall Study|Withdrawal by Subject|1|||
160977281|NCT04789577|581306456|FG005|Overall Study|Withdrawal by Subject|7|||
160977282|NCT04789577|581306457|FG006|Overall Study|Withdrawal by Subject|1|||
160977283|NCT04789577|581306451|FG000|Overall Study|Lost to Follow-up|7|||
160977284|NCT04789577|581306452|FG001|Overall Study|Lost to Follow-up|12|||
160977285|NCT04789577|581306453|FG002|Overall Study|Lost to Follow-up|7|||
160977286|NCT04789577|581306454|FG003|Overall Study|Lost to Follow-up|10|||
160977287|NCT04789577|581306455|FG004|Overall Study|Lost to Follow-up|8|||
160977288|NCT04789577|581306456|FG005|Overall Study|Lost to Follow-up|6|||
160977289|NCT04789577|581306457|FG006|Overall Study|Lost to Follow-up|10|||
160977290|NCT04789577|581306451|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
160977291|NCT04789577|581306452|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
160977292|NCT04789577|581306453|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
160977293|NCT04789577|581306454|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
160977294|NCT04789577|581306455|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
160977295|NCT04789577|581306456|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
160977296|NCT04789577|581306457|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
160977297|NCT04789577|581306451|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
160977298|NCT04789577|581306452|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
160977299|NCT04789577|581306453|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
160977300|NCT04789577|581306454|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
160977301|NCT04789577|581306455|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
160977302|NCT04789577|581306456|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
160977303|NCT04789577|581306457|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
160977304|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
161279288|NCT03971474|582402403|FG001|Overall Study|Death|3|||
161279289|NCT03971474|582402402|FG000|Overall Study|Other - not protocol specified|5|||
161279290|NCT03971474|582402403|FG001|Overall Study|Other - not protocol specified|4|||
161279291|NCT03971474|582402402|FG000|Overall Study|On treatment|0|||
161279292|NCT03971474|582402403|FG001|Overall Study|On treatment|7|||
161279293|NCT01023035|582402405|FG000|Treatment Period|Adverse Event|27|||
161279294|NCT01023035|582402406|FG001|Treatment Period|Adverse Event|32|||
161279295|NCT01023035|582402407|FG002|Treatment Period|Adverse Event|50|||
161279296|NCT01023035|582402405|FG000|Treatment Period|Non-Medical Reasons|19|||
161279297|NCT01023035|582402406|FG001|Treatment Period|Non-Medical Reasons|22|||
161279298|NCT01023035|582402407|FG002|Treatment Period|Non-Medical Reasons|44|||
161279299|NCT01023035|582402405|FG000|Treatment Period|Treatment Failure|26|||
161279300|NCT01023035|582402406|FG001|Treatment Period|Treatment Failure|31|||
161279301|NCT01023035|582402407|FG002|Treatment Period|Treatment Failure|24|||
161279302|NCT01023035|582402405|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
161279303|NCT01023035|582402406|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
161279304|NCT01023035|582402407|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
161279305|NCT01023035|582402405|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
161279306|NCT01023035|582402406|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
161279307|NCT01023035|582402407|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
161279308|NCT01937871|582402409|FG000|Overall Study|Adverse Event|6|||
161279309|NCT01937871|582402410|FG001|Overall Study|Adverse Event|6|||
161279310|NCT01937871|582402411|FG002|Overall Study|Adverse Event|2|||
161279311|NCT01937871|582402409|FG000|Overall Study|Lost to Follow-up|8|||
161279312|NCT01937871|582402410|FG001|Overall Study|Lost to Follow-up|2|||
161279313|NCT01937871|582402411|FG002|Overall Study|Lost to Follow-up|4|||
161034749|NCT00943917|581519848|FG001|Stage I|A1C elevation|0|||
161034750|NCT00943917|581519849|FG002|Stage I|A1C elevation|0|||
161034751|NCT00943917|581519850|FG003|Stage I|A1C elevation|0|||
161034752|NCT00943917|581519851|FG004|Stage I|A1C elevation|0|||
161034753|NCT00943917|581519852|FG005|Stage I|A1C elevation|0|||
161034754|NCT00943917|581519853|FG006|Stage I|A1C elevation|0|||
161034755|NCT00943917|581519854|FG007|Stage I|A1C elevation|0|||
161034756|NCT00943917|581519855|FG008|Stage I|A1C elevation|0|||
161034757|NCT00943917|581519856|FG009|Stage I|A1C elevation|0|||
161034758|NCT00943917|581519857|FG010|Stage I|A1C elevation|0|||
161034759|NCT00943917|581519858|FG011|Stage I|A1C elevation|0|||
161034760|NCT00943917|581519859|FG012|Stage I|A1C elevation|0|||
161034761|NCT00943917|581519860|FG013|Stage I|A1C elevation|0|||
161034762|NCT00943917|581519861|FG014|Stage I|A1C elevation|0|||
161034763|NCT00943917|581519847|FG000|Stage I|Withdrawal by Subject|2|||
161034764|NCT00943917|581519848|FG001|Stage I|Withdrawal by Subject|1|||
161034765|NCT00943917|581519849|FG002|Stage I|Withdrawal by Subject|2|||
161034766|NCT00943917|581519850|FG003|Stage I|Withdrawal by Subject|0|||
161034767|NCT00943917|581519851|FG004|Stage I|Withdrawal by Subject|0|||
161034768|NCT00943917|581519852|FG005|Stage I|Withdrawal by Subject|0|||
161034769|NCT00943917|581519853|FG006|Stage I|Withdrawal by Subject|0|||
161034770|NCT00943917|581519854|FG007|Stage I|Withdrawal by Subject|0|||
161034771|NCT00943917|581519855|FG008|Stage I|Withdrawal by Subject|0|||
161034772|NCT00943917|581519856|FG009|Stage I|Withdrawal by Subject|0|||
161034773|NCT00943917|581519857|FG010|Stage I|Withdrawal by Subject|0|||
161034774|NCT00943917|581519858|FG011|Stage I|Withdrawal by Subject|0|||
161034775|NCT00943917|581519859|FG012|Stage I|Withdrawal by Subject|0|||
161034776|NCT00943917|581519860|FG013|Stage I|Withdrawal by Subject|0|||
161034777|NCT00943917|581519861|FG014|Stage I|Withdrawal by Subject|0|||
161034778|NCT00943917|581519847|FG000|Stage II|Adverse Event|0|||
161034779|NCT00943917|581519848|FG001|Stage II|Adverse Event|0|||
161034780|NCT00943917|581519849|FG002|Stage II|Adverse Event|0|||
161279314|NCT01937871|582402409|FG000|Overall Study|Withdrawal by Subject|9|||
161279315|NCT01937871|582402410|FG001|Overall Study|Withdrawal by Subject|6|||
161279316|NCT01937871|582402411|FG002|Overall Study|Withdrawal by Subject|4|||
161279317|NCT01937871|582402409|FG000|Overall Study|Physician Decision|0|||
161279318|NCT01937871|582402410|FG001|Overall Study|Physician Decision|1|||
161034781|NCT00943917|581519850|FG003|Stage II|Adverse Event|0|||
161034782|NCT00943917|581519851|FG004|Stage II|Adverse Event|0|||
161034783|NCT00943917|581519852|FG005|Stage II|Adverse Event|1|||
161034784|NCT00943917|581519853|FG006|Stage II|Adverse Event|3|||
161034785|NCT00943917|581519854|FG007|Stage II|Adverse Event|0|||
161034786|NCT00943917|581519855|FG008|Stage II|Adverse Event|1|||
161034787|NCT00943917|581519856|FG009|Stage II|Adverse Event|0|||
161034788|NCT00943917|581519857|FG010|Stage II|Adverse Event|0|||
161034789|NCT00943917|581519858|FG011|Stage II|Adverse Event|0|||
161034790|NCT00943917|581519859|FG012|Stage II|Adverse Event|0|||
161034791|NCT00943917|581519860|FG013|Stage II|Adverse Event|0|||
161034792|NCT00943917|581519861|FG014|Stage II|Adverse Event|0|||
161279319|NCT01937871|582402411|FG002|Overall Study|Physician Decision|0|||
161279320|NCT01937871|582402409|FG000|Overall Study|Entry Criteria Not Met|1|||
161279321|NCT01937871|582402410|FG001|Overall Study|Entry Criteria Not Met|2|||
161279322|NCT01937871|582402411|FG002|Overall Study|Entry Criteria Not Met|1|||
161279323|NCT01482312|582402412|FG000|Period 1, 90 Minutes of Wear|Other|1|||
161279324|NCT01482312|582402413|FG001|Period 1, 90 Minutes of Wear|Other|0|||
161034793|NCT00943917|581519847|FG000|Stage II|Withdrawal by Subject|0|||
161034794|NCT00943917|581519848|FG001|Stage II|Withdrawal by Subject|0|||
161034795|NCT00943917|581519849|FG002|Stage II|Withdrawal by Subject|0|||
161034796|NCT00943917|581519850|FG003|Stage II|Withdrawal by Subject|0|||
161034797|NCT00943917|581519851|FG004|Stage II|Withdrawal by Subject|0|||
161034798|NCT00943917|581519852|FG005|Stage II|Withdrawal by Subject|1|||
161034799|NCT00943917|581519853|FG006|Stage II|Withdrawal by Subject|0|||
161034800|NCT00943917|581519854|FG007|Stage II|Withdrawal by Subject|0|||
161034801|NCT00943917|581519855|FG008|Stage II|Withdrawal by Subject|0|||
161034802|NCT00943917|581519856|FG009|Stage II|Withdrawal by Subject|0|||
161034803|NCT00943917|581519857|FG010|Stage II|Withdrawal by Subject|0|||
161034804|NCT00943917|581519858|FG011|Stage II|Withdrawal by Subject|0|||
161034805|NCT00943917|581519859|FG012|Stage II|Withdrawal by Subject|0|||
161034806|NCT00943917|581519860|FG013|Stage II|Withdrawal by Subject|0|||
161034807|NCT00943917|581519861|FG014|Stage II|Withdrawal by Subject|0|||
161034808|NCT00943917|581519847|FG000|Stage II|Pregnancy|0|||
161034809|NCT00943917|581519848|FG001|Stage II|Pregnancy|0|||
161034810|NCT00943917|581519849|FG002|Stage II|Pregnancy|0|||
161034811|NCT00943917|581519850|FG003|Stage II|Pregnancy|0|||
161034812|NCT00943917|581519851|FG004|Stage II|Pregnancy|0|||
161034813|NCT00943917|581519852|FG005|Stage II|Pregnancy|1|||
161034814|NCT00943917|581519853|FG006|Stage II|Pregnancy|0|||
161034815|NCT00943917|581519854|FG007|Stage II|Pregnancy|0|||
161034816|NCT00943917|581519855|FG008|Stage II|Pregnancy|0|||
161034817|NCT00943917|581519856|FG009|Stage II|Pregnancy|0|||
161034818|NCT00943917|581519857|FG010|Stage II|Pregnancy|0|||
161034819|NCT00943917|581519858|FG011|Stage II|Pregnancy|0|||
161034820|NCT00943917|581519859|FG012|Stage II|Pregnancy|0|||
161034821|NCT00943917|581519860|FG013|Stage II|Pregnancy|0|||
161034822|NCT00943917|581519861|FG014|Stage II|Pregnancy|0|||
161034823|NCT00943917|581519847|FG000|Stage II Continuation|Adverse Event|0|||
161034824|NCT00943917|581519848|FG001|Stage II Continuation|Adverse Event|0|||
161034825|NCT00943917|581519849|FG002|Stage II Continuation|Adverse Event|0|||
161034826|NCT00943917|581519850|FG003|Stage II Continuation|Adverse Event|0|||
161034827|NCT00943917|581519851|FG004|Stage II Continuation|Adverse Event|0|||
161034828|NCT00943917|581519852|FG005|Stage II Continuation|Adverse Event|0|||
161034829|NCT00943917|581519853|FG006|Stage II Continuation|Adverse Event|0|||
161034830|NCT00943917|581519854|FG007|Stage II Continuation|Adverse Event|0|||
161034831|NCT00943917|581519855|FG008|Stage II Continuation|Adverse Event|0|||
161034832|NCT00943917|581519856|FG009|Stage II Continuation|Adverse Event|0|||
161034833|NCT00943917|581519857|FG010|Stage II Continuation|Adverse Event|0|||
161034834|NCT00943917|581519858|FG011|Stage II Continuation|Adverse Event|1|||
161034835|NCT00943917|581519859|FG012|Stage II Continuation|Adverse Event|2|||
161034836|NCT00943917|581519860|FG013|Stage II Continuation|Adverse Event|1|||
161034837|NCT00943917|581519861|FG014|Stage II Continuation|Adverse Event|1|||
161034838|NCT00943917|581519847|FG000|Stage II Continuation|Withdrawal by Subject|0|||
161034839|NCT00943917|581519848|FG001|Stage II Continuation|Withdrawal by Subject|0|||
161034840|NCT00943917|581519849|FG002|Stage II Continuation|Withdrawal by Subject|0|||
161034841|NCT00943917|581519850|FG003|Stage II Continuation|Withdrawal by Subject|0|||
161034842|NCT00943917|581519851|FG004|Stage II Continuation|Withdrawal by Subject|0|||
161034843|NCT00943917|581519852|FG005|Stage II Continuation|Withdrawal by Subject|0|||
161034844|NCT00943917|581519853|FG006|Stage II Continuation|Withdrawal by Subject|0|||
161034845|NCT00943917|581519854|FG007|Stage II Continuation|Withdrawal by Subject|0|||
161034846|NCT00943917|581519855|FG008|Stage II Continuation|Withdrawal by Subject|0|||
161034847|NCT00943917|581519856|FG009|Stage II Continuation|Withdrawal by Subject|0|||
161034848|NCT00943917|581519857|FG010|Stage II Continuation|Withdrawal by Subject|0|||
161034849|NCT00943917|581519858|FG011|Stage II Continuation|Withdrawal by Subject|0|||
161034850|NCT00943917|581519859|FG012|Stage II Continuation|Withdrawal by Subject|0|||
161034851|NCT00943917|581519860|FG013|Stage II Continuation|Withdrawal by Subject|1|||
161034852|NCT00943917|581519861|FG014|Stage II Continuation|Withdrawal by Subject|3|||
161034853|NCT00943917|581519847|FG000|Stage II Continuation|Protocol Violation|0|||
161034854|NCT00943917|581519848|FG001|Stage II Continuation|Protocol Violation|0|||
161279325|NCT01482312|582402414|FG002|Period 1, 90 Minutes of Wear|Other|0|||
161279326|NCT01482312|582402412|FG000|Period 2, 90 Minutes of Wear|Other|1|||
161034855|NCT00943917|581519849|FG002|Stage II Continuation|Protocol Violation|0|||
161034856|NCT00943917|581519850|FG003|Stage II Continuation|Protocol Violation|0|||
161034857|NCT00943917|581519851|FG004|Stage II Continuation|Protocol Violation|0|||
161034858|NCT00943917|581519852|FG005|Stage II Continuation|Protocol Violation|0|||
161034859|NCT00943917|581519853|FG006|Stage II Continuation|Protocol Violation|0|||
161034860|NCT00943917|581519854|FG007|Stage II Continuation|Protocol Violation|0|||
161034861|NCT00943917|581519855|FG008|Stage II Continuation|Protocol Violation|0|||
161034862|NCT00943917|581519856|FG009|Stage II Continuation|Protocol Violation|1|||
161034863|NCT00943917|581519857|FG010|Stage II Continuation|Protocol Violation|0|||
161034864|NCT00943917|581519858|FG011|Stage II Continuation|Protocol Violation|1|||
161034865|NCT00943917|581519859|FG012|Stage II Continuation|Protocol Violation|0|||
161034866|NCT00943917|581519860|FG013|Stage II Continuation|Protocol Violation|0|||
161034867|NCT00943917|581519861|FG014|Stage II Continuation|Protocol Violation|0|||
161034868|NCT00943917|581519847|FG000|Stage II Continuation|hypoglycemia|0|||
161034869|NCT00943917|581519848|FG001|Stage II Continuation|hypoglycemia|0|||
161034870|NCT00943917|581519849|FG002|Stage II Continuation|hypoglycemia|0|||
161034871|NCT00943917|581519850|FG003|Stage II Continuation|hypoglycemia|0|||
161034872|NCT00943917|581519851|FG004|Stage II Continuation|hypoglycemia|0|||
161034873|NCT00943917|581519852|FG005|Stage II Continuation|hypoglycemia|0|||
161034874|NCT00943917|581519853|FG006|Stage II Continuation|hypoglycemia|0|||
161034875|NCT00943917|581519854|FG007|Stage II Continuation|hypoglycemia|0|||
161034876|NCT00943917|581519855|FG008|Stage II Continuation|hypoglycemia|0|||
161034877|NCT00943917|581519856|FG009|Stage II Continuation|hypoglycemia|0|||
161034878|NCT00943917|581519857|FG010|Stage II Continuation|hypoglycemia|0|||
161034879|NCT00943917|581519858|FG011|Stage II Continuation|hypoglycemia|0|||
161034880|NCT00943917|581519859|FG012|Stage II Continuation|hypoglycemia|1|||
161034881|NCT00943917|581519860|FG013|Stage II Continuation|hypoglycemia|0|||
161034882|NCT00943917|581519861|FG014|Stage II Continuation|hypoglycemia|0|||
161034883|NCT00943917|581519847|FG000|Stage II Continuation|A1C elevation|0|||
161034884|NCT00943917|581519848|FG001|Stage II Continuation|A1C elevation|0|||
161034885|NCT00943917|581519849|FG002|Stage II Continuation|A1C elevation|0|||
161034886|NCT00943917|581519850|FG003|Stage II Continuation|A1C elevation|0|||
161034887|NCT00943917|581519851|FG004|Stage II Continuation|A1C elevation|0|||
161034888|NCT00943917|581519852|FG005|Stage II Continuation|A1C elevation|0|||
161034889|NCT00943917|581519853|FG006|Stage II Continuation|A1C elevation|0|||
161034890|NCT00943917|581519854|FG007|Stage II Continuation|A1C elevation|0|||
161034891|NCT00943917|581519855|FG008|Stage II Continuation|A1C elevation|0|||
161034892|NCT00943917|581519856|FG009|Stage II Continuation|A1C elevation|0|||
161034893|NCT00943917|581519857|FG010|Stage II Continuation|A1C elevation|0|||
161034894|NCT00943917|581519858|FG011|Stage II Continuation|A1C elevation|0|||
161034895|NCT00943917|581519859|FG012|Stage II Continuation|A1C elevation|0|||
161034896|NCT00943917|581519860|FG013|Stage II Continuation|A1C elevation|1|||
161034897|NCT00943917|581519861|FG014|Stage II Continuation|A1C elevation|0|||
161034898|NCT01171976|581519862|FG000|Overall Study|Protocol Violation|0|||
161034899|NCT01171976|581519863|FG001|Overall Study|Protocol Violation|0|||
161034900|NCT01171976|581519864|FG002|Overall Study|Protocol Violation|1|||
161034901|NCT01171976|581519862|FG000|Overall Study|Death|2|||
161034902|NCT01171976|581519863|FG001|Overall Study|Death|4|||
161034903|NCT01171976|581519864|FG002|Overall Study|Death|1|||
161034904|NCT01171976|581519862|FG000|Overall Study|Lost to Follow-up|4|||
161034905|NCT01171976|581519863|FG001|Overall Study|Lost to Follow-up|0|||
161034906|NCT01171976|581519864|FG002|Overall Study|Lost to Follow-up|2|||
161034907|NCT01171976|581519862|FG000|Overall Study|Withdrawal by Subject|1|||
161034908|NCT01171976|581519863|FG001|Overall Study|Withdrawal by Subject|5|||
161034909|NCT01171976|581519864|FG002|Overall Study|Withdrawal by Subject|6|||
161034910|NCT01171976|581519862|FG000|Overall Study|Abnormal test result|1|||
161034911|NCT01171976|581519863|FG001|Overall Study|Abnormal test result|0|||
161034912|NCT01171976|581519864|FG002|Overall Study|Abnormal test result|0|||
161034913|NCT01171976|581519862|FG000|Overall Study|Adverse Event|6|||
161034914|NCT01171976|581519863|FG001|Overall Study|Adverse Event|2|||
160977305|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
160977306|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
160977307|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
160977308|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
160977309|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
160977310|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160977311|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
160977312|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
160977313|NCT02441946|581306458|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
160977314|NCT02441946|581306459|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
160977315|NCT02441946|581306460|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
160977316|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
160977317|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
161034915|NCT01171976|581519864|FG002|Overall Study|Adverse Event|5|||
161034916|NCT00003222|581519867|FG000|Overall Study|Physician Decision|0|||
161034917|NCT00003222|581519868|FG001|Overall Study|Physician Decision|1|||
161034918|NCT01313559|581519875|FG000|Overall Study|Withdrawal by Subject|1|||
161034919|NCT01313559|581519876|FG001|Overall Study|Withdrawal by Subject|2|||
161034920|NCT01313559|581519875|FG000|Overall Study|Disease progression|1|||
161034921|NCT01313559|581519876|FG001|Overall Study|Disease progression|0|||
161034922|NCT01313559|581519875|FG000|Overall Study|Rising PSA|2|||
161034923|NCT01313559|581519876|FG001|Overall Study|Rising PSA|0|||
161034924|NCT03872466|581519877|FG000|Overall Study|Withdrawal by Subject|1|||
161034925|NCT03872466|581519878|FG001|Overall Study|Withdrawal by Subject|0|||
161034926|NCT03872466|581519877|FG000|Overall Study|Physician Decision|2|||
161034927|NCT03872466|581519878|FG001|Overall Study|Physician Decision|0|||
161034928|NCT01778686|581519879|FG000|Overall Study|Adverse Event|0|||
161034929|NCT01778686|581519880|FG001|Overall Study|Adverse Event|0|||
160977318|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
161034930|NCT01778686|581519881|FG002|Overall Study|Adverse Event|1|||
161279327|NCT01482312|582402413|FG001|Period 2, 90 Minutes of Wear|Other|0|||
161279328|NCT01482312|582402414|FG002|Period 2, 90 Minutes of Wear|Other|0|||
161279329|NCT01295320|582402415|FG000|Overall Study|Adverse Event|2|||
161279330|NCT01295320|582402415|FG000|Overall Study|Lost to Follow-up|4|||
161279331|NCT01295320|582402415|FG000|Overall Study|Withdrawal by Subject|2|||
161279332|NCT01295320|582402415|FG000|Overall Study|Subject was bedridden|1|||
161279333|NCT01295320|582402415|FG000|Overall Study|Unable to travel|1|||
161279334|NCT00462904|582402416|FG000|Overall Study|Lost to Follow-up|1|||
161279335|NCT02652949|582402417|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
161279336|NCT02652949|582402417|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
161279337|NCT02652949|582402417|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
161279338|NCT02652949|582402417|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161279339|NCT02652949|582402417|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161279340|NCT02652949|582402417|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161279341|NCT02652949|582402417|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161279342|NCT02652949|582402417|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
161279343|NCT02652949|582402417|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
161279344|NCT02652949|582402417|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
161279345|NCT02652949|582402417|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
161279346|NCT02652949|582402417|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161279347|NCT02652949|582402417|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
160977319|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
160977320|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
160977321|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
160977322|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
160977323|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
160977324|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
160977325|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
160977326|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
160977327|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
160977328|NCT02441946|581306458|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
160977329|NCT02441946|581306459|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
160977330|NCT02441946|581306460|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
160977331|NCT02441946|581306458|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
160977332|NCT02441946|581306459|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
160977333|NCT02441946|581306460|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
160977334|NCT02441946|581306458|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
160977335|NCT02441946|581306459|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160977336|NCT02441946|581306460|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
160977337|NCT04175912|581306467|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
160977338|NCT04175912|581306468|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
160977339|NCT04175912|581306467|FG000|Overall Study|Adverse Event|0|||
160977340|NCT04175912|581306468|FG001|Overall Study|Adverse Event|3|||
160977341|NCT04175912|581306467|FG000|Overall Study|Never started treatment|3|||
160977342|NCT04175912|581306468|FG001|Overall Study|Never started treatment|3|||
160977343|NCT04175912|581306467|FG000|Overall Study|Death|0|||
160977344|NCT04175912|581306468|FG001|Overall Study|Death|1|||
160977345|NCT04654468|581306469|FG000|Overall Study|Death|1|||
160977346|NCT04654468|581306469|FG000|Overall Study|Ongoing in the Study|50|||
160977347|NCT01155661|581306470|FG000|Overall Study|Adverse Event|101|||
160977348|NCT01155661|581306470|FG000|Overall Study|Death|1|||
160977349|NCT01155661|581306470|FG000|Overall Study|Lack of Efficacy|32|||
160977350|NCT01155661|581306470|FG000|Overall Study|Lost to Follow-up|22|||
160977351|NCT01155661|581306470|FG000|Overall Study|Physician Decision|3|||
160977352|NCT01155661|581306470|FG000|Overall Study|Protocol Violation|35|||
160977353|NCT01155661|581306470|FG000|Overall Study|Withdrawal by Subject|73|||
160977354|NCT01155661|581306470|FG000|Overall Study|Sponsor Decision|13|||
160977355|NCT05064735|581306480|FG000|Overall Study|Withdrawal by Subject|7|||
160977356|NCT05064735|581306481|FG001|Overall Study|Withdrawal by Subject|8|||
160977357|NCT05064735|581306480|FG000|Overall Study|Lost to Follow-up|7|||
160977358|NCT05064735|581306481|FG001|Overall Study|Lost to Follow-up|2|||
160977359|NCT05064735|581306480|FG000|Overall Study|Physician Decision|2|||
160977360|NCT05064735|581306481|FG001|Overall Study|Physician Decision|1|||
160977361|NCT05064735|581306480|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
160977362|NCT05064735|581306481|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
160977363|NCT05064735|581306480|FG000|Overall Study|Site Closure|7|||
160977364|NCT05064735|581306481|FG001|Overall Study|Site Closure|2|||
160977365|NCT04844970|581306485|FG000|Overall Study|Adverse Event|0|||
160977366|NCT04844970|581306486|FG001|Overall Study|Adverse Event|1|||
160977367|NCT04844970|581306485|FG000|Overall Study|Withdrawal by Subject|2|||
160977368|NCT04844970|581306486|FG001|Overall Study|Withdrawal by Subject|0|||
160977369|NCT00447954|581306487|FG000|Overall Study|Adverse Event|0|||
160977370|NCT00447954|581306488|FG001|Overall Study|Adverse Event|2|||
161034931|NCT04012567|581519882|FG000|Overall Study|Lost to Follow-up|0|||
161034932|NCT04012567|581519883|FG001|Overall Study|Lost to Follow-up|1|||
161034933|NCT04012567|581519882|FG000|Overall Study|Withdrawal by Subject|1|||
161034934|NCT04012567|581519883|FG001|Overall Study|Withdrawal by Subject|0|||
161034935|NCT04018495|581519885|FG000|Overall Study|Physician Decision|1|||
161034936|NCT05934292|581519894|FG000|Overall Study|Lost to Follow-up|0|||
161034937|NCT05934292|581519895|FG001|Overall Study|Lost to Follow-up|0|||
161034938|NCT05934292|581519896|FG002|Overall Study|Lost to Follow-up|1|||
161034939|NCT05934292|581519897|FG003|Overall Study|Lost to Follow-up|0|||
161034940|NCT05714059|581519900|FG000|Overall Study|Withdrawal by Subject|2|||
161034941|NCT05714059|581519901|FG001|Overall Study|Withdrawal by Subject|2|||
161034942|NCT05714059|581519900|FG000|Overall Study|Adverse Event|0|||
161034943|NCT05714059|581519901|FG001|Overall Study|Adverse Event|1|||
161034944|NCT05714059|581519900|FG000|Overall Study|Lost to Follow-up|0|||
161034945|NCT05714059|581519901|FG001|Overall Study|Lost to Follow-up|1|||
161034946|NCT05714059|581519900|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
161034947|NCT05714059|581519901|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
161034948|NCT05714059|581519900|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
161034949|NCT05714059|581519901|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
161034950|NCT04899674|581519902|FG000|Test|Adverse Event|1|||
161034951|NCT04974047|581520704|FG000|Overall Study|Sponsor Ended Study|20|||
161034952|NCT04974047|581520705|FG001|Overall Study|Sponsor Ended Study|22|||
161034953|NCT04974047|581520704|FG000|Overall Study|Death|8|||
161034954|NCT04974047|581520705|FG001|Overall Study|Death|17|||
161034955|NCT04974047|581520704|FG000|Overall Study|Lost to Follow-up|2|||
161034956|NCT04974047|581520705|FG001|Overall Study|Lost to Follow-up|0|||
161034957|NCT04974047|581520704|FG000|Overall Study|Withdrawal by Subject|0|||
161034958|NCT04974047|581520705|FG001|Overall Study|Withdrawal by Subject|1|||
161034959|NCT00655499|581520706|FG000|Overall Study|not eligible|4|||
161034960|NCT01964300|581520708|FG000|Overall Study|Ineligible after enrollment|0|||
161034961|NCT01964300|581520709|FG001|Overall Study|Ineligible after enrollment|1|||
161034962|NCT01964300|581520708|FG000|Overall Study|Adverse Event|1|||
161034963|NCT01964300|581520709|FG001|Overall Study|Adverse Event|1|||
161034964|NCT01964300|581520708|FG000|Overall Study|Lack of Efficacy|3|||
161034965|NCT01964300|581520709|FG001|Overall Study|Lack of Efficacy|5|||
161034966|NCT01964300|581520708|FG000|Overall Study|Withdrawal by Subject|0|||
161034967|NCT01964300|581520709|FG001|Overall Study|Withdrawal by Subject|1|||
161034968|NCT01964300|581520708|FG000|Overall Study|To receive alternative therapy|1|||
161034969|NCT01964300|581520709|FG001|Overall Study|To receive alternative therapy|2|||
161034970|NCT01964300|581520708|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
161034971|NCT01964300|581520709|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
161034972|NCT01964300|581520708|FG000|Overall Study|Weight criteria not met|0|||
161034973|NCT01964300|581520709|FG001|Overall Study|Weight criteria not met|1|||
161034974|NCT01637402|581520710|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
161034975|NCT01637402|581520711|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
161034976|NCT01637402|581520710|FG000|Standard Dose Regimen|Adverse Event|1|||
161034977|NCT01637402|581520711|FG001|Standard Dose Regimen|Adverse Event|0|||
161034978|NCT01637402|581520710|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
161034979|NCT01637402|581520711|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
161034980|NCT01637402|581520710|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
161034981|NCT01637402|581520711|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
161034982|NCT01637402|581520710|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
161034983|NCT01637402|581520711|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
161034984|NCT01637402|581520710|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
161034985|NCT01637402|581520711|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
161034986|NCT02285270|581520712|FG000|Overall Study|Lost to Follow-up|1|||
161034987|NCT02285270|581520712|FG000|Overall Study|Physician Decision|3|||
161034988|NCT02285270|581520712|FG000|Overall Study|Determined to be ineligible|1|||
161034989|NCT02111096|581520713|FG000|Overall Study|Adverse Event|4|||
161034990|NCT02111096|581520714|FG001|Overall Study|Adverse Event|1|||
161034991|NCT02111096|581520715|FG002|Overall Study|Adverse Event|2|||
161034992|NCT02111096|581520713|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161034993|NCT02111096|581520714|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161034994|NCT02111096|581520715|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161034995|NCT02111096|581520713|FG000|Overall Study|Lost to Follow Up|1|||
161279348|NCT02652949|582402417|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161034996|NCT02111096|581520714|FG001|Overall Study|Lost to Follow Up|1|||
161034997|NCT02111096|581520715|FG002|Overall Study|Lost to Follow Up|1|||
161034998|NCT02111096|581520713|FG000|Overall Study|Physician Decision|0|||
161034999|NCT02111096|581520714|FG001|Overall Study|Physician Decision|1|||
161035000|NCT02111096|581520715|FG002|Overall Study|Physician Decision|0|||
161035001|NCT02111096|581520713|FG000|Overall Study|Protocol Violation|1|||
161035002|NCT02111096|581520714|FG001|Overall Study|Protocol Violation|0|||
161035003|NCT02111096|581520715|FG002|Overall Study|Protocol Violation|1|||
161035004|NCT02111096|581520713|FG000|Overall Study|Terminated by Sponsor|53|||
161035005|NCT02111096|581520714|FG001|Overall Study|Terminated by Sponsor|35|||
161279349|NCT02652949|582402417|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161279350|NCT02652949|582402417|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
161279351|NCT02652949|582402417|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161279352|NCT02125877|582402418|FG000|Overall Study|Physician Decision|1|||
161279353|NCT02125877|582402419|FG001|Overall Study|Physician Decision|0|||
161279354|NCT02125877|582402418|FG000|Overall Study|Death|0|||
161279355|NCT02125877|582402419|FG001|Overall Study|Death|1|||
161279356|NCT02125877|582402418|FG000|Overall Study|Administrative problems|0|||
161279357|NCT02125877|582402419|FG001|Overall Study|Administrative problems|1|||
161279358|NCT02125877|582402418|FG000|Overall Study|Participant/guardian decision|0|||
161279359|NCT02125877|582402419|FG001|Overall Study|Participant/guardian decision|2|||
161279360|NCT02125877|582402418|FG000|Overall Study|Withdrawal by Subject|2|||
161279361|NCT02125877|582402419|FG001|Overall Study|Withdrawal by Subject|1|||
161279362|NCT02125877|582402418|FG000|Overall Study|Protocol deviation|4|||
161279363|NCT02125877|582402419|FG001|Overall Study|Protocol deviation|1|||
161279364|NCT02125877|582402418|FG000|Overall Study|Adverse Event|6|||
161279365|NCT02125877|582402419|FG001|Overall Study|Adverse Event|4|||
161279366|NCT01973595|582402420|FG000|Washout|Withdrawal by Subject|1|||
161279367|NCT01973595|582402421|FG001|Washout|Withdrawal by Subject|0|||
161279368|NCT01973595|582402422|FG002|Washout|Withdrawal by Subject|1|||
161279369|NCT01973595|582402423|FG003|Washout|Withdrawal by Subject|0|||
161279370|NCT01141205|582402424|FG000|Overall Study|Physician Decision|1|||
161279371|NCT01141205|582402425|FG001|Overall Study|Physician Decision|1|||
161279372|NCT01141205|582402424|FG000|Overall Study|Lost to Follow-up|1|||
161279373|NCT01141205|582402425|FG001|Overall Study|Lost to Follow-up|0|||
161279374|NCT01141205|582402424|FG000|Overall Study|Withdrawal by Subject|1|||
161279375|NCT01141205|582402425|FG001|Overall Study|Withdrawal by Subject|1|||
161279376|NCT01822366|582402426|FG000|Overall Study|Lost to Follow-up|5|||
161279377|NCT01822366|582402427|FG001|Overall Study|Lost to Follow-up|1|||
161279378|NCT01822366|582402428|FG002|Overall Study|Lost to Follow-up|5|||
161279379|NCT01822366|582402429|FG003|Overall Study|Lost to Follow-up|1|||
161279380|NCT01822366|582402426|FG000|Overall Study|Withdrawal by Subject|0|||
161279381|NCT01822366|582402427|FG001|Overall Study|Withdrawal by Subject|6|||
161279382|NCT01822366|582402428|FG002|Overall Study|Withdrawal by Subject|0|||
161279383|NCT01822366|582402429|FG003|Overall Study|Withdrawal by Subject|6|||
161279384|NCT01822366|582402426|FG000|Overall Study|Partial Intervention Completion|0|||
161279385|NCT01822366|582402427|FG001|Overall Study|Partial Intervention Completion|15|||
161279386|NCT01822366|582402428|FG002|Overall Study|Partial Intervention Completion|0|||
160977371|NCT00447954|581306489|FG002|Overall Study|Adverse Event|0|||
160977372|NCT00447954|581306487|FG000|Overall Study|Withdrawal by Subject|0|||
160977373|NCT00447954|581306488|FG001|Overall Study|Withdrawal by Subject|1|||
160977374|NCT00447954|581306489|FG002|Overall Study|Withdrawal by Subject|1|||
160977375|NCT00447954|581306487|FG000|Overall Study|Lost to Follow-up|0|||
160977376|NCT00447954|581306488|FG001|Overall Study|Lost to Follow-up|1|||
160977377|NCT00447954|581306489|FG002|Overall Study|Lost to Follow-up|0|||
160977378|NCT00447954|581306487|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
160977379|NCT00447954|581306488|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
160977380|NCT00447954|581306489|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
160977381|NCT00856661|581306490|FG000|Overall Study|Death|15|||
160977382|NCT00856661|581306491|FG001|Overall Study|Death|18|||
160977383|NCT00856661|581306490|FG000|Overall Study|Protocol Violation|2|||
160977384|NCT00856661|581306491|FG001|Overall Study|Protocol Violation|1|||
160977385|NCT00856661|581306490|FG000|Overall Study|Withdrawal by Subject|1|||
160977386|NCT00856661|581306491|FG001|Overall Study|Withdrawal by Subject|2|||
160977387|NCT00856661|581306490|FG000|Overall Study|Lost to Follow-up|1|||
160977388|NCT00856661|581306491|FG001|Overall Study|Lost to Follow-up|3|||
160977389|NCT00856661|581306490|FG000|Overall Study|Physician Judgement|8|||
160977390|NCT00856661|581306491|FG001|Overall Study|Physician Judgement|5|||
160977391|NCT03936777|581306492|FG000|Overall Study|Adverse Event|3|||
160977392|NCT03936777|581306492|FG000|Overall Study|Death|3|||
160977393|NCT03936777|581306492|FG000|Overall Study|Lack of Efficacy|24|||
160977394|NCT03936777|581306492|FG000|Overall Study|Lost to Follow-up|3|||
160977395|NCT03936777|581306492|FG000|Overall Study|Physician Decision|1|||
160977396|NCT03936777|581306492|FG000|Overall Study|Withdrawal by Subject|11|||
160977397|NCT03936777|581306492|FG000|Overall Study|Subjected Weaned of ZX008|1|||
160977398|NCT03936777|581306492|FG000|Overall Study|Missing|6|||
160977399|NCT02301156|581306493|FG000|Overall Study|Adverse Event|13|||
160977400|NCT02301156|581306494|FG001|Overall Study|Adverse Event|14|||
160977401|NCT02301156|581306493|FG000|Overall Study|Death|1|||
160977402|NCT02301156|581306494|FG001|Overall Study|Death|5|||
161279387|NCT01822366|582402429|FG003|Overall Study|Partial Intervention Completion|15|||
161279388|NCT05199090|582402430|FG000|Overall Study|Adverse Event|1|||
160977403|NCT02301156|581306493|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
161035006|NCT02111096|581520715|FG002|Overall Study|Terminated by Sponsor|54|||
161279389|NCT05199090|582402431|FG001|Overall Study|Adverse Event|4|||
161279390|NCT05199090|582402432|FG002|Overall Study|Adverse Event|0|||
161279391|NCT05199090|582402433|FG003|Overall Study|Adverse Event|0|||
161035007|NCT02111096|581520713|FG000|Overall Study|Withdrawal by Subject|4|||
161035008|NCT02111096|581520714|FG001|Overall Study|Withdrawal by Subject|2|||
161035009|NCT02111096|581520715|FG002|Overall Study|Withdrawal by Subject|8|||
161035010|NCT00439270|581520718|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
161035011|NCT00439270|581520719|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
161035012|NCT00439270|581520720|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
161035013|NCT00439270|581520721|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
161035014|NCT00439270|581520722|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
161035015|NCT00439270|581520718|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161035016|NCT00439270|581520719|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
161035017|NCT00439270|581520720|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161035018|NCT00439270|581520721|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161035019|NCT00439270|581520722|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
161035020|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
161035021|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
161035022|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
161035023|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
161035024|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
161035025|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161035026|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161035027|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161279392|NCT05199090|582402434|FG004|Overall Study|Adverse Event|0|||
161279393|NCT05199090|582402435|FG005|Overall Study|Adverse Event|0|||
161279394|NCT05199090|582402430|FG000|Overall Study|Lost to Follow-up|1|||
161279395|NCT05199090|582402431|FG001|Overall Study|Lost to Follow-up|0|||
161279396|NCT05199090|582402432|FG002|Overall Study|Lost to Follow-up|1|||
161279397|NCT05199090|582402433|FG003|Overall Study|Lost to Follow-up|4|||
160977404|NCT02301156|581306494|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
160977405|NCT02301156|581306493|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
160977406|NCT02301156|581306494|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
160977407|NCT02301156|581306493|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
160977408|NCT02301156|581306494|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
160977409|NCT02301156|581306493|FG000|Overall Study|Reason not Specified|6|||
160977410|NCT02301156|581306494|FG001|Overall Study|Reason not Specified|3|||
160977411|NCT03734991|581306499|FG000|Overall Study|Adverse Event|4|||
160977412|NCT03734991|581306500|FG001|Overall Study|Adverse Event|0|||
160977413|NCT03734991|581306499|FG000|Overall Study|Lost to Follow-up|4|||
160977414|NCT03734991|581306500|FG001|Overall Study|Lost to Follow-up|0|||
160977415|NCT03734991|581306499|FG000|Overall Study|Physician Decision|0|||
160977416|NCT03734991|581306500|FG001|Overall Study|Physician Decision|1|||
160977417|NCT03734991|581306499|FG000|Overall Study|Pregnancy|1|||
160977418|NCT03734991|581306500|FG001|Overall Study|Pregnancy|0|||
160977419|NCT03734991|581306499|FG000|Overall Study|Withdrawal by Subject|6|||
160977420|NCT03734991|581306500|FG001|Overall Study|Withdrawal by Subject|3|||
160977421|NCT03734991|581306499|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
160977422|NCT03734991|581306500|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
160977423|NCT03734991|581306499|FG000|Overall Study|Other|2|||
160977424|NCT03734991|581306500|FG001|Overall Study|Other|2|||
160977425|NCT02638623|581306501|FG000|Overall Study|Surgery timing|5|||
160977426|NCT02638623|581306502|FG001|Overall Study|Surgery timing|6|||
160977427|NCT02638623|581306501|FG000|Overall Study|Not given intervention|2|||
160977428|NCT02638623|581306502|FG001|Overall Study|Not given intervention|0|||
160977429|NCT03797326|581306508|FG000|Overall Study|Lost to Follow-up|1|||
160977430|NCT03797326|581306509|FG001|Overall Study|Lost to Follow-up|0|||
160977431|NCT03797326|581306510|FG002|Overall Study|Lost to Follow-up|0|||
160977432|NCT03797326|581306511|FG003|Overall Study|Lost to Follow-up|1|||
160977433|NCT03797326|581306512|FG004|Overall Study|Lost to Follow-up|0|||
160977434|NCT03797326|581306513|FG005|Overall Study|Lost to Follow-up|0|||
160977435|NCT03797326|581306514|FG006|Overall Study|Lost to Follow-up|0|||
160977436|NCT03797326|581306515|FG007|Overall Study|Lost to Follow-up|0|||
160977437|NCT03797326|581306508|FG000|Overall Study|Withdrawal by Subject|0|||
160977438|NCT03797326|581306509|FG001|Overall Study|Withdrawal by Subject|0|||
160977439|NCT03797326|581306510|FG002|Overall Study|Withdrawal by Subject|1|||
160977440|NCT03797326|581306511|FG003|Overall Study|Withdrawal by Subject|3|||
160977441|NCT03797326|581306512|FG004|Overall Study|Withdrawal by Subject|0|||
160977442|NCT03797326|581306513|FG005|Overall Study|Withdrawal by Subject|2|||
160977443|NCT03797326|581306514|FG006|Overall Study|Withdrawal by Subject|2|||
160977444|NCT03797326|581306515|FG007|Overall Study|Withdrawal by Subject|3|||
160977445|NCT03797326|581306508|FG000|Overall Study|Sponsor Decision|3|||
160977446|NCT03797326|581306509|FG001|Overall Study|Sponsor Decision|3|||
160977447|NCT03797326|581306510|FG002|Overall Study|Sponsor Decision|3|||
160977448|NCT03797326|581306511|FG003|Overall Study|Sponsor Decision|6|||
160977449|NCT03797326|581306512|FG004|Overall Study|Sponsor Decision|0|||
160977450|NCT03797326|581306513|FG005|Overall Study|Sponsor Decision|3|||
160977451|NCT03797326|581306514|FG006|Overall Study|Sponsor Decision|3|||
160977452|NCT03797326|581306515|FG007|Overall Study|Sponsor Decision|2|||
161035028|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
161035029|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
161035030|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161035031|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161035032|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161035033|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
161035034|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
161035035|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161035036|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161035037|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161035038|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
161035039|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
161035040|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161035041|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161035042|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161035043|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
161035044|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
161035045|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161035046|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161035047|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161035048|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
161035049|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
161279398|NCT05199090|582402434|FG004|Overall Study|Lost to Follow-up|0|||
161035050|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161035051|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161035052|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161035053|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
161035054|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
161035055|NCT00439270|581520718|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161035056|NCT00439270|581520719|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161035057|NCT00439270|581520720|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161035058|NCT00439270|581520721|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
161035059|NCT00439270|581520722|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
161035060|NCT01268306|581520723|FG000|Overall Study|Lost to Follow-up|1|||
161035061|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
161035062|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
161035063|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
161035064|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
161035065|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
161279399|NCT05199090|582402435|FG005|Overall Study|Lost to Follow-up|5|||
161279400|NCT05199090|582402430|FG000|Overall Study|Physician Decision|0|||
161279401|NCT05199090|582402431|FG001|Overall Study|Physician Decision|0|||
161279402|NCT05199090|582402432|FG002|Overall Study|Physician Decision|0|||
161279403|NCT05199090|582402433|FG003|Overall Study|Physician Decision|0|||
161279404|NCT05199090|582402434|FG004|Overall Study|Physician Decision|0|||
161279405|NCT05199090|582402435|FG005|Overall Study|Physician Decision|1|||
161279406|NCT05199090|582402430|FG000|Overall Study|Study terminated by sponsor|0|||
161279407|NCT05199090|582402431|FG001|Overall Study|Study terminated by sponsor|6|||
161279408|NCT05199090|582402432|FG002|Overall Study|Study terminated by sponsor|0|||
161279409|NCT05199090|582402433|FG003|Overall Study|Study terminated by sponsor|0|||
161279410|NCT05199090|582402434|FG004|Overall Study|Study terminated by sponsor|0|||
161279411|NCT05199090|582402435|FG005|Overall Study|Study terminated by sponsor|5|||
161279412|NCT05199090|582402430|FG000|Overall Study|Subject decision|0|||
161279413|NCT05199090|582402431|FG001|Overall Study|Subject decision|4|||
161279414|NCT05199090|582402432|FG002|Overall Study|Subject decision|0|||
161279415|NCT05199090|582402433|FG003|Overall Study|Subject decision|2|||
161279416|NCT05199090|582402434|FG004|Overall Study|Subject decision|5|||
161279417|NCT05199090|582402435|FG005|Overall Study|Subject decision|2|||
161279418|NCT03489109|582402436|FG000|Overall Study|Lost to Follow-up|1|||
161279419|NCT03489109|582402437|FG001|Overall Study|Lost to Follow-up|2|||
161279420|NCT04868968|582402438|FG000|Overall Study|Lost to Follow-up|1|||
161279421|NCT00384930|582402441|FG000|Overall Study|Adverse Event|5|||
161035066|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
161035067|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
161035068|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
161035069|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
161279422|NCT00384930|582402442|FG001|Overall Study|Adverse Event|4|||
161279423|NCT00384930|582402443|FG002|Overall Study|Adverse Event|12|||
161279424|NCT00384930|582402444|FG003|Overall Study|Adverse Event|11|||
161279425|NCT00384930|582402445|FG004|Overall Study|Adverse Event|14|||
161279426|NCT00384930|582402441|FG000|Overall Study|Entry Criteria Not Met|2|||
161279427|NCT00384930|582402442|FG001|Overall Study|Entry Criteria Not Met|6|||
161035070|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161035071|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161035072|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
161035073|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
161035074|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
161035075|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
161035076|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
161035077|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
161035078|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
161035079|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
161035080|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
161035081|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
161035082|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
161035083|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
161035084|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
161035085|NCT01074294|581520729|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
161035086|NCT01074294|581520730|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
161035087|NCT01074294|581520731|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
161035088|NCT01074294|581520732|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
161035089|NCT01074294|581520729|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
161035090|NCT01074294|581520730|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
161035091|NCT01074294|581520731|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
161035092|NCT01074294|581520732|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
161035093|NCT01074294|581520729|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
161035094|NCT01074294|581520730|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
161035095|NCT01074294|581520731|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
161035096|NCT01074294|581520732|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
161035097|NCT01074294|581520729|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
161035098|NCT01074294|581520730|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
161035099|NCT01074294|581520731|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
161035100|NCT01074294|581520732|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
161035101|NCT01074294|581520729|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
161035102|NCT01074294|581520730|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
161035103|NCT01074294|581520731|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
161035104|NCT01074294|581520732|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
161035105|NCT01074294|581520729|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
161035106|NCT01074294|581520730|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
161035107|NCT01074294|581520731|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
161035108|NCT01074294|581520732|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
161035109|NCT01074294|581520729|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
161035110|NCT01074294|581520730|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
161035111|NCT01074294|581520731|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
161035112|NCT01074294|581520732|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
161035113|NCT03248492|581520733|FG000|Overall Study|Progressive Disease|24|||
161035114|NCT03248492|581520734|FG001|Overall Study|Progressive Disease|23|||
161035115|NCT03248492|581520735|FG002|Overall Study|Progressive Disease|11|||
161035116|NCT03248492|581520736|FG003|Overall Study|Progressive Disease|66|||
161035117|NCT03248492|581520737|FG004|Overall Study|Progressive Disease|1|||
161035118|NCT03248492|581520733|FG000|Overall Study|Adverse Event|14|||
161035119|NCT03248492|581520734|FG001|Overall Study|Adverse Event|13|||
161035120|NCT03248492|581520735|FG002|Overall Study|Adverse Event|9|||
161035121|NCT03248492|581520736|FG003|Overall Study|Adverse Event|22|||
161035122|NCT03248492|581520737|FG004|Overall Study|Adverse Event|2|||
161035123|NCT03248492|581520733|FG000|Overall Study|Withdrawal by Subject|5|||
161035124|NCT03248492|581520734|FG001|Overall Study|Withdrawal by Subject|4|||
161035125|NCT03248492|581520735|FG002|Overall Study|Withdrawal by Subject|0|||
161035126|NCT03248492|581520736|FG003|Overall Study|Withdrawal by Subject|8|||
161035127|NCT03248492|581520737|FG004|Overall Study|Withdrawal by Subject|1|||
161035128|NCT03248492|581520733|FG000|Overall Study|Physician Decision|1|||
161035129|NCT03248492|581520734|FG001|Overall Study|Physician Decision|1|||
161035130|NCT03248492|581520735|FG002|Overall Study|Physician Decision|1|||
161035131|NCT03248492|581520736|FG003|Overall Study|Physician Decision|7|||
161035132|NCT03248492|581520737|FG004|Overall Study|Physician Decision|0|||
161035133|NCT03248492|581520733|FG000|Overall Study|Death|1|||
161035134|NCT03248492|581520734|FG001|Overall Study|Death|1|||
161035135|NCT03248492|581520735|FG002|Overall Study|Death|0|||
161035136|NCT03248492|581520736|FG003|Overall Study|Death|6|||
161035137|NCT03248492|581520737|FG004|Overall Study|Death|0|||
161035138|NCT03248492|581520733|FG000|Overall Study|Study Terminated by Sponsor|3|||
161035139|NCT03248492|581520734|FG001|Overall Study|Study Terminated by Sponsor|1|||
161035140|NCT03248492|581520735|FG002|Overall Study|Study Terminated by Sponsor|0|||
161035141|NCT03248492|581520736|FG003|Overall Study|Study Terminated by Sponsor|7|||
161035142|NCT03248492|581520737|FG004|Overall Study|Study Terminated by Sponsor|0|||
161035143|NCT03248492|581520733|FG000|Overall Study|Other|2|||
161035144|NCT03248492|581520734|FG001|Overall Study|Other|5|||
161035145|NCT03248492|581520735|FG002|Overall Study|Other|0|||
161035146|NCT03248492|581520736|FG003|Overall Study|Other|14|||
161035147|NCT03248492|581520737|FG004|Overall Study|Other|0|||
161035148|NCT04495621|581520738|FG000|Overall Study|Withdrawal by Subject|0|||
161035149|NCT04495621|581520739|FG001|Overall Study|Withdrawal by Subject|3|||
161035150|NCT04495621|581520738|FG000|Overall Study|Death|7|||
161035151|NCT04495621|581520739|FG001|Overall Study|Death|11|||
161035152|NCT04495621|581520738|FG000|Overall Study|Investigator Decision|0|||
161035153|NCT04495621|581520739|FG001|Overall Study|Investigator Decision|7|||
161035154|NCT04495621|581520738|FG000|Overall Study|Lost to Follow-up|0|||
161035155|NCT04495621|581520739|FG001|Overall Study|Lost to Follow-up|1|||
161035156|NCT03774472|581520743|FG000|Overall Study|Physician Decision|1|||
161035157|NCT03774472|581520744|FG001|Overall Study|Physician Decision|0|||
161035158|NCT03774472|581520745|FG002|Overall Study|Physician Decision|0|||
161035159|NCT03774472|581520743|FG000|Overall Study|Progression prior to 4 weeks|0|||
161035160|NCT03774472|581520744|FG001|Overall Study|Progression prior to 4 weeks|1|||
161035161|NCT03774472|581520745|FG002|Overall Study|Progression prior to 4 weeks|0|||
161035162|NCT03774472|581520743|FG000|Overall Study|Withdrawal by Subject|0|||
161035163|NCT03774472|581520744|FG001|Overall Study|Withdrawal by Subject|1|||
161035164|NCT03774472|581520745|FG002|Overall Study|Withdrawal by Subject|0|||
161035165|NCT04059406|581520746|FG000|Overall Study|Early Treatment Termination|5|||
161035166|NCT04059406|581520747|FG001|Overall Study|Early Treatment Termination|5|||
161035167|NCT04059406|581520748|FG002|Overall Study|Early Treatment Termination|15|||
161035168|NCT05155306|581520753|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
161035169|NCT05155306|581520754|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
161035170|NCT05155306|581520755|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
161035171|NCT05155306|581520756|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
161035172|NCT05155306|581520753|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
161035173|NCT05155306|581520754|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
161035174|NCT05155306|581520755|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
161035175|NCT05155306|581520756|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
161035176|NCT04158141|581520757|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
161035177|NCT04158141|581520758|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
161035178|NCT04158141|581520759|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
161035179|NCT04158141|581520757|FG000|Step 1: Registration|Adverse Event|1|||
161035180|NCT04158141|581520758|FG001|Step 1: Registration|Adverse Event|0|||
161035181|NCT04158141|581520759|FG002|Step 1: Registration|Adverse Event|0|||
161035182|NCT04158141|581520757|FG000|Step 1: Registration|Withdrawal by Subject|1|||
161035183|NCT04158141|581520758|FG001|Step 1: Registration|Withdrawal by Subject|0|||
161035184|NCT04158141|581520759|FG002|Step 1: Registration|Withdrawal by Subject|0|||
161035185|NCT04158141|581520757|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
161035186|NCT04158141|581520758|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
161035187|NCT04158141|581520759|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
161035188|NCT04121741|581520760|FG000|Overall Study|Protocol Violation|1|||
161035189|NCT04121741|581520761|FG001|Overall Study|Protocol Violation|0|||
161035190|NCT04121741|581520762|FG002|Overall Study|Protocol Violation|0|||
161035191|NCT04121741|581520763|FG003|Overall Study|Protocol Violation|0|||
161035192|NCT04121741|581520764|FG004|Overall Study|Protocol Violation|0|||
161035193|NCT04121741|581520765|FG005|Overall Study|Protocol Violation|0|||
161035194|NCT01084863|581520767|FG000|Main Study Treatment Period|Disease progression|11|||
161035195|NCT01084863|581520768|FG001|Main Study Treatment Period|Disease progression|7|||
161035196|NCT01084863|581520767|FG000|Main Study Treatment Period|Adverse Event|5|||
161035197|NCT01084863|581520768|FG001|Main Study Treatment Period|Adverse Event|3|||
161035198|NCT01084863|581520767|FG000|Main Study Treatment Period|Other Reason|0|||
161035199|NCT01084863|581520768|FG001|Main Study Treatment Period|Other Reason|1|||
161035200|NCT01084863|581520767|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
161035201|NCT01084863|581520768|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
161035202|NCT01084863|581520767|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
161035203|NCT01084863|581520768|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
161035204|NCT01084863|581520767|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
161035205|NCT01084863|581520768|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
161035206|NCT01084863|581520767|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
161035207|NCT01084863|581520768|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
161035208|NCT01084863|581520767|FG000|Treatment Period Beyond Cycle 8|Other|0|||
161035209|NCT01084863|581520768|FG001|Treatment Period Beyond Cycle 8|Other|1|||
161035210|NCT01084863|581520767|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
161035211|NCT01084863|581520768|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
161279428|NCT00384930|582402443|FG002|Overall Study|Entry Criteria Not Met|7|||
161279429|NCT00384930|582402444|FG003|Overall Study|Entry Criteria Not Met|8|||
161279430|NCT00384930|582402445|FG004|Overall Study|Entry Criteria Not Met|4|||
161279431|NCT00384930|582402441|FG000|Overall Study|Lack of Efficacy|1|||
161279432|NCT00384930|582402442|FG001|Overall Study|Lack of Efficacy|1|||
161279433|NCT00384930|582402443|FG002|Overall Study|Lack of Efficacy|2|||
161279434|NCT00384930|582402444|FG003|Overall Study|Lack of Efficacy|1|||
161279435|NCT00384930|582402445|FG004|Overall Study|Lack of Efficacy|2|||
161279436|NCT00384930|582402441|FG000|Overall Study|Lost to Follow-up|5|||
161279437|NCT00384930|582402442|FG001|Overall Study|Lost to Follow-up|3|||
161279438|NCT00384930|582402443|FG002|Overall Study|Lost to Follow-up|0|||
161279439|NCT00384930|582402444|FG003|Overall Study|Lost to Follow-up|4|||
161279440|NCT00384930|582402445|FG004|Overall Study|Lost to Follow-up|6|||
161279441|NCT00384930|582402441|FG000|Overall Study|Physician Decision|0|||
161279442|NCT00384930|582402442|FG001|Overall Study|Physician Decision|1|||
161279443|NCT00384930|582402443|FG002|Overall Study|Physician Decision|1|||
161279444|NCT00384930|582402444|FG003|Overall Study|Physician Decision|0|||
161279445|NCT00384930|582402445|FG004|Overall Study|Physician Decision|1|||
161279446|NCT00384930|582402441|FG000|Overall Study|Protocol Violation|1|||
161279447|NCT00384930|582402442|FG001|Overall Study|Protocol Violation|0|||
161279448|NCT00384930|582402443|FG002|Overall Study|Protocol Violation|1|||
161279449|NCT00384930|582402444|FG003|Overall Study|Protocol Violation|6|||
161279450|NCT00384930|582402445|FG004|Overall Study|Protocol Violation|4|||
161279451|NCT00384930|582402441|FG000|Overall Study|Sponsor Decision|3|||
161279452|NCT00384930|582402442|FG001|Overall Study|Sponsor Decision|4|||
161279453|NCT00384930|582402443|FG002|Overall Study|Sponsor Decision|0|||
161279454|NCT00384930|582402444|FG003|Overall Study|Sponsor Decision|5|||
161279455|NCT00384930|582402445|FG004|Overall Study|Sponsor Decision|0|||
161279456|NCT00384930|582402441|FG000|Overall Study|Withdrawal by Subject|9|||
161279457|NCT00384930|582402442|FG001|Overall Study|Withdrawal by Subject|7|||
161279458|NCT00384930|582402443|FG002|Overall Study|Withdrawal by Subject|7|||
161279459|NCT00384930|582402444|FG003|Overall Study|Withdrawal by Subject|6|||
161279460|NCT00384930|582402445|FG004|Overall Study|Withdrawal by Subject|16|||
161279461|NCT00384930|582402441|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
161279462|NCT00384930|582402442|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
161279463|NCT00384930|582402443|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161279464|NCT00384930|582402444|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161279465|NCT00384930|582402445|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
161279466|NCT02552732|582402448|FG000|Overall Study|Lost to Follow-up|2|||
161279467|NCT02552732|582402448|FG000|Overall Study|Physician Decision|1|||
161279468|NCT02552732|582402448|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
161279469|NCT02552732|582402448|FG000|Overall Study|Withdrawal by Subject|6|||
161279470|NCT01547130|582402451|FG000|Overall Study|Lost to Follow-up|9|||
161279471|NCT01547130|582402452|FG001|Overall Study|Lost to Follow-up|5|||
161035212|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
161035213|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
161035214|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
161035215|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
161035216|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
161035217|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
161035218|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
161035219|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
161035220|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
161035221|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
161035222|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
161279472|NCT00025259|582402454|FG000|Overall Study|Death|1|||
161279473|NCT00025259|582402455|FG001|Overall Study|Death|3|||
161279474|NCT00025259|582402456|FG002|Overall Study|Death|0|||
161279475|NCT00025259|582402457|FG003|Overall Study|Death|3|||
161279476|NCT00025259|582402458|FG004|Overall Study|Death|0|||
161279477|NCT00025259|582402459|FG005|Overall Study|Death|1|||
161279478|NCT00025259|582402460|FG006|Overall Study|Death|2|||
161279479|NCT00025259|582402454|FG000|Overall Study|Lack of Efficacy|2|||
161035223|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
161035224|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
161035225|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
161279480|NCT00025259|582402455|FG001|Overall Study|Lack of Efficacy|46|||
161279481|NCT00025259|582402456|FG002|Overall Study|Lack of Efficacy|60|||
161279482|NCT00025259|582402457|FG003|Overall Study|Lack of Efficacy|78|||
161279483|NCT00025259|582402458|FG004|Overall Study|Lack of Efficacy|11|||
161279484|NCT00025259|582402459|FG005|Overall Study|Lack of Efficacy|30|||
161279485|NCT00025259|582402460|FG006|Overall Study|Lack of Efficacy|38|||
161279486|NCT00025259|582402454|FG000|Overall Study|Lost to Follow-up|2|||
161279487|NCT00025259|582402455|FG001|Overall Study|Lost to Follow-up|9|||
161035226|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
161035227|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
161279488|NCT00025259|582402456|FG002|Overall Study|Lost to Follow-up|13|||
161035228|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
161035229|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
161035230|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
161035231|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
161035232|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
161035233|NCT04505722|581520769|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
161035234|NCT04505722|581520770|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
161035235|NCT04505722|581520771|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
161035236|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
161035237|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
161035238|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
161035239|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
161035240|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
161035241|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
161035242|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
161035243|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
161035244|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
161035245|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
161035246|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
161035247|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
161035248|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
161035249|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
161035250|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
161035251|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
161035252|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
161035253|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
161035254|NCT04505722|581520769|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
161035255|NCT04505722|581520770|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
161035256|NCT04505722|581520771|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
161035257|NCT04755595|581520772|FG000|Overall Study|Lost to Follow-up|1|||
161035258|NCT00319696|581520773|FG000|Overall Study|Adverse Event|36|||
161035259|NCT00319696|581520773|FG000|Overall Study|withdrawal of consent|14|||
161035260|NCT00319696|581520773|FG000|Overall Study|administrative|7|||
161279489|NCT00025259|582402457|FG003|Overall Study|Lost to Follow-up|13|||
161279490|NCT00025259|582402458|FG004|Overall Study|Lost to Follow-up|1|||
161279491|NCT00025259|582402459|FG005|Overall Study|Lost to Follow-up|3|||
161279492|NCT00025259|582402460|FG006|Overall Study|Lost to Follow-up|1|||
161279493|NCT00025259|582402454|FG000|Overall Study|Physician Decision|12|||
161279494|NCT00025259|582402455|FG001|Overall Study|Physician Decision|1|||
161279495|NCT00025259|582402456|FG002|Overall Study|Physician Decision|0|||
161279496|NCT00025259|582402457|FG003|Overall Study|Physician Decision|5|||
160977453|NCT03797326|581306508|FG000|Overall Study|Death|27|||
160977454|NCT03797326|581306509|FG001|Overall Study|Death|28|||
160977455|NCT03797326|581306510|FG002|Overall Study|Death|95|||
160977456|NCT03797326|581306511|FG003|Overall Study|Death|95|||
160977457|NCT03797326|581306512|FG004|Overall Study|Death|30|||
160977458|NCT03797326|581306513|FG005|Overall Study|Death|96|||
160977459|NCT03797326|581306514|FG006|Overall Study|Death|97|||
160977460|NCT03797326|581306515|FG007|Overall Study|Death|98|||
160977461|NCT03797326|581306508|FG000|Overall Study|Enrolled in error|0|||
160977462|NCT03797326|581306509|FG001|Overall Study|Enrolled in error|0|||
160977463|NCT03797326|581306510|FG002|Overall Study|Enrolled in error|3|||
160977464|NCT03797326|581306511|FG003|Overall Study|Enrolled in error|2|||
160977465|NCT03797326|581306512|FG004|Overall Study|Enrolled in error|2|||
160977466|NCT03797326|581306513|FG005|Overall Study|Enrolled in error|1|||
160977467|NCT03797326|581306514|FG006|Overall Study|Enrolled in error|1|||
160977468|NCT03797326|581306515|FG007|Overall Study|Enrolled in error|0|||
160977469|NCT03012061|581306516|FG000|Overall Study|Withdrawal by Subject|1|||
160977470|NCT03012061|581306517|FG001|Overall Study|Withdrawal by Subject|5|||
160977471|NCT03012061|581306518|FG002|Overall Study|Withdrawal by Subject|4|||
160977472|NCT03012061|581306516|FG000|Overall Study|Investigator Site Closed|1|||
160977473|NCT03012061|581306517|FG001|Overall Study|Investigator Site Closed|2|||
160977474|NCT03012061|581306518|FG002|Overall Study|Investigator Site Closed|0|||
160977475|NCT03012061|581306516|FG000|Overall Study|Lost to Follow-up|2|||
160977476|NCT03012061|581306517|FG001|Overall Study|Lost to Follow-up|1|||
160977477|NCT03012061|581306518|FG002|Overall Study|Lost to Follow-up|0|||
160977478|NCT03012061|581306516|FG000|Overall Study|Study closed/ Terminated|0|||
160977479|NCT03012061|581306517|FG001|Overall Study|Study closed/ Terminated|0|||
160977480|NCT03012061|581306518|FG002|Overall Study|Study closed/ Terminated|1|||
160977481|NCT03012061|581306516|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
160977482|NCT03012061|581306517|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
160977483|NCT03012061|581306518|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
160977484|NCT03012061|581306516|FG000|Overall Study|Protocol Violation|0|||
160977485|NCT03012061|581306517|FG001|Overall Study|Protocol Violation|0|||
161279497|NCT00025259|582402458|FG004|Overall Study|Physician Decision|4|||
161279498|NCT00025259|582402459|FG005|Overall Study|Physician Decision|2|||
161279499|NCT00025259|582402460|FG006|Overall Study|Physician Decision|1|||
161279500|NCT00025259|582402454|FG000|Overall Study|Protocol Violation|3|||
161279501|NCT00025259|582402455|FG001|Overall Study|Protocol Violation|2|||
161279502|NCT00025259|582402456|FG002|Overall Study|Protocol Violation|2|||
161279503|NCT00025259|582402457|FG003|Overall Study|Protocol Violation|1|||
161279504|NCT00025259|582402458|FG004|Overall Study|Protocol Violation|2|||
161279505|NCT00025259|582402459|FG005|Overall Study|Protocol Violation|1|||
161279506|NCT00025259|582402460|FG006|Overall Study|Protocol Violation|3|||
161279507|NCT00025259|582402454|FG000|Overall Study|Withdrawal by Subject|9|||
161279508|NCT00025259|582402455|FG001|Overall Study|Withdrawal by Subject|27|||
161279509|NCT00025259|582402456|FG002|Overall Study|Withdrawal by Subject|6|||
161279510|NCT00025259|582402457|FG003|Overall Study|Withdrawal by Subject|14|||
161279511|NCT00025259|582402458|FG004|Overall Study|Withdrawal by Subject|11|||
161279512|NCT00025259|582402459|FG005|Overall Study|Withdrawal by Subject|8|||
161279513|NCT00025259|582402460|FG006|Overall Study|Withdrawal by Subject|3|||
161279514|NCT00025259|582402454|FG000|Overall Study|Ineligible|14|||
161279515|NCT00025259|582402455|FG001|Overall Study|Ineligible|1|||
161279516|NCT00025259|582402456|FG002|Overall Study|Ineligible|0|||
161279517|NCT00025259|582402457|FG003|Overall Study|Ineligible|0|||
161279518|NCT00025259|582402458|FG004|Overall Study|Ineligible|6|||
161279519|NCT00025259|582402459|FG005|Overall Study|Ineligible|0|||
161279520|NCT00025259|582402460|FG006|Overall Study|Ineligible|1|||
161279521|NCT00025259|582402454|FG000|Overall Study|Randomization error|1|||
161279522|NCT00025259|582402455|FG001|Overall Study|Randomization error|0|||
161279523|NCT00025259|582402456|FG002|Overall Study|Randomization error|0|||
161279524|NCT00025259|582402457|FG003|Overall Study|Randomization error|0|||
161279525|NCT00025259|582402458|FG004|Overall Study|Randomization error|1|||
161279526|NCT00025259|582402459|FG005|Overall Study|Randomization error|7|||
161279527|NCT00025259|582402460|FG006|Overall Study|Randomization error|2|||
161279528|NCT00025259|582402454|FG000|Overall Study|Adverse Event|1|||
161279529|NCT00025259|582402455|FG001|Overall Study|Adverse Event|0|||
161279530|NCT00025259|582402456|FG002|Overall Study|Adverse Event|0|||
161279531|NCT00025259|582402457|FG003|Overall Study|Adverse Event|0|||
161279532|NCT00025259|582402458|FG004|Overall Study|Adverse Event|0|||
161279533|NCT00025259|582402459|FG005|Overall Study|Adverse Event|0|||
161279534|NCT00025259|582402460|FG006|Overall Study|Adverse Event|0|||
161279535|NCT04324021|582402464|FG000|Overall Study|Adverse Event|1|||
161279536|NCT04324021|582402465|FG001|Overall Study|Adverse Event|0|||
161279537|NCT04324021|582402466|FG002|Overall Study|Adverse Event|0|||
161279538|NCT04324021|582402464|FG000|Overall Study|Lack of Efficacy|0|||
161279539|NCT04324021|582402465|FG001|Overall Study|Lack of Efficacy|0|||
161279540|NCT04324021|582402466|FG002|Overall Study|Lack of Efficacy|1|||
161279541|NCT04324021|582402464|FG000|Overall Study|Death|1|||
161279542|NCT04324021|582402465|FG001|Overall Study|Death|1|||
161279543|NCT04324021|582402466|FG002|Overall Study|Death|0|||
161279544|NCT00246324|582402467|FG000|Overall Study|Withdrawal by Subject|1|||
161279545|NCT01098487|582402469|FG000|Overall Study|Adverse Event|22|||
161279546|NCT01098487|582402469|FG000|Overall Study|Lack of Efficacy|11|||
161279547|NCT01098487|582402469|FG000|Overall Study|Withdrawal by Subject|7|||
161279548|NCT01098487|582402469|FG000|Overall Study|Lost to Follow-up|3|||
161279549|NCT01098487|582402469|FG000|Overall Study|Physician Decision|1|||
161279550|NCT00345631|582402470|FG000|Overall Study|Withdrawal by Subject|1|||
161279551|NCT00345631|582402471|FG001|Overall Study|Withdrawal by Subject|0|||
161035261|NCT00319696|581520773|FG000|Overall Study|Lost to Follow-up|3|||
161035262|NCT04305327|581520776|FG000|Overall Study|Study early termination|2|||
161035263|NCT04305327|581520777|FG001|Overall Study|Study early termination|5|||
161279552|NCT00345631|582402472|FG002|Overall Study|Withdrawal by Subject|1|||
161279553|NCT00345631|582402470|FG000|Overall Study|Adverse Event|0|||
161279554|NCT00345631|582402471|FG001|Overall Study|Adverse Event|1|||
161279555|NCT00345631|582402472|FG002|Overall Study|Adverse Event|0|||
161279556|NCT00345631|582402470|FG000|Overall Study|Lost to Follow-up|3|||
161279557|NCT00345631|582402471|FG001|Overall Study|Lost to Follow-up|7|||
161279558|NCT00345631|582402472|FG002|Overall Study|Lost to Follow-up|4|||
161279559|NCT00345631|582402470|FG000|Overall Study|Other reasons|0|||
161279560|NCT00345631|582402471|FG001|Overall Study|Other reasons|0|||
161279561|NCT00345631|582402472|FG002|Overall Study|Other reasons|1|||
161279562|NCT03301623|582402483|FG000|Overall Study|Death|3|||
161035264|NCT04305327|581520778|FG002|Overall Study|Study early termination|2|||
161279563|NCT03301623|582402484|FG001|Overall Study|Death|1|||
161035265|NCT04305327|581520779|FG003|Overall Study|Study early termination|2|||
161035266|NCT04305327|581520776|FG000|Overall Study|Withdrawal by Subject|0|||
161279564|NCT03301623|582402483|FG000|Overall Study|Withdrawal by Subject|11|||
161279565|NCT03301623|582402484|FG001|Overall Study|Withdrawal by Subject|13|||
161279566|NCT03301623|582402483|FG000|Overall Study|Lost to Follow-up|3|||
161279567|NCT03301623|582402484|FG001|Overall Study|Lost to Follow-up|1|||
161279568|NCT02516553|582402485|FG000|Overall Study|Progressive disease|2|||
161279569|NCT02516553|582402486|FG001|Overall Study|Progressive disease|2|||
161279570|NCT02516553|582402487|FG002|Overall Study|Progressive disease|3|||
161279571|NCT02516553|582402488|FG003|Overall Study|Progressive disease|5|||
161035267|NCT04305327|581520777|FG001|Overall Study|Withdrawal by Subject|1|||
161035268|NCT04305327|581520778|FG002|Overall Study|Withdrawal by Subject|0|||
161035269|NCT04305327|581520779|FG003|Overall Study|Withdrawal by Subject|0|||
161035270|NCT01288443|581521589|FG000|Overall Study|Adverse Event|0|||
161035271|NCT01288443|581521590|FG001|Overall Study|Adverse Event|0|||
161035272|NCT01288443|581521591|FG002|Overall Study|Adverse Event|1|||
161035273|NCT01288443|581521592|FG003|Overall Study|Adverse Event|1|||
161035274|NCT01288443|581521593|FG004|Overall Study|Adverse Event|3|||
161035275|NCT01288443|581521594|FG005|Overall Study|Adverse Event|1|||
161035276|NCT01288443|581521589|FG000|Overall Study|Poor compliance to protocol|0|||
161035277|NCT01288443|581521590|FG001|Overall Study|Poor compliance to protocol|0|||
161035278|NCT01288443|581521591|FG002|Overall Study|Poor compliance to protocol|0|||
161035279|NCT01288443|581521592|FG003|Overall Study|Poor compliance to protocol|0|||
161035280|NCT01288443|581521593|FG004|Overall Study|Poor compliance to protocol|0|||
161035281|NCT01288443|581521594|FG005|Overall Study|Poor compliance to protocol|1|||
161035282|NCT01288443|581521589|FG000|Overall Study|Participant Moved|0|||
161035283|NCT01288443|581521590|FG001|Overall Study|Participant Moved|0|||
161035284|NCT01288443|581521591|FG002|Overall Study|Participant Moved|0|||
161035285|NCT01288443|581521592|FG003|Overall Study|Participant Moved|1|||
161035286|NCT01288443|581521593|FG004|Overall Study|Participant Moved|2|||
161035287|NCT01288443|581521594|FG005|Overall Study|Participant Moved|1|||
161035288|NCT01288443|581521589|FG000|Overall Study|Consent withdrawn by Participant|0|||
161035289|NCT01288443|581521590|FG001|Overall Study|Consent withdrawn by Participant|0|||
161035290|NCT01288443|581521591|FG002|Overall Study|Consent withdrawn by Participant|0|||
161035291|NCT01288443|581521592|FG003|Overall Study|Consent withdrawn by Participant|0|||
161035292|NCT01288443|581521593|FG004|Overall Study|Consent withdrawn by Participant|0|||
161035293|NCT01288443|581521594|FG005|Overall Study|Consent withdrawn by Participant|1|||
161035294|NCT01288443|581521589|FG000|Overall Study|Lost to Follow-up|0|||
161035295|NCT01288443|581521590|FG001|Overall Study|Lost to Follow-up|1|||
161035296|NCT01288443|581521591|FG002|Overall Study|Lost to Follow-up|0|||
161035297|NCT01288443|581521592|FG003|Overall Study|Lost to Follow-up|0|||
161035298|NCT01288443|581521593|FG004|Overall Study|Lost to Follow-up|0|||
161035299|NCT01288443|581521594|FG005|Overall Study|Lost to Follow-up|0|||
161035300|NCT01288443|581521589|FG000|Overall Study|Study drug auto-injector administration|0|||
161035301|NCT01288443|581521590|FG001|Overall Study|Study drug auto-injector administration|0|||
161035302|NCT01288443|581521591|FG002|Overall Study|Study drug auto-injector administration|0|||
161035303|NCT01288443|581521592|FG003|Overall Study|Study drug auto-injector administration|0|||
161035304|NCT01288443|581521593|FG004|Overall Study|Study drug auto-injector administration|1|||
161035305|NCT01288443|581521594|FG005|Overall Study|Study drug auto-injector administration|1|||
161035306|NCT01288443|581521589|FG000|Overall Study|Other than above|0|||
161035307|NCT01288443|581521590|FG001|Overall Study|Other than above|0|||
161035308|NCT01288443|581521591|FG002|Overall Study|Other than above|0|||
161035309|NCT01288443|581521592|FG003|Overall Study|Other than above|2|||
161035310|NCT01288443|581521593|FG004|Overall Study|Other than above|1|||
161035311|NCT01288443|581521594|FG005|Overall Study|Other than above|0|||
161035312|NCT02438137|581521599|FG000|Overall Study|Lost to Follow-up|3|||
161035313|NCT02438137|581521600|FG001|Overall Study|Lost to Follow-up|2|||
161035314|NCT02438137|581521599|FG000|Overall Study|Adverse Event|1|||
161035315|NCT02438137|581521600|FG001|Overall Study|Adverse Event|0|||
161035316|NCT02438137|581521599|FG000|Overall Study|Withdrawal by Subject|4|||
161035317|NCT02438137|581521600|FG001|Overall Study|Withdrawal by Subject|3|||
161035318|NCT02438137|581521599|FG000|Overall Study|Physician Decision|0|||
161035319|NCT02438137|581521600|FG001|Overall Study|Physician Decision|1|||
161035320|NCT00945321|581521601|FG000|Period 1|Adverse Event|0|||
161035321|NCT00945321|581521602|FG001|Period 1|Adverse Event|0|||
161035322|NCT00945321|581521603|FG002|Period 1|Adverse Event|0|||
161279572|NCT02516553|582402489|FG004|Overall Study|Progressive disease|3|||
161035323|NCT00945321|581521604|FG003|Period 1|Adverse Event|0|||
161035324|NCT00945321|581521605|FG004|Period 1|Adverse Event|1|||
161035325|NCT00945321|581521606|FG005|Period 1|Adverse Event|0|||
161035326|NCT00945321|581521601|FG000|Period 4|Lost to Follow-up|0|||
161035327|NCT00945321|581521602|FG001|Period 4|Lost to Follow-up|0|||
161035328|NCT00945321|581521603|FG002|Period 4|Lost to Follow-up|0|||
161035329|NCT00945321|581521604|FG003|Period 4|Lost to Follow-up|0|||
161035330|NCT00945321|581521605|FG004|Period 4|Lost to Follow-up|0|||
161035331|NCT00945321|581521606|FG005|Period 4|Lost to Follow-up|1|||
161035332|NCT00692913|581521607|FG000|Overall Study|Adverse Event|8|||
161035333|NCT00692913|581521608|FG001|Overall Study|Adverse Event|4|||
161035334|NCT00692913|581521607|FG000|Overall Study|Lost to Follow-up|3|||
161035335|NCT00692913|581521608|FG001|Overall Study|Lost to Follow-up|5|||
161035336|NCT00692913|581521607|FG000|Overall Study|Physician Decision|2|||
161035337|NCT00692913|581521608|FG001|Overall Study|Physician Decision|0|||
161035338|NCT00692913|581521607|FG000|Overall Study|Protocol Violation|1|||
161035339|NCT00692913|581521608|FG001|Overall Study|Protocol Violation|1|||
161035340|NCT00692913|581521607|FG000|Overall Study|Withdrawal by Subject|15|||
161035341|NCT00692913|581521608|FG001|Overall Study|Withdrawal by Subject|20|||
161035342|NCT02291913|581521609|FG000|Overall Study|Progressive Disease|32|||
161035343|NCT02291913|581521609|FG000|Overall Study|Adverse Event|11|||
161035344|NCT02291913|581521609|FG000|Overall Study|Death|2|||
161035345|NCT02291913|581521609|FG000|Overall Study|Physician Decision|1|||
161035346|NCT02291913|581521609|FG000|Overall Study|Withdrawal by Subject|1|||
161035347|NCT02291913|581521609|FG000|Overall Study|Protocol Violation|1|||
161035348|NCT03621735|581521610|FG000|Overall Study|Withdrawal by Subject|13|||
161035349|NCT03621735|581521611|FG001|Overall Study|Withdrawal by Subject|13|||
161035350|NCT04334317|581521612|FG000|Overall Study|Adverse Event|1|||
161035351|NCT04334317|581521613|FG001|Overall Study|Adverse Event|2|||
161035352|NCT04334317|581521614|FG002|Overall Study|Adverse Event|0|||
161035353|NCT04334317|581521615|FG003|Overall Study|Adverse Event|0|||
161035354|NCT04334317|581521612|FG000|Overall Study|Protocol Deviation|0|||
161035355|NCT04334317|581521613|FG001|Overall Study|Protocol Deviation|1|||
161035356|NCT04334317|581521614|FG002|Overall Study|Protocol Deviation|0|||
161035357|NCT04334317|581521615|FG003|Overall Study|Protocol Deviation|0|||
161035358|NCT04334317|581521612|FG000|Overall Study|Withdrawal by Subject|2|||
161035359|NCT04334317|581521613|FG001|Overall Study|Withdrawal by Subject|2|||
161035360|NCT04334317|581521614|FG002|Overall Study|Withdrawal by Subject|0|||
161035361|NCT04334317|581521615|FG003|Overall Study|Withdrawal by Subject|0|||
161035362|NCT00605306|581521618|FG000|Overall Study|Adverse Event|0|||
161035363|NCT00605306|581521619|FG001|Overall Study|Adverse Event|1|||
161035364|NCT03875313|581521622|FG000|Overall Study|Withdrawal by Subject|1|||
161035365|NCT03875313|581521623|FG001|Overall Study|Withdrawal by Subject|3|||
161035366|NCT03875313|581521624|FG002|Overall Study|Withdrawal by Subject|0|||
161035367|NCT03875313|581521625|FG003|Overall Study|Withdrawal by Subject|0|||
161035368|NCT03875313|581521626|FG004|Overall Study|Withdrawal by Subject|0|||
161035369|NCT03875313|581521622|FG000|Overall Study|Death|0|||
161035370|NCT03875313|581521623|FG001|Overall Study|Death|0|||
161035371|NCT03875313|581521624|FG002|Overall Study|Death|0|||
161035372|NCT03875313|581521625|FG003|Overall Study|Death|0|||
161035373|NCT03875313|581521626|FG004|Overall Study|Death|1|||
161035374|NCT03875313|581521622|FG000|Overall Study|Lost to Follow-up|0|||
161035375|NCT03875313|581521623|FG001|Overall Study|Lost to Follow-up|0|||
161035376|NCT03875313|581521624|FG002|Overall Study|Lost to Follow-up|0|||
161035377|NCT03875313|581521625|FG003|Overall Study|Lost to Follow-up|0|||
161035378|NCT03875313|581521626|FG004|Overall Study|Lost to Follow-up|1|||
161035379|NCT03875313|581521622|FG000|Overall Study|Study Termination by Sponsor|0|||
161035380|NCT03875313|581521623|FG001|Overall Study|Study Termination by Sponsor|1|||
161035381|NCT03875313|581521624|FG002|Overall Study|Study Termination by Sponsor|1|||
161035382|NCT03875313|581521625|FG003|Overall Study|Study Termination by Sponsor|0|||
161035383|NCT03875313|581521626|FG004|Overall Study|Study Termination by Sponsor|1|||
161035384|NCT03875313|581521622|FG000|Overall Study|New Anticancer Treatment|0|||
161035385|NCT03875313|581521623|FG001|Overall Study|New Anticancer Treatment|1|||
161035386|NCT03875313|581521624|FG002|Overall Study|New Anticancer Treatment|2|||
161035387|NCT03875313|581521625|FG003|Overall Study|New Anticancer Treatment|1|||
161035388|NCT03875313|581521626|FG004|Overall Study|New Anticancer Treatment|0|||
161035389|NCT03875313|581521622|FG000|Overall Study|Other, Not Specified|2|||
161035390|NCT03875313|581521623|FG001|Overall Study|Other, Not Specified|11|||
161035391|NCT03875313|581521624|FG002|Overall Study|Other, Not Specified|3|||
161035392|NCT03875313|581521625|FG003|Overall Study|Other, Not Specified|3|||
161035393|NCT03875313|581521626|FG004|Overall Study|Other, Not Specified|1|||
161035394|NCT01092416|581521627|FG000|Enrollment|Atherectomy device not inserted|3|||
161035395|NCT01092416|581521627|FG000|30-Day Follow-up|Death|2|||
161035396|NCT01092416|581521627|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
161035397|NCT01092416|581521627|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
161035398|NCT01092416|581521627|FG000|12-Month Follow-up|Death|16|||
161035399|NCT01092416|581521627|FG000|12-Month Follow-up|Lost to Follow-up|4|||
161035400|NCT01092416|581521627|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
161035401|NCT01092416|581521627|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
161035402|NCT01092416|581521627|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
161035403|NCT03709706|581521628|FG000|Overall Study|Adverse Event|0|||
161035404|NCT03709706|581521629|FG001|Overall Study|Adverse Event|1|||
161035405|NCT03709706|581521628|FG000|Overall Study|Physician Decision|14|||
161035406|NCT03709706|581521629|FG001|Overall Study|Physician Decision|8|||
161035407|NCT03709706|581521628|FG000|Overall Study|Withdrawal by Subject|2|||
161035408|NCT03709706|581521629|FG001|Overall Study|Withdrawal by Subject|1|||
161035409|NCT03709706|581521628|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
161035410|NCT03709706|581521629|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
161035411|NCT01105975|581521630|FG000|Overall Study|Adverse Event|2|||
161035412|NCT01105975|581521631|FG001|Overall Study|Adverse Event|1|||
161035413|NCT01105975|581521632|FG002|Overall Study|Adverse Event|5|||
161035414|NCT01105975|581521633|FG003|Overall Study|Adverse Event|1|||
161035415|NCT01105975|581521634|FG004|Overall Study|Adverse Event|0|||
161035416|NCT01105975|581521635|FG005|Overall Study|Adverse Event|1|||
161035417|NCT01105975|581521636|FG006|Overall Study|Adverse Event|2|||
161035418|NCT01105975|581521637|FG007|Overall Study|Adverse Event|4|||
161035419|NCT01105975|581521638|FG008|Overall Study|Adverse Event|1|||
161035420|NCT01105975|581521639|FG009|Overall Study|Adverse Event|4|||
161035421|NCT01105975|581521630|FG000|Overall Study|Withdrawal by Subject|2|||
161279573|NCT02516553|582402490|FG005|Overall Study|Progressive disease|0|||
161279574|NCT02516553|582402491|FG006|Overall Study|Progressive disease|5|||
161279575|NCT02516553|582402492|FG007|Overall Study|Progressive disease|5|||
161279576|NCT02516553|582402493|FG008|Overall Study|Progressive disease|11|||
161279577|NCT02516553|582402494|FG009|Overall Study|Progressive disease|3|||
161279578|NCT02516553|582402495|FG010|Overall Study|Progressive disease|10|||
161279579|NCT02516553|582402496|FG011|Overall Study|Progressive disease|8|||
161279580|NCT02516553|582402497|FG012|Overall Study|Progressive disease|8|||
161279581|NCT02516553|582402498|FG013|Overall Study|Progressive disease|2|||
161279582|NCT02516553|582402499|FG014|Overall Study|Progressive disease|2|||
161279583|NCT02516553|582402500|FG015|Overall Study|Progressive disease|2|||
161279584|NCT02516553|582402501|FG016|Overall Study|Progressive disease|1|||
161279585|NCT02516553|582402502|FG017|Overall Study|Progressive disease|9|||
161279586|NCT02516553|582402503|FG018|Overall Study|Progressive disease|12|||
161279587|NCT02516553|582402504|FG019|Overall Study|Progressive disease|7|||
161279588|NCT02516553|582402505|FG020|Overall Study|Progressive disease|16|||
161279589|NCT02516553|582402506|FG021|Overall Study|Progressive disease|18|||
161279590|NCT02516553|582402485|FG000|Overall Study|Dose limiting toxicity|0|||
161279591|NCT02516553|582402486|FG001|Overall Study|Dose limiting toxicity|0|||
161279592|NCT02516553|582402487|FG002|Overall Study|Dose limiting toxicity|0|||
160977486|NCT03012061|581306518|FG002|Overall Study|Protocol Violation|2|||
160977487|NCT03012061|581306516|FG000|Overall Study|Lack of Efficacy|0|||
160977488|NCT03012061|581306517|FG001|Overall Study|Lack of Efficacy|1|||
160977489|NCT03012061|581306518|FG002|Overall Study|Lack of Efficacy|0|||
160977490|NCT03012061|581306516|FG000|Overall Study|Adverse Event|2|||
160977491|NCT03012061|581306517|FG001|Overall Study|Adverse Event|0|||
160977492|NCT03012061|581306518|FG002|Overall Study|Adverse Event|0|||
160977493|NCT04152343|581306519|FG000|Overall Study|Transplanted|5|||
160977494|NCT04152343|581306519|FG000|Overall Study|Death|20|||
160977495|NCT04152343|581306519|FG000|Overall Study|Lost to Follow-up|3|||
160977496|NCT01164228|581306520|FG000|Overall Study|Progression|24|||
160977497|NCT01164228|581306521|FG001|Overall Study|Progression|25|||
160977498|NCT01164228|581306520|FG000|Overall Study|Adverse Event|13|||
160977499|NCT01164228|581306521|FG001|Overall Study|Adverse Event|7|||
160977500|NCT01164228|581306520|FG000|Overall Study|Death|1|||
160977501|NCT01164228|581306521|FG001|Overall Study|Death|1|||
160977502|NCT01164228|581306520|FG000|Overall Study|Withdrawal by Subject|2|||
160977503|NCT01164228|581306521|FG001|Overall Study|Withdrawal by Subject|0|||
160977504|NCT01164228|581306520|FG000|Overall Study|Physician Decision|1|||
160977505|NCT01164228|581306521|FG001|Overall Study|Physician Decision|2|||
160977506|NCT01164228|581306520|FG000|Overall Study|Symptomatic deterioration|1|||
160977507|NCT01164228|581306521|FG001|Overall Study|Symptomatic deterioration|0|||
160977508|NCT01164228|581306520|FG000|Overall Study|Never started treatment|1|||
160977509|NCT01164228|581306521|FG001|Overall Study|Never started treatment|3|||
160977510|NCT01164228|581306520|FG000|Overall Study|Ineligible|1|||
160977511|NCT01164228|581306521|FG001|Overall Study|Ineligible|0|||
160977512|NCT02090634|581306522|FG000|Overall Study|Lost to Follow-up|0|||
160977513|NCT02090634|581306523|FG001|Overall Study|Lost to Follow-up|1|||
160977514|NCT02090634|581306522|FG000|Overall Study|Death|0|||
160977515|NCT02090634|581306523|FG001|Overall Study|Death|1|||
160977516|NCT02090634|581306522|FG000|Overall Study|Protocol Violation|3|||
160977517|NCT02090634|581306523|FG001|Overall Study|Protocol Violation|1|||
160977518|NCT02090634|581306522|FG000|Overall Study|Adverse Event|2|||
160977519|NCT02090634|581306523|FG001|Overall Study|Adverse Event|0|||
160977520|NCT01965938|581306524|FG000|Overall Study|Withdrawal by Subject|1|||
160977521|NCT01965938|581306525|FG001|Overall Study|Withdrawal by Subject|0|||
160977522|NCT03757234|581306526|FG000|Overall Study|Adverse Event|0|||
160977523|NCT03757234|581306527|FG001|Overall Study|Adverse Event|0|||
160977524|NCT03757234|581306528|FG002|Overall Study|Adverse Event|0|||
160977525|NCT03757234|581306529|FG003|Overall Study|Adverse Event|0|||
160977526|NCT03757234|581306530|FG004|Overall Study|Adverse Event|1|||
160977527|NCT03757234|581306526|FG000|Overall Study|Lost to Follow-up|1|||
160977528|NCT03757234|581306527|FG001|Overall Study|Lost to Follow-up|0|||
160977529|NCT03757234|581306528|FG002|Overall Study|Lost to Follow-up|0|||
160977530|NCT03757234|581306529|FG003|Overall Study|Lost to Follow-up|0|||
160977531|NCT03757234|581306530|FG004|Overall Study|Lost to Follow-up|1|||
160977532|NCT03757234|581306526|FG000|Overall Study|Withdrawal by Subject|1|||
160977533|NCT03757234|581306527|FG001|Overall Study|Withdrawal by Subject|1|||
160977534|NCT03757234|581306528|FG002|Overall Study|Withdrawal by Subject|0|||
160977535|NCT03757234|581306529|FG003|Overall Study|Withdrawal by Subject|1|||
160977536|NCT03757234|581306530|FG004|Overall Study|Withdrawal by Subject|2|||
160977537|NCT03757234|581306526|FG000|Overall Study|Other|1|||
160977538|NCT03757234|581306527|FG001|Overall Study|Other|1|||
160977539|NCT03757234|581306528|FG002|Overall Study|Other|0|||
160977540|NCT03757234|581306529|FG003|Overall Study|Other|0|||
160977541|NCT03757234|581306530|FG004|Overall Study|Other|0|||
160977542|NCT01027364|581307914|FG000|Overall Study|Adverse Event|1|||
160977543|NCT01027364|581307915|FG001|Overall Study|Adverse Event|0|||
160977544|NCT01027364|581307916|FG002|Overall Study|Adverse Event|1|||
161279593|NCT02516553|582402488|FG003|Overall Study|Dose limiting toxicity|0|||
161279594|NCT02516553|582402489|FG004|Overall Study|Dose limiting toxicity|3|||
161279595|NCT02516553|582402490|FG005|Overall Study|Dose limiting toxicity|1|||
161279596|NCT02516553|582402491|FG006|Overall Study|Dose limiting toxicity|1|||
161279597|NCT02516553|582402492|FG007|Overall Study|Dose limiting toxicity|0|||
161279598|NCT02516553|582402493|FG008|Overall Study|Dose limiting toxicity|1|||
161279599|NCT02516553|582402494|FG009|Overall Study|Dose limiting toxicity|0|||
161279600|NCT02516553|582402495|FG010|Overall Study|Dose limiting toxicity|0|||
161279601|NCT02516553|582402496|FG011|Overall Study|Dose limiting toxicity|1|||
161279602|NCT02516553|582402497|FG012|Overall Study|Dose limiting toxicity|0|||
161279603|NCT02516553|582402498|FG013|Overall Study|Dose limiting toxicity|1|||
161279604|NCT02516553|582402499|FG014|Overall Study|Dose limiting toxicity|0|||
161279605|NCT02516553|582402500|FG015|Overall Study|Dose limiting toxicity|0|||
161279606|NCT02516553|582402501|FG016|Overall Study|Dose limiting toxicity|1|||
161279607|NCT02516553|582402502|FG017|Overall Study|Dose limiting toxicity|1|||
161279608|NCT02516553|582402503|FG018|Overall Study|Dose limiting toxicity|0|||
161279609|NCT02516553|582402504|FG019|Overall Study|Dose limiting toxicity|2|||
161279610|NCT02516553|582402505|FG020|Overall Study|Dose limiting toxicity|0|||
161279611|NCT02516553|582402506|FG021|Overall Study|Dose limiting toxicity|0|||
161279612|NCT02516553|582402485|FG000|Overall Study|Other Adverse Events|0|||
161279613|NCT02516553|582402486|FG001|Overall Study|Other Adverse Events|0|||
161279614|NCT02516553|582402487|FG002|Overall Study|Other Adverse Events|0|||
161279615|NCT02516553|582402488|FG003|Overall Study|Other Adverse Events|1|||
161279616|NCT02516553|582402489|FG004|Overall Study|Other Adverse Events|0|||
161279617|NCT02516553|582402490|FG005|Overall Study|Other Adverse Events|1|||
161279618|NCT02516553|582402491|FG006|Overall Study|Other Adverse Events|0|||
161279619|NCT02516553|582402492|FG007|Overall Study|Other Adverse Events|0|||
161279620|NCT02516553|582402493|FG008|Overall Study|Other Adverse Events|0|||
161279621|NCT02516553|582402494|FG009|Overall Study|Other Adverse Events|1|||
161279622|NCT02516553|582402495|FG010|Overall Study|Other Adverse Events|3|||
161279623|NCT02516553|582402496|FG011|Overall Study|Other Adverse Events|2|||
161279624|NCT02516553|582402497|FG012|Overall Study|Other Adverse Events|0|||
161279625|NCT02516553|582402498|FG013|Overall Study|Other Adverse Events|1|||
161279626|NCT02516553|582402499|FG014|Overall Study|Other Adverse Events|0|||
161279627|NCT02516553|582402500|FG015|Overall Study|Other Adverse Events|0|||
161279628|NCT02516553|582402501|FG016|Overall Study|Other Adverse Events|0|||
161279629|NCT02516553|582402502|FG017|Overall Study|Other Adverse Events|2|||
161279630|NCT02516553|582402503|FG018|Overall Study|Other Adverse Events|1|||
161279631|NCT02516553|582402504|FG019|Overall Study|Other Adverse Events|2|||
161035422|NCT01105975|581521631|FG001|Overall Study|Withdrawal by Subject|2|||
161035423|NCT01105975|581521632|FG002|Overall Study|Withdrawal by Subject|2|||
161035424|NCT01105975|581521633|FG003|Overall Study|Withdrawal by Subject|0|||
161035425|NCT01105975|581521634|FG004|Overall Study|Withdrawal by Subject|4|||
161035426|NCT01105975|581521635|FG005|Overall Study|Withdrawal by Subject|1|||
161035427|NCT01105975|581521636|FG006|Overall Study|Withdrawal by Subject|2|||
161035428|NCT01105975|581521637|FG007|Overall Study|Withdrawal by Subject|1|||
161035429|NCT01105975|581521638|FG008|Overall Study|Withdrawal by Subject|0|||
161035430|NCT01105975|581521639|FG009|Overall Study|Withdrawal by Subject|3|||
161035431|NCT01105975|581521630|FG000|Overall Study|Lost to Follow-up|1|||
161279632|NCT02516553|582402505|FG020|Overall Study|Other Adverse Events|2|||
161279633|NCT02516553|582402506|FG021|Overall Study|Other Adverse Events|1|||
161279634|NCT02516553|582402485|FG000|Overall Study|Refused to continue trial medication|0|||
161279635|NCT02516553|582402486|FG001|Overall Study|Refused to continue trial medication|0|||
161279636|NCT02516553|582402487|FG002|Overall Study|Refused to continue trial medication|0|||
161279637|NCT02516553|582402488|FG003|Overall Study|Refused to continue trial medication|0|||
161279638|NCT02516553|582402489|FG004|Overall Study|Refused to continue trial medication|0|||
161279639|NCT02516553|582402490|FG005|Overall Study|Refused to continue trial medication|0|||
161279640|NCT02516553|582402491|FG006|Overall Study|Refused to continue trial medication|0|||
161279641|NCT02516553|582402492|FG007|Overall Study|Refused to continue trial medication|0|||
161279642|NCT02516553|582402493|FG008|Overall Study|Refused to continue trial medication|0|||
161279643|NCT02516553|582402494|FG009|Overall Study|Refused to continue trial medication|0|||
161279644|NCT02516553|582402495|FG010|Overall Study|Refused to continue trial medication|1|||
161035432|NCT01105975|581521631|FG001|Overall Study|Lost to Follow-up|0|||
161035433|NCT01105975|581521632|FG002|Overall Study|Lost to Follow-up|0|||
161035434|NCT01105975|581521633|FG003|Overall Study|Lost to Follow-up|1|||
161279645|NCT02516553|582402496|FG011|Overall Study|Refused to continue trial medication|0|||
161279646|NCT02516553|582402497|FG012|Overall Study|Refused to continue trial medication|0|||
161279647|NCT02516553|582402498|FG013|Overall Study|Refused to continue trial medication|0|||
161279648|NCT02516553|582402499|FG014|Overall Study|Refused to continue trial medication|0|||
161035435|NCT01105975|581521634|FG004|Overall Study|Lost to Follow-up|1|||
161035436|NCT01105975|581521635|FG005|Overall Study|Lost to Follow-up|0|||
161035437|NCT01105975|581521636|FG006|Overall Study|Lost to Follow-up|0|||
161035438|NCT01105975|581521637|FG007|Overall Study|Lost to Follow-up|0|||
161279649|NCT02516553|582402500|FG015|Overall Study|Refused to continue trial medication|0|||
161279650|NCT02516553|582402501|FG016|Overall Study|Refused to continue trial medication|0|||
161279651|NCT02516553|582402502|FG017|Overall Study|Refused to continue trial medication|0|||
161279652|NCT02516553|582402503|FG018|Overall Study|Refused to continue trial medication|1|||
161279653|NCT02516553|582402504|FG019|Overall Study|Refused to continue trial medication|0|||
161279654|NCT02516553|582402505|FG020|Overall Study|Refused to continue trial medication|0|||
161279655|NCT02516553|582402506|FG021|Overall Study|Refused to continue trial medication|1|||
161279656|NCT02516553|582402485|FG000|Overall Study|other reasons than listed|0|||
161279657|NCT02516553|582402486|FG001|Overall Study|other reasons than listed|0|||
161279658|NCT02516553|582402487|FG002|Overall Study|other reasons than listed|0|||
161279659|NCT02516553|582402488|FG003|Overall Study|other reasons than listed|0|||
161279660|NCT02516553|582402489|FG004|Overall Study|other reasons than listed|0|||
161279661|NCT02516553|582402490|FG005|Overall Study|other reasons than listed|0|||
161279662|NCT02516553|582402491|FG006|Overall Study|other reasons than listed|0|||
161279663|NCT02516553|582402492|FG007|Overall Study|other reasons than listed|1|||
161279664|NCT02516553|582402493|FG008|Overall Study|other reasons than listed|1|||
161279665|NCT02516553|582402494|FG009|Overall Study|other reasons than listed|0|||
161279666|NCT02516553|582402495|FG010|Overall Study|other reasons than listed|1|||
161279667|NCT02516553|582402496|FG011|Overall Study|other reasons than listed|1|||
161279668|NCT02516553|582402497|FG012|Overall Study|other reasons than listed|0|||
161279669|NCT02516553|582402498|FG013|Overall Study|other reasons than listed|0|||
161279670|NCT02516553|582402499|FG014|Overall Study|other reasons than listed|0|||
161279671|NCT02516553|582402500|FG015|Overall Study|other reasons than listed|0|||
161279672|NCT02516553|582402501|FG016|Overall Study|other reasons than listed|0|||
161279673|NCT02516553|582402502|FG017|Overall Study|other reasons than listed|0|||
161279674|NCT02516553|582402503|FG018|Overall Study|other reasons than listed|0|||
161279675|NCT02516553|582402504|FG019|Overall Study|other reasons than listed|0|||
161279676|NCT02516553|582402505|FG020|Overall Study|other reasons than listed|2|||
161279677|NCT02516553|582402506|FG021|Overall Study|other reasons than listed|2|||
161279678|NCT01374269|582402509|FG000|Overall Study|Withdrawal by Subject|4|||
161279679|NCT01374269|582402510|FG001|Overall Study|Withdrawal by Subject|0|||
161279680|NCT01374269|582402509|FG000|Overall Study|Lost to Follow-up|1|||
161279681|NCT01374269|582402510|FG001|Overall Study|Lost to Follow-up|3|||
161035439|NCT01105975|581521638|FG008|Overall Study|Lost to Follow-up|1|||
161035440|NCT01105975|581521639|FG009|Overall Study|Lost to Follow-up|0|||
161035441|NCT01105975|581521630|FG000|Overall Study|Physician Decision|0|||
161035442|NCT01105975|581521631|FG001|Overall Study|Physician Decision|0|||
161035443|NCT01105975|581521632|FG002|Overall Study|Physician Decision|0|||
161035444|NCT01105975|581521633|FG003|Overall Study|Physician Decision|0|||
161035445|NCT01105975|581521634|FG004|Overall Study|Physician Decision|0|||
161035446|NCT01105975|581521635|FG005|Overall Study|Physician Decision|0|||
161035447|NCT01105975|581521636|FG006|Overall Study|Physician Decision|2|||
161035448|NCT01105975|581521637|FG007|Overall Study|Physician Decision|0|||
161035449|NCT01105975|581521638|FG008|Overall Study|Physician Decision|0|||
161035450|NCT01105975|581521639|FG009|Overall Study|Physician Decision|0|||
161035451|NCT01105975|581521630|FG000|Overall Study|Protocol Violation|0|||
161035452|NCT01105975|581521631|FG001|Overall Study|Protocol Violation|2|||
161035453|NCT01105975|581521632|FG002|Overall Study|Protocol Violation|2|||
161035454|NCT01105975|581521633|FG003|Overall Study|Protocol Violation|0|||
161035455|NCT01105975|581521634|FG004|Overall Study|Protocol Violation|1|||
161035456|NCT01105975|581521635|FG005|Overall Study|Protocol Violation|1|||
161279682|NCT01374269|582402509|FG000|Overall Study|closed research|1|||
161279683|NCT01374269|582402510|FG001|Overall Study|closed research|2|||
161279684|NCT00708227|582402515|FG000|Overall Study|Physician Decision|0|||
161279685|NCT00708227|582402516|FG001|Overall Study|Physician Decision|3|||
161279686|NCT00708227|582402517|FG002|Overall Study|Physician Decision|1|||
161279687|NCT00708227|582402518|FG003|Overall Study|Physician Decision|2|||
161279688|NCT00708227|582402515|FG000|Overall Study|Withdrawal by Subject|1|||
161279689|NCT00708227|582402516|FG001|Overall Study|Withdrawal by Subject|2|||
161279690|NCT00708227|582402517|FG002|Overall Study|Withdrawal by Subject|0|||
161035457|NCT01105975|581521636|FG006|Overall Study|Protocol Violation|1|||
161035458|NCT01105975|581521637|FG007|Overall Study|Protocol Violation|1|||
161035459|NCT01105975|581521638|FG008|Overall Study|Protocol Violation|2|||
161035460|NCT01105975|581521639|FG009|Overall Study|Protocol Violation|2|||
161279691|NCT00708227|582402518|FG003|Overall Study|Withdrawal by Subject|1|||
161279692|NCT04007991|582402519|FG000|Overall Study|Withdrawal by Subject|1|||
161279693|NCT04007991|582402520|FG001|Overall Study|Withdrawal by Subject|1|||
161035461|NCT01105975|581521630|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161035462|NCT01105975|581521631|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161279694|NCT04007991|582402519|FG000|Overall Study|Physician Decision|1|||
161279695|NCT04007991|582402520|FG001|Overall Study|Physician Decision|1|||
161035463|NCT01105975|581521632|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161035464|NCT01105975|581521633|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161035465|NCT01105975|581521634|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161035466|NCT01105975|581521635|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
161279696|NCT04007991|582402519|FG000|Overall Study|Non-compliance with Study Drug|0|||
161279697|NCT04007991|582402520|FG001|Overall Study|Non-compliance with Study Drug|1|||
161279698|NCT04007991|582402519|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
161279699|NCT04007991|582402520|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
161279700|NCT04007991|582402519|FG000|Overall Study|Adverse event, non-fatal|5|||
161279701|NCT04007991|582402520|FG001|Overall Study|Adverse event, non-fatal|0|||
161279702|NCT04007991|582402519|FG000|Overall Study|Lost to Follow-up|2|||
161279703|NCT04007991|582402520|FG001|Overall Study|Lost to Follow-up|1|||
161279704|NCT03654599|582402523|FG000|Overall Study|Lost to Follow-up|14|||
161279705|NCT03654599|582402524|FG001|Overall Study|Lost to Follow-up|12|||
161279706|NCT03654599|582402523|FG000|Overall Study|Death|8|||
161279707|NCT03654599|582402524|FG001|Overall Study|Death|6|||
161279708|NCT03654599|582402523|FG000|Overall Study|Withdrawal by Subject|6|||
161279709|NCT03654599|582402524|FG001|Overall Study|Withdrawal by Subject|4|||
161279710|NCT02551666|582402526|FG000|Overall Study|Withdrawal by Subject|1|||
161279711|NCT02551666|582402527|FG001|Overall Study|Withdrawal by Subject|3|||
161279712|NCT00678210|582404129|FG000|Overall Study|Adverse Event|1|||
161279713|NCT00678210|582404130|FG001|Overall Study|Adverse Event|2|||
161279714|NCT00678210|582404131|FG002|Overall Study|Adverse Event|3|||
161279715|NCT00678210|582404132|FG003|Overall Study|Adverse Event|3|||
161279716|NCT00678210|582404129|FG000|Overall Study|Lack of Efficacy|2|||
161279717|NCT00678210|582404130|FG001|Overall Study|Lack of Efficacy|3|||
161279718|NCT00678210|582404131|FG002|Overall Study|Lack of Efficacy|1|||
161279719|NCT00678210|582404132|FG003|Overall Study|Lack of Efficacy|9|||
161279720|NCT00678210|582404129|FG000|Overall Study|Lost to Follow-up|4|||
161279721|NCT00678210|582404130|FG001|Overall Study|Lost to Follow-up|2|||
161279722|NCT00678210|582404131|FG002|Overall Study|Lost to Follow-up|0|||
161279723|NCT00678210|582404132|FG003|Overall Study|Lost to Follow-up|1|||
161279724|NCT00678210|582404129|FG000|Overall Study|Withdrawal by Subject|3|||
161279725|NCT00678210|582404130|FG001|Overall Study|Withdrawal by Subject|4|||
161279726|NCT00678210|582404131|FG002|Overall Study|Withdrawal by Subject|1|||
161279727|NCT00678210|582404132|FG003|Overall Study|Withdrawal by Subject|7|||
161279728|NCT00678210|582404129|FG000|Overall Study|Other|1|||
161279729|NCT00678210|582404130|FG001|Overall Study|Other|0|||
161279730|NCT00678210|582404131|FG002|Overall Study|Other|1|||
161279731|NCT00678210|582404132|FG003|Overall Study|Other|0|||
161279732|NCT04825912|582404133|FG000|Overall Study|Death|3|||
161279733|NCT04825912|582404133|FG000|Overall Study|Withdrawal by Subject|1|||
161279734|NCT00615199|582404134|FG000|Overall Study|Adverse Event|3|||
161279735|NCT00615199|582404135|FG001|Overall Study|Adverse Event|1|||
161279736|NCT00615199|582404136|FG002|Overall Study|Adverse Event|1|||
161279737|NCT00615199|582404137|FG003|Overall Study|Adverse Event|0|||
161279738|NCT00615199|582404134|FG000|Overall Study|Lack of Efficacy|2|||
161279739|NCT00615199|582404135|FG001|Overall Study|Lack of Efficacy|0|||
161279740|NCT00615199|582404136|FG002|Overall Study|Lack of Efficacy|0|||
161279741|NCT00615199|582404137|FG003|Overall Study|Lack of Efficacy|1|||
161279742|NCT00615199|582404134|FG000|Overall Study|Lost to Follow-up|1|||
161279743|NCT00615199|582404135|FG001|Overall Study|Lost to Follow-up|0|||
161279744|NCT00615199|582404136|FG002|Overall Study|Lost to Follow-up|0|||
161279745|NCT00615199|582404137|FG003|Overall Study|Lost to Follow-up|0|||
161279746|NCT00615199|582404134|FG000|Overall Study|Other|0|||
161279747|NCT00615199|582404135|FG001|Overall Study|Other|0|||
161279748|NCT00615199|582404136|FG002|Overall Study|Other|0|||
161279749|NCT00615199|582404137|FG003|Overall Study|Other|1|||
160977545|NCT01027364|581307917|FG003|Overall Study|Adverse Event|0|||
160977546|NCT01027364|581307914|FG000|Overall Study|Lost to Follow-up|1|||
160977547|NCT01027364|581307915|FG001|Overall Study|Lost to Follow-up|0|||
160977548|NCT01027364|581307916|FG002|Overall Study|Lost to Follow-up|0|||
160977549|NCT01027364|581307917|FG003|Overall Study|Lost to Follow-up|0|||
160977550|NCT01027364|581307914|FG000|Overall Study|Protocol Violation|1|||
160977551|NCT01027364|581307915|FG001|Overall Study|Protocol Violation|0|||
160977552|NCT01027364|581307916|FG002|Overall Study|Protocol Violation|0|||
160977553|NCT01027364|581307917|FG003|Overall Study|Protocol Violation|1|||
160977554|NCT01027364|581307914|FG000|Overall Study|Withdrawal by Subject|1|||
160977555|NCT01027364|581307915|FG001|Overall Study|Withdrawal by Subject|2|||
160977556|NCT01027364|581307916|FG002|Overall Study|Withdrawal by Subject|0|||
160977557|NCT01027364|581307917|FG003|Overall Study|Withdrawal by Subject|0|||
160977558|NCT01394250|581307918|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
160977559|NCT01394250|581307919|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
160977560|NCT01394250|581307918|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
160977561|NCT01394250|581307919|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
160977562|NCT00579982|581307924|FG000|Overall Study|Adverse Event|4|||
160977563|NCT00579982|581307924|FG000|Overall Study|Protocol Violation|4|||
160977564|NCT00988351|581307926|FG000|Overall Study|Withdrawal by Subject|8|||
160977565|NCT00988351|581307927|FG001|Overall Study|Withdrawal by Subject|0|||
160977566|NCT00988351|581307926|FG000|Overall Study|Lost to Follow-up|6|||
160977567|NCT00988351|581307927|FG001|Overall Study|Lost to Follow-up|9|||
160977568|NCT00988351|581307926|FG000|Overall Study|not using CPAP|5|||
161279750|NCT00615199|582404134|FG000|Overall Study|Withdrawal by Subject|2|||
161279751|NCT00615199|582404135|FG001|Overall Study|Withdrawal by Subject|1|||
161279752|NCT00615199|582404136|FG002|Overall Study|Withdrawal by Subject|0|||
161279753|NCT00615199|582404137|FG003|Overall Study|Withdrawal by Subject|0|||
161279754|NCT00459355|582404140|FG000|Overall Study|Subject no longer met inc criteria|20|||
161279755|NCT00459355|582404141|FG001|Overall Study|Subject no longer met inc criteria|18|||
161279756|NCT00618371|582404142|FG000|Overall Study|Withdrawal by Subject|2|||
161279757|NCT02653625|582404143|FG000|Overall Study|Adverse Event|1|||
161279758|NCT02653625|582404143|FG000|Overall Study|Non-compliance with Study Drug|1|||
161344788|NCT01047319|582647278|FG001|Overall Study|Withdrawal by Subject|75|||
161344789|NCT01047319|582647279|FG002|Overall Study|Withdrawal by Subject|87|||
160977569|NCT00988351|581307927|FG001|Overall Study|not using CPAP|3|||
161035467|NCT01105975|581521636|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161035468|NCT01105975|581521637|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161035469|NCT01105975|581521638|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
161035470|NCT01105975|581521639|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161035471|NCT04868617|581521640|FG000|Overall Study|Death|1|||
161035472|NCT04868617|581521641|FG001|Overall Study|Death|0|||
161035473|NCT04868617|581521640|FG000|Overall Study|Adverse Event|1|||
161035474|NCT04868617|581521641|FG001|Overall Study|Adverse Event|0|||
161035475|NCT04868617|581521640|FG000|Overall Study|Withdrawal by Subject|1|||
161035476|NCT04868617|581521641|FG001|Overall Study|Withdrawal by Subject|0|||
161035477|NCT04868617|581521640|FG000|Overall Study|Device deficiency|1|||
161035478|NCT04868617|581521641|FG001|Overall Study|Device deficiency|0|||
161035479|NCT03183050|581521642|FG000|Overall Study|Lost to Follow-up|23|||
161035480|NCT02797132|581521645|FG000|Part A (15 Days)|Adverse Event|1|||
161035481|NCT02797132|581521645|FG000|Part B (24 Weeks)|Adverse Event|3|||
161035482|NCT02502526|581521646|FG000|Overall Study|Lost to Follow-up|2|||
161035483|NCT02502526|581521647|FG001|Overall Study|Lost to Follow-up|2|||
161035484|NCT02502526|581521648|FG002|Overall Study|Lost to Follow-up|3|||
161035485|NCT02502526|581521646|FG000|Overall Study|Withdrawal by Subject|0|||
161035486|NCT02502526|581521647|FG001|Overall Study|Withdrawal by Subject|1|||
161035487|NCT02502526|581521648|FG002|Overall Study|Withdrawal by Subject|1|||
161035488|NCT02502526|581521646|FG000|Overall Study|Disqualified due to cataract grading|0|||
161035489|NCT02502526|581521647|FG001|Overall Study|Disqualified due to cataract grading|0|||
161035490|NCT02502526|581521648|FG002|Overall Study|Disqualified due to cataract grading|1|||
160977570|NCT02038764|581307928|FG000|Overall Study|Adverse Event|0|||
160977571|NCT02038764|581307929|FG001|Overall Study|Adverse Event|0|||
160977572|NCT02038764|581307930|FG002|Overall Study|Adverse Event|1|||
160977573|NCT02038764|581307931|FG003|Overall Study|Adverse Event|0|||
160977574|NCT02038764|581307932|FG004|Overall Study|Adverse Event|0|||
160977575|NCT02038764|581307928|FG000|Overall Study|Lost to Follow-up|0|||
160977576|NCT02038764|581307929|FG001|Overall Study|Lost to Follow-up|1|||
160977577|NCT02038764|581307930|FG002|Overall Study|Lost to Follow-up|0|||
160977578|NCT02038764|581307931|FG003|Overall Study|Lost to Follow-up|0|||
160977579|NCT02038764|581307932|FG004|Overall Study|Lost to Follow-up|0|||
160977580|NCT02038764|581307928|FG000|Overall Study|Withdrawal by Subject|0|||
160977581|NCT02038764|581307929|FG001|Overall Study|Withdrawal by Subject|0|||
160977582|NCT02038764|581307930|FG002|Overall Study|Withdrawal by Subject|0|||
160977583|NCT02038764|581307931|FG003|Overall Study|Withdrawal by Subject|0|||
160977584|NCT02038764|581307932|FG004|Overall Study|Withdrawal by Subject|1|||
160977585|NCT02038764|581307928|FG000|Overall Study|Other|1|||
160977586|NCT02038764|581307929|FG001|Overall Study|Other|0|||
160977587|NCT02038764|581307930|FG002|Overall Study|Other|1|||
160977588|NCT02038764|581307931|FG003|Overall Study|Other|0|||
160977589|NCT02038764|581307932|FG004|Overall Study|Other|0|||
160977590|NCT03632434|581307941|FG000|Overall Study|Withdrawal by Subject|2|||
160977591|NCT04297241|581307943|FG000|Overall Study|Withdrawal by Subject|1|||
160977592|NCT04297241|581307943|FG000|Overall Study|Adverse Event|1|||
160977593|NCT04297241|581307943|FG000|Overall Study|Physician Decision|3|||
160977594|NCT02141659|581307944|FG000|Overall Study|Major Protocol Deviation|0|||
160977595|NCT02141659|581307945|FG001|Overall Study|Major Protocol Deviation|1|||
160977596|NCT02141659|581307946|FG002|Overall Study|Major Protocol Deviation|0|||
160977597|NCT02141659|581307947|FG003|Overall Study|Major Protocol Deviation|0|||
160977598|NCT02141659|581307948|FG004|Overall Study|Major Protocol Deviation|0|||
160977599|NCT02141659|581307949|FG005|Overall Study|Major Protocol Deviation|0|||
160977600|NCT02141659|581307944|FG000|Overall Study|Lack of Efficacy|0|||
160977601|NCT02141659|581307945|FG001|Overall Study|Lack of Efficacy|0|||
160977602|NCT02141659|581307946|FG002|Overall Study|Lack of Efficacy|0|||
160977603|NCT02141659|581307947|FG003|Overall Study|Lack of Efficacy|0|||
160977604|NCT02141659|581307948|FG004|Overall Study|Lack of Efficacy|0|||
160977605|NCT02141659|581307949|FG005|Overall Study|Lack of Efficacy|1|||
160977606|NCT02141659|581307944|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
160977607|NCT02141659|581307945|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
160977608|NCT02141659|581307946|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
161035491|NCT02502526|581521646|FG000|Overall Study|Enrollment suspension|4|||
161035492|NCT02502526|581521647|FG001|Overall Study|Enrollment suspension|1|||
161035493|NCT02502526|581521648|FG002|Overall Study|Enrollment suspension|1|||
161035494|NCT03473223|581521654|FG000|Overall Study|Lost to Follow-up|1|||
161035495|NCT03473223|581521655|FG001|Overall Study|Lost to Follow-up|1|||
161035496|NCT03473223|581521654|FG000|Overall Study|Withdrawal by Subject|47|||
161035497|NCT03473223|581521655|FG001|Overall Study|Withdrawal by Subject|42|||
161035498|NCT03473223|581521654|FG000|Overall Study|Indirect contact|32|||
161035499|NCT03473223|581521655|FG001|Overall Study|Indirect contact|29|||
161035500|NCT03473223|581521654|FG000|Overall Study|Other (Not specified)|32|||
161035501|NCT03473223|581521655|FG001|Overall Study|Other (Not specified)|20|||
161035502|NCT03777657|581521657|FG000|Overall Study|Death|397|||
161035503|NCT03777657|581521658|FG001|Overall Study|Death|431|||
161035504|NCT03777657|581521657|FG000|Overall Study|Study Closed by Sponsor|77|||
161035505|NCT03777657|581521658|FG001|Overall Study|Study Closed by Sponsor|38|||
161035506|NCT03777657|581521657|FG000|Overall Study|Withdrawal by Subject|20|||
161035507|NCT03777657|581521658|FG001|Overall Study|Withdrawal by Subject|17|||
161035508|NCT03777657|581521657|FG000|Overall Study|Lost to Follow-up|6|||
161035509|NCT03777657|581521658|FG001|Overall Study|Lost to Follow-up|10|||
161035510|NCT02549352|581521661|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
161035511|NCT02549352|581521662|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
161035512|NCT02549352|581521661|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
161035513|NCT02549352|581521662|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
161035514|NCT02549352|581521661|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
161035515|NCT02549352|581521662|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
161035516|NCT02549352|581521661|FG000|12-month Follow-up|Withdrawal by Subject|4|||
161035517|NCT02549352|581521662|FG001|12-month Follow-up|Withdrawal by Subject|5|||
161035518|NCT02549352|581521661|FG000|12-month Follow-up|Lost to Follow-up|3|||
161035519|NCT02549352|581521662|FG001|12-month Follow-up|Lost to Follow-up|2|||
161035520|NCT02549352|581521661|FG000|12-month Follow-up|Death|0|||
161035521|NCT02549352|581521662|FG001|12-month Follow-up|Death|1|||
161035522|NCT02549352|581521661|FG000|12-month Follow-up|Protocol Violation|0|||
161035523|NCT02549352|581521662|FG001|12-month Follow-up|Protocol Violation|1|||
161035524|NCT02549352|581521661|FG000|12-month Follow-up|Other|1|||
161035525|NCT02549352|581521662|FG001|12-month Follow-up|Other|3|||
161091182|NCT00336895|581723828|FG000|Overall Study|Physician Decision|1|||
161091183|NCT00336895|581723828|FG000|Overall Study|screen failed|1|||
161091184|NCT01959334|581723829|FG000|Second Dose|Adverse Event|1|||
161091185|NCT01959334|581723830|FG001|Second Dose|Adverse Event|0|||
161091186|NCT01959334|581723829|FG000|Third Dose|Adverse Event|0|||
161091187|NCT01959334|581723830|FG001|Third Dose|Adverse Event|1|||
161091188|NCT01313689|581723831|FG000|24-Week Randomization 1|Adverse Event|10|||
161091189|NCT01313689|581723832|FG001|24-Week Randomization 1|Adverse Event|5|||
161091190|NCT01313689|581723833|FG002|24-Week Randomization 1|Adverse Event|0|||
161091191|NCT01313689|581723834|FG003|24-Week Randomization 1|Adverse Event|0|||
161091192|NCT01313689|581723835|FG004|24-Week Randomization 1|Adverse Event|0|||
161091193|NCT01313689|581723831|FG000|24-Week Randomization 1|Physician Decision|4|||
161091194|NCT01313689|581723832|FG001|24-Week Randomization 1|Physician Decision|5|||
161091195|NCT01313689|581723833|FG002|24-Week Randomization 1|Physician Decision|0|||
161091196|NCT01313689|581723834|FG003|24-Week Randomization 1|Physician Decision|0|||
161091197|NCT01313689|581723835|FG004|24-Week Randomization 1|Physician Decision|0|||
161091198|NCT01313689|581723831|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
161091199|NCT01313689|581723832|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
161091200|NCT01313689|581723833|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
161091201|NCT01313689|581723834|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
161091202|NCT01313689|581723835|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
161091203|NCT01313689|581723831|FG000|24-Week Randomization 2|Adverse Event|0|||
161091204|NCT01313689|581723832|FG001|24-Week Randomization 2|Adverse Event|0|||
161091205|NCT01313689|581723833|FG002|24-Week Randomization 2|Adverse Event|2|||
161091206|NCT01313689|581723834|FG003|24-Week Randomization 2|Adverse Event|0|||
161091207|NCT01313689|581723835|FG004|24-Week Randomization 2|Adverse Event|8|||
161091208|NCT01313689|581723831|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
161091209|NCT01313689|581723832|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
161091210|NCT01313689|581723833|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
161091211|NCT01313689|581723834|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
161091212|NCT01313689|581723835|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
161091213|NCT01313689|581723831|FG000|24-Week Randomization 2|Physician Decision|0|||
161091214|NCT01313689|581723832|FG001|24-Week Randomization 2|Physician Decision|0|||
161091215|NCT01313689|581723833|FG002|24-Week Randomization 2|Physician Decision|0|||
161091216|NCT01313689|581723834|FG003|24-Week Randomization 2|Physician Decision|0|||
161091217|NCT01313689|581723835|FG004|24-Week Randomization 2|Physician Decision|4|||
161091218|NCT01768637|581723836|FG000|Overall Study|Lost to Follow-up|2|||
161091219|NCT01768637|581723837|FG001|Overall Study|Lost to Follow-up|7|||
161091220|NCT01768637|581723836|FG000|Overall Study|Difficult blood draw|1|||
161091221|NCT01768637|581723837|FG001|Overall Study|Difficult blood draw|0|||
161035526|NCT05864209|581522342|FG000|Overall Study|Lost to Follow-up|2|||
161035527|NCT05864209|581522343|FG001|Overall Study|Lost to Follow-up|3|||
161035528|NCT04530487|581522344|FG000|Overall Study|Death|1|||
161035529|NCT04977583|581522345|FG000|Overall Study|Lost to Follow-up|8|||
161035530|NCT04977583|581522346|FG001|Overall Study|Lost to Follow-up|4|||
161035531|NCT04977583|581522347|FG002|Overall Study|Lost to Follow-up|13|||
161035532|NCT04977583|581522345|FG000|Overall Study|Withdrawal by Subject|3|||
161035533|NCT04977583|581522346|FG001|Overall Study|Withdrawal by Subject|2|||
161035534|NCT04977583|581522347|FG002|Overall Study|Withdrawal by Subject|1|||
161035535|NCT00146172|581522352|FG000|Overall Study|Adverse Event|0|||
161035536|NCT00146172|581522353|FG001|Overall Study|Adverse Event|0|||
161035537|NCT00146172|581522354|FG002|Overall Study|Adverse Event|1|||
161035538|NCT00146172|581522355|FG003|Overall Study|Adverse Event|1|||
161035539|NCT00146172|581522356|FG004|Overall Study|Adverse Event|0|||
161035540|NCT00146172|581522357|FG005|Overall Study|Adverse Event|2|||
161035541|NCT00146172|581522358|FG006|Overall Study|Adverse Event|3|||
161035542|NCT00146172|581522359|FG007|Overall Study|Adverse Event|10|||
161035543|NCT00146172|581522352|FG000|Overall Study|Lost to Follow-up|0|||
161035544|NCT00146172|581522353|FG001|Overall Study|Lost to Follow-up|0|||
161035545|NCT00146172|581522354|FG002|Overall Study|Lost to Follow-up|0|||
161035546|NCT00146172|581522355|FG003|Overall Study|Lost to Follow-up|0|||
161035547|NCT00146172|581522356|FG004|Overall Study|Lost to Follow-up|0|||
161035548|NCT00146172|581522357|FG005|Overall Study|Lost to Follow-up|0|||
161035549|NCT00146172|581522358|FG006|Overall Study|Lost to Follow-up|0|||
161035550|NCT00146172|581522359|FG007|Overall Study|Lost to Follow-up|1|||
161035551|NCT00146172|581522352|FG000|Overall Study|Disease Progression|2|||
161035552|NCT00146172|581522353|FG001|Overall Study|Disease Progression|4|||
161035553|NCT00146172|581522354|FG002|Overall Study|Disease Progression|2|||
161035554|NCT00146172|581522355|FG003|Overall Study|Disease Progression|5|||
161035555|NCT00146172|581522356|FG004|Overall Study|Disease Progression|2|||
161035556|NCT00146172|581522357|FG005|Overall Study|Disease Progression|2|||
161035557|NCT00146172|581522358|FG006|Overall Study|Disease Progression|1|||
161035558|NCT00146172|581522359|FG007|Overall Study|Disease Progression|22|||
161035559|NCT00146172|581522352|FG000|Overall Study|Death|0|||
161035560|NCT00146172|581522353|FG001|Overall Study|Death|0|||
161035561|NCT00146172|581522354|FG002|Overall Study|Death|0|||
161035562|NCT00146172|581522355|FG003|Overall Study|Death|0|||
161035563|NCT00146172|581522356|FG004|Overall Study|Death|0|||
161035564|NCT00146172|581522357|FG005|Overall Study|Death|0|||
161035565|NCT00146172|581522358|FG006|Overall Study|Death|1|||
161035566|NCT00146172|581522359|FG007|Overall Study|Death|0|||
161035567|NCT00146172|581522352|FG000|Overall Study|Physician Decision|0|||
161035568|NCT00146172|581522353|FG001|Overall Study|Physician Decision|0|||
161035569|NCT00146172|581522354|FG002|Overall Study|Physician Decision|0|||
161035570|NCT00146172|581522355|FG003|Overall Study|Physician Decision|0|||
161035571|NCT00146172|581522356|FG004|Overall Study|Physician Decision|0|||
161035572|NCT00146172|581522357|FG005|Overall Study|Physician Decision|0|||
161035573|NCT00146172|581522358|FG006|Overall Study|Physician Decision|0|||
161035574|NCT00146172|581522359|FG007|Overall Study|Physician Decision|1|||
161035575|NCT00146172|581522352|FG000|Overall Study|Withdrawal by Subject|0|||
161035576|NCT00146172|581522353|FG001|Overall Study|Withdrawal by Subject|0|||
161035577|NCT00146172|581522354|FG002|Overall Study|Withdrawal by Subject|0|||
161035578|NCT00146172|581522355|FG003|Overall Study|Withdrawal by Subject|0|||
161035579|NCT00146172|581522356|FG004|Overall Study|Withdrawal by Subject|0|||
161035580|NCT00146172|581522357|FG005|Overall Study|Withdrawal by Subject|1|||
161035581|NCT00146172|581522358|FG006|Overall Study|Withdrawal by Subject|1|||
161035582|NCT00146172|581522359|FG007|Overall Study|Withdrawal by Subject|4|||
161035583|NCT00146172|581522352|FG000|Overall Study|Symptomatic Deterioration|1|||
161035584|NCT00146172|581522353|FG001|Overall Study|Symptomatic Deterioration|0|||
161035585|NCT00146172|581522354|FG002|Overall Study|Symptomatic Deterioration|1|||
161035586|NCT00146172|581522355|FG003|Overall Study|Symptomatic Deterioration|0|||
161035587|NCT00146172|581522356|FG004|Overall Study|Symptomatic Deterioration|1|||
161035588|NCT00146172|581522357|FG005|Overall Study|Symptomatic Deterioration|2|||
161279759|NCT02653625|582404143|FG000|Overall Study|Protocol Violation|1|||
161279760|NCT02653625|582404143|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
161279761|NCT03965689|582404144|FG000|Overall Study|Too sick to get study intervention|2|||
161279762|NCT00764881|582404146|FG000|Overall Study|Adverse Event|5|||
161035589|NCT00146172|581522358|FG006|Overall Study|Symptomatic Deterioration|0|||
161035590|NCT00146172|581522359|FG007|Overall Study|Symptomatic Deterioration|2|||
161035591|NCT00210106|581522360|FG000|Overall Study|Death|1|||
161035592|NCT00210106|581522360|FG000|Overall Study|Protocol Violation|13|||
161035593|NCT00786864|581522361|FG000|Overall Study|Lost to Follow-up|0|||
161035594|NCT00786864|581522362|FG001|Overall Study|Lost to Follow-up|1|||
161035595|NCT00786864|581522361|FG000|Overall Study|Sustained serious back injury|1|||
161035596|NCT00786864|581522362|FG001|Overall Study|Sustained serious back injury|0|||
161035597|NCT02422615|581522363|FG000|Treatment Period|Progressive disease|314|||
161035598|NCT02422615|581522364|FG001|Treatment Period|Progressive disease|200|||
161035599|NCT02422615|581522363|FG000|Treatment Period|Adverse Event|51|||
161035600|NCT02422615|581522364|FG001|Treatment Period|Adverse Event|9|||
161035601|NCT02422615|581522363|FG000|Treatment Period|Physician Decision|32|||
161279763|NCT00764881|582404147|FG001|Overall Study|Adverse Event|1|||
161035602|NCT02422615|581522364|FG001|Treatment Period|Physician Decision|8|||
161035603|NCT02422615|581522363|FG000|Treatment Period|Subject/guardian decision|38|||
161035604|NCT02422615|581522364|FG001|Treatment Period|Subject/guardian decision|8|||
161035605|NCT02422615|581522363|FG000|Treatment Period|Death|2|||
161035606|NCT02422615|581522364|FG001|Treatment Period|Death|1|||
161035607|NCT02422615|581522363|FG000|Treatment Period|Technical problems|0|||
161035608|NCT02422615|581522364|FG001|Treatment Period|Technical problems|1|||
161035609|NCT02422615|581522363|FG000|Treatment Period|Protocol deviation|1|||
161035610|NCT02422615|581522364|FG001|Treatment Period|Protocol deviation|1|||
161035611|NCT02422615|581522363|FG000|Treatment Period|Study terminated as per protocol|46|||
161035612|NCT02422615|581522364|FG001|Treatment Period|Study terminated as per protocol|14|||
161035613|NCT02422615|581522363|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161035614|NCT02422615|581522364|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161035615|NCT02422615|581522363|FG000|Post-treatment Efficacy Follow-up|Death|2|||
161035616|NCT02422615|581522364|FG001|Post-treatment Efficacy Follow-up|Death|1|||
161035617|NCT02422615|581522363|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
161035618|NCT02422615|581522364|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161035619|NCT02422615|581522363|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
161035620|NCT02422615|581522364|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
161035621|NCT02422615|581522363|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
161035622|NCT02422615|581522364|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
161035623|NCT02422615|581522363|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
161035624|NCT02422615|581522364|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
161035625|NCT04876417|581522365|FG000|Overall Study|Lost to Follow-up|5|||
161035626|NCT04876417|581522366|FG001|Overall Study|Lost to Follow-up|8|||
161035627|NCT04876417|581522367|FG002|Overall Study|Lost to Follow-up|0|||
161035628|NCT04876417|581522368|FG003|Overall Study|Lost to Follow-up|0|||
161035629|NCT00686595|581522370|FG000|Overall Study|Adverse Event|3|||
161035630|NCT00686595|581522370|FG000|Overall Study|Protocol Violation|1|||
161035631|NCT00686595|581522370|FG000|Overall Study|Lost to Follow-up|1|||
161035632|NCT00686595|581522370|FG000|Overall Study|Lack of Efficacy|1|||
161035633|NCT00686595|581522370|FG000|Overall Study|Poor Compliance|1|||
161035634|NCT02964741|581522371|FG000|Overall Study|Protocol Violation|1|||
161035635|NCT02964741|581522372|FG001|Overall Study|Protocol Violation|0|||
161035636|NCT02964741|581522373|FG002|Overall Study|Protocol Violation|0|||
161035637|NCT02964741|581522371|FG000|Overall Study|Withdrawal by Subject|0|||
161035638|NCT02964741|581522372|FG001|Overall Study|Withdrawal by Subject|1|||
161035639|NCT02964741|581522373|FG002|Overall Study|Withdrawal by Subject|0|||
161035640|NCT02964741|581522371|FG000|Overall Study|claustrophobia|1|||
161035641|NCT02964741|581522372|FG001|Overall Study|claustrophobia|0|||
161035642|NCT02964741|581522373|FG002|Overall Study|claustrophobia|0|||
161035643|NCT00640159|581522377|FG000|Overall Study|Lost to Follow-up|2|||
161035644|NCT00112359|581522378|FG000|Overall Study|Unrelated adverse event|16|||
161035645|NCT00112359|581522379|FG001|Overall Study|Unrelated adverse event|8|||
161035646|NCT00112359|581522378|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
161035647|NCT00112359|581522379|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
161035648|NCT00112359|581522378|FG000|Overall Study|Related adverse event|5|||
161035649|NCT00112359|581522379|FG001|Overall Study|Related adverse event|3|||
161035650|NCT00112359|581522378|FG000|Overall Study|Lost to Follow-up|0|||
161035651|NCT00112359|581522379|FG001|Overall Study|Lost to Follow-up|1|||
161035652|NCT00112359|581522378|FG000|Overall Study|Personal/administrative|1|||
161035653|NCT00112359|581522379|FG001|Overall Study|Personal/administrative|1|||
161035654|NCT00112359|581522378|FG000|Overall Study|Other|3|||
161035655|NCT00112359|581522379|FG001|Overall Study|Other|0|||
161035656|NCT00312208|581522380|FG000|Overall Study|Adverse Event|97|||
161279764|NCT00764881|582404146|FG000|Overall Study|Withdrawal by Subject|1|||
161035657|NCT00312208|581522381|FG001|Overall Study|Adverse Event|61|||
161035658|NCT00312208|581522380|FG000|Overall Study|Protocol Violation|5|||
161035659|NCT00312208|581522381|FG001|Overall Study|Protocol Violation|3|||
161035660|NCT00312208|581522380|FG000|Overall Study|Death|2|||
161035661|NCT00312208|581522381|FG001|Overall Study|Death|1|||
161035662|NCT00312208|581522380|FG000|Overall Study|Lack of Efficacy|7|||
161035663|NCT00312208|581522381|FG001|Overall Study|Lack of Efficacy|4|||
161035664|NCT00312208|581522380|FG000|Overall Study|Lost to Follow-up|3|||
161035665|NCT00312208|581522381|FG001|Overall Study|Lost to Follow-up|5|||
161035666|NCT00312208|581522380|FG000|Overall Study|Withdrawal by Subject|53|||
161035667|NCT00312208|581522381|FG001|Overall Study|Withdrawal by Subject|42|||
161035668|NCT00312208|581522380|FG000|Overall Study|Other|5|||
161279765|NCT00764881|582404147|FG001|Overall Study|Withdrawal by Subject|3|||
161035669|NCT00312208|581522381|FG001|Overall Study|Other|7|||
161035670|NCT01324310|581522382|FG000|Overall Study|Adverse Event|1|||
161035671|NCT01324310|581522382|FG000|Overall Study|Disease Progression|1|||
161035672|NCT01315132|581522383|FG000|Overall Study|not treated due to disease progression|1|||
161279766|NCT00764881|582404146|FG000|Overall Study|Protocol Violation|2|||
161279767|NCT00764881|582404147|FG001|Overall Study|Protocol Violation|2|||
161035673|NCT03213457|581522389|FG000|Screening Period|Withdrawal by Subject|0|||
161035674|NCT03213457|581522390|FG001|Screening Period|Withdrawal by Subject|1|||
161035675|NCT03213457|581522391|FG002|Screening Period|Withdrawal by Subject|0|||
161035676|NCT03213457|581522389|FG000|Screening Period|Other|1|||
161035677|NCT03213457|581522390|FG001|Screening Period|Other|0|||
161035678|NCT03213457|581522391|FG002|Screening Period|Other|0|||
161035679|NCT03213457|581522389|FG000|Double-Blind Period|Adverse Event|3|||
161035680|NCT03213457|581522390|FG001|Double-Blind Period|Adverse Event|2|||
161035681|NCT03213457|581522391|FG002|Double-Blind Period|Adverse Event|7|||
161035682|NCT03213457|581522389|FG000|Double-Blind Period|Withdrawal by Subject|14|||
161035683|NCT03213457|581522390|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161035684|NCT03213457|581522391|FG002|Double-Blind Period|Withdrawal by Subject|14|||
161035685|NCT03213457|581522389|FG000|Double-Blind Period|Lost to Follow-up|2|||
161035686|NCT03213457|581522390|FG001|Double-Blind Period|Lost to Follow-up|3|||
161035687|NCT03213457|581522391|FG002|Double-Blind Period|Lost to Follow-up|9|||
161035688|NCT03213457|581522389|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
161035689|NCT03213457|581522390|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
161035690|NCT03213457|581522391|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
161035691|NCT03213457|581522389|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
161035692|NCT03213457|581522390|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
161035693|NCT03213457|581522391|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
161035694|NCT03213457|581522389|FG000|Double-Blind Period|Pregnancy|5|||
161035695|NCT03213457|581522390|FG001|Double-Blind Period|Pregnancy|0|||
161035696|NCT03213457|581522391|FG002|Double-Blind Period|Pregnancy|0|||
161035697|NCT03213457|581522389|FG000|Double-Blind Period|Other|10|||
161035698|NCT03213457|581522390|FG001|Double-Blind Period|Other|3|||
161035699|NCT03213457|581522391|FG002|Double-Blind Period|Other|17|||
161035700|NCT03213457|581522389|FG000|Open-Label Period|Adverse Event|1|||
161035701|NCT03213457|581522390|FG001|Open-Label Period|Adverse Event|2|||
161035702|NCT03213457|581522391|FG002|Open-Label Period|Adverse Event|2|||
161035703|NCT03213457|581522389|FG000|Open-Label Period|Withdrawal by Subject|12|||
161035704|NCT03213457|581522390|FG001|Open-Label Period|Withdrawal by Subject|5|||
161035705|NCT03213457|581522391|FG002|Open-Label Period|Withdrawal by Subject|24|||
161035706|NCT03213457|581522389|FG000|Open-Label Period|Lost to Follow-up|1|||
161035707|NCT03213457|581522390|FG001|Open-Label Period|Lost to Follow-up|2|||
161035708|NCT03213457|581522391|FG002|Open-Label Period|Lost to Follow-up|8|||
161035709|NCT03213457|581522389|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
161035710|NCT03213457|581522390|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
161035711|NCT03213457|581522391|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
161035712|NCT03213457|581522389|FG000|Open-Label Period|Non-compliance with study procedures|1|||
161035713|NCT03213457|581522390|FG001|Open-Label Period|Non-compliance with study procedures|1|||
161035714|NCT03213457|581522391|FG002|Open-Label Period|Non-compliance with study procedures|2|||
161035715|NCT03213457|581522389|FG000|Open-Label Period|Exclusionary medications|0|||
161035716|NCT03213457|581522390|FG001|Open-Label Period|Exclusionary medications|0|||
161035717|NCT03213457|581522391|FG002|Open-Label Period|Exclusionary medications|1|||
161035718|NCT03213457|581522389|FG000|Open-Label Period|Other|1|||
161035719|NCT03213457|581522390|FG001|Open-Label Period|Other|1|||
161035720|NCT03213457|581522391|FG002|Open-Label Period|Other|6|||
161035721|NCT03213457|581522389|FG000|Follow-Up Period|Adverse Event|16|||
161035722|NCT03213457|581522390|FG001|Follow-Up Period|Adverse Event|8|||
161035723|NCT03213457|581522391|FG002|Follow-Up Period|Adverse Event|37|||
161035724|NCT03213457|581522389|FG000|Follow-Up Period|Withdrawal by Subject|18|||
161035725|NCT03213457|581522390|FG001|Follow-Up Period|Withdrawal by Subject|11|||
161035726|NCT03213457|581522391|FG002|Follow-Up Period|Withdrawal by Subject|55|||
161035727|NCT03213457|581522389|FG000|Follow-Up Period|Lost to Follow-up|28|||
161035728|NCT03213457|581522390|FG001|Follow-Up Period|Lost to Follow-up|15|||
161035729|NCT03213457|581522391|FG002|Follow-Up Period|Lost to Follow-up|50|||
161035730|NCT03213457|581522389|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
161035731|NCT03213457|581522390|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
161035732|NCT03213457|581522391|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
161035733|NCT03213457|581522389|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
161035734|NCT03213457|581522390|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
161035735|NCT03213457|581522391|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
161035736|NCT03213457|581522389|FG000|Follow-Up Period|Pregnancy|7|||
161035737|NCT03213457|581522390|FG001|Follow-Up Period|Pregnancy|0|||
161035738|NCT03213457|581522391|FG002|Follow-Up Period|Pregnancy|18|||
161035739|NCT03213457|581522389|FG000|Follow-Up Period|Exclusionary medications|1|||
161035740|NCT03213457|581522390|FG001|Follow-Up Period|Exclusionary medications|1|||
161035741|NCT03213457|581522391|FG002|Follow-Up Period|Exclusionary medications|5|||
161035742|NCT03213457|581522389|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
161035743|NCT03213457|581522390|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
161091222|NCT01054170|581723838|FG000|Overall Study|Protocol Violation|1|||
161035744|NCT03213457|581522391|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
161035745|NCT03213457|581522389|FG000|Follow-Up Period|Other|14|||
161035746|NCT03213457|581522390|FG001|Follow-Up Period|Other|10|||
161035747|NCT03213457|581522391|FG002|Follow-Up Period|Other|31|||
161035748|NCT03150862|581522396|FG000|Overall Study|Death|2|||
161035749|NCT03150862|581522397|FG001|Overall Study|Death|7|||
161035750|NCT03150862|581522398|FG002|Overall Study|Death|8|||
161279768|NCT00764881|582404146|FG000|Overall Study|Lost to Follow-up|2|||
161279769|NCT00764881|582404147|FG001|Overall Study|Lost to Follow-up|0|||
161279770|NCT00764881|582404146|FG000|Overall Study|Noncompliant|1|||
161279771|NCT00764881|582404147|FG001|Overall Study|Noncompliant|0|||
161279772|NCT00764881|582404146|FG000|Overall Study|Accidentally discontinued study drug|1|||
161279773|NCT00764881|582404147|FG001|Overall Study|Accidentally discontinued study drug|0|||
161279774|NCT00764881|582404146|FG000|Overall Study|Wished to become pregnant|1|||
161279775|NCT00764881|582404147|FG001|Overall Study|Wished to become pregnant|0|||
161279776|NCT00764881|582404146|FG000|Overall Study|Carcinoma detected|1|||
161279777|NCT00764881|582404147|FG001|Overall Study|Carcinoma detected|0|||
161279778|NCT00764881|582404146|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
161279779|NCT00764881|582404147|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
161279780|NCT00764881|582404146|FG000|Overall Study|no treatment or no observation|2|||
161279781|NCT00764881|582404147|FG001|Overall Study|no treatment or no observation|2|||
161279782|NCT01214655|582404148|FG000|Part A|Progressive Disease|7|||
161279783|NCT01214655|582404149|FG001|Part A|Progressive Disease|0|||
161035751|NCT03150862|581522399|FG003|Overall Study|Death|27|||
161035752|NCT03150862|581522400|FG004|Overall Study|Death|4|||
161035753|NCT03150862|581522401|FG005|Overall Study|Death|8|||
161035754|NCT03150862|581522402|FG006|Overall Study|Death|6|||
161035755|NCT03150862|581522403|FG007|Overall Study|Death|21|||
161035756|NCT03150862|581522396|FG000|Overall Study|Withdrawal by Subject|1|||
161035757|NCT03150862|581522397|FG001|Overall Study|Withdrawal by Subject|1|||
161035758|NCT03150862|581522398|FG002|Overall Study|Withdrawal by Subject|0|||
161035759|NCT03150862|581522399|FG003|Overall Study|Withdrawal by Subject|3|||
161035760|NCT03150862|581522400|FG004|Overall Study|Withdrawal by Subject|1|||
161035761|NCT03150862|581522401|FG005|Overall Study|Withdrawal by Subject|1|||
161035762|NCT03150862|581522402|FG006|Overall Study|Withdrawal by Subject|1|||
161035763|NCT03150862|581522403|FG007|Overall Study|Withdrawal by Subject|3|||
161035764|NCT03150862|581522396|FG000|Overall Study|Lost to Follow-up|0|||
161035765|NCT03150862|581522397|FG001|Overall Study|Lost to Follow-up|0|||
161035766|NCT03150862|581522398|FG002|Overall Study|Lost to Follow-up|1|||
161035767|NCT03150862|581522399|FG003|Overall Study|Lost to Follow-up|0|||
161035768|NCT03150862|581522400|FG004|Overall Study|Lost to Follow-up|0|||
161035769|NCT03150862|581522401|FG005|Overall Study|Lost to Follow-up|0|||
161035770|NCT03150862|581522402|FG006|Overall Study|Lost to Follow-up|0|||
161035771|NCT03150862|581522403|FG007|Overall Study|Lost to Follow-up|2|||
161035772|NCT03150862|581522396|FG000|Overall Study|Sponsor's decision|0|||
161035773|NCT03150862|581522397|FG001|Overall Study|Sponsor's decision|0|||
161035774|NCT03150862|581522398|FG002|Overall Study|Sponsor's decision|0|||
161035775|NCT03150862|581522399|FG003|Overall Study|Sponsor's decision|10|||
161035776|NCT03150862|581522400|FG004|Overall Study|Sponsor's decision|3|||
161035777|NCT03150862|581522401|FG005|Overall Study|Sponsor's decision|0|||
161035778|NCT03150862|581522402|FG006|Overall Study|Sponsor's decision|1|||
161035779|NCT03150862|581522403|FG007|Overall Study|Sponsor's decision|1|||
161035780|NCT03150862|581522396|FG000|Overall Study|Change in Methylation status|0|||
161035781|NCT03150862|581522397|FG001|Overall Study|Change in Methylation status|0|||
161035782|NCT03150862|581522398|FG002|Overall Study|Change in Methylation status|0|||
161035783|NCT03150862|581522399|FG003|Overall Study|Change in Methylation status|0|||
161035784|NCT03150862|581522400|FG004|Overall Study|Change in Methylation status|1|||
161279784|NCT01214655|582404150|FG002|Part A|Progressive Disease|0|||
161035785|NCT03150862|581522401|FG005|Overall Study|Change in Methylation status|0|||
161035786|NCT03150862|581522402|FG006|Overall Study|Change in Methylation status|0|||
161035787|NCT03150862|581522403|FG007|Overall Study|Change in Methylation status|0|||
161035788|NCT03150862|581522396|FG000|Overall Study|Roll over in to Long Term Extension|0|||
161035789|NCT03150862|581522397|FG001|Overall Study|Roll over in to Long Term Extension|0|||
161035790|NCT03150862|581522398|FG002|Overall Study|Roll over in to Long Term Extension|0|||
161035791|NCT03150862|581522399|FG003|Overall Study|Roll over in to Long Term Extension|0|||
161279785|NCT01214655|582404148|FG000|Part A|Physician Decision|1|||
161279786|NCT01214655|582404149|FG001|Part A|Physician Decision|0|||
161279787|NCT01214655|582404150|FG002|Part A|Physician Decision|0|||
161035792|NCT03150862|581522400|FG004|Overall Study|Roll over in to Long Term Extension|0|||
161035793|NCT03150862|581522401|FG005|Overall Study|Roll over in to Long Term Extension|0|||
161035794|NCT03150862|581522402|FG006|Overall Study|Roll over in to Long Term Extension|0|||
161035795|NCT03150862|581522403|FG007|Overall Study|Roll over in to Long Term Extension|1|||
161035796|NCT03150862|581522396|FG000|Overall Study|Progressive Disease|0|||
161035797|NCT03150862|581522397|FG001|Overall Study|Progressive Disease|0|||
161279788|NCT01214655|582404148|FG000|Part B|Progressive disease|0|||
161279789|NCT01214655|582404149|FG001|Part B|Progressive disease|10|||
161279790|NCT01214655|582404150|FG002|Part B|Progressive disease|0|||
161035798|NCT03150862|581522398|FG002|Overall Study|Progressive Disease|0|||
161035799|NCT03150862|581522399|FG003|Overall Study|Progressive Disease|0|||
161035800|NCT03150862|581522400|FG004|Overall Study|Progressive Disease|0|||
161035801|NCT03150862|581522401|FG005|Overall Study|Progressive Disease|0|||
161035802|NCT03150862|581522402|FG006|Overall Study|Progressive Disease|0|||
161035803|NCT03150862|581522403|FG007|Overall Study|Progressive Disease|2|||
161035804|NCT05521516|581522406|FG000|Overall Study|Withdrawal by Subject|1|||
161035805|NCT05521516|581522407|FG001|Overall Study|Withdrawal by Subject|1|||
161035806|NCT00747565|581522408|FG000|Overall Study|Withdrawal by Subject|10|||
161035807|NCT00747565|581522409|FG001|Overall Study|Withdrawal by Subject|6|||
161035808|NCT00747565|581522408|FG000|Overall Study|Lost to Follow-up|4|||
161035809|NCT00747565|581522409|FG001|Overall Study|Lost to Follow-up|1|||
161035810|NCT01983683|581522414|FG000|Overall Study|Withdrawal by Subject|14|||
161035811|NCT01983683|581522415|FG001|Overall Study|Withdrawal by Subject|18|||
161035812|NCT01983683|581522414|FG000|Overall Study|Death|11|||
161035813|NCT01983683|581522415|FG001|Overall Study|Death|15|||
161035814|NCT01983683|581522414|FG000|Overall Study|Physician Decision|8|||
161035815|NCT01983683|581522415|FG001|Overall Study|Physician Decision|9|||
161035816|NCT01983683|581522414|FG000|Overall Study|Lost to Follow-up|4|||
161035817|NCT01983683|581522415|FG001|Overall Study|Lost to Follow-up|8|||
161035818|NCT01983683|581522414|FG000|Overall Study|Sponsor Decision|1|||
161035819|NCT01983683|581522415|FG001|Overall Study|Sponsor Decision|1|||
161035820|NCT00536120|581523186|FG000|Overall Study|Lost to Follow-up|1|||
161035821|NCT00536120|581523187|FG001|Overall Study|Lost to Follow-up|0|||
161035822|NCT00536120|581523186|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
161035823|NCT00536120|581523187|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
161035824|NCT00536120|581523186|FG000|Overall Study|Non-compliance|1|||
161035825|NCT00536120|581523187|FG001|Overall Study|Non-compliance|0|||
161035826|NCT00536120|581523186|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
161035827|NCT00536120|581523187|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
161035828|NCT00536120|581523186|FG000|Overall Study|Steroid Use|0|||
161035829|NCT00536120|581523187|FG001|Overall Study|Steroid Use|2|||
161035830|NCT00536120|581523186|FG000|Overall Study|Missed Study Visit|0|||
161035831|NCT00536120|581523187|FG001|Overall Study|Missed Study Visit|1|||
161035832|NCT04559698|581523188|FG000|Overall Study|Lost to Follow-up|14|||
161035833|NCT04559698|581523189|FG001|Overall Study|Lost to Follow-up|15|||
161035834|NCT04559698|581523188|FG000|Overall Study|Withdrawal by Subject|0|||
161035835|NCT04559698|581523189|FG001|Overall Study|Withdrawal by Subject|1|||
161035836|NCT03437733|581523190|FG000|Overall Study|Eligibility criteria not met|0|||
161035837|NCT03437733|581523191|FG001|Overall Study|Eligibility criteria not met|3|||
161035838|NCT01982682|581523195|FG000|Overall Study|Physician Decision|1|||
161035839|NCT02760654|581523196|FG000|Overall Study|Lost to Follow-up|3|||
161035840|NCT02760654|581523197|FG001|Overall Study|Lost to Follow-up|3|||
161035841|NCT02760654|581523196|FG000|Overall Study|Withdrawal by Subject|4|||
161035842|NCT02760654|581523197|FG001|Overall Study|Withdrawal by Subject|3|||
161035843|NCT03876457|581523202|FG000|Overall Study|Lost to Follow-up|1|||
161035844|NCT03876457|581523203|FG001|Overall Study|Lost to Follow-up|3|||
161035845|NCT01184326|581523204|FG000|Overall Study|Adverse Event|1|||
161035846|NCT01184326|581523205|FG001|Overall Study|Adverse Event|2|||
161035847|NCT01184326|581523206|FG002|Overall Study|Adverse Event|0|||
161035848|NCT01184326|581523204|FG000|Overall Study|Death|0|||
161035849|NCT01184326|581523205|FG001|Overall Study|Death|0|||
161035850|NCT01184326|581523206|FG002|Overall Study|Death|1|||
161035851|NCT01184326|581523204|FG000|Overall Study|Withdrawal by Subject|0|||
161035852|NCT01184326|581523205|FG001|Overall Study|Withdrawal by Subject|0|||
161035853|NCT01184326|581523206|FG002|Overall Study|Withdrawal by Subject|1|||
161035854|NCT01184326|581523204|FG000|Overall Study|Physician Decision|1|||
161035855|NCT01184326|581523205|FG001|Overall Study|Physician Decision|1|||
161035856|NCT01184326|581523206|FG002|Overall Study|Physician Decision|0|||
161035857|NCT01184326|581523204|FG000|Overall Study|Disease Progression|1|||
161035858|NCT01184326|581523205|FG001|Overall Study|Disease Progression|3|||
161035859|NCT01184326|581523206|FG002|Overall Study|Disease Progression|12|||
161035860|NCT01036724|581523207|FG000|Overall Study|Adverse Event|1|||
161035861|NCT01036724|581523208|FG001|Overall Study|Adverse Event|2|||
161035862|NCT01036724|581523207|FG000|Overall Study|Lack of Efficacy|1|||
161035863|NCT01036724|581523208|FG001|Overall Study|Lack of Efficacy|1|||
161035864|NCT01036724|581523207|FG000|Overall Study|Protocol Violation|4|||
161035865|NCT01036724|581523208|FG001|Overall Study|Protocol Violation|5|||
161035866|NCT01574716|581523210|FG000|Part 1|Death|3|||
161035867|NCT01574716|581523211|FG001|Part 1|Death|1|||
161035868|NCT01574716|581523212|FG002|Part 1|Death|8|||
161035869|NCT01574716|581523213|FG003|Part 1|Death|0|||
161035870|NCT01574716|581523214|FG004|Part 1|Death|0|||
161035871|NCT01574716|581523210|FG000|Part 1|Discontinuation of study by sponsor|0|||
161035872|NCT01574716|581523211|FG001|Part 1|Discontinuation of study by sponsor|0|||
161035873|NCT01574716|581523212|FG002|Part 1|Discontinuation of study by sponsor|1|||
161035874|NCT01574716|581523213|FG003|Part 1|Discontinuation of study by sponsor|0|||
161035875|NCT01574716|581523214|FG004|Part 1|Discontinuation of study by sponsor|0|||
161035876|NCT01574716|581523210|FG000|Part 1|Withdrawal by Subject|0|||
161035877|NCT01574716|581523211|FG001|Part 1|Withdrawal by Subject|2|||
161035878|NCT01574716|581523212|FG002|Part 1|Withdrawal by Subject|0|||
161279791|NCT01214655|582404148|FG000|Part B|Death|0|||
161279792|NCT01214655|582404149|FG001|Part B|Death|1|||
161279793|NCT01214655|582404150|FG002|Part B|Death|0|||
161279794|NCT01214655|582404148|FG000|Part B|Withdrawal by Subject|0|||
161279795|NCT01214655|582404149|FG001|Part B|Withdrawal by Subject|2|||
161279796|NCT01214655|582404150|FG002|Part B|Withdrawal by Subject|0|||
161279797|NCT01214655|582404148|FG000|Part C|Progressive Disease|0|||
161279798|NCT01214655|582404149|FG001|Part C|Progressive Disease|0|||
161279799|NCT01214655|582404150|FG002|Part C|Progressive Disease|5|||
161279800|NCT01214655|582404148|FG000|Part C|Death|0|||
161279801|NCT01214655|582404149|FG001|Part C|Death|0|||
161279802|NCT01214655|582404150|FG002|Part C|Death|1|||
161279803|NCT01214655|582404148|FG000|Part C|Physician Decision|0|||
161279804|NCT01214655|582404149|FG001|Part C|Physician Decision|0|||
161279805|NCT01214655|582404150|FG002|Part C|Physician Decision|1|||
161279806|NCT01611857|582404151|FG000|Overall Study|Withdrawal by Subject|0|||
161279807|NCT01611857|582404152|FG001|Overall Study|Withdrawal by Subject|2|||
161279808|NCT02439970|582404153|FG000|Overall Study|Study Terminated|2|||
161279809|NCT02439970|582404154|FG001|Overall Study|Study Terminated|3|||
161279810|NCT01121562|582404155|FG000|Overall Study|Objective progression or relapse|8|||
161279811|NCT01121562|582404155|FG000|Overall Study|Withdrawal by Subject|1|||
161279812|NCT01121562|582404155|FG000|Overall Study|Adverse Event|1|||
161279813|NCT01121562|582404155|FG000|Overall Study|Sponsor Decision|1|||
161279814|NCT01121562|582404155|FG000|Overall Study|Met study discontinuation criteria|1|||
161279815|NCT00616421|582404156|FG000|Overall Study|Withdrawal by Subject|9|||
161279816|NCT00616421|582404157|FG001|Overall Study|Withdrawal by Subject|11|||
161279817|NCT00616421|582404158|FG002|Overall Study|Withdrawal by Subject|8|||
161279818|NCT00616421|582404156|FG000|Overall Study|Lost to Follow-up|12|||
161279819|NCT00616421|582404157|FG001|Overall Study|Lost to Follow-up|26|||
161279820|NCT00616421|582404158|FG002|Overall Study|Lost to Follow-up|30|||
161279821|NCT00616421|582404156|FG000|Overall Study|Inappropriate enrollment|3|||
161279822|NCT00616421|582404157|FG001|Overall Study|Inappropriate enrollment|0|||
161279823|NCT00616421|582404158|FG002|Overall Study|Inappropriate enrollment|1|||
161279824|NCT00616421|582404156|FG000|Overall Study|Administrative reason|1|||
161279825|NCT00616421|582404157|FG001|Overall Study|Administrative reason|0|||
161279826|NCT00616421|582404158|FG002|Overall Study|Administrative reason|0|||
161279827|NCT00616421|582404156|FG000|Overall Study|Protocol Violation|0|||
161279828|NCT00616421|582404157|FG001|Overall Study|Protocol Violation|1|||
161279829|NCT00616421|582404158|FG002|Overall Study|Protocol Violation|2|||
161279830|NCT00616421|582404156|FG000|Overall Study|Unable to classify|1|||
161279831|NCT00616421|582404157|FG001|Overall Study|Unable to classify|0|||
161279832|NCT00616421|582404158|FG002|Overall Study|Unable to classify|0|||
161035879|NCT01574716|581523213|FG003|Part 1|Withdrawal by Subject|0|||
161035880|NCT01574716|581523214|FG004|Part 1|Withdrawal by Subject|0|||
161035881|NCT01574716|581523210|FG000|Part 1|Lost to Follow-up|0|||
161035882|NCT01574716|581523211|FG001|Part 1|Lost to Follow-up|1|||
161035883|NCT01574716|581523212|FG002|Part 1|Lost to Follow-up|0|||
161035884|NCT01574716|581523213|FG003|Part 1|Lost to Follow-up|0|||
161035885|NCT01574716|581523214|FG004|Part 1|Lost to Follow-up|0|||
161035886|NCT01574716|581523210|FG000|Part 2|Progressive disease|0|||
161035887|NCT01574716|581523211|FG001|Part 2|Progressive disease|0|||
161035888|NCT01574716|581523212|FG002|Part 2|Progressive disease|0|||
161035889|NCT01574716|581523213|FG003|Part 2|Progressive disease|1|||
161035890|NCT01574716|581523214|FG004|Part 2|Progressive disease|0|||
161035891|NCT01574716|581523210|FG000|Part 2|Death|0|||
161035892|NCT01574716|581523211|FG001|Part 2|Death|0|||
161035893|NCT01574716|581523212|FG002|Part 2|Death|0|||
161035894|NCT01574716|581523213|FG003|Part 2|Death|76|||
161035895|NCT01574716|581523214|FG004|Part 2|Death|35|||
161035896|NCT01574716|581523210|FG000|Part 2|Discontinuation of study by sponsor|0|||
161279833|NCT01495702|582404159|FG000|Randomized Phase|Randomized But Not Treated|1|||
161279834|NCT01495702|582404160|FG001|Randomized Phase|Randomized But Not Treated|4|||
161279835|NCT01495702|582404159|FG000|Randomized Phase|Adverse Event|2|||
161279836|NCT01495702|582404160|FG001|Randomized Phase|Adverse Event|2|||
161279837|NCT01495702|582404159|FG000|Randomized Phase|Death|1|||
161279838|NCT01495702|582404160|FG001|Randomized Phase|Death|0|||
161279839|NCT01495702|582404159|FG000|Randomized Phase|Lack of Efficacy|2|||
161279840|NCT01495702|582404160|FG001|Randomized Phase|Lack of Efficacy|0|||
161279841|NCT01495702|582404159|FG000|Randomized Phase|Investigators Discretion|2|||
161279842|NCT01495702|582404160|FG001|Randomized Phase|Investigators Discretion|0|||
161279843|NCT01495702|582404159|FG000|Randomized Phase|Withdrew Consent|10|||
161279844|NCT01495702|582404160|FG001|Randomized Phase|Withdrew Consent|18|||
161279845|NCT01495702|582404159|FG000|Randomized Phase|Lost to Follow-up|4|||
161279846|NCT01495702|582404160|FG001|Randomized Phase|Lost to Follow-up|3|||
161279847|NCT01495702|582404159|FG000|Randomized Phase|Participant Noncompliance|1|||
161035897|NCT01574716|581523211|FG001|Part 2|Discontinuation of study by sponsor|0|||
161279848|NCT01495702|582404160|FG001|Randomized Phase|Participant Noncompliance|0|||
161035898|NCT01574716|581523212|FG002|Part 2|Discontinuation of study by sponsor|0|||
161035899|NCT01574716|581523213|FG003|Part 2|Discontinuation of study by sponsor|51|||
161279849|NCT01495702|582404159|FG000|Randomized Phase|Protocol Violation|3|||
161279850|NCT01495702|582404160|FG001|Randomized Phase|Protocol Violation|1|||
161035900|NCT01574716|581523214|FG004|Part 2|Discontinuation of study by sponsor|31|||
161035901|NCT01574716|581523210|FG000|Part 2|Withdrawal by Subject|0|||
161035902|NCT01574716|581523211|FG001|Part 2|Withdrawal by Subject|0|||
161035903|NCT01574716|581523212|FG002|Part 2|Withdrawal by Subject|0|||
161035904|NCT01574716|581523213|FG003|Part 2|Withdrawal by Subject|5|||
161035905|NCT01574716|581523214|FG004|Part 2|Withdrawal by Subject|4|||
161035906|NCT01574716|581523210|FG000|Part 2|Brain metastases|0|||
161035907|NCT01574716|581523211|FG001|Part 2|Brain metastases|0|||
161035908|NCT01574716|581523212|FG002|Part 2|Brain metastases|0|||
161035909|NCT01574716|581523213|FG003|Part 2|Brain metastases|1|||
161035910|NCT01574716|581523214|FG004|Part 2|Brain metastases|0|||
161035911|NCT01574716|581523210|FG000|Part 2|Lost to Follow-up|0|||
161035912|NCT01574716|581523211|FG001|Part 2|Lost to Follow-up|0|||
161035913|NCT01574716|581523212|FG002|Part 2|Lost to Follow-up|0|||
161035914|NCT01574716|581523213|FG003|Part 2|Lost to Follow-up|3|||
161035915|NCT01574716|581523214|FG004|Part 2|Lost to Follow-up|0|||
161035916|NCT04017611|581523216|FG000|Overall Study|Withdrawn prior to completion|1|||
161035917|NCT00246805|581523228|FG000|Phase 1|Lost to Follow-up|1|||
161035918|NCT00246805|581523229|FG001|Phase 1|Lost to Follow-up|0|||
161035919|NCT01342367|581523231|FG000|Overall Study|Death|1|||
161035920|NCT01342367|581523232|FG001|Overall Study|Death|0|||
161035921|NCT01342367|581523231|FG000|Overall Study|Withdrawal by Subject|1|||
161035922|NCT01342367|581523232|FG001|Overall Study|Withdrawal by Subject|2|||
161035923|NCT03170882|581523235|FG000|Overall Study|Death|17|||
161035924|NCT03170882|581523236|FG001|Overall Study|Death|29|||
161035925|NCT03170882|581523235|FG000|Overall Study|Lost to Follow-up|0|||
161035926|NCT03170882|581523236|FG001|Overall Study|Lost to Follow-up|1|||
161035927|NCT03170882|581523235|FG000|Overall Study|Withdrawal by Subject|4|||
161035928|NCT03170882|581523236|FG001|Overall Study|Withdrawal by Subject|7|||
161035929|NCT03170882|581523235|FG000|Overall Study|Reason not Specified|28|||
161035930|NCT03170882|581523236|FG001|Overall Study|Reason not Specified|36|||
161035931|NCT01371994|581523240|FG000|Overall Study|Adverse Event|3|||
161035932|NCT01371994|581523241|FG001|Overall Study|Adverse Event|6|||
161035933|NCT01371994|581523240|FG000|Overall Study|Lack of Efficacy|3|||
161035934|NCT01371994|581523241|FG001|Overall Study|Lack of Efficacy|0|||
161035935|NCT01371994|581523240|FG000|Overall Study|Withdrawal by Subject|13|||
161035936|NCT01371994|581523241|FG001|Overall Study|Withdrawal by Subject|7|||
161035937|NCT01371994|581523240|FG000|Overall Study|Lost to Follow-up|1|||
161035938|NCT01371994|581523241|FG001|Overall Study|Lost to Follow-up|1|||
161035939|NCT01371994|581523240|FG000|Overall Study|Protocol Violation|24|||
161035940|NCT01371994|581523241|FG001|Overall Study|Protocol Violation|17|||
161035941|NCT01371994|581523240|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
161035942|NCT01371994|581523241|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
161035943|NCT01371994|581523240|FG000|Overall Study|Physician Decision|1|||
161035944|NCT01371994|581523241|FG001|Overall Study|Physician Decision|1|||
161035945|NCT01371994|581523240|FG000|Overall Study|Miscellaneous Reasons|6|||
161035946|NCT01371994|581523241|FG001|Overall Study|Miscellaneous Reasons|4|||
161035947|NCT00087685|581523242|FG000|Overall Study|Adverse Event|5|||
161035948|NCT00087685|581523242|FG000|Overall Study|Non-Compliance|1|||
161035949|NCT00087685|581523242|FG000|Overall Study|Progressive Disease|5|||
161035950|NCT00087685|581523242|FG000|Overall Study|Withdrawal by Subject|3|||
161035951|NCT01830595|581523243|FG000|First Period|Withdrawal by Subject|1|||
161035952|NCT01830595|581523244|FG001|First Period|Withdrawal by Subject|3|||
161035953|NCT01830595|581523243|FG000|Washout|Withdrawal by Subject|2|||
161035954|NCT01830595|581523244|FG001|Washout|Withdrawal by Subject|2|||
161035955|NCT05139992|581523246|FG000|Overall Study|Withdrawal by Subject|12|||
161035956|NCT05139992|581523246|FG000|Overall Study|Lost to Follow-up|6|||
161035957|NCT03275285|581523249|FG000|Overall Study|Ongoing|45|||
161035958|NCT03275285|581523250|FG001|Overall Study|Ongoing|69|||
161035959|NCT00115934|581523251|FG000|Overall Study|Lost to Follow-up|1|||
161035960|NCT00115934|581523252|FG001|Overall Study|Lost to Follow-up|0|||
161035961|NCT00115934|581523251|FG000|Overall Study|Did not receive intervention|3|||
161035962|NCT00115934|581523252|FG001|Overall Study|Did not receive intervention|2|||
161035963|NCT00319020|581523254|FG000|Overall Study|Death|2|||
161035964|NCT00319020|581523255|FG001|Overall Study|Death|2|||
161035965|NCT00319020|581523254|FG000|Overall Study|Withdrawal by Subject|4|||
161035966|NCT00319020|581523255|FG001|Overall Study|Withdrawal by Subject|1|||
161035967|NCT00319020|581523254|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
161035968|NCT00319020|581523255|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
161035969|NCT00319020|581523254|FG000|Overall Study|Administrative reason|0|||
161035970|NCT00319020|581523255|FG001|Overall Study|Administrative reason|5|||
161035971|NCT00319020|581523254|FG000|Overall Study|Disease progression|0|||
161035972|NCT00319020|581523255|FG001|Overall Study|Disease progression|2|||
161035973|NCT00319020|581523254|FG000|Overall Study|Transplant|0|||
161035974|NCT00319020|581523255|FG001|Overall Study|Transplant|1|||
161035975|NCT00319020|581523254|FG000|Overall Study|Treatment failure|0|||
161035976|NCT00319020|581523255|FG001|Overall Study|Treatment failure|1|||
161035977|NCT00319020|581523254|FG000|Overall Study|Adverse Event|0|||
161035978|NCT00319020|581523255|FG001|Overall Study|Adverse Event|1|||
161035979|NCT04980300|581523258|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
161035980|NCT04980300|581523259|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
161035981|NCT04980300|581523258|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
161035982|NCT04980300|581523259|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
161035983|NCT04980300|581523258|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
161035984|NCT04980300|581523259|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
161035985|NCT04980300|581523258|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
161035986|NCT04980300|581523259|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
161035987|NCT02722434|581524561|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
161035988|NCT02722434|581524562|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
161035989|NCT02722434|581524561|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
161035990|NCT02722434|581524562|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
161035991|NCT04989816|581524563|FG000|Overall Study|Death|77|||
161035992|NCT04989816|581524563|FG000|Overall Study|Lost to Follow-up|3|||
161035993|NCT01084694|581524565|FG000|Overall Study|Withdrawal by Subject|2|||
161035994|NCT01084694|581524566|FG001|Overall Study|Withdrawal by Subject|1|||
161035995|NCT01084694|581524565|FG000|Overall Study|Death|2|||
161035996|NCT01084694|581524566|FG001|Overall Study|Death|12|||
161035997|NCT01084694|581524565|FG000|Overall Study|eligibility not maintained|2|||
161035998|NCT01084694|581524566|FG001|Overall Study|eligibility not maintained|7|||
161035999|NCT01128595|581524572|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161036000|NCT01128595|581524573|FG001|Treatment Period 3|Withdrawal by Subject|1|||
161036001|NCT01128595|581524574|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161036002|NCT01128595|581524575|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161036003|NCT02185794|581524577|FG000|Overall Study|Enrolled but Never Dosed|1|||
161036004|NCT02185794|581524578|FG001|Overall Study|Enrolled but Never Dosed|6|||
161036005|NCT02185794|581524579|FG002|Overall Study|Enrolled but Never Dosed|3|||
161036006|NCT02185794|581524580|FG003|Overall Study|Enrolled but Never Dosed|1|||
161036007|NCT02185794|581524581|FG004|Overall Study|Enrolled but Never Dosed|1|||
161036008|NCT02185794|581524582|FG005|Overall Study|Enrolled but Never Dosed|0|||
161036009|NCT02185794|581524577|FG000|Overall Study|Investigator's Discretion|1|||
161036010|NCT02185794|581524578|FG001|Overall Study|Investigator's Discretion|0|||
161036011|NCT02185794|581524579|FG002|Overall Study|Investigator's Discretion|1|||
161036012|NCT02185794|581524580|FG003|Overall Study|Investigator's Discretion|2|||
161036013|NCT02185794|581524581|FG004|Overall Study|Investigator's Discretion|2|||
161036014|NCT02185794|581524582|FG005|Overall Study|Investigator's Discretion|15|||
161036015|NCT02185794|581524577|FG000|Overall Study|Withdrew Consent|2|||
161036016|NCT02185794|581524578|FG001|Overall Study|Withdrew Consent|5|||
161036017|NCT02185794|581524579|FG002|Overall Study|Withdrew Consent|10|||
161036018|NCT02185794|581524580|FG003|Overall Study|Withdrew Consent|2|||
161036019|NCT02185794|581524581|FG004|Overall Study|Withdrew Consent|0|||
161036020|NCT02185794|581524582|FG005|Overall Study|Withdrew Consent|0|||
161036021|NCT02185794|581524577|FG000|Overall Study|Lost to Follow-up|1|||
161036022|NCT02185794|581524578|FG001|Overall Study|Lost to Follow-up|2|||
161036023|NCT02185794|581524579|FG002|Overall Study|Lost to Follow-up|2|||
161036024|NCT02185794|581524580|FG003|Overall Study|Lost to Follow-up|3|||
161036025|NCT02185794|581524581|FG004|Overall Study|Lost to Follow-up|0|||
161036026|NCT02185794|581524582|FG005|Overall Study|Lost to Follow-up|1|||
161036027|NCT00336505|581524583|FG000|Overall Study|Adverse Event|10|||
161036028|NCT00336505|581524584|FG001|Overall Study|Adverse Event|9|||
161036029|NCT00336505|581524583|FG000|Overall Study|Lack of Efficacy|8|||
161036030|NCT00336505|581524584|FG001|Overall Study|Lack of Efficacy|4|||
161036031|NCT00336505|581524583|FG000|Overall Study|Lost to Follow-up|7|||
161036032|NCT00336505|581524584|FG001|Overall Study|Lost to Follow-up|4|||
161036033|NCT00336505|581524583|FG000|Overall Study|Withdrawal by Subject|5|||
161036034|NCT00336505|581524584|FG001|Overall Study|Withdrawal by Subject|3|||
161036035|NCT00336505|581524583|FG000|Overall Study|Other|7|||
161036036|NCT00336505|581524584|FG001|Overall Study|Other|7|||
161036037|NCT00366249|581524585|FG000|Overall Study|Adverse Event|53|||
161279851|NCT04152863|582404161|FG000|Overall Study|Death|13|||
161036038|NCT00366249|581524586|FG001|Overall Study|Adverse Event|28|||
161036039|NCT00366249|581524585|FG000|Overall Study|Death|0|||
161036040|NCT00366249|581524586|FG001|Overall Study|Death|1|||
161036041|NCT00366249|581524585|FG000|Overall Study|Physician Decision|5|||
161036042|NCT00366249|581524586|FG001|Overall Study|Physician Decision|2|||
161036043|NCT00366249|581524585|FG000|Overall Study|Lost to Follow-up|2|||
161036044|NCT00366249|581524586|FG001|Overall Study|Lost to Follow-up|0|||
161279852|NCT04152863|582404162|FG001|Overall Study|Death|12|||
161279853|NCT04152863|582404163|FG002|Overall Study|Death|7|||
161036045|NCT00366249|581524585|FG000|Overall Study|Protocol Violation|1|||
161036046|NCT00366249|581524586|FG001|Overall Study|Protocol Violation|2|||
161036047|NCT00366249|581524585|FG000|Overall Study|Withdrawal by Subject|18|||
161036048|NCT00366249|581524586|FG001|Overall Study|Withdrawal by Subject|4|||
161036049|NCT00366249|581524585|FG000|Overall Study|Lack of Efficacy|21|||
161036050|NCT00366249|581524586|FG001|Overall Study|Lack of Efficacy|21|||
161036051|NCT00366249|581524585|FG000|Overall Study|Most due to osteomylitis status|31|||
161036052|NCT00366249|581524586|FG001|Overall Study|Most due to osteomylitis status|20|||
161036053|NCT00609869|581524587|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
161036054|NCT00609869|581524587|FG000|Overall Study|Severe hematologic toxicity|1|||
161036055|NCT00609869|581524587|FG000|Overall Study|Withdrawal by Subject|1|||
161036056|NCT00609869|581524587|FG000|Overall Study|Seizures|1|||
161036057|NCT00609869|581524587|FG000|Overall Study|Severe tumor flare reaction|1|||
161036058|NCT00609869|581524587|FG000|Overall Study|Hepatitis B infection|1|||
161036059|NCT00609869|581524587|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
161036060|NCT00609869|581524587|FG000|Overall Study|Mantle cell: not evaluable|4|||
161036061|NCT03478969|581524588|FG000|Overall Study|Withdrawal by Subject|4|||
161036062|NCT03478969|581524589|FG001|Overall Study|Withdrawal by Subject|7|||
161036063|NCT03478969|581524590|FG002|Overall Study|Withdrawal by Subject|6|||
161036064|NCT03478969|581524588|FG000|Overall Study|Adverse Event|2|||
161036065|NCT03478969|581524589|FG001|Overall Study|Adverse Event|0|||
161036066|NCT03478969|581524590|FG002|Overall Study|Adverse Event|1|||
161036067|NCT03478969|581524588|FG000|Overall Study|Pregnancy|1|||
161036068|NCT03478969|581524589|FG001|Overall Study|Pregnancy|0|||
161279854|NCT04152863|582404161|FG000|Overall Study|Physician Decision|1|||
161279855|NCT04152863|582404162|FG001|Overall Study|Physician Decision|1|||
161279856|NCT04152863|582404163|FG002|Overall Study|Physician Decision|1|||
161279857|NCT04152863|582404161|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
161279858|NCT04152863|582404162|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
161279859|NCT04152863|582404163|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
161279860|NCT04152863|582404161|FG000|Overall Study|Withdrawal by Subject|2|||
161279861|NCT04152863|582404162|FG001|Overall Study|Withdrawal by Subject|1|||
161279862|NCT04152863|582404163|FG002|Overall Study|Withdrawal by Subject|3|||
161279863|NCT01644617|582404167|FG000|Overall Study|Withdrawal by Subject|3|||
161279864|NCT01644617|582404168|FG001|Overall Study|Withdrawal by Subject|4|||
161279865|NCT01644617|582404169|FG002|Overall Study|Withdrawal by Subject|1|||
161279866|NCT01644617|582404167|FG000|Overall Study|Lost to Follow-up|0|||
161279867|NCT01644617|582404168|FG001|Overall Study|Lost to Follow-up|1|||
161279868|NCT01644617|582404169|FG002|Overall Study|Lost to Follow-up|0|||
161279869|NCT01644617|582404167|FG000|Overall Study|Adverse Event|3|||
161279870|NCT01644617|582404168|FG001|Overall Study|Adverse Event|0|||
161279871|NCT01644617|582404169|FG002|Overall Study|Adverse Event|6|||
161279872|NCT05445492|582404178|FG000|Overall Study|Physician Decision|1|||
161279873|NCT04289363|582404180|FG000|Overall Study|Lost to Follow-up|14|||
161036069|NCT03478969|581524590|FG002|Overall Study|Pregnancy|0|||
161036070|NCT03478969|581524588|FG000|Overall Study|Personal Reasons|1|||
161036071|NCT03478969|581524589|FG001|Overall Study|Personal Reasons|0|||
161279874|NCT04289363|582404181|FG001|Overall Study|Lost to Follow-up|0|||
161279875|NCT03790657|582404182|FG000|Overall Study|Adverse Event|1|||
161279876|NCT03790657|582404183|FG001|Overall Study|Adverse Event|1|||
161279877|NCT03790657|582404182|FG000|Overall Study|Withdrawal by Subject|1|||
161279878|NCT03790657|582404183|FG001|Overall Study|Withdrawal by Subject|1|||
161279879|NCT03126435|582404184|FG000|Overall Study|Death|90|||
161279880|NCT03126435|582404185|FG001|Overall Study|Death|84|||
161279881|NCT03126435|582404184|FG000|Overall Study|Lost to Follow-up|4|||
161279882|NCT03126435|582404185|FG001|Overall Study|Lost to Follow-up|3|||
161279883|NCT03126435|582404184|FG000|Overall Study|Physician Decision|0|||
161279884|NCT03126435|582404185|FG001|Overall Study|Physician Decision|1|||
161279885|NCT03126435|582404184|FG000|Overall Study|Withdrawal by Subject|6|||
161279886|NCT03126435|582404185|FG001|Overall Study|Withdrawal by Subject|12|||
161279887|NCT03126435|582404184|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
161279888|NCT03126435|582404185|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
161279889|NCT01807065|582404186|FG000|Overall Study|Receive no sip-T due to IV access|1|||
161279890|NCT01807065|582404187|FG001|Overall Study|Receive no sip-T due to IV access|1|||
161279891|NCT01699815|582404188|FG000|Overall Study|Protocol Violation|4|||
161279892|NCT01699815|582404189|FG001|Overall Study|Protocol Violation|7|||
161279893|NCT01699815|582404188|FG000|Overall Study|record could not be located|1|||
161279894|NCT01699815|582404189|FG001|Overall Study|record could not be located|0|||
161279895|NCT01699815|582404188|FG000|Overall Study|Adverse Event|0|||
161036072|NCT03478969|581524590|FG002|Overall Study|Personal Reasons|1|||
161036073|NCT03478969|581524588|FG000|Overall Study|Covid-19|1|||
161279896|NCT01699815|582404189|FG001|Overall Study|Adverse Event|1|||
161279897|NCT00699816|582404192|FG000|Overall Study|Protocol Violation|1|||
161279898|NCT00699816|582404193|FG001|Overall Study|Protocol Violation|3|||
161036074|NCT03478969|581524589|FG001|Overall Study|Covid-19|4|||
161279899|NCT00560391|582404194|FG000|Overall Study|Still on treatment|0|||
161279900|NCT00560391|582404195|FG001|Overall Study|Still on treatment|0|||
161279901|NCT00560391|582404196|FG002|Overall Study|Still on treatment|0|||
161279902|NCT00560391|582404197|FG003|Overall Study|Still on treatment|1|||
161279903|NCT00560391|582404198|FG004|Overall Study|Still on treatment|2|||
161279904|NCT01895777|582404199|FG000|Overall Study|Adverse Event|1|||
161279905|NCT01895777|582404200|FG001|Overall Study|Adverse Event|2|||
161036075|NCT03478969|581524590|FG002|Overall Study|Covid-19|3|||
161036076|NCT03478969|581524588|FG000|Overall Study|Multiple Reasons|0|||
161036077|NCT03478969|581524589|FG001|Overall Study|Multiple Reasons|1|||
161036078|NCT03478969|581524590|FG002|Overall Study|Multiple Reasons|1|||
161279906|NCT01895777|582404199|FG000|Overall Study|Lost to Follow-up|2|||
161279907|NCT01895777|582404200|FG001|Overall Study|Lost to Follow-up|0|||
161036079|NCT03478969|581524588|FG000|Overall Study|Eligibility Criteria|0|||
161036080|NCT03478969|581524589|FG001|Overall Study|Eligibility Criteria|0|||
161036081|NCT03478969|581524590|FG002|Overall Study|Eligibility Criteria|5|||
161036082|NCT03478969|581524588|FG000|Overall Study|Lost to Follow-up|0|||
161036083|NCT03478969|581524589|FG001|Overall Study|Lost to Follow-up|0|||
161036084|NCT03478969|581524590|FG002|Overall Study|Lost to Follow-up|1|||
161036085|NCT01185600|581524591|FG000|Overall Study|Adverse Event|1|||
161036086|NCT01185600|581524592|FG001|Overall Study|Adverse Event|1|||
161036087|NCT01185600|581524591|FG000|Overall Study|Death|0|||
161036088|NCT01185600|581524592|FG001|Overall Study|Death|1|||
161036089|NCT01185600|581524591|FG000|Overall Study|Lost to Follow-up|0|||
161036090|NCT01185600|581524592|FG001|Overall Study|Lost to Follow-up|5|||
161036091|NCT01185600|581524591|FG000|Overall Study|Physician Decision|29|||
161036092|NCT01185600|581524592|FG001|Overall Study|Physician Decision|35|||
161036093|NCT01185600|581524591|FG000|Overall Study|Withdrawal by Subject|1|||
161036094|NCT01185600|581524592|FG001|Overall Study|Withdrawal by Subject|1|||
161036095|NCT01185600|581524591|FG000|Overall Study|Hold by DSMB|1|||
161036096|NCT01185600|581524592|FG001|Overall Study|Hold by DSMB|2|||
161036097|NCT05405244|581524593|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
161036098|NCT05405244|581524594|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
161036099|NCT05405244|581524593|FG000|Washout (2 Weeks)|Adverse Event|2|||
161036100|NCT05405244|581524594|FG001|Washout (2 Weeks)|Adverse Event|0|||
161036101|NCT05405244|581524593|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
161036102|NCT05405244|581524594|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
161036103|NCT00739934|581524595|FG000|Voriconazole IV|Adverse Event|6|||
161036104|NCT00739934|581524595|FG000|Voriconazole Oral|Other|3|||
161036105|NCT00754065|581524600|FG000|Overall Study|Never received treatment|12|||
161036106|NCT00754065|581524601|FG001|Overall Study|Never received treatment|2|||
161036107|NCT00754065|581524600|FG000|Overall Study|Adverse Event|19|||
161036108|NCT00754065|581524601|FG001|Overall Study|Adverse Event|25|||
161036109|NCT00754065|581524600|FG000|Overall Study|Lost to Follow-up|7|||
161036110|NCT00754065|581524601|FG001|Overall Study|Lost to Follow-up|11|||
161036111|NCT00754065|581524600|FG000|Overall Study|Protocol Violation|12|||
161036112|NCT00754065|581524601|FG001|Overall Study|Protocol Violation|10|||
161036113|NCT00754065|581524600|FG000|Overall Study|Withdrawal by Subject|4|||
161036114|NCT00754065|581524601|FG001|Overall Study|Withdrawal by Subject|5|||
161036115|NCT00754065|581524600|FG000|Overall Study|Pregnancy|6|||
161036116|NCT00754065|581524601|FG001|Overall Study|Pregnancy|0|||
161036117|NCT00754065|581524600|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
161036118|NCT00754065|581524601|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
161036119|NCT04353492|581524604|FG000|Overall Study|Subject decision|24|||
161036120|NCT04353492|581524604|FG000|Overall Study|Physician Decision|5|||
161036121|NCT04353492|581524604|FG000|Overall Study|Adverse Event|3|||
161036122|NCT04353492|581524604|FG000|Overall Study|Pregnancy|3|||
161036123|NCT04353492|581524604|FG000|Overall Study|Lost to Follow-up|2|||
161279908|NCT01895777|582404199|FG000|Overall Study|Not treated|1|||
161279909|NCT01895777|582404200|FG001|Overall Study|Not treated|0|||
161279910|NCT01895777|582404199|FG000|Overall Study|Other reasons|3|||
161279911|NCT01895777|582404200|FG001|Overall Study|Other reasons|2|||
161279912|NCT01895777|582404199|FG000|Overall Study|Non-compliance with the CTP|2|||
161279913|NCT01895777|582404200|FG001|Overall Study|Non-compliance with the CTP|1|||
161279914|NCT04223752|582404201|FG000|Overall Study|Participant enrolled in error|0|||
161279915|NCT04223752|582404202|FG001|Overall Study|Participant enrolled in error|0|||
161279916|NCT04223752|582404203|FG002|Overall Study|Participant enrolled in error|0|||
161279917|NCT04223752|582404204|FG003|Overall Study|Participant enrolled in error|0|||
161279918|NCT04223752|582404205|FG004|Overall Study|Participant enrolled in error|1|||
161279919|NCT04223752|582404201|FG000|Overall Study|Death|0|||
161279920|NCT04223752|582404202|FG001|Overall Study|Death|0|||
161279921|NCT04223752|582404203|FG002|Overall Study|Death|0|||
161279922|NCT04223752|582404204|FG003|Overall Study|Death|2|||
161279923|NCT04223752|582404205|FG004|Overall Study|Death|1|||
161036124|NCT04353492|581524604|FG000|Overall Study|Protocol deviation|1|||
161036125|NCT04353492|581524604|FG000|Overall Study|Technical problems|1|||
161279924|NCT01128543|582404206|FG000|Overall Study|Withdrawal by Subject|3|||
161279925|NCT01128543|582404206|FG000|Overall Study|Protocol Violation|1|||
161279926|NCT03340974|582404207|FG000|Completion of Study -Long Term Follow up|Death|8|||
161279927|NCT03340974|582404208|FG001|Completion of Study -Long Term Follow up|Death|5|||
161279928|NCT03340974|582404209|FG002|Completion of Study -Long Term Follow up|Death|5|||
161036126|NCT04250194|581524605|FG000|Overall Study|Declined to schedule biopsy|6|||
161036127|NCT04250194|581524606|FG001|Overall Study|Declined to schedule biopsy|10|||
161036128|NCT04250194|581524605|FG000|Overall Study|Medically Unfit for Biopsy|2|||
161036129|NCT04250194|581524606|FG001|Overall Study|Medically Unfit for Biopsy|1|||
161036130|NCT04250194|581524605|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
161036131|NCT04250194|581524606|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
161279929|NCT03340974|582404210|FG003|Completion of Study -Long Term Follow up|Death|7|||
161279930|NCT03340974|582404207|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
161091223|NCT01054170|581723839|FG001|Overall Study|Protocol Violation|0|||
161036132|NCT04250194|581524605|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
161036133|NCT04250194|581524606|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
161036134|NCT04250194|581524605|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
161036135|NCT04250194|581524606|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
161036136|NCT01500200|581524609|FG000|Stage 1|Adverse Event|1|||
161036137|NCT01500200|581524610|FG001|Stage 1|Adverse Event|4|||
161036138|NCT01500200|581524611|FG002|Stage 1|Adverse Event|5|||
161036139|NCT01500200|581524612|FG003|Stage 1|Adverse Event|0|||
161036140|NCT01500200|581524613|FG004|Stage 1|Adverse Event|0|||
161036141|NCT01500200|581524614|FG005|Stage 1|Adverse Event|0|||
161036142|NCT01500200|581524609|FG000|Stage 1|Lost to Follow-up|2|||
161036143|NCT01500200|581524610|FG001|Stage 1|Lost to Follow-up|2|||
161036144|NCT01500200|581524611|FG002|Stage 1|Lost to Follow-up|1|||
161036145|NCT01500200|581524612|FG003|Stage 1|Lost to Follow-up|0|||
161036146|NCT01500200|581524613|FG004|Stage 1|Lost to Follow-up|0|||
161036147|NCT01500200|581524614|FG005|Stage 1|Lost to Follow-up|0|||
161036148|NCT01500200|581524609|FG000|Stage 1|Withdrawal by Subject|3|||
161036149|NCT01500200|581524610|FG001|Stage 1|Withdrawal by Subject|0|||
161036150|NCT01500200|581524611|FG002|Stage 1|Withdrawal by Subject|0|||
161036151|NCT01500200|581524612|FG003|Stage 1|Withdrawal by Subject|0|||
161036152|NCT01500200|581524613|FG004|Stage 1|Withdrawal by Subject|0|||
161036153|NCT01500200|581524614|FG005|Stage 1|Withdrawal by Subject|0|||
161036154|NCT01500200|581524609|FG000|Stage 1|Noncompliance with Study Drug|1|||
161036155|NCT01500200|581524610|FG001|Stage 1|Noncompliance with Study Drug|0|||
161036156|NCT01500200|581524611|FG002|Stage 1|Noncompliance with Study Drug|0|||
161036157|NCT01500200|581524612|FG003|Stage 1|Noncompliance with Study Drug|0|||
161036158|NCT01500200|581524613|FG004|Stage 1|Noncompliance with Study Drug|0|||
161036159|NCT01500200|581524614|FG005|Stage 1|Noncompliance with Study Drug|0|||
161036160|NCT01500200|581524609|FG000|Stage 1|Physician Decision|1|||
161036161|NCT01500200|581524610|FG001|Stage 1|Physician Decision|0|||
161036162|NCT01500200|581524611|FG002|Stage 1|Physician Decision|0|||
161036163|NCT01500200|581524612|FG003|Stage 1|Physician Decision|0|||
161036164|NCT01500200|581524613|FG004|Stage 1|Physician Decision|0|||
161036165|NCT01500200|581524614|FG005|Stage 1|Physician Decision|0|||
161036166|NCT01500200|581524609|FG000|Stage 2|Adverse Event|0|||
161036167|NCT01500200|581524610|FG001|Stage 2|Adverse Event|0|||
161036168|NCT01500200|581524611|FG002|Stage 2|Adverse Event|0|||
161036169|NCT01500200|581524612|FG003|Stage 2|Adverse Event|0|||
161036170|NCT01500200|581524613|FG004|Stage 2|Adverse Event|5|||
161036171|NCT01500200|581524614|FG005|Stage 2|Adverse Event|4|||
161036172|NCT01961609|581524615|FG000|Initiation|Missing|3|||
161036173|NCT01961609|581524616|FG001|Initiation|Missing|2|||
161036174|NCT01961609|581524617|FG002|Initiation|Missing|0|||
161036175|NCT01961609|581524618|FG003|Initiation|Missing|0|||
161036176|NCT01961609|581524615|FG000|Initiation|Protocol deviation|1|||
161036177|NCT01961609|581524616|FG001|Initiation|Protocol deviation|0|||
161036178|NCT01961609|581524617|FG002|Initiation|Protocol deviation|0|||
161036179|NCT01961609|581524618|FG003|Initiation|Protocol deviation|0|||
161036180|NCT01961609|581524615|FG000|Initiation|Death|0|||
161036181|NCT01961609|581524616|FG001|Initiation|Death|1|||
161036182|NCT01961609|581524617|FG002|Initiation|Death|0|||
161036183|NCT01961609|581524618|FG003|Initiation|Death|0|||
161036184|NCT01961609|581524615|FG000|Initiation|Administrative problems|1|||
161036185|NCT01961609|581524616|FG001|Initiation|Administrative problems|0|||
161036186|NCT01961609|581524617|FG002|Initiation|Administrative problems|0|||
161279931|NCT03340974|582404208|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
161279932|NCT03340974|582404209|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
161279933|NCT03340974|582404210|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
161279934|NCT03340974|582404207|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
161279935|NCT03340974|582404208|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
161279936|NCT03340974|582404209|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
161036187|NCT01961609|581524618|FG003|Initiation|Administrative problems|0|||
161036188|NCT01961609|581524615|FG000|Initiation|Withdrawal by Subject|1|||
161036189|NCT01961609|581524616|FG001|Initiation|Withdrawal by Subject|2|||
161036190|NCT01961609|581524617|FG002|Initiation|Withdrawal by Subject|0|||
161036191|NCT01961609|581524618|FG003|Initiation|Withdrawal by Subject|0|||
161036192|NCT01961609|581524615|FG000|Initiation|Lack of Efficacy|2|||
161036193|NCT01961609|581524616|FG001|Initiation|Lack of Efficacy|1|||
161036194|NCT01961609|581524617|FG002|Initiation|Lack of Efficacy|0|||
161036195|NCT01961609|581524618|FG003|Initiation|Lack of Efficacy|0|||
161036196|NCT01961609|581524615|FG000|Initiation|Abnormal lab values|0|||
161036197|NCT01961609|581524616|FG001|Initiation|Abnormal lab values|1|||
161036198|NCT01961609|581524617|FG002|Initiation|Abnormal lab values|0|||
161036199|NCT01961609|581524618|FG003|Initiation|Abnormal lab values|0|||
161036200|NCT01961609|581524615|FG000|Initiation|Adverse Event|3|||
161036201|NCT01961609|581524616|FG001|Initiation|Adverse Event|5|||
161036202|NCT01961609|581524617|FG002|Initiation|Adverse Event|0|||
161036203|NCT01961609|581524618|FG003|Initiation|Adverse Event|0|||
161036204|NCT01961609|581524615|FG000|Initiation|Randomized but not treated|1|||
161036205|NCT01961609|581524616|FG001|Initiation|Randomized but not treated|1|||
161036206|NCT01961609|581524617|FG002|Initiation|Randomized but not treated|0|||
161036207|NCT01961609|581524618|FG003|Initiation|Randomized but not treated|0|||
161036208|NCT01961609|581524615|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
161036209|NCT01961609|581524616|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
161036210|NCT01961609|581524617|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
161036211|NCT01961609|581524618|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
161036212|NCT01961609|581524615|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
161036213|NCT01961609|581524616|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
161036214|NCT01961609|581524617|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
161036215|NCT01961609|581524618|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
161036216|NCT01961609|581524615|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
161036217|NCT01961609|581524616|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
161036218|NCT01961609|581524617|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
161036219|NCT01961609|581524618|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
161036220|NCT01961609|581524615|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
161036221|NCT01961609|581524616|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
161036222|NCT01961609|581524617|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
161279937|NCT03340974|582404210|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
161036223|NCT01961609|581524618|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
161036224|NCT01961609|581524615|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
161036225|NCT01961609|581524616|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
161036226|NCT01961609|581524617|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
161036227|NCT01961609|581524618|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
161279938|NCT03340974|582404207|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
161279939|NCT03340974|582404208|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
161279940|NCT03340974|582404209|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
161279941|NCT03340974|582404210|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
161279942|NCT02374346|582404217|FG000|Overall Study|operated or discharged during weekend|48|||
161279943|NCT00396565|582404226|FG000|Overall Study|Physician Decision|3|||
161279944|NCT00396565|582404227|FG001|Overall Study|Physician Decision|1|||
161036228|NCT01961609|581524615|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
161036229|NCT01961609|581524616|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
161036230|NCT01961609|581524617|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
161036231|NCT01961609|581524618|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
161036232|NCT01961609|581524615|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
161036233|NCT01961609|581524616|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
161036234|NCT01961609|581524617|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
161036235|NCT01961609|581524618|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
161036236|NCT01961609|581524615|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
161036237|NCT01961609|581524616|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
161036238|NCT01961609|581524617|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
161036239|NCT01961609|581524618|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
161036240|NCT01961609|581524615|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
161036241|NCT01961609|581524616|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
161036242|NCT01961609|581524617|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
161036243|NCT01961609|581524618|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
161036244|NCT01961609|581524615|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
161036245|NCT01961609|581524616|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
161036246|NCT01961609|581524617|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
161036247|NCT01961609|581524618|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
161036248|NCT01961609|581524615|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
161036249|NCT01961609|581524616|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
161036250|NCT01961609|581524617|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
161036251|NCT01961609|581524618|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
161036252|NCT01961609|581524615|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
161036253|NCT01961609|581524616|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
161344790|NCT01047319|582647277|FG000|Overall Study|Study terminated by Sponsor|198|||
161344791|NCT01047319|582647278|FG001|Overall Study|Study terminated by Sponsor|215|||
161036254|NCT01961609|581524617|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
161036255|NCT01961609|581524618|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
161036256|NCT02167451|581524622|FG000|Overall Study|Withdrawal by Subject|1|||
161036257|NCT00571649|581524623|FG000|Treatment Period|Adverse Event|438|||
161036258|NCT00571649|581524624|FG001|Treatment Period|Adverse Event|385|||
161036259|NCT00571649|581524623|FG000|Treatment Period|Clinical endpoint reached|50|||
161036260|NCT00571649|581524624|FG001|Treatment Period|Clinical endpoint reached|56|||
161279945|NCT00396565|582404228|FG002|Overall Study|Physician Decision|2|||
161279946|NCT00396565|582404226|FG000|Overall Study|Adverse Event|5|||
161279947|NCT00396565|582404227|FG001|Overall Study|Adverse Event|13|||
161279948|NCT00396565|582404228|FG002|Overall Study|Adverse Event|3|||
161279949|NCT00396565|582404226|FG000|Overall Study|Withdrawal by Subject|8|||
161279950|NCT00396565|582404227|FG001|Overall Study|Withdrawal by Subject|13|||
161279951|NCT00396565|582404228|FG002|Overall Study|Withdrawal by Subject|1|||
161279952|NCT00396565|582404226|FG000|Overall Study|Lack of Efficacy|32|||
161279953|NCT00396565|582404227|FG001|Overall Study|Lack of Efficacy|64|||
161279954|NCT00396565|582404228|FG002|Overall Study|Lack of Efficacy|11|||
161279955|NCT04487067|582404230|FG000|Overall Study|Adverse Event|3|||
161279956|NCT04487067|582404230|FG000|Overall Study|Death Other Than Progressive Disease|60|||
161279957|NCT04487067|582404230|FG000|Overall Study|Death Due To Progressive Disease|40|||
161279958|NCT04487067|582404230|FG000|Overall Study|Lost to Follow-up|3|||
161279959|NCT04487067|582404230|FG000|Overall Study|Progressive Disease|1|||
161279960|NCT04487067|582404230|FG000|Overall Study|Protocol Violation|3|||
161279961|NCT04487067|582404230|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
161279962|NCT04487067|582404230|FG000|Overall Study|Withdrawal by Subject|15|||
161279963|NCT05299528|582404231|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161279964|NCT05299528|582404232|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
161279965|NCT05299528|582404233|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161279966|NCT05299528|582404234|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161279967|NCT05299528|582404235|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161279968|NCT05299528|582404236|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161279969|NCT05299528|582404237|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
161279970|NCT05299528|582404231|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161279971|NCT05299528|582404232|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161279972|NCT05299528|582404233|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161279973|NCT05299528|582404234|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161279974|NCT05299528|582404235|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161279975|NCT05299528|582404236|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
161279976|NCT05299528|582404237|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
161279977|NCT05299528|582404231|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
161279978|NCT05299528|582404232|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
161279979|NCT05299528|582404233|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
161279980|NCT05299528|582404234|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
161279981|NCT05299528|582404235|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
161279982|NCT05299528|582404236|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
161279983|NCT05299528|582404237|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
161279984|NCT04877457|582404238|FG000|Overall Study|Early termination of study due to low enrollment|2|||
161279985|NCT04877457|582404239|FG001|Overall Study|Early termination of study due to low enrollment|1|||
161279986|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
161279987|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
161279988|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
161279989|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Death|1|||
161279990|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Death|3|||
161279991|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Death|1|||
161279992|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
161279993|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
161279994|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
161279995|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
161279996|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
161279997|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
161279998|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
161279999|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
161036261|NCT00571649|581524623|FG000|Treatment Period|Withdrawal by Subject|285|||
161036262|NCT00571649|581524624|FG001|Treatment Period|Withdrawal by Subject|255|||
161036263|NCT00571649|581524623|FG000|Treatment Period|Death|76|||
161036264|NCT00571649|581524624|FG001|Treatment Period|Death|59|||
161036265|NCT00571649|581524623|FG000|Treatment Period|Physician Decision|8|||
161036266|NCT00571649|581524624|FG001|Treatment Period|Physician Decision|9|||
161280000|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
161280001|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
161280002|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
161280003|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
161036267|NCT00571649|581524623|FG000|Treatment Period|Lost to Follow-up|43|||
161036268|NCT00571649|581524624|FG001|Treatment Period|Lost to Follow-up|41|||
161280004|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
161280005|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
161036269|NCT00571649|581524623|FG000|Treatment Period|Non-compliant with study medication|88|||
161036270|NCT00571649|581524624|FG001|Treatment Period|Non-compliant with study medication|89|||
161036271|NCT00571649|581524623|FG000|Treatment Period|Patient convenience|11|||
161036272|NCT00571649|581524624|FG001|Treatment Period|Patient convenience|13|||
161036273|NCT00571649|581524623|FG000|Treatment Period|Protocol Violation|90|||
161036274|NCT00571649|581524624|FG001|Treatment Period|Protocol Violation|92|||
161036275|NCT00571649|581524623|FG000|Treatment Period|Technical problems|3|||
161036276|NCT00571649|581524624|FG001|Treatment Period|Technical problems|5|||
161036277|NCT00571649|581524623|FG000|Follow-up Period|Adverse Event|46|||
161036278|NCT00571649|581524624|FG001|Follow-up Period|Adverse Event|40|||
161036279|NCT00571649|581524623|FG000|Follow-up Period|Clinical endpoint reached|5|||
161036280|NCT00571649|581524624|FG001|Follow-up Period|Clinical endpoint reached|2|||
161036281|NCT00571649|581524623|FG000|Follow-up Period|Withdrawal by Subject|119|||
161036282|NCT00571649|581524624|FG001|Follow-up Period|Withdrawal by Subject|115|||
161036283|NCT00571649|581524623|FG000|Follow-up Period|Death|132|||
161036284|NCT00571649|581524624|FG001|Follow-up Period|Death|133|||
161036285|NCT00571649|581524623|FG000|Follow-up Period|Physician Decision|7|||
161036286|NCT00571649|581524624|FG001|Follow-up Period|Physician Decision|13|||
161036287|NCT00571649|581524623|FG000|Follow-up Period|Lost to Follow-up|95|||
161036288|NCT00571649|581524624|FG001|Follow-up Period|Lost to Follow-up|92|||
161036289|NCT00571649|581524623|FG000|Follow-up Period|Patient convenience|136|||
161036290|NCT00571649|581524624|FG001|Follow-up Period|Patient convenience|121|||
161036291|NCT00571649|581524623|FG000|Follow-up Period|Protocol Violation|5|||
161036292|NCT00571649|581524624|FG001|Follow-up Period|Protocol Violation|12|||
161036293|NCT01218659|581524625|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
161036294|NCT01218659|581524626|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
161036295|NCT01218659|581524627|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
161036296|NCT01218659|581524625|FG000|18-Month Randomized Period|Did not receive study drug|0|||
161036297|NCT01218659|581524626|FG001|18-Month Randomized Period|Did not receive study drug|3|||
161036298|NCT01218659|581524627|FG002|18-Month Randomized Period|Did not receive study drug|0|||
161036299|NCT01218659|581524625|FG000|12-Month OLE|Withdrawal by Subject|0|||
161036300|NCT01218659|581524626|FG001|12-Month OLE|Withdrawal by Subject|0|||
161036301|NCT01218659|581524627|FG002|12-Month OLE|Withdrawal by Subject|2|||
161036302|NCT01218659|581524625|FG000|12-Month OLE|Physician Decision|0|||
161036303|NCT01218659|581524626|FG001|12-Month OLE|Physician Decision|0|||
161036304|NCT01218659|581524627|FG002|12-Month OLE|Physician Decision|1|||
161036305|NCT01218659|581524625|FG000|12-Month OLE|Lost to Follow-up|0|||
161036306|NCT01218659|581524626|FG001|12-Month OLE|Lost to Follow-up|0|||
161036307|NCT01218659|581524627|FG002|12-Month OLE|Lost to Follow-up|1|||
161036308|NCT01218659|581524625|FG000|12-Month OLE|Pregnancy|0|||
161036309|NCT01218659|581524626|FG001|12-Month OLE|Pregnancy|0|||
161036310|NCT01218659|581524627|FG002|12-Month OLE|Pregnancy|1|||
161036311|NCT01218659|581524625|FG000|12-Month OLE|Lack of Efficacy|0|||
161036312|NCT01218659|581524626|FG001|12-Month OLE|Lack of Efficacy|0|||
161036313|NCT01218659|581524627|FG002|12-Month OLE|Lack of Efficacy|1|||
161036314|NCT01218659|581524625|FG000|12-Month OLE|Declined to participate in the OLE|0|||
161036315|NCT01218659|581524626|FG001|12-Month OLE|Declined to participate in the OLE|0|||
161036316|NCT01218659|581524627|FG002|12-Month OLE|Declined to participate in the OLE|4|||
161036317|NCT03066609|581524634|FG000|INDUCTION|Pregnancy|0|||
161036318|NCT03066609|581524635|FG001|INDUCTION|Pregnancy|0|||
161036319|NCT03066609|581524636|FG002|INDUCTION|Pregnancy|1|||
161036320|NCT03066609|581524637|FG003|INDUCTION|Pregnancy|0|||
161036321|NCT03066609|581524634|FG000|INDUCTION|Lack of Efficacy|0|||
161036322|NCT03066609|581524635|FG001|INDUCTION|Lack of Efficacy|0|||
161036323|NCT03066609|581524636|FG002|INDUCTION|Lack of Efficacy|1|||
161036324|NCT03066609|581524637|FG003|INDUCTION|Lack of Efficacy|0|||
161036325|NCT03066609|581524634|FG000|INDUCTION|Adverse Event|2|||
161036326|NCT03066609|581524635|FG001|INDUCTION|Adverse Event|2|||
161036327|NCT03066609|581524636|FG002|INDUCTION|Adverse Event|0|||
161036328|NCT03066609|581524637|FG003|INDUCTION|Adverse Event|0|||
161036329|NCT03066609|581524634|FG000|MAINTENANCE|Adverse Event|0|||
161036330|NCT03066609|581524635|FG001|MAINTENANCE|Adverse Event|0|||
161036331|NCT03066609|581524636|FG002|MAINTENANCE|Adverse Event|0|||
161036332|NCT03066609|581524637|FG003|MAINTENANCE|Adverse Event|1|||
161036333|NCT03066609|581524634|FG000|MAINTENANCE|Withdrawal by Subject|4|||
161036334|NCT03066609|581524635|FG001|MAINTENANCE|Withdrawal by Subject|2|||
161036335|NCT03066609|581524636|FG002|MAINTENANCE|Withdrawal by Subject|1|||
161036336|NCT03066609|581524637|FG003|MAINTENANCE|Withdrawal by Subject|1|||
161036337|NCT03066609|581524634|FG000|MAINTENANCE|Lost to Follow-up|0|||
161036338|NCT03066609|581524635|FG001|MAINTENANCE|Lost to Follow-up|1|||
161036339|NCT03066609|581524636|FG002|MAINTENANCE|Lost to Follow-up|1|||
161036340|NCT03066609|581524637|FG003|MAINTENANCE|Lost to Follow-up|0|||
161036341|NCT03066609|581524634|FG000|MAINTENANCE|Pregnancy|1|||
161036342|NCT03066609|581524635|FG001|MAINTENANCE|Pregnancy|0|||
161036343|NCT03066609|581524636|FG002|MAINTENANCE|Pregnancy|0|||
161036344|NCT03066609|581524637|FG003|MAINTENANCE|Pregnancy|0|||
161280006|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
161280007|NCT00299130|582404240|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
161280008|NCT00299130|582404241|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
161280009|NCT00299130|582404242|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
161280010|NCT00299130|582404240|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
161280011|NCT00299130|582404241|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
161280012|NCT00299130|582404242|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
161280013|NCT00299130|582404240|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
161280014|NCT00299130|582404241|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
161280015|NCT00299130|582404242|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
161280016|NCT00299130|582404240|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
161280017|NCT00299130|582404241|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
161280018|NCT00299130|582404242|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
161280019|NCT00299130|582404240|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
161280020|NCT00299130|582404241|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
161036345|NCT03066609|581524634|FG000|MAINTENANCE|Lack of Efficacy|2|||
161280021|NCT00299130|582404242|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
161280022|NCT00299130|582404240|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
161280023|NCT00299130|582404241|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
161280024|NCT00299130|582404242|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
161280025|NCT00299130|582404240|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
161280026|NCT00299130|582404241|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
161280027|NCT00299130|582404242|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
161280028|NCT00299130|582404240|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
161036346|NCT03066609|581524635|FG001|MAINTENANCE|Lack of Efficacy|1|||
161036347|NCT03066609|581524636|FG002|MAINTENANCE|Lack of Efficacy|0|||
161036348|NCT03066609|581524637|FG003|MAINTENANCE|Lack of Efficacy|1|||
161280029|NCT00299130|582404241|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
161280030|NCT00299130|582404242|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
161280031|NCT00299130|582404240|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
161280032|NCT00299130|582404241|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
161280033|NCT00299130|582404242|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
161280034|NCT00299130|582404240|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
161280035|NCT00299130|582404241|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
161280036|NCT00299130|582404242|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
161280037|NCT02211417|582404243|FG000|Overall Study|Withdrawal by Subject|11|||
161280038|NCT02211417|582404244|FG001|Overall Study|Withdrawal by Subject|8|||
161280039|NCT02211417|582404243|FG000|Overall Study|Protocol Violation|1|||
161280040|NCT02211417|582404244|FG001|Overall Study|Protocol Violation|0|||
161280041|NCT02211417|582404243|FG000|Overall Study|Pregnancy|0|||
161280042|NCT02211417|582404244|FG001|Overall Study|Pregnancy|1|||
161280043|NCT02211417|582404243|FG000|Overall Study|Lost to Follow-up|2|||
161280044|NCT02211417|582404244|FG001|Overall Study|Lost to Follow-up|3|||
161280045|NCT02211417|582404243|FG000|Overall Study|Adverse Event|1|||
161280046|NCT02211417|582404244|FG001|Overall Study|Adverse Event|4|||
161280047|NCT01198132|582404245|FG000|Overall Study|Withdrawal by Subject|4|||
161036349|NCT03066609|581524634|FG000|OVERALL STUDY|Adverse Event|2|||
161036350|NCT03066609|581524635|FG001|OVERALL STUDY|Adverse Event|2|||
161036351|NCT03066609|581524636|FG002|OVERALL STUDY|Adverse Event|0|||
161036352|NCT03066609|581524637|FG003|OVERALL STUDY|Adverse Event|1|||
161036353|NCT03066609|581524634|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
161036354|NCT03066609|581524635|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
161036355|NCT03066609|581524636|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
161036356|NCT03066609|581524637|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
161036357|NCT03066609|581524634|FG000|OVERALL STUDY|Lost to Follow-up|1|||
161036358|NCT03066609|581524635|FG001|OVERALL STUDY|Lost to Follow-up|1|||
161036359|NCT03066609|581524636|FG002|OVERALL STUDY|Lost to Follow-up|1|||
161036360|NCT03066609|581524637|FG003|OVERALL STUDY|Lost to Follow-up|1|||
161036361|NCT03066609|581524634|FG000|OVERALL STUDY|Pregnancy|1|||
161036362|NCT03066609|581524635|FG001|OVERALL STUDY|Pregnancy|0|||
161036363|NCT03066609|581524636|FG002|OVERALL STUDY|Pregnancy|1|||
161036364|NCT03066609|581524637|FG003|OVERALL STUDY|Pregnancy|0|||
161036365|NCT03066609|581524634|FG000|OVERALL STUDY|Lack of Efficacy|2|||
161036366|NCT03066609|581524635|FG001|OVERALL STUDY|Lack of Efficacy|1|||
161036367|NCT03066609|581524636|FG002|OVERALL STUDY|Lack of Efficacy|1|||
161036368|NCT03066609|581524637|FG003|OVERALL STUDY|Lack of Efficacy|1|||
161036369|NCT03066609|581524634|FG000|OVERALL STUDY|discontinued follow up|0|||
161036370|NCT03066609|581524635|FG001|OVERALL STUDY|discontinued follow up|2|||
161036371|NCT03066609|581524636|FG002|OVERALL STUDY|discontinued follow up|0|||
161280048|NCT01198132|582404246|FG001|Overall Study|Withdrawal by Subject|5|||
161036372|NCT03066609|581524637|FG003|OVERALL STUDY|discontinued follow up|0|||
161036373|NCT03355573|581524638|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
161036374|NCT03355573|581524638|FG000|Overall Study|Sponsor's decision|1|||
161036375|NCT03355573|581524638|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
161036376|NCT03355573|581524638|FG000|Overall Study|PI's decision|2|||
161036377|NCT03355573|581524638|FG000|Overall Study|Withdrawal by Subject|23|||
161036378|NCT03355573|581524638|FG000|Overall Study|Lost to Follow-up|4|||
161036379|NCT03355573|581524638|FG000|Overall Study|Lack of Efficacy|2|||
161036380|NCT03355573|581524638|FG000|Overall Study|Adverse Event, non-fatal|17|||
161036381|NCT03355573|581524638|FG000|Overall Study|Adverse Event, serious fatal|2|||
161036382|NCT01566890|581524639|FG000|Overall Study|Adverse Event|1|||
161036383|NCT01566890|581524640|FG001|Overall Study|Adverse Event|0|||
161036384|NCT01566890|581524641|FG002|Overall Study|Adverse Event|0|||
161036385|NCT01566890|581524642|FG003|Overall Study|Adverse Event|0|||
161036386|NCT01566890|581524643|FG004|Overall Study|Adverse Event|0|||
161036387|NCT01566890|581524639|FG000|Overall Study|Withdrawal by Subject|3|||
161036388|NCT01566890|581524640|FG001|Overall Study|Withdrawal by Subject|1|||
161036389|NCT01566890|581524641|FG002|Overall Study|Withdrawal by Subject|1|||
161036390|NCT01566890|581524642|FG003|Overall Study|Withdrawal by Subject|1|||
161036391|NCT01566890|581524643|FG004|Overall Study|Withdrawal by Subject|0|||
161036392|NCT01566890|581524639|FG000|Overall Study|Screen failure|6|||
161036393|NCT01566890|581524640|FG001|Overall Study|Screen failure|0|||
161036394|NCT01566890|581524641|FG002|Overall Study|Screen failure|1|||
161036395|NCT01566890|581524642|FG003|Overall Study|Screen failure|1|||
161036396|NCT01566890|581524643|FG004|Overall Study|Screen failure|0|||
161036397|NCT01566890|581524639|FG000|Overall Study|Incomplete CEU data|1|||
161036398|NCT01566890|581524640|FG001|Overall Study|Incomplete CEU data|3|||
161036399|NCT01566890|581524641|FG002|Overall Study|Incomplete CEU data|5|||
161036400|NCT01566890|581524642|FG003|Overall Study|Incomplete CEU data|8|||
161036401|NCT01566890|581524643|FG004|Overall Study|Incomplete CEU data|0|||
161036402|NCT01566890|581524639|FG000|Overall Study|Lost to Follow-up|0|||
161036403|NCT01566890|581524640|FG001|Overall Study|Lost to Follow-up|0|||
161036404|NCT01566890|581524641|FG002|Overall Study|Lost to Follow-up|4|||
161036405|NCT01566890|581524642|FG003|Overall Study|Lost to Follow-up|4|||
161036406|NCT01566890|581524643|FG004|Overall Study|Lost to Follow-up|0|||
161036407|NCT01566890|581524639|FG000|Overall Study|Other|0|||
161036408|NCT01566890|581524640|FG001|Overall Study|Other|0|||
161036409|NCT01566890|581524641|FG002|Overall Study|Other|0|||
161036410|NCT01566890|581524642|FG003|Overall Study|Other|0|||
161036411|NCT01566890|581524643|FG004|Overall Study|Other|7|||
161036412|NCT02284113|581524646|FG000|Overall Study|Adverse Event|1|||
161036413|NCT02284113|581524647|FG001|Overall Study|Adverse Event|0|||
161036414|NCT02284113|581524646|FG000|Overall Study|non-compliance|0|||
161036415|NCT02284113|581524647|FG001|Overall Study|non-compliance|1|||
161036416|NCT02284113|581524646|FG000|Overall Study|Withdrawal by Subject|0|||
161036417|NCT02284113|581524647|FG001|Overall Study|Withdrawal by Subject|1|||
161036418|NCT02284113|581524646|FG000|Overall Study|not provided|0|||
161036419|NCT02284113|581524647|FG001|Overall Study|not provided|1|||
161036420|NCT02284113|581524646|FG000|Overall Study|surgery cancelled|2|||
161036421|NCT02284113|581524647|FG001|Overall Study|surgery cancelled|0|||
161036422|NCT04191824|581524648|FG000|Overall Study|Death|13|||
161280049|NCT01198132|582404245|FG000|Overall Study|Physician Decision|5|||
161280050|NCT01198132|582404246|FG001|Overall Study|Physician Decision|4|||
161280051|NCT01198132|582404245|FG000|Overall Study|Other Unspecified|3|||
161280052|NCT01198132|582404246|FG001|Overall Study|Other Unspecified|6|||
161280053|NCT01198132|582404245|FG000|Overall Study|Lack of Efficacy|2|||
161280054|NCT01198132|582404246|FG001|Overall Study|Lack of Efficacy|3|||
161280055|NCT01198132|582404245|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
161280056|NCT01198132|582404246|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
161280057|NCT01198132|582404245|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
161280058|NCT01198132|582404246|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
161280059|NCT01198132|582404245|FG000|Overall Study|Adverse Event|0|||
161280060|NCT01198132|582404246|FG001|Overall Study|Adverse Event|1|||
161280061|NCT01198132|582404245|FG000|Overall Study|Protocol Violation|1|||
161036423|NCT04191824|581524649|FG001|Overall Study|Death|12|||
161036424|NCT04191824|581524648|FG000|Overall Study|Lost to Follow-up|456|||
161036425|NCT04191824|581524649|FG001|Overall Study|Lost to Follow-up|435|||
161036426|NCT04191824|581524648|FG000|Overall Study|Physician Decision|2|||
161036427|NCT04191824|581524649|FG001|Overall Study|Physician Decision|1|||
161036428|NCT04191824|581524648|FG000|Overall Study|Protocol Violation|0|||
161036429|NCT04191824|581524649|FG001|Overall Study|Protocol Violation|2|||
161036430|NCT04191824|581524648|FG000|Overall Study|Withdrawal by Subject|16|||
161036431|NCT04191824|581524649|FG001|Overall Study|Withdrawal by Subject|18|||
161036432|NCT04191824|581524648|FG000|Overall Study|Early site closure|24|||
161036433|NCT04191824|581524649|FG001|Overall Study|Early site closure|22|||
161036434|NCT01218009|581524650|FG000|Overall Study|Protocol Violation|2|||
161036435|NCT01218009|581524651|FG001|Overall Study|Protocol Violation|1|||
161036436|NCT01218009|581524650|FG000|Overall Study|Withdrawal by Subject|3|||
161036437|NCT01218009|581524651|FG001|Overall Study|Withdrawal by Subject|1|||
161036438|NCT01218009|581524650|FG000|Overall Study|Sponsor terminated study|161|||
161036439|NCT01218009|581524651|FG001|Overall Study|Sponsor terminated study|163|||
161280062|NCT01198132|582404246|FG001|Overall Study|Protocol Violation|0|||
161036440|NCT02397096|581524652|FG000|Day 1 to Week 24|Adverse Event|7|||
161036441|NCT02397096|581524653|FG001|Day 1 to Week 24|Adverse Event|1|||
161036442|NCT02397096|581524652|FG000|Day 1 to Week 24|Death|1|||
161036443|NCT02397096|581524653|FG001|Day 1 to Week 24|Death|0|||
161036444|NCT02397096|581524652|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
161036445|NCT02397096|581524653|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
161036446|NCT02397096|581524652|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
161036447|NCT02397096|581524653|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
161036448|NCT02397096|581524652|FG000|Day 1 to Week 24|Physician Decision|2|||
161280063|NCT01277211|582404247|FG000|Overall Study|Adverse Event|60|||
161280064|NCT01277211|582404248|FG001|Overall Study|Adverse Event|22|||
161280065|NCT01277211|582404247|FG000|Overall Study|Pregnancy|9|||
161280066|NCT01277211|582404248|FG001|Overall Study|Pregnancy|4|||
161280067|NCT01277211|582404247|FG000|Overall Study|Lost to Follow-up|14|||
161280068|NCT01277211|582404248|FG001|Overall Study|Lost to Follow-up|9|||
161280069|NCT01277211|582404247|FG000|Overall Study|Did not wish to continue|17|||
161280070|NCT01277211|582404248|FG001|Overall Study|Did not wish to continue|0|||
161280071|NCT01277211|582404247|FG000|Overall Study|Withdrew Consent|9|||
161280072|NCT01277211|582404248|FG001|Overall Study|Withdrew Consent|9|||
161280073|NCT01277211|582404247|FG000|Overall Study|Non-compliance with protocol|13|||
161280074|NCT01277211|582404248|FG001|Overall Study|Non-compliance with protocol|4|||
161280075|NCT01277211|582404247|FG000|Overall Study|Did not meet protocol eligibility|1|||
161280076|NCT01277211|582404248|FG001|Overall Study|Did not meet protocol eligibility|0|||
161280077|NCT01277211|582404247|FG000|Overall Study|Administrative|3|||
161280078|NCT01277211|582404248|FG001|Overall Study|Administrative|0|||
161280079|NCT01277211|582404247|FG000|Overall Study|Pregnancy wish|0|||
161280080|NCT01277211|582404248|FG001|Overall Study|Pregnancy wish|2|||
161280081|NCT01277211|582404247|FG000|Overall Study|Discontinued prior to treatment|24|||
161280082|NCT01277211|582404248|FG001|Overall Study|Discontinued prior to treatment|13|||
161280083|NCT04697069|582404249|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
161280084|NCT04697069|582404250|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
161280085|NCT04697069|582404249|FG000|Overall Study|Study termination|2|||
161280086|NCT04697069|582404250|FG001|Overall Study|Study termination|1|||
161280087|NCT05180227|582404251|FG000|Overall Study|Hypertension at screening|1|||
161280088|NCT05180227|582404251|FG000|Overall Study|Lost to Follow-up|1|||
161280089|NCT04614246|582404252|FG000|Overall Study|Adverse Event|0|||
161280090|NCT04614246|582404253|FG001|Overall Study|Adverse Event|1|||
161280091|NCT04614246|582404254|FG002|Overall Study|Adverse Event|1|||
161280092|NCT04614246|582404255|FG003|Overall Study|Adverse Event|2|||
161280093|NCT04614246|582404256|FG004|Overall Study|Adverse Event|1|||
161280094|NCT04614246|582404252|FG000|Overall Study|Lost to Follow-up|0|||
161280095|NCT04614246|582404253|FG001|Overall Study|Lost to Follow-up|1|||
161280096|NCT04614246|582404254|FG002|Overall Study|Lost to Follow-up|0|||
161280097|NCT04614246|582404255|FG003|Overall Study|Lost to Follow-up|1|||
161280098|NCT04614246|582404256|FG004|Overall Study|Lost to Follow-up|3|||
161036449|NCT02397096|581524653|FG001|Day 1 to Week 24|Physician Decision|3|||
161036450|NCT02397096|581524652|FG000|Day 1 to Week 24|Protocol Violation|1|||
161036451|NCT02397096|581524653|FG001|Day 1 to Week 24|Protocol Violation|4|||
161036452|NCT02397096|581524652|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
161036453|NCT02397096|581524653|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
161036454|NCT02397096|581524652|FG000|Day 1 to Week 24|Randomized, not treated|3|||
161036455|NCT02397096|581524653|FG001|Day 1 to Week 24|Randomized, not treated|0|||
161036456|NCT02397096|581524652|FG000|Week 24 to Week 48|Adverse Event|6|||
161036457|NCT02397096|581524653|FG001|Week 24 to Week 48|Adverse Event|2|||
161036458|NCT02397096|581524652|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
161036459|NCT02397096|581524653|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
161036460|NCT02397096|581524652|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
161036461|NCT02397096|581524653|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
161036462|NCT02397096|581524652|FG000|Week 24 to Week 48|Physician Decision|2|||
161036463|NCT02397096|581524653|FG001|Week 24 to Week 48|Physician Decision|1|||
161036464|NCT02397096|581524652|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
161036465|NCT02397096|581524653|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
161280099|NCT04614246|582404252|FG000|Overall Study|Other reason|0|||
161280100|NCT04614246|582404253|FG001|Overall Study|Other reason|1|||
161036466|NCT02397096|581524652|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
161036467|NCT02397096|581524653|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
161280101|NCT04614246|582404254|FG002|Overall Study|Other reason|2|||
161036468|NCT02397096|581524652|FG000|Study Extension 1|Adverse Event|7|||
161036469|NCT02397096|581524653|FG001|Study Extension 1|Adverse Event|5|||
161036470|NCT02397096|581524652|FG000|Study Extension 1|Death|1|||
161036471|NCT02397096|581524653|FG001|Study Extension 1|Death|0|||
161280102|NCT04614246|582404255|FG003|Overall Study|Other reason|0|||
161280103|NCT04614246|582404256|FG004|Overall Study|Other reason|0|||
161280104|NCT04614246|582404252|FG000|Overall Study|Withdrawal by Subject|4|||
161280105|NCT04614246|582404253|FG001|Overall Study|Withdrawal by Subject|2|||
161280106|NCT04614246|582404254|FG002|Overall Study|Withdrawal by Subject|4|||
161280107|NCT04614246|582404255|FG003|Overall Study|Withdrawal by Subject|3|||
161036472|NCT02397096|581524652|FG000|Study Extension 1|Lack of Efficacy|2|||
161036473|NCT02397096|581524653|FG001|Study Extension 1|Lack of Efficacy|5|||
161036474|NCT02397096|581524652|FG000|Study Extension 1|Lost to Follow-up|2|||
161036475|NCT02397096|581524653|FG001|Study Extension 1|Lost to Follow-up|3|||
161036476|NCT02397096|581524652|FG000|Study Extension 1|Non-compliance with study drug|3|||
161036477|NCT02397096|581524653|FG001|Study Extension 1|Non-compliance with study drug|0|||
161036478|NCT02397096|581524652|FG000|Study Extension 1|Physician Decision|4|||
161036479|NCT02397096|581524653|FG001|Study Extension 1|Physician Decision|2|||
161036480|NCT02397096|581524652|FG000|Study Extension 1|Pregnancy|1|||
161036481|NCT02397096|581524653|FG001|Study Extension 1|Pregnancy|0|||
161036482|NCT02397096|581524652|FG000|Study Extension 1|Protocol Violation|0|||
161036483|NCT02397096|581524653|FG001|Study Extension 1|Protocol Violation|1|||
161036484|NCT02397096|581524652|FG000|Study Extension 1|Withdrawal by Subject|21|||
161036485|NCT02397096|581524653|FG001|Study Extension 1|Withdrawal by Subject|7|||
161036486|NCT02397096|581524652|FG000|Study Extension 2|Adverse Event|3|||
161036487|NCT02397096|581524653|FG001|Study Extension 2|Adverse Event|3|||
161036488|NCT02397096|581524652|FG000|Study Extension 2|Availability of study medication locally|152|||
161036489|NCT02397096|581524653|FG001|Study Extension 2|Availability of study medication locally|64|||
161036490|NCT02397096|581524652|FG000|Study Extension 2|Death|2|||
161036491|NCT02397096|581524653|FG001|Study Extension 2|Death|0|||
161036492|NCT02397096|581524652|FG000|Study Extension 2|Lack of Efficacy|1|||
161036493|NCT02397096|581524653|FG001|Study Extension 2|Lack of Efficacy|0|||
161036494|NCT02397096|581524652|FG000|Study Extension 2|Lost to Follow-up|2|||
161036495|NCT02397096|581524653|FG001|Study Extension 2|Lost to Follow-up|1|||
161036496|NCT02397096|581524652|FG000|Study Extension 2|Non-compliance with study drug|1|||
161036497|NCT02397096|581524653|FG001|Study Extension 2|Non-compliance with study drug|0|||
161036498|NCT02397096|581524652|FG000|Study Extension 2|Physician Decision|2|||
161036499|NCT02397096|581524653|FG001|Study Extension 2|Physician Decision|5|||
161036500|NCT02397096|581524652|FG000|Study Extension 2|Pregnancy|1|||
161036501|NCT02397096|581524653|FG001|Study Extension 2|Pregnancy|0|||
161036502|NCT02397096|581524652|FG000|Study Extension 2|Withdrawal by Subject|10|||
161036503|NCT02397096|581524653|FG001|Study Extension 2|Withdrawal by Subject|3|||
161036504|NCT02397096|581524652|FG000|Study Extension 3|Adverse Event|1|||
161036505|NCT02397096|581524653|FG001|Study Extension 3|Adverse Event|0|||
161036506|NCT02397096|581524652|FG000|Study Extension 3|Availability of study medication locally|11|||
161036507|NCT02397096|581524653|FG001|Study Extension 3|Availability of study medication locally|3|||
161036508|NCT02397096|581524652|FG000|Study Extension 3|Lost to Follow-up|1|||
161036509|NCT02397096|581524653|FG001|Study Extension 3|Lost to Follow-up|0|||
161036510|NCT02397096|581524652|FG000|Study Extension 3|Withdrawal by Subject|2|||
161036511|NCT02397096|581524653|FG001|Study Extension 3|Withdrawal by Subject|1|||
161036512|NCT05018143|581524654|FG000|Overall Study|Lost to Follow-up|5|||
161036513|NCT05018143|581524655|FG001|Overall Study|Lost to Follow-up|4|||
161036514|NCT05018143|581524654|FG000|Overall Study|Withdrawal by Subject|0|||
161036515|NCT05018143|581524655|FG001|Overall Study|Withdrawal by Subject|1|||
161036516|NCT06688357|581524656|FG000|Overall Study|Adverse Event|0|||
161036517|NCT06688357|581524657|FG001|Overall Study|Adverse Event|1|||
161036518|NCT05116774|581524658|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
161036519|NCT05116774|581524659|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
161036520|NCT05116774|581524658|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
161036521|NCT05116774|581524659|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
161036522|NCT05116774|581524658|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
161036523|NCT05116774|581524659|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
161036524|NCT05116774|581524658|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
161036525|NCT05116774|581524659|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
161036526|NCT03280030|581524660|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
161036527|NCT03280030|581524661|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
161036528|NCT03280030|581524662|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
161036529|NCT03280030|581524660|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
161036530|NCT03280030|581524661|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
161280108|NCT04614246|582404256|FG004|Overall Study|Withdrawal by Subject|4|||
161280109|NCT04614246|582404252|FG000|Overall Study|Physician Decision|0|||
161280110|NCT04614246|582404253|FG001|Overall Study|Physician Decision|2|||
161280111|NCT04614246|582404254|FG002|Overall Study|Physician Decision|1|||
161280112|NCT04614246|582404255|FG003|Overall Study|Physician Decision|0|||
161280113|NCT04614246|582404256|FG004|Overall Study|Physician Decision|0|||
161280114|NCT04614246|582404252|FG000|Overall Study|Study terminated by sponsor|10|||
161280115|NCT04614246|582404253|FG001|Overall Study|Study terminated by sponsor|15|||
161036531|NCT03280030|581524662|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
161036532|NCT03280030|581524660|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
161036533|NCT03280030|581524661|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
161036534|NCT03280030|581524662|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
161036535|NCT03280030|581524660|FG000|Part 2 - Efficacy|Adverse Event|0|||
161036536|NCT03280030|581524661|FG001|Part 2 - Efficacy|Adverse Event|4|||
161280116|NCT04614246|582404254|FG002|Overall Study|Study terminated by sponsor|12|||
161280117|NCT04614246|582404255|FG003|Overall Study|Study terminated by sponsor|13|||
161036537|NCT03280030|581524662|FG002|Part 2 - Efficacy|Adverse Event|6|||
161036538|NCT03280030|581524660|FG000|Part 2 - Efficacy|Death|0|||
161036539|NCT03280030|581524661|FG001|Part 2 - Efficacy|Death|3|||
161036540|NCT03280030|581524662|FG002|Part 2 - Efficacy|Death|0|||
161036541|NCT03280030|581524660|FG000|Part 2 - Efficacy|Physician Decision|0|||
161036542|NCT03280030|581524661|FG001|Part 2 - Efficacy|Physician Decision|10|||
161036543|NCT03280030|581524662|FG002|Part 2 - Efficacy|Physician Decision|16|||
161036544|NCT03280030|581524660|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
161036545|NCT03280030|581524661|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
161036546|NCT03280030|581524662|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
161036547|NCT03280030|581524660|FG000|Part 2 - Efficacy|Progressive disease|0|||
161036548|NCT03280030|581524661|FG001|Part 2 - Efficacy|Progressive disease|7|||
161036549|NCT03280030|581524662|FG002|Part 2 - Efficacy|Progressive disease|5|||
161036550|NCT04882917|581524668|FG000|Overall Study|Adverse Event|0|||
161036551|NCT04882917|581524669|FG001|Overall Study|Adverse Event|1|||
161036552|NCT04882917|581524670|FG002|Overall Study|Adverse Event|2|||
161036553|NCT04882917|581524671|FG003|Overall Study|Adverse Event|2|||
161036554|NCT04882917|581524668|FG000|Overall Study|Withdrawal by Subject|1|||
161036555|NCT04882917|581524669|FG001|Overall Study|Withdrawal by Subject|0|||
161036556|NCT04882917|581524670|FG002|Overall Study|Withdrawal by Subject|2|||
161036557|NCT04882917|581524671|FG003|Overall Study|Withdrawal by Subject|1|||
161036558|NCT04882917|581524668|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
161036559|NCT04882917|581524669|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
161036560|NCT04882917|581524670|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
161036561|NCT04882917|581524671|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
161036562|NCT03959423|581524675|FG000|Overall Study|Withdrawal by Subject|2|||
161036563|NCT03959423|581524676|FG001|Overall Study|Withdrawal by Subject|3|||
161036564|NCT03959423|581524675|FG000|Overall Study|Physician Decision|0|||
161036565|NCT03959423|581524676|FG001|Overall Study|Physician Decision|1|||
161036566|NCT03959423|581524675|FG000|Overall Study|Lost to Follow-up|1|||
161036567|NCT03959423|581524676|FG001|Overall Study|Lost to Follow-up|0|||
161036568|NCT03959423|581524675|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
161036569|NCT03959423|581524676|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161036570|NCT01470144|581524681|FG000|Overall Study|Adverse Event|2|||
161036571|NCT01470144|581524681|FG000|Overall Study|Death|1|||
161036572|NCT01470144|581524681|FG000|Overall Study|Lung transplant|6|||
161036573|NCT01470144|581524681|FG000|Overall Study|Patient's and investigator's decision|1|||
161036574|NCT00593840|581524682|FG000|Overall Study|Withdrawal by Subject|1|||
161036575|NCT06056310|581525475|FG000|Overall Study|Other Reasons|2|||
161036576|NCT06056310|581525475|FG000|Overall Study|Sponsor Request|16|||
161036577|NCT02866942|581525478|FG000|Overall Study|Invalid consent|1|||
161036578|NCT01750684|581525479|FG000|Overall Study|Death|1|||
161036579|NCT01750684|581525480|FG001|Overall Study|Death|0|||
161036580|NCT01750684|581525479|FG000|Overall Study|Non-compliance with Study Drug|0|||
161036581|NCT01750684|581525480|FG001|Overall Study|Non-compliance with Study Drug|1|||
161036582|NCT01750684|581525479|FG000|Overall Study|Withdrawn by Sponsor|0|||
161036583|NCT01750684|581525480|FG001|Overall Study|Withdrawn by Sponsor|1|||
161036584|NCT01750684|581525479|FG000|Overall Study|Protocol Violation|1|||
161036585|NCT01750684|581525480|FG001|Overall Study|Protocol Violation|0|||
161036586|NCT00372775|581525481|FG000|Overall Study|Adverse Event|8|||
161036587|NCT00372775|581525481|FG000|Overall Study|Death|15|||
161036588|NCT00372775|581525481|FG000|Overall Study|Objective progression or relapse|30|||
161036589|NCT00372775|581525481|FG000|Overall Study|Global deterioration of health status|6|||
161036590|NCT00372775|581525481|FG000|Overall Study|Withdrawal by Subject|1|||
161036591|NCT00372775|581525481|FG000|Overall Study|Other|1|||
161036592|NCT00372775|581525481|FG000|Overall Study|Not Treated|2|||
161036593|NCT01561300|581525482|FG000|Run in on Placebo|Adverse Event|1|||
161036594|NCT01561300|581525483|FG001|Run in on Placebo|Adverse Event|0|||
161036595|NCT00777049|581525484|FG000|Overall Study|Withdrawal by Subject|1|||
161036596|NCT00777049|581525485|FG001|Overall Study|Withdrawal by Subject|0|||
161036597|NCT00777049|581525484|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
161036598|NCT00777049|581525485|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
161036599|NCT01436175|581525486|FG000|Overall Study|Adverse Event|111|||
161036600|NCT01436175|581525486|FG000|Overall Study|Protocol Violation|49|||
161036601|NCT01436175|581525486|FG000|Overall Study|Withdrawal by Subject|108|||
161036602|NCT01436175|581525486|FG000|Overall Study|Lost to Follow-up|89|||
161036603|NCT01436175|581525486|FG000|Overall Study|Lack of Efficacy|24|||
161036604|NCT01436175|581525486|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
161036605|NCT01436175|581525486|FG000|Overall Study|Other|826|||
161036606|NCT01952366|581525489|FG000|Overall Study|Death|22|||
161036607|NCT01952366|581525489|FG000|Overall Study|Withdrawal by Subject|9|||
161036608|NCT00623194|581525490|FG000|Overall Study|Lack of Efficacy|1|||
161036609|NCT00623194|581525490|FG000|Overall Study|Protocol Violation|3|||
161036610|NCT00623194|581525490|FG000|Overall Study|Unclassified|1|||
161036611|NCT00857766|581525491|FG000|Overall Study|Adverse Event|13|||
161036612|NCT00857766|581525492|FG001|Overall Study|Adverse Event|12|||
161036613|NCT00857766|581525491|FG000|Overall Study|Protocol Violation|11|||
161036614|NCT00857766|581525492|FG001|Overall Study|Protocol Violation|11|||
161036615|NCT00857766|581525491|FG000|Overall Study|Lost to Follow-up|1|||
161036616|NCT00857766|581525492|FG001|Overall Study|Lost to Follow-up|0|||
161036617|NCT00857766|581525491|FG000|Overall Study|Investigator Discretion|2|||
161036618|NCT00857766|581525492|FG001|Overall Study|Investigator Discretion|3|||
161036619|NCT00857766|581525491|FG000|Overall Study|Participant Withdrew Consent|4|||
161036620|NCT00857766|581525492|FG001|Overall Study|Participant Withdrew Consent|4|||
161036621|NCT01988402|581525493|FG000|Overall Study|Adverse Event|1|||
161036622|NCT01988402|581525494|FG001|Overall Study|Adverse Event|2|||
161036623|NCT01988402|581525493|FG000|Overall Study|Withdrawal by Subject|1|||
161036624|NCT01988402|581525494|FG001|Overall Study|Withdrawal by Subject|0|||
161036625|NCT01212744|581525495|FG000|Overall Study|Withdrawal by Subject|1|||
161036626|NCT00523419|581525499|FG000|Overall Study|Adverse Event|1|||
161036627|NCT00523419|581525499|FG000|Overall Study|Withdrawal by Subject|1|||
161036628|NCT00523419|581525499|FG000|Overall Study|Physician Decision|2|||
161036629|NCT00523419|581525499|FG000|Overall Study|Progressive Disease|22|||
161036630|NCT00523419|581525499|FG000|Overall Study|Death due to Study Disease|4|||
161036631|NCT00523419|581525499|FG000|Overall Study|Death due to Adverse Event|2|||
161036632|NCT00822120|581525500|FG000|Initial Registration|Adverse Event|1|||
161036633|NCT00822120|581525501|FG001|Initial Registration|Adverse Event|0|||
161036634|NCT00822120|581525502|FG002|Initial Registration|Adverse Event|0|||
161036635|NCT00822120|581525503|FG003|Initial Registration|Adverse Event|0|||
161036636|NCT00822120|581525504|FG004|Initial Registration|Adverse Event|0|||
161036637|NCT00822120|581525505|FG005|Initial Registration|Adverse Event|0|||
161036638|NCT00822120|581525500|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
161036639|NCT00822120|581525501|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161036640|NCT00822120|581525502|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161036641|NCT00822120|581525503|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161036642|NCT00822120|581525504|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161036643|NCT00822120|581525505|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
161036644|NCT00822120|581525500|FG000|Initial Registration|Reasons not Protocol Specified|2|||
161036645|NCT00822120|581525501|FG001|Initial Registration|Reasons not Protocol Specified|0|||
161036646|NCT00822120|581525502|FG002|Initial Registration|Reasons not Protocol Specified|0|||
161036647|NCT00822120|581525503|FG003|Initial Registration|Reasons not Protocol Specified|0|||
161036648|NCT00822120|581525504|FG004|Initial Registration|Reasons not Protocol Specified|0|||
161036649|NCT00822120|581525505|FG005|Initial Registration|Reasons not Protocol Specified|0|||
161036650|NCT00822120|581525500|FG000|Initial Registration|Ineligible|22|||
161036651|NCT00822120|581525501|FG001|Initial Registration|Ineligible|1|||
161036652|NCT00822120|581525502|FG002|Initial Registration|Ineligible|0|||
161036653|NCT00822120|581525503|FG003|Initial Registration|Ineligible|0|||
161036654|NCT00822120|581525504|FG004|Initial Registration|Ineligible|0|||
161036655|NCT00822120|581525505|FG005|Initial Registration|Ineligible|0|||
161036656|NCT00822120|581525500|FG000|PET-directed Therapy|Adverse Event|0|||
161036657|NCT00822120|581525501|FG001|PET-directed Therapy|Adverse Event|0|||
161036658|NCT00822120|581525502|FG002|PET-directed Therapy|Adverse Event|0|||
161036659|NCT00822120|581525503|FG003|PET-directed Therapy|Adverse Event|1|||
161036660|NCT00822120|581525504|FG004|PET-directed Therapy|Adverse Event|0|||
161036661|NCT00822120|581525505|FG005|PET-directed Therapy|Adverse Event|0|||
161036662|NCT00822120|581525500|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161036663|NCT00822120|581525501|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161036664|NCT00822120|581525502|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161036665|NCT00822120|581525503|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
161036666|NCT00822120|581525504|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161036667|NCT00822120|581525505|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
161036668|NCT00822120|581525500|FG000|PET-directed Therapy|Death|0|||
161036669|NCT00822120|581525501|FG001|PET-directed Therapy|Death|0|||
161036670|NCT00822120|581525502|FG002|PET-directed Therapy|Death|0|||
161036671|NCT00822120|581525503|FG003|PET-directed Therapy|Death|2|||
161280118|NCT04614246|582404256|FG004|Overall Study|Study terminated by sponsor|9|||
161036672|NCT00822120|581525504|FG004|PET-directed Therapy|Death|0|||
161036673|NCT00822120|581525505|FG005|PET-directed Therapy|Death|0|||
161036674|NCT00822120|581525500|FG000|PET-directed Therapy|Protocol Violation|0|||
161036675|NCT00822120|581525501|FG001|PET-directed Therapy|Protocol Violation|0|||
161036676|NCT00822120|581525502|FG002|PET-directed Therapy|Protocol Violation|0|||
161036677|NCT00822120|581525503|FG003|PET-directed Therapy|Protocol Violation|6|||
161036678|NCT00822120|581525504|FG004|PET-directed Therapy|Protocol Violation|0|||
161036679|NCT00822120|581525505|FG005|PET-directed Therapy|Protocol Violation|0|||
161036680|NCT01759862|581525506|FG000|Overall Study|Physician Decision|3|||
161036681|NCT01759862|581525507|FG001|Overall Study|Physician Decision|1|||
161036682|NCT01759862|581525506|FG000|Overall Study|Adverse Event|0|||
161036683|NCT01759862|581525507|FG001|Overall Study|Adverse Event|1|||
161036684|NCT04060212|581525509|FG000|Overall Study|Withdrawal by Subject|7|||
161036685|NCT01437319|581525510|FG000|Phase I|Lost to Follow-up|2|||
161036686|NCT01437319|581525511|FG001|Phase I|Lost to Follow-up|0|||
161280119|NCT04614246|582404252|FG000|Overall Study|Pregnancy|2|||
161036687|NCT01437319|581525512|FG002|Phase I|Lost to Follow-up|0|||
161036688|NCT01437319|581525510|FG000|Phase I|Protocol Violation|1|||
161036689|NCT01437319|581525511|FG001|Phase I|Protocol Violation|0|||
161036690|NCT01437319|581525512|FG002|Phase I|Protocol Violation|0|||
161036691|NCT01437319|581525510|FG000|Phase I|Study related symptoms/complaints|27|||
161036692|NCT01437319|581525511|FG001|Phase I|Study related symptoms/complaints|0|||
161036693|NCT01437319|581525512|FG002|Phase I|Study related symptoms/complaints|0|||
161036694|NCT01437319|581525510|FG000|Phase I|Withdrawal by Subject|25|||
161036695|NCT01437319|581525511|FG001|Phase I|Withdrawal by Subject|0|||
161036696|NCT01437319|581525512|FG002|Phase I|Withdrawal by Subject|0|||
161036697|NCT01437319|581525510|FG000|Phase II|Withdrawal by Subject|0|||
161036698|NCT01437319|581525511|FG001|Phase II|Withdrawal by Subject|8|||
161036699|NCT01437319|581525512|FG002|Phase II|Withdrawal by Subject|16|||
161036700|NCT01437319|581525510|FG000|Phase II|Lost to Follow-up|0|||
161036701|NCT01437319|581525511|FG001|Phase II|Lost to Follow-up|7|||
161036702|NCT01437319|581525512|FG002|Phase II|Lost to Follow-up|2|||
161036703|NCT01437319|581525510|FG000|Phase II|Study related symptoms/complaints|0|||
161036704|NCT01437319|581525511|FG001|Phase II|Study related symptoms/complaints|28|||
161036705|NCT01437319|581525512|FG002|Phase II|Study related symptoms/complaints|19|||
161036706|NCT01437319|581525510|FG000|Phase II|Protocol Violation|0|||
161036707|NCT01437319|581525511|FG001|Phase II|Protocol Violation|1|||
161036708|NCT01437319|581525512|FG002|Phase II|Protocol Violation|0|||
161036709|NCT01499849|581525513|FG000|Overall Study|Adverse Event|28|||
161036710|NCT01499849|581525514|FG001|Overall Study|Adverse Event|32|||
161036711|NCT01499849|581525513|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
161036712|NCT01499849|581525514|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
161036713|NCT01499849|581525513|FG000|Overall Study|Withdrawal by Subject|43|||
161036714|NCT01499849|581525514|FG001|Overall Study|Withdrawal by Subject|43|||
161036715|NCT01499849|581525513|FG000|Overall Study|Death|5|||
161036716|NCT01499849|581525514|FG001|Overall Study|Death|7|||
161036717|NCT01499849|581525513|FG000|Overall Study|Disease Progression|11|||
161036718|NCT01499849|581525514|FG001|Overall Study|Disease Progression|10|||
161036719|NCT01499849|581525513|FG000|Overall Study|Protocol Violation|11|||
161036720|NCT01499849|581525514|FG001|Overall Study|Protocol Violation|11|||
161036721|NCT01499849|581525513|FG000|Overall Study|Physician Decision|20|||
161036722|NCT01499849|581525514|FG001|Overall Study|Physician Decision|19|||
161036723|NCT01499849|581525513|FG000|Overall Study|Lack of Efficacy|3|||
161036724|NCT01499849|581525514|FG001|Overall Study|Lack of Efficacy|4|||
161036725|NCT01499849|581525513|FG000|Overall Study|Lost to Follow-up|6|||
161036726|NCT01499849|581525514|FG001|Overall Study|Lost to Follow-up|3|||
161036727|NCT01499849|581525513|FG000|Overall Study|Other Reasons|27|||
161036728|NCT01499849|581525514|FG001|Overall Study|Other Reasons|30|||
161036729|NCT02646618|581525515|FG000|Overall Study|Lost to Follow-up|10|||
161036730|NCT02646618|581525516|FG001|Overall Study|Lost to Follow-up|14|||
161280120|NCT04614246|582404253|FG001|Overall Study|Pregnancy|0|||
161280121|NCT04614246|582404254|FG002|Overall Study|Pregnancy|1|||
161036731|NCT03885232|581525517|FG000|Overall Study|Lost to Follow-up|74|||
161036732|NCT03885232|581525518|FG001|Overall Study|Lost to Follow-up|32|||
161036733|NCT03885232|581525517|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
161036734|NCT03885232|581525518|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
161036735|NCT00274261|581525519|FG000|Overall Study|Adverse Event|19|||
161036736|NCT00274261|581525520|FG001|Overall Study|Adverse Event|11|||
161036737|NCT00274261|581525519|FG000|Overall Study|Pregnancy|114|||
161036738|NCT00274261|581525520|FG001|Overall Study|Pregnancy|83|||
161036739|NCT00274261|581525519|FG000|Overall Study|Withdrawal by Subject|179|||
161036740|NCT00274261|581525520|FG001|Overall Study|Withdrawal by Subject|126|||
161036741|NCT00274261|581525519|FG000|Overall Study|Protocol Violation|71|||
161036742|NCT00274261|581525520|FG001|Overall Study|Protocol Violation|42|||
161036743|NCT00274261|581525519|FG000|Overall Study|Lost to Follow-up|106|||
161036744|NCT00274261|581525520|FG001|Overall Study|Lost to Follow-up|75|||
161036745|NCT03500549|581525521|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
161036746|NCT03500549|581525522|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
161036747|NCT03500549|581525521|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
161036748|NCT03500549|581525522|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
161036749|NCT02016872|581525525|FG000|Overall Study|Withdrawal by Subject|10|||
161036750|NCT02016872|581525525|FG000|Overall Study|Death Progression|2|||
161036751|NCT02016872|581525525|FG000|Overall Study|No FMISO scan|1|||
161036752|NCT02016872|581525525|FG000|Overall Study|Ineligible|2|||
161036753|NCT05601882|581525526|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
161036754|NCT05601882|581525527|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
161036755|NCT05601882|581525528|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
161036756|NCT05601882|581525529|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
161036757|NCT05601882|581525526|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
161036758|NCT05601882|581525527|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
161036759|NCT05601882|581525528|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
161036760|NCT05601882|581525529|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
161280122|NCT04614246|582404255|FG003|Overall Study|Pregnancy|0|||
161280123|NCT04614246|582404256|FG004|Overall Study|Pregnancy|0|||
161036761|NCT05601882|581525526|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
161036762|NCT05601882|581525527|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
161036763|NCT05601882|581525528|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
161036764|NCT05601882|581525529|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
161036765|NCT05601882|581525526|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
161036766|NCT05601882|581525527|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
161036767|NCT05601882|581525528|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
161036768|NCT05601882|581525529|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
161036769|NCT05601882|581525526|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
161036770|NCT05601882|581525527|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
161036771|NCT05601882|581525528|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
161036772|NCT05601882|581525529|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
161036773|NCT05601882|581525526|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
161036774|NCT05601882|581525527|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
161036775|NCT05601882|581525528|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
161036776|NCT05601882|581525529|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
161036777|NCT03222609|581525532|FG000|Overall Study|Withdrew consent|2|||
161036778|NCT03222609|581525533|FG001|Overall Study|Withdrew consent|3|||
161036779|NCT03222609|581525534|FG002|Overall Study|Withdrew consent|4|||
161036780|NCT03222609|581525535|FG003|Overall Study|Withdrew consent|2|||
161036781|NCT03222609|581525532|FG000|Overall Study|Lost to Follow-up|1|||
161036782|NCT03222609|581525533|FG001|Overall Study|Lost to Follow-up|0|||
161036783|NCT03222609|581525534|FG002|Overall Study|Lost to Follow-up|0|||
161036784|NCT03222609|581525535|FG003|Overall Study|Lost to Follow-up|0|||
161036785|NCT03222609|581525532|FG000|Overall Study|Death|16|||
161036786|NCT03222609|581525533|FG001|Overall Study|Death|13|||
161036787|NCT03222609|581525534|FG002|Overall Study|Death|9|||
161036788|NCT03222609|581525535|FG003|Overall Study|Death|6|||
161036789|NCT03222609|581525532|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
161036790|NCT03222609|581525533|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
161036791|NCT03222609|581525534|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
161036792|NCT03222609|581525535|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
161036793|NCT03789110|581525536|FG000|Overall Study|Adverse Event|2|||
161036794|NCT03789110|581525536|FG000|Overall Study|Physician Decision|1|||
161036795|NCT03789110|581525536|FG000|Overall Study|Withdrawal by Subject|2|||
161036796|NCT03789110|581525536|FG000|Overall Study|Lack of Efficacy|22|||
161036797|NCT03789110|581525536|FG000|Overall Study|still on treatment|3|||
161036798|NCT00545545|581525537|FG000|Overall Study|Progressive Neoplastic Disease|1|||
161036799|NCT00545545|581525538|FG001|Overall Study|Progressive Neoplastic Disease|5|||
161036800|NCT00545545|581525539|FG002|Overall Study|Progressive Neoplastic Disease|0|||
161036801|NCT00545545|581525540|FG003|Overall Study|Progressive Neoplastic Disease|4|||
161036802|NCT00545545|581525541|FG004|Overall Study|Progressive Neoplastic Disease|8|||
161036803|NCT00545545|581525542|FG005|Overall Study|Progressive Neoplastic Disease|7|||
161036804|NCT00545545|581525537|FG000|Overall Study|Withdrawal by Subject|0|||
161036805|NCT00545545|581525538|FG001|Overall Study|Withdrawal by Subject|1|||
161036806|NCT00545545|581525539|FG002|Overall Study|Withdrawal by Subject|0|||
161036807|NCT00545545|581525540|FG003|Overall Study|Withdrawal by Subject|0|||
161036808|NCT00545545|581525541|FG004|Overall Study|Withdrawal by Subject|0|||
161036809|NCT00545545|581525542|FG005|Overall Study|Withdrawal by Subject|0|||
161036810|NCT00545545|581525537|FG000|Overall Study|Physician Decision|1|||
161036811|NCT00545545|581525538|FG001|Overall Study|Physician Decision|0|||
161036812|NCT00545545|581525539|FG002|Overall Study|Physician Decision|0|||
161036813|NCT00545545|581525540|FG003|Overall Study|Physician Decision|0|||
161036814|NCT00545545|581525541|FG004|Overall Study|Physician Decision|0|||
161036815|NCT00545545|581525542|FG005|Overall Study|Physician Decision|1|||
161036816|NCT00545545|581525537|FG000|Overall Study|Irinotecan intolerance|1|||
161036817|NCT00545545|581525538|FG001|Overall Study|Irinotecan intolerance|1|||
161036818|NCT00545545|581525539|FG002|Overall Study|Irinotecan intolerance|0|||
161036819|NCT00545545|581525540|FG003|Overall Study|Irinotecan intolerance|0|||
161036820|NCT00545545|581525541|FG004|Overall Study|Irinotecan intolerance|0|||
161036821|NCT00545545|581525542|FG005|Overall Study|Irinotecan intolerance|0|||
161036822|NCT00545545|581525537|FG000|Overall Study|No target lesions to track post surgery|0|||
161036823|NCT00545545|581525538|FG001|Overall Study|No target lesions to track post surgery|0|||
161036824|NCT00545545|581525539|FG002|Overall Study|No target lesions to track post surgery|0|||
161036825|NCT00545545|581525540|FG003|Overall Study|No target lesions to track post surgery|0|||
161036826|NCT00545545|581525541|FG004|Overall Study|No target lesions to track post surgery|1|||
161036827|NCT00545545|581525542|FG005|Overall Study|No target lesions to track post surgery|1|||
161036828|NCT03691493|581525546|FG000|Overall Study|Withdrawal by Subject|1|||
161036829|NCT00227266|581525547|FG000|Overall Study|Withdrawal by Subject|0|||
161036830|NCT00227266|581525548|FG001|Overall Study|Withdrawal by Subject|0|||
161036831|NCT00227266|581525549|FG002|Overall Study|Withdrawal by Subject|1|||
161036832|NCT00227266|581525547|FG000|Overall Study|Protocol Violation|1|||
161036833|NCT00227266|581525548|FG001|Overall Study|Protocol Violation|0|||
161036834|NCT00227266|581525549|FG002|Overall Study|Protocol Violation|1|||
161036835|NCT00227266|581525547|FG000|Overall Study|Excessive weight gain|0|||
161036836|NCT00227266|581525548|FG001|Overall Study|Excessive weight gain|0|||
161036837|NCT00227266|581525549|FG002|Overall Study|Excessive weight gain|2|||
161036838|NCT04926740|581525552|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
161036839|NCT04926740|581525553|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
161036840|NCT04926740|581525552|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
161036841|NCT04926740|581525553|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
161036842|NCT05802173|581527021|FG000|Overall Study|Withdrawal by Subject|2|||
161036843|NCT05802173|581527022|FG001|Overall Study|Withdrawal by Subject|0|||
161036844|NCT05802173|581527023|FG002|Overall Study|Withdrawal by Subject|0|||
161036845|NCT05802173|581527021|FG000|Overall Study|Protocol Violation|1|||
161036846|NCT05802173|581527022|FG001|Overall Study|Protocol Violation|0|||
161036847|NCT05802173|581527023|FG002|Overall Study|Protocol Violation|0|||
161036848|NCT05802173|581527021|FG000|Overall Study|Lost to Follow-up|0|||
161036849|NCT05802173|581527022|FG001|Overall Study|Lost to Follow-up|6|||
161036850|NCT05802173|581527023|FG002|Overall Study|Lost to Follow-up|4|||
161036851|NCT05802173|581527021|FG000|Overall Study|non-compliance|0|||
161036852|NCT05802173|581527022|FG001|Overall Study|non-compliance|1|||
161036853|NCT05802173|581527023|FG002|Overall Study|non-compliance|0|||
161036854|NCT04503681|581527024|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
161036855|NCT04503681|581527025|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
161036856|NCT03352713|581527026|FG000|Overall Study|Lost to Follow-up|8|||
161036857|NCT03352713|581527026|FG000|Overall Study|Withdrawn by investigator|5|||
161036858|NCT03352713|581527026|FG000|Overall Study|Completed 0 EMAs|8|||
161036859|NCT03352713|581527026|FG000|Overall Study|Device incompatible/stolen|5|||
161036860|NCT01812759|581527027|FG000|Overall Study|Physician Decision|0|||
161036861|NCT01812759|581527028|FG001|Overall Study|Physician Decision|0|||
161036862|NCT01812759|581527029|FG002|Overall Study|Physician Decision|1|||
161036863|NCT00360269|581527030|FG000|Overall Study|Lost to Follow-up|7|||
161036864|NCT00360269|581527031|FG001|Overall Study|Lost to Follow-up|9|||
161036865|NCT00360269|581527030|FG000|Overall Study|Physician Decision|1|||
161036866|NCT00360269|581527031|FG001|Overall Study|Physician Decision|2|||
161036867|NCT00360269|581527030|FG000|Overall Study|Adverse Event|1|||
161036868|NCT00360269|581527031|FG001|Overall Study|Adverse Event|0|||
161036869|NCT00360269|581527030|FG000|Overall Study|Withdrawal by Subject|1|||
161036870|NCT00360269|581527031|FG001|Overall Study|Withdrawal by Subject|1|||
161036871|NCT03758638|581527034|FG000|Overall Study|Pregnancy|17|||
161036872|NCT03758638|581527035|FG001|Overall Study|Pregnancy|25|||
161036873|NCT03758638|581527034|FG000|Overall Study|Lost to Follow-up|60|||
161036874|NCT03758638|581527035|FG001|Overall Study|Lost to Follow-up|54|||
161036875|NCT03758638|581527034|FG000|Overall Study|Protocol Violation|2|||
161036876|NCT03758638|581527035|FG001|Overall Study|Protocol Violation|0|||
161036877|NCT03758638|581527034|FG000|Overall Study|Withdrawal by Subject|8|||
161036878|NCT03758638|581527035|FG001|Overall Study|Withdrawal by Subject|2|||
161036879|NCT03758638|581527034|FG000|Overall Study|Providers not included in the primary outcome.|183|||
161036880|NCT03758638|581527035|FG001|Overall Study|Providers not included in the primary outcome.|128|||
161036881|NCT04213807|581527037|FG000|Overall Study|Physician Decision|0|||
161036882|NCT04213807|581527038|FG001|Overall Study|Physician Decision|0|||
161036883|NCT04213807|581527039|FG002|Overall Study|Physician Decision|1|||
161036884|NCT03442777|581527040|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
161036885|NCT03442777|581527041|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
161036886|NCT03442777|581527042|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
161036887|NCT00790569|581527043|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
161036888|NCT00790569|581527044|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
161036889|NCT00790569|581527045|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
161036890|NCT00790569|581527043|FG000|End of Treatment (6 Month Interview)|Death|0|||
161036891|NCT00790569|581527044|FG001|End of Treatment (6 Month Interview)|Death|2|||
161036892|NCT00790569|581527045|FG002|End of Treatment (6 Month Interview)|Death|1|||
161036893|NCT00790569|581527043|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
161036894|NCT00790569|581527044|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
161036895|NCT00790569|581527045|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
161280124|NCT02185053|582404257|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
161036896|NCT00790569|581527043|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
161036897|NCT00790569|581527044|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
161036898|NCT00790569|581527045|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
161036899|NCT00790569|581527043|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
161036900|NCT00790569|581527044|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
161036901|NCT00790569|581527045|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
161036902|NCT00790569|581527043|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
161036903|NCT00790569|581527044|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
161036904|NCT00790569|581527045|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
161036905|NCT01627561|581527046|FG000|Overall Study|Lost to Follow-up|1|||
161036906|NCT01627561|581527047|FG001|Overall Study|Lost to Follow-up|0|||
161036907|NCT01627561|581527046|FG000|Overall Study|Withdrawal by Subject|0|||
161036908|NCT01627561|581527047|FG001|Overall Study|Withdrawal by Subject|1|||
161036909|NCT01627561|581527046|FG000|Overall Study|Migrated/moved from study area|0|||
161036910|NCT01627561|581527047|FG001|Overall Study|Migrated/moved from study area|2|||
161036911|NCT00724126|581527048|FG000|Overall Study|Adverse Event|2|||
161036912|NCT00724126|581527049|FG001|Overall Study|Adverse Event|0|||
161036913|NCT00724126|581527048|FG000|Overall Study|Withdrawal by Subject|8|||
161036914|NCT00724126|581527049|FG001|Overall Study|Withdrawal by Subject|6|||
161036915|NCT00724126|581527048|FG000|Overall Study|Lost to Follow-up|6|||
161036916|NCT00724126|581527049|FG001|Overall Study|Lost to Follow-up|6|||
161036917|NCT00724126|581527048|FG000|Overall Study|Noncompliance|2|||
161036918|NCT00724126|581527049|FG001|Overall Study|Noncompliance|1|||
161036919|NCT00724126|581527048|FG000|Overall Study|Subject randomized although ineligible|1|||
161036920|NCT00724126|581527049|FG001|Overall Study|Subject randomized although ineligible|1|||
161036921|NCT00724126|581527048|FG000|Overall Study|Subject had to leave vicinity of site|0|||
161036922|NCT00724126|581527049|FG001|Overall Study|Subject had to leave vicinity of site|1|||
161036923|NCT03577106|581527053|FG000|Overall Study|Withdrawal by Subject|3|||
161036924|NCT03451422|581527054|FG000|Overall Study|Lost to Follow-up|0|||
161036925|NCT03451422|581527055|FG001|Overall Study|Lost to Follow-up|0|||
161036926|NCT03451422|581527056|FG002|Overall Study|Lost to Follow-up|0|||
161036927|NCT03451422|581527057|FG003|Overall Study|Lost to Follow-up|0|||
161036928|NCT03451422|581527058|FG004|Overall Study|Lost to Follow-up|0|||
161036929|NCT03451422|581527059|FG005|Overall Study|Lost to Follow-up|1|||
161036930|NCT03451422|581527054|FG000|Overall Study|Decision by sponsor|1|||
161036931|NCT03451422|581527055|FG001|Overall Study|Decision by sponsor|0|||
161036932|NCT03451422|581527056|FG002|Overall Study|Decision by sponsor|1|||
161036933|NCT03451422|581527057|FG003|Overall Study|Decision by sponsor|0|||
161036934|NCT03451422|581527058|FG004|Overall Study|Decision by sponsor|0|||
161036935|NCT03451422|581527059|FG005|Overall Study|Decision by sponsor|0|||
161036936|NCT03451422|581527054|FG000|Overall Study|Withdrawal by Subject|0|||
161036937|NCT03451422|581527055|FG001|Overall Study|Withdrawal by Subject|0|||
161036938|NCT03451422|581527056|FG002|Overall Study|Withdrawal by Subject|2|||
161036939|NCT03451422|581527057|FG003|Overall Study|Withdrawal by Subject|3|||
161036940|NCT03451422|581527058|FG004|Overall Study|Withdrawal by Subject|2|||
161036941|NCT03451422|581527059|FG005|Overall Study|Withdrawal by Subject|1|||
161036942|NCT01579318|581527060|FG000|Overall Study|Disease Progression|1|||
161036943|NCT03601715|581527063|FG000|Second Intervention|Lost to Follow-up|1|||
161036944|NCT03601715|581527064|FG001|Second Intervention|Lost to Follow-up|1|||
161036945|NCT03601715|581527065|FG002|Second Intervention|Lost to Follow-up|0|||
161036946|NCT02347332|581527066|FG000|Overall Study|Not treated|5|||
161036947|NCT02347332|581527067|FG001|Overall Study|Not treated|2|||
161036948|NCT02347332|581527066|FG000|Overall Study|Progressive disease|141|||
161036949|NCT02347332|581527067|FG001|Overall Study|Progressive disease|159|||
161036950|NCT02347332|581527066|FG000|Overall Study|Adverse Event|50|||
161036951|NCT02347332|581527067|FG001|Overall Study|Adverse Event|41|||
161036952|NCT02347332|581527066|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
161036953|NCT02347332|581527067|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
161036954|NCT02347332|581527066|FG000|Overall Study|Protocol Violation|1|||
161036955|NCT02347332|581527067|FG001|Overall Study|Protocol Violation|1|||
161036956|NCT02347332|581527066|FG000|Overall Study|Lost to Follow-up|2|||
161036957|NCT02347332|581527067|FG001|Overall Study|Lost to Follow-up|1|||
161036958|NCT02347332|581527066|FG000|Overall Study|Physician Decision|4|||
161036959|NCT02347332|581527067|FG001|Overall Study|Physician Decision|3|||
161036960|NCT02347332|581527066|FG000|Overall Study|Withdrawal by Subject|20|||
161036961|NCT02347332|581527067|FG001|Overall Study|Withdrawal by Subject|14|||
161344792|NCT01047319|582647279|FG002|Overall Study|Study terminated by Sponsor|203|||
161344793|NCT05759338|582647285|FG000|Overall Study|Withdrawal by Subject|3|||
161344794|NCT04611126|582647286|FG000|Overall Study|TIL expansion unsuccessful|1|||
161344795|NCT04611126|582647287|FG001|Overall Study|TIL expansion unsuccessful|0|||
161036962|NCT02347332|581527066|FG000|Overall Study|Protocol requirement|1|||
161036963|NCT02347332|581527067|FG001|Overall Study|Protocol requirement|1|||
161036964|NCT02347332|581527066|FG000|Overall Study|Switch Post-Trial program|0|||
161036965|NCT02347332|581527067|FG001|Overall Study|Switch Post-Trial program|1|||
161036966|NCT01478594|581527069|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
161036967|NCT01478594|581527070|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
161036968|NCT01478594|581527069|FG000|Overall Study|Death|45|||
161036969|NCT01478594|581527070|FG001|Overall Study|Death|18|||
161036970|NCT01478594|581527069|FG000|Overall Study|Lost to Follow-up|3|||
161036971|NCT01478594|581527070|FG001|Overall Study|Lost to Follow-up|1|||
161036972|NCT01478594|581527069|FG000|Overall Study|Withdrawal by Subject|9|||
161036973|NCT01478594|581527070|FG001|Overall Study|Withdrawal by Subject|3|||
161036974|NCT01478594|581527069|FG000|Overall Study|Study Closed by Sponsor|8|||
161036975|NCT01478594|581527070|FG001|Overall Study|Study Closed by Sponsor|5|||
161036976|NCT01313884|581527071|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
161036977|NCT01970007|581527072|FG000|Overall Study|Death|5|||
161036978|NCT01970007|581527072|FG000|Overall Study|Withdrawal by Subject|23|||
161036979|NCT01970007|581527072|FG000|Overall Study|Lost to Follow-up|24|||
161036980|NCT01970007|581527072|FG000|Overall Study|"Other endpoint"|3|||
161036981|NCT04384172|581527074|FG000|Overall Study|Lost to Follow-up|0|||
161036982|NCT04384172|581527075|FG001|Overall Study|Lost to Follow-up|2|||
161036983|NCT04384172|581527074|FG000|Overall Study|Pregnancy|1|||
161036984|NCT04384172|581527075|FG001|Overall Study|Pregnancy|0|||
161036985|NCT04384172|581527074|FG000|Overall Study|Withdrawal by Subject|0|||
161036986|NCT04384172|581527075|FG001|Overall Study|Withdrawal by Subject|1|||
161036987|NCT04860505|581527076|FG000|Overall Study|Lost to Follow-up|2|||
161036988|NCT00811941|581527080|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
161036989|NCT00811941|581527081|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
161036990|NCT00811941|581527080|FG000|All Treated Patients|Adverse Event|2|||
161036991|NCT00811941|581527081|FG001|All Treated Patients|Adverse Event|43|||
161036992|NCT00811941|581527080|FG000|All Treated Patients|Lack of Efficacy|2|||
161036993|NCT00811941|581527081|FG001|All Treated Patients|Lack of Efficacy|3|||
161036994|NCT00811941|581527080|FG000|All Treated Patients|Non-compliance|1|||
161036995|NCT00811941|581527081|FG001|All Treated Patients|Non-compliance|8|||
161036996|NCT00811941|581527080|FG000|All Treated Patients|Protocol Violation|5|||
161036997|NCT00811941|581527081|FG001|All Treated Patients|Protocol Violation|17|||
161036998|NCT00811941|581527080|FG000|All Treated Patients|Withdrawal by Subject|35|||
161036999|NCT00811941|581527081|FG001|All Treated Patients|Withdrawal by Subject|94|||
161037000|NCT00811941|581527080|FG000|All Treated Patients|Lost to Follow-up|3|||
161037001|NCT00811941|581527081|FG001|All Treated Patients|Lost to Follow-up|12|||
161037002|NCT00811941|581527080|FG000|All Treated Patients|Other Reason|4|||
161037003|NCT00811941|581527081|FG001|All Treated Patients|Other Reason|14|||
161037004|NCT00942266|581527089|FG000|Overall Study|Withdrawal by Subject|1|||
161037005|NCT00942266|581527090|FG001|Overall Study|Withdrawal by Subject|0|||
161037006|NCT00942266|581527089|FG000|Overall Study|Adverse Event|2|||
161037007|NCT00942266|581527090|FG001|Overall Study|Adverse Event|1|||
161037008|NCT00942266|581527089|FG000|Overall Study|Disease Progression|38|||
161037009|NCT00942266|581527090|FG001|Overall Study|Disease Progression|11|||
161037010|NCT00942266|581527089|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
161037011|NCT00942266|581527090|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
161037012|NCT00942266|581527089|FG000|Overall Study|Intercurrent illness|0|||
161037013|NCT00942266|581527090|FG001|Overall Study|Intercurrent illness|1|||
161037014|NCT00942266|581527089|FG000|Overall Study|Physician Decision|2|||
161037015|NCT00942266|581527090|FG001|Overall Study|Physician Decision|0|||
161037016|NCT00942266|581527089|FG000|Overall Study|medical deterioration (pneumonia)|0|||
161037017|NCT00942266|581527090|FG001|Overall Study|medical deterioration (pneumonia)|1|||
161037018|NCT04035447|581527107|FG000|Treatment Period|Lost to Follow-up|6|||
161037019|NCT04035447|581527108|FG001|Treatment Period|Lost to Follow-up|5|||
161037020|NCT04035447|581527107|FG000|Treatment Period|Physician Decision|0|||
161037021|NCT04035447|581527108|FG001|Treatment Period|Physician Decision|2|||
161037022|NCT03304587|581527112|FG000|Overall Study|Headache after intervention|0|||
161280125|NCT02185053|582404258|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
161280126|NCT02185053|582404259|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
161280127|NCT02185053|582404257|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
161280128|NCT02185053|582404258|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161280129|NCT02185053|582404259|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161280130|NCT02185053|582404257|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
161280131|NCT02185053|582404258|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
161280132|NCT02185053|582404259|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
161280133|NCT02185053|582404257|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
161280134|NCT02185053|582404258|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
161280135|NCT02185053|582404259|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
161280136|NCT02185053|582404257|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161280137|NCT02185053|582404258|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
161280138|NCT02185053|582404259|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
161280139|NCT02185053|582404257|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
161280140|NCT02185053|582404258|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
161037023|NCT03304587|581527113|FG001|Overall Study|Headache after intervention|1|||
161037024|NCT03304587|581527112|FG000|Overall Study|Withdrawal by Subject|1|||
161037025|NCT03304587|581527113|FG001|Overall Study|Withdrawal by Subject|0|||
161037026|NCT01458366|581527115|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
161280141|NCT02185053|582404259|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
161037027|NCT01458366|581527116|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
161037028|NCT01458366|581527117|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
161037029|NCT01458366|581527118|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
161037030|NCT01458366|581527119|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
161037031|NCT01458366|581527115|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161037032|NCT01458366|581527116|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161037033|NCT01458366|581527117|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161037034|NCT01458366|581527118|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
161037035|NCT01458366|581527119|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
161037036|NCT00174252|581527120|FG000|Overall Study|Protocol Violation|2|||
161037037|NCT05509816|581527121|FG000|Overall Study|Lost to Follow-up|1|||
161037038|NCT02107261|581527128|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
161037039|NCT02107261|581527129|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
161037040|NCT02107261|581527128|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
161037041|NCT02107261|581527129|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
161037042|NCT04337931|581527132|FG000|Overall Study|Death|4|||
161037043|NCT04337931|581527133|FG001|Overall Study|Death|1|||
161037044|NCT04337931|581527134|FG002|Overall Study|Death|7|||
161037045|NCT04337931|581527132|FG000|Overall Study|Withdrawal by Subject|0|||
161037046|NCT04337931|581527133|FG001|Overall Study|Withdrawal by Subject|1|||
161037047|NCT04337931|581527134|FG002|Overall Study|Withdrawal by Subject|0|||
161037048|NCT04337931|581527132|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
161037049|NCT04337931|581527133|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
161037050|NCT04337931|581527134|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
161037051|NCT04337931|581527132|FG000|Overall Study|Study terminated by sponsor|3|||
161037052|NCT04337931|581527133|FG001|Overall Study|Study terminated by sponsor|6|||
161037053|NCT04337931|581527134|FG002|Overall Study|Study terminated by sponsor|2|||
161037054|NCT04337931|581527132|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
161037055|NCT04337931|581527133|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
161037056|NCT04337931|581527134|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
161037057|NCT04337931|581527132|FG000|Overall Study|Colorectal cancer treatment|1|||
161037058|NCT04337931|581527133|FG001|Overall Study|Colorectal cancer treatment|0|||
161037059|NCT04337931|581527134|FG002|Overall Study|Colorectal cancer treatment|0|||
161037060|NCT04337931|581527132|FG000|Overall Study|Participant decision|0|||
161037061|NCT04337931|581527133|FG001|Overall Study|Participant decision|1|||
161037062|NCT04337931|581527134|FG002|Overall Study|Participant decision|0|||
161037063|NCT01738438|581527135|FG000|Overall Study|Disease Progression|32|||
161037064|NCT01738438|581527135|FG000|Overall Study|Adverse Event|3|||
161037065|NCT02130557|581527137|FG000|Overall Study|Withdrawal by Subject|12|||
161037066|NCT02130557|581527138|FG001|Overall Study|Withdrawal by Subject|12|||
161037067|NCT02130557|581527137|FG000|Overall Study|Investigator Request|0|||
161037068|NCT02130557|581527138|FG001|Overall Study|Investigator Request|2|||
161037069|NCT02130557|581527137|FG000|Overall Study|Deceased|14|||
161037070|NCT02130557|581527138|FG001|Overall Study|Deceased|14|||
161037071|NCT02130557|581527137|FG000|Overall Study|Lost to Follow-up|6|||
161037072|NCT02130557|581527138|FG001|Overall Study|Lost to Follow-up|7|||
161037073|NCT02130557|581527137|FG000|Overall Study|Other|2|||
161037074|NCT02130557|581527138|FG001|Overall Study|Other|1|||
161037075|NCT02130557|581527137|FG000|Overall Study|Missing|2|||
161037076|NCT02130557|581527138|FG001|Overall Study|Missing|1|||
161037077|NCT02928172|581527139|FG000|Overall Study|Device did not record data|1|||
161037078|NCT01532999|581527140|FG000|Overall Study|Lost to Follow-up|14|||
161037079|NCT01532999|581527141|FG001|Overall Study|Lost to Follow-up|8|||
161037080|NCT01532999|581527140|FG000|Overall Study|Physician Decision|1|||
161037081|NCT01532999|581527141|FG001|Overall Study|Physician Decision|2|||
161037082|NCT01532999|581527140|FG000|Overall Study|Withdrawal by Subject|5|||
161037083|NCT01532999|581527141|FG001|Overall Study|Withdrawal by Subject|0|||
161037084|NCT01532999|581527140|FG000|Overall Study|Relocated|2|||
161037085|NCT01532999|581527141|FG001|Overall Study|Relocated|0|||
161037086|NCT01532999|581527140|FG000|Overall Study|should not have been randomized|1|||
161037087|NCT01532999|581527141|FG001|Overall Study|should not have been randomized|0|||
161037088|NCT01532999|581527140|FG000|Overall Study|substantial noncompliance|2|||
161037089|NCT01532999|581527141|FG001|Overall Study|substantial noncompliance|0|||
161037090|NCT01532999|581527140|FG000|Overall Study|no show for week 9 assessments|6|||
161037091|NCT01532999|581527141|FG001|Overall Study|no show for week 9 assessments|4|||
161037092|NCT01532999|581527140|FG000|Overall Study|Adverse Event|0|||
161037093|NCT01532999|581527141|FG001|Overall Study|Adverse Event|1|||
161037094|NCT01532999|581527140|FG000|Overall Study|incarcerated|0|||
161037095|NCT01532999|581527141|FG001|Overall Study|incarcerated|1|||
161037096|NCT01532999|581527140|FG000|Overall Study|New job|0|||
161037097|NCT01532999|581527141|FG001|Overall Study|New job|2|||
161037098|NCT03333109|581527142|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
161037099|NCT03333109|581527143|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
161037100|NCT03333109|581527144|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
161037101|NCT03333109|581527142|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161037102|NCT03333109|581527143|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
161037103|NCT03333109|581527144|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
161037104|NCT03333109|581527142|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
161037105|NCT03333109|581527143|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
161037106|NCT03333109|581527144|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
161037107|NCT03333109|581527142|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
161037108|NCT03333109|581527143|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
161037109|NCT03333109|581527144|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
161037110|NCT03333109|581527142|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
161037111|NCT03333109|581527143|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
161037112|NCT03333109|581527144|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
161037113|NCT03333109|581527142|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
161037114|NCT03333109|581527143|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
161037115|NCT03333109|581527144|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
161037116|NCT03333109|581527142|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
161037117|NCT03333109|581527143|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
161037118|NCT03333109|581527144|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
161037119|NCT03333109|581527142|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
161037120|NCT03333109|581527143|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
161037121|NCT03333109|581527144|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
161037122|NCT00918203|581527145|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
161037123|NCT00918203|581527146|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
161037124|NCT00918203|581527147|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
161037125|NCT00918203|581527145|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
161037126|NCT00918203|581527146|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
161037127|NCT00918203|581527147|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
161037128|NCT00918203|581527145|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
161037129|NCT00918203|581527146|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
161037130|NCT00918203|581527147|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
161037131|NCT00918203|581527145|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
161037132|NCT00918203|581527146|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
161037133|NCT00918203|581527147|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
161037134|NCT00701701|581527150|FG000|Overall Study|Withdrawal by Subject|0|||
161037135|NCT00701701|581527151|FG001|Overall Study|Withdrawal by Subject|1|||
161037136|NCT00701701|581527150|FG000|Overall Study|Adverse Event|0|||
161037137|NCT00701701|581527151|FG001|Overall Study|Adverse Event|1|||
161037138|NCT03834740|581527152|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
161037139|NCT03834740|581527153|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
161037140|NCT03834740|581527154|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
161037141|NCT01208974|581527155|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
161037142|NCT01208974|581527156|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
161037143|NCT01208974|581527157|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
161037144|NCT01208974|581527158|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
161037145|NCT01208974|581527155|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
161037146|NCT01208974|581527156|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
161037147|NCT01208974|581527157|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
161037148|NCT01208974|581527158|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
161037149|NCT01208974|581527155|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
161037150|NCT01208974|581527156|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
161037151|NCT01208974|581527157|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
161037152|NCT01208974|581527158|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
161037153|NCT02500576|581527159|FG000|Overall Study|Adverse Event|0|||
161037154|NCT02500576|581527160|FG001|Overall Study|Adverse Event|1|||
161037155|NCT02500576|581527159|FG000|Overall Study|Death|2|||
161037156|NCT02500576|581527160|FG001|Overall Study|Death|1|||
161037157|NCT02500576|581527159|FG000|Overall Study|Lack of Efficacy|5|||
161037158|NCT02500576|581527160|FG001|Overall Study|Lack of Efficacy|5|||
161037159|NCT02500576|581527159|FG000|Overall Study|Withdrawal by Subject|1|||
161037160|NCT02500576|581527160|FG001|Overall Study|Withdrawal by Subject|1|||
161037161|NCT02678689|581527161|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
161037162|NCT02678689|581527162|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
161280142|NCT02185053|582404257|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
161280143|NCT02185053|582404258|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
161280144|NCT02185053|582404259|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
161280145|NCT02185053|582404257|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
161280146|NCT02185053|582404258|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
161280147|NCT02185053|582404259|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
161280148|NCT02521376|582404267|FG000|Overall Study|Enrolled, But Not Treated|1|||
161280149|NCT02521376|582404268|FG001|Overall Study|Enrolled, But Not Treated|0|||
161280150|NCT02521376|582404269|FG002|Overall Study|Enrolled, But Not Treated|0|||
161280151|NCT02521376|582404270|FG003|Overall Study|Enrolled, But Not Treated|0|||
161280152|NCT00340678|582404271|FG000|Overall Study|Lost to Follow-up|1|||
161280153|NCT00340678|582404272|FG001|Overall Study|Lost to Follow-up|0|||
161037163|NCT02761187|581527163|FG000|Overall Study|Too ill to Participate|13|||
161037164|NCT02761187|581527164|FG001|Overall Study|Too ill to Participate|8|||
161037165|NCT02761187|581527163|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
161037166|NCT02761187|581527164|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
161037167|NCT02761187|581527163|FG000|Overall Study|Patient withdrew consent|64|||
161037168|NCT02761187|581527164|FG001|Overall Study|Patient withdrew consent|58|||
161037169|NCT02761187|581527163|FG000|Overall Study|Physician discretion|4|||
161037170|NCT02761187|581527164|FG001|Overall Study|Physician discretion|8|||
161037171|NCT02761187|581527163|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
161037172|NCT02761187|581527164|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
161037173|NCT02761187|581527163|FG000|Overall Study|On Hospice|20|||
161037174|NCT02761187|581527164|FG001|Overall Study|On Hospice|26|||
161037175|NCT02761187|581527163|FG000|Overall Study|Deceased|474|||
161037176|NCT02761187|581527164|FG001|Overall Study|Deceased|642|||
161037177|NCT02761187|581527163|FG000|Overall Study|Lost to Follow-up|73|||
161037178|NCT02761187|581527164|FG001|Overall Study|Lost to Follow-up|63|||
161037179|NCT02761187|581527163|FG000|Overall Study|Due to study discontinued at site|100|||
161037180|NCT02761187|581527164|FG001|Overall Study|Due to study discontinued at site|85|||
161037181|NCT02761187|581527163|FG000|Overall Study|Reason not Specified|1484|||
161037182|NCT02761187|581527164|FG001|Overall Study|Reason not Specified|937|||
161037183|NCT05704725|581527166|FG000|Overall Study|Lost to Follow-up|0|||
161037184|NCT05704725|581527167|FG001|Overall Study|Lost to Follow-up|1|||
161037185|NCT05704725|581527166|FG000|Overall Study|Withdrawal by Subject|1|||
161037186|NCT05704725|581527167|FG001|Overall Study|Withdrawal by Subject|0|||
161037187|NCT02798471|581527170|FG000|Overall Study|Adverse Event|7|||
161037188|NCT02798471|581527171|FG001|Overall Study|Adverse Event|2|||
161037189|NCT02798471|581527170|FG000|Overall Study|Physician Decision|3|||
161037190|NCT02798471|581527171|FG001|Overall Study|Physician Decision|7|||
161037191|NCT02798471|581527170|FG000|Overall Study|Death|2|||
161037192|NCT02798471|581527171|FG001|Overall Study|Death|3|||
161037193|NCT02798471|581527170|FG000|Overall Study|Lost to Follow-up|0|||
161037194|NCT02798471|581527171|FG001|Overall Study|Lost to Follow-up|1|||
161037195|NCT02798471|581527170|FG000|Overall Study|Other|5|||
161037196|NCT02798471|581527171|FG001|Overall Study|Other|3|||
161037197|NCT02798471|581527170|FG000|Overall Study|Subject withdrew consent|0|||
161037198|NCT02798471|581527171|FG001|Overall Study|Subject withdrew consent|6|||
161037199|NCT02798471|581527170|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
161037200|NCT02798471|581527171|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
161037201|NCT02798471|581527170|FG000|Overall Study|Randomized, but not treated|0|||
161037202|NCT02798471|581527171|FG001|Overall Study|Randomized, but not treated|2|||
161037203|NCT03459196|581529029|FG000|Overall Study|Subject didn't receive study catheter|2|||
161037204|NCT03367156|581529030|FG000|Overall Study|Lack of interest|3|||
161037205|NCT03367156|581529031|FG001|Overall Study|Lack of interest|1|||
161037206|NCT03367156|581529030|FG000|Overall Study|Death|2|||
161037207|NCT03367156|581529031|FG001|Overall Study|Death|0|||
161037208|NCT03367156|581529030|FG000|Overall Study|Lost to Follow-up|2|||
161037209|NCT03367156|581529031|FG001|Overall Study|Lost to Follow-up|1|||
161037210|NCT03367156|581529030|FG000|Overall Study|Became ineligible|1|||
161037211|NCT03367156|581529031|FG001|Overall Study|Became ineligible|2|||
161037212|NCT03367156|581529030|FG000|Overall Study|Hospitalization|1|||
161037213|NCT03367156|581529031|FG001|Overall Study|Hospitalization|0|||
161037214|NCT03367156|581529030|FG000|Overall Study|Concerned about Treatment|11|||
161037215|NCT03367156|581529031|FG001|Overall Study|Concerned about Treatment|3|||
161037216|NCT03367156|581529030|FG000|Overall Study|Started new treatment|4|||
161037217|NCT03367156|581529031|FG001|Overall Study|Started new treatment|1|||
161037218|NCT03762850|581529032|FG000|Overall Study|Death|0|||
161037219|NCT03762850|581529033|FG001|Overall Study|Death|1|||
161037220|NCT03762850|581529032|FG000|Overall Study|Lost to Follow-up|0|||
161037221|NCT03762850|581529033|FG001|Overall Study|Lost to Follow-up|1|||
161037222|NCT03762850|581529032|FG000|Overall Study|Physician Decision|0|||
161037223|NCT03762850|581529033|FG001|Overall Study|Physician Decision|1|||
161037224|NCT03762850|581529032|FG000|Overall Study|Withdrawal by Subject|4|||
161037225|NCT03762850|581529033|FG001|Overall Study|Withdrawal by Subject|9|||
161280154|NCT00340678|582404273|FG002|Overall Study|Lost to Follow-up|0|||
161280155|NCT00340678|582404274|FG003|Overall Study|Lost to Follow-up|0|||
161037226|NCT00092534|581529036|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
161037227|NCT00092534|581529037|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
161037228|NCT00092534|581529038|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161280156|NCT01653912|582404275|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161280157|NCT01653912|582404276|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
161037229|NCT00092534|581529039|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161037230|NCT00092534|581529040|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161037231|NCT00092534|581529036|FG000|Base Study Vaccination Period|Adverse Event|3|||
161037232|NCT00092534|581529037|FG001|Base Study Vaccination Period|Adverse Event|1|||
161037233|NCT00092534|581529038|FG002|Base Study Vaccination Period|Adverse Event|0|||
161037234|NCT00092534|581529039|FG003|Base Study Vaccination Period|Adverse Event|0|||
161037235|NCT00092534|581529040|FG004|Base Study Vaccination Period|Adverse Event|0|||
161037236|NCT00092534|581529036|FG000|Base Study Vaccination Period|Death|5|||
161037237|NCT00092534|581529037|FG001|Base Study Vaccination Period|Death|4|||
161037238|NCT00092534|581529038|FG002|Base Study Vaccination Period|Death|0|||
161037239|NCT00092534|581529039|FG003|Base Study Vaccination Period|Death|0|||
161037240|NCT00092534|581529040|FG004|Base Study Vaccination Period|Death|0|||
161037241|NCT00092534|581529036|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
161037242|NCT00092534|581529037|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
161037243|NCT00092534|581529038|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161037244|NCT00092534|581529039|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161037245|NCT00092534|581529040|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161037246|NCT00092534|581529036|FG000|Base Study Vaccination Period|Physician Decision|1|||
161037247|NCT00092534|581529037|FG001|Base Study Vaccination Period|Physician Decision|0|||
161037248|NCT00092534|581529038|FG002|Base Study Vaccination Period|Physician Decision|0|||
161037249|NCT00092534|581529039|FG003|Base Study Vaccination Period|Physician Decision|0|||
161037250|NCT00092534|581529040|FG004|Base Study Vaccination Period|Physician Decision|0|||
161037251|NCT00092534|581529036|FG000|Base Study Vaccination Period|Pregnancy|9|||
161037252|NCT00092534|581529037|FG001|Base Study Vaccination Period|Pregnancy|7|||
161037253|NCT00092534|581529038|FG002|Base Study Vaccination Period|Pregnancy|0|||
161037254|NCT00092534|581529039|FG003|Base Study Vaccination Period|Pregnancy|0|||
161037255|NCT00092534|581529040|FG004|Base Study Vaccination Period|Pregnancy|0|||
161037256|NCT00092534|581529036|FG000|Base Study Vaccination Period|Protocol Violation|2|||
161037257|NCT00092534|581529037|FG001|Base Study Vaccination Period|Protocol Violation|1|||
161037258|NCT00092534|581529038|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161037259|NCT00092534|581529039|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161037260|NCT00092534|581529040|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161037261|NCT00092534|581529036|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
161037262|NCT00092534|581529037|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
161037263|NCT00092534|581529038|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161037264|NCT00092534|581529039|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161037265|NCT00092534|581529040|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161037266|NCT00092534|581529036|FG000|Base Study Vaccination Period|Moved|14|||
161037267|NCT00092534|581529037|FG001|Base Study Vaccination Period|Moved|12|||
161037268|NCT00092534|581529038|FG002|Base Study Vaccination Period|Moved|0|||
161037269|NCT00092534|581529039|FG003|Base Study Vaccination Period|Moved|0|||
161037270|NCT00092534|581529040|FG004|Base Study Vaccination Period|Moved|0|||
161037271|NCT00092534|581529036|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
161037272|NCT00092534|581529037|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161037273|NCT00092534|581529038|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161037274|NCT00092534|581529039|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161037275|NCT00092534|581529040|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
161037276|NCT00092534|581529036|FG000|Base Study Vaccination Period|Travel|1|||
161037277|NCT00092534|581529037|FG001|Base Study Vaccination Period|Travel|0|||
161037278|NCT00092534|581529038|FG002|Base Study Vaccination Period|Travel|0|||
161037279|NCT00092534|581529039|FG003|Base Study Vaccination Period|Travel|0|||
161037280|NCT00092534|581529040|FG004|Base Study Vaccination Period|Travel|0|||
161037281|NCT00092534|581529036|FG000|Base Study Vaccination Period|Site Closed|0|||
161037282|NCT00092534|581529037|FG001|Base Study Vaccination Period|Site Closed|1|||
161037283|NCT00092534|581529038|FG002|Base Study Vaccination Period|Site Closed|0|||
161037284|NCT00092534|581529039|FG003|Base Study Vaccination Period|Site Closed|0|||
161037285|NCT00092534|581529040|FG004|Base Study Vaccination Period|Site Closed|0|||
161037286|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Adverse Event|2|||
161037287|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Adverse Event|4|||
161037288|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Adverse Event|0|||
161037289|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Adverse Event|0|||
161037290|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Adverse Event|0|||
161037291|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Death|2|||
161037292|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Death|1|||
161037293|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Death|0|||
161037294|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Death|0|||
161037295|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Death|0|||
161037296|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
161037297|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
161037298|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
161037299|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
161037300|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
161037301|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Pregnancy|6|||
161037302|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Pregnancy|10|||
161037303|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Pregnancy|0|||
161037304|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Pregnancy|0|||
161037305|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Pregnancy|0|||
161037306|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
161037307|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
161037308|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
161037309|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
161037310|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
161037311|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
161037312|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
161037313|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
161037314|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
161037315|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
161037316|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Moved|62|||
161037317|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Moved|58|||
161037318|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Moved|0|||
161037319|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Moved|0|||
161037320|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Moved|0|||
161037321|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Travel|10|||
161037322|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Travel|7|||
161037323|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Travel|0|||
161037324|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Travel|0|||
161037325|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Travel|0|||
161037326|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Site Closed|0|||
161037327|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Site Closed|2|||
161037328|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Site Closed|0|||
161037329|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Site Closed|0|||
161037330|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Site Closed|0|||
161037331|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
161037332|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
161037333|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
161037334|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
161037335|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
161037336|NCT00092534|581529036|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
161037337|NCT00092534|581529037|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
161037338|NCT00092534|581529038|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
161037339|NCT00092534|581529039|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
161037340|NCT00092534|581529040|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
161037341|NCT00092534|581529036|FG000|Base Study EXT|Lost to Follow-up|0|||
161037342|NCT00092534|581529037|FG001|Base Study EXT|Lost to Follow-up|0|||
161037343|NCT00092534|581529038|FG002|Base Study EXT|Lost to Follow-up|41|||
161037344|NCT00092534|581529039|FG003|Base Study EXT|Lost to Follow-up|0|||
161037345|NCT00092534|581529040|FG004|Base Study EXT|Lost to Follow-up|0|||
161037346|NCT00092534|581529036|FG000|Base Study EXT|Physician Decision|0|||
161037347|NCT00092534|581529037|FG001|Base Study EXT|Physician Decision|0|||
161037348|NCT00092534|581529038|FG002|Base Study EXT|Physician Decision|1|||
161037349|NCT00092534|581529039|FG003|Base Study EXT|Physician Decision|0|||
161037350|NCT00092534|581529040|FG004|Base Study EXT|Physician Decision|0|||
161037351|NCT00092534|581529036|FG000|Base Study EXT|Pregnancy|0|||
161037352|NCT00092534|581529037|FG001|Base Study EXT|Pregnancy|0|||
161037353|NCT00092534|581529038|FG002|Base Study EXT|Pregnancy|12|||
161037354|NCT00092534|581529039|FG003|Base Study EXT|Pregnancy|0|||
161037355|NCT00092534|581529040|FG004|Base Study EXT|Pregnancy|0|||
161037356|NCT00092534|581529036|FG000|Base Study EXT|Withdrawal by Subject|0|||
161037357|NCT00092534|581529037|FG001|Base Study EXT|Withdrawal by Subject|0|||
161037358|NCT00092534|581529038|FG002|Base Study EXT|Withdrawal by Subject|18|||
161037359|NCT00092534|581529039|FG003|Base Study EXT|Withdrawal by Subject|0|||
161037360|NCT00092534|581529040|FG004|Base Study EXT|Withdrawal by Subject|0|||
161037361|NCT00092534|581529036|FG000|Base Study EXT|Participant moved|0|||
161037362|NCT00092534|581529037|FG001|Base Study EXT|Participant moved|0|||
161037363|NCT00092534|581529038|FG002|Base Study EXT|Participant moved|6|||
161037364|NCT00092534|581529039|FG003|Base Study EXT|Participant moved|0|||
161037365|NCT00092534|581529040|FG004|Base Study EXT|Participant moved|0|||
161037366|NCT00092534|581529036|FG000|Base Study EXT|Travel|0|||
161037367|NCT00092534|581529037|FG001|Base Study EXT|Travel|0|||
161280158|NCT01653912|582404277|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161280159|NCT01653912|582404278|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161280160|NCT01653912|582404279|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161037368|NCT00092534|581529038|FG002|Base Study EXT|Travel|2|||
161037369|NCT00092534|581529039|FG003|Base Study EXT|Travel|0|||
161037370|NCT00092534|581529040|FG004|Base Study EXT|Travel|0|||
161037371|NCT00092534|581529036|FG000|Base Study EXT|Site closed|0|||
161037372|NCT00092534|581529037|FG001|Base Study EXT|Site closed|0|||
161037373|NCT00092534|581529038|FG002|Base Study EXT|Site closed|21|||
161037374|NCT00092534|581529039|FG003|Base Study EXT|Site closed|0|||
161037375|NCT00092534|581529040|FG004|Base Study EXT|Site closed|0|||
161037376|NCT00092534|581529036|FG000|Base Study EXT|Study ended|0|||
161037377|NCT00092534|581529037|FG001|Base Study EXT|Study ended|0|||
161037378|NCT00092534|581529038|FG002|Base Study EXT|Study ended|29|||
161280161|NCT01653912|582404280|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
161037379|NCT00092534|581529039|FG003|Base Study EXT|Study ended|0|||
161037380|NCT00092534|581529040|FG004|Base Study EXT|Study ended|0|||
161037381|NCT00092534|581529036|FG000|Base Study EXT|Protocol Violation|0|||
161037382|NCT00092534|581529037|FG001|Base Study EXT|Protocol Violation|0|||
161037383|NCT00092534|581529038|FG002|Base Study EXT|Protocol Violation|15|||
161037384|NCT00092534|581529039|FG003|Base Study EXT|Protocol Violation|0|||
161037385|NCT00092534|581529040|FG004|Base Study EXT|Protocol Violation|0|||
161037386|NCT00092534|581529036|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161037387|NCT00092534|581529037|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161037388|NCT00092534|581529038|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161037389|NCT00092534|581529039|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
161037390|NCT00092534|581529040|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
161037391|NCT03083366|581529041|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
161037392|NCT03083366|581529042|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
161037393|NCT03083366|581529041|FG000|Enrollment Period|Lack of Efficacy|1|||
161037394|NCT03083366|581529042|FG001|Enrollment Period|Lack of Efficacy|0|||
161037395|NCT03752684|581529049|FG000|Overall Study|Lost to Follow-up|4|||
161037396|NCT00048932|581529052|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
161037397|NCT00048932|581529053|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
161037398|NCT00048932|581529054|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
161037399|NCT00048932|581529052|FG000|Double Blind Period (DB)|Adverse Event|51|||
161037400|NCT00048932|581529053|FG001|Double Blind Period (DB)|Adverse Event|19|||
161037401|NCT00048932|581529054|FG002|Double Blind Period (DB)|Adverse Event|0|||
161037402|NCT00048932|581529052|FG000|Double Blind Period (DB)|Death|5|||
161037403|NCT00048932|581529053|FG001|Double Blind Period (DB)|Death|3|||
161037404|NCT00048932|581529054|FG002|Double Blind Period (DB)|Death|0|||
161037405|NCT00048932|581529052|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
161037406|NCT00048932|581529053|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
161037407|NCT00048932|581529054|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
161037408|NCT00048932|581529052|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
161037409|NCT00048932|581529053|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
161037410|NCT00048932|581529054|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
161037411|NCT00048932|581529052|FG000|Double Blind Period (DB)|Relocation|1|||
161037412|NCT00048932|581529053|FG001|Double Blind Period (DB)|Relocation|0|||
161037413|NCT00048932|581529054|FG002|Double Blind Period (DB)|Relocation|0|||
161037414|NCT00048932|581529052|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
161037415|NCT00048932|581529053|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
161037416|NCT00048932|581529054|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
161037417|NCT00048932|581529052|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
161037418|NCT00048932|581529053|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
161037419|NCT00048932|581529054|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
161037420|NCT00048932|581529052|FG000|Double Blind Period (DB)|Pregnancy|1|||
161037421|NCT00048932|581529053|FG001|Double Blind Period (DB)|Pregnancy|0|||
161037422|NCT00048932|581529054|FG002|Double Blind Period (DB)|Pregnancy|0|||
161037423|NCT00048932|581529052|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
161037424|NCT00048932|581529053|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
161037425|NCT00048932|581529054|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
161037426|NCT00048932|581529052|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
161280162|NCT01653912|582404275|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161037427|NCT00048932|581529053|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
161037428|NCT00048932|581529054|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
161037429|NCT00048932|581529052|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
161037430|NCT00048932|581529053|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
161037431|NCT00048932|581529054|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
161037432|NCT00048932|581529052|FG000|Open Label Period (OL)|Death|0|||
161037433|NCT00048932|581529053|FG001|Open Label Period (OL)|Death|0|||
161037434|NCT00048932|581529054|FG002|Open Label Period (OL)|Death|25|||
161037435|NCT00048932|581529052|FG000|Open Label Period (OL)|Adverse Event|0|||
161037436|NCT00048932|581529053|FG001|Open Label Period (OL)|Adverse Event|0|||
161037437|NCT00048932|581529054|FG002|Open Label Period (OL)|Adverse Event|103|||
161037438|NCT00048932|581529052|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
161037439|NCT00048932|581529053|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
161037440|NCT00048932|581529054|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
161037441|NCT00048932|581529052|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
161037442|NCT00048932|581529053|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
161037443|NCT00048932|581529054|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
161037444|NCT00048932|581529052|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
161037445|NCT00048932|581529053|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
161037446|NCT00048932|581529054|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
161037447|NCT00048932|581529052|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
161280163|NCT01653912|582404276|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161280164|NCT01653912|582404277|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
161037448|NCT00048932|581529053|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
161037449|NCT00048932|581529054|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
161037450|NCT00048932|581529052|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
161037451|NCT00048932|581529053|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
161037452|NCT00048932|581529054|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
161037453|NCT00048932|581529052|FG000|Open Label Period (OL)|Pregnancy|0|||
161037454|NCT00048932|581529053|FG001|Open Label Period (OL)|Pregnancy|0|||
161037455|NCT00048932|581529054|FG002|Open Label Period (OL)|Pregnancy|6|||
161037456|NCT00048932|581529052|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
161037457|NCT00048932|581529053|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
161037458|NCT00048932|581529054|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
161037459|NCT00048932|581529052|FG000|Open Label Period (OL)|Investigator Retiring|0|||
161037460|NCT00048932|581529053|FG001|Open Label Period (OL)|Investigator Retiring|0|||
161037461|NCT00048932|581529054|FG002|Open Label Period (OL)|Investigator Retiring|2|||
161037462|NCT00048932|581529052|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
161037463|NCT00048932|581529053|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
161037464|NCT00048932|581529054|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
161037465|NCT00048932|581529052|FG000|Open Label Period (OL)|Participant Relocated|0|||
161037466|NCT00048932|581529053|FG001|Open Label Period (OL)|Participant Relocated|0|||
161037467|NCT00048932|581529054|FG002|Open Label Period (OL)|Participant Relocated|6|||
161037468|NCT00048932|581529052|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
161037469|NCT00048932|581529053|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
161037470|NCT00048932|581529054|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
161037471|NCT00048932|581529052|FG000|Open Label Period (OL)|Site Closure|0|||
161037472|NCT00048932|581529053|FG001|Open Label Period (OL)|Site Closure|0|||
161037473|NCT00048932|581529054|FG002|Open Label Period (OL)|Site Closure|3|||
161037474|NCT00048932|581529052|FG000|Open Label Period (OL)|Trial Terminated|0|||
161037475|NCT00048932|581529053|FG001|Open Label Period (OL)|Trial Terminated|0|||
161037476|NCT00048932|581529054|FG002|Open Label Period (OL)|Trial Terminated|1|||
161037477|NCT00048932|581529052|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
161037478|NCT00048932|581529053|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
161037479|NCT00048932|581529054|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
161037480|NCT00048932|581529052|FG000|Open Label Period (OL)|Patient Decision|0|||
161037481|NCT00048932|581529053|FG001|Open Label Period (OL)|Patient Decision|0|||
161037482|NCT00048932|581529054|FG002|Open Label Period (OL)|Patient Decision|4|||
161037483|NCT00048932|581529052|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
161037484|NCT00048932|581529053|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
161037485|NCT00048932|581529054|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
161037486|NCT00048932|581529052|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
161037487|NCT00048932|581529053|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
161037488|NCT00048932|581529054|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
161037489|NCT00048932|581529052|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
161037490|NCT00048932|581529053|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
161280165|NCT01653912|582404278|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161280166|NCT01653912|582404279|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161280167|NCT01653912|582404280|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
161280168|NCT01653912|582404275|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161280169|NCT01653912|582404276|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161280170|NCT01653912|582404277|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161280171|NCT01653912|582404278|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
161280172|NCT01653912|582404279|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161280173|NCT01653912|582404280|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
161280174|NCT01653912|582404275|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161037491|NCT00048932|581529054|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
161037492|NCT00048932|581529052|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
161037493|NCT00048932|581529053|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
161037494|NCT00048932|581529054|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
161037495|NCT00048932|581529052|FG000|Open Label Period (OL)|Investigator Decision|0|||
161037496|NCT00048932|581529053|FG001|Open Label Period (OL)|Investigator Decision|0|||
161037497|NCT00048932|581529054|FG002|Open Label Period (OL)|Investigator Decision|4|||
161037498|NCT00048932|581529052|FG000|Open Label Period (OL)|Site Staff Issues|0|||
161037499|NCT00048932|581529053|FG001|Open Label Period (OL)|Site Staff Issues|0|||
161037500|NCT00048932|581529054|FG002|Open Label Period (OL)|Site Staff Issues|2|||
161037501|NCT00048932|581529052|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
161037502|NCT00048932|581529053|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
161037503|NCT00048932|581529054|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
161037504|NCT00048932|581529052|FG000|Open Label Period (OL)|Participant Surgery|0|||
161037505|NCT00048932|581529053|FG001|Open Label Period (OL)|Participant Surgery|0|||
161037506|NCT00048932|581529054|FG002|Open Label Period (OL)|Participant Surgery|1|||
161037507|NCT03244800|581529055|FG000|Overall Study|Adverse Event|0|||
161037508|NCT03244800|581529056|FG001|Overall Study|Adverse Event|1|||
161037509|NCT03244800|581529057|FG002|Overall Study|Adverse Event|0|||
161037510|NCT03244800|581529058|FG003|Overall Study|Adverse Event|1|||
161037511|NCT03244800|581529055|FG000|Overall Study|Withdrew treatment|0|||
161037512|NCT03244800|581529056|FG001|Overall Study|Withdrew treatment|0|||
161037513|NCT03244800|581529057|FG002|Overall Study|Withdrew treatment|0|||
161037514|NCT03244800|581529058|FG003|Overall Study|Withdrew treatment|1|||
161037515|NCT03418922|581529060|FG000|Overall Study|Withdrawal by Subject|0|||
161037516|NCT03418922|581529061|FG001|Overall Study|Withdrawal by Subject|2|||
161037517|NCT03418922|581529060|FG000|Overall Study|Adverse Event|2|||
161037518|NCT03418922|581529061|FG001|Overall Study|Adverse Event|2|||
161037519|NCT03418922|581529060|FG000|Overall Study|Death|0|||
161037520|NCT03418922|581529061|FG001|Overall Study|Death|1|||
161037521|NCT03418922|581529060|FG000|Overall Study|Physician Decision|0|||
161037522|NCT03418922|581529061|FG001|Overall Study|Physician Decision|1|||
161037523|NCT01640951|581529062|FG000|Overall Study|Adverse Event|8|||
161037524|NCT01640951|581529063|FG001|Overall Study|Adverse Event|3|||
161037525|NCT01640951|581529064|FG002|Overall Study|Adverse Event|10|||
161037526|NCT01640951|581529065|FG003|Overall Study|Adverse Event|6|||
161037527|NCT01640951|581529066|FG004|Overall Study|Adverse Event|1|||
161037528|NCT01640951|581529067|FG005|Overall Study|Adverse Event|11|||
161037529|NCT01640951|581529068|FG006|Overall Study|Adverse Event|1|||
161037530|NCT01640951|581529069|FG007|Overall Study|Adverse Event|3|||
161037531|NCT01640951|581529062|FG000|Overall Study|Lack of Efficacy|20|||
161037532|NCT01640951|581529063|FG001|Overall Study|Lack of Efficacy|1|||
161037533|NCT01640951|581529064|FG002|Overall Study|Lack of Efficacy|7|||
161037534|NCT01640951|581529065|FG003|Overall Study|Lack of Efficacy|14|||
161037535|NCT01640951|581529066|FG004|Overall Study|Lack of Efficacy|0|||
161037536|NCT01640951|581529067|FG005|Overall Study|Lack of Efficacy|6|||
161037537|NCT01640951|581529068|FG006|Overall Study|Lack of Efficacy|5|||
161037538|NCT01640951|581529069|FG007|Overall Study|Lack of Efficacy|6|||
161037539|NCT01640951|581529062|FG000|Overall Study|Lost to Follow-up|1|||
161037540|NCT01640951|581529063|FG001|Overall Study|Lost to Follow-up|0|||
161037541|NCT01640951|581529064|FG002|Overall Study|Lost to Follow-up|6|||
161037542|NCT01640951|581529065|FG003|Overall Study|Lost to Follow-up|2|||
161037543|NCT01640951|581529066|FG004|Overall Study|Lost to Follow-up|2|||
161037544|NCT01640951|581529067|FG005|Overall Study|Lost to Follow-up|3|||
161037545|NCT01640951|581529068|FG006|Overall Study|Lost to Follow-up|1|||
161037546|NCT01640951|581529069|FG007|Overall Study|Lost to Follow-up|1|||
161037547|NCT01640951|581529062|FG000|Overall Study|Non-compliance with study treatment|0|||
161037548|NCT01640951|581529063|FG001|Overall Study|Non-compliance with study treatment|0|||
161037549|NCT01640951|581529064|FG002|Overall Study|Non-compliance with study treatment|1|||
161037550|NCT01640951|581529065|FG003|Overall Study|Non-compliance with study treatment|1|||
161037551|NCT01640951|581529066|FG004|Overall Study|Non-compliance with study treatment|1|||
161037552|NCT01640951|581529067|FG005|Overall Study|Non-compliance with study treatment|4|||
161037553|NCT01640951|581529068|FG006|Overall Study|Non-compliance with study treatment|1|||
161037554|NCT01640951|581529069|FG007|Overall Study|Non-compliance with study treatment|0|||
161037555|NCT01640951|581529062|FG000|Overall Study|Physician Decision|2|||
161037556|NCT01640951|581529063|FG001|Overall Study|Physician Decision|5|||
161037557|NCT01640951|581529064|FG002|Overall Study|Physician Decision|2|||
161037558|NCT01640951|581529065|FG003|Overall Study|Physician Decision|2|||
161037559|NCT01640951|581529066|FG004|Overall Study|Physician Decision|2|||
161037560|NCT01640951|581529067|FG005|Overall Study|Physician Decision|3|||
161037561|NCT01640951|581529068|FG006|Overall Study|Physician Decision|3|||
161037562|NCT01640951|581529069|FG007|Overall Study|Physician Decision|0|||
161037563|NCT01640951|581529062|FG000|Overall Study|Pregnancy|3|||
161037564|NCT01640951|581529063|FG001|Overall Study|Pregnancy|0|||
161344796|NCT05260008|582647288|FG000|Overall Study|Physician Decision|0|||
161344797|NCT05260008|582647289|FG001|Overall Study|Physician Decision|1|||
161037565|NCT01640951|581529064|FG002|Overall Study|Pregnancy|0|||
161037566|NCT01640951|581529065|FG003|Overall Study|Pregnancy|4|||
161037567|NCT01640951|581529066|FG004|Overall Study|Pregnancy|0|||
161037568|NCT01640951|581529067|FG005|Overall Study|Pregnancy|0|||
161037569|NCT01640951|581529068|FG006|Overall Study|Pregnancy|2|||
161037570|NCT01640951|581529069|FG007|Overall Study|Pregnancy|0|||
161037571|NCT01640951|581529062|FG000|Overall Study|Protocol Deviation|0|||
161037572|NCT01640951|581529063|FG001|Overall Study|Protocol Deviation|1|||
161037573|NCT01640951|581529064|FG002|Overall Study|Protocol Deviation|2|||
161037574|NCT01640951|581529065|FG003|Overall Study|Protocol Deviation|1|||
161037575|NCT01640951|581529066|FG004|Overall Study|Protocol Deviation|0|||
161037576|NCT01640951|581529067|FG005|Overall Study|Protocol Deviation|1|||
161037577|NCT01640951|581529068|FG006|Overall Study|Protocol Deviation|0|||
161037578|NCT01640951|581529069|FG007|Overall Study|Protocol Deviation|0|||
161037579|NCT01640951|581529062|FG000|Overall Study|Subject/Guardian decision|12|||
161037580|NCT01640951|581529063|FG001|Overall Study|Subject/Guardian decision|4|||
161037581|NCT01640951|581529064|FG002|Overall Study|Subject/Guardian decision|13|||
161037582|NCT01640951|581529065|FG003|Overall Study|Subject/Guardian decision|15|||
161037583|NCT01640951|581529066|FG004|Overall Study|Subject/Guardian decision|7|||
161037584|NCT01640951|581529067|FG005|Overall Study|Subject/Guardian decision|19|||
161037585|NCT01640951|581529068|FG006|Overall Study|Subject/Guardian decision|5|||
161037586|NCT01640951|581529069|FG007|Overall Study|Subject/Guardian decision|4|||
161037587|NCT01640951|581529062|FG000|Overall Study|Death|0|||
161037588|NCT01640951|581529063|FG001|Overall Study|Death|1|||
161037589|NCT01640951|581529064|FG002|Overall Study|Death|1|||
161037590|NCT01640951|581529065|FG003|Overall Study|Death|0|||
161037591|NCT01640951|581529066|FG004|Overall Study|Death|0|||
161037592|NCT01640951|581529067|FG005|Overall Study|Death|0|||
161037593|NCT01640951|581529068|FG006|Overall Study|Death|0|||
161037594|NCT01640951|581529069|FG007|Overall Study|Death|2|||
161037595|NCT00582972|581529070|FG000|Overall Study|Protocol Violation|2|||
161037596|NCT00293397|581529071|FG000|Overall Study|Death|2|||
161037597|NCT03631407|581529072|FG000|Overall Study|Withdrawal by Subject|3|||
161037598|NCT03631407|581529073|FG001|Overall Study|Withdrawal by Subject|2|||
161037599|NCT03631407|581529072|FG000|Overall Study|Sponsor Decision|0|||
161037600|NCT03631407|581529073|FG001|Overall Study|Sponsor Decision|2|||
161037601|NCT03631407|581529072|FG000|Overall Study|Death|16|||
161037602|NCT03631407|581529073|FG001|Overall Study|Death|16|||
161037603|NCT03631407|581529072|FG000|Overall Study|Randomized by mistake without study treatment|1|||
161037604|NCT03631407|581529073|FG001|Overall Study|Randomized by mistake without study treatment|0|||
161037605|NCT03802994|581529075|FG000|Overall Study|Lost to Follow-up|0|||
161037606|NCT03802994|581529076|FG001|Overall Study|Lost to Follow-up|2|||
161037607|NCT03802994|581529077|FG002|Overall Study|Lost to Follow-up|3|||
161037608|NCT03802994|581529078|FG003|Overall Study|Lost to Follow-up|2|||
161037609|NCT03802994|581529079|FG004|Overall Study|Lost to Follow-up|2|||
161037610|NCT00983294|581529080|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
161037611|NCT00983294|581529080|FG000|Colchicine With Azithromycin|Adverse Event|1|||
161037612|NCT00622700|581529081|FG000|Core Treatment Period|Randomized but Not Treated|0|||
161037613|NCT00622700|581529082|FG001|Core Treatment Period|Randomized but Not Treated|2|||
161037614|NCT00622700|581529083|FG002|Core Treatment Period|Randomized but Not Treated|2|||
161037615|NCT00622700|581529084|FG003|Core Treatment Period|Randomized but Not Treated|0|||
161037616|NCT00622700|581529085|FG004|Core Treatment Period|Randomized but Not Treated|0|||
161037617|NCT00622700|581529086|FG005|Core Treatment Period|Randomized but Not Treated|0|||
161037618|NCT00622700|581529087|FG006|Core Treatment Period|Randomized but Not Treated|0|||
161037619|NCT00622700|581529081|FG000|Core Treatment Period|Adverse Event|18|||
161037620|NCT00622700|581529082|FG001|Core Treatment Period|Adverse Event|25|||
161037621|NCT00622700|581529083|FG002|Core Treatment Period|Adverse Event|18|||
161037622|NCT00622700|581529084|FG003|Core Treatment Period|Adverse Event|0|||
161037623|NCT00622700|581529085|FG004|Core Treatment Period|Adverse Event|0|||
161037624|NCT00622700|581529086|FG005|Core Treatment Period|Adverse Event|0|||
161037625|NCT00622700|581529087|FG006|Core Treatment Period|Adverse Event|0|||
161037626|NCT00622700|581529081|FG000|Core Treatment Period|Lack of Efficacy|19|||
161037627|NCT00622700|581529082|FG001|Core Treatment Period|Lack of Efficacy|6|||
161037628|NCT00622700|581529083|FG002|Core Treatment Period|Lack of Efficacy|12|||
161037629|NCT00622700|581529084|FG003|Core Treatment Period|Lack of Efficacy|0|||
161037630|NCT00622700|581529085|FG004|Core Treatment Period|Lack of Efficacy|0|||
161037631|NCT00622700|581529086|FG005|Core Treatment Period|Lack of Efficacy|0|||
161037632|NCT00622700|581529087|FG006|Core Treatment Period|Lack of Efficacy|0|||
161037633|NCT00622700|581529081|FG000|Core Treatment Period|Lost to Follow-up|1|||
161037634|NCT00622700|581529082|FG001|Core Treatment Period|Lost to Follow-up|1|||
161037635|NCT00622700|581529083|FG002|Core Treatment Period|Lost to Follow-up|1|||
161037636|NCT00622700|581529084|FG003|Core Treatment Period|Lost to Follow-up|0|||
161037637|NCT00622700|581529085|FG004|Core Treatment Period|Lost to Follow-up|0|||
161037638|NCT00622700|581529086|FG005|Core Treatment Period|Lost to Follow-up|0|||
161037639|NCT00622700|581529087|FG006|Core Treatment Period|Lost to Follow-up|0|||
161037640|NCT00622700|581529081|FG000|Core Treatment Period|Death|1|||
161037641|NCT00622700|581529082|FG001|Core Treatment Period|Death|0|||
161037642|NCT00622700|581529083|FG002|Core Treatment Period|Death|0|||
161037643|NCT00622700|581529084|FG003|Core Treatment Period|Death|0|||
161037644|NCT00622700|581529085|FG004|Core Treatment Period|Death|0|||
161037645|NCT00622700|581529086|FG005|Core Treatment Period|Death|0|||
161037646|NCT00622700|581529087|FG006|Core Treatment Period|Death|0|||
161037647|NCT00622700|581529081|FG000|Core Treatment Period|Progressive Disease|3|||
161037648|NCT00622700|581529082|FG001|Core Treatment Period|Progressive Disease|1|||
161037649|NCT00622700|581529083|FG002|Core Treatment Period|Progressive Disease|0|||
161037650|NCT00622700|581529084|FG003|Core Treatment Period|Progressive Disease|0|||
161037651|NCT00622700|581529085|FG004|Core Treatment Period|Progressive Disease|0|||
161037652|NCT00622700|581529086|FG005|Core Treatment Period|Progressive Disease|0|||
161037653|NCT00622700|581529087|FG006|Core Treatment Period|Progressive Disease|0|||
161037654|NCT00622700|581529081|FG000|Core Treatment Period|Withdrawal by Subject|12|||
161037655|NCT00622700|581529082|FG001|Core Treatment Period|Withdrawal by Subject|18|||
161037656|NCT00622700|581529083|FG002|Core Treatment Period|Withdrawal by Subject|15|||
161037657|NCT00622700|581529084|FG003|Core Treatment Period|Withdrawal by Subject|0|||
161037658|NCT00622700|581529085|FG004|Core Treatment Period|Withdrawal by Subject|0|||
161037659|NCT00622700|581529086|FG005|Core Treatment Period|Withdrawal by Subject|0|||
161037660|NCT00622700|581529087|FG006|Core Treatment Period|Withdrawal by Subject|0|||
161037661|NCT00622700|581529081|FG000|Core Treatment Period|Other than specified above|2|||
161037662|NCT00622700|581529082|FG001|Core Treatment Period|Other than specified above|2|||
161037663|NCT00622700|581529083|FG002|Core Treatment Period|Other than specified above|5|||
161037664|NCT00622700|581529084|FG003|Core Treatment Period|Other than specified above|0|||
161037665|NCT00622700|581529085|FG004|Core Treatment Period|Other than specified above|0|||
161037666|NCT00622700|581529086|FG005|Core Treatment Period|Other than specified above|0|||
161037667|NCT00622700|581529087|FG006|Core Treatment Period|Other than specified above|0|||
161037668|NCT00622700|581529081|FG000|Extension Treatment Period|Adverse Event|0|||
161037669|NCT00622700|581529082|FG001|Extension Treatment Period|Adverse Event|0|||
161037670|NCT00622700|581529083|FG002|Extension Treatment Period|Adverse Event|0|||
161037671|NCT00622700|581529084|FG003|Extension Treatment Period|Adverse Event|5|||
161037672|NCT00622700|581529085|FG004|Extension Treatment Period|Adverse Event|9|||
161037673|NCT00622700|581529086|FG005|Extension Treatment Period|Adverse Event|6|||
161037674|NCT00622700|581529087|FG006|Extension Treatment Period|Adverse Event|8|||
161037675|NCT00622700|581529081|FG000|Extension Treatment Period|Lack of Efficacy|0|||
161037676|NCT00622700|581529082|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161037677|NCT00622700|581529083|FG002|Extension Treatment Period|Lack of Efficacy|0|||
161037678|NCT00622700|581529084|FG003|Extension Treatment Period|Lack of Efficacy|2|||
161037679|NCT00622700|581529085|FG004|Extension Treatment Period|Lack of Efficacy|8|||
161037680|NCT00622700|581529086|FG005|Extension Treatment Period|Lack of Efficacy|1|||
161037681|NCT00622700|581529087|FG006|Extension Treatment Period|Lack of Efficacy|9|||
161037682|NCT00622700|581529081|FG000|Extension Treatment Period|Protocol Violation|0|||
161037683|NCT00622700|581529082|FG001|Extension Treatment Period|Protocol Violation|0|||
161037684|NCT00622700|581529083|FG002|Extension Treatment Period|Protocol Violation|0|||
161037685|NCT00622700|581529084|FG003|Extension Treatment Period|Protocol Violation|0|||
161037686|NCT00622700|581529085|FG004|Extension Treatment Period|Protocol Violation|0|||
161037687|NCT00622700|581529086|FG005|Extension Treatment Period|Protocol Violation|2|||
161037688|NCT00622700|581529087|FG006|Extension Treatment Period|Protocol Violation|0|||
161037689|NCT00622700|581529081|FG000|Extension Treatment Period|Lost to Follow-up|0|||
161037690|NCT00622700|581529082|FG001|Extension Treatment Period|Lost to Follow-up|0|||
161037691|NCT00622700|581529083|FG002|Extension Treatment Period|Lost to Follow-up|0|||
161037692|NCT00622700|581529084|FG003|Extension Treatment Period|Lost to Follow-up|0|||
161037693|NCT00622700|581529085|FG004|Extension Treatment Period|Lost to Follow-up|1|||
161037694|NCT00622700|581529086|FG005|Extension Treatment Period|Lost to Follow-up|0|||
161037695|NCT00622700|581529087|FG006|Extension Treatment Period|Lost to Follow-up|0|||
161037696|NCT00622700|581529081|FG000|Extension Treatment Period|Progressive Disease|0|||
161037697|NCT00622700|581529082|FG001|Extension Treatment Period|Progressive Disease|0|||
161037698|NCT00622700|581529083|FG002|Extension Treatment Period|Progressive Disease|0|||
161037699|NCT00622700|581529084|FG003|Extension Treatment Period|Progressive Disease|1|||
161037700|NCT00622700|581529085|FG004|Extension Treatment Period|Progressive Disease|2|||
161037701|NCT00622700|581529086|FG005|Extension Treatment Period|Progressive Disease|0|||
161037702|NCT00622700|581529087|FG006|Extension Treatment Period|Progressive Disease|2|||
161037703|NCT00622700|581529081|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
161037704|NCT00622700|581529082|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161037705|NCT00622700|581529083|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161037706|NCT00622700|581529084|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
161037707|NCT00622700|581529085|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
161037708|NCT00622700|581529086|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
161037709|NCT00622700|581529087|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
161037710|NCT00622700|581529081|FG000|Extension Treatment Period|Missing|0|||
161037711|NCT00622700|581529082|FG001|Extension Treatment Period|Missing|0|||
161037712|NCT00622700|581529083|FG002|Extension Treatment Period|Missing|0|||
161037713|NCT00622700|581529084|FG003|Extension Treatment Period|Missing|2|||
161037714|NCT00622700|581529085|FG004|Extension Treatment Period|Missing|3|||
161037715|NCT00622700|581529086|FG005|Extension Treatment Period|Missing|1|||
161037716|NCT00622700|581529087|FG006|Extension Treatment Period|Missing|0|||
161037717|NCT00622700|581529081|FG000|Extension Treatment Period|Other than specified above|0|||
161037718|NCT00622700|581529082|FG001|Extension Treatment Period|Other than specified above|0|||
161037719|NCT00622700|581529083|FG002|Extension Treatment Period|Other than specified above|0|||
161037720|NCT00622700|581529084|FG003|Extension Treatment Period|Other than specified above|0|||
161037721|NCT00622700|581529085|FG004|Extension Treatment Period|Other than specified above|0|||
161037722|NCT00622700|581529086|FG005|Extension Treatment Period|Other than specified above|1|||
161037723|NCT00622700|581529087|FG006|Extension Treatment Period|Other than specified above|1|||
161037724|NCT03611556|581529088|FG000|Overall Study|Death|7|||
161037725|NCT03611556|581529089|FG001|Overall Study|Death|7|||
161037726|NCT03611556|581529090|FG002|Overall Study|Death|3|||
161037727|NCT03611556|581529091|FG003|Overall Study|Death|8|||
161037728|NCT03611556|581529092|FG004|Overall Study|Death|47|||
161037729|NCT03611556|581529093|FG005|Overall Study|Death|32|||
161037730|NCT03611556|581529094|FG006|Overall Study|Death|53|||
161037731|NCT03611556|581529088|FG000|Overall Study|Withdrawal by Subject|0|||
161037732|NCT03611556|581529089|FG001|Overall Study|Withdrawal by Subject|0|||
161037733|NCT03611556|581529090|FG002|Overall Study|Withdrawal by Subject|0|||
161037734|NCT03611556|581529091|FG003|Overall Study|Withdrawal by Subject|0|||
161037735|NCT03611556|581529092|FG004|Overall Study|Withdrawal by Subject|4|||
161037736|NCT03611556|581529093|FG005|Overall Study|Withdrawal by Subject|2|||
161037737|NCT03611556|581529094|FG006|Overall Study|Withdrawal by Subject|4|||
161037738|NCT03611556|581529088|FG000|Overall Study|Sponsor decision|0|||
161037739|NCT03611556|581529089|FG001|Overall Study|Sponsor decision|0|||
161037740|NCT03611556|581529090|FG002|Overall Study|Sponsor decision|0|||
161037741|NCT03611556|581529091|FG003|Overall Study|Sponsor decision|0|||
161037742|NCT03611556|581529092|FG004|Overall Study|Sponsor decision|9|||
161037743|NCT03611556|581529093|FG005|Overall Study|Sponsor decision|4|||
161037744|NCT03611556|581529094|FG006|Overall Study|Sponsor decision|12|||
161037745|NCT03611556|581529088|FG000|Overall Study|Reasons|0|||
161037746|NCT03611556|581529089|FG001|Overall Study|Reasons|0|||
161037747|NCT03611556|581529090|FG002|Overall Study|Reasons|0|||
161037748|NCT03611556|581529091|FG003|Overall Study|Reasons|0|||
161037749|NCT03611556|581529092|FG004|Overall Study|Reasons|2|||
161037750|NCT03611556|581529093|FG005|Overall Study|Reasons|0|||
161037751|NCT03611556|581529094|FG006|Overall Study|Reasons|1|||
161037752|NCT02844439|581529100|FG000|Overall Study|Withdrawal by Subject|1|||
161037753|NCT02844439|581529100|FG000|Overall Study|Lost to Follow-up|2|||
161037754|NCT02844439|581529100|FG000|Overall Study|Termination by Sponsor|4|||
161037755|NCT02844439|581529100|FG000|Overall Study|Death|28|||
161037756|NCT02844439|581529100|FG000|Overall Study|Other|5|||
161037757|NCT00390884|581529103|FG000|Overall Study|Withdrawal by Subject|2|||
161037758|NCT00390884|581529104|FG001|Overall Study|Withdrawal by Subject|2|||
161037759|NCT00756574|581529105|FG000|Overall Study|Withdrawal by Subject|9|||
161037760|NCT00756574|581529106|FG001|Overall Study|Withdrawal by Subject|7|||
161037761|NCT00756574|581529105|FG000|Overall Study|Lost to Follow-up|4|||
161037762|NCT00756574|581529106|FG001|Overall Study|Lost to Follow-up|4|||
161037763|NCT04622332|581529107|FG000|Overall Study|Withdrawal by Subject|4|||
161037764|NCT04622332|581529108|FG001|Overall Study|Withdrawal by Subject|2|||
161037765|NCT04622332|581529107|FG000|Overall Study|Physician Decision|1|||
161037766|NCT04622332|581529108|FG001|Overall Study|Physician Decision|1|||
161037767|NCT04622332|581529107|FG000|Overall Study|Adverse Event|0|||
161037768|NCT04622332|581529108|FG001|Overall Study|Adverse Event|2|||
161037769|NCT04622332|581529107|FG000|Overall Study|Protocol Violation|0|||
161037770|NCT04622332|581529108|FG001|Overall Study|Protocol Violation|1|||
161037771|NCT05966155|581529109|FG000|Overall Study|Death|1|||
161037772|NCT05966155|581529110|FG001|Overall Study|Death|2|||
161037773|NCT05966155|581529109|FG000|Overall Study|Lost to Follow-up|63|||
161037774|NCT05966155|581529110|FG001|Overall Study|Lost to Follow-up|67|||
161037775|NCT05966155|581529109|FG000|Overall Study|Protocol Violation|1|||
161037776|NCT05966155|581529110|FG001|Overall Study|Protocol Violation|0|||
161037777|NCT05966155|581529109|FG000|Overall Study|Withdrawal by Subject|8|||
161037778|NCT05966155|581529110|FG001|Overall Study|Withdrawal by Subject|9|||
161037779|NCT05966155|581529109|FG000|Overall Study|Enrolled Erroneously|0|||
161037780|NCT05966155|581529110|FG001|Overall Study|Enrolled Erroneously|1|||
161037781|NCT05966155|581529109|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
161037782|NCT05966155|581529110|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
161037783|NCT05036278|581529115|FG000|Overall Study|Withdrawal by Subject|1|||
161037784|NCT05036278|581529115|FG000|Overall Study|Adverse Event|1|||
161037785|NCT04647487|581529118|FG000|Overall Study|Protocol Deviation|0|||
161037786|NCT04647487|581529119|FG001|Overall Study|Protocol Deviation|0|||
161037787|NCT04647487|581529120|FG002|Overall Study|Protocol Deviation|1|||
161037788|NCT04647487|581529118|FG000|Overall Study|Withdrawal by Subject|1|||
161037789|NCT04647487|581529119|FG001|Overall Study|Withdrawal by Subject|0|||
161037790|NCT04647487|581529120|FG002|Overall Study|Withdrawal by Subject|2|||
161037791|NCT02787005|581529121|FG000|Overall Study|Adverse Event|24|||
161037792|NCT02787005|581529122|FG001|Overall Study|Adverse Event|9|||
161037793|NCT02787005|581529123|FG002|Overall Study|Adverse Event|9|||
161037794|NCT02787005|581529124|FG003|Overall Study|Adverse Event|7|||
161037795|NCT02787005|581529125|FG004|Overall Study|Adverse Event|2|||
161037796|NCT02787005|581529121|FG000|Overall Study|Death|100|||
161037797|NCT02787005|581529122|FG001|Overall Study|Death|53|||
161037798|NCT02787005|581529123|FG002|Overall Study|Death|48|||
161037799|NCT02787005|581529124|FG003|Overall Study|Death|69|||
161037800|NCT02787005|581529125|FG004|Overall Study|Death|38|||
161037801|NCT02787005|581529121|FG000|Overall Study|Sponsor Decision|7|||
161037802|NCT02787005|581529122|FG001|Overall Study|Sponsor Decision|4|||
161037803|NCT02787005|581529123|FG002|Overall Study|Sponsor Decision|0|||
161037804|NCT02787005|581529124|FG003|Overall Study|Sponsor Decision|4|||
161037805|NCT02787005|581529125|FG004|Overall Study|Sponsor Decision|5|||
161037806|NCT02787005|581529121|FG000|Overall Study|Withdrawal by Subject|2|||
161037807|NCT02787005|581529122|FG001|Overall Study|Withdrawal by Subject|1|||
161037808|NCT02787005|581529123|FG002|Overall Study|Withdrawal by Subject|1|||
161037809|NCT02787005|581529124|FG003|Overall Study|Withdrawal by Subject|0|||
161037810|NCT02787005|581529125|FG004|Overall Study|Withdrawal by Subject|1|||
161037811|NCT02787005|581529121|FG000|Overall Study|Screen Failure|0|||
161037812|NCT02787005|581529122|FG001|Overall Study|Screen Failure|2|||
161037813|NCT02787005|581529123|FG002|Overall Study|Screen Failure|0|||
161037814|NCT02787005|581529124|FG003|Overall Study|Screen Failure|0|||
161037815|NCT02787005|581529125|FG004|Overall Study|Screen Failure|1|||
161037816|NCT02787005|581529121|FG000|Overall Study|Lost to Follow-up|0|||
161037817|NCT02787005|581529122|FG001|Overall Study|Lost to Follow-up|0|||
161037818|NCT02787005|581529123|FG002|Overall Study|Lost to Follow-up|0|||
161037819|NCT02787005|581529124|FG003|Overall Study|Lost to Follow-up|1|||
161037820|NCT02787005|581529125|FG004|Overall Study|Lost to Follow-up|0|||
161037821|NCT03890289|581529131|FG000|Overall Study|Adverse Event|1|||
161037822|NCT03890289|581529131|FG000|Overall Study|Physician Decision|1|||
161037823|NCT03890289|581529131|FG000|Overall Study|Lack of Efficacy|2|||
161037824|NCT02744066|581529138|FG000|Overall Study|Withdrawal by parent|0|||
161037825|NCT02744066|581529139|FG001|Overall Study|Withdrawal by parent|1|||
161037826|NCT02744066|581529138|FG000|Overall Study|Discharged from NICU prior to completion|0|||
161037827|NCT02744066|581529139|FG001|Overall Study|Discharged from NICU prior to completion|4|||
161037828|NCT02408887|581529140|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
161037829|NCT02408887|581529141|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
161037830|NCT02408887|581529140|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
161037831|NCT02408887|581529141|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
161037832|NCT04066075|581529143|FG000|Overall Study|Lost to Follow-up|3|||
161037833|NCT04066075|581529144|FG001|Overall Study|Lost to Follow-up|3|||
161037834|NCT04066075|581529143|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
161037835|NCT04066075|581529144|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
161037836|NCT04066075|581529143|FG000|Overall Study|Withdrawal by Subject|2|||
161037837|NCT04066075|581529144|FG001|Overall Study|Withdrawal by Subject|2|||
161037838|NCT00309166|581529145|FG000|Overall Study|Adverse event, non-fatal|1|||
161037839|NCT00309166|581529146|FG001|Overall Study|Adverse event, non-fatal|0|||
161037840|NCT00309166|581529145|FG000|Overall Study|Withdrawal by Subject|4|||
161037841|NCT00309166|581529146|FG001|Overall Study|Withdrawal by Subject|3|||
161037842|NCT00589875|581529149|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
161037843|NCT00589875|581529149|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
161037844|NCT03357952|581529156|FG000|Overall Study|Withdrawal by Subject|0|||
161037845|NCT03357952|581529157|FG001|Overall Study|Withdrawal by Subject|1|||
161037846|NCT03357952|581529156|FG000|Overall Study|Sponsor Decision|9|||
161037847|NCT03357952|581529157|FG001|Overall Study|Sponsor Decision|0|||
161037848|NCT01675492|581529158|FG000|Overall Study|study completed early - product approval|42|||
161037849|NCT03593226|581529175|FG000|Overall Study|Disease progression|6|||
161037850|NCT03593226|581529176|FG001|Overall Study|Disease progression|13|||
161037851|NCT03593226|581529177|FG002|Overall Study|Disease progression|5|||
161037852|NCT03593226|581529178|FG003|Overall Study|Disease progression|6|||
161037853|NCT03593226|581529175|FG000|Overall Study|Adverse Event|0|||
161037854|NCT03593226|581529176|FG001|Overall Study|Adverse Event|1|||
161037855|NCT03593226|581529177|FG002|Overall Study|Adverse Event|0|||
161037856|NCT03593226|581529178|FG003|Overall Study|Adverse Event|0|||
161037857|NCT03593226|581529175|FG000|Overall Study|Withdrawal by Subject|0|||
161037858|NCT03593226|581529176|FG001|Overall Study|Withdrawal by Subject|4|||
161037859|NCT03593226|581529177|FG002|Overall Study|Withdrawal by Subject|1|||
161037860|NCT03593226|581529178|FG003|Overall Study|Withdrawal by Subject|0|||
161037861|NCT03593226|581529175|FG000|Overall Study|Physician Decision|0|||
161037862|NCT03593226|581529176|FG001|Overall Study|Physician Decision|1|||
161037863|NCT03593226|581529177|FG002|Overall Study|Physician Decision|0|||
161037864|NCT03593226|581529178|FG003|Overall Study|Physician Decision|0|||
161037865|NCT03593226|581529175|FG000|Overall Study|Clinical disease progression|0|||
161037866|NCT03593226|581529176|FG001|Overall Study|Clinical disease progression|0|||
161037867|NCT03593226|581529177|FG002|Overall Study|Clinical disease progression|1|||
161037868|NCT03593226|581529178|FG003|Overall Study|Clinical disease progression|0|||
161037869|NCT04517435|581529179|FG000|Overall Study|Withdrawal by Subject|0|||
161037870|NCT04517435|581529180|FG001|Overall Study|Withdrawal by Subject|0|||
161037871|NCT04517435|581529181|FG002|Overall Study|Withdrawal by Subject|1|||
161037872|NCT04517435|581529179|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
161037873|NCT04517435|581529180|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
161344798|NCT05260008|582647290|FG002|Overall Study|Physician Decision|0|||
161037874|NCT04517435|581529181|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
161037875|NCT06191679|581529182|FG000|Baseline|Lost to Follow-up|1|||
161037876|NCT06191679|581529183|FG001|Baseline|Lost to Follow-up|0|||
161037877|NCT06191679|581529184|FG002|Baseline|Lost to Follow-up|1|||
161037878|NCT06191679|581529185|FG003|Baseline|Lost to Follow-up|0|||
161037879|NCT06191679|581529182|FG000|Allocation to Group|Withdrawal by Subject|0|||
161037880|NCT06191679|581529183|FG001|Allocation to Group|Withdrawal by Subject|1|||
161037881|NCT06191679|581529184|FG002|Allocation to Group|Withdrawal by Subject|2|||
161037882|NCT06191679|581529185|FG003|Allocation to Group|Withdrawal by Subject|0|||
161037883|NCT06191679|581529182|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
161037884|NCT06191679|581529183|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
161037885|NCT06191679|581529184|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
161037886|NCT06191679|581529185|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
161037887|NCT06191679|581529182|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
161037888|NCT06191679|581529183|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
161037889|NCT06191679|581529184|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
161037890|NCT06191679|581529185|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
161037891|NCT06191679|581529182|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
161037892|NCT06191679|581529183|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
161037893|NCT06191679|581529184|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
161037894|NCT06191679|581529185|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
161037895|NCT03656718|581529186|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
161037896|NCT03656718|581529187|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
161037897|NCT03656718|581529188|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
161037898|NCT03656718|581529189|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
161037899|NCT03656718|581529190|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
161037900|NCT03656718|581529191|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
161037901|NCT03656718|581529192|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
161037902|NCT03656718|581529186|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
161037903|NCT03656718|581529187|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
161037904|NCT03656718|581529188|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
161037905|NCT03656718|581529189|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
161037906|NCT03656718|581529190|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
161037907|NCT03656718|581529191|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
161037908|NCT03656718|581529192|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
161037909|NCT03656718|581529186|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
161037910|NCT03656718|581529187|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
161037911|NCT03656718|581529188|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
161037912|NCT03656718|581529189|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
161037913|NCT03656718|581529190|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
161037914|NCT03656718|581529191|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
161037915|NCT03656718|581529192|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
161037916|NCT03656718|581529186|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161037917|NCT03656718|581529187|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161037918|NCT03656718|581529188|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161037919|NCT03656718|581529189|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161037920|NCT03656718|581529190|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
161037921|NCT03656718|581529191|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
161037922|NCT03656718|581529192|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
161037923|NCT03656718|581529186|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
161037924|NCT03656718|581529187|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161037925|NCT03656718|581529188|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161037926|NCT03656718|581529189|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161037927|NCT03656718|581529190|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161037928|NCT03656718|581529191|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
161037929|NCT03656718|581529192|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
161037930|NCT03656718|581529186|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161037931|NCT03656718|581529187|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161037932|NCT03656718|581529188|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161037933|NCT03656718|581529189|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161037934|NCT03656718|581529190|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
161037935|NCT03656718|581529191|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
161037936|NCT03656718|581529192|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
161037937|NCT03656718|581529186|FG000|Treatment Period Part C|Disease progression|0|||
161037938|NCT03656718|581529187|FG001|Treatment Period Part C|Disease progression|0|||
161037939|NCT03656718|581529188|FG002|Treatment Period Part C|Disease progression|0|||
161037940|NCT03656718|581529189|FG003|Treatment Period Part C|Disease progression|0|||
161037941|NCT03656718|581529190|FG004|Treatment Period Part C|Disease progression|12|||
161037942|NCT03656718|581529191|FG005|Treatment Period Part C|Disease progression|0|||
161037943|NCT03656718|581529192|FG006|Treatment Period Part C|Disease progression|0|||
161037944|NCT03656718|581529186|FG000|Treatment Period Part C|Death|0|||
161037945|NCT03656718|581529187|FG001|Treatment Period Part C|Death|0|||
161037946|NCT03656718|581529188|FG002|Treatment Period Part C|Death|0|||
161037947|NCT03656718|581529189|FG003|Treatment Period Part C|Death|0|||
161037948|NCT03656718|581529190|FG004|Treatment Period Part C|Death|1|||
161037949|NCT03656718|581529191|FG005|Treatment Period Part C|Death|0|||
161037950|NCT03656718|581529192|FG006|Treatment Period Part C|Death|0|||
161037951|NCT03656718|581529186|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161037952|NCT03656718|581529187|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161037953|NCT03656718|581529188|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161037954|NCT03656718|581529189|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161037955|NCT03656718|581529190|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
161037956|NCT03656718|581529191|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161037957|NCT03656718|581529192|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
161037958|NCT03656718|581529186|FG000|Treatment Period Part C|Other reasons|0|||
161037959|NCT03656718|581529187|FG001|Treatment Period Part C|Other reasons|0|||
161037960|NCT03656718|581529188|FG002|Treatment Period Part C|Other reasons|0|||
161037961|NCT03656718|581529189|FG003|Treatment Period Part C|Other reasons|0|||
161037962|NCT03656718|581529190|FG004|Treatment Period Part C|Other reasons|1|||
161037963|NCT03656718|581529191|FG005|Treatment Period Part C|Other reasons|0|||
161037964|NCT03656718|581529192|FG006|Treatment Period Part C|Other reasons|0|||
161037965|NCT03656718|581529186|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
161037966|NCT03656718|581529187|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
161037967|NCT03656718|581529188|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
161037968|NCT03656718|581529189|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
161037969|NCT03656718|581529190|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
161037970|NCT03656718|581529191|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
161037971|NCT03656718|581529192|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
161037972|NCT05827068|581529193|FG000|Overall Study|Lost to Follow-up|1|||
161037973|NCT05827068|581529194|FG001|Overall Study|Lost to Follow-up|4|||
161037974|NCT05827068|581529195|FG002|Overall Study|Lost to Follow-up|1|||
161037975|NCT05827068|581529196|FG003|Overall Study|Lost to Follow-up|1|||
161037976|NCT05827068|581529197|FG004|Overall Study|Lost to Follow-up|2|||
161037977|NCT05827068|581529198|FG005|Overall Study|Lost to Follow-up|4|||
161037978|NCT05827068|581529199|FG006|Overall Study|Lost to Follow-up|1|||
161037979|NCT05827068|581529193|FG000|Overall Study|Withdrawal by Subject|4|||
161037980|NCT05827068|581529194|FG001|Overall Study|Withdrawal by Subject|0|||
161037981|NCT05827068|581529195|FG002|Overall Study|Withdrawal by Subject|1|||
161037982|NCT05827068|581529196|FG003|Overall Study|Withdrawal by Subject|2|||
161037983|NCT05827068|581529197|FG004|Overall Study|Withdrawal by Subject|3|||
161037984|NCT05827068|581529198|FG005|Overall Study|Withdrawal by Subject|0|||
161037985|NCT05827068|581529199|FG006|Overall Study|Withdrawal by Subject|1|||
161037986|NCT05827068|581529193|FG000|Overall Study|Physician Decision|0|||
161037987|NCT05827068|581529194|FG001|Overall Study|Physician Decision|0|||
161037988|NCT05827068|581529195|FG002|Overall Study|Physician Decision|0|||
161037989|NCT05827068|581529196|FG003|Overall Study|Physician Decision|0|||
161037990|NCT05827068|581529197|FG004|Overall Study|Physician Decision|1|||
161037991|NCT05827068|581529198|FG005|Overall Study|Physician Decision|0|||
161037992|NCT05827068|581529199|FG006|Overall Study|Physician Decision|1|||
161037993|NCT05827068|581529193|FG000|Overall Study|Other Than Specified|0|||
161037994|NCT05827068|581529194|FG001|Overall Study|Other Than Specified|1|||
161037995|NCT05827068|581529195|FG002|Overall Study|Other Than Specified|0|||
161037996|NCT05827068|581529196|FG003|Overall Study|Other Than Specified|0|||
161037997|NCT05827068|581529197|FG004|Overall Study|Other Than Specified|0|||
161037998|NCT05827068|581529198|FG005|Overall Study|Other Than Specified|0|||
161037999|NCT05827068|581529199|FG006|Overall Study|Other Than Specified|0|||
161038000|NCT05786612|581529214|FG000|Overall Study|Adverse Event|1|||
161038001|NCT05786612|581529215|FG001|Overall Study|Adverse Event|2|||
161038002|NCT05786612|581529214|FG000|Overall Study|one screening failure|0|||
161038003|NCT05786612|581529215|FG001|Overall Study|one screening failure|2|||
161038004|NCT05630833|581529220|FG000|Overall Study|Adverse Event|3|||
161038005|NCT05630833|581529221|FG001|Overall Study|Adverse Event|0|||
161038006|NCT05630833|581529220|FG000|Overall Study|Lack of Efficacy|0|||
161038007|NCT05630833|581529221|FG001|Overall Study|Lack of Efficacy|1|||
161038008|NCT05630833|581529220|FG000|Overall Study|Lost to Follow-up|1|||
161038009|NCT05630833|581529221|FG001|Overall Study|Lost to Follow-up|0|||
161038010|NCT05630833|581529220|FG000|Overall Study|Withdrawal by Subject|3|||
161038011|NCT05630833|581529221|FG001|Overall Study|Withdrawal by Subject|1|||
161038012|NCT00490139|581529222|FG000|Overall Study|Lost to Follow-up|249|||
161038013|NCT00490139|581529223|FG001|Overall Study|Lost to Follow-up|216|||
161038014|NCT00490139|581529224|FG002|Overall Study|Lost to Follow-up|205|||
161038015|NCT00490139|581529225|FG003|Overall Study|Lost to Follow-up|229|||
161038016|NCT00490139|581529222|FG000|Overall Study|Withdrawal by Subject|333|||
161038017|NCT00490139|581529223|FG001|Overall Study|Withdrawal by Subject|322|||
161038018|NCT00490139|581529224|FG002|Overall Study|Withdrawal by Subject|396|||
161038019|NCT00490139|581529225|FG003|Overall Study|Withdrawal by Subject|295|||
161038020|NCT00490139|581529222|FG000|Overall Study|Patient did not sign ICF 12|169|||
161038021|NCT00490139|581529223|FG001|Overall Study|Patient did not sign ICF 12|176|||
161038022|NCT00490139|581529224|FG002|Overall Study|Patient did not sign ICF 12|139|||
161038023|NCT00490139|581529225|FG003|Overall Study|Patient did not sign ICF 12|167|||
161038024|NCT00490139|581529222|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
161038025|NCT00490139|581529223|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
161038026|NCT00490139|581529224|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
161038027|NCT00490139|581529225|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
161038028|NCT00490139|581529222|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
161038029|NCT00490139|581529223|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
161038030|NCT00490139|581529224|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
161038031|NCT00490139|581529225|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
161038032|NCT00490139|581529222|FG000|Overall Study|Other reasons as defined per protocol|98|||
161038033|NCT00490139|581529223|FG001|Overall Study|Other reasons as defined per protocol|84|||
161038034|NCT00490139|581529224|FG002|Overall Study|Other reasons as defined per protocol|82|||
161038035|NCT00490139|581529225|FG003|Overall Study|Other reasons as defined per protocol|105|||
161038036|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
161038037|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
161038038|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
161038039|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
161038040|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
161038041|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
161038042|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
161038043|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
161038044|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
161038045|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
161038046|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
161038047|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
161038048|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
161038049|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
161038050|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
161038051|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161038052|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
161038053|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161038054|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161038055|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
161038056|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
161038057|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
161038058|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
161038059|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
161038060|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
161038061|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Other|1|||
161038062|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Other|0|||
161038063|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Other|0|||
161038064|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Other|0|||
161038065|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Other|0|||
161038066|NCT02386098|581530621|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
161038067|NCT02386098|581530622|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
161038068|NCT02386098|581530623|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
161038069|NCT02386098|581530624|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
161038070|NCT02386098|581530625|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
161038071|NCT05250115|581530628|FG000|Overall Study|Premature study end|40|||
161038072|NCT05250115|581530628|FG000|Overall Study|Adverse Event|8|||
161038073|NCT05250115|581530628|FG000|Overall Study|Lost to Follow-up|7|||
161038074|NCT05250115|581530628|FG000|Overall Study|Withdrawal by Subject|6|||
161038075|NCT05250115|581530628|FG000|Overall Study|Withdrawal of informed consent|1|||
161038076|NCT05250115|581530628|FG000|Overall Study|Other|7|||
161038077|NCT00890591|581530637|FG000|Overall Study|Lack of Efficacy|20|||
161038078|NCT00776009|581530642|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
161038079|NCT00776009|581530643|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
161038080|NCT00776009|581530644|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
161038081|NCT00776009|581530645|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
161038082|NCT00776009|581530646|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
161038083|NCT00776009|581530647|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
161038084|NCT00776009|581530642|FG000|Period 1: First Intervention|Protocol Violation|0|||
161038085|NCT00776009|581530643|FG001|Period 1: First Intervention|Protocol Violation|1|||
161038086|NCT00776009|581530644|FG002|Period 1: First Intervention|Protocol Violation|0|||
161038087|NCT00776009|581530645|FG003|Period 1: First Intervention|Protocol Violation|0|||
161038088|NCT00776009|581530646|FG004|Period 1: First Intervention|Protocol Violation|1|||
161038089|NCT00776009|581530647|FG005|Period 1: First Intervention|Protocol Violation|0|||
161280175|NCT01653912|582404276|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280176|NCT01653912|582404277|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280177|NCT01653912|582404278|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
161280178|NCT01653912|582404279|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280179|NCT01653912|582404280|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280180|NCT01653912|582404275|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161280181|NCT01653912|582404276|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161280182|NCT01653912|582404277|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161280183|NCT01653912|582404278|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161280184|NCT01653912|582404279|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
161280185|NCT01653912|582404280|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
161280186|NCT01653912|582404275|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161280187|NCT01653912|582404276|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161280188|NCT01653912|582404277|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161280189|NCT01653912|582404278|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161280190|NCT01653912|582404279|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
161280191|NCT01653912|582404280|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
161280192|NCT01653912|582404275|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280193|NCT01653912|582404276|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280194|NCT01653912|582404277|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280195|NCT01653912|582404278|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280196|NCT01653912|582404279|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
161280197|NCT01653912|582404280|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
161280198|NCT01987479|582404281|FG000|Overall Study|Protocol Violation|1|||
161280199|NCT01987479|582404281|FG000|Overall Study|Physician Decision|2|||
161280200|NCT01987479|582404281|FG000|Overall Study|Participant/legal guardian decision|1|||
161280201|NCT01987479|582404281|FG000|Overall Study|Other|5|||
161280202|NCT01987479|582404281|FG000|Overall Study|Lost to Follow-up|1|||
161280203|NCT01987479|582404281|FG000|Overall Study|Adverse Event|7|||
161280204|NCT01954745|582404282|FG000|Overall Study|Radiological Progression|11|||
161280205|NCT01954745|582404282|FG000|Overall Study|Clinical Progression|5|||
161280206|NCT01954745|582404282|FG000|Overall Study|Adverse Event|2|||
161280207|NCT01954745|582404282|FG000|Overall Study|Death|1|||
161280208|NCT05314816|582404283|FG000|Overall Study|Lost to Follow-up|5|||
161280209|NCT05314816|582404284|FG001|Overall Study|Lost to Follow-up|0|||
161280210|NCT05314816|582404285|FG002|Overall Study|Lost to Follow-up|1|||
161280211|NCT05314816|582404283|FG000|Overall Study|Protocol Violation|13|||
161280212|NCT05314816|582404284|FG001|Overall Study|Protocol Violation|8|||
161280213|NCT05314816|582404285|FG002|Overall Study|Protocol Violation|0|||
161280214|NCT05422625|582404286|FG000|Overall Study|Withdrawal by Subject|1|||
161280215|NCT05422625|582404287|FG001|Overall Study|Withdrawal by Subject|0|||
161280216|NCT01059786|582406818|FG000|Overall Study|Did not receive 6 cycles.|0|||
161280217|NCT01059786|582406819|FG001|Overall Study|Did not receive 6 cycles.|0|||
161280218|NCT01059786|582406820|FG002|Overall Study|Did not receive 6 cycles.|4|||
161280219|NCT01059786|582406821|FG003|Overall Study|Did not receive 6 cycles.|1|||
161280220|NCT01059786|582406822|FG004|Overall Study|Did not receive 6 cycles.|0|||
161280221|NCT04205812|582406823|FG000|Randomized Treatment Period|Ongoing|28|||
161280222|NCT04205812|582406824|FG001|Randomized Treatment Period|Ongoing|138|||
161280223|NCT04205812|582406823|FG000|Randomized Treatment Period|Death|94|||
161280224|NCT04205812|582406824|FG001|Randomized Treatment Period|Death|226|||
161280225|NCT04205812|582406823|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
161280226|NCT04205812|582406824|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
161280227|NCT04205812|582406823|FG000|Randomized Treatment Period|Physician Decision|1|||
161280228|NCT04205812|582406824|FG001|Randomized Treatment Period|Physician Decision|4|||
161280229|NCT04205812|582406823|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
161280230|NCT04205812|582406824|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
161280231|NCT04205812|582406823|FG000|Randomized Treatment Period|Progressive Disease|0|||
161280232|NCT04205812|582406824|FG001|Randomized Treatment Period|Progressive Disease|1|||
161280233|NCT04205812|582406823|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
161280234|NCT04205812|582406824|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
161280235|NCT04205812|582406823|FG000|Monotherapy Treatment Period|Ongoing|17|||
161280236|NCT04205812|582406824|FG001|Monotherapy Treatment Period|Ongoing|0|||
161280237|NCT04205812|582406823|FG000|Monotherapy Treatment Period|Death|39|||
161280238|NCT04205812|582406824|FG001|Monotherapy Treatment Period|Death|0|||
161280239|NCT04205812|582406823|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
161280240|NCT04205812|582406824|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
161280241|NCT04205812|582406823|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
161280242|NCT04205812|582406824|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
161280243|NCT04559347|582406825|FG000|Overall Study|Death|1|||
161280244|NCT04559347|582406826|FG001|Overall Study|Death|0|||
161280245|NCT04559347|582406825|FG000|Overall Study|Thoracotomy conversion|1|||
161280246|NCT04559347|582406826|FG001|Overall Study|Thoracotomy conversion|1|||
161280247|NCT04559347|582406825|FG000|Overall Study|Provider unavailable|2|||
161344799|NCT05260008|582647291|FG003|Overall Study|Physician Decision|0|||
161280248|NCT04559347|582406826|FG001|Overall Study|Provider unavailable|1|||
161280249|NCT04559347|582406825|FG000|Overall Study|Other|2|||
161280250|NCT04559347|582406826|FG001|Overall Study|Other|1|||
161280251|NCT00371033|582406827|FG000|Overall Study|Lost to Follow-up|3|||
161280252|NCT00371033|582406828|FG001|Overall Study|Lost to Follow-up|2|||
161280253|NCT00371033|582406827|FG000|Overall Study|No longer interested|2|||
161280254|NCT00371033|582406828|FG001|Overall Study|No longer interested|0|||
161280255|NCT00371033|582406827|FG000|Overall Study|Uknown|3|||
161280256|NCT00371033|582406828|FG001|Overall Study|Uknown|1|||
161280257|NCT03130777|582406832|FG000|Overall Study|Death|0|||
161280258|NCT03130777|582406833|FG001|Overall Study|Death|1|||
161280259|NCT03130777|582406832|FG000|Overall Study|Did not meet eligibility criteria|1|||
161280260|NCT03130777|582406833|FG001|Overall Study|Did not meet eligibility criteria|0|||
161280261|NCT05929651|582406837|FG000|Overall Study|Protocol Deviation|1|||
161280262|NCT05929651|582406837|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
161280263|NCT05026177|582406838|FG000|Overall Study|Adverse Event|33|||
161280264|NCT05026177|582406839|FG001|Overall Study|Adverse Event|33|||
161280265|NCT05026177|582406840|FG002|Overall Study|Adverse Event|17|||
161280266|NCT05026177|582406838|FG000|Overall Study|Lost to Follow-up|7|||
161280267|NCT05026177|582406839|FG001|Overall Study|Lost to Follow-up|6|||
161280268|NCT05026177|582406840|FG002|Overall Study|Lost to Follow-up|8|||
161280269|NCT05026177|582406838|FG000|Overall Study|Noncompliance with study drug|6|||
161280270|NCT05026177|582406839|FG001|Overall Study|Noncompliance with study drug|2|||
161280271|NCT05026177|582406840|FG002|Overall Study|Noncompliance with study drug|1|||
161280272|NCT05026177|582406838|FG000|Overall Study|Physician Decision|4|||
161038090|NCT00776009|581530642|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
161038091|NCT00776009|581530643|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
161038092|NCT00776009|581530644|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
161038093|NCT00776009|581530645|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
161038094|NCT00776009|581530646|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
161038095|NCT00776009|581530647|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
161038096|NCT00776009|581530642|FG000|Period 2: Second Intervention|Protocol Violation|1|||
161038097|NCT00776009|581530643|FG001|Period 2: Second Intervention|Protocol Violation|0|||
161038098|NCT00776009|581530644|FG002|Period 2: Second Intervention|Protocol Violation|1|||
161038099|NCT00776009|581530645|FG003|Period 2: Second Intervention|Protocol Violation|0|||
161038100|NCT00776009|581530646|FG004|Period 2: Second Intervention|Protocol Violation|0|||
161038101|NCT00776009|581530647|FG005|Period 2: Second Intervention|Protocol Violation|0|||
161038102|NCT00776009|581530642|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
161038103|NCT00776009|581530643|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
161038104|NCT00776009|581530644|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
161038105|NCT00776009|581530645|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
161038106|NCT00776009|581530646|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
161038107|NCT00776009|581530647|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
161038108|NCT01536093|581530650|FG000|Overall Study|Death|1|||
161038109|NCT01536093|581530651|FG001|Overall Study|Death|2|||
161038110|NCT01536093|581530650|FG000|Overall Study|absence of maternal colostrum|2|||
161038111|NCT01536093|581530651|FG001|Overall Study|absence of maternal colostrum|0|||
161038112|NCT01536093|581530650|FG000|Overall Study|Withdrawal by Subject|0|||
161038113|NCT01536093|581530651|FG001|Overall Study|Withdrawal by Subject|1|||
161038114|NCT02275611|581530654|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
161038115|NCT02275611|581530655|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
161038116|NCT02275611|581530656|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
161038117|NCT02275611|581530657|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
161038118|NCT01211184|581530663|FG000|Overall Study|Withdrawal by Subject|0|||
161038119|NCT01211184|581530664|FG001|Overall Study|Withdrawal by Subject|2|||
161038120|NCT01211184|581530665|FG002|Overall Study|Withdrawal by Subject|1|||
161038121|NCT01421667|581530666|FG000|Overall Study|Withdrawal by Subject|0|||
161038122|NCT01421667|581530667|FG001|Overall Study|Withdrawal by Subject|1|||
161038123|NCT01421667|581530668|FG002|Overall Study|Withdrawal by Subject|2|||
161038124|NCT01421667|581530669|FG003|Overall Study|Withdrawal by Subject|1|||
161280273|NCT05026177|582406839|FG001|Overall Study|Physician Decision|1|||
161280274|NCT05026177|582406840|FG002|Overall Study|Physician Decision|0|||
161280275|NCT05026177|582406838|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
161280276|NCT05026177|582406839|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
161280277|NCT05026177|582406840|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
161280278|NCT05026177|582406838|FG000|Overall Study|Withdrawal by Subject|53|||
161280279|NCT05026177|582406839|FG001|Overall Study|Withdrawal by Subject|51|||
161280280|NCT05026177|582406840|FG002|Overall Study|Withdrawal by Subject|55|||
161280281|NCT05026177|582406838|FG000|Overall Study|Protocol Violation|0|||
161280282|NCT05026177|582406839|FG001|Overall Study|Protocol Violation|1|||
161280283|NCT05026177|582406840|FG002|Overall Study|Protocol Violation|0|||
161280284|NCT05026177|582406838|FG000|Overall Study|Study terminated by sponsor|70|||
161280285|NCT05026177|582406839|FG001|Overall Study|Study terminated by sponsor|74|||
161280286|NCT05026177|582406840|FG002|Overall Study|Study terminated by sponsor|67|||
161344800|NCT01157845|582647294|FG000|Overall Study|Lost to Follow-up|5|||
161038125|NCT01421667|581530666|FG000|Overall Study|Lost to Follow-up|0|||
161038126|NCT01421667|581530667|FG001|Overall Study|Lost to Follow-up|1|||
161038127|NCT01421667|581530668|FG002|Overall Study|Lost to Follow-up|0|||
161038128|NCT01421667|581530669|FG003|Overall Study|Lost to Follow-up|0|||
161038129|NCT00503906|581530670|FG000|Overall Study|Withdrawal by Subject|1|||
161038130|NCT05580003|581530671|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038131|NCT05580003|581530672|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038132|NCT05580003|581530673|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038133|NCT05580003|581530674|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038134|NCT05580003|581530675|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038135|NCT05580003|581530676|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038136|NCT05580003|581530677|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
161038137|NCT05580003|581530678|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038138|NCT05580003|581530679|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038139|NCT05580003|581530680|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038140|NCT05580003|581530681|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038141|NCT05580003|581530682|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038142|NCT05580003|581530683|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038143|NCT05580003|581530684|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038144|NCT05580003|581530685|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038145|NCT05580003|581530686|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038146|NCT05580003|581530687|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038147|NCT05580003|581530688|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038148|NCT05580003|581530689|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038149|NCT05580003|581530690|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038150|NCT05580003|581530691|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038151|NCT05580003|581530692|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038152|NCT05580003|581530693|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038153|NCT05580003|581530694|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038154|NCT05580003|581530695|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038155|NCT05580003|581530696|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038156|NCT05580003|581530697|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038157|NCT05580003|581530698|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
161038158|NCT05580003|581530671|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038159|NCT05580003|581530672|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038160|NCT05580003|581530673|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038161|NCT05580003|581530674|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038162|NCT05580003|581530675|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038163|NCT05580003|581530676|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
161038164|NCT05580003|581530677|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038165|NCT05580003|581530678|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038166|NCT05580003|581530679|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038167|NCT05580003|581530680|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038168|NCT05580003|581530681|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038169|NCT05580003|581530682|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038170|NCT05580003|581530683|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038171|NCT05580003|581530684|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038172|NCT05580003|581530685|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038173|NCT05580003|581530686|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038174|NCT05580003|581530687|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161280287|NCT05026177|582406838|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
161280288|NCT05026177|582406839|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
161280289|NCT05026177|582406840|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
160977609|NCT02141659|581307947|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
160977610|NCT02141659|581307948|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
160977611|NCT02141659|581307949|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
160977612|NCT00305864|581307958|FG000|Overall Study|Ineligible / No protocol treatment|0|||
160977613|NCT00305864|581307959|FG001|Overall Study|Ineligible / No protocol treatment|1|||
160977614|NCT00305864|581307960|FG002|Overall Study|Ineligible / No protocol treatment|1|||
161280290|NCT05026177|582406838|FG000|Overall Study|Starting alternative treatment|0|||
161280291|NCT05026177|582406839|FG001|Overall Study|Starting alternative treatment|1|||
160977615|NCT00305864|581307961|FG003|Overall Study|Ineligible / No protocol treatment|13|||
160977616|NCT02836613|581307964|FG000|Overall Study|Accidental drowning|1|||
160977617|NCT02836613|581307965|FG001|Overall Study|Accidental drowning|0|||
160977618|NCT02836613|581307964|FG000|Overall Study|Lost to Follow-up|0|||
161038175|NCT05580003|581530688|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038176|NCT05580003|581530689|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038177|NCT05580003|581530690|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038178|NCT05580003|581530691|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038179|NCT05580003|581530692|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038180|NCT05580003|581530693|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038181|NCT05580003|581530694|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038182|NCT05580003|581530695|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038183|NCT05580003|581530696|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038184|NCT05580003|581530697|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038185|NCT05580003|581530698|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
161038186|NCT05580003|581530671|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038187|NCT05580003|581530672|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038188|NCT05580003|581530673|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038189|NCT05580003|581530674|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
161038190|NCT05580003|581530675|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038191|NCT05580003|581530676|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038192|NCT05580003|581530677|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038193|NCT05580003|581530678|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038194|NCT05580003|581530679|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038195|NCT05580003|581530680|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038196|NCT05580003|581530681|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038197|NCT05580003|581530682|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038198|NCT05580003|581530683|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038199|NCT05580003|581530684|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038200|NCT05580003|581530685|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038201|NCT05580003|581530686|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038202|NCT05580003|581530687|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038203|NCT05580003|581530688|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038204|NCT05580003|581530689|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038205|NCT05580003|581530690|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038206|NCT05580003|581530691|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038207|NCT05580003|581530692|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038208|NCT05580003|581530693|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038209|NCT05580003|581530694|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038210|NCT05580003|581530695|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038211|NCT05580003|581530696|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038212|NCT05580003|581530697|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038213|NCT05580003|581530698|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
161038214|NCT05580003|581530671|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038215|NCT05580003|581530672|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
161038216|NCT05580003|581530673|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038217|NCT05580003|581530674|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038218|NCT05580003|581530675|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038219|NCT05580003|581530676|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038220|NCT05580003|581530677|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038221|NCT05580003|581530678|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038222|NCT05580003|581530679|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038223|NCT05580003|581530680|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038224|NCT05580003|581530681|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038225|NCT05580003|581530682|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038226|NCT05580003|581530683|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038227|NCT05580003|581530684|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038228|NCT05580003|581530685|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038229|NCT05580003|581530686|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038230|NCT05580003|581530687|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038231|NCT05580003|581530688|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038232|NCT05580003|581530689|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038233|NCT05580003|581530690|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038234|NCT05580003|581530691|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038235|NCT05580003|581530692|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038236|NCT05580003|581530693|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038237|NCT05580003|581530694|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038238|NCT05580003|581530695|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161280292|NCT05026177|582406840|FG002|Overall Study|Starting alternative treatment|1|||
161280293|NCT05026177|582406838|FG000|Overall Study|Noncompliance with study procedures|0|||
161038239|NCT05580003|581530696|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038240|NCT05580003|581530697|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161280294|NCT05026177|582406839|FG001|Overall Study|Noncompliance with study procedures|1|||
161280295|NCT05026177|582406840|FG002|Overall Study|Noncompliance with study procedures|1|||
161038241|NCT05580003|581530698|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
161038242|NCT05580003|581530671|FG000|Part 2 (up to 10 Days)|Other|0|||
161038243|NCT05580003|581530672|FG001|Part 2 (up to 10 Days)|Other|0|||
161038244|NCT05580003|581530673|FG002|Part 2 (up to 10 Days)|Other|0|||
161038245|NCT05580003|581530674|FG003|Part 2 (up to 10 Days)|Other|0|||
161038246|NCT05580003|581530675|FG004|Part 2 (up to 10 Days)|Other|0|||
161038247|NCT05580003|581530676|FG005|Part 2 (up to 10 Days)|Other|0|||
161038248|NCT05580003|581530677|FG006|Part 2 (up to 10 Days)|Other|0|||
161038249|NCT05580003|581530678|FG007|Part 2 (up to 10 Days)|Other|0|||
161038250|NCT05580003|581530679|FG008|Part 2 (up to 10 Days)|Other|0|||
161038251|NCT05580003|581530680|FG009|Part 2 (up to 10 Days)|Other|1|||
161038252|NCT05580003|581530681|FG010|Part 2 (up to 10 Days)|Other|0|||
161038253|NCT05580003|581530682|FG011|Part 2 (up to 10 Days)|Other|0|||
161038254|NCT05580003|581530683|FG012|Part 2 (up to 10 Days)|Other|0|||
161038255|NCT05580003|581530684|FG013|Part 2 (up to 10 Days)|Other|0|||
161038256|NCT05580003|581530685|FG014|Part 2 (up to 10 Days)|Other|0|||
161038257|NCT05580003|581530686|FG015|Part 2 (up to 10 Days)|Other|0|||
161038258|NCT05580003|581530687|FG016|Part 2 (up to 10 Days)|Other|0|||
161038259|NCT05580003|581530688|FG017|Part 2 (up to 10 Days)|Other|0|||
161038260|NCT05580003|581530689|FG018|Part 2 (up to 10 Days)|Other|0|||
161038261|NCT05580003|581530690|FG019|Part 2 (up to 10 Days)|Other|0|||
161038262|NCT05580003|581530691|FG020|Part 2 (up to 10 Days)|Other|0|||
161038263|NCT05580003|581530692|FG021|Part 2 (up to 10 Days)|Other|0|||
161038264|NCT05580003|581530693|FG022|Part 2 (up to 10 Days)|Other|0|||
161038265|NCT05580003|581530694|FG023|Part 2 (up to 10 Days)|Other|0|||
161038266|NCT05580003|581530695|FG024|Part 2 (up to 10 Days)|Other|0|||
161038267|NCT05580003|581530696|FG025|Part 2 (up to 10 Days)|Other|0|||
161038268|NCT05580003|581530697|FG026|Part 2 (up to 10 Days)|Other|0|||
161038269|NCT05580003|581530698|FG027|Part 2 (up to 10 Days)|Other|0|||
161038270|NCT05580003|581530671|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038271|NCT05580003|581530672|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038272|NCT05580003|581530673|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038273|NCT05580003|581530674|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038274|NCT05580003|581530675|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038275|NCT05580003|581530676|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038276|NCT05580003|581530677|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038277|NCT05580003|581530678|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038278|NCT05580003|581530679|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038279|NCT05580003|581530680|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038280|NCT05580003|581530681|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038281|NCT05580003|581530682|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038282|NCT05580003|581530683|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038283|NCT05580003|581530684|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038284|NCT05580003|581530685|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038285|NCT05580003|581530686|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038286|NCT05580003|581530687|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038287|NCT05580003|581530688|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038288|NCT05580003|581530689|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038289|NCT05580003|581530690|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
161038290|NCT05580003|581530691|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038291|NCT05580003|581530692|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038292|NCT05580003|581530693|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161280296|NCT05026177|582406838|FG000|Overall Study|Met stopping criteria|0|||
161280297|NCT05026177|582406839|FG001|Overall Study|Met stopping criteria|0|||
161280298|NCT05026177|582406840|FG002|Overall Study|Met stopping criteria|1|||
161280299|NCT05026177|582406838|FG000|Overall Study|Health issues preventing continuation|0|||
161280300|NCT05026177|582406839|FG001|Overall Study|Health issues preventing continuation|0|||
161280301|NCT05026177|582406840|FG002|Overall Study|Health issues preventing continuation|1|||
161280302|NCT05026177|582406838|FG000|Overall Study|Randomized in error, not treated|0|||
161280303|NCT05026177|582406839|FG001|Overall Study|Randomized in error, not treated|0|||
161280304|NCT05026177|582406840|FG002|Overall Study|Randomized in error, not treated|2|||
161038293|NCT05580003|581530694|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038294|NCT05580003|581530695|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038295|NCT05580003|581530696|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038296|NCT05580003|581530697|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038297|NCT05580003|581530698|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
161038298|NCT05580003|581530671|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038299|NCT05580003|581530672|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038300|NCT05580003|581530673|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038301|NCT05580003|581530674|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038302|NCT05580003|581530675|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038303|NCT05580003|581530676|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038304|NCT05580003|581530677|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161280305|NCT05109611|582406843|FG000|Overall Study|Adverse Event|13|||
161038305|NCT05580003|581530678|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161280306|NCT05109611|582406844|FG001|Overall Study|Adverse Event|10|||
161280307|NCT05109611|582406843|FG000|Overall Study|Withdrawal by Subject|1|||
161280308|NCT05109611|582406844|FG001|Overall Study|Withdrawal by Subject|0|||
161280309|NCT05109611|582406843|FG000|Overall Study|Lost to Follow-up|1|||
161280310|NCT05109611|582406844|FG001|Overall Study|Lost to Follow-up|2|||
161280311|NCT05109611|582406843|FG000|Overall Study|Protocol Violation|0|||
161280312|NCT05109611|582406844|FG001|Overall Study|Protocol Violation|4|||
161038306|NCT05580003|581530679|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038307|NCT05580003|581530680|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038308|NCT05580003|581530681|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038309|NCT05580003|581530682|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161280313|NCT05109611|582406843|FG000|Overall Study|Information unavailable|1|||
161280314|NCT05109611|582406844|FG001|Overall Study|Information unavailable|1|||
161280315|NCT03203850|582406848|FG000|Overall Study|Subject/guardian decision|4|||
161280316|NCT03203850|582406849|FG001|Overall Study|Subject/guardian decision|3|||
161280317|NCT03203850|582406848|FG000|Overall Study|Adverse Event|3|||
161280318|NCT03203850|582406849|FG001|Overall Study|Adverse Event|0|||
161280319|NCT03203850|582406848|FG000|Overall Study|Death|1|||
161280320|NCT03203850|582406849|FG001|Overall Study|Death|0|||
161280321|NCT02717455|582406850|FG000|Overall Study|Adverse Event|1|||
161280322|NCT02717455|582406851|FG001|Overall Study|Adverse Event|0|||
161280323|NCT02717455|582406852|FG002|Overall Study|Adverse Event|0|||
161280324|NCT02717455|582406853|FG003|Overall Study|Adverse Event|2|||
161280325|NCT02717455|582406854|FG004|Overall Study|Adverse Event|2|||
161280326|NCT02717455|582406855|FG005|Overall Study|Adverse Event|2|||
161280327|NCT02717455|582406850|FG000|Overall Study|Withdrawal by Subject|1|||
161280328|NCT02717455|582406851|FG001|Overall Study|Withdrawal by Subject|1|||
161280329|NCT02717455|582406852|FG002|Overall Study|Withdrawal by Subject|0|||
161038310|NCT05580003|581530683|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038311|NCT05580003|581530684|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038312|NCT05580003|581530685|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038313|NCT05580003|581530686|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038314|NCT05580003|581530687|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038315|NCT05580003|581530688|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038316|NCT05580003|581530689|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038317|NCT05580003|581530690|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038318|NCT05580003|581530691|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
161038319|NCT05580003|581530692|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038320|NCT05580003|581530693|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038321|NCT05580003|581530694|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038322|NCT05580003|581530695|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038323|NCT05580003|581530696|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038324|NCT05580003|581530697|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038325|NCT05580003|581530698|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
161038326|NCT05580003|581530671|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038327|NCT05580003|581530672|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038328|NCT05580003|581530673|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038329|NCT05580003|581530674|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038330|NCT05580003|581530675|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038331|NCT05580003|581530676|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038332|NCT05580003|581530677|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038333|NCT05580003|581530678|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038334|NCT05580003|581530679|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038335|NCT05580003|581530680|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038336|NCT05580003|581530681|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038337|NCT05580003|581530682|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038338|NCT05580003|581530683|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038339|NCT05580003|581530684|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038340|NCT05580003|581530685|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038341|NCT05580003|581530686|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161280330|NCT02717455|582406853|FG003|Overall Study|Withdrawal by Subject|2|||
161280331|NCT02717455|582406854|FG004|Overall Study|Withdrawal by Subject|2|||
161280332|NCT02717455|582406855|FG005|Overall Study|Withdrawal by Subject|1|||
161280333|NCT02717455|582406850|FG000|Overall Study|Death|1|||
161280334|NCT02717455|582406851|FG001|Overall Study|Death|0|||
161280335|NCT02717455|582406852|FG002|Overall Study|Death|0|||
161280336|NCT02717455|582406853|FG003|Overall Study|Death|0|||
161280337|NCT02717455|582406854|FG004|Overall Study|Death|1|||
161280338|NCT02717455|582406855|FG005|Overall Study|Death|0|||
161280339|NCT02717455|582406850|FG000|Overall Study|Did not receive study drug|0|||
161280340|NCT02717455|582406851|FG001|Overall Study|Did not receive study drug|0|||
161280341|NCT02717455|582406852|FG002|Overall Study|Did not receive study drug|0|||
161280342|NCT02717455|582406853|FG003|Overall Study|Did not receive study drug|1|||
161280343|NCT02717455|582406854|FG004|Overall Study|Did not receive study drug|0|||
161280344|NCT02717455|582406855|FG005|Overall Study|Did not receive study drug|1|||
161280345|NCT02717455|582406850|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161280346|NCT02717455|582406851|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161280347|NCT02717455|582406852|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161280348|NCT02717455|582406853|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161280349|NCT02717455|582406854|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
161280350|NCT02717455|582406855|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
161280351|NCT02717455|582406850|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
161280352|NCT02717455|582406851|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
161280353|NCT02717455|582406852|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
161280354|NCT02717455|582406853|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
161280355|NCT02717455|582406854|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
161280356|NCT02717455|582406855|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
161280357|NCT01433055|582406856|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
161280358|NCT01433055|582406857|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
161280359|NCT01433055|582406856|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
161280360|NCT01433055|582406857|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
161280361|NCT00733005|582406863|FG000|Overall Study|Adverse Event|0|||
161280362|NCT00733005|582406864|FG001|Overall Study|Adverse Event|1|||
161280363|NCT00733005|582406863|FG000|Overall Study|Treatment Failure|0|||
161280364|NCT00733005|582406864|FG001|Overall Study|Treatment Failure|1|||
161280365|NCT00733005|582406863|FG000|Overall Study|Withdrawal by Subject|0|||
161280366|NCT00733005|582406864|FG001|Overall Study|Withdrawal by Subject|1|||
161280367|NCT00733005|582406863|FG000|Overall Study|Protocol Violation|2|||
161280368|NCT00733005|582406864|FG001|Overall Study|Protocol Violation|0|||
161280369|NCT01769456|582406865|FG000|Overall Study|Lost to Follow-up|19|||
161280370|NCT01769456|582406865|FG000|Overall Study|Withdrawal by Subject|3|||
161280371|NCT01769456|582406865|FG000|Overall Study|Did not receive PCC intervention|6|||
161280372|NCT01769456|582406865|FG000|Overall Study|Moved out of the area|3|||
161280373|NCT01769456|582406865|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
161280374|NCT01769456|582406865|FG000|Overall Study|Parental request to youth to withdraw|1|||
161280375|NCT05244122|582406876|FG000|Overall Study|Withdrawal by Subject|318|||
161280376|NCT05377749|582406879|FG000|3 Weeks|Lost to Follow-up|2|||
161280377|NCT05377749|582406880|FG001|3 Weeks|Lost to Follow-up|4|||
161280378|NCT05377749|582406879|FG000|3 Weeks|Withdrawal by Subject|1|||
161280379|NCT05377749|582406880|FG001|3 Weeks|Withdrawal by Subject|1|||
161280380|NCT02969382|582406881|FG000|Overall Study|Adverse Event|8|||
161280381|NCT02969382|582406882|FG001|Overall Study|Adverse Event|10|||
161280382|NCT02969382|582406881|FG000|Overall Study|Lack of Efficacy|4|||
161280383|NCT02969382|582406882|FG001|Overall Study|Lack of Efficacy|5|||
161280384|NCT02969382|582406881|FG000|Overall Study|Death|0|||
161280385|NCT02969382|582406882|FG001|Overall Study|Death|1|||
161280386|NCT02969382|582406881|FG000|Overall Study|PROTOCOL DEVIATION|0|||
161038342|NCT05580003|581530687|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038343|NCT05580003|581530688|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038344|NCT05580003|581530689|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038345|NCT05580003|581530690|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038346|NCT05580003|581530691|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161280387|NCT02969382|582406882|FG001|Overall Study|PROTOCOL DEVIATION|1|||
161280388|NCT02969382|582406881|FG000|Overall Study|Withdrawal by Subject|14|||
161280389|NCT02969382|582406882|FG001|Overall Study|Withdrawal by Subject|9|||
161280390|NCT02090725|582406883|FG000|Overall Study|Withdrawal by Subject|1|||
161280391|NCT02090725|582406883|FG000|Overall Study|participants moved from area|3|||
161280392|NCT05256134|582406886|FG000|Overall Study|Study Terminated by Sponsor|11|||
161280393|NCT05256134|582406887|FG001|Overall Study|Study Terminated by Sponsor|10|||
161038347|NCT05580003|581530692|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
161038348|NCT05580003|581530693|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038349|NCT05580003|581530694|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161280394|NCT05256134|582406886|FG000|Overall Study|Withdrawal by Subject|1|||
161280395|NCT05256134|582406887|FG001|Overall Study|Withdrawal by Subject|3|||
161280396|NCT00886015|582406894|FG000|Overall Study|Death|0|||
161280397|NCT00886015|582406895|FG001|Overall Study|Death|2|||
161280398|NCT02013817|582406896|FG000|Overall Study|Adverse Event|12|||
161280399|NCT02013817|582406896|FG000|Overall Study|Withdrawal by Subject|4|||
161280400|NCT02013817|582406896|FG000|Overall Study|Death|2|||
161280401|NCT02013817|582406896|FG000|Overall Study|Other|9|||
161280402|NCT01692626|582406897|FG000|Overall Study|Death|0|||
161280403|NCT01692626|582406898|FG001|Overall Study|Death|1|||
161038350|NCT05580003|581530695|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038351|NCT05580003|581530696|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038352|NCT05580003|581530697|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038353|NCT05580003|581530698|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
161038354|NCT05580003|581530671|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038355|NCT05580003|581530672|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038356|NCT05580003|581530673|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038357|NCT05580003|581530674|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038358|NCT05580003|581530675|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038359|NCT05580003|581530676|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038360|NCT05580003|581530677|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038361|NCT05580003|581530678|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038362|NCT05580003|581530679|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038363|NCT05580003|581530680|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038364|NCT05580003|581530681|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038365|NCT05580003|581530682|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038366|NCT05580003|581530683|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038367|NCT05580003|581530684|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038368|NCT05580003|581530685|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038369|NCT05580003|581530686|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038370|NCT05580003|581530687|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038371|NCT05580003|581530688|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038372|NCT05580003|581530689|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038373|NCT05580003|581530690|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038374|NCT05580003|581530691|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038375|NCT05580003|581530692|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038376|NCT05580003|581530693|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038377|NCT05580003|581530694|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038378|NCT05580003|581530695|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038379|NCT05580003|581530696|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038380|NCT05580003|581530697|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
161038381|NCT05580003|581530698|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
161038382|NCT05580003|581530671|FG000|Part 6 Period 2 (Day 1)|Other|0|||
161038383|NCT05580003|581530672|FG001|Part 6 Period 2 (Day 1)|Other|0|||
161038384|NCT05580003|581530673|FG002|Part 6 Period 2 (Day 1)|Other|0|||
161038385|NCT05580003|581530674|FG003|Part 6 Period 2 (Day 1)|Other|0|||
161038386|NCT05580003|581530675|FG004|Part 6 Period 2 (Day 1)|Other|0|||
161038387|NCT05580003|581530676|FG005|Part 6 Period 2 (Day 1)|Other|0|||
161038388|NCT05580003|581530677|FG006|Part 6 Period 2 (Day 1)|Other|0|||
161038389|NCT05580003|581530678|FG007|Part 6 Period 2 (Day 1)|Other|0|||
161038390|NCT05580003|581530679|FG008|Part 6 Period 2 (Day 1)|Other|0|||
161038391|NCT05580003|581530680|FG009|Part 6 Period 2 (Day 1)|Other|0|||
161038392|NCT05580003|581530681|FG010|Part 6 Period 2 (Day 1)|Other|0|||
161038393|NCT05580003|581530682|FG011|Part 6 Period 2 (Day 1)|Other|0|||
161038394|NCT05580003|581530683|FG012|Part 6 Period 2 (Day 1)|Other|0|||
161038395|NCT05580003|581530684|FG013|Part 6 Period 2 (Day 1)|Other|0|||
161038396|NCT05580003|581530685|FG014|Part 6 Period 2 (Day 1)|Other|0|||
161038397|NCT05580003|581530686|FG015|Part 6 Period 2 (Day 1)|Other|0|||
161038398|NCT05580003|581530687|FG016|Part 6 Period 2 (Day 1)|Other|0|||
161038399|NCT05580003|581530688|FG017|Part 6 Period 2 (Day 1)|Other|0|||
161038400|NCT05580003|581530689|FG018|Part 6 Period 2 (Day 1)|Other|0|||
161038401|NCT05580003|581530690|FG019|Part 6 Period 2 (Day 1)|Other|0|||
161038402|NCT05580003|581530691|FG020|Part 6 Period 2 (Day 1)|Other|0|||
161038403|NCT05580003|581530692|FG021|Part 6 Period 2 (Day 1)|Other|0|||
161038404|NCT05580003|581530693|FG022|Part 6 Period 2 (Day 1)|Other|0|||
161038405|NCT05580003|581530694|FG023|Part 6 Period 2 (Day 1)|Other|0|||
161038406|NCT05580003|581530695|FG024|Part 6 Period 2 (Day 1)|Other|1|||
161038407|NCT05580003|581530696|FG025|Part 6 Period 2 (Day 1)|Other|0|||
161038408|NCT05580003|581530697|FG026|Part 6 Period 2 (Day 1)|Other|0|||
161038409|NCT05580003|581530698|FG027|Part 6 Period 2 (Day 1)|Other|0|||
161038410|NCT03516812|581530699|FG000|Overall Study|Adverse Event|4|||
161038411|NCT03516812|581530699|FG000|Overall Study|Lack of Efficacy|2|||
161038412|NCT04795167|581530700|FG000|Overall Study|Death|1|||
161038413|NCT04795167|581530701|FG001|Overall Study|Death|18|||
161038414|NCT04795167|581530702|FG002|Overall Study|Death|1|||
161038415|NCT04795167|581530700|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
161038416|NCT04795167|581530701|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
161038417|NCT04795167|581530702|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
161038418|NCT01753999|581530703|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
161038419|NCT01753999|581530704|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
161038420|NCT01753999|581530703|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
161038421|NCT01753999|581530704|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
161038422|NCT01753999|581530703|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
161038423|NCT01753999|581530704|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
161038424|NCT01753999|581530703|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
161038425|NCT01753999|581530704|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
161038426|NCT01753999|581530703|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
161038427|NCT01753999|581530704|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
161038428|NCT01753999|581530703|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
161038429|NCT01753999|581530704|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
161038430|NCT03840902|581530705|FG000|Overall Study|Randomized but not treated|1|||
161038431|NCT03840902|581530706|FG001|Overall Study|Randomized but not treated|1|||
161038432|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161038433|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
161038434|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161038435|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
161038436|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161038437|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
161038438|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161038439|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161038440|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161038441|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161038442|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
161038443|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
161038444|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161038445|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161038446|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161038447|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161038448|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
161038449|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
161038450|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
161038451|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161038452|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161038453|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
161038454|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161038455|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
161038456|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161038457|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161038458|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161038459|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161038460|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
161038461|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
161038462|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
161038463|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
161038464|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
161038465|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
161038466|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
161038467|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
161038468|NCT02392234|581530707|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161038469|NCT02392234|581530708|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161038470|NCT02392234|581530709|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
161038471|NCT02392234|581530710|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161038472|NCT02392234|581530711|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
161038473|NCT02392234|581530712|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
161038474|NCT02392234|581530707|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
161038475|NCT02392234|581530708|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161038476|NCT02392234|581530709|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161038477|NCT02392234|581530710|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161038478|NCT02392234|581530711|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161038479|NCT02392234|581530712|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
161038480|NCT04436289|581530713|FG000|Overall Study|Death prior to hospital discharge|8|||
161038481|NCT04436289|581530714|FG001|Overall Study|Death prior to hospital discharge|5|||
161038482|NCT04436289|581530715|FG002|Overall Study|Death prior to hospital discharge|0|||
161038483|NCT04436289|581530716|FG003|Overall Study|Death prior to hospital discharge|1|||
161038484|NCT04436289|581530713|FG000|Overall Study|Withdrawal by Subject|0|||
161038485|NCT04436289|581530714|FG001|Overall Study|Withdrawal by Subject|1|||
161038486|NCT04436289|581530715|FG002|Overall Study|Withdrawal by Subject|4|||
161038487|NCT04436289|581530716|FG003|Overall Study|Withdrawal by Subject|0|||
161038488|NCT04436289|581530713|FG000|Overall Study|Extended hospital stay|0|||
161038489|NCT04436289|581530714|FG001|Overall Study|Extended hospital stay|1|||
161038490|NCT04436289|581530715|FG002|Overall Study|Extended hospital stay|0|||
161038491|NCT04436289|581530716|FG003|Overall Study|Extended hospital stay|0|||
161038492|NCT04436289|581530713|FG000|Overall Study|Lost to Follow-up|0|||
161038493|NCT04436289|581530714|FG001|Overall Study|Lost to Follow-up|4|||
161038494|NCT04436289|581530715|FG002|Overall Study|Lost to Follow-up|1|||
161038495|NCT04436289|581530716|FG003|Overall Study|Lost to Follow-up|3|||
161038496|NCT03598907|581530717|FG000|Overall Study|Physician Decision|14|||
161280404|NCT01692626|582406897|FG000|Overall Study|Adverse Event|2|||
161280405|NCT01692626|582406898|FG001|Overall Study|Adverse Event|3|||
161280406|NCT01692626|582406897|FG000|Overall Study|Protocol Violation|1|||
161280407|NCT01692626|582406898|FG001|Overall Study|Protocol Violation|2|||
161280408|NCT01692626|582406897|FG000|Overall Study|Withdrawal by Subject|1|||
161280409|NCT01692626|582406898|FG001|Overall Study|Withdrawal by Subject|0|||
161280410|NCT00855894|582406899|FG000|Overall Study|Death|31|||
161280411|NCT00855894|582406899|FG000|Overall Study|Patient's decision|1|||
161280412|NCT00855894|582406899|FG000|Overall Study|Disease progression|1|||
161280413|NCT01145508|582406900|FG000|Overall Study|Adverse Event|1|||
161280414|NCT01145508|582406901|FG001|Overall Study|Adverse Event|0|||
161280415|NCT01145508|582406900|FG000|Overall Study|Death|1|||
161280416|NCT01145508|582406901|FG001|Overall Study|Death|0|||
161280417|NCT01145508|582406900|FG000|Overall Study|Physician Decision|2|||
161280418|NCT01145508|582406901|FG001|Overall Study|Physician Decision|1|||
161280419|NCT01145508|582406900|FG000|Overall Study|Never started treatment|1|||
161280420|NCT01145508|582406901|FG001|Overall Study|Never started treatment|1|||
161280421|NCT03668808|582406912|FG000|First Intervention|Withdrawal by Subject|2|||
161280422|NCT03668808|582406913|FG001|First Intervention|Withdrawal by Subject|2|||
161280423|NCT01569295|582406916|FG000|Overall Study|Progressive Disease|75|||
161038497|NCT03598907|581530718|FG001|Overall Study|Physician Decision|19|||
161038498|NCT03211247|581530721|FG000|Overall Study|Adverse Event|8|||
161038499|NCT03211247|581530722|FG001|Overall Study|Adverse Event|0|||
161038500|NCT03211247|581530723|FG002|Overall Study|Adverse Event|1|||
161038501|NCT03211247|581530724|FG003|Overall Study|Adverse Event|0|||
161038502|NCT03211247|581530725|FG004|Overall Study|Adverse Event|0|||
161038503|NCT03211247|581530721|FG000|Overall Study|Lost to Follow-up|2|||
161038504|NCT03211247|581530722|FG001|Overall Study|Lost to Follow-up|1|||
161038505|NCT03211247|581530723|FG002|Overall Study|Lost to Follow-up|0|||
161038506|NCT03211247|581530724|FG003|Overall Study|Lost to Follow-up|0|||
161038507|NCT03211247|581530725|FG004|Overall Study|Lost to Follow-up|0|||
161038508|NCT03211247|581530721|FG000|Overall Study|Physician Decision|1|||
161038509|NCT03211247|581530722|FG001|Overall Study|Physician Decision|2|||
161038510|NCT03211247|581530723|FG002|Overall Study|Physician Decision|0|||
161038511|NCT03211247|581530724|FG003|Overall Study|Physician Decision|0|||
161038512|NCT03211247|581530725|FG004|Overall Study|Physician Decision|0|||
161038513|NCT03211247|581530721|FG000|Overall Study|Non-compliance with study drug|2|||
161038514|NCT03211247|581530722|FG001|Overall Study|Non-compliance with study drug|0|||
161038515|NCT03211247|581530723|FG002|Overall Study|Non-compliance with study drug|0|||
161038516|NCT03211247|581530724|FG003|Overall Study|Non-compliance with study drug|0|||
161038517|NCT03211247|581530725|FG004|Overall Study|Non-compliance with study drug|0|||
161038518|NCT03211247|581530721|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
161038519|NCT03211247|581530722|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
161038520|NCT03211247|581530723|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
161038521|NCT03211247|581530724|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
161038522|NCT03211247|581530725|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
161038523|NCT03211247|581530721|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
161038524|NCT03211247|581530722|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
161038525|NCT03211247|581530723|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
161280424|NCT01569295|582406917|FG001|Overall Study|Progressive Disease|139|||
161038526|NCT03211247|581530724|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
161038527|NCT03211247|581530725|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
161038528|NCT03211247|581530721|FG000|Overall Study|Protocol Violation|0|||
161038529|NCT03211247|581530722|FG001|Overall Study|Protocol Violation|1|||
161038530|NCT03211247|581530723|FG002|Overall Study|Protocol Violation|0|||
161038531|NCT03211247|581530724|FG003|Overall Study|Protocol Violation|0|||
161038532|NCT03211247|581530725|FG004|Overall Study|Protocol Violation|0|||
161038533|NCT02415127|581530726|FG000|Overall Study|Adverse Event|1|||
161038534|NCT02415127|581530727|FG001|Overall Study|Adverse Event|0|||
161038535|NCT05464732|581530730|FG000|Overall Study|Lost to Follow-up|0|||
161038536|NCT05464732|581530731|FG001|Overall Study|Lost to Follow-up|1|||
161038537|NCT05464732|581530730|FG000|Overall Study|Adverse Event|1|||
161038538|NCT05464732|581530731|FG001|Overall Study|Adverse Event|0|||
161038539|NCT03997474|581530732|FG000|Overall Study|Death|6|||
161038540|NCT03997474|581530733|FG001|Overall Study|Death|2|||
161038541|NCT03997474|581530734|FG002|Overall Study|Death|1|||
161038542|NCT03997474|581530732|FG000|Overall Study|Physician Decision|2|||
161038543|NCT03997474|581530733|FG001|Overall Study|Physician Decision|0|||
161038544|NCT03997474|581530734|FG002|Overall Study|Physician Decision|0|||
161038545|NCT03997474|581530732|FG000|Overall Study|study terminated by sponsor|1|||
161038546|NCT03997474|581530733|FG001|Overall Study|study terminated by sponsor|0|||
161038547|NCT03997474|581530734|FG002|Overall Study|study terminated by sponsor|1|||
161038548|NCT03277989|581530735|FG000|Overall Study|Lost to Follow-up|6|||
161280425|NCT01569295|582406916|FG000|Overall Study|Adverse Event|39|||
161280426|NCT01569295|582406917|FG001|Overall Study|Adverse Event|14|||
161280427|NCT01569295|582406916|FG000|Overall Study|Withdrawal by Subject|25|||
161038549|NCT03277989|581530735|FG000|Overall Study|Adverse Event|6|||
161038550|NCT03277989|581530735|FG000|Overall Study|Withdrawal by Subject|3|||
161038551|NCT03277989|581530735|FG000|Overall Study|Didn't Receive Study Device|7|||
161038552|NCT03277989|581530735|FG000|Overall Study|Site Closure|26|||
161038553|NCT03277989|581530735|FG000|Overall Study|Sponsor Closure|107|||
161038554|NCT05349838|581530736|FG000|Overall Study|Virological Failure|1|||
161038555|NCT05349838|581530737|FG001|Overall Study|Virological Failure|2|||
161038556|NCT05349838|581530736|FG000|Overall Study|Withdrawal by Subject|2|||
161038557|NCT05349838|581530737|FG001|Overall Study|Withdrawal by Subject|3|||
161038558|NCT05349838|581530736|FG000|Overall Study|Adverse Event|3|||
161038559|NCT05349838|581530737|FG001|Overall Study|Adverse Event|1|||
161038560|NCT05349838|581530736|FG000|Overall Study|Lost to Follow-up|1|||
161038561|NCT05349838|581530737|FG001|Overall Study|Lost to Follow-up|2|||
161038562|NCT05349838|581530736|FG000|Overall Study|Other reasons|5|||
161038563|NCT05349838|581530737|FG001|Overall Study|Other reasons|1|||
161038564|NCT05071430|581530739|FG000|Overall Study|Adverse Event|1|||
161038565|NCT05071430|581530740|FG001|Overall Study|Adverse Event|2|||
161038566|NCT05071430|581530739|FG000|Overall Study|Lost to Follow-up|4|||
161038567|NCT05071430|581530740|FG001|Overall Study|Lost to Follow-up|4|||
161038568|NCT05071430|581530739|FG000|Overall Study|Protocol Violation|1|||
161038569|NCT05071430|581530740|FG001|Overall Study|Protocol Violation|0|||
161038570|NCT05071430|581530739|FG000|Overall Study|Withdrawal by Subject|3|||
161038571|NCT05071430|581530740|FG001|Overall Study|Withdrawal by Subject|2|||
161038572|NCT05071430|581530739|FG000|Overall Study|Other|1|||
161038573|NCT05071430|581530740|FG001|Overall Study|Other|1|||
161038574|NCT01958021|581530743|FG000|Treatment|Progressive disease|206|||
161038575|NCT01958021|581530744|FG001|Treatment|Progressive disease|265|||
161038576|NCT01958021|581530743|FG000|Treatment|Adverse Event|38|||
161038577|NCT01958021|581530744|FG001|Treatment|Adverse Event|10|||
161038578|NCT01958021|581530743|FG000|Treatment|Subject/guardian decision|29|||
161038579|NCT01958021|581530744|FG001|Treatment|Subject/guardian decision|25|||
161038580|NCT01958021|581530743|FG000|Treatment|Physician Decision|28|||
161038581|NCT01958021|581530744|FG001|Treatment|Physician Decision|21|||
161038582|NCT01958021|581530743|FG000|Treatment|Death|6|||
161038583|NCT01958021|581530744|FG001|Treatment|Death|1|||
161038584|NCT01958021|581530743|FG000|Treatment|Protocol deviation|3|||
161038585|NCT01958021|581530744|FG001|Treatment|Protocol deviation|1|||
161038586|NCT01958021|581530743|FG000|Treatment|Sponsor decision|24|||
161038587|NCT01958021|581530744|FG001|Treatment|Sponsor decision|11|||
161038588|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161038589|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161038590|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Death|1|||
161038591|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161038592|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
161038593|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161038594|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161038595|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161038596|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
161038597|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
161038598|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
161038599|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
161038600|NCT01958021|581530743|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
161038601|NCT01958021|581530744|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
161038602|NCT05037513|581530746|FG000|Intervention Period|Lost to Follow-up|1|||
161038603|NCT05037513|581530747|FG001|Intervention Period|Lost to Follow-up|2|||
161038604|NCT05037513|581530746|FG000|Follow Up Period|Lost to Follow-up|16|||
161038605|NCT05037513|581530747|FG001|Follow Up Period|Lost to Follow-up|21|||
161038606|NCT05037513|581530746|FG000|Follow Up Period|Death|0|||
161038607|NCT05037513|581530747|FG001|Follow Up Period|Death|1|||
161038608|NCT05037513|581530746|FG000|Follow Up Period|Incarcerated|4|||
161038609|NCT05037513|581530747|FG001|Follow Up Period|Incarcerated|2|||
161038610|NCT03664804|581530749|FG000|Overall Study|Withdrawal by Subject|7|||
161038611|NCT05529992|581530750|FG000|Overall Study|Withdrawal by Subject|1|||
161038612|NCT06140290|581530751|FG000|Period 1|Adverse Event|1|||
161038613|NCT06140290|581530752|FG001|Period 1|Adverse Event|0|||
161038614|NCT06140290|581530751|FG000|Period 2|Assigned but not treated|0|||
161038615|NCT06140290|581530752|FG001|Period 2|Assigned but not treated|1|||
161038616|NCT06140290|581530751|FG000|Period 2|Withdrawal by Subject|0|||
161038617|NCT06140290|581530752|FG001|Period 2|Withdrawal by Subject|1|||
161038618|NCT02036970|581532090|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161038619|NCT02036970|581532091|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161038620|NCT02036970|581532092|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
161038621|NCT02036970|581532093|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
161038622|NCT02036970|581532094|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161038623|NCT02036970|581532095|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161038624|NCT02036970|581532096|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
161038625|NCT02036970|581532097|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161038626|NCT02036970|581532098|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
161038627|NCT02036970|581532099|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
161038628|NCT02036970|581532090|FG000|Part 1: Day 1 Through Week 16|Death|0|||
161038629|NCT02036970|581532091|FG001|Part 1: Day 1 Through Week 16|Death|0|||
161038630|NCT02036970|581532092|FG002|Part 1: Day 1 Through Week 16|Death|0|||
161038631|NCT02036970|581532093|FG003|Part 1: Day 1 Through Week 16|Death|0|||
161038632|NCT02036970|581532094|FG004|Part 1: Day 1 Through Week 16|Death|0|||
161038633|NCT02036970|581532095|FG005|Part 1: Day 1 Through Week 16|Death|0|||
161038634|NCT02036970|581532096|FG006|Part 1: Day 1 Through Week 16|Death|0|||
161038635|NCT02036970|581532097|FG007|Part 1: Day 1 Through Week 16|Death|0|||
161038636|NCT02036970|581532098|FG008|Part 1: Day 1 Through Week 16|Death|1|||
161038637|NCT02036970|581532099|FG009|Part 1: Day 1 Through Week 16|Death|0|||
161038638|NCT02036970|581532090|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
161038639|NCT02036970|581532091|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038640|NCT02036970|581532092|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
161038641|NCT02036970|581532093|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038642|NCT02036970|581532094|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038643|NCT02036970|581532095|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038644|NCT02036970|581532096|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038645|NCT02036970|581532097|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038646|NCT02036970|581532098|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
161038647|NCT02036970|581532099|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
161038648|NCT02036970|581532090|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038649|NCT02036970|581532091|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038650|NCT02036970|581532092|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038651|NCT02036970|581532093|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038652|NCT02036970|581532094|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
161038653|NCT02036970|581532095|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038654|NCT02036970|581532096|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038655|NCT02036970|581532097|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
161038656|NCT02036970|581532098|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
161038657|NCT02036970|581532099|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
161038658|NCT02036970|581532090|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038659|NCT02036970|581532091|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038660|NCT02036970|581532092|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038661|NCT02036970|581532093|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
161038662|NCT02036970|581532094|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038663|NCT02036970|581532095|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038664|NCT02036970|581532096|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038665|NCT02036970|581532097|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038666|NCT02036970|581532098|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038667|NCT02036970|581532099|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
161038668|NCT02036970|581532090|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
161038669|NCT02036970|581532091|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
161038670|NCT02036970|581532092|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
161038671|NCT02036970|581532093|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
161038672|NCT02036970|581532094|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
161038673|NCT02036970|581532095|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
161038674|NCT02036970|581532096|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
161038675|NCT02036970|581532097|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
161038676|NCT02036970|581532098|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
161038677|NCT02036970|581532099|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
161038678|NCT02036970|581532090|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038679|NCT02036970|581532091|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038680|NCT02036970|581532092|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038681|NCT02036970|581532093|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038682|NCT02036970|581532094|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038683|NCT02036970|581532095|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038684|NCT02036970|581532096|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038685|NCT02036970|581532097|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
161038686|NCT02036970|581532098|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038687|NCT02036970|581532099|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
161038688|NCT02036970|581532090|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038689|NCT02036970|581532091|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
161038690|NCT02036970|581532092|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
161038691|NCT02036970|581532093|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038692|NCT02036970|581532094|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038693|NCT02036970|581532095|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038694|NCT02036970|581532096|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038695|NCT02036970|581532097|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038696|NCT02036970|581532098|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
161038697|NCT02036970|581532099|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
161038698|NCT02036970|581532090|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
161038699|NCT02036970|581532091|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
161038700|NCT02036970|581532092|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
161038701|NCT02036970|581532093|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
161038702|NCT02036970|581532094|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
161038703|NCT02036970|581532095|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
161038704|NCT02036970|581532096|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
161038705|NCT02036970|581532097|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
161038706|NCT02036970|581532098|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
161038707|NCT02036970|581532099|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
161038708|NCT02702843|581532100|FG000|Overall Study|Insufficient data to analyze|15|||
161038709|NCT02702843|581532101|FG001|Overall Study|Insufficient data to analyze|23|||
161038710|NCT02232737|581532105|FG000|Overall Study|Lost to Follow-up|18|||
161038711|NCT02232737|581532106|FG001|Overall Study|Lost to Follow-up|28|||
161038712|NCT02232737|581532107|FG002|Overall Study|Lost to Follow-up|33|||
161038713|NCT02232737|581532105|FG000|Overall Study|Personal reasons|7|||
161038714|NCT02232737|581532106|FG001|Overall Study|Personal reasons|8|||
161038715|NCT02232737|581532107|FG002|Overall Study|Personal reasons|14|||
161038716|NCT02232737|581532105|FG000|Overall Study|Adverse Event|6|||
161038717|NCT02232737|581532106|FG001|Overall Study|Adverse Event|3|||
161038718|NCT02232737|581532107|FG002|Overall Study|Adverse Event|8|||
161038719|NCT02232737|581532105|FG000|Overall Study|Incarcerated|2|||
161038720|NCT02232737|581532106|FG001|Overall Study|Incarcerated|1|||
161038721|NCT02232737|581532107|FG002|Overall Study|Incarcerated|2|||
161038722|NCT02232737|581532105|FG000|Overall Study|Withdrawal by Subject|0|||
161038723|NCT02232737|581532106|FG001|Overall Study|Withdrawal by Subject|1|||
161038724|NCT02232737|581532107|FG002|Overall Study|Withdrawal by Subject|2|||
161038725|NCT02232737|581532105|FG000|Overall Study|Death|0|||
161038726|NCT02232737|581532106|FG001|Overall Study|Death|1|||
161038727|NCT02232737|581532107|FG002|Overall Study|Death|1|||
161038728|NCT02232737|581532105|FG000|Overall Study|Physician Decision|1|||
161038729|NCT02232737|581532106|FG001|Overall Study|Physician Decision|3|||
161038730|NCT02232737|581532107|FG002|Overall Study|Physician Decision|1|||
161038731|NCT02232737|581532105|FG000|Overall Study|Protocol Violation|1|||
161038732|NCT02232737|581532106|FG001|Overall Study|Protocol Violation|0|||
161038733|NCT02232737|581532107|FG002|Overall Study|Protocol Violation|1|||
161038734|NCT02232737|581532105|FG000|Overall Study|Reason unknown|1|||
161038735|NCT02232737|581532106|FG001|Overall Study|Reason unknown|0|||
161038736|NCT02232737|581532107|FG002|Overall Study|Reason unknown|0|||
161038737|NCT00065182|581532117|FG000|Overall Study|Adverse Event|24|||
161038738|NCT00065182|581532118|FG001|Overall Study|Adverse Event|17|||
161038739|NCT00065182|581532117|FG000|Overall Study|Lost to Follow-up|0|||
161038740|NCT00065182|581532118|FG001|Overall Study|Lost to Follow-up|4|||
161038741|NCT00065182|581532117|FG000|Overall Study|Protocol Violation|3|||
161038742|NCT00065182|581532118|FG001|Overall Study|Protocol Violation|4|||
161038743|NCT00065182|581532117|FG000|Overall Study|Serious adverse events (SAE)|1|||
161038744|NCT00065182|581532118|FG001|Overall Study|Serious adverse events (SAE)|0|||
161038745|NCT00065182|581532117|FG000|Overall Study|Sponsor Decision|11|||
161038746|NCT00065182|581532118|FG001|Overall Study|Sponsor Decision|7|||
161038747|NCT00065182|581532117|FG000|Overall Study|Withdrawal by Subject|8|||
161280428|NCT01569295|582406917|FG001|Overall Study|Withdrawal by Subject|12|||
161280429|NCT01569295|582406916|FG000|Overall Study|Death|19|||
161280430|NCT01569295|582406917|FG001|Overall Study|Death|15|||
161280431|NCT01569295|582406916|FG000|Overall Study|Physician Decision|13|||
161280432|NCT01569295|582406917|FG001|Overall Study|Physician Decision|18|||
161280433|NCT01569295|582406916|FG000|Overall Study|Study Terminated by Sponsor|24|||
161280434|NCT01569295|582406917|FG001|Overall Study|Study Terminated by Sponsor|2|||
161280435|NCT01569295|582406916|FG000|Overall Study|Other Reason not Specified|3|||
161280436|NCT01569295|582406917|FG001|Overall Study|Other Reason not Specified|5|||
161280437|NCT01569295|582406916|FG000|Overall Study|Non-Compliance with Study Drug|6|||
161280438|NCT01569295|582406917|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161280439|NCT01569295|582406916|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
161280440|NCT01569295|582406917|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
161280441|NCT01569295|582406916|FG000|Overall Study|Lost to Follow-up|1|||
161280442|NCT01569295|582406917|FG001|Overall Study|Lost to Follow-up|1|||
161280443|NCT00280735|582406918|FG000|Overall Study|Adverse Event|5|||
161038748|NCT00065182|581532118|FG001|Overall Study|Withdrawal by Subject|3|||
161038749|NCT00065182|581532117|FG000|Overall Study|No clinical benefit|1|||
161038750|NCT00065182|581532118|FG001|Overall Study|No clinical benefit|0|||
161038751|NCT00065182|581532117|FG000|Overall Study|Death|0|||
161038752|NCT00065182|581532118|FG001|Overall Study|Death|1|||
161038753|NCT00065182|581532117|FG000|Overall Study|Decline in Status|0|||
161038754|NCT00065182|581532118|FG001|Overall Study|Decline in Status|1|||
161038755|NCT02568215|581532119|FG000|Overall Study|Death|1|||
161038756|NCT02568215|581532120|FG001|Overall Study|Death|2|||
161038757|NCT02568215|581532121|FG002|Overall Study|Death|0|||
161280444|NCT00280735|582406918|FG000|Overall Study|Lack of Efficacy|3|||
161280445|NCT00280735|582406918|FG000|Overall Study|Withdrawal by Subject|8|||
161280446|NCT00280735|582406918|FG000|Overall Study|Intercurrent Illness|2|||
161280447|NCT02064296|582406922|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
161280448|NCT02064296|582406923|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
161280449|NCT02064296|582406924|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
161280450|NCT02064296|582406922|FG000|Intervention|Withdrawal by Subject|0|||
160977619|NCT02836613|581307965|FG001|Overall Study|Lost to Follow-up|1|||
160977620|NCT02836613|581307964|FG000|Overall Study|Withdrawal by Subject|0|||
160977621|NCT02836613|581307965|FG001|Overall Study|Withdrawal by Subject|2|||
160977622|NCT01464255|581307966|FG000|Overall Study|unresolve corneal staining|0|||
160977623|NCT01464255|581307967|FG001|Overall Study|unresolve corneal staining|1|||
160977624|NCT01799720|581307968|FG000|Overall Study|Withdrawal by Subject|3|||
160977625|NCT01799720|581307969|FG001|Overall Study|Withdrawal by Subject|0|||
160977626|NCT01799720|581307970|FG002|Overall Study|Withdrawal by Subject|0|||
160977627|NCT01799720|581307968|FG000|Overall Study|Protocol Violation|0|||
160977628|NCT01799720|581307969|FG001|Overall Study|Protocol Violation|1|||
160977629|NCT01799720|581307970|FG002|Overall Study|Protocol Violation|0|||
160977630|NCT01799720|581307968|FG000|Overall Study|Pregnancy|0|||
160977631|NCT01799720|581307969|FG001|Overall Study|Pregnancy|0|||
160977632|NCT01799720|581307970|FG002|Overall Study|Pregnancy|1|||
160977633|NCT03169881|581307979|FG000|Overall Study|Incomplete Follow-up|10|||
160977634|NCT03169881|581307980|FG001|Overall Study|Incomplete Follow-up|15|||
160977635|NCT03169881|581307979|FG000|Overall Study|Lost to Follow-up|18|||
160977636|NCT03169881|581307980|FG001|Overall Study|Lost to Follow-up|20|||
160977637|NCT03169881|581307979|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
160977638|NCT03169881|581307980|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
160977639|NCT04908449|581307981|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
160977640|NCT04908449|581307982|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
160977641|NCT04908449|581307981|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
160977642|NCT04908449|581307982|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
160977643|NCT02401308|581307987|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
160977644|NCT02401308|581307988|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
160977645|NCT02736968|581307992|FG000|Overall Study|Lost to Follow-up|0|||
160977646|NCT02736968|581307993|FG001|Overall Study|Lost to Follow-up|0|||
160977647|NCT02736968|581307994|FG002|Overall Study|Lost to Follow-up|0|||
160977648|NCT02736968|581307995|FG003|Overall Study|Lost to Follow-up|0|||
160977649|NCT02736968|581307996|FG004|Overall Study|Lost to Follow-up|0|||
160977650|NCT02736968|581307997|FG005|Overall Study|Lost to Follow-up|0|||
160977651|NCT02736968|581307998|FG006|Overall Study|Lost to Follow-up|5|||
160977652|NCT02736968|581307999|FG007|Overall Study|Lost to Follow-up|2|||
160977653|NCT02736968|581307992|FG000|Overall Study|COVID-19 Pandemic|0|||
160977654|NCT02736968|581307993|FG001|Overall Study|COVID-19 Pandemic|0|||
160977655|NCT02736968|581307994|FG002|Overall Study|COVID-19 Pandemic|0|||
160977656|NCT02736968|581307995|FG003|Overall Study|COVID-19 Pandemic|0|||
160977657|NCT02736968|581307996|FG004|Overall Study|COVID-19 Pandemic|0|||
160977658|NCT02736968|581307997|FG005|Overall Study|COVID-19 Pandemic|0|||
160977659|NCT02736968|581307998|FG006|Overall Study|COVID-19 Pandemic|2|||
160977660|NCT02736968|581307999|FG007|Overall Study|COVID-19 Pandemic|0|||
160977661|NCT02736968|581307992|FG000|Overall Study|Withdrawal by Subject|0|||
160977662|NCT02736968|581307993|FG001|Overall Study|Withdrawal by Subject|0|||
160977663|NCT02736968|581307994|FG002|Overall Study|Withdrawal by Subject|0|||
160977664|NCT02736968|581307995|FG003|Overall Study|Withdrawal by Subject|0|||
160977665|NCT02736968|581307996|FG004|Overall Study|Withdrawal by Subject|0|||
160977666|NCT02736968|581307997|FG005|Overall Study|Withdrawal by Subject|0|||
160977667|NCT02736968|581307998|FG006|Overall Study|Withdrawal by Subject|1|||
160977668|NCT02736968|581307999|FG007|Overall Study|Withdrawal by Subject|0|||
160977669|NCT00147225|581308002|FG000|Overall Study|Withdrawal by Subject|1|||
160977670|NCT00147225|581308003|FG001|Overall Study|Withdrawal by Subject|0|||
160977671|NCT00147225|581308004|FG002|Overall Study|Withdrawal by Subject|1|||
160977672|NCT00147225|581308005|FG003|Overall Study|Withdrawal by Subject|0|||
160977673|NCT00147225|581308006|FG004|Overall Study|Withdrawal by Subject|0|||
160977674|NCT00147225|581308007|FG005|Overall Study|Withdrawal by Subject|1|||
160977675|NCT00147225|581308002|FG000|Overall Study|Adverse Event|0|||
160977676|NCT00147225|581308003|FG001|Overall Study|Adverse Event|0|||
160977677|NCT00147225|581308004|FG002|Overall Study|Adverse Event|1|||
160977678|NCT00147225|581308005|FG003|Overall Study|Adverse Event|1|||
160977679|NCT00147225|581308006|FG004|Overall Study|Adverse Event|0|||
160977680|NCT00147225|581308007|FG005|Overall Study|Adverse Event|0|||
160977681|NCT00147225|581308002|FG000|Overall Study|Screen Failure|0|||
160977682|NCT00147225|581308003|FG001|Overall Study|Screen Failure|0|||
160977683|NCT00147225|581308004|FG002|Overall Study|Screen Failure|0|||
160977684|NCT00147225|581308005|FG003|Overall Study|Screen Failure|0|||
160977685|NCT00147225|581308006|FG004|Overall Study|Screen Failure|1|||
160977686|NCT00147225|581308007|FG005|Overall Study|Screen Failure|0|||
160977687|NCT00147225|581308002|FG000|Overall Study|Chemotherapy Changed|0|||
161038758|NCT02568215|581532119|FG000|Overall Study|Physician Decision|2|||
161038759|NCT02568215|581532120|FG001|Overall Study|Physician Decision|2|||
161038760|NCT02568215|581532121|FG002|Overall Study|Physician Decision|2|||
161038761|NCT02568215|581532119|FG000|Overall Study|Lost to Follow-up|29|||
161280451|NCT02064296|582406923|FG001|Intervention|Withdrawal by Subject|1|||
161280452|NCT02064296|582406924|FG002|Intervention|Withdrawal by Subject|2|||
161280453|NCT05061420|582406936|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
161038762|NCT02568215|581532120|FG001|Overall Study|Lost to Follow-up|32|||
161038763|NCT02568215|581532121|FG002|Overall Study|Lost to Follow-up|41|||
161038764|NCT02568215|581532119|FG000|Overall Study|Withdrawal by Subject|21|||
161038765|NCT02568215|581532120|FG001|Overall Study|Withdrawal by Subject|19|||
161038766|NCT02568215|581532121|FG002|Overall Study|Withdrawal by Subject|22|||
161038767|NCT02568215|581532119|FG000|Overall Study|Protocol Violation|1|||
161038768|NCT02568215|581532120|FG001|Overall Study|Protocol Violation|1|||
161038769|NCT02568215|581532121|FG002|Overall Study|Protocol Violation|0|||
161038770|NCT02568215|581532119|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
161038771|NCT02568215|581532120|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
161038772|NCT02568215|581532121|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
161038773|NCT02568215|581532119|FG000|Overall Study|Other|0|||
161038774|NCT02568215|581532120|FG001|Overall Study|Other|1|||
161038775|NCT02568215|581532121|FG002|Overall Study|Other|4|||
161038776|NCT01641900|581532122|FG000|Overall Study|Withdrawal by Subject|2|||
161038777|NCT01641900|581532123|FG001|Overall Study|Withdrawal by Subject|2|||
161038778|NCT02941549|581532124|FG000|Overall Study|Adverse Event|1|||
161038779|NCT02941549|581532125|FG001|Overall Study|Adverse Event|0|||
161038780|NCT02941549|581532126|FG002|Overall Study|Adverse Event|0|||
161038781|NCT02941549|581532124|FG000|Overall Study|Withdrawal by Subject|2|||
161038782|NCT02941549|581532125|FG001|Overall Study|Withdrawal by Subject|1|||
161038783|NCT02941549|581532126|FG002|Overall Study|Withdrawal by Subject|2|||
161038784|NCT00263757|581532127|FG000|Overall Study|Withdrawal by Subject|5|||
161038785|NCT00263757|581532128|FG001|Overall Study|Withdrawal by Subject|4|||
161038786|NCT00263757|581532127|FG000|Overall Study|Screen failure|0|||
161038787|NCT00263757|581532128|FG001|Overall Study|Screen failure|1|||
161038788|NCT00263757|581532127|FG000|Overall Study|Adverse Event|3|||
161038789|NCT00263757|581532128|FG001|Overall Study|Adverse Event|3|||
161038790|NCT00713596|581532129|FG000|Overall Study|Study was terminated|2|||
161038791|NCT00713596|581532130|FG001|Overall Study|Study was terminated|3|||
161038792|NCT00713596|581532131|FG002|Overall Study|Study was terminated|2|||
161038793|NCT04545619|581532132|FG000|Overall Study|due to equipment challenges|1|||
161038794|NCT03712371|581532133|FG000|Overall Study|Lack of Efficacy|0|||
161038795|NCT03712371|581532134|FG001|Overall Study|Lack of Efficacy|0|||
161038796|NCT03712371|581532135|FG002|Overall Study|Lack of Efficacy|0|||
161038797|NCT03712371|581532136|FG003|Overall Study|Lack of Efficacy|1|||
161038798|NCT04949542|581532146|FG000|Overall Study|Lost to Follow-up|4|||
161038799|NCT04949542|581532147|FG001|Overall Study|Lost to Follow-up|1|||
161038800|NCT03021993|581532149|FG000|Overall Study|Withdrawal by Subject|4|||
161038801|NCT03021993|581532149|FG000|Overall Study|Physician Decision|1|||
161038802|NCT03021993|581532149|FG000|Overall Study|enrolled but were not treated|1|||
161038803|NCT03021993|581532149|FG000|Overall Study|Death|3|||
161038804|NCT02101775|581532151|FG000|Overall Study|Adverse Event|4|||
161038805|NCT02101775|581532152|FG001|Overall Study|Adverse Event|0|||
161038806|NCT02101775|581532153|FG002|Overall Study|Adverse Event|0|||
161038807|NCT02101775|581532151|FG000|Overall Study|Admission to Hospital|0|||
161038808|NCT02101775|581532152|FG001|Overall Study|Admission to Hospital|1|||
161038809|NCT02101775|581532153|FG002|Overall Study|Admission to Hospital|0|||
161038810|NCT02029235|581532167|FG000|Overall Study|Non-compliance with study meds or diary|4|||
161038811|NCT02029235|581532168|FG001|Overall Study|Non-compliance with study meds or diary|1|||
161038812|NCT02816398|581532169|FG000|Overall Study|Death|5|||
161038813|NCT02816398|581532169|FG000|Overall Study|Lack of Efficacy|8|||
161038814|NCT02816398|581532169|FG000|Overall Study|Lost to Follow-up|1|||
161038815|NCT01387516|581532170|FG000|Overall Study|Lost to Follow-up|4|||
161038816|NCT01387516|581532171|FG001|Overall Study|Lost to Follow-up|4|||
161038817|NCT01387516|581532172|FG002|Overall Study|Lost to Follow-up|2|||
161038818|NCT01387516|581532173|FG003|Overall Study|Lost to Follow-up|3|||
161038819|NCT01387516|581532170|FG000|Overall Study|Withdrawal by Subject|1|||
161038820|NCT01387516|581532171|FG001|Overall Study|Withdrawal by Subject|1|||
161280454|NCT05061420|582406937|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161280455|NCT05061420|582406938|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161038821|NCT01387516|581532172|FG002|Overall Study|Withdrawal by Subject|2|||
161038822|NCT01387516|581532173|FG003|Overall Study|Withdrawal by Subject|0|||
161038823|NCT01387516|581532170|FG000|Overall Study|Death|0|||
161038824|NCT01387516|581532171|FG001|Overall Study|Death|0|||
161038825|NCT01387516|581532172|FG002|Overall Study|Death|0|||
161038826|NCT01387516|581532173|FG003|Overall Study|Death|1|||
161038827|NCT03582475|581532174|FG000|Treatment Period|Withdrawal by Subject|0|||
161038828|NCT03582475|581532175|FG001|Treatment Period|Withdrawal by Subject|1|||
161038829|NCT03582475|581532174|FG000|Follow-up Period|Withdrawal by Subject|0|||
161038830|NCT03582475|581532175|FG001|Follow-up Period|Withdrawal by Subject|1|||
161038831|NCT03509909|581532180|FG000|Overall Study|Withdrawal by Subject|16|||
161038832|NCT03509909|581532181|FG001|Overall Study|Withdrawal by Subject|9|||
161038833|NCT03509909|581532180|FG000|Overall Study|Lost to Follow-up|3|||
161038834|NCT03509909|581532181|FG001|Overall Study|Lost to Follow-up|4|||
161038835|NCT03509909|581532180|FG000|Overall Study|Adverse Event|2|||
161038836|NCT03509909|581532181|FG001|Overall Study|Adverse Event|0|||
161038837|NCT01400958|581532183|FG000|Overall Study|Physician Decision|0|||
161038838|NCT01400958|581532184|FG001|Overall Study|Physician Decision|1|||
161038839|NCT01400958|581532183|FG000|Overall Study|Withdrawal by Subject|0|||
161038840|NCT01400958|581532184|FG001|Overall Study|Withdrawal by Subject|1|||
161038841|NCT01400958|581532183|FG000|Overall Study|Adverse Event|1|||
161038842|NCT01400958|581532184|FG001|Overall Study|Adverse Event|0|||
161038843|NCT04801420|581532187|FG000|Overall Study|Other|1|||
161038844|NCT04801420|581532188|FG001|Overall Study|Other|2|||
161038845|NCT04801420|581532189|FG002|Overall Study|Other|1|||
161038846|NCT04801420|581532187|FG000|Overall Study|Lost to Follow-up|7|||
161038847|NCT04801420|581532188|FG001|Overall Study|Lost to Follow-up|9|||
161038848|NCT04801420|581532189|FG002|Overall Study|Lost to Follow-up|10|||
161038849|NCT04801420|581532187|FG000|Overall Study|Moved from study area|0|||
161038850|NCT04801420|581532188|FG001|Overall Study|Moved from study area|1|||
161038851|NCT04801420|581532189|FG002|Overall Study|Moved from study area|1|||
161038852|NCT04801420|581532187|FG000|Overall Study|Withdrawal by Subject|5|||
161038853|NCT04801420|581532188|FG001|Overall Study|Withdrawal by Subject|1|||
161038854|NCT04801420|581532189|FG002|Overall Study|Withdrawal by Subject|4|||
161038855|NCT04801420|581532187|FG000|Overall Study|Individual stopping criteria reached|0|||
161038856|NCT04801420|581532188|FG001|Overall Study|Individual stopping criteria reached|1|||
161038857|NCT04801420|581532189|FG002|Overall Study|Individual stopping criteria reached|0|||
161038858|NCT04801420|581532187|FG000|Overall Study|Ongoing in the study|195|||
161038859|NCT04801420|581532188|FG001|Overall Study|Ongoing in the study|195|||
161038860|NCT04801420|581532189|FG002|Overall Study|Ongoing in the study|192|||
161038861|NCT01855750|581532190|FG000|Overall Study|Death|78|||
161038862|NCT01855750|581532191|FG001|Overall Study|Death|78|||
161038863|NCT01855750|581532190|FG000|Overall Study|Lost to Follow-up|9|||
161038864|NCT01855750|581532191|FG001|Overall Study|Lost to Follow-up|23|||
161038865|NCT01855750|581532190|FG000|Overall Study|Withdrawal by Subject|35|||
161038866|NCT01855750|581532191|FG001|Overall Study|Withdrawal by Subject|28|||
161038867|NCT01855750|581532190|FG000|Overall Study|Sponsor ends the study|297|||
161038868|NCT01855750|581532191|FG001|Overall Study|Sponsor ends the study|290|||
161038869|NCT05379270|581532192|FG000|Overall Study|Withdrawal by Subject|1|||
161038870|NCT05379270|581532193|FG001|Overall Study|Withdrawal by Subject|1|||
161038871|NCT03160885|581532194|FG000|Initial Treatment Period|Not dosed|2|||
161038872|NCT03160885|581532195|FG001|Initial Treatment Period|Not dosed|0|||
161038873|NCT03160885|581532196|FG002|Initial Treatment Period|Not dosed|0|||
160977688|NCT00147225|581308003|FG001|Overall Study|Chemotherapy Changed|0|||
160977689|NCT00147225|581308004|FG002|Overall Study|Chemotherapy Changed|0|||
160977690|NCT00147225|581308005|FG003|Overall Study|Chemotherapy Changed|0|||
160977691|NCT00147225|581308006|FG004|Overall Study|Chemotherapy Changed|0|||
160977692|NCT00147225|581308007|FG005|Overall Study|Chemotherapy Changed|1|||
160977693|NCT01032044|581308008|FG000|Overall Study|Protocol Violation|14|||
160977694|NCT01032044|581308009|FG001|Overall Study|Protocol Violation|8|||
160977695|NCT01032044|581308008|FG000|Overall Study|Adverse Event|0|||
160977696|NCT01032044|581308009|FG001|Overall Study|Adverse Event|1|||
160977697|NCT01032044|581308008|FG000|Overall Study|Lost to Follow-up|11|||
160977698|NCT01032044|581308009|FG001|Overall Study|Lost to Follow-up|11|||
160977699|NCT01567865|581308016|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
160977700|NCT01567865|581308017|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
160977701|NCT01567865|581308018|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
160977702|NCT01567865|581308019|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
160977703|NCT01567865|581308016|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
160977704|NCT01567865|581308017|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
160977705|NCT01567865|581308018|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
160977706|NCT01567865|581308019|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
160977707|NCT01051063|581308028|FG000|Overall Study|Death|2|||
160977708|NCT01051063|581308029|FG001|Overall Study|Death|2|||
161038874|NCT03160885|581532197|FG003|Initial Treatment Period|Not dosed|0|||
161038875|NCT03160885|581532198|FG004|Initial Treatment Period|Not dosed|0|||
161038876|NCT03160885|581532199|FG005|Initial Treatment Period|Not dosed|0|||
161038877|NCT03160885|581532200|FG006|Initial Treatment Period|Not dosed|0|||
161038878|NCT03160885|581532194|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
161038879|NCT03160885|581532195|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
161038880|NCT03160885|581532196|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161280456|NCT05061420|582406936|FG000|Overall Study|Progressive disease|11|||
160977709|NCT01051063|581308028|FG000|Overall Study|Withdrawal by Subject|1|||
160977710|NCT01051063|581308029|FG001|Overall Study|Withdrawal by Subject|1|||
160977711|NCT01051063|581308028|FG000|Overall Study|Termination of the study|5|||
161038881|NCT03160885|581532197|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161038882|NCT03160885|581532198|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161038883|NCT03160885|581532199|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161038884|NCT03160885|581532200|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
161038885|NCT03160885|581532194|FG000|Open-label Treatment|Not dosed|0|||
161038886|NCT03160885|581532195|FG001|Open-label Treatment|Not dosed|0|||
161038887|NCT03160885|581532196|FG002|Open-label Treatment|Not dosed|0|||
161038888|NCT03160885|581532197|FG003|Open-label Treatment|Not dosed|0|||
161038889|NCT03160885|581532198|FG004|Open-label Treatment|Not dosed|0|||
161038890|NCT03160885|581532199|FG005|Open-label Treatment|Not dosed|0|||
161038891|NCT03160885|581532200|FG006|Open-label Treatment|Not dosed|2|||
161038892|NCT03160885|581532194|FG000|Open-label Treatment|Discontinued IMP|0|||
161038893|NCT03160885|581532195|FG001|Open-label Treatment|Discontinued IMP|0|||
161038894|NCT03160885|581532196|FG002|Open-label Treatment|Discontinued IMP|0|||
161038895|NCT03160885|581532197|FG003|Open-label Treatment|Discontinued IMP|0|||
161038896|NCT03160885|581532198|FG004|Open-label Treatment|Discontinued IMP|0|||
161038897|NCT03160885|581532199|FG005|Open-label Treatment|Discontinued IMP|0|||
161038898|NCT03160885|581532200|FG006|Open-label Treatment|Discontinued IMP|131|||
161038899|NCT03160885|581532194|FG000|Open-label Treatment|Completed Week 50|0|||
161038900|NCT03160885|581532195|FG001|Open-label Treatment|Completed Week 50|0|||
161038901|NCT03160885|581532196|FG002|Open-label Treatment|Completed Week 50|0|||
161038902|NCT03160885|581532197|FG003|Open-label Treatment|Completed Week 50|0|||
161038903|NCT03160885|581532198|FG004|Open-label Treatment|Completed Week 50|0|||
161038904|NCT03160885|581532199|FG005|Open-label Treatment|Completed Week 50|0|||
161038905|NCT03160885|581532200|FG006|Open-label Treatment|Completed Week 50|4|||
161038906|NCT03160885|581532194|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161038907|NCT03160885|581532195|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161038908|NCT03160885|581532196|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161038909|NCT03160885|581532197|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
161038910|NCT03160885|581532198|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161038911|NCT03160885|581532199|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161038912|NCT03160885|581532200|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
161038913|NCT03160885|581532194|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
161038914|NCT03160885|581532195|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
161038915|NCT03160885|581532196|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
161038916|NCT03160885|581532197|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
161038917|NCT03160885|581532198|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
161038918|NCT03160885|581532199|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
161038919|NCT03160885|581532200|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
161038920|NCT03160885|581532194|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161038921|NCT03160885|581532195|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161038922|NCT03160885|581532196|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
161038923|NCT03160885|581532197|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
161038924|NCT03160885|581532198|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
161038925|NCT03160885|581532199|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
161038926|NCT03160885|581532200|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
161038927|NCT03160885|581532194|FG000|Maintenance Treatment Period|Completed Week 50|0|||
161038928|NCT03160885|581532195|FG001|Maintenance Treatment Period|Completed Week 50|0|||
161038929|NCT03160885|581532196|FG002|Maintenance Treatment Period|Completed Week 50|1|||
161038930|NCT03160885|581532197|FG003|Maintenance Treatment Period|Completed Week 50|0|||
161038931|NCT03160885|581532198|FG004|Maintenance Treatment Period|Completed Week 50|0|||
161038932|NCT03160885|581532199|FG005|Maintenance Treatment Period|Completed Week 50|0|||
161038933|NCT03160885|581532200|FG006|Maintenance Treatment Period|Completed Week 50|0|||
161038934|NCT03425682|581532201|FG000|Overall Study|Lost to Follow-up|2|||
161038935|NCT03425682|581532202|FG001|Overall Study|Lost to Follow-up|4|||
161038936|NCT03425682|581532201|FG000|Overall Study|Withdrawal by Subject|0|||
161038937|NCT03425682|581532202|FG001|Overall Study|Withdrawal by Subject|3|||
161038938|NCT03425682|581532201|FG000|Overall Study|Subject did not meet I/E|4|||
161038939|NCT03425682|581532202|FG001|Overall Study|Subject did not meet I/E|10|||
161038940|NCT04153890|581532203|FG000|Overall Study|Lost to Follow-up|9|||
161038941|NCT04153890|581532204|FG001|Overall Study|Lost to Follow-up|0|||
161038942|NCT04153890|581532205|FG002|Overall Study|Lost to Follow-up|9|||
161038943|NCT04153890|581532206|FG003|Overall Study|Lost to Follow-up|0|||
161038944|NCT04153890|581532203|FG000|Overall Study|Death|0|||
161038945|NCT04153890|581532204|FG001|Overall Study|Death|2|||
161038946|NCT04153890|581532205|FG002|Overall Study|Death|0|||
161038947|NCT04153890|581532206|FG003|Overall Study|Death|0|||
161038948|NCT04153890|581532203|FG000|Overall Study|Withdrawal by Subject|0|||
161038949|NCT04153890|581532204|FG001|Overall Study|Withdrawal by Subject|0|||
161038950|NCT04153890|581532205|FG002|Overall Study|Withdrawal by Subject|0|||
161038951|NCT04153890|581532206|FG003|Overall Study|Withdrawal by Subject|2|||
161038952|NCT03610581|581532207|FG000|Overall Study|Study terminated by sponsor|2|||
161038953|NCT03610581|581532208|FG001|Overall Study|Study terminated by sponsor|0|||
161038954|NCT03610581|581532207|FG000|Overall Study|Other|0|||
161038955|NCT03610581|581532208|FG001|Overall Study|Other|1|||
161038956|NCT03610581|581532207|FG000|Overall Study|Withdrawal by Subject|1|||
161038957|NCT03610581|581532208|FG001|Overall Study|Withdrawal by Subject|0|||
161038958|NCT02307682|581532213|FG000|Overall Study|Adverse Event|9|||
161038959|NCT02307682|581532214|FG001|Overall Study|Adverse Event|8|||
161038960|NCT02307682|581532215|FG002|Overall Study|Adverse Event|12|||
161038961|NCT02307682|581532213|FG000|Overall Study|Lack of Efficacy|1|||
161038962|NCT02307682|581532214|FG001|Overall Study|Lack of Efficacy|0|||
161038963|NCT02307682|581532215|FG002|Overall Study|Lack of Efficacy|1|||
161038964|NCT02307682|581532213|FG000|Overall Study|Physician Decision|2|||
161038965|NCT02307682|581532214|FG001|Overall Study|Physician Decision|2|||
161038966|NCT02307682|581532215|FG002|Overall Study|Physician Decision|8|||
161038967|NCT02307682|581532213|FG000|Overall Study|Progressive Disease|1|||
161038968|NCT02307682|581532214|FG001|Overall Study|Progressive Disease|0|||
161038969|NCT02307682|581532215|FG002|Overall Study|Progressive Disease|0|||
161038970|NCT02307682|581532213|FG000|Overall Study|Withdrawal by Subject|26|||
161038971|NCT02307682|581532214|FG001|Overall Study|Withdrawal by Subject|34|||
161038972|NCT02307682|581532215|FG002|Overall Study|Withdrawal by Subject|23|||
161038973|NCT02307682|581532213|FG000|Overall Study|Death|9|||
161038974|NCT02307682|581532214|FG001|Overall Study|Death|7|||
161038975|NCT02307682|581532215|FG002|Overall Study|Death|12|||
161038976|NCT02307682|581532213|FG000|Overall Study|Lost to Follow-up|1|||
161038977|NCT02307682|581532214|FG001|Overall Study|Lost to Follow-up|5|||
161038978|NCT02307682|581532215|FG002|Overall Study|Lost to Follow-up|6|||
161038979|NCT02307682|581532213|FG000|Overall Study|Protocol Deviation|0|||
161038980|NCT02307682|581532214|FG001|Overall Study|Protocol Deviation|0|||
161038981|NCT02307682|581532215|FG002|Overall Study|Protocol Deviation|2|||
161038982|NCT02307682|581532213|FG000|Overall Study|Other|1|||
161038983|NCT02307682|581532214|FG001|Overall Study|Other|1|||
161038984|NCT02307682|581532215|FG002|Overall Study|Other|0|||
161038985|NCT04306367|581532218|FG000|Overall Study|Progression of Disease|9|||
161038986|NCT04306367|581532218|FG000|Overall Study|Adverse Event|3|||
161038987|NCT04306367|581532218|FG000|Overall Study|Withdrawal by Subject|1|||
161038988|NCT02751528|581532225|FG000|Overall Study|Withdrawal by Subject|1|||
161038989|NCT02751528|581532225|FG000|Overall Study|Adverse Event|1|||
161038990|NCT05485805|581532226|FG000|Overall Study|Withdrawal by Subject|1|||
161038991|NCT05485805|581532227|FG001|Overall Study|Withdrawal by Subject|2|||
161038992|NCT05485805|581532228|FG002|Overall Study|Withdrawal by Subject|2|||
161038993|NCT05485805|581532229|FG003|Overall Study|Withdrawal by Subject|0|||
161038994|NCT05485805|581532230|FG004|Overall Study|Withdrawal by Subject|2|||
161038995|NCT05485805|581532226|FG000|Overall Study|Adverse Event|0|||
161038996|NCT05485805|581532227|FG001|Overall Study|Adverse Event|1|||
161038997|NCT05485805|581532228|FG002|Overall Study|Adverse Event|0|||
161038998|NCT05485805|581532229|FG003|Overall Study|Adverse Event|0|||
161038999|NCT05485805|581532230|FG004|Overall Study|Adverse Event|0|||
161039000|NCT05485805|581532226|FG000|Overall Study|Lost to Follow-up|1|||
161039001|NCT05485805|581532227|FG001|Overall Study|Lost to Follow-up|1|||
161039002|NCT05485805|581532228|FG002|Overall Study|Lost to Follow-up|3|||
161039003|NCT05485805|581532229|FG003|Overall Study|Lost to Follow-up|1|||
161039004|NCT05485805|581532230|FG004|Overall Study|Lost to Follow-up|0|||
161039005|NCT04218357|581532231|FG000|1st Allocation|Withdrawal by Subject|1|||
161039006|NCT04218357|581532232|FG001|1st Allocation|Withdrawal by Subject|0|||
161039007|NCT05029284|581533741|FG000|Overall Study|Lost to Follow-up|1|||
161039008|NCT03002194|581533742|FG000|Overall Study|Lost to Follow-up|6|||
161039009|NCT03002194|581533742|FG000|Overall Study|Adverse Event|1|||
161039010|NCT03002194|581533742|FG000|Overall Study|Lack of Efficacy|1|||
161039011|NCT03002194|581533742|FG000|Overall Study|Withdrawal by Subject|2|||
161039012|NCT02200705|581533743|FG000|Overall Study|Excluded|12|||
161039013|NCT02200705|581533743|FG000|Overall Study|Death|21|||
161039014|NCT02200705|581533743|FG000|Overall Study|Withdrawal by Subject|22|||
161039015|NCT02200705|581533743|FG000|Overall Study|Lost to Follow-up|13|||
161039016|NCT02200705|581533743|FG000|Overall Study|Physician Decision|5|||
161039017|NCT02200705|581533743|FG000|Overall Study|Adverse Event|2|||
161039018|NCT02633215|581533747|FG000|Overall Study|Lost to Follow-up|2|||
161039019|NCT02633215|581533748|FG001|Overall Study|Lost to Follow-up|3|||
161039020|NCT00754325|581533749|FG000|Initial Treatment|Continuing Active Treatment|4|||
161039021|NCT00754325|581533750|FG001|Initial Treatment|Continuing Active Treatment|5|||
161039022|NCT00754325|581533749|FG000|Initial Treatment|Adverse Event|7|||
161039023|NCT00754325|581533750|FG001|Initial Treatment|Adverse Event|6|||
161039024|NCT00754325|581533749|FG000|Initial Treatment|Withdrawal by Subject|2|||
161039025|NCT00754325|581533750|FG001|Initial Treatment|Withdrawal by Subject|2|||
161039026|NCT00754325|581533749|FG000|Initial Treatment|Physician Decision|2|||
161039027|NCT00754325|581533750|FG001|Initial Treatment|Physician Decision|0|||
161039028|NCT00754325|581533749|FG000|Initial Treatment|Sponsor Request|0|||
161039029|NCT00754325|581533750|FG001|Initial Treatment|Sponsor Request|1|||
161039030|NCT00754325|581533749|FG000|Initial Treatment|Disease Progression|35|||
161039031|NCT00754325|581533750|FG001|Initial Treatment|Disease Progression|35|||
161039032|NCT03738228|581533751|FG000|Overall Study|Never received study treatment|2|||
161039033|NCT03738228|581533752|FG001|Overall Study|Never received study treatment|2|||
161039034|NCT03801148|581533753|FG000|Period 1 (2 Days)|Adverse Event|1|||
161039035|NCT03801148|581533754|FG001|Period 1 (2 Days)|Adverse Event|1|||
161039036|NCT03801148|581533755|FG002|Period 1 (2 Days)|Adverse Event|0|||
161039037|NCT03801148|581533756|FG003|Period 1 (2 Days)|Adverse Event|0|||
161039038|NCT03801148|581533753|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161039039|NCT03801148|581533754|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161039040|NCT03801148|581533755|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
161039041|NCT03801148|581533756|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
161039042|NCT03801148|581533753|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161039043|NCT03801148|581533754|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161039044|NCT03801148|581533755|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
161039045|NCT03801148|581533756|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
161039046|NCT03801148|581533753|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
161039047|NCT03801148|581533754|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
161039048|NCT03801148|581533755|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
161039049|NCT03801148|581533756|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
161039050|NCT06212752|581533757|FG000|Overall Study|Death|5|||
161039051|NCT06212752|581533758|FG001|Overall Study|Death|3|||
161039052|NCT06212752|581533757|FG000|Overall Study|Participants ongoing|23|||
161039053|NCT06212752|581533758|FG001|Overall Study|Participants ongoing|8|||
161039054|NCT04162210|581533759|FG000|Overall Study|Lost to Follow-up|4|||
161039055|NCT04162210|581533760|FG001|Overall Study|Lost to Follow-up|1|||
161039056|NCT04162210|581533759|FG000|Overall Study|Withdrawal by Subject|17|||
161039057|NCT04162210|581533760|FG001|Overall Study|Withdrawal by Subject|9|||
161039058|NCT04162210|581533759|FG000|Overall Study|Ongoing|113|||
161039059|NCT04162210|581533760|FG001|Overall Study|Ongoing|59|||
161039060|NCT00371345|581533761|FG000|Overall Study|Disease Progression|21|||
161039061|NCT00371345|581533762|FG001|Overall Study|Disease Progression|35|||
161039062|NCT00371345|581533761|FG000|Overall Study|Study Drug Toxicity|1|||
161039063|NCT00371345|581533762|FG001|Overall Study|Study Drug Toxicity|7|||
161039064|NCT00371345|581533761|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
161039065|NCT00371345|581533762|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
161039066|NCT00371345|581533761|FG000|Overall Study|Participant Request|1|||
161039067|NCT00371345|581533762|FG001|Overall Study|Participant Request|1|||
161039068|NCT00371345|581533761|FG000|Overall Study|Participant Withdrew Consent|0|||
161039069|NCT00371345|581533762|FG001|Overall Study|Participant Withdrew Consent|1|||
161039070|NCT00705406|581533763|FG000|Overall Study|Lost to Follow-up|3|||
161039071|NCT00705406|581533764|FG001|Overall Study|Lost to Follow-up|3|||
161039072|NCT00705406|581533763|FG000|Overall Study|Did not receive study drug|1|||
161039073|NCT00705406|581533764|FG001|Overall Study|Did not receive study drug|2|||
161039074|NCT01779700|581533765|FG000|Overall Study|Adverse Event|4|||
161039075|NCT01779700|581533766|FG001|Overall Study|Adverse Event|3|||
161039076|NCT01779700|581533765|FG000|Overall Study|Withdrawal by Subject|0|||
161039077|NCT01779700|581533766|FG001|Overall Study|Withdrawal by Subject|2|||
161039078|NCT00918333|581533769|FG000|Overall Study|Drug not taken per protocol|1|||
161039079|NCT00918333|581533770|FG001|Overall Study|Drug not taken per protocol|0|||
161039080|NCT00918333|581533769|FG000|Overall Study|Inadequate amount of drugs provided|1|||
161039081|NCT00918333|581533770|FG001|Overall Study|Inadequate amount of drugs provided|4|||
161039082|NCT00918333|581533769|FG000|Overall Study|Ineligible|1|||
161039083|NCT00918333|581533770|FG001|Overall Study|Ineligible|0|||
161039084|NCT00918333|581533769|FG000|Overall Study|Withdrawal by Subject|0|||
161039085|NCT00918333|581533770|FG001|Overall Study|Withdrawal by Subject|1|||
161039086|NCT04497415|581533771|FG000|Overall Study|Lost to Follow-up|43|||
161039087|NCT04497415|581533772|FG001|Overall Study|Lost to Follow-up|27|||
161039088|NCT02463448|581533776|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
161039089|NCT02463448|581533776|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
161039090|NCT02463448|581533776|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
161039091|NCT02463448|581533776|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
161039092|NCT00683800|581533777|FG000|Overall Study|Adverse Event|195|||
161039093|NCT00683800|581533778|FG001|Overall Study|Adverse Event|102|||
161039094|NCT00683800|581533777|FG000|Overall Study|Death|0|||
161039095|NCT00683800|581533778|FG001|Overall Study|Death|1|||
161039096|NCT00683800|581533777|FG000|Overall Study|Lost to Follow-up|57|||
161039097|NCT00683800|581533778|FG001|Overall Study|Lost to Follow-up|44|||
161039098|NCT00683800|581533777|FG000|Overall Study|Other|5|||
161039099|NCT00683800|581533778|FG001|Overall Study|Other|2|||
161039100|NCT00683800|581533777|FG000|Overall Study|Protocol Violation|13|||
161039101|NCT00683800|581533778|FG001|Overall Study|Protocol Violation|16|||
161039102|NCT00683800|581533777|FG000|Overall Study|Withdrawal by Subject|66|||
161039103|NCT00683800|581533778|FG001|Overall Study|Withdrawal by Subject|64|||
161039104|NCT00683800|581533777|FG000|Overall Study|Lack of Efficacy|61|||
161039105|NCT00683800|581533778|FG001|Overall Study|Lack of Efficacy|104|||
161039106|NCT00683800|581533777|FG000|Overall Study|Randomized, not treated|35|||
161039107|NCT00683800|581533778|FG001|Overall Study|Randomized, not treated|33|||
161039108|NCT03170648|581533785|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
161039109|NCT03170648|581533785|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
161039110|NCT01588951|581533786|FG000|Overall Study|Ineligible in retrospect|0|||
161039111|NCT01588951|581533787|FG001|Overall Study|Ineligible in retrospect|0|||
161039112|NCT01588951|581533788|FG002|Overall Study|Ineligible in retrospect|1|||
161039113|NCT03683576|581533789|FG000|Overall Study|Withdrawal by Subject|2|||
161039114|NCT03683576|581533790|FG001|Overall Study|Withdrawal by Subject|0|||
161039115|NCT03683576|581533791|FG002|Overall Study|Withdrawal by Subject|8|||
161039116|NCT03683576|581533792|FG003|Overall Study|Withdrawal by Subject|3|||
161039117|NCT03683576|581533789|FG000|Overall Study|Adverse Event|3|||
161039118|NCT03683576|581533790|FG001|Overall Study|Adverse Event|0|||
161039119|NCT03683576|581533791|FG002|Overall Study|Adverse Event|0|||
161039120|NCT03683576|581533792|FG003|Overall Study|Adverse Event|4|||
161039121|NCT03683576|581533789|FG000|Overall Study|Lack of Efficacy|1|||
161039122|NCT03683576|581533790|FG001|Overall Study|Lack of Efficacy|0|||
161039123|NCT03683576|581533791|FG002|Overall Study|Lack of Efficacy|1|||
161039124|NCT03683576|581533792|FG003|Overall Study|Lack of Efficacy|1|||
161039125|NCT03683576|581533789|FG000|Overall Study|Lost to Follow-up|0|||
161039126|NCT03683576|581533790|FG001|Overall Study|Lost to Follow-up|1|||
161039127|NCT03683576|581533791|FG002|Overall Study|Lost to Follow-up|2|||
161039128|NCT03683576|581533792|FG003|Overall Study|Lost to Follow-up|0|||
161039129|NCT03683576|581533789|FG000|Overall Study|Other, Not Specified|0|||
161039130|NCT03683576|581533790|FG001|Overall Study|Other, Not Specified|2|||
161039131|NCT03683576|581533791|FG002|Overall Study|Other, Not Specified|0|||
161039132|NCT03683576|581533792|FG003|Overall Study|Other, Not Specified|0|||
161039133|NCT03683576|581533789|FG000|Overall Study|Protocol Violation|0|||
161039134|NCT03683576|581533790|FG001|Overall Study|Protocol Violation|1|||
161039135|NCT03683576|581533791|FG002|Overall Study|Protocol Violation|1|||
161039136|NCT03683576|581533792|FG003|Overall Study|Protocol Violation|0|||
161039137|NCT02454959|581533793|FG000|Overall Study|Protocol-Specified Criteria|3|||
161039138|NCT02454959|581533793|FG000|Overall Study|Physician Decision|1|||
161039139|NCT02454959|581533793|FG000|Overall Study|Withdrawal by Subject|3|||
161039140|NCT02454959|581533793|FG000|Overall Study|Adverse Event|2|||
161039141|NCT02350634|581533794|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
161039142|NCT02499328|581533804|FG000|Overall Study|Withdrawal by Subject|1|||
161039143|NCT02499328|581533805|FG001|Overall Study|Withdrawal by Subject|1|||
161039144|NCT02499328|581533806|FG002|Overall Study|Withdrawal by Subject|5|||
161039145|NCT02499328|581533807|FG003|Overall Study|Withdrawal by Subject|3|||
161039146|NCT02499328|581533808|FG004|Overall Study|Withdrawal by Subject|5|||
161039147|NCT02499328|581533809|FG005|Overall Study|Withdrawal by Subject|0|||
161039148|NCT02499328|581533810|FG006|Overall Study|Withdrawal by Subject|0|||
161039149|NCT02499328|581533811|FG007|Overall Study|Withdrawal by Subject|0|||
161039150|NCT02499328|581533812|FG008|Overall Study|Withdrawal by Subject|2|||
161039151|NCT02499328|581533813|FG009|Overall Study|Withdrawal by Subject|2|||
161039152|NCT02499328|581533814|FG010|Overall Study|Withdrawal by Subject|0|||
161039153|NCT02499328|581533815|FG011|Overall Study|Withdrawal by Subject|3|||
161039154|NCT02499328|581533816|FG012|Overall Study|Withdrawal by Subject|7|||
161039155|NCT02499328|581533817|FG013|Overall Study|Withdrawal by Subject|3|||
161039156|NCT02499328|581533818|FG014|Overall Study|Withdrawal by Subject|1|||
161039157|NCT02499328|581533819|FG015|Overall Study|Withdrawal by Subject|0|||
161039158|NCT02499328|581533820|FG016|Overall Study|Withdrawal by Subject|0|||
161039159|NCT02499328|581533821|FG017|Overall Study|Withdrawal by Subject|3|||
161039160|NCT02499328|581533822|FG018|Overall Study|Withdrawal by Subject|0|||
161039161|NCT02499328|581533804|FG000|Overall Study|Lost to Follow-up|0|||
161039162|NCT02499328|581533805|FG001|Overall Study|Lost to Follow-up|1|||
161039163|NCT02499328|581533806|FG002|Overall Study|Lost to Follow-up|1|||
161039164|NCT02499328|581533807|FG003|Overall Study|Lost to Follow-up|2|||
161039165|NCT02499328|581533808|FG004|Overall Study|Lost to Follow-up|0|||
161039166|NCT02499328|581533809|FG005|Overall Study|Lost to Follow-up|0|||
161039167|NCT02499328|581533810|FG006|Overall Study|Lost to Follow-up|0|||
161039168|NCT02499328|581533811|FG007|Overall Study|Lost to Follow-up|2|||
161280457|NCT05061420|582406937|FG001|Overall Study|Progressive disease|15|||
161280458|NCT05061420|582406938|FG002|Overall Study|Progressive disease|14|||
161280459|NCT05061420|582406936|FG000|Overall Study|Withdrawal by Subject|2|||
161280460|NCT05061420|582406937|FG001|Overall Study|Withdrawal by Subject|0|||
161280461|NCT05061420|582406938|FG002|Overall Study|Withdrawal by Subject|1|||
161280462|NCT05061420|582406936|FG000|Overall Study|Not related to COVID-19|2|||
161039169|NCT02499328|581533812|FG008|Overall Study|Lost to Follow-up|3|||
161039170|NCT02499328|581533813|FG009|Overall Study|Lost to Follow-up|0|||
161039171|NCT02499328|581533814|FG010|Overall Study|Lost to Follow-up|0|||
161039172|NCT02499328|581533815|FG011|Overall Study|Lost to Follow-up|0|||
161039173|NCT02499328|581533816|FG012|Overall Study|Lost to Follow-up|0|||
161039174|NCT02499328|581533817|FG013|Overall Study|Lost to Follow-up|0|||
161039175|NCT02499328|581533818|FG014|Overall Study|Lost to Follow-up|0|||
161039176|NCT02499328|581533819|FG015|Overall Study|Lost to Follow-up|0|||
161039177|NCT02499328|581533820|FG016|Overall Study|Lost to Follow-up|0|||
161039178|NCT02499328|581533821|FG017|Overall Study|Lost to Follow-up|0|||
161039179|NCT02499328|581533822|FG018|Overall Study|Lost to Follow-up|1|||
161280463|NCT05061420|582406937|FG001|Overall Study|Not related to COVID-19|0|||
161039180|NCT02499328|581533804|FG000|Overall Study|Death|0|||
161039181|NCT02499328|581533805|FG001|Overall Study|Death|3|||
161039182|NCT02499328|581533806|FG002|Overall Study|Death|3|||
161039183|NCT02499328|581533807|FG003|Overall Study|Death|2|||
161039184|NCT02499328|581533808|FG004|Overall Study|Death|4|||
161039185|NCT02499328|581533809|FG005|Overall Study|Death|7|||
161039186|NCT02499328|581533810|FG006|Overall Study|Death|3|||
161039187|NCT02499328|581533811|FG007|Overall Study|Death|0|||
161039188|NCT02499328|581533812|FG008|Overall Study|Death|2|||
161039189|NCT02499328|581533813|FG009|Overall Study|Death|6|||
161039190|NCT02499328|581533814|FG010|Overall Study|Death|6|||
161039191|NCT02499328|581533815|FG011|Overall Study|Death|20|||
161039192|NCT02499328|581533816|FG012|Overall Study|Death|9|||
161039193|NCT02499328|581533817|FG013|Overall Study|Death|7|||
161039194|NCT02499328|581533818|FG014|Overall Study|Death|3|||
161039195|NCT02499328|581533819|FG015|Overall Study|Death|1|||
161039196|NCT02499328|581533820|FG016|Overall Study|Death|1|||
161039197|NCT02499328|581533821|FG017|Overall Study|Death|16|||
161039198|NCT02499328|581533822|FG018|Overall Study|Death|5|||
161039199|NCT02499328|581533804|FG000|Overall Study|"Other"|2|||
161039200|NCT02499328|581533805|FG001|Overall Study|"Other"|2|||
161039201|NCT02499328|581533806|FG002|Overall Study|"Other"|1|||
161039202|NCT02499328|581533807|FG003|Overall Study|"Other"|3|||
161039203|NCT02499328|581533808|FG004|Overall Study|"Other"|6|||
161039204|NCT02499328|581533809|FG005|Overall Study|"Other"|2|||
161039205|NCT02499328|581533810|FG006|Overall Study|"Other"|3|||
161039206|NCT02499328|581533811|FG007|Overall Study|"Other"|4|||
161039207|NCT02499328|581533812|FG008|Overall Study|"Other"|6|||
161039208|NCT02499328|581533813|FG009|Overall Study|"Other"|16|||
161039209|NCT02499328|581533814|FG010|Overall Study|"Other"|13|||
161039210|NCT02499328|581533815|FG011|Overall Study|"Other"|31|||
161039211|NCT02499328|581533816|FG012|Overall Study|"Other"|8|||
161039212|NCT02499328|581533817|FG013|Overall Study|"Other"|7|||
161039213|NCT02499328|581533818|FG014|Overall Study|"Other"|6|||
161039214|NCT02499328|581533819|FG015|Overall Study|"Other"|0|||
161039215|NCT02499328|581533820|FG016|Overall Study|"Other"|0|||
161039216|NCT02499328|581533821|FG017|Overall Study|"Other"|34|||
161039217|NCT02499328|581533822|FG018|Overall Study|"Other"|43|||
161039218|NCT02499328|581533804|FG000|Overall Study|Disease Progression|0|||
161039219|NCT02499328|581533805|FG001|Overall Study|Disease Progression|0|||
161039220|NCT02499328|581533806|FG002|Overall Study|Disease Progression|0|||
161039221|NCT02499328|581533807|FG003|Overall Study|Disease Progression|0|||
161039222|NCT02499328|581533808|FG004|Overall Study|Disease Progression|0|||
161039223|NCT02499328|581533809|FG005|Overall Study|Disease Progression|0|||
161039224|NCT02499328|581533810|FG006|Overall Study|Disease Progression|1|||
161039225|NCT02499328|581533811|FG007|Overall Study|Disease Progression|0|||
161039226|NCT02499328|581533812|FG008|Overall Study|Disease Progression|1|||
161039227|NCT02499328|581533813|FG009|Overall Study|Disease Progression|0|||
161039228|NCT02499328|581533814|FG010|Overall Study|Disease Progression|1|||
161039229|NCT02499328|581533815|FG011|Overall Study|Disease Progression|0|||
161039230|NCT02499328|581533816|FG012|Overall Study|Disease Progression|0|||
161280464|NCT05061420|582406938|FG002|Overall Study|Not related to COVID-19|0|||
161280465|NCT01814553|582406939|FG000|Overall Study|PD per clinical progression|6|||
161039231|NCT02499328|581533817|FG013|Overall Study|Disease Progression|0|||
161039232|NCT02499328|581533818|FG014|Overall Study|Disease Progression|0|||
161039233|NCT02499328|581533819|FG015|Overall Study|Disease Progression|0|||
161039234|NCT02499328|581533820|FG016|Overall Study|Disease Progression|0|||
161039235|NCT02499328|581533821|FG017|Overall Study|Disease Progression|2|||
161039236|NCT02499328|581533822|FG018|Overall Study|Disease Progression|0|||
161039237|NCT02499328|581533804|FG000|Overall Study|Adverse Event|1|||
161039238|NCT02499328|581533805|FG001|Overall Study|Adverse Event|0|||
161039239|NCT02499328|581533806|FG002|Overall Study|Adverse Event|0|||
161039240|NCT02499328|581533807|FG003|Overall Study|Adverse Event|1|||
161039241|NCT02499328|581533808|FG004|Overall Study|Adverse Event|0|||
161039242|NCT02499328|581533809|FG005|Overall Study|Adverse Event|0|||
161039243|NCT02499328|581533810|FG006|Overall Study|Adverse Event|0|||
161039244|NCT02499328|581533811|FG007|Overall Study|Adverse Event|0|||
161280466|NCT01814553|582406940|FG001|Overall Study|PD per clinical progression|8|||
161039245|NCT02499328|581533812|FG008|Overall Study|Adverse Event|0|||
161039246|NCT02499328|581533813|FG009|Overall Study|Adverse Event|0|||
161039247|NCT02499328|581533814|FG010|Overall Study|Adverse Event|0|||
161039248|NCT02499328|581533815|FG011|Overall Study|Adverse Event|0|||
161039249|NCT02499328|581533816|FG012|Overall Study|Adverse Event|1|||
161039250|NCT02499328|581533817|FG013|Overall Study|Adverse Event|0|||
161039251|NCT02499328|581533818|FG014|Overall Study|Adverse Event|0|||
161039252|NCT02499328|581533819|FG015|Overall Study|Adverse Event|0|||
161039253|NCT02499328|581533820|FG016|Overall Study|Adverse Event|0|||
161039254|NCT02499328|581533821|FG017|Overall Study|Adverse Event|0|||
161039255|NCT02499328|581533822|FG018|Overall Study|Adverse Event|0|||
161039256|NCT03611075|581533823|FG000|Overall Study|Physician Decision|0|||
161039257|NCT03611075|581533824|FG001|Overall Study|Physician Decision|1|||
161039258|NCT03611075|581533825|FG002|Overall Study|Physician Decision|1|||
161039259|NCT03611075|581533826|FG003|Overall Study|Physician Decision|0|||
161039260|NCT03611075|581533827|FG004|Overall Study|Physician Decision|0|||
161039261|NCT03611075|581533828|FG005|Overall Study|Physician Decision|0|||
161039262|NCT03611075|581533829|FG006|Overall Study|Physician Decision|0|||
161039263|NCT03611075|581533830|FG007|Overall Study|Physician Decision|0|||
161039264|NCT03611075|581533831|FG008|Overall Study|Physician Decision|0|||
161039265|NCT03611075|581533823|FG000|Overall Study|Lost to Follow-up|1|||
161039266|NCT03611075|581533824|FG001|Overall Study|Lost to Follow-up|0|||
161039267|NCT03611075|581533825|FG002|Overall Study|Lost to Follow-up|0|||
161039268|NCT03611075|581533826|FG003|Overall Study|Lost to Follow-up|2|||
161039269|NCT03611075|581533827|FG004|Overall Study|Lost to Follow-up|0|||
161039270|NCT03611075|581533828|FG005|Overall Study|Lost to Follow-up|0|||
161039271|NCT03611075|581533829|FG006|Overall Study|Lost to Follow-up|0|||
161039272|NCT03611075|581533830|FG007|Overall Study|Lost to Follow-up|0|||
161039273|NCT03611075|581533831|FG008|Overall Study|Lost to Follow-up|0|||
161039274|NCT03611075|581533823|FG000|Overall Study|Withdrawal by Subject|0|||
161039275|NCT03611075|581533824|FG001|Overall Study|Withdrawal by Subject|1|||
161039276|NCT03611075|581533825|FG002|Overall Study|Withdrawal by Subject|1|||
161039277|NCT03611075|581533826|FG003|Overall Study|Withdrawal by Subject|1|||
161039278|NCT03611075|581533827|FG004|Overall Study|Withdrawal by Subject|0|||
161039279|NCT03611075|581533828|FG005|Overall Study|Withdrawal by Subject|0|||
161039280|NCT03611075|581533829|FG006|Overall Study|Withdrawal by Subject|1|||
161039281|NCT03611075|581533830|FG007|Overall Study|Withdrawal by Subject|0|||
161039282|NCT03611075|581533831|FG008|Overall Study|Withdrawal by Subject|0|||
161039283|NCT03611075|581533823|FG000|Overall Study|Reason unknown|0|||
161039284|NCT03611075|581533824|FG001|Overall Study|Reason unknown|0|||
161039285|NCT03611075|581533825|FG002|Overall Study|Reason unknown|0|||
161039286|NCT03611075|581533826|FG003|Overall Study|Reason unknown|1|||
161039287|NCT03611075|581533827|FG004|Overall Study|Reason unknown|0|||
161039288|NCT03611075|581533828|FG005|Overall Study|Reason unknown|0|||
161039289|NCT03611075|581533829|FG006|Overall Study|Reason unknown|1|||
161039290|NCT03611075|581533830|FG007|Overall Study|Reason unknown|0|||
161039291|NCT03611075|581533831|FG008|Overall Study|Reason unknown|0|||
161039292|NCT03488719|581533832|FG000|Overall Study|Adverse Event|0|||
161039293|NCT03488719|581533833|FG001|Overall Study|Adverse Event|4|||
161039294|NCT03488719|581533834|FG002|Overall Study|Adverse Event|2|||
161039295|NCT03488719|581533832|FG000|Overall Study|Other|0|||
161039296|NCT03488719|581533833|FG001|Overall Study|Other|0|||
161039297|NCT03488719|581533834|FG002|Overall Study|Other|5|||
161039298|NCT03414684|581533842|FG000|First-course Treatment|Complete response|0|||
161039299|NCT03414684|581533843|FG001|First-course Treatment|Complete response|1|||
161039300|NCT03414684|581533842|FG000|First-course Treatment|Intercurrent illness|1|||
161039301|NCT03414684|581533843|FG001|First-course Treatment|Intercurrent illness|0|||
161039302|NCT03414684|581533842|FG000|First-course Treatment|Progressive Disease|31|||
161039303|NCT03414684|581533843|FG001|First-course Treatment|Progressive Disease|32|||
161039304|NCT03414684|581533842|FG000|First-course Treatment|Adverse Event|1|||
161039305|NCT03414684|581533843|FG001|First-course Treatment|Adverse Event|2|||
161039306|NCT03414684|581533842|FG000|First-course Treatment|Physician Decision|0|||
161039307|NCT03414684|581533843|FG001|First-course Treatment|Physician Decision|1|||
161039308|NCT03414684|581533842|FG000|First-course Treatment|Withdrawal by Subject|0|||
161039309|NCT03414684|581533843|FG001|First-course Treatment|Withdrawal by Subject|1|||
161039310|NCT03414684|581533842|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
161039311|NCT03414684|581533843|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
161039312|NCT03414684|581533842|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
161039313|NCT03414684|581533843|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
161039314|NCT03414684|581533842|FG000|First-course Treatment|Still on treatment|3|||
161039315|NCT03414684|581533843|FG001|First-course Treatment|Still on treatment|0|||
161039316|NCT03414684|581533842|FG000|First-course Treatment|Never started protocol therapy|2|||
161039317|NCT03414684|581533843|FG001|First-course Treatment|Never started protocol therapy|1|||
161039318|NCT03414684|581533842|FG000|Crossover Treatment|Progressive disease|0|||
161039319|NCT03414684|581533843|FG001|Crossover Treatment|Progressive disease|12|||
161039320|NCT03414684|581533842|FG000|Crossover Treatment|Adverse Event|0|||
161039321|NCT03414684|581533843|FG001|Crossover Treatment|Adverse Event|3|||
161039322|NCT03414684|581533842|FG000|Crossover Treatment|Physician Decision|0|||
161039323|NCT03414684|581533843|FG001|Crossover Treatment|Physician Decision|1|||
161039324|NCT03414684|581533842|FG000|Crossover Treatment|Still on treatment|0|||
161344801|NCT01157845|582647294|FG000|Overall Study|Withdrawal by Subject|12|||
161039325|NCT03414684|581533843|FG001|Crossover Treatment|Still on treatment|2|||
161039326|NCT04038580|581533844|FG000|Washout 1|Death|0|||
161039327|NCT04038580|581533845|FG001|Washout 1|Death|0|||
161039328|NCT04038580|581533846|FG002|Washout 1|Death|0|||
161039329|NCT04038580|581533847|FG003|Washout 1|Death|1|||
161039330|NCT04038580|581533848|FG004|Washout 1|Death|0|||
161039331|NCT04038580|581533849|FG005|Washout 1|Death|0|||
161039332|NCT04038580|581533844|FG000|Washout 1|Withdrawal by Subject|0|||
161039333|NCT04038580|581533845|FG001|Washout 1|Withdrawal by Subject|0|||
161039334|NCT04038580|581533846|FG002|Washout 1|Withdrawal by Subject|0|||
161039335|NCT04038580|581533847|FG003|Washout 1|Withdrawal by Subject|0|||
161039336|NCT04038580|581533848|FG004|Washout 1|Withdrawal by Subject|1|||
161280467|NCT01814553|582406939|FG000|Overall Study|Other Adverse Event|4|||
161280468|NCT01814553|582406940|FG001|Overall Study|Other Adverse Event|5|||
161280469|NCT01814553|582406939|FG000|Overall Study|Withdrawal by Subject|1|||
161280470|NCT01814553|582406940|FG001|Overall Study|Withdrawal by Subject|1|||
161039337|NCT04038580|581533849|FG005|Washout 1|Withdrawal by Subject|0|||
161039338|NCT04038580|581533844|FG000|Wash-out 2|Withdrawal by Subject|1|||
161039339|NCT04038580|581533845|FG001|Wash-out 2|Withdrawal by Subject|0|||
161039340|NCT04038580|581533846|FG002|Wash-out 2|Withdrawal by Subject|0|||
161039341|NCT04038580|581533847|FG003|Wash-out 2|Withdrawal by Subject|2|||
161039342|NCT04038580|581533848|FG004|Wash-out 2|Withdrawal by Subject|0|||
161039343|NCT04038580|581533849|FG005|Wash-out 2|Withdrawal by Subject|1|||
161039344|NCT04038580|581533844|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
161039345|NCT04038580|581533845|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
161039346|NCT04038580|581533846|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
161039347|NCT04038580|581533847|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
161039348|NCT04038580|581533848|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
161039349|NCT04038580|581533849|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
161039350|NCT04038580|581533844|FG000|Wash-out 3|Withdrawal by Subject|1|||
161039351|NCT04038580|581533845|FG001|Wash-out 3|Withdrawal by Subject|0|||
161039352|NCT04038580|581533846|FG002|Wash-out 3|Withdrawal by Subject|2|||
161039353|NCT04038580|581533847|FG003|Wash-out 3|Withdrawal by Subject|0|||
161039354|NCT04038580|581533848|FG004|Wash-out 3|Withdrawal by Subject|0|||
161039355|NCT04038580|581533849|FG005|Wash-out 3|Withdrawal by Subject|0|||
161039356|NCT03477175|581533850|FG000|Overall Study|Unable to travel due to COVID-19|0|||
161039357|NCT03477175|581533851|FG001|Overall Study|Unable to travel due to COVID-19|1|||
161039358|NCT03477175|581533850|FG000|Overall Study|Physician Decision|1|||
161039359|NCT03477175|581533851|FG001|Overall Study|Physician Decision|0|||
161039360|NCT03477175|581533850|FG000|Overall Study|Transitioned to commercial drug|6|||
161039361|NCT03477175|581533851|FG001|Overall Study|Transitioned to commercial drug|6|||
161039362|NCT03477175|581533850|FG000|Overall Study|Lost to Follow-up|1|||
161039363|NCT03477175|581533851|FG001|Overall Study|Lost to Follow-up|1|||
161039364|NCT03477175|581533850|FG000|Overall Study|Withdrawal by Subject|3|||
161039365|NCT03477175|581533851|FG001|Overall Study|Withdrawal by Subject|1|||
161039366|NCT03477175|581533850|FG000|Overall Study|Adverse Event|1|||
161039367|NCT03477175|581533851|FG001|Overall Study|Adverse Event|5|||
161039368|NCT03477175|581533850|FG000|Overall Study|Disease Progression|7|||
161039369|NCT03477175|581533851|FG001|Overall Study|Disease Progression|7|||
161039370|NCT02078648|581533852|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
161280471|NCT01814553|582406939|FG000|Overall Study|Other than stated|7|||
161280472|NCT01814553|582406940|FG001|Overall Study|Other than stated|8|||
161280473|NCT03138655|582406944|FG000|Overall Study|Adverse Event|2|||
161280474|NCT03138655|582406945|FG001|Overall Study|Adverse Event|1|||
161280475|NCT03138655|582406946|FG002|Overall Study|Adverse Event|2|||
161280476|NCT03138655|582406947|FG003|Overall Study|Adverse Event|1|||
161280477|NCT03138655|582406948|FG004|Overall Study|Adverse Event|1|||
161280478|NCT03138655|582406949|FG005|Overall Study|Adverse Event|4|||
161280479|NCT03138655|582406950|FG006|Overall Study|Adverse Event|2|||
161280480|NCT03138655|582406951|FG007|Overall Study|Adverse Event|2|||
161280481|NCT03138655|582406944|FG000|Overall Study|Withdrawal by Subject|0|||
161280482|NCT03138655|582406945|FG001|Overall Study|Withdrawal by Subject|1|||
161344802|NCT01157845|582647294|FG000|Overall Study|Physician Decision|3|||
161039371|NCT02078648|581533853|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
161039372|NCT02078648|581533852|FG000|Overall Study|Adverse Event|0|||
161039373|NCT02078648|581533853|FG001|Overall Study|Adverse Event|1|||
161039374|NCT02078648|581533852|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
161039375|NCT02078648|581533853|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
161039376|NCT02078648|581533852|FG000|Overall Study|Withdrawal by Subject|3|||
161039377|NCT02078648|581533853|FG001|Overall Study|Withdrawal by Subject|1|||
161039378|NCT02078648|581533852|FG000|Overall Study|Investigator Decision|5|||
161039379|NCT02078648|581533853|FG001|Overall Study|Investigator Decision|7|||
161039380|NCT02078648|581533852|FG000|Overall Study|Death|1|||
161039381|NCT02078648|581533853|FG001|Overall Study|Death|1|||
161039382|NCT02078648|581533852|FG000|Overall Study|Undefined|0|||
161039383|NCT02078648|581533853|FG001|Overall Study|Undefined|1|||
161039384|NCT04088227|581533854|FG000|Overall Study|Withdrawal by Subject|1|||
161039385|NCT04088227|581533855|FG001|Overall Study|Withdrawal by Subject|0|||
161280483|NCT03138655|582406946|FG002|Overall Study|Withdrawal by Subject|0|||
161280484|NCT03138655|582406947|FG003|Overall Study|Withdrawal by Subject|0|||
161280485|NCT03138655|582406948|FG004|Overall Study|Withdrawal by Subject|0|||
161280486|NCT03138655|582406949|FG005|Overall Study|Withdrawal by Subject|0|||
161280487|NCT03138655|582406950|FG006|Overall Study|Withdrawal by Subject|1|||
161280488|NCT03138655|582406951|FG007|Overall Study|Withdrawal by Subject|0|||
161280489|NCT03138655|582406944|FG000|Overall Study|Reason not Specified|1|||
161280490|NCT03138655|582406945|FG001|Overall Study|Reason not Specified|0|||
161039386|NCT04088227|581533854|FG000|Overall Study|Surgery postponed >5weeks|1|||
161039387|NCT04088227|581533855|FG001|Overall Study|Surgery postponed >5weeks|0|||
161039388|NCT04021862|581533856|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161039389|NCT04021862|581533857|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
161039390|NCT04021862|581533858|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161039391|NCT04021862|581533859|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161039392|NCT04021862|581533860|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161039393|NCT04021862|581533861|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
161039394|NCT04021862|581533856|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
161039395|NCT04021862|581533857|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161039396|NCT04021862|581533858|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161039397|NCT04021862|581533859|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161039398|NCT04021862|581533860|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161039399|NCT04021862|581533861|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
161039400|NCT04021862|581533856|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161039401|NCT04021862|581533857|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161039402|NCT04021862|581533858|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
161039403|NCT04021862|581533859|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161039404|NCT04021862|581533860|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161039405|NCT04021862|581533861|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
161039406|NCT04021862|581533856|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
161039407|NCT04021862|581533857|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
161039408|NCT04021862|581533858|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
161039409|NCT04021862|581533859|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
161039410|NCT04021862|581533860|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
161039411|NCT04021862|581533861|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
161039412|NCT04021862|581533856|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161039413|NCT04021862|581533857|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161039414|NCT04021862|581533858|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161039415|NCT04021862|581533859|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
161039416|NCT04021862|581533860|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161039417|NCT04021862|581533861|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
161039418|NCT03227861|581533862|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
161039419|NCT03227861|581533862|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
161039420|NCT03227861|581533862|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
161039421|NCT03227861|581533862|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
161039422|NCT03227861|581533862|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
161039423|NCT03227861|581533862|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
161039424|NCT03227861|581533862|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
161039425|NCT03227861|581533862|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
161039426|NCT03227861|581533862|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
161039427|NCT03227861|581533862|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
161039428|NCT03116464|581534825|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
161039429|NCT00442104|581534828|FG000|Overall Study|Adverse Event|5|||
161039430|NCT00442104|581534828|FG000|Overall Study|Death|2|||
161039431|NCT00442104|581534828|FG000|Overall Study|Lost to Follow-up|3|||
161039432|NCT00442104|581534828|FG000|Overall Study|Withdrawal by Subject|5|||
161039433|NCT00442104|581534828|FG000|Overall Study|Insufficient Clinical Response|10|||
161039434|NCT00442104|581534828|FG000|Overall Study|Other|21|||
161039435|NCT00442104|581534828|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
161039436|NCT00975585|581534833|FG000|Overall Study|Adverse Event|0|||
161039437|NCT00975585|581534834|FG001|Overall Study|Adverse Event|4|||
161039438|NCT00975585|581534833|FG000|Overall Study|Lost to Follow-up|3|||
161039439|NCT00975585|581534834|FG001|Overall Study|Lost to Follow-up|5|||
161039440|NCT00975585|581534833|FG000|Overall Study|Withdrawal by Subject|2|||
161039441|NCT00975585|581534834|FG001|Overall Study|Withdrawal by Subject|1|||
161039442|NCT00975585|581534833|FG000|Overall Study|Lens issue|2|||
161039443|NCT00975585|581534834|FG001|Overall Study|Lens issue|2|||
161039444|NCT00205179|581534835|FG000|Overall Study|Death|0|||
161039445|NCT00205179|581534836|FG001|Overall Study|Death|2|||
161039446|NCT00205179|581534835|FG000|Overall Study|Physician Decision|1|||
161039447|NCT00205179|581534836|FG001|Overall Study|Physician Decision|1|||
161039448|NCT00205179|581534835|FG000|Overall Study|Adverse Event|1|||
161039449|NCT00205179|581534836|FG001|Overall Study|Adverse Event|1|||
161039450|NCT01619059|581534837|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
161039451|NCT01619059|581534838|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
161039452|NCT01619059|581534837|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
161039453|NCT01619059|581534838|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
161039454|NCT01619059|581534837|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
161039455|NCT01619059|581534838|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
161039456|NCT01619059|581534837|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
161039457|NCT01619059|581534838|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
161039458|NCT01619059|581534837|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
161039459|NCT01619059|581534838|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
161039460|NCT01619059|581534837|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
161039461|NCT01619059|581534838|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
161039462|NCT01619059|581534837|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
161039463|NCT01619059|581534838|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
161039464|NCT01619059|581534837|FG000|Long-Term (LT) Treatment Period|Death|1|||
161039465|NCT01619059|581534838|FG001|Long-Term (LT) Treatment Period|Death|0|||
161039466|NCT01619059|581534837|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
161039467|NCT01619059|581534838|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
161039468|NCT01619059|581534837|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
161039469|NCT01619059|581534838|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
161039470|NCT01787032|581534841|FG000|Overall Study|Protocol Violation|0|||
161039471|NCT01787032|581534842|FG001|Overall Study|Protocol Violation|0|||
161039472|NCT01787032|581534843|FG002|Overall Study|Protocol Violation|0|||
161039473|NCT01787032|581534844|FG003|Overall Study|Protocol Violation|0|||
161039474|NCT01787032|581534845|FG004|Overall Study|Protocol Violation|1|||
161039475|NCT01787032|581534846|FG005|Overall Study|Protocol Violation|1|||
161039476|NCT00388726|581534847|FG000|Overall Study|Adverse Event|50|||
161039477|NCT00388726|581534848|FG001|Overall Study|Adverse Event|24|||
161039478|NCT00388726|581534847|FG000|Overall Study|Progressive Disease|336|||
161039479|NCT00388726|581534848|FG001|Overall Study|Progressive Disease|153|||
161039480|NCT00388726|581534847|FG000|Overall Study|Clinical Progression|61|||
161039481|NCT00388726|581534848|FG001|Overall Study|Clinical Progression|36|||
161039482|NCT00388726|581534847|FG000|Overall Study|Withdrawal by Subject|10|||
161039483|NCT00388726|581534848|FG001|Overall Study|Withdrawal by Subject|7|||
161039484|NCT00388726|581534847|FG000|Overall Study|Administrative|6|||
161039485|NCT00388726|581534848|FG001|Overall Study|Administrative|9|||
161039486|NCT00388726|581534847|FG000|Overall Study|Physician Decision|18|||
161039487|NCT00388726|581534848|FG001|Overall Study|Physician Decision|13|||
161039488|NCT00388726|581534847|FG000|Overall Study|Death|3|||
161039489|NCT00388726|581534848|FG001|Overall Study|Death|2|||
161039490|NCT02406092|581534849|FG000|Overall Study|Screen failure|10|||
161039491|NCT02406092|581534850|FG001|Overall Study|Screen failure|7|||
161039492|NCT02406092|581534849|FG000|Overall Study|Death|22|||
161039493|NCT02406092|581534850|FG001|Overall Study|Death|5|||
161039494|NCT02406092|581534849|FG000|Overall Study|Lost to Follow-up|4|||
161039495|NCT02406092|581534850|FG001|Overall Study|Lost to Follow-up|1|||
161039496|NCT02406092|581534849|FG000|Overall Study|Adverse Event|1|||
161039497|NCT02406092|581534850|FG001|Overall Study|Adverse Event|0|||
161039498|NCT02406092|581534849|FG000|Overall Study|Withdrawal by Subject|1|||
161039499|NCT02406092|581534850|FG001|Overall Study|Withdrawal by Subject|0|||
161039500|NCT03041233|581534851|FG000|Overall Study|Death|5|||
161039501|NCT03041233|581534851|FG000|Overall Study|Physician Decision|1|||
161039502|NCT03041233|581534851|FG000|Overall Study|Lost to Follow-up|16|||
161039503|NCT03041233|581534851|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
161039504|NCT03041233|581534851|FG000|Overall Study|Sponsor Request|1|||
161039505|NCT03041233|581534851|FG000|Overall Study|Duplicate subject|1|||
161039506|NCT03041233|581534851|FG000|Overall Study|Re-ablation|1|||
161039507|NCT00853593|581534855|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
161039508|NCT00853593|581534855|FG000|Overall Study|Model 4396 lead not attempted|29|||
161039509|NCT00853593|581534855|FG000|Overall Study|Implant not attempted|4|||
161039510|NCT03229408|581534856|FG000|Overall Study|Withdrawal by Subject|4|||
161039511|NCT03229408|581534857|FG001|Overall Study|Withdrawal by Subject|1|||
161039512|NCT03229408|581534856|FG000|Overall Study|Adverse Event|2|||
161039513|NCT03229408|581534857|FG001|Overall Study|Adverse Event|0|||
161039514|NCT03229408|581534856|FG000|Overall Study|Pregnancy|0|||
161039515|NCT03229408|581534857|FG001|Overall Study|Pregnancy|1|||
161039516|NCT03229408|581534856|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
161039517|NCT03229408|581534857|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
161039518|NCT03745313|581534862|FG000|At 30 Days Follow-up|Death|2|||
161039519|NCT03745313|581534862|FG000|At 6 Months Follow-up|Death|1|||
161039520|NCT03745313|581534862|FG000|At 6 Months Follow-up|Missed Visit|1|||
161039521|NCT03745313|581534862|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
161039522|NCT03745313|581534862|FG000|At 1 Year Follow-up|Death|2|||
161039523|NCT03745313|581534862|FG000|At 1 Year Follow-up|Missed Visit|2|||
161280491|NCT03138655|582406946|FG002|Overall Study|Reason not Specified|0|||
161280492|NCT03138655|582406947|FG003|Overall Study|Reason not Specified|2|||
161039524|NCT03745313|581534862|FG000|At 2 Year Follow-up|Missed Visit|1|||
161039525|NCT02052440|581534866|FG000|Overall Study|Withdrawal by Subject|0|||
161039526|NCT02052440|581534867|FG001|Overall Study|Withdrawal by Subject|1|||
161039527|NCT01367236|581534871|FG000|Overall Study|Withdrawal by Subject|3|||
161039528|NCT01367236|581534872|FG001|Overall Study|Withdrawal by Subject|1|||
161280493|NCT03138655|582406948|FG004|Overall Study|Reason not Specified|1|||
161344803|NCT01157845|582647294|FG000|Overall Study|Protocol Violation|13|||
161039529|NCT02628626|581534877|FG000|Overall Study|Withdrawal by Subject|2|||
161039530|NCT02628626|581534878|FG001|Overall Study|Withdrawal by Subject|2|||
161039531|NCT01593020|581534879|FG000|Overall Study|Adverse Event|1|||
161039532|NCT01593020|581534880|FG001|Overall Study|Adverse Event|1|||
161039533|NCT01593020|581534879|FG000|Overall Study|Death|0|||
161039534|NCT01593020|581534880|FG001|Overall Study|Death|1|||
161039535|NCT01593020|581534879|FG000|Overall Study|Ineligible|1|||
161039536|NCT01593020|581534880|FG001|Overall Study|Ineligible|0|||
161039537|NCT02972359|581534884|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
161039538|NCT02972359|581534884|FG000|Overall Study|Lack of Efficacy|1|||
161039539|NCT02972359|581534884|FG000|Overall Study|Adverse Event|4|||
161039540|NCT02972359|581534884|FG000|Overall Study|Death|1|||
161039541|NCT02972359|581534884|FG000|Overall Study|Withdrawal by Subject|30|||
161039542|NCT02972359|581534884|FG000|Overall Study|Protocol Violation|1|||
161039543|NCT02972359|581534884|FG000|Overall Study|Lost to Follow-up|26|||
161039544|NCT02972359|581534884|FG000|Overall Study|Other reasons|5|||
161039545|NCT02972359|581534884|FG000|Overall Study|Missing|1|||
161039546|NCT05525572|581534885|FG000|Overall Study|Lost to Follow-up|2|||
161039547|NCT05025384|581534892|FG000|Overall Study|Physician Decision|5|||
161039548|NCT05025384|581534893|FG001|Overall Study|Physician Decision|6|||
161039549|NCT05251363|581534894|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
161039550|NCT05251363|581534894|FG000|Overall Study After Implant Period|Death|9|||
161039551|NCT05251363|581534894|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
161039552|NCT05251363|581534894|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
161039553|NCT05251363|581534894|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
161039554|NCT05251363|581534894|FG000|Overall Study After Implant Period|Physician Decision|1|||
161039555|NCT05251363|581534894|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
161039556|NCT00489307|581534895|FG000|Overall Study|Death|1|||
161039557|NCT00489307|581534896|FG001|Overall Study|Death|1|||
161039558|NCT00489307|581534895|FG000|Overall Study|Lost to Follow-up|2|||
161039559|NCT00489307|581534896|FG001|Overall Study|Lost to Follow-up|2|||
161039560|NCT00489307|581534895|FG000|Overall Study|Physician Decision|1|||
161039561|NCT00489307|581534896|FG001|Overall Study|Physician Decision|0|||
161039562|NCT00489307|581534895|FG000|Overall Study|Withdrawal by Subject|2|||
161039563|NCT00489307|581534896|FG001|Overall Study|Withdrawal by Subject|4|||
161039564|NCT00489307|581534895|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
161039565|NCT00489307|581534896|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
161039566|NCT00489307|581534895|FG000|Overall Study|Surgery after assignment|1|||
161039567|NCT00489307|581534896|FG001|Overall Study|Surgery after assignment|0|||
161039568|NCT00489307|581534895|FG000|Overall Study|Did not fill up the forms|2|||
161039569|NCT00489307|581534896|FG001|Overall Study|Did not fill up the forms|1|||
161039570|NCT00489307|581534895|FG000|Overall Study|Patient or family refusal|5|||
161039571|NCT00489307|581534896|FG001|Overall Study|Patient or family refusal|9|||
161039572|NCT03835754|581534897|FG000|Overall Study|Death|4|||
161039573|NCT02517268|581534900|FG000|Overall Study|Withdrawal by Subject|1|||
161039574|NCT02517268|581534901|FG001|Overall Study|Withdrawal by Subject|0|||
161039575|NCT05810285|581534907|FG000|Overall Study|Death|4|||
161039576|NCT05810285|581534908|FG001|Overall Study|Death|21|||
161039577|NCT05810285|581534907|FG000|Overall Study|Adverse Event|18|||
161039578|NCT05810285|581534908|FG001|Overall Study|Adverse Event|16|||
161039579|NCT04484623|581534909|FG000|Overall Study|Lost to Follow-up|0|||
161039580|NCT04484623|581534910|FG001|Overall Study|Lost to Follow-up|1|||
161039581|NCT04484623|581534909|FG000|Overall Study|Protocol Deviation|1|||
161039582|NCT04484623|581534910|FG001|Overall Study|Protocol Deviation|0|||
161039583|NCT04484623|581534909|FG000|Overall Study|Physician Decision|1|||
161039584|NCT04484623|581534910|FG001|Overall Study|Physician Decision|0|||
161039585|NCT04484623|581534909|FG000|Overall Study|Withdrawal by Subject|11|||
161039586|NCT04484623|581534910|FG001|Overall Study|Withdrawal by Subject|8|||
161039587|NCT04484623|581534909|FG000|Overall Study|Ongoing|94|||
161039588|NCT04484623|581534910|FG001|Overall Study|Ongoing|84|||
161039589|NCT05470114|581534911|FG000|Overall Study|Withdrawal by Subject|1|||
161039590|NCT05470114|581534912|FG001|Overall Study|Withdrawal by Subject|0|||
161039591|NCT05470114|581534911|FG000|Overall Study|Lost to Follow-up|1|||
161039592|NCT05470114|581534912|FG001|Overall Study|Lost to Follow-up|0|||
161039593|NCT04649047|581534917|FG000|Overall Study|Withdrawal by Subject|3|||
161039594|NCT05886777|581534918|FG000|Overall Study|Lost to Follow-up|1|||
161039595|NCT05886777|581534919|FG001|Overall Study|Lost to Follow-up|0|||
161039596|NCT05886777|581534920|FG002|Overall Study|Lost to Follow-up|2|||
161039597|NCT05886777|581534921|FG003|Overall Study|Lost to Follow-up|1|||
161039598|NCT05886777|581534922|FG004|Overall Study|Lost to Follow-up|0|||
161039599|NCT05886777|581534923|FG005|Overall Study|Lost to Follow-up|2|||
161039600|NCT05886777|581534924|FG006|Overall Study|Lost to Follow-up|0|||
161039601|NCT05886777|581534918|FG000|Overall Study|Other|0|||
161039602|NCT05886777|581534919|FG001|Overall Study|Other|2|||
161039603|NCT05886777|581534920|FG002|Overall Study|Other|1|||
161039604|NCT05886777|581534921|FG003|Overall Study|Other|0|||
161039605|NCT05886777|581534922|FG004|Overall Study|Other|0|||
161039606|NCT05886777|581534923|FG005|Overall Study|Other|0|||
161039607|NCT05886777|581534924|FG006|Overall Study|Other|0|||
161039608|NCT05886777|581534918|FG000|Overall Study|Withdrawal by Subject|1|||
161039609|NCT05886777|581534919|FG001|Overall Study|Withdrawal by Subject|0|||
161039610|NCT05886777|581534920|FG002|Overall Study|Withdrawal by Subject|1|||
161039611|NCT05886777|581534921|FG003|Overall Study|Withdrawal by Subject|4|||
161039612|NCT05886777|581534922|FG004|Overall Study|Withdrawal by Subject|3|||
161039613|NCT05886777|581534923|FG005|Overall Study|Withdrawal by Subject|1|||
161039614|NCT05886777|581534924|FG006|Overall Study|Withdrawal by Subject|1|||
161039615|NCT05886777|581534918|FG000|Overall Study|Protocol Violation|0|||
161039616|NCT05886777|581534919|FG001|Overall Study|Protocol Violation|0|||
161039617|NCT05886777|581534920|FG002|Overall Study|Protocol Violation|1|||
161039618|NCT05886777|581534921|FG003|Overall Study|Protocol Violation|0|||
161039619|NCT05886777|581534922|FG004|Overall Study|Protocol Violation|0|||
161039620|NCT05886777|581534923|FG005|Overall Study|Protocol Violation|0|||
161039621|NCT05886777|581534924|FG006|Overall Study|Protocol Violation|0|||
161039622|NCT05886777|581534918|FG000|Overall Study|No longer met eligibility criteria|0|||
161039623|NCT05886777|581534919|FG001|Overall Study|No longer met eligibility criteria|1|||
161039624|NCT05886777|581534920|FG002|Overall Study|No longer met eligibility criteria|0|||
161039625|NCT05886777|581534921|FG003|Overall Study|No longer met eligibility criteria|0|||
161039626|NCT05886777|581534922|FG004|Overall Study|No longer met eligibility criteria|0|||
161039627|NCT05886777|581534923|FG005|Overall Study|No longer met eligibility criteria|0|||
161039628|NCT05886777|581534924|FG006|Overall Study|No longer met eligibility criteria|0|||
161039629|NCT03773107|581534925|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
161039630|NCT03773107|581534926|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
161039631|NCT03773107|581534927|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
161039632|NCT03773107|581534928|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
161039633|NCT07204444|581534930|FG000|Overall Study|Medical/Hospitalization|6|||
161039634|NCT07204444|581534931|FG001|Overall Study|Medical/Hospitalization|9|||
161039635|NCT07204444|581534932|FG002|Overall Study|Medical/Hospitalization|6|||
161039636|NCT07204444|581534930|FG000|Overall Study|Treatment Provider Issue|1|||
161039637|NCT07204444|581534931|FG001|Overall Study|Treatment Provider Issue|3|||
161039638|NCT07204444|581534932|FG002|Overall Study|Treatment Provider Issue|0|||
161039639|NCT07204444|581534930|FG000|Overall Study|Withdrawal by Subject|11|||
161039640|NCT07204444|581534931|FG001|Overall Study|Withdrawal by Subject|5|||
161039641|NCT07204444|581534932|FG002|Overall Study|Withdrawal by Subject|5|||
161039642|NCT07204444|581534930|FG000|Overall Study|Death|3|||
161039643|NCT07204444|581534931|FG001|Overall Study|Death|6|||
161039644|NCT07204444|581534932|FG002|Overall Study|Death|1|||
161039645|NCT07204444|581534930|FG000|Overall Study|Unable To Reach|29|||
161039646|NCT07204444|581534931|FG001|Overall Study|Unable To Reach|26|||
161039647|NCT07204444|581534932|FG002|Overall Study|Unable To Reach|17|||
161039648|NCT07204444|581534930|FG000|Overall Study|Protocol Deviation|3|||
161039649|NCT07204444|581534931|FG001|Overall Study|Protocol Deviation|2|||
161039650|NCT07204444|581534932|FG002|Overall Study|Protocol Deviation|0|||
161039651|NCT02972034|581536430|FG000|Overall Study|Death|11|||
161039652|NCT02972034|581536431|FG001|Overall Study|Death|1|||
161039653|NCT02972034|581536432|FG002|Overall Study|Death|3|||
161039654|NCT02972034|581536433|FG003|Overall Study|Death|3|||
161039655|NCT02972034|581536434|FG004|Overall Study|Death|2|||
161039656|NCT02972034|581536435|FG005|Overall Study|Death|2|||
161039657|NCT02972034|581536436|FG006|Overall Study|Death|3|||
161039658|NCT02972034|581536437|FG007|Overall Study|Death|4|||
161039659|NCT02972034|581536438|FG008|Overall Study|Death|8|||
161039660|NCT02972034|581536439|FG009|Overall Study|Death|11|||
161039661|NCT02972034|581536440|FG010|Overall Study|Death|3|||
161039662|NCT02972034|581536441|FG011|Overall Study|Death|2|||
161039663|NCT02972034|581536442|FG012|Overall Study|Death|11|||
161039664|NCT02972034|581536443|FG013|Overall Study|Death|10|||
161039665|NCT02972034|581536444|FG014|Overall Study|Death|9|||
161039666|NCT02972034|581536430|FG000|Overall Study|Lost to Follow-up|0|||
161039667|NCT02972034|581536431|FG001|Overall Study|Lost to Follow-up|0|||
161039668|NCT02972034|581536432|FG002|Overall Study|Lost to Follow-up|0|||
161039669|NCT02972034|581536433|FG003|Overall Study|Lost to Follow-up|0|||
161039670|NCT02972034|581536434|FG004|Overall Study|Lost to Follow-up|1|||
161039671|NCT02972034|581536435|FG005|Overall Study|Lost to Follow-up|0|||
161039672|NCT02972034|581536436|FG006|Overall Study|Lost to Follow-up|0|||
161039673|NCT02972034|581536437|FG007|Overall Study|Lost to Follow-up|1|||
161344804|NCT01157845|582647294|FG000|Overall Study|Study was ended|1|||
161039674|NCT02972034|581536438|FG008|Overall Study|Lost to Follow-up|0|||
161039675|NCT02972034|581536439|FG009|Overall Study|Lost to Follow-up|0|||
161039676|NCT02972034|581536440|FG010|Overall Study|Lost to Follow-up|0|||
161039677|NCT02972034|581536441|FG011|Overall Study|Lost to Follow-up|0|||
161039678|NCT02972034|581536442|FG012|Overall Study|Lost to Follow-up|0|||
161039679|NCT02972034|581536443|FG013|Overall Study|Lost to Follow-up|0|||
161039680|NCT02972034|581536444|FG014|Overall Study|Lost to Follow-up|1|||
161039681|NCT02972034|581536430|FG000|Overall Study|Physician Decision|0|||
161039682|NCT02972034|581536431|FG001|Overall Study|Physician Decision|0|||
161039683|NCT02972034|581536432|FG002|Overall Study|Physician Decision|0|||
161039684|NCT02972034|581536433|FG003|Overall Study|Physician Decision|0|||
161344805|NCT01157845|582647294|FG000|Overall Study|Device malfunction|1|||
161039685|NCT02972034|581536434|FG004|Overall Study|Physician Decision|0|||
161039686|NCT02972034|581536435|FG005|Overall Study|Physician Decision|0|||
161039687|NCT02972034|581536436|FG006|Overall Study|Physician Decision|0|||
161039688|NCT02972034|581536437|FG007|Overall Study|Physician Decision|1|||
161039689|NCT02972034|581536438|FG008|Overall Study|Physician Decision|0|||
161039690|NCT02972034|581536439|FG009|Overall Study|Physician Decision|0|||
161039691|NCT02972034|581536440|FG010|Overall Study|Physician Decision|1|||
161039692|NCT02972034|581536441|FG011|Overall Study|Physician Decision|0|||
161039693|NCT02972034|581536442|FG012|Overall Study|Physician Decision|0|||
161039694|NCT02972034|581536443|FG013|Overall Study|Physician Decision|0|||
161039695|NCT02972034|581536444|FG014|Overall Study|Physician Decision|0|||
161039696|NCT02972034|581536430|FG000|Overall Study|Sponsor Decision|0|||
161039697|NCT02972034|581536431|FG001|Overall Study|Sponsor Decision|0|||
161039698|NCT02972034|581536432|FG002|Overall Study|Sponsor Decision|0|||
161039699|NCT02972034|581536433|FG003|Overall Study|Sponsor Decision|1|||
161039700|NCT02972034|581536434|FG004|Overall Study|Sponsor Decision|0|||
161039701|NCT02972034|581536435|FG005|Overall Study|Sponsor Decision|0|||
161039702|NCT02972034|581536436|FG006|Overall Study|Sponsor Decision|1|||
161039703|NCT02972034|581536437|FG007|Overall Study|Sponsor Decision|1|||
161039704|NCT02972034|581536438|FG008|Overall Study|Sponsor Decision|1|||
161039705|NCT02972034|581536439|FG009|Overall Study|Sponsor Decision|2|||
161039706|NCT02972034|581536440|FG010|Overall Study|Sponsor Decision|2|||
161039707|NCT02972034|581536441|FG011|Overall Study|Sponsor Decision|0|||
161039708|NCT02972034|581536442|FG012|Overall Study|Sponsor Decision|1|||
161039709|NCT02972034|581536443|FG013|Overall Study|Sponsor Decision|0|||
161039710|NCT02972034|581536444|FG014|Overall Study|Sponsor Decision|1|||
161039711|NCT02972034|581536430|FG000|Overall Study|Withdrawal by Subject|3|||
161039712|NCT02972034|581536431|FG001|Overall Study|Withdrawal by Subject|0|||
161039713|NCT02972034|581536432|FG002|Overall Study|Withdrawal by Subject|0|||
161039714|NCT02972034|581536433|FG003|Overall Study|Withdrawal by Subject|0|||
161039715|NCT02972034|581536434|FG004|Overall Study|Withdrawal by Subject|1|||
161039716|NCT02972034|581536435|FG005|Overall Study|Withdrawal by Subject|1|||
161039717|NCT02972034|581536436|FG006|Overall Study|Withdrawal by Subject|0|||
161039718|NCT02972034|581536437|FG007|Overall Study|Withdrawal by Subject|0|||
161039719|NCT02972034|581536438|FG008|Overall Study|Withdrawal by Subject|1|||
161039720|NCT02972034|581536439|FG009|Overall Study|Withdrawal by Subject|1|||
161039721|NCT02972034|581536440|FG010|Overall Study|Withdrawal by Subject|2|||
161039722|NCT02972034|581536441|FG011|Overall Study|Withdrawal by Subject|1|||
161039723|NCT02972034|581536442|FG012|Overall Study|Withdrawal by Subject|1|||
161039724|NCT02972034|581536443|FG013|Overall Study|Withdrawal by Subject|1|||
161039725|NCT02972034|581536444|FG014|Overall Study|Withdrawal by Subject|0|||
161039726|NCT02972034|581536430|FG000|Overall Study|Screen Failure|0|||
161039727|NCT02972034|581536431|FG001|Overall Study|Screen Failure|0|||
161039728|NCT02972034|581536432|FG002|Overall Study|Screen Failure|0|||
161039729|NCT02972034|581536433|FG003|Overall Study|Screen Failure|0|||
161039730|NCT02972034|581536434|FG004|Overall Study|Screen Failure|0|||
161039731|NCT02972034|581536435|FG005|Overall Study|Screen Failure|0|||
161039732|NCT02972034|581536436|FG006|Overall Study|Screen Failure|0|||
161039733|NCT02972034|581536437|FG007|Overall Study|Screen Failure|0|||
161039734|NCT02972034|581536438|FG008|Overall Study|Screen Failure|0|||
161039735|NCT02972034|581536439|FG009|Overall Study|Screen Failure|0|||
161039736|NCT02972034|581536440|FG010|Overall Study|Screen Failure|0|||
161039737|NCT02972034|581536441|FG011|Overall Study|Screen Failure|0|||
161039738|NCT02972034|581536442|FG012|Overall Study|Screen Failure|1|||
161039739|NCT02972034|581536443|FG013|Overall Study|Screen Failure|0|||
161039740|NCT02972034|581536444|FG014|Overall Study|Screen Failure|0|||
161039741|NCT03861052|581536445|FG000|Overall Study|Adverse Event|1|||
161039742|NCT03861052|581536446|FG001|Overall Study|Adverse Event|1|||
161039743|NCT03861052|581536447|FG002|Overall Study|Adverse Event|2|||
161039744|NCT03861052|581536448|FG003|Overall Study|Adverse Event|4|||
161039745|NCT03861052|581536445|FG000|Overall Study|Lost to Follow-up|0|||
161039746|NCT03861052|581536446|FG001|Overall Study|Lost to Follow-up|0|||
161039747|NCT03861052|581536447|FG002|Overall Study|Lost to Follow-up|0|||
161039748|NCT03861052|581536448|FG003|Overall Study|Lost to Follow-up|1|||
161039749|NCT03861052|581536445|FG000|Overall Study|Physician Decision|0|||
161039750|NCT03861052|581536446|FG001|Overall Study|Physician Decision|1|||
161039751|NCT03861052|581536447|FG002|Overall Study|Physician Decision|0|||
161039752|NCT03861052|581536448|FG003|Overall Study|Physician Decision|0|||
161039753|NCT03861052|581536445|FG000|Overall Study|Withdrawal by Subject|2|||
161039754|NCT03861052|581536446|FG001|Overall Study|Withdrawal by Subject|5|||
161039755|NCT03861052|581536447|FG002|Overall Study|Withdrawal by Subject|3|||
161039756|NCT03861052|581536448|FG003|Overall Study|Withdrawal by Subject|0|||
161039757|NCT03861052|581536445|FG000|Overall Study|Relocation to other city|1|||
161039758|NCT03861052|581536446|FG001|Overall Study|Relocation to other city|0|||
161039759|NCT03861052|581536447|FG002|Overall Study|Relocation to other city|0|||
161039760|NCT03861052|581536448|FG003|Overall Study|Relocation to other city|0|||
161039761|NCT03009344|581536449|FG000|Overall Study|Lack of Efficacy|5|||
161039762|NCT03009344|581536449|FG000|Overall Study|Withdrawal by Subject|1|||
161039763|NCT03009344|581536449|FG000|Overall Study|Adverse Event|1|||
161039764|NCT00345046|581536456|FG000|Overall Study|Protocol Violation|1|||
161039765|NCT00345046|581536457|FG001|Overall Study|Protocol Violation|1|||
161039766|NCT00345046|581536458|FG002|Overall Study|Protocol Violation|2|||
161039767|NCT03689946|581536459|FG000|Overall Study|Withdrawal by Subject|3|||
161039768|NCT03689946|581536459|FG000|Overall Study|Lost to Follow-up|3|||
161039769|NCT03689946|581536459|FG000|Overall Study|Data corruption|2|||
161039770|NCT01555138|581536460|FG000|Overall Study|Death|0|||
161039771|NCT01555138|581536461|FG001|Overall Study|Death|1|||
161039772|NCT01555138|581536460|FG000|Overall Study|Lost to Follow-up|1|||
161039773|NCT01555138|581536461|FG001|Overall Study|Lost to Follow-up|0|||
161039774|NCT01555138|581536460|FG000|Overall Study|Abnormal Lab reults|1|||
161039775|NCT01555138|581536461|FG001|Overall Study|Abnormal Lab reults|3|||
161039776|NCT01555138|581536460|FG000|Overall Study|Lack of Efficacy|2|||
161039777|NCT01555138|581536461|FG001|Overall Study|Lack of Efficacy|2|||
161039778|NCT01555138|581536460|FG000|Overall Study|Protocol Violation|5|||
161039779|NCT01555138|581536461|FG001|Overall Study|Protocol Violation|3|||
161039780|NCT01555138|581536460|FG000|Overall Study|Administrative problems|8|||
161039781|NCT01555138|581536461|FG001|Overall Study|Administrative problems|0|||
161039782|NCT01555138|581536460|FG000|Overall Study|Withdrawal by Subject|16|||
161039783|NCT01555138|581536461|FG001|Overall Study|Withdrawal by Subject|15|||
161039784|NCT01555138|581536460|FG000|Overall Study|Adverse Event|14|||
161039785|NCT01555138|581536461|FG001|Overall Study|Adverse Event|14|||
161039786|NCT00512252|581536465|FG000|Overall Study|Lost to Follow-up|0|||
161039787|NCT00512252|581536466|FG001|Overall Study|Lost to Follow-up|0|||
161039788|NCT00512252|581536467|FG002|Overall Study|Lost to Follow-up|1|||
161039789|NCT00512252|581536465|FG000|Overall Study|Protocol Violation|0|||
161039790|NCT00512252|581536466|FG001|Overall Study|Protocol Violation|0|||
161039791|NCT00512252|581536467|FG002|Overall Study|Protocol Violation|1|||
161039792|NCT00512252|581536465|FG000|Overall Study|Death|0|||
161039793|NCT00512252|581536466|FG001|Overall Study|Death|0|||
161039794|NCT00512252|581536467|FG002|Overall Study|Death|1|||
161039795|NCT02357966|581536468|FG000|Overall Study|Death|0|||
161039796|NCT02357966|581536469|FG001|Overall Study|Death|0|||
161039797|NCT02357966|581536470|FG002|Overall Study|Death|1|||
161039798|NCT02357966|581536471|FG003|Overall Study|Death|0|||
161039799|NCT02357966|581536472|FG004|Overall Study|Death|2|||
161039800|NCT02357966|581536473|FG005|Overall Study|Death|0|||
161039801|NCT02357966|581536468|FG000|Overall Study|Physician Decision|1|||
161039802|NCT02357966|581536469|FG001|Overall Study|Physician Decision|0|||
161039803|NCT02357966|581536470|FG002|Overall Study|Physician Decision|0|||
161039804|NCT02357966|581536471|FG003|Overall Study|Physician Decision|0|||
161039805|NCT02357966|581536472|FG004|Overall Study|Physician Decision|1|||
161039806|NCT02357966|581536473|FG005|Overall Study|Physician Decision|0|||
161039807|NCT04608409|581536477|FG000|Overall Study|Physician Decision|1|||
161039808|NCT04608409|581536478|FG001|Overall Study|Physician Decision|1|||
161039809|NCT04608409|581536479|FG002|Overall Study|Physician Decision|2|||
161039810|NCT00454194|581536480|FG000|Overall Study|Adverse Event|7|||
161039811|NCT00454194|581536481|FG001|Overall Study|Adverse Event|2|||
161039812|NCT00454194|581536480|FG000|Overall Study|Withdrawal by Subject|12|||
161039813|NCT00454194|581536481|FG001|Overall Study|Withdrawal by Subject|8|||
161039814|NCT00454194|581536480|FG000|Overall Study|Other Medical Problems|1|||
161039815|NCT00454194|581536481|FG001|Overall Study|Other Medical Problems|2|||
161039816|NCT00454194|581536480|FG000|Overall Study|Other Unspecified Reason|2|||
161039817|NCT00454194|581536481|FG001|Overall Study|Other Unspecified Reason|2|||
161039818|NCT00229658|581536498|FG000|Overall Study|Administrative|2|||
161039819|NCT00229658|581536499|FG001|Overall Study|Administrative|1|||
161039820|NCT00229658|581536498|FG000|Overall Study|Investigator decision|13|||
161039821|NCT00229658|581536499|FG001|Overall Study|Investigator decision|10|||
161039822|NCT00229658|581536498|FG000|Overall Study|Other|80|||
161039823|NCT00229658|581536499|FG001|Overall Study|Other|60|||
161039824|NCT00229658|581536498|FG000|Overall Study|Lost to Follow-up|82|||
161039825|NCT00229658|581536499|FG001|Overall Study|Lost to Follow-up|55|||
161039826|NCT00229658|581536498|FG000|Overall Study|Serious Adverse Event|2|||
161039827|NCT00229658|581536499|FG001|Overall Study|Serious Adverse Event|2|||
161039828|NCT00229658|581536498|FG000|Overall Study|Withdrawal of consent|46|||
161039829|NCT00229658|581536499|FG001|Overall Study|Withdrawal of consent|39|||
161039830|NCT02157116|581536500|FG000|Overall Study|Withdrawal by Subject|4|||
161039831|NCT02157116|581536500|FG000|Overall Study|Physician Decision|3|||
161039832|NCT02157116|581536500|FG000|Overall Study|Failed Screening|2|||
161039833|NCT01953224|581536501|FG000|Overall Study|Lost to Follow-up|1|||
161039834|NCT01953224|581536502|FG001|Overall Study|Lost to Follow-up|1|||
161039835|NCT01953224|581536501|FG000|Overall Study|Withdrawal by Subject|1|||
161039836|NCT01953224|581536502|FG001|Overall Study|Withdrawal by Subject|2|||
161039837|NCT00463229|581536503|FG000|Overall Study|Lost to Follow-up|5|||
161039838|NCT00463229|581536504|FG001|Overall Study|Lost to Follow-up|7|||
161039839|NCT00463229|581536503|FG000|Overall Study|Death|4|||
161039840|NCT00463229|581536504|FG001|Overall Study|Death|3|||
161039841|NCT01359150|581536511|FG000|Overall Study|Lack of Efficacy|1|||
161039842|NCT01359150|581536512|FG001|Overall Study|Lack of Efficacy|1|||
161039843|NCT01359150|581536511|FG000|Overall Study|Withdrawal by Subject|1|||
161039844|NCT01359150|581536512|FG001|Overall Study|Withdrawal by Subject|1|||
161039845|NCT01359150|581536511|FG000|Overall Study|Adverse Event|4|||
161039846|NCT01359150|581536512|FG001|Overall Study|Adverse Event|3|||
161039847|NCT01359150|581536511|FG000|Overall Study|Other|1|||
161039848|NCT01359150|581536512|FG001|Overall Study|Other|0|||
161039849|NCT01700205|581536513|FG000|Overall Study|Withdrawal by Subject|13|||
161039850|NCT01700205|581536514|FG001|Overall Study|Withdrawal by Subject|13|||
161039851|NCT01700205|581536513|FG000|Overall Study|Protocol Violation|2|||
161039852|NCT01700205|581536514|FG001|Overall Study|Protocol Violation|2|||
161039853|NCT01728324|581536515|FG000|Termination of DBV|Adverse Event|14|||
161039854|NCT01728324|581536516|FG001|Termination of DBV|Adverse Event|13|||
161039855|NCT01728324|581536517|FG002|Termination of DBV|Adverse Event|4|||
161039856|NCT01728324|581536515|FG000|Termination of DBV|Lack of Efficacy|14|||
161039857|NCT01728324|581536516|FG001|Termination of DBV|Lack of Efficacy|12|||
161039858|NCT01728324|581536517|FG002|Termination of DBV|Lack of Efficacy|8|||
161039859|NCT01728324|581536515|FG000|Termination of DBV|Withdrawal by Subject|9|||
161039860|NCT01728324|581536516|FG001|Termination of DBV|Withdrawal by Subject|6|||
161039861|NCT01728324|581536517|FG002|Termination of DBV|Withdrawal by Subject|2|||
161039862|NCT01728324|581536515|FG000|Termination of DBV|Other than stated|1|||
161039863|NCT01728324|581536516|FG001|Termination of DBV|Other than stated|3|||
161039864|NCT01728324|581536517|FG002|Termination of DBV|Other than stated|0|||
161039865|NCT01728324|581536515|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
161039866|NCT01728324|581536516|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
161039867|NCT01728324|581536517|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
161039868|NCT01728324|581536515|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
161039869|NCT01728324|581536516|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
161039870|NCT01728324|581536517|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
161039871|NCT01728324|581536515|FG000|Termination of FDV|Adverse Event|14|||
161039872|NCT01728324|581536516|FG001|Termination of FDV|Adverse Event|13|||
161039873|NCT01728324|581536517|FG002|Termination of FDV|Adverse Event|4|||
161039874|NCT01728324|581536515|FG000|Termination of FDV|Lack of Efficacy|14|||
161039875|NCT01728324|581536516|FG001|Termination of FDV|Lack of Efficacy|12|||
161039876|NCT01728324|581536517|FG002|Termination of FDV|Lack of Efficacy|8|||
161039877|NCT01728324|581536515|FG000|Termination of FDV|Withdrawal by Subject|9|||
161039878|NCT01728324|581536516|FG001|Termination of FDV|Withdrawal by Subject|6|||
161039879|NCT01728324|581536517|FG002|Termination of FDV|Withdrawal by Subject|2|||
161039880|NCT01728324|581536515|FG000|Termination of FDV|Other than stated|1|||
161039881|NCT01728324|581536516|FG001|Termination of FDV|Other than stated|3|||
161039882|NCT01728324|581536517|FG002|Termination of FDV|Other than stated|0|||
161039883|NCT01728324|581536515|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
161039884|NCT01728324|581536516|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
161039885|NCT01728324|581536517|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
161039886|NCT01728324|581536515|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
161039887|NCT01728324|581536516|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
161039888|NCT01728324|581536517|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
161039889|NCT01728324|581536515|FG000|Termination of RBV|Adverse Event|15|||
161039890|NCT01728324|581536516|FG001|Termination of RBV|Adverse Event|16|||
161039891|NCT01728324|581536517|FG002|Termination of RBV|Adverse Event|5|||
161039892|NCT01728324|581536515|FG000|Termination of RBV|Lack of Efficacy|14|||
161039893|NCT01728324|581536516|FG001|Termination of RBV|Lack of Efficacy|11|||
161039894|NCT01728324|581536517|FG002|Termination of RBV|Lack of Efficacy|7|||
161039895|NCT01728324|581536515|FG000|Termination of RBV|Withdrawal by Subject|9|||
161039896|NCT01728324|581536516|FG001|Termination of RBV|Withdrawal by Subject|5|||
161039897|NCT01728324|581536517|FG002|Termination of RBV|Withdrawal by Subject|2|||
161039898|NCT01728324|581536515|FG000|Termination of RBV|Other than stated|1|||
161039899|NCT01728324|581536516|FG001|Termination of RBV|Other than stated|3|||
161039900|NCT01728324|581536517|FG002|Termination of RBV|Other than stated|1|||
161039901|NCT01728324|581536515|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
161039902|NCT01728324|581536516|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
161039903|NCT01728324|581536517|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
161039904|NCT01728324|581536515|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
161039905|NCT01728324|581536516|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
161039906|NCT01728324|581536517|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
161039907|NCT02040870|581536520|FG000|Overall Study|Completed treatment phase|6|||
161039908|NCT02040870|581536520|FG000|Overall Study|Adverse Event|7|||
161039909|NCT02040870|581536520|FG000|Overall Study|Progressive disease|58|||
161039910|NCT02040870|581536520|FG000|Overall Study|Physician Decision|6|||
161039911|NCT02040870|581536520|FG000|Overall Study|Subject/guardian decision|10|||
161039912|NCT02040870|581536520|FG000|Overall Study|Lost to Follow-up|3|||
161039913|NCT02040870|581536520|FG000|Overall Study|Death|13|||
161039914|NCT00641537|581536530|FG000|96-week Period|Adverse Event|0|||
161039915|NCT00641537|581536531|FG001|96-week Period|Adverse Event|1|||
161039916|NCT00641537|581536532|FG002|96-week Period|Adverse Event|3|||
161039917|NCT00641537|581536533|FG003|96-week Period|Adverse Event|0|||
161039918|NCT00641537|581536534|FG004|96-week Period|Adverse Event|2|||
161039919|NCT00641537|581536535|FG005|96-week Period|Adverse Event|0|||
161039920|NCT00641537|581536536|FG006|96-week Period|Adverse Event|0|||
161039921|NCT00641537|581536537|FG007|96-week Period|Adverse Event|0|||
161039922|NCT00641537|581536530|FG000|96-week Period|Lost to Follow-up|3|||
161039923|NCT00641537|581536531|FG001|96-week Period|Lost to Follow-up|1|||
161039924|NCT00641537|581536532|FG002|96-week Period|Lost to Follow-up|2|||
161039925|NCT00641537|581536533|FG003|96-week Period|Lost to Follow-up|2|||
161039926|NCT00641537|581536534|FG004|96-week Period|Lost to Follow-up|4|||
161039927|NCT00641537|581536535|FG005|96-week Period|Lost to Follow-up|0|||
161039928|NCT00641537|581536536|FG006|96-week Period|Lost to Follow-up|1|||
161039929|NCT00641537|581536537|FG007|96-week Period|Lost to Follow-up|0|||
161039930|NCT00641537|581536530|FG000|96-week Period|Protocol Violation|0|||
161039931|NCT00641537|581536531|FG001|96-week Period|Protocol Violation|1|||
161039932|NCT00641537|581536532|FG002|96-week Period|Protocol Violation|0|||
161039933|NCT00641537|581536533|FG003|96-week Period|Protocol Violation|1|||
161039934|NCT00641537|581536534|FG004|96-week Period|Protocol Violation|0|||
161039935|NCT00641537|581536535|FG005|96-week Period|Protocol Violation|1|||
161039936|NCT00641537|581536536|FG006|96-week Period|Protocol Violation|0|||
161039937|NCT00641537|581536537|FG007|96-week Period|Protocol Violation|0|||
161039938|NCT00641537|581536530|FG000|96-week Period|Death|2|||
161039939|NCT00641537|581536531|FG001|96-week Period|Death|0|||
161039940|NCT00641537|581536532|FG002|96-week Period|Death|1|||
161039941|NCT00641537|581536533|FG003|96-week Period|Death|0|||
161039942|NCT00641537|581536534|FG004|96-week Period|Death|0|||
161039943|NCT00641537|581536535|FG005|96-week Period|Death|0|||
161039944|NCT00641537|581536536|FG006|96-week Period|Death|0|||
161039945|NCT00641537|581536537|FG007|96-week Period|Death|0|||
161039946|NCT00641537|581536530|FG000|96-week Period|Other|4|||
161039947|NCT00641537|581536531|FG001|96-week Period|Other|7|||
161039948|NCT00641537|581536532|FG002|96-week Period|Other|14|||
161039949|NCT00641537|581536533|FG003|96-week Period|Other|9|||
161039950|NCT00641537|581536534|FG004|96-week Period|Other|11|||
161039951|NCT00641537|581536535|FG005|96-week Period|Other|6|||
161039952|NCT00641537|581536536|FG006|96-week Period|Other|4|||
161039953|NCT00641537|581536537|FG007|96-week Period|Other|6|||
161039954|NCT00641537|581536530|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
161039955|NCT00641537|581536531|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
161039956|NCT00641537|581536532|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
161039957|NCT00641537|581536533|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
161039958|NCT00641537|581536534|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
161039959|NCT00641537|581536535|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
161039960|NCT00641537|581536536|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
161039961|NCT00641537|581536537|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
161039962|NCT00641537|581536530|FG000|24-Week Supplemental Follow-up Period|Other|0|||
161039963|NCT00641537|581536531|FG001|24-Week Supplemental Follow-up Period|Other|2|||
161039964|NCT00641537|581536532|FG002|24-Week Supplemental Follow-up Period|Other|2|||
161039965|NCT00641537|581536533|FG003|24-Week Supplemental Follow-up Period|Other|1|||
161039966|NCT00641537|581536534|FG004|24-Week Supplemental Follow-up Period|Other|3|||
161039967|NCT00641537|581536535|FG005|24-Week Supplemental Follow-up Period|Other|0|||
161039968|NCT00641537|581536536|FG006|24-Week Supplemental Follow-up Period|Other|1|||
161039969|NCT00641537|581536537|FG007|24-Week Supplemental Follow-up Period|Other|1|||
161039970|NCT01706159|581536538|FG000|Overall Study|Withdrawal Criteria|2|||
161039971|NCT01706159|581536539|FG001|Overall Study|Withdrawal Criteria|1|||
161039972|NCT01706159|581536538|FG000|Overall Study|Unclassified|6|||
161039973|NCT01706159|581536539|FG001|Overall Study|Unclassified|1|||
161039974|NCT02235298|581536540|FG000|Overall Study|Lost to Follow-up|6|||
161039975|NCT02235298|581536541|FG001|Overall Study|Lost to Follow-up|5|||
161039976|NCT02235298|581536540|FG000|Overall Study|Adverse Event|2|||
161039977|NCT02235298|581536541|FG001|Overall Study|Adverse Event|2|||
161039978|NCT02235298|581536540|FG000|Overall Study|Withdrawal by Subject|0|||
161039979|NCT02235298|581536541|FG001|Overall Study|Withdrawal by Subject|1|||
161039980|NCT03371017|581536546|FG000|Overall Study|Physician Decision|0|||
161039981|NCT03371017|581536547|FG001|Overall Study|Physician Decision|1|||
161039982|NCT03371017|581536546|FG000|Overall Study|Reason not Specified|0|||
161039983|NCT03371017|581536547|FG001|Overall Study|Reason not Specified|1|||
161039984|NCT03371017|581536546|FG000|Overall Study|Lost to Follow-up|13|||
161280494|NCT03138655|582406949|FG005|Overall Study|Reason not Specified|1|||
161039985|NCT03371017|581536547|FG001|Overall Study|Lost to Follow-up|16|||
161039986|NCT03371017|581536546|FG000|Overall Study|Death|228|||
161039987|NCT03371017|581536547|FG001|Overall Study|Death|215|||
161039988|NCT03371017|581536546|FG000|Overall Study|Withdrawal by Subject|20|||
161039989|NCT03371017|581536547|FG001|Overall Study|Withdrawal by Subject|25|||
161039990|NCT03371017|581536546|FG000|Overall Study|Study Ended by Sponsor|37|||
161039991|NCT03371017|581536547|FG001|Overall Study|Study Ended by Sponsor|38|||
161039992|NCT03371017|581536546|FG000|Overall Study|Protocol Deviation|0|||
161039993|NCT03371017|581536547|FG001|Overall Study|Protocol Deviation|1|||
161039994|NCT04686266|581536548|FG000|Overall Study|Withdrawal by Subject|0|||
161039995|NCT04686266|581536549|FG001|Overall Study|Withdrawal by Subject|1|||
161039996|NCT02401815|581536554|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161039997|NCT02401815|581536555|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161039998|NCT02401815|581536556|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161039999|NCT02401815|581536557|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
161040000|NCT02401815|581536558|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161040001|NCT02401815|581536559|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161040002|NCT02401815|581536560|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161040003|NCT02401815|581536561|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161040004|NCT02401815|581536562|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161040005|NCT02401815|581536563|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
161040006|NCT02401815|581536554|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
161040007|NCT02401815|581536555|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040008|NCT02401815|581536556|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040009|NCT02401815|581536557|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
161040010|NCT02401815|581536558|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040011|NCT02401815|581536559|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040012|NCT02401815|581536560|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040013|NCT02401815|581536561|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040014|NCT02401815|581536562|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040015|NCT02401815|581536563|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
161040016|NCT02401815|581536554|FG000|Dose Escalation (up to 670 Days)|Death|1|||
161040017|NCT02401815|581536555|FG001|Dose Escalation (up to 670 Days)|Death|2|||
161040018|NCT02401815|581536556|FG002|Dose Escalation (up to 670 Days)|Death|3|||
161040019|NCT02401815|581536557|FG003|Dose Escalation (up to 670 Days)|Death|5|||
161040020|NCT02401815|581536558|FG004|Dose Escalation (up to 670 Days)|Death|4|||
161040021|NCT02401815|581536559|FG005|Dose Escalation (up to 670 Days)|Death|0|||
161040022|NCT02401815|581536560|FG006|Dose Escalation (up to 670 Days)|Death|0|||
161040023|NCT02401815|581536561|FG007|Dose Escalation (up to 670 Days)|Death|0|||
161040024|NCT02401815|581536562|FG008|Dose Escalation (up to 670 Days)|Death|0|||
161040025|NCT02401815|581536563|FG009|Dose Escalation (up to 670 Days)|Death|0|||
161040026|NCT02401815|581536554|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040027|NCT02401815|581536555|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
161040028|NCT02401815|581536556|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040029|NCT02401815|581536557|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040030|NCT02401815|581536558|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
161040031|NCT02401815|581536559|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040032|NCT02401815|581536560|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040033|NCT02401815|581536561|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040034|NCT02401815|581536562|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040035|NCT02401815|581536563|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
161040036|NCT02401815|581536554|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
161040037|NCT02401815|581536555|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040038|NCT02401815|581536556|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040039|NCT02401815|581536557|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040040|NCT02401815|581536558|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
161040041|NCT02401815|581536559|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040042|NCT02401815|581536560|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040043|NCT02401815|581536561|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040044|NCT02401815|581536562|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040045|NCT02401815|581536563|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
161040046|NCT02401815|581536554|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040047|NCT02401815|581536555|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040048|NCT02401815|581536556|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040049|NCT02401815|581536557|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040050|NCT02401815|581536558|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040051|NCT02401815|581536559|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
161040052|NCT02401815|581536560|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040053|NCT02401815|581536561|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040054|NCT02401815|581536562|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040055|NCT02401815|581536563|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
161040056|NCT02401815|581536554|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040057|NCT02401815|581536555|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040058|NCT02401815|581536556|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040059|NCT02401815|581536557|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040060|NCT02401815|581536558|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040061|NCT02401815|581536559|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040062|NCT02401815|581536560|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
161344806|NCT04584788|582647295|FG000|Overall Study|Physician Decision|8|||
161040063|NCT02401815|581536561|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040064|NCT02401815|581536562|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040065|NCT02401815|581536563|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040066|NCT02401815|581536554|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040067|NCT02401815|581536555|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040068|NCT02401815|581536556|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040069|NCT02401815|581536557|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040070|NCT02401815|581536558|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040071|NCT02401815|581536559|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
161040072|NCT02401815|581536560|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
161040073|NCT02401815|581536561|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040074|NCT02401815|581536562|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040075|NCT02401815|581536563|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
161040076|NCT02401815|581536554|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040077|NCT02401815|581536555|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040078|NCT02401815|581536556|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040079|NCT02401815|581536557|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040080|NCT02401815|581536558|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040081|NCT02401815|581536559|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
161040082|NCT02401815|581536560|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040083|NCT02401815|581536561|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040084|NCT02401815|581536562|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040085|NCT02401815|581536563|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
161040086|NCT02401815|581536554|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040087|NCT02401815|581536555|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040088|NCT02401815|581536556|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040089|NCT02401815|581536557|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040090|NCT02401815|581536558|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040091|NCT02401815|581536559|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040092|NCT02401815|581536560|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
161040093|NCT02401815|581536561|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
161040094|NCT02401815|581536562|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
161040095|NCT02401815|581536563|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
161040096|NCT02401815|581536554|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040097|NCT02401815|581536555|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040098|NCT02401815|581536556|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040099|NCT02401815|581536557|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040100|NCT02401815|581536558|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040101|NCT02401815|581536559|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040102|NCT02401815|581536560|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040103|NCT02401815|581536561|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
161040104|NCT02401815|581536562|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
161040105|NCT02401815|581536563|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
161040106|NCT02401815|581536554|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040107|NCT02401815|581536555|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040108|NCT02401815|581536556|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040109|NCT02401815|581536557|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040110|NCT02401815|581536558|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040111|NCT02401815|581536559|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040112|NCT02401815|581536560|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040113|NCT02401815|581536561|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040114|NCT02401815|581536562|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
161040115|NCT02401815|581536563|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
161040116|NCT02401815|581536554|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040117|NCT02401815|581536555|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040118|NCT02401815|581536556|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040119|NCT02401815|581536557|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040120|NCT02401815|581536558|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040121|NCT02401815|581536559|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040122|NCT02401815|581536560|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161280495|NCT03138655|582406950|FG006|Overall Study|Reason not Specified|0|||
161280496|NCT03138655|582406951|FG007|Overall Study|Reason not Specified|0|||
161280497|NCT04036110|582406957|FG000|Overall Study|Lost to Follow-up|3|||
161280498|NCT04036110|582406958|FG001|Overall Study|Lost to Follow-up|2|||
161280499|NCT04036110|582406959|FG002|Overall Study|Lost to Follow-up|1|||
161040123|NCT02401815|581536561|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040124|NCT02401815|581536562|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
161040125|NCT02401815|581536563|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
161040126|NCT02401815|581536554|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040127|NCT02401815|581536555|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040128|NCT02401815|581536556|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040129|NCT02401815|581536557|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040130|NCT02401815|581536558|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040131|NCT02401815|581536559|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040132|NCT02401815|581536560|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040133|NCT02401815|581536561|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
161040134|NCT02401815|581536562|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
161040135|NCT02401815|581536563|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
161040136|NCT05613907|581536564|FG000|Overall Study|Lost to Follow-up|5|||
161040137|NCT05613907|581536564|FG000|Overall Study|Death|3|||
161040138|NCT05613907|581536564|FG000|Overall Study|Withdrawal by Subject|2|||
161040139|NCT03789656|581536572|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
161040140|NCT03789656|581536573|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
161040141|NCT03789656|581536574|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
161040142|NCT03789656|581536575|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
161040143|NCT03789656|581536576|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
161040144|NCT03789656|581536572|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161040145|NCT03789656|581536573|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161040146|NCT03789656|581536574|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
161040147|NCT03789656|581536575|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161040148|NCT03789656|581536576|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
161040149|NCT03789656|581536572|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
161040150|NCT03789656|581536573|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161040151|NCT03789656|581536574|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161040152|NCT03789656|581536575|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161040153|NCT03789656|581536576|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
161040154|NCT03789656|581536572|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
161040155|NCT03789656|581536573|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161040156|NCT03789656|581536574|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161040157|NCT03789656|581536575|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161040158|NCT03789656|581536576|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
161040159|NCT05325294|581536581|FG000|Overall Study|Adverse Event|3|||
161040160|NCT05325294|581536582|FG001|Overall Study|Adverse Event|3|||
161040161|NCT05325294|581536581|FG000|Overall Study|Physician Decision|0|||
161040162|NCT05325294|581536582|FG001|Overall Study|Physician Decision|1|||
161040163|NCT05325294|581536581|FG000|Overall Study|Withdrawal by Subject|0|||
161040164|NCT05325294|581536582|FG001|Overall Study|Withdrawal by Subject|3|||
161040165|NCT05325294|581536581|FG000|Overall Study|Lost to Follow-up|1|||
161040166|NCT05325294|581536582|FG001|Overall Study|Lost to Follow-up|0|||
161040167|NCT05325294|581536581|FG000|Overall Study|Sponsor Request|0|||
161040168|NCT05325294|581536582|FG001|Overall Study|Sponsor Request|2|||
161040169|NCT02488408|581536583|FG000|Part A|Adverse Event|2|||
161040170|NCT02488408|581536584|FG001|Part A|Adverse Event|0|||
161040171|NCT02488408|581536585|FG002|Part A|Adverse Event|0|||
161040172|NCT02488408|581536586|FG003|Part A|Adverse Event|0|||
161040173|NCT02488408|581536587|FG004|Part A|Adverse Event|0|||
161040174|NCT02488408|581536588|FG005|Part A|Adverse Event|0|||
161040175|NCT02488408|581536589|FG006|Part A|Adverse Event|0|||
161040176|NCT02488408|581536590|FG007|Part A|Adverse Event|0|||
161040177|NCT02488408|581536591|FG008|Part A|Adverse Event|0|||
161040178|NCT02488408|581536592|FG009|Part A|Adverse Event|0|||
161040179|NCT02488408|581536583|FG000|Part A|Death|1|||
161040180|NCT02488408|581536584|FG001|Part A|Death|5|||
161040181|NCT02488408|581536585|FG002|Part A|Death|0|||
161040182|NCT02488408|581536586|FG003|Part A|Death|0|||
161040183|NCT02488408|581536587|FG004|Part A|Death|3|||
161040184|NCT02488408|581536588|FG005|Part A|Death|0|||
161040185|NCT02488408|581536589|FG006|Part A|Death|0|||
161040186|NCT02488408|581536590|FG007|Part A|Death|0|||
161040187|NCT02488408|581536591|FG008|Part A|Death|0|||
161040188|NCT02488408|581536592|FG009|Part A|Death|0|||
161040189|NCT02488408|581536583|FG000|Part A|Disease Progression|2|||
161040190|NCT02488408|581536584|FG001|Part A|Disease Progression|8|||
161040191|NCT02488408|581536585|FG002|Part A|Disease Progression|2|||
161280500|NCT04036110|582406957|FG000|Overall Study|Study Suspended|4|||
161040192|NCT02488408|581536586|FG003|Part A|Disease Progression|3|||
161280501|NCT04036110|582406958|FG001|Overall Study|Study Suspended|5|||
161040193|NCT02488408|581536587|FG004|Part A|Disease Progression|4|||
161040194|NCT02488408|581536588|FG005|Part A|Disease Progression|0|||
161040195|NCT02488408|581536589|FG006|Part A|Disease Progression|0|||
161040196|NCT02488408|581536590|FG007|Part A|Disease Progression|0|||
161040197|NCT02488408|581536591|FG008|Part A|Disease Progression|0|||
161040198|NCT02488408|581536592|FG009|Part A|Disease Progression|0|||
161040199|NCT02488408|581536583|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
161040200|NCT02488408|581536584|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
161040201|NCT02488408|581536585|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
161040202|NCT02488408|581536586|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
161040203|NCT02488408|581536587|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
161040204|NCT02488408|581536588|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
161040205|NCT02488408|581536589|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
161040206|NCT02488408|581536590|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
161040207|NCT02488408|581536591|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
161040208|NCT02488408|581536592|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
161040209|NCT02488408|581536583|FG000|Part A|Investigator Decision|0|||
161040210|NCT02488408|581536584|FG001|Part A|Investigator Decision|1|||
161040211|NCT02488408|581536585|FG002|Part A|Investigator Decision|1|||
161040212|NCT02488408|581536586|FG003|Part A|Investigator Decision|0|||
161040213|NCT02488408|581536587|FG004|Part A|Investigator Decision|0|||
161040214|NCT02488408|581536588|FG005|Part A|Investigator Decision|0|||
161040215|NCT02488408|581536589|FG006|Part A|Investigator Decision|0|||
161040216|NCT02488408|581536590|FG007|Part A|Investigator Decision|0|||
161040217|NCT02488408|581536591|FG008|Part A|Investigator Decision|0|||
161040218|NCT02488408|581536592|FG009|Part A|Investigator Decision|0|||
161040219|NCT02488408|581536583|FG000|Part A|Withdrawal by Subject|0|||
161040220|NCT02488408|581536584|FG001|Part A|Withdrawal by Subject|0|||
161040221|NCT02488408|581536585|FG002|Part A|Withdrawal by Subject|2|||
161040222|NCT02488408|581536586|FG003|Part A|Withdrawal by Subject|0|||
161040223|NCT02488408|581536587|FG004|Part A|Withdrawal by Subject|0|||
161040224|NCT02488408|581536588|FG005|Part A|Withdrawal by Subject|0|||
161040225|NCT02488408|581536589|FG006|Part A|Withdrawal by Subject|0|||
161040226|NCT02488408|581536590|FG007|Part A|Withdrawal by Subject|0|||
161040227|NCT02488408|581536591|FG008|Part A|Withdrawal by Subject|0|||
161040228|NCT02488408|581536592|FG009|Part A|Withdrawal by Subject|0|||
161040229|NCT02488408|581536583|FG000|Part A|Other|1|||
161040230|NCT02488408|581536584|FG001|Part A|Other|0|||
161040231|NCT02488408|581536585|FG002|Part A|Other|0|||
161040232|NCT02488408|581536586|FG003|Part A|Other|0|||
161040233|NCT02488408|581536587|FG004|Part A|Other|0|||
161040234|NCT02488408|581536588|FG005|Part A|Other|0|||
161040235|NCT02488408|581536589|FG006|Part A|Other|0|||
161040236|NCT02488408|581536590|FG007|Part A|Other|0|||
161040237|NCT02488408|581536591|FG008|Part A|Other|0|||
161040238|NCT02488408|581536592|FG009|Part A|Other|0|||
161040239|NCT02488408|581536583|FG000|Part B|Adverse Event|0|||
161040240|NCT02488408|581536584|FG001|Part B|Adverse Event|0|||
161040241|NCT02488408|581536585|FG002|Part B|Adverse Event|0|||
161040242|NCT02488408|581536586|FG003|Part B|Adverse Event|0|||
161040243|NCT02488408|581536587|FG004|Part B|Adverse Event|0|||
161040244|NCT02488408|581536588|FG005|Part B|Adverse Event|2|||
161040245|NCT02488408|581536589|FG006|Part B|Adverse Event|2|||
161040246|NCT02488408|581536590|FG007|Part B|Adverse Event|7|||
161040247|NCT02488408|581536591|FG008|Part B|Adverse Event|2|||
161040248|NCT02488408|581536592|FG009|Part B|Adverse Event|2|||
161040249|NCT02488408|581536583|FG000|Part B|Death|0|||
161040250|NCT02488408|581536584|FG001|Part B|Death|0|||
161040251|NCT02488408|581536585|FG002|Part B|Death|0|||
161040252|NCT02488408|581536586|FG003|Part B|Death|0|||
161040253|NCT02488408|581536587|FG004|Part B|Death|0|||
161040254|NCT02488408|581536588|FG005|Part B|Death|3|||
161040255|NCT02488408|581536589|FG006|Part B|Death|1|||
161040256|NCT02488408|581536590|FG007|Part B|Death|2|||
161040257|NCT02488408|581536591|FG008|Part B|Death|2|||
161040258|NCT02488408|581536592|FG009|Part B|Death|2|||
161040259|NCT02488408|581536583|FG000|Part B|Death due to Disease Progression|0|||
161040260|NCT02488408|581536584|FG001|Part B|Death due to Disease Progression|0|||
161040261|NCT02488408|581536585|FG002|Part B|Death due to Disease Progression|0|||
161040262|NCT02488408|581536586|FG003|Part B|Death due to Disease Progression|0|||
161040263|NCT02488408|581536587|FG004|Part B|Death due to Disease Progression|0|||
161040264|NCT02488408|581536588|FG005|Part B|Death due to Disease Progression|2|||
161040265|NCT02488408|581536589|FG006|Part B|Death due to Disease Progression|2|||
161040266|NCT02488408|581536590|FG007|Part B|Death due to Disease Progression|1|||
161040267|NCT02488408|581536591|FG008|Part B|Death due to Disease Progression|1|||
161040268|NCT02488408|581536592|FG009|Part B|Death due to Disease Progression|1|||
161040269|NCT02488408|581536583|FG000|Part B|Disease Progression|0|||
161040270|NCT02488408|581536584|FG001|Part B|Disease Progression|0|||
161040271|NCT02488408|581536585|FG002|Part B|Disease Progression|0|||
161040272|NCT02488408|581536586|FG003|Part B|Disease Progression|0|||
161040273|NCT02488408|581536587|FG004|Part B|Disease Progression|0|||
161040274|NCT02488408|581536588|FG005|Part B|Disease Progression|6|||
161040275|NCT02488408|581536589|FG006|Part B|Disease Progression|9|||
161280502|NCT04036110|582406959|FG002|Overall Study|Study Suspended|1|||
161040276|NCT02488408|581536590|FG007|Part B|Disease Progression|7|||
161040277|NCT02488408|581536591|FG008|Part B|Disease Progression|9|||
161040278|NCT02488408|581536592|FG009|Part B|Disease Progression|11|||
161040279|NCT02488408|581536583|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
161040280|NCT02488408|581536584|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
161040281|NCT02488408|581536585|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
161040282|NCT02488408|581536586|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
161040283|NCT02488408|581536587|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
161040284|NCT02488408|581536588|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
161040285|NCT02488408|581536589|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
161040286|NCT02488408|581536590|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
161040287|NCT02488408|581536591|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
161040288|NCT02488408|581536592|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
161040289|NCT02488408|581536583|FG000|Part B|Investigator Decision|0|||
161040290|NCT02488408|581536584|FG001|Part B|Investigator Decision|0|||
161040291|NCT02488408|581536585|FG002|Part B|Investigator Decision|0|||
161040292|NCT02488408|581536586|FG003|Part B|Investigator Decision|0|||
161040293|NCT02488408|581536587|FG004|Part B|Investigator Decision|0|||
161040294|NCT02488408|581536588|FG005|Part B|Investigator Decision|0|||
161040295|NCT02488408|581536589|FG006|Part B|Investigator Decision|1|||
161040296|NCT02488408|581536590|FG007|Part B|Investigator Decision|0|||
161040297|NCT02488408|581536591|FG008|Part B|Investigator Decision|2|||
161040298|NCT02488408|581536592|FG009|Part B|Investigator Decision|1|||
161040299|NCT00719888|581536593|FG000|Overall Study|Death|24|||
161040300|NCT00719888|581536594|FG001|Overall Study|Death|9|||
161040301|NCT00719888|581536593|FG000|Overall Study|Relapse|8|||
161040302|NCT00719888|581536594|FG001|Overall Study|Relapse|3|||
161040303|NCT00719888|581536593|FG000|Overall Study|Physician Decision|1|||
161040304|NCT00719888|581536594|FG001|Overall Study|Physician Decision|0|||
161040305|NCT00719888|581536593|FG000|Overall Study|Withdrawal by Subject|1|||
161040306|NCT00719888|581536594|FG001|Overall Study|Withdrawal by Subject|0|||
161040307|NCT00491894|581536595|FG000|Overall Study|Adverse Event|14|||
161040308|NCT00491894|581536595|FG000|Overall Study|Withdrawal by Subject|5|||
161040309|NCT00491894|581536595|FG000|Overall Study|Death|3|||
161040310|NCT00491894|581536595|FG000|Overall Study|Lost to Follow-up|3|||
161040311|NCT00491894|581536595|FG000|Overall Study|Lack of Efficacy|2|||
161040312|NCT00491894|581536595|FG000|Overall Study|Other-Failed to meet any criteria|2|||
161040313|NCT00491894|581536595|FG000|Overall Study|Physician Decision|2|||
161040314|NCT00491894|581536595|FG000|Overall Study|Protocol Violation|2|||
161040315|NCT00491894|581536595|FG000|Overall Study|Other-Intake of prohibited medication|1|||
161040316|NCT04172675|581537718|FG000|Overall Study|Withdrawal by Subject|7|||
161040317|NCT04172675|581537719|FG001|Overall Study|Withdrawal by Subject|5|||
161040318|NCT04172675|581537720|FG002|Overall Study|Withdrawal by Subject|1|||
161040319|NCT04172675|581537721|FG003|Overall Study|Withdrawal by Subject|4|||
161040320|NCT00378898|581537722|FG000|Overall Study|Withdrawal by Subject|10|||
161040321|NCT00378898|581537723|FG001|Overall Study|Withdrawal by Subject|5|||
161040322|NCT00378898|581537722|FG000|Overall Study|Protocol Violation|1|||
161040323|NCT00378898|581537723|FG001|Overall Study|Protocol Violation|1|||
161040324|NCT00551421|581537724|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
161040325|NCT01278030|581537725|FG000|Overall Study|Withdrawal by Subject|8|||
161040326|NCT01278030|581537726|FG001|Overall Study|Withdrawal by Subject|4|||
161040327|NCT05815342|581537730|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
161040328|NCT05815342|581537730|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
161040329|NCT05815342|581537730|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
161040330|NCT05815342|581537730|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
161040331|NCT05815342|581537730|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
161040332|NCT00745875|581537735|FG000|Overall Study|Continuing study treatment|4|||
161040333|NCT00745875|581537736|FG001|Overall Study|Continuing study treatment|4|||
161040334|NCT03220724|581537741|FG000|Overall Study|Lost to Follow-up|2|||
161040335|NCT03220724|581537742|FG001|Overall Study|Lost to Follow-up|2|||
161040336|NCT03220724|581537743|FG002|Overall Study|Lost to Follow-up|0|||
161040337|NCT03220724|581537744|FG003|Overall Study|Lost to Follow-up|3|||
161040338|NCT03220724|581537745|FG004|Overall Study|Lost to Follow-up|1|||
161040339|NCT03220724|581537746|FG005|Overall Study|Lost to Follow-up|0|||
161040340|NCT03220724|581537747|FG006|Overall Study|Lost to Follow-up|2|||
161040341|NCT03220724|581537748|FG007|Overall Study|Lost to Follow-up|1|||
161040342|NCT03220724|581537749|FG008|Overall Study|Lost to Follow-up|0|||
161040343|NCT03220724|581537741|FG000|Overall Study|Withdrawal by Subject|1|||
161040344|NCT03220724|581537742|FG001|Overall Study|Withdrawal by Subject|0|||
161040345|NCT03220724|581537743|FG002|Overall Study|Withdrawal by Subject|1|||
161040346|NCT03220724|581537744|FG003|Overall Study|Withdrawal by Subject|0|||
161040347|NCT03220724|581537745|FG004|Overall Study|Withdrawal by Subject|0|||
161040348|NCT03220724|581537746|FG005|Overall Study|Withdrawal by Subject|0|||
161040349|NCT03220724|581537747|FG006|Overall Study|Withdrawal by Subject|0|||
161040350|NCT03220724|581537748|FG007|Overall Study|Withdrawal by Subject|0|||
161280503|NCT00534404|582406960|FG000|Overall Study|Death|0|||
161040351|NCT03220724|581537749|FG008|Overall Study|Withdrawal by Subject|0|||
161040352|NCT01613417|581537750|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
161040353|NCT01613417|581537751|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
161040354|NCT02000752|581537754|FG000|Overall Study|Dystocic delivery|19|||
161040355|NCT02000752|581537755|FG001|Overall Study|Dystocic delivery|8|||
161040356|NCT02000752|581537754|FG000|Overall Study|Shift Changes|12|||
161040357|NCT02000752|581537755|FG001|Overall Study|Shift Changes|5|||
161040358|NCT00019604|581537757|FG000|Overall Study|Death|1|||
161040359|NCT00019604|581537757|FG000|Overall Study|Progressive disease|23|||
161040360|NCT00019604|581537757|FG000|Overall Study|Refused treatment|1|||
161040361|NCT00019604|581537757|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
161040362|NCT00019604|581537757|FG000|Overall Study|Going to have liver transplant|1|||
161040363|NCT00019604|581537757|FG000|Overall Study|Move to a different study|1|||
161040364|NCT00019604|581537757|FG000|Overall Study|Non compliant on systemic CH|1|||
161040365|NCT00019604|581537757|FG000|Overall Study|Non compliant|1|||
161040366|NCT00019604|581537757|FG000|Overall Study|Resectable disease|1|||
161040367|NCT00019604|581537757|FG000|Overall Study|Started new chemo regimen|1|||
161040368|NCT00019604|581537757|FG000|Overall Study|Pt going to immunotherapy study|1|||
161040369|NCT00019604|581537757|FG000|Overall Study|Too much disease|1|||
161040370|NCT00019604|581537757|FG000|Overall Study|Unable to evaluate|1|||
161040371|NCT00019604|581537757|FG000|Overall Study|Details for other not available|4|||
161040372|NCT03392194|581537759|FG000|Overall Study|Withdrawal by Subject|1|||
161040373|NCT03392194|581537760|FG001|Overall Study|Withdrawal by Subject|2|||
161040374|NCT03392194|581537759|FG000|Overall Study|Conflicts with personal schedule|1|||
161040375|NCT03392194|581537760|FG001|Overall Study|Conflicts with personal schedule|0|||
161040376|NCT00620854|581537763|FG000|Washout 1|Withdrawal by Subject|0|||
161040377|NCT00620854|581537764|FG001|Washout 1|Withdrawal by Subject|0|||
161040378|NCT00620854|581537765|FG002|Washout 1|Withdrawal by Subject|1|||
161040379|NCT00620854|581537766|FG003|Washout 1|Withdrawal by Subject|1|||
161040380|NCT00620854|581537767|FG004|Washout 1|Withdrawal by Subject|0|||
161040381|NCT00620854|581537768|FG005|Washout 1|Withdrawal by Subject|0|||
161040382|NCT00093496|581537771|FG000|Overall Study|Protocol Violation|1|||
161040383|NCT00093496|581537772|FG001|Overall Study|Protocol Violation|3|||
161040384|NCT00586313|581537773|FG000|Overall Study|Lack of Efficacy|2|||
161040385|NCT03205566|581537778|FG000|Phase 1|Protocol Violation|1|||
161040386|NCT03205566|581537779|FG001|Phase 1|Protocol Violation|1|||
161040387|NCT01170208|581537782|FG000|Overall Study|Withdrawal by Subject|5|||
161040388|NCT01170208|581537783|FG001|Overall Study|Withdrawal by Subject|0|||
161040389|NCT01170208|581537784|FG002|Overall Study|Withdrawal by Subject|1|||
161040390|NCT01170208|581537782|FG000|Overall Study|Protocol Violation|1|||
161040391|NCT01170208|581537783|FG001|Overall Study|Protocol Violation|0|||
161040392|NCT01170208|581537784|FG002|Overall Study|Protocol Violation|1|||
161040393|NCT03113409|581537785|FG000|Overall Study|Withdrawal by Subject|5|||
161040394|NCT03113409|581537786|FG001|Overall Study|Withdrawal by Subject|0|||
161040395|NCT03113409|581537787|FG002|Overall Study|Withdrawal by Subject|0|||
161040396|NCT04971733|581537788|FG000|Overall Study|Adverse Event|1|||
161040397|NCT04971733|581537789|FG001|Overall Study|Adverse Event|1|||
161040398|NCT04971733|581537788|FG000|Overall Study|Subject choice|2|||
161040399|NCT04971733|581537789|FG001|Overall Study|Subject choice|0|||
161040400|NCT04971733|581537788|FG000|Overall Study|Withdrawal by Subject|1|||
161040401|NCT04971733|581537789|FG001|Overall Study|Withdrawal by Subject|0|||
161040402|NCT04971733|581537788|FG000|Overall Study|Other|1|||
161040403|NCT04971733|581537789|FG001|Overall Study|Other|0|||
161040404|NCT01160354|581537790|FG000|Overall Study|Death|0|||
161040405|NCT01160354|581537791|FG001|Overall Study|Death|1|||
161040406|NCT01160354|581537792|FG002|Overall Study|Death|1|||
161040407|NCT00600353|581537796|FG000|Overall Study|history of malignancy within 5 years|1|||
161040408|NCT00600353|581537797|FG001|Overall Study|history of malignancy within 5 years|0|||
161040409|NCT00600353|581537796|FG000|Overall Study|History of prepartive regimen|0|||
161040410|NCT00600353|581537797|FG001|Overall Study|History of prepartive regimen|1|||
161040411|NCT04941482|581537798|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
161040412|NCT04941482|581537799|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
161040413|NCT04200664|581537800|FG000|Overall Study|Withdrawal by Subject|1|||
161040414|NCT04200664|581537801|FG001|Overall Study|Withdrawal by Subject|0|||
161040415|NCT04200664|581537802|FG002|Overall Study|Withdrawal by Subject|0|||
161040416|NCT03362190|581537805|FG000|Overall Study|Adverse Event|0|||
161040417|NCT03362190|581537806|FG001|Overall Study|Adverse Event|0|||
161040418|NCT03362190|581537807|FG002|Overall Study|Adverse Event|0|||
161040419|NCT03362190|581537808|FG003|Overall Study|Adverse Event|1|||
161040420|NCT03362190|581537805|FG000|Overall Study|Withdrawal by Subject|0|||
161040421|NCT03362190|581537806|FG001|Overall Study|Withdrawal by Subject|0|||
161040422|NCT03362190|581537807|FG002|Overall Study|Withdrawal by Subject|0|||
161040423|NCT03362190|581537808|FG003|Overall Study|Withdrawal by Subject|1|||
161040424|NCT00687219|581537809|FG000|Overall Study|Adverse Event|8|||
161040425|NCT00687219|581537809|FG000|Overall Study|Discontinuance criteria met|7|||
161040426|NCT00687219|581537809|FG000|Overall Study|HCV-RNA positive conversion|34|||
161040427|NCT00687219|581537809|FG000|Overall Study|Withdrawal by Subject|1|||
161040428|NCT00687219|581537809|FG000|Overall Study|Lack of Efficacy|1|||
161040429|NCT02063659|581537817|FG000|Double-Blind Treatment Period|Adverse Event|1|||
161040430|NCT02063659|581537818|FG001|Double-Blind Treatment Period|Adverse Event|2|||
161040431|NCT02063659|581537819|FG002|Double-Blind Treatment Period|Adverse Event|0|||
161040432|NCT02063659|581537820|FG003|Double-Blind Treatment Period|Adverse Event|0|||
161040433|NCT02063659|581537817|FG000|Double-Blind Treatment Period|Physician Decision|1|||
161040434|NCT02063659|581537818|FG001|Double-Blind Treatment Period|Physician Decision|0|||
161040435|NCT02063659|581537819|FG002|Double-Blind Treatment Period|Physician Decision|0|||
161040436|NCT02063659|581537820|FG003|Double-Blind Treatment Period|Physician Decision|0|||
161040437|NCT02063659|581537817|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
161040438|NCT02063659|581537818|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
161040439|NCT02063659|581537819|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
161040440|NCT02063659|581537820|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
161040441|NCT02063659|581537817|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
161040442|NCT02063659|581537818|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
161040443|NCT02063659|581537819|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
161040444|NCT02063659|581537820|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
161040445|NCT02063659|581537817|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161040446|NCT02063659|581537818|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161040447|NCT02063659|581537819|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
161040448|NCT02063659|581537820|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
161040449|NCT02063659|581537817|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161040450|NCT02063659|581537818|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161040451|NCT02063659|581537819|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
161040452|NCT02063659|581537820|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
161040453|NCT02063659|581537817|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
161040454|NCT02063659|581537818|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
161040455|NCT02063659|581537819|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
161040456|NCT02063659|581537820|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
161040457|NCT02063659|581537817|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161040458|NCT02063659|581537818|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161040459|NCT02063659|581537819|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
161040460|NCT02063659|581537820|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
161040461|NCT04300023|581537823|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
161040462|NCT04300023|581537824|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
161040463|NCT04057131|581537825|FG000|Overall Study|Protocol Violation|24|||
161040464|NCT02830204|581537826|FG000|Overall Study|Death|9|||
161040465|NCT02830204|581537826|FG000|Overall Study|Withdrawal by Subject|1|||
161040466|NCT00748709|581537831|FG000|Overall Study|Progressive disease|15|||
161040467|NCT00748709|581537831|FG000|Overall Study|Drug reducing Toxity|2|||
161040468|NCT00748709|581537831|FG000|Overall Study|Other Adverse Event|1|||
161040469|NCT00748709|581537831|FG000|Overall Study|Withdrawal by Subject|1|||
161040470|NCT00748709|581537831|FG000|Overall Study|Other Reasons|1|||
161040471|NCT05422339|581539259|FG000|Overall Study|Withdrawal by Subject|17|||
161040472|NCT05422339|581539260|FG001|Overall Study|Withdrawal by Subject|15|||
161040473|NCT03070392|581539267|FG000|Overall Study|Not Treated|7|||
161040474|NCT03070392|581539268|FG001|Overall Study|Not Treated|0|||
161040475|NCT03070392|581539269|FG002|Overall Study|Not Treated|3|||
161040476|NCT03070392|581539270|FG003|Overall Study|Not Treated|12|||
161280504|NCT00534404|582406961|FG001|Overall Study|Death|0|||
161280505|NCT00534404|582406962|FG002|Overall Study|Death|2|||
161280506|NCT00534404|582406960|FG000|Overall Study|Withdrawal by Subject|8|||
161280507|NCT00534404|582406961|FG001|Overall Study|Withdrawal by Subject|2|||
161280508|NCT00534404|582406962|FG002|Overall Study|Withdrawal by Subject|38|||
161280509|NCT00534404|582406960|FG000|Overall Study|Removed by study staff|2|||
161280510|NCT00534404|582406961|FG001|Overall Study|Removed by study staff|3|||
161280511|NCT00534404|582406962|FG002|Overall Study|Removed by study staff|1|||
161280512|NCT00534404|582406960|FG000|Overall Study|Lost to Follow-up|170|||
161280513|NCT00534404|582406961|FG001|Overall Study|Lost to Follow-up|138|||
161280514|NCT00534404|582406962|FG002|Overall Study|Lost to Follow-up|201|||
161280515|NCT04759768|582406965|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161280516|NCT04759768|582406966|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
161280517|NCT04759768|582406965|FG000|Washout (7 Days)|Physician Decision|0|||
161280518|NCT04759768|582406966|FG001|Washout (7 Days)|Physician Decision|1|||
161280519|NCT02996487|582406967|FG000|Overall Study|Lost to Follow-up|1|||
161280520|NCT02996487|582406968|FG001|Overall Study|Lost to Follow-up|1|||
161280521|NCT02996487|582406969|FG002|Overall Study|Lost to Follow-up|0|||
161280522|NCT02996487|582406967|FG000|Overall Study|Death|0|||
161040477|NCT03070392|581539267|FG000|Overall Study|Death|3|||
161040478|NCT03070392|581539268|FG001|Overall Study|Death|0|||
161040479|NCT03070392|581539269|FG002|Overall Study|Death|0|||
161280523|NCT02996487|582406968|FG001|Overall Study|Death|1|||
161280524|NCT02996487|582406969|FG002|Overall Study|Death|0|||
161040480|NCT03070392|581539270|FG003|Overall Study|Death|1|||
161040481|NCT03070392|581539267|FG000|Overall Study|Withdrawal by Subject|7|||
161040482|NCT03070392|581539268|FG001|Overall Study|Withdrawal by Subject|0|||
161040483|NCT03070392|581539269|FG002|Overall Study|Withdrawal by Subject|0|||
161040484|NCT03070392|581539270|FG003|Overall Study|Withdrawal by Subject|3|||
161040485|NCT03070392|581539267|FG000|Overall Study|Physician Decision|1|||
161040486|NCT03070392|581539268|FG001|Overall Study|Physician Decision|0|||
161040487|NCT03070392|581539269|FG002|Overall Study|Physician Decision|0|||
161040488|NCT03070392|581539270|FG003|Overall Study|Physician Decision|2|||
161040489|NCT03070392|581539267|FG000|Overall Study|Progressive Disease|154|||
161040490|NCT03070392|581539268|FG001|Overall Study|Progressive Disease|6|||
161040491|NCT03070392|581539269|FG002|Overall Study|Progressive Disease|2|||
161040492|NCT03070392|581539270|FG003|Overall Study|Progressive Disease|70|||
161040493|NCT03070392|581539267|FG000|Overall Study|Adverse Event|6|||
161040494|NCT03070392|581539268|FG001|Overall Study|Adverse Event|1|||
161040495|NCT03070392|581539269|FG002|Overall Study|Adverse Event|1|||
161040496|NCT03070392|581539270|FG003|Overall Study|Adverse Event|3|||
161040497|NCT03070392|581539267|FG000|Overall Study|Alternate anticancer treatment|1|||
161040498|NCT03070392|581539268|FG001|Overall Study|Alternate anticancer treatment|0|||
161040499|NCT03070392|581539269|FG002|Overall Study|Alternate anticancer treatment|0|||
161040500|NCT03070392|581539270|FG003|Overall Study|Alternate anticancer treatment|1|||
161040501|NCT03070392|581539267|FG000|Overall Study|Ongoing|73|||
161040502|NCT03070392|581539268|FG001|Overall Study|Ongoing|0|||
161040503|NCT03070392|581539269|FG002|Overall Study|Ongoing|0|||
161040504|NCT03070392|581539270|FG003|Overall Study|Ongoing|11|||
161040505|NCT03678688|581539271|FG000|Overall Study|Reason not Specified|0|||
161040506|NCT03678688|581539272|FG001|Overall Study|Reason not Specified|0|||
161040507|NCT03678688|581539273|FG002|Overall Study|Reason not Specified|3|||
161040508|NCT03678688|581539274|FG003|Overall Study|Reason not Specified|0|||
161040509|NCT03678688|581539275|FG004|Overall Study|Reason not Specified|1|||
161040510|NCT03678688|581539276|FG005|Overall Study|Reason not Specified|0|||
161040511|NCT03678688|581539277|FG006|Overall Study|Reason not Specified|0|||
161040512|NCT03678688|581539278|FG007|Overall Study|Reason not Specified|0|||
161040513|NCT03678688|581539279|FG008|Overall Study|Reason not Specified|0|||
161040514|NCT03678688|581539271|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
161040515|NCT03678688|581539272|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
161040516|NCT03678688|581539273|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
161040517|NCT03678688|581539274|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
161040518|NCT03678688|581539275|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
161040519|NCT03678688|581539276|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
161040520|NCT03678688|581539277|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
161040521|NCT03678688|581539278|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
161040522|NCT03678688|581539279|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
161040523|NCT03678688|581539271|FG000|Overall Study|Covid Related Adverse Event|0|||
161040524|NCT03678688|581539272|FG001|Overall Study|Covid Related Adverse Event|0|||
161040525|NCT03678688|581539273|FG002|Overall Study|Covid Related Adverse Event|0|||
161040526|NCT03678688|581539274|FG003|Overall Study|Covid Related Adverse Event|0|||
161040527|NCT03678688|581539275|FG004|Overall Study|Covid Related Adverse Event|0|||
161040528|NCT03678688|581539276|FG005|Overall Study|Covid Related Adverse Event|3|||
161040529|NCT03678688|581539277|FG006|Overall Study|Covid Related Adverse Event|1|||
161040530|NCT03678688|581539278|FG007|Overall Study|Covid Related Adverse Event|1|||
161040531|NCT03678688|581539279|FG008|Overall Study|Covid Related Adverse Event|0|||
161040532|NCT03678688|581539271|FG000|Overall Study|Physician Decision|0|||
161040533|NCT03678688|581539272|FG001|Overall Study|Physician Decision|0|||
161040534|NCT03678688|581539273|FG002|Overall Study|Physician Decision|0|||
161040535|NCT03678688|581539274|FG003|Overall Study|Physician Decision|0|||
161040536|NCT03678688|581539275|FG004|Overall Study|Physician Decision|0|||
161040537|NCT03678688|581539276|FG005|Overall Study|Physician Decision|1|||
161040538|NCT03678688|581539277|FG006|Overall Study|Physician Decision|0|||
161040539|NCT03678688|581539278|FG007|Overall Study|Physician Decision|0|||
161040540|NCT03678688|581539279|FG008|Overall Study|Physician Decision|0|||
161040541|NCT03678688|581539271|FG000|Overall Study|Withdrawal by Subject|0|||
161040542|NCT03678688|581539272|FG001|Overall Study|Withdrawal by Subject|0|||
161040543|NCT03678688|581539273|FG002|Overall Study|Withdrawal by Subject|0|||
161040544|NCT03678688|581539274|FG003|Overall Study|Withdrawal by Subject|0|||
161040545|NCT03678688|581539275|FG004|Overall Study|Withdrawal by Subject|0|||
161040546|NCT03678688|581539276|FG005|Overall Study|Withdrawal by Subject|0|||
161040547|NCT03678688|581539277|FG006|Overall Study|Withdrawal by Subject|2|||
161040548|NCT03678688|581539278|FG007|Overall Study|Withdrawal by Subject|1|||
161040549|NCT03678688|581539279|FG008|Overall Study|Withdrawal by Subject|0|||
161280525|NCT02996487|582406967|FG000|Overall Study|Withdrawal by Subject|2|||
161040550|NCT02534233|581539282|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
161040551|NCT03136159|581539286|FG000|Overall Study|chorioamnionitis|2|||
161040552|NCT03136159|581539287|FG001|Overall Study|chorioamnionitis|0|||
161040553|NCT03136159|581539286|FG000|Overall Study|vertical skin incision|1|||
161040554|NCT03136159|581539287|FG001|Overall Study|vertical skin incision|0|||
161040555|NCT03136159|581539286|FG000|Overall Study|additional dressing|1|||
161040556|NCT03136159|581539287|FG001|Overall Study|additional dressing|0|||
161040557|NCT03136159|581539286|FG000|Overall Study|never got dressing placed|1|||
161040558|NCT03136159|581539287|FG001|Overall Study|never got dressing placed|0|||
161040559|NCT03823703|581539288|FG000|Overall Study|Sponsor request|0|||
161040560|NCT03823703|581539289|FG001|Overall Study|Sponsor request|3|||
161040561|NCT03823703|581539290|FG002|Overall Study|Sponsor request|4|||
161040562|NCT03823703|581539288|FG000|Overall Study|Adverse Event|3|||
161040563|NCT03823703|581539289|FG001|Overall Study|Adverse Event|1|||
161040564|NCT03823703|581539290|FG002|Overall Study|Adverse Event|0|||
161040565|NCT03823703|581539288|FG000|Overall Study|Withdrawal by Subject|0|||
161040566|NCT03823703|581539289|FG001|Overall Study|Withdrawal by Subject|1|||
161040567|NCT03823703|581539290|FG002|Overall Study|Withdrawal by Subject|0|||
161040568|NCT00925548|581539291|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
161040569|NCT00925548|581539292|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
161040570|NCT00458783|581539294|FG000|Overall Study|Protocol Violation|1228|||
161040571|NCT00458783|581539295|FG001|Overall Study|Protocol Violation|1220|||
161040572|NCT01737398|581539296|FG000|Overall Study|Adverse event or SAE|16|||
161040573|NCT01737398|581539297|FG001|Overall Study|Adverse event or SAE|1|||
161040574|NCT01737398|581539296|FG000|Overall Study|Stopping rule met|2|||
161040575|NCT01737398|581539297|FG001|Overall Study|Stopping rule met|1|||
161040576|NCT01737398|581539296|FG000|Overall Study|Voluntary withdrawal|2|||
161040577|NCT01737398|581539297|FG001|Overall Study|Voluntary withdrawal|3|||
161040578|NCT01737398|581539296|FG000|Overall Study|Ineligibility|1|||
161040579|NCT01737398|581539297|FG001|Overall Study|Ineligibility|0|||
161040580|NCT01737398|581539296|FG000|Overall Study|Liver transplant|1|||
161040581|NCT01737398|581539297|FG001|Overall Study|Liver transplant|0|||
161040582|NCT01737398|581539296|FG000|Overall Study|Disease progression|2|||
161040583|NCT01737398|581539297|FG001|Overall Study|Disease progression|3|||
161040584|NCT01737398|581539296|FG000|Overall Study|Sponsor's decision|2|||
161040585|NCT01737398|581539297|FG001|Overall Study|Sponsor's decision|0|||
161040586|NCT00089609|581539298|FG000|Overall Study|Withdrawal by Subject|3|||
161040587|NCT00089609|581539299|FG001|Overall Study|Withdrawal by Subject|1|||
161040588|NCT00357994|581539300|FG000|Overall Study|Adverse Event|1|||
161040589|NCT00357994|581539301|FG001|Overall Study|Adverse Event|2|||
161040590|NCT00357994|581539300|FG000|Overall Study|Lack of Efficacy|0|||
161040591|NCT00357994|581539301|FG001|Overall Study|Lack of Efficacy|1|||
161040592|NCT00357994|581539300|FG000|Overall Study|Protocol Violation|1|||
161040593|NCT00357994|581539301|FG001|Overall Study|Protocol Violation|0|||
161040594|NCT01833455|581539302|FG000|Overall Study|Withdrawal by Subject|1|||
161040595|NCT01833455|581539303|FG001|Overall Study|Withdrawal by Subject|0|||
161040596|NCT00047385|581539304|FG000|Overall Study|Death before any screening|2|||
161040597|NCT00047385|581539305|FG001|Overall Study|Death before any screening|5|||
161040598|NCT00047385|581539304|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
161040599|NCT00047385|581539305|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
161040600|NCT00047385|581539304|FG000|Overall Study|Eligible for screening but had no screen|260|||
161040601|NCT00047385|581539305|FG001|Overall Study|Eligible for screening but had no screen|492|||
161040602|NCT03865732|581539306|FG000|Overall Study|Adverse Event|0|||
161040603|NCT03865732|581539307|FG001|Overall Study|Adverse Event|1|||
161040604|NCT02095145|581539310|FG000|Overall Study|Withdrawal by Subject|1|||
161040605|NCT02095145|581539311|FG001|Overall Study|Withdrawal by Subject|0|||
161040606|NCT02085941|581539312|FG000|Overall Study|Lack of Efficacy|1|||
161040607|NCT02085941|581539313|FG001|Overall Study|Lack of Efficacy|0|||
161040608|NCT02085941|581539312|FG000|Overall Study|Death|6|||
161040609|NCT02085941|581539313|FG001|Overall Study|Death|1|||
161040610|NCT02085941|581539312|FG000|Overall Study|Lost to Follow-up|1|||
161040611|NCT02085941|581539313|FG001|Overall Study|Lost to Follow-up|0|||
161040612|NCT02085941|581539312|FG000|Overall Study|Physician Decision|0|||
161040613|NCT02085941|581539313|FG001|Overall Study|Physician Decision|2|||
161040614|NCT03184987|581539316|FG000|Overall Study|Withdrawal by Subject|0|||
161040615|NCT03184987|581539317|FG001|Overall Study|Withdrawal by Subject|1|||
161040616|NCT03184987|581539318|FG002|Overall Study|Withdrawal by Subject|2|||
161040617|NCT03184987|581539316|FG000|Overall Study|Physician Decision|0|||
161040618|NCT03184987|581539317|FG001|Overall Study|Physician Decision|0|||
161040619|NCT03184987|581539318|FG002|Overall Study|Physician Decision|1|||
161040620|NCT03184987|581539316|FG000|Overall Study|Adverse Event|1|||
161040621|NCT03184987|581539317|FG001|Overall Study|Adverse Event|0|||
161040622|NCT03184987|581539318|FG002|Overall Study|Adverse Event|1|||
161040623|NCT01767467|581539319|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
161040624|NCT01767467|581539320|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
161040625|NCT01767467|581539319|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
161040626|NCT01767467|581539320|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
161040627|NCT01767467|581539319|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
161040628|NCT01767467|581539320|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
161040629|NCT01767467|581539319|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
161040630|NCT01767467|581539320|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
161040631|NCT01767467|581539319|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
161040632|NCT01767467|581539320|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
161040633|NCT01767467|581539319|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
161040634|NCT01767467|581539320|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
161040635|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
161040636|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
161040637|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
161040638|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
161040639|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
161040640|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
161040641|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
161040642|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
161040643|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
161040644|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
161040645|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
161040646|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
161040647|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
161040648|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
161040649|NCT01767467|581539319|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
161040650|NCT01767467|581539320|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
161040651|NCT00853580|581539321|FG000|Overall Study|Lost to Follow-up|3|||
161040652|NCT00853580|581539322|FG001|Overall Study|Lost to Follow-up|5|||
161040653|NCT00853580|581539321|FG000|Overall Study|Protocol Violation|2|||
161040654|NCT00853580|581539322|FG001|Overall Study|Protocol Violation|1|||
161040655|NCT00853580|581539321|FG000|Overall Study|Withdrawal by Subject|2|||
161040656|NCT00853580|581539322|FG001|Overall Study|Withdrawal by Subject|8|||
161040657|NCT00853580|581539321|FG000|Overall Study|Commenced contraindicated therapy|0|||
161040658|NCT00853580|581539322|FG001|Overall Study|Commenced contraindicated therapy|2|||
161040659|NCT02203799|581539325|FG000|Overall Study|Withdrawal by Subject|3|||
161040660|NCT03335488|581539326|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
161040661|NCT03335488|581539327|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
161040662|NCT03335488|581539326|FG000|Safety Extension Period|Adverse Event|1|||
161040663|NCT03335488|581539327|FG001|Safety Extension Period|Adverse Event|0|||
161040664|NCT03335488|581539326|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
161040665|NCT03335488|581539327|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
161040666|NCT01801007|581539330|FG000|Overall Study|Adverse Event|2|||
161040667|NCT01801007|581539330|FG000|Overall Study|Lost to Follow-up|4|||
161040668|NCT01801007|581539330|FG000|Overall Study|Withdrawal by Subject|5|||
161040669|NCT02743819|581539331|FG000|Overall Study|Lack of Efficacy|5|||
161040670|NCT02743819|581539331|FG000|Overall Study|Death|2|||
161040671|NCT02743819|581539331|FG000|Overall Study|Adverse Event|1|||
161040672|NCT04745676|581539332|FG000|Overall Study|Death|1|||
161040673|NCT04745676|581539333|FG001|Overall Study|Death|0|||
161040674|NCT04745676|581539334|FG002|Overall Study|Death|0|||
161040675|NCT03102034|581539337|FG000|Overall Study|Withdrawal by Subject|1|||
161040676|NCT03102034|581539338|FG001|Overall Study|Withdrawal by Subject|0|||
161040677|NCT00145470|581539339|FG000|Overall Study|Adverse Event|19|||
161040678|NCT00145470|581539340|FG001|Overall Study|Adverse Event|25|||
161040679|NCT00145470|581539339|FG000|Overall Study|Lack of Efficacy|27|||
161040680|NCT00145470|581539340|FG001|Overall Study|Lack of Efficacy|13|||
161040681|NCT00145470|581539339|FG000|Overall Study|Withdrawal by Subject|36|||
161040682|NCT00145470|581539340|FG001|Overall Study|Withdrawal by Subject|34|||
161040683|NCT00145470|581539339|FG000|Overall Study|Lost to Follow-up|21|||
161040684|NCT00145470|581539340|FG001|Overall Study|Lost to Follow-up|17|||
161040685|NCT00145470|581539339|FG000|Overall Study|Reason Not Reported|9|||
161040686|NCT00145470|581539340|FG001|Overall Study|Reason Not Reported|9|||
161040687|NCT00676091|581539342|FG000|Infant Series|Parent or legal guardian request|10|||
161040688|NCT00676091|581539343|FG001|Infant Series|Parent or legal guardian request|8|||
161040689|NCT00676091|581539342|FG000|Infant Series|Protocol Violation|6|||
161040690|NCT00676091|581539343|FG001|Infant Series|Protocol Violation|3|||
161040691|NCT00676091|581539342|FG000|Infant Series|Adverse Event|2|||
161040692|NCT00676091|581539343|FG001|Infant Series|Adverse Event|3|||
161040693|NCT00676091|581539342|FG000|Infant Series|Failed to return|1|||
161040694|NCT00676091|581539343|FG001|Infant Series|Failed to return|3|||
161280526|NCT02996487|582406968|FG001|Overall Study|Withdrawal by Subject|3|||
161040695|NCT00676091|581539342|FG000|Infant Series|Lost to Follow-up|1|||
161040696|NCT00676091|581539343|FG001|Infant Series|Lost to Follow-up|0|||
161040697|NCT00676091|581539342|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
161040698|NCT00676091|581539343|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
161040699|NCT00676091|581539342|FG000|After Infant Series|Adverse Event|0|||
161040700|NCT00676091|581539343|FG001|After Infant Series|Adverse Event|1|||
161040701|NCT00676091|581539342|FG000|After Infant Series|Protocol Violation|0|||
161040702|NCT00676091|581539343|FG001|After Infant Series|Protocol Violation|1|||
161040703|NCT00676091|581539342|FG000|After Infant Series|Failed to return|1|||
161040704|NCT00676091|581539343|FG001|After Infant Series|Failed to return|1|||
161040705|NCT00676091|581539342|FG000|Toddler Dose|Failed to return|2|||
161040706|NCT00676091|581539343|FG001|Toddler Dose|Failed to return|0|||
161040707|NCT00676091|581539342|FG000|Toddler Dose|Parent or legal guardian request|1|||
161040708|NCT00676091|581539343|FG001|Toddler Dose|Parent or legal guardian request|0|||
161040709|NCT01701401|581539349|FG000|Overall Study|Randomized But Not Treated|3|||
161040710|NCT01701401|581539350|FG001|Overall Study|Randomized But Not Treated|1|||
161040711|NCT01701401|581539351|FG002|Overall Study|Randomized But Not Treated|0|||
161040712|NCT01701401|581539352|FG003|Overall Study|Randomized But Not Treated|1|||
161040713|NCT01701401|581539349|FG000|Overall Study|Lost to Follow-up|5|||
161040714|NCT01701401|581539350|FG001|Overall Study|Lost to Follow-up|5|||
161040715|NCT01701401|581539351|FG002|Overall Study|Lost to Follow-up|1|||
161040716|NCT01701401|581539352|FG003|Overall Study|Lost to Follow-up|3|||
161040717|NCT01701401|581539349|FG000|Overall Study|Withdrew Consent|0|||
161040718|NCT01701401|581539350|FG001|Overall Study|Withdrew Consent|3|||
161040719|NCT01701401|581539351|FG002|Overall Study|Withdrew Consent|1|||
161040720|NCT01701401|581539352|FG003|Overall Study|Withdrew Consent|2|||
161040721|NCT01701401|581539349|FG000|Overall Study|Lack of Efficacy|1|||
161040722|NCT01701401|581539350|FG001|Overall Study|Lack of Efficacy|0|||
161040723|NCT01701401|581539351|FG002|Overall Study|Lack of Efficacy|2|||
161040724|NCT01701401|581539352|FG003|Overall Study|Lack of Efficacy|0|||
161040725|NCT01701401|581539349|FG000|Overall Study|Adverse Event|1|||
161040726|NCT01701401|581539350|FG001|Overall Study|Adverse Event|0|||
161040727|NCT01701401|581539351|FG002|Overall Study|Adverse Event|0|||
161040728|NCT01701401|581539352|FG003|Overall Study|Adverse Event|0|||
161040729|NCT01701401|581539349|FG000|Overall Study|Protocol Violation|0|||
161040730|NCT01701401|581539350|FG001|Overall Study|Protocol Violation|0|||
161040731|NCT01701401|581539351|FG002|Overall Study|Protocol Violation|1|||
161040732|NCT01701401|581539352|FG003|Overall Study|Protocol Violation|0|||
161040733|NCT00914966|581539353|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
161040734|NCT00914966|581539353|FG000|Step 1: 1500 Units|Physician Decision|1|||
161040735|NCT00914966|581539353|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
161040736|NCT00989196|581539354|FG000|Treatment Period|Lost to Follow-up|1|||
161040737|NCT00989196|581539355|FG001|Treatment Period|Lost to Follow-up|0|||
161040738|NCT04762277|581539358|FG000|Overall Study|Withdrawal by Subject|0|||
161040739|NCT04762277|581539359|FG001|Overall Study|Withdrawal by Subject|2|||
161040740|NCT04762277|581539358|FG000|Overall Study|Protocol Violation|0|||
161040741|NCT04762277|581539359|FG001|Overall Study|Protocol Violation|1|||
161040742|NCT04762277|581539358|FG000|Overall Study|Adverse Event|1|||
161040743|NCT04762277|581539359|FG001|Overall Study|Adverse Event|0|||
161040744|NCT04827732|581539360|FG000|Overall Study|Did not start treatment|0|||
161040745|NCT04827732|581539361|FG001|Overall Study|Did not start treatment|1|||
161040746|NCT04827732|581539362|FG002|Overall Study|Did not start treatment|0|||
161040747|NCT04827732|581539363|FG003|Overall Study|Did not start treatment|1|||
161040748|NCT05293717|581539371|FG000|Overall Study|Physician Decision|1|||
161040749|NCT00799409|581541111|FG000|Overall Study|Withdrawal by Subject|1|||
161040750|NCT00799409|581541112|FG001|Overall Study|Withdrawal by Subject|0|||
161040751|NCT00799409|581541113|FG002|Overall Study|Withdrawal by Subject|0|||
161040752|NCT00799409|581541111|FG000|Overall Study|Lost to Follow-up|1|||
161040753|NCT00799409|581541112|FG001|Overall Study|Lost to Follow-up|0|||
161040754|NCT00799409|581541113|FG002|Overall Study|Lost to Follow-up|0|||
161040755|NCT00799409|581541111|FG000|Overall Study|Optimal Dose Not Achieved|2|||
161040756|NCT00799409|581541112|FG001|Overall Study|Optimal Dose Not Achieved|0|||
161040757|NCT00799409|581541113|FG002|Overall Study|Optimal Dose Not Achieved|0|||
161040758|NCT00799409|581541111|FG000|Overall Study|Failure to follow study protocol)|1|||
161040759|NCT00799409|581541112|FG001|Overall Study|Failure to follow study protocol)|0|||
161040760|NCT00799409|581541113|FG002|Overall Study|Failure to follow study protocol)|0|||
161040761|NCT00799409|581541111|FG000|Overall Study|Did not attend lab school day 1|1|||
161040762|NCT00799409|581541112|FG001|Overall Study|Did not attend lab school day 1|0|||
161040763|NCT00799409|581541113|FG002|Overall Study|Did not attend lab school day 1|0|||
161040764|NCT00799409|581541111|FG000|Overall Study|medication compliance|1|||
161040765|NCT00799409|581541112|FG001|Overall Study|medication compliance|0|||
161040766|NCT00799409|581541113|FG002|Overall Study|medication compliance|0|||
161040767|NCT04323800|581541114|FG000|Overall Study|Withdrawal by Subject|4|||
161040768|NCT04323800|581541115|FG001|Overall Study|Withdrawal by Subject|4|||
161040769|NCT04323800|581541114|FG000|Overall Study|Incomplete transfusion|1|||
161040770|NCT04323800|581541115|FG001|Overall Study|Incomplete transfusion|0|||
161040771|NCT04323800|581541114|FG000|Overall Study|Other|0|||
161040772|NCT04323800|581541115|FG001|Overall Study|Other|1|||
161040773|NCT04323800|581541114|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
161040774|NCT04323800|581541115|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
161040775|NCT01732757|581541116|FG000|Overall Study|Lost to Follow-up|1|||
161040776|NCT01732757|581541117|FG001|Overall Study|Lost to Follow-up|0|||
161040777|NCT01732757|581541118|FG002|Overall Study|Lost to Follow-up|0|||
161040778|NCT00731692|581541119|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
161040779|NCT00731692|581541120|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
161040780|NCT00731692|581541121|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
161040781|NCT00731692|581541119|FG000|Core Study (36 Months)|Physician Decision|1|||
161040782|NCT00731692|581541120|FG001|Core Study (36 Months)|Physician Decision|0|||
161040783|NCT00731692|581541121|FG002|Core Study (36 Months)|Physician Decision|2|||
161040784|NCT00731692|581541119|FG000|Core Study (36 Months)|Death|2|||
161040785|NCT00731692|581541120|FG001|Core Study (36 Months)|Death|1|||
161040786|NCT00731692|581541121|FG002|Core Study (36 Months)|Death|2|||
161040787|NCT00731692|581541119|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
161040788|NCT00731692|581541120|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
161040789|NCT00731692|581541121|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
161040790|NCT00731692|581541119|FG000|Core Study (36 Months)|Administrative|2|||
161040791|NCT00731692|581541120|FG001|Core Study (36 Months)|Administrative|2|||
161040792|NCT00731692|581541121|FG002|Core Study (36 Months)|Administrative|6|||
161040793|NCT00731692|581541119|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
161040794|NCT00731692|581541120|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
161040795|NCT00731692|581541121|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
161040796|NCT00731692|581541119|FG000|Core Study (36 Months)|Protocol Violation|4|||
161040797|NCT00731692|581541120|FG001|Core Study (36 Months)|Protocol Violation|5|||
161040798|NCT00731692|581541121|FG002|Core Study (36 Months)|Protocol Violation|8|||
161040799|NCT00731692|581541119|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
161040800|NCT00731692|581541120|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
161040801|NCT00731692|581541121|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
161040802|NCT00731692|581541119|FG000|Core Study (36 Months)|Adverse Event|25|||
161040803|NCT00731692|581541120|FG001|Core Study (36 Months)|Adverse Event|28|||
161040804|NCT00731692|581541121|FG002|Core Study (36 Months)|Adverse Event|29|||
161040805|NCT00731692|581541119|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
161040806|NCT00731692|581541120|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
161040807|NCT00731692|581541121|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
161040808|NCT00731692|581541119|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
161040809|NCT00731692|581541120|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
161040810|NCT00731692|581541121|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
161040811|NCT00731692|581541119|FG000|Extension Phase|Abnormal test procedure|0|||
161040812|NCT00731692|581541120|FG001|Extension Phase|Abnormal test procedure|0|||
161040813|NCT00731692|581541121|FG002|Extension Phase|Abnormal test procedure|1|||
161040814|NCT00731692|581541119|FG000|Extension Phase|Abnormal lab values|0|||
161040815|NCT00731692|581541120|FG001|Extension Phase|Abnormal lab values|0|||
161040816|NCT00731692|581541121|FG002|Extension Phase|Abnormal lab values|1|||
161040817|NCT00731692|581541119|FG000|Extension Phase|Lost to Follow-up|0|||
161040818|NCT00731692|581541120|FG001|Extension Phase|Lost to Follow-up|1|||
161040819|NCT00731692|581541121|FG002|Extension Phase|Lost to Follow-up|4|||
161040820|NCT00731692|581541119|FG000|Extension Phase|Withdrawal by Subject|4|||
161040821|NCT00731692|581541120|FG001|Extension Phase|Withdrawal by Subject|5|||
161040822|NCT00731692|581541121|FG002|Extension Phase|Withdrawal by Subject|3|||
161040823|NCT00731692|581541119|FG000|Extension Phase|Adverse Event|1|||
161040824|NCT00731692|581541120|FG001|Extension Phase|Adverse Event|1|||
161040825|NCT00731692|581541121|FG002|Extension Phase|Adverse Event|15|||
161040826|NCT02372799|581541122|FG000|Treatment Period|Adverse Event|3|||
161040827|NCT02372799|581541123|FG001|Treatment Period|Adverse Event|10|||
161040828|NCT02372799|581541124|FG002|Treatment Period|Adverse Event|6|||
161040829|NCT02372799|581541122|FG000|Treatment Period|Insufficient therapeutic response|2|||
161040830|NCT02372799|581541123|FG001|Treatment Period|Insufficient therapeutic response|2|||
161040831|NCT02372799|581541124|FG002|Treatment Period|Insufficient therapeutic response|0|||
161040832|NCT02372799|581541122|FG000|Treatment Period|Withdrawal by Subject|10|||
161040833|NCT02372799|581541123|FG001|Treatment Period|Withdrawal by Subject|10|||
161040834|NCT02372799|581541124|FG002|Treatment Period|Withdrawal by Subject|2|||
161040835|NCT02372799|581541122|FG000|Treatment Period|Lost to Follow-up|11|||
161040836|NCT02372799|581541123|FG001|Treatment Period|Lost to Follow-up|5|||
161040837|NCT02372799|581541124|FG002|Treatment Period|Lost to Follow-up|3|||
161280527|NCT02996487|582406969|FG002|Overall Study|Withdrawal by Subject|0|||
161280528|NCT02800642|582406970|FG000|Overall Study|Death|3|||
161280529|NCT02800642|582406970|FG000|Overall Study|Other|10|||
161280530|NCT02800642|582406970|FG000|Overall Study|Physician Decision|2|||
161040838|NCT02372799|581541122|FG000|Treatment Period|Protocol Violation|3|||
161040839|NCT02372799|581541123|FG001|Treatment Period|Protocol Violation|0|||
161040840|NCT02372799|581541124|FG002|Treatment Period|Protocol Violation|0|||
161040841|NCT02372799|581541122|FG000|Treatment Period|Non-compliance with study drug|4|||
161040842|NCT02372799|581541123|FG001|Treatment Period|Non-compliance with study drug|4|||
161040843|NCT02372799|581541124|FG002|Treatment Period|Non-compliance with study drug|4|||
161040844|NCT02372799|581541122|FG000|Treatment Period|Miscellaneous Reasons|1|||
161040845|NCT02372799|581541123|FG001|Treatment Period|Miscellaneous Reasons|1|||
161040846|NCT02372799|581541124|FG002|Treatment Period|Miscellaneous Reasons|0|||
161040847|NCT02372799|581541122|FG000|Down-taper Period|Lost to Follow-up|1|||
161040848|NCT02372799|581541123|FG001|Down-taper Period|Lost to Follow-up|2|||
161040849|NCT02372799|581541124|FG002|Down-taper Period|Lost to Follow-up|2|||
161040850|NCT00747006|581541125|FG000|Overall Study|Adverse Event|1|||
161040851|NCT00747006|581541126|FG001|Overall Study|Adverse Event|0|||
161040852|NCT00747006|581541127|FG002|Overall Study|Adverse Event|0|||
161040853|NCT00747006|581541125|FG000|Overall Study|Lost to Follow-up|0|||
161040854|NCT00747006|581541126|FG001|Overall Study|Lost to Follow-up|1|||
161040855|NCT00747006|581541127|FG002|Overall Study|Lost to Follow-up|0|||
161040856|NCT00747006|581541125|FG000|Overall Study|Physician Decision|2|||
161040857|NCT00747006|581541126|FG001|Overall Study|Physician Decision|0|||
161040858|NCT00747006|581541127|FG002|Overall Study|Physician Decision|1|||
161040859|NCT02132949|581541132|FG000|Overall Study|Death|7|||
161040860|NCT02132949|581541133|FG001|Overall Study|Death|13|||
161040861|NCT02132949|581541132|FG000|Overall Study|Lost to Follow-up|14|||
161040862|NCT02132949|581541133|FG001|Overall Study|Lost to Follow-up|4|||
161040863|NCT02132949|581541132|FG000|Overall Study|Withdrawal by Subject|6|||
161040864|NCT02132949|581541133|FG001|Overall Study|Withdrawal by Subject|5|||
161040865|NCT02132949|581541132|FG000|Overall Study|Noncompliance|5|||
161040866|NCT02132949|581541133|FG001|Overall Study|Noncompliance|1|||
161040867|NCT02132949|581541132|FG000|Overall Study|Physician Decision|3|||
161040868|NCT02132949|581541133|FG001|Overall Study|Physician Decision|1|||
161040869|NCT02132949|581541132|FG000|Overall Study|Disease Progression|3|||
161040870|NCT02132949|581541133|FG001|Overall Study|Disease Progression|0|||
161040871|NCT02132949|581541132|FG000|Overall Study|Adverse Event|2|||
161040872|NCT02132949|581541133|FG001|Overall Study|Adverse Event|1|||
161040873|NCT02132949|581541132|FG000|Overall Study|Withdrew Prior to Treatment|1|||
161040874|NCT02132949|581541133|FG001|Overall Study|Withdrew Prior to Treatment|2|||
161040875|NCT02132949|581541132|FG000|Overall Study|Reason Unspecified|0|||
161040876|NCT02132949|581541133|FG001|Overall Study|Reason Unspecified|1|||
161040877|NCT01583166|581541136|FG000|Overall Study|Withdrawal by Subject|4|||
161040878|NCT01583166|581541137|FG001|Overall Study|Withdrawal by Subject|6|||
161040879|NCT04652869|581541140|FG000|Overall Study|Withdrawal by Subject|0|||
161040880|NCT04652869|581541141|FG001|Overall Study|Withdrawal by Subject|2|||
161040881|NCT04652869|581541142|FG002|Overall Study|Withdrawal by Subject|0|||
161040882|NCT01372085|581541143|FG000|Washout Period 2|Physician Decision|0|||
161040883|NCT01372085|581541144|FG001|Washout Period 2|Physician Decision|0|||
161040884|NCT01372085|581541145|FG002|Washout Period 2|Physician Decision|0|||
161040885|NCT01372085|581541146|FG003|Washout Period 2|Physician Decision|0|||
161040886|NCT01372085|581541147|FG004|Washout Period 2|Physician Decision|1|||
161040887|NCT01372085|581541148|FG005|Washout Period 2|Physician Decision|0|||
161040888|NCT01372085|581541149|FG006|Washout Period 2|Physician Decision|0|||
161040889|NCT01372085|581541150|FG007|Washout Period 2|Physician Decision|0|||
161040890|NCT01372085|581541151|FG008|Washout Period 2|Physician Decision|0|||
161040891|NCT01372085|581541152|FG009|Washout Period 2|Physician Decision|0|||
161040892|NCT01372085|581541143|FG000|Washout Period 3|Withdrawal by Subject|0|||
161040893|NCT01372085|581541144|FG001|Washout Period 3|Withdrawal by Subject|0|||
161040894|NCT01372085|581541145|FG002|Washout Period 3|Withdrawal by Subject|0|||
161040895|NCT01372085|581541146|FG003|Washout Period 3|Withdrawal by Subject|0|||
161040896|NCT01372085|581541147|FG004|Washout Period 3|Withdrawal by Subject|0|||
161040897|NCT01372085|581541148|FG005|Washout Period 3|Withdrawal by Subject|2|||
161040898|NCT01372085|581541149|FG006|Washout Period 3|Withdrawal by Subject|0|||
161040899|NCT01372085|581541150|FG007|Washout Period 3|Withdrawal by Subject|0|||
161040900|NCT01372085|581541151|FG008|Washout Period 3|Withdrawal by Subject|0|||
161040901|NCT01372085|581541152|FG009|Washout Period 3|Withdrawal by Subject|0|||
161040902|NCT00562094|581541153|FG000|Overall Study|Lost to Follow-up|62|||
161040903|NCT03345979|581541157|FG000|Overall Study|Withdrawal by Subject|20|||
161040904|NCT03345979|581541158|FG001|Overall Study|Withdrawal by Subject|31|||
161040905|NCT03345979|581541157|FG000|Overall Study|Adverse Event|10|||
161040906|NCT03345979|581541158|FG001|Overall Study|Adverse Event|11|||
161040907|NCT03345979|581541157|FG000|Overall Study|Lost to Follow-up|8|||
161040908|NCT03345979|581541158|FG001|Overall Study|Lost to Follow-up|9|||
161040909|NCT03345979|581541157|FG000|Overall Study|Lack of Efficacy|4|||
161040910|NCT03345979|581541158|FG001|Overall Study|Lack of Efficacy|2|||
161040911|NCT03345979|581541157|FG000|Overall Study|Protocol Violation|1|||
161040912|NCT03345979|581541158|FG001|Overall Study|Protocol Violation|3|||
161040913|NCT03345979|581541157|FG000|Overall Study|Physician Decision|0|||
161040914|NCT03345979|581541158|FG001|Overall Study|Physician Decision|2|||
161040915|NCT00734578|581541159|FG000|Overall Study|Adverse Event|4|||
161040916|NCT00734578|581541160|FG001|Overall Study|Adverse Event|6|||
161040917|NCT00734578|581541161|FG002|Overall Study|Adverse Event|1|||
161040918|NCT00734578|581541159|FG000|Overall Study|Protocol Violation|8|||
161040919|NCT00734578|581541160|FG001|Overall Study|Protocol Violation|6|||
161040920|NCT00734578|581541161|FG002|Overall Study|Protocol Violation|3|||
161040921|NCT00734578|581541159|FG000|Overall Study|Withdrawal by Subject|7|||
161040922|NCT00734578|581541160|FG001|Overall Study|Withdrawal by Subject|8|||
161040923|NCT00734578|581541161|FG002|Overall Study|Withdrawal by Subject|11|||
161040924|NCT00734578|581541159|FG000|Overall Study|Lost to Follow-up|9|||
161040925|NCT00734578|581541160|FG001|Overall Study|Lost to Follow-up|3|||
161040926|NCT00734578|581541161|FG002|Overall Study|Lost to Follow-up|5|||
161040927|NCT00734578|581541159|FG000|Overall Study|Lack of Efficacy|3|||
161040928|NCT00734578|581541160|FG001|Overall Study|Lack of Efficacy|2|||
161040929|NCT00734578|581541161|FG002|Overall Study|Lack of Efficacy|5|||
161040930|NCT00734578|581541159|FG000|Overall Study|Randomized in error|1|||
161040931|NCT00734578|581541160|FG001|Overall Study|Randomized in error|0|||
161040932|NCT00734578|581541161|FG002|Overall Study|Randomized in error|0|||
161040933|NCT00734578|581541159|FG000|Overall Study|Exclusion criteria|1|||
161040934|NCT00734578|581541160|FG001|Overall Study|Exclusion criteria|0|||
161040935|NCT00734578|581541161|FG002|Overall Study|Exclusion criteria|0|||
161040936|NCT00999596|581541162|FG000|Overall Study|Statistical population not required|101|||
161040937|NCT01629589|581541169|FG000|Overall Study|Protocol Violation|4|||
161040938|NCT01629589|581541170|FG001|Overall Study|Protocol Violation|2|||
161040939|NCT01629589|581541169|FG000|Overall Study|Lost to Follow-up|2|||
161040940|NCT01629589|581541170|FG001|Overall Study|Lost to Follow-up|1|||
161040941|NCT01629589|581541169|FG000|Overall Study|Withdrawal by Subject|2|||
161040942|NCT01629589|581541170|FG001|Overall Study|Withdrawal by Subject|3|||
161040943|NCT01629589|581541169|FG000|Overall Study|Did not receive study vaccine|0|||
161040944|NCT01629589|581541170|FG001|Overall Study|Did not receive study vaccine|1|||
161040945|NCT02079649|581541171|FG000|Overall Study|Lost to Follow-up|0|||
161040946|NCT02079649|581541172|FG001|Overall Study|Lost to Follow-up|0|||
161040947|NCT02079649|581541173|FG002|Overall Study|Lost to Follow-up|0|||
161040948|NCT02079649|581541174|FG003|Overall Study|Lost to Follow-up|1|||
161040949|NCT02079649|581541171|FG000|Overall Study|Withdrawal by Subject|0|||
161040950|NCT02079649|581541172|FG001|Overall Study|Withdrawal by Subject|0|||
161040951|NCT02079649|581541173|FG002|Overall Study|Withdrawal by Subject|0|||
161040952|NCT02079649|581541174|FG003|Overall Study|Withdrawal by Subject|1|||
161040953|NCT02079649|581541171|FG000|Overall Study|Randomization error (prior to treatment)|1|||
161040954|NCT02079649|581541172|FG001|Overall Study|Randomization error (prior to treatment)|0|||
161040955|NCT02079649|581541173|FG002|Overall Study|Randomization error (prior to treatment)|1|||
161040956|NCT02079649|581541174|FG003|Overall Study|Randomization error (prior to treatment)|0|||
161040957|NCT01932970|581541196|FG000|Overall Study|Withdrawal by Subject|5|||
161040958|NCT01932970|581541196|FG000|Overall Study|Death|1|||
161040959|NCT01932970|581541196|FG000|Overall Study|Lost to Follow-up|2|||
161040960|NCT01932970|581541196|FG000|Overall Study|Protocol Specified Criteria|10|||
161040961|NCT03739866|581541200|FG000|Overall Study|Lost to Follow-up|0|||
161040962|NCT03739866|581541201|FG001|Overall Study|Lost to Follow-up|0|||
161040963|NCT03739866|581541202|FG002|Overall Study|Lost to Follow-up|0|||
161040964|NCT03739866|581541203|FG003|Overall Study|Lost to Follow-up|1|||
161040965|NCT03739866|581541204|FG004|Overall Study|Lost to Follow-up|0|||
161040966|NCT03739866|581541205|FG005|Overall Study|Lost to Follow-up|0|||
161040967|NCT03739866|581541206|FG006|Overall Study|Lost to Follow-up|0|||
161040968|NCT03739866|581541207|FG007|Overall Study|Lost to Follow-up|0|||
161040969|NCT03739866|581541200|FG000|Overall Study|Enrolled but not treated|0|||
161040970|NCT03739866|581541201|FG001|Overall Study|Enrolled but not treated|0|||
161040971|NCT03739866|581541202|FG002|Overall Study|Enrolled but not treated|1|||
161040972|NCT03739866|581541203|FG003|Overall Study|Enrolled but not treated|0|||
161040973|NCT03739866|581541204|FG004|Overall Study|Enrolled but not treated|1|||
161040974|NCT03739866|581541205|FG005|Overall Study|Enrolled but not treated|0|||
161040975|NCT03739866|581541206|FG006|Overall Study|Enrolled but not treated|0|||
161040976|NCT03739866|581541207|FG007|Overall Study|Enrolled but not treated|0|||
161040977|NCT01034306|581541208|FG000|Overall Study|Adverse Event|1|||
161040978|NCT01034306|581541209|FG001|Overall Study|Adverse Event|0|||
161040979|NCT01034306|581541208|FG000|Overall Study|Lost to Follow-up|0|||
161040980|NCT01034306|581541209|FG001|Overall Study|Lost to Follow-up|1|||
161040981|NCT01034306|581541208|FG000|Overall Study|Withdrawal by Subject|2|||
161040982|NCT01034306|581541209|FG001|Overall Study|Withdrawal by Subject|2|||
161040983|NCT01034306|581541208|FG000|Overall Study|hospitalized and decided to stop|1|||
161040984|NCT01034306|581541209|FG001|Overall Study|hospitalized and decided to stop|0|||
161040985|NCT01034306|581541208|FG000|Overall Study|Noncomplience|1|||
161040986|NCT01034306|581541209|FG001|Overall Study|Noncomplience|0|||
161040987|NCT00836498|581541210|FG000|Overall Study|Adverse Event|1|||
161040988|NCT00836498|581541211|FG001|Overall Study|Adverse Event|0|||
161040989|NCT00836498|581541210|FG000|Overall Study|Lost to Follow-up|1|||
161040990|NCT00836498|581541211|FG001|Overall Study|Lost to Follow-up|0|||
161040991|NCT00836498|581541210|FG000|Overall Study|Withdrawal by Subject|2|||
161040992|NCT00836498|581541211|FG001|Overall Study|Withdrawal by Subject|1|||
161040993|NCT03057600|581541212|FG000|Overall Study|Adverse Event|0|||
161040994|NCT03057600|581541213|FG001|Overall Study|Adverse Event|0|||
161040995|NCT03057600|581541214|FG002|Overall Study|Adverse Event|4|||
161040996|NCT03057600|581541215|FG003|Overall Study|Adverse Event|0|||
161040997|NCT03057600|581541212|FG000|Overall Study|Radiologic Disease Progression|8|||
161040998|NCT03057600|581541213|FG001|Overall Study|Radiologic Disease Progression|7|||
161040999|NCT03057600|581541214|FG002|Overall Study|Radiologic Disease Progression|13|||
161041000|NCT03057600|581541215|FG003|Overall Study|Radiologic Disease Progression|10|||
161041001|NCT03057600|581541212|FG000|Overall Study|Symptomatic Deterioration|0|||
161041002|NCT03057600|581541213|FG001|Overall Study|Symptomatic Deterioration|1|||
161041003|NCT03057600|581541214|FG002|Overall Study|Symptomatic Deterioration|1|||
161041004|NCT03057600|581541215|FG003|Overall Study|Symptomatic Deterioration|0|||
161041005|NCT03057600|581541212|FG000|Overall Study|Investigator Decision|0|||
161041006|NCT03057600|581541213|FG001|Overall Study|Investigator Decision|0|||
161041007|NCT03057600|581541214|FG002|Overall Study|Investigator Decision|1|||
161041008|NCT03057600|581541215|FG003|Overall Study|Investigator Decision|0|||
161041009|NCT03057600|581541212|FG000|Overall Study|Study Termination by Sponsor|0|||
161041010|NCT03057600|581541213|FG001|Overall Study|Study Termination by Sponsor|0|||
161041011|NCT03057600|581541214|FG002|Overall Study|Study Termination by Sponsor|0|||
161041012|NCT03057600|581541215|FG003|Overall Study|Study Termination by Sponsor|2|||
161041013|NCT03057600|581541212|FG000|Overall Study|Withdrawal by Subject|0|||
161041014|NCT03057600|581541213|FG001|Overall Study|Withdrawal by Subject|1|||
161041015|NCT03057600|581541214|FG002|Overall Study|Withdrawal by Subject|0|||
161041016|NCT03057600|581541215|FG003|Overall Study|Withdrawal by Subject|0|||
161041017|NCT03057600|581541212|FG000|Overall Study|Other, Not Specified|1|||
161041018|NCT03057600|581541213|FG001|Overall Study|Other, Not Specified|1|||
161041019|NCT03057600|581541214|FG002|Overall Study|Other, Not Specified|1|||
161041020|NCT03057600|581541215|FG003|Overall Study|Other, Not Specified|1|||
161041021|NCT02384382|581541220|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
161041022|NCT02384382|581541220|FG000|Overall Study|Death|1|||
161041023|NCT02384382|581541220|FG000|Overall Study|Adverse Event|1|||
161041024|NCT02384382|581541220|FG000|Overall Study|Disease progression|16|||
161041025|NCT01953692|581541221|FG000|Overall Study|Adverse Event|5|||
161041026|NCT01953692|581541222|FG001|Overall Study|Adverse Event|2|||
161041027|NCT01953692|581541223|FG002|Overall Study|Adverse Event|4|||
161041028|NCT01953692|581541224|FG003|Overall Study|Adverse Event|2|||
161041029|NCT01953692|581541225|FG004|Overall Study|Adverse Event|1|||
161041030|NCT01953692|581541226|FG005|Overall Study|Adverse Event|2|||
161041031|NCT01953692|581541227|FG006|Overall Study|Adverse Event|0|||
161041032|NCT01953692|581541228|FG007|Overall Study|Adverse Event|0|||
161041033|NCT01953692|581541229|FG008|Overall Study|Adverse Event|0|||
161041034|NCT01953692|581541221|FG000|Overall Study|Clinical Progression|0|||
161041035|NCT01953692|581541222|FG001|Overall Study|Clinical Progression|15|||
161041036|NCT01953692|581541223|FG002|Overall Study|Clinical Progression|7|||
161041037|NCT01953692|581541224|FG003|Overall Study|Clinical Progression|5|||
161041038|NCT01953692|581541225|FG004|Overall Study|Clinical Progression|0|||
161041039|NCT01953692|581541226|FG005|Overall Study|Clinical Progression|7|||
161041040|NCT01953692|581541227|FG006|Overall Study|Clinical Progression|20|||
161041041|NCT01953692|581541228|FG007|Overall Study|Clinical Progression|3|||
161041042|NCT01953692|581541229|FG008|Overall Study|Clinical Progression|3|||
161041043|NCT01953692|581541221|FG000|Overall Study|Death|5|||
161041044|NCT01953692|581541222|FG001|Overall Study|Death|0|||
161041045|NCT01953692|581541223|FG002|Overall Study|Death|2|||
161041046|NCT01953692|581541224|FG003|Overall Study|Death|2|||
161041047|NCT01953692|581541225|FG004|Overall Study|Death|1|||
161041048|NCT01953692|581541226|FG005|Overall Study|Death|3|||
161041049|NCT01953692|581541227|FG006|Overall Study|Death|6|||
161041050|NCT01953692|581541228|FG007|Overall Study|Death|2|||
161041051|NCT01953692|581541229|FG008|Overall Study|Death|1|||
161041052|NCT01953692|581541221|FG000|Overall Study|Excluded Medication|1|||
161041053|NCT01953692|581541222|FG001|Overall Study|Excluded Medication|0|||
161041054|NCT01953692|581541223|FG002|Overall Study|Excluded Medication|0|||
161041055|NCT01953692|581541224|FG003|Overall Study|Excluded Medication|0|||
161041056|NCT01953692|581541225|FG004|Overall Study|Excluded Medication|0|||
161041057|NCT01953692|581541226|FG005|Overall Study|Excluded Medication|0|||
161041058|NCT01953692|581541227|FG006|Overall Study|Excluded Medication|0|||
161041059|NCT01953692|581541228|FG007|Overall Study|Excluded Medication|0|||
161041060|NCT01953692|581541229|FG008|Overall Study|Excluded Medication|0|||
161041061|NCT01953692|581541221|FG000|Overall Study|Lost to Follow-up|1|||
161041062|NCT01953692|581541222|FG001|Overall Study|Lost to Follow-up|0|||
161041063|NCT01953692|581541223|FG002|Overall Study|Lost to Follow-up|3|||
161041064|NCT01953692|581541224|FG003|Overall Study|Lost to Follow-up|1|||
161041065|NCT01953692|581541225|FG004|Overall Study|Lost to Follow-up|0|||
161041066|NCT01953692|581541226|FG005|Overall Study|Lost to Follow-up|1|||
161041067|NCT01953692|581541227|FG006|Overall Study|Lost to Follow-up|0|||
161041068|NCT01953692|581541228|FG007|Overall Study|Lost to Follow-up|0|||
161041069|NCT01953692|581541229|FG008|Overall Study|Lost to Follow-up|0|||
161280531|NCT02800642|582406970|FG000|Overall Study|Adverse Event|6|||
161041070|NCT01953692|581541221|FG000|Overall Study|Physician Decision|11|||
161041071|NCT01953692|581541222|FG001|Overall Study|Physician Decision|4|||
161041072|NCT01953692|581541223|FG002|Overall Study|Physician Decision|2|||
161041073|NCT01953692|581541224|FG003|Overall Study|Physician Decision|2|||
161041074|NCT01953692|581541225|FG004|Overall Study|Physician Decision|1|||
161041075|NCT01953692|581541226|FG005|Overall Study|Physician Decision|2|||
161041076|NCT01953692|581541227|FG006|Overall Study|Physician Decision|4|||
161041077|NCT01953692|581541228|FG007|Overall Study|Physician Decision|1|||
161041078|NCT01953692|581541229|FG008|Overall Study|Physician Decision|0|||
161041079|NCT01953692|581541221|FG000|Overall Study|Protocol Violation|0|||
161041080|NCT01953692|581541222|FG001|Overall Study|Protocol Violation|2|||
161280532|NCT02800642|582406970|FG000|Overall Study|Withdrawal by Subject|3|||
161041081|NCT01953692|581541223|FG002|Overall Study|Protocol Violation|1|||
161041082|NCT01953692|581541224|FG003|Overall Study|Protocol Violation|0|||
161280533|NCT02800642|582406970|FG000|Overall Study|Lost to Follow-up|1|||
161041083|NCT01953692|581541225|FG004|Overall Study|Protocol Violation|0|||
161041084|NCT01953692|581541226|FG005|Overall Study|Protocol Violation|0|||
161041085|NCT01953692|581541227|FG006|Overall Study|Protocol Violation|0|||
161041086|NCT01953692|581541228|FG007|Overall Study|Protocol Violation|1|||
161041087|NCT01953692|581541229|FG008|Overall Study|Protocol Violation|0|||
161041088|NCT01953692|581541221|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041089|NCT01953692|581541222|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041090|NCT01953692|581541223|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041091|NCT01953692|581541224|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041092|NCT01953692|581541225|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041093|NCT01953692|581541226|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041094|NCT01953692|581541227|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041095|NCT01953692|581541228|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
161041096|NCT01953692|581541229|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
161041097|NCT01953692|581541221|FG000|Overall Study|Withdrawal by Subject|4|||
161041098|NCT01953692|581541222|FG001|Overall Study|Withdrawal by Subject|2|||
161041099|NCT01953692|581541223|FG002|Overall Study|Withdrawal by Subject|1|||
161041100|NCT01953692|581541224|FG003|Overall Study|Withdrawal by Subject|2|||
161041101|NCT01953692|581541225|FG004|Overall Study|Withdrawal by Subject|0|||
161041102|NCT01953692|581541226|FG005|Overall Study|Withdrawal by Subject|3|||
161041103|NCT01953692|581541227|FG006|Overall Study|Withdrawal by Subject|2|||
161041104|NCT01953692|581541228|FG007|Overall Study|Withdrawal by Subject|1|||
161041105|NCT01953692|581541229|FG008|Overall Study|Withdrawal by Subject|1|||
161041106|NCT01822756|581541234|FG000|Overall Study|Adverse Event|0|||
161041107|NCT01822756|581541235|FG001|Overall Study|Adverse Event|0|||
161041108|NCT01822756|581541236|FG002|Overall Study|Adverse Event|0|||
161041109|NCT01822756|581541237|FG003|Overall Study|Adverse Event|2|||
161041110|NCT01822756|581541238|FG004|Overall Study|Adverse Event|0|||
161041111|NCT01822756|581541234|FG000|Overall Study|Disease progression|11|||
161041112|NCT01822756|581541235|FG001|Overall Study|Disease progression|1|||
161041113|NCT01822756|581541236|FG002|Overall Study|Disease progression|7|||
161041114|NCT01822756|581541237|FG003|Overall Study|Disease progression|2|||
161041115|NCT01822756|581541238|FG004|Overall Study|Disease progression|6|||
161041116|NCT01822756|581541234|FG000|Overall Study|Death|2|||
161041117|NCT01822756|581541235|FG001|Overall Study|Death|2|||
161041118|NCT01822756|581541236|FG002|Overall Study|Death|1|||
161041119|NCT01822756|581541237|FG003|Overall Study|Death|0|||
161041120|NCT01822756|581541238|FG004|Overall Study|Death|0|||
161041121|NCT01822756|581541234|FG000|Overall Study|Lost to Follow-up|1|||
161041122|NCT01822756|581541235|FG001|Overall Study|Lost to Follow-up|0|||
161041123|NCT01822756|581541236|FG002|Overall Study|Lost to Follow-up|1|||
161041124|NCT01822756|581541237|FG003|Overall Study|Lost to Follow-up|0|||
161041125|NCT01822756|581541238|FG004|Overall Study|Lost to Follow-up|1|||
161041126|NCT01822756|581541234|FG000|Overall Study|Physician Decision|0|||
161041127|NCT01822756|581541235|FG001|Overall Study|Physician Decision|1|||
161041128|NCT01822756|581541236|FG002|Overall Study|Physician Decision|0|||
161041129|NCT01822756|581541237|FG003|Overall Study|Physician Decision|0|||
161041130|NCT01822756|581541238|FG004|Overall Study|Physician Decision|0|||
161041131|NCT01822756|581541234|FG000|Overall Study|disease progression & patient preference|2|||
161041132|NCT01822756|581541235|FG001|Overall Study|disease progression & patient preference|0|||
161041133|NCT01822756|581541236|FG002|Overall Study|disease progression & patient preference|1|||
161041134|NCT01822756|581541237|FG003|Overall Study|disease progression & patient preference|0|||
161041135|NCT01822756|581541238|FG004|Overall Study|disease progression & patient preference|0|||
161041136|NCT01065779|581541239|FG000|Overall Study|Duplicate Investigation|1|||
161041137|NCT01065779|581541239|FG000|Overall Study|Investigation Before Contract Date|37|||
161041138|NCT01065779|581541239|FG000|Overall Study|Non-enrollment Period Administration|10|||
161041139|NCT01065779|581541239|FG000|Overall Study|Not Administered With Study Drug|17|||
161041140|NCT01065779|581541239|FG000|Overall Study|Failed to Follow-up|10|||
161041141|NCT01065779|581541239|FG000|Overall Study|Inclusion Criteria Violation|7|||
161041142|NCT02157948|581541240|FG000|Overall Study|Withdrawal by Subject|4|||
161041143|NCT02157948|581541241|FG001|Overall Study|Withdrawal by Subject|5|||
161041144|NCT02157948|581541240|FG000|Overall Study|Lost to Follow-up|3|||
161041145|NCT02157948|581541241|FG001|Overall Study|Lost to Follow-up|2|||
161041146|NCT02157948|581541240|FG000|Overall Study|Protocol Specified Criteria|2|||
161041147|NCT02157948|581541241|FG001|Overall Study|Protocol Specified Criteria|1|||
161041148|NCT02157948|581541240|FG000|Overall Study|Decision by Sponsor|0|||
161041149|NCT02157948|581541241|FG001|Overall Study|Decision by Sponsor|1|||
161041150|NCT01683409|581541242|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161041151|NCT01683409|581541243|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161041152|NCT01683409|581541244|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
161041153|NCT01683409|581541245|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161041154|NCT01683409|581541246|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
161041155|NCT01683409|581541242|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
161041156|NCT01683409|581541243|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
161041157|NCT01683409|581541244|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
161041158|NCT01683409|581541245|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
161041159|NCT01683409|581541246|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
161041160|NCT01683409|581541242|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161041161|NCT01683409|581541243|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
161041162|NCT01683409|581541244|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161041163|NCT01683409|581541245|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161041164|NCT01683409|581541246|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
161041165|NCT01683409|581541242|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
161041166|NCT01683409|581541243|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
161041167|NCT01683409|581541244|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
161041168|NCT01683409|581541245|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
161041169|NCT01683409|581541246|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
161041170|NCT01683409|581541242|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161041171|NCT01683409|581541243|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161041172|NCT01683409|581541244|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
161041173|NCT01683409|581541245|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161041174|NCT01683409|581541246|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
161041175|NCT01683409|581541242|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
161041176|NCT01683409|581541243|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161041177|NCT01683409|581541244|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161041178|NCT01683409|581541245|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
161041179|NCT01683409|581541246|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
161041180|NCT01683409|581541242|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
161041181|NCT01683409|581541243|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
161041182|NCT01683409|581541244|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
161041183|NCT01683409|581541245|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
161041184|NCT01683409|581541246|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
161041185|NCT01683409|581541242|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
161041186|NCT01683409|581541243|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161041187|NCT01683409|581541244|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161041188|NCT01683409|581541245|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161041189|NCT01683409|581541246|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
161041190|NCT01683409|581541242|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
161041191|NCT01683409|581541243|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
161041192|NCT01683409|581541244|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
161041193|NCT01683409|581541245|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
161041194|NCT01683409|581541246|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
161041195|NCT01683409|581541242|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161041196|NCT01683409|581541243|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161041197|NCT01683409|581541244|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161041198|NCT01683409|581541245|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
161041199|NCT01683409|581541246|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
161041200|NCT01683409|581541242|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161041201|NCT01683409|581541243|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161041202|NCT01683409|581541244|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
161041203|NCT01683409|581541245|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161041204|NCT01683409|581541246|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
161041205|NCT00553332|581541248|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
161041206|NCT00467272|581541255|FG000|Overall Study|Pneumonia|2|||
161041207|NCT00467272|581541255|FG000|Overall Study|Thrombophlebitis|1|||
161041208|NCT01690624|581541261|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
161041209|NCT01690624|581541262|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
161041210|NCT01690624|581541263|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
161041211|NCT01690624|581541264|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
161041212|NCT01690624|581541261|FG000|Overall Study|Adverse event (other than DLT)|3|||
161041213|NCT01690624|581541262|FG001|Overall Study|Adverse event (other than DLT)|1|||
161041214|NCT01690624|581541263|FG002|Overall Study|Adverse event (other than DLT)|1|||
161041215|NCT01690624|581541264|FG003|Overall Study|Adverse event (other than DLT)|1|||
161041216|NCT01690624|581541261|FG000|Overall Study|Withdrawal by Subject|0|||
161041217|NCT01690624|581541262|FG001|Overall Study|Withdrawal by Subject|0|||
161041218|NCT01690624|581541263|FG002|Overall Study|Withdrawal by Subject|1|||
161041219|NCT01690624|581541264|FG003|Overall Study|Withdrawal by Subject|0|||
161041220|NCT01690624|581541261|FG000|Overall Study|Sponsor is ending trial|0|||
161280534|NCT02027428|582406971|FG000|Induction|Never treated|7|||
161280535|NCT02027428|582406972|FG001|Induction|Never treated|0|||
161041221|NCT01690624|581541262|FG001|Overall Study|Sponsor is ending trial|0|||
161041222|NCT01690624|581541263|FG002|Overall Study|Sponsor is ending trial|0|||
161280536|NCT02027428|582406973|FG002|Induction|Never treated|0|||
161041223|NCT01690624|581541264|FG003|Overall Study|Sponsor is ending trial|1|||
161041224|NCT01690624|581541261|FG000|Overall Study|Physician Decision|0|||
161280537|NCT02027428|582406971|FG000|Induction|Progressive disease|77|||
161280538|NCT02027428|582406972|FG001|Induction|Progressive disease|0|||
161280539|NCT02027428|582406973|FG002|Induction|Progressive disease|0|||
161280540|NCT02027428|582406971|FG000|Induction|Adverse Event|51|||
161280541|NCT02027428|582406972|FG001|Induction|Adverse Event|0|||
161280542|NCT02027428|582406973|FG002|Induction|Adverse Event|0|||
161041225|NCT01690624|581541262|FG001|Overall Study|Physician Decision|0|||
161041226|NCT01690624|581541263|FG002|Overall Study|Physician Decision|0|||
161041227|NCT01690624|581541264|FG003|Overall Study|Physician Decision|1|||
161041228|NCT01690624|581541261|FG000|Overall Study|Withdrawal by Subject|0|||
161041229|NCT01690624|581541262|FG001|Overall Study|Withdrawal by Subject|1|||
161041230|NCT01690624|581541263|FG002|Overall Study|Withdrawal by Subject|0|||
161041231|NCT01690624|581541264|FG003|Overall Study|Withdrawal by Subject|0|||
161041232|NCT01690624|581541261|FG000|Overall Study|Lack of Efficacy|1|||
161041233|NCT01690624|581541262|FG001|Overall Study|Lack of Efficacy|1|||
161041234|NCT01690624|581541263|FG002|Overall Study|Lack of Efficacy|3|||
161041235|NCT01690624|581541264|FG003|Overall Study|Lack of Efficacy|0|||
161041236|NCT04445831|581541265|FG000|Overall Study|Withdrawal by Subject|2|||
161041237|NCT04445831|581541266|FG001|Overall Study|Withdrawal by Subject|1|||
161041238|NCT04445831|581541267|FG002|Overall Study|Withdrawal by Subject|1|||
161041239|NCT04445831|581541268|FG003|Overall Study|Withdrawal by Subject|0|||
161041240|NCT04445831|581541269|FG004|Overall Study|Withdrawal by Subject|0|||
161041241|NCT04445831|581541270|FG005|Overall Study|Withdrawal by Subject|0|||
161041242|NCT04445831|581541271|FG006|Overall Study|Withdrawal by Subject|0|||
161041243|NCT04445831|581541265|FG000|Overall Study|Subject withdrawal by caregiver|0|||
161041244|NCT04445831|581541266|FG001|Overall Study|Subject withdrawal by caregiver|1|||
161041245|NCT04445831|581541267|FG002|Overall Study|Subject withdrawal by caregiver|0|||
161041246|NCT04445831|581541268|FG003|Overall Study|Subject withdrawal by caregiver|0|||
161041247|NCT04445831|581541269|FG004|Overall Study|Subject withdrawal by caregiver|0|||
161041248|NCT04445831|581541270|FG005|Overall Study|Subject withdrawal by caregiver|0|||
161041249|NCT04445831|581541271|FG006|Overall Study|Subject withdrawal by caregiver|0|||
161041250|NCT04701203|581541272|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
161041251|NCT04701203|581541273|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
161041252|NCT04701203|581541274|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
161041253|NCT04701203|581541272|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
161041254|NCT04701203|581541273|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
161041255|NCT04701203|581541274|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
161041256|NCT04701203|581541272|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
161041257|NCT04701203|581541273|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
161041258|NCT04701203|581541274|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
161041259|NCT04701203|581541272|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
161041260|NCT04701203|581541273|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
161041261|NCT04701203|581541274|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
161041262|NCT02434328|581541275|FG000|Overall Study|Adverse Event|9|||
161041263|NCT02434328|581541276|FG001|Overall Study|Adverse Event|4|||
161041264|NCT02434328|581541275|FG000|Overall Study|Lack of Efficacy|0|||
161041265|NCT02434328|581541276|FG001|Overall Study|Lack of Efficacy|2|||
161041266|NCT02434328|581541275|FG000|Overall Study|Physician Decision|0|||
161041267|NCT02434328|581541276|FG001|Overall Study|Physician Decision|1|||
161041268|NCT02434328|581541275|FG000|Overall Study|Withdrawal by Subject|12|||
161041269|NCT02434328|581541276|FG001|Overall Study|Withdrawal by Subject|21|||
161041270|NCT02434328|581541275|FG000|Overall Study|Death|4|||
161041271|NCT02434328|581541276|FG001|Overall Study|Death|7|||
161041272|NCT02434328|581541275|FG000|Overall Study|Lost to Follow-up|1|||
161041273|NCT02434328|581541276|FG001|Overall Study|Lost to Follow-up|6|||
161041274|NCT02434328|581541275|FG000|Overall Study|Other|4|||
161041275|NCT02434328|581541276|FG001|Overall Study|Other|1|||
161041276|NCT01563185|581541277|FG000|Overall Study|Withdrawal by Subject|1|||
161041277|NCT01563185|581541277|FG000|Overall Study|Non-Compliance with study drug|1|||
161041278|NCT04577651|581541278|FG000|Overall Study|Screen Failure|7|||
161041279|NCT04577651|581541278|FG000|Overall Study|Adverse Event|1|||
161041280|NCT04577651|581541278|FG000|Overall Study|Death|1|||
161041281|NCT04577651|581541278|FG000|Overall Study|Physician Decision|1|||
161041282|NCT04577651|581541278|FG000|Overall Study|Withdrawal by Subject|3|||
161041283|NCT03147287|581541279|FG000|Overall Study|Randomized Not Treated|2|||
161280543|NCT02027428|582406971|FG000|Induction|Withdrawal by Subject|22|||
161041284|NCT03147287|581541280|FG001|Overall Study|Randomized Not Treated|1|||
161041285|NCT03147287|581541281|FG002|Overall Study|Randomized Not Treated|1|||
161041286|NCT03147287|581541279|FG000|Overall Study|Progressive Disease RECIST|31|||
161041287|NCT03147287|581541280|FG001|Overall Study|Progressive Disease RECIST|72|||
161041288|NCT03147287|581541281|FG002|Overall Study|Progressive Disease RECIST|32|||
161041289|NCT03147287|581541279|FG000|Overall Study|Progressive Disease not RECIST|13|||
161280544|NCT02027428|582406972|FG001|Induction|Withdrawal by Subject|0|||
161280545|NCT02027428|582406973|FG002|Induction|Withdrawal by Subject|0|||
161280546|NCT02027428|582406971|FG000|Induction|Death|21|||
161041290|NCT03147287|581541280|FG001|Overall Study|Progressive Disease not RECIST|21|||
161041291|NCT03147287|581541281|FG002|Overall Study|Progressive Disease not RECIST|13|||
161280547|NCT02027428|582406972|FG001|Induction|Death|0|||
161041292|NCT03147287|581541279|FG000|Overall Study|Physician Decision|1|||
161041293|NCT03147287|581541280|FG001|Overall Study|Physician Decision|2|||
161041294|NCT03147287|581541281|FG002|Overall Study|Physician Decision|1|||
161041295|NCT03147287|581541279|FG000|Overall Study|Intercurrent illness|0|||
161041296|NCT03147287|581541280|FG001|Overall Study|Intercurrent illness|1|||
161041297|NCT03147287|581541281|FG002|Overall Study|Intercurrent illness|0|||
161041298|NCT03147287|581541279|FG000|Overall Study|Withdrawal by Subject|2|||
161041299|NCT03147287|581541280|FG001|Overall Study|Withdrawal by Subject|3|||
161041300|NCT03147287|581541281|FG002|Overall Study|Withdrawal by Subject|2|||
161041301|NCT03147287|581541279|FG000|Overall Study|Patient Non-Compliance|0|||
161041302|NCT03147287|581541280|FG001|Overall Study|Patient Non-Compliance|2|||
161041303|NCT03147287|581541281|FG002|Overall Study|Patient Non-Compliance|0|||
161041304|NCT03147287|581541279|FG000|Overall Study|Patient moved|0|||
161041305|NCT03147287|581541280|FG001|Overall Study|Patient moved|1|||
161041306|NCT03147287|581541281|FG002|Overall Study|Patient moved|0|||
161041307|NCT03147287|581541279|FG000|Overall Study|Arm A crossover without PD|1|||
161041308|NCT03147287|581541280|FG001|Overall Study|Arm A crossover without PD|0|||
161041309|NCT03147287|581541281|FG002|Overall Study|Arm A crossover without PD|0|||
161041310|NCT03147287|581541279|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
161041311|NCT03147287|581541280|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
161041312|NCT03147287|581541281|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
161041313|NCT02556918|581542894|FG000|Overall Study|Protocol Violation|5|||
161041314|NCT02556918|581542895|FG001|Overall Study|Protocol Violation|6|||
161041315|NCT02556918|581542894|FG000|Overall Study|Withdrawal by Subject|4|||
161041316|NCT02556918|581542895|FG001|Overall Study|Withdrawal by Subject|4|||
161041317|NCT04511702|581542903|FG000|Overall Study|Lost to Follow-up|3|||
161041318|NCT04511702|581542904|FG001|Overall Study|Lost to Follow-up|0|||
161041319|NCT04511702|581542905|FG002|Overall Study|Lost to Follow-up|4|||
161041320|NCT04511702|581542903|FG000|Overall Study|Withdrawal by Subject|17|||
161041321|NCT04511702|581542904|FG001|Overall Study|Withdrawal by Subject|1|||
161041322|NCT04511702|581542905|FG002|Overall Study|Withdrawal by Subject|8|||
161041323|NCT05349721|581542906|FG000|Part A (24 Weeks)|Adverse Event|9|||
161041324|NCT05349721|581542907|FG001|Part A (24 Weeks)|Adverse Event|2|||
161041325|NCT05349721|581542906|FG000|Part A (24 Weeks)|Death|8|||
161041326|NCT05349721|581542907|FG001|Part A (24 Weeks)|Death|3|||
161041327|NCT05349721|581542906|FG000|Part A (24 Weeks)|Disease Progression|1|||
161041328|NCT05349721|581542907|FG001|Part A (24 Weeks)|Disease Progression|1|||
161041329|NCT05349721|581542906|FG000|Part A (24 Weeks)|Screen Failure|2|||
161041330|NCT05349721|581542907|FG001|Part A (24 Weeks)|Screen Failure|0|||
161041331|NCT05349721|581542906|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
161041332|NCT05349721|581542907|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
161041333|NCT05349721|581542906|FG000|Part A (24 Weeks)|Other Than Specified|5|||
161041334|NCT05349721|581542907|FG001|Part A (24 Weeks)|Other Than Specified|1|||
161041335|NCT05349721|581542906|FG000|Part B (28 Weeks)|Adverse Event|3|||
161041336|NCT05349721|581542907|FG001|Part B (28 Weeks)|Adverse Event|0|||
161041337|NCT05349721|581542906|FG000|Part B (28 Weeks)|Death|21|||
161041338|NCT05349721|581542907|FG001|Part B (28 Weeks)|Death|11|||
161041339|NCT05349721|581542906|FG000|Part B (28 Weeks)|Disease Progression|2|||
161041340|NCT05349721|581542907|FG001|Part B (28 Weeks)|Disease Progression|1|||
161041341|NCT05349721|581542906|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
161041342|NCT05349721|581542907|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
161041343|NCT05349721|581542906|FG000|Part B (28 Weeks)|Physician Decision|1|||
161041344|NCT05349721|581542907|FG001|Part B (28 Weeks)|Physician Decision|0|||
161041345|NCT05349721|581542906|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
161041346|NCT05349721|581542907|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
161041347|NCT05349721|581542906|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
161041348|NCT05349721|581542907|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
161041349|NCT05349721|581542906|FG000|Part B (28 Weeks)|Other Than Specified|4|||
161041350|NCT05349721|581542907|FG001|Part B (28 Weeks)|Other Than Specified|2|||
161041351|NCT05349721|581542906|FG000|Part C (108 Weeks)|Death|0|||
161041352|NCT05349721|581542907|FG001|Part C (108 Weeks)|Death|1|||
161041353|NCT05349721|581542906|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
161041354|NCT05349721|581542907|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
161041355|NCT05349721|581542906|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
161041356|NCT05349721|581542907|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
161041357|NCT05349721|581542906|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
161041358|NCT05349721|581542907|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
161041359|NCT00489554|581542910|FG000|Overall Study|Adverse Event|2|||
161041360|NCT00489554|581542910|FG000|Overall Study|Withdrawal by Subject|1|||
161041361|NCT00489554|581542910|FG000|Overall Study|Lost to Follow-up|1|||
161041362|NCT03960645|581542911|FG000|Overall Study|Protocol Violation|1|||
161041363|NCT03960645|581542912|FG001|Overall Study|Protocol Violation|0|||
161041364|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
161041365|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
161041366|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
161041367|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
161280548|NCT02027428|582406973|FG002|Induction|Death|0|||
161041368|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
161041369|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
161041370|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
161041371|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
161041372|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161041373|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
161041374|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
161041375|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
161041376|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161041377|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
161041378|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
161041379|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
161041380|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
161041381|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
161041382|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
161041383|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
161041384|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
161041385|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
161041386|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
161041387|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
161041388|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
161041389|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
161041390|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
161041391|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
161041392|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
161041393|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
161041394|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
161041395|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
161041396|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
161041397|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
161041398|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
161041399|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161041400|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161041401|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161041402|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
161041403|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
161041404|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
161041405|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
161041406|NCT03732807|581542915|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161041407|NCT03732807|581542916|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161041408|NCT03732807|581542917|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161041409|NCT03732807|581542918|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161041410|NCT03732807|581542919|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161041411|NCT03732807|581542920|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
161041412|NCT03732807|581542921|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
161041413|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
161041414|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
161041415|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
161041416|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
161041417|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
161041418|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
161041419|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
161041420|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
161041421|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
161041422|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
161041423|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
161041424|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
161041425|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
161041426|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
161041427|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
161041428|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
161041429|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
161041430|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
161041431|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
161041432|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
161041433|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
161041434|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161041435|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
161041436|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161041437|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161041438|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161041439|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161041440|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
161041441|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161041442|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
161041443|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161041444|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
161041445|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
161041446|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161041447|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
161041448|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
161041449|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
161041450|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161041451|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161041452|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
161041453|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161041454|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
161041455|NCT03732807|581542915|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
161041456|NCT03732807|581542916|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
161041457|NCT03732807|581542917|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
161041458|NCT03732807|581542918|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
161041459|NCT03732807|581542919|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
161041460|NCT03732807|581542920|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
161041461|NCT03732807|581542921|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
161041462|NCT03737110|581542924|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
161041463|NCT03737110|581542925|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
161041464|NCT03737110|581542926|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
161041465|NCT03737110|581542927|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
161041466|NCT03737110|581542928|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
161041467|NCT03737110|581542929|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
161041468|NCT03737110|581542924|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
161041469|NCT03737110|581542925|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161041470|NCT03737110|581542926|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161041471|NCT03737110|581542927|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161041472|NCT03737110|581542928|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161041473|NCT03737110|581542929|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
161041474|NCT03737110|581542924|FG000|Run-in (RI) Period|Adverse Event|4|||
161041475|NCT03737110|581542925|FG001|Run-in (RI) Period|Adverse Event|0|||
161041476|NCT03737110|581542926|FG002|Run-in (RI) Period|Adverse Event|0|||
161041477|NCT03737110|581542927|FG003|Run-in (RI) Period|Adverse Event|0|||
161041478|NCT03737110|581542928|FG004|Run-in (RI) Period|Adverse Event|0|||
161041479|NCT03737110|581542929|FG005|Run-in (RI) Period|Adverse Event|0|||
161041480|NCT03737110|581542924|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161041481|NCT03737110|581542925|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
161041482|NCT03737110|581542926|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161041483|NCT03737110|581542927|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161041484|NCT03737110|581542928|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161041485|NCT03737110|581542929|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
161041486|NCT03737110|581542924|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161148874|NCT02639182|581926172|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
161148875|NCT02639182|581926173|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
161148876|NCT02546856|581926176|FG000|4 Months Evaluation|Death|2|||
161148877|NCT02546856|581926177|FG001|4 Months Evaluation|Death|3|||
161148878|NCT02546856|581926176|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
161148879|NCT02546856|581926177|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
161148880|NCT02546856|581926176|FG000|4 Months Evaluation|Lost to Follow-up|3|||
161148881|NCT02546856|581926177|FG001|4 Months Evaluation|Lost to Follow-up|3|||
161148882|NCT02546856|581926176|FG000|4 Months Evaluation|Physician Decision|3|||
161148883|NCT02546856|581926177|FG001|4 Months Evaluation|Physician Decision|0|||
161148884|NCT02546856|581926176|FG000|4 Months Evaluation|Working or living abroad|5|||
161148885|NCT02546856|581926177|FG001|4 Months Evaluation|Working or living abroad|1|||
161148886|NCT02546856|581926176|FG000|4 Months Evaluation|reasons not due to titration|4|||
161148887|NCT02546856|581926177|FG001|4 Months Evaluation|reasons not due to titration|1|||
161041487|NCT03737110|581542925|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161041488|NCT03737110|581542926|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
161041489|NCT03737110|581542927|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161041490|NCT03737110|581542928|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161041491|NCT03737110|581542929|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
161041492|NCT03737110|581542924|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161041493|NCT03737110|581542925|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161041494|NCT03737110|581542926|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161041495|NCT03737110|581542927|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
161041496|NCT03737110|581542928|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161041497|NCT03737110|581542929|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161041498|NCT03737110|581542924|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161041499|NCT03737110|581542925|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161041500|NCT03737110|581542926|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161041501|NCT03737110|581542927|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
161041502|NCT03737110|581542928|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
161041503|NCT03737110|581542929|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
161041504|NCT03737110|581542924|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161041505|NCT03737110|581542925|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161041506|NCT03737110|581542926|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161041507|NCT03737110|581542927|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161041508|NCT03737110|581542928|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
161041509|NCT03737110|581542929|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
161041510|NCT00599196|581542934|FG000|Overall Study|Lack of Efficacy|22|||
161041511|NCT00599196|581542934|FG000|Overall Study|Adverse Event|93|||
161041512|NCT00599196|581542934|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
161041513|NCT00599196|581542934|FG000|Overall Study|Subject withdrew consent|43|||
161041514|NCT00599196|581542934|FG000|Overall Study|Study ended per sponsor|197|||
161041515|NCT00599196|581542934|FG000|Overall Study|Lost to Follow-up|17|||
161041516|NCT00599196|581542934|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
161041517|NCT00599196|581542934|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
161041518|NCT00599196|581542934|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
161041519|NCT00599196|581542934|FG000|Overall Study|Other: Pt Moved To Australia|1|||
161041520|NCT00599196|581542934|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
161041521|NCT00599196|581542934|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
161041522|NCT01009645|581542948|FG000|Overall Study|Lost to Follow-up|2|||
161041523|NCT01009645|581542949|FG001|Overall Study|Lost to Follow-up|8|||
161041524|NCT01009645|581542950|FG002|Overall Study|Lost to Follow-up|4|||
161041525|NCT01009645|581542951|FG003|Overall Study|Lost to Follow-up|5|||
161041526|NCT01124045|581542952|FG000|Overall Study|Lost to Follow-up|0|||
161041527|NCT01124045|581542953|FG001|Overall Study|Lost to Follow-up|1|||
161041528|NCT01124045|581542952|FG000|Overall Study|Physician Decision|0|||
161041529|NCT01124045|581542953|FG001|Overall Study|Physician Decision|2|||
161041530|NCT01079806|581542959|FG000|Day 1 to Week 96|Adverse Event|0|||
161041531|NCT01079806|581542960|FG001|Day 1 to Week 96|Adverse Event|3|||
161041532|NCT01079806|581542959|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
161041533|NCT01079806|581542960|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
161041534|NCT01079806|581542959|FG000|Day 1 to Week 96|Pregnancy|0|||
161041535|NCT01079806|581542960|FG001|Day 1 to Week 96|Pregnancy|1|||
161041536|NCT01079806|581542959|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
161041537|NCT01079806|581542960|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
161041538|NCT01079806|581542959|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
161041539|NCT01079806|581542960|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
161041540|NCT01079806|581542959|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
161041541|NCT01079806|581542960|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
161041542|NCT01079806|581542959|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
161041543|NCT01079806|581542960|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
161041544|NCT01079806|581542959|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
161041545|NCT01079806|581542960|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
161041546|NCT01079806|581542959|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
161041547|NCT01079806|581542960|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
161041548|NCT01079806|581542959|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
161041549|NCT01079806|581542960|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
161041550|NCT01530334|581542965|FG000|Overall Study|Adverse Event|3|||
161041551|NCT01530334|581542965|FG000|Overall Study|unknown reason|1|||
161041552|NCT01530334|581542965|FG000|Overall Study|Progressive disease|47|||
161041553|NCT03489369|581542966|FG000|Overall Study|Documented Progressive Disease|3|||
161041554|NCT03489369|581542967|FG001|Overall Study|Documented Progressive Disease|2|||
161041555|NCT03489369|581542968|FG002|Overall Study|Documented Progressive Disease|3|||
161041556|NCT03489369|581542969|FG003|Overall Study|Documented Progressive Disease|6|||
161041557|NCT03489369|581542966|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
161041558|NCT03489369|581542967|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
161041559|NCT03489369|581542968|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
161041560|NCT03489369|581542969|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
161041561|NCT01604824|581542976|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161041562|NCT01604824|581542977|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161041563|NCT01604824|581542978|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161041564|NCT01604824|581542979|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161041565|NCT01604824|581542980|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
161041566|NCT01604824|581542981|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
161041567|NCT01604824|581542976|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
161041568|NCT01604824|581542977|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
161041569|NCT01604824|581542978|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
161041570|NCT01604824|581542979|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
161041571|NCT01604824|581542980|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
161041572|NCT01604824|581542981|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
161041573|NCT02630966|581542982|FG000|Overall Study|Adverse Event|1|||
161041574|NCT02630966|581542983|FG001|Overall Study|Adverse Event|3|||
161041575|NCT02630966|581542982|FG000|Overall Study|Significant Protocol Deviation|0|||
161041576|NCT02630966|581542983|FG001|Overall Study|Significant Protocol Deviation|2|||
161041577|NCT02630966|581542982|FG000|Overall Study|Voluntary Withdrawal|1|||
161041578|NCT02630966|581542983|FG001|Overall Study|Voluntary Withdrawal|1|||
161041579|NCT02630966|581542982|FG000|Overall Study|Lack of Efficacy|0|||
161041580|NCT02630966|581542983|FG001|Overall Study|Lack of Efficacy|2|||
161041581|NCT00665392|581542984|FG000|Overall Study|not treated|1|||
161041582|NCT00243867|581542990|FG000|Overall Study|Adverse Event|24|||
161041583|NCT00243867|581542991|FG001|Overall Study|Adverse Event|34|||
161041584|NCT00243867|581542990|FG000|Overall Study|Lack of Efficacy|115|||
161041585|NCT00243867|581542991|FG001|Overall Study|Lack of Efficacy|78|||
161041586|NCT00243867|581542990|FG000|Overall Study|Withdrawal by Subject|11|||
161041587|NCT00243867|581542991|FG001|Overall Study|Withdrawal by Subject|23|||
161041588|NCT00243867|581542990|FG000|Overall Study|Lost to Follow-up|2|||
161041589|NCT00243867|581542991|FG001|Overall Study|Lost to Follow-up|1|||
161041590|NCT00243867|581542990|FG000|Overall Study|Physician Decision|2|||
161041591|NCT00243867|581542991|FG001|Overall Study|Physician Decision|7|||
161041592|NCT00243867|581542990|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
161041593|NCT00243867|581542991|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
161041594|NCT03389802|581543015|FG000|Overall Study|Lack of Efficacy|3|||
161041595|NCT03389802|581543016|FG001|Overall Study|Lack of Efficacy|3|||
161041596|NCT03389802|581543017|FG002|Overall Study|Lack of Efficacy|13|||
161041597|NCT03389802|581543018|FG003|Overall Study|Lack of Efficacy|6|||
161041598|NCT03389802|581543019|FG004|Overall Study|Lack of Efficacy|1|||
161041599|NCT03389802|581543015|FG000|Overall Study|Adverse Event|0|||
161041600|NCT03389802|581543016|FG001|Overall Study|Adverse Event|0|||
161041601|NCT03389802|581543017|FG002|Overall Study|Adverse Event|1|||
161041602|NCT03389802|581543018|FG003|Overall Study|Adverse Event|0|||
161041603|NCT03389802|581543019|FG004|Overall Study|Adverse Event|4|||
161041604|NCT03389802|581543015|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
161041605|NCT03389802|581543016|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
161041606|NCT03389802|581543017|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
161041607|NCT03389802|581543018|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
161041608|NCT03389802|581543019|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
161041609|NCT02426138|581543020|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161041610|NCT02426138|581543021|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161041611|NCT04677738|581543022|FG000|Overall Study|Withdrawal by Subject|4|||
161041612|NCT04677738|581543023|FG001|Overall Study|Withdrawal by Subject|2|||
161041613|NCT02409680|581543029|FG000|Overall Study|Lost to Follow-up|15|||
161041614|NCT02409680|581543030|FG001|Overall Study|Lost to Follow-up|30|||
161041615|NCT04912856|581543039|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
161041616|NCT04912856|581543040|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
161041617|NCT04912856|581543039|FG000|Overall Study|Not reported in synoptic CSR.|0|||
161041618|NCT04912856|581543040|FG001|Overall Study|Not reported in synoptic CSR.|1|||
161041619|NCT06571695|581544780|FG000|Overall Study|Lost to Follow-up|1|||
161041620|NCT06571695|581544781|FG001|Overall Study|Lost to Follow-up|6|||
161041621|NCT00108355|581544782|FG000|Overall Study|Peritonitis at index paracentesis|1|||
161041622|NCT00108355|581544783|FG001|Overall Study|Peritonitis at index paracentesis|1|||
161041623|NCT00108355|581544782|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
161041624|NCT00108355|581544783|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
161280549|NCT02027428|582406971|FG000|Induction|Symptomatic deterioration|16|||
161280550|NCT02027428|582406972|FG001|Induction|Symptomatic deterioration|0|||
161280551|NCT02027428|582406973|FG002|Induction|Symptomatic deterioration|0|||
161041625|NCT04921358|581544784|FG000|Overall Study|Withdrawal by Subject|6|||
161041626|NCT04921358|581544785|FG001|Overall Study|Withdrawal by Subject|13|||
161041627|NCT04921358|581544784|FG000|Overall Study|Lost to Follow-up|3|||
161041628|NCT04921358|581544785|FG001|Overall Study|Lost to Follow-up|6|||
161041629|NCT04921358|581544784|FG000|Overall Study|Study Terminated by Sponsor|86|||
161041630|NCT04921358|581544785|FG001|Overall Study|Study Terminated by Sponsor|89|||
161041631|NCT04921358|581544784|FG000|Overall Study|Death|92|||
161041632|NCT04921358|581544785|FG001|Overall Study|Death|82|||
161041633|NCT02278796|581544786|FG000|Overall Study|Death|2|||
161041634|NCT02278796|581544787|FG001|Overall Study|Death|3|||
161041635|NCT04926857|581544788|FG000|Overall Study|Withdrawal by Subject|40|||
161041636|NCT04926857|581544788|FG000|Overall Study|Death|9|||
161041637|NCT04926857|581544788|FG000|Overall Study|Study product no longer in use|44|||
161041638|NCT04926857|581544788|FG000|Overall Study|Inadequate data to address primary objective|16|||
161041639|NCT03214081|581544789|FG000|Overall Study|Case Report Forms Uncollected|9|||
161041640|NCT03214081|581544789|FG000|Overall Study|Protocol Deviation|54|||
161041641|NCT00491400|581544790|FG000|Overall Study|Withdrawal by Subject|5|||
161041642|NCT00491400|581544791|FG001|Overall Study|Withdrawal by Subject|4|||
161041643|NCT00597376|581544792|FG000|Overall Study|Withdrawal by Subject|4|||
161041644|NCT00597376|581544793|FG001|Overall Study|Withdrawal by Subject|3|||
161041645|NCT00597376|581544792|FG000|Overall Study|Adverse Event|4|||
161041646|NCT00597376|581544793|FG001|Overall Study|Adverse Event|1|||
161041647|NCT02698475|581544794|FG000|Main Study Period|Lack of Efficacy|1|||
161041648|NCT02698475|581544794|FG000|Main Study Period|Protocol Violation|2|||
161041649|NCT02698475|581544794|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
161041650|NCT02698475|581544794|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
161041651|NCT02698475|581544794|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
161041652|NCT02698475|581544794|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
161041653|NCT02698475|581544794|FG000|Long-Term Extension Period|Other|1|||
161041654|NCT02310581|581544800|FG000|Overall Study|Adverse Event|1|||
161041655|NCT02310581|581544801|FG001|Overall Study|Adverse Event|1|||
161041656|NCT02310581|581544802|FG002|Overall Study|Adverse Event|1|||
161041657|NCT02310581|581544803|FG003|Overall Study|Adverse Event|0|||
161041658|NCT02310581|581544800|FG000|Overall Study|Withdrawal by Subject|2|||
161041659|NCT02310581|581544801|FG001|Overall Study|Withdrawal by Subject|1|||
161041660|NCT02310581|581544802|FG002|Overall Study|Withdrawal by Subject|0|||
161041661|NCT02310581|581544803|FG003|Overall Study|Withdrawal by Subject|1|||
161041662|NCT04693637|581544804|FG000|Overall Study|Death|4|||
161041663|NCT04693637|581544804|FG000|Overall Study|Withdrawal by Subject|3|||
161041664|NCT04693637|581544804|FG000|Overall Study|Physician Decision|2|||
161041665|NCT04693637|581544804|FG000|Overall Study|Lost to Follow-up|1|||
161041666|NCT04237792|581544805|FG000|Treatment (Day 1)|Adverse Event|1|||
161041667|NCT04237792|581544806|FG001|Treatment (Day 1)|Adverse Event|0|||
161041668|NCT04237792|581544807|FG002|Treatment (Day 1)|Adverse Event|0|||
161041669|NCT04237792|581544808|FG003|Treatment (Day 1)|Adverse Event|0|||
161041670|NCT04237792|581544809|FG004|Treatment (Day 1)|Adverse Event|1|||
161041671|NCT04237792|581544810|FG005|Treatment (Day 1)|Adverse Event|1|||
161041672|NCT04237792|581544805|FG000|Treatment (Day 1)|Other|0|||
161041673|NCT04237792|581544806|FG001|Treatment (Day 1)|Other|0|||
161041674|NCT04237792|581544807|FG002|Treatment (Day 1)|Other|1|||
161041675|NCT04237792|581544808|FG003|Treatment (Day 1)|Other|0|||
161041676|NCT04237792|581544809|FG004|Treatment (Day 1)|Other|0|||
161041677|NCT04237792|581544810|FG005|Treatment (Day 1)|Other|1|||
161041678|NCT04237792|581544805|FG000|Treatment (Day 1)|Not treated|1|||
161041679|NCT04237792|581544806|FG001|Treatment (Day 1)|Not treated|1|||
161041680|NCT04237792|581544807|FG002|Treatment (Day 1)|Not treated|2|||
161041681|NCT04237792|581544808|FG003|Treatment (Day 1)|Not treated|1|||
161041682|NCT04237792|581544809|FG004|Treatment (Day 1)|Not treated|0|||
161280552|NCT02027428|582406971|FG000|Induction|Study terminated by sponsor|12|||
161041683|NCT04237792|581544810|FG005|Treatment (Day 1)|Not treated|1|||
161041684|NCT03052517|581544811|FG000|Overall Study|Study Terminated By Sponsor|928|||
161041685|NCT03052517|581544812|FG001|Overall Study|Study Terminated By Sponsor|938|||
161041686|NCT03052517|581544813|FG002|Overall Study|Study Terminated By Sponsor|296|||
161041687|NCT03052517|581544811|FG000|Overall Study|Subject/Guardian Decision|50|||
161041688|NCT03052517|581544812|FG001|Overall Study|Subject/Guardian Decision|45|||
161041689|NCT03052517|581544813|FG002|Overall Study|Subject/Guardian Decision|22|||
161041690|NCT03052517|581544811|FG000|Overall Study|Lack of Efficacy|23|||
161041691|NCT03052517|581544812|FG001|Overall Study|Lack of Efficacy|14|||
161041692|NCT03052517|581544813|FG002|Overall Study|Lack of Efficacy|7|||
161280553|NCT02027428|582406972|FG001|Induction|Study terminated by sponsor|0|||
161041693|NCT03052517|581544811|FG000|Overall Study|Adverse Event|6|||
161041694|NCT03052517|581544812|FG001|Overall Study|Adverse Event|5|||
161041695|NCT03052517|581544813|FG002|Overall Study|Adverse Event|0|||
161041696|NCT03052517|581544811|FG000|Overall Study|Physician Decision|4|||
161041697|NCT03052517|581544812|FG001|Overall Study|Physician Decision|5|||
161041698|NCT03052517|581544813|FG002|Overall Study|Physician Decision|1|||
161041699|NCT03052517|581544811|FG000|Overall Study|Death|3|||
161041700|NCT03052517|581544812|FG001|Overall Study|Death|0|||
161041701|NCT03052517|581544813|FG002|Overall Study|Death|1|||
161041702|NCT03052517|581544811|FG000|Overall Study|Lost to Follow-up|2|||
161041703|NCT03052517|581544812|FG001|Overall Study|Lost to Follow-up|4|||
161041704|NCT03052517|581544813|FG002|Overall Study|Lost to Follow-up|0|||
161041705|NCT03052517|581544811|FG000|Overall Study|Pregnancy|1|||
161041706|NCT03052517|581544812|FG001|Overall Study|Pregnancy|0|||
161041707|NCT03052517|581544813|FG002|Overall Study|Pregnancy|1|||
161041708|NCT03052517|581544811|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
161041709|NCT03052517|581544812|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
161041710|NCT03052517|581544813|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
161041711|NCT03052517|581544811|FG000|Overall Study|Technical Problems|0|||
161041712|NCT03052517|581544812|FG001|Overall Study|Technical Problems|1|||
161041713|NCT03052517|581544813|FG002|Overall Study|Technical Problems|0|||
161041714|NCT04885998|581544816|FG000|Overall Study|Withdrawal by Subject|0|||
161041715|NCT04885998|581544817|FG001|Overall Study|Withdrawal by Subject|2|||
161041716|NCT04885998|581544818|FG002|Overall Study|Withdrawal by Subject|0|||
161041717|NCT04885998|581544819|FG003|Overall Study|Withdrawal by Subject|3|||
161041718|NCT04885998|581544816|FG000|Overall Study|Lost to Follow-up|1|||
161041719|NCT04885998|581544817|FG001|Overall Study|Lost to Follow-up|1|||
161041720|NCT04885998|581544818|FG002|Overall Study|Lost to Follow-up|0|||
161041721|NCT04885998|581544819|FG003|Overall Study|Lost to Follow-up|0|||
161041722|NCT04885998|581544816|FG000|Overall Study|Death|2|||
161041723|NCT04885998|581544817|FG001|Overall Study|Death|1|||
161041724|NCT04885998|581544818|FG002|Overall Study|Death|2|||
161041725|NCT04885998|581544819|FG003|Overall Study|Death|2|||
161041726|NCT04885998|581544816|FG000|Overall Study|Decision by sponsor|1|||
161041727|NCT04885998|581544817|FG001|Overall Study|Decision by sponsor|1|||
161041728|NCT04885998|581544818|FG002|Overall Study|Decision by sponsor|0|||
161041729|NCT04885998|581544819|FG003|Overall Study|Decision by sponsor|0|||
161041730|NCT05260437|581544821|FG000|Overall Study|Lost to Follow-up|5|||
161041731|NCT05260437|581544822|FG001|Overall Study|Lost to Follow-up|2|||
161041732|NCT05260437|581544823|FG002|Overall Study|Lost to Follow-up|1|||
161041733|NCT05260437|581544824|FG003|Overall Study|Lost to Follow-up|2|||
161041734|NCT05260437|581544825|FG004|Overall Study|Lost to Follow-up|2|||
161041735|NCT05260437|581544821|FG000|Overall Study|Withdrawal by Subject|3|||
161041736|NCT05260437|581544822|FG001|Overall Study|Withdrawal by Subject|0|||
161041737|NCT05260437|581544823|FG002|Overall Study|Withdrawal by Subject|4|||
161041738|NCT05260437|581544824|FG003|Overall Study|Withdrawal by Subject|5|||
161041739|NCT05260437|581544825|FG004|Overall Study|Withdrawal by Subject|0|||
161041740|NCT05260437|581544821|FG000|Overall Study|Vaccine Not Administered|0|||
161041741|NCT05260437|581544822|FG001|Overall Study|Vaccine Not Administered|1|||
161041742|NCT05260437|581544823|FG002|Overall Study|Vaccine Not Administered|0|||
161041743|NCT05260437|581544824|FG003|Overall Study|Vaccine Not Administered|0|||
161041744|NCT05260437|581544825|FG004|Overall Study|Vaccine Not Administered|0|||
161041745|NCT00910962|581544826|FG000|Overall Study|Adverse Event|5|||
161041746|NCT00910962|581544827|FG001|Overall Study|Adverse Event|20|||
161041747|NCT00910962|581544828|FG002|Overall Study|Adverse Event|17|||
161041748|NCT00910962|581544826|FG000|Overall Study|Protocol Violation|1|||
161041749|NCT00910962|581544827|FG001|Overall Study|Protocol Violation|3|||
161041750|NCT00910962|581544828|FG002|Overall Study|Protocol Violation|3|||
161041751|NCT00910962|581544826|FG000|Overall Study|Lost to Follow-up|0|||
161041752|NCT00910962|581544827|FG001|Overall Study|Lost to Follow-up|3|||
161041753|NCT00910962|581544828|FG002|Overall Study|Lost to Follow-up|1|||
161041754|NCT00910962|581544826|FG000|Overall Study|Physician Decision|0|||
161041755|NCT00910962|581544827|FG001|Overall Study|Physician Decision|6|||
161041756|NCT00910962|581544828|FG002|Overall Study|Physician Decision|6|||
161041757|NCT00910962|581544826|FG000|Overall Study|Withdrawal by Subject|25|||
161041758|NCT00910962|581544827|FG001|Overall Study|Withdrawal by Subject|32|||
161041759|NCT00910962|581544828|FG002|Overall Study|Withdrawal by Subject|32|||
161041760|NCT00910962|581544826|FG000|Overall Study|Reached defined stopping criteria|12|||
161041761|NCT00910962|581544827|FG001|Overall Study|Reached defined stopping criteria|14|||
161041762|NCT00910962|581544828|FG002|Overall Study|Reached defined stopping criteria|17|||
161041763|NCT00195819|581544829|FG000|Double-Blind|Withdrawal by Subject|1|||
161041764|NCT00195819|581544830|FG001|Double-Blind|Withdrawal by Subject|0|||
161041765|NCT00195819|581544829|FG000|Double-Blind|Moved|1|||
161041766|NCT00195819|581544830|FG001|Double-Blind|Moved|0|||
161041767|NCT00195819|581544829|FG000|Open-label|Adverse Event|0|||
161041768|NCT00195819|581544830|FG001|Open-label|Adverse Event|9|||
161041769|NCT00195819|581544829|FG000|Open-label|Lack of Efficacy|0|||
161041770|NCT00195819|581544830|FG001|Open-label|Lack of Efficacy|2|||
161041771|NCT00195819|581544829|FG000|Open-label|Pregnancy|0|||
161041772|NCT00195819|581544830|FG001|Open-label|Pregnancy|1|||
161041773|NCT00195819|581544829|FG000|Open-label|Protocol Violation|0|||
161041774|NCT00195819|581544830|FG001|Open-label|Protocol Violation|2|||
161041775|NCT00195819|581544829|FG000|Open-label|Moved|0|||
161041776|NCT00195819|581544830|FG001|Open-label|Moved|1|||
161041777|NCT00195819|581544829|FG000|Open-label|Withdrawal by Subject|0|||
161280554|NCT02027428|582406973|FG002|Induction|Study terminated by sponsor|0|||
161280555|NCT02027428|582406971|FG000|Induction|Protocol Violation|1|||
161041778|NCT00195819|581544830|FG001|Open-label|Withdrawal by Subject|5|||
161041779|NCT00787176|581544831|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
161041780|NCT00787176|581544832|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
161041781|NCT00787176|581544833|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
161041782|NCT00787176|581544834|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
161041783|NCT03298087|581544835|FG000|Overall Study|Withdrawal by Subject|4|||
161041784|NCT02788981|581544836|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
161041785|NCT02788981|581544837|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
161041786|NCT05553366|581544838|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
161041787|NCT05553366|581544839|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
161041788|NCT05553366|581544840|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
161041789|NCT05553366|581544838|FG000|Overall Study|Lost to Follow-up|3|||
161041790|NCT05553366|581544839|FG001|Overall Study|Lost to Follow-up|3|||
161041791|NCT05553366|581544840|FG002|Overall Study|Lost to Follow-up|3|||
161041792|NCT05553366|581544838|FG000|Overall Study|Other non-compliance|1|||
161041793|NCT05553366|581544839|FG001|Overall Study|Other non-compliance|1|||
161041794|NCT05553366|581544840|FG002|Overall Study|Other non-compliance|0|||
161041795|NCT05553366|581544838|FG000|Overall Study|Randomized but not dosed|0|||
161041796|NCT05553366|581544839|FG001|Overall Study|Randomized but not dosed|0|||
161041797|NCT05553366|581544840|FG002|Overall Study|Randomized but not dosed|2|||
161041798|NCT00249769|581544841|FG000|Overall Study|Withdrawal by Subject|1|||
161041799|NCT00249769|581544842|FG001|Overall Study|Withdrawal by Subject|10|||
161041800|NCT00249769|581544843|FG002|Overall Study|Withdrawal by Subject|6|||
161041801|NCT00249769|581544841|FG000|Overall Study|Migration from Study Area|1|||
161041802|NCT00249769|581544842|FG001|Overall Study|Migration from Study Area|3|||
161041803|NCT00249769|581544843|FG002|Overall Study|Migration from Study Area|14|||
161041804|NCT00249769|581544841|FG000|Overall Study|Miscellaneous|0|||
161041805|NCT00249769|581544842|FG001|Overall Study|Miscellaneous|2|||
161041806|NCT00249769|581544843|FG002|Overall Study|Miscellaneous|2|||
161041807|NCT00249769|581544841|FG000|Overall Study|Adverse Event|0|||
161041808|NCT00249769|581544842|FG001|Overall Study|Adverse Event|0|||
161041809|NCT00249769|581544843|FG002|Overall Study|Adverse Event|1|||
161041810|NCT00249769|581544841|FG000|Overall Study|Physician Decision|0|||
161041811|NCT00249769|581544842|FG001|Overall Study|Physician Decision|0|||
161041812|NCT00249769|581544843|FG002|Overall Study|Physician Decision|2|||
161041813|NCT00249769|581544841|FG000|Overall Study|Lost to Follow-up|0|||
161041814|NCT00249769|581544842|FG001|Overall Study|Lost to Follow-up|0|||
161041815|NCT00249769|581544843|FG002|Overall Study|Lost to Follow-up|3|||
161041816|NCT02022657|581544848|FG000|Overall Study|Withdrawal by Subject|2|||
161041817|NCT02022657|581544849|FG001|Overall Study|Withdrawal by Subject|0|||
161041818|NCT02022657|581544850|FG002|Overall Study|Withdrawal by Subject|1|||
161041819|NCT02022657|581544851|FG003|Overall Study|Withdrawal by Subject|0|||
161041820|NCT02022657|581544852|FG004|Overall Study|Withdrawal by Subject|0|||
161041821|NCT02022657|581544853|FG005|Overall Study|Withdrawal by Subject|0|||
161041822|NCT02022657|581544848|FG000|Overall Study|Physician Decision|0|||
161041823|NCT02022657|581544849|FG001|Overall Study|Physician Decision|0|||
161041824|NCT02022657|581544850|FG002|Overall Study|Physician Decision|0|||
161041825|NCT02022657|581544851|FG003|Overall Study|Physician Decision|0|||
161041826|NCT02022657|581544852|FG004|Overall Study|Physician Decision|0|||
161041827|NCT02022657|581544853|FG005|Overall Study|Physician Decision|1|||
161041828|NCT03274076|581544855|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
161041829|NCT03274076|581544856|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
161041830|NCT03274076|581544857|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
161041831|NCT03274076|581544858|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
161041832|NCT03274076|581544855|FG000|24 Weeks Open Label|Adverse Event|0|||
161041833|NCT03274076|581544856|FG001|24 Weeks Open Label|Adverse Event|0|||
161041834|NCT03274076|581544857|FG002|24 Weeks Open Label|Adverse Event|2|||
161041835|NCT03274076|581544858|FG003|24 Weeks Open Label|Adverse Event|0|||
161041836|NCT03274076|581544855|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
161041837|NCT03274076|581544856|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
161280556|NCT02027428|582406972|FG001|Induction|Protocol Violation|0|||
161041838|NCT03274076|581544857|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
161041839|NCT03274076|581544858|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
161041840|NCT00795184|581544859|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
161041841|NCT00795184|581544860|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
161280557|NCT02027428|582406973|FG002|Induction|Protocol Violation|0|||
161041842|NCT03781375|581544861|FG000|Double-blind Phase|Adverse Event|0|||
161280558|NCT02027428|582406971|FG000|Induction|Miscellaneous|14|||
161041843|NCT03781375|581544862|FG001|Double-blind Phase|Adverse Event|1|||
161041844|NCT03781375|581544861|FG000|Double-blind Phase|Lack of Response|6|||
161041845|NCT03781375|581544862|FG001|Double-blind Phase|Lack of Response|2|||
161041846|NCT03781375|581544861|FG000|Double-blind Phase|Other|1|||
161041847|NCT03781375|581544862|FG001|Double-blind Phase|Other|3|||
161041848|NCT03781375|581544861|FG000|Open-label Phase|Protocol Issues|0|||
161041849|NCT03781375|581544862|FG001|Open-label Phase|Protocol Issues|1|||
161041850|NCT03781375|581544861|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
161041851|NCT03781375|581544862|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
161041852|NCT03781375|581544861|FG000|Open-label Phase|Other|2|||
161041853|NCT03781375|581544862|FG001|Open-label Phase|Other|2|||
161041854|NCT01303510|581544864|FG000|Overall Study|Lost to Follow-up|1|||
161041855|NCT01303510|581544865|FG001|Overall Study|Lost to Follow-up|0|||
161041856|NCT00822900|581544869|FG000|Overall Study|Withdrawal by Subject|14|||
161041857|NCT00822900|581544870|FG001|Overall Study|Withdrawal by Subject|14|||
161041858|NCT00822900|581544869|FG000|Overall Study|Lost to Follow-up|9|||
161041859|NCT00822900|581544870|FG001|Overall Study|Lost to Follow-up|9|||
161041860|NCT00822900|581544869|FG000|Overall Study|Death|83|||
161041861|NCT00822900|581544870|FG001|Overall Study|Death|69|||
161041862|NCT00822900|581544869|FG000|Overall Study|Became a ward of the state|2|||
161041863|NCT00822900|581544870|FG001|Overall Study|Became a ward of the state|1|||
161041864|NCT01968967|581544871|FG000|Treatment Period|Other|22|||
161041865|NCT01968967|581544872|FG001|Treatment Period|Other|22|||
161041866|NCT01968967|581544873|FG002|Treatment Period|Other|0|||
161041867|NCT01968967|581544874|FG003|Treatment Period|Other|0|||
161041868|NCT01968967|581544875|FG004|Treatment Period|Other|0|||
161041869|NCT01968967|581544871|FG000|Treatment Period|Withdrawal by Subject|71|||
161041870|NCT01968967|581544872|FG001|Treatment Period|Withdrawal by Subject|61|||
161041871|NCT01968967|581544873|FG002|Treatment Period|Withdrawal by Subject|0|||
161041872|NCT01968967|581544874|FG003|Treatment Period|Withdrawal by Subject|0|||
161041873|NCT01968967|581544875|FG004|Treatment Period|Withdrawal by Subject|0|||
161041874|NCT01968967|581544871|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
161041875|NCT01968967|581544872|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
161041876|NCT01968967|581544873|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
161041877|NCT01968967|581544874|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
161041878|NCT01968967|581544875|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
161041879|NCT01968967|581544871|FG000|Treatment Period|Lost to Follow-up|26|||
161041880|NCT01968967|581544872|FG001|Treatment Period|Lost to Follow-up|31|||
161041881|NCT01968967|581544873|FG002|Treatment Period|Lost to Follow-up|0|||
161041882|NCT01968967|581544874|FG003|Treatment Period|Lost to Follow-up|0|||
161041883|NCT01968967|581544875|FG004|Treatment Period|Lost to Follow-up|0|||
161041884|NCT01968967|581544871|FG000|Treatment Period|Protocol Violation|1|||
161041885|NCT01968967|581544872|FG001|Treatment Period|Protocol Violation|2|||
161041886|NCT01968967|581544873|FG002|Treatment Period|Protocol Violation|0|||
161041887|NCT01968967|581544874|FG003|Treatment Period|Protocol Violation|0|||
161041888|NCT01968967|581544875|FG004|Treatment Period|Protocol Violation|0|||
161041889|NCT01968967|581544871|FG000|Treatment Period|Adverse Event|9|||
161041890|NCT01968967|581544872|FG001|Treatment Period|Adverse Event|8|||
161041891|NCT01968967|581544873|FG002|Treatment Period|Adverse Event|0|||
161041892|NCT01968967|581544874|FG003|Treatment Period|Adverse Event|0|||
161041893|NCT01968967|581544875|FG004|Treatment Period|Adverse Event|0|||
161041894|NCT01968967|581544871|FG000|Treatment Period|Death|9|||
161041895|NCT01968967|581544872|FG001|Treatment Period|Death|2|||
161041896|NCT01968967|581544873|FG002|Treatment Period|Death|0|||
161041897|NCT01968967|581544874|FG003|Treatment Period|Death|0|||
161041898|NCT01968967|581544875|FG004|Treatment Period|Death|0|||
161041899|NCT01968967|581544871|FG000|Treatment Period|Randomized Not Treated|6|||
161041900|NCT01968967|581544872|FG001|Treatment Period|Randomized Not Treated|5|||
161041901|NCT01968967|581544873|FG002|Treatment Period|Randomized Not Treated|0|||
161041902|NCT01968967|581544874|FG003|Treatment Period|Randomized Not Treated|0|||
161041903|NCT01968967|581544875|FG004|Treatment Period|Randomized Not Treated|0|||
161041904|NCT01968967|581544871|FG000|Extension Period|Withdrew Consent|0|||
161041905|NCT01968967|581544872|FG001|Extension Period|Withdrew Consent|0|||
161041906|NCT01968967|581544873|FG002|Extension Period|Withdrew Consent|2|||
161041907|NCT01968967|581544874|FG003|Extension Period|Withdrew Consent|0|||
161041908|NCT01968967|581544875|FG004|Extension Period|Withdrew Consent|5|||
161041909|NCT00701415|581544882|FG000|Overall Study|Adverse Event|0|||
161041910|NCT00701415|581544883|FG001|Overall Study|Adverse Event|1|||
161041911|NCT00701415|581544882|FG000|Overall Study|Social/family issues and needle phobia|1|||
161041912|NCT00701415|581544883|FG001|Overall Study|Social/family issues and needle phobia|0|||
161041913|NCT02106884|581544884|FG000|Overall Study|Change of diagnosis/exclusion|0|||
161041914|NCT02106884|581544885|FG001|Overall Study|Change of diagnosis/exclusion|1|||
161041915|NCT02022670|581544888|FG000|Overall Study|Adverse Event|1|||
161041916|NCT02022670|581544889|FG001|Overall Study|Adverse Event|0|||
161041917|NCT02022670|581544890|FG002|Overall Study|Adverse Event|1|||
161041918|NCT02113449|581544891|FG000|Overall Study|Adverse Event|4|||
161041919|NCT00109031|581544892|FG000|Overall Study|Adverse Event|0|||
161041920|NCT00109031|581544893|FG001|Overall Study|Adverse Event|0|||
161041921|NCT00109031|581544894|FG002|Overall Study|Adverse Event|1|||
161041922|NCT00109031|581544895|FG003|Overall Study|Adverse Event|0|||
161041923|NCT00109031|581544892|FG000|Overall Study|Withdrawal by Subject|0|||
161041924|NCT00109031|581544893|FG001|Overall Study|Withdrawal by Subject|1|||
161041925|NCT00109031|581544894|FG002|Overall Study|Withdrawal by Subject|0|||
161041926|NCT00109031|581544895|FG003|Overall Study|Withdrawal by Subject|0|||
161148888|NCT02546856|581926176|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
161148889|NCT02546856|581926177|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
161148890|NCT02546856|581926176|FG000|6 Months Evaluation|Death|1|||
161148891|NCT02546856|581926177|FG001|6 Months Evaluation|Death|1|||
161148892|NCT02546856|581926176|FG000|6 Months Evaluation|Lost to Follow-up|1|||
161148893|NCT02546856|581926177|FG001|6 Months Evaluation|Lost to Follow-up|1|||
161148894|NCT02546856|581926176|FG000|6 Months Evaluation|Working or living abroad|6|||
161148895|NCT02546856|581926177|FG001|6 Months Evaluation|Working or living abroad|4|||
161148896|NCT02546856|581926176|FG000|6 Months Evaluation|reasons not due to titration|0|||
161148897|NCT02546856|581926177|FG001|6 Months Evaluation|reasons not due to titration|1|||
161148898|NCT00130208|581926180|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
161148899|NCT00130208|581926181|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
161148900|NCT00130208|581926180|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
161148901|NCT00130208|581926181|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
161148902|NCT00130208|581926180|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
161148903|NCT00130208|581926181|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
161148904|NCT00130208|581926180|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
161148905|NCT00130208|581926181|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
161148906|NCT00130208|581926180|FG000|Maintenance Period (26 Weeks)|Other|1|||
161148907|NCT00130208|581926181|FG001|Maintenance Period (26 Weeks)|Other|1|||
161148908|NCT00130208|581926180|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
161148909|NCT00130208|581926181|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
161148910|NCT00130208|581926180|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
161148911|NCT00130208|581926181|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
161148912|NCT00130208|581926180|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
161148913|NCT00130208|581926181|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
161148914|NCT00130208|581926180|FG000|Washout Period (8 Weeks)|Other|1|||
161148915|NCT00130208|581926181|FG001|Washout Period (8 Weeks)|Other|1|||
161148916|NCT04655586|581926184|FG000|Overall Study|Physician Decision|1|||
161148917|NCT04655586|581926185|FG001|Overall Study|Physician Decision|3|||
161148918|NCT04655586|581926186|FG002|Overall Study|Physician Decision|4|||
161148919|NCT04655586|581926184|FG000|Overall Study|Withdrawal by Subject|1|||
161148920|NCT04655586|581926185|FG001|Overall Study|Withdrawal by Subject|3|||
161148921|NCT04655586|581926186|FG002|Overall Study|Withdrawal by Subject|1|||
161148922|NCT01372878|581926188|FG000|Overall Study|Withdrawal by Subject|63|||
161148923|NCT01372878|581926188|FG000|Overall Study|Protocol Violation|17|||
161148924|NCT01372878|581926188|FG000|Overall Study|incomplete study procedure|104|||
161148925|NCT02616029|581926192|FG000|Overall Study|Adverse Event|1|||
161148926|NCT02616029|581926193|FG001|Overall Study|Adverse Event|0|||
161148927|NCT02616029|581926192|FG000|Overall Study|Death|0|||
161148928|NCT02616029|581926193|FG001|Overall Study|Death|1|||
161148929|NCT02616029|581926192|FG000|Overall Study|Protocol Violation|1|||
161148930|NCT02616029|581926193|FG001|Overall Study|Protocol Violation|0|||
161148931|NCT02616029|581926192|FG000|Overall Study|Withdrew Consent|1|||
161148932|NCT02616029|581926193|FG001|Overall Study|Withdrew Consent|0|||
161148933|NCT02616029|581926192|FG000|Overall Study|Enrolled and Never Treated|1|||
161148934|NCT02616029|581926193|FG001|Overall Study|Enrolled and Never Treated|1|||
161148935|NCT00609609|581926194|FG000|Overall Study|Withdrawal by Subject|2|||
161148936|NCT00609609|581926195|FG001|Overall Study|Withdrawal by Subject|0|||
161148937|NCT00609609|581926194|FG000|Overall Study|Progression|4|||
161148938|NCT00609609|581926195|FG001|Overall Study|Progression|2|||
161148939|NCT03065530|581926196|FG000|Overall Study|Lack of Efficacy|1|||
161148940|NCT03065530|581926197|FG001|Overall Study|Lack of Efficacy|1|||
161148941|NCT03065530|581926198|FG002|Overall Study|Lack of Efficacy|0|||
161148942|NCT03065530|581926199|FG003|Overall Study|Lack of Efficacy|1|||
161148943|NCT03065530|581926196|FG000|Overall Study|Protocol Violation|1|||
161148944|NCT03065530|581926197|FG001|Overall Study|Protocol Violation|0|||
161148945|NCT03065530|581926198|FG002|Overall Study|Protocol Violation|1|||
161148946|NCT03065530|581926199|FG003|Overall Study|Protocol Violation|1|||
161148947|NCT00479466|581926202|FG000|Overall Study|Adverse Event|5|||
161148948|NCT00479466|581926203|FG001|Overall Study|Adverse Event|1|||
161148949|NCT00479466|581926204|FG002|Overall Study|Adverse Event|0|||
161148950|NCT00479466|581926205|FG003|Overall Study|Adverse Event|1|||
161148951|NCT00479466|581926206|FG004|Overall Study|Adverse Event|2|||
161148952|NCT00479466|581926207|FG005|Overall Study|Adverse Event|0|||
161148953|NCT00479466|581926202|FG000|Overall Study|Hyperglycemia|0|||
161148954|NCT00479466|581926203|FG001|Overall Study|Hyperglycemia|0|||
161148955|NCT00479466|581926204|FG002|Overall Study|Hyperglycemia|0|||
161148956|NCT00479466|581926205|FG003|Overall Study|Hyperglycemia|0|||
161148957|NCT00479466|581926206|FG004|Overall Study|Hyperglycemia|0|||
161148958|NCT00479466|581926207|FG005|Overall Study|Hyperglycemia|1|||
161148959|NCT00479466|581926202|FG000|Overall Study|Lack of Efficacy|2|||
161148960|NCT00479466|581926203|FG001|Overall Study|Lack of Efficacy|0|||
161148961|NCT00479466|581926204|FG002|Overall Study|Lack of Efficacy|1|||
161148962|NCT00479466|581926205|FG003|Overall Study|Lack of Efficacy|0|||
161148963|NCT00479466|581926206|FG004|Overall Study|Lack of Efficacy|0|||
161148964|NCT00479466|581926207|FG005|Overall Study|Lack of Efficacy|0|||
161148965|NCT00479466|581926202|FG000|Overall Study|Lost to Follow-up|0|||
161148966|NCT00479466|581926203|FG001|Overall Study|Lost to Follow-up|1|||
161148967|NCT00479466|581926204|FG002|Overall Study|Lost to Follow-up|1|||
161148968|NCT00479466|581926205|FG003|Overall Study|Lost to Follow-up|0|||
161148969|NCT00479466|581926206|FG004|Overall Study|Lost to Follow-up|2|||
161148970|NCT00479466|581926207|FG005|Overall Study|Lost to Follow-up|2|||
161148971|NCT00479466|581926202|FG000|Overall Study|Physician Decision|2|||
161148972|NCT00479466|581926203|FG001|Overall Study|Physician Decision|1|||
161148973|NCT00479466|581926204|FG002|Overall Study|Physician Decision|1|||
161148974|NCT00479466|581926205|FG003|Overall Study|Physician Decision|0|||
161148975|NCT00479466|581926206|FG004|Overall Study|Physician Decision|0|||
161148976|NCT00479466|581926207|FG005|Overall Study|Physician Decision|0|||
161148977|NCT00479466|581926202|FG000|Overall Study|Pregnancy|0|||
161148978|NCT00479466|581926203|FG001|Overall Study|Pregnancy|0|||
161148979|NCT00479466|581926204|FG002|Overall Study|Pregnancy|0|||
161148980|NCT00479466|581926205|FG003|Overall Study|Pregnancy|0|||
161148981|NCT00479466|581926206|FG004|Overall Study|Pregnancy|1|||
161148982|NCT00479466|581926207|FG005|Overall Study|Pregnancy|0|||
161148983|NCT00479466|581926202|FG000|Overall Study|Protocol Violation|1|||
161148984|NCT00479466|581926203|FG001|Overall Study|Protocol Violation|0|||
161148985|NCT00479466|581926204|FG002|Overall Study|Protocol Violation|0|||
161148986|NCT00479466|581926205|FG003|Overall Study|Protocol Violation|0|||
161148987|NCT00479466|581926206|FG004|Overall Study|Protocol Violation|0|||
161148988|NCT00479466|581926207|FG005|Overall Study|Protocol Violation|0|||
161148989|NCT00479466|581926202|FG000|Overall Study|Withdrawal by Subject|3|||
161148990|NCT00479466|581926203|FG001|Overall Study|Withdrawal by Subject|5|||
161148991|NCT00479466|581926204|FG002|Overall Study|Withdrawal by Subject|0|||
161148992|NCT00479466|581926205|FG003|Overall Study|Withdrawal by Subject|2|||
161148993|NCT00479466|581926206|FG004|Overall Study|Withdrawal by Subject|3|||
161148994|NCT00479466|581926207|FG005|Overall Study|Withdrawal by Subject|1|||
161148995|NCT01214434|581926220|FG000|Overall Study|Withdrawal by Subject|1|||
161148996|NCT01214434|581926221|FG001|Overall Study|Withdrawal by Subject|0|||
161148997|NCT01214434|581926220|FG000|Overall Study|Lost to Follow-up|2|||
161148998|NCT01214434|581926221|FG001|Overall Study|Lost to Follow-up|2|||
161148999|NCT01214434|581926220|FG000|Overall Study|Site error|1|||
161149000|NCT01214434|581926221|FG001|Overall Study|Site error|0|||
161149001|NCT02075255|581926223|FG000|Overall Study|Study specific withdrawal criteria|0|||
161149002|NCT02075255|581926224|FG001|Overall Study|Study specific withdrawal criteria|1|||
161149003|NCT02075255|581926225|FG002|Overall Study|Study specific withdrawal criteria|1|||
161149004|NCT02075255|581926223|FG000|Overall Study|Withdrawal by Subject|4|||
161149005|NCT02075255|581926224|FG001|Overall Study|Withdrawal by Subject|1|||
161149006|NCT02075255|581926225|FG002|Overall Study|Withdrawal by Subject|0|||
161149007|NCT02075255|581926223|FG000|Overall Study|Lost to Follow-up|0|||
161149008|NCT02075255|581926224|FG001|Overall Study|Lost to Follow-up|0|||
161149009|NCT02075255|581926225|FG002|Overall Study|Lost to Follow-up|1|||
161149010|NCT02075255|581926223|FG000|Overall Study|Adverse Event|0|||
161149011|NCT02075255|581926224|FG001|Overall Study|Adverse Event|0|||
161149012|NCT02075255|581926225|FG002|Overall Study|Adverse Event|1|||
161149013|NCT02075255|581926223|FG000|Overall Study|Death|0|||
161149014|NCT02075255|581926224|FG001|Overall Study|Death|2|||
161149015|NCT02075255|581926225|FG002|Overall Study|Death|0|||
161149016|NCT03792750|581926226|FG000|Overall Study|Death|3|||
161149017|NCT02902809|581926227|FG000|Overall Study|Discontinuation of asthma program|28|||
161280559|NCT02027428|582406972|FG001|Induction|Miscellaneous|0|||
161280560|NCT02027428|582406973|FG002|Induction|Miscellaneous|0|||
161280561|NCT02027428|582406971|FG000|Induction|Induction Treatment Ongoing|4|||
161280562|NCT02027428|582406972|FG001|Induction|Induction Treatment Ongoing|0|||
161280563|NCT02027428|582406973|FG002|Induction|Induction Treatment Ongoing|0|||
161280564|NCT02027428|582406971|FG000|Maintenance|Death|0|||
161344807|NCT04584788|582647295|FG000|Overall Study|Withdrawal by Subject|1|||
161344808|NCT04584788|582647295|FG000|Overall Study|Adverse Event|3|||
161344809|NCT03311555|582647296|FG000|Overall Study|Adverse Event|1|||
161149018|NCT00532259|581926228|FG000|Overall Study|Withdrawal by Subject|2|||
161149019|NCT00532259|581926228|FG000|Overall Study|Adverse Event|1|||
161149020|NCT00532259|581926228|FG000|Overall Study|Death|1|||
161149021|NCT00532259|581926228|FG000|Overall Study|Lack of Efficacy|21|||
161149022|NCT00532259|581926228|FG000|Overall Study|Lost to Follow-up|3|||
161280565|NCT02027428|582406972|FG001|Maintenance|Death|3|||
161280566|NCT02027428|582406973|FG002|Maintenance|Death|2|||
161280567|NCT02027428|582406971|FG000|Maintenance|Adverse Event|0|||
161280568|NCT02027428|582406972|FG001|Maintenance|Adverse Event|21|||
161149023|NCT00532259|581926228|FG000|Overall Study|Physician Decision|3|||
161149024|NCT00532259|581926228|FG000|Overall Study|Protocol Violation|1|||
161280569|NCT02027428|582406973|FG002|Maintenance|Adverse Event|1|||
161149025|NCT01879618|581926229|FG000|Overall Study|Does not meet entrance criteria|1|||
161149026|NCT01879618|581926229|FG000|Overall Study|Withdrawal by Subject|1|||
161149027|NCT01879618|581926229|FG000|Overall Study|Surgery;changed schedule; not available|8|||
161149028|NCT01879618|581926229|FG000|Overall Study|Protocol Violation|6|||
161149029|NCT01879618|581926229|FG000|Overall Study|Adverse Event|5|||
161149030|NCT00394914|581926230|FG000|Treatment Period|Adverse Event|0|||
161344810|NCT04284774|582647302|FG000|Overall Study|Progressive disease|5|||
161344811|NCT00689936|582648798|FG000|Active Treatment Phase|Adverse Event|68|||
161344812|NCT00689936|582648799|FG001|Active Treatment Phase|Adverse Event|71|||
161344813|NCT00689936|582648800|FG002|Active Treatment Phase|Adverse Event|76|||
161344814|NCT00689936|582648798|FG000|Active Treatment Phase|Disease Progression|273|||
161344815|NCT00689936|582648799|FG001|Active Treatment Phase|Disease Progression|362|||
161041927|NCT00109031|581544892|FG000|Overall Study|Physician Decision|0|||
161041928|NCT00109031|581544893|FG001|Overall Study|Physician Decision|1|||
161041929|NCT00109031|581544894|FG002|Overall Study|Physician Decision|0|||
161041930|NCT00109031|581544895|FG003|Overall Study|Physician Decision|0|||
161041931|NCT00109031|581544892|FG000|Overall Study|Protocol Violation|0|||
161041932|NCT00109031|581544893|FG001|Overall Study|Protocol Violation|0|||
161041933|NCT00109031|581544894|FG002|Overall Study|Protocol Violation|1|||
161041934|NCT00109031|581544895|FG003|Overall Study|Protocol Violation|0|||
161041935|NCT02091752|581544898|FG000|Overall Study|Study terminated by Sponsor|2|||
161041936|NCT02091752|581544898|FG000|Overall Study|Adverse Event|1|||
161041937|NCT02060487|581544899|FG000|Overall Study|Other|1|||
161041938|NCT02060487|581544900|FG001|Overall Study|Other|2|||
161041939|NCT02060487|581544901|FG002|Overall Study|Other|1|||
161041940|NCT02060487|581544899|FG000|Overall Study|Lack of Efficacy|0|||
161041941|NCT02060487|581544900|FG001|Overall Study|Lack of Efficacy|1|||
161041942|NCT02060487|581544901|FG002|Overall Study|Lack of Efficacy|0|||
161041943|NCT02060487|581544899|FG000|Overall Study|Withdrawal by Subject|3|||
161041944|NCT02060487|581544900|FG001|Overall Study|Withdrawal by Subject|10|||
161041945|NCT02060487|581544901|FG002|Overall Study|Withdrawal by Subject|4|||
161041946|NCT02060487|581544899|FG000|Overall Study|Study Terminated By Sponsor|87|||
161041947|NCT02060487|581544900|FG001|Overall Study|Study Terminated By Sponsor|89|||
161041948|NCT02060487|581544901|FG002|Overall Study|Study Terminated By Sponsor|100|||
161041949|NCT02060487|581544899|FG000|Overall Study|Randomized in error|1|||
161041950|NCT02060487|581544900|FG001|Overall Study|Randomized in error|0|||
161041951|NCT02060487|581544901|FG002|Overall Study|Randomized in error|0|||
161041952|NCT02060487|581544899|FG000|Overall Study|Protocol Violation|0|||
161041953|NCT02060487|581544900|FG001|Overall Study|Protocol Violation|1|||
161041954|NCT02060487|581544901|FG002|Overall Study|Protocol Violation|1|||
161041955|NCT02060487|581544899|FG000|Overall Study|Lost to Follow-up|3|||
161041956|NCT02060487|581544900|FG001|Overall Study|Lost to Follow-up|0|||
161041957|NCT02060487|581544901|FG002|Overall Study|Lost to Follow-up|2|||
161041958|NCT02060487|581544899|FG000|Overall Study|Death|34|||
161041959|NCT02060487|581544900|FG001|Overall Study|Death|25|||
161041960|NCT02060487|581544901|FG002|Overall Study|Death|19|||
161041961|NCT02060487|581544899|FG000|Overall Study|Adverse Event|0|||
161041962|NCT02060487|581544900|FG001|Overall Study|Adverse Event|0|||
161041963|NCT02060487|581544901|FG002|Overall Study|Adverse Event|1|||
161041964|NCT03697603|581544906|FG000|Overall Study|Adverse Event|3|||
161041965|NCT03697603|581544907|FG001|Overall Study|Adverse Event|18|||
161041966|NCT03697603|581544908|FG002|Overall Study|Adverse Event|3|||
161041967|NCT03697603|581544906|FG000|Overall Study|Physician Decision|1|||
161041968|NCT03697603|581544907|FG001|Overall Study|Physician Decision|0|||
161041969|NCT03697603|581544908|FG002|Overall Study|Physician Decision|2|||
161041970|NCT03697603|581544906|FG000|Overall Study|Protocol Violation|3|||
161041971|NCT03697603|581544907|FG001|Overall Study|Protocol Violation|8|||
161041972|NCT03697603|581544908|FG002|Overall Study|Protocol Violation|5|||
161041973|NCT03697603|581544906|FG000|Overall Study|Withdrawal by Subject|5|||
161041974|NCT03697603|581544907|FG001|Overall Study|Withdrawal by Subject|1|||
161041975|NCT03697603|581544908|FG002|Overall Study|Withdrawal by Subject|1|||
161041976|NCT03697603|581544906|FG000|Overall Study|Protocol Violation|0|||
161041977|NCT03697603|581544907|FG001|Overall Study|Protocol Violation|0|||
161041978|NCT03697603|581544908|FG002|Overall Study|Protocol Violation|1|||
161041979|NCT04218864|581544909|FG000|Overall Study|Lost to Follow-up|8|||
161041980|NCT04218864|581544910|FG001|Overall Study|Lost to Follow-up|4|||
161041981|NCT04218864|581544909|FG000|Overall Study|Withdrawal by Subject|1|||
161041982|NCT04218864|581544910|FG001|Overall Study|Withdrawal by Subject|3|||
161149031|NCT00394914|581926231|FG001|Treatment Period|Adverse Event|3|||
161344816|NCT00689936|582648800|FG002|Active Treatment Phase|Disease Progression|339|||
161041983|NCT03683030|581544911|FG000|Overall Study|Enrolled but screen failures|12|||
161041984|NCT03683030|581544912|FG001|Overall Study|Enrolled but screen failures|7|||
161041985|NCT03683030|581544911|FG000|Overall Study|Enrolled but no catheter inserted|11|||
161041986|NCT03683030|581544912|FG001|Overall Study|Enrolled but no catheter inserted|13|||
161041987|NCT03683030|581544911|FG000|Overall Study|Withdrawal by Subject|0|||
161041988|NCT03683030|581544912|FG001|Overall Study|Withdrawal by Subject|2|||
161344817|NCT00689936|582648798|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
161041989|NCT03683030|581544911|FG000|Overall Study|Early termination by subject|1|||
161041990|NCT03683030|581544912|FG001|Overall Study|Early termination by subject|0|||
161041991|NCT03683030|581544911|FG000|Overall Study|Lost to Follow-up|0|||
161041992|NCT03683030|581544912|FG001|Overall Study|Lost to Follow-up|6|||
161041993|NCT03683030|581544911|FG000|Overall Study|Death|0|||
161344818|NCT00689936|582648799|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
161041994|NCT03683030|581544912|FG001|Overall Study|Death|2|||
161041995|NCT03683030|581544911|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
161041996|NCT03683030|581544912|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
161041997|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
161041998|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
161041999|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
161042000|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
161042001|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
161042002|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
161042003|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
161042004|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
161042005|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
161042006|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
161042007|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
161042008|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
161042009|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
161042010|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
161042011|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
161042012|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
161042013|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
161042014|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
161042015|NCT02222493|581544915|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
161042016|NCT02222493|581544916|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
161042017|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
161042018|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
161042019|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
161042020|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
161042021|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
161042022|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
161042023|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
161042024|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
161042025|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
161042026|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
161042027|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
161042028|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
161042029|NCT02222493|581544915|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
161042030|NCT02222493|581544916|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
161042031|NCT02222493|581544915|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
161042032|NCT02222493|581544916|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
161042033|NCT02222493|581544915|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
161042034|NCT02222493|581544916|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
161042035|NCT02222493|581544915|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
161042036|NCT02222493|581544916|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
161042037|NCT02222493|581544915|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
161042038|NCT02222493|581544916|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
161042039|NCT02222493|581544915|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
161042040|NCT02222493|581544916|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
161042041|NCT00933270|581544919|FG000|Overall Study|Withdrawal by Subject|26|||
161042042|NCT00933270|581544919|FG000|Overall Study|Insufficient Follow-up|10|||
161042043|NCT00933270|581544919|FG000|Overall Study|Lost to Follow-up|14|||
161042044|NCT00933270|581544919|FG000|Overall Study|Adverse Event|1|||
161042045|NCT00933270|581544919|FG000|Overall Study|Missed Visit|2|||
161042046|NCT00933270|581544919|FG000|Overall Study|Death|24|||
161042047|NCT00933270|581544919|FG000|Overall Study|Moved or would not return|10|||
161042048|NCT02542943|581544920|FG000|Overall Study|Lost to Follow-up|1|||
161042049|NCT02542943|581544921|FG001|Overall Study|Lost to Follow-up|0|||
161042050|NCT02542943|581544922|FG002|Overall Study|Lost to Follow-up|0|||
161042051|NCT02542943|581544920|FG000|Overall Study|Withdrawal by Subject|0|||
161042052|NCT02542943|581544921|FG001|Overall Study|Withdrawal by Subject|1|||
161042053|NCT02542943|581544922|FG002|Overall Study|Withdrawal by Subject|0|||
161042054|NCT05824559|581544925|FG000|Overall Study|Adverse Event|2|||
161042055|NCT05824559|581544925|FG000|Overall Study|Physician Decision|2|||
161042056|NCT05824559|581544925|FG000|Overall Study|Progressive Disease|16|||
161042057|NCT05824559|581544925|FG000|Overall Study|Study Terminated by Sponsor|1|||
161042058|NCT05824559|581544925|FG000|Overall Study|Withdrawal by Subject|2|||
161042059|NCT05366751|581544926|FG000|Overall Study|Adverse Event|25|||
161042060|NCT05366751|581544926|FG000|Overall Study|Physician Decision|3|||
161042061|NCT05366751|581544926|FG000|Overall Study|Lost to Follow-up|2|||
161149032|NCT00394914|581926232|FG002|Treatment Period|Adverse Event|1|||
161042062|NCT05366751|581544926|FG000|Overall Study|Withdrawal by Subject|14|||
161042063|NCT05366751|581544926|FG000|Overall Study|Study Terminated by Sponsor|50|||
161042064|NCT05366751|581544926|FG000|Overall Study|Site Terminated by Sponsor|3|||
161042065|NCT00647387|581544929|FG000|Overall Study|Lost to Follow-up|6|||
161042066|NCT00647387|581544929|FG000|Overall Study|Unsuccessful implant|5|||
161042067|NCT00647387|581544929|FG000|Overall Study|Device explanted|3|||
161042068|NCT00647387|581544929|FG000|Overall Study|Other Reason|3|||
161042069|NCT00647387|581544929|FG000|Overall Study|Death|2|||
161042070|NCT00302211|581544930|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
161042071|NCT00302211|581544931|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
161042072|NCT00302211|581544932|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
161042073|NCT00302211|581544933|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
161042074|NCT00302211|581544934|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
161042075|NCT00302211|581544930|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
161042076|NCT00302211|581544931|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
161042077|NCT00302211|581544932|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
161042078|NCT00302211|581544933|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
161042079|NCT00302211|581544934|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
161042080|NCT00302211|581544930|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
161042081|NCT00302211|581544931|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
161042082|NCT00302211|581544932|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
161042083|NCT00302211|581544933|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
161042084|NCT00302211|581544934|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
161042085|NCT00302211|581544930|FG000|Double Blind Period (New Patients)|Disease progression|0|||
161042086|NCT00302211|581544931|FG001|Double Blind Period (New Patients)|Disease progression|1|||
161042087|NCT00302211|581544932|FG002|Double Blind Period (New Patients)|Disease progression|1|||
161042088|NCT00302211|581544933|FG003|Double Blind Period (New Patients)|Disease progression|0|||
161042089|NCT00302211|581544934|FG004|Double Blind Period (New Patients)|Disease progression|0|||
161042090|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
161042091|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
161042092|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
161042093|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
161042094|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
161042095|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
161042096|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
161042097|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
161042098|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
161042099|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
161042100|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161042101|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161042102|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161042103|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
161042104|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
161042105|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
161042106|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
161042107|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
161042108|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
161042109|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
161042110|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Death|0|||
161042111|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Death|0|||
161042112|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Death|0|||
161042113|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Death|1|||
161042114|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Death|1|||
161042115|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161042116|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161042117|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161042118|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
161042119|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
161042120|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161042121|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161042122|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161042123|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
161042124|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
161042125|NCT00302211|581544930|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161042126|NCT00302211|581544931|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161280570|NCT02027428|582406971|FG000|Maintenance|Progressive disease|0|||
161149033|NCT00394914|581926230|FG000|Treatment Period|Lost to Follow-up|0|||
161149034|NCT00394914|581926231|FG001|Treatment Period|Lost to Follow-up|1|||
161042127|NCT00302211|581544932|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161042128|NCT00302211|581544933|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
161042129|NCT00302211|581544934|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
161042130|NCT03137459|581546699|FG000|2-month Assessment|Withdrawal by Subject|13|||
161042131|NCT03137459|581546700|FG001|2-month Assessment|Withdrawal by Subject|3|||
161042132|NCT03137459|581546699|FG000|2-month Assessment|Unable to reach|42|||
161042133|NCT03137459|581546700|FG001|2-month Assessment|Unable to reach|32|||
161042134|NCT03137459|581546699|FG000|2-month Assessment|Refused assessment|7|||
161042135|NCT03137459|581546700|FG001|2-month Assessment|Refused assessment|5|||
161042136|NCT03137459|581546699|FG000|2-month Assessment|Acutely ill|6|||
161042137|NCT03137459|581546700|FG001|2-month Assessment|Acutely ill|2|||
161042138|NCT03137459|581546699|FG000|4-month Assessment|Death|4|||
161042139|NCT03137459|581546700|FG001|4-month Assessment|Death|2|||
161042140|NCT03137459|581546699|FG000|4-month Assessment|Withdrawal by Subject|4|||
161042141|NCT03137459|581546700|FG001|4-month Assessment|Withdrawal by Subject|2|||
161042142|NCT03137459|581546699|FG000|4-month Assessment|Unable to reach|44|||
161042143|NCT03137459|581546700|FG001|4-month Assessment|Unable to reach|29|||
161042144|NCT03137459|581546699|FG000|4-month Assessment|Refused assessment|24|||
161042145|NCT03137459|581546700|FG001|4-month Assessment|Refused assessment|10|||
161042146|NCT03137459|581546699|FG000|4-month Assessment|Acutely ill|2|||
161042147|NCT03137459|581546700|FG001|4-month Assessment|Acutely ill|3|||
161042148|NCT03137459|581546699|FG000|6-months|Lost to Follow-up|14|||
161042149|NCT03137459|581546700|FG001|6-months|Lost to Follow-up|11|||
161042150|NCT03137459|581546699|FG000|6-months|Death|0|||
161042151|NCT03137459|581546700|FG001|6-months|Death|2|||
161042152|NCT03137459|581546699|FG000|6-months|Refused assessment|6|||
161042153|NCT03137459|581546700|FG001|6-months|Refused assessment|3|||
161042154|NCT03137459|581546699|FG000|6-months|Acutely ill|1|||
161042155|NCT03137459|581546700|FG001|6-months|Acutely ill|1|||
161042156|NCT00985088|581546701|FG000|Overall Study|Serious Adverse Event|1|||
161042157|NCT00985088|581546702|FG001|Overall Study|Serious Adverse Event|1|||
161042158|NCT00985088|581546703|FG002|Overall Study|Serious Adverse Event|0|||
161042159|NCT00985088|581546704|FG003|Overall Study|Serious Adverse Event|0|||
161042160|NCT00985088|581546705|FG004|Overall Study|Serious Adverse Event|0|||
161042161|NCT00985088|581546706|FG005|Overall Study|Serious Adverse Event|0|||
161042162|NCT00985088|581546707|FG006|Overall Study|Serious Adverse Event|0|||
161042163|NCT00985088|581546708|FG007|Overall Study|Serious Adverse Event|1|||
161042164|NCT00985088|581546701|FG000|Overall Study|Adverse Event|0|||
161042165|NCT00985088|581546702|FG001|Overall Study|Adverse Event|0|||
161042166|NCT00985088|581546703|FG002|Overall Study|Adverse Event|1|||
161042167|NCT00985088|581546704|FG003|Overall Study|Adverse Event|0|||
161042168|NCT00985088|581546705|FG004|Overall Study|Adverse Event|0|||
161042169|NCT00985088|581546706|FG005|Overall Study|Adverse Event|0|||
161149035|NCT00394914|581926232|FG002|Treatment Period|Lost to Follow-up|0|||
161149036|NCT00394914|581926230|FG000|Treatment Period|Withdrawal by Subject|0|||
161149037|NCT00394914|581926231|FG001|Treatment Period|Withdrawal by Subject|2|||
161149038|NCT00394914|581926232|FG002|Treatment Period|Withdrawal by Subject|2|||
161149039|NCT00394914|581926230|FG000|Treatment Period|Noncompliance with protocol|0|||
161149040|NCT00394914|581926231|FG001|Treatment Period|Noncompliance with protocol|3|||
161149041|NCT00394914|581926232|FG002|Treatment Period|Noncompliance with protocol|2|||
161149042|NCT00394914|581926230|FG000|Treatment Period|Did not meet protocol eligibility|0|||
161149043|NCT00394914|581926231|FG001|Treatment Period|Did not meet protocol eligibility|1|||
161149044|NCT00394914|581926232|FG002|Treatment Period|Did not meet protocol eligibility|1|||
161149045|NCT00734929|581926236|FG000|Overall Study|Lost to Follow-up|1|||
161280571|NCT02027428|582406972|FG001|Maintenance|Progressive disease|84|||
161280572|NCT02027428|582406973|FG002|Maintenance|Progressive disease|47|||
161280573|NCT02027428|582406971|FG000|Maintenance|Symptomatic deterioration|0|||
161042170|NCT00985088|581546707|FG006|Overall Study|Adverse Event|0|||
161042171|NCT00985088|581546708|FG007|Overall Study|Adverse Event|0|||
161149046|NCT00734929|581926237|FG001|Overall Study|Lost to Follow-up|2|||
161149047|NCT00734929|581926236|FG000|Overall Study|No intervention/ screen fail|5|||
161280574|NCT02027428|582406972|FG001|Maintenance|Symptomatic deterioration|4|||
161280575|NCT02027428|582406973|FG002|Maintenance|Symptomatic deterioration|1|||
161280576|NCT02027428|582406971|FG000|Maintenance|Withdrawal by Subject|0|||
161042172|NCT00985088|581546701|FG000|Overall Study|Withdrawal by Subject|4|||
161042173|NCT00985088|581546702|FG001|Overall Study|Withdrawal by Subject|0|||
161042174|NCT00985088|581546703|FG002|Overall Study|Withdrawal by Subject|0|||
161042175|NCT00985088|581546704|FG003|Overall Study|Withdrawal by Subject|1|||
161042176|NCT00985088|581546705|FG004|Overall Study|Withdrawal by Subject|3|||
161042177|NCT00985088|581546706|FG005|Overall Study|Withdrawal by Subject|2|||
161042178|NCT00985088|581546707|FG006|Overall Study|Withdrawal by Subject|1|||
161042179|NCT00985088|581546708|FG007|Overall Study|Withdrawal by Subject|2|||
161149048|NCT00734929|581926237|FG001|Overall Study|No intervention/ screen fail|3|||
161149049|NCT02961764|581926238|FG000|Overall Study|Protocol Violation|0|||
161042180|NCT00985088|581546701|FG000|Overall Study|Migrated/moved from study area|0|||
161042181|NCT00985088|581546702|FG001|Overall Study|Migrated/moved from study area|0|||
161042182|NCT00985088|581546703|FG002|Overall Study|Migrated/moved from study area|1|||
161042183|NCT00985088|581546704|FG003|Overall Study|Migrated/moved from study area|0|||
161042184|NCT00985088|581546705|FG004|Overall Study|Migrated/moved from study area|0|||
161042185|NCT00985088|581546706|FG005|Overall Study|Migrated/moved from study area|0|||
161042186|NCT00985088|581546707|FG006|Overall Study|Migrated/moved from study area|0|||
161042187|NCT00985088|581546708|FG007|Overall Study|Migrated/moved from study area|1|||
161042188|NCT00985088|581546701|FG000|Overall Study|Lost to Follow-up|6|||
161042189|NCT00985088|581546702|FG001|Overall Study|Lost to Follow-up|1|||
161042190|NCT00985088|581546703|FG002|Overall Study|Lost to Follow-up|2|||
161042191|NCT00985088|581546704|FG003|Overall Study|Lost to Follow-up|6|||
161042192|NCT00985088|581546705|FG004|Overall Study|Lost to Follow-up|6|||
161042193|NCT00985088|581546706|FG005|Overall Study|Lost to Follow-up|5|||
161042194|NCT00985088|581546707|FG006|Overall Study|Lost to Follow-up|3|||
161042195|NCT00985088|581546708|FG007|Overall Study|Lost to Follow-up|2|||
161042196|NCT01970878|581546709|FG000|Overall Study|Withdrawal by Subject|11|||
161042197|NCT01970878|581546710|FG001|Overall Study|Withdrawal by Subject|10|||
161042198|NCT01970878|581546711|FG002|Overall Study|Withdrawal by Subject|14|||
161042199|NCT01970878|581546712|FG003|Overall Study|Withdrawal by Subject|7|||
161042200|NCT01970878|581546709|FG000|Overall Study|Lost to Follow-up|1|||
161042201|NCT01970878|581546710|FG001|Overall Study|Lost to Follow-up|3|||
161042202|NCT01970878|581546711|FG002|Overall Study|Lost to Follow-up|2|||
161042203|NCT01970878|581546712|FG003|Overall Study|Lost to Follow-up|4|||
161042204|NCT01970878|581546709|FG000|Overall Study|Administrative Reasons|1|||
161149050|NCT02961764|581926239|FG001|Overall Study|Protocol Violation|1|||
161149051|NCT02961764|581926238|FG000|Overall Study|Death|2|||
161149052|NCT02961764|581926239|FG001|Overall Study|Death|0|||
161149053|NCT02961764|581926238|FG000|Overall Study|Lost to Follow-up|35|||
161149054|NCT02961764|581926239|FG001|Overall Study|Lost to Follow-up|24|||
161149055|NCT02961764|581926238|FG000|Overall Study|Withdrawal by Subject|2|||
161149056|NCT02961764|581926239|FG001|Overall Study|Withdrawal by Subject|0|||
161149057|NCT02160977|581926240|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
161149058|NCT02160977|581926241|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
161149059|NCT02160977|581926240|FG000|Three Months After Surgery|Lost to Follow-up|0|||
161149060|NCT02160977|581926241|FG001|Three Months After Surgery|Lost to Follow-up|2|||
161149061|NCT02160977|581926240|FG000|Six Months After Surgery|Lost to Follow-up|2|||
161149062|NCT02160977|581926241|FG001|Six Months After Surgery|Lost to Follow-up|1|||
161149063|NCT01663740|581926242|FG000|Overall Study|Lost to Follow-up|1|||
161149064|NCT01663740|581926243|FG001|Overall Study|Lost to Follow-up|4|||
161149065|NCT01663740|581926242|FG000|Overall Study|Other|9|||
161149066|NCT01663740|581926243|FG001|Overall Study|Other|2|||
161149067|NCT01663740|581926242|FG000|Overall Study|Inclusion/Exclusion not met|1|||
161149068|NCT01663740|581926243|FG001|Overall Study|Inclusion/Exclusion not met|0|||
161149069|NCT01663740|581926242|FG000|Overall Study|Death|0|||
161149070|NCT01663740|581926243|FG001|Overall Study|Death|1|||
161149071|NCT01663740|581926242|FG000|Overall Study|Withdrawal by Subject|2|||
161149072|NCT01663740|581926243|FG001|Overall Study|Withdrawal by Subject|1|||
161149073|NCT01663740|581926242|FG000|Overall Study|No end of study status|3|||
161149074|NCT01663740|581926243|FG001|Overall Study|No end of study status|0|||
161149075|NCT02112448|581926244|FG000|Overall Study|lab values precluding use of ketorolac|2|||
161149076|NCT02112448|581926245|FG001|Overall Study|lab values precluding use of ketorolac|2|||
161149077|NCT02112448|581926244|FG000|Overall Study|Protocol Violation|1|||
161149078|NCT02112448|581926245|FG001|Overall Study|Protocol Violation|2|||
161280577|NCT02027428|582406972|FG001|Maintenance|Withdrawal by Subject|6|||
161280578|NCT02027428|582406973|FG002|Maintenance|Withdrawal by Subject|5|||
161280579|NCT02027428|582406971|FG000|Maintenance|Protocol Violation|0|||
161042205|NCT01970878|581546710|FG001|Overall Study|Administrative Reasons|0|||
161042206|NCT01970878|581546711|FG002|Overall Study|Administrative Reasons|0|||
161042207|NCT01970878|581546712|FG003|Overall Study|Administrative Reasons|4|||
161042208|NCT01970878|581546709|FG000|Overall Study|Lack of Efficacy|2|||
161042209|NCT01970878|581546710|FG001|Overall Study|Lack of Efficacy|1|||
161042210|NCT01970878|581546711|FG002|Overall Study|Lack of Efficacy|2|||
161042211|NCT01970878|581546712|FG003|Overall Study|Lack of Efficacy|0|||
161042212|NCT01970878|581546709|FG000|Overall Study|Adverse Event|12|||
161042213|NCT01970878|581546710|FG001|Overall Study|Adverse Event|7|||
161042214|NCT01970878|581546711|FG002|Overall Study|Adverse Event|4|||
161280580|NCT02027428|582406972|FG001|Maintenance|Protocol Violation|0|||
161280581|NCT02027428|582406973|FG002|Maintenance|Protocol Violation|1|||
161280582|NCT02027428|582406971|FG000|Maintenance|Other|0|||
161280583|NCT02027428|582406972|FG001|Maintenance|Other|6|||
161042215|NCT01970878|581546712|FG003|Overall Study|Adverse Event|3|||
161042216|NCT01970878|581546709|FG000|Overall Study|Protocol Specified Criteria|10|||
161149079|NCT02112448|581926244|FG000|Overall Study|Physician Decision|4|||
161149080|NCT02112448|581926245|FG001|Overall Study|Physician Decision|6|||
161280584|NCT02027428|582406973|FG002|Maintenance|Other|3|||
161042217|NCT01970878|581546710|FG001|Overall Study|Protocol Specified Criteria|4|||
161042218|NCT01970878|581546711|FG002|Overall Study|Protocol Specified Criteria|3|||
161280585|NCT02027428|582406971|FG000|Survival Follow-up|Death|0|||
161280586|NCT02027428|582406972|FG001|Survival Follow-up|Death|78|||
161280587|NCT02027428|582406973|FG002|Survival Follow-up|Death|45|||
161280588|NCT02027428|582406971|FG000|Survival Follow-up|Lost to Follow-up|0|||
161280589|NCT02027428|582406972|FG001|Survival Follow-up|Lost to Follow-up|1|||
161042219|NCT01970878|581546712|FG003|Overall Study|Protocol Specified Criteria|6|||
161042220|NCT01970878|581546709|FG000|Overall Study|Physician Decision|0|||
161042221|NCT01970878|581546710|FG001|Overall Study|Physician Decision|1|||
161042222|NCT01970878|581546711|FG002|Overall Study|Physician Decision|1|||
161042223|NCT01970878|581546712|FG003|Overall Study|Physician Decision|0|||
161042224|NCT01970878|581546709|FG000|Overall Study|No Completion Status|0|||
161042225|NCT01970878|581546710|FG001|Overall Study|No Completion Status|1|||
161042226|NCT01970878|581546711|FG002|Overall Study|No Completion Status|0|||
161042227|NCT01970878|581546712|FG003|Overall Study|No Completion Status|0|||
161042228|NCT02634307|581546714|FG000|Overall Study|Adverse Event|50|||
161042229|NCT02634307|581546715|FG001|Overall Study|Adverse Event|24|||
161042230|NCT02634307|581546716|FG002|Overall Study|Adverse Event|14|||
161042231|NCT02634307|581546714|FG000|Overall Study|Lost to Follow-up|21|||
161042232|NCT02634307|581546715|FG001|Overall Study|Lost to Follow-up|5|||
161042233|NCT02634307|581546716|FG002|Overall Study|Lost to Follow-up|6|||
161042234|NCT02634307|581546714|FG000|Overall Study|Pregnancy|5|||
161042235|NCT02634307|581546715|FG001|Overall Study|Pregnancy|1|||
161042236|NCT02634307|581546716|FG002|Overall Study|Pregnancy|3|||
161042237|NCT02634307|581546714|FG000|Overall Study|Withdrawal by Subject|38|||
161042238|NCT02634307|581546715|FG001|Overall Study|Withdrawal by Subject|24|||
161042239|NCT02634307|581546716|FG002|Overall Study|Withdrawal by Subject|18|||
161042240|NCT02634307|581546714|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161042241|NCT02634307|581546715|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161042242|NCT02634307|581546716|FG002|Overall Study|Non-Compliance with Study Drug|2|||
161042243|NCT02634307|581546714|FG000|Overall Study|Lack of Efficacy|1|||
161042244|NCT02634307|581546715|FG001|Overall Study|Lack of Efficacy|5|||
161042245|NCT02634307|581546716|FG002|Overall Study|Lack of Efficacy|3|||
161042246|NCT02634307|581546714|FG000|Overall Study|Physician Decision|7|||
161042247|NCT02634307|581546715|FG001|Overall Study|Physician Decision|5|||
161042248|NCT02634307|581546716|FG002|Overall Study|Physician Decision|5|||
161042249|NCT02634307|581546714|FG000|Overall Study|Reason not Specified|3|||
161042250|NCT02634307|581546715|FG001|Overall Study|Reason not Specified|5|||
161042251|NCT02634307|581546716|FG002|Overall Study|Reason not Specified|10|||
161042252|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
161042253|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
161042254|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
161042255|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
161042256|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
161042257|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
161042258|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
161042259|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
161042260|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
161042261|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
161042262|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
161042263|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
161042264|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Other|1|||
161042265|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Other|0|||
161042266|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Other|0|||
161042267|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
161042268|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
161042269|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
161042270|NCT00887224|581546722|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
161042271|NCT00887224|581546723|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
161042272|NCT00887224|581546724|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
161042273|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
161042274|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
161042275|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
161042276|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
161042277|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
161042278|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
161042279|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
161042280|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
161042281|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
161042282|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
161042283|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
161042284|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
161042285|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Other|1|||
161280590|NCT02027428|582406973|FG002|Survival Follow-up|Lost to Follow-up|1|||
161280591|NCT02859142|582406974|FG000|Overall Study|Adverse Event|1|||
161149081|NCT02112448|581926244|FG000|Overall Study|required heparin so could not use ketoro|1|||
161149082|NCT02112448|581926245|FG001|Overall Study|required heparin so could not use ketoro|0|||
161149083|NCT05270694|581927734|FG000|Overall Study|Death|1|||
161149084|NCT05270694|581927734|FG000|Overall Study|Medical issues impacted ability to participate|2|||
161149085|NCT05270694|581927734|FG000|Overall Study|Lost to Follow-up|3|||
161149086|NCT05270694|581927734|FG000|Overall Study|Withdrawal by Subject|3|||
161149087|NCT04267562|581927737|FG000|Assessed for Eligibility|Screen Failure|64|||
161149088|NCT04267562|581927737|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
161149089|NCT04267562|581927737|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
161149090|NCT04267562|581927737|FG000|Assessed for Eligibility|Site closure|6|||
161149091|NCT04267562|581927737|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
161149092|NCT04267562|581927737|FG000|Assessed for Eligibility|Physician Decision|1|||
161149093|NCT04267562|581927737|FG000|Month 24|Elective hysterectomy|1|||
161149094|NCT04267562|581927737|FG000|Month 24|Lost to Follow-up|1|||
161149095|NCT04267562|581927737|FG000|Month 36|Elective hysterectomy|2|||
161149096|NCT04267562|581927737|FG000|Month 36|Lost to Follow-up|3|||
161149097|NCT00128206|581927745|FG000|Overall Study|Lost to Follow-up|137|||
161149098|NCT00128206|581927746|FG001|Overall Study|Lost to Follow-up|118|||
161149099|NCT00128206|581927745|FG000|Overall Study|Adverse Event|0|||
161149100|NCT00128206|581927746|FG001|Overall Study|Adverse Event|2|||
161149101|NCT03032068|581927755|FG000|Overall Study|Adverse Event|1|||
161149102|NCT01597622|581927756|FG000|Overall Study|Adverse Event|7|||
161149103|NCT01597622|581927756|FG000|Overall Study|Lack of Efficacy|3|||
161149104|NCT01597622|581927756|FG000|Overall Study|Protocol Violation|1|||
161149105|NCT01597622|581927756|FG000|Overall Study|Lost to Follow-up|1|||
161149106|NCT01597622|581927756|FG000|Overall Study|Investigator Discretion|5|||
161149107|NCT01597622|581927756|FG000|Overall Study|Withdrawal by Subject|20|||
161149108|NCT01597622|581927756|FG000|Overall Study|Death|1|||
161149109|NCT00408421|581927757|FG000|Treatment Initial Randomization|Adverse Event|5|||
161149110|NCT00408421|581927758|FG001|Treatment Initial Randomization|Adverse Event|9|||
161149111|NCT00408421|581927759|FG002|Treatment Initial Randomization|Adverse Event|0|||
161149112|NCT00408421|581927757|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
161280592|NCT02859142|582406975|FG001|Overall Study|Adverse Event|2|||
161280593|NCT02859142|582406974|FG000|Overall Study|Lost to Follow-up|1|||
161042286|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Other|0|||
161042287|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Other|0|||
161042288|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
161042289|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
161042290|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
161042291|NCT00887224|581546722|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
161042292|NCT00887224|581546723|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
161042293|NCT00887224|581546724|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
161042294|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
161042295|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
161042296|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
161042297|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
161042298|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
161042299|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
161042300|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
161042301|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
161042302|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
161042303|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
161042304|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
161042305|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
161042306|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Other|30|||
161042307|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Other|0|||
161042308|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Other|0|||
161149113|NCT00408421|581927758|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
161149114|NCT00408421|581927759|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
161149115|NCT00408421|581927757|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
161149116|NCT00408421|581927758|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
161149117|NCT00408421|581927759|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
161149118|NCT00408421|581927757|FG000|Treatment Initial Randomization|Physician Decision|1|||
161149119|NCT00408421|581927758|FG001|Treatment Initial Randomization|Physician Decision|0|||
161280594|NCT02859142|582406975|FG001|Overall Study|Lost to Follow-up|4|||
161042309|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
161042310|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
161042311|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
161042312|NCT00887224|581546722|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
161149120|NCT00408421|581927759|FG002|Treatment Initial Randomization|Physician Decision|0|||
161149121|NCT00408421|581927757|FG000|Treatment Initial Randomization|Protocol Violation|0|||
161149122|NCT00408421|581927758|FG001|Treatment Initial Randomization|Protocol Violation|1|||
161042313|NCT00887224|581546723|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
161042314|NCT00887224|581546724|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
161042315|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Adverse Event|0|||
161042316|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Adverse Event|7|||
161042317|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Adverse Event|2|||
161042318|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Failed to return|0|||
161042319|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Failed to return|2|||
161042320|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Failed to return|2|||
161042321|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
161042322|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
161042323|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
161042324|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
161042325|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
161042326|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
161042327|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Other|0|||
161042328|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Other|2|||
161042329|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Other|0|||
161042330|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
161042331|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
161042332|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
161042333|NCT00887224|581546722|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
161042334|NCT00887224|581546723|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
161042335|NCT00887224|581546724|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
161042336|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
161042337|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
161042338|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
161042339|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
161042340|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
161042341|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
161042342|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
161042343|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
161042344|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
161042345|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
161042346|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
161042347|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
161042348|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
161042349|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
161042350|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
161042351|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
161042352|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
161042353|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
161042354|NCT00887224|581546722|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
161042355|NCT00887224|581546723|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
161042356|NCT00887224|581546724|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
161042357|NCT03883828|581546725|FG000|Overall Study|Did not start radiotherapy|1|||
161042358|NCT03883828|581546726|FG001|Overall Study|Did not start radiotherapy|2|||
161042359|NCT01256359|581546730|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
161042360|NCT01256359|581546731|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
161042361|NCT01256359|581546730|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
161042362|NCT01256359|581546731|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
161042363|NCT02575365|581546734|FG000|Overall Study|Lost to Follow-up|4|||
161042364|NCT00487240|581546738|FG000|Overall Study|Withdrawal by Subject|12|||
161042365|NCT00487240|581546739|FG001|Overall Study|Withdrawal by Subject|6|||
161042366|NCT00487240|581546738|FG000|Overall Study|Lost to Follow-up|7|||
161042367|NCT00487240|581546739|FG001|Overall Study|Lost to Follow-up|6|||
161042368|NCT00487240|581546738|FG000|Overall Study|Adverse Event|0|||
161042369|NCT00487240|581546739|FG001|Overall Study|Adverse Event|4|||
161042370|NCT00487240|581546738|FG000|Overall Study|Protocol Violation|5|||
161042371|NCT00487240|581546739|FG001|Overall Study|Protocol Violation|5|||
161042372|NCT00487240|581546738|FG000|Overall Study|Entry Criteria Not Met|3|||
161042373|NCT00487240|581546739|FG001|Overall Study|Entry Criteria Not Met|4|||
161042374|NCT00487240|581546738|FG000|Overall Study|Sponsor Decision|2|||
161042375|NCT00487240|581546739|FG001|Overall Study|Sponsor Decision|1|||
161042376|NCT00487240|581546738|FG000|Overall Study|Physician Decision|2|||
161042377|NCT00487240|581546739|FG001|Overall Study|Physician Decision|0|||
161042378|NCT02736188|581546740|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
161042379|NCT02736188|581546740|FG000|Overall Study|Adverse Event|1|||
161042380|NCT02736188|581546740|FG000|Overall Study|Withdrawal by Subject|1|||
161042381|NCT02736188|581546740|FG000|Overall Study|Other|6|||
161042382|NCT01698918|581546741|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
161042383|NCT01698918|581546741|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
161280595|NCT02859142|582406974|FG000|Overall Study|Withdrawal by Subject|2|||
161280596|NCT02859142|582406975|FG001|Overall Study|Withdrawal by Subject|0|||
161042384|NCT01698918|581546741|FG000|First Line Treatment (Core+Extension)|Death|2|||
161042385|NCT01698918|581546741|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
161042386|NCT01698918|581546741|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
161042387|NCT01698918|581546741|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
161042388|NCT01698918|581546741|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
161042389|NCT01698918|581546741|FG000|Second Line Treatment (Core+Extension)|Death|1|||
161042390|NCT01698918|581546741|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
161042391|NCT01698918|581546741|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
161042392|NCT01428583|581546743|FG000|Overall Study|Adverse Event|75|||
161042393|NCT01428583|581546743|FG000|Overall Study|Withdrawal by Subject|51|||
161042394|NCT01428583|581546743|FG000|Overall Study|Lack of Efficacy|37|||
161042395|NCT01428583|581546743|FG000|Overall Study|Lost to Follow-up|17|||
161042396|NCT01428583|581546743|FG000|Overall Study|Death|1|||
161042397|NCT01428583|581546743|FG000|Overall Study|Pregnancy|1|||
161042398|NCT01428583|581546743|FG000|Overall Study|Protocol Violation|1|||
161042399|NCT01428583|581546743|FG000|Overall Study|Physician Decision|12|||
161042400|NCT01428583|581546743|FG000|Overall Study|Non-compliant|25|||
161042401|NCT01428583|581546743|FG000|Overall Study|Confirmed positive urine drug test|8|||
161042402|NCT01428583|581546743|FG000|Overall Study|Sponsor's request|3|||
161042403|NCT01428583|581546743|FG000|Overall Study|Other|6|||
161042404|NCT00768755|581546746|FG000|Phase 1|Death|6|||
161042405|NCT00768755|581546747|FG001|Phase 1|Death|0|||
161042406|NCT00768755|581546748|FG002|Phase 1|Death|0|||
161042407|NCT00768755|581546749|FG003|Phase 1|Death|0|||
161042408|NCT00768755|581546746|FG000|Phase 1|Other|4|||
161042409|NCT00768755|581546747|FG001|Phase 1|Other|0|||
161042410|NCT00768755|581546748|FG002|Phase 1|Other|0|||
161042411|NCT00768755|581546749|FG003|Phase 1|Other|0|||
161042412|NCT00768755|581546746|FG000|Phase 2|Death|0|||
161042413|NCT00768755|581546747|FG001|Phase 2|Death|37|||
161042414|NCT00768755|581546748|FG002|Phase 2|Death|48|||
161042415|NCT00768755|581546749|FG003|Phase 2|Death|31|||
161042416|NCT00768755|581546746|FG000|Phase 2|Protocol Violation|0|||
161042417|NCT00768755|581546747|FG001|Phase 2|Protocol Violation|2|||
161042418|NCT00768755|581546748|FG002|Phase 2|Protocol Violation|0|||
161042419|NCT00768755|581546749|FG003|Phase 2|Protocol Violation|1|||
161042420|NCT00768755|581546746|FG000|Phase 2|Lost to Follow-up|0|||
161042421|NCT00768755|581546747|FG001|Phase 2|Lost to Follow-up|1|||
161042422|NCT00768755|581546748|FG002|Phase 2|Lost to Follow-up|1|||
161042423|NCT00768755|581546749|FG003|Phase 2|Lost to Follow-up|4|||
161042424|NCT00768755|581546746|FG000|Phase 2|Withdrawal by Subject|0|||
161042425|NCT00768755|581546747|FG001|Phase 2|Withdrawal by Subject|1|||
161042426|NCT00768755|581546748|FG002|Phase 2|Withdrawal by Subject|0|||
161042427|NCT00768755|581546749|FG003|Phase 2|Withdrawal by Subject|1|||
161042428|NCT00768755|581546746|FG000|Phase 2|Other|0|||
161042429|NCT00768755|581546747|FG001|Phase 2|Other|1|||
161042430|NCT00768755|581546748|FG002|Phase 2|Other|2|||
161042431|NCT00768755|581546749|FG003|Phase 2|Other|4|||
161042432|NCT00768755|581546746|FG000|Phase 2|Study Terminated by Sponsor|0|||
161042433|NCT00768755|581546747|FG001|Phase 2|Study Terminated by Sponsor|13|||
161042434|NCT00768755|581546748|FG002|Phase 2|Study Terminated by Sponsor|7|||
161042435|NCT00768755|581546749|FG003|Phase 2|Study Terminated by Sponsor|14|||
161042436|NCT00768755|581546746|FG000|Phase 2|Randomized but not treated|0|||
161042437|NCT00768755|581546747|FG001|Phase 2|Randomized but not treated|0|||
161042438|NCT00768755|581546748|FG002|Phase 2|Randomized but not treated|0|||
161042439|NCT00768755|581546749|FG003|Phase 2|Randomized but not treated|2|||
161042440|NCT00670488|581546750|FG000|Overall Study|Adverse Event|0|||
161042441|NCT00670488|581546751|FG001|Overall Study|Adverse Event|7|||
161042442|NCT00670488|581546752|FG002|Overall Study|Adverse Event|0|||
161280597|NCT02859142|582406974|FG000|Overall Study|Scheduling difficulties|0|||
161280598|NCT02859142|582406975|FG001|Overall Study|Scheduling difficulties|3|||
161280599|NCT02676765|582406976|FG000|Overall Study|Lost to Follow-up|0|||
161280600|NCT02676765|582406977|FG001|Overall Study|Lost to Follow-up|1|||
161280601|NCT00490841|582406978|FG000|Overall Study|Death|5|||
161042443|NCT00670488|581546753|FG003|Overall Study|Adverse Event|3|||
161042444|NCT00670488|581546754|FG004|Overall Study|Adverse Event|1|||
161280602|NCT00490841|582406978|FG000|Overall Study|Withdrawal by Subject|4|||
161280603|NCT00490841|582406978|FG000|Overall Study|Lost to Follow-up|1|||
161042445|NCT00670488|581546755|FG005|Overall Study|Adverse Event|1|||
161042446|NCT00670488|581546756|FG006|Overall Study|Adverse Event|5|||
161042447|NCT00670488|581546757|FG007|Overall Study|Adverse Event|1|||
161042448|NCT00670488|581546758|FG008|Overall Study|Adverse Event|0|||
161042449|NCT00670488|581546759|FG009|Overall Study|Adverse Event|1|||
161280604|NCT00490841|582406978|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
161280605|NCT03452943|582406979|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
161042450|NCT00670488|581546750|FG000|Overall Study|Physician Decision|1|||
161042451|NCT00670488|581546751|FG001|Overall Study|Physician Decision|9|||
161042452|NCT00670488|581546752|FG002|Overall Study|Physician Decision|0|||
161042453|NCT00670488|581546753|FG003|Overall Study|Physician Decision|1|||
161042454|NCT00670488|581546754|FG004|Overall Study|Physician Decision|0|||
161042455|NCT00670488|581546755|FG005|Overall Study|Physician Decision|0|||
161042456|NCT00670488|581546756|FG006|Overall Study|Physician Decision|0|||
161042457|NCT00670488|581546757|FG007|Overall Study|Physician Decision|0|||
161042458|NCT00670488|581546758|FG008|Overall Study|Physician Decision|0|||
161042459|NCT00670488|581546759|FG009|Overall Study|Physician Decision|0|||
161042460|NCT00670488|581546750|FG000|Overall Study|Progressive Disease|2|||
161042461|NCT00670488|581546751|FG001|Overall Study|Progressive Disease|41|||
161042462|NCT00670488|581546752|FG002|Overall Study|Progressive Disease|3|||
161042463|NCT00670488|581546753|FG003|Overall Study|Progressive Disease|2|||
161042464|NCT00670488|581546754|FG004|Overall Study|Progressive Disease|2|||
161042465|NCT00670488|581546755|FG005|Overall Study|Progressive Disease|4|||
161042466|NCT00670488|581546756|FG006|Overall Study|Progressive Disease|11|||
161042467|NCT00670488|581546757|FG007|Overall Study|Progressive Disease|2|||
161042468|NCT00670488|581546758|FG008|Overall Study|Progressive Disease|2|||
161042469|NCT00670488|581546759|FG009|Overall Study|Progressive Disease|1|||
161042470|NCT00670488|581546750|FG000|Overall Study|Withdrawal by Subject|0|||
161042471|NCT00670488|581546751|FG001|Overall Study|Withdrawal by Subject|1|||
161042472|NCT00670488|581546752|FG002|Overall Study|Withdrawal by Subject|0|||
161042473|NCT00670488|581546753|FG003|Overall Study|Withdrawal by Subject|1|||
161042474|NCT00670488|581546754|FG004|Overall Study|Withdrawal by Subject|0|||
161042475|NCT00670488|581546755|FG005|Overall Study|Withdrawal by Subject|0|||
161042476|NCT00670488|581546756|FG006|Overall Study|Withdrawal by Subject|1|||
161042477|NCT00670488|581546757|FG007|Overall Study|Withdrawal by Subject|0|||
161042478|NCT00670488|581546758|FG008|Overall Study|Withdrawal by Subject|1|||
161042479|NCT00670488|581546759|FG009|Overall Study|Withdrawal by Subject|0|||
161042480|NCT00878189|581546760|FG000|Overall Study|Death|0|||
161042481|NCT00878189|581546761|FG001|Overall Study|Death|1|||
161042482|NCT00878189|581546762|FG002|Overall Study|Death|0|||
161042483|NCT00878189|581546763|FG003|Overall Study|Death|1|||
161042484|NCT00878189|581546764|FG004|Overall Study|Death|0|||
161042485|NCT00878189|581546765|FG005|Overall Study|Death|0|||
161042486|NCT00878189|581546766|FG006|Overall Study|Death|0|||
161042487|NCT00878189|581546767|FG007|Overall Study|Death|0|||
161042488|NCT00878189|581546768|FG008|Overall Study|Death|1|||
161042489|NCT00878189|581546760|FG000|Overall Study|Participant Refused to Follow-up|0|||
161042490|NCT00878189|581546761|FG001|Overall Study|Participant Refused to Follow-up|0|||
161042491|NCT00878189|581546762|FG002|Overall Study|Participant Refused to Follow-up|0|||
161042492|NCT00878189|581546763|FG003|Overall Study|Participant Refused to Follow-up|0|||
161042493|NCT00878189|581546764|FG004|Overall Study|Participant Refused to Follow-up|0|||
161042494|NCT00878189|581546765|FG005|Overall Study|Participant Refused to Follow-up|4|||
161042495|NCT00878189|581546766|FG006|Overall Study|Participant Refused to Follow-up|0|||
161042496|NCT00878189|581546767|FG007|Overall Study|Participant Refused to Follow-up|0|||
161042497|NCT00878189|581546768|FG008|Overall Study|Participant Refused to Follow-up|0|||
161042498|NCT00878189|581546760|FG000|Overall Study|Other|3|||
161042499|NCT00878189|581546761|FG001|Overall Study|Other|2|||
161042500|NCT00878189|581546762|FG002|Overall Study|Other|4|||
161042501|NCT00878189|581546763|FG003|Overall Study|Other|7|||
161042502|NCT00878189|581546764|FG004|Overall Study|Other|4|||
161042503|NCT00878189|581546765|FG005|Overall Study|Other|18|||
161042504|NCT00878189|581546766|FG006|Overall Study|Other|15|||
161042505|NCT00878189|581546767|FG007|Overall Study|Other|3|||
161042506|NCT00878189|581546768|FG008|Overall Study|Other|4|||
161042507|NCT00878189|581546760|FG000|Overall Study|Lost to Follow-up|0|||
161042508|NCT00878189|581546761|FG001|Overall Study|Lost to Follow-up|0|||
161042509|NCT00878189|581546762|FG002|Overall Study|Lost to Follow-up|0|||
161042510|NCT00878189|581546763|FG003|Overall Study|Lost to Follow-up|0|||
161042511|NCT00878189|581546764|FG004|Overall Study|Lost to Follow-up|0|||
161042512|NCT00878189|581546765|FG005|Overall Study|Lost to Follow-up|1|||
161042513|NCT00878189|581546766|FG006|Overall Study|Lost to Follow-up|1|||
161042514|NCT00878189|581546767|FG007|Overall Study|Lost to Follow-up|0|||
161042515|NCT00878189|581546768|FG008|Overall Study|Lost to Follow-up|0|||
161042516|NCT00878189|581546760|FG000|Overall Study|Objection Progression or Relapse|0|||
161042517|NCT00878189|581546761|FG001|Overall Study|Objection Progression or Relapse|0|||
161042518|NCT00878189|581546762|FG002|Overall Study|Objection Progression or Relapse|0|||
161042519|NCT00878189|581546763|FG003|Overall Study|Objection Progression or Relapse|0|||
161042520|NCT00878189|581546764|FG004|Overall Study|Objection Progression or Relapse|0|||
161042521|NCT00878189|581546765|FG005|Overall Study|Objection Progression or Relapse|0|||
161042522|NCT00878189|581546766|FG006|Overall Study|Objection Progression or Relapse|0|||
161042523|NCT00878189|581546767|FG007|Overall Study|Objection Progression or Relapse|0|||
161042524|NCT00878189|581546768|FG008|Overall Study|Objection Progression or Relapse|3|||
161042525|NCT02708498|581546769|FG000|Overall Study|Death|20|||
161042526|NCT02708498|581546770|FG001|Overall Study|Death|19|||
161042527|NCT02708498|581546771|FG002|Overall Study|Death|0|||
161042528|NCT02708498|581546772|FG003|Overall Study|Death|0|||
161042529|NCT02708498|581546773|FG004|Overall Study|Death|1|||
161042530|NCT02708498|581546774|FG005|Overall Study|Death|0|||
161042531|NCT02708498|581546775|FG006|Overall Study|Death|0|||
161042532|NCT02708498|581546776|FG007|Overall Study|Death|0|||
161149123|NCT00408421|581927759|FG002|Treatment Initial Randomization|Protocol Violation|0|||
161149124|NCT00408421|581927757|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
161149125|NCT00408421|581927758|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
161149126|NCT00408421|581927759|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
161149127|NCT00408421|581927757|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
161149128|NCT00408421|581927758|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
161149129|NCT00408421|581927759|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
161149130|NCT00408421|581927757|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
161149131|NCT00408421|581927758|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
161149132|NCT00408421|581927759|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
161149133|NCT00408421|581927757|FG000|Treatment Re-Randomization|Adverse Event|2|||
161149134|NCT00408421|581927758|FG001|Treatment Re-Randomization|Adverse Event|2|||
161149135|NCT00408421|581927759|FG002|Treatment Re-Randomization|Adverse Event|4|||
161149136|NCT00408421|581927757|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
161149137|NCT00408421|581927758|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
161149138|NCT00408421|581927759|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
161149139|NCT00408421|581927757|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
161149140|NCT00408421|581927758|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
161149141|NCT00408421|581927759|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
161149142|NCT00408421|581927757|FG000|Treatment Re-Randomization|Physician Decision|1|||
161149143|NCT00408421|581927758|FG001|Treatment Re-Randomization|Physician Decision|3|||
161149144|NCT00408421|581927759|FG002|Treatment Re-Randomization|Physician Decision|0|||
161149145|NCT00408421|581927757|FG000|Treatment Re-Randomization|Protocol Violation|1|||
161149146|NCT00408421|581927758|FG001|Treatment Re-Randomization|Protocol Violation|1|||
161149147|NCT00408421|581927759|FG002|Treatment Re-Randomization|Protocol Violation|0|||
161149148|NCT00408421|581927757|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
161149149|NCT00408421|581927758|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
161149150|NCT00408421|581927759|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
161149151|NCT03009539|581927762|FG000|Overall Study|Lost to Follow-up|132|||
161149152|NCT03009539|581927763|FG001|Overall Study|Lost to Follow-up|113|||
161149153|NCT03009539|581927764|FG002|Overall Study|Lost to Follow-up|132|||
161149154|NCT03009539|581927765|FG003|Overall Study|Lost to Follow-up|113|||
161149155|NCT04543955|581927766|FG000|Overall Study|Company cancelled study|1|||
161149156|NCT04543955|581927767|FG001|Overall Study|Company cancelled study|0|||
161149157|NCT03918642|581927768|FG000|Overall Study|Lost to Follow-up|12|||
161149158|NCT03918642|581927769|FG001|Overall Study|Lost to Follow-up|10|||
161149159|NCT01158534|581927770|FG000|Overall Study|Withdrawal by Subject|1|||
161149160|NCT01158534|581927770|FG000|Overall Study|Death|1|||
161149161|NCT01158534|581927770|FG000|Overall Study|Other|1|||
161149162|NCT03268746|581927774|FG000|Overall Study|Withdrawal by Subject|1|||
161149163|NCT00546351|581927777|FG000|Overall Study|Adverse Event|76|||
161149164|NCT00546351|581927777|FG000|Overall Study|Lack of Efficacy|15|||
161149165|NCT00546351|581927777|FG000|Overall Study|Withdrawal by Subject|109|||
161149166|NCT00546351|581927777|FG000|Overall Study|Lost to Follow-up|9|||
161149167|NCT00546351|581927777|FG000|Overall Study|Protocol Deviation|1|||
161149168|NCT00546351|581927777|FG000|Overall Study|Unsatisfactory compliance|9|||
161344819|NCT00689936|582648800|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
161344820|NCT00689936|582648798|FG000|Active Treatment Phase|Death|60|||
161149169|NCT00546351|581927777|FG000|Overall Study|Other reasons for premature termination|17|||
161149170|NCT04734873|581927779|FG000|Overall Study|Lost to Follow-up|1|||
161149171|NCT04734873|581927780|FG001|Overall Study|Lost to Follow-up|3|||
161149172|NCT04734873|581927781|FG002|Overall Study|Lost to Follow-up|2|||
161149173|NCT04734873|581927779|FG000|Overall Study|Randomized but not dosed|1|||
161149174|NCT04734873|581927780|FG001|Overall Study|Randomized but not dosed|0|||
161149175|NCT04734873|581927781|FG002|Overall Study|Randomized but not dosed|1|||
161149176|NCT02385123|581927784|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
161149177|NCT04498910|581927785|FG000|Overall Study|Lost to Follow-up|0|||
161149178|NCT04498910|581927786|FG001|Overall Study|Lost to Follow-up|1|||
161149179|NCT04498910|581927785|FG000|Overall Study|Withdrawal by Subject|2|||
161149180|NCT04498910|581927786|FG001|Overall Study|Withdrawal by Subject|1|||
161149181|NCT04498910|581927785|FG000|Overall Study|Adverse Event|1|||
161344821|NCT00689936|582648799|FG001|Active Treatment Phase|Death|28|||
161344822|NCT00689936|582648800|FG002|Active Treatment Phase|Death|37|||
161149182|NCT04498910|581927786|FG001|Overall Study|Adverse Event|0|||
161149183|NCT02345434|581927787|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
161149184|NCT02345434|581927788|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
161149185|NCT02064439|581927789|FG000|Overall Study|Adverse Event|51|||
161149186|NCT02064439|581927790|FG001|Overall Study|Adverse Event|47|||
161149187|NCT02064439|581927791|FG002|Overall Study|Adverse Event|46|||
161149188|NCT02064439|581927789|FG000|Overall Study|Death|0|||
161149189|NCT02064439|581927790|FG001|Overall Study|Death|2|||
161149190|NCT02064439|581927791|FG002|Overall Study|Death|3|||
161149191|NCT02064439|581927789|FG000|Overall Study|Withdrawal by Subject|29|||
161149192|NCT02064439|581927790|FG001|Overall Study|Withdrawal by Subject|18|||
161149193|NCT02064439|581927791|FG002|Overall Study|Withdrawal by Subject|26|||
161149194|NCT02064439|581927789|FG000|Overall Study|Protocol Violation|3|||
161149195|NCT02064439|581927790|FG001|Overall Study|Protocol Violation|5|||
161149196|NCT02064439|581927791|FG002|Overall Study|Protocol Violation|3|||
161149197|NCT02064439|581927789|FG000|Overall Study|Lost to Follow-up|1|||
161149198|NCT02064439|581927790|FG001|Overall Study|Lost to Follow-up|3|||
161149199|NCT02064439|581927791|FG002|Overall Study|Lost to Follow-up|4|||
161149200|NCT02064439|581927789|FG000|Overall Study|Non-compliance with study medication|21|||
161149201|NCT02064439|581927790|FG001|Overall Study|Non-compliance with study medication|19|||
161149202|NCT02064439|581927791|FG002|Overall Study|Non-compliance with study medication|23|||
161149203|NCT02064439|581927789|FG000|Overall Study|Physician Decision|0|||
161149204|NCT02064439|581927790|FG001|Overall Study|Physician Decision|1|||
161149205|NCT02064439|581927791|FG002|Overall Study|Physician Decision|1|||
161149206|NCT02064439|581927789|FG000|Overall Study|Logistical difficulties|6|||
161149207|NCT02064439|581927790|FG001|Overall Study|Logistical difficulties|5|||
161149208|NCT02064439|581927791|FG002|Overall Study|Logistical difficulties|2|||
161149209|NCT02064439|581927789|FG000|Overall Study|Efficacy outcome reached|18|||
161149210|NCT02064439|581927790|FG001|Overall Study|Efficacy outcome reached|16|||
161149211|NCT02064439|581927791|FG002|Overall Study|Efficacy outcome reached|57|||
161149212|NCT02064439|581927789|FG000|Overall Study|Safety outcome reached|12|||
161149213|NCT02064439|581927790|FG001|Overall Study|Safety outcome reached|20|||
161149214|NCT02064439|581927791|FG002|Overall Study|Safety outcome reached|10|||
161149215|NCT02064439|581927789|FG000|Overall Study|Other|2|||
161149216|NCT02064439|581927790|FG001|Overall Study|Other|2|||
161149217|NCT02064439|581927791|FG002|Overall Study|Other|7|||
161149218|NCT00858702|581927794|FG000|Overall Study|Lack of Efficacy|1|||
161149219|NCT00858702|581927795|FG001|Overall Study|Lack of Efficacy|0|||
161149220|NCT00858702|581927794|FG000|Overall Study|Protocol Violation|1|||
161149221|NCT00858702|581927795|FG001|Overall Study|Protocol Violation|1|||
161149222|NCT00858702|581927794|FG000|Overall Study|Other|2|||
161149223|NCT00858702|581927795|FG001|Overall Study|Other|1|||
161042533|NCT02708498|581546769|FG000|Overall Study|Unknown reason, missing data|0|||
161042534|NCT02708498|581546770|FG001|Overall Study|Unknown reason, missing data|0|||
161042535|NCT02708498|581546771|FG002|Overall Study|Unknown reason, missing data|62|||
161042536|NCT02708498|581546772|FG003|Overall Study|Unknown reason, missing data|51|||
161042537|NCT02708498|581546773|FG004|Overall Study|Unknown reason, missing data|195|||
161042538|NCT02708498|581546774|FG005|Overall Study|Unknown reason, missing data|132|||
161042539|NCT02708498|581546775|FG006|Overall Study|Unknown reason, missing data|0|||
161042540|NCT02708498|581546776|FG007|Overall Study|Unknown reason, missing data|0|||
161042541|NCT01858688|581546777|FG000|Overall Study|Withdrawal by Subject|8|||
161042542|NCT01858688|581546777|FG000|Overall Study|Participant began another therapy|3|||
161042543|NCT01858688|581546777|FG000|Overall Study|Physician Decision|2|||
161042544|NCT01858688|581546777|FG000|Overall Study|Progressive Disease|2|||
161042545|NCT01858688|581546777|FG000|Overall Study|Reason not reproted|5|||
161042546|NCT00659373|581546789|FG000|Overall Study|Withdrawal by Subject|3|||
161042547|NCT00659373|581546790|FG001|Overall Study|Withdrawal by Subject|5|||
161042548|NCT00659373|581546789|FG000|Overall Study|Assessment Missed|2|||
161042549|NCT00659373|581546790|FG001|Overall Study|Assessment Missed|2|||
161042550|NCT03042767|581546793|FG000|Overall Study|Lost to Follow-up|1|||
161042551|NCT03042767|581546794|FG001|Overall Study|Lost to Follow-up|2|||
161042552|NCT04638816|581546796|FG000|Overall Study|Withdrawal by Subject|0|||
161042553|NCT04638816|581546797|FG001|Overall Study|Withdrawal by Subject|1|||
161042554|NCT04638816|581546796|FG000|Overall Study|Lost to Follow-up|0|||
161042555|NCT04638816|581546797|FG001|Overall Study|Lost to Follow-up|1|||
161042556|NCT01328496|581546800|FG000|Overall Study|Significant Change in Health Status|1|||
161042557|NCT01328496|581546801|FG001|Overall Study|Significant Change in Health Status|0|||
161042558|NCT02208843|581546802|FG000|Overall Study|Clinical symptoms of progression|2|||
161042559|NCT02208843|581546802|FG000|Overall Study|Progression disease according to RECIST|24|||
161149224|NCT00858702|581927794|FG000|Overall Study|Withdrawal by Subject|1|||
161149225|NCT00858702|581927795|FG001|Overall Study|Withdrawal by Subject|0|||
161149226|NCT00367640|581927796|FG000|Overall Study|Adverse Event|3|||
161149227|NCT00367640|581927797|FG001|Overall Study|Adverse Event|6|||
161149228|NCT00367640|581927798|FG002|Overall Study|Adverse Event|8|||
161149229|NCT00367640|581927799|FG003|Overall Study|Adverse Event|0|||
161149230|NCT00367640|581927796|FG000|Overall Study|Withdrawal by Subject|8|||
161149231|NCT00367640|581927797|FG001|Overall Study|Withdrawal by Subject|11|||
161149232|NCT00367640|581927798|FG002|Overall Study|Withdrawal by Subject|8|||
161149233|NCT00367640|581927799|FG003|Overall Study|Withdrawal by Subject|6|||
161149234|NCT00367640|581927796|FG000|Overall Study|Any other reason not above-mentioned|7|||
161042560|NCT02208843|581546802|FG000|Overall Study|Adverse Event|12|||
161042561|NCT02208843|581546802|FG000|Overall Study|Protocol Violation|1|||
161042562|NCT02208843|581546802|FG000|Overall Study|Withdrawal by Subject|1|||
161149235|NCT00367640|581927797|FG001|Overall Study|Any other reason not above-mentioned|5|||
161042563|NCT02208843|581546802|FG000|Overall Study|Switched to commercial afatinib|20|||
161149236|NCT00367640|581927798|FG002|Overall Study|Any other reason not above-mentioned|3|||
161149237|NCT00367640|581927799|FG003|Overall Study|Any other reason not above-mentioned|4|||
161280606|NCT03452943|582406980|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
161042564|NCT04399837|581546804|FG000|Overall Study|Other than listed|0|||
161042565|NCT04399837|581546805|FG001|Overall Study|Other than listed|2|||
161042566|NCT04399837|581546806|FG002|Overall Study|Other than listed|2|||
161042567|NCT04399837|581546807|FG003|Overall Study|Other than listed|3|||
161042568|NCT04399837|581546804|FG000|Overall Study|Withdrawal by Subject|1|||
161042569|NCT04399837|581546805|FG001|Overall Study|Withdrawal by Subject|2|||
161042570|NCT04399837|581546806|FG002|Overall Study|Withdrawal by Subject|1|||
161042571|NCT04399837|581546807|FG003|Overall Study|Withdrawal by Subject|1|||
161042572|NCT02686658|581546812|FG000|Overall Study|Adverse Event|0|||
161042573|NCT02686658|581546813|FG001|Overall Study|Adverse Event|0|||
161042574|NCT02686658|581546814|FG002|Overall Study|Adverse Event|1|||
161042575|NCT02686658|581546815|FG003|Overall Study|Adverse Event|1|||
161042576|NCT02686658|581546816|FG004|Overall Study|Adverse Event|2|||
161042577|NCT02686658|581546817|FG005|Overall Study|Adverse Event|1|||
161042578|NCT02686658|581546812|FG000|Overall Study|Investigator decision|0|||
161042579|NCT02686658|581546813|FG001|Overall Study|Investigator decision|0|||
161042580|NCT02686658|581546814|FG002|Overall Study|Investigator decision|0|||
161042581|NCT02686658|581546815|FG003|Overall Study|Investigator decision|1|||
161042582|NCT02686658|581546816|FG004|Overall Study|Investigator decision|2|||
161042583|NCT02686658|581546817|FG005|Overall Study|Investigator decision|1|||
161042584|NCT02686658|581546812|FG000|Overall Study|Sponsor decision|1|||
161042585|NCT02686658|581546813|FG001|Overall Study|Sponsor decision|2|||
161042586|NCT02686658|581546814|FG002|Overall Study|Sponsor decision|1|||
161042587|NCT02686658|581546815|FG003|Overall Study|Sponsor decision|5|||
161042588|NCT02686658|581546816|FG004|Overall Study|Sponsor decision|13|||
161042589|NCT02686658|581546817|FG005|Overall Study|Sponsor decision|2|||
161042590|NCT02686658|581546812|FG000|Overall Study|Lost to Follow-up|0|||
161042591|NCT02686658|581546813|FG001|Overall Study|Lost to Follow-up|0|||
161042592|NCT02686658|581546814|FG002|Overall Study|Lost to Follow-up|2|||
161042593|NCT02686658|581546815|FG003|Overall Study|Lost to Follow-up|0|||
161042594|NCT02686658|581546816|FG004|Overall Study|Lost to Follow-up|0|||
161042595|NCT02686658|581546817|FG005|Overall Study|Lost to Follow-up|1|||
161042596|NCT02686658|581546812|FG000|Overall Study|Death|1|||
161042597|NCT02686658|581546813|FG001|Overall Study|Death|0|||
161042598|NCT02686658|581546814|FG002|Overall Study|Death|0|||
161042599|NCT02686658|581546815|FG003|Overall Study|Death|1|||
161042600|NCT02686658|581546816|FG004|Overall Study|Death|1|||
161042601|NCT02686658|581546817|FG005|Overall Study|Death|1|||
161042602|NCT02686658|581546812|FG000|Overall Study|Withdrawal by Subject|2|||
161042603|NCT02686658|581546813|FG001|Overall Study|Withdrawal by Subject|5|||
161042604|NCT02686658|581546814|FG002|Overall Study|Withdrawal by Subject|4|||
161042605|NCT02686658|581546815|FG003|Overall Study|Withdrawal by Subject|4|||
161042606|NCT02686658|581546816|FG004|Overall Study|Withdrawal by Subject|17|||
161042607|NCT02686658|581546817|FG005|Overall Study|Withdrawal by Subject|8|||
161042608|NCT02686658|581546812|FG000|Overall Study|Placed in hospice care|0|||
161042609|NCT02686658|581546813|FG001|Overall Study|Placed in hospice care|0|||
161042610|NCT02686658|581546814|FG002|Overall Study|Placed in hospice care|1|||
161042611|NCT02686658|581546815|FG003|Overall Study|Placed in hospice care|0|||
161042612|NCT02686658|581546816|FG004|Overall Study|Placed in hospice care|0|||
161042613|NCT02686658|581546817|FG005|Overall Study|Placed in hospice care|0|||
161042614|NCT02686658|581546812|FG000|Overall Study|Participant non-compliance|0|||
161042615|NCT02686658|581546813|FG001|Overall Study|Participant non-compliance|0|||
161042616|NCT02686658|581546814|FG002|Overall Study|Participant non-compliance|0|||
161042617|NCT02686658|581546815|FG003|Overall Study|Participant non-compliance|0|||
161042618|NCT02686658|581546816|FG004|Overall Study|Participant non-compliance|0|||
161042619|NCT02686658|581546817|FG005|Overall Study|Participant non-compliance|1|||
161042620|NCT02686658|581546812|FG000|Overall Study|Concern over coronavirus disease care|0|||
161042621|NCT02686658|581546813|FG001|Overall Study|Concern over coronavirus disease care|0|||
161042622|NCT02686658|581546814|FG002|Overall Study|Concern over coronavirus disease care|0|||
161042623|NCT02686658|581546815|FG003|Overall Study|Concern over coronavirus disease care|0|||
161042624|NCT02686658|581546816|FG004|Overall Study|Concern over coronavirus disease care|2|||
161042625|NCT02686658|581546817|FG005|Overall Study|Concern over coronavirus disease care|1|||
161042626|NCT03476798|581546821|FG000|Overall Study|Death|1|||
161042627|NCT03476798|581546821|FG000|Overall Study|Withdrawal by Subject|2|||
161042628|NCT03476798|581546821|FG000|Overall Study|Protocol Violation|2|||
161042629|NCT06269003|581546822|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
161042630|NCT06269003|581546823|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
161042631|NCT06269003|581546824|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
161042632|NCT06269003|581546825|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
161042633|NCT03343704|581546829|FG000|Overall Study|Refused to complete follow up|0|||
161042634|NCT03343704|581546830|FG001|Overall Study|Refused to complete follow up|1|||
161042635|NCT03343704|581546829|FG000|Overall Study|Death|0|||
161042636|NCT03343704|581546830|FG001|Overall Study|Death|1|||
161042637|NCT03343704|581546829|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
161042638|NCT03343704|581546830|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
161042639|NCT04224272|581546831|FG000|Part 1 - Dose Finding|Death|4|||
161042640|NCT04224272|581546831|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
161042641|NCT04224272|581546831|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
161042642|NCT04224272|581546831|FG000|Part 2 - Dose Expansion|Death|10|||
161042643|NCT04224272|581546831|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
161042644|NCT02609048|581546832|FG000|Overall Study|Adverse Event|3|||
161042645|NCT02609048|581546833|FG001|Overall Study|Adverse Event|0|||
161042646|NCT02609048|581546834|FG002|Overall Study|Adverse Event|0|||
161042647|NCT02609048|581546832|FG000|Overall Study|Randomized but never treated|1|||
161042648|NCT02609048|581546833|FG001|Overall Study|Randomized but never treated|1|||
161042649|NCT02609048|581546834|FG002|Overall Study|Randomized but never treated|1|||
161042650|NCT02609048|581546832|FG000|Overall Study|Withdrawal of informed consent|1|||
161042651|NCT02609048|581546833|FG001|Overall Study|Withdrawal of informed consent|0|||
161042652|NCT02609048|581546834|FG002|Overall Study|Withdrawal of informed consent|0|||
161042653|NCT02609048|581546832|FG000|Overall Study|Reason not specified|6|||
161042654|NCT02609048|581546833|FG001|Overall Study|Reason not specified|9|||
161042655|NCT02609048|581546834|FG002|Overall Study|Reason not specified|9|||
161042656|NCT05432986|581546840|FG000|Overall Study|Withdrawal by Subject|2|||
161042657|NCT05432986|581546840|FG000|Overall Study|incomplete measurement|7|||
161042658|NCT04992273|581547974|FG000|Overall Study|Lost to Follow-up|0|||
161280607|NCT03452943|582406979|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
161280608|NCT03452943|582406980|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
161280609|NCT03452943|582406979|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
161280610|NCT03452943|582406980|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
161280611|NCT03452943|582406979|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
161280612|NCT03452943|582406980|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
161280613|NCT03452943|582406979|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
161280614|NCT03452943|582406980|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
161280615|NCT03452943|582406979|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
161280616|NCT03452943|582406980|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
161280617|NCT01301729|582406986|FG000|Overall Study|Withdrawal by Subject|2|||
161280618|NCT01301729|582406986|FG000|Overall Study|Participant did not Return for Treatment|1|||
161280619|NCT01301729|582406986|FG000|Overall Study|Violated Selection Criteria|1|||
161280620|NCT03071276|582406987|FG000|Overall Study|Adverse Event|1|||
161280621|NCT03071276|582406987|FG000|Overall Study|Lack of Efficacy|14|||
161344823|NCT00689936|582648798|FG000|Active Treatment Phase|Lost to Follow-up|0|||
161042659|NCT04992273|581547975|FG001|Overall Study|Lost to Follow-up|1|||
161042660|NCT01364597|581547976|FG000|Overall Study|Adverse Event|4|||
161042661|NCT01364597|581547977|FG001|Overall Study|Adverse Event|5|||
161042662|NCT01364597|581547978|FG002|Overall Study|Adverse Event|16|||
161042663|NCT01364597|581547979|FG003|Overall Study|Adverse Event|7|||
161042664|NCT01364597|581547976|FG000|Overall Study|Lack of Efficacy|4|||
161042665|NCT01364597|581547977|FG001|Overall Study|Lack of Efficacy|4|||
161042666|NCT01364597|581547978|FG002|Overall Study|Lack of Efficacy|23|||
161042667|NCT01364597|581547979|FG003|Overall Study|Lack of Efficacy|8|||
161042668|NCT01364597|581547976|FG000|Overall Study|Protocol Violation|0|||
161042669|NCT01364597|581547977|FG001|Overall Study|Protocol Violation|0|||
161042670|NCT01364597|581547978|FG002|Overall Study|Protocol Violation|2|||
161042671|NCT01364597|581547979|FG003|Overall Study|Protocol Violation|0|||
161042672|NCT01364597|581547976|FG000|Overall Study|Lost to Follow-up|0|||
161042673|NCT01364597|581547977|FG001|Overall Study|Lost to Follow-up|0|||
161042674|NCT01364597|581547978|FG002|Overall Study|Lost to Follow-up|5|||
161042675|NCT01364597|581547979|FG003|Overall Study|Lost to Follow-up|3|||
161042676|NCT01364597|581547976|FG000|Overall Study|Withdrawal by Subject|4|||
161042677|NCT01364597|581547977|FG001|Overall Study|Withdrawal by Subject|1|||
161042678|NCT01364597|581547978|FG002|Overall Study|Withdrawal by Subject|18|||
161042679|NCT01364597|581547979|FG003|Overall Study|Withdrawal by Subject|6|||
161042680|NCT01364597|581547976|FG000|Overall Study|Non compliance|1|||
161042681|NCT01364597|581547977|FG001|Overall Study|Non compliance|0|||
161042682|NCT01364597|581547978|FG002|Overall Study|Non compliance|1|||
161042683|NCT01364597|581547979|FG003|Overall Study|Non compliance|0|||
161280622|NCT02924727|582406988|FG000|Overall Study|Withdrawal by Subject|2|||
161344824|NCT00689936|582648799|FG001|Active Treatment Phase|Lost to Follow-up|2|||
161042684|NCT01364597|581547976|FG000|Overall Study|Lack of compliance|1|||
161042685|NCT01364597|581547977|FG001|Overall Study|Lack of compliance|0|||
161042686|NCT01364597|581547978|FG002|Overall Study|Lack of compliance|0|||
161280623|NCT02924727|582406989|FG001|Overall Study|Withdrawal by Subject|4|||
161042687|NCT01364597|581547979|FG003|Overall Study|Lack of compliance|0|||
161042688|NCT01364597|581547976|FG000|Overall Study|End of treatment epilepsy|1|||
161042689|NCT01364597|581547977|FG001|Overall Study|End of treatment epilepsy|0|||
161344825|NCT00689936|582648800|FG002|Active Treatment Phase|Lost to Follow-up|2|||
161042690|NCT01364597|581547978|FG002|Overall Study|End of treatment epilepsy|0|||
161042691|NCT01364597|581547979|FG003|Overall Study|End of treatment epilepsy|0|||
161042692|NCT01364597|581547976|FG000|Overall Study|No Seizures|1|||
161042693|NCT01364597|581547977|FG001|Overall Study|No Seizures|0|||
161042694|NCT01364597|581547978|FG002|Overall Study|No Seizures|0|||
161042695|NCT01364597|581547979|FG003|Overall Study|No Seizures|0|||
161042696|NCT01364597|581547976|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
161042697|NCT01364597|581547977|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
161042698|NCT01364597|581547978|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
161042699|NCT01364597|581547979|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
161042700|NCT01364597|581547976|FG000|Overall Study|Cure|1|||
161042701|NCT01364597|581547977|FG001|Overall Study|Cure|0|||
161042702|NCT01364597|581547978|FG002|Overall Study|Cure|0|||
161042703|NCT01364597|581547979|FG003|Overall Study|Cure|0|||
161042704|NCT01364597|581547976|FG000|Overall Study|Patient was moving|0|||
161042705|NCT01364597|581547977|FG001|Overall Study|Patient was moving|1|||
161042706|NCT01364597|581547978|FG002|Overall Study|Patient was moving|0|||
161042707|NCT01364597|581547979|FG003|Overall Study|Patient was moving|0|||
161042708|NCT01364597|581547976|FG000|Overall Study|Seizures resolved|0|||
161042709|NCT01364597|581547977|FG001|Overall Study|Seizures resolved|0|||
161042710|NCT01364597|581547978|FG002|Overall Study|Seizures resolved|1|||
161042711|NCT01364597|581547979|FG003|Overall Study|Seizures resolved|0|||
161042712|NCT01364597|581547976|FG000|Overall Study|Patient became seizure-free after surgery|0|||
161042713|NCT01364597|581547977|FG001|Overall Study|Patient became seizure-free after surgery|0|||
161042714|NCT01364597|581547978|FG002|Overall Study|Patient became seizure-free after surgery|1|||
161042715|NCT01364597|581547979|FG003|Overall Study|Patient became seizure-free after surgery|0|||
161042716|NCT01364597|581547976|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
161042717|NCT01364597|581547977|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
161042718|NCT01364597|581547978|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
161042719|NCT01364597|581547979|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
161042720|NCT01364597|581547976|FG000|Overall Study|Patient cured from Epilepsy|0|||
161042721|NCT01364597|581547977|FG001|Overall Study|Patient cured from Epilepsy|0|||
161042722|NCT01364597|581547978|FG002|Overall Study|Patient cured from Epilepsy|1|||
161042723|NCT01364597|581547979|FG003|Overall Study|Patient cured from Epilepsy|0|||
161042724|NCT01364597|581547976|FG000|Overall Study|Investigator decision|0|||
161042725|NCT01364597|581547977|FG001|Overall Study|Investigator decision|0|||
161042726|NCT01364597|581547978|FG002|Overall Study|Investigator decision|1|||
161042727|NCT01364597|581547979|FG003|Overall Study|Investigator decision|0|||
161042728|NCT01364597|581547976|FG000|Overall Study|Sponsor recommended discontinuation|0|||
161042729|NCT01364597|581547977|FG001|Overall Study|Sponsor recommended discontinuation|0|||
161042730|NCT01364597|581547978|FG002|Overall Study|Sponsor recommended discontinuation|0|||
161042731|NCT01364597|581547979|FG003|Overall Study|Sponsor recommended discontinuation|1|||
161042732|NCT01364597|581547976|FG000|Overall Study|Parents went abroad with the patient|0|||
161042733|NCT01364597|581547977|FG001|Overall Study|Parents went abroad with the patient|0|||
161042734|NCT01364597|581547978|FG002|Overall Study|Parents went abroad with the patient|1|||
161042735|NCT01364597|581547979|FG003|Overall Study|Parents went abroad with the patient|0|||
161042736|NCT01364597|581547976|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
161042737|NCT01364597|581547977|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
161042738|NCT01364597|581547978|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
161042739|NCT01364597|581547979|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
161042740|NCT01364597|581547976|FG000|Overall Study|BRV administration dropout|0|||
161042741|NCT01364597|581547977|FG001|Overall Study|BRV administration dropout|0|||
161042742|NCT01364597|581547978|FG002|Overall Study|BRV administration dropout|1|||
161042743|NCT01364597|581547979|FG003|Overall Study|BRV administration dropout|0|||
161042744|NCT01364597|581547976|FG000|Overall Study|Dropout|0|||
161042745|NCT01364597|581547977|FG001|Overall Study|Dropout|0|||
161042746|NCT01364597|581547978|FG002|Overall Study|Dropout|3|||
161042747|NCT01364597|581547979|FG003|Overall Study|Dropout|1|||
161042748|NCT01364597|581547976|FG000|Overall Study|Unreliable subject|0|||
161042749|NCT01364597|581547977|FG001|Overall Study|Unreliable subject|0|||
161042750|NCT01364597|581547978|FG002|Overall Study|Unreliable subject|0|||
161042751|NCT01364597|581547979|FG003|Overall Study|Unreliable subject|1|||
161042752|NCT01364597|581547976|FG000|Overall Study|Other|0|||
161042753|NCT01364597|581547977|FG001|Overall Study|Other|0|||
161042754|NCT01364597|581547978|FG002|Overall Study|Other|0|||
161042755|NCT01364597|581547979|FG003|Overall Study|Other|1|||
161042756|NCT02962284|581547980|FG000|Overall Study|Death|2|||
161042757|NCT02962284|581547981|FG001|Overall Study|Death|0|||
161042758|NCT02962284|581547980|FG000|Overall Study|Progressive disease|2|||
161042759|NCT02962284|581547981|FG001|Overall Study|Progressive disease|3|||
161042760|NCT02962284|581547980|FG000|Overall Study|Withdrawal by Subject|1|||
161042761|NCT02962284|581547981|FG001|Overall Study|Withdrawal by Subject|0|||
161042762|NCT03493282|581547985|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
161042763|NCT03493282|581547986|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
161042764|NCT03493282|581547987|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
161042765|NCT03493282|581547985|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
161042766|NCT03493282|581547986|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
161042767|NCT03493282|581547987|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
161042768|NCT02637063|581547988|FG000|Overall Study|Lost to Follow-up|3|||
161042769|NCT02637063|581547989|FG001|Overall Study|Lost to Follow-up|2|||
161042770|NCT02637063|581547990|FG002|Overall Study|Lost to Follow-up|3|||
161042771|NCT02637063|581547988|FG000|Overall Study|Withdrawal by Subject|2|||
161042772|NCT02637063|581547989|FG001|Overall Study|Withdrawal by Subject|2|||
161042773|NCT02637063|581547990|FG002|Overall Study|Withdrawal by Subject|3|||
161042774|NCT01380145|581547991|FG000|Overall Study|Progressive disease|4|||
161042775|NCT02038049|581547996|FG000|Overall Study|Lost to Follow-up|1|||
161042776|NCT02038049|581547997|FG001|Overall Study|Lost to Follow-up|0|||
161042777|NCT00413283|581547998|FG000|Overall Study|Withdrawal by Subject|1|||
161042778|NCT00413283|581547999|FG001|Overall Study|Withdrawal by Subject|0|||
161042779|NCT00413283|581548000|FG002|Overall Study|Withdrawal by Subject|0|||
161042780|NCT00413283|581548001|FG003|Overall Study|Withdrawal by Subject|1|||
161042781|NCT00413283|581547998|FG000|Overall Study|Death|0|||
161042782|NCT00413283|581547999|FG001|Overall Study|Death|0|||
161042783|NCT00413283|581548000|FG002|Overall Study|Death|1|||
161042784|NCT00413283|581548001|FG003|Overall Study|Death|1|||
161042785|NCT00413283|581547998|FG000|Overall Study|Adverse Event|0|||
161042786|NCT00413283|581547999|FG001|Overall Study|Adverse Event|0|||
161042787|NCT00413283|581548000|FG002|Overall Study|Adverse Event|0|||
161042788|NCT00413283|581548001|FG003|Overall Study|Adverse Event|1|||
161042789|NCT00413283|581547998|FG000|Overall Study|Ineligibility determined|0|||
161042790|NCT00413283|581547999|FG001|Overall Study|Ineligibility determined|0|||
161042791|NCT00413283|581548000|FG002|Overall Study|Ineligibility determined|0|||
161042792|NCT00413283|581548001|FG003|Overall Study|Ineligibility determined|1|||
161042793|NCT00413283|581547998|FG000|Overall Study|Protocol deviation|0|||
161042794|NCT00413283|581547999|FG001|Overall Study|Protocol deviation|1|||
161042795|NCT00413283|581548000|FG002|Overall Study|Protocol deviation|0|||
161042796|NCT00413283|581548001|FG003|Overall Study|Protocol deviation|0|||
161042797|NCT00413283|581547998|FG000|Overall Study|Requirement for alternative therapy|0|||
161042798|NCT00413283|581547999|FG001|Overall Study|Requirement for alternative therapy|2|||
161042799|NCT00413283|581548000|FG002|Overall Study|Requirement for alternative therapy|0|||
161042800|NCT00413283|581548001|FG003|Overall Study|Requirement for alternative therapy|0|||
161042801|NCT00413283|581547998|FG000|Overall Study|Other|0|||
161042802|NCT00413283|581547999|FG001|Overall Study|Other|0|||
161042803|NCT00413283|581548000|FG002|Overall Study|Other|1|||
161042804|NCT00413283|581548001|FG003|Overall Study|Other|0|||
161042805|NCT02660086|581548003|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
161042806|NCT02660086|581548004|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
161042807|NCT02660086|581548003|FG000|Overall Study- 12-month|Left full-time employment|12|||
161042808|NCT02660086|581548004|FG001|Overall Study- 12-month|Left full-time employment|20|||
161149238|NCT02417233|581927800|FG000|Overall Study|Death|4|||
161149239|NCT02417233|581927801|FG001|Overall Study|Death|10|||
161149240|NCT02417233|581927802|FG002|Overall Study|Death|14|||
161149241|NCT02417233|581927800|FG000|Overall Study|Lost to Follow-up|27|||
161149242|NCT02417233|581927801|FG001|Overall Study|Lost to Follow-up|39|||
161149243|NCT02417233|581927802|FG002|Overall Study|Lost to Follow-up|34|||
161149244|NCT02417233|581927800|FG000|Overall Study|Protocol Violation|2|||
161149245|NCT02417233|581927801|FG001|Overall Study|Protocol Violation|0|||
161149246|NCT02417233|581927802|FG002|Overall Study|Protocol Violation|2|||
161149247|NCT02417233|581927800|FG000|Overall Study|Withdrawal by Subject|2|||
161149248|NCT02417233|581927801|FG001|Overall Study|Withdrawal by Subject|1|||
161149249|NCT02417233|581927802|FG002|Overall Study|Withdrawal by Subject|8|||
161149250|NCT02417233|581927800|FG000|Overall Study|Relocation out of study area|1|||
161149251|NCT02417233|581927801|FG001|Overall Study|Relocation out of study area|0|||
161149252|NCT02417233|581927802|FG002|Overall Study|Relocation out of study area|1|||
161149253|NCT02417233|581927800|FG000|Overall Study|Mentally unstable|0|||
161149254|NCT02417233|581927801|FG001|Overall Study|Mentally unstable|1|||
161149255|NCT02417233|581927802|FG002|Overall Study|Mentally unstable|0|||
161149256|NCT01063751|581927803|FG000|Overall Study|Censored from analyses|42|||
161149257|NCT01063751|581927803|FG000|Overall Study|Withdrawal by Subject|34|||
161149258|NCT01063751|581927803|FG000|Overall Study|Lost to Follow-up|30|||
161149259|NCT01063751|581927803|FG000|Overall Study|Death|13|||
161149260|NCT01063751|581927803|FG000|Overall Study|Sponsored Terminated Study|60|||
161149261|NCT01063751|581927803|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
161042809|NCT02660086|581548003|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
161042810|NCT02660086|581548004|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
161149262|NCT01063751|581927803|FG000|Overall Study|Investigator site closed|10|||
161280624|NCT02924727|582406988|FG000|Overall Study|Lost to Follow-up|2|||
161149263|NCT01063751|581927803|FG000|Overall Study|Revision|6|||
161042811|NCT02660086|581548003|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
161042812|NCT02660086|581548004|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
161042813|NCT02660086|581548003|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
161042814|NCT02660086|581548004|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
161149264|NCT01063751|581927803|FG000|Overall Study|Physician Decision|4|||
161149265|NCT02805907|581927809|FG000|Overall Study|Lost to Follow-up|3|||
161149266|NCT02805907|581927810|FG001|Overall Study|Lost to Follow-up|3|||
161042815|NCT02660086|581548003|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
161042816|NCT02660086|581548004|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
161042817|NCT01214200|581548007|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
161042818|NCT01214200|581548007|FG000|Overall Study|Withdrawal by Subject|2|||
161042819|NCT01823224|581548008|FG000|Overall Study|Lost to Follow-up|5|||
161042820|NCT01823224|581548009|FG001|Overall Study|Lost to Follow-up|6|||
161042821|NCT01823224|581548008|FG000|Overall Study|didn't qualify|1|||
161042822|NCT01823224|581548009|FG001|Overall Study|didn't qualify|2|||
161042823|NCT01823224|581548008|FG000|Overall Study|pharmacy error|0|||
161042824|NCT01823224|581548009|FG001|Overall Study|pharmacy error|1|||
161042825|NCT01823224|581548008|FG000|Overall Study|missed med dose|0|||
161042826|NCT01823224|581548009|FG001|Overall Study|missed med dose|1|||
161042827|NCT01823224|581548008|FG000|Overall Study|Withdrawal by Subject|0|||
161042828|NCT01823224|581548009|FG001|Overall Study|Withdrawal by Subject|1|||
161042829|NCT00587171|581548010|FG000|Overall Study|Lost to Follow-up|1|||
161042830|NCT00587171|581548011|FG001|Overall Study|Lost to Follow-up|1|||
161042831|NCT01532648|581548012|FG000|Overall Study|Lost to Follow-up|3|||
161042832|NCT01532648|581548013|FG001|Overall Study|Lost to Follow-up|4|||
161042833|NCT01532648|581548012|FG000|Overall Study|Lack of Efficacy|4|||
161042834|NCT01532648|581548013|FG001|Overall Study|Lack of Efficacy|1|||
161042835|NCT01532648|581548012|FG000|Overall Study|Protocol Violation|1|||
161042836|NCT01532648|581548013|FG001|Overall Study|Protocol Violation|1|||
161042837|NCT01532648|581548012|FG000|Overall Study|Adverse Event|12|||
161042838|NCT01532648|581548013|FG001|Overall Study|Adverse Event|9|||
161042839|NCT01532648|581548012|FG000|Overall Study|Withdrawal by Subject|16|||
161042840|NCT01532648|581548013|FG001|Overall Study|Withdrawal by Subject|2|||
161042841|NCT02824198|581548017|FG000|Overall Study|Non-compliance with the protocol|5|||
161042842|NCT02824198|581548018|FG001|Overall Study|Non-compliance with the protocol|1|||
161042843|NCT02824198|581548017|FG000|Overall Study|Lost to Follow-up|5|||
161042844|NCT02824198|581548018|FG001|Overall Study|Lost to Follow-up|2|||
161042845|NCT02824198|581548017|FG000|Overall Study|Withdrawal by Subject|5|||
161042846|NCT02824198|581548018|FG001|Overall Study|Withdrawal by Subject|0|||
161042847|NCT04938453|581548019|FG000|Washout Period 1|Adverse Event|1|||
161042848|NCT04938453|581548020|FG001|Washout Period 1|Adverse Event|0|||
161042849|NCT04938453|581548019|FG000|Washout Period 1|Physician Decision|0|||
161042850|NCT04938453|581548020|FG001|Washout Period 1|Physician Decision|1|||
161042851|NCT03292406|581548021|FG000|Overall Study|Progressive Disease|6|||
161042852|NCT03292406|581548022|FG001|Overall Study|Progressive Disease|3|||
161042853|NCT03292406|581548023|FG002|Overall Study|Progressive Disease|4|||
161042854|NCT03292406|581548021|FG000|Overall Study|Adverse Event|7|||
161042855|NCT03292406|581548022|FG001|Overall Study|Adverse Event|1|||
161042856|NCT03292406|581548023|FG002|Overall Study|Adverse Event|4|||
161042857|NCT03292406|581548021|FG000|Overall Study|Withdrawal by Subject|0|||
161042858|NCT03292406|581548022|FG001|Overall Study|Withdrawal by Subject|7|||
161042859|NCT03292406|581548023|FG002|Overall Study|Withdrawal by Subject|2|||
161042860|NCT03292406|581548021|FG000|Overall Study|Protocol Violation|0|||
161042861|NCT03292406|581548022|FG001|Overall Study|Protocol Violation|1|||
161042862|NCT03292406|581548023|FG002|Overall Study|Protocol Violation|1|||
161042863|NCT03292406|581548021|FG000|Overall Study|Other|0|||
161042864|NCT03292406|581548022|FG001|Overall Study|Other|1|||
161042865|NCT03292406|581548023|FG002|Overall Study|Other|2|||
161042866|NCT03176407|581548029|FG000|Overall Study|Protocol Violation|1|||
161042867|NCT03176407|581548029|FG000|Overall Study|human failure|1|||
161042868|NCT03176407|581548029|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
161042869|NCT02128269|581548031|FG000|Treatment Period|Adverse Event|1|||
161042870|NCT02128269|581548031|FG000|Treatment Period|Physician Decision|1|||
161042871|NCT01829711|581548032|FG000|Overall Study|Lost to Follow-up|2|||
161042872|NCT01829711|581548032|FG000|Overall Study|Withdrawal by Subject|3|||
161042873|NCT01829711|581548032|FG000|Overall Study|Death|4|||
161042874|NCT01829711|581548032|FG000|Overall Study|Started new therapies|17|||
161042875|NCT01829711|581548032|FG000|Overall Study|Adverse Event|3|||
161042876|NCT01829711|581548032|FG000|Overall Study|Due to progression of disease|13|||
161042877|NCT01829711|581548032|FG000|Overall Study|Due to lack of response|1|||
161042878|NCT01480258|581548033|FG000|Infant Series|Protocol Violation|2|||
161042879|NCT01480258|581548034|FG001|Infant Series|Protocol Violation|0|||
161042880|NCT01480258|581548033|FG000|Infant Series|Physician Decision|0|||
161042881|NCT01480258|581548034|FG001|Infant Series|Physician Decision|1|||
161042882|NCT01480258|581548033|FG000|Infant Series|Not Vaccinated|3|||
161042883|NCT01480258|581548034|FG001|Infant Series|Not Vaccinated|0|||
161042884|NCT01480258|581548033|FG000|Infant Series|Adverse Event|1|||
161042885|NCT01480258|581548034|FG001|Infant Series|Adverse Event|1|||
161042886|NCT01480258|581548033|FG000|Infant Series|Withdrawal by Subject|1|||
161042887|NCT01480258|581548034|FG001|Infant Series|Withdrawal by Subject|6|||
161042888|NCT01480258|581548033|FG000|Interim Period|Lost to Follow-up|0|||
161042889|NCT01480258|581548034|FG001|Interim Period|Lost to Follow-up|2|||
161042890|NCT01480258|581548033|FG000|Interim Period|Physician Decision|1|||
161042891|NCT01480258|581548034|FG001|Interim Period|Physician Decision|0|||
161042892|NCT01480258|581548033|FG000|Interim Period|Protocol Violation|0|||
161042893|NCT01480258|581548034|FG001|Interim Period|Protocol Violation|1|||
161042894|NCT01480258|581548033|FG000|Interim Period|Withdrawal by Subject|9|||
161042895|NCT01480258|581548034|FG001|Interim Period|Withdrawal by Subject|6|||
161042896|NCT04248868|581548035|FG000|Overall Study|Death|1|||
161042897|NCT04248868|581548035|FG000|Overall Study|Lost to Follow-up|3|||
161042898|NCT04248868|581548035|FG000|Overall Study|Protocol Violation|2|||
161042899|NCT01543204|581548038|FG000|Overall Study|Non-compliance|1|||
161042900|NCT01543204|581548038|FG000|Overall Study|Adverse Event|1|||
161042901|NCT01543204|581548038|FG000|Overall Study|Withdrawal by Subject|4|||
161042902|NCT01543204|581548038|FG000|Overall Study|Requirement for Alternative Therapy|1|||
161042903|NCT01543204|581548038|FG000|Overall Study|Lost to Follow-up|1|||
161042904|NCT03822832|581548046|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
161042905|NCT03822832|581548047|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
161042906|NCT03822832|581548046|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
161042907|NCT03822832|581548047|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
161042908|NCT03822832|581548046|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
161042909|NCT03822832|581548047|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
161042910|NCT03822832|581548046|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
161042911|NCT03822832|581548047|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
161042912|NCT03822832|581548046|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
161042913|NCT03822832|581548047|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
161042914|NCT03822832|581548046|FG000|Re-allocation|Not re-allocated to open label period|2|||
161042915|NCT03822832|581548047|FG001|Re-allocation|Not re-allocated to open label period|6|||
161042916|NCT03822832|581548046|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
161042917|NCT03822832|581548047|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
161042918|NCT03822832|581548046|FG000|Period 2 - Open Label Period|Adverse Event|0|||
161042919|NCT03822832|581548047|FG001|Period 2 - Open Label Period|Adverse Event|3|||
161042920|NCT01668719|581548048|FG000|Phase I|On treatment|1|||
161042921|NCT01668719|581548049|FG001|Phase I|On treatment|0|||
161042922|NCT01668719|581548050|FG002|Phase I|On treatment|0|||
161042923|NCT01668719|581548048|FG000|Phase I|Adverse Event|2|||
161042924|NCT01668719|581548049|FG001|Phase I|Adverse Event|0|||
161042925|NCT01668719|581548050|FG002|Phase I|Adverse Event|0|||
161042926|NCT01668719|581548048|FG000|Phase I|Progression/relapse|1|||
161042927|NCT01668719|581548049|FG001|Phase I|Progression/relapse|0|||
161042928|NCT01668719|581548050|FG002|Phase I|Progression/relapse|0|||
161042929|NCT01668719|581548048|FG000|Phase I|not protocol specified|2|||
161042930|NCT01668719|581548049|FG001|Phase I|not protocol specified|0|||
161042931|NCT01668719|581548050|FG002|Phase I|not protocol specified|0|||
161042932|NCT01668719|581548048|FG000|Phase II|On treatment|0|||
161042933|NCT01668719|581548049|FG001|Phase II|On treatment|4|||
161042934|NCT01668719|581548050|FG002|Phase II|On treatment|3|||
161042935|NCT01668719|581548048|FG000|Phase II|Adverse Event|0|||
161042936|NCT01668719|581548049|FG001|Phase II|Adverse Event|18|||
161042937|NCT01668719|581548050|FG002|Phase II|Adverse Event|18|||
161042938|NCT01668719|581548048|FG000|Phase II|Refusal unrelated to adverse event|0|||
161042939|NCT01668719|581548049|FG001|Phase II|Refusal unrelated to adverse event|4|||
161042940|NCT01668719|581548050|FG002|Phase II|Refusal unrelated to adverse event|1|||
161042941|NCT01668719|581548048|FG000|Phase II|Progression/relapse|0|||
161042942|NCT01668719|581548049|FG001|Phase II|Progression/relapse|13|||
161042943|NCT01668719|581548050|FG002|Phase II|Progression/relapse|17|||
161042944|NCT01668719|581548048|FG000|Phase II|Death|0|||
161042945|NCT01668719|581548049|FG001|Phase II|Death|0|||
161042946|NCT01668719|581548050|FG002|Phase II|Death|2|||
161042947|NCT01668719|581548048|FG000|Phase II|not protocol specified|0|||
161042948|NCT01668719|581548049|FG001|Phase II|not protocol specified|13|||
161042949|NCT01668719|581548050|FG002|Phase II|not protocol specified|7|||
161042950|NCT01321073|581548051|FG000|Overall Study|Did not attempt implant|4|||
161042951|NCT01321073|581548051|FG000|Overall Study|Death|3|||
161042952|NCT04248803|581548052|FG000|Overall Study|Lost to Follow-up|7|||
161042953|NCT04248803|581548053|FG001|Overall Study|Lost to Follow-up|7|||
161042954|NCT04248803|581548054|FG002|Overall Study|Lost to Follow-up|7|||
161042955|NCT04248803|581548055|FG003|Overall Study|Lost to Follow-up|7|||
161280625|NCT02924727|582406989|FG001|Overall Study|Lost to Follow-up|5|||
161042956|NCT04248803|581548056|FG004|Overall Study|Lost to Follow-up|7|||
161042957|NCT04248803|581548057|FG005|Overall Study|Lost to Follow-up|7|||
161042958|NCT05352230|581548058|FG000|First Intervention (3 Months)|study terminated|2|||
161042959|NCT05352230|581548059|FG001|First Intervention (3 Months)|study terminated|2|||
161042960|NCT02309294|581548063|FG000|Overall Study|Withdrawal by Subject|2|||
161042961|NCT01227421|581548064|FG000|Overall Study|Lost to Follow-up|6|||
161042962|NCT01227421|581548065|FG001|Overall Study|Lost to Follow-up|7|||
161280626|NCT02924727|582406988|FG000|Overall Study|Death|221|||
161042963|NCT01227421|581548066|FG002|Overall Study|Lost to Follow-up|5|||
161042964|NCT01227421|581548064|FG000|Overall Study|Adverse Event|2|||
161042965|NCT01227421|581548065|FG001|Overall Study|Adverse Event|7|||
161042966|NCT01227421|581548066|FG002|Overall Study|Adverse Event|2|||
161042967|NCT01227421|581548064|FG000|Overall Study|Withdrawal by Subject|1|||
161042968|NCT01227421|581548065|FG001|Overall Study|Withdrawal by Subject|2|||
161042969|NCT01227421|581548066|FG002|Overall Study|Withdrawal by Subject|1|||
161042970|NCT01227421|581548064|FG000|Overall Study|Protocol Violation|1|||
161042971|NCT01227421|581548065|FG001|Overall Study|Protocol Violation|1|||
161042972|NCT01227421|581548066|FG002|Overall Study|Protocol Violation|2|||
161042973|NCT01227421|581548064|FG000|Overall Study|Randomized in error|1|||
161042974|NCT01227421|581548065|FG001|Overall Study|Randomized in error|1|||
161042975|NCT01227421|581548066|FG002|Overall Study|Randomized in error|0|||
161042976|NCT02969356|581548074|FG000|Overall Study|Adverse Event|7|||
161042977|NCT02969356|581548074|FG000|Overall Study|Consent withdrawn|2|||
161042978|NCT02969356|581548074|FG000|Overall Study|Lost to Follow-up|3|||
161042979|NCT02969356|581548074|FG000|Overall Study|Did not need to be reinjected|6|||
161042980|NCT02969356|581548074|FG000|Overall Study|Personal reasons|5|||
161042981|NCT01276509|581549927|FG000|Overall Study|Adverse Event|9|||
161042982|NCT01276509|581549928|FG001|Overall Study|Adverse Event|8|||
161042983|NCT01276509|581549929|FG002|Overall Study|Adverse Event|4|||
161042984|NCT01276509|581549930|FG003|Overall Study|Adverse Event|3|||
161042985|NCT01276509|581549927|FG000|Overall Study|Lack of Efficacy|2|||
161042986|NCT01276509|581549928|FG001|Overall Study|Lack of Efficacy|1|||
161042987|NCT01276509|581549929|FG002|Overall Study|Lack of Efficacy|1|||
161042988|NCT01276509|581549930|FG003|Overall Study|Lack of Efficacy|2|||
161042989|NCT01276509|581549927|FG000|Overall Study|Pregnancy|1|||
161042990|NCT01276509|581549928|FG001|Overall Study|Pregnancy|0|||
161042991|NCT01276509|581549929|FG002|Overall Study|Pregnancy|0|||
161042992|NCT01276509|581549930|FG003|Overall Study|Pregnancy|0|||
161042993|NCT01276509|581549927|FG000|Overall Study|Withdrawal by Subject|1|||
161042994|NCT01276509|581549928|FG001|Overall Study|Withdrawal by Subject|2|||
161042995|NCT01276509|581549929|FG002|Overall Study|Withdrawal by Subject|0|||
161042996|NCT01276509|581549930|FG003|Overall Study|Withdrawal by Subject|0|||
161042997|NCT01276509|581549927|FG000|Overall Study|Other|0|||
161042998|NCT01276509|581549928|FG001|Overall Study|Other|1|||
161042999|NCT01276509|581549929|FG002|Overall Study|Other|0|||
161043000|NCT01276509|581549930|FG003|Overall Study|Other|0|||
161043001|NCT00949117|581549932|FG000|Overall Study|Lack of Efficacy|2|||
161043002|NCT00949117|581549933|FG001|Overall Study|Lack of Efficacy|3|||
161043003|NCT00949117|581549932|FG000|Overall Study|Protocol Violation|1|||
161043004|NCT00949117|581549933|FG001|Overall Study|Protocol Violation|1|||
161043005|NCT00949117|581549932|FG000|Overall Study|Adverse Event|0|||
161043006|NCT00949117|581549933|FG001|Overall Study|Adverse Event|1|||
161043007|NCT03964974|581549934|FG000|Overall Study|Lost to Follow-up|3|||
161043008|NCT03964974|581549935|FG001|Overall Study|Lost to Follow-up|2|||
161043009|NCT03964974|581549934|FG000|Overall Study|Withdrawal by Subject|0|||
161043010|NCT03964974|581549935|FG001|Overall Study|Withdrawal by Subject|3|||
161043011|NCT02014402|581549939|FG000|Overall Study|Adverse Event|1|||
161043012|NCT02014402|581549940|FG001|Overall Study|Adverse Event|0|||
161043013|NCT02014402|581549941|FG002|Overall Study|Adverse Event|0|||
161043014|NCT02014402|581549942|FG003|Overall Study|Adverse Event|0|||
161043015|NCT02014402|581549939|FG000|Overall Study|Withdrawal by Subject|1|||
161043016|NCT02014402|581549940|FG001|Overall Study|Withdrawal by Subject|2|||
161043017|NCT02014402|581549941|FG002|Overall Study|Withdrawal by Subject|2|||
161043018|NCT02014402|581549942|FG003|Overall Study|Withdrawal by Subject|1|||
161043019|NCT02014402|581549939|FG000|Overall Study|Subject did not have transportation|0|||
161043020|NCT02014402|581549940|FG001|Overall Study|Subject did not have transportation|1|||
161043021|NCT02014402|581549941|FG002|Overall Study|Subject did not have transportation|0|||
161043022|NCT02014402|581549942|FG003|Overall Study|Subject did not have transportation|0|||
161043023|NCT02014402|581549939|FG000|Overall Study|Lost to Follow-up|0|||
161043024|NCT02014402|581549940|FG001|Overall Study|Lost to Follow-up|0|||
161043025|NCT02014402|581549941|FG002|Overall Study|Lost to Follow-up|1|||
161043026|NCT02014402|581549942|FG003|Overall Study|Lost to Follow-up|2|||
161043027|NCT00670449|581549943|FG000|Overall Study|Adverse Event|6|||
161043028|NCT00670449|581549944|FG001|Overall Study|Adverse Event|2|||
161043029|NCT00670449|581549945|FG002|Overall Study|Adverse Event|8|||
161043030|NCT00670449|581549946|FG003|Overall Study|Adverse Event|5|||
161043031|NCT00670449|581549943|FG000|Overall Study|Protocol Deviation|1|||
161043032|NCT00670449|581549944|FG001|Overall Study|Protocol Deviation|2|||
161043033|NCT00670449|581549945|FG002|Overall Study|Protocol Deviation|0|||
161280627|NCT02924727|582406989|FG001|Overall Study|Death|247|||
161043034|NCT00670449|581549946|FG003|Overall Study|Protocol Deviation|1|||
161043035|NCT00670449|581549943|FG000|Overall Study|Administrative Problems|0|||
161043036|NCT00670449|581549944|FG001|Overall Study|Administrative Problems|2|||
161043037|NCT00670449|581549945|FG002|Overall Study|Administrative Problems|0|||
161043038|NCT00670449|581549946|FG003|Overall Study|Administrative Problems|1|||
161043039|NCT00670449|581549943|FG000|Overall Study|Subject Withdrew Consent|0|||
161043040|NCT00670449|581549944|FG001|Overall Study|Subject Withdrew Consent|2|||
161043041|NCT00670449|581549945|FG002|Overall Study|Subject Withdrew Consent|0|||
161149267|NCT03799718|581927820|FG000|Overall Study|Adverse Event|2|||
161280628|NCT02924727|582406988|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
161043042|NCT00670449|581549946|FG003|Overall Study|Subject Withdrew Consent|1|||
161043043|NCT00670449|581549943|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
161043044|NCT00670449|581549944|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161043045|NCT00670449|581549945|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161149268|NCT01469013|581927821|FG000|Part A (Treatment Period)|Adverse Event|1|||
161043046|NCT00670449|581549946|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161043047|NCT00670449|581549943|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
161043048|NCT00670449|581549944|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
161043049|NCT00670449|581549945|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161043050|NCT00670449|581549946|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
161043051|NCT01377844|581549947|FG000|Overall Study|Withdrawal by Subject|25|||
161043052|NCT01377844|581549948|FG001|Overall Study|Withdrawal by Subject|28|||
161043053|NCT01377844|581549947|FG000|Overall Study|Protocol Violation|2|||
161043054|NCT01377844|581549948|FG001|Overall Study|Protocol Violation|3|||
161043055|NCT01377844|581549947|FG000|Overall Study|Adverse Event|3|||
161043056|NCT01377844|581549948|FG001|Overall Study|Adverse Event|0|||
161043057|NCT01377844|581549947|FG000|Overall Study|Physician Decision|6|||
161043058|NCT01377844|581549948|FG001|Overall Study|Physician Decision|3|||
161043059|NCT01377844|581549947|FG000|Overall Study|Study terminated by Sponsor|0|||
161043060|NCT01377844|581549948|FG001|Overall Study|Study terminated by Sponsor|1|||
161043061|NCT00667017|581549950|FG000|Overall Study|Withdrawal by Subject|1|||
161043062|NCT02148705|581549951|FG000|Overall Study|Death|2|||
161043063|NCT02148705|581549952|FG001|Overall Study|Death|0|||
161043064|NCT02148705|581549953|FG002|Overall Study|Death|0|||
161043065|NCT02148705|581549951|FG000|Overall Study|Lost to Follow-up|13|||
161043066|NCT02148705|581549952|FG001|Overall Study|Lost to Follow-up|4|||
161043067|NCT02148705|581549953|FG002|Overall Study|Lost to Follow-up|10|||
161043068|NCT02148705|581549951|FG000|Overall Study|Withdrawal by Subject|3|||
161043069|NCT02148705|581549952|FG001|Overall Study|Withdrawal by Subject|0|||
161043070|NCT02148705|581549953|FG002|Overall Study|Withdrawal by Subject|2|||
161043071|NCT02148705|581549951|FG000|Overall Study|Not Treated|0|||
161043072|NCT02148705|581549952|FG001|Overall Study|Not Treated|1|||
161043073|NCT02148705|581549953|FG002|Overall Study|Not Treated|5|||
161043074|NCT01737021|581549954|FG000|Overall Study|Lost to Follow-up|5|||
161043075|NCT01737021|581549955|FG001|Overall Study|Lost to Follow-up|3|||
161043076|NCT01673594|581549956|FG000|Overall Study|Adverse Event|3|||
161043077|NCT01673594|581549957|FG001|Overall Study|Adverse Event|1|||
161043078|NCT01673594|581549956|FG000|Overall Study|Lost to Follow-up|1|||
161043079|NCT01673594|581549957|FG001|Overall Study|Lost to Follow-up|0|||
161043080|NCT01673594|581549956|FG000|Overall Study|Physician Decision|2|||
161043081|NCT01673594|581549957|FG001|Overall Study|Physician Decision|4|||
161043082|NCT01673594|581549956|FG000|Overall Study|Withdrawal by Subject|0|||
161043083|NCT01673594|581549957|FG001|Overall Study|Withdrawal by Subject|1|||
161043084|NCT02605174|581549958|FG000|Overall Study|Adverse Event|0|||
161043085|NCT02605174|581549959|FG001|Overall Study|Adverse Event|0|||
161043086|NCT02605174|581549960|FG002|Overall Study|Adverse Event|1|||
161043087|NCT02605174|581549961|FG003|Overall Study|Adverse Event|0|||
161043088|NCT02605174|581549962|FG004|Overall Study|Adverse Event|4|||
161043089|NCT02605174|581549963|FG005|Overall Study|Adverse Event|0|||
161043090|NCT02605174|581549964|FG006|Overall Study|Adverse Event|0|||
161043091|NCT02605174|581549958|FG000|Overall Study|Lost to Follow-up|20|||
161043092|NCT02605174|581549959|FG001|Overall Study|Lost to Follow-up|7|||
161043093|NCT02605174|581549960|FG002|Overall Study|Lost to Follow-up|27|||
161043094|NCT02605174|581549961|FG003|Overall Study|Lost to Follow-up|10|||
161043095|NCT02605174|581549962|FG004|Overall Study|Lost to Follow-up|20|||
161043096|NCT02605174|581549963|FG005|Overall Study|Lost to Follow-up|10|||
161043097|NCT02605174|581549964|FG006|Overall Study|Lost to Follow-up|29|||
161043098|NCT02605174|581549958|FG000|Overall Study|Protocol Violation|10|||
161043099|NCT02605174|581549959|FG001|Overall Study|Protocol Violation|4|||
161043100|NCT02605174|581549960|FG002|Overall Study|Protocol Violation|14|||
161043101|NCT02605174|581549961|FG003|Overall Study|Protocol Violation|6|||
161149269|NCT01469013|581927822|FG001|Part A (Treatment Period)|Adverse Event|0|||
161149270|NCT01469013|581927823|FG002|Part A (Treatment Period)|Adverse Event|0|||
161149271|NCT01469013|581927824|FG003|Part A (Treatment Period)|Adverse Event|0|||
161043102|NCT02605174|581549962|FG004|Overall Study|Protocol Violation|7|||
161043103|NCT02605174|581549963|FG005|Overall Study|Protocol Violation|7|||
161043104|NCT02605174|581549964|FG006|Overall Study|Protocol Violation|12|||
161149272|NCT01469013|581927825|FG004|Part A (Treatment Period)|Adverse Event|1|||
161149273|NCT01469013|581927826|FG005|Part A (Treatment Period)|Adverse Event|0|||
161149274|NCT01469013|581927827|FG006|Part A (Treatment Period)|Adverse Event|0|||
161043105|NCT02605174|581549958|FG000|Overall Study|Pregnancy|1|||
161043106|NCT02605174|581549959|FG001|Overall Study|Pregnancy|0|||
161043107|NCT02605174|581549960|FG002|Overall Study|Pregnancy|0|||
161043108|NCT02605174|581549961|FG003|Overall Study|Pregnancy|2|||
161043109|NCT02605174|581549962|FG004|Overall Study|Pregnancy|0|||
161043110|NCT02605174|581549963|FG005|Overall Study|Pregnancy|0|||
161043111|NCT02605174|581549964|FG006|Overall Study|Pregnancy|0|||
161043112|NCT02605174|581549958|FG000|Overall Study|Withdrawal by Subject|9|||
161043113|NCT02605174|581549959|FG001|Overall Study|Withdrawal by Subject|6|||
161043114|NCT02605174|581549960|FG002|Overall Study|Withdrawal by Subject|14|||
161043115|NCT02605174|581549961|FG003|Overall Study|Withdrawal by Subject|11|||
161149275|NCT01469013|581927828|FG007|Part A (Treatment Period)|Adverse Event|0|||
161149276|NCT01469013|581927829|FG008|Part A (Treatment Period)|Adverse Event|0|||
161344826|NCT00689936|582648798|FG000|Active Treatment Phase|Protocol Violation|2|||
161344827|NCT00689936|582648799|FG001|Active Treatment Phase|Protocol Violation|2|||
161344828|NCT00689936|582648800|FG002|Active Treatment Phase|Protocol Violation|4|||
161344829|NCT00689936|582648798|FG000|Active Treatment Phase|Study Close Out|64|||
161043116|NCT02605174|581549962|FG004|Overall Study|Withdrawal by Subject|6|||
161043117|NCT02605174|581549963|FG005|Overall Study|Withdrawal by Subject|4|||
161043118|NCT02605174|581549964|FG006|Overall Study|Withdrawal by Subject|15|||
161043119|NCT02605174|581549958|FG000|Overall Study|Physician Decision|2|||
161043120|NCT02605174|581549959|FG001|Overall Study|Physician Decision|0|||
161043121|NCT02605174|581549960|FG002|Overall Study|Physician Decision|0|||
161043122|NCT02605174|581549961|FG003|Overall Study|Physician Decision|0|||
161043123|NCT02605174|581549962|FG004|Overall Study|Physician Decision|0|||
161043124|NCT02605174|581549963|FG005|Overall Study|Physician Decision|0|||
161043125|NCT02605174|581549964|FG006|Overall Study|Physician Decision|3|||
161043126|NCT02605174|581549958|FG000|Overall Study|Randomization Failure|22|||
161043127|NCT02605174|581549959|FG001|Overall Study|Randomization Failure|6|||
161043128|NCT02605174|581549960|FG002|Overall Study|Randomization Failure|20|||
161043129|NCT02605174|581549961|FG003|Overall Study|Randomization Failure|7|||
161043130|NCT02605174|581549962|FG004|Overall Study|Randomization Failure|16|||
161043131|NCT02605174|581549963|FG005|Overall Study|Randomization Failure|11|||
161043132|NCT02605174|581549964|FG006|Overall Study|Randomization Failure|30|||
161043133|NCT04250636|581549965|FG000|Overall Study|Lost to Follow-up|2|||
161043134|NCT01779050|581549966|FG000|Overall Study|Withdrawal by Subject|1|||
161043135|NCT01779050|581549967|FG001|Overall Study|Withdrawal by Subject|0|||
161043136|NCT01353274|581549968|FG000|Overall Study|No case report form (CRF) collected|28|||
161043137|NCT01128959|581549969|FG000|Lead in Period|Adverse Event|3|||
161043138|NCT01128959|581549969|FG000|Treatment Period|Adverse Event|3|||
161043139|NCT01128959|581549969|FG000|Treatment Period|Withdrawal by Subject|1|||
161043140|NCT01409837|581549972|FG000|Overall Study|Withdrawal by Subject|2|||
161043141|NCT01409837|581549973|FG001|Overall Study|Withdrawal by Subject|1|||
161043142|NCT01409837|581549972|FG000|Overall Study|Lost to Follow-up|1|||
161043143|NCT01409837|581549973|FG001|Overall Study|Lost to Follow-up|0|||
161043144|NCT01409837|581549972|FG000|Overall Study|Physician Decision|0|||
161043145|NCT01409837|581549973|FG001|Overall Study|Physician Decision|1|||
161043146|NCT00022672|581549975|FG000|Main Phase: 24 Months|Adverse Event|6|||
161043147|NCT00022672|581549976|FG001|Main Phase: 24 Months|Adverse Event|0|||
161043148|NCT00022672|581549975|FG000|Main Phase: 24 Months|Death|0|||
161043149|NCT00022672|581549976|FG001|Main Phase: 24 Months|Death|3|||
161043150|NCT00022672|581549975|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
161043151|NCT00022672|581549976|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
161043152|NCT00022672|581549975|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
161043153|NCT00022672|581549976|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
161043154|NCT00022672|581549975|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
161043155|NCT00022672|581549976|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
161043156|NCT00022672|581549975|FG000|Main Phase: 24 Months|Refused Treatment|3|||
161043157|NCT00022672|581549976|FG001|Main Phase: 24 Months|Refused Treatment|4|||
161043158|NCT00022672|581549975|FG000|Main Phase: 24 Months|Failure to Return|1|||
161043159|NCT00022672|581549976|FG001|Main Phase: 24 Months|Failure to Return|1|||
161043160|NCT00022672|581549975|FG000|Main Phase: 24 Months|Other|1|||
161043161|NCT00022672|581549976|FG001|Main Phase: 24 Months|Other|0|||
161043162|NCT00022672|581549975|FG000|Extension Phase|Adverse Event|1|||
161043163|NCT00022672|581549976|FG001|Extension Phase|Adverse Event|3|||
161043164|NCT00022672|581549975|FG000|Extension Phase|Death|0|||
161043165|NCT00022672|581549976|FG001|Extension Phase|Death|1|||
161043166|NCT00022672|581549975|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
161344830|NCT00689936|582648799|FG001|Active Treatment Phase|Study Close Out|26|||
161043167|NCT00022672|581549976|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
161043168|NCT00022672|581549975|FG000|Extension Phase|Refused Treatment|0|||
161043169|NCT00022672|581549976|FG001|Extension Phase|Refused Treatment|2|||
161043170|NCT00022672|581549975|FG000|Extension Phase|Other|1|||
161043171|NCT00022672|581549976|FG001|Extension Phase|Other|1|||
161043172|NCT00403494|581549977|FG000|Overall Study|Adverse Event|10|||
161043173|NCT00403494|581549978|FG001|Overall Study|Adverse Event|8|||
161043174|NCT00403494|581549977|FG000|Overall Study|Withdrew Consent|3|||
161043175|NCT00403494|581549978|FG001|Overall Study|Withdrew Consent|2|||
161043176|NCT00403494|581549977|FG000|Overall Study|Inappropriately enrolled|0|||
161043177|NCT00403494|581549978|FG001|Overall Study|Inappropriately enrolled|1|||
161043178|NCT00403494|581549977|FG000|Overall Study|Lost to Follow-up|0|||
161043179|NCT00403494|581549978|FG001|Overall Study|Lost to Follow-up|2|||
161344831|NCT00689936|582648800|FG002|Active Treatment Phase|Study Close Out|21|||
161043180|NCT00403494|581549977|FG000|Overall Study|Protocol noncompliance|0|||
161043181|NCT00403494|581549978|FG001|Overall Study|Protocol noncompliance|1|||
161043182|NCT00403494|581549977|FG000|Overall Study|Death|1|||
161043183|NCT00403494|581549978|FG001|Overall Study|Death|0|||
161043184|NCT00403494|581549977|FG000|Overall Study|Sponsor Request|1|||
161043185|NCT00403494|581549978|FG001|Overall Study|Sponsor Request|0|||
161344832|NCT00689936|582648798|FG000|Active Treatment Phase|Miscellaneous|52|||
161280629|NCT02924727|582406989|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
161280630|NCT00338728|582406990|FG000|Overall Study|Screen Failure|14|||
161280631|NCT04380961|582406995|FG000|Overall Study|Lost to Follow-up|17|||
161280632|NCT04380961|582406996|FG001|Overall Study|Lost to Follow-up|11|||
161280633|NCT04380961|582406995|FG000|Overall Study|Withdrawal by Subject|3|||
161280634|NCT04380961|582406996|FG001|Overall Study|Withdrawal by Subject|0|||
161280635|NCT04380961|582406995|FG000|Overall Study|Death|22|||
161043186|NCT05005247|581549979|FG000|Overall Study|Withdrawal by Subject|0|||
161043187|NCT05005247|581549980|FG001|Overall Study|Withdrawal by Subject|1|||
161043188|NCT05005247|581549981|FG002|Overall Study|Withdrawal by Subject|0|||
161043189|NCT03490032|581549984|FG000|Overall Study|family issue (child custody)|1|||
161043190|NCT03490032|581549985|FG001|Overall Study|family issue (child custody)|0|||
161043191|NCT03490032|581549986|FG002|Overall Study|family issue (child custody)|0|||
161043192|NCT00308308|581549987|FG000|Overall Study|Adverse Event|17|||
161043193|NCT00308308|581549988|FG001|Overall Study|Adverse Event|2|||
161043194|NCT00308308|581549987|FG000|Overall Study|Lost to Follow-up|5|||
161043195|NCT00308308|581549988|FG001|Overall Study|Lost to Follow-up|5|||
161043196|NCT00308308|581549987|FG000|Overall Study|Physician Decision|15|||
161043197|NCT00308308|581549988|FG001|Overall Study|Physician Decision|7|||
161043198|NCT00308308|581549987|FG000|Overall Study|Protocol Violation|3|||
161043199|NCT00308308|581549988|FG001|Overall Study|Protocol Violation|14|||
161043200|NCT00308308|581549987|FG000|Overall Study|Withdrawal by Subject|47|||
161043201|NCT00308308|581549988|FG001|Overall Study|Withdrawal by Subject|19|||
161043202|NCT00308308|581549987|FG000|Overall Study|Various|7|||
161043203|NCT00308308|581549988|FG001|Overall Study|Various|5|||
161043204|NCT00308308|581549987|FG000|Overall Study|Randomized but not dosed|8|||
161043205|NCT00308308|581549988|FG001|Overall Study|Randomized but not dosed|16|||
161043206|NCT00308308|581549987|FG000|Overall Study|Other|1|||
161043207|NCT00308308|581549988|FG001|Overall Study|Other|0|||
161043208|NCT01951703|581549991|FG000|First Intervention|Withdrawal by Subject|1|||
161043209|NCT01951703|581549992|FG001|First Intervention|Withdrawal by Subject|0|||
161043210|NCT01951703|581549991|FG000|First Intervention|Subject was not compliant|1|||
161043211|NCT01951703|581549992|FG001|First Intervention|Subject was not compliant|1|||
161043212|NCT01951703|581549991|FG000|First Intervention|Physician Decision|1|||
161043213|NCT01951703|581549992|FG001|First Intervention|Physician Decision|0|||
161043214|NCT01951703|581549991|FG000|Second Intervention|Protocol Violation|0|||
161043215|NCT01951703|581549992|FG001|Second Intervention|Protocol Violation|1|||
161043216|NCT01951703|581549991|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
161043217|NCT01951703|581549992|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
161043218|NCT01852045|581549993|FG000|Overall Study|Adverse Event|1|||
161043219|NCT01852045|581549994|FG001|Overall Study|Adverse Event|0|||
161043220|NCT01852045|581549995|FG002|Overall Study|Adverse Event|0|||
161043221|NCT01852045|581549993|FG000|Overall Study|Lack of Efficacy|3|||
161043222|NCT01852045|581549994|FG001|Overall Study|Lack of Efficacy|0|||
161043223|NCT01852045|581549995|FG002|Overall Study|Lack of Efficacy|0|||
161043224|NCT01852045|581549993|FG000|Overall Study|Lost to Follow-up|0|||
161043225|NCT01852045|581549994|FG001|Overall Study|Lost to Follow-up|1|||
161043226|NCT01852045|581549995|FG002|Overall Study|Lost to Follow-up|1|||
161043227|NCT01852045|581549993|FG000|Overall Study|Withdrawal by Subject|1|||
161043228|NCT01852045|581549994|FG001|Overall Study|Withdrawal by Subject|0|||
161043229|NCT01852045|581549995|FG002|Overall Study|Withdrawal by Subject|1|||
161043230|NCT01852045|581549993|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161043231|NCT01852045|581549994|FG001|Overall Study|Other Miscellaneous Reasons|3|||
161043232|NCT01852045|581549995|FG002|Overall Study|Other Miscellaneous Reasons|2|||
161043233|NCT02827201|581549996|FG000|Overall Study|Death|1|||
161043234|NCT02827201|581549997|FG001|Overall Study|Death|2|||
161043235|NCT02827201|581549996|FG000|Overall Study|Patients not treated|1|||
161043236|NCT02827201|581549997|FG001|Overall Study|Patients not treated|1|||
161043237|NCT01021748|581549998|FG000|Overall Study|Adverse Event|2|||
161043238|NCT01021748|581549999|FG001|Overall Study|Adverse Event|1|||
161043239|NCT01021748|581550000|FG002|Overall Study|Adverse Event|2|||
161043240|NCT01021748|581550001|FG003|Overall Study|Adverse Event|0|||
161043241|NCT01021748|581550002|FG004|Overall Study|Adverse Event|2|||
161043242|NCT01021748|581550003|FG005|Overall Study|Adverse Event|0|||
161149277|NCT01469013|581927830|FG009|Part A (Treatment Period)|Adverse Event|0|||
161280636|NCT04380961|582406996|FG001|Overall Study|Death|16|||
161344833|NCT00689936|582648799|FG001|Active Treatment Phase|Miscellaneous|34|||
161344834|NCT00689936|582648800|FG002|Active Treatment Phase|Miscellaneous|47|||
161344835|NCT00689936|582648798|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
161344836|NCT00689936|582648799|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
161043243|NCT01021748|581550004|FG006|Overall Study|Adverse Event|1|||
161043244|NCT01021748|581550005|FG007|Overall Study|Adverse Event|0|||
161149278|NCT01469013|581927831|FG010|Part A (Treatment Period)|Adverse Event|0|||
161043245|NCT01021748|581550006|FG008|Overall Study|Adverse Event|7|||
161043246|NCT01021748|581549998|FG000|Overall Study|Physician Decision|1|||
161043247|NCT01021748|581549999|FG001|Overall Study|Physician Decision|0|||
161043248|NCT01021748|581550000|FG002|Overall Study|Physician Decision|1|||
161280637|NCT04380961|582406995|FG000|Overall Study|Other|1|||
161043249|NCT01021748|581550001|FG003|Overall Study|Physician Decision|1|||
161043250|NCT01021748|581550002|FG004|Overall Study|Physician Decision|0|||
161043251|NCT01021748|581550003|FG005|Overall Study|Physician Decision|0|||
161043252|NCT01021748|581550004|FG006|Overall Study|Physician Decision|1|||
161043253|NCT01021748|581550005|FG007|Overall Study|Physician Decision|1|||
161043254|NCT01021748|581550006|FG008|Overall Study|Physician Decision|2|||
161043255|NCT01021748|581549998|FG000|Overall Study|Progressive Disease|3|||
161043256|NCT01021748|581549999|FG001|Overall Study|Progressive Disease|3|||
161043257|NCT01021748|581550000|FG002|Overall Study|Progressive Disease|4|||
161043258|NCT01021748|581550001|FG003|Overall Study|Progressive Disease|6|||
161043259|NCT01021748|581550002|FG004|Overall Study|Progressive Disease|7|||
161043260|NCT01021748|581550003|FG005|Overall Study|Progressive Disease|3|||
161043261|NCT01021748|581550004|FG006|Overall Study|Progressive Disease|0|||
161043262|NCT01021748|581550005|FG007|Overall Study|Progressive Disease|5|||
161043263|NCT01021748|581550006|FG008|Overall Study|Progressive Disease|6|||
161043264|NCT01021748|581549998|FG000|Overall Study|Withdrawal by Subject|0|||
161043265|NCT01021748|581549999|FG001|Overall Study|Withdrawal by Subject|0|||
161043266|NCT01021748|581550000|FG002|Overall Study|Withdrawal by Subject|0|||
161043267|NCT01021748|581550001|FG003|Overall Study|Withdrawal by Subject|0|||
161043268|NCT01021748|581550002|FG004|Overall Study|Withdrawal by Subject|0|||
161043269|NCT01021748|581550003|FG005|Overall Study|Withdrawal by Subject|0|||
161043270|NCT01021748|581550004|FG006|Overall Study|Withdrawal by Subject|1|||
161043271|NCT01021748|581550005|FG007|Overall Study|Withdrawal by Subject|0|||
161043272|NCT01021748|581550006|FG008|Overall Study|Withdrawal by Subject|1|||
161043273|NCT01021748|581549998|FG000|Overall Study|Not Treated|0|||
161043274|NCT01021748|581549999|FG001|Overall Study|Not Treated|1|||
161043275|NCT01021748|581550000|FG002|Overall Study|Not Treated|0|||
161043276|NCT01021748|581550001|FG003|Overall Study|Not Treated|0|||
161043277|NCT01021748|581550002|FG004|Overall Study|Not Treated|0|||
161043278|NCT01021748|581550003|FG005|Overall Study|Not Treated|0|||
161043279|NCT01021748|581550004|FG006|Overall Study|Not Treated|0|||
161043280|NCT01021748|581550005|FG007|Overall Study|Not Treated|0|||
161043281|NCT01021748|581550006|FG008|Overall Study|Not Treated|0|||
161043282|NCT01640288|581550009|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
161043283|NCT01640288|581550010|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
161043284|NCT01640288|581550009|FG000|Overall Study|Screen Failure|20|||
161043285|NCT01640288|581550010|FG001|Overall Study|Screen Failure|18|||
161043286|NCT01640288|581550009|FG000|Overall Study|Withdrawn by PI|5|||
161043287|NCT01640288|581550010|FG001|Overall Study|Withdrawn by PI|0|||
161043288|NCT01640288|581550009|FG000|Overall Study|Withdrawal by Subject|1|||
161043289|NCT01640288|581550010|FG001|Overall Study|Withdrawal by Subject|0|||
161043290|NCT01485887|581550011|FG000|Overall Study|Withdrawal by Subject|2|||
161043291|NCT01485887|581550011|FG000|Overall Study|Adverse Event|8|||
161043292|NCT01485887|581550011|FG000|Overall Study|Deterioration of primary disease|1|||
161043293|NCT01485887|581550011|FG000|Overall Study|Primary disease markedly improved|1|||
161043294|NCT02234141|581550012|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
161043295|NCT02234141|581550013|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
161043296|NCT02234141|581550014|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
161043297|NCT02234141|581550015|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
161043298|NCT02234141|581550016|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
161043299|NCT02234141|581550017|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
161043300|NCT02234141|581550018|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
161043301|NCT02234141|581550012|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161043302|NCT02234141|581550013|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
161043303|NCT02234141|581550014|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161043304|NCT02234141|581550015|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161043305|NCT02234141|581550016|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161043306|NCT02234141|581550017|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161043307|NCT02234141|581550018|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
161043308|NCT02234141|581550012|FG000|Treatment Period (24 Weeks)|Death|1|||
161043309|NCT02234141|581550013|FG001|Treatment Period (24 Weeks)|Death|2|||
161043310|NCT02234141|581550014|FG002|Treatment Period (24 Weeks)|Death|0|||
161043311|NCT02234141|581550015|FG003|Treatment Period (24 Weeks)|Death|1|||
161043312|NCT02234141|581550016|FG004|Treatment Period (24 Weeks)|Death|0|||
161043313|NCT02234141|581550017|FG005|Treatment Period (24 Weeks)|Death|0|||
161043314|NCT02234141|581550018|FG006|Treatment Period (24 Weeks)|Death|0|||
161043315|NCT02234141|581550012|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
161043316|NCT02234141|581550013|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
161043317|NCT02234141|581550014|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
161043318|NCT02234141|581550015|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
161149279|NCT01469013|581927832|FG011|Part A (Treatment Period)|Adverse Event|0|||
161149280|NCT01469013|581927833|FG012|Part A (Treatment Period)|Adverse Event|0|||
161280638|NCT04380961|582406996|FG001|Overall Study|Other|0|||
161280639|NCT04380961|582406995|FG000|Overall Study|Randomized but Not Treated|1|||
161043319|NCT02234141|581550016|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
161043320|NCT02234141|581550017|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
161149281|NCT01469013|581927821|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
161043321|NCT02234141|581550018|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
161043322|NCT02234141|581550012|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161043323|NCT02234141|581550013|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
161043324|NCT02234141|581550014|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161043325|NCT02234141|581550015|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161043326|NCT02234141|581550016|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161043327|NCT02234141|581550017|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161043328|NCT02234141|581550018|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
161043329|NCT02234141|581550012|FG000|Long-Term Treatment Period|Death|0|||
161043330|NCT02234141|581550013|FG001|Long-Term Treatment Period|Death|0|||
161043331|NCT02234141|581550014|FG002|Long-Term Treatment Period|Death|0|||
161043332|NCT02234141|581550015|FG003|Long-Term Treatment Period|Death|0|||
161043333|NCT02234141|581550016|FG004|Long-Term Treatment Period|Death|0|||
161043334|NCT02234141|581550017|FG005|Long-Term Treatment Period|Death|1|||
161043335|NCT02234141|581550018|FG006|Long-Term Treatment Period|Death|0|||
161043336|NCT02234141|581550012|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
161043337|NCT02234141|581550013|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
161043338|NCT02234141|581550014|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
161043339|NCT02234141|581550015|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
161043340|NCT02234141|581550016|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
161043341|NCT02234141|581550017|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
161043342|NCT02234141|581550018|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
161043343|NCT02234141|581550012|FG000|Long-Term Treatment Period|Adverse Event|4|||
161043344|NCT02234141|581550013|FG001|Long-Term Treatment Period|Adverse Event|0|||
161043345|NCT02234141|581550014|FG002|Long-Term Treatment Period|Adverse Event|5|||
161043346|NCT02234141|581550015|FG003|Long-Term Treatment Period|Adverse Event|0|||
161043347|NCT02234141|581550016|FG004|Long-Term Treatment Period|Adverse Event|1|||
161043348|NCT02234141|581550017|FG005|Long-Term Treatment Period|Adverse Event|1|||
161043349|NCT02234141|581550018|FG006|Long-Term Treatment Period|Adverse Event|1|||
161043350|NCT02234141|581550012|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
161043351|NCT02234141|581550013|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
161043352|NCT02234141|581550014|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
161043353|NCT02234141|581550015|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
161043354|NCT02234141|581550016|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
161043355|NCT02234141|581550017|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
161043356|NCT02234141|581550018|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
161043357|NCT02234141|581550012|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
161043358|NCT02234141|581550013|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
161043359|NCT02234141|581550014|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
161043360|NCT02234141|581550015|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
161043361|NCT02234141|581550016|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
161043362|NCT02234141|581550017|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
161043363|NCT02234141|581550018|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
161043364|NCT00895245|581550019|FG000|Overall Study|Lack of Efficacy|6|||
161043365|NCT02095678|581550020|FG000|Overall Study|Withdrawal by Subject|0|||
161043366|NCT02095678|581550021|FG001|Overall Study|Withdrawal by Subject|1|||
161043367|NCT02095678|581550020|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
161043368|NCT02095678|581550021|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
161043369|NCT02095678|581550020|FG000|Overall Study|lesion impacted by previous treatment|1|||
161043370|NCT02095678|581550021|FG001|Overall Study|lesion impacted by previous treatment|1|||
161280640|NCT04380961|582406996|FG001|Overall Study|Randomized but Not Treated|2|||
161280641|NCT04803305|582406997|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
161280642|NCT04803305|582406998|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
161280643|NCT04803305|582406997|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
161280644|NCT04803305|582406998|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
161280645|NCT04803305|582406997|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
161280646|NCT04803305|582406998|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
161280647|NCT04803305|582406997|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
161043371|NCT02095678|581550020|FG000|Overall Study|No Confirmed Diagnosis|0|||
161043372|NCT02095678|581550021|FG001|Overall Study|No Confirmed Diagnosis|3|||
161043373|NCT02095678|581550020|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
161043374|NCT02095678|581550021|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
161043375|NCT02095678|581550020|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
161043376|NCT02095678|581550021|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
161043377|NCT03418545|581550022|FG000|Overall Study|Withdrawal by Participant|2|||
161043378|NCT03418545|581550023|FG001|Overall Study|Withdrawal by Participant|4|||
161043379|NCT03418545|581550022|FG000|Overall Study|Lost to Follow-up|3|||
161043380|NCT03418545|581550023|FG001|Overall Study|Lost to Follow-up|5|||
161280648|NCT04803305|582406998|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
161043381|NCT03418545|581550022|FG000|Overall Study|Reason Not Specified|0|||
161043382|NCT03418545|581550023|FG001|Overall Study|Reason Not Specified|1|||
161043383|NCT03418545|581550022|FG000|Overall Study|Missing Completion Status|0|||
161043384|NCT03418545|581550023|FG001|Overall Study|Missing Completion Status|1|||
161043385|NCT02706483|581550024|FG000|Overall Study|Adverse Event|97|||
161043386|NCT02706483|581550024|FG000|Overall Study|Death|1|||
161043387|NCT02706483|581550024|FG000|Overall Study|Lack of Efficacy|39|||
161043388|NCT02706483|581550024|FG000|Overall Study|Lost to Follow-up|101|||
161043389|NCT02706483|581550024|FG000|Overall Study|Non-compliance with study drug|15|||
161043390|NCT02706483|581550024|FG000|Overall Study|Physician Decision|6|||
161043391|NCT02706483|581550024|FG000|Overall Study|Pregnancy|6|||
161043392|NCT02706483|581550024|FG000|Overall Study|Protocol Violation|18|||
161043393|NCT02706483|581550024|FG000|Overall Study|Withdrawal by Subject|136|||
161043394|NCT02706483|581550024|FG000|Overall Study|Non-compliance with visits|6|||
161043395|NCT02706483|581550024|FG000|Overall Study|Site closure|4|||
161043396|NCT02706483|581550024|FG000|Overall Study|Subject moved|1|||
161043397|NCT04660799|581550025|FG000|Overall Study|Progressive Disease|1|||
161043398|NCT04660799|581550026|FG001|Overall Study|Progressive Disease|1|||
161043399|NCT04660799|581550025|FG000|Overall Study|Death|2|||
161043400|NCT04660799|581550026|FG001|Overall Study|Death|1|||
161043401|NCT04660799|581550025|FG000|Overall Study|Adverse Event|2|||
161043402|NCT04660799|581550026|FG001|Overall Study|Adverse Event|1|||
161043403|NCT04660799|581550025|FG000|Overall Study|Withdrawal by Subject|2|||
161043404|NCT04660799|581550026|FG001|Overall Study|Withdrawal by Subject|5|||
161043405|NCT03131713|581550029|FG000|Overall Study|Lost to Follow-up|5|||
161043406|NCT03131713|581550030|FG001|Overall Study|Lost to Follow-up|0|||
161043407|NCT01972776|581550031|FG000|Part 1|Withdrawal by Subject|0|||
161043408|NCT01972776|581550032|FG001|Part 1|Withdrawal by Subject|0|||
161043409|NCT01972776|581550033|FG002|Part 1|Withdrawal by Subject|1|||
161043410|NCT01972776|581550034|FG003|Part 1|Withdrawal by Subject|0|||
161043411|NCT01972776|581550035|FG004|Part 1|Withdrawal by Subject|0|||
161043412|NCT01972776|581550036|FG005|Part 1|Withdrawal by Subject|0|||
161043413|NCT01972776|581550031|FG000|Part 1|Adverse Event|0|||
161043414|NCT01972776|581550032|FG001|Part 1|Adverse Event|0|||
161043415|NCT01972776|581550033|FG002|Part 1|Adverse Event|1|||
161043416|NCT01972776|581550034|FG003|Part 1|Adverse Event|1|||
161043417|NCT01972776|581550035|FG004|Part 1|Adverse Event|0|||
161043418|NCT01972776|581550036|FG005|Part 1|Adverse Event|0|||
161043419|NCT01972776|581550031|FG000|Part 2|Adverse Event|0|||
161043420|NCT01972776|581550032|FG001|Part 2|Adverse Event|0|||
161043421|NCT01972776|581550033|FG002|Part 2|Adverse Event|0|||
161043422|NCT01972776|581550034|FG003|Part 2|Adverse Event|0|||
161043423|NCT01972776|581550035|FG004|Part 2|Adverse Event|3|||
161043424|NCT01972776|581550036|FG005|Part 2|Adverse Event|0|||
161043425|NCT01972776|581550031|FG000|Part 2|Administrative problems|0|||
161043426|NCT01972776|581550032|FG001|Part 2|Administrative problems|0|||
161043427|NCT01972776|581550033|FG002|Part 2|Administrative problems|0|||
161043428|NCT01972776|581550034|FG003|Part 2|Administrative problems|0|||
161043429|NCT01972776|581550035|FG004|Part 2|Administrative problems|10|||
161043430|NCT01972776|581550036|FG005|Part 2|Administrative problems|7|||
161043431|NCT01228734|581550040|FG000|Overall Study|Randomized, but not treated|0|||
161043432|NCT01228734|581550041|FG001|Overall Study|Randomized, but not treated|4|||
161043433|NCT02382640|581550045|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
161043434|NCT02382640|581550046|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
161043435|NCT02382640|581550047|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
161043436|NCT02382640|581550048|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
161043437|NCT01220999|581550049|FG000|Overall Study|Progressive disease|0|||
161043438|NCT01220999|581550050|FG001|Overall Study|Progressive disease|0|||
161043439|NCT01220999|581550051|FG002|Overall Study|Progressive disease|1|||
161043440|NCT01220999|581550052|FG003|Overall Study|Progressive disease|0|||
161043441|NCT01220999|581550053|FG004|Overall Study|Progressive disease|0|||
161043442|NCT01560429|581550056|FG000|Overall Study|Protocol Violation|3|||
161344837|NCT00689936|582648800|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
161043443|NCT01560429|581550057|FG001|Overall Study|Protocol Violation|6|||
161043444|NCT02449902|581550058|FG000|Overall Study|Adverse Event|0|||
161043445|NCT02449902|581550059|FG001|Overall Study|Adverse Event|1|||
161043446|NCT02449902|581550058|FG000|Overall Study|Withdrawal by Subject|0|||
161043447|NCT02449902|581550059|FG001|Overall Study|Withdrawal by Subject|1|||
161043448|NCT01365546|581550060|FG000|Overall Study|Withdrawal by Subject|1|||
161043449|NCT01365546|581550060|FG000|Overall Study|Screen failure|9|||
161043450|NCT01365546|581550060|FG000|Overall Study|Study termination|1|||
161043451|NCT03326856|581550061|FG000|Overall Study|Lost to Follow-up|1|||
161043452|NCT03326856|581550062|FG001|Overall Study|Lost to Follow-up|1|||
161043453|NCT03326856|581550063|FG002|Overall Study|Lost to Follow-up|0|||
161043454|NCT03326856|581550064|FG003|Overall Study|Lost to Follow-up|0|||
161043455|NCT03326856|581550065|FG004|Overall Study|Lost to Follow-up|0|||
161043456|NCT03162614|581550066|FG000|Overall Study|Lost to Follow-up|2|||
161043457|NCT03162614|581550067|FG001|Overall Study|Lost to Follow-up|1|||
161043458|NCT03162614|581550068|FG002|Overall Study|Lost to Follow-up|1|||
161043459|NCT03162614|581550069|FG003|Overall Study|Lost to Follow-up|1|||
161043460|NCT03162614|581550070|FG004|Overall Study|Lost to Follow-up|2|||
161043461|NCT03162614|581550071|FG005|Overall Study|Lost to Follow-up|0|||
161043462|NCT03162614|581550066|FG000|Overall Study|Protocol Violation|0|||
161043463|NCT03162614|581550067|FG001|Overall Study|Protocol Violation|1|||
161043464|NCT03162614|581550068|FG002|Overall Study|Protocol Violation|0|||
161043465|NCT03162614|581550069|FG003|Overall Study|Protocol Violation|1|||
161043466|NCT03162614|581550070|FG004|Overall Study|Protocol Violation|0|||
161043467|NCT03162614|581550071|FG005|Overall Study|Protocol Violation|0|||
161043468|NCT03162614|581550066|FG000|Overall Study|Withdrawal by Subject|2|||
161043469|NCT03162614|581550067|FG001|Overall Study|Withdrawal by Subject|1|||
161043470|NCT03162614|581550068|FG002|Overall Study|Withdrawal by Subject|1|||
161043471|NCT03162614|581550069|FG003|Overall Study|Withdrawal by Subject|1|||
161043472|NCT03162614|581550070|FG004|Overall Study|Withdrawal by Subject|0|||
161043473|NCT03162614|581550071|FG005|Overall Study|Withdrawal by Subject|0|||
161043474|NCT03162614|581550066|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
161043475|NCT03162614|581550067|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
161043476|NCT03162614|581550068|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
161043477|NCT03162614|581550069|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
161043478|NCT03162614|581550070|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
161043479|NCT03162614|581550071|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
161043480|NCT03861234|581550072|FG000|Overall Study|Not treated|0|||
161043481|NCT03861234|581550073|FG001|Overall Study|Not treated|0|||
161043482|NCT03861234|581550074|FG002|Overall Study|Not treated|0|||
161043483|NCT03861234|581550075|FG003|Overall Study|Not treated|0|||
161043484|NCT03861234|581550076|FG004|Overall Study|Not treated|0|||
161043485|NCT03861234|581550077|FG005|Overall Study|Not treated|1|||
161043486|NCT03861234|581550078|FG006|Overall Study|Not treated|0|||
161043487|NCT03861234|581550079|FG007|Overall Study|Not treated|0|||
161043488|NCT03861234|581550072|FG000|Overall Study|Adverse Event|0|||
161043489|NCT03861234|581550073|FG001|Overall Study|Adverse Event|0|||
161043490|NCT03861234|581550074|FG002|Overall Study|Adverse Event|0|||
161043491|NCT03861234|581550075|FG003|Overall Study|Adverse Event|0|||
161043492|NCT03861234|581550076|FG004|Overall Study|Adverse Event|0|||
161043493|NCT03861234|581550077|FG005|Overall Study|Adverse Event|1|||
161043494|NCT03861234|581550078|FG006|Overall Study|Adverse Event|0|||
161043495|NCT03861234|581550079|FG007|Overall Study|Adverse Event|0|||
161043496|NCT03861234|581550072|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
161043497|NCT03861234|581550073|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
161043498|NCT03861234|581550074|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
161043499|NCT03861234|581550075|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
161043500|NCT03861234|581550076|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
161043501|NCT03861234|581550077|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
161043502|NCT03861234|581550078|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
161043503|NCT03861234|581550079|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
161043504|NCT03861234|581550072|FG000|Overall Study|As per sponsor decision|0|||
161043505|NCT03861234|581550073|FG001|Overall Study|As per sponsor decision|0|||
161043506|NCT03861234|581550074|FG002|Overall Study|As per sponsor decision|0|||
161043507|NCT03861234|581550075|FG003|Overall Study|As per sponsor decision|0|||
161043508|NCT03861234|581550076|FG004|Overall Study|As per sponsor decision|0|||
161043509|NCT03861234|581550077|FG005|Overall Study|As per sponsor decision|0|||
161043510|NCT03861234|581550078|FG006|Overall Study|As per sponsor decision|1|||
161043511|NCT03861234|581550079|FG007|Overall Study|As per sponsor decision|0|||
161043512|NCT03861234|581550072|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
161043513|NCT03861234|581550073|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
161043514|NCT03861234|581550074|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
161043515|NCT03861234|581550075|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
161043516|NCT03861234|581550076|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
161043517|NCT03861234|581550077|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
161043518|NCT03861234|581550078|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
161043519|NCT03861234|581550079|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
161043520|NCT00621842|581550080|FG000|Overall Study|Adverse Event|6|||
161043521|NCT00621842|581550080|FG000|Overall Study|Withdrawal by Subject|7|||
161149282|NCT01469013|581927822|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149283|NCT01469013|581927823|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
161344838|NCT06001866|582648807|FG000|Overall Study|Withdrawal by Subject|0|||
161043522|NCT00621842|581550080|FG000|Overall Study|Protocol Violation|4|||
161043523|NCT00621842|581550080|FG000|Overall Study|Lack of Efficacy|2|||
161149284|NCT01469013|581927824|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
161043524|NCT01074242|581550083|FG000|Overall Study|Case report before date of contract|40|||
161043525|NCT01074242|581550083|FG000|Overall Study|Lost to Follow-up|1|||
161043526|NCT01074242|581550083|FG000|Overall Study|Case report unclear|6|||
161043527|NCT01074242|581550083|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
161344839|NCT06001866|582648808|FG001|Overall Study|Withdrawal by Subject|2|||
161043528|NCT01074242|581550083|FG000|Overall Study|Duplicate Case Report Form|5|||
161043529|NCT01957163|581550084|FG000|Overall Study|Adverse Event|5|||
161043530|NCT01957163|581550085|FG001|Overall Study|Adverse Event|2|||
161043531|NCT01957163|581550086|FG002|Overall Study|Adverse Event|4|||
161043532|NCT01957163|581550084|FG000|Overall Study|Lack of Efficacy|5|||
161043533|NCT01957163|581550085|FG001|Overall Study|Lack of Efficacy|4|||
161043534|NCT01957163|581550086|FG002|Overall Study|Lack of Efficacy|9|||
161043535|NCT01957163|581550084|FG000|Overall Study|Protocol Violation|1|||
161043536|NCT01957163|581550085|FG001|Overall Study|Protocol Violation|2|||
161043537|NCT01957163|581550086|FG002|Overall Study|Protocol Violation|0|||
161043538|NCT01957163|581550084|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
161043539|NCT01957163|581550085|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
161043540|NCT01957163|581550086|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
161043541|NCT01957163|581550084|FG000|Overall Study|Lost to Follow-up|0|||
161043542|NCT01957163|581550085|FG001|Overall Study|Lost to Follow-up|1|||
161043543|NCT01957163|581550086|FG002|Overall Study|Lost to Follow-up|0|||
161043544|NCT01957163|581550084|FG000|Overall Study|Withdrawal by Subject|4|||
161043545|NCT01957163|581550085|FG001|Overall Study|Withdrawal by Subject|2|||
161043546|NCT01957163|581550086|FG002|Overall Study|Withdrawal by Subject|4|||
161043547|NCT03539055|581550087|FG000|Overall Study|Death|4|||
161043548|NCT03539055|581550087|FG000|Overall Study|Lost to Follow-up|1|||
161043549|NCT03539055|581550087|FG000|Overall Study|Withdrawal by Subject|2|||
161043550|NCT03539055|581550087|FG000|Overall Study|Screen Fail|7|||
161043551|NCT03539055|581550087|FG000|Overall Study|Drug Intolerance|2|||
161043552|NCT01638000|581550089|FG000|Overall Study|Randomized but Never Received Drug|7|||
161043553|NCT01638000|581550090|FG001|Overall Study|Randomized but Never Received Drug|10|||
161043554|NCT01638000|581550089|FG000|Overall Study|Adverse Event|14|||
161043555|NCT01638000|581550090|FG001|Overall Study|Adverse Event|16|||
161043556|NCT01638000|581550089|FG000|Overall Study|Lack of Efficacy|5|||
161043557|NCT01638000|581550090|FG001|Overall Study|Lack of Efficacy|6|||
161043558|NCT01638000|581550089|FG000|Overall Study|Protocol Violation|11|||
161043559|NCT01638000|581550090|FG001|Overall Study|Protocol Violation|13|||
161043560|NCT01638000|581550089|FG000|Overall Study|Withdrawal by Subject|21|||
161043561|NCT01638000|581550090|FG001|Overall Study|Withdrawal by Subject|24|||
161043562|NCT01638000|581550089|FG000|Overall Study|Miscellaneous|2|||
161043563|NCT01638000|581550090|FG001|Overall Study|Miscellaneous|2|||
161043564|NCT00875706|581550091|FG000|Overall Study|Withdrawal by Subject|1|||
161043565|NCT00875706|581550092|FG001|Overall Study|Withdrawal by Subject|0|||
161043566|NCT00875706|581550093|FG002|Overall Study|Withdrawal by Subject|0|||
161043567|NCT03775213|581550094|FG000|Overall Study|Withdrawal by Subject|51|||
161043568|NCT03775213|581550095|FG001|Overall Study|Withdrawal by Subject|53|||
161043569|NCT03775213|581550094|FG000|Overall Study|Incomplete Survey|7|||
161043570|NCT03775213|581550095|FG001|Overall Study|Incomplete Survey|7|||
161043571|NCT00786188|581550096|FG000|Overall Study|Adverse Event|3|||
161043572|NCT00786188|581550097|FG001|Overall Study|Adverse Event|1|||
161043573|NCT00786188|581550096|FG000|Overall Study|Withdrawal by Subject|2|||
161043574|NCT00786188|581550097|FG001|Overall Study|Withdrawal by Subject|0|||
161043575|NCT00326183|581550098|FG000|Overall Study|Lost to Follow-up|104|||
161043576|NCT00326183|581550099|FG001|Overall Study|Lost to Follow-up|56|||
161043577|NCT00326183|581550098|FG000|Overall Study|Protocol Violation|6|||
161043578|NCT00326183|581550099|FG001|Overall Study|Protocol Violation|3|||
161043579|NCT00326183|581550098|FG000|Overall Study|Withdrawal by Subject|35|||
161043580|NCT00326183|581550099|FG001|Overall Study|Withdrawal by Subject|7|||
161043581|NCT00326183|581550098|FG000|Overall Study|Subject Moved|7|||
161043582|NCT00326183|581550099|FG001|Overall Study|Subject Moved|4|||
161043583|NCT00326183|581550098|FG000|Overall Study|Other|47|||
161043584|NCT00326183|581550099|FG001|Overall Study|Other|13|||
161043585|NCT00326183|581550098|FG000|Overall Study|Adverse Event|1|||
161043586|NCT00326183|581550099|FG001|Overall Study|Adverse Event|0|||
161043587|NCT01827839|581550103|FG000|Overall Study|Adverse Event|1|||
161043588|NCT01827839|581550103|FG000|Overall Study|Consent Withdrawal|2|||
161043589|NCT00570505|581550104|FG000|Overall Study|Adverse Event|7|||
161043590|NCT00570505|581550104|FG000|Overall Study|Withdrawal by Subject|7|||
161043591|NCT00570505|581550104|FG000|Overall Study|Lost to Follow-up|23|||
161043592|NCT00570505|581550104|FG000|Overall Study|Other loss to follow-up|4|||
161043593|NCT00614614|581550105|FG000|Primary Vaccination Phase|Adverse Event|6|||
161043594|NCT00614614|581550106|FG001|Primary Vaccination Phase|Adverse Event|0|||
161043595|NCT00614614|581550107|FG002|Primary Vaccination Phase|Adverse Event|0|||
161043596|NCT00614614|581550108|FG003|Primary Vaccination Phase|Adverse Event|0|||
161043597|NCT00614614|581550109|FG004|Primary Vaccination Phase|Adverse Event|0|||
161043598|NCT00614614|581550105|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
161043599|NCT00614614|581550106|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
161043600|NCT00614614|581550107|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
161043601|NCT00614614|581550108|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
161043602|NCT00614614|581550109|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
161043603|NCT00614614|581550105|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
161043604|NCT00614614|581550106|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
161043605|NCT00614614|581550107|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
161043606|NCT00614614|581550108|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
161043607|NCT00614614|581550109|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
161043608|NCT00614614|581550105|FG000|Primary Vaccination Phase|Protocol Violation|9|||
161043609|NCT00614614|581550106|FG001|Primary Vaccination Phase|Protocol Violation|3|||
161043610|NCT00614614|581550107|FG002|Primary Vaccination Phase|Protocol Violation|0|||
161043611|NCT00614614|581550108|FG003|Primary Vaccination Phase|Protocol Violation|0|||
161043612|NCT00614614|581550109|FG004|Primary Vaccination Phase|Protocol Violation|0|||
161043613|NCT00614614|581550105|FG000|Primary Vaccination Phase|Other|4|||
161043614|NCT00614614|581550106|FG001|Primary Vaccination Phase|Other|0|||
161043615|NCT00614614|581550107|FG002|Primary Vaccination Phase|Other|0|||
161043616|NCT00614614|581550108|FG003|Primary Vaccination Phase|Other|0|||
161043617|NCT00614614|581550109|FG004|Primary Vaccination Phase|Other|0|||
161043618|NCT00614614|581550105|FG000|Booster Vaccination Phase|Adverse Event|0|||
161043619|NCT00614614|581550106|FG001|Booster Vaccination Phase|Adverse Event|0|||
161043620|NCT00614614|581550107|FG002|Booster Vaccination Phase|Adverse Event|1|||
161043621|NCT00614614|581550108|FG003|Booster Vaccination Phase|Adverse Event|1|||
161043622|NCT00614614|581550109|FG004|Booster Vaccination Phase|Adverse Event|0|||
161043623|NCT00614614|581550105|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
161043624|NCT00614614|581550106|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
161043625|NCT00614614|581550107|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
161043626|NCT00614614|581550108|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
161043627|NCT00614614|581550109|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
161043628|NCT00614614|581550105|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
161043629|NCT00614614|581550106|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
161043630|NCT00614614|581550107|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
161043631|NCT00614614|581550108|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
161043632|NCT00614614|581550109|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
161043633|NCT00614614|581550105|FG000|Booster Vaccination Phase|Protocol Violation|0|||
161043634|NCT00614614|581550106|FG001|Booster Vaccination Phase|Protocol Violation|0|||
161043635|NCT00614614|581550107|FG002|Booster Vaccination Phase|Protocol Violation|2|||
161043636|NCT00614614|581550108|FG003|Booster Vaccination Phase|Protocol Violation|3|||
161043637|NCT00614614|581550109|FG004|Booster Vaccination Phase|Protocol Violation|0|||
161043638|NCT00614614|581550105|FG000|Booster Vaccination Phase|Other|0|||
161043639|NCT00614614|581550106|FG001|Booster Vaccination Phase|Other|1|||
161043640|NCT00614614|581550107|FG002|Booster Vaccination Phase|Other|3|||
161043641|NCT00614614|581550108|FG003|Booster Vaccination Phase|Other|2|||
161043642|NCT00614614|581550109|FG004|Booster Vaccination Phase|Other|1|||
161043643|NCT05426109|581550110|FG000|Overall Study|Withdrawal by Subject|0|||
161043644|NCT05426109|581550111|FG001|Overall Study|Withdrawal by Subject|1|||
161043645|NCT05212285|581550112|FG000|Overall Study|Lack of Efficacy|12|||
161043646|NCT05212285|581550113|FG001|Overall Study|Lack of Efficacy|8|||
161043647|NCT05212285|581550112|FG000|Overall Study|Withdrawal by Subject|8|||
161043648|NCT05212285|581550113|FG001|Overall Study|Withdrawal by Subject|1|||
161043649|NCT05212285|581550112|FG000|Overall Study|Lost to Follow-up|13|||
161043650|NCT05212285|581550113|FG001|Overall Study|Lost to Follow-up|1|||
161043651|NCT05212285|581550112|FG000|Overall Study|miss data|21|||
161043652|NCT05212285|581550113|FG001|Overall Study|miss data|2|||
161043653|NCT01000805|581550114|FG000|Overall Study|Adverse Event|21|||
161043654|NCT01000805|581550115|FG001|Overall Study|Adverse Event|9|||
161043655|NCT01000805|581550114|FG000|Overall Study|Lack of Efficacy|5|||
161043656|NCT01000805|581550115|FG001|Overall Study|Lack of Efficacy|16|||
161043657|NCT01000805|581550114|FG000|Overall Study|Lost to Follow-up|16|||
161043658|NCT01000805|581550115|FG001|Overall Study|Lost to Follow-up|21|||
161043659|NCT01000805|581550114|FG000|Overall Study|Physician Decision|0|||
161043660|NCT01000805|581550115|FG001|Overall Study|Physician Decision|1|||
161043661|NCT01000805|581550114|FG000|Overall Study|Protocol Violation|12|||
161043662|NCT01000805|581550115|FG001|Overall Study|Protocol Violation|8|||
161043663|NCT01000805|581550114|FG000|Overall Study|Withdrawal by Subject|16|||
161043664|NCT01000805|581550115|FG001|Overall Study|Withdrawal by Subject|6|||
161043665|NCT01000805|581550114|FG000|Overall Study|Sponsor Decision|0|||
161149285|NCT01469013|581927825|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149286|NCT01469013|581927826|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
161043666|NCT01000805|581550115|FG001|Overall Study|Sponsor Decision|1|||
161043667|NCT04118894|581550116|FG000|Overall Study|Lost to Follow-up|21|||
161043668|NCT04118894|581550116|FG000|Overall Study|Withdrawal by Subject|10|||
161043669|NCT04118894|581550116|FG000|Overall Study|Adverse Event|4|||
161043670|NCT03332589|581551356|FG000|Overall Study|Lack of Efficacy|2|||
161043671|NCT03332589|581551357|FG001|Overall Study|Lack of Efficacy|0|||
161043672|NCT03332589|581551358|FG002|Overall Study|Lack of Efficacy|0|||
161043673|NCT03332589|581551356|FG000|Overall Study|Adverse Event|1|||
161043674|NCT03332589|581551357|FG001|Overall Study|Adverse Event|0|||
161043675|NCT03332589|581551358|FG002|Overall Study|Adverse Event|0|||
161043676|NCT03332589|581551356|FG000|Overall Study|Death|1|||
161043677|NCT03332589|581551357|FG001|Overall Study|Death|0|||
161043678|NCT03332589|581551358|FG002|Overall Study|Death|0|||
161043679|NCT02713594|581551359|FG000|Overall Study|Withdrawal by Subject|32|||
161149287|NCT01469013|581927827|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149288|NCT01469013|581927828|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149289|NCT01469013|581927829|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149290|NCT01469013|581927830|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149291|NCT01469013|581927831|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149292|NCT01469013|581927832|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149293|NCT01469013|581927833|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
161149294|NCT01469013|581927821|FG000|Part B (Extension Period)|Adverse Event|0|||
161344840|NCT06001866|582648807|FG000|Overall Study|Protocol Violation|0|||
161344841|NCT06001866|582648808|FG001|Overall Study|Protocol Violation|2|||
161043680|NCT02713594|581551360|FG001|Overall Study|Withdrawal by Subject|22|||
161043681|NCT02713594|581551359|FG000|Overall Study|Lost to Follow-up|358|||
161043682|NCT02713594|581551360|FG001|Overall Study|Lost to Follow-up|374|||
161043683|NCT02771366|581551361|FG000|Period 1|Withdrawal by Subject|0|||
161043684|NCT02771366|581551362|FG001|Period 1|Withdrawal by Subject|2|||
161043685|NCT02771366|581551361|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
161043686|NCT02771366|581551362|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
161043687|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
161043688|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161043689|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161043690|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161043691|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
161043692|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161043693|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161043694|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161043695|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
161043696|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161043697|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161043698|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161043699|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
161043700|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161043701|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161043702|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161043703|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
161043704|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161043705|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161043706|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161043707|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
161043708|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161043709|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161043710|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161043711|NCT01185340|581551365|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
161043712|NCT01185340|581551366|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161043713|NCT01185340|581551367|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161043714|NCT01185340|581551368|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161043715|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
161043716|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
161043717|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
161043718|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
161043719|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
161043720|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
161043721|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
161043722|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
161043723|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161043724|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
161043725|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
161043726|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
161043727|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161043728|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161043729|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161043730|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161043731|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
161043732|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161043733|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
161149295|NCT01469013|581927822|FG001|Part B (Extension Period)|Adverse Event|0|||
161043734|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161043735|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
161344842|NCT04703192|582648809|FG000|Overall Study|Withdrawal by Subject|2|||
161149296|NCT01469013|581927823|FG002|Part B (Extension Period)|Adverse Event|0|||
161344843|NCT04703192|582648810|FG001|Overall Study|Withdrawal by Subject|0|||
161043736|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
161043737|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
161043738|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
161043739|NCT01185340|581551365|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161043740|NCT01185340|581551366|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161043741|NCT01185340|581551367|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
161043742|NCT01185340|581551368|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
161043743|NCT00246129|581551371|FG000|Overall Study|Lost to Follow-up|1|||
161043744|NCT00246129|581551372|FG001|Overall Study|Lost to Follow-up|0|||
161043745|NCT00246129|581551371|FG000|Overall Study|Death|2|||
161043746|NCT00246129|581551372|FG001|Overall Study|Death|1|||
161043747|NCT00246129|581551371|FG000|Overall Study|suffered primary non-function|1|||
161043748|NCT00246129|581551372|FG001|Overall Study|suffered primary non-function|0|||
161043749|NCT00246129|581551371|FG000|Overall Study|grafts failed|3|||
161043750|NCT00246129|581551372|FG001|Overall Study|grafts failed|1|||
161043751|NCT03469258|581551373|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
161043752|NCT03403036|581551379|FG000|Overall Study|Lack of Efficacy|5|||
161043753|NCT03648541|581551381|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
161043754|NCT03648541|581551382|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
161043755|NCT03648541|581551381|FG000|Re-induction Period Only|Lack of Efficacy|7|||
161043756|NCT03648541|581551382|FG001|Re-induction Period Only|Lack of Efficacy|0|||
161043757|NCT03648541|581551381|FG000|Maintenance Period Only|Missing|0|||
161043758|NCT03648541|581551382|FG001|Maintenance Period Only|Missing|1|||
161043759|NCT03648541|581551381|FG000|Maintenance Period Only|Other not listed below|0|||
161043760|NCT03648541|581551382|FG001|Maintenance Period Only|Other not listed below|4|||
161043761|NCT03648541|581551381|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
161043762|NCT03648541|581551382|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
161043763|NCT03648541|581551381|FG000|Maintenance Period Only|Protocol Violation|0|||
161043764|NCT03648541|581551382|FG001|Maintenance Period Only|Protocol Violation|1|||
161043765|NCT03648541|581551381|FG000|Maintenance Period Only|Lack of Efficacy|0|||
161043766|NCT03648541|581551382|FG001|Maintenance Period Only|Lack of Efficacy|18|||
161043767|NCT03648541|581551381|FG000|Maintenance Period Only|Adverse Event|0|||
161043768|NCT03648541|581551382|FG001|Maintenance Period Only|Adverse Event|4|||
161043769|NCT03648541|581551381|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
161043770|NCT03648541|581551382|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
161043771|NCT02392507|581551383|FG000|Induction Regimen|Death|3|||
161043772|NCT02392507|581551383|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
161043773|NCT02392507|581551383|FG000|Induction Regimen|Physician Decision|1|||
161043774|NCT02392507|581551383|FG000|Induction Regimen|Withdrawal by Subject|2|||
161043775|NCT02392507|581551383|FG000|Maintenance Regimen|Death|1|||
161043776|NCT02392507|581551383|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
161043777|NCT00273052|581551384|FG000|Overall Study|Withdrawal by Subject|16|||
161043778|NCT00273052|581551385|FG001|Overall Study|Withdrawal by Subject|19|||
161043779|NCT00273052|581551384|FG000|Overall Study|Adverse Event|21|||
161043780|NCT00273052|581551385|FG001|Overall Study|Adverse Event|19|||
161043781|NCT00273052|581551384|FG000|Overall Study|Protocol Violation|14|||
161043782|NCT00273052|581551385|FG001|Overall Study|Protocol Violation|18|||
161043783|NCT00273052|581551384|FG000|Overall Study|Lost to Follow-up|7|||
161043784|NCT00273052|581551385|FG001|Overall Study|Lost to Follow-up|25|||
161043785|NCT00273052|581551384|FG000|Overall Study|Lack of Efficacy|6|||
161043786|NCT00273052|581551385|FG001|Overall Study|Lack of Efficacy|4|||
161043787|NCT00273052|581551384|FG000|Overall Study|Non-Compliance|3|||
161043788|NCT00273052|581551385|FG001|Overall Study|Non-Compliance|1|||
161043789|NCT00273052|581551384|FG000|Overall Study|Other|2|||
161043790|NCT00273052|581551385|FG001|Overall Study|Other|0|||
161043791|NCT00273052|581551384|FG000|Overall Study|Worsening serum lipid levels|0|||
161043792|NCT00273052|581551385|FG001|Overall Study|Worsening serum lipid levels|2|||
161043793|NCT00240994|581551386|FG000|Overall Study|Lost to Follow-up|1|||
161344844|NCT04703192|582648809|FG000|Overall Study|Death|3|||
161043794|NCT00240994|581551386|FG000|Overall Study|Protocol Violation|1|||
161043795|NCT00240994|581551386|FG000|Overall Study|Graft failure|1|||
161043796|NCT02630186|581551388|FG000|Overall Study|Withdrawal by Subject|1|||
161043797|NCT00439218|581551389|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
161043798|NCT03142932|581551392|FG000|Overall Study|Lost to Follow-up|2|||
161043799|NCT03142932|581551393|FG001|Overall Study|Lost to Follow-up|11|||
161043800|NCT00624377|581551396|FG000|Overall Study|Lost to Follow-up|355|||
161043801|NCT00624377|581551396|FG000|Overall Study|Withdrawal by Subject|100|||
161043802|NCT00624377|581551396|FG000|Overall Study|Adverse Event|14|||
161043803|NCT00624377|581551396|FG000|Overall Study|Other|91|||
161043804|NCT00624377|581551396|FG000|Overall Study|Non-evaluable population|84|||
161043805|NCT02037568|581551400|FG000|Overall Study|Withdrawal by Subject|17|||
161043806|NCT02037568|581551401|FG001|Overall Study|Withdrawal by Subject|24|||
161344845|NCT04703192|582648810|FG001|Overall Study|Death|1|||
161043807|NCT02037568|581551400|FG000|Overall Study|Lost to Follow-up|16|||
161043808|NCT02037568|581551401|FG001|Overall Study|Lost to Follow-up|13|||
161043809|NCT02037568|581551400|FG000|Overall Study|Screen Failure|3|||
161043810|NCT02037568|581551401|FG001|Overall Study|Screen Failure|1|||
161043811|NCT02037568|581551400|FG000|Overall Study|Patient did not receive transplant|0|||
161043812|NCT02037568|581551401|FG001|Overall Study|Patient did not receive transplant|1|||
161043813|NCT00721734|581551402|FG000|Overall Study|Progressive Disease|3|||
161043814|NCT00721734|581551403|FG001|Overall Study|Progressive Disease|10|||
161043815|NCT00721734|581551404|FG002|Overall Study|Progressive Disease|4|||
161043816|NCT00721734|581551405|FG003|Overall Study|Progressive Disease|5|||
161043817|NCT00721734|581551406|FG004|Overall Study|Progressive Disease|2|||
161043818|NCT00721734|581551402|FG000|Overall Study|Adverse Event|3|||
161043819|NCT00721734|581551403|FG001|Overall Study|Adverse Event|1|||
161043820|NCT00721734|581551404|FG002|Overall Study|Adverse Event|4|||
161043821|NCT00721734|581551405|FG003|Overall Study|Adverse Event|0|||
161043822|NCT00721734|581551406|FG004|Overall Study|Adverse Event|3|||
161043823|NCT00721734|581551402|FG000|Overall Study|Withdrawal by Subject|2|||
161043824|NCT00721734|581551403|FG001|Overall Study|Withdrawal by Subject|1|||
161043825|NCT00721734|581551404|FG002|Overall Study|Withdrawal by Subject|0|||
161043826|NCT00721734|581551405|FG003|Overall Study|Withdrawal by Subject|0|||
161043827|NCT00721734|581551406|FG004|Overall Study|Withdrawal by Subject|1|||
161043828|NCT00721734|581551402|FG000|Overall Study|Other|0|||
161043829|NCT00721734|581551403|FG001|Overall Study|Other|0|||
161043830|NCT00721734|581551404|FG002|Overall Study|Other|0|||
161043831|NCT00721734|581551405|FG003|Overall Study|Other|1|||
161043832|NCT00721734|581551406|FG004|Overall Study|Other|0|||
161043833|NCT05169684|581551412|FG000|Overall Study|Adverse Event|1|||
161043834|NCT05169684|581551413|FG001|Overall Study|Adverse Event|3|||
161043835|NCT05169684|581551412|FG000|Overall Study|Physician Decision|0|||
161043836|NCT05169684|581551413|FG001|Overall Study|Physician Decision|1|||
161043837|NCT05169684|581551412|FG000|Overall Study|Progressive Disease|1|||
161043838|NCT05169684|581551413|FG001|Overall Study|Progressive Disease|1|||
161043839|NCT05169684|581551412|FG000|Overall Study|Participant request to discontinue treatment|0|||
161043840|NCT05169684|581551413|FG001|Overall Study|Participant request to discontinue treatment|1|||
161043841|NCT05169684|581551412|FG000|Overall Study|Other Reason|0|||
161043842|NCT05169684|581551413|FG001|Overall Study|Other Reason|1|||
161043843|NCT05484661|581551419|FG000|Overall Study|Withdrawal by Subject|1|||
161043844|NCT05484661|581551420|FG001|Overall Study|Withdrawal by Subject|0|||
161043845|NCT03205488|581551426|FG000|Overall Study|Adverse Event|1|||
161043846|NCT03205488|581551427|FG001|Overall Study|Adverse Event|2|||
161043847|NCT03205488|581551428|FG002|Overall Study|Adverse Event|4|||
161043848|NCT03205488|581551426|FG000|Overall Study|Protocol Violation|0|||
161043849|NCT03205488|581551427|FG001|Overall Study|Protocol Violation|0|||
161043850|NCT03205488|581551428|FG002|Overall Study|Protocol Violation|1|||
161043851|NCT03652610|581551429|FG000|Overall Study|Lost to Follow-up|1|||
161043852|NCT03652610|581551430|FG001|Overall Study|Lost to Follow-up|0|||
161043853|NCT03652610|581551429|FG000|Overall Study|Withdrawal by Subject|3|||
161043854|NCT03652610|581551430|FG001|Overall Study|Withdrawal by Subject|5|||
161043855|NCT04748341|581551433|FG000|Overall Study|Lost to Follow-up|1|||
161043856|NCT04748341|581551434|FG001|Overall Study|Lost to Follow-up|1|||
161043857|NCT02334215|581551437|FG000|Overall Study|Death|1|||
161043858|NCT02334215|581551438|FG001|Overall Study|Death|1|||
161043859|NCT02334215|581551439|FG002|Overall Study|Death|0|||
161043860|NCT02334215|581551437|FG000|Overall Study|Lost to Follow-up|1|||
161043861|NCT02334215|581551438|FG001|Overall Study|Lost to Follow-up|0|||
161043862|NCT02334215|581551439|FG002|Overall Study|Lost to Follow-up|4|||
161043863|NCT02334215|581551437|FG000|Overall Study|Withdrawal by Subject|2|||
161043864|NCT02334215|581551438|FG001|Overall Study|Withdrawal by Subject|2|||
161043865|NCT02334215|581551439|FG002|Overall Study|Withdrawal by Subject|1|||
161043866|NCT02334215|581551437|FG000|Overall Study|Not released from incarceration on time|3|||
161043867|NCT02334215|581551438|FG001|Overall Study|Not released from incarceration on time|3|||
161043868|NCT02334215|581551439|FG002|Overall Study|Not released from incarceration on time|3|||
161043869|NCT02334215|581551437|FG000|Overall Study|Incarcerated|0|||
161043870|NCT02334215|581551438|FG001|Overall Study|Incarcerated|0|||
161043871|NCT02334215|581551439|FG002|Overall Study|Incarcerated|7|||
161043872|NCT05615363|581551440|FG000|Overall Study|Adverse Event|0|||
161043873|NCT05615363|581551441|FG001|Overall Study|Adverse Event|4|||
161043874|NCT05615363|581551442|FG002|Overall Study|Adverse Event|4|||
161043875|NCT05615363|581551443|FG003|Overall Study|Adverse Event|3|||
161043876|NCT05615363|581551444|FG004|Overall Study|Adverse Event|1|||
161043877|NCT05615363|581551440|FG000|Overall Study|Physician Decision|2|||
161043878|NCT05615363|581551441|FG001|Overall Study|Physician Decision|0|||
161043879|NCT05615363|581551442|FG002|Overall Study|Physician Decision|4|||
161043880|NCT05615363|581551443|FG003|Overall Study|Physician Decision|1|||
161043881|NCT05615363|581551444|FG004|Overall Study|Physician Decision|3|||
161043882|NCT05615363|581551440|FG000|Overall Study|Protocol Violation|2|||
161043883|NCT05615363|581551441|FG001|Overall Study|Protocol Violation|0|||
161043884|NCT05615363|581551442|FG002|Overall Study|Protocol Violation|0|||
161043885|NCT05615363|581551443|FG003|Overall Study|Protocol Violation|0|||
161149297|NCT01469013|581927824|FG003|Part B (Extension Period)|Adverse Event|0|||
161149298|NCT01469013|581927825|FG004|Part B (Extension Period)|Adverse Event|0|||
161149299|NCT01469013|581927826|FG005|Part B (Extension Period)|Adverse Event|2|||
161149300|NCT01469013|581927827|FG006|Part B (Extension Period)|Adverse Event|5|||
161149301|NCT01469013|581927828|FG007|Part B (Extension Period)|Adverse Event|5|||
161149302|NCT01469013|581927829|FG008|Part B (Extension Period)|Adverse Event|3|||
161149303|NCT01469013|581927830|FG009|Part B (Extension Period)|Adverse Event|3|||
161149304|NCT01469013|581927831|FG010|Part B (Extension Period)|Adverse Event|1|||
161149305|NCT01469013|581927832|FG011|Part B (Extension Period)|Adverse Event|6|||
161149306|NCT01469013|581927833|FG012|Part B (Extension Period)|Adverse Event|3|||
161149307|NCT01469013|581927821|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
161149308|NCT01469013|581927822|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
161149309|NCT01469013|581927823|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
161149310|NCT01469013|581927824|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
161149311|NCT01469013|581927825|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
161149312|NCT01469013|581927826|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
161149313|NCT01469013|581927827|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
161149314|NCT01469013|581927828|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
161149315|NCT01469013|581927829|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
161149316|NCT01469013|581927830|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
161149317|NCT01469013|581927831|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
161149318|NCT01469013|581927832|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
161149319|NCT01469013|581927833|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
161149320|NCT05232097|581927834|FG000|Overall Study|Physician Decision|1|||
161149321|NCT00425438|581927837|FG000|Overall Study|Termination by Sponsor|25|||
161149322|NCT00425438|581927838|FG001|Overall Study|Termination by Sponsor|27|||
161149323|NCT00871858|581927841|FG000|Overall Study|Protocol Violation|3|||
161149324|NCT00871858|581927842|FG001|Overall Study|Protocol Violation|4|||
161149325|NCT00871858|581927841|FG000|Overall Study|Adverse Event|1|||
161149326|NCT00871858|581927842|FG001|Overall Study|Adverse Event|1|||
161149327|NCT00871858|581927841|FG000|Overall Study|Withdrawal by Subject|1|||
161149328|NCT00871858|581927842|FG001|Overall Study|Withdrawal by Subject|1|||
161149329|NCT00871858|581927841|FG000|Overall Study|Lost to Follow-up|0|||
161149330|NCT00871858|581927842|FG001|Overall Study|Lost to Follow-up|1|||
161149331|NCT02795767|581927845|FG000|Overall Study|Received Commercial Emicizumab|1|||
161043886|NCT05615363|581551444|FG004|Overall Study|Protocol Violation|1|||
161043887|NCT05615363|581551440|FG000|Overall Study|Withdrawal by Subject|0|||
161043888|NCT05615363|581551441|FG001|Overall Study|Withdrawal by Subject|0|||
161043889|NCT05615363|581551442|FG002|Overall Study|Withdrawal by Subject|1|||
161043890|NCT05615363|581551443|FG003|Overall Study|Withdrawal by Subject|0|||
161043891|NCT05615363|581551444|FG004|Overall Study|Withdrawal by Subject|0|||
161043892|NCT05865392|581551447|FG000|Overall Study|Withdrawal by Subject|4|||
161043893|NCT05865392|581551448|FG001|Overall Study|Withdrawal by Subject|0|||
161043894|NCT05865392|581551447|FG000|Overall Study|Didn't meet inclusion criteria|4|||
161043895|NCT05865392|581551448|FG001|Overall Study|Didn't meet inclusion criteria|0|||
161043896|NCT02159989|581551449|FG000|Overall Study|Adverse Event|1|||
161043897|NCT02159989|581551450|FG001|Overall Study|Adverse Event|0|||
161043898|NCT02159989|581551451|FG002|Overall Study|Adverse Event|0|||
161043899|NCT02159989|581551452|FG003|Overall Study|Adverse Event|0|||
161043900|NCT02159989|581551453|FG004|Overall Study|Adverse Event|1|||
161043901|NCT02159989|581551454|FG005|Overall Study|Adverse Event|0|||
161043902|NCT02159989|581551455|FG006|Overall Study|Adverse Event|1|||
161043903|NCT02159989|581551456|FG007|Overall Study|Adverse Event|2|||
161149332|NCT02795767|581927846|FG001|Overall Study|Received Commercial Emicizumab|0|||
161149333|NCT02795767|581927847|FG002|Overall Study|Received Commercial Emicizumab|0|||
161149334|NCT04983940|581927848|FG000|Overall Study|Lost to Follow-up|14|||
161149335|NCT04983940|581927848|FG000|Overall Study|Lack of Efficacy|2|||
161149336|NCT01748760|581927854|FG000|Overall Study|Withdrawal by Subject|1|||
161043904|NCT02159989|581551457|FG008|Overall Study|Adverse Event|0|||
161043905|NCT02159989|581551458|FG009|Overall Study|Adverse Event|2|||
161149337|NCT01748760|581927855|FG001|Overall Study|Withdrawal by Subject|1|||
161149338|NCT01748760|581927854|FG000|Overall Study|Lost to Follow-up|5|||
161149339|NCT01748760|581927855|FG001|Overall Study|Lost to Follow-up|1|||
161149340|NCT03176966|581927861|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
161043906|NCT02159989|581551459|FG010|Overall Study|Adverse Event|1|||
161043907|NCT02159989|581551449|FG000|Overall Study|Death|0|||
161043908|NCT02159989|581551450|FG001|Overall Study|Death|0|||
161043909|NCT02159989|581551451|FG002|Overall Study|Death|0|||
161043910|NCT02159989|581551452|FG003|Overall Study|Death|0|||
161043911|NCT02159989|581551453|FG004|Overall Study|Death|0|||
161149341|NCT03176966|581927862|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
161149342|NCT03176966|581927861|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
161149343|NCT03176966|581927862|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
161149344|NCT03176966|581927861|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
161149345|NCT03176966|581927862|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
161043912|NCT02159989|581551454|FG005|Overall Study|Death|0|||
161043913|NCT02159989|581551455|FG006|Overall Study|Death|0|||
161043914|NCT02159989|581551456|FG007|Overall Study|Death|0|||
161043915|NCT02159989|581551457|FG008|Overall Study|Death|0|||
161043916|NCT02159989|581551458|FG009|Overall Study|Death|0|||
161043917|NCT02159989|581551459|FG010|Overall Study|Death|1|||
161043918|NCT02159989|581551449|FG000|Overall Study|Lack of Efficacy|2|||
161043919|NCT02159989|581551450|FG001|Overall Study|Lack of Efficacy|3|||
161043920|NCT02159989|581551451|FG002|Overall Study|Lack of Efficacy|3|||
161043921|NCT02159989|581551452|FG003|Overall Study|Lack of Efficacy|0|||
161043922|NCT02159989|581551453|FG004|Overall Study|Lack of Efficacy|2|||
161043923|NCT02159989|581551454|FG005|Overall Study|Lack of Efficacy|3|||
161043924|NCT02159989|581551455|FG006|Overall Study|Lack of Efficacy|3|||
161043925|NCT02159989|581551456|FG007|Overall Study|Lack of Efficacy|1|||
161043926|NCT02159989|581551457|FG008|Overall Study|Lack of Efficacy|3|||
161043927|NCT02159989|581551458|FG009|Overall Study|Lack of Efficacy|6|||
161043928|NCT02159989|581551459|FG010|Overall Study|Lack of Efficacy|7|||
161043929|NCT02159989|581551449|FG000|Overall Study|Lost to Follow-up|0|||
161043930|NCT02159989|581551450|FG001|Overall Study|Lost to Follow-up|0|||
161043931|NCT02159989|581551451|FG002|Overall Study|Lost to Follow-up|0|||
161043932|NCT02159989|581551452|FG003|Overall Study|Lost to Follow-up|1|||
161043933|NCT02159989|581551453|FG004|Overall Study|Lost to Follow-up|0|||
161043934|NCT02159989|581551454|FG005|Overall Study|Lost to Follow-up|0|||
161043935|NCT02159989|581551455|FG006|Overall Study|Lost to Follow-up|0|||
161043936|NCT02159989|581551456|FG007|Overall Study|Lost to Follow-up|0|||
161043937|NCT02159989|581551457|FG008|Overall Study|Lost to Follow-up|0|||
161043938|NCT02159989|581551458|FG009|Overall Study|Lost to Follow-up|0|||
161043939|NCT02159989|581551459|FG010|Overall Study|Lost to Follow-up|1|||
161043940|NCT02159989|581551449|FG000|Overall Study|Withdrawal by Subject|2|||
161043941|NCT02159989|581551450|FG001|Overall Study|Withdrawal by Subject|0|||
161043942|NCT02159989|581551451|FG002|Overall Study|Withdrawal by Subject|0|||
161043943|NCT02159989|581551452|FG003|Overall Study|Withdrawal by Subject|2|||
161043944|NCT02159989|581551453|FG004|Overall Study|Withdrawal by Subject|1|||
161043945|NCT02159989|581551454|FG005|Overall Study|Withdrawal by Subject|0|||
161043946|NCT02159989|581551455|FG006|Overall Study|Withdrawal by Subject|3|||
161043947|NCT02159989|581551456|FG007|Overall Study|Withdrawal by Subject|1|||
161043948|NCT02159989|581551457|FG008|Overall Study|Withdrawal by Subject|0|||
161043949|NCT02159989|581551458|FG009|Overall Study|Withdrawal by Subject|0|||
161043950|NCT02159989|581551459|FG010|Overall Study|Withdrawal by Subject|0|||
161043951|NCT02159989|581551449|FG000|Overall Study|New treatment|0|||
161043952|NCT02159989|581551450|FG001|Overall Study|New treatment|1|||
161043953|NCT02159989|581551451|FG002|Overall Study|New treatment|0|||
161043954|NCT02159989|581551452|FG003|Overall Study|New treatment|0|||
161043955|NCT02159989|581551453|FG004|Overall Study|New treatment|0|||
161043956|NCT02159989|581551454|FG005|Overall Study|New treatment|0|||
161043957|NCT02159989|581551455|FG006|Overall Study|New treatment|0|||
161043958|NCT02159989|581551456|FG007|Overall Study|New treatment|0|||
161043959|NCT02159989|581551457|FG008|Overall Study|New treatment|0|||
161043960|NCT02159989|581551458|FG009|Overall Study|New treatment|0|||
161043961|NCT02159989|581551459|FG010|Overall Study|New treatment|0|||
161043962|NCT02159989|581551449|FG000|Overall Study|Insurance Issues|0|||
161043963|NCT02159989|581551450|FG001|Overall Study|Insurance Issues|0|||
161043964|NCT02159989|581551451|FG002|Overall Study|Insurance Issues|0|||
161043965|NCT02159989|581551452|FG003|Overall Study|Insurance Issues|0|||
161043966|NCT02159989|581551453|FG004|Overall Study|Insurance Issues|0|||
161043967|NCT02159989|581551454|FG005|Overall Study|Insurance Issues|0|||
161043968|NCT02159989|581551455|FG006|Overall Study|Insurance Issues|0|||
161043969|NCT02159989|581551456|FG007|Overall Study|Insurance Issues|0|||
161043970|NCT02159989|581551457|FG008|Overall Study|Insurance Issues|0|||
161043971|NCT02159989|581551458|FG009|Overall Study|Insurance Issues|1|||
161043972|NCT02159989|581551459|FG010|Overall Study|Insurance Issues|0|||
161043973|NCT04447027|581551461|FG000|Dose Escalation|Withdrawal by Subject|1|||
161043974|NCT04447027|581551462|FG001|Dose Escalation|Withdrawal by Subject|4|||
161043975|NCT04447027|581551463|FG002|Dose Escalation|Withdrawal by Subject|3|||
161043976|NCT04447027|581551464|FG003|Dose Escalation|Withdrawal by Subject|3|||
161043977|NCT04447027|581551465|FG004|Dose Escalation|Withdrawal by Subject|1|||
161043978|NCT04447027|581551466|FG005|Dose Escalation|Withdrawal by Subject|0|||
161043979|NCT04447027|581551467|FG006|Dose Escalation|Withdrawal by Subject|0|||
161043980|NCT04447027|581551468|FG007|Dose Escalation|Withdrawal by Subject|0|||
161043981|NCT04447027|581551469|FG008|Dose Escalation|Withdrawal by Subject|0|||
161043982|NCT04447027|581551461|FG000|Dose Escalation|Refused further treatment|0|||
161043983|NCT04447027|581551462|FG001|Dose Escalation|Refused further treatment|1|||
161043984|NCT04447027|581551463|FG002|Dose Escalation|Refused further treatment|1|||
161043985|NCT04447027|581551464|FG003|Dose Escalation|Refused further treatment|0|||
161043986|NCT04447027|581551465|FG004|Dose Escalation|Refused further treatment|0|||
161043987|NCT04447027|581551466|FG005|Dose Escalation|Refused further treatment|0|||
161043988|NCT04447027|581551467|FG006|Dose Escalation|Refused further treatment|0|||
161043989|NCT04447027|581551468|FG007|Dose Escalation|Refused further treatment|0|||
161043990|NCT04447027|581551469|FG008|Dose Escalation|Refused further treatment|0|||
161043991|NCT04447027|581551461|FG000|Dose Expansion|Withdrawal by Subject|0|||
161043992|NCT04447027|581551462|FG001|Dose Expansion|Withdrawal by Subject|0|||
161043993|NCT04447027|581551463|FG002|Dose Expansion|Withdrawal by Subject|0|||
161043994|NCT04447027|581551464|FG003|Dose Expansion|Withdrawal by Subject|0|||
161043995|NCT04447027|581551465|FG004|Dose Expansion|Withdrawal by Subject|0|||
161043996|NCT04447027|581551466|FG005|Dose Expansion|Withdrawal by Subject|2|||
161043997|NCT04447027|581551467|FG006|Dose Expansion|Withdrawal by Subject|0|||
161043998|NCT04447027|581551468|FG007|Dose Expansion|Withdrawal by Subject|2|||
161043999|NCT04447027|581551469|FG008|Dose Expansion|Withdrawal by Subject|0|||
161044000|NCT02485925|581551472|FG000|Overall Study|Withdrawal by Subject|3|||
161044001|NCT02485925|581551472|FG000|Overall Study|Death|1|||
161044002|NCT02485925|581551472|FG000|Overall Study|Lost to Follow-up|11|||
161044003|NCT04937504|581551473|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
161044004|NCT04937504|581551474|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
161044005|NCT04937504|581551473|FG000|9 Months Assessment|Lost to Follow-up|3|||
161044006|NCT04937504|581551474|FG001|9 Months Assessment|Lost to Follow-up|2|||
161044007|NCT03662659|581551475|FG000|Pre-treatment|Participant no longer met study criteria|1|||
161044008|NCT03662659|581551476|FG001|Pre-treatment|Participant no longer met study criteria|1|||
161044009|NCT03662659|581551475|FG000|Pre-treatment|Other reasons|1|||
161044010|NCT03662659|581551476|FG001|Pre-treatment|Other reasons|0|||
161044011|NCT03662659|581551475|FG000|Treatment|Completed Treatment|0|||
161044012|NCT03662659|581551476|FG001|Treatment|Completed Treatment|2|||
161044013|NCT03662659|581551475|FG000|Treatment|Disease Progression|85|||
161044014|NCT03662659|581551476|FG001|Treatment|Disease Progression|97|||
161044015|NCT03662659|581551475|FG000|Treatment|Study Drug Toxicity|19|||
161044016|NCT03662659|581551476|FG001|Treatment|Study Drug Toxicity|9|||
161044017|NCT03662659|581551475|FG000|Treatment|Death|11|||
161044018|NCT03662659|581551476|FG001|Treatment|Death|9|||
161044019|NCT03662659|581551475|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
161044020|NCT03662659|581551476|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
161044021|NCT03662659|581551475|FG000|Treatment|Withdrawal by Subject|1|||
161044022|NCT03662659|581551476|FG001|Treatment|Withdrawal by Subject|1|||
161044023|NCT03662659|581551475|FG000|Treatment|Poor/Non-compliance|1|||
161044024|NCT03662659|581551476|FG001|Treatment|Poor/Non-compliance|0|||
161044025|NCT03662659|581551475|FG000|Treatment|Participant no longer meets study criteria|1|||
161044026|NCT03662659|581551476|FG001|Treatment|Participant no longer meets study criteria|0|||
161044027|NCT03662659|581551475|FG000|Treatment|Other reasons|10|||
161044028|NCT03662659|581551476|FG001|Treatment|Other reasons|8|||
161044029|NCT03662659|581551475|FG000|Treatment|Administrative reasons by sponsor|1|||
161044030|NCT03662659|581551476|FG001|Treatment|Administrative reasons by sponsor|0|||
161044031|NCT03662659|581551475|FG000|Treatment|maximum clinical benefit|0|||
161044032|NCT03662659|581551476|FG001|Treatment|maximum clinical benefit|2|||
161044033|NCT04369664|581552816|FG000|Overall Study|Physician Decision|1|||
161044034|NCT04369664|581552817|FG001|Overall Study|Physician Decision|0|||
161044035|NCT03840200|581552818|FG000|Overall Study|Death|6|||
161044036|NCT03840200|581552819|FG001|Overall Study|Death|3|||
161044037|NCT03840200|581552820|FG002|Overall Study|Death|6|||
161044038|NCT03840200|581552821|FG003|Overall Study|Death|10|||
161044039|NCT03840200|581552818|FG000|Overall Study|Reason Not Specified|2|||
161044040|NCT03840200|581552819|FG001|Overall Study|Reason Not Specified|2|||
161044041|NCT03840200|581552820|FG002|Overall Study|Reason Not Specified|1|||
161044042|NCT03840200|581552821|FG003|Overall Study|Reason Not Specified|15|||
161044043|NCT03840200|581552818|FG000|Overall Study|Physician Decision|0|||
161044044|NCT03840200|581552819|FG001|Overall Study|Physician Decision|0|||
161044045|NCT03840200|581552820|FG002|Overall Study|Physician Decision|0|||
161044046|NCT03840200|581552821|FG003|Overall Study|Physician Decision|2|||
161044047|NCT03840200|581552818|FG000|Overall Study|Progressive Disease|0|||
161044048|NCT03840200|581552819|FG001|Overall Study|Progressive Disease|0|||
161044049|NCT03840200|581552820|FG002|Overall Study|Progressive Disease|0|||
161044050|NCT03840200|581552821|FG003|Overall Study|Progressive Disease|1|||
161044051|NCT03840200|581552818|FG000|Overall Study|Withdrawal by Subject|0|||
161044052|NCT03840200|581552819|FG001|Overall Study|Withdrawal by Subject|1|||
161044053|NCT03840200|581552820|FG002|Overall Study|Withdrawal by Subject|0|||
161044054|NCT03840200|581552821|FG003|Overall Study|Withdrawal by Subject|2|||
161044055|NCT04493424|581552822|FG000|Overall Study|Termination of the trial by the sponsor|89|||
161044056|NCT04493424|581552822|FG000|Overall Study|Withdrawal by Subject|9|||
161044057|NCT04493424|581552822|FG000|Overall Study|Lost to Follow-up|2|||
161044058|NCT04493424|581552822|FG000|Overall Study|Lack of Efficacy|3|||
161044059|NCT04493424|581552822|FG000|Overall Study|Adverse Event|5|||
161044060|NCT03769090|581552824|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
161044061|NCT03769090|581552825|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
161044062|NCT03769090|581552826|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
161044063|NCT03769090|581552824|FG000|Overall Study|Withdrawal by Subject|52|||
161044064|NCT03769090|581552825|FG001|Overall Study|Withdrawal by Subject|62|||
161044065|NCT03769090|581552826|FG002|Overall Study|Withdrawal by Subject|74|||
161044066|NCT03769090|581552824|FG000|Overall Study|Death|4|||
161044067|NCT03769090|581552825|FG001|Overall Study|Death|2|||
161044068|NCT03769090|581552826|FG002|Overall Study|Death|2|||
161044069|NCT03769090|581552824|FG000|Overall Study|Adverse Event|7|||
161044070|NCT03769090|581552825|FG001|Overall Study|Adverse Event|7|||
161044071|NCT03769090|581552826|FG002|Overall Study|Adverse Event|8|||
161044072|NCT03769090|581552824|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
161044073|NCT03769090|581552825|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
161044074|NCT03769090|581552826|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
161044075|NCT03769090|581552824|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
161044076|NCT03769090|581552825|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
161044077|NCT03769090|581552826|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
161044078|NCT03769090|581552824|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
161044079|NCT03769090|581552825|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
161044080|NCT03769090|581552826|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
161044081|NCT03769090|581552824|FG000|Overall Study|Protocol Violation|5|||
161044082|NCT03769090|581552825|FG001|Overall Study|Protocol Violation|6|||
161044083|NCT03769090|581552826|FG002|Overall Study|Protocol Violation|8|||
161044084|NCT03769090|581552824|FG000|Overall Study|Pregnancy|1|||
161044085|NCT03769090|581552825|FG001|Overall Study|Pregnancy|0|||
161044086|NCT03769090|581552826|FG002|Overall Study|Pregnancy|3|||
161044087|NCT03769090|581552824|FG000|Overall Study|Lost to Follow-up|19|||
161044088|NCT03769090|581552825|FG001|Overall Study|Lost to Follow-up|25|||
161044089|NCT03769090|581552826|FG002|Overall Study|Lost to Follow-up|21|||
161044090|NCT03769090|581552824|FG000|Overall Study|Condition under investigation worsened|2|||
161044091|NCT03769090|581552825|FG001|Overall Study|Condition under investigation worsened|0|||
161044092|NCT03769090|581552826|FG002|Overall Study|Condition under investigation worsened|1|||
161044093|NCT03769090|581552824|FG000|Overall Study|Lack of Efficacy|1|||
161044094|NCT03769090|581552825|FG001|Overall Study|Lack of Efficacy|2|||
161044095|NCT03769090|581552826|FG002|Overall Study|Lack of Efficacy|2|||
161044096|NCT03769090|581552824|FG000|Overall Study|Other reasons|8|||
161044097|NCT03769090|581552825|FG001|Overall Study|Other reasons|12|||
161044098|NCT03769090|581552826|FG002|Overall Study|Other reasons|15|||
161044099|NCT02830893|581552832|FG000|Overall Study|Relocation to out of the country|1|||
161044100|NCT02830893|581552833|FG001|Overall Study|Relocation to out of the country|0|||
161044101|NCT02830893|581552832|FG000|Overall Study|Lost to Follow-up|0|||
161044102|NCT02830893|581552833|FG001|Overall Study|Lost to Follow-up|2|||
161044103|NCT02830893|581552832|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
161044104|NCT02830893|581552833|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
161044105|NCT01277302|581552834|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
161044106|NCT01277302|581552835|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
161044107|NCT01277302|581552836|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
161044108|NCT01277302|581552834|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
161044109|NCT01277302|581552835|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
161044110|NCT01277302|581552836|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
161044111|NCT01277302|581552834|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
161044112|NCT01277302|581552835|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
161044113|NCT01277302|581552836|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
161044114|NCT01277302|581552834|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
161044115|NCT01277302|581552835|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
161044116|NCT01277302|581552836|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
161044117|NCT01277302|581552834|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
161044118|NCT01277302|581552835|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
161044119|NCT01277302|581552836|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
161044120|NCT01277302|581552834|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
161044121|NCT01277302|581552835|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
161044122|NCT01277302|581552836|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
161044123|NCT01277302|581552834|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
161044124|NCT01277302|581552835|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
161044125|NCT01277302|581552836|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
161044126|NCT01277302|581552834|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
161044127|NCT01277302|581552835|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
161044128|NCT01277302|581552836|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
161044129|NCT01277302|581552834|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
161044130|NCT01277302|581552835|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
161044131|NCT01277302|581552836|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
161044132|NCT02710669|581552839|FG000|Overall Study|Physician Decision|2|||
161044133|NCT02710669|581552840|FG001|Overall Study|Physician Decision|1|||
161044134|NCT02710669|581552841|FG002|Overall Study|Physician Decision|0|||
161044135|NCT02710669|581552839|FG000|Overall Study|Institutional delays (including COVID)|2|||
161044136|NCT02710669|581552840|FG001|Overall Study|Institutional delays (including COVID)|2|||
161344846|NCT04703192|582648809|FG000|Overall Study|Adverse Event|13|||
161344847|NCT04703192|582648810|FG001|Overall Study|Adverse Event|2|||
161344848|NCT04703192|582648809|FG000|Overall Study|Progressive or Relapsed Disease|46|||
161344849|NCT04703192|582648810|FG001|Overall Study|Progressive or Relapsed Disease|7|||
161344850|NCT04703192|582648809|FG000|Overall Study|Clinical Progression|19|||
161344851|NCT04703192|582648810|FG001|Overall Study|Clinical Progression|8|||
161344852|NCT04703192|582648809|FG000|Overall Study|Lost to Follow-up|1|||
161344853|NCT04703192|582648810|FG001|Overall Study|Lost to Follow-up|0|||
161044137|NCT02710669|581552841|FG002|Overall Study|Institutional delays (including COVID)|0|||
161044138|NCT02710669|581552839|FG000|Overall Study|arrived in afib/aflutter|10|||
161044139|NCT02710669|581552840|FG001|Overall Study|arrived in afib/aflutter|8|||
161044140|NCT02710669|581552841|FG002|Overall Study|arrived in afib/aflutter|2|||
161044141|NCT01567852|581552842|FG000|Overall Study|Withdrawal by Subject|3|||
161044142|NCT01567852|581552843|FG001|Overall Study|Withdrawal by Subject|6|||
161044143|NCT01567852|581552842|FG000|Overall Study|ECT discontinued|1|||
161044144|NCT01567852|581552843|FG001|Overall Study|ECT discontinued|1|||
161044145|NCT01190124|581552845|FG000|Overall Study|Death|3|||
161044146|NCT01190124|581552846|FG001|Overall Study|Death|0|||
161044147|NCT01190124|581552847|FG002|Overall Study|Death|0|||
161044148|NCT01190124|581552845|FG000|Overall Study|Therapeutic Failure|12|||
161044149|NCT01190124|581552846|FG001|Overall Study|Therapeutic Failure|0|||
161044150|NCT01190124|581552847|FG002|Overall Study|Therapeutic Failure|1|||
161044151|NCT01190124|581552845|FG000|Overall Study|Lost to Follow-up|2|||
161044152|NCT01190124|581552846|FG001|Overall Study|Lost to Follow-up|0|||
161044153|NCT01190124|581552847|FG002|Overall Study|Lost to Follow-up|0|||
161044154|NCT03690219|581552848|FG000|Overall Study|no injuries|9|||
161044155|NCT03690219|581552849|FG001|Overall Study|no injuries|20|||
161044156|NCT03690219|581552848|FG000|Overall Study|missing information|7|||
161044157|NCT03690219|581552849|FG001|Overall Study|missing information|7|||
161044158|NCT01523392|581552850|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161044159|NCT01523392|581552851|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161044160|NCT01523392|581552850|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
161044161|NCT01523392|581552851|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
161044162|NCT01523392|581552850|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
161044163|NCT01523392|581552851|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
161044164|NCT04809623|581552852|FG000|Overall Study|Study Terminated by Sponsor|1|||
161044165|NCT04809623|581552853|FG001|Overall Study|Study Terminated by Sponsor|0|||
161044166|NCT00671853|581552855|FG000|Overall Study|Lack of Efficacy|3|||
161044167|NCT00671853|581552856|FG001|Overall Study|Lack of Efficacy|7|||
161044168|NCT00671853|581552855|FG000|Overall Study|Adverse Event|7|||
161044169|NCT00671853|581552856|FG001|Overall Study|Adverse Event|1|||
161044170|NCT00671853|581552855|FG000|Overall Study|Withdrawal by Subject|1|||
161044171|NCT00671853|581552856|FG001|Overall Study|Withdrawal by Subject|5|||
161044172|NCT00671853|581552855|FG000|Overall Study|Lost to Follow-up|8|||
161044173|NCT00671853|581552856|FG001|Overall Study|Lost to Follow-up|8|||
161044174|NCT00671853|581552855|FG000|Overall Study|Physician Decision|0|||
161044175|NCT00671853|581552856|FG001|Overall Study|Physician Decision|2|||
161044176|NCT00671853|581552855|FG000|Overall Study|Non-adherence with study procedures|1|||
161044177|NCT00671853|581552856|FG001|Overall Study|Non-adherence with study procedures|4|||
161044178|NCT02354417|581552857|FG000|Overall Study|Physician Decision|1|||
161044179|NCT02092285|581552858|FG000|Induction Phase|Adverse Event|7|||
161044180|NCT02092285|581552858|FG000|Induction Phase|Physician Decision|4|||
161044181|NCT02092285|581552858|FG000|Induction Phase|Pregnancy|1|||
161044182|NCT02092285|581552858|FG000|Induction Phase|Relapse/Recurrence|7|||
161044183|NCT02092285|581552858|FG000|Induction Phase|Withdrawal by Subject|2|||
161044184|NCT02092285|581552858|FG000|Induction Phase|Lack of Efficacy|14|||
161044185|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
161044186|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
161044187|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
161044188|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
161044189|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
161044190|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
161044191|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
161044192|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
161044193|NCT02092285|581552858|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
161044194|NCT00087516|581552859|FG000|Overall Study|Adverse Event|10|||
161044195|NCT00087516|581552860|FG001|Overall Study|Adverse Event|10|||
161044196|NCT00087516|581552861|FG002|Overall Study|Adverse Event|3|||
161044197|NCT00087516|581552862|FG003|Overall Study|Adverse Event|6|||
161044198|NCT00087516|581552859|FG000|Overall Study|Lack of Efficacy|82|||
161044199|NCT00087516|581552860|FG001|Overall Study|Lack of Efficacy|80|||
161344854|NCT04703192|582648809|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
161044200|NCT00087516|581552861|FG002|Overall Study|Lack of Efficacy|39|||
161044201|NCT00087516|581552862|FG003|Overall Study|Lack of Efficacy|29|||
161044202|NCT00087516|581552859|FG000|Overall Study|Lost to Follow-up|8|||
161044203|NCT00087516|581552860|FG001|Overall Study|Lost to Follow-up|6|||
161344855|NCT04703192|582648810|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
161149346|NCT03176966|581927861|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
161149347|NCT03176966|581927862|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
161149348|NCT03176966|581927861|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
161149349|NCT03176966|581927862|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
161149350|NCT03176966|581927861|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
161149351|NCT03176966|581927862|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
161149352|NCT03176966|581927861|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
161149353|NCT03176966|581927862|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
161149354|NCT01903434|581927870|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
161149355|NCT01903434|581927871|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
161149356|NCT01903434|581927870|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
161149357|NCT01903434|581927871|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
161149358|NCT00404768|581927872|FG000|Part A and B|Withdrawn due to labor progression|1|||
161149359|NCT00404768|581927873|FG001|Part A and B|Withdrawn due to labor progression|0|||
161149360|NCT00404768|581927874|FG002|Part A and B|Withdrawn due to labor progression|0|||
161149361|NCT00404768|581927875|FG003|Part A and B|Withdrawn due to labor progression|0|||
161149362|NCT00404768|581927872|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
161149363|NCT00404768|581927873|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
161149364|NCT00404768|581927874|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
161149365|NCT00404768|581927875|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
161149366|NCT00404768|581927872|FG000|Part C|Adverse Event|0|||
161149367|NCT00404768|581927873|FG001|Part C|Adverse Event|0|||
161149368|NCT00404768|581927874|FG002|Part C|Adverse Event|0|||
161149369|NCT00404768|581927875|FG003|Part C|Adverse Event|3|||
161149370|NCT00404768|581927872|FG000|Part C|Lost to Follow-up|0|||
161149371|NCT00404768|581927873|FG001|Part C|Lost to Follow-up|0|||
161149372|NCT00404768|581927874|FG002|Part C|Lost to Follow-up|3|||
161149373|NCT00404768|581927875|FG003|Part C|Lost to Follow-up|1|||
161149374|NCT00404768|581927872|FG000|Part C|Withdrawal by Subject|0|||
161149375|NCT00404768|581927873|FG001|Part C|Withdrawal by Subject|0|||
161149376|NCT00404768|581927874|FG002|Part C|Withdrawal by Subject|2|||
161149377|NCT00404768|581927875|FG003|Part C|Withdrawal by Subject|1|||
161149378|NCT00404768|581927872|FG000|Part C|Early withdrawal from study medication|0|||
161149379|NCT00404768|581927873|FG001|Part C|Early withdrawal from study medication|0|||
161149380|NCT00404768|581927874|FG002|Part C|Early withdrawal from study medication|1|||
161149381|NCT00404768|581927875|FG003|Part C|Early withdrawal from study medication|0|||
161149382|NCT00404768|581927872|FG000|Part C|Participant did not respond to therapy|0|||
161149383|NCT00404768|581927873|FG001|Part C|Participant did not respond to therapy|0|||
161044204|NCT00087516|581552861|FG002|Overall Study|Lost to Follow-up|5|||
161044205|NCT00087516|581552862|FG003|Overall Study|Lost to Follow-up|5|||
161044206|NCT00087516|581552859|FG000|Overall Study|Protocol Violation|4|||
161044207|NCT00087516|581552860|FG001|Overall Study|Protocol Violation|8|||
161044208|NCT00087516|581552861|FG002|Overall Study|Protocol Violation|3|||
161044209|NCT00087516|581552862|FG003|Overall Study|Protocol Violation|6|||
161044210|NCT00087516|581552859|FG000|Overall Study|Withdrawal by Subject|16|||
161044211|NCT00087516|581552860|FG001|Overall Study|Withdrawal by Subject|27|||
161044212|NCT00087516|581552861|FG002|Overall Study|Withdrawal by Subject|11|||
161044213|NCT00087516|581552862|FG003|Overall Study|Withdrawal by Subject|12|||
161044214|NCT00087516|581552859|FG000|Overall Study|Site terminated|0|||
161044215|NCT00087516|581552860|FG001|Overall Study|Site terminated|2|||
161044216|NCT00087516|581552861|FG002|Overall Study|Site terminated|1|||
161044217|NCT00087516|581552862|FG003|Overall Study|Site terminated|0|||
161044218|NCT00087516|581552859|FG000|Overall Study|Protocol specified discontinuation|35|||
161044219|NCT00087516|581552860|FG001|Overall Study|Protocol specified discontinuation|33|||
161044220|NCT00087516|581552861|FG002|Overall Study|Protocol specified discontinuation|33|||
161044221|NCT00087516|581552862|FG003|Overall Study|Protocol specified discontinuation|26|||
161044222|NCT00087516|581552859|FG000|Overall Study|Patient moved|3|||
161044223|NCT00087516|581552860|FG001|Overall Study|Patient moved|2|||
161044224|NCT00087516|581552861|FG002|Overall Study|Patient moved|1|||
161044225|NCT00087516|581552862|FG003|Overall Study|Patient moved|0|||
161149384|NCT00404768|581927874|FG002|Part C|Participant did not respond to therapy|1|||
161149385|NCT00404768|581927875|FG003|Part C|Participant did not respond to therapy|1|||
161149386|NCT00404768|581927872|FG000|Part C|Physician withdrew the study medication|0|||
161149387|NCT00404768|581927873|FG001|Part C|Physician withdrew the study medication|0|||
161149388|NCT00404768|581927874|FG002|Part C|Physician withdrew the study medication|1|||
161044226|NCT00087516|581552859|FG000|Overall Study|Patient was non-compliant|3|||
161149389|NCT00404768|581927875|FG003|Part C|Physician withdrew the study medication|0|||
161149390|NCT00404768|581927872|FG000|Part C|Participant delivered baby|0|||
161149391|NCT00404768|581927873|FG001|Part C|Participant delivered baby|0|||
161149392|NCT00404768|581927874|FG002|Part C|Participant delivered baby|0|||
161149393|NCT00404768|581927875|FG003|Part C|Participant delivered baby|1|||
161044227|NCT00087516|581552860|FG001|Overall Study|Patient was non-compliant|1|||
161044228|NCT00087516|581552861|FG002|Overall Study|Patient was non-compliant|0|||
161344856|NCT04703192|582648809|FG000|Overall Study|Other|5|||
161044229|NCT00087516|581552862|FG003|Overall Study|Patient was non-compliant|0|||
161149394|NCT00404768|581927872|FG000|Part C|Unsatisfactory uterine response to IP|0|||
161149395|NCT00404768|581927873|FG001|Part C|Unsatisfactory uterine response to IP|0|||
161149396|NCT00404768|581927874|FG002|Part C|Unsatisfactory uterine response to IP|0|||
161149397|NCT00404768|581927875|FG003|Part C|Unsatisfactory uterine response to IP|1|||
161149398|NCT00404768|581927872|FG000|Part C|Active labor|0|||
161149399|NCT00404768|581927873|FG001|Part C|Active labor|0|||
161149400|NCT00404768|581927874|FG002|Part C|Active labor|0|||
161149401|NCT00404768|581927875|FG003|Part C|Active labor|1|||
161149402|NCT00404768|581927872|FG000|Part C|Lack of Efficacy|0|||
161149403|NCT00404768|581927873|FG001|Part C|Lack of Efficacy|0|||
161149404|NCT00404768|581927874|FG002|Part C|Lack of Efficacy|0|||
161149405|NCT00404768|581927875|FG003|Part C|Lack of Efficacy|2|||
161149406|NCT00404768|581927872|FG000|Part C|Treatment failure|0|||
161149407|NCT00404768|581927873|FG001|Part C|Treatment failure|0|||
161149408|NCT00404768|581927874|FG002|Part C|Treatment failure|0|||
161149409|NCT00404768|581927875|FG003|Part C|Treatment failure|1|||
161149410|NCT00404768|581927872|FG000|Part C|Investigator discretion|0|||
161149411|NCT00404768|581927873|FG001|Part C|Investigator discretion|0|||
161149412|NCT00404768|581927874|FG002|Part C|Investigator discretion|0|||
161149413|NCT00404768|581927875|FG003|Part C|Investigator discretion|1|||
161149414|NCT00404768|581927872|FG000|Part C|Researcher suspended study medication|0|||
161149415|NCT00404768|581927873|FG001|Part C|Researcher suspended study medication|0|||
161149416|NCT00404768|581927874|FG002|Part C|Researcher suspended study medication|0|||
161149417|NCT00404768|581927875|FG003|Part C|Researcher suspended study medication|1|||
161149418|NCT01118143|581927876|FG000|Overall Study|Withdrawal by Subject|2|||
161149419|NCT01118143|581927877|FG001|Overall Study|Withdrawal by Subject|5|||
161149420|NCT00960440|581929847|FG000|Overall Study|Death|0|||
161149421|NCT00960440|581929848|FG001|Overall Study|Death|0|||
161149422|NCT00960440|581929849|FG002|Overall Study|Death|0|||
161149423|NCT00960440|581929850|FG003|Overall Study|Death|1|||
161149424|NCT00960440|581929847|FG000|Overall Study|Adverse Event|12|||
161149425|NCT00960440|581929848|FG001|Overall Study|Adverse Event|12|||
161149426|NCT00960440|581929849|FG002|Overall Study|Adverse Event|4|||
161149427|NCT00960440|581929850|FG003|Overall Study|Adverse Event|4|||
161149428|NCT00960440|581929847|FG000|Overall Study|Lack of Efficacy|2|||
161149429|NCT00960440|581929848|FG001|Overall Study|Lack of Efficacy|5|||
161149430|NCT00960440|581929849|FG002|Overall Study|Lack of Efficacy|3|||
161149431|NCT00960440|581929850|FG003|Overall Study|Lack of Efficacy|8|||
161149432|NCT00960440|581929847|FG000|Overall Study|Protocol Violation|2|||
161149433|NCT00960440|581929848|FG001|Overall Study|Protocol Violation|8|||
161149434|NCT00960440|581929849|FG002|Overall Study|Protocol Violation|3|||
161149435|NCT00960440|581929850|FG003|Overall Study|Protocol Violation|4|||
161149436|NCT00960440|581929847|FG000|Overall Study|Withdrawal by Subject|9|||
161044230|NCT00087516|581552859|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
161044231|NCT00087516|581552860|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
161044232|NCT00087516|581552861|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
161044233|NCT00087516|581552862|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
161044234|NCT00087516|581552859|FG000|Overall Study|Other|0|||
161044235|NCT00087516|581552860|FG001|Overall Study|Other|0|||
161044236|NCT00087516|581552861|FG002|Overall Study|Other|1|||
161044237|NCT00087516|581552862|FG003|Overall Study|Other|0|||
161044238|NCT01719172|581552863|FG000|Overall Study|Lost to Follow-up|1|||
161044239|NCT01719172|581552863|FG000|Overall Study|Death|1|||
161044240|NCT01848483|581552864|FG000|Overall Study|Death|2|||
161044241|NCT01848483|581552865|FG001|Overall Study|Death|1|||
161044242|NCT01848483|581552864|FG000|Overall Study|Lost to Follow-up|6|||
161044243|NCT01848483|581552865|FG001|Overall Study|Lost to Follow-up|8|||
161044244|NCT01848483|581552864|FG000|Overall Study|Withdrawal by Subject|1|||
161044245|NCT01848483|581552865|FG001|Overall Study|Withdrawal by Subject|0|||
161044246|NCT01848483|581552864|FG000|Overall Study|Incarceration|2|||
161149437|NCT00960440|581929848|FG001|Overall Study|Withdrawal by Subject|5|||
161149438|NCT00960440|581929849|FG002|Overall Study|Withdrawal by Subject|2|||
161149439|NCT00960440|581929850|FG003|Overall Study|Withdrawal by Subject|1|||
161149440|NCT00960440|581929847|FG000|Overall Study|Other|1|||
161149441|NCT00960440|581929848|FG001|Overall Study|Other|1|||
161149442|NCT00960440|581929849|FG002|Overall Study|Other|1|||
161149443|NCT00960440|581929850|FG003|Overall Study|Other|0|||
161044247|NCT01848483|581552865|FG001|Overall Study|Incarceration|2|||
161149444|NCT03504774|581929851|FG000|Overall Study|Adverse Event|2|||
161149445|NCT03504774|581929852|FG001|Overall Study|Adverse Event|0|||
161149446|NCT03504774|581929851|FG000|Overall Study|Lost to Follow-up|0|||
161149447|NCT03504774|581929852|FG001|Overall Study|Lost to Follow-up|1|||
161149448|NCT03504774|581929851|FG000|Overall Study|Protocol Violation|11|||
161149449|NCT03504774|581929852|FG001|Overall Study|Protocol Violation|3|||
161044248|NCT02236611|581552868|FG000|Overall Study|Adverse Event|10|||
161044249|NCT02236611|581552869|FG001|Overall Study|Adverse Event|16|||
161044250|NCT02236611|581552868|FG000|Overall Study|Lack of Efficacy|4|||
161149450|NCT03504774|581929851|FG000|Overall Study|failed wk 52 DBPCFC|1|||
161044251|NCT02236611|581552869|FG001|Overall Study|Lack of Efficacy|7|||
161044252|NCT02236611|581552868|FG000|Overall Study|Lost to Follow-up|0|||
161044253|NCT02236611|581552869|FG001|Overall Study|Lost to Follow-up|2|||
161044254|NCT02236611|581552868|FG000|Overall Study|Protocol deviation|3|||
161044255|NCT02236611|581552869|FG001|Overall Study|Protocol deviation|5|||
161344857|NCT04703192|582648810|FG001|Overall Study|Other|1|||
161044256|NCT02236611|581552868|FG000|Overall Study|Withdrew consent|9|||
161044257|NCT02236611|581552869|FG001|Overall Study|Withdrew consent|4|||
161044258|NCT03041090|581552870|FG000|Overall Study|technical error|0|||
161044259|NCT03041090|581552871|FG001|Overall Study|technical error|3|||
161044260|NCT02202317|581552872|FG000|Overall Study|Lost to Follow-up|1|||
161044261|NCT02338999|581552873|FG000|First Intervention|Withdrawal by Subject|3|||
161044262|NCT02338999|581552874|FG001|First Intervention|Withdrawal by Subject|1|||
161044263|NCT02338999|581552873|FG000|Washout Period|Withdrawal by Subject|0|||
161044264|NCT02338999|581552874|FG001|Washout Period|Withdrawal by Subject|2|||
161044265|NCT02338999|581552873|FG000|Second Intervention|Withdrawal by Subject|0|||
161044266|NCT02338999|581552874|FG001|Second Intervention|Withdrawal by Subject|2|||
161044267|NCT02701296|581552875|FG000|Overall Study|Incomplete Data|0|||
161044268|NCT02701296|581552876|FG001|Overall Study|Incomplete Data|2|||
161044269|NCT01450007|581552878|FG000|Overall Study|Late exclusion before treatment|2|||
161044270|NCT01450007|581552879|FG001|Overall Study|Late exclusion before treatment|3|||
161044271|NCT01450007|581552880|FG002|Overall Study|Late exclusion before treatment|2|||
161044272|NCT01450007|581552878|FG000|Overall Study|Protocol Violation|0|||
161044273|NCT01450007|581552879|FG001|Overall Study|Protocol Violation|1|||
161044274|NCT01450007|581552880|FG002|Overall Study|Protocol Violation|1|||
161044275|NCT01450007|581552878|FG000|Overall Study|Adverse Event|0|||
161044276|NCT01450007|581552879|FG001|Overall Study|Adverse Event|1|||
161044277|NCT01450007|581552880|FG002|Overall Study|Adverse Event|0|||
161044278|NCT03851094|581552881|FG000|Overall Study|Withdrawal by Subject|0|||
161044279|NCT03851094|581552882|FG001|Overall Study|Withdrawal by Subject|1|||
161044280|NCT03851094|581552881|FG000|Overall Study|Participant lost device|0|||
161044281|NCT03851094|581552882|FG001|Overall Study|Participant lost device|1|||
161044282|NCT03851094|581552881|FG000|Overall Study|Participant returned device|0|||
161044283|NCT03851094|581552882|FG001|Overall Study|Participant returned device|2|||
161044284|NCT00484198|581552883|FG000|Overall Study|Participant Withdrew Consent|12|||
161044285|NCT00484198|581552884|FG001|Overall Study|Participant Withdrew Consent|21|||
161044286|NCT00484198|581552885|FG002|Overall Study|Participant Withdrew Consent|47|||
161044287|NCT00484198|581552886|FG003|Overall Study|Participant Withdrew Consent|59|||
161044288|NCT00484198|581552883|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
161044289|NCT00484198|581552884|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
161044290|NCT00484198|581552885|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
161044291|NCT00484198|581552886|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
161044292|NCT00484198|581552883|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
161044293|NCT00484198|581552884|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
161044294|NCT00484198|581552885|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
161044295|NCT00484198|581552886|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
161044296|NCT00484198|581552883|FG000|Overall Study|Adverse Event|3|||
161044297|NCT00484198|581552884|FG001|Overall Study|Adverse Event|11|||
161044298|NCT00484198|581552885|FG002|Overall Study|Adverse Event|32|||
161044299|NCT00484198|581552886|FG003|Overall Study|Adverse Event|31|||
161044300|NCT00484198|581552883|FG000|Overall Study|Protocol Violation|0|||
161044301|NCT00484198|581552884|FG001|Overall Study|Protocol Violation|5|||
161044302|NCT00484198|581552885|FG002|Overall Study|Protocol Violation|6|||
161044303|NCT00484198|581552886|FG003|Overall Study|Protocol Violation|8|||
161044304|NCT00484198|581552883|FG000|Overall Study|Other|7|||
161044305|NCT00484198|581552884|FG001|Overall Study|Other|10|||
161044306|NCT00484198|581552885|FG002|Overall Study|Other|31|||
161044307|NCT00484198|581552886|FG003|Overall Study|Other|28|||
161044308|NCT01536704|581552887|FG000|Washout Period 1|Withdrawal by Subject|1|||
161044309|NCT01536704|581552888|FG001|Washout Period 1|Withdrawal by Subject|2|||
161044310|NCT01536704|581552889|FG002|Washout Period 1|Withdrawal by Subject|0|||
161044311|NCT01536704|581552890|FG003|Washout Period 1|Withdrawal by Subject|0|||
161044312|NCT01536704|581552887|FG000|Washout Period 2|Adverse Event|1|||
161044313|NCT01536704|581552888|FG001|Washout Period 2|Adverse Event|0|||
161044314|NCT01536704|581552889|FG002|Washout Period 2|Adverse Event|0|||
161044315|NCT01536704|581552890|FG003|Washout Period 2|Adverse Event|0|||
161044316|NCT01536704|581552887|FG000|Washout Period 2|Withdrawal by Subject|0|||
161044317|NCT01536704|581552888|FG001|Washout Period 2|Withdrawal by Subject|0|||
161044318|NCT01536704|581552889|FG002|Washout Period 2|Withdrawal by Subject|0|||
161044319|NCT01536704|581552890|FG003|Washout Period 2|Withdrawal by Subject|1|||
161044320|NCT01536704|581552887|FG000|Period 3|Adverse Event|0|||
161044321|NCT01536704|581552888|FG001|Period 3|Adverse Event|0|||
161044322|NCT01536704|581552889|FG002|Period 3|Adverse Event|0|||
161044323|NCT01536704|581552890|FG003|Period 3|Adverse Event|1|||
161044324|NCT01536704|581552887|FG000|Washout Period 3|Adverse Event|0|||
161044325|NCT01536704|581552888|FG001|Washout Period 3|Adverse Event|0|||
161044326|NCT01536704|581552889|FG002|Washout Period 3|Adverse Event|1|||
161044327|NCT01536704|581552890|FG003|Washout Period 3|Adverse Event|0|||
161044328|NCT04658784|581552891|FG000|6-month Follow-up|Lost to Follow-up|2|||
161044329|NCT04658784|581552892|FG001|6-month Follow-up|Lost to Follow-up|5|||
161044330|NCT02958553|581552893|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
161044331|NCT02958553|581552893|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
161044332|NCT00704340|581552901|FG000|Overall Study|Lost to Follow-up|2|||
161044333|NCT00704340|581552902|FG001|Overall Study|Lost to Follow-up|1|||
161044334|NCT00704340|581552901|FG000|Overall Study|Death|0|||
161044335|NCT00704340|581552902|FG001|Overall Study|Death|1|||
161044336|NCT00703092|581552906|FG000|Overall Study|Withdrawal by Subject|2|||
161044337|NCT02007070|581552907|FG000|Overall Study|Adverse Event|4|||
161044338|NCT02007070|581552907|FG000|Overall Study|Clinical Progression|4|||
161044339|NCT02007070|581552907|FG000|Overall Study|Death|1|||
161044340|NCT02007070|581552907|FG000|Overall Study|Protocol Violation|2|||
161044341|NCT02007070|581552907|FG000|Overall Study|Physician Decision|1|||
161044342|NCT02007070|581552907|FG000|Overall Study|Progressive Disease|21|||
161044343|NCT00403845|581552911|FG000|Treatment Period 1|Subject withdrew consent|1|||
161044344|NCT00403845|581552912|FG001|Treatment Period 1|Subject withdrew consent|0|||
161044345|NCT00403845|581552913|FG002|Treatment Period 1|Subject withdrew consent|0|||
161044346|NCT00403845|581552914|FG003|Treatment Period 1|Subject withdrew consent|0|||
161044347|NCT00403845|581552911|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
161044348|NCT00403845|581552912|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
161044349|NCT00403845|581552913|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
161044350|NCT00403845|581552914|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
161044351|NCT00403845|581552911|FG000|Treatment Period 2|Subject withdrew consent|1|||
161044352|NCT00403845|581552912|FG001|Treatment Period 2|Subject withdrew consent|0|||
161044353|NCT00403845|581552913|FG002|Treatment Period 2|Subject withdrew consent|0|||
161044354|NCT00403845|581552914|FG003|Treatment Period 2|Subject withdrew consent|0|||
161044355|NCT00403845|581552911|FG000|Treatment Period 3|Subject withdrew consent|0|||
161044356|NCT00403845|581552912|FG001|Treatment Period 3|Subject withdrew consent|0|||
161044357|NCT00403845|581552913|FG002|Treatment Period 3|Subject withdrew consent|0|||
161044358|NCT00403845|581552914|FG003|Treatment Period 3|Subject withdrew consent|1|||
161044359|NCT00403845|581552911|FG000|Treatment Period 3|Adverse Event|0|||
161044360|NCT00403845|581552912|FG001|Treatment Period 3|Adverse Event|0|||
161044361|NCT00403845|581552913|FG002|Treatment Period 3|Adverse Event|0|||
161044362|NCT00403845|581552914|FG003|Treatment Period 3|Adverse Event|1|||
161044363|NCT03316170|581552915|FG000|Overall Study|Death|1|||
161044364|NCT03316170|581552916|FG001|Overall Study|Death|0|||
161044365|NCT03316170|581552915|FG000|Overall Study|Lost to Follow-up|6|||
161044366|NCT03316170|581552916|FG001|Overall Study|Lost to Follow-up|7|||
161044367|NCT02935673|581552917|FG000|Overall Study|Adverse Event|0|||
161044368|NCT02935673|581552918|FG001|Overall Study|Adverse Event|1|||
161044369|NCT02935673|581552919|FG002|Overall Study|Adverse Event|0|||
161044370|NCT02935673|581552917|FG000|Overall Study|Withdrawal by Subject|1|||
161044371|NCT02935673|581552918|FG001|Overall Study|Withdrawal by Subject|2|||
161044372|NCT02935673|581552919|FG002|Overall Study|Withdrawal by Subject|0|||
161044373|NCT01836523|581552920|FG000|Overall Study|Adverse Event|15|||
161044374|NCT01836523|581552921|FG001|Overall Study|Adverse Event|41|||
161044375|NCT01836523|581552922|FG002|Overall Study|Adverse Event|49|||
161044376|NCT01836523|581552923|FG003|Overall Study|Adverse Event|14|||
161044377|NCT01836523|581552920|FG000|Overall Study|Protocol Violation|6|||
161044378|NCT01836523|581552921|FG001|Overall Study|Protocol Violation|3|||
161044379|NCT01836523|581552922|FG002|Overall Study|Protocol Violation|2|||
161044380|NCT01836523|581552923|FG003|Overall Study|Protocol Violation|4|||
161044381|NCT01836523|581552920|FG000|Overall Study|Met Withdrawal Criteria|13|||
161044382|NCT01836523|581552921|FG001|Overall Study|Met Withdrawal Criteria|13|||
161044383|NCT01836523|581552922|FG002|Overall Study|Met Withdrawal Criteria|21|||
161044384|NCT01836523|581552923|FG003|Overall Study|Met Withdrawal Criteria|27|||
161044385|NCT01836523|581552920|FG000|Overall Study|Unclassified|17|||
161044386|NCT01836523|581552921|FG001|Overall Study|Unclassified|28|||
161149451|NCT03504774|581929852|FG001|Overall Study|failed wk 52 DBPCFC|0|||
161149452|NCT01781429|581929853|FG000|Overall Study|Death|0|||
161044387|NCT01836523|581552922|FG002|Overall Study|Unclassified|19|||
161044388|NCT01836523|581552923|FG003|Overall Study|Unclassified|29|||
161044389|NCT00749944|581552924|FG000|Overall Study|Lost to Follow-up|2|||
161044390|NCT00749944|581552925|FG001|Overall Study|Lost to Follow-up|1|||
161044391|NCT00749944|581552924|FG000|Overall Study|Other|1|||
161044392|NCT00749944|581552925|FG001|Overall Study|Other|0|||
161044393|NCT00749944|581552924|FG000|Overall Study|Withdrawal by Subject|2|||
161044394|NCT00749944|581552925|FG001|Overall Study|Withdrawal by Subject|0|||
161044395|NCT00681109|581552926|FG000|Overall Study|Lost to Follow-up|2|||
161044396|NCT00681109|581552927|FG001|Overall Study|Lost to Follow-up|6|||
161044397|NCT00681109|581552928|FG002|Overall Study|Lost to Follow-up|0|||
161044398|NCT03128099|581552929|FG000|Overall Study|High dose task was too long|0|||
161149453|NCT01781429|581929854|FG001|Overall Study|Death|0|||
161149454|NCT01781429|581929855|FG002|Overall Study|Death|0|||
161044399|NCT03128099|581552930|FG001|Overall Study|High dose task was too long|4|||
161044400|NCT03128099|581552931|FG002|Overall Study|High dose task was too long|0|||
161044401|NCT03128099|581552929|FG000|Overall Study|Participant got a full time job.|1|||
161044402|NCT03128099|581552930|FG001|Overall Study|Participant got a full time job.|0|||
161044403|NCT03128099|581552931|FG002|Overall Study|Participant got a full time job.|0|||
161044404|NCT03128099|581552929|FG000|Overall Study|Became homeless and lost contact|1|||
161044405|NCT03128099|581552930|FG001|Overall Study|Became homeless and lost contact|0|||
161044406|NCT03128099|581552931|FG002|Overall Study|Became homeless and lost contact|0|||
161044407|NCT03128099|581552929|FG000|Overall Study|Did not complete all the assessments|0|||
161044408|NCT03128099|581552930|FG001|Overall Study|Did not complete all the assessments|0|||
161044409|NCT03128099|581552931|FG002|Overall Study|Did not complete all the assessments|1|||
161044410|NCT00148122|581552932|FG000|Overall Study|Withdrawal by Subject|2|||
161044411|NCT02362789|581552942|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
161044412|NCT02362789|581552943|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
161044413|NCT02362789|581552944|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
161044414|NCT02362789|581552942|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
161044415|NCT02362789|581552943|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
161044416|NCT02362789|581552944|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
161044417|NCT02362789|581552942|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
161044418|NCT02362789|581552943|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
161044419|NCT02362789|581552944|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
161044420|NCT02362789|581552942|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
161044421|NCT02362789|581552943|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
161044422|NCT02362789|581552944|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
161044423|NCT02362789|581552942|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
161044424|NCT02362789|581552943|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
161044425|NCT02362789|581552944|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
161044426|NCT03035942|581552949|FG000|Overall Study|Adverse Event|8|||
161044427|NCT03035942|581552950|FG001|Overall Study|Adverse Event|4|||
161044428|NCT03035942|581552951|FG002|Overall Study|Adverse Event|5|||
161044429|NCT05270460|581552952|FG000|Overall Study|Adverse Event|0|||
161044430|NCT05270460|581552953|FG001|Overall Study|Adverse Event|1|||
161044431|NCT05270460|581552954|FG002|Overall Study|Adverse Event|0|||
161044432|NCT05270460|581552952|FG000|Overall Study|Early Termination|0|||
161044433|NCT05270460|581552953|FG001|Overall Study|Early Termination|1|||
161044434|NCT05270460|581552954|FG002|Overall Study|Early Termination|0|||
161044435|NCT00380250|581552955|FG000|Overall Study|Withdrawal by Subject|39|||
161044436|NCT00380250|581552956|FG001|Overall Study|Withdrawal by Subject|28|||
161044437|NCT00380250|581552955|FG000|Overall Study|Adverse Event|20|||
161044438|NCT00380250|581552956|FG001|Overall Study|Adverse Event|9|||
161044439|NCT00380250|581552955|FG000|Overall Study|Lack of Efficacy|10|||
161044440|NCT00380250|581552956|FG001|Overall Study|Lack of Efficacy|8|||
161044441|NCT00380250|581552955|FG000|Overall Study|Protocol Violation|15|||
161044442|NCT00380250|581552956|FG001|Overall Study|Protocol Violation|5|||
161044443|NCT00380250|581552955|FG000|Overall Study|Lost to Follow-up|14|||
161044444|NCT00380250|581552956|FG001|Overall Study|Lost to Follow-up|5|||
161044445|NCT00380250|581552955|FG000|Overall Study|Physician Decision|1|||
161044446|NCT00380250|581552956|FG001|Overall Study|Physician Decision|0|||
161044447|NCT01989104|581552957|FG000|Overall Study|Withdrawal by Subject|3|||
161044448|NCT01989104|581552958|FG001|Overall Study|Withdrawal by Subject|0|||
161044449|NCT01989104|581552959|FG002|Overall Study|Withdrawal by Subject|0|||
161044450|NCT01989104|581552960|FG003|Overall Study|Withdrawal by Subject|0|||
161044451|NCT01989104|581552961|FG004|Overall Study|Withdrawal by Subject|0|||
161044452|NCT01802333|581555224|FG000|Overall Study|Ineligible|2|||
161044453|NCT01802333|581555225|FG001|Overall Study|Ineligible|6|||
161044454|NCT01802333|581555226|FG002|Overall Study|Ineligible|8|||
161044455|NCT01802333|581555224|FG000|Overall Study|Adverse Event|1|||
161044456|NCT01802333|581555225|FG001|Overall Study|Adverse Event|8|||
161044457|NCT01802333|581555226|FG002|Overall Study|Adverse Event|8|||
161044458|NCT01802333|581555224|FG000|Overall Study|Withdrawal by Subject|6|||
161044459|NCT01802333|581555225|FG001|Overall Study|Withdrawal by Subject|6|||
161044460|NCT01802333|581555226|FG002|Overall Study|Withdrawal by Subject|5|||
161044461|NCT01802333|581555224|FG000|Overall Study|Progression/relapse|1|||
161044462|NCT01802333|581555225|FG001|Overall Study|Progression/relapse|3|||
161044463|NCT01802333|581555226|FG002|Overall Study|Progression/relapse|0|||
161044464|NCT01802333|581555224|FG000|Overall Study|Death|7|||
161044465|NCT01802333|581555225|FG001|Overall Study|Death|14|||
161044466|NCT01802333|581555226|FG002|Overall Study|Death|13|||
161044467|NCT01802333|581555224|FG000|Overall Study|Other - not protocol specified|32|||
161044468|NCT01802333|581555225|FG001|Overall Study|Other - not protocol specified|22|||
161149455|NCT01781429|581929856|FG003|Overall Study|Death|0|||
161044469|NCT01802333|581555226|FG002|Overall Study|Other - not protocol specified|24|||
161044470|NCT01802333|581555224|FG000|Overall Study|Did not start treatment|0|||
161044471|NCT01802333|581555225|FG001|Overall Study|Did not start treatment|2|||
161044472|NCT01802333|581555226|FG002|Overall Study|Did not start treatment|5|||
161044473|NCT01947491|581555228|FG000|Overall Study|Lost to Follow-up|5|||
161044474|NCT01947491|581555229|FG001|Overall Study|Lost to Follow-up|3|||
161149456|NCT01781429|581929857|FG004|Overall Study|Death|0|||
161280649|NCT04803305|582406997|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
161044475|NCT01947491|581555230|FG002|Overall Study|Lost to Follow-up|1|||
161044476|NCT01947491|581555231|FG003|Overall Study|Lost to Follow-up|2|||
161044477|NCT01947491|581555228|FG000|Overall Study|Lack of Efficacy|1|||
161044478|NCT01947491|581555229|FG001|Overall Study|Lack of Efficacy|0|||
161044479|NCT01947491|581555230|FG002|Overall Study|Lack of Efficacy|0|||
161044480|NCT01947491|581555231|FG003|Overall Study|Lack of Efficacy|1|||
161044481|NCT01947491|581555228|FG000|Overall Study|Protocol Violation|1|||
161044482|NCT01947491|581555229|FG001|Overall Study|Protocol Violation|0|||
161044483|NCT01947491|581555230|FG002|Overall Study|Protocol Violation|0|||
161044484|NCT01947491|581555231|FG003|Overall Study|Protocol Violation|0|||
161044485|NCT01947491|581555228|FG000|Overall Study|Withdrawal by Subject|1|||
161044486|NCT01947491|581555229|FG001|Overall Study|Withdrawal by Subject|1|||
161044487|NCT01947491|581555230|FG002|Overall Study|Withdrawal by Subject|1|||
161044488|NCT01947491|581555231|FG003|Overall Study|Withdrawal by Subject|0|||
161044489|NCT01947491|581555228|FG000|Overall Study|Worsening of condition|0|||
161044490|NCT01947491|581555229|FG001|Overall Study|Worsening of condition|1|||
161044491|NCT01947491|581555230|FG002|Overall Study|Worsening of condition|0|||
161044492|NCT01947491|581555231|FG003|Overall Study|Worsening of condition|0|||
161044493|NCT01947491|581555228|FG000|Overall Study|Adverse Event|0|||
161044494|NCT01947491|581555229|FG001|Overall Study|Adverse Event|1|||
161044495|NCT01947491|581555230|FG002|Overall Study|Adverse Event|0|||
161044496|NCT01947491|581555231|FG003|Overall Study|Adverse Event|2|||
161044497|NCT02224755|581555232|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
161044498|NCT02224755|581555233|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
161044499|NCT02224755|581555232|FG000|Two Year Follow up Post-implant|Death|103|||
161044500|NCT02224755|581555233|FG001|Two Year Follow up Post-implant|Death|98|||
161044501|NCT02224755|581555232|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
161044502|NCT02224755|581555233|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
161044503|NCT02224755|581555232|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
161044504|NCT02224755|581555233|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
161044505|NCT02224755|581555232|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
161044506|NCT02224755|581555233|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
161044507|NCT02067663|581555234|FG000|Overall Study|Lost to Follow-up|13|||
161044508|NCT02067663|581555235|FG001|Overall Study|Lost to Follow-up|14|||
161044509|NCT04311983|581555236|FG000|Overall Study|Lost to Follow-up|421|||
161044510|NCT04311983|581555237|FG001|Overall Study|Lost to Follow-up|456|||
161044511|NCT04311983|581555236|FG000|Overall Study|Incomplete survey|7|||
161044512|NCT04311983|581555237|FG001|Overall Study|Incomplete survey|9|||
161044513|NCT04311983|581555236|FG000|Overall Study|Death|1|||
161044514|NCT04311983|581555237|FG001|Overall Study|Death|0|||
161044515|NCT00486954|581555241|FG000|Pilot Part|Adverse Event|4|||
161044516|NCT00486954|581555242|FG001|Pilot Part|Adverse Event|0|||
161044517|NCT00486954|581555243|FG002|Pilot Part|Adverse Event|5|||
161044518|NCT00486954|581555244|FG003|Pilot Part|Adverse Event|0|||
161044519|NCT00486954|581555245|FG004|Pilot Part|Adverse Event|0|||
161044520|NCT00486954|581555241|FG000|Pilot Part|Disease Progression|2|||
161044521|NCT00486954|581555242|FG001|Pilot Part|Disease Progression|0|||
161044522|NCT00486954|581555243|FG002|Pilot Part|Disease Progression|1|||
161044523|NCT00486954|581555244|FG003|Pilot Part|Disease Progression|0|||
161044524|NCT00486954|581555245|FG004|Pilot Part|Disease Progression|0|||
161044525|NCT00486954|581555241|FG000|Randomized Part|Lost to Follow-up|0|||
161044526|NCT00486954|581555242|FG001|Randomized Part|Lost to Follow-up|0|||
161044527|NCT00486954|581555243|FG002|Randomized Part|Lost to Follow-up|0|||
161044528|NCT00486954|581555244|FG003|Randomized Part|Lost to Follow-up|0|||
161044529|NCT00486954|581555245|FG004|Randomized Part|Lost to Follow-up|1|||
161044530|NCT00486954|581555241|FG000|Randomized Part|Withdrawal by Subject|0|||
161044531|NCT00486954|581555242|FG001|Randomized Part|Withdrawal by Subject|0|||
161044532|NCT00486954|581555243|FG002|Randomized Part|Withdrawal by Subject|0|||
161149457|NCT01781429|581929858|FG005|Overall Study|Death|0|||
161149458|NCT01781429|581929859|FG006|Overall Study|Death|0|||
161149459|NCT01781429|581929860|FG007|Overall Study|Death|0|||
161280650|NCT04803305|582406998|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
161280651|NCT04803305|582406997|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
161044533|NCT00486954|581555244|FG003|Randomized Part|Withdrawal by Subject|1|||
161044534|NCT00486954|581555245|FG004|Randomized Part|Withdrawal by Subject|0|||
161044535|NCT00486954|581555241|FG000|Randomized Part|Sponsor Terminated Study|0|||
161044536|NCT00486954|581555242|FG001|Randomized Part|Sponsor Terminated Study|0|||
161044537|NCT00486954|581555243|FG002|Randomized Part|Sponsor Terminated Study|0|||
161044538|NCT00486954|581555244|FG003|Randomized Part|Sponsor Terminated Study|19|||
161044539|NCT00486954|581555245|FG004|Randomized Part|Sponsor Terminated Study|13|||
161044540|NCT05124210|581555246|FG000|Overall Study|Lost to Follow-up|1|||
161044541|NCT05124210|581555247|FG001|Overall Study|Lost to Follow-up|0|||
161044542|NCT05124210|581555246|FG000|Overall Study|Withdrawal by Subject|1|||
161044543|NCT05124210|581555247|FG001|Overall Study|Withdrawal by Subject|0|||
161044544|NCT00638456|581555250|FG000|Overall Study|Withdrawal by Subject|6|||
161044545|NCT00638456|581555251|FG001|Overall Study|Withdrawal by Subject|2|||
161044546|NCT03236779|581555252|FG000|Overall Study|Lost to Follow-up|13|||
161044547|NCT03236779|581555253|FG001|Overall Study|Lost to Follow-up|21|||
161044548|NCT00929526|581555255|FG000|Overall Study|Withdrawal by Subject|1|||
161044549|NCT00929526|581555256|FG001|Overall Study|Withdrawal by Subject|11|||
161044550|NCT00929526|581555255|FG000|Overall Study|Lost to Follow-up|8|||
161044551|NCT00929526|581555256|FG001|Overall Study|Lost to Follow-up|12|||
161044552|NCT00929526|581555255|FG000|Overall Study|Other|8|||
161044553|NCT00929526|581555256|FG001|Overall Study|Other|6|||
161044554|NCT02169414|581555259|FG000|Overall Study|Withdrawal by Subject|1|||
161044555|NCT02169414|581555260|FG001|Overall Study|Withdrawal by Subject|0|||
161044556|NCT02169414|581555261|FG002|Overall Study|Withdrawal by Subject|0|||
161044557|NCT02169414|581555262|FG003|Overall Study|Withdrawal by Subject|0|||
161044558|NCT02169414|581555259|FG000|Overall Study|Adverse Event|0|||
161044559|NCT02169414|581555260|FG001|Overall Study|Adverse Event|1|||
161044560|NCT02169414|581555261|FG002|Overall Study|Adverse Event|0|||
161044561|NCT02169414|581555262|FG003|Overall Study|Adverse Event|0|||
161044562|NCT02309515|581555263|FG000|Overall Study|Withdrawal by Subject|0|||
161044563|NCT02309515|581555264|FG001|Overall Study|Withdrawal by Subject|1|||
161044564|NCT04070105|581555265|FG000|Overall Study|Lost to Follow-up|0|||
161044565|NCT04070105|581555266|FG001|Overall Study|Lost to Follow-up|0|||
161044566|NCT04070105|581555267|FG002|Overall Study|Lost to Follow-up|0|||
161044567|NCT04070105|581555268|FG003|Overall Study|Lost to Follow-up|0|||
161044568|NCT04070105|581555269|FG004|Overall Study|Lost to Follow-up|0|||
161044569|NCT04070105|581555270|FG005|Overall Study|Lost to Follow-up|1|||
161044570|NCT02547974|581555271|FG000|Overall Study|Withdrawal by Subject|1|||
161044571|NCT02547974|581555272|FG001|Overall Study|Withdrawal by Subject|0|||
161044572|NCT02547974|581555273|FG002|Overall Study|Withdrawal by Subject|0|||
161044573|NCT02547974|581555274|FG003|Overall Study|Withdrawal by Subject|0|||
161044574|NCT01072149|581555275|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044575|NCT01072149|581555276|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044576|NCT01072149|581555277|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
161044577|NCT01072149|581555278|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044578|NCT01072149|581555279|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044579|NCT01072149|581555280|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044580|NCT01072149|581555281|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044581|NCT01072149|581555282|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044582|NCT01072149|581555283|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044583|NCT01072149|581555284|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044584|NCT01072149|581555285|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044585|NCT01072149|581555286|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044586|NCT01072149|581555287|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044587|NCT01072149|581555288|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044588|NCT01072149|581555289|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044589|NCT01072149|581555290|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044590|NCT01072149|581555291|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044591|NCT01072149|581555292|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
161044592|NCT01072149|581555275|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044593|NCT01072149|581555276|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044594|NCT01072149|581555277|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044595|NCT01072149|581555278|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044596|NCT01072149|581555279|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044597|NCT01072149|581555280|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044598|NCT01072149|581555281|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044599|NCT01072149|581555282|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044600|NCT01072149|581555283|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044601|NCT01072149|581555284|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044602|NCT01072149|581555285|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044603|NCT01072149|581555286|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044604|NCT01072149|581555287|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044605|NCT01072149|581555288|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044606|NCT01072149|581555289|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044607|NCT01072149|581555290|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044608|NCT01072149|581555291|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
161044609|NCT01072149|581555292|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
161044610|NCT01072149|581555275|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161280652|NCT04803305|582406998|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
161280653|NCT04803305|582406997|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
161044611|NCT01072149|581555276|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044612|NCT01072149|581555277|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161149460|NCT01781429|581929861|FG008|Overall Study|Death|0|||
161280654|NCT04803305|582406998|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
161149461|NCT01781429|581929862|FG009|Overall Study|Death|1|||
161149462|NCT01781429|581929863|FG010|Overall Study|Death|0|||
161149463|NCT01781429|581929864|FG011|Overall Study|Death|0|||
161149464|NCT01781429|581929865|FG012|Overall Study|Death|1|||
161149465|NCT01781429|581929866|FG013|Overall Study|Death|0|||
161149466|NCT01781429|581929867|FG014|Overall Study|Death|1|||
161149467|NCT01781429|581929868|FG015|Overall Study|Death|0|||
161149468|NCT01781429|581929853|FG000|Overall Study|Withdrawal by Subject|0|||
161149469|NCT01781429|581929854|FG001|Overall Study|Withdrawal by Subject|0|||
161149470|NCT01781429|581929855|FG002|Overall Study|Withdrawal by Subject|0|||
161149471|NCT01781429|581929856|FG003|Overall Study|Withdrawal by Subject|0|||
161149472|NCT01781429|581929857|FG004|Overall Study|Withdrawal by Subject|0|||
161149473|NCT01781429|581929858|FG005|Overall Study|Withdrawal by Subject|0|||
161149474|NCT01781429|581929859|FG006|Overall Study|Withdrawal by Subject|0|||
161149475|NCT01781429|581929860|FG007|Overall Study|Withdrawal by Subject|0|||
161149476|NCT01781429|581929861|FG008|Overall Study|Withdrawal by Subject|1|||
161149477|NCT01781429|581929862|FG009|Overall Study|Withdrawal by Subject|3|||
161149478|NCT01781429|581929863|FG010|Overall Study|Withdrawal by Subject|1|||
161149479|NCT01781429|581929864|FG011|Overall Study|Withdrawal by Subject|1|||
161149480|NCT01781429|581929865|FG012|Overall Study|Withdrawal by Subject|5|||
161149481|NCT01781429|581929866|FG013|Overall Study|Withdrawal by Subject|2|||
161149482|NCT01781429|581929867|FG014|Overall Study|Withdrawal by Subject|3|||
161149483|NCT01781429|581929868|FG015|Overall Study|Withdrawal by Subject|0|||
161149484|NCT01781429|581929853|FG000|Overall Study|Disease Progression|1|||
161149485|NCT01781429|581929854|FG001|Overall Study|Disease Progression|0|||
161149486|NCT01781429|581929855|FG002|Overall Study|Disease Progression|1|||
161149487|NCT01781429|581929856|FG003|Overall Study|Disease Progression|1|||
161149488|NCT01781429|581929857|FG004|Overall Study|Disease Progression|1|||
161149489|NCT01781429|581929858|FG005|Overall Study|Disease Progression|4|||
161149490|NCT01781429|581929859|FG006|Overall Study|Disease Progression|7|||
161149491|NCT01781429|581929860|FG007|Overall Study|Disease Progression|4|||
161149492|NCT01781429|581929861|FG008|Overall Study|Disease Progression|6|||
161149493|NCT01781429|581929862|FG009|Overall Study|Disease Progression|15|||
161149494|NCT01781429|581929863|FG010|Overall Study|Disease Progression|15|||
161149495|NCT01781429|581929864|FG011|Overall Study|Disease Progression|15|||
161149496|NCT01781429|581929865|FG012|Overall Study|Disease Progression|15|||
161149497|NCT01781429|581929866|FG013|Overall Study|Disease Progression|4|||
161149498|NCT01781429|581929867|FG014|Overall Study|Disease Progression|11|||
161149499|NCT01781429|581929868|FG015|Overall Study|Disease Progression|0|||
161149500|NCT01781429|581929853|FG000|Overall Study|Unacceptable Toxicity|0|||
161149501|NCT01781429|581929854|FG001|Overall Study|Unacceptable Toxicity|0|||
161149502|NCT01781429|581929855|FG002|Overall Study|Unacceptable Toxicity|0|||
161149503|NCT01781429|581929856|FG003|Overall Study|Unacceptable Toxicity|0|||
161149504|NCT01781429|581929857|FG004|Overall Study|Unacceptable Toxicity|0|||
161149505|NCT01781429|581929858|FG005|Overall Study|Unacceptable Toxicity|0|||
161149506|NCT01781429|581929859|FG006|Overall Study|Unacceptable Toxicity|0|||
161149507|NCT01781429|581929860|FG007|Overall Study|Unacceptable Toxicity|0|||
161149508|NCT01781429|581929861|FG008|Overall Study|Unacceptable Toxicity|0|||
161149509|NCT01781429|581929862|FG009|Overall Study|Unacceptable Toxicity|0|||
161149510|NCT01781429|581929863|FG010|Overall Study|Unacceptable Toxicity|0|||
161149511|NCT01781429|581929864|FG011|Overall Study|Unacceptable Toxicity|2|||
161149512|NCT01781429|581929865|FG012|Overall Study|Unacceptable Toxicity|0|||
161149513|NCT01781429|581929866|FG013|Overall Study|Unacceptable Toxicity|0|||
161149514|NCT01781429|581929867|FG014|Overall Study|Unacceptable Toxicity|0|||
161149515|NCT01781429|581929868|FG015|Overall Study|Unacceptable Toxicity|0|||
161149516|NCT01781429|581929853|FG000|Overall Study|Patient Condition Changed|0|||
161149517|NCT01781429|581929854|FG001|Overall Study|Patient Condition Changed|0|||
161149518|NCT01781429|581929855|FG002|Overall Study|Patient Condition Changed|0|||
161149519|NCT01781429|581929856|FG003|Overall Study|Patient Condition Changed|0|||
161149520|NCT01781429|581929857|FG004|Overall Study|Patient Condition Changed|0|||
161149521|NCT01781429|581929858|FG005|Overall Study|Patient Condition Changed|0|||
161149522|NCT01781429|581929859|FG006|Overall Study|Patient Condition Changed|0|||
161149523|NCT01781429|581929860|FG007|Overall Study|Patient Condition Changed|0|||
161149524|NCT01781429|581929861|FG008|Overall Study|Patient Condition Changed|0|||
161149525|NCT01781429|581929862|FG009|Overall Study|Patient Condition Changed|4|||
161149526|NCT01781429|581929863|FG010|Overall Study|Patient Condition Changed|0|||
161149527|NCT01781429|581929864|FG011|Overall Study|Patient Condition Changed|1|||
161149528|NCT01781429|581929865|FG012|Overall Study|Patient Condition Changed|0|||
161149529|NCT01781429|581929866|FG013|Overall Study|Patient Condition Changed|1|||
161149530|NCT01781429|581929867|FG014|Overall Study|Patient Condition Changed|0|||
161149531|NCT01781429|581929868|FG015|Overall Study|Patient Condition Changed|0|||
161149532|NCT01781429|581929853|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
161149533|NCT01781429|581929854|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
161149534|NCT01781429|581929855|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
161149535|NCT01781429|581929856|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
161149536|NCT01781429|581929857|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
161149537|NCT01781429|581929858|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
161149538|NCT01781429|581929859|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
161044613|NCT01072149|581555278|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044614|NCT01072149|581555279|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044615|NCT01072149|581555280|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044616|NCT01072149|581555281|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044617|NCT01072149|581555282|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044618|NCT01072149|581555283|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044619|NCT01072149|581555284|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044620|NCT01072149|581555285|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
161044621|NCT01072149|581555286|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044622|NCT01072149|581555287|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044623|NCT01072149|581555288|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044624|NCT01072149|581555289|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044625|NCT01072149|581555290|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044626|NCT01072149|581555291|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044627|NCT01072149|581555292|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
161044628|NCT01072149|581555275|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044629|NCT01072149|581555276|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
161044630|NCT01072149|581555277|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044631|NCT01072149|581555278|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044632|NCT01072149|581555279|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044633|NCT01072149|581555280|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044634|NCT01072149|581555281|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044635|NCT01072149|581555282|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044636|NCT01072149|581555283|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044637|NCT01072149|581555284|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044638|NCT01072149|581555285|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044639|NCT01072149|581555286|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044640|NCT01072149|581555287|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044641|NCT01072149|581555288|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044642|NCT01072149|581555289|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044643|NCT01072149|581555290|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044644|NCT01072149|581555291|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044645|NCT01072149|581555292|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
161044646|NCT01072149|581555275|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044647|NCT01072149|581555276|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044648|NCT01072149|581555277|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
161044649|NCT01072149|581555278|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044650|NCT01072149|581555279|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044651|NCT01072149|581555280|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044652|NCT01072149|581555281|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044653|NCT01072149|581555282|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044654|NCT01072149|581555283|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044655|NCT01072149|581555284|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044656|NCT01072149|581555285|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044657|NCT01072149|581555286|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044658|NCT01072149|581555287|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044659|NCT01072149|581555288|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044660|NCT01072149|581555289|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044661|NCT01072149|581555290|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044662|NCT01072149|581555291|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044663|NCT01072149|581555292|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
161044664|NCT01072149|581555275|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044665|NCT01072149|581555276|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044666|NCT01072149|581555277|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044667|NCT01072149|581555278|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044668|NCT01072149|581555279|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044669|NCT01072149|581555280|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044670|NCT01072149|581555281|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044671|NCT01072149|581555282|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
161044672|NCT01072149|581555283|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044673|NCT01072149|581555284|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044674|NCT01072149|581555285|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
161149539|NCT01781429|581929860|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
161044675|NCT01072149|581555286|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044676|NCT01072149|581555287|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044677|NCT01072149|581555288|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044678|NCT01072149|581555289|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044679|NCT01072149|581555290|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
161344858|NCT04725188|582648813|FG000|Overall Study|Death|72|||
161044680|NCT01072149|581555291|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044681|NCT01072149|581555292|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
161044682|NCT01072149|581555275|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
161044683|NCT01072149|581555276|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
161044684|NCT01072149|581555277|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
161044685|NCT01072149|581555278|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
161044686|NCT01072149|581555279|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
161044687|NCT01072149|581555280|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
161044688|NCT01072149|581555281|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
161044689|NCT01072149|581555282|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
161044690|NCT01072149|581555283|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
161044691|NCT01072149|581555284|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
161044692|NCT01072149|581555285|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
161044693|NCT01072149|581555286|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
161044694|NCT01072149|581555287|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
161044695|NCT01072149|581555288|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
161044696|NCT01072149|581555289|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
161044697|NCT01072149|581555290|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
161044698|NCT01072149|581555291|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
161044699|NCT01072149|581555292|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
161044700|NCT01072149|581555275|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044701|NCT01072149|581555276|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044702|NCT01072149|581555277|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044703|NCT01072149|581555278|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044704|NCT01072149|581555279|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044705|NCT01072149|581555280|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044706|NCT01072149|581555281|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044707|NCT01072149|581555282|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044708|NCT01072149|581555283|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044709|NCT01072149|581555284|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044710|NCT01072149|581555285|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044711|NCT01072149|581555286|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044712|NCT01072149|581555287|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044713|NCT01072149|581555288|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044714|NCT01072149|581555289|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044715|NCT01072149|581555290|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
161044716|NCT01072149|581555291|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044717|NCT01072149|581555292|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
161044718|NCT01072149|581555275|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
161044719|NCT01072149|581555276|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
161044720|NCT01072149|581555277|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
161044721|NCT01072149|581555278|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
161044722|NCT01072149|581555279|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
161044723|NCT01072149|581555280|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
161044724|NCT01072149|581555281|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
161044725|NCT01072149|581555282|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
161044726|NCT01072149|581555283|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
161044727|NCT01072149|581555284|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
161044728|NCT01072149|581555285|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
161044729|NCT01072149|581555286|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
161044730|NCT01072149|581555287|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
161044731|NCT01072149|581555288|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
161044732|NCT01072149|581555289|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
161044733|NCT01072149|581555290|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
161044734|NCT01072149|581555291|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
161044735|NCT01072149|581555292|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
161044736|NCT01072149|581555275|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044737|NCT01072149|581555276|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044738|NCT01072149|581555277|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044739|NCT01072149|581555278|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161149540|NCT01781429|581929861|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
161149541|NCT01781429|581929862|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
161044740|NCT01072149|581555279|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044741|NCT01072149|581555280|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044742|NCT01072149|581555281|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044743|NCT01072149|581555282|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044744|NCT01072149|581555283|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161149542|NCT01781429|581929863|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
161044745|NCT01072149|581555284|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044746|NCT01072149|581555285|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161149543|NCT01781429|581929864|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
161149544|NCT01781429|581929865|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
161149545|NCT01781429|581929866|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
161149546|NCT01781429|581929867|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
161149547|NCT01781429|581929868|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
161149548|NCT01781429|581929853|FG000|Overall Study|Enrolled, but not treated|0|||
161149549|NCT01781429|581929854|FG001|Overall Study|Enrolled, but not treated|0|||
161149550|NCT01781429|581929855|FG002|Overall Study|Enrolled, but not treated|0|||
161149551|NCT01781429|581929856|FG003|Overall Study|Enrolled, but not treated|0|||
161149552|NCT01781429|581929857|FG004|Overall Study|Enrolled, but not treated|0|||
161149553|NCT01781429|581929858|FG005|Overall Study|Enrolled, but not treated|0|||
161149554|NCT01781429|581929859|FG006|Overall Study|Enrolled, but not treated|0|||
161149555|NCT01781429|581929860|FG007|Overall Study|Enrolled, but not treated|0|||
161149556|NCT01781429|581929861|FG008|Overall Study|Enrolled, but not treated|0|||
161149557|NCT01781429|581929862|FG009|Overall Study|Enrolled, but not treated|0|||
161149558|NCT01781429|581929863|FG010|Overall Study|Enrolled, but not treated|1|||
161149559|NCT01781429|581929864|FG011|Overall Study|Enrolled, but not treated|0|||
161149560|NCT01781429|581929865|FG012|Overall Study|Enrolled, but not treated|0|||
161149561|NCT01781429|581929866|FG013|Overall Study|Enrolled, but not treated|0|||
161149562|NCT01781429|581929867|FG014|Overall Study|Enrolled, but not treated|0|||
161149563|NCT01781429|581929868|FG015|Overall Study|Enrolled, but not treated|0|||
161149564|NCT00986258|581929869|FG000|Observation Period|Not eligible to be dosed|11|||
161149565|NCT00986258|581929869|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
161149566|NCT00986258|581929869|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
161149567|NCT00986258|581929869|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
161149568|NCT00986258|581929869|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
161149569|NCT00986258|581929869|FG000|Titration and Optimal Dose Period|Other|1|||
161044747|NCT01072149|581555286|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044748|NCT01072149|581555287|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
161044749|NCT01072149|581555288|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044750|NCT01072149|581555289|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044751|NCT01072149|581555290|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044752|NCT01072149|581555291|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044753|NCT01072149|581555292|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
161044754|NCT01072149|581555275|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044755|NCT01072149|581555276|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044756|NCT01072149|581555277|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
161044757|NCT01072149|581555278|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044758|NCT01072149|581555279|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161149570|NCT00986258|581929869|FG000|Maintenance Period|Adverse Event|5|||
161149571|NCT00986258|581929869|FG000|Maintenance Period|Lack of Efficacy|2|||
161149572|NCT00986258|581929869|FG000|Maintenance Period|Withdrawal by Subject|2|||
161149573|NCT03332667|581929870|FG000|Overall Study|Adverse Event|0|||
161149574|NCT03332667|581929871|FG001|Overall Study|Adverse Event|0|||
161149575|NCT03332667|581929872|FG002|Overall Study|Adverse Event|2|||
161149576|NCT03332667|581929873|FG003|Overall Study|Adverse Event|1|||
161149577|NCT03332667|581929870|FG000|Overall Study|Withdrawal by Subject|2|||
161149578|NCT03332667|581929871|FG001|Overall Study|Withdrawal by Subject|1|||
161149579|NCT03332667|581929872|FG002|Overall Study|Withdrawal by Subject|5|||
161149580|NCT03332667|581929873|FG003|Overall Study|Withdrawal by Subject|1|||
161149581|NCT03332667|581929870|FG000|Overall Study|Disease Progression or Relapse|2|||
161149582|NCT03332667|581929871|FG001|Overall Study|Disease Progression or Relapse|1|||
161149583|NCT03332667|581929872|FG002|Overall Study|Disease Progression or Relapse|3|||
161149584|NCT03332667|581929873|FG003|Overall Study|Disease Progression or Relapse|0|||
161149585|NCT03332667|581929870|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161149586|NCT03332667|581929871|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161149587|NCT03332667|581929872|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
161149588|NCT03332667|581929873|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
161149589|NCT03332667|581929870|FG000|Overall Study|No Treatment Received|0|||
161280655|NCT04803305|582406997|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
161044759|NCT01072149|581555280|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044760|NCT01072149|581555281|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044761|NCT01072149|581555282|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044762|NCT01072149|581555283|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161149590|NCT03332667|581929871|FG001|Overall Study|No Treatment Received|0|||
161149591|NCT03332667|581929872|FG002|Overall Study|No Treatment Received|1|||
161149592|NCT03332667|581929873|FG003|Overall Study|No Treatment Received|0|||
161149593|NCT01035606|581929874|FG000|Overall Study|change in health, job demands,family|3|||
161149594|NCT01035606|581929875|FG001|Overall Study|change in health, job demands,family|3|||
161149595|NCT01035606|581929876|FG002|Overall Study|change in health, job demands,family|4|||
161280656|NCT04803305|582406998|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
161044763|NCT01072149|581555284|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044764|NCT01072149|581555285|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044765|NCT01072149|581555286|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044766|NCT01072149|581555287|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044767|NCT01072149|581555288|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
161044768|NCT01072149|581555289|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044769|NCT01072149|581555290|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044770|NCT01072149|581555291|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044771|NCT01072149|581555292|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
161044772|NCT01768572|581555293|FG000|Overall Study|Adverse Event|7|||
161044773|NCT01768572|581555294|FG001|Overall Study|Adverse Event|8|||
161044774|NCT01768572|581555295|FG002|Overall Study|Adverse Event|4|||
161044775|NCT01768572|581555293|FG000|Overall Study|Lack of Efficacy|1|||
161044776|NCT01768572|581555294|FG001|Overall Study|Lack of Efficacy|3|||
161044777|NCT01768572|581555295|FG002|Overall Study|Lack of Efficacy|1|||
161044778|NCT01768572|581555293|FG000|Overall Study|Other, Not due to an adverse event|1|||
161044779|NCT01768572|581555294|FG001|Overall Study|Other, Not due to an adverse event|1|||
161044780|NCT01768572|581555295|FG002|Overall Study|Other, Not due to an adverse event|1|||
161044781|NCT03265132|581555306|FG000|Overall Study|Adverse Event|0|||
161044782|NCT03265132|581555307|FG001|Overall Study|Adverse Event|1|||
161044783|NCT03265132|581555306|FG000|Overall Study|Lack of Efficacy|0|||
161044784|NCT03265132|581555307|FG001|Overall Study|Lack of Efficacy|2|||
161044785|NCT03265132|581555306|FG000|Overall Study|Progressive disease|0|||
161044786|NCT03265132|581555307|FG001|Overall Study|Progressive disease|2|||
161044787|NCT03265132|581555306|FG000|Overall Study|Withdrawal by Subject|0|||
161044788|NCT03265132|581555307|FG001|Overall Study|Withdrawal by Subject|1|||
161044789|NCT03259568|581555313|FG000|Overall Study|Participant performance was low|3|||
161044790|NCT00089791|581555314|FG000|Overall Study|Physician Decision|6|||
161044791|NCT00089791|581555315|FG001|Overall Study|Physician Decision|3|||
161044792|NCT00089791|581555314|FG000|Overall Study|Adverse Event|81|||
161044793|NCT00089791|581555315|FG001|Overall Study|Adverse Event|93|||
161044794|NCT00089791|581555314|FG000|Overall Study|Withdrawal by Subject|403|||
161044795|NCT00089791|581555315|FG001|Overall Study|Withdrawal by Subject|344|||
161044796|NCT00089791|581555314|FG000|Overall Study|Death|78|||
161044797|NCT00089791|581555315|FG001|Overall Study|Death|62|||
161044798|NCT00089791|581555314|FG000|Overall Study|Disease progression|7|||
161044799|NCT00089791|581555315|FG001|Overall Study|Disease progression|3|||
161044800|NCT00089791|581555314|FG000|Overall Study|Ineligibility determined|12|||
161044801|NCT00089791|581555315|FG001|Overall Study|Ineligibility determined|9|||
161044802|NCT00089791|581555314|FG000|Overall Study|Lost to Follow-up|57|||
161044803|NCT00089791|581555315|FG001|Overall Study|Lost to Follow-up|57|||
161044804|NCT00089791|581555314|FG000|Overall Study|Noncompliance|17|||
161044805|NCT00089791|581555315|FG001|Overall Study|Noncompliance|13|||
161044806|NCT00089791|581555314|FG000|Overall Study|Other|20|||
161044807|NCT00089791|581555315|FG001|Overall Study|Other|32|||
161044808|NCT00089791|581555314|FG000|Overall Study|Protocol deviation|12|||
161044809|NCT00089791|581555315|FG001|Overall Study|Protocol deviation|10|||
161044810|NCT00089791|581555314|FG000|Overall Study|Requirement for alternative therapy|7|||
161044811|NCT00089791|581555315|FG001|Overall Study|Requirement for alternative therapy|4|||
161044812|NCT02161458|581555316|FG000|Overall Study|Withdrawal by Subject|0|||
161044813|NCT02161458|581555317|FG001|Overall Study|Withdrawal by Subject|4|||
161044814|NCT02161458|581555318|FG002|Overall Study|Withdrawal by Subject|4|||
161044815|NCT02161458|581555319|FG003|Overall Study|Withdrawal by Subject|0|||
161044816|NCT02161458|581555316|FG000|Overall Study|Lost to Follow-up|0|||
161044817|NCT02161458|581555317|FG001|Overall Study|Lost to Follow-up|2|||
161044818|NCT02161458|581555318|FG002|Overall Study|Lost to Follow-up|1|||
161044819|NCT02161458|581555319|FG003|Overall Study|Lost to Follow-up|0|||
161044820|NCT05074433|581555320|FG000|Overall Study|Adverse Event|0|||
161044821|NCT05074433|581555321|FG001|Overall Study|Adverse Event|2|||
161044822|NCT05074433|581555322|FG002|Overall Study|Adverse Event|0|||
161044823|NCT05074433|581555323|FG003|Overall Study|Adverse Event|1|||
161044824|NCT05074433|581555320|FG000|Overall Study|Sponsor Request|0|||
161044825|NCT05074433|581555321|FG001|Overall Study|Sponsor Request|1|||
161044826|NCT05074433|581555322|FG002|Overall Study|Sponsor Request|1|||
161044827|NCT05074433|581555323|FG003|Overall Study|Sponsor Request|0|||
161044828|NCT05074433|581555320|FG000|Overall Study|Death|1|||
161044829|NCT05074433|581555321|FG001|Overall Study|Death|0|||
161044830|NCT05074433|581555322|FG002|Overall Study|Death|0|||
161044831|NCT05074433|581555323|FG003|Overall Study|Death|0|||
161044832|NCT05074433|581555320|FG000|Overall Study|Lost to Follow-up|0|||
161044833|NCT05074433|581555321|FG001|Overall Study|Lost to Follow-up|0|||
161044834|NCT05074433|581555322|FG002|Overall Study|Lost to Follow-up|2|||
161044835|NCT05074433|581555323|FG003|Overall Study|Lost to Follow-up|0|||
161044836|NCT05074433|581555320|FG000|Overall Study|Subject Decision|8|||
161044837|NCT05074433|581555321|FG001|Overall Study|Subject Decision|6|||
161044838|NCT05074433|581555322|FG002|Overall Study|Subject Decision|4|||
161044839|NCT05074433|581555323|FG003|Overall Study|Subject Decision|5|||
161280657|NCT01862484|582407000|FG000|Overall Study|Lack of Efficacy|1|||
161044840|NCT04397263|581555324|FG000|Overall Study|Withdrawal by Subject|2|||
161044841|NCT02251652|581555325|FG000|Overall Study|Withdrawal by Subject|1|||
161044842|NCT01989689|581555326|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
161044843|NCT01989689|581555327|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
161044844|NCT01989689|581555326|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
161044845|NCT01989689|581555327|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
161044846|NCT04492475|581555328|FG000|Overall Study|Enrolled but not treated|8|||
161044847|NCT04492475|581555329|FG001|Overall Study|Enrolled but not treated|8|||
161044848|NCT04492475|581555328|FG000|Overall Study|Withdrawal by Subject|4|||
161044849|NCT04492475|581555329|FG001|Overall Study|Withdrawal by Subject|0|||
161044850|NCT04492475|581555328|FG000|Overall Study|Became ineligible after enrollment|2|||
161044851|NCT04492475|581555329|FG001|Overall Study|Became ineligible after enrollment|0|||
161044852|NCT02066636|581555330|FG000|Overall Study|Disease progression|51|||
161044853|NCT02066636|581555331|FG001|Overall Study|Disease progression|60|||
161044854|NCT02066636|581555332|FG002|Overall Study|Disease progression|700|||
161044855|NCT02066636|581555330|FG000|Overall Study|Study drug toxicity|13|||
161044856|NCT02066636|581555331|FG001|Overall Study|Study drug toxicity|2|||
161044857|NCT02066636|581555332|FG002|Overall Study|Study drug toxicity|58|||
161044858|NCT02066636|581555330|FG000|Overall Study|Death|4|||
161044859|NCT02066636|581555331|FG001|Overall Study|Death|2|||
161044860|NCT02066636|581555332|FG002|Overall Study|Death|158|||
161044861|NCT02066636|581555330|FG000|Overall Study|Adverse event unrelated to study drug|6|||
161044862|NCT02066636|581555331|FG001|Overall Study|Adverse event unrelated to study drug|4|||
161044863|NCT02066636|581555332|FG002|Overall Study|Adverse event unrelated to study drug|45|||
161044864|NCT02066636|581555330|FG000|Overall Study|Participant request to discontinue treatment|12|||
161044865|NCT02066636|581555331|FG001|Overall Study|Participant request to discontinue treatment|12|||
161044866|NCT02066636|581555332|FG002|Overall Study|Participant request to discontinue treatment|70|||
161044867|NCT02066636|581555330|FG000|Overall Study|Participant withdrew consent|10|||
161044868|NCT02066636|581555331|FG001|Overall Study|Participant withdrew consent|18|||
161044869|NCT02066636|581555332|FG002|Overall Study|Participant withdrew consent|61|||
161044870|NCT02066636|581555330|FG000|Overall Study|Lost to Follow-up|0|||
161044871|NCT02066636|581555331|FG001|Overall Study|Lost to Follow-up|2|||
161044872|NCT02066636|581555332|FG002|Overall Study|Lost to Follow-up|2|||
161044873|NCT02066636|581555330|FG000|Overall Study|Maximum clinical benefit|2|||
161044874|NCT02066636|581555331|FG001|Overall Study|Maximum clinical benefit|2|||
161044875|NCT02066636|581555332|FG002|Overall Study|Maximum clinical benefit|3|||
161044876|NCT02066636|581555330|FG000|Overall Study|Poor/non-compliance|2|||
161044877|NCT02066636|581555331|FG001|Overall Study|Poor/non-compliance|1|||
161044878|NCT02066636|581555332|FG002|Overall Study|Poor/non-compliance|1|||
161044879|NCT02066636|581555330|FG000|Overall Study|Participant no loner meets study criteria|3|||
161044880|NCT02066636|581555331|FG001|Overall Study|Participant no loner meets study criteria|2|||
161044881|NCT02066636|581555332|FG002|Overall Study|Participant no loner meets study criteria|28|||
161044882|NCT02066636|581555330|FG000|Overall Study|Administrative reasons by sponsor|8|||
161044883|NCT02066636|581555331|FG001|Overall Study|Administrative reasons by sponsor|5|||
161044884|NCT02066636|581555332|FG002|Overall Study|Administrative reasons by sponsor|0|||
161044885|NCT02066636|581555330|FG000|Overall Study|Other reasons|16|||
161044886|NCT02066636|581555331|FG001|Overall Study|Other reasons|15|||
161044887|NCT02066636|581555332|FG002|Overall Study|Other reasons|50|||
161044888|NCT00391170|581555341|FG000|Overall Study|Withdrawal by Subject|1|||
161044889|NCT00391170|581555342|FG001|Overall Study|Withdrawal by Subject|0|||
161044890|NCT00391170|581555341|FG000|Overall Study|Adverse Event|3|||
161044891|NCT00391170|581555342|FG001|Overall Study|Adverse Event|2|||
161044892|NCT00391170|581555341|FG000|Overall Study|Physician Decision|2|||
161044893|NCT00391170|581555342|FG001|Overall Study|Physician Decision|2|||
161044894|NCT03567616|581555345|FG000|Overall Study|Disease progression|4|||
161044895|NCT03567616|581555345|FG000|Overall Study|Withdrawal by Subject|1|||
161044896|NCT03567616|581555345|FG000|Overall Study|Physician Decision|1|||
161044897|NCT03567616|581555345|FG000|Overall Study|Death|1|||
161044898|NCT03567616|581555345|FG000|Overall Study|Adverse Event|1|||
161044899|NCT02833948|581555347|FG000|Overall Study|Death|2|||
161044900|NCT02833948|581555348|FG001|Overall Study|Death|3|||
161044901|NCT02833948|581555347|FG000|Overall Study|were not scanned|8|||
161044902|NCT02833948|581555348|FG001|Overall Study|were not scanned|13|||
161044903|NCT02833948|581555347|FG000|Overall Study|scans could not be evaluated|5|||
161044904|NCT02833948|581555348|FG001|Overall Study|scans could not be evaluated|2|||
161044905|NCT00680771|581555351|FG000|Overall Study|Withdrawal by Subject|1|||
161044906|NCT00680771|581555352|FG001|Overall Study|Withdrawal by Subject|0|||
161044907|NCT00680771|581555351|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
161044908|NCT00680771|581555352|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
161044909|NCT00680771|581555351|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
161044910|NCT00680771|581555352|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
161044911|NCT02691702|581555353|FG000|Overall Study|Adverse Event|1|||
161044912|NCT02691702|581555354|FG001|Overall Study|Adverse Event|0|||
161280658|NCT01862484|582407001|FG001|Overall Study|Lack of Efficacy|1|||
161044913|NCT02691702|581555355|FG002|Overall Study|Adverse Event|0|||
161044914|NCT02691702|581555356|FG003|Overall Study|Adverse Event|0|||
161149596|NCT01070303|581929877|FG000|Overall Study|Adverse Event|39|||
161149597|NCT01070303|581929877|FG000|Overall Study|Withdrawal by Subject|20|||
161149598|NCT01070303|581929877|FG000|Overall Study|Lost to Follow-up|9|||
161149599|NCT01070303|581929877|FG000|Overall Study|Protocol Violation|0|||
161149600|NCT01070303|581929877|FG000|Overall Study|Lack of Efficacy|2|||
161149601|NCT01070303|581929877|FG000|Overall Study|Administrative Reason|1|||
161149602|NCT01070303|581929877|FG000|Overall Study|Other|18|||
161149603|NCT01809262|581929878|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149604|NCT01809262|581929879|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149605|NCT01809262|581929880|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149606|NCT01809262|581929881|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149607|NCT01809262|581929882|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
161149608|NCT01809262|581929883|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149609|NCT01809262|581929884|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149610|NCT01809262|581929885|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149611|NCT01809262|581929886|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149612|NCT01809262|581929887|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
161149613|NCT01809262|581929878|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149614|NCT01809262|581929879|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
161149615|NCT01809262|581929880|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149616|NCT01809262|581929881|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149617|NCT01809262|581929882|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149618|NCT01809262|581929883|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149619|NCT01809262|581929884|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149620|NCT01809262|581929885|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149621|NCT01809262|581929886|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149622|NCT01809262|581929887|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
161149623|NCT00859898|581929892|FG000|Overall Study|Lack of Efficacy|0|||
161149624|NCT00859898|581929893|FG001|Overall Study|Lack of Efficacy|1|||
161149625|NCT00859898|581929894|FG002|Overall Study|Lack of Efficacy|1|||
161149626|NCT00859898|581929892|FG000|Overall Study|Adverse Event|4|||
161149627|NCT00859898|581929893|FG001|Overall Study|Adverse Event|9|||
161149628|NCT00859898|581929894|FG002|Overall Study|Adverse Event|8|||
161149629|NCT00859898|581929892|FG000|Overall Study|Withdrawal by Subject|11|||
161149630|NCT00859898|581929893|FG001|Overall Study|Withdrawal by Subject|8|||
161149631|NCT00859898|581929894|FG002|Overall Study|Withdrawal by Subject|11|||
161149632|NCT00859898|581929892|FG000|Overall Study|Death|0|||
161149633|NCT00859898|581929893|FG001|Overall Study|Death|0|||
161149634|NCT00859898|581929894|FG002|Overall Study|Death|1|||
161149635|NCT00859898|581929892|FG000|Overall Study|Lost to Follow-up|10|||
161149636|NCT00859898|581929893|FG001|Overall Study|Lost to Follow-up|11|||
161149637|NCT00859898|581929894|FG002|Overall Study|Lost to Follow-up|5|||
161149638|NCT00859898|581929892|FG000|Overall Study|poor/non-compliance|2|||
161280659|NCT01862484|582407000|FG000|Overall Study|Lost to Follow-up|1|||
161280660|NCT01862484|582407001|FG001|Overall Study|Lost to Follow-up|2|||
161280661|NCT01862484|582407000|FG000|Overall Study|Protocol Violation|0|||
161280662|NCT01862484|582407001|FG001|Overall Study|Protocol Violation|2|||
161280663|NCT01862484|582407000|FG000|Overall Study|Withdrawal by Subject|0|||
161280664|NCT01862484|582407001|FG001|Overall Study|Withdrawal by Subject|3|||
161280665|NCT00996892|582407002|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
161280666|NCT00996892|582407003|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
161280667|NCT00996892|582407004|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
161280668|NCT00996892|582407005|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
161280669|NCT00996892|582407006|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
161280670|NCT00996892|582407007|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
161280671|NCT00996892|582407008|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
161280672|NCT00996892|582407009|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
161280673|NCT00996892|582407010|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
161280674|NCT00996892|582407011|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
161280675|NCT00996892|582407012|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
161280676|NCT00996892|582407013|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
161280677|NCT00996892|582407014|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
161280678|NCT00996892|582407015|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
161280679|NCT00996892|582407016|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
161280680|NCT00996892|582407017|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
161280681|NCT00996892|582407018|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
161044915|NCT02691702|581555357|FG004|Overall Study|Adverse Event|0|||
161044916|NCT02691702|581555358|FG005|Overall Study|Adverse Event|0|||
161044917|NCT02691702|581555359|FG006|Overall Study|Adverse Event|0|||
161044918|NCT02691702|581555360|FG007|Overall Study|Adverse Event|0|||
161044919|NCT02691702|581555361|FG008|Overall Study|Adverse Event|1|||
161044920|NCT02691702|581555362|FG009|Overall Study|Adverse Event|0|||
161044921|NCT02691702|581555363|FG010|Overall Study|Adverse Event|1|||
161044922|NCT02691702|581555353|FG000|Overall Study|Lost to Follow-up|0|||
161044923|NCT02691702|581555354|FG001|Overall Study|Lost to Follow-up|0|||
161044924|NCT02691702|581555355|FG002|Overall Study|Lost to Follow-up|1|||
161044925|NCT02691702|581555356|FG003|Overall Study|Lost to Follow-up|0|||
161044926|NCT02691702|581555357|FG004|Overall Study|Lost to Follow-up|0|||
161044927|NCT02691702|581555358|FG005|Overall Study|Lost to Follow-up|2|||
161044928|NCT02691702|581555359|FG006|Overall Study|Lost to Follow-up|0|||
161044929|NCT02691702|581555360|FG007|Overall Study|Lost to Follow-up|0|||
161044930|NCT02691702|581555361|FG008|Overall Study|Lost to Follow-up|0|||
161044931|NCT02691702|581555362|FG009|Overall Study|Lost to Follow-up|0|||
161044932|NCT02691702|581555363|FG010|Overall Study|Lost to Follow-up|1|||
161044933|NCT02691702|581555353|FG000|Overall Study|Withdrawal by Subject|1|||
161044934|NCT02691702|581555354|FG001|Overall Study|Withdrawal by Subject|1|||
161044935|NCT02691702|581555355|FG002|Overall Study|Withdrawal by Subject|0|||
161044936|NCT02691702|581555356|FG003|Overall Study|Withdrawal by Subject|0|||
161044937|NCT02691702|581555357|FG004|Overall Study|Withdrawal by Subject|0|||
161044938|NCT02691702|581555358|FG005|Overall Study|Withdrawal by Subject|1|||
161044939|NCT02691702|581555359|FG006|Overall Study|Withdrawal by Subject|2|||
161044940|NCT02691702|581555360|FG007|Overall Study|Withdrawal by Subject|0|||
161044941|NCT02691702|581555361|FG008|Overall Study|Withdrawal by Subject|0|||
161044942|NCT02691702|581555362|FG009|Overall Study|Withdrawal by Subject|0|||
161044943|NCT02691702|581555363|FG010|Overall Study|Withdrawal by Subject|0|||
161044944|NCT02691702|581555353|FG000|Overall Study|Other|0|||
161044945|NCT02691702|581555354|FG001|Overall Study|Other|0|||
161044946|NCT02691702|581555355|FG002|Overall Study|Other|0|||
161044947|NCT02691702|581555356|FG003|Overall Study|Other|0|||
161044948|NCT02691702|581555357|FG004|Overall Study|Other|0|||
161044949|NCT02691702|581555358|FG005|Overall Study|Other|0|||
161044950|NCT02691702|581555359|FG006|Overall Study|Other|1|||
161044951|NCT02691702|581555360|FG007|Overall Study|Other|0|||
161044952|NCT02691702|581555361|FG008|Overall Study|Other|1|||
161044953|NCT02691702|581555362|FG009|Overall Study|Other|0|||
161044954|NCT02691702|581555363|FG010|Overall Study|Other|0|||
161044955|NCT02691702|581555353|FG000|Overall Study|Protocol Violation|0|||
161044956|NCT02691702|581555354|FG001|Overall Study|Protocol Violation|0|||
161044957|NCT02691702|581555355|FG002|Overall Study|Protocol Violation|0|||
161044958|NCT02691702|581555356|FG003|Overall Study|Protocol Violation|0|||
161044959|NCT02691702|581555357|FG004|Overall Study|Protocol Violation|0|||
161149639|NCT00859898|581929893|FG001|Overall Study|poor/non-compliance|0|||
161149640|NCT00859898|581929894|FG002|Overall Study|poor/non-compliance|0|||
161149641|NCT00859898|581929892|FG000|Overall Study|No longer meets criteria|0|||
161149642|NCT00859898|581929893|FG001|Overall Study|No longer meets criteria|1|||
161149643|NCT00859898|581929894|FG002|Overall Study|No longer meets criteria|0|||
161149644|NCT00859898|581929892|FG000|Overall Study|non-specified|1|||
161149645|NCT00859898|581929893|FG001|Overall Study|non-specified|1|||
161149646|NCT00859898|581929894|FG002|Overall Study|non-specified|1|||
161149647|NCT03215264|581929895|FG000|Dose Level 2|Adverse Event|0|||
161280682|NCT00996892|582407019|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
161280683|NCT00996892|582407020|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
161280684|NCT00996892|582407021|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
161280685|NCT00996892|582407002|FG000|Dose-Escalation Stage 1|Death|1|||
161280686|NCT00996892|582407003|FG001|Dose-Escalation Stage 1|Death|0|||
161280687|NCT00996892|582407004|FG002|Dose-Escalation Stage 1|Death|0|||
161280688|NCT00996892|582407005|FG003|Dose-Escalation Stage 1|Death|0|||
161280689|NCT00996892|582407006|FG004|Dose-Escalation Stage 1|Death|0|||
161280690|NCT00996892|582407007|FG005|Dose-Escalation Stage 1|Death|1|||
161280691|NCT00996892|582407008|FG006|Dose-Escalation Stage 1|Death|0|||
161280692|NCT00996892|582407009|FG007|Dose-Escalation Stage 1|Death|0|||
161280693|NCT00996892|582407010|FG008|Dose-Escalation Stage 1|Death|0|||
161280694|NCT00996892|582407011|FG009|Dose-Escalation Stage 1|Death|0|||
161280695|NCT00996892|582407012|FG010|Dose-Escalation Stage 1|Death|0|||
161280696|NCT00996892|582407013|FG011|Dose-Escalation Stage 1|Death|0|||
161280697|NCT00996892|582407014|FG012|Dose-Escalation Stage 1|Death|0|||
161280698|NCT00996892|582407015|FG013|Dose-Escalation Stage 1|Death|0|||
161280699|NCT00996892|582407016|FG014|Dose-Escalation Stage 1|Death|0|||
161280700|NCT00996892|582407017|FG015|Dose-Escalation Stage 1|Death|0|||
161280701|NCT00996892|582407018|FG016|Dose-Escalation Stage 1|Death|0|||
161280702|NCT00996892|582407019|FG017|Dose-Escalation Stage 1|Death|0|||
161280703|NCT00996892|582407020|FG018|Dose-Escalation Stage 1|Death|0|||
161044960|NCT02691702|581555358|FG005|Overall Study|Protocol Violation|0|||
161044961|NCT02691702|581555359|FG006|Overall Study|Protocol Violation|0|||
161044962|NCT02691702|581555360|FG007|Overall Study|Protocol Violation|0|||
161044963|NCT02691702|581555361|FG008|Overall Study|Protocol Violation|0|||
161044964|NCT02691702|581555362|FG009|Overall Study|Protocol Violation|2|||
161044965|NCT02691702|581555363|FG010|Overall Study|Protocol Violation|0|||
161149648|NCT03215264|581929896|FG001|Dose Level 2|Adverse Event|1|||
161280704|NCT00996892|582407021|FG019|Dose-Escalation Stage 1|Death|0|||
161280705|NCT00996892|582407002|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
161280706|NCT00996892|582407003|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
161280707|NCT00996892|582407004|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
161044966|NCT05613088|581555364|FG000|Treatment|Ongoing Study Treatment|9|||
161149649|NCT03215264|581929897|FG002|Dose Level 2|Adverse Event|0|||
161280708|NCT00996892|582407005|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
161149650|NCT03215264|581929895|FG000|Dose Level 3|Withdrawal by Subject|0|||
161149651|NCT03215264|581929896|FG001|Dose Level 3|Withdrawal by Subject|0|||
161149652|NCT03215264|581929897|FG002|Dose Level 3|Withdrawal by Subject|1|||
161149653|NCT02145156|581929898|FG000|Overall Study|No match to vaccination records|60|||
161149654|NCT02145156|581929899|FG001|Overall Study|No match to vaccination records|52|||
161149655|NCT02145156|581929900|FG002|Overall Study|No match to vaccination records|41|||
161149656|NCT02433288|581929902|FG000|Overall Study|Severe non-compliance to protocol|13|||
161149657|NCT02433288|581929903|FG001|Overall Study|Severe non-compliance to protocol|7|||
161149658|NCT02433288|581929902|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
161149659|NCT02433288|581929903|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
161149660|NCT02433288|581929902|FG000|Overall Study|Withdrawal by Subject|101|||
161149661|NCT02433288|581929903|FG001|Overall Study|Withdrawal by Subject|99|||
161149662|NCT02433288|581929902|FG000|Overall Study|Lost to Follow-up|2|||
161149663|NCT02433288|581929903|FG001|Overall Study|Lost to Follow-up|14|||
161149664|NCT02433288|581929902|FG000|Overall Study|Death|0|||
161149665|NCT02433288|581929903|FG001|Overall Study|Death|3|||
161149666|NCT01740440|581929906|FG000|Overall Study|Lost to Follow-up|3|||
161149667|NCT03408873|581929909|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
161149668|NCT03408873|581929909|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
161149669|NCT03408873|581929909|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
161149670|NCT03408873|581929909|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
161149671|NCT03408873|581929909|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
161149672|NCT03408873|581929909|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
161149673|NCT01264965|581929910|FG000|Overall Study|Withdrawal by Subject|10|||
161149674|NCT01327339|581929912|FG000|Overall Study|Protocol Violation|8|||
161149675|NCT01172288|581929913|FG000|Overall Study|Adverse Event|1|||
161149676|NCT01172288|581929914|FG001|Overall Study|Adverse Event|0|||
161149677|NCT01172288|581929913|FG000|Overall Study|Protocol Violation|0|||
161149678|NCT01172288|581929914|FG001|Overall Study|Protocol Violation|1|||
161149679|NCT01188798|581929917|FG000|Overall Study|Death|0|||
161149680|NCT01188798|581929918|FG001|Overall Study|Death|1|||
161149681|NCT01188798|581929917|FG000|Overall Study|Required additional transplant|1|||
161149682|NCT01188798|581929918|FG001|Overall Study|Required additional transplant|1|||
161149683|NCT01188798|581929917|FG000|Overall Study|Protocol closure|1|||
161149684|NCT01188798|581929918|FG001|Overall Study|Protocol closure|1|||
161149685|NCT00700752|581929924|FG000|First Intervention|Withdrawal by Subject|0|||
161149686|NCT00700752|581929925|FG001|First Intervention|Withdrawal by Subject|2|||
161149687|NCT03662334|581929926|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
161149688|NCT03662334|581929927|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
161149689|NCT03964415|581929928|FG000|Overall Study|Sponsor's decision|1563|||
161149690|NCT03964415|581929929|FG001|Overall Study|Sponsor's decision|1528|||
161149691|NCT03964415|581929928|FG000|Overall Study|Lost to Follow-up|139|||
161149692|NCT03964415|581929929|FG001|Overall Study|Lost to Follow-up|146|||
161149693|NCT03964415|581929928|FG000|Overall Study|Withdrawal by Subject|68|||
161149694|NCT03964415|581929929|FG001|Overall Study|Withdrawal by Subject|72|||
161149695|NCT03964415|581929928|FG000|Overall Study|Physician Decision|34|||
161149696|NCT03964415|581929929|FG001|Overall Study|Physician Decision|48|||
161149697|NCT03964415|581929928|FG000|Overall Study|Adverse Event|3|||
161149698|NCT03964415|581929929|FG001|Overall Study|Adverse Event|0|||
161149699|NCT03964415|581929928|FG000|Overall Study|Death|4|||
161149700|NCT03964415|581929929|FG001|Overall Study|Death|6|||
161149701|NCT03964415|581929928|FG000|Overall Study|Protocol Violation|1|||
161149702|NCT03964415|581929929|FG001|Overall Study|Protocol Violation|4|||
161149703|NCT03964415|581929928|FG000|Overall Study|Other|35|||
161149704|NCT03964415|581929929|FG001|Overall Study|Other|38|||
161149705|NCT03964415|581929928|FG000|Overall Study|Randomized but not treated|6|||
161149706|NCT03964415|581929929|FG001|Overall Study|Randomized but not treated|7|||
161149707|NCT01097330|581929937|FG000|Overall Study|Study terminated early|7|||
161149708|NCT01097330|581929938|FG001|Overall Study|Study terminated early|5|||
161149709|NCT01734993|581929939|FG000|Overall Study|Adverse Event|1|||
161149710|NCT01734993|581929939|FG000|Overall Study|Lack of Efficacy|1|||
161149711|NCT03303339|581929940|FG000|Overall Study|Death|2|||
161149712|NCT03303339|581929941|FG001|Overall Study|Death|2|||
161149713|NCT03303339|581929942|FG002|Overall Study|Death|2|||
161149714|NCT03303339|581929943|FG003|Overall Study|Death|1|||
161149715|NCT03303339|581929944|FG004|Overall Study|Death|4|||
161149716|NCT03303339|581929945|FG005|Overall Study|Death|2|||
161149717|NCT03303339|581929946|FG006|Overall Study|Death|2|||
161280709|NCT00996892|582407006|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
161149718|NCT03303339|581929947|FG007|Overall Study|Death|2|||
161149719|NCT03303339|581929948|FG008|Overall Study|Death|3|||
161149720|NCT03303339|581929949|FG009|Overall Study|Death|3|||
161149721|NCT03303339|581929950|FG010|Overall Study|Death|4|||
161149722|NCT03303339|581929951|FG011|Overall Study|Death|24|||
161149723|NCT03303339|581929940|FG000|Overall Study|Study Terminated by Sponsor|0|||
161149724|NCT03303339|581929941|FG001|Overall Study|Study Terminated by Sponsor|0|||
161149725|NCT03303339|581929942|FG002|Overall Study|Study Terminated by Sponsor|0|||
161149726|NCT03303339|581929943|FG003|Overall Study|Study Terminated by Sponsor|0|||
161044967|NCT05613088|581555365|FG001|Treatment|Ongoing Study Treatment|2|||
161044968|NCT05613088|581555364|FG000|Treatment|Adverse Event|3|||
161044969|NCT05613088|581555365|FG001|Treatment|Adverse Event|1|||
161044970|NCT05613088|581555364|FG000|Treatment|Other Reasons|0|||
161044971|NCT05613088|581555365|FG001|Treatment|Other Reasons|1|||
161044972|NCT05613088|581555364|FG000|Treatment|Progressive Disease|58|||
161044973|NCT05613088|581555365|FG001|Treatment|Progressive Disease|26|||
161044974|NCT05613088|581555364|FG000|Treatment|Withdrawal by Subject|0|||
161044975|NCT05613088|581555365|FG001|Treatment|Withdrawal by Subject|4|||
161044976|NCT05163353|581555368|FG000|Overall Study|Adverse Event|1|||
161044977|NCT05163353|581555369|FG001|Overall Study|Adverse Event|0|||
161044978|NCT05163353|581555368|FG000|Overall Study|Withdrawal by Subject|21|||
161044979|NCT05163353|581555369|FG001|Overall Study|Withdrawal by Subject|6|||
161044980|NCT05163353|581555368|FG000|Overall Study|Protocol Violation|0|||
161044981|NCT05163353|581555369|FG001|Overall Study|Protocol Violation|1|||
161044982|NCT05163353|581555368|FG000|Overall Study|Lost to Follow-up|13|||
161044983|NCT05163353|581555369|FG001|Overall Study|Lost to Follow-up|2|||
161044984|NCT06086028|581555371|FG000|Overall Study|Withdrawal by Subject|1|||
161044985|NCT06086028|581555372|FG001|Overall Study|Withdrawal by Subject|1|||
161044986|NCT06086028|581555371|FG000|Overall Study|Lost to Follow-up|2|||
161044987|NCT06086028|581555372|FG001|Overall Study|Lost to Follow-up|3|||
161044988|NCT00824408|581555373|FG000|Run-in Phase|Progressive disease|4|||
161044989|NCT00824408|581555374|FG001|Run-in Phase|Progressive disease|4|||
161044990|NCT00824408|581555375|FG002|Run-in Phase|Progressive disease|0|||
161044991|NCT00824408|581555376|FG003|Run-in Phase|Progressive disease|0|||
161044992|NCT00824408|581555377|FG004|Run-in Phase|Progressive disease|0|||
161044993|NCT00824408|581555373|FG000|Run-in Phase|Adverse Event|1|||
161044994|NCT00824408|581555374|FG001|Run-in Phase|Adverse Event|1|||
161044995|NCT00824408|581555375|FG002|Run-in Phase|Adverse Event|0|||
161044996|NCT00824408|581555376|FG003|Run-in Phase|Adverse Event|0|||
161044997|NCT00824408|581555377|FG004|Run-in Phase|Adverse Event|0|||
161044998|NCT00824408|581555373|FG000|Run-in Phase|Refused to continue medication|1|||
161044999|NCT00824408|581555374|FG001|Run-in Phase|Refused to continue medication|0|||
161045000|NCT00824408|581555375|FG002|Run-in Phase|Refused to continue medication|0|||
161045001|NCT00824408|581555376|FG003|Run-in Phase|Refused to continue medication|0|||
161045002|NCT00824408|581555377|FG004|Run-in Phase|Refused to continue medication|0|||
161045003|NCT00824408|581555373|FG000|Run-in Phase|Other reason not defined above|0|||
161045004|NCT00824408|581555374|FG001|Run-in Phase|Other reason not defined above|1|||
161045005|NCT00824408|581555375|FG002|Run-in Phase|Other reason not defined above|0|||
161045006|NCT00824408|581555376|FG003|Run-in Phase|Other reason not defined above|0|||
161045007|NCT00824408|581555377|FG004|Run-in Phase|Other reason not defined above|0|||
161045008|NCT00824408|581555373|FG000|Randomized Phase|Not treated|0|||
161045009|NCT00824408|581555374|FG001|Randomized Phase|Not treated|0|||
161045010|NCT00824408|581555375|FG002|Randomized Phase|Not treated|1|||
161045011|NCT00824408|581555376|FG003|Randomized Phase|Not treated|1|||
161045012|NCT00824408|581555377|FG004|Randomized Phase|Not treated|1|||
161045013|NCT00824408|581555373|FG000|Randomized Phase|Progressive disease|0|||
161045014|NCT00824408|581555374|FG001|Randomized Phase|Progressive disease|0|||
161045015|NCT00824408|581555375|FG002|Randomized Phase|Progressive disease|25|||
161045016|NCT00824408|581555376|FG003|Randomized Phase|Progressive disease|36|||
161045017|NCT00824408|581555377|FG004|Randomized Phase|Progressive disease|34|||
161045018|NCT00824408|581555373|FG000|Randomized Phase|Adverse Event|0|||
161045019|NCT00824408|581555374|FG001|Randomized Phase|Adverse Event|0|||
161045020|NCT00824408|581555375|FG002|Randomized Phase|Adverse Event|4|||
161045021|NCT00824408|581555376|FG003|Randomized Phase|Adverse Event|5|||
161045022|NCT00824408|581555377|FG004|Randomized Phase|Adverse Event|5|||
161045023|NCT00824408|581555373|FG000|Randomized Phase|Refused to continue medication|0|||
161045024|NCT00824408|581555374|FG001|Randomized Phase|Refused to continue medication|0|||
161045025|NCT00824408|581555375|FG002|Randomized Phase|Refused to continue medication|2|||
161045026|NCT00824408|581555376|FG003|Randomized Phase|Refused to continue medication|2|||
161045027|NCT00824408|581555377|FG004|Randomized Phase|Refused to continue medication|2|||
161045028|NCT00824408|581555373|FG000|Randomized Phase|Other reason not defined above|0|||
161045029|NCT00824408|581555374|FG001|Randomized Phase|Other reason not defined above|0|||
161045030|NCT00824408|581555375|FG002|Randomized Phase|Other reason not defined above|4|||
161045031|NCT00824408|581555376|FG003|Randomized Phase|Other reason not defined above|2|||
161045032|NCT00824408|581555377|FG004|Randomized Phase|Other reason not defined above|4|||
161045033|NCT01263496|581555380|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
161045034|NCT01263496|581555381|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045035|NCT01263496|581555382|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045036|NCT01263496|581555383|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045037|NCT01263496|581555384|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045038|NCT01263496|581555385|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045039|NCT01263496|581555386|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045040|NCT01263496|581555387|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161045041|NCT01263496|581555388|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
161149727|NCT03303339|581929944|FG004|Overall Study|Study Terminated by Sponsor|0|||
161149728|NCT03303339|581929945|FG005|Overall Study|Study Terminated by Sponsor|0|||
161149729|NCT03303339|581929946|FG006|Overall Study|Study Terminated by Sponsor|0|||
161149730|NCT03303339|581929947|FG007|Overall Study|Study Terminated by Sponsor|0|||
161149731|NCT03303339|581929948|FG008|Overall Study|Study Terminated by Sponsor|1|||
161149732|NCT03303339|581929949|FG009|Overall Study|Study Terminated by Sponsor|0|||
161149733|NCT03303339|581929950|FG010|Overall Study|Study Terminated by Sponsor|1|||
161149734|NCT03303339|581929951|FG011|Overall Study|Study Terminated by Sponsor|1|||
161149735|NCT03303339|581929940|FG000|Overall Study|Withdrawal by Subject|1|||
161149736|NCT03303339|581929941|FG001|Overall Study|Withdrawal by Subject|0|||
161149737|NCT03303339|581929942|FG002|Overall Study|Withdrawal by Subject|0|||
161045042|NCT01263496|581555380|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045043|NCT01263496|581555381|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045044|NCT01263496|581555382|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045045|NCT01263496|581555383|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
161045046|NCT01263496|581555384|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
161045047|NCT01263496|581555385|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045048|NCT01263496|581555386|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045049|NCT01263496|581555387|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045050|NCT01263496|581555388|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
161045051|NCT01263496|581555380|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
161045052|NCT01263496|581555381|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
161045053|NCT01263496|581555382|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
161045054|NCT01263496|581555383|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
161045055|NCT01263496|581555384|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
161045056|NCT01263496|581555385|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
161045057|NCT01263496|581555386|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
161045058|NCT01263496|581555387|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
161045059|NCT01263496|581555388|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
161045060|NCT01263496|581555380|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045061|NCT01263496|581555381|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
161045062|NCT01263496|581555382|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045063|NCT01263496|581555383|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045064|NCT01263496|581555384|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045065|NCT01263496|581555385|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045066|NCT01263496|581555386|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045067|NCT01263496|581555387|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045068|NCT01263496|581555388|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
161045069|NCT01263496|581555380|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161045070|NCT01263496|581555381|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161045071|NCT01263496|581555382|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161045072|NCT01263496|581555383|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161045073|NCT01263496|581555384|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
161045074|NCT01263496|581555385|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161045075|NCT01263496|581555386|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161045076|NCT01263496|581555387|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161045077|NCT01263496|581555388|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161045078|NCT01263496|581555380|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
161045079|NCT01263496|581555381|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
161045080|NCT01263496|581555382|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
161045081|NCT01263496|581555383|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161045082|NCT01263496|581555384|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
161045083|NCT01263496|581555385|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161045084|NCT01263496|581555386|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161045085|NCT01263496|581555387|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161149738|NCT03303339|581929943|FG003|Overall Study|Withdrawal by Subject|0|||
161149739|NCT03303339|581929944|FG004|Overall Study|Withdrawal by Subject|0|||
161149740|NCT03303339|581929945|FG005|Overall Study|Withdrawal by Subject|1|||
161149741|NCT03303339|581929946|FG006|Overall Study|Withdrawal by Subject|1|||
161149742|NCT03303339|581929947|FG007|Overall Study|Withdrawal by Subject|0|||
161149743|NCT03303339|581929948|FG008|Overall Study|Withdrawal by Subject|0|||
161149744|NCT03303339|581929949|FG009|Overall Study|Withdrawal by Subject|0|||
161149745|NCT03303339|581929950|FG010|Overall Study|Withdrawal by Subject|0|||
161045086|NCT01263496|581555388|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161149746|NCT03303339|581929951|FG011|Overall Study|Withdrawal by Subject|2|||
161149747|NCT03303339|581929940|FG000|Overall Study|Physician Decision|0|||
161045087|NCT01263496|581555380|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045088|NCT01263496|581555381|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161149748|NCT03303339|581929941|FG001|Overall Study|Physician Decision|0|||
161045089|NCT01263496|581555382|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045090|NCT01263496|581555383|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045091|NCT01263496|581555384|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045092|NCT01263496|581555385|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045093|NCT01263496|581555386|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045094|NCT01263496|581555387|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
161045095|NCT01263496|581555388|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161045096|NCT01218594|581555389|FG000|Overall Study|Death|1|||
161045097|NCT01218594|581555389|FG000|Overall Study|Withdrawal by Subject|3|||
161045098|NCT01218594|581555389|FG000|Overall Study|Adverse Event|2|||
161045099|NCT01218594|581555389|FG000|Overall Study|Physician Decision|6|||
161045100|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
161045101|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
161045102|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
161045103|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
161045104|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
161045105|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
161045106|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
161045107|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
161045108|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
161045109|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
161045110|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
161045111|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
161045112|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
161045113|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
161045114|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
161045115|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
161045116|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
161045117|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
161045118|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
161045119|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
161045120|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
161045121|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
161045122|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
161045123|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
161045124|NCT02203032|581555391|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
161045125|NCT02203032|581555392|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
161045126|NCT02203032|581555393|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
161045127|NCT02203032|581555394|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
161045128|NCT02203032|581555391|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
161045129|NCT02203032|581555392|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
161045130|NCT02203032|581555393|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
161045131|NCT02203032|581555394|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
161045132|NCT02203032|581555391|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
161045133|NCT02203032|581555392|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
161045134|NCT02203032|581555393|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
161045135|NCT02203032|581555394|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
161045136|NCT02203032|581555391|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
161045137|NCT02203032|581555392|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
161045138|NCT02203032|581555393|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
161045139|NCT02203032|581555394|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
161045140|NCT02203032|581555391|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
161045141|NCT02203032|581555392|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
161045142|NCT02203032|581555393|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
161045143|NCT02203032|581555394|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
161045144|NCT02203032|581555391|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
161045145|NCT02203032|581555392|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
161045146|NCT02203032|581555393|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
161045147|NCT02203032|581555394|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
161045148|NCT02241785|581555395|FG000|Overall Study|Sponsor Termination|43|||
161045149|NCT02241785|581555395|FG000|Overall Study|Withdrawal by Subject|1|||
161045150|NCT02241785|581555395|FG000|Overall Study|Lost to Follow-up|2|||
161280710|NCT00996892|582407007|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
161280711|NCT00996892|582407008|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
161280712|NCT00996892|582407009|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
161280713|NCT00996892|582407010|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
161280714|NCT00996892|582407011|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
161149749|NCT03303339|581929942|FG002|Overall Study|Physician Decision|0|||
161149750|NCT03303339|581929943|FG003|Overall Study|Physician Decision|0|||
161149751|NCT03303339|581929944|FG004|Overall Study|Physician Decision|1|||
161149752|NCT03303339|581929945|FG005|Overall Study|Physician Decision|0|||
161149753|NCT03303339|581929946|FG006|Overall Study|Physician Decision|0|||
161149754|NCT03303339|581929947|FG007|Overall Study|Physician Decision|0|||
161149755|NCT03303339|581929948|FG008|Overall Study|Physician Decision|0|||
161149756|NCT03303339|581929949|FG009|Overall Study|Physician Decision|0|||
161149757|NCT03303339|581929950|FG010|Overall Study|Physician Decision|0|||
161149758|NCT03303339|581929951|FG011|Overall Study|Physician Decision|0|||
161149759|NCT03303339|581929940|FG000|Overall Study|Safety/Non-compliance|0|||
161149760|NCT03303339|581929941|FG001|Overall Study|Safety/Non-compliance|0|||
161149761|NCT03303339|581929942|FG002|Overall Study|Safety/Non-compliance|0|||
161149762|NCT03303339|581929943|FG003|Overall Study|Safety/Non-compliance|0|||
161149763|NCT03303339|581929944|FG004|Overall Study|Safety/Non-compliance|0|||
161149764|NCT03303339|581929945|FG005|Overall Study|Safety/Non-compliance|0|||
161149765|NCT03303339|581929946|FG006|Overall Study|Safety/Non-compliance|0|||
161149766|NCT03303339|581929947|FG007|Overall Study|Safety/Non-compliance|0|||
161149767|NCT03303339|581929948|FG008|Overall Study|Safety/Non-compliance|0|||
161149768|NCT03303339|581929949|FG009|Overall Study|Safety/Non-compliance|0|||
161149769|NCT03303339|581929950|FG010|Overall Study|Safety/Non-compliance|0|||
161149770|NCT03303339|581929951|FG011|Overall Study|Safety/Non-compliance|1|||
161149771|NCT02522377|581929953|FG000|Overall Study|Withdrawal by Subject|1|||
161149772|NCT02522377|581929954|FG001|Overall Study|Withdrawal by Subject|0|||
161149773|NCT02522377|581929953|FG000|Overall Study|Remission Achieved|3|||
161149774|NCT02522377|581929954|FG001|Overall Study|Remission Achieved|0|||
161149775|NCT01158950|581929955|FG000|1st Intervention (1 Day)|Physician Decision|1|||
161149776|NCT01158950|581929956|FG001|1st Intervention (1 Day)|Physician Decision|2|||
161149777|NCT00510692|581929957|FG000|Overall Study|Adverse Event|1|||
161149778|NCT00510692|581929958|FG001|Overall Study|Adverse Event|3|||
161149779|NCT00510692|581929957|FG000|Overall Study|Withdrawal by Subject|1|||
161149780|NCT00510692|581929958|FG001|Overall Study|Withdrawal by Subject|0|||
161149781|NCT00945191|581929959|FG000|Overall Study|Did not achieve a complete response|18|||
161149782|NCT00945191|581929959|FG000|Overall Study|Participant relocated to another state|1|||
161149783|NCT00945191|581929959|FG000|Overall Study|Disease progression|3|||
161149784|NCT00945191|581929959|FG000|Overall Study|Serious adverse event or adverse event|1|||
161149785|NCT00945191|581929959|FG000|Overall Study|Investigator's discretion|1|||
161149786|NCT02116972|581929960|FG000|Overall Study|Adverse Event|4|||
161149787|NCT02116972|581929961|FG001|Overall Study|Adverse Event|4|||
161149788|NCT02116972|581929962|FG002|Overall Study|Adverse Event|1|||
161149789|NCT02116972|581929960|FG000|Overall Study|Withdrawal by Subject|1|||
161344859|NCT04725188|582648814|FG001|Overall Study|Death|69|||
161344860|NCT04725188|582648815|FG002|Overall Study|Death|76|||
161344861|NCT04725188|582648813|FG000|Overall Study|Lost to Follow-up|1|||
161344862|NCT04725188|582648814|FG001|Overall Study|Lost to Follow-up|0|||
161344863|NCT04725188|582648815|FG002|Overall Study|Lost to Follow-up|1|||
161344864|NCT04725188|582648813|FG000|Overall Study|Withdrawal by Subject|2|||
161344865|NCT04725188|582648814|FG001|Overall Study|Withdrawal by Subject|2|||
161344866|NCT04725188|582648815|FG002|Overall Study|Withdrawal by Subject|1|||
161344867|NCT04725188|582648813|FG000|Overall Study|Sponsor Decision|12|||
161344868|NCT04725188|582648814|FG001|Overall Study|Sponsor Decision|12|||
161149790|NCT02116972|581929961|FG001|Overall Study|Withdrawal by Subject|1|||
161149791|NCT02116972|581929962|FG002|Overall Study|Withdrawal by Subject|5|||
161149792|NCT02116972|581929960|FG000|Overall Study|Protocol Violation|1|||
161149793|NCT02116972|581929961|FG001|Overall Study|Protocol Violation|0|||
161149794|NCT02116972|581929962|FG002|Overall Study|Protocol Violation|1|||
161149795|NCT02116972|581929960|FG000|Overall Study|Lost to Follow-up|4|||
161149796|NCT02116972|581929961|FG001|Overall Study|Lost to Follow-up|3|||
161149797|NCT02116972|581929962|FG002|Overall Study|Lost to Follow-up|1|||
161149798|NCT02116972|581929960|FG000|Overall Study|Lack of Efficacy|6|||
161149799|NCT02116972|581929961|FG001|Overall Study|Lack of Efficacy|6|||
161149800|NCT02116972|581929962|FG002|Overall Study|Lack of Efficacy|5|||
161344869|NCT04725188|582648815|FG002|Overall Study|Sponsor Decision|7|||
161149801|NCT02116972|581929960|FG000|Overall Study|scheduling conflicts and relocation|3|||
161149802|NCT02116972|581929961|FG001|Overall Study|scheduling conflicts and relocation|3|||
161149803|NCT02116972|581929962|FG002|Overall Study|scheduling conflicts and relocation|6|||
161344870|NCT00390013|582648817|FG000|Phase 1|tired|0|||
161344871|NCT00390013|582648818|FG001|Phase 1|tired|0|||
161344872|NCT00390013|582648819|FG002|Phase 1|tired|0|||
161149804|NCT00784784|581929963|FG000|Overall Study|Withdrawal by Subject|2|||
161149805|NCT00784784|581929964|FG001|Overall Study|Withdrawal by Subject|2|||
161149806|NCT00872898|581929965|FG000|Part Two - Double Blind|Adverse Event|4|||
161149807|NCT00872898|581929966|FG001|Part Two - Double Blind|Adverse Event|3|||
161149808|NCT00872898|581929965|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
161149809|NCT00872898|581929966|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
161344873|NCT00390013|582648820|FG003|Phase 1|tired|1|||
161344874|NCT00390013|582648817|FG000|Phase 2 First Treatment|tired|1|||
161344875|NCT00390013|582648818|FG001|Phase 2 First Treatment|tired|0|||
161045151|NCT02241785|581555395|FG000|Overall Study|Adverse Event|1|||
161045152|NCT03905642|581555400|FG000|Overall Study|Withdrawal by Subject|3|||
161045153|NCT03905642|581555400|FG000|Overall Study|Pregnancy|1|||
161045154|NCT03905642|581555400|FG000|Overall Study|Adverse Event|1|||
161045155|NCT03905642|581555400|FG000|Overall Study|Lack of Efficacy|1|||
161045156|NCT03905642|581555400|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
161045157|NCT05995977|581555401|FG000|Overall Study|Withdrawal by Subject|1|||
161045158|NCT05995977|581555402|FG001|Overall Study|Withdrawal by Subject|4|||
161045159|NCT05995977|581555401|FG000|Overall Study|Lost to Follow-up|2|||
161045160|NCT05995977|581555402|FG001|Overall Study|Lost to Follow-up|0|||
161045161|NCT04181788|581555403|FG000|TREATMENT|Adverse Event|0|||
161045162|NCT04181788|581555404|FG001|TREATMENT|Adverse Event|2|||
161045163|NCT04181788|581555405|FG002|TREATMENT|Adverse Event|1|||
161045164|NCT04181788|581555406|FG003|TREATMENT|Adverse Event|0|||
161045165|NCT04181788|581555407|FG004|TREATMENT|Adverse Event|1|||
161045166|NCT04181788|581555408|FG005|TREATMENT|Adverse Event|3|||
161045167|NCT04181788|581555403|FG000|TREATMENT|Death|0|||
161045168|NCT04181788|581555404|FG001|TREATMENT|Death|0|||
161045169|NCT04181788|581555405|FG002|TREATMENT|Death|0|||
161045170|NCT04181788|581555406|FG003|TREATMENT|Death|0|||
161045171|NCT04181788|581555407|FG004|TREATMENT|Death|8|||
161045172|NCT04181788|581555408|FG005|TREATMENT|Death|8|||
161045173|NCT04181788|581555403|FG000|TREATMENT|Physician Decision|0|||
161045174|NCT04181788|581555404|FG001|TREATMENT|Physician Decision|0|||
161045175|NCT04181788|581555405|FG002|TREATMENT|Physician Decision|0|||
161045176|NCT04181788|581555406|FG003|TREATMENT|Physician Decision|0|||
161045177|NCT04181788|581555407|FG004|TREATMENT|Physician Decision|0|||
161045178|NCT04181788|581555408|FG005|TREATMENT|Physician Decision|1|||
161045179|NCT04181788|581555403|FG000|TREATMENT|Progressive disease|3|||
161045180|NCT04181788|581555404|FG001|TREATMENT|Progressive disease|3|||
161045181|NCT04181788|581555405|FG002|TREATMENT|Progressive disease|5|||
161045182|NCT04181788|581555406|FG003|TREATMENT|Progressive disease|7|||
161045183|NCT04181788|581555407|FG004|TREATMENT|Progressive disease|20|||
161045184|NCT04181788|581555408|FG005|TREATMENT|Progressive disease|38|||
161045185|NCT04181788|581555403|FG000|TREATMENT|Global deterioration of health status|0|||
161045186|NCT04181788|581555404|FG001|TREATMENT|Global deterioration of health status|2|||
161045187|NCT04181788|581555405|FG002|TREATMENT|Global deterioration of health status|0|||
161045188|NCT04181788|581555406|FG003|TREATMENT|Global deterioration of health status|0|||
161045189|NCT04181788|581555407|FG004|TREATMENT|Global deterioration of health status|2|||
161045190|NCT04181788|581555408|FG005|TREATMENT|Global deterioration of health status|8|||
161045191|NCT04181788|581555403|FG000|TREATMENT|Withdrawal by Subject|1|||
161045192|NCT04181788|581555404|FG001|TREATMENT|Withdrawal by Subject|2|||
161045193|NCT04181788|581555405|FG002|TREATMENT|Withdrawal by Subject|0|||
161045194|NCT04181788|581555406|FG003|TREATMENT|Withdrawal by Subject|0|||
161045195|NCT04181788|581555407|FG004|TREATMENT|Withdrawal by Subject|3|||
161045196|NCT04181788|581555408|FG005|TREATMENT|Withdrawal by Subject|5|||
161045197|NCT04181788|581555403|FG000|TREATMENT|Other unspecified|0|||
161045198|NCT04181788|581555404|FG001|TREATMENT|Other unspecified|0|||
161045199|NCT04181788|581555405|FG002|TREATMENT|Other unspecified|0|||
161045200|NCT04181788|581555406|FG003|TREATMENT|Other unspecified|0|||
161045201|NCT04181788|581555407|FG004|TREATMENT|Other unspecified|0|||
161045202|NCT04181788|581555408|FG005|TREATMENT|Other unspecified|2|||
161045203|NCT04181788|581555403|FG000|TREATMENT|Ongoing|0|||
161045204|NCT04181788|581555404|FG001|TREATMENT|Ongoing|3|||
161045205|NCT04181788|581555405|FG002|TREATMENT|Ongoing|0|||
161045206|NCT04181788|581555406|FG003|TREATMENT|Ongoing|5|||
161045207|NCT04181788|581555407|FG004|TREATMENT|Ongoing|7|||
161045208|NCT04181788|581555408|FG005|TREATMENT|Ongoing|15|||
161045209|NCT04181788|581555403|FG000|FOLLOW-UP|Death|0|||
161045210|NCT04181788|581555404|FG001|FOLLOW-UP|Death|0|||
161280715|NCT00996892|582407012|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
161280716|NCT00996892|582407013|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
161280717|NCT00996892|582407014|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
161045211|NCT04181788|581555405|FG002|FOLLOW-UP|Death|1|||
161280718|NCT00996892|582407015|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
161045212|NCT04181788|581555406|FG003|FOLLOW-UP|Death|2|||
161045213|NCT04181788|581555407|FG004|FOLLOW-UP|Death|8|||
161045214|NCT04181788|581555408|FG005|FOLLOW-UP|Death|20|||
161045215|NCT04181788|581555403|FG000|FOLLOW-UP|Lost to Follow-up|0|||
161045216|NCT04181788|581555404|FG001|FOLLOW-UP|Lost to Follow-up|0|||
161045217|NCT04181788|581555405|FG002|FOLLOW-UP|Lost to Follow-up|0|||
161045218|NCT04181788|581555406|FG003|FOLLOW-UP|Lost to Follow-up|0|||
161045219|NCT04181788|581555407|FG004|FOLLOW-UP|Lost to Follow-up|0|||
161045220|NCT04181788|581555408|FG005|FOLLOW-UP|Lost to Follow-up|2|||
161045221|NCT04181788|581555403|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
161344876|NCT00390013|582648819|FG002|Phase 2 First Treatment|tired|0|||
161045222|NCT04181788|581555404|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
161045223|NCT04181788|581555405|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
161045224|NCT04181788|581555406|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
161045225|NCT04181788|581555407|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
161045226|NCT04181788|581555408|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
161045227|NCT04181788|581555403|FG000|FOLLOW-UP|Other unspecified|0|||
161045228|NCT04181788|581555404|FG001|FOLLOW-UP|Other unspecified|1|||
161149810|NCT00872898|581929965|FG000|Part Two - Double Blind|Protocol Violation|1|||
161149811|NCT00872898|581929966|FG001|Part Two - Double Blind|Protocol Violation|0|||
161149812|NCT00872898|581929965|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
161149813|NCT00872898|581929966|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
161149814|NCT00872898|581929965|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
161149815|NCT00872898|581929966|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
161149816|NCT00872898|581929965|FG000|Part Two - Double Blind|Other reasons|2|||
161149817|NCT00872898|581929966|FG001|Part Two - Double Blind|Other reasons|0|||
161149818|NCT00863928|581929969|FG000|Overall Study|Protocol Violation|26|||
161149819|NCT00863928|581929970|FG001|Overall Study|Protocol Violation|0|||
161149820|NCT00863928|581929969|FG000|Overall Study|Withdrawal by Subject|3|||
161149821|NCT00863928|581929970|FG001|Overall Study|Withdrawal by Subject|0|||
161149822|NCT00863928|581929969|FG000|Overall Study|surgery cancellation|4|||
161149823|NCT00863928|581929970|FG001|Overall Study|surgery cancellation|0|||
161149824|NCT00863928|581929969|FG000|Overall Study|medication allergy|3|||
161149825|NCT00863928|581929970|FG001|Overall Study|medication allergy|0|||
161149826|NCT02124798|581929971|FG000|Overall Study|Adverse Event|3|||
161149827|NCT02124798|581929971|FG000|Overall Study|Lost to Follow-up|1|||
161149828|NCT01797432|581929972|FG000|Overall Study|Lost to Follow-up|1|||
161149829|NCT01797432|581929972|FG000|Overall Study|Adverse Event|1|||
161149830|NCT01797432|581929972|FG000|Overall Study|Withdrawal by Subject|1|||
161149831|NCT01797432|581929972|FG000|Overall Study|lived too far from study site|1|||
161149832|NCT02792777|581929973|FG000|Overall Study|Withdrawal by Subject|2|||
161149833|NCT02792777|581929974|FG001|Overall Study|Withdrawal by Subject|0|||
161149834|NCT02792777|581929973|FG000|Overall Study|Recording malfunction|2|||
161149835|NCT02792777|581929974|FG001|Overall Study|Recording malfunction|0|||
161149836|NCT02792777|581929973|FG000|Overall Study|Later determined to be ineligible|2|||
161149837|NCT02792777|581929974|FG001|Overall Study|Later determined to be ineligible|0|||
161149838|NCT02792777|581929973|FG000|Overall Study|Participant interviewed twice|1|||
161149839|NCT02792777|581929974|FG001|Overall Study|Participant interviewed twice|0|||
161149840|NCT02795156|581929975|FG000|Overall Study|Progressive Disease|22|||
161149841|NCT02795156|581929976|FG001|Overall Study|Progressive Disease|7|||
161149842|NCT02795156|581929977|FG002|Overall Study|Progressive Disease|34|||
161149843|NCT02795156|581929978|FG003|Overall Study|Progressive Disease|7|||
161149844|NCT02795156|581929975|FG000|Overall Study|Adverse Event|13|||
161149845|NCT02795156|581929976|FG001|Overall Study|Adverse Event|2|||
161149846|NCT02795156|581929977|FG002|Overall Study|Adverse Event|3|||
161149847|NCT02795156|581929978|FG003|Overall Study|Adverse Event|2|||
161149848|NCT02795156|581929975|FG000|Overall Study|Death|1|||
161149849|NCT02795156|581929976|FG001|Overall Study|Death|1|||
161149850|NCT02795156|581929977|FG002|Overall Study|Death|1|||
161149851|NCT02795156|581929978|FG003|Overall Study|Death|0|||
161149852|NCT02795156|581929975|FG000|Overall Study|Physician Decision|1|||
161149853|NCT02795156|581929976|FG001|Overall Study|Physician Decision|0|||
161149854|NCT02795156|581929977|FG002|Overall Study|Physician Decision|1|||
161149855|NCT02795156|581929978|FG003|Overall Study|Physician Decision|0|||
161149856|NCT02795156|581929975|FG000|Overall Study|Withdrawal by Subject|2|||
161149857|NCT02795156|581929976|FG001|Overall Study|Withdrawal by Subject|0|||
161149858|NCT02795156|581929977|FG002|Overall Study|Withdrawal by Subject|3|||
161149859|NCT02795156|581929978|FG003|Overall Study|Withdrawal by Subject|0|||
161149860|NCT00638846|581929982|FG000|Overall Study|Adverse Event|0|||
161149861|NCT00638846|581929983|FG001|Overall Study|Adverse Event|1|||
161149862|NCT00638846|581929982|FG000|Overall Study|Lost to Follow-up|3|||
161149863|NCT00638846|581929983|FG001|Overall Study|Lost to Follow-up|2|||
161149864|NCT00638846|581929982|FG000|Overall Study|lens issue|1|||
161149865|NCT00638846|581929983|FG001|Overall Study|lens issue|3|||
161149866|NCT02746679|581929991|FG000|Overall Study|Lost to Follow-up|4|||
161149867|NCT02746679|581929992|FG001|Overall Study|Lost to Follow-up|6|||
161149868|NCT01520922|581929996|FG000|Treatment Phase|Physician Decision|2|||
161149869|NCT01520922|581929997|FG001|Treatment Phase|Physician Decision|1|||
161149870|NCT01520922|581929996|FG000|Treatment Phase|Progression|0|||
161149871|NCT01520922|581929997|FG001|Treatment Phase|Progression|2|||
161149872|NCT01520922|581929996|FG000|Treatment Phase|Adverse Event|3|||
161149873|NCT01520922|581929997|FG001|Treatment Phase|Adverse Event|5|||
161149874|NCT01520922|581929996|FG000|Follow up|Lost to Follow-up|0|||
161149875|NCT01520922|581929997|FG001|Follow up|Lost to Follow-up|1|||
161149876|NCT01520922|581929996|FG000|Survival Follow-up|Withdrawal by Subject|1|||
161149877|NCT01520922|581929997|FG001|Survival Follow-up|Withdrawal by Subject|0|||
161149878|NCT01696877|581929998|FG000|Overall Study|Adverse Event|0|||
161149879|NCT01696877|581929999|FG001|Overall Study|Adverse Event|1|||
161149880|NCT01422304|581930002|FG000|Overall Study|Adverse Event|0|||
161149881|NCT01422304|581930003|FG001|Overall Study|Adverse Event|1|||
161149882|NCT01422304|581930002|FG000|Overall Study|Lost to Follow-up|14|||
161149883|NCT01422304|581930003|FG001|Overall Study|Lost to Follow-up|20|||
161149884|NCT01422304|581930002|FG000|Overall Study|Never Entered Follow-up|2|||
161149885|NCT01422304|581930003|FG001|Overall Study|Never Entered Follow-up|1|||
161149886|NCT01422304|581930002|FG000|Overall Study|Protocol Violation|1|||
161149887|NCT01422304|581930003|FG001|Overall Study|Protocol Violation|0|||
161045229|NCT04181788|581555405|FG002|FOLLOW-UP|Other unspecified|0|||
161045230|NCT04181788|581555406|FG003|FOLLOW-UP|Other unspecified|0|||
161045231|NCT04181788|581555407|FG004|FOLLOW-UP|Other unspecified|0|||
161045232|NCT04181788|581555408|FG005|FOLLOW-UP|Other unspecified|3|||
161045233|NCT04181788|581555403|FG000|FOLLOW-UP|Ongoing|0|||
161045234|NCT04181788|581555404|FG001|FOLLOW-UP|Ongoing|0|||
161045235|NCT04181788|581555405|FG002|FOLLOW-UP|Ongoing|1|||
161045236|NCT04181788|581555406|FG003|FOLLOW-UP|Ongoing|3|||
161045237|NCT04181788|581555407|FG004|FOLLOW-UP|Ongoing|2|||
161045238|NCT04181788|581555408|FG005|FOLLOW-UP|Ongoing|2|||
161045239|NCT04535414|581555409|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
161045240|NCT04535414|581555410|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
161045241|NCT04535414|581555409|FG000|Overall Study|Cancelled appointment|1|||
161045242|NCT04535414|581555410|FG001|Overall Study|Cancelled appointment|0|||
161045243|NCT04535414|581555409|FG000|Overall Study|cancelled - food in stomach|2|||
161045244|NCT04535414|581555410|FG001|Overall Study|cancelled - food in stomach|0|||
161045245|NCT04535414|581555409|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
161045246|NCT04535414|581555410|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
161045247|NCT04535414|581555409|FG000|Overall Study|Withdrawal by Subject|0|||
161045248|NCT04535414|581555410|FG001|Overall Study|Withdrawal by Subject|1|||
161045249|NCT02196259|581557111|FG000|Overall Study|Researcher choice|0|||
161045250|NCT02196259|581557112|FG001|Overall Study|Researcher choice|0|||
161045251|NCT02196259|581557113|FG002|Overall Study|Researcher choice|1|||
161045252|NCT02196259|581557111|FG000|Overall Study|Partial data analysis|0|||
161045253|NCT02196259|581557112|FG001|Overall Study|Partial data analysis|3|||
161045254|NCT02196259|581557113|FG002|Overall Study|Partial data analysis|0|||
161045255|NCT01668355|581557115|FG000|Overall Study|Death|3|||
161045256|NCT01668355|581557116|FG001|Overall Study|Death|1|||
161045257|NCT01668355|581557115|FG000|Overall Study|Withdrawal by Subject|6|||
161045258|NCT01668355|581557116|FG001|Overall Study|Withdrawal by Subject|1|||
161045259|NCT00535626|581557117|FG000|Overall Study|Death|15|||
161045260|NCT00535626|581557117|FG000|Overall Study|Lost to Follow-up|29|||
161045261|NCT00535626|581557117|FG000|Overall Study|Withdrawal by Subject|20|||
161045262|NCT00535626|581557117|FG000|Overall Study|Removal/revision of study component|8|||
161045263|NCT00535626|581557117|FG000|Overall Study|Subject terminated|31|||
161045264|NCT00535626|581557117|FG000|Overall Study|Unable to return|2|||
161045265|NCT04633200|581557118|FG000|Overall Study|Lost to Follow-up|3|||
161045266|NCT04633200|581557119|FG001|Overall Study|Lost to Follow-up|5|||
161045267|NCT02002689|581557120|FG000|Overall Study|Disease Progression|7|||
161045268|NCT02002689|581557120|FG000|Overall Study|Adverse Event|3|||
161045269|NCT01808534|581557121|FG000|Overall Study|Disease progression|3|||
161045270|NCT01808534|581557121|FG000|Overall Study|Physician Decision|1|||
161045271|NCT01148017|581557124|FG000|Overall Study|Withdrawal by Subject|31|||
161045272|NCT01148017|581557125|FG001|Overall Study|Withdrawal by Subject|14|||
161045273|NCT01148017|581557126|FG002|Overall Study|Withdrawal by Subject|0|||
161045274|NCT01148017|581557127|FG003|Overall Study|Withdrawal by Subject|0|||
161045275|NCT01148017|581557124|FG000|Overall Study|Lost to Follow-up|23|||
161045276|NCT01148017|581557125|FG001|Overall Study|Lost to Follow-up|10|||
161045277|NCT01148017|581557126|FG002|Overall Study|Lost to Follow-up|0|||
161045278|NCT01148017|581557127|FG003|Overall Study|Lost to Follow-up|0|||
161045279|NCT01148017|581557124|FG000|Overall Study|Inappropriate enrollment|1|||
161045280|NCT01148017|581557125|FG001|Overall Study|Inappropriate enrollment|0|||
161045281|NCT01148017|581557126|FG002|Overall Study|Inappropriate enrollment|0|||
161045282|NCT01148017|581557127|FG003|Overall Study|Inappropriate enrollment|0|||
161045283|NCT01148017|581557124|FG000|Overall Study|Administrative reason|22|||
161045284|NCT01148017|581557125|FG001|Overall Study|Administrative reason|9|||
161045285|NCT01148017|581557126|FG002|Overall Study|Administrative reason|0|||
161045286|NCT01148017|581557127|FG003|Overall Study|Administrative reason|0|||
161045287|NCT01148017|581557124|FG000|Overall Study|Unable to classify|3|||
161045288|NCT01148017|581557125|FG001|Overall Study|Unable to classify|1|||
161045289|NCT01148017|581557126|FG002|Overall Study|Unable to classify|0|||
161045290|NCT01148017|581557127|FG003|Overall Study|Unable to classify|0|||
161045291|NCT01332266|581557128|FG000|Phase 1b|Death|3|||
161045292|NCT01332266|581557129|FG001|Phase 1b|Death|3|||
161045293|NCT01332266|581557130|FG002|Phase 1b|Death|2|||
161045294|NCT01332266|581557131|FG003|Phase 1b|Death|0|||
161045295|NCT01332266|581557132|FG004|Phase 1b|Death|0|||
161045296|NCT01332266|581557128|FG000|Phase 1b|Lost to Follow-up|0|||
161045297|NCT01332266|581557129|FG001|Phase 1b|Lost to Follow-up|1|||
161045298|NCT01332266|581557130|FG002|Phase 1b|Lost to Follow-up|0|||
161045299|NCT01332266|581557131|FG003|Phase 1b|Lost to Follow-up|0|||
161045300|NCT01332266|581557132|FG004|Phase 1b|Lost to Follow-up|0|||
161045301|NCT01332266|581557128|FG000|Phase 1b|Withdrawal by Subject|1|||
161045302|NCT01332266|581557129|FG001|Phase 1b|Withdrawal by Subject|1|||
161045303|NCT01332266|581557130|FG002|Phase 1b|Withdrawal by Subject|1|||
161045304|NCT01332266|581557131|FG003|Phase 1b|Withdrawal by Subject|0|||
161045305|NCT01332266|581557132|FG004|Phase 1b|Withdrawal by Subject|0|||
161045306|NCT01332266|581557128|FG000|Phase 2|Death|0|||
161045307|NCT01332266|581557129|FG001|Phase 2|Death|0|||
161045308|NCT01332266|581557130|FG002|Phase 2|Death|0|||
161045309|NCT01332266|581557131|FG003|Phase 2|Death|33|||
161045310|NCT01332266|581557132|FG004|Phase 2|Death|36|||
161045311|NCT01332266|581557128|FG000|Phase 2|Lost to Follow-up|0|||
161045312|NCT01332266|581557129|FG001|Phase 2|Lost to Follow-up|0|||
161045313|NCT01332266|581557130|FG002|Phase 2|Lost to Follow-up|0|||
161045314|NCT01332266|581557131|FG003|Phase 2|Lost to Follow-up|2|||
161045315|NCT01332266|581557132|FG004|Phase 2|Lost to Follow-up|0|||
161045316|NCT01332266|581557128|FG000|Phase 2|Physician Decision|0|||
161045317|NCT01332266|581557129|FG001|Phase 2|Physician Decision|0|||
161045318|NCT01332266|581557130|FG002|Phase 2|Physician Decision|0|||
161045319|NCT01332266|581557131|FG003|Phase 2|Physician Decision|3|||
161045320|NCT01332266|581557132|FG004|Phase 2|Physician Decision|1|||
161045321|NCT01332266|581557128|FG000|Phase 2|Symptomatic deterioration|0|||
161045322|NCT01332266|581557129|FG001|Phase 2|Symptomatic deterioration|0|||
161045323|NCT01332266|581557130|FG002|Phase 2|Symptomatic deterioration|0|||
161045324|NCT01332266|581557131|FG003|Phase 2|Symptomatic deterioration|0|||
161045325|NCT01332266|581557132|FG004|Phase 2|Symptomatic deterioration|1|||
161045326|NCT01332266|581557128|FG000|Phase 2|Progression Disease|0|||
161045327|NCT01332266|581557129|FG001|Phase 2|Progression Disease|0|||
161045328|NCT01332266|581557130|FG002|Phase 2|Progression Disease|0|||
161045329|NCT01332266|581557131|FG003|Phase 2|Progression Disease|2|||
161045330|NCT01332266|581557132|FG004|Phase 2|Progression Disease|1|||
161045331|NCT01332266|581557128|FG000|Phase 2|Withdrawal by Subject|0|||
161045332|NCT01332266|581557129|FG001|Phase 2|Withdrawal by Subject|0|||
161045333|NCT01332266|581557130|FG002|Phase 2|Withdrawal by Subject|0|||
161045334|NCT01332266|581557131|FG003|Phase 2|Withdrawal by Subject|2|||
161045335|NCT01332266|581557132|FG004|Phase 2|Withdrawal by Subject|2|||
161045336|NCT01686152|581557135|FG000|Overall Study|Withdrawal by Subject|11|||
161045337|NCT01686152|581557136|FG001|Overall Study|Withdrawal by Subject|11|||
161045338|NCT01686152|581557137|FG002|Overall Study|Withdrawal by Subject|3|||
161045339|NCT01686152|581557135|FG000|Overall Study|Drug Code Unblinded|0|||
161045340|NCT01686152|581557136|FG001|Overall Study|Drug Code Unblinded|1|||
161045341|NCT01686152|581557137|FG002|Overall Study|Drug Code Unblinded|0|||
161045342|NCT01686152|581557135|FG000|Overall Study|Protocol Violation|6|||
161045343|NCT01686152|581557136|FG001|Overall Study|Protocol Violation|1|||
161045344|NCT01686152|581557137|FG002|Overall Study|Protocol Violation|0|||
161045345|NCT01686152|581557135|FG000|Overall Study|Adverse Event|12|||
161045346|NCT01686152|581557136|FG001|Overall Study|Adverse Event|11|||
161045347|NCT01686152|581557137|FG002|Overall Study|Adverse Event|0|||
161045348|NCT01686152|581557135|FG000|Overall Study|Lack of Efficacy|0|||
161045349|NCT01686152|581557136|FG001|Overall Study|Lack of Efficacy|0|||
161045350|NCT01686152|581557137|FG002|Overall Study|Lack of Efficacy|1|||
161045351|NCT01686152|581557135|FG000|Overall Study|IP Non-compliance|5|||
161045352|NCT01686152|581557136|FG001|Overall Study|IP Non-compliance|5|||
161045353|NCT01686152|581557137|FG002|Overall Study|IP Non-compliance|0|||
161045354|NCT01686152|581557135|FG000|Overall Study|Lost to Follow-up|7|||
161045355|NCT01686152|581557136|FG001|Overall Study|Lost to Follow-up|6|||
161045356|NCT01686152|581557137|FG002|Overall Study|Lost to Follow-up|5|||
161045357|NCT01853384|581557138|FG000|Randomized|Adverse Event|5|||
161045358|NCT01853384|581557139|FG001|Randomized|Adverse Event|3|||
161045359|NCT01853384|581557138|FG000|Randomized|Death|1|||
161045360|NCT01853384|581557139|FG001|Randomized|Death|2|||
161045361|NCT01853384|581557138|FG000|Randomized|Lost to Follow-up|1|||
161045362|NCT01853384|581557139|FG001|Randomized|Lost to Follow-up|1|||
161045363|NCT01853384|581557138|FG000|Randomized|Withdrawal by Subject|5|||
161045364|NCT01853384|581557139|FG001|Randomized|Withdrawal by Subject|3|||
161045365|NCT01853384|581557138|FG000|Randomized|Sponsor Decision|47|||
161045366|NCT01853384|581557139|FG001|Randomized|Sponsor Decision|34|||
161045367|NCT01853384|581557138|FG000|Randomized|Other|3|||
161045368|NCT01853384|581557139|FG001|Randomized|Other|3|||
161045369|NCT01853384|581557138|FG000|Completed Follow up Visit 1|Early Termination|13|||
161045370|NCT01853384|581557139|FG001|Completed Follow up Visit 1|Early Termination|9|||
161045371|NCT01853384|581557138|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
161045372|NCT01853384|581557139|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
161045373|NCT01853384|581557138|FG000|Completed Follow up Visit 2|Adverse Event|1|||
161045374|NCT01853384|581557139|FG001|Completed Follow up Visit 2|Adverse Event|0|||
161045375|NCT01853384|581557138|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
161045376|NCT01853384|581557139|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
161045377|NCT01853384|581557138|FG000|Completed Follow up Visit 2|Death|1|||
161045378|NCT01853384|581557139|FG001|Completed Follow up Visit 2|Death|0|||
161045379|NCT01853384|581557138|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
161045380|NCT01853384|581557139|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
161045381|NCT01019135|581557140|FG000|Overall Study|Did not receive allocated intervention|12|||
161045382|NCT01019135|581557141|FG001|Overall Study|Did not receive allocated intervention|6|||
161045383|NCT01019135|581557142|FG002|Overall Study|Did not receive allocated intervention|25|||
161045384|NCT01019135|581557140|FG000|Overall Study|Did not attend CR|8|||
161045385|NCT01019135|581557141|FG001|Overall Study|Did not attend CR|13|||
161045386|NCT01019135|581557142|FG002|Overall Study|Did not attend CR|6|||
161045387|NCT01205126|581557143|FG000|Titration Phase|Adverse Event|5|||
161045388|NCT01205126|581557144|FG001|Titration Phase|Adverse Event|3|||
161045389|NCT01205126|581557143|FG000|Titration Phase|Withdrawal by Subject|5|||
161045390|NCT01205126|581557144|FG001|Titration Phase|Withdrawal by Subject|5|||
161045391|NCT01205126|581557143|FG000|Titration Phase|Lost to Follow-up|2|||
161045392|NCT01205126|581557144|FG001|Titration Phase|Lost to Follow-up|2|||
161045393|NCT01205126|581557143|FG000|Titration Phase|No stable titration dose|1|||
161045394|NCT01205126|581557144|FG001|Titration Phase|No stable titration dose|0|||
161045395|NCT01205126|581557143|FG000|Titration Phase|More than maximum dosage required|2|||
161045396|NCT01205126|581557144|FG001|Titration Phase|More than maximum dosage required|3|||
161045397|NCT01205126|581557143|FG000|Titration Phase|Other|8|||
161045398|NCT01205126|581557144|FG001|Titration Phase|Other|6|||
161045399|NCT01205126|581557143|FG000|Between Titration & Maintenance Phase|Other|0|||
161045400|NCT01205126|581557144|FG001|Between Titration & Maintenance Phase|Other|4|||
161045401|NCT01205126|581557143|FG000|Maintenance Phase|Adverse Event|3|||
161045402|NCT01205126|581557144|FG001|Maintenance Phase|Adverse Event|7|||
161045403|NCT01205126|581557143|FG000|Maintenance Phase|Death|4|||
161045404|NCT01205126|581557144|FG001|Maintenance Phase|Death|4|||
161045405|NCT01205126|581557143|FG000|Maintenance Phase|More than the maximum dosage required|5|||
161045406|NCT01205126|581557144|FG001|Maintenance Phase|More than the maximum dosage required|5|||
161045407|NCT01205126|581557143|FG000|Maintenance Phase|Prohibited drugs used|1|||
161045408|NCT01205126|581557144|FG001|Maintenance Phase|Prohibited drugs used|0|||
161045409|NCT01205126|581557143|FG000|Maintenance Phase|Other|11|||
161045410|NCT01205126|581557144|FG001|Maintenance Phase|Other|8|||
161045411|NCT01205126|581557143|FG000|Maintenance Phase|Lost to Follow-up|5|||
161045412|NCT01205126|581557144|FG001|Maintenance Phase|Lost to Follow-up|5|||
161045413|NCT01205126|581557143|FG000|Maintenance Phase|Withdrawal by Subject|8|||
161045414|NCT01205126|581557144|FG001|Maintenance Phase|Withdrawal by Subject|11|||
161045415|NCT00578344|581557145|FG000|Overall Study|Insurance problems|1|||
161045416|NCT00578344|581557145|FG000|Overall Study|Graft failure|1|||
161045417|NCT03374254|581557148|FG000|Overall Study|Death|5|||
161045418|NCT03374254|581557149|FG001|Overall Study|Death|16|||
161045419|NCT03374254|581557150|FG002|Overall Study|Death|13|||
161045420|NCT03374254|581557151|FG003|Overall Study|Death|11|||
161045421|NCT03374254|581557152|FG004|Overall Study|Death|9|||
161045422|NCT03374254|581557153|FG005|Overall Study|Death|12|||
161045423|NCT03374254|581557154|FG006|Overall Study|Death|11|||
161045424|NCT03374254|581557155|FG007|Overall Study|Death|6|||
161045425|NCT03374254|581557156|FG008|Overall Study|Death|7|||
161045426|NCT03374254|581557148|FG000|Overall Study|Lost to Follow-up|0|||
161045427|NCT03374254|581557149|FG001|Overall Study|Lost to Follow-up|0|||
161045428|NCT03374254|581557150|FG002|Overall Study|Lost to Follow-up|0|||
161045429|NCT03374254|581557151|FG003|Overall Study|Lost to Follow-up|0|||
161045430|NCT03374254|581557152|FG004|Overall Study|Lost to Follow-up|0|||
161045431|NCT03374254|581557153|FG005|Overall Study|Lost to Follow-up|0|||
161045432|NCT03374254|581557154|FG006|Overall Study|Lost to Follow-up|2|||
161045433|NCT03374254|581557155|FG007|Overall Study|Lost to Follow-up|0|||
161045434|NCT03374254|581557156|FG008|Overall Study|Lost to Follow-up|0|||
161045435|NCT03374254|581557148|FG000|Overall Study|Sponsor Decision|1|||
161045436|NCT03374254|581557149|FG001|Overall Study|Sponsor Decision|0|||
161045437|NCT03374254|581557150|FG002|Overall Study|Sponsor Decision|2|||
161045438|NCT03374254|581557151|FG003|Overall Study|Sponsor Decision|3|||
161045439|NCT03374254|581557152|FG004|Overall Study|Sponsor Decision|2|||
161045440|NCT03374254|581557153|FG005|Overall Study|Sponsor Decision|3|||
161045441|NCT03374254|581557154|FG006|Overall Study|Sponsor Decision|3|||
161045442|NCT03374254|581557155|FG007|Overall Study|Sponsor Decision|3|||
161045443|NCT03374254|581557156|FG008|Overall Study|Sponsor Decision|4|||
161045444|NCT03374254|581557148|FG000|Overall Study|Withdrawal by Subject|0|||
161045445|NCT03374254|581557149|FG001|Overall Study|Withdrawal by Subject|0|||
161045446|NCT03374254|581557150|FG002|Overall Study|Withdrawal by Subject|0|||
161045447|NCT03374254|581557151|FG003|Overall Study|Withdrawal by Subject|2|||
161045448|NCT03374254|581557152|FG004|Overall Study|Withdrawal by Subject|0|||
161045449|NCT03374254|581557153|FG005|Overall Study|Withdrawal by Subject|1|||
161280719|NCT00996892|582407016|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
161045450|NCT03374254|581557154|FG006|Overall Study|Withdrawal by Subject|0|||
161280720|NCT00996892|582407017|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
161045451|NCT03374254|581557155|FG007|Overall Study|Withdrawal by Subject|0|||
161045452|NCT03374254|581557156|FG008|Overall Study|Withdrawal by Subject|0|||
161344877|NCT00390013|582648820|FG003|Phase 2 First Treatment|tired|0|||
161045453|NCT00923078|581557160|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
161045454|NCT00923078|581557161|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
161045455|NCT00923078|581557162|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
161045456|NCT00923078|581557160|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
161045457|NCT00923078|581557161|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
161045458|NCT00923078|581557162|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
161045459|NCT02245620|581557169|FG000|Overall Study|Physician Decision|1|||
161045460|NCT02245620|581557170|FG001|Overall Study|Physician Decision|1|||
161045461|NCT04766996|581557173|FG000|Overall Study|Withdrawal by Subject|1|||
161045462|NCT04766996|581557174|FG001|Overall Study|Withdrawal by Subject|0|||
161045463|NCT04766996|581557175|FG002|Overall Study|Withdrawal by Subject|13|||
161045464|NCT01322386|581557176|FG000|Overall Study|Protocol Violation|0|||
161045465|NCT01322386|581557177|FG001|Overall Study|Protocol Violation|1|||
161045466|NCT01322386|581557176|FG000|Overall Study|Physician Decision|0|||
161045467|NCT01322386|581557177|FG001|Overall Study|Physician Decision|1|||
161045468|NCT01102426|581557180|FG000|Overall Study|Randomized but not treated|4|||
161045469|NCT01102426|581557181|FG001|Overall Study|Randomized but not treated|1|||
161045470|NCT01102426|581557180|FG000|Overall Study|Adverse Events (treatment-related)|15|||
161045471|NCT01102426|581557181|FG001|Overall Study|Adverse Events (treatment-related)|8|||
161045472|NCT01102426|581557180|FG000|Overall Study|Physician Decision|9|||
161045473|NCT01102426|581557181|FG001|Overall Study|Physician Decision|6|||
161045474|NCT01102426|581557180|FG000|Overall Study|Progressive Disease|85|||
161045475|NCT01102426|581557181|FG001|Overall Study|Progressive Disease|44|||
161045476|NCT01102426|581557180|FG000|Overall Study|Adverse Events (unrelated to|9|||
161045477|NCT01102426|581557181|FG001|Overall Study|Adverse Events (unrelated to|1|||
161045478|NCT01102426|581557180|FG000|Overall Study|Patient Refusal|24|||
161045479|NCT01102426|581557181|FG001|Overall Study|Patient Refusal|12|||
161045480|NCT01102426|581557180|FG000|Overall Study|Death (due to adverse events|0|||
161045481|NCT01102426|581557181|FG001|Overall Study|Death (due to adverse events|1|||
161045482|NCT01102426|581557180|FG000|Overall Study|Death (non-related to the study|19|||
161045483|NCT01102426|581557181|FG001|Overall Study|Death (non-related to the study|8|||
161045484|NCT00871494|581557185|FG000|Overall Study|Protocol Violation|5|||
161045485|NCT00871494|581557185|FG000|Overall Study|Lack of Efficacy|4|||
161045486|NCT00871494|581557185|FG000|Overall Study|Adverse Event|4|||
161045487|NCT00871494|581557185|FG000|Overall Study|Lost to Follow-up|1|||
161045488|NCT02988713|581557192|FG000|Overall Study|Withdrawal by Subject|1|||
161045489|NCT02988713|581557192|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
161045490|NCT02404441|581557193|FG000|Phase 1 Part|Adverse Event|1|||
161045491|NCT02404441|581557194|FG001|Phase 1 Part|Adverse Event|0|||
161045492|NCT02404441|581557195|FG002|Phase 1 Part|Adverse Event|0|||
161045493|NCT02404441|581557196|FG003|Phase 1 Part|Adverse Event|0|||
161045494|NCT02404441|581557197|FG004|Phase 1 Part|Adverse Event|0|||
161045495|NCT02404441|581557198|FG005|Phase 1 Part|Adverse Event|0|||
161045496|NCT02404441|581557199|FG006|Phase 1 Part|Adverse Event|0|||
161045497|NCT02404441|581557200|FG007|Phase 1 Part|Adverse Event|0|||
161045498|NCT02404441|581557201|FG008|Phase 1 Part|Adverse Event|0|||
161045499|NCT02404441|581557202|FG009|Phase 1 Part|Adverse Event|0|||
161045500|NCT02404441|581557193|FG000|Phase 1 Part|Physician Decision|0|||
161045501|NCT02404441|581557194|FG001|Phase 1 Part|Physician Decision|1|||
161045502|NCT02404441|581557195|FG002|Phase 1 Part|Physician Decision|0|||
161045503|NCT02404441|581557196|FG003|Phase 1 Part|Physician Decision|0|||
161045504|NCT02404441|581557197|FG004|Phase 1 Part|Physician Decision|0|||
161045505|NCT02404441|581557198|FG005|Phase 1 Part|Physician Decision|0|||
161045506|NCT02404441|581557199|FG006|Phase 1 Part|Physician Decision|0|||
161045507|NCT02404441|581557200|FG007|Phase 1 Part|Physician Decision|0|||
161045508|NCT02404441|581557201|FG008|Phase 1 Part|Physician Decision|0|||
161045509|NCT02404441|581557202|FG009|Phase 1 Part|Physician Decision|0|||
161045510|NCT02404441|581557193|FG000|Phase 1 Part|Progressive Disease|14|||
161045511|NCT02404441|581557194|FG001|Phase 1 Part|Progressive Disease|11|||
161045512|NCT02404441|581557195|FG002|Phase 1 Part|Progressive Disease|7|||
161045513|NCT02404441|581557196|FG003|Phase 1 Part|Progressive Disease|6|||
161045514|NCT02404441|581557197|FG004|Phase 1 Part|Progressive Disease|9|||
161045515|NCT02404441|581557198|FG005|Phase 1 Part|Progressive Disease|0|||
161045516|NCT02404441|581557199|FG006|Phase 1 Part|Progressive Disease|0|||
161045517|NCT02404441|581557200|FG007|Phase 1 Part|Progressive Disease|0|||
161045518|NCT02404441|581557201|FG008|Phase 1 Part|Progressive Disease|0|||
161045519|NCT02404441|581557202|FG009|Phase 1 Part|Progressive Disease|0|||
161045520|NCT02404441|581557193|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
161045521|NCT02404441|581557194|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
161045522|NCT02404441|581557195|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
161045523|NCT02404441|581557196|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
161045524|NCT02404441|581557197|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
161045525|NCT02404441|581557198|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
161045526|NCT02404441|581557199|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
161045527|NCT02404441|581557200|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
161045528|NCT02404441|581557201|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
161045529|NCT02404441|581557202|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
161045530|NCT02404441|581557193|FG000|Phase 1 Part|Death|1|||
161045531|NCT02404441|581557194|FG001|Phase 1 Part|Death|1|||
161045532|NCT02404441|581557195|FG002|Phase 1 Part|Death|1|||
161045533|NCT02404441|581557196|FG003|Phase 1 Part|Death|0|||
161045534|NCT02404441|581557197|FG004|Phase 1 Part|Death|1|||
161045535|NCT02404441|581557198|FG005|Phase 1 Part|Death|0|||
161045536|NCT02404441|581557199|FG006|Phase 1 Part|Death|0|||
161045537|NCT02404441|581557200|FG007|Phase 1 Part|Death|0|||
161045538|NCT02404441|581557201|FG008|Phase 1 Part|Death|0|||
161045539|NCT02404441|581557202|FG009|Phase 1 Part|Death|0|||
161045540|NCT02404441|581557193|FG000|Phase 2 Part|Adverse Event|0|||
161045541|NCT02404441|581557194|FG001|Phase 2 Part|Adverse Event|0|||
161344878|NCT00390013|582648817|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
161045542|NCT02404441|581557195|FG002|Phase 2 Part|Adverse Event|0|||
161045543|NCT02404441|581557196|FG003|Phase 2 Part|Adverse Event|0|||
161045544|NCT02404441|581557197|FG004|Phase 2 Part|Adverse Event|0|||
161045545|NCT02404441|581557198|FG005|Phase 2 Part|Adverse Event|2|||
161045546|NCT02404441|581557199|FG006|Phase 2 Part|Adverse Event|3|||
161045547|NCT02404441|581557200|FG007|Phase 2 Part|Adverse Event|3|||
161045548|NCT02404441|581557201|FG008|Phase 2 Part|Adverse Event|6|||
161045549|NCT02404441|581557202|FG009|Phase 2 Part|Adverse Event|1|||
161045550|NCT02404441|581557193|FG000|Phase 2 Part|Physician Decision|0|||
161045551|NCT02404441|581557194|FG001|Phase 2 Part|Physician Decision|0|||
161045552|NCT02404441|581557195|FG002|Phase 2 Part|Physician Decision|0|||
161045553|NCT02404441|581557196|FG003|Phase 2 Part|Physician Decision|0|||
161045554|NCT02404441|581557197|FG004|Phase 2 Part|Physician Decision|0|||
161045555|NCT02404441|581557198|FG005|Phase 2 Part|Physician Decision|7|||
161045556|NCT02404441|581557199|FG006|Phase 2 Part|Physician Decision|9|||
161045557|NCT02404441|581557200|FG007|Phase 2 Part|Physician Decision|2|||
161045558|NCT02404441|581557201|FG008|Phase 2 Part|Physician Decision|1|||
161045559|NCT02404441|581557202|FG009|Phase 2 Part|Physician Decision|3|||
161045560|NCT02404441|581557193|FG000|Phase 2 Part|Progressive disease|0|||
161045561|NCT02404441|581557194|FG001|Phase 2 Part|Progressive disease|0|||
161045562|NCT02404441|581557195|FG002|Phase 2 Part|Progressive disease|0|||
161045563|NCT02404441|581557196|FG003|Phase 2 Part|Progressive disease|0|||
161045564|NCT02404441|581557197|FG004|Phase 2 Part|Progressive disease|0|||
161045565|NCT02404441|581557198|FG005|Phase 2 Part|Progressive disease|43|||
161045566|NCT02404441|581557199|FG006|Phase 2 Part|Progressive disease|32|||
161045567|NCT02404441|581557200|FG007|Phase 2 Part|Progressive disease|31|||
161045568|NCT02404441|581557201|FG008|Phase 2 Part|Progressive disease|39|||
161045569|NCT02404441|581557202|FG009|Phase 2 Part|Progressive disease|27|||
161045570|NCT02404441|581557193|FG000|Phase 2 Part|Subject/guardian decision|0|||
161045571|NCT02404441|581557194|FG001|Phase 2 Part|Subject/guardian decision|0|||
161045572|NCT02404441|581557195|FG002|Phase 2 Part|Subject/guardian decision|0|||
161045573|NCT02404441|581557196|FG003|Phase 2 Part|Subject/guardian decision|0|||
161045574|NCT02404441|581557197|FG004|Phase 2 Part|Subject/guardian decision|0|||
161045575|NCT02404441|581557198|FG005|Phase 2 Part|Subject/guardian decision|3|||
161045576|NCT02404441|581557199|FG006|Phase 2 Part|Subject/guardian decision|9|||
161045577|NCT02404441|581557200|FG007|Phase 2 Part|Subject/guardian decision|0|||
161045578|NCT02404441|581557201|FG008|Phase 2 Part|Subject/guardian decision|3|||
161045579|NCT02404441|581557202|FG009|Phase 2 Part|Subject/guardian decision|2|||
161045580|NCT02404441|581557193|FG000|Phase 2 Part|Death|0|||
161045581|NCT02404441|581557194|FG001|Phase 2 Part|Death|0|||
161045582|NCT02404441|581557195|FG002|Phase 2 Part|Death|0|||
161045583|NCT02404441|581557196|FG003|Phase 2 Part|Death|0|||
161045584|NCT02404441|581557197|FG004|Phase 2 Part|Death|0|||
161045585|NCT02404441|581557198|FG005|Phase 2 Part|Death|4|||
161045586|NCT02404441|581557199|FG006|Phase 2 Part|Death|8|||
161045587|NCT02404441|581557200|FG007|Phase 2 Part|Death|4|||
161045588|NCT02404441|581557201|FG008|Phase 2 Part|Death|10|||
161045589|NCT02404441|581557202|FG009|Phase 2 Part|Death|9|||
161045590|NCT00088166|581557203|FG000|Overall Study|Adverse Event|11|||
161045591|NCT00088166|581557204|FG001|Overall Study|Adverse Event|9|||
161045592|NCT00088166|581557203|FG000|Overall Study|Death|3|||
161045593|NCT00088166|581557204|FG001|Overall Study|Death|1|||
161045594|NCT00088166|581557203|FG000|Overall Study|Lost to Follow-up|0|||
161045595|NCT00088166|581557204|FG001|Overall Study|Lost to Follow-up|1|||
161045596|NCT00088166|581557203|FG000|Overall Study|Physician Decision|4|||
161045597|NCT00088166|581557204|FG001|Overall Study|Physician Decision|1|||
161045598|NCT00088166|581557203|FG000|Overall Study|Protocol Violation|1|||
161045599|NCT00088166|581557204|FG001|Overall Study|Protocol Violation|5|||
161045600|NCT00088166|581557203|FG000|Overall Study|Patient deterioration|29|||
161045601|NCT00088166|581557204|FG001|Overall Study|Patient deterioration|39|||
161045602|NCT00088166|581557203|FG000|Overall Study|Withdrawal by Subject|5|||
161045603|NCT00088166|581557204|FG001|Overall Study|Withdrawal by Subject|5|||
161045604|NCT02671266|581557205|FG000|Overall Study|Withdrawal by Subject|1|||
161045605|NCT02671266|581557206|FG001|Overall Study|Withdrawal by Subject|1|||
161045606|NCT00666705|581557207|FG000|Overall Study|Withdrawal by Subject|1|||
161045607|NCT01976507|581557210|FG000|Overall Study|Adverse Event|6|||
161045608|NCT01976507|581557210|FG000|Overall Study|ablation not done, drug not given|1|||
161045609|NCT01029704|581557212|FG000|Overall Study|Adverse Event|0|||
161045610|NCT01029704|581557213|FG001|Overall Study|Adverse Event|0|||
161045611|NCT01029704|581557214|FG002|Overall Study|Adverse Event|0|||
161045612|NCT01029704|581557215|FG003|Overall Study|Adverse Event|0|||
161045613|NCT01029704|581557216|FG004|Overall Study|Adverse Event|0|||
161045614|NCT01029704|581557217|FG005|Overall Study|Adverse Event|0|||
161045615|NCT01029704|581557218|FG006|Overall Study|Adverse Event|1|||
161045616|NCT01029704|581557219|FG007|Overall Study|Adverse Event|1|||
161045617|NCT01029704|581557220|FG008|Overall Study|Adverse Event|0|||
161045618|NCT01029704|581557212|FG000|Overall Study|Withdrawal by Subject|0|||
161045619|NCT01029704|581557213|FG001|Overall Study|Withdrawal by Subject|0|||
161045620|NCT01029704|581557214|FG002|Overall Study|Withdrawal by Subject|0|||
161149888|NCT01422304|581930002|FG000|Overall Study|Withdrawal by Subject|4|||
161045621|NCT01029704|581557215|FG003|Overall Study|Withdrawal by Subject|0|||
161045622|NCT01029704|581557216|FG004|Overall Study|Withdrawal by Subject|2|||
161045623|NCT01029704|581557217|FG005|Overall Study|Withdrawal by Subject|1|||
161045624|NCT01029704|581557218|FG006|Overall Study|Withdrawal by Subject|1|||
161045625|NCT01029704|581557219|FG007|Overall Study|Withdrawal by Subject|1|||
161045626|NCT01029704|581557220|FG008|Overall Study|Withdrawal by Subject|0|||
161045627|NCT01029704|581557212|FG000|Overall Study|Lost to Follow-up|0|||
161045628|NCT01029704|581557213|FG001|Overall Study|Lost to Follow-up|0|||
161045629|NCT01029704|581557214|FG002|Overall Study|Lost to Follow-up|0|||
161045630|NCT01029704|581557215|FG003|Overall Study|Lost to Follow-up|0|||
161045631|NCT01029704|581557216|FG004|Overall Study|Lost to Follow-up|0|||
161045632|NCT01029704|581557217|FG005|Overall Study|Lost to Follow-up|0|||
161045633|NCT01029704|581557218|FG006|Overall Study|Lost to Follow-up|1|||
161045634|NCT01029704|581557219|FG007|Overall Study|Lost to Follow-up|1|||
161045635|NCT01029704|581557220|FG008|Overall Study|Lost to Follow-up|1|||
161045636|NCT01029704|581557212|FG000|Overall Study|Lack of Efficacy|0|||
161045637|NCT01029704|581557213|FG001|Overall Study|Lack of Efficacy|0|||
161045638|NCT01029704|581557214|FG002|Overall Study|Lack of Efficacy|0|||
161045639|NCT01029704|581557215|FG003|Overall Study|Lack of Efficacy|0|||
161045640|NCT01029704|581557216|FG004|Overall Study|Lack of Efficacy|2|||
161045641|NCT01029704|581557217|FG005|Overall Study|Lack of Efficacy|3|||
161045642|NCT01029704|581557218|FG006|Overall Study|Lack of Efficacy|1|||
161045643|NCT01029704|581557219|FG007|Overall Study|Lack of Efficacy|2|||
161045644|NCT01029704|581557220|FG008|Overall Study|Lack of Efficacy|0|||
161045645|NCT01029704|581557212|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
161045646|NCT01029704|581557213|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
161045647|NCT01029704|581557214|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
161045648|NCT01029704|581557215|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
161045649|NCT01029704|581557216|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
161045650|NCT01029704|581557217|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
161045651|NCT01029704|581557218|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
161045652|NCT01029704|581557219|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
161045653|NCT01029704|581557220|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
161045654|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
161045655|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
161045656|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
161045657|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
161045658|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Death|0|||
161045659|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Death|0|||
161045660|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Death|1|||
161045661|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Death|0|||
161045662|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
161045663|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
161045664|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
161045665|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
161045666|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161045667|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
161045668|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161045669|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
161045670|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
161045671|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
161045672|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
161045673|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
161045674|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
161045675|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
161045676|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
161045677|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
161045678|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
161045679|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
161045680|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
161045681|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
161045682|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Other|2|||
161045683|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Other|0|||
161045684|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Other|0|||
161045685|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Other|0|||
161045686|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
161045687|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
161045688|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
161045689|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
161045690|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
161045691|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
161045692|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
161045693|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
161045694|NCT03845517|581557221|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
161045695|NCT03845517|581557222|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
161045696|NCT03845517|581557223|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
161045697|NCT03845517|581557224|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
161045698|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
161045699|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
161045700|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
161045701|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
161045702|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Death|0|||
161045703|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Death|0|||
161045704|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Death|1|||
161045705|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Death|1|||
161045706|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
161045707|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
161045708|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
161045709|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
161045710|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
161045711|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
161045712|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
161045713|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
161045714|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
161045715|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
161045716|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
161045717|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
161045718|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Other|1|||
161045719|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Other|0|||
161045720|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Other|1|||
161045721|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Other|0|||
161045722|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
161045723|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
161045724|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
161045725|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
161045726|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
161045727|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
161045728|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
161045729|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
161045730|NCT03845517|581557221|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
161045731|NCT03845517|581557222|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
161045732|NCT03845517|581557223|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
161045733|NCT03845517|581557224|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
161045734|NCT01109979|581557225|FG000|Overall Study|Physician Decision|2|||
161045735|NCT01109979|581557226|FG001|Overall Study|Physician Decision|0|||
161045736|NCT01109979|581557225|FG000|Overall Study|Withdrawal by Subject|0|||
161045737|NCT01109979|581557226|FG001|Overall Study|Withdrawal by Subject|1|||
161045738|NCT03136861|581557229|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
161045739|NCT03136861|581557230|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
161045740|NCT03136861|581557231|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161045741|NCT03136861|581557232|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161045742|NCT03136861|581557233|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161045743|NCT03136861|581557234|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161045744|NCT03136861|581557235|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
161045745|NCT03136861|581557229|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
161045746|NCT03136861|581557230|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
161045747|NCT03136861|581557231|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161045748|NCT03136861|581557232|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161045749|NCT03136861|581557233|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161045750|NCT03136861|581557234|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161045751|NCT03136861|581557235|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
161045752|NCT03136861|581557229|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
161045753|NCT03136861|581557230|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
161045754|NCT03136861|581557231|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161045755|NCT03136861|581557232|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161045756|NCT03136861|581557233|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161045757|NCT03136861|581557234|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161045758|NCT03136861|581557235|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
161045759|NCT03136861|581557229|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161045760|NCT03136861|581557230|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
161045761|NCT03136861|581557231|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161149889|NCT01422304|581930003|FG001|Overall Study|Withdrawal by Subject|2|||
161149890|NCT01422304|581930002|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161149891|NCT01422304|581930003|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
161149892|NCT01422304|581930002|FG000|Overall Study|Not Treated|3|||
161149893|NCT01422304|581930003|FG001|Overall Study|Not Treated|11|||
161149894|NCT03241173|581930006|FG000|Overall Study|Death|3|||
161149895|NCT03241173|581930007|FG001|Overall Study|Death|2|||
161149896|NCT03241173|581930008|FG002|Overall Study|Death|4|||
161149897|NCT03241173|581930009|FG003|Overall Study|Death|4|||
161149898|NCT03241173|581930010|FG004|Overall Study|Death|2|||
161149899|NCT03241173|581930011|FG005|Overall Study|Death|2|||
161149900|NCT03241173|581930012|FG006|Overall Study|Death|3|||
161149901|NCT03241173|581930013|FG007|Overall Study|Death|1|||
161149902|NCT03241173|581930014|FG008|Overall Study|Death|0|||
161149903|NCT03241173|581930015|FG009|Overall Study|Death|5|||
161149904|NCT03241173|581930016|FG010|Overall Study|Death|4|||
161149905|NCT03241173|581930017|FG011|Overall Study|Death|3|||
161149906|NCT03241173|581930018|FG012|Overall Study|Death|0|||
161149907|NCT03241173|581930019|FG013|Overall Study|Death|0|||
161149908|NCT03241173|581930020|FG014|Overall Study|Death|0|||
161149909|NCT03241173|581930006|FG000|Overall Study|Withdrawal by Subject|0|||
161149910|NCT03241173|581930007|FG001|Overall Study|Withdrawal by Subject|0|||
161149911|NCT03241173|581930008|FG002|Overall Study|Withdrawal by Subject|1|||
161149912|NCT03241173|581930009|FG003|Overall Study|Withdrawal by Subject|0|||
161149913|NCT03241173|581930010|FG004|Overall Study|Withdrawal by Subject|0|||
161149914|NCT03241173|581930011|FG005|Overall Study|Withdrawal by Subject|1|||
161149915|NCT03241173|581930012|FG006|Overall Study|Withdrawal by Subject|0|||
161149916|NCT03241173|581930013|FG007|Overall Study|Withdrawal by Subject|0|||
161149917|NCT03241173|581930014|FG008|Overall Study|Withdrawal by Subject|0|||
161149918|NCT03241173|581930015|FG009|Overall Study|Withdrawal by Subject|0|||
161149919|NCT03241173|581930016|FG010|Overall Study|Withdrawal by Subject|0|||
161149920|NCT03241173|581930017|FG011|Overall Study|Withdrawal by Subject|0|||
161149921|NCT03241173|581930018|FG012|Overall Study|Withdrawal by Subject|0|||
161149922|NCT03241173|581930019|FG013|Overall Study|Withdrawal by Subject|0|||
161149923|NCT03241173|581930020|FG014|Overall Study|Withdrawal by Subject|0|||
161149924|NCT03241173|581930006|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161149925|NCT03241173|581930007|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161149926|NCT03241173|581930008|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161149927|NCT03241173|581930009|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161149928|NCT03241173|581930010|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161149929|NCT03241173|581930011|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161149930|NCT03241173|581930012|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
161149931|NCT03241173|581930013|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161149932|NCT03241173|581930014|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161149933|NCT03241173|581930015|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161149934|NCT03241173|581930016|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
161149935|NCT03241173|581930017|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
161149936|NCT03241173|581930018|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161149937|NCT03241173|581930019|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161149938|NCT03241173|581930020|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
161149939|NCT03241173|581930006|FG000|Overall Study|Lost to Follow-up|0|||
161149940|NCT03241173|581930007|FG001|Overall Study|Lost to Follow-up|0|||
161149941|NCT03241173|581930008|FG002|Overall Study|Lost to Follow-up|0|||
161149942|NCT03241173|581930009|FG003|Overall Study|Lost to Follow-up|0|||
161149943|NCT03241173|581930010|FG004|Overall Study|Lost to Follow-up|1|||
161149944|NCT03241173|581930011|FG005|Overall Study|Lost to Follow-up|0|||
161149945|NCT03241173|581930012|FG006|Overall Study|Lost to Follow-up|0|||
161149946|NCT03241173|581930013|FG007|Overall Study|Lost to Follow-up|0|||
161149947|NCT03241173|581930014|FG008|Overall Study|Lost to Follow-up|0|||
161149948|NCT03241173|581930015|FG009|Overall Study|Lost to Follow-up|1|||
161149949|NCT03241173|581930016|FG010|Overall Study|Lost to Follow-up|0|||
161149950|NCT03241173|581930017|FG011|Overall Study|Lost to Follow-up|0|||
161149951|NCT03241173|581930018|FG012|Overall Study|Lost to Follow-up|0|||
161149952|NCT03241173|581930019|FG013|Overall Study|Lost to Follow-up|0|||
161045762|NCT03136861|581557232|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161149953|NCT03241173|581930020|FG014|Overall Study|Lost to Follow-up|0|||
161045763|NCT03136861|581557233|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161045764|NCT03136861|581557234|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161045765|NCT03136861|581557235|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
161045766|NCT03136861|581557229|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
161045767|NCT03136861|581557230|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
161149954|NCT00564629|581930021|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
161149955|NCT00564629|581930022|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
161149956|NCT00515463|581930023|FG000|Overall Study|Physician Decision|4|||
161149957|NCT00515463|581930024|FG001|Overall Study|Physician Decision|2|||
161149958|NCT00515463|581930023|FG000|Overall Study|Adverse Event|1|||
161149959|NCT00515463|581930024|FG001|Overall Study|Adverse Event|2|||
161149960|NCT00515463|581930023|FG000|Overall Study|Withdrawal by Subject|3|||
161149961|NCT00515463|581930024|FG001|Overall Study|Withdrawal by Subject|4|||
161149962|NCT00515463|581930023|FG000|Overall Study|Lost to Follow-up|6|||
161149963|NCT00515463|581930024|FG001|Overall Study|Lost to Follow-up|5|||
161149964|NCT00515463|581930023|FG000|Overall Study|Other|0|||
161149965|NCT00515463|581930024|FG001|Overall Study|Other|1|||
161149966|NCT01507246|581930027|FG000|Overall Study|Required different surgical procedures|2|||
161149967|NCT01507246|581930028|FG001|Overall Study|Required different surgical procedures|1|||
161149968|NCT03103750|581930029|FG000|Overall Study|Adverse Event|1|||
161149969|NCT03103750|581930030|FG001|Overall Study|Adverse Event|0|||
161149970|NCT03103750|581930029|FG000|Overall Study|Lost to Follow-up|1|||
161149971|NCT03103750|581930030|FG001|Overall Study|Lost to Follow-up|0|||
161149972|NCT03103750|581930029|FG000|Overall Study|PET Equipment Related|2|||
161149973|NCT03103750|581930030|FG001|Overall Study|PET Equipment Related|2|||
161149974|NCT03575468|581930034|FG000|Overall Study|Withdrawal by Subject|3|||
161149975|NCT03575468|581930035|FG001|Overall Study|Withdrawal by Subject|0|||
161149976|NCT03575468|581930034|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
161149977|NCT03575468|581930035|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
161149978|NCT03575468|581930034|FG000|Overall Study|Lost to Follow-up|13|||
161149979|NCT03575468|581930035|FG001|Overall Study|Lost to Follow-up|17|||
161149980|NCT01522651|581930038|FG000|Overall Study|Adverse Event|3|||
161149981|NCT01522651|581930039|FG001|Overall Study|Adverse Event|4|||
161149982|NCT01522651|581930040|FG002|Overall Study|Adverse Event|4|||
161149983|NCT01522651|581930041|FG003|Overall Study|Adverse Event|5|||
161149984|NCT01522651|581930042|FG004|Overall Study|Adverse Event|4|||
161149985|NCT01522651|581930038|FG000|Overall Study|Cardioversion|1|||
161149986|NCT01522651|581930039|FG001|Overall Study|Cardioversion|0|||
161149987|NCT01522651|581930040|FG002|Overall Study|Cardioversion|0|||
161149988|NCT01522651|581930041|FG003|Overall Study|Cardioversion|0|||
161149989|NCT01522651|581930042|FG004|Overall Study|Cardioversion|0|||
161149990|NCT01522651|581930038|FG000|Overall Study|Device Malfunction|0|||
161149991|NCT01522651|581930039|FG001|Overall Study|Device Malfunction|1|||
161149992|NCT01522651|581930040|FG002|Overall Study|Device Malfunction|0|||
161149993|NCT01522651|581930041|FG003|Overall Study|Device Malfunction|0|||
161149994|NCT01522651|581930042|FG004|Overall Study|Device Malfunction|0|||
161149995|NCT01522651|581930038|FG000|Overall Study|Investigator's Discretion|0|||
161149996|NCT01522651|581930039|FG001|Overall Study|Investigator's Discretion|1|||
161149997|NCT01522651|581930040|FG002|Overall Study|Investigator's Discretion|0|||
161149998|NCT01522651|581930041|FG003|Overall Study|Investigator's Discretion|0|||
161149999|NCT01522651|581930042|FG004|Overall Study|Investigator's Discretion|0|||
161150000|NCT01522651|581930038|FG000|Overall Study|Protocol Violation|3|||
161150001|NCT01522651|581930039|FG001|Overall Study|Protocol Violation|0|||
161150002|NCT01522651|581930040|FG002|Overall Study|Protocol Violation|0|||
161150003|NCT01522651|581930041|FG003|Overall Study|Protocol Violation|0|||
161150004|NCT01522651|581930042|FG004|Overall Study|Protocol Violation|0|||
161150005|NCT01522651|581930038|FG000|Overall Study|Reason Not Specified|0|||
161150006|NCT01522651|581930039|FG001|Overall Study|Reason Not Specified|0|||
161150007|NCT01522651|581930040|FG002|Overall Study|Reason Not Specified|0|||
161150008|NCT01522651|581930041|FG003|Overall Study|Reason Not Specified|1|||
161150009|NCT01522651|581930042|FG004|Overall Study|Reason Not Specified|0|||
161150010|NCT01522651|581930038|FG000|Overall Study|Participant Non-Compliance|1|||
161150011|NCT01522651|581930039|FG001|Overall Study|Participant Non-Compliance|0|||
161150012|NCT01522651|581930040|FG002|Overall Study|Participant Non-Compliance|0|||
161150013|NCT01522651|581930041|FG003|Overall Study|Participant Non-Compliance|0|||
161150014|NCT01522651|581930042|FG004|Overall Study|Participant Non-Compliance|0|||
161150015|NCT01522651|581930038|FG000|Overall Study|Withdrew Consent|1|||
161150016|NCT01522651|581930039|FG001|Overall Study|Withdrew Consent|1|||
161150017|NCT01522651|581930040|FG002|Overall Study|Withdrew Consent|0|||
161150018|NCT01522651|581930041|FG003|Overall Study|Withdrew Consent|1|||
161150019|NCT01522651|581930042|FG004|Overall Study|Withdrew Consent|1|||
161150020|NCT01522651|581930038|FG000|Overall Study|Randomized but Never Treated|0|||
161150021|NCT01522651|581930039|FG001|Overall Study|Randomized but Never Treated|1|||
161150022|NCT01522651|581930040|FG002|Overall Study|Randomized but Never Treated|0|||
161150023|NCT01522651|581930041|FG003|Overall Study|Randomized but Never Treated|1|||
161150024|NCT01522651|581930042|FG004|Overall Study|Randomized but Never Treated|1|||
161207100|NCT05004181|582138110|FG001|Overall Study|Not further specified|0|||
161207101|NCT05004181|582138111|FG002|Overall Study|Not further specified|0|||
161207102|NCT05004181|582138112|FG003|Overall Study|Not further specified|0|||
161207103|NCT05004181|582138113|FG004|Overall Study|Not further specified|0|||
161207104|NCT05004181|582138114|FG005|Overall Study|Not further specified|0|||
161045768|NCT03136861|581557231|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161045769|NCT03136861|581557232|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161045770|NCT03136861|581557233|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161045771|NCT03136861|581557234|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161045772|NCT03136861|581557235|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
161045773|NCT03136861|581557229|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161045774|NCT03136861|581557230|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161045775|NCT03136861|581557231|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161045776|NCT03136861|581557232|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
161045777|NCT03136861|581557233|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
161045778|NCT03136861|581557234|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
161045779|NCT03136861|581557235|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
161045780|NCT03136861|581557229|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161045781|NCT03136861|581557230|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161045782|NCT03136861|581557231|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
161045783|NCT03136861|581557232|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161045784|NCT03136861|581557233|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161045785|NCT03136861|581557234|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161045786|NCT03136861|581557235|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
161045787|NCT03136861|581557229|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161045788|NCT03136861|581557230|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161045789|NCT03136861|581557231|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
161045790|NCT03136861|581557232|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161045791|NCT03136861|581557233|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161045792|NCT03136861|581557234|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161045793|NCT03136861|581557235|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
161045794|NCT03200574|581557237|FG000|Overall Study|Death|4|||
161045795|NCT03200574|581557237|FG000|Overall Study|Withdrawal by Subject|8|||
161045796|NCT03200574|581557237|FG000|Overall Study|Long-Term need for anticoagulation|1|||
161045797|NCT03200574|581557237|FG000|Overall Study|Relocation|2|||
161045798|NCT03200574|581557237|FG000|Overall Study|Lost to Follow-up|2|||
161045799|NCT00705159|581557241|FG000|Overall Study|Withdrawal by Subject|0|||
161045800|NCT00705159|581557242|FG001|Overall Study|Withdrawal by Subject|1|||
161045801|NCT00705159|581557243|FG002|Overall Study|Withdrawal by Subject|1|||
161045802|NCT00705159|581557244|FG003|Overall Study|Withdrawal by Subject|1|||
161045803|NCT00705159|581557241|FG000|Overall Study|Protocol Violation|0|||
161045804|NCT00705159|581557242|FG001|Overall Study|Protocol Violation|1|||
161045805|NCT00705159|581557243|FG002|Overall Study|Protocol Violation|0|||
161045806|NCT00705159|581557244|FG003|Overall Study|Protocol Violation|0|||
161045807|NCT00705159|581557241|FG000|Overall Study|Adverse Event|0|||
161045808|NCT00705159|581557242|FG001|Overall Study|Adverse Event|0|||
161045809|NCT00705159|581557243|FG002|Overall Study|Adverse Event|1|||
161045810|NCT00705159|581557244|FG003|Overall Study|Adverse Event|0|||
161045811|NCT00705159|581557241|FG000|Overall Study|Lost to Follow-up|0|||
161045812|NCT00705159|581557242|FG001|Overall Study|Lost to Follow-up|0|||
161045813|NCT00705159|581557243|FG002|Overall Study|Lost to Follow-up|3|||
161045814|NCT00705159|581557244|FG003|Overall Study|Lost to Follow-up|2|||
161045815|NCT00705159|581557241|FG000|Overall Study|Screen Failure|0|||
161045816|NCT00705159|581557242|FG001|Overall Study|Screen Failure|0|||
161045817|NCT00705159|581557243|FG002|Overall Study|Screen Failure|0|||
161045818|NCT00705159|581557244|FG003|Overall Study|Screen Failure|1|||
161045819|NCT03026166|581557245|FG000|Overall Study|Death|22|||
161045820|NCT03026166|581557246|FG001|Overall Study|Death|7|||
161045821|NCT03026166|581557245|FG000|Overall Study|Physician Decision|2|||
161045822|NCT03026166|581557246|FG001|Overall Study|Physician Decision|0|||
161045823|NCT03026166|581557245|FG000|Overall Study|Withdrawal by Subject|1|||
161045824|NCT03026166|581557246|FG001|Overall Study|Withdrawal by Subject|2|||
161045825|NCT03026166|581557245|FG000|Overall Study|Lost to Follow-up|1|||
161045826|NCT03026166|581557246|FG001|Overall Study|Lost to Follow-up|0|||
161045827|NCT03026166|581557245|FG000|Overall Study|Study Terminated by Sponsor|3|||
161045828|NCT03026166|581557246|FG001|Overall Study|Study Terminated by Sponsor|3|||
161045829|NCT03026166|581557245|FG000|Overall Study|Other|1|||
161045830|NCT03026166|581557246|FG001|Overall Study|Other|0|||
161045831|NCT01262456|581557247|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
161045832|NCT01262456|581557248|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
161045833|NCT01262456|581557249|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
161045834|NCT01262456|581557247|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
161045835|NCT01262456|581557248|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
161045836|NCT01262456|581557249|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
161045837|NCT01262456|581557247|FG000|3-Month Double-Blind Period|Adverse Event|6|||
161045838|NCT01262456|581557248|FG001|3-Month Double-Blind Period|Adverse Event|4|||
161045839|NCT01262456|581557249|FG002|3-Month Double-Blind Period|Adverse Event|8|||
161045840|NCT01262456|581557247|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
161045841|NCT01262456|581557248|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
161045842|NCT01262456|581557249|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
161045843|NCT01262456|581557247|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
161045844|NCT01262456|581557248|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
161045845|NCT01262456|581557249|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
161045846|NCT01262456|581557247|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
161045847|NCT01262456|581557248|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
161045848|NCT01262456|581557249|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
161045849|NCT01262456|581557247|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
161045850|NCT01262456|581557248|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
161150025|NCT03625986|581931754|FG000|Randomization Period|Lost to Follow-up|7|||
161150026|NCT03625986|581931755|FG001|Randomization Period|Lost to Follow-up|12|||
161150027|NCT03625986|581931754|FG000|Randomization Period|Withdrawal by Subject|10|||
161150028|NCT03625986|581931755|FG001|Randomization Period|Withdrawal by Subject|6|||
161150029|NCT04359823|581931756|FG000|Overall Study|Lost to Follow-up|0|||
161150030|NCT04359823|581931757|FG001|Overall Study|Lost to Follow-up|1|||
161150031|NCT04359823|581931756|FG000|Overall Study|Withdrawal by Subject|0|||
161150032|NCT04359823|581931757|FG001|Overall Study|Withdrawal by Subject|1|||
161150033|NCT01850563|581931758|FG000|Overall Study|Not eligible|3|||
161150034|NCT01850563|581931759|FG001|Overall Study|Not eligible|0|||
161150035|NCT03132805|581931760|FG000|Overall Study|Lost to Follow-up|142|||
161150036|NCT03132805|581931761|FG001|Overall Study|Lost to Follow-up|141|||
161150037|NCT03132805|581931762|FG002|Overall Study|Lost to Follow-up|113|||
161150038|NCT03151148|581931763|FG000|Overall Study|Lost to Follow-up|1|||
161150039|NCT03151148|581931764|FG001|Overall Study|Lost to Follow-up|0|||
161150040|NCT03151148|581931763|FG000|Overall Study|Withdrawal by Subject|1|||
161150041|NCT03151148|581931764|FG001|Overall Study|Withdrawal by Subject|0|||
161150042|NCT01115569|581931769|FG000|Conversion/Titration Phase|Adverse Event|59|||
161150043|NCT01115569|581931770|FG001|Conversion/Titration Phase|Adverse Event|0|||
161150044|NCT01115569|581931769|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
161150045|NCT01115569|581931770|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
161150046|NCT01115569|581931769|FG000|Conversion/Titration Phase|Physician Decision|5|||
161150047|NCT01115569|581931770|FG001|Conversion/Titration Phase|Physician Decision|0|||
161150048|NCT01115569|581931769|FG000|Conversion/Titration Phase|Protocol Violation|68|||
161150049|NCT01115569|581931770|FG001|Conversion/Titration Phase|Protocol Violation|0|||
161150050|NCT01115569|581931769|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
161150051|NCT01115569|581931770|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
161150052|NCT01115569|581931769|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
161150053|NCT01115569|581931770|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
161150054|NCT01115569|581931769|FG000|Maintenance Phase|Adverse Event|0|||
161150055|NCT01115569|581931770|FG001|Maintenance Phase|Adverse Event|43|||
161150056|NCT01115569|581931769|FG000|Maintenance Phase|Lost to Follow-up|0|||
161150057|NCT01115569|581931770|FG001|Maintenance Phase|Lost to Follow-up|8|||
161150058|NCT01115569|581931769|FG000|Maintenance Phase|Physician Decision|0|||
161150059|NCT01115569|581931770|FG001|Maintenance Phase|Physician Decision|3|||
161150060|NCT01115569|581931769|FG000|Maintenance Phase|Protocol Violation|0|||
161150061|NCT01115569|581931770|FG001|Maintenance Phase|Protocol Violation|9|||
161150062|NCT01115569|581931769|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161150063|NCT01115569|581931770|FG001|Maintenance Phase|Withdrawal by Subject|27|||
161150064|NCT01115569|581931769|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
161150065|NCT01115569|581931770|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
161150066|NCT01115569|581931769|FG000|Maintenance Phase|Administrative|0|||
161150067|NCT01115569|581931770|FG001|Maintenance Phase|Administrative|1|||
161150068|NCT01614769|581931771|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
161150069|NCT01614769|581931772|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
161344879|NCT00390013|582648818|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
161344880|NCT00390013|582648819|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
161344881|NCT00390013|582648820|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
161045851|NCT01262456|581557249|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
161045852|NCT01262456|581557247|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
161045853|NCT01262456|581557248|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
161150070|NCT01614769|581931773|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
161150071|NCT01614769|581931774|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
161150072|NCT01614769|581931775|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
161150073|NCT01614769|581931776|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
161150074|NCT01614769|581931771|FG000|Period 1|Protocol Violation|0|||
161150075|NCT01614769|581931772|FG001|Period 1|Protocol Violation|0|||
161150076|NCT01614769|581931773|FG002|Period 1|Protocol Violation|0|||
161150077|NCT01614769|581931774|FG003|Period 1|Protocol Violation|1|||
161150078|NCT01614769|581931775|FG004|Period 1|Protocol Violation|0|||
161150079|NCT01614769|581931776|FG005|Period 1|Protocol Violation|0|||
161344882|NCT03839641|582648821|FG000|Overall Study|Withdrawal by Subject|1|||
161150080|NCT01614769|581931771|FG000|Period 1|Withdrawal by Subject|1|||
161150081|NCT01614769|581931772|FG001|Period 1|Withdrawal by Subject|0|||
161150082|NCT01614769|581931773|FG002|Period 1|Withdrawal by Subject|0|||
161150083|NCT01614769|581931774|FG003|Period 1|Withdrawal by Subject|0|||
161150084|NCT01614769|581931775|FG004|Period 1|Withdrawal by Subject|0|||
161150085|NCT01614769|581931776|FG005|Period 1|Withdrawal by Subject|0|||
161150086|NCT01614769|581931771|FG000|Period 3|Withdrawal by Subject|0|||
161150087|NCT01614769|581931772|FG001|Period 3|Withdrawal by Subject|0|||
161150088|NCT01614769|581931773|FG002|Period 3|Withdrawal by Subject|1|||
161150089|NCT01614769|581931774|FG003|Period 3|Withdrawal by Subject|0|||
161150090|NCT01614769|581931775|FG004|Period 3|Withdrawal by Subject|0|||
161150091|NCT01614769|581931776|FG005|Period 3|Withdrawal by Subject|0|||
161150092|NCT02115815|581931777|FG000|Overall Study|Withdrawal by Subject|2|||
161150093|NCT02115815|581931778|FG001|Overall Study|Withdrawal by Subject|0|||
161150094|NCT02115815|581931779|FG002|Overall Study|Withdrawal by Subject|0|||
161150095|NCT02115815|581931780|FG003|Overall Study|Withdrawal by Subject|0|||
161150096|NCT02115815|581931781|FG004|Overall Study|Withdrawal by Subject|0|||
161150097|NCT02115815|581931782|FG005|Overall Study|Withdrawal by Subject|0|||
161150098|NCT02115815|581931783|FG006|Overall Study|Withdrawal by Subject|0|||
161150099|NCT02115815|581931777|FG000|Overall Study|Not enough drug to dose participant|0|||
161150100|NCT02115815|581931778|FG001|Overall Study|Not enough drug to dose participant|0|||
161150101|NCT02115815|581931779|FG002|Overall Study|Not enough drug to dose participant|0|||
161150102|NCT02115815|581931780|FG003|Overall Study|Not enough drug to dose participant|0|||
161150103|NCT02115815|581931781|FG004|Overall Study|Not enough drug to dose participant|0|||
161150104|NCT02115815|581931782|FG005|Overall Study|Not enough drug to dose participant|1|||
161150105|NCT02115815|581931783|FG006|Overall Study|Not enough drug to dose participant|0|||
161150106|NCT02115815|581931777|FG000|Overall Study|Missed appointment, randomized in error|0|||
161150107|NCT02115815|581931778|FG001|Overall Study|Missed appointment, randomized in error|0|||
161150108|NCT02115815|581931779|FG002|Overall Study|Missed appointment, randomized in error|0|||
161150109|NCT02115815|581931780|FG003|Overall Study|Missed appointment, randomized in error|0|||
161150110|NCT02115815|581931781|FG004|Overall Study|Missed appointment, randomized in error|0|||
161150111|NCT02115815|581931782|FG005|Overall Study|Missed appointment, randomized in error|1|||
161150112|NCT02115815|581931783|FG006|Overall Study|Missed appointment, randomized in error|0|||
161150113|NCT01228071|581931784|FG000|Overall Study|Protocol Violation|1|||
161150114|NCT01228071|581931784|FG000|Overall Study|Withdrawal by Subject|1|||
161150115|NCT01989546|581931785|FG000|Overall Study|Clinical Progression|1|||
161150116|NCT01989546|581931785|FG000|Overall Study|Disease progression on study|8|||
161150117|NCT00059215|581931788|FG000|Overall Study|Adverse Event|5|||
161150118|NCT00059215|581931789|FG001|Overall Study|Adverse Event|5|||
161150119|NCT00059215|581931790|FG002|Overall Study|Adverse Event|9|||
161150120|NCT00059215|581931791|FG003|Overall Study|Adverse Event|9|||
161150121|NCT00059215|581931788|FG000|Overall Study|Death|0|||
161150122|NCT00059215|581931789|FG001|Overall Study|Death|0|||
161150123|NCT00059215|581931790|FG002|Overall Study|Death|3|||
161150124|NCT00059215|581931791|FG003|Overall Study|Death|0|||
161150125|NCT00059215|581931788|FG000|Overall Study|Lost to Follow-up|1|||
161150126|NCT00059215|581931789|FG001|Overall Study|Lost to Follow-up|2|||
161280721|NCT00996892|582407018|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
161280722|NCT00996892|582407019|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
161280723|NCT00996892|582407020|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
161280724|NCT00996892|582407021|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
161280725|NCT00996892|582407002|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280726|NCT00996892|582407003|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161280727|NCT00996892|582407004|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280728|NCT00996892|582407005|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
161280729|NCT00996892|582407006|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161280730|NCT00996892|582407007|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161280731|NCT00996892|582407008|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
161280732|NCT00996892|582407009|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280733|NCT00996892|582407010|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280734|NCT00996892|582407011|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280735|NCT00996892|582407012|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280736|NCT00996892|582407013|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280737|NCT00996892|582407014|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161150127|NCT00059215|581931790|FG002|Overall Study|Lost to Follow-up|0|||
161280738|NCT00996892|582407015|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280739|NCT00996892|582407016|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161150128|NCT00059215|581931791|FG003|Overall Study|Lost to Follow-up|0|||
161150129|NCT00059215|581931788|FG000|Overall Study|Withdrawal by Subject|4|||
161150130|NCT00059215|581931789|FG001|Overall Study|Withdrawal by Subject|4|||
161150131|NCT00059215|581931790|FG002|Overall Study|Withdrawal by Subject|1|||
161150132|NCT00059215|581931791|FG003|Overall Study|Withdrawal by Subject|3|||
161150133|NCT00059215|581931788|FG000|Overall Study|Protocol Violation|1|||
161150134|NCT00059215|581931789|FG001|Overall Study|Protocol Violation|0|||
161045854|NCT01262456|581557249|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
161045855|NCT01262456|581557247|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
161045856|NCT01262456|581557248|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
161045857|NCT01262456|581557249|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
161045858|NCT03938272|581557250|FG000|Overall Study|Withdrawal by Subject|1|||
161045859|NCT03938272|581557251|FG001|Overall Study|Withdrawal by Subject|0|||
161045860|NCT03938272|581557250|FG000|Overall Study|Physician Decision|0|||
161045861|NCT03938272|581557251|FG001|Overall Study|Physician Decision|2|||
161045862|NCT03938272|581557250|FG000|Overall Study|Study termination by sponsor|10|||
161045863|NCT03938272|581557251|FG001|Overall Study|Study termination by sponsor|8|||
161045864|NCT00266656|581557259|FG000|Overall Study|Death|1|||
161045865|NCT00266656|581557260|FG001|Overall Study|Death|0|||
161045866|NCT00266656|581557259|FG000|Overall Study|Lost to Follow-up|4|||
161045867|NCT00266656|581557260|FG001|Overall Study|Lost to Follow-up|1|||
161045868|NCT00266656|581557259|FG000|Overall Study|Withdrawal by Subject|4|||
161045869|NCT00266656|581557260|FG001|Overall Study|Withdrawal by Subject|2|||
161045870|NCT00266656|581557259|FG000|Overall Study|Did Not Reach Final Height|4|||
161045871|NCT00266656|581557260|FG001|Overall Study|Did Not Reach Final Height|8|||
161045872|NCT00266656|581557259|FG000|Overall Study|Parent/Caregiver Decision|1|||
161045873|NCT00266656|581557260|FG001|Overall Study|Parent/Caregiver Decision|2|||
161045874|NCT04602728|581557261|FG000|Overall Study|Lost to Follow-up|4|||
161045875|NCT04602728|581557262|FG001|Overall Study|Lost to Follow-up|4|||
161045876|NCT04186247|581557263|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
161045877|NCT04186247|581557264|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161045878|NCT04186247|581557265|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161045879|NCT04186247|581557266|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161045880|NCT04186247|581557267|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
161045881|NCT04852978|581557268|FG000|Overall Study|Physician Decision|0|||
161045882|NCT04852978|581557269|FG001|Overall Study|Physician Decision|1|||
161045883|NCT04852978|581557270|FG002|Overall Study|Physician Decision|0|||
161045884|NCT04852978|581557271|FG003|Overall Study|Physician Decision|0|||
161045885|NCT04852978|581557272|FG004|Overall Study|Physician Decision|0|||
161045886|NCT04852978|581557273|FG005|Overall Study|Physician Decision|0|||
161045887|NCT04852978|581557274|FG006|Overall Study|Physician Decision|0|||
161045888|NCT04852978|581557275|FG007|Overall Study|Physician Decision|2|||
161045889|NCT04852978|581557276|FG008|Overall Study|Physician Decision|0|||
161045890|NCT04852978|581557268|FG000|Overall Study|Sponsor request|0|||
161045891|NCT04852978|581557269|FG001|Overall Study|Sponsor request|0|||
161045892|NCT04852978|581557270|FG002|Overall Study|Sponsor request|1|||
161045893|NCT04852978|581557271|FG003|Overall Study|Sponsor request|0|||
161045894|NCT04852978|581557272|FG004|Overall Study|Sponsor request|0|||
161045895|NCT04852978|581557273|FG005|Overall Study|Sponsor request|0|||
161045896|NCT04852978|581557274|FG006|Overall Study|Sponsor request|0|||
161045897|NCT04852978|581557275|FG007|Overall Study|Sponsor request|0|||
161045898|NCT04852978|581557276|FG008|Overall Study|Sponsor request|0|||
161045899|NCT04852978|581557268|FG000|Overall Study|Death|0|||
161045900|NCT04852978|581557269|FG001|Overall Study|Death|0|||
161045901|NCT04852978|581557270|FG002|Overall Study|Death|0|||
161045902|NCT04852978|581557271|FG003|Overall Study|Death|0|||
161045903|NCT04852978|581557272|FG004|Overall Study|Death|0|||
161045904|NCT04852978|581557273|FG005|Overall Study|Death|0|||
161045905|NCT04852978|581557274|FG006|Overall Study|Death|1|||
161045906|NCT04852978|581557275|FG007|Overall Study|Death|0|||
161045907|NCT04852978|581557276|FG008|Overall Study|Death|0|||
161045908|NCT04852978|581557268|FG000|Overall Study|Lost to Follow-up|3|||
161045909|NCT04852978|581557269|FG001|Overall Study|Lost to Follow-up|2|||
161045910|NCT04852978|581557270|FG002|Overall Study|Lost to Follow-up|2|||
161045911|NCT04852978|581557271|FG003|Overall Study|Lost to Follow-up|0|||
161045912|NCT04852978|581557272|FG004|Overall Study|Lost to Follow-up|2|||
161045913|NCT04852978|581557273|FG005|Overall Study|Lost to Follow-up|4|||
161045914|NCT04852978|581557274|FG006|Overall Study|Lost to Follow-up|1|||
161045915|NCT04852978|581557275|FG007|Overall Study|Lost to Follow-up|2|||
161045916|NCT04852978|581557276|FG008|Overall Study|Lost to Follow-up|2|||
161045917|NCT04852978|581557268|FG000|Overall Study|Withdrawal by Subject|4|||
161045918|NCT04852978|581557269|FG001|Overall Study|Withdrawal by Subject|2|||
161045919|NCT04852978|581557270|FG002|Overall Study|Withdrawal by Subject|2|||
161045920|NCT04852978|581557271|FG003|Overall Study|Withdrawal by Subject|1|||
161045921|NCT04852978|581557272|FG004|Overall Study|Withdrawal by Subject|5|||
161045922|NCT04852978|581557273|FG005|Overall Study|Withdrawal by Subject|3|||
161045923|NCT04852978|581557274|FG006|Overall Study|Withdrawal by Subject|2|||
161045924|NCT04852978|581557275|FG007|Overall Study|Withdrawal by Subject|2|||
161045925|NCT04852978|581557276|FG008|Overall Study|Withdrawal by Subject|1|||
161045926|NCT00569166|581558964|FG000|Overall Study|Withdrawal by Subject|7|||
161045927|NCT00569166|581558965|FG001|Overall Study|Withdrawal by Subject|5|||
161045928|NCT00569166|581558966|FG002|Overall Study|Withdrawal by Subject|3|||
161045929|NCT00569166|581558964|FG000|Overall Study|Lost to Follow-up|2|||
161045930|NCT00569166|581558965|FG001|Overall Study|Lost to Follow-up|1|||
161045931|NCT00569166|581558966|FG002|Overall Study|Lost to Follow-up|1|||
161045932|NCT02784834|581558968|FG000|Overall Study|Lack of Efficacy|1|||
161045933|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
161045934|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
161045935|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
161045936|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
161045937|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Adverse Event|7|||
161045938|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Adverse Event|8|||
161045939|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Adverse Event|8|||
161045940|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Adverse Event|9|||
161045941|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
161045942|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
161045943|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
161045944|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
161045945|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
161045946|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
161045947|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
161045948|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
161045949|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Pregnancy|0|||
161045950|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Pregnancy|2|||
161045951|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Pregnancy|2|||
161045952|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Pregnancy|0|||
161045953|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Non-compliance|1|||
161045954|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Non-compliance|0|||
161045955|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Non-compliance|0|||
161045956|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Non-compliance|3|||
161045957|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Other|3|||
161045958|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Other|0|||
161045959|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Other|3|||
161045960|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Other|2|||
161045961|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
161045962|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
161045963|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
161045964|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
161045965|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
161045966|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
161045967|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
161045968|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
161045969|NCT02143713|581558969|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
161045970|NCT02143713|581558970|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
161045971|NCT02143713|581558971|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
161045972|NCT02143713|581558972|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
161045973|NCT02143713|581558969|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
161045974|NCT02143713|581558970|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
161045975|NCT02143713|581558971|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
161045976|NCT02143713|581558972|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
161045977|NCT02143713|581558969|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
161045978|NCT02143713|581558970|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
161045979|NCT02143713|581558971|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
161045980|NCT02143713|581558972|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
161045981|NCT02143713|581558969|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
161045982|NCT02143713|581558970|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
161045983|NCT02143713|581558971|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
161045984|NCT02143713|581558972|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
161045985|NCT02143713|581558969|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
161045986|NCT02143713|581558970|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
161045987|NCT02143713|581558971|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
161045988|NCT02143713|581558972|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
161045989|NCT02143713|581558969|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
161045990|NCT02143713|581558970|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
161045991|NCT02143713|581558971|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
161045992|NCT02143713|581558972|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
161045993|NCT02143713|581558969|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
161045994|NCT02143713|581558970|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
161045995|NCT02143713|581558971|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
161045996|NCT02143713|581558972|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
161045997|NCT01999335|581558973|FG000|Overall Study|Discontinued before receiving treatment|0|||
161045998|NCT01999335|581558974|FG001|Overall Study|Discontinued before receiving treatment|0|||
161045999|NCT01999335|581558975|FG002|Overall Study|Discontinued before receiving treatment|0|||
161046000|NCT01999335|581558976|FG003|Overall Study|Discontinued before receiving treatment|0|||
161046001|NCT01999335|581558977|FG004|Overall Study|Discontinued before receiving treatment|2|||
161046002|NCT01215253|581558978|FG000|Overall Study|Withdrawal by Subject|57|||
161046003|NCT01215253|581558979|FG001|Overall Study|Withdrawal by Subject|35|||
161046004|NCT01215253|581558978|FG000|Overall Study|Physician Decision|9|||
161046005|NCT01215253|581558979|FG001|Overall Study|Physician Decision|12|||
161046006|NCT01215253|581558978|FG000|Overall Study|Lost to Follow-up|6|||
161046007|NCT01215253|581558979|FG001|Overall Study|Lost to Follow-up|4|||
161046008|NCT01215253|581558978|FG000|Overall Study|Other|14|||
161046009|NCT01215253|581558979|FG001|Overall Study|Other|12|||
161046010|NCT00080119|581558980|FG000|Overall Study|Discontinued because of study closure|0|||
161046011|NCT00080119|581558981|FG001|Overall Study|Discontinued because of study closure|0|||
161046012|NCT00080119|581558982|FG002|Overall Study|Discontinued because of study closure|130|||
161046013|NCT00080119|581558983|FG003|Overall Study|Discontinued because of study closure|141|||
161046014|NCT00080119|581558980|FG000|Overall Study|Unable to get to clinic|24|||
161046015|NCT00080119|581558981|FG001|Overall Study|Unable to get to clinic|24|||
161046016|NCT00080119|581558982|FG002|Overall Study|Unable to get to clinic|7|||
161046017|NCT00080119|581558983|FG003|Overall Study|Unable to get to clinic|1|||
161046018|NCT00080119|581558980|FG000|Overall Study|Consent withdrawn|13|||
161046019|NCT00080119|581558981|FG001|Overall Study|Consent withdrawn|17|||
161046020|NCT00080119|581558982|FG002|Overall Study|Consent withdrawn|4|||
161046021|NCT00080119|581558983|FG003|Overall Study|Consent withdrawn|6|||
161046022|NCT00080119|581558980|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
161046023|NCT00080119|581558981|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
161046024|NCT00080119|581558982|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
161046025|NCT00080119|581558983|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
161046026|NCT00080119|581558980|FG000|Overall Study|Lost to Follow-up|16|||
161046027|NCT00080119|581558981|FG001|Overall Study|Lost to Follow-up|19|||
161046028|NCT00080119|581558982|FG002|Overall Study|Lost to Follow-up|19|||
161046029|NCT00080119|581558983|FG003|Overall Study|Lost to Follow-up|14|||
161046030|NCT01090739|581558988|FG000|Enrollment|Withdrawal by Subject|24|||
161046031|NCT01090739|581558988|FG000|Enrollment|Protocol Violation|14|||
161046032|NCT01090739|581558988|FG000|Enrollment|Lost to Follow-up|5|||
161046033|NCT01090739|581558988|FG000|Enrollment|Physician Decision|5|||
161046034|NCT01090739|581558988|FG000|Enrollment|Sponsor termination of site|4|||
161046035|NCT01090739|581558988|FG000|Enrollment|Study implant limit reached|2|||
161046036|NCT01090739|581558988|FG000|Enrollment|Adverse Event|1|||
161046037|NCT01090739|581558988|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
161046038|NCT01090739|581558988|FG000|12 Month Follow-up|Lost to Follow-up|1|||
161046039|NCT01090739|581558988|FG000|12 Month Follow-up|Physician Decision|1|||
161046040|NCT01090739|581558988|FG000|12 Month Follow-up|Death|1|||
161046041|NCT01090739|581558988|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
161046042|NCT01090739|581558988|FG000|24 Month Follow-up|Lost to Follow-up|1|||
161046043|NCT01090739|581558988|FG000|24 Month Follow-up|Death|1|||
161046044|NCT01090739|581558988|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
161046045|NCT01090739|581558988|FG000|36 Month Follow-up|Visit still pending|17|||
161046046|NCT00441168|581558989|FG000|Treatment Period|Death|3|||
161046047|NCT00441168|581558990|FG001|Treatment Period|Death|0|||
161046048|NCT00441168|581558989|FG000|Treatment Period|Adverse Event|1|||
161046049|NCT00441168|581558990|FG001|Treatment Period|Adverse Event|2|||
161046050|NCT00441168|581558989|FG000|Treatment Period|Progressive Disease|0|||
161046051|NCT00441168|581558990|FG001|Treatment Period|Progressive Disease|2|||
161046052|NCT00441168|581558989|FG000|Treatment Period|Protocol Violation|0|||
161046053|NCT00441168|581558990|FG001|Treatment Period|Protocol Violation|1|||
161046054|NCT00441168|581558989|FG000|Treatment Period|Lost to Follow-up|0|||
161046055|NCT00441168|581558990|FG001|Treatment Period|Lost to Follow-up|1|||
161046056|NCT00441168|581558989|FG000|Treatment Period|Withdrawal by Subject|3|||
161046057|NCT00441168|581558990|FG001|Treatment Period|Withdrawal by Subject|0|||
161046058|NCT00441168|581558989|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
161046059|NCT00441168|581558990|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
161046060|NCT00441168|581558989|FG000|Treatment Period|refractory disease|1|||
161046061|NCT00441168|581558990|FG001|Treatment Period|refractory disease|0|||
161046062|NCT00441168|581558989|FG000|Follow-up Period|Death|3|||
161046063|NCT00441168|581558990|FG001|Follow-up Period|Death|0|||
161150135|NCT00059215|581931790|FG002|Overall Study|Protocol Violation|1|||
161150136|NCT00059215|581931791|FG003|Overall Study|Protocol Violation|0|||
161046064|NCT00441168|581558989|FG000|Follow-up Period|Lost to Follow-up|5|||
161046065|NCT00441168|581558990|FG001|Follow-up Period|Lost to Follow-up|6|||
161046066|NCT00441168|581558989|FG000|Follow-up Period|Withdrawal by Subject|3|||
161046067|NCT00441168|581558990|FG001|Follow-up Period|Withdrawal by Subject|0|||
161046068|NCT00441168|581558989|FG000|Follow-up Period|Other|1|||
161046069|NCT00441168|581558990|FG001|Follow-up Period|Other|3|||
161046070|NCT04410445|581558992|FG000|Overall Study|Lost to Follow-up|3|||
161046071|NCT04410445|581558993|FG001|Overall Study|Lost to Follow-up|9|||
161046072|NCT04410445|581558992|FG000|Overall Study|Withdrawal by Subject|27|||
161150137|NCT00059215|581931788|FG000|Overall Study|Protocol entry criteria not met|1|||
161150138|NCT00059215|581931789|FG001|Overall Study|Protocol entry criteria not met|1|||
161150139|NCT00059215|581931790|FG002|Overall Study|Protocol entry criteria not met|0|||
161150140|NCT00059215|581931791|FG003|Overall Study|Protocol entry criteria not met|2|||
161150141|NCT00059215|581931788|FG000|Overall Study|Physician Decision|1|||
161150142|NCT00059215|581931789|FG001|Overall Study|Physician Decision|2|||
161150143|NCT00059215|581931790|FG002|Overall Study|Physician Decision|1|||
161150144|NCT00059215|581931791|FG003|Overall Study|Physician Decision|1|||
161150145|NCT04439838|581931792|FG000|Overall Study|Withdrawal by Subject|0|||
161150146|NCT04439838|581931793|FG001|Overall Study|Withdrawal by Subject|0|||
161150147|NCT04439838|581931794|FG002|Overall Study|Withdrawal by Subject|0|||
161150148|NCT04439838|581931795|FG003|Overall Study|Withdrawal by Subject|0|||
161150149|NCT04439838|581931796|FG004|Overall Study|Withdrawal by Subject|0|||
161150150|NCT04439838|581931797|FG005|Overall Study|Withdrawal by Subject|0|||
161150151|NCT04439838|581931798|FG006|Overall Study|Withdrawal by Subject|0|||
161150152|NCT04439838|581931799|FG007|Overall Study|Withdrawal by Subject|0|||
161150153|NCT04439838|581931800|FG008|Overall Study|Withdrawal by Subject|1|||
161150154|NCT04494633|581931805|FG000|Overall Study|Lost to Follow-up|5|||
161150155|NCT04494633|581931806|FG001|Overall Study|Lost to Follow-up|3|||
161150156|NCT04494633|581931805|FG000|Overall Study|Protocol Violation|1|||
161150157|NCT04494633|581931806|FG001|Overall Study|Protocol Violation|1|||
161150158|NCT01254604|581931807|FG000|Overall Study|Lost to Follow-up|1|||
161150159|NCT01254604|581931808|FG001|Overall Study|Lost to Follow-up|1|||
161150160|NCT01254604|581931807|FG000|Overall Study|Protocol Violation|2|||
161150161|NCT01254604|581931808|FG001|Overall Study|Protocol Violation|2|||
161150162|NCT01254604|581931807|FG000|Overall Study|Withdrawal by Subject|2|||
161150163|NCT01254604|581931808|FG001|Overall Study|Withdrawal by Subject|4|||
161150164|NCT01254604|581931807|FG000|Overall Study|Adverse Event|3|||
161150165|NCT01254604|581931808|FG001|Overall Study|Adverse Event|2|||
161150166|NCT03074162|581931809|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161150167|NCT03074162|581931810|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161150168|NCT03074162|581931811|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
161150169|NCT03074162|581931812|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161150170|NCT03074162|581931813|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161150171|NCT03074162|581931814|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
161150172|NCT03074162|581931809|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161150173|NCT03074162|581931810|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161150174|NCT03074162|581931811|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
161150175|NCT03074162|581931812|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161150176|NCT03074162|581931813|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
161150177|NCT03074162|581931814|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
161150178|NCT03074162|581931809|FG000|Period 3|Withdrawal by Subject|1|||
161150179|NCT03074162|581931810|FG001|Period 3|Withdrawal by Subject|0|||
161150180|NCT03074162|581931811|FG002|Period 3|Withdrawal by Subject|0|||
161150181|NCT03074162|581931812|FG003|Period 3|Withdrawal by Subject|0|||
161150182|NCT03074162|581931813|FG004|Period 3|Withdrawal by Subject|1|||
161150183|NCT03074162|581931814|FG005|Period 3|Withdrawal by Subject|0|||
161150184|NCT01958671|581931815|FG000|Overall Study|Adverse Event|1|||
161150185|NCT01958671|581931816|FG001|Overall Study|Adverse Event|1|||
161150186|NCT01958671|581931817|FG002|Overall Study|Adverse Event|5|||
161150187|NCT01958671|581931815|FG000|Overall Study|Death|1|||
161150188|NCT01958671|581931816|FG001|Overall Study|Death|0|||
161150189|NCT01958671|581931817|FG002|Overall Study|Death|0|||
161150190|NCT01958671|581931815|FG000|Overall Study|Excluded medication|0|||
161150191|NCT01958671|581931816|FG001|Overall Study|Excluded medication|0|||
161150192|NCT01958671|581931817|FG002|Overall Study|Excluded medication|1|||
161150193|NCT01958671|581931815|FG000|Overall Study|Hyperglycemia|0|||
161150194|NCT01958671|581931816|FG001|Overall Study|Hyperglycemia|0|||
161150195|NCT01958671|581931817|FG002|Overall Study|Hyperglycemia|2|||
161150196|NCT01958671|581931815|FG000|Overall Study|Lost to Follow-up|7|||
161280740|NCT00996892|582407017|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280741|NCT00996892|582407018|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280742|NCT00996892|582407019|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161280743|NCT00996892|582407020|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161150197|NCT01958671|581931816|FG001|Overall Study|Lost to Follow-up|11|||
161150198|NCT01958671|581931817|FG002|Overall Study|Lost to Follow-up|7|||
161150199|NCT01958671|581931815|FG000|Overall Study|Non-compliance with study drug|1|||
161280744|NCT00996892|582407021|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
161150200|NCT01958671|581931816|FG001|Overall Study|Non-compliance with study drug|1|||
161150201|NCT01958671|581931817|FG002|Overall Study|Non-compliance with study drug|1|||
161150202|NCT01958671|581931815|FG000|Overall Study|Pregnancy|0|||
161150203|NCT01958671|581931816|FG001|Overall Study|Pregnancy|0|||
161150204|NCT01958671|581931817|FG002|Overall Study|Pregnancy|1|||
161150205|NCT01958671|581931815|FG000|Overall Study|Protocol Violation|0|||
161150206|NCT01958671|581931816|FG001|Overall Study|Protocol Violation|1|||
161150207|NCT01958671|581931817|FG002|Overall Study|Protocol Violation|0|||
161046073|NCT04410445|581558993|FG001|Overall Study|Withdrawal by Subject|15|||
161046074|NCT01320683|581558994|FG000|Overall Study|Positive antibody response|1|||
161046075|NCT02291861|581558995|FG000|Overall Study|Adverse Event|2|||
161046076|NCT02291861|581558996|FG001|Overall Study|Adverse Event|4|||
161046077|NCT02291861|581558997|FG002|Overall Study|Adverse Event|1|||
161046078|NCT02291861|581558998|FG003|Overall Study|Adverse Event|2|||
161046079|NCT02291861|581558995|FG000|Overall Study|Death|0|||
161046080|NCT02291861|581558996|FG001|Overall Study|Death|0|||
161046081|NCT02291861|581558997|FG002|Overall Study|Death|1|||
161046082|NCT02291861|581558998|FG003|Overall Study|Death|1|||
161046083|NCT02291861|581558995|FG000|Overall Study|Protocol Violation|1|||
161046084|NCT02291861|581558996|FG001|Overall Study|Protocol Violation|0|||
161046085|NCT02291861|581558997|FG002|Overall Study|Protocol Violation|0|||
161046086|NCT02291861|581558998|FG003|Overall Study|Protocol Violation|1|||
161046087|NCT02291861|581558995|FG000|Overall Study|Withdrawal by Subject|1|||
161046088|NCT02291861|581558996|FG001|Overall Study|Withdrawal by Subject|2|||
161046089|NCT02291861|581558997|FG002|Overall Study|Withdrawal by Subject|1|||
161046090|NCT02291861|581558998|FG003|Overall Study|Withdrawal by Subject|4|||
161046091|NCT02291861|581558995|FG000|Overall Study|Noncompliance|1|||
161046092|NCT02291861|581558996|FG001|Overall Study|Noncompliance|1|||
161046093|NCT02291861|581558997|FG002|Overall Study|Noncompliance|2|||
161046094|NCT02291861|581558998|FG003|Overall Study|Noncompliance|1|||
161046095|NCT02291861|581558995|FG000|Overall Study|Lost to Follow-up|2|||
161046096|NCT02291861|581558996|FG001|Overall Study|Lost to Follow-up|1|||
161046097|NCT02291861|581558997|FG002|Overall Study|Lost to Follow-up|4|||
161046098|NCT02291861|581558998|FG003|Overall Study|Lost to Follow-up|0|||
161046099|NCT02291861|581558995|FG000|Overall Study|Other|0|||
161046100|NCT02291861|581558996|FG001|Overall Study|Other|0|||
161046101|NCT02291861|581558997|FG002|Overall Study|Other|0|||
161046102|NCT02291861|581558998|FG003|Overall Study|Other|1|||
161046103|NCT02005484|581559001|FG000|Overall Study|Death|1|||
161046104|NCT02005484|581559001|FG000|Overall Study|Disease progression|1|||
161046105|NCT02005484|581559001|FG000|Overall Study|Changed to a Different Study|1|||
161046106|NCT02005484|581559001|FG000|Overall Study|Sponsor decision|1|||
161046107|NCT03547154|581559006|FG000|Overall Study|Disease Progression/Recurrence|6|||
161046108|NCT03547154|581559007|FG001|Overall Study|Disease Progression/Recurrence|14|||
161046109|NCT03547154|581559006|FG000|Overall Study|Adverse Event|26|||
161046110|NCT03547154|581559007|FG001|Overall Study|Adverse Event|31|||
161046111|NCT03547154|581559006|FG000|Overall Study|Protocol Violation|6|||
161046112|NCT03547154|581559007|FG001|Overall Study|Protocol Violation|1|||
161046113|NCT03547154|581559006|FG000|Overall Study|Physician Decision|4|||
161046114|NCT03547154|581559007|FG001|Overall Study|Physician Decision|3|||
161046115|NCT03547154|581559006|FG000|Overall Study|Insufficient Therapeutic Response|13|||
161046116|NCT03547154|581559007|FG001|Overall Study|Insufficient Therapeutic Response|10|||
161046117|NCT03547154|581559006|FG000|Overall Study|Withdrawal by Subject|10|||
161046118|NCT03547154|581559007|FG001|Overall Study|Withdrawal by Subject|6|||
161046119|NCT03547154|581559006|FG000|Overall Study|Not Selected|0|||
161046120|NCT03547154|581559007|FG001|Overall Study|Not Selected|1|||
161046121|NCT03547154|581559006|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
161046122|NCT03547154|581559007|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
161046123|NCT03390166|581559009|FG000|Overall Study|Death|0|||
161046124|NCT03390166|581559010|FG001|Overall Study|Death|1|||
161046125|NCT03390166|581559009|FG000|Overall Study|Lost to Follow-up|6|||
161046126|NCT03390166|581559010|FG001|Overall Study|Lost to Follow-up|4|||
161046127|NCT03390166|581559009|FG000|Overall Study|Physician Decision|2|||
161046128|NCT03390166|581559010|FG001|Overall Study|Physician Decision|1|||
161046129|NCT03390166|581559009|FG000|Overall Study|Move from study area|3|||
161046130|NCT03390166|581559010|FG001|Overall Study|Move from study area|2|||
161046131|NCT03390166|581559009|FG000|Overall Study|To militarycamp for conscript|1|||
161046132|NCT03390166|581559010|FG001|Overall Study|To militarycamp for conscript|0|||
161046133|NCT03390166|581559009|FG000|Overall Study|To drug therapy course|0|||
161150208|NCT01958671|581931815|FG000|Overall Study|Study site terminated by sponsor|1|||
161150209|NCT01958671|581931816|FG001|Overall Study|Study site terminated by sponsor|0|||
161046134|NCT03390166|581559010|FG001|Overall Study|To drug therapy course|1|||
161046135|NCT03390166|581559009|FG000|Overall Study|Move to work oversea|0|||
161046136|NCT03390166|581559010|FG001|Overall Study|Move to work oversea|1|||
161150210|NCT01958671|581931817|FG002|Overall Study|Study site terminated by sponsor|1|||
161344883|NCT03839641|582648822|FG001|Overall Study|Withdrawal by Subject|1|||
161046137|NCT00526994|581559025|FG000|Overall Study|Lost to Follow-up|98|||
161046138|NCT00526994|581559026|FG001|Overall Study|Lost to Follow-up|108|||
161046139|NCT00526994|581559027|FG002|Overall Study|Lost to Follow-up|96|||
161046140|NCT00526994|581559025|FG000|Overall Study|Death|4|||
161046141|NCT00526994|581559026|FG001|Overall Study|Death|3|||
161046142|NCT00526994|581559027|FG002|Overall Study|Death|3|||
161046143|NCT00526994|581559025|FG000|Overall Study|Withdrawal by Subject|2|||
161150211|NCT01958671|581931815|FG000|Overall Study|Participant moved|0|||
161046144|NCT00526994|581559026|FG001|Overall Study|Withdrawal by Subject|7|||
161046145|NCT00526994|581559027|FG002|Overall Study|Withdrawal by Subject|5|||
161046146|NCT00526994|581559025|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
161046147|NCT00526994|581559026|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
161046148|NCT00526994|581559027|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
161046149|NCT04821271|581559033|FG000|Period 1|Withdrawal by Subject|2|||
161046150|NCT04821271|581559034|FG001|Period 1|Withdrawal by Subject|0|||
161046151|NCT02521493|581559036|FG000|Overall Study|Death|3|||
161046152|NCT02521493|581559037|FG001|Overall Study|Death|4|||
161046153|NCT02521493|581559038|FG002|Overall Study|Death|1|||
161046154|NCT02521493|581559036|FG000|Overall Study|Physician Decision|19|||
161046155|NCT02521493|581559037|FG001|Overall Study|Physician Decision|1|||
161046156|NCT02521493|581559038|FG002|Overall Study|Physician Decision|2|||
161046157|NCT02521493|581559036|FG000|Overall Study|Withdrawal by Subject|3|||
161046158|NCT02521493|581559037|FG001|Overall Study|Withdrawal by Subject|0|||
161046159|NCT02521493|581559038|FG002|Overall Study|Withdrawal by Subject|0|||
161046160|NCT02521493|581559036|FG000|Overall Study|Ineligible|0|||
161046161|NCT02521493|581559037|FG001|Overall Study|Ineligible|1|||
161046162|NCT02521493|581559038|FG002|Overall Study|Ineligible|0|||
161046163|NCT02521493|581559036|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
161046164|NCT02521493|581559037|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
161046165|NCT02521493|581559038|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
161046166|NCT02521493|581559036|FG000|Overall Study|No MRD result|0|||
161046167|NCT02521493|581559037|FG001|Overall Study|No MRD result|0|||
161046168|NCT02521493|581559038|FG002|Overall Study|No MRD result|4|||
161046169|NCT01880736|581559039|FG000|Overall Study|Adverse Event|0|||
161046170|NCT01880736|581559040|FG001|Overall Study|Adverse Event|0|||
161046171|NCT01880736|581559041|FG002|Overall Study|Adverse Event|0|||
161046172|NCT01880736|581559042|FG003|Overall Study|Adverse Event|1|||
161046173|NCT01880736|581559039|FG000|Overall Study|Withdrawal Criteria|1|||
161046174|NCT01880736|581559040|FG001|Overall Study|Withdrawal Criteria|2|||
161046175|NCT01880736|581559041|FG002|Overall Study|Withdrawal Criteria|1|||
161046176|NCT01880736|581559042|FG003|Overall Study|Withdrawal Criteria|5|||
161046177|NCT00428714|581559045|FG000|Overall Study|Progressive Disease|28|||
161046178|NCT00428714|581559046|FG001|Overall Study|Progressive Disease|36|||
161046179|NCT00428714|581559045|FG000|Overall Study|Withdrawal by Subject|0|||
161046180|NCT00428714|581559046|FG001|Overall Study|Withdrawal by Subject|3|||
161046181|NCT00428714|581559045|FG000|Overall Study|Adverse Event|0|||
161046182|NCT00428714|581559046|FG001|Overall Study|Adverse Event|2|||
161046183|NCT00428714|581559045|FG000|Overall Study|Physician Decision|1|||
161046184|NCT00428714|581559046|FG001|Overall Study|Physician Decision|1|||
161046185|NCT00428714|581559045|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
161046186|NCT00428714|581559046|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
161046187|NCT00428714|581559045|FG000|Overall Study|Death due to other then PD|1|||
161046188|NCT00428714|581559046|FG001|Overall Study|Death due to other then PD|0|||
161046189|NCT02807857|581559049|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
161046190|NCT02807857|581559049|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
161046191|NCT02807857|581559049|FG000|Follow-Up Set|Withdrawal by Subject|8|||
161046192|NCT02807857|581559049|FG000|Follow-Up Set|Lost to Follow-up|7|||
161046193|NCT02807857|581559049|FG000|Follow-Up Set|Physician Decision|6|||
161046194|NCT02807857|581559049|FG000|Follow-Up Set|Adverse Event|3|||
161046195|NCT02807857|581559049|FG000|Follow-Up Set|Death|27|||
161046196|NCT02807857|581559049|FG000|Follow-Up Set|Relocation|2|||
161046197|NCT00513071|581559051|FG000|Overall Study|Adverse Event|1|||
161046198|NCT00513071|581559051|FG000|Overall Study|Withdrawal by Subject|1|||
161046199|NCT00513071|581559051|FG000|Overall Study|Physician Decision|3|||
161046200|NCT00667732|581559053|FG000|Run -In (8 Weeks)|Adverse Event|4|||
161046201|NCT00667732|581559054|FG001|Run -In (8 Weeks)|Adverse Event|0|||
161046202|NCT00667732|581559055|FG002|Run -In (8 Weeks)|Adverse Event|0|||
161046203|NCT00667732|581559053|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
161046204|NCT00667732|581559054|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
161046205|NCT00667732|581559055|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
161046206|NCT00667732|581559053|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
161046207|NCT00667732|581559054|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
161046208|NCT00667732|581559055|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
161046209|NCT02106325|581559058|FG000|Phase 1|Lost to Follow-up|2|||
161046210|NCT02106325|581559059|FG001|Phase 1|Lost to Follow-up|2|||
161046211|NCT02106325|581559058|FG000|Phase 2|Lost to Follow-up|2|||
161046212|NCT02106325|581559059|FG001|Phase 2|Lost to Follow-up|3|||
161046213|NCT02106325|581559058|FG000|Phase 3|Lost to Follow-up|2|||
161046214|NCT02106325|581559059|FG001|Phase 3|Lost to Follow-up|1|||
161046215|NCT00452114|581559060|FG000|Overall Study|Physician Decision|3|||
161046216|NCT00452114|581559061|FG001|Overall Study|Physician Decision|3|||
161046217|NCT03242863|581559063|FG000|Study Week 1|Withdrawal by Subject|0|||
161150212|NCT01958671|581931816|FG001|Overall Study|Participant moved|0|||
161150213|NCT01958671|581931817|FG002|Overall Study|Participant moved|1|||
161046218|NCT03242863|581559064|FG001|Study Week 1|Withdrawal by Subject|1|||
161046219|NCT03242863|581559065|FG002|Study Week 1|Withdrawal by Subject|0|||
161046220|NCT03242863|581559066|FG003|Study Week 1|Withdrawal by Subject|0|||
161046221|NCT03242863|581559067|FG004|Study Week 1|Withdrawal by Subject|3|||
161046222|NCT03242863|581559068|FG005|Study Week 1|Withdrawal by Subject|0|||
161046223|NCT05289037|581559076|FG000|Overall Study|Withdrawal by Subject|7|||
161046224|NCT05289037|581559077|FG001|Overall Study|Withdrawal by Subject|0|||
161280745|NCT00996892|582407002|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
161280746|NCT00996892|582407003|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
161046225|NCT05289037|581559078|FG002|Overall Study|Withdrawal by Subject|3|||
161046226|NCT05289037|581559079|FG003|Overall Study|Withdrawal by Subject|3|||
161046227|NCT05289037|581559080|FG004|Overall Study|Withdrawal by Subject|1|||
161046228|NCT05289037|581559081|FG005|Overall Study|Withdrawal by Subject|5|||
161046229|NCT05289037|581559082|FG006|Overall Study|Withdrawal by Subject|2|||
161046230|NCT05289037|581559083|FG007|Overall Study|Withdrawal by Subject|1|||
161046231|NCT05289037|581559084|FG008|Overall Study|Withdrawal by Subject|2|||
161046232|NCT05289037|581559085|FG009|Overall Study|Withdrawal by Subject|2|||
161046233|NCT05289037|581559086|FG010|Overall Study|Withdrawal by Subject|1|||
161046234|NCT05289037|581559087|FG011|Overall Study|Withdrawal by Subject|0|||
161046235|NCT05289037|581559088|FG012|Overall Study|Withdrawal by Subject|1|||
161046236|NCT05289037|581559089|FG013|Overall Study|Withdrawal by Subject|2|||
161046237|NCT05289037|581559090|FG014|Overall Study|Withdrawal by Subject|0|||
161046238|NCT05289037|581559091|FG015|Overall Study|Withdrawal by Subject|3|||
161046239|NCT05289037|581559092|FG016|Overall Study|Withdrawal by Subject|3|||
161046240|NCT05289037|581559076|FG000|Overall Study|Lost to Follow-up|1|||
161046241|NCT05289037|581559077|FG001|Overall Study|Lost to Follow-up|4|||
161046242|NCT05289037|581559078|FG002|Overall Study|Lost to Follow-up|3|||
161046243|NCT05289037|581559079|FG003|Overall Study|Lost to Follow-up|3|||
161046244|NCT05289037|581559080|FG004|Overall Study|Lost to Follow-up|3|||
161046245|NCT05289037|581559081|FG005|Overall Study|Lost to Follow-up|2|||
161046246|NCT05289037|581559082|FG006|Overall Study|Lost to Follow-up|3|||
161046247|NCT05289037|581559083|FG007|Overall Study|Lost to Follow-up|2|||
161046248|NCT05289037|581559084|FG008|Overall Study|Lost to Follow-up|2|||
161046249|NCT05289037|581559085|FG009|Overall Study|Lost to Follow-up|1|||
161046250|NCT05289037|581559086|FG010|Overall Study|Lost to Follow-up|3|||
161046251|NCT05289037|581559087|FG011|Overall Study|Lost to Follow-up|4|||
161046252|NCT05289037|581559088|FG012|Overall Study|Lost to Follow-up|2|||
161046253|NCT05289037|581559089|FG013|Overall Study|Lost to Follow-up|7|||
161046254|NCT05289037|581559090|FG014|Overall Study|Lost to Follow-up|4|||
161046255|NCT05289037|581559091|FG015|Overall Study|Lost to Follow-up|6|||
161046256|NCT05289037|581559092|FG016|Overall Study|Lost to Follow-up|4|||
161046257|NCT05289037|581559076|FG000|Overall Study|Death|0|||
161046258|NCT05289037|581559077|FG001|Overall Study|Death|0|||
161046259|NCT05289037|581559078|FG002|Overall Study|Death|0|||
161046260|NCT05289037|581559079|FG003|Overall Study|Death|0|||
161046261|NCT05289037|581559080|FG004|Overall Study|Death|0|||
161046262|NCT05289037|581559081|FG005|Overall Study|Death|1|||
161046263|NCT05289037|581559082|FG006|Overall Study|Death|0|||
161046264|NCT05289037|581559083|FG007|Overall Study|Death|0|||
161046265|NCT05289037|581559084|FG008|Overall Study|Death|0|||
161046266|NCT05289037|581559085|FG009|Overall Study|Death|0|||
161046267|NCT05289037|581559086|FG010|Overall Study|Death|0|||
161046268|NCT05289037|581559087|FG011|Overall Study|Death|0|||
161046269|NCT05289037|581559088|FG012|Overall Study|Death|0|||
161046270|NCT05289037|581559089|FG013|Overall Study|Death|0|||
161046271|NCT05289037|581559090|FG014|Overall Study|Death|1|||
161046272|NCT05289037|581559091|FG015|Overall Study|Death|0|||
161046273|NCT05289037|581559092|FG016|Overall Study|Death|0|||
161046274|NCT05289037|581559076|FG000|Overall Study|Did not receive vaccine|0|||
161046275|NCT05289037|581559077|FG001|Overall Study|Did not receive vaccine|3|||
161046276|NCT05289037|581559078|FG002|Overall Study|Did not receive vaccine|0|||
161046277|NCT05289037|581559079|FG003|Overall Study|Did not receive vaccine|0|||
161046278|NCT05289037|581559080|FG004|Overall Study|Did not receive vaccine|1|||
161046279|NCT05289037|581559081|FG005|Overall Study|Did not receive vaccine|1|||
161046280|NCT05289037|581559082|FG006|Overall Study|Did not receive vaccine|1|||
161046281|NCT05289037|581559083|FG007|Overall Study|Did not receive vaccine|0|||
161046282|NCT05289037|581559084|FG008|Overall Study|Did not receive vaccine|0|||
161046283|NCT05289037|581559085|FG009|Overall Study|Did not receive vaccine|0|||
161046284|NCT05289037|581559086|FG010|Overall Study|Did not receive vaccine|0|||
161046285|NCT05289037|581559087|FG011|Overall Study|Did not receive vaccine|0|||
161046286|NCT05289037|581559088|FG012|Overall Study|Did not receive vaccine|0|||
161046287|NCT05289037|581559089|FG013|Overall Study|Did not receive vaccine|0|||
161046288|NCT05289037|581559090|FG014|Overall Study|Did not receive vaccine|1|||
161150214|NCT01958671|581931815|FG000|Overall Study|Withdrawal by Subject|8|||
161280747|NCT00996892|582407004|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
161046289|NCT05289037|581559091|FG015|Overall Study|Did not receive vaccine|0|||
161046290|NCT05289037|581559092|FG016|Overall Study|Did not receive vaccine|0|||
161150215|NCT01958671|581931816|FG001|Overall Study|Withdrawal by Subject|10|||
161046291|NCT05289037|581559076|FG000|Overall Study|Unable to make last visit|0|||
161046292|NCT05289037|581559077|FG001|Overall Study|Unable to make last visit|0|||
161046293|NCT05289037|581559078|FG002|Overall Study|Unable to make last visit|1|||
161150216|NCT01958671|581931817|FG002|Overall Study|Withdrawal by Subject|13|||
161046294|NCT05289037|581559079|FG003|Overall Study|Unable to make last visit|0|||
161046295|NCT05289037|581559080|FG004|Overall Study|Unable to make last visit|0|||
161280748|NCT00996892|582407005|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
161046296|NCT05289037|581559081|FG005|Overall Study|Unable to make last visit|0|||
161046297|NCT05289037|581559082|FG006|Overall Study|Unable to make last visit|0|||
161046298|NCT05289037|581559083|FG007|Overall Study|Unable to make last visit|0|||
161046299|NCT05289037|581559084|FG008|Overall Study|Unable to make last visit|0|||
161046300|NCT05289037|581559085|FG009|Overall Study|Unable to make last visit|0|||
161046301|NCT05289037|581559086|FG010|Overall Study|Unable to make last visit|0|||
161046302|NCT05289037|581559087|FG011|Overall Study|Unable to make last visit|0|||
161046303|NCT05289037|581559088|FG012|Overall Study|Unable to make last visit|0|||
161046304|NCT05289037|581559089|FG013|Overall Study|Unable to make last visit|0|||
161046305|NCT05289037|581559090|FG014|Overall Study|Unable to make last visit|0|||
161046306|NCT05289037|581559091|FG015|Overall Study|Unable to make last visit|0|||
161046307|NCT05289037|581559092|FG016|Overall Study|Unable to make last visit|0|||
161046308|NCT05289037|581559076|FG000|Overall Study|Protocol deviation|0|||
161046309|NCT05289037|581559077|FG001|Overall Study|Protocol deviation|0|||
161046310|NCT05289037|581559078|FG002|Overall Study|Protocol deviation|0|||
161046311|NCT05289037|581559079|FG003|Overall Study|Protocol deviation|0|||
161046312|NCT05289037|581559080|FG004|Overall Study|Protocol deviation|0|||
161046313|NCT05289037|581559081|FG005|Overall Study|Protocol deviation|0|||
161046314|NCT05289037|581559082|FG006|Overall Study|Protocol deviation|0|||
161046315|NCT05289037|581559083|FG007|Overall Study|Protocol deviation|0|||
161046316|NCT05289037|581559084|FG008|Overall Study|Protocol deviation|0|||
161046317|NCT05289037|581559085|FG009|Overall Study|Protocol deviation|0|||
161046318|NCT05289037|581559086|FG010|Overall Study|Protocol deviation|0|||
161046319|NCT05289037|581559087|FG011|Overall Study|Protocol deviation|0|||
161046320|NCT05289037|581559088|FG012|Overall Study|Protocol deviation|0|||
161046321|NCT05289037|581559089|FG013|Overall Study|Protocol deviation|0|||
161046322|NCT05289037|581559090|FG014|Overall Study|Protocol deviation|0|||
161046323|NCT05289037|581559091|FG015|Overall Study|Protocol deviation|1|||
161046324|NCT05289037|581559092|FG016|Overall Study|Protocol deviation|0|||
161046325|NCT02831049|581559093|FG000|Overall Study|Lost to Follow-up|0|||
161046326|NCT02831049|581559094|FG001|Overall Study|Lost to Follow-up|0|||
161046327|NCT02831049|581559095|FG002|Overall Study|Lost to Follow-up|1|||
161046328|NCT02831049|581559093|FG000|Overall Study|Withdrawal by Subject|0|||
161046329|NCT02831049|581559094|FG001|Overall Study|Withdrawal by Subject|1|||
161046330|NCT02831049|581559095|FG002|Overall Study|Withdrawal by Subject|1|||
161046331|NCT02831049|581559093|FG000|Overall Study|Pandemic shutdown|1|||
161046332|NCT02831049|581559094|FG001|Overall Study|Pandemic shutdown|0|||
161046333|NCT02831049|581559095|FG002|Overall Study|Pandemic shutdown|0|||
161046334|NCT03786471|581559097|FG000|Overall Study|Death|254|||
161046335|NCT03786471|581559098|FG001|Overall Study|Death|223|||
161046336|NCT03786471|581559099|FG002|Overall Study|Death|37|||
161046337|NCT03786471|581559097|FG000|Overall Study|Lost to Follow-up|63|||
161046338|NCT03786471|581559098|FG001|Overall Study|Lost to Follow-up|50|||
161046339|NCT03786471|581559099|FG002|Overall Study|Lost to Follow-up|15|||
161046340|NCT03786471|581559097|FG000|Overall Study|Withdrawal by Subject|99|||
161046341|NCT03786471|581559098|FG001|Overall Study|Withdrawal by Subject|81|||
161046342|NCT03786471|581559099|FG002|Overall Study|Withdrawal by Subject|11|||
161046343|NCT03141177|581560553|FG000|Overall Study|Death|62|||
161046344|NCT03141177|581560554|FG001|Overall Study|Death|13|||
161046345|NCT03141177|581560555|FG002|Overall Study|Death|84|||
161046346|NCT03141177|581560553|FG000|Overall Study|Participant withdrew consent|9|||
161046347|NCT03141177|581560554|FG001|Overall Study|Participant withdrew consent|2|||
161046348|NCT03141177|581560555|FG002|Overall Study|Participant withdrew consent|13|||
161046349|NCT03141177|581560553|FG000|Overall Study|Not reported|1|||
161046350|NCT03141177|581560554|FG001|Overall Study|Not reported|0|||
161046351|NCT03141177|581560555|FG002|Overall Study|Not reported|1|||
161046352|NCT03141177|581560553|FG000|Overall Study|Lost to Follow-up|2|||
161046353|NCT03141177|581560554|FG001|Overall Study|Lost to Follow-up|1|||
161046354|NCT03141177|581560555|FG002|Overall Study|Lost to Follow-up|1|||
161046355|NCT03141177|581560553|FG000|Overall Study|Other reasons|4|||
161046356|NCT03141177|581560554|FG001|Overall Study|Other reasons|0|||
161046357|NCT03141177|581560555|FG002|Overall Study|Other reasons|11|||
161046358|NCT03141177|581560553|FG000|Overall Study|Participants did not start treatment period|3|||
161046359|NCT03141177|581560554|FG001|Overall Study|Participants did not start treatment period|0|||
161046360|NCT03141177|581560555|FG002|Overall Study|Participants did not start treatment period|8|||
161046361|NCT05006703|581560556|FG000|Overall Study|Withdrawal by Subject|1|||
161046362|NCT05006703|581560557|FG001|Overall Study|Withdrawal by Subject|0|||
161046363|NCT05006703|581560556|FG000|Overall Study|Lost to Follow-up|13|||
161046364|NCT05006703|581560557|FG001|Overall Study|Lost to Follow-up|5|||
161046365|NCT00264576|581560562|FG000|Overall Study|Lost to Follow-up|1|||
161046366|NCT00264576|581560563|FG001|Overall Study|Lost to Follow-up|1|||
161046367|NCT02659059|581560564|FG000|Overall Study|Other reasons|6|||
161046368|NCT02659059|581560565|FG001|Overall Study|Other reasons|1|||
161046369|NCT02659059|581560564|FG000|Overall Study|Disease Progression|143|||
161046370|NCT02659059|581560565|FG001|Overall Study|Disease Progression|16|||
161046371|NCT02659059|581560564|FG000|Overall Study|Study Drug toxicity|56|||
161046372|NCT02659059|581560565|FG001|Overall Study|Study Drug toxicity|9|||
161046373|NCT02659059|581560564|FG000|Overall Study|Death|3|||
161046374|NCT02659059|581560565|FG001|Overall Study|Death|1|||
161046375|NCT02659059|581560564|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
161046376|NCT02659059|581560565|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
161046377|NCT02659059|581560564|FG000|Overall Study|Participant request to discontinue study treatment|5|||
161046378|NCT02659059|581560565|FG001|Overall Study|Participant request to discontinue study treatment|0|||
161046379|NCT02659059|581560564|FG000|Overall Study|Participant withdrew consent|6|||
161046380|NCT02659059|581560565|FG001|Overall Study|Participant withdrew consent|1|||
161046381|NCT00092456|581560568|FG000|Overall Study|Adverse Event|0|||
161046382|NCT00092456|581560569|FG001|Overall Study|Adverse Event|0|||
161046383|NCT00092456|581560570|FG002|Overall Study|Adverse Event|1|||
161046384|NCT00092456|581560571|FG003|Overall Study|Adverse Event|1|||
161046385|NCT00092456|581560568|FG000|Overall Study|Lost to Follow-up|2|||
161046386|NCT00092456|581560569|FG001|Overall Study|Lost to Follow-up|2|||
161046387|NCT00092456|581560570|FG002|Overall Study|Lost to Follow-up|1|||
161046388|NCT00092456|581560571|FG003|Overall Study|Lost to Follow-up|2|||
161046389|NCT00092456|581560568|FG000|Overall Study|Protocol Violation|5|||
161046390|NCT00092456|581560569|FG001|Overall Study|Protocol Violation|7|||
161046391|NCT00092456|581560570|FG002|Overall Study|Protocol Violation|8|||
161046392|NCT00092456|581560571|FG003|Overall Study|Protocol Violation|6|||
161046393|NCT00092456|581560568|FG000|Overall Study|Withdrawal by Subject|13|||
161046394|NCT00092456|581560569|FG001|Overall Study|Withdrawal by Subject|5|||
161046395|NCT00092456|581560570|FG002|Overall Study|Withdrawal by Subject|16|||
161046396|NCT00092456|581560571|FG003|Overall Study|Withdrawal by Subject|6|||
161046397|NCT00092456|581560568|FG000|Overall Study|Moved|1|||
161046398|NCT00092456|581560569|FG001|Overall Study|Moved|1|||
161046399|NCT00092456|581560570|FG002|Overall Study|Moved|0|||
161046400|NCT00092456|581560571|FG003|Overall Study|Moved|1|||
161046401|NCT00092456|581560568|FG000|Overall Study|Other|4|||
161046402|NCT00092456|581560569|FG001|Overall Study|Other|2|||
161046403|NCT00092456|581560570|FG002|Overall Study|Other|3|||
161046404|NCT00092456|581560571|FG003|Overall Study|Other|0|||
161046405|NCT00215943|581560572|FG000|Overall Study|Disease Progression|3|||
161046406|NCT00215943|581560573|FG001|Overall Study|Disease Progression|5|||
161046407|NCT00215943|581560572|FG000|Overall Study|Alternate therapy|0|||
161046408|NCT00215943|581560573|FG001|Overall Study|Alternate therapy|1|||
161046409|NCT00215943|581560572|FG000|Overall Study|Adverse Event|3|||
161046410|NCT00215943|581560573|FG001|Overall Study|Adverse Event|6|||
161046411|NCT00215943|581560572|FG000|Overall Study|Other disease|0|||
161046412|NCT00215943|581560573|FG001|Overall Study|Other disease|1|||
161046413|NCT00215943|581560572|FG000|Overall Study|Other complications|3|||
161046414|NCT00215943|581560573|FG001|Overall Study|Other complications|1|||
161046415|NCT00443820|581560574|FG000|Overall Study|Adverse Event|1|||
161046416|NCT00443820|581560575|FG001|Overall Study|Adverse Event|1|||
161046417|NCT00443820|581560576|FG002|Overall Study|Adverse Event|0|||
161046418|NCT00443820|581560577|FG003|Overall Study|Adverse Event|0|||
161046419|NCT00443820|581560574|FG000|Overall Study|Lack of Efficacy|3|||
161046420|NCT00443820|581560575|FG001|Overall Study|Lack of Efficacy|2|||
161046421|NCT00443820|581560576|FG002|Overall Study|Lack of Efficacy|1|||
161046422|NCT00443820|581560577|FG003|Overall Study|Lack of Efficacy|1|||
161046423|NCT00443820|581560574|FG000|Overall Study|Protocol Violation|2|||
161046424|NCT00443820|581560575|FG001|Overall Study|Protocol Violation|1|||
161046425|NCT00443820|581560576|FG002|Overall Study|Protocol Violation|2|||
161046426|NCT00443820|581560577|FG003|Overall Study|Protocol Violation|1|||
161046427|NCT00443820|581560574|FG000|Overall Study|Withdrawal by Subject|6|||
161046428|NCT00443820|581560575|FG001|Overall Study|Withdrawal by Subject|7|||
161046429|NCT00443820|581560576|FG002|Overall Study|Withdrawal by Subject|8|||
161046430|NCT00443820|581560577|FG003|Overall Study|Withdrawal by Subject|9|||
161046431|NCT00443820|581560574|FG000|Overall Study|Lost to Follow-up|9|||
161046432|NCT00443820|581560575|FG001|Overall Study|Lost to Follow-up|8|||
161046433|NCT00443820|581560576|FG002|Overall Study|Lost to Follow-up|6|||
161046434|NCT00443820|581560577|FG003|Overall Study|Lost to Follow-up|5|||
161046435|NCT00443820|581560574|FG000|Overall Study|Administrative problems|0|||
161046436|NCT00443820|581560575|FG001|Overall Study|Administrative problems|0|||
161046437|NCT00443820|581560576|FG002|Overall Study|Administrative problems|0|||
161046438|NCT00443820|581560577|FG003|Overall Study|Administrative problems|1|||
161046439|NCT00443820|581560574|FG000|Overall Study|Death|0|||
161046440|NCT00443820|581560575|FG001|Overall Study|Death|0|||
161046441|NCT00443820|581560576|FG002|Overall Study|Death|1|||
161046442|NCT00443820|581560577|FG003|Overall Study|Death|0|||
161046443|NCT02121808|581560578|FG000|Overall Study|Technical problem|3|||
161046444|NCT03924193|581560579|FG000|Overall Study|Adverse Event|10|||
161046445|NCT03924193|581560580|FG001|Overall Study|Adverse Event|0|||
161046446|NCT03924193|581560581|FG002|Overall Study|Adverse Event|10|||
161046447|NCT03924193|581560579|FG000|Overall Study|Withdrawal by Subject|5|||
161046448|NCT03924193|581560580|FG001|Overall Study|Withdrawal by Subject|10|||
161046449|NCT03924193|581560581|FG002|Overall Study|Withdrawal by Subject|2|||
161046450|NCT01304940|581560591|FG000|Overall Study|not meet symptom severity requirement|3|||
161046451|NCT01304940|581560592|FG001|Overall Study|not meet symptom severity requirement|0|||
161046452|NCT00278395|581560593|FG000|Overall Study|Adverse Event|2|||
161150217|NCT02948777|581931818|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
161150218|NCT03242928|581931820|FG000|Overall Study|Adverse Event|2|||
161150219|NCT03242928|581931821|FG001|Overall Study|Adverse Event|1|||
161046453|NCT00278395|581560593|FG000|Overall Study|Nonevaluable|1|||
161046454|NCT03740737|581560594|FG000|Overall Study|Protocol deviation|13|||
161150220|NCT03242928|581931820|FG000|Overall Study|Lost to Follow-up|2|||
161150221|NCT03242928|581931821|FG001|Overall Study|Lost to Follow-up|0|||
161150222|NCT03242928|581931820|FG000|Overall Study|Physician Decision|0|||
161150223|NCT03242928|581931821|FG001|Overall Study|Physician Decision|1|||
161150224|NCT03242928|581931820|FG000|Overall Study|Withdrawal by Subject|5|||
161150225|NCT03242928|581931821|FG001|Overall Study|Withdrawal by Subject|3|||
161150226|NCT00625365|581931825|FG000|Overall Study|Withdrawal by Subject|1|||
161150227|NCT00625365|581931825|FG000|Overall Study|No IV access|5|||
161150228|NCT00625365|581931825|FG000|Overall Study|VSD|1|||
161150229|NCT01703286|581931827|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
161150230|NCT01703286|581931828|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
161150231|NCT01703286|581931829|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
161150232|NCT01703286|581931830|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
161150233|NCT01703286|581931831|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
161150234|NCT01703286|581931832|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
161150235|NCT01703286|581931827|FG000|Period 2 Including Washout|Adverse Event|0|||
161150236|NCT01703286|581931828|FG001|Period 2 Including Washout|Adverse Event|0|||
161150237|NCT01703286|581931829|FG002|Period 2 Including Washout|Adverse Event|0|||
161150238|NCT01703286|581931830|FG003|Period 2 Including Washout|Adverse Event|1|||
161150239|NCT01703286|581931831|FG004|Period 2 Including Washout|Adverse Event|0|||
161150240|NCT01703286|581931832|FG005|Period 2 Including Washout|Adverse Event|0|||
161150241|NCT00931892|581931833|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
161150242|NCT00931892|581931834|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
161150243|NCT02207530|581931837|FG000|Overall Study|Worsening condition under investigation|78|||
161150244|NCT02207530|581931837|FG000|Overall Study|Patient decision to stop study treatment|5|||
161344884|NCT04537299|582648829|FG000|Overall Study|Withdrawal by Subject|2|||
161344885|NCT04537299|582648830|FG001|Overall Study|Withdrawal by Subject|0|||
161344886|NCT04537299|582648829|FG000|Overall Study|Protocol Violation|1|||
161344887|NCT04537299|582648830|FG001|Overall Study|Protocol Violation|1|||
161344888|NCT00876343|582648831|FG000|Overall Study|Adverse Event|7|||
161344889|NCT00876343|582648832|FG001|Overall Study|Adverse Event|8|||
161344890|NCT00876343|582648833|FG002|Overall Study|Adverse Event|2|||
161344891|NCT00876343|582648831|FG000|Overall Study|Withdrawal by Subject|4|||
161046455|NCT03740737|581560595|FG001|Overall Study|Protocol deviation|0|||
161046456|NCT03740737|581560594|FG000|Overall Study|Adverse Event|2|||
161046457|NCT03740737|581560595|FG001|Overall Study|Adverse Event|0|||
161046458|NCT03740737|581560594|FG000|Overall Study|Lost to Follow-up|1|||
161046459|NCT03740737|581560595|FG001|Overall Study|Lost to Follow-up|0|||
161046460|NCT03740737|581560594|FG000|Overall Study|Randomization failure|1|||
161046461|NCT03740737|581560595|FG001|Overall Study|Randomization failure|0|||
161046462|NCT03740737|581560594|FG000|Overall Study|Participant withdrew consent|1|||
161046463|NCT03740737|581560595|FG001|Overall Study|Participant withdrew consent|0|||
161046464|NCT03740737|581560594|FG000|Overall Study|Participant withdrew from trial|2|||
161046465|NCT03740737|581560595|FG001|Overall Study|Participant withdrew from trial|1|||
161046466|NCT02753075|581560602|FG000|Overall Study|Adverse Event|2|||
161046467|NCT02753075|581560603|FG001|Overall Study|Adverse Event|1|||
161046468|NCT02753075|581560604|FG002|Overall Study|Adverse Event|0|||
161046469|NCT02753075|581560602|FG000|Overall Study|Lost to Follow-up|2|||
161046470|NCT02753075|581560603|FG001|Overall Study|Lost to Follow-up|0|||
161344892|NCT00876343|582648832|FG001|Overall Study|Withdrawal by Subject|4|||
161344893|NCT00876343|582648833|FG002|Overall Study|Withdrawal by Subject|3|||
161344894|NCT00876343|582648831|FG000|Overall Study|Lack of Efficacy|0|||
161344895|NCT00876343|582648832|FG001|Overall Study|Lack of Efficacy|0|||
161344896|NCT00876343|582648833|FG002|Overall Study|Lack of Efficacy|1|||
161344897|NCT00876343|582648831|FG000|Overall Study|Protocol Violation|4|||
161344898|NCT00876343|582648832|FG001|Overall Study|Protocol Violation|1|||
161344899|NCT00876343|582648833|FG002|Overall Study|Protocol Violation|1|||
161046471|NCT02753075|581560604|FG002|Overall Study|Lost to Follow-up|0|||
161046472|NCT02753075|581560602|FG000|Overall Study|Withdrawal of Consent|1|||
161046473|NCT02753075|581560603|FG001|Overall Study|Withdrawal of Consent|1|||
161046474|NCT02753075|581560604|FG002|Overall Study|Withdrawal of Consent|3|||
161046475|NCT02753075|581560602|FG000|Overall Study|Physician Decision|3|||
161046476|NCT02753075|581560603|FG001|Overall Study|Physician Decision|1|||
161046477|NCT02753075|581560604|FG002|Overall Study|Physician Decision|0|||
161150245|NCT02207530|581931837|FG000|Overall Study|Adverse Event|8|||
161150246|NCT03952468|581931846|FG000|Overall Study|Death|0|||
161150247|NCT03952468|581931847|FG001|Overall Study|Death|1|||
161150248|NCT03952468|581931846|FG000|Overall Study|Adverse Event|0|||
161150249|NCT03952468|581931847|FG001|Overall Study|Adverse Event|1|||
161150250|NCT03952468|581931846|FG000|Overall Study|Physician Decision|1|||
161344900|NCT00876343|582648831|FG000|Overall Study|Physician Decision|0|||
161344901|NCT00876343|582648832|FG001|Overall Study|Physician Decision|1|||
161344902|NCT00876343|582648833|FG002|Overall Study|Physician Decision|1|||
161344903|NCT00876343|582648831|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
161344904|NCT00876343|582648832|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
161344905|NCT00876343|582648833|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
161344906|NCT00876343|582648831|FG000|Overall Study|Change of residence or other commitments|2|||
161344907|NCT00876343|582648832|FG001|Overall Study|Change of residence or other commitments|2|||
161344908|NCT00876343|582648833|FG002|Overall Study|Change of residence or other commitments|3|||
161344909|NCT00924898|582648837|FG000|Overall Study|Withdrawal by Subject|2|||
161344910|NCT02278354|582648841|FG000|Overall Study|Lost to Follow-up|2|||
161344911|NCT02278354|582648842|FG001|Overall Study|Lost to Follow-up|2|||
161344912|NCT02278354|582648841|FG000|Overall Study|Withdrawal by Subject|0|||
161344913|NCT02278354|582648842|FG001|Overall Study|Withdrawal by Subject|1|||
161150251|NCT03952468|581931847|FG001|Overall Study|Physician Decision|0|||
161150252|NCT03952468|581931846|FG000|Overall Study|Lost to Follow-up|3|||
161150253|NCT03952468|581931847|FG001|Overall Study|Lost to Follow-up|4|||
161150254|NCT03952468|581931846|FG000|Overall Study|Withdrawal by Subject|2|||
161150255|NCT03952468|581931847|FG001|Overall Study|Withdrawal by Subject|1|||
161150256|NCT06094296|581931848|FG000|Overall Study|Progressive Disease|1|||
161150257|NCT06094296|581931849|FG001|Overall Study|Progressive Disease|0|||
161150258|NCT06094296|581931850|FG002|Overall Study|Progressive Disease|0|||
161150259|NCT06094296|581931851|FG003|Overall Study|Progressive Disease|0|||
161150260|NCT04964063|581931852|FG000|Overall Study|Adverse Event|4|||
161150261|NCT04964063|581931852|FG000|Overall Study|Lost to Follow-up|47|||
161150262|NCT04964063|581931852|FG000|Overall Study|Withdrawal by Subject|5|||
161150263|NCT04964063|581931852|FG000|Overall Study|Baseline Tasks Expired|41|||
161150264|NCT04964063|581931852|FG000|Overall Study|Participant withdrawn in error|1|||
161150265|NCT03350750|581931856|FG000|Overall Study|Death|1|||
161150266|NCT03350750|581931857|FG001|Overall Study|Death|1|||
161150267|NCT00406315|581931859|FG000|Overall Study|Death|1|||
161150268|NCT00406315|581931859|FG000|Overall Study|Adverse Event|39|||
161150269|NCT00406315|581931859|FG000|Overall Study|Laboratory Abnormality|4|||
161150270|NCT00406315|581931859|FG000|Overall Study|Lack of Efficacy|13|||
161150271|NCT00406315|581931859|FG000|Overall Study|Other|33|||
161150272|NCT00406315|581931859|FG000|Overall Study|Lost to Follow-up|21|||
161150273|NCT00406315|581931859|FG000|Overall Study|Withdrawal by Subject|30|||
161150274|NCT01797783|581931862|FG000|Overall Study|Adverse Event|1|||
161150275|NCT01797783|581931863|FG001|Overall Study|Adverse Event|1|||
161150276|NCT01797783|581931862|FG000|Overall Study|Withdrawal by Subject|1|||
161150277|NCT01797783|581931863|FG001|Overall Study|Withdrawal by Subject|0|||
161150278|NCT02202031|581931865|FG000|Overall Study|Lost to Follow-up|1|||
161150279|NCT02202031|581931866|FG001|Overall Study|Lost to Follow-up|0|||
161150280|NCT02202031|581931865|FG000|Overall Study|Too Busy|1|||
161150281|NCT02202031|581931866|FG001|Overall Study|Too Busy|3|||
161150282|NCT02202031|581931865|FG000|Overall Study|Illness/Medical Reason|0|||
161150283|NCT02202031|581931866|FG001|Overall Study|Illness/Medical Reason|2|||
161150284|NCT02202031|581931865|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
161150285|NCT02202031|581931866|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
161150286|NCT02184143|581931867|FG000|Overall Study|Withdrawal by Subject|4|||
161150287|NCT02184143|581931868|FG001|Overall Study|Withdrawal by Subject|4|||
161150288|NCT02184143|581931867|FG000|Overall Study|Lost to Follow-up|5|||
161150289|NCT02184143|581931868|FG001|Overall Study|Lost to Follow-up|3|||
161150290|NCT02184143|581931867|FG000|Overall Study|Death|1|||
161150291|NCT02184143|581931868|FG001|Overall Study|Death|0|||
161150292|NCT00321984|581931869|FG000|Overall Study|Adverse Event|9|||
161150293|NCT00321984|581931870|FG001|Overall Study|Adverse Event|6|||
161150294|NCT00321984|581931871|FG002|Overall Study|Adverse Event|8|||
161150295|NCT00321984|581931869|FG000|Overall Study|Protocol Violation|0|||
161150296|NCT00321984|581931870|FG001|Overall Study|Protocol Violation|1|||
161150297|NCT00321984|581931871|FG002|Overall Study|Protocol Violation|1|||
161150298|NCT00321984|581931869|FG000|Overall Study|Lost to Follow-up|2|||
161344914|NCT02278354|582648841|FG000|Overall Study|<10 professional fights|2|||
161344915|NCT02278354|582648842|FG001|Overall Study|<10 professional fights|0|||
161344916|NCT01901562|582648847|FG000|Overall Study|Protocol Violation|5|||
161150299|NCT00321984|581931870|FG001|Overall Study|Lost to Follow-up|4|||
161150300|NCT00321984|581931871|FG002|Overall Study|Lost to Follow-up|2|||
161150301|NCT00321984|581931869|FG000|Overall Study|Withdrawal by Subject|8|||
161150302|NCT00321984|581931870|FG001|Overall Study|Withdrawal by Subject|6|||
161150303|NCT00321984|581931871|FG002|Overall Study|Withdrawal by Subject|5|||
161150304|NCT00321984|581931869|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
161150305|NCT00321984|581931870|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
161150306|NCT00321984|581931871|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
161150307|NCT00321984|581931869|FG000|Overall Study|Lack of Efficacy|3|||
161150308|NCT00321984|581931870|FG001|Overall Study|Lack of Efficacy|1|||
161150309|NCT00321984|581931871|FG002|Overall Study|Lack of Efficacy|3|||
161150310|NCT00321984|581931869|FG000|Overall Study|Noncompliant|0|||
161150311|NCT00321984|581931870|FG001|Overall Study|Noncompliant|0|||
161150312|NCT00321984|581931871|FG002|Overall Study|Noncompliant|2|||
161046478|NCT00889863|581560605|FG000|Part I: Open Label|Death|1|||
161046479|NCT00889863|581560606|FG001|Part I: Open Label|Death|0|||
161046480|NCT00889863|581560605|FG000|Part I: Open Label|Adverse Event|4|||
161046481|NCT00889863|581560606|FG001|Part I: Open Label|Adverse Event|0|||
161046482|NCT00889863|581560605|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
161046483|NCT00889863|581560606|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
161046484|NCT00889863|581560605|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
161046485|NCT00889863|581560606|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
161046486|NCT00889863|581560605|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
161046487|NCT00889863|581560606|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
161046488|NCT00889863|581560605|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
161046489|NCT00889863|581560606|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
161046490|NCT00889863|581560605|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
161046491|NCT00889863|581560606|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
161046492|NCT03909100|581560607|FG000|Overall Study|Protocol Deviation|2|||
161046493|NCT03909100|581560607|FG000|Overall Study|Technical Problems|4|||
161046494|NCT03909100|581560607|FG000|Overall Study|Withdrawal by Subject|4|||
161046495|NCT03909100|581560607|FG000|Overall Study|Lost to Follow-up|1|||
161046496|NCT03909100|581560607|FG000|Overall Study|Reason not Specified|4|||
161046497|NCT01794299|581560609|FG000|Overall Study|ATIR manufacturing not possible|1|||
161046498|NCT01794299|581560609|FG000|Overall Study|Death|14|||
161046499|NCT01794299|581560609|FG000|Overall Study|Graft failure|1|||
161046500|NCT01794299|581560609|FG000|Overall Study|ATIR batch rejected|2|||
161046501|NCT01794299|581560609|FG000|Overall Study|Relapse|2|||
161046502|NCT01794299|581560609|FG000|Overall Study|Discontinued from active follow-up|1|||
161046503|NCT01794299|581560609|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
161046504|NCT03006393|581560610|FG000|Overall Study|Withdrawal by Subject|1|||
161046505|NCT03006393|581560611|FG001|Overall Study|Withdrawal by Subject|1|||
161046506|NCT03006393|581560610|FG000|Overall Study|Pregnancy|0|||
161046507|NCT03006393|581560611|FG001|Overall Study|Pregnancy|1|||
161046508|NCT03006393|581560610|FG000|Overall Study|Lost to Follow-up|0|||
161046509|NCT03006393|581560611|FG001|Overall Study|Lost to Follow-up|1|||
161046510|NCT00807599|581560614|FG000|Overall Study|Not treated on protocol study|0|||
161046511|NCT00807599|581560615|FG001|Overall Study|Not treated on protocol study|0|||
161046512|NCT00807599|581560616|FG002|Overall Study|Not treated on protocol study|2|||
161046513|NCT00807599|581560614|FG000|Overall Study|Adverse Event|0|||
161046514|NCT00807599|581560615|FG001|Overall Study|Adverse Event|0|||
161046515|NCT00807599|581560616|FG002|Overall Study|Adverse Event|5|||
161046516|NCT00807599|581560614|FG000|Overall Study|Inadequate response to induction|0|||
161046517|NCT00807599|581560615|FG001|Overall Study|Inadequate response to induction|0|||
161046518|NCT00807599|581560616|FG002|Overall Study|Inadequate response to induction|9|||
161046519|NCT00807599|581560614|FG000|Overall Study|Withdrawal by Subject|0|||
161046520|NCT00807599|581560615|FG001|Overall Study|Withdrawal by Subject|0|||
161046521|NCT00807599|581560616|FG002|Overall Study|Withdrawal by Subject|1|||
161046522|NCT03695185|581560617|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
161046523|NCT03695185|581560617|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
161046524|NCT03695185|581560617|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
161046525|NCT03695185|581560617|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
161046526|NCT03695185|581560617|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
161046527|NCT03695185|581560617|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
161046528|NCT01328756|581560621|FG000|Overall Study|Protocol Violation|4|||
161046529|NCT01328756|581560621|FG000|Overall Study|Adverse Event|39|||
161046530|NCT01328756|581560621|FG000|Overall Study|Lack of Efficacy|5|||
161046531|NCT01328756|581560621|FG000|Overall Study|Withdrawal by Subject|41|||
161046532|NCT01328756|581560621|FG000|Overall Study|Lost to Follow-up|5|||
161046533|NCT01328756|581560621|FG000|Overall Study|Other|29|||
161046534|NCT00274287|581560624|FG000|Overall Study|Withdrawal by Subject|1|||
161046535|NCT00274287|581560624|FG000|Overall Study|subject non-compliance|1|||
161046536|NCT04183491|581560628|FG000|Overall Study|Withdrawal by Subject|0|||
161046537|NCT04183491|581560629|FG001|Overall Study|Withdrawal by Subject|0|||
161046538|NCT04183491|581560630|FG002|Overall Study|Withdrawal by Subject|1|||
161046539|NCT04183491|581560631|FG003|Overall Study|Withdrawal by Subject|0|||
161046540|NCT04183491|581560632|FG004|Overall Study|Withdrawal by Subject|0|||
161046541|NCT04183491|581560633|FG005|Overall Study|Withdrawal by Subject|1|||
161046542|NCT04183491|581560634|FG006|Overall Study|Withdrawal by Subject|0|||
161046543|NCT02538094|581560635|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
161046544|NCT02538094|581560636|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
161046545|NCT02538094|581560635|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
161046546|NCT02538094|581560636|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
161046547|NCT03288506|581560637|FG000|Overall Study|Withdrawal by Subject|52|||
161046548|NCT03692871|581560638|FG000|Overall Study|Death|1|||
161046549|NCT03692871|581560639|FG001|Overall Study|Death|1|||
161046550|NCT03692871|581560638|FG000|Overall Study|Lost to Follow-up|24|||
161046551|NCT03692871|581560639|FG001|Overall Study|Lost to Follow-up|9|||
161150313|NCT00321984|581931869|FG000|Overall Study|Pregnancy|0|||
161150314|NCT00321984|581931870|FG001|Overall Study|Pregnancy|1|||
161150315|NCT00321984|581931871|FG002|Overall Study|Pregnancy|0|||
161150316|NCT00321984|581931869|FG000|Overall Study|Per Subject Request|1|||
161150317|NCT00321984|581931870|FG001|Overall Study|Per Subject Request|0|||
161150318|NCT00321984|581931871|FG002|Overall Study|Per Subject Request|0|||
161150319|NCT00321984|581931869|FG000|Overall Study|Per Investigator Request|1|||
161150320|NCT00321984|581931870|FG001|Overall Study|Per Investigator Request|0|||
161150321|NCT00321984|581931871|FG002|Overall Study|Per Investigator Request|0|||
161150322|NCT00321984|581931869|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
161150323|NCT00321984|581931870|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
161150324|NCT00321984|581931871|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
161150325|NCT01302769|581931872|FG000|Overall Study|Lost to Follow-up|1|||
161150326|NCT01302769|581931873|FG001|Overall Study|Lost to Follow-up|1|||
161150327|NCT00723840|581931876|FG000|Overall Study|Lost to Follow-up|2|||
161150328|NCT00723840|581931876|FG000|Overall Study|Failure to return|18|||
161046552|NCT03692871|581560638|FG000|Overall Study|Physician Decision|22|||
161046553|NCT03692871|581560639|FG001|Overall Study|Physician Decision|7|||
161046554|NCT03692871|581560638|FG000|Overall Study|Protocol Deviation|1|||
161046555|NCT03692871|581560639|FG001|Overall Study|Protocol Deviation|0|||
161046556|NCT03692871|581560638|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
161046557|NCT03692871|581560639|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
161046558|NCT02852824|581560643|FG000|Overall Study|Withdrawal by Subject|1|||
161046559|NCT02852824|581560644|FG001|Overall Study|Withdrawal by Subject|0|||
161046560|NCT02852824|581560645|FG002|Overall Study|Withdrawal by Subject|0|||
161046561|NCT02852824|581560646|FG003|Overall Study|Withdrawal by Subject|0|||
161046562|NCT02852824|581560647|FG004|Overall Study|Withdrawal by Subject|0|||
161046563|NCT02852824|581560648|FG005|Overall Study|Withdrawal by Subject|0|||
161046564|NCT02852824|581560649|FG006|Overall Study|Withdrawal by Subject|0|||
161046565|NCT02852824|581560643|FG000|Overall Study|Adverse Event|0|||
161046566|NCT02852824|581560644|FG001|Overall Study|Adverse Event|0|||
161046567|NCT02852824|581560645|FG002|Overall Study|Adverse Event|0|||
161046568|NCT02852824|581560646|FG003|Overall Study|Adverse Event|0|||
161046569|NCT02852824|581560647|FG004|Overall Study|Adverse Event|2|||
161046570|NCT02852824|581560648|FG005|Overall Study|Adverse Event|0|||
161046571|NCT02852824|581560649|FG006|Overall Study|Adverse Event|0|||
161046572|NCT01316913|581560650|FG000|Overall Study|Adverse Event|17|||
161046573|NCT01316913|581560651|FG001|Overall Study|Adverse Event|20|||
161046574|NCT01316913|581560652|FG002|Overall Study|Adverse Event|15|||
161046575|NCT01316913|581560653|FG003|Overall Study|Adverse Event|11|||
161046576|NCT01316913|581560650|FG000|Overall Study|Lack of Efficacy|22|||
161046577|NCT01316913|581560651|FG001|Overall Study|Lack of Efficacy|12|||
161046578|NCT01316913|581560652|FG002|Overall Study|Lack of Efficacy|9|||
161046579|NCT01316913|581560653|FG003|Overall Study|Lack of Efficacy|13|||
161046580|NCT01316913|581560650|FG000|Overall Study|Protocol Violation|1|||
161046581|NCT01316913|581560651|FG001|Overall Study|Protocol Violation|4|||
161046582|NCT01316913|581560652|FG002|Overall Study|Protocol Violation|4|||
161046583|NCT01316913|581560653|FG003|Overall Study|Protocol Violation|1|||
161046584|NCT01316913|581560650|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
161046585|NCT01316913|581560651|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
161046586|NCT01316913|581560652|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
161046587|NCT01316913|581560653|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
161046588|NCT01316913|581560650|FG000|Overall Study|Lost to Follow-up|0|||
161046589|NCT01316913|581560651|FG001|Overall Study|Lost to Follow-up|1|||
161046590|NCT01316913|581560652|FG002|Overall Study|Lost to Follow-up|0|||
161046591|NCT01316913|581560653|FG003|Overall Study|Lost to Follow-up|2|||
161046592|NCT01316913|581560650|FG000|Overall Study|Withdrawal by Subject|10|||
161046593|NCT01316913|581560651|FG001|Overall Study|Withdrawal by Subject|9|||
161046594|NCT01316913|581560652|FG002|Overall Study|Withdrawal by Subject|10|||
161046595|NCT01316913|581560653|FG003|Overall Study|Withdrawal by Subject|6|||
161150329|NCT00723840|581931876|FG000|Overall Study|Withdrawal by Subject|55|||
161344917|NCT01901562|582648847|FG000|Overall Study|Excluded intraoperatively|4|||
161344918|NCT01925794|582648848|FG000|180 Days|Death|2|||
161046596|NCT01860079|581560654|FG000|Overall Study|Physician Decision|14|||
161046597|NCT01860079|581560655|FG001|Overall Study|Physician Decision|22|||
161150330|NCT00723840|581931876|FG000|Overall Study|Serious Adverse Events|3|||
161344919|NCT01925794|582648848|FG000|180 Days|Withdrawal by Subject|2|||
161150331|NCT00723840|581931876|FG000|Overall Study|Other Medical Event|2|||
161150332|NCT00723840|581931876|FG000|Overall Study|Unspecified reason|2|||
161344920|NCT01925794|582648848|FG000|270 Days|Death|2|||
161046598|NCT02102724|581560656|FG000|Overall Study|Lost to Follow-up|1|||
161046599|NCT02102724|581560657|FG001|Overall Study|Lost to Follow-up|0|||
161046600|NCT02102724|581560656|FG000|Overall Study|surgery for brain aneurysm|1|||
161046601|NCT02102724|581560657|FG001|Overall Study|surgery for brain aneurysm|1|||
161046602|NCT02008916|581560658|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
161046603|NCT02008916|581560659|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
161046604|NCT02008916|581560660|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
161150333|NCT01426386|581931883|FG000|Overall Study|Adverse Event|0|||
161280749|NCT00996892|582407006|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
161046605|NCT02008916|581560658|FG000|Week 16 - 156|Adverse Event|4|||
161046606|NCT02008916|581560659|FG001|Week 16 - 156|Adverse Event|2|||
161046607|NCT02008916|581560660|FG002|Week 16 - 156|Adverse Event|3|||
161046608|NCT02008916|581560658|FG000|Week 16 - 156|Withdrawal by Subject|7|||
161046609|NCT02008916|581560659|FG001|Week 16 - 156|Withdrawal by Subject|3|||
161046610|NCT02008916|581560660|FG002|Week 16 - 156|Withdrawal by Subject|5|||
161046611|NCT02008916|581560658|FG000|Week 16 - 156|No longer requires treatment|0|||
161046612|NCT02008916|581560659|FG001|Week 16 - 156|No longer requires treatment|1|||
161046613|NCT02008916|581560660|FG002|Week 16 - 156|No longer requires treatment|0|||
161046614|NCT02008916|581560658|FG000|Week 16 - 156|Lost to Follow-up|5|||
161046615|NCT02008916|581560659|FG001|Week 16 - 156|Lost to Follow-up|0|||
161046616|NCT02008916|581560660|FG002|Week 16 - 156|Lost to Follow-up|0|||
161046617|NCT02008916|581560658|FG000|Week 16 - 156|Lack of Efficacy|3|||
161046618|NCT02008916|581560659|FG001|Week 16 - 156|Lack of Efficacy|5|||
161046619|NCT02008916|581560660|FG002|Week 16 - 156|Lack of Efficacy|2|||
161046620|NCT02008916|581560658|FG000|Week 16 - 156|Pregnancy|0|||
161046621|NCT02008916|581560659|FG001|Week 16 - 156|Pregnancy|1|||
161046622|NCT02008916|581560660|FG002|Week 16 - 156|Pregnancy|0|||
161046623|NCT02008916|581560658|FG000|Week 16 - 156|Physician Decision|0|||
161046624|NCT02008916|581560659|FG001|Week 16 - 156|Physician Decision|1|||
161046625|NCT02008916|581560660|FG002|Week 16 - 156|Physician Decision|0|||
161046626|NCT03803475|581560661|FG000|Overall Study|Physician Decision|1|||
161046627|NCT02915783|581560669|FG000|Overall Study|Death|21|||
161046628|NCT02915783|581560669|FG000|Overall Study|Lost to Follow-up|1|||
161046629|NCT02915783|581560669|FG000|Overall Study|Withdrawal by Subject|2|||
161046630|NCT02950961|581560670|FG000|Overall Study|Study had to stop due to COVID.|7|||
161046631|NCT01915914|581560671|FG000|Acute Phase|Withdrawal by Subject|4|||
161046632|NCT01915914|581560672|FG001|Acute Phase|Withdrawal by Subject|0|||
161046633|NCT01915914|581560673|FG002|Acute Phase|Withdrawal by Subject|0|||
161046634|NCT01915914|581560674|FG003|Acute Phase|Withdrawal by Subject|0|||
161046635|NCT01915914|581560671|FG000|Acute Phase|Lost to Follow-up|4|||
161046636|NCT01915914|581560672|FG001|Acute Phase|Lost to Follow-up|0|||
161046637|NCT01915914|581560673|FG002|Acute Phase|Lost to Follow-up|0|||
161046638|NCT01915914|581560674|FG003|Acute Phase|Lost to Follow-up|0|||
161046639|NCT01915914|581560671|FG000|Acute Phase|Physician Decision|1|||
161046640|NCT01915914|581560672|FG001|Acute Phase|Physician Decision|0|||
161046641|NCT01915914|581560673|FG002|Acute Phase|Physician Decision|0|||
161046642|NCT01915914|581560674|FG003|Acute Phase|Physician Decision|0|||
161046643|NCT01915914|581560671|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
161046644|NCT01915914|581560672|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
161046645|NCT01915914|581560673|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
161046646|NCT01915914|581560674|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
161046647|NCT01915914|581560671|FG000|Acute Phase|"Not Achieved treatment success"|1|||
161046648|NCT01915914|581560672|FG001|Acute Phase|"Not Achieved treatment success"|0|||
161046649|NCT01915914|581560673|FG002|Acute Phase|"Not Achieved treatment success"|0|||
161046650|NCT01915914|581560674|FG003|Acute Phase|"Not Achieved treatment success"|0|||
161046651|NCT01915914|581560671|FG000|Acute Phase|Missing|1|||
161046652|NCT01915914|581560672|FG001|Acute Phase|Missing|0|||
161046653|NCT01915914|581560673|FG002|Acute Phase|Missing|0|||
161046654|NCT01915914|581560674|FG003|Acute Phase|Missing|0|||
161046655|NCT01915914|581560671|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161046656|NCT01915914|581560672|FG001|Maintenance Phase|Withdrawal by Subject|1|||
161046657|NCT01915914|581560673|FG002|Maintenance Phase|Withdrawal by Subject|1|||
161046658|NCT01915914|581560674|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161046659|NCT01915914|581560671|FG000|Maintenance Phase|Lost to Follow-up|0|||
161046660|NCT01915914|581560672|FG001|Maintenance Phase|Lost to Follow-up|4|||
161046661|NCT01915914|581560673|FG002|Maintenance Phase|Lost to Follow-up|1|||
161046662|NCT01915914|581560674|FG003|Maintenance Phase|Lost to Follow-up|0|||
161046663|NCT01915914|581560671|FG000|Maintenance Phase|Missing|0|||
161046664|NCT01915914|581560672|FG001|Maintenance Phase|Missing|1|||
161046665|NCT01915914|581560673|FG002|Maintenance Phase|Missing|0|||
161046666|NCT01915914|581560674|FG003|Maintenance Phase|Missing|0|||
161046667|NCT01915914|581560671|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161046668|NCT01915914|581560672|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161046669|NCT01915914|581560673|FG002|Follow-up Phase|Withdrawal by Subject|0|||
161046670|NCT01915914|581560674|FG003|Follow-up Phase|Withdrawal by Subject|1|||
161046671|NCT01915914|581560671|FG000|Follow-up Phase|Physician Decision|0|||
161046672|NCT01915914|581560672|FG001|Follow-up Phase|Physician Decision|0|||
161046673|NCT01915914|581560673|FG002|Follow-up Phase|Physician Decision|0|||
161046674|NCT01915914|581560674|FG003|Follow-up Phase|Physician Decision|1|||
161150334|NCT01426386|581931884|FG001|Overall Study|Adverse Event|1|||
161046675|NCT02432274|581560676|FG000|Overall Study|Death|2|||
161046676|NCT02432274|581560677|FG001|Overall Study|Death|6|||
161046677|NCT02432274|581560678|FG002|Overall Study|Death|7|||
161046678|NCT02432274|581560679|FG003|Overall Study|Death|0|||
161046679|NCT02432274|581560680|FG004|Overall Study|Death|27|||
161046680|NCT02432274|581560681|FG005|Overall Study|Death|7|||
161046681|NCT02432274|581560682|FG006|Overall Study|Death|9|||
161046682|NCT02432274|581560683|FG007|Overall Study|Death|14|||
161046683|NCT02432274|581560676|FG000|Overall Study|Withdrawal of Consent|0|||
161046684|NCT02432274|581560677|FG001|Overall Study|Withdrawal of Consent|0|||
161046685|NCT02432274|581560678|FG002|Overall Study|Withdrawal of Consent|0|||
161046686|NCT02432274|581560679|FG003|Overall Study|Withdrawal of Consent|0|||
161046687|NCT02432274|581560680|FG004|Overall Study|Withdrawal of Consent|2|||
161046688|NCT02432274|581560681|FG005|Overall Study|Withdrawal of Consent|0|||
161046689|NCT02432274|581560682|FG006|Overall Study|Withdrawal of Consent|1|||
161046690|NCT02432274|581560683|FG007|Overall Study|Withdrawal of Consent|2|||
161046691|NCT02114515|581560684|FG000|Overall Study|Lost to Follow-up|52|||
161046692|NCT02114515|581560685|FG001|Overall Study|Lost to Follow-up|55|||
161046693|NCT02114515|581560684|FG000|Overall Study|Death|12|||
161046694|NCT02114515|581560685|FG001|Overall Study|Death|12|||
161046695|NCT02114515|581560684|FG000|Overall Study|Withdrawal by Subject|4|||
161046696|NCT02114515|581560685|FG001|Overall Study|Withdrawal by Subject|22|||
161046697|NCT02114515|581560684|FG000|Overall Study|Other|65|||
161046698|NCT02114515|581560685|FG001|Overall Study|Other|61|||
161046699|NCT04197713|581560686|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
161046700|NCT04197713|581560687|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
161046701|NCT05338476|581560697|FG000|Period 2|Adverse Event|0|||
161046702|NCT05338476|581560698|FG001|Period 2|Adverse Event|1|||
161046703|NCT00747149|581562139|FG000|Overall Study|Adverse Event|0|||
161046704|NCT00747149|581562140|FG001|Overall Study|Adverse Event|15|||
161046705|NCT00747149|581562139|FG000|Overall Study|Lost to Follow-up|0|||
161046706|NCT00747149|581562140|FG001|Overall Study|Lost to Follow-up|10|||
161046707|NCT00747149|581562139|FG000|Overall Study|Withdrawal by Subject|0|||
161046708|NCT00747149|581562140|FG001|Overall Study|Withdrawal by Subject|6|||
161046709|NCT00747149|581562139|FG000|Overall Study|Did not receive treatment|0|||
161046710|NCT00747149|581562140|FG001|Overall Study|Did not receive treatment|1|||
161046711|NCT00747149|581562139|FG000|Overall Study|Incorrect enrollment|0|||
161046712|NCT00747149|581562140|FG001|Overall Study|Incorrect enrollment|6|||
161046713|NCT00747149|581562139|FG000|Overall Study|Severe non-compliance to protocol|0|||
161046714|NCT00747149|581562140|FG001|Overall Study|Severe non-compliance to protocol|1|||
161046715|NCT00747149|581562139|FG000|Overall Study|Not reported|1|||
161046716|NCT00747149|581562140|FG001|Overall Study|Not reported|4|||
161046717|NCT05487300|581562145|FG000|Overall Study|Withdrawal by Subject|1|||
161046718|NCT05487300|581562146|FG001|Overall Study|Withdrawal by Subject|0|||
161046719|NCT02507297|581562147|FG000|Overall Study|Withdrawal by Subject|1|||
161046720|NCT02507297|581562148|FG001|Overall Study|Withdrawal by Subject|0|||
161046721|NCT02507297|581562147|FG000|Overall Study|Lost to Follow-up|0|||
161046722|NCT02507297|581562148|FG001|Overall Study|Lost to Follow-up|1|||
161046723|NCT01863368|581562149|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
161046724|NCT01863368|581562150|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
161046725|NCT01863368|581562149|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
161046726|NCT01863368|581562150|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
161046727|NCT01863368|581562149|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
161046728|NCT01863368|581562150|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
161046729|NCT01863368|581562149|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
161046730|NCT01863368|581562150|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
161046731|NCT01863368|581562149|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
161046732|NCT01863368|581562150|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
161046733|NCT01863368|581562149|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
161046734|NCT01863368|581562150|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
161046735|NCT00070707|581562151|FG000|Overall Study|Adverse Event|1|||
161046736|NCT00070707|581562152|FG001|Overall Study|Adverse Event|2|||
161046737|NCT00070707|581562151|FG000|Overall Study|Lack of Efficacy|4|||
161046738|NCT00070707|581562152|FG001|Overall Study|Lack of Efficacy|1|||
161046739|NCT00070707|581562151|FG000|Overall Study|Protocol Violation|8|||
161046740|NCT00070707|581562152|FG001|Overall Study|Protocol Violation|4|||
161046741|NCT00070707|581562151|FG000|Overall Study|Unrelated to Study Medication|1|||
161280750|NCT00996892|582407007|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
161046742|NCT00070707|581562152|FG001|Overall Study|Unrelated to Study Medication|0|||
161046743|NCT00647699|581562153|FG000|Overall Study|Lost to Follow-up|5|||
161150335|NCT01426386|581931885|FG002|Overall Study|Adverse Event|0|||
161150336|NCT01426386|581931886|FG003|Overall Study|Adverse Event|0|||
161280751|NCT00996892|582407008|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
161280752|NCT00996892|582407009|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
161046744|NCT00647699|581562154|FG001|Overall Study|Lost to Follow-up|4|||
161280753|NCT00996892|582407010|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
161046745|NCT00647699|581562153|FG000|Overall Study|Withdrawal by Subject|3|||
161046746|NCT00647699|581562154|FG001|Overall Study|Withdrawal by Subject|8|||
161046747|NCT02489799|581562155|FG000|Overall Study|Lost to Follow-up|4|||
161046748|NCT02489799|581562156|FG001|Overall Study|Lost to Follow-up|1|||
161046749|NCT02489799|581562155|FG000|Overall Study|Failure to Maintain Eligibility|4|||
161150337|NCT01426386|581931887|FG004|Overall Study|Adverse Event|0|||
161280754|NCT00996892|582407011|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
161280755|NCT00996892|582407012|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
161280756|NCT00996892|582407013|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
161280757|NCT00996892|582407014|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
161046750|NCT02489799|581562156|FG001|Overall Study|Failure to Maintain Eligibility|6|||
161046751|NCT02489799|581562155|FG000|Overall Study|Withdrawal by Subject|1|||
161046752|NCT02489799|581562156|FG001|Overall Study|Withdrawal by Subject|1|||
161046753|NCT02489799|581562155|FG000|Overall Study|Death|0|||
161046754|NCT02489799|581562156|FG001|Overall Study|Death|1|||
161046755|NCT00515112|581562158|FG000|Overall Study|Death|0|||
161046756|NCT00515112|581562159|FG001|Overall Study|Death|1|||
161046757|NCT00515112|581562158|FG000|Overall Study|The study was terminated|3|||
161046758|NCT00515112|581562159|FG001|Overall Study|The study was terminated|2|||
161046759|NCT01241448|581562160|FG000|Overall Study|Adverse Event|1|||
161046760|NCT01241448|581562161|FG001|Overall Study|Adverse Event|0|||
161046761|NCT01241448|581562162|FG002|Overall Study|Adverse Event|2|||
161046762|NCT01241448|581562163|FG003|Overall Study|Adverse Event|2|||
161046763|NCT01241448|581562160|FG000|Overall Study|Lost to Follow-up|2|||
161046764|NCT01241448|581562161|FG001|Overall Study|Lost to Follow-up|1|||
161046765|NCT01241448|581562162|FG002|Overall Study|Lost to Follow-up|1|||
161046766|NCT01241448|581562163|FG003|Overall Study|Lost to Follow-up|1|||
161046767|NCT01241448|581562160|FG000|Overall Study|Physician Decision|0|||
161046768|NCT01241448|581562161|FG001|Overall Study|Physician Decision|2|||
161046769|NCT01241448|581562162|FG002|Overall Study|Physician Decision|0|||
161046770|NCT01241448|581562163|FG003|Overall Study|Physician Decision|0|||
161046771|NCT01241448|581562160|FG000|Overall Study|Protocol Violation|10|||
161046772|NCT01241448|581562161|FG001|Overall Study|Protocol Violation|5|||
161046773|NCT01241448|581562162|FG002|Overall Study|Protocol Violation|3|||
161046774|NCT01241448|581562163|FG003|Overall Study|Protocol Violation|6|||
161046775|NCT01241448|581562160|FG000|Overall Study|Sponsor Decision|17|||
161046776|NCT01241448|581562161|FG001|Overall Study|Sponsor Decision|14|||
161046777|NCT01241448|581562162|FG002|Overall Study|Sponsor Decision|12|||
161046778|NCT01241448|581562163|FG003|Overall Study|Sponsor Decision|6|||
161046779|NCT01241448|581562160|FG000|Overall Study|Withdrawal by Subject|4|||
161046780|NCT01241448|581562161|FG001|Overall Study|Withdrawal by Subject|5|||
161046781|NCT01241448|581562162|FG002|Overall Study|Withdrawal by Subject|3|||
161046782|NCT01241448|581562163|FG003|Overall Study|Withdrawal by Subject|6|||
161046783|NCT01241448|581562160|FG000|Overall Study|Excluded due to data integrity issues|3|||
161046784|NCT01241448|581562161|FG001|Overall Study|Excluded due to data integrity issues|2|||
161046785|NCT01241448|581562162|FG002|Overall Study|Excluded due to data integrity issues|2|||
161046786|NCT01241448|581562163|FG003|Overall Study|Excluded due to data integrity issues|2|||
161046787|NCT00307489|581562164|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
161046788|NCT00307489|581562165|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
161046789|NCT00307489|581562164|FG000|Baseline Through Week 48|Physician Decision|1|||
161046790|NCT00307489|581562165|FG001|Baseline Through Week 48|Physician Decision|0|||
161046791|NCT00307489|581562164|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
161046792|NCT00307489|581562165|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
161046793|NCT00307489|581562164|FG000|Week 48 Through Week 168|Adverse Event|1|||
161046794|NCT00307489|581562165|FG001|Week 48 Through Week 168|Adverse Event|0|||
161046795|NCT00307489|581562164|FG000|Week 48 Through Week 168|Physician Decision|1|||
161046796|NCT00307489|581562165|FG001|Week 48 Through Week 168|Physician Decision|0|||
161046797|NCT00307489|581562164|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
161046798|NCT00307489|581562165|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
161046799|NCT00307489|581562164|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
161046800|NCT00307489|581562165|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
161046801|NCT00307489|581562164|FG000|Week 48 Through Week 168|Death|0|||
161046802|NCT00307489|581562165|FG001|Week 48 Through Week 168|Death|1|||
161046803|NCT00307489|581562164|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
161046804|NCT00307489|581562165|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
161046805|NCT00307489|581562164|FG000|Week 48 Through Week 168|Seroconversion|1|||
161046806|NCT00307489|581562165|FG001|Week 48 Through Week 168|Seroconversion|0|||
161046807|NCT00304278|581562168|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
161046808|NCT00304278|581562168|FG000|Overall Study|PT had medical condition preventing TX|1|||
161046809|NCT02065895|581562171|FG000|Overall Study|Protocol Violation|1|||
161046810|NCT02065895|581562172|FG001|Overall Study|Protocol Violation|0|||
161046811|NCT02065895|581562173|FG002|Overall Study|Protocol Violation|0|||
161046812|NCT02065895|581562174|FG003|Overall Study|Protocol Violation|1|||
161046813|NCT02065895|581562175|FG004|Overall Study|Protocol Violation|0|||
161046814|NCT02065895|581562176|FG005|Overall Study|Protocol Violation|0|||
161046815|NCT02065895|581562171|FG000|Overall Study|Scheduling conflicts|0|||
161046816|NCT02065895|581562172|FG001|Overall Study|Scheduling conflicts|1|||
161046817|NCT02065895|581562173|FG002|Overall Study|Scheduling conflicts|0|||
161046818|NCT02065895|581562174|FG003|Overall Study|Scheduling conflicts|0|||
161046819|NCT02065895|581562175|FG004|Overall Study|Scheduling conflicts|0|||
161280758|NCT00996892|582407015|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
161046820|NCT02065895|581562176|FG005|Overall Study|Scheduling conflicts|0|||
161150338|NCT01426386|581931888|FG005|Overall Study|Adverse Event|0|||
161046821|NCT03340961|581562182|FG000|Overall Study|Adverse Event|1|||
161046822|NCT03340961|581562183|FG001|Overall Study|Adverse Event|3|||
161046823|NCT03340961|581562184|FG002|Overall Study|Adverse Event|2|||
161046824|NCT03340961|581562185|FG003|Overall Study|Adverse Event|4|||
161046825|NCT03340961|581562182|FG000|Overall Study|Lost to Follow-up|0|||
161046826|NCT03340961|581562183|FG001|Overall Study|Lost to Follow-up|1|||
161046827|NCT03340961|581562184|FG002|Overall Study|Lost to Follow-up|0|||
161046828|NCT03340961|581562185|FG003|Overall Study|Lost to Follow-up|1|||
161046829|NCT03340961|581562182|FG000|Overall Study|Withdrawal by Subject|3|||
161046830|NCT03340961|581562183|FG001|Overall Study|Withdrawal by Subject|2|||
161046831|NCT03340961|581562184|FG002|Overall Study|Withdrawal by Subject|4|||
161046832|NCT03340961|581562185|FG003|Overall Study|Withdrawal by Subject|7|||
161046833|NCT03340961|581562182|FG000|Overall Study|Use of prohibited treatment|0|||
161046834|NCT03340961|581562183|FG001|Overall Study|Use of prohibited treatment|3|||
161046835|NCT03340961|581562184|FG002|Overall Study|Use of prohibited treatment|2|||
161046836|NCT03340961|581562185|FG003|Overall Study|Use of prohibited treatment|4|||
161046837|NCT03340961|581562182|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
161046838|NCT03340961|581562183|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
161046839|NCT03340961|581562184|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
161046840|NCT03340961|581562185|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
161046841|NCT03340961|581562182|FG000|Overall Study|Subject developed an exclusion criterion|0|||
161046842|NCT03340961|581562183|FG001|Overall Study|Subject developed an exclusion criterion|1|||
161046843|NCT03340961|581562184|FG002|Overall Study|Subject developed an exclusion criterion|0|||
161046844|NCT03340961|581562185|FG003|Overall Study|Subject developed an exclusion criterion|0|||
161046845|NCT03340961|581562182|FG000|Overall Study|Protocol Violation|1|||
161046846|NCT03340961|581562183|FG001|Overall Study|Protocol Violation|0|||
161046847|NCT03340961|581562184|FG002|Overall Study|Protocol Violation|1|||
161046848|NCT03340961|581562185|FG003|Overall Study|Protocol Violation|0|||
161046849|NCT03340961|581562182|FG000|Overall Study|Adverse Event|1|||
161046850|NCT03340961|581562183|FG001|Overall Study|Adverse Event|1|||
161046851|NCT03340961|581562184|FG002|Overall Study|Adverse Event|0|||
161046852|NCT03340961|581562185|FG003|Overall Study|Adverse Event|0|||
161046853|NCT03340961|581562182|FG000|Overall Study|Lack of Efficacy|0|||
161046854|NCT03340961|581562183|FG001|Overall Study|Lack of Efficacy|0|||
161046855|NCT03340961|581562184|FG002|Overall Study|Lack of Efficacy|0|||
161046856|NCT03340961|581562185|FG003|Overall Study|Lack of Efficacy|1|||
161046857|NCT03137784|581562188|FG000|Overall Study|Adverse Event|1|||
161046858|NCT03137784|581562189|FG001|Overall Study|Adverse Event|1|||
161046859|NCT03137784|581562190|FG002|Overall Study|Adverse Event|0|||
161046860|NCT03137784|581562191|FG003|Overall Study|Adverse Event|0|||
161046861|NCT03137784|581562192|FG004|Overall Study|Adverse Event|0|||
161046862|NCT03137784|581562193|FG005|Overall Study|Adverse Event|0|||
161046863|NCT03137784|581562188|FG000|Overall Study|Subject/guardian decision|1|||
161046864|NCT03137784|581562189|FG001|Overall Study|Subject/guardian decision|0|||
161046865|NCT03137784|581562190|FG002|Overall Study|Subject/guardian decision|0|||
161046866|NCT03137784|581562191|FG003|Overall Study|Subject/guardian decision|0|||
161046867|NCT03137784|581562192|FG004|Overall Study|Subject/guardian decision|0|||
161046868|NCT03137784|581562193|FG005|Overall Study|Subject/guardian decision|0|||
161046869|NCT03137784|581562188|FG000|Overall Study|Non-compliance with study treatment|0|||
161046870|NCT03137784|581562189|FG001|Overall Study|Non-compliance with study treatment|0|||
161046871|NCT03137784|581562190|FG002|Overall Study|Non-compliance with study treatment|0|||
161046872|NCT03137784|581562191|FG003|Overall Study|Non-compliance with study treatment|0|||
161046873|NCT03137784|581562192|FG004|Overall Study|Non-compliance with study treatment|1|||
161046874|NCT03137784|581562193|FG005|Overall Study|Non-compliance with study treatment|0|||
161046875|NCT04803734|581562199|FG000|Overall Study|Withdrawal by Subject|0|||
161150339|NCT01426386|581931883|FG000|Overall Study|Did not attend scheduled visit|1|||
161150340|NCT01426386|581931884|FG001|Overall Study|Did not attend scheduled visit|4|||
161150341|NCT01426386|581931885|FG002|Overall Study|Did not attend scheduled visit|0|||
161150342|NCT01426386|581931886|FG003|Overall Study|Did not attend scheduled visit|0|||
161150343|NCT01426386|581931887|FG004|Overall Study|Did not attend scheduled visit|2|||
161046876|NCT04803734|581562200|FG001|Overall Study|Withdrawal by Subject|1|||
161046877|NCT04803734|581562199|FG000|Overall Study|Protocol Violation|0|||
161046878|NCT04803734|581562200|FG001|Overall Study|Protocol Violation|1|||
161046879|NCT02152384|581562208|FG000|Period 1|Withdrawal by Subject|0|||
161046880|NCT02152384|581562209|FG001|Period 1|Withdrawal by Subject|1|||
161046881|NCT02152384|581562208|FG000|Period 1|Adverse Event|1|||
161046882|NCT02152384|581562209|FG001|Period 1|Adverse Event|1|||
161046883|NCT01393600|581562211|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
161046884|NCT01393600|581562212|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
161046885|NCT01393600|581562213|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
161046886|NCT01393600|581562214|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
161046887|NCT01393600|581562211|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
161150344|NCT01426386|581931888|FG005|Overall Study|Did not attend scheduled visit|1|||
161150345|NCT01426386|581931883|FG000|Overall Study|Poor response|2|||
161344921|NCT01925794|582648848|FG000|270 Days|Protocol Violation|3|||
161046888|NCT01393600|581562212|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
161046889|NCT01393600|581562213|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
161046890|NCT01393600|581562214|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
161046891|NCT01393600|581562211|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161046892|NCT01393600|581562212|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161046893|NCT01393600|581562213|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
161046894|NCT01393600|581562214|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
161046895|NCT01393600|581562211|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
161046896|NCT01393600|581562212|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
161046897|NCT01393600|581562213|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
161046898|NCT01393600|581562214|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
161046899|NCT01393600|581562211|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
161046900|NCT01393600|581562212|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
161046901|NCT01393600|581562213|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
161046902|NCT01393600|581562214|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
161046903|NCT01393600|581562211|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
161046904|NCT01393600|581562212|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
161046905|NCT01393600|581562213|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
161046906|NCT01393600|581562214|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
161046907|NCT01393600|581562211|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
161046908|NCT01393600|581562212|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
161046909|NCT01393600|581562213|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
161046910|NCT01393600|581562214|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
161046911|NCT00603798|581562215|FG000|Overall Study|Adverse Event|4|||
161046912|NCT00603798|581562216|FG001|Overall Study|Adverse Event|2|||
161046913|NCT00603798|581562217|FG002|Overall Study|Adverse Event|1|||
161046914|NCT00603798|581562215|FG000|Overall Study|Withdrawal by Subject|4|||
161046915|NCT00603798|581562216|FG001|Overall Study|Withdrawal by Subject|3|||
161046916|NCT00603798|581562217|FG002|Overall Study|Withdrawal by Subject|4|||
161046917|NCT00603798|581562215|FG000|Overall Study|Lost to Follow-up|1|||
161046918|NCT00603798|581562216|FG001|Overall Study|Lost to Follow-up|0|||
161046919|NCT00603798|581562217|FG002|Overall Study|Lost to Follow-up|1|||
161046920|NCT00603798|581562215|FG000|Overall Study|Non-compliance with study procedures|0|||
161046921|NCT00603798|581562216|FG001|Overall Study|Non-compliance with study procedures|1|||
161046922|NCT00603798|581562217|FG002|Overall Study|Non-compliance with study procedures|0|||
161046923|NCT00603798|581562215|FG000|Overall Study|Not due to AE|1|||
161046924|NCT00603798|581562216|FG001|Overall Study|Not due to AE|1|||
161046925|NCT00603798|581562217|FG002|Overall Study|Not due to AE|4|||
161046926|NCT02964234|581562223|FG000|Overall Study|Lost to Follow-up|22|||
161046927|NCT02964234|581562224|FG001|Overall Study|Lost to Follow-up|13|||
161046928|NCT01799993|581562225|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
161046929|NCT01799993|581562226|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
161046930|NCT01799993|581562225|FG000|Overall Study|Death|61|||
161046931|NCT01799993|581562226|FG001|Overall Study|Death|45|||
161046932|NCT01799993|581562225|FG000|Overall Study|Withdrawal by Subject|23|||
161046933|NCT01799993|581562226|FG001|Overall Study|Withdrawal by Subject|24|||
161046934|NCT01799993|581562225|FG000|Overall Study|Lost to Follow-up|5|||
161344922|NCT03126110|582648849|FG000|Phase 1|Death|2|||
161344923|NCT03126110|582648850|FG001|Phase 1|Death|2|||
161344924|NCT03126110|582648851|FG002|Phase 1|Death|4|||
161344925|NCT03126110|582648852|FG003|Phase 1|Death|3|||
161344926|NCT03126110|582648853|FG004|Phase 1|Death|4|||
161344927|NCT03126110|582648854|FG005|Phase 1|Death|4|||
161344928|NCT03126110|582648855|FG006|Phase 1|Death|3|||
161344929|NCT03126110|582648856|FG007|Phase 1|Death|4|||
161344930|NCT03126110|582648857|FG008|Phase 1|Death|5|||
161344931|NCT03126110|582648858|FG009|Phase 1|Death|2|||
161344932|NCT03126110|582648859|FG010|Phase 1|Death|6|||
161344933|NCT03126110|582648860|FG011|Phase 1|Death|0|||
161344934|NCT03126110|582648861|FG012|Phase 1|Death|0|||
161344935|NCT03126110|582648862|FG013|Phase 1|Death|0|||
161344936|NCT03126110|582648863|FG014|Phase 1|Death|0|||
161344937|NCT03126110|582648864|FG015|Phase 1|Death|0|||
161046935|NCT01799993|581562226|FG001|Overall Study|Lost to Follow-up|8|||
161046936|NCT01799993|581562225|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
161046937|NCT01799993|581562226|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
161344938|NCT03126110|582648865|FG016|Phase 1|Death|0|||
161046938|NCT01799993|581562225|FG000|Overall Study|Protocol driven decision point|0|||
161344939|NCT03126110|582648849|FG000|Phase 1|Lost to Follow-up|0|||
161344940|NCT03126110|582648850|FG001|Phase 1|Lost to Follow-up|1|||
161344941|NCT03126110|582648851|FG002|Phase 1|Lost to Follow-up|0|||
161344942|NCT03126110|582648852|FG003|Phase 1|Lost to Follow-up|0|||
161344943|NCT03126110|582648853|FG004|Phase 1|Lost to Follow-up|0|||
161344944|NCT03126110|582648854|FG005|Phase 1|Lost to Follow-up|0|||
161344945|NCT03126110|582648855|FG006|Phase 1|Lost to Follow-up|0|||
161344946|NCT03126110|582648856|FG007|Phase 1|Lost to Follow-up|0|||
161344947|NCT03126110|582648857|FG008|Phase 1|Lost to Follow-up|1|||
161046939|NCT01799993|581562226|FG001|Overall Study|Protocol driven decision point|3|||
161046940|NCT01799993|581562225|FG000|Overall Study|Protocol Violation|1|||
161046941|NCT01799993|581562226|FG001|Overall Study|Protocol Violation|1|||
161046942|NCT01799993|581562225|FG000|Overall Study|Deterioration of general conditions|2|||
161046943|NCT01799993|581562226|FG001|Overall Study|Deterioration of general conditions|0|||
161046944|NCT01799993|581562225|FG000|Overall Study|Screen failure|0|||
161046945|NCT01799993|581562226|FG001|Overall Study|Screen failure|1|||
161046946|NCT01799993|581562225|FG000|Overall Study|Adverse Event|1|||
161046947|NCT01799993|581562226|FG001|Overall Study|Adverse Event|0|||
161046948|NCT01799993|581562225|FG000|Overall Study|Lack of Efficacy|1|||
161046949|NCT01799993|581562226|FG001|Overall Study|Lack of Efficacy|0|||
161046950|NCT01799993|581562225|FG000|Overall Study|Recovery|0|||
161046951|NCT01799993|581562226|FG001|Overall Study|Recovery|1|||
161046952|NCT01799993|581562225|FG000|Overall Study|Logistical difficulties|1|||
161046953|NCT01799993|581562226|FG001|Overall Study|Logistical difficulties|0|||
161046954|NCT01799993|581562225|FG000|Overall Study|Protocol deviation|1|||
161046955|NCT01799993|581562226|FG001|Overall Study|Protocol deviation|0|||
161046956|NCT01799993|581562225|FG000|Overall Study|Non-compliance with medical device|1|||
161046957|NCT01799993|581562226|FG001|Overall Study|Non-compliance with medical device|0|||
161046958|NCT01799993|581562225|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161046959|NCT01799993|581562226|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161046960|NCT01799993|581562225|FG000|Overall Study|Other|1|||
161046961|NCT01799993|581562226|FG001|Overall Study|Other|0|||
161046962|NCT01799993|581562225|FG000|Overall Study|Subject didn't return for follow-up|0|||
161046963|NCT01799993|581562226|FG001|Overall Study|Subject didn't return for follow-up|1|||
161046964|NCT04361617|581562227|FG000|Overall Study|Withdrawal by Subject|0|||
161046965|NCT04361617|581562228|FG001|Overall Study|Withdrawal by Subject|1|||
161046966|NCT01263223|581562229|FG000|Period 2|Withdrawal by Subject|0|||
161046967|NCT01263223|581562230|FG001|Period 2|Withdrawal by Subject|1|||
161046968|NCT01263223|581562229|FG000|7-day Follow-up|Withdrawal by Subject|0|||
161046969|NCT01263223|581562230|FG001|7-day Follow-up|Withdrawal by Subject|1|||
161046970|NCT01263223|581562229|FG000|7-day Follow-up|Lost to Follow-up|1|||
161046971|NCT01263223|581562230|FG001|7-day Follow-up|Lost to Follow-up|0|||
161046972|NCT02246647|581562231|FG000|Overall Study|Withdrawal by Subject|1|||
161046973|NCT02246647|581562232|FG001|Overall Study|Withdrawal by Subject|1|||
161046974|NCT01113541|581562234|FG000|Overall Study|Withdrawal by Subject|1|||
161046975|NCT01113541|581562234|FG000|Overall Study|Protocol Violation|1|||
161046976|NCT01113541|581562234|FG000|Overall Study|Study Terminated by Sponsor|7|||
161046977|NCT01113541|581562234|FG000|Overall Study|Adverse Event|4|||
161046978|NCT01918033|581562238|FG000|Overall Study|Adverse Event|1|||
161046979|NCT01918033|581562239|FG001|Overall Study|Adverse Event|0|||
161046980|NCT01918033|581562240|FG002|Overall Study|Adverse Event|2|||
161046981|NCT01918033|581562238|FG000|Overall Study|Lost to Follow-up|0|||
161046982|NCT01918033|581562239|FG001|Overall Study|Lost to Follow-up|1|||
161046983|NCT01918033|581562240|FG002|Overall Study|Lost to Follow-up|0|||
161046984|NCT01918033|581562238|FG000|Overall Study|Protocol Violation|2|||
161046985|NCT01918033|581562239|FG001|Overall Study|Protocol Violation|0|||
161046986|NCT01918033|581562240|FG002|Overall Study|Protocol Violation|1|||
161046987|NCT01918033|581562238|FG000|Overall Study|Withdrawal by Subject|2|||
161046988|NCT01918033|581562239|FG001|Overall Study|Withdrawal by Subject|1|||
161046989|NCT01918033|581562240|FG002|Overall Study|Withdrawal by Subject|0|||
161046990|NCT04679675|581562241|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
161046991|NCT04679675|581562242|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
161046992|NCT04679675|581562243|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
161046993|NCT04679675|581562244|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
161046994|NCT04679675|581562241|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
161046995|NCT04679675|581562242|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
161046996|NCT04679675|581562243|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
161046997|NCT04679675|581562244|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
161046998|NCT00687297|581562252|FG000|Randomization|Withdrawal by Subject|2|||
161046999|NCT00687297|581562253|FG001|Randomization|Withdrawal by Subject|0|||
161150346|NCT01426386|581931884|FG001|Overall Study|Poor response|1|||
161150347|NCT01426386|581931885|FG002|Overall Study|Poor response|2|||
161047000|NCT00687297|581562252|FG000|Randomization|Withdrew before treatment, ineligible|1|||
161047001|NCT00687297|581562253|FG001|Randomization|Withdrew before treatment, ineligible|1|||
161047002|NCT00687297|581562252|FG000|Induction|Withdrawal by Subject|4|||
161047003|NCT00687297|581562253|FG001|Induction|Withdrawal by Subject|4|||
161047004|NCT00687297|581562252|FG000|Induction|Adverse Event|16|||
161047005|NCT00687297|581562253|FG001|Induction|Adverse Event|15|||
161047006|NCT00687297|581562252|FG000|Induction|Death|7|||
161047007|NCT00687297|581562253|FG001|Induction|Death|11|||
161047008|NCT00687297|581562252|FG000|Induction|Lack of Efficacy|17|||
161047009|NCT00687297|581562253|FG001|Induction|Lack of Efficacy|21|||
161047010|NCT00687297|581562252|FG000|Induction|Ineligible|0|||
161150348|NCT01426386|581931886|FG003|Overall Study|Poor response|0|||
161047011|NCT00687297|581562253|FG001|Induction|Ineligible|1|||
161047012|NCT00687297|581562252|FG000|Induction|Patient Noncompliance|1|||
161047013|NCT00687297|581562253|FG001|Induction|Patient Noncompliance|0|||
161047014|NCT00687297|581562252|FG000|Induction|Physician Decision|0|||
161047015|NCT00687297|581562253|FG001|Induction|Physician Decision|2|||
161047016|NCT00687297|581562252|FG000|Induction|Other|0|||
161047017|NCT00687297|581562253|FG001|Induction|Other|1|||
161047018|NCT02525744|581562256|FG000|Period 1|Physician Decision|0|||
161047019|NCT02525744|581562257|FG001|Period 1|Physician Decision|0|||
161047020|NCT02525744|581562258|FG002|Period 1|Physician Decision|1|||
161047021|NCT02525744|581562259|FG003|Period 1|Physician Decision|0|||
161047022|NCT02525744|581562256|FG000|Period 3|Adverse Event|0|||
161047023|NCT02525744|581562257|FG001|Period 3|Adverse Event|1|||
161047024|NCT02525744|581562258|FG002|Period 3|Adverse Event|0|||
161047025|NCT02525744|581562259|FG003|Period 3|Adverse Event|0|||
161047026|NCT02525744|581562256|FG000|Period 4|Withdrawal by Subject|1|||
161047027|NCT02525744|581562257|FG001|Period 4|Withdrawal by Subject|0|||
161047028|NCT02525744|581562258|FG002|Period 4|Withdrawal by Subject|0|||
161047029|NCT02525744|581562259|FG003|Period 4|Withdrawal by Subject|0|||
161047030|NCT02525744|581562256|FG000|Period 5|Physician Decision|1|||
161047031|NCT02525744|581562257|FG001|Period 5|Physician Decision|0|||
161047032|NCT02525744|581562258|FG002|Period 5|Physician Decision|0|||
161047033|NCT02525744|581562259|FG003|Period 5|Physician Decision|0|||
161047034|NCT01182285|581562260|FG000|First Intervention Week 1-10|Disease progression|1|||
161047035|NCT01182285|581562261|FG001|First Intervention Week 1-10|Disease progression|0|||
161047036|NCT01182285|581562262|FG002|First Intervention Week 1-10|Disease progression|0|||
161047037|NCT01182285|581562260|FG000|First Intervention Week 1-10|Adverse Event|1|||
161047038|NCT01182285|581562261|FG001|First Intervention Week 1-10|Adverse Event|0|||
161047039|NCT01182285|581562262|FG002|First Intervention Week 1-10|Adverse Event|0|||
161047040|NCT01182285|581562260|FG000|First Intervention Week 1-10|Non-compliance|1|||
161047041|NCT01182285|581562261|FG001|First Intervention Week 1-10|Non-compliance|0|||
161047042|NCT01182285|581562262|FG002|First Intervention Week 1-10|Non-compliance|0|||
161047043|NCT01182285|581562260|FG000|Third Intervention Week 11-52|Disease Progression|0|||
161047044|NCT01182285|581562261|FG001|Third Intervention Week 11-52|Disease Progression|0|||
161047045|NCT01182285|581562262|FG002|Third Intervention Week 11-52|Disease Progression|6|||
161047046|NCT01182285|581562260|FG000|Third Intervention Week 11-52|Other|0|||
161047047|NCT01182285|581562261|FG001|Third Intervention Week 11-52|Other|0|||
161047048|NCT01182285|581562262|FG002|Third Intervention Week 11-52|Other|2|||
161047049|NCT00472082|581562263|FG000|Overall Study|Study prematurely terminated|5|||
161047050|NCT02069379|581562264|FG000|Baseline Measurements|Lost to Follow-up|1|||
161047051|NCT02069379|581562265|FG001|Baseline Measurements|Lost to Follow-up|0|||
161047052|NCT02069379|581562266|FG002|Baseline Measurements|Lost to Follow-up|0|||
161047053|NCT02069379|581562267|FG003|Baseline Measurements|Lost to Follow-up|0|||
161047054|NCT02069379|581562264|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
161047055|NCT02069379|581562265|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
161047056|NCT02069379|581562266|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
161047057|NCT02069379|581562267|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
161047058|NCT02069379|581562264|FG000|First Treatment Arm|Lost to Follow-up|0|||
161047059|NCT02069379|581562265|FG001|First Treatment Arm|Lost to Follow-up|1|||
161047060|NCT02069379|581562266|FG002|First Treatment Arm|Lost to Follow-up|1|||
161047061|NCT02069379|581562267|FG003|First Treatment Arm|Lost to Follow-up|0|||
161047062|NCT02069379|581562264|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
161047063|NCT02069379|581562265|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
161047064|NCT02069379|581562266|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
161047065|NCT02069379|581562267|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
161047066|NCT02069379|581562264|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
161047067|NCT02069379|581562265|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
161047068|NCT02069379|581562266|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
161047069|NCT02069379|581562267|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
161047070|NCT02069379|581562264|FG000|Second Treatment Arm|Lost to Follow-up|0|||
161047071|NCT02069379|581562265|FG001|Second Treatment Arm|Lost to Follow-up|0|||
161047072|NCT02069379|581562266|FG002|Second Treatment Arm|Lost to Follow-up|1|||
161047073|NCT02069379|581562267|FG003|Second Treatment Arm|Lost to Follow-up|0|||
161047074|NCT04617847|581562270|FG000|Overall Study|Withdrawal by Subject|1|||
161047075|NCT04617847|581562271|FG001|Overall Study|Withdrawal by Subject|0|||
161047076|NCT04617847|581562270|FG000|Overall Study|Adverse Event|0|||
161047077|NCT04617847|581562271|FG001|Overall Study|Adverse Event|2|||
161047078|NCT04617847|581562270|FG000|Overall Study|Death|0|||
161047079|NCT04617847|581562271|FG001|Overall Study|Death|1|||
161047080|NCT04617847|581562270|FG000|Overall Study|Termination of Study by Sponsor|2|||
161047081|NCT04617847|581562271|FG001|Overall Study|Termination of Study by Sponsor|21|||
161047082|NCT01525875|581562272|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
161047083|NCT01525875|581562273|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
161047084|NCT01525875|581562272|FG000|Open-label Period|Lost to Follow-up|0|||
161047085|NCT01525875|581562273|FG001|Open-label Period|Lost to Follow-up|2|||
161047086|NCT00700999|581562274|FG000|Overall Study|Lost to Follow-up|7|||
161344948|NCT03126110|582648858|FG009|Phase 1|Lost to Follow-up|0|||
161047087|NCT00700999|581562275|FG001|Overall Study|Lost to Follow-up|7|||
161047088|NCT00700999|581562274|FG000|Overall Study|Excluded - did not meet study criteria|0|||
161047089|NCT00700999|581562275|FG001|Overall Study|Excluded - did not meet study criteria|1|||
161047090|NCT00700999|581562274|FG000|Overall Study|Withdrawal by Subject|8|||
161047091|NCT00700999|581562275|FG001|Overall Study|Withdrawal by Subject|1|||
161047092|NCT00244751|581562276|FG000|Overall Study|Adverse Event|7|||
161047093|NCT00244751|581562277|FG001|Overall Study|Adverse Event|7|||
161047094|NCT00244751|581562278|FG002|Overall Study|Adverse Event|5|||
161047095|NCT00244751|581562276|FG000|Overall Study|Lost to Follow-up|0|||
161047096|NCT00244751|581562277|FG001|Overall Study|Lost to Follow-up|1|||
161047097|NCT00244751|581562278|FG002|Overall Study|Lost to Follow-up|0|||
161047098|NCT00244751|581562276|FG000|Overall Study|Protocol Violation|1|||
161047099|NCT00244751|581562277|FG001|Overall Study|Protocol Violation|0|||
161047100|NCT00244751|581562278|FG002|Overall Study|Protocol Violation|1|||
161047101|NCT00244751|581562276|FG000|Overall Study|Withdrawal by Subject|7|||
161047102|NCT00244751|581562277|FG001|Overall Study|Withdrawal by Subject|5|||
161047103|NCT00244751|581562278|FG002|Overall Study|Withdrawal by Subject|3|||
161047104|NCT00244751|581562276|FG000|Overall Study|Elevated liver enzymes|1|||
161047105|NCT00244751|581562277|FG001|Overall Study|Elevated liver enzymes|0|||
161047106|NCT00244751|581562278|FG002|Overall Study|Elevated liver enzymes|0|||
161047107|NCT00244751|581562276|FG000|Overall Study|Lack of compliance with protocol|0|||
161047108|NCT00244751|581562277|FG001|Overall Study|Lack of compliance with protocol|1|||
161047109|NCT00244751|581562278|FG002|Overall Study|Lack of compliance with protocol|0|||
161047110|NCT00244751|581562276|FG000|Overall Study|Safety reasons|0|||
161047111|NCT00244751|581562277|FG001|Overall Study|Safety reasons|1|||
161047112|NCT00244751|581562278|FG002|Overall Study|Safety reasons|0|||
161047113|NCT00244751|581562276|FG000|Overall Study|Participant randomized by mistake|0|||
161047114|NCT00244751|581562277|FG001|Overall Study|Participant randomized by mistake|0|||
161047115|NCT00244751|581562278|FG002|Overall Study|Participant randomized by mistake|1|||
161047116|NCT03031782|581562281|FG000|Treatment Period 1|Lack of Efficacy|3|||
161047117|NCT03031782|581562282|FG001|Treatment Period 1|Lack of Efficacy|0|||
161047118|NCT03031782|581562283|FG002|Treatment Period 1|Lack of Efficacy|0|||
161047119|NCT03031782|581562284|FG003|Treatment Period 1|Lack of Efficacy|0|||
161047120|NCT03031782|581562285|FG004|Treatment Period 1|Lack of Efficacy|0|||
161047121|NCT03031782|581562281|FG000|Treatment Period 2|Physician Decision|0|||
161047122|NCT03031782|581562282|FG001|Treatment Period 2|Physician Decision|1|||
161047123|NCT03031782|581562283|FG002|Treatment Period 2|Physician Decision|0|||
161047124|NCT03031782|581562284|FG003|Treatment Period 2|Physician Decision|0|||
161047125|NCT03031782|581562285|FG004|Treatment Period 2|Physician Decision|3|||
161047126|NCT03031782|581562281|FG000|Treatment Period 2|Lack of Efficacy|0|||
161047127|NCT03031782|581562282|FG001|Treatment Period 2|Lack of Efficacy|1|||
161047128|NCT03031782|581562283|FG002|Treatment Period 2|Lack of Efficacy|0|||
161047129|NCT03031782|581562284|FG003|Treatment Period 2|Lack of Efficacy|0|||
161047130|NCT03031782|581562285|FG004|Treatment Period 2|Lack of Efficacy|1|||
161047131|NCT03031782|581562281|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161047132|NCT03031782|581562282|FG001|Treatment Period 2|Withdrawal by Subject|3|||
161047133|NCT03031782|581562283|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161047134|NCT03031782|581562284|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161047135|NCT03031782|581562285|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161047136|NCT03031782|581562281|FG000|Treatment Period 2|Adverse Event|0|||
161047137|NCT03031782|581562282|FG001|Treatment Period 2|Adverse Event|1|||
161047138|NCT03031782|581562283|FG002|Treatment Period 2|Adverse Event|2|||
161047139|NCT03031782|581562284|FG003|Treatment Period 2|Adverse Event|0|||
161047140|NCT03031782|581562285|FG004|Treatment Period 2|Adverse Event|0|||
161047141|NCT03031782|581562281|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161047142|NCT03031782|581562282|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161047143|NCT03031782|581562283|FG002|Treatment Period 3|Withdrawal by Subject|0|||
161047144|NCT03031782|581562284|FG003|Treatment Period 3|Withdrawal by Subject|1|||
161047145|NCT03031782|581562285|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161047146|NCT04867382|581562288|FG000|Overall Study|Did not complete the survey|2|||
161047147|NCT04867382|581562289|FG001|Overall Study|Did not complete the survey|1|||
161047148|NCT05445557|581562290|FG000|Double Blind Part|Lost to Follow-up|1|||
161047149|NCT01323790|581562291|FG000|Overall Study|Other|3|||
161047150|NCT01323790|581562292|FG001|Overall Study|Other|2|||
161047151|NCT01323790|581562293|FG002|Overall Study|Other|1|||
161047152|NCT01323790|581562291|FG000|Overall Study|Lost to Follow-up|11|||
161047153|NCT01323790|581562292|FG001|Overall Study|Lost to Follow-up|9|||
161047154|NCT01323790|581562293|FG002|Overall Study|Lost to Follow-up|9|||
161047155|NCT01323790|581562291|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
161047156|NCT01323790|581562292|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
161047157|NCT01323790|581562293|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
161047158|NCT01323790|581562291|FG000|Overall Study|Lack of Efficacy|3|||
161047159|NCT01323790|581562292|FG001|Overall Study|Lack of Efficacy|0|||
161047160|NCT01323790|581562293|FG002|Overall Study|Lack of Efficacy|3|||
161047161|NCT01323790|581562291|FG000|Overall Study|Adverse Event|11|||
161047162|NCT01323790|581562292|FG001|Overall Study|Adverse Event|24|||
161047163|NCT01323790|581562293|FG002|Overall Study|Adverse Event|12|||
161047164|NCT01323790|581562291|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161047165|NCT01323790|581562292|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161047166|NCT01323790|581562293|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
161047167|NCT01323790|581562291|FG000|Overall Study|Withdrawal by Subject|23|||
161047168|NCT01323790|581562292|FG001|Overall Study|Withdrawal by Subject|20|||
161047169|NCT01323790|581562293|FG002|Overall Study|Withdrawal by Subject|13|||
161047170|NCT01323790|581562291|FG000|Overall Study|Did Not Receive Treatment|2|||
161047171|NCT01323790|581562292|FG001|Overall Study|Did Not Receive Treatment|0|||
161047172|NCT01323790|581562293|FG002|Overall Study|Did Not Receive Treatment|1|||
161047173|NCT01323790|581562291|FG000|Overall Study|Severe non-compliance with protocol|2|||
161047174|NCT01323790|581562292|FG001|Overall Study|Severe non-compliance with protocol|2|||
161047175|NCT01323790|581562293|FG002|Overall Study|Severe non-compliance with protocol|2|||
161047176|NCT01736475|581562294|FG000|Overall Study|Adverse Event|4|||
161047177|NCT01736475|581562295|FG001|Overall Study|Adverse Event|0|||
161047178|NCT01736475|581562294|FG000|Overall Study|Withdrawal by Subject|2|||
161047179|NCT01736475|581562295|FG001|Overall Study|Withdrawal by Subject|0|||
161047180|NCT01736475|581562294|FG000|Overall Study|Protocol Violation|4|||
161047181|NCT01736475|581562295|FG001|Overall Study|Protocol Violation|0|||
161047182|NCT01736475|581562294|FG000|Overall Study|Other - Screen failure|1|||
161047183|NCT01736475|581562295|FG001|Overall Study|Other - Screen failure|0|||
161047184|NCT01736475|581562294|FG000|Overall Study|Other - Surgical procedure|1|||
161047185|NCT01736475|581562295|FG001|Overall Study|Other - Surgical procedure|0|||
161047186|NCT02144285|581562297|FG000|Overall Study|Withdrawal by Subject|0|||
161047187|NCT02144285|581562298|FG001|Overall Study|Withdrawal by Subject|0|||
161047188|NCT02144285|581562299|FG002|Overall Study|Withdrawal by Subject|0|||
161047189|NCT02144285|581562300|FG003|Overall Study|Withdrawal by Subject|0|||
161047190|NCT02144285|581562301|FG004|Overall Study|Withdrawal by Subject|1|||
161047191|NCT02144285|581562302|FG005|Overall Study|Withdrawal by Subject|0|||
161047192|NCT02144285|581562303|FG006|Overall Study|Withdrawal by Subject|0|||
161047193|NCT02144285|581562304|FG007|Overall Study|Withdrawal by Subject|0|||
161047194|NCT02144285|581562305|FG008|Overall Study|Withdrawal by Subject|0|||
161047195|NCT02144285|581562306|FG009|Overall Study|Withdrawal by Subject|0|||
161047196|NCT01529632|581562307|FG000|Overall Study|Administrative problem|2|||
161047197|NCT01529632|581562308|FG001|Overall Study|Administrative problem|1|||
161047198|NCT01529632|581562307|FG000|Overall Study|Protocol Violation|0|||
161047199|NCT01529632|581562308|FG001|Overall Study|Protocol Violation|1|||
161047200|NCT01529632|581562307|FG000|Overall Study|Adverse Event|1|||
161047201|NCT01529632|581562308|FG001|Overall Study|Adverse Event|1|||
161047202|NCT05184062|581562310|FG000|Overall Study|Lost to Follow-up|5|||
161047203|NCT05184062|581562311|FG001|Overall Study|Lost to Follow-up|1|||
161047204|NCT05184062|581562310|FG000|Overall Study|Withdrawal by Subject|1|||
161047205|NCT05184062|581562311|FG001|Overall Study|Withdrawal by Subject|0|||
161047206|NCT05522777|581563802|FG000|Overall Study|Lack of Efficacy|1|||
161047207|NCT05522777|581563802|FG000|Overall Study|Withdrawal by Subject|1|||
161047208|NCT04914897|581563805|FG000|Overall Study|Withdrawal by Subject|3|||
161047209|NCT04914897|581563806|FG001|Overall Study|Withdrawal by Subject|1|||
161047210|NCT04914897|581563807|FG002|Overall Study|Withdrawal by Subject|1|||
161047211|NCT04914897|581563808|FG003|Overall Study|Withdrawal by Subject|1|||
161047212|NCT04914897|581563805|FG000|Overall Study|Poor compliance to protocol|0|||
161047213|NCT04914897|581563806|FG001|Overall Study|Poor compliance to protocol|0|||
161150349|NCT01426386|581931887|FG004|Overall Study|Poor response|1|||
161150350|NCT01426386|581931888|FG005|Overall Study|Poor response|0|||
161150351|NCT01426386|581931883|FG000|Overall Study|Personal reasons|0|||
161150352|NCT01426386|581931884|FG001|Overall Study|Personal reasons|0|||
161150353|NCT01426386|581931885|FG002|Overall Study|Personal reasons|0|||
161150354|NCT01426386|581931886|FG003|Overall Study|Personal reasons|0|||
161344949|NCT03126110|582648859|FG010|Phase 1|Lost to Follow-up|0|||
161047214|NCT04914897|581563807|FG002|Overall Study|Poor compliance to protocol|1|||
161047215|NCT04914897|581563808|FG003|Overall Study|Poor compliance to protocol|0|||
161047216|NCT04914897|581563805|FG000|Overall Study|Progressive disease|5|||
161047217|NCT04914897|581563806|FG001|Overall Study|Progressive disease|14|||
161047218|NCT04914897|581563807|FG002|Overall Study|Progressive disease|30|||
161047219|NCT04914897|581563808|FG003|Overall Study|Progressive disease|21|||
161047220|NCT04914897|581563805|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
161047221|NCT04914897|581563806|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
161047222|NCT04914897|581563807|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
161047223|NCT04914897|581563808|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
161047224|NCT04914897|581563805|FG000|Overall Study|Other|1|||
161150355|NCT01426386|581931887|FG004|Overall Study|Personal reasons|1|||
161344950|NCT03126110|582648860|FG011|Phase 1|Lost to Follow-up|0|||
161047225|NCT04914897|581563806|FG001|Overall Study|Other|0|||
161047226|NCT04914897|581563807|FG002|Overall Study|Other|0|||
161047227|NCT04914897|581563808|FG003|Overall Study|Other|1|||
161344951|NCT03126110|582648861|FG012|Phase 1|Lost to Follow-up|0|||
161344952|NCT03126110|582648862|FG013|Phase 1|Lost to Follow-up|0|||
161047228|NCT04783389|581563818|FG000|Overall Study|Withdrawal by Subject|2|||
161047229|NCT04783389|581563819|FG001|Overall Study|Withdrawal by Subject|0|||
161047230|NCT04783389|581563820|FG002|Overall Study|Withdrawal by Subject|0|||
161047231|NCT04783389|581563818|FG000|Overall Study|Termination of Study by Sponsor|10|||
161047232|NCT04783389|581563819|FG001|Overall Study|Termination of Study by Sponsor|12|||
161047233|NCT04783389|581563820|FG002|Overall Study|Termination of Study by Sponsor|14|||
161047234|NCT02164578|581563822|FG000|Treatment Period|Withdrawal by Subject|3|||
161047235|NCT02164578|581563823|FG001|Treatment Period|Withdrawal by Subject|3|||
161047236|NCT02164578|581563822|FG000|Treatment Period|Adverse Event|13|||
161047237|NCT02164578|581563823|FG001|Treatment Period|Adverse Event|6|||
161047238|NCT02164578|581563822|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
161047239|NCT02164578|581563823|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
161047240|NCT02164578|581563822|FG000|Treatment Period|Protocol Violation|0|||
161047241|NCT02164578|581563823|FG001|Treatment Period|Protocol Violation|2|||
161047242|NCT02164578|581563822|FG000|Extension Period|Withdrawal by Subject|2|||
161047243|NCT02164578|581563823|FG001|Extension Period|Withdrawal by Subject|0|||
161047244|NCT02164578|581563822|FG000|Extension Period|Adverse Event|4|||
161047245|NCT02164578|581563823|FG001|Extension Period|Adverse Event|0|||
161047246|NCT02164578|581563822|FG000|Extension Period|Expiry of study medication|1|||
161047247|NCT02164578|581563823|FG001|Extension Period|Expiry of study medication|0|||
161047248|NCT02164578|581563822|FG000|Extension Period|Protocol Violation|0|||
161047249|NCT02164578|581563823|FG001|Extension Period|Protocol Violation|1|||
161047250|NCT01562275|581563829|FG000|Stage 1|Adverse Event|0|||
161047251|NCT01562275|581563830|FG001|Stage 1|Adverse Event|0|||
161047252|NCT01562275|581563831|FG002|Stage 1|Adverse Event|0|||
161047253|NCT01562275|581563832|FG003|Stage 1|Adverse Event|1|||
161047254|NCT01562275|581563833|FG004|Stage 1|Adverse Event|1|||
161280759|NCT00996892|582407016|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
161280760|NCT00996892|582407017|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
161280761|NCT00996892|582407018|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
161280762|NCT00996892|582407019|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
161280763|NCT00996892|582407020|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
161047255|NCT01562275|581563834|FG005|Stage 1|Adverse Event|0|||
161047256|NCT01562275|581563835|FG006|Stage 1|Adverse Event|0|||
161047257|NCT01562275|581563836|FG007|Stage 1|Adverse Event|0|||
161047258|NCT01562275|581563837|FG008|Stage 1|Adverse Event|0|||
161047259|NCT01562275|581563838|FG009|Stage 1|Adverse Event|1|||
161047260|NCT01562275|581563839|FG010|Stage 1|Adverse Event|0|||
161047261|NCT01562275|581563840|FG011|Stage 1|Adverse Event|0|||
161047262|NCT01562275|581563841|FG012|Stage 1|Adverse Event|0|||
161047263|NCT01562275|581563829|FG000|Stage 1|Death|1|||
161047264|NCT01562275|581563830|FG001|Stage 1|Death|0|||
161047265|NCT01562275|581563831|FG002|Stage 1|Death|0|||
161047266|NCT01562275|581563832|FG003|Stage 1|Death|0|||
161047267|NCT01562275|581563833|FG004|Stage 1|Death|0|||
161047268|NCT01562275|581563834|FG005|Stage 1|Death|0|||
161047269|NCT01562275|581563835|FG006|Stage 1|Death|0|||
161280764|NCT00996892|582407021|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
161280765|NCT00996892|582407002|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
161280766|NCT00996892|582407003|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
161280767|NCT00996892|582407004|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
161280768|NCT00996892|582407005|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
161280769|NCT00996892|582407006|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
161280770|NCT00996892|582407007|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
161280771|NCT00996892|582407008|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
161280772|NCT00996892|582407009|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
161280773|NCT00996892|582407010|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
161280774|NCT00996892|582407011|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
161280775|NCT00996892|582407012|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
161280776|NCT00996892|582407013|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
161280777|NCT00996892|582407014|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
161280778|NCT00996892|582407015|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
161280779|NCT00996892|582407016|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
161047270|NCT01562275|581563836|FG007|Stage 1|Death|0|||
161047271|NCT01562275|581563837|FG008|Stage 1|Death|0|||
161047272|NCT01562275|581563838|FG009|Stage 1|Death|0|||
161047273|NCT01562275|581563839|FG010|Stage 1|Death|0|||
161047274|NCT01562275|581563840|FG011|Stage 1|Death|0|||
161047275|NCT01562275|581563841|FG012|Stage 1|Death|0|||
161047276|NCT01562275|581563829|FG000|Stage 1|Non Compliance|0|||
161047277|NCT01562275|581563830|FG001|Stage 1|Non Compliance|0|||
161047278|NCT01562275|581563831|FG002|Stage 1|Non Compliance|1|||
161047279|NCT01562275|581563832|FG003|Stage 1|Non Compliance|0|||
161047280|NCT01562275|581563833|FG004|Stage 1|Non Compliance|0|||
161047281|NCT01562275|581563834|FG005|Stage 1|Non Compliance|0|||
161047282|NCT01562275|581563835|FG006|Stage 1|Non Compliance|0|||
161047283|NCT01562275|581563836|FG007|Stage 1|Non Compliance|0|||
161047284|NCT01562275|581563837|FG008|Stage 1|Non Compliance|0|||
161280780|NCT00996892|582407017|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
161280781|NCT00996892|582407018|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
161280782|NCT00996892|582407019|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
161280783|NCT00996892|582407020|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
161280784|NCT00996892|582407021|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
161047285|NCT01562275|581563838|FG009|Stage 1|Non Compliance|0|||
161047286|NCT01562275|581563839|FG010|Stage 1|Non Compliance|0|||
161047287|NCT01562275|581563840|FG011|Stage 1|Non Compliance|0|||
161047288|NCT01562275|581563841|FG012|Stage 1|Non Compliance|0|||
161047289|NCT01562275|581563829|FG000|Stage 1|Physician Decision|0|||
161047290|NCT01562275|581563830|FG001|Stage 1|Physician Decision|0|||
161047291|NCT01562275|581563831|FG002|Stage 1|Physician Decision|0|||
161047292|NCT01562275|581563832|FG003|Stage 1|Physician Decision|0|||
161047293|NCT01562275|581563833|FG004|Stage 1|Physician Decision|1|||
161047294|NCT01562275|581563834|FG005|Stage 1|Physician Decision|0|||
161047295|NCT01562275|581563835|FG006|Stage 1|Physician Decision|1|||
161047296|NCT01562275|581563836|FG007|Stage 1|Physician Decision|0|||
161047297|NCT01562275|581563837|FG008|Stage 1|Physician Decision|1|||
161047298|NCT01562275|581563838|FG009|Stage 1|Physician Decision|0|||
161047299|NCT01562275|581563839|FG010|Stage 1|Physician Decision|0|||
161047300|NCT01562275|581563840|FG011|Stage 1|Physician Decision|0|||
161047301|NCT01562275|581563841|FG012|Stage 1|Physician Decision|0|||
161047302|NCT01562275|581563829|FG000|Stage 1|Progression of Disease|2|||
161047303|NCT01562275|581563830|FG001|Stage 1|Progression of Disease|6|||
161047304|NCT01562275|581563831|FG002|Stage 1|Progression of Disease|2|||
161047305|NCT01562275|581563832|FG003|Stage 1|Progression of Disease|1|||
161047306|NCT01562275|581563833|FG004|Stage 1|Progression of Disease|2|||
161047307|NCT01562275|581563834|FG005|Stage 1|Progression of Disease|4|||
161047308|NCT01562275|581563835|FG006|Stage 1|Progression of Disease|1|||
161047309|NCT01562275|581563836|FG007|Stage 1|Progression of Disease|7|||
161047310|NCT01562275|581563837|FG008|Stage 1|Progression of Disease|2|||
161047311|NCT01562275|581563838|FG009|Stage 1|Progression of Disease|5|||
161047312|NCT01562275|581563839|FG010|Stage 1|Progression of Disease|3|||
161047313|NCT01562275|581563840|FG011|Stage 1|Progression of Disease|0|||
161047314|NCT01562275|581563841|FG012|Stage 1|Progression of Disease|0|||
161047315|NCT01562275|581563829|FG000|Stage 1|Withdrawal by Subject|0|||
161047316|NCT01562275|581563830|FG001|Stage 1|Withdrawal by Subject|1|||
161047317|NCT01562275|581563831|FG002|Stage 1|Withdrawal by Subject|0|||
161047318|NCT01562275|581563832|FG003|Stage 1|Withdrawal by Subject|2|||
161047319|NCT01562275|581563833|FG004|Stage 1|Withdrawal by Subject|0|||
161047320|NCT01562275|581563834|FG005|Stage 1|Withdrawal by Subject|0|||
161047321|NCT01562275|581563835|FG006|Stage 1|Withdrawal by Subject|1|||
161047322|NCT01562275|581563836|FG007|Stage 1|Withdrawal by Subject|0|||
161047323|NCT01562275|581563837|FG008|Stage 1|Withdrawal by Subject|0|||
161047324|NCT01562275|581563838|FG009|Stage 1|Withdrawal by Subject|1|||
161047325|NCT01562275|581563839|FG010|Stage 1|Withdrawal by Subject|0|||
161047326|NCT01562275|581563840|FG011|Stage 1|Withdrawal by Subject|0|||
161047327|NCT01562275|581563841|FG012|Stage 1|Withdrawal by Subject|0|||
161047328|NCT01562275|581563829|FG000|Stage 2|Death|0|||
161047329|NCT01562275|581563830|FG001|Stage 2|Death|0|||
161047330|NCT01562275|581563831|FG002|Stage 2|Death|0|||
161047331|NCT01562275|581563832|FG003|Stage 2|Death|0|||
161047332|NCT01562275|581563833|FG004|Stage 2|Death|0|||
161047333|NCT01562275|581563834|FG005|Stage 2|Death|0|||
161047334|NCT01562275|581563835|FG006|Stage 2|Death|0|||
161047335|NCT01562275|581563836|FG007|Stage 2|Death|0|||
161047336|NCT01562275|581563837|FG008|Stage 2|Death|0|||
161047337|NCT01562275|581563838|FG009|Stage 2|Death|0|||
161047338|NCT01562275|581563839|FG010|Stage 2|Death|0|||
161047339|NCT01562275|581563840|FG011|Stage 2|Death|2|||
161047340|NCT01562275|581563841|FG012|Stage 2|Death|1|||
161047341|NCT01562275|581563829|FG000|Stage 2|Progression of Disease|0|||
161047342|NCT01562275|581563830|FG001|Stage 2|Progression of Disease|0|||
161047343|NCT01562275|581563831|FG002|Stage 2|Progression of Disease|0|||
161047344|NCT01562275|581563832|FG003|Stage 2|Progression of Disease|0|||
161047345|NCT01562275|581563833|FG004|Stage 2|Progression of Disease|0|||
161047346|NCT01562275|581563834|FG005|Stage 2|Progression of Disease|0|||
161047347|NCT01562275|581563835|FG006|Stage 2|Progression of Disease|0|||
161047348|NCT01562275|581563836|FG007|Stage 2|Progression of Disease|0|||
161047349|NCT01562275|581563837|FG008|Stage 2|Progression of Disease|0|||
161047350|NCT01562275|581563838|FG009|Stage 2|Progression of Disease|0|||
161047351|NCT01562275|581563839|FG010|Stage 2|Progression of Disease|0|||
161047352|NCT01562275|581563840|FG011|Stage 2|Progression of Disease|12|||
161047353|NCT01562275|581563841|FG012|Stage 2|Progression of Disease|4|||
161047354|NCT04909593|581563842|FG000|Overall Study|Withdrawal by Subject|1|||
161047355|NCT01018992|581563843|FG000|Overall Study|Adverse Event|8|||
161047356|NCT01018992|581563844|FG001|Overall Study|Adverse Event|3|||
161047357|NCT01018992|581563843|FG000|Overall Study|Withdrawal by Subject|3|||
161047358|NCT01018992|581563844|FG001|Overall Study|Withdrawal by Subject|8|||
161047359|NCT01018992|581563843|FG000|Overall Study|Protocol Violation|0|||
161047360|NCT01018992|581563844|FG001|Overall Study|Protocol Violation|4|||
161047361|NCT01018992|581563843|FG000|Overall Study|Lost to Follow-up|5|||
161047362|NCT01018992|581563844|FG001|Overall Study|Lost to Follow-up|1|||
161047363|NCT03029585|581563847|FG000|Overall Study|Death|1|||
161047364|NCT03029585|581563848|FG001|Overall Study|Death|1|||
161047365|NCT03029585|581563847|FG000|Overall Study|Withdrawal by Subject|1|||
161047366|NCT03029585|581563848|FG001|Overall Study|Withdrawal by Subject|0|||
161047367|NCT02400749|581563849|FG000|Week 0 -16|Withdrawal by Subject|5|||
161047368|NCT02400749|581563850|FG001|Week 0 -16|Withdrawal by Subject|5|||
161047369|NCT02400749|581563849|FG000|Week 0 -16|Adverse Event|3|||
161047370|NCT02400749|581563850|FG001|Week 0 -16|Adverse Event|1|||
161047371|NCT02400749|581563849|FG000|Week 0 -16|Lost to Follow-up|2|||
161047372|NCT02400749|581563850|FG001|Week 0 -16|Lost to Follow-up|0|||
161047373|NCT02400749|581563849|FG000|Week 0 -16|Protocol Violation|1|||
161047374|NCT02400749|581563850|FG001|Week 0 -16|Protocol Violation|0|||
161047375|NCT02400749|581563849|FG000|Week 17 - 32|Withdrawal by Subject|3|||
161047376|NCT02400749|581563850|FG001|Week 17 - 32|Withdrawal by Subject|2|||
161047377|NCT02400749|581563849|FG000|Week 17 - 32|Adverse Event|2|||
161047378|NCT02400749|581563850|FG001|Week 17 - 32|Adverse Event|1|||
161047379|NCT04425252|581563851|FG000|Overall Study|Withdrawal by Subject|2|||
161047380|NCT04425252|581563852|FG001|Overall Study|Withdrawal by Subject|1|||
161047381|NCT04425252|581563851|FG000|Overall Study|Lost to Follow-up|1|||
161047382|NCT04425252|581563852|FG001|Overall Study|Lost to Follow-up|0|||
161047383|NCT04425252|581563851|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
161047384|NCT04425252|581563852|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
161047385|NCT01825785|581563853|FG000|Overall Study|Adverse Event|0|||
161047386|NCT01825785|581563854|FG001|Overall Study|Adverse Event|0|||
161047387|NCT01825785|581563855|FG002|Overall Study|Adverse Event|0|||
161047388|NCT01825785|581563856|FG003|Overall Study|Adverse Event|0|||
161047389|NCT01825785|581563857|FG004|Overall Study|Adverse Event|1|||
161047390|NCT01825785|581563858|FG005|Overall Study|Adverse Event|0|||
161047391|NCT01825785|581563859|FG006|Overall Study|Adverse Event|0|||
161047392|NCT01825785|581563853|FG000|Overall Study|Withdrawal by Subject|0|||
161047393|NCT01825785|581563854|FG001|Overall Study|Withdrawal by Subject|0|||
161047394|NCT01825785|581563855|FG002|Overall Study|Withdrawal by Subject|0|||
161047395|NCT01825785|581563856|FG003|Overall Study|Withdrawal by Subject|0|||
161047396|NCT01825785|581563857|FG004|Overall Study|Withdrawal by Subject|1|||
161047397|NCT01825785|581563858|FG005|Overall Study|Withdrawal by Subject|1|||
161047398|NCT01825785|581563859|FG006|Overall Study|Withdrawal by Subject|0|||
161047399|NCT00507429|581563860|FG000|Treatment Phase|Disease Progression|12|||
161047400|NCT00507429|581563861|FG001|Treatment Phase|Disease Progression|5|||
161047401|NCT00507429|581563860|FG000|Treatment Phase|Adverse Event|12|||
161047402|NCT00507429|581563861|FG001|Treatment Phase|Adverse Event|5|||
161047403|NCT00507429|581563860|FG000|Treatment Phase|Withdrawal by Subject|3|||
161047404|NCT00507429|581563861|FG001|Treatment Phase|Withdrawal by Subject|3|||
161047405|NCT00507429|581563860|FG000|Treatment Phase|Physician Decision|4|||
161047406|NCT00507429|581563861|FG001|Treatment Phase|Physician Decision|2|||
161047407|NCT00507429|581563860|FG000|Treatment Phase|Other|6|||
161047408|NCT00507429|581563861|FG001|Treatment Phase|Other|3|||
161047409|NCT00507429|581563860|FG000|Maintenance Phase|Progressive Disease|14|||
161047410|NCT00507429|581563861|FG001|Maintenance Phase|Progressive Disease|0|||
161047411|NCT04025762|581563862|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
161047412|NCT04025762|581563863|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
161047413|NCT01286311|581563865|FG000|Overall Study|Physician did not want outreach sent|14|||
161047414|NCT01286311|581563866|FG001|Overall Study|Physician did not want outreach sent|0|||
161047415|NCT01437540|581563867|FG000|Overall Study|Not listed below|7|||
161047416|NCT01437540|581563868|FG001|Overall Study|Not listed below|6|||
161047417|NCT01437540|581563867|FG000|Overall Study|COPD exacerbation|13|||
161047418|NCT01437540|581563868|FG001|Overall Study|COPD exacerbation|3|||
161047419|NCT01437540|581563867|FG000|Overall Study|Lost to Follow-up|3|||
161280785|NCT00996892|582407002|FG000|Dose-Escalation Stage 1A|Death|0|||
161047420|NCT01437540|581563868|FG001|Overall Study|Lost to Follow-up|5|||
161047421|NCT01437540|581563867|FG000|Overall Study|Lack of Efficacy|23|||
161047422|NCT01437540|581563868|FG001|Overall Study|Lack of Efficacy|11|||
161047423|NCT01437540|581563867|FG000|Overall Study|Protocol Violation|24|||
161047424|NCT01437540|581563868|FG001|Overall Study|Protocol Violation|12|||
161047425|NCT01437540|581563867|FG000|Overall Study|Adverse Event|26|||
161047426|NCT01437540|581563868|FG001|Overall Study|Adverse Event|13|||
161047427|NCT01437540|581563867|FG000|Overall Study|Withdrawal by Subject|31|||
161047428|NCT01437540|581563868|FG001|Overall Study|Withdrawal by Subject|15|||
161047429|NCT01381549|581563869|FG000|Overall Study|Ineligible: No organisms isolated|0|||
161047430|NCT01381549|581563870|FG001|Overall Study|Ineligible: No organisms isolated|0|||
161047431|NCT01381549|581563871|FG002|Overall Study|Ineligible: No organisms isolated|1|||
161047432|NCT02981953|581563872|FG000|Overall Study|Death|9|||
161047433|NCT02981953|581563872|FG000|Overall Study|Withdrawal by Subject|1|||
161047434|NCT02981953|581563872|FG000|Overall Study|Withdrawal to non-compliance|1|||
161047435|NCT00805792|581563877|FG000|Overall Study|Death|3|||
161047436|NCT00805792|581563877|FG000|Overall Study|Lost to Follow-up|2|||
161047437|NCT02165202|581563882|FG000|Oral Phase|Refused further participation|5|||
161280786|NCT00996892|582407003|FG001|Dose-Escalation Stage 1A|Death|0|||
161047438|NCT02165202|581563883|FG001|Oral Phase|Refused further participation|1|||
161047439|NCT02165202|581563882|FG000|Oral Phase|Study product Related Toxicity|1|||
161047440|NCT02165202|581563883|FG001|Oral Phase|Study product Related Toxicity|0|||
161047441|NCT02165202|581563882|FG000|Oral Phase|Unable to contact Participant|1|||
161047442|NCT02165202|581563883|FG001|Oral Phase|Unable to contact Participant|1|||
161047443|NCT02165202|581563882|FG000|Oral Phase|Clinical reasons|1|||
161047444|NCT02165202|581563883|FG001|Oral Phase|Clinical reasons|0|||
161047445|NCT02165202|581563882|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
161047446|NCT02165202|581563883|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
161047447|NCT02165202|581563882|FG000|Oral Phase|CMC advised termination|1|||
161047448|NCT02165202|581563883|FG001|Oral Phase|CMC advised termination|0|||
161047449|NCT02165202|581563882|FG000|Oral Phase|Relocated, no follow-up planned|1|||
161047450|NCT02165202|581563883|FG001|Oral Phase|Relocated, no follow-up planned|0|||
161047451|NCT02165202|581563882|FG000|Oral Phase|Abnormal EKG|0|||
161047452|NCT02165202|581563883|FG001|Oral Phase|Abnormal EKG|1|||
161047453|NCT02165202|581563882|FG000|Injection Phase|Abnormal Lab Value|5|||
161047454|NCT02165202|581563883|FG001|Injection Phase|Abnormal Lab Value|1|||
161047455|NCT02165202|581563882|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
161047456|NCT02165202|581563883|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
161047457|NCT02165202|581563882|FG000|Injection Phase|Unable to attend within Visit Window|1|||
161047458|NCT02165202|581563883|FG001|Injection Phase|Unable to attend within Visit Window|0|||
161047459|NCT02165202|581563882|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
161047460|NCT02165202|581563883|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
161047461|NCT02165202|581563882|FG000|Injection Phase|End of Study|2|||
161047462|NCT02165202|581563883|FG001|Injection Phase|End of Study|1|||
161047463|NCT02165202|581563882|FG000|Injection Phase|Study Product related Toxicity|1|||
161047464|NCT02165202|581563883|FG001|Injection Phase|Study Product related Toxicity|0|||
161047465|NCT02165202|581563882|FG000|Injection Phase|No longer interested|0|||
161047466|NCT02165202|581563883|FG001|Injection Phase|No longer interested|1|||
161047467|NCT02165202|581563882|FG000|Injection Phase|Participant unwilling to comply|1|||
161047468|NCT02165202|581563883|FG001|Injection Phase|Participant unwilling to comply|0|||
161047469|NCT04328467|581563893|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
161047470|NCT04328467|581563894|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
161047471|NCT04328467|581563895|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
161047472|NCT00990184|581563896|FG000|Overall Study|Physician Decision|1|||
161047473|NCT01975701|581563897|FG000|Overall Study|Lost to Follow-up|1|||
161047474|NCT01975701|581563897|FG000|Overall Study|Death|23|||
161047475|NCT01975701|581563897|FG000|Overall Study|Physician Decision|1|||
161047476|NCT01655498|581563898|FG000|Overall Study|Unrelated health issue|2|||
161047477|NCT01655498|581563898|FG000|Overall Study|Protocol Violation|2|||
161047478|NCT01655498|581563898|FG000|Overall Study|Withdrawal by Subject|1|||
161047479|NCT02446015|581563901|FG000|Overall Study|Adverse Event|0|||
161047480|NCT02446015|581563902|FG001|Overall Study|Adverse Event|1|||
161047481|NCT02446015|581563901|FG000|Overall Study|Withdrawal by Subject|1|||
161047482|NCT02446015|581563902|FG001|Overall Study|Withdrawal by Subject|0|||
161047483|NCT00988429|581563903|FG000|Overall Study|Adverse Event|9|||
161047484|NCT00988429|581563904|FG001|Overall Study|Adverse Event|21|||
161047485|NCT00988429|581563905|FG002|Overall Study|Adverse Event|45|||
161047486|NCT00988429|581563903|FG000|Overall Study|Lack of Efficacy|0|||
161047487|NCT00988429|581563904|FG001|Overall Study|Lack of Efficacy|0|||
161047488|NCT00988429|581563905|FG002|Overall Study|Lack of Efficacy|1|||
161047489|NCT00988429|581563903|FG000|Overall Study|Non-Compliance with Study Drug|5|||
161047490|NCT00988429|581563904|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161047491|NCT00988429|581563905|FG002|Overall Study|Non-Compliance with Study Drug|3|||
161047492|NCT00988429|581563903|FG000|Overall Study|Physician Decision|1|||
161047493|NCT00988429|581563904|FG001|Overall Study|Physician Decision|0|||
161047494|NCT00988429|581563905|FG002|Overall Study|Physician Decision|3|||
161047495|NCT00988429|581563903|FG000|Overall Study|Pregnancy|2|||
161047496|NCT00988429|581563904|FG001|Overall Study|Pregnancy|1|||
161280787|NCT00996892|582407004|FG002|Dose-Escalation Stage 1A|Death|0|||
161280788|NCT00996892|582407005|FG003|Dose-Escalation Stage 1A|Death|0|||
161280789|NCT00996892|582407006|FG004|Dose-Escalation Stage 1A|Death|0|||
161280790|NCT00996892|582407007|FG005|Dose-Escalation Stage 1A|Death|0|||
161280791|NCT00996892|582407008|FG006|Dose-Escalation Stage 1A|Death|0|||
161047497|NCT00988429|581563905|FG002|Overall Study|Pregnancy|0|||
161047498|NCT00988429|581563903|FG000|Overall Study|Protocol Violation|4|||
161047499|NCT00988429|581563904|FG001|Overall Study|Protocol Violation|3|||
161047500|NCT00988429|581563905|FG002|Overall Study|Protocol Violation|3|||
161047501|NCT00988429|581563903|FG000|Overall Study|Withdrawal by Subject|7|||
161047502|NCT00988429|581563904|FG001|Overall Study|Withdrawal by Subject|7|||
161047503|NCT00988429|581563905|FG002|Overall Study|Withdrawal by Subject|12|||
161047504|NCT00988429|581563903|FG000|Overall Study|Administrative Reasons|1|||
161047505|NCT00988429|581563904|FG001|Overall Study|Administrative Reasons|2|||
161047506|NCT00988429|581563905|FG002|Overall Study|Administrative Reasons|1|||
161280792|NCT00996892|582407009|FG007|Dose-Escalation Stage 1A|Death|0|||
161280793|NCT00996892|582407010|FG008|Dose-Escalation Stage 1A|Death|0|||
161047507|NCT00988429|581563903|FG000|Overall Study|other reasons|8|||
161047508|NCT00988429|581563904|FG001|Overall Study|other reasons|8|||
161047509|NCT00988429|581563905|FG002|Overall Study|other reasons|1|||
161047510|NCT01714947|581563906|FG000|Part B|Progressive Disease|3|||
161047511|NCT00376259|581563909|FG000|Overall Study|Sponsor request - study termination|21|||
161047512|NCT00376259|581563910|FG001|Overall Study|Sponsor request - study termination|21|||
161047513|NCT00376259|581563909|FG000|Overall Study|Patient request|1|||
161047514|NCT00376259|581563910|FG001|Overall Study|Patient request|0|||
161047515|NCT01877720|581563912|FG000|Overall Study|Adverse Event|1|||
161047516|NCT01877720|581563913|FG001|Overall Study|Adverse Event|0|||
161047517|NCT00267956|581563916|FG000|Controlled Period|Adverse Event|4|||
161047518|NCT00267956|581563917|FG001|Controlled Period|Adverse Event|1|||
161047519|NCT00267956|581563918|FG002|Controlled Period|Adverse Event|0|||
161047520|NCT00267956|581563919|FG003|Controlled Period|Adverse Event|0|||
161047521|NCT00267956|581563916|FG000|Controlled Period|Lack of Efficacy|4|||
161047522|NCT00267956|581563917|FG001|Controlled Period|Lack of Efficacy|2|||
161047523|NCT00267956|581563918|FG002|Controlled Period|Lack of Efficacy|0|||
161047524|NCT00267956|581563919|FG003|Controlled Period|Lack of Efficacy|0|||
161047525|NCT00267956|581563916|FG000|Controlled Period|Lost to Follow-up|2|||
161047526|NCT00267956|581563917|FG001|Controlled Period|Lost to Follow-up|0|||
161047527|NCT00267956|581563918|FG002|Controlled Period|Lost to Follow-up|0|||
161047528|NCT00267956|581563919|FG003|Controlled Period|Lost to Follow-up|0|||
161047529|NCT00267956|581563916|FG000|Controlled Period|Withdrew consent|3|||
161047530|NCT00267956|581563917|FG001|Controlled Period|Withdrew consent|1|||
161047531|NCT00267956|581563918|FG002|Controlled Period|Withdrew consent|0|||
161047532|NCT00267956|581563919|FG003|Controlled Period|Withdrew consent|0|||
161047533|NCT00267956|581563916|FG000|After Controlled Period|Adverse Event|0|||
161047534|NCT00267956|581563917|FG001|After Controlled Period|Adverse Event|0|||
161047535|NCT00267956|581563918|FG002|After Controlled Period|Adverse Event|2|||
161047536|NCT00267956|581563919|FG003|After Controlled Period|Adverse Event|1|||
161047537|NCT00267956|581563916|FG000|After Controlled Period|Lack of Efficacy|0|||
161047538|NCT00267956|581563917|FG001|After Controlled Period|Lack of Efficacy|0|||
161047539|NCT00267956|581563918|FG002|After Controlled Period|Lack of Efficacy|1|||
161047540|NCT00267956|581563919|FG003|After Controlled Period|Lack of Efficacy|1|||
161047541|NCT00267956|581563916|FG000|After Controlled Period|Lost to Follow-up|0|||
161047542|NCT00267956|581563917|FG001|After Controlled Period|Lost to Follow-up|0|||
161047543|NCT00267956|581563918|FG002|After Controlled Period|Lost to Follow-up|1|||
161047544|NCT00267956|581563919|FG003|After Controlled Period|Lost to Follow-up|0|||
161047545|NCT00267956|581563916|FG000|After Controlled Period|Withdrew consent|0|||
161047546|NCT00267956|581563917|FG001|After Controlled Period|Withdrew consent|0|||
161047547|NCT00267956|581563918|FG002|After Controlled Period|Withdrew consent|1|||
161047548|NCT00267956|581563919|FG003|After Controlled Period|Withdrew consent|0|||
161047549|NCT01393964|581563924|FG000|Overall Study|Disease Progression|4|||
161047550|NCT01393964|581563925|FG001|Overall Study|Disease Progression|3|||
161047551|NCT01393964|581563926|FG002|Overall Study|Disease Progression|5|||
161047552|NCT01393964|581563924|FG000|Overall Study|Study drug toxicity|1|||
161047553|NCT01393964|581563925|FG001|Overall Study|Study drug toxicity|0|||
161047554|NCT01393964|581563926|FG002|Overall Study|Study drug toxicity|0|||
161047555|NCT01393964|581563924|FG000|Overall Study|Withdrawal by Subject|0|||
161047556|NCT01393964|581563925|FG001|Overall Study|Withdrawal by Subject|0|||
161047557|NCT01393964|581563926|FG002|Overall Study|Withdrawal by Subject|1|||
161047558|NCT01393964|581563924|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161047559|NCT01393964|581563925|FG001|Overall Study|Adverse event unrelated to study drug|3|||
161047560|NCT01393964|581563926|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161047561|NCT01393964|581563924|FG000|Overall Study|Subject request stop study treatment|0|||
161047562|NCT01393964|581563925|FG001|Overall Study|Subject request stop study treatment|1|||
161047563|NCT01393964|581563926|FG002|Overall Study|Subject request stop study treatment|0|||
161047564|NCT01393964|581563924|FG000|Overall Study|Subject decided to move to transplant|1|||
161047565|NCT01393964|581563925|FG001|Overall Study|Subject decided to move to transplant|0|||
161047566|NCT01393964|581563926|FG002|Overall Study|Subject decided to move to transplant|0|||
161047567|NCT01393964|581563924|FG000|Overall Study|Subject switched to commercial supply|1|||
161047568|NCT01393964|581563925|FG001|Overall Study|Subject switched to commercial supply|0|||
161047569|NCT01393964|581563926|FG002|Overall Study|Subject switched to commercial supply|2|||
161047570|NCT01393964|581563924|FG000|Overall Study|Subject plateaued in terms of effect|1|||
161047571|NCT01393964|581563925|FG001|Overall Study|Subject plateaued in terms of effect|0|||
161047572|NCT01393964|581563926|FG002|Overall Study|Subject plateaued in terms of effect|0|||
161047573|NCT01393964|581563924|FG000|Overall Study|Investigator removed subject from study|0|||
161047574|NCT01393964|581563925|FG001|Overall Study|Investigator removed subject from study|1|||
161047575|NCT01393964|581563926|FG002|Overall Study|Investigator removed subject from study|0|||
161047576|NCT01393964|581563924|FG000|Overall Study|Subject converted to roll-over study|0|||
161047577|NCT01393964|581563925|FG001|Overall Study|Subject converted to roll-over study|1|||
161047578|NCT01393964|581563926|FG002|Overall Study|Subject converted to roll-over study|0|||
161047579|NCT01393964|581563924|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
161047580|NCT01393964|581563925|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
161047581|NCT01393964|581563926|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
161047582|NCT02399449|581563931|FG000|Overall Study|Withdrawal by Subject|3|||
161047583|NCT02399449|581563932|FG001|Overall Study|Withdrawal by Subject|9|||
161047584|NCT02399449|581563931|FG000|Overall Study|Physician Decision|0|||
161047585|NCT02399449|581563932|FG001|Overall Study|Physician Decision|1|||
161047586|NCT01020435|581563933|FG000|Overall Study|Lost to Follow-up|0|||
161047587|NCT01020435|581563934|FG001|Overall Study|Lost to Follow-up|1|||
161047588|NCT00346398|581563935|FG000|Overall Study|Lost to Follow-up|3|||
161047589|NCT00346398|581563936|FG001|Overall Study|Lost to Follow-up|0|||
161047590|NCT00346398|581563935|FG000|Overall Study|Withdrawal by Subject|0|||
161047591|NCT00346398|581563936|FG001|Overall Study|Withdrawal by Subject|2|||
161047592|NCT03979040|581563937|FG000|Overall Study|Withdrawal by Subject|24|||
161047593|NCT03979040|581563938|FG001|Overall Study|Withdrawal by Subject|32|||
161047594|NCT03979040|581563937|FG000|Overall Study|randomized but never started treatment|32|||
161047595|NCT03979040|581563938|FG001|Overall Study|randomized but never started treatment|39|||
161047596|NCT03979040|581563937|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
161047597|NCT03979040|581563938|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
161047598|NCT02607956|581563939|FG000|Double-Blinded Phase|Withdrew Consent|17|||
161047599|NCT02607956|581563940|FG001|Double-Blinded Phase|Withdrew Consent|19|||
161047600|NCT02607956|581563941|FG002|Double-Blinded Phase|Withdrew Consent|0|||
161047601|NCT02607956|581563942|FG003|Double-Blinded Phase|Withdrew Consent|0|||
161047602|NCT02607956|581563939|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
161047603|NCT02607956|581563940|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
161047604|NCT02607956|581563941|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
161047605|NCT02607956|581563942|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
161047606|NCT02607956|581563939|FG000|Double-Blinded Phase|Randomized but never treated|7|||
161047607|NCT02607956|581563940|FG001|Double-Blinded Phase|Randomized but never treated|5|||
161047608|NCT02607956|581563941|FG002|Double-Blinded Phase|Randomized but never treated|0|||
161047609|NCT02607956|581563942|FG003|Double-Blinded Phase|Randomized but never treated|0|||
161047610|NCT02607956|581563939|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
161047611|NCT02607956|581563940|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
161047612|NCT02607956|581563941|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
161047613|NCT02607956|581563942|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
161047614|NCT02607956|581563939|FG000|Double-Blinded Phase|Death|4|||
161047615|NCT02607956|581563940|FG001|Double-Blinded Phase|Death|4|||
161047616|NCT02607956|581563941|FG002|Double-Blinded Phase|Death|0|||
161047617|NCT02607956|581563942|FG003|Double-Blinded Phase|Death|0|||
161047618|NCT02607956|581563939|FG000|Double-Blinded Phase|Adverse Event|4|||
161047619|NCT02607956|581563940|FG001|Double-Blinded Phase|Adverse Event|3|||
161047620|NCT02607956|581563941|FG002|Double-Blinded Phase|Adverse Event|0|||
161047621|NCT02607956|581563942|FG003|Double-Blinded Phase|Adverse Event|0|||
161047622|NCT02607956|581563939|FG000|Double-Blinded Phase|Protocol Violation|3|||
161047623|NCT02607956|581563940|FG001|Double-Blinded Phase|Protocol Violation|1|||
161047624|NCT02607956|581563941|FG002|Double-Blinded Phase|Protocol Violation|0|||
161047625|NCT02607956|581563942|FG003|Double-Blinded Phase|Protocol Violation|0|||
161047626|NCT02607956|581563939|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
161047627|NCT02607956|581563940|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
161047628|NCT02607956|581563941|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
161047629|NCT02607956|581563942|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
161047630|NCT02607956|581563939|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
161047631|NCT02607956|581563940|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
161047632|NCT02607956|581563941|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
161047633|NCT02607956|581563942|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
161047634|NCT02607956|581563939|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
161047635|NCT02607956|581563940|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
161047636|NCT02607956|581563941|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
161047637|NCT02607956|581563942|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
161047638|NCT02607956|581563939|FG000|Open-Label Extension Phase|Death|0|||
161047639|NCT02607956|581563940|FG001|Open-Label Extension Phase|Death|0|||
161344953|NCT03126110|582648863|FG014|Phase 1|Lost to Follow-up|0|||
161047640|NCT02607956|581563941|FG002|Open-Label Extension Phase|Death|1|||
161047641|NCT02607956|581563942|FG003|Open-Label Extension Phase|Death|3|||
161047642|NCT02607956|581563939|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
161047643|NCT02607956|581563940|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161047644|NCT02607956|581563941|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
161047645|NCT02607956|581563942|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
161047646|NCT02607956|581563939|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
161047647|NCT02607956|581563940|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
161047648|NCT02607956|581563941|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
161047649|NCT02607956|581563942|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
161047650|NCT02607956|581563939|FG000|Open-Label Extension Phase|Protocol Violation|0|||
161280794|NCT00996892|582407011|FG009|Dose-Escalation Stage 1A|Death|2|||
161280795|NCT00996892|582407012|FG010|Dose-Escalation Stage 1A|Death|0|||
161280796|NCT00996892|582407013|FG011|Dose-Escalation Stage 1A|Death|1|||
161280797|NCT00996892|582407014|FG012|Dose-Escalation Stage 1A|Death|1|||
161280798|NCT00996892|582407015|FG013|Dose-Escalation Stage 1A|Death|0|||
161047651|NCT02607956|581563940|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161047652|NCT02607956|581563941|FG002|Open-Label Extension Phase|Protocol Violation|0|||
161047653|NCT02607956|581563942|FG003|Open-Label Extension Phase|Protocol Violation|2|||
161047654|NCT02607956|581563939|FG000|Open-Label Extension Phase|Pregnancy|0|||
161047655|NCT02607956|581563940|FG001|Open-Label Extension Phase|Pregnancy|0|||
161047656|NCT02607956|581563941|FG002|Open-Label Extension Phase|Pregnancy|0|||
161047657|NCT02607956|581563942|FG003|Open-Label Extension Phase|Pregnancy|1|||
161047658|NCT00824850|581563951|FG000|Overall Study|Withdrawal by Subject|0|||
161047659|NCT00824850|581563952|FG001|Overall Study|Withdrawal by Subject|1|||
161047660|NCT01075152|581563953|FG000|Overall Study|Withdrawal by Subject|1|||
161047661|NCT01075152|581563954|FG001|Overall Study|Withdrawal by Subject|0|||
161047662|NCT01079949|581563957|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
161047663|NCT01079949|581563958|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
161047664|NCT01079949|581563957|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
161047665|NCT01079949|581563958|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
161047666|NCT01079949|581563957|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
161047667|NCT01079949|581563958|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
161047668|NCT01079949|581563957|FG000|Overall Study|Randomized but not treated|1|||
161047669|NCT01079949|581563958|FG001|Overall Study|Randomized but not treated|0|||
161047670|NCT03659136|581563963|FG000|Overall Study|Not treated|2|||
161047671|NCT03659136|581563964|FG001|Overall Study|Not treated|0|||
161047672|NCT03659136|581563963|FG000|Overall Study|Covid-19 related|1|||
161047673|NCT03659136|581563964|FG001|Overall Study|Covid-19 related|1|||
161047674|NCT03659136|581563963|FG000|Overall Study|Withdrawal by Subject|1|||
161047675|NCT03659136|581563964|FG001|Overall Study|Withdrawal by Subject|6|||
161047676|NCT03659136|581563963|FG000|Overall Study|Adverse Event|4|||
161047677|NCT03659136|581563964|FG001|Overall Study|Adverse Event|6|||
161047678|NCT03659136|581563963|FG000|Overall Study|Progressive disease|37|||
161047679|NCT03659136|581563964|FG001|Overall Study|Progressive disease|31|||
161047680|NCT03659136|581563963|FG000|Overall Study|Study closure|2|||
161047681|NCT03659136|581563964|FG001|Overall Study|Study closure|2|||
161047682|NCT03659136|581563963|FG000|Overall Study|Sponsor decision/recommendation|3|||
161047683|NCT03659136|581563964|FG001|Overall Study|Sponsor decision/recommendation|2|||
161047684|NCT03659136|581563963|FG000|Overall Study|Switched to other drug/therapy|2|||
161047685|NCT03659136|581563964|FG001|Overall Study|Switched to other drug/therapy|2|||
161047686|NCT03659136|581563963|FG000|Overall Study|Lack of clinical benefit|0|||
161047687|NCT03659136|581563964|FG001|Overall Study|Lack of clinical benefit|1|||
161047688|NCT00711555|581565903|FG000|Overall Study|Adverse Event|3|||
161047689|NCT05066230|581565906|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
161047690|NCT05066230|581565907|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
161047691|NCT05066230|581565906|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
161047692|NCT05066230|581565907|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
161047693|NCT05066230|581565906|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
161047694|NCT05066230|581565907|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
161047695|NCT05066230|581565906|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
161047696|NCT05066230|581565907|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
161047697|NCT05066230|581565906|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
161047698|NCT05066230|581565907|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
161047699|NCT05066230|581565906|FG000|After Week 48|Adverse Event|1|||
161047700|NCT05066230|581565907|FG001|After Week 48|Adverse Event|0|||
161047701|NCT05066230|581565906|FG000|After Week 48|Non-compliance with study schedule|1|||
161047702|NCT05066230|581565907|FG001|After Week 48|Non-compliance with study schedule|0|||
161047703|NCT05066230|581565906|FG000|After Week 48|Withdrawal by Subject|0|||
161047704|NCT05066230|581565907|FG001|After Week 48|Withdrawal by Subject|1|||
161047705|NCT05066230|581565906|FG000|After Week 48|Lost to Follow-up|3|||
161047706|NCT05066230|581565907|FG001|After Week 48|Lost to Follow-up|3|||
161047707|NCT05066230|581565906|FG000|After Week 48|Sponsor Request|115|||
161047708|NCT05066230|581565907|FG001|After Week 48|Sponsor Request|111|||
161280799|NCT00996892|582407016|FG014|Dose-Escalation Stage 1A|Death|0|||
161047709|NCT00813709|581565908|FG000|Double Blind Period|Adverse Event|4|||
161047710|NCT00813709|581565909|FG001|Double Blind Period|Adverse Event|1|||
161047711|NCT00813709|581565910|FG002|Double Blind Period|Adverse Event|4|||
161047712|NCT00813709|581565911|FG003|Double Blind Period|Adverse Event|0|||
161047713|NCT00813709|581565912|FG004|Double Blind Period|Adverse Event|0|||
161280800|NCT00996892|582407017|FG015|Dose-Escalation Stage 1A|Death|0|||
161280801|NCT00996892|582407018|FG016|Dose-Escalation Stage 1A|Death|0|||
161344954|NCT03126110|582648864|FG015|Phase 1|Lost to Follow-up|0|||
161047714|NCT00813709|581565913|FG005|Double Blind Period|Adverse Event|0|||
161280802|NCT00996892|582407019|FG017|Dose-Escalation Stage 1A|Death|0|||
161280803|NCT00996892|582407020|FG018|Dose-Escalation Stage 1A|Death|0|||
161344955|NCT03126110|582648865|FG016|Phase 1|Lost to Follow-up|0|||
161344956|NCT03126110|582648849|FG000|Phase 1|Withdrawal by Subject|1|||
161344957|NCT03126110|582648850|FG001|Phase 1|Withdrawal by Subject|0|||
161047715|NCT00813709|581565908|FG000|Double Blind Period|Lost to Follow-up|3|||
161047716|NCT00813709|581565909|FG001|Double Blind Period|Lost to Follow-up|2|||
161047717|NCT00813709|581565910|FG002|Double Blind Period|Lost to Follow-up|2|||
161047718|NCT00813709|581565911|FG003|Double Blind Period|Lost to Follow-up|0|||
161047719|NCT00813709|581565912|FG004|Double Blind Period|Lost to Follow-up|0|||
161047720|NCT00813709|581565913|FG005|Double Blind Period|Lost to Follow-up|0|||
161047721|NCT00813709|581565908|FG000|Double Blind Period|Switched to open label phase|9|||
161047722|NCT00813709|581565909|FG001|Double Blind Period|Switched to open label phase|26|||
161047723|NCT00813709|581565910|FG002|Double Blind Period|Switched to open label phase|18|||
161047724|NCT00813709|581565911|FG003|Double Blind Period|Switched to open label phase|0|||
161047725|NCT00813709|581565912|FG004|Double Blind Period|Switched to open label phase|0|||
161047726|NCT00813709|581565913|FG005|Double Blind Period|Switched to open label phase|0|||
161047727|NCT00813709|581565908|FG000|Double Blind Period|Randomized but not treated|1|||
161047728|NCT00813709|581565909|FG001|Double Blind Period|Randomized but not treated|3|||
161047729|NCT00813709|581565910|FG002|Double Blind Period|Randomized but not treated|1|||
161047730|NCT00813709|581565911|FG003|Double Blind Period|Randomized but not treated|0|||
161047731|NCT00813709|581565912|FG004|Double Blind Period|Randomized but not treated|0|||
161047732|NCT00813709|581565913|FG005|Double Blind Period|Randomized but not treated|0|||
161047733|NCT00813709|581565908|FG000|Double Blind Period|Other|14|||
161047734|NCT00813709|581565909|FG001|Double Blind Period|Other|9|||
161047735|NCT00813709|581565910|FG002|Double Blind Period|Other|6|||
161047736|NCT00813709|581565911|FG003|Double Blind Period|Other|0|||
161047737|NCT00813709|581565912|FG004|Double Blind Period|Other|0|||
161047738|NCT00813709|581565913|FG005|Double Blind Period|Other|0|||
161047739|NCT00813709|581565908|FG000|Open Label Period|Adverse Event|0|||
161047740|NCT00813709|581565909|FG001|Open Label Period|Adverse Event|0|||
161047741|NCT00813709|581565910|FG002|Open Label Period|Adverse Event|0|||
161047742|NCT00813709|581565911|FG003|Open Label Period|Adverse Event|5|||
161047743|NCT00813709|581565912|FG004|Open Label Period|Adverse Event|4|||
161047744|NCT00813709|581565913|FG005|Open Label Period|Adverse Event|3|||
161047745|NCT00813709|581565908|FG000|Open Label Period|Lack of Efficacy|0|||
161047746|NCT00813709|581565909|FG001|Open Label Period|Lack of Efficacy|0|||
161047747|NCT00813709|581565910|FG002|Open Label Period|Lack of Efficacy|0|||
161047748|NCT00813709|581565911|FG003|Open Label Period|Lack of Efficacy|3|||
161047749|NCT00813709|581565912|FG004|Open Label Period|Lack of Efficacy|1|||
161047750|NCT00813709|581565913|FG005|Open Label Period|Lack of Efficacy|1|||
161047751|NCT00813709|581565908|FG000|Open Label Period|Randomized but not treated|0|||
161047752|NCT00813709|581565909|FG001|Open Label Period|Randomized but not treated|0|||
161047753|NCT00813709|581565910|FG002|Open Label Period|Randomized but not treated|0|||
161047754|NCT00813709|581565911|FG003|Open Label Period|Randomized but not treated|1|||
161047755|NCT00813709|581565912|FG004|Open Label Period|Randomized but not treated|0|||
161047756|NCT00813709|581565913|FG005|Open Label Period|Randomized but not treated|1|||
161047757|NCT00813709|581565908|FG000|Open Label Period|Other|0|||
161047758|NCT00813709|581565909|FG001|Open Label Period|Other|0|||
161047759|NCT00813709|581565910|FG002|Open Label Period|Other|0|||
161047760|NCT00813709|581565911|FG003|Open Label Period|Other|11|||
161047761|NCT00813709|581565912|FG004|Open Label Period|Other|5|||
161047762|NCT00813709|581565913|FG005|Open Label Period|Other|6|||
161047763|NCT01123356|581565914|FG000|Overall Study|Adverse Event|2|||
161047764|NCT01123356|581565914|FG000|Overall Study|Lack of Efficacy|4|||
161047765|NCT01123356|581565914|FG000|Overall Study|Withdrawal by Subject|1|||
161047766|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
161047767|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
161047768|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
161047769|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
161047770|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
161047771|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
161047772|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
161047773|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
161150356|NCT01426386|581931888|FG005|Overall Study|Personal reasons|0|||
161150357|NCT03694522|581931889|FG000|Overall Study|Withdrawal by Subject|8|||
161047774|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
161047775|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
161047776|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
161047777|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
161047778|NCT01494467|581565917|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
161047779|NCT01494467|581565918|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
161047780|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
161047781|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
161047782|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
161150358|NCT03694522|581931890|FG001|Overall Study|Withdrawal by Subject|10|||
161344958|NCT03126110|582648851|FG002|Phase 1|Withdrawal by Subject|0|||
161047783|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
161047784|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
161047785|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
161047786|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
161047787|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
161047788|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
161047789|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
161047790|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
161047791|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
161047792|NCT01494467|581565917|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
161047793|NCT01494467|581565918|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
161047794|NCT02410278|581565919|FG000|Run-in Period|Adverse Event|5|||
161047795|NCT02410278|581565920|FG001|Run-in Period|Adverse Event|0|||
161047796|NCT02410278|581565921|FG002|Run-in Period|Adverse Event|0|||
161047797|NCT02410278|581565919|FG000|Run-in Period|GSRS Threshold Not Met|30|||
161047798|NCT02410278|581565920|FG001|Run-in Period|GSRS Threshold Not Met|0|||
161047799|NCT02410278|581565921|FG002|Run-in Period|GSRS Threshold Not Met|0|||
161047800|NCT02410278|581565919|FG000|Run-in Period|Lost to Follow-up|1|||
161047801|NCT02410278|581565920|FG001|Run-in Period|Lost to Follow-up|0|||
161047802|NCT02410278|581565921|FG002|Run-in Period|Lost to Follow-up|0|||
161047803|NCT02410278|581565919|FG000|Run-in Period|Withdrawal by Subject|1|||
161047804|NCT02410278|581565920|FG001|Run-in Period|Withdrawal by Subject|0|||
161047805|NCT02410278|581565921|FG002|Run-in Period|Withdrawal by Subject|0|||
161047806|NCT02410278|581565919|FG000|Run-in Period|Pregnancy|1|||
161047807|NCT02410278|581565920|FG001|Run-in Period|Pregnancy|0|||
161047808|NCT02410278|581565921|FG002|Run-in Period|Pregnancy|0|||
161047809|NCT02410278|581565919|FG000|Study Treatment Period|Adverse Event|0|||
161047810|NCT02410278|581565920|FG001|Study Treatment Period|Adverse Event|6|||
161047811|NCT02410278|581565921|FG002|Study Treatment Period|Adverse Event|3|||
161047812|NCT02410278|581565919|FG000|Study Treatment Period|Physician Decision|0|||
161047813|NCT02410278|581565920|FG001|Study Treatment Period|Physician Decision|0|||
161047814|NCT02410278|581565921|FG002|Study Treatment Period|Physician Decision|1|||
161047815|NCT02410278|581565919|FG000|Study Treatment Period|Withdrawal by Subject|0|||
161047816|NCT02410278|581565920|FG001|Study Treatment Period|Withdrawal by Subject|1|||
161047817|NCT02410278|581565921|FG002|Study Treatment Period|Withdrawal by Subject|0|||
161047818|NCT02410278|581565919|FG000|Study Treatment Period|Other|0|||
161047819|NCT02410278|581565920|FG001|Study Treatment Period|Other|3|||
161047820|NCT02410278|581565921|FG002|Study Treatment Period|Other|0|||
161047821|NCT02410278|581565919|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
161047822|NCT02410278|581565920|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
161047823|NCT02410278|581565921|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
161047824|NCT02584257|581565922|FG000|Period 1|Withdrawal by Subject|0|||
161047825|NCT02584257|581565923|FG001|Period 1|Withdrawal by Subject|0|||
161047826|NCT02584257|581565924|FG002|Period 1|Withdrawal by Subject|0|||
161047827|NCT02584257|581565925|FG003|Period 1|Withdrawal by Subject|0|||
161047828|NCT02584257|581565926|FG004|Period 1|Withdrawal by Subject|0|||
161047829|NCT02584257|581565927|FG005|Period 1|Withdrawal by Subject|0|||
161047830|NCT02584257|581565928|FG006|Period 1|Withdrawal by Subject|1|||
161047831|NCT02584257|581565929|FG007|Period 1|Withdrawal by Subject|0|||
161047832|NCT02584257|581565930|FG008|Period 1|Withdrawal by Subject|0|||
161047833|NCT02584257|581565922|FG000|Period 2|Physician Decision|1|||
161047834|NCT02584257|581565923|FG001|Period 2|Physician Decision|0|||
161047835|NCT02584257|581565924|FG002|Period 2|Physician Decision|0|||
161047836|NCT02584257|581565925|FG003|Period 2|Physician Decision|0|||
161047837|NCT02584257|581565926|FG004|Period 2|Physician Decision|0|||
161047838|NCT02584257|581565927|FG005|Period 2|Physician Decision|0|||
161047839|NCT02584257|581565928|FG006|Period 2|Physician Decision|0|||
161047840|NCT02584257|581565929|FG007|Period 2|Physician Decision|0|||
161047841|NCT02584257|581565930|FG008|Period 2|Physician Decision|0|||
161047842|NCT02584257|581565922|FG000|Period 2|Adverse Event|0|||
161047843|NCT02584257|581565923|FG001|Period 2|Adverse Event|1|||
161047844|NCT02584257|581565924|FG002|Period 2|Adverse Event|0|||
161047845|NCT02584257|581565925|FG003|Period 2|Adverse Event|0|||
161047846|NCT02584257|581565926|FG004|Period 2|Adverse Event|0|||
161047847|NCT02584257|581565927|FG005|Period 2|Adverse Event|0|||
161047848|NCT02584257|581565928|FG006|Period 2|Adverse Event|0|||
161047849|NCT02584257|581565929|FG007|Period 2|Adverse Event|0|||
161047850|NCT02584257|581565930|FG008|Period 2|Adverse Event|0|||
161047851|NCT01670877|581565931|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161047852|NCT01670877|581565932|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
161047853|NCT01670877|581565933|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161047854|NCT01670877|581565934|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161047855|NCT01670877|581565935|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161047856|NCT01670877|581565936|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
161047857|NCT01670877|581565931|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161150359|NCT03694522|581931889|FG000|Overall Study|Physician Decision|53|||
161150360|NCT03694522|581931890|FG001|Overall Study|Physician Decision|54|||
161150361|NCT03694522|581931889|FG000|Overall Study|Other|1|||
161150362|NCT03694522|581931890|FG001|Overall Study|Other|1|||
161150363|NCT03694522|581931889|FG000|Overall Study|Lost to Follow-up|0|||
161150364|NCT03694522|581931890|FG001|Overall Study|Lost to Follow-up|1|||
161150365|NCT02760407|581931891|FG000|Overall Study|Death|2|||
161150366|NCT02760407|581931892|FG001|Overall Study|Death|3|||
161150367|NCT02760407|581931893|FG002|Overall Study|Death|1|||
161150368|NCT02760407|581931894|FG003|Overall Study|Death|1|||
161150369|NCT02760407|581931891|FG000|Overall Study|Lost to Follow-up|1|||
161150370|NCT02760407|581931892|FG001|Overall Study|Lost to Follow-up|7|||
161150371|NCT02760407|581931893|FG002|Overall Study|Lost to Follow-up|4|||
161150372|NCT02760407|581931894|FG003|Overall Study|Lost to Follow-up|6|||
161150373|NCT02760407|581931891|FG000|Overall Study|Withdrawal by Subject|25|||
161150374|NCT02760407|581931892|FG001|Overall Study|Withdrawal by Subject|31|||
161150375|NCT02760407|581931893|FG002|Overall Study|Withdrawal by Subject|37|||
161150376|NCT02760407|581931894|FG003|Overall Study|Withdrawal by Subject|25|||
161150377|NCT02760407|581931891|FG000|Overall Study|Violation of Eligibility criteria|0|||
161150378|NCT02760407|581931892|FG001|Overall Study|Violation of Eligibility criteria|0|||
161150379|NCT02760407|581931893|FG002|Overall Study|Violation of Eligibility criteria|1|||
161150380|NCT02760407|581931894|FG003|Overall Study|Violation of Eligibility criteria|1|||
161150381|NCT02760407|581931891|FG000|Overall Study|Personal reasons|0|||
161150382|NCT02760407|581931892|FG001|Overall Study|Personal reasons|0|||
161150383|NCT02760407|581931893|FG002|Overall Study|Personal reasons|0|||
161150384|NCT02760407|581931894|FG003|Overall Study|Personal reasons|1|||
161150385|NCT02760407|581931891|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
161150386|NCT02760407|581931892|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161047858|NCT01670877|581565932|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161047859|NCT01670877|581565933|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
161047860|NCT01670877|581565934|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161047861|NCT01670877|581565935|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161047862|NCT01670877|581565936|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
161047863|NCT01670877|581565931|FG000|Part I and Part 2|Grade 2 vomiting|0|||
161047864|NCT01670877|581565932|FG001|Part I and Part 2|Grade 2 vomiting|0|||
161047865|NCT01670877|581565933|FG002|Part I and Part 2|Grade 2 vomiting|0|||
161047866|NCT01670877|581565934|FG003|Part I and Part 2|Grade 2 vomiting|1|||
161047867|NCT01670877|581565935|FG004|Part I and Part 2|Grade 2 vomiting|0|||
161047868|NCT01670877|581565936|FG005|Part I and Part 2|Grade 2 vomiting|0|||
161047869|NCT01670877|581565931|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161047870|NCT01670877|581565932|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161047871|NCT01670877|581565933|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161047872|NCT01670877|581565934|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
161047873|NCT01670877|581565935|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161047874|NCT01670877|581565936|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
161047875|NCT01670877|581565931|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161047876|NCT01670877|581565932|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161047877|NCT01670877|581565933|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161047878|NCT01670877|581565934|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
161047879|NCT01670877|581565935|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161150387|NCT02760407|581931893|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161150388|NCT02760407|581931894|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
161150389|NCT02760407|581931891|FG000|Overall Study|Use of prohibited Medication|0|||
161150390|NCT02760407|581931892|FG001|Overall Study|Use of prohibited Medication|0|||
161150391|NCT02760407|581931893|FG002|Overall Study|Use of prohibited Medication|1|||
161150392|NCT02760407|581931894|FG003|Overall Study|Use of prohibited Medication|0|||
161150393|NCT02760407|581931891|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161150394|NCT02760407|581931892|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161207105|NCT05004181|582138115|FG006|Overall Study|Not further specified|1|||
161207106|NCT05004181|582138116|FG007|Overall Study|Not further specified|0|||
161207107|NCT05004181|582138117|FG008|Overall Study|Not further specified|2|||
161207108|NCT05004181|582138118|FG009|Overall Study|Not further specified|1|||
161207109|NCT05004181|582138119|FG010|Overall Study|Not further specified|0|||
161207110|NCT05004181|582138120|FG011|Overall Study|Not further specified|1|||
161207111|NCT03868059|582138122|FG000|Overall Study|Adverse Event|3|||
161207112|NCT03868059|582138122|FG000|Overall Study|Lost to Follow-up|3|||
161207113|NCT03868059|582138122|FG000|Overall Study|Withdrawal by Subject|6|||
161207114|NCT02949219|582138129|FG000|Overall Study|Withdrawal by Subject|1|||
161207115|NCT04278872|582138130|FG000|Overall Study|Adverse Event|1|||
161207116|NCT04278872|582138131|FG001|Overall Study|Adverse Event|0|||
161207117|NCT04278872|582138130|FG000|Overall Study|Protocol Violation|0|||
161047880|NCT01670877|581565936|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
161047881|NCT02309892|581565937|FG000|Overall Study|Physician Decision|1|||
161047882|NCT02309892|581565938|FG001|Overall Study|Physician Decision|0|||
161047883|NCT02309892|581565939|FG002|Overall Study|Physician Decision|0|||
161047884|NCT02309892|581565940|FG003|Overall Study|Physician Decision|0|||
161047885|NCT02309892|581565941|FG004|Overall Study|Physician Decision|0|||
161047886|NCT02309892|581565942|FG005|Overall Study|Physician Decision|0|||
161047887|NCT02309892|581565943|FG006|Overall Study|Physician Decision|0|||
161047888|NCT02309892|581565937|FG000|Overall Study|Adverse Event|1|||
161047889|NCT02309892|581565938|FG001|Overall Study|Adverse Event|0|||
161047890|NCT02309892|581565939|FG002|Overall Study|Adverse Event|1|||
161047891|NCT02309892|581565940|FG003|Overall Study|Adverse Event|0|||
161047892|NCT02309892|581565941|FG004|Overall Study|Adverse Event|0|||
161047893|NCT02309892|581565942|FG005|Overall Study|Adverse Event|0|||
161047894|NCT02309892|581565943|FG006|Overall Study|Adverse Event|0|||
161047895|NCT02309892|581565937|FG000|Overall Study|Progressive Disease|0|||
161047896|NCT02309892|581565938|FG001|Overall Study|Progressive Disease|1|||
161047897|NCT02309892|581565939|FG002|Overall Study|Progressive Disease|0|||
161047898|NCT02309892|581565940|FG003|Overall Study|Progressive Disease|0|||
161047899|NCT02309892|581565941|FG004|Overall Study|Progressive Disease|1|||
161047900|NCT02309892|581565942|FG005|Overall Study|Progressive Disease|0|||
161047901|NCT02309892|581565943|FG006|Overall Study|Progressive Disease|0|||
161047902|NCT02309892|581565937|FG000|Overall Study|Death|0|||
161047903|NCT02309892|581565938|FG001|Overall Study|Death|0|||
161047904|NCT02309892|581565939|FG002|Overall Study|Death|0|||
161047905|NCT02309892|581565940|FG003|Overall Study|Death|0|||
161047906|NCT02309892|581565941|FG004|Overall Study|Death|0|||
161047907|NCT02309892|581565942|FG005|Overall Study|Death|1|||
161047908|NCT02309892|581565943|FG006|Overall Study|Death|0|||
161047909|NCT05376397|581565946|FG000|Overall Study|Lost to Follow-up|1|||
161047910|NCT02721147|581565947|FG000|Overall Study|Lost to Follow-up|2|||
161047911|NCT02721147|581565948|FG001|Overall Study|Lost to Follow-up|0|||
161047912|NCT02721147|581565949|FG002|Overall Study|Lost to Follow-up|0|||
161047913|NCT01722097|581565950|FG000|Overall Study|Patient sheets not returned|6|||
161047914|NCT01722097|581565951|FG001|Overall Study|Patient sheets not returned|5|||
161047915|NCT01535261|581565953|FG000|Overall Study|Physician Decision|8|||
161047916|NCT01535261|581565953|FG000|Overall Study|Protocol Violation|3|||
161047917|NCT01535261|581565953|FG000|Overall Study|Death|5|||
161047918|NCT01535261|581565953|FG000|Overall Study|Lost to Follow-up|8|||
161047919|NCT01535261|581565953|FG000|Overall Study|Withdrawal by Subject|14|||
161047920|NCT01535261|581565953|FG000|Overall Study|Adverse Event|12|||
161047921|NCT01137682|581565956|FG000|Overall Study|Adverse Event-CORE|2|||
161047922|NCT01137682|581565957|FG001|Overall Study|Adverse Event-CORE|4|||
161047923|NCT01137682|581565958|FG002|Overall Study|Adverse Event-CORE|0|||
161047924|NCT01137682|581565956|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
161047925|NCT01137682|581565957|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
161047926|NCT01137682|581565958|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
161047927|NCT01137682|581565956|FG000|Overall Study|Administrative problems-CORE|2|||
161047928|NCT01137682|581565957|FG001|Overall Study|Administrative problems-CORE|1|||
161047929|NCT01137682|581565958|FG002|Overall Study|Administrative problems-CORE|0|||
161047930|NCT01137682|581565956|FG000|Overall Study|Protocol Violation-CORE|0|||
161047931|NCT01137682|581565957|FG001|Overall Study|Protocol Violation-CORE|1|||
161047932|NCT01137682|581565958|FG002|Overall Study|Protocol Violation-CORE|1|||
161047933|NCT01137682|581565956|FG000|Overall Study|Adverse Event-Extension|4|||
161047934|NCT01137682|581565957|FG001|Overall Study|Adverse Event-Extension|8|||
161047935|NCT01137682|581565958|FG002|Overall Study|Adverse Event-Extension|7|||
161047936|NCT01137682|581565956|FG000|Overall Study|Lack of Efficacy-Extension|15|||
161047937|NCT01137682|581565957|FG001|Overall Study|Lack of Efficacy-Extension|9|||
161047938|NCT01137682|581565958|FG002|Overall Study|Lack of Efficacy-Extension|13|||
161047939|NCT01137682|581565956|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
161047940|NCT01137682|581565957|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
161047941|NCT01137682|581565958|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
161047942|NCT01137682|581565956|FG000|Overall Study|Lost to Follow Up-Extension|0|||
161047943|NCT01137682|581565957|FG001|Overall Study|Lost to Follow Up-Extension|1|||
161047944|NCT01137682|581565958|FG002|Overall Study|Lost to Follow Up-Extension|0|||
161047945|NCT01137682|581565956|FG000|Overall Study|Administrative problems-Extension|0|||
161047946|NCT01137682|581565957|FG001|Overall Study|Administrative problems-Extension|2|||
161047947|NCT01137682|581565958|FG002|Overall Study|Administrative problems-Extension|0|||
161047948|NCT01137682|581565956|FG000|Overall Study|Death-Extension|2|||
161047949|NCT01137682|581565957|FG001|Overall Study|Death-Extension|0|||
161047950|NCT01137682|581565958|FG002|Overall Study|Death-Extension|0|||
161047951|NCT01137682|581565956|FG000|Overall Study|Protocol Violation-Extension|2|||
161047952|NCT01137682|581565957|FG001|Overall Study|Protocol Violation-Extension|1|||
161047953|NCT01137682|581565958|FG002|Overall Study|Protocol Violation-Extension|0|||
161047954|NCT01137682|581565956|FG000|Overall Study|Did not enter extension|2|||
161047955|NCT01137682|581565957|FG001|Overall Study|Did not enter extension|3|||
161047956|NCT01137682|581565958|FG002|Overall Study|Did not enter extension|2|||
161047957|NCT01137682|581565956|FG000|Overall Study|Did not receive treatment in extension|0|||
161047958|NCT01137682|581565957|FG001|Overall Study|Did not receive treatment in extension|0|||
161047959|NCT01137682|581565958|FG002|Overall Study|Did not receive treatment in extension|1|||
161047960|NCT02009332|581565959|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161047961|NCT02009332|581565960|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
161047962|NCT02009332|581565961|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161047963|NCT02009332|581565962|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161047964|NCT02009332|581565963|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161047965|NCT02009332|581565964|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
161047966|NCT02009332|581565959|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161047967|NCT02009332|581565960|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161047968|NCT02009332|581565961|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161047969|NCT02009332|581565962|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161047970|NCT02009332|581565963|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
161047971|NCT02009332|581565964|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
161047972|NCT02009332|581565959|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161047973|NCT02009332|581565960|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161047974|NCT02009332|581565961|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161047975|NCT02009332|581565962|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161047976|NCT02009332|581565963|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
161047977|NCT02009332|581565964|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
161047978|NCT01912599|581565965|FG000|Overall Study|Withdrawal by Subject|0|||
161047979|NCT01912599|581565966|FG001|Overall Study|Withdrawal by Subject|1|||
161047980|NCT01280721|581565970|FG000|Overall Study|Adverse Event|4|||
161047981|NCT01280721|581565970|FG000|Overall Study|Physician Decision|3|||
161047982|NCT01280721|581565970|FG000|Overall Study|Withdrawal by Subject|6|||
161047983|NCT01280721|581565970|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
161047984|NCT01280721|581565970|FG000|Overall Study|No tolerability for the lowest dose|2|||
161047985|NCT01180400|581565971|FG000|Overall Study|Withdrawal by Subject|5|||
161047986|NCT01180400|581565972|FG001|Overall Study|Withdrawal by Subject|6|||
161047987|NCT01180400|581565971|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161047988|NCT01180400|581565972|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161047989|NCT01180400|581565971|FG000|Overall Study|Adverse Event|12|||
161047990|NCT01180400|581565972|FG001|Overall Study|Adverse Event|10|||
161047991|NCT01180400|581565971|FG000|Overall Study|Severe non-compliance to protocol|1|||
161047992|NCT01180400|581565972|FG001|Overall Study|Severe non-compliance to protocol|2|||
161047993|NCT01180400|581565971|FG000|Overall Study|Condition under investigation worsened|2|||
161047994|NCT01180400|581565972|FG001|Overall Study|Condition under investigation worsened|1|||
161047995|NCT01180400|581565971|FG000|Overall Study|Lack of Efficacy|2|||
161047996|NCT01180400|581565972|FG001|Overall Study|Lack of Efficacy|0|||
161047997|NCT01180400|581565971|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161047998|NCT01180400|581565972|FG001|Overall Study|Study-specific withdrawal criteria|2|||
161047999|NCT01180400|581565971|FG000|Overall Study|Lost to Follow-up|2|||
161048000|NCT01180400|581565972|FG001|Overall Study|Lost to Follow-up|3|||
161048001|NCT01180400|581565971|FG000|Overall Study|Other|0|||
161048002|NCT01180400|581565972|FG001|Overall Study|Other|1|||
161048003|NCT00042939|581565974|FG000|Overall Study|Adverse Event|6|||
161048004|NCT00042939|581565975|FG001|Overall Study|Adverse Event|7|||
161048005|NCT00042939|581565974|FG000|Overall Study|Death|3|||
161048006|NCT00042939|581565975|FG001|Overall Study|Death|2|||
161048007|NCT00042939|581565974|FG000|Overall Study|Withdrawal by Subject|3|||
161048008|NCT00042939|581565975|FG001|Overall Study|Withdrawal by Subject|4|||
161048009|NCT00042939|581565974|FG000|Overall Study|Other disease|1|||
161048010|NCT00042939|581565975|FG001|Overall Study|Other disease|0|||
161048011|NCT00042939|581565974|FG000|Overall Study|Ineligible|2|||
161048012|NCT00042939|581565975|FG001|Overall Study|Ineligible|2|||
161048013|NCT00042939|581565974|FG000|Overall Study|Deterioration of health|3|||
161048014|NCT00042939|581565975|FG001|Overall Study|Deterioration of health|4|||
161048015|NCT00042939|581565974|FG000|Overall Study|QOL diminished|1|||
161048016|NCT00042939|581565975|FG001|Overall Study|QOL diminished|0|||
161048017|NCT00042939|581565974|FG000|Overall Study|Rising ca 19-9|1|||
161048018|NCT00042939|581565975|FG001|Overall Study|Rising ca 19-9|0|||
161048019|NCT00042939|581565974|FG000|Overall Study|Patient non-compliance|1|||
161048020|NCT00042939|581565975|FG001|Overall Study|Patient non-compliance|0|||
161048021|NCT00042939|581565974|FG000|Overall Study|Still on treatment|1|||
161048022|NCT00042939|581565975|FG001|Overall Study|Still on treatment|0|||
161048023|NCT00042939|581565974|FG000|Overall Study|Treatment break > 4 weeks|0|||
161048024|NCT00042939|581565975|FG001|Overall Study|Treatment break > 4 weeks|1|||
161048025|NCT00042939|581565974|FG000|Overall Study|Did not start treatment|2|||
161048026|NCT00042939|581565975|FG001|Overall Study|Did not start treatment|1|||
161048027|NCT00795639|581565976|FG000|Overall Study|Death|1|||
161048028|NCT00795639|581565977|FG001|Overall Study|Death|6|||
161150395|NCT02760407|581931893|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
161150396|NCT02760407|581931894|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
161048029|NCT00795639|581565976|FG000|Overall Study|Withdrawal by Subject|1|||
161048030|NCT00795639|581565977|FG001|Overall Study|Withdrawal by Subject|3|||
161048031|NCT00795639|581565976|FG000|Overall Study|Pregnancy|1|||
161048032|NCT00795639|581565977|FG001|Overall Study|Pregnancy|0|||
161048033|NCT00795639|581565976|FG000|Overall Study|Adverse Event|5|||
161048034|NCT00795639|581565977|FG001|Overall Study|Adverse Event|2|||
161048035|NCT00795639|581565976|FG000|Overall Study|Other|0|||
161048036|NCT00795639|581565977|FG001|Overall Study|Other|2|||
161048037|NCT00795639|581565976|FG000|Overall Study|Terminated by sponsor|13|||
161048038|NCT00795639|581565977|FG001|Overall Study|Terminated by sponsor|12|||
161048039|NCT00795639|581565976|FG000|Overall Study|Randomized and not treated|0|||
161048040|NCT00795639|581565977|FG001|Overall Study|Randomized and not treated|1|||
161048041|NCT03349476|581565978|FG000|Overall Study|Physician Decision|3|||
161048042|NCT03449979|581565979|FG000|Overall Study|Technical difficulty|0|||
161048043|NCT03449979|581565980|FG001|Overall Study|Technical difficulty|0|||
161048044|NCT03449979|581565981|FG002|Overall Study|Technical difficulty|0|||
161048045|NCT03449979|581565982|FG003|Overall Study|Technical difficulty|1|||
161048046|NCT01762345|581565983|FG000|Overall Study|Adverse Event|5|||
161048047|NCT01762345|581565983|FG000|Overall Study|Protocol Violation|2|||
161048048|NCT02379078|581565984|FG000|Overall Study|Lost to Follow-up|33|||
161048049|NCT02379078|581565985|FG001|Overall Study|Lost to Follow-up|30|||
161048050|NCT02379078|581565984|FG000|Overall Study|Withdrawal by Subject|6|||
161048051|NCT02379078|581565985|FG001|Overall Study|Withdrawal by Subject|5|||
161048052|NCT03481725|581565986|FG000|Overall Study|Withdrawal by Subject|1|||
161048053|NCT03481725|581565987|FG001|Overall Study|Withdrawal by Subject|0|||
161048054|NCT03444155|581565990|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
161048055|NCT03444155|581565991|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
161048056|NCT02877680|581565992|FG000|Overall Study|Lost to Follow-up|1|||
161048057|NCT02877680|581565993|FG001|Overall Study|Lost to Follow-up|1|||
161048058|NCT01133678|581565994|FG000|Overall Study|Death|1|||
161048059|NCT01133678|581565995|FG001|Overall Study|Death|1|||
161048060|NCT01864200|581566002|FG000|Overall Study|Lost to Follow-up|1|||
161048061|NCT01864200|581566003|FG001|Overall Study|Lost to Follow-up|3|||
161048062|NCT01864200|581566002|FG000|Overall Study|Protocol Violation|1|||
161048063|NCT01864200|581566003|FG001|Overall Study|Protocol Violation|0|||
161048064|NCT02077374|581566008|FG000|Overall Study|Withdrawal by Subject|0|||
161048065|NCT02077374|581566009|FG001|Overall Study|Withdrawal by Subject|1|||
161048066|NCT02077374|581566008|FG000|Overall Study|Protocol Violation|0|||
161048067|NCT02077374|581566009|FG001|Overall Study|Protocol Violation|1|||
161048068|NCT01777932|581566010|FG000|Overall Study|Disease progression|136|||
161048069|NCT01777932|581566010|FG000|Overall Study|Death|3|||
161048070|NCT01777932|581566010|FG000|Overall Study|Adverse Event|34|||
161048071|NCT01777932|581566010|FG000|Overall Study|Lost to Follow-up|3|||
161048072|NCT01777932|581566010|FG000|Overall Study|Investigator decision|10|||
161048073|NCT01777932|581566010|FG000|Overall Study|Reimbursement limit|9|||
161048074|NCT01777932|581566010|FG000|Overall Study|Patient refused further treatment|10|||
161048075|NCT00068107|581566016|FG000|Overall Study|end-stage renal disease|6|||
161048076|NCT00068107|581566016|FG000|Overall Study|Death|2|||
161048077|NCT00068107|581566016|FG000|Overall Study|Withdrawal by Subject|1|||
161048078|NCT01419184|581566017|FG000|Overall Study|Site data not available|3|||
161048079|NCT01419184|581566018|FG001|Overall Study|Site data not available|2|||
161048080|NCT01419184|581566017|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
161048081|NCT01419184|581566018|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
161048082|NCT01419184|581566017|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
161048083|NCT01419184|581566018|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
161048084|NCT01419184|581566017|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
161048085|NCT01419184|581566018|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
161048086|NCT01419184|581566017|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
161048087|NCT01419184|581566018|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
161048088|NCT01419184|581566017|FG000|Overall Study|Participant randomized, not treated|1|||
161048089|NCT01419184|581566018|FG001|Overall Study|Participant randomized, not treated|0|||
161048090|NCT03989232|581566025|FG000|Overall Study|Lost to Follow-up|3|||
161150397|NCT02760407|581931891|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
161280804|NCT00996892|582407021|FG019|Dose-Escalation Stage 1A|Death|0|||
161280805|NCT00996892|582407002|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
161280806|NCT00996892|582407003|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
161280807|NCT00996892|582407004|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
161280808|NCT00996892|582407005|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
161048091|NCT03989232|581566026|FG001|Overall Study|Lost to Follow-up|10|||
161048092|NCT03989232|581566025|FG000|Overall Study|Withdrawal by Subject|6|||
161048093|NCT03989232|581566026|FG001|Overall Study|Withdrawal by Subject|6|||
161048094|NCT03989232|581566025|FG000|Overall Study|Death|1|||
161048095|NCT03989232|581566026|FG001|Overall Study|Death|2|||
161048096|NCT02644122|581566029|FG000|Overall Study|Withdrawal by Subject|1|||
161048097|NCT00424476|581566030|FG000|Overall Study|Withdrawal by Subject|7|||
161280809|NCT00996892|582407006|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
161150398|NCT02760407|581931892|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161150399|NCT02760407|581931893|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161150400|NCT02760407|581931894|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
161150401|NCT02760407|581931891|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
161150402|NCT02760407|581931892|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
161048098|NCT00424476|581566031|FG001|Overall Study|Withdrawal by Subject|6|||
161048099|NCT00424476|581566032|FG002|Overall Study|Withdrawal by Subject|3|||
161048100|NCT00424476|581566030|FG000|Overall Study|Adverse Event|19|||
161150403|NCT02760407|581931893|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
161150404|NCT02760407|581931894|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
161150405|NCT02760407|581931891|FG000|Overall Study|Inadequately Enrolled|0|||
161150406|NCT02760407|581931892|FG001|Overall Study|Inadequately Enrolled|0|||
161150407|NCT02760407|581931893|FG002|Overall Study|Inadequately Enrolled|0|||
161150408|NCT02760407|581931894|FG003|Overall Study|Inadequately Enrolled|1|||
161150409|NCT02760407|581931891|FG000|Overall Study|Withdrawal By PI's Decision|0|||
161150410|NCT02760407|581931892|FG001|Overall Study|Withdrawal By PI's Decision|1|||
161150411|NCT02760407|581931893|FG002|Overall Study|Withdrawal By PI's Decision|0|||
161150412|NCT02760407|581931894|FG003|Overall Study|Withdrawal By PI's Decision|0|||
161150413|NCT02760407|581931891|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
161150414|NCT02760407|581931892|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
161150415|NCT02760407|581931893|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
161150416|NCT02760407|581931894|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
161150417|NCT02760407|581931891|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161150418|NCT02760407|581931892|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161150419|NCT02760407|581931893|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
161150420|NCT02760407|581931894|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
161150421|NCT02760407|581931891|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
161150422|NCT02760407|581931892|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161150423|NCT02760407|581931893|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161150424|NCT02760407|581931894|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
161150425|NCT02760407|581931891|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
161150426|NCT02760407|581931892|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
161150427|NCT02760407|581931893|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
161150428|NCT02760407|581931894|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
161150429|NCT02760407|581931891|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
161150430|NCT02760407|581931892|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161150431|NCT02760407|581931893|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161150432|NCT02760407|581931894|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
161150433|NCT02760407|581931891|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
161150434|NCT02760407|581931892|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161150435|NCT02760407|581931893|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161048101|NCT00424476|581566031|FG001|Overall Study|Adverse Event|16|||
161048102|NCT00424476|581566032|FG002|Overall Study|Adverse Event|15|||
161048103|NCT00424476|581566030|FG000|Overall Study|Lack of Efficacy|16|||
161048104|NCT00424476|581566031|FG001|Overall Study|Lack of Efficacy|12|||
161048105|NCT00424476|581566032|FG002|Overall Study|Lack of Efficacy|12|||
161048106|NCT00424476|581566030|FG000|Overall Study|Lack of Compliance|1|||
161048107|NCT00424476|581566031|FG001|Overall Study|Lack of Compliance|1|||
161048108|NCT00424476|581566032|FG002|Overall Study|Lack of Compliance|1|||
161150436|NCT02760407|581931894|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
161150437|NCT02760407|581931891|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
161150438|NCT02760407|581931892|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
161150439|NCT02760407|581931893|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
161150440|NCT02760407|581931894|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
161150441|NCT02760407|581931891|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
161150442|NCT02760407|581931892|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161150443|NCT02760407|581931893|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161280810|NCT00996892|582407007|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
161280811|NCT00996892|582407008|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
161280812|NCT00996892|582407009|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
161048109|NCT00424476|581566030|FG000|Overall Study|Lost to Follow-up|4|||
161048110|NCT00424476|581566031|FG001|Overall Study|Lost to Follow-up|6|||
161048111|NCT00424476|581566032|FG002|Overall Study|Lost to Follow-up|3|||
161048112|NCT00424476|581566030|FG000|Overall Study|Protocol Violation|7|||
161048113|NCT00424476|581566031|FG001|Overall Study|Protocol Violation|2|||
161048114|NCT00424476|581566032|FG002|Overall Study|Protocol Violation|3|||
161048115|NCT00424476|581566030|FG000|Overall Study|Physician Decision|3|||
161048116|NCT00424476|581566031|FG001|Overall Study|Physician Decision|2|||
161048117|NCT00424476|581566032|FG002|Overall Study|Physician Decision|3|||
161048118|NCT00424476|581566030|FG000|Overall Study|Other|4|||
161048119|NCT00424476|581566031|FG001|Overall Study|Other|3|||
161048120|NCT00424476|581566032|FG002|Overall Study|Other|9|||
161048121|NCT01930188|581566033|FG000|Overall Study|unclassified|4|||
161048122|NCT01930188|581566034|FG001|Overall Study|unclassified|5|||
161048123|NCT01930188|581566035|FG002|Overall Study|unclassified|3|||
161048124|NCT01930188|581566033|FG000|Overall Study|Missing follow-up information|2|||
161048125|NCT01930188|581566034|FG001|Overall Study|Missing follow-up information|2|||
161048126|NCT01930188|581566035|FG002|Overall Study|Missing follow-up information|3|||
161048127|NCT01930188|581566033|FG000|Overall Study|Lost to Follow-up|5|||
161048128|NCT01930188|581566034|FG001|Overall Study|Lost to Follow-up|2|||
161048129|NCT01930188|581566035|FG002|Overall Study|Lost to Follow-up|2|||
161048130|NCT01930188|581566033|FG000|Overall Study|Death|2|||
161048131|NCT01930188|581566034|FG001|Overall Study|Death|1|||
161048132|NCT01930188|581566035|FG002|Overall Study|Death|3|||
161048133|NCT01930188|581566033|FG000|Overall Study|Withdrawal by Subject|9|||
161048134|NCT01930188|581566034|FG001|Overall Study|Withdrawal by Subject|11|||
161048135|NCT01930188|581566035|FG002|Overall Study|Withdrawal by Subject|8|||
161048136|NCT02514824|581566036|FG000|Overall Study|Withdrawal by Subject|1|||
161048137|NCT02514824|581566037|FG001|Overall Study|Withdrawal by Subject|0|||
161048138|NCT02514824|581566038|FG002|Overall Study|Withdrawal by Subject|0|||
161048139|NCT02514824|581566039|FG003|Overall Study|Withdrawal by Subject|0|||
161048140|NCT02514824|581566036|FG000|Overall Study|Dose-Limiting Toxicity|0|||
161048141|NCT02514824|581566037|FG001|Overall Study|Dose-Limiting Toxicity|1|||
161048142|NCT02514824|581566038|FG002|Overall Study|Dose-Limiting Toxicity|0|||
161048143|NCT02514824|581566039|FG003|Overall Study|Dose-Limiting Toxicity|0|||
161048144|NCT02170207|581566042|FG000|Overall Study|Case report forms unavailable|5|||
161048145|NCT00657709|581566043|FG000|Overall Study|AE or Death|7|||
161048146|NCT00657709|581566044|FG001|Overall Study|AE or Death|7|||
161048147|NCT00657709|581566045|FG002|Overall Study|AE or Death|6|||
161048148|NCT00657709|581566046|FG003|Overall Study|AE or Death|7|||
161048149|NCT00657709|581566047|FG004|Overall Study|AE or Death|1|||
161048150|NCT00657709|581566043|FG000|Overall Study|Withdrawal by Subject|7|||
161048151|NCT00657709|581566044|FG001|Overall Study|Withdrawal by Subject|15|||
161048152|NCT00657709|581566045|FG002|Overall Study|Withdrawal by Subject|15|||
161048153|NCT00657709|581566046|FG003|Overall Study|Withdrawal by Subject|5|||
161048154|NCT00657709|581566047|FG004|Overall Study|Withdrawal by Subject|9|||
161048155|NCT00657709|581566043|FG000|Overall Study|Lost to Follow-up|9|||
161048156|NCT00657709|581566044|FG001|Overall Study|Lost to Follow-up|9|||
161048157|NCT00657709|581566045|FG002|Overall Study|Lost to Follow-up|7|||
161048158|NCT00657709|581566046|FG003|Overall Study|Lost to Follow-up|1|||
161048159|NCT00657709|581566047|FG004|Overall Study|Lost to Follow-up|21|||
161048160|NCT00657709|581566043|FG000|Overall Study|Protocol Violation|0|||
161048161|NCT00657709|581566044|FG001|Overall Study|Protocol Violation|2|||
161048162|NCT00657709|581566045|FG002|Overall Study|Protocol Violation|0|||
161048163|NCT00657709|581566046|FG003|Overall Study|Protocol Violation|1|||
161048164|NCT00657709|581566047|FG004|Overall Study|Protocol Violation|2|||
161048165|NCT03122860|581566048|FG000|Overall Study|Discontinued Before Treatment|1|||
161048166|NCT03122860|581566049|FG001|Overall Study|Discontinued Before Treatment|1|||
161048167|NCT03122860|581566050|FG002|Overall Study|Discontinued Before Treatment|2|||
161048168|NCT03122860|581566051|FG003|Overall Study|Discontinued Before Treatment|0|||
161048169|NCT03122860|581566052|FG004|Overall Study|Discontinued Before Treatment|1|||
161048170|NCT03122860|581566053|FG005|Overall Study|Discontinued Before Treatment|0|||
161048171|NCT03122860|581566048|FG000|Overall Study|Adverse Event|1|||
161048172|NCT03122860|581566049|FG001|Overall Study|Adverse Event|0|||
161048173|NCT03122860|581566050|FG002|Overall Study|Adverse Event|1|||
161048174|NCT03122860|581566051|FG003|Overall Study|Adverse Event|1|||
161048175|NCT03122860|581566052|FG004|Overall Study|Adverse Event|0|||
161048176|NCT03122860|581566053|FG005|Overall Study|Adverse Event|0|||
161048177|NCT03122860|581566048|FG000|Overall Study|Lost to Follow-up|5|||
161048178|NCT03122860|581566049|FG001|Overall Study|Lost to Follow-up|2|||
161048179|NCT03122860|581566050|FG002|Overall Study|Lost to Follow-up|3|||
161048180|NCT03122860|581566051|FG003|Overall Study|Lost to Follow-up|3|||
161048181|NCT03122860|581566052|FG004|Overall Study|Lost to Follow-up|5|||
161048182|NCT03122860|581566053|FG005|Overall Study|Lost to Follow-up|4|||
161048183|NCT03122860|581566048|FG000|Overall Study|Subject Non-Compliance|0|||
161048184|NCT03122860|581566049|FG001|Overall Study|Subject Non-Compliance|0|||
161207118|NCT04278872|582138131|FG001|Overall Study|Protocol Violation|1|||
161048185|NCT03122860|581566050|FG002|Overall Study|Subject Non-Compliance|1|||
161048186|NCT03122860|581566051|FG003|Overall Study|Subject Non-Compliance|0|||
161048187|NCT03122860|581566052|FG004|Overall Study|Subject Non-Compliance|0|||
161048188|NCT03122860|581566053|FG005|Overall Study|Subject Non-Compliance|0|||
161048189|NCT03122860|581566048|FG000|Overall Study|Withdrawal by Subject|3|||
161048190|NCT03122860|581566049|FG001|Overall Study|Withdrawal by Subject|2|||
161048191|NCT03122860|581566050|FG002|Overall Study|Withdrawal by Subject|5|||
161048192|NCT03122860|581566051|FG003|Overall Study|Withdrawal by Subject|7|||
161048193|NCT03122860|581566052|FG004|Overall Study|Withdrawal by Subject|9|||
161048194|NCT03122860|581566053|FG005|Overall Study|Withdrawal by Subject|8|||
161048195|NCT01138657|581566054|FG000|Overall Study|Adverse Event|3|||
161048196|NCT01138657|581566055|FG001|Overall Study|Adverse Event|10|||
161048197|NCT01138657|581566054|FG000|Overall Study|Lack of Efficacy|2|||
161048198|NCT01138657|581566055|FG001|Overall Study|Lack of Efficacy|1|||
161048199|NCT01138657|581566054|FG000|Overall Study|Lost to Follow-up|0|||
161048200|NCT01138657|581566055|FG001|Overall Study|Lost to Follow-up|3|||
161048201|NCT01138657|581566054|FG000|Overall Study|Miscellaneous Reasons|3|||
161048202|NCT01138657|581566055|FG001|Overall Study|Miscellaneous Reasons|4|||
161048203|NCT02574286|581566056|FG000|Overall Study|Adverse Event|3|||
161048204|NCT02574286|581566056|FG000|Overall Study|Withdrawal by Subject|2|||
161048205|NCT00090519|581566059|FG000|Overall Study|Adverse Event|5|||
161048206|NCT00090519|581566060|FG001|Overall Study|Adverse Event|4|||
161048207|NCT00090519|581566059|FG000|Overall Study|Death|9|||
161048208|NCT00090519|581566060|FG001|Overall Study|Death|9|||
161048209|NCT00090519|581566059|FG000|Overall Study|Lost to Follow-up|26|||
161048210|NCT00090519|581566060|FG001|Overall Study|Lost to Follow-up|29|||
161048211|NCT00090519|581566059|FG000|Overall Study|Withdrawal by Subject|28|||
161048212|NCT00090519|581566060|FG001|Overall Study|Withdrawal by Subject|29|||
161048213|NCT00090519|581566059|FG000|Overall Study|Physician Decision|2|||
161048214|NCT00090519|581566060|FG001|Overall Study|Physician Decision|3|||
161048215|NCT00090519|581566059|FG000|Overall Study|Sponsor Decision|3|||
161048216|NCT00090519|581566060|FG001|Overall Study|Sponsor Decision|1|||
161048217|NCT00960206|581566061|FG000|Overall Study|Death|7|||
161048218|NCT00960206|581566062|FG001|Overall Study|Death|4|||
161048219|NCT00960206|581566063|FG002|Overall Study|Death|1|||
161048220|NCT00960206|581566061|FG000|Overall Study|Unwilling/Unable to return|1|||
161048221|NCT00960206|581566062|FG001|Overall Study|Unwilling/Unable to return|2|||
161048222|NCT00960206|581566063|FG002|Overall Study|Unwilling/Unable to return|0|||
161048223|NCT00960206|581566061|FG000|Overall Study|Lost to Follow-up|8|||
161048224|NCT00960206|581566062|FG001|Overall Study|Lost to Follow-up|14|||
161048225|NCT00960206|581566063|FG002|Overall Study|Lost to Follow-up|8|||
161048226|NCT00960206|581566061|FG000|Overall Study|Withdrawal by Subject|2|||
161048227|NCT00960206|581566062|FG001|Overall Study|Withdrawal by Subject|4|||
161048228|NCT00960206|581566063|FG002|Overall Study|Withdrawal by Subject|0|||
161048229|NCT00960206|581566061|FG000|Overall Study|Revision of study component|2|||
161048230|NCT00960206|581566062|FG001|Overall Study|Revision of study component|2|||
161048231|NCT00960206|581566063|FG002|Overall Study|Revision of study component|2|||
161048232|NCT00960206|581566061|FG000|Overall Study|Missing 10 year data|20|||
161048233|NCT00960206|581566062|FG001|Overall Study|Missing 10 year data|1|||
161048234|NCT00960206|581566063|FG002|Overall Study|Missing 10 year data|1|||
161048235|NCT02326220|581566068|FG000|Double-blind Treatment Period|Adverse Event|1|||
161048236|NCT02326220|581566069|FG001|Double-blind Treatment Period|Adverse Event|2|||
161048237|NCT02326220|581566070|FG002|Double-blind Treatment Period|Adverse Event|0|||
161048238|NCT02326220|581566068|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161048239|NCT02326220|581566069|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161048240|NCT02326220|581566070|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161048241|NCT02326220|581566068|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161048242|NCT02326220|581566069|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161048243|NCT02326220|581566070|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161048244|NCT02326220|581566068|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161048245|NCT02326220|581566069|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161048246|NCT02326220|581566070|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
161048247|NCT02326220|581566068|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161048248|NCT02326220|581566069|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161048249|NCT02326220|581566070|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
161048250|NCT02699099|581566071|FG000|Overall Study|Adverse Event|1|||
161048251|NCT02699099|581566072|FG001|Overall Study|Adverse Event|0|||
161048252|NCT02699099|581566073|FG002|Overall Study|Adverse Event|2|||
161048253|NCT02699099|581566071|FG000|Overall Study|Lost to Follow-up|0|||
161048254|NCT02699099|581566072|FG001|Overall Study|Lost to Follow-up|1|||
161048255|NCT02699099|581566073|FG002|Overall Study|Lost to Follow-up|0|||
161048256|NCT02699099|581566071|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
161048257|NCT02699099|581566072|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
161048258|NCT02699099|581566073|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
161048259|NCT01240590|581566076|FG000|Phase I|Refused further treatment|0|||
161048260|NCT01240590|581566077|FG001|Phase I|Refused further treatment|0|||
161048261|NCT01240590|581566078|FG002|Phase I|Refused further treatment|3|||
161048262|NCT01240590|581566079|FG003|Phase I|Refused further treatment|0|||
161150444|NCT02760407|581931894|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
161048263|NCT01240590|581566080|FG004|Phase I|Refused further treatment|0|||
161048264|NCT01240590|581566076|FG000|Phase II|Refused further treatment|0|||
161048265|NCT01240590|581566077|FG001|Phase II|Refused further treatment|0|||
161048266|NCT01240590|581566078|FG002|Phase II|Refused further treatment|0|||
161048267|NCT01240590|581566079|FG003|Phase II|Refused further treatment|2|||
161048268|NCT01240590|581566080|FG004|Phase II|Refused further treatment|1|||
161048269|NCT02659540|581566081|FG000|Overall Study|Adverse Event|3|||
161048270|NCT02659540|581566082|FG001|Overall Study|Adverse Event|2|||
161048271|NCT02659540|581566081|FG000|Overall Study|Death|1|||
161048272|NCT02659540|581566082|FG001|Overall Study|Death|0|||
161048273|NCT02659540|581566081|FG000|Overall Study|Progressive disease|2|||
161048274|NCT02659540|581566082|FG001|Overall Study|Progressive disease|6|||
161048275|NCT02548585|581566083|FG000|Overall Study|Withdrawal by Subject|0|||
161048276|NCT02548585|581566084|FG001|Overall Study|Withdrawal by Subject|0|||
161048277|NCT02548585|581566085|FG002|Overall Study|Withdrawal by Subject|0|||
161048278|NCT02548585|581566086|FG003|Overall Study|Withdrawal by Subject|0|||
161048279|NCT02548585|581566087|FG004|Overall Study|Withdrawal by Subject|0|||
161048280|NCT02548585|581566088|FG005|Overall Study|Withdrawal by Subject|1|||
161048281|NCT02548585|581566089|FG006|Overall Study|Withdrawal by Subject|0|||
161048282|NCT02548585|581566083|FG000|Overall Study|Lost to Follow-up|1|||
161048283|NCT02548585|581566084|FG001|Overall Study|Lost to Follow-up|0|||
161048284|NCT02548585|581566085|FG002|Overall Study|Lost to Follow-up|0|||
161048285|NCT02548585|581566086|FG003|Overall Study|Lost to Follow-up|0|||
161048286|NCT02548585|581566087|FG004|Overall Study|Lost to Follow-up|0|||
161048287|NCT02548585|581566088|FG005|Overall Study|Lost to Follow-up|0|||
161048288|NCT02548585|581566089|FG006|Overall Study|Lost to Follow-up|0|||
161048289|NCT02548585|581566083|FG000|Overall Study|Other|1|||
161048290|NCT02548585|581566084|FG001|Overall Study|Other|0|||
161048291|NCT02548585|581566085|FG002|Overall Study|Other|0|||
161048292|NCT02548585|581566086|FG003|Overall Study|Other|2|||
161048293|NCT02548585|581566087|FG004|Overall Study|Other|3|||
161048294|NCT02548585|581566088|FG005|Overall Study|Other|0|||
161048295|NCT02548585|581566089|FG006|Overall Study|Other|1|||
161048296|NCT02548585|581566083|FG000|Overall Study|Randomized but not treated|0|||
161048297|NCT02548585|581566084|FG001|Overall Study|Randomized but not treated|0|||
161048298|NCT02548585|581566085|FG002|Overall Study|Randomized but not treated|0|||
161048299|NCT02548585|581566086|FG003|Overall Study|Randomized but not treated|0|||
161048300|NCT02548585|581566087|FG004|Overall Study|Randomized but not treated|0|||
161048301|NCT02548585|581566088|FG005|Overall Study|Randomized but not treated|1|||
161048302|NCT02548585|581566089|FG006|Overall Study|Randomized but not treated|0|||
161048303|NCT04820491|581566094|FG000|Overall Study|Withdrawal by Subject|1|||
161048304|NCT04820491|581566095|FG001|Overall Study|Withdrawal by Subject|0|||
161048305|NCT00452452|581566096|FG000|Overall Study|Protocol Violation|0|||
161048306|NCT00452452|581566097|FG001|Overall Study|Protocol Violation|0|||
161048307|NCT00452452|581566098|FG002|Overall Study|Protocol Violation|1|||
161048308|NCT00452452|581566096|FG000|Overall Study|Withdrawal by Subject|1|||
161048309|NCT00452452|581566097|FG001|Overall Study|Withdrawal by Subject|0|||
161048310|NCT00452452|581566098|FG002|Overall Study|Withdrawal by Subject|0|||
161048311|NCT00452452|581566096|FG000|Overall Study|Lost to Follow-up|1|||
161048312|NCT00452452|581566097|FG001|Overall Study|Lost to Follow-up|0|||
161048313|NCT00452452|581566098|FG002|Overall Study|Lost to Follow-up|0|||
161048314|NCT03020914|581567989|FG000|Overall Study|Surgery Cancelled|1|||
161048315|NCT03020914|581567990|FG001|Overall Study|Surgery Cancelled|0|||
161048316|NCT03976102|581567991|FG000|Overall Study|Withdrawal by Subject|4|||
161048317|NCT03976102|581567992|FG001|Overall Study|Withdrawal by Subject|4|||
161048318|NCT03976102|581567991|FG000|Overall Study|Adverse Event|2|||
161048319|NCT03976102|581567992|FG001|Overall Study|Adverse Event|4|||
161048320|NCT03976102|581567991|FG000|Overall Study|Not related to Covid-19|9|||
161048321|NCT03976102|581567992|FG001|Overall Study|Not related to Covid-19|13|||
161048322|NCT03976102|581567991|FG000|Overall Study|Lost to Follow-up|0|||
161048323|NCT03976102|581567992|FG001|Overall Study|Lost to Follow-up|2|||
161048324|NCT03976102|581567991|FG000|Overall Study|Death|3|||
161048325|NCT03976102|581567992|FG001|Overall Study|Death|2|||
161048326|NCT03976102|581567991|FG000|Overall Study|Physician Decision|1|||
161048327|NCT03976102|581567992|FG001|Overall Study|Physician Decision|1|||
161048328|NCT03072238|581567997|FG000|Overall Study|Withdrawal by Subject|44|||
161048329|NCT03072238|581567998|FG001|Overall Study|Withdrawal by Subject|64|||
161048330|NCT03072238|581567997|FG000|Overall Study|Lost to Follow-up|14|||
161048331|NCT03072238|581567998|FG001|Overall Study|Lost to Follow-up|5|||
161048332|NCT03072238|581567997|FG000|Overall Study|Physician Decision|4|||
161048333|NCT03072238|581567998|FG001|Overall Study|Physician Decision|6|||
161048334|NCT03072238|581567997|FG000|Overall Study|Death|351|||
161048335|NCT03072238|581567998|FG001|Overall Study|Death|318|||
161048336|NCT03072238|581567997|FG000|Overall Study|Progressive Disease|3|||
161048337|NCT03072238|581567998|FG001|Overall Study|Progressive Disease|4|||
161048338|NCT03072238|581567997|FG000|Overall Study|Reason Not Specified|138|||
161048339|NCT03072238|581567998|FG001|Overall Study|Reason Not Specified|150|||
161048340|NCT02889900|581568004|FG000|Overall Study|Adverse Event|11|||
161048341|NCT02889900|581568004|FG000|Overall Study|Condition under investigation worsened|32|||
161048342|NCT02889900|581568004|FG000|Overall Study|Other|5|||
161207119|NCT04278872|582138130|FG000|Overall Study|Study Termination|2|||
161048343|NCT02889900|581568004|FG000|Overall Study|Withdrawal by Subject|7|||
161048344|NCT02889900|581568004|FG000|Overall Study|Not treated|2|||
161048345|NCT01416285|581568005|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
161048346|NCT01416285|581568006|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
161048347|NCT01248715|581568007|FG000|Overall Study|Not influenza positive|501|||
161048348|NCT01248715|581568008|FG001|Overall Study|Not influenza positive|510|||
161048349|NCT01919489|581568012|FG000|Overall Study|Rejected the need of injections|4|||
161048350|NCT01919489|581568013|FG001|Overall Study|Rejected the need of injections|7|||
161048351|NCT01919489|581568012|FG000|Overall Study|Adverse Event|10|||
161048352|NCT01919489|581568013|FG001|Overall Study|Adverse Event|0|||
161048353|NCT01919489|581568012|FG000|Overall Study|Hospital readmission|2|||
161048354|NCT01919489|581568013|FG001|Overall Study|Hospital readmission|9|||
161048355|NCT01919489|581568012|FG000|Overall Study|Death|2|||
161048356|NCT01919489|581568013|FG001|Overall Study|Death|1|||
161048357|NCT01919489|581568012|FG000|Overall Study|Lost to Follow-up|38|||
161048358|NCT01919489|581568013|FG001|Overall Study|Lost to Follow-up|27|||
161048359|NCT00857311|581568014|FG000|Overall Study|Lost to Follow-up|1|||
161048360|NCT00857311|581568015|FG001|Overall Study|Lost to Follow-up|0|||
161048361|NCT00857311|581568016|FG002|Overall Study|Lost to Follow-up|0|||
161048362|NCT00857311|581568017|FG003|Overall Study|Lost to Follow-up|0|||
161048363|NCT01587703|581568018|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
161048364|NCT01587703|581568019|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048365|NCT01587703|581568020|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048366|NCT01587703|581568021|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048367|NCT01587703|581568022|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048368|NCT01587703|581568023|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048369|NCT01587703|581568024|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048370|NCT01587703|581568025|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048371|NCT01587703|581568026|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048372|NCT01587703|581568027|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048373|NCT01587703|581568028|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048374|NCT01587703|581568029|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048375|NCT01587703|581568030|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048376|NCT01587703|581568031|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048377|NCT01587703|581568032|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048378|NCT01587703|581568033|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048379|NCT01587703|581568034|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048380|NCT01587703|581568035|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048381|NCT01587703|581568036|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
161048382|NCT01587703|581568018|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048383|NCT01587703|581568019|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048384|NCT01587703|581568020|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048385|NCT01587703|581568021|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048386|NCT01587703|581568022|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048387|NCT01587703|581568023|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
161048388|NCT01587703|581568024|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161280813|NCT00996892|582407010|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
161280814|NCT00996892|582407011|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
161280815|NCT00996892|582407012|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
161280816|NCT00996892|582407013|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
161280817|NCT00996892|582407014|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
161280818|NCT00996892|582407015|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
161280819|NCT00996892|582407016|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
161280820|NCT00996892|582407017|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
161344959|NCT03126110|582648852|FG003|Phase 1|Withdrawal by Subject|1|||
161048389|NCT01587703|581568025|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
161048390|NCT01587703|581568026|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161150445|NCT02760407|581931891|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
161207120|NCT04278872|582138131|FG001|Overall Study|Study Termination|0|||
161207121|NCT02044094|582138146|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
161207122|NCT02044094|582138146|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
161207123|NCT02044094|582138146|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
161207124|NCT02044094|582138146|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
161207125|NCT02044094|582138146|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
161207126|NCT02044094|582138146|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
161207127|NCT02044094|582138146|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
161207128|NCT02044094|582138146|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
161048391|NCT01587703|581568027|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048392|NCT01587703|581568028|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048393|NCT01587703|581568029|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048394|NCT01587703|581568030|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048395|NCT01587703|581568031|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048396|NCT01587703|581568032|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048397|NCT01587703|581568033|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048398|NCT01587703|581568034|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048399|NCT01587703|581568035|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048400|NCT01587703|581568036|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
161048401|NCT01587703|581568018|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048402|NCT01587703|581568019|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048403|NCT01587703|581568020|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048404|NCT01587703|581568021|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048405|NCT01587703|581568022|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048406|NCT01587703|581568023|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048407|NCT01587703|581568024|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
161048408|NCT01587703|581568025|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048409|NCT01587703|581568026|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048410|NCT01587703|581568027|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048411|NCT01587703|581568028|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048412|NCT01587703|581568029|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048413|NCT01587703|581568030|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048414|NCT01587703|581568031|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048415|NCT01587703|581568032|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048416|NCT01587703|581568033|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048417|NCT01587703|581568034|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048418|NCT01587703|581568035|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048419|NCT01587703|581568036|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
161048420|NCT01587703|581568018|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
161048421|NCT01587703|581568019|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
161048422|NCT01587703|581568020|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
161048423|NCT01587703|581568021|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
161048424|NCT01587703|581568022|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
161048425|NCT01587703|581568023|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
161048426|NCT01587703|581568024|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
161048427|NCT01587703|581568025|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
161048428|NCT01587703|581568026|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048429|NCT01587703|581568027|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048430|NCT01587703|581568028|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048431|NCT01587703|581568029|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048432|NCT01587703|581568030|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048433|NCT01587703|581568031|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048434|NCT01587703|581568032|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048435|NCT01587703|581568033|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048436|NCT01587703|581568034|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048437|NCT01587703|581568035|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048438|NCT01587703|581568036|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
161048439|NCT01587703|581568018|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048440|NCT01587703|581568019|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048441|NCT01587703|581568020|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048442|NCT01587703|581568021|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048443|NCT01587703|581568022|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048444|NCT01587703|581568023|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161150446|NCT02760407|581931892|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
161150447|NCT02760407|581931893|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
161150448|NCT02760407|581931894|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
161048445|NCT01587703|581568024|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161150449|NCT02137772|581931901|FG000|Overall Study|Adverse Event|6|||
161150450|NCT02137772|581931902|FG001|Overall Study|Adverse Event|3|||
161150451|NCT02137772|581931901|FG000|Overall Study|Death|71|||
161150452|NCT02137772|581931902|FG001|Overall Study|Death|44|||
161150453|NCT02137772|581931901|FG000|Overall Study|Lost to Follow-up|8|||
161280821|NCT00996892|582407018|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
161280822|NCT00996892|582407019|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
161280823|NCT00996892|582407020|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
161280824|NCT00996892|582407021|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
161280825|NCT00996892|582407002|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280826|NCT00996892|582407003|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161048446|NCT01587703|581568025|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048447|NCT01587703|581568026|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
161048448|NCT01587703|581568027|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
161048449|NCT01587703|581568028|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
161048450|NCT01587703|581568029|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048451|NCT01587703|581568030|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048452|NCT01587703|581568031|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048453|NCT01587703|581568032|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048454|NCT01587703|581568033|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048455|NCT01587703|581568034|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048456|NCT01587703|581568035|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048457|NCT01587703|581568036|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
161048458|NCT01587703|581568018|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048459|NCT01587703|581568019|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048460|NCT01587703|581568020|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048461|NCT01587703|581568021|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048462|NCT01587703|581568022|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048463|NCT01587703|581568023|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048464|NCT01587703|581568024|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048465|NCT01587703|581568025|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048466|NCT01587703|581568026|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
161048467|NCT01587703|581568027|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048468|NCT01587703|581568028|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
161048469|NCT01587703|581568029|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048470|NCT01587703|581568030|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048471|NCT01587703|581568031|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048472|NCT01587703|581568032|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048473|NCT01587703|581568033|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048474|NCT01587703|581568034|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048475|NCT01587703|581568035|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048476|NCT01587703|581568036|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
161048477|NCT01587703|581568018|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048478|NCT01587703|581568019|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048479|NCT01587703|581568020|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048480|NCT01587703|581568021|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048481|NCT01587703|581568022|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048482|NCT01587703|581568023|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048483|NCT01587703|581568024|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048484|NCT01587703|581568025|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048485|NCT01587703|581568026|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048486|NCT01587703|581568027|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
161048487|NCT01587703|581568028|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
161048488|NCT01587703|581568029|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048489|NCT01587703|581568030|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048490|NCT01587703|581568031|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048491|NCT01587703|581568032|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048492|NCT01587703|581568033|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048493|NCT01587703|581568034|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048494|NCT01587703|581568035|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048495|NCT01587703|581568036|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
161048496|NCT01587703|581568018|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048497|NCT01587703|581568019|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048498|NCT01587703|581568020|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048499|NCT01587703|581568021|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048500|NCT01587703|581568022|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048501|NCT01587703|581568023|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048502|NCT01587703|581568024|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048503|NCT01587703|581568025|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048504|NCT01587703|581568026|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
161150454|NCT02137772|581931902|FG001|Overall Study|Lost to Follow-up|4|||
161150455|NCT02137772|581931901|FG000|Overall Study|Physician Decision|15|||
161150456|NCT02137772|581931902|FG001|Overall Study|Physician Decision|5|||
161150457|NCT02137772|581931901|FG000|Overall Study|Withdrawal by Subject|28|||
161150458|NCT02137772|581931902|FG001|Overall Study|Withdrawal by Subject|17|||
161150459|NCT02137772|581931901|FG000|Overall Study|Non-compliance with study drug|1|||
161048505|NCT01587703|581568027|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048506|NCT01587703|581568028|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048507|NCT01587703|581568029|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048508|NCT01587703|581568030|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048509|NCT01587703|581568031|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048510|NCT01587703|581568032|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048511|NCT01587703|581568033|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048512|NCT01587703|581568034|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048513|NCT01587703|581568035|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048514|NCT01587703|581568036|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
161048515|NCT01587703|581568018|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048516|NCT01587703|581568019|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048517|NCT01587703|581568020|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048518|NCT01587703|581568021|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048519|NCT01587703|581568022|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048520|NCT01587703|581568023|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048521|NCT01587703|581568024|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048522|NCT01587703|581568025|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048523|NCT01587703|581568026|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048524|NCT01587703|581568027|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048525|NCT01587703|581568028|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048526|NCT01587703|581568029|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048527|NCT01587703|581568030|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048528|NCT01587703|581568031|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048529|NCT01587703|581568032|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048530|NCT01587703|581568033|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048531|NCT01587703|581568034|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048532|NCT01587703|581568035|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
161048533|NCT01587703|581568036|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
161048534|NCT01587703|581568018|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048535|NCT01587703|581568019|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048536|NCT01587703|581568020|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048537|NCT01587703|581568021|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048538|NCT01587703|581568022|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048539|NCT01587703|581568023|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048540|NCT01587703|581568024|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048541|NCT01587703|581568025|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048542|NCT01587703|581568026|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048543|NCT01587703|581568027|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048544|NCT01587703|581568028|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048545|NCT01587703|581568029|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048546|NCT01587703|581568030|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048547|NCT01587703|581568031|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048548|NCT01587703|581568032|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048549|NCT01587703|581568033|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048550|NCT01587703|581568034|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
161048551|NCT01587703|581568035|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
161048552|NCT01587703|581568036|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
161048553|NCT01587703|581568018|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048554|NCT01587703|581568019|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048555|NCT01587703|581568020|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048556|NCT01587703|581568021|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048557|NCT01587703|581568022|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048558|NCT01587703|581568023|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048559|NCT01587703|581568024|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048560|NCT01587703|581568025|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161344960|NCT03126110|582648853|FG004|Phase 1|Withdrawal by Subject|1|||
161344961|NCT03126110|582648854|FG005|Phase 1|Withdrawal by Subject|0|||
161048561|NCT01587703|581568026|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048562|NCT01587703|581568027|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048563|NCT01587703|581568028|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048564|NCT01587703|581568029|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161344962|NCT03126110|582648855|FG006|Phase 1|Withdrawal by Subject|0|||
161344963|NCT03126110|582648856|FG007|Phase 1|Withdrawal by Subject|0|||
161344964|NCT03126110|582648857|FG008|Phase 1|Withdrawal by Subject|2|||
161048565|NCT01587703|581568030|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048566|NCT01587703|581568031|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048567|NCT01587703|581568032|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048568|NCT01587703|581568033|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
161048569|NCT01587703|581568034|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048570|NCT01587703|581568035|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048571|NCT01587703|581568036|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
161048572|NCT01587703|581568018|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048573|NCT01587703|581568019|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161280827|NCT00996892|582407004|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280828|NCT00996892|582407005|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161048574|NCT01587703|581568020|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048575|NCT01587703|581568021|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048576|NCT01587703|581568022|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048577|NCT01587703|581568023|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048578|NCT01587703|581568024|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048579|NCT01587703|581568025|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048580|NCT01587703|581568026|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048581|NCT01587703|581568027|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048582|NCT01587703|581568028|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048583|NCT01587703|581568029|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
161048584|NCT01587703|581568030|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048585|NCT01587703|581568031|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048586|NCT01587703|581568032|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
161048587|NCT01587703|581568033|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048588|NCT01587703|581568034|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048589|NCT01587703|581568035|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048590|NCT01587703|581568036|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
161048591|NCT01587703|581568018|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048592|NCT01587703|581568019|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048593|NCT01587703|581568020|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048594|NCT01587703|581568021|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161280829|NCT00996892|582407006|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161048595|NCT01587703|581568022|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048596|NCT01587703|581568023|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048597|NCT01587703|581568024|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048598|NCT01587703|581568025|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048599|NCT01587703|581568026|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048600|NCT01587703|581568027|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048601|NCT01587703|581568028|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048602|NCT01587703|581568029|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
161048603|NCT01587703|581568030|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
161048604|NCT01587703|581568031|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
161048605|NCT01587703|581568032|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
161048606|NCT01587703|581568033|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
161048607|NCT01587703|581568034|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
161048608|NCT01587703|581568035|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048609|NCT01587703|581568036|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
161048610|NCT01587703|581568018|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048611|NCT01587703|581568019|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048612|NCT01587703|581568020|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048613|NCT01587703|581568021|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048614|NCT01587703|581568022|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
161280830|NCT00996892|582407007|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280831|NCT00996892|582407008|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280832|NCT00996892|582407009|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280833|NCT00996892|582407010|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161048615|NCT01587703|581568023|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048616|NCT01587703|581568024|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
161280834|NCT00996892|582407011|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161280835|NCT00996892|582407012|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161280836|NCT00996892|582407013|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161048617|NCT01587703|581568025|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048618|NCT01587703|581568026|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048619|NCT01587703|581568027|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048620|NCT01587703|581568028|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
161344965|NCT03126110|582648858|FG009|Phase 1|Withdrawal by Subject|1|||
161344966|NCT03126110|582648859|FG010|Phase 1|Withdrawal by Subject|0|||
161048621|NCT01587703|581568029|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
161048622|NCT01587703|581568030|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
161048623|NCT01587703|581568031|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
161048624|NCT01587703|581568032|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
161048625|NCT01587703|581568033|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
161048626|NCT01587703|581568034|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
161048627|NCT01587703|581568035|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048628|NCT01587703|581568036|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
161048629|NCT01587703|581568018|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048630|NCT01587703|581568019|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048631|NCT01587703|581568020|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048632|NCT01587703|581568021|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048633|NCT01587703|581568022|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048634|NCT01587703|581568023|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048635|NCT01587703|581568024|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048636|NCT01587703|581568025|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048637|NCT01587703|581568026|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048638|NCT01587703|581568027|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048639|NCT01587703|581568028|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048640|NCT01587703|581568029|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
161048641|NCT01587703|581568030|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048642|NCT01587703|581568031|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048643|NCT01587703|581568032|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048644|NCT01587703|581568033|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048645|NCT01587703|581568034|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048646|NCT01587703|581568035|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048647|NCT01587703|581568036|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
161048648|NCT04751929|581568037|FG000|Overall Study|Withdrawal by Subject|2|||
161048649|NCT04751929|581568038|FG001|Overall Study|Withdrawal by Subject|0|||
161048650|NCT04751929|581568039|FG002|Overall Study|Withdrawal by Subject|0|||
161048651|NCT04751929|581568040|FG003|Overall Study|Withdrawal by Subject|0|||
161048652|NCT04751929|581568037|FG000|Overall Study|Rising PSA|0|||
161048653|NCT04751929|581568038|FG001|Overall Study|Rising PSA|1|||
161048654|NCT04751929|581568039|FG002|Overall Study|Rising PSA|0|||
161048655|NCT04751929|581568040|FG003|Overall Study|Rising PSA|0|||
161048656|NCT04751929|581568037|FG000|Overall Study|Adverse Event|1|||
161048657|NCT04751929|581568038|FG001|Overall Study|Adverse Event|2|||
161048658|NCT04751929|581568039|FG002|Overall Study|Adverse Event|0|||
161048659|NCT04751929|581568040|FG003|Overall Study|Adverse Event|0|||
161048660|NCT04751929|581568037|FG000|Overall Study|Progressive Disease|3|||
161048661|NCT04751929|581568038|FG001|Overall Study|Progressive Disease|4|||
161048662|NCT04751929|581568039|FG002|Overall Study|Progressive Disease|4|||
161048663|NCT04751929|581568040|FG003|Overall Study|Progressive Disease|0|||
161048664|NCT04751929|581568037|FG000|Overall Study|Death|1|||
161048665|NCT04751929|581568038|FG001|Overall Study|Death|1|||
161048666|NCT04751929|581568039|FG002|Overall Study|Death|0|||
161048667|NCT04751929|581568040|FG003|Overall Study|Death|0|||
161048668|NCT00759681|581568041|FG000|Overall Study|Death|2|||
161048669|NCT00759681|581568042|FG001|Overall Study|Death|5|||
161048670|NCT00759681|581568041|FG000|Overall Study|Lost to Follow-up|8|||
161048671|NCT00759681|581568042|FG001|Overall Study|Lost to Follow-up|5|||
161048672|NCT00930644|581568043|FG000|Overall Study|Withdrawal by Subject|4|||
161048673|NCT00930644|581568043|FG000|Overall Study|Physician Decision|2|||
161048674|NCT00930644|581568043|FG000|Overall Study|Death|1|||
161048675|NCT00930644|581568043|FG000|Overall Study|Adverse Event|16|||
161048676|NCT00473512|581568046|FG000|Period 1 (Phase 1)|Adverse Event|0|||
161048677|NCT00473512|581568047|FG001|Period 1 (Phase 1)|Adverse Event|0|||
161048678|NCT00473512|581568048|FG002|Period 1 (Phase 1)|Adverse Event|0|||
161048679|NCT00473512|581568049|FG003|Period 1 (Phase 1)|Adverse Event|5|||
161048680|NCT00473512|581568050|FG004|Period 1 (Phase 1)|Adverse Event|0|||
161048681|NCT00473512|581568046|FG000|Period 1 (Phase 1)|Death|0|||
161048682|NCT00473512|581568047|FG001|Period 1 (Phase 1)|Death|0|||
161048683|NCT00473512|581568048|FG002|Period 1 (Phase 1)|Death|0|||
161048684|NCT00473512|581568049|FG003|Period 1 (Phase 1)|Death|1|||
161048685|NCT00473512|581568050|FG004|Period 1 (Phase 1)|Death|0|||
161048686|NCT00473512|581568046|FG000|Period 1 (Phase 1)|Disease Progression|1|||
161048687|NCT00473512|581568047|FG001|Period 1 (Phase 1)|Disease Progression|1|||
161048688|NCT00473512|581568048|FG002|Period 1 (Phase 1)|Disease Progression|0|||
161048689|NCT00473512|581568049|FG003|Period 1 (Phase 1)|Disease Progression|10|||
161048690|NCT00473512|581568050|FG004|Period 1 (Phase 1)|Disease Progression|1|||
161048691|NCT00473512|581568046|FG000|Period 1 (Phase 1)|Other|0|||
161048692|NCT00473512|581568047|FG001|Period 1 (Phase 1)|Other|0|||
161048693|NCT00473512|581568048|FG002|Period 1 (Phase 1)|Other|0|||
161048694|NCT00473512|581568049|FG003|Period 1 (Phase 1)|Other|1|||
161048695|NCT00473512|581568050|FG004|Period 1 (Phase 1)|Other|0|||
161048696|NCT00473512|581568046|FG000|Period 2 (Phase 2)|Adverse Event|0|||
161150460|NCT02137772|581931902|FG001|Overall Study|Non-compliance with study drug|0|||
161150461|NCT02137772|581931901|FG000|Overall Study|Not treated|3|||
161150462|NCT02137772|581931902|FG001|Overall Study|Not treated|2|||
161150463|NCT01844700|581931903|FG000|Overall Study|Lack of Efficacy|1|||
161150464|NCT01844700|581931904|FG001|Overall Study|Lack of Efficacy|0|||
161150465|NCT01844700|581931903|FG000|Overall Study|refused medication switch|1|||
161150466|NCT01844700|581931904|FG001|Overall Study|refused medication switch|0|||
161150467|NCT01844700|581931903|FG000|Overall Study|Withdrawal by Subject|1|||
161150468|NCT01844700|581931904|FG001|Overall Study|Withdrawal by Subject|0|||
161150469|NCT01844700|581931903|FG000|Overall Study|stopped taking meds|0|||
161150470|NCT01844700|581931904|FG001|Overall Study|stopped taking meds|1|||
161150471|NCT03290300|581931905|FG000|Overall Study|Lost to Follow-up|3|||
161150472|NCT00487279|581931906|FG000|Overall Study|Death|1|||
161150473|NCT00487279|581931907|FG001|Overall Study|Death|0|||
161150474|NCT00487279|581931906|FG000|Overall Study|Withdrawal by Subject|0|||
161150475|NCT00487279|581931907|FG001|Overall Study|Withdrawal by Subject|2|||
161150476|NCT01171521|581931910|FG000|Overall Study|Lost to Follow-up|5|||
161150477|NCT01171521|581931910|FG000|Overall Study|screen failure|1|||
161150478|NCT00492921|581931911|FG000|Overall Study|Death|1|||
161150479|NCT00492921|581931912|FG001|Overall Study|Death|0|||
161150480|NCT00492921|581931913|FG002|Overall Study|Death|1|||
161150481|NCT00652093|581931914|FG000|Overall Study|Withdrawal by Subject|0|||
161150482|NCT00652093|581931915|FG001|Overall Study|Withdrawal by Subject|0|||
161150483|NCT00652093|581931916|FG002|Overall Study|Withdrawal by Subject|1|||
161150484|NCT00652093|581931917|FG003|Overall Study|Withdrawal by Subject|0|||
161150485|NCT00652093|581931918|FG004|Overall Study|Withdrawal by Subject|1|||
161150486|NCT00652093|581931919|FG005|Overall Study|Withdrawal by Subject|0|||
161150487|NCT00652093|581931914|FG000|Overall Study|Physician Decision|0|||
161150488|NCT00652093|581931915|FG001|Overall Study|Physician Decision|0|||
161150489|NCT00652093|581931916|FG002|Overall Study|Physician Decision|0|||
161150490|NCT00652093|581931917|FG003|Overall Study|Physician Decision|0|||
161150491|NCT00652093|581931918|FG004|Overall Study|Physician Decision|1|||
161150492|NCT00652093|581931919|FG005|Overall Study|Physician Decision|0|||
161150493|NCT00469014|581931920|FG000|Initial Phase Randomization|Disease Progression|0|||
161150494|NCT00469014|581931921|FG001|Initial Phase Randomization|Disease Progression|1|||
161150495|NCT00469014|581931922|FG002|Initial Phase Randomization|Disease Progression|1|||
161150496|NCT00469014|581931923|FG003|Initial Phase Randomization|Disease Progression|0|||
161150497|NCT00469014|581931920|FG000|Initial Phase Randomization|No Response|1|||
161150498|NCT00469014|581931921|FG001|Initial Phase Randomization|No Response|0|||
161150499|NCT00469014|581931922|FG002|Initial Phase Randomization|No Response|0|||
161150500|NCT00469014|581931923|FG003|Initial Phase Randomization|No Response|1|||
161150501|NCT00469014|581931920|FG000|Adaptive Randomization|Not Evaluable|1|||
161150502|NCT00469014|581931921|FG001|Adaptive Randomization|Not Evaluable|0|||
161150503|NCT00469014|581931922|FG002|Adaptive Randomization|Not Evaluable|0|||
161150504|NCT00469014|581931923|FG003|Adaptive Randomization|Not Evaluable|1|||
161150505|NCT00469014|581931920|FG000|Adaptive Randomization|No Response|0|||
161150506|NCT00469014|581931921|FG001|Adaptive Randomization|No Response|1|||
161150507|NCT00469014|581931922|FG002|Adaptive Randomization|No Response|0|||
161150508|NCT00469014|581931923|FG003|Adaptive Randomization|No Response|0|||
161150509|NCT00469014|581931920|FG000|Adaptive Randomization|Death|0|||
161150510|NCT00469014|581931921|FG001|Adaptive Randomization|Death|0|||
161150511|NCT00469014|581931922|FG002|Adaptive Randomization|Death|1|||
161150512|NCT00469014|581931923|FG003|Adaptive Randomization|Death|0|||
161150513|NCT03461289|581931927|FG000|Overall Study|Death|1|||
161150514|NCT01519427|581931930|FG000|Overall Study|disease progression|2|||
161150515|NCT00633139|581931938|FG000|Overall Study|Non compliance|0|||
161150516|NCT00633139|581931939|FG001|Overall Study|Non compliance|0|||
161150517|NCT00633139|581931940|FG002|Overall Study|Non compliance|1|||
161150518|NCT00633139|581931938|FG000|Overall Study|Withdrawal by Subject|0|||
161150519|NCT00633139|581931939|FG001|Overall Study|Withdrawal by Subject|1|||
161150520|NCT00633139|581931940|FG002|Overall Study|Withdrawal by Subject|0|||
161150521|NCT02269319|581931941|FG000|Overall Study|Lost to Follow-up|4|||
161150522|NCT02269319|581931942|FG001|Overall Study|Lost to Follow-up|3|||
161150523|NCT02269319|581931941|FG000|Overall Study|Adverse Event|0|||
161150524|NCT02269319|581931942|FG001|Overall Study|Adverse Event|1|||
161150525|NCT02269319|581931941|FG000|Overall Study|Instructions not followed|1|||
161150526|NCT02269319|581931942|FG001|Overall Study|Instructions not followed|0|||
161150527|NCT02819310|581933507|FG000|Overall Study|Withdrawal by Subject|37|||
161150528|NCT02819310|581933507|FG000|Overall Study|Lost to Follow-up|16|||
161150529|NCT02819310|581933507|FG000|Overall Study|Adverse Event|13|||
161150530|NCT02819310|581933507|FG000|Overall Study|Lack of Efficacy|5|||
161280837|NCT00996892|582407014|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
161150531|NCT02819310|581933507|FG000|Overall Study|Physician Decision|8|||
161150532|NCT02819310|581933507|FG000|Overall Study|Protocol Violation|30|||
161150533|NCT02778867|581933511|FG000|Phase 1|Withdrawal by Subject|2|||
161150534|NCT02778867|581933512|FG001|Phase 1|Withdrawal by Subject|3|||
161150535|NCT02778867|581933513|FG002|Phase 1|Withdrawal by Subject|0|||
161150536|NCT02778867|581933514|FG003|Phase 1|Withdrawal by Subject|0|||
161150537|NCT02778867|581933511|FG000|Phase 2|Withdrawal by Subject|0|||
161150538|NCT02778867|581933512|FG001|Phase 2|Withdrawal by Subject|0|||
161150539|NCT02778867|581933513|FG002|Phase 2|Withdrawal by Subject|1|||
161150540|NCT02778867|581933514|FG003|Phase 2|Withdrawal by Subject|0|||
161150541|NCT02778867|581933511|FG000|Phase 2|Physician Decision|0|||
161150542|NCT02778867|581933512|FG001|Phase 2|Physician Decision|0|||
161150543|NCT02778867|581933513|FG002|Phase 2|Physician Decision|0|||
161150544|NCT02778867|581933514|FG003|Phase 2|Physician Decision|1|||
161150545|NCT02778867|581933511|FG000|Phase 2|Adverse Event|0|||
161150546|NCT02778867|581933512|FG001|Phase 2|Adverse Event|0|||
161150547|NCT02778867|581933513|FG002|Phase 2|Adverse Event|0|||
161150548|NCT02778867|581933514|FG003|Phase 2|Adverse Event|1|||
161150549|NCT02311478|581933515|FG000|Overall Study|Withdrawal by Subject|1|||
161150550|NCT02311478|581933515|FG000|Overall Study|Lost to Follow-up|5|||
161150551|NCT02311478|581933515|FG000|Overall Study|Failed IUD Insertion|1|||
161150552|NCT03276936|581933516|FG000|Overall Study|Adverse Event|4|||
161150553|NCT03276936|581933517|FG001|Overall Study|Adverse Event|2|||
161150554|NCT03276936|581933516|FG000|Overall Study|Lost to Follow-up|16|||
161150555|NCT03276936|581933517|FG001|Overall Study|Lost to Follow-up|13|||
161150556|NCT03276936|581933516|FG000|Overall Study|Withdrawal by Subject|30|||
161150557|NCT03276936|581933517|FG001|Overall Study|Withdrawal by Subject|20|||
161150558|NCT03276936|581933516|FG000|Overall Study|Not mentioned|6|||
161150559|NCT03276936|581933517|FG001|Overall Study|Not mentioned|3|||
161150560|NCT00943319|581933518|FG000|Overall Study|Death|1|||
161150561|NCT02043301|581933519|FG000|Overall Study|Discontinued|0|||
161150562|NCT02043301|581933520|FG001|Overall Study|Discontinued|1|||
161150563|NCT02043301|581933521|FG002|Overall Study|Discontinued|0|||
161150564|NCT03703375|581933522|FG000|Randomization Period|Withdrawal by Subject|0|||
161150565|NCT03703375|581933523|FG001|Randomization Period|Withdrawal by Subject|0|||
161150566|NCT03703375|581933524|FG002|Randomization Period|Withdrawal by Subject|0|||
161150567|NCT03703375|581933525|FG003|Randomization Period|Withdrawal by Subject|1|||
161150568|NCT03703375|581933522|FG000|Randomization Period|Completed safety run-in treatment|7|||
161150569|NCT03703375|581933523|FG001|Randomization Period|Completed safety run-in treatment|0|||
161150570|NCT03703375|581933524|FG002|Randomization Period|Completed safety run-in treatment|0|||
161150571|NCT03703375|581933525|FG003|Randomization Period|Completed safety run-in treatment|0|||
161150572|NCT03703375|581933522|FG000|Treatment Period|Other Reasons|0|||
161150573|NCT03703375|581933523|FG001|Treatment Period|Other Reasons|1|||
161150574|NCT03703375|581933524|FG002|Treatment Period|Other Reasons|0|||
161150575|NCT03703375|581933525|FG003|Treatment Period|Other Reasons|3|||
161150576|NCT03703375|581933522|FG000|Treatment Period|Consent Withdrawal|0|||
161150577|NCT03703375|581933523|FG001|Treatment Period|Consent Withdrawal|0|||
161150578|NCT03703375|581933524|FG002|Treatment Period|Consent Withdrawal|0|||
161150579|NCT03703375|581933525|FG003|Treatment Period|Consent Withdrawal|1|||
161150580|NCT03703375|581933522|FG000|Treatment Period|Death|1|||
161150581|NCT03703375|581933523|FG001|Treatment Period|Death|0|||
161150582|NCT03703375|581933524|FG002|Treatment Period|Death|1|||
161150583|NCT03703375|581933525|FG003|Treatment Period|Death|2|||
161150584|NCT03703375|581933522|FG000|Treatment Period|Toxicity of Study Treatment|2|||
161150585|NCT03703375|581933523|FG001|Treatment Period|Toxicity of Study Treatment|0|||
161150586|NCT03703375|581933524|FG002|Treatment Period|Toxicity of Study Treatment|4|||
161150587|NCT03703375|581933525|FG003|Treatment Period|Toxicity of Study Treatment|1|||
161150588|NCT03703375|581933522|FG000|Treatment Period|Progression|32|||
161150589|NCT03703375|581933523|FG001|Treatment Period|Progression|1|||
161150590|NCT03703375|581933524|FG002|Treatment Period|Progression|7|||
161150591|NCT03703375|581933525|FG003|Treatment Period|Progression|11|||
161150592|NCT03703375|581933522|FG000|Treatment Period|Completed treatment|7|||
161150593|NCT03703375|581933523|FG001|Treatment Period|Completed treatment|2|||
161150594|NCT03703375|581933524|FG002|Treatment Period|Completed treatment|0|||
161150595|NCT03703375|581933525|FG003|Treatment Period|Completed treatment|0|||
161150596|NCT02421120|581933528|FG000|Overall Study|Adverse Event|1|||
161150597|NCT00273858|581933542|FG000|Overall Study|Not completed 24 month observation time|334|||
161280838|NCT00996892|582407015|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161150598|NCT00273858|581933542|FG000|Overall Study|Lost to Follow-up|101|||
161150599|NCT00273858|581933542|FG000|Overall Study|Withdrawal by Subject|21|||
161150600|NCT00273858|581933542|FG000|Overall Study|Adverse Event|81|||
161150601|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
161150602|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
161150603|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
161150604|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
161150605|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
161150606|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
161150607|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
161150608|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
161150609|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
161150610|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
161150611|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
161048697|NCT00473512|581568047|FG001|Period 2 (Phase 2)|Adverse Event|0|||
161048698|NCT00473512|581568048|FG002|Period 2 (Phase 2)|Adverse Event|0|||
161048699|NCT00473512|581568049|FG003|Period 2 (Phase 2)|Adverse Event|1|||
161048700|NCT00473512|581568050|FG004|Period 2 (Phase 2)|Adverse Event|0|||
161048701|NCT00473512|581568046|FG000|Period 2 (Phase 2)|Death|0|||
161048702|NCT00473512|581568047|FG001|Period 2 (Phase 2)|Death|0|||
161048703|NCT00473512|581568048|FG002|Period 2 (Phase 2)|Death|0|||
161048704|NCT00473512|581568049|FG003|Period 2 (Phase 2)|Death|1|||
161048705|NCT00473512|581568050|FG004|Period 2 (Phase 2)|Death|1|||
161048706|NCT00473512|581568046|FG000|Period 2 (Phase 2)|Disease Progression|0|||
161048707|NCT00473512|581568047|FG001|Period 2 (Phase 2)|Disease Progression|2|||
161048708|NCT00473512|581568048|FG002|Period 2 (Phase 2)|Disease Progression|2|||
161048709|NCT00473512|581568049|FG003|Period 2 (Phase 2)|Disease Progression|17|||
161048710|NCT00473512|581568050|FG004|Period 2 (Phase 2)|Disease Progression|1|||
161048711|NCT00473512|581568046|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161048712|NCT00473512|581568047|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161048713|NCT00473512|581568048|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161048714|NCT00473512|581568049|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
161048715|NCT00473512|581568050|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
161048716|NCT00473512|581568046|FG000|Period 2 (Phase 2)|Other|1|||
161048717|NCT00473512|581568047|FG001|Period 2 (Phase 2)|Other|0|||
161048718|NCT00473512|581568048|FG002|Period 2 (Phase 2)|Other|0|||
161048719|NCT00473512|581568049|FG003|Period 2 (Phase 2)|Other|3|||
161048720|NCT00473512|581568050|FG004|Period 2 (Phase 2)|Other|0|||
161048721|NCT01129011|581568053|FG000|Overall Study|Adverse Event|20|||
161048722|NCT01129011|581568054|FG001|Overall Study|Adverse Event|30|||
161048723|NCT01129011|581568053|FG000|Overall Study|Withdrawal by Subject|24|||
161048724|NCT01129011|581568054|FG001|Overall Study|Withdrawal by Subject|8|||
161048725|NCT01129011|581568053|FG000|Overall Study|Lost to Follow-up|6|||
161048726|NCT01129011|581568054|FG001|Overall Study|Lost to Follow-up|7|||
161048727|NCT01129011|581568053|FG000|Overall Study|Duodenal Ulcer|2|||
161048728|NCT01129011|581568054|FG001|Overall Study|Duodenal Ulcer|8|||
161048729|NCT01129011|581568053|FG000|Overall Study|misc|7|||
161048730|NCT01129011|581568054|FG001|Overall Study|misc|4|||
161048731|NCT01012999|581568055|FG000|Overall Study|Protocol Violation|1|||
161048732|NCT01369147|581568056|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
161048733|NCT01369147|581568057|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
161048734|NCT01369147|581568058|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
161048735|NCT00417885|581568059|FG000|Overall Study|Adverse Event|1|||
161048736|NCT00417885|581568059|FG000|Overall Study|Objective Progression or Relapse|3|||
161048737|NCT00417885|581568059|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
161048738|NCT01757288|581568064|FG000|Overall Study|Consent withdrawal|0|||
161048739|NCT01757288|581568065|FG001|Overall Study|Consent withdrawal|4|||
161048740|NCT01757288|581568066|FG002|Overall Study|Consent withdrawal|4|||
161048741|NCT01757288|581568064|FG000|Overall Study|Patient off study, IRB hold.|0|||
161048742|NCT01757288|581568065|FG001|Overall Study|Patient off study, IRB hold.|0|||
161048743|NCT01757288|581568066|FG002|Overall Study|Patient off study, IRB hold.|1|||
161048744|NCT01757288|581568064|FG000|Overall Study|Patient death prior to starting treatment|0|||
161048745|NCT01757288|581568065|FG001|Overall Study|Patient death prior to starting treatment|0|||
161048746|NCT01757288|581568066|FG002|Overall Study|Patient death prior to starting treatment|1|||
161048747|NCT01757288|581568064|FG000|Overall Study|Wrong medication administered|0|||
161048748|NCT01757288|581568065|FG001|Overall Study|Wrong medication administered|1|||
161048749|NCT01757288|581568066|FG002|Overall Study|Wrong medication administered|0|||
161048750|NCT01757288|581568064|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
161048751|NCT01757288|581568065|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
161048752|NCT01757288|581568066|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
161150612|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
161150613|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
161280839|NCT00996892|582407016|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280840|NCT00996892|582407017|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280841|NCT00996892|582407018|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280842|NCT00996892|582407019|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280843|NCT00996892|582407020|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161280844|NCT00996892|582407021|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
161048753|NCT01757288|581568064|FG000|Overall Study|Not meeting protocol constraints|0|||
161048754|NCT01757288|581568065|FG001|Overall Study|Not meeting protocol constraints|1|||
161048755|NCT01757288|581568066|FG002|Overall Study|Not meeting protocol constraints|1|||
161048756|NCT01757288|581568064|FG000|Overall Study|Multiple missed appointments|0|||
161048757|NCT01757288|581568065|FG001|Overall Study|Multiple missed appointments|1|||
161048758|NCT01757288|581568066|FG002|Overall Study|Multiple missed appointments|0|||
161048759|NCT01757288|581568064|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
161048760|NCT01757288|581568065|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
161280845|NCT00996892|582407002|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
161344967|NCT03126110|582648860|FG011|Phase 1|Withdrawal by Subject|0|||
161048761|NCT01757288|581568066|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
161048762|NCT01757288|581568064|FG000|Overall Study|>2 weeks treatment break|0|||
161048763|NCT01757288|581568065|FG001|Overall Study|>2 weeks treatment break|0|||
161048764|NCT01757288|581568066|FG002|Overall Study|>2 weeks treatment break|1|||
161048765|NCT02825550|581568068|FG000|Overall Study|Physician Decision|1|||
161048766|NCT03386344|581568069|FG000|Overall Study|Adverse Event|6|||
161048767|NCT03386344|581568070|FG001|Overall Study|Adverse Event|3|||
161048768|NCT03386344|581568071|FG002|Overall Study|Adverse Event|1|||
161048769|NCT03386344|581568069|FG000|Overall Study|Poor Compliance to Protocol|0|||
161048770|NCT03386344|581568070|FG001|Overall Study|Poor Compliance to Protocol|1|||
161048771|NCT03386344|581568071|FG002|Overall Study|Poor Compliance to Protocol|0|||
161048772|NCT03386344|581568069|FG000|Overall Study|Study Terminated by Sponsor|101|||
161048773|NCT03386344|581568070|FG001|Overall Study|Study Terminated by Sponsor|102|||
161048774|NCT03386344|581568071|FG002|Overall Study|Study Terminated by Sponsor|106|||
161048775|NCT03386344|581568069|FG000|Overall Study|Lost to Follow-up|3|||
161048776|NCT03386344|581568070|FG001|Overall Study|Lost to Follow-up|2|||
161048777|NCT03386344|581568071|FG002|Overall Study|Lost to Follow-up|1|||
161048778|NCT03386344|581568069|FG000|Overall Study|At the Participant's own Request|7|||
161048779|NCT03386344|581568070|FG001|Overall Study|At the Participant's own Request|7|||
161048780|NCT03386344|581568071|FG002|Overall Study|At the Participant's own Request|8|||
161048781|NCT03386344|581568069|FG000|Overall Study|Reason not Specified|0|||
161048782|NCT03386344|581568070|FG001|Overall Study|Reason not Specified|1|||
161048783|NCT03386344|581568071|FG002|Overall Study|Reason not Specified|0|||
161048784|NCT01077284|581568074|FG000|Overall Study|Adverse Event|2|||
161048785|NCT01077284|581568075|FG001|Overall Study|Adverse Event|0|||
161048786|NCT01077284|581568076|FG002|Overall Study|Adverse Event|1|||
161048787|NCT01077284|581568074|FG000|Overall Study|Lost to Follow-up|1|||
161048788|NCT01077284|581568075|FG001|Overall Study|Lost to Follow-up|2|||
161048789|NCT01077284|581568076|FG002|Overall Study|Lost to Follow-up|0|||
161048790|NCT01077284|581568074|FG000|Overall Study|Withdrawal by Subject|2|||
161048791|NCT01077284|581568075|FG001|Overall Study|Withdrawal by Subject|3|||
161048792|NCT01077284|581568076|FG002|Overall Study|Withdrawal by Subject|1|||
161048793|NCT01077284|581568074|FG000|Overall Study|Other|0|||
161048794|NCT01077284|581568075|FG001|Overall Study|Other|0|||
161048795|NCT01077284|581568076|FG002|Overall Study|Other|1|||
161048796|NCT04626128|581568077|FG000|Overall Study|Withdrawal by Subject|0|||
161048797|NCT04626128|581568078|FG001|Overall Study|Withdrawal by Subject|1|||
161048798|NCT04626128|581568079|FG002|Overall Study|Withdrawal by Subject|0|||
161048799|NCT04626128|581568080|FG003|Overall Study|Withdrawal by Subject|0|||
161048800|NCT00248794|581568083|FG000|Overall Study|Lost to Follow-up|6|||
161048801|NCT00248794|581568084|FG001|Overall Study|Lost to Follow-up|8|||
161048802|NCT00248794|581568085|FG002|Overall Study|Lost to Follow-up|3|||
161048803|NCT03209492|581568086|FG000|Overall Study|Case Report Forms Uncollected|5|||
161048804|NCT04908488|581568087|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161048805|NCT04908488|581568088|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161048806|NCT04908488|581568087|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
161048807|NCT04908488|581568088|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
161048808|NCT01107912|581568091|FG000|Period 1|Adverse Event|0|||
161048809|NCT01107912|581568092|FG001|Period 1|Adverse Event|0|||
161048810|NCT01107912|581568093|FG002|Period 1|Adverse Event|0|||
161048811|NCT01107912|581568094|FG003|Period 1|Adverse Event|0|||
161150614|NCT02232516|581933543|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
161150615|NCT02232516|581933543|FG000|Survival Follow-up|Death|15|||
161048812|NCT01107912|581568095|FG004|Period 1|Adverse Event|2|||
161048813|NCT01107912|581568096|FG005|Period 1|Adverse Event|0|||
161048814|NCT01107912|581568091|FG000|Period 1|Physician Decision|0|||
161048815|NCT01107912|581568092|FG001|Period 1|Physician Decision|0|||
161048816|NCT01107912|581568093|FG002|Period 1|Physician Decision|0|||
161048817|NCT01107912|581568094|FG003|Period 1|Physician Decision|0|||
161048818|NCT01107912|581568095|FG004|Period 1|Physician Decision|1|||
161048819|NCT01107912|581568096|FG005|Period 1|Physician Decision|0|||
161048820|NCT01107912|581568091|FG000|Period 1|Withdrawal by Subject|1|||
161048821|NCT01107912|581568092|FG001|Period 1|Withdrawal by Subject|0|||
161048822|NCT01107912|581568093|FG002|Period 1|Withdrawal by Subject|0|||
161150616|NCT02232516|581933543|FG000|Survival Follow-up|Withdrawal by Subject|3|||
161048823|NCT01107912|581568094|FG003|Period 1|Withdrawal by Subject|0|||
161048824|NCT01107912|581568095|FG004|Period 1|Withdrawal by Subject|0|||
161048825|NCT01107912|581568096|FG005|Period 1|Withdrawal by Subject|0|||
161048826|NCT01107912|581568091|FG000|Period 2|Physician Decision|0|||
161048827|NCT01107912|581568092|FG001|Period 2|Physician Decision|0|||
161048828|NCT01107912|581568093|FG002|Period 2|Physician Decision|1|||
161048829|NCT01107912|581568094|FG003|Period 2|Physician Decision|0|||
161150617|NCT02232516|581933543|FG000|Survival Follow-up|Lost to Follow-up|1|||
161048830|NCT01107912|581568095|FG004|Period 2|Physician Decision|0|||
161048831|NCT01107912|581568096|FG005|Period 2|Physician Decision|0|||
161048832|NCT01107912|581568091|FG000|Period 3|Adverse Event|0|||
161048833|NCT01107912|581568092|FG001|Period 3|Adverse Event|1|||
161048834|NCT01107912|581568093|FG002|Period 3|Adverse Event|1|||
161048835|NCT01107912|581568094|FG003|Period 3|Adverse Event|0|||
161344968|NCT03126110|582648861|FG012|Phase 1|Withdrawal by Subject|0|||
161344969|NCT03126110|582648862|FG013|Phase 1|Withdrawal by Subject|0|||
161048836|NCT01107912|581568095|FG004|Period 3|Adverse Event|0|||
161048837|NCT01107912|581568096|FG005|Period 3|Adverse Event|0|||
161048838|NCT01107912|581568091|FG000|Period 3|Withdrawal by Subject|0|||
161048839|NCT01107912|581568092|FG001|Period 3|Withdrawal by Subject|0|||
161048840|NCT01107912|581568093|FG002|Period 3|Withdrawal by Subject|0|||
161048841|NCT01107912|581568094|FG003|Period 3|Withdrawal by Subject|1|||
161048842|NCT01107912|581568095|FG004|Period 3|Withdrawal by Subject|0|||
161048843|NCT01107912|581568096|FG005|Period 3|Withdrawal by Subject|0|||
161048844|NCT01894620|581568097|FG000|Overall Study|Withdrawal by Subject|0|||
161048845|NCT01894620|581568098|FG001|Overall Study|Withdrawal by Subject|1|||
161048846|NCT01124916|581568099|FG000|Overall Study|Lost to Follow-up|3|||
161048847|NCT01124916|581568100|FG001|Overall Study|Lost to Follow-up|2|||
161048848|NCT02206607|581568101|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
161048849|NCT02206607|581568102|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
161048850|NCT02206607|581568103|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
161048851|NCT02206607|581568104|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
161048852|NCT02206607|581568105|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
161048853|NCT02206607|581568101|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
161048854|NCT02206607|581568102|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
161048855|NCT02206607|581568103|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
161048856|NCT02206607|581568104|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
161048857|NCT02206607|581568105|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
161048858|NCT00879710|581568106|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
161048859|NCT00879710|581568107|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
161048860|NCT00879710|581568108|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
161048861|NCT00879710|581568109|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
161048862|NCT00879710|581568106|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
161048863|NCT00879710|581568107|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
161048864|NCT00879710|581568108|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
161048865|NCT00879710|581568109|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
161048866|NCT00761267|581568110|FG000|Overall Study|Death|1|||
161048867|NCT00761267|581568111|FG001|Overall Study|Death|2|||
161048868|NCT00761267|581568112|FG002|Overall Study|Death|5|||
161048869|NCT00761267|581568110|FG000|Overall Study|Lost to Follow-up|0|||
161048870|NCT00761267|581568111|FG001|Overall Study|Lost to Follow-up|0|||
161048871|NCT00761267|581568112|FG002|Overall Study|Lost to Follow-up|1|||
161048872|NCT00761267|581568110|FG000|Overall Study|Randomized but not treated|1|||
161048873|NCT00761267|581568111|FG001|Overall Study|Randomized but not treated|1|||
161048874|NCT00761267|581568112|FG002|Overall Study|Randomized but not treated|0|||
161048875|NCT00761267|581568110|FG000|Overall Study|Withdrawal by Subject|0|||
161048876|NCT00761267|581568111|FG001|Overall Study|Withdrawal by Subject|1|||
161048877|NCT00761267|581568112|FG002|Overall Study|Withdrawal by Subject|0|||
161048878|NCT00963924|581568115|FG000|Overall Study|Adverse Event|1|||
161048879|NCT00963924|581568116|FG001|Overall Study|Adverse Event|0|||
161048880|NCT00963924|581568115|FG000|Overall Study|Withdrawal by Subject|0|||
161048881|NCT00963924|581568116|FG001|Overall Study|Withdrawal by Subject|1|||
161048882|NCT00963924|581568115|FG000|Overall Study|Changed antipsychotic|0|||
161048883|NCT00963924|581568116|FG001|Overall Study|Changed antipsychotic|1|||
161048884|NCT00963924|581568115|FG000|Overall Study|Lost to Follow-up|0|||
161048885|NCT00963924|581568116|FG001|Overall Study|Lost to Follow-up|1|||
161048886|NCT00446095|581568117|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
161048887|NCT00446095|581568118|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
161048888|NCT00446095|581568119|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
161048889|NCT00446095|581568120|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
161048890|NCT00446095|581568121|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
161048891|NCT00446095|581568117|FG000|Phase II (8 Weeks)|Adverse Event|0|||
161048892|NCT00446095|581568118|FG001|Phase II (8 Weeks)|Adverse Event|1|||
161048893|NCT00446095|581568119|FG002|Phase II (8 Weeks)|Adverse Event|1|||
161048894|NCT00446095|581568120|FG003|Phase II (8 Weeks)|Adverse Event|0|||
161048895|NCT00446095|581568121|FG004|Phase II (8 Weeks)|Adverse Event|0|||
161344970|NCT03126110|582648863|FG014|Phase 1|Withdrawal by Subject|0|||
161048896|NCT00446095|581568117|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
161048897|NCT00446095|581568118|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161048898|NCT00446095|581568119|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161048899|NCT00446095|581568120|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161048900|NCT00446095|581568121|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
161048901|NCT00446095|581568117|FG000|Phase II (8 Weeks)|Physician Decision|1|||
161048902|NCT00446095|581568118|FG001|Phase II (8 Weeks)|Physician Decision|0|||
161048903|NCT00446095|581568119|FG002|Phase II (8 Weeks)|Physician Decision|0|||
161048904|NCT00446095|581568120|FG003|Phase II (8 Weeks)|Physician Decision|0|||
161048905|NCT00446095|581568121|FG004|Phase II (8 Weeks)|Physician Decision|0|||
161150618|NCT02232516|581933543|FG000|Survival Follow-up|Still in follow-up|5|||
161344971|NCT03126110|582648864|FG015|Phase 1|Withdrawal by Subject|0|||
161048906|NCT00446095|581568117|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
161048907|NCT00446095|581568118|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
161048908|NCT00446095|581568119|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
161048909|NCT00446095|581568120|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
161048910|NCT00446095|581568121|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
161048911|NCT00446095|581568117|FG000|Phase II (8 Weeks)|Ongoing|0|||
161048912|NCT00446095|581568118|FG001|Phase II (8 Weeks)|Ongoing|0|||
161048913|NCT00446095|581568119|FG002|Phase II (8 Weeks)|Ongoing|1|||
161048914|NCT00446095|581568120|FG003|Phase II (8 Weeks)|Ongoing|0|||
161048915|NCT00446095|581568121|FG004|Phase II (8 Weeks)|Ongoing|0|||
161048916|NCT00446095|581568117|FG000|Phase I (28 Days)|Adverse Event|0|||
161048917|NCT00446095|581568118|FG001|Phase I (28 Days)|Adverse Event|0|||
161048918|NCT00446095|581568119|FG002|Phase I (28 Days)|Adverse Event|0|||
161048919|NCT00446095|581568120|FG003|Phase I (28 Days)|Adverse Event|1|||
161048920|NCT00446095|581568121|FG004|Phase I (28 Days)|Adverse Event|0|||
161048921|NCT00446095|581568117|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
161048922|NCT00446095|581568118|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
161048923|NCT00446095|581568119|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
161048924|NCT00446095|581568120|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
161048925|NCT00446095|581568121|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
161048926|NCT02159352|581568125|FG000|Overall Study|Adverse Event|3|||
161048927|NCT02159352|581568126|FG001|Overall Study|Adverse Event|1|||
161048928|NCT02159352|581568125|FG000|Overall Study|Withdrawal by Subject|0|||
161048929|NCT02159352|581568126|FG001|Overall Study|Withdrawal by Subject|1|||
161048930|NCT00529529|581568127|FG000|Overall Study|Adverse Event|12|||
161048931|NCT00529529|581568128|FG001|Overall Study|Adverse Event|17|||
161048932|NCT00529529|581568129|FG002|Overall Study|Adverse Event|8|||
161048933|NCT00529529|581568127|FG000|Overall Study|Subject withdrew consent|12|||
161048934|NCT00529529|581568128|FG001|Overall Study|Subject withdrew consent|9|||
161048935|NCT00529529|581568129|FG002|Overall Study|Subject withdrew consent|12|||
161048936|NCT00529529|581568127|FG000|Overall Study|Protocol deviation|8|||
161048937|NCT00529529|581568128|FG001|Overall Study|Protocol deviation|12|||
161048938|NCT00529529|581568129|FG002|Overall Study|Protocol deviation|5|||
161048939|NCT00529529|581568127|FG000|Overall Study|Lost to Follow-up|5|||
161048940|NCT00529529|581568128|FG001|Overall Study|Lost to Follow-up|3|||
161048941|NCT00529529|581568129|FG002|Overall Study|Lost to Follow-up|1|||
161048942|NCT00529529|581568127|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161048943|NCT00529529|581568128|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161048944|NCT00529529|581568129|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
161048945|NCT00529529|581568127|FG000|Overall Study|Death|2|||
161048946|NCT00529529|581568128|FG001|Overall Study|Death|0|||
161048947|NCT00529529|581568129|FG002|Overall Study|Death|0|||
161048948|NCT00529529|581568127|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161048949|NCT00529529|581568128|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161048950|NCT00529529|581568129|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161048951|NCT00529529|581568127|FG000|Overall Study|Administrative problems|1|||
161048952|NCT00529529|581568128|FG001|Overall Study|Administrative problems|0|||
161048953|NCT00529529|581568129|FG002|Overall Study|Administrative problems|3|||
161048954|NCT00337610|581568130|FG000|Overall Study|Adverse Event|2|||
161048955|NCT00337610|581568131|FG001|Overall Study|Adverse Event|2|||
161048956|NCT00337610|581568130|FG000|Overall Study|Death|0|||
161048957|NCT00337610|581568131|FG001|Overall Study|Death|1|||
161048958|NCT00337610|581568130|FG000|Overall Study|Lack of Efficacy|6|||
161048959|NCT00337610|581568131|FG001|Overall Study|Lack of Efficacy|3|||
161048960|NCT00337610|581568130|FG000|Overall Study|Lost to Follow-up|3|||
161048961|NCT00337610|581568131|FG001|Overall Study|Lost to Follow-up|3|||
161048962|NCT00337610|581568130|FG000|Overall Study|Withdrawal by Subject|6|||
161048963|NCT00337610|581568131|FG001|Overall Study|Withdrawal by Subject|5|||
161048964|NCT02279732|581568136|FG000|Overall Study|Death|23|||
161048965|NCT02279732|581568137|FG001|Overall Study|Death|20|||
161048966|NCT02279732|581568136|FG000|Overall Study|Disease Progression|13|||
161048967|NCT02279732|581568137|FG001|Overall Study|Disease Progression|3|||
161048968|NCT02279732|581568136|FG000|Overall Study|Withdrawal by Subject|2|||
161048969|NCT02279732|581568137|FG001|Overall Study|Withdrawal by Subject|7|||
161048970|NCT02279732|581568136|FG000|Overall Study|Adverse Event|1|||
161048971|NCT02279732|581568137|FG001|Overall Study|Adverse Event|2|||
161048972|NCT02279732|581568136|FG000|Overall Study|Administrative Reason By Sponsor|0|||
161048973|NCT02279732|581568137|FG001|Overall Study|Administrative Reason By Sponsor|2|||
161048974|NCT02279732|581568136|FG000|Overall Study|Study Drug Toxicity|2|||
161048975|NCT02279732|581568137|FG001|Overall Study|Study Drug Toxicity|0|||
161048976|NCT02279732|581568136|FG000|Overall Study|Lost to Follow-up|0|||
161048977|NCT02279732|581568137|FG001|Overall Study|Lost to Follow-up|1|||
161048978|NCT02279732|581568136|FG000|Overall Study|Maximum Clinical Benefit|1|||
161048979|NCT02279732|581568137|FG001|Overall Study|Maximum Clinical Benefit|0|||
161048980|NCT02279732|581568136|FG000|Overall Study|Subject Requested to Discontinue|0|||
161048981|NCT02279732|581568137|FG001|Overall Study|Subject Requested to Discontinue|1|||
161048982|NCT02279732|581568136|FG000|Overall Study|Other|53|||
161048983|NCT02279732|581568137|FG001|Overall Study|Other|67|||
161048984|NCT02279732|581568136|FG000|Overall Study|Other|3|||
161048985|NCT02279732|581568137|FG001|Overall Study|Other|3|||
161048986|NCT02203513|581568141|FG000|Overall Study|Refused further treatment|2|||
161150619|NCT01070550|581933544|FG000|Overall Study|Adverse Event|43|||
161150620|NCT01070550|581933545|FG001|Overall Study|Adverse Event|1|||
161150621|NCT01070550|581933546|FG002|Overall Study|Adverse Event|3|||
161150622|NCT01070550|581933547|FG003|Overall Study|Adverse Event|0|||
161150623|NCT01070550|581933548|FG004|Overall Study|Adverse Event|0|||
161150624|NCT01070550|581933549|FG005|Overall Study|Adverse Event|0|||
161150625|NCT01070550|581933544|FG000|Overall Study|Death|20|||
161150626|NCT01070550|581933545|FG001|Overall Study|Death|4|||
161150627|NCT01070550|581933546|FG002|Overall Study|Death|3|||
161150628|NCT01070550|581933547|FG003|Overall Study|Death|0|||
161150629|NCT01070550|581933548|FG004|Overall Study|Death|0|||
161150630|NCT01070550|581933549|FG005|Overall Study|Death|0|||
161150631|NCT01070550|581933544|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
161150632|NCT01070550|581933545|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161150633|NCT01070550|581933546|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
161150634|NCT01070550|581933547|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161150635|NCT01070550|581933548|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161150636|NCT01070550|581933549|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
161150637|NCT01070550|581933544|FG000|Overall Study|Early termination|3|||
161150638|NCT01070550|581933545|FG001|Overall Study|Early termination|0|||
161150639|NCT01070550|581933546|FG002|Overall Study|Early termination|0|||
161150640|NCT01070550|581933547|FG003|Overall Study|Early termination|0|||
161150641|NCT01070550|581933548|FG004|Overall Study|Early termination|0|||
161150642|NCT01070550|581933549|FG005|Overall Study|Early termination|0|||
161150643|NCT01070550|581933544|FG000|Overall Study|Failed to return|450|||
161150644|NCT01070550|581933545|FG001|Overall Study|Failed to return|33|||
161150645|NCT01070550|581933546|FG002|Overall Study|Failed to return|144|||
161150646|NCT01070550|581933547|FG003|Overall Study|Failed to return|40|||
161150647|NCT01070550|581933548|FG004|Overall Study|Failed to return|1|||
161150648|NCT01070550|581933549|FG005|Overall Study|Failed to return|2|||
161150649|NCT01070550|581933544|FG000|Overall Study|Incomplete treatment|2|||
161150650|NCT01070550|581933545|FG001|Overall Study|Incomplete treatment|0|||
161150651|NCT01070550|581933546|FG002|Overall Study|Incomplete treatment|0|||
161150652|NCT01070550|581933547|FG003|Overall Study|Incomplete treatment|0|||
161048987|NCT02203513|581568142|FG001|Overall Study|Refused further treatment|0|||
161048988|NCT02203513|581568143|FG002|Overall Study|Refused further treatment|1|||
161048989|NCT02203513|581568144|FG003|Overall Study|Refused further treatment|0|||
161048990|NCT02203513|581568145|FG004|Overall Study|Refused further treatment|0|||
161048991|NCT02203513|581568141|FG000|Overall Study|Switched to alternative treatment|3|||
161048992|NCT02203513|581568142|FG001|Overall Study|Switched to alternative treatment|4|||
161048993|NCT02203513|581568143|FG002|Overall Study|Switched to alternative treatment|0|||
161048994|NCT02203513|581568144|FG003|Overall Study|Switched to alternative treatment|0|||
161048995|NCT02203513|581568145|FG004|Overall Study|Switched to alternative treatment|4|||
161048996|NCT02203513|581568141|FG000|Overall Study|Did not receive investigational product (IP)|0|||
161048997|NCT02203513|581568142|FG001|Overall Study|Did not receive investigational product (IP)|1|||
161048998|NCT02203513|581568143|FG002|Overall Study|Did not receive investigational product (IP)|0|||
161048999|NCT02203513|581568144|FG003|Overall Study|Did not receive investigational product (IP)|0|||
161049000|NCT02203513|581568145|FG004|Overall Study|Did not receive investigational product (IP)|0|||
161049001|NCT02203513|581568141|FG000|Overall Study|Death (unrelated to study therapy)|1|||
161049002|NCT02203513|581568142|FG001|Overall Study|Death (unrelated to study therapy)|3|||
161049003|NCT02203513|581568143|FG002|Overall Study|Death (unrelated to study therapy)|1|||
161049004|NCT02203513|581568144|FG003|Overall Study|Death (unrelated to study therapy)|0|||
161049005|NCT02203513|581568145|FG004|Overall Study|Death (unrelated to study therapy)|2|||
161049006|NCT02203513|581568141|FG000|Overall Study|Lost to Follow-up|0|||
161049007|NCT02203513|581568142|FG001|Overall Study|Lost to Follow-up|0|||
161049008|NCT02203513|581568143|FG002|Overall Study|Lost to Follow-up|1|||
161049009|NCT02203513|581568144|FG003|Overall Study|Lost to Follow-up|1|||
161150653|NCT01070550|581933548|FG004|Overall Study|Incomplete treatment|0|||
161150654|NCT01070550|581933549|FG005|Overall Study|Incomplete treatment|0|||
161150655|NCT01070550|581933544|FG000|Overall Study|Lab test not done|22|||
161150656|NCT01070550|581933545|FG001|Overall Study|Lab test not done|3|||
161150657|NCT01070550|581933546|FG002|Overall Study|Lab test not done|4|||
161280846|NCT00996892|582407003|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
161049010|NCT02203513|581568145|FG004|Overall Study|Lost to Follow-up|0|||
161049011|NCT01441596|581568146|FG000|Overall Study|Other reason not defined below|0|||
161049012|NCT01441596|581568147|FG001|Overall Study|Other reason not defined below|2|||
161049013|NCT01441596|581568148|FG002|Overall Study|Other reason not defined below|1|||
161049014|NCT01441596|581568146|FG000|Overall Study|Withdrawal by Subject|4|||
161049015|NCT01441596|581568147|FG001|Overall Study|Withdrawal by Subject|0|||
161049016|NCT01441596|581568148|FG002|Overall Study|Withdrawal by Subject|2|||
161150658|NCT01070550|581933547|FG003|Overall Study|Lab test not done|1|||
161150659|NCT01070550|581933548|FG004|Overall Study|Lab test not done|0|||
161150660|NCT01070550|581933549|FG005|Overall Study|Lab test not done|1|||
161150661|NCT01070550|581933544|FG000|Overall Study|Lack of Efficacy|65|||
161150662|NCT01070550|581933545|FG001|Overall Study|Lack of Efficacy|1|||
161049017|NCT01441596|581568146|FG000|Overall Study|Not treated|0|||
161049018|NCT01441596|581568147|FG001|Overall Study|Not treated|1|||
161049019|NCT01441596|581568148|FG002|Overall Study|Not treated|1|||
161049020|NCT03055988|581568149|FG000|Period 1|Adverse Event|0|||
161049021|NCT03055988|581568150|FG001|Period 1|Adverse Event|1|||
161049022|NCT03055988|581568149|FG000|Period 1|Lost to Follow-up|1|||
161049023|NCT03055988|581568150|FG001|Period 1|Lost to Follow-up|0|||
161049024|NCT03055988|581568149|FG000|Period 1|Withdrawal by Subject|0|||
161049025|NCT03055988|581568150|FG001|Period 1|Withdrawal by Subject|4|||
161049026|NCT03055988|581568149|FG000|Period 2|Adverse Event|0|||
161049027|NCT03055988|581568150|FG001|Period 2|Adverse Event|1|||
161049028|NCT03055988|581568149|FG000|Period 2|Other than listed|1|||
161049029|NCT03055988|581568150|FG001|Period 2|Other than listed|1|||
161049030|NCT01681511|581568151|FG000|Overall Study|No Treatment Received|1|||
161049031|NCT01681511|581568152|FG001|Overall Study|No Treatment Received|3|||
161049032|NCT01681511|581568151|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
161049033|NCT01681511|581568152|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
161049034|NCT01681511|581568151|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
161049035|NCT01681511|581568152|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
161049036|NCT01681511|581568151|FG000|Overall Study|No Daily Urine Sample Collected|0|||
161049037|NCT01681511|581568152|FG001|Overall Study|No Daily Urine Sample Collected|1|||
161049038|NCT01681511|581568151|FG000|Overall Study|No post-catheter sample collected|11|||
161049039|NCT01681511|581568152|FG001|Overall Study|No post-catheter sample collected|4|||
161049040|NCT01156675|581568153|FG000|Overall Study|Death|5|||
161049041|NCT01156675|581568154|FG001|Overall Study|Death|3|||
161049042|NCT01156675|581568155|FG002|Overall Study|Death|0|||
161049043|NCT01156675|581568153|FG000|Overall Study|No data|29|||
161049044|NCT01156675|581568154|FG001|Overall Study|No data|22|||
161049045|NCT01156675|581568155|FG002|Overall Study|No data|2|||
161049046|NCT00116649|581568169|FG000|Overall Study|Adverse Event|20|||
161049047|NCT00116649|581568169|FG000|Overall Study|Lack of Efficacy|1|||
161049048|NCT00116649|581568169|FG000|Overall Study|Lost to Follow-up|32|||
161049049|NCT00116649|581568169|FG000|Overall Study|Withdrawal by Subject|68|||
161049050|NCT00116649|581568169|FG000|Overall Study|Local Skin Reaction|9|||
161049051|NCT00116649|581568169|FG000|Overall Study|Various Reasons|18|||
161049052|NCT00116649|581568169|FG000|Overall Study|Protocol Specified|7|||
161049053|NCT02161146|581568170|FG000|Overall Study|Adverse Event|1|||
161049054|NCT02161146|581568171|FG001|Overall Study|Adverse Event|1|||
161049055|NCT02161146|581568172|FG002|Overall Study|Adverse Event|0|||
161049056|NCT02161146|581568173|FG003|Overall Study|Adverse Event|1|||
161049057|NCT02161146|581568174|FG004|Overall Study|Adverse Event|0|||
161049058|NCT02161146|581568170|FG000|Overall Study|Lost to Follow-up|0|||
161049059|NCT02161146|581568171|FG001|Overall Study|Lost to Follow-up|1|||
161049060|NCT02161146|581568172|FG002|Overall Study|Lost to Follow-up|0|||
161049061|NCT02161146|581568173|FG003|Overall Study|Lost to Follow-up|0|||
161049062|NCT02161146|581568174|FG004|Overall Study|Lost to Follow-up|0|||
161049063|NCT02161146|581568170|FG000|Overall Study|Personal Reasons|0|||
161049064|NCT02161146|581568171|FG001|Overall Study|Personal Reasons|1|||
161049065|NCT02161146|581568172|FG002|Overall Study|Personal Reasons|0|||
161049066|NCT02161146|581568173|FG003|Overall Study|Personal Reasons|2|||
161049067|NCT02161146|581568174|FG004|Overall Study|Personal Reasons|1|||
161049068|NCT02161146|581568170|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161049069|NCT02161146|581568171|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161049070|NCT02161146|581568172|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161049071|NCT02161146|581568173|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161049072|NCT02161146|581568174|FG004|Overall Study|Other Miscellaneous Reasons|0|||
161049073|NCT00845520|581568175|FG000|Overall Study|Death|1|||
161049074|NCT00845520|581568176|FG001|Overall Study|Death|2|||
161049075|NCT00845520|581568177|FG002|Overall Study|Death|0|||
161049076|NCT00845520|581568175|FG000|Overall Study|Lost to Follow-up|1|||
161049077|NCT00845520|581568176|FG001|Overall Study|Lost to Follow-up|0|||
161049078|NCT00845520|581568177|FG002|Overall Study|Lost to Follow-up|0|||
161049079|NCT00845520|581568175|FG000|Overall Study|Adverse Event|0|||
161049080|NCT00845520|581568176|FG001|Overall Study|Adverse Event|0|||
161049081|NCT00845520|581568177|FG002|Overall Study|Adverse Event|1|||
161049082|NCT02613403|581568178|FG000|Overall Study|Lost to Follow-up|0|||
161049083|NCT02613403|581568179|FG001|Overall Study|Lost to Follow-up|1|||
161049084|NCT02613403|581568180|FG002|Overall Study|Lost to Follow-up|0|||
161049085|NCT02613403|581568181|FG003|Overall Study|Lost to Follow-up|0|||
161049086|NCT02613403|581568182|FG004|Overall Study|Lost to Follow-up|0|||
161049087|NCT02613403|581568178|FG000|Overall Study|Withdrawal by Subject|2|||
161049088|NCT02613403|581568179|FG001|Overall Study|Withdrawal by Subject|0|||
161049089|NCT02613403|581568180|FG002|Overall Study|Withdrawal by Subject|0|||
161049090|NCT02613403|581568181|FG003|Overall Study|Withdrawal by Subject|0|||
161049091|NCT02613403|581568182|FG004|Overall Study|Withdrawal by Subject|0|||
161049092|NCT00800176|581568183|FG000|Overall Study|Adverse Event|2|||
161049093|NCT00800176|581568184|FG001|Overall Study|Adverse Event|1|||
161049094|NCT00800176|581568185|FG002|Overall Study|Adverse Event|0|||
161049095|NCT00800176|581568186|FG003|Overall Study|Adverse Event|2|||
161049096|NCT00800176|581568187|FG004|Overall Study|Adverse Event|1|||
161049097|NCT00800176|581568188|FG005|Overall Study|Adverse Event|1|||
161049098|NCT00800176|581568183|FG000|Overall Study|Refused treatment|3|||
161049099|NCT00800176|581568184|FG001|Overall Study|Refused treatment|2|||
161049100|NCT00800176|581568185|FG002|Overall Study|Refused treatment|0|||
161049101|NCT00800176|581568186|FG003|Overall Study|Refused treatment|0|||
161049102|NCT00800176|581568187|FG004|Overall Study|Refused treatment|1|||
161049103|NCT00800176|581568188|FG005|Overall Study|Refused treatment|4|||
161049104|NCT00800176|581568183|FG000|Overall Study|Failure to return|3|||
161049105|NCT00800176|581568184|FG001|Overall Study|Failure to return|3|||
161049106|NCT00800176|581568185|FG002|Overall Study|Failure to return|0|||
161049107|NCT00800176|581568186|FG003|Overall Study|Failure to return|2|||
161049108|NCT00800176|581568187|FG004|Overall Study|Failure to return|0|||
161049109|NCT00800176|581568188|FG005|Overall Study|Failure to return|0|||
161049110|NCT00800176|581568183|FG000|Overall Study|Other|1|||
161049111|NCT00800176|581568184|FG001|Overall Study|Other|0|||
161049112|NCT00800176|581568185|FG002|Overall Study|Other|0|||
161049113|NCT00800176|581568186|FG003|Overall Study|Other|0|||
161049114|NCT00800176|581568187|FG004|Overall Study|Other|2|||
161049115|NCT00800176|581568188|FG005|Overall Study|Other|0|||
161049116|NCT04620733|581570049|FG000|Overall Study|Adverse Event|4|||
161049117|NCT04620733|581570050|FG001|Overall Study|Adverse Event|3|||
161049118|NCT04620733|581570049|FG000|Overall Study|Withdrawal by Subject|2|||
161049119|NCT04620733|581570050|FG001|Overall Study|Withdrawal by Subject|5|||
161049120|NCT04620733|581570049|FG000|Overall Study|Lost to Follow-up|1|||
161049121|NCT04620733|581570050|FG001|Overall Study|Lost to Follow-up|1|||
161049122|NCT04620733|581570049|FG000|Overall Study|Protocol Deviation|1|||
161049123|NCT04620733|581570050|FG001|Overall Study|Protocol Deviation|1|||
161049124|NCT04620733|581570049|FG000|Overall Study|Reason Not Specified|0|||
161049125|NCT04620733|581570050|FG001|Overall Study|Reason Not Specified|1|||
161049126|NCT00451906|581570055|FG000|Overall Study|Adverse Event|515|||
161049127|NCT00451906|581570055|FG000|Overall Study|Lost to Follow-up|31|||
161049128|NCT00451906|581570055|FG000|Overall Study|Withdrawal by Subject|111|||
161049129|NCT00451906|581570055|FG000|Overall Study|Protocol Violation|21|||
161049130|NCT00451906|581570055|FG000|Overall Study|Progressive disease|1328|||
161049131|NCT00451906|581570055|FG000|Overall Study|Termination of the study|108|||
161049132|NCT00451906|581570055|FG000|Overall Study|Other Reasons|121|||
161049133|NCT00451906|581570055|FG000|Overall Study|Did not complete final visit|4|||
161049134|NCT00608959|581570056|FG000|Part 1|Did not meet eligibility criteria|1|||
161049135|NCT01005602|581570057|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
161049136|NCT01005602|581570058|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
161049137|NCT03761849|581570061|FG000|Overall Study|transferred to OpenLabelExtension|35|||
161049138|NCT03761849|581570062|FG001|Overall Study|transferred to OpenLabelExtension|34|||
161049139|NCT03761849|581570063|FG002|Overall Study|transferred to OpenLabelExtension|36|||
161049140|NCT03761849|581570064|FG003|Overall Study|transferred to OpenLabelExtension|0|||
161049141|NCT03761849|581570065|FG004|Overall Study|transferred to OpenLabelExtension|0|||
161049142|NCT03761849|581570066|FG005|Overall Study|transferred to OpenLabelExtension|0|||
161049143|NCT03761849|581570061|FG000|Overall Study|Adverse Event|1|||
161049144|NCT03761849|581570062|FG001|Overall Study|Adverse Event|0|||
161049145|NCT03761849|581570063|FG002|Overall Study|Adverse Event|0|||
161049146|NCT03761849|581570064|FG003|Overall Study|Adverse Event|0|||
161049147|NCT03761849|581570065|FG004|Overall Study|Adverse Event|2|||
161049148|NCT03761849|581570066|FG005|Overall Study|Adverse Event|3|||
161049149|NCT03761849|581570061|FG000|Overall Study|Withdrawal by Subject|0|||
161049150|NCT03761849|581570062|FG001|Overall Study|Withdrawal by Subject|0|||
161049151|NCT03761849|581570063|FG002|Overall Study|Withdrawal by Subject|0|||
161049152|NCT03761849|581570064|FG003|Overall Study|Withdrawal by Subject|41|||
161049153|NCT03761849|581570065|FG004|Overall Study|Withdrawal by Subject|43|||
161049154|NCT03761849|581570066|FG005|Overall Study|Withdrawal by Subject|35|||
161280847|NCT00996892|582407004|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
161280848|NCT00996892|582407005|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
161280849|NCT00996892|582407006|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
161049155|NCT03761849|581570061|FG000|Overall Study|Lost to Follow-up|0|||
161049156|NCT03761849|581570062|FG001|Overall Study|Lost to Follow-up|1|||
161280850|NCT00996892|582407007|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
161049157|NCT03761849|581570063|FG002|Overall Study|Lost to Follow-up|0|||
161049158|NCT03761849|581570064|FG003|Overall Study|Lost to Follow-up|2|||
161049159|NCT03761849|581570065|FG004|Overall Study|Lost to Follow-up|4|||
161049160|NCT03761849|581570066|FG005|Overall Study|Lost to Follow-up|5|||
161049161|NCT03761849|581570061|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
161049162|NCT03761849|581570062|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
161049163|NCT03761849|581570063|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
161049164|NCT03761849|581570064|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
161049165|NCT03761849|581570065|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
161049166|NCT03761849|581570066|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
161049167|NCT03761849|581570061|FG000|Overall Study|Physician Decision|0|||
161049168|NCT03761849|581570062|FG001|Overall Study|Physician Decision|0|||
161049169|NCT03761849|581570063|FG002|Overall Study|Physician Decision|0|||
161049170|NCT03761849|581570064|FG003|Overall Study|Physician Decision|1|||
161049171|NCT03761849|581570065|FG004|Overall Study|Physician Decision|4|||
161049172|NCT03761849|581570066|FG005|Overall Study|Physician Decision|4|||
161049173|NCT03761849|581570061|FG000|Overall Study|Death|0|||
161049174|NCT03761849|581570062|FG001|Overall Study|Death|0|||
161049175|NCT03761849|581570063|FG002|Overall Study|Death|0|||
161049176|NCT03761849|581570064|FG003|Overall Study|Death|1|||
161049177|NCT03761849|581570065|FG004|Overall Study|Death|1|||
161049178|NCT03761849|581570066|FG005|Overall Study|Death|3|||
161049179|NCT03761849|581570061|FG000|Overall Study|Protocol Violation|0|||
161049180|NCT03761849|581570062|FG001|Overall Study|Protocol Violation|0|||
161049181|NCT03761849|581570063|FG002|Overall Study|Protocol Violation|0|||
161049182|NCT03761849|581570064|FG003|Overall Study|Protocol Violation|2|||
161049183|NCT03761849|581570065|FG004|Overall Study|Protocol Violation|2|||
161049184|NCT03761849|581570066|FG005|Overall Study|Protocol Violation|1|||
161049185|NCT03761849|581570061|FG000|Overall Study|Participant could not come to site|0|||
161049186|NCT03761849|581570062|FG001|Overall Study|Participant could not come to site|0|||
161049187|NCT03761849|581570063|FG002|Overall Study|Participant could not come to site|0|||
161049188|NCT03761849|581570064|FG003|Overall Study|Participant could not come to site|0|||
161049189|NCT03761849|581570065|FG004|Overall Study|Participant could not come to site|1|||
161049190|NCT03761849|581570066|FG005|Overall Study|Participant could not come to site|0|||
161049191|NCT03761849|581570061|FG000|Overall Study|SF- safety Finding|0|||
161049192|NCT03761849|581570062|FG001|Overall Study|SF- safety Finding|0|||
161049193|NCT03761849|581570063|FG002|Overall Study|SF- safety Finding|0|||
161049194|NCT03761849|581570064|FG003|Overall Study|SF- safety Finding|0|||
161049195|NCT03761849|581570065|FG004|Overall Study|SF- safety Finding|0|||
161049196|NCT03761849|581570066|FG005|Overall Study|SF- safety Finding|1|||
161049197|NCT03761849|581570061|FG000|Overall Study|Patient did not attend visit|0|||
161049198|NCT03761849|581570062|FG001|Overall Study|Patient did not attend visit|0|||
161049199|NCT03761849|581570063|FG002|Overall Study|Patient did not attend visit|0|||
161049200|NCT03761849|581570064|FG003|Overall Study|Patient did not attend visit|0|||
161049201|NCT03761849|581570065|FG004|Overall Study|Patient did not attend visit|0|||
161049202|NCT03761849|581570066|FG005|Overall Study|Patient did not attend visit|1|||
161049203|NCT01131325|581570067|FG000|Overall Study|Adverse Event|1|||
161049204|NCT01131325|581570067|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
161049205|NCT03884478|581570068|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
161049206|NCT03884478|581570069|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
161049207|NCT03884478|581570070|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
161049208|NCT03884478|581570068|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
161049209|NCT03884478|581570069|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
161049210|NCT03884478|581570070|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
161049211|NCT03884478|581570068|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
161049212|NCT03884478|581570069|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
161049213|NCT03884478|581570070|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
161049214|NCT03884478|581570068|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
161049215|NCT03884478|581570069|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
161049216|NCT03884478|581570070|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
161049217|NCT01807234|581570071|FG000|Overall Study|Lost to Follow-up|2|||
161049218|NCT01807234|581570072|FG001|Overall Study|Lost to Follow-up|5|||
161049219|NCT01807234|581570073|FG002|Overall Study|Lost to Follow-up|1|||
161049220|NCT01807234|581570074|FG003|Overall Study|Lost to Follow-up|1|||
161049221|NCT01807234|581570075|FG004|Overall Study|Lost to Follow-up|1|||
161049222|NCT01807234|581570076|FG005|Overall Study|Lost to Follow-up|2|||
161049223|NCT01807234|581570071|FG000|Overall Study|Withdrawal by Subject|3|||
161049224|NCT01807234|581570072|FG001|Overall Study|Withdrawal by Subject|1|||
161049225|NCT01807234|581570073|FG002|Overall Study|Withdrawal by Subject|1|||
161049226|NCT01807234|581570074|FG003|Overall Study|Withdrawal by Subject|1|||
161049227|NCT01807234|581570075|FG004|Overall Study|Withdrawal by Subject|2|||
161049228|NCT01807234|581570076|FG005|Overall Study|Withdrawal by Subject|1|||
161280851|NCT00996892|582407008|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
161280852|NCT00996892|582407009|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
161280853|NCT00996892|582407010|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
161280854|NCT00996892|582407011|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
161280855|NCT00996892|582407012|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
161049229|NCT01807234|581570071|FG000|Overall Study|Lack of Efficacy|0|||
161049230|NCT01807234|581570072|FG001|Overall Study|Lack of Efficacy|0|||
161049231|NCT01807234|581570073|FG002|Overall Study|Lack of Efficacy|0|||
161049232|NCT01807234|581570074|FG003|Overall Study|Lack of Efficacy|0|||
161049233|NCT01807234|581570075|FG004|Overall Study|Lack of Efficacy|1|||
161049234|NCT01807234|581570076|FG005|Overall Study|Lack of Efficacy|1|||
161049235|NCT01540474|581570077|FG000|Vaccination Period|Lost to Follow-up|0|||
161049236|NCT01540474|581570078|FG001|Vaccination Period|Lost to Follow-up|1|||
161049237|NCT01540474|581570079|FG002|Vaccination Period|Lost to Follow-up|0|||
161049238|NCT01540474|581570080|FG003|Vaccination Period|Lost to Follow-up|0|||
161150663|NCT01070550|581933546|FG002|Overall Study|Lack of Efficacy|5|||
161150664|NCT01070550|581933547|FG003|Overall Study|Lack of Efficacy|5|||
161049239|NCT00828139|581570081|FG000|Overall Study|Adverse Event|8|||
161049240|NCT00828139|581570082|FG001|Overall Study|Adverse Event|1|||
161049241|NCT00828139|581570083|FG002|Overall Study|Adverse Event|10|||
161049242|NCT00828139|581570084|FG003|Overall Study|Adverse Event|5|||
161049243|NCT00828139|581570081|FG000|Overall Study|Death|2|||
161049244|NCT00828139|581570082|FG001|Overall Study|Death|1|||
161150665|NCT01070550|581933548|FG004|Overall Study|Lack of Efficacy|0|||
161150666|NCT01070550|581933549|FG005|Overall Study|Lack of Efficacy|1|||
161150667|NCT01070550|581933544|FG000|Overall Study|Miscellaneous|12|||
161150668|NCT01070550|581933545|FG001|Overall Study|Miscellaneous|2|||
161150669|NCT01070550|581933546|FG002|Overall Study|Miscellaneous|3|||
161150670|NCT01070550|581933547|FG003|Overall Study|Miscellaneous|1|||
161150671|NCT01070550|581933548|FG004|Overall Study|Miscellaneous|0|||
161150672|NCT01070550|581933549|FG005|Overall Study|Miscellaneous|0|||
161150673|NCT01070550|581933544|FG000|Overall Study|New treatment started|3|||
161150674|NCT01070550|581933545|FG001|Overall Study|New treatment started|1|||
161150675|NCT01070550|581933546|FG002|Overall Study|New treatment started|0|||
161150676|NCT01070550|581933547|FG003|Overall Study|New treatment started|2|||
161150677|NCT01070550|581933548|FG004|Overall Study|New treatment started|0|||
161150678|NCT01070550|581933549|FG005|Overall Study|New treatment started|0|||
161150679|NCT01070550|581933544|FG000|Overall Study|Non-responders|493|||
161150680|NCT01070550|581933545|FG001|Overall Study|Non-responders|4|||
161150681|NCT01070550|581933546|FG002|Overall Study|Non-responders|21|||
161150682|NCT01070550|581933547|FG003|Overall Study|Non-responders|20|||
161150683|NCT01070550|581933548|FG004|Overall Study|Non-responders|0|||
161150684|NCT01070550|581933549|FG005|Overall Study|Non-responders|2|||
161150685|NCT01070550|581933544|FG000|Overall Study|Not categorized|33|||
161150686|NCT01070550|581933545|FG001|Overall Study|Not categorized|2|||
161150687|NCT01070550|581933546|FG002|Overall Study|Not categorized|6|||
161150688|NCT01070550|581933547|FG003|Overall Study|Not categorized|1|||
161150689|NCT01070550|581933548|FG004|Overall Study|Not categorized|0|||
161150690|NCT01070550|581933549|FG005|Overall Study|Not categorized|1|||
161150691|NCT01070550|581933544|FG000|Overall Study|Protocol Violation|15|||
161150692|NCT01070550|581933545|FG001|Overall Study|Protocol Violation|1|||
161150693|NCT01070550|581933546|FG002|Overall Study|Protocol Violation|1|||
161150694|NCT01070550|581933547|FG003|Overall Study|Protocol Violation|1|||
161150695|NCT01070550|581933548|FG004|Overall Study|Protocol Violation|0|||
161150696|NCT01070550|581933549|FG005|Overall Study|Protocol Violation|0|||
161150697|NCT01070550|581933544|FG000|Overall Study|Relapse|44|||
161150698|NCT01070550|581933545|FG001|Overall Study|Relapse|5|||
161150699|NCT01070550|581933546|FG002|Overall Study|Relapse|14|||
161150700|NCT01070550|581933547|FG003|Overall Study|Relapse|4|||
161150701|NCT01070550|581933548|FG004|Overall Study|Relapse|0|||
161150702|NCT01070550|581933549|FG005|Overall Study|Relapse|0|||
161150703|NCT01070550|581933544|FG000|Overall Study|Result not available|3|||
161150704|NCT01070550|581933545|FG001|Overall Study|Result not available|1|||
161150705|NCT01070550|581933546|FG002|Overall Study|Result not available|3|||
161150706|NCT01070550|581933547|FG003|Overall Study|Result not available|0|||
161150707|NCT01070550|581933548|FG004|Overall Study|Result not available|0|||
161150708|NCT01070550|581933549|FG005|Overall Study|Result not available|0|||
161280856|NCT00996892|582407013|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
161280857|NCT00996892|582407014|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
161049245|NCT00828139|581570083|FG002|Overall Study|Death|0|||
161049246|NCT00828139|581570084|FG003|Overall Study|Death|2|||
161280858|NCT00996892|582407015|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
161280859|NCT00996892|582407016|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
161280860|NCT00996892|582407017|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
161049247|NCT00828139|581570081|FG000|Overall Study|Refusal unrelated to toxicity|3|||
161049248|NCT00828139|581570082|FG001|Overall Study|Refusal unrelated to toxicity|4|||
161150709|NCT01070550|581933544|FG000|Overall Study|Screen failure|1|||
161150710|NCT01070550|581933545|FG001|Overall Study|Screen failure|0|||
161150711|NCT01070550|581933546|FG002|Overall Study|Screen failure|0|||
161150712|NCT01070550|581933547|FG003|Overall Study|Screen failure|0|||
161280861|NCT00996892|582407018|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
161280862|NCT00996892|582407019|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
161049249|NCT00828139|581570083|FG002|Overall Study|Refusal unrelated to toxicity|5|||
161049250|NCT00828139|581570084|FG003|Overall Study|Refusal unrelated to toxicity|3|||
161150713|NCT01070550|581933548|FG004|Overall Study|Screen failure|0|||
161150714|NCT01070550|581933549|FG005|Overall Study|Screen failure|0|||
161150715|NCT01070550|581933544|FG000|Overall Study|Sponsor decision|1|||
161150716|NCT01070550|581933545|FG001|Overall Study|Sponsor decision|0|||
161150717|NCT01070550|581933546|FG002|Overall Study|Sponsor decision|0|||
161150718|NCT01070550|581933547|FG003|Overall Study|Sponsor decision|0|||
161150719|NCT01070550|581933548|FG004|Overall Study|Sponsor decision|0|||
161150720|NCT01070550|581933549|FG005|Overall Study|Sponsor decision|0|||
161150721|NCT01070550|581933544|FG000|Overall Study|Treatment duration shortened|1|||
161150722|NCT01070550|581933545|FG001|Overall Study|Treatment duration shortened|0|||
161150723|NCT01070550|581933546|FG002|Overall Study|Treatment duration shortened|0|||
161150724|NCT01070550|581933547|FG003|Overall Study|Treatment duration shortened|0|||
161150725|NCT01070550|581933548|FG004|Overall Study|Treatment duration shortened|0|||
161150726|NCT01070550|581933549|FG005|Overall Study|Treatment duration shortened|0|||
161150727|NCT01070550|581933544|FG000|Overall Study|Treatment interrupted|7|||
161150728|NCT01070550|581933545|FG001|Overall Study|Treatment interrupted|0|||
161150729|NCT01070550|581933546|FG002|Overall Study|Treatment interrupted|1|||
161150730|NCT01070550|581933547|FG003|Overall Study|Treatment interrupted|1|||
161150731|NCT01070550|581933548|FG004|Overall Study|Treatment interrupted|0|||
161150732|NCT01070550|581933549|FG005|Overall Study|Treatment interrupted|0|||
161150733|NCT01070550|581933544|FG000|Overall Study|Treatment not started|14|||
161150734|NCT01070550|581933545|FG001|Overall Study|Treatment not started|2|||
161150735|NCT01070550|581933546|FG002|Overall Study|Treatment not started|4|||
161150736|NCT01070550|581933547|FG003|Overall Study|Treatment not started|0|||
161150737|NCT01070550|581933548|FG004|Overall Study|Treatment not started|0|||
161150738|NCT01070550|581933549|FG005|Overall Study|Treatment not started|0|||
161150739|NCT01070550|581933544|FG000|Overall Study|Treatment restarted|0|||
161150740|NCT01070550|581933545|FG001|Overall Study|Treatment restarted|1|||
161150741|NCT01070550|581933546|FG002|Overall Study|Treatment restarted|0|||
161150742|NCT01070550|581933547|FG003|Overall Study|Treatment restarted|0|||
161150743|NCT01070550|581933548|FG004|Overall Study|Treatment restarted|0|||
161150744|NCT01070550|581933549|FG005|Overall Study|Treatment restarted|0|||
161150745|NCT01070550|581933544|FG000|Overall Study|Treatment stopped|3|||
161150746|NCT01070550|581933545|FG001|Overall Study|Treatment stopped|0|||
161150747|NCT01070550|581933546|FG002|Overall Study|Treatment stopped|0|||
161150748|NCT01070550|581933547|FG003|Overall Study|Treatment stopped|0|||
161150749|NCT01070550|581933548|FG004|Overall Study|Treatment stopped|0|||
161150750|NCT01070550|581933549|FG005|Overall Study|Treatment stopped|0|||
161150751|NCT01070550|581933544|FG000|Overall Study|Treatment unavailable|1|||
161150752|NCT01070550|581933545|FG001|Overall Study|Treatment unavailable|0|||
161150753|NCT01070550|581933546|FG002|Overall Study|Treatment unavailable|0|||
161150754|NCT01070550|581933547|FG003|Overall Study|Treatment unavailable|0|||
161150755|NCT01070550|581933548|FG004|Overall Study|Treatment unavailable|0|||
161150756|NCT01070550|581933549|FG005|Overall Study|Treatment unavailable|0|||
161150757|NCT01070550|581933544|FG000|Overall Study|Treatment was stopped early|7|||
161150758|NCT01070550|581933545|FG001|Overall Study|Treatment was stopped early|0|||
161150759|NCT01070550|581933546|FG002|Overall Study|Treatment was stopped early|0|||
161150760|NCT01070550|581933547|FG003|Overall Study|Treatment was stopped early|0|||
161150761|NCT01070550|581933548|FG004|Overall Study|Treatment was stopped early|0|||
161150762|NCT01070550|581933549|FG005|Overall Study|Treatment was stopped early|0|||
161150763|NCT01070550|581933544|FG000|Overall Study|Other|5|||
161150764|NCT01070550|581933545|FG001|Overall Study|Other|0|||
161150765|NCT01070550|581933546|FG002|Overall Study|Other|0|||
161150766|NCT01070550|581933547|FG003|Overall Study|Other|1|||
161150767|NCT01070550|581933548|FG004|Overall Study|Other|0|||
161150768|NCT01070550|581933549|FG005|Overall Study|Other|0|||
161150769|NCT01070550|581933544|FG000|Overall Study|Withdrawal by Subject|35|||
161150770|NCT01070550|581933545|FG001|Overall Study|Withdrawal by Subject|0|||
161150771|NCT01070550|581933546|FG002|Overall Study|Withdrawal by Subject|3|||
161150772|NCT01070550|581933547|FG003|Overall Study|Withdrawal by Subject|0|||
161150773|NCT01070550|581933548|FG004|Overall Study|Withdrawal by Subject|0|||
161049251|NCT00828139|581570081|FG000|Overall Study|Disease Progression|24|||
161049252|NCT00828139|581570082|FG001|Overall Study|Disease Progression|33|||
161049253|NCT00828139|581570083|FG002|Overall Study|Disease Progression|35|||
161049254|NCT00828139|581570084|FG003|Overall Study|Disease Progression|39|||
161049255|NCT00828139|581570081|FG000|Overall Study|Other|4|||
161049256|NCT00828139|581570082|FG001|Overall Study|Other|2|||
161049257|NCT00828139|581570083|FG002|Overall Study|Other|5|||
161049258|NCT00828139|581570084|FG003|Overall Study|Other|2|||
161049259|NCT04271254|581570088|FG000|Overall Study|Withdrawal by Subject|3|||
161049260|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
161049261|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
161049262|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
161049263|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
161049264|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
161049265|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
161150774|NCT01070550|581933549|FG005|Overall Study|Withdrawal by Subject|0|||
161150775|NCT01505491|581933550|FG000|Overall Study|Other reason not listed|1|||
161150776|NCT01505491|581933551|FG001|Overall Study|Other reason not listed|0|||
161150777|NCT01505491|581933552|FG002|Overall Study|Other reason not listed|0|||
161150778|NCT01505491|581933550|FG000|Overall Study|Withdrawal by Subject|1|||
161150779|NCT01505491|581933551|FG001|Overall Study|Withdrawal by Subject|1|||
161150780|NCT01505491|581933552|FG002|Overall Study|Withdrawal by Subject|4|||
161150781|NCT01505491|581933550|FG000|Overall Study|Lost to Follow-up|0|||
161049266|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
161049267|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
161049268|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
161049269|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
161049270|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
161049271|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
161049272|NCT01345253|581570089|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
161049273|NCT01345253|581570090|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
161049274|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
161049275|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
161049276|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
161049277|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
161049278|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
161049279|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
161049280|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
161049281|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
161049282|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
161049283|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
161049284|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
161049285|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
161049286|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
161049287|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
161049288|NCT01345253|581570089|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
161049289|NCT01345253|581570090|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
161049290|NCT03693989|581570095|FG000|Overall Study|Protocol Violation|3|||
161049291|NCT03693989|581570096|FG001|Overall Study|Protocol Violation|4|||
161049292|NCT01190436|581570097|FG000|Overall Study|Lost to Follow-up|35|||
161049293|NCT01190436|581570097|FG000|Overall Study|Other|4|||
161049294|NCT03146845|581570098|FG000|Overall Study|Reference ulcer healed|1|||
161049295|NCT03146845|581570099|FG001|Overall Study|Reference ulcer healed|0|||
161049296|NCT03146845|581570098|FG000|Overall Study|Physician Decision|1|||
161049297|NCT03146845|581570099|FG001|Overall Study|Physician Decision|0|||
161049298|NCT03146845|581570098|FG000|Overall Study|Adverse Event|1|||
161049299|NCT03146845|581570099|FG001|Overall Study|Adverse Event|0|||
161049300|NCT03146845|581570098|FG000|Overall Study|Withdrawal by Subject|2|||
161049301|NCT03146845|581570099|FG001|Overall Study|Withdrawal by Subject|0|||
161049302|NCT03146845|581570098|FG000|Overall Study|Noncompliance|0|||
161049303|NCT03146845|581570099|FG001|Overall Study|Noncompliance|1|||
161049304|NCT03146845|581570098|FG000|Overall Study|Protocol Violation|0|||
161049305|NCT03146845|581570099|FG001|Overall Study|Protocol Violation|2|||
161049306|NCT03146845|581570098|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
161049307|NCT03146845|581570099|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
161049308|NCT01052272|581570102|FG000|Overall Study|Death|0|||
161049309|NCT01052272|581570103|FG001|Overall Study|Death|0|||
161049310|NCT01052272|581570104|FG002|Overall Study|Death|1|||
161049311|NCT01052272|581570105|FG003|Overall Study|Death|1|||
161049312|NCT01052272|581570102|FG000|Overall Study|Physician Decision|0|||
161049313|NCT01052272|581570103|FG001|Overall Study|Physician Decision|1|||
161049314|NCT01052272|581570104|FG002|Overall Study|Physician Decision|0|||
161049315|NCT01052272|581570105|FG003|Overall Study|Physician Decision|0|||
161049316|NCT01052272|581570102|FG000|Overall Study|patient refuses follow-up|5|||
161049317|NCT01052272|581570103|FG001|Overall Study|patient refuses follow-up|4|||
161049318|NCT01052272|581570104|FG002|Overall Study|patient refuses follow-up|2|||
161049319|NCT01052272|581570105|FG003|Overall Study|patient refuses follow-up|4|||
161049320|NCT01052272|581570102|FG000|Overall Study|Withdrawal by Subject|0|||
161049321|NCT01052272|581570103|FG001|Overall Study|Withdrawal by Subject|2|||
161049322|NCT01052272|581570104|FG002|Overall Study|Withdrawal by Subject|3|||
161049323|NCT01052272|581570105|FG003|Overall Study|Withdrawal by Subject|2|||
161049324|NCT01052272|581570102|FG000|Overall Study|placed in long-term care|0|||
161049325|NCT01052272|581570103|FG001|Overall Study|placed in long-term care|0|||
161049326|NCT01052272|581570104|FG002|Overall Study|placed in long-term care|1|||
161049327|NCT01052272|581570105|FG003|Overall Study|placed in long-term care|0|||
161049328|NCT01052272|581570102|FG000|Overall Study|decline in health|0|||
161049329|NCT01052272|581570103|FG001|Overall Study|decline in health|0|||
161049330|NCT01052272|581570104|FG002|Overall Study|decline in health|1|||
161049331|NCT01052272|581570105|FG003|Overall Study|decline in health|0|||
161049332|NCT00113529|581570107|FG000|Overall Study|Adverse Event|4|||
161049333|NCT00113529|581570107|FG000|Overall Study|Lack of Efficacy|20|||
161049334|NCT00113529|581570107|FG000|Overall Study|Decision of sponsor|6|||
161049335|NCT00113529|581570107|FG000|Overall Study|Withdrawal by Subject|4|||
161049336|NCT00648895|581570109|FG000|Overall Study|Lack of Efficacy|0|||
161049337|NCT00648895|581570110|FG001|Overall Study|Lack of Efficacy|1|||
161049338|NCT00841321|581570115|FG000|Overall Study|Lost to Follow-up|1|||
161049339|NCT00841321|581570116|FG001|Overall Study|Lost to Follow-up|1|||
161049340|NCT00841321|581570115|FG000|Overall Study|Adverse Event|0|||
161280863|NCT00996892|582407020|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
161280864|NCT00996892|582407021|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
161280865|NCT00996892|582407002|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
161280866|NCT00996892|582407003|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
161280867|NCT00996892|582407004|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
161280868|NCT00996892|582407005|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
161280869|NCT00996892|582407006|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
161280870|NCT00996892|582407007|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
161280871|NCT00996892|582407008|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
161344972|NCT03126110|582648865|FG016|Phase 1|Withdrawal by Subject|0|||
161049341|NCT00841321|581570116|FG001|Overall Study|Adverse Event|2|||
161049342|NCT02632747|581570119|FG000|Wash-out Period|Adverse Event|1|||
161049343|NCT02632747|581570120|FG001|Wash-out Period|Adverse Event|0|||
161049344|NCT04421456|581570121|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
161049345|NCT04421456|581570122|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
161049346|NCT04421456|581570123|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
161049347|NCT04421456|581570121|FG000|Randomized Treatment Period|Adverse Event|0|||
161049348|NCT04421456|581570122|FG001|Randomized Treatment Period|Adverse Event|1|||
161049349|NCT04421456|581570123|FG002|Randomized Treatment Period|Adverse Event|0|||
161049350|NCT04421456|581570121|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
161049351|NCT04421456|581570122|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
161049352|NCT04421456|581570123|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
161049353|NCT04421456|581570121|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
161049354|NCT04421456|581570122|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
161049355|NCT04421456|581570123|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
161049356|NCT04421456|581570121|FG000|Randomized Treatment Period|Participant non-compliance|1|||
161049357|NCT04421456|581570122|FG001|Randomized Treatment Period|Participant non-compliance|1|||
161049358|NCT04421456|581570123|FG002|Randomized Treatment Period|Participant non-compliance|2|||
161049359|NCT04421456|581570121|FG000|Randomized Treatment Period|Other|0|||
161049360|NCT04421456|581570122|FG001|Randomized Treatment Period|Other|1|||
161049361|NCT04421456|581570123|FG002|Randomized Treatment Period|Other|3|||
161049362|NCT03875729|581570128|FG000|Overall Study|Adverse Event|0|||
161049363|NCT03875729|581570129|FG001|Overall Study|Adverse Event|5|||
161049364|NCT03875729|581570128|FG000|Overall Study|Withdrawal by Subject|8|||
161049365|NCT03875729|581570129|FG001|Overall Study|Withdrawal by Subject|11|||
161049366|NCT03875729|581570128|FG000|Overall Study|Pregnancy|0|||
161049367|NCT03875729|581570129|FG001|Overall Study|Pregnancy|1|||
161049368|NCT03875729|581570128|FG000|Overall Study|Lost to Follow-up|0|||
161049369|NCT03875729|581570129|FG001|Overall Study|Lost to Follow-up|5|||
161049370|NCT03875729|581570128|FG000|Overall Study|Personal reasons|2|||
161049371|NCT03875729|581570129|FG001|Overall Study|Personal reasons|0|||
161049372|NCT00753896|581570130|FG000|Overall Study|Adverse Event|4|||
161049373|NCT00753896|581570130|FG000|Overall Study|Death|1|||
161049374|NCT00753896|581570130|FG000|Overall Study|Lost to Follow-up|2|||
161049375|NCT00753896|581570130|FG000|Overall Study|Protocol Violation|1|||
161049376|NCT00753896|581570130|FG000|Overall Study|Withdrawal by Subject|4|||
161049377|NCT00753896|581570130|FG000|Overall Study|Entry Criteria Not Met|4|||
161049378|NCT01280656|581570131|FG000|Overall Study|Adverse Event|1|||
161049379|NCT01280656|581570132|FG001|Overall Study|Adverse Event|14|||
161049380|NCT01280656|581570133|FG002|Overall Study|Adverse Event|13|||
161049381|NCT01280656|581570131|FG000|Overall Study|Lack of Efficacy|1|||
161049382|NCT01280656|581570132|FG001|Overall Study|Lack of Efficacy|22|||
161049383|NCT01280656|581570133|FG002|Overall Study|Lack of Efficacy|38|||
161049384|NCT01280656|581570131|FG000|Overall Study|Treatment shortening (RGT)|0|||
161280872|NCT00996892|582407009|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
161280873|NCT00996892|582407010|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
161280874|NCT00996892|582407011|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
161280875|NCT00996892|582407012|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
161280876|NCT00996892|582407013|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
161344973|NCT03126110|582648849|FG000|Phase 1|Safety follow-up no longer necessary|1|||
161049385|NCT01280656|581570132|FG001|Overall Study|Treatment shortening (RGT)|4|||
161049386|NCT01280656|581570133|FG002|Overall Study|Treatment shortening (RGT)|5|||
161049387|NCT01280656|581570131|FG000|Overall Study|Other|1|||
161049388|NCT01280656|581570132|FG001|Overall Study|Other|7|||
161049389|NCT01280656|581570133|FG002|Overall Study|Other|7|||
161049390|NCT00952523|581570134|FG000|Overall Study|Withdrawal by Subject|7|||
161049391|NCT05265247|581570135|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
161049392|NCT05265247|581570136|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
161049393|NCT05265247|581570135|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
161049394|NCT05265247|581570136|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
161049395|NCT05265247|581570135|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
161049396|NCT05265247|581570136|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
161049397|NCT01029925|581570137|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
161049398|NCT01029925|581570137|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
161049399|NCT01029925|581570137|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
161049400|NCT02707952|581570142|FG000|Overall Study|Adverse Event|1|||
161049401|NCT02707952|581570143|FG001|Overall Study|Adverse Event|0|||
161049402|NCT02707952|581570144|FG002|Overall Study|Adverse Event|0|||
161049403|NCT02707952|581570145|FG003|Overall Study|Adverse Event|0|||
161049404|NCT02707952|581570142|FG000|Overall Study|Lost to Follow-up|1|||
161049405|NCT02707952|581570143|FG001|Overall Study|Lost to Follow-up|0|||
161049406|NCT02707952|581570144|FG002|Overall Study|Lost to Follow-up|0|||
161049407|NCT02707952|581570145|FG003|Overall Study|Lost to Follow-up|0|||
161049408|NCT02707952|581570142|FG000|Overall Study|Withdrawal by Subject|0|||
161049409|NCT02707952|581570143|FG001|Overall Study|Withdrawal by Subject|1|||
161049410|NCT02707952|581570144|FG002|Overall Study|Withdrawal by Subject|2|||
161049411|NCT02707952|581570145|FG003|Overall Study|Withdrawal by Subject|0|||
161049412|NCT01287832|581570147|FG000|Overall Study|Adverse Event|1|||
161049413|NCT01287832|581570148|FG001|Overall Study|Adverse Event|0|||
161049414|NCT01287832|581570147|FG000|Overall Study|Death|0|||
161049415|NCT01287832|581570148|FG001|Overall Study|Death|1|||
161049416|NCT03065400|581570151|FG000|Overall Study|Adverse Event|1|||
161049417|NCT03065400|581570151|FG000|Overall Study|Physician Decision|3|||
161049418|NCT03065400|581570151|FG000|Overall Study|Withdrawal by Subject|1|||
161049419|NCT03065400|581570151|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
161049420|NCT03072862|581570152|FG000|Overall Study|Withdrawal by Subject|4|||
161049421|NCT03072862|581570152|FG000|Overall Study|Lost to Follow-up|6|||
161049422|NCT03072862|581570152|FG000|Overall Study|Protocol Violation|4|||
161049423|NCT03072862|581570152|FG000|Overall Study|Physician Decision|2|||
161049424|NCT03072862|581570152|FG000|Overall Study|Death|1|||
161049425|NCT03072862|581570152|FG000|Overall Study|Adverse Event|1|||
161049426|NCT00632736|581570153|FG000|Overall Study|Adverse Event|104|||
161049427|NCT00632736|581570153|FG000|Overall Study|Lost to Follow-up|15|||
161049428|NCT00632736|581570153|FG000|Overall Study|Protocol Violation|14|||
161049429|NCT00632736|581570153|FG000|Overall Study|Withdrawal by Subject|99|||
161049430|NCT00632736|581570153|FG000|Overall Study|Lack of Efficacy|5|||
161049431|NCT00632736|581570153|FG000|Overall Study|Sponsor terminated study|5|||
161049432|NCT00632736|581570153|FG000|Overall Study|Non-compliance|10|||
161049433|NCT00632736|581570153|FG000|Overall Study|Other|16|||
161049434|NCT03015220|581570155|FG000|Overall Study|Withdrawal by Subject|3|||
161049435|NCT03015220|581570156|FG001|Overall Study|Withdrawal by Subject|2|||
161049436|NCT03015220|581570157|FG002|Overall Study|Withdrawal by Subject|2|||
161049437|NCT03015220|581570158|FG003|Overall Study|Withdrawal by Subject|2|||
161049438|NCT03015220|581570155|FG000|Overall Study|Lost to Follow-up|0|||
161049439|NCT03015220|581570156|FG001|Overall Study|Lost to Follow-up|0|||
161049440|NCT03015220|581570157|FG002|Overall Study|Lost to Follow-up|1|||
161049441|NCT03015220|581570158|FG003|Overall Study|Lost to Follow-up|0|||
161049442|NCT01670526|581570160|FG000|Overall Study|Withdrawal by Subject|3|||
161049443|NCT01670526|581570161|FG001|Overall Study|Withdrawal by Subject|1|||
161049444|NCT01670526|581570160|FG000|Overall Study|Lost to Follow-up|9|||
161049445|NCT01670526|581570161|FG001|Overall Study|Lost to Follow-up|5|||
161049446|NCT00392197|581570162|FG000|Overall Study|Adverse Event|4|||
161049447|NCT00392197|581570163|FG001|Overall Study|Adverse Event|12|||
161049448|NCT00392197|581570162|FG000|Overall Study|Lack of Efficacy|3|||
161280877|NCT00996892|582407014|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
161280878|NCT00996892|582407015|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
161280879|NCT00996892|582407016|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
161280880|NCT00996892|582407017|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
161280881|NCT00996892|582407018|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
161280882|NCT00996892|582407019|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
161280883|NCT00996892|582407020|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
161344974|NCT03126110|582648850|FG001|Phase 1|Safety follow-up no longer necessary|0|||
161049449|NCT00392197|581570163|FG001|Overall Study|Lack of Efficacy|4|||
161049450|NCT00392197|581570162|FG000|Overall Study|Lost to Follow-up|0|||
161049451|NCT00392197|581570163|FG001|Overall Study|Lost to Follow-up|1|||
161049452|NCT00392197|581570162|FG000|Overall Study|Physician Decision|3|||
161049453|NCT00392197|581570163|FG001|Overall Study|Physician Decision|2|||
161049454|NCT00392197|581570162|FG000|Overall Study|Protocol Violation|7|||
161049455|NCT00392197|581570163|FG001|Overall Study|Protocol Violation|5|||
161049456|NCT00392197|581570162|FG000|Overall Study|Withdrawal by Subject|4|||
161049457|NCT00392197|581570163|FG001|Overall Study|Withdrawal by Subject|6|||
161049458|NCT01794689|581570164|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
161049459|NCT01794689|581570165|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
161049460|NCT01794689|581570166|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
161049461|NCT01794689|581570167|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
161049462|NCT01794689|581570164|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
161049463|NCT01794689|581570165|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
161049464|NCT01794689|581570166|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
161049465|NCT01794689|581570167|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
161150782|NCT01505491|581933551|FG001|Overall Study|Lost to Follow-up|0|||
161150783|NCT01505491|581933552|FG002|Overall Study|Lost to Follow-up|1|||
161344975|NCT03126110|582648851|FG002|Phase 1|Safety follow-up no longer necessary|0|||
161344976|NCT03126110|582648852|FG003|Phase 1|Safety follow-up no longer necessary|0|||
161344977|NCT03126110|582648853|FG004|Phase 1|Safety follow-up no longer necessary|0|||
161344978|NCT03126110|582648854|FG005|Phase 1|Safety follow-up no longer necessary|0|||
161344979|NCT03126110|582648855|FG006|Phase 1|Safety follow-up no longer necessary|0|||
161344980|NCT03126110|582648856|FG007|Phase 1|Safety follow-up no longer necessary|0|||
161344981|NCT03126110|582648857|FG008|Phase 1|Safety follow-up no longer necessary|0|||
161344982|NCT03126110|582648858|FG009|Phase 1|Safety follow-up no longer necessary|0|||
161344983|NCT03126110|582648859|FG010|Phase 1|Safety follow-up no longer necessary|0|||
161344984|NCT03126110|582648860|FG011|Phase 1|Safety follow-up no longer necessary|0|||
161344985|NCT03126110|582648861|FG012|Phase 1|Safety follow-up no longer necessary|0|||
161344986|NCT03126110|582648862|FG013|Phase 1|Safety follow-up no longer necessary|0|||
161344987|NCT03126110|582648863|FG014|Phase 1|Safety follow-up no longer necessary|0|||
161344988|NCT03126110|582648864|FG015|Phase 1|Safety follow-up no longer necessary|0|||
161344989|NCT03126110|582648865|FG016|Phase 1|Safety follow-up no longer necessary|0|||
161344990|NCT03126110|582648849|FG000|Phase 1|Survival follow-up no longer necessary|0|||
161344991|NCT03126110|582648850|FG001|Phase 1|Survival follow-up no longer necessary|0|||
161344992|NCT03126110|582648851|FG002|Phase 1|Survival follow-up no longer necessary|1|||
161049466|NCT01794689|581570164|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
161344993|NCT03126110|582648852|FG003|Phase 1|Survival follow-up no longer necessary|0|||
161344994|NCT03126110|582648853|FG004|Phase 1|Survival follow-up no longer necessary|0|||
161344995|NCT03126110|582648854|FG005|Phase 1|Survival follow-up no longer necessary|0|||
161344996|NCT03126110|582648855|FG006|Phase 1|Survival follow-up no longer necessary|0|||
161344997|NCT03126110|582648856|FG007|Phase 1|Survival follow-up no longer necessary|0|||
161344998|NCT03126110|582648857|FG008|Phase 1|Survival follow-up no longer necessary|0|||
161344999|NCT03126110|582648858|FG009|Phase 1|Survival follow-up no longer necessary|0|||
161345000|NCT03126110|582648859|FG010|Phase 1|Survival follow-up no longer necessary|0|||
161345001|NCT03126110|582648860|FG011|Phase 1|Survival follow-up no longer necessary|0|||
161345002|NCT03126110|582648861|FG012|Phase 1|Survival follow-up no longer necessary|0|||
161345003|NCT03126110|582648862|FG013|Phase 1|Survival follow-up no longer necessary|0|||
161049467|NCT01794689|581570165|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
161049468|NCT01794689|581570166|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
161049469|NCT01794689|581570167|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
161049470|NCT01794689|581570164|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
161049471|NCT01794689|581570165|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
161049472|NCT01794689|581570166|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
161049473|NCT01794689|581570167|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
161049474|NCT01528605|581570168|FG000|Overall Study|Lost to Follow-up|1|||
161049475|NCT01528605|581570169|FG001|Overall Study|Lost to Follow-up|0|||
161049476|NCT01528605|581570170|FG002|Overall Study|Lost to Follow-up|1|||
161049477|NCT01528605|581570171|FG003|Overall Study|Lost to Follow-up|1|||
161049478|NCT01528605|581570172|FG004|Overall Study|Lost to Follow-up|0|||
161049479|NCT01528605|581570173|FG005|Overall Study|Lost to Follow-up|0|||
161049480|NCT01528605|581570168|FG000|Overall Study|Death|1|||
161049481|NCT01528605|581570169|FG001|Overall Study|Death|0|||
161049482|NCT01528605|581570170|FG002|Overall Study|Death|0|||
161049483|NCT01528605|581570171|FG003|Overall Study|Death|0|||
161049484|NCT01528605|581570172|FG004|Overall Study|Death|0|||
161049485|NCT01528605|581570173|FG005|Overall Study|Death|0|||
161049486|NCT04447287|581570175|FG000|Period 1: Run-in Period|Adverse Event|3|||
161049487|NCT04447287|581570176|FG001|Period 1: Run-in Period|Adverse Event|0|||
161049488|NCT04447287|581570177|FG002|Period 1: Run-in Period|Adverse Event|0|||
161049489|NCT04447287|581570175|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
161049490|NCT04447287|581570176|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
161049491|NCT04447287|581570177|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
161049492|NCT04447287|581570175|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
161150784|NCT01702363|581933555|FG000|Overall Study|Adverse Event|14|||
161150785|NCT01702363|581933555|FG000|Overall Study|Lack of Efficacy|4|||
161345004|NCT03126110|582648863|FG014|Phase 1|Survival follow-up no longer necessary|0|||
161345005|NCT03126110|582648864|FG015|Phase 1|Survival follow-up no longer necessary|0|||
161345006|NCT03126110|582648865|FG016|Phase 1|Survival follow-up no longer necessary|0|||
161345007|NCT03126110|582648849|FG000|Phase 2|Study terminated by the sponsor|0|||
161049493|NCT04447287|581570176|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
161049494|NCT04447287|581570177|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
161049495|NCT05700851|581570178|FG000|Overall Study|Received a kidney transplant|1|||
161049496|NCT05700851|581570178|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
161049497|NCT05700851|581570178|FG000|Overall Study|Withdrawal by Subject|1|||
161049498|NCT02978716|581570179|FG000|Overall Study|Death|25|||
161049499|NCT02978716|581570180|FG001|Overall Study|Death|13|||
161049500|NCT02978716|581570181|FG002|Overall Study|Death|20|||
161049501|NCT02978716|581570179|FG000|Overall Study|Lost to Follow-up|0|||
161049502|NCT02978716|581570180|FG001|Overall Study|Lost to Follow-up|0|||
161049503|NCT02978716|581570181|FG002|Overall Study|Lost to Follow-up|1|||
161049504|NCT02978716|581570179|FG000|Overall Study|Withdrawal by Subject|6|||
161049505|NCT02978716|581570180|FG001|Overall Study|Withdrawal by Subject|4|||
161049506|NCT02978716|581570181|FG002|Overall Study|Withdrawal by Subject|5|||
161049507|NCT02978716|581570179|FG000|Overall Study|Sponsor terminated|2|||
161049508|NCT02978716|581570180|FG001|Overall Study|Sponsor terminated|13|||
161049509|NCT02978716|581570181|FG002|Overall Study|Sponsor terminated|9|||
161049510|NCT02978716|581570179|FG000|Overall Study|Other|1|||
161049511|NCT02978716|581570180|FG001|Overall Study|Other|3|||
161049512|NCT02978716|581570181|FG002|Overall Study|Other|0|||
161049513|NCT00866619|581570192|FG000|Overall Study|Adverse Event|112|||
161049514|NCT00866619|581570193|FG001|Overall Study|Adverse Event|106|||
161049515|NCT00866619|581570194|FG002|Overall Study|Adverse Event|47|||
161049516|NCT00866619|581570195|FG003|Overall Study|Adverse Event|44|||
161049517|NCT00866619|581570192|FG000|Overall Study|Protocol Violation|2|||
161049518|NCT00866619|581570193|FG001|Overall Study|Protocol Violation|39|||
161049519|NCT00866619|581570194|FG002|Overall Study|Protocol Violation|2|||
161049520|NCT00866619|581570195|FG003|Overall Study|Protocol Violation|17|||
161049521|NCT00866619|581570192|FG000|Overall Study|Withdrawal by Subject|587|||
161049522|NCT00866619|581570193|FG001|Overall Study|Withdrawal by Subject|295|||
161049523|NCT00866619|581570194|FG002|Overall Study|Withdrawal by Subject|272|||
161049524|NCT00866619|581570195|FG003|Overall Study|Withdrawal by Subject|144|||
161049525|NCT00866619|581570192|FG000|Overall Study|Lost to Follow-up|1145|||
161049526|NCT00866619|581570193|FG001|Overall Study|Lost to Follow-up|830|||
161049527|NCT00866619|581570194|FG002|Overall Study|Lost to Follow-up|568|||
161049528|NCT00866619|581570195|FG003|Overall Study|Lost to Follow-up|425|||
161049529|NCT00882050|581570199|FG000|Overall Study|Physician Decision|1|||
161049530|NCT00882050|581570200|FG001|Overall Study|Physician Decision|0|||
161049531|NCT00882050|581570201|FG002|Overall Study|Physician Decision|0|||
161049532|NCT00805441|581570202|FG000|Overall Study|Adverse Event|5|||
161049533|NCT00805441|581570203|FG001|Overall Study|Adverse Event|2|||
161049534|NCT00805441|581570202|FG000|Overall Study|Lack of Efficacy|0|||
161049535|NCT00805441|581570203|FG001|Overall Study|Lack of Efficacy|2|||
161049536|NCT00805441|581570202|FG000|Overall Study|Protocol Violation|4|||
161049537|NCT00805441|581570203|FG001|Overall Study|Protocol Violation|8|||
161049538|NCT00805441|581570202|FG000|Overall Study|Lost to Follow-up|10|||
161049539|NCT00805441|581570203|FG001|Overall Study|Lost to Follow-up|13|||
161049540|NCT00805441|581570202|FG000|Overall Study|Withdrawal by Subject|15|||
161049541|NCT00805441|581570203|FG001|Overall Study|Withdrawal by Subject|9|||
161049542|NCT00805441|581570202|FG000|Overall Study|Physician Decision|0|||
161049543|NCT00805441|581570203|FG001|Overall Study|Physician Decision|1|||
161049544|NCT00805441|581570202|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
161049545|NCT00805441|581570203|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
161049546|NCT01945593|581571946|FG000|Overall Study|Adverse Event|0|||
161049547|NCT01945593|581571947|FG001|Overall Study|Adverse Event|0|||
161049548|NCT01945593|581571948|FG002|Overall Study|Adverse Event|0|||
161049549|NCT01945593|581571949|FG003|Overall Study|Adverse Event|5|||
161049550|NCT01945593|581571946|FG000|Overall Study|Physician Decision|0|||
161049551|NCT01945593|581571947|FG001|Overall Study|Physician Decision|0|||
161049552|NCT01945593|581571948|FG002|Overall Study|Physician Decision|1|||
161049553|NCT01945593|581571949|FG003|Overall Study|Physician Decision|1|||
161049554|NCT01945593|581571946|FG000|Overall Study|Withdrawal by Subject|0|||
161049555|NCT01945593|581571947|FG001|Overall Study|Withdrawal by Subject|2|||
161049556|NCT01945593|581571948|FG002|Overall Study|Withdrawal by Subject|0|||
161049557|NCT01945593|581571949|FG003|Overall Study|Withdrawal by Subject|4|||
161049558|NCT01945593|581571946|FG000|Overall Study|Protocol Violation|0|||
161150786|NCT01702363|581933555|FG000|Overall Study|Withdrawal by Subject|2|||
161049559|NCT01945593|581571947|FG001|Overall Study|Protocol Violation|2|||
161049560|NCT01945593|581571948|FG002|Overall Study|Protocol Violation|1|||
161049561|NCT01945593|581571949|FG003|Overall Study|Protocol Violation|3|||
161049562|NCT01945593|581571946|FG000|Overall Study|Death|0|||
161049563|NCT01945593|581571947|FG001|Overall Study|Death|0|||
161049564|NCT01945593|581571948|FG002|Overall Study|Death|1|||
161049565|NCT01945593|581571949|FG003|Overall Study|Death|0|||
161049566|NCT01945593|581571946|FG000|Overall Study|Other: Terminated|0|||
161049567|NCT01945593|581571947|FG001|Overall Study|Other: Terminated|0|||
161049568|NCT01945593|581571948|FG002|Overall Study|Other: Terminated|0|||
161049569|NCT01945593|581571949|FG003|Overall Study|Other: Terminated|1|||
161049570|NCT01945593|581571946|FG000|Overall Study|Other: Surgical Procedure|0|||
161049571|NCT01945593|581571947|FG001|Overall Study|Other: Surgical Procedure|2|||
161049572|NCT01945593|581571948|FG002|Overall Study|Other: Surgical Procedure|0|||
161049573|NCT01945593|581571949|FG003|Overall Study|Other: Surgical Procedure|6|||
161049574|NCT01945593|581571946|FG000|Overall Study|Other: Screen Failure|0|||
161049575|NCT01945593|581571947|FG001|Overall Study|Other: Screen Failure|2|||
161049576|NCT01945593|581571948|FG002|Overall Study|Other: Screen Failure|0|||
161049577|NCT01945593|581571949|FG003|Overall Study|Other: Screen Failure|0|||
161049578|NCT00228813|581571950|FG000|Overall Study|Death|4|||
161049579|NCT02068352|581571951|FG000|Overall Study|Lost to Follow-up|0|||
161049580|NCT02068352|581571952|FG001|Overall Study|Lost to Follow-up|2|||
161049581|NCT02068352|581571953|FG002|Overall Study|Lost to Follow-up|0|||
161049582|NCT02068352|581571951|FG000|Overall Study|Adverse Event|4|||
161049583|NCT02068352|581571952|FG001|Overall Study|Adverse Event|2|||
161049584|NCT02068352|581571953|FG002|Overall Study|Adverse Event|7|||
161049585|NCT02068352|581571951|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
161049586|NCT02068352|581571952|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
161049587|NCT02068352|581571953|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
161049588|NCT02068352|581571951|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
161049589|NCT02068352|581571952|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
161049590|NCT02068352|581571953|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
161049591|NCT02068352|581571951|FG000|Overall Study|Protocol Deviation|0|||
161049592|NCT02068352|581571952|FG001|Overall Study|Protocol Deviation|0|||
161049593|NCT02068352|581571953|FG002|Overall Study|Protocol Deviation|1|||
161049594|NCT01767376|581571957|FG000|Overall Study|Lost to Follow-up|3|||
161049595|NCT01767376|581571958|FG001|Overall Study|Lost to Follow-up|2|||
161049596|NCT01767376|581571959|FG002|Overall Study|Lost to Follow-up|0|||
161049597|NCT01767376|581571957|FG000|Overall Study|Withdrawal by Subject|1|||
161049598|NCT01767376|581571958|FG001|Overall Study|Withdrawal by Subject|1|||
161049599|NCT01767376|581571959|FG002|Overall Study|Withdrawal by Subject|0|||
161049600|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
161049601|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
161049602|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
161049603|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
161049604|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
161049605|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
161049606|NCT03557307|581571960|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
161049607|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
161049608|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|Death|3|||
161049609|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
161049610|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
161049611|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
161049612|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
161049613|NCT03557307|581571960|FG000|Period 2: Maintenance Phase|other|3|||
161049614|NCT03745651|581571961|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
161049615|NCT03745651|581571962|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
161049616|NCT03745651|581571963|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161049617|NCT03745651|581571964|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161049618|NCT03745651|581571965|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161049619|NCT03745651|581571966|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161049620|NCT03745651|581571967|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
161049621|NCT03745651|581571961|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
161049622|NCT03745651|581571962|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
161049623|NCT03745651|581571963|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
161049624|NCT03745651|581571964|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161049625|NCT03745651|581571965|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161049626|NCT03745651|581571966|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161049627|NCT03745651|581571967|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
161049628|NCT03745651|581571961|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
161049629|NCT03745651|581571962|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161049630|NCT03745651|581571963|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
161049631|NCT03745651|581571964|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161049632|NCT03745651|581571965|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161049633|NCT03745651|581571966|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161049634|NCT03745651|581571967|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
161049635|NCT03745651|581571961|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161049636|NCT03745651|581571962|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
161049637|NCT03745651|581571963|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161049638|NCT03745651|581571964|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161049639|NCT03745651|581571965|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161049640|NCT03745651|581571966|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161049641|NCT03745651|581571967|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
161049642|NCT03745651|581571961|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
161049643|NCT03745651|581571962|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
161049644|NCT03745651|581571963|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
161049645|NCT03745651|581571964|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161345008|NCT03126110|582648850|FG001|Phase 2|Study terminated by the sponsor|0|||
161345009|NCT03126110|582648851|FG002|Phase 2|Study terminated by the sponsor|0|||
161345010|NCT03126110|582648852|FG003|Phase 2|Study terminated by the sponsor|0|||
161345011|NCT03126110|582648853|FG004|Phase 2|Study terminated by the sponsor|0|||
161345012|NCT03126110|582648854|FG005|Phase 2|Study terminated by the sponsor|0|||
161345013|NCT03126110|582648855|FG006|Phase 2|Study terminated by the sponsor|0|||
161345014|NCT03126110|582648856|FG007|Phase 2|Study terminated by the sponsor|0|||
161345015|NCT03126110|582648857|FG008|Phase 2|Study terminated by the sponsor|0|||
161345016|NCT03126110|582648858|FG009|Phase 2|Study terminated by the sponsor|0|||
161345017|NCT03126110|582648859|FG010|Phase 2|Study terminated by the sponsor|0|||
161345018|NCT03126110|582648860|FG011|Phase 2|Study terminated by the sponsor|0|||
161345019|NCT03126110|582648861|FG012|Phase 2|Study terminated by the sponsor|0|||
161345020|NCT03126110|582648862|FG013|Phase 2|Study terminated by the sponsor|4|||
161345021|NCT03126110|582648863|FG014|Phase 2|Study terminated by the sponsor|0|||
161345022|NCT03126110|582648864|FG015|Phase 2|Study terminated by the sponsor|0|||
161345023|NCT03126110|582648865|FG016|Phase 2|Study terminated by the sponsor|0|||
161345024|NCT03126110|582648849|FG000|Phase 2|Withdrawal by Subject|0|||
161345025|NCT03126110|582648850|FG001|Phase 2|Withdrawal by Subject|0|||
161345026|NCT03126110|582648851|FG002|Phase 2|Withdrawal by Subject|0|||
161345027|NCT03126110|582648852|FG003|Phase 2|Withdrawal by Subject|0|||
161345028|NCT03126110|582648853|FG004|Phase 2|Withdrawal by Subject|0|||
161345029|NCT03126110|582648854|FG005|Phase 2|Withdrawal by Subject|0|||
161345030|NCT03126110|582648855|FG006|Phase 2|Withdrawal by Subject|0|||
161345031|NCT03126110|582648856|FG007|Phase 2|Withdrawal by Subject|0|||
161345032|NCT03126110|582648857|FG008|Phase 2|Withdrawal by Subject|0|||
161345033|NCT03126110|582648858|FG009|Phase 2|Withdrawal by Subject|0|||
161049646|NCT03745651|581571965|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161049647|NCT03745651|581571966|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161049648|NCT03745651|581571967|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
161049649|NCT03745651|581571961|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
161049650|NCT03745651|581571962|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
161049651|NCT03745651|581571963|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
161049652|NCT03745651|581571964|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161049653|NCT03745651|581571965|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161049654|NCT03745651|581571966|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161049655|NCT03745651|581571967|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
161049656|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161049657|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161049658|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161049659|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161049660|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161049661|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
161049662|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
161049663|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161049664|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161049665|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161049666|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
161049667|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
161049668|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
161049669|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
161049670|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161345034|NCT03126110|582648859|FG010|Phase 2|Withdrawal by Subject|0|||
161345035|NCT03126110|582648860|FG011|Phase 2|Withdrawal by Subject|1|||
161345036|NCT03126110|582648861|FG012|Phase 2|Withdrawal by Subject|3|||
161345037|NCT03126110|582648862|FG013|Phase 2|Withdrawal by Subject|3|||
161345038|NCT03126110|582648863|FG014|Phase 2|Withdrawal by Subject|2|||
161345039|NCT03126110|582648864|FG015|Phase 2|Withdrawal by Subject|1|||
161345040|NCT03126110|582648865|FG016|Phase 2|Withdrawal by Subject|0|||
161345041|NCT03126110|582648849|FG000|Phase 2|Lost to Follow-up|0|||
161345042|NCT03126110|582648850|FG001|Phase 2|Lost to Follow-up|0|||
161345043|NCT03126110|582648851|FG002|Phase 2|Lost to Follow-up|0|||
161345044|NCT03126110|582648852|FG003|Phase 2|Lost to Follow-up|0|||
161345045|NCT03126110|582648853|FG004|Phase 2|Lost to Follow-up|0|||
161345046|NCT03126110|582648854|FG005|Phase 2|Lost to Follow-up|0|||
161345047|NCT03126110|582648855|FG006|Phase 2|Lost to Follow-up|0|||
161345048|NCT03126110|582648856|FG007|Phase 2|Lost to Follow-up|0|||
161049671|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161049672|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
161049673|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
161345049|NCT03126110|582648857|FG008|Phase 2|Lost to Follow-up|0|||
161150787|NCT02214186|581933561|FG000|Overall Study|Lost to Follow-up|1|||
161345050|NCT03126110|582648858|FG009|Phase 2|Lost to Follow-up|0|||
161345051|NCT03126110|582648859|FG010|Phase 2|Lost to Follow-up|0|||
161049674|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
161049675|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
161049676|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
161049677|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161049678|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161049679|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161049680|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
161049681|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
161049682|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
161049683|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
161049684|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161049685|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161049686|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161049687|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
161049688|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161049689|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
161049690|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
161049691|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161049692|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161049693|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161049694|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161049695|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161049696|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
161049697|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
161049698|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161049699|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161049700|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
161049701|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
161049702|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
161049703|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
161049704|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
161049705|NCT03745651|581571961|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161049706|NCT03745651|581571962|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161049707|NCT03745651|581571963|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161049708|NCT03745651|581571964|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
161049709|NCT03745651|581571965|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
161049710|NCT03745651|581571966|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
161049711|NCT03745651|581571967|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
161049712|NCT04175834|581571968|FG000|Overall Study|Withdrawal by Subject|1|||
161049713|NCT04175834|581571969|FG001|Overall Study|Withdrawal by Subject|0|||
161049714|NCT01322347|581571970|FG000|Overall Study|Adverse Event|7|||
161049715|NCT01322347|581571971|FG001|Overall Study|Adverse Event|2|||
161049716|NCT01322347|581571970|FG000|Overall Study|Death|5|||
161049717|NCT01322347|581571971|FG001|Overall Study|Death|3|||
161049718|NCT01322347|581571970|FG000|Overall Study|Physician Decision|2|||
161049719|NCT01322347|581571971|FG001|Overall Study|Physician Decision|1|||
161049720|NCT01322347|581571970|FG000|Overall Study|Protocol Violation|5|||
161049721|NCT01322347|581571971|FG001|Overall Study|Protocol Violation|2|||
161049722|NCT01322347|581571970|FG000|Overall Study|Withdrawal by Subject|1|||
161049723|NCT01322347|581571971|FG001|Overall Study|Withdrawal by Subject|4|||
161049724|NCT01322347|581571970|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
161049725|NCT01322347|581571971|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
161049726|NCT01322347|581571970|FG000|Overall Study|blood transfusion|5|||
161049727|NCT01322347|581571971|FG001|Overall Study|blood transfusion|5|||
161150788|NCT02214186|581933562|FG001|Overall Study|Lost to Follow-up|1|||
161150789|NCT02214186|581933561|FG000|Overall Study|Protocol Violation|1|||
161280884|NCT00996892|582407021|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
161049728|NCT01322347|581571970|FG000|Overall Study|sponsor decision|1|||
161049729|NCT01322347|581571971|FG001|Overall Study|sponsor decision|3|||
161150790|NCT02214186|581933562|FG001|Overall Study|Protocol Violation|1|||
161150791|NCT01525849|581933565|FG000|Overall Study|Lost to Follow-up|3|||
161150792|NCT01525849|581933566|FG001|Overall Study|Lost to Follow-up|2|||
161280885|NCT00996892|582407002|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
161049730|NCT01322347|581571970|FG000|Overall Study|ineligible|6|||
161049731|NCT01322347|581571971|FG001|Overall Study|ineligible|3|||
161049732|NCT01322347|581571970|FG000|Overall Study|kidney transplant|3|||
161049733|NCT01322347|581571971|FG001|Overall Study|kidney transplant|1|||
161049734|NCT01322347|581571970|FG000|Overall Study|study drug withheld > 12 wks|0|||
161150793|NCT01525849|581933565|FG000|Overall Study|Withdrawal by Subject|1|||
161049735|NCT01322347|581571971|FG001|Overall Study|study drug withheld > 12 wks|1|||
161049736|NCT01322347|581571970|FG000|Overall Study|moved/changed dialysis|2|||
161049737|NCT01322347|581571971|FG001|Overall Study|moved/changed dialysis|4|||
161049738|NCT01193283|581571972|FG000|Overall Study|Death|1|||
161049739|NCT04883541|581571973|FG000|Overall Study|Not attending regular yoga class|16|||
161049740|NCT04883541|581571974|FG001|Overall Study|Not attending regular yoga class|0|||
161049741|NCT04883541|581571973|FG000|Overall Study|Not attending the pregnancy school|0|||
161049742|NCT04883541|581571974|FG001|Overall Study|Not attending the pregnancy school|9|||
161049743|NCT04239911|581571975|FG000|Overall Study|Lost to Follow-up|2|||
161049744|NCT04239911|581571976|FG001|Overall Study|Lost to Follow-up|1|||
161049745|NCT02137785|581571977|FG000|Overall Study|Lost to Follow-up|1|||
161049746|NCT02137785|581571978|FG001|Overall Study|Lost to Follow-up|0|||
161049747|NCT02137785|581571977|FG000|Overall Study|Withdrawal by Subject|1|||
161049748|NCT02137785|581571978|FG001|Overall Study|Withdrawal by Subject|4|||
161049749|NCT02137785|581571977|FG000|Overall Study|subject moved out of state|1|||
161049750|NCT02137785|581571978|FG001|Overall Study|subject moved out of state|0|||
161049751|NCT03345407|581571980|FG000|Overall Study|Withdrawal by Subject|11|||
161049752|NCT03345407|581571981|FG001|Overall Study|Withdrawal by Subject|1|||
161049753|NCT03345407|581571982|FG002|Overall Study|Withdrawal by Subject|5|||
161049754|NCT03345407|581571983|FG003|Overall Study|Withdrawal by Subject|6|||
161049755|NCT03345407|581571984|FG004|Overall Study|Withdrawal by Subject|3|||
161049756|NCT03345407|581571985|FG005|Overall Study|Withdrawal by Subject|6|||
161049757|NCT03345407|581571986|FG006|Overall Study|Withdrawal by Subject|16|||
161049758|NCT03345407|581571980|FG000|Overall Study|Physician Decision|3|||
161049759|NCT03345407|581571981|FG001|Overall Study|Physician Decision|1|||
161049760|NCT03345407|581571982|FG002|Overall Study|Physician Decision|0|||
161049761|NCT03345407|581571983|FG003|Overall Study|Physician Decision|0|||
161049762|NCT03345407|581571984|FG004|Overall Study|Physician Decision|1|||
161049763|NCT03345407|581571985|FG005|Overall Study|Physician Decision|2|||
161049764|NCT03345407|581571986|FG006|Overall Study|Physician Decision|3|||
161049765|NCT03345407|581571980|FG000|Overall Study|Lost to Follow-up|2|||
161049766|NCT03345407|581571981|FG001|Overall Study|Lost to Follow-up|0|||
161049767|NCT03345407|581571982|FG002|Overall Study|Lost to Follow-up|1|||
161049768|NCT03345407|581571983|FG003|Overall Study|Lost to Follow-up|0|||
161049769|NCT03345407|581571984|FG004|Overall Study|Lost to Follow-up|1|||
161049770|NCT03345407|581571985|FG005|Overall Study|Lost to Follow-up|2|||
161049771|NCT03345407|581571986|FG006|Overall Study|Lost to Follow-up|3|||
161049772|NCT03345407|581571980|FG000|Overall Study|Protocol-defined stopping criteria|9|||
161049773|NCT03345407|581571981|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161049774|NCT03345407|581571982|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161049775|NCT03345407|581571983|FG003|Overall Study|Protocol-defined stopping criteria|0|||
161049776|NCT03345407|581571984|FG004|Overall Study|Protocol-defined stopping criteria|2|||
161049777|NCT03345407|581571985|FG005|Overall Study|Protocol-defined stopping criteria|1|||
161049778|NCT03345407|581571986|FG006|Overall Study|Protocol-defined stopping criteria|1|||
161049779|NCT03345407|581571980|FG000|Overall Study|Protocol Violation|2|||
161049780|NCT03345407|581571981|FG001|Overall Study|Protocol Violation|0|||
161049781|NCT03345407|581571982|FG002|Overall Study|Protocol Violation|0|||
161049782|NCT03345407|581571983|FG003|Overall Study|Protocol Violation|0|||
161049783|NCT03345407|581571984|FG004|Overall Study|Protocol Violation|1|||
161049784|NCT03345407|581571985|FG005|Overall Study|Protocol Violation|0|||
161049785|NCT03345407|581571986|FG006|Overall Study|Protocol Violation|3|||
161049786|NCT03345407|581571980|FG000|Overall Study|Lack of Efficacy|1|||
161049787|NCT03345407|581571981|FG001|Overall Study|Lack of Efficacy|1|||
161049788|NCT03345407|581571982|FG002|Overall Study|Lack of Efficacy|1|||
161049789|NCT03345407|581571983|FG003|Overall Study|Lack of Efficacy|1|||
161049790|NCT03345407|581571984|FG004|Overall Study|Lack of Efficacy|1|||
161049791|NCT03345407|581571985|FG005|Overall Study|Lack of Efficacy|0|||
161049792|NCT03345407|581571986|FG006|Overall Study|Lack of Efficacy|3|||
161049793|NCT03345407|581571980|FG000|Overall Study|Adverse Event|4|||
161049794|NCT03345407|581571981|FG001|Overall Study|Adverse Event|0|||
161049795|NCT03345407|581571982|FG002|Overall Study|Adverse Event|5|||
161049796|NCT03345407|581571983|FG003|Overall Study|Adverse Event|4|||
161049797|NCT03345407|581571984|FG004|Overall Study|Adverse Event|6|||
161049798|NCT03345407|581571985|FG005|Overall Study|Adverse Event|5|||
161049799|NCT03345407|581571986|FG006|Overall Study|Adverse Event|16|||
161049800|NCT01584648|581571987|FG000|Overall Study|Death|136|||
161049801|NCT01584648|581571988|FG001|Overall Study|Death|146|||
161049802|NCT01584648|581571987|FG000|Overall Study|Lost to Follow-up|9|||
161049803|NCT01584648|581571988|FG001|Overall Study|Lost to Follow-up|9|||
161049804|NCT01584648|581571987|FG000|Overall Study|Investigator discretion|3|||
161049805|NCT01584648|581571988|FG001|Overall Study|Investigator discretion|2|||
161049806|NCT01584648|581571987|FG000|Overall Study|Withdrew consent|13|||
161049807|NCT01584648|581571988|FG001|Overall Study|Withdrew consent|4|||
161049808|NCT01584648|581571987|FG000|Overall Study|Study closed/terminated|50|||
161049809|NCT01584648|581571988|FG001|Overall Study|Study closed/terminated|23|||
161049810|NCT01584648|581571987|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
161049811|NCT01584648|581571988|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
161049812|NCT02256553|581571991|FG000|Period I|Adverse Event|5|||
161049813|NCT02256553|581571991|FG000|Period I|Protocol Violation|1|||
161049814|NCT02256553|581571991|FG000|Period II|Adverse Event|1|||
161049815|NCT02256553|581571991|FG000|Period II|Subject Moved|1|||
161049816|NCT02256553|581571991|FG000|Period III|Adverse Event|3|||
161049817|NCT00379210|581571994|FG000|Overall Study|Withdrawal by Subject|10|||
161049818|NCT00379210|581571995|FG001|Overall Study|Withdrawal by Subject|7|||
161049819|NCT01358175|581571996|FG000|Overall Study|Death|1|||
161049820|NCT01358175|581571997|FG001|Overall Study|Death|0|||
161049821|NCT01358175|581571998|FG002|Overall Study|Death|1|||
161049822|NCT01358175|581571996|FG000|Overall Study|Withdrawal by Subject|9|||
161049823|NCT01358175|581571997|FG001|Overall Study|Withdrawal by Subject|5|||
161049824|NCT01358175|581571998|FG002|Overall Study|Withdrawal by Subject|10|||
161049825|NCT01358175|581571996|FG000|Overall Study|Technical issues|0|||
161049826|NCT01358175|581571997|FG001|Overall Study|Technical issues|1|||
161049827|NCT01358175|581571998|FG002|Overall Study|Technical issues|0|||
161049828|NCT01358175|581571996|FG000|Overall Study|Pregnancy|0|||
161049829|NCT01358175|581571997|FG001|Overall Study|Pregnancy|1|||
161049830|NCT01358175|581571998|FG002|Overall Study|Pregnancy|0|||
161049831|NCT01358175|581571996|FG000|Overall Study|Physician Decision|1|||
161049832|NCT01358175|581571997|FG001|Overall Study|Physician Decision|0|||
161049833|NCT01358175|581571998|FG002|Overall Study|Physician Decision|0|||
161049834|NCT01358175|581571996|FG000|Overall Study|Non Compliance with Study Treatment|0|||
161049835|NCT01358175|581571997|FG001|Overall Study|Non Compliance with Study Treatment|1|||
161049836|NCT01358175|581571998|FG002|Overall Study|Non Compliance with Study Treatment|1|||
161049837|NCT01358175|581571996|FG000|Overall Study|Lost to Follow-up|1|||
161049838|NCT01358175|581571997|FG001|Overall Study|Lost to Follow-up|1|||
161049839|NCT01358175|581571998|FG002|Overall Study|Lost to Follow-up|3|||
161049840|NCT01358175|581571996|FG000|Overall Study|Lack of Efficacy|3|||
161049841|NCT01358175|581571997|FG001|Overall Study|Lack of Efficacy|8|||
161049842|NCT01358175|581571998|FG002|Overall Study|Lack of Efficacy|6|||
161049843|NCT01358175|581571996|FG000|Overall Study|Adverse Event|6|||
161049844|NCT01358175|581571997|FG001|Overall Study|Adverse Event|11|||
161049845|NCT01358175|581571998|FG002|Overall Study|Adverse Event|11|||
161049846|NCT00595959|581571999|FG000|Overall Study|Withdrawal by Subject|1|||
161049847|NCT00595959|581571999|FG000|Overall Study|Lost to Follow-up|1|||
161049848|NCT00886834|581572000|FG000|Overall Study|Protocol Violation|0|||
161049849|NCT00886834|581572001|FG001|Overall Study|Protocol Violation|3|||
161049850|NCT04085614|581572002|FG000|Overall Study|Protocol Violation|9|||
161049851|NCT04085614|581572003|FG001|Overall Study|Protocol Violation|6|||
161049852|NCT01405508|581572004|FG000|Overall Study|AE, non-serious non-fatal|1|||
161150794|NCT01525849|581933566|FG001|Overall Study|Withdrawal by Subject|9|||
161150795|NCT01525849|581933565|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
161150796|NCT01525849|581933566|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
161150797|NCT01525849|581933565|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
161150798|NCT01525849|581933566|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
161150799|NCT00446446|581933569|FG000|Overall Study|Death|10|||
161150800|NCT00446446|581933569|FG000|Overall Study|Withdrawal by Subject|6|||
161150801|NCT00446446|581933569|FG000|Overall Study|Other|4|||
161150802|NCT00446446|581933569|FG000|Overall Study|Disease Progession|2|||
161150803|NCT00446446|581933569|FG000|Overall Study|Adverse Event|1|||
161150804|NCT00446446|581933569|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
161150805|NCT02142894|581933570|FG000|Overall Study|Protocol Violation|8|||
161150806|NCT00611130|581933576|FG000|Overall Study|Lost to Follow-up|25|||
161150807|NCT00611130|581933577|FG001|Overall Study|Lost to Follow-up|29|||
161150808|NCT00611130|581933576|FG000|Overall Study|Protocol noncompliance|7|||
161150809|NCT00611130|581933577|FG001|Overall Study|Protocol noncompliance|6|||
161150810|NCT00611130|581933576|FG000|Overall Study|Withdrawal by Subject|6|||
161150811|NCT00611130|581933577|FG001|Overall Study|Withdrawal by Subject|5|||
161150812|NCT00611130|581933576|FG000|Overall Study|Other|5|||
161049853|NCT01405508|581572005|FG001|Overall Study|AE, non-serious non-fatal|1|||
161049854|NCT01405508|581572006|FG002|Overall Study|AE, non-serious non-fatal|0|||
161049855|NCT01405508|581572007|FG003|Overall Study|AE, non-serious non-fatal|0|||
161049856|NCT00476957|581572012|FG000|Overall Study|Lost to Follow-up|176|||
161049857|NCT00476957|581572013|FG001|Overall Study|Lost to Follow-up|193|||
161150813|NCT00611130|581933577|FG001|Overall Study|Other|4|||
161049858|NCT02516202|581572014|FG000|Overall Study|Withdrawal by Subject|1|||
161049859|NCT02516202|581572015|FG001|Overall Study|Withdrawal by Subject|0|||
161049860|NCT02516202|581572016|FG002|Overall Study|Withdrawal by Subject|1|||
161150814|NCT00611130|581933576|FG000|Overall Study|Incarceration|3|||
161049861|NCT02516202|581572014|FG000|Overall Study|Lost to Follow-up|1|||
161049862|NCT02516202|581572015|FG001|Overall Study|Lost to Follow-up|1|||
161049863|NCT02516202|581572016|FG002|Overall Study|Lost to Follow-up|1|||
161049864|NCT02516202|581572014|FG000|Overall Study|Stopped Follow-up|0|||
161049865|NCT02516202|581572015|FG001|Overall Study|Stopped Follow-up|0|||
161049866|NCT02516202|581572016|FG002|Overall Study|Stopped Follow-up|1|||
161049867|NCT00409747|581572017|FG000|Overall Study|Withdrawal by Subject|1|||
161049868|NCT01000649|581572018|FG000|Overall Study|Adverse Event|5|||
161150815|NCT00611130|581933577|FG001|Overall Study|Incarceration|2|||
161150816|NCT00611130|581933576|FG000|Overall Study|Administrative|1|||
161049869|NCT01000649|581572019|FG001|Overall Study|Adverse Event|1|||
161049870|NCT01000649|581572020|FG002|Overall Study|Adverse Event|2|||
161049871|NCT01000649|581572021|FG003|Overall Study|Adverse Event|4|||
161049872|NCT01000649|581572018|FG000|Overall Study|Lost to Follow-up|0|||
161049873|NCT01000649|581572019|FG001|Overall Study|Lost to Follow-up|2|||
161049874|NCT01000649|581572020|FG002|Overall Study|Lost to Follow-up|0|||
161049875|NCT01000649|581572021|FG003|Overall Study|Lost to Follow-up|2|||
161049876|NCT01916109|581572024|FG000|Overall Study|Withdrawal by Subject|1|||
161049877|NCT00103857|581572025|FG000|54-Week Base Study|Adverse Event|12|||
161049878|NCT00103857|581572026|FG001|54-Week Base Study|Adverse Event|9|||
161049879|NCT00103857|581572027|FG002|54-Week Base Study|Adverse Event|11|||
161049880|NCT00103857|581572028|FG003|54-Week Base Study|Adverse Event|6|||
161049881|NCT00103857|581572029|FG004|54-Week Base Study|Adverse Event|5|||
161049882|NCT00103857|581572030|FG005|54-Week Base Study|Adverse Event|11|||
161049883|NCT00103857|581572031|FG006|54-Week Base Study|Adverse Event|3|||
161049884|NCT00103857|581572025|FG000|54-Week Base Study|Death|0|||
161049885|NCT00103857|581572026|FG001|54-Week Base Study|Death|0|||
161049886|NCT00103857|581572027|FG002|54-Week Base Study|Death|0|||
161049887|NCT00103857|581572028|FG003|54-Week Base Study|Death|0|||
161049888|NCT00103857|581572029|FG004|54-Week Base Study|Death|1|||
161049889|NCT00103857|581572030|FG005|54-Week Base Study|Death|1|||
161049890|NCT00103857|581572031|FG006|54-Week Base Study|Death|0|||
161049891|NCT00103857|581572025|FG000|54-Week Base Study|Lack of Efficacy|11|||
161049892|NCT00103857|581572026|FG001|54-Week Base Study|Lack of Efficacy|14|||
161049893|NCT00103857|581572027|FG002|54-Week Base Study|Lack of Efficacy|8|||
161049894|NCT00103857|581572028|FG003|54-Week Base Study|Lack of Efficacy|4|||
161049895|NCT00103857|581572029|FG004|54-Week Base Study|Lack of Efficacy|3|||
161049896|NCT00103857|581572030|FG005|54-Week Base Study|Lack of Efficacy|14|||
161049897|NCT00103857|581572031|FG006|54-Week Base Study|Lack of Efficacy|19|||
161049898|NCT00103857|581572025|FG000|54-Week Base Study|Lost to Follow-up|5|||
161049899|NCT00103857|581572026|FG001|54-Week Base Study|Lost to Follow-up|4|||
161049900|NCT00103857|581572027|FG002|54-Week Base Study|Lost to Follow-up|7|||
161049901|NCT00103857|581572028|FG003|54-Week Base Study|Lost to Follow-up|5|||
161049902|NCT00103857|581572029|FG004|54-Week Base Study|Lost to Follow-up|10|||
161049903|NCT00103857|581572030|FG005|54-Week Base Study|Lost to Follow-up|9|||
161049904|NCT00103857|581572031|FG006|54-Week Base Study|Lost to Follow-up|3|||
161049905|NCT00103857|581572025|FG000|54-Week Base Study|Physician Decision|1|||
161049906|NCT00103857|581572026|FG001|54-Week Base Study|Physician Decision|1|||
161049907|NCT00103857|581572027|FG002|54-Week Base Study|Physician Decision|0|||
161049908|NCT00103857|581572028|FG003|54-Week Base Study|Physician Decision|0|||
161049909|NCT00103857|581572029|FG004|54-Week Base Study|Physician Decision|1|||
161049910|NCT00103857|581572030|FG005|54-Week Base Study|Physician Decision|0|||
161049911|NCT00103857|581572031|FG006|54-Week Base Study|Physician Decision|0|||
161049912|NCT00103857|581572025|FG000|54-Week Base Study|Pregnancy|1|||
161049913|NCT00103857|581572026|FG001|54-Week Base Study|Pregnancy|0|||
161049914|NCT00103857|581572027|FG002|54-Week Base Study|Pregnancy|0|||
161049915|NCT00103857|581572028|FG003|54-Week Base Study|Pregnancy|0|||
161049916|NCT00103857|581572029|FG004|54-Week Base Study|Pregnancy|1|||
161049917|NCT00103857|581572030|FG005|54-Week Base Study|Pregnancy|0|||
161049918|NCT00103857|581572031|FG006|54-Week Base Study|Pregnancy|1|||
161049919|NCT00103857|581572025|FG000|54-Week Base Study|Protocol Violation|6|||
161049920|NCT00103857|581572026|FG001|54-Week Base Study|Protocol Violation|4|||
161049921|NCT00103857|581572027|FG002|54-Week Base Study|Protocol Violation|2|||
161049922|NCT00103857|581572028|FG003|54-Week Base Study|Protocol Violation|4|||
161049923|NCT00103857|581572029|FG004|54-Week Base Study|Protocol Violation|0|||
161049924|NCT00103857|581572030|FG005|54-Week Base Study|Protocol Violation|3|||
161049925|NCT00103857|581572031|FG006|54-Week Base Study|Protocol Violation|3|||
161049926|NCT00103857|581572025|FG000|54-Week Base Study|Withdrawal by Subject|17|||
161049927|NCT00103857|581572026|FG001|54-Week Base Study|Withdrawal by Subject|16|||
161049928|NCT00103857|581572027|FG002|54-Week Base Study|Withdrawal by Subject|16|||
161150817|NCT00611130|581933577|FG001|Overall Study|Administrative|1|||
161280886|NCT00996892|582407003|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
161049929|NCT00103857|581572028|FG003|54-Week Base Study|Withdrawal by Subject|15|||
161049930|NCT00103857|581572029|FG004|54-Week Base Study|Withdrawal by Subject|10|||
161049931|NCT00103857|581572030|FG005|54-Week Base Study|Withdrawal by Subject|15|||
161049932|NCT00103857|581572031|FG006|54-Week Base Study|Withdrawal by Subject|4|||
161049933|NCT00103857|581572025|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
161150818|NCT00611130|581933576|FG000|Overall Study|Adverse Event|1|||
161150819|NCT00611130|581933577|FG001|Overall Study|Adverse Event|0|||
161280887|NCT00996892|582407004|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
161280888|NCT00996892|582407005|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
161049934|NCT00103857|581572026|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
161049935|NCT00103857|581572027|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
161049936|NCT00103857|581572028|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
161049937|NCT00103857|581572029|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
161049938|NCT00103857|581572030|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
161049939|NCT00103857|581572031|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
161049940|NCT00103857|581572025|FG000|54-Week Base Study|patient moved|0|||
161049941|NCT00103857|581572026|FG001|54-Week Base Study|patient moved|1|||
161049942|NCT00103857|581572027|FG002|54-Week Base Study|patient moved|1|||
161049943|NCT00103857|581572028|FG003|54-Week Base Study|patient moved|2|||
161049944|NCT00103857|581572029|FG004|54-Week Base Study|patient moved|3|||
161049945|NCT00103857|581572030|FG005|54-Week Base Study|patient moved|1|||
161049946|NCT00103857|581572031|FG006|54-Week Base Study|patient moved|0|||
161049947|NCT00103857|581572025|FG000|54-Week Base Study|non-compliance with study procedures|1|||
161049948|NCT00103857|581572026|FG001|54-Week Base Study|non-compliance with study procedures|2|||
161049949|NCT00103857|581572027|FG002|54-Week Base Study|non-compliance with study procedures|0|||
161049950|NCT00103857|581572028|FG003|54-Week Base Study|non-compliance with study procedures|0|||
161049951|NCT00103857|581572029|FG004|54-Week Base Study|non-compliance with study procedures|0|||
161049952|NCT00103857|581572030|FG005|54-Week Base Study|non-compliance with study procedures|2|||
161049953|NCT00103857|581572031|FG006|54-Week Base Study|non-compliance with study procedures|0|||
161049954|NCT00103857|581572025|FG000|54-Week Base Study|patient incarcerated|0|||
161049955|NCT00103857|581572026|FG001|54-Week Base Study|patient incarcerated|0|||
161049956|NCT00103857|581572027|FG002|54-Week Base Study|patient incarcerated|0|||
161049957|NCT00103857|581572028|FG003|54-Week Base Study|patient incarcerated|0|||
161049958|NCT00103857|581572029|FG004|54-Week Base Study|patient incarcerated|1|||
161049959|NCT00103857|581572030|FG005|54-Week Base Study|patient incarcerated|1|||
161049960|NCT00103857|581572031|FG006|54-Week Base Study|patient incarcerated|0|||
161049961|NCT00103857|581572025|FG000|54-Week Base Study|laboratory reporting error|0|||
161049962|NCT00103857|581572026|FG001|54-Week Base Study|laboratory reporting error|0|||
161049963|NCT00103857|581572027|FG002|54-Week Base Study|laboratory reporting error|0|||
161049964|NCT00103857|581572028|FG003|54-Week Base Study|laboratory reporting error|0|||
161049965|NCT00103857|581572029|FG004|54-Week Base Study|laboratory reporting error|1|||
161280889|NCT00996892|582407006|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
161280890|NCT00996892|582407007|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
161280891|NCT00996892|582407008|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
161280892|NCT00996892|582407009|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
161280893|NCT00996892|582407010|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
161280894|NCT00996892|582407011|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
161280895|NCT00996892|582407012|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
161280896|NCT00996892|582407013|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
161280897|NCT00996892|582407014|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
161280898|NCT00996892|582407015|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
161280899|NCT00996892|582407016|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
161280900|NCT00996892|582407017|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
161280901|NCT00996892|582407018|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
161280902|NCT00996892|582407019|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
161280903|NCT00996892|582407020|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
161280904|NCT00996892|582407021|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
161280905|NCT00996892|582407002|FG000|Expansion Stage 2|Adverse Event|0|||
161280906|NCT00996892|582407003|FG001|Expansion Stage 2|Adverse Event|0|||
161280907|NCT00996892|582407004|FG002|Expansion Stage 2|Adverse Event|0|||
161280908|NCT00996892|582407005|FG003|Expansion Stage 2|Adverse Event|0|||
161280909|NCT00996892|582407006|FG004|Expansion Stage 2|Adverse Event|0|||
161280910|NCT00996892|582407007|FG005|Expansion Stage 2|Adverse Event|0|||
161280911|NCT00996892|582407008|FG006|Expansion Stage 2|Adverse Event|0|||
161280912|NCT00996892|582407009|FG007|Expansion Stage 2|Adverse Event|0|||
161280913|NCT00996892|582407010|FG008|Expansion Stage 2|Adverse Event|0|||
161280914|NCT00996892|582407011|FG009|Expansion Stage 2|Adverse Event|0|||
161280915|NCT00996892|582407012|FG010|Expansion Stage 2|Adverse Event|0|||
161280916|NCT00996892|582407013|FG011|Expansion Stage 2|Adverse Event|0|||
161280917|NCT00996892|582407014|FG012|Expansion Stage 2|Adverse Event|0|||
161280918|NCT00996892|582407015|FG013|Expansion Stage 2|Adverse Event|0|||
161280919|NCT00996892|582407016|FG014|Expansion Stage 2|Adverse Event|0|||
161049966|NCT00103857|581572030|FG005|54-Week Base Study|laboratory reporting error|0|||
161049967|NCT00103857|581572031|FG006|54-Week Base Study|laboratory reporting error|0|||
161049968|NCT00103857|581572025|FG000|54-Week Base Study|site error|0|||
161049969|NCT00103857|581572026|FG001|54-Week Base Study|site error|0|||
161049970|NCT00103857|581572027|FG002|54-Week Base Study|site error|0|||
161049971|NCT00103857|581572028|FG003|54-Week Base Study|site error|0|||
161049972|NCT00103857|581572029|FG004|54-Week Base Study|site error|0|||
161280920|NCT00996892|582407017|FG015|Expansion Stage 2|Adverse Event|0|||
161280921|NCT00996892|582407018|FG016|Expansion Stage 2|Adverse Event|0|||
161280922|NCT00996892|582407019|FG017|Expansion Stage 2|Adverse Event|0|||
161280923|NCT00996892|582407020|FG018|Expansion Stage 2|Adverse Event|3|||
161049973|NCT00103857|581572030|FG005|54-Week Base Study|site error|1|||
161049974|NCT00103857|581572031|FG006|54-Week Base Study|site error|0|||
161049975|NCT00103857|581572025|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
161049976|NCT00103857|581572026|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
161280924|NCT00996892|582407021|FG019|Expansion Stage 2|Adverse Event|0|||
161280925|NCT00996892|582407002|FG000|Expansion Stage 2|Death|0|||
161280926|NCT00996892|582407003|FG001|Expansion Stage 2|Death|0|||
161280927|NCT00996892|582407004|FG002|Expansion Stage 2|Death|0|||
161049977|NCT00103857|581572027|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
161049978|NCT00103857|581572028|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
161049979|NCT00103857|581572029|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
161049980|NCT00103857|581572030|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
161049981|NCT00103857|581572031|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
161049982|NCT00103857|581572025|FG000|50-Week Extension Study|Adverse Event|2|||
161049983|NCT00103857|581572026|FG001|50-Week Extension Study|Adverse Event|3|||
161049984|NCT00103857|581572027|FG002|50-Week Extension Study|Adverse Event|2|||
161049985|NCT00103857|581572028|FG003|50-Week Extension Study|Adverse Event|0|||
161049986|NCT00103857|581572029|FG004|50-Week Extension Study|Adverse Event|1|||
161049987|NCT00103857|581572030|FG005|50-Week Extension Study|Adverse Event|1|||
161049988|NCT00103857|581572031|FG006|50-Week Extension Study|Adverse Event|0|||
161049989|NCT00103857|581572025|FG000|50-Week Extension Study|Death|0|||
161049990|NCT00103857|581572026|FG001|50-Week Extension Study|Death|0|||
161049991|NCT00103857|581572027|FG002|50-Week Extension Study|Death|0|||
161049992|NCT00103857|581572028|FG003|50-Week Extension Study|Death|1|||
161049993|NCT00103857|581572029|FG004|50-Week Extension Study|Death|0|||
161049994|NCT00103857|581572030|FG005|50-Week Extension Study|Death|1|||
161049995|NCT00103857|581572031|FG006|50-Week Extension Study|Death|0|||
161049996|NCT00103857|581572025|FG000|50-Week Extension Study|Lack of Efficacy|26|||
161049997|NCT00103857|581572026|FG001|50-Week Extension Study|Lack of Efficacy|15|||
161049998|NCT00103857|581572027|FG002|50-Week Extension Study|Lack of Efficacy|13|||
161049999|NCT00103857|581572028|FG003|50-Week Extension Study|Lack of Efficacy|16|||
161050000|NCT00103857|581572029|FG004|50-Week Extension Study|Lack of Efficacy|8|||
161050001|NCT00103857|581572030|FG005|50-Week Extension Study|Lack of Efficacy|8|||
161050002|NCT00103857|581572031|FG006|50-Week Extension Study|Lack of Efficacy|0|||
161050003|NCT00103857|581572025|FG000|50-Week Extension Study|Lost to Follow-up|4|||
161050004|NCT00103857|581572026|FG001|50-Week Extension Study|Lost to Follow-up|0|||
161050005|NCT00103857|581572027|FG002|50-Week Extension Study|Lost to Follow-up|1|||
161050006|NCT00103857|581572028|FG003|50-Week Extension Study|Lost to Follow-up|4|||
161050007|NCT00103857|581572029|FG004|50-Week Extension Study|Lost to Follow-up|3|||
161050008|NCT00103857|581572030|FG005|50-Week Extension Study|Lost to Follow-up|3|||
161050009|NCT00103857|581572031|FG006|50-Week Extension Study|Lost to Follow-up|0|||
161050010|NCT00103857|581572025|FG000|50-Week Extension Study|Physician Decision|0|||
161050011|NCT00103857|581572026|FG001|50-Week Extension Study|Physician Decision|1|||
161050012|NCT00103857|581572027|FG002|50-Week Extension Study|Physician Decision|1|||
161050013|NCT00103857|581572028|FG003|50-Week Extension Study|Physician Decision|0|||
161050014|NCT00103857|581572029|FG004|50-Week Extension Study|Physician Decision|0|||
161050015|NCT00103857|581572030|FG005|50-Week Extension Study|Physician Decision|0|||
161050016|NCT00103857|581572031|FG006|50-Week Extension Study|Physician Decision|0|||
161050017|NCT00103857|581572025|FG000|50-Week Extension Study|Pregnancy|0|||
161050018|NCT00103857|581572026|FG001|50-Week Extension Study|Pregnancy|0|||
161050019|NCT00103857|581572027|FG002|50-Week Extension Study|Pregnancy|1|||
161050020|NCT00103857|581572028|FG003|50-Week Extension Study|Pregnancy|0|||
161050021|NCT00103857|581572029|FG004|50-Week Extension Study|Pregnancy|1|||
161050022|NCT00103857|581572030|FG005|50-Week Extension Study|Pregnancy|0|||
161050023|NCT00103857|581572031|FG006|50-Week Extension Study|Pregnancy|0|||
161050024|NCT00103857|581572025|FG000|50-Week Extension Study|Protocol Violation|1|||
161050025|NCT00103857|581572026|FG001|50-Week Extension Study|Protocol Violation|1|||
161050026|NCT00103857|581572027|FG002|50-Week Extension Study|Protocol Violation|1|||
161050027|NCT00103857|581572028|FG003|50-Week Extension Study|Protocol Violation|2|||
161050028|NCT00103857|581572029|FG004|50-Week Extension Study|Protocol Violation|0|||
161280928|NCT00996892|582407005|FG003|Expansion Stage 2|Death|0|||
161280929|NCT00996892|582407006|FG004|Expansion Stage 2|Death|0|||
161050029|NCT00103857|581572030|FG005|50-Week Extension Study|Protocol Violation|1|||
161050030|NCT00103857|581572031|FG006|50-Week Extension Study|Protocol Violation|0|||
161050031|NCT00103857|581572025|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
161050032|NCT00103857|581572026|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
161050033|NCT00103857|581572027|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
161050034|NCT00103857|581572028|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
161050035|NCT00103857|581572029|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
161050036|NCT00103857|581572030|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
161050037|NCT00103857|581572031|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
161050038|NCT00103857|581572025|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
161050039|NCT00103857|581572026|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
161050040|NCT00103857|581572027|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
161050041|NCT00103857|581572028|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
161050042|NCT00103857|581572029|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
161050043|NCT00103857|581572030|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
161050044|NCT00103857|581572031|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
161050045|NCT00103857|581572025|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
161280930|NCT00996892|582407007|FG005|Expansion Stage 2|Death|0|||
161345052|NCT03126110|582648860|FG011|Phase 2|Lost to Follow-up|1|||
161345053|NCT03126110|582648861|FG012|Phase 2|Lost to Follow-up|1|||
161345054|NCT03126110|582648862|FG013|Phase 2|Lost to Follow-up|1|||
161345055|NCT03126110|582648863|FG014|Phase 2|Lost to Follow-up|2|||
161345056|NCT03126110|582648864|FG015|Phase 2|Lost to Follow-up|0|||
161345057|NCT03126110|582648865|FG016|Phase 2|Lost to Follow-up|0|||
161345058|NCT03126110|582648849|FG000|Phase 2|Death|0|||
161345059|NCT03126110|582648850|FG001|Phase 2|Death|0|||
161345060|NCT03126110|582648851|FG002|Phase 2|Death|0|||
161345061|NCT03126110|582648852|FG003|Phase 2|Death|0|||
161345062|NCT03126110|582648853|FG004|Phase 2|Death|0|||
161345063|NCT03126110|582648854|FG005|Phase 2|Death|0|||
161050046|NCT00103857|581572026|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
161050047|NCT00103857|581572027|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
161050048|NCT00103857|581572028|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
161050049|NCT00103857|581572029|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
161050050|NCT00103857|581572030|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
161050051|NCT00103857|581572031|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
161050052|NCT00103857|581572025|FG000|50-Week Extension Study|patient moved|0|||
161050053|NCT00103857|581572026|FG001|50-Week Extension Study|patient moved|0|||
161050054|NCT00103857|581572027|FG002|50-Week Extension Study|patient moved|1|||
161050055|NCT00103857|581572028|FG003|50-Week Extension Study|patient moved|2|||
161050056|NCT00103857|581572029|FG004|50-Week Extension Study|patient moved|0|||
161050057|NCT00103857|581572030|FG005|50-Week Extension Study|patient moved|0|||
161050058|NCT00103857|581572031|FG006|50-Week Extension Study|patient moved|0|||
161050059|NCT00103857|581572025|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
161050060|NCT00103857|581572026|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
161050061|NCT00103857|581572027|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
161050062|NCT00103857|581572028|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
161050063|NCT00103857|581572029|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
161050064|NCT00103857|581572030|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
161050065|NCT00103857|581572031|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
161050066|NCT00103857|581572025|FG000|50-Week Extension Study|reason unspecified|0|||
161050067|NCT00103857|581572026|FG001|50-Week Extension Study|reason unspecified|0|||
161050068|NCT00103857|581572027|FG002|50-Week Extension Study|reason unspecified|0|||
161050069|NCT00103857|581572028|FG003|50-Week Extension Study|reason unspecified|0|||
161050070|NCT00103857|581572029|FG004|50-Week Extension Study|reason unspecified|1|||
161050071|NCT00103857|581572030|FG005|50-Week Extension Study|reason unspecified|0|||
161050072|NCT00103857|581572031|FG006|50-Week Extension Study|reason unspecified|0|||
161050073|NCT03347396|581572032|FG000|Part A (26 Weeks)|Adverse Event|1|||
161050074|NCT03347396|581572033|FG001|Part A (26 Weeks)|Adverse Event|0|||
161050075|NCT03347396|581572032|FG000|Part A (26 Weeks)|Death|0|||
161050076|NCT03347396|581572033|FG001|Part A (26 Weeks)|Death|1|||
161050077|NCT03347396|581572032|FG000|Part B (149 Weeks)|Adverse Event|1|||
161050078|NCT03347396|581572033|FG001|Part B (149 Weeks)|Adverse Event|1|||
161050079|NCT03347396|581572032|FG000|Part B (149 Weeks)|Death|1|||
161050080|NCT03347396|581572033|FG001|Part B (149 Weeks)|Death|0|||
161050081|NCT02312258|581572036|FG000|Overall Study|Lost to Follow-up|8|||
161050082|NCT02312258|581572037|FG001|Overall Study|Lost to Follow-up|8|||
161050083|NCT02312258|581572036|FG000|Overall Study|Withdrawal by Patient|49|||
161050084|NCT02312258|581572037|FG001|Overall Study|Withdrawal by Patient|76|||
161050085|NCT02312258|581572036|FG000|Overall Study|Reason not Specified|107|||
161050086|NCT02312258|581572037|FG001|Overall Study|Reason not Specified|159|||
161050087|NCT02312258|581572036|FG000|Overall Study|Missing|2|||
161050088|NCT02312258|581572037|FG001|Overall Study|Missing|1|||
161050089|NCT02312258|581572036|FG000|Overall Study|Death|115|||
161050090|NCT02312258|581572037|FG001|Overall Study|Death|181|||
161345064|NCT03126110|582648855|FG006|Phase 2|Death|0|||
161345065|NCT03126110|582648856|FG007|Phase 2|Death|0|||
161345066|NCT03126110|582648857|FG008|Phase 2|Death|0|||
161050091|NCT01697956|581572038|FG000|Overall Study|Protocol Violation|1|||
161150820|NCT00611130|581933576|FG000|Overall Study|Death|1|||
161150821|NCT00611130|581933577|FG001|Overall Study|Death|0|||
161150822|NCT01024465|581933583|FG000|Overall Study|Adverse Event|2|||
161345067|NCT03126110|582648858|FG009|Phase 2|Death|0|||
161050092|NCT01697956|581572039|FG001|Overall Study|Protocol Violation|1|||
161050093|NCT01970527|581572040|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
161050094|NCT01970527|581572041|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
161050095|NCT01970527|581572040|FG000|Treatment|Disease progression|0|||
161050096|NCT01970527|581572041|FG001|Treatment|Disease progression|1|||
161050097|NCT01970527|581572040|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
161050098|NCT01970527|581572041|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
161050099|NCT01970527|581572040|FG000|Treatment|Death|0|||
161345068|NCT03126110|582648859|FG010|Phase 2|Death|0|||
161345069|NCT03126110|582648860|FG011|Phase 2|Death|6|||
161345070|NCT03126110|582648861|FG012|Phase 2|Death|12|||
161345071|NCT03126110|582648862|FG013|Phase 2|Death|25|||
161345072|NCT03126110|582648863|FG014|Phase 2|Death|11|||
161150823|NCT01024465|581933583|FG000|Overall Study|Physician Decision|1|||
161150824|NCT00525148|581933585|FG000|Overall Study|Other Adverse Event|3|||
161150825|NCT00525148|581933586|FG001|Overall Study|Other Adverse Event|5|||
161150826|NCT00525148|581933587|FG002|Overall Study|Other Adverse Event|1|||
161150827|NCT00525148|581933588|FG003|Overall Study|Other Adverse Event|8|||
161150828|NCT00525148|581933585|FG000|Overall Study|Progressive disease|18|||
161150829|NCT00525148|581933586|FG001|Overall Study|Progressive disease|30|||
161150830|NCT00525148|581933587|FG002|Overall Study|Progressive disease|6|||
161150831|NCT00525148|581933588|FG003|Overall Study|Progressive disease|49|||
161150832|NCT00525148|581933585|FG000|Overall Study|Refused continuation of study medication|0|||
161150833|NCT00525148|581933586|FG001|Overall Study|Refused continuation of study medication|2|||
161150834|NCT00525148|581933587|FG002|Overall Study|Refused continuation of study medication|0|||
161150835|NCT00525148|581933588|FG003|Overall Study|Refused continuation of study medication|1|||
161150836|NCT00525148|581933585|FG000|Overall Study|Other than stated|2|||
161150837|NCT00525148|581933586|FG001|Overall Study|Other than stated|1|||
161150838|NCT00525148|581933587|FG002|Overall Study|Other than stated|0|||
161150839|NCT00525148|581933588|FG003|Overall Study|Other than stated|3|||
161150840|NCT03078608|581933589|FG000|Overall Study|Death|1|||
161150841|NCT03078608|581933590|FG001|Overall Study|Death|2|||
161150842|NCT03078608|581933591|FG002|Overall Study|Death|0|||
161150843|NCT03078608|581933592|FG003|Overall Study|Death|0|||
161150844|NCT03078608|581933589|FG000|Overall Study|Withdrawal by Subject|8|||
161150845|NCT03078608|581933590|FG001|Overall Study|Withdrawal by Subject|1|||
161150846|NCT03078608|581933591|FG002|Overall Study|Withdrawal by Subject|0|||
161150847|NCT03078608|581933592|FG003|Overall Study|Withdrawal by Subject|0|||
161150848|NCT03078608|581933589|FG000|Overall Study|Lost to Follow-up|5|||
161150849|NCT03078608|581933590|FG001|Overall Study|Lost to Follow-up|8|||
161150850|NCT03078608|581933591|FG002|Overall Study|Lost to Follow-up|4|||
161150851|NCT03078608|581933592|FG003|Overall Study|Lost to Follow-up|1|||
161150852|NCT01905397|581933593|FG000|Overall Study|Death|0|||
161150853|NCT01905397|581933594|FG001|Overall Study|Death|1|||
161150854|NCT01905397|581933593|FG000|Overall Study|Withdrawal by Subject|2|||
161150855|NCT01905397|581933594|FG001|Overall Study|Withdrawal by Subject|0|||
161150856|NCT01905397|581933593|FG000|Overall Study|Surgery canceled/aborted|9|||
161150857|NCT01905397|581933594|FG001|Overall Study|Surgery canceled/aborted|5|||
161150858|NCT01905397|581933593|FG000|Overall Study|Incision < 7 cm|2|||
161150859|NCT01905397|581933594|FG001|Overall Study|Incision < 7 cm|0|||
161150860|NCT01905397|581933593|FG000|Overall Study|Wrong treatment|1|||
161150861|NCT01905397|581933594|FG001|Overall Study|Wrong treatment|1|||
161150862|NCT01905397|581933593|FG000|Overall Study|Device not applied|3|||
161150863|NCT01905397|581933594|FG001|Overall Study|Device not applied|0|||
161150864|NCT01905397|581933593|FG000|Overall Study|Dressing not applied in operating room|1|||
161150865|NCT01905397|581933594|FG001|Overall Study|Dressing not applied in operating room|0|||
161150866|NCT01905397|581933593|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
161150867|NCT01905397|581933594|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
161280931|NCT00996892|582407008|FG006|Expansion Stage 2|Death|0|||
161280932|NCT00996892|582407009|FG007|Expansion Stage 2|Death|0|||
161280933|NCT00996892|582407010|FG008|Expansion Stage 2|Death|0|||
161280934|NCT00996892|582407011|FG009|Expansion Stage 2|Death|0|||
161280935|NCT00996892|582407012|FG010|Expansion Stage 2|Death|0|||
161280936|NCT00996892|582407013|FG011|Expansion Stage 2|Death|0|||
161280937|NCT00996892|582407014|FG012|Expansion Stage 2|Death|0|||
161280938|NCT00996892|582407015|FG013|Expansion Stage 2|Death|0|||
161280939|NCT00996892|582407016|FG014|Expansion Stage 2|Death|0|||
161280940|NCT00996892|582407017|FG015|Expansion Stage 2|Death|0|||
161280941|NCT00996892|582407018|FG016|Expansion Stage 2|Death|0|||
161280942|NCT00996892|582407019|FG017|Expansion Stage 2|Death|0|||
161280943|NCT00996892|582407020|FG018|Expansion Stage 2|Death|2|||
161345073|NCT03126110|582648864|FG015|Phase 2|Death|3|||
161150868|NCT01921270|581933595|FG000|Overall Study|Withdrawal by Subject|1|||
161150869|NCT00864227|581933596|FG000|Overall Study|Withdrawal by Subject|1|||
161150870|NCT00864227|581933596|FG000|Overall Study|Disease Relapse/Progression|3|||
161150871|NCT01137435|581933597|FG000|Overall Study|Lost to Follow-up|24|||
161150872|NCT01137435|581933597|FG000|Overall Study|Off label usage|4|||
161280944|NCT00996892|582407021|FG019|Expansion Stage 2|Death|0|||
161280945|NCT00996892|582407002|FG000|Expansion Stage 2|Physician Decision|0|||
161345074|NCT03126110|582648865|FG016|Phase 2|Death|2|||
161280946|NCT00996892|582407003|FG001|Expansion Stage 2|Physician Decision|0|||
161280947|NCT00996892|582407004|FG002|Expansion Stage 2|Physician Decision|0|||
161280948|NCT00996892|582407005|FG003|Expansion Stage 2|Physician Decision|0|||
161345075|NCT03126110|582648849|FG000|Phase 2|Progressive Disease|0|||
161150873|NCT00501852|581933598|FG000|Overall Study|Adverse Event|3|||
161150874|NCT00501852|581933598|FG000|Overall Study|Withdrawal by Subject|2|||
161150875|NCT01416610|581933599|FG000|Overall Study|Adverse Event|4|||
161150876|NCT01416610|581933599|FG000|Overall Study|Adverse Event -Patient decision|3|||
161150877|NCT01416610|581933599|FG000|Overall Study|Lack of Efficacy|4|||
161150878|NCT01416610|581933599|FG000|Overall Study|No reason given|5|||
161280949|NCT00996892|582407006|FG004|Expansion Stage 2|Physician Decision|0|||
161280950|NCT00996892|582407007|FG005|Expansion Stage 2|Physician Decision|0|||
161345076|NCT03126110|582648850|FG001|Phase 2|Progressive Disease|0|||
161150879|NCT01416610|581933599|FG000|Overall Study|Withdrawal by Subject|13|||
161150880|NCT01416610|581933599|FG000|Overall Study|Lost to Follow-up|7|||
161150881|NCT01416610|581933599|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
161150882|NCT00399802|581933601|FG000|Overall Study|Adverse Event|0|||
161150883|NCT00399802|581933602|FG001|Overall Study|Adverse Event|2|||
161150884|NCT00399802|581933601|FG000|Overall Study|Participant discontinued by mistake|0|||
161150885|NCT00399802|581933602|FG001|Overall Study|Participant discontinued by mistake|1|||
161150886|NCT04172831|581933605|FG000|Overall Study|Adverse Event|21|||
161150887|NCT04172831|581933606|FG001|Overall Study|Adverse Event|9|||
161150888|NCT04172831|581933605|FG000|Overall Study|Lack of Efficacy|2|||
161150889|NCT04172831|581933606|FG001|Overall Study|Lack of Efficacy|8|||
161150890|NCT04172831|581933605|FG000|Overall Study|Physician Decision|0|||
161150891|NCT04172831|581933606|FG001|Overall Study|Physician Decision|1|||
161150892|NCT04172831|581933605|FG000|Overall Study|Withdrawal by Subject|12|||
161150893|NCT04172831|581933606|FG001|Overall Study|Withdrawal by Subject|11|||
161150894|NCT04172831|581933605|FG000|Overall Study|Lost to Follow-up|4|||
161150895|NCT04172831|581933606|FG001|Overall Study|Lost to Follow-up|9|||
161150896|NCT04172831|581933605|FG000|Overall Study|COVID-19 related crisis|3|||
161150897|NCT04172831|581933606|FG001|Overall Study|COVID-19 related crisis|3|||
161150898|NCT04172831|581933605|FG000|Overall Study|Subject non-compliance|1|||
161050100|NCT01970527|581572041|FG001|Treatment|Death|1|||
161050101|NCT01970527|581572040|FG000|Follow-up Clinic Visit|Disease progression|1|||
161050102|NCT01970527|581572041|FG001|Follow-up Clinic Visit|Disease progression|1|||
161050103|NCT01970527|581572040|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
161150899|NCT04172831|581933606|FG001|Overall Study|Subject non-compliance|1|||
161150900|NCT04172831|581933605|FG000|Overall Study|Family emergency|1|||
161150901|NCT04172831|581933606|FG001|Overall Study|Family emergency|0|||
161050104|NCT01970527|581572041|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
161050105|NCT01970527|581572040|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
161050106|NCT01970527|581572041|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
161050107|NCT03060525|581572042|FG000|Overall Study|moved out of state|1|||
161050108|NCT03060525|581572043|FG001|Overall Study|moved out of state|1|||
161050109|NCT03060525|581572044|FG002|Overall Study|moved out of state|1|||
161050110|NCT03060525|581572045|FG003|Overall Study|moved out of state|1|||
161050111|NCT03060525|581572042|FG000|Overall Study|unable to meet time commitment required of study|2|||
161050112|NCT03060525|581572043|FG001|Overall Study|unable to meet time commitment required of study|3|||
161050113|NCT03060525|581572044|FG002|Overall Study|unable to meet time commitment required of study|3|||
161050114|NCT03060525|581572045|FG003|Overall Study|unable to meet time commitment required of study|1|||
161050115|NCT03060525|581572042|FG000|Overall Study|no longer interested in doing intervention|0|||
161050116|NCT03060525|581572043|FG001|Overall Study|no longer interested in doing intervention|0|||
161050117|NCT03060525|581572044|FG002|Overall Study|no longer interested in doing intervention|0|||
161050118|NCT03060525|581572045|FG003|Overall Study|no longer interested in doing intervention|1|||
161050119|NCT01964547|581572046|FG000|Overall Study|Adverse Event|8|||
161050120|NCT01964547|581572047|FG001|Overall Study|Adverse Event|2|||
161050121|NCT01964547|581572046|FG000|Overall Study|Withdrawal by Subject|4|||
161050122|NCT01964547|581572047|FG001|Overall Study|Withdrawal by Subject|7|||
161050123|NCT01964547|581572046|FG000|Overall Study|Lost to Follow-up|0|||
161050124|NCT01964547|581572047|FG001|Overall Study|Lost to Follow-up|1|||
161050125|NCT01964547|581572046|FG000|Overall Study|Withdrawal by Investigator|0|||
161050126|NCT01964547|581572047|FG001|Overall Study|Withdrawal by Investigator|1|||
161050127|NCT01115309|581572048|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
161050128|NCT01115309|581572048|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
161050129|NCT01115309|581572048|FG000|Long-term Follow-up|Lost to Follow-up|6|||
161050130|NCT02147093|581572051|FG000|Period 1|Lost to Follow-up|0|||
161050131|NCT02147093|581572052|FG001|Period 1|Lost to Follow-up|1|||
161150902|NCT01899144|581933610|FG000|Treatment Period 2|Other|1|||
161150903|NCT01899144|581933610|FG000|Treatment Period 3|Other|2|||
161150904|NCT01899144|581933610|FG000|Treatment Period 5|Other|1|||
161150905|NCT00866294|581933611|FG000|Overall Study|Adverse Event|12|||
161280951|NCT00996892|582407008|FG006|Expansion Stage 2|Physician Decision|0|||
161280952|NCT00996892|582407009|FG007|Expansion Stage 2|Physician Decision|0|||
161280953|NCT00996892|582407010|FG008|Expansion Stage 2|Physician Decision|0|||
161280954|NCT00996892|582407011|FG009|Expansion Stage 2|Physician Decision|0|||
161280955|NCT00996892|582407012|FG010|Expansion Stage 2|Physician Decision|0|||
161280956|NCT00996892|582407013|FG011|Expansion Stage 2|Physician Decision|0|||
161280957|NCT00996892|582407014|FG012|Expansion Stage 2|Physician Decision|0|||
161280958|NCT00996892|582407015|FG013|Expansion Stage 2|Physician Decision|0|||
161050132|NCT02147093|581572051|FG000|Period 2|Protocol Violation|2|||
161150906|NCT00866294|581933612|FG001|Overall Study|Adverse Event|13|||
161150907|NCT00866294|581933613|FG002|Overall Study|Adverse Event|9|||
161150908|NCT00866294|581933611|FG000|Overall Study|Lack of Efficacy|7|||
161150909|NCT00866294|581933612|FG001|Overall Study|Lack of Efficacy|1|||
161150910|NCT00866294|581933613|FG002|Overall Study|Lack of Efficacy|0|||
161150911|NCT00866294|581933611|FG000|Overall Study|Protocol Violation|2|||
161150912|NCT00866294|581933612|FG001|Overall Study|Protocol Violation|0|||
161280959|NCT00996892|582407016|FG014|Expansion Stage 2|Physician Decision|0|||
161050133|NCT02147093|581572052|FG001|Period 2|Protocol Violation|0|||
161050134|NCT03246724|581572053|FG000|Overall Study|Withdrawal by Subject|5|||
161050135|NCT03246724|581572054|FG001|Overall Study|Withdrawal by Subject|2|||
161050136|NCT03246724|581572055|FG002|Overall Study|Withdrawal by Subject|4|||
161050137|NCT03246724|581572056|FG003|Overall Study|Withdrawal by Subject|2|||
161050138|NCT03246724|581572053|FG000|Overall Study|Ineligible on day of surgery|7|||
161050139|NCT03246724|581572054|FG001|Overall Study|Ineligible on day of surgery|2|||
161050140|NCT03246724|581572055|FG002|Overall Study|Ineligible on day of surgery|0|||
161050141|NCT03246724|581572056|FG003|Overall Study|Ineligible on day of surgery|3|||
161050142|NCT03246724|581572053|FG000|Overall Study|Study completed before surgical date|2|||
161050143|NCT03246724|581572054|FG001|Overall Study|Study completed before surgical date|1|||
161050144|NCT03246724|581572055|FG002|Overall Study|Study completed before surgical date|8|||
161050145|NCT03246724|581572056|FG003|Overall Study|Study completed before surgical date|1|||
161050146|NCT03246724|581572053|FG000|Overall Study|Transferred to other arm|0|||
161050147|NCT03246724|581572054|FG001|Overall Study|Transferred to other arm|0|||
161050148|NCT03246724|581572055|FG002|Overall Study|Transferred to other arm|1|||
161050149|NCT03246724|581572056|FG003|Overall Study|Transferred to other arm|0|||
161050150|NCT03246724|581572053|FG000|Overall Study|Unable to obtain medication timely|0|||
161050151|NCT03246724|581572054|FG001|Overall Study|Unable to obtain medication timely|2|||
161050152|NCT03246724|581572055|FG002|Overall Study|Unable to obtain medication timely|2|||
161050153|NCT03246724|581572056|FG003|Overall Study|Unable to obtain medication timely|1|||
161050154|NCT03246724|581572053|FG000|Overall Study|Re-consented to participate|0|||
161050155|NCT03246724|581572054|FG001|Overall Study|Re-consented to participate|0|||
161050156|NCT03246724|581572055|FG002|Overall Study|Re-consented to participate|0|||
161050157|NCT03246724|581572056|FG003|Overall Study|Re-consented to participate|1|||
161050158|NCT00655824|581572057|FG000|Overall Study|Adverse Event|3|||
161050159|NCT00655824|581572057|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
161050160|NCT00655824|581572057|FG000|Overall Study|Protocol Violation|1|||
161050161|NCT00655824|581572057|FG000|Overall Study|Withdrawal by Subject|4|||
161050162|NCT00655824|581572057|FG000|Overall Study|Deterioration of Trial Disease|2|||
161050163|NCT00589628|581572058|FG000|Overall Study|Lost to Follow-up|0|||
161050164|NCT00589628|581572059|FG001|Overall Study|Lost to Follow-up|1|||
161050165|NCT02189759|581572062|FG000|Overall Study|Lost to Follow-up|0|||
161050166|NCT02189759|581572063|FG001|Overall Study|Lost to Follow-up|0|||
161050167|NCT02189759|581572064|FG002|Overall Study|Lost to Follow-up|2|||
161050168|NCT02189759|581572065|FG003|Overall Study|Lost to Follow-up|5|||
161050169|NCT03032198|581572066|FG000|Overall Study|Screen Fail|1|||
161050170|NCT02470806|581572067|FG000|Overall Study|Lost to Follow-up|1|||
161050171|NCT02470806|581572068|FG001|Overall Study|Lost to Follow-up|1|||
161050172|NCT02470806|581572067|FG000|Overall Study|Adverse Event|5|||
161050173|NCT02470806|581572068|FG001|Overall Study|Adverse Event|2|||
161050174|NCT02470806|581572067|FG000|Overall Study|Protocol Violation|4|||
161050175|NCT02470806|581572068|FG001|Overall Study|Protocol Violation|11|||
161050176|NCT02470806|581572067|FG000|Overall Study|Physician Decision|0|||
161050177|NCT02470806|581572068|FG001|Overall Study|Physician Decision|3|||
161050178|NCT02470806|581572067|FG000|Overall Study|Withdrawal by Subject|3|||
161050179|NCT02470806|581572068|FG001|Overall Study|Withdrawal by Subject|10|||
161050180|NCT02470806|581572067|FG000|Overall Study|Lack of Efficacy|5|||
161050181|NCT02470806|581572068|FG001|Overall Study|Lack of Efficacy|15|||
161050182|NCT02892019|581572073|FG000|Overall Study|randomized but not treated|0|||
161050183|NCT02892019|581572074|FG001|Overall Study|randomized but not treated|1|||
161050184|NCT02892019|581572073|FG000|Overall Study|Withdrawal by Subject|0|||
161050185|NCT02892019|581572074|FG001|Overall Study|Withdrawal by Subject|1|||
161050186|NCT02892019|581572073|FG000|Overall Study|Adverse Event|1|||
161050187|NCT02892019|581572074|FG001|Overall Study|Adverse Event|1|||
161050188|NCT03890484|581572075|FG000|Overall Study|Lost to Follow-up|1|||
161050189|NCT03890484|581572076|FG001|Overall Study|Lost to Follow-up|1|||
161050190|NCT00518206|581572077|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
161050191|NCT00518206|581572078|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
161050192|NCT00518206|581572077|FG000|Overall Study|Withdrawal by Subject|2|||
161050193|NCT00518206|581572078|FG001|Overall Study|Withdrawal by Subject|0|||
161345077|NCT03126110|582648851|FG002|Phase 2|Progressive Disease|0|||
161345078|NCT03126110|582648852|FG003|Phase 2|Progressive Disease|0|||
161050194|NCT00518206|581572077|FG000|Overall Study|Drug Supply Issue|1|||
161050195|NCT00518206|581572078|FG001|Overall Study|Drug Supply Issue|0|||
161050196|NCT00518206|581572077|FG000|Overall Study|Reason Unknown|1|||
161050197|NCT00518206|581572078|FG001|Overall Study|Reason Unknown|0|||
161050198|NCT00518206|581572077|FG000|Overall Study|Completion Status Unknown|1|||
161050199|NCT00518206|581572078|FG001|Overall Study|Completion Status Unknown|0|||
161050200|NCT03075878|581572079|FG000|Overall Study|Physician Decision|1|||
161050201|NCT02188459|581572080|FG000|Overall Study|Lost to Follow-up|3|||
161050202|NCT02188459|581572081|FG001|Overall Study|Lost to Follow-up|4|||
161345079|NCT03126110|582648853|FG004|Phase 2|Progressive Disease|0|||
161050203|NCT02188459|581572080|FG000|Overall Study|Early Termination|0|||
161050204|NCT02188459|581572081|FG001|Overall Study|Early Termination|3|||
161050205|NCT02612285|581572086|FG000|Overall Study|Withdrawal by Subject|1|||
161150913|NCT00866294|581933613|FG002|Overall Study|Protocol Violation|0|||
161150914|NCT00866294|581933611|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
161150915|NCT00866294|581933612|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161150916|NCT00866294|581933613|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161150917|NCT00866294|581933611|FG000|Overall Study|Lost to Follow-up|1|||
161150918|NCT00866294|581933612|FG001|Overall Study|Lost to Follow-up|3|||
161150919|NCT00866294|581933613|FG002|Overall Study|Lost to Follow-up|0|||
161150920|NCT00866294|581933611|FG000|Overall Study|Physician Decision|6|||
161150921|NCT00866294|581933612|FG001|Overall Study|Physician Decision|2|||
161150922|NCT00866294|581933613|FG002|Overall Study|Physician Decision|1|||
161150923|NCT00081289|581933614|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
161150924|NCT00081289|581933615|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
161150925|NCT00081289|581933614|FG000|Overall Study|Ineligible / no protocol treatment|3|||
161150926|NCT00081289|581933615|FG001|Overall Study|Ineligible / no protocol treatment|4|||
161150927|NCT00916721|581933618|FG000|Overall Study|Lost to Follow-up|0|||
161150928|NCT00916721|581933619|FG001|Overall Study|Lost to Follow-up|1|||
161150929|NCT00916721|581933618|FG000|Overall Study|Adverse Event|6|||
161150930|NCT00916721|581933619|FG001|Overall Study|Adverse Event|3|||
161150931|NCT00916721|581933618|FG000|Overall Study|Withdrawal by Subject|2|||
161150932|NCT00916721|581933619|FG001|Overall Study|Withdrawal by Subject|2|||
161050206|NCT02935894|581572087|FG000|Overall Study|Subject dismissed|1|||
161050207|NCT04895085|581572090|FG000|Overall Study|Death|1|||
161050208|NCT04895085|581572090|FG000|Overall Study|Withdrawal by Subject|1|||
161050209|NCT04895085|581572090|FG000|Overall Study|No longer eligible: Moved from area|1|||
161050210|NCT04919499|581572095|FG000|Overall Study|Adverse Event|0|||
161050211|NCT04919499|581572096|FG001|Overall Study|Adverse Event|0|||
161050212|NCT04919499|581572097|FG002|Overall Study|Adverse Event|0|||
161050213|NCT04919499|581572098|FG003|Overall Study|Adverse Event|0|||
161050214|NCT04919499|581572099|FG004|Overall Study|Adverse Event|2|||
161050215|NCT04919499|581572095|FG000|Overall Study|Not treated|0|||
161050216|NCT04919499|581572096|FG001|Overall Study|Not treated|0|||
161050217|NCT04919499|581572097|FG002|Overall Study|Not treated|0|||
161050218|NCT04919499|581572098|FG003|Overall Study|Not treated|1|||
161050219|NCT04919499|581572099|FG004|Overall Study|Not treated|0|||
161050220|NCT00946998|581573630|FG000|Overall Study|Exited prior to first outcome assessment|5|||
161050221|NCT00946998|581573631|FG001|Overall Study|Exited prior to first outcome assessment|3|||
161050222|NCT02213094|581573638|FG000|Overall Study|Adverse Event|1|||
161050223|NCT02213094|581573639|FG001|Overall Study|Adverse Event|0|||
161050224|NCT02163499|581573640|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
161050225|NCT02163499|581573640|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
161050226|NCT02163499|581573640|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
161050227|NCT02163499|581573640|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
161050228|NCT02163499|581573640|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
161050229|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
161050230|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
161050231|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
161050232|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
161050233|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
161050234|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
161050235|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
161050236|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
161050237|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
161050238|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Death|8|||
161050239|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
161050240|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
161050241|NCT02163499|581573640|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
161050242|NCT00555620|581573644|FG000|Overall Study|Death|0|||
161150933|NCT00916721|581933618|FG000|Overall Study|Protocol Violation|2|||
161150934|NCT00916721|581933619|FG001|Overall Study|Protocol Violation|4|||
161150935|NCT03648996|581933620|FG000|Overall Study|Withdrawal by Subject|0|||
161150936|NCT03648996|581933621|FG001|Overall Study|Withdrawal by Subject|2|||
161150937|NCT03648996|581933622|FG002|Overall Study|Withdrawal by Subject|2|||
161150938|NCT03648996|581933620|FG000|Overall Study|Physician Decision|2|||
161150939|NCT03648996|581933621|FG001|Overall Study|Physician Decision|0|||
161050243|NCT00555620|581573645|FG001|Overall Study|Death|1|||
161050244|NCT00555620|581573646|FG002|Overall Study|Death|0|||
161150940|NCT03648996|581933622|FG002|Overall Study|Physician Decision|0|||
161150941|NCT00365976|581933626|FG000|Overall Study|Withdrawal by Subject|1|||
161150942|NCT00365976|581933627|FG001|Overall Study|Withdrawal by Subject|5|||
161050245|NCT00555620|581573647|FG003|Overall Study|Death|0|||
161050246|NCT00555620|581573648|FG004|Overall Study|Death|0|||
161050247|NCT00555620|581573649|FG005|Overall Study|Death|1|||
161050248|NCT00555620|581573644|FG000|Overall Study|Study terminated by sponsor|0|||
161050249|NCT00555620|581573645|FG001|Overall Study|Study terminated by sponsor|0|||
161050250|NCT00555620|581573646|FG002|Overall Study|Study terminated by sponsor|1|||
161050251|NCT00555620|581573647|FG003|Overall Study|Study terminated by sponsor|0|||
161050252|NCT00555620|581573648|FG004|Overall Study|Study terminated by sponsor|0|||
161050253|NCT00555620|581573649|FG005|Overall Study|Study terminated by sponsor|0|||
161050254|NCT00555620|581573644|FG000|Overall Study|Adverse Event|0|||
161050255|NCT00555620|581573645|FG001|Overall Study|Adverse Event|0|||
161050256|NCT00555620|581573646|FG002|Overall Study|Adverse Event|1|||
161050257|NCT00555620|581573647|FG003|Overall Study|Adverse Event|5|||
161050258|NCT00555620|581573648|FG004|Overall Study|Adverse Event|0|||
161050259|NCT00555620|581573649|FG005|Overall Study|Adverse Event|1|||
161050260|NCT00555620|581573644|FG000|Overall Study|Objective progression or relapse|6|||
161050261|NCT00555620|581573645|FG001|Overall Study|Objective progression or relapse|5|||
161050262|NCT00555620|581573646|FG002|Overall Study|Objective progression or relapse|12|||
161050263|NCT00555620|581573647|FG003|Overall Study|Objective progression or relapse|17|||
161050264|NCT00555620|581573648|FG004|Overall Study|Objective progression or relapse|3|||
161050265|NCT00555620|581573649|FG005|Overall Study|Objective progression or relapse|16|||
161050266|NCT00555620|581573644|FG000|Overall Study|Participant refused treatment|0|||
161050267|NCT00555620|581573645|FG001|Overall Study|Participant refused treatment|1|||
161050268|NCT00555620|581573646|FG002|Overall Study|Participant refused treatment|1|||
161050269|NCT00555620|581573647|FG003|Overall Study|Participant refused treatment|0|||
161050270|NCT00555620|581573648|FG004|Overall Study|Participant refused treatment|0|||
161050271|NCT00555620|581573649|FG005|Overall Study|Participant refused treatment|1|||
161050272|NCT00555620|581573644|FG000|Overall Study|Other|0|||
161050273|NCT00555620|581573645|FG001|Overall Study|Other|0|||
161050274|NCT00555620|581573646|FG002|Overall Study|Other|0|||
161050275|NCT00555620|581573647|FG003|Overall Study|Other|1|||
161050276|NCT00555620|581573648|FG004|Overall Study|Other|0|||
161050277|NCT00555620|581573649|FG005|Overall Study|Other|3|||
161050278|NCT00476151|581573650|FG000|Overall Study|Adverse Event|0|||
161050279|NCT00476151|581573651|FG001|Overall Study|Adverse Event|2|||
161050280|NCT00476151|581573650|FG000|Overall Study|Protocol Violation|1|||
161050281|NCT00476151|581573651|FG001|Overall Study|Protocol Violation|3|||
161050282|NCT00476151|581573650|FG000|Overall Study|Withdrawal by Subject|2|||
161050283|NCT00476151|581573651|FG001|Overall Study|Withdrawal by Subject|0|||
161050284|NCT00476151|581573650|FG000|Overall Study|Physician Decision|0|||
161050285|NCT00476151|581573651|FG001|Overall Study|Physician Decision|2|||
161050286|NCT00946088|581573653|FG000|Overall Study|Withdrawal by Subject|0|||
161050287|NCT00946088|581573654|FG001|Overall Study|Withdrawal by Subject|1|||
161050288|NCT03456856|581573658|FG000|Overall Study|Lost to Follow-up|2|||
161050289|NCT03456856|581573658|FG000|Overall Study|Withdrawal by Subject|1|||
161050290|NCT02542696|581573660|FG000|Overall Study|Adverse Event|167|||
161050291|NCT02542696|581573660|FG000|Overall Study|Lack of Efficacy|26|||
161050292|NCT02542696|581573660|FG000|Overall Study|Lost to Follow-up|6|||
161050293|NCT02542696|581573660|FG000|Overall Study|Withdrawal by Subject|104|||
161050294|NCT02542696|581573660|FG000|Overall Study|Protocol Violation|5|||
161050295|NCT02542696|581573660|FG000|Overall Study|Death|8|||
161050296|NCT02542696|581573660|FG000|Overall Study|DECREASED OFF TIME|1|||
161050297|NCT02542696|581573660|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
161050298|NCT02542696|581573660|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
161050299|NCT02542696|581573660|FG000|Overall Study|MEDICAL HISTORY|1|||
161050300|NCT02542696|581573660|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
161050301|NCT02542696|581573660|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
161050302|NCT02542696|581573660|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
161050303|NCT02542696|581573660|FG000|Overall Study|SPONSOR DECISION|3|||
161050304|NCT02542696|581573660|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
161050305|NCT02542696|581573660|FG000|Overall Study|SUBJECT DECISION|2|||
161050306|NCT03262389|581573661|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
161050307|NCT03262389|581573661|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
161050308|NCT03262389|581573661|FG000|Overall Study|opted out of PET/MR|1|||
161050309|NCT03651271|581573663|FG000|Overall Study|Death|4|||
161050310|NCT03651271|581573664|FG001|Overall Study|Death|37|||
161050311|NCT03651271|581573665|FG002|Overall Study|Death|0|||
161050312|NCT03651271|581573666|FG003|Overall Study|Death|2|||
161050313|NCT03651271|581573667|FG004|Overall Study|Death|6|||
161050314|NCT03651271|581573663|FG000|Overall Study|Lost to Follow-up|1|||
161050315|NCT03651271|581573664|FG001|Overall Study|Lost to Follow-up|5|||
161050316|NCT03651271|581573665|FG002|Overall Study|Lost to Follow-up|0|||
161050317|NCT03651271|581573666|FG003|Overall Study|Lost to Follow-up|1|||
161050318|NCT03651271|581573667|FG004|Overall Study|Lost to Follow-up|0|||
161050319|NCT03651271|581573663|FG000|Overall Study|Physician Decision|0|||
161050320|NCT03651271|581573664|FG001|Overall Study|Physician Decision|2|||
161050321|NCT03651271|581573665|FG002|Overall Study|Physician Decision|0|||
161050322|NCT03651271|581573666|FG003|Overall Study|Physician Decision|0|||
161050323|NCT03651271|581573667|FG004|Overall Study|Physician Decision|0|||
161050324|NCT03651271|581573663|FG000|Overall Study|Withdrawal by Subject|1|||
161050325|NCT03651271|581573664|FG001|Overall Study|Withdrawal by Subject|15|||
161050326|NCT03651271|581573665|FG002|Overall Study|Withdrawal by Subject|0|||
161050327|NCT03651271|581573666|FG003|Overall Study|Withdrawal by Subject|0|||
161050328|NCT03651271|581573667|FG004|Overall Study|Withdrawal by Subject|1|||
161050329|NCT03651271|581573663|FG000|Overall Study|Patient medically unable to continue|0|||
161050330|NCT03651271|581573664|FG001|Overall Study|Patient medically unable to continue|0|||
161050331|NCT03651271|581573665|FG002|Overall Study|Patient medically unable to continue|0|||
161050332|NCT03651271|581573666|FG003|Overall Study|Patient medically unable to continue|1|||
161050333|NCT03651271|581573667|FG004|Overall Study|Patient medically unable to continue|0|||
161050334|NCT00821093|581573668|FG000|Overall Study|Adverse Event|20|||
161050335|NCT00821093|581573669|FG001|Overall Study|Adverse Event|12|||
161050336|NCT00821093|581573668|FG000|Overall Study|Withdrawal by Subject|9|||
161050337|NCT00821093|581573669|FG001|Overall Study|Withdrawal by Subject|13|||
161050338|NCT00821093|581573668|FG000|Overall Study|Lost to Follow-up|9|||
161050339|NCT00821093|581573669|FG001|Overall Study|Lost to Follow-up|3|||
161050340|NCT00821093|581573668|FG000|Overall Study|Protocol deviation|3|||
161050341|NCT00821093|581573669|FG001|Overall Study|Protocol deviation|6|||
161050342|NCT00821093|581573668|FG000|Overall Study|Abnormal laboratory value(s)|2|||
161050343|NCT00821093|581573669|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161050344|NCT00821093|581573668|FG000|Overall Study|Lack of Efficacy|2|||
161050345|NCT00821093|581573669|FG001|Overall Study|Lack of Efficacy|2|||
161050346|NCT00821093|581573668|FG000|Overall Study|Death|2|||
161050347|NCT00821093|581573669|FG001|Overall Study|Death|1|||
161050348|NCT00821093|581573668|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161050349|NCT00821093|581573669|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161050350|NCT00821093|581573668|FG000|Overall Study|Administrative problems|1|||
161050351|NCT00821093|581573669|FG001|Overall Study|Administrative problems|2|||
161050352|NCT05104242|581573670|FG000|Overall Study|Withdrawal by Subject|1|||
161050353|NCT05104242|581573671|FG001|Overall Study|Withdrawal by Subject|5|||
161050354|NCT05104242|581573670|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
161050355|NCT05104242|581573671|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
161050356|NCT02469155|581573676|FG000|Overall Study|Adverse Event|6|||
161050357|NCT02469155|581573677|FG001|Overall Study|Adverse Event|0|||
161050358|NCT02469155|581573678|FG002|Overall Study|Adverse Event|1|||
161050359|NCT02469155|581573679|FG003|Overall Study|Adverse Event|10|||
161050360|NCT02469155|581573676|FG000|Overall Study|Lack of Efficacy|13|||
161050361|NCT02469155|581573677|FG001|Overall Study|Lack of Efficacy|10|||
161050362|NCT02469155|581573678|FG002|Overall Study|Lack of Efficacy|10|||
161050363|NCT02469155|581573679|FG003|Overall Study|Lack of Efficacy|8|||
161050364|NCT02469155|581573676|FG000|Overall Study|Death|0|||
161050365|NCT02469155|581573677|FG001|Overall Study|Death|0|||
161050366|NCT02469155|581573678|FG002|Overall Study|Death|0|||
161050367|NCT02469155|581573679|FG003|Overall Study|Death|1|||
161050368|NCT02469155|581573676|FG000|Overall Study|Lost to Follow-up|5|||
161050369|NCT02469155|581573677|FG001|Overall Study|Lost to Follow-up|2|||
161050370|NCT02469155|581573678|FG002|Overall Study|Lost to Follow-up|7|||
161050371|NCT02469155|581573679|FG003|Overall Study|Lost to Follow-up|2|||
161050372|NCT02469155|581573676|FG000|Overall Study|Physician Decision|0|||
161050373|NCT02469155|581573677|FG001|Overall Study|Physician Decision|0|||
161050374|NCT02469155|581573678|FG002|Overall Study|Physician Decision|1|||
161050375|NCT02469155|581573679|FG003|Overall Study|Physician Decision|0|||
161050376|NCT02469155|581573676|FG000|Overall Study|Withdrawal by Subject|34|||
161050377|NCT02469155|581573677|FG001|Overall Study|Withdrawal by Subject|30|||
161050378|NCT02469155|581573678|FG002|Overall Study|Withdrawal by Subject|20|||
161050379|NCT02469155|581573679|FG003|Overall Study|Withdrawal by Subject|37|||
161050380|NCT02469155|581573676|FG000|Overall Study|Other|3|||
161050381|NCT02469155|581573677|FG001|Overall Study|Other|3|||
161050382|NCT02469155|581573678|FG002|Overall Study|Other|2|||
161050383|NCT02469155|581573679|FG003|Overall Study|Other|10|||
161050384|NCT02469155|581573676|FG000|Overall Study|Protocol Violation|0|||
161050385|NCT02469155|581573677|FG001|Overall Study|Protocol Violation|1|||
161050386|NCT02469155|581573678|FG002|Overall Study|Protocol Violation|0|||
161050387|NCT02469155|581573679|FG003|Overall Study|Protocol Violation|1|||
161050388|NCT02991118|581573680|FG000|Overall Study|Death|3|||
161050389|NCT02991118|581573681|FG001|Overall Study|Death|8|||
161050390|NCT02991118|581573680|FG000|Overall Study|Protocol Violation|0|||
161050391|NCT02991118|581573681|FG001|Overall Study|Protocol Violation|3|||
161050392|NCT02991118|581573680|FG000|Overall Study|Physician Decision|0|||
161050393|NCT02991118|581573681|FG001|Overall Study|Physician Decision|1|||
161050394|NCT02991118|581573680|FG000|Overall Study|Moved out of the country|0|||
161050395|NCT02991118|581573681|FG001|Overall Study|Moved out of the country|1|||
161050396|NCT02991118|581573680|FG000|Overall Study|Adverse Event|2|||
161050397|NCT02991118|581573681|FG001|Overall Study|Adverse Event|2|||
161050398|NCT02991118|581573680|FG000|Overall Study|Withdrawal by Subject|1|||
161050399|NCT02991118|581573681|FG001|Overall Study|Withdrawal by Subject|7|||
161050400|NCT02991118|581573680|FG000|Overall Study|Could not attend study visits|0|||
161050401|NCT02991118|581573681|FG001|Overall Study|Could not attend study visits|1|||
161050402|NCT02991118|581573680|FG000|Overall Study|Lost to Follow-up|1|||
161050403|NCT02991118|581573681|FG001|Overall Study|Lost to Follow-up|9|||
161050404|NCT02764320|581573689|FG000|Overall Study|Withdrawal by Subject|35|||
161050405|NCT02764320|581573690|FG001|Overall Study|Withdrawal by Subject|38|||
161280960|NCT00996892|582407017|FG015|Expansion Stage 2|Physician Decision|0|||
161050406|NCT02764320|581573689|FG000|Overall Study|Protocol Violation|11|||
161050407|NCT02764320|581573690|FG001|Overall Study|Protocol Violation|6|||
161050408|NCT02764320|581573689|FG000|Overall Study|Adverse Event|2|||
161050409|NCT02764320|581573690|FG001|Overall Study|Adverse Event|0|||
161050410|NCT02764320|581573689|FG000|Overall Study|Health Issues unable to continue|2|||
161050411|NCT02764320|581573690|FG001|Overall Study|Health Issues unable to continue|0|||
161050412|NCT02764320|581573689|FG000|Overall Study|Did not meet inclusion criteria|1|||
161050413|NCT02764320|581573690|FG001|Overall Study|Did not meet inclusion criteria|0|||
161050414|NCT02764320|581573689|FG000|Overall Study|Subject moved|0|||
161050415|NCT02764320|581573690|FG001|Overall Study|Subject moved|2|||
161050416|NCT02764320|581573689|FG000|Overall Study|Overused medication unavailable|0|||
161050417|NCT02764320|581573690|FG001|Overall Study|Overused medication unavailable|1|||
161050418|NCT02764320|581573689|FG000|Overall Study|Seeking care outside site|0|||
161050419|NCT02764320|581573690|FG001|Overall Study|Seeking care outside site|1|||
161050420|NCT02764320|581573689|FG000|Overall Study|Technology barriers|0|||
161050421|NCT02764320|581573690|FG001|Overall Study|Technology barriers|1|||
161050422|NCT04765046|581573691|FG000|Overall Study|Screen Failure|2|||
161050423|NCT04765046|581573691|FG000|Overall Study|Withdrawal by Subject|4|||
161050424|NCT04765046|581573691|FG000|Overall Study|Physician Decision|4|||
161050425|NCT04765046|581573691|FG000|Overall Study|Surgery Cancelled|8|||
161050426|NCT03150589|581573693|FG000|Overall Study|Withdrawal by Subject|16|||
161050427|NCT03150589|581573694|FG001|Overall Study|Withdrawal by Subject|9|||
161050428|NCT03150589|581573693|FG000|Overall Study|Adverse Event|7|||
161050429|NCT03150589|581573694|FG001|Overall Study|Adverse Event|6|||
161050430|NCT03150589|581573693|FG000|Overall Study|Protocol Violation|4|||
161050431|NCT03150589|581573694|FG001|Overall Study|Protocol Violation|3|||
161050432|NCT03150589|581573693|FG000|Overall Study|Lost to Follow-up|3|||
161050433|NCT03150589|581573694|FG001|Overall Study|Lost to Follow-up|3|||
161050434|NCT03150589|581573693|FG000|Overall Study|Death|2|||
161050435|NCT03150589|581573694|FG001|Overall Study|Death|3|||
161050436|NCT03150589|581573693|FG000|Overall Study|IP non-compliance and other reasons|12|||
161050437|NCT03150589|581573694|FG001|Overall Study|IP non-compliance and other reasons|3|||
161050438|NCT03529942|581573695|FG000|Overall Study|Withdrawal by Subject|13|||
161050439|NCT03529942|581573695|FG000|Overall Study|Physician Decision|1|||
161050440|NCT03529942|581573695|FG000|Overall Study|Lost to Follow-up|7|||
161050441|NCT03529942|581573695|FG000|Overall Study|Needle inserted but no drug administered|1|||
161050442|NCT03529942|581573695|FG000|Overall Study|Personal reasons|1|||
161050443|NCT01989156|581573702|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
161050444|NCT01989156|581573703|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
161050445|NCT01989156|581573704|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
161050446|NCT01989156|581573702|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
161050447|NCT01989156|581573703|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
161050448|NCT01989156|581573704|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
161050449|NCT01989156|581573702|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
161050450|NCT01989156|581573703|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
161050451|NCT01989156|581573704|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
161050452|NCT01989156|581573702|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161050453|NCT01989156|581573703|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161050454|NCT01989156|581573704|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
161050455|NCT01989156|581573702|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
161050456|NCT01989156|581573703|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
161050457|NCT01989156|581573704|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
161050458|NCT01989156|581573702|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
161050459|NCT01989156|581573703|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
161050460|NCT01989156|581573704|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
161050461|NCT01989156|581573702|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
161050462|NCT01989156|581573703|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
161050463|NCT01989156|581573704|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
161050464|NCT01989156|581573702|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
161280961|NCT00996892|582407018|FG016|Expansion Stage 2|Physician Decision|0|||
161050465|NCT01989156|581573703|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
161050466|NCT01989156|581573704|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
161050467|NCT03839355|581573705|FG000|Overall Study|Withdrawal by Subject|1|||
161050468|NCT03839355|581573706|FG001|Overall Study|Withdrawal by Subject|0|||
161050469|NCT03541369|581573708|FG000|Overall Study|Death|0|||
161050470|NCT03541369|581573709|FG001|Overall Study|Death|0|||
161050471|NCT03541369|581573710|FG002|Overall Study|Death|0|||
161280962|NCT00996892|582407019|FG017|Expansion Stage 2|Physician Decision|0|||
161280963|NCT00996892|582407020|FG018|Expansion Stage 2|Physician Decision|1|||
161050472|NCT03541369|581573711|FG003|Overall Study|Death|0|||
161050473|NCT03541369|581573712|FG004|Overall Study|Death|1|||
161050474|NCT03541369|581573713|FG005|Overall Study|Death|1|||
161050475|NCT03541369|581573714|FG006|Overall Study|Death|0|||
161050476|NCT03541369|581573715|FG007|Overall Study|Death|2|||
161050477|NCT03541369|581573716|FG008|Overall Study|Death|1|||
161050478|NCT03541369|581573717|FG009|Overall Study|Death|2|||
161050479|NCT03541369|581573718|FG010|Overall Study|Death|1|||
161050480|NCT03541369|581573719|FG011|Overall Study|Death|0|||
161050481|NCT03541369|581573720|FG012|Overall Study|Death|2|||
161050482|NCT03541369|581573721|FG013|Overall Study|Death|1|||
161050483|NCT03541369|581573722|FG014|Overall Study|Death|1|||
161050484|NCT03541369|581573723|FG015|Overall Study|Death|1|||
161050485|NCT03541369|581573724|FG016|Overall Study|Death|0|||
161050486|NCT03541369|581573725|FG017|Overall Study|Death|1|||
161050487|NCT03541369|581573708|FG000|Overall Study|Decision by sponsor|0|||
161050488|NCT03541369|581573709|FG001|Overall Study|Decision by sponsor|0|||
161050489|NCT03541369|581573710|FG002|Overall Study|Decision by sponsor|0|||
161050490|NCT03541369|581573711|FG003|Overall Study|Decision by sponsor|1|||
161050491|NCT03541369|581573712|FG004|Overall Study|Decision by sponsor|0|||
161050492|NCT03541369|581573713|FG005|Overall Study|Decision by sponsor|2|||
161050493|NCT03541369|581573714|FG006|Overall Study|Decision by sponsor|0|||
161050494|NCT03541369|581573715|FG007|Overall Study|Decision by sponsor|1|||
161050495|NCT03541369|581573716|FG008|Overall Study|Decision by sponsor|2|||
161050496|NCT03541369|581573717|FG009|Overall Study|Decision by sponsor|0|||
161050497|NCT03541369|581573718|FG010|Overall Study|Decision by sponsor|0|||
161050498|NCT03541369|581573719|FG011|Overall Study|Decision by sponsor|0|||
161050499|NCT03541369|581573720|FG012|Overall Study|Decision by sponsor|2|||
161050500|NCT03541369|581573721|FG013|Overall Study|Decision by sponsor|2|||
161050501|NCT03541369|581573722|FG014|Overall Study|Decision by sponsor|0|||
161050502|NCT03541369|581573723|FG015|Overall Study|Decision by sponsor|1|||
161050503|NCT03541369|581573724|FG016|Overall Study|Decision by sponsor|1|||
161050504|NCT03541369|581573725|FG017|Overall Study|Decision by sponsor|1|||
161050505|NCT03541369|581573708|FG000|Overall Study|Withdrawal by Subject|0|||
161050506|NCT03541369|581573709|FG001|Overall Study|Withdrawal by Subject|0|||
161050507|NCT03541369|581573710|FG002|Overall Study|Withdrawal by Subject|0|||
161050508|NCT03541369|581573711|FG003|Overall Study|Withdrawal by Subject|0|||
161050509|NCT03541369|581573712|FG004|Overall Study|Withdrawal by Subject|0|||
161050510|NCT03541369|581573713|FG005|Overall Study|Withdrawal by Subject|0|||
161050511|NCT03541369|581573714|FG006|Overall Study|Withdrawal by Subject|1|||
161050512|NCT03541369|581573715|FG007|Overall Study|Withdrawal by Subject|0|||
161050513|NCT03541369|581573716|FG008|Overall Study|Withdrawal by Subject|0|||
161050514|NCT03541369|581573717|FG009|Overall Study|Withdrawal by Subject|0|||
161050515|NCT03541369|581573718|FG010|Overall Study|Withdrawal by Subject|0|||
161050516|NCT03541369|581573719|FG011|Overall Study|Withdrawal by Subject|1|||
161050517|NCT03541369|581573720|FG012|Overall Study|Withdrawal by Subject|0|||
161050518|NCT03541369|581573721|FG013|Overall Study|Withdrawal by Subject|0|||
161050519|NCT03541369|581573722|FG014|Overall Study|Withdrawal by Subject|3|||
161050520|NCT03541369|581573723|FG015|Overall Study|Withdrawal by Subject|0|||
161050521|NCT03541369|581573724|FG016|Overall Study|Withdrawal by Subject|4|||
161050522|NCT03541369|581573725|FG017|Overall Study|Withdrawal by Subject|2|||
161050523|NCT03541369|581573708|FG000|Overall Study|Lost to Follow-up|0|||
161050524|NCT03541369|581573709|FG001|Overall Study|Lost to Follow-up|0|||
161050525|NCT03541369|581573710|FG002|Overall Study|Lost to Follow-up|0|||
161050526|NCT03541369|581573711|FG003|Overall Study|Lost to Follow-up|0|||
161050527|NCT03541369|581573712|FG004|Overall Study|Lost to Follow-up|1|||
161050528|NCT03541369|581573713|FG005|Overall Study|Lost to Follow-up|0|||
161050529|NCT03541369|581573714|FG006|Overall Study|Lost to Follow-up|0|||
161050530|NCT03541369|581573715|FG007|Overall Study|Lost to Follow-up|0|||
161050531|NCT03541369|581573716|FG008|Overall Study|Lost to Follow-up|1|||
161050532|NCT03541369|581573717|FG009|Overall Study|Lost to Follow-up|0|||
161050533|NCT03541369|581573718|FG010|Overall Study|Lost to Follow-up|0|||
161150943|NCT00798967|581933628|FG000|Overall Study|Adverse Event|2|||
161150944|NCT00798967|581933629|FG001|Overall Study|Adverse Event|3|||
161050534|NCT03541369|581573719|FG011|Overall Study|Lost to Follow-up|0|||
161050535|NCT03541369|581573720|FG012|Overall Study|Lost to Follow-up|1|||
161050536|NCT03541369|581573721|FG013|Overall Study|Lost to Follow-up|0|||
161050537|NCT03541369|581573722|FG014|Overall Study|Lost to Follow-up|0|||
161050538|NCT03541369|581573723|FG015|Overall Study|Lost to Follow-up|0|||
161050539|NCT03541369|581573724|FG016|Overall Study|Lost to Follow-up|0|||
161050540|NCT03541369|581573725|FG017|Overall Study|Lost to Follow-up|0|||
161050541|NCT01856569|581573726|FG000|Overall Study|Other|1|||
161050542|NCT01856569|581573726|FG000|Overall Study|Changed Site/Structure|1|||
161050543|NCT01856569|581573726|FG000|Overall Study|Lost to Follow-up|3|||
161050544|NCT01856569|581573726|FG000|Overall Study|Did not met inclusion criteria|8|||
161050545|NCT00696241|581573727|FG000|Overall Study|Adverse Event|11|||
161050546|NCT00696241|581573728|FG001|Overall Study|Adverse Event|3|||
161345080|NCT03126110|582648854|FG005|Phase 2|Progressive Disease|0|||
161050547|NCT00696241|581573729|FG002|Overall Study|Adverse Event|6|||
161050548|NCT00696241|581573730|FG003|Overall Study|Adverse Event|4|||
161050549|NCT00696241|581573731|FG004|Overall Study|Adverse Event|5|||
161050550|NCT00696241|581573727|FG000|Overall Study|Protocol Violation|1|||
161050551|NCT00696241|581573728|FG001|Overall Study|Protocol Violation|1|||
161050552|NCT00696241|581573729|FG002|Overall Study|Protocol Violation|2|||
161050553|NCT00696241|581573730|FG003|Overall Study|Protocol Violation|0|||
161050554|NCT00696241|581573731|FG004|Overall Study|Protocol Violation|3|||
161050555|NCT00696241|581573727|FG000|Overall Study|Lost to Follow-up|1|||
161050556|NCT00696241|581573728|FG001|Overall Study|Lost to Follow-up|4|||
161050557|NCT00696241|581573729|FG002|Overall Study|Lost to Follow-up|1|||
161050558|NCT00696241|581573730|FG003|Overall Study|Lost to Follow-up|2|||
161050559|NCT00696241|581573731|FG004|Overall Study|Lost to Follow-up|0|||
161050560|NCT00696241|581573727|FG000|Overall Study|Withdrawal by Subject|4|||
161050561|NCT00696241|581573728|FG001|Overall Study|Withdrawal by Subject|8|||
161050562|NCT00696241|581573729|FG002|Overall Study|Withdrawal by Subject|6|||
161050563|NCT00696241|581573730|FG003|Overall Study|Withdrawal by Subject|1|||
161050564|NCT00696241|581573731|FG004|Overall Study|Withdrawal by Subject|0|||
161050565|NCT00696241|581573727|FG000|Overall Study|Lack of Efficacy|1|||
161050566|NCT00696241|581573728|FG001|Overall Study|Lack of Efficacy|5|||
161050567|NCT00696241|581573729|FG002|Overall Study|Lack of Efficacy|4|||
161050568|NCT00696241|581573730|FG003|Overall Study|Lack of Efficacy|5|||
161050569|NCT00696241|581573731|FG004|Overall Study|Lack of Efficacy|3|||
161050570|NCT00696241|581573727|FG000|Overall Study|Other|6|||
161050571|NCT00696241|581573728|FG001|Overall Study|Other|1|||
161050572|NCT00696241|581573729|FG002|Overall Study|Other|5|||
161050573|NCT00696241|581573730|FG003|Overall Study|Other|2|||
161050574|NCT00696241|581573731|FG004|Overall Study|Other|1|||
161050575|NCT04749797|581573733|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
161050576|NCT04749797|581573734|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
161050577|NCT04749797|581573735|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
161050578|NCT02513667|581573736|FG000|Overall Study|Withdrawal by Subject|0|||
161050579|NCT02513667|581573737|FG001|Overall Study|Withdrawal by Subject|1|||
161050580|NCT00871715|581573742|FG000|Overall Study|Withdrawal by Subject|6|||
161050581|NCT00871715|581573743|FG001|Overall Study|Withdrawal by Subject|10|||
161050582|NCT00871715|581573744|FG002|Overall Study|Withdrawal by Subject|15|||
161050583|NCT00871715|581573742|FG000|Overall Study|Physician Decision|6|||
161050584|NCT00871715|581573743|FG001|Overall Study|Physician Decision|0|||
161050585|NCT00871715|581573744|FG002|Overall Study|Physician Decision|2|||
161050586|NCT00871715|581573742|FG000|Overall Study|Lost to Follow-up|3|||
161050587|NCT00871715|581573743|FG001|Overall Study|Lost to Follow-up|6|||
161050588|NCT00871715|581573744|FG002|Overall Study|Lost to Follow-up|9|||
161050589|NCT02291549|581573745|FG000|Overall Study|Lost to Follow-up|1|||
161050590|NCT02291549|581573746|FG001|Overall Study|Lost to Follow-up|0|||
161050591|NCT02291549|581573745|FG000|Overall Study|Withdrawal by Subject|0|||
161050592|NCT02291549|581573746|FG001|Overall Study|Withdrawal by Subject|1|||
161050593|NCT00537914|581573747|FG000|Overall Study|Death|1|||
161050594|NCT00537914|581573747|FG000|Overall Study|Adverse Event|7|||
161050595|NCT00537914|581573747|FG000|Overall Study|Treatment failure|10|||
161050596|NCT00537914|581573747|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
161050597|NCT00537914|581573747|FG000|Overall Study|Lost to Follow-up|19|||
161050598|NCT00537914|581573747|FG000|Overall Study|Withdrawal of informed consent|59|||
161050599|NCT01147471|581573751|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
161050600|NCT01147471|581573752|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
161050601|NCT01147471|581573751|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
161050602|NCT01147471|581573752|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
161050603|NCT01147471|581573751|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
161050604|NCT01147471|581573752|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
161050605|NCT01147471|581573751|FG000|3 Month Follow Up|Lost to Follow-up|1|||
161050606|NCT01147471|581573752|FG001|3 Month Follow Up|Lost to Follow-up|1|||
161050607|NCT01147471|581573751|FG000|3 Month Follow Up|Physician Decision|0|||
161050608|NCT01147471|581573752|FG001|3 Month Follow Up|Physician Decision|1|||
161050609|NCT01147471|581573751|FG000|6 Month Follow Up|Lost to Follow-up|4|||
161050610|NCT01147471|581573752|FG001|6 Month Follow Up|Lost to Follow-up|2|||
161050611|NCT01229176|581573753|FG000|Overall Study|Withdrawal by Subject|0|||
161050612|NCT01229176|581573754|FG001|Overall Study|Withdrawal by Subject|0|||
161050613|NCT01229176|581573755|FG002|Overall Study|Withdrawal by Subject|0|||
161050614|NCT01229176|581573756|FG003|Overall Study|Withdrawal by Subject|1|||
161050615|NCT01229176|581573757|FG004|Overall Study|Withdrawal by Subject|1|||
161050616|NCT01229176|581573758|FG005|Overall Study|Withdrawal by Subject|1|||
161050617|NCT01229176|581573759|FG006|Overall Study|Withdrawal by Subject|0|||
161345081|NCT03126110|582648855|FG006|Phase 2|Progressive Disease|0|||
161050618|NCT01229176|581573760|FG007|Overall Study|Withdrawal by Subject|1|||
161050619|NCT01229176|581573753|FG000|Overall Study|Lost to Follow-up|0|||
161050620|NCT01229176|581573754|FG001|Overall Study|Lost to Follow-up|3|||
161050621|NCT01229176|581573755|FG002|Overall Study|Lost to Follow-up|0|||
161050622|NCT01229176|581573756|FG003|Overall Study|Lost to Follow-up|0|||
161050623|NCT01229176|581573757|FG004|Overall Study|Lost to Follow-up|1|||
161050624|NCT01229176|581573758|FG005|Overall Study|Lost to Follow-up|1|||
161050625|NCT01229176|581573759|FG006|Overall Study|Lost to Follow-up|0|||
161050626|NCT01229176|581573760|FG007|Overall Study|Lost to Follow-up|2|||
161050627|NCT02367794|581573761|FG000|Overall Study|Death|252|||
161050628|NCT02367794|581573762|FG001|Overall Study|Death|245|||
161150945|NCT00798967|581933628|FG000|Overall Study|Withdrawal by Subject|0|||
161150946|NCT00798967|581933629|FG001|Overall Study|Withdrawal by Subject|1|||
161150947|NCT00798967|581933628|FG000|Overall Study|Physician Decision|1|||
161150948|NCT00798967|581933629|FG001|Overall Study|Physician Decision|0|||
161150949|NCT00798967|581933628|FG000|Overall Study|Randomized in error by site|1|||
161150950|NCT00798967|581933629|FG001|Overall Study|Randomized in error by site|0|||
161150951|NCT01415440|581933630|FG000|Overall Study|Lost to Follow-up|0|||
161150952|NCT01415440|581933631|FG001|Overall Study|Lost to Follow-up|1|||
161150953|NCT01415440|581933632|FG002|Overall Study|Lost to Follow-up|2|||
161150954|NCT01415440|581933630|FG000|Overall Study|Physician Decision|3|||
161150955|NCT01415440|581933631|FG001|Overall Study|Physician Decision|0|||
161150956|NCT01415440|581933632|FG002|Overall Study|Physician Decision|0|||
161150957|NCT01415440|581933630|FG000|Overall Study|Withdrawal by Subject|1|||
161150958|NCT01415440|581933631|FG001|Overall Study|Withdrawal by Subject|0|||
161150959|NCT01415440|581933632|FG002|Overall Study|Withdrawal by Subject|0|||
161150960|NCT01781026|581933635|FG000|Overall Study|Lack of Efficacy|2|||
161150961|NCT03090737|581933636|FG000|Overall Study|Other reasons|1|||
161150962|NCT03090737|581933636|FG000|Overall Study|Completed treatment as per protocol|17|||
161150963|NCT03090737|581933636|FG000|Overall Study|Maximum clinical benefit|2|||
161150964|NCT03090737|581933636|FG000|Overall Study|Adverse event unrelated to study drug|7|||
161150965|NCT03090737|581933636|FG000|Overall Study|Study drug toxicity|4|||
161150966|NCT03090737|581933636|FG000|Overall Study|Disease progression|98|||
161150967|NCT03141307|581933637|FG000|In-Hospital|Withdrawal by Subject|0|||
161150968|NCT03141307|581933638|FG001|In-Hospital|Withdrawal by Subject|2|||
161150969|NCT03141307|581933637|FG000|In-Hospital|Protocol Violation|4|||
161150970|NCT03141307|581933638|FG001|In-Hospital|Protocol Violation|0|||
161150971|NCT03141307|581933637|FG000|Follow-Up|Lost to Follow-up|97|||
161150972|NCT03141307|581933638|FG001|Follow-Up|Lost to Follow-up|54|||
161150973|NCT00227877|581933639|FG000|Pre-visit Assessment|Technical difficulties|7|||
161150974|NCT00227877|581933640|FG001|Pre-visit Assessment|Technical difficulties|3|||
161150975|NCT00227877|581933641|FG002|Pre-visit Assessment|Technical difficulties|0|||
161150976|NCT00227877|581933642|FG003|Pre-visit Assessment|Technical difficulties|0|||
161150977|NCT00227877|581933639|FG000|Post-visit Checklist|Lost to Follow-up|24|||
161150978|NCT00227877|581933640|FG001|Post-visit Checklist|Lost to Follow-up|13|||
161150979|NCT00227877|581933641|FG002|Post-visit Checklist|Lost to Follow-up|1|||
161150980|NCT00227877|581933642|FG003|Post-visit Checklist|Lost to Follow-up|0|||
161150981|NCT00227877|581933639|FG000|3-months Follow-up|Completed late|135|||
161150982|NCT00227877|581933640|FG001|3-months Follow-up|Completed late|128|||
161150983|NCT00227877|581933641|FG002|3-months Follow-up|Completed late|34|||
161150984|NCT00227877|581933642|FG003|3-months Follow-up|Completed late|8|||
161150985|NCT00227877|581933639|FG000|3-months Follow-up|Lost to Follow-up|178|||
161150986|NCT00227877|581933640|FG001|3-months Follow-up|Lost to Follow-up|139|||
161150987|NCT00227877|581933641|FG002|3-months Follow-up|Lost to Follow-up|18|||
161150988|NCT00227877|581933642|FG003|3-months Follow-up|Lost to Follow-up|13|||
161150989|NCT00227877|581933639|FG000|12-months Follow-up|Completed late|78|||
161150990|NCT00227877|581933640|FG001|12-months Follow-up|Completed late|74|||
161150991|NCT00227877|581933641|FG002|12-months Follow-up|Completed late|1|||
161150992|NCT00227877|581933642|FG003|12-months Follow-up|Completed late|0|||
161280964|NCT00996892|582407021|FG019|Expansion Stage 2|Physician Decision|0|||
161280965|NCT00996892|582407002|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
161280966|NCT00996892|582407003|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
161280967|NCT00996892|582407004|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
161280968|NCT00996892|582407005|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
161280969|NCT00996892|582407006|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
161280970|NCT00996892|582407007|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
161280971|NCT00996892|582407008|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
161280972|NCT00996892|582407009|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
161280973|NCT00996892|582407010|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
161280974|NCT00996892|582407011|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
161150993|NCT00227877|581933639|FG000|12-months Follow-up|Lost to Follow-up|232|||
161280975|NCT00996892|582407012|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
161150994|NCT00227877|581933640|FG001|12-months Follow-up|Lost to Follow-up|189|||
161150995|NCT00227877|581933641|FG002|12-months Follow-up|Lost to Follow-up|30|||
161150996|NCT00227877|581933642|FG003|12-months Follow-up|Lost to Follow-up|26|||
161150997|NCT03596177|581933645|FG000|Single Blind Period|Withdrawal by Subject|1|||
161150998|NCT03596177|581933646|FG001|Single Blind Period|Withdrawal by Subject|1|||
161150999|NCT03596177|581933645|FG000|Single Blind Period|Other|1|||
161151000|NCT03596177|581933646|FG001|Single Blind Period|Other|0|||
161151001|NCT03596177|581933645|FG000|Double Blind Period|Withdrawal by Subject|0|||
161151002|NCT03596177|581933646|FG001|Double Blind Period|Withdrawal by Subject|1|||
161151003|NCT03596177|581933645|FG000|Double Blind Period|Other|0|||
161151004|NCT03596177|581933646|FG001|Double Blind Period|Other|4|||
161151005|NCT03596177|581933645|FG000|Double Blind Period|Death during safety follow-up|0|||
161151006|NCT03596177|581933646|FG001|Double Blind Period|Death during safety follow-up|1|||
161280976|NCT00996892|582407013|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
161280977|NCT00996892|582407014|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
161280978|NCT00996892|582407015|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
161050629|NCT02367794|581573763|FG002|Overall Study|Death|243|||
161050630|NCT02367794|581573761|FG000|Overall Study|Lost to Follow-up|1|||
161050631|NCT02367794|581573762|FG001|Overall Study|Lost to Follow-up|2|||
161050632|NCT02367794|581573763|FG002|Overall Study|Lost to Follow-up|2|||
161050633|NCT02367794|581573761|FG000|Overall Study|Physician Decision|0|||
161050634|NCT02367794|581573762|FG001|Overall Study|Physician Decision|5|||
161050635|NCT02367794|581573763|FG002|Overall Study|Physician Decision|3|||
161050636|NCT02367794|581573761|FG000|Overall Study|Protocol Violation|1|||
161050637|NCT02367794|581573762|FG001|Overall Study|Protocol Violation|0|||
161050638|NCT02367794|581573763|FG002|Overall Study|Protocol Violation|1|||
161050639|NCT02367794|581573761|FG000|Overall Study|Withdrawal by Subject|25|||
161050640|NCT02367794|581573762|FG001|Overall Study|Withdrawal by Subject|12|||
161050641|NCT02367794|581573763|FG002|Overall Study|Withdrawal by Subject|20|||
161050642|NCT02367794|581573761|FG000|Overall Study|Brain metastasis|1|||
161050643|NCT02367794|581573762|FG001|Overall Study|Brain metastasis|0|||
161050644|NCT02367794|581573763|FG002|Overall Study|Brain metastasis|0|||
161050645|NCT02367794|581573761|FG000|Overall Study|Randomized in error|0|||
161050646|NCT02367794|581573762|FG001|Overall Study|Randomized in error|0|||
161050647|NCT02367794|581573763|FG002|Overall Study|Randomized in error|1|||
161050648|NCT02367794|581573761|FG000|Overall Study|Patient unable to receive carboplatin|0|||
161050649|NCT02367794|581573762|FG001|Overall Study|Patient unable to receive carboplatin|0|||
161050650|NCT02367794|581573763|FG002|Overall Study|Patient unable to receive carboplatin|1|||
161050651|NCT02367794|581573761|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
161050652|NCT02367794|581573762|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
161050653|NCT02367794|581573763|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
161050654|NCT02367794|581573761|FG000|Overall Study|Adverse Event|0|||
161050655|NCT02367794|581573762|FG001|Overall Study|Adverse Event|0|||
161050656|NCT02367794|581573763|FG002|Overall Study|Adverse Event|2|||
161050657|NCT02367794|581573761|FG000|Overall Study|Study Terminated By Sponsor|0|||
161050658|NCT02367794|581573762|FG001|Overall Study|Study Terminated By Sponsor|1|||
161050659|NCT02367794|581573763|FG002|Overall Study|Study Terminated By Sponsor|1|||
161050660|NCT02367794|581573761|FG000|Overall Study|Moved to Roll-Over Study|0|||
161050661|NCT02367794|581573762|FG001|Overall Study|Moved to Roll-Over Study|15|||
161050662|NCT02367794|581573763|FG002|Overall Study|Moved to Roll-Over Study|13|||
161050663|NCT02367794|581573761|FG000|Overall Study|Sponsor Request|60|||
161050664|NCT02367794|581573762|FG001|Overall Study|Sponsor Request|57|||
161050665|NCT02367794|581573763|FG002|Overall Study|Sponsor Request|45|||
161050666|NCT02367794|581573761|FG000|Overall Study|Moved into PTAP Study|0|||
161050667|NCT02367794|581573762|FG001|Overall Study|Moved into PTAP Study|2|||
161050668|NCT02367794|581573763|FG002|Overall Study|Moved into PTAP Study|3|||
161050669|NCT02367794|581573761|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
161050670|NCT02367794|581573762|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
161050671|NCT02367794|581573763|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
161050672|NCT02367794|581573761|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
161050673|NCT02367794|581573762|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
161050674|NCT02367794|581573763|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
161050675|NCT02367794|581573761|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
161050676|NCT02367794|581573762|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
161050677|NCT02367794|581573763|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
161050678|NCT02367794|581573761|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
161050679|NCT02367794|581573762|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
161050680|NCT02367794|581573763|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
161050681|NCT01986348|581573764|FG000|Overall Study|Death|8|||
161050682|NCT01986348|581573765|FG001|Overall Study|Death|22|||
161050683|NCT01986348|581573766|FG002|Overall Study|Death|10|||
161050684|NCT01986348|581573767|FG003|Overall Study|Death|21|||
161050685|NCT01986348|581573764|FG000|Overall Study|Lost to Follow-up|0|||
161050686|NCT01986348|581573765|FG001|Overall Study|Lost to Follow-up|0|||
161050687|NCT01986348|581573766|FG002|Overall Study|Lost to Follow-up|0|||
161050688|NCT01986348|581573767|FG003|Overall Study|Lost to Follow-up|2|||
161050689|NCT01986348|581573764|FG000|Overall Study|Physician Decision|0|||
161050690|NCT01986348|581573765|FG001|Overall Study|Physician Decision|0|||
161050691|NCT01986348|581573766|FG002|Overall Study|Physician Decision|0|||
161050692|NCT01986348|581573767|FG003|Overall Study|Physician Decision|1|||
161050693|NCT01986348|581573764|FG000|Overall Study|Progressive Disease|0|||
161050694|NCT01986348|581573765|FG001|Overall Study|Progressive Disease|0|||
161050695|NCT01986348|581573766|FG002|Overall Study|Progressive Disease|2|||
161050696|NCT01986348|581573767|FG003|Overall Study|Progressive Disease|0|||
161050697|NCT01986348|581573764|FG000|Overall Study|Withdrawal by Participant|0|||
161050698|NCT01986348|581573765|FG001|Overall Study|Withdrawal by Participant|1|||
161050699|NCT01986348|581573766|FG002|Overall Study|Withdrawal by Participant|2|||
161050700|NCT01986348|581573767|FG003|Overall Study|Withdrawal by Participant|1|||
161050701|NCT01986348|581573764|FG000|Overall Study|Study Terminated by Sponsor|0|||
161050702|NCT01986348|581573765|FG001|Overall Study|Study Terminated by Sponsor|0|||
161050703|NCT01986348|581573766|FG002|Overall Study|Study Terminated by Sponsor|0|||
161345082|NCT03126110|582648856|FG007|Phase 2|Progressive Disease|0|||
161050704|NCT01986348|581573767|FG003|Overall Study|Study Terminated by Sponsor|3|||
161050705|NCT01986348|581573764|FG000|Overall Study|Other-unspecified|0|||
161050706|NCT01986348|581573765|FG001|Overall Study|Other-unspecified|1|||
161050707|NCT01986348|581573766|FG002|Overall Study|Other-unspecified|0|||
161050708|NCT01986348|581573767|FG003|Overall Study|Other-unspecified|2|||
161050709|NCT02010684|581573768|FG000|Overall Study|Lost to Follow-up|8|||
161050710|NCT02010684|581573769|FG001|Overall Study|Lost to Follow-up|18|||
161050711|NCT02010684|581573768|FG000|Overall Study|Withdrawal by Subject|4|||
161050712|NCT02010684|581573769|FG001|Overall Study|Withdrawal by Subject|5|||
161050713|NCT02942771|581573775|FG000|Overall Study|Adverse Event|1|||
161050714|NCT02942771|581573776|FG001|Overall Study|Adverse Event|0|||
161050715|NCT02942771|581573777|FG002|Overall Study|Adverse Event|0|||
161050716|NCT02942771|581573778|FG003|Overall Study|Adverse Event|0|||
161050717|NCT02942771|581573779|FG004|Overall Study|Adverse Event|2|||
161050718|NCT02942771|581573775|FG000|Overall Study|Lost to Follow-up|1|||
161050719|NCT02942771|581573776|FG001|Overall Study|Lost to Follow-up|0|||
161050720|NCT02942771|581573777|FG002|Overall Study|Lost to Follow-up|0|||
161050721|NCT02942771|581573778|FG003|Overall Study|Lost to Follow-up|0|||
161050722|NCT02942771|581573779|FG004|Overall Study|Lost to Follow-up|0|||
161050723|NCT02942771|581573775|FG000|Overall Study|Withdrawal by Subject|1|||
161050724|NCT02942771|581573776|FG001|Overall Study|Withdrawal by Subject|0|||
161050725|NCT02942771|581573777|FG002|Overall Study|Withdrawal by Subject|0|||
161050726|NCT02942771|581573778|FG003|Overall Study|Withdrawal by Subject|0|||
161050727|NCT02942771|581573779|FG004|Overall Study|Withdrawal by Subject|2|||
161050728|NCT02158806|581573780|FG000|Overall Study|Death|2|||
161050729|NCT02158806|581573781|FG001|Overall Study|Death|0|||
161050730|NCT02158806|581573780|FG000|Overall Study|Withdrawal by Subject|2|||
161050731|NCT02158806|581573781|FG001|Overall Study|Withdrawal by Subject|0|||
161050732|NCT02158806|581573780|FG000|Overall Study|Lost to Follow-up|0|||
161050733|NCT02158806|581573781|FG001|Overall Study|Lost to Follow-up|3|||
161050734|NCT02158806|581573780|FG000|Overall Study|Moved out of area|0|||
161050735|NCT02158806|581573781|FG001|Overall Study|Moved out of area|1|||
161050736|NCT02158806|581573780|FG000|Overall Study|Transferred to palliative care|0|||
161050737|NCT02158806|581573781|FG001|Overall Study|Transferred to palliative care|1|||
161050738|NCT01898299|581573782|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
161050739|NCT01898299|581573783|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
161050740|NCT02340806|581573787|FG000|Overall Study|Protocol Violation|2|||
161050741|NCT02340806|581573788|FG001|Overall Study|Protocol Violation|0|||
161280979|NCT00996892|582407016|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
161280980|NCT00996892|582407017|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
161280981|NCT00996892|582407018|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
161280982|NCT00996892|582407019|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
161280983|NCT00996892|582407020|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
161280984|NCT00996892|582407021|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
161050742|NCT02340806|581573787|FG000|Overall Study|epidural catheter replaced|2|||
161050743|NCT02340806|581573788|FG001|Overall Study|epidural catheter replaced|1|||
161050744|NCT02340806|581573787|FG000|Overall Study|history of chronic pain medication|1|||
161050745|NCT02340806|581573788|FG001|Overall Study|history of chronic pain medication|0|||
161050746|NCT02340806|581573787|FG000|Overall Study|re-dose < 90 min of CSE|1|||
161050747|NCT02340806|581573788|FG001|Overall Study|re-dose < 90 min of CSE|3|||
161050748|NCT01186809|581573789|FG000|Overall Study|Death|30|||
161050749|NCT01159600|581573790|FG000|Overall Study|Not treated|0|||
161050750|NCT01159600|581573791|FG001|Overall Study|Not treated|0|||
161050751|NCT01159600|581573792|FG002|Overall Study|Not treated|1|||
161050752|NCT01159600|581573793|FG003|Overall Study|Not treated|0|||
161050753|NCT01159600|581573794|FG004|Overall Study|Not treated|0|||
161050754|NCT01159600|581573795|FG005|Overall Study|Not treated|1|||
161050755|NCT01159600|581573796|FG006|Overall Study|Not treated|2|||
161050756|NCT01159600|581573797|FG007|Overall Study|Not treated|2|||
161050757|NCT01159600|581573790|FG000|Overall Study|Adverse Event|7|||
161050758|NCT01159600|581573791|FG001|Overall Study|Adverse Event|2|||
161050759|NCT01159600|581573792|FG002|Overall Study|Adverse Event|5|||
161050760|NCT01159600|581573793|FG003|Overall Study|Adverse Event|1|||
161050761|NCT01159600|581573794|FG004|Overall Study|Adverse Event|8|||
161050762|NCT01159600|581573795|FG005|Overall Study|Adverse Event|6|||
161050763|NCT01159600|581573796|FG006|Overall Study|Adverse Event|7|||
161050764|NCT01159600|581573797|FG007|Overall Study|Adverse Event|5|||
161050765|NCT01159600|581573790|FG000|Overall Study|Lack of Efficacy|0|||
161280985|NCT00996892|582407002|FG000|Expansion Stage 2|Disease Progression|0|||
161050766|NCT01159600|581573791|FG001|Overall Study|Lack of Efficacy|0|||
161050767|NCT01159600|581573792|FG002|Overall Study|Lack of Efficacy|0|||
161050768|NCT01159600|581573793|FG003|Overall Study|Lack of Efficacy|0|||
161050769|NCT01159600|581573794|FG004|Overall Study|Lack of Efficacy|2|||
161050770|NCT01159600|581573795|FG005|Overall Study|Lack of Efficacy|0|||
161050771|NCT01159600|581573796|FG006|Overall Study|Lack of Efficacy|0|||
161050772|NCT01159600|581573797|FG007|Overall Study|Lack of Efficacy|1|||
161050773|NCT01159600|581573790|FG000|Overall Study|Non compliant with protocol|2|||
161050774|NCT01159600|581573791|FG001|Overall Study|Non compliant with protocol|1|||
161050775|NCT01159600|581573792|FG002|Overall Study|Non compliant with protocol|0|||
161050776|NCT01159600|581573793|FG003|Overall Study|Non compliant with protocol|0|||
161050777|NCT01159600|581573794|FG004|Overall Study|Non compliant with protocol|2|||
161050778|NCT01159600|581573795|FG005|Overall Study|Non compliant with protocol|0|||
161050779|NCT01159600|581573796|FG006|Overall Study|Non compliant with protocol|2|||
161050780|NCT01159600|581573797|FG007|Overall Study|Non compliant with protocol|0|||
161050781|NCT01159600|581573790|FG000|Overall Study|Lost to Follow-up|2|||
161050782|NCT01159600|581573791|FG001|Overall Study|Lost to Follow-up|3|||
161050783|NCT01159600|581573792|FG002|Overall Study|Lost to Follow-up|4|||
161050784|NCT01159600|581573793|FG003|Overall Study|Lost to Follow-up|3|||
161050785|NCT01159600|581573794|FG004|Overall Study|Lost to Follow-up|3|||
161050786|NCT01159600|581573795|FG005|Overall Study|Lost to Follow-up|0|||
160977712|NCT01051063|581308029|FG001|Overall Study|Termination of the study|0|||
160977713|NCT01051063|581308028|FG000|Overall Study|Moved from the study site area|1|||
160977714|NCT01051063|581308029|FG001|Overall Study|Moved from the study site area|0|||
160977715|NCT01051063|581308028|FG000|Overall Study|Other|1|||
161050787|NCT01159600|581573796|FG006|Overall Study|Lost to Follow-up|3|||
161050788|NCT01159600|581573797|FG007|Overall Study|Lost to Follow-up|2|||
161050789|NCT01159600|581573790|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
161050790|NCT01159600|581573791|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
161050791|NCT01159600|581573792|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
161050792|NCT01159600|581573793|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
161050793|NCT01159600|581573794|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
161050794|NCT01159600|581573795|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
161050795|NCT01159600|581573796|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
161050796|NCT01159600|581573797|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
161050797|NCT01159600|581573790|FG000|Overall Study|Other reason not defined above|3|||
161050798|NCT01159600|581573791|FG001|Overall Study|Other reason not defined above|0|||
161050799|NCT01159600|581573792|FG002|Overall Study|Other reason not defined above|4|||
161050800|NCT01159600|581573793|FG003|Overall Study|Other reason not defined above|2|||
161050801|NCT01159600|581573794|FG004|Overall Study|Other reason not defined above|5|||
161050802|NCT01159600|581573795|FG005|Overall Study|Other reason not defined above|7|||
161050803|NCT01159600|581573796|FG006|Overall Study|Other reason not defined above|3|||
161050804|NCT01159600|581573797|FG007|Overall Study|Other reason not defined above|3|||
161050805|NCT05356130|581575200|FG000|Overall Study|Withdrawal by Subject|0|||
161050806|NCT05356130|581575201|FG001|Overall Study|Withdrawal by Subject|0|||
161050807|NCT05356130|581575202|FG002|Overall Study|Withdrawal by Subject|3|||
161050808|NCT04820023|581575205|FG000|Overall Study|Death|0|||
161050809|NCT04820023|581575206|FG001|Overall Study|Death|0|||
161050810|NCT04820023|581575207|FG002|Overall Study|Death|0|||
161050811|NCT04820023|581575208|FG003|Overall Study|Death|0|||
161050812|NCT04820023|581575209|FG004|Overall Study|Death|0|||
161050813|NCT04820023|581575210|FG005|Overall Study|Death|0|||
161050814|NCT04820023|581575211|FG006|Overall Study|Death|1|||
161050815|NCT04820023|581575212|FG007|Overall Study|Death|0|||
161050816|NCT04820023|581575213|FG008|Overall Study|Death|1|||
161050817|NCT04820023|581575205|FG000|Overall Study|Withdrawal by Subject|1|||
161050818|NCT04820023|581575206|FG001|Overall Study|Withdrawal by Subject|2|||
161050819|NCT04820023|581575207|FG002|Overall Study|Withdrawal by Subject|2|||
161050820|NCT04820023|581575208|FG003|Overall Study|Withdrawal by Subject|1|||
161050821|NCT04820023|581575209|FG004|Overall Study|Withdrawal by Subject|4|||
161050822|NCT04820023|581575210|FG005|Overall Study|Withdrawal by Subject|3|||
161050823|NCT04820023|581575211|FG006|Overall Study|Withdrawal by Subject|3|||
161050824|NCT04820023|581575212|FG007|Overall Study|Withdrawal by Subject|6|||
161050825|NCT04820023|581575213|FG008|Overall Study|Withdrawal by Subject|5|||
161050826|NCT04820023|581575205|FG000|Overall Study|Progressive Disease|3|||
161050827|NCT04820023|581575206|FG001|Overall Study|Progressive Disease|0|||
161050828|NCT04820023|581575207|FG002|Overall Study|Progressive Disease|2|||
161050829|NCT04820023|581575208|FG003|Overall Study|Progressive Disease|2|||
161050830|NCT04820023|581575209|FG004|Overall Study|Progressive Disease|2|||
161050831|NCT04820023|581575210|FG005|Overall Study|Progressive Disease|0|||
161050832|NCT04820023|581575211|FG006|Overall Study|Progressive Disease|1|||
161050833|NCT04820023|581575212|FG007|Overall Study|Progressive Disease|1|||
161280986|NCT00996892|582407003|FG001|Expansion Stage 2|Disease Progression|0|||
161280987|NCT00996892|582407004|FG002|Expansion Stage 2|Disease Progression|0|||
161280988|NCT00996892|582407005|FG003|Expansion Stage 2|Disease Progression|0|||
161050834|NCT04820023|581575213|FG008|Overall Study|Progressive Disease|0|||
161050835|NCT04820023|581575205|FG000|Overall Study|New anti-cancer therapy|0|||
161280989|NCT00996892|582407006|FG004|Expansion Stage 2|Disease Progression|0|||
160977716|NCT01051063|581308029|FG001|Overall Study|Other|0|||
160977717|NCT01051063|581308028|FG000|Overall Study|Lost to Follow-up|0|||
160977718|NCT01051063|581308029|FG001|Overall Study|Lost to Follow-up|1|||
160977719|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
160977720|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
160977721|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
160977722|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
161050836|NCT04820023|581575206|FG001|Overall Study|New anti-cancer therapy|0|||
161050837|NCT04820023|581575207|FG002|Overall Study|New anti-cancer therapy|0|||
161050838|NCT04820023|581575208|FG003|Overall Study|New anti-cancer therapy|0|||
161050839|NCT04820023|581575209|FG004|Overall Study|New anti-cancer therapy|2|||
161050840|NCT04820023|581575210|FG005|Overall Study|New anti-cancer therapy|0|||
161050841|NCT04820023|581575211|FG006|Overall Study|New anti-cancer therapy|0|||
161050842|NCT04820023|581575212|FG007|Overall Study|New anti-cancer therapy|0|||
161050843|NCT04820023|581575213|FG008|Overall Study|New anti-cancer therapy|0|||
161050844|NCT04820023|581575205|FG000|Overall Study|Other|0|||
161050845|NCT04820023|581575206|FG001|Overall Study|Other|1|||
161050846|NCT04820023|581575207|FG002|Overall Study|Other|0|||
161050847|NCT04820023|581575208|FG003|Overall Study|Other|0|||
161050848|NCT04820023|581575209|FG004|Overall Study|Other|0|||
161050849|NCT04820023|581575210|FG005|Overall Study|Other|0|||
161050850|NCT04820023|581575211|FG006|Overall Study|Other|0|||
161050851|NCT04820023|581575212|FG007|Overall Study|Other|2|||
161050852|NCT04820023|581575213|FG008|Overall Study|Other|0|||
161050853|NCT02109172|581575224|FG000|Overall Study|Withdrawal by Subject|1|||
161050854|NCT02109172|581575225|FG001|Overall Study|Withdrawal by Subject|0|||
161050855|NCT02109172|581575226|FG002|Overall Study|Withdrawal by Subject|0|||
161050856|NCT02109172|581575227|FG003|Overall Study|Withdrawal by Subject|1|||
161050857|NCT02109172|581575228|FG004|Overall Study|Withdrawal by Subject|0|||
161050858|NCT02109172|581575229|FG005|Overall Study|Withdrawal by Subject|0|||
161050859|NCT02109172|581575224|FG000|Overall Study|Adverse Event|0|||
161050860|NCT02109172|581575225|FG001|Overall Study|Adverse Event|0|||
161050861|NCT02109172|581575226|FG002|Overall Study|Adverse Event|1|||
161050862|NCT02109172|581575227|FG003|Overall Study|Adverse Event|0|||
160977723|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
160977724|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
160977725|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
160977726|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
160977727|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
160977728|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
160977729|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
160977730|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
160977731|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
160977732|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
160977733|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
160977734|NCT02023879|581308032|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
160977735|NCT02023879|581308033|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
160977736|NCT02023879|581308034|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
160977737|NCT02023879|581308032|FG000|Extension Open Label Treatment|Adverse Event|1|||
160977738|NCT02023879|581308033|FG001|Extension Open Label Treatment|Adverse Event|7|||
160977739|NCT02023879|581308034|FG002|Extension Open Label Treatment|Adverse Event|3|||
160977740|NCT02023879|581308032|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
160977741|NCT02023879|581308033|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
160977742|NCT02023879|581308034|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
161050863|NCT02109172|581575228|FG004|Overall Study|Adverse Event|0|||
161050864|NCT02109172|581575229|FG005|Overall Study|Adverse Event|1|||
161050865|NCT02109172|581575224|FG000|Overall Study|Death|0|||
161050866|NCT02109172|581575225|FG001|Overall Study|Death|0|||
161050867|NCT02109172|581575226|FG002|Overall Study|Death|0|||
161151007|NCT04083222|581933649|FG000|Overall Study|Voluntary Withdrawal|0|||
160977743|NCT02023879|581308032|FG000|Extension Open Label Treatment|Participant moved|1|||
160977744|NCT02023879|581308033|FG001|Extension Open Label Treatment|Participant moved|2|||
160977745|NCT02023879|581308034|FG002|Extension Open Label Treatment|Participant moved|0|||
161050868|NCT02109172|581575227|FG003|Overall Study|Death|0|||
161050869|NCT02109172|581575228|FG004|Overall Study|Death|1|||
161050870|NCT02109172|581575229|FG005|Overall Study|Death|0|||
161050871|NCT00538629|581575232|FG000|Overall Study|At subject's request|1|||
161050872|NCT00538629|581575232|FG000|Overall Study|Adverse Event|2|||
161050873|NCT00538629|581575232|FG000|Overall Study|Lack of Efficacy|12|||
161151008|NCT04083222|581933650|FG001|Overall Study|Voluntary Withdrawal|1|||
161151009|NCT04083222|581933649|FG000|Overall Study|Reason not Specified|0|||
160977746|NCT02023879|581308032|FG000|Extension Open Label Treatment|Other than specified above|2|||
161050874|NCT00538629|581575232|FG000|Overall Study|Lost to Follow-up|6|||
161050875|NCT00538629|581575232|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
161050876|NCT01922102|581575233|FG000|Overall Study|Withdrawal by Subject|7|||
161050877|NCT01922102|581575234|FG001|Overall Study|Withdrawal by Subject|3|||
161050878|NCT01922102|581575235|FG002|Overall Study|Withdrawal by Subject|7|||
161050879|NCT01922102|581575233|FG000|Overall Study|Physician Decision|0|||
161050880|NCT01922102|581575234|FG001|Overall Study|Physician Decision|2|||
161050881|NCT01922102|581575235|FG002|Overall Study|Physician Decision|1|||
161280990|NCT00996892|582407007|FG005|Expansion Stage 2|Disease Progression|0|||
161280991|NCT00996892|582407008|FG006|Expansion Stage 2|Disease Progression|0|||
161050882|NCT01922102|581575233|FG000|Overall Study|Adverse Event|1|||
161050883|NCT01922102|581575234|FG001|Overall Study|Adverse Event|2|||
161050884|NCT01922102|581575235|FG002|Overall Study|Adverse Event|0|||
161050885|NCT01922102|581575233|FG000|Overall Study|Lost to Follow-up|1|||
161050886|NCT01922102|581575234|FG001|Overall Study|Lost to Follow-up|0|||
161050887|NCT01922102|581575235|FG002|Overall Study|Lost to Follow-up|0|||
161050888|NCT01922102|581575233|FG000|Overall Study|Administrative problems|0|||
161050889|NCT01922102|581575234|FG001|Overall Study|Administrative problems|2|||
161050890|NCT01922102|581575235|FG002|Overall Study|Administrative problems|0|||
161050891|NCT05203822|581575236|FG000|Overall Study|Adverse Event|1|||
161050892|NCT05203822|581575236|FG000|Overall Study|Withdrawal by Subject|1|||
161050893|NCT01816165|581575243|FG000|Overall Study|Adverse Event|1|||
161050894|NCT01816165|581575244|FG001|Overall Study|Adverse Event|0|||
161050895|NCT01816165|581575245|FG002|Overall Study|Adverse Event|0|||
161050896|NCT01816165|581575246|FG003|Overall Study|Adverse Event|0|||
161050897|NCT00447499|581575247|FG000|Overall Study|Adverse Event|1|||
161050898|NCT00447499|581575247|FG000|Overall Study|Patient Decision|4|||
161050899|NCT00447499|581575247|FG000|Overall Study|Sponsor Decision|1|||
161050900|NCT00447499|581575247|FG000|Overall Study|Physician Decision|1|||
161050901|NCT03360071|581575249|FG000|Overall Study|Lost to Follow-up|1|||
161050902|NCT03360071|581575250|FG001|Overall Study|Lost to Follow-up|0|||
161050903|NCT03184519|581575259|FG000|Overall Study|Lost to Follow-up|6|||
161050904|NCT03184519|581575259|FG000|Overall Study|Physician Decision|21|||
161050905|NCT02823574|581575263|FG000|Randomization|Disease Progression|0|||
161050906|NCT02823574|581575264|FG001|Randomization|Disease Progression|0|||
161050907|NCT02823574|581575265|FG002|Randomization|Disease Progression|1|||
161050908|NCT02823574|581575266|FG003|Randomization|Disease Progression|0|||
161050909|NCT02823574|581575263|FG000|Randomization|AE unrelated to Study Drug|1|||
161050910|NCT02823574|581575264|FG001|Randomization|AE unrelated to Study Drug|0|||
161050911|NCT02823574|581575265|FG002|Randomization|AE unrelated to Study Drug|0|||
161050912|NCT02823574|581575266|FG003|Randomization|AE unrelated to Study Drug|0|||
161050913|NCT02823574|581575263|FG000|Treatment Period|Poor/Non Compliance|1|||
161050914|NCT02823574|581575264|FG001|Treatment Period|Poor/Non Compliance|0|||
161050915|NCT02823574|581575265|FG002|Treatment Period|Poor/Non Compliance|0|||
161050916|NCT02823574|581575266|FG003|Treatment Period|Poor/Non Compliance|1|||
161050917|NCT02823574|581575263|FG000|Treatment Period|Maximum Clinical Benefit|8|||
161050918|NCT02823574|581575264|FG001|Treatment Period|Maximum Clinical Benefit|4|||
161050919|NCT02823574|581575265|FG002|Treatment Period|Maximum Clinical Benefit|7|||
161050920|NCT02823574|581575266|FG003|Treatment Period|Maximum Clinical Benefit|1|||
161050921|NCT02823574|581575263|FG000|Treatment Period|Lost to Follow-up|1|||
161050922|NCT02823574|581575264|FG001|Treatment Period|Lost to Follow-up|1|||
161050923|NCT02823574|581575265|FG002|Treatment Period|Lost to Follow-up|0|||
161050924|NCT02823574|581575266|FG003|Treatment Period|Lost to Follow-up|0|||
161050925|NCT02823574|581575263|FG000|Treatment Period|Participant withdrew consent|4|||
161050926|NCT02823574|581575264|FG001|Treatment Period|Participant withdrew consent|0|||
161050927|NCT02823574|581575265|FG002|Treatment Period|Participant withdrew consent|0|||
161050928|NCT02823574|581575266|FG003|Treatment Period|Participant withdrew consent|1|||
161050929|NCT02823574|581575263|FG000|Treatment Period|Participant request to discontinue|5|||
161050930|NCT02823574|581575264|FG001|Treatment Period|Participant request to discontinue|0|||
161050931|NCT02823574|581575265|FG002|Treatment Period|Participant request to discontinue|3|||
161050932|NCT02823574|581575266|FG003|Treatment Period|Participant request to discontinue|2|||
161050933|NCT02823574|581575263|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
161050934|NCT02823574|581575264|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
161280992|NCT00996892|582407009|FG007|Expansion Stage 2|Disease Progression|0|||
161280993|NCT00996892|582407010|FG008|Expansion Stage 2|Disease Progression|0|||
161280994|NCT00996892|582407011|FG009|Expansion Stage 2|Disease Progression|0|||
161280995|NCT00996892|582407012|FG010|Expansion Stage 2|Disease Progression|0|||
161280996|NCT00996892|582407013|FG011|Expansion Stage 2|Disease Progression|0|||
161280997|NCT00996892|582407014|FG012|Expansion Stage 2|Disease Progression|0|||
161050935|NCT02823574|581575265|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
161050936|NCT02823574|581575266|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
161050937|NCT02823574|581575263|FG000|Treatment Period|Study Drug Toxicity|11|||
161050938|NCT02823574|581575264|FG001|Treatment Period|Study Drug Toxicity|2|||
161050939|NCT02823574|581575265|FG002|Treatment Period|Study Drug Toxicity|14|||
161050940|NCT02823574|581575266|FG003|Treatment Period|Study Drug Toxicity|4|||
161050941|NCT02823574|581575263|FG000|Treatment Period|Disease Progression|113|||
161050942|NCT02823574|581575264|FG001|Treatment Period|Disease Progression|64|||
161050943|NCT02823574|581575265|FG002|Treatment Period|Disease Progression|82|||
161050944|NCT02823574|581575266|FG003|Treatment Period|Disease Progression|43|||
161050945|NCT02823574|581575263|FG000|Treatment Period|Other reasons|5|||
161050946|NCT02823574|581575264|FG001|Treatment Period|Other reasons|9|||
161280998|NCT00996892|582407015|FG013|Expansion Stage 2|Disease Progression|0|||
161280999|NCT00996892|582407016|FG014|Expansion Stage 2|Disease Progression|0|||
161281000|NCT00996892|582407017|FG015|Expansion Stage 2|Disease Progression|0|||
161050947|NCT02823574|581575265|FG002|Treatment Period|Other reasons|3|||
161050948|NCT02823574|581575266|FG003|Treatment Period|Other reasons|6|||
161050949|NCT02823574|581575263|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161050950|NCT02823574|581575264|FG001|Treatment Period|Participant no longer meets study criteria|0|||
161050951|NCT02823574|581575265|FG002|Treatment Period|Participant no longer meets study criteria|1|||
161050952|NCT02823574|581575266|FG003|Treatment Period|Participant no longer meets study criteria|0|||
161050953|NCT02823574|581575263|FG000|Treatment Period|Death|0|||
161050954|NCT02823574|581575264|FG001|Treatment Period|Death|0|||
161050955|NCT02823574|581575265|FG002|Treatment Period|Death|3|||
161050956|NCT02823574|581575266|FG003|Treatment Period|Death|1|||
161050957|NCT00590759|581575267|FG000|Overall Study|Death|52|||
161050958|NCT00590759|581575267|FG000|Overall Study|Lost to Follow-up|28|||
161050959|NCT00096278|581575272|FG000|Overall Study|No follow-up data|15|||
161050960|NCT00096278|581575273|FG001|Overall Study|No follow-up data|18|||
161050961|NCT00096278|581575272|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
161050962|NCT00096278|581575273|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
161050963|NCT02865083|581575274|FG000|Overall Study|Early Termination|3|||
161050964|NCT02865083|581575275|FG001|Overall Study|Early Termination|1|||
161050965|NCT02959866|581575281|FG000|Overall Study|Withdrawal by Subject|1|||
161050966|NCT00636168|581575282|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
161050967|NCT00636168|581575283|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
160977747|NCT02023879|581308033|FG001|Extension Open Label Treatment|Other than specified above|7|||
160977748|NCT02023879|581308034|FG002|Extension Open Label Treatment|Other than specified above|2|||
160977749|NCT00874432|581308035|FG000|Overall Study|Withdrawal by Subject|1|||
160977750|NCT00874432|581308036|FG001|Overall Study|Withdrawal by Subject|0|||
160977751|NCT00874432|581308037|FG002|Overall Study|Withdrawal by Subject|0|||
160977752|NCT00874432|581308038|FG003|Overall Study|Withdrawal by Subject|0|||
160977753|NCT00874432|581308035|FG000|Overall Study|Physician Decision|1|||
160977754|NCT00874432|581308036|FG001|Overall Study|Physician Decision|0|||
160977755|NCT00874432|581308037|FG002|Overall Study|Physician Decision|0|||
161050968|NCT00636168|581575282|FG000|Randomized to Study Drug|Adverse Event|1|||
161050969|NCT00636168|581575283|FG001|Randomized to Study Drug|Adverse Event|0|||
161050970|NCT00636168|581575282|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
161050971|NCT00636168|581575283|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
161050972|NCT00636168|581575282|FG000|Treated With Study Drug|Recurrence of disease|135|||
161050973|NCT00636168|581575283|FG001|Treated With Study Drug|Recurrence of disease|282|||
161050974|NCT00636168|581575282|FG000|Treated With Study Drug|Adverse Event|250|||
161050975|NCT00636168|581575283|FG001|Treated With Study Drug|Adverse Event|22|||
161050976|NCT00636168|581575282|FG000|Treated With Study Drug|Participant withdrew consent|16|||
161151010|NCT04083222|581933650|FG001|Overall Study|Reason not Specified|1|||
161151011|NCT02522481|581933651|FG000|Overall Study|discontinued|1|||
161151012|NCT02522481|581933651|FG000|Overall Study|Not dosed|2|||
161151013|NCT03123939|581933652|FG000|Overall Study|Lack of Efficacy|6|||
161151014|NCT03123939|581933652|FG000|Overall Study|Death|5|||
161151015|NCT03123939|581933652|FG000|Overall Study|Physician Decision|2|||
161151016|NCT03123939|581933652|FG000|Overall Study|Subject/guardian decision|2|||
161151017|NCT03123939|581933652|FG000|Overall Study|Lost to Follow-up|1|||
161151018|NCT03123939|581933652|FG000|Overall Study|New therapy for study indication|1|||
161151019|NCT03123939|581933652|FG000|Overall Study|Protocol deviation|1|||
161151020|NCT03123939|581933652|FG000|Overall Study|Progressive disease|18|||
161151021|NCT03123939|581933652|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
161151022|NCT03123939|581933652|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
161151023|NCT04400318|581935397|FG000|Overall Study|Adverse Event|1|||
161151024|NCT04400318|581935398|FG001|Overall Study|Adverse Event|0|||
161151025|NCT04400318|581935397|FG000|Overall Study|Withdrawal by Subject|1|||
161151026|NCT04400318|581935398|FG001|Overall Study|Withdrawal by Subject|1|||
161151027|NCT04400318|581935397|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
161151028|NCT04400318|581935398|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
161050977|NCT00636168|581575283|FG001|Treated With Study Drug|Participant withdrew consent|21|||
161050978|NCT00636168|581575282|FG000|Treated With Study Drug|Poor/non-compliance|1|||
161050979|NCT00636168|581575283|FG001|Treated With Study Drug|Poor/non-compliance|3|||
161151029|NCT02078713|581935399|FG000|Overall Study|Lost to Follow-up|49|||
161151030|NCT02078713|581935400|FG001|Overall Study|Lost to Follow-up|55|||
161151031|NCT02078713|581935401|FG002|Overall Study|Lost to Follow-up|0|||
161151032|NCT02078713|581935402|FG003|Overall Study|Lost to Follow-up|0|||
161151033|NCT02078713|581935399|FG000|Overall Study|Pregnant at baseline|3|||
161151034|NCT02078713|581935400|FG001|Overall Study|Pregnant at baseline|5|||
161151035|NCT02078713|581935401|FG002|Overall Study|Pregnant at baseline|0|||
161151036|NCT02078713|581935402|FG003|Overall Study|Pregnant at baseline|0|||
161151037|NCT02078713|581935399|FG000|Overall Study|Enrolled twice|0|||
161281001|NCT00996892|582407018|FG016|Expansion Stage 2|Disease Progression|0|||
161345083|NCT03126110|582648857|FG008|Phase 2|Progressive Disease|0|||
160977756|NCT00874432|581308038|FG003|Overall Study|Physician Decision|0|||
160977757|NCT00874432|581308035|FG000|Overall Study|Other|1|||
160977758|NCT00874432|581308036|FG001|Overall Study|Other|2|||
161050980|NCT00636168|581575282|FG000|Treated With Study Drug|Death|3|||
161050981|NCT00636168|581575283|FG001|Treated With Study Drug|Death|0|||
161050982|NCT00636168|581575282|FG000|Treated With Study Drug|Pregnancy|1|||
161050983|NCT00636168|581575283|FG001|Treated With Study Drug|Pregnancy|0|||
161050984|NCT00636168|581575282|FG000|Treated With Study Drug|No longer meets study criteria|1|||
161050985|NCT00636168|581575283|FG001|Treated With Study Drug|No longer meets study criteria|0|||
161050986|NCT00636168|581575282|FG000|Treated With Study Drug|Other reason|1|||
161050987|NCT00636168|581575283|FG001|Treated With Study Drug|Other reason|3|||
161050988|NCT00636168|581575282|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
161050989|NCT00636168|581575283|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
161050990|NCT00636168|581575282|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
161050991|NCT00636168|581575283|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
161050992|NCT00636168|581575282|FG000|Long Term Follow-Up|Death|8|||
161050993|NCT00636168|581575283|FG001|Long Term Follow-Up|Death|9|||
161050994|NCT01240785|581575286|FG000|Overall Study|Lost to Follow-up|1|||
161050995|NCT01240785|581575287|FG001|Overall Study|Lost to Follow-up|0|||
161050996|NCT01240785|581575286|FG000|Overall Study|Protocol Violation|0|||
160977759|NCT00874432|581308037|FG002|Overall Study|Other|8|||
160977760|NCT00874432|581308038|FG003|Overall Study|Other|3|||
161050997|NCT01240785|581575287|FG001|Overall Study|Protocol Violation|3|||
161050998|NCT02006641|581575288|FG000|Overall Study|Withdrawal before treatment|2|||
161050999|NCT02006641|581575289|FG001|Overall Study|Withdrawal before treatment|5|||
161051000|NCT02006641|581575290|FG002|Overall Study|Withdrawal before treatment|3|||
161051001|NCT02006641|581575288|FG000|Overall Study|Adverse Event|15|||
161051002|NCT02006641|581575289|FG001|Overall Study|Adverse Event|11|||
161051003|NCT02006641|581575290|FG002|Overall Study|Adverse Event|15|||
161051004|NCT02006641|581575288|FG000|Overall Study|Protocol Violation|0|||
161051005|NCT02006641|581575289|FG001|Overall Study|Protocol Violation|2|||
161051006|NCT02006641|581575290|FG002|Overall Study|Protocol Violation|2|||
161051007|NCT02006641|581575288|FG000|Overall Study|Lost to Follow-up|0|||
161051008|NCT02006641|581575289|FG001|Overall Study|Lost to Follow-up|1|||
161051009|NCT02006641|581575290|FG002|Overall Study|Lost to Follow-up|0|||
161051010|NCT02006641|581575288|FG000|Overall Study|Withdrawal by Subject|7|||
161051011|NCT02006641|581575289|FG001|Overall Study|Withdrawal by Subject|12|||
161051012|NCT02006641|581575290|FG002|Overall Study|Withdrawal by Subject|11|||
161051013|NCT02006641|581575288|FG000|Overall Study|Other reason: patient didn't show up|1|||
160977761|NCT05256381|581308039|FG000|Overall Study|Withdrawal by Subject|4|||
160977762|NCT05256381|581308040|FG001|Overall Study|Withdrawal by Subject|0|||
160977763|NCT05256381|581308041|FG002|Overall Study|Withdrawal by Subject|2|||
160977764|NCT05256381|581308042|FG003|Overall Study|Withdrawal by Subject|2|||
160977765|NCT05256381|581308043|FG004|Overall Study|Withdrawal by Subject|8|||
160977766|NCT05256381|581308044|FG005|Overall Study|Withdrawal by Subject|6|||
160977767|NCT05256381|581308039|FG000|Overall Study|Physician Decision|0|||
160977768|NCT05256381|581308040|FG001|Overall Study|Physician Decision|0|||
160977769|NCT05256381|581308041|FG002|Overall Study|Physician Decision|1|||
160977770|NCT05256381|581308042|FG003|Overall Study|Physician Decision|0|||
160977771|NCT05256381|581308043|FG004|Overall Study|Physician Decision|2|||
160977772|NCT05256381|581308044|FG005|Overall Study|Physician Decision|0|||
160977773|NCT05256381|581308039|FG000|Overall Study|Death|17|||
160977774|NCT05256381|581308040|FG001|Overall Study|Death|3|||
160977775|NCT05256381|581308041|FG002|Overall Study|Death|4|||
160977776|NCT05256381|581308042|FG003|Overall Study|Death|5|||
160977777|NCT05256381|581308043|FG004|Overall Study|Death|24|||
160977778|NCT05256381|581308044|FG005|Overall Study|Death|21|||
160977779|NCT05256381|581308039|FG000|Overall Study|Other, not specified|0|||
160977780|NCT05256381|581308040|FG001|Overall Study|Other, not specified|0|||
160977781|NCT05256381|581308041|FG002|Overall Study|Other, not specified|0|||
160977782|NCT05256381|581308042|FG003|Overall Study|Other, not specified|0|||
160977783|NCT05256381|581308043|FG004|Overall Study|Other, not specified|2|||
160977784|NCT05256381|581308044|FG005|Overall Study|Other, not specified|1|||
160977785|NCT05256381|581308039|FG000|Overall Study|Study terminated by sponsor|18|||
160977786|NCT05256381|581308040|FG001|Overall Study|Study terminated by sponsor|5|||
160977787|NCT05256381|581308041|FG002|Overall Study|Study terminated by sponsor|5|||
160977788|NCT05256381|581308042|FG003|Overall Study|Study terminated by sponsor|5|||
160977789|NCT05256381|581308043|FG004|Overall Study|Study terminated by sponsor|18|||
160977790|NCT05256381|581308044|FG005|Overall Study|Study terminated by sponsor|11|||
160977791|NCT05256381|581308039|FG000|Overall Study|Lost to Follow-up|1|||
160977792|NCT05256381|581308040|FG001|Overall Study|Lost to Follow-up|0|||
160977793|NCT05256381|581308041|FG002|Overall Study|Lost to Follow-up|0|||
160977794|NCT05256381|581308042|FG003|Overall Study|Lost to Follow-up|0|||
160977795|NCT05256381|581308043|FG004|Overall Study|Lost to Follow-up|1|||
161051014|NCT02006641|581575289|FG001|Overall Study|Other reason: patient didn't show up|0|||
161051015|NCT02006641|581575290|FG002|Overall Study|Other reason: patient didn't show up|0|||
161051016|NCT02006641|581575288|FG000|Overall Study|Other reason:patient didn't want to come|0|||
161051017|NCT02006641|581575289|FG001|Overall Study|Other reason:patient didn't want to come|0|||
161051018|NCT02006641|581575290|FG002|Overall Study|Other reason:patient didn't want to come|1|||
160977796|NCT05256381|581308044|FG005|Overall Study|Lost to Follow-up|0|||
160977797|NCT01518946|581308047|FG000|Open-label Phase|Other|4|||
161151038|NCT02078713|581935400|FG001|Overall Study|Enrolled twice|1|||
161151039|NCT02078713|581935401|FG002|Overall Study|Enrolled twice|0|||
161151040|NCT02078713|581935402|FG003|Overall Study|Enrolled twice|0|||
161151041|NCT01793051|581935413|FG000|Overall Study|Withdrawal by Subject|6|||
161151042|NCT01793051|581935414|FG001|Overall Study|Withdrawal by Subject|4|||
161151043|NCT01793051|581935413|FG000|Overall Study|Adverse Event|0|||
161151044|NCT01793051|581935414|FG001|Overall Study|Adverse Event|2|||
161151045|NCT01793051|581935413|FG000|Overall Study|Too ill to continue|1|||
161151046|NCT01793051|581935414|FG001|Overall Study|Too ill to continue|0|||
161151047|NCT01793051|581935413|FG000|Overall Study|Switched chemo|1|||
161151048|NCT01793051|581935414|FG001|Overall Study|Switched chemo|1|||
161151049|NCT01793051|581935413|FG000|Overall Study|Lack of compliance|1|||
161151050|NCT01793051|581935414|FG001|Overall Study|Lack of compliance|0|||
161151051|NCT01793051|581935413|FG000|Overall Study|Requested to be removed from the study|1|||
161151052|NCT01793051|581935414|FG001|Overall Study|Requested to be removed from the study|1|||
161151053|NCT00372190|581935415|FG000|Overall Study|Lost to Follow-up|3|||
161151054|NCT00372190|581935416|FG001|Overall Study|Lost to Follow-up|1|||
161151055|NCT00623467|581935417|FG000|Overall Study|Lost to Follow-up|1|||
161151056|NCT00623467|581935417|FG000|Overall Study|Protocol Violation|4|||
161151057|NCT00623467|581935417|FG000|Overall Study|Withdrawal by Subject|2|||
161151058|NCT01585961|581935419|FG000|Overall Study|Death|6|||
161151059|NCT01585961|581935419|FG000|Overall Study|Physician Decision|1|||
161151060|NCT01585961|581935419|FG000|Overall Study|Decision to use non-study catheter|1|||
161151061|NCT01585961|581935419|FG000|Overall Study|Withdrawal by Subject|1|||
161151062|NCT01585961|581935419|FG000|Overall Study|Lost to Follow-up|23|||
161151063|NCT01585961|581935419|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
161151064|NCT01258348|581935420|FG000|Overall Study|Adverse Event|1|||
161151065|NCT01258348|581935421|FG001|Overall Study|Adverse Event|1|||
161151066|NCT01258348|581935422|FG002|Overall Study|Adverse Event|3|||
161151067|NCT01258348|581935423|FG003|Overall Study|Adverse Event|2|||
161151068|NCT01258348|581935424|FG004|Overall Study|Adverse Event|4|||
161151069|NCT01258348|581935420|FG000|Overall Study|Progressive Disease|0|||
161151070|NCT01258348|581935421|FG001|Overall Study|Progressive Disease|3|||
161151071|NCT01258348|581935422|FG002|Overall Study|Progressive Disease|0|||
161151072|NCT01258348|581935423|FG003|Overall Study|Progressive Disease|2|||
161151073|NCT01258348|581935424|FG004|Overall Study|Progressive Disease|2|||
161151074|NCT01258348|581935420|FG000|Overall Study|Physician Decision|0|||
161151075|NCT01258348|581935421|FG001|Overall Study|Physician Decision|0|||
161151076|NCT01258348|581935422|FG002|Overall Study|Physician Decision|0|||
161151077|NCT01258348|581935423|FG003|Overall Study|Physician Decision|2|||
161151078|NCT01258348|581935424|FG004|Overall Study|Physician Decision|0|||
161151079|NCT01258348|581935420|FG000|Overall Study|Withdrawal by Subject|0|||
161151080|NCT01258348|581935421|FG001|Overall Study|Withdrawal by Subject|1|||
161151081|NCT01258348|581935422|FG002|Overall Study|Withdrawal by Subject|0|||
161151082|NCT01258348|581935423|FG003|Overall Study|Withdrawal by Subject|0|||
161151083|NCT01258348|581935424|FG004|Overall Study|Withdrawal by Subject|0|||
161151084|NCT01849848|581935426|FG000|Overall Study|Physician Decision|1|||
161151085|NCT01849848|581935426|FG000|Overall Study|Progression of the primary disease|3|||
161151086|NCT01120093|581935435|FG000|Treatment Period 1|Adverse Event|0|||
161151087|NCT01120093|581935436|FG001|Treatment Period 1|Adverse Event|0|||
161151088|NCT01120093|581935437|FG002|Treatment Period 1|Adverse Event|1|||
161151089|NCT01120093|581935438|FG003|Treatment Period 1|Adverse Event|0|||
161151090|NCT01120093|581935439|FG004|Treatment Period 1|Adverse Event|1|||
161151091|NCT01120093|581935435|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161151092|NCT01120093|581935436|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161151093|NCT01120093|581935437|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161151094|NCT01120093|581935438|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161151095|NCT01120093|581935439|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161151096|NCT01120093|581935435|FG000|Treatment Period 2|Adverse Event|0|||
161151097|NCT01120093|581935436|FG001|Treatment Period 2|Adverse Event|0|||
161151098|NCT01120093|581935437|FG002|Treatment Period 2|Adverse Event|0|||
161151099|NCT01120093|581935438|FG003|Treatment Period 2|Adverse Event|1|||
161151100|NCT01120093|581935439|FG004|Treatment Period 2|Adverse Event|0|||
161151101|NCT01120093|581935435|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161151102|NCT01120093|581935436|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161345084|NCT03126110|582648858|FG009|Phase 2|Progressive Disease|0|||
161151103|NCT01120093|581935437|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161151104|NCT01120093|581935438|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161151105|NCT01120093|581935439|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161151106|NCT01120093|581935435|FG000|Treatment Period 3|Lack of Efficacy|0|||
161151107|NCT01120093|581935436|FG001|Treatment Period 3|Lack of Efficacy|0|||
161151108|NCT01120093|581935437|FG002|Treatment Period 3|Lack of Efficacy|0|||
161151109|NCT01120093|581935438|FG003|Treatment Period 3|Lack of Efficacy|1|||
161151110|NCT01120093|581935439|FG004|Treatment Period 3|Lack of Efficacy|0|||
161151111|NCT01120093|581935435|FG000|Treatment Period 3|Adverse Event|0|||
161151112|NCT01120093|581935436|FG001|Treatment Period 3|Adverse Event|0|||
161151113|NCT01120093|581935437|FG002|Treatment Period 3|Adverse Event|0|||
161151114|NCT01120093|581935438|FG003|Treatment Period 3|Adverse Event|0|||
160977798|NCT01518946|581308048|FG001|Open-label Phase|Other|0|||
160977799|NCT01518946|581308049|FG002|Open-label Phase|Other|0|||
160977800|NCT01518946|581308047|FG000|Randomized Phase (First Intervention)|Other|0|||
160977801|NCT01518946|581308048|FG001|Randomized Phase (First Intervention)|Other|1|||
160977802|NCT01518946|581308049|FG002|Randomized Phase (First Intervention)|Other|0|||
161051019|NCT02006641|581575288|FG000|Overall Study|Other reason: patient has moved|1|||
161051020|NCT02006641|581575289|FG001|Overall Study|Other reason: patient has moved|0|||
161051021|NCT02006641|581575290|FG002|Overall Study|Other reason: patient has moved|1|||
161051022|NCT02006641|581575288|FG000|Overall Study|Other reason: caregiver in hospital|0|||
161051023|NCT02006641|581575289|FG001|Overall Study|Other reason: caregiver in hospital|1|||
161051024|NCT02006641|581575290|FG002|Overall Study|Other reason: caregiver in hospital|0|||
161051025|NCT02006641|581575288|FG000|Overall Study|Other reason: patient's wife has died|0|||
161051026|NCT02006641|581575289|FG001|Overall Study|Other reason: patient's wife has died|0|||
161051027|NCT02006641|581575290|FG002|Overall Study|Other reason: patient's wife has died|1|||
161051028|NCT02006641|581575288|FG000|Overall Study|Other reason: hospitalisation|0|||
161051029|NCT02006641|581575289|FG001|Overall Study|Other reason: hospitalisation|1|||
161051030|NCT02006641|581575290|FG002|Overall Study|Other reason: hospitalisation|0|||
161051031|NCT02006641|581575288|FG000|Overall Study|Other reason: caregiver impossibility|0|||
161051032|NCT02006641|581575289|FG001|Overall Study|Other reason: caregiver impossibility|0|||
161051033|NCT02006641|581575290|FG002|Overall Study|Other reason: caregiver impossibility|1|||
161051034|NCT02006641|581575288|FG000|Overall Study|Other reason: protocol non-compliance|0|||
161051035|NCT02006641|581575289|FG001|Overall Study|Other reason: protocol non-compliance|0|||
161051036|NCT02006641|581575290|FG002|Overall Study|Other reason: protocol non-compliance|1|||
161051037|NCT01613599|581575291|FG000|Overall Study|Death|9|||
161051038|NCT01613599|581575291|FG000|Overall Study|Lost to Follow-up|5|||
161051039|NCT01613599|581575291|FG000|Overall Study|Withdrawal by Subject|8|||
161051040|NCT01613599|581575291|FG000|Overall Study|Reason not specified|3|||
161051041|NCT02132195|581575292|FG000|Initial Assignment|Relapsed|14|||
161051042|NCT02132195|581575293|FG001|Initial Assignment|Relapsed|0|||
161051043|NCT02132195|581575294|FG002|Initial Assignment|Relapsed|0|||
161051044|NCT02132195|581575292|FG000|Rescue Therapy|Relapsed|0|||
161051045|NCT02132195|581575293|FG001|Rescue Therapy|Relapsed|0|||
161051046|NCT02132195|581575294|FG002|Rescue Therapy|Relapsed|7|||
161051047|NCT02132195|581575292|FG000|Rescue Therapy|Physician Decision|0|||
161051048|NCT02132195|581575293|FG001|Rescue Therapy|Physician Decision|0|||
161051049|NCT02132195|581575294|FG002|Rescue Therapy|Physician Decision|1|||
161051050|NCT02132195|581575292|FG000|Rescue Therapy|Withdrawal by Subject|0|||
161051051|NCT02132195|581575293|FG001|Rescue Therapy|Withdrawal by Subject|0|||
161051052|NCT02132195|581575294|FG002|Rescue Therapy|Withdrawal by Subject|1|||
161051053|NCT02132195|581575292|FG000|Rescue Therapy|Adverse Event|0|||
161051054|NCT02132195|581575293|FG001|Rescue Therapy|Adverse Event|0|||
161051055|NCT02132195|581575294|FG002|Rescue Therapy|Adverse Event|2|||
161051056|NCT01307800|581575304|FG000|Overall Study|Adverse Event|9|||
161051057|NCT01307800|581575305|FG001|Overall Study|Adverse Event|8|||
161051058|NCT01307800|581575306|FG002|Overall Study|Adverse Event|10|||
161051059|NCT01307800|581575307|FG003|Overall Study|Adverse Event|14|||
161051060|NCT01307800|581575304|FG000|Overall Study|Entry Criteria Not Met|0|||
161051061|NCT01307800|581575305|FG001|Overall Study|Entry Criteria Not Met|0|||
161051062|NCT01307800|581575306|FG002|Overall Study|Entry Criteria Not Met|0|||
161051063|NCT01307800|581575307|FG003|Overall Study|Entry Criteria Not Met|2|||
161051064|NCT01307800|581575304|FG000|Overall Study|Lost to Follow-up|5|||
161051065|NCT01307800|581575305|FG001|Overall Study|Lost to Follow-up|6|||
161051066|NCT01307800|581575306|FG002|Overall Study|Lost to Follow-up|2|||
161051067|NCT01307800|581575307|FG003|Overall Study|Lost to Follow-up|8|||
161051068|NCT01307800|581575304|FG000|Overall Study|Perceived Lack of Efficacy|24|||
161051069|NCT01307800|581575305|FG001|Overall Study|Perceived Lack of Efficacy|23|||
161051070|NCT01307800|581575306|FG002|Overall Study|Perceived Lack of Efficacy|20|||
161051071|NCT01307800|581575307|FG003|Overall Study|Perceived Lack of Efficacy|33|||
161051072|NCT01307800|581575304|FG000|Overall Study|Protocol Violation|0|||
161051073|NCT01307800|581575305|FG001|Overall Study|Protocol Violation|3|||
161051074|NCT01307800|581575306|FG002|Overall Study|Protocol Violation|4|||
161051075|NCT01307800|581575307|FG003|Overall Study|Protocol Violation|5|||
161281002|NCT00996892|582407019|FG017|Expansion Stage 2|Disease Progression|0|||
161281003|NCT00996892|582407020|FG018|Expansion Stage 2|Disease Progression|28|||
161051076|NCT01307800|581575304|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
161051077|NCT01307800|581575305|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
161051078|NCT01307800|581575306|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
161281004|NCT00996892|582407021|FG019|Expansion Stage 2|Disease Progression|0|||
161281005|NCT00996892|582407002|FG000|Expansion Stage 2A|Adverse Event|0|||
161051079|NCT01307800|581575307|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
161051080|NCT01307800|581575304|FG000|Overall Study|Sponsor Decision|6|||
161051081|NCT01307800|581575305|FG001|Overall Study|Sponsor Decision|9|||
161051082|NCT01307800|581575306|FG002|Overall Study|Sponsor Decision|12|||
161051083|NCT01307800|581575307|FG003|Overall Study|Sponsor Decision|28|||
161051084|NCT01307800|581575304|FG000|Overall Study|Withdrawal by Subject|10|||
161051085|NCT01307800|581575305|FG001|Overall Study|Withdrawal by Subject|11|||
161051086|NCT01307800|581575306|FG002|Overall Study|Withdrawal by Subject|8|||
161051087|NCT01307800|581575307|FG003|Overall Study|Withdrawal by Subject|15|||
161051088|NCT01307800|581575304|FG000|Overall Study|Participant Moved|0|||
161051089|NCT01307800|581575305|FG001|Overall Study|Participant Moved|2|||
161051090|NCT01307800|581575306|FG002|Overall Study|Participant Moved|1|||
161051091|NCT01307800|581575307|FG003|Overall Study|Participant Moved|3|||
161051092|NCT00689351|581575310|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
161051093|NCT00689351|581575311|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
161051094|NCT00689351|581575310|FG000|Infant Series of Dosing|Adverse Event|1|||
161051095|NCT00689351|581575311|FG001|Infant Series of Dosing|Adverse Event|0|||
161051096|NCT00689351|581575310|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
161051097|NCT00689351|581575311|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
161051098|NCT00689351|581575310|FG000|After Infant Series|Parent/legal guardian request|1|||
161051099|NCT00689351|581575311|FG001|After Infant Series|Parent/legal guardian request|0|||
161051100|NCT01766206|581575312|FG000|Overall Study|Withdrawal by Subject|22|||
161051101|NCT01766206|581575312|FG000|Overall Study|Lost to Follow-up|10|||
161051102|NCT01766206|581575312|FG000|Overall Study|Inappropriate enrollment|18|||
161051103|NCT01766206|581575312|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
161051104|NCT01662505|581575313|FG000|Overall Study|Progressive disease|6|||
161051105|NCT01662505|581575314|FG001|Overall Study|Progressive disease|1|||
161051106|NCT01662505|581575315|FG002|Overall Study|Progressive disease|5|||
161051107|NCT01662505|581575313|FG000|Overall Study|Refused cont. medication|0|||
161051108|NCT01662505|581575314|FG001|Overall Study|Refused cont. medication|0|||
161051109|NCT01662505|581575315|FG002|Overall Study|Refused cont. medication|1|||
161051110|NCT01662505|581575313|FG000|Overall Study|Not specified above|1|||
161051111|NCT01662505|581575314|FG001|Overall Study|Not specified above|3|||
161051112|NCT01662505|581575315|FG002|Overall Study|Not specified above|2|||
161051113|NCT01313663|581575316|FG000|Overall Study|Study Closed/Terminated|2|||
161051114|NCT01313663|581575317|FG001|Overall Study|Study Closed/Terminated|4|||
161051115|NCT01313663|581575316|FG000|Overall Study|Lost to Follow-up|0|||
161051116|NCT01313663|581575317|FG001|Overall Study|Lost to Follow-up|1|||
161051117|NCT01313663|581575316|FG000|Overall Study|Physician Decision|0|||
161051118|NCT01313663|581575317|FG001|Overall Study|Physician Decision|2|||
161051119|NCT01313663|581575316|FG000|Overall Study|Withdrawal by Subject|2|||
161051120|NCT01313663|581575317|FG001|Overall Study|Withdrawal by Subject|1|||
161051121|NCT00508144|581575318|FG000|Overall Study|Not eligible|6|||
161051122|NCT00508144|581575318|FG000|Overall Study|Death|5|||
161051123|NCT01661972|581575321|FG000|Overall Study|Adverse Event|1|||
161051124|NCT01661972|581575322|FG001|Overall Study|Adverse Event|2|||
161051125|NCT01661972|581575321|FG000|Overall Study|Death during Treatment period|1|||
161051126|NCT01661972|581575322|FG001|Overall Study|Death during Treatment period|1|||
161051127|NCT01661972|581575321|FG000|Overall Study|Withdrawal by Subject|0|||
161051128|NCT01661972|581575322|FG001|Overall Study|Withdrawal by Subject|1|||
161051129|NCT02138838|581575326|FG000|Overall Study|Study Closure|7|||
161051130|NCT02138838|581575327|FG001|Overall Study|Study Closure|6|||
161051131|NCT02138838|581575326|FG000|Overall Study|Withdrawal by Subject|1|||
161051132|NCT02138838|581575327|FG001|Overall Study|Withdrawal by Subject|5|||
161151115|NCT01120093|581935439|FG004|Treatment Period 3|Adverse Event|1|||
161151116|NCT01120093|581935435|FG000|Treatment Period 3|Withdrawal by Subject|0|||
161151117|NCT01120093|581935436|FG001|Treatment Period 3|Withdrawal by Subject|0|||
161051133|NCT01084772|581575331|FG000|Baseline|Withdrawal by Subject|7|||
161051134|NCT01084772|581575332|FG001|Baseline|Withdrawal by Subject|6|||
161051135|NCT01084772|581575331|FG000|3 Months|Death|1|||
161051136|NCT01084772|581575332|FG001|3 Months|Death|0|||
161051137|NCT01084772|581575331|FG000|3 Months|Study Termination|2|||
161051138|NCT01084772|581575332|FG001|3 Months|Study Termination|2|||
161051139|NCT01084772|581575331|FG000|1 Year|Withdrawal by Subject|0|||
161051140|NCT01084772|581575332|FG001|1 Year|Withdrawal by Subject|1|||
161051141|NCT01084772|581575331|FG000|1 Year|Lost to Follow-up|3|||
161051142|NCT01084772|581575332|FG001|1 Year|Lost to Follow-up|0|||
161051143|NCT01084772|581575331|FG000|1 Year|Study Termination|0|||
161051144|NCT01084772|581575332|FG001|1 Year|Study Termination|7|||
161051145|NCT01084772|581575331|FG000|2 Years|Withdrawal by Subject|1|||
161051146|NCT01084772|581575332|FG001|2 Years|Withdrawal by Subject|0|||
161051147|NCT01084772|581575331|FG000|2 Years|Lost to Follow-up|5|||
161051148|NCT01084772|581575332|FG001|2 Years|Lost to Follow-up|2|||
161151118|NCT01120093|581935437|FG002|Treatment Period 3|Withdrawal by Subject|1|||
161051149|NCT01084772|581575331|FG000|2 Years|Study Termination|3|||
161051150|NCT01084772|581575332|FG001|2 Years|Study Termination|2|||
161051151|NCT01294644|581575333|FG000|Overall Study|Adverse Event|2|||
161051152|NCT01294644|581575334|FG001|Overall Study|Adverse Event|0|||
161151119|NCT01120093|581935438|FG003|Treatment Period 3|Withdrawal by Subject|0|||
161051153|NCT01294644|581575335|FG002|Overall Study|Adverse Event|1|||
161051154|NCT01294644|581575333|FG000|Overall Study|Withdrawal by Subject|3|||
161051155|NCT01294644|581575334|FG001|Overall Study|Withdrawal by Subject|7|||
161051156|NCT01294644|581575335|FG002|Overall Study|Withdrawal by Subject|4|||
161051157|NCT01294644|581575333|FG000|Overall Study|Lost to Follow-up|3|||
161051158|NCT01294644|581575334|FG001|Overall Study|Lost to Follow-up|2|||
161051159|NCT01294644|581575335|FG002|Overall Study|Lost to Follow-up|5|||
161051160|NCT01294644|581575333|FG000|Overall Study|Miscellaneous Reason|2|||
161051161|NCT01294644|581575334|FG001|Overall Study|Miscellaneous Reason|1|||
161051162|NCT01294644|581575335|FG002|Overall Study|Miscellaneous Reason|4|||
161051163|NCT00853957|581575336|FG000|Overall Study|Adverse Event|9|||
161051164|NCT00853957|581575337|FG001|Overall Study|Adverse Event|3|||
161051165|NCT00853957|581575336|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161051166|NCT00853957|581575337|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161051167|NCT00853957|581575336|FG000|Overall Study|Subject withdrew consent|4|||
161051168|NCT00853957|581575337|FG001|Overall Study|Subject withdrew consent|5|||
161051169|NCT00853957|581575336|FG000|Overall Study|Lost to Follow-up|1|||
161051170|NCT00853957|581575337|FG001|Overall Study|Lost to Follow-up|6|||
161051171|NCT00853957|581575336|FG000|Overall Study|Protocol deviation|0|||
161051172|NCT00853957|581575337|FG001|Overall Study|Protocol deviation|3|||
161051173|NCT01884571|581575338|FG000|Overall Study|Adverse Event|1|||
161051174|NCT01884571|581575338|FG000|Overall Study|Death|2|||
161051175|NCT01884571|581575338|FG000|Overall Study|Withdrawal by Subject|2|||
161051176|NCT01884571|581575338|FG000|Overall Study|Disease progression|3|||
161051177|NCT00760877|581576671|FG000|Overall Study|Protocol Violation|1|||
161051178|NCT00760877|581576672|FG001|Overall Study|Protocol Violation|0|||
161051179|NCT00760877|581576671|FG000|Overall Study|Non-compliance with protocol treatment|2|||
161051180|NCT00760877|581576672|FG001|Overall Study|Non-compliance with protocol treatment|1|||
161051181|NCT00760877|581576671|FG000|Overall Study|Pregnancy|1|||
161051182|NCT00760877|581576672|FG001|Overall Study|Pregnancy|4|||
161051183|NCT00760877|581576671|FG000|Overall Study|Death|2|||
161051184|NCT00760877|581576672|FG001|Overall Study|Death|1|||
161051185|NCT00760877|581576671|FG000|Overall Study|Withdrawal by Subject|7|||
161051186|NCT00760877|581576672|FG001|Overall Study|Withdrawal by Subject|3|||
161051187|NCT00760877|581576671|FG000|Overall Study|Adverse Event|19|||
161051188|NCT00760877|581576672|FG001|Overall Study|Adverse Event|12|||
161051189|NCT00760877|581576671|FG000|Overall Study|Participant diagnosed with AML|0|||
161051190|NCT00760877|581576672|FG001|Overall Study|Participant diagnosed with AML|1|||
161051191|NCT00760877|581576671|FG000|Overall Study|Participant not eligible to cross-over|0|||
161051192|NCT00760877|581576672|FG001|Overall Study|Participant not eligible to cross-over|1|||
161051193|NCT00760877|581576671|FG000|Overall Study|Physician Decision|1|||
161051194|NCT00760877|581576672|FG001|Overall Study|Physician Decision|2|||
161051195|NCT00760877|581576671|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
161051196|NCT00760877|581576672|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
161051197|NCT00760877|581576671|FG000|Overall Study|Treatment failure|1|||
161051198|NCT00760877|581576672|FG001|Overall Study|Treatment failure|0|||
161051199|NCT04413149|581576675|FG000|Overall Study|Death|10|||
161051200|NCT04413149|581576676|FG001|Overall Study|Death|5|||
161051201|NCT04413149|581576675|FG000|Overall Study|Lung transplantation|1|||
161051202|NCT04413149|581576676|FG001|Overall Study|Lung transplantation|0|||
161051203|NCT02878590|581576677|FG000|Overall Study|Withdrawal by Subject|2|||
161051204|NCT01730118|581576678|FG000|Dose Escalation|Death on study|5|||
161051205|NCT01730118|581576679|FG001|Dose Escalation|Death on study|7|||
161051206|NCT01730118|581576680|FG002|Dose Escalation|Death on study|2|||
161051207|NCT01730118|581576681|FG003|Dose Escalation|Death on study|6|||
161051208|NCT01730118|581576682|FG004|Dose Escalation|Death on study|0|||
161051209|NCT01730118|581576683|FG005|Dose Escalation|Death on study|0|||
161051210|NCT01730118|581576684|FG006|Dose Escalation|Death on study|0|||
161051211|NCT01730118|581576678|FG000|Dose Escalation|Died before treatment|0|||
161151120|NCT01120093|581935439|FG004|Treatment Period 3|Withdrawal by Subject|0|||
161281006|NCT00996892|582407003|FG001|Expansion Stage 2A|Adverse Event|0|||
161281007|NCT00996892|582407004|FG002|Expansion Stage 2A|Adverse Event|0|||
161051212|NCT01730118|581576679|FG001|Dose Escalation|Died before treatment|0|||
161051213|NCT01730118|581576680|FG002|Dose Escalation|Died before treatment|0|||
161051214|NCT01730118|581576681|FG003|Dose Escalation|Died before treatment|0|||
161051215|NCT01730118|581576682|FG004|Dose Escalation|Died before treatment|0|||
161051216|NCT01730118|581576683|FG005|Dose Escalation|Died before treatment|0|||
161051217|NCT01730118|581576684|FG006|Dose Escalation|Died before treatment|1|||
161051218|NCT01730118|581576678|FG000|Dose Escalation|Chose to start a different treatment|1|||
161051219|NCT01730118|581576679|FG001|Dose Escalation|Chose to start a different treatment|0|||
161051220|NCT01730118|581576680|FG002|Dose Escalation|Chose to start a different treatment|0|||
161051221|NCT01730118|581576681|FG003|Dose Escalation|Chose to start a different treatment|0|||
161051222|NCT01730118|581576682|FG004|Dose Escalation|Chose to start a different treatment|0|||
161051223|NCT01730118|581576683|FG005|Dose Escalation|Chose to start a different treatment|0|||
161051224|NCT01730118|581576684|FG006|Dose Escalation|Chose to start a different treatment|0|||
161051225|NCT01730118|581576678|FG000|Dose Escalation|Withdrawal by Subject|0|||
161051226|NCT01730118|581576679|FG001|Dose Escalation|Withdrawal by Subject|0|||
161051227|NCT01730118|581576680|FG002|Dose Escalation|Withdrawal by Subject|1|||
161051228|NCT01730118|581576681|FG003|Dose Escalation|Withdrawal by Subject|0|||
161051229|NCT01730118|581576682|FG004|Dose Escalation|Withdrawal by Subject|0|||
161051230|NCT01730118|581576683|FG005|Dose Escalation|Withdrawal by Subject|0|||
161151121|NCT01120093|581935435|FG000|Treatment Period 4|Adverse Event|1|||
161151122|NCT01120093|581935436|FG001|Treatment Period 4|Adverse Event|0|||
161151123|NCT01120093|581935437|FG002|Treatment Period 4|Adverse Event|0|||
161151124|NCT01120093|581935438|FG003|Treatment Period 4|Adverse Event|0|||
161151125|NCT01120093|581935439|FG004|Treatment Period 4|Adverse Event|0|||
161151126|NCT01120093|581935435|FG000|Treatment Period 5|Adverse Event|0|||
161151127|NCT01120093|581935436|FG001|Treatment Period 5|Adverse Event|1|||
161151128|NCT01120093|581935437|FG002|Treatment Period 5|Adverse Event|0|||
161151129|NCT01120093|581935438|FG003|Treatment Period 5|Adverse Event|1|||
161151130|NCT01120093|581935439|FG004|Treatment Period 5|Adverse Event|0|||
161151131|NCT03649321|581935442|FG000|Overall Study|Withdrawal by Subject|1|||
161151132|NCT03649321|581935443|FG001|Overall Study|Withdrawal by Subject|0|||
161151133|NCT03649321|581935442|FG000|Overall Study|Death|1|||
161151134|NCT03649321|581935443|FG001|Overall Study|Death|0|||
161051231|NCT01730118|581576684|FG006|Dose Escalation|Withdrawal by Subject|0|||
161051232|NCT01730118|581576678|FG000|Dose Escalation|Disease progression prior to treatment|0|||
161051233|NCT01730118|581576679|FG001|Dose Escalation|Disease progression prior to treatment|0|||
161051234|NCT01730118|581576680|FG002|Dose Escalation|Disease progression prior to treatment|0|||
161051235|NCT01730118|581576681|FG003|Dose Escalation|Disease progression prior to treatment|0|||
161051236|NCT01730118|581576682|FG004|Dose Escalation|Disease progression prior to treatment|0|||
161051237|NCT01730118|581576683|FG005|Dose Escalation|Disease progression prior to treatment|0|||
161051238|NCT01730118|581576684|FG006|Dose Escalation|Disease progression prior to treatment|1|||
161051239|NCT01730118|581576678|FG000|Dose Expansion|Death|0|||
161051240|NCT01730118|581576679|FG001|Dose Expansion|Death|0|||
161051241|NCT01730118|581576680|FG002|Dose Expansion|Death|0|||
161051242|NCT01730118|581576681|FG003|Dose Expansion|Death|0|||
161051243|NCT01730118|581576682|FG004|Dose Expansion|Death|1|||
161051244|NCT01730118|581576683|FG005|Dose Expansion|Death|0|||
161051245|NCT01730118|581576684|FG006|Dose Expansion|Death|0|||
161051246|NCT01730118|581576678|FG000|Dose Expansion|Other medical condition|0|||
161051247|NCT01730118|581576679|FG001|Dose Expansion|Other medical condition|0|||
161051248|NCT01730118|581576680|FG002|Dose Expansion|Other medical condition|0|||
161051249|NCT01730118|581576681|FG003|Dose Expansion|Other medical condition|0|||
161051250|NCT01730118|581576682|FG004|Dose Expansion|Other medical condition|1|||
161051251|NCT01730118|581576683|FG005|Dose Expansion|Other medical condition|0|||
161051252|NCT01730118|581576684|FG006|Dose Expansion|Other medical condition|0|||
161051253|NCT01730118|581576678|FG000|Dose Expansion|Withdrawal by Subject|0|||
161051254|NCT01730118|581576679|FG001|Dose Expansion|Withdrawal by Subject|0|||
161051255|NCT01730118|581576680|FG002|Dose Expansion|Withdrawal by Subject|0|||
161051256|NCT01730118|581576681|FG003|Dose Expansion|Withdrawal by Subject|0|||
161051257|NCT01730118|581576682|FG004|Dose Expansion|Withdrawal by Subject|1|||
161051258|NCT01730118|581576683|FG005|Dose Expansion|Withdrawal by Subject|0|||
161051259|NCT01730118|581576684|FG006|Dose Expansion|Withdrawal by Subject|0|||
161051260|NCT01730118|581576678|FG000|Dose Expansion|Disease progression|0|||
161051261|NCT01730118|581576679|FG001|Dose Expansion|Disease progression|0|||
161051262|NCT01730118|581576680|FG002|Dose Expansion|Disease progression|0|||
161051263|NCT01730118|581576681|FG003|Dose Expansion|Disease progression|0|||
161051264|NCT01730118|581576682|FG004|Dose Expansion|Disease progression|0|||
161051265|NCT01730118|581576683|FG005|Dose Expansion|Disease progression|1|||
161051266|NCT01730118|581576684|FG006|Dose Expansion|Disease progression|0|||
161051267|NCT01730118|581576678|FG000|Dose Expansion|Inability to return|0|||
161051268|NCT01730118|581576679|FG001|Dose Expansion|Inability to return|0|||
161051269|NCT01730118|581576680|FG002|Dose Expansion|Inability to return|0|||
161051270|NCT01730118|581576681|FG003|Dose Expansion|Inability to return|0|||
161051271|NCT01730118|581576682|FG004|Dose Expansion|Inability to return|0|||
161051272|NCT01730118|581576683|FG005|Dose Expansion|Inability to return|1|||
161151135|NCT01312428|581935444|FG000|Overall Study|Study Termination|3|||
161281008|NCT00996892|582407005|FG003|Expansion Stage 2A|Adverse Event|0|||
161151136|NCT01312428|581935445|FG001|Overall Study|Study Termination|4|||
161151137|NCT00431847|581935449|FG000|Overall Study|completion of less than two study visits|6|||
161151138|NCT00431847|581935450|FG001|Overall Study|completion of less than two study visits|3|||
161151139|NCT00431847|581935451|FG002|Overall Study|completion of less than two study visits|4|||
161151140|NCT00431847|581935452|FG003|Overall Study|completion of less than two study visits|14|||
161151141|NCT00431847|581935453|FG004|Overall Study|completion of less than two study visits|0|||
161151142|NCT00431847|581935449|FG000|Overall Study|Protocol Violation|0|||
161281009|NCT00996892|582407006|FG004|Expansion Stage 2A|Adverse Event|0|||
161151143|NCT00431847|581935450|FG001|Overall Study|Protocol Violation|0|||
161151144|NCT00431847|581935451|FG002|Overall Study|Protocol Violation|0|||
161281010|NCT00996892|582407007|FG005|Expansion Stage 2A|Adverse Event|0|||
161281011|NCT00996892|582407008|FG006|Expansion Stage 2A|Adverse Event|0|||
161051273|NCT01730118|581576684|FG006|Dose Expansion|Inability to return|0|||
161051274|NCT01730118|581576678|FG000|Dose Expansion|Physician Decision|0|||
161051275|NCT01730118|581576679|FG001|Dose Expansion|Physician Decision|0|||
161051276|NCT01730118|581576680|FG002|Dose Expansion|Physician Decision|0|||
161051277|NCT01730118|581576681|FG003|Dose Expansion|Physician Decision|0|||
161051278|NCT01730118|581576682|FG004|Dose Expansion|Physician Decision|0|||
161051279|NCT01730118|581576683|FG005|Dose Expansion|Physician Decision|1|||
161281012|NCT00996892|582407009|FG007|Expansion Stage 2A|Adverse Event|0|||
161151145|NCT00431847|581935452|FG003|Overall Study|Protocol Violation|0|||
161151146|NCT00431847|581935453|FG004|Overall Study|Protocol Violation|1|||
161151147|NCT00339183|581935454|FG000|Overall Study|Adverse Event|5|||
161151148|NCT00339183|581935455|FG001|Overall Study|Adverse Event|3|||
161151149|NCT00339183|581935454|FG000|Overall Study|Withdrawal by Subject|16|||
161151150|NCT00339183|581935455|FG001|Overall Study|Withdrawal by Subject|19|||
161151151|NCT00339183|581935454|FG000|Overall Study|Physician Decision|2|||
161151152|NCT00339183|581935455|FG001|Overall Study|Physician Decision|4|||
161151153|NCT00339183|581935454|FG000|Overall Study|Lost to Follow-up|17|||
161151154|NCT00339183|581935455|FG001|Overall Study|Lost to Follow-up|17|||
161151155|NCT00339183|581935454|FG000|Overall Study|Protocol-specified criteria|12|||
161151156|NCT00339183|581935455|FG001|Overall Study|Protocol-specified criteria|8|||
161151157|NCT00339183|581935454|FG000|Overall Study|Missing reason|3|||
161151158|NCT00339183|581935455|FG001|Overall Study|Missing reason|1|||
161151159|NCT00339183|581935454|FG000|Overall Study|Other|46|||
161151160|NCT00339183|581935455|FG001|Overall Study|Other|40|||
161151161|NCT00339183|581935454|FG000|Overall Study|Ongoing|20|||
161151162|NCT00339183|581935455|FG001|Overall Study|Ongoing|13|||
161151163|NCT00793819|581935456|FG000|Overall Study|Adverse Event|8|||
161151164|NCT00793819|581935457|FG001|Overall Study|Adverse Event|4|||
161151165|NCT00793819|581935456|FG000|Overall Study|Lack of Efficacy|1|||
161151166|NCT00793819|581935457|FG001|Overall Study|Lack of Efficacy|1|||
161151167|NCT00793819|581935456|FG000|Overall Study|Withdrawal by Subject|4|||
161151168|NCT00793819|581935457|FG001|Overall Study|Withdrawal by Subject|3|||
161151169|NCT00793819|581935456|FG000|Overall Study|Lost to Follow-up|1|||
161151170|NCT00793819|581935457|FG001|Overall Study|Lost to Follow-up|1|||
161151171|NCT00002663|581935458|FG000|Overall Study|Death|4|||
161151172|NCT00002663|581935459|FG001|Overall Study|Death|1|||
161151173|NCT00002663|581935460|FG002|Overall Study|Death|1|||
161151174|NCT00002663|581935461|FG003|Overall Study|Death|0|||
161151175|NCT00002663|581935462|FG004|Overall Study|Death|0|||
161151176|NCT00002663|581935463|FG005|Overall Study|Death|13|||
161151177|NCT00002663|581935464|FG006|Overall Study|Death|0|||
161151178|NCT00002663|581935465|FG007|Overall Study|Death|1|||
161151179|NCT00002663|581935466|FG008|Overall Study|Death|1|||
161151180|NCT00002663|581935467|FG009|Overall Study|Death|1|||
161151181|NCT00002663|581935458|FG000|Overall Study|Lost to Follow-up|3|||
161151182|NCT00002663|581935459|FG001|Overall Study|Lost to Follow-up|0|||
161151183|NCT00002663|581935460|FG002|Overall Study|Lost to Follow-up|0|||
161151184|NCT00002663|581935461|FG003|Overall Study|Lost to Follow-up|1|||
161151185|NCT00002663|581935462|FG004|Overall Study|Lost to Follow-up|0|||
161151186|NCT00002663|581935463|FG005|Overall Study|Lost to Follow-up|1|||
161151187|NCT00002663|581935464|FG006|Overall Study|Lost to Follow-up|0|||
161051280|NCT01730118|581576684|FG006|Dose Expansion|Physician Decision|0|||
161051281|NCT05379400|581576690|FG000|Overall Study|Lost to Follow-up|1|||
161051282|NCT05379400|581576691|FG001|Overall Study|Lost to Follow-up|1|||
161051283|NCT04851587|581576693|FG000|Overall Study|Lost to Follow-up|18|||
161051284|NCT01020487|581576697|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
161051285|NCT01020487|581576698|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
161051286|NCT01020487|581576699|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
161051287|NCT01020487|581576697|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
161051288|NCT01020487|581576698|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
161051289|NCT01020487|581576699|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
161051290|NCT01020487|581576697|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
161051291|NCT01020487|581576698|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
161051292|NCT01020487|581576699|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
161151188|NCT00002663|581935465|FG007|Overall Study|Lost to Follow-up|0|||
161151189|NCT00002663|581935466|FG008|Overall Study|Lost to Follow-up|0|||
161151190|NCT00002663|581935467|FG009|Overall Study|Lost to Follow-up|0|||
161151191|NCT00002663|581935458|FG000|Overall Study|Other|0|||
161051293|NCT01020487|581576697|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
161051294|NCT01020487|581576698|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
161151192|NCT00002663|581935459|FG001|Overall Study|Other|1|||
161151193|NCT00002663|581935460|FG002|Overall Study|Other|0|||
161151194|NCT00002663|581935461|FG003|Overall Study|Other|0|||
161151195|NCT00002663|581935462|FG004|Overall Study|Other|0|||
161151196|NCT00002663|581935463|FG005|Overall Study|Other|1|||
161151197|NCT00002663|581935464|FG006|Overall Study|Other|1|||
161151198|NCT00002663|581935465|FG007|Overall Study|Other|0|||
161151199|NCT00002663|581935466|FG008|Overall Study|Other|0|||
161151200|NCT00002663|581935467|FG009|Overall Study|Other|0|||
161281013|NCT00996892|582407010|FG008|Expansion Stage 2A|Adverse Event|0|||
161281014|NCT00996892|582407011|FG009|Expansion Stage 2A|Adverse Event|0|||
161151201|NCT00002663|581935458|FG000|Overall Study|Physician Decision|0|||
161151202|NCT00002663|581935459|FG001|Overall Study|Physician Decision|0|||
161151203|NCT00002663|581935460|FG002|Overall Study|Physician Decision|0|||
161151204|NCT00002663|581935461|FG003|Overall Study|Physician Decision|0|||
161151205|NCT00002663|581935462|FG004|Overall Study|Physician Decision|1|||
161151206|NCT00002663|581935463|FG005|Overall Study|Physician Decision|0|||
161281015|NCT00996892|582407012|FG010|Expansion Stage 2A|Adverse Event|0|||
161051295|NCT01020487|581576699|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
161051296|NCT01020487|581576697|FG000|Part 2 Open-label Period|Adverse Event|0|||
161051297|NCT01020487|581576698|FG001|Part 2 Open-label Period|Adverse Event|4|||
161051298|NCT01020487|581576699|FG002|Part 2 Open-label Period|Adverse Event|1|||
161051299|NCT04049578|581576700|FG000|Overall Study|Physician Decision|1|||
161051300|NCT05878990|581576701|FG000|Overall Study|Lost to Follow-up|7|||
161051301|NCT05878990|581576701|FG000|Overall Study|Withdrawal by Subject|1|||
161051302|NCT03409276|581576702|FG000|Overall Study|Withdrawal by Subject|0|||
161051303|NCT03409276|581576703|FG001|Overall Study|Withdrawal by Subject|0|||
161051304|NCT03409276|581576704|FG002|Overall Study|Withdrawal by Subject|0|||
161051305|NCT03409276|581576705|FG003|Overall Study|Withdrawal by Subject|0|||
161051306|NCT03409276|581576706|FG004|Overall Study|Withdrawal by Subject|1|||
161051307|NCT03409276|581576702|FG000|Overall Study|Lost to Follow-up|0|||
161051308|NCT03409276|581576703|FG001|Overall Study|Lost to Follow-up|0|||
161051309|NCT03409276|581576704|FG002|Overall Study|Lost to Follow-up|0|||
161051310|NCT03409276|581576705|FG003|Overall Study|Lost to Follow-up|2|||
161051311|NCT03409276|581576706|FG004|Overall Study|Lost to Follow-up|2|||
161051312|NCT03605745|581576707|FG000|Overall Study|Study was terminated for business reasons|47|||
161051313|NCT01279447|581576708|FG000|Overall Study|Lost to Follow-up|3|||
161051314|NCT01279447|581576709|FG001|Overall Study|Lost to Follow-up|1|||
161051315|NCT01074229|581576710|FG000|Overall Study|Lost to Follow-up|1|||
161051316|NCT01074229|581576711|FG001|Overall Study|Lost to Follow-up|0|||
161051317|NCT01074229|581576712|FG002|Overall Study|Lost to Follow-up|0|||
161051318|NCT01074229|581576710|FG000|Overall Study|Change to open surgical procedure|1|||
161051319|NCT01074229|581576711|FG001|Overall Study|Change to open surgical procedure|3|||
161051320|NCT01074229|581576712|FG002|Overall Study|Change to open surgical procedure|4|||
161051321|NCT04454125|581576713|FG000|Overall Study|Lost to Follow-up|0|||
161051322|NCT04454125|581576714|FG001|Overall Study|Lost to Follow-up|1|||
161051323|NCT01183013|581576715|FG000|Overall Study|Adverse Event|6|||
161051324|NCT01183013|581576716|FG001|Overall Study|Adverse Event|8|||
161051325|NCT01183013|581576717|FG002|Overall Study|Adverse Event|5|||
161051326|NCT01183013|581576718|FG003|Overall Study|Adverse Event|5|||
161051327|NCT01183013|581576719|FG004|Overall Study|Adverse Event|10|||
161051328|NCT01183013|581576720|FG005|Overall Study|Adverse Event|10|||
161051329|NCT01183013|581576721|FG006|Overall Study|Adverse Event|6|||
161051330|NCT01183013|581576715|FG000|Overall Study|Lack of Efficacy|3|||
161051331|NCT01183013|581576716|FG001|Overall Study|Lack of Efficacy|2|||
161051332|NCT01183013|581576717|FG002|Overall Study|Lack of Efficacy|1|||
161051333|NCT01183013|581576718|FG003|Overall Study|Lack of Efficacy|2|||
161051334|NCT01183013|581576719|FG004|Overall Study|Lack of Efficacy|1|||
161051335|NCT01183013|581576720|FG005|Overall Study|Lack of Efficacy|2|||
161051336|NCT01183013|581576721|FG006|Overall Study|Lack of Efficacy|0|||
161051337|NCT01183013|581576715|FG000|Overall Study|Protocol Violation|5|||
161051338|NCT01183013|581576716|FG001|Overall Study|Protocol Violation|2|||
161051339|NCT01183013|581576717|FG002|Overall Study|Protocol Violation|4|||
161051340|NCT01183013|581576718|FG003|Overall Study|Protocol Violation|0|||
161051341|NCT01183013|581576719|FG004|Overall Study|Protocol Violation|4|||
161051342|NCT01183013|581576720|FG005|Overall Study|Protocol Violation|3|||
161051343|NCT01183013|581576721|FG006|Overall Study|Protocol Violation|3|||
161051344|NCT01183013|581576715|FG000|Overall Study|Lost to Follow-up|7|||
161051345|NCT01183013|581576716|FG001|Overall Study|Lost to Follow-up|3|||
161051346|NCT01183013|581576717|FG002|Overall Study|Lost to Follow-up|4|||
161051347|NCT01183013|581576718|FG003|Overall Study|Lost to Follow-up|3|||
161051348|NCT01183013|581576719|FG004|Overall Study|Lost to Follow-up|2|||
161051349|NCT01183013|581576720|FG005|Overall Study|Lost to Follow-up|6|||
161051350|NCT01183013|581576721|FG006|Overall Study|Lost to Follow-up|5|||
161151207|NCT00002663|581935464|FG006|Overall Study|Physician Decision|0|||
161151208|NCT00002663|581935465|FG007|Overall Study|Physician Decision|0|||
161151209|NCT00002663|581935466|FG008|Overall Study|Physician Decision|1|||
161151210|NCT00002663|581935467|FG009|Overall Study|Physician Decision|1|||
161151211|NCT00002663|581935458|FG000|Overall Study|Adverse Event|0|||
161151212|NCT00002663|581935459|FG001|Overall Study|Adverse Event|0|||
161151213|NCT00002663|581935460|FG002|Overall Study|Adverse Event|0|||
161151214|NCT00002663|581935461|FG003|Overall Study|Adverse Event|1|||
161051351|NCT01183013|581576715|FG000|Overall Study|Withdrawal by Subject|9|||
161051352|NCT01183013|581576716|FG001|Overall Study|Withdrawal by Subject|13|||
161051353|NCT01183013|581576717|FG002|Overall Study|Withdrawal by Subject|10|||
161051354|NCT01183013|581576718|FG003|Overall Study|Withdrawal by Subject|8|||
161051355|NCT01183013|581576719|FG004|Overall Study|Withdrawal by Subject|7|||
161051356|NCT01183013|581576720|FG005|Overall Study|Withdrawal by Subject|9|||
161051357|NCT01183013|581576721|FG006|Overall Study|Withdrawal by Subject|10|||
161051358|NCT01183013|581576715|FG000|Overall Study|Reasons other than stated above|15|||
161051359|NCT01183013|581576716|FG001|Overall Study|Reasons other than stated above|11|||
161051360|NCT01183013|581576717|FG002|Overall Study|Reasons other than stated above|17|||
161051361|NCT01183013|581576718|FG003|Overall Study|Reasons other than stated above|12|||
161051362|NCT01183013|581576719|FG004|Overall Study|Reasons other than stated above|12|||
161051363|NCT01183013|581576720|FG005|Overall Study|Reasons other than stated above|15|||
161051364|NCT01183013|581576721|FG006|Overall Study|Reasons other than stated above|13|||
161051365|NCT02092909|581576722|FG000|Overall Study|Adverse Event|0|||
161051366|NCT02092909|581576723|FG001|Overall Study|Adverse Event|0|||
161051367|NCT02092909|581576724|FG002|Overall Study|Adverse Event|4|||
161051368|NCT02092909|581576725|FG003|Overall Study|Adverse Event|2|||
161051369|NCT02092909|581576722|FG000|Overall Study|Lack of Efficacy|0|||
161051370|NCT02092909|581576723|FG001|Overall Study|Lack of Efficacy|2|||
161051371|NCT02092909|581576724|FG002|Overall Study|Lack of Efficacy|1|||
161051372|NCT02092909|581576725|FG003|Overall Study|Lack of Efficacy|0|||
161051373|NCT02092909|581576722|FG000|Overall Study|Withdrawal by Subject|0|||
161051374|NCT02092909|581576723|FG001|Overall Study|Withdrawal by Subject|0|||
161051375|NCT02092909|581576724|FG002|Overall Study|Withdrawal by Subject|2|||
161051376|NCT02092909|581576725|FG003|Overall Study|Withdrawal by Subject|1|||
161051377|NCT02092909|581576722|FG000|Overall Study|Study terminated by Sponsor|0|||
161051378|NCT02092909|581576723|FG001|Overall Study|Study terminated by Sponsor|0|||
161051379|NCT02092909|581576724|FG002|Overall Study|Study terminated by Sponsor|0|||
161051380|NCT02092909|581576725|FG003|Overall Study|Study terminated by Sponsor|2|||
161051381|NCT02092909|581576722|FG000|Overall Study|Miscellaneous|1|||
161051382|NCT02092909|581576723|FG001|Overall Study|Miscellaneous|1|||
161051383|NCT02092909|581576724|FG002|Overall Study|Miscellaneous|2|||
161051384|NCT02092909|581576725|FG003|Overall Study|Miscellaneous|1|||
161051385|NCT02727998|581576726|FG000|Overall Study|Lost to Follow-up|3|||
161051386|NCT02727998|581576727|FG001|Overall Study|Lost to Follow-up|3|||
161051387|NCT02727998|581576726|FG000|Overall Study|Withdrawal by Subject|0|||
161051388|NCT02727998|581576727|FG001|Overall Study|Withdrawal by Subject|1|||
161051389|NCT02105688|581576728|FG000|Part A: Double-Blind|Adverse Event|1|||
161051390|NCT02105688|581576729|FG001|Part A: Double-Blind|Adverse Event|0|||
161051391|NCT02105688|581576728|FG000|Part A: Double-Blind|Death|0|||
161051392|NCT02105688|581576729|FG001|Part A: Double-Blind|Death|1|||
161051393|NCT02105688|581576728|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
161051394|NCT02105688|581576729|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
161051395|NCT02105688|581576728|FG000|Part A: Double-Blind|Physician Decision|0|||
161051396|NCT02105688|581576729|FG001|Part A: Double-Blind|Physician Decision|1|||
161051397|NCT02105688|581576728|FG000|Part A: Double-Blind|Status Unknown|0|||
161051398|NCT02105688|581576729|FG001|Part A: Double-Blind|Status Unknown|2|||
161051399|NCT02105688|581576728|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
161051400|NCT02105688|581576729|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
161051401|NCT02105688|581576728|FG000|Part B: Observational Follow-up|Death|2|||
161051402|NCT02105688|581576729|FG001|Part B: Observational Follow-up|Death|1|||
161051403|NCT02105688|581576728|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
161051404|NCT02105688|581576729|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
161051405|NCT02105688|581576728|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
161051406|NCT02105688|581576729|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
161051407|NCT02105688|581576728|FG000|Part B: Observational Follow-up|Physician Decision|3|||
161051408|NCT02105688|581576729|FG001|Part B: Observational Follow-up|Physician Decision|1|||
161051409|NCT00901459|581576732|FG000|Overall Study|Withdrawal by Subject|6|||
161051410|NCT00910871|581576744|FG000|Overall Study|Adverse Event|5|||
161051411|NCT00910871|581576744|FG000|Overall Study|Death|12|||
161051412|NCT00910871|581576744|FG000|Overall Study|Lost to Follow-up|8|||
161051413|NCT00910871|581576744|FG000|Overall Study|Protocol Violation|11|||
161051414|NCT00910871|581576744|FG000|Overall Study|Withdrawal by Subject|12|||
161051415|NCT00910871|581576744|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
161051416|NCT00910871|581576744|FG000|Overall Study|Undefined|1|||
161051417|NCT00850993|581576745|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
161051418|NCT00850993|581576746|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
161051419|NCT00850993|581576747|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
161051420|NCT00850993|581576748|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
161051421|NCT04501614|581576755|FG000|Overall Study|Study Terminated by Sponsor|6|||
161051422|NCT04501614|581576756|FG001|Overall Study|Study Terminated by Sponsor|3|||
161051423|NCT04501614|581576755|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
161051424|NCT04501614|581576756|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
161051425|NCT02555397|581576760|FG000|Overall Study|Withdrawal by Subject|1|||
161051426|NCT02555397|581576761|FG001|Overall Study|Withdrawal by Subject|0|||
161051427|NCT02555397|581576762|FG002|Overall Study|Withdrawal by Subject|0|||
161051428|NCT02555397|581576763|FG003|Overall Study|Withdrawal by Subject|0|||
161051429|NCT02555397|581576764|FG004|Overall Study|Withdrawal by Subject|0|||
161051430|NCT04529941|581576767|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
161051431|NCT04529941|581576768|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
161051432|NCT01005914|581576770|FG000|Overall Study|Adverse Event|4|||
161051433|NCT01005914|581576770|FG000|Overall Study|Death|4|||
161051434|NCT01005914|581576770|FG000|Overall Study|Lack of Efficacy|1|||
161051435|NCT01005914|581576770|FG000|Overall Study|Withdrawal by Subject|1|||
161051436|NCT00237809|581576773|FG000|Overall Study|Lost to Follow-up|11|||
161051437|NCT00237809|581576774|FG001|Overall Study|Lost to Follow-up|10|||
161051438|NCT00237809|581576775|FG002|Overall Study|Lost to Follow-up|9|||
161051439|NCT00237809|581576776|FG003|Overall Study|Lost to Follow-up|9|||
161151215|NCT00002663|581935462|FG004|Overall Study|Adverse Event|0|||
161151216|NCT00002663|581935463|FG005|Overall Study|Adverse Event|0|||
161151217|NCT00002663|581935464|FG006|Overall Study|Adverse Event|0|||
161151218|NCT00002663|581935465|FG007|Overall Study|Adverse Event|1|||
161151219|NCT00002663|581935466|FG008|Overall Study|Adverse Event|0|||
161151220|NCT00002663|581935467|FG009|Overall Study|Adverse Event|0|||
161151221|NCT05100199|581935469|FG000|Overall Study|Lost to Follow-up|5|||
161151222|NCT05100199|581935470|FG001|Overall Study|Lost to Follow-up|8|||
161151223|NCT05100199|581935471|FG002|Overall Study|Lost to Follow-up|3|||
161151224|NCT05100199|581935472|FG003|Overall Study|Lost to Follow-up|6|||
161151225|NCT05100199|581935469|FG000|Overall Study|Withdrawal by Subject|3|||
161151226|NCT05100199|581935470|FG001|Overall Study|Withdrawal by Subject|3|||
161151227|NCT05100199|581935471|FG002|Overall Study|Withdrawal by Subject|9|||
161151228|NCT05100199|581935472|FG003|Overall Study|Withdrawal by Subject|7|||
161151229|NCT05100199|581935469|FG000|Overall Study|Other|0|||
161151230|NCT05100199|581935470|FG001|Overall Study|Other|0|||
161151231|NCT05100199|581935471|FG002|Overall Study|Other|1|||
161151232|NCT05100199|581935472|FG003|Overall Study|Other|1|||
161151233|NCT01455428|581935473|FG000|Overall Study|Protocol Violation|2|||
161151234|NCT01455428|581935474|FG001|Overall Study|Protocol Violation|1|||
161151235|NCT01455428|581935473|FG000|Overall Study|Adverse Event|6|||
161151236|NCT01455428|581935474|FG001|Overall Study|Adverse Event|2|||
161151237|NCT01455428|581935473|FG000|Overall Study|Lost to Follow-up|1|||
161151238|NCT01455428|581935474|FG001|Overall Study|Lost to Follow-up|1|||
161151239|NCT01455428|581935473|FG000|Overall Study|Withdrawal by Subject|2|||
161151240|NCT01455428|581935474|FG001|Overall Study|Withdrawal by Subject|5|||
161151241|NCT01455428|581935473|FG000|Overall Study|Did not meet entrance criteria|0|||
161151242|NCT01455428|581935474|FG001|Overall Study|Did not meet entrance criteria|2|||
161151243|NCT01455428|581935473|FG000|Overall Study|Insufficient clinical response|0|||
161151244|NCT01455428|581935474|FG001|Overall Study|Insufficient clinical response|2|||
161151245|NCT01455428|581935473|FG000|Overall Study|Did not receive treatment|1|||
161151246|NCT01455428|581935474|FG001|Overall Study|Did not receive treatment|1|||
161151247|NCT01455428|581935473|FG000|Overall Study|Other|2|||
161151248|NCT01455428|581935474|FG001|Overall Study|Other|4|||
161151249|NCT00257192|581935480|FG000|Overall Study|Adverse Event|21|||
161151250|NCT00257192|581935481|FG001|Overall Study|Adverse Event|10|||
161151251|NCT00257192|581935480|FG000|Overall Study|Laboratory abnormality|1|||
161151252|NCT00257192|581935481|FG001|Overall Study|Laboratory abnormality|1|||
161151253|NCT00257192|581935480|FG000|Overall Study|Lost to Follow-up|3|||
161151254|NCT00257192|581935481|FG001|Overall Study|Lost to Follow-up|3|||
161151255|NCT00257192|581935480|FG000|Overall Study|Insufficient clinical response|18|||
161151256|NCT00257192|581935481|FG001|Overall Study|Insufficient clinical response|18|||
161151257|NCT00257192|581935480|FG000|Overall Study|Withdrawal by Subject|14|||
161151258|NCT00257192|581935481|FG001|Overall Study|Withdrawal by Subject|2|||
161151259|NCT00257192|581935480|FG000|Overall Study|Randomized but not treated|0|||
161151260|NCT00257192|581935481|FG001|Overall Study|Randomized but not treated|1|||
161151261|NCT00257192|581935480|FG000|Overall Study|Study terminated by sponsor|1|||
161151262|NCT00257192|581935481|FG001|Overall Study|Study terminated by sponsor|0|||
161151263|NCT00257192|581935480|FG000|Overall Study|Miscellaneous|0|||
161151264|NCT00257192|581935481|FG001|Overall Study|Miscellaneous|4|||
161151265|NCT02062151|581935482|FG000|Overall Study|screen failure|1|||
161151266|NCT02021812|581935483|FG000|Overall Study|Death|8|||
161151267|NCT02021812|581935483|FG000|Overall Study|Withdrawal by Subject|3|||
161151268|NCT02021812|581935483|FG000|Overall Study|Lost to Follow-up|2|||
161151269|NCT02021812|581935483|FG000|Overall Study|Refuse to return, COVD 19|2|||
161151270|NCT02119104|581935484|FG000|Overall Study|Protocol Violation|16|||
161151271|NCT01651260|581935486|FG000|Overall Study|unable to apply product|3|||
161151272|NCT01952015|581935489|FG000|Induction|Protocol Violation|1|||
161151273|NCT01952015|581935489|FG000|Maintenance|Adverse Event|2|||
161151274|NCT01952015|581935489|FG000|Treatment Period 3|Physician Decision|9|||
161151275|NCT02239094|581935490|FG000|Overall Study|Withdrawal by Subject|1|||
161151276|NCT02239094|581935490|FG000|Overall Study|Remitted before started|1|||
161151277|NCT01469052|581935495|FG000|Overall Study|Adverse Event|2|||
161151278|NCT01469052|581935496|FG001|Overall Study|Adverse Event|3|||
161151279|NCT01469052|581935497|FG002|Overall Study|Adverse Event|0|||
161151280|NCT01469052|581935498|FG003|Overall Study|Adverse Event|2|||
161151281|NCT01469052|581935499|FG004|Overall Study|Adverse Event|0|||
161151282|NCT01469052|581935500|FG005|Overall Study|Adverse Event|1|||
161151283|NCT01469052|581935495|FG000|Overall Study|Progressive disease|3|||
161151284|NCT01469052|581935496|FG001|Overall Study|Progressive disease|0|||
161151285|NCT01469052|581935497|FG002|Overall Study|Progressive disease|5|||
161151286|NCT01469052|581935498|FG003|Overall Study|Progressive disease|3|||
161151287|NCT01469052|581935499|FG004|Overall Study|Progressive disease|7|||
161151288|NCT01469052|581935500|FG005|Overall Study|Progressive disease|2|||
161151289|NCT01469052|581935495|FG000|Overall Study|Lack of Efficacy|0|||
161151290|NCT01469052|581935496|FG001|Overall Study|Lack of Efficacy|0|||
161151291|NCT01469052|581935497|FG002|Overall Study|Lack of Efficacy|0|||
161151292|NCT01469052|581935498|FG003|Overall Study|Lack of Efficacy|0|||
161151293|NCT01469052|581935499|FG004|Overall Study|Lack of Efficacy|0|||
161281016|NCT00996892|582407013|FG011|Expansion Stage 2A|Adverse Event|0|||
161051440|NCT00321555|581576782|FG000|Overall Study|Developed antibodies|1|||
161051441|NCT00321555|581576782|FG000|Overall Study|Switched to alternative treatment|3|||
161051442|NCT00321555|581576782|FG000|Overall Study|Physician Decision|1|||
161051443|NCT00321555|581576782|FG000|Overall Study|Disease progression on study|1|||
161051444|NCT02066389|581576783|FG000|Overall Study|Adverse Event|1|||
161051445|NCT02066389|581576784|FG001|Overall Study|Adverse Event|1|||
161051446|NCT02066389|581576785|FG002|Overall Study|Adverse Event|1|||
161051447|NCT02066389|581576786|FG003|Overall Study|Adverse Event|1|||
161051448|NCT02066389|581576787|FG004|Overall Study|Adverse Event|5|||
161051449|NCT02066389|581576788|FG005|Overall Study|Adverse Event|1|||
161051450|NCT02066389|581576783|FG000|Overall Study|Withdrawal by Subject|4|||
161051451|NCT02066389|581576784|FG001|Overall Study|Withdrawal by Subject|0|||
161051452|NCT02066389|581576785|FG002|Overall Study|Withdrawal by Subject|5|||
161051453|NCT02066389|581576786|FG003|Overall Study|Withdrawal by Subject|1|||
161051454|NCT02066389|581576787|FG004|Overall Study|Withdrawal by Subject|1|||
161051455|NCT02066389|581576788|FG005|Overall Study|Withdrawal by Subject|2|||
161051456|NCT02066389|581576783|FG000|Overall Study|Lost to Follow-up|0|||
161051457|NCT02066389|581576784|FG001|Overall Study|Lost to Follow-up|0|||
161051458|NCT02066389|581576785|FG002|Overall Study|Lost to Follow-up|0|||
161051459|NCT02066389|581576786|FG003|Overall Study|Lost to Follow-up|1|||
161051460|NCT02066389|581576787|FG004|Overall Study|Lost to Follow-up|1|||
161051461|NCT02066389|581576788|FG005|Overall Study|Lost to Follow-up|1|||
161051462|NCT02066389|581576783|FG000|Overall Study|Randomized in Error|0|||
161051463|NCT02066389|581576784|FG001|Overall Study|Randomized in Error|0|||
161051464|NCT02066389|581576785|FG002|Overall Study|Randomized in Error|0|||
161051465|NCT02066389|581576786|FG003|Overall Study|Randomized in Error|0|||
161051466|NCT02066389|581576787|FG004|Overall Study|Randomized in Error|0|||
161051467|NCT02066389|581576788|FG005|Overall Study|Randomized in Error|1|||
161051468|NCT02561195|581576790|FG000|Vaccination 1 to 3|Adverse Event|4|||
161051469|NCT02561195|581576791|FG001|Vaccination 1 to 3|Adverse Event|5|||
161051470|NCT02561195|581576792|FG002|Vaccination 1 to 3|Adverse Event|0|||
161051471|NCT02561195|581576793|FG003|Vaccination 1 to 3|Adverse Event|3|||
161051472|NCT02561195|581576794|FG004|Vaccination 1 to 3|Adverse Event|4|||
161051473|NCT02561195|581576795|FG005|Vaccination 1 to 3|Adverse Event|0|||
161051474|NCT02561195|581576796|FG006|Vaccination 1 to 3|Adverse Event|0|||
161051475|NCT02561195|581576797|FG007|Vaccination 1 to 3|Adverse Event|0|||
161051476|NCT02561195|581576798|FG008|Vaccination 1 to 3|Adverse Event|0|||
161051477|NCT02561195|581576799|FG009|Vaccination 1 to 3|Adverse Event|0|||
161051478|NCT02561195|581576800|FG010|Vaccination 1 to 3|Adverse Event|0|||
161051479|NCT02561195|581576801|FG011|Vaccination 1 to 3|Adverse Event|0|||
161051480|NCT02561195|581576802|FG012|Vaccination 1 to 3|Adverse Event|0|||
161051481|NCT02561195|581576803|FG013|Vaccination 1 to 3|Adverse Event|0|||
161051482|NCT02561195|581576790|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
161051483|NCT02561195|581576791|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
161051484|NCT02561195|581576792|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
161051485|NCT02561195|581576793|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
161051486|NCT02561195|581576794|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
161051487|NCT02561195|581576795|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
161051488|NCT02561195|581576796|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
161051489|NCT02561195|581576797|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
161051490|NCT02561195|581576798|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
161051491|NCT02561195|581576799|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
161051492|NCT02561195|581576800|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
161051493|NCT02561195|581576801|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
161051494|NCT02561195|581576802|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
161051495|NCT02561195|581576803|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
161051496|NCT02561195|581576790|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051497|NCT02561195|581576791|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
161051498|NCT02561195|581576792|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051499|NCT02561195|581576793|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
161051500|NCT02561195|581576794|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
161051501|NCT02561195|581576795|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
161051502|NCT02561195|581576796|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051503|NCT02561195|581576797|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051504|NCT02561195|581576798|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051505|NCT02561195|581576799|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051506|NCT02561195|581576800|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051507|NCT02561195|581576801|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051508|NCT02561195|581576802|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051509|NCT02561195|581576803|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
161051510|NCT02561195|581576790|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
161051511|NCT02561195|581576791|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
161051512|NCT02561195|581576792|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
161051513|NCT02561195|581576793|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
161345085|NCT03126110|582648859|FG010|Phase 2|Progressive Disease|0|||
161345086|NCT03126110|582648860|FG011|Phase 2|Progressive Disease|0|||
161345087|NCT03126110|582648861|FG012|Phase 2|Progressive Disease|0|||
161345088|NCT03126110|582648862|FG013|Phase 2|Progressive Disease|1|||
161051514|NCT02561195|581576794|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
161051515|NCT02561195|581576795|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
161051516|NCT02561195|581576796|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
161051517|NCT02561195|581576797|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
161051518|NCT02561195|581576798|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
161051519|NCT02561195|581576799|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
161051520|NCT02561195|581576800|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
161051521|NCT02561195|581576801|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
161051522|NCT02561195|581576802|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
161051523|NCT02561195|581576803|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
161051524|NCT02561195|581576790|FG000|Vaccination 1 to 3|Other|7|||
161051525|NCT02561195|581576791|FG001|Vaccination 1 to 3|Other|3|||
161051526|NCT02561195|581576792|FG002|Vaccination 1 to 3|Other|1|||
161051527|NCT02561195|581576793|FG003|Vaccination 1 to 3|Other|7|||
161051528|NCT02561195|581576794|FG004|Vaccination 1 to 3|Other|5|||
161051529|NCT02561195|581576795|FG005|Vaccination 1 to 3|Other|1|||
161051530|NCT02561195|581576796|FG006|Vaccination 1 to 3|Other|0|||
161051531|NCT02561195|581576797|FG007|Vaccination 1 to 3|Other|0|||
161051532|NCT02561195|581576798|FG008|Vaccination 1 to 3|Other|0|||
161051533|NCT02561195|581576799|FG009|Vaccination 1 to 3|Other|0|||
161051534|NCT02561195|581576800|FG010|Vaccination 1 to 3|Other|0|||
161051535|NCT02561195|581576801|FG011|Vaccination 1 to 3|Other|0|||
161051536|NCT02561195|581576802|FG012|Vaccination 1 to 3|Other|0|||
161051537|NCT02561195|581576803|FG013|Vaccination 1 to 3|Other|0|||
161051538|NCT02561195|581576790|FG000|Vaccination 1 to 3|Protocol Violation|1|||
161051539|NCT02561195|581576791|FG001|Vaccination 1 to 3|Protocol Violation|0|||
161051540|NCT02561195|581576792|FG002|Vaccination 1 to 3|Protocol Violation|1|||
161051541|NCT02561195|581576793|FG003|Vaccination 1 to 3|Protocol Violation|2|||
161051542|NCT02561195|581576794|FG004|Vaccination 1 to 3|Protocol Violation|5|||
161051543|NCT02561195|581576795|FG005|Vaccination 1 to 3|Protocol Violation|2|||
161051544|NCT02561195|581576796|FG006|Vaccination 1 to 3|Protocol Violation|0|||
161051545|NCT02561195|581576797|FG007|Vaccination 1 to 3|Protocol Violation|0|||
161051546|NCT02561195|581576798|FG008|Vaccination 1 to 3|Protocol Violation|0|||
161051547|NCT02561195|581576799|FG009|Vaccination 1 to 3|Protocol Violation|0|||
161051548|NCT02561195|581576800|FG010|Vaccination 1 to 3|Protocol Violation|0|||
161051549|NCT02561195|581576801|FG011|Vaccination 1 to 3|Protocol Violation|0|||
161051550|NCT02561195|581576802|FG012|Vaccination 1 to 3|Protocol Violation|0|||
161051551|NCT02561195|581576803|FG013|Vaccination 1 to 3|Protocol Violation|0|||
161051552|NCT02561195|581576790|FG000|Vaccination 1 to 3|Death|2|||
161051553|NCT02561195|581576791|FG001|Vaccination 1 to 3|Death|1|||
161051554|NCT02561195|581576792|FG002|Vaccination 1 to 3|Death|0|||
161051555|NCT02561195|581576793|FG003|Vaccination 1 to 3|Death|2|||
161051556|NCT02561195|581576794|FG004|Vaccination 1 to 3|Death|0|||
161051557|NCT02561195|581576795|FG005|Vaccination 1 to 3|Death|0|||
161051558|NCT02561195|581576796|FG006|Vaccination 1 to 3|Death|0|||
161051559|NCT02561195|581576797|FG007|Vaccination 1 to 3|Death|0|||
161051560|NCT02561195|581576798|FG008|Vaccination 1 to 3|Death|0|||
161051561|NCT02561195|581576799|FG009|Vaccination 1 to 3|Death|0|||
161051562|NCT02561195|581576800|FG010|Vaccination 1 to 3|Death|0|||
161151294|NCT01469052|581935500|FG005|Overall Study|Lack of Efficacy|2|||
161151295|NCT01469052|581935495|FG000|Overall Study|Moved to rollover protocol|1|||
161151296|NCT01469052|581935496|FG001|Overall Study|Moved to rollover protocol|0|||
161151297|NCT01469052|581935497|FG002|Overall Study|Moved to rollover protocol|1|||
161151298|NCT01469052|581935498|FG003|Overall Study|Moved to rollover protocol|0|||
161151299|NCT01469052|581935499|FG004|Overall Study|Moved to rollover protocol|0|||
161151300|NCT01469052|581935500|FG005|Overall Study|Moved to rollover protocol|1|||
161151301|NCT01469052|581935495|FG000|Overall Study|Other|0|||
161151302|NCT01469052|581935496|FG001|Overall Study|Other|1|||
161151303|NCT01469052|581935497|FG002|Overall Study|Other|0|||
161151304|NCT01469052|581935498|FG003|Overall Study|Other|0|||
161151305|NCT01469052|581935499|FG004|Overall Study|Other|1|||
161151306|NCT01469052|581935500|FG005|Overall Study|Other|0|||
161345089|NCT03126110|582648863|FG014|Phase 2|Progressive Disease|0|||
161051563|NCT02561195|581576801|FG011|Vaccination 1 to 3|Death|0|||
161051564|NCT02561195|581576802|FG012|Vaccination 1 to 3|Death|0|||
161051565|NCT02561195|581576803|FG013|Vaccination 1 to 3|Death|0|||
161051566|NCT02561195|581576790|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
161051567|NCT02561195|581576791|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
161051568|NCT02561195|581576792|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
161345090|NCT03126110|582648864|FG015|Phase 2|Progressive Disease|0|||
161051569|NCT02561195|581576793|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
161051570|NCT02561195|581576794|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
161051571|NCT02561195|581576795|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
161151307|NCT02508701|581935501|FG000|Overall Study|Lost to Follow-up|9|||
161151308|NCT02508701|581935502|FG001|Overall Study|Lost to Follow-up|5|||
161051572|NCT02561195|581576796|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051573|NCT02561195|581576797|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051574|NCT02561195|581576798|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051575|NCT02561195|581576799|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051576|NCT02561195|581576800|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051577|NCT02561195|581576801|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051578|NCT02561195|581576802|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051579|NCT02561195|581576803|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
161051580|NCT02561195|581576790|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
161051581|NCT02561195|581576791|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
161051582|NCT02561195|581576792|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
161051583|NCT02561195|581576793|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
161051584|NCT02561195|581576794|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
161051585|NCT02561195|581576795|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
161051586|NCT02561195|581576796|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
161051587|NCT02561195|581576797|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
161051588|NCT02561195|581576798|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
161051589|NCT02561195|581576799|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
161051590|NCT02561195|581576800|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
161051591|NCT02561195|581576801|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
161051592|NCT02561195|581576802|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
161051593|NCT02561195|581576803|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
161051594|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051595|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051596|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051597|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051598|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051599|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051600|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051601|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051602|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
161051603|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
161051604|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
161051605|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
161051606|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
161051607|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
161051608|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051609|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051610|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051611|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051612|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051613|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051614|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051615|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051616|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051617|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051618|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051619|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051620|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
161051621|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
161051622|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|Death|0|||
161051623|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|Death|0|||
161051624|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|Death|0|||
161051625|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|Death|0|||
161051626|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|Death|0|||
161051627|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|Death|0|||
161051628|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|Death|0|||
161051629|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|Death|0|||
161051630|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|Death|0|||
161051631|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|Death|1|||
161051632|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|Death|0|||
161051633|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|Death|0|||
161051634|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|Death|0|||
161051635|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|Death|0|||
161051636|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051637|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051638|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051639|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051640|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051641|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051642|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161151309|NCT02508701|581935503|FG002|Overall Study|Lost to Follow-up|5|||
161051643|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161051644|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051645|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
161051646|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
161051647|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161051648|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
161051649|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
161051650|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051651|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051652|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051653|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051654|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051655|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051656|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051657|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051658|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051659|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051660|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
161051661|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161051662|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161051663|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
161051664|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|Other|0|||
161051665|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|Other|0|||
161051666|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|Other|0|||
161051667|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|Other|0|||
161051668|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|Other|0|||
161051669|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|Other|0|||
161051670|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|Other|0|||
161051671|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|Other|0|||
161051672|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|Other|0|||
161051673|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|Other|0|||
161051674|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|Other|2|||
161051675|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|Other|2|||
161051676|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|Other|1|||
161051677|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|Other|0|||
161051678|NCT02561195|581576790|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051679|NCT02561195|581576791|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051680|NCT02561195|581576792|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051681|NCT02561195|581576793|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051682|NCT02561195|581576794|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051683|NCT02561195|581576795|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051684|NCT02561195|581576796|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
161051685|NCT02561195|581576797|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051686|NCT02561195|581576798|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051687|NCT02561195|581576799|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051688|NCT02561195|581576800|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
161051689|NCT02561195|581576801|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
161051690|NCT02561195|581576802|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
161051691|NCT02561195|581576803|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
161051692|NCT03905512|581576804|FG000|Overall Study|Withdrawal by Subject|9|||
161051693|NCT03905512|581576805|FG001|Overall Study|Withdrawal by Subject|8|||
161051694|NCT03905512|581576804|FG000|Overall Study|Adverse Event|1|||
161051695|NCT03905512|581576805|FG001|Overall Study|Adverse Event|2|||
161051696|NCT03905512|581576804|FG000|Overall Study|Lost to Follow-up|4|||
161051697|NCT03905512|581576805|FG001|Overall Study|Lost to Follow-up|3|||
161051698|NCT03905512|581576804|FG000|Overall Study|Other than Specified|7|||
161051699|NCT03905512|581576805|FG001|Overall Study|Other than Specified|4|||
161051700|NCT00736502|581576812|FG000|Overall Study|Adverse Event|22|||
161051701|NCT00736502|581576812|FG000|Overall Study|Lack of Efficacy|16|||
161051702|NCT00736502|581576812|FG000|Overall Study|Lost to Follow-up|27|||
161051703|NCT00070317|581576813|FG000|Overall Study|Inevaluable (Never Treated)|1|||
161051704|NCT00070317|581576813|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
161051705|NCT00070317|581576813|FG000|Overall Study|Ineligible required test not done|1|||
161051706|NCT00070317|581576813|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
161281017|NCT00996892|582407014|FG012|Expansion Stage 2A|Adverse Event|0|||
161281018|NCT00996892|582407015|FG013|Expansion Stage 2A|Adverse Event|0|||
161281019|NCT00996892|582407016|FG014|Expansion Stage 2A|Adverse Event|0|||
161281020|NCT00996892|582407017|FG015|Expansion Stage 2A|Adverse Event|0|||
161281021|NCT00996892|582407018|FG016|Expansion Stage 2A|Adverse Event|0|||
161051707|NCT00070317|581576813|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
161051708|NCT03987074|581576815|FG000|Overall Study|Withdrew Consent|1|||
161051709|NCT03987074|581576816|FG001|Overall Study|Withdrew Consent|1|||
161051710|NCT03987074|581576817|FG002|Overall Study|Withdrew Consent|0|||
161051711|NCT03987074|581576818|FG003|Overall Study|Withdrew Consent|2|||
161051712|NCT03987074|581576819|FG004|Overall Study|Withdrew Consent|1|||
161051713|NCT03987074|581576815|FG000|Overall Study|Adverse Event|2|||
161051714|NCT03987074|581576816|FG001|Overall Study|Adverse Event|1|||
161051715|NCT03987074|581576817|FG002|Overall Study|Adverse Event|0|||
161051716|NCT03987074|581576818|FG003|Overall Study|Adverse Event|0|||
161051717|NCT03987074|581576819|FG004|Overall Study|Adverse Event|1|||
161051718|NCT03987074|581576815|FG000|Overall Study|Lost to Follow-up|0|||
161051719|NCT03987074|581576816|FG001|Overall Study|Lost to Follow-up|0|||
161051720|NCT03987074|581576817|FG002|Overall Study|Lost to Follow-up|1|||
161051721|NCT03987074|581576818|FG003|Overall Study|Lost to Follow-up|1|||
161051722|NCT03987074|581576819|FG004|Overall Study|Lost to Follow-up|0|||
161051723|NCT03987074|581576815|FG000|Overall Study|Investigator's Discretion|0|||
161051724|NCT03987074|581576816|FG001|Overall Study|Investigator's Discretion|0|||
161051725|NCT03987074|581576817|FG002|Overall Study|Investigator's Discretion|0|||
161051726|NCT03987074|581576818|FG003|Overall Study|Investigator's Discretion|1|||
161051727|NCT03987074|581576819|FG004|Overall Study|Investigator's Discretion|0|||
161051728|NCT04520256|581576821|FG000|Overall Study|Lost to Follow-up|6|||
161051729|NCT04520256|581576822|FG001|Overall Study|Lost to Follow-up|4|||
161051730|NCT04520256|581576823|FG002|Overall Study|Lost to Follow-up|2|||
161051731|NCT04520256|581576824|FG003|Overall Study|Lost to Follow-up|3|||
161051732|NCT04520256|581576825|FG004|Overall Study|Lost to Follow-up|6|||
161051733|NCT04520256|581576826|FG005|Overall Study|Lost to Follow-up|6|||
161051734|NCT04520256|581576827|FG006|Overall Study|Lost to Follow-up|4|||
161051735|NCT04520256|581576828|FG007|Overall Study|Lost to Follow-up|6|||
161051736|NCT04520256|581576829|FG008|Overall Study|Lost to Follow-up|1|||
161051737|NCT04520256|581576830|FG009|Overall Study|Lost to Follow-up|3|||
161051738|NCT04520256|581576831|FG010|Overall Study|Lost to Follow-up|3|||
161051739|NCT04520256|581576832|FG011|Overall Study|Lost to Follow-up|2|||
161051740|NCT04520256|581576833|FG012|Overall Study|Lost to Follow-up|5|||
161051741|NCT04520256|581576834|FG013|Overall Study|Lost to Follow-up|3|||
161051742|NCT04520256|581576835|FG014|Overall Study|Lost to Follow-up|3|||
161051743|NCT04520256|581576836|FG015|Overall Study|Lost to Follow-up|6|||
161051744|NCT04520256|581576837|FG016|Overall Study|Lost to Follow-up|6|||
161051745|NCT04520256|581576838|FG017|Overall Study|Lost to Follow-up|4|||
161051746|NCT04520256|581576839|FG018|Overall Study|Lost to Follow-up|3|||
161051747|NCT04520256|581576840|FG019|Overall Study|Lost to Follow-up|3|||
161051748|NCT04520256|581576841|FG020|Overall Study|Lost to Follow-up|7|||
161051749|NCT04520256|581576842|FG021|Overall Study|Lost to Follow-up|3|||
161051750|NCT04520256|581576843|FG022|Overall Study|Lost to Follow-up|3|||
161051751|NCT04520256|581576844|FG023|Overall Study|Lost to Follow-up|8|||
161051752|NCT04520256|581576845|FG024|Overall Study|Lost to Follow-up|5|||
161051753|NCT04520256|581576846|FG025|Overall Study|Lost to Follow-up|4|||
161051754|NCT04520256|581576847|FG026|Overall Study|Lost to Follow-up|3|||
161051755|NCT04520256|581576848|FG027|Overall Study|Lost to Follow-up|4|||
161051756|NCT04520256|581576849|FG028|Overall Study|Lost to Follow-up|3|||
161051757|NCT04520256|581576850|FG029|Overall Study|Lost to Follow-up|4|||
161051758|NCT04520256|581576851|FG030|Overall Study|Lost to Follow-up|4|||
161051759|NCT04520256|581576852|FG031|Overall Study|Lost to Follow-up|4|||
161051760|NCT02880293|581577996|FG000|Overall Study|Inevaluable|5|||
161051761|NCT02101554|581577999|FG000|Overall Study|Protocol Violation|0|||
161051762|NCT02101554|581578000|FG001|Overall Study|Protocol Violation|1|||
161051763|NCT02101554|581578001|FG002|Overall Study|Protocol Violation|0|||
161051764|NCT02101554|581577999|FG000|Overall Study|Insufficient Clinical Response|0|||
161051765|NCT02101554|581578000|FG001|Overall Study|Insufficient Clinical Response|2|||
161051766|NCT02101554|581578001|FG002|Overall Study|Insufficient Clinical Response|0|||
161051767|NCT02101554|581577999|FG000|Overall Study|Adverse Event|2|||
161051768|NCT02101554|581578000|FG001|Overall Study|Adverse Event|1|||
161051769|NCT02101554|581578001|FG002|Overall Study|Adverse Event|1|||
161051770|NCT02101554|581577999|FG000|Overall Study|Lost to Follow-up|0|||
161051771|NCT02101554|581578000|FG001|Overall Study|Lost to Follow-up|1|||
161051772|NCT02101554|581578001|FG002|Overall Study|Lost to Follow-up|0|||
161051773|NCT02101554|581577999|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
161051774|NCT02101554|581578000|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
161151310|NCT02508701|581935504|FG003|Overall Study|Lost to Follow-up|3|||
161051775|NCT02101554|581578001|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
161051776|NCT00668746|581578002|FG000|Overall Study|Lost to Follow-up|2|||
161151311|NCT00530712|581935510|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
161051777|NCT00668746|581578003|FG001|Overall Study|Lost to Follow-up|1|||
161051778|NCT05361304|581578011|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
161051779|NCT05361304|581578012|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
161051780|NCT05361304|581578011|FG000|Overall Study|COVID-19 Related|1|||
161051781|NCT05361304|581578012|FG001|Overall Study|COVID-19 Related|2|||
161051782|NCT05361304|581578011|FG000|Overall Study|Withdrawal by Subject|1|||
161051783|NCT05361304|581578012|FG001|Overall Study|Withdrawal by Subject|0|||
161051784|NCT03320941|581578013|FG000|Overall Study|subject/guardian decision|0|||
161051785|NCT03320941|581578014|FG001|Overall Study|subject/guardian decision|0|||
161051786|NCT03320941|581578015|FG002|Overall Study|subject/guardian decision|0|||
161051787|NCT03320941|581578016|FG003|Overall Study|subject/guardian decision|1|||
161051788|NCT03320941|581578017|FG004|Overall Study|subject/guardian decision|0|||
161051789|NCT02368691|581578019|FG000|Overall Study|Death|13|||
161051790|NCT02368691|581578019|FG000|Overall Study|Lack of Efficacy|15|||
161051791|NCT02368691|581578019|FG000|Overall Study|Physician Decision|4|||
161051792|NCT01838447|581578020|FG000|Overall Study|Change in surgical plan|1|||
161051793|NCT01838447|581578021|FG001|Overall Study|Change in surgical plan|2|||
161051794|NCT01838447|581578020|FG000|Overall Study|Withdrawal by Subject|1|||
161051795|NCT01838447|581578021|FG001|Overall Study|Withdrawal by Subject|1|||
161051796|NCT01114217|581578022|FG000|Overall Study|Adverse Event|5|||
161051797|NCT01114217|581578023|FG001|Overall Study|Adverse Event|3|||
161051798|NCT01114217|581578022|FG000|Overall Study|Lost to Follow-up|17|||
161051799|NCT01114217|581578023|FG001|Overall Study|Lost to Follow-up|33|||
161051800|NCT01114217|581578022|FG000|Overall Study|Withdrawal by Subject|21|||
161051801|NCT01114217|581578023|FG001|Overall Study|Withdrawal by Subject|28|||
161051802|NCT01114217|581578022|FG000|Overall Study|Other-Clerical Error|3|||
161051803|NCT01114217|581578023|FG001|Overall Study|Other-Clerical Error|0|||
161051804|NCT01114217|581578022|FG000|Overall Study|Other-Early termination|6|||
161051805|NCT01114217|581578023|FG001|Overall Study|Other-Early termination|10|||
161051806|NCT01114217|581578022|FG000|Overall Study|Other-Procedure|1|||
161051807|NCT01114217|581578023|FG001|Overall Study|Other-Procedure|1|||
161051808|NCT01114217|581578022|FG000|Overall Study|Other-Pregnancy|2|||
161051809|NCT01114217|581578023|FG001|Overall Study|Other-Pregnancy|4|||
161051810|NCT01114217|581578022|FG000|Overall Study|Other-Protocol Violation|1|||
161051811|NCT01114217|581578023|FG001|Overall Study|Other-Protocol Violation|3|||
161051812|NCT01114217|581578022|FG000|Overall Study|Other-Lack of Efficacy|1|||
161051813|NCT01114217|581578023|FG001|Overall Study|Other-Lack of Efficacy|0|||
161051814|NCT01114217|581578022|FG000|Overall Study|Other-Non Compliance|2|||
161051815|NCT01114217|581578023|FG001|Overall Study|Other-Non Compliance|0|||
161051816|NCT01114217|581578022|FG000|Overall Study|Other-Physician Decision|1|||
161051817|NCT01114217|581578023|FG001|Overall Study|Other-Physician Decision|1|||
161051818|NCT01114217|581578022|FG000|Overall Study|Other-Sponsor Decision|10|||
161051819|NCT01114217|581578023|FG001|Overall Study|Other-Sponsor Decision|12|||
161051820|NCT01114217|581578022|FG000|Overall Study|Other-Study Termination|0|||
161051821|NCT01114217|581578023|FG001|Overall Study|Other-Study Termination|1|||
161051822|NCT01114217|581578022|FG000|Overall Study|Other-Study Withdrawn|1|||
161051823|NCT01114217|581578023|FG001|Overall Study|Other-Study Withdrawn|1|||
161051824|NCT01114217|581578022|FG000|Overall Study|Other-Site Stopped Communicating|2|||
161051825|NCT01114217|581578023|FG001|Overall Study|Other-Site Stopped Communicating|0|||
161051826|NCT01114217|581578022|FG000|Overall Study|Other-Lost to Follow-up|1|||
161051827|NCT01114217|581578023|FG001|Overall Study|Other-Lost to Follow-up|0|||
161051828|NCT01114217|581578022|FG000|Overall Study|Other-Withdrawal by Subject|1|||
161051829|NCT01114217|581578023|FG001|Overall Study|Other-Withdrawal by Subject|1|||
161051830|NCT06247488|581578024|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
161051831|NCT06247488|581578025|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161051832|NCT06247488|581578026|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161051833|NCT06247488|581578027|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161051834|NCT06247488|581578028|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161051835|NCT06247488|581578029|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
161051836|NCT06247488|581578024|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161051837|NCT06247488|581578025|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161051838|NCT06247488|581578026|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161051839|NCT06247488|581578027|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
161051840|NCT06247488|581578028|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161051841|NCT06247488|581578029|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
161051842|NCT06247488|581578024|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
161051843|NCT06247488|581578025|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161051844|NCT06247488|581578026|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161051845|NCT06247488|581578027|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161051846|NCT06247488|581578028|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161051847|NCT06247488|581578029|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
161051848|NCT06247488|581578024|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161051849|NCT06247488|581578025|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161051850|NCT06247488|581578026|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161051851|NCT06247488|581578027|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
161051852|NCT06247488|581578028|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161051853|NCT06247488|581578029|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
161051854|NCT06247488|581578024|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161051855|NCT06247488|581578025|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161051856|NCT06247488|581578026|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161051857|NCT06247488|581578027|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161051858|NCT06247488|581578028|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
161051859|NCT06247488|581578029|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
161051860|NCT06247488|581578024|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
161051861|NCT06247488|581578025|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161051862|NCT06247488|581578026|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161051863|NCT06247488|581578027|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
161051864|NCT06247488|581578028|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
161051865|NCT06247488|581578029|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
161051866|NCT06247488|581578024|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161051867|NCT06247488|581578025|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161051868|NCT06247488|581578026|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161051869|NCT06247488|581578027|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161051870|NCT06247488|581578028|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
161051871|NCT06247488|581578029|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
161051872|NCT00584909|581578033|FG000|Overall Study|Adverse Event|4|||
161051873|NCT03436797|581578034|FG000|Main Study|Withdrawal by Subject|2|||
161051874|NCT03436797|581578034|FG000|Main Study|Adverse Event|4|||
161051875|NCT03436797|581578034|FG000|Main Study|Lost to Follow-up|1|||
161051876|NCT03436797|581578034|FG000|Main Study|Death|1|||
161051877|NCT03436797|581578034|FG000|Main Study|Non-Specific|2|||
161051878|NCT03436797|581578034|FG000|Extended Dosing|Patient decision|1|||
161051879|NCT04739306|581578035|FG000|Main Study Period|Adverse Event|6|||
161051880|NCT04739306|581578036|FG001|Main Study Period|Adverse Event|7|||
161051881|NCT04739306|581578035|FG000|Main Study Period|Lost to Follow-up|4|||
161051882|NCT04739306|581578036|FG001|Main Study Period|Lost to Follow-up|6|||
161051883|NCT04739306|581578035|FG000|Main Study Period|Physician Decision|1|||
161051884|NCT04739306|581578036|FG001|Main Study Period|Physician Decision|1|||
161051885|NCT04739306|581578035|FG000|Main Study Period|Withdrawal by Subject|8|||
161051886|NCT04739306|581578036|FG001|Main Study Period|Withdrawal by Subject|6|||
161051887|NCT04739306|581578035|FG000|Main Study Period|Protocol Violation|0|||
161051888|NCT04739306|581578036|FG001|Main Study Period|Protocol Violation|1|||
161051889|NCT04739306|581578035|FG000|Main Study Period|War in Ukraine|1|||
161051890|NCT04739306|581578036|FG001|Main Study Period|War in Ukraine|1|||
161051891|NCT01951105|581578041|FG000|Overall Study|Adverse Event|0|||
161051892|NCT01951105|581578042|FG001|Overall Study|Adverse Event|5|||
161051893|NCT01951105|581578043|FG002|Overall Study|Adverse Event|0|||
161051894|NCT01951105|581578041|FG000|Overall Study|Lost to Follow-up|0|||
161051895|NCT01951105|581578042|FG001|Overall Study|Lost to Follow-up|1|||
161051896|NCT01951105|581578043|FG002|Overall Study|Lost to Follow-up|0|||
161051897|NCT01951105|581578041|FG000|Overall Study|Protocol Violation|1|||
161051898|NCT01951105|581578042|FG001|Overall Study|Protocol Violation|1|||
161051899|NCT01951105|581578043|FG002|Overall Study|Protocol Violation|1|||
161051900|NCT01951105|581578041|FG000|Overall Study|Withdrawal by Subject|0|||
161051901|NCT01951105|581578042|FG001|Overall Study|Withdrawal by Subject|3|||
161051902|NCT01951105|581578043|FG002|Overall Study|Withdrawal by Subject|1|||
161051903|NCT04175392|581578044|FG000|Overall Study|Withdrawal by Subject|3|||
161051904|NCT04175392|581578045|FG001|Overall Study|Withdrawal by Subject|2|||
161051905|NCT01103141|581578046|FG000|Overall Study|Death|0|||
161051906|NCT01103141|581578047|FG001|Overall Study|Death|1|||
161051907|NCT01103141|581578046|FG000|Overall Study|Lost to Follow-up|2|||
161051908|NCT01103141|581578047|FG001|Overall Study|Lost to Follow-up|1|||
161051909|NCT05072795|581578050|FG000|Overall Study|Lost to Follow-up|5|||
161051910|NCT00422162|581578054|FG000|Overall Study|Adverse Event|11|||
161051911|NCT00422162|581578055|FG001|Overall Study|Adverse Event|9|||
161051912|NCT00422162|581578054|FG000|Overall Study|Lack of Efficacy|4|||
161051913|NCT00422162|581578055|FG001|Overall Study|Lack of Efficacy|10|||
161051914|NCT00422162|581578054|FG000|Overall Study|Withdrawal by Subject|7|||
161051915|NCT00422162|581578055|FG001|Overall Study|Withdrawal by Subject|6|||
161051916|NCT00422162|581578054|FG000|Overall Study|Lost to Follow-up|1|||
161051917|NCT00422162|581578055|FG001|Overall Study|Lost to Follow-up|2|||
161051918|NCT00422162|581578054|FG000|Overall Study|Non-Compliant with Protocol|1|||
161051919|NCT00422162|581578055|FG001|Overall Study|Non-Compliant with Protocol|1|||
161051920|NCT00422162|581578054|FG000|Overall Study|Other|0|||
161051921|NCT00422162|581578055|FG001|Overall Study|Other|1|||
161051922|NCT00422162|581578054|FG000|Overall Study|Didn't Receive Treatment|0|||
161051923|NCT00422162|581578055|FG001|Overall Study|Didn't Receive Treatment|1|||
161051924|NCT05274906|581578056|FG000|Overall Study|Withdrawal by Subject|2|||
161051925|NCT05274906|581578057|FG001|Overall Study|Withdrawal by Subject|1|||
161051926|NCT00848198|581578058|FG000|Overall Study|Incomplete Case Report Forms|15|||
161051927|NCT02062827|581578062|FG000|Overall Study|Death|1|||
161051928|NCT02062827|581578063|FG001|Overall Study|Death|0|||
161051929|NCT02062827|581578064|FG002|Overall Study|Death|0|||
161051930|NCT02062827|581578065|FG003|Overall Study|Death|0|||
161051931|NCT02062827|581578066|FG004|Overall Study|Death|0|||
161051932|NCT02062827|581578067|FG005|Overall Study|Death|0|||
161051933|NCT02062827|581578068|FG006|Overall Study|Death|0|||
161051934|NCT02062827|581578069|FG007|Overall Study|Death|0|||
161051935|NCT02062827|581578062|FG000|Overall Study|Withdrawal by Subject|3|||
161051936|NCT02062827|581578063|FG001|Overall Study|Withdrawal by Subject|1|||
161051937|NCT02062827|581578064|FG002|Overall Study|Withdrawal by Subject|1|||
161051938|NCT02062827|581578065|FG003|Overall Study|Withdrawal by Subject|2|||
161051939|NCT02062827|581578066|FG004|Overall Study|Withdrawal by Subject|6|||
161051940|NCT02062827|581578067|FG005|Overall Study|Withdrawal by Subject|0|||
161051941|NCT02062827|581578068|FG006|Overall Study|Withdrawal by Subject|5|||
161051942|NCT02062827|581578069|FG007|Overall Study|Withdrawal by Subject|0|||
161051943|NCT02062827|581578062|FG000|Overall Study|Screen Fail|0|||
161051944|NCT02062827|581578063|FG001|Overall Study|Screen Fail|0|||
161051945|NCT02062827|581578064|FG002|Overall Study|Screen Fail|0|||
161051946|NCT02062827|581578065|FG003|Overall Study|Screen Fail|0|||
161051947|NCT02062827|581578066|FG004|Overall Study|Screen Fail|0|||
161051948|NCT02062827|581578067|FG005|Overall Study|Screen Fail|0|||
161051949|NCT02062827|581578068|FG006|Overall Study|Screen Fail|0|||
161051950|NCT02062827|581578069|FG007|Overall Study|Screen Fail|8|||
161051951|NCT04930263|581578070|FG000|Overall Study|Withdrawal by Subject|3|||
161051952|NCT04930263|581578071|FG001|Overall Study|Withdrawal by Subject|5|||
161051953|NCT02812706|581578073|FG000|Phase 1|Adverse Event|0|||
161051954|NCT02812706|581578074|FG001|Phase 1|Adverse Event|2|||
161051955|NCT02812706|581578075|FG002|Phase 1|Adverse Event|0|||
161051956|NCT02812706|581578073|FG000|Phase 1|Progressive disease|3|||
161051957|NCT02812706|581578074|FG001|Phase 1|Progressive disease|3|||
161051958|NCT02812706|581578075|FG002|Phase 1|Progressive disease|0|||
161051959|NCT02812706|581578073|FG000|Phase 2|Adverse Event|0|||
161051960|NCT02812706|581578074|FG001|Phase 2|Adverse Event|0|||
161051961|NCT02812706|581578075|FG002|Phase 2|Adverse Event|2|||
161051962|NCT02812706|581578073|FG000|Phase 2|Progressive disease|0|||
161051963|NCT02812706|581578074|FG001|Phase 2|Progressive disease|0|||
161051964|NCT02812706|581578075|FG002|Phase 2|Progressive disease|22|||
161051965|NCT02812706|581578073|FG000|Phase 2|Other-Unspecified|0|||
161051966|NCT02812706|581578074|FG001|Phase 2|Other-Unspecified|0|||
161051967|NCT02812706|581578075|FG002|Phase 2|Other-Unspecified|4|||
161051968|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
161051969|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
161051970|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
161051971|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
161051972|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
161051973|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
161051974|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
161051975|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
161051976|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
161051977|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
161051978|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
161051979|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
161051980|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
161051981|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
161345091|NCT03126110|582648865|FG016|Phase 2|Progressive Disease|0|||
161345092|NCT03126110|582648849|FG000|Phase 2|Started new treatment|0|||
161051982|NCT02971683|581578076|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
161051983|NCT02971683|581578077|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
161051984|NCT02971683|581578076|FG000|Open-Label|Lost to Follow-up|1|||
161051985|NCT02971683|581578077|FG001|Open-Label|Lost to Follow-up|0|||
161051986|NCT02971683|581578076|FG000|Open-Label|Participants withdrew consent|0|||
161051987|NCT02971683|581578077|FG001|Open-Label|Participants withdrew consent|2|||
161051988|NCT02971683|581578076|FG000|Open-Label|Participant request to discontinue study treatment|1|||
161051989|NCT02971683|581578077|FG001|Open-Label|Participant request to discontinue study treatment|0|||
161051990|NCT02971683|581578076|FG000|Open-Label|Lack of Efficacy|2|||
161051991|NCT02971683|581578077|FG001|Open-Label|Lack of Efficacy|0|||
161051992|NCT02971683|581578076|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
161051993|NCT02971683|581578077|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
161051994|NCT02971683|581578076|FG000|Long-Term Open Label|Participant withdrew consent|1|||
161051995|NCT02971683|581578077|FG001|Long-Term Open Label|Participant withdrew consent|0|||
161051996|NCT02971683|581578076|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
161051997|NCT02971683|581578077|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
161051998|NCT02971683|581578076|FG000|Long-Term Open Label|Adverse Event|1|||
161051999|NCT02971683|581578077|FG001|Long-Term Open Label|Adverse Event|2|||
161052000|NCT02971683|581578076|FG000|Long-Term Open Label|Lack of Efficacy|1|||
161052001|NCT02971683|581578077|FG001|Long-Term Open Label|Lack of Efficacy|1|||
161052002|NCT01699178|581578078|FG000|Overall Study|Adverse Event|1|||
161052003|NCT01699178|581578079|FG001|Overall Study|Adverse Event|5|||
161052004|NCT01699178|581578078|FG000|Overall Study|Lost to Follow-up|1|||
161052005|NCT01699178|581578079|FG001|Overall Study|Lost to Follow-up|6|||
161052006|NCT01699178|581578078|FG000|Overall Study|Non-compliance with Study Drug|3|||
161345093|NCT03126110|582648850|FG001|Phase 2|Started new treatment|0|||
161052007|NCT01699178|581578079|FG001|Overall Study|Non-compliance with Study Drug|1|||
161052008|NCT01699178|581578078|FG000|Overall Study|Physician Decision|1|||
161281022|NCT00996892|582407019|FG017|Expansion Stage 2A|Adverse Event|0|||
161281023|NCT00996892|582407020|FG018|Expansion Stage 2A|Adverse Event|0|||
161281024|NCT00996892|582407021|FG019|Expansion Stage 2A|Adverse Event|8|||
161281025|NCT00996892|582407002|FG000|Expansion Stage 2A|Physician Decision|0|||
161052009|NCT01699178|581578079|FG001|Overall Study|Physician Decision|0|||
161052010|NCT01699178|581578078|FG000|Overall Study|Withdrawal by Subject|4|||
161052011|NCT01699178|581578079|FG001|Overall Study|Withdrawal by Subject|12|||
161052012|NCT01699178|581578078|FG000|Overall Study|Hematocrit >54%|1|||
161052013|NCT01699178|581578079|FG001|Overall Study|Hematocrit >54%|1|||
161052014|NCT01699178|581578078|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
161052015|NCT01699178|581578079|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
161052016|NCT01699178|581578078|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
161052017|NCT01699178|581578079|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
161052018|NCT01468597|581578083|FG000|Overall Study|Found ineligible|17|||
161052019|NCT01468597|581578083|FG000|Overall Study|concomitant valves|12|||
161052020|NCT01468597|581578083|FG000|Overall Study|off-pump CABG|1|||
161052021|NCT01468597|581578083|FG000|Overall Study|no platelet function data|5|||
161052022|NCT00912964|581578084|FG000|Overall Study|Eligibility criterion not met|1|||
161052023|NCT00912964|581578085|FG001|Overall Study|Eligibility criterion not met|1|||
161052024|NCT00912964|581578086|FG002|Overall Study|Eligibility criterion not met|0|||
161052025|NCT00912964|581578084|FG000|Overall Study|Adverse Event|15|||
161052026|NCT00912964|581578085|FG001|Overall Study|Adverse Event|18|||
161052027|NCT00912964|581578086|FG002|Overall Study|Adverse Event|12|||
161052028|NCT00912964|581578084|FG000|Overall Study|Lack of Efficacy|11|||
161052029|NCT00912964|581578085|FG001|Overall Study|Lack of Efficacy|4|||
161052030|NCT00912964|581578086|FG002|Overall Study|Lack of Efficacy|3|||
161052031|NCT00912964|581578084|FG000|Overall Study|Withdrawal by Subject|20|||
161052032|NCT00912964|581578085|FG001|Overall Study|Withdrawal by Subject|12|||
161052033|NCT00912964|581578086|FG002|Overall Study|Withdrawal by Subject|18|||
161052034|NCT00912964|581578084|FG000|Overall Study|Lost to Follow-up|4|||
161052035|NCT00912964|581578085|FG001|Overall Study|Lost to Follow-up|3|||
161052036|NCT00912964|581578086|FG002|Overall Study|Lost to Follow-up|3|||
161052037|NCT00912964|581578084|FG000|Overall Study|Protocol Violation|5|||
161052038|NCT00912964|581578085|FG001|Overall Study|Protocol Violation|3|||
161052039|NCT00912964|581578086|FG002|Overall Study|Protocol Violation|8|||
161052040|NCT00912964|581578084|FG000|Overall Study|Taking exclusionary medications|7|||
161052041|NCT00912964|581578085|FG001|Overall Study|Taking exclusionary medications|4|||
161052042|NCT00912964|581578086|FG002|Overall Study|Taking exclusionary medications|8|||
161052043|NCT00912964|581578084|FG000|Overall Study|Medical History|1|||
161052044|NCT00912964|581578085|FG001|Overall Study|Medical History|0|||
161052045|NCT00912964|581578086|FG002|Overall Study|Medical History|0|||
161052046|NCT00912964|581578084|FG000|Overall Study|Non-compliance with study procedures|2|||
161052047|NCT00912964|581578085|FG001|Overall Study|Non-compliance with study procedures|0|||
161052048|NCT00912964|581578086|FG002|Overall Study|Non-compliance with study procedures|0|||
161052049|NCT00912964|581578084|FG000|Overall Study|Violation of exclusion criterion|0|||
161052050|NCT00912964|581578085|FG001|Overall Study|Violation of exclusion criterion|0|||
161052051|NCT00912964|581578086|FG002|Overall Study|Violation of exclusion criterion|2|||
161052052|NCT00912964|581578084|FG000|Overall Study|Randomized but never received study drug|0|||
161052053|NCT00912964|581578085|FG001|Overall Study|Randomized but never received study drug|1|||
161281026|NCT00996892|582407003|FG001|Expansion Stage 2A|Physician Decision|0|||
161281027|NCT00996892|582407004|FG002|Expansion Stage 2A|Physician Decision|0|||
161281028|NCT00996892|582407005|FG003|Expansion Stage 2A|Physician Decision|0|||
161281029|NCT00996892|582407006|FG004|Expansion Stage 2A|Physician Decision|0|||
161281030|NCT00996892|582407007|FG005|Expansion Stage 2A|Physician Decision|0|||
161052054|NCT00912964|581578086|FG002|Overall Study|Randomized but never received study drug|0|||
161052055|NCT01517282|581578091|FG000|Overall Study|Consent withdrawn|0|||
161052056|NCT01517282|581578092|FG001|Overall Study|Consent withdrawn|1|||
161052057|NCT01517282|581578093|FG002|Overall Study|Consent withdrawn|1|||
161052058|NCT01517282|581578094|FG003|Overall Study|Consent withdrawn|1|||
161052059|NCT01517282|581578091|FG000|Overall Study|Physician Decision|1|||
161052060|NCT01517282|581578092|FG001|Overall Study|Physician Decision|0|||
161052061|NCT01517282|581578093|FG002|Overall Study|Physician Decision|0|||
161052062|NCT01517282|581578094|FG003|Overall Study|Physician Decision|0|||
161052063|NCT01199302|581578099|FG000|Overall Study|Adverse Event|1|||
161052064|NCT01199302|581578100|FG001|Overall Study|Adverse Event|1|||
161052065|NCT01199302|581578101|FG002|Overall Study|Adverse Event|2|||
161052066|NCT01199302|581578102|FG003|Overall Study|Adverse Event|0|||
161052067|NCT01199302|581578099|FG000|Overall Study|Withdrawal by Subject|2|||
161052068|NCT01199302|581578100|FG001|Overall Study|Withdrawal by Subject|2|||
161052069|NCT01199302|581578101|FG002|Overall Study|Withdrawal by Subject|3|||
161052070|NCT01199302|581578102|FG003|Overall Study|Withdrawal by Subject|0|||
161052071|NCT01199302|581578099|FG000|Overall Study|Disease Progression|3|||
161052072|NCT01199302|581578100|FG001|Overall Study|Disease Progression|4|||
161281031|NCT00996892|582407008|FG006|Expansion Stage 2A|Physician Decision|0|||
161052073|NCT01199302|581578101|FG002|Overall Study|Disease Progression|4|||
161052074|NCT01199302|581578102|FG003|Overall Study|Disease Progression|2|||
161052075|NCT01199302|581578099|FG000|Overall Study|Study Termination|13|||
161052076|NCT01199302|581578100|FG001|Overall Study|Study Termination|8|||
161052077|NCT01199302|581578101|FG002|Overall Study|Study Termination|11|||
161052078|NCT01199302|581578102|FG003|Overall Study|Study Termination|9|||
161052079|NCT01199302|581578099|FG000|Overall Study|Lost to Follow-up|0|||
161052080|NCT01199302|581578100|FG001|Overall Study|Lost to Follow-up|1|||
161052081|NCT01199302|581578101|FG002|Overall Study|Lost to Follow-up|0|||
161052082|NCT01199302|581578102|FG003|Overall Study|Lost to Follow-up|0|||
161052083|NCT01199302|581578099|FG000|Overall Study|Other|1|||
161052084|NCT01199302|581578100|FG001|Overall Study|Other|0|||
161052085|NCT01199302|581578101|FG002|Overall Study|Other|0|||
161052086|NCT01199302|581578102|FG003|Overall Study|Other|0|||
161052087|NCT04433091|581578103|FG000|Overall Study|Lost to Follow-up|1|||
161052088|NCT04433091|581578104|FG001|Overall Study|Lost to Follow-up|0|||
161052089|NCT04433091|581578103|FG000|Overall Study|Withdrawn .|2|||
161052090|NCT04433091|581578104|FG001|Overall Study|Withdrawn .|4|||
161052091|NCT03070301|581578105|FG000|Overall Study|Progression of disease|16|||
161052092|NCT03070301|581578105|FG000|Overall Study|Physician Decision|3|||
161052093|NCT03070301|581578105|FG000|Overall Study|Withdrawal by Subject|1|||
161052094|NCT03820024|581578106|FG000|Overall Study|Physician Decision|1|||
161052095|NCT03820024|581578107|FG001|Overall Study|Physician Decision|2|||
161052096|NCT00814632|581579323|FG000|Overall Study|Lack of Efficacy|2|||
161052097|NCT03978130|581579328|FG000|Overall Study|Lost to Follow-up|13|||
161052098|NCT03978130|581579329|FG001|Overall Study|Lost to Follow-up|14|||
161052099|NCT03978130|581579328|FG000|Overall Study|Withdrawal by Subject|12|||
161052100|NCT03978130|581579329|FG001|Overall Study|Withdrawal by Subject|2|||
161052101|NCT03978130|581579328|FG000|Overall Study|Adverse Event|2|||
161052102|NCT03978130|581579329|FG001|Overall Study|Adverse Event|1|||
161052103|NCT04198428|581579330|FG000|Overall Study|Withdrawal by Subject|150|||
161052104|NCT04198428|581579331|FG001|Overall Study|Withdrawal by Subject|156|||
161052105|NCT02069366|581579342|FG000|Overall Study|Lost to Follow-up|0|||
161052106|NCT02069366|581579343|FG001|Overall Study|Lost to Follow-up|0|||
161052107|NCT02069366|581579344|FG002|Overall Study|Lost to Follow-up|1|||
161052108|NCT02069366|581579345|FG003|Overall Study|Lost to Follow-up|0|||
161052109|NCT02069366|581579346|FG004|Overall Study|Lost to Follow-up|0|||
161052110|NCT02069366|581579347|FG005|Overall Study|Lost to Follow-up|2|||
161052111|NCT02069366|581579342|FG000|Overall Study|Protocol Violation|0|||
161052112|NCT02069366|581579343|FG001|Overall Study|Protocol Violation|0|||
161052113|NCT02069366|581579344|FG002|Overall Study|Protocol Violation|1|||
161052114|NCT02069366|581579345|FG003|Overall Study|Protocol Violation|0|||
161052115|NCT02069366|581579346|FG004|Overall Study|Protocol Violation|0|||
161052116|NCT02069366|581579347|FG005|Overall Study|Protocol Violation|0|||
161052117|NCT02069366|581579342|FG000|Overall Study|Withdrawal by Subject|1|||
161052118|NCT02069366|581579343|FG001|Overall Study|Withdrawal by Subject|0|||
161052119|NCT02069366|581579344|FG002|Overall Study|Withdrawal by Subject|1|||
161052120|NCT02069366|581579345|FG003|Overall Study|Withdrawal by Subject|2|||
161052121|NCT02069366|581579346|FG004|Overall Study|Withdrawal by Subject|0|||
161052122|NCT02069366|581579347|FG005|Overall Study|Withdrawal by Subject|0|||
161052123|NCT03314233|581579349|FG000|Overall Study|No longer eligible at time of delivery|1|||
161052124|NCT01797705|581579350|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
161052125|NCT01797705|581579350|FG000|Overall Study|Withdrawal by Subject|1|||
161052126|NCT02030847|581579352|FG000|Overall Study|Death|10|||
161052127|NCT02030847|581579352|FG000|Overall Study|Disease Progression|15|||
161052128|NCT02030847|581579352|FG000|Overall Study|New Cancer Therapy|8|||
161052129|NCT02030847|581579352|FG000|Overall Study|Physician Decision|3|||
161052130|NCT02030847|581579352|FG000|Overall Study|Withdrawal by Subject|1|||
161052131|NCT00168805|581579353|FG000|Overall Study|Adverse Event|7|||
161052132|NCT00168805|581579354|FG001|Overall Study|Adverse Event|11|||
161052133|NCT00168805|581579355|FG002|Overall Study|Adverse Event|16|||
161052134|NCT00168805|581579353|FG000|Overall Study|Protocol Violation|12|||
161052135|NCT00168805|581579354|FG001|Overall Study|Protocol Violation|11|||
161052136|NCT00168805|581579355|FG002|Overall Study|Protocol Violation|8|||
161052137|NCT00168805|581579353|FG000|Overall Study|Lost to Follow-up|12|||
161052138|NCT00168805|581579354|FG001|Overall Study|Lost to Follow-up|17|||
161052139|NCT00168805|581579355|FG002|Overall Study|Lost to Follow-up|11|||
161052140|NCT00168805|581579353|FG000|Overall Study|Withdrawal by Subject|16|||
161052141|NCT00168805|581579354|FG001|Overall Study|Withdrawal by Subject|18|||
161052142|NCT00168805|581579355|FG002|Overall Study|Withdrawal by Subject|21|||
161151312|NCT00530712|581935510|FG000|30 Day Follow-up Visit|Missed Visit|5|||
161052143|NCT00168805|581579353|FG000|Overall Study|Other|24|||
161052144|NCT00168805|581579354|FG001|Overall Study|Other|21|||
161052145|NCT00168805|581579355|FG002|Overall Study|Other|22|||
161052146|NCT00168805|581579353|FG000|Treatment|Adverse Event|25|||
161052147|NCT00168805|581579354|FG001|Treatment|Adverse Event|26|||
161052148|NCT00168805|581579355|FG002|Treatment|Adverse Event|32|||
161052149|NCT00168805|581579353|FG000|Treatment|Protocol Violation|3|||
161052150|NCT00168805|581579354|FG001|Treatment|Protocol Violation|5|||
161052151|NCT00168805|581579355|FG002|Treatment|Protocol Violation|5|||
161052152|NCT00168805|581579353|FG000|Treatment|Withdrawal by Subject|3|||
161052153|NCT00168805|581579354|FG001|Treatment|Withdrawal by Subject|7|||
161052154|NCT00168805|581579355|FG002|Treatment|Withdrawal by Subject|8|||
161052155|NCT00168805|581579353|FG000|Treatment|Other|18|||
161052156|NCT00168805|581579354|FG001|Treatment|Other|18|||
161052157|NCT00168805|581579355|FG002|Treatment|Other|17|||
161052158|NCT01837719|581579356|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
161052159|NCT01837719|581579356|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
161052160|NCT01703988|581579357|FG000|Overall Study|Investigator Judgment|0|||
161052161|NCT01703988|581579358|FG001|Overall Study|Investigator Judgment|0|||
161052162|NCT01703988|581579359|FG002|Overall Study|Investigator Judgment|0|||
161052163|NCT01703988|581579360|FG003|Overall Study|Investigator Judgment|1|||
161052164|NCT02995733|581579361|FG000|Overall Study|Study site closed|9|||
161052165|NCT02995733|581579362|FG001|Overall Study|Study site closed|10|||
161052166|NCT02995733|581579361|FG000|Overall Study|Death|3|||
161052167|NCT02995733|581579362|FG001|Overall Study|Death|4|||
161052168|NCT02995733|581579361|FG000|Overall Study|Withdrawal by Subject|6|||
161052169|NCT02995733|581579362|FG001|Overall Study|Withdrawal by Subject|2|||
161052170|NCT02995733|581579361|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
161052171|NCT02995733|581579362|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
161052172|NCT02995733|581579361|FG000|Overall Study|Lost to Follow-up|48|||
161052173|NCT02995733|581579362|FG001|Overall Study|Lost to Follow-up|37|||
161052174|NCT02995733|581579361|FG000|Overall Study|Other|0|||
161052175|NCT02995733|581579362|FG001|Overall Study|Other|1|||
161052176|NCT03785210|581579365|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
161052177|NCT03785210|581579366|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
161052178|NCT04468633|581579367|FG000|Overall Study|Withdrawal by Subject|4|||
161052179|NCT04468633|581579368|FG001|Overall Study|Withdrawal by Subject|0|||
161052180|NCT00460434|581579371|FG000|Overall Study|Lost to Follow-up|3|||
161052181|NCT00460434|581579372|FG001|Overall Study|Lost to Follow-up|7|||
161052182|NCT01498445|581579373|FG000|Overall Study|Lack of Efficacy|0|||
161052183|NCT01498445|581579374|FG001|Overall Study|Lack of Efficacy|0|||
161052184|NCT01498445|581579375|FG002|Overall Study|Lack of Efficacy|1|||
161052185|NCT01498445|581579376|FG003|Overall Study|Lack of Efficacy|2|||
161052186|NCT01498445|581579377|FG004|Overall Study|Lack of Efficacy|0|||
161052187|NCT01498445|581579378|FG005|Overall Study|Lack of Efficacy|0|||
161052188|NCT01498445|581579373|FG000|Overall Study|Screen Failure|0|||
161052189|NCT01498445|581579374|FG001|Overall Study|Screen Failure|0|||
161052190|NCT01498445|581579375|FG002|Overall Study|Screen Failure|0|||
161052191|NCT01498445|581579376|FG003|Overall Study|Screen Failure|0|||
161052192|NCT01498445|581579377|FG004|Overall Study|Screen Failure|1|||
161052193|NCT01498445|581579378|FG005|Overall Study|Screen Failure|1|||
161052194|NCT02465866|581579379|FG000|Period 3|Withdrawal by Subject|0|||
161052195|NCT02465866|581579380|FG001|Period 3|Withdrawal by Subject|1|||
161052196|NCT02465866|581579381|FG002|Period 3|Withdrawal by Subject|0|||
161052197|NCT02465866|581579382|FG003|Period 3|Withdrawal by Subject|0|||
161052198|NCT02023099|581579383|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
161052199|NCT02023099|581579384|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
161052200|NCT02023099|581579385|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
161052201|NCT02023099|581579383|FG000|Overall Study|Withdrawn Consent|3|||
161052202|NCT02023099|581579384|FG001|Overall Study|Withdrawn Consent|0|||
161052203|NCT02023099|581579385|FG002|Overall Study|Withdrawn Consent|1|||
161052204|NCT02023099|581579383|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
161052205|NCT02023099|581579384|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
161151313|NCT00530712|581935510|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
161281032|NCT00996892|582407009|FG007|Expansion Stage 2A|Physician Decision|0|||
161052206|NCT02023099|581579385|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
161052207|NCT00203502|581579386|FG000|Overall Study|Death|1|||
161052208|NCT01469819|581579387|FG000|Overall Study|Withdrawal by Subject|1|||
161052209|NCT01469819|581579387|FG000|Overall Study|Did not meet inclusionary criteria|2|||
161052210|NCT01469819|581579387|FG000|Overall Study|Could not swallow SmartPill|2|||
161052211|NCT01469819|581579387|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
161052212|NCT00561678|581579388|FG000|Overall Study|Withdrawal by Subject|4|||
161052213|NCT00561678|581579389|FG001|Overall Study|Withdrawal by Subject|3|||
161052214|NCT00561678|581579388|FG000|Overall Study|surgery cancelled|1|||
161052215|NCT00561678|581579389|FG001|Overall Study|surgery cancelled|1|||
161052216|NCT00561678|581579388|FG000|Overall Study|surgery rescheduled to different site|2|||
161052217|NCT00561678|581579389|FG001|Overall Study|surgery rescheduled to different site|2|||
161052218|NCT00561678|581579388|FG000|Overall Study|anesthesia provider refusal|1|||
161052219|NCT00561678|581579389|FG001|Overall Study|anesthesia provider refusal|0|||
161052220|NCT01403805|581579390|FG000|Overall Study|Withdrawal by Subject|0|||
161052221|NCT01403805|581579391|FG001|Overall Study|Withdrawal by Subject|4|||
161052222|NCT01403805|581579390|FG000|Overall Study|Lost to Follow-up|0|||
161052223|NCT01403805|581579391|FG001|Overall Study|Lost to Follow-up|2|||
161052224|NCT01403805|581579390|FG000|Overall Study|Death|0|||
161052225|NCT01403805|581579391|FG001|Overall Study|Death|1|||
161052226|NCT00472199|581579392|FG000|Overall Study|Adverse Event|19|||
161052227|NCT00472199|581579393|FG001|Overall Study|Adverse Event|23|||
161052228|NCT00472199|581579392|FG000|Overall Study|Lack of Efficacy|4|||
161052229|NCT00472199|581579393|FG001|Overall Study|Lack of Efficacy|25|||
161052230|NCT00472199|581579392|FG000|Overall Study|Lost to Follow-up|2|||
161052231|NCT00472199|581579393|FG001|Overall Study|Lost to Follow-up|4|||
161052232|NCT00472199|581579392|FG000|Overall Study|Protocol Violation|3|||
161052233|NCT00472199|581579393|FG001|Overall Study|Protocol Violation|2|||
161052234|NCT00472199|581579392|FG000|Overall Study|Withdrawal by Subject|6|||
161052235|NCT00472199|581579393|FG001|Overall Study|Withdrawal by Subject|5|||
161052236|NCT00472199|581579392|FG000|Overall Study|personal reason|0|||
161052237|NCT00472199|581579393|FG001|Overall Study|personal reason|1|||
161052238|NCT00472199|581579392|FG000|Overall Study|patient was asymptomatic|1|||
161052239|NCT00472199|581579393|FG001|Overall Study|patient was asymptomatic|0|||
161052240|NCT01601821|581579396|FG000|Overall Study|Death|2|||
161052241|NCT01601821|581579397|FG001|Overall Study|Death|5|||
161052242|NCT01601821|581579396|FG000|Overall Study|Protocol Violation|2|||
161052243|NCT01601821|581579397|FG001|Overall Study|Protocol Violation|2|||
161052244|NCT01601821|581579396|FG000|Overall Study|Lost to Follow-up|6|||
161052245|NCT01601821|581579397|FG001|Overall Study|Lost to Follow-up|14|||
161052246|NCT01601821|581579396|FG000|Overall Study|Withdrawal by Subject|1|||
161052247|NCT01601821|581579397|FG001|Overall Study|Withdrawal by Subject|0|||
161052248|NCT01601821|581579396|FG000|Overall Study|Graft Loss|6|||
161052249|NCT01601821|581579397|FG001|Overall Study|Graft Loss|6|||
161052250|NCT01601821|581579396|FG000|Overall Study|Study Events|7|||
161052251|NCT01601821|581579397|FG001|Overall Study|Study Events|1|||
161052252|NCT01601821|581579396|FG000|Overall Study|Other|5|||
161052253|NCT01601821|581579397|FG001|Overall Study|Other|1|||
161052254|NCT03708744|581579400|FG000|Overall Study|Withdrawal by Subject|0|||
161052255|NCT03708744|581579401|FG001|Overall Study|Withdrawal by Subject|0|||
161052256|NCT03708744|581579402|FG002|Overall Study|Withdrawal by Subject|1|||
161052257|NCT03708744|581579403|FG003|Overall Study|Withdrawal by Subject|0|||
161052258|NCT02213458|581579406|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
161052259|NCT02213458|581579407|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
161052260|NCT02213458|581579406|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
161052261|NCT02213458|581579407|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
161052262|NCT02213458|581579406|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
161052263|NCT02213458|581579407|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
161052264|NCT02213458|581579406|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
161052265|NCT02213458|581579407|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
161052266|NCT02213458|581579406|FG000|Overall Study|Refused re-consent|6|||
161052267|NCT02213458|581579407|FG001|Overall Study|Refused re-consent|0|||
161052268|NCT02213458|581579406|FG000|Overall Study|Lost to Follow-up|2|||
161052269|NCT02213458|581579407|FG001|Overall Study|Lost to Follow-up|2|||
161052270|NCT02213458|581579406|FG000|Overall Study|Withdrawal by Subject|26|||
161052271|NCT02213458|581579407|FG001|Overall Study|Withdrawal by Subject|8|||
161052272|NCT01622088|581579408|FG000|Overall Study|Adverse Event|20|||
161052273|NCT01622088|581579408|FG000|Overall Study|Lost to Follow-up|1|||
161052274|NCT01622088|581579408|FG000|Overall Study|Withdrawal by Subject|20|||
161052275|NCT01622088|581579408|FG000|Overall Study|Investigator Decision|1|||
161052276|NCT01622088|581579408|FG000|Overall Study|Death|53|||
161052277|NCT01622088|581579408|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
161052278|NCT04016415|581579412|FG000|Overall Study|Adverse Event|2|||
161052279|NCT04016415|581579413|FG001|Overall Study|Adverse Event|1|||
161052280|NCT04016415|581579412|FG000|Overall Study|Lost to Follow-up|6|||
161151314|NCT00530712|581935510|FG000|6 Month Follow-up Visit|Missed Visit|3|||
161151315|NCT00530712|581935510|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
161151316|NCT00530712|581935510|FG000|6 Month Follow-up Visit|Death|2|||
161151317|NCT00530712|581935510|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
161052281|NCT04016415|581579413|FG001|Overall Study|Lost to Follow-up|2|||
161052282|NCT04016415|581579412|FG000|Overall Study|Physician Decision|5|||
161052283|NCT04016415|581579413|FG001|Overall Study|Physician Decision|1|||
161052284|NCT04016415|581579412|FG000|Overall Study|Pregnancy|0|||
161052285|NCT04016415|581579413|FG001|Overall Study|Pregnancy|1|||
161052286|NCT04016415|581579412|FG000|Overall Study|Withdrawal by Subject|24|||
161052287|NCT04016415|581579413|FG001|Overall Study|Withdrawal by Subject|27|||
161052288|NCT04016415|581579412|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
161052289|NCT04016415|581579413|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
161052290|NCT03547167|581579416|FG000|Overall Study|Withdrawal by Subject|34|||
161052291|NCT03547167|581579417|FG001|Overall Study|Withdrawal by Subject|12|||
161052292|NCT03547167|581579416|FG000|Overall Study|Screen Failure|0|||
161052293|NCT03547167|581579417|FG001|Overall Study|Screen Failure|1|||
161052294|NCT03547167|581579416|FG000|Overall Study|Lost to Follow-up|59|||
161052295|NCT03547167|581579417|FG001|Overall Study|Lost to Follow-up|15|||
161052296|NCT03547167|581579416|FG000|Overall Study|Death|4|||
161052297|NCT03547167|581579417|FG001|Overall Study|Death|2|||
161052298|NCT01885559|581579418|FG000|Overall Study|Lost to Follow-up|15|||
161052299|NCT01885559|581579419|FG001|Overall Study|Lost to Follow-up|16|||
161052300|NCT01885559|581579418|FG000|Overall Study|Less than full participation|9|||
161052301|NCT01885559|581579419|FG001|Overall Study|Less than full participation|19|||
161052302|NCT01885559|581579418|FG000|Overall Study|Protocol Violation|0|||
161052303|NCT01885559|581579419|FG001|Overall Study|Protocol Violation|1|||
161052304|NCT00645411|581579420|FG000|Overall Study|Adverse Event|0|||
161052305|NCT00645411|581579421|FG001|Overall Study|Adverse Event|0|||
161052306|NCT00645411|581579422|FG002|Overall Study|Adverse Event|0|||
161052307|NCT00645411|581579423|FG003|Overall Study|Adverse Event|2|||
161052308|NCT00645411|581579420|FG000|Overall Study|Withdrawal by Subject|2|||
161052309|NCT00645411|581579421|FG001|Overall Study|Withdrawal by Subject|1|||
161052310|NCT00645411|581579422|FG002|Overall Study|Withdrawal by Subject|19|||
161052311|NCT00645411|581579423|FG003|Overall Study|Withdrawal by Subject|21|||
161052312|NCT00645411|581579420|FG000|Overall Study|Lost to Follow-up|10|||
161052313|NCT00645411|581579421|FG001|Overall Study|Lost to Follow-up|5|||
161052314|NCT00645411|581579422|FG002|Overall Study|Lost to Follow-up|124|||
161052315|NCT00645411|581579423|FG003|Overall Study|Lost to Follow-up|75|||
161052316|NCT00645411|581579420|FG000|Overall Study|Protocol Violation|1|||
161052317|NCT00645411|581579421|FG001|Overall Study|Protocol Violation|0|||
161052318|NCT00645411|581579422|FG002|Overall Study|Protocol Violation|1|||
161052319|NCT00645411|581579423|FG003|Overall Study|Protocol Violation|0|||
161052320|NCT00645411|581579420|FG000|Overall Study|Inappropriate enrollment|0|||
161052321|NCT00645411|581579421|FG001|Overall Study|Inappropriate enrollment|0|||
161052322|NCT00645411|581579422|FG002|Overall Study|Inappropriate enrollment|4|||
161052323|NCT00645411|581579423|FG003|Overall Study|Inappropriate enrollment|1|||
161052324|NCT00645411|581579420|FG000|Overall Study|Unable to classify|0|||
161052325|NCT00645411|581579421|FG001|Overall Study|Unable to classify|0|||
161052326|NCT00645411|581579422|FG002|Overall Study|Unable to classify|3|||
161052327|NCT00645411|581579423|FG003|Overall Study|Unable to classify|4|||
161052328|NCT03100370|581579427|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161052329|NCT03100370|581579428|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161052330|NCT03100370|581579429|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161052331|NCT03100370|581579430|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161052332|NCT03100370|581579431|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161052333|NCT03100370|581579432|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
161052334|NCT02674399|581579433|FG000|Overall Study|Lost to Follow-up|2|||
161052335|NCT02674399|581579434|FG001|Overall Study|Lost to Follow-up|0|||
161052336|NCT01867307|581579435|FG000|Overall Study|Protocol Violation|2|||
161052337|NCT01867307|581579436|FG001|Overall Study|Protocol Violation|0|||
161052338|NCT01867307|581579435|FG000|Overall Study|Other Adverse Event|1|||
161052339|NCT01867307|581579436|FG001|Overall Study|Other Adverse Event|3|||
161052340|NCT00091572|581579446|FG000|Overall Study|Lost to Follow-up|1|||
161052341|NCT00091572|581579447|FG001|Overall Study|Lost to Follow-up|1|||
161052342|NCT00091572|581579446|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
161052343|NCT00091572|581579447|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
161052344|NCT00091572|581579446|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
161052345|NCT00091572|581579447|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
161052346|NCT00091572|581579446|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
161052347|NCT00091572|581579447|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
161052348|NCT00091572|581579446|FG000|Overall Study|Other Reason|6|||
161052349|NCT00091572|581579447|FG001|Overall Study|Other Reason|13|||
161052350|NCT00091572|581579446|FG000|Overall Study|Ongoing (still on treatment)|8|||
161052351|NCT00091572|581579447|FG001|Overall Study|Ongoing (still on treatment)|12|||
161052352|NCT00091572|581579446|FG000|Overall Study|Major Protocol Violation|2|||
161052353|NCT00091572|581579447|FG001|Overall Study|Major Protocol Violation|0|||
161052354|NCT00091572|581579446|FG000|Overall Study|Toxicity (Related AE)|53|||
161052355|NCT00091572|581579447|FG001|Overall Study|Toxicity (Related AE)|9|||
161052356|NCT03122548|581579452|FG000|Overall Study|Death|2|||
161052357|NCT03122548|581579452|FG000|Overall Study|Progression - subject went into hospice|1|||
161052358|NCT03122548|581579452|FG000|Overall Study|Study Terminated by Sponsor|2|||
161052359|NCT01634165|581579456|FG000|Period 2|Adverse Event|0|||
161052360|NCT01634165|581579457|FG001|Period 2|Adverse Event|1|||
161052361|NCT01634165|581579458|FG002|Period 2|Adverse Event|0|||
161052362|NCT01634165|581579459|FG003|Period 2|Adverse Event|0|||
161052363|NCT04097535|581579462|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
161052364|NCT00676195|581581015|FG000|Overall Study|Lost to Follow-up|1|||
161052365|NCT00676195|581581015|FG000|Overall Study|Adverse Event|1|||
161052366|NCT00676195|581581015|FG000|Overall Study|Physician Decision|1|||
161052367|NCT03322514|581581016|FG000|Overall Study|Withdrawal by Subject|1|||
161052368|NCT03322514|581581017|FG001|Overall Study|Withdrawal by Subject|1|||
161281033|NCT00996892|582407010|FG008|Expansion Stage 2A|Physician Decision|0|||
161281034|NCT00996892|582407011|FG009|Expansion Stage 2A|Physician Decision|0|||
161052369|NCT02514577|581581023|FG000|Overall Study|Lost to Follow-up|6|||
161052370|NCT02514577|581581024|FG001|Overall Study|Lost to Follow-up|6|||
161052371|NCT02514577|581581023|FG000|Overall Study|Protocol Violation|1|||
161052372|NCT02514577|581581024|FG001|Overall Study|Protocol Violation|0|||
161052373|NCT02514577|581581023|FG000|Overall Study|Withdrawal by Subject|6|||
161052374|NCT02514577|581581024|FG001|Overall Study|Withdrawal by Subject|6|||
161052375|NCT02514577|581581023|FG000|Overall Study|Adverse Event|1|||
161052376|NCT02514577|581581024|FG001|Overall Study|Adverse Event|1|||
161052377|NCT00489489|581581025|FG000|Overall Study|Not treated due to protocol violation|0|||
161052378|NCT00489489|581581026|FG001|Overall Study|Not treated due to protocol violation|1|||
161052379|NCT00489489|581581027|FG002|Overall Study|Not treated due to protocol violation|1|||
161052380|NCT00489489|581581025|FG000|Overall Study|Adverse Event|1|||
161052381|NCT00489489|581581026|FG001|Overall Study|Adverse Event|1|||
161052382|NCT00489489|581581027|FG002|Overall Study|Adverse Event|1|||
161052383|NCT00489489|581581025|FG000|Overall Study|Protocol Violation|1|||
161052384|NCT00489489|581581026|FG001|Overall Study|Protocol Violation|0|||
161052385|NCT00489489|581581027|FG002|Overall Study|Protocol Violation|1|||
161052386|NCT00489489|581581025|FG000|Overall Study|Progressive disease|0|||
161052387|NCT00489489|581581026|FG001|Overall Study|Progressive disease|1|||
161052388|NCT00489489|581581027|FG002|Overall Study|Progressive disease|0|||
161052389|NCT00489489|581581025|FG000|Overall Study|Participant did not wish to continue|1|||
161052390|NCT00489489|581581026|FG001|Overall Study|Participant did not wish to continue|1|||
161052391|NCT00489489|581581027|FG002|Overall Study|Participant did not wish to continue|0|||
161052392|NCT00489489|581581025|FG000|Overall Study|Other than above|0|||
161052393|NCT00489489|581581026|FG001|Overall Study|Other than above|1|||
161052394|NCT00489489|581581027|FG002|Overall Study|Other than above|0|||
161052395|NCT02136797|581581028|FG000|Overall Study|Not Treated|8|||
161052396|NCT04523571|581581029|FG000|Received 2 Doses|Withdrawal by Subject|0|||
161052397|NCT04523571|581581030|FG001|Received 2 Doses|Withdrawal by Subject|0|||
161052398|NCT04523571|581581031|FG002|Received 2 Doses|Withdrawal by Subject|0|||
161052399|NCT04523571|581581032|FG003|Received 2 Doses|Withdrawal by Subject|1|||
161052400|NCT04523571|581581033|FG004|Received 2 Doses|Withdrawal by Subject|1|||
161052401|NCT04523571|581581034|FG005|Received 2 Doses|Withdrawal by Subject|0|||
161052402|NCT04523571|581581029|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
161052403|NCT04523571|581581030|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161052404|NCT04523571|581581031|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
161052405|NCT04523571|581581032|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161052406|NCT04523571|581581033|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161052407|NCT04523571|581581034|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
161052408|NCT04523571|581581029|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161052409|NCT04523571|581581030|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161052410|NCT04523571|581581031|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161052411|NCT04523571|581581032|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161052412|NCT04523571|581581033|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
161052413|NCT04523571|581581034|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
161052414|NCT04523571|581581029|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161052415|NCT04523571|581581030|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161052416|NCT04523571|581581031|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161052417|NCT04523571|581581032|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
161052418|NCT04523571|581581033|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
161052419|NCT04523571|581581034|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
161052420|NCT00627523|581581035|FG000|Overall Study|Lack of Efficacy|1|||
161052421|NCT00627523|581581036|FG001|Overall Study|Lack of Efficacy|0|||
161052422|NCT00627523|581581035|FG000|Overall Study|Withdrawal by Subject|0|||
161052423|NCT00627523|581581036|FG001|Overall Study|Withdrawal by Subject|2|||
161052424|NCT00627523|581581035|FG000|Overall Study|Other|1|||
161052425|NCT00627523|581581036|FG001|Overall Study|Other|0|||
161052426|NCT02011568|581581041|FG000|Overall Study|Withdrawal by Subject|8|||
161052427|NCT02011568|581581042|FG001|Overall Study|Withdrawal by Subject|10|||
161052428|NCT02011568|581581041|FG000|Overall Study|Physician Decision|1|||
161052429|NCT02011568|581581042|FG001|Overall Study|Physician Decision|3|||
161052430|NCT01038128|581581043|FG000|Overall Study|Lack of Efficacy|1|||
161052431|NCT01038128|581581043|FG000|Overall Study|Lost to Follow-up|1|||
161052432|NCT01038128|581581043|FG000|Overall Study|Withdrawal by Subject|2|||
161052433|NCT03344458|581581048|FG000|Overall Study|Physician Decision|1|||
161052434|NCT03344458|581581048|FG000|Overall Study|Withdrawal by Subject|16|||
161052435|NCT03344458|581581048|FG000|Overall Study|Other reasons|10|||
161052436|NCT03344458|581581048|FG000|Overall Study|Lost to Follow-up|9|||
161052437|NCT03344458|581581048|FG000|Overall Study|Protocol Violation|3|||
161052438|NCT04203199|581581049|FG000|First Intervention Period|Lost to Follow-up|0|||
161052439|NCT04203199|581581050|FG001|First Intervention Period|Lost to Follow-up|1|||
161052440|NCT04203199|581581049|FG000|Second Intervention Period|Medication change|1|||
161052441|NCT04203199|581581050|FG001|Second Intervention Period|Medication change|0|||
161052442|NCT03960437|581581051|FG000|Overall Study|Removed by PI|4|||
161052443|NCT03960437|581581051|FG000|Overall Study|Lost to Follow-up|2|||
161052444|NCT03960437|581581051|FG000|Overall Study|Withdrawal by Subject|1|||
161052445|NCT03960437|581581051|FG000|Overall Study|Death|2|||
161052446|NCT01838499|581581057|FG000|Overall Study|Protocol Violation|0|||
161052447|NCT01838499|581581058|FG001|Overall Study|Protocol Violation|1|||
161052448|NCT01838499|581581057|FG000|Overall Study|Lost to Follow-up|2|||
161052449|NCT01838499|581581058|FG001|Overall Study|Lost to Follow-up|4|||
161052450|NCT01838499|581581057|FG000|Overall Study|Lack of Efficacy|1|||
161052451|NCT01838499|581581058|FG001|Overall Study|Lack of Efficacy|2|||
161052452|NCT01838499|581581057|FG000|Overall Study|Adverse Event|2|||
161052453|NCT01838499|581581058|FG001|Overall Study|Adverse Event|1|||
161052454|NCT01838499|581581057|FG000|Overall Study|Withdrawal by Subject|19|||
161052455|NCT01838499|581581058|FG001|Overall Study|Withdrawal by Subject|9|||
161052456|NCT03614923|581581059|FG000|Overall Study|Withdrawal by Subject|2|||
161052457|NCT03614923|581581060|FG001|Overall Study|Withdrawal by Subject|1|||
161052458|NCT03614923|581581061|FG002|Overall Study|Withdrawal by Subject|1|||
161052459|NCT03614923|581581059|FG000|Overall Study|Adverse Event|0|||
161052460|NCT03614923|581581060|FG001|Overall Study|Adverse Event|2|||
161052461|NCT03614923|581581061|FG002|Overall Study|Adverse Event|1|||
161052462|NCT03614923|581581059|FG000|Overall Study|Lost to Follow-up|1|||
161052463|NCT03614923|581581060|FG001|Overall Study|Lost to Follow-up|0|||
161052464|NCT03614923|581581061|FG002|Overall Study|Lost to Follow-up|1|||
161052465|NCT03614923|581581059|FG000|Overall Study|Lack of Efficacy|2|||
161052466|NCT03614923|581581060|FG001|Overall Study|Lack of Efficacy|0|||
161052467|NCT03614923|581581061|FG002|Overall Study|Lack of Efficacy|1|||
161052468|NCT03614923|581581059|FG000|Overall Study|Non-compliance|0|||
161052469|NCT03614923|581581060|FG001|Overall Study|Non-compliance|1|||
161052470|NCT03614923|581581061|FG002|Overall Study|Non-compliance|0|||
161052471|NCT03614923|581581059|FG000|Overall Study|Other|0|||
161052472|NCT03614923|581581060|FG001|Overall Study|Other|1|||
161052473|NCT03614923|581581061|FG002|Overall Study|Other|1|||
161052474|NCT01136733|581581062|FG000|Phase 1b|Adverse Event|0|||
161052475|NCT01136733|581581063|FG001|Phase 1b|Adverse Event|3|||
161052476|NCT01136733|581581064|FG002|Phase 1b|Adverse Event|1|||
161052477|NCT01136733|581581065|FG003|Phase 1b|Adverse Event|0|||
161052478|NCT01136733|581581066|FG004|Phase 1b|Adverse Event|0|||
161052479|NCT01136733|581581067|FG005|Phase 1b|Adverse Event|0|||
161052480|NCT01136733|581581068|FG006|Phase 1b|Adverse Event|0|||
161052481|NCT01136733|581581062|FG000|Phase 1b|Participant Choice|0|||
161052482|NCT01136733|581581063|FG001|Phase 1b|Participant Choice|0|||
161052483|NCT01136733|581581064|FG002|Phase 1b|Participant Choice|1|||
161052484|NCT01136733|581581065|FG003|Phase 1b|Participant Choice|0|||
161052485|NCT01136733|581581066|FG004|Phase 1b|Participant Choice|0|||
161052486|NCT01136733|581581067|FG005|Phase 1b|Participant Choice|0|||
161052487|NCT01136733|581581068|FG006|Phase 1b|Participant Choice|0|||
161052488|NCT01136733|581581062|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
161052489|NCT01136733|581581063|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
161052490|NCT01136733|581581064|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
161052491|NCT01136733|581581065|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
161052492|NCT01136733|581581066|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
161052493|NCT01136733|581581067|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
161052494|NCT01136733|581581068|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
161052495|NCT01136733|581581062|FG000|Phase 1b|Clinical Progression|1|||
161052496|NCT01136733|581581063|FG001|Phase 1b|Clinical Progression|1|||
161052497|NCT01136733|581581064|FG002|Phase 1b|Clinical Progression|0|||
161052498|NCT01136733|581581065|FG003|Phase 1b|Clinical Progression|0|||
161052499|NCT01136733|581581066|FG004|Phase 1b|Clinical Progression|0|||
161052500|NCT01136733|581581067|FG005|Phase 1b|Clinical Progression|0|||
161052501|NCT01136733|581581068|FG006|Phase 1b|Clinical Progression|0|||
161052502|NCT01136733|581581062|FG000|Phase 2|Disease Progression|0|||
161052503|NCT01136733|581581063|FG001|Phase 2|Disease Progression|0|||
161052504|NCT01136733|581581064|FG002|Phase 2|Disease Progression|0|||
161052505|NCT01136733|581581065|FG003|Phase 2|Disease Progression|0|||
161151318|NCT00530712|581935510|FG000|12 Month Follow-up Visit|Missed Visit|3|||
161151319|NCT00530712|581935510|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
161345094|NCT03126110|582648851|FG002|Phase 2|Started new treatment|0|||
161345095|NCT03126110|582648852|FG003|Phase 2|Started new treatment|0|||
161052506|NCT01136733|581581066|FG004|Phase 2|Disease Progression|30|||
161052507|NCT01136733|581581067|FG005|Phase 2|Disease Progression|32|||
161052508|NCT01136733|581581068|FG006|Phase 2|Disease Progression|38|||
161151320|NCT00530712|581935510|FG000|12 Month Follow-up Visit|Death|9|||
161052509|NCT01136733|581581062|FG000|Phase 2|Adverse Event|0|||
161052510|NCT01136733|581581063|FG001|Phase 2|Adverse Event|0|||
161052511|NCT01136733|581581064|FG002|Phase 2|Adverse Event|0|||
161052512|NCT01136733|581581065|FG003|Phase 2|Adverse Event|0|||
161052513|NCT01136733|581581066|FG004|Phase 2|Adverse Event|11|||
161052514|NCT01136733|581581067|FG005|Phase 2|Adverse Event|13|||
161052515|NCT01136733|581581068|FG006|Phase 2|Adverse Event|5|||
161052516|NCT01136733|581581062|FG000|Phase 2|Participant Choice|0|||
161052517|NCT01136733|581581063|FG001|Phase 2|Participant Choice|0|||
161052518|NCT01136733|581581064|FG002|Phase 2|Participant Choice|0|||
161052519|NCT01136733|581581065|FG003|Phase 2|Participant Choice|0|||
161052520|NCT01136733|581581066|FG004|Phase 2|Participant Choice|3|||
161052521|NCT01136733|581581067|FG005|Phase 2|Participant Choice|0|||
161052522|NCT01136733|581581068|FG006|Phase 2|Participant Choice|1|||
161052523|NCT01136733|581581062|FG000|Phase 2|Administrative-Withdrew Consent|0|||
161052524|NCT01136733|581581063|FG001|Phase 2|Administrative-Withdrew Consent|0|||
161052525|NCT01136733|581581064|FG002|Phase 2|Administrative-Withdrew Consent|0|||
161052526|NCT01136733|581581065|FG003|Phase 2|Administrative-Withdrew Consent|0|||
161052527|NCT01136733|581581066|FG004|Phase 2|Administrative-Withdrew Consent|1|||
161052528|NCT01136733|581581067|FG005|Phase 2|Administrative-Withdrew Consent|0|||
161052529|NCT01136733|581581068|FG006|Phase 2|Administrative-Withdrew Consent|0|||
161052530|NCT01136733|581581062|FG000|Phase 2|Other|0|||
161052531|NCT01136733|581581063|FG001|Phase 2|Other|0|||
161052532|NCT01136733|581581064|FG002|Phase 2|Other|0|||
161052533|NCT01136733|581581065|FG003|Phase 2|Other|0|||
161052534|NCT01136733|581581066|FG004|Phase 2|Other|6|||
161052535|NCT01136733|581581067|FG005|Phase 2|Other|7|||
161052536|NCT01136733|581581068|FG006|Phase 2|Other|6|||
161052537|NCT01882088|581581070|FG000|Overall Study|Intolerance of esophageal manometry|1|||
161052538|NCT01882088|581581070|FG000|Overall Study|no possibility to place the catheter|1|||
161052539|NCT01882088|581581070|FG000|Overall Study|Protocol Violation|1|||
161052540|NCT01882088|581581070|FG000|Overall Study|inadequate pH-impedance tracings|2|||
161052541|NCT02186015|581581071|FG000|Overall Study|Physician Decision|1|||
161052542|NCT02186015|581581072|FG001|Overall Study|Physician Decision|0|||
161052543|NCT02720198|581581075|FG000|Overall Study|Withdrawal by Subject|0|||
161052544|NCT02720198|581581076|FG001|Overall Study|Withdrawal by Subject|1|||
161052545|NCT02722278|581581079|FG000|Overall Study|Withdrawal by Subject|5|||
161052546|NCT02722278|581581080|FG001|Overall Study|Withdrawal by Subject|3|||
161052547|NCT02722278|581581079|FG000|Overall Study|Adverse Event|4|||
161052548|NCT02722278|581581080|FG001|Overall Study|Adverse Event|1|||
161052549|NCT02722278|581581079|FG000|Overall Study|Lost to Follow-up|2|||
161052550|NCT02722278|581581080|FG001|Overall Study|Lost to Follow-up|0|||
161052551|NCT02722278|581581079|FG000|Overall Study|Protocol Violation|1|||
161052552|NCT02722278|581581080|FG001|Overall Study|Protocol Violation|0|||
161052553|NCT02722278|581581079|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
161052554|NCT02722278|581581080|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
161052555|NCT02722278|581581079|FG000|Overall Study|Subject declined after tx assignment|0|||
161052556|NCT02722278|581581080|FG001|Overall Study|Subject declined after tx assignment|1|||
161052557|NCT02722278|581581079|FG000|Overall Study|Site closure not study related|0|||
161052558|NCT02722278|581581080|FG001|Overall Study|Site closure not study related|1|||
161052559|NCT02592434|581581081|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
161052560|NCT02592434|581581082|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
161052561|NCT02592434|581581083|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
161052562|NCT02592434|581581081|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
161052563|NCT02592434|581581082|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
161052564|NCT02592434|581581083|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
161052565|NCT02592434|581581081|FG000|Open-Label Phase (18 Weeks)|Other|3|||
161052566|NCT02592434|581581082|FG001|Open-Label Phase (18 Weeks)|Other|0|||
161052567|NCT02592434|581581083|FG002|Open-Label Phase (18 Weeks)|Other|0|||
161052568|NCT02592434|581581081|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
161052569|NCT02592434|581581082|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
161052570|NCT02592434|581581083|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
161052571|NCT02592434|581581081|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
161052572|NCT02592434|581581082|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
161052573|NCT02592434|581581083|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
161052574|NCT02592434|581581081|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
161052575|NCT02592434|581581082|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
161052576|NCT02592434|581581083|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
161052577|NCT02592434|581581081|FG000|Double Blind Phase (26 Weeks)|Other|0|||
161052578|NCT02592434|581581082|FG001|Double Blind Phase (26 Weeks)|Other|1|||
161052579|NCT02592434|581581083|FG002|Double Blind Phase (26 Weeks)|Other|0|||
161151321|NCT02749370|581935511|FG000|Overall Study|Withdrawal by Subject|11|||
161151322|NCT02749370|581935511|FG000|Overall Study|Lost to Follow-up|3|||
161151323|NCT03894904|581935517|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
161151324|NCT03894904|581935518|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
161151325|NCT03894904|581935517|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
161281035|NCT00996892|582407012|FG010|Expansion Stage 2A|Physician Decision|0|||
161052580|NCT02592434|581581081|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
161052581|NCT02592434|581581082|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
161052582|NCT02592434|581581083|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
161052583|NCT02592434|581581081|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
161052584|NCT02592434|581581082|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
161052585|NCT02592434|581581083|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
161052586|NCT02592434|581581081|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
161052587|NCT02592434|581581082|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
161052588|NCT02592434|581581083|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
161052589|NCT01695993|581581086|FG000|Overall Study|Lost to Follow-up|2|||
161052590|NCT01695993|581581087|FG001|Overall Study|Lost to Follow-up|1|||
161052591|NCT01695993|581581088|FG002|Overall Study|Lost to Follow-up|3|||
161052592|NCT01695993|581581086|FG000|Overall Study|Withdrawal by Subject|2|||
161052593|NCT01695993|581581087|FG001|Overall Study|Withdrawal by Subject|2|||
161052594|NCT01695993|581581088|FG002|Overall Study|Withdrawal by Subject|2|||
161052595|NCT01695993|581581086|FG000|Overall Study|To ill to continue|1|||
161052596|NCT01695993|581581087|FG001|Overall Study|To ill to continue|2|||
161052597|NCT01695993|581581088|FG002|Overall Study|To ill to continue|0|||
161052598|NCT01695993|581581086|FG000|Overall Study|Changed Medical Facility|0|||
161052599|NCT01695993|581581087|FG001|Overall Study|Changed Medical Facility|0|||
161052600|NCT01695993|581581088|FG002|Overall Study|Changed Medical Facility|1|||
161052601|NCT00147745|581581090|FG000|Overall Study|Withdrawal by Subject|1|||
161052602|NCT00147745|581581091|FG001|Overall Study|Withdrawal by Subject|0|||
161052603|NCT00147745|581581092|FG002|Overall Study|Withdrawal by Subject|0|||
161052604|NCT01901302|581581093|FG000|Overall Study|Adverse Event|2|||
161052605|NCT01901302|581581094|FG001|Overall Study|Adverse Event|1|||
161052606|NCT01901302|581581093|FG000|Overall Study|Lack of Efficacy|0|||
161052607|NCT01901302|581581094|FG001|Overall Study|Lack of Efficacy|2|||
161052608|NCT01901302|581581093|FG000|Overall Study|Study Terminated by Sponsor|23|||
161052609|NCT01901302|581581094|FG001|Overall Study|Study Terminated by Sponsor|20|||
161052610|NCT01901302|581581093|FG000|Overall Study|Withdrawal by Subject|2|||
161052611|NCT01901302|581581094|FG001|Overall Study|Withdrawal by Subject|0|||
161052612|NCT00510783|581581096|FG000|Overall Study|Lost to Follow-up|29|||
161052613|NCT00510783|581581097|FG001|Overall Study|Lost to Follow-up|25|||
161052614|NCT00510783|581581096|FG000|Overall Study|Withdrawal by Subject|2|||
161052615|NCT00510783|581581097|FG001|Overall Study|Withdrawal by Subject|3|||
161052616|NCT00510783|581581096|FG000|Overall Study|Protocol Violation|0|||
161052617|NCT00510783|581581097|FG001|Overall Study|Protocol Violation|1|||
161052618|NCT00316121|581581098|FG000|Overall Study|Death|1|||
161052619|NCT00316121|581581099|FG001|Overall Study|Death|0|||
161052620|NCT00316121|581581098|FG000|Overall Study|Lost to Follow-up|14|||
161052621|NCT00316121|581581099|FG001|Overall Study|Lost to Follow-up|8|||
161052622|NCT00316121|581581098|FG000|Overall Study|Withdrawal by Subject|2|||
161052623|NCT00316121|581581099|FG001|Overall Study|Withdrawal by Subject|0|||
161052624|NCT00316121|581581098|FG000|Overall Study|Reason is missing|1|||
161052625|NCT00316121|581581099|FG001|Overall Study|Reason is missing|0|||
161052626|NCT00316121|581581098|FG000|Overall Study|Subject relocated|1|||
161052627|NCT00316121|581581099|FG001|Overall Study|Subject relocated|1|||
161052628|NCT00316121|581581098|FG000|Overall Study|Subject refused to return|1|||
161052629|NCT00316121|581581099|FG001|Overall Study|Subject refused to return|0|||
161052630|NCT00316121|581581098|FG000|Overall Study|Subject no show for visit x 3|1|||
161052631|NCT00316121|581581099|FG001|Overall Study|Subject no show for visit x 3|0|||
161052632|NCT00316121|581581098|FG000|Overall Study|Subject did not have 24 month visit|1|||
161052633|NCT00316121|581581099|FG001|Overall Study|Subject did not have 24 month visit|0|||
161052634|NCT00460577|581581105|FG000|Overall Study|Protocol Violation|2|||
161052635|NCT00460577|581581106|FG001|Overall Study|Protocol Violation|6|||
161052636|NCT04043806|581581107|FG000|Overall Study|Commercial drug is available for participants|13|||
161052637|NCT04043806|581581107|FG000|Overall Study|Physician Decision|2|||
161052638|NCT04043806|581581107|FG000|Overall Study|Other|12|||
161052639|NCT04043806|581581107|FG000|Overall Study|Adverse Event|2|||
161052640|NCT04043806|581581107|FG000|Overall Study|Lost to Follow-up|6|||
161052641|NCT04043806|581581107|FG000|Overall Study|Other non-compliance|2|||
161052642|NCT04043806|581581107|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
161052643|NCT04043806|581581107|FG000|Overall Study|Never Dosed|1|||
161052644|NCT03166215|581581112|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
161052645|NCT03166215|581581113|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
161052646|NCT03166215|581581114|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
161052647|NCT03166215|581581112|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
161052648|NCT03166215|581581113|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
161052649|NCT03166215|581581114|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
161052650|NCT04362176|581581117|FG000|Overall Study|Lost to Follow-up|5|||
161052651|NCT04362176|581581118|FG001|Overall Study|Lost to Follow-up|8|||
161052652|NCT04362176|581581117|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
161052653|NCT04362176|581581118|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
161052654|NCT04985604|581581120|FG000|Overall Study|Death|4|||
161052655|NCT04985604|581581121|FG001|Overall Study|Death|6|||
161052656|NCT04985604|581581120|FG000|Overall Study|Withdrawal by Subject|0|||
161052657|NCT04985604|581581121|FG001|Overall Study|Withdrawal by Subject|1|||
161151326|NCT03894904|581935518|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
161151327|NCT03242759|581935519|FG000|Overall Study|Adverse Event|5|||
161052658|NCT04598776|581581122|FG000|Overall Study|Protocol Violation|5|||
161052659|NCT04598776|581581122|FG000|Overall Study|Physician Decision|4|||
161052660|NCT02282761|581581123|FG000|Overall Study|Death|0|||
161052661|NCT02282761|581581124|FG001|Overall Study|Death|0|||
161052662|NCT02282761|581581125|FG002|Overall Study|Death|1|||
161052663|NCT02282761|581581123|FG000|Overall Study|Adverse Event|6|||
161052664|NCT02282761|581581124|FG001|Overall Study|Adverse Event|2|||
161052665|NCT02282761|581581125|FG002|Overall Study|Adverse Event|0|||
161052666|NCT02282761|581581123|FG000|Overall Study|Lack of Efficacy|11|||
161052667|NCT02282761|581581124|FG001|Overall Study|Lack of Efficacy|6|||
161052668|NCT02282761|581581125|FG002|Overall Study|Lack of Efficacy|17|||
161052669|NCT02282761|581581123|FG000|Overall Study|Lost to Follow-up|2|||
161052670|NCT02282761|581581124|FG001|Overall Study|Lost to Follow-up|2|||
161052671|NCT02282761|581581125|FG002|Overall Study|Lost to Follow-up|1|||
161052672|NCT02282761|581581123|FG000|Overall Study|Physician Decision|0|||
161052673|NCT02282761|581581124|FG001|Overall Study|Physician Decision|0|||
161052674|NCT02282761|581581125|FG002|Overall Study|Physician Decision|2|||
161052675|NCT02282761|581581123|FG000|Overall Study|Withdrawal by Subject|8|||
161052676|NCT02282761|581581124|FG001|Overall Study|Withdrawal by Subject|10|||
161052677|NCT02282761|581581125|FG002|Overall Study|Withdrawal by Subject|16|||
161052678|NCT02282761|581581123|FG000|Overall Study|Other|3|||
161052679|NCT02282761|581581124|FG001|Overall Study|Other|2|||
161052680|NCT02282761|581581125|FG002|Overall Study|Other|1|||
161052681|NCT00658632|581581128|FG000|Overall Study|Adverse Event|13|||
161052682|NCT00658632|581581129|FG001|Overall Study|Adverse Event|11|||
161052683|NCT00658632|581581128|FG000|Overall Study|Lost to Follow-up|25|||
161052684|NCT00658632|581581129|FG001|Overall Study|Lost to Follow-up|23|||
161052685|NCT00658632|581581128|FG000|Overall Study|Withdrawal by Subject|10|||
161052686|NCT00658632|581581129|FG001|Overall Study|Withdrawal by Subject|7|||
161052687|NCT00658632|581581128|FG000|Overall Study|Lack of Efficacy|0|||
161052688|NCT00658632|581581129|FG001|Overall Study|Lack of Efficacy|1|||
161052689|NCT00658632|581581128|FG000|Overall Study|Withdrawal of consent|8|||
161052690|NCT00658632|581581129|FG001|Overall Study|Withdrawal of consent|14|||
161052691|NCT00658632|581581128|FG000|Overall Study|Pregnancy|1|||
161052692|NCT00658632|581581129|FG001|Overall Study|Pregnancy|1|||
161052693|NCT00658632|581581128|FG000|Overall Study|Other|7|||
161052694|NCT00658632|581581129|FG001|Overall Study|Other|8|||
161052695|NCT06312566|581581130|FG000|Overall Study|Protocol Violation|0|||
161052696|NCT06312566|581581131|FG001|Overall Study|Protocol Violation|1|||
161052697|NCT02632045|581581132|FG000|Overall Study|Withdrawal by Subject|1|||
161052698|NCT02632045|581581133|FG001|Overall Study|Withdrawal by Subject|2|||
161052699|NCT04551053|581581134|FG000|Overall Study|Death|10|||
161052700|NCT04551053|581581135|FG001|Overall Study|Death|9|||
161052701|NCT04551053|581581134|FG000|Overall Study|Lost to Follow-up|0|||
161052702|NCT04551053|581581135|FG001|Overall Study|Lost to Follow-up|2|||
161052703|NCT04551053|581581134|FG000|Overall Study|Study Terminated by Sponsor|57|||
161052704|NCT04551053|581581135|FG001|Overall Study|Study Terminated by Sponsor|65|||
161052705|NCT04551053|581581134|FG000|Overall Study|Withdrawal by Subject|12|||
161052706|NCT04551053|581581135|FG001|Overall Study|Withdrawal by Subject|5|||
161052707|NCT04551053|581581134|FG000|Overall Study|Adverse Event|2|||
161052708|NCT04551053|581581135|FG001|Overall Study|Adverse Event|0|||
161052709|NCT04551053|581581134|FG000|Overall Study|Lack of Efficacy|2|||
161052710|NCT04551053|581581135|FG001|Overall Study|Lack of Efficacy|1|||
161052711|NCT04551053|581581134|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
161052712|NCT04551053|581581135|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
161052713|NCT04551053|581581134|FG000|Overall Study|Splenapendectomi|1|||
161052714|NCT04551053|581581135|FG001|Overall Study|Splenapendectomi|0|||
161052715|NCT04551053|581581134|FG000|Overall Study|Medical Decision|1|||
161052716|NCT04551053|581581135|FG001|Overall Study|Medical Decision|1|||
161052717|NCT03861078|581581136|FG000|Overall Study|COVID-19 shut down|4|||
161052718|NCT03861078|581581136|FG000|Overall Study|Lost to Follow-up|1|||
161052719|NCT03861078|581581136|FG000|Overall Study|Protocol Violation|2|||
161052720|NCT03861078|581581136|FG000|Overall Study|lack of venous access|1|||
161052721|NCT00596960|581581138|FG000|Overall Study|Death|1|||
161052722|NCT00596960|581581139|FG001|Overall Study|Death|2|||
161052723|NCT00596960|581581138|FG000|Overall Study|Lost to Follow-up|6|||
161052724|NCT00596960|581581139|FG001|Overall Study|Lost to Follow-up|5|||
161052725|NCT00596960|581581138|FG000|Overall Study|Withdrawal by Subject|1|||
161052726|NCT00596960|581581139|FG001|Overall Study|Withdrawal by Subject|0|||
161052727|NCT00596960|581581138|FG000|Overall Study|Incarcerated|2|||
161052728|NCT00596960|581581139|FG001|Overall Study|Incarcerated|0|||
161052729|NCT00596960|581581138|FG000|Overall Study|Physician Decision|1|||
161052730|NCT00596960|581581139|FG001|Overall Study|Physician Decision|0|||
161052731|NCT00596960|581581138|FG000|Overall Study|Protocol Violation|0|||
161151328|NCT03242759|581935520|FG001|Overall Study|Adverse Event|1|||
161052732|NCT00596960|581581139|FG001|Overall Study|Protocol Violation|1|||
161052733|NCT00596960|581581138|FG000|Overall Study|No alcohol use data|0|||
161052734|NCT00596960|581581139|FG001|Overall Study|No alcohol use data|1|||
161052735|NCT03503188|581581140|FG000|Overall Study|Non eligible in the sub study|0|||
161052736|NCT03503188|581581141|FG001|Overall Study|Non eligible in the sub study|1|||
161052737|NCT02260154|581581143|FG000|Overall Study|Screening failure|2|||
161052738|NCT03560206|581581144|FG000|Overall Study|Lost to Follow-up|19|||
161052739|NCT03560206|581581145|FG001|Overall Study|Lost to Follow-up|11|||
161281036|NCT00996892|582407013|FG011|Expansion Stage 2A|Physician Decision|0|||
161281037|NCT00996892|582407014|FG012|Expansion Stage 2A|Physician Decision|0|||
161281038|NCT00996892|582407015|FG013|Expansion Stage 2A|Physician Decision|0|||
161281039|NCT00996892|582407016|FG014|Expansion Stage 2A|Physician Decision|0|||
161281040|NCT00996892|582407017|FG015|Expansion Stage 2A|Physician Decision|0|||
161281041|NCT00996892|582407018|FG016|Expansion Stage 2A|Physician Decision|0|||
161052740|NCT03560206|581581144|FG000|Overall Study|Withdrawal by Subject|2|||
161052741|NCT03560206|581581145|FG001|Overall Study|Withdrawal by Subject|4|||
161052742|NCT03560206|581581144|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
161052743|NCT03560206|581581145|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
161052744|NCT03560206|581581144|FG000|Overall Study|Busy schedule|14|||
161052745|NCT03560206|581581145|FG001|Overall Study|Busy schedule|2|||
161052746|NCT03560206|581581144|FG000|Overall Study|patients' new health condition such as cancer|10|||
161052747|NCT03560206|581581145|FG001|Overall Study|patients' new health condition such as cancer|1|||
161052748|NCT00738400|581581146|FG000|Overall Study|Adverse Event|3|||
161052749|NCT00738400|581581147|FG001|Overall Study|Adverse Event|1|||
161052750|NCT00738400|581581146|FG000|Overall Study|Withdrawal by Subject|0|||
161052751|NCT00738400|581581147|FG001|Overall Study|Withdrawal by Subject|1|||
161052752|NCT00738400|581581146|FG000|Overall Study|Lack of Efficacy|0|||
161052753|NCT00738400|581581147|FG001|Overall Study|Lack of Efficacy|1|||
161052754|NCT00738400|581581146|FG000|Overall Study|Lost to Follow-up|0|||
161052755|NCT00738400|581581147|FG001|Overall Study|Lost to Follow-up|3|||
161052756|NCT00738400|581581146|FG000|Overall Study|Protocol Violation|1|||
161052757|NCT00738400|581581147|FG001|Overall Study|Protocol Violation|0|||
161052758|NCT00738400|581581146|FG000|Overall Study|Non-compliant with study medication|0|||
161052759|NCT00738400|581581147|FG001|Overall Study|Non-compliant with study medication|1|||
161052760|NCT02255474|581581148|FG000|Overall Study|Lost to Follow-up|1|||
161052761|NCT02255474|581581149|FG001|Overall Study|Lost to Follow-up|1|||
161052762|NCT02255474|581581150|FG002|Overall Study|Lost to Follow-up|3|||
161052763|NCT02255474|581581148|FG000|Overall Study|Withdrawal by Subject|1|||
161052764|NCT02255474|581581149|FG001|Overall Study|Withdrawal by Subject|1|||
161052765|NCT02255474|581581150|FG002|Overall Study|Withdrawal by Subject|0|||
161052766|NCT02993926|581581151|FG000|Enantone Treatment Phase|Adverse Event|1|||
161052767|NCT02993926|581581152|FG001|Enantone Treatment Phase|Adverse Event|0|||
161052768|NCT02993926|581581153|FG002|Enantone Treatment Phase|Adverse Event|0|||
161052769|NCT02993926|581581151|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
161052770|NCT02993926|581581152|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
161052771|NCT02993926|581581153|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
161052772|NCT02993926|581581151|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
161052773|NCT02993926|581581152|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
161052774|NCT02993926|581581153|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
161052775|NCT02993926|581581151|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
161052776|NCT02993926|581581152|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
161052777|NCT02993926|581581153|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
161052778|NCT01760876|581581154|FG000|Overall Study|Non-cardiac death (head injury)|1|||
161052779|NCT01760876|581581154|FG000|Overall Study|Carcinoma of prostate|1|||
161052780|NCT01760876|581581154|FG000|Overall Study|Impaired renal function|1|||
161052781|NCT01760876|581581154|FG000|Overall Study|Major depression|1|||
161052782|NCT01760876|581581154|FG000|Overall Study|Very poor baseline OCT quality|2|||
161052783|NCT04295499|581581158|FG000|Overall Study|moving out of state|1|||
161052784|NCT04295499|581581159|FG001|Overall Study|moving out of state|0|||
161052785|NCT04295499|581581158|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
161052786|NCT04295499|581581159|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
161052787|NCT00308113|581581160|FG000|Overall Study|Protocol closure|0|||
161052788|NCT00308113|581581161|FG001|Overall Study|Protocol closure|0|||
161052789|NCT00308113|581581162|FG002|Overall Study|Protocol closure|0|||
161052790|NCT00308113|581581163|FG003|Overall Study|Protocol closure|1|||
161052791|NCT02332889|581581164|FG000|Overall Study|Physician Decision|1|||
161052792|NCT02135445|581581167|FG000|Overall Study|Lost to Follow-up|1|||
161281042|NCT00996892|582407019|FG017|Expansion Stage 2A|Physician Decision|0|||
161281043|NCT00996892|582407020|FG018|Expansion Stage 2A|Physician Decision|0|||
161281044|NCT00996892|582407021|FG019|Expansion Stage 2A|Physician Decision|2|||
161281045|NCT00996892|582407002|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
161052793|NCT02135445|581581168|FG001|Overall Study|Lost to Follow-up|0|||
161052794|NCT02135445|581581167|FG000|Overall Study|Withdrawal by Subject|1|||
161052795|NCT02135445|581581168|FG001|Overall Study|Withdrawal by Subject|0|||
161052796|NCT00705614|581582722|FG000|Initial Intervention|Adverse Event|40|||
161052797|NCT00705614|581582723|FG001|Initial Intervention|Adverse Event|21|||
161052798|NCT00705614|581582722|FG000|Initial Intervention|Lost to Follow-up|310|||
161052799|NCT00705614|581582723|FG001|Initial Intervention|Lost to Follow-up|191|||
161052800|NCT00705614|581582722|FG000|Initial Intervention|Withdrawal by Subject|114|||
161052801|NCT00705614|581582723|FG001|Initial Intervention|Withdrawal by Subject|71|||
161052802|NCT00705614|581582722|FG000|Initial Intervention|Administrative Reason|51|||
161052803|NCT00705614|581582723|FG001|Initial Intervention|Administrative Reason|38|||
161052804|NCT00705614|581582722|FG000|Initial Intervention|Status completion unknown|3|||
161052805|NCT00705614|581582723|FG001|Initial Intervention|Status completion unknown|0|||
161052806|NCT00705614|581582722|FG000|Switch to Remicade|Adverse Event|0|||
161052807|NCT00705614|581582723|FG001|Switch to Remicade|Adverse Event|5|||
161052808|NCT00705614|581582722|FG000|Switch to Remicade|Lost to Follow-up|0|||
161052809|NCT00705614|581582723|FG001|Switch to Remicade|Lost to Follow-up|23|||
161052810|NCT00705614|581582722|FG000|Switch to Remicade|Withdrawal by Subject|0|||
161052811|NCT00705614|581582723|FG001|Switch to Remicade|Withdrawal by Subject|12|||
161052812|NCT00705614|581582722|FG000|Switch to Remicade|Administrative Reason|0|||
161052813|NCT00705614|581582723|FG001|Switch to Remicade|Administrative Reason|9|||
161052814|NCT02661490|581582724|FG000|Overall Study|Lost to Follow-up|0|||
161052815|NCT02661490|581582725|FG001|Overall Study|Lost to Follow-up|1|||
161052816|NCT02661490|581582726|FG002|Overall Study|Lost to Follow-up|0|||
161052817|NCT02661490|581582727|FG003|Overall Study|Lost to Follow-up|0|||
161052818|NCT02661490|581582728|FG004|Overall Study|Lost to Follow-up|2|||
161052819|NCT02661490|581582724|FG000|Overall Study|Withdrawal by Subject|2|||
161052820|NCT02661490|581582725|FG001|Overall Study|Withdrawal by Subject|0|||
161052821|NCT02661490|581582726|FG002|Overall Study|Withdrawal by Subject|2|||
161052822|NCT02661490|581582727|FG003|Overall Study|Withdrawal by Subject|0|||
161052823|NCT02661490|581582728|FG004|Overall Study|Withdrawal by Subject|0|||
161052824|NCT02661490|581582724|FG000|Overall Study|Death|1|||
161052825|NCT02661490|581582725|FG001|Overall Study|Death|1|||
161052826|NCT02661490|581582726|FG002|Overall Study|Death|0|||
161052827|NCT02661490|581582727|FG003|Overall Study|Death|1|||
161052828|NCT02661490|581582728|FG004|Overall Study|Death|0|||
161052829|NCT02661490|581582724|FG000|Overall Study|Reason not Specified|0|||
161052830|NCT02661490|581582725|FG001|Overall Study|Reason not Specified|0|||
161052831|NCT02661490|581582726|FG002|Overall Study|Reason not Specified|0|||
161052832|NCT02661490|581582727|FG003|Overall Study|Reason not Specified|0|||
161052833|NCT02661490|581582728|FG004|Overall Study|Reason not Specified|1|||
161052834|NCT00088452|581582729|FG000|Overall Study|Did not receive intervention|1|||
161052835|NCT00088452|581582730|FG001|Overall Study|Did not receive intervention|0|||
161052836|NCT00088452|581582731|FG002|Overall Study|Did not receive intervention|1|||
161052837|NCT02081196|581582733|FG000|Overall Study|Lost to Follow-up|1|||
161052838|NCT00961298|581582734|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
161052839|NCT00961298|581582734|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
161052840|NCT00961298|581582734|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
161052841|NCT01232569|581582737|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
161052842|NCT01232569|581582738|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161052843|NCT01232569|581582739|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161052844|NCT01232569|581582740|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
161052845|NCT01232569|581582737|FG000|Double-blind Treatment Period|Escape|2|||
161052846|NCT01232569|581582738|FG001|Double-blind Treatment Period|Escape|2|||
161052847|NCT01232569|581582739|FG002|Double-blind Treatment Period|Escape|0|||
161052848|NCT01232569|581582740|FG003|Double-blind Treatment Period|Escape|0|||
161052849|NCT01232569|581582737|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
161052850|NCT01232569|581582738|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161052851|NCT01232569|581582739|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161052852|NCT01232569|581582740|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161052853|NCT01232569|581582737|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
161052854|NCT01232569|581582738|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
161052855|NCT01232569|581582739|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161052856|NCT01232569|581582740|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161052857|NCT01232569|581582737|FG000|Double-blind Treatment Period|Physician Decision|1|||
161052858|NCT01232569|581582738|FG001|Double-blind Treatment Period|Physician Decision|0|||
161052859|NCT01232569|581582739|FG002|Double-blind Treatment Period|Physician Decision|0|||
161052860|NCT01232569|581582740|FG003|Double-blind Treatment Period|Physician Decision|0|||
161052861|NCT01232569|581582737|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
161052862|NCT01232569|581582738|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
161052863|NCT01232569|581582739|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
161052864|NCT01232569|581582740|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
161052865|NCT01232569|581582737|FG000|Double-blind Treatment Period|Death|2|||
161052866|NCT01232569|581582738|FG001|Double-blind Treatment Period|Death|0|||
161052867|NCT01232569|581582739|FG002|Double-blind Treatment Period|Death|0|||
161052868|NCT01232569|581582740|FG003|Double-blind Treatment Period|Death|0|||
161052869|NCT04044352|581582741|FG000|Overall Study|Lost to Follow-up|9|||
161052870|NCT04044352|581582741|FG000|Overall Study|Withdrawal by Subject|2|||
161052871|NCT04385849|581582752|FG000|Overall Study|Lost to Follow-up|1|||
161052872|NCT04385849|581582753|FG001|Overall Study|Lost to Follow-up|0|||
161052873|NCT03602053|581582754|FG000|Overall Study|Withdrawal by Subject|7|||
161052874|NCT03602053|581582755|FG001|Overall Study|Withdrawal by Subject|9|||
161052875|NCT03602053|581582756|FG002|Overall Study|Withdrawal by Subject|7|||
161052876|NCT03602053|581582754|FG000|Overall Study|Lost to Follow-up|5|||
161052877|NCT03602053|581582755|FG001|Overall Study|Lost to Follow-up|6|||
161052878|NCT03602053|581582756|FG002|Overall Study|Lost to Follow-up|0|||
161052879|NCT03602053|581582754|FG000|Overall Study|Protocol Violation|3|||
161052880|NCT03602053|581582755|FG001|Overall Study|Protocol Violation|0|||
161052881|NCT03602053|581582756|FG002|Overall Study|Protocol Violation|4|||
161052882|NCT03602053|581582754|FG000|Overall Study|Physician Decision|1|||
161052883|NCT03602053|581582755|FG001|Overall Study|Physician Decision|0|||
161052884|NCT03602053|581582756|FG002|Overall Study|Physician Decision|0|||
161052885|NCT03602053|581582754|FG000|Overall Study|migration|2|||
161052886|NCT03602053|581582755|FG001|Overall Study|migration|3|||
161052887|NCT03602053|581582756|FG002|Overall Study|migration|0|||
161052888|NCT03602053|581582754|FG000|Overall Study|Other|1|||
161052889|NCT03602053|581582755|FG001|Overall Study|Other|0|||
161052890|NCT03602053|581582756|FG002|Overall Study|Other|0|||
161052891|NCT01234675|581582763|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
161052892|NCT01234675|581582764|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
161052893|NCT01234675|581582763|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161052894|NCT01234675|581582764|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
161052895|NCT00396409|581582765|FG000|Period 1 - 2007|Adverse Event|0|||
161052896|NCT00396409|581582766|FG001|Period 1 - 2007|Adverse Event|1|||
161052897|NCT00396409|581582765|FG000|Period 1 - 2007|Lack of Efficacy|0|||
161052898|NCT00396409|581582766|FG001|Period 1 - 2007|Lack of Efficacy|1|||
161052899|NCT00396409|581582765|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
161052900|NCT00396409|581582766|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
161052901|NCT00396409|581582765|FG000|Period 1 - 2007|Lost to Follow-up|2|||
161052902|NCT00396409|581582766|FG001|Period 1 - 2007|Lost to Follow-up|3|||
161052903|NCT00396409|581582765|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
161052904|NCT00396409|581582766|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
161052905|NCT00396409|581582765|FG000|Period 2 - 2008|Protocol Violation|1|||
161052906|NCT00396409|581582766|FG001|Period 2 - 2008|Protocol Violation|0|||
161052907|NCT00396409|581582765|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
161052908|NCT00396409|581582766|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
161052909|NCT00396409|581582765|FG000|Period 2 - 2008|Lost to Follow-up|3|||
161052910|NCT00396409|581582766|FG001|Period 2 - 2008|Lost to Follow-up|1|||
161052911|NCT00331799|581582767|FG000|Overall Study|Withdrawal by Subject|2|||
161052912|NCT00331799|581582767|FG000|Overall Study|Sedation|1|||
161052913|NCT02889809|581582768|FG000|Overall Study|Withdrawal by Subject|30|||
161052914|NCT02889809|581582769|FG001|Overall Study|Withdrawal by Subject|21|||
161052915|NCT02889809|581582768|FG000|Overall Study|Lost to Follow-up|1|||
161052916|NCT02889809|581582769|FG001|Overall Study|Lost to Follow-up|1|||
161052917|NCT02889809|581582768|FG000|Overall Study|Site Closed|12|||
161052918|NCT02889809|581582769|FG001|Overall Study|Site Closed|11|||
161052919|NCT03696342|581582770|FG000|Overall Study|Lost to Follow-up|1|||
161052920|NCT03696342|581582771|FG001|Overall Study|Lost to Follow-up|0|||
161052921|NCT02409732|581582772|FG000|Overall Study|Withdrawal by Subject|4|||
161052922|NCT02409732|581582772|FG000|Overall Study|Lost to Follow-up|2|||
161052923|NCT01870999|581582774|FG000|Overall Study|Adverse Event|0|||
161052924|NCT01870999|581582775|FG001|Overall Study|Adverse Event|4|||
161052925|NCT01870999|581582776|FG002|Overall Study|Adverse Event|1|||
161052926|NCT01870999|581582774|FG000|Overall Study|Subject met withdrawal criteria|3|||
161052927|NCT01870999|581582775|FG001|Overall Study|Subject met withdrawal criteria|2|||
161052928|NCT01870999|581582776|FG002|Overall Study|Subject met withdrawal criteria|0|||
161052929|NCT01870999|581582774|FG000|Overall Study|Subject withdrawn by Investigator|1|||
161052930|NCT01870999|581582775|FG001|Overall Study|Subject withdrawn by Investigator|0|||
161052931|NCT01870999|581582776|FG002|Overall Study|Subject withdrawn by Investigator|0|||
161052932|NCT01870999|581582774|FG000|Overall Study|Withdrawal by Subject|0|||
161052933|NCT01870999|581582775|FG001|Overall Study|Withdrawal by Subject|2|||
161052934|NCT01870999|581582776|FG002|Overall Study|Withdrawal by Subject|5|||
161052935|NCT01870999|581582774|FG000|Overall Study|Protocol Violation|0|||
161052936|NCT01870999|581582775|FG001|Overall Study|Protocol Violation|0|||
161052937|NCT01870999|581582776|FG002|Overall Study|Protocol Violation|1|||
161052938|NCT00116584|581582777|FG000|Overall Study|Withdrawal by Subject|1|||
161052939|NCT00116584|581582778|FG001|Overall Study|Withdrawal by Subject|0|||
161052940|NCT00116584|581582777|FG000|Overall Study|Protocol Violation|1|||
161052941|NCT00116584|581582778|FG001|Overall Study|Protocol Violation|1|||
161052942|NCT03034772|581582779|FG000|Overall Study|Adverse Event|0|||
161052943|NCT03034772|581582780|FG001|Overall Study|Adverse Event|1|||
161052944|NCT03034772|581582779|FG000|Overall Study|Withdrawal by Subject|0|||
161052945|NCT03034772|581582780|FG001|Overall Study|Withdrawal by Subject|1|||
161052946|NCT01533181|581582785|FG000|Overall Study|Disease progression pre-active treatment|0|||
161052947|NCT01533181|581582786|FG001|Overall Study|Disease progression pre-active treatment|1|||
161052948|NCT01533181|581582785|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
161052949|NCT01533181|581582786|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
161052950|NCT01757171|581582787|FG000|Overall Study|Adverse Event|5|||
161052951|NCT01757171|581582788|FG001|Overall Study|Adverse Event|1|||
161052952|NCT01757171|581582787|FG000|Overall Study|Disease Progression|1|||
161052953|NCT01757171|581582788|FG001|Overall Study|Disease Progression|0|||
161052954|NCT01757171|581582787|FG000|Overall Study|Hospitalization|1|||
161052955|NCT01757171|581582788|FG001|Overall Study|Hospitalization|0|||
161052956|NCT01757171|581582787|FG000|Overall Study|ECOG decline|1|||
161052957|NCT01757171|581582788|FG001|Overall Study|ECOG decline|0|||
161052958|NCT00105521|581582790|FG000|Overall Study|Other|1|||
161052959|NCT00105521|581582791|FG001|Overall Study|Other|1|||
161052960|NCT00105521|581582792|FG002|Overall Study|Other|2|||
161052961|NCT00105521|581582793|FG003|Overall Study|Other|0|||
161052962|NCT00105521|581582790|FG000|Overall Study|Adverse Event|10|||
161052963|NCT00105521|581582791|FG001|Overall Study|Adverse Event|4|||
161052964|NCT00105521|581582792|FG002|Overall Study|Adverse Event|10|||
161052965|NCT00105521|581582793|FG003|Overall Study|Adverse Event|8|||
161052966|NCT00105521|581582790|FG000|Overall Study|Withdrawal by Subject|1|||
161052967|NCT00105521|581582791|FG001|Overall Study|Withdrawal by Subject|0|||
161052968|NCT00105521|581582792|FG002|Overall Study|Withdrawal by Subject|1|||
161052969|NCT00105521|581582793|FG003|Overall Study|Withdrawal by Subject|4|||
161052970|NCT00105521|581582790|FG000|Overall Study|Lack of Efficacy|0|||
161052971|NCT00105521|581582791|FG001|Overall Study|Lack of Efficacy|0|||
161052972|NCT00105521|581582792|FG002|Overall Study|Lack of Efficacy|0|||
161052973|NCT00105521|581582793|FG003|Overall Study|Lack of Efficacy|1|||
161052974|NCT00105521|581582790|FG000|Overall Study|Protocol Violation|3|||
161052975|NCT00105521|581582791|FG001|Overall Study|Protocol Violation|5|||
161052976|NCT00105521|581582792|FG002|Overall Study|Protocol Violation|4|||
161052977|NCT00105521|581582793|FG003|Overall Study|Protocol Violation|4|||
161052978|NCT00105521|581582790|FG000|Overall Study|Lost to Follow-up|0|||
161052979|NCT00105521|581582791|FG001|Overall Study|Lost to Follow-up|1|||
161052980|NCT00105521|581582792|FG002|Overall Study|Lost to Follow-up|0|||
161052981|NCT00105521|581582793|FG003|Overall Study|Lost to Follow-up|0|||
161052982|NCT00385697|581582796|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
161052983|NCT00385697|581582797|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
161052984|NCT00385697|581582798|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
161052985|NCT00385697|581582799|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
161052986|NCT00385697|581582800|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
161052987|NCT00385697|581582796|FG000|Open-label Segment 1|Lost to Follow-up|1|||
161052988|NCT00385697|581582797|FG001|Open-label Segment 1|Lost to Follow-up|0|||
161052989|NCT00385697|581582798|FG002|Open-label Segment 1|Lost to Follow-up|0|||
161052990|NCT00385697|581582799|FG003|Open-label Segment 1|Lost to Follow-up|0|||
161052991|NCT00385697|581582800|FG004|Open-label Segment 1|Lost to Follow-up|0|||
161052992|NCT00385697|581582796|FG000|Double-blind Segment 2|Adverse Event|0|||
161052993|NCT00385697|581582797|FG001|Double-blind Segment 2|Adverse Event|3|||
161052994|NCT00385697|581582798|FG002|Double-blind Segment 2|Adverse Event|1|||
161052995|NCT00385697|581582799|FG003|Double-blind Segment 2|Adverse Event|0|||
161052996|NCT00385697|581582800|FG004|Double-blind Segment 2|Adverse Event|0|||
161052997|NCT00385697|581582796|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
161052998|NCT00385697|581582797|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
161052999|NCT00385697|581582798|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
161053000|NCT00385697|581582799|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
161053001|NCT00385697|581582800|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
161053002|NCT00385697|581582796|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
161053003|NCT00385697|581582797|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
161053004|NCT00385697|581582798|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
161053005|NCT00385697|581582799|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
161053006|NCT00385697|581582800|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
161053007|NCT00385697|581582796|FG000|Double-blind Segment 2|Other|0|||
161053008|NCT00385697|581582797|FG001|Double-blind Segment 2|Other|2|||
161053009|NCT00385697|581582798|FG002|Double-blind Segment 2|Other|0|||
161053010|NCT00385697|581582799|FG003|Double-blind Segment 2|Other|0|||
161053011|NCT00385697|581582800|FG004|Double-blind Segment 2|Other|0|||
161053012|NCT01721109|581582812|FG000|Overall Study|Lack of Efficacy|1|||
161053013|NCT01721109|581582812|FG000|Overall Study|Non- Compliance with Study Drug|3|||
161053014|NCT01721109|581582812|FG000|Overall Study|Withdrew Consent|1|||
161053015|NCT01721109|581582812|FG000|Overall Study|Lost to Follow-up|2|||
161053016|NCT03045302|581582813|FG000|Overall Study|Pre-treatment adverse event|1|||
161053017|NCT00134056|581582814|FG000|Randomization|Not eligible for assigned treatment|22|||
161053018|NCT00134056|581582815|FG001|Randomization|Not eligible for assigned treatment|20|||
161053019|NCT00134056|581582814|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
161053020|NCT00134056|581582815|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
161053021|NCT00134056|581582814|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
161053022|NCT00134056|581582815|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
161053023|NCT00134056|581582814|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
161053024|NCT00134056|581582815|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
161053025|NCT00134056|581582814|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
161053026|NCT00134056|581582815|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
161053027|NCT00742560|581582817|FG000|Overall Study|Adverse Event|0|||
161053028|NCT00742560|581582818|FG001|Overall Study|Adverse Event|0|||
161053029|NCT00742560|581582819|FG002|Overall Study|Adverse Event|1|||
161053030|NCT00742560|581582820|FG003|Overall Study|Adverse Event|1|||
161053031|NCT00742560|581582821|FG004|Overall Study|Adverse Event|1|||
161053032|NCT00742560|581582817|FG000|Overall Study|Death|0|||
161053033|NCT00742560|581582818|FG001|Overall Study|Death|2|||
161053034|NCT00742560|581582819|FG002|Overall Study|Death|0|||
161053035|NCT00742560|581582820|FG003|Overall Study|Death|2|||
161053036|NCT00742560|581582821|FG004|Overall Study|Death|3|||
161053037|NCT00742560|581582817|FG000|Overall Study|Subject's Decision|1|||
161053038|NCT00742560|581582818|FG001|Overall Study|Subject's Decision|0|||
161053039|NCT00742560|581582819|FG002|Overall Study|Subject's Decision|2|||
161053040|NCT00742560|581582820|FG003|Overall Study|Subject's Decision|3|||
161053041|NCT00742560|581582821|FG004|Overall Study|Subject's Decision|3|||
161053042|NCT00742560|581582817|FG000|Overall Study|Investigator's Decision|0|||
161053043|NCT00742560|581582818|FG001|Overall Study|Investigator's Decision|0|||
161053044|NCT00742560|581582819|FG002|Overall Study|Investigator's Decision|4|||
161053045|NCT00742560|581582820|FG003|Overall Study|Investigator's Decision|1|||
161053046|NCT00742560|581582821|FG004|Overall Study|Investigator's Decision|0|||
161053047|NCT00742560|581582817|FG000|Overall Study|Disease Progression|1|||
161053048|NCT00742560|581582818|FG001|Overall Study|Disease Progression|0|||
161053049|NCT00742560|581582819|FG002|Overall Study|Disease Progression|5|||
161053050|NCT00742560|581582820|FG003|Overall Study|Disease Progression|17|||
161053051|NCT00742560|581582821|FG004|Overall Study|Disease Progression|16|||
161053052|NCT00742560|581582817|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
161053053|NCT00742560|581582818|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
161053054|NCT00742560|581582819|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
161053055|NCT00742560|581582820|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
161053056|NCT00742560|581582821|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
161053057|NCT00742560|581582817|FG000|Overall Study|Other|0|||
161053058|NCT00742560|581582818|FG001|Overall Study|Other|1|||
161053059|NCT00742560|581582819|FG002|Overall Study|Other|8|||
161053060|NCT00742560|581582820|FG003|Overall Study|Other|9|||
161053061|NCT00742560|581582821|FG004|Overall Study|Other|9|||
161053062|NCT00742560|581582817|FG000|Overall Study|MIssing|0|||
161053063|NCT00742560|581582818|FG001|Overall Study|MIssing|0|||
161053064|NCT00742560|581582819|FG002|Overall Study|MIssing|0|||
161053065|NCT00742560|581582820|FG003|Overall Study|MIssing|0|||
161053066|NCT00742560|581582821|FG004|Overall Study|MIssing|1|||
161053067|NCT01536795|581582822|FG000|Overall Study|Lost to Follow-up|0|||
161053068|NCT01536795|581582823|FG001|Overall Study|Lost to Follow-up|2|||
161053069|NCT01536795|581582822|FG000|Overall Study|Lack of Efficacy|1|||
161053070|NCT01536795|581582823|FG001|Overall Study|Lack of Efficacy|0|||
161053071|NCT02267746|581582824|FG000|Overall Study|Adverse Event|0|||
161053072|NCT02267746|581582825|FG001|Overall Study|Adverse Event|2|||
161053073|NCT02267746|581582826|FG002|Overall Study|Adverse Event|1|||
161053074|NCT02267746|581582824|FG000|Overall Study|Protocol Violation|8|||
161053075|NCT02267746|581582825|FG001|Overall Study|Protocol Violation|7|||
161053076|NCT02267746|581582826|FG002|Overall Study|Protocol Violation|3|||
161053077|NCT02267746|581582824|FG000|Overall Study|Lack of Efficacy|11|||
161053078|NCT02267746|581582825|FG001|Overall Study|Lack of Efficacy|11|||
161053079|NCT02267746|581582826|FG002|Overall Study|Lack of Efficacy|15|||
161053080|NCT02267746|581582824|FG000|Overall Study|Protocol Violation|1|||
161053081|NCT02267746|581582825|FG001|Overall Study|Protocol Violation|2|||
161053082|NCT02267746|581582826|FG002|Overall Study|Protocol Violation|1|||
161053083|NCT02267746|581582824|FG000|Overall Study|Miscellaneous|1|||
161053084|NCT02267746|581582825|FG001|Overall Study|Miscellaneous|0|||
161053085|NCT02267746|581582826|FG002|Overall Study|Miscellaneous|1|||
161053086|NCT05008224|581582827|FG000|Overall Study|Death|3|||
161053087|NCT05008224|581582827|FG000|Overall Study|Lost to Follow-up|2|||
161053088|NCT05008224|581582827|FG000|Overall Study|Did Not Continue on Extension Study|39|||
161053089|NCT05008224|581582827|FG000|Overall Study|Transferred to Extension Study|100|||
161151329|NCT03242759|581935519|FG000|Overall Study|Withdrawal by Subject|4|||
161345096|NCT03126110|582648853|FG004|Phase 2|Started new treatment|0|||
161053090|NCT05008224|581582827|FG000|Overall Study|Withdrawal by Subject|2|||
161053091|NCT00348283|581582828|FG000|Induction|Adverse Event|0|||
161053092|NCT00348283|581582829|FG001|Induction|Adverse Event|2|||
161053093|NCT00348283|581582828|FG000|Induction|Protocol Violation|0|||
161053094|NCT00348283|581582829|FG001|Induction|Protocol Violation|4|||
161053095|NCT00348283|581582828|FG000|Double Blind|Adverse Event|2|||
161053096|NCT00348283|581582829|FG001|Double Blind|Adverse Event|5|||
161151330|NCT03242759|581935520|FG001|Overall Study|Withdrawal by Subject|3|||
161053097|NCT00348283|581582828|FG000|Double Blind|Withdrawal by Subject|1|||
161151331|NCT03242759|581935519|FG000|Overall Study|Lost to Follow-up|3|||
161151332|NCT03242759|581935520|FG001|Overall Study|Lost to Follow-up|1|||
161151333|NCT03242759|581935519|FG000|Overall Study|Administrative problems|1|||
161053098|NCT00348283|581582829|FG001|Double Blind|Withdrawal by Subject|1|||
161053099|NCT00348283|581582828|FG000|Double Blind|Protocol Violation|0|||
161053100|NCT00348283|581582829|FG001|Double Blind|Protocol Violation|1|||
161053101|NCT00348283|581582828|FG000|Double Blind|Lack of Efficacy|2|||
161053102|NCT00348283|581582829|FG001|Double Blind|Lack of Efficacy|2|||
161053103|NCT00348283|581582828|FG000|Double Blind|Pregnancy|0|||
161053104|NCT00348283|581582829|FG001|Double Blind|Pregnancy|1|||
161053105|NCT00348283|581582828|FG000|Open Label|Adverse Event|0|||
161053106|NCT00348283|581582829|FG001|Open Label|Adverse Event|8|||
161053107|NCT00348283|581582828|FG000|Open Label|Withdrawal by Subject|0|||
161053108|NCT00348283|581582829|FG001|Open Label|Withdrawal by Subject|4|||
161053109|NCT00348283|581582828|FG000|Open Label|Lost to Follow-up|0|||
161053110|NCT00348283|581582829|FG001|Open Label|Lost to Follow-up|1|||
161053111|NCT00348283|581582828|FG000|Open Label|Lack of Efficacy|0|||
161053112|NCT00348283|581582829|FG001|Open Label|Lack of Efficacy|13|||
161053113|NCT00348283|581582828|FG000|Open Label|Administrative reasons|0|||
161053114|NCT00348283|581582829|FG001|Open Label|Administrative reasons|5|||
161053115|NCT00348283|581582828|FG000|Open Label|Subject moved to the United States|0|||
161053116|NCT00348283|581582829|FG001|Open Label|Subject moved to the United States|1|||
161053117|NCT00348283|581582828|FG000|Open Label|Pregnancy|0|||
161053118|NCT00348283|581582829|FG001|Open Label|Pregnancy|1|||
161053119|NCT00348283|581582828|FG000|Open Label|Sponsor decision|0|||
161053120|NCT00348283|581582829|FG001|Open Label|Sponsor decision|1|||
161053121|NCT05878522|581582833|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053122|NCT05878522|581582834|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053123|NCT05878522|581582835|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053124|NCT05878522|581582836|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053125|NCT05878522|581582837|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053126|NCT05878522|581582838|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053127|NCT05878522|581582839|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053128|NCT05878522|581582840|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053129|NCT05878522|581582841|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
161053130|NCT05878522|581582842|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053131|NCT05878522|581582843|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053132|NCT05878522|581582844|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
161053133|NCT05878522|581582833|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
161053134|NCT05878522|581582834|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053135|NCT05878522|581582835|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053136|NCT05878522|581582836|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053137|NCT05878522|581582837|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053138|NCT05878522|581582838|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053139|NCT05878522|581582839|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053140|NCT05878522|581582840|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053141|NCT05878522|581582841|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053142|NCT05878522|581582842|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
161053143|NCT05878522|581582843|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053144|NCT05878522|581582844|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
161053145|NCT05878522|581582833|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053146|NCT05878522|581582834|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
161053147|NCT05878522|581582835|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053148|NCT05878522|581582836|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
161053149|NCT05878522|581582837|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053150|NCT05878522|581582838|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053151|NCT05878522|581582839|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053152|NCT05878522|581582840|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053153|NCT05878522|581582841|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053154|NCT05878522|581582842|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053155|NCT05878522|581582843|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053156|NCT05878522|581582844|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
161053157|NCT05878522|581582833|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053158|NCT05878522|581582834|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053159|NCT05878522|581582835|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053160|NCT05878522|581582836|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053161|NCT05878522|581582837|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
161053162|NCT05878522|581582838|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053163|NCT05878522|581582839|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161281046|NCT00996892|582407003|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
161281047|NCT00996892|582407004|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
161281048|NCT00996892|582407005|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
161281049|NCT00996892|582407006|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
161053164|NCT05878522|581582840|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053165|NCT05878522|581582841|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161281050|NCT00996892|582407007|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
161053166|NCT05878522|581582842|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053167|NCT05878522|581582843|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161053168|NCT05878522|581582844|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
161281051|NCT00996892|582407008|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
161053169|NCT05263492|581582845|FG000|Overall Study|Adverse Event|1|||
161053170|NCT05263492|581582845|FG000|Overall Study|Disease progression during active treatment|3|||
161053171|NCT02058992|581582848|FG000|Overall Study|Lost to Follow-up|4|||
161053172|NCT02058992|581582848|FG000|Overall Study|Protocol Violation|92|||
161053173|NCT02058992|581582848|FG000|Overall Study|CRF Uncollected|20|||
161053174|NCT03747575|581582849|FG000|Overall Study|Withdrawal by Subject|6|||
161053175|NCT03747575|581582850|FG001|Overall Study|Withdrawal by Subject|3|||
161053176|NCT03747575|581582849|FG000|Overall Study|Lost to Follow-up|3|||
161053177|NCT03747575|581582850|FG001|Overall Study|Lost to Follow-up|3|||
161053178|NCT03747575|581582849|FG000|Overall Study|Adverse Event|0|||
161053179|NCT03747575|581582850|FG001|Overall Study|Adverse Event|1|||
161053180|NCT01549951|581582851|FG000|Overall Study|Adverse Event|15|||
161053181|NCT01549951|581582851|FG000|Overall Study|Withdrawal by Subject|2|||
161053182|NCT01549951|581582851|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161053183|NCT01549951|581582851|FG000|Overall Study|Progressive disease|29|||
161053184|NCT01549951|581582851|FG000|Overall Study|Symptomatic deterioration|1|||
161053185|NCT01549951|581582851|FG000|Overall Study|Other|2|||
161053186|NCT02009865|581582860|FG000|Overall Study|Adverse Event|0|||
161053187|NCT02009865|581582861|FG001|Overall Study|Adverse Event|2|||
161053188|NCT02009865|581582860|FG000|Overall Study|Protocol Violation|0|||
161053189|NCT02009865|581582861|FG001|Overall Study|Protocol Violation|2|||
161053190|NCT02009865|581582860|FG000|Overall Study|Withdrawal by Subject|1|||
161053191|NCT02009865|581582861|FG001|Overall Study|Withdrawal by Subject|1|||
161053192|NCT03689452|581582862|FG000|Overall Study|Lost to Follow-up|1|||
161053193|NCT03689452|581582863|FG001|Overall Study|Lost to Follow-up|1|||
161053194|NCT00525915|581582865|FG000|Overall Study|Non-Compliance|0|||
161053195|NCT00525915|581582866|FG001|Overall Study|Non-Compliance|1|||
161053196|NCT00525915|581582865|FG000|Overall Study|Disease Progression|5|||
161053197|NCT00525915|581582866|FG001|Overall Study|Disease Progression|6|||
161053198|NCT00525915|581582865|FG000|Overall Study|Withdrawal by Subject|1|||
161053199|NCT00525915|581582866|FG001|Overall Study|Withdrawal by Subject|0|||
161053200|NCT00525915|581582865|FG000|Overall Study|Refused Surgery|1|||
161053201|NCT00525915|581582866|FG001|Overall Study|Refused Surgery|2|||
161053202|NCT00525915|581582865|FG000|Overall Study|Unrelated illness|1|||
161053203|NCT00525915|581582866|FG001|Overall Study|Unrelated illness|0|||
161053204|NCT00732498|581582867|FG000|Overall Study|Ineligible|1|||
161053205|NCT00732498|581582867|FG000|Overall Study|Adverse Event|2|||
161053206|NCT00732498|581582867|FG000|Overall Study|Physician Decision|3|||
161053207|NCT03394508|581582870|FG000|Overall Study|Protocol Violation|0|||
161053208|NCT03394508|581582871|FG001|Overall Study|Protocol Violation|3|||
161053209|NCT03394508|581582870|FG000|Overall Study|Lost to Follow-up|1|||
161053210|NCT03394508|581582871|FG001|Overall Study|Lost to Follow-up|0|||
161053211|NCT00267865|581582872|FG000|Induction Treatment|Died before completing.|2|||
161053212|NCT00267865|581582872|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
161053213|NCT01755598|581582873|FG000|Overall Study|Other|109|||
161053214|NCT01755598|581582874|FG001|Overall Study|Other|109|||
161053215|NCT01755598|581582873|FG000|Overall Study|Lost to Follow-up|32|||
161053216|NCT01755598|581582874|FG001|Overall Study|Lost to Follow-up|43|||
161053217|NCT01755598|581582873|FG000|Overall Study|Migrated/moved from study area|76|||
161053218|NCT01755598|581582874|FG001|Overall Study|Migrated/moved from study area|65|||
161053219|NCT01755598|581582873|FG000|Overall Study|Withdrawal by Subject|22|||
161053220|NCT01755598|581582874|FG001|Overall Study|Withdrawal by Subject|31|||
161053221|NCT01755598|581582873|FG000|Overall Study|Protocol Violation|7|||
161053222|NCT01755598|581582874|FG001|Overall Study|Protocol Violation|7|||
161053223|NCT01755598|581582873|FG000|Overall Study|Adverse Event|19|||
161053224|NCT01755598|581582874|FG001|Overall Study|Adverse Event|28|||
161053225|NCT03556891|581582875|FG000|Initial Pivotal Study|Adverse Event|4|||
161053226|NCT03556891|581582875|FG000|Initial Pivotal Study|MRI Need|3|||
161053227|NCT03556891|581582875|FG000|Initial Pivotal Study|Device Failure|1|||
161053228|NCT03556891|581582875|FG000|Initial Pivotal Study|Death|1|||
161053229|NCT03556891|581582875|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
161053230|NCT03556891|581582875|FG000|Initial Pivotal Study|Missing at random|1|||
161053231|NCT03556891|581582875|FG000|Initial Pivotal Study|Missing due to COVID|1|||
161053232|NCT03556891|581582875|FG000|Initial Pivotal Study|Protocol Violation|1|||
161053233|NCT02388932|581584767|FG000|Overall Study|Death|1|||
161053234|NCT05335005|581584770|FG000|Overall Study|Lost to Follow-up|1|||
161053235|NCT05927753|581584771|FG000|Overall Study|Withdrawal by Subject|0|||
161053236|NCT05927753|581584772|FG001|Overall Study|Withdrawal by Subject|2|||
161053237|NCT05927753|581584771|FG000|Overall Study|Physician Decision|0|||
161053238|NCT05927753|581584772|FG001|Overall Study|Physician Decision|1|||
161053239|NCT00409006|581584776|FG000|Overall Study|Death|15|||
161281052|NCT00996892|582407009|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
161281053|NCT00996892|582407010|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
161281054|NCT00996892|582407011|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
161053240|NCT00409006|581584777|FG001|Overall Study|Death|6|||
161053241|NCT00409006|581584776|FG000|Overall Study|Lost to Follow-up|1|||
161053242|NCT00409006|581584777|FG001|Overall Study|Lost to Follow-up|2|||
161053243|NCT00409006|581584776|FG000|Overall Study|Withdrawal by Subject|3|||
161053244|NCT00409006|581584777|FG001|Overall Study|Withdrawal by Subject|2|||
161053245|NCT00409006|581584776|FG000|Overall Study|Physician Decision|1|||
161053246|NCT00409006|581584777|FG001|Overall Study|Physician Decision|2|||
161053247|NCT02123797|581584778|FG000|Baseline Intervention|Death|9|||
161053248|NCT02123797|581584779|FG001|Baseline Intervention|Death|16|||
161053249|NCT02123797|581584780|FG002|Baseline Intervention|Death|0|||
161053250|NCT02123797|581584781|FG003|Baseline Intervention|Death|0|||
161053251|NCT02123797|581584782|FG004|Baseline Intervention|Death|0|||
161053252|NCT02123797|581584778|FG000|Baseline Intervention|Withdrawal by Subject|2|||
161053253|NCT02123797|581584779|FG001|Baseline Intervention|Withdrawal by Subject|8|||
161053254|NCT02123797|581584780|FG002|Baseline Intervention|Withdrawal by Subject|0|||
161053255|NCT02123797|581584781|FG003|Baseline Intervention|Withdrawal by Subject|0|||
161053256|NCT02123797|581584782|FG004|Baseline Intervention|Withdrawal by Subject|0|||
161053257|NCT02123797|581584778|FG000|Baseline Intervention|Relocation|2|||
161053258|NCT02123797|581584779|FG001|Baseline Intervention|Relocation|0|||
161053259|NCT02123797|581584780|FG002|Baseline Intervention|Relocation|0|||
161053260|NCT02123797|581584781|FG003|Baseline Intervention|Relocation|0|||
161053261|NCT02123797|581584782|FG004|Baseline Intervention|Relocation|0|||
161053262|NCT02123797|581584778|FG000|Baseline Intervention|Out of window for initial survey|6|||
161053263|NCT02123797|581584779|FG001|Baseline Intervention|Out of window for initial survey|13|||
161053264|NCT02123797|581584780|FG002|Baseline Intervention|Out of window for initial survey|0|||
161053265|NCT02123797|581584781|FG003|Baseline Intervention|Out of window for initial survey|0|||
161053266|NCT02123797|581584782|FG004|Baseline Intervention|Out of window for initial survey|0|||
161053267|NCT02123797|581584778|FG000|Baseline Intervention|Lost to Follow-up|0|||
161053268|NCT02123797|581584779|FG001|Baseline Intervention|Lost to Follow-up|5|||
161053269|NCT02123797|581584780|FG002|Baseline Intervention|Lost to Follow-up|0|||
161053270|NCT02123797|581584781|FG003|Baseline Intervention|Lost to Follow-up|0|||
161053271|NCT02123797|581584782|FG004|Baseline Intervention|Lost to Follow-up|0|||
161053272|NCT02123797|581584778|FG000|Baseline Intervention|Other Disease|3|||
161053273|NCT02123797|581584779|FG001|Baseline Intervention|Other Disease|0|||
161053274|NCT02123797|581584780|FG002|Baseline Intervention|Other Disease|0|||
161053275|NCT02123797|581584781|FG003|Baseline Intervention|Other Disease|0|||
161053276|NCT02123797|581584782|FG004|Baseline Intervention|Other Disease|0|||
161053277|NCT02123797|581584778|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
161053278|NCT02123797|581584779|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
161053279|NCT02123797|581584780|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
161053280|NCT02123797|581584781|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
161053281|NCT02123797|581584782|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
161053282|NCT02123797|581584778|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
161053283|NCT02123797|581584779|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
161053284|NCT02123797|581584780|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
161053285|NCT02123797|581584781|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
161053286|NCT02123797|581584782|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
161053287|NCT02123797|581584778|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
161053288|NCT02123797|581584779|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
161053289|NCT02123797|581584780|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161053290|NCT02123797|581584781|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161053291|NCT02123797|581584782|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161053292|NCT02123797|581584778|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
161053293|NCT02123797|581584779|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
161053294|NCT02123797|581584780|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
161053295|NCT02123797|581584781|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
161053296|NCT02123797|581584782|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
161053297|NCT02123797|581584778|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
161053298|NCT02123797|581584779|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
161053299|NCT02123797|581584780|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
161053300|NCT02123797|581584781|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
161053301|NCT02123797|581584782|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
161053302|NCT02123797|581584778|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
161053303|NCT02123797|581584779|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
161053304|NCT02123797|581584780|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
161053305|NCT02123797|581584781|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
161053306|NCT02123797|581584782|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
161053307|NCT02123797|581584778|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
161053308|NCT02123797|581584779|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
161053309|NCT02123797|581584780|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
161053310|NCT02123797|581584781|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
161053311|NCT02123797|581584782|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
161053312|NCT02123797|581584778|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
161053313|NCT02123797|581584779|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
161053314|NCT02123797|581584780|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161053315|NCT02123797|581584781|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161053316|NCT02123797|581584782|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
161053317|NCT02123797|581584778|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
161053318|NCT02123797|581584779|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
161053319|NCT02123797|581584780|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
161053320|NCT02123797|581584781|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
161053321|NCT02123797|581584782|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
161053322|NCT01375777|581584785|FG000|Overall Study|Withdrawal by Subject|0|||
161053323|NCT01375777|581584786|FG001|Overall Study|Withdrawal by Subject|2|||
161053324|NCT01375777|581584787|FG002|Overall Study|Withdrawal by Subject|1|||
161053325|NCT01375777|581584788|FG003|Overall Study|Withdrawal by Subject|0|||
161053326|NCT01375777|581584789|FG004|Overall Study|Withdrawal by Subject|1|||
161053327|NCT01375777|581584790|FG005|Overall Study|Withdrawal by Subject|1|||
161053328|NCT01375777|581584791|FG006|Overall Study|Withdrawal by Subject|1|||
161053329|NCT01375777|581584792|FG007|Overall Study|Withdrawal by Subject|2|||
161053330|NCT01375777|581584793|FG008|Overall Study|Withdrawal by Subject|1|||
161053331|NCT01375777|581584785|FG000|Overall Study|Lost to Follow-up|1|||
161053332|NCT01375777|581584786|FG001|Overall Study|Lost to Follow-up|0|||
161053333|NCT01375777|581584787|FG002|Overall Study|Lost to Follow-up|0|||
161053334|NCT01375777|581584788|FG003|Overall Study|Lost to Follow-up|0|||
161053335|NCT01375777|581584789|FG004|Overall Study|Lost to Follow-up|0|||
161053336|NCT01375777|581584790|FG005|Overall Study|Lost to Follow-up|0|||
161053337|NCT01375777|581584791|FG006|Overall Study|Lost to Follow-up|1|||
161053338|NCT01375777|581584792|FG007|Overall Study|Lost to Follow-up|0|||
161053339|NCT01375777|581584793|FG008|Overall Study|Lost to Follow-up|0|||
161053340|NCT01375777|581584785|FG000|Overall Study|Other|1|||
161053341|NCT01375777|581584786|FG001|Overall Study|Other|1|||
161053342|NCT01375777|581584787|FG002|Overall Study|Other|0|||
161053343|NCT01375777|581584788|FG003|Overall Study|Other|0|||
161053344|NCT01375777|581584789|FG004|Overall Study|Other|0|||
161053345|NCT01375777|581584790|FG005|Overall Study|Other|0|||
161053346|NCT01375777|581584791|FG006|Overall Study|Other|0|||
161053347|NCT01375777|581584792|FG007|Overall Study|Other|0|||
161053348|NCT01375777|581584793|FG008|Overall Study|Other|1|||
161053349|NCT00355784|581584794|FG000|Overall Study|Withdrawal by Subject|0|||
161053350|NCT00355784|581584795|FG001|Overall Study|Withdrawal by Subject|0|||
161053351|NCT00355784|581584796|FG002|Overall Study|Withdrawal by Subject|2|||
161053352|NCT03672188|581584803|FG000|Overall Study|Withdrawal by Subject|0|||
161053353|NCT03672188|581584804|FG001|Overall Study|Withdrawal by Subject|0|||
161053354|NCT03672188|581584805|FG002|Overall Study|Withdrawal by Subject|0|||
161053355|NCT03672188|581584806|FG003|Overall Study|Withdrawal by Subject|3|||
161053356|NCT03672188|581584807|FG004|Overall Study|Withdrawal by Subject|0|||
161053357|NCT03672188|581584808|FG005|Overall Study|Withdrawal by Subject|0|||
161053358|NCT03672188|581584809|FG006|Overall Study|Withdrawal by Subject|0|||
161053359|NCT03672188|581584810|FG007|Overall Study|Withdrawal by Subject|0|||
161053360|NCT03672188|581584811|FG008|Overall Study|Withdrawal by Subject|0|||
161053361|NCT03672188|581584812|FG009|Overall Study|Withdrawal by Subject|0|||
161053362|NCT03672188|581584813|FG010|Overall Study|Withdrawal by Subject|0|||
161053363|NCT03672188|581584814|FG011|Overall Study|Withdrawal by Subject|0|||
161053364|NCT03672188|581584815|FG012|Overall Study|Withdrawal by Subject|0|||
161053365|NCT03672188|581584816|FG013|Overall Study|Withdrawal by Subject|0|||
161053366|NCT03672188|581584817|FG014|Overall Study|Withdrawal by Subject|0|||
161053367|NCT03672188|581584803|FG000|Overall Study|Death|0|||
161053368|NCT03672188|581584804|FG001|Overall Study|Death|0|||
161053369|NCT03672188|581584805|FG002|Overall Study|Death|0|||
161053370|NCT03672188|581584806|FG003|Overall Study|Death|0|||
161053371|NCT03672188|581584807|FG004|Overall Study|Death|0|||
161053372|NCT03672188|581584808|FG005|Overall Study|Death|0|||
161053373|NCT03672188|581584809|FG006|Overall Study|Death|0|||
161053374|NCT03672188|581584810|FG007|Overall Study|Death|0|||
161053375|NCT03672188|581584811|FG008|Overall Study|Death|0|||
161053376|NCT03672188|581584812|FG009|Overall Study|Death|0|||
161053377|NCT03672188|581584813|FG010|Overall Study|Death|0|||
161053378|NCT03672188|581584814|FG011|Overall Study|Death|0|||
161053379|NCT03672188|581584815|FG012|Overall Study|Death|1|||
161053380|NCT03672188|581584816|FG013|Overall Study|Death|0|||
161053381|NCT03672188|581584817|FG014|Overall Study|Death|0|||
161053382|NCT03672188|581584803|FG000|Overall Study|Lost to Follow-up|0|||
161053383|NCT03672188|581584804|FG001|Overall Study|Lost to Follow-up|0|||
161053384|NCT03672188|581584805|FG002|Overall Study|Lost to Follow-up|1|||
161053385|NCT03672188|581584806|FG003|Overall Study|Lost to Follow-up|0|||
161053386|NCT03672188|581584807|FG004|Overall Study|Lost to Follow-up|0|||
161053387|NCT03672188|581584808|FG005|Overall Study|Lost to Follow-up|0|||
161053388|NCT03672188|581584809|FG006|Overall Study|Lost to Follow-up|0|||
161053389|NCT03672188|581584810|FG007|Overall Study|Lost to Follow-up|0|||
161053390|NCT03672188|581584811|FG008|Overall Study|Lost to Follow-up|0|||
161053391|NCT03672188|581584812|FG009|Overall Study|Lost to Follow-up|0|||
161053392|NCT03672188|581584813|FG010|Overall Study|Lost to Follow-up|0|||
161053393|NCT03672188|581584814|FG011|Overall Study|Lost to Follow-up|0|||
161053394|NCT03672188|581584815|FG012|Overall Study|Lost to Follow-up|0|||
161053395|NCT03672188|581584816|FG013|Overall Study|Lost to Follow-up|0|||
161053396|NCT03672188|581584817|FG014|Overall Study|Lost to Follow-up|0|||
161053397|NCT03997409|581584818|FG000|Overall Study|Protocol Violation|1|||
161053398|NCT03997409|581584819|FG001|Overall Study|Protocol Violation|1|||
161053399|NCT03997409|581584820|FG002|Overall Study|Protocol Violation|0|||
161053400|NCT03997409|581584818|FG000|Overall Study|Withdrawal by Subject|3|||
161053401|NCT03997409|581584819|FG001|Overall Study|Withdrawal by Subject|0|||
161053402|NCT03997409|581584820|FG002|Overall Study|Withdrawal by Subject|0|||
161053403|NCT03997409|581584818|FG000|Overall Study|Lost to Follow-up|0|||
161053404|NCT03997409|581584819|FG001|Overall Study|Lost to Follow-up|0|||
161053405|NCT03997409|581584820|FG002|Overall Study|Lost to Follow-up|1|||
161053406|NCT01753323|581584821|FG000|Overall Study|Lack of Efficacy|0|||
161053407|NCT01753323|581584822|FG001|Overall Study|Lack of Efficacy|0|||
161053408|NCT01753323|581584823|FG002|Overall Study|Lack of Efficacy|8|||
161053409|NCT01753323|581584821|FG000|Overall Study|Protocol deviation|1|||
161053410|NCT01753323|581584822|FG001|Overall Study|Protocol deviation|0|||
161053411|NCT01753323|581584823|FG002|Overall Study|Protocol deviation|0|||
161053412|NCT01753323|581584821|FG000|Overall Study|Adverse Event|0|||
161053413|NCT01753323|581584822|FG001|Overall Study|Adverse Event|0|||
161053414|NCT01753323|581584823|FG002|Overall Study|Adverse Event|1|||
161053415|NCT01636258|581584824|FG000|Overall Study|Lost to Follow-up|1|||
161053416|NCT01636258|581584825|FG001|Overall Study|Lost to Follow-up|0|||
161053417|NCT01745380|581584836|FG000|Overall Study|Lost to Follow-up|1|||
161053418|NCT01745380|581584837|FG001|Overall Study|Lost to Follow-up|0|||
161053419|NCT01745380|581584836|FG000|Overall Study|Lack of Efficacy|0|||
161053420|NCT01745380|581584837|FG001|Overall Study|Lack of Efficacy|1|||
161053421|NCT02660034|581584838|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
161053422|NCT02660034|581584839|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
161053423|NCT02660034|581584840|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
161053424|NCT02660034|581584841|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
161053425|NCT02660034|581584842|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
161053426|NCT02660034|581584843|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
161053427|NCT02660034|581584844|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
161053428|NCT02660034|581584845|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
161053429|NCT02660034|581584846|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
161053430|NCT02660034|581584847|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
161053431|NCT02660034|581584848|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
161053432|NCT02660034|581584849|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
161053433|NCT02660034|581584850|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
161053434|NCT02660034|581584851|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
161053435|NCT02660034|581584838|FG000|Overall Study|Progressive Disease (Clinical)|7|||
161053436|NCT02660034|581584839|FG001|Overall Study|Progressive Disease (Clinical)|8|||
161053437|NCT02660034|581584840|FG002|Overall Study|Progressive Disease (Clinical)|3|||
161053438|NCT02660034|581584841|FG003|Overall Study|Progressive Disease (Clinical)|9|||
161053439|NCT02660034|581584842|FG004|Overall Study|Progressive Disease (Clinical)|3|||
161053440|NCT02660034|581584843|FG005|Overall Study|Progressive Disease (Clinical)|0|||
161053441|NCT02660034|581584844|FG006|Overall Study|Progressive Disease (Clinical)|0|||
161053442|NCT02660034|581584845|FG007|Overall Study|Progressive Disease (Clinical)|0|||
161053443|NCT02660034|581584846|FG008|Overall Study|Progressive Disease (Clinical)|0|||
161053444|NCT02660034|581584847|FG009|Overall Study|Progressive Disease (Clinical)|0|||
161053445|NCT02660034|581584848|FG010|Overall Study|Progressive Disease (Clinical)|0|||
161053446|NCT02660034|581584849|FG011|Overall Study|Progressive Disease (Clinical)|0|||
161053447|NCT02660034|581584850|FG012|Overall Study|Progressive Disease (Clinical)|0|||
161053448|NCT02660034|581584851|FG013|Overall Study|Progressive Disease (Clinical)|0|||
161053449|NCT02660034|581584838|FG000|Overall Study|Lost to Follow-up|0|||
161053450|NCT02660034|581584839|FG001|Overall Study|Lost to Follow-up|0|||
161053451|NCT02660034|581584840|FG002|Overall Study|Lost to Follow-up|1|||
161053452|NCT02660034|581584841|FG003|Overall Study|Lost to Follow-up|1|||
161053453|NCT02660034|581584842|FG004|Overall Study|Lost to Follow-up|0|||
161151334|NCT03242759|581935520|FG001|Overall Study|Administrative problems|1|||
161151335|NCT03242759|581935519|FG000|Overall Study|Death|22|||
161151336|NCT03242759|581935520|FG001|Overall Study|Death|0|||
161053454|NCT02660034|581584843|FG005|Overall Study|Lost to Follow-up|0|||
161053455|NCT02660034|581584844|FG006|Overall Study|Lost to Follow-up|0|||
161151337|NCT03242759|581935519|FG000|Overall Study|Change visit schedule|0|||
161053456|NCT02660034|581584845|FG007|Overall Study|Lost to Follow-up|0|||
161053457|NCT02660034|581584846|FG008|Overall Study|Lost to Follow-up|0|||
161053458|NCT02660034|581584847|FG009|Overall Study|Lost to Follow-up|1|||
161151338|NCT03242759|581935520|FG001|Overall Study|Change visit schedule|1|||
161053459|NCT02660034|581584848|FG010|Overall Study|Lost to Follow-up|1|||
161053460|NCT02660034|581584849|FG011|Overall Study|Lost to Follow-up|1|||
161151339|NCT00504166|581935523|FG000|Overall Study|Adverse Event|1|||
161281055|NCT00996892|582407012|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
161151340|NCT00504166|581935524|FG001|Overall Study|Adverse Event|4|||
161053461|NCT02660034|581584850|FG012|Overall Study|Lost to Follow-up|0|||
161053462|NCT02660034|581584851|FG013|Overall Study|Lost to Follow-up|0|||
161053463|NCT02660034|581584838|FG000|Overall Study|Participant moved into special access scheme|1|||
161053464|NCT02660034|581584839|FG001|Overall Study|Participant moved into special access scheme|2|||
161053465|NCT02660034|581584840|FG002|Overall Study|Participant moved into special access scheme|0|||
161053466|NCT02660034|581584841|FG003|Overall Study|Participant moved into special access scheme|0|||
161053467|NCT02660034|581584842|FG004|Overall Study|Participant moved into special access scheme|0|||
161053468|NCT02660034|581584843|FG005|Overall Study|Participant moved into special access scheme|0|||
161053469|NCT02660034|581584844|FG006|Overall Study|Participant moved into special access scheme|0|||
161053470|NCT02660034|581584845|FG007|Overall Study|Participant moved into special access scheme|0|||
161053471|NCT02660034|581584846|FG008|Overall Study|Participant moved into special access scheme|0|||
161053472|NCT02660034|581584847|FG009|Overall Study|Participant moved into special access scheme|0|||
161053473|NCT02660034|581584848|FG010|Overall Study|Participant moved into special access scheme|0|||
161053474|NCT02660034|581584849|FG011|Overall Study|Participant moved into special access scheme|0|||
161053475|NCT02660034|581584850|FG012|Overall Study|Participant moved into special access scheme|0|||
161053476|NCT02660034|581584851|FG013|Overall Study|Participant moved into special access scheme|0|||
161053477|NCT02660034|581584838|FG000|Overall Study|Adverse Event|1|||
161053478|NCT02660034|581584839|FG001|Overall Study|Adverse Event|0|||
161053479|NCT02660034|581584840|FG002|Overall Study|Adverse Event|0|||
161053480|NCT02660034|581584841|FG003|Overall Study|Adverse Event|0|||
161053481|NCT02660034|581584842|FG004|Overall Study|Adverse Event|0|||
161053482|NCT02660034|581584843|FG005|Overall Study|Adverse Event|0|||
161053483|NCT02660034|581584844|FG006|Overall Study|Adverse Event|0|||
161053484|NCT02660034|581584845|FG007|Overall Study|Adverse Event|0|||
161053485|NCT02660034|581584846|FG008|Overall Study|Adverse Event|0|||
161053486|NCT02660034|581584847|FG009|Overall Study|Adverse Event|0|||
161053487|NCT02660034|581584848|FG010|Overall Study|Adverse Event|0|||
161053488|NCT02660034|581584849|FG011|Overall Study|Adverse Event|0|||
161053489|NCT02660034|581584850|FG012|Overall Study|Adverse Event|0|||
161053490|NCT02660034|581584851|FG013|Overall Study|Adverse Event|0|||
161053491|NCT02660034|581584838|FG000|Overall Study|Sponsor Decision|0|||
161053492|NCT02660034|581584839|FG001|Overall Study|Sponsor Decision|1|||
161053493|NCT02660034|581584840|FG002|Overall Study|Sponsor Decision|2|||
161053494|NCT02660034|581584841|FG003|Overall Study|Sponsor Decision|2|||
161053495|NCT02660034|581584842|FG004|Overall Study|Sponsor Decision|3|||
161053496|NCT02660034|581584843|FG005|Overall Study|Sponsor Decision|0|||
161053497|NCT02660034|581584844|FG006|Overall Study|Sponsor Decision|0|||
161053498|NCT02660034|581584845|FG007|Overall Study|Sponsor Decision|0|||
161053499|NCT02660034|581584846|FG008|Overall Study|Sponsor Decision|0|||
161053500|NCT02660034|581584847|FG009|Overall Study|Sponsor Decision|0|||
161053501|NCT02660034|581584848|FG010|Overall Study|Sponsor Decision|0|||
161053502|NCT02660034|581584849|FG011|Overall Study|Sponsor Decision|0|||
161053503|NCT02660034|581584850|FG012|Overall Study|Sponsor Decision|0|||
161053504|NCT02660034|581584851|FG013|Overall Study|Sponsor Decision|1|||
161053505|NCT02660034|581584838|FG000|Overall Study|Withdrawal by Subject|0|||
161053506|NCT02660034|581584839|FG001|Overall Study|Withdrawal by Subject|0|||
161053507|NCT02660034|581584840|FG002|Overall Study|Withdrawal by Subject|0|||
161053508|NCT02660034|581584841|FG003|Overall Study|Withdrawal by Subject|0|||
161053509|NCT02660034|581584842|FG004|Overall Study|Withdrawal by Subject|0|||
161053510|NCT02660034|581584843|FG005|Overall Study|Withdrawal by Subject|0|||
161053511|NCT02660034|581584844|FG006|Overall Study|Withdrawal by Subject|1|||
161053512|NCT02660034|581584845|FG007|Overall Study|Withdrawal by Subject|1|||
161053513|NCT02660034|581584846|FG008|Overall Study|Withdrawal by Subject|1|||
161053514|NCT02660034|581584847|FG009|Overall Study|Withdrawal by Subject|0|||
161053515|NCT02660034|581584848|FG010|Overall Study|Withdrawal by Subject|0|||
161053516|NCT02660034|581584849|FG011|Overall Study|Withdrawal by Subject|1|||
161053517|NCT02660034|581584850|FG012|Overall Study|Withdrawal by Subject|2|||
161053518|NCT02660034|581584851|FG013|Overall Study|Withdrawal by Subject|0|||
161053519|NCT02660034|581584838|FG000|Overall Study|Death|0|||
161053520|NCT02660034|581584839|FG001|Overall Study|Death|0|||
161053521|NCT02660034|581584840|FG002|Overall Study|Death|0|||
161053522|NCT02660034|581584841|FG003|Overall Study|Death|0|||
161053523|NCT02660034|581584842|FG004|Overall Study|Death|0|||
161053524|NCT02660034|581584843|FG005|Overall Study|Death|13|||
161053525|NCT02660034|581584844|FG006|Overall Study|Death|14|||
161053526|NCT02660034|581584845|FG007|Overall Study|Death|10|||
161053527|NCT02660034|581584846|FG008|Overall Study|Death|9|||
161053528|NCT02660034|581584847|FG009|Overall Study|Death|21|||
161053529|NCT02660034|581584848|FG010|Overall Study|Death|17|||
161053530|NCT02660034|581584849|FG011|Overall Study|Death|15|||
161053531|NCT02660034|581584850|FG012|Overall Study|Death|18|||
161053532|NCT02660034|581584851|FG013|Overall Study|Death|7|||
161053533|NCT02660034|581584838|FG000|Overall Study|Physician Decision|0|||
161053534|NCT02660034|581584839|FG001|Overall Study|Physician Decision|0|||
161053535|NCT02660034|581584840|FG002|Overall Study|Physician Decision|0|||
161053536|NCT02660034|581584841|FG003|Overall Study|Physician Decision|0|||
161053537|NCT02660034|581584842|FG004|Overall Study|Physician Decision|0|||
161053538|NCT02660034|581584843|FG005|Overall Study|Physician Decision|0|||
161053539|NCT02660034|581584844|FG006|Overall Study|Physician Decision|0|||
161053540|NCT02660034|581584845|FG007|Overall Study|Physician Decision|0|||
161053541|NCT02660034|581584846|FG008|Overall Study|Physician Decision|0|||
161053542|NCT02660034|581584847|FG009|Overall Study|Physician Decision|0|||
161053543|NCT02660034|581584848|FG010|Overall Study|Physician Decision|0|||
161053544|NCT02660034|581584849|FG011|Overall Study|Physician Decision|0|||
161053545|NCT02660034|581584850|FG012|Overall Study|Physician Decision|0|||
161053546|NCT02660034|581584851|FG013|Overall Study|Physician Decision|1|||
161053547|NCT02660034|581584838|FG000|Overall Study|Participants transferred to LTE|0|||
161053548|NCT02660034|581584839|FG001|Overall Study|Participants transferred to LTE|0|||
161053549|NCT02660034|581584840|FG002|Overall Study|Participants transferred to LTE|0|||
161053550|NCT02660034|581584841|FG003|Overall Study|Participants transferred to LTE|0|||
161053551|NCT02660034|581584842|FG004|Overall Study|Participants transferred to LTE|0|||
161053552|NCT02660034|581584843|FG005|Overall Study|Participants transferred to LTE|10|||
161053553|NCT02660034|581584844|FG006|Overall Study|Participants transferred to LTE|8|||
161053554|NCT02660034|581584845|FG007|Overall Study|Participants transferred to LTE|8|||
161053555|NCT02660034|581584846|FG008|Overall Study|Participants transferred to LTE|10|||
161053556|NCT02660034|581584847|FG009|Overall Study|Participants transferred to LTE|1|||
161053557|NCT02660034|581584848|FG010|Overall Study|Participants transferred to LTE|2|||
161053558|NCT02660034|581584849|FG011|Overall Study|Participants transferred to LTE|4|||
161053559|NCT02660034|581584850|FG012|Overall Study|Participants transferred to LTE|1|||
161053560|NCT02660034|581584851|FG013|Overall Study|Participants transferred to LTE|1|||
161053561|NCT04879823|581584859|FG000|Overall Study|Physician Decision|3|||
161053562|NCT04879823|581584860|FG001|Overall Study|Physician Decision|1|||
161053563|NCT04879823|581584859|FG000|Overall Study|Protocol Violation|2|||
161053564|NCT04879823|581584860|FG001|Overall Study|Protocol Violation|3|||
161053565|NCT04879823|581584859|FG000|Overall Study|Lost to Follow-up|43|||
161053566|NCT04879823|581584860|FG001|Overall Study|Lost to Follow-up|35|||
161053567|NCT00730925|581584861|FG000|Overall Study|Progressive Disease|21|||
161053568|NCT00730925|581584861|FG000|Overall Study|Dose reducing Event|2|||
161053569|NCT00730925|581584861|FG000|Overall Study|Other Averse Event|7|||
161053570|NCT00730925|581584861|FG000|Overall Study|Protocol Violation|1|||
161053571|NCT00730925|581584861|FG000|Overall Study|Withdrawal by Subject|1|||
161053572|NCT00730925|581584861|FG000|Overall Study|Switch to combination therapy|8|||
161053573|NCT00730925|581584861|FG000|Overall Study|Other|1|||
161053574|NCT02137239|581584862|FG000|Overall Study|Discontinued Study Treatment|0|||
161053575|NCT02137239|581584863|FG001|Overall Study|Discontinued Study Treatment|3|||
161053576|NCT02137239|581584862|FG000|Overall Study|Withdrew Consent|1|||
161053577|NCT02137239|581584863|FG001|Overall Study|Withdrew Consent|1|||
161053578|NCT02137239|581584862|FG000|Overall Study|Adverse Event|2|||
161053579|NCT02137239|581584863|FG001|Overall Study|Adverse Event|2|||
161053580|NCT04057937|581584864|FG000|Placebo-controlled Phase|Adverse Event|3|||
161053581|NCT04057937|581584865|FG001|Placebo-controlled Phase|Adverse Event|0|||
161053582|NCT04057937|581584864|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
161053583|NCT04057937|581584865|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
161053584|NCT04057937|581584864|FG000|Active-treatment Phase|Pregnancy|0|||
161053585|NCT04057937|581584865|FG001|Active-treatment Phase|Pregnancy|1|||
161053586|NCT04057937|581584864|FG000|Active-treatment Phase|Physician Decision|0|||
161053587|NCT04057937|581584865|FG001|Active-treatment Phase|Physician Decision|1|||
161053588|NCT02029521|581584866|FG000|Overall Study|Protocol Violation|1|||
161053589|NCT02029521|581584867|FG001|Overall Study|Protocol Violation|0|||
161281056|NCT00996892|582407013|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
161281057|NCT00996892|582407014|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
161281058|NCT00996892|582407015|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
161281059|NCT00996892|582407016|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
161053590|NCT02029521|581584866|FG000|Overall Study|Withdrawal by Subject|1|||
161053591|NCT02029521|581584867|FG001|Overall Study|Withdrawal by Subject|1|||
161281060|NCT00996892|582407017|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
161053592|NCT01072396|581584868|FG000|Period One|Adverse Event|1|||
161053593|NCT01072396|581584869|FG001|Period One|Adverse Event|1|||
161053594|NCT01072396|581584868|FG000|Period One|Protocol Violation|2|||
161281061|NCT00996892|582407018|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
161053595|NCT01072396|581584869|FG001|Period One|Protocol Violation|1|||
161053596|NCT01072396|581584868|FG000|Period One|Withdrawal by Subject|2|||
161281062|NCT00996892|582407019|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
161281063|NCT00996892|582407020|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
161281064|NCT00996892|582407021|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
161053597|NCT01072396|581584869|FG001|Period One|Withdrawal by Subject|0|||
161281065|NCT00996892|582407002|FG000|Expansion Stage 2A|Disease Progression|0|||
161053598|NCT01072396|581584868|FG000|Washout Period|Missing termination information|0|||
161281066|NCT00996892|582407003|FG001|Expansion Stage 2A|Disease Progression|0|||
161053599|NCT01072396|581584869|FG001|Washout Period|Missing termination information|1|||
161053600|NCT01072396|581584868|FG000|Period Two|Adverse Event|0|||
161053601|NCT01072396|581584869|FG001|Period Two|Adverse Event|3|||
161053602|NCT01072396|581584868|FG000|Period Two|Lost to Follow-up|1|||
161053603|NCT01072396|581584869|FG001|Period Two|Lost to Follow-up|0|||
161053604|NCT02446912|581584870|FG000|Overall Study|Adverse Event|3|||
161053605|NCT02446912|581584871|FG001|Overall Study|Adverse Event|13|||
161053606|NCT02446912|581584872|FG002|Overall Study|Adverse Event|5|||
161053607|NCT02446912|581584870|FG000|Overall Study|Condition under investigation worsened|0|||
161053608|NCT02446912|581584871|FG001|Overall Study|Condition under investigation worsened|1|||
161053609|NCT02446912|581584872|FG002|Overall Study|Condition under investigation worsened|1|||
161053610|NCT02446912|581584870|FG000|Overall Study|Study-specific withdrawal criteria|1|||
161053611|NCT02446912|581584871|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161053612|NCT02446912|581584872|FG002|Overall Study|Study-specific withdrawal criteria|0|||
161053613|NCT02446912|581584870|FG000|Overall Study|Lack of Efficacy|1|||
161053614|NCT02446912|581584871|FG001|Overall Study|Lack of Efficacy|4|||
161053615|NCT02446912|581584872|FG002|Overall Study|Lack of Efficacy|7|||
161053616|NCT02446912|581584870|FG000|Overall Study|Lost to Follow-up|0|||
161053617|NCT02446912|581584871|FG001|Overall Study|Lost to Follow-up|0|||
161053618|NCT02446912|581584872|FG002|Overall Study|Lost to Follow-up|2|||
161053619|NCT02446912|581584870|FG000|Overall Study|Severe non-compliance to protocol|1|||
161053620|NCT02446912|581584871|FG001|Overall Study|Severe non-compliance to protocol|0|||
161053621|NCT02446912|581584872|FG002|Overall Study|Severe non-compliance to protocol|1|||
161053622|NCT02446912|581584870|FG000|Overall Study|Withdrawal by Subject|10|||
161053623|NCT02446912|581584871|FG001|Overall Study|Withdrawal by Subject|15|||
161053624|NCT02446912|581584872|FG002|Overall Study|Withdrawal by Subject|15|||
161053625|NCT02446912|581584870|FG000|Overall Study|Miscellaneous|2|||
161053626|NCT02446912|581584871|FG001|Overall Study|Miscellaneous|2|||
161053627|NCT02446912|581584872|FG002|Overall Study|Miscellaneous|4|||
161053628|NCT01268488|581584873|FG000|Overall Study|Adverse Event|3|||
161053629|NCT01268488|581584873|FG000|Overall Study|Physician Decision|2|||
161053630|NCT01106586|581584876|FG000|Overall Study|Adverse Event|9|||
161053631|NCT01106586|581584877|FG001|Overall Study|Adverse Event|15|||
161053632|NCT01106586|581584876|FG000|Overall Study|Death|1|||
161053633|NCT01106586|581584877|FG001|Overall Study|Death|3|||
161053634|NCT01106586|581584876|FG000|Overall Study|Pregnancy|2|||
161053635|NCT01106586|581584877|FG001|Overall Study|Pregnancy|2|||
161053636|NCT01106586|581584876|FG000|Overall Study|Lack of Efficacy|1|||
161053637|NCT01106586|581584877|FG001|Overall Study|Lack of Efficacy|0|||
161053638|NCT01106586|581584876|FG000|Overall Study|Investigator's Discretion|5|||
161053639|NCT01106586|581584877|FG001|Overall Study|Investigator's Discretion|8|||
161053640|NCT01106586|581584876|FG000|Overall Study|Withdrew Consent|18|||
161053641|NCT01106586|581584877|FG001|Overall Study|Withdrew Consent|30|||
161053642|NCT01106586|581584876|FG000|Overall Study|Lost to Follow-up|24|||
161053643|NCT01106586|581584877|FG001|Overall Study|Lost to Follow-up|20|||
161053644|NCT01106586|581584876|FG000|Overall Study|Participant Noncompliance|12|||
161053645|NCT01106586|581584877|FG001|Overall Study|Participant Noncompliance|10|||
161053646|NCT01106586|581584876|FG000|Overall Study|Protocol Violation|1|||
161053647|NCT01106586|581584877|FG001|Overall Study|Protocol Violation|0|||
161053648|NCT01106586|581584876|FG000|Overall Study|Participant Transferred to Another Study|212|||
161053649|NCT01106586|581584877|FG001|Overall Study|Participant Transferred to Another Study|197|||
161053650|NCT03906240|581584883|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
161053651|NCT03906240|581584884|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
161053652|NCT03906240|581584883|FG000|Overall Study|Lost to Follow-up|1|||
161053653|NCT03906240|581584884|FG001|Overall Study|Lost to Follow-up|0|||
161053654|NCT03906240|581584883|FG000|Overall Study|Withdrawal by Subject|0|||
161053655|NCT03906240|581584884|FG001|Overall Study|Withdrawal by Subject|1|||
161053656|NCT01426217|581584885|FG000|Overall Study|lost sample|8|||
161053657|NCT01426217|581584886|FG001|Overall Study|lost sample|14|||
161053658|NCT05216835|581584887|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161053659|NCT05216835|581584888|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161053660|NCT05216835|581584889|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161053661|NCT05216835|581584890|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
161053662|NCT05216835|581584891|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
161053663|NCT05216835|581584892|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
161053664|NCT05216835|581584893|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
161053665|NCT05216835|581584894|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
161053666|NCT05216835|581584887|FG000|Overall Study|Death|0|||
161345097|NCT03126110|582648854|FG005|Phase 2|Started new treatment|0|||
161053667|NCT05216835|581584888|FG001|Overall Study|Death|0|||
161053668|NCT05216835|581584889|FG002|Overall Study|Death|0|||
161053669|NCT05216835|581584890|FG003|Overall Study|Death|1|||
161053670|NCT05216835|581584891|FG004|Overall Study|Death|1|||
161053671|NCT05216835|581584892|FG005|Overall Study|Death|1|||
161053672|NCT05216835|581584893|FG006|Overall Study|Death|1|||
161053673|NCT05216835|581584894|FG007|Overall Study|Death|1|||
161053674|NCT05216835|581584887|FG000|Overall Study|Physician Decision|0|||
161053675|NCT05216835|581584888|FG001|Overall Study|Physician Decision|0|||
161053676|NCT05216835|581584889|FG002|Overall Study|Physician Decision|0|||
161053677|NCT05216835|581584890|FG003|Overall Study|Physician Decision|0|||
161053678|NCT05216835|581584891|FG004|Overall Study|Physician Decision|0|||
161053679|NCT05216835|581584892|FG005|Overall Study|Physician Decision|1|||
161053680|NCT05216835|581584893|FG006|Overall Study|Physician Decision|1|||
161053681|NCT05216835|581584894|FG007|Overall Study|Physician Decision|0|||
161053682|NCT05216835|581584887|FG000|Overall Study|Study terminated by Sponsor|0|||
161053683|NCT05216835|581584888|FG001|Overall Study|Study terminated by Sponsor|0|||
161053684|NCT05216835|581584889|FG002|Overall Study|Study terminated by Sponsor|0|||
161053685|NCT05216835|581584890|FG003|Overall Study|Study terminated by Sponsor|0|||
161053686|NCT05216835|581584891|FG004|Overall Study|Study terminated by Sponsor|0|||
161053687|NCT05216835|581584892|FG005|Overall Study|Study terminated by Sponsor|0|||
161053688|NCT05216835|581584893|FG006|Overall Study|Study terminated by Sponsor|0|||
161053689|NCT05216835|581584894|FG007|Overall Study|Study terminated by Sponsor|1|||
161053690|NCT05216835|581584887|FG000|Overall Study|Withdrawal by Subject|1|||
161053691|NCT05216835|581584888|FG001|Overall Study|Withdrawal by Subject|0|||
161053692|NCT05216835|581584889|FG002|Overall Study|Withdrawal by Subject|1|||
161053693|NCT05216835|581584890|FG003|Overall Study|Withdrawal by Subject|0|||
161053694|NCT05216835|581584891|FG004|Overall Study|Withdrawal by Subject|1|||
161053695|NCT05216835|581584892|FG005|Overall Study|Withdrawal by Subject|0|||
161053696|NCT05216835|581584893|FG006|Overall Study|Withdrawal by Subject|0|||
161053697|NCT05216835|581584894|FG007|Overall Study|Withdrawal by Subject|1|||
161053698|NCT05216835|581584887|FG000|Overall Study|Other|0|||
161053699|NCT05216835|581584888|FG001|Overall Study|Other|1|||
161053700|NCT05216835|581584889|FG002|Overall Study|Other|0|||
161053701|NCT05216835|581584890|FG003|Overall Study|Other|0|||
161053702|NCT05216835|581584891|FG004|Overall Study|Other|0|||
161053703|NCT05216835|581584892|FG005|Overall Study|Other|0|||
161053704|NCT05216835|581584893|FG006|Overall Study|Other|0|||
161053705|NCT05216835|581584894|FG007|Overall Study|Other|0|||
161053706|NCT00617708|581584895|FG000|Overall Study|Adverse Event|0|||
161053707|NCT00617708|581584896|FG001|Overall Study|Adverse Event|6|||
161053708|NCT00617708|581584897|FG002|Overall Study|Adverse Event|9|||
161053709|NCT00617708|581584895|FG000|Overall Study|Withdrawal by Subject|1|||
161053710|NCT00617708|581584896|FG001|Overall Study|Withdrawal by Subject|1|||
161053711|NCT00617708|581584897|FG002|Overall Study|Withdrawal by Subject|7|||
161053712|NCT00617708|581584895|FG000|Overall Study|Death|0|||
161053713|NCT00617708|581584896|FG001|Overall Study|Death|6|||
161053714|NCT00617708|581584897|FG002|Overall Study|Death|5|||
161053715|NCT00617708|581584895|FG000|Overall Study|Progression/Relapse|7|||
161053716|NCT00617708|581584896|FG001|Overall Study|Progression/Relapse|40|||
161053717|NCT00617708|581584897|FG002|Overall Study|Progression/Relapse|36|||
161053718|NCT00617708|581584895|FG000|Overall Study|Not protocol specified|1|||
161053719|NCT00617708|581584896|FG001|Overall Study|Not protocol specified|4|||
161053720|NCT00617708|581584897|FG002|Overall Study|Not protocol specified|2|||
161053721|NCT00617708|581584895|FG000|Overall Study|Not eligible|1|||
161053722|NCT00617708|581584896|FG001|Overall Study|Not eligible|3|||
161053723|NCT00617708|581584897|FG002|Overall Study|Not eligible|5|||
161053724|NCT01075815|581584898|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
161053725|NCT01075815|581584899|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
161053726|NCT01075815|581584898|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
161053727|NCT01075815|581584899|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
161053728|NCT01075815|581584898|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
161053729|NCT01075815|581584899|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
161053730|NCT02991456|581584900|FG000|Overall Study|Adverse Event|2|||
161053731|NCT02991456|581584901|FG001|Overall Study|Adverse Event|0|||
161053732|NCT02991456|581584900|FG000|Overall Study|Lost to Follow-up|0|||
161053733|NCT02991456|581584901|FG001|Overall Study|Lost to Follow-up|2|||
161053734|NCT02991456|581584900|FG000|Overall Study|Withdrawal by Subject|1|||
161053735|NCT02991456|581584901|FG001|Overall Study|Withdrawal by Subject|0|||
161053736|NCT02374476|581584903|FG000|VT Induced Ablation|Screening Failures|36|||
161053737|NCT02374476|581584904|FG001|VT Induced Ablation|Screening Failures|0|||
161053738|NCT02374476|581584905|FG002|VT Induced Ablation|Screening Failures|0|||
161053739|NCT02374476|581584903|FG000|Arm Assignment|Withdrawal by Subject|0|||
161053740|NCT02374476|581584904|FG001|Arm Assignment|Withdrawal by Subject|0|||
161053741|NCT02374476|581584905|FG002|Arm Assignment|Withdrawal by Subject|1|||
161053742|NCT02924051|581584908|FG000|Overall Study|Withdrawal by Subject|1|||
161053743|NCT02924051|581584909|FG001|Overall Study|Withdrawal by Subject|9|||
161053744|NCT02130401|581584910|FG000|Overall Study|Poor enrollment|6|||
161053745|NCT03953079|581584911|FG000|Core Study|Withdrawal by Subject|1|||
161053746|NCT03953079|581584912|FG001|Core Study|Withdrawal by Subject|2|||
161053747|NCT03953079|581584913|FG002|Core Study|Withdrawal by Subject|1|||
161053748|NCT03953079|581584911|FG000|Core Study|COVID-19|0|||
161053749|NCT03953079|581584912|FG001|Core Study|COVID-19|1|||
161053750|NCT03953079|581584913|FG002|Core Study|COVID-19|0|||
161053751|NCT03953079|581584911|FG000|Core Study|Difficulties leaving the house|0|||
161053752|NCT03953079|581584912|FG001|Core Study|Difficulties leaving the house|1|||
161053753|NCT03953079|581584913|FG002|Core Study|Difficulties leaving the house|0|||
161053754|NCT03953079|581584911|FG000|Extension Study|Withdrawal by Subject|1|||
161053755|NCT03953079|581584912|FG001|Extension Study|Withdrawal by Subject|0|||
161053756|NCT03953079|581584913|FG002|Extension Study|Withdrawal by Subject|0|||
161053757|NCT03953079|581584911|FG000|Extension Study|Received Rescue Treatment|5|||
161053758|NCT03953079|581584912|FG001|Extension Study|Received Rescue Treatment|6|||
161053759|NCT03953079|581584913|FG002|Extension Study|Received Rescue Treatment|5|||
161053760|NCT00936065|581584914|FG000|Overall Study|Adverse Event|1|||
161053761|NCT00936065|581584915|FG001|Overall Study|Adverse Event|0|||
161053762|NCT00936065|581584916|FG002|Overall Study|Adverse Event|1|||
161053763|NCT00936065|581584914|FG000|Overall Study|Lack of Efficacy|1|||
161053764|NCT00936065|581584915|FG001|Overall Study|Lack of Efficacy|0|||
161053765|NCT00936065|581584916|FG002|Overall Study|Lack of Efficacy|1|||
161053766|NCT00936065|581584914|FG000|Overall Study|Lost to Follow-up|1|||
161053767|NCT00936065|581584915|FG001|Overall Study|Lost to Follow-up|0|||
161053768|NCT00936065|581584916|FG002|Overall Study|Lost to Follow-up|0|||
161053769|NCT00936065|581584914|FG000|Overall Study|Protocol Violation|1|||
161053770|NCT00936065|581584915|FG001|Overall Study|Protocol Violation|2|||
161053771|NCT00936065|581584916|FG002|Overall Study|Protocol Violation|1|||
161053772|NCT00936065|581584914|FG000|Overall Study|Withdrawal by Subject|0|||
161053773|NCT00936065|581584915|FG001|Overall Study|Withdrawal by Subject|2|||
161053774|NCT00936065|581584916|FG002|Overall Study|Withdrawal by Subject|4|||
161053775|NCT02819141|581584922|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
161053776|NCT02819141|581584923|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
161053777|NCT01002547|581586441|FG000|Overall Study|Withdrawal by Subject|4|||
161053778|NCT01002547|581586442|FG001|Overall Study|Withdrawal by Subject|0|||
161053779|NCT01002547|581586443|FG002|Overall Study|Withdrawal by Subject|5|||
161053780|NCT01002547|581586441|FG000|Overall Study|Lost to Follow-up|2|||
161053781|NCT01002547|581586442|FG001|Overall Study|Lost to Follow-up|1|||
161053782|NCT01002547|581586443|FG002|Overall Study|Lost to Follow-up|1|||
161053783|NCT01002547|581586441|FG000|Overall Study|Physician Decision|1|||
161053784|NCT01002547|581586442|FG001|Overall Study|Physician Decision|0|||
161053785|NCT01002547|581586443|FG002|Overall Study|Physician Decision|0|||
161053786|NCT01002547|581586441|FG000|Overall Study|Death|0|||
161053787|NCT01002547|581586442|FG001|Overall Study|Death|2|||
161053788|NCT01002547|581586443|FG002|Overall Study|Death|2|||
161053789|NCT01002547|581586441|FG000|Overall Study|Adverse Event|1|||
161053790|NCT01002547|581586442|FG001|Overall Study|Adverse Event|0|||
161053791|NCT01002547|581586443|FG002|Overall Study|Adverse Event|0|||
161053792|NCT01184859|581586451|FG000|Period 1: Single Dose|Insufficient urine production|0|||
161053793|NCT01184859|581586452|FG001|Period 1: Single Dose|Insufficient urine production|1|||
161053794|NCT01184859|581586453|FG002|Period 1: Single Dose|Insufficient urine production|0|||
161053795|NCT01184859|581586454|FG003|Period 1: Single Dose|Insufficient urine production|0|||
161053796|NCT01184859|581586455|FG004|Period 1: Single Dose|Insufficient urine production|0|||
161053797|NCT01184859|581586451|FG000|Period 1: Single Dose|Protocol Violation|0|||
161053798|NCT01184859|581586452|FG001|Period 1: Single Dose|Protocol Violation|1|||
161053799|NCT01184859|581586453|FG002|Period 1: Single Dose|Protocol Violation|0|||
161053800|NCT01184859|581586454|FG003|Period 1: Single Dose|Protocol Violation|0|||
161053801|NCT01184859|581586455|FG004|Period 1: Single Dose|Protocol Violation|0|||
161053802|NCT01184859|581586451|FG000|Period 1: Single Dose|Adverse Event|0|||
161053803|NCT01184859|581586452|FG001|Period 1: Single Dose|Adverse Event|0|||
161053804|NCT01184859|581586453|FG002|Period 1: Single Dose|Adverse Event|0|||
161053805|NCT01184859|581586454|FG003|Period 1: Single Dose|Adverse Event|0|||
161053806|NCT01184859|581586455|FG004|Period 1: Single Dose|Adverse Event|1|||
161053807|NCT01184859|581586451|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161053808|NCT01184859|581586452|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161053809|NCT01184859|581586453|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161151341|NCT00504166|581935523|FG000|Overall Study|Withdrawal by Subject|3|||
161151342|NCT00504166|581935524|FG001|Overall Study|Withdrawal by Subject|6|||
161151343|NCT00504166|581935523|FG000|Overall Study|Physician Decision|1|||
161151344|NCT00504166|581935524|FG001|Overall Study|Physician Decision|1|||
161151345|NCT00504166|581935523|FG000|Overall Study|Lost to Follow-up|1|||
161151346|NCT00504166|581935524|FG001|Overall Study|Lost to Follow-up|3|||
161151347|NCT03117049|581935525|FG000|Overall Study|Continued the follow-up period|109|||
161151348|NCT03117049|581935526|FG001|Overall Study|Continued the follow-up period|129|||
161151349|NCT03117049|581935525|FG000|Overall Study|Died|82|||
161281067|NCT00996892|582407004|FG002|Expansion Stage 2A|Disease Progression|0|||
161281068|NCT00996892|582407005|FG003|Expansion Stage 2A|Disease Progression|0|||
161281069|NCT00996892|582407006|FG004|Expansion Stage 2A|Disease Progression|0|||
161281070|NCT00996892|582407007|FG005|Expansion Stage 2A|Disease Progression|0|||
161281071|NCT00996892|582407008|FG006|Expansion Stage 2A|Disease Progression|0|||
161053810|NCT01184859|581586454|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
161053811|NCT01184859|581586455|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
161053812|NCT01184859|581586451|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
161053813|NCT01184859|581586452|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161053814|NCT01184859|581586453|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161053815|NCT01184859|581586454|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161053816|NCT01184859|581586455|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
161151350|NCT03117049|581935526|FG001|Overall Study|Died|93|||
161281072|NCT00996892|582407009|FG007|Expansion Stage 2A|Disease Progression|0|||
161345098|NCT03126110|582648855|FG006|Phase 2|Started new treatment|0|||
161281073|NCT00996892|582407010|FG008|Expansion Stage 2A|Disease Progression|0|||
161281074|NCT00996892|582407011|FG009|Expansion Stage 2A|Disease Progression|0|||
161281075|NCT00996892|582407012|FG010|Expansion Stage 2A|Disease Progression|0|||
161281076|NCT00996892|582407013|FG011|Expansion Stage 2A|Disease Progression|0|||
161281077|NCT00996892|582407014|FG012|Expansion Stage 2A|Disease Progression|0|||
161281078|NCT00996892|582407015|FG013|Expansion Stage 2A|Disease Progression|0|||
161281079|NCT00996892|582407016|FG014|Expansion Stage 2A|Disease Progression|0|||
161281080|NCT00996892|582407017|FG015|Expansion Stage 2A|Disease Progression|0|||
161053817|NCT00958711|581586465|FG000|Overall Study|Withdrawal by Subject|0|||
161053818|NCT00958711|581586466|FG001|Overall Study|Withdrawal by Subject|4|||
161053819|NCT00958711|581586465|FG000|Overall Study|Physician Decision|5|||
161053820|NCT00958711|581586466|FG001|Overall Study|Physician Decision|7|||
161053821|NCT00958711|581586465|FG000|Overall Study|Lost to Follow-up|4|||
161053822|NCT00958711|581586466|FG001|Overall Study|Lost to Follow-up|1|||
161053823|NCT00958711|581586465|FG000|Overall Study|Other|2|||
161053824|NCT00958711|581586466|FG001|Overall Study|Other|5|||
161053825|NCT00958711|581586465|FG000|Overall Study|Death|1|||
161053826|NCT00958711|581586466|FG001|Overall Study|Death|2|||
161053827|NCT00958711|581586465|FG000|Overall Study|Adverse Event|1|||
161053828|NCT00958711|581586466|FG001|Overall Study|Adverse Event|2|||
161053829|NCT03722485|581586467|FG000|Overall Study|Withdrawal by Subject|1|||
161053830|NCT03722485|581586468|FG001|Overall Study|Withdrawal by Subject|0|||
161053831|NCT03722485|581586467|FG000|Overall Study|Adverse Event|0|||
161053832|NCT03722485|581586468|FG001|Overall Study|Adverse Event|2|||
161053833|NCT03722485|581586467|FG000|Overall Study|subject discharged prior to study completion|1|||
161053834|NCT03722485|581586468|FG001|Overall Study|subject discharged prior to study completion|5|||
161053835|NCT03722485|581586467|FG000|Overall Study|eligibility criteria not met|2|||
161053836|NCT03722485|581586468|FG001|Overall Study|eligibility criteria not met|0|||
161053837|NCT02151643|581586471|FG000|Overall Study|Adverse Event|2|||
161053838|NCT02151643|581586472|FG001|Overall Study|Adverse Event|0|||
161053839|NCT02151643|581586473|FG002|Overall Study|Adverse Event|1|||
161053840|NCT02151643|581586474|FG003|Overall Study|Adverse Event|4|||
161053841|NCT02151643|581586475|FG004|Overall Study|Adverse Event|0|||
161053842|NCT02151643|581586471|FG000|Overall Study|Withdrawal by Subject|0|||
161053843|NCT02151643|581586472|FG001|Overall Study|Withdrawal by Subject|1|||
161053844|NCT02151643|581586473|FG002|Overall Study|Withdrawal by Subject|1|||
161053845|NCT02151643|581586474|FG003|Overall Study|Withdrawal by Subject|1|||
161053846|NCT02151643|581586475|FG004|Overall Study|Withdrawal by Subject|1|||
161053847|NCT02151643|581586471|FG000|Overall Study|Hyperphosphataemia|1|||
161053848|NCT02151643|581586472|FG001|Overall Study|Hyperphosphataemia|0|||
161053849|NCT02151643|581586473|FG002|Overall Study|Hyperphosphataemia|0|||
161053850|NCT02151643|581586474|FG003|Overall Study|Hyperphosphataemia|0|||
161053851|NCT02151643|581586475|FG004|Overall Study|Hyperphosphataemia|1|||
161053852|NCT02151643|581586471|FG000|Overall Study|High Ferritin levels|3|||
161053853|NCT02151643|581586472|FG001|Overall Study|High Ferritin levels|3|||
161053854|NCT02151643|581586473|FG002|Overall Study|High Ferritin levels|2|||
161053855|NCT02151643|581586474|FG003|Overall Study|High Ferritin levels|2|||
161053856|NCT02151643|581586475|FG004|Overall Study|High Ferritin levels|1|||
161053857|NCT03087851|581586476|FG000|Overall Study|Withdraw on medical grounds|0|||
161053858|NCT03087851|581586477|FG001|Overall Study|Withdraw on medical grounds|1|||
161053859|NCT03087851|581586478|FG002|Overall Study|Withdraw on medical grounds|2|||
161053860|NCT00644332|581586479|FG000|Overall Study|Adverse Event|11|||
161053861|NCT00644332|581586479|FG000|Overall Study|Withdrawal by Subject|6|||
161053862|NCT00644332|581586479|FG000|Overall Study|Completion Status Unknown|2|||
161053863|NCT00644332|581586479|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
161053864|NCT00644332|581586479|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
161053865|NCT03694210|581586480|FG000|Overall Study|Death|1|||
161053866|NCT03694210|581586480|FG000|Overall Study|Screen Failure|7|||
161053867|NCT03050372|581586483|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
161053868|NCT03050372|581586484|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
161053869|NCT03050372|581586483|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
161053870|NCT03050372|581586484|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
161053871|NCT00443755|581586487|FG000|Overall Study|Withdrawal by Subject|2|||
161053872|NCT00443755|581586488|FG001|Overall Study|Withdrawal by Subject|1|||
161053873|NCT02775214|581586489|FG000|Overall Study|Withdrawal by Subject|2|||
161053874|NCT02775214|581586490|FG001|Overall Study|Withdrawal by Subject|0|||
161053875|NCT02706834|581586491|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161053876|NCT02706834|581586492|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161053877|NCT02706834|581586493|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161053878|NCT02706834|581586494|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
161053879|NCT02706834|581586495|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161053880|NCT02706834|581586496|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
161053881|NCT02706834|581586497|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
161053882|NCT02706834|581586498|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
161053883|NCT02706834|581586499|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
161053884|NCT02706834|581586500|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
161053885|NCT02706834|581586501|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
161053886|NCT02706834|581586491|FG000|Overall Study|Lost to Follow-up|0|||
161053887|NCT02706834|581586492|FG001|Overall Study|Lost to Follow-up|0|||
161053888|NCT02706834|581586493|FG002|Overall Study|Lost to Follow-up|1|||
161053889|NCT02706834|581586494|FG003|Overall Study|Lost to Follow-up|0|||
161053890|NCT02706834|581586495|FG004|Overall Study|Lost to Follow-up|0|||
161053891|NCT02706834|581586496|FG005|Overall Study|Lost to Follow-up|0|||
161053892|NCT02706834|581586497|FG006|Overall Study|Lost to Follow-up|0|||
161053893|NCT02706834|581586498|FG007|Overall Study|Lost to Follow-up|0|||
161053894|NCT02706834|581586499|FG008|Overall Study|Lost to Follow-up|0|||
161053895|NCT02706834|581586500|FG009|Overall Study|Lost to Follow-up|0|||
161053896|NCT02706834|581586501|FG010|Overall Study|Lost to Follow-up|0|||
161053897|NCT02706834|581586491|FG000|Overall Study|Voluntary Withdrawal|1|||
161053898|NCT02706834|581586492|FG001|Overall Study|Voluntary Withdrawal|0|||
161053899|NCT02706834|581586493|FG002|Overall Study|Voluntary Withdrawal|0|||
161053900|NCT02706834|581586494|FG003|Overall Study|Voluntary Withdrawal|0|||
161053901|NCT02706834|581586495|FG004|Overall Study|Voluntary Withdrawal|0|||
161053902|NCT02706834|581586496|FG005|Overall Study|Voluntary Withdrawal|0|||
161053903|NCT02706834|581586497|FG006|Overall Study|Voluntary Withdrawal|0|||
161053904|NCT02706834|581586498|FG007|Overall Study|Voluntary Withdrawal|0|||
161053905|NCT02706834|581586499|FG008|Overall Study|Voluntary Withdrawal|0|||
161053906|NCT02706834|581586500|FG009|Overall Study|Voluntary Withdrawal|1|||
161053907|NCT02706834|581586501|FG010|Overall Study|Voluntary Withdrawal|0|||
161053908|NCT02706834|581586491|FG000|Overall Study|Other Reason Not Specified|1|||
161053909|NCT02706834|581586492|FG001|Overall Study|Other Reason Not Specified|0|||
161053910|NCT02706834|581586493|FG002|Overall Study|Other Reason Not Specified|0|||
161053911|NCT02706834|581586494|FG003|Overall Study|Other Reason Not Specified|0|||
161053912|NCT02706834|581586495|FG004|Overall Study|Other Reason Not Specified|1|||
161053913|NCT02706834|581586496|FG005|Overall Study|Other Reason Not Specified|0|||
161053914|NCT02706834|581586497|FG006|Overall Study|Other Reason Not Specified|0|||
161053915|NCT02706834|581586498|FG007|Overall Study|Other Reason Not Specified|0|||
161053916|NCT02706834|581586499|FG008|Overall Study|Other Reason Not Specified|0|||
161053917|NCT02706834|581586500|FG009|Overall Study|Other Reason Not Specified|0|||
161053918|NCT02706834|581586501|FG010|Overall Study|Other Reason Not Specified|0|||
161053919|NCT00678899|581586502|FG000|Overall Study|Adverse Event|1|||
161053920|NCT01107353|581586508|FG000|Overall Study|Positive Drug Screen|1|||
161053921|NCT01107353|581586509|FG001|Overall Study|Positive Drug Screen|0|||
161053922|NCT02798861|581586512|FG000|Overall Study|Lost to Follow-up|22|||
161053923|NCT02798861|581586512|FG000|Overall Study|Withdrawal by Subject|1|||
161053924|NCT02475733|581586535|FG000|Overall Study|Withdrawal by Subject|1|||
161053925|NCT02475733|581586536|FG001|Overall Study|Withdrawal by Subject|0|||
161053926|NCT02475733|581586535|FG000|Overall Study|Physician Decision|1|||
161053927|NCT02475733|581586536|FG001|Overall Study|Physician Decision|0|||
161053928|NCT03575572|581586537|FG000|Overall Study|Withdrawal by Subject|2|||
161053929|NCT03575572|581586537|FG000|Overall Study|Physician Decision|2|||
161053930|NCT03647709|581586541|FG000|Overall Study|Lost to Follow-up|5|||
161053931|NCT03647709|581586541|FG000|Overall Study|Physician Decision|6|||
161053932|NCT03647709|581586541|FG000|Overall Study|Withdrawal by Subject|3|||
161053933|NCT05287178|581586542|FG000|Overall Study|Lost to Follow-up|2|||
161053934|NCT01920178|581586543|FG000|Overall Study|Lost to Follow-up|2|||
161053935|NCT01920178|581586544|FG001|Overall Study|Lost to Follow-up|1|||
161053936|NCT03023878|581586545|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
161053937|NCT03023878|581586545|FG000|Pre-Study Run-In Period|Death|1|||
161281081|NCT00996892|582407018|FG016|Expansion Stage 2A|Disease Progression|0|||
161281082|NCT00996892|582407019|FG017|Expansion Stage 2A|Disease Progression|0|||
161281083|NCT00996892|582407020|FG018|Expansion Stage 2A|Disease Progression|0|||
161281084|NCT00996892|582407021|FG019|Expansion Stage 2A|Disease Progression|31|||
161281085|NCT00993421|582407022|FG000|Overall Study|Adverse Event|2|||
161281086|NCT00993421|582407023|FG001|Overall Study|Adverse Event|7|||
161281087|NCT00993421|582407024|FG002|Overall Study|Adverse Event|6|||
161281088|NCT00993421|582407025|FG003|Overall Study|Adverse Event|9|||
161281089|NCT00993421|582407026|FG004|Overall Study|Adverse Event|5|||
161281090|NCT00993421|582407027|FG005|Overall Study|Adverse Event|7|||
161281091|NCT00993421|582407028|FG006|Overall Study|Adverse Event|1|||
161281092|NCT00993421|582407022|FG000|Overall Study|Sponsor Decision|36|||
161053938|NCT03023878|581586545|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
161053939|NCT03023878|581586545|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
161053940|NCT03023878|581586545|FG000|Treatment Period|Disease Progression|1|||
161053941|NCT03023878|581586545|FG000|Treatment Period|Withdrawal by Subject|1|||
161053942|NCT03023878|581586545|FG000|Treatment Period|Adverse Event|1|||
161053943|NCT03023878|581586545|FG000|Long Term Follow-Up Period|Death|2|||
161053944|NCT01812837|581586546|FG000|Overall Study|Lost to Follow-up|1|||
161053945|NCT01812837|581586547|FG001|Overall Study|Lost to Follow-up|1|||
161053946|NCT01812837|581586548|FG002|Overall Study|Lost to Follow-up|0|||
161053947|NCT01812837|581586546|FG000|Overall Study|Protocol Violation|1|||
161281093|NCT00993421|582407023|FG001|Overall Study|Sponsor Decision|31|||
161053948|NCT01812837|581586547|FG001|Overall Study|Protocol Violation|0|||
161053949|NCT01812837|581586548|FG002|Overall Study|Protocol Violation|0|||
161053950|NCT00288353|581586553|FG000|Overall Study|Lack of Efficacy|2|||
161053951|NCT00288353|581586554|FG001|Overall Study|Lack of Efficacy|2|||
161053952|NCT00288353|581586553|FG000|Overall Study|Withdrawal by Subject|5|||
161053953|NCT00288353|581586554|FG001|Overall Study|Withdrawal by Subject|5|||
161053954|NCT05234632|581586555|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
161053955|NCT05234632|581586556|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
161053956|NCT05234632|581586555|FG000|Overall Study|Withdrawal by Subject|2|||
161053957|NCT05234632|581586556|FG001|Overall Study|Withdrawal by Subject|0|||
161053958|NCT05234632|581586555|FG000|Overall Study|Adverse Event|0|||
161053959|NCT05234632|581586556|FG001|Overall Study|Adverse Event|4|||
161053960|NCT05234632|581586555|FG000|Overall Study|Physician Decision|1|||
161053961|NCT05234632|581586556|FG001|Overall Study|Physician Decision|1|||
161053962|NCT05234632|581586555|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
161053963|NCT05234632|581586556|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
161053964|NCT05234632|581586555|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
161053965|NCT05234632|581586556|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
161053966|NCT04799587|581586557|FG000|Overall Study|Withdrawal by Subject|0|||
161053967|NCT04799587|581586558|FG001|Overall Study|Withdrawal by Subject|1|||
161053968|NCT00728884|581586559|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
161053969|NCT00728884|581586559|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
161053970|NCT02849509|581586561|FG000|Overall Study|Worsening of disease under study|1|||
161053971|NCT02849509|581586562|FG001|Overall Study|Worsening of disease under study|1|||
161053972|NCT02849509|581586563|FG002|Overall Study|Worsening of disease under study|1|||
161053973|NCT02849509|581586561|FG000|Overall Study|Worsening of other pre-existing disease|0|||
161053974|NCT02849509|581586562|FG001|Overall Study|Worsening of other pre-existing disease|1|||
161053975|NCT02849509|581586563|FG002|Overall Study|Worsening of other pre-existing disease|2|||
161053976|NCT02849509|581586561|FG000|Overall Study|Other adverse event|36|||
161053977|NCT02849509|581586562|FG001|Overall Study|Other adverse event|41|||
161053978|NCT02849509|581586563|FG002|Overall Study|Other adverse event|8|||
161053979|NCT02849509|581586561|FG000|Overall Study|Withdrawal by Subject|6|||
161053980|NCT02849509|581586562|FG001|Overall Study|Withdrawal by Subject|17|||
161053981|NCT02849509|581586563|FG002|Overall Study|Withdrawal by Subject|12|||
161053982|NCT02849509|581586561|FG000|Overall Study|Lost to Follow-up|27|||
161053983|NCT02849509|581586562|FG001|Overall Study|Lost to Follow-up|67|||
161053984|NCT02849509|581586563|FG002|Overall Study|Lost to Follow-up|36|||
161053985|NCT02849509|581586561|FG000|Overall Study|Other, reason not specified|14|||
161053986|NCT02849509|581586562|FG001|Overall Study|Other, reason not specified|29|||
161053987|NCT02849509|581586563|FG002|Overall Study|Other, reason not specified|25|||
161053988|NCT02849509|581586561|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
161053989|NCT02849509|581586562|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
161053990|NCT02849509|581586563|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
161053991|NCT05431543|581586575|FG000|Overall Study|Medical History|1|||
161053992|NCT05431543|581586576|FG001|Overall Study|Medical History|0|||
161053993|NCT05431543|581586577|FG002|Overall Study|Medical History|0|||
161053994|NCT02784535|581586578|FG000|Overall Study|Adverse Event|1|||
161053995|NCT02784535|581586579|FG001|Overall Study|Adverse Event|0|||
161053996|NCT02784535|581586578|FG000|Overall Study|Withdrawal by Subject|0|||
161053997|NCT02784535|581586579|FG001|Overall Study|Withdrawal by Subject|1|||
161053998|NCT02784535|581586578|FG000|Overall Study|Physician Decision|0|||
161053999|NCT02784535|581586579|FG001|Overall Study|Physician Decision|1|||
161054000|NCT00914732|581586583|FG000|Overall Study|Lost to Follow-up|6|||
161054001|NCT00914732|581586584|FG001|Overall Study|Lost to Follow-up|7|||
161054002|NCT00914732|581586585|FG002|Overall Study|Lost to Follow-up|9|||
161054003|NCT00914732|581586583|FG000|Overall Study|Withdrawal by Subject|3|||
161054004|NCT00914732|581586584|FG001|Overall Study|Withdrawal by Subject|0|||
161054005|NCT00914732|581586585|FG002|Overall Study|Withdrawal by Subject|2|||
161054006|NCT00914732|581586583|FG000|Overall Study|Adverse Event|1|||
161054007|NCT00914732|581586584|FG001|Overall Study|Adverse Event|0|||
161054008|NCT00914732|581586585|FG002|Overall Study|Adverse Event|0|||
161054009|NCT05615870|581586586|FG000|Overall Study|Lost to Follow-up|10|||
161054010|NCT05615870|581586587|FG001|Overall Study|Lost to Follow-up|13|||
161054011|NCT05615870|581586586|FG000|Overall Study|Physician Decision|2|||
161054012|NCT05615870|581586587|FG001|Overall Study|Physician Decision|0|||
161054013|NCT05615870|581586586|FG000|Overall Study|Withdrawal by Subject|0|||
161054014|NCT05615870|581586587|FG001|Overall Study|Withdrawal by Subject|2|||
161281094|NCT00993421|582407024|FG002|Overall Study|Sponsor Decision|28|||
161281095|NCT00993421|582407025|FG003|Overall Study|Sponsor Decision|30|||
161054015|NCT05615870|581586586|FG000|Overall Study|Protocol Violation|0|||
161054016|NCT05615870|581586587|FG001|Overall Study|Protocol Violation|3|||
161054017|NCT05615870|581586586|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
161054018|NCT05615870|581586587|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
161151351|NCT03117049|581935525|FG000|Overall Study|Consent withdrawal|7|||
161054019|NCT05615870|581586586|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
161054020|NCT05615870|581586587|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
161054021|NCT05615870|581586586|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
161054022|NCT05615870|581586587|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
161054023|NCT00145496|581586590|FG000|Overall Study|Adverse Event|42|||
161054024|NCT00145496|581586591|FG001|Overall Study|Adverse Event|30|||
161054025|NCT00145496|581586590|FG000|Overall Study|Lack of Efficacy|12|||
161054026|NCT00145496|581586591|FG001|Overall Study|Lack of Efficacy|7|||
161054027|NCT00145496|581586590|FG000|Overall Study|Withdrawal by Subject|32|||
161054028|NCT00145496|581586591|FG001|Overall Study|Withdrawal by Subject|26|||
161054029|NCT00145496|581586590|FG000|Overall Study|Lost to Follow-up|12|||
161054030|NCT00145496|581586591|FG001|Overall Study|Lost to Follow-up|5|||
161054031|NCT00145496|581586590|FG000|Overall Study|Other|25|||
161054032|NCT00145496|581586591|FG001|Overall Study|Other|13|||
161054033|NCT01334606|581586595|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
161054034|NCT00990314|581586596|FG000|Overall Study|Death|2|||
161054035|NCT00990314|581586596|FG000|Overall Study|Adverse Event|2|||
161054036|NCT00990314|581586596|FG000|Overall Study|Withdrawal by Subject|3|||
161054037|NCT00990314|581586596|FG000|Overall Study|Non-Compliance|1|||
161054038|NCT00990314|581586596|FG000|Overall Study|Physician Decision|3|||
161054039|NCT00990314|581586596|FG000|Overall Study|Lack of Efficacy|1|||
161054040|NCT02676778|581586597|FG000|Overall Study|Disease Progression|7|||
161054041|NCT02676778|581586598|FG001|Overall Study|Disease Progression|3|||
161054042|NCT02676778|581586599|FG002|Overall Study|Disease Progression|1|||
161054043|NCT02676778|581586597|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
161054044|NCT02676778|581586598|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
161054045|NCT02676778|581586599|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
161054046|NCT02676778|581586597|FG000|Overall Study|Withdrawal by Subject|3|||
161054047|NCT02676778|581586598|FG001|Overall Study|Withdrawal by Subject|2|||
161054048|NCT02676778|581586599|FG002|Overall Study|Withdrawal by Subject|0|||
161054049|NCT02676778|581586597|FG000|Overall Study|Other|4|||
161054050|NCT02676778|581586598|FG001|Overall Study|Other|3|||
161054051|NCT02676778|581586599|FG002|Overall Study|Other|0|||
161054052|NCT02676778|581586597|FG000|Overall Study|Adverse Event|2|||
161054053|NCT02676778|581586598|FG001|Overall Study|Adverse Event|3|||
161054054|NCT02676778|581586599|FG002|Overall Study|Adverse Event|0|||
161054055|NCT03214198|581586604|FG000|Overall Study|Case Report Forms Uncollected|18|||
161054056|NCT03214198|581586604|FG000|Overall Study|Protocol Deviation|18|||
161054057|NCT03686176|581586605|FG000|Overall Study|Procedure cancelled|1|||
161054058|NCT03686176|581586606|FG001|Overall Study|Procedure cancelled|0|||
161054059|NCT03686176|581586607|FG002|Overall Study|Procedure cancelled|0|||
161054060|NCT03686176|581586605|FG000|Overall Study|VR Malfunction|1|||
161054061|NCT03686176|581586606|FG001|Overall Study|VR Malfunction|0|||
161054062|NCT03686176|581586607|FG002|Overall Study|VR Malfunction|0|||
161054063|NCT00925288|581588503|FG000|Overall Study|Lost to Follow-up|9|||
161054064|NCT00925288|581588504|FG001|Overall Study|Lost to Follow-up|7|||
161054065|NCT00434577|581588505|FG000|Months 0-3|Serious Adverse Event|0|||
161054066|NCT00434577|581588506|FG001|Months 0-3|Serious Adverse Event|0|||
161151352|NCT03117049|581935526|FG001|Overall Study|Consent withdrawal|6|||
161054067|NCT00434577|581588507|FG002|Months 0-3|Serious Adverse Event|1|||
161054068|NCT00434577|581588508|FG003|Months 0-3|Serious Adverse Event|0|||
161054069|NCT00434577|581588509|FG004|Months 0-3|Serious Adverse Event|0|||
161054070|NCT00434577|581588505|FG000|Months 0-3|Adverse Event|0|||
161054071|NCT00434577|581588506|FG001|Months 0-3|Adverse Event|1|||
161151353|NCT03117049|581935525|FG000|Overall Study|Missing contact|3|||
161151354|NCT03117049|581935526|FG001|Overall Study|Missing contact|3|||
161151355|NCT00651118|581935527|FG000|Overall Study|Adverse Event|4|||
161281096|NCT00993421|582407026|FG004|Overall Study|Sponsor Decision|38|||
161281097|NCT00993421|582407027|FG005|Overall Study|Sponsor Decision|30|||
161281098|NCT00993421|582407028|FG006|Overall Study|Sponsor Decision|29|||
161281099|NCT00993421|582407022|FG000|Overall Study|Lost to Follow-up|3|||
161281100|NCT00993421|582407023|FG001|Overall Study|Lost to Follow-up|5|||
161054072|NCT00434577|581588507|FG002|Months 0-3|Adverse Event|1|||
161054073|NCT00434577|581588508|FG003|Months 0-3|Adverse Event|0|||
161151356|NCT00651118|581935528|FG001|Overall Study|Adverse Event|0|||
161151357|NCT00651118|581935529|FG002|Overall Study|Adverse Event|1|||
161281101|NCT00993421|582407024|FG002|Overall Study|Lost to Follow-up|5|||
161281102|NCT00993421|582407025|FG003|Overall Study|Lost to Follow-up|0|||
161281103|NCT00993421|582407026|FG004|Overall Study|Lost to Follow-up|0|||
161054074|NCT00434577|581588509|FG004|Months 0-3|Adverse Event|0|||
161054075|NCT00434577|581588505|FG000|Months 0-3|Lost to Follow-up|0|||
161054076|NCT00434577|581588506|FG001|Months 0-3|Lost to Follow-up|0|||
161054077|NCT00434577|581588507|FG002|Months 0-3|Lost to Follow-up|0|||
161054078|NCT00434577|581588508|FG003|Months 0-3|Lost to Follow-up|0|||
161054079|NCT00434577|581588509|FG004|Months 0-3|Lost to Follow-up|2|||
161054080|NCT00434577|581588505|FG000|Months 0-3|Protocol Violation|1|||
161054081|NCT00434577|581588506|FG001|Months 0-3|Protocol Violation|0|||
161281104|NCT00993421|582407027|FG005|Overall Study|Lost to Follow-up|0|||
161151358|NCT00651118|581935530|FG003|Overall Study|Adverse Event|1|||
161151359|NCT00651118|581935527|FG000|Overall Study|Protocol Violation|2|||
161151360|NCT00651118|581935528|FG001|Overall Study|Protocol Violation|2|||
161151361|NCT00651118|581935529|FG002|Overall Study|Protocol Violation|6|||
161151362|NCT00651118|581935530|FG003|Overall Study|Protocol Violation|2|||
161151363|NCT00651118|581935527|FG000|Overall Study|Lost to Follow-up|2|||
161151364|NCT00651118|581935528|FG001|Overall Study|Lost to Follow-up|0|||
161151365|NCT00651118|581935529|FG002|Overall Study|Lost to Follow-up|1|||
161151366|NCT00651118|581935530|FG003|Overall Study|Lost to Follow-up|2|||
161151367|NCT00651118|581935527|FG000|Overall Study|administrative|1|||
161151368|NCT00651118|581935528|FG001|Overall Study|administrative|4|||
161151369|NCT00651118|581935529|FG002|Overall Study|administrative|2|||
161151370|NCT00651118|581935530|FG003|Overall Study|administrative|1|||
161151371|NCT00651118|581935527|FG000|Overall Study|Withdrawal by Subject|0|||
161151372|NCT00651118|581935528|FG001|Overall Study|Withdrawal by Subject|1|||
161151373|NCT00651118|581935529|FG002|Overall Study|Withdrawal by Subject|1|||
161151374|NCT00651118|581935530|FG003|Overall Study|Withdrawal by Subject|1|||
161151375|NCT01096550|581935531|FG000|Overall Study|discontinued site|10|||
161151376|NCT01096550|581935532|FG001|Overall Study|discontinued site|11|||
161151377|NCT01096550|581935531|FG000|Overall Study|non-regular treatment track at clinic|1|||
161151378|NCT01096550|581935532|FG001|Overall Study|non-regular treatment track at clinic|1|||
161054082|NCT00434577|581588507|FG002|Months 0-3|Protocol Violation|1|||
161054083|NCT00434577|581588508|FG003|Months 0-3|Protocol Violation|0|||
161054084|NCT00434577|581588509|FG004|Months 0-3|Protocol Violation|0|||
161054085|NCT00434577|581588505|FG000|Months 0-3|Withdrawal by Subject|2|||
161054086|NCT00434577|581588506|FG001|Months 0-3|Withdrawal by Subject|1|||
161054087|NCT00434577|581588507|FG002|Months 0-3|Withdrawal by Subject|1|||
161054088|NCT00434577|581588508|FG003|Months 0-3|Withdrawal by Subject|1|||
161054089|NCT00434577|581588509|FG004|Months 0-3|Withdrawal by Subject|1|||
161054090|NCT02176356|581588513|FG000|Overall Study|Screen Failure|14|||
161054091|NCT02176356|581588513|FG000|Overall Study|Lost to Follow-up|4|||
161054092|NCT02176356|581588513|FG000|Overall Study|Personal Reasons|3|||
161054093|NCT02176356|581588513|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161054094|NCT00381888|581588514|FG000|Overall Study|Death|1|||
161054095|NCT00381888|581588514|FG000|Overall Study|Withdrawal by Subject|1|||
161054096|NCT00381888|581588514|FG000|Overall Study|Physician Decision|1|||
161054097|NCT00381888|581588514|FG000|Overall Study|Protocol Violation|9|||
161054098|NCT00381888|581588514|FG000|Overall Study|Had laparoscopic surgery|2|||
161054099|NCT00381888|581588514|FG000|Overall Study|Surgery was cancelled|2|||
161054100|NCT00381888|581588514|FG000|Overall Study|Adverse Event|1|||
161054101|NCT01537120|581588518|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
161054102|NCT01537120|581588518|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
161054103|NCT02543294|581588520|FG000|Overall Study|Lost to Follow-up|3|||
161054104|NCT02543294|581588520|FG000|Overall Study|Physician Decision|2|||
161054105|NCT02543294|581588520|FG000|Overall Study|Withdrawal by Subject|7|||
161054106|NCT02131155|581588521|FG000|Overall Study|Adverse Event|1|||
161054107|NCT02131155|581588522|FG001|Overall Study|Adverse Event|0|||
161054108|NCT02131155|581588521|FG000|Overall Study|Treatment completed|1|||
161054109|NCT02131155|581588522|FG001|Overall Study|Treatment completed|0|||
161054110|NCT02131155|581588521|FG000|Overall Study|Primary tumour recurrence|2|||
161054111|NCT02131155|581588522|FG001|Overall Study|Primary tumour recurrence|1|||
161054112|NCT02131155|581588521|FG000|Overall Study|Refused to continue study medication|1|||
161054113|NCT02131155|581588522|FG001|Overall Study|Refused to continue study medication|0|||
161054114|NCT02131155|581588521|FG000|Overall Study|Study early termination|20|||
161054115|NCT02131155|581588522|FG001|Overall Study|Study early termination|10|||
161054116|NCT01887418|581588523|FG000|Overall Study|Travelling difficulties|0|||
161054117|NCT01887418|581588524|FG001|Overall Study|Travelling difficulties|0|||
161054118|NCT01887418|581588525|FG002|Overall Study|Travelling difficulties|1|||
161054119|NCT01014013|581588526|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
161054120|NCT01014013|581588527|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
161054121|NCT01014013|581588526|FG000|Overall Study|Clinical adverse experience|4|||
161054122|NCT01014013|581588527|FG001|Overall Study|Clinical adverse experience|2|||
161054123|NCT01014013|581588526|FG000|Overall Study|Laboratory adverse experience|1|||
161054124|NCT01014013|581588527|FG001|Overall Study|Laboratory adverse experience|1|||
161054125|NCT01014013|581588526|FG000|Overall Study|Protocol Violation|1|||
161281105|NCT00993421|582407028|FG006|Overall Study|Lost to Follow-up|6|||
161281106|NCT00993421|582407022|FG000|Overall Study|Withdrawal by Subject|3|||
161281107|NCT00993421|582407023|FG001|Overall Study|Withdrawal by Subject|2|||
161054126|NCT01014013|581588527|FG001|Overall Study|Protocol Violation|3|||
161151379|NCT01096550|581935531|FG000|Overall Study|clinic readmission|1|||
161281108|NCT00993421|582407024|FG002|Overall Study|Withdrawal by Subject|3|||
161151380|NCT01096550|581935532|FG001|Overall Study|clinic readmission|1|||
161281109|NCT00993421|582407025|FG003|Overall Study|Withdrawal by Subject|3|||
161054127|NCT01014013|581588526|FG000|Overall Study|Withdrawal by Subject|7|||
161054128|NCT01014013|581588527|FG001|Overall Study|Withdrawal by Subject|4|||
161151381|NCT01096550|581935531|FG000|Overall Study|Withdrawal by Subject|0|||
161151382|NCT01096550|581935532|FG001|Overall Study|Withdrawal by Subject|1|||
161054129|NCT01014013|581588526|FG000|Overall Study|Clinical/microbiologic failure|1|||
161054130|NCT01014013|581588527|FG001|Overall Study|Clinical/microbiologic failure|2|||
161054131|NCT01014013|581588526|FG000|Overall Study|Pathogen culture = no growth|26|||
161054132|NCT01014013|581588527|FG001|Overall Study|Pathogen culture = no growth|34|||
161054133|NCT01014013|581588526|FG000|Overall Study|Negative urine culture|2|||
161054134|NCT01014013|581588527|FG001|Overall Study|Negative urine culture|0|||
161054135|NCT01014013|581588526|FG000|Overall Study|Pathogen resistant|7|||
161054136|NCT01014013|581588527|FG001|Overall Study|Pathogen resistant|4|||
161054137|NCT01014013|581588526|FG000|Overall Study|Physician Decision|0|||
161054138|NCT01014013|581588527|FG001|Overall Study|Physician Decision|1|||
161054139|NCT01014013|581588526|FG000|Overall Study|Another antibiotic therapy required|0|||
161054140|NCT01014013|581588527|FG001|Overall Study|Another antibiotic therapy required|1|||
161054141|NCT01014013|581588526|FG000|Overall Study|Appendectomy|1|||
161054142|NCT01014013|581588527|FG001|Overall Study|Appendectomy|0|||
161054143|NCT01014013|581588526|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
161054144|NCT01014013|581588527|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
161054145|NCT00442559|581588534|FG000|Overall Study|Lost to Follow-up|32|||
161054146|NCT00442559|581588535|FG001|Overall Study|Lost to Follow-up|34|||
161054147|NCT00442559|581588534|FG000|Overall Study|Protocol Violation|1|||
161054148|NCT00442559|581588535|FG001|Overall Study|Protocol Violation|1|||
161054149|NCT00442559|581588534|FG000|Overall Study|Withdrawal by Subject|1|||
161054150|NCT00442559|581588535|FG001|Overall Study|Withdrawal by Subject|0|||
161054151|NCT02305797|581588536|FG000|Overall Study|Adverse Event|11|||
161054152|NCT02305797|581588537|FG001|Overall Study|Adverse Event|2|||
161054153|NCT02305797|581588536|FG000|Overall Study|Withdrawal by Subject|9|||
161054154|NCT02305797|581588537|FG001|Overall Study|Withdrawal by Subject|10|||
161054155|NCT02305797|581588536|FG000|Overall Study|Lack of Efficacy|6|||
161054156|NCT02305797|581588537|FG001|Overall Study|Lack of Efficacy|0|||
161054157|NCT02305797|581588536|FG000|Overall Study|Lost to Follow-up|5|||
161054158|NCT02305797|581588537|FG001|Overall Study|Lost to Follow-up|11|||
161054159|NCT02305797|581588536|FG000|Overall Study|Pregnancy|0|||
161054160|NCT02305797|581588537|FG001|Overall Study|Pregnancy|2|||
161054161|NCT02305797|581588536|FG000|Overall Study|Noncompliance|14|||
161054162|NCT02305797|581588537|FG001|Overall Study|Noncompliance|12|||
161054163|NCT02305797|581588536|FG000|Overall Study|Reason not collected|0|||
161054164|NCT02305797|581588537|FG001|Overall Study|Reason not collected|1|||
161054165|NCT03508830|581588538|FG000|Overall Study|Withdrawal by Subject|3|||
161054166|NCT03508830|581588539|FG001|Overall Study|Withdrawal by Subject|4|||
161054167|NCT03508830|581588538|FG000|Overall Study|Physician Decision|2|||
161054168|NCT03508830|581588539|FG001|Overall Study|Physician Decision|2|||
161054169|NCT04908800|581588540|FG000|Overall Study|Adverse Event|0|||
161054170|NCT04908800|581588541|FG001|Overall Study|Adverse Event|0|||
161054171|NCT04908800|581588542|FG002|Overall Study|Adverse Event|0|||
161054172|NCT04908800|581588543|FG003|Overall Study|Adverse Event|0|||
161054173|NCT04908800|581588544|FG004|Overall Study|Adverse Event|0|||
161054174|NCT04908800|581588545|FG005|Overall Study|Adverse Event|0|||
161054175|NCT04908800|581588546|FG006|Overall Study|Adverse Event|0|||
161054176|NCT04908800|581588547|FG007|Overall Study|Adverse Event|0|||
161054177|NCT04908800|581588548|FG008|Overall Study|Adverse Event|0|||
161054178|NCT04908800|581588549|FG009|Overall Study|Adverse Event|0|||
161054179|NCT04908800|581588550|FG010|Overall Study|Adverse Event|1|||
161054180|NCT04908800|581588551|FG011|Overall Study|Adverse Event|0|||
161054181|NCT04908800|581588552|FG012|Overall Study|Adverse Event|0|||
161054182|NCT03751280|581588553|FG000|Overall Study|Adverse Event|0|||
161054183|NCT03751280|581588554|FG001|Overall Study|Adverse Event|1|||
161054184|NCT03751280|581588553|FG000|Overall Study|Lost to Follow-up|3|||
161054185|NCT03751280|581588554|FG001|Overall Study|Lost to Follow-up|5|||
161054186|NCT03751280|581588553|FG000|Overall Study|Physician Decision|0|||
161054187|NCT03751280|581588554|FG001|Overall Study|Physician Decision|2|||
161054188|NCT03751280|581588553|FG000|Overall Study|Protocol Violation|0|||
161054189|NCT03751280|581588554|FG001|Overall Study|Protocol Violation|2|||
161054190|NCT03751280|581588553|FG000|Overall Study|Withdrawal by Subject|5|||
161054191|NCT03751280|581588554|FG001|Overall Study|Withdrawal by Subject|2|||
161054192|NCT00296504|581588556|FG000|Interim Analysis|Withdrawal by Subject|8|||
161054193|NCT00296504|581588557|FG001|Interim Analysis|Withdrawal by Subject|0|||
161054194|NCT00296504|581588558|FG002|Interim Analysis|Withdrawal by Subject|12|||
161054195|NCT00296504|581588559|FG003|Interim Analysis|Withdrawal by Subject|0|||
161345099|NCT03126110|582648856|FG007|Phase 2|Started new treatment|0|||
161345100|NCT03126110|582648857|FG008|Phase 2|Started new treatment|0|||
161345101|NCT03126110|582648858|FG009|Phase 2|Started new treatment|0|||
161054196|NCT00296504|581588560|FG004|Interim Analysis|Withdrawal by Subject|5|||
161054197|NCT00296504|581588561|FG005|Interim Analysis|Withdrawal by Subject|5|||
161054198|NCT00296504|581588562|FG006|Interim Analysis|Withdrawal by Subject|9|||
161054199|NCT00296504|581588563|FG007|Interim Analysis|Withdrawal by Subject|3|||
161054200|NCT00296504|581588564|FG008|Interim Analysis|Withdrawal by Subject|0|||
161054201|NCT00296504|581588556|FG000|Interim Analysis|Lost to Follow-up|13|||
161054202|NCT00296504|581588557|FG001|Interim Analysis|Lost to Follow-up|3|||
161054203|NCT00296504|581588558|FG002|Interim Analysis|Lost to Follow-up|26|||
161151383|NCT01096550|581935531|FG000|Overall Study|non-African American participant|13|||
161151384|NCT01096550|581935532|FG001|Overall Study|non-African American participant|6|||
161151385|NCT01096550|581935531|FG000|Overall Study|Lost to Follow-up|12|||
161151386|NCT01096550|581935532|FG001|Overall Study|Lost to Follow-up|9|||
161151387|NCT00839098|581935535|FG000|Overall Study|Withdrawal by Subject|2|||
161151388|NCT00839098|581935536|FG001|Overall Study|Withdrawal by Subject|1|||
161151389|NCT00839098|581935537|FG002|Overall Study|Withdrawal by Subject|7|||
161151390|NCT01345786|581935538|FG000|Overall Study|Adverse Event|0|||
161151391|NCT01345786|581935539|FG001|Overall Study|Adverse Event|1|||
161151392|NCT01345786|581935540|FG002|Overall Study|Adverse Event|3|||
161151393|NCT01345786|581935541|FG003|Overall Study|Adverse Event|1|||
161151394|NCT01345786|581935538|FG000|Overall Study|Subject withdrew consent|2|||
161151395|NCT01345786|581935539|FG001|Overall Study|Subject withdrew consent|2|||
161151396|NCT01345786|581935540|FG002|Overall Study|Subject withdrew consent|1|||
161151397|NCT01345786|581935541|FG003|Overall Study|Subject withdrew consent|0|||
161151398|NCT01345786|581935538|FG000|Overall Study|Noncompliance with protocol|1|||
161151399|NCT01345786|581935539|FG001|Overall Study|Noncompliance with protocol|0|||
161151400|NCT01345786|581935540|FG002|Overall Study|Noncompliance with protocol|1|||
161151401|NCT01345786|581935541|FG003|Overall Study|Noncompliance with protocol|0|||
161151402|NCT01345786|581935538|FG000|Overall Study|Administrative|3|||
161151403|NCT01345786|581935539|FG001|Overall Study|Administrative|5|||
161151404|NCT01345786|581935540|FG002|Overall Study|Administrative|0|||
161151405|NCT01345786|581935541|FG003|Overall Study|Administrative|0|||
161151406|NCT01345786|581935538|FG000|Overall Study|Lost to Follow-up|0|||
161151407|NCT01345786|581935539|FG001|Overall Study|Lost to Follow-up|0|||
161151408|NCT01345786|581935540|FG002|Overall Study|Lost to Follow-up|0|||
161151409|NCT01345786|581935541|FG003|Overall Study|Lost to Follow-up|2|||
161151410|NCT02190435|581935542|FG000|Overall Study|First 12 patients were lead-ins|12|||
161151411|NCT02190435|581935543|FG001|Overall Study|First 12 patients were lead-ins|0|||
161151412|NCT02190435|581935542|FG000|Overall Study|3 consented screen fails|3|||
161151413|NCT02190435|581935543|FG001|Overall Study|3 consented screen fails|0|||
161151414|NCT02399475|581935552|FG000|Overall Study|Physician Decision|1|||
161151415|NCT02399475|581935553|FG001|Overall Study|Physician Decision|0|||
161151416|NCT02260193|581935554|FG000|Overall Study|Lack of Efficacy|0|||
161151417|NCT02260193|581935555|FG001|Overall Study|Lack of Efficacy|1|||
161151418|NCT02260193|581935556|FG002|Overall Study|Lack of Efficacy|6|||
161151419|NCT02260193|581935554|FG000|Overall Study|Adverse Event|3|||
161151420|NCT02260193|581935555|FG001|Overall Study|Adverse Event|4|||
161151421|NCT02260193|581935556|FG002|Overall Study|Adverse Event|1|||
161151422|NCT02260193|581935554|FG000|Overall Study|Protocol Violation|0|||
161151423|NCT02260193|581935555|FG001|Overall Study|Protocol Violation|4|||
161151424|NCT02260193|581935556|FG002|Overall Study|Protocol Violation|0|||
161151425|NCT02260193|581935554|FG000|Overall Study|Withdrawal by Subject|3|||
161151426|NCT02260193|581935555|FG001|Overall Study|Withdrawal by Subject|0|||
161151427|NCT02260193|581935556|FG002|Overall Study|Withdrawal by Subject|2|||
161151428|NCT02260193|581935554|FG000|Overall Study|Kidney Transplantation|0|||
161151429|NCT02260193|581935555|FG001|Overall Study|Kidney Transplantation|0|||
161151430|NCT02260193|581935556|FG002|Overall Study|Kidney Transplantation|1|||
161151431|NCT01963117|581935557|FG000|Overall Study|Death|1|||
161151432|NCT01070784|581935558|FG000|Overall Study|Withdrawal by Subject|6|||
161281110|NCT00993421|582407026|FG004|Overall Study|Withdrawal by Subject|3|||
161281111|NCT00993421|582407027|FG005|Overall Study|Withdrawal by Subject|5|||
161281112|NCT00993421|582407028|FG006|Overall Study|Withdrawal by Subject|3|||
161281113|NCT00993421|582407022|FG000|Overall Study|Death|0|||
161281114|NCT00993421|582407023|FG001|Overall Study|Death|0|||
161281115|NCT00993421|582407024|FG002|Overall Study|Death|0|||
161281116|NCT00993421|582407025|FG003|Overall Study|Death|0|||
161281117|NCT00993421|582407026|FG004|Overall Study|Death|0|||
161281118|NCT00993421|582407027|FG005|Overall Study|Death|0|||
161281119|NCT00993421|582407028|FG006|Overall Study|Death|1|||
161281120|NCT00993421|582407022|FG000|Overall Study|Entry Criteria Exclusion|0|||
161281121|NCT00993421|582407023|FG001|Overall Study|Entry Criteria Exclusion|0|||
161151433|NCT01070784|581935559|FG001|Overall Study|Withdrawal by Subject|9|||
161151434|NCT01070784|581935558|FG000|Overall Study|Adverse Event|14|||
161151435|NCT01070784|581935559|FG001|Overall Study|Adverse Event|9|||
161151436|NCT01780389|581935560|FG000|Overall Study|Adverse Event|1|||
161151437|NCT00935220|581935561|FG000|Overall Study|Adverse Event|1|||
161151438|NCT00935220|581935561|FG000|Overall Study|Other reason (not specified)|1|||
161151439|NCT01000064|581935562|FG000|Overall Study|Withdrawal by Subject|1|||
161151440|NCT01000064|581935563|FG001|Overall Study|Withdrawal by Subject|1|||
161151441|NCT02518620|581935564|FG000|Overall Study|Adverse Event|23|||
161281122|NCT00993421|582407024|FG002|Overall Study|Entry Criteria Exclusion|1|||
161281123|NCT00993421|582407025|FG003|Overall Study|Entry Criteria Exclusion|3|||
161151442|NCT02518620|581935565|FG001|Overall Study|Adverse Event|11|||
161151443|NCT02518620|581935564|FG000|Overall Study|Lack of Efficacy|2|||
161151444|NCT02518620|581935565|FG001|Overall Study|Lack of Efficacy|0|||
161151445|NCT02518620|581935564|FG000|Overall Study|Non-Compliance with Study Drug|1|||
161151446|NCT02518620|581935565|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161054204|NCT00296504|581588559|FG003|Interim Analysis|Lost to Follow-up|8|||
161054205|NCT00296504|581588560|FG004|Interim Analysis|Lost to Follow-up|14|||
161054206|NCT00296504|581588561|FG005|Interim Analysis|Lost to Follow-up|4|||
161054207|NCT00296504|581588562|FG006|Interim Analysis|Lost to Follow-up|11|||
161054208|NCT00296504|581588563|FG007|Interim Analysis|Lost to Follow-up|4|||
161054209|NCT00296504|581588564|FG008|Interim Analysis|Lost to Follow-up|0|||
161054210|NCT00296504|581588556|FG000|Interim Analysis|Clinical Progression|1|||
161054211|NCT00296504|581588557|FG001|Interim Analysis|Clinical Progression|0|||
161054212|NCT00296504|581588558|FG002|Interim Analysis|Clinical Progression|1|||
161054213|NCT00296504|581588559|FG003|Interim Analysis|Clinical Progression|1|||
161054214|NCT00296504|581588560|FG004|Interim Analysis|Clinical Progression|0|||
161054215|NCT00296504|581588561|FG005|Interim Analysis|Clinical Progression|2|||
161054216|NCT00296504|581588562|FG006|Interim Analysis|Clinical Progression|1|||
161054217|NCT00296504|581588563|FG007|Interim Analysis|Clinical Progression|2|||
161054218|NCT00296504|581588564|FG008|Interim Analysis|Clinical Progression|0|||
161054219|NCT00296504|581588556|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
161054220|NCT00296504|581588557|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
161054221|NCT00296504|581588558|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
161054222|NCT00296504|581588559|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
161054223|NCT00296504|581588560|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
161054224|NCT00296504|581588561|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
161054225|NCT00296504|581588562|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
161054226|NCT00296504|581588563|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
161054227|NCT00296504|581588564|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
161054228|NCT00296504|581588556|FG000|Interim Analysis|Adverse Event|0|||
161054229|NCT00296504|581588557|FG001|Interim Analysis|Adverse Event|0|||
161054230|NCT00296504|581588558|FG002|Interim Analysis|Adverse Event|13|||
161054231|NCT00296504|581588559|FG003|Interim Analysis|Adverse Event|4|||
161054232|NCT00296504|581588560|FG004|Interim Analysis|Adverse Event|6|||
161054233|NCT00296504|581588561|FG005|Interim Analysis|Adverse Event|3|||
161054234|NCT00296504|581588562|FG006|Interim Analysis|Adverse Event|4|||
161054235|NCT00296504|581588563|FG007|Interim Analysis|Adverse Event|5|||
161054236|NCT00296504|581588564|FG008|Interim Analysis|Adverse Event|0|||
161054237|NCT00296504|581588556|FG000|Interim Analysis|Protocol Violation|0|||
161054238|NCT00296504|581588557|FG001|Interim Analysis|Protocol Violation|0|||
161054239|NCT00296504|581588558|FG002|Interim Analysis|Protocol Violation|2|||
161054240|NCT00296504|581588559|FG003|Interim Analysis|Protocol Violation|0|||
161054241|NCT00296504|581588560|FG004|Interim Analysis|Protocol Violation|1|||
161054242|NCT00296504|581588561|FG005|Interim Analysis|Protocol Violation|0|||
161054243|NCT00296504|581588562|FG006|Interim Analysis|Protocol Violation|0|||
161054244|NCT00296504|581588563|FG007|Interim Analysis|Protocol Violation|1|||
161054245|NCT00296504|581588564|FG008|Interim Analysis|Protocol Violation|0|||
161054246|NCT00296504|581588556|FG000|Interim Analysis|Insufficient CD4 Response|0|||
161054247|NCT00296504|581588557|FG001|Interim Analysis|Insufficient CD4 Response|0|||
161054248|NCT00296504|581588558|FG002|Interim Analysis|Insufficient CD4 Response|0|||
161054249|NCT00296504|581588559|FG003|Interim Analysis|Insufficient CD4 Response|0|||
161054250|NCT00296504|581588560|FG004|Interim Analysis|Insufficient CD4 Response|1|||
161054251|NCT00296504|581588561|FG005|Interim Analysis|Insufficient CD4 Response|1|||
161054252|NCT00296504|581588562|FG006|Interim Analysis|Insufficient CD4 Response|0|||
161054253|NCT00296504|581588563|FG007|Interim Analysis|Insufficient CD4 Response|0|||
161054254|NCT00296504|581588564|FG008|Interim Analysis|Insufficient CD4 Response|0|||
161054255|NCT00296504|581588556|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
161054256|NCT00296504|581588557|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
161054257|NCT00296504|581588558|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
161054258|NCT00296504|581588559|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
161054259|NCT00296504|581588560|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
161054260|NCT00296504|581588561|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
161054261|NCT00296504|581588562|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
161054262|NCT00296504|581588563|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
161054263|NCT00296504|581588564|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
161054264|NCT00296504|581588556|FG000|Interim Analysis|Pregnancy|4|||
161054265|NCT00296504|581588557|FG001|Interim Analysis|Pregnancy|1|||
161054266|NCT00296504|581588558|FG002|Interim Analysis|Pregnancy|4|||
161054267|NCT00296504|581588559|FG003|Interim Analysis|Pregnancy|2|||
161054268|NCT00296504|581588560|FG004|Interim Analysis|Pregnancy|0|||
161054269|NCT00296504|581588561|FG005|Interim Analysis|Pregnancy|1|||
161054270|NCT00296504|581588562|FG006|Interim Analysis|Pregnancy|1|||
161054271|NCT00296504|581588563|FG007|Interim Analysis|Pregnancy|1|||
161054272|NCT00296504|581588564|FG008|Interim Analysis|Pregnancy|0|||
161054273|NCT00296504|581588556|FG000|Interim Analysis|Death|1|||
161151447|NCT02518620|581935564|FG000|Overall Study|Physician Decision|1|||
161054274|NCT00296504|581588557|FG001|Interim Analysis|Death|0|||
161054275|NCT00296504|581588558|FG002|Interim Analysis|Death|3|||
161054276|NCT00296504|581588559|FG003|Interim Analysis|Death|0|||
161054277|NCT00296504|581588560|FG004|Interim Analysis|Death|0|||
161054278|NCT00296504|581588561|FG005|Interim Analysis|Death|0|||
161054279|NCT00296504|581588562|FG006|Interim Analysis|Death|0|||
161054280|NCT00296504|581588563|FG007|Interim Analysis|Death|0|||
161054281|NCT00296504|581588564|FG008|Interim Analysis|Death|0|||
161054282|NCT00296504|581588556|FG000|Interim Analysis|Participant Non-compliant|0|||
161054283|NCT00296504|581588557|FG001|Interim Analysis|Participant Non-compliant|1|||
161054284|NCT00296504|581588558|FG002|Interim Analysis|Participant Non-compliant|2|||
161054285|NCT00296504|581588559|FG003|Interim Analysis|Participant Non-compliant|1|||
161054286|NCT00296504|581588560|FG004|Interim Analysis|Participant Non-compliant|1|||
161054287|NCT00296504|581588561|FG005|Interim Analysis|Participant Non-compliant|3|||
161054288|NCT00296504|581588562|FG006|Interim Analysis|Participant Non-compliant|6|||
161054289|NCT00296504|581588563|FG007|Interim Analysis|Participant Non-compliant|2|||
161054290|NCT00296504|581588564|FG008|Interim Analysis|Participant Non-compliant|0|||
161054291|NCT00296504|581588556|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054292|NCT00296504|581588557|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054293|NCT00296504|581588558|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
161054294|NCT00296504|581588559|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054295|NCT00296504|581588560|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054296|NCT00296504|581588561|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
161054297|NCT00296504|581588562|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054298|NCT00296504|581588563|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054299|NCT00296504|581588564|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
161054300|NCT00296504|581588556|FG000|Interim Analysis|To Simplify Treatment|0|||
161054301|NCT00296504|581588557|FG001|Interim Analysis|To Simplify Treatment|0|||
161054302|NCT00296504|581588558|FG002|Interim Analysis|To Simplify Treatment|1|||
161054303|NCT00296504|581588559|FG003|Interim Analysis|To Simplify Treatment|0|||
161054304|NCT00296504|581588560|FG004|Interim Analysis|To Simplify Treatment|0|||
161054305|NCT00296504|581588561|FG005|Interim Analysis|To Simplify Treatment|0|||
161054306|NCT00296504|581588562|FG006|Interim Analysis|To Simplify Treatment|2|||
161054307|NCT00296504|581588563|FG007|Interim Analysis|To Simplify Treatment|0|||
161054308|NCT00296504|581588564|FG008|Interim Analysis|To Simplify Treatment|0|||
161054309|NCT00296504|581588556|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054310|NCT00296504|581588557|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054311|NCT00296504|581588558|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
161054312|NCT00296504|581588559|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054313|NCT00296504|581588560|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054314|NCT00296504|581588561|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054315|NCT00296504|581588562|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054316|NCT00296504|581588563|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054317|NCT00296504|581588564|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
161054318|NCT00296504|581588556|FG000|Interim Analysis|Participant Moved|1|||
161054319|NCT00296504|581588557|FG001|Interim Analysis|Participant Moved|0|||
161054320|NCT00296504|581588558|FG002|Interim Analysis|Participant Moved|1|||
161054321|NCT00296504|581588559|FG003|Interim Analysis|Participant Moved|0|||
161054322|NCT00296504|581588560|FG004|Interim Analysis|Participant Moved|0|||
161054323|NCT00296504|581588561|FG005|Interim Analysis|Participant Moved|1|||
161054324|NCT00296504|581588562|FG006|Interim Analysis|Participant Moved|1|||
161054325|NCT00296504|581588563|FG007|Interim Analysis|Participant Moved|0|||
161054326|NCT00296504|581588564|FG008|Interim Analysis|Participant Moved|0|||
161054327|NCT00296504|581588556|FG000|Interim Analysis|Participant Was Incarcerated|2|||
161054328|NCT00296504|581588557|FG001|Interim Analysis|Participant Was Incarcerated|0|||
161054329|NCT00296504|581588558|FG002|Interim Analysis|Participant Was Incarcerated|1|||
161054330|NCT00296504|581588559|FG003|Interim Analysis|Participant Was Incarcerated|0|||
161054331|NCT00296504|581588560|FG004|Interim Analysis|Participant Was Incarcerated|0|||
161054332|NCT00296504|581588561|FG005|Interim Analysis|Participant Was Incarcerated|0|||
161054333|NCT00296504|581588562|FG006|Interim Analysis|Participant Was Incarcerated|0|||
161054334|NCT00296504|581588563|FG007|Interim Analysis|Participant Was Incarcerated|0|||
161281124|NCT00993421|582407026|FG004|Overall Study|Entry Criteria Exclusion|0|||
161281125|NCT00993421|582407027|FG005|Overall Study|Entry Criteria Exclusion|1|||
161281126|NCT00993421|582407028|FG006|Overall Study|Entry Criteria Exclusion|0|||
161281127|NCT00993421|582407022|FG000|Overall Study|Physician Decision|0|||
161281128|NCT00993421|582407023|FG001|Overall Study|Physician Decision|0|||
161054335|NCT00296504|581588564|FG008|Interim Analysis|Participant Was Incarcerated|0|||
161054336|NCT00296504|581588556|FG000|Interim Analysis|Resistance to FPV|0|||
161054337|NCT00296504|581588557|FG001|Interim Analysis|Resistance to FPV|0|||
161054338|NCT00296504|581588558|FG002|Interim Analysis|Resistance to FPV|1|||
161054339|NCT00296504|581588559|FG003|Interim Analysis|Resistance to FPV|0|||
161054340|NCT00296504|581588560|FG004|Interim Analysis|Resistance to FPV|0|||
161054341|NCT00296504|581588561|FG005|Interim Analysis|Resistance to FPV|0|||
161054342|NCT00296504|581588562|FG006|Interim Analysis|Resistance to FPV|0|||
161054343|NCT00296504|581588563|FG007|Interim Analysis|Resistance to FPV|0|||
161054344|NCT00296504|581588564|FG008|Interim Analysis|Resistance to FPV|0|||
161054345|NCT00296504|581588556|FG000|Interim Analysis|Physician Decision|0|||
161054346|NCT00296504|581588557|FG001|Interim Analysis|Physician Decision|0|||
161054347|NCT00296504|581588558|FG002|Interim Analysis|Physician Decision|1|||
161054348|NCT00296504|581588559|FG003|Interim Analysis|Physician Decision|0|||
161054349|NCT00296504|581588560|FG004|Interim Analysis|Physician Decision|0|||
161054350|NCT00296504|581588561|FG005|Interim Analysis|Physician Decision|0|||
161054351|NCT00296504|581588562|FG006|Interim Analysis|Physician Decision|0|||
161054352|NCT00296504|581588563|FG007|Interim Analysis|Physician Decision|0|||
161054353|NCT00296504|581588564|FG008|Interim Analysis|Physician Decision|0|||
161054354|NCT00296504|581588556|FG000|Interim Analysis|Principle Investigator Discretion|2|||
161054355|NCT00296504|581588557|FG001|Interim Analysis|Principle Investigator Discretion|0|||
161054356|NCT00296504|581588558|FG002|Interim Analysis|Principle Investigator Discretion|1|||
161054357|NCT00296504|581588559|FG003|Interim Analysis|Principle Investigator Discretion|1|||
161054358|NCT00296504|581588560|FG004|Interim Analysis|Principle Investigator Discretion|0|||
161054359|NCT00296504|581588561|FG005|Interim Analysis|Principle Investigator Discretion|0|||
161054360|NCT00296504|581588562|FG006|Interim Analysis|Principle Investigator Discretion|0|||
161054361|NCT00296504|581588563|FG007|Interim Analysis|Principle Investigator Discretion|0|||
161054362|NCT00296504|581588564|FG008|Interim Analysis|Principle Investigator Discretion|0|||
161054363|NCT00296504|581588556|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
161054364|NCT00296504|581588557|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
161054365|NCT00296504|581588558|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
161054366|NCT00296504|581588559|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
161054367|NCT00296504|581588560|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
161054368|NCT00296504|581588561|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
161054369|NCT00296504|581588562|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
161054370|NCT00296504|581588563|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
161054371|NCT00296504|581588564|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
161054372|NCT00296504|581588556|FG000|Interim Analysis|Non-adherence|2|||
161054373|NCT00296504|581588557|FG001|Interim Analysis|Non-adherence|0|||
161054374|NCT00296504|581588558|FG002|Interim Analysis|Non-adherence|0|||
161054375|NCT00296504|581588559|FG003|Interim Analysis|Non-adherence|0|||
161054376|NCT00296504|581588560|FG004|Interim Analysis|Non-adherence|1|||
161054377|NCT00296504|581588561|FG005|Interim Analysis|Non-adherence|0|||
161054378|NCT00296504|581588562|FG006|Interim Analysis|Non-adherence|0|||
161054379|NCT00296504|581588563|FG007|Interim Analysis|Non-adherence|1|||
161054380|NCT00296504|581588564|FG008|Interim Analysis|Non-adherence|0|||
161054381|NCT00296504|581588556|FG000|Interim Analysis|Site Closing|1|||
161054382|NCT00296504|581588557|FG001|Interim Analysis|Site Closing|0|||
161054383|NCT00296504|581588558|FG002|Interim Analysis|Site Closing|0|||
161054384|NCT00296504|581588559|FG003|Interim Analysis|Site Closing|0|||
161054385|NCT00296504|581588560|FG004|Interim Analysis|Site Closing|0|||
161054386|NCT00296504|581588561|FG005|Interim Analysis|Site Closing|1|||
161054387|NCT00296504|581588562|FG006|Interim Analysis|Site Closing|2|||
161054388|NCT00296504|581588563|FG007|Interim Analysis|Site Closing|0|||
161054389|NCT00296504|581588564|FG008|Interim Analysis|Site Closing|0|||
161054390|NCT00296504|581588556|FG000|Interim Analysis|Lack of Personnel at Site|1|||
161054391|NCT00296504|581588557|FG001|Interim Analysis|Lack of Personnel at Site|0|||
161054392|NCT00296504|581588558|FG002|Interim Analysis|Lack of Personnel at Site|0|||
161054393|NCT00296504|581588559|FG003|Interim Analysis|Lack of Personnel at Site|0|||
161054394|NCT00296504|581588560|FG004|Interim Analysis|Lack of Personnel at Site|0|||
161054395|NCT00296504|581588561|FG005|Interim Analysis|Lack of Personnel at Site|0|||
161054396|NCT00296504|581588562|FG006|Interim Analysis|Lack of Personnel at Site|0|||
161054397|NCT00296504|581588563|FG007|Interim Analysis|Lack of Personnel at Site|0|||
161054398|NCT00296504|581588564|FG008|Interim Analysis|Lack of Personnel at Site|0|||
161054399|NCT00296504|581588556|FG000|Interim Analysis|Missed Schedule Date|1|||
161054400|NCT00296504|581588557|FG001|Interim Analysis|Missed Schedule Date|0|||
161054401|NCT00296504|581588558|FG002|Interim Analysis|Missed Schedule Date|0|||
161054402|NCT00296504|581588559|FG003|Interim Analysis|Missed Schedule Date|0|||
161054403|NCT00296504|581588560|FG004|Interim Analysis|Missed Schedule Date|0|||
161054404|NCT00296504|581588561|FG005|Interim Analysis|Missed Schedule Date|0|||
161054405|NCT00296504|581588562|FG006|Interim Analysis|Missed Schedule Date|0|||
161054406|NCT00296504|581588563|FG007|Interim Analysis|Missed Schedule Date|0|||
161054407|NCT00296504|581588564|FG008|Interim Analysis|Missed Schedule Date|0|||
161054408|NCT00296504|581588556|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
161054409|NCT00296504|581588557|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
161054410|NCT00296504|581588558|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
161054411|NCT00296504|581588559|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
161054412|NCT00296504|581588560|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
161054413|NCT00296504|581588561|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
161054414|NCT00296504|581588562|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
161054415|NCT00296504|581588563|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
161054416|NCT00296504|581588564|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
161151448|NCT02518620|581935565|FG001|Overall Study|Physician Decision|1|||
161054417|NCT00296504|581588556|FG000|Interim Analysis|Participant Stopped|0|||
161054418|NCT00296504|581588557|FG001|Interim Analysis|Participant Stopped|0|||
161054419|NCT00296504|581588558|FG002|Interim Analysis|Participant Stopped|0|||
161054420|NCT00296504|581588559|FG003|Interim Analysis|Participant Stopped|0|||
161281129|NCT00993421|582407024|FG002|Overall Study|Physician Decision|0|||
161281130|NCT00993421|582407025|FG003|Overall Study|Physician Decision|0|||
161281131|NCT00993421|582407026|FG004|Overall Study|Physician Decision|0|||
161281132|NCT00993421|582407027|FG005|Overall Study|Physician Decision|1|||
161054421|NCT00296504|581588560|FG004|Interim Analysis|Participant Stopped|1|||
161054422|NCT00296504|581588561|FG005|Interim Analysis|Participant Stopped|0|||
161054423|NCT00296504|581588562|FG006|Interim Analysis|Participant Stopped|0|||
161054424|NCT00296504|581588563|FG007|Interim Analysis|Participant Stopped|0|||
161054425|NCT00296504|581588564|FG008|Interim Analysis|Participant Stopped|0|||
161054426|NCT00296504|581588556|FG000|Interim Analysis|Physician and Participant Decision|0|||
161054427|NCT00296504|581588557|FG001|Interim Analysis|Physician and Participant Decision|0|||
161054428|NCT00296504|581588558|FG002|Interim Analysis|Physician and Participant Decision|0|||
161054429|NCT00296504|581588559|FG003|Interim Analysis|Physician and Participant Decision|0|||
161054430|NCT00296504|581588560|FG004|Interim Analysis|Physician and Participant Decision|0|||
161054431|NCT00296504|581588561|FG005|Interim Analysis|Physician and Participant Decision|1|||
161054432|NCT00296504|581588562|FG006|Interim Analysis|Physician and Participant Decision|0|||
161054433|NCT00296504|581588563|FG007|Interim Analysis|Physician and Participant Decision|0|||
161054434|NCT00296504|581588564|FG008|Interim Analysis|Physician and Participant Decision|0|||
161054435|NCT00296504|581588556|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
161054436|NCT00296504|581588557|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
161054437|NCT00296504|581588558|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
161054438|NCT00296504|581588559|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
161054439|NCT00296504|581588560|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
161054440|NCT00296504|581588561|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
161054441|NCT00296504|581588562|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
161054442|NCT00296504|581588563|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
161054443|NCT00296504|581588564|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
161054444|NCT00296504|581588556|FG000|Interim Analysis|Study Ended|0|||
161054445|NCT00296504|581588557|FG001|Interim Analysis|Study Ended|0|||
161054446|NCT00296504|581588558|FG002|Interim Analysis|Study Ended|0|||
161054447|NCT00296504|581588559|FG003|Interim Analysis|Study Ended|0|||
161054448|NCT00296504|581588560|FG004|Interim Analysis|Study Ended|0|||
161151449|NCT02518620|581935564|FG000|Overall Study|Sponsor's Decision|0|||
161151450|NCT02518620|581935565|FG001|Overall Study|Sponsor's Decision|3|||
161151451|NCT02518620|581935564|FG000|Overall Study|Lost to Follow-up|1|||
161151452|NCT02518620|581935565|FG001|Overall Study|Lost to Follow-up|1|||
161151453|NCT02518620|581935564|FG000|Overall Study|Withdrawal by Subject|17|||
161151454|NCT02518620|581935565|FG001|Overall Study|Withdrawal by Subject|9|||
161151455|NCT02518620|581935564|FG000|Overall Study|Death|1|||
161151456|NCT02518620|581935565|FG001|Overall Study|Death|0|||
161151457|NCT02518620|581935564|FG000|Overall Study|Pregnancy Wish|3|||
161151458|NCT02518620|581935565|FG001|Overall Study|Pregnancy Wish|0|||
161151459|NCT02518620|581935564|FG000|Overall Study|Pregnancy|1|||
161151460|NCT02518620|581935565|FG001|Overall Study|Pregnancy|0|||
161151461|NCT02518620|581935564|FG000|Overall Study|Relocation|2|||
161151462|NCT02518620|581935565|FG001|Overall Study|Relocation|1|||
161151463|NCT03844633|581935569|FG000|1 Week FU|Lost to Follow-up|0|||
161151464|NCT03844633|581935570|FG001|1 Week FU|Lost to Follow-up|1|||
161151465|NCT03844633|581935571|FG002|1 Week FU|Lost to Follow-up|4|||
161151466|NCT03844633|581935569|FG000|12-month Follow-up|Lost to Follow-up|7|||
161151467|NCT03844633|581935570|FG001|12-month Follow-up|Lost to Follow-up|5|||
161281133|NCT00993421|582407028|FG006|Overall Study|Physician Decision|1|||
161281134|NCT00993421|582407022|FG000|Overall Study|Protocol Violation|0|||
161281135|NCT00993421|582407023|FG001|Overall Study|Protocol Violation|0|||
161281136|NCT00993421|582407024|FG002|Overall Study|Protocol Violation|0|||
161281137|NCT00993421|582407025|FG003|Overall Study|Protocol Violation|0|||
161151468|NCT03844633|581935571|FG002|12-month Follow-up|Lost to Follow-up|8|||
161151469|NCT02588248|581935574|FG000|Overall Study|Physician Decision|4|||
161151470|NCT02588248|581935575|FG001|Overall Study|Physician Decision|3|||
161151471|NCT01355068|581935578|FG000|First Intervention Period|Adverse Event|0|||
161151472|NCT01355068|581935579|FG001|First Intervention Period|Adverse Event|1|||
161151473|NCT01355068|581935578|FG000|First Intervention Period|Withdrawal by Subject|0|||
161054449|NCT00296504|581588561|FG005|Interim Analysis|Study Ended|0|||
161054450|NCT00296504|581588562|FG006|Interim Analysis|Study Ended|1|||
161281138|NCT00993421|582407026|FG004|Overall Study|Protocol Violation|0|||
161151474|NCT01355068|581935579|FG001|First Intervention Period|Withdrawal by Subject|1|||
161151475|NCT00336492|581935580|FG000|Overall Study|Adverse Event|4|||
161151476|NCT00336492|581935581|FG001|Overall Study|Adverse Event|3|||
161281139|NCT00993421|582407027|FG005|Overall Study|Protocol Violation|2|||
161281140|NCT00993421|582407028|FG006|Overall Study|Protocol Violation|1|||
161281141|NCT02759692|582407029|FG000|Period 1|Test article no longer available|1|||
161281142|NCT02759692|582407030|FG001|Period 1|Test article no longer available|1|||
161281143|NCT02759692|582407029|FG000|Period 1|No longer meets eligibility criteria.|1|||
161281144|NCT02759692|582407030|FG001|Period 1|No longer meets eligibility criteria.|0|||
161281145|NCT02759692|582407029|FG000|Period 1|Miss-Randomized|1|||
161281146|NCT02759692|582407030|FG001|Period 1|Miss-Randomized|1|||
161054451|NCT00296504|581588563|FG007|Interim Analysis|Study Ended|0|||
161054452|NCT00296504|581588564|FG008|Interim Analysis|Study Ended|0|||
161054453|NCT00296504|581588556|FG000|Interim Analysis|Participant Needed Interferon|0|||
161054454|NCT00296504|581588557|FG001|Interim Analysis|Participant Needed Interferon|0|||
161054455|NCT00296504|581588558|FG002|Interim Analysis|Participant Needed Interferon|0|||
161054456|NCT00296504|581588559|FG003|Interim Analysis|Participant Needed Interferon|0|||
161054457|NCT00296504|581588560|FG004|Interim Analysis|Participant Needed Interferon|0|||
161054458|NCT00296504|581588561|FG005|Interim Analysis|Participant Needed Interferon|0|||
161054459|NCT00296504|581588562|FG006|Interim Analysis|Participant Needed Interferon|0|||
161054460|NCT00296504|581588563|FG007|Interim Analysis|Participant Needed Interferon|1|||
161054461|NCT00296504|581588564|FG008|Interim Analysis|Participant Needed Interferon|0|||
161054462|NCT00296504|581588556|FG000|Interim Analysis|Ongoing|32|||
161054463|NCT00296504|581588557|FG001|Interim Analysis|Ongoing|12|||
161054464|NCT00296504|581588558|FG002|Interim Analysis|Ongoing|16|||
161054465|NCT00296504|581588559|FG003|Interim Analysis|Ongoing|22|||
161054466|NCT00296504|581588560|FG004|Interim Analysis|Ongoing|0|||
161054467|NCT00296504|581588561|FG005|Interim Analysis|Ongoing|0|||
161054468|NCT00296504|581588562|FG006|Interim Analysis|Ongoing|30|||
161054469|NCT00296504|581588563|FG007|Interim Analysis|Ongoing|1|||
161054470|NCT00296504|581588564|FG008|Interim Analysis|Ongoing|0|||
161054471|NCT00296504|581588556|FG000|Final Analysis|Withdrawal by Subject|0|||
161054472|NCT00296504|581588557|FG001|Final Analysis|Withdrawal by Subject|0|||
161054473|NCT00296504|581588558|FG002|Final Analysis|Withdrawal by Subject|0|||
161054474|NCT00296504|581588559|FG003|Final Analysis|Withdrawal by Subject|0|||
161054475|NCT00296504|581588560|FG004|Final Analysis|Withdrawal by Subject|0|||
161054476|NCT00296504|581588561|FG005|Final Analysis|Withdrawal by Subject|0|||
161054477|NCT00296504|581588562|FG006|Final Analysis|Withdrawal by Subject|0|||
161054478|NCT00296504|581588563|FG007|Final Analysis|Withdrawal by Subject|0|||
161054479|NCT00296504|581588564|FG008|Final Analysis|Withdrawal by Subject|1|||
161054480|NCT00296504|581588556|FG000|Final Analysis|Lost to Follow-up|0|||
161054481|NCT00296504|581588557|FG001|Final Analysis|Lost to Follow-up|0|||
161054482|NCT00296504|581588558|FG002|Final Analysis|Lost to Follow-up|0|||
161054483|NCT00296504|581588559|FG003|Final Analysis|Lost to Follow-up|0|||
161054484|NCT00296504|581588560|FG004|Final Analysis|Lost to Follow-up|0|||
161054485|NCT00296504|581588561|FG005|Final Analysis|Lost to Follow-up|0|||
161054486|NCT00296504|581588562|FG006|Final Analysis|Lost to Follow-up|0|||
161054487|NCT00296504|581588563|FG007|Final Analysis|Lost to Follow-up|0|||
161054488|NCT00296504|581588564|FG008|Final Analysis|Lost to Follow-up|5|||
161054489|NCT00296504|581588556|FG000|Final Analysis|Insufficient Viral Load Response|0|||
161054490|NCT00296504|581588557|FG001|Final Analysis|Insufficient Viral Load Response|0|||
161054491|NCT00296504|581588558|FG002|Final Analysis|Insufficient Viral Load Response|0|||
161054492|NCT00296504|581588559|FG003|Final Analysis|Insufficient Viral Load Response|0|||
161054493|NCT00296504|581588560|FG004|Final Analysis|Insufficient Viral Load Response|0|||
161054494|NCT00296504|581588561|FG005|Final Analysis|Insufficient Viral Load Response|0|||
161054495|NCT00296504|581588562|FG006|Final Analysis|Insufficient Viral Load Response|0|||
161054496|NCT00296504|581588563|FG007|Final Analysis|Insufficient Viral Load Response|0|||
161054497|NCT00296504|581588564|FG008|Final Analysis|Insufficient Viral Load Response|6|||
161054498|NCT00296504|581588556|FG000|Final Analysis|Adverse Event|0|||
161054499|NCT00296504|581588557|FG001|Final Analysis|Adverse Event|0|||
161054500|NCT00296504|581588558|FG002|Final Analysis|Adverse Event|0|||
161054501|NCT00296504|581588559|FG003|Final Analysis|Adverse Event|0|||
161054502|NCT00296504|581588560|FG004|Final Analysis|Adverse Event|0|||
161054503|NCT00296504|581588561|FG005|Final Analysis|Adverse Event|0|||
161054504|NCT00296504|581588562|FG006|Final Analysis|Adverse Event|0|||
161054505|NCT00296504|581588563|FG007|Final Analysis|Adverse Event|0|||
161054506|NCT00296504|581588564|FG008|Final Analysis|Adverse Event|2|||
161054507|NCT00296504|581588556|FG000|Final Analysis|Pregnancy|0|||
161054508|NCT00296504|581588557|FG001|Final Analysis|Pregnancy|0|||
161054509|NCT00296504|581588558|FG002|Final Analysis|Pregnancy|0|||
161054510|NCT00296504|581588559|FG003|Final Analysis|Pregnancy|0|||
161054511|NCT00296504|581588560|FG004|Final Analysis|Pregnancy|0|||
161054512|NCT00296504|581588561|FG005|Final Analysis|Pregnancy|0|||
161054513|NCT00296504|581588562|FG006|Final Analysis|Pregnancy|0|||
161054514|NCT00296504|581588563|FG007|Final Analysis|Pregnancy|0|||
161054515|NCT00296504|581588564|FG008|Final Analysis|Pregnancy|4|||
161281147|NCT02759692|582407029|FG000|Period 2|Lost to Follow-up|1|||
161281148|NCT02759692|582407030|FG001|Period 2|Lost to Follow-up|0|||
161281149|NCT02759692|582407029|FG000|Period 2|Test article no longer available|0|||
161281150|NCT02759692|582407030|FG001|Period 2|Test article no longer available|1|||
161281151|NCT04042376|582407036|FG000|Overall Study|Withdrawal by Subject|1|||
161054516|NCT00296504|581588556|FG000|Final Analysis|Tuberculosis|0|||
161054517|NCT00296504|581588557|FG001|Final Analysis|Tuberculosis|0|||
161054518|NCT00296504|581588558|FG002|Final Analysis|Tuberculosis|0|||
161054519|NCT00296504|581588559|FG003|Final Analysis|Tuberculosis|0|||
161054520|NCT00296504|581588560|FG004|Final Analysis|Tuberculosis|0|||
161054521|NCT00296504|581588561|FG005|Final Analysis|Tuberculosis|0|||
161054522|NCT00296504|581588562|FG006|Final Analysis|Tuberculosis|0|||
161054523|NCT00296504|581588563|FG007|Final Analysis|Tuberculosis|0|||
161054524|NCT00296504|581588564|FG008|Final Analysis|Tuberculosis|1|||
161054525|NCT00296504|581588556|FG000|Final Analysis|Participant Moved to Another Country|0|||
161054526|NCT00296504|581588557|FG001|Final Analysis|Participant Moved to Another Country|0|||
161054527|NCT00296504|581588558|FG002|Final Analysis|Participant Moved to Another Country|0|||
161054528|NCT00296504|581588559|FG003|Final Analysis|Participant Moved to Another Country|0|||
161054529|NCT00296504|581588560|FG004|Final Analysis|Participant Moved to Another Country|0|||
161054530|NCT00296504|581588561|FG005|Final Analysis|Participant Moved to Another Country|0|||
161054531|NCT00296504|581588562|FG006|Final Analysis|Participant Moved to Another Country|0|||
161054532|NCT00296504|581588563|FG007|Final Analysis|Participant Moved to Another Country|0|||
161054533|NCT00296504|581588564|FG008|Final Analysis|Participant Moved to Another Country|1|||
161054534|NCT00296504|581588556|FG000|Final Analysis|Poor Adherence|0|||
161054535|NCT00296504|581588557|FG001|Final Analysis|Poor Adherence|0|||
161054536|NCT00296504|581588558|FG002|Final Analysis|Poor Adherence|0|||
161054537|NCT00296504|581588559|FG003|Final Analysis|Poor Adherence|0|||
161054538|NCT00296504|581588560|FG004|Final Analysis|Poor Adherence|0|||
161054539|NCT00296504|581588561|FG005|Final Analysis|Poor Adherence|0|||
161054540|NCT00296504|581588562|FG006|Final Analysis|Poor Adherence|0|||
161054541|NCT00296504|581588563|FG007|Final Analysis|Poor Adherence|0|||
161054542|NCT00296504|581588564|FG008|Final Analysis|Poor Adherence|1|||
161054543|NCT01323309|581588570|FG000|Overall Study|Death|9|||
161054544|NCT01323309|581588571|FG001|Overall Study|Death|15|||
161054545|NCT01323309|581588572|FG002|Overall Study|Death|5|||
161054546|NCT01323309|581588570|FG000|Overall Study|Lost to Follow-up|11|||
161054547|NCT01323309|581588571|FG001|Overall Study|Lost to Follow-up|14|||
161054548|NCT01323309|581588572|FG002|Overall Study|Lost to Follow-up|24|||
161054549|NCT01323309|581588570|FG000|Overall Study|Withdrawal by Subject|14|||
161054550|NCT01323309|581588571|FG001|Overall Study|Withdrawal by Subject|14|||
161054551|NCT01323309|581588572|FG002|Overall Study|Withdrawal by Subject|18|||
161054552|NCT01323309|581588570|FG000|Overall Study|Disease progression|5|||
161054553|NCT01323309|581588571|FG001|Overall Study|Disease progression|11|||
161054554|NCT01323309|581588572|FG002|Overall Study|Disease progression|4|||
161054555|NCT02162771|581588576|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
161054556|NCT02162771|581588577|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
161054557|NCT02162771|581588576|FG000|Core Study Period (Part 2)|Adverse Event|4|||
161054558|NCT02162771|581588577|FG001|Core Study Period (Part 2)|Adverse Event|1|||
161054559|NCT02162771|581588576|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
161054560|NCT02162771|581588577|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
161054561|NCT02162771|581588576|FG000|Core Study Period (Part 2)|Physician Decision|0|||
161054562|NCT02162771|581588577|FG001|Core Study Period (Part 2)|Physician Decision|2|||
161054563|NCT02162771|581588576|FG000|Core Study Period (Part 2)|Death|1|||
161054564|NCT02162771|581588577|FG001|Core Study Period (Part 2)|Death|0|||
161054565|NCT02162771|581588576|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
161054566|NCT02162771|581588577|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
161054567|NCT02162771|581588576|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
161054568|NCT02162771|581588577|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
161054569|NCT02162771|581588576|FG000|Maintenance Study Period (Part 2)|Death|2|||
161054570|NCT02162771|581588577|FG001|Maintenance Study Period (Part 2)|Death|1|||
161054571|NCT02162771|581588576|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
161054572|NCT02162771|581588577|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
161054573|NCT02162771|581588576|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
161054574|NCT02162771|581588577|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
161054575|NCT02162771|581588576|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
161054576|NCT02162771|581588577|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
161054577|NCT01078571|581588578|FG000|Overall Study|Adverse Event|36|||
161054578|NCT01078571|581588578|FG000|Overall Study|Lack of effectiveness|36|||
161054579|NCT01078571|581588578|FG000|Overall Study|Reason not reported|21|||
161054580|NCT01078571|581588578|FG000|Overall Study|Withdrawal by Subject|12|||
161054581|NCT01078571|581588578|FG000|Overall Study|Lost to Follow-up|8|||
161054582|NCT01078571|581588578|FG000|Overall Study|Protocol Violation|2|||
161054583|NCT01047306|581588582|FG000|Overall Study|Withdrawal by Subject|2|||
161054584|NCT01047306|581588583|FG001|Overall Study|Withdrawal by Subject|0|||
161054585|NCT01047306|581588582|FG000|Overall Study|Lost to Follow-up|1|||
161054586|NCT01047306|581588583|FG001|Overall Study|Lost to Follow-up|0|||
161054587|NCT01878253|581588584|FG000|Overall Study|Death|1|||
161054588|NCT01878253|581588584|FG000|Overall Study|SIdus System Removal|3|||
161054589|NCT01878253|581588584|FG000|Overall Study|Withdrawal by Subject|1|||
161054590|NCT01878253|581588584|FG000|Overall Study|Lost to Follow-up|2|||
161054591|NCT01878253|581588584|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
161054592|NCT00449033|581588589|FG000|Treatment Period|Adverse Event|117|||
161054593|NCT00449033|581588590|FG001|Treatment Period|Adverse Event|83|||
161054594|NCT00449033|581588589|FG000|Treatment Period|Death|21|||
161054595|NCT00449033|581588590|FG001|Treatment Period|Death|12|||
161151477|NCT00336492|581935582|FG002|Overall Study|Adverse Event|6|||
161151478|NCT00336492|581935580|FG000|Overall Study|Lack of Efficacy|6|||
161151479|NCT00336492|581935581|FG001|Overall Study|Lack of Efficacy|1|||
161151480|NCT00336492|581935582|FG002|Overall Study|Lack of Efficacy|4|||
161151481|NCT00336492|581935580|FG000|Overall Study|Other|5|||
161151482|NCT00336492|581935581|FG001|Overall Study|Other|0|||
161151483|NCT00336492|581935582|FG002|Overall Study|Other|1|||
161151484|NCT04229446|581935585|FG000|Overall Study|Death|12|||
161151485|NCT04229446|581935586|FG001|Overall Study|Death|10|||
161151486|NCT04229446|581935585|FG000|Overall Study|Lost to Follow-up|5|||
161151487|NCT04229446|581935586|FG001|Overall Study|Lost to Follow-up|8|||
161151488|NCT04191967|581937004|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
161151489|NCT04191967|581937004|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
161151490|NCT02322892|581937007|FG000|Overall Study|Surgery cancelled|1|||
161151491|NCT02322892|581937008|FG001|Overall Study|Surgery cancelled|2|||
161151492|NCT02322892|581937007|FG000|Overall Study|Met exclusion criteria|0|||
161151493|NCT02322892|581937008|FG001|Overall Study|Met exclusion criteria|1|||
161151494|NCT02322892|581937007|FG000|Overall Study|Protocol Violation|1|||
161151495|NCT02322892|581937008|FG001|Overall Study|Protocol Violation|0|||
161151496|NCT01798134|581937016|FG000|Overall Study|Lost to Follow-up|1|||
161151497|NCT01798134|581937016|FG000|Overall Study|Withdrawal by Subject|3|||
161151498|NCT01798134|581937016|FG000|Overall Study|Death|2|||
161151499|NCT01798134|581937016|FG000|Overall Study|Adverse Event|3|||
161151500|NCT01798134|581937016|FG000|Overall Study|Physician Decision|3|||
161151501|NCT01798134|581937016|FG000|Overall Study|Liver transplant/surgery|4|||
161151502|NCT02653976|581937017|FG000|Overall Study|Withdrawal by Subject|5|||
161151503|NCT02653976|581937017|FG000|Overall Study|Death|4|||
161151504|NCT02436577|581937018|FG000|Overall Study|Protocol Deviation|0|||
161151505|NCT02436577|581937019|FG001|Overall Study|Protocol Deviation|1|||
161151506|NCT02436577|581937020|FG002|Overall Study|Protocol Deviation|0|||
161151507|NCT02436577|581937021|FG003|Overall Study|Protocol Deviation|0|||
161151508|NCT02436577|581937022|FG004|Overall Study|Protocol Deviation|0|||
161151509|NCT02436577|581937023|FG005|Overall Study|Protocol Deviation|0|||
161151510|NCT01675011|581937024|FG000|Overall Study|Trial terminated by Sponsor|3|||
161151511|NCT01675011|581937025|FG001|Overall Study|Trial terminated by Sponsor|1|||
161054596|NCT00449033|581588589|FG000|Treatment Period|Lost to Follow-up|0|||
161054597|NCT00449033|581588590|FG001|Treatment Period|Lost to Follow-up|2|||
161054598|NCT00449033|581588589|FG000|Treatment Period|Physician Decision|4|||
161054599|NCT00449033|581588590|FG001|Treatment Period|Physician Decision|5|||
161054600|NCT00449033|581588589|FG000|Treatment Period|Protocol Violation|8|||
161054601|NCT00449033|581588590|FG001|Treatment Period|Protocol Violation|7|||
161054602|NCT00449033|581588589|FG000|Treatment Period|Disease Progression|231|||
161054603|NCT00449033|581588590|FG001|Treatment Period|Disease Progression|288|||
161054604|NCT00449033|581588589|FG000|Treatment Period|Consent Withdrawn|36|||
161054605|NCT00449033|581588590|FG001|Treatment Period|Consent Withdrawn|20|||
161054606|NCT00449033|581588589|FG000|Treatment Period|Amended Protocol Criteria|22|||
161054607|NCT00449033|581588590|FG001|Treatment Period|Amended Protocol Criteria|18|||
161054608|NCT00449033|581588589|FG000|Treatment Period|Non-compliance|7|||
161054609|NCT00449033|581588590|FG001|Treatment Period|Non-compliance|8|||
161054610|NCT00449033|581588589|FG000|Treatment Period|Second Malignancy|0|||
161054611|NCT00449033|581588590|FG001|Treatment Period|Second Malignancy|1|||
161054612|NCT00449033|581588589|FG000|Treatment Period|Reason Missing|0|||
161151512|NCT00615290|581937026|FG000|Overall Study|Adverse Event|2|||
161151513|NCT00615290|581937026|FG000|Overall Study|Lost to Follow-up|3|||
161151514|NCT00615290|581937026|FG000|Overall Study|Withdrawal by Subject|1|||
161151515|NCT00615290|581937026|FG000|Overall Study|Other|2|||
161151516|NCT00366548|581937027|FG000|Infant Series|Adverse Event|1|||
161151517|NCT00366548|581937028|FG001|Infant Series|Adverse Event|3|||
161151518|NCT00366548|581937027|FG000|Infant Series|Protocol Violation|0|||
161151519|NCT00366548|581937028|FG001|Infant Series|Protocol Violation|1|||
161054613|NCT00449033|581588590|FG001|Treatment Period|Reason Missing|4|||
161054614|NCT00449033|581588589|FG000|Treatment Period|Treatment Ongoing|6|||
161054615|NCT00449033|581588590|FG001|Treatment Period|Treatment Ongoing|4|||
161151520|NCT00366548|581937027|FG000|Infant Series|Withdrawal by Subject|3|||
161151521|NCT00366548|581937028|FG001|Infant Series|Withdrawal by Subject|1|||
161151522|NCT00366548|581937027|FG000|After Infant Series|Withdrawal by Subject|3|||
161151523|NCT00366548|581937028|FG001|After Infant Series|Withdrawal by Subject|1|||
161151524|NCT00366548|581937027|FG000|After Infant Series|Adverse Event|2|||
161151525|NCT00366548|581937028|FG001|After Infant Series|Adverse Event|0|||
161151526|NCT00366548|581937027|FG000|After Infant Series|Lost to Follow-up|1|||
161151527|NCT00366548|581937028|FG001|After Infant Series|Lost to Follow-up|0|||
161151528|NCT02849990|581937029|FG000|Overall Study|Adverse Event|1|||
161151529|NCT02849990|581937029|FG000|Overall Study|Withdrawal by Subject|1|||
161151530|NCT01252134|581937030|FG000|Period 1, 8 Hours|Personal Reasons|0|||
161345102|NCT03126110|582648859|FG010|Phase 2|Started new treatment|0|||
161054616|NCT00449033|581588589|FG000|Follow-up Period|Death|299|||
161054617|NCT00449033|581588590|FG001|Follow-up Period|Death|311|||
161054618|NCT00449033|581588589|FG000|Follow-up Period|Lost to Follow-up|6|||
161054619|NCT00449033|581588590|FG001|Follow-up Period|Lost to Follow-up|10|||
161054620|NCT00449033|581588589|FG000|Follow-up Period|Reason Missing|120|||
161054621|NCT00449033|581588590|FG001|Follow-up Period|Reason Missing|113|||
161054622|NCT04393779|581588593|FG000|Overall Study|Death|1|||
161054623|NCT04393779|581588593|FG000|Overall Study|Device reintervention or explant|4|||
161054624|NCT03802513|581588594|FG000|Overall Study|Lost to Follow-up|1|||
161054625|NCT01648699|581588598|FG000|Overall Study|Death|1|||
161054626|NCT01648699|581588598|FG000|Overall Study|Lost to Follow-up|2|||
161054627|NCT01648699|581588598|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
161054628|NCT04803214|581588599|FG000|Overall Study|Adverse Event|1|||
161054629|NCT04803214|581588600|FG001|Overall Study|Adverse Event|0|||
161054630|NCT04803214|581588599|FG000|Overall Study|Withdrawal by Subject|1|||
161054631|NCT04803214|581588600|FG001|Overall Study|Withdrawal by Subject|2|||
161054632|NCT04803214|581588599|FG000|Overall Study|Lost to Follow-up|2|||
161054633|NCT04803214|581588600|FG001|Overall Study|Lost to Follow-up|4|||
161054634|NCT04803214|581588599|FG000|Overall Study|Physician Decision|1|||
161054635|NCT04803214|581588600|FG001|Overall Study|Physician Decision|1|||
161054636|NCT04803214|581588599|FG000|Overall Study|Missed 12 month visit|0|||
161054637|NCT04803214|581588600|FG001|Overall Study|Missed 12 month visit|3|||
161054638|NCT03219216|581588601|FG000|Overall Study|Lost to Follow-up|0|||
161054639|NCT03219216|581588602|FG001|Overall Study|Lost to Follow-up|1|||
161054640|NCT03520036|581588606|FG000|Overall Study|Adverse Event|1|||
161054641|NCT03520036|581588607|FG001|Overall Study|Adverse Event|2|||
161054642|NCT03520036|581588608|FG002|Overall Study|Adverse Event|0|||
161054643|NCT03520036|581588606|FG000|Overall Study|Protocol Violation|1|||
161054644|NCT03520036|581588607|FG001|Overall Study|Protocol Violation|0|||
161054645|NCT03520036|581588608|FG002|Overall Study|Protocol Violation|0|||
161054646|NCT03520036|581588606|FG000|Overall Study|Withdrawal by Subject|0|||
161054647|NCT03520036|581588607|FG001|Overall Study|Withdrawal by Subject|1|||
161054648|NCT03520036|581588608|FG002|Overall Study|Withdrawal by Subject|4|||
161054649|NCT03520036|581588606|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
161054650|NCT03520036|581588607|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
161054651|NCT03520036|581588608|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
161054652|NCT03005106|581588609|FG000|Overall Study|Lost to Follow-up|16|||
161054653|NCT03005106|581588609|FG000|Overall Study|Adverse Event|1|||
161054654|NCT03005106|581588609|FG000|Overall Study|Physician Decision|1|||
161054655|NCT03005106|581588609|FG000|Overall Study|Death|2|||
161054656|NCT01855399|581588610|FG000|6 Month|Lost to Follow-up|12|||
161054657|NCT01855399|581588611|FG001|6 Month|Lost to Follow-up|9|||
161054658|NCT01855399|581588610|FG000|6 Month|Withdrawal by Subject|8|||
161054659|NCT01855399|581588611|FG001|6 Month|Withdrawal by Subject|6|||
161054660|NCT01855399|581588610|FG000|12 Month|Lost to Follow-up|7|||
161054661|NCT01855399|581588611|FG001|12 Month|Lost to Follow-up|11|||
161054662|NCT00321672|581588612|FG000|Overall Study|Withdrawal by Subject|5|||
161054663|NCT00321672|581588613|FG001|Overall Study|Withdrawal by Subject|1|||
161054664|NCT00321672|581588614|FG002|Overall Study|Withdrawal by Subject|2|||
161054665|NCT00321672|581588615|FG003|Overall Study|Withdrawal by Subject|0|||
161054666|NCT00321672|581588612|FG000|Overall Study|Noncompliance|1|||
161054667|NCT00321672|581588613|FG001|Overall Study|Noncompliance|2|||
161054668|NCT00321672|581588614|FG002|Overall Study|Noncompliance|1|||
161054669|NCT00321672|581588615|FG003|Overall Study|Noncompliance|0|||
161054670|NCT00321672|581588612|FG000|Overall Study|Adverse Event|1|||
161054671|NCT00321672|581588613|FG001|Overall Study|Adverse Event|1|||
161054672|NCT00321672|581588614|FG002|Overall Study|Adverse Event|0|||
161054673|NCT00321672|581588615|FG003|Overall Study|Adverse Event|0|||
161054674|NCT00321672|581588612|FG000|Overall Study|Lack of Efficacy|1|||
161054675|NCT00321672|581588613|FG001|Overall Study|Lack of Efficacy|1|||
161054676|NCT00321672|581588614|FG002|Overall Study|Lack of Efficacy|0|||
161054677|NCT00321672|581588615|FG003|Overall Study|Lack of Efficacy|0|||
161054678|NCT00321672|581588612|FG000|Overall Study|Lost to Follow-up|2|||
161054679|NCT00321672|581588613|FG001|Overall Study|Lost to Follow-up|0|||
161054680|NCT00321672|581588614|FG002|Overall Study|Lost to Follow-up|4|||
161054681|NCT00321672|581588615|FG003|Overall Study|Lost to Follow-up|2|||
161054682|NCT00321672|581588612|FG000|Overall Study|Death|1|||
161151531|NCT01252134|581937031|FG001|Period 1, 8 Hours|Personal Reasons|1|||
161281152|NCT04042376|582407036|FG000|Overall Study|Death|3|||
161054683|NCT00321672|581588613|FG001|Overall Study|Death|0|||
161054684|NCT00321672|581588614|FG002|Overall Study|Death|0|||
161054685|NCT00321672|581588615|FG003|Overall Study|Death|0|||
161054686|NCT00321672|581588612|FG000|Overall Study|Too far to travel for visits|1|||
161054687|NCT00321672|581588613|FG001|Overall Study|Too far to travel for visits|0|||
161054688|NCT00321672|581588614|FG002|Overall Study|Too far to travel for visits|0|||
161054689|NCT00321672|581588615|FG003|Overall Study|Too far to travel for visits|0|||
161151532|NCT01252134|581937032|FG002|Period 1, 8 Hours|Personal Reasons|1|||
161281153|NCT02514447|582408622|FG000|Overall Study|Withdrawal by Subject|3|||
161054690|NCT00321672|581588612|FG000|Overall Study|Incarcerated|0|||
161054691|NCT00321672|581588613|FG001|Overall Study|Incarcerated|0|||
161054692|NCT00321672|581588614|FG002|Overall Study|Incarcerated|2|||
161054693|NCT00321672|581588615|FG003|Overall Study|Incarcerated|0|||
161054694|NCT00321672|581588612|FG000|Overall Study|Moved out of state|0|||
161054695|NCT00321672|581588613|FG001|Overall Study|Moved out of state|1|||
161054696|NCT00321672|581588614|FG002|Overall Study|Moved out of state|1|||
161054697|NCT00321672|581588615|FG003|Overall Study|Moved out of state|0|||
161054698|NCT00321672|581588612|FG000|Overall Study|Protocol Violation|0|||
161054699|NCT00321672|581588613|FG001|Overall Study|Protocol Violation|0|||
161054700|NCT00321672|581588614|FG002|Overall Study|Protocol Violation|1|||
161054701|NCT00321672|581588615|FG003|Overall Study|Protocol Violation|0|||
161054702|NCT00321672|581588612|FG000|Overall Study|Diagnosis of testicular cancer|0|||
161054703|NCT00321672|581588613|FG001|Overall Study|Diagnosis of testicular cancer|1|||
161054704|NCT00321672|581588614|FG002|Overall Study|Diagnosis of testicular cancer|0|||
161054705|NCT00321672|581588615|FG003|Overall Study|Diagnosis of testicular cancer|0|||
161054706|NCT00321672|581588612|FG000|Overall Study|Extensive travel required for new job|0|||
161054707|NCT00321672|581588613|FG001|Overall Study|Extensive travel required for new job|1|||
161054708|NCT00321672|581588614|FG002|Overall Study|Extensive travel required for new job|0|||
161054709|NCT00321672|581588615|FG003|Overall Study|Extensive travel required for new job|0|||
161054710|NCT00512902|581588616|FG000|Overall Study|Adverse Event|7|||
161054711|NCT00512902|581588616|FG000|Overall Study|Lost to Follow-up|1|||
161054712|NCT03019289|581588617|FG000|Overall Study|Adverse Event|1|||
161054713|NCT03019289|581588618|FG001|Overall Study|Adverse Event|0|||
161054714|NCT03019289|581588619|FG002|Overall Study|Adverse Event|0|||
161054715|NCT03019289|581588620|FG003|Overall Study|Adverse Event|0|||
161054716|NCT03019289|581588621|FG004|Overall Study|Adverse Event|0|||
161054717|NCT03019289|581588622|FG005|Overall Study|Adverse Event|0|||
161054718|NCT03019289|581588623|FG006|Overall Study|Adverse Event|0|||
161054719|NCT03019289|581588624|FG007|Overall Study|Adverse Event|0|||
161054720|NCT03019289|581588625|FG008|Overall Study|Adverse Event|1|||
161054721|NCT03019289|581588617|FG000|Overall Study|Other|1|||
161054722|NCT03019289|581588618|FG001|Overall Study|Other|0|||
161054723|NCT03019289|581588619|FG002|Overall Study|Other|0|||
161054724|NCT03019289|581588620|FG003|Overall Study|Other|0|||
161054725|NCT03019289|581588621|FG004|Overall Study|Other|0|||
161054726|NCT03019289|581588622|FG005|Overall Study|Other|0|||
161054727|NCT03019289|581588623|FG006|Overall Study|Other|0|||
161054728|NCT03019289|581588624|FG007|Overall Study|Other|0|||
161054729|NCT03019289|581588625|FG008|Overall Study|Other|0|||
161054730|NCT02389894|581588626|FG000|Overall Study|Death|4|||
161054731|NCT02389894|581588627|FG001|Overall Study|Death|5|||
161054732|NCT02389894|581588628|FG002|Overall Study|Death|3|||
161054733|NCT02389894|581588626|FG000|Overall Study|Withdrawal by Subject|2|||
161054734|NCT02389894|581588627|FG001|Overall Study|Withdrawal by Subject|4|||
161054735|NCT02389894|581588628|FG002|Overall Study|Withdrawal by Subject|5|||
161054736|NCT02389894|581588626|FG000|Overall Study|Lost to Follow-up|2|||
161054737|NCT02389894|581588627|FG001|Overall Study|Lost to Follow-up|1|||
161054738|NCT02389894|581588628|FG002|Overall Study|Lost to Follow-up|1|||
161054739|NCT01429285|581588630|FG000|Overall Study|Protocol Violation|9|||
161054740|NCT01429285|581588631|FG001|Overall Study|Protocol Violation|4|||
161054741|NCT01429285|581588630|FG000|Overall Study|Missing Data|5|||
161054742|NCT01429285|581588631|FG001|Overall Study|Missing Data|3|||
161054743|NCT01429285|581588630|FG000|Overall Study|Erroneously Enrolled Twice|8|||
161054744|NCT01429285|581588631|FG001|Overall Study|Erroneously Enrolled Twice|2|||
161054745|NCT02312245|581588632|FG000|Overall Study|Death|0|||
161054746|NCT02312245|581588633|FG001|Overall Study|Death|0|||
161054747|NCT02312245|581588634|FG002|Overall Study|Death|0|||
161054748|NCT02312245|581588635|FG003|Overall Study|Death|1|||
161054749|NCT02312245|581588632|FG000|Overall Study|Withdrawal by Subject|1|||
161054750|NCT02312245|581588633|FG001|Overall Study|Withdrawal by Subject|1|||
161054751|NCT02312245|581588634|FG002|Overall Study|Withdrawal by Subject|0|||
161054752|NCT02312245|581588635|FG003|Overall Study|Withdrawal by Subject|2|||
161054753|NCT02312245|581588632|FG000|Overall Study|Alternative Therapy|1|||
161054754|NCT02312245|581588633|FG001|Overall Study|Alternative Therapy|0|||
161054755|NCT02312245|581588634|FG002|Overall Study|Alternative Therapy|0|||
161054756|NCT02312245|581588635|FG003|Overall Study|Alternative Therapy|0|||
161054757|NCT02312245|581588632|FG000|Overall Study|Progression|0|||
161054758|NCT02312245|581588633|FG001|Overall Study|Progression|0|||
161054759|NCT02312245|581588634|FG002|Overall Study|Progression|0|||
161054760|NCT02312245|581588635|FG003|Overall Study|Progression|5|||
161054761|NCT02312245|581588632|FG000|Overall Study|Patient went to hospice|0|||
161054762|NCT02312245|581588633|FG001|Overall Study|Patient went to hospice|0|||
161054763|NCT02312245|581588634|FG002|Overall Study|Patient went to hospice|0|||
161054764|NCT02312245|581588635|FG003|Overall Study|Patient went to hospice|1|||
161054765|NCT02312245|581588632|FG000|Overall Study|Ineligible|1|||
161054766|NCT02312245|581588633|FG001|Overall Study|Ineligible|0|||
161054767|NCT02312245|581588634|FG002|Overall Study|Ineligible|0|||
161054768|NCT02312245|581588635|FG003|Overall Study|Ineligible|0|||
161054769|NCT01288729|581588644|FG000|Overall Study|Withdrawal by Subject|1|||
161054770|NCT01288729|581588645|FG001|Overall Study|Withdrawal by Subject|0|||
161054771|NCT02442622|581588650|FG000|Overall Study|Withdrawal by Subject|3|||
161054772|NCT02442622|581588651|FG001|Overall Study|Withdrawal by Subject|1|||
161054773|NCT02938520|581588652|FG000|Overall Study|On-going at the time of analysis|258|||
161151533|NCT01252134|581937033|FG003|Period 1, 8 Hours|Personal Reasons|0|||
161151534|NCT01252134|581937034|FG004|Period 1, 8 Hours|Personal Reasons|0|||
161151535|NCT01252134|581937035|FG005|Period 1, 8 Hours|Personal Reasons|0|||
161151536|NCT02678741|581937037|FG000|Overall Study|Death|4|||
161151537|NCT02678741|581937037|FG000|Overall Study|Withdrawal by Subject|1|||
161151538|NCT02678741|581937037|FG000|Overall Study|ineligible|3|||
161151539|NCT02678741|581937037|FG000|Overall Study|Not RECIST Measurable|2|||
161151540|NCT02678741|581937037|FG000|Overall Study|Lack of Efficacy|10|||
161151541|NCT01795898|581937038|FG000|Overall Study|Adverse Event|27|||
161151542|NCT01795898|581937038|FG000|Overall Study|Lost to Follow-up|20|||
161151543|NCT01795898|581937038|FG000|Overall Study|Withdrawal of consent|6|||
161151544|NCT01795898|581937038|FG000|Overall Study|Diagnosed with metastasis|1|||
161151545|NCT01795898|581937038|FG000|Overall Study|No pain|1|||
161151546|NCT01795898|581937038|FG000|Overall Study|Death|1|||
161151547|NCT01795898|581937038|FG000|Overall Study|Withdrew consent & had adverse events|3|||
161151548|NCT01795898|581937038|FG000|Overall Study|Physician Decision|1|||
161151549|NCT02531373|581937049|FG000|Overall Study|Lack of Efficacy|0|||
161151550|NCT02531373|581937050|FG001|Overall Study|Lack of Efficacy|0|||
161151551|NCT02531373|581937051|FG002|Overall Study|Lack of Efficacy|0|||
161151552|NCT02531373|581937052|FG003|Overall Study|Lack of Efficacy|0|||
161281154|NCT02514447|582408623|FG001|Overall Study|Withdrawal by Subject|1|||
161281155|NCT02514447|582408624|FG002|Overall Study|Withdrawal by Subject|1|||
161281156|NCT02514447|582408625|FG003|Overall Study|Withdrawal by Subject|0|||
161281157|NCT02514447|582408626|FG004|Overall Study|Withdrawal by Subject|0|||
161281158|NCT02514447|582408627|FG005|Overall Study|Withdrawal by Subject|0|||
161281159|NCT02514447|582408628|FG006|Overall Study|Withdrawal by Subject|0|||
161345103|NCT03126110|582648860|FG011|Phase 2|Started new treatment|0|||
161054774|NCT02938520|581588653|FG001|Overall Study|On-going at the time of analysis|261|||
161054775|NCT02938520|581588652|FG000|Overall Study|Physician Decision|2|||
161054776|NCT02938520|581588653|FG001|Overall Study|Physician Decision|5|||
161054777|NCT02938520|581588652|FG000|Overall Study|Lost to Follow-up|2|||
161054778|NCT02938520|581588653|FG001|Overall Study|Lost to Follow-up|2|||
161054779|NCT02938520|581588652|FG000|Overall Study|Withdrawal by Subject|7|||
161054780|NCT02938520|581588653|FG001|Overall Study|Withdrawal by Subject|7|||
161054781|NCT02938520|581588652|FG000|Overall Study|Protocol Violation|0|||
161054782|NCT02938520|581588653|FG001|Overall Study|Protocol Violation|1|||
161054783|NCT02938520|581588652|FG000|Overall Study|Lack of Efficacy|5|||
161054784|NCT02938520|581588653|FG001|Overall Study|Lack of Efficacy|3|||
161054785|NCT02938520|581588652|FG000|Overall Study|Adverse Event|9|||
161054786|NCT02938520|581588653|FG001|Overall Study|Adverse Event|4|||
161054787|NCT00635570|581590207|FG000|Overall Study|Lost to Follow-up|8|||
161054788|NCT00635570|581590208|FG001|Overall Study|Lost to Follow-up|8|||
161054789|NCT00635570|581590207|FG000|Overall Study|Withdrawal by Subject|1|||
161054790|NCT00635570|581590208|FG001|Overall Study|Withdrawal by Subject|1|||
161054791|NCT00635570|581590207|FG000|Overall Study|Adverse Event|2|||
161054792|NCT00635570|581590208|FG001|Overall Study|Adverse Event|0|||
161054793|NCT00635570|581590207|FG000|Overall Study|Physician Decision|1|||
161054794|NCT00635570|581590208|FG001|Overall Study|Physician Decision|0|||
161054795|NCT00635570|581590207|FG000|Overall Study|Did not complete survey|2|||
161054796|NCT00635570|581590208|FG001|Overall Study|Did not complete survey|1|||
161054797|NCT00635570|581590207|FG000|Overall Study|Early termination(No sexual activity)|1|||
161054798|NCT00635570|581590208|FG001|Overall Study|Early termination(No sexual activity)|1|||
161054799|NCT04816708|581590209|FG000|Overall Study|Lost to Follow-up|10|||
161054800|NCT04816708|581590210|FG001|Overall Study|Lost to Follow-up|4|||
161054801|NCT02255435|581590211|FG000|Overall Study|Patient's Limited Time Availability|0|||
161054802|NCT02255435|581590212|FG001|Overall Study|Patient's Limited Time Availability|0|||
161054803|NCT02255435|581590213|FG002|Overall Study|Patient's Limited Time Availability|0|||
161054804|NCT02255435|581590214|FG003|Overall Study|Patient's Limited Time Availability|0|||
161054805|NCT02255435|581590215|FG004|Overall Study|Patient's Limited Time Availability|0|||
161054806|NCT02255435|581590216|FG005|Overall Study|Patient's Limited Time Availability|0|||
161054807|NCT02255435|581590217|FG006|Overall Study|Patient's Limited Time Availability|0|||
161054808|NCT02255435|581590218|FG007|Overall Study|Patient's Limited Time Availability|1|||
161054809|NCT02255435|581590219|FG008|Overall Study|Patient's Limited Time Availability|0|||
161151553|NCT02531373|581937053|FG004|Overall Study|Lack of Efficacy|3|||
161151554|NCT02531373|581937054|FG005|Overall Study|Lack of Efficacy|2|||
161151555|NCT02531373|581937055|FG006|Overall Study|Lack of Efficacy|4|||
161151556|NCT02531373|581937056|FG007|Overall Study|Lack of Efficacy|8|||
161281160|NCT02514447|582408629|FG007|Overall Study|Withdrawal by Subject|1|||
161281161|NCT02514447|582408630|FG008|Overall Study|Withdrawal by Subject|1|||
161281162|NCT02514447|582408622|FG000|Overall Study|Death|24|||
161054810|NCT02255435|581590220|FG009|Overall Study|Patient's Limited Time Availability|0|||
161151557|NCT02531373|581937057|FG008|Overall Study|Lack of Efficacy|5|||
161054811|NCT02255435|581590211|FG000|Overall Study|Withdrawal by Subject|0|||
161054812|NCT02255435|581590212|FG001|Overall Study|Withdrawal by Subject|0|||
161151558|NCT02531373|581937049|FG000|Overall Study|Lost to Follow-up|0|||
161151559|NCT02531373|581937050|FG001|Overall Study|Lost to Follow-up|0|||
161345104|NCT03126110|582648861|FG012|Phase 2|Started new treatment|0|||
161151560|NCT02531373|581937051|FG002|Overall Study|Lost to Follow-up|0|||
161151561|NCT02531373|581937052|FG003|Overall Study|Lost to Follow-up|0|||
161151562|NCT02531373|581937053|FG004|Overall Study|Lost to Follow-up|0|||
161151563|NCT02531373|581937054|FG005|Overall Study|Lost to Follow-up|2|||
161151564|NCT02531373|581937055|FG006|Overall Study|Lost to Follow-up|2|||
161151565|NCT02531373|581937056|FG007|Overall Study|Lost to Follow-up|0|||
161151566|NCT02531373|581937057|FG008|Overall Study|Lost to Follow-up|0|||
161151567|NCT02531373|581937049|FG000|Overall Study|Physician Decision|0|||
161151568|NCT02531373|581937050|FG001|Overall Study|Physician Decision|0|||
161151569|NCT02531373|581937051|FG002|Overall Study|Physician Decision|0|||
161151570|NCT02531373|581937052|FG003|Overall Study|Physician Decision|0|||
161151571|NCT02531373|581937053|FG004|Overall Study|Physician Decision|2|||
161151572|NCT02531373|581937054|FG005|Overall Study|Physician Decision|1|||
161151573|NCT02531373|581937055|FG006|Overall Study|Physician Decision|0|||
161151574|NCT02531373|581937056|FG007|Overall Study|Physician Decision|0|||
161151575|NCT02531373|581937057|FG008|Overall Study|Physician Decision|0|||
161151576|NCT02531373|581937049|FG000|Overall Study|Protocol Violation|0|||
161151577|NCT02531373|581937050|FG001|Overall Study|Protocol Violation|0|||
161151578|NCT02531373|581937051|FG002|Overall Study|Protocol Violation|0|||
161151579|NCT02531373|581937052|FG003|Overall Study|Protocol Violation|0|||
161151580|NCT02531373|581937053|FG004|Overall Study|Protocol Violation|0|||
161151581|NCT02531373|581937054|FG005|Overall Study|Protocol Violation|1|||
161151582|NCT02531373|581937055|FG006|Overall Study|Protocol Violation|1|||
161151583|NCT02531373|581937056|FG007|Overall Study|Protocol Violation|0|||
161151584|NCT02531373|581937057|FG008|Overall Study|Protocol Violation|1|||
161151585|NCT02531373|581937049|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161151586|NCT02531373|581937050|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161151587|NCT02531373|581937051|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161151588|NCT02531373|581937052|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161151589|NCT02531373|581937053|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161151590|NCT02531373|581937054|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
161151591|NCT02531373|581937055|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
161151592|NCT02531373|581937056|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
161151593|NCT02531373|581937057|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
161151594|NCT02531373|581937049|FG000|Overall Study|Withdrawal by Subject|0|||
161151595|NCT02531373|581937050|FG001|Overall Study|Withdrawal by Subject|0|||
161151596|NCT02531373|581937051|FG002|Overall Study|Withdrawal by Subject|0|||
161151597|NCT02531373|581937052|FG003|Overall Study|Withdrawal by Subject|0|||
161151598|NCT02531373|581937053|FG004|Overall Study|Withdrawal by Subject|3|||
161151599|NCT02531373|581937054|FG005|Overall Study|Withdrawal by Subject|0|||
161151600|NCT02531373|581937055|FG006|Overall Study|Withdrawal by Subject|0|||
161151601|NCT02531373|581937056|FG007|Overall Study|Withdrawal by Subject|0|||
161151602|NCT02531373|581937057|FG008|Overall Study|Withdrawal by Subject|0|||
161151603|NCT01675531|581937058|FG000|Overall Study|Adverse Event|9|||
161151604|NCT01675531|581937058|FG000|Overall Study|Withdrawal by Subject|7|||
161151605|NCT01675531|581937058|FG000|Overall Study|Lack of Efficacy|1|||
161151606|NCT01675531|581937058|FG000|Overall Study|Protocol Violation|8|||
161151607|NCT01623531|581937059|FG000|Overall Study|Death|1|||
161151608|NCT01623531|581937060|FG001|Overall Study|Death|0|||
161151609|NCT01623531|581937059|FG000|Overall Study|Protocol Violation|2|||
161151610|NCT01623531|581937060|FG001|Overall Study|Protocol Violation|1|||
161151611|NCT01623531|581937059|FG000|Overall Study|Missing data at primary outcome time poi|1|||
161151612|NCT01623531|581937060|FG001|Overall Study|Missing data at primary outcome time poi|1|||
161151613|NCT02834403|581937065|FG000|Overall Study|Physician Decision|2|||
161281163|NCT02514447|582408623|FG001|Overall Study|Death|28|||
161281164|NCT02514447|582408624|FG002|Overall Study|Death|29|||
161281165|NCT02514447|582408625|FG003|Overall Study|Death|0|||
161281166|NCT02514447|582408626|FG004|Overall Study|Death|3|||
161151614|NCT02834403|581937066|FG001|Overall Study|Physician Decision|1|||
161281167|NCT02514447|582408627|FG005|Overall Study|Death|4|||
161281168|NCT02514447|582408628|FG006|Overall Study|Death|8|||
161281169|NCT02514447|582408629|FG007|Overall Study|Death|6|||
161281170|NCT02514447|582408630|FG008|Overall Study|Death|5|||
161281171|NCT02514447|582408622|FG000|Overall Study|Lost to Follow-up|1|||
161281172|NCT02514447|582408623|FG001|Overall Study|Lost to Follow-up|0|||
161281173|NCT02514447|582408624|FG002|Overall Study|Lost to Follow-up|0|||
161281174|NCT02514447|582408625|FG003|Overall Study|Lost to Follow-up|0|||
161281175|NCT02514447|582408626|FG004|Overall Study|Lost to Follow-up|0|||
161281176|NCT02514447|582408627|FG005|Overall Study|Lost to Follow-up|0|||
161281177|NCT02514447|582408628|FG006|Overall Study|Lost to Follow-up|0|||
161281178|NCT02514447|582408629|FG007|Overall Study|Lost to Follow-up|0|||
161281179|NCT02514447|582408630|FG008|Overall Study|Lost to Follow-up|1|||
161281180|NCT02514447|582408622|FG000|Overall Study|Sponsor Termination of Study|0|||
161281181|NCT02514447|582408623|FG001|Overall Study|Sponsor Termination of Study|1|||
161281182|NCT02514447|582408624|FG002|Overall Study|Sponsor Termination of Study|1|||
161281183|NCT02514447|582408625|FG003|Overall Study|Sponsor Termination of Study|0|||
161281184|NCT02514447|582408626|FG004|Overall Study|Sponsor Termination of Study|0|||
161281185|NCT02514447|582408627|FG005|Overall Study|Sponsor Termination of Study|0|||
161054813|NCT02255435|581590213|FG002|Overall Study|Withdrawal by Subject|0|||
161054814|NCT02255435|581590214|FG003|Overall Study|Withdrawal by Subject|0|||
161054815|NCT02255435|581590215|FG004|Overall Study|Withdrawal by Subject|0|||
161054816|NCT02255435|581590216|FG005|Overall Study|Withdrawal by Subject|0|||
161054817|NCT02255435|581590217|FG006|Overall Study|Withdrawal by Subject|0|||
161054818|NCT02255435|581590218|FG007|Overall Study|Withdrawal by Subject|0|||
161054819|NCT02255435|581590219|FG008|Overall Study|Withdrawal by Subject|1|||
161054820|NCT02255435|581590220|FG009|Overall Study|Withdrawal by Subject|4|||
161054821|NCT02255435|581590211|FG000|Overall Study|Administrative reasons|0|||
161054822|NCT02255435|581590212|FG001|Overall Study|Administrative reasons|0|||
161054823|NCT02255435|581590213|FG002|Overall Study|Administrative reasons|0|||
161054824|NCT02255435|581590214|FG003|Overall Study|Administrative reasons|0|||
161054825|NCT02255435|581590215|FG004|Overall Study|Administrative reasons|0|||
161054826|NCT02255435|581590216|FG005|Overall Study|Administrative reasons|0|||
161054827|NCT02255435|581590217|FG006|Overall Study|Administrative reasons|0|||
161054828|NCT02255435|581590218|FG007|Overall Study|Administrative reasons|0|||
161054829|NCT02255435|581590219|FG008|Overall Study|Administrative reasons|0|||
161054830|NCT02255435|581590220|FG009|Overall Study|Administrative reasons|2|||
161054831|NCT03596905|581590221|FG000|Overall Study|Protocol Violation|0|||
161054832|NCT03596905|581590222|FG001|Overall Study|Protocol Violation|0|||
161054833|NCT03596905|581590223|FG002|Overall Study|Protocol Violation|0|||
161054834|NCT03596905|581590224|FG003|Overall Study|Protocol Violation|0|||
161054835|NCT03596905|581590225|FG004|Overall Study|Protocol Violation|1|||
161054836|NCT03596905|581590226|FG005|Overall Study|Protocol Violation|0|||
161054837|NCT03596905|581590227|FG006|Overall Study|Protocol Violation|0|||
161054838|NCT03596905|581590221|FG000|Overall Study|Withdrawal by Subject|0|||
161054839|NCT03596905|581590222|FG001|Overall Study|Withdrawal by Subject|2|||
161054840|NCT03596905|581590223|FG002|Overall Study|Withdrawal by Subject|1|||
161054841|NCT03596905|581590224|FG003|Overall Study|Withdrawal by Subject|0|||
161054842|NCT03596905|581590225|FG004|Overall Study|Withdrawal by Subject|2|||
161054843|NCT03596905|581590226|FG005|Overall Study|Withdrawal by Subject|0|||
161054844|NCT03596905|581590227|FG006|Overall Study|Withdrawal by Subject|0|||
161054845|NCT03596905|581590221|FG000|Overall Study|Participant moved and was unable to complete study|0|||
161054846|NCT03596905|581590222|FG001|Overall Study|Participant moved and was unable to complete study|1|||
161054847|NCT03596905|581590223|FG002|Overall Study|Participant moved and was unable to complete study|0|||
161054848|NCT03596905|581590224|FG003|Overall Study|Participant moved and was unable to complete study|0|||
161054849|NCT03596905|581590225|FG004|Overall Study|Participant moved and was unable to complete study|0|||
161054850|NCT03596905|581590226|FG005|Overall Study|Participant moved and was unable to complete study|0|||
161054851|NCT03596905|581590227|FG006|Overall Study|Participant moved and was unable to complete study|0|||
161054852|NCT03596905|581590221|FG000|Overall Study|Adverse Event|0|||
161054853|NCT03596905|581590222|FG001|Overall Study|Adverse Event|0|||
161054854|NCT03596905|581590223|FG002|Overall Study|Adverse Event|0|||
161054855|NCT03596905|581590224|FG003|Overall Study|Adverse Event|0|||
161054856|NCT03596905|581590225|FG004|Overall Study|Adverse Event|0|||
161054857|NCT03596905|581590226|FG005|Overall Study|Adverse Event|0|||
161054858|NCT03596905|581590227|FG006|Overall Study|Adverse Event|1|||
161054859|NCT03596905|581590221|FG000|Overall Study|Non-Compliance with eDiary|1|||
161054860|NCT03596905|581590222|FG001|Overall Study|Non-Compliance with eDiary|0|||
161054861|NCT03596905|581590223|FG002|Overall Study|Non-Compliance with eDiary|0|||
161054862|NCT03596905|581590224|FG003|Overall Study|Non-Compliance with eDiary|0|||
161054863|NCT03596905|581590225|FG004|Overall Study|Non-Compliance with eDiary|1|||
161054864|NCT03596905|581590226|FG005|Overall Study|Non-Compliance with eDiary|0|||
161054865|NCT03596905|581590227|FG006|Overall Study|Non-Compliance with eDiary|2|||
161054866|NCT03596905|581590221|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161054867|NCT03596905|581590222|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161054868|NCT03596905|581590223|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161054869|NCT03596905|581590224|FG003|Overall Study|Non-Compliance with Study Drug|0|||
161054870|NCT03596905|581590225|FG004|Overall Study|Non-Compliance with Study Drug|1|||
161054871|NCT03596905|581590226|FG005|Overall Study|Non-Compliance with Study Drug|0|||
161054872|NCT03596905|581590227|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161054873|NCT03596905|581590221|FG000|Overall Study|Lost to Follow-up|0|||
161054874|NCT03596905|581590222|FG001|Overall Study|Lost to Follow-up|0|||
161054875|NCT03596905|581590223|FG002|Overall Study|Lost to Follow-up|0|||
161054876|NCT03596905|581590224|FG003|Overall Study|Lost to Follow-up|0|||
161054877|NCT03596905|581590225|FG004|Overall Study|Lost to Follow-up|0|||
161054878|NCT03596905|581590226|FG005|Overall Study|Lost to Follow-up|1|||
161054879|NCT03596905|581590227|FG006|Overall Study|Lost to Follow-up|0|||
161054880|NCT04307134|581590228|FG000|Overall Study|Lost to Follow-up|2|||
161054881|NCT04307134|581590228|FG000|Overall Study|Withdrawal by Subject|3|||
161054882|NCT04307134|581590228|FG000|Overall Study|Other|3|||
161054883|NCT04307134|581590228|FG000|Overall Study|Death|21|||
161054884|NCT04307134|581590228|FG000|Overall Study|Enrolled but not Treated|1|||
161054885|NCT01809691|581590229|FG000|Overall Study|Currently on Treatment|192|||
161054886|NCT01809691|581590230|FG001|Overall Study|Currently on Treatment|100|||
161054887|NCT01809691|581590229|FG000|Overall Study|No Protocol Treatment|10|||
161054888|NCT01809691|581590230|FG001|Overall Study|No Protocol Treatment|11|||
161054889|NCT01809691|581590229|FG000|Overall Study|Adverse Event|80|||
161054890|NCT01809691|581590230|FG001|Overall Study|Adverse Event|21|||
161054891|NCT01809691|581590229|FG000|Overall Study|Disease Progression|226|||
161054892|NCT01809691|581590230|FG001|Overall Study|Disease Progression|372|||
161054893|NCT01809691|581590229|FG000|Overall Study|Death|26|||
161054894|NCT01809691|581590230|FG001|Overall Study|Death|13|||
161054895|NCT01809691|581590229|FG000|Overall Study|Participant Refusal|70|||
161054896|NCT01809691|581590230|FG001|Overall Study|Participant Refusal|72|||
161054897|NCT01809691|581590229|FG000|Overall Study|Other, Not Specified|34|||
161054898|NCT01809691|581590230|FG001|Overall Study|Other, Not Specified|52|||
161054899|NCT00907517|581590233|FG000|Overall Study|Progressive Disease|3|||
161054900|NCT00907517|581590234|FG001|Overall Study|Progressive Disease|3|||
161054901|NCT00907517|581590235|FG002|Overall Study|Progressive Disease|4|||
161054902|NCT00907517|581590236|FG003|Overall Study|Progressive Disease|4|||
161054903|NCT00907517|581590237|FG004|Overall Study|Progressive Disease|4|||
161054904|NCT00907517|581590233|FG000|Overall Study|Symptomatic Deterioration|0|||
161054905|NCT00907517|581590234|FG001|Overall Study|Symptomatic Deterioration|0|||
161054906|NCT00907517|581590235|FG002|Overall Study|Symptomatic Deterioration|0|||
161054907|NCT00907517|581590236|FG003|Overall Study|Symptomatic Deterioration|0|||
161054908|NCT00907517|581590237|FG004|Overall Study|Symptomatic Deterioration|1|||
161054909|NCT01732627|581590238|FG000|Overall Study|Withdrawal by Subject|1|||
161054910|NCT01732627|581590239|FG001|Overall Study|Withdrawal by Subject|0|||
161054911|NCT03541200|581590243|FG000|Overall Study|Adverse Event|19|||
161054912|NCT03541200|581590243|FG000|Overall Study|Death|1|||
161054913|NCT03541200|581590243|FG000|Overall Study|Lost to Follow-up|10|||
161054914|NCT03541200|581590243|FG000|Overall Study|Physician Decision|1|||
161054915|NCT03541200|581590243|FG000|Overall Study|Protocol Violation|51|||
161054916|NCT03541200|581590243|FG000|Overall Study|Withdrawal by Subject|23|||
161054917|NCT03541200|581590243|FG000|Overall Study|other|8|||
161054918|NCT02522299|581590244|FG000|Overall Study|Adverse Event|2|||
161054919|NCT02522299|581590245|FG001|Overall Study|Adverse Event|0|||
161054920|NCT02522299|581590244|FG000|Overall Study|Physician Decision|0|||
161054921|NCT02522299|581590245|FG001|Overall Study|Physician Decision|1|||
161054922|NCT02522299|581590244|FG000|Overall Study|Withdrawal by Subject|2|||
161054923|NCT02522299|581590245|FG001|Overall Study|Withdrawal by Subject|0|||
161054924|NCT02097056|581590246|FG000|Overall Study|Protocol Violation|2|||
161054925|NCT02097056|581590246|FG000|Overall Study|Withdrawal by Subject|15|||
161054926|NCT02097056|581590246|FG000|Overall Study|Lost to Follow-up|2|||
161054927|NCT02097056|581590246|FG000|Overall Study|Adverse Event|37|||
161054928|NCT02097056|581590246|FG000|Overall Study|Other|2|||
161054929|NCT01446042|581590249|FG000|Overall Study|Withdrawal by Subject|12|||
161054930|NCT01446042|581590250|FG001|Overall Study|Withdrawal by Subject|2|||
161054931|NCT01446042|581590251|FG002|Overall Study|Withdrawal by Subject|4|||
161054932|NCT01446042|581590249|FG000|Overall Study|Adverse Event|1|||
161054933|NCT01446042|581590250|FG001|Overall Study|Adverse Event|0|||
161054934|NCT01446042|581590251|FG002|Overall Study|Adverse Event|4|||
161054935|NCT01446042|581590249|FG000|Overall Study|Lost to Follow-up|5|||
161054936|NCT01446042|581590250|FG001|Overall Study|Lost to Follow-up|0|||
161054937|NCT01446042|581590251|FG002|Overall Study|Lost to Follow-up|0|||
161054938|NCT01446042|581590249|FG000|Overall Study|Other reasons|2|||
161054939|NCT01446042|581590250|FG001|Overall Study|Other reasons|1|||
161054940|NCT01446042|581590251|FG002|Overall Study|Other reasons|1|||
161054941|NCT05714345|581590258|FG000|Overall Study|Death|1|||
161054942|NCT05714345|581590259|FG001|Overall Study|Death|1|||
161054943|NCT01257698|581590268|FG000|Overall Study|Protocol Violation|4|||
161054944|NCT01257698|581590269|FG001|Overall Study|Protocol Violation|0|||
161054945|NCT00274846|581590275|FG000|Overall Study|Did not receive adequate NK cells|1|||
161151615|NCT02834403|581937067|FG002|Overall Study|Physician Decision|2|||
161151616|NCT02834403|581937068|FG003|Overall Study|Physician Decision|1|||
161151617|NCT02834403|581937069|FG004|Overall Study|Physician Decision|1|||
161054946|NCT01190228|581590276|FG000|Overall Study|Protocol Violation|4|||
161054947|NCT01190228|581590277|FG001|Overall Study|Protocol Violation|0|||
161151618|NCT02834403|581937070|FG005|Overall Study|Physician Decision|2|||
161151619|NCT02834403|581937071|FG006|Overall Study|Physician Decision|12|||
161281186|NCT02514447|582408628|FG006|Overall Study|Sponsor Termination of Study|0|||
161281187|NCT02514447|582408629|FG007|Overall Study|Sponsor Termination of Study|0|||
161054948|NCT01190228|581590278|FG002|Overall Study|Protocol Violation|0|||
161054949|NCT01190228|581590276|FG000|Overall Study|Withdrawal by Subject|1|||
161054950|NCT01190228|581590277|FG001|Overall Study|Withdrawal by Subject|0|||
161281188|NCT02514447|582408630|FG008|Overall Study|Sponsor Termination of Study|0|||
161345105|NCT03126110|582648862|FG013|Phase 2|Started new treatment|0|||
161054951|NCT01190228|581590278|FG002|Overall Study|Withdrawal by Subject|0|||
161054952|NCT01395914|581590284|FG000|Overall Study|Unrelated to study drug AE|6|||
161054953|NCT01395914|581590285|FG001|Overall Study|Unrelated to study drug AE|1|||
161054954|NCT01395914|581590284|FG000|Overall Study|Death|23|||
161054955|NCT01395914|581590285|FG001|Overall Study|Death|17|||
161054956|NCT01395914|581590284|FG000|Overall Study|Other|9|||
161054957|NCT01395914|581590285|FG001|Overall Study|Other|3|||
161151620|NCT02834403|581937065|FG000|Overall Study|Adverse Event|0|||
161151621|NCT02834403|581937066|FG001|Overall Study|Adverse Event|0|||
161151622|NCT02834403|581937067|FG002|Overall Study|Adverse Event|0|||
161151623|NCT02834403|581937068|FG003|Overall Study|Adverse Event|0|||
161151624|NCT02834403|581937069|FG004|Overall Study|Adverse Event|1|||
161151625|NCT02834403|581937070|FG005|Overall Study|Adverse Event|1|||
161151626|NCT02834403|581937071|FG006|Overall Study|Adverse Event|3|||
161151627|NCT02834403|581937065|FG000|Overall Study|Withdrawal by Subject|0|||
161151628|NCT02834403|581937066|FG001|Overall Study|Withdrawal by Subject|1|||
161151629|NCT02834403|581937067|FG002|Overall Study|Withdrawal by Subject|0|||
161151630|NCT02834403|581937068|FG003|Overall Study|Withdrawal by Subject|0|||
161151631|NCT02834403|581937069|FG004|Overall Study|Withdrawal by Subject|1|||
161151632|NCT02834403|581937070|FG005|Overall Study|Withdrawal by Subject|0|||
161151633|NCT02834403|581937071|FG006|Overall Study|Withdrawal by Subject|0|||
161054958|NCT01395914|581590284|FG000|Overall Study|Withdrawal by patient|27|||
161054959|NCT01395914|581590285|FG001|Overall Study|Withdrawal by patient|14|||
161054960|NCT01395914|581590284|FG000|Overall Study|Study drug-related AE|1|||
161054961|NCT01395914|581590285|FG001|Overall Study|Study drug-related AE|0|||
161054962|NCT01395914|581590284|FG000|Overall Study|Lost to Follow-up|6|||
161054963|NCT01395914|581590285|FG001|Overall Study|Lost to Follow-up|2|||
161054964|NCT04601857|581590286|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
161054965|NCT04601857|581590287|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
161054966|NCT04601857|581590286|FG000|Overall Study|Disease Progression|2|||
161054967|NCT04601857|581590287|FG001|Overall Study|Disease Progression|4|||
161054968|NCT04601857|581590286|FG000|Overall Study|Clinical Disease Progression|2|||
161054969|NCT04601857|581590287|FG001|Overall Study|Clinical Disease Progression|1|||
161054970|NCT04601857|581590286|FG000|Overall Study|Radiological Progression|4|||
161054971|NCT04601857|581590287|FG001|Overall Study|Radiological Progression|11|||
161054972|NCT04601857|581590286|FG000|Overall Study|Death|1|||
161054973|NCT04601857|581590287|FG001|Overall Study|Death|0|||
161054974|NCT04601857|581590286|FG000|Overall Study|Reason Not Specified|0|||
161054975|NCT04601857|581590287|FG001|Overall Study|Reason Not Specified|1|||
161054976|NCT04601857|581590286|FG000|Overall Study|At the Participant's Request|0|||
161054977|NCT04601857|581590287|FG001|Overall Study|At the Participant's Request|1|||
161054978|NCT00980954|581590288|FG000|Overall Study|Protocol Violation|9|||
161054979|NCT00980954|581590289|FG001|Overall Study|Protocol Violation|15|||
161054980|NCT04115319|581590290|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
161054981|NCT04115319|581590291|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
161054982|NCT04115319|581590290|FG000|Overall Study|Withdrawal by participant|17|||
161054983|NCT04115319|581590291|FG001|Overall Study|Withdrawal by participant|9|||
161054984|NCT04115319|581590290|FG000|Overall Study|Geopolitical Conflict Related|2|||
161054985|NCT04115319|581590291|FG001|Overall Study|Geopolitical Conflict Related|1|||
161054986|NCT04115319|581590290|FG000|Overall Study|COVID-19 Related|1|||
161054987|NCT04115319|581590291|FG001|Overall Study|COVID-19 Related|0|||
161054988|NCT04115319|581590290|FG000|Overall Study|Adverse Event|48|||
161054989|NCT04115319|581590291|FG001|Overall Study|Adverse Event|21|||
161054990|NCT04115319|581590290|FG000|Overall Study|Noncompliance with Study Drug|5|||
161054991|NCT04115319|581590291|FG001|Overall Study|Noncompliance with Study Drug|1|||
161054992|NCT04115319|581590290|FG000|Overall Study|Lack of Efficacy|6|||
161054993|NCT04115319|581590291|FG001|Overall Study|Lack of Efficacy|2|||
161054994|NCT04115319|581590290|FG000|Overall Study|Lost to Follow-up|6|||
161054995|NCT04115319|581590291|FG001|Overall Study|Lost to Follow-up|7|||
161054996|NCT04115319|581590290|FG000|Overall Study|Protocol Deviation|5|||
161054997|NCT04115319|581590291|FG001|Overall Study|Protocol Deviation|1|||
161054998|NCT04115319|581590290|FG000|Overall Study|Participant relocated|5|||
161054999|NCT04115319|581590291|FG001|Overall Study|Participant relocated|2|||
161055000|NCT04115319|581590290|FG000|Overall Study|Personal Reasons|0|||
161055001|NCT04115319|581590291|FG001|Overall Study|Personal Reasons|1|||
161055002|NCT04115319|581590290|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
161055003|NCT04115319|581590291|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
161055004|NCT02256488|581590297|FG000|Overall Study|Lost to Follow-up|6|||
161055005|NCT02256488|581590298|FG001|Overall Study|Lost to Follow-up|6|||
161055006|NCT02256488|581590299|FG002|Overall Study|Lost to Follow-up|9|||
161055007|NCT02256488|581590300|FG003|Overall Study|Lost to Follow-up|3|||
161055008|NCT02256488|581590297|FG000|Overall Study|OTHER|1|||
161055009|NCT02256488|581590298|FG001|Overall Study|OTHER|0|||
161055010|NCT02256488|581590299|FG002|Overall Study|OTHER|1|||
161055011|NCT02256488|581590300|FG003|Overall Study|OTHER|1|||
161055012|NCT02256488|581590297|FG000|Overall Study|Withdrawal by Subject|1|||
161055013|NCT02256488|581590298|FG001|Overall Study|Withdrawal by Subject|0|||
161055014|NCT02256488|581590299|FG002|Overall Study|Withdrawal by Subject|0|||
161055015|NCT02256488|581590300|FG003|Overall Study|Withdrawal by Subject|2|||
161055016|NCT04930445|581590301|FG000|Overall Study|Adverse Event|7|||
161055017|NCT04930445|581590301|FG000|Overall Study|Lost to Follow-up|1|||
161055018|NCT04930445|581590301|FG000|Overall Study|Physician Decision|1|||
161055019|NCT04930445|581590301|FG000|Overall Study|Lack of Efficacy|1|||
161055020|NCT04930445|581590301|FG000|Overall Study|Study Terminated by Sponsor|245|||
161055021|NCT04930445|581590301|FG000|Overall Study|Screen Failure|8|||
161055022|NCT04930445|581590301|FG000|Overall Study|Other|2|||
161055023|NCT00975130|581590302|FG000|Study Part 1|Adverse Event|150|||
161055024|NCT00975130|581590303|FG001|Study Part 1|Adverse Event|0|||
161055025|NCT00975130|581590304|FG002|Study Part 1|Adverse Event|0|||
161055026|NCT00975130|581590302|FG000|Study Part 1|Lost to Follow-up|19|||
161055027|NCT00975130|581590303|FG001|Study Part 1|Lost to Follow-up|0|||
161055028|NCT00975130|581590304|FG002|Study Part 1|Lost to Follow-up|0|||
161055029|NCT00975130|581590302|FG000|Study Part 1|Withdrawal by Subject|61|||
161055030|NCT00975130|581590303|FG001|Study Part 1|Withdrawal by Subject|0|||
161055031|NCT00975130|581590304|FG002|Study Part 1|Withdrawal by Subject|0|||
161055032|NCT00975130|581590302|FG000|Study Part 1|Protocol Violation|13|||
161055033|NCT00975130|581590303|FG001|Study Part 1|Protocol Violation|0|||
161055034|NCT00975130|581590304|FG002|Study Part 1|Protocol Violation|0|||
161055035|NCT00975130|581590302|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
161055036|NCT00975130|581590303|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
161055037|NCT00975130|581590304|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
161055038|NCT00975130|581590302|FG000|Study Part 1|Administrative|4|||
161055039|NCT00975130|581590303|FG001|Study Part 1|Administrative|0|||
161055040|NCT00975130|581590304|FG002|Study Part 1|Administrative|0|||
161055041|NCT00975130|581590302|FG000|Study Part 1|Withdrew Consent|24|||
161055042|NCT00975130|581590303|FG001|Study Part 1|Withdrew Consent|0|||
161055043|NCT00975130|581590304|FG002|Study Part 1|Withdrew Consent|0|||
161055044|NCT00975130|581590302|FG000|Study Part 2|Adverse Event|0|||
161055045|NCT00975130|581590303|FG001|Study Part 2|Adverse Event|14|||
161055046|NCT00975130|581590304|FG002|Study Part 2|Adverse Event|7|||
161055047|NCT00975130|581590302|FG000|Study Part 2|Lost to Follow-up|0|||
161055048|NCT00975130|581590303|FG001|Study Part 2|Lost to Follow-up|0|||
161055049|NCT00975130|581590304|FG002|Study Part 2|Lost to Follow-up|1|||
161055050|NCT00975130|581590302|FG000|Study Part 2|Withdrawal by Subject|0|||
161055051|NCT00975130|581590303|FG001|Study Part 2|Withdrawal by Subject|13|||
161055052|NCT00975130|581590304|FG002|Study Part 2|Withdrawal by Subject|5|||
161055053|NCT00975130|581590302|FG000|Study Part 2|Withdrew Consent|0|||
161055054|NCT00975130|581590303|FG001|Study Part 2|Withdrew Consent|6|||
161055055|NCT00975130|581590304|FG002|Study Part 2|Withdrew Consent|2|||
161055056|NCT00975130|581590302|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
161055057|NCT00975130|581590303|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
161055058|NCT00975130|581590304|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
161055059|NCT00975130|581590302|FG000|Study Part 2|Administrative|0|||
161055060|NCT00975130|581590303|FG001|Study Part 2|Administrative|1|||
161055061|NCT00975130|581590304|FG002|Study Part 2|Administrative|0|||
161055062|NCT00975130|581590302|FG000|Study Part 2|Protocol Violation|0|||
161055063|NCT00975130|581590303|FG001|Study Part 2|Protocol Violation|0|||
161055064|NCT00975130|581590304|FG002|Study Part 2|Protocol Violation|1|||
161055065|NCT01261793|581590305|FG000|Overall Study|Lack of Efficacy|44|||
161055066|NCT01261793|581590306|FG001|Overall Study|Lack of Efficacy|37|||
161055067|NCT01261793|581590307|FG002|Overall Study|Lack of Efficacy|32|||
161055068|NCT01261793|581590305|FG000|Overall Study|Protocol Violation|3|||
161055069|NCT01261793|581590306|FG001|Overall Study|Protocol Violation|5|||
161055070|NCT01261793|581590307|FG002|Overall Study|Protocol Violation|6|||
161055071|NCT01261793|581590305|FG000|Overall Study|Lost to Follow-up|10|||
161055072|NCT01261793|581590306|FG001|Overall Study|Lost to Follow-up|3|||
161055073|NCT01261793|581590307|FG002|Overall Study|Lost to Follow-up|7|||
161055074|NCT01261793|581590305|FG000|Overall Study|Withdrawal by Subject|12|||
161055075|NCT01261793|581590306|FG001|Overall Study|Withdrawal by Subject|14|||
161055076|NCT01261793|581590307|FG002|Overall Study|Withdrawal by Subject|14|||
161055077|NCT01261793|581590305|FG000|Overall Study|Death|3|||
161055078|NCT01261793|581590306|FG001|Overall Study|Death|1|||
161055079|NCT01261793|581590307|FG002|Overall Study|Death|0|||
161055080|NCT01261793|581590305|FG000|Overall Study|Adverse Event|9|||
161055081|NCT01261793|581590306|FG001|Overall Study|Adverse Event|24|||
161281189|NCT02514447|582408622|FG000|Overall Study|Study completion per Investigator|1|||
161055082|NCT01261793|581590307|FG002|Overall Study|Adverse Event|19|||
161055083|NCT01261793|581590305|FG000|Overall Study|Patient non-availability|1|||
161055084|NCT01261793|581590306|FG001|Overall Study|Patient non-availability|1|||
161055085|NCT01261793|581590307|FG002|Overall Study|Patient non-availability|1|||
161055086|NCT01261793|581590305|FG000|Overall Study|Suspected pregnancy|1|||
161055087|NCT01261793|581590306|FG001|Overall Study|Suspected pregnancy|1|||
161055088|NCT01261793|581590307|FG002|Overall Study|Suspected pregnancy|0|||
161055089|NCT01261793|581590305|FG000|Overall Study|Patient non-compliance|1|||
161055090|NCT01261793|581590306|FG001|Overall Study|Patient non-compliance|0|||
161055091|NCT01261793|581590307|FG002|Overall Study|Patient non-compliance|1|||
161055092|NCT01261793|581590305|FG000|Overall Study|Patient pregnant|1|||
161055093|NCT01261793|581590306|FG001|Overall Study|Patient pregnant|0|||
161055094|NCT01261793|581590307|FG002|Overall Study|Patient pregnant|0|||
161055095|NCT01261793|581590305|FG000|Overall Study|Outside the study area|0|||
161055096|NCT01261793|581590306|FG001|Overall Study|Outside the study area|2|||
161055097|NCT01261793|581590307|FG002|Overall Study|Outside the study area|1|||
161055098|NCT01261793|581590305|FG000|Overall Study|Lack of efficacy & patient not available|0|||
161055099|NCT01261793|581590306|FG001|Overall Study|Lack of efficacy & patient not available|1|||
161055100|NCT01261793|581590307|FG002|Overall Study|Lack of efficacy & patient not available|0|||
161055101|NCT01261793|581590305|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
161055102|NCT01261793|581590306|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
161055103|NCT01261793|581590307|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
161055104|NCT01261793|581590305|FG000|Overall Study|Randomization error|0|||
161055105|NCT01261793|581590306|FG001|Overall Study|Randomization error|1|||
161055106|NCT01261793|581590307|FG002|Overall Study|Randomization error|0|||
161055107|NCT01261793|581590305|FG000|Overall Study|Patient unable to start IV line|0|||
161055108|NCT01261793|581590306|FG001|Overall Study|Patient unable to start IV line|0|||
161055109|NCT01261793|581590307|FG002|Overall Study|Patient unable to start IV line|1|||
161055110|NCT03562117|581590308|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
161055111|NCT03562117|581590309|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
161055112|NCT03562117|581590310|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
161055113|NCT03928821|581590311|FG000|Overall Study|Death|0|||
161055114|NCT03928821|581590312|FG001|Overall Study|Death|1|||
161055115|NCT03928821|581590313|FG002|Overall Study|Death|0|||
161055116|NCT03928821|581590314|FG003|Overall Study|Death|0|||
161055117|NCT03928821|581590311|FG000|Overall Study|Lost to Follow-up|0|||
161055118|NCT03928821|581590312|FG001|Overall Study|Lost to Follow-up|2|||
161055119|NCT03928821|581590313|FG002|Overall Study|Lost to Follow-up|3|||
161055120|NCT03928821|581590314|FG003|Overall Study|Lost to Follow-up|0|||
161055121|NCT03928821|581590311|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161055122|NCT03928821|581590312|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161055123|NCT03928821|581590313|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
161055124|NCT03928821|581590314|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161055125|NCT04743999|581590315|FG000|3-month Questionnaire|Death|1|||
161055126|NCT04743999|581590315|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
161055127|NCT04743999|581590315|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
161055128|NCT04743999|581590315|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
161055129|NCT01721759|581590316|FG000|Treatment Period|Disease Progression|85|||
161055130|NCT01721759|581590316|FG000|Treatment Period|Study drug toxicity|14|||
161055131|NCT01721759|581590316|FG000|Treatment Period|Death|1|||
161055132|NCT01721759|581590316|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
161055133|NCT01721759|581590316|FG000|Treatment Period|Participant request to withdraw|3|||
161055134|NCT01721759|581590316|FG000|Treatment Period|Other Reasons|3|||
161055135|NCT01721759|581590316|FG000|End of Study Period|Participant Withdrew Consent|5|||
161055136|NCT01721759|581590316|FG000|End of Study Period|Death|101|||
161055137|NCT01721759|581590316|FG000|End of Study Period|Lost to Follow-up|1|||
161055138|NCT01721759|581590316|FG000|End of Study Period|Other Reasons|10|||
161055139|NCT01123200|581590317|FG000|Overall Study|Withdrawal by Subject|1|||
161055140|NCT02577315|581590320|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161055141|NCT02577315|581590321|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161055142|NCT01636778|581590322|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
161055143|NCT01636778|581590323|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
161055144|NCT01636778|581590324|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
161055145|NCT01636778|581590322|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
161055146|NCT01636778|581590323|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
161055147|NCT01636778|581590324|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
161055148|NCT01636778|581590322|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
161055149|NCT01636778|581590323|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
161055150|NCT01636778|581590324|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
161055151|NCT01636778|581590322|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
161055152|NCT01636778|581590323|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
161055153|NCT01636778|581590324|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
161055154|NCT01636778|581590322|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
161055155|NCT01636778|581590323|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
161055156|NCT01636778|581590324|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
161055157|NCT01636778|581590322|FG000|Follow-up Period After Part 2|Other|0|||
161055158|NCT01636778|581590323|FG001|Follow-up Period After Part 2|Other|0|||
161055159|NCT01636778|581590324|FG002|Follow-up Period After Part 2|Other|1|||
161055160|NCT01636778|581590322|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
161055161|NCT01636778|581590323|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
161055162|NCT01636778|581590324|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
161055163|NCT01636778|581590322|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
161055164|NCT01636778|581590323|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
161055165|NCT01636778|581590324|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
161281190|NCT02514447|582408623|FG001|Overall Study|Study completion per Investigator|0|||
161345106|NCT03126110|582648863|FG014|Phase 2|Started new treatment|1|||
161055166|NCT03530345|581590328|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
161055167|NCT03530345|581590329|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
161055168|NCT03530345|581590328|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
161055169|NCT03530345|581590329|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
161055170|NCT03530345|581590328|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
161055171|NCT03530345|581590329|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
161055172|NCT03530345|581590328|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
161055173|NCT03530345|581590329|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
161055174|NCT00170950|581590330|FG000|Overall Study|Death|236|||
161055175|NCT00170950|581590331|FG001|Overall Study|Death|274|||
161055176|NCT00170950|581590330|FG000|Overall Study|Withdrawal by Subject|496|||
161055177|NCT00170950|581590331|FG001|Overall Study|Withdrawal by Subject|498|||
161055178|NCT00170950|581590330|FG000|Overall Study|Lost to Follow-up|134|||
161055179|NCT00170950|581590331|FG001|Overall Study|Lost to Follow-up|115|||
161055180|NCT00170950|581590330|FG000|Overall Study|Missing|2|||
161055181|NCT00170950|581590331|FG001|Overall Study|Missing|1|||
161055182|NCT00170950|581590330|FG000|Overall Study|Termination Data Not Recorded|17|||
161055183|NCT00170950|581590331|FG001|Overall Study|Termination Data Not Recorded|22|||
161055184|NCT00748098|581590332|FG000|First Treatment Intervention Period|Adverse Event|1|||
161055185|NCT00748098|581590333|FG001|First Treatment Intervention Period|Adverse Event|1|||
161055186|NCT00748098|581590332|FG000|First Treatment Intervention Period|Protocol Violation|1|||
161055187|NCT00748098|581590333|FG001|First Treatment Intervention Period|Protocol Violation|0|||
161055188|NCT00748098|581590332|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
161055189|NCT00748098|581590333|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
161055190|NCT00748098|581590332|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
161055191|NCT00748098|581590333|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
161055192|NCT00748098|581590332|FG000|First Taper Period|Protocol Violation|1|||
161055193|NCT00748098|581590333|FG001|First Taper Period|Protocol Violation|0|||
161055194|NCT00748098|581590332|FG000|First Taper Period|Withdrawal by Subject|2|||
161055195|NCT00748098|581590333|FG001|First Taper Period|Withdrawal by Subject|0|||
161055196|NCT00748098|581590332|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
161055197|NCT00748098|581590333|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
161055198|NCT00748098|581590332|FG000|1-Week Washout Period|Adverse Event|0|||
161055199|NCT00748098|581590333|FG001|1-Week Washout Period|Adverse Event|1|||
161055200|NCT00748098|581590332|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
161055201|NCT00748098|581590333|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
161055202|NCT00748098|581590332|FG000|Second Treatment Intervention Period|Adverse Event|4|||
161055203|NCT00748098|581590333|FG001|Second Treatment Intervention Period|Adverse Event|1|||
161055204|NCT00748098|581590332|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
161055205|NCT00748098|581590333|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
161055206|NCT00748098|581590332|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
161055207|NCT00748098|581590333|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
161055208|NCT04448561|581590339|FG000|Overall Study|Noncompliance|1|||
161055209|NCT04448561|581590340|FG001|Overall Study|Noncompliance|0|||
161055210|NCT00197106|581591545|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
161055211|NCT00197106|581591546|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
161055212|NCT00197106|581591547|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
161055213|NCT00197106|581591545|FG000|Overall Treatment Period|Lack of Efficacy|0|||
161055214|NCT00197106|581591546|FG001|Overall Treatment Period|Lack of Efficacy|1|||
161055215|NCT00197106|581591547|FG002|Overall Treatment Period|Lack of Efficacy|0|||
161055216|NCT00197106|581591545|FG000|Overall Treatment Period|Lost to Follow-up|0|||
161055217|NCT00197106|581591546|FG001|Overall Treatment Period|Lost to Follow-up|0|||
161281191|NCT02514447|582408624|FG002|Overall Study|Study completion per Investigator|1|||
161281192|NCT02514447|582408625|FG003|Overall Study|Study completion per Investigator|2|||
161281193|NCT02514447|582408626|FG004|Overall Study|Study completion per Investigator|0|||
161281194|NCT02514447|582408627|FG005|Overall Study|Study completion per Investigator|0|||
161281195|NCT02514447|582408628|FG006|Overall Study|Study completion per Investigator|0|||
161281196|NCT02514447|582408629|FG007|Overall Study|Study completion per Investigator|0|||
161281197|NCT02514447|582408630|FG008|Overall Study|Study completion per Investigator|1|||
161281198|NCT01434810|582408638|FG000|Overall Study|Did not receive treatment|11|||
161281199|NCT01434810|582408639|FG001|Overall Study|Did not receive treatment|3|||
161281200|NCT01434810|582408638|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
161055218|NCT00197106|581591547|FG002|Overall Treatment Period|Lost to Follow-up|2|||
161055219|NCT00197106|581591545|FG000|Overall Treatment Period|Protocol Violation|0|||
161055220|NCT00197106|581591546|FG001|Overall Treatment Period|Protocol Violation|0|||
161055221|NCT00197106|581591547|FG002|Overall Treatment Period|Protocol Violation|2|||
161055222|NCT00197106|581591545|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
161055223|NCT00197106|581591546|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
161055224|NCT00197106|581591547|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
161055225|NCT02531126|581591548|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
161345107|NCT03126110|582648864|FG015|Phase 2|Started new treatment|0|||
161345108|NCT03126110|582648865|FG016|Phase 2|Started new treatment|0|||
161345109|NCT00314145|582648866|FG000|Overall Study|Withdrawal by Subject|8|||
161345110|NCT00314145|582648867|FG001|Overall Study|Withdrawal by Subject|10|||
161345111|NCT00314145|582648866|FG000|Overall Study|Lost to Follow-up|5|||
161345112|NCT00314145|582648867|FG001|Overall Study|Lost to Follow-up|12|||
161345113|NCT00314145|582648866|FG000|Overall Study|Physician Decision|3|||
161345114|NCT00314145|582648867|FG001|Overall Study|Physician Decision|4|||
161345115|NCT00314145|582648866|FG000|Overall Study|Adverse Event|0|||
161345116|NCT00314145|582648867|FG001|Overall Study|Adverse Event|3|||
161345117|NCT00314145|582648866|FG000|Overall Study|Protocol Violation|3|||
161345118|NCT00314145|582648867|FG001|Overall Study|Protocol Violation|0|||
161345119|NCT00314145|582648866|FG000|Overall Study|Sponsor Decision|2|||
161345120|NCT00314145|582648867|FG001|Overall Study|Sponsor Decision|0|||
161055226|NCT02531126|581591549|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
161055227|NCT02531126|581591550|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
161055228|NCT02531126|581591551|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
161055229|NCT02531126|581591548|FG000|Overall Study|Adverse Event|16|||
161055230|NCT02531126|581591549|FG001|Overall Study|Adverse Event|13|||
161055231|NCT02531126|581591550|FG002|Overall Study|Adverse Event|27|||
161055232|NCT02531126|581591551|FG003|Overall Study|Adverse Event|4|||
161055233|NCT02531126|581591548|FG000|Overall Study|Lack of Efficacy|50|||
161055234|NCT02531126|581591549|FG001|Overall Study|Lack of Efficacy|32|||
161055235|NCT02531126|581591550|FG002|Overall Study|Lack of Efficacy|121|||
161055236|NCT02531126|581591551|FG003|Overall Study|Lack of Efficacy|0|||
161055237|NCT02531126|581591548|FG000|Overall Study|Withdrawal by Subject|38|||
161055238|NCT02531126|581591549|FG001|Overall Study|Withdrawal by Subject|31|||
161055239|NCT02531126|581591550|FG002|Overall Study|Withdrawal by Subject|96|||
161055240|NCT02531126|581591551|FG003|Overall Study|Withdrawal by Subject|6|||
161055241|NCT02531126|581591548|FG000|Overall Study|Pregnancy|2|||
161055242|NCT02531126|581591549|FG001|Overall Study|Pregnancy|3|||
161055243|NCT02531126|581591550|FG002|Overall Study|Pregnancy|2|||
161055244|NCT02531126|581591551|FG003|Overall Study|Pregnancy|0|||
161055245|NCT02531126|581591548|FG000|Overall Study|Switched to commercial drug|2|||
161055246|NCT02531126|581591549|FG001|Overall Study|Switched to commercial drug|4|||
161055247|NCT02531126|581591550|FG002|Overall Study|Switched to commercial drug|4|||
161055248|NCT02531126|581591551|FG003|Overall Study|Switched to commercial drug|0|||
161055249|NCT02531126|581591548|FG000|Overall Study|Other reasons|23|||
161055250|NCT02531126|581591549|FG001|Overall Study|Other reasons|29|||
161055251|NCT02531126|581591550|FG002|Overall Study|Other reasons|27|||
161055252|NCT02531126|581591551|FG003|Overall Study|Other reasons|15|||
161055253|NCT02531126|581591548|FG000|Overall Study|Physician Decision|6|||
161055254|NCT02531126|581591549|FG001|Overall Study|Physician Decision|6|||
161055255|NCT02531126|581591550|FG002|Overall Study|Physician Decision|28|||
161055256|NCT02531126|581591551|FG003|Overall Study|Physician Decision|0|||
161055257|NCT02531126|581591548|FG000|Overall Study|Non-compliance with investigational drug|1|||
161055258|NCT02531126|581591549|FG001|Overall Study|Non-compliance with investigational drug|0|||
161055259|NCT02531126|581591550|FG002|Overall Study|Non-compliance with investigational drug|0|||
161055260|NCT02531126|581591551|FG003|Overall Study|Non-compliance with investigational drug|0|||
161055261|NCT00762723|581591552|FG000|Overall Study|Study Terminated slow enrollement|5|||
161055262|NCT00762723|581591553|FG001|Overall Study|Study Terminated slow enrollement|5|||
161055263|NCT00762723|581591554|FG002|Overall Study|Study Terminated slow enrollement|3|||
161055264|NCT00382408|581591555|FG000|Overall Study|Did not meet protocol requirement|3|||
161055265|NCT00382408|581591556|FG001|Overall Study|Did not meet protocol requirement|3|||
161055266|NCT00382408|581591555|FG000|Overall Study|Protocol Violation|2|||
161055267|NCT00382408|581591556|FG001|Overall Study|Protocol Violation|2|||
161055268|NCT00382408|581591555|FG000|Overall Study|Physician Decision|1|||
161055269|NCT00382408|581591556|FG001|Overall Study|Physician Decision|0|||
161055270|NCT00382408|581591555|FG000|Overall Study|Withdrawal by Subject|17|||
161055271|NCT00382408|581591556|FG001|Overall Study|Withdrawal by Subject|6|||
161055272|NCT00382408|581591555|FG000|Overall Study|Pregnancy|2|||
161055273|NCT00382408|581591556|FG001|Overall Study|Pregnancy|0|||
161055274|NCT00382408|581591555|FG000|Overall Study|Lost to Follow-up|19|||
161055275|NCT00382408|581591556|FG001|Overall Study|Lost to Follow-up|8|||
161055276|NCT00382408|581591555|FG000|Overall Study|Other|100|||
161055277|NCT00382408|581591556|FG001|Overall Study|Other|35|||
161055278|NCT03085433|581591557|FG000|Overall Study|Withdrawal by Subject|2|||
161055279|NCT03085433|581591558|FG001|Overall Study|Withdrawal by Subject|4|||
161345121|NCT00294658|582648868|FG000|Overall Study|Death|0|||
161055280|NCT03085433|581591557|FG000|Overall Study|Physician Decision|33|||
161055281|NCT03085433|581591558|FG001|Overall Study|Physician Decision|50|||
161055282|NCT03809039|581591559|FG000|Part 1|Withdrawal by Subject|1|||
161055283|NCT03809039|581591560|FG001|Part 1|Withdrawal by Subject|0|||
161055284|NCT03809039|581591561|FG002|Part 1|Withdrawal by Subject|0|||
161055285|NCT03809039|581591562|FG003|Part 1|Withdrawal by Subject|1|||
161345122|NCT00294658|582648869|FG001|Overall Study|Death|1|||
161345123|NCT00294658|582648868|FG000|Overall Study|Lost to Follow-up|4|||
161345124|NCT00294658|582648869|FG001|Overall Study|Lost to Follow-up|0|||
161055286|NCT03809039|581591563|FG004|Part 1|Withdrawal by Subject|0|||
161055287|NCT03809039|581591564|FG005|Part 1|Withdrawal by Subject|0|||
161055288|NCT03809039|581591565|FG006|Part 1|Withdrawal by Subject|0|||
161055289|NCT03809039|581591566|FG007|Part 1|Withdrawal by Subject|0|||
161055290|NCT03809039|581591567|FG008|Part 1|Withdrawal by Subject|0|||
161055291|NCT03809039|581591559|FG000|Part 3|Withdrawn by study termination|0|||
161055292|NCT03809039|581591560|FG001|Part 3|Withdrawn by study termination|0|||
161055293|NCT03809039|581591561|FG002|Part 3|Withdrawn by study termination|0|||
161055294|NCT03809039|581591562|FG003|Part 3|Withdrawn by study termination|0|||
161055295|NCT03809039|581591563|FG004|Part 3|Withdrawn by study termination|0|||
161055296|NCT03809039|581591564|FG005|Part 3|Withdrawn by study termination|0|||
161055297|NCT03809039|581591565|FG006|Part 3|Withdrawn by study termination|0|||
161055298|NCT03809039|581591566|FG007|Part 3|Withdrawn by study termination|2|||
161055299|NCT03809039|581591567|FG008|Part 3|Withdrawn by study termination|6|||
161055300|NCT05271552|581591568|FG000|Overall Study|Adverse Event|4|||
161055301|NCT05271552|581591569|FG001|Overall Study|Adverse Event|6|||
161055302|NCT05271552|581591570|FG002|Overall Study|Adverse Event|3|||
161055303|NCT05271552|581591568|FG000|Overall Study|Death|1|||
161055304|NCT05271552|581591569|FG001|Overall Study|Death|1|||
161055305|NCT05271552|581591570|FG002|Overall Study|Death|1|||
161055306|NCT05271552|581591568|FG000|Overall Study|Lost to Follow-up|1|||
161055307|NCT05271552|581591569|FG001|Overall Study|Lost to Follow-up|5|||
161055308|NCT05271552|581591570|FG002|Overall Study|Lost to Follow-up|4|||
161055309|NCT05271552|581591568|FG000|Overall Study|Withdrawal by Subject|0|||
161055310|NCT05271552|581591569|FG001|Overall Study|Withdrawal by Subject|4|||
161055311|NCT05271552|581591570|FG002|Overall Study|Withdrawal by Subject|7|||
161055312|NCT05271552|581591568|FG000|Overall Study|Other medical reason.|1|||
161055313|NCT05271552|581591569|FG001|Overall Study|Other medical reason.|2|||
161055314|NCT05271552|581591570|FG002|Overall Study|Other medical reason.|0|||
161055315|NCT05271552|581591568|FG000|Overall Study|Other|3|||
161055316|NCT05271552|581591569|FG001|Overall Study|Other|3|||
161055317|NCT05271552|581591570|FG002|Overall Study|Other|6|||
161055318|NCT03840993|581591571|FG000|Overall Study|Adverse Event|1|||
161055319|NCT03840993|581591572|FG001|Overall Study|Adverse Event|0|||
161055320|NCT03840993|581591571|FG000|Overall Study|Lost to Follow-up|4|||
161055321|NCT03840993|581591572|FG001|Overall Study|Lost to Follow-up|0|||
161055322|NCT03840993|581591571|FG000|Overall Study|Physician Decision|0|||
161055323|NCT03840993|581591572|FG001|Overall Study|Physician Decision|1|||
161055324|NCT03840993|581591571|FG000|Overall Study|Pregnancy|0|||
161055325|NCT03840993|581591572|FG001|Overall Study|Pregnancy|1|||
161055326|NCT03840993|581591571|FG000|Overall Study|Withdrawal by Subject|1|||
161055327|NCT03840993|581591572|FG001|Overall Study|Withdrawal by Subject|3|||
161055328|NCT03840993|581591571|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
161055329|NCT03840993|581591572|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
161055330|NCT01572493|581591573|FG000|Overall Study|Physician Decision|1|||
161055331|NCT01572493|581591574|FG001|Overall Study|Physician Decision|0|||
161055332|NCT01572493|581591575|FG002|Overall Study|Physician Decision|0|||
161055333|NCT01572493|581591576|FG003|Overall Study|Physician Decision|0|||
161055334|NCT01572493|581591577|FG004|Overall Study|Physician Decision|0|||
161055335|NCT01572493|581591578|FG005|Overall Study|Physician Decision|0|||
161055336|NCT01572493|581591579|FG006|Overall Study|Physician Decision|0|||
161055337|NCT01572493|581591580|FG007|Overall Study|Physician Decision|0|||
161055338|NCT01572493|581591581|FG008|Overall Study|Physician Decision|0|||
161055339|NCT01572493|581591573|FG000|Overall Study|Switched to alternative treatment|0|||
161055340|NCT01572493|581591574|FG001|Overall Study|Switched to alternative treatment|1|||
161055341|NCT01572493|581591575|FG002|Overall Study|Switched to alternative treatment|2|||
161055342|NCT01572493|581591576|FG003|Overall Study|Switched to alternative treatment|1|||
161055343|NCT01572493|581591577|FG004|Overall Study|Switched to alternative treatment|2|||
161055344|NCT01572493|581591578|FG005|Overall Study|Switched to alternative treatment|0|||
161055345|NCT01572493|581591579|FG006|Overall Study|Switched to alternative treatment|2|||
161055346|NCT01572493|581591580|FG007|Overall Study|Switched to alternative treatment|0|||
161055347|NCT01572493|581591581|FG008|Overall Study|Switched to alternative treatment|2|||
161151634|NCT02834403|581937065|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
161151635|NCT02834403|581937066|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
161055348|NCT01572493|581591573|FG000|Overall Study|Death|0|||
161055349|NCT01572493|581591574|FG001|Overall Study|Death|0|||
161055350|NCT01572493|581591575|FG002|Overall Study|Death|0|||
161055351|NCT01572493|581591576|FG003|Overall Study|Death|1|||
161055352|NCT01572493|581591577|FG004|Overall Study|Death|0|||
161055353|NCT01572493|581591578|FG005|Overall Study|Death|1|||
161055354|NCT01572493|581591579|FG006|Overall Study|Death|0|||
161345125|NCT00294658|582648868|FG000|Overall Study|Physician Decision|1|||
161055355|NCT01572493|581591580|FG007|Overall Study|Death|0|||
161055356|NCT01572493|581591581|FG008|Overall Study|Death|0|||
161055357|NCT01572493|581591573|FG000|Overall Study|Adverse Event|0|||
161055358|NCT01572493|581591574|FG001|Overall Study|Adverse Event|0|||
161055359|NCT01572493|581591575|FG002|Overall Study|Adverse Event|0|||
161055360|NCT01572493|581591576|FG003|Overall Study|Adverse Event|0|||
161055361|NCT01572493|581591577|FG004|Overall Study|Adverse Event|0|||
161151636|NCT02834403|581937067|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
161151637|NCT02834403|581937068|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
161151638|NCT02834403|581937069|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
161151639|NCT02834403|581937070|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
161151640|NCT02834403|581937071|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
161151641|NCT04705597|581937072|FG000|Overall Study|Death|16|||
161151642|NCT04705597|581937073|FG001|Overall Study|Death|9|||
161151643|NCT04705597|581937072|FG000|Overall Study|Lost to Follow-up|1|||
161151644|NCT04705597|581937073|FG001|Overall Study|Lost to Follow-up|0|||
161151645|NCT04705597|581937072|FG000|Overall Study|Withdrawal by Subject|1|||
161151646|NCT04705597|581937073|FG001|Overall Study|Withdrawal by Subject|2|||
161151647|NCT00390780|581937074|FG000|Overall Study|Not completed|10|||
161151648|NCT00390780|581937075|FG001|Overall Study|Not completed|4|||
161151649|NCT00390780|581937074|FG000|Overall Study|Protocol Violation|6|||
161151650|NCT00390780|581937075|FG001|Overall Study|Protocol Violation|4|||
161151651|NCT00390780|581937074|FG000|Overall Study|Lost to Follow-up|3|||
161151652|NCT00390780|581937075|FG001|Overall Study|Lost to Follow-up|6|||
161151653|NCT00390780|581937074|FG000|Overall Study|Adverse Event|2|||
161151654|NCT00390780|581937075|FG001|Overall Study|Adverse Event|3|||
161151655|NCT00390780|581937074|FG000|Overall Study|Death|1|||
161151656|NCT00390780|581937075|FG001|Overall Study|Death|3|||
161151657|NCT00390780|581937074|FG000|Overall Study|Withdrawal by Subject|1|||
161151658|NCT00390780|581937075|FG001|Overall Study|Withdrawal by Subject|2|||
161151659|NCT00390780|581937074|FG000|Overall Study|Inclusion criteria not satisfied|0|||
161151660|NCT00390780|581937075|FG001|Overall Study|Inclusion criteria not satisfied|2|||
161151661|NCT00390780|581937074|FG000|Overall Study|Lost to follow up and other reasons|0|||
161151662|NCT00390780|581937075|FG001|Overall Study|Lost to follow up and other reasons|1|||
161151663|NCT00390780|581937074|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
161151664|NCT00390780|581937075|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
161151665|NCT00390780|581937074|FG000|Overall Study|SAE, death|0|||
161151666|NCT00390780|581937075|FG001|Overall Study|SAE, death|1|||
161151667|NCT00305006|581937076|FG000|Overall Study|Withdrawal by Subject|1|||
161151668|NCT00305006|581937077|FG001|Overall Study|Withdrawal by Subject|0|||
161151669|NCT00305006|581937076|FG000|Overall Study|Failure to complete pretest|0|||
161151670|NCT00305006|581937077|FG001|Overall Study|Failure to complete pretest|1|||
161151671|NCT02606045|581937078|FG000|Overall Study|Study closed before treament could begin|1|||
161151672|NCT02606045|581937079|FG001|Overall Study|Study closed before treament could begin|2|||
161151673|NCT01996319|581937080|FG000|Overall Study|Protocol Violation|1|||
161151674|NCT01996319|581937081|FG001|Overall Study|Protocol Violation|0|||
161151675|NCT01996319|581937080|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
161151676|NCT01996319|581937081|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
161151677|NCT01996319|581937080|FG000|Overall Study|Adverse Event|2|||
161151678|NCT01996319|581937081|FG001|Overall Study|Adverse Event|2|||
161151679|NCT01671085|581937083|FG000|Overall Study|Withdrawal by Subject|1|||
161151680|NCT01671085|581937084|FG001|Overall Study|Withdrawal by Subject|0|||
161151681|NCT00637273|581937085|FG000|Overall Study|Adverse Event|11|||
161151682|NCT00637273|581937086|FG001|Overall Study|Adverse Event|5|||
161151683|NCT00637273|581937087|FG002|Overall Study|Adverse Event|7|||
161151684|NCT00637273|581937085|FG000|Overall Study|Lost to Follow-up|8|||
161151685|NCT00637273|581937086|FG001|Overall Study|Lost to Follow-up|9|||
161151686|NCT00637273|581937087|FG002|Overall Study|Lost to Follow-up|13|||
161151687|NCT00637273|581937085|FG000|Overall Study|Protocol Violation|2|||
161151688|NCT00637273|581937086|FG001|Overall Study|Protocol Violation|4|||
161151689|NCT00637273|581937087|FG002|Overall Study|Protocol Violation|1|||
161151690|NCT00637273|581937085|FG000|Overall Study|Withdrawal of Consent|18|||
161151691|NCT00637273|581937086|FG001|Overall Study|Withdrawal of Consent|6|||
161151692|NCT00637273|581937087|FG002|Overall Study|Withdrawal of Consent|18|||
161151693|NCT00637273|581937085|FG000|Overall Study|Investigator Decision|1|||
161055362|NCT01572493|581591578|FG005|Overall Study|Adverse Event|0|||
161055363|NCT01572493|581591579|FG006|Overall Study|Adverse Event|1|||
161055364|NCT01572493|581591580|FG007|Overall Study|Adverse Event|0|||
161055365|NCT01572493|581591581|FG008|Overall Study|Adverse Event|0|||
161055366|NCT01284634|581591583|FG000|Overall Study|Adverse Event|1|||
161055367|NCT01284634|581591584|FG001|Overall Study|Adverse Event|0|||
161055368|NCT01284634|581591585|FG002|Overall Study|Adverse Event|2|||
161055369|NCT01284634|581591586|FG003|Overall Study|Adverse Event|1|||
161151694|NCT00637273|581937086|FG001|Overall Study|Investigator Decision|3|||
161345126|NCT00294658|582648869|FG001|Overall Study|Physician Decision|2|||
161055370|NCT03807700|581591587|FG000|Overall Study|Withdrawal by Subject|2|||
161055371|NCT03807700|581591588|FG001|Overall Study|Withdrawal by Subject|1|||
161151695|NCT00637273|581937087|FG002|Overall Study|Investigator Decision|1|||
161151696|NCT00637273|581937085|FG000|Overall Study|Administrative|2|||
161151697|NCT00637273|581937086|FG001|Overall Study|Administrative|0|||
161055372|NCT02236598|581591589|FG000|Overall Study|Adverse Event|0|||
161151698|NCT00637273|581937087|FG002|Overall Study|Administrative|0|||
161151699|NCT00637273|581937085|FG000|Overall Study|Loss of Glucose Control|1|||
161345127|NCT00294658|582648868|FG000|Overall Study|Pregnancy|0|||
161055373|NCT02236598|581591590|FG001|Overall Study|Adverse Event|1|||
161055374|NCT02236598|581591589|FG000|Overall Study|Withdrawal by Subject|0|||
161055375|NCT02236598|581591590|FG001|Overall Study|Withdrawal by Subject|1|||
161055376|NCT03132753|581591604|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
161055377|NCT03132753|581591605|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
161055378|NCT03132753|581591604|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
161055379|NCT03132753|581591605|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
161055380|NCT00084747|581591606|FG000|Overall Study|Relapsed|8|||
161055381|NCT00084747|581591606|FG000|Overall Study|Death|3|||
161055382|NCT00084747|581591606|FG000|Overall Study|Withdrawal by Subject|2|||
161055383|NCT04203160|581591607|FG000|Overall Study|Alternative Therapy|3|||
161055384|NCT04203160|581591608|FG001|Overall Study|Alternative Therapy|0|||
161055385|NCT04203160|581591609|FG002|Overall Study|Alternative Therapy|1|||
161055386|NCT04203160|581591610|FG003|Overall Study|Alternative Therapy|0|||
161055387|NCT04203160|581591611|FG004|Overall Study|Alternative Therapy|0|||
161055388|NCT04203160|581591612|FG005|Overall Study|Alternative Therapy|2|||
161055389|NCT04203160|581591607|FG000|Overall Study|Withdrawal by Subject|4|||
161055390|NCT04203160|581591608|FG001|Overall Study|Withdrawal by Subject|5|||
161055391|NCT04203160|581591609|FG002|Overall Study|Withdrawal by Subject|0|||
161055392|NCT04203160|581591610|FG003|Overall Study|Withdrawal by Subject|0|||
161055393|NCT04203160|581591611|FG004|Overall Study|Withdrawal by Subject|0|||
161055394|NCT04203160|581591612|FG005|Overall Study|Withdrawal by Subject|4|||
161055395|NCT04203160|581591607|FG000|Overall Study|Adverse Event|7|||
161055396|NCT04203160|581591608|FG001|Overall Study|Adverse Event|5|||
161055397|NCT04203160|581591609|FG002|Overall Study|Adverse Event|0|||
161055398|NCT04203160|581591610|FG003|Overall Study|Adverse Event|0|||
161055399|NCT04203160|581591611|FG004|Overall Study|Adverse Event|0|||
161055400|NCT04203160|581591612|FG005|Overall Study|Adverse Event|0|||
161055401|NCT04203160|581591607|FG000|Overall Study|Sponsor Termination|1|||
161055402|NCT04203160|581591608|FG001|Overall Study|Sponsor Termination|0|||
161055403|NCT04203160|581591609|FG002|Overall Study|Sponsor Termination|0|||
161055404|NCT04203160|581591610|FG003|Overall Study|Sponsor Termination|0|||
161055405|NCT04203160|581591611|FG004|Overall Study|Sponsor Termination|0|||
161055406|NCT04203160|581591612|FG005|Overall Study|Sponsor Termination|0|||
161055407|NCT04203160|581591607|FG000|Overall Study|Physician Decision|3|||
161055408|NCT04203160|581591608|FG001|Overall Study|Physician Decision|2|||
161055409|NCT04203160|581591609|FG002|Overall Study|Physician Decision|0|||
161055410|NCT04203160|581591610|FG003|Overall Study|Physician Decision|0|||
161055411|NCT04203160|581591611|FG004|Overall Study|Physician Decision|0|||
161055412|NCT04203160|581591612|FG005|Overall Study|Physician Decision|0|||
161055413|NCT00679549|581591613|FG000|Overall Study|dropout|2|||
161055414|NCT00679549|581591614|FG001|Overall Study|dropout|4|||
161055415|NCT00679549|581591613|FG000|Overall Study|missing outcome echocardiograms|4|||
161055416|NCT00679549|581591614|FG001|Overall Study|missing outcome echocardiograms|5|||
161055417|NCT03048058|581591620|FG000|Overall Study|Lost to Follow-up|4|||
161055418|NCT03048058|581591621|FG001|Overall Study|Lost to Follow-up|0|||
161055419|NCT03048058|581591620|FG000|Overall Study|Withdrawal by Subject|0|||
161055420|NCT03048058|581591621|FG001|Overall Study|Withdrawal by Subject|4|||
161055421|NCT03305458|581591622|FG000|Overall Study|Withdrawal by Subject|50|||
161055422|NCT03305458|581591623|FG001|Overall Study|Withdrawal by Subject|46|||
161055423|NCT03305458|581591624|FG002|Overall Study|Withdrawal by Subject|93|||
161055424|NCT03305458|581591622|FG000|Overall Study|Lost to Follow-up|85|||
161055425|NCT03305458|581591623|FG001|Overall Study|Lost to Follow-up|85|||
161055426|NCT03305458|581591624|FG002|Overall Study|Lost to Follow-up|35|||
161055427|NCT02332824|581591625|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
161055428|NCT02332824|581591626|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161055429|NCT02332824|581591627|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
161055430|NCT02332824|581591628|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161055431|NCT02332824|581591629|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
161055432|NCT02332824|581591630|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
161055433|NCT02332824|581591625|FG000|Overall Study|Voluntary Withdrawal|1|||
161055434|NCT02332824|581591626|FG001|Overall Study|Voluntary Withdrawal|0|||
161055435|NCT02332824|581591627|FG002|Overall Study|Voluntary Withdrawal|0|||
161055436|NCT02332824|581591628|FG003|Overall Study|Voluntary Withdrawal|0|||
161055437|NCT02332824|581591629|FG004|Overall Study|Voluntary Withdrawal|0|||
161055438|NCT02332824|581591630|FG005|Overall Study|Voluntary Withdrawal|0|||
161055439|NCT02332824|581591625|FG000|Overall Study|Inconvenient schedule|1|||
161055440|NCT02332824|581591626|FG001|Overall Study|Inconvenient schedule|1|||
161055441|NCT02332824|581591627|FG002|Overall Study|Inconvenient schedule|0|||
161055442|NCT02332824|581591628|FG003|Overall Study|Inconvenient schedule|0|||
161055443|NCT02332824|581591629|FG004|Overall Study|Inconvenient schedule|0|||
161055444|NCT02332824|581591630|FG005|Overall Study|Inconvenient schedule|0|||
161055445|NCT02332824|581591625|FG000|Overall Study|Transfer|0|||
161055446|NCT02332824|581591626|FG001|Overall Study|Transfer|0|||
161055447|NCT02332824|581591627|FG002|Overall Study|Transfer|1|||
161055448|NCT02332824|581591628|FG003|Overall Study|Transfer|1|||
161055449|NCT02332824|581591629|FG004|Overall Study|Transfer|0|||
161055450|NCT02332824|581591630|FG005|Overall Study|Transfer|0|||
161055451|NCT03926117|581591637|FG000|Overall Study|Unclassified|1|||
161055452|NCT03926117|581591638|FG001|Overall Study|Unclassified|4|||
161055453|NCT03926117|581591639|FG002|Overall Study|Unclassified|1|||
161055454|NCT03926117|581591640|FG003|Overall Study|Unclassified|4|||
161055455|NCT03926117|581591637|FG000|Overall Study|Withdrawal by Subject|3|||
161055456|NCT03926117|581591638|FG001|Overall Study|Withdrawal by Subject|0|||
161055457|NCT03926117|581591639|FG002|Overall Study|Withdrawal by Subject|1|||
161055458|NCT03926117|581591640|FG003|Overall Study|Withdrawal by Subject|1|||
161055459|NCT03926117|581591637|FG000|Overall Study|Lost to Follow-up|0|||
161055460|NCT03926117|581591638|FG001|Overall Study|Lost to Follow-up|2|||
161055461|NCT03926117|581591639|FG002|Overall Study|Lost to Follow-up|1|||
161055462|NCT03926117|581591640|FG003|Overall Study|Lost to Follow-up|0|||
161055463|NCT03926117|581591637|FG000|Overall Study|Adverse Event|1|||
161055464|NCT03926117|581591638|FG001|Overall Study|Adverse Event|2|||
161055465|NCT03926117|581591639|FG002|Overall Study|Adverse Event|3|||
161055466|NCT03926117|581591640|FG003|Overall Study|Adverse Event|1|||
161055467|NCT03926117|581591637|FG000|Overall Study|Randomized but not treated|1|||
161055468|NCT03926117|581591638|FG001|Overall Study|Randomized but not treated|1|||
161055469|NCT03926117|581591639|FG002|Overall Study|Randomized but not treated|0|||
161055470|NCT03926117|581591640|FG003|Overall Study|Randomized but not treated|1|||
161055471|NCT03138499|581591641|FG000|Overall Study|Lost to Follow-up|1|||
161055472|NCT03138499|581591642|FG001|Overall Study|Lost to Follow-up|0|||
161055473|NCT03138499|581591641|FG000|Overall Study|Participants withdrew consent|1|||
161055474|NCT03138499|581591642|FG001|Overall Study|Participants withdrew consent|0|||
161055475|NCT03138499|581591641|FG000|Overall Study|Participant discontinued study before treatment|0|||
161055476|NCT03138499|581591642|FG001|Overall Study|Participant discontinued study before treatment|1|||
161055477|NCT03138499|581591641|FG000|Overall Study|Disease Progression|2|||
161055478|NCT03138499|581591642|FG001|Overall Study|Disease Progression|6|||
161055479|NCT03138499|581591641|FG000|Overall Study|Study drug toxicity|2|||
161055480|NCT03138499|581591642|FG001|Overall Study|Study drug toxicity|2|||
161055481|NCT03138499|581591641|FG000|Overall Study|Participant request to discontinue study treatment|1|||
161055482|NCT03138499|581591642|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161055483|NCT03138499|581591641|FG000|Overall Study|Other reasons|2|||
161055484|NCT03138499|581591642|FG001|Overall Study|Other reasons|0|||
161055485|NCT00990821|581591643|FG000|Overall Study|Withdrawal by Subject|0|||
161055486|NCT00990821|581591644|FG001|Overall Study|Withdrawal by Subject|2|||
161055487|NCT00990821|581591645|FG002|Overall Study|Withdrawal by Subject|0|||
161055488|NCT00990821|581591646|FG003|Overall Study|Withdrawal by Subject|0|||
161055489|NCT00990821|581591647|FG004|Overall Study|Withdrawal by Subject|3|||
161055490|NCT00990821|581591648|FG005|Overall Study|Withdrawal by Subject|3|||
161055491|NCT00990821|581591649|FG006|Overall Study|Withdrawal by Subject|1|||
161055492|NCT00990821|581591650|FG007|Overall Study|Withdrawal by Subject|0|||
161055493|NCT00990821|581591651|FG008|Overall Study|Withdrawal by Subject|0|||
161055494|NCT00990821|581591652|FG009|Overall Study|Withdrawal by Subject|1|||
161055495|NCT00990821|581591653|FG010|Overall Study|Withdrawal by Subject|3|||
161055496|NCT00990821|581591654|FG011|Overall Study|Withdrawal by Subject|5|||
161055497|NCT00990821|581591655|FG012|Overall Study|Withdrawal by Subject|2|||
161055498|NCT00990821|581591656|FG013|Overall Study|Withdrawal by Subject|1|||
161055499|NCT04150250|581591657|FG000|Overall Study|Lost to Follow-up|0|||
161055500|NCT04150250|581591658|FG001|Overall Study|Lost to Follow-up|2|||
161055501|NCT05379023|581591665|FG000|Overall Study|Lost to Follow-up|1|||
161055502|NCT05379023|581591666|FG001|Overall Study|Lost to Follow-up|0|||
161055503|NCT05379023|581591667|FG002|Overall Study|Lost to Follow-up|0|||
161055504|NCT05379023|581591665|FG000|Overall Study|Withdrawal by Subject|2|||
161055505|NCT05379023|581591666|FG001|Overall Study|Withdrawal by Subject|0|||
161055506|NCT05379023|581591667|FG002|Overall Study|Withdrawal by Subject|0|||
161055507|NCT05147662|581591668|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161055508|NCT05147662|581591668|FG000|Overall Study|Assigned to treatment but never treated|1|||
161055509|NCT00506922|581592630|FG000|Overall Study|Physician Decision|0|||
161055510|NCT00506922|581592631|FG001|Overall Study|Physician Decision|0|||
161055511|NCT00506922|581592632|FG002|Overall Study|Physician Decision|0|||
161055512|NCT00506922|581592633|FG003|Overall Study|Physician Decision|2|||
161055513|NCT00506922|581592634|FG004|Overall Study|Physician Decision|0|||
161055514|NCT00506922|581592630|FG000|Overall Study|Withdrawal by Subject|0|||
161055515|NCT00506922|581592631|FG001|Overall Study|Withdrawal by Subject|0|||
161055516|NCT00506922|581592632|FG002|Overall Study|Withdrawal by Subject|0|||
161055517|NCT00506922|581592633|FG003|Overall Study|Withdrawal by Subject|0|||
161055518|NCT00506922|581592634|FG004|Overall Study|Withdrawal by Subject|1|||
161055519|NCT05244226|581592635|FG000|Overall Study|Adverse Event|1|||
161055520|NCT05244226|581592636|FG001|Overall Study|Adverse Event|0|||
161055521|NCT05244226|581592637|FG002|Overall Study|Adverse Event|0|||
161055522|NCT05244226|581592635|FG000|Overall Study|Lost to Follow-up|0|||
161055523|NCT05244226|581592636|FG001|Overall Study|Lost to Follow-up|0|||
161055524|NCT05244226|581592637|FG002|Overall Study|Lost to Follow-up|1|||
161055525|NCT05244226|581592635|FG000|Overall Study|Protocol Violation|0|||
161055526|NCT05244226|581592636|FG001|Overall Study|Protocol Violation|2|||
161055527|NCT05244226|581592637|FG002|Overall Study|Protocol Violation|2|||
161055528|NCT00508274|581592643|FG000|Overall Study|Adverse Event|5|||
161055529|NCT00508274|581592643|FG000|Overall Study|Death|7|||
161055530|NCT00508274|581592643|FG000|Overall Study|Disease progression|32|||
161055531|NCT00508274|581592643|FG000|Overall Study|Withdrawal by Subject|1|||
161055532|NCT00508274|581592643|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
161055533|NCT00508274|581592643|FG000|Overall Study|Missing|3|||
161055534|NCT04050722|581592644|FG000|Overall Study|Withdrawal by Subject|1|||
161055535|NCT04050722|581592645|FG001|Overall Study|Withdrawal by Subject|0|||
161055536|NCT00111839|581592649|FG000|Overall Study|Disease Progression|30|||
161055537|NCT00111839|581592650|FG001|Overall Study|Disease Progression|33|||
161055538|NCT00111839|581592651|FG002|Overall Study|Disease Progression|33|||
161055539|NCT00111839|581592649|FG000|Overall Study|Adverse Event|5|||
161055540|NCT00111839|581592650|FG001|Overall Study|Adverse Event|3|||
161055541|NCT00111839|581592651|FG002|Overall Study|Adverse Event|1|||
161055542|NCT00111839|581592649|FG000|Overall Study|Protocol Violation|2|||
161055543|NCT00111839|581592650|FG001|Overall Study|Protocol Violation|4|||
161055544|NCT00111839|581592651|FG002|Overall Study|Protocol Violation|2|||
161055545|NCT00111839|581592649|FG000|Overall Study|Death|1|||
161055546|NCT00111839|581592650|FG001|Overall Study|Death|1|||
161055547|NCT00111839|581592651|FG002|Overall Study|Death|6|||
161055548|NCT00111839|581592649|FG000|Overall Study|Withdrawal by Subject|2|||
161055549|NCT00111839|581592650|FG001|Overall Study|Withdrawal by Subject|2|||
161055550|NCT00111839|581592651|FG002|Overall Study|Withdrawal by Subject|2|||
161055551|NCT00111839|581592649|FG000|Overall Study|Lost to Follow-up|1|||
161055552|NCT00111839|581592650|FG001|Overall Study|Lost to Follow-up|0|||
161055553|NCT00111839|581592651|FG002|Overall Study|Lost to Follow-up|0|||
161055554|NCT00111839|581592649|FG000|Overall Study|Logistical Constraint|1|||
161055555|NCT00111839|581592650|FG001|Overall Study|Logistical Constraint|0|||
161055556|NCT00111839|581592651|FG002|Overall Study|Logistical Constraint|0|||
161055557|NCT00111839|581592649|FG000|Overall Study|Other|6|||
161055558|NCT00111839|581592650|FG001|Overall Study|Other|3|||
161055559|NCT00111839|581592651|FG002|Overall Study|Other|3|||
161055560|NCT00111839|581592649|FG000|Overall Study|Randomized but Not Treated|0|||
161055561|NCT00111839|581592650|FG001|Overall Study|Randomized but Not Treated|0|||
161055562|NCT00111839|581592651|FG002|Overall Study|Randomized but Not Treated|2|||
161055563|NCT00377312|581592652|FG000|Overall Study|Adverse Event|1|||
161055564|NCT00377312|581592653|FG001|Overall Study|Adverse Event|1|||
161055565|NCT03924947|581592656|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161055566|NCT03924947|581592657|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161055567|NCT03924947|581592658|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
161055568|NCT03924947|581592659|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161055569|NCT03924947|581592660|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161055570|NCT03924947|581592661|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
161055571|NCT03451292|581592662|FG000|Overall Study|Death|44|||
161055572|NCT03451292|581592663|FG001|Overall Study|Death|59|||
161055573|NCT03451292|581592662|FG000|Overall Study|Withdrawal by Subject|18|||
161055574|NCT03451292|581592663|FG001|Overall Study|Withdrawal by Subject|13|||
161055575|NCT03451292|581592662|FG000|Overall Study|Transplantation|18|||
161055576|NCT03451292|581592663|FG001|Overall Study|Transplantation|12|||
161055577|NCT03451292|581592662|FG000|Overall Study|Lost to Follow-up|4|||
161055578|NCT03451292|581592663|FG001|Overall Study|Lost to Follow-up|12|||
161055579|NCT03451292|581592662|FG000|Overall Study|Physician Decision|4|||
161055580|NCT03451292|581592663|FG001|Overall Study|Physician Decision|3|||
161055581|NCT03451292|581592662|FG000|Overall Study|Adverse Event|3|||
161055582|NCT03451292|581592663|FG001|Overall Study|Adverse Event|3|||
161055583|NCT03451292|581592662|FG000|Overall Study|Non-compliance with Study Drug|2|||
161055584|NCT03451292|581592663|FG001|Overall Study|Non-compliance with Study Drug|0|||
161055585|NCT00609245|581592671|FG000|Overall Study|Adverse Event|1|||
161055586|NCT01090076|581592672|FG000|Overall Study|Death|1|||
161055587|NCT01090076|581592673|FG001|Overall Study|Death|1|||
161055588|NCT01090076|581592672|FG000|Overall Study|Withdrawal by Subject|0|||
161055589|NCT01090076|581592673|FG001|Overall Study|Withdrawal by Subject|1|||
161055590|NCT02176018|581592674|FG000|Overall Study|Adverse Event|0|||
161055591|NCT02176018|581592675|FG001|Overall Study|Adverse Event|2|||
161055592|NCT02176018|581592674|FG000|Overall Study|Lost to Follow-up|3|||
161055593|NCT02176018|581592675|FG001|Overall Study|Lost to Follow-up|1|||
161055594|NCT02176018|581592674|FG000|Overall Study|Protocol Violation|1|||
161281201|NCT01434810|582408639|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
161055595|NCT02176018|581592675|FG001|Overall Study|Protocol Violation|1|||
161055596|NCT02176018|581592674|FG000|Overall Study|Withdrawal by Subject|1|||
161055597|NCT02176018|581592675|FG001|Overall Study|Withdrawal by Subject|2|||
161055598|NCT03022045|581592677|FG000|Overall Study|Adverse Event|0|||
161055599|NCT03022045|581592678|FG001|Overall Study|Adverse Event|1|||
161055600|NCT03022045|581592677|FG000|Overall Study|Withdrawal by Subject|1|||
161055601|NCT03022045|581592678|FG001|Overall Study|Withdrawal by Subject|1|||
161055602|NCT02973477|581592679|FG000|First Intervention|Lost to Follow-up|0|||
161055603|NCT02973477|581592680|FG001|First Intervention|Lost to Follow-up|2|||
161055604|NCT02973477|581592679|FG000|Washout|Withdrawal by Subject|1|||
161055605|NCT02973477|581592680|FG001|Washout|Withdrawal by Subject|0|||
161055606|NCT02973477|581592679|FG000|Second Intervention|Lost to Follow-up|1|||
161055607|NCT02973477|581592680|FG001|Second Intervention|Lost to Follow-up|0|||
161055608|NCT02402465|581592682|FG000|Overall Study|Withdrawal by Subject|0|||
161055609|NCT02402465|581592683|FG001|Overall Study|Withdrawal by Subject|0|||
161055610|NCT02402465|581592684|FG002|Overall Study|Withdrawal by Subject|0|||
161055611|NCT02402465|581592685|FG003|Overall Study|Withdrawal by Subject|0|||
161055612|NCT02402465|581592686|FG004|Overall Study|Withdrawal by Subject|0|||
161055613|NCT02402465|581592687|FG005|Overall Study|Withdrawal by Subject|1|||
161055614|NCT02402465|581592682|FG000|Overall Study|Lost to Follow-up|0|||
161055615|NCT02402465|581592683|FG001|Overall Study|Lost to Follow-up|1|||
161055616|NCT02402465|581592684|FG002|Overall Study|Lost to Follow-up|0|||
161055617|NCT02402465|581592685|FG003|Overall Study|Lost to Follow-up|0|||
161055618|NCT02402465|581592686|FG004|Overall Study|Lost to Follow-up|1|||
161055619|NCT02402465|581592687|FG005|Overall Study|Lost to Follow-up|0|||
161055620|NCT01059526|581592688|FG000|Overall Study|Patient enrolled but not treated|20|||
161055621|NCT01059526|581592689|FG001|Overall Study|Patient enrolled but not treated|17|||
161055622|NCT01059526|581592688|FG000|Overall Study|Adverse Event|2|||
161055623|NCT01059526|581592689|FG001|Overall Study|Adverse Event|2|||
161055624|NCT01059526|581592688|FG000|Overall Study|Protocol Violation|0|||
161055625|NCT01059526|581592689|FG001|Overall Study|Protocol Violation|1|||
161055626|NCT01059526|581592688|FG000|Overall Study|Withdrawal by Subject|3|||
161055627|NCT01059526|581592689|FG001|Overall Study|Withdrawal by Subject|1|||
161055628|NCT01059526|581592688|FG000|Overall Study|Lost to Follow-up|4|||
161055629|NCT01059526|581592689|FG001|Overall Study|Lost to Follow-up|1|||
161055630|NCT01059526|581592688|FG000|Overall Study|Patient found to be dermatographic|1|||
161055631|NCT01059526|581592689|FG001|Overall Study|Patient found to be dermatographic|0|||
161055632|NCT02720081|581592690|FG000|Overall Study|Adverse Event|0|||
161055633|NCT02720081|581592691|FG001|Overall Study|Adverse Event|3|||
161055634|NCT02720081|581592690|FG000|Overall Study|Protocol Violation|4|||
161055635|NCT02720081|581592691|FG001|Overall Study|Protocol Violation|1|||
161055636|NCT01732588|581592692|FG000|First Intervention (7 Days)|Adverse Event|0|||
161055637|NCT01732588|581592693|FG001|First Intervention (7 Days)|Adverse Event|1|||
161055638|NCT01732588|581592694|FG002|First Intervention (7 Days)|Adverse Event|0|||
161055639|NCT00428441|581592696|FG000|Overall Study|Lost to Follow-up|1|||
161055640|NCT00125853|581592698|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
161055641|NCT00125853|581592699|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
161055642|NCT02744898|581592702|FG000|Overall Study|Progressive Disease|2|||
161055643|NCT02744898|581592702|FG000|Overall Study|Physician Decision|1|||
161055644|NCT02744898|581592702|FG000|Overall Study|Toxicity|1|||
161055645|NCT00157209|581592703|FG000|Overall Study|Ongoing at data cut-off|10|||
161055646|NCT00157209|581592704|FG001|Overall Study|Ongoing at data cut-off|0|||
161055647|NCT04474691|581592705|FG000|Overall Study|Withdrawal by Subject|9|||
161055648|NCT01348763|581592706|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
161055649|NCT01348763|581592706|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
161055650|NCT02268526|581592707|FG000|Overall Study|Adverse Event|0|||
161055651|NCT02268526|581592708|FG001|Overall Study|Adverse Event|2|||
161055652|NCT02268526|581592709|FG002|Overall Study|Adverse Event|1|||
161055653|NCT02268526|581592707|FG000|Overall Study|Death|1|||
161055654|NCT02268526|581592708|FG001|Overall Study|Death|11|||
161055655|NCT02268526|581592709|FG002|Overall Study|Death|0|||
161055656|NCT02268526|581592707|FG000|Overall Study|protocol deviation|0|||
161055657|NCT02268526|581592708|FG001|Overall Study|protocol deviation|1|||
161055658|NCT02268526|581592709|FG002|Overall Study|protocol deviation|0|||
161055659|NCT02268526|581592707|FG000|Overall Study|Physician Decision|0|||
161055660|NCT02268526|581592708|FG001|Overall Study|Physician Decision|0|||
161055661|NCT02268526|581592709|FG002|Overall Study|Physician Decision|1|||
161055662|NCT02268526|581592707|FG000|Overall Study|Subject/guardian decision|0|||
161055663|NCT02268526|581592708|FG001|Overall Study|Subject/guardian decision|7|||
161345128|NCT00294658|582648869|FG001|Overall Study|Pregnancy|1|||
161055664|NCT02268526|581592709|FG002|Overall Study|Subject/guardian decision|3|||
161055665|NCT00498797|581592710|FG000|Overall Study|Withdrawal by Subject|4|||
161055666|NCT00498797|581592711|FG001|Overall Study|Withdrawal by Subject|2|||
161055667|NCT00498797|581592710|FG000|Overall Study|Adverse Event|12|||
161055668|NCT00498797|581592711|FG001|Overall Study|Adverse Event|5|||
161055669|NCT00498797|581592710|FG000|Overall Study|Condition under investigation worsened|19|||
161055670|NCT00498797|581592711|FG001|Overall Study|Condition under investigation worsened|21|||
161055671|NCT00498797|581592710|FG000|Overall Study|Other|3|||
161055672|NCT00498797|581592711|FG001|Overall Study|Other|1|||
161055673|NCT00448344|581592715|FG000|Overall Study|Lost to Follow-up|20|||
161151700|NCT00637273|581937086|FG001|Overall Study|Loss of Glucose Control|1|||
161055674|NCT00448344|581592716|FG001|Overall Study|Lost to Follow-up|22|||
161055675|NCT00448344|581592715|FG000|Overall Study|Withdrawal by Subject|6|||
161055676|NCT00448344|581592716|FG001|Overall Study|Withdrawal by Subject|8|||
161055677|NCT00448344|581592715|FG000|Overall Study|Death|3|||
161345129|NCT00294658|582648868|FG000|Overall Study|Withdrawal by Subject|0|||
161055678|NCT00448344|581592716|FG001|Overall Study|Death|4|||
161055679|NCT00448344|581592715|FG000|Overall Study|Physician Decision|1|||
161055680|NCT00448344|581592716|FG001|Overall Study|Physician Decision|2|||
161055681|NCT01052714|581592722|FG000|Overall Study|Adverse Event|6|||
161055682|NCT01052714|581592723|FG001|Overall Study|Adverse Event|3|||
161055683|NCT01052714|581592724|FG002|Overall Study|Adverse Event|0|||
161055684|NCT01052714|581592722|FG000|Overall Study|Death|1|||
161055685|NCT01052714|581592723|FG001|Overall Study|Death|2|||
161055686|NCT01052714|581592724|FG002|Overall Study|Death|0|||
161055687|NCT01052714|581592722|FG000|Overall Study|Lost to Follow-up|2|||
161055688|NCT01052714|581592723|FG001|Overall Study|Lost to Follow-up|3|||
161055689|NCT01052714|581592724|FG002|Overall Study|Lost to Follow-up|0|||
161055690|NCT01052714|581592722|FG000|Overall Study|Physician Decision|9|||
161055691|NCT01052714|581592723|FG001|Overall Study|Physician Decision|9|||
161055692|NCT01052714|581592724|FG002|Overall Study|Physician Decision|1|||
161055693|NCT01052714|581592722|FG000|Overall Study|Withdrawal by Subject|7|||
161055694|NCT01052714|581592723|FG001|Overall Study|Withdrawal by Subject|12|||
161055695|NCT01052714|581592724|FG002|Overall Study|Withdrawal by Subject|1|||
161055696|NCT00417989|581592728|FG000|Overall Study|Withdrawal by Subject|13|||
161055697|NCT00417989|581592729|FG001|Overall Study|Withdrawal by Subject|13|||
161055698|NCT00417989|581592728|FG000|Overall Study|Lost to Follow-up|1|||
161055699|NCT00417989|581592729|FG001|Overall Study|Lost to Follow-up|6|||
161055700|NCT00417989|581592728|FG000|Overall Study|Protocol Violation|1|||
161055701|NCT00417989|581592729|FG001|Overall Study|Protocol Violation|0|||
161055702|NCT00417989|581592728|FG000|Overall Study|Death|0|||
161055703|NCT00417989|581592729|FG001|Overall Study|Death|1|||
161055704|NCT00417989|581592728|FG000|Overall Study|Physician Decision|5|||
161055705|NCT00417989|581592729|FG001|Overall Study|Physician Decision|2|||
161055706|NCT04212299|581592730|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
161055707|NCT02951052|581592731|FG000|Overall Study|Adverse Event|13|||
161055708|NCT02951052|581592732|FG001|Overall Study|Adverse Event|5|||
161055709|NCT02951052|581592731|FG000|Overall Study|Withdrawal by Subject|1|||
161055710|NCT02951052|581592732|FG001|Overall Study|Withdrawal by Subject|5|||
161055711|NCT02951052|581592731|FG000|Overall Study|Physician Decision|2|||
161055712|NCT02951052|581592732|FG001|Overall Study|Physician Decision|0|||
161055713|NCT02951052|581592731|FG000|Overall Study|Lost to Follow-up|1|||
161055714|NCT02951052|581592732|FG001|Overall Study|Lost to Follow-up|1|||
161055715|NCT02951052|581592731|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
161055716|NCT02951052|581592732|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
161055717|NCT02951052|581592731|FG000|Overall Study|Protocol Violation|5|||
161055718|NCT02951052|581592732|FG001|Overall Study|Protocol Violation|3|||
161055719|NCT02951052|581592731|FG000|Overall Study|Lack of Efficacy|3|||
161055720|NCT02951052|581592732|FG001|Overall Study|Lack of Efficacy|4|||
161055721|NCT02951052|581592731|FG000|Overall Study|Ongoing|1|||
161055722|NCT02951052|581592732|FG001|Overall Study|Ongoing|0|||
161055723|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
161055724|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
161055725|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
161055726|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
161055727|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
161055728|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161055729|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161055730|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
161055731|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
161055732|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
161055733|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
161055734|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
161055735|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
161055736|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
161055737|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
161055738|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
161055739|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
161055740|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
161055741|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
161055742|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
161055743|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
161055744|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
161055745|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
161055746|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
161055747|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
161055748|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
161055749|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
161055750|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
161281202|NCT02794870|582408641|FG000|Overall Study|Withdrawal by Subject|2|||
161055751|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
161055752|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
161055753|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
161055754|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
161055755|NCT03602859|581592733|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
161055756|NCT03602859|581592734|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
161055757|NCT03602859|581592735|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
161055758|NCT03602859|581592736|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
161055759|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
161055760|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
161055761|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
161055762|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
161055763|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
161055764|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
161055765|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
161055766|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
161055767|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
161055768|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
161055769|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
161055770|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
161055771|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
161055772|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
161055773|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
161055774|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
161055775|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
161055776|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
161055777|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
161055778|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
161055779|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
161055780|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
161055781|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
161055782|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
161055783|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
161055784|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
161055785|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
161055786|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
161055787|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
161055788|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
161055789|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
161055790|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
161055791|NCT03602859|581592733|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
161055792|NCT03602859|581592734|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
161055793|NCT03602859|581592735|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
161055794|NCT03602859|581592736|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
161055795|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
161055796|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
161055797|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
161055798|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
161055799|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
161055800|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
161055801|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
161055802|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
161055803|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
161055804|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
161055805|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
161055806|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
161055807|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
161055808|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
161055809|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
161055810|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
161055811|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
161055812|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
161151701|NCT00637273|581937087|FG002|Overall Study|Loss of Glucose Control|1|||
161151702|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
161055813|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
161055814|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
161055815|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
161055816|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
161055817|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
161055818|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
161055819|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
161055820|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
161055821|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
161055822|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
161055823|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
161055824|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
161055825|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
161055826|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
161055827|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
161055828|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
161055829|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
161055830|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
161055831|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
161055832|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
161055833|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
161055834|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
161055835|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161055836|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161055837|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
161055838|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
161055839|NCT03602859|581592733|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
161055840|NCT03602859|581592734|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
161055841|NCT03602859|581592735|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
161055842|NCT03602859|581592736|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
161055843|NCT01904019|581594351|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
161055844|NCT01904019|581594351|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
161055845|NCT01904019|581594351|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
161055846|NCT01904019|581594351|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
161055847|NCT01904019|581594351|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
161055848|NCT01904019|581594351|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
161055849|NCT01816685|581594354|FG000|Overall Study|Lost to Follow-up|7|||
161055850|NCT01816685|581594355|FG001|Overall Study|Lost to Follow-up|9|||
161055851|NCT01816685|581594354|FG000|Overall Study|Surgery Cancelled|3|||
161055852|NCT01816685|581594355|FG001|Overall Study|Surgery Cancelled|2|||
161055853|NCT01157351|581594356|FG000|Overall Study|Adverse Event|5|||
161055854|NCT01157351|581594357|FG001|Overall Study|Adverse Event|4|||
161055855|NCT01157351|581594356|FG000|Overall Study|Death|1|||
161055856|NCT01157351|581594357|FG001|Overall Study|Death|0|||
161055857|NCT01157351|581594356|FG000|Overall Study|Lost to Follow-up|53|||
161055858|NCT01157351|581594357|FG001|Overall Study|Lost to Follow-up|55|||
161055859|NCT01157351|581594356|FG000|Overall Study|Withdrawal by Subject|37|||
161055860|NCT01157351|581594357|FG001|Overall Study|Withdrawal by Subject|27|||
161055861|NCT01157351|581594356|FG000|Overall Study|Physician Decision|5|||
161055862|NCT01157351|581594357|FG001|Overall Study|Physician Decision|4|||
161055863|NCT01157351|581594356|FG000|Overall Study|Protocol Violation|0|||
161055864|NCT01157351|581594357|FG001|Overall Study|Protocol Violation|1|||
161055865|NCT01157351|581594356|FG000|Overall Study|Other|32|||
161055866|NCT01157351|581594357|FG001|Overall Study|Other|36|||
161055867|NCT01157351|581594356|FG000|Overall Study|Noncompliance with Study Drug|0|||
161055868|NCT01157351|581594357|FG001|Overall Study|Noncompliance with Study Drug|3|||
161055869|NCT01157351|581594356|FG000|Overall Study|Randomized but not Treated|4|||
161055870|NCT01157351|581594357|FG001|Overall Study|Randomized but not Treated|2|||
161055871|NCT01589523|581594358|FG000|Overall Study|Withdrawal by Subject|1|||
161055872|NCT00332488|581594359|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
161151703|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
161281203|NCT02794870|582408642|FG001|Overall Study|Withdrawal by Subject|0|||
161281204|NCT02540083|582408649|FG000|Overall Study|Withdrawal by Subject|16|||
161055873|NCT00332488|581594360|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
161055874|NCT00332488|581594361|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
161055875|NCT00332488|581594359|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
161281205|NCT02301390|582408650|FG000|Overall Study|Withdrawal by Subject|3|||
161055876|NCT00332488|581594360|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
161055877|NCT00332488|581594361|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
161055878|NCT00332488|581594359|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
161055879|NCT00332488|581594360|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
161055880|NCT00332488|581594361|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
161055881|NCT00332488|581594359|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
161055882|NCT00332488|581594360|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
161055883|NCT00332488|581594361|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
161055884|NCT00332488|581594359|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
161055885|NCT00332488|581594360|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
161055886|NCT00332488|581594361|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
161055887|NCT00332488|581594359|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
161055888|NCT00332488|581594360|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
161055889|NCT00332488|581594361|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
161055890|NCT00332488|581594359|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
161055891|NCT00332488|581594360|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
161055892|NCT00332488|581594361|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
161055893|NCT00332488|581594359|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
161055894|NCT00332488|581594360|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
161055895|NCT00332488|581594361|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
161055896|NCT00332488|581594359|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
161055897|NCT00332488|581594360|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
161055898|NCT00332488|581594361|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
161055899|NCT00332488|581594359|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
161055900|NCT00332488|581594360|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
161055901|NCT00332488|581594361|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
161055902|NCT00332488|581594359|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
161055903|NCT00332488|581594360|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
161055904|NCT00332488|581594361|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
161055905|NCT00332488|581594359|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
161055906|NCT00332488|581594360|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
161055907|NCT00332488|581594361|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
161055908|NCT03721978|581594362|FG000|Overall Study|Withdrawal by Subject|6|||
161055909|NCT03721978|581594363|FG001|Overall Study|Withdrawal by Subject|1|||
161055910|NCT03721978|581594362|FG000|Overall Study|Adverse Event|1|||
161055911|NCT03721978|581594363|FG001|Overall Study|Adverse Event|1|||
161055912|NCT03721978|581594362|FG000|Overall Study|Progressive Disease|1|||
161055913|NCT03721978|581594363|FG001|Overall Study|Progressive Disease|0|||
161055914|NCT03721978|581594362|FG000|Overall Study|Lost to Follow-up|5|||
161055915|NCT03721978|581594363|FG001|Overall Study|Lost to Follow-up|1|||
161055916|NCT03721978|581594362|FG000|Overall Study|Reason not Specified|0|||
161055917|NCT03721978|581594363|FG001|Overall Study|Reason not Specified|2|||
161055918|NCT02675998|581594364|FG000|8-Week Treatment Period|Adverse Event|6|||
161055919|NCT02675998|581594365|FG001|8-Week Treatment Period|Adverse Event|5|||
161055920|NCT02675998|581594366|FG002|8-Week Treatment Period|Adverse Event|6|||
161055921|NCT02675998|581594367|FG003|8-Week Treatment Period|Adverse Event|0|||
161055922|NCT02675998|581594364|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
161055923|NCT02675998|581594365|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
161055924|NCT02675998|581594366|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
161055925|NCT02675998|581594367|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
161055926|NCT02675998|581594364|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
161055927|NCT02675998|581594365|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
161055928|NCT02675998|581594366|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
161055929|NCT02675998|581594367|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
161055930|NCT02675998|581594364|FG000|8-Week Treatment Period|Physician Decision|1|||
161055931|NCT02675998|581594365|FG001|8-Week Treatment Period|Physician Decision|0|||
161055932|NCT02675998|581594366|FG002|8-Week Treatment Period|Physician Decision|2|||
161055933|NCT02675998|581594367|FG003|8-Week Treatment Period|Physician Decision|0|||
161055934|NCT02675998|581594364|FG000|8-Week Treatment Period|GI side Effects|1|||
161055935|NCT02675998|581594365|FG001|8-Week Treatment Period|GI side Effects|4|||
161281206|NCT02301390|582408651|FG001|Overall Study|Withdrawal by Subject|5|||
161281207|NCT02301390|582408650|FG000|Overall Study|Protocol Violation|1|||
161281208|NCT02301390|582408651|FG001|Overall Study|Protocol Violation|0|||
161281209|NCT02301390|582408650|FG000|Overall Study|Physician Decision|1|||
161281210|NCT02301390|582408651|FG001|Overall Study|Physician Decision|0|||
161281211|NCT02301390|582408650|FG000|Overall Study|Lost to Follow-up|0|||
161281212|NCT02301390|582408651|FG001|Overall Study|Lost to Follow-up|1|||
161281213|NCT02301390|582408650|FG000|Overall Study|Death|2|||
161055936|NCT02675998|581594366|FG002|8-Week Treatment Period|GI side Effects|2|||
161281214|NCT02301390|582408651|FG001|Overall Study|Death|2|||
161055937|NCT02675998|581594367|FG003|8-Week Treatment Period|GI side Effects|0|||
161151704|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161151705|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161151706|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161151707|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161151708|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
161151709|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161151710|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
161151711|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161151712|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161151713|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
161151714|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161151715|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
161151716|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
161151717|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
161151718|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
161151719|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
161151720|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161151721|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161151722|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
161151723|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Other|0|||
161151724|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Other|1|||
161151725|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Other|0|||
161151726|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Other|0|||
161151727|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Other|0|||
161151728|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Other|0|||
161151729|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Other|0|||
161151730|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
161151731|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
161151732|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
161151733|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
161151734|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
161151735|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
161151736|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
161151737|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
161151738|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
161151739|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161151740|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
161151741|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
161151742|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161151743|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
161151744|NCT00365716|581937088|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
161151745|NCT00365716|581937089|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
161151746|NCT00365716|581937090|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
161151747|NCT00365716|581937091|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
161151748|NCT00365716|581937092|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
161151749|NCT00365716|581937093|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
161151750|NCT00365716|581937094|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
161055938|NCT02675998|581594364|FG000|8-Week Treatment Period|Protocol Violation|1|||
161055939|NCT02675998|581594365|FG001|8-Week Treatment Period|Protocol Violation|1|||
161055940|NCT02675998|581594366|FG002|8-Week Treatment Period|Protocol Violation|1|||
161055941|NCT02675998|581594367|FG003|8-Week Treatment Period|Protocol Violation|0|||
161055942|NCT02675998|581594364|FG000|8-Week Treatment Period|Other|3|||
161055943|NCT02675998|581594365|FG001|8-Week Treatment Period|Other|1|||
161055944|NCT02675998|581594366|FG002|8-Week Treatment Period|Other|2|||
161055945|NCT02675998|581594367|FG003|8-Week Treatment Period|Other|0|||
161055946|NCT02675998|581594364|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
161055947|NCT02675998|581594365|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
161055948|NCT02675998|581594366|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
161151751|NCT00365716|581937088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
161151752|NCT00365716|581937089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161151753|NCT00365716|581937090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161151754|NCT00365716|581937091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
161151755|NCT00365716|581937092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
161151756|NCT00365716|581937093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161151757|NCT00365716|581937094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
161151758|NCT00365716|581937088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
161151759|NCT00365716|581937089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
161055949|NCT02675998|581594367|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
161055950|NCT02675998|581594364|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
161055951|NCT02675998|581594365|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
161151760|NCT00365716|581937090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
161151761|NCT00365716|581937091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
161151762|NCT00365716|581937092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
161151763|NCT00365716|581937093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
161151764|NCT00365716|581937094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
161151765|NCT00365716|581937088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
161151766|NCT00365716|581937089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
161151767|NCT00365716|581937090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
161151768|NCT00365716|581937091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
161151769|NCT00365716|581937092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161151770|NCT00365716|581937093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161151771|NCT00365716|581937094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
161151772|NCT00365716|581937088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
161151773|NCT00365716|581937089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161151774|NCT00365716|581937090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161151775|NCT00365716|581937091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161151776|NCT00365716|581937092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
161151777|NCT00365716|581937093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161151778|NCT00365716|581937094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
161151779|NCT00365716|581937088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161151780|NCT00365716|581937089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
161055952|NCT02675998|581594366|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
161055953|NCT02675998|581594367|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
161055954|NCT02675998|581594364|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161055955|NCT02675998|581594365|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161055956|NCT02675998|581594366|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
161055957|NCT02675998|581594367|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
161055958|NCT02675998|581594364|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
161055959|NCT02675998|581594365|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
161055960|NCT02675998|581594366|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
161055961|NCT02675998|581594367|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
161055962|NCT02675998|581594364|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
161055963|NCT02675998|581594365|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
161055964|NCT02675998|581594366|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
161055965|NCT02675998|581594367|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
161055966|NCT02561078|581594376|FG000|Overall Study|Adverse Event|5|||
161055967|NCT02561078|581594377|FG001|Overall Study|Adverse Event|2|||
161055968|NCT02561078|581594376|FG000|Overall Study|Death|2|||
161055969|NCT02561078|581594377|FG001|Overall Study|Death|1|||
161055970|NCT02561078|581594376|FG000|Overall Study|Lost to Follow-up|2|||
161055971|NCT02561078|581594377|FG001|Overall Study|Lost to Follow-up|6|||
161055972|NCT02561078|581594376|FG000|Overall Study|Non-Compliance with Study Drug|6|||
161055973|NCT02561078|581594377|FG001|Overall Study|Non-Compliance with Study Drug|3|||
161055974|NCT02561078|581594376|FG000|Overall Study|Physician Decision|2|||
161055975|NCT02561078|581594377|FG001|Overall Study|Physician Decision|3|||
161055976|NCT02561078|581594376|FG000|Overall Study|Withdrawal by Subject|13|||
161055977|NCT02561078|581594377|FG001|Overall Study|Withdrawal by Subject|10|||
161055978|NCT00598871|581594378|FG000|Overall Study|Adverse Event|0|||
161055979|NCT00598871|581594379|FG001|Overall Study|Adverse Event|1|||
161055980|NCT01194271|581594380|FG000|Overall Study|Withdrawal by Subject|1|||
161055981|NCT01194271|581594380|FG000|Overall Study|Ineligible, Screen Failure|1|||
161055982|NCT01194271|581594380|FG000|Overall Study|Death|1|||
161055983|NCT00443898|581594381|FG000|Overall Study|Adverse Event|0|||
161055984|NCT00443898|581594382|FG001|Overall Study|Adverse Event|0|||
161055985|NCT00443898|581594383|FG002|Overall Study|Adverse Event|1|||
161055986|NCT00443898|581594384|FG003|Overall Study|Adverse Event|1|||
161055987|NCT00443898|581594381|FG000|Overall Study|Lack of Efficacy|2|||
161055988|NCT00443898|581594382|FG001|Overall Study|Lack of Efficacy|3|||
161055989|NCT00443898|581594383|FG002|Overall Study|Lack of Efficacy|3|||
161055990|NCT00443898|581594384|FG003|Overall Study|Lack of Efficacy|1|||
161055991|NCT00443898|581594381|FG000|Overall Study|Protocol Violation|1|||
161055992|NCT00443898|581594382|FG001|Overall Study|Protocol Violation|1|||
161055993|NCT00443898|581594383|FG002|Overall Study|Protocol Violation|1|||
161055994|NCT00443898|581594384|FG003|Overall Study|Protocol Violation|0|||
161055995|NCT00443898|581594381|FG000|Overall Study|Withdrawal by Subject|11|||
161055996|NCT00443898|581594382|FG001|Overall Study|Withdrawal by Subject|10|||
161055997|NCT00443898|581594383|FG002|Overall Study|Withdrawal by Subject|10|||
161055998|NCT00443898|581594384|FG003|Overall Study|Withdrawal by Subject|6|||
161055999|NCT00443898|581594381|FG000|Overall Study|Lost to Follow-up|10|||
161056000|NCT00443898|581594382|FG001|Overall Study|Lost to Follow-up|10|||
161056001|NCT00443898|581594383|FG002|Overall Study|Lost to Follow-up|14|||
161056002|NCT00443898|581594384|FG003|Overall Study|Lost to Follow-up|10|||
161056003|NCT00443898|581594381|FG000|Overall Study|Death|0|||
161056004|NCT00443898|581594382|FG001|Overall Study|Death|1|||
161056005|NCT00443898|581594383|FG002|Overall Study|Death|0|||
161056006|NCT00443898|581594384|FG003|Overall Study|Death|0|||
161056007|NCT00043186|581594385|FG000|Overall Study|Physician Decision|0|||
161056008|NCT00043186|581594386|FG001|Overall Study|Physician Decision|0|||
161056009|NCT00043186|581594387|FG002|Overall Study|Physician Decision|3|||
161056010|NCT00043186|581594388|FG003|Overall Study|Physician Decision|0|||
161056011|NCT00043186|581594389|FG004|Overall Study|Physician Decision|1|||
161056012|NCT00043186|581594390|FG005|Overall Study|Physician Decision|0|||
161056013|NCT00043186|581594391|FG006|Overall Study|Physician Decision|0|||
161056014|NCT00043186|581594392|FG007|Overall Study|Physician Decision|1|||
161056015|NCT00043186|581594393|FG008|Overall Study|Physician Decision|1|||
161056016|NCT00043186|581594385|FG000|Overall Study|Adverse Event|2|||
161056017|NCT00043186|581594386|FG001|Overall Study|Adverse Event|2|||
161056018|NCT00043186|581594387|FG002|Overall Study|Adverse Event|2|||
161056019|NCT00043186|581594388|FG003|Overall Study|Adverse Event|3|||
161056020|NCT00043186|581594389|FG004|Overall Study|Adverse Event|2|||
161056021|NCT00043186|581594390|FG005|Overall Study|Adverse Event|1|||
161056022|NCT00043186|581594391|FG006|Overall Study|Adverse Event|2|||
161056023|NCT00043186|581594392|FG007|Overall Study|Adverse Event|1|||
161056024|NCT00043186|581594393|FG008|Overall Study|Adverse Event|3|||
161056025|NCT00043186|581594385|FG000|Overall Study|Withdrawal by Subject|11|||
161056026|NCT00043186|581594386|FG001|Overall Study|Withdrawal by Subject|8|||
161056027|NCT00043186|581594387|FG002|Overall Study|Withdrawal by Subject|11|||
161056028|NCT00043186|581594388|FG003|Overall Study|Withdrawal by Subject|13|||
161056029|NCT00043186|581594389|FG004|Overall Study|Withdrawal by Subject|14|||
161056030|NCT00043186|581594390|FG005|Overall Study|Withdrawal by Subject|6|||
161056031|NCT00043186|581594391|FG006|Overall Study|Withdrawal by Subject|12|||
161056032|NCT00043186|581594392|FG007|Overall Study|Withdrawal by Subject|9|||
161056033|NCT00043186|581594393|FG008|Overall Study|Withdrawal by Subject|10|||
161056034|NCT00043186|581594385|FG000|Overall Study|Death|0|||
161056035|NCT00043186|581594386|FG001|Overall Study|Death|0|||
161056036|NCT00043186|581594387|FG002|Overall Study|Death|1|||
161056037|NCT00043186|581594388|FG003|Overall Study|Death|0|||
161056038|NCT00043186|581594389|FG004|Overall Study|Death|0|||
161056039|NCT00043186|581594390|FG005|Overall Study|Death|0|||
161056040|NCT00043186|581594391|FG006|Overall Study|Death|2|||
161056041|NCT00043186|581594392|FG007|Overall Study|Death|0|||
161056042|NCT00043186|581594393|FG008|Overall Study|Death|0|||
161056043|NCT00043186|581594385|FG000|Overall Study|Disease progression|1|||
161056044|NCT00043186|581594386|FG001|Overall Study|Disease progression|0|||
161056045|NCT00043186|581594387|FG002|Overall Study|Disease progression|0|||
161056046|NCT00043186|581594388|FG003|Overall Study|Disease progression|3|||
161056047|NCT00043186|581594389|FG004|Overall Study|Disease progression|0|||
161056048|NCT00043186|581594390|FG005|Overall Study|Disease progression|0|||
161056049|NCT00043186|581594391|FG006|Overall Study|Disease progression|0|||
161056050|NCT00043186|581594392|FG007|Overall Study|Disease progression|4|||
161056051|NCT00043186|581594393|FG008|Overall Study|Disease progression|0|||
161056052|NCT00043186|581594385|FG000|Overall Study|Ineligibility determined|0|||
161056053|NCT00043186|581594386|FG001|Overall Study|Ineligibility determined|0|||
161056054|NCT00043186|581594387|FG002|Overall Study|Ineligibility determined|0|||
161056055|NCT00043186|581594388|FG003|Overall Study|Ineligibility determined|0|||
161056056|NCT00043186|581594389|FG004|Overall Study|Ineligibility determined|0|||
161056057|NCT00043186|581594390|FG005|Overall Study|Ineligibility determined|0|||
161056058|NCT00043186|581594391|FG006|Overall Study|Ineligibility determined|0|||
161056059|NCT00043186|581594392|FG007|Overall Study|Ineligibility determined|0|||
161056060|NCT00043186|581594393|FG008|Overall Study|Ineligibility determined|1|||
161056061|NCT00043186|581594385|FG000|Overall Study|Lost to Follow-up|3|||
161056062|NCT00043186|581594386|FG001|Overall Study|Lost to Follow-up|5|||
161056063|NCT00043186|581594387|FG002|Overall Study|Lost to Follow-up|1|||
161056064|NCT00043186|581594388|FG003|Overall Study|Lost to Follow-up|1|||
161056065|NCT00043186|581594389|FG004|Overall Study|Lost to Follow-up|1|||
161056066|NCT00043186|581594390|FG005|Overall Study|Lost to Follow-up|1|||
161056067|NCT00043186|581594391|FG006|Overall Study|Lost to Follow-up|1|||
161056068|NCT00043186|581594392|FG007|Overall Study|Lost to Follow-up|1|||
161056069|NCT00043186|581594393|FG008|Overall Study|Lost to Follow-up|2|||
161056070|NCT00043186|581594385|FG000|Overall Study|Noncompliance|0|||
161056071|NCT00043186|581594386|FG001|Overall Study|Noncompliance|0|||
161056072|NCT00043186|581594387|FG002|Overall Study|Noncompliance|1|||
161056073|NCT00043186|581594388|FG003|Overall Study|Noncompliance|1|||
161056074|NCT00043186|581594389|FG004|Overall Study|Noncompliance|0|||
161056075|NCT00043186|581594390|FG005|Overall Study|Noncompliance|0|||
161056076|NCT00043186|581594391|FG006|Overall Study|Noncompliance|0|||
161056077|NCT00043186|581594392|FG007|Overall Study|Noncompliance|0|||
161056078|NCT00043186|581594393|FG008|Overall Study|Noncompliance|0|||
161056079|NCT00043186|581594385|FG000|Overall Study|Other|0|||
161056080|NCT00043186|581594386|FG001|Overall Study|Other|0|||
161056081|NCT00043186|581594387|FG002|Overall Study|Other|1|||
161056082|NCT00043186|581594388|FG003|Overall Study|Other|1|||
161056083|NCT00043186|581594389|FG004|Overall Study|Other|0|||
161151781|NCT00365716|581937090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
161151782|NCT00365716|581937091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161151783|NCT00365716|581937092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161151784|NCT00365716|581937093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161151785|NCT00365716|581937094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
161151786|NCT00365716|581937088|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
161151787|NCT00365716|581937089|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
161151788|NCT00365716|581937090|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
161151789|NCT00365716|581937091|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
161151790|NCT00365716|581937092|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
161151791|NCT00365716|581937093|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
161151792|NCT00365716|581937094|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
161151793|NCT00365716|581937088|FG000|Extension 1|Lost to Follow-up|0|||
161151794|NCT00365716|581937089|FG001|Extension 1|Lost to Follow-up|0|||
161151795|NCT00365716|581937090|FG002|Extension 1|Lost to Follow-up|0|||
161151796|NCT00365716|581937091|FG003|Extension 1|Lost to Follow-up|0|||
161151797|NCT00365716|581937092|FG004|Extension 1|Lost to Follow-up|0|||
161151798|NCT00365716|581937093|FG005|Extension 1|Lost to Follow-up|1|||
161151799|NCT00365716|581937094|FG006|Extension 1|Lost to Follow-up|0|||
161151800|NCT00365716|581937088|FG000|Extension 1|Other|0|||
161151801|NCT00365716|581937089|FG001|Extension 1|Other|0|||
161151802|NCT00365716|581937090|FG002|Extension 1|Other|0|||
161151803|NCT00365716|581937091|FG003|Extension 1|Other|0|||
161151804|NCT00365716|581937092|FG004|Extension 1|Other|0|||
161151805|NCT00365716|581937093|FG005|Extension 1|Other|9|||
161151806|NCT00365716|581937094|FG006|Extension 1|Other|0|||
161151807|NCT00365716|581937088|FG000|Extension 1|Moved|0|||
161151808|NCT00365716|581937089|FG001|Extension 1|Moved|0|||
161151809|NCT00365716|581937090|FG002|Extension 1|Moved|0|||
161151810|NCT00365716|581937091|FG003|Extension 1|Moved|0|||
161151811|NCT00365716|581937092|FG004|Extension 1|Moved|0|||
161151812|NCT00365716|581937093|FG005|Extension 1|Moved|4|||
161151813|NCT00365716|581937094|FG006|Extension 1|Moved|0|||
161151814|NCT00365716|581937088|FG000|Extension 1|Withdrawal by Subject|0|||
161151815|NCT00365716|581937089|FG001|Extension 1|Withdrawal by Subject|0|||
161151816|NCT00365716|581937090|FG002|Extension 1|Withdrawal by Subject|0|||
161151817|NCT00365716|581937091|FG003|Extension 1|Withdrawal by Subject|0|||
161151818|NCT00365716|581937092|FG004|Extension 1|Withdrawal by Subject|0|||
161151819|NCT00365716|581937093|FG005|Extension 1|Withdrawal by Subject|3|||
161151820|NCT00365716|581937094|FG006|Extension 1|Withdrawal by Subject|0|||
161151821|NCT00365716|581937088|FG000|Extension 1|Pregnancy|0|||
161281215|NCT02301390|582408650|FG000|Overall Study|Procedure not completed|0|||
161281216|NCT02301390|582408651|FG001|Overall Study|Procedure not completed|4|||
161281217|NCT02301390|582408650|FG000|Overall Study|Missed multiple visits|1|||
161056084|NCT00043186|581594390|FG005|Overall Study|Other|0|||
161056085|NCT00043186|581594391|FG006|Overall Study|Other|0|||
161056086|NCT00043186|581594392|FG007|Overall Study|Other|0|||
161056087|NCT00043186|581594393|FG008|Overall Study|Other|0|||
161056088|NCT01145417|581594404|FG000|Overall Study|Death|1|||
161056089|NCT01145417|581594405|FG001|Overall Study|Death|0|||
161056090|NCT01145417|581594404|FG000|Overall Study|Lost to Follow-up|2|||
161056091|NCT01145417|581594405|FG001|Overall Study|Lost to Follow-up|1|||
161056092|NCT01145417|581594404|FG000|Overall Study|Withdrawal by Subject|1|||
161056093|NCT01145417|581594405|FG001|Overall Study|Withdrawal by Subject|2|||
161056094|NCT01145417|581594404|FG000|Overall Study|Pregnancy|1|||
161056095|NCT01145417|581594405|FG001|Overall Study|Pregnancy|0|||
161056096|NCT01145417|581594404|FG000|Overall Study|Adverse Event|0|||
161056097|NCT01145417|581594405|FG001|Overall Study|Adverse Event|1|||
161056098|NCT01145417|581594404|FG000|Overall Study|Study terminated by sponsor|35|||
161151822|NCT00365716|581937089|FG001|Extension 1|Pregnancy|0|||
161151823|NCT00365716|581937090|FG002|Extension 1|Pregnancy|0|||
161151824|NCT00365716|581937091|FG003|Extension 1|Pregnancy|0|||
161151825|NCT00365716|581937092|FG004|Extension 1|Pregnancy|0|||
161281218|NCT02301390|582408651|FG001|Overall Study|Missed multiple visits|1|||
161056099|NCT01145417|581594405|FG001|Overall Study|Study terminated by sponsor|43|||
161151826|NCT00365716|581937093|FG005|Extension 1|Pregnancy|4|||
161151827|NCT00365716|581937094|FG006|Extension 1|Pregnancy|0|||
161151828|NCT00365716|581937088|FG000|Extension 1|Protocol Violation|0|||
161151829|NCT00365716|581937089|FG001|Extension 1|Protocol Violation|0|||
161151830|NCT00365716|581937090|FG002|Extension 1|Protocol Violation|0|||
161281219|NCT02301390|582408650|FG000|Overall Study|study terminated|2|||
161281220|NCT02301390|582408651|FG001|Overall Study|study terminated|0|||
161056100|NCT01145417|581594404|FG000|Overall Study|Other|1|||
161151831|NCT00365716|581937091|FG003|Extension 1|Protocol Violation|0|||
161151832|NCT00365716|581937092|FG004|Extension 1|Protocol Violation|0|||
161151833|NCT00365716|581937093|FG005|Extension 1|Protocol Violation|1|||
161151834|NCT00365716|581937094|FG006|Extension 1|Protocol Violation|0|||
161151835|NCT00365716|581937088|FG000|Extension 2|Lost to Follow-up|0|||
161151836|NCT00365716|581937089|FG001|Extension 2|Lost to Follow-up|0|||
161151837|NCT00365716|581937090|FG002|Extension 2|Lost to Follow-up|0|||
161151838|NCT00365716|581937091|FG003|Extension 2|Lost to Follow-up|0|||
161151839|NCT00365716|581937092|FG004|Extension 2|Lost to Follow-up|0|||
161151840|NCT00365716|581937093|FG005|Extension 2|Lost to Follow-up|0|||
161151841|NCT00365716|581937094|FG006|Extension 2|Lost to Follow-up|2|||
161151842|NCT00365716|581937088|FG000|Extension 2|Other|0|||
161151843|NCT00365716|581937089|FG001|Extension 2|Other|0|||
161151844|NCT00365716|581937090|FG002|Extension 2|Other|0|||
161151845|NCT00365716|581937091|FG003|Extension 2|Other|0|||
161151846|NCT00365716|581937092|FG004|Extension 2|Other|0|||
161151847|NCT00365716|581937093|FG005|Extension 2|Other|0|||
161151848|NCT00365716|581937094|FG006|Extension 2|Other|3|||
161151849|NCT00365716|581937088|FG000|Extension 2|Withdrawal by Subject|0|||
161151850|NCT00365716|581937089|FG001|Extension 2|Withdrawal by Subject|0|||
161151851|NCT00365716|581937090|FG002|Extension 2|Withdrawal by Subject|0|||
161151852|NCT00365716|581937091|FG003|Extension 2|Withdrawal by Subject|0|||
161151853|NCT00365716|581937092|FG004|Extension 2|Withdrawal by Subject|0|||
161151854|NCT00365716|581937093|FG005|Extension 2|Withdrawal by Subject|0|||
161151855|NCT00365716|581937094|FG006|Extension 2|Withdrawal by Subject|5|||
161151856|NCT02853331|581937095|FG000|Overall Study|Death|59|||
161151857|NCT02853331|581937096|FG001|Overall Study|Death|95|||
161151858|NCT02853331|581937095|FG000|Overall Study|Withdrawal by Subject|5|||
161151859|NCT02853331|581937096|FG001|Overall Study|Withdrawal by Subject|9|||
161151860|NCT02853331|581937095|FG000|Overall Study|Ongoing in study|368|||
161151861|NCT02853331|581937096|FG001|Overall Study|Ongoing in study|325|||
161151862|NCT00751101|581937097|FG000|Overall Study|Withdrawal by Subject|1|||
161151863|NCT00751101|581937098|FG001|Overall Study|Withdrawal by Subject|0|||
161151864|NCT00751101|581937097|FG000|Overall Study|No HFS / Never Started Patch/|0|||
161151865|NCT00751101|581937098|FG001|Overall Study|No HFS / Never Started Patch/|4|||
161151866|NCT00751101|581937097|FG000|Overall Study|Never began capecitabine|1|||
161151867|NCT00751101|581937098|FG001|Overall Study|Never began capecitabine|0|||
161151868|NCT00751101|581937097|FG000|Overall Study|Physician Decision|0|||
161151869|NCT00751101|581937098|FG001|Overall Study|Physician Decision|1|||
161151870|NCT00844428|581937102|FG000|Screening Period|Screen Failure|3|||
161151871|NCT00844428|581937102|FG000|Extension Treatment Period|Death|1|||
161151872|NCT00844428|581937102|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
161151873|NCT00789477|581937103|FG000|Overall Study|Withdrawal by Subject|2|||
161151874|NCT00789477|581937104|FG001|Overall Study|Withdrawal by Subject|1|||
161151875|NCT00789477|581937105|FG002|Overall Study|Withdrawal by Subject|3|||
161151876|NCT00789477|581937106|FG003|Overall Study|Withdrawal by Subject|2|||
161151877|NCT00789477|581937107|FG004|Overall Study|Withdrawal by Subject|3|||
161151878|NCT00789477|581937103|FG000|Overall Study|Protocol Violation|1|||
161151879|NCT00789477|581937104|FG001|Overall Study|Protocol Violation|0|||
161151880|NCT00789477|581937105|FG002|Overall Study|Protocol Violation|0|||
161151881|NCT00789477|581937106|FG003|Overall Study|Protocol Violation|1|||
161151882|NCT00789477|581937107|FG004|Overall Study|Protocol Violation|0|||
161056101|NCT01145417|581594405|FG001|Overall Study|Other|0|||
161056102|NCT01441583|581594406|FG000|Overall Study|Withdrawal by Subject|1|||
161056103|NCT01441583|581594407|FG001|Overall Study|Withdrawal by Subject|1|||
161056104|NCT01441583|581594408|FG002|Overall Study|Withdrawal by Subject|1|||
161056105|NCT01441583|581594406|FG000|Overall Study|Death|1|||
161056106|NCT01441583|581594407|FG001|Overall Study|Death|0|||
161056107|NCT01441583|581594408|FG002|Overall Study|Death|4|||
161056108|NCT01441583|581594406|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
161056109|NCT01441583|581594407|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
161056110|NCT01441583|581594408|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
161056111|NCT03275402|581594409|FG000|Overall Study|Death|17|||
161056112|NCT03275402|581594409|FG000|Overall Study|Study terminated by sponsor|21|||
161056113|NCT03275402|581594409|FG000|Overall Study|Withdrawal by Subject|1|||
161056114|NCT02253147|581594411|FG000|Overall Study|Protocol Violation|30|||
161056115|NCT02253147|581594411|FG000|Overall Study|Did not consent to study extension|9|||
161056116|NCT02253147|581594411|FG000|Overall Study|Conditional re-treatment at W52|5|||
161056117|NCT02253147|581594411|FG000|Overall Study|Lost to Follow-up|2|||
161056118|NCT02253147|581594411|FG000|Overall Study|Withdrawal by Subject|1|||
161151883|NCT00789477|581937103|FG000|Overall Study|Adverse Event|3|||
161151884|NCT00789477|581937104|FG001|Overall Study|Adverse Event|3|||
161151885|NCT00789477|581937105|FG002|Overall Study|Adverse Event|1|||
161151886|NCT00789477|581937106|FG003|Overall Study|Adverse Event|0|||
161151887|NCT00789477|581937107|FG004|Overall Study|Adverse Event|0|||
161281221|NCT00185588|582408652|FG000|Overall Study|Adverse Event|3|||
161056119|NCT02986659|581594412|FG000|First Intervention Period|Adverse Event|3|||
161056120|NCT02986659|581594413|FG001|First Intervention Period|Adverse Event|1|||
161151888|NCT00789477|581937103|FG000|Overall Study|Death|1|||
161151889|NCT00789477|581937104|FG001|Overall Study|Death|1|||
161151890|NCT00789477|581937105|FG002|Overall Study|Death|2|||
161151891|NCT00789477|581937106|FG003|Overall Study|Death|2|||
161056121|NCT02986659|581594412|FG000|First Intervention Period|Lost to Follow-up|1|||
161151892|NCT00789477|581937107|FG004|Overall Study|Death|0|||
161151893|NCT00789477|581937103|FG000|Overall Study|Lost to Follow-up|0|||
161151894|NCT00789477|581937104|FG001|Overall Study|Lost to Follow-up|1|||
161151895|NCT00789477|581937105|FG002|Overall Study|Lost to Follow-up|4|||
161056122|NCT02986659|581594413|FG001|First Intervention Period|Lost to Follow-up|0|||
161056123|NCT02986659|581594412|FG000|First Intervention Period|Withdrawal by Subject|0|||
161056124|NCT02986659|581594413|FG001|First Intervention Period|Withdrawal by Subject|1|||
161056125|NCT02986659|581594412|FG000|Second Intervention Period|Adverse Event|0|||
161056126|NCT02986659|581594413|FG001|Second Intervention Period|Adverse Event|6|||
161056127|NCT02469077|581594414|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
161056128|NCT02469077|581594415|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
161056129|NCT02469077|581594414|FG000|Post Randomization/Intervention Period|Relocated|1|||
161056130|NCT02469077|581594415|FG001|Post Randomization/Intervention Period|Relocated|1|||
161056131|NCT02469077|581594414|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
161056132|NCT02469077|581594415|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
161056133|NCT02469077|581594414|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
161056134|NCT02469077|581594415|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
161056135|NCT05012397|581594416|FG000|Overall Study|Death|10|||
161056136|NCT05012397|581594416|FG000|Overall Study|Physician Decision|9|||
161056137|NCT05012397|581594416|FG000|Overall Study|Withdrawal by Subject|5|||
161056138|NCT05012397|581594416|FG000|Overall Study|Lost to Follow-up|2|||
161056139|NCT03334747|581594417|FG000|Treatment Phase|Technical problems|0|||
161056140|NCT03334747|581594418|FG001|Treatment Phase|Technical problems|0|||
161056141|NCT03334747|581594419|FG002|Treatment Phase|Technical problems|0|||
161056142|NCT03334747|581594420|FG003|Treatment Phase|Technical problems|0|||
161056143|NCT03334747|581594421|FG004|Treatment Phase|Technical problems|1|||
161056144|NCT03334747|581594422|FG005|Treatment Phase|Technical problems|0|||
161056145|NCT03334747|581594423|FG006|Treatment Phase|Technical problems|0|||
161056146|NCT03334747|581594424|FG007|Treatment Phase|Technical problems|0|||
161056147|NCT03334747|581594425|FG008|Treatment Phase|Technical problems|0|||
161056148|NCT03334747|581594417|FG000|Treatment Phase|Subject/guardian decision|1|||
161056149|NCT03334747|581594418|FG001|Treatment Phase|Subject/guardian decision|0|||
161056150|NCT03334747|581594419|FG002|Treatment Phase|Subject/guardian decision|0|||
161056151|NCT03334747|581594420|FG003|Treatment Phase|Subject/guardian decision|0|||
161056152|NCT03334747|581594421|FG004|Treatment Phase|Subject/guardian decision|0|||
161056153|NCT03334747|581594422|FG005|Treatment Phase|Subject/guardian decision|1|||
161056154|NCT03334747|581594423|FG006|Treatment Phase|Subject/guardian decision|0|||
161056155|NCT03334747|581594424|FG007|Treatment Phase|Subject/guardian decision|0|||
161056156|NCT03334747|581594425|FG008|Treatment Phase|Subject/guardian decision|0|||
161056157|NCT03334747|581594417|FG000|Follow-Up Phase|Subject/guardian decision|0|||
161056158|NCT03334747|581594418|FG001|Follow-Up Phase|Subject/guardian decision|0|||
161056159|NCT03334747|581594419|FG002|Follow-Up Phase|Subject/guardian decision|0|||
161056160|NCT03334747|581594420|FG003|Follow-Up Phase|Subject/guardian decision|0|||
161056161|NCT03334747|581594421|FG004|Follow-Up Phase|Subject/guardian decision|0|||
161056162|NCT03334747|581594422|FG005|Follow-Up Phase|Subject/guardian decision|0|||
161056163|NCT03334747|581594423|FG006|Follow-Up Phase|Subject/guardian decision|1|||
161056164|NCT03334747|581594424|FG007|Follow-Up Phase|Subject/guardian decision|0|||
161056165|NCT03334747|581594425|FG008|Follow-Up Phase|Subject/guardian decision|1|||
161056166|NCT00191984|581594426|FG000|Overall Study|Disease Progression|21|||
161056167|NCT00191984|581594426|FG000|Overall Study|Adverse Event|4|||
161056168|NCT00191984|581594426|FG000|Overall Study|Death|2|||
161056169|NCT00191984|581594426|FG000|Overall Study|Entry Criteria Exclusion|1|||
161056170|NCT00191984|581594426|FG000|Overall Study|Withdrawal by Subject|7|||
161056171|NCT00191984|581594426|FG000|Overall Study|Physician Decision|4|||
161056172|NCT03303521|581594427|FG000|Overall Study|Withdrawal by Subject|2|||
161056173|NCT03303521|581594428|FG001|Overall Study|Withdrawal by Subject|0|||
161056174|NCT03303521|581594427|FG000|Overall Study|Death|1|||
161056175|NCT03303521|581594428|FG001|Overall Study|Death|0|||
161056176|NCT03303521|581594427|FG000|Overall Study|Kidney transplantation|0|||
161056177|NCT03303521|581594428|FG001|Overall Study|Kidney transplantation|1|||
161056178|NCT03303521|581594427|FG000|Overall Study|Investigational product discontinuation|0|||
161056179|NCT03303521|581594428|FG001|Overall Study|Investigational product discontinuation|1|||
161056180|NCT03303521|581594427|FG000|Overall Study|Transferred to non-study dialysis center|1|||
161056181|NCT03303521|581594428|FG001|Overall Study|Transferred to non-study dialysis center|0|||
161056182|NCT03303521|581594427|FG000|Overall Study|Non-comliance to study protocol|0|||
161056183|NCT03303521|581594428|FG001|Overall Study|Non-comliance to study protocol|1|||
161056184|NCT03303521|581594427|FG000|Overall Study|Adverse Event|1|||
161056185|NCT03303521|581594428|FG001|Overall Study|Adverse Event|0|||
161056186|NCT01654289|581594429|FG000|Overall Study|Withdrawal by Subject|10|||
161056187|NCT01654289|581594430|FG001|Overall Study|Withdrawal by Subject|8|||
161056188|NCT01654289|581594431|FG002|Overall Study|Withdrawal by Subject|5|||
161056189|NCT01654289|581594429|FG000|Overall Study|Withdrew from intervention only|17|||
161056190|NCT01654289|581594430|FG001|Overall Study|Withdrew from intervention only|20|||
161056191|NCT01654289|581594431|FG002|Overall Study|Withdrew from intervention only|0|||
161345130|NCT00294658|582648869|FG001|Overall Study|Withdrawal by Subject|4|||
161056192|NCT00005908|581594435|FG000|Overall Study|Withdrawal by Subject|1|||
161345131|NCT00294658|582648868|FG000|Overall Study|Found to have invasive thymoma|1|||
161056193|NCT00005908|581594436|FG001|Overall Study|Withdrawal by Subject|0|||
161056194|NCT04748445|581594437|FG000|Overall Study|No longer met eligibility criteria|12|||
161056195|NCT04748445|581594437|FG000|Overall Study|Other|36|||
161056196|NCT04748445|581594437|FG000|Overall Study|Withdrawal by Subject|553|||
161056197|NCT04748445|581594437|FG000|Overall Study|Lost to Follow-up|30|||
161056198|NCT04736602|581594438|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
161056199|NCT04736602|581594438|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
161056200|NCT00938041|581594445|FG000|Overall Study|Lost to Follow-up|6|||
161056201|NCT00938041|581594445|FG000|Overall Study|Received Alternative Therapy|1|||
161056202|NCT00938041|581594445|FG000|Overall Study|Progressive Disease|5|||
161056203|NCT00938041|581594445|FG000|Overall Study|Death|12|||
161056204|NCT00938041|581594445|FG000|Overall Study|Adrenal Insufficiency|3|||
161056205|NCT02504502|581594446|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
161056206|NCT02504502|581594447|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
161056207|NCT02504502|581594446|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
161056208|NCT02504502|581594447|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
161056209|NCT03042559|581594451|FG000|Overall Study|drop out|1|||
161056210|NCT03042559|581594452|FG001|Overall Study|drop out|1|||
161056211|NCT01536535|581594454|FG000|Overall Study|Withdrawal by Subject|10|||
161056212|NCT01536535|581594455|FG001|Overall Study|Withdrawal by Subject|5|||
161056213|NCT01536535|581594454|FG000|Overall Study|Lost to Follow-up|4|||
161056214|NCT01536535|581594455|FG001|Overall Study|Lost to Follow-up|6|||
161056215|NCT01536535|581594454|FG000|Overall Study|Physician Decision|1|||
161056216|NCT01536535|581594455|FG001|Overall Study|Physician Decision|1|||
161056217|NCT01536535|581594454|FG000|Overall Study|Participant moved|0|||
161056218|NCT01536535|581594455|FG001|Overall Study|Participant moved|1|||
161056219|NCT00404547|581594456|FG000|Overall Study|Adverse Event|39|||
161056220|NCT00404547|581594457|FG001|Overall Study|Adverse Event|6|||
161056221|NCT00404547|581594456|FG000|Overall Study|Withdrawal by Subject|19|||
161056222|NCT00404547|581594457|FG001|Overall Study|Withdrawal by Subject|2|||
161056223|NCT00404547|581594456|FG000|Overall Study|Protocol Violation|0|||
161056224|NCT00404547|581594457|FG001|Overall Study|Protocol Violation|1|||
161056225|NCT00404547|581594456|FG000|Overall Study|Lost to Follow-up|20|||
161056226|NCT00404547|581594457|FG001|Overall Study|Lost to Follow-up|9|||
161056227|NCT00404547|581594456|FG000|Overall Study|Lack of compliance|5|||
161056228|NCT00404547|581594457|FG001|Overall Study|Lack of compliance|1|||
161056229|NCT00404547|581594456|FG000|Overall Study|Other|4|||
161056230|NCT00404547|581594457|FG001|Overall Study|Other|0|||
161056231|NCT00404547|581594456|FG000|Overall Study|Reason not stated|3|||
161056232|NCT00404547|581594457|FG001|Overall Study|Reason not stated|6|||
161056233|NCT01485991|581594458|FG000|Overall Study|Adverse Event|0|||
161056234|NCT01485991|581594459|FG001|Overall Study|Adverse Event|4|||
161056235|NCT01485991|581594458|FG000|Overall Study|Lost to Follow-up|13|||
161056236|NCT01485991|581594459|FG001|Overall Study|Lost to Follow-up|10|||
161056237|NCT01485991|581594458|FG000|Overall Study|Withdrawal by Subject|13|||
161056238|NCT01485991|581594459|FG001|Overall Study|Withdrawal by Subject|20|||
161056239|NCT01485991|581594458|FG000|Overall Study|randomized but not treated|6|||
161056240|NCT01485991|581594459|FG001|Overall Study|randomized but not treated|2|||
161056241|NCT01475370|581594460|FG000|Overall Study|Exacerbation of primary disease|2|||
161056242|NCT01475370|581594461|FG001|Overall Study|Exacerbation of primary disease|2|||
161056243|NCT01475370|581594462|FG002|Overall Study|Exacerbation of primary disease|2|||
161056244|NCT01475370|581594460|FG000|Overall Study|Study drug administration difficult|0|||
161151896|NCT00789477|581937106|FG003|Overall Study|Lost to Follow-up|2|||
161151897|NCT00789477|581937107|FG004|Overall Study|Lost to Follow-up|4|||
161151898|NCT00789477|581937103|FG000|Overall Study|Lack of Efficacy|2|||
161151899|NCT00789477|581937104|FG001|Overall Study|Lack of Efficacy|0|||
161151900|NCT00789477|581937105|FG002|Overall Study|Lack of Efficacy|0|||
161151901|NCT00789477|581937106|FG003|Overall Study|Lack of Efficacy|0|||
161151902|NCT00789477|581937107|FG004|Overall Study|Lack of Efficacy|0|||
161151903|NCT00789477|581937103|FG000|Overall Study|Other|2|||
161151904|NCT00789477|581937104|FG001|Overall Study|Other|0|||
161151905|NCT00789477|581937105|FG002|Overall Study|Other|1|||
161151906|NCT00789477|581937106|FG003|Overall Study|Other|3|||
161151907|NCT00789477|581937107|FG004|Overall Study|Other|0|||
161151908|NCT00455858|581937108|FG000|Overall Study|Lost to Follow-up|2|||
161056245|NCT01475370|581594461|FG001|Overall Study|Study drug administration difficult|1|||
161056246|NCT01475370|581594462|FG002|Overall Study|Study drug administration difficult|1|||
161056247|NCT01475370|581594460|FG000|Overall Study|Other than specified|1|||
161056248|NCT01475370|581594461|FG001|Overall Study|Other than specified|0|||
161056249|NCT01475370|581594462|FG002|Overall Study|Other than specified|0|||
161056250|NCT04372186|581594463|FG000|Overall Study|Death|24|||
161056251|NCT04372186|581594464|FG001|Overall Study|Death|11|||
161056252|NCT04372186|581594463|FG000|Overall Study|Transferred to a different facility for care|0|||
161056253|NCT04372186|581594464|FG001|Overall Study|Transferred to a different facility for care|2|||
161056254|NCT04736472|581594465|FG000|Overall Study|Lost to Follow-up|1|||
161056255|NCT04736472|581594466|FG001|Overall Study|Lost to Follow-up|0|||
161056256|NCT04736472|581594467|FG002|Overall Study|Lost to Follow-up|0|||
161151909|NCT00455858|581937108|FG000|Overall Study|Protocol Violation|1|||
161056257|NCT04736472|581594465|FG000|Overall Study|Withdrawal by Subject|2|||
161056258|NCT04736472|581594466|FG001|Overall Study|Withdrawal by Subject|0|||
161056259|NCT04736472|581594467|FG002|Overall Study|Withdrawal by Subject|0|||
161056260|NCT04736472|581594465|FG000|Overall Study|Protocol Violation|48|||
161056261|NCT04736472|581594466|FG001|Overall Study|Protocol Violation|0|||
161056262|NCT04736472|581594467|FG002|Overall Study|Protocol Violation|6|||
161056263|NCT00577096|581594470|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
161056264|NCT00577096|581594471|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
161056265|NCT00577096|581594470|FG000|Short Term Participation|Withdrawal by Subject|3|||
161056266|NCT00577096|581594471|FG001|Short Term Participation|Withdrawal by Subject|5|||
161056267|NCT00577096|581594470|FG000|Short Term Participation|Death|1|||
161056268|NCT00577096|581594471|FG001|Short Term Participation|Death|1|||
161056269|NCT00832650|581594472|FG000|Overall Study|Randomized but not treated|0|||
161056270|NCT00832650|581594473|FG001|Overall Study|Randomized but not treated|0|||
161056271|NCT00832650|581594474|FG002|Overall Study|Randomized but not treated|1|||
161056272|NCT00440037|581594476|FG000|Overall Study|Withdrawal by Subject|6|||
161056273|NCT00440037|581594476|FG000|Overall Study|Administrative decision|3|||
161056274|NCT03740919|581594479|FG000|Lead-in Period|Lost to Follow-up|1|||
161056275|NCT03740919|581594480|FG001|Lead-in Period|Lost to Follow-up|0|||
161056276|NCT03740919|581594481|FG002|Lead-in Period|Lost to Follow-up|0|||
161056277|NCT03740919|581594482|FG003|Lead-in Period|Lost to Follow-up|0|||
161056278|NCT03740919|581594479|FG000|Lead-in Period|Physician Decision|2|||
161056279|NCT03740919|581594480|FG001|Lead-in Period|Physician Decision|0|||
161056280|NCT03740919|581594481|FG002|Lead-in Period|Physician Decision|0|||
161056281|NCT03740919|581594482|FG003|Lead-in Period|Physician Decision|0|||
161056282|NCT03740919|581594479|FG000|Lead-in Period|Protocol Violation|1|||
161056283|NCT03740919|581594480|FG001|Lead-in Period|Protocol Violation|0|||
161056284|NCT03740919|581594481|FG002|Lead-in Period|Protocol Violation|0|||
161056285|NCT03740919|581594482|FG003|Lead-in Period|Protocol Violation|0|||
161056286|NCT03740919|581594479|FG000|Lead-in Period|Withdrawal by Subject|10|||
161056287|NCT03740919|581594480|FG001|Lead-in Period|Withdrawal by Subject|0|||
161056288|NCT03740919|581594481|FG002|Lead-in Period|Withdrawal by Subject|0|||
161056289|NCT03740919|581594482|FG003|Lead-in Period|Withdrawal by Subject|0|||
161056290|NCT03740919|581594479|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
161056291|NCT03740919|581594480|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
161056292|NCT03740919|581594481|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
161056293|NCT03740919|581594482|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
161056294|NCT03740919|581594479|FG000|Lead-in Period|Study Task Too Burdensome|1|||
161056295|NCT03740919|581594480|FG001|Lead-in Period|Study Task Too Burdensome|0|||
161056296|NCT03740919|581594481|FG002|Lead-in Period|Study Task Too Burdensome|0|||
161056297|NCT03740919|581594482|FG003|Lead-in Period|Study Task Too Burdensome|0|||
161056298|NCT03740919|581594479|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
161056299|NCT03740919|581594480|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
161056300|NCT03740919|581594481|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
161056301|NCT03740919|581594482|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
161056302|NCT03740919|581594479|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
161056303|NCT03740919|581594480|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
161056304|NCT03740919|581594481|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
161056305|NCT03740919|581594482|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
161056306|NCT03740919|581594479|FG000|Treatment Period|Adverse Event|0|||
161056307|NCT03740919|581594480|FG001|Treatment Period|Adverse Event|0|||
161056308|NCT03740919|581594481|FG002|Treatment Period|Adverse Event|2|||
161056309|NCT03740919|581594482|FG003|Treatment Period|Adverse Event|0|||
161056310|NCT03740919|581594479|FG000|Treatment Period|Protocol Violation|0|||
161056311|NCT03740919|581594480|FG001|Treatment Period|Protocol Violation|1|||
161056312|NCT03740919|581594481|FG002|Treatment Period|Protocol Violation|0|||
161056313|NCT03740919|581594482|FG003|Treatment Period|Protocol Violation|0|||
161056314|NCT03740919|581594479|FG000|Treatment Period|Withdrawal by Subject|0|||
161056315|NCT03740919|581594480|FG001|Treatment Period|Withdrawal by Subject|7|||
161056316|NCT03740919|581594481|FG002|Treatment Period|Withdrawal by Subject|6|||
161056317|NCT03740919|581594482|FG003|Treatment Period|Withdrawal by Subject|2|||
161056318|NCT03740919|581594479|FG000|Treatment Period|Terminated by Sponsor|0|||
161056319|NCT03740919|581594480|FG001|Treatment Period|Terminated by Sponsor|1|||
161056320|NCT03740919|581594481|FG002|Treatment Period|Terminated by Sponsor|0|||
161056321|NCT03740919|581594482|FG003|Treatment Period|Terminated by Sponsor|0|||
161056322|NCT03740919|581594479|FG000|Treatment Period|Issue with Insulin Pump|0|||
161056323|NCT03740919|581594480|FG001|Treatment Period|Issue with Insulin Pump|1|||
161056324|NCT03740919|581594481|FG002|Treatment Period|Issue with Insulin Pump|0|||
161056325|NCT03740919|581594482|FG003|Treatment Period|Issue with Insulin Pump|0|||
161056326|NCT03740919|581594479|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
161056327|NCT03740919|581594480|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
161056328|NCT03740919|581594481|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
161056329|NCT03740919|581594482|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
161056330|NCT03740919|581594479|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
161056331|NCT03740919|581594480|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
161151910|NCT00455858|581937108|FG000|Overall Study|Lack of Efficacy|1|||
161151911|NCT00455858|581937108|FG000|Overall Study|Well controlled FPG without insulin|1|||
161151912|NCT00455858|581937108|FG000|Overall Study|Withdrawal|1|||
161151913|NCT02092389|581937109|FG000|Overall Study|Adverse Event|1|||
161151914|NCT02092389|581937109|FG000|Overall Study|Other|5|||
161151915|NCT01242020|581937110|FG000|Overall Study|Withdrawal by Subject|2|||
161151916|NCT01242020|581937111|FG001|Overall Study|Withdrawal by Subject|0|||
161151917|NCT01242020|581937110|FG000|Overall Study|Failed screening|1|||
161151918|NCT01242020|581937111|FG001|Overall Study|Failed screening|0|||
161151919|NCT02680847|581937112|FG000|Overall Study|Other|2|||
161151920|NCT02680847|581937113|FG001|Overall Study|Other|0|||
161151921|NCT02680847|581937114|FG002|Overall Study|Other|0|||
161151922|NCT02680847|581937112|FG000|Overall Study|No longer met eligibility criteria|2|||
161151923|NCT02680847|581937113|FG001|Overall Study|No longer met eligibility criteria|2|||
161151924|NCT02680847|581937114|FG002|Overall Study|No longer met eligibility criteria|0|||
161151925|NCT02680847|581937112|FG000|Overall Study|Unwilling to participate in study|1|||
161151926|NCT02680847|581937113|FG001|Overall Study|Unwilling to participate in study|1|||
161151927|NCT02680847|581937114|FG002|Overall Study|Unwilling to participate in study|0|||
161151928|NCT02680847|581937112|FG000|Overall Study|Lack of Efficacy|0|||
161151929|NCT02680847|581937113|FG001|Overall Study|Lack of Efficacy|0|||
161151930|NCT02680847|581937114|FG002|Overall Study|Lack of Efficacy|2|||
161151931|NCT02680847|581937112|FG000|Overall Study|Adverse Event|0|||
161056332|NCT03740919|581594481|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
161151932|NCT02680847|581937113|FG001|Overall Study|Adverse Event|0|||
161151933|NCT02680847|581937114|FG002|Overall Study|Adverse Event|1|||
161056333|NCT03740919|581594482|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
161056334|NCT03740919|581594479|FG000|Treatment Period|Not Completing Diary|0|||
161056335|NCT03740919|581594480|FG001|Treatment Period|Not Completing Diary|0|||
161056336|NCT03740919|581594481|FG002|Treatment Period|Not Completing Diary|1|||
161056337|NCT03740919|581594482|FG003|Treatment Period|Not Completing Diary|0|||
161056338|NCT03740919|581594479|FG000|Treatment Period|Insulin Painful to Participant|0|||
161056339|NCT03740919|581594480|FG001|Treatment Period|Insulin Painful to Participant|0|||
161056340|NCT03740919|581594481|FG002|Treatment Period|Insulin Painful to Participant|1|||
161056341|NCT03740919|581594482|FG003|Treatment Period|Insulin Painful to Participant|0|||
161056342|NCT01911819|581594485|FG000|Overall Study|Adverse Event|0|||
161056343|NCT01911819|581594486|FG001|Overall Study|Adverse Event|1|||
161056344|NCT01911819|581594487|FG002|Overall Study|Adverse Event|0|||
161056345|NCT01911819|581594485|FG000|Overall Study|Withdrawal by Subject|1|||
161056346|NCT01911819|581594486|FG001|Overall Study|Withdrawal by Subject|1|||
161056347|NCT01911819|581594487|FG002|Overall Study|Withdrawal by Subject|0|||
161056348|NCT04374253|581594492|FG000|Overall Study|Adverse Event|0|||
161056349|NCT04374253|581594493|FG001|Overall Study|Adverse Event|26|||
161056350|NCT04374253|581594494|FG002|Overall Study|Adverse Event|2|||
161056351|NCT04374253|581594495|FG003|Overall Study|Adverse Event|12|||
161056352|NCT04374253|581594492|FG000|Overall Study|Study terminated by sponsor|13|||
161056353|NCT04374253|581594493|FG001|Overall Study|Study terminated by sponsor|593|||
161056354|NCT04374253|581594494|FG002|Overall Study|Study terminated by sponsor|21|||
161056355|NCT04374253|581594495|FG003|Overall Study|Study terminated by sponsor|567|||
161056356|NCT04374253|581594492|FG000|Overall Study|Withdrawal by Subject|0|||
161056357|NCT04374253|581594493|FG001|Overall Study|Withdrawal by Subject|55|||
161056358|NCT04374253|581594494|FG002|Overall Study|Withdrawal by Subject|3|||
161056359|NCT04374253|581594495|FG003|Overall Study|Withdrawal by Subject|40|||
161056360|NCT04374253|581594492|FG000|Overall Study|Physician Decision|1|||
161056361|NCT04374253|581594493|FG001|Overall Study|Physician Decision|10|||
161056362|NCT04374253|581594494|FG002|Overall Study|Physician Decision|1|||
161056363|NCT04374253|581594495|FG003|Overall Study|Physician Decision|10|||
161056364|NCT04374253|581594492|FG000|Overall Study|Protocol Violation|0|||
161056365|NCT04374253|581594493|FG001|Overall Study|Protocol Violation|0|||
161056366|NCT04374253|581594494|FG002|Overall Study|Protocol Violation|0|||
161056367|NCT04374253|581594495|FG003|Overall Study|Protocol Violation|2|||
161056368|NCT04374253|581594492|FG000|Overall Study|Death|0|||
161151934|NCT02375698|581937115|FG000|Overall Study|Withdrawal by Subject|0|||
161151935|NCT02375698|581937116|FG001|Overall Study|Withdrawal by Subject|2|||
161151936|NCT02375698|581937115|FG000|Overall Study|Physician Decision|2|||
161151937|NCT02375698|581937116|FG001|Overall Study|Physician Decision|0|||
161151938|NCT01595646|581937121|FG000|Overall Study|Withdrawal by Subject|1|||
161056369|NCT04374253|581594493|FG001|Overall Study|Death|3|||
161345132|NCT00294658|582648869|FG001|Overall Study|Found to have invasive thymoma|0|||
161151939|NCT01595646|581937122|FG001|Overall Study|Withdrawal by Subject|0|||
161151940|NCT01595646|581937123|FG002|Overall Study|Withdrawal by Subject|0|||
161151941|NCT01927562|581937126|FG000|Overall Study|Lost to Follow-up|30|||
161151942|NCT01927562|581937126|FG000|Overall Study|Withdrawal by Subject|3|||
161056370|NCT04374253|581594494|FG002|Overall Study|Death|1|||
161151943|NCT01927562|581937126|FG000|Overall Study|Physician Decision|5|||
161151944|NCT00642616|581937127|FG000|Overall Study|Adverse Event|2|||
161345133|NCT00294658|582648868|FG000|Overall Study|Patient and family were not satisfied|0|||
161056371|NCT04374253|581594495|FG003|Overall Study|Death|1|||
161056372|NCT04374253|581594492|FG000|Overall Study|Lack of Efficacy|0|||
161056373|NCT04374253|581594493|FG001|Overall Study|Lack of Efficacy|0|||
161056374|NCT04374253|581594494|FG002|Overall Study|Lack of Efficacy|0|||
161056375|NCT04374253|581594495|FG003|Overall Study|Lack of Efficacy|1|||
161056376|NCT04374253|581594492|FG000|Overall Study|Lost to Follow-up|1|||
161056377|NCT04374253|581594493|FG001|Overall Study|Lost to Follow-up|1|||
161056378|NCT04374253|581594494|FG002|Overall Study|Lost to Follow-up|0|||
161056379|NCT04374253|581594495|FG003|Overall Study|Lost to Follow-up|2|||
161056380|NCT04374253|581594492|FG000|Overall Study|Reason Not Specified|0|||
161056381|NCT04374253|581594493|FG001|Overall Study|Reason Not Specified|8|||
161056382|NCT04374253|581594494|FG002|Overall Study|Reason Not Specified|0|||
161056383|NCT04374253|581594495|FG003|Overall Study|Reason Not Specified|8|||
161056384|NCT04382053|581594498|FG000|Overall Study|Death|6|||
161056385|NCT04382053|581594499|FG001|Overall Study|Death|8|||
161056386|NCT04382053|581594498|FG000|Overall Study|Lost to Follow-up|0|||
161056387|NCT04382053|581594499|FG001|Overall Study|Lost to Follow-up|2|||
161056388|NCT04382053|581594498|FG000|Overall Study|Protocol Deviation|1|||
161056389|NCT04382053|581594499|FG001|Overall Study|Protocol Deviation|2|||
161056390|NCT04382053|581594498|FG000|Overall Study|Withdrawal by Subject|2|||
161056391|NCT04382053|581594499|FG001|Overall Study|Withdrawal by Subject|1|||
161056392|NCT01945086|581594502|FG000|Overall Study|Withdrawal by Subject|1|||
161056393|NCT01945086|581594503|FG001|Overall Study|Withdrawal by Subject|0|||
161056394|NCT01945086|581594504|FG002|Overall Study|Withdrawal by Subject|1|||
161056395|NCT01945086|581594502|FG000|Overall Study|Adverse Event|0|||
161056396|NCT01945086|581594503|FG001|Overall Study|Adverse Event|0|||
161056397|NCT01945086|581594504|FG002|Overall Study|Adverse Event|1|||
161056398|NCT02093897|581595959|FG000|Overall Study|Physician Decision|1|||
161056399|NCT02093897|581595959|FG000|Overall Study|Planned age group closure - no's reached|17|||
161056400|NCT02093897|581595959|FG000|Overall Study|Adverse event, non-fatal|1|||
161056401|NCT02972242|581595960|FG000|Overall Study|Withdrawal by Subject|1|||
161056402|NCT02972242|581595961|FG001|Overall Study|Withdrawal by Subject|0|||
161056403|NCT04572997|581595962|FG000|Overall Study|Adverse Event|1|||
161056404|NCT03098797|581595963|FG000|Part 2 Open Label Extension|Adverse Event|2|||
161056405|NCT03098797|581595964|FG001|Part 2 Open Label Extension|Adverse Event|0|||
161056406|NCT02956278|581595965|FG000|Overall Study|Withdrawal by Subject|6|||
161056407|NCT02956278|581595966|FG001|Overall Study|Withdrawal by Subject|2|||
161056408|NCT02956278|581595967|FG002|Overall Study|Withdrawal by Subject|0|||
161056409|NCT01967719|581595968|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
161056410|NCT01967719|581595969|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
161056411|NCT01967719|581595970|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161056412|NCT01967719|581595971|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
161056413|NCT01967719|581595968|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161056414|NCT01967719|581595969|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
161056415|NCT01967719|581595970|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161056416|NCT01967719|581595971|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
161056417|NCT02329223|581595972|FG000|Overall Study|Withdrawal by Subject|1|||
161056418|NCT02329223|581595973|FG001|Overall Study|Withdrawal by Subject|2|||
161056419|NCT02329223|581595974|FG002|Overall Study|Withdrawal by Subject|5|||
161056420|NCT02329223|581595972|FG000|Overall Study|Physician Decision|0|||
161056421|NCT02329223|581595973|FG001|Overall Study|Physician Decision|0|||
161056422|NCT02329223|581595974|FG002|Overall Study|Physician Decision|1|||
161056423|NCT02329223|581595972|FG000|Overall Study|Adverse Event|0|||
161056424|NCT02329223|581595973|FG001|Overall Study|Adverse Event|1|||
161056425|NCT02329223|581595974|FG002|Overall Study|Adverse Event|0|||
161056426|NCT00651937|581595976|FG000|Overall Study|Withdrawal by Subject|4|||
161056427|NCT00651937|581595977|FG001|Overall Study|Withdrawal by Subject|1|||
161056428|NCT00509821|581595978|FG000|Study Period 1 (Induction)|Death|0|||
161056429|NCT00509821|581595979|FG001|Study Period 1 (Induction)|Death|1|||
161056430|NCT00509821|581595978|FG000|Study Period 1 (Induction)|Adverse Event|0|||
161056431|NCT00509821|581595979|FG001|Study Period 1 (Induction)|Adverse Event|2|||
161056432|NCT00509821|581595978|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
161056433|NCT00509821|581595979|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
161056434|NCT00552513|581595984|FG000|Overall Study|Lost to Follow-up|5|||
161056435|NCT00552513|581595985|FG001|Overall Study|Lost to Follow-up|1|||
161056436|NCT02720185|581595986|FG000|Overall Study|Lost to Follow-up|1|||
161056437|NCT00792259|581595987|FG000|Overall Study|Poor Quality Scans|1|||
161056438|NCT00792259|581595988|FG001|Overall Study|Poor Quality Scans|0|||
161056439|NCT00792259|581595989|FG002|Overall Study|Poor Quality Scans|0|||
161056440|NCT00371462|581595990|FG000|Overall Study|Withdrawal by Subject|1|||
161056441|NCT00371462|581595991|FG001|Overall Study|Withdrawal by Subject|0|||
161056442|NCT00371462|581595990|FG000|Overall Study|Other|7|||
161056443|NCT00371462|581595991|FG001|Overall Study|Other|8|||
161056444|NCT02507687|581595994|FG000|Overall Study|Adverse Event|3|||
161056445|NCT02507687|581595995|FG001|Overall Study|Adverse Event|2|||
161056446|NCT02507687|581595996|FG002|Overall Study|Adverse Event|2|||
161056447|NCT02507687|581595997|FG003|Overall Study|Adverse Event|2|||
161056448|NCT02507687|581595994|FG000|Overall Study|Withdrawal by Subject|1|||
161056449|NCT02507687|581595995|FG001|Overall Study|Withdrawal by Subject|4|||
161056450|NCT02507687|581595996|FG002|Overall Study|Withdrawal by Subject|6|||
161056451|NCT02507687|581595997|FG003|Overall Study|Withdrawal by Subject|6|||
161056452|NCT02507687|581595994|FG000|Overall Study|Protocol Violation|1|||
161056453|NCT02507687|581595995|FG001|Overall Study|Protocol Violation|0|||
161056454|NCT02507687|581595996|FG002|Overall Study|Protocol Violation|2|||
161056455|NCT02507687|581595997|FG003|Overall Study|Protocol Violation|0|||
161056456|NCT02507687|581595994|FG000|Overall Study|Lost to Follow-up|0|||
161056457|NCT02507687|581595995|FG001|Overall Study|Lost to Follow-up|0|||
161056458|NCT02507687|581595996|FG002|Overall Study|Lost to Follow-up|2|||
161056459|NCT02507687|581595997|FG003|Overall Study|Lost to Follow-up|1|||
161056460|NCT02507687|581595994|FG000|Overall Study|Screen Failure|0|||
161056461|NCT02507687|581595995|FG001|Overall Study|Screen Failure|0|||
161056462|NCT02507687|581595996|FG002|Overall Study|Screen Failure|1|||
161056463|NCT02507687|581595997|FG003|Overall Study|Screen Failure|0|||
161056464|NCT02507687|581595994|FG000|Overall Study|Other, Not Specified|0|||
161056465|NCT02507687|581595995|FG001|Overall Study|Other, Not Specified|0|||
161056466|NCT02507687|581595996|FG002|Overall Study|Other, Not Specified|2|||
161056467|NCT02507687|581595997|FG003|Overall Study|Other, Not Specified|4|||
161056468|NCT00275301|581595998|FG000|Overall Study|Adverse Event|5|||
161056469|NCT04357964|581595999|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
161056470|NCT04357964|581596000|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
161056471|NCT04357964|581595999|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
161056472|NCT04357964|581596000|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
161056473|NCT04357964|581595999|FG000|Overall Study|Adipose sample was insufficient quality|0|||
161056474|NCT04357964|581596000|FG001|Overall Study|Adipose sample was insufficient quality|1|||
161056475|NCT00848393|581596003|FG000|Overall Study|Protocol Violation|0|||
161056476|NCT00848393|581596004|FG001|Overall Study|Protocol Violation|0|||
161056477|NCT00848393|581596005|FG002|Overall Study|Protocol Violation|1|||
161056478|NCT00848393|581596003|FG000|Overall Study|surgical complications unrelated to stud|0|||
161056479|NCT00848393|581596004|FG001|Overall Study|surgical complications unrelated to stud|0|||
161056480|NCT00848393|581596005|FG002|Overall Study|surgical complications unrelated to stud|2|||
161056481|NCT00349622|581596012|FG000|Overall Study|Death|168|||
161056482|NCT00349622|581596013|FG001|Overall Study|Death|86|||
161056483|NCT00349622|581596012|FG000|Overall Study|Lost to Follow-up|5|||
161056484|NCT00349622|581596013|FG001|Overall Study|Lost to Follow-up|1|||
161056485|NCT00349622|581596012|FG000|Overall Study|Withdrawal by Subject|5|||
161056486|NCT00349622|581596013|FG001|Overall Study|Withdrawal by Subject|9|||
161056487|NCT03296566|581596014|FG000|Overall Study|Lost to Follow-up|19|||
161056488|NCT03296566|581596015|FG001|Overall Study|Lost to Follow-up|46|||
161056489|NCT03296566|581596014|FG000|Overall Study|Withdrawal by Subject|0|||
161056490|NCT03296566|581596015|FG001|Overall Study|Withdrawal by Subject|3|||
161056491|NCT01503515|581596021|FG000|Overall Study|Adverse Event|4|||
161056492|NCT01503515|581596022|FG001|Overall Study|Adverse Event|5|||
161056493|NCT01503515|581596021|FG000|Overall Study|Death|0|||
161056494|NCT01503515|581596022|FG001|Overall Study|Death|1|||
161056495|NCT01503515|581596021|FG000|Overall Study|Physician Decision|14|||
161056496|NCT01503515|581596022|FG001|Overall Study|Physician Decision|23|||
161056497|NCT01503515|581596021|FG000|Overall Study|Withdrawal by Subject|0|||
161056498|NCT01503515|581596022|FG001|Overall Study|Withdrawal by Subject|1|||
161056499|NCT01503515|581596021|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
161056500|NCT01503515|581596022|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
161056501|NCT01503515|581596021|FG000|Overall Study|Ineligible|1|||
161056502|NCT01503515|581596022|FG001|Overall Study|Ineligible|1|||
161056503|NCT01350102|581596023|FG000|Overall Study|Adverse Event|0|||
161056504|NCT01350102|581596024|FG001|Overall Study|Adverse Event|0|||
161056505|NCT01350102|581596025|FG002|Overall Study|Adverse Event|1|||
161056506|NCT01350102|581596026|FG003|Overall Study|Adverse Event|0|||
161056507|NCT00550771|581596027|FG000|Overall Study|Adverse Event|11|||
161056508|NCT00550771|581596028|FG001|Overall Study|Adverse Event|3|||
161056509|NCT00550771|581596027|FG000|Overall Study|Discontinued for study-related reasons|0|||
161056510|NCT00550771|581596028|FG001|Overall Study|Discontinued for study-related reasons|1|||
161056511|NCT00550771|581596027|FG000|Overall Study|Physician Decision|2|||
161056512|NCT00550771|581596028|FG001|Overall Study|Physician Decision|0|||
161056513|NCT00550771|581596027|FG000|Overall Study|Withdrawal by Subject|0|||
161056514|NCT00550771|581596028|FG001|Overall Study|Withdrawal by Subject|1|||
161056515|NCT00550771|581596027|FG000|Overall Study|Protocol Violation|4|||
161056516|NCT00550771|581596028|FG001|Overall Study|Protocol Violation|5|||
161056517|NCT03681353|581596031|FG000|Overall Study|Lost to Follow-up|2|||
161151945|NCT00642616|581937128|FG001|Overall Study|Adverse Event|0|||
161151946|NCT00642616|581937129|FG002|Overall Study|Adverse Event|1|||
161151947|NCT00642616|581937130|FG003|Overall Study|Adverse Event|0|||
161056518|NCT03681353|581596031|FG000|Overall Study|Withdrawal by Subject|3|||
161056519|NCT03681353|581596031|FG000|Overall Study|withdrawn by PI|2|||
161056520|NCT00726388|581596032|FG000|Overall Study|Withdrawal by Subject|5|||
161056521|NCT00726388|581596032|FG000|Overall Study|Adverse Event|3|||
161151948|NCT00642616|581937127|FG000|Overall Study|Study Terminated by Sponsor|7|||
161151949|NCT00642616|581937128|FG001|Overall Study|Study Terminated by Sponsor|6|||
161151950|NCT00642616|581937129|FG002|Overall Study|Study Terminated by Sponsor|4|||
161151951|NCT00642616|581937130|FG003|Overall Study|Study Terminated by Sponsor|5|||
161151952|NCT00642616|581937127|FG000|Overall Study|Withdrawal by Subject|0|||
161151953|NCT00642616|581937128|FG001|Overall Study|Withdrawal by Subject|1|||
161151954|NCT00642616|581937129|FG002|Overall Study|Withdrawal by Subject|1|||
161151955|NCT00642616|581937130|FG003|Overall Study|Withdrawal by Subject|1|||
161151956|NCT00642616|581937127|FG000|Overall Study|Protocol Violation|0|||
161151957|NCT00642616|581937128|FG001|Overall Study|Protocol Violation|0|||
161151958|NCT00642616|581937129|FG002|Overall Study|Protocol Violation|2|||
161151959|NCT00642616|581937130|FG003|Overall Study|Protocol Violation|0|||
161151960|NCT00642616|581937127|FG000|Overall Study|Physician Decision|0|||
161151961|NCT00642616|581937128|FG001|Overall Study|Physician Decision|0|||
161151962|NCT00642616|581937129|FG002|Overall Study|Physician Decision|1|||
161151963|NCT00642616|581937130|FG003|Overall Study|Physician Decision|1|||
161151964|NCT01161524|581937131|FG000|Core Study (23 Weeks)|Adverse Event|3|||
161151965|NCT01161524|581937132|FG001|Core Study (23 Weeks)|Adverse Event|0|||
161151966|NCT01161524|581937133|FG002|Core Study (23 Weeks)|Adverse Event|0|||
161151967|NCT01161524|581937131|FG000|Core Study (23 Weeks)|Other|1|||
161151968|NCT01161524|581937132|FG001|Core Study (23 Weeks)|Other|0|||
161151969|NCT01161524|581937133|FG002|Core Study (23 Weeks)|Other|0|||
161151970|NCT01161524|581937131|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
161151971|NCT01161524|581937132|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
161151972|NCT01161524|581937133|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
161151973|NCT01161524|581937131|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
161151974|NCT01161524|581937132|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
161151975|NCT01161524|581937133|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
161151976|NCT01161524|581937131|FG000|Core Study (23 Weeks)|Subject Choice|3|||
161151977|NCT01161524|581937132|FG001|Core Study (23 Weeks)|Subject Choice|2|||
161151978|NCT01161524|581937133|FG002|Core Study (23 Weeks)|Subject Choice|0|||
161151979|NCT01161524|581937131|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
161151980|NCT01161524|581937132|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
161151981|NCT01161524|581937133|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
161151982|NCT01161524|581937131|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
161151983|NCT01161524|581937132|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
161151984|NCT01161524|581937133|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
161151985|NCT01161524|581937131|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
161151986|NCT01161524|581937132|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
161151987|NCT01161524|581937133|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
161151988|NCT01161524|581937131|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
161151989|NCT01161524|581937132|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
161151990|NCT01161524|581937133|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
161151991|NCT01161524|581937131|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
161151992|NCT01161524|581937132|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
161151993|NCT01161524|581937133|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
161151994|NCT02955186|581937134|FG000|Overall Study|Withdrawal by Subject|6|||
161151995|NCT02955186|581937135|FG001|Overall Study|Withdrawal by Subject|2|||
161151996|NCT02955186|581937134|FG000|Overall Study|Protocol Violation|1|||
161281222|NCT00185588|582408653|FG001|Overall Study|Adverse Event|1|||
161281223|NCT00185588|582408654|FG002|Overall Study|Adverse Event|4|||
161281224|NCT00185588|582408655|FG003|Overall Study|Adverse Event|2|||
161281225|NCT00185588|582408652|FG000|Overall Study|Lost to Follow-up|0|||
161281226|NCT00185588|582408653|FG001|Overall Study|Lost to Follow-up|0|||
161056522|NCT00726388|581596032|FG000|Overall Study|Lost to Follow-up|10|||
161056523|NCT00726388|581596032|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
161056524|NCT00726388|581596032|FG000|Overall Study|Other|5|||
161056525|NCT00726388|581596032|FG000|Overall Study|Enrolled, Not Treated|79|||
161056526|NCT00520403|581596035|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
161056527|NCT00520403|581596035|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
161056528|NCT00520403|581596035|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
161056529|NCT00520403|581596035|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
161151997|NCT02955186|581937135|FG001|Overall Study|Protocol Violation|0|||
161151998|NCT01276847|581937137|FG000|Overall Study|Withdrawal by Subject|1|||
161151999|NCT01276847|581937138|FG001|Overall Study|Withdrawal by Subject|0|||
161152000|NCT01276847|581937139|FG002|Overall Study|Withdrawal by Subject|0|||
161152001|NCT01618656|581937140|FG000|Overall Study|Withdrawal by Subject|7|||
161056530|NCT00520403|581596035|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
161152002|NCT01618656|581937141|FG001|Overall Study|Withdrawal by Subject|3|||
161152003|NCT01618656|581937140|FG000|Overall Study|Physician Decision|1|||
161281227|NCT00185588|582408654|FG002|Overall Study|Lost to Follow-up|1|||
161281228|NCT00185588|582408655|FG003|Overall Study|Lost to Follow-up|2|||
161281229|NCT00185588|582408652|FG000|Overall Study|Withdrawal by Subject|0|||
161281230|NCT00185588|582408653|FG001|Overall Study|Withdrawal by Subject|1|||
161281231|NCT00185588|582408654|FG002|Overall Study|Withdrawal by Subject|0|||
161281232|NCT00185588|582408655|FG003|Overall Study|Withdrawal by Subject|0|||
161281233|NCT00185588|582408652|FG000|Overall Study|Physician Decision|0|||
161281234|NCT00185588|582408653|FG001|Overall Study|Physician Decision|0|||
161281235|NCT00185588|582408654|FG002|Overall Study|Physician Decision|1|||
161281236|NCT00185588|582408655|FG003|Overall Study|Physician Decision|0|||
161281237|NCT00398866|582408656|FG000|Overall Study|Adverse Event|1|||
161281238|NCT00398866|582408657|FG001|Overall Study|Adverse Event|0|||
161056531|NCT00520403|581596035|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
161056532|NCT00520403|581596035|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
161056533|NCT00520403|581596035|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
161056534|NCT01797562|581596036|FG000|Overall Study|Protocol Violation|5|||
161056535|NCT00917462|581596039|FG000|Overall Study|Clinical Deterioration|1|||
161056536|NCT03341312|581596040|FG000|Period 1|Withdrawal by Subject|0|||
161056537|NCT03341312|581596041|FG001|Period 1|Withdrawal by Subject|1|||
161056538|NCT03341312|581596042|FG002|Period 1|Withdrawal by Subject|0|||
161056539|NCT03341312|581596043|FG003|Period 1|Withdrawal by Subject|0|||
161056540|NCT00744796|581596044|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
161056541|NCT05372913|581596048|FG000|Overall Study|Withdrawal by Subject|0|||
161056542|NCT05372913|581596049|FG001|Overall Study|Withdrawal by Subject|2|||
161056543|NCT05372913|581596048|FG000|Overall Study|Protocol Violation|2|||
161056544|NCT05372913|581596049|FG001|Overall Study|Protocol Violation|2|||
161056545|NCT05372913|581596048|FG000|Overall Study|Adverse Event|0|||
161056546|NCT05372913|581596049|FG001|Overall Study|Adverse Event|1|||
161056547|NCT05135156|581596050|FG000|Overall Study|Lost to Follow-up|0|||
161056548|NCT05135156|581596051|FG001|Overall Study|Lost to Follow-up|0|||
161056549|NCT05135156|581596052|FG002|Overall Study|Lost to Follow-up|2|||
161056550|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Adverse Event|3|||
161056551|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Adverse Event|0|||
161056552|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
161056553|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
161056554|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Disease Progression|23|||
161056555|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Disease Progression|22|||
161056556|NCT01379521|581596056|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
161056557|NCT01379521|581596057|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
161056558|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
161056559|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
161056560|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
161056561|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
161056562|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
161056563|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
161056564|NCT01379521|581596056|FG000|Overall Study -Treatment Period|Death|2|||
161056565|NCT01379521|581596057|FG001|Overall Study -Treatment Period|Death|1|||
161056566|NCT01379521|581596056|FG000|Post-Treatment Evaluations|Disease Progression|22|||
161056567|NCT01379521|581596057|FG001|Post-Treatment Evaluations|Disease Progression|20|||
161056568|NCT01379521|581596056|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
161056569|NCT01379521|581596057|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
161056570|NCT01379521|581596056|FG000|Post-Treatment Evaluations|Death|1|||
161056571|NCT01379521|581596057|FG001|Post-Treatment Evaluations|Death|0|||
161056572|NCT02538471|581596060|FG000|Overall Study|Progression of disease|2|||
161056573|NCT00475735|581596061|FG000|Treatment Period 1|Adverse Event|2|||
161056574|NCT00475735|581596062|FG001|Treatment Period 1|Adverse Event|0|||
161056575|NCT00475735|581596063|FG002|Treatment Period 1|Adverse Event|0|||
161056576|NCT00475735|581596064|FG003|Treatment Period 1|Adverse Event|0|||
161056577|NCT00475735|581596065|FG004|Treatment Period 1|Adverse Event|0|||
161056578|NCT00475735|581596066|FG005|Treatment Period 1|Adverse Event|0|||
161056579|NCT00475735|581596061|FG000|Treatment Period 1|Lack of Efficacy|1|||
161056580|NCT00475735|581596062|FG001|Treatment Period 1|Lack of Efficacy|0|||
161056581|NCT00475735|581596063|FG002|Treatment Period 1|Lack of Efficacy|0|||
161056582|NCT00475735|581596064|FG003|Treatment Period 1|Lack of Efficacy|0|||
161056583|NCT00475735|581596065|FG004|Treatment Period 1|Lack of Efficacy|0|||
161056584|NCT00475735|581596066|FG005|Treatment Period 1|Lack of Efficacy|0|||
161056585|NCT00475735|581596061|FG000|Treatment Period 1|Lost to Follow-up|0|||
161056586|NCT00475735|581596062|FG001|Treatment Period 1|Lost to Follow-up|0|||
161056587|NCT00475735|581596063|FG002|Treatment Period 1|Lost to Follow-up|0|||
161056588|NCT00475735|581596064|FG003|Treatment Period 1|Lost to Follow-up|0|||
161056589|NCT00475735|581596065|FG004|Treatment Period 1|Lost to Follow-up|0|||
161056590|NCT00475735|581596066|FG005|Treatment Period 1|Lost to Follow-up|1|||
161056591|NCT00475735|581596061|FG000|Treatment Period 1|Protocol Violation|0|||
161056592|NCT00475735|581596062|FG001|Treatment Period 1|Protocol Violation|0|||
161056593|NCT00475735|581596063|FG002|Treatment Period 1|Protocol Violation|0|||
161152004|NCT01618656|581937141|FG001|Overall Study|Physician Decision|1|||
161281239|NCT00398866|582408658|FG002|Overall Study|Adverse Event|0|||
161281240|NCT00398866|582408656|FG000|Overall Study|Lack of Efficacy|0|||
161281241|NCT00398866|582408657|FG001|Overall Study|Lack of Efficacy|0|||
161281242|NCT00398866|582408658|FG002|Overall Study|Lack of Efficacy|1|||
161281243|NCT00398866|582408656|FG000|Overall Study|Lost to Follow-up|7|||
161281244|NCT00398866|582408657|FG001|Overall Study|Lost to Follow-up|6|||
161281245|NCT00398866|582408658|FG002|Overall Study|Lost to Follow-up|4|||
161056594|NCT00475735|581596064|FG003|Treatment Period 1|Protocol Violation|1|||
161056595|NCT00475735|581596065|FG004|Treatment Period 1|Protocol Violation|0|||
161056596|NCT00475735|581596066|FG005|Treatment Period 1|Protocol Violation|0|||
161056597|NCT00475735|581596061|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161056598|NCT00475735|581596062|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161056599|NCT00475735|581596063|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161056600|NCT00475735|581596064|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161056601|NCT00475735|581596065|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161056602|NCT00475735|581596066|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161056603|NCT00475735|581596061|FG000|Treatment Period 1|DC due to AE but continuing|0|||
161056604|NCT00475735|581596062|FG001|Treatment Period 1|DC due to AE but continuing|0|||
161056605|NCT00475735|581596063|FG002|Treatment Period 1|DC due to AE but continuing|0|||
161056606|NCT00475735|581596064|FG003|Treatment Period 1|DC due to AE but continuing|1|||
161056607|NCT00475735|581596065|FG004|Treatment Period 1|DC due to AE but continuing|2|||
161056608|NCT00475735|581596066|FG005|Treatment Period 1|DC due to AE but continuing|2|||
161056609|NCT00475735|581596061|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161056610|NCT00475735|581596062|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
161056611|NCT00475735|581596063|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161056612|NCT00475735|581596064|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161056613|NCT00475735|581596065|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161056614|NCT00475735|581596066|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
161056615|NCT00475735|581596061|FG000|Treatment Washout|Lost to Follow-up|0|||
161056616|NCT00475735|581596062|FG001|Treatment Washout|Lost to Follow-up|1|||
161056617|NCT00475735|581596063|FG002|Treatment Washout|Lost to Follow-up|0|||
161056618|NCT00475735|581596064|FG003|Treatment Washout|Lost to Follow-up|0|||
161056619|NCT00475735|581596065|FG004|Treatment Washout|Lost to Follow-up|0|||
161056620|NCT00475735|581596066|FG005|Treatment Washout|Lost to Follow-up|0|||
161056621|NCT00475735|581596061|FG000|Treatment Washout|Protocol Violation|0|||
161056622|NCT00475735|581596062|FG001|Treatment Washout|Protocol Violation|1|||
161056623|NCT00475735|581596063|FG002|Treatment Washout|Protocol Violation|0|||
161056624|NCT00475735|581596064|FG003|Treatment Washout|Protocol Violation|0|||
161056625|NCT00475735|581596065|FG004|Treatment Washout|Protocol Violation|0|||
161056626|NCT00475735|581596066|FG005|Treatment Washout|Protocol Violation|0|||
161056627|NCT00475735|581596061|FG000|Treatment Period 2|Adverse Event|0|||
161056628|NCT00475735|581596062|FG001|Treatment Period 2|Adverse Event|1|||
161056629|NCT00475735|581596063|FG002|Treatment Period 2|Adverse Event|0|||
161056630|NCT00475735|581596064|FG003|Treatment Period 2|Adverse Event|2|||
161056631|NCT00475735|581596065|FG004|Treatment Period 2|Adverse Event|0|||
161056632|NCT00475735|581596066|FG005|Treatment Period 2|Adverse Event|0|||
161056633|NCT00475735|581596061|FG000|Treatment Period 2|Lack of Efficacy|0|||
161056634|NCT00475735|581596062|FG001|Treatment Period 2|Lack of Efficacy|0|||
161056635|NCT00475735|581596063|FG002|Treatment Period 2|Lack of Efficacy|0|||
161056636|NCT00475735|581596064|FG003|Treatment Period 2|Lack of Efficacy|0|||
161056637|NCT00475735|581596065|FG004|Treatment Period 2|Lack of Efficacy|0|||
161056638|NCT00475735|581596066|FG005|Treatment Period 2|Lack of Efficacy|1|||
161056639|NCT00475735|581596061|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161056640|NCT00475735|581596062|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161056641|NCT00475735|581596063|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161056642|NCT00475735|581596064|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161056643|NCT00475735|581596065|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161056644|NCT00475735|581596066|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161056645|NCT02350127|581596067|FG000|4-Month Assessment|Withdrawal by Subject|10|||
161056646|NCT02350127|581596068|FG001|4-Month Assessment|Withdrawal by Subject|9|||
161056647|NCT02350127|581596067|FG000|4-Month Assessment|Death|1|||
161056648|NCT02350127|581596068|FG001|4-Month Assessment|Death|0|||
161056649|NCT02350127|581596067|FG000|8-Month Assessment|Death|1|||
161056650|NCT02350127|581596068|FG001|8-Month Assessment|Death|1|||
161056651|NCT02350127|581596067|FG000|8-Month Assessment|Withdrawal by Subject|5|||
161056652|NCT02350127|581596068|FG001|8-Month Assessment|Withdrawal by Subject|8|||
161056653|NCT00050167|581596070|FG000|Overall Study|not eligible not invasive|1|||
161056654|NCT00050167|581596071|FG001|Overall Study|not eligible not invasive|1|||
161281246|NCT00398866|582408656|FG000|Overall Study|Withdrawal by Subject|5|||
161281247|NCT00398866|582408657|FG001|Overall Study|Withdrawal by Subject|1|||
161281248|NCT00398866|582408658|FG002|Overall Study|Withdrawal by Subject|2|||
161281249|NCT00398866|582408656|FG000|Overall Study|Unable to complete requirements of study|1|||
161281250|NCT00398866|582408657|FG001|Overall Study|Unable to complete requirements of study|1|||
161056655|NCT01363297|581596072|FG000|Overall Study|Other|0|||
161281251|NCT00398866|582408658|FG002|Overall Study|Unable to complete requirements of study|1|||
161056656|NCT01363297|581596073|FG001|Overall Study|Other|0|||
161152005|NCT00751881|581937142|FG000|Core Treatment Period|Not treated|1|||
161152006|NCT00751881|581937143|FG001|Core Treatment Period|Not treated|1|||
161152007|NCT00751881|581937144|FG002|Core Treatment Period|Not treated|2|||
161152008|NCT00751881|581937142|FG000|Core Treatment Period|Adverse Event|26|||
161152009|NCT00751881|581937143|FG001|Core Treatment Period|Adverse Event|54|||
161152010|NCT00751881|581937144|FG002|Core Treatment Period|Adverse Event|58|||
161152011|NCT00751881|581937142|FG000|Core Treatment Period|Lack of Efficacy|37|||
161152012|NCT00751881|581937143|FG001|Core Treatment Period|Lack of Efficacy|30|||
161152013|NCT00751881|581937144|FG002|Core Treatment Period|Lack of Efficacy|20|||
161152014|NCT00751881|581937142|FG000|Core Treatment Period|Poor compliance to protocol|15|||
161152015|NCT00751881|581937143|FG001|Core Treatment Period|Poor compliance to protocol|3|||
161152016|NCT00751881|581937144|FG002|Core Treatment Period|Poor compliance to protocol|4|||
161152017|NCT00751881|581937142|FG000|Core Treatment Period|Lost to Follow-up|6|||
161152018|NCT00751881|581937143|FG001|Core Treatment Period|Lost to Follow-up|4|||
161152019|NCT00751881|581937144|FG002|Core Treatment Period|Lost to Follow-up|3|||
161152020|NCT00751881|581937142|FG000|Core Treatment Period|Other: protocol deviation|3|||
161152021|NCT00751881|581937143|FG001|Core Treatment Period|Other: protocol deviation|3|||
161152022|NCT00751881|581937144|FG002|Core Treatment Period|Other: protocol deviation|7|||
161152023|NCT00751881|581937142|FG000|Core Treatment Period|Other: wish to parent|5|||
161152024|NCT00751881|581937143|FG001|Core Treatment Period|Other: wish to parent|7|||
161152025|NCT00751881|581937144|FG002|Core Treatment Period|Other: wish to parent|4|||
161152026|NCT00751881|581937142|FG000|Core Treatment Period|Other: personal/family constraints|6|||
161152027|NCT00751881|581937143|FG001|Core Treatment Period|Other: personal/family constraints|7|||
161152028|NCT00751881|581937144|FG002|Core Treatment Period|Other: personal/family constraints|10|||
161152029|NCT00751881|581937142|FG000|Core Treatment Period|Other: MS treatment change|6|||
161152030|NCT00751881|581937143|FG001|Core Treatment Period|Other: MS treatment change|4|||
161152031|NCT00751881|581937144|FG002|Core Treatment Period|Other: MS treatment change|4|||
161152032|NCT00751881|581937142|FG000|Core Treatment Period|Other: tolerability complaints|2|||
161152033|NCT00751881|581937143|FG001|Core Treatment Period|Other: tolerability complaints|0|||
161152034|NCT00751881|581937144|FG002|Core Treatment Period|Other: tolerability complaints|0|||
161152035|NCT00751881|581937142|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
161152036|NCT00751881|581937143|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
161152037|NCT00751881|581937144|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
161152038|NCT00751881|581937142|FG000|Extension Study Period|Adverse Event|18|||
161152039|NCT00751881|581937143|FG001|Extension Study Period|Adverse Event|20|||
161152040|NCT00751881|581937144|FG002|Extension Study Period|Adverse Event|21|||
161152041|NCT00751881|581937142|FG000|Extension Study Period|Lack of Efficacy|14|||
161152042|NCT00751881|581937143|FG001|Extension Study Period|Lack of Efficacy|10|||
161152043|NCT00751881|581937144|FG002|Extension Study Period|Lack of Efficacy|20|||
161152044|NCT00751881|581937142|FG000|Extension Study Period|Lost to Follow-up|4|||
161152045|NCT00751881|581937143|FG001|Extension Study Period|Lost to Follow-up|9|||
161152046|NCT00751881|581937144|FG002|Extension Study Period|Lost to Follow-up|6|||
161152047|NCT00751881|581937142|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
161152048|NCT00751881|581937143|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
161152049|NCT00751881|581937144|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
161152050|NCT00751881|581937142|FG000|Extension Study Period|Other than specified above|26|||
161281252|NCT02481869|582408663|FG000|Overall Study|Lost to Follow-up|3|||
161281253|NCT02481869|582408664|FG001|Overall Study|Lost to Follow-up|4|||
161281254|NCT02481869|582408663|FG000|Overall Study|Withdrawal by Subject|2|||
161281255|NCT02481869|582408664|FG001|Overall Study|Withdrawal by Subject|0|||
161152051|NCT00751881|581937143|FG001|Extension Study Period|Other than specified above|30|||
161152052|NCT00751881|581937144|FG002|Extension Study Period|Other than specified above|18|||
161152053|NCT04770155|581937145|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152054|NCT04770155|581937146|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152055|NCT04770155|581937147|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152056|NCT04770155|581937148|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152057|NCT04770155|581937149|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152058|NCT04770155|581937150|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152059|NCT04770155|581937151|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161281256|NCT01153425|582408670|FG000|Overall Study|Withdrawal by Subject|3|||
161281257|NCT01153425|582408671|FG001|Overall Study|Withdrawal by Subject|3|||
161281258|NCT03154125|582408672|FG000|Overall Study|Lost to Follow-up|11|||
161281259|NCT03154125|582408673|FG001|Overall Study|Lost to Follow-up|11|||
161281260|NCT03154125|582408674|FG002|Overall Study|Lost to Follow-up|0|||
161281261|NCT03154125|582408672|FG000|Overall Study|Withdrawal by Subject|49|||
161281262|NCT03154125|582408673|FG001|Overall Study|Withdrawal by Subject|55|||
161281263|NCT03154125|582408674|FG002|Overall Study|Withdrawal by Subject|8|||
161281264|NCT03154125|582408672|FG000|Overall Study|Physician Decision|13|||
161281265|NCT03154125|582408673|FG001|Overall Study|Physician Decision|6|||
161056657|NCT01363297|581596074|FG002|Overall Study|Other|0|||
161056658|NCT01363297|581596075|FG003|Overall Study|Other|0|||
161056659|NCT01363297|581596076|FG004|Overall Study|Other|1|||
161056660|NCT01363297|581596072|FG000|Overall Study|Death|3|||
161056661|NCT01363297|581596073|FG001|Overall Study|Death|6|||
161056662|NCT01363297|581596074|FG002|Overall Study|Death|6|||
161056663|NCT01363297|581596075|FG003|Overall Study|Death|10|||
161056664|NCT01363297|581596076|FG004|Overall Study|Death|30|||
161056665|NCT02038803|581596080|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
161056666|NCT02038803|581596080|FG000|Overall Study|Lost to Follow-up|1|||
161056667|NCT04754594|581596081|FG000|Blinded Period|Withdrawal by Subject|4|||
161056668|NCT04754594|581596082|FG001|Blinded Period|Withdrawal by Subject|9|||
161056669|NCT04754594|581596083|FG002|Blinded Period|Withdrawal by Subject|0|||
161056670|NCT04754594|581596084|FG003|Blinded Period|Withdrawal by Subject|0|||
161056671|NCT04754594|581596081|FG000|Blinded Period|Protocol Violation|2|||
161056672|NCT04754594|581596082|FG001|Blinded Period|Protocol Violation|2|||
161056673|NCT04754594|581596083|FG002|Blinded Period|Protocol Violation|0|||
161056674|NCT04754594|581596084|FG003|Blinded Period|Protocol Violation|0|||
161056675|NCT04754594|581596081|FG000|Blinded Period|Lost to Follow-up|1|||
161056676|NCT04754594|581596082|FG001|Blinded Period|Lost to Follow-up|1|||
161056677|NCT04754594|581596083|FG002|Blinded Period|Lost to Follow-up|0|||
161056678|NCT04754594|581596084|FG003|Blinded Period|Lost to Follow-up|0|||
161056679|NCT04754594|581596081|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
161056680|NCT04754594|581596082|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
161056681|NCT04754594|581596083|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
161056682|NCT04754594|581596084|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
161056683|NCT04754594|581596081|FG000|Unblinded Period|Withdrawal by Subject|6|||
161056684|NCT04754594|581596082|FG001|Unblinded Period|Withdrawal by Subject|8|||
161056685|NCT04754594|581596083|FG002|Unblinded Period|Withdrawal by Subject|0|||
161056686|NCT04754594|581596084|FG003|Unblinded Period|Withdrawal by Subject|0|||
161056687|NCT04754594|581596081|FG000|Unblinded Period|Lost to Follow-up|5|||
161056688|NCT04754594|581596082|FG001|Unblinded Period|Lost to Follow-up|3|||
161056689|NCT04754594|581596083|FG002|Unblinded Period|Lost to Follow-up|0|||
161056690|NCT04754594|581596084|FG003|Unblinded Period|Lost to Follow-up|0|||
161056691|NCT04754594|581596081|FG000|Unblinded Period|Protocol Violation|2|||
161056692|NCT04754594|581596082|FG001|Unblinded Period|Protocol Violation|4|||
161056693|NCT04754594|581596083|FG002|Unblinded Period|Protocol Violation|0|||
161056694|NCT04754594|581596084|FG003|Unblinded Period|Protocol Violation|0|||
161056695|NCT04754594|581596081|FG000|Unblinded Period|Other|3|||
161056696|NCT04754594|581596082|FG001|Unblinded Period|Other|0|||
161056697|NCT04754594|581596083|FG002|Unblinded Period|Other|0|||
161056698|NCT04754594|581596084|FG003|Unblinded Period|Other|0|||
161056699|NCT04754594|581596081|FG000|Infant Participants|Withdrawal by Subject|0|||
161056700|NCT04754594|581596082|FG001|Infant Participants|Withdrawal by Subject|0|||
161056701|NCT04754594|581596083|FG002|Infant Participants|Withdrawal by Subject|9|||
161056702|NCT04754594|581596084|FG003|Infant Participants|Withdrawal by Subject|17|||
161056703|NCT04754594|581596081|FG000|Infant Participants|Lost to Follow-up|0|||
161056704|NCT04754594|581596082|FG001|Infant Participants|Lost to Follow-up|0|||
161056705|NCT04754594|581596083|FG002|Infant Participants|Lost to Follow-up|4|||
161056706|NCT04754594|581596084|FG003|Infant Participants|Lost to Follow-up|10|||
161056707|NCT04754594|581596081|FG000|Infant Participants|Death|0|||
161056708|NCT04754594|581596082|FG001|Infant Participants|Death|0|||
161056709|NCT04754594|581596083|FG002|Infant Participants|Death|1|||
161056710|NCT04754594|581596084|FG003|Infant Participants|Death|1|||
161056711|NCT04754594|581596081|FG000|Infant Participants|Other|0|||
161056712|NCT04754594|581596082|FG001|Infant Participants|Other|0|||
161056713|NCT04754594|581596083|FG002|Infant Participants|Other|1|||
161056714|NCT04754594|581596084|FG003|Infant Participants|Other|1|||
161056715|NCT01247922|581596085|FG000|Overall Study|Disease progression|4|||
161056716|NCT01876823|581596086|FG000|Overall Study|Withdrawal by Subject|5|||
161056717|NCT01876823|581596086|FG000|Overall Study|Physician Decision|2|||
161056718|NCT01876823|581596086|FG000|Overall Study|Patients moved|2|||
161056719|NCT00794573|581596091|FG000|Overall Study|Death|3|||
161056720|NCT00794573|581596092|FG001|Overall Study|Death|0|||
161056721|NCT00794573|581596091|FG000|Overall Study|Withdrawal by Subject|9|||
161056722|NCT00794573|581596092|FG001|Overall Study|Withdrawal by Subject|12|||
161056723|NCT00794573|581596091|FG000|Overall Study|Lost to Follow-up|26|||
161056724|NCT00794573|581596092|FG001|Overall Study|Lost to Follow-up|33|||
161056725|NCT00905255|581596093|FG000|Overall Study|Adverse Event|7|||
161056726|NCT00905255|581596094|FG001|Overall Study|Adverse Event|5|||
161056727|NCT00905255|581596093|FG000|Overall Study|Withdrawal by Subject|5|||
161281266|NCT03154125|582408674|FG002|Overall Study|Physician Decision|0|||
161056728|NCT00905255|581596094|FG001|Overall Study|Withdrawal by Subject|4|||
161281267|NCT03154125|582408672|FG000|Overall Study|Protocol Violation|3|||
161056729|NCT00905255|581596093|FG000|Overall Study|Familial and Personal Reasons|1|||
161056730|NCT00905255|581596094|FG001|Overall Study|Familial and Personal Reasons|0|||
161056731|NCT02418819|581596098|FG000|Overall Study|Adverse Event|0|||
161056732|NCT02418819|581596099|FG001|Overall Study|Adverse Event|0|||
161056733|NCT02418819|581596100|FG002|Overall Study|Adverse Event|1|||
161056734|NCT02418819|581596101|FG003|Overall Study|Adverse Event|0|||
161056735|NCT02418819|581596098|FG000|Overall Study|Lost to Follow-up|1|||
161056736|NCT02418819|581596099|FG001|Overall Study|Lost to Follow-up|0|||
161056737|NCT02418819|581596100|FG002|Overall Study|Lost to Follow-up|0|||
161056738|NCT02418819|581596101|FG003|Overall Study|Lost to Follow-up|0|||
161056739|NCT02418819|581596098|FG000|Overall Study|No longer meets eligibility criteria|0|||
161056740|NCT02418819|581596099|FG001|Overall Study|No longer meets eligibility criteria|0|||
161056741|NCT02418819|581596100|FG002|Overall Study|No longer meets eligibility criteria|1|||
161056742|NCT02418819|581596101|FG003|Overall Study|No longer meets eligibility criteria|0|||
161056743|NCT02418819|581596098|FG000|Overall Study|No longer willing to participate|0|||
161056744|NCT02418819|581596099|FG001|Overall Study|No longer willing to participate|0|||
161056745|NCT02418819|581596100|FG002|Overall Study|No longer willing to participate|2|||
161056746|NCT02418819|581596101|FG003|Overall Study|No longer willing to participate|1|||
161056747|NCT01332318|581596105|FG000|Overall Study|Adverse Event|0|||
161056748|NCT01332318|581596106|FG001|Overall Study|Adverse Event|3|||
161056749|NCT01332318|581596107|FG002|Overall Study|Adverse Event|0|||
161056750|NCT01332318|581596108|FG003|Overall Study|Adverse Event|0|||
161056751|NCT01332318|581596105|FG000|Overall Study|Withdrawal by Subject|1|||
161056752|NCT01332318|581596106|FG001|Overall Study|Withdrawal by Subject|1|||
161056753|NCT01332318|581596107|FG002|Overall Study|Withdrawal by Subject|0|||
161056754|NCT01332318|581596108|FG003|Overall Study|Withdrawal by Subject|1|||
161056755|NCT01332318|581596105|FG000|Overall Study|Protocol Violation|1|||
161056756|NCT01332318|581596106|FG001|Overall Study|Protocol Violation|0|||
161056757|NCT01332318|581596107|FG002|Overall Study|Protocol Violation|1|||
161056758|NCT01332318|581596108|FG003|Overall Study|Protocol Violation|1|||
161056759|NCT02040532|581596109|FG000|Overall Study|Lost to Follow-up|1|||
161056760|NCT02040532|581596109|FG000|Overall Study|Physician Decision|4|||
161056761|NCT02040532|581596109|FG000|Overall Study|Adverse Event|4|||
161056762|NCT02040532|581596109|FG000|Overall Study|Withdrawal by Subject|3|||
161056763|NCT01207453|581596110|FG000|First Intervention|Adverse Event|2|||
161056764|NCT01207453|581596111|FG001|First Intervention|Adverse Event|1|||
161056765|NCT01207453|581596110|FG000|Washout|Adverse Event|1|||
161056766|NCT01207453|581596111|FG001|Washout|Adverse Event|0|||
161056767|NCT01207453|581596110|FG000|Washout|Lost to Follow-up|1|||
161056768|NCT01207453|581596111|FG001|Washout|Lost to Follow-up|0|||
161056769|NCT01207453|581596110|FG000|2nd Intervention|Adverse Event|1|||
161056770|NCT01207453|581596111|FG001|2nd Intervention|Adverse Event|2|||
161056771|NCT01207453|581596110|FG000|2nd Intervention|Lost to Follow-up|1|||
161056772|NCT01207453|581596111|FG001|2nd Intervention|Lost to Follow-up|0|||
161056773|NCT01399905|581596112|FG000|Overall Study|Withdrawal by Subject|1|||
161056774|NCT01399905|581596113|FG001|Overall Study|Withdrawal by Subject|1|||
161056775|NCT01786551|581596117|FG000|Overall Study|Participant withdrew consent|2|||
161056776|NCT01524887|581596118|FG000|Overall Study|Withdrawal by Subject|6|||
161056777|NCT01524887|581596119|FG001|Overall Study|Withdrawal by Subject|2|||
161056778|NCT01524887|581596120|FG002|Overall Study|Withdrawal by Subject|3|||
161056779|NCT01524887|581596118|FG000|Overall Study|Adverse Event|5|||
161056780|NCT01524887|581596119|FG001|Overall Study|Adverse Event|1|||
161056781|NCT01524887|581596120|FG002|Overall Study|Adverse Event|1|||
161056782|NCT01524887|581596118|FG000|Overall Study|Protocol Violation|0|||
161056783|NCT01524887|581596119|FG001|Overall Study|Protocol Violation|0|||
161056784|NCT01524887|581596120|FG002|Overall Study|Protocol Violation|1|||
161056785|NCT01524887|581596118|FG000|Overall Study|Study termination|73|||
161056786|NCT01524887|581596119|FG001|Overall Study|Study termination|87|||
161056787|NCT01524887|581596120|FG002|Overall Study|Study termination|79|||
161056788|NCT01524887|581596118|FG000|Overall Study|Withdrawal by Caregiver|0|||
161056789|NCT01524887|581596119|FG001|Overall Study|Withdrawal by Caregiver|0|||
161056790|NCT01524887|581596120|FG002|Overall Study|Withdrawal by Caregiver|2|||
161056791|NCT01524887|581596118|FG000|Overall Study|Use of prohibited medication|1|||
161056792|NCT01524887|581596119|FG001|Overall Study|Use of prohibited medication|0|||
161056793|NCT01524887|581596120|FG002|Overall Study|Use of prohibited medication|0|||
161056794|NCT01808144|581596123|FG000|Overall Study|Death|1|||
161056795|NCT01808144|581596124|FG001|Overall Study|Death|0|||
161056796|NCT01808144|581596123|FG000|Overall Study|Withdrawal by Subject|16|||
161056797|NCT01808144|581596124|FG001|Overall Study|Withdrawal by Subject|23|||
161056798|NCT01808144|581596123|FG000|Overall Study|Lost to Follow-up|6|||
161056799|NCT01808144|581596124|FG001|Overall Study|Lost to Follow-up|3|||
161056800|NCT01808144|581596123|FG000|Overall Study|Protocol Violation|6|||
161056801|NCT01808144|581596124|FG001|Overall Study|Protocol Violation|6|||
161056802|NCT01808144|581596123|FG000|Overall Study|Gout flare|0|||
161056803|NCT01808144|581596124|FG001|Overall Study|Gout flare|1|||
161056804|NCT01808144|581596123|FG000|Overall Study|Adverse Event|11|||
161056805|NCT01808144|581596124|FG001|Overall Study|Adverse Event|15|||
161056806|NCT00733226|581598017|FG000|Overall Study|Withdrawal by Subject|1|||
161056807|NCT00733226|581598018|FG001|Overall Study|Withdrawal by Subject|0|||
161056808|NCT00733226|581598017|FG000|Overall Study|Lost to Follow-up|2|||
161056809|NCT00733226|581598018|FG001|Overall Study|Lost to Follow-up|0|||
161056810|NCT00733226|581598017|FG000|Overall Study|moved to another place|2|||
161281268|NCT03154125|582408673|FG001|Overall Study|Protocol Violation|5|||
161281269|NCT03154125|582408674|FG002|Overall Study|Protocol Violation|0|||
161281270|NCT00810511|582408675|FG000|Overall Study|Protocol Violation|0|||
161281271|NCT00810511|582408676|FG001|Overall Study|Protocol Violation|1|||
161056811|NCT00733226|581598018|FG001|Overall Study|moved to another place|0|||
161056812|NCT03511378|581598019|FG000|Overall Study|Withdrawal by Subject|2|||
161056813|NCT03511378|581598020|FG001|Overall Study|Withdrawal by Subject|2|||
161056814|NCT03511378|581598019|FG000|Overall Study|Patient not coming or schedule visit|1|||
161056815|NCT03511378|581598020|FG001|Overall Study|Patient not coming or schedule visit|0|||
161056816|NCT02229396|581598022|FG000|Overall Study|Adverse Event|6|||
161056817|NCT02229396|581598023|FG001|Overall Study|Adverse Event|12|||
161056818|NCT02229396|581598024|FG002|Overall Study|Adverse Event|12|||
161056819|NCT02229396|581598022|FG000|Overall Study|Death|2|||
161056820|NCT02229396|581598023|FG001|Overall Study|Death|3|||
161056821|NCT02229396|581598024|FG002|Overall Study|Death|1|||
161056822|NCT02229396|581598022|FG000|Overall Study|Lost to Follow-up|14|||
161056823|NCT02229396|581598023|FG001|Overall Study|Lost to Follow-up|14|||
161056824|NCT02229396|581598024|FG002|Overall Study|Lost to Follow-up|21|||
161056825|NCT02229396|581598022|FG000|Overall Study|Protocol Violation|2|||
161056826|NCT02229396|581598023|FG001|Overall Study|Protocol Violation|1|||
161056827|NCT02229396|581598024|FG002|Overall Study|Protocol Violation|0|||
161056828|NCT02229396|581598022|FG000|Overall Study|Patient Incorrectly Randomized|0|||
161056829|NCT02229396|581598023|FG001|Overall Study|Patient Incorrectly Randomized|0|||
161056830|NCT02229396|581598024|FG002|Overall Study|Patient Incorrectly Randomized|1|||
161056831|NCT02229396|581598022|FG000|Overall Study|Other|10|||
161056832|NCT02229396|581598023|FG001|Overall Study|Other|18|||
161056833|NCT02229396|581598024|FG002|Overall Study|Other|15|||
161056834|NCT02229396|581598022|FG000|Overall Study|Withdrawal by Subject|42|||
161056835|NCT02229396|581598023|FG001|Overall Study|Withdrawal by Subject|28|||
161056836|NCT02229396|581598024|FG002|Overall Study|Withdrawal by Subject|41|||
161056837|NCT02229396|581598022|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
161056838|NCT02229396|581598023|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161056839|NCT02229396|581598024|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
161056840|NCT02229396|581598022|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
161056841|NCT02229396|581598023|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
161056842|NCT02229396|581598024|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
161056843|NCT03022578|581598028|FG000|Overall Study|Adverse Event|1|||
161056844|NCT03022578|581598028|FG000|Overall Study|Lack of Efficacy|2|||
161056845|NCT03022578|581598028|FG000|Overall Study|Withdrawal by Subject|1|||
161056846|NCT02679079|581598029|FG000|Overall Study|Adverse Event|2|||
161056847|NCT02679079|581598030|FG001|Overall Study|Adverse Event|0|||
161056848|NCT02679079|581598031|FG002|Overall Study|Adverse Event|2|||
161056849|NCT02679079|581598029|FG000|Overall Study|Protocol Violation|0|||
161056850|NCT02679079|581598030|FG001|Overall Study|Protocol Violation|1|||
161056851|NCT02679079|581598031|FG002|Overall Study|Protocol Violation|0|||
161056852|NCT02679079|581598029|FG000|Overall Study|Withdrawal by Subject|2|||
161056853|NCT02679079|581598030|FG001|Overall Study|Withdrawal by Subject|1|||
161056854|NCT02679079|581598031|FG002|Overall Study|Withdrawal by Subject|0|||
161056855|NCT00805285|581598034|FG000|Overall Study|Lack of Efficacy|1|||
161056856|NCT00839306|581598038|FG000|Overall Study|Adverse Event|3|||
161056857|NCT00839306|581598039|FG001|Overall Study|Adverse Event|5|||
161056858|NCT00839306|581598038|FG000|Overall Study|Lost to Follow-up|6|||
161056859|NCT00839306|581598039|FG001|Overall Study|Lost to Follow-up|9|||
161056860|NCT00839306|581598038|FG000|Overall Study|Withdrawal by Subject|5|||
161056861|NCT00839306|581598039|FG001|Overall Study|Withdrawal by Subject|7|||
161056862|NCT00839306|581598038|FG000|Overall Study|Lack of Efficacy|5|||
161056863|NCT00839306|581598039|FG001|Overall Study|Lack of Efficacy|4|||
161056864|NCT00839306|581598038|FG000|Overall Study|Other|6|||
161056865|NCT00839306|581598039|FG001|Overall Study|Other|18|||
161056866|NCT01812707|581598040|FG000|Overall Study|Adverse Event|0|||
161281272|NCT00810511|582408675|FG000|Overall Study|Lack of Efficacy|9|||
161281273|NCT00810511|582408676|FG001|Overall Study|Lack of Efficacy|1|||
161281274|NCT00810511|582408675|FG000|Overall Study|death in the family|0|||
161281275|NCT00810511|582408676|FG001|Overall Study|death in the family|1|||
161056867|NCT01812707|581598041|FG001|Overall Study|Adverse Event|0|||
161056868|NCT01812707|581598042|FG002|Overall Study|Adverse Event|0|||
161056869|NCT01812707|581598043|FG003|Overall Study|Adverse Event|2|||
161056870|NCT01812707|581598040|FG000|Overall Study|Poor compliance to protocol|1|||
161056871|NCT01812707|581598041|FG001|Overall Study|Poor compliance to protocol|0|||
161056872|NCT01812707|581598042|FG002|Overall Study|Poor compliance to protocol|0|||
161056873|NCT01812707|581598043|FG003|Overall Study|Poor compliance to protocol|0|||
161056874|NCT01812707|581598040|FG000|Overall Study|Consent withdrawn by participant|1|||
161056875|NCT01812707|581598041|FG001|Overall Study|Consent withdrawn by participant|0|||
161056876|NCT01812707|581598042|FG002|Overall Study|Consent withdrawn by participant|0|||
161056877|NCT01812707|581598043|FG003|Overall Study|Consent withdrawn by participant|0|||
161056878|NCT05060237|581598045|FG000|Overall Study|Withdrawal by Subject|4|||
161056879|NCT05060237|581598045|FG000|Overall Study|Screening failure|8|||
161281276|NCT00810511|582408675|FG000|Overall Study|Lost to Follow-up|1|||
161056880|NCT01066897|581598046|FG000|Overall Study|Withdrawal by Subject|1|||
161056881|NCT01066897|581598047|FG001|Overall Study|Withdrawal by Subject|0|||
161056882|NCT01066897|581598046|FG000|Overall Study|stopped study after developing the flu.|1|||
161056883|NCT01066897|581598047|FG001|Overall Study|stopped study after developing the flu.|0|||
161056884|NCT01697592|581598050|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
161056885|NCT01697592|581598051|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056886|NCT01697592|581598052|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056887|NCT01697592|581598053|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056888|NCT01697592|581598054|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056889|NCT01697592|581598055|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056890|NCT01697592|581598056|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056891|NCT01697592|581598057|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056892|NCT01697592|581598058|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056893|NCT01697592|581598059|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
161056894|NCT01697592|581598050|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056895|NCT01697592|581598051|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056896|NCT01697592|581598052|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056897|NCT01697592|581598053|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056898|NCT01697592|581598054|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056899|NCT01697592|581598055|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
161056900|NCT01697592|581598056|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056901|NCT01697592|581598057|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056902|NCT01697592|581598058|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056903|NCT01697592|581598059|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
161056904|NCT01697592|581598050|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
161056905|NCT01697592|581598051|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056906|NCT01697592|581598052|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056907|NCT01697592|581598053|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056908|NCT01697592|581598054|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056909|NCT01697592|581598055|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056910|NCT01697592|581598056|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056911|NCT01697592|581598057|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056912|NCT01697592|581598058|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056913|NCT01697592|581598059|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
161056914|NCT01697592|581598050|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161056915|NCT01697592|581598051|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161152060|NCT04770155|581937152|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
161152061|NCT01632878|581937156|FG000|Screening|Physician Decision|268|||
161152062|NCT01632878|581937156|FG000|Treatment|Lost to Follow-up|41|||
161152063|NCT01632878|581937156|FG000|Treatment|Withdrawal by Subject|36|||
161152064|NCT01632878|581937156|FG000|Treatment|Physician Decision|34|||
161152065|NCT01632878|581937156|FG000|Treatment|missing information|4|||
161152066|NCT01632878|581937156|FG000|Treatment|no information on study completion|43|||
161152067|NCT02698423|581937157|FG000|Overall Study|Lost to Follow-up|19|||
161152068|NCT02698423|581937158|FG001|Overall Study|Lost to Follow-up|24|||
161152069|NCT01095250|581937166|FG000|Overall Study|administrative reasons|8|||
161152070|NCT01095250|581937167|FG001|Overall Study|administrative reasons|10|||
161152071|NCT01095250|581937168|FG002|Overall Study|administrative reasons|7|||
161152072|NCT01095250|581937169|FG003|Overall Study|administrative reasons|5|||
161152073|NCT01095250|581937166|FG000|Overall Study|Withdrawal by Subject|0|||
161152074|NCT01095250|581937167|FG001|Overall Study|Withdrawal by Subject|0|||
161152075|NCT01095250|581937168|FG002|Overall Study|Withdrawal by Subject|1|||
161152076|NCT01095250|581937169|FG003|Overall Study|Withdrawal by Subject|0|||
161152077|NCT01323673|581937170|FG000|Overall Study|Adverse Event|0|||
161152078|NCT01323673|581937171|FG001|Overall Study|Adverse Event|1|||
161152079|NCT01323673|581937170|FG000|Overall Study|Lost to Follow-up|0|||
161152080|NCT01323673|581937171|FG001|Overall Study|Lost to Follow-up|1|||
161152081|NCT01323673|581937170|FG000|Overall Study|Protocol Violation|1|||
161152082|NCT01323673|581937171|FG001|Overall Study|Protocol Violation|0|||
161152083|NCT01323673|581937170|FG000|Overall Study|Withdrawal by Subject|2|||
161152084|NCT01323673|581937171|FG001|Overall Study|Withdrawal by Subject|3|||
161152085|NCT00953043|581939189|FG000|Overall Study|Withdrawal by Subject|4|||
161152086|NCT00953043|581939190|FG001|Overall Study|Withdrawal by Subject|0|||
161152087|NCT00953043|581939189|FG000|Overall Study|Physician Decision|0|||
161152088|NCT00953043|581939190|FG001|Overall Study|Physician Decision|2|||
161152089|NCT00747617|581939191|FG000|Overall Study|Lost to Follow-up|3|||
161152090|NCT00747617|581939192|FG001|Overall Study|Lost to Follow-up|1|||
161152091|NCT03509207|581939193|FG000|Overall Study|Death|2|||
161152092|NCT02125331|581939194|FG000|Overall Study|Protocol Violation|1|||
161152093|NCT02125331|581939195|FG001|Overall Study|Protocol Violation|0|||
161152094|NCT02125331|581939194|FG000|Overall Study|technical problem|2|||
161056916|NCT01697592|581598052|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161152095|NCT02125331|581939195|FG001|Overall Study|technical problem|0|||
161281277|NCT00810511|582408676|FG001|Overall Study|Lost to Follow-up|0|||
161281278|NCT00810511|582408675|FG000|Overall Study|deposits on contact lens|0|||
161281279|NCT00810511|582408676|FG001|Overall Study|deposits on contact lens|1|||
161281280|NCT04342819|582408678|FG000|Overall Study|Declined|4|||
161281281|NCT04342819|582408678|FG000|Overall Study|Not meeeting selection criteria|1|||
161281282|NCT00911300|582408679|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
161281283|NCT00911300|582408680|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
161056917|NCT01697592|581598053|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161056918|NCT01697592|581598054|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161152096|NCT02125331|581939194|FG000|Overall Study|screen failure|2|||
161152097|NCT02125331|581939195|FG001|Overall Study|screen failure|0|||
161152098|NCT01432262|581939196|FG000|Overall Study|Withdrawal by Subject|2|||
161152099|NCT01432262|581939197|FG001|Overall Study|Withdrawal by Subject|1|||
161152100|NCT00165646|581939198|FG000|Overall Study|Adverse Event|1|||
161152101|NCT00165646|581939199|FG001|Overall Study|Adverse Event|1|||
161152102|NCT00165646|581939200|FG002|Overall Study|Adverse Event|1|||
161152103|NCT00165646|581939198|FG000|Overall Study|Lack of Efficacy|1|||
161152104|NCT00165646|581939199|FG001|Overall Study|Lack of Efficacy|2|||
161152105|NCT00165646|581939200|FG002|Overall Study|Lack of Efficacy|0|||
161152106|NCT00165646|581939198|FG000|Overall Study|Withdrawal by Subject|0|||
161152107|NCT00165646|581939199|FG001|Overall Study|Withdrawal by Subject|2|||
161152108|NCT00165646|581939200|FG002|Overall Study|Withdrawal by Subject|1|||
161152109|NCT00165646|581939198|FG000|Overall Study|Physician Decision|2|||
161152110|NCT00165646|581939199|FG001|Overall Study|Physician Decision|0|||
161152111|NCT00165646|581939200|FG002|Overall Study|Physician Decision|2|||
161056919|NCT01697592|581598055|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161056920|NCT01697592|581598056|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161056921|NCT01697592|581598057|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161056922|NCT01697592|581598058|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
161056923|NCT01697592|581598059|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
161056924|NCT01697592|581598050|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161056925|NCT01697592|581598051|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161056926|NCT01697592|581598052|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
161056927|NCT01697592|581598053|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
161056928|NCT01697592|581598054|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161056929|NCT01697592|581598055|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161056930|NCT01697592|581598056|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
161056931|NCT01697592|581598057|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161056932|NCT01697592|581598058|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
161056933|NCT01697592|581598059|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
161056934|NCT01697592|581598050|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
161056935|NCT01697592|581598051|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056936|NCT01697592|581598052|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056937|NCT01697592|581598053|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
161056938|NCT01697592|581598054|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056939|NCT01697592|581598055|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056940|NCT01697592|581598056|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056941|NCT01697592|581598057|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056942|NCT01697592|581598058|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056943|NCT01697592|581598059|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
161056944|NCT01697592|581598050|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
161056945|NCT01697592|581598051|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056946|NCT01697592|581598052|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056947|NCT01697592|581598053|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056948|NCT01697592|581598054|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056949|NCT01697592|581598055|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
161056950|NCT01697592|581598056|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056951|NCT01697592|581598057|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
161152112|NCT00165646|581939198|FG000|Overall Study|Protocol Violation|1|||
161152113|NCT00165646|581939199|FG001|Overall Study|Protocol Violation|0|||
161152114|NCT00165646|581939200|FG002|Overall Study|Protocol Violation|0|||
161152115|NCT04657016|581939201|FG000|Overall Study|Adverse Event|2|||
161152116|NCT04657016|581939202|FG001|Overall Study|Adverse Event|4|||
161281284|NCT00911300|582408679|FG000|Overall Study|Death|1|||
161056952|NCT01697592|581598058|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056953|NCT01697592|581598059|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
161056954|NCT01697592|581598050|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
161056955|NCT01697592|581598051|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161056956|NCT01697592|581598052|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161152117|NCT04657016|581939201|FG000|Overall Study|Death|1|||
161152118|NCT04657016|581939202|FG001|Overall Study|Death|1|||
161281285|NCT00911300|582408680|FG001|Overall Study|Death|0|||
161281286|NCT00911300|582408679|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
161281287|NCT00911300|582408680|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
161152119|NCT04657016|581939201|FG000|Overall Study|Lost to Follow-up|24|||
161152120|NCT04657016|581939202|FG001|Overall Study|Lost to Follow-up|12|||
161152121|NCT04657016|581939201|FG000|Overall Study|Physician Decision|1|||
161152122|NCT04657016|581939202|FG001|Overall Study|Physician Decision|2|||
161152123|NCT04657016|581939201|FG000|Overall Study|Pregnancy|2|||
161152124|NCT04657016|581939202|FG001|Overall Study|Pregnancy|2|||
161152125|NCT04657016|581939201|FG000|Overall Study|Protocol Deviation|1|||
161152126|NCT04657016|581939202|FG001|Overall Study|Protocol Deviation|0|||
161152127|NCT04657016|581939201|FG000|Overall Study|Withdrawal by Subject|28|||
161152128|NCT04657016|581939202|FG001|Overall Study|Withdrawal by Subject|14|||
161152129|NCT04657016|581939201|FG000|Overall Study|Other - as reported by the investigator|6|||
161152130|NCT04657016|581939202|FG001|Overall Study|Other - as reported by the investigator|0|||
161152131|NCT01104558|581939203|FG000|Overall Study|Protocol Violation|6|||
161152132|NCT01104558|581939203|FG000|Overall Study|Missing of primary efficacy assessment|10|||
161152133|NCT01104558|581939203|FG000|Overall Study|Missing of genetic analysis results|1|||
161152134|NCT00696657|581939204|FG000|Overall Study|Protocol Violation|0|||
161152135|NCT00696657|581939205|FG001|Overall Study|Protocol Violation|0|||
161152136|NCT00696657|581939206|FG002|Overall Study|Protocol Violation|0|||
161152137|NCT00696657|581939207|FG003|Overall Study|Protocol Violation|0|||
161152138|NCT00696657|581939208|FG004|Overall Study|Protocol Violation|0|||
161152139|NCT00696657|581939209|FG005|Overall Study|Protocol Violation|1|||
161152140|NCT00696657|581939210|FG006|Overall Study|Protocol Violation|0|||
161152141|NCT00696657|581939211|FG007|Overall Study|Protocol Violation|0|||
161152142|NCT00696657|581939212|FG008|Overall Study|Protocol Violation|1|||
161152143|NCT00696657|581939204|FG000|Overall Study|Lack of Efficacy|0|||
161152144|NCT00696657|581939205|FG001|Overall Study|Lack of Efficacy|1|||
161152145|NCT00696657|581939206|FG002|Overall Study|Lack of Efficacy|0|||
161152146|NCT00696657|581939207|FG003|Overall Study|Lack of Efficacy|0|||
161152147|NCT00696657|581939208|FG004|Overall Study|Lack of Efficacy|0|||
161152148|NCT00696657|581939209|FG005|Overall Study|Lack of Efficacy|0|||
161152149|NCT00696657|581939210|FG006|Overall Study|Lack of Efficacy|0|||
161152150|NCT00696657|581939211|FG007|Overall Study|Lack of Efficacy|0|||
161152151|NCT00696657|581939212|FG008|Overall Study|Lack of Efficacy|0|||
161152152|NCT00696657|581939204|FG000|Overall Study|Withdrawal criteria|1|||
161152153|NCT00696657|581939205|FG001|Overall Study|Withdrawal criteria|3|||
161152154|NCT00696657|581939206|FG002|Overall Study|Withdrawal criteria|2|||
161152155|NCT00696657|581939207|FG003|Overall Study|Withdrawal criteria|2|||
161152156|NCT00696657|581939208|FG004|Overall Study|Withdrawal criteria|0|||
161152157|NCT00696657|581939209|FG005|Overall Study|Withdrawal criteria|0|||
161152158|NCT00696657|581939210|FG006|Overall Study|Withdrawal criteria|1|||
161152159|NCT00696657|581939211|FG007|Overall Study|Withdrawal criteria|1|||
161152160|NCT00696657|581939212|FG008|Overall Study|Withdrawal criteria|2|||
161152161|NCT00696657|581939204|FG000|Overall Study|Unclassified|0|||
161152162|NCT00696657|581939205|FG001|Overall Study|Unclassified|1|||
161152163|NCT00696657|581939206|FG002|Overall Study|Unclassified|3|||
161152164|NCT00696657|581939207|FG003|Overall Study|Unclassified|2|||
161152165|NCT00696657|581939208|FG004|Overall Study|Unclassified|4|||
161152166|NCT00696657|581939209|FG005|Overall Study|Unclassified|2|||
161056957|NCT01697592|581598053|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
161056958|NCT01697592|581598054|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
161056959|NCT01697592|581598055|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161056960|NCT01697592|581598056|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
161056961|NCT01697592|581598057|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
161056962|NCT01697592|581598058|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
161056963|NCT01697592|581598059|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
161056964|NCT02396758|581598060|FG000|Overall Study|Withdrawal by Subject|2|||
161056965|NCT02396758|581598061|FG001|Overall Study|Withdrawal by Subject|0|||
161056966|NCT02396758|581598062|FG002|Overall Study|Withdrawal by Subject|0|||
161056967|NCT02396758|581598063|FG003|Overall Study|Withdrawal by Subject|1|||
161152167|NCT00696657|581939210|FG006|Overall Study|Unclassified|0|||
161056968|NCT02396758|581598060|FG000|Overall Study|Lost to Follow-up|8|||
161056969|NCT02396758|581598061|FG001|Overall Study|Lost to Follow-up|5|||
161152168|NCT00696657|581939211|FG007|Overall Study|Unclassified|0|||
161152169|NCT00696657|581939212|FG008|Overall Study|Unclassified|1|||
161152170|NCT00696657|581939204|FG000|Overall Study|Adverse Event|0|||
161152171|NCT00696657|581939205|FG001|Overall Study|Adverse Event|0|||
161152172|NCT00696657|581939206|FG002|Overall Study|Adverse Event|3|||
161152173|NCT00696657|581939207|FG003|Overall Study|Adverse Event|7|||
161152174|NCT00696657|581939208|FG004|Overall Study|Adverse Event|6|||
161152175|NCT00696657|581939209|FG005|Overall Study|Adverse Event|9|||
161281288|NCT00911300|582408679|FG000|Overall Study|Adverse Event|14|||
161152176|NCT00696657|581939210|FG006|Overall Study|Adverse Event|14|||
161152177|NCT00696657|581939211|FG007|Overall Study|Adverse Event|2|||
161152178|NCT00696657|581939212|FG008|Overall Study|Adverse Event|5|||
161152179|NCT00523341|581939216|FG000|Overall Study|Withdrawal by Subject|399|||
161152180|NCT00523341|581939217|FG001|Overall Study|Withdrawal by Subject|427|||
161281289|NCT00911300|582408680|FG001|Overall Study|Adverse Event|6|||
161281290|NCT00911300|582408679|FG000|Overall Study|Protocol Violation|3|||
161281291|NCT00911300|582408680|FG001|Overall Study|Protocol Violation|2|||
161152181|NCT00523341|581939216|FG000|Overall Study|Other|181|||
161152182|NCT00523341|581939217|FG001|Overall Study|Other|198|||
161152183|NCT00523341|581939216|FG000|Overall Study|Adverse Event|122|||
161152184|NCT00523341|581939217|FG001|Overall Study|Adverse Event|155|||
161152185|NCT00523341|581939216|FG000|Overall Study|Death|101|||
161152186|NCT00523341|581939217|FG001|Overall Study|Death|110|||
161152187|NCT00523341|581939216|FG000|Overall Study|Lost to Follow-up|73|||
161152188|NCT00523341|581939217|FG001|Overall Study|Lost to Follow-up|61|||
161152189|NCT00523341|581939216|FG000|Overall Study|Non-compliance|20|||
161152190|NCT00523341|581939217|FG001|Overall Study|Non-compliance|13|||
161152191|NCT00523341|581939216|FG000|Overall Study|Physician Decision|14|||
161152192|NCT00523341|581939217|FG001|Overall Study|Physician Decision|13|||
161152193|NCT00523341|581939216|FG000|Overall Study|Requirement for Alternative Therapy|4|||
161152194|NCT00523341|581939217|FG001|Overall Study|Requirement for Alternative Therapy|14|||
161152195|NCT00523341|581939216|FG000|Overall Study|Protocol Deviation|6|||
161152196|NCT00523341|581939217|FG001|Overall Study|Protocol Deviation|5|||
161152197|NCT00523341|581939216|FG000|Overall Study|Ineligibility Determined|3|||
161152198|NCT00523341|581939217|FG001|Overall Study|Ineligibility Determined|4|||
161152199|NCT00523341|581939216|FG000|Overall Study|Disease Progression|1|||
161152200|NCT00523341|581939217|FG001|Overall Study|Disease Progression|0|||
161152201|NCT02601001|581939220|FG000|Dosing Period 2|Adverse Event|0|||
161152202|NCT02601001|581939221|FG001|Dosing Period 2|Adverse Event|0|||
161152203|NCT02601001|581939222|FG002|Dosing Period 2|Adverse Event|0|||
161152204|NCT02601001|581939223|FG003|Dosing Period 2|Adverse Event|0|||
161152205|NCT02601001|581939224|FG004|Dosing Period 2|Adverse Event|0|||
161152206|NCT02601001|581939225|FG005|Dosing Period 2|Adverse Event|0|||
161152207|NCT02601001|581939226|FG006|Dosing Period 2|Adverse Event|1|||
161152208|NCT01790438|581939227|FG000|Overall Study|Adverse Event|3|||
161152209|NCT01790438|581939228|FG001|Overall Study|Adverse Event|2|||
161152210|NCT01790438|581939227|FG000|Overall Study|Death|4|||
161152211|NCT01790438|581939228|FG001|Overall Study|Death|0|||
161152212|NCT01790438|581939227|FG000|Overall Study|Lost to Follow-up|5|||
161152213|NCT01790438|581939228|FG001|Overall Study|Lost to Follow-up|2|||
161152214|NCT01790438|581939227|FG000|Overall Study|Withdrawal by Subject|13|||
161152215|NCT01790438|581939228|FG001|Overall Study|Withdrawal by Subject|2|||
161152216|NCT01790438|581939227|FG000|Overall Study|Physician Decision|3|||
161152217|NCT01790438|581939228|FG001|Overall Study|Physician Decision|1|||
161152218|NCT01790438|581939227|FG000|Overall Study|Sponsor Decision|0|||
161152219|NCT01790438|581939228|FG001|Overall Study|Sponsor Decision|3|||
161152220|NCT01790438|581939227|FG000|Overall Study|Protocol Required Discontinuation|7|||
161152221|NCT01790438|581939228|FG001|Overall Study|Protocol Required Discontinuation|1|||
161152222|NCT01356602|581939231|FG000|Overall Study|Protocol Deviation|0|||
161152223|NCT01356602|581939232|FG001|Overall Study|Protocol Deviation|1|||
161152224|NCT01356602|581939233|FG002|Overall Study|Protocol Deviation|1|||
161152225|NCT01356602|581939231|FG000|Overall Study|Administrative Problems|1|||
161152226|NCT01356602|581939232|FG001|Overall Study|Administrative Problems|4|||
161152227|NCT01356602|581939233|FG002|Overall Study|Administrative Problems|5|||
161152228|NCT01356602|581939231|FG000|Overall Study|Lost to Follow-up|4|||
161152229|NCT01356602|581939232|FG001|Overall Study|Lost to Follow-up|5|||
161152230|NCT01356602|581939233|FG002|Overall Study|Lost to Follow-up|6|||
161152231|NCT01356602|581939231|FG000|Overall Study|Withdrawal by Subject|4|||
161152232|NCT01356602|581939232|FG001|Overall Study|Withdrawal by Subject|3|||
161152233|NCT01356602|581939233|FG002|Overall Study|Withdrawal by Subject|7|||
161152234|NCT01356602|581939231|FG000|Overall Study|Lack of Efficacy|0|||
161152235|NCT01356602|581939232|FG001|Overall Study|Lack of Efficacy|1|||
161152236|NCT01356602|581939233|FG002|Overall Study|Lack of Efficacy|4|||
161152237|NCT01356602|581939231|FG000|Overall Study|Adverse Event|0|||
161152238|NCT01356602|581939232|FG001|Overall Study|Adverse Event|1|||
161152239|NCT01356602|581939233|FG002|Overall Study|Adverse Event|1|||
161152240|NCT03123354|581939234|FG000|Overall Study|Physician Decision|6|||
161152241|NCT01931462|581939235|FG000|Overall Study|Withdrawal by Subject|1|||
161152242|NCT04907539|581939236|FG000|Overall Study|Consent withdrawn|1|||
161152243|NCT04907539|581939237|FG001|Overall Study|Consent withdrawn|0|||
161152244|NCT04907539|581939236|FG000|Overall Study|Death|14|||
161152245|NCT04907539|581939237|FG001|Overall Study|Death|3|||
161152246|NCT01701583|581939238|FG000|Overall Study|Withdrawal by Subject|2|||
161152247|NCT01701583|581939239|FG001|Overall Study|Withdrawal by Subject|0|||
161152248|NCT05070429|581939240|FG000|Overall Study|Death|0|||
161152249|NCT05070429|581939241|FG001|Overall Study|Death|4|||
161152250|NCT05070429|581939240|FG000|Overall Study|Withdrawal by Subject|2|||
161152251|NCT05070429|581939241|FG001|Overall Study|Withdrawal by Subject|1|||
161152252|NCT05070429|581939240|FG000|Overall Study|Other|15|||
161152253|NCT05070429|581939241|FG001|Overall Study|Other|5|||
161152254|NCT03041116|581939242|FG000|Double-blind|Death|0|||
161152255|NCT03041116|581939243|FG001|Double-blind|Death|2|||
161152256|NCT03041116|581939242|FG000|Double-blind|Withdrawal by Subject|0|||
161152257|NCT03041116|581939243|FG001|Double-blind|Withdrawal by Subject|4|||
161152258|NCT03041116|581939242|FG000|Open-label|Death|1|||
161152259|NCT03041116|581939243|FG001|Open-label|Death|0|||
161152260|NCT03041116|581939242|FG000|Open-label|Termination of the study by Sponsor|39|||
161152261|NCT03041116|581939243|FG001|Open-label|Termination of the study by Sponsor|37|||
161152262|NCT03041116|581939242|FG000|Open-label|Withdrawal by Subject|1|||
161152263|NCT03041116|581939243|FG001|Open-label|Withdrawal by Subject|0|||
161152264|NCT01345123|581939244|FG000|Overall Study|participants no longer with health plan|79|||
161152265|NCT01345123|581939245|FG001|Overall Study|participants no longer with health plan|85|||
161152266|NCT01345123|581939246|FG002|Overall Study|participants no longer with health plan|88|||
161152267|NCT03650452|581939247|FG000|Overall Study|Physician Decision|1|||
161152268|NCT03650452|581939248|FG001|Overall Study|Physician Decision|0|||
161152269|NCT03650452|581939247|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
161152270|NCT03650452|581939248|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161152271|NCT03650452|581939247|FG000|Overall Study|Adverse Event|3|||
161152272|NCT03650452|581939248|FG001|Overall Study|Adverse Event|4|||
161152273|NCT03650452|581939247|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
161152274|NCT03650452|581939248|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
161152275|NCT01984346|581939251|FG000|Overall Study|Physician Decision|4|||
161152276|NCT01984346|581939252|FG001|Overall Study|Physician Decision|2|||
161152277|NCT01984346|581939251|FG000|Overall Study|Withdrawal by Subject|2|||
161152278|NCT01984346|581939252|FG001|Overall Study|Withdrawal by Subject|2|||
161152279|NCT01984346|581939251|FG000|Overall Study|Enrollment Closed|8|||
161152280|NCT01984346|581939252|FG001|Overall Study|Enrollment Closed|1|||
161152281|NCT01984346|581939251|FG000|Overall Study|Insurance Coverage|1|||
161152282|NCT01984346|581939252|FG001|Overall Study|Insurance Coverage|0|||
161152283|NCT01984346|581939251|FG000|Overall Study|Intra-operative Exclusion|2|||
161152284|NCT01984346|581939252|FG001|Overall Study|Intra-operative Exclusion|0|||
161152285|NCT02042404|581939255|FG000|Overall Study|Death|1|||
161152286|NCT02042404|581939256|FG001|Overall Study|Death|0|||
161152287|NCT02042404|581939255|FG000|Overall Study|Unrelated Adverse Event|3|||
161152288|NCT02042404|581939256|FG001|Overall Study|Unrelated Adverse Event|0|||
161152289|NCT02042404|581939255|FG000|Overall Study|Inability to meet time requirements|1|||
161152290|NCT02042404|581939256|FG001|Overall Study|Inability to meet time requirements|0|||
161152291|NCT03100942|581939257|FG000|Randomized Treatment Period|Withdrew Consent|4|||
161152292|NCT03100942|581939258|FG001|Randomized Treatment Period|Withdrew Consent|5|||
161152293|NCT03100942|581939259|FG002|Randomized Treatment Period|Withdrew Consent|3|||
161152294|NCT03100942|581939260|FG003|Randomized Treatment Period|Withdrew Consent|3|||
161152295|NCT03100942|581939261|FG004|Randomized Treatment Period|Withdrew Consent|0|||
161152296|NCT03100942|581939262|FG005|Randomized Treatment Period|Withdrew Consent|0|||
161152297|NCT03100942|581939263|FG006|Randomized Treatment Period|Withdrew Consent|0|||
161152298|NCT03100942|581939257|FG000|Randomized Treatment Period|Adverse Event|5|||
161152299|NCT03100942|581939258|FG001|Randomized Treatment Period|Adverse Event|2|||
161152300|NCT03100942|581939259|FG002|Randomized Treatment Period|Adverse Event|1|||
161152301|NCT03100942|581939260|FG003|Randomized Treatment Period|Adverse Event|0|||
161152302|NCT03100942|581939261|FG004|Randomized Treatment Period|Adverse Event|0|||
161152303|NCT03100942|581939262|FG005|Randomized Treatment Period|Adverse Event|0|||
161152304|NCT03100942|581939263|FG006|Randomized Treatment Period|Adverse Event|0|||
161152305|NCT03100942|581939257|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
161152306|NCT03100942|581939258|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
161152307|NCT03100942|581939259|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
161056970|NCT02396758|581598062|FG002|Overall Study|Lost to Follow-up|3|||
161056971|NCT02396758|581598063|FG003|Overall Study|Lost to Follow-up|3|||
161056972|NCT02396758|581598060|FG000|Overall Study|Death|1|||
161056973|NCT02396758|581598061|FG001|Overall Study|Death|1|||
161056974|NCT02396758|581598062|FG002|Overall Study|Death|0|||
161056975|NCT02396758|581598063|FG003|Overall Study|Death|1|||
161056976|NCT02396758|581598060|FG000|Overall Study|Randomized but not treated|1|||
161056977|NCT02396758|581598061|FG001|Overall Study|Randomized but not treated|0|||
161056978|NCT02396758|581598062|FG002|Overall Study|Randomized but not treated|1|||
161152308|NCT03100942|581939260|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
161152309|NCT03100942|581939261|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
161152310|NCT03100942|581939262|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
161152311|NCT03100942|581939263|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
161152312|NCT03100942|581939257|FG000|Randomized Treatment Period|Protocol Violation|0|||
161152313|NCT03100942|581939258|FG001|Randomized Treatment Period|Protocol Violation|1|||
161152314|NCT03100942|581939259|FG002|Randomized Treatment Period|Protocol Violation|1|||
161152315|NCT03100942|581939260|FG003|Randomized Treatment Period|Protocol Violation|1|||
161152316|NCT03100942|581939261|FG004|Randomized Treatment Period|Protocol Violation|0|||
161152317|NCT03100942|581939262|FG005|Randomized Treatment Period|Protocol Violation|0|||
161152318|NCT03100942|581939263|FG006|Randomized Treatment Period|Protocol Violation|0|||
161056979|NCT02396758|581598063|FG003|Overall Study|Randomized but not treated|0|||
161056980|NCT01631825|581598064|FG000|Overall Study|Adverse Event|42|||
161152319|NCT03100942|581939257|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
161152320|NCT03100942|581939258|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
161152321|NCT03100942|581939259|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
161056981|NCT01631825|581598064|FG000|Overall Study|Lack of Efficacy|7|||
161056982|NCT01631825|581598064|FG000|Overall Study|Withdrawal by Subject|9|||
161056983|NCT01631825|581598064|FG000|Overall Study|Protocol Violation|4|||
161056984|NCT01631825|581598064|FG000|Overall Study|Discontinuation criteria|1|||
161056985|NCT01631825|581598064|FG000|Overall Study|Physician Decision|2|||
161056986|NCT02110225|581598065|FG000|Overall Study|Lost to Follow-up|0|||
161056987|NCT02110225|581598066|FG001|Overall Study|Lost to Follow-up|1|||
161056988|NCT02110225|581598067|FG002|Overall Study|Lost to Follow-up|0|||
161056989|NCT00265096|581598068|FG000|Overall Study|Adverse Event|14|||
161056990|NCT00265096|581598069|FG001|Overall Study|Adverse Event|18|||
161056991|NCT00265096|581598070|FG002|Overall Study|Adverse Event|18|||
161056992|NCT00265096|581598068|FG000|Overall Study|Lost to Follow-up|2|||
161056993|NCT00265096|581598069|FG001|Overall Study|Lost to Follow-up|5|||
161056994|NCT00265096|581598070|FG002|Overall Study|Lost to Follow-up|3|||
161056995|NCT00265096|581598068|FG000|Overall Study|Death|0|||
161056996|NCT00265096|581598069|FG001|Overall Study|Death|1|||
161056997|NCT00265096|581598070|FG002|Overall Study|Death|2|||
161056998|NCT00265096|581598068|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161056999|NCT00265096|581598069|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161057000|NCT00265096|581598070|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
161057001|NCT00265096|581598068|FG000|Overall Study|Other|11|||
161057002|NCT00265096|581598069|FG001|Overall Study|Other|19|||
161057003|NCT00265096|581598070|FG002|Overall Study|Other|10|||
161057004|NCT01116440|581598071|FG000|Treatment|Withdrawal by Subject|2|||
161057005|NCT01116440|581598072|FG001|Treatment|Withdrawal by Subject|2|||
161057006|NCT01116440|581598071|FG000|Treatment|Lost to Follow-up|1|||
161057007|NCT01116440|581598072|FG001|Treatment|Lost to Follow-up|1|||
161057008|NCT01116440|581598071|FG000|Treatment|Protocol Violation|0|||
161057009|NCT01116440|581598072|FG001|Treatment|Protocol Violation|2|||
161057010|NCT01116440|581598071|FG000|Treatment|Lack of Efficacy|0|||
161057011|NCT01116440|581598072|FG001|Treatment|Lack of Efficacy|1|||
161057012|NCT01116440|581598071|FG000|Treatment|Adverse Event|0|||
161057013|NCT01116440|581598072|FG001|Treatment|Adverse Event|1|||
161057014|NCT01116440|581598071|FG000|Withdrawal|Withdrawal by Subject|0|||
161057015|NCT01116440|581598072|FG001|Withdrawal|Withdrawal by Subject|1|||
161057016|NCT01116440|581598071|FG000|Withdrawal|Lost to Follow-up|0|||
161057017|NCT01116440|581598072|FG001|Withdrawal|Lost to Follow-up|1|||
161057018|NCT01116440|581598071|FG000|Follow-up|Lost to Follow-up|0|||
161057019|NCT01116440|581598072|FG001|Follow-up|Lost to Follow-up|1|||
161057020|NCT01116440|581598071|FG000|Follow-up|Withdrawal by Subject|0|||
161057021|NCT01116440|581598072|FG001|Follow-up|Withdrawal by Subject|1|||
161057022|NCT00774306|581598073|FG000|Overall Study|Adverse Event|3|||
161057023|NCT00774306|581598074|FG001|Overall Study|Adverse Event|0|||
161057024|NCT00774306|581598075|FG002|Overall Study|Adverse Event|0|||
161057025|NCT00774306|581598076|FG003|Overall Study|Adverse Event|0|||
161057026|NCT00774306|581598073|FG000|Overall Study|Protocol Violation|2|||
161057027|NCT00774306|581598074|FG001|Overall Study|Protocol Violation|0|||
161057028|NCT00774306|581598075|FG002|Overall Study|Protocol Violation|3|||
161057029|NCT00774306|581598076|FG003|Overall Study|Protocol Violation|0|||
161057030|NCT00774306|581598073|FG000|Overall Study|Withdrawal by Subject|6|||
161057031|NCT00774306|581598074|FG001|Overall Study|Withdrawal by Subject|1|||
161057032|NCT00774306|581598075|FG002|Overall Study|Withdrawal by Subject|1|||
161057033|NCT00774306|581598076|FG003|Overall Study|Withdrawal by Subject|0|||
161057034|NCT00774306|581598073|FG000|Overall Study|Lost to Follow-up|6|||
161057035|NCT00774306|581598074|FG001|Overall Study|Lost to Follow-up|0|||
161057036|NCT00774306|581598075|FG002|Overall Study|Lost to Follow-up|4|||
161057037|NCT00774306|581598076|FG003|Overall Study|Lost to Follow-up|5|||
161057038|NCT00774306|581598073|FG000|Overall Study|Death|1|||
161057039|NCT00774306|581598074|FG001|Overall Study|Death|1|||
161057040|NCT00774306|581598075|FG002|Overall Study|Death|0|||
161057041|NCT00774306|581598076|FG003|Overall Study|Death|0|||
161057042|NCT03568708|581598082|FG000|Overall Study|Withdrawal by Subject|1|||
161057043|NCT03568708|581598083|FG001|Overall Study|Withdrawal by Subject|1|||
161057044|NCT03568708|581598082|FG000|Overall Study|Lost to Follow-up|0|||
161057045|NCT03568708|581598083|FG001|Overall Study|Lost to Follow-up|1|||
161057046|NCT00666835|581598084|FG000|Overall Study|Withdrawal by Subject|5|||
161057047|NCT00666835|581598085|FG001|Overall Study|Withdrawal by Subject|2|||
161057048|NCT00666835|581598084|FG000|Overall Study|Lack of Efficacy|0|||
161057049|NCT00666835|581598085|FG001|Overall Study|Lack of Efficacy|1|||
161057050|NCT00666835|581598084|FG000|Overall Study|Incl./excl. not fulfilled|7|||
161057051|NCT00666835|581598085|FG001|Overall Study|Incl./excl. not fulfilled|2|||
161057052|NCT00666835|581598084|FG000|Overall Study|Adverse Event|7|||
161057053|NCT00666835|581598085|FG001|Overall Study|Adverse Event|6|||
161057054|NCT00666835|581598084|FG000|Overall Study|Protocol Violation|2|||
161057055|NCT00666835|581598085|FG001|Overall Study|Protocol Violation|0|||
161057056|NCT00666835|581598084|FG000|Overall Study|Death|15|||
161057057|NCT00666835|581598085|FG001|Overall Study|Death|4|||
161057058|NCT00666835|581598084|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
161057059|NCT00666835|581598085|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
161057060|NCT00666835|581598084|FG000|Overall Study|Hemoglobulin concentration|4|||
161057061|NCT00666835|581598085|FG001|Overall Study|Hemoglobulin concentration|3|||
161152322|NCT03100942|581939260|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
161152323|NCT03100942|581939261|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
161152324|NCT03100942|581939262|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
161152325|NCT03100942|581939263|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
161152326|NCT03100942|581939257|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
161152327|NCT03100942|581939258|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161152328|NCT03100942|581939259|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161152329|NCT03100942|581939260|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
161152330|NCT03100942|581939261|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161152331|NCT03100942|581939262|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161152332|NCT03100942|581939263|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
161152333|NCT03100942|581939257|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161152334|NCT03100942|581939258|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161152335|NCT03100942|581939259|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161152336|NCT03100942|581939260|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161152337|NCT03100942|581939261|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161152338|NCT03100942|581939262|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
161152339|NCT03100942|581939263|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
161057062|NCT00666835|581598084|FG000|Overall Study|Planned operation|2|||
161057063|NCT00666835|581598085|FG001|Overall Study|Planned operation|0|||
161057064|NCT00666835|581598084|FG000|Overall Study|Physician Decision|1|||
161057065|NCT00666835|581598085|FG001|Overall Study|Physician Decision|2|||
161057066|NCT01126879|581598086|FG000|Overall Study|Progressive Disease|3|||
161057067|NCT01126879|581598087|FG001|Overall Study|Progressive Disease|1|||
161057068|NCT01126879|581598086|FG000|Overall Study|Withdrawal by Subject|1|||
161057069|NCT01126879|581598087|FG001|Overall Study|Withdrawal by Subject|0|||
161057070|NCT01126879|581598086|FG000|Overall Study|Adverse Event|0|||
161057071|NCT01126879|581598087|FG001|Overall Study|Adverse Event|1|||
161057072|NCT01126879|581598086|FG000|Overall Study|Physician Decision|1|||
161057073|NCT01126879|581598087|FG001|Overall Study|Physician Decision|0|||
161057074|NCT00511147|581598090|FG000|Overall Study|Withdrawal by Subject|1|||
161057075|NCT00511147|581598090|FG000|Overall Study|Disease progression|5|||
161057076|NCT00511147|581598090|FG000|Overall Study|Required platelet transfusion|1|||
161057077|NCT00899379|581598091|FG000|Overall Study|Adverse Event|2|||
161057078|NCT00899379|581598092|FG001|Overall Study|Adverse Event|2|||
161057079|NCT00899379|581598093|FG002|Overall Study|Adverse Event|1|||
161057080|NCT00899379|581598094|FG003|Overall Study|Adverse Event|1|||
161057081|NCT00899379|581598095|FG004|Overall Study|Adverse Event|2|||
161057082|NCT00899379|581598091|FG000|Overall Study|Lack of Efficacy|0|||
161057083|NCT00899379|581598092|FG001|Overall Study|Lack of Efficacy|4|||
161057084|NCT00899379|581598093|FG002|Overall Study|Lack of Efficacy|3|||
161057085|NCT00899379|581598094|FG003|Overall Study|Lack of Efficacy|0|||
161057086|NCT00899379|581598095|FG004|Overall Study|Lack of Efficacy|1|||
161057087|NCT00899379|581598091|FG000|Overall Study|Lost to Follow-up|9|||
161057088|NCT00899379|581598092|FG001|Overall Study|Lost to Follow-up|3|||
161057089|NCT00899379|581598093|FG002|Overall Study|Lost to Follow-up|0|||
161057090|NCT00899379|581598094|FG003|Overall Study|Lost to Follow-up|6|||
161057091|NCT00899379|581598095|FG004|Overall Study|Lost to Follow-up|2|||
161057092|NCT00899379|581598091|FG000|Overall Study|Protocol Violation|0|||
161057093|NCT00899379|581598092|FG001|Overall Study|Protocol Violation|0|||
161057094|NCT00899379|581598093|FG002|Overall Study|Protocol Violation|1|||
161057095|NCT00899379|581598094|FG003|Overall Study|Protocol Violation|1|||
161057096|NCT00899379|581598095|FG004|Overall Study|Protocol Violation|0|||
161057097|NCT00899379|581598091|FG000|Overall Study|Withdrawal by Subject|2|||
161057098|NCT00899379|581598092|FG001|Overall Study|Withdrawal by Subject|4|||
161057099|NCT00899379|581598093|FG002|Overall Study|Withdrawal by Subject|2|||
161057100|NCT00899379|581598094|FG003|Overall Study|Withdrawal by Subject|3|||
161057101|NCT00899379|581598095|FG004|Overall Study|Withdrawal by Subject|6|||
161057102|NCT00899379|581598091|FG000|Overall Study|Pregnancy|0|||
161057103|NCT00899379|581598092|FG001|Overall Study|Pregnancy|0|||
161057104|NCT00899379|581598093|FG002|Overall Study|Pregnancy|1|||
161057105|NCT00899379|581598094|FG003|Overall Study|Pregnancy|0|||
161057106|NCT00899379|581598095|FG004|Overall Study|Pregnancy|1|||
161057107|NCT00899379|581598091|FG000|Overall Study|Patient Uncooperative|0|||
161057108|NCT00899379|581598092|FG001|Overall Study|Patient Uncooperative|1|||
161057109|NCT00899379|581598093|FG002|Overall Study|Patient Uncooperative|0|||
161057110|NCT00899379|581598094|FG003|Overall Study|Patient Uncooperative|1|||
161057111|NCT00899379|581598095|FG004|Overall Study|Patient Uncooperative|2|||
161057112|NCT00899379|581598091|FG000|Overall Study|Abnormal Baseline ECG|0|||
161057113|NCT00899379|581598092|FG001|Overall Study|Abnormal Baseline ECG|0|||
161057114|NCT00899379|581598093|FG002|Overall Study|Abnormal Baseline ECG|0|||
161057115|NCT00899379|581598094|FG003|Overall Study|Abnormal Baseline ECG|1|||
161152340|NCT01876732|581939268|FG000|Overall Study|MMA was not over 800mg/dL|75|||
161152341|NCT00536731|581939269|FG000|Overall Study|Adverse Event|3|||
161057116|NCT00899379|581598095|FG004|Overall Study|Abnormal Baseline ECG|0|||
161152342|NCT00536731|581939270|FG001|Overall Study|Adverse Event|2|||
161152343|NCT00536731|581939271|FG002|Overall Study|Adverse Event|3|||
161152344|NCT00536731|581939269|FG000|Overall Study|Withdrawal by Subject|0|||
161152345|NCT00536731|581939270|FG001|Overall Study|Withdrawal by Subject|2|||
161152346|NCT00536731|581939271|FG002|Overall Study|Withdrawal by Subject|0|||
161152347|NCT00536731|581939269|FG000|Overall Study|Intake of prohibited conc. medication|0|||
161152348|NCT00536731|581939270|FG001|Overall Study|Intake of prohibited conc. medication|0|||
161152349|NCT00536731|581939271|FG002|Overall Study|Intake of prohibited conc. medication|1|||
161152350|NCT00536731|581939269|FG000|Overall Study|Safety reasons|0|||
161152351|NCT00536731|581939270|FG001|Overall Study|Safety reasons|0|||
161152352|NCT00536731|581939271|FG002|Overall Study|Safety reasons|1|||
161152353|NCT00536731|581939269|FG000|Overall Study|Other|1|||
161152354|NCT00536731|581939270|FG001|Overall Study|Other|1|||
161152355|NCT00536731|581939271|FG002|Overall Study|Other|0|||
161152356|NCT00718419|581939272|FG000|Overall Study|Adverse Event|2|||
161152357|NCT00718419|581939273|FG001|Overall Study|Adverse Event|1|||
161152358|NCT00718419|581939272|FG000|Overall Study|Physician Decision|1|||
161152359|NCT00718419|581939273|FG001|Overall Study|Physician Decision|6|||
161152360|NCT00718419|581939272|FG000|Overall Study|Sponsor decision|0|||
161152361|NCT00718419|581939273|FG001|Overall Study|Sponsor decision|1|||
161152362|NCT00718419|581939272|FG000|Overall Study|Withdrawal by Subject|0|||
161152363|NCT00718419|581939273|FG001|Overall Study|Withdrawal by Subject|5|||
161152364|NCT00718419|581939272|FG000|Overall Study|Progressive Disease|7|||
161152365|NCT00718419|581939273|FG001|Overall Study|Progressive Disease|25|||
161152366|NCT00718419|581939272|FG000|Overall Study|Death Due to Progressive Disease|2|||
161152367|NCT00718419|581939273|FG001|Overall Study|Death Due to Progressive Disease|0|||
161152368|NCT00718419|581939272|FG000|Overall Study|Death Due to Study Drug Related|0|||
161152369|NCT00718419|581939273|FG001|Overall Study|Death Due to Study Drug Related|1|||
161152370|NCT00718419|581939272|FG000|Overall Study|Death Due to Adverse Events|1|||
161152371|NCT00718419|581939273|FG001|Overall Study|Death Due to Adverse Events|0|||
161152372|NCT02795988|581939276|FG000|Phase 1b|Withdrawal by Subject|0|||
161152373|NCT02795988|581939277|FG001|Phase 1b|Withdrawal by Subject|1|||
161152374|NCT02795988|581939278|FG002|Phase 1b|Withdrawal by Subject|0|||
161152375|NCT02795988|581939279|FG003|Phase 1b|Withdrawal by Subject|0|||
161152376|NCT02795988|581939280|FG004|Phase 1b|Withdrawal by Subject|0|||
161152377|NCT02795988|581939281|FG005|Phase 1b|Withdrawal by Subject|0|||
161152378|NCT02795988|581939282|FG006|Phase 1b|Withdrawal by Subject|0|||
161152379|NCT02795988|581939276|FG000|Phase 1b|Death|1|||
161152380|NCT02795988|581939277|FG001|Phase 1b|Death|2|||
161152381|NCT02795988|581939278|FG002|Phase 1b|Death|1|||
161152382|NCT02795988|581939279|FG003|Phase 1b|Death|0|||
161152383|NCT02795988|581939280|FG004|Phase 1b|Death|0|||
161152384|NCT02795988|581939281|FG005|Phase 1b|Death|0|||
161152385|NCT02795988|581939282|FG006|Phase 1b|Death|0|||
161152386|NCT02795988|581939276|FG000|Phase 1b|Physician Decision|0|||
161152387|NCT02795988|581939277|FG001|Phase 1b|Physician Decision|0|||
161152388|NCT02795988|581939278|FG002|Phase 1b|Physician Decision|1|||
161152389|NCT02795988|581939279|FG003|Phase 1b|Physician Decision|0|||
161152390|NCT02795988|581939280|FG004|Phase 1b|Physician Decision|0|||
161152391|NCT02795988|581939281|FG005|Phase 1b|Physician Decision|0|||
161152392|NCT02795988|581939282|FG006|Phase 1b|Physician Decision|0|||
161345134|NCT00294658|582648869|FG001|Overall Study|Patient and family were not satisfied|1|||
161345135|NCT00976027|582648871|FG000|Overall Study|Serious Adverse Event|36|||
161152393|NCT02795988|581939276|FG000|Phase 1b|Progressive Disease|2|||
161152394|NCT02795988|581939277|FG001|Phase 1b|Progressive Disease|2|||
161152395|NCT02795988|581939278|FG002|Phase 1b|Progressive Disease|0|||
161152396|NCT02795988|581939279|FG003|Phase 1b|Progressive Disease|0|||
161152397|NCT02795988|581939280|FG004|Phase 1b|Progressive Disease|0|||
161152398|NCT02795988|581939281|FG005|Phase 1b|Progressive Disease|0|||
161152399|NCT02795988|581939282|FG006|Phase 1b|Progressive Disease|0|||
161152400|NCT02795988|581939276|FG000|Phase 2|Withdrawal by Subject|0|||
161152401|NCT02795988|581939277|FG001|Phase 2|Withdrawal by Subject|0|||
161152402|NCT02795988|581939278|FG002|Phase 2|Withdrawal by Subject|0|||
161152403|NCT02795988|581939279|FG003|Phase 2|Withdrawal by Subject|1|||
161152404|NCT02795988|581939280|FG004|Phase 2|Withdrawal by Subject|0|||
161152405|NCT02795988|581939281|FG005|Phase 2|Withdrawal by Subject|0|||
161152406|NCT02795988|581939282|FG006|Phase 2|Withdrawal by Subject|0|||
161152407|NCT02795988|581939276|FG000|Phase 2|Death|0|||
161152408|NCT02795988|581939277|FG001|Phase 2|Death|0|||
161152409|NCT02795988|581939278|FG002|Phase 2|Death|0|||
161152410|NCT02795988|581939279|FG003|Phase 2|Death|17|||
161152411|NCT02795988|581939280|FG004|Phase 2|Death|17|||
161152412|NCT02795988|581939281|FG005|Phase 2|Death|0|||
161152413|NCT02795988|581939282|FG006|Phase 2|Death|0|||
161345136|NCT00976027|582648872|FG001|Overall Study|Serious Adverse Event|17|||
161152414|NCT02795988|581939276|FG000|Phase 2|Other|0|||
161152415|NCT02795988|581939277|FG001|Phase 2|Other|0|||
161152416|NCT02795988|581939278|FG002|Phase 2|Other|0|||
161152417|NCT02795988|581939279|FG003|Phase 2|Other|1|||
161152418|NCT02795988|581939280|FG004|Phase 2|Other|0|||
161152419|NCT02795988|581939281|FG005|Phase 2|Other|0|||
161152420|NCT02795988|581939282|FG006|Phase 2|Other|0|||
161152421|NCT02795988|581939276|FG000|Phase 2 Extension|Death|0|||
161152422|NCT02795988|581939277|FG001|Phase 2 Extension|Death|0|||
161152423|NCT02795988|581939278|FG002|Phase 2 Extension|Death|0|||
161152424|NCT02795988|581939279|FG003|Phase 2 Extension|Death|0|||
161152425|NCT02795988|581939280|FG004|Phase 2 Extension|Death|0|||
161152426|NCT02795988|581939281|FG005|Phase 2 Extension|Death|5|||
161152427|NCT02795988|581939282|FG006|Phase 2 Extension|Death|6|||
161152428|NCT02795988|581939276|FG000|Phase 2 Extension|Other reasons|0|||
161152429|NCT02795988|581939277|FG001|Phase 2 Extension|Other reasons|0|||
161152430|NCT02795988|581939278|FG002|Phase 2 Extension|Other reasons|0|||
161152431|NCT02795988|581939279|FG003|Phase 2 Extension|Other reasons|0|||
161152432|NCT02795988|581939280|FG004|Phase 2 Extension|Other reasons|0|||
161152433|NCT02795988|581939281|FG005|Phase 2 Extension|Other reasons|2|||
161152434|NCT02795988|581939282|FG006|Phase 2 Extension|Other reasons|1|||
161152435|NCT00726323|581939283|FG000|Overall Study|Withdrawal by Subject|3|||
161152436|NCT00726323|581939284|FG001|Overall Study|Withdrawal by Subject|1|||
161152437|NCT00726323|581939283|FG000|Overall Study|Physician Decision|1|||
161152438|NCT00726323|581939284|FG001|Overall Study|Physician Decision|0|||
161152439|NCT00726323|581939283|FG000|Overall Study|Progressive disease|23|||
161152440|NCT00726323|581939284|FG001|Overall Study|Progressive disease|16|||
161152441|NCT00726323|581939283|FG000|Overall Study|Clinical progression|0|||
161152442|NCT00726323|581939284|FG001|Overall Study|Clinical progression|3|||
161152443|NCT00726323|581939283|FG000|Overall Study|Adverse Event|9|||
161152444|NCT00726323|581939284|FG001|Overall Study|Adverse Event|9|||
161152445|NCT00726323|581939283|FG000|Overall Study|Death|1|||
161152446|NCT00726323|581939284|FG001|Overall Study|Death|0|||
161152447|NCT00726323|581939283|FG000|Overall Study|Participant wished to discontinue|0|||
161152448|NCT00726323|581939284|FG001|Overall Study|Participant wished to discontinue|1|||
161152449|NCT00726323|581939283|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
161152450|NCT00726323|581939284|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
161152451|NCT02341014|581939285|FG000|Overall Study|Adverse Event|0|||
161152452|NCT02341014|581939286|FG001|Overall Study|Adverse Event|1|||
161152453|NCT02341014|581939287|FG002|Overall Study|Adverse Event|0|||
161152454|NCT02341014|581939288|FG003|Overall Study|Adverse Event|0|||
161152455|NCT02341014|581939289|FG004|Overall Study|Adverse Event|2|||
161152456|NCT01234402|581939295|FG000|Overall Study|Lost to Follow-up|0|||
161152457|NCT01234402|581939296|FG001|Overall Study|Lost to Follow-up|1|||
161152458|NCT01234402|581939297|FG002|Overall Study|Lost to Follow-up|3|||
161152459|NCT01234402|581939295|FG000|Overall Study|Withdrawal by Subject|1|||
161152460|NCT01234402|581939296|FG001|Overall Study|Withdrawal by Subject|3|||
161152461|NCT01234402|581939297|FG002|Overall Study|Withdrawal by Subject|4|||
161152462|NCT01234402|581939295|FG000|Overall Study|Never treated: Death|0|||
161152463|NCT01234402|581939296|FG001|Overall Study|Never treated: Death|0|||
161152464|NCT01234402|581939297|FG002|Overall Study|Never treated: Death|1|||
161152465|NCT01234402|581939295|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
161152466|NCT01234402|581939296|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
161152467|NCT01234402|581939297|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
161152468|NCT01234402|581939295|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
161152469|NCT01234402|581939296|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
161152470|NCT01234402|581939297|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
161152471|NCT00316303|581939299|FG000|Overall Study|Lost to Follow-up|11|||
161152472|NCT00316303|581939300|FG001|Overall Study|Lost to Follow-up|16|||
161152473|NCT01106534|581939301|FG000|Overall Study|Withdrawal by Subject|18|||
161152474|NCT01106534|581939301|FG000|Overall Study|Lost to Follow-up|2|||
161152475|NCT01106534|581939301|FG000|Overall Study|Death|16|||
161152476|NCT01106534|581939301|FG000|Overall Study|Physician Decision|1|||
161152477|NCT00570739|581939302|FG000|Overall Study|Adverse Event|8|||
161152478|NCT00570739|581939303|FG001|Overall Study|Adverse Event|6|||
161152479|NCT00570739|581939304|FG002|Overall Study|Adverse Event|2|||
161152480|NCT00570739|581939305|FG003|Overall Study|Adverse Event|2|||
161152481|NCT00570739|581939302|FG000|Overall Study|Lost to Follow-up|4|||
161152482|NCT00570739|581939303|FG001|Overall Study|Lost to Follow-up|5|||
161152483|NCT00570739|581939304|FG002|Overall Study|Lost to Follow-up|4|||
161152484|NCT00570739|581939305|FG003|Overall Study|Lost to Follow-up|1|||
161152485|NCT00570739|581939302|FG000|Overall Study|Physician Decision|1|||
161152486|NCT00570739|581939303|FG001|Overall Study|Physician Decision|1|||
161345137|NCT00976027|582648871|FG000|Overall Study|Adverse Event|0|||
161152487|NCT00570739|581939304|FG002|Overall Study|Physician Decision|0|||
161152488|NCT00570739|581939305|FG003|Overall Study|Physician Decision|0|||
161152489|NCT00570739|581939302|FG000|Overall Study|Withdrawal by Subject|7|||
161152490|NCT00570739|581939303|FG001|Overall Study|Withdrawal by Subject|7|||
161152491|NCT00570739|581939304|FG002|Overall Study|Withdrawal by Subject|3|||
161345138|NCT00976027|582648872|FG001|Overall Study|Adverse Event|2|||
161152492|NCT00570739|581939305|FG003|Overall Study|Withdrawal by Subject|5|||
161152493|NCT00570739|581939302|FG000|Overall Study|Required restricted medication|0|||
161152494|NCT00570739|581939303|FG001|Overall Study|Required restricted medication|0|||
161152495|NCT00570739|581939304|FG002|Overall Study|Required restricted medication|1|||
161152496|NCT00570739|581939305|FG003|Overall Study|Required restricted medication|0|||
161152497|NCT00570739|581939302|FG000|Overall Study|Met discontinuation criteria|1|||
161057117|NCT00899379|581598091|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161057118|NCT00899379|581598092|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161057119|NCT00899379|581598093|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161057120|NCT00899379|581598094|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161057121|NCT00899379|581598095|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161057122|NCT00899379|581598091|FG000|Overall Study|Not Completed/Entered Extn|5|||
161057123|NCT00899379|581598092|FG001|Overall Study|Not Completed/Entered Extn|1|||
161057124|NCT00899379|581598093|FG002|Overall Study|Not Completed/Entered Extn|6|||
161057125|NCT00899379|581598094|FG003|Overall Study|Not Completed/Entered Extn|4|||
161057126|NCT00899379|581598095|FG004|Overall Study|Not Completed/Entered Extn|3|||
161057127|NCT00899379|581598091|FG000|Overall Study|Study Terminated|3|||
161057128|NCT00899379|581598092|FG001|Overall Study|Study Terminated|0|||
161057129|NCT00899379|581598093|FG002|Overall Study|Study Terminated|3|||
161057130|NCT00899379|581598094|FG003|Overall Study|Study Terminated|3|||
161057131|NCT00899379|581598095|FG004|Overall Study|Study Terminated|1|||
161057132|NCT00899379|581598091|FG000|Overall Study|Lost to Follow-up|3|||
161057133|NCT00899379|581598092|FG001|Overall Study|Lost to Follow-up|1|||
161057134|NCT00899379|581598093|FG002|Overall Study|Lost to Follow-up|0|||
161057135|NCT00899379|581598094|FG003|Overall Study|Lost to Follow-up|2|||
161057136|NCT00899379|581598095|FG004|Overall Study|Lost to Follow-up|5|||
161057137|NCT00899379|581598091|FG000|Overall Study|Withdrawal by Subject|4|||
161057138|NCT00899379|581598092|FG001|Overall Study|Withdrawal by Subject|7|||
161057139|NCT00899379|581598093|FG002|Overall Study|Withdrawal by Subject|4|||
161057140|NCT00899379|581598094|FG003|Overall Study|Withdrawal by Subject|7|||
161057141|NCT00899379|581598095|FG004|Overall Study|Withdrawal by Subject|2|||
161057142|NCT00899379|581598091|FG000|Overall Study|Pregnancy|1|||
161057143|NCT00899379|581598092|FG001|Overall Study|Pregnancy|0|||
161057144|NCT00899379|581598093|FG002|Overall Study|Pregnancy|0|||
161057145|NCT00899379|581598094|FG003|Overall Study|Pregnancy|0|||
161057146|NCT00899379|581598095|FG004|Overall Study|Pregnancy|0|||
161057147|NCT00899379|581598091|FG000|Overall Study|Patient Uncooperative|0|||
161057148|NCT00899379|581598092|FG001|Overall Study|Patient Uncooperative|0|||
161057149|NCT00899379|581598093|FG002|Overall Study|Patient Uncooperative|0|||
161057150|NCT00899379|581598094|FG003|Overall Study|Patient Uncooperative|1|||
161057151|NCT00899379|581598095|FG004|Overall Study|Patient Uncooperative|0|||
161057152|NCT00899379|581598091|FG000|Overall Study|Abnormal Prestudy Labs|0|||
161057153|NCT00899379|581598092|FG001|Overall Study|Abnormal Prestudy Labs|0|||
161057154|NCT00899379|581598093|FG002|Overall Study|Abnormal Prestudy Labs|0|||
161057155|NCT00899379|581598094|FG003|Overall Study|Abnormal Prestudy Labs|0|||
161057156|NCT00899379|581598095|FG004|Overall Study|Abnormal Prestudy Labs|2|||
161057157|NCT00899379|581598091|FG000|Overall Study|Abnormal Baseline ECG|0|||
161057158|NCT00899379|581598092|FG001|Overall Study|Abnormal Baseline ECG|0|||
161057159|NCT00899379|581598093|FG002|Overall Study|Abnormal Baseline ECG|1|||
161057160|NCT00899379|581598094|FG003|Overall Study|Abnormal Baseline ECG|1|||
161057161|NCT00899379|581598095|FG004|Overall Study|Abnormal Baseline ECG|0|||
161057162|NCT00899379|581598091|FG000|Overall Study|No Attack Pretreatment|3|||
161057163|NCT00899379|581598092|FG001|Overall Study|No Attack Pretreatment|5|||
161057164|NCT00899379|581598093|FG002|Overall Study|No Attack Pretreatment|5|||
161057165|NCT00899379|581598094|FG003|Overall Study|No Attack Pretreatment|6|||
161057166|NCT00899379|581598095|FG004|Overall Study|No Attack Pretreatment|4|||
161057167|NCT00899379|581598091|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
161057168|NCT00899379|581598092|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161057169|NCT00899379|581598093|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161057170|NCT00899379|581598094|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161057171|NCT00899379|581598095|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
161057172|NCT00899379|581598091|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
161057173|NCT00899379|581598092|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
161057174|NCT00899379|581598093|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
161281292|NCT00911300|582408679|FG000|Overall Study|Consent Withdrawn|4|||
161281293|NCT00911300|582408680|FG001|Overall Study|Consent Withdrawn|12|||
161281294|NCT00911300|582408679|FG000|Overall Study|Coronary Angiography Performed|1|||
161057175|NCT00899379|581598094|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
161057176|NCT00899379|581598095|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
161057177|NCT00809783|581598098|FG000|Overall Study|Death|1|||
161057178|NCT00809783|581598099|FG001|Overall Study|Death|0|||
161057179|NCT00809783|581598100|FG002|Overall Study|Death|0|||
161057180|NCT00809783|581598098|FG000|Overall Study|Adverse Event|34|||
161057181|NCT00809783|581598099|FG001|Overall Study|Adverse Event|52|||
161057182|NCT00809783|581598100|FG002|Overall Study|Adverse Event|71|||
161057183|NCT00809783|581598098|FG000|Overall Study|Lack of Efficacy|39|||
161057184|NCT00809783|581598099|FG001|Overall Study|Lack of Efficacy|52|||
161281295|NCT00911300|582408680|FG001|Overall Study|Coronary Angiography Performed|0|||
161281296|NCT00911300|582408679|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
161057185|NCT00809783|581598100|FG002|Overall Study|Lack of Efficacy|63|||
161057186|NCT00809783|581598098|FG000|Overall Study|Lost to Follow-up|0|||
161057187|NCT00809783|581598099|FG001|Overall Study|Lost to Follow-up|3|||
161281297|NCT00911300|582408680|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
161152498|NCT00570739|581939303|FG001|Overall Study|Met discontinuation criteria|0|||
161152499|NCT00570739|581939304|FG002|Overall Study|Met discontinuation criteria|1|||
161057188|NCT00809783|581598100|FG002|Overall Study|Lost to Follow-up|4|||
161057189|NCT00809783|581598098|FG000|Overall Study|Withdrawal by Subject|47|||
161057190|NCT00809783|581598099|FG001|Overall Study|Withdrawal by Subject|72|||
161057191|NCT00809783|581598100|FG002|Overall Study|Withdrawal by Subject|64|||
161057192|NCT00809783|581598098|FG000|Overall Study|Protocol Violation|2|||
161057193|NCT00809783|581598099|FG001|Overall Study|Protocol Violation|6|||
161057194|NCT00809783|581598100|FG002|Overall Study|Protocol Violation|5|||
161057195|NCT00809783|581598098|FG000|Overall Study|Randomized, but not treated|3|||
161057196|NCT00809783|581598099|FG001|Overall Study|Randomized, but not treated|0|||
161057197|NCT00809783|581598100|FG002|Overall Study|Randomized, but not treated|2|||
161057198|NCT00809783|581598098|FG000|Overall Study|Study Terminated by Sponsor|378|||
161057199|NCT00809783|581598099|FG001|Overall Study|Study Terminated by Sponsor|626|||
161057200|NCT00809783|581598100|FG002|Overall Study|Study Terminated by Sponsor|565|||
161057201|NCT00809783|581598098|FG000|Overall Study|Other|21|||
161057202|NCT00809783|581598099|FG001|Overall Study|Other|21|||
161057203|NCT00809783|581598100|FG002|Overall Study|Other|16|||
161057204|NCT00126555|581598101|FG000|Overall Study|Withdrawal by Subject|1|||
161057205|NCT00126555|581598101|FG000|Overall Study|Adverse Event|2|||
161057206|NCT00126555|581598101|FG000|Overall Study|Progressive Disease|3|||
161057207|NCT01780545|581598108|FG000|Overall Study|Withdrawal by Subject|3|||
161057208|NCT01780545|581598109|FG001|Overall Study|Withdrawal by Subject|1|||
161057209|NCT01780545|581598108|FG000|Overall Study|Lost to Follow-up|1|||
161057210|NCT01780545|581598109|FG001|Overall Study|Lost to Follow-up|1|||
161057211|NCT03441789|581598110|FG000|Overall Study|Withdrawal by Subject|1|||
161057212|NCT03441789|581598111|FG001|Overall Study|Withdrawal by Subject|1|||
161057213|NCT03441789|581598110|FG000|Overall Study|Adverse Event|0|||
161057214|NCT03441789|581598111|FG001|Overall Study|Adverse Event|1|||
161057215|NCT03441789|581598110|FG000|Overall Study|Protocol Violation|0|||
161057216|NCT03441789|581598111|FG001|Overall Study|Protocol Violation|1|||
161057217|NCT03441789|581598110|FG000|Overall Study|Lost to Follow-up|0|||
161057218|NCT03441789|581598111|FG001|Overall Study|Lost to Follow-up|1|||
161057219|NCT02581189|581598116|FG000|Overall Study|Failure to return|36|||
161057220|NCT02581189|581598116|FG000|Overall Study|Withdrew consent|5|||
161057221|NCT02581189|581598116|FG000|Overall Study|Death|3|||
161057222|NCT02581189|581598116|FG000|Overall Study|Insufficient virological response|2|||
161057223|NCT02581189|581598116|FG000|Overall Study|Other, not specified|7|||
161057224|NCT01514864|581598121|FG000|Overall Study|Disease progression|7|||
161057225|NCT01514864|581598122|FG001|Overall Study|Disease progression|5|||
161057226|NCT01514864|581598121|FG000|Overall Study|Study drug toxicity|2|||
161057227|NCT01514864|581598122|FG001|Overall Study|Study drug toxicity|0|||
161057228|NCT02254681|581598130|FG000|Overall Study|Lack of Efficacy|6|||
161057229|NCT00396097|581598131|FG000|Overall Study|Withdrawal by Subject|17|||
161057230|NCT00396097|581598132|FG001|Overall Study|Withdrawal by Subject|17|||
161057231|NCT00396097|581598131|FG000|Overall Study|Lost to Follow-up|4|||
161057232|NCT00396097|581598132|FG001|Overall Study|Lost to Follow-up|9|||
161057233|NCT00396097|581598131|FG000|Overall Study|Other|3|||
161057234|NCT00396097|581598132|FG001|Overall Study|Other|5|||
161057235|NCT00396097|581598131|FG000|Overall Study|Protocol Violation|0|||
161057236|NCT00396097|581598132|FG001|Overall Study|Protocol Violation|6|||
161057237|NCT00396097|581598131|FG000|Overall Study|Adverse Event|1|||
161057238|NCT00396097|581598132|FG001|Overall Study|Adverse Event|5|||
161057239|NCT00396097|581598131|FG000|Overall Study|Insufficient Clinical Response|1|||
161057240|NCT00396097|581598132|FG001|Overall Study|Insufficient Clinical Response|4|||
161057241|NCT03461211|581598133|FG000|Overall Study|Adverse Event|1|||
161057242|NCT03461211|581598134|FG001|Overall Study|Adverse Event|1|||
161057243|NCT03461211|581598133|FG000|Overall Study|Lack of Efficacy|0|||
161057244|NCT03461211|581598134|FG001|Overall Study|Lack of Efficacy|1|||
161057245|NCT02316847|581598136|FG000|Overall Study|Adverse Event|0|||
161057246|NCT02316847|581598137|FG001|Overall Study|Adverse Event|3|||
161057247|NCT02316847|581598136|FG000|Overall Study|Lost to Follow-up|0|||
161057248|NCT02316847|581598137|FG001|Overall Study|Lost to Follow-up|2|||
161057249|NCT02316847|581598136|FG000|Overall Study|Physician Decision|0|||
161057250|NCT02316847|581598137|FG001|Overall Study|Physician Decision|1|||
161057251|NCT02316847|581598136|FG000|Overall Study|Pregnancy|0|||
161152500|NCT00570739|581939305|FG003|Overall Study|Met discontinuation criteria|1|||
161152501|NCT00570739|581939302|FG000|Overall Study|Other|0|||
161152502|NCT00570739|581939303|FG001|Overall Study|Other|2|||
161152503|NCT00570739|581939304|FG002|Overall Study|Other|5|||
161152504|NCT00570739|581939305|FG003|Overall Study|Other|3|||
161152505|NCT02086565|581939307|FG000|Overall Study|Lost to Follow-up|9|||
161057252|NCT02316847|581598137|FG001|Overall Study|Pregnancy|1|||
161152506|NCT02086565|581939308|FG001|Overall Study|Lost to Follow-up|7|||
161057253|NCT02316847|581598136|FG000|Overall Study|Withdrawal by Subject|2|||
161057254|NCT02316847|581598137|FG001|Overall Study|Withdrawal by Subject|9|||
161057255|NCT02316847|581598136|FG000|Overall Study|Noncompliance with study drug|0|||
161057256|NCT02316847|581598137|FG001|Overall Study|Noncompliance with study drug|3|||
161057257|NCT02316847|581598136|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
161152507|NCT02086565|581939307|FG000|Overall Study|Withdrawal by Subject|2|||
161152508|NCT02086565|581939308|FG001|Overall Study|Withdrawal by Subject|1|||
161281298|NCT00911300|582408679|FG000|Overall Study|Received Commercial Treatment|1|||
161281299|NCT00911300|582408680|FG001|Overall Study|Received Commercial Treatment|0|||
161281300|NCT00911300|582408679|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
161281301|NCT00911300|582408680|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
161057258|NCT02316847|581598137|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
161057259|NCT01370018|581598138|FG000|Overall Study|Did not meet criteria for analysis|1|||
161057260|NCT02204319|581598139|FG000|Overall Study|Pregnancy|1|||
161057261|NCT02204319|581598139|FG000|Overall Study|Withdrawal by Subject|2|||
161057262|NCT03746483|581598140|FG000|Overall Study|Adverse Event|0|||
161057263|NCT03746483|581598141|FG001|Overall Study|Adverse Event|1|||
161057264|NCT03746483|581598140|FG000|Overall Study|Lack of Efficacy|3|||
161057265|NCT03746483|581598141|FG001|Overall Study|Lack of Efficacy|2|||
161057266|NCT03746483|581598140|FG000|Overall Study|Lost to Follow-up|1|||
161057267|NCT03746483|581598141|FG001|Overall Study|Lost to Follow-up|0|||
161057268|NCT03746483|581598140|FG000|Overall Study|Protocol Violation|2|||
161057269|NCT03746483|581598141|FG001|Overall Study|Protocol Violation|0|||
161057270|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
161057271|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161057272|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161057273|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161057274|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
161057275|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
161057276|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161057277|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161057278|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161057279|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
161057280|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
161057281|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161057282|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161057283|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161057284|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
161057285|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
161057286|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161057287|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161057288|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161057289|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
161057290|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
161057291|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161057292|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161057293|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161057294|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
161057295|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
161057296|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161057297|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161057298|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161057299|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
161057300|NCT01187407|581598142|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
161057301|NCT01187407|581598143|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161057302|NCT01187407|581598144|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161057303|NCT01187407|581598145|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161057304|NCT01187407|581598146|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
161057305|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
161057306|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
161057307|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
161057308|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
161057309|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
161281302|NCT00911300|582408679|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
161281303|NCT00911300|582408680|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
161281304|NCT00911300|582408679|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
161057310|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
161057311|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
161057312|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
161057313|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
161057314|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
161057315|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
161057316|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
161057317|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
161281305|NCT00911300|582408680|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
161281306|NCT00911300|582408679|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
161281307|NCT00911300|582408680|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
161281308|NCT00911300|582408679|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
161281309|NCT00911300|582408680|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
161281310|NCT00911300|582408679|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
161281311|NCT00911300|582408680|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
161281312|NCT00911300|582408679|FG000|Overall Study|International Normalized Ratio Too High|0|||
161281313|NCT00911300|582408680|FG001|Overall Study|International Normalized Ratio Too High|1|||
161281314|NCT00911300|582408679|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
161281315|NCT00911300|582408680|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
161281316|NCT00911300|582408679|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
161057318|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
161057319|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
161057320|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161057321|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161057322|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
161057323|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
161057324|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
161057325|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
161057326|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
161057327|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
161057328|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
161057329|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
161057330|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
161057331|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
161057332|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
161057333|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
161057334|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
161057335|NCT01187407|581598142|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
161057336|NCT01187407|581598143|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161057337|NCT01187407|581598144|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161057338|NCT01187407|581598145|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
161057339|NCT01187407|581598146|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
161057340|NCT02382406|581598149|FG000|Study Treatment|Disease Progression|8|||
161057341|NCT02382406|581598150|FG001|Study Treatment|Disease Progression|0|||
161057342|NCT02382406|581598151|FG002|Study Treatment|Disease Progression|20|||
161057343|NCT02382406|581598149|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
161057344|NCT02382406|581598150|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
161057345|NCT02382406|581598151|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
161057346|NCT02382406|581598149|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
161057347|NCT02382406|581598150|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
161057348|NCT02382406|581598151|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
161057349|NCT02382406|581598149|FG000|Study Treatment|symptomatic deterioration|1|||
161057350|NCT02382406|581598150|FG001|Study Treatment|symptomatic deterioration|0|||
161057351|NCT02382406|581598151|FG002|Study Treatment|symptomatic deterioration|1|||
161057352|NCT02382406|581598149|FG000|Study Treatment|Death|0|||
161057353|NCT02382406|581598150|FG001|Study Treatment|Death|0|||
161057354|NCT02382406|581598151|FG002|Study Treatment|Death|2|||
161057355|NCT02382406|581598149|FG000|Follow up|Death|11|||
161057356|NCT02382406|581598150|FG001|Follow up|Death|0|||
161057357|NCT02382406|581598151|FG002|Follow up|Death|19|||
161057358|NCT02382406|581598149|FG000|Follow up|Symptomatic deterioration|1|||
161057359|NCT02382406|581598150|FG001|Follow up|Symptomatic deterioration|0|||
161057360|NCT02382406|581598151|FG002|Follow up|Symptomatic deterioration|1|||
161057361|NCT02382406|581598149|FG000|Follow up|Patient Refused Follow-up|1|||
161152509|NCT02086565|581939307|FG000|Overall Study|Death|3|||
161281317|NCT00911300|582408680|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
161281318|NCT00911300|582408679|FG000|Overall Study|Physician Decision|0|||
161281319|NCT00911300|582408680|FG001|Overall Study|Physician Decision|1|||
161281320|NCT00911300|582408679|FG000|Overall Study|Treatment Stopped by Mistake|0|||
161281321|NCT00911300|582408680|FG001|Overall Study|Treatment Stopped by Mistake|1|||
161281322|NCT00911300|582408679|FG000|Overall Study|Randomized; No Study Medication Received|0|||
161281323|NCT00911300|582408680|FG001|Overall Study|Randomized; No Study Medication Received|2|||
161057362|NCT02382406|581598150|FG001|Follow up|Patient Refused Follow-up|0|||
161057363|NCT02382406|581598151|FG002|Follow up|Patient Refused Follow-up|0|||
161057364|NCT02382406|581598149|FG000|Follow up|Study Terminated|1|||
161057365|NCT02382406|581598150|FG001|Follow up|Study Terminated|0|||
161281324|NCT00666328|582408684|FG000|Overall Study|Death|2|||
161281325|NCT00666328|582408684|FG000|Overall Study|Lost to Follow-up|2|||
161152510|NCT02086565|581939308|FG001|Overall Study|Death|2|||
161152511|NCT02086565|581939307|FG000|Overall Study|withdrawn by research team|2|||
161152512|NCT02086565|581939308|FG001|Overall Study|withdrawn by research team|2|||
161152513|NCT00739297|581939309|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
161152514|NCT00739297|581939310|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
161152515|NCT00739297|581939311|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
161152516|NCT00739297|581939312|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
161152517|NCT00739297|581939313|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
161152518|NCT00739297|581939314|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
161152519|NCT00739297|581939315|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
161152520|NCT00739297|581939309|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161152521|NCT00739297|581939310|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161152522|NCT00739297|581939311|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161152523|NCT00739297|581939312|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161152524|NCT00739297|581939313|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
161152525|NCT00739297|581939314|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
161152526|NCT00739297|581939315|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
161152527|NCT01400971|581939316|FG000|Overall Study|Death|82|||
161152528|NCT01400971|581939316|FG000|Overall Study|Lost to Follow-up|196|||
161152529|NCT01400971|581939316|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
161152530|NCT01400971|581939316|FG000|Overall Study|Physician Decision|57|||
161152531|NCT01400971|581939316|FG000|Overall Study|Withdrawal by Subject|158|||
161152532|NCT01400971|581939316|FG000|Overall Study|Other|422|||
161152533|NCT01041573|581939326|FG000|Overall Study|Withdrawal by Subject|2|||
161152534|NCT01041573|581939327|FG001|Overall Study|Withdrawal by Subject|5|||
161152535|NCT01041573|581939328|FG002|Overall Study|Withdrawal by Subject|2|||
161152536|NCT01041573|581939329|FG003|Overall Study|Withdrawal by Subject|0|||
161152537|NCT01041573|581939326|FG000|Overall Study|Death|1|||
161152538|NCT01041573|581939327|FG001|Overall Study|Death|0|||
161152539|NCT01041573|581939328|FG002|Overall Study|Death|0|||
161152540|NCT01041573|581939329|FG003|Overall Study|Death|0|||
161281326|NCT00666328|582408684|FG000|Overall Study|No longer met eligibility criteria|1|||
161281327|NCT02288325|582408685|FG000|Run-in Period|Adverse Event|48|||
161152541|NCT01041573|581939326|FG000|Overall Study|Lost to Follow-up|0|||
161152542|NCT01041573|581939327|FG001|Overall Study|Lost to Follow-up|1|||
161152543|NCT01041573|581939328|FG002|Overall Study|Lost to Follow-up|2|||
161152544|NCT01041573|581939329|FG003|Overall Study|Lost to Follow-up|1|||
161152545|NCT01041573|581939326|FG000|Overall Study|Adverse Event|0|||
161152546|NCT01041573|581939327|FG001|Overall Study|Adverse Event|2|||
161152547|NCT01041573|581939328|FG002|Overall Study|Adverse Event|0|||
161152548|NCT01041573|581939329|FG003|Overall Study|Adverse Event|0|||
161152549|NCT01041573|581939326|FG000|Overall Study|relocation|1|||
161152550|NCT01041573|581939327|FG001|Overall Study|relocation|4|||
161152551|NCT01041573|581939328|FG002|Overall Study|relocation|3|||
161152552|NCT01041573|581939329|FG003|Overall Study|relocation|1|||
161152553|NCT01041573|581939326|FG000|Overall Study|further blood extraction|0|||
161152554|NCT01041573|581939327|FG001|Overall Study|further blood extraction|1|||
161152555|NCT01041573|581939328|FG002|Overall Study|further blood extraction|0|||
161152556|NCT01041573|581939329|FG003|Overall Study|further blood extraction|0|||
161152557|NCT01041573|581939326|FG000|Overall Study|positive to anti-HCV|1|||
161152558|NCT01041573|581939327|FG001|Overall Study|positive to anti-HCV|0|||
161281328|NCT02288325|582408686|FG001|Run-in Period|Adverse Event|0|||
161281329|NCT02288325|582408687|FG002|Run-in Period|Adverse Event|0|||
161281330|NCT02288325|582408685|FG000|Run-in Period|Lack of Efficacy|16|||
161281331|NCT02288325|582408686|FG001|Run-in Period|Lack of Efficacy|0|||
161281332|NCT02288325|582408687|FG002|Run-in Period|Lack of Efficacy|0|||
161281333|NCT02288325|582408685|FG000|Run-in Period|Withdrawal of Consent|28|||
161152559|NCT01041573|581939328|FG002|Overall Study|positive to anti-HCV|0|||
161152560|NCT01041573|581939329|FG003|Overall Study|positive to anti-HCV|0|||
161152561|NCT03634072|581939330|FG000|Overall Study|Early termination of overall study|1|||
161152562|NCT03634072|581939331|FG001|Overall Study|Early termination of overall study|0|||
161152563|NCT01765764|581939332|FG000|Treatment Period|Adverse Event|1|||
161152564|NCT01765764|581939333|FG001|Treatment Period|Adverse Event|2|||
161152565|NCT01765764|581939334|FG002|Treatment Period|Adverse Event|1|||
161152566|NCT01765764|581939332|FG000|Treatment Period|Lost to Follow-up|0|||
161152567|NCT01765764|581939333|FG001|Treatment Period|Lost to Follow-up|3|||
161152568|NCT01765764|581939334|FG002|Treatment Period|Lost to Follow-up|2|||
161152569|NCT01765764|581939332|FG000|Treatment Period|Personal Reasons|1|||
161152570|NCT01765764|581939333|FG001|Treatment Period|Personal Reasons|2|||
161152571|NCT01765764|581939334|FG002|Treatment Period|Personal Reasons|1|||
161152572|NCT01765764|581939332|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
161152573|NCT01765764|581939333|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
161152574|NCT01765764|581939334|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
161281334|NCT02288325|582408686|FG001|Run-in Period|Withdrawal of Consent|0|||
161281335|NCT02288325|582408687|FG002|Run-in Period|Withdrawal of Consent|0|||
161345139|NCT00976027|582648871|FG000|Overall Study|Protocol Violation|60|||
161345140|NCT00976027|582648872|FG001|Overall Study|Protocol Violation|27|||
161345141|NCT00976027|582648871|FG000|Overall Study|Lost to Follow-up|208|||
161345142|NCT00976027|582648872|FG001|Overall Study|Lost to Follow-up|103|||
161057366|NCT02382406|581598151|FG002|Follow up|Study Terminated|8|||
161057367|NCT02382406|581598149|FG000|Follow up|Withdrawal by Subject|0|||
161057368|NCT02382406|581598150|FG001|Follow up|Withdrawal by Subject|0|||
161057369|NCT02382406|581598151|FG002|Follow up|Withdrawal by Subject|2|||
161057370|NCT01713998|581598152|FG000|Overall Study|Lost to Follow-up|2|||
161057371|NCT01713998|581598153|FG001|Overall Study|Lost to Follow-up|0|||
161057372|NCT01713998|581598154|FG002|Overall Study|Lost to Follow-up|2|||
161057373|NCT01713998|581598152|FG000|Overall Study|Withdrawal by Subject|1|||
161057374|NCT01713998|581598153|FG001|Overall Study|Withdrawal by Subject|0|||
161057375|NCT01713998|581598154|FG002|Overall Study|Withdrawal by Subject|0|||
161057376|NCT02116582|581598165|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
161057377|NCT02116582|581598165|FG000|Overall Study|Adverse Event|22|||
161057378|NCT02116582|581598165|FG000|Overall Study|Death|9|||
161057379|NCT02116582|581598165|FG000|Overall Study|Progressive Disease|148|||
161057380|NCT02116582|581598165|FG000|Overall Study|Protocol Violation|3|||
161057381|NCT02116582|581598165|FG000|Overall Study|Withdrawal by Subject|8|||
161057382|NCT02116582|581598165|FG000|Overall Study|Other: Miscellaneous|11|||
161057383|NCT02116582|581598165|FG000|Overall Study|Lost to Follow-up|1|||
161057384|NCT02116582|581598165|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
161057385|NCT03356145|581598166|FG000|Overall Study|Withdrawal by Subject|2|||
161057386|NCT03356145|581598167|FG001|Overall Study|Withdrawal by Subject|1|||
161057387|NCT03356145|581598166|FG000|Overall Study|Did not meet inclusion criteria|1|||
161057388|NCT03356145|581598167|FG001|Overall Study|Did not meet inclusion criteria|0|||
161057389|NCT00985621|581598170|FG000|Overall Study|Adverse Event|2|||
161057390|NCT00985621|581598171|FG001|Overall Study|Adverse Event|3|||
161057391|NCT00985621|581598172|FG002|Overall Study|Adverse Event|4|||
161057392|NCT00985621|581598173|FG003|Overall Study|Adverse Event|16|||
161057393|NCT00985621|581598170|FG000|Overall Study|Lack of Efficacy|10|||
161057394|NCT00985621|581598171|FG001|Overall Study|Lack of Efficacy|6|||
161057395|NCT00985621|581598172|FG002|Overall Study|Lack of Efficacy|5|||
161057396|NCT00985621|581598173|FG003|Overall Study|Lack of Efficacy|12|||
161057397|NCT00985621|581598170|FG000|Overall Study|Lost to Follow-up|2|||
161057398|NCT00985621|581598171|FG001|Overall Study|Lost to Follow-up|3|||
161057399|NCT00985621|581598172|FG002|Overall Study|Lost to Follow-up|4|||
161057400|NCT00985621|581598173|FG003|Overall Study|Lost to Follow-up|4|||
161057401|NCT00985621|581598170|FG000|Overall Study|Study Terminated by Sponsor|89|||
161057402|NCT00985621|581598171|FG001|Overall Study|Study Terminated by Sponsor|108|||
161057403|NCT00985621|581598172|FG002|Overall Study|Study Terminated by Sponsor|99|||
161057404|NCT00985621|581598173|FG003|Overall Study|Study Terminated by Sponsor|92|||
161057405|NCT00985621|581598170|FG000|Overall Study|Protocol Violation|1|||
161057406|NCT00985621|581598171|FG001|Overall Study|Protocol Violation|1|||
161057407|NCT00985621|581598172|FG002|Overall Study|Protocol Violation|1|||
161057408|NCT00985621|581598173|FG003|Overall Study|Protocol Violation|0|||
161057409|NCT00985621|581598170|FG000|Overall Study|Withdrawal by Subject|8|||
161057410|NCT00985621|581598171|FG001|Overall Study|Withdrawal by Subject|10|||
161057411|NCT00985621|581598172|FG002|Overall Study|Withdrawal by Subject|8|||
161057412|NCT00985621|581598173|FG003|Overall Study|Withdrawal by Subject|12|||
161057413|NCT00985621|581598170|FG000|Overall Study|Other|1|||
161057414|NCT00985621|581598171|FG001|Overall Study|Other|0|||
161057415|NCT00985621|581598172|FG002|Overall Study|Other|0|||
161057416|NCT00985621|581598173|FG003|Overall Study|Other|0|||
161057417|NCT00985621|581598170|FG000|Overall Study|Randomized but not Treated|1|||
161057418|NCT00985621|581598171|FG001|Overall Study|Randomized but not Treated|0|||
161057419|NCT00985621|581598172|FG002|Overall Study|Randomized but not Treated|2|||
161057420|NCT00985621|581598173|FG003|Overall Study|Randomized but not Treated|1|||
161057421|NCT01774929|581598177|FG000|Overall Study|Adverse Event|3|||
161057422|NCT00714688|581598180|FG000|Overall Study|Lack of Efficacy|14|||
161057423|NCT00714688|581598181|FG001|Overall Study|Lack of Efficacy|1|||
161057424|NCT00714688|581598182|FG002|Overall Study|Lack of Efficacy|4|||
161057425|NCT00714688|581598180|FG000|Overall Study|Withdrawal by Subject|4|||
161057426|NCT00714688|581598181|FG001|Overall Study|Withdrawal by Subject|3|||
161057427|NCT00714688|581598182|FG002|Overall Study|Withdrawal by Subject|3|||
161057428|NCT00714688|581598180|FG000|Overall Study|Lost to Follow-up|5|||
161057429|NCT00714688|581598181|FG001|Overall Study|Lost to Follow-up|2|||
161057430|NCT00714688|581598182|FG002|Overall Study|Lost to Follow-up|0|||
161057431|NCT00714688|581598180|FG000|Overall Study|Adverse Event|2|||
161057432|NCT00714688|581598181|FG001|Overall Study|Adverse Event|15|||
161057433|NCT00714688|581598182|FG002|Overall Study|Adverse Event|19|||
161057434|NCT00714688|581598180|FG000|Overall Study|Subject Non-compliant|3|||
161345143|NCT00976027|582648871|FG000|Overall Study|Withdrawal by Subject|107|||
161057435|NCT00714688|581598181|FG001|Overall Study|Subject Non-compliant|5|||
161057436|NCT00714688|581598182|FG002|Overall Study|Subject Non-compliant|5|||
161057437|NCT00714688|581598180|FG000|Overall Study|Ineligible to Continue the Study|0|||
161057438|NCT00714688|581598181|FG001|Overall Study|Ineligible to Continue the Study|1|||
161152575|NCT00064662|581939337|FG000|Overall Study|Death|1|||
161152576|NCT00064662|581939338|FG001|Overall Study|Death|1|||
161152577|NCT00064662|581939337|FG000|Overall Study|Lost to Follow-up|57|||
161152578|NCT00064662|581939338|FG001|Overall Study|Lost to Follow-up|44|||
161152579|NCT00064662|581939337|FG000|Overall Study|Withdrawal by Subject|14|||
161152580|NCT00064662|581939338|FG001|Overall Study|Withdrawal by Subject|14|||
161152581|NCT00064662|581939337|FG000|Overall Study|Administratively withdrawn|2|||
161152582|NCT00064662|581939338|FG001|Overall Study|Administratively withdrawn|2|||
161152583|NCT01555463|581939343|FG000|Treatment|Adverse Event|6|||
161152584|NCT01555463|581939344|FG001|Treatment|Adverse Event|12|||
161152585|NCT01555463|581939343|FG000|Treatment|Withdrawal by Subject|24|||
161152586|NCT01555463|581939344|FG001|Treatment|Withdrawal by Subject|36|||
161152587|NCT01555463|581939343|FG000|Treatment|Lost to Follow-up|28|||
161152588|NCT01555463|581939344|FG001|Treatment|Lost to Follow-up|23|||
161152589|NCT01555463|581939343|FG000|Treatment|Protocol Violation|4|||
161152590|NCT01555463|581939344|FG001|Treatment|Protocol Violation|5|||
161152591|NCT01555463|581939343|FG000|Treatment|Other reason|2|||
161152592|NCT01555463|581939344|FG001|Treatment|Other reason|3|||
161152593|NCT01555463|581939343|FG000|Follow up|Adverse Event|2|||
161281336|NCT02288325|582408685|FG000|Run-in Period|Lost to Follow-up|25|||
161281337|NCT02288325|582408686|FG001|Run-in Period|Lost to Follow-up|0|||
161281338|NCT02288325|582408687|FG002|Run-in Period|Lost to Follow-up|0|||
161281339|NCT02288325|582408685|FG000|Run-in Period|Protocol Violation|17|||
161281340|NCT02288325|582408686|FG001|Run-in Period|Protocol Violation|0|||
161281341|NCT02288325|582408687|FG002|Run-in Period|Protocol Violation|0|||
161281342|NCT02288325|582408685|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
161281343|NCT02288325|582408686|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
161281344|NCT02288325|582408687|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
161057439|NCT00714688|581598182|FG002|Overall Study|Ineligible to Continue the Study|1|||
161057440|NCT00714688|581598180|FG000|Overall Study|Sponsor's Decision|0|||
161057441|NCT00714688|581598181|FG001|Overall Study|Sponsor's Decision|2|||
161057442|NCT00714688|581598182|FG002|Overall Study|Sponsor's Decision|0|||
161057443|NCT00714688|581598180|FG000|Overall Study|Other|1|||
161057444|NCT00714688|581598181|FG001|Overall Study|Other|6|||
161057445|NCT00714688|581598182|FG002|Overall Study|Other|5|||
161057446|NCT00500539|581598183|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
161057447|NCT00500539|581598183|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
161057448|NCT00500539|581598183|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
161057449|NCT00500539|581598183|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
161057450|NCT00500539|581598183|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
161057451|NCT00500539|581598183|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
161057452|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
161057453|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
161057454|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
161057455|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
161057456|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Death|1|||
161057457|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
161057458|NCT00500539|581598183|FG000|Follow-up Period (16 Weeks)|Missing|3|||
161057459|NCT04853394|581598184|FG000|Follow-up Interviews|Lost to Follow-up|22|||
161057460|NCT04853394|581598185|FG001|Follow-up Interviews|Lost to Follow-up|15|||
161057461|NCT03993054|581598188|FG000|Overall Study|PI Decision|1|||
161057462|NCT00383500|581598189|FG000|Overall Study|Withdrawal by Subject|8|||
161057463|NCT00383500|581598190|FG001|Overall Study|Withdrawal by Subject|3|||
161057464|NCT00383500|581598191|FG002|Overall Study|Withdrawal by Subject|0|||
161057465|NCT00383500|581598189|FG000|Overall Study|Lost to Follow-up|0|||
161057466|NCT00383500|581598190|FG001|Overall Study|Lost to Follow-up|0|||
161057467|NCT00383500|581598191|FG002|Overall Study|Lost to Follow-up|2|||
161057468|NCT00961896|581599868|FG000|Overall Study|Abnormal laboratory value|0|||
161057469|NCT00961896|581599869|FG001|Overall Study|Abnormal laboratory value|0|||
161057470|NCT00961896|581599870|FG002|Overall Study|Abnormal laboratory value|1|||
161057471|NCT01983462|581599871|FG000|Overall Study|Adverse Event|1|||
161057472|NCT01983462|581599872|FG001|Overall Study|Adverse Event|0|||
161057473|NCT01983462|581599873|FG002|Overall Study|Adverse Event|0|||
161057474|NCT00755716|581599874|FG000|Overall Study|Adverse Event|1|||
161057475|NCT00755716|581599875|FG001|Overall Study|Adverse Event|4|||
161057476|NCT00755716|581599876|FG002|Overall Study|Adverse Event|1|||
161057477|NCT00755716|581599874|FG000|Overall Study|Lack of Efficacy|2|||
161057478|NCT00755716|581599875|FG001|Overall Study|Lack of Efficacy|0|||
161057479|NCT00755716|581599876|FG002|Overall Study|Lack of Efficacy|0|||
161057480|NCT00755716|581599874|FG000|Overall Study|Lost to Follow-up|5|||
161057481|NCT00755716|581599875|FG001|Overall Study|Lost to Follow-up|3|||
161057482|NCT00755716|581599876|FG002|Overall Study|Lost to Follow-up|1|||
161057483|NCT00755716|581599874|FG000|Overall Study|work schedule issues|0|||
161057484|NCT00755716|581599875|FG001|Overall Study|work schedule issues|1|||
161057485|NCT00755716|581599876|FG002|Overall Study|work schedule issues|1|||
161152594|NCT01555463|581939344|FG001|Follow up|Adverse Event|5|||
161152595|NCT01555463|581939343|FG000|Follow up|Death|0|||
161152596|NCT01555463|581939344|FG001|Follow up|Death|1|||
161152597|NCT01555463|581939343|FG000|Follow up|Withdrawal by Subject|22|||
161152598|NCT01555463|581939344|FG001|Follow up|Withdrawal by Subject|22|||
161152599|NCT01555463|581939343|FG000|Follow up|Lost to Follow-up|9|||
161152600|NCT01555463|581939344|FG001|Follow up|Lost to Follow-up|10|||
161152601|NCT01555463|581939343|FG000|Follow up|Protocol Violation|2|||
161152602|NCT01555463|581939344|FG001|Follow up|Protocol Violation|4|||
161152603|NCT01555463|581939343|FG000|Follow up|Other reason|3|||
161152604|NCT01555463|581939344|FG001|Follow up|Other reason|3|||
161152605|NCT01165203|581939345|FG000|Active Phase|Serious Adverse Event|1|||
161152606|NCT01165203|581939346|FG001|Active Phase|Serious Adverse Event|0|||
161152607|NCT01165203|581939345|FG000|Active Phase|Withdrawal by Subject|2|||
161152608|NCT01165203|581939346|FG001|Active Phase|Withdrawal by Subject|1|||
161152609|NCT01165203|581939345|FG000|Active Phase|Migrated/moved from study area|0|||
161152610|NCT01165203|581939346|FG001|Active Phase|Migrated/moved from study area|1|||
161152611|NCT01165203|581939345|FG000|Active Phase|Lost to Follow-up|2|||
161152612|NCT01165203|581939346|FG001|Active Phase|Lost to Follow-up|0|||
161152613|NCT01165203|581939345|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
161152614|NCT01165203|581939346|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
161152615|NCT01165203|581939345|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
161152616|NCT01165203|581939346|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
161152617|NCT01165203|581939345|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
161152618|NCT01165203|581939346|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
161152619|NCT01165203|581939345|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
161152620|NCT01165203|581939346|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
161152621|NCT01165203|581939345|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
161152622|NCT01165203|581939346|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
161152623|NCT01937130|581940856|FG000|Overall Study|Withdrawal by Subject|0|||
161152624|NCT01937130|581940857|FG001|Overall Study|Withdrawal by Subject|0|||
161152625|NCT01937130|581940858|FG002|Overall Study|Withdrawal by Subject|0|||
161152626|NCT01937130|581940859|FG003|Overall Study|Withdrawal by Subject|1|||
161152627|NCT01937130|581940856|FG000|Overall Study|Adverse Event|0|||
161152628|NCT01937130|581940857|FG001|Overall Study|Adverse Event|1|||
161152629|NCT01937130|581940858|FG002|Overall Study|Adverse Event|0|||
161152630|NCT01937130|581940859|FG003|Overall Study|Adverse Event|1|||
161152631|NCT01937130|581940856|FG000|Overall Study|Death|1|||
161152632|NCT01937130|581940857|FG001|Overall Study|Death|1|||
161152633|NCT01937130|581940858|FG002|Overall Study|Death|1|||
161152634|NCT01937130|581940859|FG003|Overall Study|Death|0|||
161152635|NCT01937130|581940856|FG000|Overall Study|Lost to Follow-up|2|||
161152636|NCT01937130|581940857|FG001|Overall Study|Lost to Follow-up|0|||
161152637|NCT01937130|581940858|FG002|Overall Study|Lost to Follow-up|2|||
161152638|NCT01937130|581940859|FG003|Overall Study|Lost to Follow-up|0|||
161152639|NCT01937130|581940856|FG000|Overall Study|Physician Decision|0|||
161152640|NCT01937130|581940857|FG001|Overall Study|Physician Decision|1|||
161152641|NCT01937130|581940858|FG002|Overall Study|Physician Decision|0|||
161152642|NCT01937130|581940859|FG003|Overall Study|Physician Decision|0|||
161152643|NCT01937130|581940856|FG000|Overall Study|Patients unable to swallow|0|||
161152644|NCT01937130|581940857|FG001|Overall Study|Patients unable to swallow|1|||
161152645|NCT01937130|581940858|FG002|Overall Study|Patients unable to swallow|0|||
161152646|NCT01937130|581940859|FG003|Overall Study|Patients unable to swallow|0|||
161152647|NCT01937130|581940856|FG000|Overall Study|Patient lost to FU due to death|2|||
161152648|NCT01937130|581940857|FG001|Overall Study|Patient lost to FU due to death|0|||
161152649|NCT01937130|581940858|FG002|Overall Study|Patient lost to FU due to death|0|||
161152650|NCT01937130|581940859|FG003|Overall Study|Patient lost to FU due to death|0|||
161152651|NCT01431144|581940860|FG000|Overall Study|Implant mobility and removal|2|||
161152652|NCT01431144|581940861|FG001|Overall Study|Implant mobility and removal|0|||
161152653|NCT01746732|581940867|FG000|Lead-In Period|Withdrawal by Subject|1|||
161152654|NCT01746732|581940868|FG001|Lead-In Period|Withdrawal by Subject|0|||
161152655|NCT01746732|581940869|FG002|Lead-In Period|Withdrawal by Subject|0|||
161281345|NCT02288325|582408685|FG000|Run-in Period|Reason not Specified|8|||
161281346|NCT02288325|582408686|FG001|Run-in Period|Reason not Specified|0|||
161281347|NCT02288325|582408687|FG002|Run-in Period|Reason not Specified|0|||
161152656|NCT01746732|581940867|FG000|Period 1|Physician Decision|0|||
161152657|NCT01746732|581940868|FG001|Period 1|Physician Decision|1|||
161152658|NCT01746732|581940869|FG002|Period 1|Physician Decision|0|||
161152659|NCT01746732|581940867|FG000|Period 2|Withdrawal by Subject|0|||
161152660|NCT01746732|581940868|FG001|Period 2|Withdrawal by Subject|0|||
161152661|NCT01746732|581940869|FG002|Period 2|Withdrawal by Subject|2|||
161152662|NCT01746732|581940867|FG000|Period 2|Adverse Event|0|||
161152663|NCT01746732|581940868|FG001|Period 2|Adverse Event|0|||
161152664|NCT01746732|581940869|FG002|Period 2|Adverse Event|1|||
161152665|NCT01746732|581940867|FG000|Period 2|Lost to Follow-up|0|||
161152666|NCT01746732|581940868|FG001|Period 2|Lost to Follow-up|0|||
161281348|NCT02288325|582408685|FG000|Stabilization Period|Adverse Event|13|||
161281349|NCT02288325|582408686|FG001|Stabilization Period|Adverse Event|0|||
161152667|NCT01746732|581940869|FG002|Period 2|Lost to Follow-up|1|||
161152668|NCT02817555|581940870|FG000|Overall Study|Death|1|||
161281350|NCT02288325|582408687|FG002|Stabilization Period|Adverse Event|0|||
161281351|NCT02288325|582408685|FG000|Stabilization Period|Lack of Efficacy|22|||
161281352|NCT02288325|582408686|FG001|Stabilization Period|Lack of Efficacy|0|||
161281353|NCT02288325|582408687|FG002|Stabilization Period|Lack of Efficacy|0|||
161281354|NCT02288325|582408685|FG000|Stabilization Period|Withdrawal of Consent|23|||
161281355|NCT02288325|582408686|FG001|Stabilization Period|Withdrawal of Consent|0|||
161281356|NCT02288325|582408687|FG002|Stabilization Period|Withdrawal of Consent|0|||
161281357|NCT02288325|582408685|FG000|Stabilization Period|Lost to Follow-up|12|||
161057486|NCT00843115|581599877|FG000|Overall Study|Death|4|||
161057487|NCT00843115|581599877|FG000|Overall Study|Adverse Event|30|||
161057488|NCT00843115|581599877|FG000|Overall Study|Lost to Follow-up|4|||
161057489|NCT00843115|581599877|FG000|Overall Study|Withdrawal by Subject|17|||
161057490|NCT00843115|581599877|FG000|Overall Study|Family wanted meds stopped|1|||
161057491|NCT00843115|581599877|FG000|Overall Study|Family does not want continuation|1|||
161057492|NCT00843115|581599877|FG000|Overall Study|Patient forgot to take meds|1|||
161057493|NCT00843115|581599877|FG000|Overall Study|Does not meet entrance criteria|1|||
161057494|NCT00843115|581599877|FG000|Overall Study|Physician Decision|1|||
161057495|NCT00843115|581599877|FG000|Overall Study|Family discontinued meds|1|||
161057496|NCT00843115|581599877|FG000|Overall Study|patient took for 2 days then stopped|1|||
161057497|NCT00843115|581599877|FG000|Overall Study|patient never took the medication|1|||
161057498|NCT00843115|581599877|FG000|Overall Study|hospitalized due to deterioration|1|||
161057499|NCT00843115|581599877|FG000|Overall Study|week 12 not done|1|||
161057500|NCT00843115|581599877|FG000|Overall Study|Syndrome De Glissement|1|||
161057501|NCT02005029|581599878|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
161057502|NCT02005029|581599879|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
161057503|NCT02621047|581599880|FG000|Overall Study|Adverse Event|0|||
161057504|NCT02621047|581599881|FG001|Overall Study|Adverse Event|0|||
161057505|NCT02621047|581599882|FG002|Overall Study|Adverse Event|1|||
161057506|NCT01525641|581599885|FG000|Overall Study|Case report form not collected|25|||
161057507|NCT01525641|581599885|FG000|Overall Study|No visit since the first visit|16|||
161057508|NCT01525641|581599885|FG000|Overall Study|Adverse Event|73|||
161057509|NCT01525641|581599885|FG000|Overall Study|Lack of Efficacy|24|||
161057510|NCT01525641|581599885|FG000|Overall Study|Improvement|5|||
161057511|NCT01525641|581599885|FG000|Overall Study|Lost to follow-up (relocation)|1|||
161057512|NCT01525641|581599885|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
161057513|NCT01525641|581599885|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
161057514|NCT01525641|581599885|FG000|Overall Study|Other than stated above|7|||
161057515|NCT03772041|581599886|FG000|Overall Study|Adverse Event|8|||
161057516|NCT03772041|581599887|FG001|Overall Study|Adverse Event|3|||
161057517|NCT03772041|581599886|FG000|Overall Study|Withdrawal by Subject|0|||
161057518|NCT03772041|581599887|FG001|Overall Study|Withdrawal by Subject|2|||
161057519|NCT03772041|581599886|FG000|Overall Study|Protocol Violation|4|||
161057520|NCT03772041|581599887|FG001|Overall Study|Protocol Violation|2|||
161057521|NCT03772041|581599886|FG000|Overall Study|Physician Decision|2|||
161057522|NCT03772041|581599887|FG001|Overall Study|Physician Decision|3|||
161057523|NCT03371485|581599892|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
161057524|NCT03371485|581599892|FG000|2-year Follow-up|Death|5|||
161057525|NCT01264887|581599893|FG000|Overall Study|Adverse Event|5|||
161057526|NCT01264887|581599893|FG000|Overall Study|Death|7|||
161057527|NCT01264887|581599893|FG000|Overall Study|Lack of Efficacy|5|||
161057528|NCT01264887|581599893|FG000|Overall Study|Physician Decision|4|||
161057529|NCT01264887|581599893|FG000|Overall Study|Withdrawal by Subject|6|||
161057530|NCT01264887|581599893|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
161057531|NCT01264887|581599893|FG000|Overall Study|Other|2|||
161057532|NCT02959177|581599895|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
161057533|NCT02959177|581599896|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
161057534|NCT02959177|581599897|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161057535|NCT02959177|581599895|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
161057536|NCT02959177|581599896|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
161057537|NCT02959177|581599897|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
161057538|NCT02959177|581599895|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
161057539|NCT02959177|581599896|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161057540|NCT02959177|581599897|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161057541|NCT02959177|581599895|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161057542|NCT02959177|581599896|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161057543|NCT02959177|581599897|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161057544|NCT02959177|581599895|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
161057545|NCT02959177|581599896|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
161057546|NCT02959177|581599897|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
161057547|NCT02959177|581599895|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
161057548|NCT02959177|581599896|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
161057549|NCT02959177|581599897|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
161057550|NCT02959177|581599895|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
161281358|NCT02288325|582408686|FG001|Stabilization Period|Lost to Follow-up|0|||
161281359|NCT02288325|582408687|FG002|Stabilization Period|Lost to Follow-up|0|||
161281360|NCT02288325|582408685|FG000|Stabilization Period|Protocol Violation|8|||
161281361|NCT02288325|582408686|FG001|Stabilization Period|Protocol Violation|0|||
161281362|NCT02288325|582408687|FG002|Stabilization Period|Protocol Violation|0|||
161281363|NCT02288325|582408685|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
161152669|NCT02817555|581940871|FG001|Overall Study|Death|3|||
161152670|NCT02817555|581940870|FG000|Overall Study|moved away|1|||
161152671|NCT02817555|581940871|FG001|Overall Study|moved away|0|||
161152672|NCT02817555|581940870|FG000|Overall Study|transplant|1|||
161152673|NCT02817555|581940871|FG001|Overall Study|transplant|1|||
161152674|NCT02817555|581940870|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
161152675|NCT02817555|581940871|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
161152676|NCT00137436|581940872|FG000|Overall Study|Adverse Event|13|||
161152677|NCT00137436|581940872|FG000|Overall Study|Death|2|||
161152678|NCT00137436|581940872|FG000|Overall Study|Lack of Efficacy|17|||
161152679|NCT00137436|581940872|FG000|Overall Study|Withdrawal by Subject|6|||
161152680|NCT00137436|581940872|FG000|Overall Study|Other|5|||
161152681|NCT00701727|581940873|FG000|First Treatment Period|Adverse Event|0|||
161152682|NCT00701727|581940874|FG001|First Treatment Period|Adverse Event|0|||
161152683|NCT00701727|581940873|FG000|First Treatment Period|Withdrawal by Subject|1|||
161152684|NCT00701727|581940874|FG001|First Treatment Period|Withdrawal by Subject|0|||
161152685|NCT00701727|581940873|FG000|First Treatment Period|sponsor decision|0|||
161152686|NCT00701727|581940874|FG001|First Treatment Period|sponsor decision|1|||
161152687|NCT00701727|581940873|FG000|First Treatment Period|Lost to Follow-up|0|||
161281364|NCT02288325|582408686|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
161281365|NCT02288325|582408687|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
161281366|NCT02288325|582408685|FG000|Stabilization Period|Reason not Specified|15|||
161281367|NCT02288325|582408686|FG001|Stabilization Period|Reason not Specified|0|||
161057551|NCT02959177|581599896|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
161057552|NCT02959177|581599897|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
161057553|NCT02853305|581599899|FG000|Overall Study|Death|287|||
161057554|NCT02853305|581599900|FG001|Overall Study|Death|249|||
161057555|NCT02853305|581599901|FG002|Overall Study|Death|300|||
161057556|NCT02853305|581599899|FG000|Overall Study|Withdrawal by Subject|2|||
161057557|NCT02853305|581599900|FG001|Overall Study|Withdrawal by Subject|8|||
161057558|NCT02853305|581599901|FG002|Overall Study|Withdrawal by Subject|3|||
161057559|NCT02853305|581599899|FG000|Overall Study|Transferred to Extension Study|46|||
161057560|NCT02853305|581599900|FG001|Overall Study|Transferred to Extension Study|30|||
161057561|NCT02853305|581599901|FG002|Overall Study|Transferred to Extension Study|25|||
161057562|NCT02853305|581599899|FG000|Overall Study|Did Not Continue on Extension Study|16|||
161057563|NCT02853305|581599900|FG001|Overall Study|Did Not Continue on Extension Study|20|||
161057564|NCT02853305|581599901|FG002|Overall Study|Did Not Continue on Extension Study|24|||
161057565|NCT01836198|581599902|FG000|Part A, Period 2|Protocol Violation|0|||
161057566|NCT01836198|581599903|FG001|Part A, Period 2|Protocol Violation|1|||
161057567|NCT01836198|581599904|FG002|Part A, Period 2|Protocol Violation|0|||
161057568|NCT02642159|581599909|FG000|Overall Study|Randomized but not treated|1|||
161057569|NCT02642159|581599910|FG001|Overall Study|Randomized but not treated|0|||
161057570|NCT02642159|581599909|FG000|Overall Study|Adverse Event|10|||
161057571|NCT02642159|581599910|FG001|Overall Study|Adverse Event|4|||
161057572|NCT02642159|581599909|FG000|Overall Study|Withdrawal by Subject|9|||
161057573|NCT02642159|581599910|FG001|Overall Study|Withdrawal by Subject|1|||
161057574|NCT02642159|581599909|FG000|Overall Study|Poor compliance to study protocol|1|||
161057575|NCT02642159|581599910|FG001|Overall Study|Poor compliance to study protocol|0|||
161057576|NCT02642159|581599909|FG000|Overall Study|Other than specified above|10|||
161057577|NCT02642159|581599910|FG001|Overall Study|Other than specified above|3|||
161057578|NCT00588341|581599911|FG000|Overall Study|Withdrawal by Subject|3|||
161057579|NCT00588341|581599911|FG000|Overall Study|Not treated due to metastatic disease|1|||
161057580|NCT00588341|581599911|FG000|Overall Study|Patient ineligible|1|||
161057581|NCT01924806|581599914|FG000|Overall Study|Physician Decision|2|||
161057582|NCT01924806|581599915|FG001|Overall Study|Physician Decision|1|||
161057583|NCT01954771|581599916|FG000|Overall Study|Missing HbA1c of end-point|1|||
161281368|NCT02288325|582408687|FG002|Stabilization Period|Reason not Specified|0|||
161281369|NCT02288325|582408685|FG000|Double-blind Treatment Period|Adverse Event|0|||
161057584|NCT01954771|581599917|FG001|Overall Study|Missing HbA1c of end-point|1|||
161057585|NCT01954771|581599918|FG002|Overall Study|Missing HbA1c of end-point|0|||
161057586|NCT01954771|581599916|FG000|Overall Study|Missing CGMS of end-point|1|||
161152688|NCT00701727|581940874|FG001|First Treatment Period|Lost to Follow-up|1|||
161057587|NCT01954771|581599917|FG001|Overall Study|Missing CGMS of end-point|1|||
161057588|NCT01954771|581599918|FG002|Overall Study|Missing CGMS of end-point|0|||
161057589|NCT01954771|581599916|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
161152689|NCT00701727|581940873|FG000|Second Treatment Period|Withdrawal by Subject|2|||
161152690|NCT00701727|581940874|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161152691|NCT00912015|581940875|FG000|Overall Study|Lack of Efficacy|1|||
161152692|NCT00912015|581940876|FG001|Overall Study|Lack of Efficacy|0|||
161281370|NCT02288325|582408686|FG001|Double-blind Treatment Period|Adverse Event|2|||
161281371|NCT02288325|582408687|FG002|Double-blind Treatment Period|Adverse Event|5|||
161281372|NCT02288325|582408685|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
161281373|NCT02288325|582408686|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
161281374|NCT02288325|582408687|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
161281375|NCT02288325|582408685|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161281376|NCT02288325|582408686|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
161281377|NCT02288325|582408687|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161281378|NCT02288325|582408685|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161281379|NCT02288325|582408686|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161281380|NCT02288325|582408687|FG002|Double-blind Treatment Period|Protocol Violation|2|||
161281381|NCT02288325|582408685|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
161281382|NCT02288325|582408686|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
161281383|NCT02288325|582408687|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
161281384|NCT02288325|582408685|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
161281385|NCT02288325|582408686|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
161281386|NCT02288325|582408687|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
161281387|NCT03607487|582408691|FG000|Overall Study|Withdrawal by Subject|2|||
161281388|NCT03607487|582408692|FG001|Overall Study|Withdrawal by Subject|0|||
161281389|NCT03607487|582408693|FG002|Overall Study|Withdrawal by Subject|0|||
161281390|NCT03607487|582408694|FG003|Overall Study|Withdrawal by Subject|1|||
161281391|NCT04759703|582408696|FG000|Overall Study|Withdrawal by Subject|4|||
161281392|NCT04759703|582408697|FG001|Overall Study|Withdrawal by Subject|9|||
161281393|NCT04759703|582408696|FG000|Overall Study|Adverse Event|1|||
161281394|NCT04759703|582408697|FG001|Overall Study|Adverse Event|0|||
161281395|NCT04759703|582408696|FG000|Overall Study|Lost to Follow-up|2|||
161281396|NCT04759703|582408697|FG001|Overall Study|Lost to Follow-up|0|||
161281397|NCT04186845|582408705|FG000|Overall Study|Death|2|||
161281398|NCT04186845|582408705|FG000|Overall Study|Lost to Follow-up|1|||
161281399|NCT04186845|582408705|FG000|Overall Study|Physician Decision|1|||
161281400|NCT04186845|582408705|FG000|Overall Study|Protocol Violation|1|||
161281401|NCT04186845|582408705|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
161281402|NCT04186845|582408705|FG000|Overall Study|Biopsy ordered but not done|1|||
161281403|NCT04186845|582408705|FG000|Overall Study|It was previously confirmed|1|||
161281404|NCT04186845|582408705|FG000|Overall Study|Patient cancelled scheduled scans|2|||
161281405|NCT04186845|582408705|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
161281406|NCT04186845|582408705|FG000|Overall Study|Subject refused confirmatory imaging|1|||
161281407|NCT04186845|582408705|FG000|Overall Study|Too small to biopsy|1|||
161281408|NCT04138823|582408706|FG000|Overall Study|Clinical disease progression|0|||
161281409|NCT04138823|582408707|FG001|Overall Study|Clinical disease progression|0|||
161281410|NCT04138823|582408708|FG002|Overall Study|Clinical disease progression|1|||
161281411|NCT04138823|582408706|FG000|Overall Study|Objective disease progression|3|||
161281412|NCT04138823|582408707|FG001|Overall Study|Objective disease progression|2|||
161281413|NCT04138823|582408708|FG002|Overall Study|Objective disease progression|5|||
161281414|NCT03151304|582408709|FG000|Overall Study|Termination of study by Sponsor|23|||
161281415|NCT03151304|582408709|FG000|Overall Study|missing|3|||
161281416|NCT03151304|582408709|FG000|Overall Study|Withdrawal by Subject|8|||
161281417|NCT03151304|582408709|FG000|Overall Study|multiple reasons|30|||
161281418|NCT04868500|582408710|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
161057590|NCT01954771|581599917|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
161057591|NCT01954771|581599918|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
161057592|NCT01026103|581599923|FG000|Overall Study|Physician Decision|1|||
161057593|NCT01026103|581599923|FG000|Overall Study|did not receive study device bc of error|1|||
161057594|NCT03635775|581599924|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
161057595|NCT03635775|581599925|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
161057596|NCT03635775|581599926|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
161057597|NCT03635775|581599927|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
161057598|NCT02498418|581599928|FG000|Overall Study|Lack of Efficacy|0|||
161057599|NCT02498418|581599929|FG001|Overall Study|Lack of Efficacy|0|||
161057600|NCT02498418|581599930|FG002|Overall Study|Lack of Efficacy|1|||
161057601|NCT02498418|581599928|FG000|Overall Study|Withdrawal by Subject|2|||
161057602|NCT02498418|581599929|FG001|Overall Study|Withdrawal by Subject|0|||
161057603|NCT02498418|581599930|FG002|Overall Study|Withdrawal by Subject|3|||
161281419|NCT04868500|582408711|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
161281420|NCT04868500|582408710|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
161281421|NCT04868500|582408711|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
161281422|NCT02466685|582408712|FG000|Overall Study|Adverse Event|5|||
161281423|NCT02466685|582408713|FG001|Overall Study|Adverse Event|2|||
161281424|NCT02466685|582408712|FG000|Overall Study|Lost to Follow-up|1|||
161281425|NCT02466685|582408713|FG001|Overall Study|Lost to Follow-up|1|||
161281426|NCT02466685|582408712|FG000|Overall Study|Withdrawal by Subject|1|||
161152693|NCT00912015|581940877|FG002|Overall Study|Lack of Efficacy|0|||
161152694|NCT00912015|581940878|FG003|Overall Study|Lack of Efficacy|0|||
161152695|NCT00912015|581940875|FG000|Overall Study|Withdrawal by Subject|8|||
161152696|NCT00912015|581940876|FG001|Overall Study|Withdrawal by Subject|8|||
161152697|NCT00912015|581940877|FG002|Overall Study|Withdrawal by Subject|3|||
161152698|NCT00912015|581940878|FG003|Overall Study|Withdrawal by Subject|0|||
161152699|NCT00912015|581940875|FG000|Overall Study|Protocol Violation|1|||
161152700|NCT00912015|581940876|FG001|Overall Study|Protocol Violation|0|||
161152701|NCT00912015|581940877|FG002|Overall Study|Protocol Violation|0|||
161152702|NCT00912015|581940878|FG003|Overall Study|Protocol Violation|1|||
161152703|NCT00912015|581940875|FG000|Overall Study|Adverse Event|6|||
161152704|NCT00912015|581940876|FG001|Overall Study|Adverse Event|0|||
161152705|NCT00912015|581940877|FG002|Overall Study|Adverse Event|0|||
161152706|NCT00912015|581940878|FG003|Overall Study|Adverse Event|1|||
161152707|NCT05137041|581940879|FG000|Overall Study|Lost to Follow-up|1|||
161152708|NCT05137041|581940880|FG001|Overall Study|Lost to Follow-up|1|||
161152709|NCT05137041|581940879|FG000|Overall Study|Withdrawal by Subject|0|||
161152710|NCT05137041|581940880|FG001|Overall Study|Withdrawal by Subject|2|||
161152711|NCT05137041|581940879|FG000|Overall Study|Reason not Specified|0|||
161152712|NCT05137041|581940880|FG001|Overall Study|Reason not Specified|1|||
161152713|NCT02433210|581940881|FG000|Overall Study|Physician Decision|1|||
161152714|NCT02433210|581940882|FG001|Overall Study|Physician Decision|0|||
161152715|NCT02433210|581940883|FG002|Overall Study|Physician Decision|0|||
161152716|NCT02090114|581940884|FG000|Overall Study|Withdrawal by Subject|3|||
161152717|NCT02090114|581940885|FG001|Overall Study|Withdrawal by Subject|6|||
161152718|NCT02090114|581940886|FG002|Overall Study|Withdrawal by Subject|2|||
161152719|NCT02090114|581940887|FG003|Overall Study|Withdrawal by Subject|1|||
161152720|NCT02090114|581940884|FG000|Overall Study|Physician Decision|5|||
161152721|NCT02090114|581940885|FG001|Overall Study|Physician Decision|0|||
161152722|NCT02090114|581940886|FG002|Overall Study|Physician Decision|1|||
161152723|NCT02090114|581940887|FG003|Overall Study|Physician Decision|1|||
161152724|NCT02090114|581940884|FG000|Overall Study|Adverse Event|1|||
161152725|NCT02090114|581940885|FG001|Overall Study|Adverse Event|2|||
161152726|NCT02090114|581940886|FG002|Overall Study|Adverse Event|2|||
161152727|NCT02090114|581940887|FG003|Overall Study|Adverse Event|0|||
161152728|NCT02090114|581940884|FG000|Overall Study|Progressive Disease|20|||
161152729|NCT02090114|581940885|FG001|Overall Study|Progressive Disease|21|||
161152730|NCT02090114|581940886|FG002|Overall Study|Progressive Disease|23|||
161152731|NCT02090114|581940887|FG003|Overall Study|Progressive Disease|6|||
161152732|NCT02090114|581940884|FG000|Overall Study|Death|1|||
161152733|NCT02090114|581940885|FG001|Overall Study|Death|0|||
161152734|NCT02090114|581940886|FG002|Overall Study|Death|1|||
161152735|NCT02090114|581940887|FG003|Overall Study|Death|0|||
161152736|NCT01605071|581940888|FG000|Overall Study|Withdrawal by Subject|3|||
161152737|NCT01605071|581940889|FG001|Overall Study|Withdrawal by Subject|2|||
161152738|NCT00051558|581940892|FG000|Overall Study|Adverse Event|30|||
161152739|NCT00051558|581940893|FG001|Overall Study|Adverse Event|18|||
161152740|NCT00051558|581940892|FG000|Overall Study|Withdrawal by Subject|29|||
161152741|NCT00051558|581940893|FG001|Overall Study|Withdrawal by Subject|42|||
161152742|NCT00051558|581940892|FG000|Overall Study|Death|9|||
161152743|NCT00051558|581940893|FG001|Overall Study|Death|15|||
161152744|NCT00051558|581940892|FG000|Overall Study|Lost to Follow-up|4|||
161152745|NCT00051558|581940893|FG001|Overall Study|Lost to Follow-up|13|||
161152746|NCT00051558|581940892|FG000|Overall Study|Protocol Violation|3|||
161281427|NCT02466685|582408713|FG001|Overall Study|Withdrawal by Subject|0|||
161281428|NCT02466685|582408712|FG000|Overall Study|Physician Decision|1|||
161281429|NCT02466685|582408713|FG001|Overall Study|Physician Decision|1|||
161281430|NCT02565511|582408714|FG000|Overall Study|Study terminated by Sponsor|35|||
161281431|NCT02565511|582408715|FG001|Overall Study|Study terminated by Sponsor|22|||
161152747|NCT00051558|581940893|FG001|Overall Study|Protocol Violation|4|||
161152748|NCT00051558|581940892|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
161152749|NCT00051558|581940893|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
161281432|NCT02565511|582408716|FG002|Overall Study|Study terminated by Sponsor|235|||
161281433|NCT02565511|582408717|FG003|Overall Study|Study terminated by Sponsor|156|||
161281434|NCT02565511|582408714|FG000|Overall Study|Withdrawal by Subject|3|||
161152750|NCT00051558|581940892|FG000|Overall Study|Sponsor Decision|6|||
161152751|NCT00051558|581940893|FG001|Overall Study|Sponsor Decision|1|||
161152752|NCT00051558|581940892|FG000|Overall Study|Other|2|||
161152753|NCT00051558|581940893|FG001|Overall Study|Other|1|||
161281435|NCT02565511|582408715|FG001|Overall Study|Withdrawal by Subject|0|||
161152754|NCT00051558|581940892|FG000|Overall Study|Significant Lab Value|2|||
161152755|NCT00051558|581940893|FG001|Overall Study|Significant Lab Value|0|||
161152756|NCT00051558|581940892|FG000|Overall Study|Physician Decision|5|||
161152757|NCT00051558|581940893|FG001|Overall Study|Physician Decision|0|||
161152758|NCT02163993|581940895|FG000|Treatment Period|Adverse Event|0|||
161152759|NCT02163993|581940896|FG001|Treatment Period|Adverse Event|1|||
161152760|NCT02163993|581940897|FG002|Treatment Period|Adverse Event|0|||
161152761|NCT02163993|581940898|FG003|Treatment Period|Adverse Event|0|||
161152762|NCT02163993|581940899|FG004|Treatment Period|Adverse Event|1|||
161057604|NCT02498418|581599928|FG000|Overall Study|Lost to Follow-up|0|||
161057605|NCT02498418|581599929|FG001|Overall Study|Lost to Follow-up|1|||
161057606|NCT02498418|581599930|FG002|Overall Study|Lost to Follow-up|1|||
161057607|NCT02498418|581599928|FG000|Overall Study|Participant taken prohibited medication|0|||
161057608|NCT02498418|581599929|FG001|Overall Study|Participant taken prohibited medication|1|||
161057609|NCT02498418|581599930|FG002|Overall Study|Participant taken prohibited medication|1|||
161057610|NCT00762502|581599931|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
161057611|NCT00762502|581599932|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
161057612|NCT00762502|581599933|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
161057613|NCT00762502|581599931|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
161057614|NCT00762502|581599932|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
161057615|NCT00762502|581599933|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
161057616|NCT00762502|581599931|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
161057617|NCT00762502|581599932|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
161057618|NCT00762502|581599933|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
161057619|NCT02996097|581599939|FG000|Overall Study|Lost to Follow-up|11|||
161057620|NCT02996097|581599940|FG001|Overall Study|Lost to Follow-up|11|||
161057621|NCT03638258|581599941|FG000|Overall Study|Adverse Event|1|||
161057622|NCT03638258|581599942|FG001|Overall Study|Adverse Event|0|||
161057623|NCT03638258|581599943|FG002|Overall Study|Adverse Event|2|||
161057624|NCT03638258|581599941|FG000|Overall Study|Lost to Follow-up|2|||
161057625|NCT03638258|581599942|FG001|Overall Study|Lost to Follow-up|4|||
161057626|NCT03638258|581599943|FG002|Overall Study|Lost to Follow-up|5|||
161057627|NCT03638258|581599941|FG000|Overall Study|Pregnancy|0|||
161057628|NCT03638258|581599942|FG001|Overall Study|Pregnancy|0|||
161057629|NCT03638258|581599943|FG002|Overall Study|Pregnancy|1|||
161057630|NCT03638258|581599941|FG000|Overall Study|Protocol Violation|0|||
161057631|NCT03638258|581599942|FG001|Overall Study|Protocol Violation|0|||
161057632|NCT03638258|581599943|FG002|Overall Study|Protocol Violation|1|||
161057633|NCT03638258|581599941|FG000|Overall Study|Withdrawal by Subject|4|||
161057634|NCT03638258|581599942|FG001|Overall Study|Withdrawal by Subject|5|||
161057635|NCT03638258|581599943|FG002|Overall Study|Withdrawal by Subject|12|||
161057636|NCT03638258|581599941|FG000|Overall Study|Lack of Efficacy|0|||
161057637|NCT03638258|581599942|FG001|Overall Study|Lack of Efficacy|0|||
161057638|NCT03638258|581599943|FG002|Overall Study|Lack of Efficacy|2|||
161057639|NCT02205476|581599944|FG000|Overall Study|Study termination by Sponsor|7|||
161057640|NCT02205476|581599945|FG001|Overall Study|Study termination by Sponsor|3|||
161057641|NCT02588027|581599963|FG000|Overall Study|Withdrawal by Subject|1|||
161057642|NCT02588027|581599964|FG001|Overall Study|Withdrawal by Subject|3|||
161057643|NCT02588027|581599963|FG000|Overall Study|Protocol Violation|4|||
161057644|NCT02588027|581599964|FG001|Overall Study|Protocol Violation|1|||
161057645|NCT00853021|581599968|FG000|Overall Study|Adverse Event|2|||
161057646|NCT00853021|581599968|FG000|Overall Study|Withdrawal by Subject|2|||
161057647|NCT00853021|581599968|FG000|Overall Study|Death|1|||
161057648|NCT02864147|581599969|FG000|Overall Study|Withdrawal by Subject|3|||
161057649|NCT02864147|581599970|FG001|Overall Study|Withdrawal by Subject|2|||
161057650|NCT02864147|581599971|FG002|Overall Study|Withdrawal by Subject|1|||
161057651|NCT02864147|581599969|FG000|Overall Study|Lost to Follow-up|0|||
161057652|NCT02864147|581599970|FG001|Overall Study|Lost to Follow-up|4|||
161057653|NCT02864147|581599971|FG002|Overall Study|Lost to Follow-up|0|||
161057654|NCT02864147|581599969|FG000|Overall Study|Adverse Event|0|||
161057655|NCT02864147|581599970|FG001|Overall Study|Adverse Event|1|||
161057656|NCT02864147|581599971|FG002|Overall Study|Adverse Event|0|||
161057657|NCT02864147|581599969|FG000|Overall Study|Pregnancy|4|||
161057658|NCT02864147|581599970|FG001|Overall Study|Pregnancy|0|||
161057659|NCT02864147|581599971|FG002|Overall Study|Pregnancy|0|||
161057660|NCT02864147|581599969|FG000|Overall Study|Physician Decision|0|||
161057661|NCT02864147|581599970|FG001|Overall Study|Physician Decision|0|||
161057662|NCT02864147|581599971|FG002|Overall Study|Physician Decision|1|||
161057663|NCT02864147|581599969|FG000|Overall Study|Opted for excisional procedures|0|||
161057664|NCT02864147|581599970|FG001|Overall Study|Opted for excisional procedures|0|||
161281436|NCT02565511|582408716|FG002|Overall Study|Withdrawal by Subject|12|||
161057665|NCT02864147|581599971|FG002|Overall Study|Opted for excisional procedures|3|||
161057666|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
161057667|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
161057668|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
161057669|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
161057670|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
161057671|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
161057672|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
161057673|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
161281437|NCT02565511|582408717|FG003|Overall Study|Withdrawal by Subject|5|||
161057674|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
161057675|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
161057676|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
161281438|NCT02565511|582408714|FG000|Overall Study|Adverse Event|0|||
161057677|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
161057678|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
161057679|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
161057680|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
161057681|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
161057682|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
161057683|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
161057684|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
161057685|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
161057686|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
161057687|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
161057688|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
161057689|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
161057690|NCT02269917|581599972|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
161057691|NCT02269917|581599973|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
161057692|NCT02269917|581599974|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
161057693|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
161057694|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
161057695|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
161057696|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
161057697|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
161057698|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
161057699|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
161057700|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
161057701|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
161057702|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
161057703|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
161057704|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
161057705|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
161057706|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
161057707|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
161057708|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
161057709|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
161057710|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
161057711|NCT02269917|581599972|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161057712|NCT02269917|581599973|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
161057713|NCT02269917|581599974|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
161057714|NCT01770509|581599975|FG000|Overall Study|Injury|0|||
161057715|NCT01770509|581599976|FG001|Overall Study|Injury|1|||
161057716|NCT01770509|581599975|FG000|Overall Study|Lost to Follow-up|1|||
161057717|NCT01770509|581599976|FG001|Overall Study|Lost to Follow-up|2|||
161057718|NCT02865135|581599980|FG000|Overall Study|Death|0|||
161057719|NCT02865135|581599981|FG001|Overall Study|Death|1|||
161057720|NCT02865135|581599982|FG002|Overall Study|Death|0|||
161057721|NCT02865135|581599980|FG000|Overall Study|Progression|6|||
161057722|NCT02865135|581599981|FG001|Overall Study|Progression|2|||
161057723|NCT02865135|581599982|FG002|Overall Study|Progression|2|||
161057724|NCT04394624|581599983|FG000|Overall Study|Adverse Event|6|||
161057725|NCT04394624|581599984|FG001|Overall Study|Adverse Event|0|||
161057726|NCT04394624|581599983|FG000|Overall Study|Progressive disease|24|||
161057727|NCT04394624|581599984|FG001|Overall Study|Progressive disease|0|||
161057728|NCT04394624|581599983|FG000|Overall Study|Not related to COVID-19|1|||
161057729|NCT04394624|581599984|FG001|Overall Study|Not related to COVID-19|0|||
161057730|NCT00676663|581599985|FG000|Overall Study|Death|43|||
161057731|NCT00676663|581599986|FG001|Overall Study|Death|27|||
161057732|NCT00676663|581599985|FG000|Overall Study|Withdrew Consent|1|||
161057733|NCT00676663|581599986|FG001|Overall Study|Withdrew Consent|8|||
161057734|NCT00676663|581599985|FG000|Overall Study|Lost to Follow-up|1|||
161057735|NCT00676663|581599986|FG001|Overall Study|Lost to Follow-up|3|||
161057736|NCT01123642|581599990|FG000|Overall Study|Lost to Follow-up|23|||
161057737|NCT01123642|581599990|FG000|Overall Study|Withdrawal by Subject|9|||
161057738|NCT01123642|581599990|FG000|Overall Study|ineligible at baseline assessment|36|||
161057739|NCT04853238|581599991|FG000|Overall Study|Death|4|||
161057740|NCT04853238|581599992|FG001|Overall Study|Death|0|||
161057741|NCT04853238|581599993|FG002|Overall Study|Death|2|||
161057742|NCT04853238|581599991|FG000|Overall Study|Lost to Follow-up|16|||
161057743|NCT04853238|581599992|FG001|Overall Study|Lost to Follow-up|2|||
161057744|NCT04853238|581599993|FG002|Overall Study|Lost to Follow-up|37|||
161057745|NCT04853238|581599991|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
161057746|NCT04853238|581599992|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
161057747|NCT04853238|581599993|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
161281439|NCT02565511|582408715|FG001|Overall Study|Adverse Event|0|||
161152763|NCT02163993|581940895|FG000|Treatment Period|Lost to Follow-up|2|||
161152764|NCT02163993|581940896|FG001|Treatment Period|Lost to Follow-up|3|||
161152765|NCT02163993|581940897|FG002|Treatment Period|Lost to Follow-up|1|||
161152766|NCT02163993|581940898|FG003|Treatment Period|Lost to Follow-up|3|||
161152767|NCT02163993|581940899|FG004|Treatment Period|Lost to Follow-up|1|||
161152768|NCT02163993|581940895|FG000|Treatment Period|Physician Decision|1|||
161152769|NCT02163993|581940896|FG001|Treatment Period|Physician Decision|0|||
161152770|NCT02163993|581940897|FG002|Treatment Period|Physician Decision|0|||
161152771|NCT02163993|581940898|FG003|Treatment Period|Physician Decision|0|||
161152772|NCT02163993|581940899|FG004|Treatment Period|Physician Decision|0|||
161152773|NCT02163993|581940895|FG000|Treatment Period|Protocol Violation|2|||
161152774|NCT02163993|581940896|FG001|Treatment Period|Protocol Violation|1|||
161152775|NCT02163993|581940897|FG002|Treatment Period|Protocol Violation|0|||
161152776|NCT02163993|581940898|FG003|Treatment Period|Protocol Violation|1|||
161152777|NCT02163993|581940899|FG004|Treatment Period|Protocol Violation|2|||
161152778|NCT02163993|581940895|FG000|Treatment Period|Withdrawal by Subject|6|||
161152779|NCT02163993|581940896|FG001|Treatment Period|Withdrawal by Subject|4|||
161152780|NCT02163993|581940897|FG002|Treatment Period|Withdrawal by Subject|1|||
161152781|NCT02163993|581940898|FG003|Treatment Period|Withdrawal by Subject|4|||
161152782|NCT02163993|581940899|FG004|Treatment Period|Withdrawal by Subject|1|||
161152783|NCT02163993|581940895|FG000|Treatment Period|Not treated|1|||
161152784|NCT02163993|581940896|FG001|Treatment Period|Not treated|0|||
161152785|NCT02163993|581940897|FG002|Treatment Period|Not treated|0|||
161152786|NCT02163993|581940898|FG003|Treatment Period|Not treated|1|||
161152787|NCT02163993|581940899|FG004|Treatment Period|Not treated|2|||
161152788|NCT02163993|581940895|FG000|Post-treatment Period|Adverse Event|0|||
161152789|NCT02163993|581940896|FG001|Post-treatment Period|Adverse Event|0|||
161152790|NCT02163993|581940897|FG002|Post-treatment Period|Adverse Event|1|||
161152791|NCT02163993|581940898|FG003|Post-treatment Period|Adverse Event|0|||
161152792|NCT02163993|581940899|FG004|Post-treatment Period|Adverse Event|0|||
161152793|NCT02163993|581940895|FG000|Post-treatment Period|Lost to Follow-up|2|||
161057748|NCT04853238|581599991|FG000|Overall Study|Withdrawal by Subject|6|||
161057749|NCT04853238|581599992|FG001|Overall Study|Withdrawal by Subject|0|||
161057750|NCT04853238|581599993|FG002|Overall Study|Withdrawal by Subject|21|||
161057751|NCT04853238|581599991|FG000|Overall Study|Physician Decision|0|||
161057752|NCT04853238|581599992|FG001|Overall Study|Physician Decision|0|||
161057753|NCT04853238|581599993|FG002|Overall Study|Physician Decision|2|||
161057754|NCT04853238|581599991|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
161057755|NCT04853238|581599992|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
161057756|NCT04853238|581599993|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
161057757|NCT01772147|581601751|FG000|Overall Study|Adverse Event|13|||
161057758|NCT01772147|581601752|FG001|Overall Study|Adverse Event|10|||
161057759|NCT01772147|581601753|FG002|Overall Study|Adverse Event|6|||
161057760|NCT01772147|581601751|FG000|Overall Study|Withdrew Consent|7|||
161057761|NCT01772147|581601752|FG001|Overall Study|Withdrew Consent|8|||
161057762|NCT01772147|581601753|FG002|Overall Study|Withdrew Consent|4|||
161057763|NCT01772147|581601751|FG000|Overall Study|Lost to Follow-up|1|||
161057764|NCT01772147|581601752|FG001|Overall Study|Lost to Follow-up|0|||
161057765|NCT01772147|581601753|FG002|Overall Study|Lost to Follow-up|1|||
161057766|NCT01772147|581601751|FG000|Overall Study|Protocol Deviation|2|||
161057767|NCT01772147|581601752|FG001|Overall Study|Protocol Deviation|1|||
161057768|NCT01772147|581601753|FG002|Overall Study|Protocol Deviation|1|||
161057769|NCT01772147|581601751|FG000|Overall Study|Lack of Efficacy|8|||
161057770|NCT01772147|581601752|FG001|Overall Study|Lack of Efficacy|6|||
161152794|NCT02163993|581940896|FG001|Post-treatment Period|Lost to Follow-up|2|||
161281440|NCT02565511|582408716|FG002|Overall Study|Adverse Event|1|||
161057771|NCT01772147|581601753|FG002|Overall Study|Lack of Efficacy|6|||
161057772|NCT00796614|581601761|FG000|Overall Study|Adverse Event|1|||
161057773|NCT00796614|581601762|FG001|Overall Study|Adverse Event|2|||
161057774|NCT00796614|581601763|FG002|Overall Study|Adverse Event|0|||
161057775|NCT00796614|581601764|FG003|Overall Study|Adverse Event|0|||
161057776|NCT00796614|581601761|FG000|Overall Study|Protocol Violation|0|||
161057777|NCT00796614|581601762|FG001|Overall Study|Protocol Violation|0|||
161057778|NCT00796614|581601763|FG002|Overall Study|Protocol Violation|2|||
161057779|NCT00796614|581601764|FG003|Overall Study|Protocol Violation|0|||
161057780|NCT00796614|581601761|FG000|Overall Study|Lost to Follow-up|2|||
161057781|NCT00796614|581601762|FG001|Overall Study|Lost to Follow-up|2|||
161057782|NCT00796614|581601763|FG002|Overall Study|Lost to Follow-up|1|||
161057783|NCT00796614|581601764|FG003|Overall Study|Lost to Follow-up|0|||
161057784|NCT00796614|581601761|FG000|Overall Study|Withdrawal by Subject|1|||
161057785|NCT00796614|581601762|FG001|Overall Study|Withdrawal by Subject|0|||
161057786|NCT00796614|581601763|FG002|Overall Study|Withdrawal by Subject|0|||
161057787|NCT00796614|581601764|FG003|Overall Study|Withdrawal by Subject|1|||
161057788|NCT00796614|581601761|FG000|Overall Study|Other than stated|1|||
161057789|NCT00796614|581601762|FG001|Overall Study|Other than stated|0|||
161057790|NCT00796614|581601763|FG002|Overall Study|Other than stated|0|||
161057791|NCT00796614|581601764|FG003|Overall Study|Other than stated|0|||
161057792|NCT00740597|581601765|FG000|Overall Study|insurance would not cover treatment|1|||
161057793|NCT00957996|581601772|FG000|Overall Study|Death|4|||
161057794|NCT00957996|581601773|FG001|Overall Study|Death|10|||
161057795|NCT00957996|581601772|FG000|Overall Study|Lost to Follow-up|4|||
161057796|NCT00957996|581601773|FG001|Overall Study|Lost to Follow-up|7|||
161281441|NCT02565511|582408717|FG003|Overall Study|Adverse Event|1|||
161281442|NCT02565511|582408714|FG000|Overall Study|Lost to Follow-up|4|||
161281443|NCT02565511|582408715|FG001|Overall Study|Lost to Follow-up|1|||
161281444|NCT02565511|582408716|FG002|Overall Study|Lost to Follow-up|0|||
161281445|NCT02565511|582408717|FG003|Overall Study|Lost to Follow-up|1|||
161281446|NCT02565511|582408714|FG000|Overall Study|Physician Decision|0|||
161281447|NCT02565511|582408715|FG001|Overall Study|Physician Decision|0|||
161281448|NCT02565511|582408716|FG002|Overall Study|Physician Decision|0|||
161281449|NCT02565511|582408717|FG003|Overall Study|Physician Decision|1|||
161281450|NCT02565511|582408714|FG000|Overall Study|Protocol deviation|0|||
161281451|NCT02565511|582408715|FG001|Overall Study|Protocol deviation|0|||
161281452|NCT02565511|582408716|FG002|Overall Study|Protocol deviation|3|||
161281453|NCT02565511|582408717|FG003|Overall Study|Protocol deviation|0|||
161281454|NCT01941498|582408718|FG000|Overall Study|Relocated out of state|1|||
161281455|NCT02969044|582408719|FG000|Overall Study|Withdrawal by Subject|2|||
161281456|NCT02969044|582408720|FG001|Overall Study|Withdrawal by Subject|6|||
161281457|NCT02969044|582408719|FG000|Overall Study|Adverse Event|3|||
161281458|NCT02969044|582408720|FG001|Overall Study|Adverse Event|0|||
161281459|NCT01330303|582408722|FG000|Period 1|Adverse Event|1|||
161281460|NCT01330303|582408723|FG001|Period 1|Adverse Event|0|||
161281461|NCT01330303|582408722|FG000|Period 1|Protocol Violation|0|||
161281462|NCT01330303|582408723|FG001|Period 1|Protocol Violation|1|||
161281463|NCT01330303|582408722|FG000|Period 1|Withdrawal by Subject|0|||
161281464|NCT01330303|582408723|FG001|Period 1|Withdrawal by Subject|1|||
161281465|NCT00796757|582408724|FG000|Overall Study|Withdrawal by Subject|14|||
161281466|NCT00796757|582408724|FG000|Overall Study|Death|61|||
161281467|NCT00796757|582408724|FG000|Overall Study|Protocol Violation|1|||
161281468|NCT00796757|582408724|FG000|Overall Study|Participant noncompliance|1|||
161281469|NCT00796757|582408724|FG000|Overall Study|Investigator's decision|2|||
161281470|NCT00796757|582408724|FG000|Overall Study|Other|7|||
161281471|NCT01107197|582408725|FG000|Overall Study|Death|12|||
161281472|NCT01107197|582408726|FG001|Overall Study|Death|10|||
161281473|NCT01107197|582408725|FG000|Overall Study|Lost to Follow-up|5|||
161281474|NCT01107197|582408726|FG001|Overall Study|Lost to Follow-up|8|||
161057797|NCT00957996|581601772|FG000|Overall Study|Withdrawal by Subject|9|||
161057798|NCT00957996|581601773|FG001|Overall Study|Withdrawal by Subject|2|||
161057799|NCT00957996|581601772|FG000|Overall Study|Adverse Event|2|||
161057800|NCT00957996|581601773|FG001|Overall Study|Adverse Event|1|||
161057801|NCT00957996|581601772|FG000|Overall Study|Physician Decision|1|||
161057802|NCT00957996|581601773|FG001|Overall Study|Physician Decision|1|||
161057803|NCT00957996|581601772|FG000|Overall Study|Influenza-related complication|0|||
161057804|NCT00957996|581601773|FG001|Overall Study|Influenza-related complication|1|||
161057805|NCT00957996|581601772|FG000|Overall Study|Missing|1|||
161057806|NCT00957996|581601773|FG001|Overall Study|Missing|0|||
161057807|NCT00957996|581601772|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
161057808|NCT00957996|581601773|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
161057809|NCT00381797|581601781|FG000|Overall Study|Withdrawal by Subject|1|||
161057810|NCT00381797|581601782|FG001|Overall Study|Withdrawal by Subject|1|||
161057811|NCT00381797|581601783|FG002|Overall Study|Withdrawal by Subject|0|||
161057812|NCT00381797|581601784|FG003|Overall Study|Withdrawal by Subject|0|||
161057813|NCT00381797|581601785|FG004|Overall Study|Withdrawal by Subject|2|||
161057814|NCT00381797|581601781|FG000|Overall Study|Ineligible|0|||
161057815|NCT00381797|581601782|FG001|Overall Study|Ineligible|0|||
161057816|NCT00381797|581601783|FG002|Overall Study|Ineligible|0|||
161057817|NCT00381797|581601784|FG003|Overall Study|Ineligible|1|||
161057818|NCT00381797|581601785|FG004|Overall Study|Ineligible|0|||
161057819|NCT00684203|581601786|FG000|Overall Study|Adverse Event|6|||
161057820|NCT00684203|581601787|FG001|Overall Study|Adverse Event|4|||
161057821|NCT00684203|581601788|FG002|Overall Study|Adverse Event|8|||
161057822|NCT00684203|581601789|FG003|Overall Study|Adverse Event|0|||
161057823|NCT00684203|581601790|FG004|Overall Study|Adverse Event|0|||
161057824|NCT00684203|581601791|FG005|Overall Study|Adverse Event|0|||
161057825|NCT00684203|581601786|FG000|Overall Study|Protocol-defined clinical event|3|||
161057826|NCT00684203|581601787|FG001|Overall Study|Protocol-defined clinical event|1|||
161057827|NCT00684203|581601788|FG002|Overall Study|Protocol-defined clinical event|0|||
161057828|NCT00684203|581601789|FG003|Overall Study|Protocol-defined clinical event|0|||
161057829|NCT00684203|581601790|FG004|Overall Study|Protocol-defined clinical event|0|||
161057830|NCT00684203|581601791|FG005|Overall Study|Protocol-defined clinical event|0|||
161057831|NCT00684203|581601786|FG000|Overall Study|Withdrawal by Subject|0|||
161057832|NCT00684203|581601787|FG001|Overall Study|Withdrawal by Subject|2|||
161057833|NCT00684203|581601788|FG002|Overall Study|Withdrawal by Subject|1|||
161057834|NCT00684203|581601789|FG003|Overall Study|Withdrawal by Subject|0|||
161057835|NCT00684203|581601790|FG004|Overall Study|Withdrawal by Subject|0|||
161057836|NCT00684203|581601791|FG005|Overall Study|Withdrawal by Subject|0|||
161281475|NCT01107197|582408725|FG000|Overall Study|Withdrawal by Subject|3|||
161057837|NCT00684203|581601786|FG000|Overall Study|Did not meet protocol eligibility|0|||
161057838|NCT00684203|581601787|FG001|Overall Study|Did not meet protocol eligibility|1|||
161057839|NCT00684203|581601788|FG002|Overall Study|Did not meet protocol eligibility|0|||
161057840|NCT00684203|581601789|FG003|Overall Study|Did not meet protocol eligibility|0|||
161057841|NCT00684203|581601790|FG004|Overall Study|Did not meet protocol eligibility|0|||
161057842|NCT00684203|581601791|FG005|Overall Study|Did not meet protocol eligibility|0|||
161057843|NCT01902381|581601794|FG000|Overall Study|Withdrawal by Subject|1|||
161057844|NCT02762500|581601797|FG000|Overall Study|Lack of Efficacy|1|||
161057845|NCT02762500|581601798|FG001|Overall Study|Lack of Efficacy|0|||
161057846|NCT02762500|581601797|FG000|Overall Study|Withdrawal by Subject|1|||
161057847|NCT02762500|581601798|FG001|Overall Study|Withdrawal by Subject|1|||
161057848|NCT02762500|581601797|FG000|Overall Study|Adverse Event|0|||
161057849|NCT02762500|581601798|FG001|Overall Study|Adverse Event|2|||
161057850|NCT00730847|581601799|FG000|Overall Study|Adverse Event|1|||
161057851|NCT00730847|581601799|FG000|Overall Study|Protocol Violation|2|||
161057852|NCT00730847|581601799|FG000|Overall Study|Withdrawal by Subject|16|||
161057853|NCT00730847|581601799|FG000|Overall Study|Lost to Follow-up|67|||
161057854|NCT00730847|581601799|FG000|Overall Study|Unknown completion status|21|||
161057855|NCT00730847|581601799|FG000|Overall Study|Other|24|||
161057856|NCT00280683|581601800|FG000|Overall Study|Withdrawal by Subject|1|||
161057857|NCT00280683|581601801|FG001|Overall Study|Withdrawal by Subject|2|||
161057858|NCT00280683|581601800|FG000|Overall Study|Adverse Event|1|||
161057859|NCT00280683|581601801|FG001|Overall Study|Adverse Event|1|||
161057860|NCT01243411|581601802|FG000|Overall Study|Withdrawal by Subject|18|||
161057861|NCT01243411|581601802|FG000|Overall Study|Lost to Follow-up|10|||
161057862|NCT01243411|581601802|FG000|Overall Study|Adverse Event|5|||
161057863|NCT01243411|581601802|FG000|Overall Study|Other|8|||
161057864|NCT00488319|581601810|FG000|Overall Study|Adverse Event|1|||
161057865|NCT00488319|581601811|FG001|Overall Study|Adverse Event|2|||
161057866|NCT00488319|581601812|FG002|Overall Study|Adverse Event|23|||
161057867|NCT00488319|581601810|FG000|Overall Study|Lack of Efficacy|6|||
161057868|NCT00488319|581601811|FG001|Overall Study|Lack of Efficacy|12|||
161057869|NCT00488319|581601812|FG002|Overall Study|Lack of Efficacy|27|||
161057870|NCT00488319|581601810|FG000|Overall Study|Lost to Follow-up|3|||
161057871|NCT00488319|581601811|FG001|Overall Study|Lost to Follow-up|5|||
161057872|NCT00488319|581601812|FG002|Overall Study|Lost to Follow-up|16|||
161057873|NCT00488319|581601810|FG000|Overall Study|Withdrawal by Subject|5|||
161057874|NCT00488319|581601811|FG001|Overall Study|Withdrawal by Subject|20|||
161057875|NCT00488319|581601812|FG002|Overall Study|Withdrawal by Subject|44|||
161057876|NCT00488319|581601810|FG000|Overall Study|Other reasons for withdrawal|0|||
161057877|NCT00488319|581601811|FG001|Overall Study|Other reasons for withdrawal|4|||
161057878|NCT00488319|581601812|FG002|Overall Study|Other reasons for withdrawal|12|||
161057879|NCT03193216|581601813|FG000|Overall Study|Lost to Follow-up|1|||
161057880|NCT03193216|581601814|FG001|Overall Study|Lost to Follow-up|0|||
161057881|NCT03193216|581601813|FG000|Overall Study|Withdrawal by Subject|5|||
161057882|NCT03193216|581601814|FG001|Overall Study|Withdrawal by Subject|0|||
161057883|NCT03193216|581601813|FG000|Overall Study|Physician Decision|4|||
161057884|NCT03193216|581601814|FG001|Overall Study|Physician Decision|0|||
161057885|NCT02490878|581601815|FG000|Overall Study|deemed ineligible|0|||
161057886|NCT02490878|581601816|FG001|Overall Study|deemed ineligible|1|||
161057887|NCT02490878|581601815|FG000|Overall Study|progression prior to treatment|0|||
161057888|NCT02490878|581601816|FG001|Overall Study|progression prior to treatment|1|||
161057889|NCT02490878|581601815|FG000|Overall Study|only submitted baseline QOL|0|||
161057890|NCT02490878|581601816|FG001|Overall Study|only submitted baseline QOL|1|||
161057891|NCT00317603|581601819|FG000|Overall Study|Progressive Disease|3|||
161057892|NCT00523549|581601820|FG000|Overall Study|Adverse Event|6|||
161057893|NCT00523549|581601821|FG001|Overall Study|Adverse Event|3|||
161057894|NCT00523549|581601820|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161281476|NCT01107197|582408726|FG001|Overall Study|Withdrawal by Subject|5|||
161281477|NCT03516513|582408728|FG000|Overall Study|Withdrawal by Subject|2|||
161281478|NCT03516513|582408729|FG001|Overall Study|Withdrawal by Subject|2|||
161281479|NCT03516513|582408730|FG002|Overall Study|Withdrawal by Subject|0|||
161281480|NCT03516513|582408731|FG003|Overall Study|Withdrawal by Subject|0|||
161057895|NCT00523549|581601821|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161057896|NCT00523549|581601820|FG000|Overall Study|Protocol Deviation|3|||
161057897|NCT00523549|581601821|FG001|Overall Study|Protocol Deviation|1|||
161281481|NCT02593110|582408732|FG000|Overall Study|Withdrawal by Subject|0|||
161057898|NCT00523549|581601820|FG000|Overall Study|Patient withdrew consent|7|||
161057899|NCT00523549|581601821|FG001|Overall Study|Patient withdrew consent|6|||
161057900|NCT00523549|581601820|FG000|Overall Study|Lost to Follow-up|3|||
161057901|NCT00523549|581601821|FG001|Overall Study|Lost to Follow-up|5|||
161057902|NCT00677092|581601830|FG000|Overall Study|Adverse Event|1|||
161057903|NCT00677092|581601830|FG000|Overall Study|Lost to Follow-up|1|||
161057904|NCT00677092|581601830|FG000|Overall Study|Withdrawal by Subject|3|||
161057905|NCT00677092|581601830|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
161057906|NCT02381652|581601833|FG000|Overall Study|Withdrawal by Subject|0|||
161057907|NCT02381652|581601834|FG001|Overall Study|Withdrawal by Subject|0|||
161057908|NCT02381652|581601835|FG002|Overall Study|Withdrawal by Subject|1|||
161057909|NCT03544229|581601836|FG000|Overall Study|Adverse Event|1|||
161057910|NCT03544229|581601837|FG001|Overall Study|Adverse Event|0|||
161057911|NCT03544229|581601838|FG002|Overall Study|Adverse Event|1|||
161057912|NCT03544229|581601839|FG003|Overall Study|Adverse Event|0|||
161057913|NCT03544229|581601836|FG000|Overall Study|Protocol Deviation|0|||
161057914|NCT03544229|581601837|FG001|Overall Study|Protocol Deviation|0|||
161057915|NCT03544229|581601838|FG002|Overall Study|Protocol Deviation|1|||
161057916|NCT03544229|581601839|FG003|Overall Study|Protocol Deviation|0|||
161057917|NCT03544229|581601836|FG000|Overall Study|Lost to Follow-up|3|||
161057918|NCT03544229|581601837|FG001|Overall Study|Lost to Follow-up|0|||
161057919|NCT03544229|581601838|FG002|Overall Study|Lost to Follow-up|0|||
161057920|NCT03544229|581601839|FG003|Overall Study|Lost to Follow-up|2|||
161057921|NCT03544229|581601836|FG000|Overall Study|Voluntary Withdrawal|2|||
161057922|NCT03544229|581601837|FG001|Overall Study|Voluntary Withdrawal|1|||
161057923|NCT03544229|581601838|FG002|Overall Study|Voluntary Withdrawal|3|||
161057924|NCT03544229|581601839|FG003|Overall Study|Voluntary Withdrawal|0|||
161057925|NCT03544229|581601836|FG000|Overall Study|Lack of Efficacy|0|||
161057926|NCT03544229|581601837|FG001|Overall Study|Lack of Efficacy|1|||
161057927|NCT03544229|581601838|FG002|Overall Study|Lack of Efficacy|0|||
161057928|NCT03544229|581601839|FG003|Overall Study|Lack of Efficacy|0|||
161281482|NCT02593110|582408733|FG001|Overall Study|Withdrawal by Subject|3|||
161281483|NCT02593110|582408734|FG002|Overall Study|Withdrawal by Subject|3|||
161057929|NCT04772313|581601840|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
161057930|NCT04772313|581601840|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
161057931|NCT03187353|581601841|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
161057932|NCT03187353|581601842|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
161057933|NCT03187353|581601841|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
161057934|NCT03187353|581601842|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
161057935|NCT03187353|581601841|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
161057936|NCT03187353|581601842|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
161057937|NCT03187353|581601841|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
161057938|NCT03187353|581601842|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
161057939|NCT03187353|581601841|FG000|Washout (2 Weeks)|Adverse Event|2|||
161057940|NCT03187353|581601842|FG001|Washout (2 Weeks)|Adverse Event|0|||
161057941|NCT03187353|581601841|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
161057942|NCT03187353|581601842|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
161057943|NCT02215954|581601843|FG000|Overall Study|Adverse Event|0|||
161057944|NCT02215954|581601844|FG001|Overall Study|Adverse Event|0|||
161057945|NCT02215954|581601845|FG002|Overall Study|Adverse Event|1|||
161057946|NCT02215954|581601843|FG000|Overall Study|Withdrawal by Subject|0|||
161057947|NCT02215954|581601844|FG001|Overall Study|Withdrawal by Subject|0|||
161057948|NCT02215954|581601845|FG002|Overall Study|Withdrawal by Subject|2|||
161057949|NCT02215954|581601843|FG000|Overall Study|Not exposed|1|||
161057950|NCT02215954|581601844|FG001|Overall Study|Not exposed|1|||
161057951|NCT02215954|581601845|FG002|Overall Study|Not exposed|3|||
161057952|NCT02460562|581601847|FG000|Overall Study|Lost to Follow-up|15|||
161057953|NCT02460562|581601848|FG001|Overall Study|Lost to Follow-up|16|||
161057954|NCT01061775|581601849|FG000|Overall Study|Physician Decision|2|||
161057955|NCT01061775|581601849|FG000|Overall Study|Lost to Follow-up|1|||
161057956|NCT00784277|581601850|FG000|IR Treatment|Adverse Event|4|||
161057957|NCT00784277|581601851|FG001|IR Treatment|Adverse Event|8|||
161057958|NCT00784277|581601852|FG002|IR Treatment|Adverse Event|19|||
161057959|NCT00784277|581601853|FG003|IR Treatment|Adverse Event|35|||
161057960|NCT00784277|581601854|FG004|IR Treatment|Adverse Event|0|||
161057961|NCT00784277|581601855|FG005|IR Treatment|Adverse Event|0|||
161057962|NCT00784277|581601856|FG006|IR Treatment|Adverse Event|0|||
161057963|NCT00784277|581601850|FG000|IR Treatment|Lack of Efficacy|4|||
161057964|NCT00784277|581601851|FG001|IR Treatment|Lack of Efficacy|4|||
161057965|NCT00784277|581601852|FG002|IR Treatment|Lack of Efficacy|1|||
161057966|NCT00784277|581601853|FG003|IR Treatment|Lack of Efficacy|0|||
161057967|NCT00784277|581601854|FG004|IR Treatment|Lack of Efficacy|0|||
161057968|NCT00784277|581601855|FG005|IR Treatment|Lack of Efficacy|0|||
161057969|NCT00784277|581601856|FG006|IR Treatment|Lack of Efficacy|0|||
161057970|NCT00784277|581601850|FG000|IR Treatment|Lost to Follow-up|1|||
161057971|NCT00784277|581601851|FG001|IR Treatment|Lost to Follow-up|0|||
161057972|NCT00784277|581601852|FG002|IR Treatment|Lost to Follow-up|1|||
161057973|NCT00784277|581601853|FG003|IR Treatment|Lost to Follow-up|0|||
161057974|NCT00784277|581601854|FG004|IR Treatment|Lost to Follow-up|0|||
161057975|NCT00784277|581601855|FG005|IR Treatment|Lost to Follow-up|0|||
161057976|NCT00784277|581601856|FG006|IR Treatment|Lost to Follow-up|0|||
161057977|NCT00784277|581601850|FG000|IR Treatment|Withdrawal by Subject|5|||
161057978|NCT00784277|581601851|FG001|IR Treatment|Withdrawal by Subject|1|||
161057979|NCT00784277|581601852|FG002|IR Treatment|Withdrawal by Subject|4|||
161057980|NCT00784277|581601853|FG003|IR Treatment|Withdrawal by Subject|6|||
161281484|NCT02593110|582408735|FG003|Overall Study|Withdrawal by Subject|2|||
161057981|NCT00784277|581601854|FG004|IR Treatment|Withdrawal by Subject|0|||
161057982|NCT00784277|581601855|FG005|IR Treatment|Withdrawal by Subject|0|||
161281485|NCT02593110|582408732|FG000|Overall Study|Death|0|||
161281486|NCT02593110|582408733|FG001|Overall Study|Death|0|||
161281487|NCT02593110|582408734|FG002|Overall Study|Death|1|||
161281488|NCT02593110|582408735|FG003|Overall Study|Death|0|||
161281489|NCT03548337|582408736|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
161281490|NCT03548337|582408737|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
161281491|NCT03548337|582408736|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
161281492|NCT03548337|582408737|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
161281493|NCT03548337|582408736|FG000|Infant Series|Lost to Follow-up|2|||
161281494|NCT03548337|582408737|FG001|Infant Series|Lost to Follow-up|1|||
161281495|NCT03548337|582408736|FG000|Infant Series|Adverse Event|0|||
161281496|NCT03548337|582408737|FG001|Infant Series|Adverse Event|2|||
161281497|NCT03548337|582408736|FG000|Infant Series|Randomized but Not Vaccinated|1|||
161281498|NCT03548337|582408737|FG001|Infant Series|Randomized but Not Vaccinated|0|||
161281499|NCT03548337|582408736|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
161281500|NCT03548337|582408737|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
161281501|NCT01130597|582408738|FG000|Overall Study|Protocol-specified (High K+)|1|||
161281502|NCT01130597|582408738|FG000|Overall Study|Adverse Event|4|||
161281503|NCT01130597|582408738|FG000|Overall Study|Death|1|||
161281504|NCT01130597|582408738|FG000|Overall Study|Protocol Violation|1|||
161281505|NCT05794503|582408740|FG000|Overall Study|Operation Cancelled|2|||
161281506|NCT05794503|582408741|FG001|Overall Study|Operation Cancelled|0|||
161281507|NCT05794503|582408740|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
161281508|NCT05794503|582408741|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
161281509|NCT05794503|582408740|FG000|Overall Study|Protocol Violation|1|||
161281510|NCT05794503|582408741|FG001|Overall Study|Protocol Violation|0|||
161281511|NCT00447993|582408742|FG000|Overall Study|Lost to Follow-up|0|||
161281512|NCT00447993|582408743|FG001|Overall Study|Lost to Follow-up|0|||
161281513|NCT00447993|582408744|FG002|Overall Study|Lost to Follow-up|2|||
161281514|NCT00447993|582408745|FG003|Overall Study|Lost to Follow-up|2|||
161281515|NCT00447993|582408742|FG000|Overall Study|Withdrawal by Subject|0|||
161281516|NCT00447993|582408743|FG001|Overall Study|Withdrawal by Subject|0|||
161281517|NCT00447993|582408744|FG002|Overall Study|Withdrawal by Subject|2|||
161281518|NCT00447993|582408745|FG003|Overall Study|Withdrawal by Subject|2|||
161281519|NCT03052127|582408746|FG000|Overall Study|Withdrawal by Subject|0|||
161281520|NCT03052127|582408747|FG001|Overall Study|Withdrawal by Subject|0|||
161281521|NCT03052127|582408748|FG002|Overall Study|Withdrawal by Subject|0|||
161281522|NCT03052127|582408749|FG003|Overall Study|Withdrawal by Subject|0|||
161281523|NCT03052127|582408750|FG004|Overall Study|Withdrawal by Subject|0|||
161281524|NCT03052127|582408751|FG005|Overall Study|Withdrawal by Subject|0|||
161281525|NCT03052127|582408752|FG006|Overall Study|Withdrawal by Subject|0|||
161281526|NCT03052127|582408753|FG007|Overall Study|Withdrawal by Subject|1|||
161281527|NCT03052127|582408754|FG008|Overall Study|Withdrawal by Subject|1|||
161057983|NCT00784277|581601856|FG006|IR Treatment|Withdrawal by Subject|0|||
161057984|NCT00784277|581601850|FG000|IR Treatment|Resolution Of Pain|0|||
161057985|NCT00784277|581601851|FG001|IR Treatment|Resolution Of Pain|1|||
161057986|NCT00784277|581601852|FG002|IR Treatment|Resolution Of Pain|0|||
161057987|NCT00784277|581601853|FG003|IR Treatment|Resolution Of Pain|0|||
161057988|NCT00784277|581601854|FG004|IR Treatment|Resolution Of Pain|0|||
161281528|NCT03052127|582408755|FG009|Overall Study|Withdrawal by Subject|1|||
161281529|NCT03052127|582408756|FG010|Overall Study|Withdrawal by Subject|0|||
161281530|NCT03052127|582408757|FG011|Overall Study|Withdrawal by Subject|0|||
161281531|NCT03052127|582408746|FG000|Overall Study|Discontinuation by Sponsor|0|||
161281532|NCT03052127|582408747|FG001|Overall Study|Discontinuation by Sponsor|0|||
161281533|NCT03052127|582408748|FG002|Overall Study|Discontinuation by Sponsor|0|||
161281534|NCT03052127|582408749|FG003|Overall Study|Discontinuation by Sponsor|0|||
161281535|NCT03052127|582408750|FG004|Overall Study|Discontinuation by Sponsor|0|||
161281536|NCT03052127|582408751|FG005|Overall Study|Discontinuation by Sponsor|0|||
161281537|NCT03052127|582408752|FG006|Overall Study|Discontinuation by Sponsor|0|||
161281538|NCT03052127|582408753|FG007|Overall Study|Discontinuation by Sponsor|0|||
161281539|NCT03052127|582408754|FG008|Overall Study|Discontinuation by Sponsor|4|||
161281540|NCT03052127|582408755|FG009|Overall Study|Discontinuation by Sponsor|2|||
161281541|NCT03052127|582408756|FG010|Overall Study|Discontinuation by Sponsor|5|||
161281542|NCT03052127|582408757|FG011|Overall Study|Discontinuation by Sponsor|13|||
161281543|NCT03052127|582408746|FG000|Overall Study|Inability to comply with trial requirements|0|||
161281544|NCT03052127|582408747|FG001|Overall Study|Inability to comply with trial requirements|0|||
161281545|NCT03052127|582408748|FG002|Overall Study|Inability to comply with trial requirements|1|||
161281546|NCT03052127|582408749|FG003|Overall Study|Inability to comply with trial requirements|0|||
161281547|NCT03052127|582408750|FG004|Overall Study|Inability to comply with trial requirements|0|||
161281548|NCT03052127|582408751|FG005|Overall Study|Inability to comply with trial requirements|0|||
161281549|NCT03052127|582408752|FG006|Overall Study|Inability to comply with trial requirements|0|||
161281550|NCT03052127|582408753|FG007|Overall Study|Inability to comply with trial requirements|0|||
161281551|NCT03052127|582408754|FG008|Overall Study|Inability to comply with trial requirements|0|||
161281552|NCT03052127|582408755|FG009|Overall Study|Inability to comply with trial requirements|0|||
161281553|NCT03052127|582408756|FG010|Overall Study|Inability to comply with trial requirements|0|||
161057989|NCT00784277|581601855|FG005|IR Treatment|Resolution Of Pain|0|||
161057990|NCT00784277|581601856|FG006|IR Treatment|Resolution Of Pain|0|||
161057991|NCT00784277|581601850|FG000|IR Treatment|Other|2|||
161057992|NCT00784277|581601851|FG001|IR Treatment|Other|3|||
161057993|NCT00784277|581601852|FG002|IR Treatment|Other|3|||
161057994|NCT00784277|581601853|FG003|IR Treatment|Other|2|||
161057995|NCT00784277|581601854|FG004|IR Treatment|Other|0|||
161057996|NCT00784277|581601855|FG005|IR Treatment|Other|0|||
161057997|NCT00784277|581601856|FG006|IR Treatment|Other|0|||
161057998|NCT00784277|581601850|FG000|ER Treatment|Adverse Event|0|||
161057999|NCT00784277|581601851|FG001|ER Treatment|Adverse Event|0|||
161058000|NCT00784277|581601852|FG002|ER Treatment|Adverse Event|0|||
161058001|NCT00784277|581601853|FG003|ER Treatment|Adverse Event|0|||
161058002|NCT00784277|581601854|FG004|ER Treatment|Adverse Event|1|||
161058003|NCT00784277|581601855|FG005|ER Treatment|Adverse Event|7|||
161058004|NCT00784277|581601856|FG006|ER Treatment|Adverse Event|7|||
161058005|NCT00784277|581601850|FG000|ER Treatment|Lack of Efficacy|0|||
161058006|NCT00784277|581601851|FG001|ER Treatment|Lack of Efficacy|0|||
161058007|NCT00784277|581601852|FG002|ER Treatment|Lack of Efficacy|0|||
161058008|NCT00784277|581601853|FG003|ER Treatment|Lack of Efficacy|0|||
161058009|NCT00784277|581601854|FG004|ER Treatment|Lack of Efficacy|3|||
161058010|NCT00784277|581601855|FG005|ER Treatment|Lack of Efficacy|4|||
161058011|NCT00784277|581601856|FG006|ER Treatment|Lack of Efficacy|0|||
161058012|NCT00784277|581601850|FG000|ER Treatment|Lost to Follow-up|0|||
161058013|NCT00784277|581601851|FG001|ER Treatment|Lost to Follow-up|0|||
161058014|NCT00784277|581601852|FG002|ER Treatment|Lost to Follow-up|0|||
161058015|NCT00784277|581601853|FG003|ER Treatment|Lost to Follow-up|0|||
161058016|NCT00784277|581601854|FG004|ER Treatment|Lost to Follow-up|0|||
161058017|NCT00784277|581601855|FG005|ER Treatment|Lost to Follow-up|2|||
161058018|NCT00784277|581601856|FG006|ER Treatment|Lost to Follow-up|0|||
161058019|NCT00784277|581601850|FG000|ER Treatment|Withdrawal by Subject|0|||
161058020|NCT00784277|581601851|FG001|ER Treatment|Withdrawal by Subject|0|||
161058021|NCT00784277|581601852|FG002|ER Treatment|Withdrawal by Subject|0|||
161058022|NCT00784277|581601853|FG003|ER Treatment|Withdrawal by Subject|0|||
161058023|NCT00784277|581601854|FG004|ER Treatment|Withdrawal by Subject|2|||
161058024|NCT00784277|581601855|FG005|ER Treatment|Withdrawal by Subject|5|||
161058025|NCT00784277|581601856|FG006|ER Treatment|Withdrawal by Subject|3|||
161058026|NCT00784277|581601850|FG000|ER Treatment|Study Medication Non-Compliant|0|||
161058027|NCT00784277|581601851|FG001|ER Treatment|Study Medication Non-Compliant|0|||
161058028|NCT00784277|581601852|FG002|ER Treatment|Study Medication Non-Compliant|0|||
161058029|NCT00784277|581601853|FG003|ER Treatment|Study Medication Non-Compliant|0|||
161058030|NCT00784277|581601854|FG004|ER Treatment|Study Medication Non-Compliant|2|||
161058031|NCT00784277|581601855|FG005|ER Treatment|Study Medication Non-Compliant|3|||
161058032|NCT00784277|581601856|FG006|ER Treatment|Study Medication Non-Compliant|3|||
161058033|NCT00784277|581601850|FG000|ER Treatment|Other|0|||
161058034|NCT00784277|581601851|FG001|ER Treatment|Other|0|||
161058035|NCT00784277|581601852|FG002|ER Treatment|Other|0|||
161058036|NCT00784277|581601853|FG003|ER Treatment|Other|0|||
161058037|NCT00784277|581601854|FG004|ER Treatment|Other|1|||
161058038|NCT00784277|581601855|FG005|ER Treatment|Other|3|||
161058039|NCT00784277|581601856|FG006|ER Treatment|Other|2|||
161058040|NCT01093222|581601857|FG000|Overall Study|Ineligible|6|||
161058041|NCT01093222|581601857|FG000|Overall Study|Adverse Event|7|||
161058042|NCT01093222|581601857|FG000|Overall Study|Progression/relapse|24|||
161058043|NCT01093222|581601857|FG000|Overall Study|Death|2|||
161058044|NCT01093222|581601857|FG000|Overall Study|Not protocol specified|1|||
161058045|NCT04194541|581601858|FG000|Day 1 Through 13|Lost to Follow-up|3|||
161058046|NCT04194541|581601858|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
161058047|NCT04194541|581601858|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
161058048|NCT02567227|581601859|FG000|9 Weeks|Adverse Event|5|||
161058049|NCT02567227|581601860|FG001|9 Weeks|Adverse Event|5|||
161058050|NCT02567227|581601859|FG000|9 Weeks|Withdrawal by Subject|18|||
161058051|NCT02567227|581601860|FG001|9 Weeks|Withdrawal by Subject|8|||
161058052|NCT02567227|581601859|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
161058053|NCT02567227|581601860|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
161058054|NCT02567227|581601859|FG000|6 Month|Death|2|||
161058055|NCT02567227|581601860|FG001|6 Month|Death|0|||
161058056|NCT02567227|581601859|FG000|6 Month|Lost to Follow-up|43|||
161058057|NCT02567227|581601860|FG001|6 Month|Lost to Follow-up|40|||
161058058|NCT02567227|581601859|FG000|12 Months|Lost to Follow-up|31|||
161058059|NCT02567227|581601860|FG001|12 Months|Lost to Follow-up|32|||
161058060|NCT02567227|581601859|FG000|12 Months|Death|0|||
161058061|NCT02567227|581601860|FG001|12 Months|Death|2|||
161058062|NCT00187135|581601863|FG000|Visit One|Withdrawal by Subject|1|||
161058063|NCT00187135|581601864|FG001|Visit One|Withdrawal by Subject|0|||
161058064|NCT00187135|581601865|FG002|Visit One|Withdrawal by Subject|0|||
161058065|NCT00187135|581601866|FG003|Visit One|Withdrawal by Subject|0|||
161058066|NCT00187135|581601867|FG004|Visit One|Withdrawal by Subject|0|||
161058067|NCT00187135|581601868|FG005|Visit One|Withdrawal by Subject|1|||
161058068|NCT00187135|581601863|FG000|Visit One|Physician Decision|3|||
161058069|NCT00187135|581601864|FG001|Visit One|Physician Decision|1|||
161058070|NCT00187135|581601865|FG002|Visit One|Physician Decision|0|||
161058071|NCT00187135|581601866|FG003|Visit One|Physician Decision|0|||
161058072|NCT00187135|581601867|FG004|Visit One|Physician Decision|0|||
161058073|NCT00187135|581601868|FG005|Visit One|Physician Decision|1|||
161058074|NCT00187135|581601863|FG000|Visit Two|Death|0|||
161058075|NCT00187135|581601864|FG001|Visit Two|Death|0|||
161058076|NCT00187135|581601865|FG002|Visit Two|Death|0|||
161058077|NCT00187135|581601866|FG003|Visit Two|Death|1|||
161058078|NCT00187135|581601867|FG004|Visit Two|Death|0|||
161058079|NCT00187135|581601868|FG005|Visit Two|Death|1|||
161058080|NCT00187135|581601863|FG000|Visit Two|Physician Decision|1|||
161058081|NCT00187135|581601864|FG001|Visit Two|Physician Decision|0|||
161058082|NCT00187135|581601865|FG002|Visit Two|Physician Decision|0|||
161058083|NCT00187135|581601866|FG003|Visit Two|Physician Decision|0|||
161058084|NCT00187135|581601867|FG004|Visit Two|Physician Decision|0|||
161058085|NCT00187135|581601868|FG005|Visit Two|Physician Decision|0|||
161058086|NCT00187135|581601863|FG000|Visit Two|Withdrawal by Subject|1|||
161058087|NCT00187135|581601864|FG001|Visit Two|Withdrawal by Subject|1|||
161058088|NCT00187135|581601865|FG002|Visit Two|Withdrawal by Subject|1|||
161058089|NCT00187135|581601866|FG003|Visit Two|Withdrawal by Subject|0|||
161058090|NCT00187135|581601867|FG004|Visit Two|Withdrawal by Subject|1|||
161058091|NCT00187135|581601868|FG005|Visit Two|Withdrawal by Subject|1|||
161058092|NCT00187135|581601863|FG000|Visit Two|Study Discontinued|3|||
161058093|NCT00187135|581601864|FG001|Visit Two|Study Discontinued|2|||
161058094|NCT00187135|581601865|FG002|Visit Two|Study Discontinued|1|||
161058095|NCT00187135|581601866|FG003|Visit Two|Study Discontinued|7|||
161058096|NCT00187135|581601867|FG004|Visit Two|Study Discontinued|5|||
161058097|NCT00187135|581601868|FG005|Visit Two|Study Discontinued|6|||
161058098|NCT00187135|581601863|FG000|Visit Three|Death|0|||
161058099|NCT00187135|581601864|FG001|Visit Three|Death|0|||
161058100|NCT00187135|581601865|FG002|Visit Three|Death|1|||
161058101|NCT00187135|581601866|FG003|Visit Three|Death|0|||
161058102|NCT00187135|581601867|FG004|Visit Three|Death|1|||
161058103|NCT00187135|581601868|FG005|Visit Three|Death|0|||
161058104|NCT00187135|581601863|FG000|Visit Three|Withdrawal by Subject|0|||
161058105|NCT00187135|581601864|FG001|Visit Three|Withdrawal by Subject|1|||
161058106|NCT00187135|581601865|FG002|Visit Three|Withdrawal by Subject|1|||
161058107|NCT00187135|581601866|FG003|Visit Three|Withdrawal by Subject|2|||
161058108|NCT00187135|581601867|FG004|Visit Three|Withdrawal by Subject|0|||
161058109|NCT00187135|581601868|FG005|Visit Three|Withdrawal by Subject|0|||
161058110|NCT00187135|581601863|FG000|Visit Three|Study Discontinued|7|||
161058111|NCT00187135|581601864|FG001|Visit Three|Study Discontinued|6|||
161058112|NCT00187135|581601865|FG002|Visit Three|Study Discontinued|7|||
161058113|NCT00187135|581601866|FG003|Visit Three|Study Discontinued|7|||
161058114|NCT00187135|581601867|FG004|Visit Three|Study Discontinued|7|||
161058115|NCT00187135|581601868|FG005|Visit Three|Study Discontinued|6|||
161058116|NCT01675050|581601872|FG000|Period One Treatment|Withdrawal by Subject|1|||
161058117|NCT01675050|581601873|FG001|Period One Treatment|Withdrawal by Subject|0|||
161058118|NCT00745121|581601874|FG000|Overall Study|Death|3|||
161058119|NCT00745121|581601875|FG001|Overall Study|Death|0|||
161058120|NCT00745121|581601874|FG000|Overall Study|Adverse Event|1|||
161058121|NCT00745121|581601875|FG001|Overall Study|Adverse Event|0|||
161058122|NCT00745121|581601874|FG000|Overall Study|Lost to Follow-up|1|||
161058123|NCT00745121|581601875|FG001|Overall Study|Lost to Follow-up|0|||
161058124|NCT00745121|581601874|FG000|Overall Study|Withdrawal by Subject|4|||
161058125|NCT00745121|581601875|FG001|Overall Study|Withdrawal by Subject|2|||
161058126|NCT03280108|581601877|FG000|Overall Study|Lost to Follow-up|2|||
161058127|NCT03280108|581601878|FG001|Overall Study|Lost to Follow-up|0|||
161058128|NCT01820637|581601879|FG000|Overall Study|Death|2|||
161281554|NCT03052127|582408757|FG011|Overall Study|Inability to comply with trial requirements|0|||
161281555|NCT03052127|582408746|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161281556|NCT03052127|582408747|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161281557|NCT03052127|582408748|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161281558|NCT03052127|582408749|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161058129|NCT01820637|581601879|FG000|Overall Study|Withdrawal by Subject|1|||
161058130|NCT00264498|581601880|FG000|Randomized Treatment|Death|0|||
161058131|NCT00264498|581601881|FG001|Randomized Treatment|Death|3|||
161058132|NCT00264498|581601880|FG000|Randomized Treatment|Withdrawal by Subject|0|||
161058133|NCT00264498|581601881|FG001|Randomized Treatment|Withdrawal by Subject|1|||
161058134|NCT00264498|581601880|FG000|Randomized Treatment|Objective disease Progression|13|||
161058135|NCT00264498|581601881|FG001|Randomized Treatment|Objective disease Progression|14|||
161058136|NCT00264498|581601880|FG000|Randomized Treatment|Physician Decision|1|||
161058137|NCT00264498|581601881|FG001|Randomized Treatment|Physician Decision|0|||
161058138|NCT00264498|581601880|FG000|Randomized Treatment|Incorrectly randomized|1|||
161058139|NCT00264498|581601881|FG001|Randomized Treatment|Incorrectly randomized|0|||
161058140|NCT00264498|581601880|FG000|Randomized Treatment|Study Closure|1|||
161058141|NCT00264498|581601881|FG001|Randomized Treatment|Study Closure|0|||
161058142|NCT00264498|581601880|FG000|Randomized Treatment|Protocol Violation|1|||
161058143|NCT00264498|581601881|FG001|Randomized Treatment|Protocol Violation|0|||
161058144|NCT00264498|581601880|FG000|Crossover Treatment|Death|1|||
161058145|NCT00264498|581601881|FG001|Crossover Treatment|Death|3|||
161058146|NCT00264498|581601880|FG000|Crossover Treatment|Objective disease progression|4|||
161058147|NCT00264498|581601881|FG001|Crossover Treatment|Objective disease progression|5|||
161058148|NCT00264498|581601880|FG000|Crossover Treatment|Study closure|0|||
161058149|NCT00264498|581601881|FG001|Crossover Treatment|Study closure|1|||
161058150|NCT00264498|581601880|FG000|Crossover Treatment|Withdrawal by Subject|1|||
161058151|NCT00264498|581601881|FG001|Crossover Treatment|Withdrawal by Subject|0|||
161058152|NCT03794609|581601882|FG000|Overall Study|Other|10|||
161058153|NCT03794609|581601882|FG000|Overall Study|Withdrawal by Subject|66|||
161058154|NCT03794609|581601882|FG000|Overall Study|The child is enrolled in an interventional study|70|||
161058155|NCT03794609|581601882|FG000|Overall Study|Inclusion/exclusion criteria|8|||
161058156|NCT03794609|581601882|FG000|Overall Study|At sponsor's request|151|||
161058157|NCT03794609|581601882|FG000|Overall Study|Physician Decision|1|||
161058158|NCT03794609|581601882|FG000|Overall Study|Lost to Follow-up|5|||
161058159|NCT04543942|581601883|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
161058160|NCT04543942|581601884|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
161058161|NCT04543942|581601883|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
161058162|NCT04543942|581601884|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
161058163|NCT00139659|581601887|FG000|Overall Study|Adverse Event|12|||
161058164|NCT00139659|581601888|FG001|Overall Study|Adverse Event|1|||
161058165|NCT00139659|581601887|FG000|Overall Study|Lack of Efficacy|1|||
161058166|NCT00139659|581601888|FG001|Overall Study|Lack of Efficacy|1|||
161058167|NCT00139659|581601887|FG000|Overall Study|Lost to Follow-up|7|||
161058168|NCT00139659|581601888|FG001|Overall Study|Lost to Follow-up|3|||
161058169|NCT00139659|581601887|FG000|Overall Study|Reason not Specified|6|||
161058170|NCT00139659|581601888|FG001|Overall Study|Reason not Specified|3|||
161058171|NCT00139659|581601887|FG000|Overall Study|Withdrawal by Subject|14|||
161058172|NCT00139659|581601888|FG001|Overall Study|Withdrawal by Subject|10|||
161058173|NCT02625922|581601894|FG000|Overall Study|Non-availability of IMP|1|||
161058174|NCT02625922|581601895|FG001|Overall Study|Non-availability of IMP|1|||
161058175|NCT02625922|581601894|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
161058176|NCT02625922|581601895|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
161058177|NCT00640042|581601896|FG000|Enrollment|Did not receive study drug|83|||
161058178|NCT02359552|581601897|FG000|Overall Study|Lost to Follow-up|3|||
161058179|NCT02359552|581601898|FG001|Overall Study|Lost to Follow-up|4|||
161058180|NCT02391116|581601911|FG000|Treatment|Withdrawal by Subject|1|||
161058181|NCT02391116|581601911|FG000|Treatment|Protocol Violation|1|||
161058182|NCT02391116|581601911|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
161058183|NCT02391116|581601911|FG000|Treatment|AE with Clinical PD|3|||
161058184|NCT02391116|581601911|FG000|Safety Follow-up|Adverse Event|1|||
161058185|NCT02391116|581601911|FG000|Safety Follow-up|Withdrawal by Subject|4|||
161058186|NCT02391116|581601911|FG000|Safety Follow-up|Switching to Other Therapy|4|||
161058187|NCT02391116|581601911|FG000|Safety Follow-up|No Follow Up|1|||
161058188|NCT02391116|581601911|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
161058189|NCT02391116|581601911|FG000|Active Follow-up|Withdrawal by Subject|1|||
161058190|NCT02391116|581601911|FG000|Active Follow-up|Switching to Other Therapy|2|||
161058191|NCT02391116|581601911|FG000|Survival Follow-up|Withdrawal by Subject|3|||
161058192|NCT02391116|581601911|FG000|Survival Follow-up|Switching to Other Therapy|1|||
161058193|NCT01747629|581601913|FG000|Overall Study|Adverse Event|1|||
161058194|NCT01747629|581601914|FG001|Overall Study|Adverse Event|2|||
161058195|NCT01747629|581601913|FG000|Overall Study|Withdrawal by Subject|2|||
161058196|NCT01747629|581601914|FG001|Overall Study|Withdrawal by Subject|2|||
161058197|NCT01747629|581601913|FG000|Overall Study|Noncompliance|1|||
161058198|NCT01747629|581601914|FG001|Overall Study|Noncompliance|1|||
161058199|NCT01747629|581601913|FG000|Overall Study|Inclusion criteria not met|1|||
161058200|NCT01747629|581601914|FG001|Overall Study|Inclusion criteria not met|0|||
161058201|NCT01747629|581601913|FG000|Overall Study|Not treated|1|||
161058202|NCT01747629|581601914|FG001|Overall Study|Not treated|0|||
161058203|NCT01747629|581601913|FG000|Overall Study|Other|2|||
161058204|NCT01747629|581601914|FG001|Overall Study|Other|1|||
161058205|NCT00607789|581601915|FG000|Overall Study|Adverse Event|3|||
161058206|NCT00607789|581601916|FG001|Overall Study|Adverse Event|0|||
161058207|NCT00607789|581601915|FG000|Overall Study|Lack of Efficacy|0|||
161058208|NCT00607789|581601916|FG001|Overall Study|Lack of Efficacy|1|||
161058209|NCT00607789|581601915|FG000|Overall Study|Inadequate adherence|3|||
161058210|NCT00607789|581601916|FG001|Overall Study|Inadequate adherence|0|||
161058211|NCT00607789|581601915|FG000|Overall Study|Lost to Follow-up|0|||
161058212|NCT00607789|581601916|FG001|Overall Study|Lost to Follow-up|5|||
161058213|NCT00607789|581601915|FG000|Overall Study|Withdrawal by Subject|1|||
161058214|NCT00607789|581601916|FG001|Overall Study|Withdrawal by Subject|0|||
161058215|NCT01313299|581601917|FG000|Overall Study|Adverse Event|3|||
161058216|NCT01313299|581601918|FG001|Overall Study|Adverse Event|1|||
161058217|NCT01313299|581601919|FG002|Overall Study|Adverse Event|1|||
161058218|NCT01313299|581601917|FG000|Overall Study|Lost to Follow-up|1|||
161058219|NCT01313299|581601918|FG001|Overall Study|Lost to Follow-up|0|||
161058220|NCT01313299|581601919|FG002|Overall Study|Lost to Follow-up|0|||
161058221|NCT01313299|581601917|FG000|Overall Study|Protocol Violation|2|||
161058222|NCT01313299|581601918|FG001|Overall Study|Protocol Violation|0|||
161058223|NCT01313299|581601919|FG002|Overall Study|Protocol Violation|0|||
161058224|NCT01313299|581601917|FG000|Overall Study|Withdrawal by Subject|1|||
161058225|NCT01313299|581601918|FG001|Overall Study|Withdrawal by Subject|0|||
161058226|NCT01313299|581601919|FG002|Overall Study|Withdrawal by Subject|2|||
161058227|NCT01313299|581601917|FG000|Overall Study|Family reason and moved out of state|0|||
161058228|NCT01313299|581601918|FG001|Overall Study|Family reason and moved out of state|2|||
161058229|NCT01313299|581601919|FG002|Overall Study|Family reason and moved out of state|0|||
161058230|NCT01313299|581601917|FG000|Overall Study|Lack of subject compliance|0|||
161058231|NCT01313299|581601918|FG001|Overall Study|Lack of subject compliance|0|||
161058232|NCT01313299|581601919|FG002|Overall Study|Lack of subject compliance|1|||
161058233|NCT02506881|581601920|FG000|First Intervention (Day 1)|Protocol Violation|0|||
161058234|NCT02506881|581601921|FG001|First Intervention (Day 1)|Protocol Violation|0|||
161058235|NCT02506881|581601922|FG002|First Intervention (Day 1)|Protocol Violation|1|||
161058236|NCT02506881|581601923|FG003|First Intervention (Day 1)|Protocol Violation|0|||
161058237|NCT02506881|581601920|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161058238|NCT02506881|581601921|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
161058239|NCT02506881|581601922|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161058240|NCT02506881|581601923|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161058241|NCT02506881|581601920|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
161058242|NCT02506881|581601921|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
161058243|NCT02506881|581601922|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
161058244|NCT02506881|581601923|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
161058245|NCT01919398|581601924|FG000|Overall Study|Progressive Disease|0|||
161058246|NCT01919398|581601925|FG001|Overall Study|Progressive Disease|0|||
161058247|NCT01919398|581601926|FG002|Overall Study|Progressive Disease|4|||
161058248|NCT02391545|581601928|FG000|Overall Study|Death|0|||
161058249|NCT02391545|581601929|FG001|Overall Study|Death|2|||
161058250|NCT02391545|581601928|FG000|Overall Study|Lost to Follow-up|0|||
161058251|NCT02391545|581601929|FG001|Overall Study|Lost to Follow-up|1|||
161058252|NCT02391545|581601928|FG000|Overall Study|Termination of study by sponsor|20|||
161058253|NCT02391545|581601929|FG001|Overall Study|Termination of study by sponsor|20|||
161058254|NCT02391545|581601928|FG000|Overall Study|Withdrawal by Subject|0|||
161058255|NCT02391545|581601929|FG001|Overall Study|Withdrawal by Subject|1|||
161058256|NCT02391545|581601928|FG000|Overall Study|Other Reasons|6|||
161058257|NCT02391545|581601929|FG001|Overall Study|Other Reasons|4|||
161058258|NCT02016690|581601930|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
161058259|NCT02016690|581601930|FG000|Overall Study|Excluded from SAS: Duplication|2|||
161058260|NCT02016690|581601930|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
161058261|NCT02016690|581601930|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
161058262|NCT02016690|581601930|FG000|Overall Study|Did not meet inclusion criteria|13|||
161058263|NCT02016690|581601930|FG000|Overall Study|Hospitalized for RSV at study start|3|||
161058264|NCT01222078|581601931|FG000|Overall Study|Early termination of the study|1|||
161058265|NCT04089332|581601932|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
161058266|NCT04089332|581601932|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
161058267|NCT04089332|581601932|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
161058268|NCT00603278|581601936|FG000|Overall Study|Lack of Efficacy|35|||
161058269|NCT00603278|581601937|FG001|Overall Study|Lack of Efficacy|10|||
161058270|NCT00603278|581601938|FG002|Overall Study|Lack of Efficacy|11|||
161058271|NCT00603278|581601939|FG003|Overall Study|Lack of Efficacy|8|||
161058272|NCT00603278|581601940|FG004|Overall Study|Lack of Efficacy|7|||
161058273|NCT00603278|581601941|FG005|Overall Study|Lack of Efficacy|14|||
161058274|NCT00603278|581601936|FG000|Overall Study|Adverse Event|0|||
161058275|NCT00603278|581601937|FG001|Overall Study|Adverse Event|3|||
161058276|NCT00603278|581601938|FG002|Overall Study|Adverse Event|1|||
161058277|NCT00603278|581601939|FG003|Overall Study|Adverse Event|0|||
161281559|NCT03052127|582408750|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161281560|NCT03052127|582408751|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161281561|NCT03052127|582408752|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
161281562|NCT03052127|582408753|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161058278|NCT00603278|581601940|FG004|Overall Study|Adverse Event|2|||
161058279|NCT00603278|581601941|FG005|Overall Study|Adverse Event|1|||
161058280|NCT00603278|581601936|FG000|Overall Study|Withdrawal by Subject|2|||
161058281|NCT00603278|581601937|FG001|Overall Study|Withdrawal by Subject|3|||
161058282|NCT00603278|581601938|FG002|Overall Study|Withdrawal by Subject|1|||
161058283|NCT00603278|581601939|FG003|Overall Study|Withdrawal by Subject|2|||
161058284|NCT00603278|581601940|FG004|Overall Study|Withdrawal by Subject|1|||
161058285|NCT00603278|581601941|FG005|Overall Study|Withdrawal by Subject|2|||
161058286|NCT00603278|581601936|FG000|Overall Study|Protocol Violation|3|||
161058287|NCT00603278|581601937|FG001|Overall Study|Protocol Violation|0|||
161058288|NCT00603278|581601938|FG002|Overall Study|Protocol Violation|1|||
161058289|NCT00603278|581601939|FG003|Overall Study|Protocol Violation|1|||
161058290|NCT00603278|581601940|FG004|Overall Study|Protocol Violation|0|||
161058291|NCT00603278|581601941|FG005|Overall Study|Protocol Violation|1|||
161058292|NCT00603278|581601936|FG000|Overall Study|Physician Decision|0|||
161058293|NCT00603278|581601937|FG001|Overall Study|Physician Decision|1|||
161058294|NCT00603278|581601938|FG002|Overall Study|Physician Decision|0|||
161058295|NCT00603278|581601939|FG003|Overall Study|Physician Decision|0|||
161058296|NCT00603278|581601940|FG004|Overall Study|Physician Decision|2|||
161058297|NCT00603278|581601941|FG005|Overall Study|Physician Decision|1|||
161058298|NCT00603278|581601936|FG000|Overall Study|Lost to Follow-up|1|||
161058299|NCT00603278|581601937|FG001|Overall Study|Lost to Follow-up|0|||
161058300|NCT00603278|581601938|FG002|Overall Study|Lost to Follow-up|0|||
161058301|NCT00603278|581601939|FG003|Overall Study|Lost to Follow-up|0|||
161058302|NCT00603278|581601940|FG004|Overall Study|Lost to Follow-up|1|||
161058303|NCT00603278|581601941|FG005|Overall Study|Lost to Follow-up|0|||
161058304|NCT00746785|581603665|FG000|Overall Study|Lost to Follow-up|29|||
161058305|NCT00746785|581603666|FG001|Overall Study|Lost to Follow-up|25|||
161058306|NCT00746785|581603667|FG002|Overall Study|Lost to Follow-up|27|||
161058307|NCT01231464|581603668|FG000|Overall Study|Adverse Event|0|||
161058308|NCT01231464|581603669|FG001|Overall Study|Adverse Event|1|||
161058309|NCT01231464|581603668|FG000|Overall Study|Protocol Violation|1|||
161058310|NCT01231464|581603669|FG001|Overall Study|Protocol Violation|2|||
161058311|NCT01231464|581603668|FG000|Overall Study|Lost to Follow-up|1|||
161058312|NCT01231464|581603669|FG001|Overall Study|Lost to Follow-up|2|||
161058313|NCT01231464|581603668|FG000|Overall Study|Withdrawal by Subject|3|||
161058314|NCT01231464|581603669|FG001|Overall Study|Withdrawal by Subject|2|||
161058315|NCT00632931|581603680|FG000|Part 1, Period 1|Protocol Violation|1|||
161058316|NCT00632931|581603681|FG001|Part 1, Period 1|Protocol Violation|0|||
161058317|NCT00632931|581603682|FG002|Part 1, Period 1|Protocol Violation|0|||
161058318|NCT00632931|581603680|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
161058319|NCT00632931|581603681|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
161058320|NCT00632931|581603682|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
161058321|NCT00632931|581603680|FG000|Part 2|Adverse Event|0|||
161058322|NCT00632931|581603681|FG001|Part 2|Adverse Event|0|||
161058323|NCT00632931|581603682|FG002|Part 2|Adverse Event|3|||
161058324|NCT00632931|581603680|FG000|Part 2|Death|0|||
161058325|NCT00632931|581603681|FG001|Part 2|Death|0|||
161058326|NCT00632931|581603682|FG002|Part 2|Death|1|||
161058327|NCT00632931|581603680|FG000|Part 2|Lack of Efficacy|0|||
161058328|NCT00632931|581603681|FG001|Part 2|Lack of Efficacy|0|||
161058329|NCT00632931|581603682|FG002|Part 2|Lack of Efficacy|17|||
161058330|NCT00632931|581603680|FG000|Part 2|Withdrawal by Subject|0|||
161058331|NCT00632931|581603681|FG001|Part 2|Withdrawal by Subject|0|||
161058332|NCT00632931|581603682|FG002|Part 2|Withdrawal by Subject|3|||
161058333|NCT02499835|581603688|FG000|Overall Study|Withdrawal by Subject|1|||
161058334|NCT02499835|581603689|FG001|Overall Study|Withdrawal by Subject|0|||
161058335|NCT02499835|581603690|FG002|Overall Study|Withdrawal by Subject|0|||
161058336|NCT02499835|581603691|FG003|Overall Study|Withdrawal by Subject|1|||
161058337|NCT02499835|581603688|FG000|Overall Study|Physician Decision|0|||
161058338|NCT02499835|581603689|FG001|Overall Study|Physician Decision|3|||
161058339|NCT02499835|581603690|FG002|Overall Study|Physician Decision|18|||
161058340|NCT02499835|581603691|FG003|Overall Study|Physician Decision|7|||
161058341|NCT02499835|581603688|FG000|Overall Study|Adverse Event|0|||
161058342|NCT02499835|581603689|FG001|Overall Study|Adverse Event|0|||
161058343|NCT02499835|581603690|FG002|Overall Study|Adverse Event|0|||
161058344|NCT02499835|581603691|FG003|Overall Study|Adverse Event|1|||
161058345|NCT02499835|581603688|FG000|Overall Study|Disease progression|2|||
161058346|NCT02499835|581603689|FG001|Overall Study|Disease progression|1|||
161058347|NCT02499835|581603690|FG002|Overall Study|Disease progression|0|||
161058348|NCT02499835|581603691|FG003|Overall Study|Disease progression|7|||
161058349|NCT03319719|581603699|FG000|Overall Study|Lost to Follow-up|1|||
161058350|NCT00922441|581603700|FG000|Overall Study|Protocol Violation|0|||
161058351|NCT00922441|581603701|FG001|Overall Study|Protocol Violation|0|||
161058352|NCT00922441|581603702|FG002|Overall Study|Protocol Violation|2|||
161058353|NCT00922441|581603700|FG000|Overall Study|Withdrawal by Subject|0|||
161058354|NCT00922441|581603701|FG001|Overall Study|Withdrawal by Subject|0|||
161281563|NCT03052127|582408754|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161281564|NCT03052127|582408755|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161281565|NCT03052127|582408756|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161281566|NCT03052127|582408757|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
161058355|NCT00922441|581603702|FG002|Overall Study|Withdrawal by Subject|1|||
161058356|NCT00468858|581603704|FG000|Overall Study|Adverse Event|0|||
161058357|NCT00468858|581603705|FG001|Overall Study|Adverse Event|1|||
161058358|NCT00468858|581603706|FG002|Overall Study|Adverse Event|0|||
161058359|NCT00468858|581603704|FG000|Overall Study|Withdrawal by Subject|7|||
161058360|NCT00468858|581603705|FG001|Overall Study|Withdrawal by Subject|4|||
161058361|NCT00468858|581603706|FG002|Overall Study|Withdrawal by Subject|5|||
161058362|NCT00468858|581603704|FG000|Overall Study|Relocation|1|||
161058363|NCT00468858|581603705|FG001|Overall Study|Relocation|3|||
161058364|NCT00468858|581603706|FG002|Overall Study|Relocation|3|||
161058365|NCT00468858|581603704|FG000|Overall Study|Lost to Follow-up|1|||
161058366|NCT00468858|581603705|FG001|Overall Study|Lost to Follow-up|2|||
161058367|NCT00468858|581603706|FG002|Overall Study|Lost to Follow-up|5|||
161058368|NCT00468858|581603704|FG000|Overall Study|Other|0|||
161058369|NCT00468858|581603705|FG001|Overall Study|Other|0|||
161058370|NCT00468858|581603706|FG002|Overall Study|Other|1|||
161058371|NCT03214250|581603709|FG000|Overall Study|Death|5|||
161058372|NCT03214250|581603710|FG001|Overall Study|Death|5|||
161058373|NCT03214250|581603711|FG002|Overall Study|Death|7|||
161058374|NCT03214250|581603712|FG003|Overall Study|Death|4|||
161058375|NCT03214250|581603713|FG004|Overall Study|Death|23|||
161058376|NCT03214250|581603714|FG005|Overall Study|Death|23|||
161058377|NCT03214250|581603715|FG006|Overall Study|Death|24|||
161058378|NCT03214250|581603709|FG000|Overall Study|Lost to Follow-up|0|||
161058379|NCT03214250|581603710|FG001|Overall Study|Lost to Follow-up|0|||
161058380|NCT03214250|581603711|FG002|Overall Study|Lost to Follow-up|0|||
161058381|NCT03214250|581603712|FG003|Overall Study|Lost to Follow-up|1|||
161058382|NCT03214250|581603713|FG004|Overall Study|Lost to Follow-up|1|||
161058383|NCT03214250|581603714|FG005|Overall Study|Lost to Follow-up|2|||
161058384|NCT03214250|581603715|FG006|Overall Study|Lost to Follow-up|0|||
161058385|NCT03214250|581603709|FG000|Overall Study|Other|0|||
161058386|NCT03214250|581603710|FG001|Overall Study|Other|0|||
161058387|NCT03214250|581603711|FG002|Overall Study|Other|0|||
161058388|NCT03214250|581603712|FG003|Overall Study|Other|0|||
161058389|NCT03214250|581603713|FG004|Overall Study|Other|1|||
161058390|NCT03214250|581603714|FG005|Overall Study|Other|1|||
161058391|NCT03214250|581603715|FG006|Overall Study|Other|2|||
161058392|NCT03214250|581603709|FG000|Overall Study|Remains on Study|2|||
161058393|NCT03214250|581603710|FG001|Overall Study|Remains on Study|2|||
161058394|NCT03214250|581603711|FG002|Overall Study|Remains on Study|0|||
161058395|NCT03214250|581603712|FG003|Overall Study|Remains on Study|1|||
161058396|NCT03214250|581603713|FG004|Overall Study|Remains on Study|7|||
161058397|NCT03214250|581603714|FG005|Overall Study|Remains on Study|5|||
161058398|NCT03214250|581603715|FG006|Overall Study|Remains on Study|3|||
161058399|NCT03214250|581603709|FG000|Overall Study|Withdrawal by Subject|0|||
161058400|NCT03214250|581603710|FG001|Overall Study|Withdrawal by Subject|0|||
161058401|NCT03214250|581603711|FG002|Overall Study|Withdrawal by Subject|1|||
161058402|NCT03214250|581603712|FG003|Overall Study|Withdrawal by Subject|2|||
161058403|NCT03214250|581603713|FG004|Overall Study|Withdrawal by Subject|5|||
161058404|NCT03214250|581603714|FG005|Overall Study|Withdrawal by Subject|0|||
161058405|NCT03214250|581603715|FG006|Overall Study|Withdrawal by Subject|2|||
161058406|NCT00439647|581603720|FG000|Overall Study|Withdrawal by Subject|25|||
161058407|NCT00439647|581603721|FG001|Overall Study|Withdrawal by Subject|22|||
161058408|NCT00439647|581603720|FG000|Overall Study|Death|15|||
161058409|NCT00439647|581603721|FG001|Overall Study|Death|18|||
161058410|NCT00439647|581603720|FG000|Overall Study|Adverse Event|11|||
161058411|NCT00439647|581603721|FG001|Overall Study|Adverse Event|11|||
161058412|NCT00439647|581603720|FG000|Overall Study|Lost to Follow-up|4|||
161058413|NCT00439647|581603721|FG001|Overall Study|Lost to Follow-up|12|||
161058414|NCT00439647|581603720|FG000|Overall Study|Protocol Violation|3|||
161058415|NCT00439647|581603721|FG001|Overall Study|Protocol Violation|4|||
161058416|NCT00439647|581603720|FG000|Overall Study|Lack of Efficacy|0|||
161058417|NCT00439647|581603721|FG001|Overall Study|Lack of Efficacy|4|||
161058418|NCT02171130|581603726|FG000|Overall Study|Death|1|||
161058419|NCT02171130|581603726|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
161058420|NCT02171130|581603726|FG000|Overall Study|Discontinued; Site Termination|5|||
161058421|NCT02171130|581603726|FG000|Overall Study|Withdrawal by Subject|3|||
161058422|NCT02171130|581603726|FG000|Overall Study|Physician Decision|1|||
161058423|NCT02171130|581603726|FG000|Overall Study|Lost to Follow-up|1|||
161058424|NCT02171130|581603726|FG000|Overall Study|Met Exclusion Criteria|1|||
161058425|NCT00591409|581603727|FG000|Overall Study|Not Treated|0|||
161058426|NCT00591409|581603728|FG001|Overall Study|Not Treated|0|||
161058427|NCT00591409|581603729|FG002|Overall Study|Not Treated|0|||
161058428|NCT00591409|581603730|FG003|Overall Study|Not Treated|0|||
161058429|NCT00591409|581603731|FG004|Overall Study|Not Treated|1|||
161058430|NCT00591409|581603732|FG005|Overall Study|Not Treated|0|||
161058431|NCT00591409|581603733|FG006|Overall Study|Not Treated|0|||
161058432|NCT00591409|581603734|FG007|Overall Study|Not Treated|0|||
161058433|NCT00591409|581603735|FG008|Overall Study|Not Treated|0|||
161058434|NCT00591409|581603736|FG009|Overall Study|Not Treated|1|||
161058435|NCT02109107|581603739|FG000|Overall Study|Lost to Follow-up|2|||
161058436|NCT00495612|581603741|FG000|Overall Study|Lost to Follow-up|1|||
161058437|NCT00495612|581603742|FG001|Overall Study|Lost to Follow-up|0|||
161058438|NCT00495612|581603741|FG000|Overall Study|Subject's Decision to Withdraw|3|||
161058439|NCT00495612|581603742|FG001|Overall Study|Subject's Decision to Withdraw|0|||
161058440|NCT06016127|581603745|FG000|Overall Study|Withdrawal by Subject|4|||
161058441|NCT06016127|581603746|FG001|Overall Study|Withdrawal by Subject|3|||
161058442|NCT03340766|581603751|FG000|Overall Study|Withdrawal by Subject|2|||
161058443|NCT03340766|581603752|FG001|Overall Study|Withdrawal by Subject|1|||
161058444|NCT03340766|581603753|FG002|Overall Study|Withdrawal by Subject|3|||
161058445|NCT03340766|581603751|FG000|Overall Study|Lost to Follow-up|0|||
161058446|NCT03340766|581603752|FG001|Overall Study|Lost to Follow-up|0|||
161058447|NCT03340766|581603753|FG002|Overall Study|Lost to Follow-up|1|||
161058448|NCT03340766|581603751|FG000|Overall Study|Death|6|||
161058449|NCT03340766|581603752|FG001|Overall Study|Death|7|||
161058450|NCT03340766|581603753|FG002|Overall Study|Death|4|||
161058451|NCT00240097|581603754|FG000|Part I|Adverse Event|1|||
161058452|NCT00240097|581603754|FG000|Part I|Death|1|||
161058453|NCT00240097|581603754|FG000|Part I|histology|1|||
161058454|NCT00240097|581603754|FG000|Part I|unevaluable|1|||
161058455|NCT00240097|581603754|FG000|Part II|did not continue from Part I|23|||
161058456|NCT02383927|581603755|FG000|Overall Study|Disease Progression|8|||
161058457|NCT02383927|581603756|FG001|Overall Study|Disease Progression|8|||
161058458|NCT02383927|581603757|FG002|Overall Study|Disease Progression|15|||
161058459|NCT02383927|581603758|FG003|Overall Study|Disease Progression|4|||
161058460|NCT02383927|581603755|FG000|Overall Study|Physician Decision|0|||
161058461|NCT02383927|581603756|FG001|Overall Study|Physician Decision|0|||
161058462|NCT02383927|581603757|FG002|Overall Study|Physician Decision|2|||
161058463|NCT02383927|581603758|FG003|Overall Study|Physician Decision|0|||
161058464|NCT02383927|581603755|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
161058465|NCT02383927|581603756|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
161058466|NCT02383927|581603757|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
161058467|NCT02383927|581603758|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
161058468|NCT02383927|581603755|FG000|Overall Study|Adverse Event|4|||
161058469|NCT02383927|581603756|FG001|Overall Study|Adverse Event|1|||
161058470|NCT02383927|581603757|FG002|Overall Study|Adverse Event|3|||
161058471|NCT02383927|581603758|FG003|Overall Study|Adverse Event|5|||
161058472|NCT02383927|581603755|FG000|Overall Study|Miscellaneous|1|||
161058473|NCT02383927|581603756|FG001|Overall Study|Miscellaneous|0|||
161058474|NCT02383927|581603757|FG002|Overall Study|Miscellaneous|0|||
161058475|NCT02383927|581603758|FG003|Overall Study|Miscellaneous|1|||
161058476|NCT02383927|581603755|FG000|Overall Study|Withdrawal by Subject|0|||
161058477|NCT02383927|581603756|FG001|Overall Study|Withdrawal by Subject|1|||
161058478|NCT02383927|581603757|FG002|Overall Study|Withdrawal by Subject|4|||
161058479|NCT02383927|581603758|FG003|Overall Study|Withdrawal by Subject|0|||
161058480|NCT00734851|581603759|FG000|Overall Study|Withdrawal by Subject|2|||
161058481|NCT00734851|581603759|FG000|Overall Study|Lost to Follow-up|1|||
161058482|NCT00734851|581603759|FG000|Overall Study|Physician Decision|18|||
161058483|NCT00981578|581603763|FG000|Overall Study|Death|1|||
161058484|NCT00981578|581603763|FG000|Overall Study|Withdrawal by Subject|2|||
161058485|NCT01294358|581603768|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161058486|NCT01294358|581603769|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
161058487|NCT01294358|581603770|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161058488|NCT01294358|581603771|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161058489|NCT01294358|581603772|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
161058490|NCT01294358|581603768|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161058491|NCT01294358|581603769|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161058492|NCT01294358|581603770|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
161058493|NCT01294358|581603771|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161058494|NCT01294358|581603772|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
161058495|NCT01294358|581603768|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161058496|NCT01294358|581603769|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161058497|NCT01294358|581603770|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161058498|NCT01294358|581603771|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
161058499|NCT01294358|581603772|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
161058500|NCT01294358|581603768|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161058501|NCT01294358|581603769|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161058502|NCT01294358|581603770|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161058503|NCT01294358|581603771|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
161058504|NCT01294358|581603772|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
161058505|NCT03613454|581603773|FG000|Overall Study|Protocol Violation|1|||
161058506|NCT03613454|581603774|FG001|Overall Study|Protocol Violation|0|||
161058507|NCT03613454|581603773|FG000|Overall Study|Protocol Violation|0|||
161058508|NCT03613454|581603774|FG001|Overall Study|Protocol Violation|1|||
161058509|NCT02963922|581603775|FG000|Overall Study|Adverse Event|15|||
161281567|NCT03694327|582408758|FG000|Overall Study|Lost to Follow-up|13|||
161058510|NCT02963922|581603776|FG001|Overall Study|Adverse Event|6|||
161058511|NCT02963922|581603775|FG000|Overall Study|Protocol deviation|6|||
161058512|NCT02963922|581603776|FG001|Overall Study|Protocol deviation|6|||
161058513|NCT02963922|581603775|FG000|Overall Study|Lack of Efficacy|1|||
161058514|NCT02963922|581603776|FG001|Overall Study|Lack of Efficacy|1|||
161058515|NCT02963922|581603775|FG000|Overall Study|Lost to Follow-up|2|||
161058516|NCT02963922|581603776|FG001|Overall Study|Lost to Follow-up|3|||
161058517|NCT02963922|581603775|FG000|Overall Study|Other|8|||
161058518|NCT02963922|581603776|FG001|Overall Study|Other|14|||
161058519|NCT00655668|581603785|FG000|Overall Study|Adverse Event|6|||
161058520|NCT00655668|581603785|FG000|Overall Study|Death|5|||
161058521|NCT00655668|581603785|FG000|Overall Study|Disease Progression|27|||
161058522|NCT00655668|581603785|FG000|Overall Study|Study Terminated|9|||
161058523|NCT00655668|581603785|FG000|Overall Study|Other|1|||
161058524|NCT00655668|581603785|FG000|Overall Study|New Lymphoma Treatment Started|4|||
161058525|NCT00655668|581603785|FG000|Overall Study|Withdrawal by Subject|2|||
161058526|NCT00257556|581603786|FG000|Overall Study|Adverse Event|1|||
161058527|NCT00257556|581603787|FG001|Overall Study|Adverse Event|4|||
161058528|NCT00257556|581603786|FG000|Overall Study|Physician Decision|6|||
161058529|NCT00257556|581603787|FG001|Overall Study|Physician Decision|0|||
161058530|NCT00257556|581603786|FG000|Overall Study|Did not meet hCG criterion|3|||
161058531|NCT00257556|581603787|FG001|Overall Study|Did not meet hCG criterion|0|||
161058532|NCT00257556|581603786|FG000|Overall Study|other reason|4|||
161058533|NCT00257556|581603787|FG001|Overall Study|other reason|6|||
161058534|NCT02820298|581603792|FG000|Overall Study|Withdrawal by Subject|0|||
161058535|NCT02820298|581603793|FG001|Overall Study|Withdrawal by Subject|1|||
161058536|NCT02820298|581603792|FG000|Overall Study|Physician Decision|1|||
161058537|NCT02820298|581603793|FG001|Overall Study|Physician Decision|0|||
161058538|NCT02820298|581603792|FG000|Overall Study|Protocol Violation|0|||
161058539|NCT02820298|581603793|FG001|Overall Study|Protocol Violation|1|||
161058540|NCT01780584|581603794|FG000|Overall Study|Death|1|||
161058541|NCT01780584|581603795|FG001|Overall Study|Death|0|||
161058542|NCT01780584|581603796|FG002|Overall Study|Death|1|||
161058543|NCT01780584|581603794|FG000|Overall Study|Adverse Event|0|||
161058544|NCT01780584|581603795|FG001|Overall Study|Adverse Event|1|||
161058545|NCT01780584|581603796|FG002|Overall Study|Adverse Event|0|||
161058546|NCT01780584|581603794|FG000|Overall Study|Protocol Violation|0|||
161058547|NCT01780584|581603795|FG001|Overall Study|Protocol Violation|0|||
161058548|NCT01780584|581603796|FG002|Overall Study|Protocol Violation|1|||
161058549|NCT00141271|581603801|FG000|Overall Study|Adverse Event|31|||
161058550|NCT00141271|581603802|FG001|Overall Study|Adverse Event|19|||
161058551|NCT00141271|581603803|FG002|Overall Study|Adverse Event|17|||
161058552|NCT00141271|581603801|FG000|Overall Study|Laboratory Abnormality|2|||
161058553|NCT00141271|581603802|FG001|Overall Study|Laboratory Abnormality|1|||
161058554|NCT00141271|581603803|FG002|Overall Study|Laboratory Abnormality|1|||
161058555|NCT00141271|581603801|FG000|Overall Study|Lack of Efficacy|7|||
161058556|NCT00141271|581603802|FG001|Overall Study|Lack of Efficacy|7|||
161058557|NCT00141271|581603803|FG002|Overall Study|Lack of Efficacy|3|||
161058558|NCT00141271|581603801|FG000|Overall Study|Lost to Follow-up|15|||
161058559|NCT00141271|581603802|FG001|Overall Study|Lost to Follow-up|15|||
161058560|NCT00141271|581603803|FG002|Overall Study|Lost to Follow-up|21|||
161058561|NCT00141271|581603801|FG000|Overall Study|Withdrawal by Subject|14|||
161058562|NCT00141271|581603802|FG001|Overall Study|Withdrawal by Subject|9|||
161058563|NCT00141271|581603803|FG002|Overall Study|Withdrawal by Subject|10|||
161058564|NCT00141271|581603801|FG000|Overall Study|Other|11|||
161058565|NCT00141271|581603802|FG001|Overall Study|Other|12|||
161058566|NCT00141271|581603803|FG002|Overall Study|Other|5|||
161058567|NCT01544153|581603804|FG000|Overall Study|Under 18|0|||
161058568|NCT01544153|581603805|FG001|Overall Study|Under 18|1|||
161058569|NCT01544153|581603806|FG002|Overall Study|Under 18|0|||
161058570|NCT01544153|581603807|FG003|Overall Study|Under 18|0|||
161058571|NCT01544153|581603804|FG000|Overall Study|Non-smoker|0|||
161058572|NCT01544153|581603805|FG001|Overall Study|Non-smoker|0|||
161058573|NCT01544153|581603806|FG002|Overall Study|Non-smoker|1|||
161058574|NCT01544153|581603807|FG003|Overall Study|Non-smoker|0|||
161058575|NCT00390806|581603812|FG000|Overall Study|Lost to Follow-up|7|||
161058576|NCT00390806|581603813|FG001|Overall Study|Lost to Follow-up|6|||
161058577|NCT00390806|581603812|FG000|Overall Study|Protocol Violation|2|||
161058578|NCT00390806|581603813|FG001|Overall Study|Protocol Violation|2|||
161058579|NCT00390806|581603812|FG000|Overall Study|Withdrawal by Subject|12|||
161058580|NCT00390806|581603813|FG001|Overall Study|Withdrawal by Subject|15|||
161058581|NCT00390806|581603812|FG000|Overall Study|Investigator Decision|4|||
161058582|NCT00390806|581603813|FG001|Overall Study|Investigator Decision|6|||
161281568|NCT03694327|582408759|FG001|Overall Study|Lost to Follow-up|23|||
161058583|NCT00390806|581603812|FG000|Overall Study|Death|1|||
161058584|NCT00390806|581603813|FG001|Overall Study|Death|0|||
161058585|NCT00390806|581603812|FG000|Overall Study|Physician Decision|0|||
161058586|NCT00390806|581603813|FG001|Overall Study|Physician Decision|1|||
161058587|NCT00390806|581603812|FG000|Overall Study|Ongoing|4|||
161058588|NCT00390806|581603813|FG001|Overall Study|Ongoing|2|||
161058589|NCT03169530|581603816|FG000|Overall Study|Study ended by NIH|15|||
161058590|NCT03169530|581603817|FG001|Overall Study|Study ended by NIH|17|||
161058591|NCT00884793|581603818|FG000|Overall Study|Withdrawal by Subject|1|||
161058592|NCT04783519|581603819|FG000|Overall Study|Withdrawal by Subject|2|||
161058593|NCT04783519|581603820|FG001|Overall Study|Withdrawal by Subject|7|||
161058594|NCT04783519|581603821|FG002|Overall Study|Withdrawal by Subject|3|||
161058595|NCT04783519|581603819|FG000|Overall Study|Lost to Follow-up|9|||
161058596|NCT04783519|581603820|FG001|Overall Study|Lost to Follow-up|7|||
161058597|NCT04783519|581603821|FG002|Overall Study|Lost to Follow-up|6|||
161058598|NCT01032200|581603822|FG000|Overall Study|Death|1|||
161058599|NCT01032200|581603823|FG001|Overall Study|Death|1|||
161058600|NCT01032200|581603822|FG000|Overall Study|Withdrawal by Subject|1|||
161058601|NCT01032200|581603823|FG001|Overall Study|Withdrawal by Subject|3|||
161058602|NCT01032200|581603822|FG000|Overall Study|Toxicity|0|||
161058603|NCT01032200|581603823|FG001|Overall Study|Toxicity|2|||
161058604|NCT01032200|581603822|FG000|Overall Study|Progression|1|||
161281569|NCT01464931|582408760|FG000|Overall Study|Withdrawal by Subject|1|||
161281570|NCT01464931|582408761|FG001|Overall Study|Withdrawal by Subject|0|||
161281571|NCT01982812|582408764|FG000|Overall Study|Death|1|||
161281572|NCT01982812|582408765|FG001|Overall Study|Death|5|||
161281573|NCT01982812|582408764|FG000|Overall Study|Adverse Event|0|||
161281574|NCT01982812|582408765|FG001|Overall Study|Adverse Event|5|||
161281575|NCT00307437|582408767|FG000|Controlled Period|Adverse Event|7|||
161281576|NCT00307437|582408768|FG001|Controlled Period|Adverse Event|2|||
161281577|NCT00307437|582408769|FG002|Controlled Period|Adverse Event|5|||
161281578|NCT00307437|582408770|FG003|Controlled Period|Adverse Event|0|||
161281579|NCT00307437|582408771|FG004|Controlled Period|Adverse Event|0|||
161281580|NCT00307437|582408772|FG005|Controlled Period|Adverse Event|0|||
161281581|NCT00307437|582408773|FG006|Controlled Period|Adverse Event|0|||
161281582|NCT00307437|582408767|FG000|Controlled Period|Death|0|||
161281583|NCT00307437|582408768|FG001|Controlled Period|Death|0|||
161281584|NCT00307437|582408769|FG002|Controlled Period|Death|1|||
161281585|NCT00307437|582408770|FG003|Controlled Period|Death|0|||
161281586|NCT00307437|582408771|FG004|Controlled Period|Death|0|||
161281587|NCT00307437|582408772|FG005|Controlled Period|Death|0|||
161281588|NCT00307437|582408773|FG006|Controlled Period|Death|0|||
161281589|NCT00307437|582408767|FG000|Controlled Period|Lack of Efficacy|2|||
161281590|NCT00307437|582408768|FG001|Controlled Period|Lack of Efficacy|0|||
161281591|NCT00307437|582408769|FG002|Controlled Period|Lack of Efficacy|0|||
161281592|NCT00307437|582408770|FG003|Controlled Period|Lack of Efficacy|0|||
161281593|NCT00307437|582408771|FG004|Controlled Period|Lack of Efficacy|0|||
161281594|NCT00307437|582408772|FG005|Controlled Period|Lack of Efficacy|0|||
161281595|NCT00307437|582408773|FG006|Controlled Period|Lack of Efficacy|0|||
161281596|NCT00307437|582408767|FG000|Controlled Period|Lost to Follow-up|2|||
161281597|NCT00307437|582408768|FG001|Controlled Period|Lost to Follow-up|3|||
161281598|NCT00307437|582408769|FG002|Controlled Period|Lost to Follow-up|0|||
161281599|NCT00307437|582408770|FG003|Controlled Period|Lost to Follow-up|0|||
161281600|NCT00307437|582408771|FG004|Controlled Period|Lost to Follow-up|0|||
161281601|NCT00307437|582408772|FG005|Controlled Period|Lost to Follow-up|0|||
161281602|NCT00307437|582408773|FG006|Controlled Period|Lost to Follow-up|0|||
161281603|NCT00307437|582408767|FG000|Controlled Period|Other|5|||
161281604|NCT00307437|582408768|FG001|Controlled Period|Other|1|||
161281605|NCT00307437|582408769|FG002|Controlled Period|Other|3|||
161281606|NCT00307437|582408770|FG003|Controlled Period|Other|0|||
161281607|NCT00307437|582408771|FG004|Controlled Period|Other|0|||
161281608|NCT00307437|582408772|FG005|Controlled Period|Other|0|||
161281609|NCT00307437|582408773|FG006|Controlled Period|Other|0|||
161281610|NCT00307437|582408767|FG000|After Controlled Period|Adverse Event|0|||
161281611|NCT00307437|582408768|FG001|After Controlled Period|Adverse Event|0|||
161281612|NCT00307437|582408769|FG002|After Controlled Period|Adverse Event|0|||
161281613|NCT00307437|582408770|FG003|After Controlled Period|Adverse Event|18|||
161281614|NCT00307437|582408771|FG004|After Controlled Period|Adverse Event|16|||
161281615|NCT00307437|582408772|FG005|After Controlled Period|Adverse Event|31|||
161281616|NCT00307437|582408773|FG006|After Controlled Period|Adverse Event|40|||
161281617|NCT00307437|582408767|FG000|After Controlled Period|Death|0|||
161281618|NCT00307437|582408768|FG001|After Controlled Period|Death|0|||
161281619|NCT00307437|582408769|FG002|After Controlled Period|Death|0|||
161281620|NCT00307437|582408770|FG003|After Controlled Period|Death|3|||
161281621|NCT00307437|582408771|FG004|After Controlled Period|Death|1|||
161281622|NCT00307437|582408772|FG005|After Controlled Period|Death|1|||
161281623|NCT00307437|582408773|FG006|After Controlled Period|Death|3|||
161281624|NCT00307437|582408767|FG000|After Controlled Period|Lack of Efficacy|0|||
161058605|NCT01032200|581603823|FG001|Overall Study|Progression|0|||
161281625|NCT00307437|582408768|FG001|After Controlled Period|Lack of Efficacy|0|||
161281626|NCT00307437|582408769|FG002|After Controlled Period|Lack of Efficacy|0|||
161345144|NCT00976027|582648872|FG001|Overall Study|Withdrawal by Subject|66|||
161345145|NCT01771107|582648878|FG000|Overall Study|Adverse Event|1|||
161345146|NCT01771107|582648879|FG001|Overall Study|Adverse Event|3|||
161058606|NCT01032200|581603822|FG000|Overall Study|Multiple|1|||
161058607|NCT01032200|581603823|FG001|Overall Study|Multiple|1|||
161058608|NCT00727259|581603827|FG000|Overall Study|Not all questionnaires completed|1055|||
161058609|NCT01021683|581603828|FG000|Overall Study|Lack of Efficacy|12|||
161058610|NCT01021683|581603828|FG000|Overall Study|Recovery of neutrophil count|51|||
161058611|NCT01021683|581603828|FG000|Overall Study|Other|8|||
161281627|NCT00307437|582408770|FG003|After Controlled Period|Lack of Efficacy|15|||
161281628|NCT00307437|582408771|FG004|After Controlled Period|Lack of Efficacy|17|||
161281629|NCT00307437|582408772|FG005|After Controlled Period|Lack of Efficacy|37|||
161281630|NCT00307437|582408773|FG006|After Controlled Period|Lack of Efficacy|24|||
161281631|NCT00307437|582408767|FG000|After Controlled Period|Lost to Follow-up|0|||
161345147|NCT01771107|582648878|FG000|Overall Study|Withdrawal by Subject|0|||
161281632|NCT00307437|582408768|FG001|After Controlled Period|Lost to Follow-up|0|||
161281633|NCT00307437|582408769|FG002|After Controlled Period|Lost to Follow-up|0|||
161281634|NCT00307437|582408770|FG003|After Controlled Period|Lost to Follow-up|7|||
161345148|NCT01771107|582648879|FG001|Overall Study|Withdrawal by Subject|2|||
161345149|NCT01771107|582648878|FG000|Overall Study|Lost to Follow-up|0|||
161345150|NCT01771107|582648879|FG001|Overall Study|Lost to Follow-up|1|||
161345151|NCT01771107|582648878|FG000|Overall Study|participant moved|0|||
161345152|NCT01771107|582648879|FG001|Overall Study|participant moved|1|||
161345153|NCT01771107|582648878|FG000|Overall Study|Other|0|||
161345154|NCT01771107|582648879|FG001|Overall Study|Other|1|||
161345155|NCT03805841|582648880|FG000|Overall Study|Clinical Progression|2|||
161345156|NCT03805841|582648881|FG001|Overall Study|Clinical Progression|0|||
161345157|NCT03805841|582648882|FG002|Overall Study|Clinical Progression|0|||
161345158|NCT03805841|582648880|FG000|Overall Study|Death|0|||
161345159|NCT03805841|582648881|FG001|Overall Study|Death|3|||
161345160|NCT03805841|582648882|FG002|Overall Study|Death|1|||
161345161|NCT03805841|582648880|FG000|Overall Study|Lost to Follow-up|0|||
161345162|NCT03805841|582648881|FG001|Overall Study|Lost to Follow-up|0|||
161345163|NCT03805841|582648882|FG002|Overall Study|Lost to Follow-up|1|||
161345164|NCT03805841|582648880|FG000|Overall Study|Withdrawal by Subject|2|||
161345165|NCT03805841|582648881|FG001|Overall Study|Withdrawal by Subject|3|||
161345166|NCT03805841|582648882|FG002|Overall Study|Withdrawal by Subject|0|||
161345167|NCT03805841|582648880|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
161345168|NCT03805841|582648881|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
161345169|NCT03805841|582648882|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
161345170|NCT05049122|582648885|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
161345171|NCT05049122|582648885|FG000|Overall Study|Participant moved|1|||
161345172|NCT05049122|582648885|FG000|Overall Study|At the direction of the doctor|1|||
161345173|NCT05845619|582648886|FG000|Overall Study|duplicate enrollment|2|||
161345174|NCT05845619|582648887|FG001|Overall Study|duplicate enrollment|2|||
161345175|NCT05845619|582648888|FG002|Overall Study|duplicate enrollment|1|||
161345176|NCT03621592|582648889|FG000|Overall Study|Lost to Follow-up|1|||
161345177|NCT03621592|582648890|FG001|Overall Study|Lost to Follow-up|0|||
161345178|NCT03621592|582648889|FG000|Overall Study|Lack of Improvement|1|||
161345179|NCT03621592|582648890|FG001|Overall Study|Lack of Improvement|0|||
161345180|NCT03621592|582648889|FG000|Overall Study|Preference to receive wound care closer to home|1|||
161345181|NCT03621592|582648890|FG001|Overall Study|Preference to receive wound care closer to home|0|||
161345182|NCT03621592|582648889|FG000|Overall Study|Lack of healing|0|||
161345183|NCT03621592|582648890|FG001|Overall Study|Lack of healing|2|||
161345184|NCT00831844|582648898|FG000|Overall Study|Adverse Event|2|||
161345185|NCT00831844|582648899|FG001|Overall Study|Adverse Event|0|||
161345186|NCT00831844|582648900|FG002|Overall Study|Adverse Event|0|||
161345187|NCT00831844|582648901|FG003|Overall Study|Adverse Event|0|||
161345188|NCT00831844|582648902|FG004|Overall Study|Adverse Event|1|||
161345189|NCT00831844|582648903|FG005|Overall Study|Adverse Event|1|||
161345190|NCT00831844|582648904|FG006|Overall Study|Adverse Event|2|||
161345191|NCT00831844|582648905|FG007|Overall Study|Adverse Event|0|||
161345192|NCT00831844|582648906|FG008|Overall Study|Adverse Event|0|||
161345193|NCT00831844|582648907|FG009|Overall Study|Adverse Event|0|||
161345194|NCT00831844|582648898|FG000|Overall Study|Death|0|||
161345195|NCT00831844|582648899|FG001|Overall Study|Death|0|||
161345196|NCT00831844|582648900|FG002|Overall Study|Death|0|||
161345197|NCT00831844|582648901|FG003|Overall Study|Death|1|||
161345198|NCT00831844|582648902|FG004|Overall Study|Death|0|||
161345199|NCT00831844|582648903|FG005|Overall Study|Death|0|||
161345200|NCT00831844|582648904|FG006|Overall Study|Death|0|||
161345201|NCT00831844|582648905|FG007|Overall Study|Death|0|||
161345202|NCT00831844|582648906|FG008|Overall Study|Death|0|||
161345203|NCT00831844|582648907|FG009|Overall Study|Death|0|||
161345204|NCT00831844|582648898|FG000|Overall Study|Lack of Efficacy|8|||
161345205|NCT00831844|582648899|FG001|Overall Study|Lack of Efficacy|10|||
161345206|NCT00831844|582648900|FG002|Overall Study|Lack of Efficacy|15|||
161345207|NCT00831844|582648901|FG003|Overall Study|Lack of Efficacy|8|||
161345208|NCT00831844|582648902|FG004|Overall Study|Lack of Efficacy|11|||
161345209|NCT00831844|582648903|FG005|Overall Study|Lack of Efficacy|17|||
161345210|NCT00831844|582648904|FG006|Overall Study|Lack of Efficacy|8|||
161345211|NCT00831844|582648905|FG007|Overall Study|Lack of Efficacy|9|||
161345212|NCT00831844|582648906|FG008|Overall Study|Lack of Efficacy|7|||
161345213|NCT00831844|582648907|FG009|Overall Study|Lack of Efficacy|0|||
161345214|NCT00831844|582648898|FG000|Overall Study|Physician Decision|0|||
161345215|NCT00831844|582648899|FG001|Overall Study|Physician Decision|1|||
161345216|NCT00831844|582648900|FG002|Overall Study|Physician Decision|3|||
161345217|NCT00831844|582648901|FG003|Overall Study|Physician Decision|1|||
161345218|NCT00831844|582648902|FG004|Overall Study|Physician Decision|1|||
161345219|NCT00831844|582648903|FG005|Overall Study|Physician Decision|1|||
161345220|NCT00831844|582648904|FG006|Overall Study|Physician Decision|0|||
161345221|NCT00831844|582648905|FG007|Overall Study|Physician Decision|0|||
161345222|NCT00831844|582648906|FG008|Overall Study|Physician Decision|1|||
161345223|NCT00831844|582648907|FG009|Overall Study|Physician Decision|0|||
161345224|NCT00831844|582648898|FG000|Overall Study|Withdrawal by Subject|0|||
161345225|NCT00831844|582648899|FG001|Overall Study|Withdrawal by Subject|0|||
161281635|NCT00307437|582408771|FG004|After Controlled Period|Lost to Follow-up|12|||
161281636|NCT00307437|582408772|FG005|After Controlled Period|Lost to Follow-up|13|||
161281637|NCT00307437|582408773|FG006|After Controlled Period|Lost to Follow-up|18|||
161281638|NCT00307437|582408767|FG000|After Controlled Period|Other|0|||
161058612|NCT01374971|581603829|FG000|Overall Study|Withdrawal by Subject|1|||
161058613|NCT02273180|581603830|FG000|Overall Study|Adverse Event|2|||
161058614|NCT02273180|581603831|FG001|Overall Study|Adverse Event|2|||
161058615|NCT02273180|581603830|FG000|Overall Study|Lack of Efficacy|1|||
161058616|NCT02273180|581603831|FG001|Overall Study|Lack of Efficacy|0|||
161058617|NCT02273180|581603830|FG000|Overall Study|Protocol Violation|1|||
161058618|NCT02273180|581603831|FG001|Overall Study|Protocol Violation|7|||
161058619|NCT02273180|581603830|FG000|Overall Study|Randomized but not treated|1|||
161058620|NCT02273180|581603831|FG001|Overall Study|Randomized but not treated|0|||
161058621|NCT02273180|581603830|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
161058622|NCT02273180|581603831|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
161058623|NCT02273180|581603830|FG000|Overall Study|Other than specified above|21|||
161058624|NCT02273180|581603831|FG001|Overall Study|Other than specified above|10|||
161058625|NCT04531813|581603832|FG000|Overall Study|Protocol Violation|1|||
161058626|NCT04531813|581603832|FG000|Overall Study|Withdrawal by Subject|1|||
161058627|NCT03449134|581605526|FG000|52-Week Treatment Period|Death|2|||
161058628|NCT03449134|581605527|FG001|52-Week Treatment Period|Death|1|||
161058629|NCT03449134|581605528|FG002|52-Week Treatment Period|Death|0|||
161058630|NCT03449134|581605526|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
161058631|NCT03449134|581605527|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
161058632|NCT03449134|581605528|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
161058633|NCT03449134|581605526|FG000|52-Week Treatment Period|Physician Decision|2|||
161058634|NCT03449134|581605527|FG001|52-Week Treatment Period|Physician Decision|3|||
161058635|NCT03449134|581605528|FG002|52-Week Treatment Period|Physician Decision|3|||
161058636|NCT03449134|581605526|FG000|52-Week Treatment Period|Screen Failure|1|||
161058637|NCT03449134|581605527|FG001|52-Week Treatment Period|Screen Failure|0|||
161058638|NCT03449134|581605528|FG002|52-Week Treatment Period|Screen Failure|1|||
161058639|NCT03449134|581605526|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
161058640|NCT03449134|581605527|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
161058641|NCT03449134|581605528|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
161058642|NCT03449134|581605526|FG000|52-Week Treatment Period|Site Closure|1|||
161058643|NCT03449134|581605527|FG001|52-Week Treatment Period|Site Closure|0|||
161058644|NCT03449134|581605528|FG002|52-Week Treatment Period|Site Closure|0|||
161058645|NCT01821729|581605529|FG000|Overall Study|Withdrawal by Subject|1|||
161058646|NCT00837096|581605533|FG000|Overall Study|Physician Decision|1|||
161058647|NCT00837096|581605534|FG001|Overall Study|Physician Decision|1|||
161058648|NCT00837096|581605533|FG000|Overall Study|Not reported|9|||
161058649|NCT00837096|581605534|FG001|Overall Study|Not reported|8|||
161058650|NCT00983905|581605535|FG000|Theophylline Alone|Adverse Event|1|||
161058651|NCT00983905|581605535|FG000|Colchicine Alone|Adverse Event|2|||
161058652|NCT01169636|581605536|FG000|Overall Study|Adverse Event|0|||
161058653|NCT01169636|581605537|FG001|Overall Study|Adverse Event|0|||
161058654|NCT01169636|581605538|FG002|Overall Study|Adverse Event|1|||
161058655|NCT01169636|581605539|FG003|Overall Study|Adverse Event|1|||
161058656|NCT01169636|581605540|FG004|Overall Study|Adverse Event|0|||
161058657|NCT01169636|581605536|FG000|Overall Study|Screen failure|0|||
161058658|NCT01169636|581605537|FG001|Overall Study|Screen failure|0|||
161058659|NCT01169636|581605538|FG002|Overall Study|Screen failure|2|||
161058660|NCT01169636|581605539|FG003|Overall Study|Screen failure|0|||
161058661|NCT01169636|581605540|FG004|Overall Study|Screen failure|0|||
161058662|NCT01169636|581605536|FG000|Overall Study|Withdrawal by Subject|0|||
161058663|NCT01169636|581605537|FG001|Overall Study|Withdrawal by Subject|0|||
161058664|NCT01169636|581605538|FG002|Overall Study|Withdrawal by Subject|0|||
161058665|NCT01169636|581605539|FG003|Overall Study|Withdrawal by Subject|0|||
161058666|NCT01169636|581605540|FG004|Overall Study|Withdrawal by Subject|3|||
161058667|NCT00494026|581605541|FG000|Overall Study|Sponsor Decision|4|||
161058668|NCT00352053|581605545|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
161058669|NCT00352053|581605546|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
161058670|NCT00352053|581605545|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
161058671|NCT00352053|581605546|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
161058672|NCT00352053|581605545|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
161058673|NCT00352053|581605546|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
161058674|NCT00352053|581605545|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
161058675|NCT00352053|581605546|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
161058676|NCT00352053|581605545|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
161058677|NCT00352053|581605546|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
161058678|NCT00352053|581605545|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
161058679|NCT00352053|581605546|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
161058680|NCT00352053|581605545|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
161058681|NCT00352053|581605546|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
161281639|NCT00307437|582408768|FG001|After Controlled Period|Other|0|||
161281640|NCT00307437|582408769|FG002|After Controlled Period|Other|0|||
161281641|NCT00307437|582408770|FG003|After Controlled Period|Other|15|||
161281642|NCT00307437|582408771|FG004|After Controlled Period|Other|9|||
161281643|NCT00307437|582408772|FG005|After Controlled Period|Other|40|||
161281644|NCT00307437|582408773|FG006|After Controlled Period|Other|28|||
161058682|NCT00352053|581605545|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
161058683|NCT00352053|581605546|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
161058684|NCT00352053|581605545|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
161058685|NCT00352053|581605546|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
161058686|NCT00352053|581605545|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
161058687|NCT00352053|581605546|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
161058688|NCT00352053|581605545|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
161058689|NCT00352053|581605546|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
161058690|NCT00352053|581605545|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
161058691|NCT00352053|581605546|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
161058692|NCT00352053|581605545|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
161058693|NCT00352053|581605546|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
161058694|NCT00833898|581605547|FG000|Overall Study|Withdrawal by Subject|33|||
161058695|NCT00833898|581605548|FG001|Overall Study|Withdrawal by Subject|27|||
161058696|NCT00833898|581605547|FG000|Overall Study|Lost to Follow-up|7|||
161058697|NCT00833898|581605548|FG001|Overall Study|Lost to Follow-up|7|||
161058698|NCT00833898|581605547|FG000|Overall Study|Patient did not receive transplant|0|||
161058699|NCT00833898|581605548|FG001|Overall Study|Patient did not receive transplant|2|||
161058700|NCT03972137|581605555|FG000|Overall Study|Lost to Follow-up|2|||
161058701|NCT03972137|581605555|FG000|Overall Study|Withdrawal by Subject|4|||
161058702|NCT03226353|581605556|FG000|Overall Study|Withdrawal by Subject|1|||
161058703|NCT03226353|581605556|FG000|Overall Study|Screen Failure|5|||
161058704|NCT03168425|581605559|FG000|Overall Study|Lost to Follow-up|5|||
161058705|NCT03168425|581605560|FG001|Overall Study|Lost to Follow-up|8|||
161058706|NCT03168425|581605559|FG000|Overall Study|unable to confirm post op opioids|2|||
161058707|NCT03168425|581605560|FG001|Overall Study|unable to confirm post op opioids|3|||
161058708|NCT03029234|581605561|FG000|Overall Study|Sponsor Decision|1|||
161058709|NCT03029234|581605561|FG000|Overall Study|Withdrawal by Subject|5|||
161058710|NCT03029234|581605561|FG000|Overall Study|Death|91|||
161058711|NCT03029234|581605561|FG000|Overall Study|Lost to Follow-up|2|||
161058712|NCT00498433|581605562|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
161058713|NCT00498433|581605563|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
161058714|NCT00498433|581605564|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
161058715|NCT00498433|581605562|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
161058716|NCT00498433|581605563|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
161058717|NCT00498433|581605564|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
161058718|NCT00498433|581605562|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
161058719|NCT00498433|581605563|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
161058720|NCT00498433|581605564|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
161058721|NCT00498433|581605562|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
161058722|NCT00498433|581605563|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
161058723|NCT00498433|581605564|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
161058724|NCT01960114|581605565|FG000|Overall Study|Adverse Event|1|||
161058725|NCT01960114|581605566|FG001|Overall Study|Adverse Event|0|||
161058726|NCT01960114|581605565|FG000|Overall Study|Could not swallow study medication|0|||
161058727|NCT01960114|581605566|FG001|Overall Study|Could not swallow study medication|1|||
161058728|NCT01885936|581605577|FG000|Overall Study|Withdrawal by Subject|1|||
161058729|NCT01885936|581605578|FG001|Overall Study|Withdrawal by Subject|0|||
161058730|NCT00797511|581605579|FG000|Overall Study|Withdrawal by Subject|1|||
161058731|NCT00427778|581605580|FG000|First Intervention (4 Weeks)|no longer interested|1|||
161058732|NCT00427778|581605581|FG001|First Intervention (4 Weeks)|no longer interested|0|||
161058733|NCT00427778|581605580|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
161058734|NCT00427778|581605581|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
161058735|NCT00427778|581605580|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
161058736|NCT00427778|581605581|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
161058737|NCT00427778|581605580|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
161058738|NCT00427778|581605581|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
161058739|NCT02845375|581605582|FG000|Overall Study|upper airway obstruction|1|||
161281645|NCT03017612|582408776|FG000|Overall Study|Adverse Event|2|||
161058740|NCT02845375|581605583|FG001|Overall Study|upper airway obstruction|2|||
161058741|NCT02845375|581605584|FG002|Overall Study|upper airway obstruction|1|||
161058742|NCT00225277|581605587|FG000|Overall Study|Adverse Event|30|||
161058743|NCT00225277|581605588|FG001|Overall Study|Adverse Event|34|||
161281646|NCT01893346|582408778|FG000|Overall Study|Lost to Follow-up|0|||
161058744|NCT00225277|581605587|FG000|Overall Study|Lack of Efficacy|4|||
161281647|NCT01893346|582408779|FG001|Overall Study|Lost to Follow-up|1|||
161281648|NCT01893346|582408780|FG002|Overall Study|Lost to Follow-up|0|||
161281649|NCT01893346|582408781|FG003|Overall Study|Lost to Follow-up|0|||
161281650|NCT01893346|582408778|FG000|Overall Study|Protocol Violation|1|||
161281651|NCT01893346|582408779|FG001|Overall Study|Protocol Violation|0|||
161281652|NCT01893346|582408780|FG002|Overall Study|Protocol Violation|0|||
161281653|NCT01893346|582408781|FG003|Overall Study|Protocol Violation|0|||
161281654|NCT01893346|582408778|FG000|Overall Study|Withdrawal by Subject|2|||
161281655|NCT01893346|582408779|FG001|Overall Study|Withdrawal by Subject|0|||
161281656|NCT01893346|582408780|FG002|Overall Study|Withdrawal by Subject|0|||
161281657|NCT01893346|582408781|FG003|Overall Study|Withdrawal by Subject|0|||
161281658|NCT02121652|582410273|FG000|Overall Study|Lost to Follow-up|2|||
161281659|NCT02121652|582410274|FG001|Overall Study|Lost to Follow-up|1|||
161281660|NCT02121652|582410273|FG000|Overall Study|Death|1|||
161281661|NCT02121652|582410274|FG001|Overall Study|Death|0|||
161281662|NCT02121652|582410273|FG000|Overall Study|Withdrawal by Subject|3|||
161281663|NCT02121652|582410274|FG001|Overall Study|Withdrawal by Subject|3|||
161281664|NCT01090414|582410275|FG000|Study 101-99|Progressive Disease|28|||
161281665|NCT01090414|582410276|FG001|Study 101-99|Progressive Disease|48|||
161281666|NCT01090414|582410277|FG002|Study 101-99|Progressive Disease|10|||
161281667|NCT01090414|582410278|FG003|Study 101-99|Progressive Disease|4|||
161281668|NCT01090414|582410275|FG000|Study 101-99|Adverse Event|10|||
161281669|NCT01090414|582410276|FG001|Study 101-99|Adverse Event|28|||
161281670|NCT01090414|582410277|FG002|Study 101-99|Adverse Event|18|||
161281671|NCT01090414|582410278|FG003|Study 101-99|Adverse Event|0|||
161281672|NCT01090414|582410275|FG000|Study 101-99|Investigator Request|1|||
161281673|NCT01090414|582410276|FG001|Study 101-99|Investigator Request|11|||
161281674|NCT01090414|582410277|FG002|Study 101-99|Investigator Request|4|||
161281675|NCT01090414|582410278|FG003|Study 101-99|Investigator Request|0|||
161281676|NCT01090414|582410275|FG000|Study 101-99|Death|3|||
161281677|NCT01090414|582410276|FG001|Study 101-99|Death|8|||
161281678|NCT01090414|582410277|FG002|Study 101-99|Death|1|||
161281679|NCT01090414|582410278|FG003|Study 101-99|Death|0|||
161281680|NCT01090414|582410275|FG000|Study 101-99|Sponsor Discontinued Study|0|||
161281681|NCT01090414|582410276|FG001|Study 101-99|Sponsor Discontinued Study|7|||
161281682|NCT01090414|582410277|FG002|Study 101-99|Sponsor Discontinued Study|5|||
161281683|NCT01090414|582410278|FG003|Study 101-99|Sponsor Discontinued Study|0|||
161281684|NCT01090414|582410275|FG000|Study 101-99|Other (Unknown Reasons)|3|||
161281685|NCT01090414|582410276|FG001|Study 101-99|Other (Unknown Reasons)|3|||
161281686|NCT01090414|582410277|FG002|Study 101-99|Other (Unknown Reasons)|0|||
161281687|NCT01090414|582410278|FG003|Study 101-99|Other (Unknown Reasons)|0|||
161281688|NCT01090414|582410275|FG000|Study 101-99|Withdrew Consent|0|||
161281689|NCT01090414|582410276|FG001|Study 101-99|Withdrew Consent|2|||
161281690|NCT01090414|582410277|FG002|Study 101-99|Withdrew Consent|3|||
161281691|NCT01090414|582410278|FG003|Study 101-99|Withdrew Consent|1|||
161281692|NCT01090414|582410275|FG000|Study 101-99|Participant Request|3|||
161281693|NCT01090414|582410276|FG001|Study 101-99|Participant Request|1|||
161281694|NCT01090414|582410277|FG002|Study 101-99|Participant Request|0|||
161281695|NCT01090414|582410278|FG003|Study 101-99|Participant Request|0|||
161281696|NCT03022370|582410279|FG000|Overall Study|Death|6|||
161281697|NCT03022370|582410280|FG001|Overall Study|Death|12|||
161281698|NCT03022370|582410279|FG000|Overall Study|Lost to Follow-up|174|||
161058745|NCT00225277|581605588|FG001|Overall Study|Lack of Efficacy|1|||
161281699|NCT03022370|582410280|FG001|Overall Study|Lost to Follow-up|109|||
161281700|NCT00668317|582410281|FG000|Overall Study|Adverse Event|2|||
161281701|NCT04753216|582410282|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
161281702|NCT04753216|582410282|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
161281703|NCT04753216|582410282|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
161281704|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
161281705|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Death|1|||
161281706|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
161281707|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
161281708|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
161281709|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
161281710|NCT02001987|582410284|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
161281711|NCT02001987|582410284|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
161281712|NCT02001987|582410284|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
161058746|NCT00225277|581605587|FG000|Overall Study|Lost to Follow-up|4|||
161281713|NCT02001987|582410284|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
161281714|NCT02001987|582410284|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
161281715|NCT02001987|582410284|FG000|LTE Period (52 Weeks)|Other|3|||
161281716|NCT01965860|582410285|FG000|Overall Study|Pregnancy|1|||
161281717|NCT01965860|582410286|FG001|Overall Study|Pregnancy|0|||
161058747|NCT00225277|581605588|FG001|Overall Study|Lost to Follow-up|6|||
161281718|NCT01965860|582410287|FG002|Overall Study|Pregnancy|1|||
161281719|NCT01965860|582410285|FG000|Overall Study|Logistics|1|||
161281720|NCT01965860|582410286|FG001|Overall Study|Logistics|0|||
161281721|NCT01965860|582410287|FG002|Overall Study|Logistics|0|||
161281722|NCT01884337|582410292|FG000|Treatment|Adverse Event|2|||
161058748|NCT00225277|581605587|FG000|Overall Study|Physician Decision|6|||
161058749|NCT00225277|581605588|FG001|Overall Study|Physician Decision|8|||
161058750|NCT00225277|581605587|FG000|Overall Study|Protocol Violation|6|||
161058751|NCT00225277|581605588|FG001|Overall Study|Protocol Violation|3|||
161058752|NCT00225277|581605587|FG000|Overall Study|Withdrawal by Subject|40|||
161058753|NCT00225277|581605588|FG001|Overall Study|Withdrawal by Subject|34|||
161058754|NCT00225277|581605587|FG000|Overall Study|Other|7|||
161058755|NCT00225277|581605588|FG001|Overall Study|Other|9|||
161058756|NCT01340300|581605591|FG000|Overall Study|Lost to Follow-up|3|||
161058757|NCT01340300|581605592|FG001|Overall Study|Lost to Follow-up|0|||
161058758|NCT01340300|581605593|FG002|Overall Study|Lost to Follow-up|5|||
161058759|NCT01340300|581605594|FG003|Overall Study|Lost to Follow-up|10|||
161058760|NCT01340300|581605591|FG000|Overall Study|Withdrawal by Subject|5|||
161058761|NCT01340300|581605592|FG001|Overall Study|Withdrawal by Subject|6|||
161058762|NCT01340300|581605593|FG002|Overall Study|Withdrawal by Subject|6|||
161058763|NCT01340300|581605594|FG003|Overall Study|Withdrawal by Subject|3|||
161058764|NCT01340300|581605591|FG000|Overall Study|Adverse Event|1|||
161058765|NCT01340300|581605592|FG001|Overall Study|Adverse Event|0|||
161058766|NCT01340300|581605593|FG002|Overall Study|Adverse Event|4|||
161058767|NCT01340300|581605594|FG003|Overall Study|Adverse Event|0|||
161058768|NCT01340300|581605591|FG000|Overall Study|Physician Decision|0|||
161152795|NCT02163993|581940897|FG002|Post-treatment Period|Lost to Follow-up|3|||
161152796|NCT02163993|581940898|FG003|Post-treatment Period|Lost to Follow-up|1|||
161152797|NCT02163993|581940899|FG004|Post-treatment Period|Lost to Follow-up|0|||
161152798|NCT02163993|581940895|FG000|Post-treatment Period|Protocol Violation|0|||
161152799|NCT02163993|581940896|FG001|Post-treatment Period|Protocol Violation|0|||
161152800|NCT02163993|581940897|FG002|Post-treatment Period|Protocol Violation|0|||
161152801|NCT02163993|581940898|FG003|Post-treatment Period|Protocol Violation|0|||
161152802|NCT02163993|581940899|FG004|Post-treatment Period|Protocol Violation|1|||
161152803|NCT02163993|581940895|FG000|Post-treatment Period|Withdrawal by Subject|2|||
161152804|NCT02163993|581940896|FG001|Post-treatment Period|Withdrawal by Subject|4|||
161152805|NCT02163993|581940897|FG002|Post-treatment Period|Withdrawal by Subject|0|||
161152806|NCT02163993|581940898|FG003|Post-treatment Period|Withdrawal by Subject|1|||
161152807|NCT02163993|581940899|FG004|Post-treatment Period|Withdrawal by Subject|2|||
161152808|NCT01808118|581940900|FG000|Period 1|Adverse Event|15|||
161152809|NCT01808118|581940901|FG001|Period 1|Adverse Event|0|||
161152810|NCT01808118|581940902|FG002|Period 1|Adverse Event|0|||
161152811|NCT01808118|581940900|FG000|Period 1|Withdrew consent|24|||
161152812|NCT01808118|581940901|FG001|Period 1|Withdrew consent|0|||
161152813|NCT01808118|581940902|FG002|Period 1|Withdrew consent|0|||
161152814|NCT01808118|581940900|FG000|Period 1|Lost to Follow-up|9|||
161152815|NCT01808118|581940901|FG001|Period 1|Lost to Follow-up|0|||
161152816|NCT01808118|581940902|FG002|Period 1|Lost to Follow-up|0|||
161152817|NCT01808118|581940900|FG000|Period 1|Did not meet criteria for remission|303|||
161152818|NCT01808118|581940901|FG001|Period 1|Did not meet criteria for remission|0|||
161152819|NCT01808118|581940902|FG002|Period 1|Did not meet criteria for remission|0|||
161152820|NCT01808118|581940900|FG000|Period 1|Enrolled in error|7|||
161152821|NCT01808118|581940901|FG001|Period 1|Enrolled in error|0|||
161152822|NCT01808118|581940902|FG002|Period 1|Enrolled in error|0|||
161152823|NCT01808118|581940900|FG000|Period 1|Did not meet inclusion criteria|3|||
161152824|NCT01808118|581940901|FG001|Period 1|Did not meet inclusion criteria|0|||
161152825|NCT01808118|581940902|FG002|Period 1|Did not meet inclusion criteria|0|||
161152826|NCT01808118|581940900|FG000|Period 1|Non-conformance with inclusion criteria|3|||
161152827|NCT01808118|581940901|FG001|Period 1|Non-conformance with inclusion criteria|0|||
161152828|NCT01808118|581940902|FG002|Period 1|Non-conformance with inclusion criteria|0|||
161152829|NCT01808118|581940900|FG000|Period 1|Investigator decision: site closure|2|||
161152830|NCT01808118|581940901|FG001|Period 1|Investigator decision: site closure|0|||
161152831|NCT01808118|581940902|FG002|Period 1|Investigator decision: site closure|0|||
161152832|NCT01808118|581940900|FG000|Period 1|Non-compliance per sponsor|1|||
161152833|NCT01808118|581940901|FG001|Period 1|Non-compliance per sponsor|0|||
161152834|NCT01808118|581940902|FG002|Period 1|Non-compliance per sponsor|0|||
161152835|NCT01808118|581940900|FG000|Period 1|Lack of Efficacy|1|||
161152836|NCT01808118|581940901|FG001|Period 1|Lack of Efficacy|0|||
161152837|NCT01808118|581940902|FG002|Period 1|Lack of Efficacy|0|||
161152838|NCT01808118|581940900|FG000|Period 2|Adverse Event|0|||
161152839|NCT01808118|581940901|FG001|Period 2|Adverse Event|4|||
161152840|NCT01808118|581940902|FG002|Period 2|Adverse Event|0|||
161152841|NCT01808118|581940900|FG000|Period 2|Withdrew consent|0|||
161152842|NCT01808118|581940901|FG001|Period 2|Withdrew consent|7|||
161152843|NCT01808118|581940902|FG002|Period 2|Withdrew consent|6|||
161152844|NCT01808118|581940900|FG000|Period 2|Lost to Follow-up|0|||
161152845|NCT01808118|581940901|FG001|Period 2|Lost to Follow-up|0|||
161152846|NCT01808118|581940902|FG002|Period 2|Lost to Follow-up|2|||
161058769|NCT01340300|581605592|FG001|Overall Study|Physician Decision|1|||
161152847|NCT01808118|581940900|FG000|Period 2|Investigator no longer conducting trials|0|||
161152848|NCT01808118|581940901|FG001|Period 2|Investigator no longer conducting trials|1|||
161152849|NCT01808118|581940902|FG002|Period 2|Investigator no longer conducting trials|0|||
161152850|NCT01808118|581940900|FG000|Period 2|Switched to other therapy|0|||
161152851|NCT01808118|581940901|FG001|Period 2|Switched to other therapy|1|||
161152852|NCT01808118|581940902|FG002|Period 2|Switched to other therapy|0|||
161152853|NCT03097328|581940908|FG000|Overall Study|Still on Therapy|2|||
161152854|NCT03097328|581940908|FG000|Overall Study|Progressive Disease|29|||
161152855|NCT03097328|581940908|FG000|Overall Study|Adverse Event|4|||
161152856|NCT03097328|581940908|FG000|Overall Study|Withdrawal by Subject|1|||
161152857|NCT03097328|581940908|FG000|Overall Study|Physician Decision|1|||
161152858|NCT03097328|581940908|FG000|Overall Study|Patient Decision|1|||
161152859|NCT03097328|581940908|FG000|Overall Study|Ineligible for Study Drug|1|||
161152860|NCT02023164|581940909|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
161152861|NCT02023164|581940910|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
161152862|NCT04184622|581940912|FG000|Primary Treatment Period|Adverse Event|6|||
161152863|NCT04184622|581940913|FG001|Primary Treatment Period|Adverse Event|4|||
161152864|NCT04184622|581940914|FG002|Primary Treatment Period|Adverse Event|8|||
161152865|NCT04184622|581940915|FG003|Primary Treatment Period|Adverse Event|6|||
161152866|NCT04184622|581940912|FG000|Primary Treatment Period|Death|4|||
161152867|NCT04184622|581940913|FG001|Primary Treatment Period|Death|4|||
161152868|NCT04184622|581940914|FG002|Primary Treatment Period|Death|2|||
161152869|NCT04184622|581940915|FG003|Primary Treatment Period|Death|1|||
161152870|NCT04184622|581940912|FG000|Primary Treatment Period|Lost to Follow-up|41|||
161152871|NCT04184622|581940913|FG001|Primary Treatment Period|Lost to Follow-up|17|||
161152872|NCT04184622|581940914|FG002|Primary Treatment Period|Lost to Follow-up|15|||
161152873|NCT04184622|581940915|FG003|Primary Treatment Period|Lost to Follow-up|13|||
161152874|NCT04184622|581940912|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
161152875|NCT04184622|581940913|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
161152876|NCT04184622|581940914|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
161152877|NCT04184622|581940915|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
161152878|NCT04184622|581940912|FG000|Primary Treatment Period|Physician Decision|0|||
161152879|NCT04184622|581940913|FG001|Primary Treatment Period|Physician Decision|0|||
161152880|NCT04184622|581940914|FG002|Primary Treatment Period|Physician Decision|3|||
161152881|NCT04184622|581940915|FG003|Primary Treatment Period|Physician Decision|1|||
161152882|NCT04184622|581940912|FG000|Primary Treatment Period|Pregnancy|4|||
161152883|NCT04184622|581940913|FG001|Primary Treatment Period|Pregnancy|3|||
161152884|NCT04184622|581940914|FG002|Primary Treatment Period|Pregnancy|4|||
161152885|NCT04184622|581940915|FG003|Primary Treatment Period|Pregnancy|1|||
161152886|NCT04184622|581940912|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
161152887|NCT04184622|581940913|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
161152888|NCT04184622|581940914|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
161152889|NCT04184622|581940915|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
161152890|NCT04184622|581940912|FG000|Additional Treatment Period|Adverse Event|1|||
161152891|NCT04184622|581940913|FG001|Additional Treatment Period|Adverse Event|2|||
161152892|NCT04184622|581940914|FG002|Additional Treatment Period|Adverse Event|1|||
161152893|NCT04184622|581940915|FG003|Additional Treatment Period|Adverse Event|0|||
161152894|NCT04184622|581940912|FG000|Additional Treatment Period|Death|0|||
161152895|NCT04184622|581940913|FG001|Additional Treatment Period|Death|0|||
161152896|NCT04184622|581940914|FG002|Additional Treatment Period|Death|1|||
161152897|NCT04184622|581940915|FG003|Additional Treatment Period|Death|1|||
161152898|NCT04184622|581940912|FG000|Additional Treatment Period|Lost to Follow-up|6|||
161152899|NCT04184622|581940913|FG001|Additional Treatment Period|Lost to Follow-up|4|||
161152900|NCT04184622|581940914|FG002|Additional Treatment Period|Lost to Follow-up|8|||
161152901|NCT04184622|581940915|FG003|Additional Treatment Period|Lost to Follow-up|6|||
161152902|NCT04184622|581940912|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
161152903|NCT04184622|581940913|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
161152904|NCT04184622|581940914|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
161152905|NCT04184622|581940915|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
161152906|NCT04184622|581940912|FG000|Additional Treatment Period|Physician Decision|0|||
161152907|NCT04184622|581940913|FG001|Additional Treatment Period|Physician Decision|0|||
161152908|NCT04184622|581940914|FG002|Additional Treatment Period|Physician Decision|1|||
161152909|NCT04184622|581940915|FG003|Additional Treatment Period|Physician Decision|0|||
161152910|NCT04184622|581940912|FG000|Additional Treatment Period|Pregnancy|0|||
161152911|NCT04184622|581940913|FG001|Additional Treatment Period|Pregnancy|0|||
161152912|NCT04184622|581940914|FG002|Additional Treatment Period|Pregnancy|0|||
161152913|NCT04184622|581940915|FG003|Additional Treatment Period|Pregnancy|1|||
161152914|NCT04184622|581940912|FG000|Additional Treatment Period|Protocol deviation|0|||
161152915|NCT04184622|581940913|FG001|Additional Treatment Period|Protocol deviation|0|||
161152916|NCT04184622|581940914|FG002|Additional Treatment Period|Protocol deviation|1|||
161152917|NCT04184622|581940915|FG003|Additional Treatment Period|Protocol deviation|0|||
161152918|NCT04184622|581940912|FG000|Additional Treatment Period|Site closed|1|||
161152919|NCT04184622|581940913|FG001|Additional Treatment Period|Site closed|0|||
161152920|NCT04184622|581940914|FG002|Additional Treatment Period|Site closed|1|||
161152921|NCT04184622|581940915|FG003|Additional Treatment Period|Site closed|0|||
161152922|NCT04184622|581940912|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
161058770|NCT01340300|581605593|FG002|Overall Study|Physician Decision|0|||
161058771|NCT01340300|581605594|FG003|Overall Study|Physician Decision|0|||
161058772|NCT01340300|581605591|FG000|Overall Study|Unrelated sickness|0|||
161058773|NCT01340300|581605592|FG001|Overall Study|Unrelated sickness|2|||
161058774|NCT01340300|581605593|FG002|Overall Study|Unrelated sickness|0|||
161058775|NCT01340300|581605594|FG003|Overall Study|Unrelated sickness|1|||
161058776|NCT01951261|581605595|FG000|Overall Study|Death|1|||
161058777|NCT01951261|581605596|FG001|Overall Study|Death|0|||
161058778|NCT01951261|581605595|FG000|Overall Study|Lost to Follow-up|4|||
161058779|NCT01951261|581605596|FG001|Overall Study|Lost to Follow-up|3|||
161058780|NCT01951261|581605595|FG000|Overall Study|Protocol Violation|4|||
161058781|NCT01951261|581605596|FG001|Overall Study|Protocol Violation|3|||
161058782|NCT03927222|581605600|FG000|Overall Study|Progression|3|||
161058783|NCT03927222|581605600|FG000|Overall Study|CMV testing results inconclusive|1|||
161058784|NCT03927222|581605600|FG000|Overall Study|Unable to generate enough vaccines|1|||
161058785|NCT03927222|581605600|FG000|Overall Study|Early study termination|1|||
161058786|NCT03723915|581605606|FG000|Screening|Failed to meet screening requirements.|2|||
161058787|NCT03723915|581605606|FG000|On Treatment|Failed to meet treatment requirements|2|||
161058788|NCT02201771|581605607|FG000|Overall Study|Death|3|||
161058789|NCT02201771|581605608|FG001|Overall Study|Death|2|||
161058790|NCT02201771|581605609|FG002|Overall Study|Death|0|||
161058791|NCT02201771|581605607|FG000|Overall Study|Protocol Violation|10|||
161058792|NCT02201771|581605608|FG001|Overall Study|Protocol Violation|8|||
161058793|NCT02201771|581605609|FG002|Overall Study|Protocol Violation|10|||
161058794|NCT01287416|581605612|FG000|Pre-post Training|Withdrawal by Subject|17|||
161058795|NCT01287416|581605613|FG001|Pre-post Training|Withdrawal by Subject|24|||
161058796|NCT01287416|581605612|FG000|Pre-post Training|Lost to Follow-up|5|||
161058797|NCT01287416|581605613|FG001|Pre-post Training|Lost to Follow-up|1|||
161058798|NCT01287416|581605612|FG000|6 Month Follow-up|Lost to Follow-up|3|||
161058799|NCT01287416|581605613|FG001|6 Month Follow-up|Lost to Follow-up|2|||
161058800|NCT00818519|581605619|FG000|Overall Study|Adverse Event|2|||
161058801|NCT00818519|581605620|FG001|Overall Study|Adverse Event|2|||
161058802|NCT00818519|581605619|FG000|Overall Study|Lost to Follow-up|4|||
161058803|NCT00818519|581605620|FG001|Overall Study|Lost to Follow-up|6|||
161058804|NCT00818519|581605619|FG000|Overall Study|Protocol Violation|2|||
161058805|NCT00818519|581605620|FG001|Overall Study|Protocol Violation|1|||
161058806|NCT00818519|581605619|FG000|Overall Study|Pregnancy|0|||
161058807|NCT00818519|581605620|FG001|Overall Study|Pregnancy|1|||
161058808|NCT00818519|581605619|FG000|Overall Study|Withdrawal by Subject|4|||
161058809|NCT00818519|581605620|FG001|Overall Study|Withdrawal by Subject|9|||
161058810|NCT00818519|581605619|FG000|Overall Study|participant recovered completely|1|||
161058811|NCT00818519|581605620|FG001|Overall Study|participant recovered completely|0|||
161058812|NCT00818519|581605619|FG000|Overall Study|participant will leave for long tme|1|||
161058813|NCT00818519|581605620|FG001|Overall Study|participant will leave for long tme|0|||
161058814|NCT01180790|581605622|FG000|Overall Study|Adverse Event|1|||
161058815|NCT01180790|581605623|FG001|Overall Study|Adverse Event|1|||
161058816|NCT01180790|581605624|FG002|Overall Study|Adverse Event|2|||
161058817|NCT01180790|581605625|FG003|Overall Study|Adverse Event|0|||
161058818|NCT01180790|581605626|FG004|Overall Study|Adverse Event|1|||
161058819|NCT01180790|581605627|FG005|Overall Study|Adverse Event|3|||
161058820|NCT01180790|581605628|FG006|Overall Study|Adverse Event|0|||
161058821|NCT01180790|581605622|FG000|Overall Study|Withdrawal by Subject|3|||
161058822|NCT01180790|581605623|FG001|Overall Study|Withdrawal by Subject|0|||
161058823|NCT01180790|581605624|FG002|Overall Study|Withdrawal by Subject|5|||
161058824|NCT01180790|581605625|FG003|Overall Study|Withdrawal by Subject|0|||
161058825|NCT01180790|581605626|FG004|Overall Study|Withdrawal by Subject|2|||
161058826|NCT01180790|581605627|FG005|Overall Study|Withdrawal by Subject|1|||
161058827|NCT01180790|581605628|FG006|Overall Study|Withdrawal by Subject|0|||
161058828|NCT01180790|581605622|FG000|Overall Study|Lost to Follow-up|3|||
161058829|NCT01180790|581605623|FG001|Overall Study|Lost to Follow-up|1|||
161058830|NCT01180790|581605624|FG002|Overall Study|Lost to Follow-up|0|||
161281723|NCT01884337|582410293|FG001|Treatment|Adverse Event|2|||
161152923|NCT04184622|581940913|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
161058831|NCT01180790|581605625|FG003|Overall Study|Lost to Follow-up|2|||
161058832|NCT01180790|581605626|FG004|Overall Study|Lost to Follow-up|1|||
161058833|NCT01180790|581605627|FG005|Overall Study|Lost to Follow-up|0|||
161058834|NCT01180790|581605628|FG006|Overall Study|Lost to Follow-up|1|||
161058835|NCT01180790|581605622|FG000|Overall Study|Physician Decision|1|||
161058836|NCT01180790|581605623|FG001|Overall Study|Physician Decision|0|||
161058837|NCT01180790|581605624|FG002|Overall Study|Physician Decision|0|||
161058838|NCT01180790|581605625|FG003|Overall Study|Physician Decision|1|||
161058839|NCT01180790|581605626|FG004|Overall Study|Physician Decision|0|||
161058840|NCT01180790|581605627|FG005|Overall Study|Physician Decision|0|||
161058841|NCT01180790|581605628|FG006|Overall Study|Physician Decision|0|||
161058842|NCT01180790|581605622|FG000|Overall Study|Lack of Efficacy|1|||
161058843|NCT01180790|581605623|FG001|Overall Study|Lack of Efficacy|2|||
161058844|NCT01180790|581605624|FG002|Overall Study|Lack of Efficacy|5|||
161058845|NCT01180790|581605625|FG003|Overall Study|Lack of Efficacy|6|||
161058846|NCT01180790|581605626|FG004|Overall Study|Lack of Efficacy|1|||
161058847|NCT01180790|581605627|FG005|Overall Study|Lack of Efficacy|3|||
161058848|NCT01180790|581605628|FG006|Overall Study|Lack of Efficacy|0|||
161058849|NCT01180790|581605622|FG000|Overall Study|compliance|0|||
161058850|NCT01180790|581605623|FG001|Overall Study|compliance|1|||
161058851|NCT01180790|581605624|FG002|Overall Study|compliance|0|||
161058852|NCT01180790|581605625|FG003|Overall Study|compliance|0|||
161058853|NCT01180790|581605626|FG004|Overall Study|compliance|0|||
161058854|NCT01180790|581605627|FG005|Overall Study|compliance|0|||
161058855|NCT01180790|581605628|FG006|Overall Study|compliance|0|||
161058856|NCT01180790|581605622|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
161058857|NCT01180790|581605623|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
161058858|NCT01180790|581605624|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
161058859|NCT01180790|581605625|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
161058860|NCT01180790|581605626|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
161058861|NCT01180790|581605627|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
161058862|NCT01180790|581605628|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
161058863|NCT02335242|581605629|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
161058864|NCT02335242|581605630|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
161058865|NCT02335242|581605629|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
161058866|NCT02335242|581605630|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
161058867|NCT02335242|581605629|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
161058868|NCT02335242|581605630|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
161058869|NCT04167085|581605631|FG000|Baseline|Withdrawal by Subject|2|||
161058870|NCT04167085|581605632|FG001|Baseline|Withdrawal by Subject|1|||
161058871|NCT04167085|581605631|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
161058872|NCT04167085|581605632|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
161058873|NCT03840148|581605633|FG000|Study Drug Disposition|Adverse Event|13|||
161058874|NCT03840148|581605634|FG001|Study Drug Disposition|Adverse Event|2|||
161058875|NCT03840148|581605633|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
161058876|NCT03840148|581605634|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
161058877|NCT03840148|581605633|FG000|Study Drug Disposition|Lack of Efficacy|3|||
161058878|NCT03840148|581605634|FG001|Study Drug Disposition|Lack of Efficacy|0|||
161058879|NCT03840148|581605633|FG000|Study Drug Disposition|Physician Decision|2|||
161058880|NCT03840148|581605634|FG001|Study Drug Disposition|Physician Decision|0|||
161058881|NCT03840148|581605633|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
161058882|NCT03840148|581605634|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
161058883|NCT03840148|581605633|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
161058884|NCT03840148|581605634|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
161058885|NCT03840148|581605633|FG000|Study Completion Disposition|Physician Decision|2|||
161058886|NCT03840148|581605634|FG001|Study Completion Disposition|Physician Decision|0|||
161058887|NCT03840148|581605633|FG000|Study Completion Disposition|Covid-19 related|2|||
161058888|NCT03840148|581605634|FG001|Study Completion Disposition|Covid-19 related|0|||
161058889|NCT03840148|581605633|FG000|Study Completion Disposition|Lost to Follow-up|1|||
161058890|NCT03840148|581605634|FG001|Study Completion Disposition|Lost to Follow-up|1|||
161058891|NCT03840148|581605633|FG000|Study Completion Disposition|Death|1|||
161058892|NCT03840148|581605634|FG001|Study Completion Disposition|Death|0|||
161058893|NCT03840148|581605633|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
161058894|NCT03840148|581605634|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
161058895|NCT03615404|581605635|FG000|Overall Study|Death|1|||
161058896|NCT03615404|581605635|FG000|Overall Study|vaccine did not pass quality assurance|1|||
161058897|NCT03873038|581605636|FG000|Part 2|Withdrawal by Subject|0|||
161058898|NCT03873038|581605637|FG001|Part 2|Withdrawal by Subject|0|||
161058899|NCT03873038|581605638|FG002|Part 2|Withdrawal by Subject|0|||
161058900|NCT03873038|581605639|FG003|Part 2|Withdrawal by Subject|0|||
161058901|NCT03873038|581605640|FG004|Part 2|Withdrawal by Subject|0|||
161058902|NCT03873038|581605641|FG005|Part 2|Withdrawal by Subject|1|||
161058903|NCT03873038|581605636|FG000|Part 2|Unknon|0|||
161058904|NCT03873038|581605637|FG001|Part 2|Unknon|0|||
161058905|NCT03873038|581605638|FG002|Part 2|Unknon|0|||
161058906|NCT03873038|581605639|FG003|Part 2|Unknon|0|||
161058907|NCT03873038|581605640|FG004|Part 2|Unknon|1|||
161058908|NCT03873038|581605641|FG005|Part 2|Unknon|0|||
161058909|NCT00595764|581605643|FG000|Overall Study|Protocol Violation|24|||
161058910|NCT00595764|581605644|FG001|Overall Study|Protocol Violation|19|||
161058911|NCT00595764|581605643|FG000|Overall Study|Missed Medication >1 week|10|||
161058912|NCT00595764|581605644|FG001|Overall Study|Missed Medication >1 week|17|||
161058913|NCT00595764|581605643|FG000|Overall Study|Missed 3 PM visits|1|||
161058914|NCT00595764|581605644|FG001|Overall Study|Missed 3 PM visits|7|||
161058915|NCT00595764|581605643|FG000|Overall Study|Withdrawal by Subject|4|||
161058916|NCT00595764|581605644|FG001|Overall Study|Withdrawal by Subject|0|||
161058917|NCT04222088|581605645|FG000|Overall Study|Lost to Follow-up|5|||
161058918|NCT04222088|581605646|FG001|Overall Study|Lost to Follow-up|1|||
161058919|NCT04222088|581605645|FG000|Overall Study|Withdrawal by Subject|4|||
161281724|NCT01884337|582410292|FG000|Treatment|Subj. request to discont. treatment|2|||
161281725|NCT01884337|582410293|FG001|Treatment|Subj. request to discont. treatment|0|||
161281726|NCT01884337|582410292|FG000|Follow-up Period|Lost to Follow-up|1|||
161281727|NCT01884337|582410293|FG001|Follow-up Period|Lost to Follow-up|1|||
161281728|NCT02455518|582410294|FG000|Overall Study|Protocol Violation|0|||
161281729|NCT02455518|582410295|FG001|Overall Study|Protocol Violation|1|||
161281730|NCT02455518|582410296|FG002|Overall Study|Protocol Violation|1|||
161281731|NCT02455518|582410297|FG003|Overall Study|Protocol Violation|3|||
161281732|NCT02508935|582410298|FG000|Overall Study|Withdrawal by Subject|1|||
161281733|NCT02508935|582410298|FG000|Overall Study|Withdrawal by Caregiver|8|||
161281734|NCT02508935|582410298|FG000|Overall Study|Pain Score <4|1|||
161281735|NCT02508935|582410298|FG000|Overall Study|Emesis|3|||
161281736|NCT02508935|582410298|FG000|Overall Study|Adverse Event|3|||
161281737|NCT02508935|582410298|FG000|Overall Study|Protocol Violation|1|||
161281738|NCT02508935|582410298|FG000|Overall Study|Physician Decision|1|||
161281739|NCT02508935|582410298|FG000|Overall Study|Trial terminated by sponsor|5|||
161281740|NCT01332292|582410312|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161281741|NCT01332292|582410313|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161281742|NCT01332292|582410312|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161058920|NCT04222088|581605646|FG001|Overall Study|Withdrawal by Subject|0|||
161058921|NCT03849300|581605647|FG000|Overall Study|move out to different area|1|||
161058922|NCT03849300|581605648|FG001|Overall Study|move out to different area|3|||
161058923|NCT03849300|581605649|FG002|Overall Study|move out to different area|1|||
161058924|NCT03849300|581605650|FG003|Overall Study|move out to different area|4|||
161058925|NCT03849300|581605647|FG000|Overall Study|scheduling/transportation conflict|4|||
161281743|NCT01332292|582410313|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161058926|NCT03849300|581605648|FG001|Overall Study|scheduling/transportation conflict|4|||
161058927|NCT03849300|581605649|FG002|Overall Study|scheduling/transportation conflict|3|||
161058928|NCT03849300|581605650|FG003|Overall Study|scheduling/transportation conflict|2|||
161058929|NCT04839289|581605651|FG000|Overall Study|Withdrawal by Subject|1|||
161058930|NCT04839289|581605652|FG001|Overall Study|Withdrawal by Subject|0|||
161058931|NCT00464737|581605654|FG000|Overall Study|Adverse Event|12|||
161058932|NCT00464737|581605655|FG001|Overall Study|Adverse Event|17|||
161058933|NCT00464737|581605656|FG002|Overall Study|Adverse Event|33|||
161058934|NCT00464737|581605654|FG000|Overall Study|Lack of Efficacy|7|||
161058935|NCT00464737|581605655|FG001|Overall Study|Lack of Efficacy|7|||
161058936|NCT00464737|581605656|FG002|Overall Study|Lack of Efficacy|4|||
161058937|NCT00464737|581605654|FG000|Overall Study|Withdrawal by Subject|5|||
161058938|NCT00464737|581605655|FG001|Overall Study|Withdrawal by Subject|3|||
161058939|NCT00464737|581605656|FG002|Overall Study|Withdrawal by Subject|5|||
161058940|NCT00464737|581605654|FG000|Overall Study|Protocol Violation|1|||
161058941|NCT00464737|581605655|FG001|Overall Study|Protocol Violation|1|||
161058942|NCT00464737|581605656|FG002|Overall Study|Protocol Violation|5|||
161058943|NCT00464737|581605654|FG000|Overall Study|Non-compliance|0|||
161058944|NCT00464737|581605655|FG001|Overall Study|Non-compliance|1|||
161058945|NCT00464737|581605656|FG002|Overall Study|Non-compliance|1|||
161058946|NCT00464737|581605654|FG000|Overall Study|Lost to Follow-up|5|||
161058947|NCT00464737|581605655|FG001|Overall Study|Lost to Follow-up|2|||
161058948|NCT00464737|581605656|FG002|Overall Study|Lost to Follow-up|5|||
161058949|NCT00464737|581605654|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
161058950|NCT00464737|581605655|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
161058951|NCT00464737|581605656|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
161058952|NCT00464737|581605654|FG000|Overall Study|Other: Subject left town; family illness|1|||
161058953|NCT00464737|581605655|FG001|Overall Study|Other: Subject left town; family illness|0|||
161058954|NCT00464737|581605656|FG002|Overall Study|Other: Subject left town; family illness|0|||
161058955|NCT00464737|581605654|FG000|Overall Study|Other: Study demands too great|0|||
161058956|NCT00464737|581605655|FG001|Overall Study|Other: Study demands too great|1|||
161058957|NCT00464737|581605656|FG002|Overall Study|Other: Study demands too great|0|||
161058958|NCT00464737|581605654|FG000|Overall Study|Other: Personal family reasons|0|||
161058959|NCT00464737|581605655|FG001|Overall Study|Other: Personal family reasons|0|||
161058960|NCT00464737|581605656|FG002|Overall Study|Other: Personal family reasons|1|||
161058961|NCT00464737|581605654|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
161058962|NCT00464737|581605655|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
161152924|NCT04184622|581940914|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
161281744|NCT01332292|582410312|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
161281745|NCT01332292|582410313|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
161281746|NCT00104572|582410314|FG000|Overall Study|Withdrawal by Subject|3|||
161281747|NCT00104572|582410315|FG001|Overall Study|Withdrawal by Subject|3|||
161058963|NCT00464737|581605656|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
161058964|NCT00580047|581605659|FG000|Overall Study|Lost to Follow-up|1|||
161058965|NCT00580047|581605660|FG001|Overall Study|Lost to Follow-up|1|||
161058966|NCT00580047|581605661|FG002|Overall Study|Lost to Follow-up|0|||
161058967|NCT00580047|581605659|FG000|Overall Study|Withdrawal by Subject|1|||
161058968|NCT00580047|581605660|FG001|Overall Study|Withdrawal by Subject|1|||
161058969|NCT00580047|581605661|FG002|Overall Study|Withdrawal by Subject|2|||
161058970|NCT00580047|581605659|FG000|Overall Study|Withdrawal by Subject|1|||
161058971|NCT00580047|581605660|FG001|Overall Study|Withdrawal by Subject|0|||
161058972|NCT00580047|581605661|FG002|Overall Study|Withdrawal by Subject|0|||
161058973|NCT03406507|581605667|FG000|Extension Period|Lack of Efficacy|0|||
161058974|NCT03406507|581605668|FG001|Extension Period|Lack of Efficacy|1|||
161058975|NCT04341584|581605669|FG000|Overall Study|Withdrew consent|0|||
161058976|NCT04341584|581605670|FG001|Overall Study|Withdrew consent|2|||
161058977|NCT04341584|581605671|FG002|Overall Study|Withdrew consent|2|||
161058978|NCT04341584|581605672|FG003|Overall Study|Withdrew consent|1|||
161058979|NCT04130061|581605673|FG000|Overall Study|OR team forgot to request membrane|1|||
161058980|NCT04130061|581605674|FG001|Overall Study|OR team forgot to request membrane|0|||
161058981|NCT01960348|581607508|FG000|Overall Study|Adverse event, not serious|2|||
161058982|NCT01960348|581607509|FG001|Overall Study|Adverse event, not serious|2|||
161058983|NCT01960348|581607508|FG000|Overall Study|Adverse event, serious fatal|6|||
161058984|NCT01960348|581607509|FG001|Overall Study|Adverse event, serious fatal|5|||
161058985|NCT01960348|581607508|FG000|Overall Study|Adverse event, serious non-fatal|0|||
161058986|NCT01960348|581607509|FG001|Overall Study|Adverse event, serious non-fatal|3|||
161058987|NCT01960348|581607508|FG000|Overall Study|Withdrawal by Subject|1|||
161058988|NCT01960348|581607509|FG001|Overall Study|Withdrawal by Subject|11|||
161058989|NCT01960348|581607508|FG000|Overall Study|Physician Decision|0|||
161058990|NCT01960348|581607509|FG001|Overall Study|Physician Decision|1|||
161058991|NCT01960348|581607508|FG000|Overall Study|Protocol Violation|1|||
161058992|NCT01960348|581607509|FG001|Overall Study|Protocol Violation|0|||
161058993|NCT01093599|581607515|FG000|Overall Study|Lost to Follow-up|32|||
161058994|NCT01093599|581607516|FG001|Overall Study|Lost to Follow-up|46|||
161058995|NCT01644188|581607517|FG000|Overall Study|Adverse Event|44|||
161058996|NCT01644188|581607518|FG001|Overall Study|Adverse Event|20|||
161058997|NCT01644188|581607517|FG000|Overall Study|Poor compliance to protocol|26|||
161058998|NCT01644188|581607518|FG001|Overall Study|Poor compliance to protocol|14|||
161058999|NCT01644188|581607517|FG000|Overall Study|Physician Decision|1|||
161059000|NCT01644188|581607518|FG001|Overall Study|Physician Decision|3|||
161059001|NCT01644188|581607517|FG000|Overall Study|Participant moved|7|||
161059002|NCT01644188|581607518|FG001|Overall Study|Participant moved|2|||
161059003|NCT01644188|581607517|FG000|Overall Study|Related to auto-injector administration|2|||
161059004|NCT01644188|581607518|FG001|Overall Study|Related to auto-injector administration|2|||
161059005|NCT01644188|581607517|FG000|Overall Study|Consent withdrawn by participant|14|||
161059006|NCT01644188|581607518|FG001|Overall Study|Consent withdrawn by participant|7|||
161059007|NCT01644188|581607517|FG000|Overall Study|Selection criteria finally not met|2|||
161059008|NCT01644188|581607518|FG001|Overall Study|Selection criteria finally not met|0|||
161059009|NCT01644188|581607517|FG000|Overall Study|Lost to Follow-up|1|||
161059010|NCT01644188|581607518|FG001|Overall Study|Lost to Follow-up|0|||
161059011|NCT01644188|581607517|FG000|Overall Study|Death|4|||
161059012|NCT01644188|581607518|FG001|Overall Study|Death|3|||
161059013|NCT01644188|581607517|FG000|Overall Study|Last visit outside protocol visit window|14|||
161059014|NCT01644188|581607518|FG001|Overall Study|Last visit outside protocol visit window|16|||
161059015|NCT01644188|581607517|FG000|Overall Study|Site closure|1|||
161059016|NCT01644188|581607518|FG001|Overall Study|Site closure|1|||
161059017|NCT01644188|581607517|FG000|Overall Study|Other than specified above|6|||
161059018|NCT01644188|581607518|FG001|Overall Study|Other than specified above|7|||
161059019|NCT01845649|581607524|FG000|Overall Study|Adverse Event|7|||
161059020|NCT01845649|581607525|FG001|Overall Study|Adverse Event|10|||
161059021|NCT01845649|581607524|FG000|Overall Study|Lack of Efficacy|1|||
161059022|NCT01845649|581607525|FG001|Overall Study|Lack of Efficacy|1|||
161059023|NCT01845649|581607524|FG000|Overall Study|Lost to Follow-up|2|||
161059024|NCT01845649|581607525|FG001|Overall Study|Lost to Follow-up|2|||
161059025|NCT01845649|581607524|FG000|Overall Study|Withdrew Consent|12|||
161059026|NCT01845649|581607525|FG001|Overall Study|Withdrew Consent|4|||
161059027|NCT01845649|581607524|FG000|Overall Study|Protocol Deviation|7|||
161152925|NCT04184622|581940915|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
161152926|NCT04184622|581940912|FG000|Safety Follow-up Period|Adverse Event|6|||
161152927|NCT04184622|581940913|FG001|Safety Follow-up Period|Adverse Event|8|||
161345226|NCT00831844|582648900|FG002|Overall Study|Withdrawal by Subject|1|||
161059028|NCT01845649|581607525|FG001|Overall Study|Protocol Deviation|4|||
161059029|NCT01845649|581607524|FG000|Overall Study|Reason not Specified|2|||
161059030|NCT01845649|581607525|FG001|Overall Study|Reason not Specified|1|||
161059031|NCT00719212|581607528|FG000|Overall Study|Death|41|||
161059032|NCT00719212|581607528|FG000|Overall Study|Lost to Follow-up|2|||
161059033|NCT00719212|581607528|FG000|Overall Study|Withdrawal by Subject|1|||
161059034|NCT00526097|581607532|FG000|Overall Study|Adverse Event|6|||
161059035|NCT00526097|581607533|FG001|Overall Study|Adverse Event|44|||
161152928|NCT04184622|581940914|FG002|Safety Follow-up Period|Adverse Event|9|||
161059036|NCT00526097|581607532|FG000|Overall Study|Protocol Violation|4|||
161059037|NCT00526097|581607533|FG001|Overall Study|Protocol Violation|10|||
161059038|NCT00526097|581607532|FG000|Overall Study|Withdrawal by Subject|3|||
161059039|NCT00526097|581607533|FG001|Overall Study|Withdrawal by Subject|1|||
161059040|NCT00526097|581607532|FG000|Overall Study|Other|2|||
161281748|NCT00104572|582410316|FG002|Overall Study|Withdrawal by Subject|0|||
161281749|NCT00098774|582410317|FG000|Overall Study|Adverse Event|2|||
161281750|NCT00098774|582410317|FG000|Overall Study|Disease Progression|9|||
161281751|NCT00098774|582410317|FG000|Overall Study|Withdrawal by Subject|1|||
161281752|NCT00098774|582410317|FG000|Overall Study|Failed (to respond) during induction|4|||
161281753|NCT00098774|582410317|FG000|Overall Study|Physician Decision|2|||
161281754|NCT03097991|582410318|FG000|Overall Study|Didn't meet study criteria|8|||
161281755|NCT03097991|582410319|FG001|Overall Study|Didn't meet study criteria|0|||
161281756|NCT03097991|582410318|FG000|Overall Study|Withdrawal by Subject|12|||
161281757|NCT03097991|582410319|FG001|Overall Study|Withdrawal by Subject|6|||
161281758|NCT03097991|582410318|FG000|Overall Study|Death of Baby|3|||
161281759|NCT03097991|582410319|FG001|Overall Study|Death of Baby|1|||
161281760|NCT03097991|582410318|FG000|Overall Study|Lost to Follow-up|24|||
161281761|NCT03097991|582410319|FG001|Overall Study|Lost to Follow-up|38|||
161281762|NCT03097991|582410318|FG000|Overall Study|Adverse Event|3|||
161281763|NCT03097991|582410319|FG001|Overall Study|Adverse Event|5|||
161281764|NCT02006732|582410320|FG000|Overall Study|Adverse Event|10|||
161281765|NCT02006732|582410321|FG001|Overall Study|Adverse Event|7|||
161281766|NCT02006732|582410322|FG002|Overall Study|Adverse Event|4|||
161281767|NCT02006732|582410323|FG003|Overall Study|Adverse Event|2|||
161281768|NCT02006732|582410320|FG000|Overall Study|Lack of Efficacy|6|||
161059041|NCT00526097|581607533|FG001|Overall Study|Other|1|||
161059042|NCT00966979|581607534|FG000|Overall Study|Death|1|||
161059043|NCT00966979|581607534|FG000|Overall Study|Lost to Follow-up|6|||
161059044|NCT00966979|581607534|FG000|Overall Study|Withdrawal by Subject|14|||
161059045|NCT00966979|581607534|FG000|Overall Study|Adverse Event|5|||
161059046|NCT00966979|581607534|FG000|Overall Study|Sponsor terminated early|49|||
161059047|NCT00966979|581607534|FG000|Overall Study|Censored because surgery not done|2|||
161059048|NCT00966979|581607534|FG000|Overall Study|Censored because study device was not implanted|14|||
161059049|NCT00966979|581607534|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
161059050|NCT03713281|581607535|FG000|Overall Study|Lens handling difficuluties|2|||
161059051|NCT03713281|581607535|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
161059052|NCT01990313|581607537|FG000|Overall Study|Lost to Follow-up|1|||
161059053|NCT02412111|581607538|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
161059054|NCT02412111|581607539|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
161059055|NCT02412111|581607540|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
161059056|NCT02412111|581607538|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
161059057|NCT02412111|581607539|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
161059058|NCT02412111|581607540|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
161059059|NCT02412111|581607538|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
161059060|NCT02412111|581607539|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
161059061|NCT02412111|581607540|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
161059062|NCT02412111|581607538|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
161059063|NCT02412111|581607539|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
161059064|NCT02412111|581607540|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
161059065|NCT02412111|581607538|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
161059066|NCT02412111|581607539|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
161059067|NCT02412111|581607540|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
161059068|NCT02412111|581607538|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
161059069|NCT02412111|581607539|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
161059070|NCT02412111|581607540|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
161059071|NCT02412111|581607538|FG000|Active Comparator Period (8 Weeks)|Other|0|||
161059072|NCT02412111|581607539|FG001|Active Comparator Period (8 Weeks)|Other|0|||
161059073|NCT02412111|581607540|FG002|Active Comparator Period (8 Weeks)|Other|2|||
161059074|NCT00721214|581607542|FG000|Overall Study|Chose another center for transplant|1|||
161059075|NCT00721214|581607542|FG000|Overall Study|Death|3|||
161059076|NCT02396953|581607543|FG000|Overall Study|Withdrawal by Subject|0|||
161059077|NCT02396953|581607544|FG001|Overall Study|Withdrawal by Subject|0|||
161059078|NCT02396953|581607545|FG002|Overall Study|Withdrawal by Subject|1|||
161059079|NCT02396953|581607543|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
161059080|NCT02396953|581607544|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
161059081|NCT02396953|581607545|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
161059082|NCT02396953|581607543|FG000|Overall Study|Personal Reasons|1|||
161059083|NCT02396953|581607544|FG001|Overall Study|Personal Reasons|1|||
161059084|NCT02396953|581607545|FG002|Overall Study|Personal Reasons|0|||
161059085|NCT02624869|581607546|FG000|Overall Study|Lost to Follow-up|0|||
161281769|NCT02006732|582410321|FG001|Overall Study|Lack of Efficacy|3|||
161281770|NCT02006732|582410322|FG002|Overall Study|Lack of Efficacy|1|||
161059086|NCT02624869|581607547|FG001|Overall Study|Lost to Follow-up|0|||
161281771|NCT02006732|582410323|FG003|Overall Study|Lack of Efficacy|1|||
161281772|NCT02006732|582410320|FG000|Overall Study|Protocol Violation|1|||
161059087|NCT02624869|581607548|FG002|Overall Study|Lost to Follow-up|1|||
161281773|NCT02006732|582410321|FG001|Overall Study|Protocol Violation|1|||
161059088|NCT02624869|581607546|FG000|Overall Study|Withdrawal by Subject|1|||
161059089|NCT02624869|581607547|FG001|Overall Study|Withdrawal by Subject|3|||
161059090|NCT02624869|581607548|FG002|Overall Study|Withdrawal by Subject|1|||
161059091|NCT00510198|581607549|FG000|Overall Study|Withdrawal by Subject|5|||
161059092|NCT00510198|581607550|FG001|Overall Study|Withdrawal by Subject|4|||
161059093|NCT00329550|581607552|FG000|Overall Study|Adverse Event|3|||
161059094|NCT00329550|581607553|FG001|Overall Study|Adverse Event|4|||
161059095|NCT00329550|581607554|FG002|Overall Study|Adverse Event|2|||
161059096|NCT00329550|581607552|FG000|Overall Study|Withdrawal of Consent|1|||
161059097|NCT00329550|581607553|FG001|Overall Study|Withdrawal of Consent|0|||
161059098|NCT00329550|581607554|FG002|Overall Study|Withdrawal of Consent|1|||
161152929|NCT04184622|581940915|FG003|Safety Follow-up Period|Adverse Event|16|||
161152930|NCT04184622|581940912|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
161152931|NCT04184622|581940913|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
161152932|NCT04184622|581940914|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
161152933|NCT04184622|581940915|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
161152934|NCT04184622|581940912|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
161152935|NCT04184622|581940913|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
161152936|NCT04184622|581940914|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
161152937|NCT04184622|581940915|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
161152938|NCT04184622|581940912|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
161152939|NCT04184622|581940913|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
161152940|NCT04184622|581940914|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
161152941|NCT04184622|581940915|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
161152942|NCT04184622|581940912|FG000|Safety Follow-up Period|Physician Decision|1|||
161152943|NCT04184622|581940913|FG001|Safety Follow-up Period|Physician Decision|0|||
161152944|NCT04184622|581940914|FG002|Safety Follow-up Period|Physician Decision|0|||
161152945|NCT04184622|581940915|FG003|Safety Follow-up Period|Physician Decision|1|||
161152946|NCT04184622|581940912|FG000|Safety Follow-up Period|Pregnancy|1|||
161152947|NCT04184622|581940913|FG001|Safety Follow-up Period|Pregnancy|3|||
161152948|NCT04184622|581940914|FG002|Safety Follow-up Period|Pregnancy|0|||
161152949|NCT04184622|581940915|FG003|Safety Follow-up Period|Pregnancy|6|||
161152950|NCT04184622|581940912|FG000|Safety Follow-up Period|Protocol deviation|1|||
161152951|NCT04184622|581940913|FG001|Safety Follow-up Period|Protocol deviation|0|||
161152952|NCT04184622|581940914|FG002|Safety Follow-up Period|Protocol deviation|0|||
161152953|NCT04184622|581940915|FG003|Safety Follow-up Period|Protocol deviation|0|||
161152954|NCT04184622|581940912|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
161152955|NCT04184622|581940913|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
161152956|NCT04184622|581940914|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
161152957|NCT04184622|581940915|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
161152958|NCT05058664|581940916|FG000|Overall Study|No follow-up data provided|4|||
161152959|NCT05058664|581940917|FG001|Overall Study|No follow-up data provided|0|||
161152960|NCT05058664|581940918|FG002|Overall Study|No follow-up data provided|2|||
161152961|NCT05058664|581940916|FG000|Overall Study|Withdrawal by Subject|0|||
161152962|NCT05058664|581940917|FG001|Overall Study|Withdrawal by Subject|0|||
161152963|NCT05058664|581940918|FG002|Overall Study|Withdrawal by Subject|1|||
161152964|NCT01617681|581940919|FG000|Period 1 Double Blind|Adverse Event|2|||
161152965|NCT01617681|581940920|FG001|Period 1 Double Blind|Adverse Event|0|||
161152966|NCT01617681|581940921|FG002|Period 1 Double Blind|Adverse Event|0|||
161152967|NCT01617681|581940922|FG003|Period 1 Double Blind|Adverse Event|2|||
161152968|NCT01617681|581940923|FG004|Period 1 Double Blind|Adverse Event|0|||
161152969|NCT01617681|581940919|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
161152970|NCT01617681|581940920|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
161152971|NCT01617681|581940921|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
161152972|NCT01617681|581940922|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
161152973|NCT01617681|581940923|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
161152974|NCT01617681|581940919|FG000|Period 2 Open Label|Adverse Event|0|||
161152975|NCT01617681|581940920|FG001|Period 2 Open Label|Adverse Event|0|||
161152976|NCT01617681|581940921|FG002|Period 2 Open Label|Adverse Event|0|||
161152977|NCT01617681|581940922|FG003|Period 2 Open Label|Adverse Event|0|||
161152978|NCT01617681|581940923|FG004|Period 2 Open Label|Adverse Event|3|||
161152979|NCT01617681|581940919|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
161152980|NCT01617681|581940920|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
161152981|NCT01617681|581940921|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
161152982|NCT01617681|581940922|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
161152983|NCT01617681|581940923|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
161152984|NCT00109733|581940929|FG000|Overall Study|Protocol Violation|0|||
161152985|NCT00109733|581940930|FG001|Overall Study|Protocol Violation|1|||
161152986|NCT00109733|581940929|FG000|Overall Study|Stopped taking study drug|1|||
161152987|NCT00109733|581940930|FG001|Overall Study|Stopped taking study drug|1|||
161152988|NCT00109733|581940929|FG000|Overall Study|Non-compliant|0|||
161059099|NCT00329550|581607552|FG000|Overall Study|Due to Relocation|0|||
161059100|NCT00329550|581607553|FG001|Overall Study|Due to Relocation|0|||
161059101|NCT00329550|581607554|FG002|Overall Study|Due to Relocation|1|||
161281774|NCT02006732|582410322|FG002|Overall Study|Protocol Violation|0|||
161281775|NCT02006732|582410323|FG003|Overall Study|Protocol Violation|0|||
161281776|NCT02006732|582410320|FG000|Overall Study|Lost to Follow-up|0|||
161281777|NCT02006732|582410321|FG001|Overall Study|Lost to Follow-up|1|||
161281778|NCT02006732|582410322|FG002|Overall Study|Lost to Follow-up|0|||
161281779|NCT02006732|582410323|FG003|Overall Study|Lost to Follow-up|0|||
161281780|NCT02006732|582410320|FG000|Overall Study|Withdrawal by Subject|3|||
161059102|NCT02994784|581607555|FG000|6 Months Follow-up|Lost to Follow-up|3|||
161059103|NCT02466243|581607556|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
161059104|NCT02466243|581607557|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
161059105|NCT02466243|581607556|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
161059106|NCT02466243|581607557|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
161059107|NCT02466243|581607556|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
161059108|NCT02466243|581607557|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
161059109|NCT02466243|581607556|FG000|Part B Open-label Treatment Period|Missing|2|||
161059110|NCT02466243|581607557|FG001|Part B Open-label Treatment Period|Missing|2|||
161059111|NCT01649557|581607558|FG000|Overall Study|Lost to Follow-up|5|||
161059112|NCT01649557|581607559|FG001|Overall Study|Lost to Follow-up|0|||
161059113|NCT01649557|581607560|FG002|Overall Study|Lost to Follow-up|3|||
161059114|NCT01649557|581607558|FG000|Overall Study|Adverse Event|7|||
161059115|NCT01649557|581607559|FG001|Overall Study|Adverse Event|5|||
161059116|NCT01649557|581607560|FG002|Overall Study|Adverse Event|1|||
161059117|NCT01649557|581607558|FG000|Overall Study|Met withdrawal criteria|4|||
161059118|NCT01649557|581607559|FG001|Overall Study|Met withdrawal criteria|0|||
161059119|NCT01649557|581607560|FG002|Overall Study|Met withdrawal criteria|0|||
161059120|NCT01649557|581607558|FG000|Overall Study|Physician Decision|8|||
161059121|NCT01649557|581607559|FG001|Overall Study|Physician Decision|2|||
161059122|NCT01649557|581607560|FG002|Overall Study|Physician Decision|1|||
161059123|NCT01649557|581607558|FG000|Overall Study|Withdrawal by Subject|15|||
161059124|NCT01649557|581607559|FG001|Overall Study|Withdrawal by Subject|5|||
161059125|NCT01649557|581607560|FG002|Overall Study|Withdrawal by Subject|4|||
161059126|NCT01649557|581607558|FG000|Overall Study|Protocol deviation|0|||
161059127|NCT01649557|581607559|FG001|Overall Study|Protocol deviation|2|||
161059128|NCT01649557|581607560|FG002|Overall Study|Protocol deviation|0|||
161059129|NCT01649557|581607558|FG000|Overall Study|Lack of Efficacy|5|||
161059130|NCT01649557|581607559|FG001|Overall Study|Lack of Efficacy|0|||
161059131|NCT01649557|581607560|FG002|Overall Study|Lack of Efficacy|0|||
161059132|NCT01011049|581607561|FG000|Overall Study|Protocol Violation|0|||
161059133|NCT01011049|581607562|FG001|Overall Study|Protocol Violation|0|||
161059134|NCT01011049|581607563|FG002|Overall Study|Protocol Violation|2|||
161059135|NCT01011049|581607564|FG003|Overall Study|Protocol Violation|0|||
161059136|NCT01011049|581607561|FG000|Overall Study|Lost to Follow-up|1|||
161059137|NCT01011049|581607562|FG001|Overall Study|Lost to Follow-up|2|||
161059138|NCT01011049|581607563|FG002|Overall Study|Lost to Follow-up|1|||
161059139|NCT01011049|581607564|FG003|Overall Study|Lost to Follow-up|0|||
161059140|NCT01011049|581607561|FG000|Overall Study|Withdrawal by Subject|0|||
161059141|NCT01011049|581607562|FG001|Overall Study|Withdrawal by Subject|0|||
161059142|NCT01011049|581607563|FG002|Overall Study|Withdrawal by Subject|1|||
161059143|NCT01011049|581607564|FG003|Overall Study|Withdrawal by Subject|0|||
161059144|NCT02815735|581607565|FG000|First Intervention (4 Weeks)|Discomfort|1|||
161059145|NCT02815735|581607566|FG001|First Intervention (4 Weeks)|Discomfort|0|||
161059146|NCT02815735|581607565|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161059147|NCT02815735|581607566|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161059148|NCT02815735|581607565|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
161059149|NCT02815735|581607566|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
161059150|NCT02815735|581607565|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
161059151|NCT02815735|581607566|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
161281781|NCT02006732|582410321|FG001|Overall Study|Withdrawal by Subject|0|||
161281782|NCT02006732|582410322|FG002|Overall Study|Withdrawal by Subject|4|||
161059152|NCT02435381|581607567|FG000|Overall Study|Lost to Follow-up|2|||
161059153|NCT02435381|581607568|FG001|Overall Study|Lost to Follow-up|1|||
161059154|NCT04150341|581607571|FG000|Overall Study|Physician Decision|0|||
161059155|NCT04150341|581607572|FG001|Overall Study|Physician Decision|0|||
161059156|NCT04150341|581607573|FG002|Overall Study|Physician Decision|1|||
161059157|NCT04150341|581607574|FG003|Overall Study|Physician Decision|0|||
161059158|NCT04150341|581607575|FG004|Overall Study|Physician Decision|0|||
161059159|NCT04150341|581607576|FG005|Overall Study|Physician Decision|0|||
161059160|NCT04150341|581607571|FG000|Overall Study|Adverse Event|0|||
161059161|NCT04150341|581607572|FG001|Overall Study|Adverse Event|0|||
161059162|NCT04150341|581607573|FG002|Overall Study|Adverse Event|0|||
161059163|NCT04150341|581607574|FG003|Overall Study|Adverse Event|0|||
161059164|NCT04150341|581607575|FG004|Overall Study|Adverse Event|1|||
161059165|NCT04150341|581607576|FG005|Overall Study|Adverse Event|0|||
161059166|NCT00875615|581607577|FG000|Overall Study|Withdrawal by Subject|1|||
161059167|NCT00405912|581607578|FG000|Overall Study|Withdrawal by Subject|12|||
161059168|NCT00405912|581607579|FG001|Overall Study|Withdrawal by Subject|11|||
161152989|NCT00109733|581940930|FG001|Overall Study|Non-compliant|1|||
161059169|NCT00405912|581607580|FG002|Overall Study|Withdrawal by Subject|12|||
161152990|NCT00109733|581940929|FG000|Overall Study|Could not commit time for study|1|||
161152991|NCT00109733|581940930|FG001|Overall Study|Could not commit time for study|1|||
161152992|NCT02280291|581940935|FG000|Overall Study|Lost to Follow-up|2|||
161152993|NCT02280291|581940936|FG001|Overall Study|Lost to Follow-up|1|||
161152994|NCT02280291|581940937|FG002|Overall Study|Lost to Follow-up|3|||
161152995|NCT02280291|581940938|FG003|Overall Study|Lost to Follow-up|8|||
161152996|NCT02280291|581940935|FG000|Overall Study|Protocol Violation|1|||
161152997|NCT02280291|581940936|FG001|Overall Study|Protocol Violation|0|||
161152998|NCT02280291|581940937|FG002|Overall Study|Protocol Violation|0|||
161152999|NCT02280291|581940938|FG003|Overall Study|Protocol Violation|0|||
161153000|NCT02280291|581940935|FG000|Overall Study|Other|1|||
161059170|NCT00405912|581607578|FG000|Overall Study|Lost to Follow-up|4|||
161059171|NCT00405912|581607579|FG001|Overall Study|Lost to Follow-up|8|||
161059172|NCT00405912|581607580|FG002|Overall Study|Lost to Follow-up|4|||
161059173|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
161059174|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
161059175|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
161059176|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
161059177|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
161059178|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
161059179|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
161059180|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
161059181|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Death|6|||
161059182|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Death|2|||
161059183|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Death|2|||
161059184|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Death|9|||
161059185|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
161059186|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161059187|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161059188|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
161059189|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
161059190|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
161059191|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
161059192|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
161059193|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
161059194|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
161059195|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
161059196|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
161059197|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
161059198|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
161059199|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
161059200|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
161059201|NCT03730662|581607582|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
161059202|NCT03730662|581607583|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
161059203|NCT03730662|581607584|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
161059204|NCT03730662|581607585|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
161059205|NCT03730662|581607582|FG000|Variable Treatment Period|Adverse Event|1|||
161059206|NCT03730662|581607583|FG001|Variable Treatment Period|Adverse Event|2|||
161059207|NCT03730662|581607584|FG002|Variable Treatment Period|Adverse Event|0|||
161059208|NCT03730662|581607585|FG003|Variable Treatment Period|Adverse Event|7|||
161059209|NCT03730662|581607582|FG000|Variable Treatment Period|Death|9|||
161059210|NCT03730662|581607583|FG001|Variable Treatment Period|Death|0|||
161059211|NCT03730662|581607584|FG002|Variable Treatment Period|Death|6|||
161059212|NCT03730662|581607585|FG003|Variable Treatment Period|Death|26|||
161059213|NCT03730662|581607582|FG000|Variable Treatment Period|Lost to Follow-up|2|||
161059214|NCT03730662|581607583|FG001|Variable Treatment Period|Lost to Follow-up|1|||
161059215|NCT03730662|581607584|FG002|Variable Treatment Period|Lost to Follow-up|4|||
161059216|NCT03730662|581607585|FG003|Variable Treatment Period|Lost to Follow-up|11|||
161059217|NCT03730662|581607582|FG000|Variable Treatment Period|Personal Reason|0|||
161059218|NCT03730662|581607583|FG001|Variable Treatment Period|Personal Reason|2|||
161059219|NCT03730662|581607584|FG002|Variable Treatment Period|Personal Reason|1|||
161059220|NCT03730662|581607585|FG003|Variable Treatment Period|Personal Reason|6|||
161059221|NCT03730662|581607582|FG000|Variable Treatment Period|Physician Decision|0|||
161153001|NCT02280291|581940936|FG001|Overall Study|Other|1|||
161153002|NCT02280291|581940937|FG002|Overall Study|Other|0|||
161153003|NCT02280291|581940938|FG003|Overall Study|Other|0|||
161059222|NCT03730662|581607583|FG001|Variable Treatment Period|Physician Decision|0|||
161059223|NCT03730662|581607584|FG002|Variable Treatment Period|Physician Decision|0|||
161059224|NCT03730662|581607585|FG003|Variable Treatment Period|Physician Decision|3|||
161059225|NCT03730662|581607582|FG000|Variable Treatment Period|Protocol Violation|0|||
161059226|NCT03730662|581607583|FG001|Variable Treatment Period|Protocol Violation|1|||
161153004|NCT02985450|581940949|FG000|Overall Study|Lost to Follow-up|7|||
161153005|NCT03015610|581940950|FG000|Overall Study|Lost to Follow-up|1|||
161153006|NCT03015610|581940951|FG001|Overall Study|Lost to Follow-up|5|||
161153007|NCT01603641|581940952|FG000|Overall Study|Did not Receive Treatment|3|||
161153008|NCT01603641|581940952|FG000|Overall Study|Adverse Event|1|||
161153009|NCT01603641|581940952|FG000|Overall Study|Lack of Efficacy|1|||
161153010|NCT01603641|581940952|FG000|Overall Study|Lost to Follow-up|6|||
161153011|NCT01603641|581940952|FG000|Overall Study|Personal Reasons|18|||
161153012|NCT01603641|581940952|FG000|Overall Study|Other Miscellaneous Reasons|6|||
161153013|NCT00358917|581940953|FG000|Overall Study|Adverse Event|14|||
161153014|NCT00358917|581940954|FG001|Overall Study|Adverse Event|21|||
161153015|NCT00358917|581940953|FG000|Overall Study|Withdrawal by Subject|5|||
161153016|NCT00358917|581940954|FG001|Overall Study|Withdrawal by Subject|7|||
161153017|NCT00358917|581940953|FG000|Overall Study|Lost to Follow-up|20|||
161153018|NCT00358917|581940954|FG001|Overall Study|Lost to Follow-up|17|||
161153019|NCT00358917|581940953|FG000|Overall Study|Noncompliance|12|||
161153020|NCT00358917|581940954|FG001|Overall Study|Noncompliance|11|||
161153021|NCT00358917|581940953|FG000|Overall Study|Death|2|||
161153022|NCT00358917|581940954|FG001|Overall Study|Death|3|||
161153023|NCT00358917|581940953|FG000|Overall Study|Virologic failure|11|||
161153024|NCT00358917|581940954|FG001|Overall Study|Virologic failure|8|||
161153025|NCT00358917|581940953|FG000|Overall Study|Unable to Continue Participation|2|||
161153026|NCT00358917|581940954|FG001|Overall Study|Unable to Continue Participation|2|||
161153027|NCT01757704|581940959|FG000|Overall Study|Protocol Violation|1|||
161153028|NCT01757704|581940960|FG001|Overall Study|Protocol Violation|3|||
161153029|NCT02890329|581940961|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161153030|NCT02890329|581940962|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
161153031|NCT02890329|581940963|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161153032|NCT02890329|581940964|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161153033|NCT02890329|581940965|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161153034|NCT02890329|581940966|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
161153035|NCT02890329|581940961|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
161153036|NCT02890329|581940962|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
161153037|NCT02890329|581940963|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161153038|NCT02890329|581940964|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161153039|NCT02890329|581940965|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161153040|NCT02890329|581940966|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
161153041|NCT02890329|581940961|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161153042|NCT02890329|581940962|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161153043|NCT02890329|581940963|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161153044|NCT02890329|581940964|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
161153045|NCT02890329|581940965|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161153046|NCT02890329|581940966|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
161153047|NCT02890329|581940961|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161153048|NCT02890329|581940962|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161153049|NCT02890329|581940963|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
161153050|NCT02890329|581940964|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161153051|NCT02890329|581940965|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161153052|NCT02890329|581940966|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
161153053|NCT01558089|581940967|FG000|Overall Study|Adverse Event|1|||
161153054|NCT01558089|581940967|FG000|Overall Study|Lack of Efficacy|1|||
161153055|NCT01558089|581940967|FG000|Overall Study|Lost to Follow-up|5|||
161153056|NCT01558089|581940967|FG000|Overall Study|Withdrawal by Subject|6|||
161153057|NCT01597193|581940968|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
161153058|NCT01597193|581940969|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
161153059|NCT01597193|581940970|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161153060|NCT01597193|581940971|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161153061|NCT01597193|581940972|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161153062|NCT01597193|581940973|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161153063|NCT01597193|581940974|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
161153064|NCT01597193|581940968|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161153065|NCT01597193|581940969|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161153066|NCT01597193|581940970|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161153067|NCT01597193|581940971|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
161153068|NCT01597193|581940972|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
161281783|NCT02006732|582410323|FG003|Overall Study|Withdrawal by Subject|1|||
161281784|NCT01755091|582410324|FG000|Overall Study|Withdrawal by Subject|6|||
161281785|NCT01755091|582410325|FG001|Overall Study|Withdrawal by Subject|1|||
161281786|NCT01755091|582410326|FG002|Overall Study|Withdrawal by Subject|3|||
161281787|NCT01755091|582410324|FG000|Overall Study|Adverse Event|1|||
161281788|NCT01755091|582410325|FG001|Overall Study|Adverse Event|1|||
161153069|NCT01597193|581940973|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
161281789|NCT01755091|582410326|FG002|Overall Study|Adverse Event|1|||
161059227|NCT03730662|581607584|FG002|Variable Treatment Period|Protocol Violation|1|||
161059228|NCT03730662|581607585|FG003|Variable Treatment Period|Protocol Violation|1|||
161059229|NCT03730662|581607582|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
161059230|NCT03730662|581607583|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
161059231|NCT03730662|581607584|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
161059232|NCT03730662|581607585|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
161059233|NCT02895360|581607594|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
161059234|NCT02895360|581607595|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161059235|NCT02895360|581607596|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161059236|NCT02895360|581607597|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161059237|NCT02895360|581607598|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161059238|NCT02895360|581607599|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
161059239|NCT02895360|581607594|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161059240|NCT02895360|581607595|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
161059241|NCT02895360|581607596|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161059242|NCT02895360|581607597|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161059243|NCT02895360|581607598|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161059244|NCT02895360|581607599|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
161059245|NCT02895360|581607594|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161059246|NCT02895360|581607595|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161059247|NCT02895360|581607596|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
161059248|NCT02895360|581607597|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161059249|NCT02895360|581607598|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161059250|NCT02895360|581607599|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
161059251|NCT02895360|581607594|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161059252|NCT02895360|581607595|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161059253|NCT02895360|581607596|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
161059254|NCT02895360|581607597|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161059255|NCT02895360|581607598|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161059256|NCT02895360|581607599|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
161059257|NCT02895360|581607594|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161059258|NCT02895360|581607595|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161059259|NCT02895360|581607596|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161059260|NCT02895360|581607597|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
161059261|NCT02895360|581607598|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161059262|NCT02895360|581607599|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
161059263|NCT02895360|581607594|FG000|Phase 2a|Adverse Event|0|||
161059264|NCT02895360|581607595|FG001|Phase 2a|Adverse Event|0|||
161059265|NCT02895360|581607596|FG002|Phase 2a|Adverse Event|0|||
161059266|NCT02895360|581607597|FG003|Phase 2a|Adverse Event|0|||
161059267|NCT02895360|581607598|FG004|Phase 2a|Adverse Event|0|||
161059268|NCT02895360|581607599|FG005|Phase 2a|Adverse Event|1|||
161059269|NCT02895360|581607594|FG000|Phase 2a|Progressive disease|0|||
161059270|NCT02895360|581607595|FG001|Phase 2a|Progressive disease|0|||
161059271|NCT02895360|581607596|FG002|Phase 2a|Progressive disease|0|||
161059272|NCT02895360|581607597|FG003|Phase 2a|Progressive disease|0|||
161059273|NCT02895360|581607598|FG004|Phase 2a|Progressive disease|11|||
161059274|NCT02895360|581607599|FG005|Phase 2a|Progressive disease|11|||
161059275|NCT00307164|581607600|FG000|Overall Study|Death|1|||
161059276|NCT00307164|581607601|FG001|Overall Study|Death|0|||
161059277|NCT00307164|581607600|FG000|Overall Study|Severe debilitation, unable to continue|1|||
161059278|NCT00307164|581607601|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161059279|NCT00307164|581607600|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
161059280|NCT00307164|581607601|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
161059281|NCT00307164|581607600|FG000|Overall Study|Withdrawal by Subject|1|||
161059282|NCT00307164|581607601|FG001|Overall Study|Withdrawal by Subject|8|||
161059283|NCT00307164|581607600|FG000|Overall Study|Not compliant with requirements|4|||
161059284|NCT00307164|581607601|FG001|Overall Study|Not compliant with requirements|4|||
161059285|NCT00307164|581607600|FG000|Overall Study|Lost to Follow-up|6|||
161059286|NCT00307164|581607601|FG001|Overall Study|Lost to Follow-up|1|||
161059287|NCT03712449|581607602|FG000|Overall Study|Withdraw Consent|0|||
161059288|NCT03712449|581607603|FG001|Overall Study|Withdraw Consent|1|||
161059289|NCT00666198|581607604|FG000|Overall Study|Protocol Violation|10|||
161059290|NCT00666198|581607604|FG000|Overall Study|No Visit After First Day of Treatment|13|||
161059291|NCT00666198|581607604|FG000|Overall Study|Safety Not Assessable|6|||
161059292|NCT00666198|581607604|FG000|Overall Study|No Drug Administration|4|||
161059293|NCT03220776|581607607|FG000|Overall Study|Claustrophobia|0|||
161059294|NCT03220776|581607608|FG001|Overall Study|Claustrophobia|1|||
161059295|NCT03220776|581607609|FG002|Overall Study|Claustrophobia|1|||
161059296|NCT03220776|581607610|FG003|Overall Study|Claustrophobia|0|||
161059297|NCT03220776|581607611|FG004|Overall Study|Claustrophobia|1|||
161059298|NCT03220776|581607612|FG005|Overall Study|Claustrophobia|0|||
161059299|NCT03220776|581607607|FG000|Overall Study|MRI Equipment Failure|1|||
161059300|NCT03220776|581607608|FG001|Overall Study|MRI Equipment Failure|0|||
161281790|NCT01755091|582410324|FG000|Overall Study|Lost to Follow-up|1|||
161153070|NCT01597193|581940974|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
161153071|NCT01597193|581940968|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
161153072|NCT01597193|581940969|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
161153073|NCT01597193|581940970|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
161153074|NCT01597193|581940971|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
161153075|NCT01597193|581940972|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
161153076|NCT01597193|581940973|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
161153077|NCT01597193|581940974|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
161153078|NCT01597193|581940968|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161153079|NCT01597193|581940969|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161153080|NCT01597193|581940970|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161153081|NCT01597193|581940971|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161153082|NCT01597193|581940972|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161059301|NCT03220776|581607609|FG002|Overall Study|MRI Equipment Failure|0|||
161059302|NCT03220776|581607610|FG003|Overall Study|MRI Equipment Failure|0|||
161059303|NCT03220776|581607611|FG004|Overall Study|MRI Equipment Failure|0|||
161059304|NCT03220776|581607612|FG005|Overall Study|MRI Equipment Failure|0|||
161059305|NCT03220776|581607607|FG000|Overall Study|Inclimate Weather|0|||
161059306|NCT03220776|581607608|FG001|Overall Study|Inclimate Weather|0|||
161059307|NCT03220776|581607609|FG002|Overall Study|Inclimate Weather|0|||
161059308|NCT03220776|581607610|FG003|Overall Study|Inclimate Weather|0|||
161059309|NCT03220776|581607611|FG004|Overall Study|Inclimate Weather|0|||
161059310|NCT03220776|581607612|FG005|Overall Study|Inclimate Weather|1|||
161059311|NCT03220776|581607607|FG000|Overall Study|Physician Decision|0|||
161059312|NCT03220776|581607608|FG001|Overall Study|Physician Decision|0|||
161059313|NCT03220776|581607609|FG002|Overall Study|Physician Decision|0|||
161059314|NCT03220776|581607610|FG003|Overall Study|Physician Decision|1|||
161059315|NCT03220776|581607611|FG004|Overall Study|Physician Decision|0|||
161059316|NCT03220776|581607612|FG005|Overall Study|Physician Decision|0|||
161059317|NCT03220776|581607607|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161059318|NCT03220776|581607608|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161059319|NCT03220776|581607609|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161059320|NCT03220776|581607610|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
161059321|NCT03220776|581607611|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161059322|NCT03220776|581607612|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
161059323|NCT03220776|581607607|FG000|Overall Study|Protocol Violation|0|||
161059324|NCT03220776|581607608|FG001|Overall Study|Protocol Violation|0|||
161059325|NCT03220776|581607609|FG002|Overall Study|Protocol Violation|0|||
161059326|NCT03220776|581607610|FG003|Overall Study|Protocol Violation|2|||
161059327|NCT03220776|581607611|FG004|Overall Study|Protocol Violation|0|||
161059328|NCT03220776|581607612|FG005|Overall Study|Protocol Violation|1|||
161059329|NCT03220776|581607607|FG000|Overall Study|Withdrawal by Subject|1|||
161059330|NCT03220776|581607608|FG001|Overall Study|Withdrawal by Subject|0|||
161059331|NCT03220776|581607609|FG002|Overall Study|Withdrawal by Subject|0|||
161059332|NCT03220776|581607610|FG003|Overall Study|Withdrawal by Subject|0|||
161059333|NCT03220776|581607611|FG004|Overall Study|Withdrawal by Subject|0|||
161059334|NCT03220776|581607612|FG005|Overall Study|Withdrawal by Subject|0|||
161059335|NCT04491006|581607613|FG000|Overall Study|Adverse Event|0|||
161059336|NCT04491006|581607614|FG001|Overall Study|Adverse Event|3|||
161059337|NCT04491006|581607615|FG002|Overall Study|Adverse Event|5|||
161059338|NCT04491006|581607613|FG000|Overall Study|Withdrawal by Subject|1|||
161059339|NCT04491006|581607614|FG001|Overall Study|Withdrawal by Subject|0|||
161059340|NCT04491006|581607615|FG002|Overall Study|Withdrawal by Subject|2|||
161059341|NCT01177137|581607616|FG000|Overall Study|Withdrawal by Subject|10|||
161059342|NCT01177137|581607617|FG001|Overall Study|Withdrawal by Subject|10|||
161153083|NCT01597193|581940973|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
161153084|NCT01597193|581940974|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
161153085|NCT01597193|581940968|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161153086|NCT01597193|581940969|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161153087|NCT01597193|581940970|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161153088|NCT01597193|581940971|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
161153089|NCT01597193|581940972|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161153090|NCT01597193|581940973|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
161153091|NCT01597193|581940974|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
161153092|NCT03184701|581940976|FG000|Overall Study|Death|3|||
161153093|NCT03184701|581940976|FG000|Overall Study|Physician Decision|3|||
161059343|NCT01177137|581607618|FG002|Overall Study|Withdrawal by Subject|2|||
161059344|NCT00583115|581607619|FG000|Overall Study|Death|1|||
161059345|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
161059346|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
161059347|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
161059348|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161059349|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
161059350|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
161059351|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
161059352|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
161059353|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
161059354|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
161059355|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
161059356|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
161059357|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161059358|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161059359|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
161059360|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
161059361|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
161059362|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
161059363|NCT03569475|581607620|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
161059364|NCT03569475|581607621|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
161059365|NCT03569475|581607622|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
161059366|NCT03569475|581607620|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
161059367|NCT03569475|581607621|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
161059368|NCT03569475|581607622|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
161059369|NCT03569475|581607620|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
161059370|NCT03569475|581607621|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
161059371|NCT03569475|581607622|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
161059372|NCT00645099|581607632|FG000|Overall Study|Lack of Efficacy|15|||
161059373|NCT00645099|581607633|FG001|Overall Study|Lack of Efficacy|6|||
161059374|NCT00645099|581607632|FG000|Overall Study|Withdrawal by Subject|30|||
161059375|NCT00645099|581607633|FG001|Overall Study|Withdrawal by Subject|22|||
161059376|NCT00645099|581607632|FG000|Overall Study|Lost to Follow-up|6|||
161059377|NCT00645099|581607633|FG001|Overall Study|Lost to Follow-up|4|||
161059378|NCT00645099|581607632|FG000|Overall Study|Adverse Event|11|||
161059379|NCT00645099|581607633|FG001|Overall Study|Adverse Event|5|||
161059380|NCT00645099|581607632|FG000|Overall Study|Other|9|||
161059381|NCT00645099|581607633|FG001|Overall Study|Other|5|||
161059382|NCT01201915|581607634|FG000|Overall Study|Adverse Event|2|||
161059383|NCT01201915|581607635|FG001|Overall Study|Adverse Event|1|||
161059384|NCT01201915|581607636|FG002|Overall Study|Adverse Event|1|||
161059385|NCT01201915|581607634|FG000|Overall Study|Lost to Follow-up|0|||
161059386|NCT01201915|581607635|FG001|Overall Study|Lost to Follow-up|4|||
161059387|NCT01201915|581607636|FG002|Overall Study|Lost to Follow-up|0|||
161059388|NCT01201915|581607634|FG000|Overall Study|Physician Decision|3|||
161059389|NCT01201915|581607635|FG001|Overall Study|Physician Decision|0|||
161059390|NCT01201915|581607636|FG002|Overall Study|Physician Decision|0|||
161059391|NCT01201915|581607634|FG000|Overall Study|Subject Decision|3|||
161059392|NCT01201915|581607635|FG001|Overall Study|Subject Decision|3|||
161059393|NCT01201915|581607636|FG002|Overall Study|Subject Decision|5|||
161059394|NCT01201915|581607634|FG000|Overall Study|Target Lesion Progression|0|||
161059395|NCT01201915|581607635|FG001|Overall Study|Target Lesion Progression|3|||
161059396|NCT01201915|581607636|FG002|Overall Study|Target Lesion Progression|0|||
161059397|NCT02154516|581607637|FG000|Overall Study|Withdrawal by Subject|0|||
161059398|NCT02154516|581607638|FG001|Overall Study|Withdrawal by Subject|1|||
161059399|NCT02154516|581607637|FG000|Overall Study|Lost to Follow-up|1|||
161059400|NCT02154516|581607638|FG001|Overall Study|Lost to Follow-up|0|||
161059401|NCT02154516|581607637|FG000|Overall Study|Removal/revision of device|1|||
161059402|NCT02154516|581607638|FG001|Overall Study|Removal/revision of device|0|||
161059403|NCT02154516|581607637|FG000|Overall Study|Death|2|||
161059404|NCT02154516|581607638|FG001|Overall Study|Death|1|||
161059405|NCT00663923|581607639|FG000|Overall Study|Lost to Follow-up|2|||
161281791|NCT01755091|582410325|FG001|Overall Study|Lost to Follow-up|0|||
161281792|NCT01755091|582410326|FG002|Overall Study|Lost to Follow-up|1|||
161281793|NCT01755091|582410324|FG000|Overall Study|Physician Decision|1|||
161281794|NCT01755091|582410325|FG001|Overall Study|Physician Decision|1|||
161281795|NCT01755091|582410326|FG002|Overall Study|Physician Decision|2|||
161281796|NCT04502212|582410331|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
161059406|NCT02316171|581607644|FG000|Overall Study|difficulties with urinary catheter|1|||
161059407|NCT02316171|581607645|FG001|Overall Study|difficulties with urinary catheter|0|||
161059408|NCT02316171|581607646|FG002|Overall Study|difficulties with urinary catheter|0|||
161059409|NCT02316171|581607647|FG003|Overall Study|difficulties with urinary catheter|0|||
161059410|NCT01804140|581607648|FG000|Overall Study|No sampling or biopsy procedures done|114|||
161059411|NCT00547300|581607649|FG000|Overall Study|Study was Administratively Terminated|25|||
161059412|NCT00547300|581607650|FG001|Overall Study|Study was Administratively Terminated|24|||
161153094|NCT03184701|581940976|FG000|Overall Study|Withdrawal by Subject|6|||
161059413|NCT00547300|581607649|FG000|Overall Study|Did not Meet Entry Criteria|0|||
161059414|NCT00547300|581607650|FG001|Overall Study|Did not Meet Entry Criteria|2|||
161059415|NCT02785900|581607651|FG000|Overall Study|Study Termination by Sponsor|64|||
161059416|NCT02785900|581607652|FG001|Overall Study|Study Termination by Sponsor|81|||
161059417|NCT02785900|581607651|FG000|Overall Study|Death|46|||
161059418|NCT02785900|581607652|FG001|Overall Study|Death|32|||
161059419|NCT02785900|581607651|FG000|Overall Study|Withdrawal by Subject|4|||
161059420|NCT02785900|581607652|FG001|Overall Study|Withdrawal by Subject|8|||
161059421|NCT02785900|581607651|FG000|Overall Study|Physician Decision|3|||
161059422|NCT02785900|581607652|FG001|Overall Study|Physician Decision|2|||
161059423|NCT04435522|581607655|FG000|Overall Study|Withdrawal by Subject|2|||
161059424|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
161059425|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
161059426|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
161059427|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
161059428|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
161059429|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
161059430|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
161059431|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
161059432|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
161059433|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
161059434|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
161059435|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
161059436|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
161059437|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
161059438|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
161059439|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
161059440|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
161059441|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
161059442|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
161059443|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
161059444|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
161059445|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
161059446|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
161059447|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
161059448|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
161059449|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
161059450|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
161059451|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
161059452|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
161059453|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
161059454|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
161059455|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
161059456|NCT00092521|581609211|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
161059457|NCT00092521|581609212|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
161059458|NCT00092521|581609213|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
161059459|NCT00092521|581609214|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
161059460|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
161059461|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
161059462|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
161059463|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
161059464|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
161059465|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
161059466|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
161059467|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
161059468|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
161059469|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
161059470|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
161059471|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
161059472|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Death|2|||
161059473|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Death|0|||
161153095|NCT03184701|581940976|FG000|Overall Study|Lost to Follow-up|5|||
161153096|NCT00590681|581940979|FG000|Overall Study|Withdrawal by Subject|7|||
161153097|NCT00590681|581940979|FG000|Overall Study|Adverse Event|8|||
161153098|NCT00590681|581940979|FG000|Overall Study|Death|3|||
161059474|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Death|1|||
161153099|NCT00590681|581940979|FG000|Overall Study|Lost to Follow-up|1|||
161059475|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Death|0|||
161059476|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
161059477|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
161059478|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
161059479|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
161281797|NCT04502212|582410331|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
161281798|NCT01320150|582410332|FG000|Overall Study|Protocol Violation|15|||
161281799|NCT01320150|582410332|FG000|Overall Study|Withdrawal by Subject|5|||
161281800|NCT01320150|582410332|FG000|Overall Study|Death|2|||
161281801|NCT01320150|582410332|FG000|Overall Study|Lost to Follow-up|44|||
161281802|NCT00919854|582410333|FG000|Overall Study|Adverse Event|1|||
161059480|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
161059481|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
161059482|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
161059483|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
161059484|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
161059485|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
161059486|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
161059487|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
161059488|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Moved|32|||
161059489|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Moved|2|||
161059490|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Moved|28|||
161059491|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Moved|0|||
161059492|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
161059493|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
161059494|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
161059495|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
161059496|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Travel|2|||
161059497|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Travel|0|||
161059498|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Travel|0|||
161059499|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Travel|0|||
161059500|NCT00092521|581609211|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
161059501|NCT00092521|581609212|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
161059502|NCT00092521|581609213|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
161059503|NCT00092521|581609214|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
161059504|NCT00092521|581609211|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
161059505|NCT00092521|581609212|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
161059506|NCT00092521|581609213|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
161059507|NCT00092521|581609214|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
161059508|NCT00092521|581609211|FG000|Extension Study (Group 4)|Adverse Event|0|||
161059509|NCT00092521|581609212|FG001|Extension Study (Group 4)|Adverse Event|0|||
161059510|NCT00092521|581609213|FG002|Extension Study (Group 4)|Adverse Event|0|||
161059511|NCT00092521|581609214|FG003|Extension Study (Group 4)|Adverse Event|2|||
161059512|NCT00092521|581609211|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
161059513|NCT00092521|581609212|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
161059514|NCT00092521|581609213|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
161059515|NCT00092521|581609214|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
161059516|NCT00092521|581609211|FG000|Extension Study (Group 4)|Pregnancy|0|||
161059517|NCT00092521|581609212|FG001|Extension Study (Group 4)|Pregnancy|0|||
161059518|NCT00092521|581609213|FG002|Extension Study (Group 4)|Pregnancy|0|||
161059519|NCT00092521|581609214|FG003|Extension Study (Group 4)|Pregnancy|4|||
161059520|NCT00092521|581609211|FG000|Extension Study (Group 4)|Protocol Violation|0|||
161059521|NCT00092521|581609212|FG001|Extension Study (Group 4)|Protocol Violation|0|||
161059522|NCT00092521|581609213|FG002|Extension Study (Group 4)|Protocol Violation|0|||
161059523|NCT00092521|581609214|FG003|Extension Study (Group 4)|Protocol Violation|2|||
161059524|NCT00092521|581609211|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
161059525|NCT00092521|581609212|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
161059526|NCT00092521|581609213|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
161059527|NCT00092521|581609214|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
161059528|NCT00092521|581609211|FG000|Extension Study (Group 4)|Moved|0|||
161059529|NCT00092521|581609212|FG001|Extension Study (Group 4)|Moved|0|||
161059530|NCT00092521|581609213|FG002|Extension Study (Group 4)|Moved|0|||
161059531|NCT00092521|581609214|FG003|Extension Study (Group 4)|Moved|16|||
161059532|NCT00092521|581609211|FG000|Extension Study (Group 4)|Site Terminated|0|||
161059533|NCT00092521|581609212|FG001|Extension Study (Group 4)|Site Terminated|0|||
161281803|NCT00985491|582410335|FG000|Overall Study|Adverse Event|8|||
161281804|NCT00985491|582410335|FG000|Overall Study|device migration|7|||
161281805|NCT00985491|582410335|FG000|Overall Study|Withdrawal by Subject|1|||
161281806|NCT00985491|582410335|FG000|Overall Study|implant failure|3|||
161281807|NCT00143247|582410341|FG000|Overall Study|Death|8|||
161281808|NCT00143247|582410341|FG000|Overall Study|Adverse Event|19|||
161059534|NCT00092521|581609213|FG002|Extension Study (Group 4)|Site Terminated|0|||
161059535|NCT00092521|581609214|FG003|Extension Study (Group 4)|Site Terminated|4|||
161059536|NCT00092521|581609211|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
161059537|NCT00092521|581609212|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
161059538|NCT00092521|581609213|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
161059539|NCT00092521|581609214|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
161059540|NCT01878383|581609215|FG000|Overall Study|Lost to Follow-up|0|||
161059541|NCT01878383|581609216|FG001|Overall Study|Lost to Follow-up|1499|||
161059542|NCT03464383|581609217|FG000|Overall Study|Lost to Follow-up|1|||
161059543|NCT03464383|581609218|FG001|Overall Study|Lost to Follow-up|0|||
161059544|NCT03464383|581609219|FG002|Overall Study|Lost to Follow-up|0|||
161059545|NCT03464383|581609217|FG000|Overall Study|Withdrawal by Subject|0|||
161059546|NCT03464383|581609218|FG001|Overall Study|Withdrawal by Subject|1|||
161059547|NCT03464383|581609219|FG002|Overall Study|Withdrawal by Subject|0|||
161059548|NCT00560313|581609220|FG000|Overall Study|Adverse Events or Death|2|||
161059549|NCT00560313|581609220|FG000|Overall Study|Withdrawal by Subject|2|||
161059550|NCT00560313|581609220|FG000|Overall Study|Lost to Follow-up|1|||
161059551|NCT00560313|581609220|FG000|Overall Study|Protocol Violation|1|||
161059552|NCT00605566|581609221|FG000|Overall Study|Adverse Event|1|||
161059553|NCT00605566|581609221|FG000|Overall Study|Clinical deterioration|1|||
161059554|NCT00605566|581609221|FG000|Overall Study|Poor compliance in run-in period|1|||
161059555|NCT03475056|581609222|FG000|Overall Study|Lost to Follow-up|0|||
161059556|NCT03475056|581609223|FG001|Overall Study|Lost to Follow-up|1|||
161059557|NCT03475056|581609222|FG000|Overall Study|Moved from Area|0|||
161059558|NCT03475056|581609223|FG001|Overall Study|Moved from Area|2|||
161059559|NCT00113269|581609226|FG000|Overall Study|Not transplanted, donor issues|4|||
161059560|NCT00113269|581609227|FG001|Overall Study|Not transplanted, donor issues|0|||
161059561|NCT00113269|581609228|FG002|Overall Study|Not transplanted, donor issues|2|||
161059562|NCT00113269|581609229|FG003|Overall Study|Not transplanted, donor issues|2|||
161059563|NCT00113269|581609226|FG000|Overall Study|Not transplanted, recipient issues|2|||
161059564|NCT00113269|581609227|FG001|Overall Study|Not transplanted, recipient issues|1|||
161059565|NCT00113269|581609228|FG002|Overall Study|Not transplanted, recipient issues|7|||
161059566|NCT00113269|581609229|FG003|Overall Study|Not transplanted, recipient issues|4|||
161059567|NCT00113269|581609226|FG000|Overall Study|Early graft loss, technical|0|||
161059568|NCT00113269|581609227|FG001|Overall Study|Early graft loss, technical|0|||
161059569|NCT00113269|581609228|FG002|Overall Study|Early graft loss, technical|2|||
161059570|NCT00113269|581609229|FG003|Overall Study|Early graft loss, technical|0|||
161059571|NCT00113269|581609226|FG000|Overall Study|Death in operating room|0|||
161059572|NCT00113269|581609227|FG001|Overall Study|Death in operating room|0|||
161059573|NCT00113269|581609228|FG002|Overall Study|Death in operating room|0|||
161059574|NCT00113269|581609229|FG003|Overall Study|Death in operating room|1|||
161059575|NCT00113269|581609226|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
161059576|NCT00113269|581609227|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
161059577|NCT00113269|581609228|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
161059578|NCT00113269|581609229|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
161059579|NCT00113269|581609226|FG000|Overall Study|Adverse Event|2|||
161059580|NCT00113269|581609227|FG001|Overall Study|Adverse Event|7|||
161059581|NCT00113269|581609228|FG002|Overall Study|Adverse Event|11|||
161059582|NCT00113269|581609229|FG003|Overall Study|Adverse Event|7|||
161059583|NCT00113269|581609226|FG000|Overall Study|Withdrawal by Subject|4|||
161059584|NCT00113269|581609227|FG001|Overall Study|Withdrawal by Subject|3|||
161059585|NCT00113269|581609228|FG002|Overall Study|Withdrawal by Subject|4|||
161059586|NCT00113269|581609229|FG003|Overall Study|Withdrawal by Subject|2|||
161059587|NCT00113269|581609226|FG000|Overall Study|Graft loss|6|||
161059588|NCT00113269|581609227|FG001|Overall Study|Graft loss|6|||
161059589|NCT00113269|581609228|FG002|Overall Study|Graft loss|4|||
161059590|NCT00113269|581609229|FG003|Overall Study|Graft loss|9|||
161059591|NCT00113269|581609226|FG000|Overall Study|Protocol Violation|1|||
161059592|NCT00113269|581609227|FG001|Overall Study|Protocol Violation|0|||
161059593|NCT00113269|581609228|FG002|Overall Study|Protocol Violation|4|||
161059594|NCT00113269|581609229|FG003|Overall Study|Protocol Violation|2|||
161059595|NCT00113269|581609226|FG000|Overall Study|Lost to Follow-up|2|||
161059596|NCT00113269|581609227|FG001|Overall Study|Lost to Follow-up|3|||
161059597|NCT00113269|581609228|FG002|Overall Study|Lost to Follow-up|6|||
161059598|NCT00113269|581609229|FG003|Overall Study|Lost to Follow-up|3|||
161059599|NCT00113269|581609226|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
161059600|NCT00113269|581609227|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
161059601|NCT00113269|581609228|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
161059602|NCT00113269|581609229|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
161059603|NCT00113269|581609226|FG000|Overall Study|Discontinued due to rejection|0|||
161059604|NCT00113269|581609227|FG001|Overall Study|Discontinued due to rejection|0|||
161059605|NCT00113269|581609228|FG002|Overall Study|Discontinued due to rejection|1|||
161059606|NCT00113269|581609229|FG003|Overall Study|Discontinued due to rejection|0|||
161059607|NCT00113269|581609226|FG000|Overall Study|Moved|0|||
161059608|NCT00113269|581609227|FG001|Overall Study|Moved|1|||
161059609|NCT00113269|581609228|FG002|Overall Study|Moved|0|||
161059610|NCT00113269|581609229|FG003|Overall Study|Moved|3|||
161059611|NCT00113269|581609226|FG000|Overall Study|Received pancreas transplant|0|||
161059612|NCT00113269|581609227|FG001|Overall Study|Received pancreas transplant|0|||
161059613|NCT00113269|581609228|FG002|Overall Study|Received pancreas transplant|0|||
161059614|NCT00113269|581609229|FG003|Overall Study|Received pancreas transplant|2|||
161059615|NCT00113269|581609226|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
161153100|NCT00590681|581940979|FG000|Overall Study|disease progression|1|||
161059616|NCT00113269|581609227|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
161059617|NCT00113269|581609228|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
161059618|NCT00113269|581609229|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
161059619|NCT00113269|581609226|FG000|Overall Study|Did not meet eligibility criteria|1|||
161059620|NCT00113269|581609227|FG001|Overall Study|Did not meet eligibility criteria|0|||
161059621|NCT00113269|581609228|FG002|Overall Study|Did not meet eligibility criteria|0|||
161059622|NCT00113269|581609229|FG003|Overall Study|Did not meet eligibility criteria|1|||
161059623|NCT00113269|581609226|FG000|Overall Study|Unable to return for follow up|2|||
161059624|NCT00113269|581609227|FG001|Overall Study|Unable to return for follow up|1|||
161059625|NCT00113269|581609228|FG002|Overall Study|Unable to return for follow up|0|||
161059626|NCT00113269|581609229|FG003|Overall Study|Unable to return for follow up|0|||
161059627|NCT03864341|581609233|FG000|Overall Study|Withdrawal by Subject|1|||
161059628|NCT01066936|581609234|FG000|Overall Study|Death|2|||
161059629|NCT01066936|581609234|FG000|Overall Study|Device revised/removed|1|||
161059630|NCT01066936|581609234|FG000|Overall Study|Lost to Follow-up|3|||
161059631|NCT01066936|581609234|FG000|Overall Study|Withdrawal by Subject|4|||
161059632|NCT01904136|581609235|FG000|Overall Study|Physician Decision|0|||
161059633|NCT01904136|581609236|FG001|Overall Study|Physician Decision|0|||
161059634|NCT01904136|581609237|FG002|Overall Study|Physician Decision|0|||
161059635|NCT01904136|581609238|FG003|Overall Study|Physician Decision|0|||
161059636|NCT01904136|581609239|FG004|Overall Study|Physician Decision|0|||
161059637|NCT01904136|581609240|FG005|Overall Study|Physician Decision|1|||
161059638|NCT01904136|581609241|FG006|Overall Study|Physician Decision|0|||
161059639|NCT01904136|581609242|FG007|Overall Study|Physician Decision|0|||
161059640|NCT01904136|581609243|FG008|Overall Study|Physician Decision|0|||
161059641|NCT00853372|581609244|FG000|Overall Study|Death|30|||
161059642|NCT00853372|581609245|FG001|Overall Study|Death|26|||
161059643|NCT00853372|581609244|FG000|Overall Study|Lost to Follow-up|1|||
161059644|NCT00853372|581609245|FG001|Overall Study|Lost to Follow-up|2|||
161059645|NCT00853372|581609244|FG000|Overall Study|Full Consent Withdrawn|1|||
161059646|NCT00853372|581609245|FG001|Overall Study|Full Consent Withdrawn|1|||
161059647|NCT01580995|581609246|FG000|Overall Study|Lost to Follow-up|2|||
161059648|NCT01580995|581609247|FG001|Overall Study|Lost to Follow-up|2|||
161059649|NCT02517528|581609249|FG000|Overall Study|Withdrawal by Subject|1|||
161059650|NCT02202109|581609251|FG000|Overall Study|Lost to Follow-up|88|||
161059651|NCT02202109|581609252|FG001|Overall Study|Lost to Follow-up|87|||
161059652|NCT02202109|581609251|FG000|Overall Study|Withdrawal by Subject|2|||
161059653|NCT02202109|581609252|FG001|Overall Study|Withdrawal by Subject|0|||
161059654|NCT01268098|581609255|FG000|Overall Study|Adverse Event|1|||
161059655|NCT01268098|581609256|FG001|Overall Study|Adverse Event|0|||
161059656|NCT04156399|581609263|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
161059657|NCT04156399|581609263|FG000|Overall Study|study suspension due to COVID pandemic|3|||
161059658|NCT01703845|581609264|FG000|Overall Study|Adverse Event|1|||
161059659|NCT01703845|581609265|FG001|Overall Study|Adverse Event|0|||
161059660|NCT01703845|581609264|FG000|Overall Study|Protocol Violation|1|||
161059661|NCT01703845|581609265|FG001|Overall Study|Protocol Violation|0|||
161059662|NCT01703845|581609264|FG000|Overall Study|other than stated above|1|||
161059663|NCT01703845|581609265|FG001|Overall Study|other than stated above|0|||
161059664|NCT03418493|581609266|FG000|Overall Study|Adverse Event|1|||
161059665|NCT03418493|581609267|FG001|Overall Study|Adverse Event|0|||
161059666|NCT03418493|581609268|FG002|Overall Study|Adverse Event|0|||
161059667|NCT03418493|581609269|FG003|Overall Study|Adverse Event|0|||
161059668|NCT03418493|581609270|FG004|Overall Study|Adverse Event|0|||
161059669|NCT03418493|581609271|FG005|Overall Study|Adverse Event|0|||
161059670|NCT03418493|581609272|FG006|Overall Study|Adverse Event|0|||
161059671|NCT03418493|581609273|FG007|Overall Study|Adverse Event|0|||
161059672|NCT03418493|581609274|FG008|Overall Study|Adverse Event|0|||
161059673|NCT03418493|581609275|FG009|Overall Study|Adverse Event|0|||
161059674|NCT03418493|581609276|FG010|Overall Study|Adverse Event|0|||
161059675|NCT03418493|581609266|FG000|Overall Study|Protocol Violation|0|||
161059676|NCT03418493|581609267|FG001|Overall Study|Protocol Violation|0|||
161059677|NCT03418493|581609268|FG002|Overall Study|Protocol Violation|0|||
161153101|NCT01259297|581940980|FG000|Double Blind Randomized Period|Death|1|||
161153102|NCT01259297|581940981|FG001|Double Blind Randomized Period|Death|1|||
161153103|NCT01259297|581940982|FG002|Double Blind Randomized Period|Death|1|||
161153104|NCT01259297|581940983|FG003|Double Blind Randomized Period|Death|2|||
161059678|NCT03418493|581609269|FG003|Overall Study|Protocol Violation|0|||
161059679|NCT03418493|581609270|FG004|Overall Study|Protocol Violation|0|||
161059680|NCT03418493|581609271|FG005|Overall Study|Protocol Violation|0|||
161059681|NCT03418493|581609272|FG006|Overall Study|Protocol Violation|0|||
161059682|NCT03418493|581609273|FG007|Overall Study|Protocol Violation|0|||
161059683|NCT03418493|581609274|FG008|Overall Study|Protocol Violation|0|||
161059684|NCT03418493|581609275|FG009|Overall Study|Protocol Violation|1|||
161059685|NCT03418493|581609276|FG010|Overall Study|Protocol Violation|0|||
161059686|NCT04140266|581609278|FG000|Overall Study|Physician Decision|2|||
161059687|NCT04140266|581609279|FG001|Overall Study|Physician Decision|0|||
161059688|NCT04140266|581609278|FG000|Overall Study|Withdrawal by Subject|4|||
161059689|NCT04140266|581609279|FG001|Overall Study|Withdrawal by Subject|2|||
161059690|NCT00943618|581609280|FG000|Overall Study|Lost to Follow-up|38|||
161059691|NCT00943618|581609281|FG001|Overall Study|Lost to Follow-up|48|||
161059692|NCT00943618|581609282|FG002|Overall Study|Lost to Follow-up|20|||
161059693|NCT00943618|581609280|FG000|Overall Study|Discontinued Medication|17|||
161059694|NCT00943618|581609281|FG001|Overall Study|Discontinued Medication|29|||
161059695|NCT00943618|581609282|FG002|Overall Study|Discontinued Medication|11|||
161059696|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
161059697|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
161059698|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
161059699|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
161059700|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
161059701|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
161059702|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
161059703|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
161059704|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
161059705|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
161059706|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
161059707|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
161059708|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
161059709|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
161059710|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
161059711|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
161059712|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
161059713|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
161059714|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
161059715|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
161059716|NCT02637856|581609293|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
161059717|NCT02637856|581609294|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
161059718|NCT02637856|581609293|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
161059719|NCT02637856|581609294|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
161059720|NCT02637856|581609293|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
161059721|NCT02637856|581609294|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
161059722|NCT02509312|581609295|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
161059723|NCT02509312|581609296|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
161059724|NCT02509312|581609295|FG000|Overall Study|Obstetrician refusal|0|||
161059725|NCT02509312|581609296|FG001|Overall Study|Obstetrician refusal|1|||
161059726|NCT02509312|581609295|FG000|Overall Study|Patient elected for TOLAC|1|||
161059727|NCT02509312|581609296|FG001|Overall Study|Patient elected for TOLAC|0|||
161059728|NCT02509312|581609295|FG000|Overall Study|Cesarean deemed stat|1|||
161059729|NCT02509312|581609296|FG001|Overall Study|Cesarean deemed stat|0|||
161059730|NCT02509312|581609295|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
161059731|NCT02509312|581609296|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
161059732|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
161059733|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
161059734|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
161059735|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
161059736|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Death|0|||
161059737|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Death|1|||
161059738|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
161059739|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
161059740|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
161059741|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
161059742|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
161059743|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
161059744|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
161059745|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
161059746|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
161059747|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
161059748|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
161059749|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
161059750|NCT01309243|581609297|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
161059751|NCT01309243|581609298|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
161059752|NCT01309243|581609297|FG000|Extension Phase|Lost to Follow-up|6|||
161059753|NCT01309243|581609298|FG001|Extension Phase|Lost to Follow-up|0|||
161059754|NCT01402063|581609301|FG000|Overall Study|Withdrawal by Subject|3|||
161059755|NCT01402063|581609302|FG001|Overall Study|Withdrawal by Subject|3|||
161059756|NCT05153499|581609303|FG000|Overall Study|Withdrawal by Subject|1|||
161059757|NCT05153499|581609304|FG001|Overall Study|Withdrawal by Subject|0|||
161153105|NCT01259297|581940984|FG004|Double Blind Randomized Period|Death|1|||
161153106|NCT01259297|581940985|FG005|Double Blind Randomized Period|Death|5|||
161153107|NCT01259297|581940986|FG006|Double Blind Randomized Period|Death|2|||
161153108|NCT01259297|581940987|FG007|Double Blind Randomized Period|Death|1|||
161153109|NCT01259297|581940980|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161153110|NCT01259297|581940981|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161153111|NCT01259297|581940982|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
161153112|NCT01259297|581940983|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
161153113|NCT01259297|581940984|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
161153114|NCT01259297|581940985|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161153115|NCT01259297|581940986|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161153116|NCT01259297|581940987|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
161153117|NCT01259297|581940980|FG000|Double Blind Randomized Period|Other reasons|0|||
161153118|NCT01259297|581940981|FG001|Double Blind Randomized Period|Other reasons|1|||
161153119|NCT01259297|581940982|FG002|Double Blind Randomized Period|Other reasons|0|||
161153120|NCT01259297|581940983|FG003|Double Blind Randomized Period|Other reasons|0|||
161153121|NCT01259297|581940984|FG004|Double Blind Randomized Period|Other reasons|1|||
161153122|NCT01259297|581940985|FG005|Double Blind Randomized Period|Other reasons|2|||
161153123|NCT01259297|581940986|FG006|Double Blind Randomized Period|Other reasons|3|||
161153124|NCT01259297|581940987|FG007|Double Blind Randomized Period|Other reasons|1|||
161153125|NCT02815397|581940988|FG000|Overall Study|Physician Decision|2|||
161153126|NCT04598165|581940991|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
161153127|NCT04598165|581940992|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
161153128|NCT04598165|581940991|FG000|Completed 6-week Follow-up|Death|2|||
161153129|NCT04598165|581940992|FG001|Completed 6-week Follow-up|Death|1|||
161153130|NCT04598165|581940991|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
161153131|NCT04598165|581940992|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
161153132|NCT04598165|581940991|FG000|Completed 6-week Follow-up|Ineligible|4|||
161153133|NCT04598165|581940992|FG001|Completed 6-week Follow-up|Ineligible|3|||
161153134|NCT04598165|581940991|FG000|Completed 6-week Follow-up|Partner refusal|0|||
161153135|NCT04598165|581940992|FG001|Completed 6-week Follow-up|Partner refusal|1|||
161153136|NCT04598165|581940991|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
161153137|NCT04598165|581940992|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
161153138|NCT00576693|581940993|FG000|Overall Study|Lost to Follow-up|7|||
161153139|NCT00576693|581940994|FG001|Overall Study|Lost to Follow-up|11|||
161153140|NCT00576693|581940993|FG000|Overall Study|Withdrawal by Subject|3|||
161153141|NCT00576693|581940994|FG001|Overall Study|Withdrawal by Subject|13|||
161153142|NCT00705224|581940995|FG000|Overall Study|Adverse Event|1|||
161153143|NCT00705224|581940995|FG000|Overall Study|Lack of Efficacy|2|||
161153144|NCT00705224|581940995|FG000|Overall Study|Withdrawal by Subject|3|||
161153145|NCT00705224|581940995|FG000|Overall Study|Lost to Follow-up|5|||
161153146|NCT01721408|581940996|FG000|Overall Study|Adverse Event|6|||
161153147|NCT01721408|581940997|FG001|Overall Study|Adverse Event|1|||
161153148|NCT01721408|581940996|FG000|Overall Study|Death|1|||
161153149|NCT01721408|581940997|FG001|Overall Study|Death|0|||
161153150|NCT01721408|581940996|FG000|Overall Study|Insufficient clinical response|15|||
161153151|NCT01721408|581940997|FG001|Overall Study|Insufficient clinical response|6|||
161153152|NCT01721408|581940996|FG000|Overall Study|No longer willing to participate study|9|||
161153153|NCT01721408|581940997|FG001|Overall Study|No longer willing to participate study|10|||
161153154|NCT01721408|581940996|FG000|Overall Study|Protocol Violation|0|||
161153155|NCT01721408|581940997|FG001|Overall Study|Protocol Violation|2|||
161153156|NCT01721408|581940996|FG000|Overall Study|Other|3|||
161153157|NCT01721408|581940997|FG001|Overall Study|Other|3|||
161153158|NCT01721408|581940996|FG000|Overall Study|Lost to Follow-up|1|||
161153159|NCT01721408|581940997|FG001|Overall Study|Lost to Follow-up|2|||
161153160|NCT01721408|581940996|FG000|Overall Study|Does not meet entrance criteria|1|||
161153161|NCT01721408|581940997|FG001|Overall Study|Does not meet entrance criteria|0|||
161153162|NCT04160468|581940998|FG000|Overall Study|Lost to Follow-up|19|||
161153163|NCT04160468|581940999|FG001|Overall Study|Lost to Follow-up|4|||
161153164|NCT04160468|581940998|FG000|Overall Study|Randomized but not dosed|6|||
161153165|NCT04160468|581940999|FG001|Overall Study|Randomized but not dosed|0|||
161153166|NCT04160468|581940998|FG000|Overall Study|Withdrawal by Subject|4|||
161281809|NCT00143247|582410341|FG000|Overall Study|Lack of Efficacy|3|||
161281810|NCT00143247|582410341|FG000|Overall Study|Withdrawal by Subject|55|||
161281811|NCT00143247|582410341|FG000|Overall Study|Study terminated by sponsor|31|||
161281812|NCT00143247|582410341|FG000|Overall Study|Protocol Violation|15|||
161153167|NCT04160468|581940999|FG001|Overall Study|Withdrawal by Subject|1|||
161153168|NCT04160468|581940998|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
161153169|NCT04160468|581940999|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
161153170|NCT04160468|581940998|FG000|Overall Study|Participant incarcerated|1|||
161153171|NCT04160468|581940999|FG001|Overall Study|Participant incarcerated|0|||
161153172|NCT01187901|581941000|FG000|Overall Study|Protocol Violation|1|||
161153173|NCT01187901|581941001|FG001|Overall Study|Protocol Violation|0|||
161153174|NCT01187901|581941000|FG000|Overall Study|Lost to Follow-up|1|||
161153175|NCT01187901|581941001|FG001|Overall Study|Lost to Follow-up|2|||
161153176|NCT01187901|581941000|FG000|Overall Study|Unrelated Health Reasons|1|||
161153177|NCT01187901|581941001|FG001|Overall Study|Unrelated Health Reasons|2|||
161153178|NCT01187901|581941000|FG000|Overall Study|Suspected Allergic Reaction|1|||
161153179|NCT01187901|581941001|FG001|Overall Study|Suspected Allergic Reaction|1|||
161153180|NCT01187901|581941000|FG000|Overall Study|Adverse Event|3|||
161153181|NCT01187901|581941001|FG001|Overall Study|Adverse Event|0|||
161153182|NCT01187901|581941000|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
161345227|NCT00831844|582648901|FG003|Overall Study|Withdrawal by Subject|0|||
161345228|NCT00831844|582648902|FG004|Overall Study|Withdrawal by Subject|0|||
161345229|NCT00831844|582648903|FG005|Overall Study|Withdrawal by Subject|0|||
161345230|NCT00831844|582648904|FG006|Overall Study|Withdrawal by Subject|0|||
161059758|NCT05153499|581609303|FG000|Overall Study|Clinical Hold|1|||
161059759|NCT05153499|581609304|FG001|Overall Study|Clinical Hold|0|||
161059760|NCT05153499|581609303|FG000|Overall Study|Study Termination|6|||
161153183|NCT01187901|581941001|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
161153184|NCT01187901|581941000|FG000|Overall Study|Pregnancy|0|||
161153185|NCT01187901|581941001|FG001|Overall Study|Pregnancy|2|||
161153186|NCT03987620|581941004|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
161153187|NCT03987620|581941005|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
161153188|NCT03987620|581941004|FG000|Overall Study|Adverse Event|3|||
161153189|NCT03987620|581941005|FG001|Overall Study|Adverse Event|0|||
161153190|NCT03987620|581941004|FG000|Overall Study|Lost to Follow-up|1|||
161153191|NCT03987620|581941005|FG001|Overall Study|Lost to Follow-up|2|||
161059761|NCT05153499|581609304|FG001|Overall Study|Study Termination|5|||
161059762|NCT05109117|581609305|FG000|Overall Study|Lost to Follow-up|1|||
161059763|NCT05109117|581609305|FG000|Overall Study|Discontinued for non-compliance|1|||
161059764|NCT02166047|581609307|FG000|Overall Study|Withdrawal by Participant|0|||
161059765|NCT02166047|581609308|FG001|Overall Study|Withdrawal by Participant|1|||
161059766|NCT02166047|581609309|FG002|Overall Study|Withdrawal by Participant|2|||
161059767|NCT02166047|581609310|FG003|Overall Study|Withdrawal by Participant|0|||
161059768|NCT02166047|581609311|FG004|Overall Study|Withdrawal by Participant|0|||
161059769|NCT02166047|581609312|FG005|Overall Study|Withdrawal by Participant|0|||
161059770|NCT02166047|581609313|FG006|Overall Study|Withdrawal by Participant|1|||
161059771|NCT02166047|581609314|FG007|Overall Study|Withdrawal by Participant|0|||
161059772|NCT02166047|581609315|FG008|Overall Study|Withdrawal by Participant|0|||
161059773|NCT02166047|581609316|FG009|Overall Study|Withdrawal by Participant|0|||
161059774|NCT02166047|581609317|FG010|Overall Study|Withdrawal by Participant|0|||
161059775|NCT02166047|581609318|FG011|Overall Study|Withdrawal by Participant|0|||
161059776|NCT02166047|581609307|FG000|Overall Study|Adverse Event|0|||
161059777|NCT02166047|581609308|FG001|Overall Study|Adverse Event|0|||
161059778|NCT02166047|581609309|FG002|Overall Study|Adverse Event|0|||
161059779|NCT02166047|581609310|FG003|Overall Study|Adverse Event|0|||
161059780|NCT02166047|581609311|FG004|Overall Study|Adverse Event|1|||
161059781|NCT02166047|581609312|FG005|Overall Study|Adverse Event|0|||
161059782|NCT02166047|581609313|FG006|Overall Study|Adverse Event|1|||
161059783|NCT02166047|581609314|FG007|Overall Study|Adverse Event|0|||
161059784|NCT02166047|581609315|FG008|Overall Study|Adverse Event|0|||
161059785|NCT02166047|581609316|FG009|Overall Study|Adverse Event|0|||
161059786|NCT02166047|581609317|FG010|Overall Study|Adverse Event|2|||
161059787|NCT02166047|581609318|FG011|Overall Study|Adverse Event|0|||
161059788|NCT00451555|581609324|FG000|Overall Study|Protocol Violation|2|||
161059789|NCT00451555|581609325|FG001|Overall Study|Protocol Violation|2|||
161059790|NCT00451555|581609324|FG000|Overall Study|Adverse Event|3|||
161059791|NCT00451555|581609325|FG001|Overall Study|Adverse Event|1|||
161059792|NCT00451555|581609324|FG000|Overall Study|Withdrawal by Subject|6|||
161153192|NCT03987620|581941004|FG000|Overall Study|Physician Decision|0|||
161153193|NCT03987620|581941005|FG001|Overall Study|Physician Decision|1|||
161153194|NCT03987620|581941004|FG000|Overall Study|Pregnancy|1|||
161153195|NCT03987620|581941005|FG001|Overall Study|Pregnancy|0|||
161153196|NCT03987620|581941004|FG000|Overall Study|Withdrawal by Subject|7|||
161059793|NCT00451555|581609325|FG001|Overall Study|Withdrawal by Subject|0|||
161153197|NCT03987620|581941005|FG001|Overall Study|Withdrawal by Subject|1|||
161153198|NCT03987620|581941004|FG000|Overall Study|Other|2|||
161153199|NCT03987620|581941005|FG001|Overall Study|Other|5|||
161153200|NCT02149836|581941006|FG000|Overall Study|Withdrawal by Subject|1|||
161153201|NCT00376688|581941007|FG000|Overall Study|Adverse Event|3|||
161153202|NCT00376688|581941007|FG000|Overall Study|Death|1|||
161153203|NCT01770353|581941008|FG000|Overall Study|Progressive disease|2|||
161059794|NCT00451555|581609324|FG000|Overall Study|Physician Decision|2|||
161059795|NCT00451555|581609325|FG001|Overall Study|Physician Decision|1|||
161059796|NCT00827775|581609328|FG000|Overall Study|Withdrawal by Subject|0|||
161059797|NCT00827775|581609329|FG001|Overall Study|Withdrawal by Subject|5|||
161153204|NCT01770353|581941009|FG001|Overall Study|Progressive disease|1|||
161153205|NCT01770353|581941008|FG000|Overall Study|Adverse Event|0|||
161153206|NCT01770353|581941009|FG001|Overall Study|Adverse Event|1|||
161153207|NCT01770353|581941008|FG000|Overall Study|Protocol Violation|1|||
161153208|NCT01770353|581941009|FG001|Overall Study|Protocol Violation|0|||
161153209|NCT01770353|581941008|FG000|Overall Study|Physician Decision|0|||
161059798|NCT00297778|581609338|FG000|Overall Study|Adverse Event|16|||
161153210|NCT01770353|581941009|FG001|Overall Study|Physician Decision|3|||
161153211|NCT01770353|581941008|FG000|Overall Study|Clinical deterioration|3|||
161153212|NCT01770353|581941009|FG001|Overall Study|Clinical deterioration|6|||
161153213|NCT01770353|581941008|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
161153214|NCT01770353|581941009|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
161153215|NCT00370149|581941010|FG000|Overall Study|Physician Decision|16|||
161153216|NCT00370149|581941011|FG001|Overall Study|Physician Decision|16|||
161153217|NCT00370149|581941010|FG000|Overall Study|Protocol Violation|1|||
161153218|NCT00370149|581941011|FG001|Overall Study|Protocol Violation|0|||
161153219|NCT00370149|581941010|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
161153220|NCT00370149|581941011|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
161153221|NCT00370149|581941010|FG000|Overall Study|Pre-existing infection|0|||
161153222|NCT00370149|581941011|FG001|Overall Study|Pre-existing infection|1|||
161153223|NCT00370149|581941010|FG000|Overall Study|Antibiotic coated dressing placed|0|||
161153224|NCT00370149|581941011|FG001|Overall Study|Antibiotic coated dressing placed|1|||
161153225|NCT00620321|581942452|FG000|Overall Study|Adverse Event|1|||
161059799|NCT00297778|581609339|FG001|Overall Study|Adverse Event|10|||
161059800|NCT00297778|581609338|FG000|Overall Study|Withdrawal by Subject|1|||
161059801|NCT00297778|581609339|FG001|Overall Study|Withdrawal by Subject|5|||
161059802|NCT00297778|581609338|FG000|Overall Study|Lack of Efficacy|2|||
161059803|NCT00297778|581609339|FG001|Overall Study|Lack of Efficacy|1|||
161059804|NCT00297778|581609338|FG000|Overall Study|Non-compliant with trial protocol|0|||
161059805|NCT00297778|581609339|FG001|Overall Study|Non-compliant with trial protocol|3|||
161059806|NCT00297778|581609338|FG000|Overall Study|Other|0|||
161059807|NCT00297778|581609339|FG001|Overall Study|Other|1|||
161059808|NCT00839332|581609341|FG000|Phase 1|Disease Progression|38|||
161059809|NCT00839332|581609342|FG001|Phase 1|Disease Progression|0|||
161059810|NCT00839332|581609343|FG002|Phase 1|Disease Progression|0|||
161059811|NCT00839332|581609341|FG000|Phase 1|Adverse Event|6|||
161059812|NCT00839332|581609342|FG001|Phase 1|Adverse Event|0|||
161059813|NCT00839332|581609343|FG002|Phase 1|Adverse Event|0|||
161059814|NCT00839332|581609341|FG000|Phase 1|Withdrawal by Subject|4|||
161059815|NCT00839332|581609342|FG001|Phase 1|Withdrawal by Subject|0|||
161059816|NCT00839332|581609343|FG002|Phase 1|Withdrawal by Subject|0|||
161059817|NCT00839332|581609341|FG000|Phase 1|Physician Decision|2|||
161059818|NCT00839332|581609342|FG001|Phase 1|Physician Decision|0|||
161059819|NCT00839332|581609343|FG002|Phase 1|Physician Decision|0|||
161059820|NCT00839332|581609341|FG000|Phase 2|Protocol Violation|0|||
161059821|NCT00839332|581609342|FG001|Phase 2|Protocol Violation|1|||
161059822|NCT00839332|581609343|FG002|Phase 2|Protocol Violation|0|||
161059823|NCT00839332|581609341|FG000|Phase 2|Disease Progression|0|||
161059824|NCT00839332|581609342|FG001|Phase 2|Disease Progression|46|||
161059825|NCT00839332|581609343|FG002|Phase 2|Disease Progression|21|||
161059826|NCT00839332|581609341|FG000|Phase 2|Adverse Event|0|||
161059827|NCT00839332|581609342|FG001|Phase 2|Adverse Event|8|||
161059828|NCT00839332|581609343|FG002|Phase 2|Adverse Event|6|||
161153226|NCT00620321|581942453|FG001|Overall Study|Adverse Event|1|||
161153227|NCT00620321|581942452|FG000|Overall Study|Death|1|||
161153228|NCT00620321|581942453|FG001|Overall Study|Death|1|||
161153229|NCT00620321|581942452|FG000|Overall Study|Physician Decision|0|||
161153230|NCT00620321|581942453|FG001|Overall Study|Physician Decision|7|||
161153231|NCT00620321|581942452|FG000|Overall Study|Progressive Disease|5|||
161153232|NCT00620321|581942453|FG001|Overall Study|Progressive Disease|5|||
161153233|NCT00620321|581942452|FG000|Overall Study|Sponsor Decision|0|||
161153234|NCT00620321|581942453|FG001|Overall Study|Sponsor Decision|1|||
161153235|NCT00620321|581942452|FG000|Overall Study|Withdrawal by Subject|1|||
161153236|NCT00620321|581942453|FG001|Overall Study|Withdrawal by Subject|1|||
161153237|NCT02410902|581942454|FG000|Overall Study|Adverse Event|2|||
161153238|NCT02410902|581942455|FG001|Overall Study|Adverse Event|3|||
161059829|NCT00839332|581609341|FG000|Phase 2|Death|0|||
161059830|NCT00839332|581609342|FG001|Phase 2|Death|4|||
161059831|NCT00839332|581609343|FG002|Phase 2|Death|2|||
161059832|NCT00839332|581609341|FG000|Phase 2|Withdrawal by Subject|0|||
161059833|NCT00839332|581609342|FG001|Phase 2|Withdrawal by Subject|5|||
161059834|NCT00839332|581609343|FG002|Phase 2|Withdrawal by Subject|8|||
161059835|NCT00839332|581609341|FG000|Phase 2|Physician Decision|0|||
161059836|NCT00839332|581609342|FG001|Phase 2|Physician Decision|4|||
161059837|NCT00839332|581609343|FG002|Phase 2|Physician Decision|1|||
161059838|NCT00839332|581609341|FG000|Phase 2|Lost to Follow-up|0|||
161059839|NCT00839332|581609342|FG001|Phase 2|Lost to Follow-up|0|||
161153239|NCT02410902|581942454|FG000|Overall Study|Lost to Follow-up|4|||
161153240|NCT02410902|581942455|FG001|Overall Study|Lost to Follow-up|1|||
161059840|NCT00839332|581609343|FG002|Phase 2|Lost to Follow-up|1|||
161059841|NCT01200485|581609344|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
161153241|NCT02410902|581942454|FG000|Overall Study|Protocol Violation|1|||
161153242|NCT02410902|581942455|FG001|Overall Study|Protocol Violation|4|||
161059842|NCT01200485|581609345|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
161059843|NCT01200485|581609346|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
161059844|NCT01200485|581609344|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
161059845|NCT01200485|581609345|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
161059846|NCT01200485|581609346|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
161059847|NCT02630706|581609347|FG000|Overall Study|Adverse Event|2|||
161059848|NCT02630706|581609348|FG001|Overall Study|Adverse Event|1|||
161059849|NCT02630706|581609349|FG002|Overall Study|Adverse Event|1|||
161059850|NCT02630706|581609347|FG000|Overall Study|Lost to Follow-up|0|||
161281813|NCT00143247|582410341|FG000|Overall Study|Lost to Follow-up|12|||
161281814|NCT00143247|582410341|FG000|Overall Study|following inaccurate lab adverse event|1|||
161059851|NCT02630706|581609348|FG001|Overall Study|Lost to Follow-up|1|||
161059852|NCT02630706|581609349|FG002|Overall Study|Lost to Follow-up|2|||
161059853|NCT02630706|581609347|FG000|Overall Study|Physician Decision|1|||
161059854|NCT02630706|581609348|FG001|Overall Study|Physician Decision|1|||
161059855|NCT02630706|581609349|FG002|Overall Study|Physician Decision|0|||
161059856|NCT02630706|581609347|FG000|Overall Study|Pregnancy|0|||
161059857|NCT02630706|581609348|FG001|Overall Study|Pregnancy|1|||
161059858|NCT02630706|581609349|FG002|Overall Study|Pregnancy|0|||
161059859|NCT02630706|581609347|FG000|Overall Study|Withdrawal by Subject|4|||
161059860|NCT02630706|581609348|FG001|Overall Study|Withdrawal by Subject|5|||
161059861|NCT02630706|581609349|FG002|Overall Study|Withdrawal by Subject|7|||
161059862|NCT01678898|581609350|FG000|PB-102-F01|Adverse Event|0|||
161059863|NCT01678898|581609351|FG001|PB-102-F01|Adverse Event|1|||
161059864|NCT01678898|581609352|FG002|PB-102-F01|Adverse Event|0|||
161059865|NCT01678898|581609350|FG000|PB-102-F01|Physician Decision|0|||
161059866|NCT01678898|581609351|FG001|PB-102-F01|Physician Decision|1|||
161059867|NCT01678898|581609352|FG002|PB-102-F01|Physician Decision|0|||
161059868|NCT02515097|581609357|FG000|Overall Study|Lost to Follow-up|4|||
161059869|NCT02515097|581609358|FG001|Overall Study|Lost to Follow-up|2|||
161059870|NCT02515097|581609357|FG000|Overall Study|Withdrawal by Subject|1|||
161059871|NCT02515097|581609358|FG001|Overall Study|Withdrawal by Subject|3|||
161059872|NCT02515097|581609357|FG000|Overall Study|Adverse Event|2|||
161059873|NCT02515097|581609358|FG001|Overall Study|Adverse Event|1|||
161059874|NCT01894256|581609361|FG000|Part A|Adverse Event|0|||
161059875|NCT01894256|581609362|FG001|Part A|Adverse Event|1|||
161059876|NCT01894256|581609363|FG002|Part A|Adverse Event|0|||
161059877|NCT01894256|581609361|FG000|Part B|Death|0|||
161059878|NCT01894256|581609362|FG001|Part B|Death|1|||
161059879|NCT01894256|581609363|FG002|Part B|Death|1|||
161059880|NCT01894256|581609361|FG000|Part B|Withdrawal by Subject|0|||
161059881|NCT01894256|581609362|FG001|Part B|Withdrawal by Subject|1|||
161059882|NCT01894256|581609363|FG002|Part B|Withdrawal by Subject|0|||
161059883|NCT01894256|581609361|FG000|Part B|Lack of Efficacy|15|||
161059884|NCT01894256|581609362|FG001|Part B|Lack of Efficacy|12|||
161059885|NCT01894256|581609363|FG002|Part B|Lack of Efficacy|13|||
161059886|NCT02965599|581609364|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
161059887|NCT02965599|581609365|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
161059888|NCT00230971|581609366|FG000|Randomization|No study drug administered|3|||
161059889|NCT00230971|581609367|FG001|Randomization|No study drug administered|3|||
161059890|NCT00230971|581609366|FG000|Baseline Participants|Lost to Follow-up|5|||
161059891|NCT00230971|581609367|FG001|Baseline Participants|Lost to Follow-up|12|||
161059892|NCT00230971|581609366|FG000|Baseline Participants|Death|6|||
161059893|NCT00230971|581609367|FG001|Baseline Participants|Death|5|||
161059894|NCT00230971|581609366|FG000|Baseline Participants|Withdrawal by Subject|7|||
161059895|NCT00230971|581609367|FG001|Baseline Participants|Withdrawal by Subject|1|||
161059896|NCT00230971|581609366|FG000|Baseline Participants|Adverse Event|1|||
161059897|NCT00230971|581609367|FG001|Baseline Participants|Adverse Event|0|||
161059898|NCT00230971|581609366|FG000|Baseline Participants|No bacteria observed|1|||
161059899|NCT00230971|581609367|FG001|Baseline Participants|No bacteria observed|0|||
161059900|NCT00230971|581609366|FG000|Baseline Participants|Failure to return|1|||
161281815|NCT00143247|582410341|FG000|Overall Study|Other|12|||
161281816|NCT00489827|582410342|FG000|Overall Study|Intraoperative exclusion criteria|1|||
161281817|NCT00489827|582410343|FG001|Overall Study|Intraoperative exclusion criteria|1|||
161059901|NCT00230971|581609367|FG001|Baseline Participants|Failure to return|1|||
161059902|NCT00230971|581609366|FG000|Baseline Participants|Reintervention|1|||
161059903|NCT00230971|581609367|FG001|Baseline Participants|Reintervention|0|||
161059904|NCT04267393|581609371|FG000|Randomization|Adverse Event|1|||
161059905|NCT04267393|581609372|FG001|Randomization|Adverse Event|0|||
161059906|NCT04267393|581609373|FG002|Randomization|Adverse Event|0|||
161059907|NCT04267393|581609371|FG000|Randomization|Administrative Reasons by Sponsor|0|||
161059908|NCT04267393|581609372|FG001|Randomization|Administrative Reasons by Sponsor|1|||
161059909|NCT04267393|581609373|FG002|Randomization|Administrative Reasons by Sponsor|0|||
161059910|NCT04267393|581609371|FG000|Treatment Period|Adverse Event|0|||
161059911|NCT04267393|581609372|FG001|Treatment Period|Adverse Event|2|||
161059912|NCT04267393|581609373|FG002|Treatment Period|Adverse Event|3|||
161059913|NCT04267393|581609371|FG000|Treatment Period|Participant Withdrew Consent|0|||
161059914|NCT04267393|581609372|FG001|Treatment Period|Participant Withdrew Consent|0|||
161281818|NCT00489827|582410342|FG000|Overall Study|Intraoperative exclusion criteria|1|||
161281819|NCT00489827|582410343|FG001|Overall Study|Intraoperative exclusion criteria|1|||
161281820|NCT02766283|582410344|FG000|Overall Study|Lost to Follow-up|27|||
161281821|NCT00721227|582410345|FG000|Overall Study|Lost to Follow-up|3|||
161281822|NCT00721227|582410346|FG001|Overall Study|Lost to Follow-up|0|||
161059915|NCT04267393|581609373|FG002|Treatment Period|Participant Withdrew Consent|1|||
161059916|NCT04267393|581609371|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
161281823|NCT00721227|582410345|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
161281824|NCT00721227|582410346|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
161059917|NCT04267393|581609372|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
161059918|NCT04267393|581609373|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
161059919|NCT02799745|581609374|FG000|Overall Study|Participant moved out of state|1|||
161059920|NCT02799745|581609375|FG001|Overall Study|Participant moved out of state|0|||
161059921|NCT02799745|581609374|FG000|Overall Study|Discontinued due to planned surgery|1|||
161059922|NCT02799745|581609375|FG001|Overall Study|Discontinued due to planned surgery|0|||
161059923|NCT02799745|581609374|FG000|Overall Study|Withdrawal by Subject|16|||
161059924|NCT02799745|581609375|FG001|Overall Study|Withdrawal by Subject|25|||
161059925|NCT02799745|581609374|FG000|Overall Study|Protocol Deviation|4|||
161059926|NCT02799745|581609375|FG001|Overall Study|Protocol Deviation|5|||
161059927|NCT02799745|581609374|FG000|Overall Study|Progressive Disease|28|||
161059928|NCT02799745|581609375|FG001|Overall Study|Progressive Disease|38|||
161059929|NCT02799745|581609374|FG000|Overall Study|Lost to Follow-up|3|||
161059930|NCT02799745|581609375|FG001|Overall Study|Lost to Follow-up|2|||
161059931|NCT02799745|581609374|FG000|Overall Study|Death|3|||
161059932|NCT02799745|581609375|FG001|Overall Study|Death|0|||
161059933|NCT02799745|581609374|FG000|Overall Study|Adverse Event|0|||
161059934|NCT02799745|581609375|FG001|Overall Study|Adverse Event|1|||
161059935|NCT02210208|581611014|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
161059936|NCT02210208|581611014|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
161059937|NCT02210208|581611014|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
161059938|NCT01726049|581611015|FG000|Overall Study|Death|1|||
161059939|NCT01726049|581611016|FG001|Overall Study|Death|1|||
161059940|NCT01726049|581611015|FG000|Overall Study|Adverse Event|4|||
161059941|NCT01726049|581611016|FG001|Overall Study|Adverse Event|1|||
161059942|NCT01726049|581611015|FG000|Overall Study|refused second HC|0|||
161059943|NCT01726049|581611016|FG001|Overall Study|refused second HC|2|||
161059944|NCT01929876|581611017|FG000|Period 2|Non-Compliance|1|||
161059945|NCT01222533|581611019|FG000|Overall Study|Adverse Event|5|||
161059946|NCT01222533|581611019|FG000|Overall Study|Withdrawal by Subject|5|||
161059947|NCT01222533|581611019|FG000|Overall Study|Other|4|||
161059948|NCT03834623|581611020|FG000|Overall Study|Progression|0|||
161059949|NCT03834623|581611021|FG001|Overall Study|Progression|1|||
161059950|NCT01947517|581611022|FG000|Overall Study|Withdrawal by Subject|1|||
161059951|NCT01947517|581611023|FG001|Overall Study|Withdrawal by Subject|1|||
161059952|NCT00460564|581611024|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
161059953|NCT00460564|581611025|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
161059954|NCT00460564|581611026|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161059955|NCT00460564|581611027|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161059956|NCT00460564|581611028|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161059957|NCT00460564|581611029|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161059958|NCT00460564|581611030|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161059959|NCT00460564|581611031|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
161059960|NCT00460564|581611024|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
161059961|NCT00460564|581611025|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161059962|NCT00460564|581611026|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161059963|NCT00460564|581611027|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161059964|NCT00460564|581611028|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161059965|NCT00460564|581611029|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161059966|NCT00460564|581611030|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161281825|NCT01632280|582410360|FG000|Overall Study|Withdrawal by Subject|1|||
161281826|NCT01632280|582410361|FG001|Overall Study|Withdrawal by Subject|0|||
161281827|NCT03086551|582410362|FG000|First Intervention|Failure to meet inclusion criterion|1|||
161281828|NCT03086551|582410363|FG001|First Intervention|Failure to meet inclusion criterion|0|||
161281829|NCT03086551|582410362|FG000|First Intervention|Lost to Follow-up|0|||
161281830|NCT03086551|582410363|FG001|First Intervention|Lost to Follow-up|1|||
161281831|NCT03086551|582410362|FG000|Washout|Lost to Follow-up|1|||
161059967|NCT00460564|581611031|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
161059968|NCT00460564|581611024|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161059969|NCT00460564|581611025|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161059970|NCT00460564|581611026|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161059971|NCT00460564|581611027|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161059972|NCT00460564|581611028|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
161281832|NCT03086551|582410363|FG001|Washout|Lost to Follow-up|2|||
161281833|NCT03086551|582410362|FG000|Washout|Withdrawal by Subject|2|||
161345231|NCT00831844|582648905|FG007|Overall Study|Withdrawal by Subject|1|||
161345232|NCT00831844|582648906|FG008|Overall Study|Withdrawal by Subject|1|||
161059973|NCT00460564|581611029|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
161059974|NCT00460564|581611030|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
161059975|NCT00460564|581611031|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
161059976|NCT00460564|581611024|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161059977|NCT00460564|581611025|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161059978|NCT00460564|581611026|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161059979|NCT00460564|581611027|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161059980|NCT00460564|581611028|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
161059981|NCT00460564|581611029|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
161059982|NCT00460564|581611030|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161059983|NCT00460564|581611031|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
161059984|NCT00460564|581611024|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059985|NCT00460564|581611025|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059986|NCT00460564|581611026|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059987|NCT00460564|581611027|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059988|NCT00460564|581611028|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
161059989|NCT00460564|581611029|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059990|NCT00460564|581611030|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059991|NCT00460564|581611031|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
161059992|NCT03226106|581611037|FG000|Overall Study|Withdrawal by Subject|2|||
161059993|NCT03226106|581611038|FG001|Overall Study|Withdrawal by Subject|0|||
161059994|NCT03226106|581611037|FG000|Overall Study|Adverse Event|1|||
161059995|NCT03226106|581611038|FG001|Overall Study|Adverse Event|0|||
161059996|NCT03226106|581611037|FG000|Overall Study|Lost to Follow-up|2|||
161059997|NCT03226106|581611038|FG001|Overall Study|Lost to Follow-up|0|||
161059998|NCT04349644|581611039|FG000|Allocation/Pretest|Lost to pretest|0|||
161059999|NCT04349644|581611040|FG001|Allocation/Pretest|Lost to pretest|3|||
161153243|NCT02410902|581942454|FG000|Overall Study|Withdrawal by Subject|6|||
161153244|NCT02410902|581942455|FG001|Overall Study|Withdrawal by Subject|8|||
161153245|NCT02410902|581942454|FG000|Overall Study|Non-Compliance|8|||
161153246|NCT02410902|581942455|FG001|Overall Study|Non-Compliance|2|||
161153247|NCT00414310|581942459|FG000|Overall Study|Not treated|1|||
161153248|NCT00414310|581942460|FG001|Overall Study|Not treated|0|||
161153249|NCT01441440|581942464|FG000|Overall Study|Death|1|||
161153250|NCT01441440|581942465|FG001|Overall Study|Death|0|||
161153251|NCT01441440|581942466|FG002|Overall Study|Death|1|||
161153252|NCT01441440|581942464|FG000|Overall Study|Adverse Event|2|||
161153253|NCT01441440|581942465|FG001|Overall Study|Adverse Event|9|||
161153254|NCT01441440|581942466|FG002|Overall Study|Adverse Event|9|||
161153255|NCT01441440|581942464|FG000|Overall Study|Lost to Follow-up|0|||
161153256|NCT01441440|581942465|FG001|Overall Study|Lost to Follow-up|2|||
161153257|NCT01441440|581942466|FG002|Overall Study|Lost to Follow-up|1|||
161153258|NCT01441440|581942464|FG000|Overall Study|Withdrawal by Subject|11|||
161153259|NCT01441440|581942465|FG001|Overall Study|Withdrawal by Subject|9|||
161153260|NCT01441440|581942466|FG002|Overall Study|Withdrawal by Subject|9|||
161153261|NCT01441440|581942464|FG000|Overall Study|Pregnancy|1|||
161153262|NCT01441440|581942465|FG001|Overall Study|Pregnancy|0|||
161153263|NCT01441440|581942466|FG002|Overall Study|Pregnancy|0|||
161153264|NCT01441440|581942464|FG000|Overall Study|Lack of Efficacy|1|||
161153265|NCT01441440|581942465|FG001|Overall Study|Lack of Efficacy|0|||
161153266|NCT01441440|581942466|FG002|Overall Study|Lack of Efficacy|1|||
161153267|NCT01441440|581942464|FG000|Overall Study|Moving|0|||
161153268|NCT01441440|581942465|FG001|Overall Study|Moving|1|||
161153269|NCT01441440|581942466|FG002|Overall Study|Moving|1|||
161153270|NCT01441440|581942464|FG000|Overall Study|Work-related matter|0|||
161153271|NCT01441440|581942465|FG001|Overall Study|Work-related matter|1|||
161153272|NCT01441440|581942466|FG002|Overall Study|Work-related matter|0|||
161153273|NCT01441440|581942464|FG000|Overall Study|Difficllty in keeping the schedule|1|||
161153274|NCT01441440|581942465|FG001|Overall Study|Difficllty in keeping the schedule|1|||
161153275|NCT01441440|581942466|FG002|Overall Study|Difficllty in keeping the schedule|0|||
161153276|NCT01993329|581942467|FG000|Period 2|Adverse Event|0|||
161153277|NCT01993329|581942468|FG001|Period 2|Adverse Event|0|||
161153278|NCT01993329|581942469|FG002|Period 2|Adverse Event|0|||
161153279|NCT01993329|581942470|FG003|Period 2|Adverse Event|0|||
161345233|NCT00831844|582648907|FG009|Overall Study|Withdrawal by Subject|0|||
161060000|NCT04349644|581611039|FG000|Posttest|Lost to posttest|0|||
161060001|NCT04349644|581611040|FG001|Posttest|Lost to posttest|8|||
161060002|NCT04349644|581611039|FG000|Posttest|Discontinued intervention|6|||
161060003|NCT04349644|581611040|FG001|Posttest|Discontinued intervention|0|||
161153280|NCT01993329|581942471|FG004|Period 2|Adverse Event|0|||
161153281|NCT01993329|581942472|FG005|Period 2|Adverse Event|1|||
161153282|NCT01993329|581942467|FG000|Wash-out|Personal reasons|0|||
161153283|NCT01993329|581942468|FG001|Wash-out|Personal reasons|1|||
161153284|NCT01993329|581942469|FG002|Wash-out|Personal reasons|0|||
161153285|NCT01993329|581942470|FG003|Wash-out|Personal reasons|0|||
161281834|NCT03086551|582410363|FG001|Washout|Withdrawal by Subject|1|||
161281835|NCT03736031|582410367|FG000|Overall Study|Death|2|||
161281836|NCT03736031|582410368|FG001|Overall Study|Death|4|||
161281837|NCT03736031|582410367|FG000|Overall Study|Lost to Follow-up|21|||
161281838|NCT03736031|582410368|FG001|Overall Study|Lost to Follow-up|2|||
161281839|NCT03736031|582410367|FG000|Overall Study|Withdrawal by Subject|9|||
161281840|NCT03736031|582410368|FG001|Overall Study|Withdrawal by Subject|0|||
161281841|NCT00451178|582410369|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
161281842|NCT00451178|582410370|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
161281843|NCT00451178|582410369|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
161281844|NCT00451178|582410370|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
161281845|NCT00451178|582410369|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
161281846|NCT00451178|582410370|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
161281847|NCT00451178|582410369|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
161281848|NCT00451178|582410370|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
161281849|NCT00451178|582410369|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
161281850|NCT00451178|582410370|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
161281851|NCT00451178|582410369|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
161281852|NCT00451178|582410370|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
161281853|NCT00451178|582410369|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
161281854|NCT00451178|582410370|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
161281855|NCT00451178|582410369|FG000|Prior to Maintenance Therapy|PD|2|||
161281856|NCT00451178|582410370|FG001|Prior to Maintenance Therapy|PD|0|||
161281857|NCT00451178|582410369|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
161281858|NCT00451178|582410370|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
161281859|NCT00451178|582410369|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
161281860|NCT00451178|582410370|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
161281861|NCT00451178|582410369|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
161281862|NCT00451178|582410370|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
161281863|NCT00451178|582410369|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
161281864|NCT00451178|582410370|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
161281865|NCT00451178|582410369|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
161281866|NCT00451178|582410370|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
161281867|NCT00451178|582410369|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
161281868|NCT00451178|582410370|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
161281869|NCT00451178|582410369|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
161281870|NCT00451178|582410370|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
161281871|NCT00352417|582410373|FG000|Overall Study|Adverse Event|1|||
161281872|NCT00352417|582410374|FG001|Overall Study|Adverse Event|0|||
161281873|NCT00352417|582410373|FG000|Overall Study|Protocol Violation|0|||
161281874|NCT00352417|582410374|FG001|Overall Study|Protocol Violation|2|||
161281875|NCT00352417|582410373|FG000|Overall Study|Withdrawal by Subject|1|||
161060004|NCT04349644|581611039|FG000|Follow-up|Lost to Follow-up|0|||
161060005|NCT04349644|581611040|FG001|Follow-up|Lost to Follow-up|2|||
161060006|NCT01084239|581611041|FG000|28-Day Follow-up|Lost to Follow-up|4|||
161060007|NCT01084239|581611042|FG001|28-Day Follow-up|Lost to Follow-up|9|||
161060008|NCT05006417|581611043|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
161060009|NCT00863798|581611044|FG000|Overall Study|Adverse Event|5|||
161060010|NCT00863798|581611045|FG001|Overall Study|Adverse Event|2|||
161060011|NCT00863798|581611046|FG002|Overall Study|Adverse Event|4|||
161060012|NCT00863798|581611044|FG000|Overall Study|Participant failed to return|2|||
161060013|NCT00863798|581611045|FG001|Overall Study|Participant failed to return|1|||
161060014|NCT00863798|581611046|FG002|Overall Study|Participant failed to return|0|||
161153286|NCT01993329|581942471|FG004|Wash-out|Personal reasons|0|||
161281876|NCT00352417|582410374|FG001|Overall Study|Withdrawal by Subject|2|||
161281877|NCT00352417|582410373|FG000|Overall Study|Lost to Follow-up|1|||
161281878|NCT00352417|582410374|FG001|Overall Study|Lost to Follow-up|0|||
161281879|NCT00352417|582410373|FG000|Overall Study|Schedule Change|2|||
161281880|NCT00352417|582410374|FG001|Overall Study|Schedule Change|1|||
161060015|NCT00863798|581611044|FG000|Overall Study|Investigator request|1|||
161153287|NCT01993329|581942472|FG005|Wash-out|Personal reasons|0|||
161153288|NCT00883558|581942473|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
161281881|NCT02447744|582410375|FG000|Overall Study|Withdrawal by Subject|3|||
161281882|NCT02447744|582410376|FG001|Overall Study|Withdrawal by Subject|1|||
161281883|NCT02447744|582410375|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
161281884|NCT02447744|582410376|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
161281885|NCT00912912|582410377|FG000|Overall Study|Withdrawal by Subject|1|||
161281886|NCT00912912|582410377|FG000|Overall Study|Disease Progression|3|||
161281887|NCT00306995|582410378|FG000|Study Part I|Withdrawal by Subject|0|||
161281888|NCT00306995|582410379|FG001|Study Part I|Withdrawal by Subject|0|||
161060016|NCT00863798|581611045|FG001|Overall Study|Investigator request|2|||
161153289|NCT00883558|581942474|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
161153290|NCT00883558|581942475|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
161153291|NCT00883558|581942473|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
161153292|NCT00883558|581942474|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
161153293|NCT00883558|581942475|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
161153294|NCT00883558|581942473|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
161153295|NCT00883558|581942474|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
161153296|NCT00883558|581942475|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
161153297|NCT00883558|581942473|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
161153298|NCT00883558|581942474|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
161153299|NCT00883558|581942475|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
161153300|NCT00883558|581942473|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
161153301|NCT00883558|581942474|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
161153302|NCT00883558|581942475|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
161153303|NCT03539458|581942476|FG000|Overall Study|Death|1|||
161153304|NCT00643487|581942482|FG000|Overall Study|Technical difficulty|3|||
161153305|NCT05628181|581942487|FG000|Overall Study|Death|2|||
161153306|NCT05628181|581942488|FG001|Overall Study|Death|4|||
161153307|NCT05628181|581942489|FG002|Overall Study|Death|0|||
161153308|NCT03508622|581942490|FG000|Overall Study|Protocol Violation|1|||
161153309|NCT03508622|581942491|FG001|Overall Study|Protocol Violation|0|||
161153310|NCT03508622|581942490|FG000|Overall Study|Withdrawal by Subject|1|||
161153311|NCT03508622|581942491|FG001|Overall Study|Withdrawal by Subject|0|||
161153312|NCT03508622|581942490|FG000|Overall Study|Lost to Follow-up|16|||
161153313|NCT03508622|581942491|FG001|Overall Study|Lost to Follow-up|0|||
161153314|NCT03508622|581942490|FG000|Overall Study|Incomplete data|0|||
161153315|NCT03508622|581942491|FG001|Overall Study|Incomplete data|24|||
161153316|NCT00506077|581942492|FG000|Treatment Period 1|Adverse Event|2|||
161153317|NCT00506077|581942493|FG001|Treatment Period 1|Adverse Event|1|||
161153318|NCT00506077|581942492|FG000|Treatment Period 1|Lost to Follow-up|0|||
161153319|NCT00506077|581942493|FG001|Treatment Period 1|Lost to Follow-up|2|||
161153320|NCT00506077|581942492|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161153321|NCT00506077|581942493|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161153322|NCT00506077|581942492|FG000|Treatment Period 2|Adverse Event|0|||
161153323|NCT00506077|581942493|FG001|Treatment Period 2|Adverse Event|1|||
161153324|NCT00506077|581942492|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161153325|NCT00506077|581942493|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161153326|NCT00069576|581942496|FG000|Original Trial|Lost to Follow-up|25|||
161281889|NCT00306995|582410380|FG002|Study Part I|Withdrawal by Subject|0|||
161281890|NCT00306995|582410381|FG003|Study Part I|Withdrawal by Subject|0|||
161281891|NCT00306995|582410382|FG004|Study Part I|Withdrawal by Subject|0|||
161281892|NCT00306995|582410383|FG005|Study Part I|Withdrawal by Subject|0|||
161281893|NCT00306995|582410384|FG006|Study Part I|Withdrawal by Subject|1|||
161281894|NCT00306995|582410378|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
161281895|NCT00306995|582410379|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
161281896|NCT00306995|582410380|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
161281897|NCT00306995|582410381|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
161281898|NCT00306995|582410382|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
161281899|NCT00306995|582410383|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
161281900|NCT00306995|582410384|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
161153327|NCT00069576|581942497|FG001|Original Trial|Lost to Follow-up|33|||
161153328|NCT00069576|581942496|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
161153329|NCT00069576|581942497|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
161153330|NCT00905307|581942498|FG000|Overall Study|Switched to Open Label Rescue|7|||
161153331|NCT00905307|581942499|FG001|Overall Study|Switched to Open Label Rescue|17|||
161153332|NCT00905307|581942500|FG002|Overall Study|Switched to Open Label Rescue|11|||
161153333|NCT00905307|581942501|FG003|Overall Study|Switched to Open Label Rescue|11|||
161153334|NCT00905307|581942502|FG004|Overall Study|Switched to Open Label Rescue|4|||
161153335|NCT00905307|581942503|FG005|Overall Study|Switched to Open Label Rescue|15|||
161153336|NCT00905307|581942498|FG000|Overall Study|Lost to Follow-up|0|||
161153337|NCT00905307|581942499|FG001|Overall Study|Lost to Follow-up|0|||
161153338|NCT00905307|581942500|FG002|Overall Study|Lost to Follow-up|0|||
161153339|NCT00905307|581942501|FG003|Overall Study|Lost to Follow-up|0|||
161153340|NCT00905307|581942502|FG004|Overall Study|Lost to Follow-up|1|||
161153341|NCT00905307|581942503|FG005|Overall Study|Lost to Follow-up|1|||
161281901|NCT06419907|582412851|FG000|Overall Study|Protocol Violation|0|||
161281902|NCT06419907|582412852|FG001|Overall Study|Protocol Violation|3|||
161281903|NCT06419907|582412853|FG002|Overall Study|Protocol Violation|0|||
161281904|NCT06419907|582412854|FG003|Overall Study|Protocol Violation|1|||
161281905|NCT06419907|582412851|FG000|Overall Study|Lost to Follow-up|0|||
161281906|NCT06419907|582412852|FG001|Overall Study|Lost to Follow-up|0|||
161281907|NCT06419907|582412853|FG002|Overall Study|Lost to Follow-up|2|||
161281908|NCT06419907|582412854|FG003|Overall Study|Lost to Follow-up|1|||
161281909|NCT02586688|582412855|FG000|Overall Study|Lost to Follow-up|2|||
161281910|NCT02586688|582412856|FG001|Overall Study|Lost to Follow-up|1|||
161153342|NCT00905307|581942498|FG000|Overall Study|Adverse Event|3|||
161153343|NCT00905307|581942499|FG001|Overall Study|Adverse Event|4|||
161153344|NCT00905307|581942500|FG002|Overall Study|Adverse Event|5|||
161153345|NCT00905307|581942501|FG003|Overall Study|Adverse Event|11|||
161153346|NCT00905307|581942502|FG004|Overall Study|Adverse Event|3|||
161153347|NCT00905307|581942503|FG005|Overall Study|Adverse Event|5|||
161153348|NCT00905307|581942498|FG000|Overall Study|Withdrawal by Subject|5|||
161153349|NCT00905307|581942499|FG001|Overall Study|Withdrawal by Subject|13|||
161153350|NCT00905307|581942500|FG002|Overall Study|Withdrawal by Subject|15|||
161153351|NCT00905307|581942501|FG003|Overall Study|Withdrawal by Subject|11|||
161153352|NCT00905307|581942502|FG004|Overall Study|Withdrawal by Subject|4|||
161153353|NCT00905307|581942503|FG005|Overall Study|Withdrawal by Subject|13|||
161153354|NCT00905307|581942498|FG000|Overall Study|Protocol Violation|1|||
161153355|NCT00905307|581942499|FG001|Overall Study|Protocol Violation|0|||
161153356|NCT00905307|581942500|FG002|Overall Study|Protocol Violation|1|||
161153357|NCT00905307|581942501|FG003|Overall Study|Protocol Violation|0|||
161153358|NCT00905307|581942502|FG004|Overall Study|Protocol Violation|0|||
161153359|NCT00905307|581942503|FG005|Overall Study|Protocol Violation|0|||
161153360|NCT00905307|581942498|FG000|Overall Study|Lack of Efficacy|6|||
161153361|NCT00905307|581942499|FG001|Overall Study|Lack of Efficacy|3|||
161153362|NCT00905307|581942500|FG002|Overall Study|Lack of Efficacy|5|||
161153363|NCT00905307|581942501|FG003|Overall Study|Lack of Efficacy|4|||
161153364|NCT00905307|581942502|FG004|Overall Study|Lack of Efficacy|4|||
161153365|NCT00905307|581942503|FG005|Overall Study|Lack of Efficacy|8|||
161153366|NCT05590793|581942504|FG000|Overall Study|Withdrawal by Subject|6|||
161153367|NCT05590793|581942504|FG000|Overall Study|Physician Decision|1|||
161153368|NCT04060667|581942505|FG000|Overall Study|Lost to Follow-up|75|||
161153369|NCT04060667|581942506|FG001|Overall Study|Lost to Follow-up|10|||
161153370|NCT04488822|581942507|FG000|Overall Study|Adverse Event|8|||
161153371|NCT04488822|581942507|FG000|Overall Study|Withdrawal by Subject|1|||
161153372|NCT03838367|581942508|FG000|Overall Study|Early termination of study|3|||
161153373|NCT03838367|581942509|FG001|Overall Study|Early termination of study|4|||
161153374|NCT03838367|581942510|FG002|Overall Study|Early termination of study|3|||
161153375|NCT03838367|581942511|FG003|Overall Study|Early termination of study|0|||
161153376|NCT03406104|581942512|FG000|Overall Study|Lost to Follow-up|2|||
161153377|NCT03406104|581942512|FG000|Overall Study|Withdrawal by Subject|2|||
161153378|NCT03406104|581942512|FG000|Overall Study|due to Covid patient did not want to travel|1|||
161153379|NCT03406104|581942512|FG000|Overall Study|Death|2|||
161153380|NCT00114972|581942515|FG000|Overall Study|Withdrawal by Subject|40|||
161153381|NCT00114972|581942516|FG001|Overall Study|Withdrawal by Subject|7|||
161153382|NCT00114972|581942515|FG000|Overall Study|Lost to Follow-up|8|||
161153383|NCT00114972|581942516|FG001|Overall Study|Lost to Follow-up|5|||
161153384|NCT01035255|581942525|FG000|Overall Study|Death|724|||
161153385|NCT01035255|581942526|FG001|Overall Study|Death|844|||
161153386|NCT01035255|581942525|FG000|Overall Study|Lost to Follow-up|2|||
161153387|NCT01035255|581942526|FG001|Overall Study|Lost to Follow-up|5|||
161153388|NCT01035255|581942525|FG000|Overall Study|patient's request|15|||
161153389|NCT01035255|581942526|FG001|Overall Study|patient's request|13|||
161153390|NCT00195260|581942532|FG000|Part 1: Dose Escalation|Adverse Event|0|||
161153391|NCT00195260|581942533|FG001|Part 1: Dose Escalation|Adverse Event|1|||
161153392|NCT00195260|581942534|FG002|Part 1: Dose Escalation|Adverse Event|0|||
161153393|NCT00195260|581942535|FG003|Part 1: Dose Escalation|Adverse Event|1|||
161153394|NCT00195260|581942536|FG004|Part 1: Dose Escalation|Adverse Event|1|||
161153395|NCT00195260|581942537|FG005|Part 1: Dose Escalation|Adverse Event|0|||
161153396|NCT00195260|581942538|FG006|Part 1: Dose Escalation|Adverse Event|3|||
161153397|NCT00195260|581942539|FG007|Part 1: Dose Escalation|Adverse Event|0|||
161153398|NCT00195260|581942540|FG008|Part 1: Dose Escalation|Adverse Event|0|||
161153399|NCT00195260|581942541|FG009|Part 1: Dose Escalation|Adverse Event|0|||
161153400|NCT00195260|581942542|FG010|Part 1: Dose Escalation|Adverse Event|0|||
161153401|NCT00195260|581942532|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153402|NCT00195260|581942533|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153403|NCT00195260|581942534|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153404|NCT00195260|581942535|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153405|NCT00195260|581942536|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
161153406|NCT00195260|581942537|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153407|NCT00195260|581942538|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153408|NCT00195260|581942539|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
161153409|NCT00195260|581942540|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153410|NCT00195260|581942541|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153411|NCT00195260|581942542|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
161153412|NCT00195260|581942532|FG000|Part 1: Dose Escalation|Death|0|||
161153413|NCT00195260|581942533|FG001|Part 1: Dose Escalation|Death|0|||
161153414|NCT00195260|581942534|FG002|Part 1: Dose Escalation|Death|0|||
161153415|NCT00195260|581942535|FG003|Part 1: Dose Escalation|Death|0|||
161153416|NCT00195260|581942536|FG004|Part 1: Dose Escalation|Death|0|||
161153417|NCT00195260|581942537|FG005|Part 1: Dose Escalation|Death|0|||
161153418|NCT00195260|581942538|FG006|Part 1: Dose Escalation|Death|0|||
161153419|NCT00195260|581942539|FG007|Part 1: Dose Escalation|Death|1|||
161153420|NCT00195260|581942540|FG008|Part 1: Dose Escalation|Death|0|||
161153421|NCT00195260|581942541|FG009|Part 1: Dose Escalation|Death|0|||
161153422|NCT00195260|581942542|FG010|Part 1: Dose Escalation|Death|0|||
161153423|NCT00195260|581942532|FG000|Part 1: Dose Escalation|Disease Progression|3|||
161153424|NCT00195260|581942533|FG001|Part 1: Dose Escalation|Disease Progression|2|||
161153425|NCT00195260|581942534|FG002|Part 1: Dose Escalation|Disease Progression|5|||
161153426|NCT00195260|581942535|FG003|Part 1: Dose Escalation|Disease Progression|6|||
161153427|NCT00195260|581942536|FG004|Part 1: Dose Escalation|Disease Progression|4|||
161153428|NCT00195260|581942537|FG005|Part 1: Dose Escalation|Disease Progression|6|||
161153429|NCT00195260|581942538|FG006|Part 1: Dose Escalation|Disease Progression|7|||
161153430|NCT00195260|581942539|FG007|Part 1: Dose Escalation|Disease Progression|4|||
161153431|NCT00195260|581942540|FG008|Part 1: Dose Escalation|Disease Progression|0|||
161153432|NCT00195260|581942541|FG009|Part 1: Dose Escalation|Disease Progression|0|||
161153433|NCT00195260|581942542|FG010|Part 1: Dose Escalation|Disease Progression|0|||
161153434|NCT00195260|581942532|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161153435|NCT00195260|581942533|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161153436|NCT00195260|581942534|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161153437|NCT00195260|581942535|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153438|NCT00195260|581942536|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153439|NCT00195260|581942537|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
161153440|NCT00195260|581942538|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153441|NCT00195260|581942539|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153442|NCT00195260|581942540|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153443|NCT00195260|581942541|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153444|NCT00195260|581942542|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
161153445|NCT00195260|581942532|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153446|NCT00195260|581942533|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153447|NCT00195260|581942534|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153448|NCT00195260|581942535|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153449|NCT00195260|581942536|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153450|NCT00195260|581942537|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153451|NCT00195260|581942538|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153452|NCT00195260|581942539|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
161153453|NCT00195260|581942540|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
161153454|NCT00195260|581942541|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
161153455|NCT00195260|581942542|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
161153456|NCT00195260|581942532|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153457|NCT00195260|581942533|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153458|NCT00195260|581942534|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153459|NCT00195260|581942535|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153460|NCT00195260|581942536|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153461|NCT00195260|581942537|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153462|NCT00195260|581942538|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153463|NCT00195260|581942539|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
161153464|NCT00195260|581942540|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
161153465|NCT00195260|581942541|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
161153466|NCT00195260|581942542|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
161153467|NCT00195260|581942532|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153468|NCT00195260|581942533|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153469|NCT00195260|581942534|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153470|NCT00195260|581942535|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153471|NCT00195260|581942536|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153472|NCT00195260|581942537|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153473|NCT00195260|581942538|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153474|NCT00195260|581942539|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
161153475|NCT00195260|581942540|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
161153476|NCT00195260|581942541|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
161153477|NCT00195260|581942542|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
161153478|NCT00195260|581942532|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153479|NCT00195260|581942533|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153480|NCT00195260|581942534|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153481|NCT00195260|581942535|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153482|NCT00195260|581942536|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153483|NCT00195260|581942537|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153484|NCT00195260|581942538|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153485|NCT00195260|581942539|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
161153486|NCT00195260|581942540|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
161060017|NCT00863798|581611046|FG002|Overall Study|Investigator request|1|||
161060018|NCT00863798|581611044|FG000|Overall Study|Lack of Efficacy|4|||
161060019|NCT00863798|581611045|FG001|Overall Study|Lack of Efficacy|3|||
161060020|NCT00863798|581611046|FG002|Overall Study|Lack of Efficacy|6|||
161060021|NCT00863798|581611044|FG000|Overall Study|Lost to Follow-up|6|||
161060022|NCT00863798|581611045|FG001|Overall Study|Lost to Follow-up|9|||
161060023|NCT00863798|581611046|FG002|Overall Study|Lost to Follow-up|5|||
161060024|NCT00863798|581611044|FG000|Overall Study|Other|2|||
161060025|NCT00863798|581611045|FG001|Overall Study|Other|3|||
161060026|NCT00863798|581611046|FG002|Overall Study|Other|1|||
161060027|NCT00863798|581611044|FG000|Overall Study|Protocol Violation|0|||
161060028|NCT00863798|581611045|FG001|Overall Study|Protocol Violation|1|||
161060029|NCT00863798|581611046|FG002|Overall Study|Protocol Violation|1|||
161060030|NCT00863798|581611044|FG000|Overall Study|Withdrawal by Subject|8|||
161060031|NCT00863798|581611045|FG001|Overall Study|Withdrawal by Subject|7|||
161060032|NCT00863798|581611046|FG002|Overall Study|Withdrawal by Subject|4|||
161060033|NCT00863798|581611044|FG000|Overall Study|Randomized not treated|4|||
161060034|NCT00863798|581611045|FG001|Overall Study|Randomized not treated|2|||
161060035|NCT00863798|581611046|FG002|Overall Study|Randomized not treated|3|||
161060036|NCT04238520|581611047|FG000|Overall Study|Withdrawal by Subject|1|||
161060037|NCT04238520|581611048|FG001|Overall Study|Withdrawal by Subject|1|||
161060038|NCT04238520|581611047|FG000|Overall Study|Lost to Follow-up|1|||
161060039|NCT04238520|581611048|FG001|Overall Study|Lost to Follow-up|2|||
161060040|NCT04238520|581611047|FG000|Overall Study|Death|0|||
161060041|NCT04238520|581611048|FG001|Overall Study|Death|2|||
161060042|NCT04238520|581611047|FG000|Overall Study|Unsafe home environment for research staff|0|||
161060043|NCT04238520|581611048|FG001|Overall Study|Unsafe home environment for research staff|1|||
161060044|NCT01470599|581611049|FG000|Overall Study|Did not meet entrance criteria|1|||
161060045|NCT01470599|581611050|FG001|Overall Study|Did not meet entrance criteria|0|||
161060046|NCT01470599|581611049|FG000|Overall Study|Lost to Follow-up|2|||
161060047|NCT01470599|581611050|FG001|Overall Study|Lost to Follow-up|1|||
161060048|NCT01470599|581611049|FG000|Overall Study|Withdrawal by Subject|3|||
161060049|NCT01470599|581611050|FG001|Overall Study|Withdrawal by Subject|4|||
161060050|NCT01470599|581611049|FG000|Overall Study|Other|1|||
161060051|NCT01470599|581611050|FG001|Overall Study|Other|0|||
161060052|NCT01470599|581611049|FG000|Overall Study|Protocol Violation|3|||
161060053|NCT01470599|581611050|FG001|Overall Study|Protocol Violation|1|||
161060054|NCT01470599|581611049|FG000|Overall Study|Adverse event related to study drug|2|||
161060055|NCT01470599|581611050|FG001|Overall Study|Adverse event related to study drug|5|||
161060056|NCT01470599|581611049|FG000|Overall Study|Insufficient clinical response|6|||
161060057|NCT01470599|581611050|FG001|Overall Study|Insufficient clinical response|27|||
161060058|NCT01470599|581611049|FG000|Overall Study|Adverse event not related to study drug|1|||
161060059|NCT01470599|581611050|FG001|Overall Study|Adverse event not related to study drug|5|||
161060060|NCT00195442|581611051|FG000|Overall Study|Less than expected therapeutic effect|38|||
161060061|NCT00195442|581611051|FG000|Overall Study|Lost to Follow-up|27|||
161060062|NCT00195442|581611051|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
161060063|NCT00195442|581611051|FG000|Overall Study|Intermittent product shortage|21|||
161060064|NCT00195442|581611051|FG000|Overall Study|Death|7|||
161060065|NCT00195442|581611051|FG000|Overall Study|No reason specified|4|||
161060066|NCT00195442|581611051|FG000|Overall Study|Poor cooperation|2|||
161060067|NCT00195442|581611051|FG000|Overall Study|Other|14|||
161060068|NCT01917006|581611052|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
161060069|NCT01917006|581611053|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
161060070|NCT01917006|581611054|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
161060071|NCT01917006|581611055|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
161060072|NCT01917006|581611056|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
161060073|NCT01917006|581611057|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
161060074|NCT01917006|581611058|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
161060075|NCT01917006|581611059|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
161060076|NCT01917006|581611052|FG000|Randomized-treatment Period|Personal Reasons|0|||
161060077|NCT01917006|581611053|FG001|Randomized-treatment Period|Personal Reasons|0|||
161060078|NCT01917006|581611054|FG002|Randomized-treatment Period|Personal Reasons|0|||
161060079|NCT01917006|581611055|FG003|Randomized-treatment Period|Personal Reasons|0|||
161060080|NCT01917006|581611056|FG004|Randomized-treatment Period|Personal Reasons|0|||
161060081|NCT01917006|581611057|FG005|Randomized-treatment Period|Personal Reasons|1|||
161060082|NCT01917006|581611058|FG006|Randomized-treatment Period|Personal Reasons|0|||
161060083|NCT01917006|581611059|FG007|Randomized-treatment Period|Personal Reasons|0|||
161060084|NCT01917006|581611052|FG000|Randomized-treatment Period|Protocol Violation|1|||
161060085|NCT01917006|581611053|FG001|Randomized-treatment Period|Protocol Violation|0|||
161060086|NCT01917006|581611054|FG002|Randomized-treatment Period|Protocol Violation|0|||
161060087|NCT01917006|581611055|FG003|Randomized-treatment Period|Protocol Violation|0|||
161060088|NCT01917006|581611056|FG004|Randomized-treatment Period|Protocol Violation|0|||
161060089|NCT01917006|581611057|FG005|Randomized-treatment Period|Protocol Violation|0|||
161060090|NCT01917006|581611058|FG006|Randomized-treatment Period|Protocol Violation|0|||
161060091|NCT01917006|581611059|FG007|Randomized-treatment Period|Protocol Violation|0|||
161281911|NCT02586688|582412855|FG000|Overall Study|Withdrawal by Subject|1|||
161281912|NCT02586688|582412856|FG001|Overall Study|Withdrawal by Subject|1|||
161281913|NCT02586688|582412855|FG000|Overall Study|Adverse Event|3|||
161281914|NCT02586688|582412856|FG001|Overall Study|Adverse Event|1|||
161281915|NCT04856917|582412857|FG000|Overall Study|Withdrawal by Subject|4|||
161281916|NCT04856917|582412858|FG001|Overall Study|Withdrawal by Subject|3|||
161281917|NCT04856917|582412859|FG002|Overall Study|Withdrawal by Subject|1|||
161281918|NCT04856917|582412857|FG000|Overall Study|Lost to Follow-up|3|||
161281919|NCT04856917|582412858|FG001|Overall Study|Lost to Follow-up|1|||
161281920|NCT04856917|582412859|FG002|Overall Study|Lost to Follow-up|1|||
161281921|NCT04856917|582412857|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
161060092|NCT01917006|581611052|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060093|NCT01917006|581611053|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060094|NCT01917006|581611054|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060095|NCT01917006|581611055|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060096|NCT01917006|581611056|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060097|NCT01917006|581611057|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060098|NCT01917006|581611058|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
161060099|NCT01917006|581611059|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
161060100|NCT01917006|581611052|FG000|Open-label Period|Adverse Event|0|||
161281922|NCT04856917|582412858|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
161281923|NCT04856917|582412859|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
161060101|NCT01917006|581611053|FG001|Open-label Period|Adverse Event|0|||
161060102|NCT01917006|581611054|FG002|Open-label Period|Adverse Event|0|||
161060103|NCT01917006|581611055|FG003|Open-label Period|Adverse Event|0|||
161060104|NCT01917006|581611056|FG004|Open-label Period|Adverse Event|0|||
161060105|NCT01917006|581611057|FG005|Open-label Period|Adverse Event|0|||
161060106|NCT01917006|581611058|FG006|Open-label Period|Adverse Event|0|||
161060107|NCT01917006|581611059|FG007|Open-label Period|Adverse Event|1|||
161060108|NCT01917006|581611052|FG000|Open-label Period|Lost to Follow-up|0|||
161060109|NCT01917006|581611053|FG001|Open-label Period|Lost to Follow-up|0|||
161060110|NCT01917006|581611054|FG002|Open-label Period|Lost to Follow-up|0|||
161060111|NCT01917006|581611055|FG003|Open-label Period|Lost to Follow-up|0|||
161060112|NCT01917006|581611056|FG004|Open-label Period|Lost to Follow-up|0|||
161060113|NCT01917006|581611057|FG005|Open-label Period|Lost to Follow-up|0|||
161060114|NCT01917006|581611058|FG006|Open-label Period|Lost to Follow-up|0|||
161060115|NCT01917006|581611059|FG007|Open-label Period|Lost to Follow-up|1|||
161060116|NCT02158247|581611065|FG000|Overall Study|Invisible vocal cords|5|||
161060117|NCT00702650|581611066|FG000|Overall Study|Withdrawal by Subject|9|||
161060118|NCT00702650|581611066|FG000|Overall Study|Non-Compliance of Study Drug|3|||
161060119|NCT00702650|581611066|FG000|Overall Study|Lost to Follow-up|2|||
161060120|NCT00702650|581611066|FG000|Overall Study|Non-Compliance with Site Directives|1|||
161060121|NCT00702650|581611066|FG000|Overall Study|Sponsor Request|1|||
161060122|NCT00702650|581611066|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
161060123|NCT00702650|581611066|FG000|Overall Study|Adverse Event|3|||
161060124|NCT00943722|581611068|FG000|Base Study|Adverse Event|0|||
161060125|NCT00943722|581611069|FG001|Base Study|Adverse Event|0|||
161060126|NCT00943722|581611070|FG002|Base Study|Adverse Event|0|||
161060127|NCT00943722|581611071|FG003|Base Study|Adverse Event|1|||
161060128|NCT00943722|581611072|FG004|Base Study|Adverse Event|0|||
161060129|NCT00943722|581611073|FG005|Base Study|Adverse Event|0|||
161060130|NCT00943722|581611074|FG006|Base Study|Adverse Event|0|||
161060131|NCT00943722|581611068|FG000|Base Study|Lost to Follow-up|12|||
161060132|NCT00943722|581611069|FG001|Base Study|Lost to Follow-up|8|||
161060133|NCT00943722|581611070|FG002|Base Study|Lost to Follow-up|10|||
161281924|NCT04856917|582412857|FG000|Overall Study|Other|1|||
161345234|NCT00831844|582648898|FG000|Overall Study|Ineligible|0|||
161060134|NCT00943722|581611071|FG003|Base Study|Lost to Follow-up|8|||
161060135|NCT00943722|581611072|FG004|Base Study|Lost to Follow-up|11|||
161060136|NCT00943722|581611073|FG005|Base Study|Lost to Follow-up|0|||
161060137|NCT00943722|581611074|FG006|Base Study|Lost to Follow-up|0|||
161060138|NCT00943722|581611068|FG000|Base Study|Physician Decision|1|||
161060139|NCT00943722|581611069|FG001|Base Study|Physician Decision|0|||
161060140|NCT00943722|581611070|FG002|Base Study|Physician Decision|0|||
161060141|NCT00943722|581611071|FG003|Base Study|Physician Decision|0|||
161060142|NCT00943722|581611072|FG004|Base Study|Physician Decision|1|||
161281925|NCT04856917|582412858|FG001|Overall Study|Other|1|||
161281926|NCT04856917|582412859|FG002|Overall Study|Other|0|||
161060143|NCT00943722|581611073|FG005|Base Study|Physician Decision|0|||
161060144|NCT00943722|581611074|FG006|Base Study|Physician Decision|0|||
161060145|NCT00943722|581611068|FG000|Base Study|Pregnancy|0|||
161060146|NCT00943722|581611069|FG001|Base Study|Pregnancy|0|||
161060147|NCT00943722|581611070|FG002|Base Study|Pregnancy|1|||
161060148|NCT00943722|581611071|FG003|Base Study|Pregnancy|0|||
161060149|NCT00943722|581611072|FG004|Base Study|Pregnancy|2|||
161060150|NCT00943722|581611073|FG005|Base Study|Pregnancy|0|||
161281927|NCT03573830|582412862|FG000|Overall Study|Dropped without completing treatment|0|||
161345235|NCT00831844|582648899|FG001|Overall Study|Ineligible|1|||
161153487|NCT00195260|581942541|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
161153488|NCT00195260|581942542|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
161153489|NCT02749721|581942543|FG000|Screening|Withdrawal by Subject|1|||
161153490|NCT02749721|581942543|FG000|Screening|Lost to Follow-up|2|||
161153491|NCT02749721|581942543|FG000|Screening|Protocol Violation|3|||
161153492|NCT02749721|581942543|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
161153493|NCT02749721|581942543|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
161153494|NCT01379534|581942544|FG000|Treatment Phase|Withdrawal by Subject|2|||
161153495|NCT01379534|581942545|FG001|Treatment Phase|Withdrawal by Subject|2|||
161345236|NCT00831844|582648900|FG002|Overall Study|Ineligible|1|||
161345237|NCT00831844|582648901|FG003|Overall Study|Ineligible|0|||
161345238|NCT00831844|582648902|FG004|Overall Study|Ineligible|1|||
161345239|NCT00831844|582648903|FG005|Overall Study|Ineligible|0|||
161345240|NCT00831844|582648904|FG006|Overall Study|Ineligible|0|||
161345241|NCT00831844|582648905|FG007|Overall Study|Ineligible|0|||
161345242|NCT00831844|582648906|FG008|Overall Study|Ineligible|0|||
161345243|NCT00831844|582648907|FG009|Overall Study|Ineligible|0|||
161345244|NCT04133909|582648910|FG000|Overall Study|Death|11|||
161345245|NCT04133909|582648911|FG001|Overall Study|Death|11|||
161345246|NCT04133909|582648910|FG000|Overall Study|Adverse Event|4|||
161345247|NCT04133909|582648911|FG001|Overall Study|Adverse Event|5|||
161345248|NCT04133909|582648910|FG000|Overall Study|Lost to Follow-up|3|||
161345249|NCT04133909|582648911|FG001|Overall Study|Lost to Follow-up|5|||
161345250|NCT04133909|582648910|FG000|Overall Study|Physician Decision|4|||
161345251|NCT04133909|582648911|FG001|Overall Study|Physician Decision|7|||
161345252|NCT04133909|582648910|FG000|Overall Study|Withdrawal by Subject|40|||
161345253|NCT04133909|582648911|FG001|Overall Study|Withdrawal by Subject|35|||
161345254|NCT04133909|582648910|FG000|Overall Study|Lack of Efficacy|2|||
161345255|NCT04133909|582648911|FG001|Overall Study|Lack of Efficacy|7|||
161345256|NCT04133909|582648910|FG000|Overall Study|Randomized in error|1|||
161345257|NCT04133909|582648911|FG001|Overall Study|Randomized in error|1|||
161345258|NCT02340949|582648912|FG000|Overall Study|Adverse Event|4|||
161345259|NCT02340949|582648913|FG001|Overall Study|Adverse Event|2|||
161345260|NCT02340949|582648912|FG000|Overall Study|Withdrawal by Subject|2|||
161345261|NCT02340949|582648913|FG001|Overall Study|Withdrawal by Subject|0|||
161060151|NCT00943722|581611074|FG006|Base Study|Pregnancy|0|||
161060152|NCT00943722|581611068|FG000|Base Study|Protocol Violation|0|||
161060153|NCT00943722|581611069|FG001|Base Study|Protocol Violation|1|||
161060154|NCT00943722|581611070|FG002|Base Study|Protocol Violation|0|||
161060155|NCT00943722|581611071|FG003|Base Study|Protocol Violation|0|||
161060156|NCT00943722|581611072|FG004|Base Study|Protocol Violation|2|||
161060157|NCT00943722|581611073|FG005|Base Study|Protocol Violation|0|||
161060158|NCT00943722|581611074|FG006|Base Study|Protocol Violation|0|||
161060159|NCT00943722|581611068|FG000|Base Study|Withdrawal by Subject|12|||
161060160|NCT00943722|581611069|FG001|Base Study|Withdrawal by Subject|13|||
161060161|NCT00943722|581611070|FG002|Base Study|Withdrawal by Subject|2|||
161060162|NCT00943722|581611071|FG003|Base Study|Withdrawal by Subject|13|||
161060163|NCT00943722|581611072|FG004|Base Study|Withdrawal by Subject|8|||
161060164|NCT00943722|581611073|FG005|Base Study|Withdrawal by Subject|0|||
161060165|NCT00943722|581611074|FG006|Base Study|Withdrawal by Subject|0|||
161060166|NCT00943722|581611068|FG000|Base Study|Month 12 visit not completed|0|||
161060167|NCT00943722|581611069|FG001|Base Study|Month 12 visit not completed|0|||
161060168|NCT00943722|581611070|FG002|Base Study|Month 12 visit not completed|0|||
161060169|NCT00943722|581611071|FG003|Base Study|Month 12 visit not completed|0|||
161060170|NCT00943722|581611072|FG004|Base Study|Month 12 visit not completed|2|||
161060171|NCT00943722|581611073|FG005|Base Study|Month 12 visit not completed|0|||
161060172|NCT00943722|581611074|FG006|Base Study|Month 12 visit not completed|0|||
161060173|NCT00943722|581611068|FG000|First Extension Study: EXT 1|Adverse Event|0|||
161060174|NCT00943722|581611069|FG001|First Extension Study: EXT 1|Adverse Event|0|||
161060175|NCT00943722|581611070|FG002|First Extension Study: EXT 1|Adverse Event|0|||
161060176|NCT00943722|581611071|FG003|First Extension Study: EXT 1|Adverse Event|0|||
161060177|NCT00943722|581611072|FG004|First Extension Study: EXT 1|Adverse Event|0|||
161153496|NCT01379534|581942544|FG000|Treatment Phase|Progressive disease|13|||
161345262|NCT02340949|582648912|FG000|Overall Study|Progression disease|6|||
161345263|NCT02340949|582648913|FG001|Overall Study|Progression disease|2|||
161345264|NCT02340949|582648912|FG000|Overall Study|Death|3|||
161345265|NCT02340949|582648913|FG001|Overall Study|Death|0|||
161345266|NCT02340949|582648912|FG000|Overall Study|Physician Decision|1|||
161345267|NCT02340949|582648913|FG001|Overall Study|Physician Decision|0|||
161345268|NCT03980223|582648914|FG000|Overall Study|Lost to Follow-up|3|||
161060178|NCT00943722|581611073|FG005|First Extension Study: EXT 1|Adverse Event|1|||
161153497|NCT01379534|581942545|FG001|Treatment Phase|Progressive disease|22|||
161153498|NCT01379534|581942544|FG000|Treatment Phase|Adverse Event|7|||
161153499|NCT01379534|581942545|FG001|Treatment Phase|Adverse Event|7|||
161345269|NCT03980223|582648915|FG001|Overall Study|Lost to Follow-up|7|||
161345270|NCT03980223|582648916|FG002|Overall Study|Lost to Follow-up|10|||
161345271|NCT03980223|582648917|FG003|Overall Study|Lost to Follow-up|8|||
161345272|NCT03980223|582648914|FG000|Overall Study|Withdrawal by Subject|0|||
161345273|NCT03980223|582648915|FG001|Overall Study|Withdrawal by Subject|0|||
161281928|NCT03573830|582412863|FG001|Overall Study|Dropped without completing treatment|7|||
161281929|NCT03573830|582412862|FG000|Overall Study|Lost to Follow-up|4|||
161281930|NCT03573830|582412863|FG001|Overall Study|Lost to Follow-up|0|||
161281931|NCT00266630|582412864|FG000|Overall Study|Adverse Event|8|||
161281932|NCT00266630|582412865|FG001|Overall Study|Adverse Event|6|||
161281933|NCT00266630|582412864|FG000|Overall Study|Lack of Efficacy|1|||
161281934|NCT00266630|582412865|FG001|Overall Study|Lack of Efficacy|4|||
161281935|NCT00266630|582412864|FG000|Overall Study|Entry Criteria not met|1|||
161281936|NCT00266630|582412865|FG001|Overall Study|Entry Criteria not met|0|||
161281937|NCT00266630|582412864|FG000|Overall Study|Protocol Violation|1|||
161281938|NCT00266630|582412865|FG001|Overall Study|Protocol Violation|3|||
161281939|NCT00266630|582412864|FG000|Overall Study|Physician Decision|1|||
161281940|NCT00266630|582412865|FG001|Overall Study|Physician Decision|2|||
161281941|NCT00266630|582412864|FG000|Overall Study|Withdrawal by Subject|10|||
161281942|NCT00266630|582412865|FG001|Overall Study|Withdrawal by Subject|2|||
161060179|NCT00943722|581611074|FG006|First Extension Study: EXT 1|Adverse Event|0|||
161060180|NCT00943722|581611068|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
161060181|NCT00943722|581611069|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
161060182|NCT00943722|581611070|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
161060183|NCT00943722|581611071|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
161060184|NCT00943722|581611072|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
161060185|NCT00943722|581611073|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
161060186|NCT00943722|581611074|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
161060187|NCT00943722|581611068|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161060188|NCT00943722|581611069|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161060189|NCT00943722|581611070|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161060190|NCT00943722|581611071|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161060191|NCT00943722|581611072|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
161060192|NCT00943722|581611073|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
161060193|NCT00943722|581611074|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
161060194|NCT00943722|581611068|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
161060195|NCT00943722|581611069|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
161060196|NCT00943722|581611070|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
161060197|NCT00943722|581611071|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
161060198|NCT00943722|581611072|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
161060199|NCT00943722|581611073|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
161060200|NCT00943722|581611074|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
161060201|NCT00943722|581611068|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
161060202|NCT00943722|581611069|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
161060203|NCT00943722|581611070|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
161060204|NCT00943722|581611071|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
161060205|NCT00943722|581611072|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
161060206|NCT00943722|581611073|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
161060207|NCT00943722|581611074|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
161060208|NCT00943722|581611068|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161060209|NCT00943722|581611069|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161060210|NCT00943722|581611070|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161060211|NCT00943722|581611071|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161060212|NCT00943722|581611072|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
161060213|NCT00943722|581611073|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
161060214|NCT00943722|581611074|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
161060215|NCT00943722|581611068|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
161060216|NCT00943722|581611069|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
161060217|NCT00943722|581611070|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
161060218|NCT00943722|581611071|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
161060219|NCT00943722|581611072|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
161060220|NCT00943722|581611073|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
161060221|NCT00943722|581611074|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
161060222|NCT00943722|581611068|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
161060223|NCT00943722|581611069|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
161060224|NCT00943722|581611070|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
161060225|NCT00943722|581611071|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
161060226|NCT00943722|581611072|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
161060227|NCT00943722|581611073|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
161281943|NCT00266630|582412864|FG000|Overall Study|Lost to Follow-up|1|||
161281944|NCT00266630|582412865|FG001|Overall Study|Lost to Follow-up|0|||
161281945|NCT00266630|582412864|FG000|Overall Study|Other|19|||
161281946|NCT00266630|582412865|FG001|Overall Study|Other|11|||
161281947|NCT03284723|582412870|FG000|Overall Study|Death|0|||
161281948|NCT03284723|582412871|FG001|Overall Study|Death|0|||
161281949|NCT03284723|582412872|FG002|Overall Study|Death|0|||
161281950|NCT03284723|582412873|FG003|Overall Study|Death|1|||
161281951|NCT03284723|582412874|FG004|Overall Study|Death|0|||
161060228|NCT00943722|581611074|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
161060229|NCT00943722|581611068|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161060230|NCT00943722|581611069|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161060231|NCT00943722|581611070|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161060232|NCT00943722|581611071|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161060233|NCT00943722|581611072|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
161060234|NCT00943722|581611073|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
161060235|NCT00943722|581611074|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
161060236|NCT01772823|581611075|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
161060237|NCT01772823|581611076|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
161060238|NCT01772823|581611075|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
161060239|NCT01772823|581611076|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
161060240|NCT01772823|581611075|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
161060241|NCT01772823|581611076|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
161060242|NCT01772823|581611075|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
161060243|NCT01772823|581611076|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
161060244|NCT01772823|581611075|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
161060245|NCT01772823|581611076|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
161060246|NCT01772823|581611075|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
161060247|NCT01772823|581611076|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
161060248|NCT01772823|581611075|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
161060249|NCT01772823|581611076|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
161060250|NCT01772823|581611075|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
161060251|NCT01772823|581611076|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
161060252|NCT01772823|581611075|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
161060253|NCT01772823|581611076|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
161060254|NCT01772823|581611075|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
161060255|NCT01772823|581611076|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
161060256|NCT01772823|581611075|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
161060257|NCT01772823|581611076|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
161060258|NCT01772823|581611075|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
161060259|NCT01772823|581611076|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
161060260|NCT01772823|581611075|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
161060261|NCT01772823|581611076|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
161060262|NCT01772823|581611075|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
161060263|NCT01772823|581611076|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
161060264|NCT01772823|581611075|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
161060265|NCT01772823|581611076|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
161060266|NCT01772823|581611075|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
161060267|NCT01772823|581611076|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
161060268|NCT01004185|581611077|FG000|Overall Study|Adverse Event|1|||
161060269|NCT01004185|581611078|FG001|Overall Study|Adverse Event|1|||
161060270|NCT01004185|581611077|FG000|Overall Study|Lost to Follow-up|0|||
161060271|NCT01004185|581611078|FG001|Overall Study|Lost to Follow-up|1|||
161060272|NCT01004185|581611077|FG000|Overall Study|Lack of Efficacy|2|||
161060273|NCT01004185|581611078|FG001|Overall Study|Lack of Efficacy|1|||
161060274|NCT01004185|581611077|FG000|Overall Study|Sponsor Terminated Study|4|||
161060275|NCT01004185|581611078|FG001|Overall Study|Sponsor Terminated Study|5|||
161281952|NCT03284723|582412875|FG005|Overall Study|Death|0|||
161060276|NCT01004185|581611077|FG000|Overall Study|Withdrawal by Subject|2|||
161060277|NCT01004185|581611078|FG001|Overall Study|Withdrawal by Subject|1|||
161060278|NCT01388478|581611083|FG000|Overall Study|Adverse Event|4|||
161060279|NCT01388478|581611083|FG000|Overall Study|Withdrawal by Subject|1|||
161060280|NCT01990664|581611084|FG000|Overall Study|Lost to Follow-up|2|||
161060281|NCT01990664|581611085|FG001|Overall Study|Lost to Follow-up|6|||
161060282|NCT01990664|581611084|FG000|Overall Study|Withdrawal by Subject|2|||
161060283|NCT01990664|581611085|FG001|Overall Study|Withdrawal by Subject|3|||
161060284|NCT01990664|581611084|FG000|Overall Study|Protocol Violation|1|||
161060285|NCT01990664|581611085|FG001|Overall Study|Protocol Violation|0|||
161060286|NCT01990664|581611084|FG000|Overall Study|Lens Discomfort|1|||
161060287|NCT01990664|581611085|FG001|Overall Study|Lens Discomfort|1|||
161060288|NCT01990664|581611084|FG000|Overall Study|Lens Handling Difficulties|1|||
161060289|NCT01990664|581611085|FG001|Overall Study|Lens Handling Difficulties|0|||
161060290|NCT01990664|581611084|FG000|Overall Study|Unsatisfactory Visual Response|0|||
161060291|NCT01990664|581611085|FG001|Overall Study|Unsatisfactory Visual Response|1|||
161060292|NCT01037413|581611086|FG000|Part A: Skin Testing|Adverse Event|1|||
161060293|NCT01037413|581611087|FG001|Part A: Skin Testing|Adverse Event|0|||
161281953|NCT03284723|582412876|FG006|Overall Study|Death|1|||
161060294|NCT01037413|581611086|FG000|Part A: Skin Testing|Protocol Violation|1|||
161060295|NCT01037413|581611087|FG001|Part A: Skin Testing|Protocol Violation|0|||
161060296|NCT01037413|581611086|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
161060297|NCT01037413|581611087|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
161060298|NCT01037413|581611086|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
161060299|NCT01037413|581611087|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
161060300|NCT00619983|581611088|FG000|Test Drug Alone|Withdrawal by Subject|1|||
161060301|NCT00619983|581611089|FG001|Test Drug Alone|Withdrawal by Subject|0|||
161060302|NCT00619983|581611090|FG002|Test Drug Alone|Withdrawal by Subject|0|||
161060303|NCT00619983|581611091|FG003|Test Drug Alone|Withdrawal by Subject|1|||
161060304|NCT00619983|581611088|FG000|Test Drug Alone|Failure of daily diary device|1|||
161060305|NCT00619983|581611089|FG001|Test Drug Alone|Failure of daily diary device|1|||
161060306|NCT00619983|581611090|FG002|Test Drug Alone|Failure of daily diary device|2|||
161060307|NCT00619983|581611091|FG003|Test Drug Alone|Failure of daily diary device|2|||
161060308|NCT02560389|581611097|FG000|Overall Study|Lost to Follow-up|1|||
161060309|NCT02560389|581611098|FG001|Overall Study|Lost to Follow-up|2|||
161060310|NCT02560389|581611099|FG002|Overall Study|Lost to Follow-up|2|||
161060311|NCT02560389|581611097|FG000|Overall Study|Tested positive for illicit substance|0|||
161060312|NCT02560389|581611098|FG001|Overall Study|Tested positive for illicit substance|1|||
161060313|NCT02560389|581611099|FG002|Overall Study|Tested positive for illicit substance|0|||
161060314|NCT02716298|581611100|FG000|First Intervention (1 Month)|Lens discomfort|1|||
161060315|NCT02716298|581611101|FG001|First Intervention (1 Month)|Lens discomfort|1|||
161060316|NCT00713206|581611104|FG000|Overall Study|Lost to Follow-up|4|||
161060317|NCT00713206|581611105|FG001|Overall Study|Lost to Follow-up|4|||
161060318|NCT00713206|581611104|FG000|Overall Study|Death|1|||
161060319|NCT00713206|581611105|FG001|Overall Study|Death|0|||
161060320|NCT04081389|581611112|FG000|Overall Study|Withdrawal by Subject|0|||
161060321|NCT04081389|581611113|FG001|Overall Study|Withdrawal by Subject|0|||
161060322|NCT04081389|581611114|FG002|Overall Study|Withdrawal by Subject|1|||
161060323|NCT04081389|581611115|FG003|Overall Study|Withdrawal by Subject|0|||
161060324|NCT01114672|581611116|FG000|Overall Study|Death|0|||
161060325|NCT01114672|581611117|FG001|Overall Study|Death|1|||
161060326|NCT01114672|581611116|FG000|Overall Study|Withdrawal by Subject|2|||
161060327|NCT01114672|581611117|FG001|Overall Study|Withdrawal by Subject|1|||
161060328|NCT01114672|581611116|FG000|Overall Study|Lost to Follow-up|1|||
161060329|NCT01114672|581611117|FG001|Overall Study|Lost to Follow-up|0|||
161060330|NCT01114672|581611116|FG000|Overall Study|transplanted|1|||
161060331|NCT01114672|581611117|FG001|Overall Study|transplanted|0|||
161060332|NCT02212301|581611118|FG000|Period 1|Lost to Follow-up|0|||
161060333|NCT02212301|581611119|FG001|Period 1|Lost to Follow-up|1|||
161060334|NCT00866918|581611122|FG000|Overall Study|Death|1|||
161060335|NCT00866918|581611123|FG001|Overall Study|Death|5|||
161060336|NCT00866918|581611122|FG000|Overall Study|Lack of Efficacy|1|||
161060337|NCT00866918|581611123|FG001|Overall Study|Lack of Efficacy|1|||
161060338|NCT00866918|581611122|FG000|Overall Study|Physician Decision|10|||
161060339|NCT00866918|581611123|FG001|Overall Study|Physician Decision|2|||
161060340|NCT00866918|581611122|FG000|Overall Study|Ineligible|2|||
161060341|NCT00866918|581611123|FG001|Overall Study|Ineligible|4|||
161060342|NCT00866918|581611122|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
161060343|NCT00866918|581611123|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
161060344|NCT00866918|581611122|FG000|Overall Study|Secondary malignancy|1|||
161060345|NCT00866918|581611123|FG001|Overall Study|Secondary malignancy|0|||
161060346|NCT03041701|581611124|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
161060347|NCT03041701|581611125|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
161060348|NCT03041701|581611126|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
161060349|NCT03041701|581611124|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
161060350|NCT03041701|581611125|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
161060351|NCT03041701|581611126|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
161060352|NCT00527514|581611127|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
161060353|NCT00527514|581611127|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
161060354|NCT00527514|581611127|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
161060355|NCT00527514|581611127|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
161060356|NCT00527514|581611127|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
161060357|NCT00527514|581611127|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
161060358|NCT00527514|581611127|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
161060359|NCT00802438|581611131|FG000|Overall Study|Screen Failure|20|||
161060360|NCT00802438|581611131|FG000|Overall Study|Withdrawal by Subject|7|||
161060361|NCT00802438|581611131|FG000|Overall Study|Physician Decision|1|||
161060362|NCT04016805|581611133|FG000|Overall Study|Sponsor's Discretion|30|||
161060363|NCT04016805|581611134|FG001|Overall Study|Sponsor's Discretion|6|||
161060364|NCT04016805|581611135|FG002|Overall Study|Sponsor's Discretion|5|||
161060365|NCT02101268|581611138|FG000|Randomized Treatment Phase|Subject Decision|8|||
161060366|NCT02101268|581611139|FG001|Randomized Treatment Phase|Subject Decision|4|||
161060367|NCT02101268|581611140|FG002|Randomized Treatment Phase|Subject Decision|0|||
161060368|NCT02101268|581611141|FG003|Randomized Treatment Phase|Subject Decision|0|||
161060369|NCT02101268|581611138|FG000|Randomized Treatment Phase|Physician Decision|4|||
161060370|NCT02101268|581611139|FG001|Randomized Treatment Phase|Physician Decision|1|||
161060371|NCT02101268|581611140|FG002|Randomized Treatment Phase|Physician Decision|0|||
161060372|NCT02101268|581611141|FG003|Randomized Treatment Phase|Physician Decision|0|||
161060373|NCT02101268|581611138|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
161060374|NCT02101268|581611139|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
161060375|NCT02101268|581611140|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
161060376|NCT02101268|581611141|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
161060377|NCT02101268|581611138|FG000|Randomized Treatment Phase|Adverse Event|6|||
161060378|NCT02101268|581611139|FG001|Randomized Treatment Phase|Adverse Event|0|||
161060379|NCT02101268|581611140|FG002|Randomized Treatment Phase|Adverse Event|0|||
161060380|NCT02101268|581611141|FG003|Randomized Treatment Phase|Adverse Event|0|||
161060381|NCT02101268|581611138|FG000|Randomized Treatment Phase|Death|5|||
161060382|NCT02101268|581611139|FG001|Randomized Treatment Phase|Death|4|||
161060383|NCT02101268|581611140|FG002|Randomized Treatment Phase|Death|0|||
161060384|NCT02101268|581611141|FG003|Randomized Treatment Phase|Death|0|||
161060385|NCT02101268|581611138|FG000|Randomized Treatment Phase|Disease Progression|4|||
161060386|NCT02101268|581611139|FG001|Randomized Treatment Phase|Disease Progression|1|||
161153500|NCT01379534|581942544|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
161153501|NCT01379534|581942545|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
161153502|NCT01379534|581942544|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
161153503|NCT01379534|581942545|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
161153504|NCT01379534|581942544|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
161153505|NCT01379534|581942545|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
161153506|NCT01379534|581942544|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
161153507|NCT01379534|581942545|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
161153508|NCT00616239|581942547|FG000|Overall Study|Withdrawal by Subject|2|||
161345274|NCT03980223|582648916|FG002|Overall Study|Withdrawal by Subject|1|||
161153509|NCT00933335|581942550|FG000|Overall Study|Lost to Follow-up|1|||
161153510|NCT00933335|581942551|FG001|Overall Study|Lost to Follow-up|3|||
161153511|NCT00933335|581942550|FG000|Overall Study|Withdrawal by Subject|0|||
161153512|NCT00933335|581942551|FG001|Overall Study|Withdrawal by Subject|1|||
161153513|NCT00933335|581942550|FG000|Overall Study|Progressive Disease|0|||
161153514|NCT00933335|581942551|FG001|Overall Study|Progressive Disease|11|||
161153515|NCT00933335|581942550|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
161153516|NCT00933335|581942551|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
161153517|NCT00933335|581942550|FG000|Overall Study|Co-morbid Illness|1|||
161153518|NCT00933335|581942551|FG001|Overall Study|Co-morbid Illness|0|||
161153519|NCT02229864|581942552|FG000|Overall Study|Death|2|||
161153520|NCT02229864|581942552|FG000|Overall Study|Lost to Follow-up|1|||
161153521|NCT02650284|581942555|FG000|Overall Study|Lost to Follow-up|3|||
161153522|NCT02650284|581942556|FG001|Overall Study|Lost to Follow-up|3|||
161153523|NCT02650284|581942555|FG000|Overall Study|Consent incorrectly taken|0|||
161153524|NCT02650284|581942556|FG001|Overall Study|Consent incorrectly taken|1|||
161153525|NCT00374907|581942561|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
161153526|NCT00374907|581942562|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
161153527|NCT00374907|581942561|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
161153528|NCT00374907|581942562|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
161153529|NCT00374907|581942561|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
161153530|NCT00374907|581942562|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
161153531|NCT00374907|581942561|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
161153532|NCT00374907|581942562|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
161153533|NCT00374907|581942561|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
161153534|NCT00374907|581942562|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
161153535|NCT00085540|581942566|FG000|Overall Study|Withdrawal by Subject|0|||
161153536|NCT00085540|581942567|FG001|Overall Study|Withdrawal by Subject|1|||
161153537|NCT00085540|581942566|FG000|Overall Study|Protocol Violation|0|||
161153538|NCT00085540|581942567|FG001|Overall Study|Protocol Violation|1|||
161153539|NCT01605396|581942568|FG000|Overall Study|Adverse Event|5|||
161153540|NCT01605396|581942569|FG001|Overall Study|Adverse Event|3|||
161060387|NCT02101268|581611140|FG002|Randomized Treatment Phase|Disease Progression|0|||
161060388|NCT02101268|581611141|FG003|Randomized Treatment Phase|Disease Progression|0|||
161060389|NCT02101268|581611138|FG000|Extended Treatment Phase|Subject Decision|0|||
161060390|NCT02101268|581611139|FG001|Extended Treatment Phase|Subject Decision|0|||
161060391|NCT02101268|581611140|FG002|Extended Treatment Phase|Subject Decision|3|||
161060392|NCT02101268|581611141|FG003|Extended Treatment Phase|Subject Decision|2|||
161060393|NCT02101268|581611138|FG000|Extended Treatment Phase|Physician Decision|0|||
161060394|NCT02101268|581611139|FG001|Extended Treatment Phase|Physician Decision|0|||
161060395|NCT02101268|581611140|FG002|Extended Treatment Phase|Physician Decision|5|||
161153541|NCT01605396|581942568|FG000|Overall Study|Lost to Follow-up|1|||
161281954|NCT03284723|582412877|FG007|Overall Study|Death|0|||
161281955|NCT03284723|582412878|FG008|Overall Study|Death|0|||
161281956|NCT03284723|582412879|FG009|Overall Study|Death|2|||
161281957|NCT03284723|582412880|FG010|Overall Study|Death|1|||
161281958|NCT03284723|582412881|FG011|Overall Study|Death|0|||
161281959|NCT03284723|582412870|FG000|Overall Study|Lost to Follow-up|0|||
161281960|NCT03284723|582412871|FG001|Overall Study|Lost to Follow-up|0|||
161060396|NCT02101268|581611141|FG003|Extended Treatment Phase|Physician Decision|2|||
161060397|NCT02101268|581611138|FG000|Extended Treatment Phase|Adverse Event|0|||
161060398|NCT02101268|581611139|FG001|Extended Treatment Phase|Adverse Event|0|||
161060399|NCT02101268|581611140|FG002|Extended Treatment Phase|Adverse Event|14|||
161060400|NCT02101268|581611141|FG003|Extended Treatment Phase|Adverse Event|18|||
161060401|NCT02101268|581611138|FG000|Extended Treatment Phase|Death|0|||
161060402|NCT02101268|581611139|FG001|Extended Treatment Phase|Death|0|||
161060403|NCT02101268|581611140|FG002|Extended Treatment Phase|Death|5|||
161060404|NCT02101268|581611141|FG003|Extended Treatment Phase|Death|1|||
161060405|NCT02101268|581611138|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
161060406|NCT02101268|581611139|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
161060407|NCT02101268|581611140|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
161060408|NCT02101268|581611141|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
161060409|NCT02101268|581611138|FG000|Extended Treatment Phase|Disease Progression|0|||
161060410|NCT02101268|581611139|FG001|Extended Treatment Phase|Disease Progression|0|||
161060411|NCT02101268|581611140|FG002|Extended Treatment Phase|Disease Progression|13|||
161060412|NCT02101268|581611141|FG003|Extended Treatment Phase|Disease Progression|6|||
161060413|NCT02101268|581611138|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
161060414|NCT02101268|581611139|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
161060415|NCT02101268|581611140|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
161060416|NCT02101268|581611141|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
161060417|NCT00740870|581611142|FG000|Overall Study|Not Catheterized|4|||
161060418|NCT00740870|581611142|FG000|Overall Study|Further testing contraindicated implant|17|||
161060419|NCT00819013|581611143|FG000|Overall Study|Not meeting continuing study eligibility|2|||
161060420|NCT00819013|581611144|FG001|Overall Study|Not meeting continuing study eligibility|1|||
161060421|NCT00819013|581611145|FG002|Overall Study|Not meeting continuing study eligibility|2|||
161060422|NCT00819013|581611146|FG003|Overall Study|Not meeting continuing study eligibility|1|||
161060423|NCT00819013|581611143|FG000|Overall Study|Adverse Event|0|||
161060424|NCT00819013|581611144|FG001|Overall Study|Adverse Event|0|||
161060425|NCT00819013|581611145|FG002|Overall Study|Adverse Event|1|||
161060426|NCT00819013|581611146|FG003|Overall Study|Adverse Event|0|||
161060427|NCT00819013|581611143|FG000|Overall Study|Withdrawal by Subject|1|||
161060428|NCT00819013|581611144|FG001|Overall Study|Withdrawal by Subject|0|||
161060429|NCT00819013|581611145|FG002|Overall Study|Withdrawal by Subject|1|||
161060430|NCT00819013|581611146|FG003|Overall Study|Withdrawal by Subject|0|||
161060431|NCT00819013|581611143|FG000|Overall Study|Lost to Follow-up|0|||
161060432|NCT00819013|581611144|FG001|Overall Study|Lost to Follow-up|0|||
161060433|NCT00819013|581611145|FG002|Overall Study|Lost to Follow-up|1|||
161060434|NCT00819013|581611146|FG003|Overall Study|Lost to Follow-up|2|||
161060435|NCT00819013|581611143|FG000|Overall Study|Death|0|||
161060436|NCT00819013|581611144|FG001|Overall Study|Death|0|||
161060437|NCT00819013|581611145|FG002|Overall Study|Death|0|||
161060438|NCT00819013|581611146|FG003|Overall Study|Death|1|||
161060439|NCT00576823|581611147|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
161060440|NCT00576823|581611148|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
161060441|NCT00576823|581611149|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
161060442|NCT00576823|581611147|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
161281961|NCT03284723|582412872|FG002|Overall Study|Lost to Follow-up|0|||
161281962|NCT03284723|582412873|FG003|Overall Study|Lost to Follow-up|0|||
161060443|NCT00576823|581611148|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
161060444|NCT00576823|581611149|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
161060445|NCT02132117|581611151|FG000|Overall Study|Adverse Event|6|||
161060446|NCT02132117|581611152|FG001|Overall Study|Adverse Event|1|||
161060447|NCT02132117|581611151|FG000|Overall Study|Lost to Follow-up|2|||
161060448|NCT02132117|581611152|FG001|Overall Study|Lost to Follow-up|2|||
161060449|NCT02132117|581611151|FG000|Overall Study|Personal Reasons|1|||
161060450|NCT02132117|581611152|FG001|Overall Study|Personal Reasons|2|||
161060451|NCT02132117|581611151|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161060452|NCT02132117|581611152|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161060453|NCT03078751|581611153|FG000|Overall Study|Adverse Event|4|||
161153542|NCT01605396|581942569|FG001|Overall Study|Lost to Follow-up|0|||
161281963|NCT03284723|582412874|FG004|Overall Study|Lost to Follow-up|0|||
161281964|NCT03284723|582412875|FG005|Overall Study|Lost to Follow-up|2|||
161281965|NCT03284723|582412876|FG006|Overall Study|Lost to Follow-up|1|||
161281966|NCT03284723|582412877|FG007|Overall Study|Lost to Follow-up|0|||
161281967|NCT03284723|582412878|FG008|Overall Study|Lost to Follow-up|0|||
161281968|NCT03284723|582412879|FG009|Overall Study|Lost to Follow-up|2|||
161281969|NCT03284723|582412880|FG010|Overall Study|Lost to Follow-up|0|||
161281970|NCT03284723|582412881|FG011|Overall Study|Lost to Follow-up|0|||
161153543|NCT01605396|581942568|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161153544|NCT01605396|581942569|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161153545|NCT01605396|581942568|FG000|Overall Study|Physician Decision|2|||
161153546|NCT01605396|581942569|FG001|Overall Study|Physician Decision|2|||
161153547|NCT01605396|581942568|FG000|Overall Study|Progressive Disease|23|||
161153548|NCT01605396|581942569|FG001|Overall Study|Progressive Disease|27|||
161153549|NCT01605396|581942568|FG000|Overall Study|Withdrawal by Subject|4|||
161153550|NCT01605396|581942569|FG001|Overall Study|Withdrawal by Subject|2|||
161153551|NCT01605396|581942568|FG000|Overall Study|Transfer Off Study|4|||
161153552|NCT01605396|581942569|FG001|Overall Study|Transfer Off Study|5|||
161153553|NCT00878072|581942570|FG000|Overall Study|Withdrew consent|2|||
161153554|NCT00426751|581942581|FG000|Overall Study|Adverse Event|8|||
161153555|NCT00426751|581942582|FG001|Overall Study|Adverse Event|1|||
161153556|NCT00426751|581942581|FG000|Overall Study|Lost to Follow-up|7|||
161153557|NCT00426751|581942582|FG001|Overall Study|Lost to Follow-up|6|||
161153558|NCT00426751|581942581|FG000|Overall Study|Consent Withdrawn|0|||
161153559|NCT00426751|581942582|FG001|Overall Study|Consent Withdrawn|1|||
161153560|NCT00426751|581942581|FG000|Overall Study|Other Reasons|7|||
161153561|NCT00426751|581942582|FG001|Overall Study|Other Reasons|12|||
161153562|NCT01200511|581942583|FG000|Overall Study|Lost to Follow-up|3|||
161153563|NCT01200511|581942583|FG000|Overall Study|Withdrawal by Subject|1|||
161153564|NCT01200511|581942583|FG000|Overall Study|Adverse Event|1|||
161153565|NCT02504892|581942584|FG000|Overall Study|Adverse event-pneumonitis|2|||
161153566|NCT01413178|581942585|FG000|Overall Study|Toxicity|1|||
161153567|NCT01413178|581942586|FG001|Overall Study|Toxicity|0|||
161153568|NCT01413178|581942585|FG000|Overall Study|Ineligible|0|||
161153569|NCT01413178|581942586|FG001|Overall Study|Ineligible|2|||
161153570|NCT00540449|581942587|FG000|Overall Study|Adverse Event|12|||
161153571|NCT00540449|581942588|FG001|Overall Study|Adverse Event|32|||
161153572|NCT00540449|581942587|FG000|Overall Study|Sponsor's Decision|1|||
161153573|NCT00540449|581942588|FG001|Overall Study|Sponsor's Decision|1|||
161153574|NCT00540449|581942587|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
161153575|NCT00540449|581942588|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
161153576|NCT00540449|581942587|FG000|Overall Study|Lost to Follow-up|19|||
161153577|NCT00540449|581942588|FG001|Overall Study|Lost to Follow-up|17|||
161153578|NCT00540449|581942587|FG000|Overall Study|Subject Non-Compliant|7|||
161153579|NCT00540449|581942588|FG001|Overall Study|Subject Non-Compliant|5|||
161153580|NCT00540449|581942587|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
161153581|NCT00540449|581942588|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
161153582|NCT00540449|581942587|FG000|Overall Study|Withdrawal by Subject|10|||
161153583|NCT00540449|581942588|FG001|Overall Study|Withdrawal by Subject|10|||
161153584|NCT00540449|581942587|FG000|Overall Study|Other|1|||
161153585|NCT00540449|581942588|FG001|Overall Study|Other|4|||
161153586|NCT03283163|581942589|FG000|Overall Study|Lost to Follow-up|1|||
161153587|NCT03283163|581942589|FG000|Overall Study|other life commitments|6|||
161153588|NCT03283163|581942589|FG000|Overall Study|COVID-19 institution wide halting|1|||
161153589|NCT03283163|581942589|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
161153590|NCT03283163|581942589|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
161153591|NCT00237796|581942590|FG000|Overall Study|Baseline and one other ILSS required|10|||
161153592|NCT00237796|581942591|FG001|Overall Study|Baseline and one other ILSS required|5|||
161153593|NCT04238663|581942592|FG000|Overall Study|Lost to Follow-up|0|||
161153594|NCT04238663|581942593|FG001|Overall Study|Lost to Follow-up|1|||
161153595|NCT04238663|581942594|FG002|Overall Study|Lost to Follow-up|0|||
161153596|NCT02566525|581942595|FG000|Overall Study|Protocol Violation|3|||
161153597|NCT02566525|581942596|FG001|Overall Study|Protocol Violation|5|||
161153598|NCT00337467|581942597|FG000|Overall Study|Adverse Event|3|||
161153599|NCT00337467|581942597|FG000|Overall Study|Subject Withdrew Consent|2|||
161153600|NCT00337467|581942597|FG000|Overall Study|Pregnancy|1|||
161153601|NCT00337467|581942597|FG000|Overall Study|Lost to Follow-up|2|||
161153602|NCT00337467|581942597|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
161153603|NCT03141086|581942600|FG000|Overall Study|Study Terminated By Sponsor|1|||
161153604|NCT03141086|581942601|FG001|Overall Study|Study Terminated By Sponsor|1|||
161153605|NCT03141086|581942600|FG000|Overall Study|Withdrawal by Subject|0|||
161153606|NCT03141086|581942601|FG001|Overall Study|Withdrawal by Subject|1|||
161153607|NCT03141086|581942600|FG000|Overall Study|Protocol Violation|0|||
161060454|NCT03078751|581611154|FG001|Overall Study|Adverse Event|0|||
161060455|NCT03078751|581611153|FG000|Overall Study|Physician Decision|1|||
161060456|NCT03078751|581611154|FG001|Overall Study|Physician Decision|0|||
161060457|NCT03078751|581611153|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
161060458|NCT03078751|581611154|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
161060459|NCT03078751|581611153|FG000|Overall Study|Subject/guardian decision|8|||
161060460|NCT03078751|581611154|FG001|Overall Study|Subject/guardian decision|1|||
161060461|NCT03078751|581611153|FG000|Overall Study|Untreated|0|||
161060462|NCT03078751|581611154|FG001|Overall Study|Untreated|4|||
161153608|NCT03141086|581942601|FG001|Overall Study|Protocol Violation|1|||
161153609|NCT03141086|581942600|FG000|Overall Study|Adverse Event|0|||
161060463|NCT04414397|581611155|FG000|Control Period|Withdrawal by Subject|2|||
161060464|NCT04414397|581611156|FG001|Control Period|Withdrawal by Subject|2|||
161060465|NCT04414397|581611155|FG000|Control Period|Lost to Follow-up|0|||
161060466|NCT04414397|581611156|FG001|Control Period|Lost to Follow-up|4|||
161060467|NCT04414397|581611155|FG000|Control Period|Protocol deviation|0|||
161060468|NCT04414397|581611156|FG001|Control Period|Protocol deviation|1|||
161060469|NCT04414397|581611155|FG000|Post-Control Period|Withdrawal by Subject|3|||
161060470|NCT04414397|581611156|FG001|Post-Control Period|Withdrawal by Subject|6|||
161060471|NCT04414397|581611155|FG000|Post-Control Period|Lost to Follow-up|4|||
161060472|NCT04414397|581611156|FG001|Post-Control Period|Lost to Follow-up|9|||
161060473|NCT04414397|581611155|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
161060474|NCT04414397|581611156|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
161060475|NCT04414397|581611155|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
161060476|NCT04414397|581611156|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
161060477|NCT02551692|581611158|FG000|Overall Study|Lost to Follow-up|0|||
161060478|NCT02551692|581611159|FG001|Overall Study|Lost to Follow-up|1|||
161060479|NCT02551692|581611160|FG002|Overall Study|Lost to Follow-up|4|||
161060480|NCT02551692|581611158|FG000|Overall Study|Withdrawal by Subject|1|||
161060481|NCT02551692|581611159|FG001|Overall Study|Withdrawal by Subject|0|||
161060482|NCT02551692|581611160|FG002|Overall Study|Withdrawal by Subject|1|||
161060483|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
161060484|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
161060485|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
161060486|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Other|1|||
161060487|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Other|0|||
161060488|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Other|0|||
161060489|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Physician Decision|3|||
161060490|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Physician Decision|0|||
161060491|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Physician Decision|0|||
161060492|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
161060493|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
161060494|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
161060495|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
161060496|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
161060497|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
161060498|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Adverse Event|18|||
161060499|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Adverse Event|0|||
161060500|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Adverse Event|0|||
161060501|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
161060502|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
161060503|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
161060504|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
161060505|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
161060506|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
161060507|NCT03030599|581611161|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
161060508|NCT03030599|581611162|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
161060509|NCT03030599|581611163|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
161060510|NCT03030599|581611161|FG000|Stable Dose|Protocol deviation|3|||
161060511|NCT03030599|581611162|FG001|Stable Dose|Protocol deviation|0|||
161060512|NCT03030599|581611163|FG002|Stable Dose|Protocol deviation|0|||
161060513|NCT03030599|581611161|FG000|Stable Dose|Adverse Event|1|||
161060514|NCT03030599|581611162|FG001|Stable Dose|Adverse Event|0|||
161060515|NCT03030599|581611163|FG002|Stable Dose|Adverse Event|0|||
161060516|NCT03030599|581611161|FG000|Stable Dose|Lost to Follow-up|1|||
161060517|NCT03030599|581611162|FG001|Stable Dose|Lost to Follow-up|0|||
161060518|NCT03030599|581611163|FG002|Stable Dose|Lost to Follow-up|0|||
161060519|NCT03030599|581611161|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
161060520|NCT03030599|581611162|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
161060521|NCT03030599|581611163|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
161060522|NCT03030599|581611161|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
161060523|NCT03030599|581611162|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
161060524|NCT03030599|581611163|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
161060525|NCT03030599|581611161|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
161060526|NCT03030599|581611162|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
161060527|NCT03030599|581611163|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
161060528|NCT03030599|581611161|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
161060529|NCT03030599|581611162|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
161060530|NCT03030599|581611163|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
161060531|NCT03030599|581611161|FG000|Open-label Extension|Adverse Event|3|||
161060532|NCT03030599|581611162|FG001|Open-label Extension|Adverse Event|0|||
161060533|NCT03030599|581611163|FG002|Open-label Extension|Adverse Event|0|||
161060534|NCT03030599|581611161|FG000|Open-label Extension|Lost to Follow-up|2|||
161060535|NCT03030599|581611162|FG001|Open-label Extension|Lost to Follow-up|0|||
161060536|NCT03030599|581611163|FG002|Open-label Extension|Lost to Follow-up|0|||
161060537|NCT03030599|581611161|FG000|Open-label Extension|Lack of Efficacy|1|||
161060538|NCT03030599|581611162|FG001|Open-label Extension|Lack of Efficacy|0|||
161060539|NCT03030599|581611163|FG002|Open-label Extension|Lack of Efficacy|0|||
161060540|NCT03030599|581611161|FG000|Open-label Extension|Other Reason|1|||
161060541|NCT03030599|581611162|FG001|Open-label Extension|Other Reason|0|||
161060542|NCT03030599|581611163|FG002|Open-label Extension|Other Reason|0|||
161060543|NCT01064856|581611164|FG000|Double-blind (DB) Period|Adverse Event|1|||
161060544|NCT01064856|581611165|FG001|Double-blind (DB) Period|Adverse Event|0|||
161060545|NCT01064856|581611166|FG002|Double-blind (DB) Period|Adverse Event|0|||
161060546|NCT01064856|581611167|FG003|Double-blind (DB) Period|Adverse Event|0|||
161060547|NCT01064856|581611164|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
161060548|NCT01064856|581611165|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
161060549|NCT01064856|581611166|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
161060550|NCT01064856|581611167|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
161060551|NCT01064856|581611164|FG000|Open-label (OL) Period|Adverse Event|0|||
161060552|NCT01064856|581611165|FG001|Open-label (OL) Period|Adverse Event|0|||
161060553|NCT01064856|581611166|FG002|Open-label (OL) Period|Adverse Event|12|||
161060554|NCT01064856|581611167|FG003|Open-label (OL) Period|Adverse Event|6|||
161060555|NCT01064856|581611164|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
161060556|NCT01064856|581611165|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
161060557|NCT01064856|581611166|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
161060558|NCT01064856|581611167|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
161060559|NCT01064856|581611164|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
161060560|NCT01064856|581611165|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
161060561|NCT01064856|581611166|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
161060562|NCT01064856|581611167|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
161060563|NCT01064856|581611164|FG000|Open-label (OL) Period|Other|0|||
161060564|NCT01064856|581611165|FG001|Open-label (OL) Period|Other|0|||
161060565|NCT01064856|581611166|FG002|Open-label (OL) Period|Other|7|||
161060566|NCT01064856|581611167|FG003|Open-label (OL) Period|Other|7|||
161060567|NCT02133131|581611168|FG000|Overall Study|Adverse Event|0|||
161060568|NCT02133131|581611169|FG001|Overall Study|Adverse Event|0|||
161060569|NCT02133131|581611170|FG002|Overall Study|Adverse Event|0|||
161060570|NCT02133131|581611171|FG003|Overall Study|Adverse Event|1|||
161060571|NCT02133131|581611172|FG004|Overall Study|Adverse Event|0|||
161060572|NCT02133131|581611173|FG005|Overall Study|Adverse Event|0|||
161060573|NCT02133131|581611174|FG006|Overall Study|Adverse Event|0|||
161060574|NCT02133131|581611168|FG000|Overall Study|Lost to Follow-up|1|||
161060575|NCT02133131|581611169|FG001|Overall Study|Lost to Follow-up|0|||
161060576|NCT02133131|581611170|FG002|Overall Study|Lost to Follow-up|0|||
161060577|NCT02133131|581611171|FG003|Overall Study|Lost to Follow-up|1|||
161060578|NCT02133131|581611172|FG004|Overall Study|Lost to Follow-up|0|||
161060579|NCT02133131|581611173|FG005|Overall Study|Lost to Follow-up|0|||
161060580|NCT02133131|581611174|FG006|Overall Study|Lost to Follow-up|0|||
161060581|NCT02133131|581611168|FG000|Overall Study|Status not recorded|4|||
161060582|NCT02133131|581611169|FG001|Overall Study|Status not recorded|5|||
161060583|NCT02133131|581611170|FG002|Overall Study|Status not recorded|1|||
161060584|NCT02133131|581611171|FG003|Overall Study|Status not recorded|4|||
161060585|NCT02133131|581611172|FG004|Overall Study|Status not recorded|0|||
161060586|NCT02133131|581611173|FG005|Overall Study|Status not recorded|0|||
161060587|NCT02133131|581611174|FG006|Overall Study|Status not recorded|0|||
161060588|NCT02133131|581611168|FG000|Overall Study|Ongoing in study|0|||
161060589|NCT02133131|581611169|FG001|Overall Study|Ongoing in study|0|||
161060590|NCT02133131|581611170|FG002|Overall Study|Ongoing in study|0|||
161060591|NCT02133131|581611171|FG003|Overall Study|Ongoing in study|0|||
161060592|NCT02133131|581611172|FG004|Overall Study|Ongoing in study|15|||
161060593|NCT02133131|581611173|FG005|Overall Study|Ongoing in study|14|||
161060594|NCT02133131|581611174|FG006|Overall Study|Ongoing in study|11|||
161060595|NCT02133131|581611168|FG000|Overall Study|Protocol Violation|0|||
161060596|NCT02133131|581611169|FG001|Overall Study|Protocol Violation|0|||
161060597|NCT02133131|581611170|FG002|Overall Study|Protocol Violation|0|||
161060598|NCT02133131|581611171|FG003|Overall Study|Protocol Violation|0|||
161060599|NCT02133131|581611172|FG004|Overall Study|Protocol Violation|0|||
161060600|NCT02133131|581611173|FG005|Overall Study|Protocol Violation|0|||
161060601|NCT02133131|581611174|FG006|Overall Study|Protocol Violation|1|||
161060602|NCT00509925|581611175|FG000|Overall Study|Personal reasons|0|||
161060603|NCT00509925|581611176|FG001|Overall Study|Personal reasons|1|||
161060604|NCT00951171|581611180|FG000|Overall Study|Adverse Event|2|||
161060605|NCT00951171|581611181|FG001|Overall Study|Adverse Event|0|||
161060606|NCT01932762|581613042|FG000|Overall Study|Withdrawal by Subject|1|||
161060607|NCT01932762|581613043|FG001|Overall Study|Withdrawal by Subject|2|||
161060608|NCT01932762|581613044|FG002|Overall Study|Withdrawal by Subject|0|||
161060609|NCT01932762|581613045|FG003|Overall Study|Withdrawal by Subject|0|||
161060610|NCT01932762|581613042|FG000|Overall Study|Lost to Follow-up|4|||
161060611|NCT01932762|581613043|FG001|Overall Study|Lost to Follow-up|0|||
161060612|NCT01932762|581613044|FG002|Overall Study|Lost to Follow-up|0|||
161060613|NCT01932762|581613045|FG003|Overall Study|Lost to Follow-up|1|||
161060614|NCT01932762|581613042|FG000|Overall Study|Physician Decision|1|||
161060615|NCT01932762|581613043|FG001|Overall Study|Physician Decision|0|||
161060616|NCT01932762|581613044|FG002|Overall Study|Physician Decision|0|||
161060617|NCT01932762|581613045|FG003|Overall Study|Physician Decision|0|||
161060618|NCT00695136|581613046|FG000|Overall Study|Withdrawal by Subject|1|||
161060619|NCT00695136|581613046|FG000|Overall Study|unrelated adverse event|1|||
161060620|NCT01333111|581613050|FG000|Overall Study|patient undergoing major surgery|0|||
161060621|NCT01333111|581613051|FG001|Overall Study|patient undergoing major surgery|2|||
161060622|NCT01333111|581613052|FG002|Overall Study|patient undergoing major surgery|0|||
161060623|NCT01333111|581613050|FG000|Overall Study|personal reasons|0|||
161060624|NCT01333111|581613051|FG001|Overall Study|personal reasons|0|||
161060625|NCT01333111|581613052|FG002|Overall Study|personal reasons|1|||
161060626|NCT01333111|581613050|FG000|Overall Study|unclassified|1|||
161060627|NCT01333111|581613051|FG001|Overall Study|unclassified|0|||
161060628|NCT01333111|581613052|FG002|Overall Study|unclassified|0|||
161060629|NCT01333111|581613050|FG000|Overall Study|withdrawal criteria|0|||
161060630|NCT01333111|581613051|FG001|Overall Study|withdrawal criteria|1|||
161060631|NCT01333111|581613052|FG002|Overall Study|withdrawal criteria|0|||
161060632|NCT01333111|581613050|FG000|Overall Study|Non-compliance|1|||
161060633|NCT01333111|581613051|FG001|Overall Study|Non-compliance|0|||
161060634|NCT01333111|581613052|FG002|Overall Study|Non-compliance|0|||
161060635|NCT01333111|581613050|FG000|Overall Study|Ineffective therapy|0|||
161060636|NCT01333111|581613051|FG001|Overall Study|Ineffective therapy|0|||
161060637|NCT01333111|581613052|FG002|Overall Study|Ineffective therapy|1|||
161060638|NCT02161406|581613053|FG000|Overall Study|Death|2|||
161060639|NCT02161406|581613054|FG001|Overall Study|Death|1|||
161060640|NCT02161406|581613053|FG000|Overall Study|Lost to Follow-up|2|||
161060641|NCT02161406|581613054|FG001|Overall Study|Lost to Follow-up|1|||
161060642|NCT02161406|581613053|FG000|Overall Study|Withdrawal by Subject|2|||
161060643|NCT02161406|581613054|FG001|Overall Study|Withdrawal by Subject|4|||
161060644|NCT02161406|581613053|FG000|Overall Study|investigator withdrew subject|3|||
161060645|NCT02161406|581613054|FG001|Overall Study|investigator withdrew subject|1|||
161060646|NCT02161406|581613053|FG000|Overall Study|Lack of Efficacy|1|||
161060647|NCT02161406|581613054|FG001|Overall Study|Lack of Efficacy|1|||
161060648|NCT02161406|581613053|FG000|Overall Study|relocation|0|||
161060649|NCT02161406|581613054|FG001|Overall Study|relocation|1|||
161060650|NCT00664105|581613055|FG000|Overall Study|Death|3|||
161060651|NCT00664105|581613055|FG000|Overall Study|Withdrawal by Subject|5|||
161060652|NCT00664105|581613055|FG000|Overall Study|Adverse Event|9|||
161060653|NCT00664105|581613055|FG000|Overall Study|Disease progression|7|||
161060654|NCT01468077|581613058|FG000|Overall Study|Adverse Event|2|||
161060655|NCT01468077|581613059|FG001|Overall Study|Adverse Event|2|||
161060656|NCT01468077|581613058|FG000|Overall Study|Lack of Efficacy|1|||
161060657|NCT01468077|581613059|FG001|Overall Study|Lack of Efficacy|1|||
161060658|NCT01468077|581613058|FG000|Overall Study|Physician Decision|1|||
161060659|NCT01468077|581613059|FG001|Overall Study|Physician Decision|0|||
161060660|NCT05446714|581613060|FG000|Overall Study|Lost to Follow-up|1|||
161060661|NCT05446714|581613061|FG001|Overall Study|Lost to Follow-up|3|||
161060662|NCT05446714|581613062|FG002|Overall Study|Lost to Follow-up|2|||
161060663|NCT05446714|581613060|FG000|Overall Study|Protocol Violation|2|||
161060664|NCT05446714|581613061|FG001|Overall Study|Protocol Violation|0|||
161060665|NCT05446714|581613062|FG002|Overall Study|Protocol Violation|0|||
161060666|NCT03024996|581613063|FG000|Overall Study|Death|57|||
161060667|NCT03024996|581613064|FG001|Overall Study|Death|55|||
161060668|NCT03024996|581613063|FG000|Overall Study|Disease relapse|1|||
161060669|NCT03024996|581613064|FG001|Overall Study|Disease relapse|0|||
161060670|NCT03024996|581613063|FG000|Overall Study|Lost to Follow-up|5|||
161060671|NCT03024996|581613064|FG001|Overall Study|Lost to Follow-up|10|||
161060672|NCT03024996|581613063|FG000|Overall Study|Other|3|||
161060673|NCT03024996|581613064|FG001|Overall Study|Other|3|||
161281971|NCT03284723|582412870|FG000|Overall Study|Study Terminated By Sponsor|0|||
161060674|NCT03024996|581613063|FG000|Overall Study|Physician Decision|0|||
161060675|NCT03024996|581613064|FG001|Overall Study|Physician Decision|1|||
161060676|NCT03024996|581613063|FG000|Overall Study|Study terminated by sponsor|303|||
161060677|NCT03024996|581613064|FG001|Overall Study|Study terminated by sponsor|283|||
161060678|NCT03024996|581613063|FG000|Overall Study|Withdrawal by Subject|21|||
161060679|NCT03024996|581613064|FG001|Overall Study|Withdrawal by Subject|36|||
161060680|NCT02418845|581613067|FG000|Overall Study|Lost to Follow-up|7|||
161060681|NCT02418845|581613068|FG001|Overall Study|Lost to Follow-up|2|||
161060682|NCT02418845|581613067|FG000|Overall Study|Lack of Efficacy|0|||
161060683|NCT02418845|581613068|FG001|Overall Study|Lack of Efficacy|3|||
161060684|NCT02418845|581613067|FG000|Overall Study|Physician Decision|5|||
161060685|NCT02418845|581613068|FG001|Overall Study|Physician Decision|5|||
161060686|NCT02418845|581613067|FG000|Overall Study|Protocol Violation|1|||
161060687|NCT02418845|581613068|FG001|Overall Study|Protocol Violation|0|||
161060688|NCT02418845|581613067|FG000|Overall Study|Withdrawal by Subject|3|||
161060689|NCT02418845|581613068|FG001|Overall Study|Withdrawal by Subject|2|||
161060690|NCT00478647|581613069|FG000|Overall Study|Adverse Event|1|||
161153610|NCT03141086|581942601|FG001|Overall Study|Adverse Event|2|||
161153611|NCT04430582|581942603|FG000|Overall Study|Found to meet exclusionary criteria|1|||
161153612|NCT04430582|581942604|FG001|Overall Study|Found to meet exclusionary criteria|0|||
161153613|NCT04430582|581942603|FG000|Overall Study|Withdrawal by Subject|0|||
161153614|NCT04430582|581942604|FG001|Overall Study|Withdrawal by Subject|1|||
161153615|NCT03607682|581942605|FG000|Overall Study|Withdrawal by Subject|1|||
161153616|NCT03607682|581942605|FG000|Overall Study|Disease progression|1|||
161153617|NCT05128162|581942606|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
161153618|NCT05128162|581942606|FG000|Overall Study|Physician Decision|1|||
161153619|NCT04920084|581943902|FG000|Overall Study|Adverse Event|1|||
161153620|NCT04920084|581943902|FG000|Overall Study|Lost to Follow-up|2|||
161153621|NCT04920084|581943902|FG000|Overall Study|Withdrawal by Subject|2|||
161153622|NCT01096446|581943903|FG000|Overall Study|Death|1|||
161153623|NCT01096446|581943904|FG001|Overall Study|Death|0|||
161153624|NCT01096446|581943903|FG000|Overall Study|Protocol Violation|2|||
161153625|NCT01096446|581943904|FG001|Overall Study|Protocol Violation|0|||
161153626|NCT02279524|581943905|FG000|Overall Study|Withdrawal by Subject|3|||
161153627|NCT02279524|581943906|FG001|Overall Study|Withdrawal by Subject|6|||
161153628|NCT02279524|581943907|FG002|Overall Study|Withdrawal by Subject|3|||
161153629|NCT02279524|581943905|FG000|Overall Study|Adverse Event|4|||
161153630|NCT02279524|581943906|FG001|Overall Study|Adverse Event|3|||
161153631|NCT02279524|581943907|FG002|Overall Study|Adverse Event|2|||
161153632|NCT02279524|581943905|FG000|Overall Study|Lost to Follow-up|1|||
161153633|NCT02279524|581943906|FG001|Overall Study|Lost to Follow-up|1|||
161153634|NCT02279524|581943907|FG002|Overall Study|Lost to Follow-up|0|||
161153635|NCT02279524|581943905|FG000|Overall Study|Disallowed medication|1|||
161345275|NCT03980223|582648917|FG003|Overall Study|Withdrawal by Subject|2|||
161060691|NCT00478647|581613069|FG000|Overall Study|Withdrawal by Subject|1|||
161060692|NCT04333147|581613070|FG000|Overall Study|Adverse Event|43|||
161060693|NCT04333147|581613071|FG001|Overall Study|Adverse Event|40|||
161060694|NCT04333147|581613070|FG000|Overall Study|Lack of Efficacy|49|||
161060695|NCT04333147|581613071|FG001|Overall Study|Lack of Efficacy|48|||
161060696|NCT04333147|581613070|FG000|Overall Study|Lost to Follow-up|19|||
161060697|NCT04333147|581613071|FG001|Overall Study|Lost to Follow-up|16|||
161060698|NCT04333147|581613070|FG000|Overall Study|Physician Decision|17|||
161060699|NCT04333147|581613071|FG001|Overall Study|Physician Decision|20|||
161060700|NCT04333147|581613070|FG000|Overall Study|Withdrawal by Subject|65|||
161060701|NCT04333147|581613071|FG001|Overall Study|Withdrawal by Subject|68|||
161060702|NCT04333147|581613070|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
161060703|NCT04333147|581613071|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
161060704|NCT04333147|581613070|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
161060705|NCT04333147|581613071|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
161060706|NCT04333147|581613070|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
161060707|NCT04333147|581613071|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
161060708|NCT00487552|581613081|FG000|Overall Study|Unsuccessful magnet placements|3|||
161060709|NCT00487552|581613081|FG000|Overall Study|Death due to progressive malignancy|2|||
161060710|NCT00487552|581613081|FG000|Overall Study|Stent not placed|1|||
161060711|NCT03119688|581613082|FG000|Overall Study|Adverse Event|4|||
161060712|NCT00320398|581613083|FG000|Overall Study|Adverse Event|1|||
161060713|NCT00320398|581613084|FG001|Overall Study|Adverse Event|4|||
161060714|NCT00320398|581613083|FG000|Overall Study|Other|1|||
161060715|NCT00320398|581613084|FG001|Overall Study|Other|0|||
161060716|NCT00630552|581613085|FG000|Overall Study|Adverse Event|0|||
161060717|NCT00630552|581613086|FG001|Overall Study|Adverse Event|1|||
161060718|NCT00630552|581613087|FG002|Overall Study|Adverse Event|5|||
161060719|NCT00630552|581613088|FG003|Overall Study|Adverse Event|4|||
161060720|NCT00630552|581613089|FG004|Overall Study|Adverse Event|2|||
161060721|NCT00630552|581613085|FG000|Overall Study|Disease progression|5|||
161060722|NCT00630552|581613086|FG001|Overall Study|Disease progression|6|||
161060723|NCT00630552|581613087|FG002|Overall Study|Disease progression|27|||
161060724|NCT00630552|581613088|FG003|Overall Study|Disease progression|22|||
161060725|NCT00630552|581613089|FG004|Overall Study|Disease progression|31|||
161060726|NCT00630552|581613085|FG000|Overall Study|Never received IP|0|||
161060727|NCT00630552|581613086|FG001|Overall Study|Never received IP|0|||
161153636|NCT02279524|581943906|FG001|Overall Study|Disallowed medication|1|||
161153637|NCT02279524|581943907|FG002|Overall Study|Disallowed medication|2|||
161153638|NCT02279524|581943905|FG000|Overall Study|Bariatric surgery|1|||
161345276|NCT03980223|582648914|FG000|Overall Study|Physician Decision|0|||
161060728|NCT00630552|581613087|FG002|Overall Study|Never received IP|0|||
161060729|NCT00630552|581613088|FG003|Overall Study|Never received IP|2|||
161060730|NCT00630552|581613089|FG004|Overall Study|Never received IP|2|||
161060731|NCT00630552|581613085|FG000|Overall Study|Ineligibility determined|0|||
161060732|NCT00630552|581613086|FG001|Overall Study|Ineligibility determined|0|||
161060733|NCT00630552|581613087|FG002|Overall Study|Ineligibility determined|0|||
161153639|NCT02279524|581943906|FG001|Overall Study|Bariatric surgery|0|||
161153640|NCT02279524|581943907|FG002|Overall Study|Bariatric surgery|0|||
161153641|NCT00392171|581943912|FG000|Overall Study|Did not meet inclusion criteria|4|||
161153642|NCT00392171|581943912|FG000|Overall Study|Disease progression|101|||
161060734|NCT00630552|581613088|FG003|Overall Study|Ineligibility determined|0|||
161060735|NCT00630552|581613089|FG004|Overall Study|Ineligibility determined|1|||
161060736|NCT00630552|581613085|FG000|Overall Study|Protocol Violation|0|||
161060737|NCT00630552|581613086|FG001|Overall Study|Protocol Violation|0|||
161060738|NCT00630552|581613087|FG002|Overall Study|Protocol Violation|0|||
161060739|NCT00630552|581613088|FG003|Overall Study|Protocol Violation|1|||
161060740|NCT00630552|581613089|FG004|Overall Study|Protocol Violation|0|||
161060741|NCT00630552|581613085|FG000|Overall Study|Physician Decision|0|||
161060742|NCT00630552|581613086|FG001|Overall Study|Physician Decision|0|||
161060743|NCT00630552|581613087|FG002|Overall Study|Physician Decision|0|||
161060744|NCT00630552|581613088|FG003|Overall Study|Physician Decision|0|||
161060745|NCT00630552|581613089|FG004|Overall Study|Physician Decision|1|||
161060746|NCT00630552|581613085|FG000|Overall Study|Death|0|||
161060747|NCT00630552|581613086|FG001|Overall Study|Death|0|||
161060748|NCT00630552|581613087|FG002|Overall Study|Death|1|||
161060749|NCT00630552|581613088|FG003|Overall Study|Death|2|||
161060750|NCT00630552|581613089|FG004|Overall Study|Death|2|||
161060751|NCT00630552|581613085|FG000|Overall Study|Withdrawal by Subject|0|||
161060752|NCT00630552|581613086|FG001|Overall Study|Withdrawal by Subject|0|||
161060753|NCT00630552|581613087|FG002|Overall Study|Withdrawal by Subject|0|||
161060754|NCT00630552|581613088|FG003|Overall Study|Withdrawal by Subject|1|||
161060755|NCT00630552|581613089|FG004|Overall Study|Withdrawal by Subject|0|||
161060756|NCT00630552|581613085|FG000|Overall Study|Other|0|||
161060757|NCT00630552|581613086|FG001|Overall Study|Other|0|||
161060758|NCT00630552|581613087|FG002|Overall Study|Other|4|||
161060759|NCT00630552|581613088|FG003|Overall Study|Other|2|||
161060760|NCT00630552|581613089|FG004|Overall Study|Other|0|||
161060761|NCT01746108|581613096|FG000|Overall Study|Migrated /moved from study area|0|||
161060762|NCT01746108|581613097|FG001|Overall Study|Migrated /moved from study area|1|||
161060763|NCT01746108|581613098|FG002|Overall Study|Migrated /moved from study area|0|||
161060764|NCT01746108|581613096|FG000|Overall Study|Adverse event, non-fatal|0|||
161060765|NCT01746108|581613097|FG001|Overall Study|Adverse event, non-fatal|1|||
161060766|NCT01746108|581613098|FG002|Overall Study|Adverse event, non-fatal|0|||
161060767|NCT01746108|581613096|FG000|Overall Study|Withdrawal by Subject|0|||
161060768|NCT01746108|581613097|FG001|Overall Study|Withdrawal by Subject|1|||
161060769|NCT01746108|581613098|FG002|Overall Study|Withdrawal by Subject|0|||
161060770|NCT01746108|581613096|FG000|Overall Study|Lost to Follow-up|0|||
161060771|NCT01746108|581613097|FG001|Overall Study|Lost to Follow-up|1|||
161060772|NCT01746108|581613098|FG002|Overall Study|Lost to Follow-up|0|||
161060773|NCT03036150|581613099|FG000|Overall Study|Withdrawal by Subject|8|||
161060774|NCT03036150|581613100|FG001|Overall Study|Withdrawal by Subject|3|||
161060775|NCT03036150|581613099|FG000|Overall Study|Lost to Follow-up|2|||
161060776|NCT03036150|581613100|FG001|Overall Study|Lost to Follow-up|2|||
161060777|NCT00053352|581613109|FG000|Overall Study|Lost to Follow-up|0|||
161060778|NCT00053352|581613110|FG001|Overall Study|Lost to Follow-up|1|||
161060779|NCT00053352|581613109|FG000|Overall Study|Physician Decision|11|||
161060780|NCT00053352|581613110|FG001|Overall Study|Physician Decision|1|||
161060781|NCT00053352|581613109|FG000|Overall Study|Withdrawal by Subject|1|||
161060782|NCT00053352|581613110|FG001|Overall Study|Withdrawal by Subject|0|||
161060783|NCT00053352|581613109|FG000|Overall Study|Ineligible|8|||
161060784|NCT00053352|581613110|FG001|Overall Study|Ineligible|8|||
161060785|NCT00053352|581613109|FG000|Overall Study|Disease at new site|1|||
161060786|NCT00053352|581613110|FG001|Overall Study|Disease at new site|0|||
161060787|NCT00931918|581613113|FG000|Overall Study|Adverse Event|4|||
161060788|NCT00931918|581613114|FG001|Overall Study|Adverse Event|6|||
161060789|NCT00931918|581613113|FG000|Overall Study|Progressive Disease|2|||
161060790|NCT00931918|581613114|FG001|Overall Study|Progressive Disease|1|||
161060791|NCT00931918|581613113|FG000|Overall Study|Symptomatic Deterioration|1|||
161060792|NCT00931918|581613114|FG001|Overall Study|Symptomatic Deterioration|0|||
161281972|NCT03284723|582412871|FG001|Overall Study|Study Terminated By Sponsor|0|||
161060793|NCT00931918|581613113|FG000|Overall Study|Withdrawal by Patient|3|||
161060794|NCT00931918|581613114|FG001|Overall Study|Withdrawal by Patient|4|||
161060795|NCT00931918|581613113|FG000|Overall Study|Other Reason not Specified|4|||
161060796|NCT00931918|581613114|FG001|Overall Study|Other Reason not Specified|4|||
161060797|NCT00931918|581613113|FG000|Overall Study|Did not receive study drug|3|||
161060798|NCT00931918|581613114|FG001|Overall Study|Did not receive study drug|2|||
161060799|NCT00809341|581613115|FG000|Overall Study|Physician Decision|0|||
161060800|NCT00809341|581613116|FG001|Overall Study|Physician Decision|1|||
161060801|NCT00570921|581613119|FG000|Overall Study|Protocol Violation|1|||
161060802|NCT00570921|581613119|FG000|Overall Study|Physician Decision|1|||
161060803|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
161060804|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
161060805|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
161060806|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
161060807|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
161060808|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
161060809|NCT03201900|581613120|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
161060810|NCT03201900|581613120|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
161060811|NCT03201900|581613120|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
161060812|NCT03201900|581613120|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
161060813|NCT03201900|581613120|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
161060814|NCT03201900|581613120|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
161060815|NCT03201900|581613120|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
161060816|NCT00550446|581613121|FG000|Up To Week 12|Adverse Event|2|||
161060817|NCT00550446|581613122|FG001|Up To Week 12|Adverse Event|2|||
161060818|NCT00550446|581613123|FG002|Up To Week 12|Adverse Event|0|||
161060819|NCT00550446|581613124|FG003|Up To Week 12|Adverse Event|0|||
161060820|NCT00550446|581613125|FG004|Up To Week 12|Adverse Event|2|||
161060821|NCT00550446|581613126|FG005|Up To Week 12|Adverse Event|2|||
161060822|NCT00550446|581613127|FG006|Up To Week 12|Adverse Event|1|||
161281973|NCT03284723|582412872|FG002|Overall Study|Study Terminated By Sponsor|0|||
161060823|NCT00550446|581613128|FG007|Up To Week 12|Adverse Event|0|||
161060824|NCT00550446|581613129|FG008|Up To Week 12|Adverse Event|0|||
161060825|NCT00550446|581613130|FG009|Up To Week 12|Adverse Event|0|||
161060826|NCT00550446|581613131|FG010|Up To Week 12|Adverse Event|0|||
161060827|NCT00550446|581613121|FG000|Up To Week 12|Lack of Efficacy|3|||
161060828|NCT00550446|581613122|FG001|Up To Week 12|Lack of Efficacy|1|||
161060829|NCT00550446|581613123|FG002|Up To Week 12|Lack of Efficacy|0|||
161060830|NCT00550446|581613124|FG003|Up To Week 12|Lack of Efficacy|1|||
161060831|NCT00550446|581613125|FG004|Up To Week 12|Lack of Efficacy|0|||
161060832|NCT00550446|581613126|FG005|Up To Week 12|Lack of Efficacy|3|||
161060833|NCT00550446|581613127|FG006|Up To Week 12|Lack of Efficacy|3|||
161060834|NCT00550446|581613128|FG007|Up To Week 12|Lack of Efficacy|0|||
161060835|NCT00550446|581613129|FG008|Up To Week 12|Lack of Efficacy|0|||
161060836|NCT00550446|581613130|FG009|Up To Week 12|Lack of Efficacy|0|||
161060837|NCT00550446|581613131|FG010|Up To Week 12|Lack of Efficacy|0|||
161060838|NCT00550446|581613121|FG000|Up To Week 12|Lost to Follow-up|0|||
161060839|NCT00550446|581613122|FG001|Up To Week 12|Lost to Follow-up|1|||
161060840|NCT00550446|581613123|FG002|Up To Week 12|Lost to Follow-up|0|||
161060841|NCT00550446|581613124|FG003|Up To Week 12|Lost to Follow-up|0|||
161060842|NCT00550446|581613125|FG004|Up To Week 12|Lost to Follow-up|1|||
161060843|NCT00550446|581613126|FG005|Up To Week 12|Lost to Follow-up|1|||
161060844|NCT00550446|581613127|FG006|Up To Week 12|Lost to Follow-up|2|||
161060845|NCT00550446|581613128|FG007|Up To Week 12|Lost to Follow-up|0|||
161060846|NCT00550446|581613129|FG008|Up To Week 12|Lost to Follow-up|0|||
161060847|NCT00550446|581613130|FG009|Up To Week 12|Lost to Follow-up|0|||
161060848|NCT00550446|581613131|FG010|Up To Week 12|Lost to Follow-up|0|||
161060849|NCT00550446|581613121|FG000|Up To Week 12|Withdrawal by Subject|2|||
161060850|NCT00550446|581613122|FG001|Up To Week 12|Withdrawal by Subject|0|||
161060851|NCT00550446|581613123|FG002|Up To Week 12|Withdrawal by Subject|3|||
161060852|NCT00550446|581613124|FG003|Up To Week 12|Withdrawal by Subject|2|||
161060853|NCT00550446|581613125|FG004|Up To Week 12|Withdrawal by Subject|0|||
161060854|NCT00550446|581613126|FG005|Up To Week 12|Withdrawal by Subject|1|||
161060855|NCT00550446|581613127|FG006|Up To Week 12|Withdrawal by Subject|3|||
161060856|NCT00550446|581613128|FG007|Up To Week 12|Withdrawal by Subject|0|||
161060857|NCT00550446|581613129|FG008|Up To Week 12|Withdrawal by Subject|0|||
161060858|NCT00550446|581613130|FG009|Up To Week 12|Withdrawal by Subject|0|||
161060859|NCT00550446|581613131|FG010|Up To Week 12|Withdrawal by Subject|0|||
161060860|NCT00550446|581613121|FG000|Up To Week 12|Other|3|||
161060861|NCT00550446|581613122|FG001|Up To Week 12|Other|0|||
161060862|NCT00550446|581613123|FG002|Up To Week 12|Other|0|||
161060863|NCT00550446|581613124|FG003|Up To Week 12|Other|0|||
161060864|NCT00550446|581613125|FG004|Up To Week 12|Other|0|||
161153643|NCT03488472|581943913|FG000|Overall Study|disease progression additional mets|1|||
161281974|NCT03284723|582412873|FG003|Overall Study|Study Terminated By Sponsor|0|||
161281975|NCT03284723|582412874|FG004|Overall Study|Study Terminated By Sponsor|1|||
161060865|NCT00550446|581613126|FG005|Up To Week 12|Other|1|||
161060866|NCT00550446|581613127|FG006|Up To Week 12|Other|4|||
161060867|NCT00550446|581613128|FG007|Up To Week 12|Other|0|||
161060868|NCT00550446|581613129|FG008|Up To Week 12|Other|0|||
161060869|NCT00550446|581613130|FG009|Up To Week 12|Other|0|||
161060870|NCT00550446|581613131|FG010|Up To Week 12|Other|0|||
161060871|NCT00550446|581613121|FG000|Up To Week 12|Randomized not treated|0|||
161060872|NCT00550446|581613122|FG001|Up To Week 12|Randomized not treated|1|||
161060873|NCT00550446|581613123|FG002|Up To Week 12|Randomized not treated|1|||
161060874|NCT00550446|581613124|FG003|Up To Week 12|Randomized not treated|0|||
161060875|NCT00550446|581613125|FG004|Up To Week 12|Randomized not treated|0|||
161060876|NCT00550446|581613126|FG005|Up To Week 12|Randomized not treated|0|||
161060877|NCT00550446|581613127|FG006|Up To Week 12|Randomized not treated|0|||
161060878|NCT00550446|581613128|FG007|Up To Week 12|Randomized not treated|0|||
161060879|NCT00550446|581613129|FG008|Up To Week 12|Randomized not treated|0|||
161060880|NCT00550446|581613130|FG009|Up To Week 12|Randomized not treated|0|||
161060881|NCT00550446|581613131|FG010|Up To Week 12|Randomized not treated|0|||
161060882|NCT00550446|581613121|FG000|Post Week 12|Adverse Event|2|||
161060883|NCT00550446|581613122|FG001|Post Week 12|Adverse Event|1|||
161060884|NCT00550446|581613123|FG002|Post Week 12|Adverse Event|1|||
161060885|NCT00550446|581613124|FG003|Post Week 12|Adverse Event|1|||
161060886|NCT00550446|581613125|FG004|Post Week 12|Adverse Event|1|||
161060887|NCT00550446|581613126|FG005|Post Week 12|Adverse Event|1|||
161060888|NCT00550446|581613127|FG006|Post Week 12|Adverse Event|0|||
161060889|NCT00550446|581613128|FG007|Post Week 12|Adverse Event|0|||
161060890|NCT00550446|581613129|FG008|Post Week 12|Adverse Event|0|||
161060891|NCT00550446|581613130|FG009|Post Week 12|Adverse Event|4|||
161060892|NCT00550446|581613131|FG010|Post Week 12|Adverse Event|0|||
161060893|NCT00550446|581613121|FG000|Post Week 12|Lack of Efficacy|0|||
161060894|NCT00550446|581613122|FG001|Post Week 12|Lack of Efficacy|0|||
161060895|NCT00550446|581613123|FG002|Post Week 12|Lack of Efficacy|1|||
161060896|NCT00550446|581613124|FG003|Post Week 12|Lack of Efficacy|0|||
161060897|NCT00550446|581613125|FG004|Post Week 12|Lack of Efficacy|0|||
161060898|NCT00550446|581613126|FG005|Post Week 12|Lack of Efficacy|0|||
161060899|NCT00550446|581613127|FG006|Post Week 12|Lack of Efficacy|0|||
161060900|NCT00550446|581613128|FG007|Post Week 12|Lack of Efficacy|1|||
161060901|NCT00550446|581613129|FG008|Post Week 12|Lack of Efficacy|1|||
161060902|NCT00550446|581613130|FG009|Post Week 12|Lack of Efficacy|2|||
161060903|NCT00550446|581613131|FG010|Post Week 12|Lack of Efficacy|1|||
161060904|NCT00550446|581613121|FG000|Post Week 12|Lost to Follow-up|0|||
161060905|NCT00550446|581613122|FG001|Post Week 12|Lost to Follow-up|0|||
161060906|NCT00550446|581613123|FG002|Post Week 12|Lost to Follow-up|1|||
161060907|NCT00550446|581613124|FG003|Post Week 12|Lost to Follow-up|1|||
161060908|NCT00550446|581613125|FG004|Post Week 12|Lost to Follow-up|0|||
161060909|NCT00550446|581613126|FG005|Post Week 12|Lost to Follow-up|0|||
161060910|NCT00550446|581613127|FG006|Post Week 12|Lost to Follow-up|1|||
161060911|NCT00550446|581613128|FG007|Post Week 12|Lost to Follow-up|0|||
161060912|NCT00550446|581613129|FG008|Post Week 12|Lost to Follow-up|0|||
161060913|NCT00550446|581613130|FG009|Post Week 12|Lost to Follow-up|0|||
161060914|NCT00550446|581613131|FG010|Post Week 12|Lost to Follow-up|0|||
161060915|NCT00550446|581613121|FG000|Post Week 12|Withdrawal by Subject|0|||
161060916|NCT00550446|581613122|FG001|Post Week 12|Withdrawal by Subject|0|||
161060917|NCT00550446|581613123|FG002|Post Week 12|Withdrawal by Subject|0|||
161060918|NCT00550446|581613124|FG003|Post Week 12|Withdrawal by Subject|0|||
161060919|NCT00550446|581613125|FG004|Post Week 12|Withdrawal by Subject|1|||
161060920|NCT00550446|581613126|FG005|Post Week 12|Withdrawal by Subject|0|||
161060921|NCT00550446|581613127|FG006|Post Week 12|Withdrawal by Subject|0|||
161060922|NCT00550446|581613128|FG007|Post Week 12|Withdrawal by Subject|0|||
161060923|NCT00550446|581613129|FG008|Post Week 12|Withdrawal by Subject|0|||
161060924|NCT00550446|581613130|FG009|Post Week 12|Withdrawal by Subject|0|||
161060925|NCT00550446|581613131|FG010|Post Week 12|Withdrawal by Subject|0|||
161060926|NCT00550446|581613121|FG000|Post Week 12|Other|1|||
161060927|NCT00550446|581613122|FG001|Post Week 12|Other|1|||
161060928|NCT00550446|581613123|FG002|Post Week 12|Other|0|||
161060929|NCT00550446|581613124|FG003|Post Week 12|Other|1|||
161060930|NCT00550446|581613125|FG004|Post Week 12|Other|0|||
161060931|NCT00550446|581613126|FG005|Post Week 12|Other|0|||
161060932|NCT00550446|581613127|FG006|Post Week 12|Other|1|||
161281976|NCT03284723|582412875|FG005|Overall Study|Study Terminated By Sponsor|0|||
161281977|NCT03284723|582412876|FG006|Overall Study|Study Terminated By Sponsor|0|||
161281978|NCT03284723|582412877|FG007|Overall Study|Study Terminated By Sponsor|0|||
161281979|NCT03284723|582412878|FG008|Overall Study|Study Terminated By Sponsor|1|||
161281980|NCT03284723|582412879|FG009|Overall Study|Study Terminated By Sponsor|1|||
161281981|NCT03284723|582412880|FG010|Overall Study|Study Terminated By Sponsor|1|||
161281982|NCT03284723|582412881|FG011|Overall Study|Study Terminated By Sponsor|1|||
161281983|NCT03284723|582412870|FG000|Overall Study|Withdrawal by Subject|0|||
161281984|NCT03284723|582412871|FG001|Overall Study|Withdrawal by Subject|0|||
161281985|NCT03284723|582412872|FG002|Overall Study|Withdrawal by Subject|0|||
161281986|NCT03284723|582412873|FG003|Overall Study|Withdrawal by Subject|0|||
161281987|NCT03284723|582412874|FG004|Overall Study|Withdrawal by Subject|5|||
161060933|NCT00550446|581613128|FG007|Post Week 12|Other|0|||
161060934|NCT00550446|581613129|FG008|Post Week 12|Other|1|||
161060935|NCT00550446|581613130|FG009|Post Week 12|Other|1|||
161060936|NCT00550446|581613131|FG010|Post Week 12|Other|0|||
161060937|NCT00025506|581613132|FG000|Overall Study|Ineligible: clerical error|1|||
161060938|NCT00025506|581613132|FG000|Overall Study|Ineligible: wrong cell type|5|||
161060939|NCT00025506|581613132|FG000|Overall Study|Ineligible: inadequate pathology|2|||
161060940|NCT00025506|581613132|FG000|Overall Study|Never Treated|2|||
161060941|NCT03891641|581613140|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
161060942|NCT03891641|581613141|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
161060943|NCT00578318|581613142|FG000|Overall Study|Lost to Follow-up|2|||
161060944|NCT00578318|581613143|FG001|Overall Study|Lost to Follow-up|0|||
161060945|NCT00578318|581613142|FG000|Overall Study|Physician Decision|1|||
161060946|NCT00578318|581613143|FG001|Overall Study|Physician Decision|0|||
161060947|NCT00920699|581613151|FG000|Overall Study|Withdrawal by Subject|2|||
161060948|NCT00920699|581613152|FG001|Overall Study|Withdrawal by Subject|0|||
161060949|NCT00920699|581613153|FG002|Overall Study|Withdrawal by Subject|2|||
161060950|NCT00920699|581613151|FG000|Overall Study|no longer met eligibility|0|||
161060951|NCT00920699|581613152|FG001|Overall Study|no longer met eligibility|1|||
161060952|NCT00920699|581613153|FG002|Overall Study|no longer met eligibility|0|||
161060953|NCT00920699|581613151|FG000|Overall Study|Lost to Follow-up|0|||
161060954|NCT00920699|581613152|FG001|Overall Study|Lost to Follow-up|0|||
161060955|NCT00920699|581613153|FG002|Overall Study|Lost to Follow-up|2|||
161060956|NCT00001941|581613155|FG000|Overall Study|not treated- rapidly progressing disease|0|||
161060957|NCT00001941|581613156|FG001|Overall Study|not treated- rapidly progressing disease|0|||
161060958|NCT00001941|581613157|FG002|Overall Study|not treated- rapidly progressing disease|0|||
161060959|NCT00001941|581613158|FG003|Overall Study|not treated- rapidly progressing disease|0|||
161060960|NCT00001941|581613159|FG004|Overall Study|not treated- rapidly progressing disease|1|||
161060961|NCT02287883|581613160|FG000|Overall Study|Death|8|||
161060962|NCT02287883|581613161|FG001|Overall Study|Death|7|||
161060963|NCT02287883|581613160|FG000|Overall Study|No longer eligible|222|||
161060964|NCT02287883|581613161|FG001|Overall Study|No longer eligible|182|||
161060965|NCT02287883|581613160|FG000|Overall Study|Non-response to survey|229|||
161060966|NCT02287883|581613161|FG001|Overall Study|Non-response to survey|237|||
161060967|NCT01281917|581613165|FG000|Overall Study|Withdrawal by Subject|1|||
161060968|NCT00510146|581613166|FG000|Double-Blind Treatment|Adverse Event|30|||
161060969|NCT00510146|581613167|FG001|Double-Blind Treatment|Adverse Event|13|||
161060970|NCT00510146|581613166|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
161060971|NCT00510146|581613167|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
161060972|NCT00510146|581613166|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
161060973|NCT00510146|581613167|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
161060974|NCT00510146|581613166|FG000|Double-Blind Treatment|Physician Decision|6|||
161060975|NCT00510146|581613167|FG001|Double-Blind Treatment|Physician Decision|0|||
161060976|NCT00510146|581613166|FG000|Double-Blind Treatment|Protocol Violation|1|||
161060977|NCT00510146|581613167|FG001|Double-Blind Treatment|Protocol Violation|2|||
161060978|NCT00510146|581613166|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
161060979|NCT00510146|581613167|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
161060980|NCT00510146|581613166|FG000|Double-Blind Treatment|Clinical Relapse|0|||
161060981|NCT00510146|581613167|FG001|Double-Blind Treatment|Clinical Relapse|1|||
161060982|NCT00510146|581613166|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
161060983|NCT00510146|581613167|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
161060984|NCT00510146|581613166|FG000|Open-Label Treatment|Adverse Event|22|||
161153644|NCT00028002|581943914|FG000|Overall Study|Withdrawal by Subject|3|||
161153645|NCT00028002|581943914|FG000|Overall Study|Ineligible|8|||
161153646|NCT02750800|581943918|FG000|Overall Study|Adverse Event|18|||
161153647|NCT02750800|581943918|FG000|Overall Study|Lost to Follow-up|12|||
161153648|NCT02750800|581943918|FG000|Overall Study|Investigator decision|53|||
161153649|NCT02750800|581943918|FG000|Overall Study|Patient request|12|||
161153650|NCT02750800|581943918|FG000|Overall Study|Other, not specified|3|||
161153651|NCT00879814|581943919|FG000|Overall Study|Adverse Event|0|||
161153652|NCT00879814|581943920|FG001|Overall Study|Adverse Event|1|||
161153653|NCT00879814|581943921|FG002|Overall Study|Adverse Event|0|||
161153654|NCT00879814|581943922|FG003|Overall Study|Adverse Event|0|||
161153655|NCT00879814|581943919|FG000|Overall Study|Lost to Follow-up|1|||
161153656|NCT00879814|581943920|FG001|Overall Study|Lost to Follow-up|0|||
161153657|NCT00879814|581943921|FG002|Overall Study|Lost to Follow-up|0|||
161153658|NCT00879814|581943922|FG003|Overall Study|Lost to Follow-up|2|||
161153659|NCT00879814|581943919|FG000|Overall Study|Participant Failed to Return|0|||
161153660|NCT00879814|581943920|FG001|Overall Study|Participant Failed to Return|0|||
161153661|NCT00879814|581943921|FG002|Overall Study|Participant Failed to Return|0|||
161153662|NCT00879814|581943922|FG003|Overall Study|Participant Failed to Return|1|||
161153663|NCT00879814|581943919|FG000|Overall Study|Withdrawal by Subject|3|||
161153664|NCT00879814|581943920|FG001|Overall Study|Withdrawal by Subject|1|||
161153665|NCT00879814|581943921|FG002|Overall Study|Withdrawal by Subject|1|||
161153666|NCT00879814|581943922|FG003|Overall Study|Withdrawal by Subject|2|||
161153667|NCT00879814|581943919|FG000|Overall Study|Physician Decision|0|||
161153668|NCT00879814|581943920|FG001|Overall Study|Physician Decision|0|||
161153669|NCT00879814|581943921|FG002|Overall Study|Physician Decision|1|||
161153670|NCT00879814|581943922|FG003|Overall Study|Physician Decision|0|||
161153671|NCT00879814|581943919|FG000|Overall Study|Other|0|||
161345277|NCT03980223|582648915|FG001|Overall Study|Physician Decision|0|||
161153672|NCT00879814|581943920|FG001|Overall Study|Other|0|||
161060985|NCT00510146|581613167|FG001|Open-Label Treatment|Adverse Event|8|||
161060986|NCT00510146|581613166|FG000|Open-Label Treatment|Death|1|||
161060987|NCT00510146|581613167|FG001|Open-Label Treatment|Death|1|||
161060988|NCT00510146|581613166|FG000|Open-Label Treatment|Lack of Efficacy|4|||
161060989|NCT00510146|581613167|FG001|Open-Label Treatment|Lack of Efficacy|0|||
161060990|NCT00510146|581613166|FG000|Open-Label Treatment|Lost to Follow-up|10|||
161060991|NCT00510146|581613167|FG001|Open-Label Treatment|Lost to Follow-up|1|||
161060992|NCT00510146|581613166|FG000|Open-Label Treatment|Physician Decision|3|||
161060993|NCT00510146|581613167|FG001|Open-Label Treatment|Physician Decision|1|||
161060994|NCT00510146|581613166|FG000|Open-Label Treatment|Protocol Violation|4|||
161060995|NCT00510146|581613167|FG001|Open-Label Treatment|Protocol Violation|2|||
161060996|NCT00510146|581613166|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
161153673|NCT00879814|581943921|FG002|Overall Study|Other|1|||
161153674|NCT00879814|581943922|FG003|Overall Study|Other|0|||
161153675|NCT00972478|581943923|FG000|Overall Study|Adverse Event|3|||
161060997|NCT00510146|581613167|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
161060998|NCT00510146|581613166|FG000|Open-Label Treatment|Clinical Relapse|1|||
161060999|NCT00510146|581613167|FG001|Open-Label Treatment|Clinical Relapse|1|||
161061000|NCT00510146|581613166|FG000|Open-Label Treatment|Sponsor Decision|2|||
161061001|NCT00510146|581613167|FG001|Open-Label Treatment|Sponsor Decision|0|||
161061002|NCT04947436|581613169|FG000|Overall Study|Lost to Follow-up|3|||
161061003|NCT04947436|581613170|FG001|Overall Study|Lost to Follow-up|7|||
161061004|NCT04947436|581613171|FG002|Overall Study|Lost to Follow-up|5|||
161061005|NCT04947436|581613169|FG000|Overall Study|Death|1|||
161061006|NCT04947436|581613170|FG001|Overall Study|Death|1|||
161061007|NCT04947436|581613171|FG002|Overall Study|Death|1|||
161061008|NCT01544309|581613174|FG000|Overall Study|Withdrawal by Subject|12|||
161061009|NCT01544309|581613175|FG001|Overall Study|Withdrawal by Subject|7|||
161061010|NCT01544309|581613174|FG000|Overall Study|Protocol Violation|2|||
161061011|NCT01544309|581613175|FG001|Overall Study|Protocol Violation|1|||
161153676|NCT00972478|581943924|FG001|Overall Study|Adverse Event|16|||
161153677|NCT00972478|581943923|FG000|Overall Study|Withdrawal by Subject|1|||
161153678|NCT00972478|581943924|FG001|Overall Study|Withdrawal by Subject|8|||
161153679|NCT00972478|581943923|FG000|Overall Study|Progression/Relapse|0|||
161153680|NCT00972478|581943924|FG001|Overall Study|Progression/Relapse|2|||
161153681|NCT00972478|581943923|FG000|Overall Study|Death|0|||
161153682|NCT00972478|581943924|FG001|Overall Study|Death|2|||
161153683|NCT00972478|581943923|FG000|Overall Study|Not protocol specified|1|||
161153684|NCT00972478|581943924|FG001|Overall Study|Not protocol specified|1|||
161153685|NCT00972478|581943923|FG000|Overall Study|Ineligible|1|||
161061012|NCT01544309|581613174|FG000|Overall Study|Physician Decision|4|||
161061013|NCT01544309|581613175|FG001|Overall Study|Physician Decision|1|||
161061014|NCT01544309|581613174|FG000|Overall Study|Not performed pre-dose examination|1|||
161061015|NCT01544309|581613175|FG001|Overall Study|Not performed pre-dose examination|2|||
161061016|NCT01544309|581613174|FG000|Overall Study|Administered prohibit prior medication|1|||
161061017|NCT01544309|581613175|FG001|Overall Study|Administered prohibit prior medication|0|||
161061018|NCT01196741|581613176|FG000|Overall Study|Disease progression|34|||
161061019|NCT01196741|581613177|FG001|Overall Study|Disease progression|14|||
161061020|NCT01196741|581613176|FG000|Overall Study|Adverse Event|10|||
161061021|NCT01196741|581613177|FG001|Overall Study|Adverse Event|6|||
161061022|NCT01196741|581613176|FG000|Overall Study|Serious Adverse Event|3|||
161061023|NCT01196741|581613177|FG001|Overall Study|Serious Adverse Event|1|||
161061024|NCT01196741|581613176|FG000|Overall Study|Dose limiting Adverse Event|2|||
161061025|NCT01196741|581613177|FG001|Overall Study|Dose limiting Adverse Event|1|||
161061026|NCT01196741|581613176|FG000|Overall Study|Withdrawal by Subject|3|||
161061027|NCT01196741|581613177|FG001|Overall Study|Withdrawal by Subject|0|||
161061028|NCT01196741|581613176|FG000|Overall Study|Other reason|3|||
161061029|NCT01196741|581613177|FG001|Overall Study|Other reason|3|||
161061030|NCT01196741|581613176|FG000|Overall Study|Other|3|||
161061031|NCT01196741|581613177|FG001|Overall Study|Other|2|||
161061032|NCT01196741|581613176|FG000|Overall Study|Protocol Violation|2|||
161061033|NCT01196741|581613177|FG001|Overall Study|Protocol Violation|1|||
161061034|NCT01592383|581613178|FG000|Overall Study|Adverse Event|1|||
161061035|NCT04582864|581613179|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
161061036|NCT04582864|581613179|FG000|Overall Study|Death|1|||
161061037|NCT03640754|581613180|FG000|Overall Study|Withdrawal by Subject|1|||
161061038|NCT03640754|581613181|FG001|Overall Study|Withdrawal by Subject|0|||
161061039|NCT03640754|581613180|FG000|Overall Study|Lost to Follow-up|0|||
161061040|NCT03640754|581613181|FG001|Overall Study|Lost to Follow-up|1|||
161061041|NCT01679613|581613184|FG000|Overall Study|other than stated above|0|||
161061042|NCT01679613|581613185|FG001|Overall Study|other than stated above|1|||
161061043|NCT01679613|581613186|FG002|Overall Study|other than stated above|2|||
161061044|NCT01679613|581613187|FG003|Overall Study|other than stated above|2|||
161153686|NCT00972478|581943924|FG001|Overall Study|Ineligible|7|||
161153687|NCT00972478|581943923|FG000|Overall Study|Not start protocol treatment|1|||
161153688|NCT00972478|581943924|FG001|Overall Study|Not start protocol treatment|2|||
161153689|NCT02561000|581943925|FG000|Overall Study|Withdrawal by Subject|2|||
161153690|NCT02561000|581943926|FG001|Overall Study|Withdrawal by Subject|3|||
161153691|NCT02561000|581943927|FG002|Overall Study|Withdrawal by Subject|0|||
161061045|NCT04380688|581613189|FG000|Overall Study|Death|2|||
161061046|NCT04380688|581613190|FG001|Overall Study|Death|2|||
161281988|NCT03284723|582412875|FG005|Overall Study|Withdrawal by Subject|3|||
161281989|NCT03284723|582412876|FG006|Overall Study|Withdrawal by Subject|1|||
161281990|NCT03284723|582412877|FG007|Overall Study|Withdrawal by Subject|0|||
161061047|NCT04380688|581613189|FG000|Overall Study|Lost to Follow-up|2|||
161061048|NCT04380688|581613190|FG001|Overall Study|Lost to Follow-up|4|||
161061049|NCT04380688|581613189|FG000|Overall Study|Withdrawal by Subject|3|||
161061050|NCT04380688|581613190|FG001|Overall Study|Withdrawal by Subject|3|||
161061051|NCT00919061|581613191|FG000|Overall Study|Adverse Event|1|||
161061052|NCT00919061|581613191|FG000|Overall Study|Withdrawal by Subject|1|||
161061053|NCT05294328|581613192|FG000|Overall Study|Adverse Event|1|||
161153692|NCT02561000|581943925|FG000|Overall Study|Adverse Event|0|||
161153693|NCT02561000|581943926|FG001|Overall Study|Adverse Event|1|||
161061054|NCT05294328|581613193|FG001|Overall Study|Adverse Event|0|||
161061055|NCT05294328|581613194|FG002|Overall Study|Adverse Event|0|||
161061056|NCT05294328|581613192|FG000|Overall Study|Physician Decision|1|||
161061057|NCT05294328|581613193|FG001|Overall Study|Physician Decision|1|||
161061058|NCT05294328|581613194|FG002|Overall Study|Physician Decision|0|||
161061059|NCT05294328|581613192|FG000|Overall Study|Withdrawal by Subject|0|||
161061060|NCT05294328|581613193|FG001|Overall Study|Withdrawal by Subject|2|||
161061061|NCT05294328|581613194|FG002|Overall Study|Withdrawal by Subject|1|||
161061062|NCT05294328|581613192|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
161061063|NCT05294328|581613193|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
161061064|NCT05294328|581613194|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
161061065|NCT02056873|581613195|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
161061066|NCT02705625|581615301|FG000|Overall Study|Protocol Violation|1|||
161061067|NCT02705625|581615302|FG001|Overall Study|Protocol Violation|0|||
161061068|NCT02705625|581615303|FG002|Overall Study|Protocol Violation|0|||
161061069|NCT02705625|581615301|FG000|Overall Study|Adverse Event|6|||
161061070|NCT02705625|581615302|FG001|Overall Study|Adverse Event|5|||
161061071|NCT02705625|581615303|FG002|Overall Study|Adverse Event|2|||
161061072|NCT02705625|581615301|FG000|Overall Study|Death|0|||
161061073|NCT02705625|581615302|FG001|Overall Study|Death|0|||
161061074|NCT02705625|581615303|FG002|Overall Study|Death|1|||
161061075|NCT02705625|581615301|FG000|Overall Study|Withdrawal by Subject|1|||
161061076|NCT02705625|581615302|FG001|Overall Study|Withdrawal by Subject|4|||
161061077|NCT02705625|581615303|FG002|Overall Study|Withdrawal by Subject|5|||
161061078|NCT02705625|581615301|FG000|Overall Study|Lost to Follow-up|0|||
161061079|NCT02705625|581615302|FG001|Overall Study|Lost to Follow-up|0|||
161061080|NCT02705625|581615303|FG002|Overall Study|Lost to Follow-up|1|||
161061081|NCT02705625|581615301|FG000|Overall Study|Non-compliance|0|||
161061082|NCT02705625|581615302|FG001|Overall Study|Non-compliance|1|||
161061083|NCT02705625|581615303|FG002|Overall Study|Non-compliance|1|||
161061084|NCT02705625|581615301|FG000|Overall Study|Overdosing|0|||
161061085|NCT02705625|581615302|FG001|Overall Study|Overdosing|0|||
161061086|NCT02705625|581615303|FG002|Overall Study|Overdosing|1|||
161061087|NCT00847132|581615305|FG000|Overall Study|Death|1|||
161061088|NCT00847132|581615306|FG001|Overall Study|Death|1|||
161061089|NCT00784147|581615308|FG000|Overall Study|Lost to Follow-up|2|||
161061090|NCT00784147|581615309|FG001|Overall Study|Lost to Follow-up|4|||
161061091|NCT00784147|581615308|FG000|Overall Study|Withdrawal by Subject|1|||
161061092|NCT00784147|581615309|FG001|Overall Study|Withdrawal by Subject|3|||
161061093|NCT00784147|581615308|FG000|Overall Study|Physician Decision|2|||
161061094|NCT00784147|581615309|FG001|Overall Study|Physician Decision|1|||
161061095|NCT00784147|581615308|FG000|Overall Study|Protocol Violation|1|||
161061096|NCT00784147|581615309|FG001|Overall Study|Protocol Violation|1|||
161061097|NCT00784147|581615308|FG000|Overall Study|Death|2|||
161061098|NCT00784147|581615309|FG001|Overall Study|Death|0|||
161061099|NCT01057251|581615310|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
161061100|NCT01057251|581615311|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
161061101|NCT01057251|581615310|FG000|Overall Study|Adverse Event|4|||
161061102|NCT01057251|581615311|FG001|Overall Study|Adverse Event|2|||
161061103|NCT01057251|581615310|FG000|Overall Study|Lack of Efficacy|2|||
161061104|NCT01057251|581615311|FG001|Overall Study|Lack of Efficacy|11|||
161061105|NCT01057251|581615310|FG000|Overall Study|Protocol Violation|6|||
161061106|NCT01057251|581615311|FG001|Overall Study|Protocol Violation|2|||
161061107|NCT01057251|581615310|FG000|Overall Study|Withdrawal by Subject|4|||
161061108|NCT01057251|581615311|FG001|Overall Study|Withdrawal by Subject|5|||
161061109|NCT01057251|581615310|FG000|Overall Study|Lost to Follow-up|7|||
161061110|NCT01057251|581615311|FG001|Overall Study|Lost to Follow-up|6|||
161061111|NCT01057251|581615310|FG000|Overall Study|Other Reason|1|||
161061112|NCT01057251|581615311|FG001|Overall Study|Other Reason|1|||
161061113|NCT03596242|581615313|FG000|Overall Study|Lost to Follow-up|2|||
161061114|NCT03596242|581615314|FG001|Overall Study|Lost to Follow-up|2|||
161061115|NCT04544865|581615315|FG000|Overall Study|Death|0|||
161061116|NCT04544865|581615316|FG001|Overall Study|Death|2|||
161061117|NCT04544865|581615315|FG000|Overall Study|Lost to Follow-up|11|||
161061118|NCT04544865|581615316|FG001|Overall Study|Lost to Follow-up|7|||
161061119|NCT04544865|581615315|FG000|Overall Study|Withdrawal by Subject|0|||
161061120|NCT04544865|581615316|FG001|Overall Study|Withdrawal by Subject|1|||
161061121|NCT04544865|581615315|FG000|Overall Study|Other|0|||
161061122|NCT04544865|581615316|FG001|Overall Study|Other|1|||
161061123|NCT02973802|581615322|FG000|Overall Study|Lost to Follow-up|1|||
161061124|NCT02973802|581615322|FG000|Overall Study|Withdrawal by Subject|1|||
161061125|NCT03357471|581615323|FG000|Overall Study|Adverse Event|1|||
161061126|NCT03357471|581615324|FG001|Overall Study|Adverse Event|0|||
161061127|NCT03357471|581615323|FG000|Overall Study|Lost to Follow-up|1|||
161061128|NCT03357471|581615324|FG001|Overall Study|Lost to Follow-up|0|||
161061129|NCT00706914|581615325|FG000|Overall Study|Lack of Efficacy|0|||
161061130|NCT00706914|581615326|FG001|Overall Study|Lack of Efficacy|1|||
161061131|NCT00706914|581615327|FG002|Overall Study|Lack of Efficacy|0|||
161061132|NCT00706914|581615325|FG000|Overall Study|Lost to Follow-up|1|||
161061133|NCT00706914|581615326|FG001|Overall Study|Lost to Follow-up|0|||
161061134|NCT00706914|581615327|FG002|Overall Study|Lost to Follow-up|0|||
161061135|NCT00706914|581615325|FG000|Overall Study|Adverse Event|2|||
161061136|NCT00706914|581615326|FG001|Overall Study|Adverse Event|2|||
161061137|NCT00706914|581615327|FG002|Overall Study|Adverse Event|0|||
161061138|NCT00706914|581615325|FG000|Overall Study|Protocol Violation|3|||
161061139|NCT00706914|581615326|FG001|Overall Study|Protocol Violation|1|||
161061140|NCT00706914|581615327|FG002|Overall Study|Protocol Violation|1|||
161061141|NCT01850823|581615329|FG000|Overall Study|Early Visit Window|0|||
161061142|NCT01850823|581615330|FG001|Overall Study|Early Visit Window|1|||
161061143|NCT01850823|581615331|FG002|Overall Study|Early Visit Window|4|||
161061144|NCT01850823|581615329|FG000|Overall Study|Enrolled in Error|0|||
161061145|NCT01850823|581615330|FG001|Overall Study|Enrolled in Error|1|||
161061146|NCT01850823|581615331|FG002|Overall Study|Enrolled in Error|2|||
161061147|NCT01850823|581615329|FG000|Overall Study|Lack of Efficacy|1|||
161061148|NCT01850823|581615330|FG001|Overall Study|Lack of Efficacy|0|||
161061149|NCT01850823|581615331|FG002|Overall Study|Lack of Efficacy|0|||
161061150|NCT01850823|581615329|FG000|Overall Study|Lost to Follow-up|0|||
161061151|NCT01850823|581615330|FG001|Overall Study|Lost to Follow-up|0|||
161061152|NCT01850823|581615331|FG002|Overall Study|Lost to Follow-up|1|||
161061153|NCT01850823|581615329|FG000|Overall Study|Restricted Medication|0|||
161061154|NCT01850823|581615330|FG001|Overall Study|Restricted Medication|0|||
161061155|NCT01850823|581615331|FG002|Overall Study|Restricted Medication|2|||
161061156|NCT01850823|581615329|FG000|Overall Study|Significant worstening of SAR|0|||
161061157|NCT01850823|581615330|FG001|Overall Study|Significant worstening of SAR|1|||
161061158|NCT01850823|581615331|FG002|Overall Study|Significant worstening of SAR|0|||
161061159|NCT01850823|581615329|FG000|Overall Study|Withdrawal by Subject|2|||
161061160|NCT01850823|581615330|FG001|Overall Study|Withdrawal by Subject|0|||
161061161|NCT01850823|581615331|FG002|Overall Study|Withdrawal by Subject|1|||
161061162|NCT00988533|581615332|FG000|Overall Study|Lost to Follow-up|3|||
161061163|NCT00913523|581615335|FG000|Overall Study|Withdrawal by Subject|3|||
161061164|NCT00913523|581615336|FG001|Overall Study|Withdrawal by Subject|2|||
161061165|NCT00913523|581615337|FG002|Overall Study|Withdrawal by Subject|2|||
161061166|NCT00913523|581615335|FG000|Overall Study|Lost to Follow-up|1|||
161061167|NCT00913523|581615336|FG001|Overall Study|Lost to Follow-up|1|||
161061168|NCT00913523|581615337|FG002|Overall Study|Lost to Follow-up|1|||
161061169|NCT00913523|581615335|FG000|Overall Study|Adverse Event|1|||
161061170|NCT00913523|581615336|FG001|Overall Study|Adverse Event|0|||
161061171|NCT00913523|581615337|FG002|Overall Study|Adverse Event|0|||
161061172|NCT00913523|581615335|FG000|Overall Study|Protocol Violation|5|||
161061173|NCT00913523|581615336|FG001|Overall Study|Protocol Violation|8|||
161061174|NCT00913523|581615337|FG002|Overall Study|Protocol Violation|8|||
161061175|NCT00913523|581615335|FG000|Overall Study|Pregnancy|1|||
161061176|NCT00913523|581615336|FG001|Overall Study|Pregnancy|3|||
161061177|NCT00913523|581615337|FG002|Overall Study|Pregnancy|0|||
161061178|NCT00913523|581615335|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
161061179|NCT00913523|581615336|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
161061180|NCT00913523|581615337|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
161061181|NCT01649297|581615338|FG000|Overall Study|Adverse Event|5|||
161061182|NCT01649297|581615339|FG001|Overall Study|Adverse Event|5|||
161061183|NCT01649297|581615340|FG002|Overall Study|Adverse Event|4|||
161061184|NCT01649297|581615341|FG003|Overall Study|Adverse Event|13|||
161061185|NCT01649297|581615342|FG004|Overall Study|Adverse Event|1|||
161061186|NCT01649297|581615338|FG000|Overall Study|Lack of Efficacy|0|||
161061187|NCT01649297|581615339|FG001|Overall Study|Lack of Efficacy|0|||
161061188|NCT01649297|581615340|FG002|Overall Study|Lack of Efficacy|0|||
161061189|NCT01649297|581615341|FG003|Overall Study|Lack of Efficacy|0|||
161061190|NCT01649297|581615342|FG004|Overall Study|Lack of Efficacy|1|||
161061191|NCT01649297|581615338|FG000|Overall Study|Non compliant with Protocol|1|||
161061192|NCT01649297|581615339|FG001|Overall Study|Non compliant with Protocol|0|||
161061193|NCT01649297|581615340|FG002|Overall Study|Non compliant with Protocol|3|||
161061194|NCT01649297|581615341|FG003|Overall Study|Non compliant with Protocol|2|||
161061195|NCT01649297|581615342|FG004|Overall Study|Non compliant with Protocol|1|||
161061196|NCT01649297|581615338|FG000|Overall Study|Lost to Follow-up|1|||
161061197|NCT01649297|581615339|FG001|Overall Study|Lost to Follow-up|1|||
161061198|NCT01649297|581615340|FG002|Overall Study|Lost to Follow-up|4|||
161061199|NCT01649297|581615341|FG003|Overall Study|Lost to Follow-up|3|||
161061200|NCT01649297|581615342|FG004|Overall Study|Lost to Follow-up|0|||
161061201|NCT01649297|581615338|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
161061202|NCT01649297|581615339|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
161061203|NCT01649297|581615340|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
161061204|NCT01649297|581615341|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
161061205|NCT01649297|581615342|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
161061206|NCT01649297|581615338|FG000|Overall Study|For other reason|4|||
161061207|NCT01649297|581615339|FG001|Overall Study|For other reason|1|||
161061208|NCT01649297|581615340|FG002|Overall Study|For other reason|2|||
161061209|NCT01649297|581615341|FG003|Overall Study|For other reason|0|||
161061210|NCT01649297|581615342|FG004|Overall Study|For other reason|0|||
161061211|NCT01685047|581615343|FG000|Overall Study|Withdrawal by Subject|20|||
161061212|NCT01685047|581615343|FG000|Overall Study|Death|26|||
161281991|NCT03284723|582412878|FG008|Overall Study|Withdrawal by Subject|6|||
161281992|NCT03284723|582412879|FG009|Overall Study|Withdrawal by Subject|0|||
161281993|NCT03284723|582412880|FG010|Overall Study|Withdrawal by Subject|3|||
161061213|NCT01685047|581615343|FG000|Overall Study|Lost to Follow-up|8|||
161061214|NCT01685047|581615343|FG000|Overall Study|Physician Decision|25|||
161061215|NCT01685047|581615343|FG000|Overall Study|Adverse Event|5|||
161061216|NCT01685047|581615343|FG000|Overall Study|patient withdrawn by sponsor|1|||
161061217|NCT01202409|581615344|FG000|Overall Study|Adverse Event|1|||
161061218|NCT01202409|581615344|FG000|Overall Study|Ineligible - KRAS mutants|7|||
161061219|NCT01732926|581615347|FG000|Overall Study|Study Terminated by Sponsor|168|||
161061220|NCT01732926|581615348|FG001|Overall Study|Study Terminated by Sponsor|80|||
161061221|NCT01732926|581615347|FG000|Overall Study|Withdrawal by Subject|46|||
161061222|NCT01732926|581615348|FG001|Overall Study|Withdrawal by Subject|8|||
161061223|NCT01732926|581615347|FG000|Overall Study|Physician Decision|24|||
161061224|NCT01732926|581615348|FG001|Overall Study|Physician Decision|11|||
161061225|NCT01732926|581615347|FG000|Overall Study|Other Reason|21|||
161061226|NCT01732926|581615348|FG001|Overall Study|Other Reason|4|||
161061227|NCT01732926|581615347|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
161061228|NCT01732926|581615348|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
161061229|NCT01732926|581615347|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
161061230|NCT01732926|581615348|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
161061231|NCT02544113|581615349|FG000|Overall Study|Death|3|||
161061232|NCT02544113|581615350|FG001|Overall Study|Death|4|||
161061233|NCT02847637|581615354|FG000|Overall Study|Withdrawal by Subject|0|||
161061234|NCT02847637|581615355|FG001|Overall Study|Withdrawal by Subject|1|||
161061235|NCT02847637|581615356|FG002|Overall Study|Withdrawal by Subject|1|||
161061236|NCT02847637|581615357|FG003|Overall Study|Withdrawal by Subject|0|||
161061237|NCT02847637|581615354|FG000|Overall Study|Lost to Follow-up|1|||
161061238|NCT02847637|581615355|FG001|Overall Study|Lost to Follow-up|1|||
161061239|NCT02847637|581615356|FG002|Overall Study|Lost to Follow-up|0|||
161061240|NCT02847637|581615357|FG003|Overall Study|Lost to Follow-up|0|||
161061241|NCT02741713|581615358|FG000|Overall Study|Surgery type changed intra-operatively|2|||
161061242|NCT02741713|581615359|FG001|Overall Study|Surgery type changed intra-operatively|1|||
161061243|NCT00496626|581615360|FG000|Overall Study|Lost to Follow-up|0|||
161061244|NCT00496626|581615361|FG001|Overall Study|Lost to Follow-up|1|||
161061245|NCT00496626|581615360|FG000|Overall Study|Protocol Violation|1|||
161061246|NCT00496626|581615361|FG001|Overall Study|Protocol Violation|0|||
161061247|NCT00496626|581615360|FG000|Overall Study|Withdrawal by Subject|5|||
161061248|NCT00496626|581615361|FG001|Overall Study|Withdrawal by Subject|4|||
161061249|NCT00496626|581615360|FG000|Overall Study|Relocated|0|||
161061250|NCT00496626|581615361|FG001|Overall Study|Relocated|1|||
161061251|NCT04191148|581615364|FG000|Overall Study|Withdrawal by Subject|1|||
161061252|NCT04191148|581615365|FG001|Overall Study|Withdrawal by Subject|0|||
161061253|NCT04191148|581615364|FG000|Overall Study|Adverse Event|1|||
161061254|NCT04191148|581615365|FG001|Overall Study|Adverse Event|0|||
161061255|NCT02647788|581615366|FG000|Overall Study|Lost to Follow-up|13|||
161061256|NCT02647788|581615367|FG001|Overall Study|Lost to Follow-up|11|||
161061257|NCT02647788|581615366|FG000|Overall Study|Did not want opiate|0|||
161061258|NCT02647788|581615367|FG001|Overall Study|Did not want opiate|1|||
161061259|NCT02647788|581615366|FG000|Overall Study|Withdrawal by Subject|1|||
161061260|NCT02647788|581615367|FG001|Overall Study|Withdrawal by Subject|0|||
161061261|NCT02647788|581615366|FG000|Overall Study|Felt itchy with assigned medication|1|||
161061262|NCT02647788|581615367|FG001|Overall Study|Felt itchy with assigned medication|0|||
161061263|NCT02647788|581615366|FG000|Overall Study|Felt nauseous with assigned medication|1|||
161061264|NCT02647788|581615367|FG001|Overall Study|Felt nauseous with assigned medication|1|||
161061265|NCT01274559|581615368|FG000|Overall Study|Adverse Event|57|||
161061266|NCT01274559|581615369|FG001|Overall Study|Adverse Event|13|||
161061267|NCT01274559|581615368|FG000|Overall Study|Death|1|||
161061268|NCT01274559|581615369|FG001|Overall Study|Death|1|||
161061269|NCT01274559|581615368|FG000|Overall Study|Lost to Follow-up|3|||
161061270|NCT01274559|581615369|FG001|Overall Study|Lost to Follow-up|3|||
161061271|NCT01274559|581615368|FG000|Overall Study|Non-compliance with Study Drug|2|||
161061272|NCT01274559|581615369|FG001|Overall Study|Non-compliance with Study Drug|4|||
161061273|NCT01274559|581615368|FG000|Overall Study|Physician Decision|2|||
161061274|NCT01274559|581615369|FG001|Overall Study|Physician Decision|1|||
161061275|NCT01274559|581615368|FG000|Overall Study|Protocol Violation|28|||
161061276|NCT01274559|581615369|FG001|Overall Study|Protocol Violation|23|||
161061277|NCT01274559|581615368|FG000|Overall Study|Study Terminated by Sponsor|79|||
161061278|NCT01274559|581615369|FG001|Overall Study|Study Terminated by Sponsor|87|||
161281994|NCT03284723|582412881|FG011|Overall Study|Withdrawal by Subject|1|||
161281995|NCT03284723|582412870|FG000|Overall Study|Other|1|||
161061279|NCT01274559|581615368|FG000|Overall Study|Withdrawal by Subject|25|||
161061280|NCT01274559|581615369|FG001|Overall Study|Withdrawal by Subject|13|||
161061281|NCT01233999|581615370|FG000|Overall Study|Withdrawal by Subject|1|||
161061282|NCT01233999|581615370|FG000|Overall Study|Lost to Follow-up|1|||
161281996|NCT03284723|582412871|FG001|Overall Study|Other|0|||
161061283|NCT02835092|581615371|FG000|Overall Study|Withdrawal by Subject|3|||
161281997|NCT03284723|582412872|FG002|Overall Study|Other|1|||
161061284|NCT02835092|581615372|FG001|Overall Study|Withdrawal by Subject|6|||
161061285|NCT02835092|581615373|FG002|Overall Study|Withdrawal by Subject|3|||
161061286|NCT02835092|581615371|FG000|Overall Study|Lost to Follow-up|0|||
161061287|NCT02835092|581615372|FG001|Overall Study|Lost to Follow-up|2|||
161061288|NCT02835092|581615373|FG002|Overall Study|Lost to Follow-up|0|||
161061289|NCT01321723|581615374|FG000|Overall Study|Adverse Event|3|||
161061290|NCT01321723|581615375|FG001|Overall Study|Adverse Event|5|||
161061291|NCT01321723|581615376|FG002|Overall Study|Adverse Event|2|||
161061292|NCT01321723|581615374|FG000|Overall Study|Withdrawal by Subject|2|||
161061293|NCT01321723|581615375|FG001|Overall Study|Withdrawal by Subject|0|||
161061294|NCT01321723|581615376|FG002|Overall Study|Withdrawal by Subject|2|||
161061295|NCT02246218|581615377|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161061296|NCT02246218|581615378|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161061297|NCT02246218|581615377|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
161061298|NCT02246218|581615378|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
161061299|NCT02246218|581615377|FG000|Overall Study|Adverse Event|1|||
161061300|NCT02246218|581615378|FG001|Overall Study|Adverse Event|1|||
161061301|NCT02246218|581615377|FG000|Overall Study|Lost to Follow-up|1|||
161061302|NCT02246218|581615378|FG001|Overall Study|Lost to Follow-up|0|||
161061303|NCT01322009|581615379|FG000|Overall Study|Death|0|||
161061304|NCT01322009|581615380|FG001|Overall Study|Death|1|||
161061305|NCT01322009|581615379|FG000|Overall Study|Adverse Event|0|||
161061306|NCT01322009|581615380|FG001|Overall Study|Adverse Event|1|||
161061307|NCT01322009|581615379|FG000|Overall Study|ng tube discontinued|0|||
161061308|NCT01322009|581615380|FG001|Overall Study|ng tube discontinued|1|||
161061309|NCT01657877|581615381|FG000|Overall Study|Withdrawal by Subject|4|||
161061310|NCT01657877|581615381|FG000|Overall Study|Protocol Violation|6|||
161061311|NCT01657877|581615381|FG000|Overall Study|Adverse Event|2|||
161061312|NCT01657877|581615381|FG000|Overall Study|Other Reason|2|||
161061313|NCT00905034|581615382|FG000|Overall Study|Withdrawal by Subject|1|||
161061314|NCT03409731|581615383|FG000|Overall Study|Withdrawal by Subject|17|||
161061315|NCT03409731|581615383|FG000|Overall Study|Death|4|||
161061316|NCT01710800|581615386|FG000|Overall Study|Withdrawal by Subject|21|||
161061317|NCT01710800|581615386|FG000|Overall Study|Protocol Violation|1|||
161061318|NCT01585298|581615390|FG000|Overall Study|Study completion was not documented.|1|||
161061319|NCT01585298|581615390|FG000|Overall Study|Protocol deviation|1|||
161061320|NCT01585298|581615390|FG000|Overall Study|Administrative problems|4|||
161061321|NCT01585298|581615390|FG000|Overall Study|Lost to Follow-up|2|||
161061322|NCT01585298|581615390|FG000|Overall Study|Withdrawal by Subject|4|||
161061323|NCT01585298|581615390|FG000|Overall Study|Abnormal test procedure results|1|||
161061324|NCT01585298|581615390|FG000|Overall Study|Adverse Event|24|||
161061325|NCT01670188|581615391|FG000|Overall Study|Death|0|||
161061326|NCT01670188|581615392|FG001|Overall Study|Death|1|||
161061327|NCT02427958|581615397|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
161061328|NCT02427958|581615397|FG000|Overall Study|Lost to Follow-up|6|||
161061329|NCT02427958|581615397|FG000|Overall Study|Withdrawal by Subject|14|||
161061330|NCT02427958|581615397|FG000|Overall Study|Lack of Efficacy|1|||
161061331|NCT02025985|581615398|FG000|Overall Study|Consent withdrawn|0|||
161061332|NCT02025985|581615399|FG001|Overall Study|Consent withdrawn|0|||
161061333|NCT02025985|581615400|FG002|Overall Study|Consent withdrawn|1|||
161061334|NCT02025985|581615401|FG003|Overall Study|Consent withdrawn|0|||
161061335|NCT02025985|581615402|FG004|Overall Study|Consent withdrawn|0|||
161061336|NCT02025985|581615398|FG000|Overall Study|Termination of study by Sponsor|4|||
161061337|NCT02025985|581615399|FG001|Overall Study|Termination of study by Sponsor|3|||
161061338|NCT02025985|581615400|FG002|Overall Study|Termination of study by Sponsor|1|||
161061339|NCT02025985|581615401|FG003|Overall Study|Termination of study by Sponsor|1|||
161061340|NCT02025985|581615402|FG004|Overall Study|Termination of study by Sponsor|3|||
161061341|NCT02025985|581615398|FG000|Overall Study|Death|21|||
161061342|NCT02025985|581615399|FG001|Overall Study|Death|20|||
161061343|NCT02025985|581615400|FG002|Overall Study|Death|23|||
161281998|NCT03284723|582412873|FG003|Overall Study|Other|0|||
161281999|NCT03284723|582412874|FG004|Overall Study|Other|1|||
161282000|NCT03284723|582412875|FG005|Overall Study|Other|0|||
161282001|NCT03284723|582412876|FG006|Overall Study|Other|0|||
161282002|NCT03284723|582412877|FG007|Overall Study|Other|0|||
161061344|NCT02025985|581615401|FG003|Overall Study|Death|20|||
161061345|NCT02025985|581615402|FG004|Overall Study|Death|17|||
161061346|NCT00607997|581615403|FG000|Overall Study|Lack of Efficacy|6|||
161061347|NCT00607997|581615404|FG001|Overall Study|Lack of Efficacy|20|||
161061348|NCT00607997|581615405|FG002|Overall Study|Lack of Efficacy|14|||
161061349|NCT00607997|581615406|FG003|Overall Study|Lack of Efficacy|10|||
161061350|NCT00607997|581615403|FG000|Overall Study|Death|8|||
161061351|NCT00607997|581615404|FG001|Overall Study|Death|5|||
161061352|NCT00607997|581615405|FG002|Overall Study|Death|2|||
161061353|NCT00607997|581615406|FG003|Overall Study|Death|5|||
161282003|NCT03284723|582412878|FG008|Overall Study|Other|0|||
161061354|NCT00607997|581615403|FG000|Overall Study|Adverse Event|3|||
161061355|NCT00607997|581615404|FG001|Overall Study|Adverse Event|1|||
161282004|NCT03284723|582412879|FG009|Overall Study|Other|0|||
161282005|NCT03284723|582412880|FG010|Overall Study|Other|1|||
161282006|NCT03284723|582412881|FG011|Overall Study|Other|0|||
161061356|NCT00607997|581615405|FG002|Overall Study|Adverse Event|2|||
161061357|NCT00607997|581615406|FG003|Overall Study|Adverse Event|0|||
161061358|NCT00607997|581615403|FG000|Overall Study|Physician Decision|4|||
161061359|NCT00607997|581615404|FG001|Overall Study|Physician Decision|1|||
161061360|NCT00607997|581615405|FG002|Overall Study|Physician Decision|0|||
161061361|NCT00607997|581615406|FG003|Overall Study|Physician Decision|0|||
161061362|NCT00607997|581615403|FG000|Overall Study|Relapse, recurrent illness|4|||
161061363|NCT00607997|581615404|FG001|Overall Study|Relapse, recurrent illness|0|||
161061364|NCT00607997|581615405|FG002|Overall Study|Relapse, recurrent illness|2|||
161061365|NCT00607997|581615406|FG003|Overall Study|Relapse, recurrent illness|0|||
161061366|NCT00607997|581615403|FG000|Overall Study|Other without explanation|2|||
161061367|NCT00607997|581615404|FG001|Overall Study|Other without explanation|0|||
161061368|NCT00607997|581615405|FG002|Overall Study|Other without explanation|4|||
161061369|NCT00607997|581615406|FG003|Overall Study|Other without explanation|1|||
161061370|NCT01242371|581615407|FG000|Overall Study|Withdrawal by Subject|2|||
161061371|NCT01242371|581615408|FG001|Overall Study|Withdrawal by Subject|2|||
161061372|NCT01242371|581615407|FG000|Overall Study|Protocol Violation|0|||
161061373|NCT01242371|581615408|FG001|Overall Study|Protocol Violation|3|||
161061374|NCT06080438|581615411|FG000|Overall Study|Lost to Follow-up|2|||
161061375|NCT03589300|581615412|FG000|Overall Study|Adverse Event|2|||
161061376|NCT03589300|581615412|FG000|Overall Study|Death|4|||
161061377|NCT03589300|581615412|FG000|Overall Study|Lost to Follow-up|12|||
161061378|NCT03589300|581615412|FG000|Overall Study|Withdrawal by Subject|5|||
161061379|NCT01527500|581615413|FG000|Part A|Administrative|11|||
161061380|NCT01527500|581615414|FG001|Part A|Administrative|7|||
161061381|NCT01527500|581615413|FG000|Part A|Adverse Event|4|||
161061382|NCT01527500|581615414|FG001|Part A|Adverse Event|2|||
161061383|NCT01527500|581615413|FG000|Part A|Death|4|||
161061384|NCT01527500|581615414|FG001|Part A|Death|1|||
161061385|NCT01527500|581615413|FG000|Part A|Lost to Follow-up|0|||
161061386|NCT01527500|581615414|FG001|Part A|Lost to Follow-up|1|||
161061387|NCT01527500|581615413|FG000|Part A|Protocol Deviation|9|||
161061388|NCT01527500|581615414|FG001|Part A|Protocol Deviation|2|||
161061389|NCT01527500|581615413|FG000|Part A|Withdrawal by Subject|2|||
161061390|NCT01527500|581615414|FG001|Part A|Withdrawal by Subject|0|||
161061391|NCT01527500|581615413|FG000|Part B|Adverse Event|1|||
161061392|NCT01527500|581615414|FG001|Part B|Adverse Event|0|||
161061393|NCT00372255|581615415|FG000|Overall Study|Withdrawn for other reasons|2|||
161061394|NCT00372255|581615416|FG001|Overall Study|Withdrawn for other reasons|1|||
161061395|NCT00776984|581615417|FG000|Overall Study|Adverse Event|8|||
161061396|NCT00776984|581615418|FG001|Overall Study|Adverse Event|2|||
161061397|NCT00776984|581615417|FG000|Overall Study|Protocol Violation|4|||
161061398|NCT00776984|581615418|FG001|Overall Study|Protocol Violation|2|||
161061399|NCT00776984|581615417|FG000|Overall Study|Lost to Follow-up|2|||
161061400|NCT00776984|581615418|FG001|Overall Study|Lost to Follow-up|0|||
161061401|NCT00776984|581615417|FG000|Overall Study|Withdrawal by Subject|12|||
161061402|NCT00776984|581615418|FG001|Overall Study|Withdrawal by Subject|7|||
161061403|NCT00776984|581615417|FG000|Overall Study|Lack of Efficacy|0|||
161061404|NCT00776984|581615418|FG001|Overall Study|Lack of Efficacy|1|||
161061405|NCT00776984|581615417|FG000|Overall Study|Other|5|||
161061406|NCT00776984|581615418|FG001|Overall Study|Other|9|||
161153694|NCT02561000|581943927|FG002|Overall Study|Adverse Event|0|||
161282007|NCT03284723|582412870|FG000|Overall Study|Adverse Event|0|||
161282008|NCT03284723|582412871|FG001|Overall Study|Adverse Event|0|||
161282009|NCT03284723|582412872|FG002|Overall Study|Adverse Event|0|||
161061407|NCT02573883|581615424|FG000|Six Month Follow Up|Lost to Follow-up|1|||
161061408|NCT02573883|581615425|FG001|Six Month Follow Up|Lost to Follow-up|0|||
161061409|NCT02573883|581615426|FG002|Six Month Follow Up|Lost to Follow-up|0|||
161061410|NCT02573883|581615427|FG003|Six Month Follow Up|Lost to Follow-up|0|||
161061411|NCT02573883|581615424|FG000|One Year Follow Up|Lost to Follow-up|2|||
161061412|NCT02573883|581615425|FG001|One Year Follow Up|Lost to Follow-up|1|||
161153695|NCT03430245|581943928|FG000|Overall Study|Withdrawal by Subject|6|||
161282010|NCT03284723|582412873|FG003|Overall Study|Adverse Event|0|||
161282011|NCT03284723|582412874|FG004|Overall Study|Adverse Event|0|||
161061413|NCT02573883|581615426|FG002|One Year Follow Up|Lost to Follow-up|0|||
161061414|NCT02573883|581615427|FG003|One Year Follow Up|Lost to Follow-up|0|||
161061415|NCT00582114|581615428|FG000|Overall Study|Death|4|||
161061416|NCT00582114|581615429|FG001|Overall Study|Death|4|||
161061417|NCT00582114|581615428|FG000|Overall Study|Kidney Transplant|3|||
161061418|NCT00582114|581615429|FG001|Overall Study|Kidney Transplant|1|||
161061419|NCT00582114|581615428|FG000|Overall Study|Lost to Follow-up|7|||
161061420|NCT00582114|581615429|FG001|Overall Study|Lost to Follow-up|6|||
161061421|NCT00582114|581615428|FG000|Overall Study|Withdrawal by Subject|8|||
161061422|NCT00582114|581615429|FG001|Overall Study|Withdrawal by Subject|16|||
161061423|NCT00582114|581615428|FG000|Overall Study|Adverse Event|1|||
161061424|NCT00582114|581615429|FG001|Overall Study|Adverse Event|1|||
161061425|NCT00582114|581615428|FG000|Overall Study|Physician Decision|0|||
161061426|NCT00582114|581615429|FG001|Overall Study|Physician Decision|6|||
161282012|NCT03284723|582412875|FG005|Overall Study|Adverse Event|0|||
161061427|NCT00582114|581615428|FG000|Overall Study|Stopped by data safety monitoring board|19|||
161061428|NCT00582114|581615429|FG001|Overall Study|Stopped by data safety monitoring board|20|||
161061429|NCT00130728|581615437|FG000|Overall Study|Death|258|||
161282013|NCT03284723|582412876|FG006|Overall Study|Adverse Event|0|||
161282014|NCT03284723|582412877|FG007|Overall Study|Adverse Event|0|||
161282015|NCT03284723|582412878|FG008|Overall Study|Adverse Event|1|||
161282016|NCT03284723|582412879|FG009|Overall Study|Adverse Event|0|||
161282017|NCT03284723|582412880|FG010|Overall Study|Adverse Event|0|||
161282018|NCT03284723|582412881|FG011|Overall Study|Adverse Event|0|||
161282019|NCT00064987|582412886|FG000|Overall Study|Physician Decision|3|||
161282020|NCT00064987|582412887|FG001|Overall Study|Physician Decision|0|||
161282021|NCT01499095|582412888|FG000|Overall Study|Randomized But Not Treated|1|||
161282022|NCT01499095|582412889|FG001|Overall Study|Randomized But Not Treated|1|||
161282023|NCT01499095|582412888|FG000|Overall Study|Adverse Event|12|||
161282024|NCT01499095|582412889|FG001|Overall Study|Adverse Event|7|||
161282025|NCT01499095|582412888|FG000|Overall Study|Lack of Efficacy|2|||
161282026|NCT01499095|582412889|FG001|Overall Study|Lack of Efficacy|1|||
161282027|NCT01499095|582412888|FG000|Overall Study|Protocol Violation|6|||
161282028|NCT01499095|582412889|FG001|Overall Study|Protocol Violation|7|||
161282029|NCT01499095|582412888|FG000|Overall Study|Received Rescue Therapy|32|||
161282030|NCT01499095|582412889|FG001|Overall Study|Received Rescue Therapy|40|||
161282031|NCT01499095|582412888|FG000|Overall Study|Diverse Reasons|22|||
161282032|NCT01499095|582412889|FG001|Overall Study|Diverse Reasons|25|||
161282033|NCT01499095|582412888|FG000|Overall Study|Lost to Follow-up|6|||
161282034|NCT01499095|582412889|FG001|Overall Study|Lost to Follow-up|4|||
161282035|NCT01499095|582412888|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
161282036|NCT01499095|582412889|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
161282037|NCT01499095|582412888|FG000|Overall Study|Hypoglycemia|3|||
161282038|NCT01499095|582412889|FG001|Overall Study|Hypoglycemia|1|||
161282039|NCT01499095|582412888|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
161282040|NCT01499095|582412889|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
161282041|NCT01499095|582412888|FG000|Overall Study|Change in Injection Schedule|2|||
161282042|NCT01499095|582412889|FG001|Overall Study|Change in Injection Schedule|0|||
161282043|NCT01499095|582412888|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161282044|NCT01499095|582412889|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161282045|NCT01368497|582412890|FG000|Overall Study|Lost to Follow-up|2|||
161282046|NCT00443729|582412894|FG000|Overall Study|Never Treated|0|||
161282047|NCT00443729|582412895|FG001|Overall Study|Never Treated|1|||
161282048|NCT00443729|582412894|FG000|Overall Study|Lack of Efficacy|4|||
161282049|NCT00443729|582412895|FG001|Overall Study|Lack of Efficacy|2|||
161282050|NCT00443729|582412894|FG000|Overall Study|Lost to Follow-up|0|||
161282051|NCT00443729|582412895|FG001|Overall Study|Lost to Follow-up|1|||
161282052|NCT00443729|582412894|FG000|Overall Study|Physician Decision|2|||
161282053|NCT00443729|582412895|FG001|Overall Study|Physician Decision|1|||
161282054|NCT00443729|582412894|FG000|Overall Study|Protocol Violation|1|||
161282055|NCT00443729|582412895|FG001|Overall Study|Protocol Violation|1|||
161282056|NCT00443729|582412894|FG000|Overall Study|Withdrawal by Subject|3|||
161282057|NCT00443729|582412895|FG001|Overall Study|Withdrawal by Subject|1|||
161282058|NCT00782626|582412899|FG000|Overall Study|Adverse Event|1|||
161282059|NCT00782626|582412899|FG000|Overall Study|Progressive Disease|5|||
161282060|NCT00782626|582412899|FG000|Overall Study|Other Complicating Disease|1|||
161282061|NCT00077207|582412902|FG000|Overall Study|Adverse Event|5|||
161282062|NCT00077207|582412902|FG000|Overall Study|Lack of Efficacy|12|||
161282063|NCT00077207|582412902|FG000|Overall Study|Physician Decision|6|||
161282064|NCT00077207|582412902|FG000|Overall Study|Withdrawal by Subject|6|||
161282065|NCT00077207|582412902|FG000|Overall Study|Ineligible|1|||
161282066|NCT03052751|582412905|FG000|Dosing Period 1|Adverse Event|0|||
161282067|NCT03052751|582412906|FG001|Dosing Period 1|Adverse Event|1|||
161282068|NCT03052751|582412907|FG002|Dosing Period 1|Adverse Event|0|||
161282069|NCT03052751|582412908|FG003|Dosing Period 1|Adverse Event|0|||
161282070|NCT03052751|582412909|FG004|Dosing Period 1|Adverse Event|0|||
161282071|NCT03052751|582412910|FG005|Dosing Period 1|Adverse Event|0|||
161282072|NCT03052751|582412905|FG000|Dosing Period 2|Adverse Event|0|||
161282073|NCT03052751|582412906|FG001|Dosing Period 2|Adverse Event|0|||
161282074|NCT03052751|582412907|FG002|Dosing Period 2|Adverse Event|3|||
161282075|NCT03052751|582412908|FG003|Dosing Period 2|Adverse Event|0|||
161282076|NCT03052751|582412909|FG004|Dosing Period 2|Adverse Event|0|||
161282077|NCT03052751|582412910|FG005|Dosing Period 2|Adverse Event|0|||
161282078|NCT03052751|582412905|FG000|Observation Period|Adverse Event|0|||
161282079|NCT03052751|582412906|FG001|Observation Period|Adverse Event|0|||
161345278|NCT03980223|582648916|FG002|Overall Study|Physician Decision|1|||
161282080|NCT03052751|582412907|FG002|Observation Period|Adverse Event|0|||
161345279|NCT03980223|582648917|FG003|Overall Study|Physician Decision|0|||
161061430|NCT00130728|581615438|FG001|Overall Study|Death|258|||
161282081|NCT03052751|582412908|FG003|Observation Period|Adverse Event|0|||
161282082|NCT03052751|582412909|FG004|Observation Period|Adverse Event|1|||
161282083|NCT03052751|582412910|FG005|Observation Period|Adverse Event|0|||
161282084|NCT01427608|582412921|FG000|Overall Study|Death|1|||
161282085|NCT01427608|582412922|FG001|Overall Study|Death|0|||
161061431|NCT00130728|581615437|FG000|Overall Study|Lost to Follow-up|4|||
161061432|NCT00130728|581615438|FG001|Overall Study|Lost to Follow-up|0|||
161282086|NCT01427608|582412921|FG000|Overall Study|Withdrawal by Subject|7|||
161282087|NCT01427608|582412922|FG001|Overall Study|Withdrawal by Subject|3|||
161282088|NCT01427608|582412921|FG000|Overall Study|Relapsed-all cause|13|||
161282089|NCT01427608|582412922|FG001|Overall Study|Relapsed-all cause|34|||
161282090|NCT01427608|582412921|FG000|Overall Study|Events not attributed to study meds|0|||
161282091|NCT01427608|582412922|FG001|Overall Study|Events not attributed to study meds|1|||
161282092|NCT01473407|582412923|FG000|Overall Study|Physician Decision|1|||
161282093|NCT01473407|582412924|FG001|Overall Study|Physician Decision|4|||
161282094|NCT01473407|582412923|FG000|Overall Study|Lost to Follow-up|10|||
161282095|NCT01473407|582412924|FG001|Overall Study|Lost to Follow-up|4|||
161282096|NCT01473407|582412923|FG000|Overall Study|Adverse Event|8|||
161282097|NCT01473407|582412924|FG001|Overall Study|Adverse Event|8|||
161282098|NCT01473407|582412923|FG000|Overall Study|Randomization Error|3|||
161282099|NCT01473407|582412924|FG001|Overall Study|Randomization Error|1|||
161282100|NCT01473407|582412923|FG000|Overall Study|Withdrawal by Subject|4|||
161282101|NCT01473407|582412924|FG001|Overall Study|Withdrawal by Subject|7|||
161282102|NCT01473407|582412923|FG000|Overall Study|Kidney Transplant|7|||
161282103|NCT01473407|582412924|FG001|Overall Study|Kidney Transplant|6|||
161282104|NCT01473407|582412923|FG000|Overall Study|Vacation/Travel|1|||
161282105|NCT01473407|582412924|FG001|Overall Study|Vacation/Travel|1|||
161282106|NCT01473407|582412923|FG000|Overall Study|Elevated Hemoglobin|1|||
161282107|NCT01473407|582412924|FG001|Overall Study|Elevated Hemoglobin|0|||
161282108|NCT01473407|582412923|FG000|Overall Study|Patient Received Aranesp|1|||
161282109|NCT01473407|582412924|FG001|Overall Study|Patient Received Aranesp|0|||
161282110|NCT01473407|582412923|FG000|Overall Study|Patient Lost Green Card Status|1|||
161282111|NCT01473407|582412924|FG001|Overall Study|Patient Lost Green Card Status|0|||
161282112|NCT01473407|582412923|FG000|Overall Study|Temperature Excursion|2|||
161282113|NCT01473407|582412924|FG001|Overall Study|Temperature Excursion|3|||
161282114|NCT01473407|582412923|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
161282115|NCT01473407|582412924|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
161282116|NCT01473407|582412923|FG000|Overall Study|Sponsor's Decision|10|||
161282117|NCT01473407|582412924|FG001|Overall Study|Sponsor's Decision|10|||
161282118|NCT01473407|582412923|FG000|Overall Study|Site Closure|1|||
161282119|NCT01473407|582412924|FG001|Overall Study|Site Closure|0|||
161282120|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
161282121|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
161282122|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
161282123|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
161282124|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
161282125|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
161282126|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161282127|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
161282128|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
161282129|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
161282130|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
161282131|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
161282132|NCT02422797|582412925|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
161282133|NCT02422797|582412926|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
161282134|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
161282135|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
161282136|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
161282137|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
161282138|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
161282139|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
161282140|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
161282141|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
161282142|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
161061433|NCT00130728|581615437|FG000|Overall Study|Withdrawal by Subject|0|||
161061434|NCT00130728|581615438|FG001|Overall Study|Withdrawal by Subject|2|||
161061435|NCT02212197|581615439|FG000|Overall Study|Need for radiotherapy|1|||
161061436|NCT02212197|581615440|FG001|Overall Study|Need for radiotherapy|0|||
161061437|NCT02212197|581615441|FG002|Overall Study|Need for radiotherapy|0|||
161061438|NCT01078584|581615444|FG000|Overall Study|Final Status Unknown|1073|||
161061439|NCT01078584|581615444|FG000|Overall Study|Lost to Follow-up|670|||
161061440|NCT01078584|581615444|FG000|Overall Study|Non-serious Adverse Event|577|||
161061441|NCT01078584|581615444|FG000|Overall Study|Withdrawal of Consent|244|||
161061442|NCT01078584|581615444|FG000|Overall Study|Physician Withdrew from Study|90|||
161061443|NCT01078584|581615444|FG000|Overall Study|Non-compliance|67|||
161153696|NCT03430245|581943928|FG000|Overall Study|Lost to Follow-up|1|||
161282143|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
161282144|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
161282145|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
161282146|NCT02422797|582412925|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
161282147|NCT02422797|582412926|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
161282148|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
161282149|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
161282150|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
161282151|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
161282152|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
161282153|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
161282154|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
161282155|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
161282156|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
161282157|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
161282158|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
161282159|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
161282160|NCT02422797|582412925|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
161282161|NCT02422797|582412926|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
161282162|NCT04071405|582412927|FG000|Overall Study|Protocol Violation|3|||
161282163|NCT01027702|582412932|FG000|Overall Study|Received subsequent therapy|1|||
161282164|NCT01027702|582412933|FG001|Overall Study|Received subsequent therapy|2|||
161282165|NCT01027702|582412934|FG002|Overall Study|Received subsequent therapy|0|||
161282166|NCT01027702|582412935|FG003|Overall Study|Received subsequent therapy|4|||
161282167|NCT01027702|582412936|FG004|Overall Study|Received subsequent therapy|1|||
161282168|NCT01027702|582412937|FG005|Overall Study|Received subsequent therapy|0|||
161282169|NCT01027702|582412938|FG006|Overall Study|Received subsequent therapy|1|||
161282170|NCT01027702|582412932|FG000|Overall Study|Death|0|||
161282171|NCT01027702|582412933|FG001|Overall Study|Death|0|||
161282172|NCT01027702|582412934|FG002|Overall Study|Death|1|||
161282173|NCT01027702|582412935|FG003|Overall Study|Death|0|||
161282174|NCT01027702|582412936|FG004|Overall Study|Death|0|||
161282175|NCT01027702|582412937|FG005|Overall Study|Death|0|||
161282176|NCT01027702|582412938|FG006|Overall Study|Death|0|||
161282177|NCT00403585|582412939|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
161282178|NCT00403585|582412939|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
161282179|NCT00403585|582412939|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
161282180|NCT02604407|582412940|FG000|Overall Study|Adverse Event|0|||
161282181|NCT02604407|582412941|FG001|Overall Study|Adverse Event|7|||
161282182|NCT02604407|582412942|FG002|Overall Study|Adverse Event|5|||
161282183|NCT02604407|582412940|FG000|Overall Study|Protocol Violation|2|||
161282184|NCT02604407|582412941|FG001|Overall Study|Protocol Violation|0|||
161282185|NCT02604407|582412942|FG002|Overall Study|Protocol Violation|0|||
161282186|NCT02604407|582412940|FG000|Overall Study|Withdrawal by Subject|3|||
161282187|NCT02604407|582412941|FG001|Overall Study|Withdrawal by Subject|3|||
161282188|NCT02604407|582412942|FG002|Overall Study|Withdrawal by Subject|5|||
161282189|NCT02604407|582412940|FG000|Overall Study|Lost to Follow-up|2|||
161282190|NCT02604407|582412941|FG001|Overall Study|Lost to Follow-up|1|||
161282191|NCT02604407|582412942|FG002|Overall Study|Lost to Follow-up|2|||
161282192|NCT02604407|582412940|FG000|Overall Study|Lack of Efficacy|1|||
161282193|NCT02604407|582412941|FG001|Overall Study|Lack of Efficacy|0|||
161282194|NCT02604407|582412942|FG002|Overall Study|Lack of Efficacy|0|||
161282195|NCT02604407|582412940|FG000|Overall Study|Other|3|||
161282196|NCT02604407|582412941|FG001|Overall Study|Other|1|||
161282197|NCT02604407|582412942|FG002|Overall Study|Other|4|||
161282198|NCT02862730|582412945|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161282199|NCT02862730|582412946|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161282200|NCT02862730|582412947|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
161282201|NCT02862730|582412948|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161282202|NCT02862730|582412949|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161282203|NCT02862730|582412950|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161282204|NCT02862730|582412951|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
161282205|NCT02862730|582412945|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
161282206|NCT02862730|582412946|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161282207|NCT02862730|582412947|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161282208|NCT02862730|582412948|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161282209|NCT02862730|582412949|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161282210|NCT02862730|582412950|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161282211|NCT02862730|582412951|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
161282212|NCT02862730|582412945|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161282213|NCT02862730|582412946|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161282214|NCT02862730|582412947|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
161282215|NCT02862730|582412948|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161282216|NCT02862730|582412949|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
161282217|NCT02862730|582412950|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161282218|NCT02862730|582412951|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
161282219|NCT02862730|582412945|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161282220|NCT02862730|582412946|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161282221|NCT02862730|582412947|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161282222|NCT02862730|582412948|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
161282223|NCT02862730|582412949|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161282224|NCT02862730|582412950|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161282225|NCT02862730|582412951|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
161282226|NCT03685344|582412952|FG000|Overall Study|Withdrawal by Subject|1|||
161282227|NCT03685344|582412953|FG001|Overall Study|Withdrawal by Subject|1|||
161282228|NCT03685344|582412954|FG002|Overall Study|Withdrawal by Subject|2|||
161282229|NCT03685344|582412955|FG003|Overall Study|Withdrawal by Subject|0|||
161282230|NCT03685344|582412952|FG000|Overall Study|Physician Decision|1|||
161282231|NCT03685344|582412953|FG001|Overall Study|Physician Decision|1|||
161282232|NCT03685344|582412954|FG002|Overall Study|Physician Decision|5|||
161282233|NCT03685344|582412955|FG003|Overall Study|Physician Decision|0|||
161282234|NCT03685344|582412952|FG000|Overall Study|Death|1|||
161282235|NCT03685344|582412953|FG001|Overall Study|Death|1|||
161282236|NCT03685344|582412954|FG002|Overall Study|Death|0|||
161282237|NCT03685344|582412955|FG003|Overall Study|Death|0|||
161282238|NCT00191191|582412956|FG000|Overall Study|Entry Criteria Exclusion|2|||
161282239|NCT00191191|582412957|FG001|Overall Study|Entry Criteria Exclusion|0|||
161282240|NCT00191191|582412956|FG000|Overall Study|Treated with Another Systemic Agent|1|||
161282241|NCT00191191|582412957|FG001|Overall Study|Treated with Another Systemic Agent|1|||
161282242|NCT00191191|582412956|FG000|Overall Study|Adverse Event|11|||
161282243|NCT00191191|582412957|FG001|Overall Study|Adverse Event|21|||
161282244|NCT00191191|582412956|FG000|Overall Study|Progressive Disease|84|||
161282245|NCT00191191|582412957|FG001|Overall Study|Progressive Disease|72|||
161282246|NCT00191191|582412956|FG000|Overall Study|Toxicity After Dose Reduction|7|||
161282247|NCT00191191|582412957|FG001|Overall Study|Toxicity After Dose Reduction|8|||
161282248|NCT00191191|582412956|FG000|Overall Study|Family/Caregiver Decision|5|||
161282249|NCT00191191|582412957|FG001|Overall Study|Family/Caregiver Decision|7|||
161282250|NCT00191191|582412956|FG000|Overall Study|Lost to Follow-up|1|||
161282251|NCT00191191|582412957|FG001|Overall Study|Lost to Follow-up|0|||
161282252|NCT00191191|582412956|FG000|Overall Study|Physician Decision|3|||
161282253|NCT00191191|582412957|FG001|Overall Study|Physician Decision|2|||
161282254|NCT00191191|582412956|FG000|Overall Study|Good Clinical Practice Violation|0|||
161282255|NCT00191191|582412957|FG001|Overall Study|Good Clinical Practice Violation|1|||
161282256|NCT02276807|582412960|FG000|Overall Study|Withdrawal by Subject|8|||
161282257|NCT02276807|582412961|FG001|Overall Study|Withdrawal by Subject|7|||
161282258|NCT02276807|582412960|FG000|Overall Study|Lost to Follow-up|10|||
161282259|NCT02276807|582412961|FG001|Overall Study|Lost to Follow-up|10|||
161282260|NCT00261950|582412963|FG000|Overall Study|Lost to Follow-up|2|||
161282261|NCT00261950|582412963|FG000|Overall Study|Death|6|||
161282262|NCT00261950|582412963|FG000|Overall Study|Withdrawal by Subject|5|||
161282263|NCT00261950|582412963|FG000|Overall Study|Other|1|||
161282264|NCT00261950|582412963|FG000|Overall Study|Physician Decision|1|||
161282265|NCT00261950|582412963|FG000|Overall Study|Protocol specified Criteria|11|||
161282266|NCT00445432|582412968|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
161282267|NCT00445432|582412969|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
161282268|NCT00445432|582412970|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
161282269|NCT00445432|582412971|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
161282270|NCT00445432|582412968|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161282271|NCT00445432|582412969|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161282272|NCT00445432|582412970|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
161282273|NCT00445432|582412971|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
161282274|NCT00445432|582412968|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
161282275|NCT00445432|582412969|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
161282276|NCT00445432|582412970|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
161282277|NCT00445432|582412971|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
161282278|NCT00445432|582412968|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
161282279|NCT00445432|582412969|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
161282280|NCT00445432|582412970|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
161282281|NCT00445432|582412971|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
161282282|NCT00445432|582412968|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161282283|NCT00445432|582412969|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161282284|NCT00445432|582412970|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
161153697|NCT04742907|581943935|FG000|Overall Study|Adverse Event|1|||
161061444|NCT01078584|581615444|FG000|Overall Study|Blood Pressure Controlled|49|||
161061445|NCT01078584|581615444|FG000|Overall Study|Physician Switched Medication|26|||
161061446|NCT01078584|581615444|FG000|Overall Study|Physician Discontinued Patient|12|||
161061447|NCT01078584|581615444|FG000|Overall Study|Lack of Efficacy|98|||
161061448|NCT01078584|581615444|FG000|Overall Study|Protocol Violation|75|||
161061449|NCT01078584|581615444|FG000|Overall Study|Serious Adverse Event|27|||
161061450|NCT01078584|581615444|FG000|Overall Study|Multiple Reasons|2|||
161061451|NCT01208870|581615445|FG000|Overall Study|Lost to Follow-up|2|||
161061452|NCT01208870|581615446|FG001|Overall Study|Lost to Follow-up|8|||
161061453|NCT00356759|581615447|FG000|Overall Study|Death|5|||
161061454|NCT00356759|581615448|FG001|Overall Study|Death|2|||
161153698|NCT04742907|581943936|FG001|Overall Study|Adverse Event|0|||
161153699|NCT04742907|581943937|FG002|Overall Study|Adverse Event|1|||
161153700|NCT04742907|581943935|FG000|Overall Study|Lost to Follow-up|3|||
161153701|NCT04742907|581943936|FG001|Overall Study|Lost to Follow-up|3|||
161153702|NCT04742907|581943937|FG002|Overall Study|Lost to Follow-up|2|||
161153703|NCT04742907|581943935|FG000|Overall Study|Physician Decision|0|||
161153704|NCT04742907|581943936|FG001|Overall Study|Physician Decision|1|||
161153705|NCT04742907|581943937|FG002|Overall Study|Physician Decision|0|||
161153706|NCT04742907|581943935|FG000|Overall Study|Protocol Violation|1|||
161153707|NCT04742907|581943936|FG001|Overall Study|Protocol Violation|1|||
161153708|NCT04742907|581943937|FG002|Overall Study|Protocol Violation|1|||
161153709|NCT04742907|581943935|FG000|Overall Study|Withdrawal by Subject|5|||
161153710|NCT04742907|581943936|FG001|Overall Study|Withdrawal by Subject|6|||
161153711|NCT04742907|581943937|FG002|Overall Study|Withdrawal by Subject|4|||
161153712|NCT04742907|581943935|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
161153713|NCT04742907|581943936|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
161153714|NCT04742907|581943937|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
161153715|NCT04742907|581943935|FG000|Overall Study|Did Not Receive the Study Drug|2|||
161153716|NCT04742907|581943936|FG001|Overall Study|Did Not Receive the Study Drug|4|||
161153717|NCT04742907|581943937|FG002|Overall Study|Did Not Receive the Study Drug|4|||
161153718|NCT01428063|581943938|FG000|Overall Study|Lack of Efficacy|8|||
161153719|NCT01428063|581943939|FG001|Overall Study|Lack of Efficacy|4|||
161153720|NCT01428063|581943940|FG002|Overall Study|Lack of Efficacy|1|||
161153721|NCT01428063|581943938|FG000|Overall Study|Adverse Event|2|||
161153722|NCT01428063|581943939|FG001|Overall Study|Adverse Event|3|||
161153723|NCT01428063|581943940|FG002|Overall Study|Adverse Event|0|||
161153724|NCT01428063|581943938|FG000|Overall Study|Lost to Follow-up|0|||
161153725|NCT01428063|581943939|FG001|Overall Study|Lost to Follow-up|2|||
161153726|NCT01428063|581943940|FG002|Overall Study|Lost to Follow-up|0|||
161153727|NCT01428063|581943938|FG000|Overall Study|No longer meets study criteria|0|||
161153728|NCT01428063|581943939|FG001|Overall Study|No longer meets study criteria|1|||
161153729|NCT01428063|581943940|FG002|Overall Study|No longer meets study criteria|0|||
161153730|NCT03196505|581943941|FG000|Overall Study|Physician Decision|26|||
161153731|NCT03196505|581943942|FG001|Overall Study|Physician Decision|26|||
161153732|NCT01005719|581943943|FG000|Period 1|Adverse Event|0|||
161153733|NCT01005719|581943944|FG001|Period 1|Adverse Event|0|||
161153734|NCT01005719|581943945|FG002|Period 1|Adverse Event|0|||
161153735|NCT01005719|581943946|FG003|Period 1|Adverse Event|1|||
161153736|NCT01005719|581943947|FG004|Period 1|Adverse Event|0|||
161153737|NCT01005719|581943948|FG005|Period 1|Adverse Event|0|||
161153738|NCT01005719|581943943|FG000|Period 1|Delay in completing study procedures|0|||
161153739|NCT01005719|581943944|FG001|Period 1|Delay in completing study procedures|0|||
161153740|NCT01005719|581943945|FG002|Period 1|Delay in completing study procedures|0|||
161153741|NCT01005719|581943946|FG003|Period 1|Delay in completing study procedures|0|||
161153742|NCT01005719|581943947|FG004|Period 1|Delay in completing study procedures|0|||
161153743|NCT01005719|581943948|FG005|Period 1|Delay in completing study procedures|1|||
161153744|NCT01005719|581943943|FG000|Period 2|Adverse Event|0|||
161153745|NCT01005719|581943944|FG001|Period 2|Adverse Event|0|||
161153746|NCT01005719|581943945|FG002|Period 2|Adverse Event|0|||
161153747|NCT01005719|581943946|FG003|Period 2|Adverse Event|0|||
161153748|NCT01005719|581943947|FG004|Period 2|Adverse Event|1|||
161153749|NCT01005719|581943948|FG005|Period 2|Adverse Event|1|||
161153750|NCT01753076|581943949|FG000|Overall Study|Adverse Event|17|||
161153751|NCT01753076|581943950|FG001|Overall Study|Adverse Event|18|||
161153752|NCT01753076|581943949|FG000|Overall Study|Lack of Efficacy|3|||
161153753|NCT01753076|581943950|FG001|Overall Study|Lack of Efficacy|1|||
161061455|NCT00356759|581615447|FG000|Overall Study|Withdrawal by Subject|2|||
161061456|NCT00356759|581615448|FG001|Overall Study|Withdrawal by Subject|2|||
161153754|NCT01753076|581943949|FG000|Overall Study|Lost to Follow-up|2|||
161153755|NCT01753076|581943950|FG001|Overall Study|Lost to Follow-up|1|||
161153756|NCT01753076|581943949|FG000|Overall Study|Physician Decision|4|||
161153757|NCT01753076|581943950|FG001|Overall Study|Physician Decision|2|||
161153758|NCT01753076|581943949|FG000|Overall Study|Withdrawal by Subject|14|||
161153759|NCT01753076|581943950|FG001|Overall Study|Withdrawal by Subject|24|||
161153760|NCT01753076|581943949|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
161153761|NCT01753076|581943950|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
161153762|NCT02575079|581943951|FG000|Overall Study|Death|3|||
161153763|NCT02575079|581943952|FG001|Overall Study|Death|0|||
161153764|NCT02575079|581943951|FG000|Overall Study|Withdrawal by Subject|3|||
161153765|NCT02575079|581943952|FG001|Overall Study|Withdrawal by Subject|0|||
161153766|NCT02918266|581943953|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
161153767|NCT02918266|581943954|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153768|NCT02918266|581943955|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153769|NCT02918266|581943956|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153770|NCT02918266|581943957|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153771|NCT02918266|581943958|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153772|NCT02918266|581943959|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
161153773|NCT02918266|581943960|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153774|NCT02918266|581943961|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
161153775|NCT02918266|581943962|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153776|NCT02918266|581943963|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
161153777|NCT01259856|581943964|FG000|Overall Study|Adverse Event|12|||
161153778|NCT01259856|581943965|FG001|Overall Study|Adverse Event|9|||
161153779|NCT01259856|581943964|FG000|Overall Study|Death|0|||
161153780|NCT01259856|581943965|FG001|Overall Study|Death|1|||
161153781|NCT01259856|581943964|FG000|Overall Study|Lack of Efficacy|3|||
161153782|NCT01259856|581943965|FG001|Overall Study|Lack of Efficacy|1|||
161153783|NCT01259856|581943964|FG000|Overall Study|Lost to Follow-up|1|||
161153784|NCT01259856|581943965|FG001|Overall Study|Lost to Follow-up|1|||
161153785|NCT01259856|581943964|FG000|Overall Study|Physician Decision|2|||
161153786|NCT01259856|581943965|FG001|Overall Study|Physician Decision|1|||
161153787|NCT01259856|581943964|FG000|Overall Study|Withdrawal by Subject|9|||
161153788|NCT01259856|581943965|FG001|Overall Study|Withdrawal by Subject|10|||
161153789|NCT01259856|581943964|FG000|Overall Study|Treatment never started|0|||
161153790|NCT01259856|581943965|FG001|Overall Study|Treatment never started|6|||
161153791|NCT01259856|581943964|FG000|Overall Study|Study closure by sponsor|40|||
161153792|NCT01259856|581943965|FG001|Overall Study|Study closure by sponsor|41|||
161153793|NCT01259856|581943964|FG000|Overall Study|Patient developed other disease|0|||
161153794|NCT01259856|581943965|FG001|Overall Study|Patient developed other disease|1|||
161153795|NCT01259856|581943964|FG000|Overall Study|Transfer to another study|0|||
161153796|NCT01259856|581943965|FG001|Overall Study|Transfer to another study|1|||
161153797|NCT01259856|581943964|FG000|Overall Study|Unknown/missing|2|||
161153798|NCT01259856|581943965|FG001|Overall Study|Unknown/missing|2|||
161153799|NCT00788775|581943968|FG000|Overall Study|Progressive Disease|8|||
161153800|NCT00788775|581943969|FG001|Overall Study|Progressive Disease|6|||
161153801|NCT00788775|581943968|FG000|Overall Study|Withdrawal by Subject|0|||
161153802|NCT00788775|581943969|FG001|Overall Study|Withdrawal by Subject|2|||
161153803|NCT00788775|581943968|FG000|Overall Study|Patient Non-Compliance|1|||
161153804|NCT00788775|581943969|FG001|Overall Study|Patient Non-Compliance|0|||
161153805|NCT00788775|581943968|FG000|Overall Study|Patient's measurable disease resected.|1|||
161282285|NCT00445432|582412971|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
161282286|NCT00445432|582412968|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161282287|NCT00445432|582412969|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161282288|NCT00445432|582412970|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
161282289|NCT00445432|582412971|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
161282290|NCT00445432|582412968|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
161282291|NCT00445432|582412969|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
161282292|NCT00445432|582412970|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
161282293|NCT00445432|582412971|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
161282294|NCT02789137|582412972|FG000|Overall Study|Dropped out/Died|58|||
161282295|NCT00799058|582412981|FG000|Overall Study|Withdrawal by Subject|2|||
161282296|NCT00799058|582412982|FG001|Overall Study|Withdrawal by Subject|2|||
161282297|NCT00799058|582412983|FG002|Overall Study|Withdrawal by Subject|2|||
161282298|NCT00799058|582412981|FG000|Overall Study|Lost to Follow-up|1|||
161153806|NCT00788775|581943969|FG001|Overall Study|Patient's measurable disease resected.|0|||
161153807|NCT01293032|581943973|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161282299|NCT00799058|582412982|FG001|Overall Study|Lost to Follow-up|2|||
161282300|NCT00799058|582412983|FG002|Overall Study|Lost to Follow-up|1|||
161282301|NCT00799058|582412981|FG000|Overall Study|Adverse Event|0|||
161282302|NCT00799058|582412982|FG001|Overall Study|Adverse Event|2|||
161282303|NCT00799058|582412983|FG002|Overall Study|Adverse Event|0|||
161282304|NCT00799058|582412981|FG000|Overall Study|Pregnancy|1|||
161282305|NCT00799058|582412982|FG001|Overall Study|Pregnancy|0|||
161282306|NCT00799058|582412983|FG002|Overall Study|Pregnancy|0|||
161282307|NCT00799058|582412981|FG000|Overall Study|Not adherent|3|||
161153808|NCT01293032|581943974|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161282308|NCT00799058|582412982|FG001|Overall Study|Not adherent|2|||
161153809|NCT01293032|581943975|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
161153810|NCT01293032|581943976|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
161153811|NCT01293032|581943973|FG000|Treatment|Adverse Event|0|||
161345280|NCT03980223|582648914|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
161345281|NCT03980223|582648915|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
161345282|NCT03980223|582648916|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
161345283|NCT03980223|582648917|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
161345284|NCT02460289|582648921|FG000|Overall Study|Adverse Event|1|||
161345285|NCT02460289|582648921|FG000|Overall Study|Withdrawal by Subject|8|||
161345286|NCT02460289|582648921|FG000|Overall Study|Lost to Follow-up|1|||
161345287|NCT02916927|582648922|FG000|Overall Study|Discharged prior to study drug receipt|0|||
161345288|NCT02916927|582648923|FG001|Overall Study|Discharged prior to study drug receipt|2|||
161345289|NCT02916927|582648922|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
161345290|NCT02916927|582648923|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
161345291|NCT02916927|582648922|FG000|Overall Study|Withdrawal before first time point|1|||
161345292|NCT02916927|582648923|FG001|Overall Study|Withdrawal before first time point|0|||
161345293|NCT01020123|582648924|FG000|Main Period|Withdrawal by Subject|6|||
161345294|NCT01020123|582648925|FG001|Main Period|Withdrawal by Subject|5|||
161345295|NCT01020123|582648926|FG002|Main Period|Withdrawal by Subject|3|||
161345296|NCT01020123|582648927|FG003|Main Period|Withdrawal by Subject|1|||
161345297|NCT01020123|582648928|FG004|Main Period|Withdrawal by Subject|6|||
161345298|NCT01020123|582648929|FG005|Main Period|Withdrawal by Subject|3|||
161345299|NCT01020123|582648930|FG006|Main Period|Withdrawal by Subject|2|||
161345300|NCT01020123|582648924|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
161345301|NCT01020123|582648925|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
161345302|NCT01020123|582648926|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
161061457|NCT00356759|581615447|FG000|Overall Study|Adverse Event|1|||
161061458|NCT00356759|581615448|FG001|Overall Study|Adverse Event|3|||
161061459|NCT00356759|581615447|FG000|Overall Study|Lost to Follow-up|1|||
161061460|NCT00356759|581615448|FG001|Overall Study|Lost to Follow-up|1|||
161061461|NCT00356759|581615447|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
161061462|NCT00356759|581615448|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
161061463|NCT01204775|581615449|FG000|Overall Study|Poor/non-compliance|0|||
161061464|NCT01204775|581615450|FG001|Overall Study|Poor/non-compliance|1|||
161061465|NCT01204775|581615449|FG000|Overall Study|Withdrawal by Subject|1|||
161061466|NCT01204775|581615450|FG001|Overall Study|Withdrawal by Subject|0|||
161061467|NCT00276016|581615451|FG000|Intervention 1|Withdrawal by Subject|0|||
161061468|NCT00276016|581615452|FG001|Intervention 1|Withdrawal by Subject|1|||
161061469|NCT00276016|581615453|FG002|Intervention 1|Withdrawal by Subject|0|||
161061470|NCT00276016|581615454|FG003|Intervention 1|Withdrawal by Subject|0|||
161061471|NCT00276016|581615455|FG004|Intervention 1|Withdrawal by Subject|0|||
161061472|NCT00276016|581615456|FG005|Intervention 1|Withdrawal by Subject|0|||
161061473|NCT05041439|581615457|FG000|Overall Study|Withdrawal by Subject|1|||
161061474|NCT05041439|581615458|FG001|Overall Study|Withdrawal by Subject|1|||
161061475|NCT05041439|581615457|FG000|Overall Study|Death|1|||
161061476|NCT05041439|581615458|FG001|Overall Study|Death|0|||
161061477|NCT02979613|581615459|FG000|Double-Blind Phase|Withdrew Consent|2|||
161061478|NCT02979613|581615460|FG001|Double-Blind Phase|Withdrew Consent|4|||
161061479|NCT02979613|581615459|FG000|Double-Blind Phase|Pregnancy|2|||
161061480|NCT02979613|581615460|FG001|Double-Blind Phase|Pregnancy|2|||
161061481|NCT02979613|581615459|FG000|Double-Blind Phase|Adverse Event|2|||
161061482|NCT02979613|581615460|FG001|Double-Blind Phase|Adverse Event|0|||
161061483|NCT02979613|581615459|FG000|Double-Blind Phase|Lost to Follow-up|1|||
161061484|NCT02979613|581615460|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161061485|NCT02979613|581615459|FG000|Double-Blind Phase|Protocol Violation|1|||
161061486|NCT02979613|581615460|FG001|Double-Blind Phase|Protocol Violation|1|||
161061487|NCT02979613|581615459|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
161061488|NCT02979613|581615460|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
161061489|NCT02979613|581615459|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
161061490|NCT02979613|581615460|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
161061491|NCT02979613|581615459|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
161061492|NCT02979613|581615460|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161061493|NCT02979613|581615459|FG000|Open-Label Extension (OLE) Phase|Death|0|||
161061494|NCT02979613|581615460|FG001|Open-Label Extension (OLE) Phase|Death|1|||
161061495|NCT02979613|581615459|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
161061496|NCT02979613|581615460|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
161061497|NCT01181609|581617180|FG000|Overall Study|Adverse Event|1|||
161061498|NCT01181609|581617180|FG000|Overall Study|Withdrawal by Subject|1|||
161061499|NCT01181609|581617180|FG000|Overall Study|Lost to Follow-up|1|||
161061500|NCT01181609|581617180|FG000|Overall Study|Death|50|||
161345303|NCT01020123|582648927|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
161061501|NCT03991988|581617184|FG000|Overall Study|Withdrawal by Subject|2|||
161061502|NCT03991988|581617185|FG001|Overall Study|Withdrawal by Subject|2|||
161061503|NCT00408928|581617189|FG000|Overall Study|Withdrawal by Subject|1|||
161061504|NCT00408928|581617189|FG000|Overall Study|Death|1|||
161153812|NCT01293032|581943974|FG001|Treatment|Adverse Event|0|||
161153813|NCT01293032|581943975|FG002|Treatment|Adverse Event|1|||
161153814|NCT01293032|581943976|FG003|Treatment|Adverse Event|1|||
161153815|NCT01293032|581943973|FG000|Treatment|Withdrawal by Subject|2|||
161153816|NCT01293032|581943974|FG001|Treatment|Withdrawal by Subject|4|||
161153817|NCT01293032|581943975|FG002|Treatment|Withdrawal by Subject|0|||
161153818|NCT01293032|581943976|FG003|Treatment|Withdrawal by Subject|0|||
161153819|NCT01293032|581943973|FG000|Treatment|Disease Progression, relapse|0|||
161153820|NCT01293032|581943974|FG001|Treatment|Disease Progression, relapse|1|||
161153821|NCT01293032|581943975|FG002|Treatment|Disease Progression, relapse|0|||
161153822|NCT01293032|581943976|FG003|Treatment|Disease Progression, relapse|0|||
161153823|NCT01087528|581943979|FG000|Overall Study|Withdrawal by Subject|1|||
161153824|NCT01087528|581943979|FG000|Overall Study|Incomplete CE procedure|6|||
161153825|NCT03116399|581943982|FG000|Overall Study|Death|8|||
161153826|NCT03116399|581943983|FG001|Overall Study|Death|3|||
161153827|NCT03116399|581943982|FG000|Overall Study|Lost to Follow-up|7|||
161153828|NCT03116399|581943983|FG001|Overall Study|Lost to Follow-up|11|||
161282309|NCT00799058|582412983|FG002|Overall Study|Not adherent|1|||
161282310|NCT00799058|582412981|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
161061505|NCT00408928|581617189|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
161061506|NCT01751165|581617190|FG000|Overall Study|Adverse event, serious fatal|1|||
161061507|NCT01751165|581617191|FG001|Overall Study|Adverse event, serious fatal|0|||
161061508|NCT01751165|581617192|FG002|Overall Study|Adverse event, serious fatal|1|||
161061509|NCT01751165|581617190|FG000|Overall Study|Withdrawal by Subject|0|||
161061510|NCT01751165|581617191|FG001|Overall Study|Withdrawal by Subject|0|||
161061511|NCT01751165|581617192|FG002|Overall Study|Withdrawal by Subject|1|||
161061512|NCT01751165|581617190|FG000|Overall Study|Serious adverse event|0|||
161061513|NCT01751165|581617191|FG001|Overall Study|Serious adverse event|2|||
161061514|NCT01751165|581617192|FG002|Overall Study|Serious adverse event|0|||
161061515|NCT01751165|581617190|FG000|Overall Study|Lost to Follow-up|1|||
161061516|NCT01751165|581617191|FG001|Overall Study|Lost to Follow-up|1|||
161061517|NCT01751165|581617192|FG002|Overall Study|Lost to Follow-up|1|||
161061518|NCT01036165|581617193|FG000|Overall Study|Adverse Event|6|||
161061519|NCT01036165|581617193|FG000|Overall Study|Lost to Follow-up|2|||
161061520|NCT01036165|581617193|FG000|Overall Study|Withdrawal by Subject|3|||
161061521|NCT01036165|581617193|FG000|Overall Study|Device Related Issues|3|||
161061522|NCT01036165|581617193|FG000|Overall Study|Problems finding proper area to inject|1|||
161061523|NCT04051242|581617195|FG000|Overall Study|Withdrawal by Subject|1|||
161061524|NCT04051242|581617195|FG000|Overall Study|Physician Decision|1|||
161061525|NCT02262364|581617198|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
161061526|NCT01049984|581617199|FG000|Overall Study|Withdrawal by Subject|1|||
161061527|NCT01049984|581617200|FG001|Overall Study|Withdrawal by Subject|5|||
161061528|NCT01049984|581617199|FG000|Overall Study|Protocol Violation|3|||
161061529|NCT01049984|581617200|FG001|Overall Study|Protocol Violation|4|||
161061530|NCT01049984|581617199|FG000|Overall Study|Lost to Follow-up|2|||
161061531|NCT01049984|581617200|FG001|Overall Study|Lost to Follow-up|1|||
161061532|NCT01049984|581617199|FG000|Overall Study|Adverse Event|13|||
161061533|NCT01049984|581617200|FG001|Overall Study|Adverse Event|7|||
161061534|NCT01049984|581617199|FG000|Overall Study|Treatment failure|0|||
161061535|NCT01049984|581617200|FG001|Overall Study|Treatment failure|2|||
161061536|NCT00337285|581617201|FG000|Overall Study|Withdrawal by Subject|42|||
161061537|NCT00337285|581617201|FG000|Overall Study|Lost to Follow-up|41|||
161061538|NCT00337285|581617201|FG000|Overall Study|Adverse Event|28|||
161061539|NCT00337285|581617201|FG000|Overall Study|Protocol Violation|27|||
161061540|NCT00337285|581617201|FG000|Overall Study|Lack of Efficacy|11|||
161153829|NCT03116399|581943982|FG000|Overall Study|Investigator Decision|1|||
161153830|NCT03116399|581943983|FG001|Overall Study|Investigator Decision|1|||
161153831|NCT03116399|581943982|FG000|Overall Study|Withdrawal by Subject|24|||
161153832|NCT03116399|581943983|FG001|Overall Study|Withdrawal by Subject|9|||
161153833|NCT02691247|581943987|FG000|Overall Study|Withdrawal by Subject|1|||
161153834|NCT02691247|581943988|FG001|Overall Study|Withdrawal by Subject|2|||
161153835|NCT02691247|581943989|FG002|Overall Study|Withdrawal by Subject|2|||
161153836|NCT02691247|581943987|FG000|Overall Study|Lost to Follow-up|2|||
161282311|NCT00799058|582412982|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
161282312|NCT00799058|582412983|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
161282313|NCT00799058|582412981|FG000|Overall Study|IP dispensing error|1|||
161282314|NCT00799058|582412982|FG001|Overall Study|IP dispensing error|0|||
161282315|NCT00799058|582412983|FG002|Overall Study|IP dispensing error|0|||
161061541|NCT00337285|581617201|FG000|Overall Study|Death|1|||
161153837|NCT02691247|581943988|FG001|Overall Study|Lost to Follow-up|0|||
161153838|NCT02691247|581943989|FG002|Overall Study|Lost to Follow-up|1|||
161061542|NCT00337285|581617201|FG000|Overall Study|Physician Decision|1|||
161061543|NCT00337285|581617201|FG000|Overall Study|Lack of protocol compliance|7|||
161061544|NCT01040403|581617205|FG000|Overall Study|Adverse Event|10|||
161153839|NCT01519245|581943990|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
161153840|NCT01519245|581943991|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
161153841|NCT00772967|581943992|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
161061545|NCT01040403|581617205|FG000|Overall Study|Protocol Violation|2|||
161061546|NCT01040403|581617205|FG000|Overall Study|Lost to Follow-up|1|||
161061547|NCT01040403|581617205|FG000|Overall Study|Not treated|1|||
161061548|NCT01040403|581617205|FG000|Overall Study|Other reason not defined above|6|||
161061549|NCT00292981|581617206|FG000|Overall Study|Adverse Event|1|||
161061550|NCT00292981|581617206|FG000|Overall Study|Lost to Follow-up|13|||
161061551|NCT00292981|581617206|FG000|Overall Study|Withdrawal by Subject|22|||
161061552|NCT00292981|581617206|FG000|Overall Study|Other|3|||
161061553|NCT01085812|581617207|FG000|Open-Label Period|Adverse Event|0|||
161061554|NCT01085812|581617208|FG001|Open-Label Period|Adverse Event|80|||
161061555|NCT01085812|581617207|FG000|Open-Label Period|Lack of Efficacy|0|||
161061556|NCT01085812|581617208|FG001|Open-Label Period|Lack of Efficacy|26|||
161061557|NCT01085812|581617207|FG000|Open-Label Period|Protocol Violation|0|||
161061558|NCT01085812|581617208|FG001|Open-Label Period|Protocol Violation|39|||
161061559|NCT01085812|581617207|FG000|Open-Label Period|Withdrawal by Subject|0|||
161061560|NCT01085812|581617208|FG001|Open-Label Period|Withdrawal by Subject|53|||
161061561|NCT01085812|581617207|FG000|Open-Label Period|Lost to Follow-up|0|||
161061562|NCT01085812|581617208|FG001|Open-Label Period|Lost to Follow-up|42|||
161061563|NCT01085812|581617207|FG000|Double-Blind Period|Adverse Event|3|||
161061564|NCT01085812|581617208|FG001|Double-Blind Period|Adverse Event|8|||
161061565|NCT01085812|581617207|FG000|Double-Blind Period|Protocol Violation|2|||
161061566|NCT01085812|581617208|FG001|Double-Blind Period|Protocol Violation|7|||
161061567|NCT01085812|581617207|FG000|Double-Blind Period|Withdrawal by Subject|11|||
161061568|NCT01085812|581617208|FG001|Double-Blind Period|Withdrawal by Subject|24|||
161061569|NCT01085812|581617207|FG000|Double-Blind Period|Lost to Follow-up|5|||
161061570|NCT01085812|581617208|FG001|Double-Blind Period|Lost to Follow-up|17|||
161061571|NCT01085812|581617207|FG000|Double-Blind Period|Other Reasons|0|||
161061572|NCT01085812|581617208|FG001|Double-Blind Period|Other Reasons|2|||
161061573|NCT01085812|581617207|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
161061574|NCT01085812|581617208|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
161061575|NCT01085812|581617207|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
161061576|NCT01085812|581617208|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
161061577|NCT01085812|581617207|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
161061578|NCT01085812|581617208|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
161061579|NCT01085812|581617207|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
161061580|NCT01085812|581617208|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
161061581|NCT01085812|581617207|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
161061582|NCT01085812|581617208|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
161061583|NCT00594178|581617209|FG000|Overall Study|Physician Decision|5|||
161282316|NCT00799058|582412981|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
161282317|NCT00799058|582412982|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
161282318|NCT00799058|582412983|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
161282319|NCT00799058|582412981|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
161282320|NCT00799058|582412982|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
161282321|NCT00799058|582412983|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
161061584|NCT01874665|581617212|FG000|Overall Study|Adverse Event|6|||
161061585|NCT01874665|581617213|FG001|Overall Study|Adverse Event|2|||
161061586|NCT01874665|581617212|FG000|Overall Study|Withdrawal by Subject|4|||
161061587|NCT01874665|581617213|FG001|Overall Study|Withdrawal by Subject|1|||
161061588|NCT01874665|581617212|FG000|Overall Study|Physician Decision|3|||
161061589|NCT01874665|581617213|FG001|Overall Study|Physician Decision|0|||
161061590|NCT01874665|581617212|FG000|Overall Study|Clinical Progressive Disease|4|||
161061591|NCT01874665|581617213|FG001|Overall Study|Clinical Progressive Disease|3|||
161061592|NCT01874665|581617212|FG000|Overall Study|Study Terminated by Sponsor|0|||
161061593|NCT01874665|581617213|FG001|Overall Study|Study Terminated by Sponsor|2|||
161061594|NCT01874665|581617212|FG000|Overall Study|Documented Progressive Disease|11|||
161061595|NCT01874665|581617213|FG001|Overall Study|Documented Progressive Disease|7|||
161061596|NCT01874665|581617212|FG000|Overall Study|Other|2|||
161061597|NCT01874665|581617213|FG001|Overall Study|Other|0|||
161061598|NCT02447432|581617214|FG000|Epoch 001|Adverse Event|1|||
161061599|NCT02447432|581617215|FG001|Epoch 001|Adverse Event|1|||
161061600|NCT02447432|581617214|FG000|Epoch 001|Withdrawal by Subject|0|||
161061601|NCT02447432|581617215|FG001|Epoch 001|Withdrawal by Subject|4|||
161282322|NCT00799058|582412981|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
161282323|NCT00799058|582412982|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
161282324|NCT00799058|582412983|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
161061602|NCT02447432|581617214|FG000|Epoch 001|Migrated/moved from study area|3|||
161061603|NCT02447432|581617215|FG001|Epoch 001|Migrated/moved from study area|5|||
161061604|NCT02447432|581617214|FG000|Epoch 001|Lost to Follow-up|1|||
161061605|NCT02447432|581617215|FG001|Epoch 001|Lost to Follow-up|3|||
161061606|NCT03245619|581617217|FG000|Part A (Up to Day 22)|Physician Decision|4|||
161061607|NCT03245619|581617218|FG001|Part A (Up to Day 22)|Physician Decision|6|||
161153842|NCT00772967|581943993|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
161153843|NCT00772967|581943994|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
161153844|NCT00772967|581943995|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
161153845|NCT00772967|581943996|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
161153846|NCT00772967|581943997|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
161153847|NCT00772967|581943992|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161061608|NCT03245619|581617219|FG002|Part A (Up to Day 22)|Physician Decision|6|||
161061609|NCT03245619|581617220|FG003|Part A (Up to Day 22)|Physician Decision|0|||
161061610|NCT03245619|581617221|FG004|Part A (Up to Day 22)|Physician Decision|0|||
161061611|NCT03245619|581617222|FG005|Part A (Up to Day 22)|Physician Decision|0|||
161061612|NCT03245619|581617223|FG006|Part A (Up to Day 22)|Physician Decision|0|||
161061613|NCT03245619|581617224|FG007|Part A (Up to Day 22)|Physician Decision|0|||
161061614|NCT03245619|581617225|FG008|Part A (Up to Day 22)|Physician Decision|0|||
161061615|NCT03245619|581617226|FG009|Part A (Up to Day 22)|Physician Decision|0|||
161061616|NCT03245619|581617227|FG010|Part A (Up to Day 22)|Physician Decision|0|||
161061617|NCT03245619|581617228|FG011|Part A (Up to Day 22)|Physician Decision|0|||
161061618|NCT03245619|581617229|FG012|Part A (Up to Day 22)|Physician Decision|0|||
161061619|NCT03245619|581617230|FG013|Part A (Up to Day 22)|Physician Decision|0|||
161061620|NCT03245619|581617231|FG014|Part A (Up to Day 22)|Physician Decision|0|||
161061621|NCT03245619|581617232|FG015|Part A (Up to Day 22)|Physician Decision|0|||
161061622|NCT03245619|581617233|FG016|Part A (Up to Day 22)|Physician Decision|0|||
161061623|NCT00776659|581617249|FG000|Overall Study|Lost to Follow-up|15|||
161061624|NCT00776659|581617249|FG000|Overall Study|Withdrawal by Subject|10|||
161061625|NCT00776659|581617249|FG000|Overall Study|Study Terminated by Sponsor|1|||
161061626|NCT02971228|581617250|FG000|Overall Study|Withdrawal by Subject|1|||
161061627|NCT02971228|581617251|FG001|Overall Study|Withdrawal by Subject|1|||
161061628|NCT02971228|581617252|FG002|Overall Study|Withdrawal by Subject|0|||
161061629|NCT02971228|581617253|FG003|Overall Study|Withdrawal by Subject|0|||
161061630|NCT02971228|581617254|FG004|Overall Study|Withdrawal by Subject|0|||
161061631|NCT02971228|581617250|FG000|Overall Study|Logistical challenges|0|||
161061632|NCT02971228|581617251|FG001|Overall Study|Logistical challenges|1|||
161061633|NCT02971228|581617252|FG002|Overall Study|Logistical challenges|0|||
161061634|NCT02971228|581617253|FG003|Overall Study|Logistical challenges|0|||
161061635|NCT02971228|581617254|FG004|Overall Study|Logistical challenges|0|||
161061636|NCT01167192|581617255|FG000|Overall Study|Adverse Event|1|||
161061637|NCT01167192|581617255|FG000|Overall Study|Death|1|||
161061638|NCT01167192|581617255|FG000|Overall Study|Withdrawal by Subject|1|||
161061639|NCT01167192|581617255|FG000|Overall Study|Insurance denial|1|||
161061640|NCT00129649|581617266|FG000|Overall Study|Withdrawal by Subject|76|||
161061641|NCT00129649|581617267|FG001|Overall Study|Withdrawal by Subject|65|||
161061642|NCT02482935|581617271|FG000|Period 1|Withdrawal by Subject|1|||
161061643|NCT02482935|581617272|FG001|Period 1|Withdrawal by Subject|0|||
161061644|NCT03503162|581617273|FG000|Overall Study|did not meet eligibility|1|||
161061645|NCT02561806|581617274|FG000|Induction Period|Adverse Event|0|||
161061646|NCT02561806|581617275|FG001|Induction Period|Adverse Event|2|||
161061647|NCT02561806|581617274|FG000|Induction Period|Lack of Efficacy|1|||
161061648|NCT02561806|581617275|FG001|Induction Period|Lack of Efficacy|0|||
161061649|NCT02561806|581617274|FG000|Induction Period|Withdrawal by Subject|0|||
161061650|NCT02561806|581617275|FG001|Induction Period|Withdrawal by Subject|2|||
161061651|NCT02561806|581617274|FG000|Induction Period|Site staff became unblinded|1|||
161061652|NCT02561806|581617275|FG001|Induction Period|Site staff became unblinded|0|||
161061653|NCT02561806|581617274|FG000|Induction Period|Randomized but not treated|0|||
161061654|NCT02561806|581617275|FG001|Induction Period|Randomized but not treated|1|||
161061655|NCT02561806|581617274|FG000|Maintenance Period|Adverse Event|2|||
161061656|NCT02561806|581617275|FG001|Maintenance Period|Adverse Event|1|||
161061657|NCT02561806|581617274|FG000|Maintenance Period|Lack of Efficacy|3|||
161153848|NCT00772967|581943993|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
161153849|NCT00772967|581943994|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161345304|NCT01020123|582648928|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
161061658|NCT02561806|581617275|FG001|Maintenance Period|Lack of Efficacy|1|||
161061659|NCT02561806|581617274|FG000|Maintenance Period|Lost to Follow-up|2|||
161061660|NCT02561806|581617275|FG001|Maintenance Period|Lost to Follow-up|2|||
161061661|NCT02561806|581617274|FG000|Maintenance Period|Protocol Violation|1|||
161061662|NCT02561806|581617275|FG001|Maintenance Period|Protocol Violation|0|||
161061663|NCT02561806|581617274|FG000|Maintenance Period|Withdrawal by Subject|5|||
161061664|NCT02561806|581617275|FG001|Maintenance Period|Withdrawal by Subject|3|||
161153850|NCT00772967|581943995|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161345305|NCT01020123|582648929|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
161061665|NCT02561806|581617274|FG000|Maintenance Period|Site staff became unblinded|0|||
161061666|NCT02561806|581617275|FG001|Maintenance Period|Site staff became unblinded|1|||
161061667|NCT02561806|581617274|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
161061668|NCT02561806|581617275|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
161345306|NCT01020123|582648930|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
161061669|NCT02561806|581617274|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
161153851|NCT00772967|581943996|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161061670|NCT02561806|581617275|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
161061671|NCT02547441|581617276|FG000|Double-Blind Study Period|Adverse Event|4|||
161061672|NCT02547441|581617277|FG001|Double-Blind Study Period|Adverse Event|9|||
161061673|NCT02547441|581617276|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
161061674|NCT02547441|581617277|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
161061675|NCT02547441|581617276|FG000|Double-Blind Study Period|Physician Decision|1|||
161061676|NCT02547441|581617277|FG001|Double-Blind Study Period|Physician Decision|0|||
161061677|NCT02547441|581617276|FG000|Double-Blind Study Period|Protocol Violation|1|||
161061678|NCT02547441|581617277|FG001|Double-Blind Study Period|Protocol Violation|2|||
161061679|NCT02547441|581617276|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
161061680|NCT02547441|581617277|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
161061681|NCT02547441|581617276|FG000|Double-Blind Study Period|Sponsor Decision|1|||
161061682|NCT02547441|581617277|FG001|Double-Blind Study Period|Sponsor Decision|0|||
161061683|NCT02547441|581617276|FG000|Open-Label Study Period|Adverse Event|10|||
161061684|NCT02547441|581617277|FG001|Open-Label Study Period|Adverse Event|11|||
161061685|NCT02547441|581617276|FG000|Open-Label Study Period|Lack of Efficacy|3|||
161061686|NCT02547441|581617277|FG001|Open-Label Study Period|Lack of Efficacy|2|||
161061687|NCT02547441|581617276|FG000|Open-Label Study Period|Lost to Follow-up|7|||
161061688|NCT02547441|581617277|FG001|Open-Label Study Period|Lost to Follow-up|8|||
161061689|NCT02547441|581617276|FG000|Open-Label Study Period|Physician Decision|1|||
161061690|NCT02547441|581617277|FG001|Open-Label Study Period|Physician Decision|0|||
161061691|NCT02547441|581617276|FG000|Open-Label Study Period|Protocol Violation|2|||
161061692|NCT02547441|581617277|FG001|Open-Label Study Period|Protocol Violation|0|||
161061693|NCT02547441|581617276|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
161061694|NCT02547441|581617277|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
161061695|NCT02547441|581617276|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
161061696|NCT02547441|581617277|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
161061697|NCT00394589|581617278|FG000|Overall Study|Adverse Event|2|||
161061698|NCT00394589|581617279|FG001|Overall Study|Adverse Event|1|||
161061699|NCT00394589|581617280|FG002|Overall Study|Adverse Event|2|||
161061700|NCT00394589|581617278|FG000|Overall Study|Lack of Efficacy|2|||
161061701|NCT00394589|581617279|FG001|Overall Study|Lack of Efficacy|2|||
161061702|NCT00394589|581617280|FG002|Overall Study|Lack of Efficacy|3|||
161061703|NCT00394589|581617278|FG000|Overall Study|Protocol Violation|4|||
161061704|NCT00394589|581617279|FG001|Overall Study|Protocol Violation|0|||
161061705|NCT00394589|581617280|FG002|Overall Study|Protocol Violation|2|||
161061706|NCT03175198|581617281|FG000|Overall Study|Adverse Event|480|||
161061707|NCT03175198|581617281|FG000|Overall Study|No actual visit|120|||
161061708|NCT03175198|581617281|FG000|Overall Study|Registration rule not followed|4|||
161061709|NCT03175198|581617281|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
161061710|NCT03175198|581617281|FG000|Overall Study|Other personal reason|509|||
161061711|NCT03175198|581617281|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
161061712|NCT03175198|581617281|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
161061713|NCT03175198|581617281|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
161061714|NCT03175198|581617281|FG000|Overall Study|To conduct invasive treatment of operation|53|||
161061715|NCT03175198|581617281|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
161061716|NCT00545571|581617282|FG000|Overall Study|Administrative Reasons|1|||
161061717|NCT00545571|581617282|FG000|Overall Study|Adverse Event|2|||
161061718|NCT00545571|581617282|FG000|Overall Study|Death|5|||
161061719|NCT00545571|581617282|FG000|Overall Study|Lack of Efficacy|1|||
161061720|NCT00545571|581617282|FG000|Overall Study|Protocol Violation|2|||
161061721|NCT00545571|581617282|FG000|Overall Study|Refused Treatment|1|||
161061722|NCT00545571|581617282|FG000|Overall Study|Screen Failure|16|||
161061723|NCT00545571|581617282|FG000|Overall Study|Transfusion|12|||
161061724|NCT00545571|581617282|FG000|Overall Study|Early Termination of Study|24|||
161061725|NCT00545571|581617282|FG000|Overall Study|Kidney Transplantation|3|||
161061726|NCT01978236|581617283|FG000|Overall Study|Discontinued due to study close|2|||
161061727|NCT00874497|581617284|FG000|Overall Study|Lost to Follow-up|2|||
161061728|NCT00874497|581617285|FG001|Overall Study|Lost to Follow-up|4|||
161061729|NCT00874497|581617284|FG000|Overall Study|Adverse Event|9|||
161061730|NCT00874497|581617285|FG001|Overall Study|Adverse Event|4|||
161153852|NCT00772967|581943997|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
161153853|NCT00772967|581943992|FG000|Crossover Treatment 3|Adverse Event|0|||
161061731|NCT00874497|581617284|FG000|Overall Study|Sponsor Discontinued Trial|7|||
161061732|NCT00874497|581617285|FG001|Overall Study|Sponsor Discontinued Trial|3|||
161061733|NCT00874497|581617284|FG000|Overall Study|Met Withdrawal Criteria|4|||
161061734|NCT00874497|581617285|FG001|Overall Study|Met Withdrawal Criteria|2|||
161061735|NCT00874497|581617284|FG000|Overall Study|Physician Decision|1|||
161061736|NCT00874497|581617285|FG001|Overall Study|Physician Decision|1|||
161061737|NCT00874497|581617284|FG000|Overall Study|Withdrawal by Subject|5|||
161061738|NCT00874497|581617285|FG001|Overall Study|Withdrawal by Subject|4|||
161061739|NCT00505414|581617287|FG000|Titration Phase|Adverse Event|0|||
161061740|NCT00505414|581617288|FG001|Titration Phase|Adverse Event|0|||
161061741|NCT00505414|581617289|FG002|Titration Phase|Adverse Event|0|||
161153854|NCT00772967|581943993|FG001|Crossover Treatment 3|Adverse Event|0|||
161153855|NCT00772967|581943994|FG002|Crossover Treatment 3|Adverse Event|0|||
161061742|NCT00505414|581617290|FG003|Titration Phase|Adverse Event|8|||
161061743|NCT00505414|581617291|FG004|Titration Phase|Adverse Event|3|||
161061744|NCT00505414|581617287|FG000|Titration Phase|Death|0|||
161061745|NCT00505414|581617288|FG001|Titration Phase|Death|0|||
161061746|NCT00505414|581617289|FG002|Titration Phase|Death|0|||
161061747|NCT00505414|581617290|FG003|Titration Phase|Death|2|||
161061748|NCT00505414|581617291|FG004|Titration Phase|Death|0|||
161153856|NCT00772967|581943995|FG003|Crossover Treatment 3|Adverse Event|0|||
161153857|NCT00772967|581943996|FG004|Crossover Treatment 3|Adverse Event|1|||
161153858|NCT00772967|581943997|FG005|Crossover Treatment 3|Adverse Event|0|||
161153859|NCT00231062|581943998|FG000|Overall Study|Physician Decision|6|||
161061749|NCT00505414|581617287|FG000|Titration Phase|Lack of Efficacy|0|||
161061750|NCT00505414|581617288|FG001|Titration Phase|Lack of Efficacy|0|||
161061751|NCT00505414|581617289|FG002|Titration Phase|Lack of Efficacy|0|||
161061752|NCT00505414|581617290|FG003|Titration Phase|Lack of Efficacy|10|||
161061753|NCT00505414|581617291|FG004|Titration Phase|Lack of Efficacy|1|||
161061754|NCT00505414|581617287|FG000|Titration Phase|Protocol Violation|0|||
161061755|NCT00505414|581617288|FG001|Titration Phase|Protocol Violation|0|||
161061756|NCT00505414|581617289|FG002|Titration Phase|Protocol Violation|0|||
161061757|NCT00505414|581617290|FG003|Titration Phase|Protocol Violation|0|||
161061758|NCT00505414|581617291|FG004|Titration Phase|Protocol Violation|1|||
161061759|NCT00505414|581617287|FG000|Titration Phase|Withdrawal by Subject|0|||
161061760|NCT00505414|581617288|FG001|Titration Phase|Withdrawal by Subject|0|||
161061761|NCT00505414|581617289|FG002|Titration Phase|Withdrawal by Subject|0|||
161061762|NCT00505414|581617290|FG003|Titration Phase|Withdrawal by Subject|3|||
161061763|NCT00505414|581617291|FG004|Titration Phase|Withdrawal by Subject|4|||
161061764|NCT00505414|581617287|FG000|Titration Phase|Underlying disease and therapy required|0|||
161061765|NCT00505414|581617288|FG001|Titration Phase|Underlying disease and therapy required|0|||
161061766|NCT00505414|581617289|FG002|Titration Phase|Underlying disease and therapy required|0|||
161061767|NCT00505414|581617290|FG003|Titration Phase|Underlying disease and therapy required|7|||
161061768|NCT00505414|581617291|FG004|Titration Phase|Underlying disease and therapy required|3|||
161061769|NCT00505414|581617287|FG000|Maintenance Phase|Adverse Event|2|||
161061770|NCT00505414|581617288|FG001|Maintenance Phase|Adverse Event|2|||
161061771|NCT00505414|581617289|FG002|Maintenance Phase|Adverse Event|3|||
161061772|NCT00505414|581617290|FG003|Maintenance Phase|Adverse Event|0|||
161061773|NCT00505414|581617291|FG004|Maintenance Phase|Adverse Event|0|||
161061774|NCT00505414|581617287|FG000|Maintenance Phase|Death|2|||
161061775|NCT00505414|581617288|FG001|Maintenance Phase|Death|0|||
161061776|NCT00505414|581617289|FG002|Maintenance Phase|Death|1|||
161061777|NCT00505414|581617290|FG003|Maintenance Phase|Death|0|||
161061778|NCT00505414|581617291|FG004|Maintenance Phase|Death|0|||
161061779|NCT00505414|581617287|FG000|Maintenance Phase|Lack of Efficacy|2|||
161061780|NCT00505414|581617288|FG001|Maintenance Phase|Lack of Efficacy|1|||
161061781|NCT00505414|581617289|FG002|Maintenance Phase|Lack of Efficacy|1|||
161061782|NCT00505414|581617290|FG003|Maintenance Phase|Lack of Efficacy|0|||
161061783|NCT00505414|581617291|FG004|Maintenance Phase|Lack of Efficacy|0|||
161061784|NCT00505414|581617287|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161061785|NCT00505414|581617288|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161061786|NCT00505414|581617289|FG002|Maintenance Phase|Withdrawal by Subject|1|||
161061787|NCT00505414|581617290|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161061788|NCT00505414|581617291|FG004|Maintenance Phase|Withdrawal by Subject|0|||
161061789|NCT00505414|581617287|FG000|Maintenance Phase|underlying disease and therapy required|0|||
161061790|NCT00505414|581617288|FG001|Maintenance Phase|underlying disease and therapy required|2|||
161153860|NCT00803244|581943999|FG000|Overall Study|Adverse Event|1|||
161153861|NCT00803244|581944000|FG001|Overall Study|Adverse Event|2|||
161153862|NCT00803244|581943999|FG000|Overall Study|Withdrawal by Subject|2|||
161153863|NCT00803244|581944000|FG001|Overall Study|Withdrawal by Subject|3|||
161153864|NCT00803244|581943999|FG000|Overall Study|Any other reason not above-mentioned|4|||
161153865|NCT00803244|581944000|FG001|Overall Study|Any other reason not above-mentioned|10|||
161153866|NCT03321929|581944001|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
161345307|NCT01020123|582648924|FG000|Main Period|Adverse Event|5|||
161345308|NCT01020123|582648925|FG001|Main Period|Adverse Event|2|||
161345309|NCT01020123|582648926|FG002|Main Period|Adverse Event|2|||
161061791|NCT00505414|581617289|FG002|Maintenance Phase|underlying disease and therapy required|2|||
161061792|NCT00505414|581617290|FG003|Maintenance Phase|underlying disease and therapy required|0|||
161061793|NCT00505414|581617291|FG004|Maintenance Phase|underlying disease and therapy required|0|||
161061794|NCT00634920|581617294|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
161061795|NCT00634920|581617295|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
161061796|NCT00634920|581617296|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
161061797|NCT00634920|581617294|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
161061798|NCT00634920|581617295|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
161153867|NCT02873715|581944002|FG000|Overall Study|Lost to Follow-up|84|||
161153868|NCT02873715|581944003|FG001|Overall Study|Lost to Follow-up|94|||
161153869|NCT02873715|581944002|FG000|Overall Study|Withdrawal by Subject|7|||
161345310|NCT01020123|582648927|FG003|Main Period|Adverse Event|1|||
161282325|NCT00799058|582412981|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
161282326|NCT00799058|582412982|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
161282327|NCT00799058|582412983|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
161061799|NCT00634920|581617296|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
161282328|NCT02088697|582412986|FG000|Period I|Physician Decision|1|||
161282329|NCT02088697|582412987|FG001|Period I|Physician Decision|4|||
161282330|NCT02088697|582412986|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
161282331|NCT02088697|582412987|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
161282332|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Other|34|||
161282333|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Other|0|||
161282334|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Other|0|||
161282335|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Other|0|||
161282336|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Death|14|||
161282337|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Death|0|||
161282338|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Death|0|||
161282339|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Death|0|||
161282340|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
161282341|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
161282342|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
161282343|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
161282344|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
161282345|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161282346|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161282347|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
161282348|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
161282349|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
161282350|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
161282351|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
161282352|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
161282353|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161282354|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161282355|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
161282356|NCT01995513|582412990|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
161282357|NCT01995513|582412991|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161282358|NCT01995513|582412992|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161282359|NCT01995513|582412993|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
161282360|NCT01995513|582412990|FG000|Period 1: Second Open Label Treatment|Other|0|||
161282361|NCT01995513|582412991|FG001|Period 1: Second Open Label Treatment|Other|2|||
161282362|NCT01995513|582412992|FG002|Period 1: Second Open Label Treatment|Other|0|||
161061800|NCT00634920|581617294|FG000|Period 1 - Pre-Randomization|Rejections|0|||
161061801|NCT00634920|581617295|FG001|Period 1 - Pre-Randomization|Rejections|0|||
161061802|NCT00634920|581617296|FG002|Period 1 - Pre-Randomization|Rejections|55|||
161061803|NCT00634920|581617294|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
161061804|NCT00634920|581617295|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
161061805|NCT00634920|581617296|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
161061806|NCT00634920|581617294|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
161061807|NCT00634920|581617295|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
161061808|NCT00634920|581617296|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
161061809|NCT00634920|581617294|FG000|Period 1 - Pre-Randomization|Other issues|0|||
161061810|NCT00634920|581617295|FG001|Period 1 - Pre-Randomization|Other issues|0|||
161061811|NCT00634920|581617296|FG002|Period 1 - Pre-Randomization|Other issues|6|||
161061812|NCT00634920|581617294|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
161061813|NCT00634920|581617295|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
161061814|NCT00634920|581617296|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
161282363|NCT01995513|582412993|FG003|Period 1: Second Open Label Treatment|Other|0|||
161282364|NCT01995513|582412990|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
161282365|NCT01995513|582412991|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
161282366|NCT01995513|582412992|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
161282367|NCT01995513|582412993|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
161282368|NCT01995513|582412990|FG000|Period 2: Double Blind Treatment|Death|0|||
161282369|NCT01995513|582412991|FG001|Period 2: Double Blind Treatment|Death|0|||
161282370|NCT01995513|582412992|FG002|Period 2: Double Blind Treatment|Death|0|||
161282371|NCT01995513|582412993|FG003|Period 2: Double Blind Treatment|Death|1|||
161282372|NCT01995513|582412990|FG000|Period 2: Double Blind Treatment|Other|0|||
161345311|NCT01020123|582648928|FG004|Main Period|Adverse Event|1|||
161345312|NCT01020123|582648929|FG005|Main Period|Adverse Event|2|||
161061815|NCT00634920|581617294|FG000|Period 2 - Post-Randomization|Rejection|11|||
161061816|NCT00634920|581617295|FG001|Period 2 - Post-Randomization|Rejection|5|||
161153870|NCT02873715|581944003|FG001|Overall Study|Withdrawal by Subject|26|||
161153871|NCT02144220|581944004|FG000|Overall Study|technology incompatibility|9|||
161153872|NCT02144220|581944004|FG000|Overall Study|Lack of Efficacy|4|||
161153873|NCT02144220|581944004|FG000|Overall Study|Physician Decision|3|||
161061817|NCT00634920|581617296|FG002|Period 2 - Post-Randomization|Rejection|0|||
161061818|NCT00634920|581617294|FG000|Period 2 - Post-Randomization|Death|2|||
161153874|NCT02144220|581944004|FG000|Overall Study|Withdrawal by Subject|2|||
161153875|NCT02144220|581944004|FG000|Overall Study|Protocol Violation|1|||
161153876|NCT00443430|581944007|FG000|Overall Study|Lack of Efficacy|3|||
161153877|NCT00443430|581944008|FG001|Overall Study|Lack of Efficacy|3|||
161153878|NCT00443430|581944007|FG000|Overall Study|Adverse Event|1|||
161153879|NCT00443430|581944008|FG001|Overall Study|Adverse Event|1|||
161153880|NCT00053846|581944009|FG000|Overall Study|Changed mind|8|||
161153881|NCT00053846|581944010|FG001|Overall Study|Changed mind|13|||
161153882|NCT00053846|581944009|FG000|Overall Study|Became too ill|8|||
161153883|NCT00053846|581944010|FG001|Overall Study|Became too ill|7|||
161153884|NCT00053846|581944009|FG000|Overall Study|Expired|5|||
161153885|NCT00053846|581944010|FG001|Overall Study|Expired|0|||
161153886|NCT00053846|581944009|FG000|Overall Study|Became ineligible|3|||
161153887|NCT00053846|581944010|FG001|Overall Study|Became ineligible|1|||
161153888|NCT00053846|581944009|FG000|Overall Study|Did not return data|1|||
161153889|NCT00053846|581944010|FG001|Overall Study|Did not return data|2|||
161153890|NCT00053846|581944009|FG000|Overall Study|Quit due to side effects|1|||
161153891|NCT00053846|581944010|FG001|Overall Study|Quit due to side effects|3|||
161153892|NCT00053846|581944009|FG000|Overall Study|Pills too large|0|||
161153893|NCT00053846|581944010|FG001|Overall Study|Pills too large|1|||
161153894|NCT00592501|581944011|FG000|Overall Study|Withdrawal by Subject|1|||
161061819|NCT00634920|581617295|FG001|Period 2 - Post-Randomization|Death|5|||
161061820|NCT00634920|581617296|FG002|Period 2 - Post-Randomization|Death|0|||
161061821|NCT00634920|581617294|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
161061822|NCT00634920|581617295|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
161061823|NCT00634920|581617296|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
161061824|NCT00634920|581617294|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
161061825|NCT00634920|581617295|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
161061826|NCT00634920|581617296|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
161061827|NCT04353817|581617297|FG000|Overall Study|Adverse Event|0|||
161061828|NCT04353817|581617298|FG001|Overall Study|Adverse Event|1|||
161061829|NCT01193218|581617299|FG000|0-12 Weeks|Adverse Event|6|||
161061830|NCT01193218|581617300|FG001|0-12 Weeks|Adverse Event|0|||
161061831|NCT01193218|581617301|FG002|0-12 Weeks|Adverse Event|1|||
161061832|NCT01193218|581617302|FG003|0-12 Weeks|Adverse Event|0|||
161061833|NCT01193218|581617303|FG004|0-12 Weeks|Adverse Event|0|||
161061834|NCT01193218|581617304|FG005|0-12 Weeks|Adverse Event|2|||
161061835|NCT01193218|581617305|FG006|0-12 Weeks|Adverse Event|2|||
161061836|NCT01193218|581617306|FG007|0-12 Weeks|Adverse Event|0|||
161061837|NCT01193218|581617299|FG000|0-12 Weeks|Protocol Violation|0|||
161061838|NCT01193218|581617300|FG001|0-12 Weeks|Protocol Violation|0|||
161061839|NCT01193218|581617301|FG002|0-12 Weeks|Protocol Violation|0|||
161061840|NCT01193218|581617302|FG003|0-12 Weeks|Protocol Violation|0|||
161061841|NCT01193218|581617303|FG004|0-12 Weeks|Protocol Violation|1|||
161061842|NCT01193218|581617304|FG005|0-12 Weeks|Protocol Violation|1|||
161061843|NCT01193218|581617305|FG006|0-12 Weeks|Protocol Violation|0|||
161061844|NCT01193218|581617306|FG007|0-12 Weeks|Protocol Violation|0|||
161061845|NCT01193218|581617299|FG000|0-12 Weeks|Withdrawal by Subject|3|||
161061846|NCT01193218|581617300|FG001|0-12 Weeks|Withdrawal by Subject|0|||
161061847|NCT01193218|581617301|FG002|0-12 Weeks|Withdrawal by Subject|2|||
161061848|NCT01193218|581617302|FG003|0-12 Weeks|Withdrawal by Subject|0|||
161061849|NCT01193218|581617303|FG004|0-12 Weeks|Withdrawal by Subject|0|||
161061850|NCT01193218|581617304|FG005|0-12 Weeks|Withdrawal by Subject|0|||
161061851|NCT01193218|581617305|FG006|0-12 Weeks|Withdrawal by Subject|1|||
161061852|NCT01193218|581617306|FG007|0-12 Weeks|Withdrawal by Subject|0|||
161061853|NCT01193218|581617299|FG000|12-52 Weeks|Adverse Event|1|||
161153895|NCT00592501|581944011|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
161282373|NCT01995513|582412991|FG001|Period 2: Double Blind Treatment|Other|0|||
161061854|NCT01193218|581617300|FG001|12-52 Weeks|Adverse Event|0|||
161061855|NCT01193218|581617301|FG002|12-52 Weeks|Adverse Event|1|||
161061856|NCT01193218|581617302|FG003|12-52 Weeks|Adverse Event|2|||
161061857|NCT01193218|581617303|FG004|12-52 Weeks|Adverse Event|3|||
161061858|NCT01193218|581617304|FG005|12-52 Weeks|Adverse Event|3|||
161061859|NCT01193218|581617305|FG006|12-52 Weeks|Adverse Event|1|||
161153896|NCT02275026|581944016|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
161153897|NCT02275026|581944016|FG000|Overall Study|Withdrawal by Subject|4|||
161153898|NCT02275026|581944016|FG000|Overall Study|Ineligible due to medical history|13|||
161153899|NCT02275026|581944016|FG000|Overall Study|MRI malfunction precluded testing|1|||
161153900|NCT02275026|581944016|FG000|Overall Study|Ineligible after MRI findings|1|||
161153901|NCT02275026|581944016|FG000|Overall Study|Lost to Follow-up|2|||
161061860|NCT01193218|581617306|FG007|12-52 Weeks|Adverse Event|2|||
161061861|NCT01193218|581617299|FG000|12-52 Weeks|Lack of Efficacy|0|||
161061862|NCT01193218|581617300|FG001|12-52 Weeks|Lack of Efficacy|0|||
161061863|NCT01193218|581617301|FG002|12-52 Weeks|Lack of Efficacy|0|||
161061864|NCT01193218|581617302|FG003|12-52 Weeks|Lack of Efficacy|0|||
161061865|NCT01193218|581617303|FG004|12-52 Weeks|Lack of Efficacy|0|||
161061866|NCT01193218|581617304|FG005|12-52 Weeks|Lack of Efficacy|0|||
161061867|NCT01193218|581617305|FG006|12-52 Weeks|Lack of Efficacy|1|||
161061868|NCT01193218|581617306|FG007|12-52 Weeks|Lack of Efficacy|0|||
161061869|NCT01193218|581617299|FG000|12-52 Weeks|Withdrawal by Subject|3|||
161061870|NCT01193218|581617300|FG001|12-52 Weeks|Withdrawal by Subject|0|||
161061871|NCT01193218|581617301|FG002|12-52 Weeks|Withdrawal by Subject|3|||
161061872|NCT01193218|581617302|FG003|12-52 Weeks|Withdrawal by Subject|0|||
161061873|NCT01193218|581617303|FG004|12-52 Weeks|Withdrawal by Subject|0|||
161061874|NCT01193218|581617304|FG005|12-52 Weeks|Withdrawal by Subject|2|||
161061875|NCT01193218|581617305|FG006|12-52 Weeks|Withdrawal by Subject|1|||
161061876|NCT01193218|581617306|FG007|12-52 Weeks|Withdrawal by Subject|2|||
161061877|NCT01193218|581617299|FG000|12-52 Weeks|Other reason than above|1|||
161061878|NCT01193218|581617300|FG001|12-52 Weeks|Other reason than above|0|||
161061879|NCT01193218|581617301|FG002|12-52 Weeks|Other reason than above|0|||
161061880|NCT01193218|581617302|FG003|12-52 Weeks|Other reason than above|1|||
161061881|NCT01193218|581617303|FG004|12-52 Weeks|Other reason than above|1|||
161061882|NCT01193218|581617304|FG005|12-52 Weeks|Other reason than above|0|||
161061883|NCT01193218|581617305|FG006|12-52 Weeks|Other reason than above|0|||
161061884|NCT01193218|581617306|FG007|12-52 Weeks|Other reason than above|0|||
161061885|NCT00665223|581617309|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
161061886|NCT00665223|581617310|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
161061887|NCT00665223|581617311|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
161061888|NCT00665223|581617309|FG000|Randomized Phase (26 Weeks)|Death|0|||
161061889|NCT00665223|581617310|FG001|Randomized Phase (26 Weeks)|Death|0|||
161061890|NCT00665223|581617311|FG002|Randomized Phase (26 Weeks)|Death|1|||
161061891|NCT00665223|581617309|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
161061892|NCT00665223|581617310|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
161061893|NCT00665223|581617311|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
161061894|NCT00665223|581617309|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
161061895|NCT00665223|581617310|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
161061896|NCT00665223|581617311|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
161061897|NCT00665223|581617309|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
161061898|NCT00665223|581617310|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
161061899|NCT00665223|581617311|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
161061900|NCT00665223|581617309|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
161061901|NCT00665223|581617310|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
161061902|NCT00665223|581617311|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
161061903|NCT00665223|581617309|FG000|Open-Label Period (26 Weeks)|Death|0|||
161061904|NCT00665223|581617310|FG001|Open-Label Period (26 Weeks)|Death|1|||
161061905|NCT00665223|581617311|FG002|Open-Label Period (26 Weeks)|Death|0|||
161061906|NCT00665223|581617309|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
161061907|NCT00665223|581617310|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
161282374|NCT01995513|582412992|FG002|Period 2: Double Blind Treatment|Other|3|||
161282375|NCT01995513|582412993|FG003|Period 2: Double Blind Treatment|Other|3|||
161282376|NCT01995513|582412990|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
161282377|NCT01995513|582412991|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
161282378|NCT01995513|582412992|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
161282379|NCT01995513|582412993|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
161282380|NCT01995513|582412990|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
161282381|NCT01995513|582412991|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
161282382|NCT01995513|582412992|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
161282383|NCT01995513|582412993|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
161282384|NCT01995513|582412990|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
161282385|NCT01995513|582412991|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
161282386|NCT01995513|582412992|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
161282387|NCT01995513|582412993|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
161282388|NCT01995513|582412990|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161061908|NCT00665223|581617311|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
161282389|NCT01995513|582412991|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161061909|NCT00665223|581617309|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
161061910|NCT00665223|581617310|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
161061911|NCT00665223|581617311|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
161061912|NCT00665223|581617309|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
161061913|NCT00665223|581617310|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
161061914|NCT00665223|581617311|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
161061915|NCT00665223|581617309|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
161061916|NCT00665223|581617310|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
161061917|NCT00665223|581617311|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
161282390|NCT01995513|582412992|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
161061918|NCT00363649|581617312|FG000|Overall Study|Withdrawal by Subject|1|||
161061919|NCT00363649|581617313|FG001|Overall Study|Withdrawal by Subject|1|||
161061920|NCT00363649|581617312|FG000|Overall Study|Adverse Event|6|||
161061921|NCT00363649|581617313|FG001|Overall Study|Adverse Event|0|||
161061922|NCT00591591|581617314|FG000|Overall Study|Withdrawal by Subject|1|||
161061923|NCT00591591|581617315|FG001|Overall Study|Withdrawal by Subject|37|||
161061924|NCT00591591|581617314|FG000|Overall Study|Lack of Efficacy|10|||
161061925|NCT00591591|581617315|FG001|Overall Study|Lack of Efficacy|2|||
161061926|NCT01013740|581617316|FG000|Overall Study|Lost to Follow-up|3|||
161061927|NCT01013740|581617317|FG001|Overall Study|Lost to Follow-up|5|||
161061928|NCT01013740|581617316|FG000|Overall Study|Physician Decision|2|||
161061929|NCT01013740|581617317|FG001|Overall Study|Physician Decision|0|||
161061930|NCT01013740|581617316|FG000|Overall Study|Withdrawal by Subject|2|||
161061931|NCT01013740|581617317|FG001|Overall Study|Withdrawal by Subject|10|||
161061932|NCT01013740|581617316|FG000|Overall Study|study close / terminated : done in error|2|||
161061933|NCT01013740|581617317|FG001|Overall Study|study close / terminated : done in error|1|||
161061934|NCT01013740|581617316|FG000|Overall Study|Missing|2|||
161061935|NCT01013740|581617317|FG001|Overall Study|Missing|1|||
161061936|NCT01013740|581617316|FG000|Overall Study|Ongoing: Study records not completed|0|||
161061937|NCT01013740|581617317|FG001|Overall Study|Ongoing: Study records not completed|2|||
161061938|NCT00002597|581617318|FG000|Overall Study|Protocol Violation|19|||
161061939|NCT00002597|581617319|FG001|Overall Study|Protocol Violation|17|||
161061940|NCT00002597|581617318|FG000|Overall Study|Withdrawal by Subject|7|||
161061941|NCT00002597|581617319|FG001|Overall Study|Withdrawal by Subject|6|||
161061942|NCT03811834|581617320|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
161061943|NCT00912223|581617321|FG000|Overall Study|Withdrawal by Subject|1|||
161061944|NCT00912223|581617321|FG000|Overall Study|Not transplanted|1|||
161061945|NCT00912223|581617321|FG000|Overall Study|Transformed disease|1|||
161061946|NCT00025662|581617325|FG000|Overall Study|Withdrawal by Subject|2|||
161061947|NCT00025662|581617325|FG000|Overall Study|Technical failure of manipulation|1|||
161061948|NCT02161185|581617326|FG000|Treatment Phase|Administrative/Other|7|||
161061949|NCT00519285|581617334|FG000|Overall Study|Adverse Event|127|||
161061950|NCT00519285|581617335|FG001|Overall Study|Adverse Event|266|||
161061951|NCT00519285|581617334|FG000|Overall Study|Disease progression|334|||
161061952|NCT00519285|581617335|FG001|Overall Study|Disease progression|186|||
161061953|NCT00519285|581617334|FG000|Overall Study|Physician Decision|75|||
161061954|NCT00519285|581617335|FG001|Overall Study|Physician Decision|47|||
161061955|NCT00519285|581617334|FG000|Overall Study|Participant's request|53|||
161061956|NCT00519285|581617335|FG001|Overall Study|Participant's request|84|||
161061957|NCT00519285|581617334|FG000|Overall Study|Consent withdrawn|4|||
161061958|NCT00519285|581617335|FG001|Overall Study|Consent withdrawn|5|||
161061959|NCT00519285|581617334|FG000|Overall Study|Poor compliance to protocol|5|||
161061960|NCT00519285|581617335|FG001|Overall Study|Poor compliance to protocol|7|||
161061961|NCT00519285|581617334|FG000|Overall Study|Reason unspecified|5|||
161061962|NCT00519285|581617335|FG001|Overall Study|Reason unspecified|8|||
161061963|NCT00519285|581617334|FG000|Overall Study|Not treated|8|||
161061964|NCT00519285|581617335|FG001|Overall Study|Not treated|7|||
161061965|NCT00519285|581617334|FG000|Overall Study|Treatment ongoing|1|||
161061966|NCT00519285|581617335|FG001|Overall Study|Treatment ongoing|2|||
161061967|NCT02970305|581617336|FG000|Overall Study|Adverse Event|10|||
161061968|NCT02970305|581617337|FG001|Overall Study|Adverse Event|6|||
161061969|NCT02970305|581617336|FG000|Overall Study|Lack of Efficacy|1|||
161061970|NCT02970305|581617337|FG001|Overall Study|Lack of Efficacy|1|||
161061971|NCT02970305|581617336|FG000|Overall Study|Noncompliance with study drug|2|||
161061972|NCT02970305|581617337|FG001|Overall Study|Noncompliance with study drug|4|||
161061973|NCT02970305|581617336|FG000|Overall Study|Protocol Violation|2|||
161061974|NCT02970305|581617337|FG001|Overall Study|Protocol Violation|2|||
161061975|NCT02970305|581617336|FG000|Overall Study|Withdrawal by Subject|12|||
161061976|NCT02970305|581617337|FG001|Overall Study|Withdrawal by Subject|11|||
161061977|NCT02970305|581617336|FG000|Overall Study|Not further specified|1|||
161061978|NCT02970305|581617337|FG001|Overall Study|Not further specified|2|||
161061979|NCT02970305|581617336|FG000|Overall Study|Lost to Follow-up|1|||
161061980|NCT02970305|581617337|FG001|Overall Study|Lost to Follow-up|2|||
161061981|NCT02175745|581617338|FG000|Overall Study|Not Eligible|1|||
161061982|NCT00808899|581617340|FG000|Overall Study|Death|1|||
161282391|NCT01995513|582412993|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
161282392|NCT01232452|582412994|FG000|Overall Study|Adverse Event|17|||
161061983|NCT00808899|581617340|FG000|Overall Study|Physician Decision|3|||
161061984|NCT04088500|581617341|FG000|Overall Study|Reason unknown|1|||
161061985|NCT04088500|581617341|FG000|Overall Study|Participant withdrew consent|1|||
161061986|NCT04088500|581617341|FG000|Overall Study|Disease progression|3|||
161061987|NCT00612352|581619303|FG000|Overall Study|Adverse Event|1|||
161061988|NCT00612352|581619304|FG001|Overall Study|Adverse Event|0|||
161061989|NCT00612352|581619303|FG000|Overall Study|Withdrawal by Subject|3|||
161061990|NCT00612352|581619304|FG001|Overall Study|Withdrawal by Subject|5|||
161061991|NCT00612352|581619303|FG000|Overall Study|moved out of state|1|||
161061992|NCT00612352|581619304|FG001|Overall Study|moved out of state|0|||
161061993|NCT00612352|581619303|FG000|Overall Study|didn't return calls/show up on test date|4|||
161282393|NCT01232452|582412995|FG001|Overall Study|Adverse Event|15|||
161282394|NCT01232452|582412994|FG000|Overall Study|Withdrawal by Subject|11|||
161282395|NCT01232452|582412995|FG001|Overall Study|Withdrawal by Subject|8|||
161282396|NCT01232452|582412994|FG000|Overall Study|Physician Decision|8|||
161061994|NCT00612352|581619304|FG001|Overall Study|didn't return calls/show up on test date|1|||
161061995|NCT00263211|581619305|FG000|Overall Study|Death|1|||
161061996|NCT00263211|581619306|FG001|Overall Study|Death|0|||
161061997|NCT00263211|581619305|FG000|Overall Study|Withdrawal by Subject|3|||
161061998|NCT00263211|581619306|FG001|Overall Study|Withdrawal by Subject|0|||
161061999|NCT00263211|581619305|FG000|Overall Study|Protocol Violation|1|||
161062000|NCT00263211|581619306|FG001|Overall Study|Protocol Violation|0|||
161062001|NCT00263211|581619305|FG000|Overall Study|Disease Progression|0|||
161062002|NCT00263211|581619306|FG001|Overall Study|Disease Progression|1|||
161062003|NCT02820597|581619307|FG000|Overall Study|Lost to Follow-up|12|||
161062004|NCT04606199|581619308|FG000|Overall Study|Withdrawal by Subject|2|||
161062005|NCT01475461|581619313|FG000|Run-in Period|Not meet eligibility criteria|16|||
161062006|NCT01475461|581619314|FG001|Run-in Period|Not meet eligibility criteria|0|||
161062007|NCT01475461|581619315|FG002|Run-in Period|Not meet eligibility criteria|0|||
161062008|NCT01475461|581619316|FG003|Run-in Period|Not meet eligibility criteria|0|||
161062009|NCT01475461|581619317|FG004|Run-in Period|Not meet eligibility criteria|0|||
161062010|NCT01475461|581619318|FG005|Run-in Period|Not meet eligibility criteria|0|||
161062011|NCT01475461|581619319|FG006|Run-in Period|Not meet eligibility criteria|0|||
161062012|NCT01475461|581619313|FG000|Run-in Period|Lost to Follow-up|7|||
161062013|NCT01475461|581619314|FG001|Run-in Period|Lost to Follow-up|0|||
161062014|NCT01475461|581619315|FG002|Run-in Period|Lost to Follow-up|0|||
161062015|NCT01475461|581619316|FG003|Run-in Period|Lost to Follow-up|0|||
161062016|NCT01475461|581619317|FG004|Run-in Period|Lost to Follow-up|0|||
161062017|NCT01475461|581619318|FG005|Run-in Period|Lost to Follow-up|0|||
161062018|NCT01475461|581619319|FG006|Run-in Period|Lost to Follow-up|0|||
161062019|NCT01475461|581619313|FG000|Run-in Period|Withdrawal by Subject|11|||
161062020|NCT01475461|581619314|FG001|Run-in Period|Withdrawal by Subject|0|||
161062021|NCT01475461|581619315|FG002|Run-in Period|Withdrawal by Subject|0|||
161062022|NCT01475461|581619316|FG003|Run-in Period|Withdrawal by Subject|0|||
161062023|NCT01475461|581619317|FG004|Run-in Period|Withdrawal by Subject|0|||
161062024|NCT01475461|581619318|FG005|Run-in Period|Withdrawal by Subject|0|||
161062025|NCT01475461|581619319|FG006|Run-in Period|Withdrawal by Subject|0|||
161062026|NCT01475461|581619313|FG000|Run-in Period|Other|3|||
161062027|NCT01475461|581619314|FG001|Run-in Period|Other|0|||
161062028|NCT01475461|581619315|FG002|Run-in Period|Other|0|||
161062029|NCT01475461|581619316|FG003|Run-in Period|Other|0|||
161062030|NCT01475461|581619317|FG004|Run-in Period|Other|0|||
161062031|NCT01475461|581619318|FG005|Run-in Period|Other|0|||
161062032|NCT01475461|581619319|FG006|Run-in Period|Other|0|||
161062033|NCT01475461|581619313|FG000|Run-in Period|Protocol Violation|4|||
161062034|NCT01475461|581619314|FG001|Run-in Period|Protocol Violation|0|||
161062035|NCT01475461|581619315|FG002|Run-in Period|Protocol Violation|0|||
161062036|NCT01475461|581619316|FG003|Run-in Period|Protocol Violation|0|||
161062037|NCT01475461|581619317|FG004|Run-in Period|Protocol Violation|0|||
161062038|NCT01475461|581619318|FG005|Run-in Period|Protocol Violation|0|||
161062039|NCT01475461|581619319|FG006|Run-in Period|Protocol Violation|0|||
161153902|NCT02275026|581944016|FG000|Overall Study|Scanner failure|1|||
161282397|NCT01232452|582412995|FG001|Overall Study|Physician Decision|12|||
161282398|NCT01232452|582412994|FG000|Overall Study|Protocol entry criterion not met|0|||
161282399|NCT01232452|582412995|FG001|Overall Study|Protocol entry criterion not met|2|||
161282400|NCT01232452|582412994|FG000|Overall Study|Sponsor Decision|3|||
161282401|NCT01232452|582412995|FG001|Overall Study|Sponsor Decision|1|||
161282402|NCT01232452|582412994|FG000|Overall Study|Protocol Violation|0|||
161282403|NCT01232452|582412995|FG001|Overall Study|Protocol Violation|1|||
161282404|NCT00247676|582413000|FG000|Overall Study|Death|5|||
161282405|NCT00247676|582413000|FG000|Overall Study|Adverse Event|11|||
161282406|NCT00247676|582413000|FG000|Overall Study|Lack of Efficacy|15|||
161282407|NCT00247676|582413000|FG000|Overall Study|Other|3|||
161282408|NCT00247676|582413000|FG000|Overall Study|Withdrawal by Subject|2|||
161282409|NCT03594071|582413001|FG000|Overall Study|Re-operation|3|||
161282410|NCT03594071|582413001|FG000|Overall Study|Missed visit|2|||
161062040|NCT01475461|581619313|FG000|Treatment Period|Death|0|||
161062041|NCT01475461|581619314|FG001|Treatment Period|Death|0|||
161062042|NCT01475461|581619315|FG002|Treatment Period|Death|0|||
161062043|NCT01475461|581619316|FG003|Treatment Period|Death|1|||
161062044|NCT01475461|581619317|FG004|Treatment Period|Death|0|||
161153903|NCT02379923|581944017|FG000|Overall Study|Death|5|||
161062045|NCT01475461|581619318|FG005|Treatment Period|Death|0|||
161062046|NCT01475461|581619319|FG006|Treatment Period|Death|0|||
161062047|NCT01475461|581619313|FG000|Treatment Period|Lost to Follow-up|0|||
161062048|NCT01475461|581619314|FG001|Treatment Period|Lost to Follow-up|3|||
161153904|NCT03288779|581944022|FG000|Overall Study|Withdrawal by Subject|3|||
161282411|NCT05219448|582413002|FG000|Overall Study|Lost to Follow-up|9|||
161282412|NCT05219448|582413003|FG001|Overall Study|Lost to Follow-up|0|||
161282413|NCT01750190|582413004|FG000|Overall Study|Adverse Event|47|||
161282414|NCT01750190|582413005|FG001|Overall Study|Adverse Event|19|||
161282415|NCT01750190|582413004|FG000|Overall Study|Death|38|||
161282416|NCT01750190|582413005|FG001|Overall Study|Death|11|||
161282417|NCT01750190|582413004|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
161282418|NCT01750190|582413005|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
161282419|NCT01750190|582413004|FG000|Overall Study|Lost to Follow-up|28|||
161282420|NCT01750190|582413005|FG001|Overall Study|Lost to Follow-up|7|||
161282421|NCT01750190|582413004|FG000|Overall Study|Physician Decision|16|||
161282422|NCT01750190|582413005|FG001|Overall Study|Physician Decision|17|||
161062049|NCT01475461|581619315|FG002|Treatment Period|Lost to Follow-up|2|||
161062050|NCT01475461|581619316|FG003|Treatment Period|Lost to Follow-up|3|||
161062051|NCT01475461|581619317|FG004|Treatment Period|Lost to Follow-up|1|||
161062052|NCT01475461|581619318|FG005|Treatment Period|Lost to Follow-up|2|||
161062053|NCT01475461|581619319|FG006|Treatment Period|Lost to Follow-up|1|||
161062054|NCT01475461|581619313|FG000|Treatment Period|Withdrawal by Subject|0|||
161062055|NCT01475461|581619314|FG001|Treatment Period|Withdrawal by Subject|2|||
161062056|NCT01475461|581619315|FG002|Treatment Period|Withdrawal by Subject|2|||
161062057|NCT01475461|581619316|FG003|Treatment Period|Withdrawal by Subject|0|||
161062058|NCT01475461|581619317|FG004|Treatment Period|Withdrawal by Subject|2|||
161062059|NCT01475461|581619318|FG005|Treatment Period|Withdrawal by Subject|2|||
161062060|NCT01475461|581619319|FG006|Treatment Period|Withdrawal by Subject|0|||
161062061|NCT01475461|581619313|FG000|Treatment Period|Other|0|||
161062062|NCT01475461|581619314|FG001|Treatment Period|Other|1|||
161062063|NCT01475461|581619315|FG002|Treatment Period|Other|0|||
161062064|NCT01475461|581619316|FG003|Treatment Period|Other|0|||
161062065|NCT01475461|581619317|FG004|Treatment Period|Other|0|||
161062066|NCT01475461|581619318|FG005|Treatment Period|Other|0|||
161062067|NCT01475461|581619319|FG006|Treatment Period|Other|0|||
161062068|NCT01475461|581619313|FG000|Treatment Period|Protocol Violation|0|||
161062069|NCT01475461|581619314|FG001|Treatment Period|Protocol Violation|1|||
161062070|NCT01475461|581619315|FG002|Treatment Period|Protocol Violation|0|||
161062071|NCT01475461|581619316|FG003|Treatment Period|Protocol Violation|0|||
161062072|NCT01475461|581619317|FG004|Treatment Period|Protocol Violation|0|||
161062073|NCT01475461|581619318|FG005|Treatment Period|Protocol Violation|0|||
161062074|NCT01475461|581619319|FG006|Treatment Period|Protocol Violation|1|||
161062075|NCT01475461|581619313|FG000|Treatment Period|Lack of Efficacy|0|||
161062076|NCT01475461|581619314|FG001|Treatment Period|Lack of Efficacy|2|||
161062077|NCT01475461|581619315|FG002|Treatment Period|Lack of Efficacy|0|||
161062078|NCT01475461|581619316|FG003|Treatment Period|Lack of Efficacy|2|||
161062079|NCT01475461|581619317|FG004|Treatment Period|Lack of Efficacy|1|||
161062080|NCT01475461|581619318|FG005|Treatment Period|Lack of Efficacy|1|||
161062081|NCT01475461|581619319|FG006|Treatment Period|Lack of Efficacy|0|||
161062082|NCT01475461|581619313|FG000|Treatment Period|Medication Error|0|||
161062083|NCT01475461|581619314|FG001|Treatment Period|Medication Error|0|||
161062084|NCT01475461|581619315|FG002|Treatment Period|Medication Error|0|||
161062085|NCT01475461|581619316|FG003|Treatment Period|Medication Error|1|||
161062086|NCT01475461|581619317|FG004|Treatment Period|Medication Error|0|||
161062087|NCT01475461|581619318|FG005|Treatment Period|Medication Error|0|||
161062088|NCT01475461|581619319|FG006|Treatment Period|Medication Error|0|||
161062089|NCT01475461|581619313|FG000|Treatment Period|Adverse Event|0|||
161062090|NCT01475461|581619314|FG001|Treatment Period|Adverse Event|0|||
161062091|NCT01475461|581619315|FG002|Treatment Period|Adverse Event|0|||
161282423|NCT01750190|582413004|FG000|Overall Study|Protocol Violation|6|||
161282424|NCT01750190|582413005|FG001|Overall Study|Protocol Violation|5|||
161282425|NCT01750190|582413004|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
161282426|NCT01750190|582413005|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
161282427|NCT01750190|582413004|FG000|Overall Study|Withdrawal by Subject|83|||
161282428|NCT01750190|582413005|FG001|Overall Study|Withdrawal by Subject|89|||
161282429|NCT01750190|582413004|FG000|Overall Study|Kidney Transplant|8|||
161062092|NCT01475461|581619316|FG003|Treatment Period|Adverse Event|1|||
161062093|NCT01475461|581619317|FG004|Treatment Period|Adverse Event|0|||
161062094|NCT01475461|581619318|FG005|Treatment Period|Adverse Event|0|||
161062095|NCT01475461|581619319|FG006|Treatment Period|Adverse Event|0|||
161062096|NCT02512861|581619320|FG000|Overall Study|Protocol Violation|3|||
161062097|NCT02512861|581619321|FG001|Overall Study|Protocol Violation|7|||
161062098|NCT02512861|581619320|FG000|Overall Study|Physician Decision|3|||
161062099|NCT02512861|581619321|FG001|Overall Study|Physician Decision|1|||
161062100|NCT02512861|581619320|FG000|Overall Study|Withdrawal by Subject|0|||
161062101|NCT02512861|581619321|FG001|Overall Study|Withdrawal by Subject|1|||
161062102|NCT00553605|581619322|FG000|Overall Study|Did not meet entrance criteria|1|||
161062103|NCT00553605|581619323|FG001|Overall Study|Did not meet entrance criteria|3|||
161062104|NCT00553605|581619322|FG000|Overall Study|Did not receive full dose|1|||
161062105|NCT00553605|581619323|FG001|Overall Study|Did not receive full dose|0|||
161282430|NCT01750190|582413005|FG001|Overall Study|Kidney Transplant|4|||
161282431|NCT01750190|582413004|FG000|Overall Study|Dialysis|22|||
161062106|NCT00553605|581619322|FG000|Overall Study|Randomized but not treated|2|||
161062107|NCT00553605|581619323|FG001|Overall Study|Randomized but not treated|0|||
161062108|NCT04582669|581619333|FG000|Overall Study|Subject missed appointment(s).|1|||
161062109|NCT04582669|581619334|FG001|Overall Study|Subject missed appointment(s).|0|||
161282432|NCT01750190|582413005|FG001|Overall Study|Dialysis|8|||
161062110|NCT04582669|581619335|FG002|Overall Study|Subject missed appointment(s).|1|||
161062111|NCT04582669|581619336|FG003|Overall Study|Subject missed appointment(s).|2|||
161062112|NCT04582669|581619333|FG000|Overall Study|Protocol Violation|0|||
161062113|NCT04582669|581619334|FG001|Overall Study|Protocol Violation|1|||
161062114|NCT04582669|581619335|FG002|Overall Study|Protocol Violation|1|||
161062115|NCT04582669|581619336|FG003|Overall Study|Protocol Violation|0|||
161062116|NCT01336205|581619343|FG000|Overall Study|Other|22|||
161062117|NCT01336205|581619344|FG001|Overall Study|Other|9|||
161062118|NCT01336205|581619343|FG000|Overall Study|Lost to Follow-up|40|||
161062119|NCT01336205|581619344|FG001|Overall Study|Lost to Follow-up|20|||
161062120|NCT01336205|581619343|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
161062121|NCT01336205|581619344|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
161062122|NCT01336205|581619343|FG000|Overall Study|Lack of Efficacy|4|||
161062123|NCT01336205|581619344|FG001|Overall Study|Lack of Efficacy|0|||
161062124|NCT01336205|581619343|FG000|Overall Study|Severe noncompliance with protocol|9|||
161062125|NCT01336205|581619344|FG001|Overall Study|Severe noncompliance with protocol|2|||
161062126|NCT01336205|581619343|FG000|Overall Study|Adverse Event|56|||
161062127|NCT01336205|581619344|FG001|Overall Study|Adverse Event|6|||
161062128|NCT01336205|581619343|FG000|Overall Study|Death|1|||
161062129|NCT01336205|581619344|FG001|Overall Study|Death|1|||
161062130|NCT01336205|581619343|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
161062131|NCT01336205|581619344|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
161062132|NCT01336205|581619343|FG000|Overall Study|Withdrawal by Subject|72|||
161062133|NCT01336205|581619344|FG001|Overall Study|Withdrawal by Subject|38|||
161062134|NCT01336205|581619343|FG000|Overall Study|Did not receive treatment|4|||
161062135|NCT01336205|581619344|FG001|Overall Study|Did not receive treatment|0|||
161062136|NCT04952701|581619345|FG000|Control Lens|Physician Decision|4|||
161062137|NCT04952701|581619345|FG000|Test Lens|Physician Decision|1|||
161062138|NCT04545476|581619348|FG000|Overall Study|Lost to Follow-up|1|||
161062139|NCT04545476|581619349|FG001|Overall Study|Lost to Follow-up|1|||
161062140|NCT04545476|581619350|FG002|Overall Study|Lost to Follow-up|0|||
161062141|NCT04545476|581619351|FG003|Overall Study|Lost to Follow-up|0|||
161062142|NCT00846768|581619356|FG000|Overall Study|Adverse Event|0|||
161062143|NCT00846768|581619357|FG001|Overall Study|Adverse Event|1|||
161062144|NCT00846768|581619358|FG002|Overall Study|Adverse Event|0|||
161062145|NCT00846768|581619359|FG003|Overall Study|Adverse Event|0|||
161062146|NCT00644878|581619360|FG000|Overall Study|Adverse Event|2|||
161062147|NCT00644878|581619360|FG000|Overall Study|Abnormal laboratory value|3|||
161062148|NCT00644878|581619360|FG000|Overall Study|Protocol deviation|2|||
161062149|NCT00644878|581619360|FG000|Overall Study|Treatment duration completed as per protocol|11|||
161062150|NCT04358068|581619361|FG000|Overall Study|Did not initiate study treatment|2|||
161062151|NCT04358068|581619362|FG001|Overall Study|Did not initiate study treatment|2|||
161062152|NCT02143063|581619365|FG000|Overall Study|Lost to Follow-up|16|||
161062153|NCT02143063|581619366|FG001|Overall Study|Lost to Follow-up|28|||
161062154|NCT02143063|581619367|FG002|Overall Study|Lost to Follow-up|29|||
161062155|NCT02143063|581619365|FG000|Overall Study|Withdrawal by Subject|0|||
161062156|NCT02143063|581619366|FG001|Overall Study|Withdrawal by Subject|1|||
161062157|NCT02143063|581619367|FG002|Overall Study|Withdrawal by Subject|0|||
161062158|NCT02143063|581619365|FG000|Overall Study|Death|0|||
161062159|NCT02143063|581619366|FG001|Overall Study|Death|1|||
161062160|NCT02143063|581619367|FG002|Overall Study|Death|1|||
161062161|NCT03517111|581619368|FG000|Enrolled|Withdrawal by Subject|0|||
161062162|NCT03517111|581619369|FG001|Enrolled|Withdrawal by Subject|1|||
161282433|NCT01750190|582413004|FG000|Overall Study|Other than Specified|13|||
161282434|NCT01750190|582413005|FG001|Overall Study|Other than Specified|4|||
161282435|NCT02287922|582413006|FG000|Overall Study|Adverse Event|1|||
161282436|NCT02287922|582413007|FG001|Overall Study|Adverse Event|1|||
161282437|NCT02287922|582413008|FG002|Overall Study|Adverse Event|3|||
161282438|NCT02287922|582413009|FG003|Overall Study|Adverse Event|4|||
161282439|NCT02287922|582413006|FG000|Overall Study|Withdrawal by Subject|1|||
161062163|NCT03517111|581619370|FG002|Enrolled|Withdrawal by Subject|0|||
161062164|NCT03517111|581619368|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
161062165|NCT03517111|581619369|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
161062166|NCT03517111|581619370|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
161062167|NCT03517111|581619368|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
161062168|NCT03517111|581619369|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
161062169|NCT03517111|581619370|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
161062170|NCT03517111|581619368|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
161062171|NCT03517111|581619369|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
161062172|NCT03517111|581619370|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
161282440|NCT02287922|582413007|FG001|Overall Study|Withdrawal by Subject|1|||
161062173|NCT03517111|581619368|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
161062174|NCT03517111|581619369|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
161062175|NCT03517111|581619370|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
161062176|NCT02062645|581619373|FG000|Overall Study|Adverse Event|2|||
161062177|NCT02062645|581619373|FG000|Overall Study|Protocol Violation|8|||
161062178|NCT02062645|581619373|FG000|Overall Study|Lost to Follow-up|5|||
161062179|NCT02864342|581619375|FG000|Overall Study|Eligibility Criteria Deviation|2|||
161062180|NCT02864342|581619376|FG001|Overall Study|Eligibility Criteria Deviation|3|||
161062181|NCT02864342|581619375|FG000|Overall Study|Withdrawal by Subject|4|||
161062182|NCT02864342|581619376|FG001|Overall Study|Withdrawal by Subject|2|||
161062183|NCT02864342|581619375|FG000|Overall Study|Device Technology Issue|6|||
161062184|NCT02864342|581619376|FG001|Overall Study|Device Technology Issue|7|||
161062185|NCT02864342|581619375|FG000|Overall Study|Death|0|||
161062186|NCT02864342|581619376|FG001|Overall Study|Death|1|||
161062187|NCT02864342|581619375|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
161062188|NCT02864342|581619376|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
161062189|NCT02864342|581619375|FG000|Overall Study|Lost to Follow-up|1|||
161062190|NCT02864342|581619376|FG001|Overall Study|Lost to Follow-up|5|||
161062191|NCT02864342|581619375|FG000|Overall Study|Lost Device|1|||
161062192|NCT02864342|581619376|FG001|Overall Study|Lost Device|0|||
161062193|NCT02864342|581619375|FG000|Overall Study|Adverse Event|1|||
161062194|NCT02864342|581619376|FG001|Overall Study|Adverse Event|0|||
161062195|NCT02261285|581619377|FG000|Overall Study|Disease progression|0|||
161062196|NCT02261285|581619378|FG001|Overall Study|Disease progression|0|||
161062197|NCT02261285|581619379|FG002|Overall Study|Disease progression|1|||
161062198|NCT00927901|581619380|FG000|Treatment Period 1|Subject withdrew consent|0|||
161062199|NCT00927901|581619381|FG001|Treatment Period 1|Subject withdrew consent|0|||
161062200|NCT00927901|581619382|FG002|Treatment Period 1|Subject withdrew consent|1|||
161062201|NCT00927901|581619383|FG003|Treatment Period 1|Subject withdrew consent|0|||
161062202|NCT00927901|581619380|FG000|Treatment Period 4|Adverse Event|0|||
161062203|NCT00927901|581619381|FG001|Treatment Period 4|Adverse Event|0|||
161062204|NCT00927901|581619382|FG002|Treatment Period 4|Adverse Event|0|||
161062205|NCT00927901|581619383|FG003|Treatment Period 4|Adverse Event|1|||
161062206|NCT00927901|581619380|FG000|Treatment Period 4|Subject withdrew consent|0|||
161062207|NCT00927901|581619381|FG001|Treatment Period 4|Subject withdrew consent|0|||
161062208|NCT00927901|581619382|FG002|Treatment Period 4|Subject withdrew consent|1|||
161062209|NCT00927901|581619383|FG003|Treatment Period 4|Subject withdrew consent|0|||
161062210|NCT01209286|581619384|FG000|Overall Study|Adverse Event|4|||
161062211|NCT01209286|581619385|FG001|Overall Study|Adverse Event|3|||
161062212|NCT01209286|581619386|FG002|Overall Study|Adverse Event|1|||
161062213|NCT01209286|581619384|FG000|Overall Study|Hematological Relapse After Remission|0|||
161062214|NCT01209286|581619385|FG001|Overall Study|Hematological Relapse After Remission|1|||
161062215|NCT01209286|581619386|FG002|Overall Study|Hematological Relapse After Remission|1|||
161062216|NCT01209286|581619384|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
161062217|NCT01209286|581619385|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
161062218|NCT01209286|581619386|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
161062219|NCT01209286|581619384|FG000|Overall Study|Physician Decision|0|||
161062220|NCT01209286|581619385|FG001|Overall Study|Physician Decision|2|||
161062221|NCT01209286|581619386|FG002|Overall Study|Physician Decision|0|||
161062222|NCT01209286|581619384|FG000|Overall Study|Other|0|||
161062223|NCT01209286|581619385|FG001|Overall Study|Other|1|||
161062224|NCT01209286|581619386|FG002|Overall Study|Other|0|||
161062225|NCT01349036|581619387|FG000|Overall Study|Disease progression|13|||
161062226|NCT01349036|581619388|FG001|Overall Study|Disease progression|22|||
161062227|NCT01349036|581619387|FG000|Overall Study|Other|1|||
161062228|NCT01349036|581619388|FG001|Overall Study|Other|0|||
161062229|NCT01349036|581619387|FG000|Overall Study|Withdrawal by Subject|0|||
161062230|NCT01349036|581619388|FG001|Overall Study|Withdrawal by Subject|2|||
161062231|NCT03796208|581619389|FG000|Overall Study|Withdrawal by Subject|3|||
161062232|NCT03796208|581619390|FG001|Overall Study|Withdrawal by Subject|0|||
161062233|NCT03796208|581619389|FG000|Overall Study|Loss of pregnancy|1|||
161062234|NCT03796208|581619390|FG001|Overall Study|Loss of pregnancy|1|||
161062235|NCT03796208|581619389|FG000|Overall Study|Changed prenatal clinics|0|||
161062236|NCT03796208|581619390|FG001|Overall Study|Changed prenatal clinics|5|||
161062237|NCT03796208|581619389|FG000|Overall Study|Lost to Follow-up|20|||
161062238|NCT03796208|581619390|FG001|Overall Study|Lost to Follow-up|16|||
161062239|NCT01161628|581619391|FG000|Overall Study|Death|6|||
161062240|NCT01161628|581619391|FG000|Overall Study|Lack of Efficacy|2|||
161062241|NCT00746356|581619395|FG000|Overall Study|Withdrawal by Subject|2|||
161062242|NCT00746356|581619396|FG001|Overall Study|Withdrawal by Subject|3|||
161062243|NCT00746356|581619395|FG000|Overall Study|Death|7|||
161062244|NCT00746356|581619396|FG001|Overall Study|Death|3|||
161062245|NCT00746356|581619395|FG000|Overall Study|Lost to Follow-up|1|||
161062246|NCT00746356|581619396|FG001|Overall Study|Lost to Follow-up|0|||
161062247|NCT00746356|581619395|FG000|Overall Study|Removal of Device|0|||
161062248|NCT00746356|581619396|FG001|Overall Study|Removal of Device|1|||
161062249|NCT00746356|581619395|FG000|Overall Study|Patient relocated|1|||
161062250|NCT00746356|581619396|FG001|Overall Study|Patient relocated|0|||
161062251|NCT01263925|581619397|FG000|Overall Study|Protocol Violation|1|||
161062252|NCT01263925|581619398|FG001|Overall Study|Protocol Violation|0|||
161062253|NCT01263925|581619397|FG000|Overall Study|Lack of Efficacy|0|||
161062254|NCT01263925|581619398|FG001|Overall Study|Lack of Efficacy|1|||
161153905|NCT03382899|581944023|FG000|Overall Study|Ineligibility Determined|0|||
161153906|NCT03382899|581944024|FG001|Overall Study|Ineligibility Determined|1|||
161153907|NCT03382899|581944023|FG000|Overall Study|Lost to Follow-up|0|||
161153908|NCT03382899|581944024|FG001|Overall Study|Lost to Follow-up|1|||
161153909|NCT03382899|581944023|FG000|Overall Study|Sponsor's decision|31|||
161153910|NCT03382899|581944024|FG001|Overall Study|Sponsor's decision|28|||
161153911|NCT03382899|581944023|FG000|Overall Study|Withdrawal by Subject|0|||
161153912|NCT03382899|581944024|FG001|Overall Study|Withdrawal by Subject|5|||
161153913|NCT00524745|581944026|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
161153914|NCT00524745|581944027|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
161153915|NCT00524745|581944028|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
161153916|NCT00524745|581944029|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
161153917|NCT03643432|581944030|FG000|Overall Study|Lost to Follow-up|1|||
161153918|NCT03643432|581944031|FG001|Overall Study|Lost to Follow-up|0|||
161153919|NCT02574312|581944032|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
161153920|NCT02574312|581944033|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
161153921|NCT00074412|581945467|FG000|Overall Study|Death|30|||
161153922|NCT00074412|581945468|FG001|Overall Study|Death|26|||
161153923|NCT00074412|581945467|FG000|Overall Study|Lost to Follow-up|52|||
161153924|NCT00074412|581945468|FG001|Overall Study|Lost to Follow-up|58|||
161153925|NCT01043185|581945469|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
161153926|NCT01043185|581945470|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
161153927|NCT01043185|581945471|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
161153928|NCT01043185|581945472|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
161153929|NCT01043185|581945473|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
161153930|NCT01043185|581945474|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
161153931|NCT01043185|581945475|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
161153932|NCT01043185|581945476|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
161153933|NCT01043185|581945477|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
161153934|NCT01043185|581945478|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
161153935|NCT01881620|581945479|FG000|Overall Study|Protocol Violation|4|||
161153936|NCT04467164|581945481|FG000|Washout (1 Week)|Lost to Follow-up|2|||
161153937|NCT04467164|581945482|FG001|Washout (1 Week)|Lost to Follow-up|0|||
161153938|NCT02273050|581945485|FG000|Overall Study|Adverse Event|4|||
161153939|NCT02273050|581945486|FG001|Overall Study|Adverse Event|3|||
161153940|NCT02273050|581945487|FG002|Overall Study|Adverse Event|3|||
161153941|NCT02273050|581945485|FG000|Overall Study|Death|0|||
161153942|NCT02273050|581945486|FG001|Overall Study|Death|0|||
161153943|NCT02273050|581945487|FG002|Overall Study|Death|1|||
161153944|NCT02273050|581945485|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
161153945|NCT02273050|581945486|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
161153946|NCT02273050|581945487|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
161153947|NCT02273050|581945485|FG000|Overall Study|Lack of Efficacy|0|||
161153948|NCT02273050|581945486|FG001|Overall Study|Lack of Efficacy|1|||
161153949|NCT02273050|581945487|FG002|Overall Study|Lack of Efficacy|1|||
161153950|NCT02273050|581945485|FG000|Overall Study|Withdrawal by Subject|17|||
161153951|NCT02273050|581945486|FG001|Overall Study|Withdrawal by Subject|14|||
161153952|NCT02273050|581945487|FG002|Overall Study|Withdrawal by Subject|16|||
161153953|NCT02273050|581945485|FG000|Overall Study|Lost to Follow-up|0|||
161153954|NCT02273050|581945486|FG001|Overall Study|Lost to Follow-up|2|||
161153955|NCT02273050|581945487|FG002|Overall Study|Lost to Follow-up|3|||
161345313|NCT01020123|582648930|FG006|Main Period|Adverse Event|1|||
161062255|NCT01263925|581619397|FG000|Overall Study|Adverse Event|23|||
161062256|NCT01263925|581619398|FG001|Overall Study|Adverse Event|22|||
161062257|NCT01263925|581619397|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
161062258|NCT01263925|581619398|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
161062259|NCT01263925|581619397|FG000|Overall Study|Withdrawal by Subject|6|||
161062260|NCT01263925|581619398|FG001|Overall Study|Withdrawal by Subject|8|||
161062261|NCT01263925|581619397|FG000|Overall Study|Other|4|||
161062262|NCT01263925|581619398|FG001|Overall Study|Other|4|||
161062263|NCT01263925|581619397|FG000|Overall Study|Lost to Follow-up|3|||
161062264|NCT01263925|581619398|FG001|Overall Study|Lost to Follow-up|1|||
161062265|NCT01263925|581619397|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
161062266|NCT01263925|581619398|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
161062267|NCT01263925|581619397|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
161062268|NCT01263925|581619398|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
161153956|NCT02273050|581945485|FG000|Overall Study|Protocol Violation|3|||
161153957|NCT02273050|581945486|FG001|Overall Study|Protocol Violation|1|||
161153958|NCT02273050|581945487|FG002|Overall Study|Protocol Violation|4|||
161153959|NCT02273752|581945488|FG000|Overall Study|Trial was terminated early|2|||
161153960|NCT00903032|581945489|FG000|Overall Study|Withdrawal by Subject|5|||
161153961|NCT00903032|581945490|FG001|Overall Study|Withdrawal by Subject|3|||
161153962|NCT00903032|581945489|FG000|Overall Study|Lost to Follow-up|2|||
161153963|NCT00903032|581945490|FG001|Overall Study|Lost to Follow-up|2|||
161153964|NCT01429792|581945491|FG000|Overall Study|Other Reasons|67|||
161282441|NCT02287922|582413008|FG002|Overall Study|Withdrawal by Subject|1|||
161282442|NCT02287922|582413009|FG003|Overall Study|Withdrawal by Subject|2|||
161282443|NCT02287922|582413006|FG000|Overall Study|Lost to Follow-up|0|||
161282444|NCT02287922|582413007|FG001|Overall Study|Lost to Follow-up|0|||
161062269|NCT01263925|581619397|FG000|Overall Study|AE/ Withdrawal|1|||
161062270|NCT01263925|581619398|FG001|Overall Study|AE/ Withdrawal|4|||
161062271|NCT01263925|581619397|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
161062272|NCT01263925|581619398|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
161062273|NCT01263925|581619397|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
161062274|NCT01263925|581619398|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
161062275|NCT01263925|581619397|FG000|Overall Study|Withdrawal/ Not specified|0|||
161062276|NCT01263925|581619398|FG001|Overall Study|Withdrawal/ Not specified|1|||
161062277|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
161062278|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
161062279|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
161062280|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
161062281|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
161062282|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
161062283|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
161062284|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
161062285|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
161062286|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
161062287|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
161062288|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
161062289|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
161062290|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
161062291|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
161062292|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
161062293|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
161062294|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
161062295|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
161062296|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
161062297|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
161062298|NCT01125566|581619399|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
161062299|NCT01125566|581619400|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
161062300|NCT01125566|581619401|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
161062301|NCT01125566|581619399|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
161062302|NCT01125566|581619400|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
161062303|NCT01125566|581619401|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
161062304|NCT01125566|581619399|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
161062305|NCT01125566|581619400|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
161062306|NCT01125566|581619401|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
161062307|NCT01125566|581619399|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
161062308|NCT01125566|581619400|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
161062309|NCT01125566|581619401|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
161062310|NCT01125566|581619399|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
161062311|NCT01125566|581619400|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
161062312|NCT01125566|581619401|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
161062313|NCT01560585|581619402|FG000|Overall Study|Physician Decision|3|||
161062314|NCT00983892|581619403|FG000|Overall Study|Withdrawal by Subject|10|||
161062315|NCT00983892|581619404|FG001|Overall Study|Withdrawal by Subject|12|||
161062316|NCT01726517|581619405|FG000|Overall Study|Withdrawal by Subject|0|||
161062317|NCT01726517|581619406|FG001|Overall Study|Withdrawal by Subject|0|||
161062318|NCT01726517|581619407|FG002|Overall Study|Withdrawal by Subject|1|||
161062319|NCT01726517|581619408|FG003|Overall Study|Withdrawal by Subject|0|||
161062320|NCT01726517|581619409|FG004|Overall Study|Withdrawal by Subject|0|||
161062321|NCT03765164|581619414|FG000|Pre-intervention|Withdrawal by Subject|5|||
161062322|NCT03765164|581619415|FG001|Pre-intervention|Withdrawal by Subject|6|||
161062323|NCT02484547|581619416|FG000|Placebo-Controlled Period|Adverse Event|10|||
161062324|NCT02484547|581619417|FG001|Placebo-Controlled Period|Adverse Event|13|||
161062325|NCT02484547|581619418|FG002|Placebo-Controlled Period|Adverse Event|20|||
161062326|NCT02484547|581619419|FG003|Placebo-Controlled Period|Adverse Event|0|||
161062327|NCT02484547|581619420|FG004|Placebo-Controlled Period|Adverse Event|0|||
161062328|NCT02484547|581619421|FG005|Placebo-Controlled Period|Adverse Event|0|||
161282445|NCT02287922|582413008|FG002|Overall Study|Lost to Follow-up|1|||
161282446|NCT02287922|582413009|FG003|Overall Study|Lost to Follow-up|0|||
161062329|NCT02484547|581619422|FG006|Placebo-Controlled Period|Adverse Event|0|||
161062330|NCT02484547|581619416|FG000|Placebo-Controlled Period|Change of Treatment|0|||
161062331|NCT02484547|581619417|FG001|Placebo-Controlled Period|Change of Treatment|0|||
161062332|NCT02484547|581619418|FG002|Placebo-Controlled Period|Change of Treatment|1|||
161062333|NCT02484547|581619419|FG003|Placebo-Controlled Period|Change of Treatment|0|||
161062334|NCT02484547|581619420|FG004|Placebo-Controlled Period|Change of Treatment|0|||
161062335|NCT02484547|581619421|FG005|Placebo-Controlled Period|Change of Treatment|0|||
161062336|NCT02484547|581619422|FG006|Placebo-Controlled Period|Change of Treatment|0|||
161062337|NCT02484547|581619416|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
161062338|NCT02484547|581619417|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
161062339|NCT02484547|581619418|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
161062340|NCT02484547|581619419|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
161062341|NCT02484547|581619420|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
161062342|NCT02484547|581619421|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
161062343|NCT02484547|581619422|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
161062344|NCT02484547|581619416|FG000|Placebo-Controlled Period|Death|5|||
161062345|NCT02484547|581619417|FG001|Placebo-Controlled Period|Death|0|||
161062346|NCT02484547|581619418|FG002|Placebo-Controlled Period|Death|6|||
161062347|NCT02484547|581619419|FG003|Placebo-Controlled Period|Death|0|||
161062348|NCT02484547|581619420|FG004|Placebo-Controlled Period|Death|0|||
161062349|NCT02484547|581619421|FG005|Placebo-Controlled Period|Death|0|||
161062350|NCT02484547|581619422|FG006|Placebo-Controlled Period|Death|0|||
161062351|NCT02484547|581619416|FG000|Placebo-Controlled Period|Disease Progression|2|||
161062352|NCT02484547|581619417|FG001|Placebo-Controlled Period|Disease Progression|0|||
161062353|NCT02484547|581619418|FG002|Placebo-Controlled Period|Disease Progression|1|||
161062354|NCT02484547|581619419|FG003|Placebo-Controlled Period|Disease Progression|0|||
161062355|NCT02484547|581619420|FG004|Placebo-Controlled Period|Disease Progression|0|||
161062356|NCT02484547|581619421|FG005|Placebo-Controlled Period|Disease Progression|0|||
161062357|NCT02484547|581619422|FG006|Placebo-Controlled Period|Disease Progression|0|||
161062358|NCT02484547|581619416|FG000|Placebo-Controlled Period|Investigator Decision|2|||
161062359|NCT02484547|581619417|FG001|Placebo-Controlled Period|Investigator Decision|2|||
161062360|NCT02484547|581619418|FG002|Placebo-Controlled Period|Investigator Decision|5|||
161062361|NCT02484547|581619419|FG003|Placebo-Controlled Period|Investigator Decision|0|||
161062362|NCT02484547|581619420|FG004|Placebo-Controlled Period|Investigator Decision|0|||
161062363|NCT02484547|581619421|FG005|Placebo-Controlled Period|Investigator Decision|0|||
161062364|NCT02484547|581619422|FG006|Placebo-Controlled Period|Investigator Decision|0|||
161062365|NCT02484547|581619416|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
161062366|NCT02484547|581619417|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
161062367|NCT02484547|581619418|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
161062368|NCT02484547|581619419|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
161062369|NCT02484547|581619420|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
161062370|NCT02484547|581619421|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
161062371|NCT02484547|581619422|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
161062372|NCT02484547|581619416|FG000|Placebo-Controlled Period|Relocation|1|||
161062373|NCT02484547|581619417|FG001|Placebo-Controlled Period|Relocation|1|||
161062374|NCT02484547|581619418|FG002|Placebo-Controlled Period|Relocation|1|||
161062375|NCT02484547|581619419|FG003|Placebo-Controlled Period|Relocation|0|||
161062376|NCT02484547|581619420|FG004|Placebo-Controlled Period|Relocation|0|||
161062377|NCT02484547|581619421|FG005|Placebo-Controlled Period|Relocation|0|||
161062378|NCT02484547|581619422|FG006|Placebo-Controlled Period|Relocation|0|||
161062379|NCT02484547|581619416|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
161062380|NCT02484547|581619417|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
161062381|NCT02484547|581619418|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
161062382|NCT02484547|581619419|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
161062383|NCT02484547|581619420|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
161062384|NCT02484547|581619421|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
161062385|NCT02484547|581619422|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
161062386|NCT02484547|581619416|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
161062387|NCT02484547|581619417|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161062388|NCT02484547|581619418|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161062389|NCT02484547|581619419|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161062390|NCT02484547|581619420|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161062391|NCT02484547|581619421|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161062392|NCT02484547|581619422|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161345314|NCT01020123|582648924|FG000|Main Period|Protocol Violation|4|||
161062393|NCT02484547|581619416|FG000|Placebo-Controlled Period|Reason not Specified|216|||
161062394|NCT02484547|581619417|FG001|Placebo-Controlled Period|Reason not Specified|194|||
161062395|NCT02484547|581619418|FG002|Placebo-Controlled Period|Reason not Specified|183|||
161062396|NCT02484547|581619419|FG003|Placebo-Controlled Period|Reason not Specified|0|||
161345315|NCT01020123|582648925|FG001|Main Period|Protocol Violation|4|||
161345316|NCT01020123|582648926|FG002|Main Period|Protocol Violation|2|||
161345317|NCT01020123|582648927|FG003|Main Period|Protocol Violation|5|||
161062397|NCT02484547|581619420|FG004|Placebo-Controlled Period|Reason not Specified|0|||
161062398|NCT02484547|581619421|FG005|Placebo-Controlled Period|Reason not Specified|0|||
161062399|NCT02484547|581619422|FG006|Placebo-Controlled Period|Reason not Specified|0|||
161062400|NCT02484547|581619416|FG000|Long-Term Extension Period|Adverse Event|0|||
161062401|NCT02484547|581619417|FG001|Long-Term Extension Period|Adverse Event|0|||
161062402|NCT02484547|581619418|FG002|Long-Term Extension Period|Adverse Event|0|||
161062403|NCT02484547|581619419|FG003|Long-Term Extension Period|Adverse Event|0|||
161062404|NCT02484547|581619420|FG004|Long-Term Extension Period|Adverse Event|1|||
161062405|NCT02484547|581619421|FG005|Long-Term Extension Period|Adverse Event|3|||
161062406|NCT02484547|581619422|FG006|Long-Term Extension Period|Adverse Event|2|||
161062407|NCT02484547|581619416|FG000|Long-Term Extension Period|Death|0|||
161062408|NCT02484547|581619417|FG001|Long-Term Extension Period|Death|0|||
161062409|NCT02484547|581619418|FG002|Long-Term Extension Period|Death|0|||
161062410|NCT02484547|581619419|FG003|Long-Term Extension Period|Death|0|||
161062411|NCT02484547|581619420|FG004|Long-Term Extension Period|Death|0|||
161062412|NCT02484547|581619421|FG005|Long-Term Extension Period|Death|3|||
161062413|NCT02484547|581619422|FG006|Long-Term Extension Period|Death|0|||
161062414|NCT02484547|581619416|FG000|Long-Term Extension Period|Disease Progression|0|||
161062415|NCT02484547|581619417|FG001|Long-Term Extension Period|Disease Progression|0|||
161062416|NCT02484547|581619418|FG002|Long-Term Extension Period|Disease Progression|0|||
161062417|NCT02484547|581619419|FG003|Long-Term Extension Period|Disease Progression|0|||
161062418|NCT02484547|581619420|FG004|Long-Term Extension Period|Disease Progression|2|||
161062419|NCT02484547|581619421|FG005|Long-Term Extension Period|Disease Progression|4|||
161062420|NCT02484547|581619422|FG006|Long-Term Extension Period|Disease Progression|0|||
161062421|NCT02484547|581619416|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
161062422|NCT02484547|581619417|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
161062423|NCT02484547|581619418|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
161062424|NCT02484547|581619419|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
161062425|NCT02484547|581619420|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
161062426|NCT02484547|581619421|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
161062427|NCT02484547|581619422|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
161062428|NCT02484547|581619416|FG000|Long-Term Extension Period|Loss of Capacity|0|||
161062429|NCT02484547|581619417|FG001|Long-Term Extension Period|Loss of Capacity|0|||
161062430|NCT02484547|581619418|FG002|Long-Term Extension Period|Loss of Capacity|0|||
161062431|NCT02484547|581619419|FG003|Long-Term Extension Period|Loss of Capacity|0|||
161062432|NCT02484547|581619420|FG004|Long-Term Extension Period|Loss of Capacity|1|||
161062433|NCT02484547|581619421|FG005|Long-Term Extension Period|Loss of Capacity|0|||
161062434|NCT02484547|581619422|FG006|Long-Term Extension Period|Loss of Capacity|0|||
161062435|NCT02484547|581619416|FG000|Long-Term Extension Period|Change of Treatment|0|||
161062436|NCT02484547|581619417|FG001|Long-Term Extension Period|Change of Treatment|0|||
161062437|NCT02484547|581619418|FG002|Long-Term Extension Period|Change of Treatment|0|||
161062438|NCT02484547|581619419|FG003|Long-Term Extension Period|Change of Treatment|0|||
161062439|NCT02484547|581619420|FG004|Long-Term Extension Period|Change of Treatment|0|||
161062440|NCT02484547|581619421|FG005|Long-Term Extension Period|Change of Treatment|0|||
161062441|NCT02484547|581619422|FG006|Long-Term Extension Period|Change of Treatment|1|||
161062442|NCT02484547|581619416|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
161062443|NCT02484547|581619417|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
161062444|NCT02484547|581619418|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
161062445|NCT02484547|581619419|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
161062446|NCT02484547|581619420|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
161062447|NCT02484547|581619421|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
161062448|NCT02484547|581619422|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
161062449|NCT02484547|581619416|FG000|Long-Term Extension Period|Investigator Decision|0|||
161062450|NCT02484547|581619417|FG001|Long-Term Extension Period|Investigator Decision|0|||
161062451|NCT02484547|581619418|FG002|Long-Term Extension Period|Investigator Decision|0|||
161062452|NCT02484547|581619419|FG003|Long-Term Extension Period|Investigator Decision|2|||
161062453|NCT02484547|581619420|FG004|Long-Term Extension Period|Investigator Decision|1|||
161062454|NCT02484547|581619421|FG005|Long-Term Extension Period|Investigator Decision|0|||
161062455|NCT02484547|581619422|FG006|Long-Term Extension Period|Investigator Decision|1|||
161062456|NCT02484547|581619416|FG000|Long-Term Extension Period|Relocation|0|||
161153965|NCT01429792|581945491|FG000|Overall Study|Unknown Disposition|94|||
161153966|NCT01429792|581945491|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
161062457|NCT02484547|581619417|FG001|Long-Term Extension Period|Relocation|0|||
161062458|NCT02484547|581619418|FG002|Long-Term Extension Period|Relocation|0|||
161062459|NCT02484547|581619419|FG003|Long-Term Extension Period|Relocation|1|||
161062460|NCT02484547|581619420|FG004|Long-Term Extension Period|Relocation|1|||
161062461|NCT02484547|581619421|FG005|Long-Term Extension Period|Relocation|0|||
161062462|NCT02484547|581619422|FG006|Long-Term Extension Period|Relocation|0|||
161062463|NCT02484547|581619416|FG000|Long-Term Extension Period|Study Visit Burden|0|||
161062464|NCT02484547|581619417|FG001|Long-Term Extension Period|Study Visit Burden|0|||
161062465|NCT02484547|581619418|FG002|Long-Term Extension Period|Study Visit Burden|0|||
161062466|NCT02484547|581619419|FG003|Long-Term Extension Period|Study Visit Burden|2|||
161062467|NCT02484547|581619420|FG004|Long-Term Extension Period|Study Visit Burden|0|||
161062468|NCT02484547|581619421|FG005|Long-Term Extension Period|Study Visit Burden|0|||
161062469|NCT02484547|581619422|FG006|Long-Term Extension Period|Study Visit Burden|3|||
161062470|NCT02484547|581619416|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161062471|NCT02484547|581619417|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161062472|NCT02484547|581619418|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161062473|NCT02484547|581619419|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
161062474|NCT02484547|581619420|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
161062475|NCT02484547|581619421|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
161062476|NCT02484547|581619422|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
161062477|NCT02484547|581619416|FG000|Long-Term Extension Period|Reason not Specified|0|||
161062478|NCT02484547|581619417|FG001|Long-Term Extension Period|Reason not Specified|0|||
161062479|NCT02484547|581619418|FG002|Long-Term Extension Period|Reason not Specified|0|||
161062480|NCT02484547|581619419|FG003|Long-Term Extension Period|Reason not Specified|119|||
161062481|NCT02484547|581619420|FG004|Long-Term Extension Period|Reason not Specified|117|||
161062482|NCT02484547|581619421|FG005|Long-Term Extension Period|Reason not Specified|223|||
161062483|NCT02484547|581619422|FG006|Long-Term Extension Period|Reason not Specified|231|||
161062484|NCT01813305|581619423|FG000|Overall Study|Withdrawal by Subject|12|||
161062485|NCT01813305|581619424|FG001|Overall Study|Withdrawal by Subject|5|||
161062486|NCT01813305|581619423|FG000|Overall Study|Safety Concern|4|||
161062487|NCT01813305|581619424|FG001|Overall Study|Safety Concern|0|||
161062488|NCT01813305|581619423|FG000|Overall Study|Ulcer became worse|4|||
161062489|NCT01813305|581619424|FG001|Overall Study|Ulcer became worse|0|||
161062490|NCT01813305|581619423|FG000|Overall Study|Physician Decision|4|||
161062491|NCT01813305|581619424|FG001|Overall Study|Physician Decision|0|||
161062492|NCT01813305|581619423|FG000|Overall Study|Lost to Follow-up|3|||
161062493|NCT01813305|581619424|FG001|Overall Study|Lost to Follow-up|1|||
161062494|NCT01813305|581619423|FG000|Overall Study|Protocol Violation|1|||
161062495|NCT01813305|581619424|FG001|Overall Study|Protocol Violation|0|||
161062496|NCT01813305|581619423|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
161062497|NCT01813305|581619424|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
161062498|NCT00770588|581619425|FG000|Overall Study|Adverse Event|9|||
161062499|NCT00770588|581619426|FG001|Overall Study|Adverse Event|2|||
161062500|NCT00770588|581619425|FG000|Overall Study|Death caused by progression of disease|70|||
161062501|NCT00770588|581619426|FG001|Overall Study|Death caused by progression of disease|91|||
161062502|NCT00770588|581619425|FG000|Overall Study|Lost to Follow-up|1|||
161062503|NCT00770588|581619426|FG001|Overall Study|Lost to Follow-up|1|||
161062504|NCT00770588|581619425|FG000|Overall Study|Withdrawal by Subject|1|||
161062505|NCT00770588|581619426|FG001|Overall Study|Withdrawal by Subject|1|||
161062506|NCT01424189|581619427|FG000|Overall Study|Adverse Event|1|||
161062507|NCT01424189|581619428|FG001|Overall Study|Adverse Event|0|||
161062508|NCT01424189|581619427|FG000|Overall Study|Lost to Follow-up|4|||
161062509|NCT01424189|581619428|FG001|Overall Study|Lost to Follow-up|1|||
161062510|NCT01424189|581619427|FG000|Overall Study|Withdrawal by Subject|4|||
161062511|NCT01424189|581619428|FG001|Overall Study|Withdrawal by Subject|4|||
161062512|NCT01424189|581619427|FG000|Overall Study|Subject moved|1|||
161062513|NCT01424189|581619428|FG001|Overall Study|Subject moved|0|||
161062514|NCT01424189|581619427|FG000|Overall Study|Death|3|||
161062515|NCT01424189|581619428|FG001|Overall Study|Death|1|||
161062516|NCT03120949|581619429|FG000|Overall Study|randomized in error|1|||
161062517|NCT03120949|581619430|FG001|Overall Study|randomized in error|0|||
161062518|NCT03120949|581619429|FG000|Overall Study|Death|13|||
161062519|NCT03120949|581619430|FG001|Overall Study|Death|13|||
161062520|NCT03120949|581619429|FG000|Overall Study|Lost to Follow-up|23|||
161062521|NCT03120949|581619430|FG001|Overall Study|Lost to Follow-up|13|||
161062522|NCT03120949|581619429|FG000|Overall Study|Withdrawal by Subject|139|||
161062523|NCT03120949|581619430|FG001|Overall Study|Withdrawal by Subject|124|||
161062524|NCT03120949|581619429|FG000|Overall Study|Covid-19|43|||
161062525|NCT03120949|581619430|FG001|Overall Study|Covid-19|34|||
161062526|NCT03120949|581619429|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
161062527|NCT03120949|581619430|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
161062528|NCT03120949|581619429|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
161062529|NCT03120949|581619430|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
161345318|NCT01020123|582648928|FG004|Main Period|Protocol Violation|2|||
161062530|NCT03120949|581619429|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
161062531|NCT03120949|581619430|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
161062532|NCT03120949|581619429|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
161345319|NCT01020123|582648929|FG005|Main Period|Protocol Violation|3|||
161062533|NCT03120949|581619430|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
161062534|NCT03120949|581619429|FG000|Overall Study|Site was closed|2|||
161062535|NCT03120949|581619430|FG001|Overall Study|Site was closed|3|||
161062536|NCT03120949|581619429|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
161062537|NCT03120949|581619430|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
161062538|NCT03120949|581619429|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
161062539|NCT03120949|581619430|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
161062540|NCT03120949|581619429|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
161062541|NCT03120949|581619430|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
161062542|NCT03120949|581619429|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
161062543|NCT03120949|581619430|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
161062544|NCT03120949|581619429|FG000|Overall Study|Other: Adverse Event|0|||
161062545|NCT03120949|581619430|FG001|Overall Study|Other: Adverse Event|1|||
161062546|NCT03120949|581619429|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
161062547|NCT03120949|581619430|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
161062548|NCT03120949|581619429|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
161062549|NCT03120949|581619430|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
161062550|NCT03120949|581619429|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
161062551|NCT03120949|581619430|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
161062552|NCT03120949|581619429|FG000|Overall Study|Personal Reasons|0|||
161062553|NCT03120949|581619430|FG001|Overall Study|Personal Reasons|1|||
161062554|NCT03120949|581619429|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
161062555|NCT03120949|581619430|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
161062556|NCT03120949|581619429|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
161062557|NCT03120949|581619430|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
161062558|NCT03120949|581619429|FG000|Overall Study|Compliance With Medication|0|||
161062559|NCT03120949|581619430|FG001|Overall Study|Compliance With Medication|1|||
161062560|NCT03120949|581619429|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
161062561|NCT03120949|581619430|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
161062562|NCT03120949|581619429|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
161062563|NCT03120949|581619430|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
161062564|NCT03120949|581619429|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
161062565|NCT03120949|581619430|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
161062566|NCT01705145|581619431|FG000|Part B|Adverse Event|1|||
161062567|NCT00988117|581619432|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
161062568|NCT00988117|581619432|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
161062569|NCT01203956|581619433|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
161062570|NCT01203956|581619434|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
161062571|NCT04206384|581619437|FG000|Overall Study|Withdrawal by Subject|8|||
161062572|NCT04206384|581619437|FG000|Overall Study|Adverse Event|2|||
161062573|NCT01121185|581619438|FG000|Overall Study|Not infused|0|||
161062574|NCT01121185|581619439|FG001|Overall Study|Not infused|1|||
161062575|NCT01121185|581619438|FG000|Overall Study|Not transplanted|1|||
161062576|NCT01121185|581619439|FG001|Overall Study|Not transplanted|0|||
161062577|NCT01260142|581619441|FG000|Treatment Period 1|Study on hold|1|||
161062578|NCT01260142|581619442|FG001|Treatment Period 1|Study on hold|1|||
161062579|NCT01260142|581619443|FG002|Treatment Period 1|Study on hold|0|||
161062580|NCT01260142|581619444|FG003|Treatment Period 1|Study on hold|0|||
161062581|NCT01260142|581619445|FG004|Treatment Period 1|Study on hold|1|||
161062582|NCT01260142|581619446|FG005|Treatment Period 1|Study on hold|2|||
161062583|NCT01260142|581619441|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
161062584|NCT01260142|581619442|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
161062585|NCT01260142|581619443|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
161062586|NCT01260142|581619444|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
161062587|NCT01260142|581619445|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
161062588|NCT01260142|581619446|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
161062589|NCT01260142|581619441|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161062590|NCT01260142|581619442|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161062591|NCT01260142|581619443|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161282447|NCT02287922|582413006|FG000|Overall Study|Sponsor's decision|0|||
161282448|NCT02287922|582413007|FG001|Overall Study|Sponsor's decision|0|||
161062592|NCT01260142|581619444|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161062593|NCT01260142|581619445|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161062594|NCT01260142|581619446|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161062595|NCT00496834|581619452|FG000|Overall Study|Withdrawal by Subject|4|||
161062596|NCT00496834|581619453|FG001|Overall Study|Withdrawal by Subject|6|||
161062597|NCT00496834|581619452|FG000|Overall Study|Contraindicated medication administered|0|||
161062598|NCT00496834|581619453|FG001|Overall Study|Contraindicated medication administered|1|||
161062599|NCT00496834|581619452|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
161062600|NCT00496834|581619453|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
161062601|NCT00496834|581619452|FG000|Overall Study|Adverse Event|5|||
161062602|NCT00496834|581619453|FG001|Overall Study|Adverse Event|3|||
161062603|NCT00496834|581619452|FG000|Overall Study|IP administration violation|2|||
161062604|NCT00496834|581619453|FG001|Overall Study|IP administration violation|0|||
161062605|NCT00496834|581619452|FG000|Overall Study|Lost to Follow-up|2|||
161062606|NCT00496834|581619453|FG001|Overall Study|Lost to Follow-up|0|||
161062607|NCT00496834|581619452|FG000|Overall Study|Blood Pressure control failure|2|||
161062608|NCT00496834|581619453|FG001|Overall Study|Blood Pressure control failure|1|||
161062609|NCT01503164|581619454|FG000|Overall Study|Withdrawal by Subject|2|||
161062610|NCT01503164|581619455|FG001|Overall Study|Withdrawal by Subject|1|||
161062611|NCT04088136|581619458|FG000|Overall Study|Withdrawal by Subject|5|||
161062612|NCT04088136|581619459|FG001|Overall Study|Withdrawal by Subject|0|||
161062613|NCT04088136|581619458|FG000|Overall Study|Lack of Efficacy|0|||
161062614|NCT04088136|581619459|FG001|Overall Study|Lack of Efficacy|1|||
161062615|NCT01494298|581619460|FG000|Overall Study|Protocol Violation|2|||
161062616|NCT01494298|581619461|FG001|Overall Study|Protocol Violation|8|||
161062617|NCT04159805|581619462|FG000|Overall Study|Withdrawal by Subject|0|||
161062618|NCT04159805|581619463|FG001|Overall Study|Withdrawal by Subject|2|||
161062619|NCT04159805|581619464|FG002|Overall Study|Withdrawal by Subject|2|||
161062620|NCT02998918|581619468|FG000|Overall Study|Withdrawal by Subject|1|||
161062621|NCT02998918|581619469|FG001|Overall Study|Withdrawal by Subject|0|||
161062622|NCT01283971|581619474|FG000|Overall Study|Adverse Event|3|||
161062623|NCT01283971|581619475|FG001|Overall Study|Adverse Event|5|||
161062624|NCT01283971|581619474|FG000|Overall Study|Insufficient therapeutic responses|3|||
161062625|NCT01283971|581619475|FG001|Overall Study|Insufficient therapeutic responses|3|||
161062626|NCT01283971|581619474|FG000|Overall Study|Protocol Violation|5|||
161062627|NCT01283971|581619475|FG001|Overall Study|Protocol Violation|1|||
161062628|NCT01283971|581619474|FG000|Overall Study|Refused treatment|3|||
161062629|NCT01283971|581619475|FG001|Overall Study|Refused treatment|1|||
161062630|NCT01283971|581619474|FG000|Overall Study|Failure to return|0|||
161062631|NCT01283971|581619475|FG001|Overall Study|Failure to return|1|||
161062632|NCT01283971|581619474|FG000|Overall Study|Administrative reasons|1|||
161062633|NCT01283971|581619475|FG001|Overall Study|Administrative reasons|1|||
161062634|NCT02598934|581619481|FG000|Overall Study|Adverse Event|11|||
161062635|NCT02598934|581619482|FG001|Overall Study|Adverse Event|13|||
161062636|NCT02598934|581619481|FG000|Overall Study|Failure to Return|3|||
161062637|NCT02598934|581619482|FG001|Overall Study|Failure to Return|3|||
161062638|NCT02598934|581619481|FG000|Overall Study|Withdrawal by Subject|2|||
161062639|NCT02598934|581619482|FG001|Overall Study|Withdrawal by Subject|3|||
161062640|NCT02598934|581619481|FG000|Overall Study|Administrative|2|||
161062641|NCT02598934|581619482|FG001|Overall Study|Administrative|1|||
161062642|NCT02598934|581619481|FG000|Overall Study|Protocol Violation|1|||
161062643|NCT02598934|581619482|FG001|Overall Study|Protocol Violation|2|||
161062644|NCT00702520|581619483|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
161062645|NCT00702520|581619484|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
161062646|NCT00702520|581619485|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
161062647|NCT00702520|581619486|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
161062648|NCT00702520|581619483|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
161062649|NCT00702520|581619484|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
161062650|NCT00702520|581619485|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
161062651|NCT00702520|581619486|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
161062652|NCT00702520|581619483|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
161062653|NCT00702520|581619484|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
161062654|NCT00702520|581619485|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
161062655|NCT00702520|581619486|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
161062656|NCT02154347|581619487|FG000|Double-blind Period|Adverse Event|1|||
161062657|NCT02154347|581619488|FG001|Double-blind Period|Adverse Event|2|||
161062658|NCT02154347|581619487|FG000|Double-blind Period|Lack of Efficacy|1|||
161062659|NCT02154347|581619488|FG001|Double-blind Period|Lack of Efficacy|0|||
161062660|NCT02154347|581619487|FG000|Double-blind Period|Physician Decision|0|||
161062661|NCT02154347|581619488|FG001|Double-blind Period|Physician Decision|1|||
161062662|NCT02154347|581619487|FG000|Double-blind Period|Withdrawal by Subject|1|||
161062663|NCT02154347|581619488|FG001|Double-blind Period|Withdrawal by Subject|1|||
161062664|NCT02154347|581619487|FG000|Open-label Period|Adverse Event|3|||
161062665|NCT02154347|581619488|FG001|Open-label Period|Adverse Event|4|||
161062666|NCT02154347|581619487|FG000|Open-label Period|Lack of Efficacy|4|||
161062667|NCT02154347|581619488|FG001|Open-label Period|Lack of Efficacy|19|||
161062668|NCT02154347|581619487|FG000|Open-label Period|Protocol Violation|0|||
161062669|NCT02154347|581619488|FG001|Open-label Period|Protocol Violation|1|||
161062670|NCT02154347|581619487|FG000|Open-label Period|Withdrawal by Subject|0|||
161062671|NCT02154347|581619488|FG001|Open-label Period|Withdrawal by Subject|1|||
161062672|NCT02481934|581619489|FG000|Overall Study|Death|2|||
161062673|NCT02473913|581619490|FG000|Overall Study|Lost to Follow-up|3|||
161062674|NCT02473913|581619491|FG001|Overall Study|Lost to Follow-up|3|||
161062675|NCT02250183|581619494|FG000|Overall Study|Withdrawal by Subject|2|||
161062676|NCT02250183|581619494|FG000|Overall Study|Adverse Event|5|||
161062677|NCT02250183|581619494|FG000|Overall Study|Lost to Follow-up|1|||
161062678|NCT02388347|581620814|FG000|Overall Study|Withdrawal by Subject|0|||
161062679|NCT02388347|581620815|FG001|Overall Study|Withdrawal by Subject|0|||
161062680|NCT02388347|581620816|FG002|Overall Study|Withdrawal by Subject|1|||
161062681|NCT02388347|581620817|FG003|Overall Study|Withdrawal by Subject|0|||
161062682|NCT02388347|581620818|FG004|Overall Study|Withdrawal by Subject|0|||
161062683|NCT00497874|581620819|FG000|Overall Study|Withdrawal by Subject|48|||
161062684|NCT00497874|581620820|FG001|Overall Study|Withdrawal by Subject|17|||
161062685|NCT00497874|581620819|FG000|Overall Study|Illness|8|||
161062686|NCT00497874|581620820|FG001|Overall Study|Illness|4|||
161062687|NCT00497874|581620819|FG000|Overall Study|Death|2|||
161062688|NCT00497874|581620820|FG001|Overall Study|Death|4|||
161062689|NCT00497874|581620819|FG000|Overall Study|Unable to contact|52|||
161062690|NCT00497874|581620820|FG001|Overall Study|Unable to contact|67|||
161062691|NCT00497874|581620819|FG000|Overall Study|Unable to schedule|37|||
161062692|NCT00497874|581620820|FG001|Overall Study|Unable to schedule|24|||
161062693|NCT01101334|581620821|FG000|Overall Study|Adverse Event|9|||
161062694|NCT01101334|581620822|FG001|Overall Study|Adverse Event|4|||
161062695|NCT01101334|581620821|FG000|Overall Study|Death|7|||
161062696|NCT01101334|581620822|FG001|Overall Study|Death|1|||
161062697|NCT01101334|581620821|FG000|Overall Study|Withdrawal by Subject|4|||
161062698|NCT01101334|581620822|FG001|Overall Study|Withdrawal by Subject|3|||
161062699|NCT01101334|581620821|FG000|Overall Study|Withdrawal by Sponsor|1|||
161062700|NCT01101334|581620822|FG001|Overall Study|Withdrawal by Sponsor|1|||
161062701|NCT01101334|581620821|FG000|Overall Study|Progressive Disease|22|||
161062702|NCT01101334|581620822|FG001|Overall Study|Progressive Disease|35|||
161062703|NCT01101334|581620821|FG000|Overall Study|Other|2|||
161062704|NCT01101334|581620822|FG001|Overall Study|Other|1|||
161062705|NCT04843579|581620827|FG000|Overall Study|Adverse Event|1|||
161062706|NCT04843579|581620827|FG000|Overall Study|Disease Progression|1|||
161062707|NCT04398368|581620828|FG000|Overall Study|Withdrawal by Subject|2|||
161062708|NCT02106195|581620829|FG000|Overall Study|Adverse Event|2|||
161062709|NCT02106195|581620829|FG000|Overall Study|Protocol Violation|1|||
161062710|NCT01114139|581620831|FG000|Overall Study|Adverse Event|3|||
161062711|NCT01114139|581620832|FG001|Overall Study|Adverse Event|2|||
161062712|NCT01114139|581620831|FG000|Overall Study|Lost to Follow-up|15|||
161062713|NCT01114139|581620832|FG001|Overall Study|Lost to Follow-up|3|||
161062714|NCT01114139|581620831|FG000|Overall Study|Withdrawal by Subject|17|||
161062715|NCT01114139|581620832|FG001|Overall Study|Withdrawal by Subject|6|||
161062716|NCT01114139|581620831|FG000|Overall Study|Other-Missed 1 visit|1|||
161062717|NCT01114139|581620832|FG001|Overall Study|Other-Missed 1 visit|0|||
161062718|NCT01114139|581620831|FG000|Overall Study|Other-Protocol Violation|1|||
161062719|NCT01114139|581620832|FG001|Overall Study|Other-Protocol Violation|0|||
161062720|NCT01114139|581620831|FG000|Overall Study|Other-Out of window for study drug dose|1|||
161062721|NCT01114139|581620832|FG001|Overall Study|Other-Out of window for study drug dose|0|||
161062722|NCT01114139|581620831|FG000|Overall Study|Other-Participant falsified records|0|||
161062723|NCT01114139|581620832|FG001|Overall Study|Other-Participant falsified records|1|||
161062724|NCT01114139|581620831|FG000|Overall Study|Other-Participant went on hospice|0|||
161062725|NCT01114139|581620832|FG001|Overall Study|Other-Participant went on hospice|1|||
161062726|NCT01114139|581620831|FG000|Overall Study|Other-Physician changed treatment|1|||
161062727|NCT01114139|581620832|FG001|Overall Study|Other-Physician changed treatment|0|||
161062728|NCT01114139|581620831|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
161062729|NCT01114139|581620832|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
161062730|NCT00477464|581620834|FG000|Overall Study|Lost to Follow-up|1|||
161062731|NCT00477464|581620834|FG000|Overall Study|Death|36|||
161062732|NCT00477464|581620834|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
161062733|NCT03568812|581620835|FG000|Overall Study|Physician Decision|0|||
161062734|NCT03568812|581620836|FG001|Overall Study|Physician Decision|1|||
161062735|NCT00639769|581620838|FG000|Overall Study|Death|2|||
161062736|NCT00639769|581620838|FG000|Overall Study|Adverse Event|7|||
161062737|NCT00639769|581620838|FG000|Overall Study|Lack of Efficacy|1|||
161062738|NCT00639769|581620838|FG000|Overall Study|Disease progression|26|||
161062739|NCT00639769|581620838|FG000|Overall Study|Withdrawal by Subject|4|||
161062740|NCT01774019|581620840|FG000|Overall Study|No longer meets protocol criteria|2|||
161062741|NCT01774019|581620841|FG001|Overall Study|No longer meets protocol criteria|0|||
161062742|NCT01774019|581620840|FG000|Overall Study|Withdrawal by Subject|1|||
161062743|NCT01774019|581620841|FG001|Overall Study|Withdrawal by Subject|0|||
161062744|NCT01774019|581620840|FG000|Overall Study|Surgery delayed > 120 days|1|||
161062745|NCT01774019|581620841|FG001|Overall Study|Surgery delayed > 120 days|0|||
161062746|NCT01774019|581620840|FG000|Overall Study|Patient refused surgery|1|||
161062747|NCT01774019|581620841|FG001|Overall Study|Patient refused surgery|1|||
161062748|NCT01774019|581620840|FG000|Overall Study|Unable to implant study device|1|||
161062749|NCT01774019|581620841|FG001|Overall Study|Unable to implant study device|0|||
161062750|NCT01774019|581620840|FG000|Overall Study|Lost to Follow-up|0|||
161062751|NCT01774019|581620841|FG001|Overall Study|Lost to Follow-up|3|||
161062752|NCT03470545|581620844|FG000|Overall Study|Death|0|||
161062753|NCT03470545|581620845|FG001|Overall Study|Death|1|||
161062754|NCT03470545|581620844|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
161062755|NCT03470545|581620845|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
161062756|NCT03470545|581620844|FG000|Overall Study|Adverse Event|2|||
161062757|NCT03470545|581620845|FG001|Overall Study|Adverse Event|0|||
161062758|NCT03470545|581620844|FG000|Overall Study|Withdrawal by Subject|1|||
161062759|NCT03470545|581620845|FG001|Overall Study|Withdrawal by Subject|1|||
161062760|NCT03470545|581620844|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
161062761|NCT03470545|581620845|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
161062762|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
161062763|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
161062764|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
161062765|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
161062766|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
161062767|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
161062768|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
161062769|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
161062770|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
161062771|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
161062772|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
161062773|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
161062774|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
161062775|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
161062776|NCT01664923|581620846|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
161062777|NCT01664923|581620847|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
161062778|NCT01664923|581620846|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
161062779|NCT01664923|581620847|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
161062780|NCT01664923|581620846|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
161062781|NCT01664923|581620847|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
161062782|NCT01664923|581620846|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
161062783|NCT01664923|581620847|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
161062784|NCT01664923|581620846|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
161062785|NCT01664923|581620847|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
161062786|NCT01664923|581620846|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
161062787|NCT01664923|581620847|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
161062788|NCT01664923|581620846|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
161062789|NCT01664923|581620847|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
161062790|NCT04035577|581620848|FG000|Overall Study|Lost to Follow-up|1|||
161062791|NCT04035577|581620848|FG000|Overall Study|Withdrawal by Subject|1|||
161062792|NCT00878553|581620851|FG000|Sleep Study|Withdrawal by Subject|2|||
161062793|NCT00878553|581620852|FG001|Sleep Study|Withdrawal by Subject|0|||
161062794|NCT00878553|581620853|FG002|Sleep Study|Withdrawal by Subject|0|||
161062795|NCT00878553|581620854|FG003|Sleep Study|Withdrawal by Subject|0|||
161062796|NCT00878553|581620855|FG004|Sleep Study|Withdrawal by Subject|0|||
161062797|NCT00878553|581620851|FG000|Sleep Study|Lost to Follow-up|1|||
161062798|NCT00878553|581620852|FG001|Sleep Study|Lost to Follow-up|0|||
161062799|NCT00878553|581620853|FG002|Sleep Study|Lost to Follow-up|0|||
161062800|NCT00878553|581620854|FG003|Sleep Study|Lost to Follow-up|0|||
161062801|NCT00878553|581620855|FG004|Sleep Study|Lost to Follow-up|0|||
161062802|NCT00878553|581620851|FG000|Sleep Study|car accident|1|||
161062803|NCT00878553|581620852|FG001|Sleep Study|car accident|0|||
161062804|NCT00878553|581620853|FG002|Sleep Study|car accident|0|||
161062805|NCT00878553|581620854|FG003|Sleep Study|car accident|0|||
161062806|NCT00878553|581620855|FG004|Sleep Study|car accident|0|||
161062807|NCT00878553|581620851|FG000|Sleep Study|family emergency|1|||
161062808|NCT00878553|581620852|FG001|Sleep Study|family emergency|0|||
161062809|NCT00878553|581620853|FG002|Sleep Study|family emergency|0|||
161062810|NCT00878553|581620854|FG003|Sleep Study|family emergency|0|||
161062811|NCT00878553|581620855|FG004|Sleep Study|family emergency|0|||
161062812|NCT00878553|581620851|FG000|PK Study|Withdrawal by Subject|0|||
161062813|NCT00878553|581620852|FG001|PK Study|Withdrawal by Subject|0|||
161062814|NCT00878553|581620853|FG002|PK Study|Withdrawal by Subject|0|||
161062815|NCT00878553|581620854|FG003|PK Study|Withdrawal by Subject|1|||
161062816|NCT00878553|581620855|FG004|PK Study|Withdrawal by Subject|0|||
161062817|NCT03188536|581620858|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
161062818|NCT03188536|581620858|FG000|Overall Study|Not participated/met inclusion criteria|1|||
161062819|NCT00118703|581620859|FG000|Overall Study|Protocol Violation|1|||
161062820|NCT00118703|581620860|FG001|Overall Study|Protocol Violation|0|||
161062821|NCT00118703|581620859|FG000|Overall Study|Adverse Event|1|||
161062822|NCT00118703|581620860|FG001|Overall Study|Adverse Event|1|||
161062823|NCT00118703|581620859|FG000|Overall Study|Participant took two different treatment|0|||
161062824|NCT00118703|581620860|FG001|Overall Study|Participant took two different treatment|1|||
161062825|NCT00118703|581620859|FG000|Overall Study|Withdrawal by Subject|2|||
161062826|NCT00118703|581620860|FG001|Overall Study|Withdrawal by Subject|5|||
161062827|NCT00118703|581620859|FG000|Overall Study|Lost to Follow-up|1|||
161062828|NCT00118703|581620860|FG001|Overall Study|Lost to Follow-up|2|||
161062829|NCT02344173|581620861|FG000|Procedure|Ablation Procedure Not Performed|7|||
161062830|NCT02344173|581620861|FG000|12-month Visit|Death|8|||
161062831|NCT02344173|581620861|FG000|12-month Visit|Withdrawal by Subject|30|||
161062832|NCT02344173|581620861|FG000|12-month Visit|Lost to Follow-up|58|||
161062833|NCT01891890|581620863|FG000|Overall Study|Lost to Follow-up|0|||
161062834|NCT01891890|581620864|FG001|Overall Study|Lost to Follow-up|0|||
161062835|NCT01891890|581620865|FG002|Overall Study|Lost to Follow-up|1|||
161062836|NCT01891890|581620863|FG000|Overall Study|Study ended before endpoint reached|7|||
161062837|NCT01891890|581620864|FG001|Overall Study|Study ended before endpoint reached|3|||
161062838|NCT01891890|581620865|FG002|Overall Study|Study ended before endpoint reached|6|||
161062839|NCT03605368|581620871|FG000|Overall Study|Lost to Follow-up|2|||
161062840|NCT03605368|581620872|FG001|Overall Study|Lost to Follow-up|1|||
161062841|NCT03605368|581620873|FG002|Overall Study|Lost to Follow-up|3|||
161062842|NCT03605368|581620874|FG003|Overall Study|Lost to Follow-up|2|||
161062843|NCT03605368|581620871|FG000|Overall Study|Withdrawal by Subject|0|||
161062844|NCT03605368|581620872|FG001|Overall Study|Withdrawal by Subject|0|||
161062845|NCT03605368|581620873|FG002|Overall Study|Withdrawal by Subject|4|||
161062846|NCT03605368|581620874|FG003|Overall Study|Withdrawal by Subject|3|||
161062847|NCT01215032|581620875|FG000|Overall Study|Adverse Event|3|||
161062848|NCT01215032|581620875|FG000|Overall Study|Lack of Efficacy|17|||
161062849|NCT01020747|581620880|FG000|Overall Study|Withdrawal by Subject|1|||
161062850|NCT02881047|581620881|FG000|Overall Study|Adverse Event|1|||
161062851|NCT02881047|581620881|FG000|Overall Study|Withdrawal by Subject|1|||
161062852|NCT03028012|581620882|FG000|Overall Study|Lost to Follow-up|2|||
161062853|NCT03028012|581620883|FG001|Overall Study|Lost to Follow-up|3|||
161062854|NCT03028012|581620884|FG002|Overall Study|Lost to Follow-up|3|||
161062855|NCT03448536|581620889|FG000|Overall Study|Protocol Violation|2|||
161062856|NCT03448536|581620890|FG001|Overall Study|Protocol Violation|0|||
161062857|NCT03448536|581620889|FG000|Overall Study|Pregnancy|1|||
161062858|NCT03448536|581620890|FG001|Overall Study|Pregnancy|0|||
161062859|NCT03448536|581620889|FG000|Overall Study|Withdrawal by Subject|1|||
161062860|NCT03448536|581620890|FG001|Overall Study|Withdrawal by Subject|2|||
161062861|NCT03448536|581620889|FG000|Overall Study|Lost to Follow-up|3|||
161062862|NCT03448536|581620890|FG001|Overall Study|Lost to Follow-up|2|||
161062863|NCT03448536|581620889|FG000|Overall Study|Inadequate pain reporter|1|||
161062864|NCT03448536|581620890|FG001|Overall Study|Inadequate pain reporter|0|||
161062865|NCT03448536|581620889|FG000|Overall Study|Other|3|||
161062866|NCT03448536|581620890|FG001|Overall Study|Other|0|||
161062867|NCT03448536|581620889|FG000|Overall Study|Physician Decision|1|||
161062868|NCT03448536|581620890|FG001|Overall Study|Physician Decision|0|||
161062869|NCT01665599|581620891|FG000|Overall Study|Adverse Event|1|||
161062870|NCT01665599|581620891|FG000|Overall Study|Consent Withdrawn|1|||
161062871|NCT01665599|581620891|FG000|Overall Study|Investigator/Sponsor decision|1|||
161062872|NCT01665599|581620891|FG000|Overall Study|Death|1|||
161062873|NCT01665599|581620891|FG000|Overall Study|Lost to Follow-up|2|||
161062874|NCT01665599|581620891|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
161062875|NCT01665599|581620891|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
161062876|NCT02230306|581620892|FG000|Overall Study|Did not receive study treatment|1|||
161062877|NCT00312845|581620894|FG000|Overall Study|Adverse Event|19|||
161062878|NCT00312845|581620895|FG001|Overall Study|Adverse Event|5|||
161062879|NCT00312845|581620894|FG000|Overall Study|Death|2|||
161062880|NCT00312845|581620895|FG001|Overall Study|Death|2|||
161062881|NCT00312845|581620894|FG000|Overall Study|Withdrawal by Subject|14|||
161062882|NCT00312845|581620895|FG001|Overall Study|Withdrawal by Subject|6|||
161062883|NCT00312845|581620894|FG000|Overall Study|Disease Progression|56|||
161062884|NCT00312845|581620895|FG001|Overall Study|Disease Progression|77|||
161062885|NCT00312845|581620894|FG000|Overall Study|Lost to Follow-up|2|||
161282449|NCT02287922|582413008|FG002|Overall Study|Sponsor's decision|0|||
161062886|NCT00312845|581620895|FG001|Overall Study|Lost to Follow-up|0|||
161062887|NCT00312845|581620894|FG000|Overall Study|Other|6|||
161062888|NCT00312845|581620895|FG001|Overall Study|Other|5|||
161062889|NCT01077622|581620896|FG000|Overall Study|Physician Decision|2|||
161062890|NCT01077622|581620896|FG000|Overall Study|Withdrawal by Subject|1|||
161062891|NCT00424177|581620897|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
161062892|NCT00424177|581620897|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
161062893|NCT00424177|581620897|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
161062894|NCT00424177|581620897|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
161062895|NCT00424177|581620897|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
161062896|NCT00424177|581620897|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
161282450|NCT02287922|582413009|FG003|Overall Study|Sponsor's decision|1|||
161062897|NCT00424177|581620897|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
161062898|NCT00424177|581620897|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
161062899|NCT00424177|581620897|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
161062900|NCT00424177|581620897|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
161062901|NCT01091519|581620902|FG000|Overall Study|Adverse Event|12|||
161062902|NCT01091519|581620903|FG001|Overall Study|Adverse Event|16|||
161062903|NCT01091519|581620902|FG000|Overall Study|Death|1|||
161062904|NCT01091519|581620903|FG001|Overall Study|Death|0|||
161062905|NCT01091519|581620902|FG000|Overall Study|Lack of Efficacy|16|||
161062906|NCT01091519|581620903|FG001|Overall Study|Lack of Efficacy|19|||
161062907|NCT01091519|581620902|FG000|Overall Study|Lost to Follow-up|14|||
161062908|NCT01091519|581620903|FG001|Overall Study|Lost to Follow-up|24|||
161062909|NCT01091519|581620902|FG000|Overall Study|Withdrawal by Subject|2|||
161062910|NCT01091519|581620903|FG001|Overall Study|Withdrawal by Subject|2|||
161062911|NCT01091519|581620902|FG000|Overall Study|Other|6|||
161062912|NCT01091519|581620903|FG001|Overall Study|Other|8|||
161062913|NCT01091519|581620902|FG000|Overall Study|Randomized not treated|4|||
161062914|NCT01091519|581620903|FG001|Overall Study|Randomized not treated|4|||
161062915|NCT01227928|581620904|FG000|Overall Study|Lost to Follow-up|4|||
161062916|NCT01227928|581620905|FG001|Overall Study|Lost to Follow-up|2|||
161062917|NCT01227928|581620904|FG000|Overall Study|Withdrawal by Subject|4|||
161062918|NCT01227928|581620905|FG001|Overall Study|Withdrawal by Subject|3|||
161062919|NCT01227928|581620904|FG000|Overall Study|Death|14|||
161062920|NCT01227928|581620905|FG001|Overall Study|Death|12|||
161062921|NCT02930837|581620906|FG000|Overall Study|Adverse Event|6|||
161062922|NCT02930837|581620906|FG000|Overall Study|Lost to Follow-up|5|||
161062923|NCT02930837|581620906|FG000|Overall Study|Withdrawal by Subject|1|||
161062924|NCT01393613|581620907|FG000|Overall Study|Adverse Event|11|||
161062925|NCT01393613|581620908|FG001|Overall Study|Adverse Event|11|||
161062926|NCT01393613|581620909|FG002|Overall Study|Adverse Event|13|||
161062927|NCT01393613|581620910|FG003|Overall Study|Adverse Event|22|||
161062928|NCT01393613|581620907|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
161062929|NCT01393613|581620908|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
161062930|NCT01393613|581620909|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
161062931|NCT01393613|581620910|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
161062932|NCT01393613|581620907|FG000|Overall Study|Physician Decision|2|||
161062933|NCT01393613|581620908|FG001|Overall Study|Physician Decision|0|||
161062934|NCT01393613|581620909|FG002|Overall Study|Physician Decision|0|||
161062935|NCT01393613|581620910|FG003|Overall Study|Physician Decision|1|||
161062936|NCT01393613|581620907|FG000|Overall Study|Withdrawal by Subject|15|||
161062937|NCT01393613|581620908|FG001|Overall Study|Withdrawal by Subject|25|||
161062938|NCT01393613|581620909|FG002|Overall Study|Withdrawal by Subject|23|||
161062939|NCT01393613|581620910|FG003|Overall Study|Withdrawal by Subject|21|||
161062940|NCT01393613|581620907|FG000|Overall Study|Protocol Deviation|2|||
161062941|NCT01393613|581620908|FG001|Overall Study|Protocol Deviation|1|||
161062942|NCT01393613|581620909|FG002|Overall Study|Protocol Deviation|0|||
161062943|NCT01393613|581620910|FG003|Overall Study|Protocol Deviation|0|||
161062944|NCT01393613|581620907|FG000|Overall Study|Lack of Efficacy|9|||
161062945|NCT01393613|581620908|FG001|Overall Study|Lack of Efficacy|20|||
161062946|NCT01393613|581620909|FG002|Overall Study|Lack of Efficacy|16|||
161062947|NCT01393613|581620910|FG003|Overall Study|Lack of Efficacy|21|||
161062948|NCT01071317|581620913|FG000|Overall Study|Lost to Follow-up|2|||
161062949|NCT01071317|581620914|FG001|Overall Study|Lost to Follow-up|2|||
161062950|NCT00316589|581620915|FG000|Overall Study|Withdrawal by Subject|0|||
161062951|NCT00316589|581620916|FG001|Overall Study|Withdrawal by Subject|5|||
161062952|NCT00316589|581620917|FG002|Overall Study|Withdrawal by Subject|0|||
161062953|NCT00316589|581620918|FG003|Overall Study|Withdrawal by Subject|1|||
161062954|NCT00316589|581620915|FG000|Overall Study|Subject unwilling/unable to comply|0|||
161062955|NCT00316589|581620916|FG001|Overall Study|Subject unwilling/unable to comply|6|||
161062956|NCT00316589|581620917|FG002|Overall Study|Subject unwilling/unable to comply|0|||
161153967|NCT01429792|581945491|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
161153968|NCT01429792|581945491|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
161062957|NCT00316589|581620918|FG003|Overall Study|Subject unwilling/unable to comply|2|||
161062958|NCT00316589|581620915|FG000|Overall Study|Adverse Event|1|||
161062959|NCT00316589|581620916|FG001|Overall Study|Adverse Event|0|||
161062960|NCT00316589|581620917|FG002|Overall Study|Adverse Event|0|||
161062961|NCT00316589|581620918|FG003|Overall Study|Adverse Event|1|||
161062962|NCT00316589|581620915|FG000|Overall Study|Physician Decision|0|||
161062963|NCT00316589|581620916|FG001|Overall Study|Physician Decision|1|||
161062964|NCT00316589|581620917|FG002|Overall Study|Physician Decision|0|||
161062965|NCT00316589|581620918|FG003|Overall Study|Physician Decision|0|||
161062966|NCT00316589|581620915|FG000|Overall Study|Other reason|0|||
161062967|NCT00316589|581620916|FG001|Overall Study|Other reason|12|||
161062968|NCT00316589|581620917|FG002|Overall Study|Other reason|1|||
161062969|NCT00316589|581620918|FG003|Overall Study|Other reason|1|||
161062970|NCT00562484|581620923|FG000|Overall Study|Adverse Event|6|||
161153969|NCT01429792|581945491|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
161062971|NCT00562484|581620924|FG001|Overall Study|Adverse Event|1|||
161062972|NCT00562484|581620923|FG000|Overall Study|Protocol Violation|11|||
161062973|NCT00562484|581620924|FG001|Overall Study|Protocol Violation|2|||
161062974|NCT00562484|581620923|FG000|Overall Study|Withdrawal by Subject|12|||
161062975|NCT00562484|581620924|FG001|Overall Study|Withdrawal by Subject|9|||
161062976|NCT00562484|581620923|FG000|Overall Study|Moved away from the study area|20|||
161062977|NCT00562484|581620924|FG001|Overall Study|Moved away from the study area|9|||
161062978|NCT00562484|581620923|FG000|Overall Study|Lost to Follow-up|132|||
161062979|NCT00562484|581620924|FG001|Overall Study|Lost to Follow-up|71|||
161062980|NCT00562484|581620923|FG000|Overall Study|Reason not provided or not specified|25|||
161062981|NCT00562484|581620924|FG001|Overall Study|Reason not provided or not specified|12|||
161062982|NCT03282799|581620928|FG000|Overall Study|Pregnancy|1|||
161062983|NCT03282799|581620929|FG001|Overall Study|Pregnancy|0|||
161062984|NCT03282799|581620928|FG000|Overall Study|Physician Decision|1|||
161062985|NCT03282799|581620929|FG001|Overall Study|Physician Decision|0|||
161062986|NCT03749616|581620930|FG000|Overall Study|Lost to Follow-up|4|||
161062987|NCT03749616|581620931|FG001|Overall Study|Lost to Follow-up|7|||
161062988|NCT03749616|581620930|FG000|Overall Study|Screen Failure|1|||
161062989|NCT03749616|581620931|FG001|Overall Study|Screen Failure|1|||
161062990|NCT03749616|581620930|FG000|Overall Study|Withdrawal by Subject|2|||
161062991|NCT03749616|581620931|FG001|Overall Study|Withdrawal by Subject|0|||
161062992|NCT03302559|581620932|FG000|Overall Study|Adverse Event|2|||
161062993|NCT03302559|581620932|FG000|Overall Study|Lost to Follow-up|1|||
161062994|NCT03302559|581620932|FG000|Overall Study|Withdrew Consent|3|||
161062995|NCT01171183|581622554|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
161062996|NCT01171183|581622555|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
161062997|NCT01171183|581622554|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
161062998|NCT01171183|581622555|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
161062999|NCT01171183|581622554|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
161063000|NCT01171183|581622555|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
161063001|NCT01171183|581622554|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
161063002|NCT01171183|581622555|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
161063003|NCT01171183|581622554|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
161063004|NCT01171183|581622555|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
161063005|NCT01171183|581622554|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
161063006|NCT01171183|581622555|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
161063007|NCT03440047|581622560|FG000|Overall Study|Withdrawal by Subject|2|||
161063008|NCT01053247|581622561|FG000|Overall Study|Withdrawal by Subject|9|||
161063009|NCT01053247|581622562|FG001|Overall Study|Withdrawal by Subject|4|||
161063010|NCT01053247|581622563|FG002|Overall Study|Withdrawal by Subject|15|||
161063011|NCT01053247|581622561|FG000|Overall Study|Lack of Efficacy|1|||
161063012|NCT01053247|581622562|FG001|Overall Study|Lack of Efficacy|0|||
161063013|NCT01053247|581622563|FG002|Overall Study|Lack of Efficacy|1|||
161063014|NCT01053247|581622561|FG000|Overall Study|Protocol Violation|2|||
161063015|NCT01053247|581622562|FG001|Overall Study|Protocol Violation|1|||
161063016|NCT01053247|581622563|FG002|Overall Study|Protocol Violation|2|||
161063017|NCT01053247|581622561|FG000|Overall Study|Lost to Follow-up|8|||
161063018|NCT01053247|581622562|FG001|Overall Study|Lost to Follow-up|5|||
161063019|NCT01053247|581622563|FG002|Overall Study|Lost to Follow-up|7|||
161063020|NCT01053247|581622561|FG000|Overall Study|Adverse Event|0|||
161063021|NCT01053247|581622562|FG001|Overall Study|Adverse Event|9|||
161063022|NCT01053247|581622563|FG002|Overall Study|Adverse Event|3|||
161063023|NCT03458728|581622564|FG000|Overall Study|Adverse Event|1|||
161063024|NCT03458728|581622565|FG001|Overall Study|Adverse Event|0|||
161063025|NCT03458728|581622564|FG000|Overall Study|Physician Decision|1|||
161063026|NCT03458728|581622565|FG001|Overall Study|Physician Decision|0|||
161063027|NCT03458728|581622564|FG000|Overall Study|Progressive disease - clinical assessment|1|||
161063028|NCT03458728|581622565|FG001|Overall Study|Progressive disease - clinical assessment|0|||
161063029|NCT03458728|581622564|FG000|Overall Study|Progressive disease - radiological progression|21|||
161063030|NCT03458728|581622565|FG001|Overall Study|Progressive disease - radiological progression|6|||
161063031|NCT03458728|581622564|FG000|Overall Study|Withdrawal by Subject|0|||
161063032|NCT03458728|581622565|FG001|Overall Study|Withdrawal by Subject|1|||
161063033|NCT03898700|581622568|FG000|Overall Study|Withdrawal by Subject|2|||
161282451|NCT02287922|582413006|FG000|Overall Study|Other|1|||
161282452|NCT02287922|582413007|FG001|Overall Study|Other|0|||
161063034|NCT00701909|581622569|FG000|Overall Study|Withdrawal by Subject|0|||
161063035|NCT00701909|581622570|FG001|Overall Study|Withdrawal by Subject|1|||
161063036|NCT00908349|581622571|FG000|Overall Study|Adverse Event|10|||
161063037|NCT00908349|581622571|FG000|Overall Study|Withdrawal by Subject|9|||
161063038|NCT00908349|581622571|FG000|Overall Study|Physician Decision|5|||
161063039|NCT00908349|581622571|FG000|Overall Study|Lost to Follow-up|5|||
161063040|NCT00908349|581622571|FG000|Overall Study|Various|6|||
161063041|NCT04009629|581622575|FG000|Overall Study|Withdrawal by Subject|2|||
161063042|NCT04009629|581622576|FG001|Overall Study|Withdrawal by Subject|0|||
161282453|NCT02287922|582413008|FG002|Overall Study|Other|2|||
161282454|NCT02287922|582413009|FG003|Overall Study|Other|0|||
161153970|NCT01429792|581945491|FG000|Overall Study|Withdrawal by Subject|70|||
161153971|NCT01429792|581945491|FG000|Overall Study|Lost to Follow-up|88|||
161153972|NCT03456713|581945492|FG000|Overall Study|Lost to Follow-up|1|||
161153973|NCT03456713|581945493|FG001|Overall Study|Lost to Follow-up|0|||
161153974|NCT03456713|581945494|FG002|Overall Study|Lost to Follow-up|0|||
161153975|NCT03456713|581945495|FG003|Overall Study|Lost to Follow-up|0|||
161153976|NCT01263691|581945496|FG000|Overall Study|Lost to Follow-up|1|||
161153977|NCT01263691|581945497|FG001|Overall Study|Lost to Follow-up|0|||
161153978|NCT01263691|581945498|FG002|Overall Study|Lost to Follow-up|1|||
161153979|NCT01263691|581945499|FG003|Overall Study|Lost to Follow-up|1|||
161153980|NCT01263691|581945500|FG004|Overall Study|Lost to Follow-up|0|||
161153981|NCT01263691|581945501|FG005|Overall Study|Lost to Follow-up|0|||
161153982|NCT01263691|581945496|FG000|Overall Study|Withdrawal by Subject|1|||
161153983|NCT01263691|581945497|FG001|Overall Study|Withdrawal by Subject|0|||
161153984|NCT01263691|581945498|FG002|Overall Study|Withdrawal by Subject|0|||
161153985|NCT01263691|581945499|FG003|Overall Study|Withdrawal by Subject|0|||
161153986|NCT01263691|581945500|FG004|Overall Study|Withdrawal by Subject|0|||
161153987|NCT01263691|581945501|FG005|Overall Study|Withdrawal by Subject|0|||
161153988|NCT01263691|581945496|FG000|Overall Study|Adverse Event|1|||
161153989|NCT01263691|581945497|FG001|Overall Study|Adverse Event|0|||
161153990|NCT01263691|581945498|FG002|Overall Study|Adverse Event|0|||
161153991|NCT01263691|581945499|FG003|Overall Study|Adverse Event|0|||
161153992|NCT01263691|581945500|FG004|Overall Study|Adverse Event|0|||
161153993|NCT01263691|581945501|FG005|Overall Study|Adverse Event|0|||
161153994|NCT00630812|581945513|FG000|Randomisation to First Dose|Adverse Event|1|||
161153995|NCT00630812|581945514|FG001|Randomisation to First Dose|Adverse Event|1|||
161153996|NCT00630812|581945513|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
161153997|NCT00630812|581945514|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
161153998|NCT00630812|581945513|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
161153999|NCT00630812|581945514|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
161154000|NCT00630812|581945513|FG000|Randomisation to First Dose|Protocol Violation|4|||
161154001|NCT00630812|581945514|FG001|Randomisation to First Dose|Protocol Violation|1|||
161154002|NCT00630812|581945513|FG000|Double Blind Treatment Period|Adverse Event|13|||
161154003|NCT00630812|581945514|FG001|Double Blind Treatment Period|Adverse Event|5|||
161154004|NCT00630812|581945513|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
161154005|NCT00630812|581945514|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161154006|NCT00630812|581945513|FG000|Double Blind Treatment Period|Physician Decision|2|||
161154007|NCT00630812|581945514|FG001|Double Blind Treatment Period|Physician Decision|1|||
161154008|NCT00630812|581945513|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161154009|NCT00630812|581945514|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161154010|NCT00630812|581945513|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
161154011|NCT00630812|581945514|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
161154012|NCT00630812|581945513|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
161154013|NCT00630812|581945514|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
161154014|NCT00630812|581945513|FG000|Double Blind Treatment Period|Non-compliance|0|||
161154015|NCT00630812|581945514|FG001|Double Blind Treatment Period|Non-compliance|1|||
161154016|NCT03656926|581945517|FG000|Overall Study|Adverse Event|5|||
161154017|NCT03656926|581945518|FG001|Overall Study|Adverse Event|4|||
161154018|NCT03656926|581945517|FG000|Overall Study|Withdrawal by Subject|7|||
161154019|NCT03656926|581945518|FG001|Overall Study|Withdrawal by Subject|2|||
161154020|NCT03656926|581945517|FG000|Overall Study|Screen fail after randomization|1|||
161154021|NCT03656926|581945518|FG001|Overall Study|Screen fail after randomization|0|||
161154022|NCT03656926|581945517|FG000|Overall Study|PI decision due to patient condition|1|||
161154023|NCT03656926|581945518|FG001|Overall Study|PI decision due to patient condition|0|||
161154024|NCT03656926|581945517|FG000|Overall Study|Patient unresponsiveness|1|||
161154025|NCT03656926|581945518|FG001|Overall Study|Patient unresponsiveness|0|||
161154026|NCT05761444|581945519|FG000|Overall Study|Protocol Violation|2|||
161154027|NCT05761444|581945520|FG001|Overall Study|Protocol Violation|1|||
161154028|NCT05761444|581945519|FG000|Overall Study|Adverse Event|2|||
161154029|NCT05761444|581945520|FG001|Overall Study|Adverse Event|2|||
161154030|NCT05761444|581945519|FG000|Overall Study|Withdrawal by Subject|3|||
161154031|NCT05761444|581945520|FG001|Overall Study|Withdrawal by Subject|2|||
161154032|NCT05761444|581945519|FG000|Overall Study|Other|1|||
161154033|NCT05761444|581945520|FG001|Overall Study|Other|0|||
161154034|NCT00850759|581945525|FG000|Overall Study|Lost to Follow-up|7|||
161154035|NCT00850759|581945526|FG001|Overall Study|Lost to Follow-up|5|||
161154036|NCT00850759|581945527|FG002|Overall Study|Lost to Follow-up|5|||
161154037|NCT00850759|581945528|FG003|Overall Study|Lost to Follow-up|3|||
161154038|NCT00578864|581945530|FG000|Overall Study|Death|1|||
161154039|NCT00578864|581945531|FG001|Overall Study|Death|0|||
161154040|NCT01253044|581945532|FG000|Overall Study|Lost to Follow-up|38|||
161154041|NCT01253044|581945533|FG001|Overall Study|Lost to Follow-up|29|||
161154042|NCT00987623|581945534|FG000|Overall Study|Lost to Follow-up|2|||
161154043|NCT00987623|581945535|FG001|Overall Study|Lost to Follow-up|1|||
161154044|NCT00987623|581945534|FG000|Overall Study|Time/job conflict|2|||
161154045|NCT00987623|581945535|FG001|Overall Study|Time/job conflict|0|||
161063043|NCT03602586|581622579|FG000|Overall Study|Withdrawal by Subject|3|||
161063044|NCT00511836|581622584|FG000|Double-blind Period|Lost to Follow-up|1|||
161063045|NCT00511836|581622585|FG001|Double-blind Period|Lost to Follow-up|0|||
161063046|NCT00030823|581622586|FG000|Overall Study|Withdrawal by Subject|1|||
161063047|NCT01755546|581622588|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
161063048|NCT01755546|581622588|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
161063049|NCT01755546|581622588|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
161063050|NCT01755546|581622588|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
161063051|NCT01755546|581622588|FG000|Titration Phase|Adverse Event|11|||
161063052|NCT01755546|581622588|FG000|Titration Phase|Lack of Efficacy|18|||
161063053|NCT01755546|581622588|FG000|Titration Phase|Protocol Violation|9|||
161063054|NCT01755546|581622588|FG000|Titration Phase|Lost to Follow-up|2|||
161063055|NCT01755546|581622588|FG000|Titration Phase|Other and Continuing|22|||
161063056|NCT01755546|581622588|FG000|Titration Phase|Withdrawal by Subject|8|||
161063057|NCT01755546|581622588|FG000|Long Term Treatment|Adverse Event|12|||
161063058|NCT01755546|581622588|FG000|Long Term Treatment|Lack of Efficacy|6|||
161063059|NCT01755546|581622588|FG000|Long Term Treatment|Protocol Violation|10|||
161063060|NCT01755546|581622588|FG000|Long Term Treatment|Withdrawal by Subject|35|||
161063061|NCT01755546|581622588|FG000|Long Term Treatment|Lost to Follow-up|17|||
161063062|NCT01755546|581622588|FG000|Long Term Treatment|other and ongoing|41|||
161063063|NCT00891046|581622593|FG000|Overall Study|Protocol Violation|1|||
161063064|NCT00891046|581622594|FG001|Overall Study|Protocol Violation|1|||
161063065|NCT00891046|581622595|FG002|Overall Study|Protocol Violation|0|||
161063066|NCT00891046|581622596|FG003|Overall Study|Protocol Violation|0|||
161063067|NCT00891046|581622597|FG004|Overall Study|Protocol Violation|1|||
161063068|NCT00891046|581622593|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161063069|NCT00891046|581622594|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161063070|NCT00891046|581622595|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
161063071|NCT00891046|581622596|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
161063072|NCT00891046|581622597|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
161063073|NCT00891046|581622593|FG000|Overall Study|Administrative problems|0|||
161063074|NCT00891046|581622594|FG001|Overall Study|Administrative problems|0|||
161063075|NCT00891046|581622595|FG002|Overall Study|Administrative problems|0|||
161063076|NCT00891046|581622596|FG003|Overall Study|Administrative problems|0|||
161063077|NCT00891046|581622597|FG004|Overall Study|Administrative problems|1|||
161063078|NCT00891046|581622593|FG000|Overall Study|Participant no longer required drug|0|||
161063079|NCT00891046|581622594|FG001|Overall Study|Participant no longer required drug|2|||
161063080|NCT00891046|581622595|FG002|Overall Study|Participant no longer required drug|0|||
161063081|NCT00891046|581622596|FG003|Overall Study|Participant no longer required drug|0|||
161063082|NCT00891046|581622597|FG004|Overall Study|Participant no longer required drug|1|||
161063083|NCT00891046|581622593|FG000|Overall Study|Adverse Event|4|||
161063084|NCT00891046|581622594|FG001|Overall Study|Adverse Event|3|||
161063085|NCT00891046|581622595|FG002|Overall Study|Adverse Event|2|||
161063086|NCT00891046|581622596|FG003|Overall Study|Adverse Event|0|||
161063087|NCT00891046|581622597|FG004|Overall Study|Adverse Event|14|||
161063088|NCT00891046|581622593|FG000|Overall Study|Withdrawal by Subject|2|||
161063089|NCT00891046|581622594|FG001|Overall Study|Withdrawal by Subject|1|||
161063090|NCT00891046|581622595|FG002|Overall Study|Withdrawal by Subject|2|||
161063091|NCT00891046|581622596|FG003|Overall Study|Withdrawal by Subject|1|||
161063092|NCT00891046|581622597|FG004|Overall Study|Withdrawal by Subject|1|||
161063093|NCT00891046|581622593|FG000|Overall Study|Lost to Follow-up|0|||
161063094|NCT00891046|581622594|FG001|Overall Study|Lost to Follow-up|0|||
161063095|NCT00891046|581622595|FG002|Overall Study|Lost to Follow-up|0|||
161063096|NCT00891046|581622596|FG003|Overall Study|Lost to Follow-up|0|||
161282455|NCT01526655|582413012|FG000|Overall Study|Withdrawal by Subject|0|||
161063097|NCT00891046|581622597|FG004|Overall Study|Lost to Follow-up|1|||
161063098|NCT00362375|581622598|FG000|Overall Study|Lost to Follow-up|40|||
161063099|NCT00362375|581622599|FG001|Overall Study|Lost to Follow-up|35|||
161063100|NCT04984239|581622600|FG000|Overall Study|Lost to Follow-up|1|||
161063101|NCT04702893|581622601|FG000|Overall Study|Other reasons than listed|11|||
161063102|NCT04702893|581622601|FG000|Overall Study|Withdrawal by Subject|3|||
161063103|NCT04702893|581622601|FG000|Overall Study|Lost to Follow-up|7|||
161063104|NCT04702893|581622601|FG000|Overall Study|Death|10|||
161282456|NCT01526655|582413013|FG001|Overall Study|Withdrawal by Subject|1|||
161063105|NCT04702893|581622601|FG000|Overall Study|Not treated|6|||
161063106|NCT01951378|581622602|FG000|Overall Study|Study Terminated-Not completed|23|||
161063107|NCT01951378|581622603|FG001|Overall Study|Study Terminated-Not completed|17|||
161063108|NCT00634842|581622604|FG000|Overall Study|Adverse Event|2|||
161063109|NCT00634842|581622605|FG001|Overall Study|Adverse Event|3|||
161063110|NCT00634842|581622604|FG000|Overall Study|Protocol Violation|8|||
161063111|NCT00634842|581622605|FG001|Overall Study|Protocol Violation|4|||
161063112|NCT00634842|581622604|FG000|Overall Study|Move to another state|1|||
161063113|NCT00634842|581622605|FG001|Overall Study|Move to another state|0|||
161063114|NCT00634842|581622604|FG000|Overall Study|Inclusion criteria were not met|1|||
161063115|NCT00634842|581622605|FG001|Overall Study|Inclusion criteria were not met|0|||
161154046|NCT00987623|581945534|FG000|Overall Study|Discomfort|1|||
161154047|NCT00987623|581945535|FG001|Overall Study|Discomfort|0|||
161154048|NCT00987623|581945534|FG000|Overall Study|Biomicroscopy|0|||
161154049|NCT00987623|581945535|FG001|Overall Study|Biomicroscopy|1|||
161154050|NCT00987623|581945534|FG000|Overall Study|Influenza|0|||
161154051|NCT00987623|581945535|FG001|Overall Study|Influenza|1|||
161154052|NCT03880227|581945545|FG000|First Visit|Withdrawal by Subject|1|||
161154053|NCT03880227|581945546|FG001|First Visit|Withdrawal by Subject|0|||
161154054|NCT03880227|581945547|FG002|First Visit|Withdrawal by Subject|0|||
161154055|NCT03880227|581945548|FG003|First Visit|Withdrawal by Subject|0|||
161154056|NCT03880227|581945545|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
161154057|NCT03880227|581945546|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
161154058|NCT03880227|581945547|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
161154059|NCT03880227|581945548|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
161154060|NCT03880227|581945545|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161154061|NCT03880227|581945546|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161154062|NCT03880227|581945547|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
161154063|NCT03880227|581945548|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
161154064|NCT03880227|581945545|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161154065|NCT03880227|581945546|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161154066|NCT03880227|581945547|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
161154067|NCT03880227|581945548|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
161154068|NCT04590937|581945549|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
161154069|NCT01635933|581945550|FG000|Overall Study|Adverse Event|1|||
161154070|NCT01635933|581945551|FG001|Overall Study|Adverse Event|0|||
161154071|NCT01635933|581945550|FG000|Overall Study|Lost to Follow-up|0|||
161154072|NCT01635933|581945551|FG001|Overall Study|Lost to Follow-up|5|||
161154073|NCT01635933|581945550|FG000|Overall Study|Subject decision|1|||
161154074|NCT01635933|581945551|FG001|Overall Study|Subject decision|1|||
161154075|NCT01635933|581945550|FG000|Overall Study|Noncompliance|0|||
161154076|NCT01635933|581945551|FG001|Overall Study|Noncompliance|1|||
161154077|NCT01635933|581945550|FG000|Overall Study|No longer had transportation|0|||
161154078|NCT01635933|581945551|FG001|Overall Study|No longer had transportation|1|||
161154079|NCT01544595|581945552|FG000|Status at Week 68|Adverse Event|3|||
161154080|NCT01544595|581945553|FG001|Status at Week 68|Adverse Event|2|||
161154081|NCT01544595|581945554|FG002|Status at Week 68|Adverse Event|1|||
161154082|NCT01544595|581945555|FG003|Status at Week 68|Adverse Event|0|||
161154083|NCT01544595|581945556|FG004|Status at Week 68|Adverse Event|0|||
161154084|NCT01544595|581945557|FG005|Status at Week 68|Adverse Event|0|||
161154085|NCT01544595|581945552|FG000|Status at Week 68|Lack of Efficacy|1|||
161154086|NCT01544595|581945553|FG001|Status at Week 68|Lack of Efficacy|0|||
161154087|NCT01544595|581945554|FG002|Status at Week 68|Lack of Efficacy|0|||
161154088|NCT01544595|581945555|FG003|Status at Week 68|Lack of Efficacy|0|||
161154089|NCT01544595|581945556|FG004|Status at Week 68|Lack of Efficacy|0|||
161154090|NCT01544595|581945557|FG005|Status at Week 68|Lack of Efficacy|0|||
161154091|NCT01544595|581945552|FG000|Status at Week 68|Lost to Follow-up|1|||
161154092|NCT01544595|581945553|FG001|Status at Week 68|Lost to Follow-up|1|||
161154093|NCT01544595|581945554|FG002|Status at Week 68|Lost to Follow-up|0|||
161154094|NCT01544595|581945555|FG003|Status at Week 68|Lost to Follow-up|0|||
161154095|NCT01544595|581945556|FG004|Status at Week 68|Lost to Follow-up|0|||
161154096|NCT01544595|581945557|FG005|Status at Week 68|Lost to Follow-up|0|||
161154097|NCT01544595|581945552|FG000|Status at Week 68|Non-compliance with study treatment|1|||
161154098|NCT01544595|581945553|FG001|Status at Week 68|Non-compliance with study treatment|0|||
161154099|NCT01544595|581945554|FG002|Status at Week 68|Non-compliance with study treatment|0|||
161154100|NCT01544595|581945555|FG003|Status at Week 68|Non-compliance with study treatment|1|||
161154101|NCT01544595|581945556|FG004|Status at Week 68|Non-compliance with study treatment|0|||
161154102|NCT01544595|581945557|FG005|Status at Week 68|Non-compliance with study treatment|0|||
161154103|NCT01544595|581945552|FG000|Status at Week 68|Protocol Violation|2|||
161154104|NCT01544595|581945553|FG001|Status at Week 68|Protocol Violation|0|||
161154105|NCT01544595|581945554|FG002|Status at Week 68|Protocol Violation|1|||
161154106|NCT01544595|581945555|FG003|Status at Week 68|Protocol Violation|1|||
161154107|NCT01544595|581945556|FG004|Status at Week 68|Protocol Violation|0|||
161154108|NCT01544595|581945557|FG005|Status at Week 68|Protocol Violation|0|||
161154109|NCT01544595|581945552|FG000|Status at Week 68|Technical problems|1|||
161154110|NCT01544595|581945553|FG001|Status at Week 68|Technical problems|0|||
161154111|NCT01544595|581945554|FG002|Status at Week 68|Technical problems|0|||
161154112|NCT01544595|581945555|FG003|Status at Week 68|Technical problems|1|||
161154113|NCT01544595|581945556|FG004|Status at Week 68|Technical problems|0|||
161154114|NCT01544595|581945557|FG005|Status at Week 68|Technical problems|0|||
161154115|NCT01544595|581945552|FG000|Status at Week 68|Withdrawal by Subject|0|||
161154116|NCT01544595|581945553|FG001|Status at Week 68|Withdrawal by Subject|1|||
161154117|NCT01544595|581945554|FG002|Status at Week 68|Withdrawal by Subject|1|||
161154118|NCT01544595|581945555|FG003|Status at Week 68|Withdrawal by Subject|2|||
161154119|NCT01544595|581945556|FG004|Status at Week 68|Withdrawal by Subject|0|||
161063116|NCT00634842|581622604|FG000|Overall Study|Lost to Follow-up|1|||
161063117|NCT00634842|581622605|FG001|Overall Study|Lost to Follow-up|2|||
161063118|NCT00634842|581622604|FG000|Overall Study|Physician Decision|1|||
161063119|NCT00634842|581622605|FG001|Overall Study|Physician Decision|0|||
161063120|NCT00634842|581622604|FG000|Overall Study|Withdrawal by Subject|1|||
161063121|NCT00634842|581622605|FG001|Overall Study|Withdrawal by Subject|3|||
161063122|NCT00634842|581622604|FG000|Overall Study|Lack of time and intolerance to drug|0|||
161063123|NCT00634842|581622605|FG001|Overall Study|Lack of time and intolerance to drug|1|||
161063124|NCT00634842|581622604|FG000|Overall Study|Discontinued due to injection|0|||
161063125|NCT00634842|581622605|FG001|Overall Study|Discontinued due to injection|2|||
161063126|NCT00634842|581622604|FG000|Overall Study|No need of study drug to treat diabetes|0|||
161063127|NCT00634842|581622605|FG001|Overall Study|No need of study drug to treat diabetes|1|||
161063128|NCT00634842|581622604|FG000|Overall Study|No wish to keep taking Avandia|0|||
161063129|NCT00634842|581622605|FG001|Overall Study|No wish to keep taking Avandia|1|||
161063130|NCT00634842|581622604|FG000|Overall Study|Subject off study drug for too long|0|||
161063131|NCT00634842|581622605|FG001|Overall Study|Subject off study drug for too long|1|||
161063132|NCT04629443|581622606|FG000|Overall Study|Adverse Event|2|||
161063133|NCT04629443|581622607|FG001|Overall Study|Adverse Event|1|||
161063134|NCT04629443|581622608|FG002|Overall Study|Adverse Event|2|||
161063135|NCT04629443|581622606|FG000|Overall Study|Progressive Disease|2|||
161063136|NCT04629443|581622607|FG001|Overall Study|Progressive Disease|3|||
161063137|NCT04629443|581622608|FG002|Overall Study|Progressive Disease|3|||
161063138|NCT04629443|581622606|FG000|Overall Study|Physician Decision|1|||
161063139|NCT04629443|581622607|FG001|Overall Study|Physician Decision|3|||
161063140|NCT04629443|581622608|FG002|Overall Study|Physician Decision|0|||
161063141|NCT01844726|581622614|FG000|Overall Study|Withdrawal by Subject|0|||
161063142|NCT01844726|581622615|FG001|Overall Study|Withdrawal by Subject|1|||
161063143|NCT01844726|581622614|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
161063144|NCT01844726|581622615|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
161063145|NCT00858247|581622620|FG000|Baseline Assessment|Withdrawal by Subject|1|||
161063146|NCT00858247|581622621|FG001|Baseline Assessment|Withdrawal by Subject|1|||
161063147|NCT00858247|581622620|FG000|Baseline Assessment|Poor IV access|1|||
161063148|NCT00858247|581622621|FG001|Baseline Assessment|Poor IV access|0|||
161063149|NCT00858247|581622620|FG000|Baseline Assessment|Protocol Violation|0|||
161063150|NCT00858247|581622621|FG001|Baseline Assessment|Protocol Violation|1|||
161063151|NCT00858247|581622620|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
161063152|NCT00858247|581622621|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
161063153|NCT01379703|581622622|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
161063154|NCT01379703|581622623|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
161063155|NCT01379703|581622624|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
161063156|NCT01379703|581622622|FG000|Study Start Through 9 Months|Adverse Event|0|||
161063157|NCT01379703|581622623|FG001|Study Start Through 9 Months|Adverse Event|14|||
161063158|NCT01379703|581622624|FG002|Study Start Through 9 Months|Adverse Event|10|||
161063159|NCT01379703|581622622|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
161063160|NCT01379703|581622623|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
161063161|NCT01379703|581622624|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
161063162|NCT01379703|581622622|FG000|Study Start Through 9 Months|Treatment Failure|0|||
161063163|NCT01379703|581622623|FG001|Study Start Through 9 Months|Treatment Failure|2|||
161063164|NCT01379703|581622624|FG002|Study Start Through 9 Months|Treatment Failure|2|||
161063165|NCT01379703|581622622|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
161063166|NCT01379703|581622623|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
161063167|NCT01379703|581622624|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
161063168|NCT01379703|581622622|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
161063169|NCT01379703|581622623|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
161063170|NCT01379703|581622624|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
161063171|NCT01379703|581622622|FG000|Study Start Through 9 Months|Medication not available|0|||
161063172|NCT01379703|581622623|FG001|Study Start Through 9 Months|Medication not available|2|||
161063173|NCT01379703|581622624|FG002|Study Start Through 9 Months|Medication not available|1|||
161063174|NCT01379703|581622622|FG000|Study Start Through 9 Months|Poor general condition|0|||
161063175|NCT01379703|581622623|FG001|Study Start Through 9 Months|Poor general condition|1|||
161154120|NCT01544595|581945557|FG005|Status at Week 68|Withdrawal by Subject|0|||
161154121|NCT01544595|581945552|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
161154122|NCT01544595|581945553|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
161154123|NCT01544595|581945554|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
161154124|NCT01544595|581945555|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
161154125|NCT01544595|581945556|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
161063176|NCT01379703|581622624|FG002|Study Start Through 9 Months|Poor general condition|0|||
161063177|NCT01379703|581622622|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
161063178|NCT01379703|581622623|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
161063179|NCT01379703|581622624|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
161063180|NCT01379703|581622622|FG000|Study Start Through 9 Months|Reason unknown|2|||
161063181|NCT01379703|581622623|FG001|Study Start Through 9 Months|Reason unknown|31|||
161063182|NCT01379703|581622624|FG002|Study Start Through 9 Months|Reason unknown|24|||
161063183|NCT01379703|581622622|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
161063184|NCT01379703|581622623|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
161063185|NCT01379703|581622624|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
161063186|NCT01379703|581622622|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
161063187|NCT01379703|581622623|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
161063188|NCT01379703|581622624|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
161063189|NCT01379703|581622622|FG000|9 Months Through 18 Months|Adverse Event|0|||
161063190|NCT01379703|581622623|FG001|9 Months Through 18 Months|Adverse Event|6|||
161063191|NCT01379703|581622624|FG002|9 Months Through 18 Months|Adverse Event|0|||
161063192|NCT01379703|581622622|FG000|9 Months Through 18 Months|Treatment failure|0|||
161063193|NCT01379703|581622623|FG001|9 Months Through 18 Months|Treatment failure|5|||
161063194|NCT01379703|581622624|FG002|9 Months Through 18 Months|Treatment failure|0|||
161063195|NCT01379703|581622622|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
161063196|NCT01379703|581622623|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
161063197|NCT01379703|581622624|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
161063198|NCT01379703|581622622|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
161063199|NCT01379703|581622623|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
161063200|NCT01379703|581622624|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
161063201|NCT01379703|581622622|FG000|9 Months Through 18 Months|Fatigue|0|||
161063202|NCT01379703|581622623|FG001|9 Months Through 18 Months|Fatigue|1|||
161063203|NCT01379703|581622624|FG002|9 Months Through 18 Months|Fatigue|0|||
161063204|NCT01379703|581622622|FG000|9 Months Through 18 Months|Reason Unknown|0|||
161063205|NCT01379703|581622623|FG001|9 Months Through 18 Months|Reason Unknown|23|||
161063206|NCT01379703|581622624|FG002|9 Months Through 18 Months|Reason Unknown|0|||
161063207|NCT03481556|581622625|FG000|Overall Study|Adverse Event|1|||
161063208|NCT03481556|581622626|FG001|Overall Study|Adverse Event|0|||
161063209|NCT03481556|581622627|FG002|Overall Study|Adverse Event|0|||
161063210|NCT03481556|581622628|FG003|Overall Study|Adverse Event|0|||
161063211|NCT03481556|581622625|FG000|Overall Study|Death|4|||
161063212|NCT03481556|581622626|FG001|Overall Study|Death|2|||
161063213|NCT03481556|581622627|FG002|Overall Study|Death|3|||
161063214|NCT03481556|581622628|FG003|Overall Study|Death|16|||
161063215|NCT03481556|581622625|FG000|Overall Study|Study Terminated by Sponsor|10|||
161063216|NCT03481556|581622626|FG001|Overall Study|Study Terminated by Sponsor|5|||
161063217|NCT03481556|581622627|FG002|Overall Study|Study Terminated by Sponsor|2|||
161063218|NCT03481556|581622628|FG003|Overall Study|Study Terminated by Sponsor|9|||
161063219|NCT01172639|581622629|FG000|Overall Study|Death|1|||
161063220|NCT01172639|581622630|FG001|Overall Study|Death|1|||
161063221|NCT01172639|581622631|FG002|Overall Study|Death|0|||
161063222|NCT01172639|581622632|FG003|Overall Study|Death|0|||
161063223|NCT01172639|581622633|FG004|Overall Study|Death|0|||
161063224|NCT01172639|581622629|FG000|Overall Study|Lost to Follow-up|9|||
161063225|NCT01172639|581622630|FG001|Overall Study|Lost to Follow-up|7|||
161063226|NCT01172639|581622631|FG002|Overall Study|Lost to Follow-up|11|||
161063227|NCT01172639|581622632|FG003|Overall Study|Lost to Follow-up|6|||
161063228|NCT01172639|581622633|FG004|Overall Study|Lost to Follow-up|6|||
161063229|NCT01172639|581622629|FG000|Overall Study|Withdrawal by Subject|3|||
161063230|NCT01172639|581622630|FG001|Overall Study|Withdrawal by Subject|3|||
161063231|NCT01172639|581622631|FG002|Overall Study|Withdrawal by Subject|5|||
161063232|NCT01172639|581622632|FG003|Overall Study|Withdrawal by Subject|5|||
161063233|NCT01172639|581622633|FG004|Overall Study|Withdrawal by Subject|0|||
161063234|NCT01316887|581622634|FG000|Overall Study|Adverse Event|13|||
161063235|NCT01316887|581622635|FG001|Overall Study|Adverse Event|21|||
161063236|NCT01316887|581622636|FG002|Overall Study|Adverse Event|17|||
161063237|NCT01316887|581622634|FG000|Overall Study|Lack of Efficacy|9|||
161063238|NCT01316887|581622635|FG001|Overall Study|Lack of Efficacy|3|||
161063239|NCT01316887|581622636|FG002|Overall Study|Lack of Efficacy|1|||
161063240|NCT01316887|581622634|FG000|Overall Study|Protocol Violation|2|||
161063241|NCT01316887|581622635|FG001|Overall Study|Protocol Violation|6|||
161063242|NCT01316887|581622636|FG002|Overall Study|Protocol Violation|6|||
161063243|NCT01316887|581622634|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
161063244|NCT01316887|581622635|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
161063245|NCT01316887|581622636|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
161063246|NCT01316887|581622634|FG000|Overall Study|Study Closed/Terminated|2|||
161063247|NCT01316887|581622635|FG001|Overall Study|Study Closed/Terminated|4|||
161063248|NCT01316887|581622636|FG002|Overall Study|Study Closed/Terminated|3|||
161063249|NCT01316887|581622634|FG000|Overall Study|Lost to Follow-up|1|||
161063250|NCT01316887|581622635|FG001|Overall Study|Lost to Follow-up|7|||
161063251|NCT01316887|581622636|FG002|Overall Study|Lost to Follow-up|5|||
161063252|NCT01316887|581622634|FG000|Overall Study|Withdrawal by Subject|8|||
161063253|NCT01316887|581622635|FG001|Overall Study|Withdrawal by Subject|16|||
161063254|NCT01316887|581622636|FG002|Overall Study|Withdrawal by Subject|15|||
161063255|NCT02172950|581622637|FG000|Overall Study|Physician Decision|3|||
161063256|NCT02172950|581622638|FG001|Overall Study|Physician Decision|3|||
161063257|NCT02172950|581622637|FG000|Overall Study|Lack of Efficacy|1|||
161063258|NCT02172950|581622638|FG001|Overall Study|Lack of Efficacy|0|||
161063259|NCT02172950|581622637|FG000|Overall Study|Adverse Event|4|||
161063260|NCT02172950|581622638|FG001|Overall Study|Adverse Event|1|||
161063261|NCT02172950|581622637|FG000|Overall Study|Withdrawal by Subject|10|||
161063262|NCT02172950|581622638|FG001|Overall Study|Withdrawal by Subject|0|||
161063263|NCT02172950|581622637|FG000|Overall Study|Protocol Violation|1|||
161063264|NCT02172950|581622638|FG001|Overall Study|Protocol Violation|0|||
161063265|NCT02172950|581622637|FG000|Overall Study|Lost to Follow-up|1|||
161063266|NCT02172950|581622638|FG001|Overall Study|Lost to Follow-up|0|||
161063267|NCT02172950|581622637|FG000|Overall Study|Death|1|||
161063268|NCT02172950|581622638|FG001|Overall Study|Death|0|||
161063269|NCT02172950|581622637|FG000|Overall Study|Patient traveling|1|||
161063270|NCT02172950|581622638|FG001|Overall Study|Patient traveling|0|||
161063271|NCT02172950|581622637|FG000|Overall Study|Patient went to other country|1|||
161063272|NCT02172950|581622638|FG001|Overall Study|Patient went to other country|0|||
161063273|NCT02172950|581622637|FG000|Overall Study|Patient relocated overseas|1|||
161063274|NCT02172950|581622638|FG001|Overall Study|Patient relocated overseas|1|||
161063275|NCT02172950|581622637|FG000|Overall Study|Patient moving|1|||
161063276|NCT02172950|581622638|FG001|Overall Study|Patient moving|0|||
161063277|NCT00469456|581622639|FG000|Overall Study|Adverse Event|4|||
161063278|NCT00469456|581622640|FG001|Overall Study|Adverse Event|3|||
161063279|NCT00469456|581622639|FG000|Overall Study|Protocol Violation|1|||
161063280|NCT00469456|581622640|FG001|Overall Study|Protocol Violation|0|||
161063281|NCT00469456|581622639|FG000|Overall Study|Withdrawal by Subject|4|||
161063282|NCT00469456|581622640|FG001|Overall Study|Withdrawal by Subject|1|||
161063283|NCT01086384|581622650|FG000|2-week Run-in Period|Adverse Event|1|||
161063284|NCT01086384|581622651|FG001|2-week Run-in Period|Adverse Event|0|||
161063285|NCT01086384|581622652|FG002|2-week Run-in Period|Adverse Event|0|||
161063286|NCT01086384|581622650|FG000|2-week Run-in Period|Protocol Violation|1|||
161063287|NCT01086384|581622651|FG001|2-week Run-in Period|Protocol Violation|0|||
161063288|NCT01086384|581622652|FG002|2-week Run-in Period|Protocol Violation|0|||
161063289|NCT01086384|581622650|FG000|2-week Run-in Period|Lost to Follow-up|1|||
161063290|NCT01086384|581622651|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161063291|NCT01086384|581622652|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161063292|NCT01086384|581622650|FG000|2-week Run-in Period|Physician Decision|6|||
161063293|NCT01086384|581622651|FG001|2-week Run-in Period|Physician Decision|0|||
161063294|NCT01086384|581622652|FG002|2-week Run-in Period|Physician Decision|0|||
161063295|NCT01086384|581622650|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
161063296|NCT01086384|581622651|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161063297|NCT01086384|581622652|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161063298|NCT01086384|581622650|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
161063299|NCT01086384|581622651|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
161063300|NCT01086384|581622652|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
161063301|NCT01086384|581622650|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
161063302|NCT01086384|581622651|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
161063303|NCT01086384|581622652|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
161063304|NCT01086384|581622650|FG000|2-week Run-in Period|Randomized in Error|1|||
161063305|NCT01086384|581622651|FG001|2-week Run-in Period|Randomized in Error|0|||
161063306|NCT01086384|581622652|FG002|2-week Run-in Period|Randomized in Error|0|||
161063307|NCT01086384|581622650|FG000|Treatment Period|Withdrawal by Subject|0|||
161063308|NCT01086384|581622651|FG001|Treatment Period|Withdrawal by Subject|53|||
161063309|NCT01086384|581622652|FG002|Treatment Period|Withdrawal by Subject|55|||
161063310|NCT01086384|581622650|FG000|Treatment Period|Protocol Violation|0|||
161063311|NCT01086384|581622651|FG001|Treatment Period|Protocol Violation|26|||
161063312|NCT01086384|581622652|FG002|Treatment Period|Protocol Violation|17|||
161063313|NCT01086384|581622650|FG000|Treatment Period|Lack of Efficacy|0|||
161063314|NCT01086384|581622651|FG001|Treatment Period|Lack of Efficacy|22|||
161063315|NCT01086384|581622652|FG002|Treatment Period|Lack of Efficacy|13|||
161063316|NCT01086384|581622650|FG000|Treatment Period|Adverse Event|0|||
161063317|NCT01086384|581622651|FG001|Treatment Period|Adverse Event|19|||
161063318|NCT01086384|581622652|FG002|Treatment Period|Adverse Event|15|||
161063319|NCT01086384|581622650|FG000|Treatment Period|Lost to Follow-up|0|||
161063320|NCT01086384|581622651|FG001|Treatment Period|Lost to Follow-up|11|||
161063321|NCT01086384|581622652|FG002|Treatment Period|Lost to Follow-up|9|||
161063322|NCT01086384|581622650|FG000|Treatment Period|Physician Decision|0|||
161063323|NCT01086384|581622651|FG001|Treatment Period|Physician Decision|9|||
161063324|NCT01086384|581622652|FG002|Treatment Period|Physician Decision|6|||
161063325|NCT01086384|581622650|FG000|Treatment Period|Study Closed/Terminated|0|||
161063326|NCT01086384|581622651|FG001|Treatment Period|Study Closed/Terminated|7|||
161063327|NCT01086384|581622652|FG002|Treatment Period|Study Closed/Terminated|8|||
161063328|NCT01086384|581622650|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
161063329|NCT01086384|581622651|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
161063330|NCT01086384|581622652|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
161063331|NCT01086384|581622650|FG000|Treatment Period|Received Treatment in Error|0|||
161063332|NCT01086384|581622651|FG001|Treatment Period|Received Treatment in Error|1|||
161063333|NCT01086384|581622652|FG002|Treatment Period|Received Treatment in Error|0|||
161063334|NCT02586415|581622655|FG000|Overall Study|Death|13|||
161063335|NCT02586415|581622656|FG001|Overall Study|Death|23|||
161063336|NCT02586415|581622655|FG000|Overall Study|Lost to Follow-up|1|||
161063337|NCT02586415|581622656|FG001|Overall Study|Lost to Follow-up|2|||
161063338|NCT00832000|581622657|FG000|Overall Study|Adverse Event|2|||
161063339|NCT00832000|581622658|FG001|Overall Study|Adverse Event|0|||
161063340|NCT00832000|581622657|FG000|Overall Study|Withdrawal by Subject|1|||
161063341|NCT00832000|581622658|FG001|Overall Study|Withdrawal by Subject|0|||
161063342|NCT00832000|581622657|FG000|Overall Study|No calls to IVR in either period|1|||
161063343|NCT00832000|581622658|FG001|Overall Study|No calls to IVR in either period|1|||
161063344|NCT00832000|581622657|FG000|Overall Study|No calls to IVR in period 2|2|||
161063345|NCT00832000|581622658|FG001|Overall Study|No calls to IVR in period 2|0|||
161063346|NCT00937521|581622661|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161063347|NCT00937521|581622662|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161063348|NCT00937521|581622663|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
161063349|NCT00937521|581622664|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161063350|NCT00937521|581622665|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161063351|NCT00937521|581622666|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161063352|NCT00937521|581622667|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
161063353|NCT00937521|581622668|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
161063354|NCT00937521|581622661|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
161063355|NCT00937521|581622662|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161063356|NCT00937521|581622663|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
161063357|NCT00937521|581622664|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
161063358|NCT00937521|581622665|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161063359|NCT00937521|581622666|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
161063360|NCT00937521|581622667|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
161063361|NCT00937521|581622668|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
161063362|NCT00937521|581622661|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161063363|NCT00937521|581622662|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161063364|NCT00937521|581622663|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
161063365|NCT00937521|581622664|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
161063366|NCT00937521|581622665|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161063367|NCT00937521|581622666|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161063368|NCT00937521|581622667|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161063369|NCT00937521|581622668|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
161063370|NCT00937521|581622661|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161063371|NCT00937521|581622662|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
161063372|NCT00937521|581622663|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161063373|NCT00937521|581622664|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161063374|NCT00937521|581622665|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
161063375|NCT00937521|581622666|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
161063376|NCT00937521|581622667|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
161063377|NCT00937521|581622668|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
161063378|NCT00937521|581622661|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
161063379|NCT00937521|581622662|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161063380|NCT00937521|581622663|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161063381|NCT00937521|581622664|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161063382|NCT00937521|581622665|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161063383|NCT00937521|581622666|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161063384|NCT00937521|581622667|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
161063385|NCT00937521|581622668|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
161063386|NCT00937521|581622661|FG000|Booster Phase|Adverse Event|0|||
161063387|NCT00937521|581622662|FG001|Booster Phase|Adverse Event|0|||
161063388|NCT00937521|581622663|FG002|Booster Phase|Adverse Event|0|||
161063389|NCT00937521|581622664|FG003|Booster Phase|Adverse Event|0|||
161063390|NCT00937521|581622665|FG004|Booster Phase|Adverse Event|0|||
161063391|NCT00937521|581622666|FG005|Booster Phase|Adverse Event|0|||
161063392|NCT00937521|581622667|FG006|Booster Phase|Adverse Event|1|||
161063393|NCT00937521|581622668|FG007|Booster Phase|Adverse Event|0|||
161063394|NCT00937521|581622661|FG000|Booster Phase|Withdrawal by Subject|1|||
161063395|NCT00937521|581622662|FG001|Booster Phase|Withdrawal by Subject|0|||
161063396|NCT00937521|581622663|FG002|Booster Phase|Withdrawal by Subject|0|||
161063397|NCT00937521|581622664|FG003|Booster Phase|Withdrawal by Subject|1|||
161154126|NCT01544595|581945557|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
161154127|NCT01544595|581945552|FG000|Status at Week 156|Withdrawal by Subject|9|||
161154128|NCT01544595|581945553|FG001|Status at Week 156|Withdrawal by Subject|10|||
161063398|NCT00937521|581622665|FG004|Booster Phase|Withdrawal by Subject|0|||
161063399|NCT00937521|581622666|FG005|Booster Phase|Withdrawal by Subject|0|||
161063400|NCT00937521|581622667|FG006|Booster Phase|Withdrawal by Subject|0|||
161063401|NCT00937521|581622668|FG007|Booster Phase|Withdrawal by Subject|2|||
161063402|NCT00937521|581622661|FG000|Booster Phase|Lost to Follow-up|2|||
161063403|NCT00937521|581622662|FG001|Booster Phase|Lost to Follow-up|2|||
161063404|NCT00937521|581622663|FG002|Booster Phase|Lost to Follow-up|4|||
161063405|NCT00937521|581622664|FG003|Booster Phase|Lost to Follow-up|2|||
161063406|NCT00937521|581622665|FG004|Booster Phase|Lost to Follow-up|4|||
161063407|NCT00937521|581622666|FG005|Booster Phase|Lost to Follow-up|4|||
161063408|NCT00937521|581622667|FG006|Booster Phase|Lost to Follow-up|3|||
161063409|NCT00937521|581622668|FG007|Booster Phase|Lost to Follow-up|0|||
161063410|NCT00937521|581622661|FG000|Booster Phase|Administrative Reason|0|||
161063411|NCT00937521|581622662|FG001|Booster Phase|Administrative Reason|0|||
161063412|NCT00937521|581622663|FG002|Booster Phase|Administrative Reason|1|||
161063413|NCT00937521|581622664|FG003|Booster Phase|Administrative Reason|0|||
161063414|NCT00937521|581622665|FG004|Booster Phase|Administrative Reason|1|||
161063415|NCT00937521|581622666|FG005|Booster Phase|Administrative Reason|1|||
161063416|NCT00937521|581622667|FG006|Booster Phase|Administrative Reason|0|||
161063417|NCT00937521|581622668|FG007|Booster Phase|Administrative Reason|0|||
161063418|NCT00937521|581622661|FG000|Booster Phase|Protocol Deviation|0|||
161063419|NCT00937521|581622662|FG001|Booster Phase|Protocol Deviation|0|||
161063420|NCT00937521|581622663|FG002|Booster Phase|Protocol Deviation|0|||
161063421|NCT00937521|581622664|FG003|Booster Phase|Protocol Deviation|0|||
161063422|NCT00937521|581622665|FG004|Booster Phase|Protocol Deviation|0|||
161063423|NCT00937521|581622666|FG005|Booster Phase|Protocol Deviation|0|||
161063424|NCT00937521|581622667|FG006|Booster Phase|Protocol Deviation|1|||
161063425|NCT00937521|581622668|FG007|Booster Phase|Protocol Deviation|0|||
161063426|NCT01426113|581622669|FG000|Overall Study|Study Discontinued|1|||
161063427|NCT01426113|581622670|FG001|Overall Study|Study Discontinued|1|||
161063428|NCT01426113|581622669|FG000|Overall Study|Adverse Event|0|||
161063429|NCT01426113|581622670|FG001|Overall Study|Adverse Event|1|||
161063430|NCT00338949|581622671|FG000|Subject Screening|Screen failures|11|||
161063431|NCT00338949|581622672|FG001|Subject Screening|Screen failures|11|||
161063432|NCT00338949|581622671|FG000|Randomization|Withdrawal by Subject|1|||
161063433|NCT00338949|581622672|FG001|Randomization|Withdrawal by Subject|0|||
161063434|NCT00338949|581622671|FG000|Randomization|Adverse Event|0|||
161063435|NCT00338949|581622672|FG001|Randomization|Adverse Event|5|||
161063436|NCT00436956|581622675|FG000|Overall Study|Not evaluable|1|||
161063437|NCT00436956|581622676|FG001|Overall Study|Not evaluable|0|||
161063438|NCT00909532|581622682|FG000|Overall Study|Adverse Event|4|||
161063439|NCT00909532|581622683|FG001|Overall Study|Adverse Event|1|||
161063440|NCT00909532|581622682|FG000|Overall Study|Pregnancy|0|||
161063441|NCT00909532|581622683|FG001|Overall Study|Pregnancy|1|||
161063442|NCT00909532|581622682|FG000|Overall Study|Prohibited Medication|2|||
161063443|NCT00909532|581622683|FG001|Overall Study|Prohibited Medication|1|||
161063444|NCT00909532|581622682|FG000|Overall Study|Withdrawal of Consent|1|||
161063445|NCT00909532|581622683|FG001|Overall Study|Withdrawal of Consent|1|||
161063446|NCT00909532|581622682|FG000|Overall Study|Noncompliance with Study Requirements|0|||
161063447|NCT00909532|581622683|FG001|Overall Study|Noncompliance with Study Requirements|2|||
161063448|NCT00909532|581622682|FG000|Overall Study|Physician Decision|1|||
161063449|NCT00909532|581622683|FG001|Overall Study|Physician Decision|0|||
161063450|NCT00909532|581622682|FG000|Overall Study|Wrong Genotype|1|||
161063451|NCT00909532|581622683|FG001|Overall Study|Wrong Genotype|0|||
161063452|NCT00909532|581622682|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
161063453|NCT00909532|581622683|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
161063454|NCT00461123|581622687|FG000|Overall Study|Adverse Event|1|||
161063455|NCT00461123|581622688|FG001|Overall Study|Adverse Event|0|||
161063456|NCT00461123|581622687|FG000|Overall Study|Lost to Follow-up|1|||
161063457|NCT00461123|581622688|FG001|Overall Study|Lost to Follow-up|1|||
161063458|NCT00461123|581622687|FG000|Overall Study|Protocol Violation|3|||
161063459|NCT00461123|581622688|FG001|Overall Study|Protocol Violation|2|||
161063460|NCT00461123|581622687|FG000|Overall Study|Withdrawal by Subject|1|||
161063461|NCT00461123|581622688|FG001|Overall Study|Withdrawal by Subject|3|||
161063462|NCT02024750|581622689|FG000|Overall Study|Withdrawal by Subject|2|||
161063463|NCT02024750|581622690|FG001|Overall Study|Withdrawal by Subject|1|||
161063464|NCT03029819|581622693|FG000|Overall Study|Lost to Follow-up|3|||
161063465|NCT03029819|581622694|FG001|Overall Study|Lost to Follow-up|5|||
161063466|NCT03029819|581622693|FG000|Overall Study|Removed due to disruptive behavior|0|||
161063467|NCT03029819|581622694|FG001|Overall Study|Removed due to disruptive behavior|1|||
161063468|NCT03015181|581622698|FG000|Overall Study|Enrolled, but product never administered|1|||
161063469|NCT03015181|581622699|FG001|Overall Study|Enrolled, but product never administered|0|||
161063470|NCT03015181|581622700|FG002|Overall Study|Enrolled, but product never administered|0|||
161063471|NCT03015181|581622701|FG003|Overall Study|Enrolled, but product never administered|0|||
161063472|NCT03015181|581622702|FG004|Overall Study|Enrolled, but product never administered|0|||
161063473|NCT03015181|581622703|FG005|Overall Study|Enrolled, but product never administered|0|||
161063474|NCT03015181|581622704|FG006|Overall Study|Enrolled, but product never administered|0|||
161063475|NCT03015181|581622698|FG000|Overall Study|Withdrawal by Subject|0|||
161063476|NCT03015181|581622699|FG001|Overall Study|Withdrawal by Subject|0|||
161063477|NCT03015181|581622700|FG002|Overall Study|Withdrawal by Subject|0|||
161063478|NCT03015181|581622701|FG003|Overall Study|Withdrawal by Subject|0|||
161063479|NCT03015181|581622702|FG004|Overall Study|Withdrawal by Subject|0|||
161063480|NCT03015181|581622703|FG005|Overall Study|Withdrawal by Subject|1|||
161063481|NCT03015181|581622704|FG006|Overall Study|Withdrawal by Subject|0|||
161063482|NCT03015181|581622698|FG000|Overall Study|Physician Decision|0|||
161063483|NCT03015181|581622699|FG001|Overall Study|Physician Decision|0|||
161063484|NCT03015181|581622700|FG002|Overall Study|Physician Decision|0|||
161063485|NCT03015181|581622701|FG003|Overall Study|Physician Decision|0|||
161063486|NCT03015181|581622702|FG004|Overall Study|Physician Decision|0|||
161063487|NCT03015181|581622703|FG005|Overall Study|Physician Decision|0|||
161063488|NCT03015181|581622704|FG006|Overall Study|Physician Decision|1|||
161063489|NCT01177228|581622714|FG000|Overall Study|Positive tuberculosis test|0|||
161063490|NCT01177228|581622715|FG001|Overall Study|Positive tuberculosis test|1|||
161063491|NCT01177228|581622716|FG002|Overall Study|Positive tuberculosis test|0|||
161063492|NCT01177228|581622717|FG003|Overall Study|Positive tuberculosis test|0|||
161063493|NCT01177228|581622714|FG000|Overall Study|Worsening disease activity|1|||
161063494|NCT01177228|581622715|FG001|Overall Study|Worsening disease activity|0|||
161063495|NCT01177228|581622716|FG002|Overall Study|Worsening disease activity|0|||
161063496|NCT01177228|581622717|FG003|Overall Study|Worsening disease activity|0|||
161063497|NCT01177228|581622714|FG000|Overall Study|Withdrawal by Subject|0|||
161282457|NCT03571828|582413018|FG000|Overall Study|Withdrawal by Subject|1|||
161282458|NCT03571828|582413019|FG001|Overall Study|Withdrawal by Subject|0|||
161282459|NCT03571828|582413018|FG000|Overall Study|Decision by sponsor|5|||
161282460|NCT03571828|582413019|FG001|Overall Study|Decision by sponsor|1|||
161282461|NCT03571828|582413018|FG000|Overall Study|Death|2|||
161282462|NCT03571828|582413019|FG001|Overall Study|Death|0|||
161282463|NCT02232984|582413020|FG000|Overall Study|Withdrawal by Subject|5|||
161282464|NCT02232984|582413020|FG000|Overall Study|Death|1|||
161282465|NCT02232984|582413020|FG000|Overall Study|Investigator withdrawal|10|||
161282466|NCT02232984|582413020|FG000|Overall Study|Device implant unsuccessful|53|||
161282467|NCT02232984|582413020|FG000|Overall Study|not disclosed by site|7|||
161282468|NCT02232984|582413020|FG000|Overall Study|Protocol Violation|1|||
161282469|NCT00769379|582413025|FG000|Overall Study|No follow up data mapped to Other.|3|||
161282470|NCT00769379|582413026|FG001|Overall Study|No follow up data mapped to Other.|13|||
161282471|NCT03762239|582413029|FG000|Overall Study|Appointment to the doctor|1|||
161282472|NCT03762239|582413030|FG001|Overall Study|Appointment to the doctor|1|||
161282473|NCT02933255|582413036|FG000|Overall Study|Discontinued due to study closure.|1|||
161282474|NCT02933255|582413037|FG001|Overall Study|Discontinued due to study closure.|0|||
161282475|NCT02215967|582413042|FG000|Overall Study|Patient became ineligible for treatment|0|||
161345320|NCT01020123|582648930|FG006|Main Period|Protocol Violation|2|||
161345321|NCT01020123|582648924|FG000|Main Period|Lost to Follow-up|0|||
161063498|NCT01177228|581622715|FG001|Overall Study|Withdrawal by Subject|1|||
161063499|NCT01177228|581622716|FG002|Overall Study|Withdrawal by Subject|0|||
161063500|NCT01177228|581622717|FG003|Overall Study|Withdrawal by Subject|0|||
161063501|NCT01251887|581622718|FG000|Overall Study|Scheduling conflict|1|||
161063502|NCT01251887|581622719|FG001|Overall Study|Scheduling conflict|2|||
161063503|NCT01251887|581622720|FG002|Overall Study|Scheduling conflict|2|||
161063504|NCT01251887|581622718|FG000|Overall Study|Physician Decision|0|||
161063505|NCT01251887|581622719|FG001|Overall Study|Physician Decision|1|||
161063506|NCT01251887|581622720|FG002|Overall Study|Physician Decision|0|||
161282476|NCT02215967|582413043|FG001|Overall Study|Patient became ineligible for treatment|0|||
161345322|NCT01020123|582648925|FG001|Main Period|Lost to Follow-up|2|||
161345323|NCT01020123|582648926|FG002|Main Period|Lost to Follow-up|0|||
161345324|NCT01020123|582648927|FG003|Main Period|Lost to Follow-up|0|||
161345325|NCT01020123|582648928|FG004|Main Period|Lost to Follow-up|0|||
161063507|NCT02080403|581624141|FG000|Overall Study|Adverse Event|5|||
161063508|NCT02080403|581624142|FG001|Overall Study|Adverse Event|1|||
161063509|NCT02080403|581624141|FG000|Overall Study|Death|0|||
161063510|NCT02080403|581624142|FG001|Overall Study|Death|2|||
161063511|NCT02080403|581624141|FG000|Overall Study|Lost to Follow-up|2|||
161282477|NCT02215967|582413044|FG002|Overall Study|Patient became ineligible for treatment|0|||
161282478|NCT02215967|582413045|FG003|Overall Study|Patient became ineligible for treatment|3|||
161282479|NCT02215967|582413042|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
161282480|NCT02215967|582413043|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
161282481|NCT02215967|582413044|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
161282482|NCT02215967|582413045|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
161282483|NCT03207867|582413046|FG000|Overall Study|Adverse Event|1|||
161345326|NCT01020123|582648929|FG005|Main Period|Lost to Follow-up|0|||
161345327|NCT01020123|582648930|FG006|Main Period|Lost to Follow-up|0|||
161063512|NCT02080403|581624142|FG001|Overall Study|Lost to Follow-up|0|||
161063513|NCT02080403|581624141|FG000|Overall Study|Pregnancy|0|||
161063514|NCT02080403|581624142|FG001|Overall Study|Pregnancy|1|||
161063515|NCT02080403|581624141|FG000|Overall Study|Protocol Violation|3|||
161063516|NCT02080403|581624142|FG001|Overall Study|Protocol Violation|7|||
161345328|NCT01020123|582648924|FG000|Main Period|Unclasified|2|||
161345329|NCT01020123|582648925|FG001|Main Period|Unclasified|0|||
161345330|NCT01020123|582648926|FG002|Main Period|Unclasified|1|||
161345331|NCT01020123|582648927|FG003|Main Period|Unclasified|0|||
161345332|NCT01020123|582648928|FG004|Main Period|Unclasified|1|||
161345333|NCT01020123|582648929|FG005|Main Period|Unclasified|3|||
161345334|NCT01020123|582648930|FG006|Main Period|Unclasified|6|||
161345335|NCT01020123|582648924|FG000|Extention Period|Withdrawal by Subject|2|||
161345336|NCT01020123|582648925|FG001|Extention Period|Withdrawal by Subject|1|||
161345337|NCT01020123|582648926|FG002|Extention Period|Withdrawal by Subject|1|||
161345338|NCT01020123|582648927|FG003|Extention Period|Withdrawal by Subject|0|||
161345339|NCT01020123|582648928|FG004|Extention Period|Withdrawal by Subject|0|||
161345340|NCT01020123|582648929|FG005|Extention Period|Withdrawal by Subject|0|||
161345341|NCT01020123|582648930|FG006|Extention Period|Withdrawal by Subject|0|||
161345342|NCT01020123|582648924|FG000|Extention Period|Adverse Event|0|||
161345343|NCT01020123|582648925|FG001|Extention Period|Adverse Event|0|||
161345344|NCT01020123|582648926|FG002|Extention Period|Adverse Event|0|||
161345345|NCT01020123|582648927|FG003|Extention Period|Adverse Event|1|||
161345346|NCT01020123|582648928|FG004|Extention Period|Adverse Event|0|||
161345347|NCT01020123|582648929|FG005|Extention Period|Adverse Event|0|||
161345348|NCT01020123|582648930|FG006|Extention Period|Adverse Event|0|||
161345349|NCT01020123|582648924|FG000|Extention Period|Protocol Violation|1|||
161345350|NCT01020123|582648925|FG001|Extention Period|Protocol Violation|1|||
161345351|NCT01020123|582648926|FG002|Extention Period|Protocol Violation|1|||
161345352|NCT01020123|582648927|FG003|Extention Period|Protocol Violation|0|||
161345353|NCT01020123|582648928|FG004|Extention Period|Protocol Violation|0|||
161345354|NCT01020123|582648929|FG005|Extention Period|Protocol Violation|0|||
161345355|NCT01020123|582648930|FG006|Extention Period|Protocol Violation|1|||
161345356|NCT01020123|582648924|FG000|Extention Period|Lost to Follow-up|0|||
161345357|NCT01020123|582648925|FG001|Extention Period|Lost to Follow-up|0|||
161345358|NCT01020123|582648926|FG002|Extention Period|Lost to Follow-up|0|||
161345359|NCT01020123|582648927|FG003|Extention Period|Lost to Follow-up|0|||
161063517|NCT02080403|581624141|FG000|Overall Study|Withdrawal by Subject|5|||
161063518|NCT02080403|581624142|FG001|Overall Study|Withdrawal by Subject|1|||
161063519|NCT02826798|581624143|FG000|Overall Study|Withdrawal by Subject|0|||
161063520|NCT02826798|581624144|FG001|Overall Study|Withdrawal by Subject|1|||
161063521|NCT02826798|581624145|FG002|Overall Study|Withdrawal by Subject|0|||
161063522|NCT02826798|581624146|FG003|Overall Study|Withdrawal by Subject|1|||
161063523|NCT02826798|581624147|FG004|Overall Study|Withdrawal by Subject|0|||
161063524|NCT02806505|581624148|FG000|Overall Study|Adverse event/intercurrent illness|1|||
161063525|NCT02806505|581624149|FG001|Overall Study|Adverse event/intercurrent illness|3|||
161063526|NCT02806505|581624148|FG000|Overall Study|Death|4|||
161063527|NCT02806505|581624149|FG001|Overall Study|Death|0|||
161063528|NCT02806505|581624148|FG000|Overall Study|Did not cooperate/refused treatment|3|||
161063529|NCT02806505|581624149|FG001|Overall Study|Did not cooperate/refused treatment|3|||
161063530|NCT02806505|581624148|FG000|Overall Study|Failure to return|0|||
161063531|NCT02806505|581624149|FG001|Overall Study|Failure to return|1|||
161063532|NCT02806505|581624148|FG000|Overall Study|Insufficient therapeutic response|2|||
161063533|NCT02806505|581624149|FG001|Overall Study|Insufficient therapeutic response|4|||
161063534|NCT01722045|581624151|FG000|Overall Study|Adverse Event|8|||
161063535|NCT01722045|581624151|FG000|Overall Study|Death|3|||
161063536|NCT01722045|581624151|FG000|Overall Study|Withdrawal by Subject|8|||
161063537|NCT01722045|581624151|FG000|Overall Study|Lost to Follow-up|4|||
161063538|NCT01722045|581624151|FG000|Overall Study|Protocol Deviation|1|||
161063539|NCT01722045|581624151|FG000|Overall Study|Physician Decision|3|||
161063540|NCT01722045|581624151|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
161063541|NCT02034162|581624152|FG000|Double-blind|Lost to Follow-up|3|||
161063542|NCT02034162|581624153|FG001|Double-blind|Lost to Follow-up|0|||
161154129|NCT01544595|581945554|FG002|Status at Week 156|Withdrawal by Subject|4|||
161154130|NCT01544595|581945555|FG003|Status at Week 156|Withdrawal by Subject|9|||
161154131|NCT01544595|581945556|FG004|Status at Week 156|Withdrawal by Subject|20|||
161154132|NCT01544595|581945557|FG005|Status at Week 156|Withdrawal by Subject|6|||
161154133|NCT01544595|581945552|FG000|Status at Week 156|Adverse Event|9|||
161154134|NCT01544595|581945553|FG001|Status at Week 156|Adverse Event|11|||
161154135|NCT01544595|581945554|FG002|Status at Week 156|Adverse Event|1|||
161154136|NCT01544595|581945555|FG003|Status at Week 156|Adverse Event|3|||
161154137|NCT01544595|581945556|FG004|Status at Week 156|Adverse Event|4|||
161345360|NCT01020123|582648928|FG004|Extention Period|Lost to Follow-up|0|||
161063543|NCT02034162|581624154|FG002|Double-blind|Lost to Follow-up|0|||
161063544|NCT02034162|581624152|FG000|Double-blind|Physician Decision|1|||
161345361|NCT01020123|582648929|FG005|Extention Period|Lost to Follow-up|2|||
161345362|NCT01020123|582648930|FG006|Extention Period|Lost to Follow-up|0|||
161345363|NCT01349595|582648931|FG000|Overall Study|Lack of funding|2|||
161345364|NCT01349595|582648932|FG001|Overall Study|Lack of funding|2|||
161345365|NCT03479905|582648933|FG000|Overall Study|Other airway method used|4|||
161063545|NCT02034162|581624153|FG001|Double-blind|Physician Decision|0|||
161063546|NCT02034162|581624154|FG002|Double-blind|Physician Decision|0|||
161345366|NCT03479905|582648934|FG001|Overall Study|Other airway method used|5|||
161063547|NCT02034162|581624152|FG000|Double-blind|Protocol Violation|0|||
161063548|NCT02034162|581624153|FG001|Double-blind|Protocol Violation|1|||
161063549|NCT02034162|581624154|FG002|Double-blind|Protocol Violation|0|||
161063550|NCT02034162|581624152|FG000|Double-blind|Withdrawal by Subject|5|||
161063551|NCT02034162|581624153|FG001|Double-blind|Withdrawal by Subject|7|||
161063552|NCT02034162|581624154|FG002|Double-blind|Withdrawal by Subject|0|||
161063553|NCT00760513|581624155|FG000|Overall Study|Withdrawal by Subject|5|||
161063554|NCT00760513|581624156|FG001|Overall Study|Withdrawal by Subject|7|||
161063555|NCT00971997|581624165|FG000|Overall Study|Adverse Event|2|||
161063556|NCT00971997|581624165|FG000|Overall Study|Death|1|||
161063557|NCT00971997|581624165|FG000|Overall Study|Protocol Violation|4|||
161063558|NCT00971997|581624165|FG000|Overall Study|Withdrawal by Subject|5|||
161063559|NCT00971997|581624165|FG000|Overall Study|Physician Decision|7|||
161063560|NCT00761956|581624170|FG000|Overall Study|Lost to Follow-up|6|||
161063561|NCT00761956|581624171|FG001|Overall Study|Lost to Follow-up|11|||
161063562|NCT00761956|581624170|FG000|Overall Study|Withdrawal by Subject|3|||
161063563|NCT00761956|581624171|FG001|Overall Study|Withdrawal by Subject|8|||
161063564|NCT00761956|581624170|FG000|Overall Study|Death|0|||
161063565|NCT00761956|581624171|FG001|Overall Study|Death|1|||
161063566|NCT00761956|581624170|FG000|Overall Study|Adverse Event|26|||
161063567|NCT00761956|581624171|FG001|Overall Study|Adverse Event|34|||
161063568|NCT02808975|581624172|FG000|Overall Study|Adverse Event|3|||
161063569|NCT02808975|581624173|FG001|Overall Study|Adverse Event|4|||
161063570|NCT02808975|581624172|FG000|Overall Study|Withdrew consent|9|||
161063571|NCT02808975|581624173|FG001|Overall Study|Withdrew consent|8|||
161063572|NCT02808975|581624172|FG000|Overall Study|Lost to Follow-up|4|||
161063573|NCT02808975|581624173|FG001|Overall Study|Lost to Follow-up|6|||
161063574|NCT02808975|581624172|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
161063575|NCT02808975|581624173|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
161063576|NCT02808975|581624172|FG000|Overall Study|Other, not specified|5|||
161063577|NCT02808975|581624173|FG001|Overall Study|Other, not specified|1|||
161063578|NCT03294941|581624174|FG000|Overall Study|Withdrawal by Subject|0|||
161063579|NCT03294941|581624175|FG001|Overall Study|Withdrawal by Subject|2|||
161063580|NCT00916305|581624176|FG000|Overall Study|Lost to Follow-up|21|||
161063581|NCT00916305|581624177|FG001|Overall Study|Lost to Follow-up|27|||
161063582|NCT00916305|581624176|FG000|Overall Study|Withdrawal by Subject|0|||
161063583|NCT00916305|581624177|FG001|Overall Study|Withdrawal by Subject|1|||
161063584|NCT01288209|581624178|FG000|Overall Study|Withdrawal by Subject|1|||
161063585|NCT01288209|581624179|FG001|Overall Study|Withdrawal by Subject|3|||
161063586|NCT01288209|581624178|FG000|Overall Study|Other|1|||
161063587|NCT01288209|581624179|FG001|Overall Study|Other|0|||
161063588|NCT01646385|581624180|FG000|Overall Study|Death|202|||
161063589|NCT01646385|581624181|FG001|Overall Study|Death|222|||
161063590|NCT01646385|581624180|FG000|Overall Study|Switched to alternate biologic|636|||
161063591|NCT01646385|581624181|FG001|Overall Study|Switched to alternate biologic|649|||
161063592|NCT01101997|581624182|FG000|Overall Study|Withdrawal by Subject|2|||
161063593|NCT00704171|581624183|FG000|Overall Study|Withdrawal by Subject|1|||
161063594|NCT00704171|581624184|FG001|Overall Study|Withdrawal by Subject|0|||
161063595|NCT00813098|581624187|FG000|Overall Study|Adverse Event|2|||
161063596|NCT00813098|581624188|FG001|Overall Study|Adverse Event|4|||
161063597|NCT00813098|581624189|FG002|Overall Study|Adverse Event|1|||
161063598|NCT00813098|581624187|FG000|Overall Study|Withdrawal by Subject|0|||
161063599|NCT00813098|581624188|FG001|Overall Study|Withdrawal by Subject|1|||
161063600|NCT00813098|581624189|FG002|Overall Study|Withdrawal by Subject|0|||
161063601|NCT00813098|581624187|FG000|Overall Study|Inability to complete study procedures|1|||
161063602|NCT00813098|581624188|FG001|Overall Study|Inability to complete study procedures|0|||
161063603|NCT00813098|581624189|FG002|Overall Study|Inability to complete study procedures|0|||
161063604|NCT00813098|581624187|FG000|Overall Study|Lost to Follow-up|0|||
161063605|NCT00813098|581624188|FG001|Overall Study|Lost to Follow-up|1|||
161063606|NCT00813098|581624189|FG002|Overall Study|Lost to Follow-up|0|||
161063607|NCT00813098|581624187|FG000|Overall Study|Protocol Violation|0|||
161063608|NCT00813098|581624188|FG001|Overall Study|Protocol Violation|0|||
161063609|NCT00813098|581624189|FG002|Overall Study|Protocol Violation|1|||
161063610|NCT00813098|581624187|FG000|Overall Study|Principal Investigator decision|0|||
161154138|NCT01544595|581945557|FG005|Status at Week 156|Adverse Event|2|||
161154139|NCT01544595|581945552|FG000|Status at Week 156|Lost to Follow-up|4|||
161154140|NCT01544595|581945553|FG001|Status at Week 156|Lost to Follow-up|4|||
161154141|NCT01544595|581945554|FG002|Status at Week 156|Lost to Follow-up|0|||
161063611|NCT00813098|581624188|FG001|Overall Study|Principal Investigator decision|1|||
161063612|NCT00813098|581624189|FG002|Overall Study|Principal Investigator decision|0|||
161063613|NCT00813098|581624187|FG000|Overall Study|Withdrew Consent|0|||
161063614|NCT00813098|581624188|FG001|Overall Study|Withdrew Consent|1|||
161063615|NCT00813098|581624189|FG002|Overall Study|Withdrew Consent|0|||
161063616|NCT01772563|581624190|FG000|Cycle 1|Dose limiting toxicity|2|||
161063617|NCT01772563|581624190|FG000|Cycle 1|Progressive disease|2|||
161063618|NCT01772563|581624190|FG000|Cycle 2 and Beyond|Progressive disease|17|||
161154142|NCT01544595|581945555|FG003|Status at Week 156|Lost to Follow-up|1|||
161154143|NCT01544595|581945556|FG004|Status at Week 156|Lost to Follow-up|4|||
161282484|NCT03207867|582413047|FG001|Overall Study|Adverse Event|0|||
161282485|NCT03207867|582413048|FG002|Overall Study|Adverse Event|1|||
161282486|NCT03207867|582413049|FG003|Overall Study|Adverse Event|0|||
161282487|NCT03207867|582413050|FG004|Overall Study|Adverse Event|0|||
161282488|NCT03207867|582413051|FG005|Overall Study|Adverse Event|2|||
161063619|NCT01772563|581624190|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
161063620|NCT01772563|581624190|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
161063621|NCT01898442|581624193|FG000|Overall Study|Hemolysis/technical problems|1|||
161063622|NCT01898442|581624194|FG001|Overall Study|Hemolysis/technical problems|2|||
161063623|NCT01898442|581624195|FG002|Overall Study|Hemolysis/technical problems|2|||
161063624|NCT01898442|581624193|FG000|Overall Study|Patient vomited pills|0|||
161063625|NCT01898442|581624194|FG001|Overall Study|Patient vomited pills|0|||
161063626|NCT01898442|581624195|FG002|Overall Study|Patient vomited pills|1|||
161063627|NCT03974100|581624196|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
161063628|NCT03974100|581624197|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
161063629|NCT03974100|581624198|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
161063630|NCT03974100|581624199|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
161063631|NCT03974100|581624200|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
161063632|NCT03974100|581624196|FG000|TP1 - Day 1 to Week 52|Death|1|||
161063633|NCT03974100|581624197|FG001|TP1 - Day 1 to Week 52|Death|0|||
161063634|NCT03974100|581624198|FG002|TP1 - Day 1 to Week 52|Death|0|||
161063635|NCT03974100|581624199|FG003|TP1 - Day 1 to Week 52|Death|0|||
161063636|NCT03974100|581624200|FG004|TP1 - Day 1 to Week 52|Death|0|||
161063637|NCT03974100|581624196|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161063638|NCT03974100|581624197|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
161063639|NCT03974100|581624198|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161063640|NCT03974100|581624199|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161063641|NCT03974100|581624200|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
161063642|NCT03974100|581624196|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
161063643|NCT03974100|581624197|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
161063644|NCT03974100|581624198|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
161063645|NCT03974100|581624199|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
161063646|NCT03974100|581624200|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
161063647|NCT03974100|581624196|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
161063648|NCT03974100|581624197|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
161063649|NCT03974100|581624198|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
161063650|NCT03974100|581624199|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
161063651|NCT03974100|581624200|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
161063652|NCT03974100|581624196|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161063653|NCT03974100|581624197|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161063654|NCT03974100|581624198|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161063655|NCT03974100|581624199|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
161063656|NCT03974100|581624200|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
161063657|NCT03974100|581624196|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
161063658|NCT03974100|581624197|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
161063659|NCT03974100|581624198|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
161063660|NCT03974100|581624199|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
161063661|NCT03974100|581624200|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
161063662|NCT03318783|581624201|FG000|Overall Study|Withdrawal by Subject|0|||
161063663|NCT03318783|581624202|FG001|Overall Study|Withdrawal by Subject|1|||
161063664|NCT03318783|581624201|FG000|Overall Study|Death|0|||
161063665|NCT03318783|581624202|FG001|Overall Study|Death|1|||
161063666|NCT03856047|581624203|FG000|Overall Study|Withdrawal by Subject|0|||
161063667|NCT03856047|581624204|FG001|Overall Study|Withdrawal by Subject|1|||
161063668|NCT03856047|581624205|FG002|Overall Study|Withdrawal by Subject|1|||
161063669|NCT03856047|581624206|FG003|Overall Study|Withdrawal by Subject|0|||
161063670|NCT03856047|581624207|FG004|Overall Study|Withdrawal by Subject|3|||
161063671|NCT03856047|581624208|FG005|Overall Study|Withdrawal by Subject|0|||
161063672|NCT03856047|581624209|FG006|Overall Study|Withdrawal by Subject|2|||
161063673|NCT03856047|581624203|FG000|Overall Study|Lost to Follow-up|4|||
161063674|NCT03856047|581624204|FG001|Overall Study|Lost to Follow-up|2|||
161282489|NCT03207867|582413052|FG006|Overall Study|Adverse Event|1|||
161063675|NCT03856047|581624205|FG002|Overall Study|Lost to Follow-up|3|||
161063676|NCT03856047|581624206|FG003|Overall Study|Lost to Follow-up|1|||
161063677|NCT03856047|581624207|FG004|Overall Study|Lost to Follow-up|4|||
161063678|NCT03856047|581624208|FG005|Overall Study|Lost to Follow-up|4|||
161063679|NCT03856047|581624209|FG006|Overall Study|Lost to Follow-up|4|||
161063680|NCT02980705|581624217|FG000|Overall Study|Adverse Event|0|||
161063681|NCT02980705|581624218|FG001|Overall Study|Adverse Event|1|||
161063682|NCT02980705|581624217|FG000|Overall Study|Withdrawal by Subject|6|||
161063683|NCT02980705|581624218|FG001|Overall Study|Withdrawal by Subject|9|||
161063684|NCT02980705|581624217|FG000|Overall Study|withdrew participation|0|||
161063685|NCT02980705|581624218|FG001|Overall Study|withdrew participation|1|||
161063686|NCT02980705|581624217|FG000|Overall Study|Lost to Follow-up|2|||
161063687|NCT02980705|581624218|FG001|Overall Study|Lost to Follow-up|0|||
161063688|NCT00263575|581624219|FG000|Titration Period|Adverse Event|14|||
161063689|NCT00263575|581624219|FG000|Titration Period|Withdrawal by Subject|10|||
161063690|NCT00263575|581624219|FG000|Titration Period|Protocol Violation|9|||
161063691|NCT00263575|581624219|FG000|Titration Period|Sponsor Decision|2|||
161063692|NCT00263575|581624219|FG000|Titration Period|Other|2|||
161063693|NCT00263575|581624219|FG000|Titration Period|Lack of Efficacy|6|||
161063694|NCT00263575|581624219|FG000|Maintence Period|Adverse Event|23|||
161063695|NCT00263575|581624219|FG000|Maintence Period|Withdrawal by Subject|8|||
161063696|NCT00263575|581624219|FG000|Maintence Period|Protocol Violation|4|||
161063697|NCT00263575|581624219|FG000|Maintence Period|Lack of Efficacy|4|||
161063698|NCT00263575|581624219|FG000|Maintence Period|Physician Decision|6|||
161063699|NCT00263575|581624219|FG000|Maintence Period|Lost to Follow-up|1|||
161063700|NCT00263575|581624219|FG000|Maintence Period|Sponsor Decision|24|||
161063701|NCT00263575|581624219|FG000|Maintence Period|Other|7|||
161063702|NCT01841112|581624220|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
161063703|NCT01841112|581624221|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
161063704|NCT01841112|581624222|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
161063705|NCT01841112|581624223|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
161063706|NCT01841112|581624224|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
161063707|NCT01880437|581624225|FG000|Overall Study|Death|12|||
161063708|NCT01880437|581624226|FG001|Overall Study|Death|4|||
161063709|NCT01880437|581624227|FG002|Overall Study|Death|17|||
161063710|NCT01880437|581624225|FG000|Overall Study|Study terminated by Sponsor|3|||
161063711|NCT01880437|581624226|FG001|Overall Study|Study terminated by Sponsor|0|||
161063712|NCT01880437|581624227|FG002|Overall Study|Study terminated by Sponsor|2|||
161063713|NCT02719743|581624229|FG000|Overall Study|Consent withdrawal|0|||
161063714|NCT02719743|581624230|FG001|Overall Study|Consent withdrawal|2|||
161063715|NCT02719743|581624231|FG002|Overall Study|Consent withdrawal|0|||
161063716|NCT02719743|581624232|FG003|Overall Study|Consent withdrawal|1|||
161063717|NCT02719743|581624233|FG004|Overall Study|Consent withdrawal|0|||
161063718|NCT02719743|581624229|FG000|Overall Study|Migrated/moved from study area|0|||
161063719|NCT02719743|581624230|FG001|Overall Study|Migrated/moved from study area|0|||
161063720|NCT02719743|581624231|FG002|Overall Study|Migrated/moved from study area|0|||
161063721|NCT02719743|581624232|FG003|Overall Study|Migrated/moved from study area|0|||
161063722|NCT02719743|581624233|FG004|Overall Study|Migrated/moved from study area|2|||
161063723|NCT02719743|581624229|FG000|Overall Study|Lost to Follow-up|1|||
161063724|NCT02719743|581624230|FG001|Overall Study|Lost to Follow-up|1|||
161063725|NCT02719743|581624231|FG002|Overall Study|Lost to Follow-up|0|||
161063726|NCT02719743|581624232|FG003|Overall Study|Lost to Follow-up|0|||
161063727|NCT02719743|581624233|FG004|Overall Study|Lost to Follow-up|0|||
161063728|NCT01438840|581624234|FG000|Core Study|Adverse Event|0|||
161063729|NCT01438840|581624235|FG001|Core Study|Adverse Event|3|||
161063730|NCT01438840|581624236|FG002|Core Study|Adverse Event|0|||
161063731|NCT01438840|581624234|FG000|Core Study|Lack of Efficacy|15|||
161063732|NCT01438840|581624235|FG001|Core Study|Lack of Efficacy|7|||
161063733|NCT01438840|581624236|FG002|Core Study|Lack of Efficacy|0|||
161063734|NCT01438840|581624234|FG000|Core Study|Withdrawal of consent|1|||
161063735|NCT01438840|581624235|FG001|Core Study|Withdrawal of consent|0|||
161063736|NCT01438840|581624236|FG002|Core Study|Withdrawal of consent|0|||
161063737|NCT01438840|581624234|FG000|Extension Phase|Adverse Event|0|||
161063738|NCT01438840|581624235|FG001|Extension Phase|Adverse Event|0|||
161063739|NCT01438840|581624236|FG002|Extension Phase|Adverse Event|3|||
161063740|NCT01438840|581624234|FG000|Extension Phase|Lost to Follow-up|0|||
161063741|NCT01438840|581624235|FG001|Extension Phase|Lost to Follow-up|0|||
161063742|NCT01438840|581624236|FG002|Extension Phase|Lost to Follow-up|1|||
161063743|NCT01438840|581624234|FG000|Extension Phase|Withdrawal by Subject|0|||
161063744|NCT01438840|581624235|FG001|Extension Phase|Withdrawal by Subject|0|||
161063745|NCT01438840|581624236|FG002|Extension Phase|Withdrawal by Subject|3|||
161063746|NCT01438840|581624234|FG000|Extension Phase|Lack of Efficacy|0|||
161063747|NCT01438840|581624235|FG001|Extension Phase|Lack of Efficacy|0|||
161063748|NCT01438840|581624236|FG002|Extension Phase|Lack of Efficacy|2|||
161063749|NCT01438840|581624234|FG000|Extension Phase|Other|0|||
161063750|NCT01438840|581624235|FG001|Extension Phase|Other|0|||
161063751|NCT01438840|581624236|FG002|Extension Phase|Other|1|||
161063752|NCT01930214|581624237|FG000|Overall Study|Death|4|||
161063753|NCT01930214|581624238|FG001|Overall Study|Death|4|||
161282490|NCT03207867|582413053|FG007|Overall Study|Adverse Event|1|||
161063754|NCT01930214|581624239|FG002|Overall Study|Death|11|||
161063755|NCT01930214|581624237|FG000|Overall Study|Lost to Follow-up|12|||
161063756|NCT01930214|581624238|FG001|Overall Study|Lost to Follow-up|13|||
161063757|NCT01930214|581624239|FG002|Overall Study|Lost to Follow-up|12|||
161063758|NCT01930214|581624237|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
161063759|NCT01930214|581624238|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
161063760|NCT01930214|581624239|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
161063761|NCT01930214|581624237|FG000|Overall Study|Physician Decision|2|||
161063762|NCT01930214|581624238|FG001|Overall Study|Physician Decision|0|||
161063763|NCT01930214|581624239|FG002|Overall Study|Physician Decision|0|||
161063764|NCT02601209|581624240|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
161063765|NCT02601209|581624241|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
161063766|NCT02601209|581624242|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
161063767|NCT02601209|581624243|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161063768|NCT02601209|581624244|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161063769|NCT02601209|581624245|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161063770|NCT02601209|581624246|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161063771|NCT02601209|581624247|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161063772|NCT02601209|581624248|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
161063773|NCT02601209|581624240|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161063774|NCT02601209|581624241|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161063775|NCT02601209|581624242|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161063776|NCT02601209|581624243|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161063777|NCT02601209|581624244|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
161063778|NCT02601209|581624245|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
161063779|NCT02601209|581624246|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
161063780|NCT02601209|581624247|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161063781|NCT02601209|581624248|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
161063782|NCT02604342|581624252|FG000|Overall Study|Death|32|||
161063783|NCT02604342|581624253|FG001|Overall Study|Death|16|||
161063784|NCT02604342|581624252|FG000|Overall Study|Progression of disease|1|||
161063785|NCT02604342|581624253|FG001|Overall Study|Progression of disease|0|||
161063786|NCT02604342|581624252|FG000|Overall Study|Withdrawal by Subject|5|||
161063787|NCT02604342|581624253|FG001|Overall Study|Withdrawal by Subject|6|||
161063788|NCT02604342|581624252|FG000|Overall Study|Other|1|||
161063789|NCT02604342|581624253|FG001|Overall Study|Other|0|||
161063790|NCT02604342|581624252|FG000|Overall Study|Study Termination by Sponsor|1|||
161063791|NCT02604342|581624253|FG001|Overall Study|Study Termination by Sponsor|0|||
161063792|NCT02604342|581624252|FG000|Overall Study|Lost to Follow-up|1|||
161063793|NCT02604342|581624253|FG001|Overall Study|Lost to Follow-up|1|||
161063794|NCT02604342|581624252|FG000|Overall Study|Physician Decision|2|||
161063795|NCT02604342|581624253|FG001|Overall Study|Physician Decision|0|||
161063796|NCT01702519|581624254|FG000|Washout Period|Lost to Follow-up|1|||
161063797|NCT01702519|581624255|FG001|Washout Period|Lost to Follow-up|0|||
161063798|NCT01702519|581624254|FG000|Washout Period|Withdrawal by Subject|0|||
161063799|NCT01702519|581624255|FG001|Washout Period|Withdrawal by Subject|2|||
161063800|NCT02725008|581624260|FG000|Overall Study|Lost to Follow-up|7|||
161063801|NCT02725008|581624261|FG001|Overall Study|Lost to Follow-up|9|||
161063802|NCT02725008|581624260|FG000|Overall Study|Withdrawal by Subject|2|||
161063803|NCT02725008|581624261|FG001|Overall Study|Withdrawal by Subject|2|||
161063804|NCT02725008|581624260|FG000|Overall Study|Admitted to hospital|0|||
161063805|NCT02725008|581624261|FG001|Overall Study|Admitted to hospital|1|||
161063806|NCT04688086|581624262|FG000|Overall Study|Lost to Follow-up|164|||
161063807|NCT04688086|581624262|FG000|Overall Study|Imaging error;|64|||
161063808|NCT01329419|581624265|FG000|Overall Study|Protocol Violation|235|||
161063809|NCT00934700|581624270|FG000|Overall Study|missing scan|5|||
161063810|NCT00934700|581624271|FG001|Overall Study|missing scan|9|||
161063811|NCT00934700|581624270|FG000|Overall Study|Death|8|||
161063812|NCT00934700|581624271|FG001|Overall Study|Death|3|||
161063813|NCT01831726|581624272|FG000|Overall Study|Adverse Event|16|||
161063814|NCT01831726|581624272|FG000|Overall Study|Death|7|||
161063815|NCT01831726|581624272|FG000|Overall Study|Disease Progression|49|||
161063816|NCT01831726|581624272|FG000|Overall Study|Physician Decision|1|||
161063817|NCT01831726|581624272|FG000|Overall Study|Subject/guardian decision|7|||
161063818|NCT00514813|581624275|FG000|Overall Study|Study terminated|14|||
161063819|NCT00514813|581624276|FG001|Overall Study|Study terminated|74|||
161063820|NCT00514813|581624277|FG002|Overall Study|Study terminated|40|||
161063821|NCT00514813|581624278|FG003|Overall Study|Study terminated|2|||
161063822|NCT00514813|581624275|FG000|Overall Study|Adverse Event|0|||
161063823|NCT00514813|581624276|FG001|Overall Study|Adverse Event|2|||
161063824|NCT00514813|581624277|FG002|Overall Study|Adverse Event|2|||
161063825|NCT00514813|581624278|FG003|Overall Study|Adverse Event|0|||
161063826|NCT00514813|581624275|FG000|Overall Study|Protocol Violation|1|||
161063827|NCT00514813|581624276|FG001|Overall Study|Protocol Violation|0|||
161063828|NCT00514813|581624277|FG002|Overall Study|Protocol Violation|0|||
161063829|NCT00514813|581624278|FG003|Overall Study|Protocol Violation|0|||
161063830|NCT00514813|581624275|FG000|Overall Study|Withdrawal by Subject|0|||
161063831|NCT00514813|581624276|FG001|Overall Study|Withdrawal by Subject|1|||
161063832|NCT00514813|581624277|FG002|Overall Study|Withdrawal by Subject|0|||
161063833|NCT00514813|581624278|FG003|Overall Study|Withdrawal by Subject|0|||
161063834|NCT00514813|581624275|FG000|Overall Study|Lack of Efficacy|0|||
161063835|NCT00514813|581624276|FG001|Overall Study|Lack of Efficacy|1|||
161063836|NCT00514813|581624277|FG002|Overall Study|Lack of Efficacy|0|||
161063837|NCT00514813|581624278|FG003|Overall Study|Lack of Efficacy|0|||
161063838|NCT00514813|581624275|FG000|Overall Study|Kidney transplant|0|||
161063839|NCT00514813|581624276|FG001|Overall Study|Kidney transplant|6|||
161063840|NCT00514813|581624277|FG002|Overall Study|Kidney transplant|2|||
161282491|NCT03207867|582413054|FG008|Overall Study|Adverse Event|2|||
161282492|NCT03207867|582413055|FG009|Overall Study|Adverse Event|2|||
161282493|NCT03207867|582413056|FG010|Overall Study|Adverse Event|0|||
161282494|NCT03207867|582413057|FG011|Overall Study|Adverse Event|0|||
161282495|NCT03207867|582413058|FG012|Overall Study|Adverse Event|0|||
161282496|NCT03207867|582413059|FG013|Overall Study|Adverse Event|0|||
161282497|NCT03207867|582413060|FG014|Overall Study|Adverse Event|0|||
161282498|NCT03207867|582413061|FG015|Overall Study|Adverse Event|0|||
161282499|NCT03207867|582413062|FG016|Overall Study|Adverse Event|3|||
161282500|NCT03207867|582413063|FG017|Overall Study|Adverse Event|1|||
161282501|NCT03207867|582413064|FG018|Overall Study|Adverse Event|2|||
161282502|NCT03207867|582413065|FG019|Overall Study|Adverse Event|1|||
161282503|NCT03207867|582413066|FG020|Overall Study|Adverse Event|0|||
161282504|NCT03207867|582413067|FG021|Overall Study|Adverse Event|0|||
161282505|NCT03207867|582413068|FG022|Overall Study|Adverse Event|0|||
161282506|NCT03207867|582413069|FG023|Overall Study|Adverse Event|0|||
161282507|NCT03207867|582413046|FG000|Overall Study|Death|0|||
161282508|NCT03207867|582413047|FG001|Overall Study|Death|0|||
161282509|NCT03207867|582413048|FG002|Overall Study|Death|0|||
161282510|NCT03207867|582413049|FG003|Overall Study|Death|0|||
161282511|NCT03207867|582413050|FG004|Overall Study|Death|0|||
161282512|NCT03207867|582413051|FG005|Overall Study|Death|1|||
161282513|NCT03207867|582413052|FG006|Overall Study|Death|0|||
161282514|NCT03207867|582413053|FG007|Overall Study|Death|3|||
161063841|NCT00514813|581624278|FG003|Overall Study|Kidney transplant|0|||
161063842|NCT00514813|581624275|FG000|Overall Study|Death|0|||
161063843|NCT00514813|581624276|FG001|Overall Study|Death|2|||
161063844|NCT00514813|581624277|FG002|Overall Study|Death|3|||
161063845|NCT00514813|581624278|FG003|Overall Study|Death|2|||
161063846|NCT01075100|581624281|FG000|Overall Study|Adverse Event|15|||
161063847|NCT01075100|581624282|FG001|Overall Study|Adverse Event|18|||
161063848|NCT01075100|581624281|FG000|Overall Study|Patient Request|4|||
161063849|NCT01075100|581624282|FG001|Overall Study|Patient Request|4|||
161063850|NCT01075100|581624281|FG000|Overall Study|Investigator Request|2|||
161063851|NCT01075100|581624282|FG001|Overall Study|Investigator Request|1|||
161063852|NCT01075100|581624281|FG000|Overall Study|Disease Progression|25|||
161063853|NCT01075100|581624282|FG001|Overall Study|Disease Progression|29|||
161063854|NCT01075100|581624281|FG000|Overall Study|Other|3|||
161063855|NCT01075100|581624282|FG001|Overall Study|Other|1|||
161063856|NCT03614676|581625590|FG000|Overall Study|Delivery before planned visit|2|||
161063857|NCT03614676|581625591|FG001|Overall Study|Delivery before planned visit|0|||
161063858|NCT03614676|581625590|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
161063859|NCT03614676|581625591|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
161063860|NCT03614676|581625590|FG000|Overall Study|Migrated / moved from the study area|30|||
161063861|NCT03614676|581625591|FG001|Overall Study|Migrated / moved from the study area|22|||
161063862|NCT03614676|581625590|FG000|Overall Study|Lost to Follow-up|17|||
161063863|NCT03614676|581625591|FG001|Overall Study|Lost to Follow-up|42|||
161063864|NCT03614676|581625590|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
161063865|NCT03614676|581625591|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
161063866|NCT03614676|581625590|FG000|Overall Study|Other|16|||
161063867|NCT03614676|581625591|FG001|Overall Study|Other|47|||
161063868|NCT03614676|581625590|FG000|Overall Study|Protocol Violation|0|||
161063869|NCT03614676|581625591|FG001|Overall Study|Protocol Violation|2|||
161063870|NCT03614676|581625590|FG000|Overall Study|Neonatal event of interest|0|||
161063871|NCT03614676|581625591|FG001|Overall Study|Neonatal event of interest|6|||
161063872|NCT03614676|581625590|FG000|Overall Study|Death in infant greater than 28 days old|0|||
161063873|NCT03614676|581625591|FG001|Overall Study|Death in infant greater than 28 days old|12|||
161063874|NCT03614676|581625590|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
161063875|NCT03614676|581625591|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
161063876|NCT01999972|581625592|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
161282515|NCT03207867|582413054|FG008|Overall Study|Death|1|||
161282516|NCT03207867|582413055|FG009|Overall Study|Death|2|||
161282517|NCT03207867|582413056|FG010|Overall Study|Death|0|||
161282518|NCT03207867|582413057|FG011|Overall Study|Death|1|||
161282519|NCT03207867|582413058|FG012|Overall Study|Death|0|||
161282520|NCT03207867|582413059|FG013|Overall Study|Death|1|||
161282521|NCT03207867|582413060|FG014|Overall Study|Death|0|||
161282522|NCT03207867|582413061|FG015|Overall Study|Death|0|||
161282523|NCT03207867|582413062|FG016|Overall Study|Death|0|||
161063877|NCT01999972|581625593|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
161063878|NCT01999972|581625594|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
161063879|NCT01999972|581625595|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
161282524|NCT03207867|582413063|FG017|Overall Study|Death|2|||
161282525|NCT03207867|582413064|FG018|Overall Study|Death|0|||
161282526|NCT03207867|582413065|FG019|Overall Study|Death|1|||
161282527|NCT03207867|582413066|FG020|Overall Study|Death|0|||
161282528|NCT03207867|582413067|FG021|Overall Study|Death|0|||
161154144|NCT01544595|581945557|FG005|Status at Week 156|Lost to Follow-up|1|||
161154145|NCT01544595|581945552|FG000|Status at Week 156|Non-compliance with study treatement|0|||
161154146|NCT01544595|581945553|FG001|Status at Week 156|Non-compliance with study treatement|1|||
161154147|NCT01544595|581945554|FG002|Status at Week 156|Non-compliance with study treatement|0|||
161154148|NCT01544595|581945555|FG003|Status at Week 156|Non-compliance with study treatement|1|||
161154149|NCT01544595|581945556|FG004|Status at Week 156|Non-compliance with study treatement|0|||
161154150|NCT01544595|581945557|FG005|Status at Week 156|Non-compliance with study treatement|1|||
161154151|NCT01544595|581945552|FG000|Status at Week 156|Physician Decision|0|||
161154152|NCT01544595|581945553|FG001|Status at Week 156|Physician Decision|3|||
161154153|NCT01544595|581945554|FG002|Status at Week 156|Physician Decision|1|||
161154154|NCT01544595|581945555|FG003|Status at Week 156|Physician Decision|0|||
161154155|NCT01544595|581945556|FG004|Status at Week 156|Physician Decision|0|||
161154156|NCT01544595|581945557|FG005|Status at Week 156|Physician Decision|0|||
161154157|NCT01544595|581945552|FG000|Status at Week 156|Pregnancy|2|||
161154158|NCT01544595|581945553|FG001|Status at Week 156|Pregnancy|3|||
161154159|NCT01544595|581945554|FG002|Status at Week 156|Pregnancy|0|||
161154160|NCT01544595|581945555|FG003|Status at Week 156|Pregnancy|0|||
161154161|NCT01544595|581945556|FG004|Status at Week 156|Pregnancy|0|||
161154162|NCT01544595|581945557|FG005|Status at Week 156|Pregnancy|0|||
161154163|NCT01544595|581945552|FG000|Status at Week 156|Protocol Violation|3|||
161154164|NCT01544595|581945553|FG001|Status at Week 156|Protocol Violation|1|||
161154165|NCT01544595|581945554|FG002|Status at Week 156|Protocol Violation|2|||
161154166|NCT01544595|581945555|FG003|Status at Week 156|Protocol Violation|2|||
161154167|NCT01544595|581945556|FG004|Status at Week 156|Protocol Violation|0|||
161154168|NCT01544595|581945557|FG005|Status at Week 156|Protocol Violation|0|||
161154169|NCT01544595|581945552|FG000|Status at Week 156|Technical problems|3|||
161154170|NCT01544595|581945553|FG001|Status at Week 156|Technical problems|1|||
161154171|NCT01544595|581945554|FG002|Status at Week 156|Technical problems|0|||
161154172|NCT01544595|581945555|FG003|Status at Week 156|Technical problems|1|||
161154173|NCT01544595|581945556|FG004|Status at Week 156|Technical problems|0|||
161154174|NCT01544595|581945557|FG005|Status at Week 156|Technical problems|0|||
161154175|NCT01544595|581945552|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
161154176|NCT01544595|581945553|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
161154177|NCT01544595|581945554|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
161154178|NCT01544595|581945555|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
161154179|NCT01544595|581945556|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
161154180|NCT01544595|581945557|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
161154181|NCT01544595|581945552|FG000|Status at Week 156|Lack of Efficacy|1|||
161154182|NCT01544595|581945553|FG001|Status at Week 156|Lack of Efficacy|0|||
161154183|NCT01544595|581945554|FG002|Status at Week 156|Lack of Efficacy|1|||
161154184|NCT01544595|581945555|FG003|Status at Week 156|Lack of Efficacy|4|||
161154185|NCT01544595|581945556|FG004|Status at Week 156|Lack of Efficacy|10|||
161154186|NCT01544595|581945557|FG005|Status at Week 156|Lack of Efficacy|5|||
161154187|NCT01929044|581945558|FG000|Overall Study|Adverse Event|1|||
161154188|NCT01929044|581945559|FG001|Overall Study|Adverse Event|0|||
161154189|NCT01929044|581945558|FG000|Overall Study|Protocol Violation|9|||
161154190|NCT01929044|581945559|FG001|Overall Study|Protocol Violation|14|||
161154191|NCT01929044|581945558|FG000|Overall Study|Not Treated|1|||
161154192|NCT01929044|581945559|FG001|Overall Study|Not Treated|3|||
161154193|NCT02084134|581945562|FG000|Overall Study|Protocol Violation|4|||
161154194|NCT02084134|581945563|FG001|Overall Study|Protocol Violation|2|||
161154195|NCT02084134|581945562|FG000|Overall Study|Death|0|||
161154196|NCT02084134|581945563|FG001|Overall Study|Death|1|||
161282529|NCT03207867|582413068|FG022|Overall Study|Death|0|||
161282530|NCT03207867|582413069|FG023|Overall Study|Death|0|||
161282531|NCT03207867|582413046|FG000|Overall Study|Physician Decision|3|||
161154197|NCT04333433|581945564|FG000|Overall Study|Withdrawal by Subject|6|||
161154198|NCT04333433|581945565|FG001|Overall Study|Withdrawal by Subject|3|||
161154199|NCT04333433|581945564|FG000|Overall Study|Death|3|||
161154200|NCT04333433|581945565|FG001|Overall Study|Death|0|||
161154201|NCT04333433|581945564|FG000|Overall Study|Lost to Follow-up|6|||
161154202|NCT04333433|581945565|FG001|Overall Study|Lost to Follow-up|1|||
161154203|NCT04333433|581945564|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
161154204|NCT04333433|581945565|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
161154205|NCT02026271|581945566|FG000|Overall Study|Adverse Event|2|||
161154206|NCT02026271|581945567|FG001|Overall Study|Adverse Event|3|||
161282532|NCT03207867|582413047|FG001|Overall Study|Physician Decision|5|||
161154207|NCT02026271|581945568|FG002|Overall Study|Adverse Event|2|||
161154208|NCT02026271|581945569|FG003|Overall Study|Adverse Event|3|||
161282533|NCT03207867|582413048|FG002|Overall Study|Physician Decision|0|||
161154209|NCT02026271|581945570|FG004|Overall Study|Adverse Event|0|||
161154210|NCT02026271|581945566|FG000|Overall Study|Withdrawal by Subject|0|||
161154211|NCT02026271|581945567|FG001|Overall Study|Withdrawal by Subject|0|||
161154212|NCT02026271|581945568|FG002|Overall Study|Withdrawal by Subject|0|||
161154213|NCT02026271|581945569|FG003|Overall Study|Withdrawal by Subject|0|||
161282534|NCT03207867|582413049|FG003|Overall Study|Physician Decision|3|||
161063880|NCT01999972|581625596|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
161063881|NCT01999972|581625597|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
161063882|NCT01999972|581625592|FG000|Dose Escalation Part|Death|0|||
161063883|NCT01999972|581625593|FG001|Dose Escalation Part|Death|1|||
161063884|NCT01999972|581625594|FG002|Dose Escalation Part|Death|0|||
161063885|NCT01999972|581625595|FG003|Dose Escalation Part|Death|0|||
161063886|NCT01999972|581625596|FG004|Dose Escalation Part|Death|0|||
161063887|NCT01999972|581625597|FG005|Dose Escalation Part|Death|0|||
161063888|NCT01999972|581625592|FG000|Dose Escalation Part|Enrolled but not treated|0|||
161063889|NCT01999972|581625593|FG001|Dose Escalation Part|Enrolled but not treated|0|||
161063890|NCT01999972|581625594|FG002|Dose Escalation Part|Enrolled but not treated|1|||
161063891|NCT01999972|581625595|FG003|Dose Escalation Part|Enrolled but not treated|1|||
161063892|NCT01999972|581625596|FG004|Dose Escalation Part|Enrolled but not treated|0|||
161063893|NCT01999972|581625597|FG005|Dose Escalation Part|Enrolled but not treated|0|||
161063894|NCT01999972|581625592|FG000|Dose Escalation Part|Disease progression|3|||
161063895|NCT01999972|581625593|FG001|Dose Escalation Part|Disease progression|2|||
161063896|NCT01999972|581625594|FG002|Dose Escalation Part|Disease progression|3|||
161063897|NCT01999972|581625595|FG003|Dose Escalation Part|Disease progression|6|||
161063898|NCT01999972|581625596|FG004|Dose Escalation Part|Disease progression|0|||
161063899|NCT01999972|581625597|FG005|Dose Escalation Part|Disease progression|0|||
161063900|NCT01999972|581625592|FG000|Dose Escalation Part|Adverse Event|0|||
161063901|NCT01999972|581625593|FG001|Dose Escalation Part|Adverse Event|0|||
161063902|NCT01999972|581625594|FG002|Dose Escalation Part|Adverse Event|0|||
161063903|NCT01999972|581625595|FG003|Dose Escalation Part|Adverse Event|2|||
161063904|NCT01999972|581625596|FG004|Dose Escalation Part|Adverse Event|0|||
161063905|NCT01999972|581625597|FG005|Dose Escalation Part|Adverse Event|0|||
161063906|NCT01999972|581625592|FG000|Dose Escalation Part|Global deterioration of health status|1|||
161063907|NCT01999972|581625593|FG001|Dose Escalation Part|Global deterioration of health status|0|||
161063908|NCT01999972|581625594|FG002|Dose Escalation Part|Global deterioration of health status|0|||
161063909|NCT01999972|581625595|FG003|Dose Escalation Part|Global deterioration of health status|1|||
161063910|NCT01999972|581625596|FG004|Dose Escalation Part|Global deterioration of health status|0|||
161063911|NCT01999972|581625597|FG005|Dose Escalation Part|Global deterioration of health status|0|||
161063912|NCT01999972|581625592|FG000|Dose Expansion Part|Death|0|||
161063913|NCT01999972|581625593|FG001|Dose Expansion Part|Death|0|||
161063914|NCT01999972|581625594|FG002|Dose Expansion Part|Death|0|||
161063915|NCT01999972|581625595|FG003|Dose Expansion Part|Death|0|||
161063916|NCT01999972|581625596|FG004|Dose Expansion Part|Death|2|||
161063917|NCT01999972|581625597|FG005|Dose Expansion Part|Death|1|||
161063918|NCT01999972|581625592|FG000|Dose Expansion Part|Disease progression|0|||
161063919|NCT01999972|581625593|FG001|Dose Expansion Part|Disease progression|0|||
161063920|NCT01999972|581625594|FG002|Dose Expansion Part|Disease progression|0|||
161063921|NCT01999972|581625595|FG003|Dose Expansion Part|Disease progression|0|||
161063922|NCT01999972|581625596|FG004|Dose Expansion Part|Disease progression|9|||
161063923|NCT01999972|581625597|FG005|Dose Expansion Part|Disease progression|3|||
161063924|NCT01999972|581625592|FG000|Dose Expansion Part|Sponsor decision|0|||
161063925|NCT01999972|581625593|FG001|Dose Expansion Part|Sponsor decision|0|||
161063926|NCT01999972|581625594|FG002|Dose Expansion Part|Sponsor decision|0|||
161063927|NCT01999972|581625595|FG003|Dose Expansion Part|Sponsor decision|0|||
161063928|NCT01999972|581625596|FG004|Dose Expansion Part|Sponsor decision|1|||
161063929|NCT01999972|581625597|FG005|Dose Expansion Part|Sponsor decision|0|||
161063930|NCT01999972|581625592|FG000|Dose Expansion Part|Adverse Event|0|||
161063931|NCT01999972|581625593|FG001|Dose Expansion Part|Adverse Event|0|||
161063932|NCT01999972|581625594|FG002|Dose Expansion Part|Adverse Event|0|||
161063933|NCT01999972|581625595|FG003|Dose Expansion Part|Adverse Event|0|||
161063934|NCT01999972|581625596|FG004|Dose Expansion Part|Adverse Event|4|||
161063935|NCT01999972|581625597|FG005|Dose Expansion Part|Adverse Event|2|||
161063936|NCT01999972|581625592|FG000|Dose Expansion Part|Participant's non-compliance|0|||
161063937|NCT01999972|581625593|FG001|Dose Expansion Part|Participant's non-compliance|0|||
161063938|NCT01999972|581625594|FG002|Dose Expansion Part|Participant's non-compliance|0|||
161063939|NCT01999972|581625595|FG003|Dose Expansion Part|Participant's non-compliance|0|||
161063940|NCT01999972|581625596|FG004|Dose Expansion Part|Participant's non-compliance|0|||
161282535|NCT03207867|582413050|FG004|Overall Study|Physician Decision|2|||
161282536|NCT03207867|582413051|FG005|Overall Study|Physician Decision|0|||
161063941|NCT01999972|581625597|FG005|Dose Expansion Part|Participant's non-compliance|1|||
161063942|NCT01999972|581625592|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
161063943|NCT01999972|581625593|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
161063944|NCT01999972|581625594|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
161063945|NCT01999972|581625595|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
161063946|NCT01999972|581625596|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
161063947|NCT01999972|581625597|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
161063948|NCT01999972|581625592|FG000|Dose Expansion Part|Changed to standard of care|0|||
161063949|NCT01999972|581625593|FG001|Dose Expansion Part|Changed to standard of care|0|||
161282537|NCT03207867|582413052|FG006|Overall Study|Physician Decision|0|||
161063950|NCT01999972|581625594|FG002|Dose Expansion Part|Changed to standard of care|0|||
161063951|NCT01999972|581625595|FG003|Dose Expansion Part|Changed to standard of care|0|||
161063952|NCT01999972|581625596|FG004|Dose Expansion Part|Changed to standard of care|1|||
161063953|NCT01999972|581625597|FG005|Dose Expansion Part|Changed to standard of care|0|||
161063954|NCT02166476|581625610|FG000|Overall Study|Withdrawal by Subject|5|||
161063955|NCT02166476|581625611|FG001|Overall Study|Withdrawal by Subject|7|||
161063956|NCT02166476|581625610|FG000|Overall Study|Adverse Event|3|||
161063957|NCT02166476|581625611|FG001|Overall Study|Adverse Event|3|||
161063958|NCT02166476|581625610|FG000|Overall Study|Lost to Follow-up|5|||
161063959|NCT02166476|581625611|FG001|Overall Study|Lost to Follow-up|10|||
161063960|NCT02166476|581625610|FG000|Overall Study|Physician Decision|1|||
161063961|NCT02166476|581625611|FG001|Overall Study|Physician Decision|0|||
161063962|NCT02166476|581625610|FG000|Overall Study|Unable to Come for Visit|0|||
161063963|NCT02166476|581625611|FG001|Overall Study|Unable to Come for Visit|3|||
161063964|NCT04367480|581625618|FG000|Overall Study|Adverse Event|1|||
161063965|NCT04367480|581625619|FG001|Overall Study|Adverse Event|1|||
161063966|NCT04367480|581625618|FG000|Overall Study|Death|1|||
161063967|NCT04367480|581625619|FG001|Overall Study|Death|0|||
161063968|NCT04367480|581625618|FG000|Overall Study|Lost to Follow-up|1|||
161063969|NCT04367480|581625619|FG001|Overall Study|Lost to Follow-up|1|||
161063970|NCT04367480|581625618|FG000|Overall Study|Withdrawal by Subject|0|||
161063971|NCT04367480|581625619|FG001|Overall Study|Withdrawal by Subject|3|||
161063972|NCT04367480|581625618|FG000|Overall Study|App glitch during the study|1|||
161063973|NCT04367480|581625619|FG001|Overall Study|App glitch during the study|0|||
161063974|NCT04367480|581625618|FG000|Overall Study|Device Distribution Error|0|||
161063975|NCT04367480|581625619|FG001|Overall Study|Device Distribution Error|2|||
161063976|NCT04367480|581625618|FG000|Overall Study|Ineligible after Randomization|0|||
161063977|NCT04367480|581625619|FG001|Overall Study|Ineligible after Randomization|1|||
161063978|NCT04367480|581625618|FG000|Overall Study|Other Medical Reasons|0|||
161063979|NCT04367480|581625619|FG001|Overall Study|Other Medical Reasons|2|||
161063980|NCT03382561|581625620|FG000|Overall Study|Disease progression|47|||
161063981|NCT03382561|581625621|FG001|Overall Study|Disease progression|6|||
161063982|NCT03382561|581625620|FG000|Overall Study|Adverse Event|10|||
161063983|NCT03382561|581625621|FG001|Overall Study|Adverse Event|2|||
161063984|NCT03382561|581625620|FG000|Overall Study|Death|8|||
161063985|NCT03382561|581625621|FG001|Overall Study|Death|3|||
161063986|NCT03382561|581625620|FG000|Overall Study|Withdrawal by Subject|6|||
161063987|NCT03382561|581625621|FG001|Overall Study|Withdrawal by Subject|5|||
161063988|NCT03382561|581625620|FG000|Overall Study|Alternative therapy|2|||
161063989|NCT03382561|581625621|FG001|Overall Study|Alternative therapy|8|||
161063990|NCT03382561|581625620|FG000|Overall Study|Never started treatment|3|||
161063991|NCT03382561|581625621|FG001|Overall Study|Never started treatment|6|||
161063992|NCT03382561|581625620|FG000|Overall Study|Lack of Efficacy|0|||
161063993|NCT03382561|581625621|FG001|Overall Study|Lack of Efficacy|1|||
161063994|NCT03382561|581625620|FG000|Overall Study|Physician Decision|0|||
161063995|NCT03382561|581625621|FG001|Overall Study|Physician Decision|1|||
161063996|NCT03382561|581625620|FG000|Overall Study|Other complicating disease|0|||
161063997|NCT03382561|581625621|FG001|Overall Study|Other complicating disease|1|||
161063998|NCT01131104|581625622|FG000|Overall Study|Withdrawal by Subject|3|||
161063999|NCT01131104|581625622|FG000|Overall Study|Physician Decision|4|||
161064000|NCT01131104|581625622|FG000|Overall Study|Information Not Available|5|||
161154214|NCT02026271|581945570|FG004|Overall Study|Withdrawal by Subject|1|||
161154215|NCT02807454|581945571|FG000|Overall Study|Adverse Event|1|||
161154216|NCT02807454|581945572|FG001|Overall Study|Adverse Event|0|||
161154217|NCT02807454|581945571|FG000|Overall Study|Withdrawal by Subject|0|||
161154218|NCT02807454|581945572|FG001|Overall Study|Withdrawal by Subject|1|||
161154219|NCT02807454|581945571|FG000|Overall Study|Progressive Disease|30|||
161154220|NCT02807454|581945572|FG001|Overall Study|Progressive Disease|3|||
161154221|NCT02807454|581945571|FG000|Overall Study|Other Reasons|1|||
161154222|NCT02807454|581945572|FG001|Overall Study|Other Reasons|1|||
161154223|NCT05468086|581945575|FG000|Overall Study|Withdrawal by Subject|3|||
161154224|NCT05468086|581945575|FG000|Overall Study|Subject was found ineligible after consent|1|||
161154225|NCT01108809|581945576|FG000|Overall Study|Adverse Event|3|||
161154226|NCT01108809|581945576|FG000|Overall Study|Lost to Follow-up|1|||
161154227|NCT00804193|581945581|FG000|Overall Study|Lack of baseline fungus|32|||
161154228|NCT00804193|581945582|FG001|Overall Study|Lack of baseline fungus|31|||
161154229|NCT00804193|581945583|FG002|Overall Study|Lack of baseline fungus|19|||
161064001|NCT01131104|581625622|FG000|Overall Study|No Information on Index Date of Onset|1|||
161064002|NCT02438371|581625626|FG000|Overall Study|Lost to Follow-up|3|||
161064003|NCT02438371|581625627|FG001|Overall Study|Lost to Follow-up|2|||
161064004|NCT02438371|581625626|FG000|Overall Study|Withdrawal by Subject|1|||
161064005|NCT02438371|581625627|FG001|Overall Study|Withdrawal by Subject|1|||
161064006|NCT03065933|581625631|FG000|Overall Study|study terminated|5|||
161064007|NCT02536742|581625632|FG000|Overall Study|Did not start protocol therapy|1|||
161064008|NCT02536742|581625632|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
161154230|NCT00804193|581945581|FG000|Overall Study|Adverse Event|0|||
161282538|NCT03207867|582413053|FG007|Overall Study|Physician Decision|0|||
161282539|NCT03207867|582413054|FG008|Overall Study|Physician Decision|4|||
161282540|NCT03207867|582413055|FG009|Overall Study|Physician Decision|2|||
161282541|NCT03207867|582413056|FG010|Overall Study|Physician Decision|0|||
161282542|NCT03207867|582413057|FG011|Overall Study|Physician Decision|4|||
161282543|NCT03207867|582413058|FG012|Overall Study|Physician Decision|0|||
161282544|NCT03207867|582413059|FG013|Overall Study|Physician Decision|0|||
161282545|NCT03207867|582413060|FG014|Overall Study|Physician Decision|2|||
161282546|NCT03207867|582413061|FG015|Overall Study|Physician Decision|1|||
161282547|NCT03207867|582413062|FG016|Overall Study|Physician Decision|1|||
161282548|NCT03207867|582413063|FG017|Overall Study|Physician Decision|2|||
161282549|NCT03207867|582413064|FG018|Overall Study|Physician Decision|1|||
161282550|NCT03207867|582413065|FG019|Overall Study|Physician Decision|3|||
161282551|NCT03207867|582413066|FG020|Overall Study|Physician Decision|0|||
161282552|NCT03207867|582413067|FG021|Overall Study|Physician Decision|0|||
161282553|NCT03207867|582413068|FG022|Overall Study|Physician Decision|0|||
161282554|NCT03207867|582413069|FG023|Overall Study|Physician Decision|0|||
161282555|NCT03207867|582413046|FG000|Overall Study|Progressive Disease|7|||
161282556|NCT03207867|582413047|FG001|Overall Study|Progressive Disease|7|||
161282557|NCT03207867|582413048|FG002|Overall Study|Progressive Disease|9|||
161282558|NCT03207867|582413049|FG003|Overall Study|Progressive Disease|10|||
161282559|NCT03207867|582413050|FG004|Overall Study|Progressive Disease|11|||
161282560|NCT03207867|582413051|FG005|Overall Study|Progressive Disease|10|||
161282561|NCT03207867|582413052|FG006|Overall Study|Progressive Disease|9|||
161282562|NCT03207867|582413053|FG007|Overall Study|Progressive Disease|8|||
161282563|NCT03207867|582413054|FG008|Overall Study|Progressive Disease|19|||
161282564|NCT03207867|582413055|FG009|Overall Study|Progressive Disease|23|||
161282565|NCT03207867|582413056|FG010|Overall Study|Progressive Disease|2|||
161282566|NCT03207867|582413057|FG011|Overall Study|Progressive Disease|24|||
161282567|NCT03207867|582413058|FG012|Overall Study|Progressive Disease|3|||
161282568|NCT03207867|582413059|FG013|Overall Study|Progressive Disease|11|||
161282569|NCT03207867|582413060|FG014|Overall Study|Progressive Disease|9|||
161282570|NCT03207867|582413061|FG015|Overall Study|Progressive Disease|5|||
161282571|NCT03207867|582413062|FG016|Overall Study|Progressive Disease|10|||
161282572|NCT03207867|582413063|FG017|Overall Study|Progressive Disease|14|||
161282573|NCT03207867|582413064|FG018|Overall Study|Progressive Disease|13|||
161282574|NCT03207867|582413065|FG019|Overall Study|Progressive Disease|14|||
161282575|NCT03207867|582413066|FG020|Overall Study|Progressive Disease|6|||
161282576|NCT03207867|582413067|FG021|Overall Study|Progressive Disease|3|||
161282577|NCT03207867|582413068|FG022|Overall Study|Progressive Disease|3|||
161282578|NCT03207867|582413069|FG023|Overall Study|Progressive Disease|3|||
161282579|NCT03207867|582413046|FG000|Overall Study|Patient/guardian Decision|0|||
161282580|NCT03207867|582413047|FG001|Overall Study|Patient/guardian Decision|0|||
161282581|NCT03207867|582413048|FG002|Overall Study|Patient/guardian Decision|1|||
161282582|NCT03207867|582413049|FG003|Overall Study|Patient/guardian Decision|1|||
161064009|NCT01513330|581625633|FG000|SenSura Mio First,|Adverse Event|2|||
161064010|NCT01513330|581625634|FG001|SenSura Mio First,|Adverse Event|0|||
161064011|NCT01513330|581625633|FG000|SenSura Mio First,|Lack of Efficacy|0|||
161064012|NCT01513330|581625634|FG001|SenSura Mio First,|Lack of Efficacy|1|||
161064013|NCT01513330|581625633|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
161064014|NCT01513330|581625634|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
161064015|NCT01513330|581625633|FG000|SenSura Mio First,|Other|1|||
161064016|NCT01513330|581625634|FG001|SenSura Mio First,|Other|0|||
161064017|NCT01513330|581625633|FG000|Standard Care First,|Lack of Efficacy|2|||
161064018|NCT01513330|581625634|FG001|Standard Care First,|Lack of Efficacy|2|||
161064019|NCT01513330|581625633|FG000|Standard Care First,|Withdrawal by Subject|1|||
161064020|NCT01513330|581625634|FG001|Standard Care First,|Withdrawal by Subject|2|||
161064021|NCT01513330|581625633|FG000|Standard Care First,|Other|1|||
161064022|NCT01513330|581625634|FG001|Standard Care First,|Other|0|||
161064023|NCT01496365|581625639|FG000|Overall Study|Adverse Event|2|||
161154231|NCT00804193|581945582|FG001|Overall Study|Adverse Event|0|||
161282583|NCT03207867|582413050|FG004|Overall Study|Patient/guardian Decision|1|||
161282584|NCT03207867|582413051|FG005|Overall Study|Patient/guardian Decision|2|||
161282585|NCT03207867|582413052|FG006|Overall Study|Patient/guardian Decision|1|||
161282586|NCT03207867|582413053|FG007|Overall Study|Patient/guardian Decision|0|||
161154232|NCT00804193|581945583|FG002|Overall Study|Adverse Event|2|||
161282587|NCT03207867|582413054|FG008|Overall Study|Patient/guardian Decision|1|||
161064024|NCT01496365|581625640|FG001|Overall Study|Adverse Event|3|||
161154233|NCT00804193|581945581|FG000|Overall Study|Lack of Efficacy|1|||
161064025|NCT01496365|581625641|FG002|Overall Study|Adverse Event|3|||
161064026|NCT01496365|581625642|FG003|Overall Study|Adverse Event|2|||
161154234|NCT00804193|581945582|FG001|Overall Study|Lack of Efficacy|1|||
161282588|NCT03207867|582413055|FG009|Overall Study|Patient/guardian Decision|0|||
161282589|NCT03207867|582413056|FG010|Overall Study|Patient/guardian Decision|0|||
161282590|NCT03207867|582413057|FG011|Overall Study|Patient/guardian Decision|1|||
161282591|NCT03207867|582413058|FG012|Overall Study|Patient/guardian Decision|0|||
161282592|NCT03207867|582413059|FG013|Overall Study|Patient/guardian Decision|1|||
161282593|NCT03207867|582413060|FG014|Overall Study|Patient/guardian Decision|2|||
161282594|NCT03207867|582413061|FG015|Overall Study|Patient/guardian Decision|0|||
161064027|NCT01496365|581625643|FG004|Overall Study|Adverse Event|5|||
161282595|NCT03207867|582413062|FG016|Overall Study|Patient/guardian Decision|1|||
161282596|NCT03207867|582413063|FG017|Overall Study|Patient/guardian Decision|3|||
161282597|NCT03207867|582413064|FG018|Overall Study|Patient/guardian Decision|4|||
161282598|NCT03207867|582413065|FG019|Overall Study|Patient/guardian Decision|1|||
161064028|NCT01496365|581625644|FG005|Overall Study|Adverse Event|6|||
161064029|NCT01496365|581625645|FG006|Overall Study|Adverse Event|4|||
161064030|NCT01496365|581625639|FG000|Overall Study|Withdrawal by Subject|6|||
161064031|NCT01496365|581625640|FG001|Overall Study|Withdrawal by Subject|6|||
161064032|NCT01496365|581625641|FG002|Overall Study|Withdrawal by Subject|0|||
161064033|NCT01496365|581625642|FG003|Overall Study|Withdrawal by Subject|1|||
161064034|NCT01496365|581625643|FG004|Overall Study|Withdrawal by Subject|3|||
161064035|NCT01496365|581625644|FG005|Overall Study|Withdrawal by Subject|2|||
161064036|NCT01496365|581625645|FG006|Overall Study|Withdrawal by Subject|1|||
161064037|NCT01496365|581625639|FG000|Overall Study|Protocol Violation|2|||
161064038|NCT01496365|581625640|FG001|Overall Study|Protocol Violation|1|||
161064039|NCT01496365|581625641|FG002|Overall Study|Protocol Violation|1|||
161064040|NCT01496365|581625642|FG003|Overall Study|Protocol Violation|0|||
161064041|NCT01496365|581625643|FG004|Overall Study|Protocol Violation|0|||
161064042|NCT01496365|581625644|FG005|Overall Study|Protocol Violation|1|||
161064043|NCT01496365|581625645|FG006|Overall Study|Protocol Violation|0|||
161064044|NCT01496365|581625639|FG000|Overall Study|Lack of Efficacy|1|||
161064045|NCT01496365|581625640|FG001|Overall Study|Lack of Efficacy|0|||
161064046|NCT01496365|581625641|FG002|Overall Study|Lack of Efficacy|0|||
161064047|NCT01496365|581625642|FG003|Overall Study|Lack of Efficacy|0|||
161064048|NCT01496365|581625643|FG004|Overall Study|Lack of Efficacy|0|||
161064049|NCT01496365|581625644|FG005|Overall Study|Lack of Efficacy|1|||
161064050|NCT01496365|581625645|FG006|Overall Study|Lack of Efficacy|0|||
161064051|NCT01496365|581625639|FG000|Overall Study|Lost to Follow-up|0|||
161064052|NCT01496365|581625640|FG001|Overall Study|Lost to Follow-up|1|||
161064053|NCT01496365|581625641|FG002|Overall Study|Lost to Follow-up|0|||
161064054|NCT01496365|581625642|FG003|Overall Study|Lost to Follow-up|0|||
161064055|NCT01496365|581625643|FG004|Overall Study|Lost to Follow-up|2|||
161064056|NCT01496365|581625644|FG005|Overall Study|Lost to Follow-up|0|||
161064057|NCT01496365|581625645|FG006|Overall Study|Lost to Follow-up|0|||
161064058|NCT01496365|581625639|FG000|Overall Study|Other|4|||
161064059|NCT01496365|581625640|FG001|Overall Study|Other|4|||
161064060|NCT01496365|581625641|FG002|Overall Study|Other|2|||
161064061|NCT01496365|581625642|FG003|Overall Study|Other|1|||
161064062|NCT01496365|581625643|FG004|Overall Study|Other|3|||
161064063|NCT01496365|581625644|FG005|Overall Study|Other|0|||
161064064|NCT01496365|581625645|FG006|Overall Study|Other|1|||
161064065|NCT01015677|581625646|FG000|Overall Study|Adverse Event|0|||
161064066|NCT01015677|581625647|FG001|Overall Study|Adverse Event|1|||
161064067|NCT01015677|581625648|FG002|Overall Study|Adverse Event|0|||
161064068|NCT01015677|581625646|FG000|Overall Study|Lack of Efficacy|0|||
161064069|NCT01015677|581625647|FG001|Overall Study|Lack of Efficacy|1|||
161064070|NCT01015677|581625648|FG002|Overall Study|Lack of Efficacy|0|||
161064071|NCT01015677|581625646|FG000|Overall Study|Protocol Violation|0|||
161064072|NCT01015677|581625647|FG001|Overall Study|Protocol Violation|1|||
161064073|NCT01015677|581625648|FG002|Overall Study|Protocol Violation|0|||
161064074|NCT01015677|581625646|FG000|Overall Study|Withdrawal by Subject|1|||
161064075|NCT01015677|581625647|FG001|Overall Study|Withdrawal by Subject|1|||
161064076|NCT01015677|581625648|FG002|Overall Study|Withdrawal by Subject|0|||
161064077|NCT01660256|581625649|FG000|Overall Study|Adverse Event|4|||
161064078|NCT01660256|581625650|FG001|Overall Study|Adverse Event|0|||
161064079|NCT01660256|581625651|FG002|Overall Study|Adverse Event|2|||
161064080|NCT01660256|581625649|FG000|Overall Study|Withdrawal by Subject|1|||
161064081|NCT01660256|581625650|FG001|Overall Study|Withdrawal by Subject|0|||
161064082|NCT01660256|581625651|FG002|Overall Study|Withdrawal by Subject|2|||
161064083|NCT03898960|581625656|FG000|Overall Study|Death|10|||
161282599|NCT03207867|582413066|FG020|Overall Study|Patient/guardian Decision|0|||
161282600|NCT03207867|582413067|FG021|Overall Study|Patient/guardian Decision|0|||
161282601|NCT03207867|582413068|FG022|Overall Study|Patient/guardian Decision|0|||
161064084|NCT03463577|581625657|FG000|Overall Study|Lost to Follow-up|238|||
161064085|NCT03463577|581625658|FG001|Overall Study|Lost to Follow-up|435|||
161064086|NCT03463577|581625659|FG002|Overall Study|Lost to Follow-up|0|||
161064087|NCT03463577|581625660|FG003|Overall Study|Lost to Follow-up|0|||
161064088|NCT03463577|581625661|FG004|Overall Study|Lost to Follow-up|0|||
161064089|NCT03463577|581625662|FG005|Overall Study|Lost to Follow-up|0|||
161064090|NCT03463577|581625657|FG000|Overall Study|With unknown pregnancy outcome|0|||
161064091|NCT03463577|581625658|FG001|Overall Study|With unknown pregnancy outcome|5|||
161064092|NCT03463577|581625659|FG002|Overall Study|With unknown pregnancy outcome|0|||
161064093|NCT03463577|581625660|FG003|Overall Study|With unknown pregnancy outcome|0|||
161064094|NCT03463577|581625661|FG004|Overall Study|With unknown pregnancy outcome|0|||
161064095|NCT03463577|581625662|FG005|Overall Study|With unknown pregnancy outcome|0|||
161064096|NCT03463577|581625657|FG000|Overall Study|Maternal death|2|||
161064097|NCT03463577|581625658|FG001|Overall Study|Maternal death|0|||
161064098|NCT03463577|581625659|FG002|Overall Study|Maternal death|0|||
161064099|NCT03463577|581625660|FG003|Overall Study|Maternal death|0|||
161064100|NCT03463577|581625661|FG004|Overall Study|Maternal death|0|||
161064101|NCT03463577|581625662|FG005|Overall Study|Maternal death|0|||
161064102|NCT03463577|581625657|FG000|Overall Study|Neonatal death|0|||
161064103|NCT03463577|581625658|FG001|Overall Study|Neonatal death|0|||
161064104|NCT03463577|581625659|FG002|Overall Study|Neonatal death|0|||
161064105|NCT03463577|581625660|FG003|Overall Study|Neonatal death|15|||
161064106|NCT03463577|581625661|FG004|Overall Study|Neonatal death|17|||
161064107|NCT03463577|581625662|FG005|Overall Study|Neonatal death|0|||
161064108|NCT00236184|581625663|FG000|Overall Study|Adverse Event|5|||
161064109|NCT00236184|581625664|FG001|Overall Study|Adverse Event|2|||
161064110|NCT00236184|581625663|FG000|Overall Study|Lack of Efficacy|0|||
161064111|NCT00236184|581625664|FG001|Overall Study|Lack of Efficacy|1|||
161064112|NCT00236184|581625663|FG000|Overall Study|Lost to Follow-up|3|||
161064113|NCT00236184|581625664|FG001|Overall Study|Lost to Follow-up|4|||
161064114|NCT00236184|581625663|FG000|Overall Study|Physician Decision|1|||
161064115|NCT00236184|581625664|FG001|Overall Study|Physician Decision|1|||
161064116|NCT00236184|581625663|FG000|Overall Study|Withdrawal by Subject|3|||
161064117|NCT00236184|581625664|FG001|Overall Study|Withdrawal by Subject|0|||
161064118|NCT00236184|581625663|FG000|Overall Study|Protocol Violation|3|||
161064119|NCT00236184|581625664|FG001|Overall Study|Protocol Violation|0|||
161064120|NCT00236184|581625663|FG000|Overall Study|non-compliance with study drug|2|||
161064121|NCT00236184|581625664|FG001|Overall Study|non-compliance with study drug|1|||
161064122|NCT00236184|581625663|FG000|Overall Study|other|1|||
161064123|NCT00236184|581625664|FG001|Overall Study|other|2|||
161064124|NCT01777490|581625665|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
161064125|NCT01777490|581625666|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
161064126|NCT01777490|581625667|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
161064127|NCT01777490|581625668|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
161064128|NCT00255944|581625672|FG000|Overall Study|Lost to Follow-up|797|||
161064129|NCT00255944|581625673|FG001|Overall Study|Lost to Follow-up|834|||
161064130|NCT00935259|581625681|FG000|Period 1|Administrative (scheduling conflict)|1|||
161064131|NCT00935259|581625682|FG001|Period 1|Administrative (scheduling conflict)|1|||
161064132|NCT01721746|581625683|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
161064133|NCT01721746|581625684|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
161064134|NCT01721746|581625683|FG000|Pre-Treatment|Withdrawal by Subject|1|||
161064135|NCT01721746|581625684|FG001|Pre-Treatment|Withdrawal by Subject|16|||
161064136|NCT01721746|581625683|FG000|Pre-Treatment|Poor/Non-compliance|1|||
161064137|NCT01721746|581625684|FG001|Pre-Treatment|Poor/Non-compliance|0|||
161064138|NCT01721746|581625683|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
161064139|NCT01721746|581625684|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
161064140|NCT01721746|581625683|FG000|Treatment|Disease Progression|192|||
161064141|NCT01721746|581625684|FG001|Treatment|Disease Progression|74|||
161064142|NCT01721746|581625683|FG000|Treatment|Study Drug Toxicity|19|||
161064143|NCT01721746|581625684|FG001|Treatment|Study Drug Toxicity|11|||
161064144|NCT01721746|581625683|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
161064145|NCT01721746|581625684|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
161064146|NCT01721746|581625683|FG000|Treatment|Participant request to discontinue Study treatment|26|||
161064147|NCT01721746|581625684|FG001|Treatment|Participant request to discontinue Study treatment|7|||
161064148|NCT01721746|581625683|FG000|Treatment|Participant withdrew consent|4|||
161064149|NCT01721746|581625684|FG001|Treatment|Participant withdrew consent|2|||
161064150|NCT01721746|581625683|FG000|Treatment|Maximum Clinical Benefit|9|||
161064151|NCT01721746|581625684|FG001|Treatment|Maximum Clinical Benefit|3|||
161064152|NCT01721746|581625683|FG000|Treatment|Poor/Non-compliance|2|||
161064153|NCT01721746|581625684|FG001|Treatment|Poor/Non-compliance|0|||
161064154|NCT01721746|581625683|FG000|Treatment|Participant no longer met Study criteria|4|||
161064155|NCT01721746|581625684|FG001|Treatment|Participant no longer met Study criteria|0|||
161064156|NCT01721746|581625683|FG000|Treatment|Other reasons|6|||
161064157|NCT01721746|581625684|FG001|Treatment|Other reasons|2|||
161064158|NCT01209598|581625690|FG000|Overall Study|Withdrawal by Subject|1|||
161064159|NCT01209598|581625691|FG001|Overall Study|Withdrawal by Subject|0|||
161064160|NCT00085566|581625693|FG000|Overall Study|Adverse Event|0|||
161154235|NCT00804193|581945583|FG002|Overall Study|Lack of Efficacy|3|||
161154236|NCT00804193|581945581|FG000|Overall Study|Protocol Violation|0|||
161064161|NCT00085566|581625694|FG001|Overall Study|Adverse Event|0|||
161064162|NCT00085566|581625695|FG002|Overall Study|Adverse Event|10|||
161064163|NCT00085566|581625693|FG000|Overall Study|Patient Not treated|0|||
161064164|NCT00085566|581625694|FG001|Overall Study|Patient Not treated|0|||
161064165|NCT00085566|581625695|FG002|Overall Study|Patient Not treated|3|||
161064166|NCT00085566|581625693|FG000|Overall Study|Clinical progression|0|||
161064167|NCT00085566|581625694|FG001|Overall Study|Clinical progression|0|||
161064168|NCT00085566|581625695|FG002|Overall Study|Clinical progression|1|||
161064169|NCT00361842|581625696|FG000|Overall Study|Withdrawal by Subject|2|||
161064170|NCT00361842|581625697|FG001|Overall Study|Withdrawal by Subject|3|||
161064171|NCT00361842|581625696|FG000|Overall Study|Death|2|||
161064172|NCT00361842|581625697|FG001|Overall Study|Death|1|||
161282602|NCT03207867|582413069|FG023|Overall Study|Patient/guardian Decision|0|||
161064173|NCT00361842|581625696|FG000|Overall Study|Disease progression|19|||
161064174|NCT00361842|581625697|FG001|Overall Study|Disease progression|20|||
161064175|NCT00361842|581625696|FG000|Overall Study|Adverse Event|2|||
161064176|NCT00361842|581625697|FG001|Overall Study|Adverse Event|3|||
161064177|NCT00361842|581625696|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
161064178|NCT00361842|581625697|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
161064179|NCT00361842|581625696|FG000|Overall Study|Other|1|||
161064180|NCT00361842|581625697|FG001|Overall Study|Other|0|||
161064181|NCT00361842|581625696|FG000|Overall Study|Other|0|||
161064182|NCT00361842|581625697|FG001|Overall Study|Other|2|||
161064183|NCT03821064|581625698|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
161064184|NCT00474383|581625700|FG000|Main Study|Adverse Event|11|||
161064185|NCT00474383|581625701|FG001|Main Study|Adverse Event|0|||
161064186|NCT00474383|581625700|FG000|Main Study|Symptomatic Deterioration|1|||
161064187|NCT00474383|581625701|FG001|Main Study|Symptomatic Deterioration|0|||
161064188|NCT00474383|581625700|FG000|Main Study|Progressive Disease|23|||
161064189|NCT00474383|581625701|FG001|Main Study|Progressive Disease|0|||
161064190|NCT00474383|581625700|FG000|Main Study|Other|1|||
161064191|NCT00474383|581625701|FG001|Main Study|Other|0|||
161064192|NCT00474383|581625700|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
161064193|NCT00474383|581625701|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
161064194|NCT00474383|581625700|FG000|Extension|Progressive Disease|0|||
161064195|NCT00474383|581625701|FG001|Extension|Progressive Disease|5|||
161064196|NCT01482819|581625702|FG000|Overall Study|Lost to Follow-up|2|||
161064197|NCT01502371|581625707|FG000|Overall Study|Withdrawal by Subject|1|||
161064198|NCT01502371|581625708|FG001|Overall Study|Withdrawal by Subject|2|||
161064199|NCT01502371|581625709|FG002|Overall Study|Withdrawal by Subject|1|||
161064200|NCT01502371|581625710|FG003|Overall Study|Withdrawal by Subject|1|||
161064201|NCT01502371|581625711|FG004|Overall Study|Withdrawal by Subject|1|||
161064202|NCT01502371|581625707|FG000|Overall Study|Adverse Event|2|||
161064203|NCT01502371|581625708|FG001|Overall Study|Adverse Event|1|||
161064204|NCT01502371|581625709|FG002|Overall Study|Adverse Event|0|||
161064205|NCT01502371|581625710|FG003|Overall Study|Adverse Event|4|||
161064206|NCT01502371|581625711|FG004|Overall Study|Adverse Event|3|||
161064207|NCT01502371|581625707|FG000|Overall Study|Treatment Failure|22|||
161064208|NCT01502371|581625708|FG001|Overall Study|Treatment Failure|20|||
161064209|NCT01502371|581625709|FG002|Overall Study|Treatment Failure|12|||
161064210|NCT01502371|581625710|FG003|Overall Study|Treatment Failure|19|||
161064211|NCT01502371|581625711|FG004|Overall Study|Treatment Failure|30|||
161064212|NCT01502371|581625707|FG000|Overall Study|Lack of Efficacy|3|||
161064213|NCT01502371|581625708|FG001|Overall Study|Lack of Efficacy|3|||
161064214|NCT01502371|581625709|FG002|Overall Study|Lack of Efficacy|2|||
161064215|NCT01502371|581625710|FG003|Overall Study|Lack of Efficacy|2|||
161064216|NCT01502371|581625711|FG004|Overall Study|Lack of Efficacy|4|||
161064217|NCT01502371|581625707|FG000|Overall Study|Physician Decision|3|||
161064218|NCT01502371|581625708|FG001|Overall Study|Physician Decision|0|||
161064219|NCT01502371|581625709|FG002|Overall Study|Physician Decision|0|||
161064220|NCT01502371|581625710|FG003|Overall Study|Physician Decision|0|||
161064221|NCT01502371|581625711|FG004|Overall Study|Physician Decision|1|||
161064222|NCT01502371|581625707|FG000|Overall Study|Noncompliance with Study Drug|0|||
161064223|NCT01502371|581625708|FG001|Overall Study|Noncompliance with Study Drug|0|||
161064224|NCT01502371|581625709|FG002|Overall Study|Noncompliance with Study Drug|1|||
161064225|NCT01502371|581625710|FG003|Overall Study|Noncompliance with Study Drug|2|||
161064226|NCT01502371|581625711|FG004|Overall Study|Noncompliance with Study Drug|1|||
161064227|NCT01502371|581625707|FG000|Overall Study|Technical Problems|1|||
161064228|NCT01502371|581625708|FG001|Overall Study|Technical Problems|0|||
161064229|NCT01502371|581625709|FG002|Overall Study|Technical Problems|2|||
161064230|NCT01502371|581625710|FG003|Overall Study|Technical Problems|4|||
161064231|NCT01502371|581625711|FG004|Overall Study|Technical Problems|1|||
161282603|NCT06473519|582414952|FG000|Overall Study|Lost to Follow-up|2|||
161282604|NCT06473519|582414953|FG001|Overall Study|Lost to Follow-up|5|||
161282605|NCT06473519|582414952|FG000|Overall Study|Withdrawal by Subject|1|||
161282606|NCT06473519|582414953|FG001|Overall Study|Withdrawal by Subject|4|||
161064232|NCT01502371|581625707|FG000|Overall Study|Protocol Violation|9|||
161064233|NCT01502371|581625708|FG001|Overall Study|Protocol Violation|5|||
161064234|NCT01502371|581625709|FG002|Overall Study|Protocol Violation|6|||
161064235|NCT01502371|581625710|FG003|Overall Study|Protocol Violation|5|||
161064236|NCT01502371|581625711|FG004|Overall Study|Protocol Violation|10|||
161064237|NCT01502371|581625707|FG000|Overall Study|Excluded Medication|0|||
161064238|NCT01502371|581625708|FG001|Overall Study|Excluded Medication|1|||
161064239|NCT01502371|581625709|FG002|Overall Study|Excluded Medication|1|||
161064240|NCT01502371|581625710|FG003|Overall Study|Excluded Medication|0|||
161064241|NCT01502371|581625711|FG004|Overall Study|Excluded Medication|1|||
161064242|NCT03325608|581625714|FG000|Overall Study|Lost to Follow-up|23|||
161064243|NCT03325608|581625715|FG001|Overall Study|Lost to Follow-up|23|||
161064244|NCT03325608|581625716|FG002|Overall Study|Lost to Follow-up|30|||
161282607|NCT06473519|582414952|FG000|Overall Study|Randomized but not vaccinated|1|||
161282608|NCT06473519|582414953|FG001|Overall Study|Randomized but not vaccinated|2|||
161282609|NCT03560037|582414955|FG000|Overall Study|Protocol Violation|1|||
161282610|NCT03560037|582414956|FG001|Overall Study|Protocol Violation|0|||
161064245|NCT03325608|581625717|FG003|Overall Study|Lost to Follow-up|30|||
161064246|NCT03325608|581625714|FG000|Overall Study|Death of Caregiver|0|||
161064247|NCT03325608|581625715|FG001|Overall Study|Death of Caregiver|0|||
161064248|NCT03325608|581625716|FG002|Overall Study|Death of Caregiver|2|||
161064249|NCT03325608|581625717|FG003|Overall Study|Death of Caregiver|2|||
161064250|NCT03325608|581625714|FG000|Overall Study|Death of Care Recipient|34|||
161064251|NCT03325608|581625715|FG001|Overall Study|Death of Care Recipient|34|||
161064252|NCT03325608|581625716|FG002|Overall Study|Death of Care Recipient|28|||
161064253|NCT03325608|581625717|FG003|Overall Study|Death of Care Recipient|28|||
161064254|NCT03325608|581625714|FG000|Overall Study|Withdrawal by Subject|49|||
161064255|NCT03325608|581625715|FG001|Overall Study|Withdrawal by Subject|49|||
161064256|NCT03325608|581625716|FG002|Overall Study|Withdrawal by Subject|35|||
161064257|NCT03325608|581625717|FG003|Overall Study|Withdrawal by Subject|35|||
161064258|NCT03325608|581625714|FG000|Overall Study|Ineligible|7|||
161064259|NCT03325608|581625715|FG001|Overall Study|Ineligible|7|||
161064260|NCT03325608|581625716|FG002|Overall Study|Ineligible|5|||
161064261|NCT03325608|581625717|FG003|Overall Study|Ineligible|5|||
161064262|NCT00942188|581625718|FG000|Overall Study|Adverse Event|0|||
161064263|NCT00942188|581625719|FG001|Overall Study|Adverse Event|3|||
161064264|NCT00942188|581625720|FG002|Overall Study|Adverse Event|2|||
161064265|NCT00942188|581625721|FG003|Overall Study|Adverse Event|0|||
161064266|NCT00942188|581625718|FG000|Overall Study|Lack of Efficacy|0|||
161064267|NCT00942188|581625719|FG001|Overall Study|Lack of Efficacy|0|||
161064268|NCT00942188|581625720|FG002|Overall Study|Lack of Efficacy|0|||
161064269|NCT00942188|581625721|FG003|Overall Study|Lack of Efficacy|1|||
161064270|NCT00942188|581625718|FG000|Overall Study|Protocol Violation|1|||
161064271|NCT00942188|581625719|FG001|Overall Study|Protocol Violation|1|||
161064272|NCT00942188|581625720|FG002|Overall Study|Protocol Violation|0|||
161064273|NCT00942188|581625721|FG003|Overall Study|Protocol Violation|0|||
161064274|NCT00942188|581625718|FG000|Overall Study|Lost to Follow-up|2|||
161064275|NCT00942188|581625719|FG001|Overall Study|Lost to Follow-up|1|||
161064276|NCT00942188|581625720|FG002|Overall Study|Lost to Follow-up|2|||
161064277|NCT00942188|581625721|FG003|Overall Study|Lost to Follow-up|0|||
161064278|NCT00942188|581625718|FG000|Overall Study|Withdrawal by Subject|1|||
161064279|NCT00942188|581625719|FG001|Overall Study|Withdrawal by Subject|3|||
161064280|NCT00942188|581625720|FG002|Overall Study|Withdrawal by Subject|4|||
161064281|NCT00942188|581625721|FG003|Overall Study|Withdrawal by Subject|2|||
161064282|NCT00942188|581625718|FG000|Overall Study|Physician Decision|0|||
161064283|NCT00942188|581625719|FG001|Overall Study|Physician Decision|0|||
161064284|NCT00942188|581625720|FG002|Overall Study|Physician Decision|1|||
161064285|NCT00942188|581625721|FG003|Overall Study|Physician Decision|0|||
161064286|NCT00942188|581625718|FG000|Overall Study|Sponsor Decision|0|||
161064287|NCT00942188|581625719|FG001|Overall Study|Sponsor Decision|2|||
161064288|NCT00942188|581625720|FG002|Overall Study|Sponsor Decision|0|||
161064289|NCT00942188|581625721|FG003|Overall Study|Sponsor Decision|1|||
161064290|NCT02188784|581625722|FG000|Overall Study|Death|3|||
161064291|NCT02188784|581625723|FG001|Overall Study|Death|1|||
161064292|NCT02188784|581625722|FG000|Overall Study|Lost to Follow-up|1|||
161064293|NCT02188784|581625723|FG001|Overall Study|Lost to Follow-up|0|||
161064294|NCT02188784|581625722|FG000|Overall Study|Withdrawal by Subject|3|||
161064295|NCT02188784|581625723|FG001|Overall Study|Withdrawal by Subject|9|||
161064296|NCT02188784|581625722|FG000|Overall Study|Physician Decision|2|||
161064297|NCT02188784|581625723|FG001|Overall Study|Physician Decision|3|||
161064298|NCT00143598|581625727|FG000|Overall Study|Lost to Follow-up|23|||
161064299|NCT00143598|581625728|FG001|Overall Study|Lost to Follow-up|21|||
161064300|NCT00143598|581625727|FG000|Overall Study|Withdrawal by Subject|33|||
161064301|NCT00143598|581625728|FG001|Overall Study|Withdrawal by Subject|37|||
161064302|NCT00143598|581625727|FG000|Overall Study|Death|36|||
161064303|NCT00143598|581625728|FG001|Overall Study|Death|36|||
161064304|NCT04944784|581625731|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
161064305|NCT04944784|581625732|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
161064306|NCT04944784|581625733|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
161064307|NCT04944784|581625734|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
161064308|NCT04944784|581625731|FG000|Double-blind Period|Adverse Event|20|||
161064309|NCT04944784|581625732|FG001|Double-blind Period|Adverse Event|4|||
161064310|NCT04944784|581625733|FG002|Double-blind Period|Adverse Event|0|||
161064311|NCT04944784|581625734|FG003|Double-blind Period|Adverse Event|0|||
161064312|NCT04944784|581625731|FG000|Double-blind Period|Withdrawal by Subject|15|||
161064313|NCT04944784|581625732|FG001|Double-blind Period|Withdrawal by Subject|4|||
161064314|NCT04944784|581625733|FG002|Double-blind Period|Withdrawal by Subject|0|||
161064315|NCT04944784|581625734|FG003|Double-blind Period|Withdrawal by Subject|0|||
161064316|NCT04944784|581625731|FG000|Double-blind Period|Death|7|||
161064317|NCT04944784|581625732|FG001|Double-blind Period|Death|2|||
161064318|NCT04944784|581625733|FG002|Double-blind Period|Death|0|||
161064319|NCT04944784|581625734|FG003|Double-blind Period|Death|0|||
161064320|NCT04944784|581625731|FG000|Double-blind Period|Physician Decision|2|||
161282611|NCT03560037|582414955|FG000|Overall Study|Physician Decision|0|||
161064321|NCT04944784|581625732|FG001|Double-blind Period|Physician Decision|1|||
161064322|NCT04944784|581625733|FG002|Double-blind Period|Physician Decision|0|||
161064323|NCT04944784|581625734|FG003|Double-blind Period|Physician Decision|0|||
161064324|NCT04944784|581625731|FG000|Double-blind Period|Lack of Efficacy|0|||
161064325|NCT04944784|581625732|FG001|Double-blind Period|Lack of Efficacy|1|||
161064326|NCT04944784|581625733|FG002|Double-blind Period|Lack of Efficacy|0|||
161064327|NCT04944784|581625734|FG003|Double-blind Period|Lack of Efficacy|0|||
161064328|NCT04944784|581625731|FG000|Double-blind Period|Sponsor Request|2|||
161064329|NCT04944784|581625732|FG001|Double-blind Period|Sponsor Request|1|||
161064330|NCT04944784|581625733|FG002|Double-blind Period|Sponsor Request|0|||
161064331|NCT04944784|581625734|FG003|Double-blind Period|Sponsor Request|0|||
161064332|NCT04944784|581625731|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
161064333|NCT04944784|581625732|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
161064334|NCT04944784|581625733|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
161064335|NCT04944784|581625734|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
161064336|NCT04944784|581625731|FG000|Double-blind Period|Participant Choice|1|||
161064337|NCT04944784|581625732|FG001|Double-blind Period|Participant Choice|1|||
161064338|NCT04944784|581625733|FG002|Double-blind Period|Participant Choice|0|||
161064339|NCT04944784|581625734|FG003|Double-blind Period|Participant Choice|0|||
161064340|NCT04944784|581625731|FG000|Double-blind Period|Progressive Disease|2|||
161064341|NCT04944784|581625732|FG001|Double-blind Period|Progressive Disease|2|||
161064342|NCT04944784|581625733|FG002|Double-blind Period|Progressive Disease|0|||
161064343|NCT04944784|581625734|FG003|Double-blind Period|Progressive Disease|0|||
161064344|NCT04944784|581625731|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
161064345|NCT04944784|581625732|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
161064346|NCT04944784|581625733|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
161064347|NCT04944784|581625734|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
161064348|NCT04944784|581625731|FG000|Active Drug Period|Adverse Event|0|||
161064349|NCT04944784|581625732|FG001|Active Drug Period|Adverse Event|0|||
161064350|NCT04944784|581625733|FG002|Active Drug Period|Adverse Event|3|||
161064351|NCT04944784|581625734|FG003|Active Drug Period|Adverse Event|6|||
161064352|NCT04944784|581625731|FG000|Active Drug Period|Withdrawal by Subject|0|||
161064353|NCT04944784|581625732|FG001|Active Drug Period|Withdrawal by Subject|0|||
161064354|NCT04944784|581625733|FG002|Active Drug Period|Withdrawal by Subject|4|||
161064355|NCT04944784|581625734|FG003|Active Drug Period|Withdrawal by Subject|7|||
161064356|NCT04944784|581625731|FG000|Active Drug Period|Death|0|||
161064357|NCT04944784|581625732|FG001|Active Drug Period|Death|0|||
161064358|NCT04944784|581625733|FG002|Active Drug Period|Death|3|||
161064359|NCT04944784|581625734|FG003|Active Drug Period|Death|4|||
161064360|NCT04944784|581625731|FG000|Active Drug Period|Lack of Efficacy|0|||
161064361|NCT04944784|581625732|FG001|Active Drug Period|Lack of Efficacy|0|||
161064362|NCT04944784|581625733|FG002|Active Drug Period|Lack of Efficacy|2|||
161064363|NCT04944784|581625734|FG003|Active Drug Period|Lack of Efficacy|2|||
161064364|NCT04944784|581625731|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
161064365|NCT04944784|581625732|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
161064366|NCT04944784|581625733|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
161064367|NCT04944784|581625734|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
161064368|NCT04944784|581625731|FG000|Active Drug Period|Participant Choice|0|||
161064369|NCT04944784|581625732|FG001|Active Drug Period|Participant Choice|0|||
161064370|NCT04944784|581625733|FG002|Active Drug Period|Participant Choice|0|||
161064371|NCT04944784|581625734|FG003|Active Drug Period|Participant Choice|1|||
161282612|NCT03560037|582414956|FG001|Overall Study|Physician Decision|1|||
161282613|NCT03620708|582414957|FG000|Overall Study|Lost to Follow-up|1|||
161282614|NCT03620708|582414958|FG001|Overall Study|Lost to Follow-up|1|||
161282615|NCT03620708|582414959|FG002|Overall Study|Lost to Follow-up|2|||
161064372|NCT04944784|581625731|FG000|Active Drug Period|Progressive Disease|0|||
161064373|NCT04944784|581625732|FG001|Active Drug Period|Progressive Disease|0|||
161064374|NCT04944784|581625733|FG002|Active Drug Period|Progressive Disease|4|||
161064375|NCT04944784|581625734|FG003|Active Drug Period|Progressive Disease|4|||
161064376|NCT04944784|581625731|FG000|Active Drug Period|Lost to Follow-up|0|||
161064377|NCT04944784|581625732|FG001|Active Drug Period|Lost to Follow-up|0|||
161064378|NCT04944784|581625733|FG002|Active Drug Period|Lost to Follow-up|0|||
161064379|NCT04944784|581625734|FG003|Active Drug Period|Lost to Follow-up|1|||
161064380|NCT03900715|581625735|FG000|Overall Study|Protocol Deviation|1|||
161064381|NCT03900715|581625735|FG000|Overall Study|Lack of Efficacy|1|||
161064382|NCT03900715|581625735|FG000|Overall Study|Progressive Disease|6|||
161064383|NCT03900715|581625735|FG000|Overall Study|Adverse Event|2|||
161064384|NCT03900715|581625735|FG000|Overall Study|Other reasons|11|||
161064385|NCT01568112|581625736|FG000|Overall Study|Randomized But Not Treated|0|||
161064386|NCT01568112|581625737|FG001|Overall Study|Randomized But Not Treated|1|||
161064387|NCT01568112|581625738|FG002|Overall Study|Randomized But Not Treated|0|||
161064388|NCT01568112|581625739|FG003|Overall Study|Randomized But Not Treated|0|||
161064389|NCT01568112|581625736|FG000|Overall Study|Withdrew due to Adverse Event|2|||
161064390|NCT01568112|581625737|FG001|Overall Study|Withdrew due to Adverse Event|4|||
161282616|NCT03620708|582414957|FG000|Overall Study|Withdrawal by Subject|0|||
161282617|NCT03620708|582414958|FG001|Overall Study|Withdrawal by Subject|0|||
161282618|NCT03620708|582414959|FG002|Overall Study|Withdrawal by Subject|1|||
161282619|NCT02498613|582414960|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
161282620|NCT02498613|582414961|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
161282621|NCT02498613|582414962|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
161282622|NCT02498613|582414963|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
161282623|NCT02498613|582414960|FG000|Overall Study|Withdrawal by Subject|3|||
161282624|NCT02498613|582414961|FG001|Overall Study|Withdrawal by Subject|1|||
161064391|NCT01568112|581625738|FG002|Overall Study|Withdrew due to Adverse Event|6|||
161064392|NCT01568112|581625739|FG003|Overall Study|Withdrew due to Adverse Event|3|||
161064393|NCT01568112|581625736|FG000|Overall Study|Lost to Follow-up|0|||
161064394|NCT01568112|581625737|FG001|Overall Study|Lost to Follow-up|0|||
161064395|NCT01568112|581625738|FG002|Overall Study|Lost to Follow-up|0|||
161064396|NCT01568112|581625739|FG003|Overall Study|Lost to Follow-up|1|||
161064397|NCT01568112|581625736|FG000|Overall Study|Withdrawal by Subject|2|||
161064398|NCT01568112|581625737|FG001|Overall Study|Withdrawal by Subject|3|||
161064399|NCT01568112|581625738|FG002|Overall Study|Withdrawal by Subject|0|||
161064400|NCT01568112|581625739|FG003|Overall Study|Withdrawal by Subject|7|||
161064401|NCT01568112|581625736|FG000|Overall Study|Withdrawal by Physician|1|||
161064402|NCT01568112|581625737|FG001|Overall Study|Withdrawal by Physician|0|||
161064403|NCT01568112|581625738|FG002|Overall Study|Withdrawal by Physician|1|||
161064404|NCT01568112|581625739|FG003|Overall Study|Withdrawal by Physician|1|||
161091224|NCT01054170|581723838|FG000|Overall Study|Withdrawal by Subject|3|||
161091225|NCT01054170|581723839|FG001|Overall Study|Withdrawal by Subject|2|||
161091226|NCT01054170|581723838|FG000|Overall Study|Adverse Event|0|||
161091227|NCT01054170|581723839|FG001|Overall Study|Adverse Event|4|||
161091228|NCT02951767|581723840|FG000|Overall Study|Study Terminated By Sponsor|9|||
161091229|NCT02951767|581723840|FG000|Overall Study|Withdrawal by Subject|11|||
161091230|NCT02951767|581723840|FG000|Overall Study|Death|96|||
161091231|NCT02951767|581723840|FG000|Overall Study|Lost to Follow-up|2|||
161091232|NCT02951767|581723840|FG000|Overall Study|Physician Decision|1|||
161091233|NCT01337115|581723841|FG000|Overall Study|Protocol Violation|2|||
161091234|NCT01337115|581723842|FG001|Overall Study|Protocol Violation|0|||
161091235|NCT03426267|581723852|FG000|Overall Study|Physician Decision|1|||
161091236|NCT03426267|581723853|FG001|Overall Study|Physician Decision|4|||
161091237|NCT03426267|581723852|FG000|Overall Study|Lost to Follow-up|1|||
161091238|NCT03426267|581723853|FG001|Overall Study|Lost to Follow-up|0|||
161091239|NCT03426267|581723852|FG000|Overall Study|Withdrawal by Subject|4|||
161091240|NCT03426267|581723853|FG001|Overall Study|Withdrawal by Subject|10|||
161091241|NCT03426267|581723852|FG000|Overall Study|Protocol Violation|1|||
161091242|NCT03426267|581723853|FG001|Overall Study|Protocol Violation|3|||
161091243|NCT03426267|581723852|FG000|Overall Study|Adverse Event|9|||
161091244|NCT03426267|581723853|FG001|Overall Study|Adverse Event|27|||
161091245|NCT03426267|581723852|FG000|Overall Study|Prohibited Treatment Intake|2|||
161091246|NCT03426267|581723853|FG001|Overall Study|Prohibited Treatment Intake|3|||
161091247|NCT03426267|581723852|FG000|Overall Study|Lack of Efficacy|0|||
161091248|NCT03426267|581723853|FG001|Overall Study|Lack of Efficacy|25|||
161091249|NCT03426267|581723852|FG000|Overall Study|other|3|||
161091250|NCT03426267|581723853|FG001|Overall Study|other|0|||
161091251|NCT02054520|581723862|FG000|Overall Study|Adverse Event|1|||
161091252|NCT02054520|581723863|FG001|Overall Study|Adverse Event|4|||
161091253|NCT02054520|581723864|FG002|Overall Study|Adverse Event|2|||
161091254|NCT02054520|581723865|FG003|Overall Study|Adverse Event|1|||
161091255|NCT02054520|581723866|FG004|Overall Study|Adverse Event|1|||
161091256|NCT02054520|581723867|FG005|Overall Study|Adverse Event|0|||
161091257|NCT02054520|581723862|FG000|Overall Study|Lack of Efficacy|7|||
161091258|NCT02054520|581723863|FG001|Overall Study|Lack of Efficacy|0|||
161091259|NCT02054520|581723864|FG002|Overall Study|Lack of Efficacy|2|||
161091260|NCT02054520|581723865|FG003|Overall Study|Lack of Efficacy|1|||
161091261|NCT02054520|581723866|FG004|Overall Study|Lack of Efficacy|3|||
161091262|NCT02054520|581723867|FG005|Overall Study|Lack of Efficacy|2|||
161091263|NCT02054520|581723862|FG000|Overall Study|Withdrawal by Subject|1|||
161091264|NCT02054520|581723863|FG001|Overall Study|Withdrawal by Subject|0|||
161091265|NCT02054520|581723864|FG002|Overall Study|Withdrawal by Subject|0|||
161091266|NCT02054520|581723865|FG003|Overall Study|Withdrawal by Subject|2|||
161091267|NCT02054520|581723866|FG004|Overall Study|Withdrawal by Subject|1|||
161091268|NCT02054520|581723867|FG005|Overall Study|Withdrawal by Subject|0|||
161091269|NCT02054520|581723862|FG000|Overall Study|Physician Decision|0|||
161091270|NCT02054520|581723863|FG001|Overall Study|Physician Decision|1|||
161091271|NCT02054520|581723864|FG002|Overall Study|Physician Decision|0|||
161091272|NCT02054520|581723865|FG003|Overall Study|Physician Decision|1|||
161091273|NCT02054520|581723866|FG004|Overall Study|Physician Decision|0|||
161091274|NCT02054520|581723867|FG005|Overall Study|Physician Decision|1|||
161091275|NCT02054520|581723862|FG000|Overall Study|Study terminated by Sponsor|0|||
161091276|NCT02054520|581723863|FG001|Overall Study|Study terminated by Sponsor|0|||
161091277|NCT02054520|581723864|FG002|Overall Study|Study terminated by Sponsor|2|||
161091278|NCT02054520|581723865|FG003|Overall Study|Study terminated by Sponsor|1|||
161091279|NCT02054520|581723866|FG004|Overall Study|Study terminated by Sponsor|0|||
161064405|NCT00966264|581628198|FG000|Overall Study|Lost to Follow-up|4|||
161064406|NCT00966264|581628199|FG001|Overall Study|Lost to Follow-up|3|||
161064407|NCT00416598|581628204|FG000|Induction & Intensification|Adverse Event|38|||
161064408|NCT00416598|581628204|FG000|Induction & Intensification|Death|32|||
161064409|NCT00416598|581628204|FG000|Induction & Intensification|Withdrawal by Subject|46|||
161064410|NCT00416598|581628204|FG000|Induction & Intensification|Alternative Treatment|135|||
161064411|NCT00416598|581628204|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
161064412|NCT00416598|581628204|FG000|Induction & Intensification|Relapse/progression|29|||
161064413|NCT00416598|581628204|FG000|Induction & Intensification|Failed induction|87|||
161064414|NCT00416598|581628204|FG000|Decitabine Maintenance|Adverse Event|5|||
161064415|NCT00416598|581628204|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
161064416|NCT00416598|581628204|FG000|Decitabine Maintenance|Progression/relapse|38|||
161064417|NCT00416598|581628204|FG000|Decitabine Maintenance|Alternative treatment|2|||
161064418|NCT00416598|581628204|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
161064419|NCT04523207|581628205|FG000|Overall Study|Adverse Event|5|||
161064420|NCT04523207|581628206|FG001|Overall Study|Adverse Event|1|||
161064421|NCT04523207|581628205|FG000|Overall Study|Lost to Follow-up|2|||
161064422|NCT04523207|581628206|FG001|Overall Study|Lost to Follow-up|0|||
161064423|NCT04523207|581628205|FG000|Overall Study|Withdrawal by Subject|2|||
161064424|NCT04523207|581628206|FG001|Overall Study|Withdrawal by Subject|0|||
161064425|NCT04523207|581628205|FG000|Overall Study|Progressive Disease|2|||
161064426|NCT04523207|581628206|FG001|Overall Study|Progressive Disease|1|||
161064427|NCT04523207|581628205|FG000|Overall Study|Other|7|||
161064428|NCT04523207|581628206|FG001|Overall Study|Other|1|||
161064429|NCT03113383|581628207|FG000|Overall Study|Death|4|||
161064430|NCT03113383|581628208|FG001|Overall Study|Death|0|||
161064431|NCT04469465|581628210|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
161064432|NCT04469465|581628211|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
161064433|NCT04469465|581628210|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
161064434|NCT04469465|581628211|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
161064435|NCT04469465|581628210|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
161064436|NCT04469465|581628211|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
161064437|NCT04469465|581628210|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
161064438|NCT04469465|581628211|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
161064439|NCT04469465|581628210|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
161064440|NCT04469465|581628211|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
161064441|NCT04469465|581628210|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
161064442|NCT04469465|581628211|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
161064443|NCT04469465|581628210|FG000|Long-Term Extension (LTE)|Death|0|||
161064444|NCT04469465|581628211|FG001|Long-Term Extension (LTE)|Death|1|||
161064445|NCT04469465|581628210|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
161064446|NCT04469465|581628211|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
161064447|NCT02641587|581628212|FG000|Confinement Period|Adverse Event|1|||
161064448|NCT02641587|581628213|FG001|Confinement Period|Adverse Event|0|||
161064449|NCT02641587|581628212|FG000|Confinement Period|Withdrawal by Subject|2|||
161064450|NCT02641587|581628213|FG001|Confinement Period|Withdrawal by Subject|1|||
161064451|NCT02641587|581628212|FG000|Ambulatory Period|Withdrawal by Subject|1|||
161064452|NCT02641587|581628213|FG001|Ambulatory Period|Withdrawal by Subject|0|||
161064453|NCT03194867|581628217|FG000|Overall Study|Incorrect completion of end of study form|0|||
161064454|NCT03194867|581628218|FG001|Overall Study|Incorrect completion of end of study form|0|||
161064455|NCT03194867|581628219|FG002|Overall Study|Incorrect completion of end of study form|1|||
161064456|NCT03194867|581628220|FG003|Overall Study|Incorrect completion of end of study form|0|||
161064457|NCT00464945|581628221|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
161064458|NCT00464945|581628222|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
161064459|NCT00464945|581628221|FG000|Infant Series|Protocol Violation|1|||
161064460|NCT00464945|581628222|FG001|Infant Series|Protocol Violation|0|||
161064461|NCT00464945|581628221|FG000|Infant Series|Lost to Follow-up|1|||
161064462|NCT00464945|581628222|FG001|Infant Series|Lost to Follow-up|0|||
161064463|NCT00464945|581628221|FG000|After Infant Series|Withdrawal by Subject|0|||
161064464|NCT00464945|581628222|FG001|After Infant Series|Withdrawal by Subject|2|||
161064465|NCT00464945|581628221|FG000|Toddler Dose|Lost to Follow-up|0|||
161064466|NCT00464945|581628222|FG001|Toddler Dose|Lost to Follow-up|1|||
161064467|NCT00543062|581628223|FG000|Overall Study|Withdrawal by Subject|1|||
161154237|NCT00804193|581945582|FG001|Overall Study|Protocol Violation|8|||
161154238|NCT00804193|581945583|FG002|Overall Study|Protocol Violation|2|||
161345367|NCT03479905|582648935|FG002|Overall Study|Other airway method used|5|||
161064468|NCT00543062|581628224|FG001|Overall Study|Withdrawal by Subject|0|||
161064469|NCT00543062|581628225|FG002|Overall Study|Withdrawal by Subject|2|||
161064470|NCT00543062|581628226|FG003|Overall Study|Withdrawal by Subject|0|||
161064471|NCT00543062|581628223|FG000|Overall Study|Adverse Event|0|||
161064472|NCT00543062|581628224|FG001|Overall Study|Adverse Event|1|||
161064473|NCT00543062|581628225|FG002|Overall Study|Adverse Event|1|||
161064474|NCT00543062|581628226|FG003|Overall Study|Adverse Event|1|||
161064475|NCT00543062|581628223|FG000|Overall Study|Protocol Violation|1|||
161064476|NCT00543062|581628224|FG001|Overall Study|Protocol Violation|0|||
161282625|NCT02498613|582414962|FG002|Overall Study|Withdrawal by Subject|0|||
161282626|NCT02498613|582414963|FG003|Overall Study|Withdrawal by Subject|0|||
161282627|NCT05168202|582414964|FG000|Overall Study|Progressive Disease|4|||
161282628|NCT05168202|582414965|FG001|Overall Study|Progressive Disease|4|||
161282629|NCT05168202|582414966|FG002|Overall Study|Progressive Disease|2|||
161282630|NCT05168202|582414967|FG003|Overall Study|Progressive Disease|3|||
161282631|NCT05168202|582414968|FG004|Overall Study|Progressive Disease|2|||
161282632|NCT05168202|582414969|FG005|Overall Study|Progressive Disease|3|||
161282633|NCT05168202|582414970|FG006|Overall Study|Progressive Disease|2|||
161282634|NCT05168202|582414964|FG000|Overall Study|Adverse Event|2|||
161282635|NCT05168202|582414965|FG001|Overall Study|Adverse Event|1|||
161282636|NCT05168202|582414966|FG002|Overall Study|Adverse Event|4|||
161282637|NCT05168202|582414967|FG003|Overall Study|Adverse Event|4|||
161282638|NCT05168202|582414968|FG004|Overall Study|Adverse Event|3|||
161282639|NCT05168202|582414969|FG005|Overall Study|Adverse Event|2|||
161282640|NCT05168202|582414970|FG006|Overall Study|Adverse Event|0|||
161282641|NCT05168202|582414964|FG000|Overall Study|Lack of Efficacy|0|||
161282642|NCT05168202|582414965|FG001|Overall Study|Lack of Efficacy|1|||
161282643|NCT05168202|582414966|FG002|Overall Study|Lack of Efficacy|1|||
161282644|NCT05168202|582414967|FG003|Overall Study|Lack of Efficacy|0|||
161282645|NCT05168202|582414968|FG004|Overall Study|Lack of Efficacy|1|||
161282646|NCT05168202|582414969|FG005|Overall Study|Lack of Efficacy|2|||
161282647|NCT05168202|582414970|FG006|Overall Study|Lack of Efficacy|2|||
161282648|NCT05168202|582414964|FG000|Overall Study|Withdrawal by Subject|0|||
161282649|NCT05168202|582414965|FG001|Overall Study|Withdrawal by Subject|0|||
161282650|NCT05168202|582414966|FG002|Overall Study|Withdrawal by Subject|1|||
161282651|NCT05168202|582414967|FG003|Overall Study|Withdrawal by Subject|1|||
161282652|NCT05168202|582414968|FG004|Overall Study|Withdrawal by Subject|1|||
161282653|NCT05168202|582414969|FG005|Overall Study|Withdrawal by Subject|1|||
161282654|NCT05168202|582414970|FG006|Overall Study|Withdrawal by Subject|0|||
161282655|NCT05168202|582414964|FG000|Overall Study|Disease Relapse|0|||
161282656|NCT05168202|582414965|FG001|Overall Study|Disease Relapse|1|||
161282657|NCT05168202|582414966|FG002|Overall Study|Disease Relapse|0|||
161064477|NCT00543062|581628225|FG002|Overall Study|Protocol Violation|0|||
161064478|NCT00543062|581628226|FG003|Overall Study|Protocol Violation|0|||
161064479|NCT01663506|581628230|FG000|Overall Study|Lack of Efficacy|3|||
161064480|NCT01663506|581628230|FG000|Overall Study|Consent Withdrawal by Subject|1|||
161064481|NCT01663506|581628230|FG000|Overall Study|Lost to Follow-up|1|||
161064482|NCT01663506|581628230|FG000|Overall Study|Adverse Event|1|||
161064483|NCT01663506|581628230|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
161064484|NCT02094898|581628236|FG000|Overall Study|Clinical Worsening|2|||
161064485|NCT02094898|581628236|FG000|Overall Study|Adverse Event|2|||
161064486|NCT02094898|581628236|FG000|Overall Study|Lack of Efficacy|1|||
161064487|NCT03520075|581628237|FG000|Phase 1 (Dose Escalation)|Death|2|||
161064488|NCT03520075|581628238|FG001|Phase 1 (Dose Escalation)|Death|2|||
161064489|NCT03520075|581628239|FG002|Phase 1 (Dose Escalation)|Death|3|||
161064490|NCT03520075|581628240|FG003|Phase 1 (Dose Escalation)|Death|2|||
161064491|NCT03520075|581628241|FG004|Phase 1 (Dose Escalation)|Death|6|||
161064492|NCT03520075|581628242|FG005|Phase 1 (Dose Escalation)|Death|5|||
161064493|NCT03520075|581628243|FG006|Phase 1 (Dose Escalation)|Death|3|||
161064494|NCT03520075|581628244|FG007|Phase 1 (Dose Escalation)|Death|2|||
161064495|NCT03520075|581628245|FG008|Phase 1 (Dose Escalation)|Death|3|||
161064496|NCT03520075|581628246|FG009|Phase 1 (Dose Escalation)|Death|1|||
161064497|NCT03520075|581628247|FG010|Phase 1 (Dose Escalation)|Death|5|||
161064498|NCT03520075|581628248|FG011|Phase 1 (Dose Escalation)|Death|7|||
161064499|NCT03520075|581628249|FG012|Phase 1 (Dose Escalation)|Death|11|||
161064500|NCT03520075|581628250|FG013|Phase 1 (Dose Escalation)|Death|0|||
161064501|NCT03520075|581628251|FG014|Phase 1 (Dose Escalation)|Death|0|||
161064502|NCT03520075|581628252|FG015|Phase 1 (Dose Escalation)|Death|0|||
161064503|NCT03520075|581628253|FG016|Phase 1 (Dose Escalation)|Death|0|||
161064504|NCT03520075|581628254|FG017|Phase 1 (Dose Escalation)|Death|0|||
161064505|NCT03520075|581628255|FG018|Phase 1 (Dose Escalation)|Death|0|||
161064506|NCT03520075|581628237|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161064507|NCT03520075|581628238|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064508|NCT03520075|581628239|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064509|NCT03520075|581628240|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
161064510|NCT03520075|581628241|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
161282658|NCT05168202|582414967|FG003|Overall Study|Disease Relapse|1|||
161282659|NCT05168202|582414968|FG004|Overall Study|Disease Relapse|1|||
161064511|NCT03520075|581628242|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
161064512|NCT03520075|581628243|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064513|NCT03520075|581628244|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161064514|NCT03520075|581628245|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064515|NCT03520075|581628246|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
161282660|NCT05168202|582414969|FG005|Overall Study|Disease Relapse|0|||
161282661|NCT05168202|582414970|FG006|Overall Study|Disease Relapse|0|||
161282662|NCT05168202|582414964|FG000|Overall Study|Other Reasons|0|||
161282663|NCT05168202|582414965|FG001|Overall Study|Other Reasons|0|||
161064516|NCT03520075|581628247|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064517|NCT03520075|581628248|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064518|NCT03520075|581628249|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
161064519|NCT03520075|581628250|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064520|NCT03520075|581628251|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064521|NCT03520075|581628252|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064522|NCT03520075|581628253|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064523|NCT03520075|581628254|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064524|NCT03520075|581628255|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
161064525|NCT03520075|581628237|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064526|NCT03520075|581628238|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161064527|NCT03520075|581628239|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064528|NCT03520075|581628240|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161064529|NCT03520075|581628241|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161064530|NCT03520075|581628242|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064531|NCT03520075|581628243|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064532|NCT03520075|581628244|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064533|NCT03520075|581628245|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064534|NCT03520075|581628246|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064535|NCT03520075|581628247|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161064536|NCT03520075|581628248|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064537|NCT03520075|581628249|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
161064538|NCT03520075|581628250|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064539|NCT03520075|581628251|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064540|NCT03520075|581628252|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064541|NCT03520075|581628253|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064542|NCT03520075|581628254|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064543|NCT03520075|581628255|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
161064544|NCT03520075|581628237|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064545|NCT03520075|581628238|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064546|NCT03520075|581628239|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064547|NCT03520075|581628240|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064548|NCT03520075|581628241|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064549|NCT03520075|581628242|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064550|NCT03520075|581628243|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064551|NCT03520075|581628244|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161154239|NCT00804193|581945581|FG000|Overall Study|Lost to Follow-up|3|||
161154240|NCT00804193|581945582|FG001|Overall Study|Lost to Follow-up|3|||
161154241|NCT00804193|581945583|FG002|Overall Study|Lost to Follow-up|4|||
161154242|NCT00804193|581945581|FG000|Overall Study|Withdrawal by Subject|3|||
161154243|NCT00804193|581945582|FG001|Overall Study|Withdrawal by Subject|1|||
161154244|NCT00804193|581945583|FG002|Overall Study|Withdrawal by Subject|2|||
161154245|NCT01193348|581945586|FG000|Screening Period|Screen Failure|5|||
161154246|NCT01193348|581945586|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
161154247|NCT01193348|581945586|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
161154248|NCT01193348|581945586|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
161154249|NCT01193348|581945586|FG000|Extension Treatment Period|Physician Decision|1|||
161154250|NCT01193348|581945586|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
161154251|NCT00968253|581945587|FG000|Overall Study|Death|0|||
161154252|NCT00968253|581945588|FG001|Overall Study|Death|0|||
161154253|NCT00968253|581945589|FG002|Overall Study|Death|2|||
161154254|NCT00968253|581945587|FG000|Overall Study|Withdrawal by Subject|0|||
161154255|NCT00968253|581945588|FG001|Overall Study|Withdrawal by Subject|0|||
161154256|NCT00968253|581945589|FG002|Overall Study|Withdrawal by Subject|1|||
161154257|NCT00968253|581945587|FG000|Overall Study|Disease Progression|0|||
161154258|NCT00968253|581945588|FG001|Overall Study|Disease Progression|3|||
161154259|NCT00968253|581945589|FG002|Overall Study|Disease Progression|3|||
161154260|NCT00968253|581945587|FG000|Overall Study|Adverse Event|0|||
161154261|NCT00968253|581945588|FG001|Overall Study|Adverse Event|0|||
161154262|NCT00968253|581945589|FG002|Overall Study|Adverse Event|1|||
161154263|NCT01745393|581945590|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
161154264|NCT01745393|581945591|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
161282664|NCT05168202|582414966|FG002|Overall Study|Other Reasons|0|||
161282665|NCT05168202|582414967|FG003|Overall Study|Other Reasons|0|||
161154265|NCT01745393|581945590|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
161154266|NCT01745393|581945591|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
161154267|NCT01745393|581945590|FG000|12-month Follow-up|Lost to Follow-up|6|||
161154268|NCT01745393|581945591|FG001|12-month Follow-up|Lost to Follow-up|5|||
161154269|NCT00905021|581945596|FG000|Overall Study|Adverse Event|2|||
161282666|NCT05168202|582414968|FG004|Overall Study|Other Reasons|0|||
161282667|NCT05168202|582414969|FG005|Overall Study|Other Reasons|2|||
161064552|NCT03520075|581628245|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161282668|NCT05168202|582414970|FG006|Overall Study|Other Reasons|1|||
161282669|NCT05168202|582414964|FG000|Overall Study|Physician Decision|0|||
161282670|NCT05168202|582414965|FG001|Overall Study|Physician Decision|1|||
161282671|NCT05168202|582414966|FG002|Overall Study|Physician Decision|1|||
161282672|NCT05168202|582414967|FG003|Overall Study|Physician Decision|0|||
161282673|NCT05168202|582414968|FG004|Overall Study|Physician Decision|0|||
161282674|NCT05168202|582414969|FG005|Overall Study|Physician Decision|0|||
161282675|NCT05168202|582414970|FG006|Overall Study|Physician Decision|0|||
161282676|NCT05168202|582414964|FG000|Overall Study|Study Terminated by Sponsor|0|||
161282677|NCT05168202|582414965|FG001|Overall Study|Study Terminated by Sponsor|0|||
161282678|NCT05168202|582414966|FG002|Overall Study|Study Terminated by Sponsor|0|||
161282679|NCT05168202|582414967|FG003|Overall Study|Study Terminated by Sponsor|1|||
161282680|NCT05168202|582414968|FG004|Overall Study|Study Terminated by Sponsor|0|||
161282681|NCT05168202|582414969|FG005|Overall Study|Study Terminated by Sponsor|0|||
161064553|NCT03520075|581628246|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
161064554|NCT03520075|581628247|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064555|NCT03520075|581628248|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064556|NCT03520075|581628249|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
161064557|NCT03520075|581628250|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064558|NCT03520075|581628251|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064559|NCT03520075|581628252|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064560|NCT03520075|581628253|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064561|NCT03520075|581628254|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064562|NCT03520075|581628255|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
161064563|NCT03520075|581628237|FG000|Phase 2 (Dose Expansion)|Death|0|||
161064564|NCT03520075|581628238|FG001|Phase 2 (Dose Expansion)|Death|0|||
161064565|NCT03520075|581628239|FG002|Phase 2 (Dose Expansion)|Death|0|||
161064566|NCT03520075|581628240|FG003|Phase 2 (Dose Expansion)|Death|0|||
161064567|NCT03520075|581628241|FG004|Phase 2 (Dose Expansion)|Death|0|||
161064568|NCT03520075|581628242|FG005|Phase 2 (Dose Expansion)|Death|0|||
161064569|NCT03520075|581628243|FG006|Phase 2 (Dose Expansion)|Death|0|||
161064570|NCT03520075|581628244|FG007|Phase 2 (Dose Expansion)|Death|0|||
161064571|NCT03520075|581628245|FG008|Phase 2 (Dose Expansion)|Death|0|||
161064572|NCT03520075|581628246|FG009|Phase 2 (Dose Expansion)|Death|0|||
161064573|NCT03520075|581628247|FG010|Phase 2 (Dose Expansion)|Death|0|||
161064574|NCT03520075|581628248|FG011|Phase 2 (Dose Expansion)|Death|0|||
161064575|NCT03520075|581628249|FG012|Phase 2 (Dose Expansion)|Death|0|||
161064576|NCT03520075|581628250|FG013|Phase 2 (Dose Expansion)|Death|20|||
161064577|NCT03520075|581628251|FG014|Phase 2 (Dose Expansion)|Death|13|||
161064578|NCT03520075|581628252|FG015|Phase 2 (Dose Expansion)|Death|9|||
161064579|NCT03520075|581628253|FG016|Phase 2 (Dose Expansion)|Death|5|||
161064580|NCT03520075|581628254|FG017|Phase 2 (Dose Expansion)|Death|14|||
161064581|NCT03520075|581628255|FG018|Phase 2 (Dose Expansion)|Death|12|||
161064582|NCT03520075|581628237|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064583|NCT03520075|581628238|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064584|NCT03520075|581628239|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064585|NCT03520075|581628240|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064586|NCT03520075|581628241|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064587|NCT03520075|581628242|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064588|NCT03520075|581628243|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064589|NCT03520075|581628244|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064590|NCT03520075|581628245|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064591|NCT03520075|581628246|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064592|NCT03520075|581628247|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064593|NCT03520075|581628248|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064594|NCT03520075|581628249|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064595|NCT03520075|581628250|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
161064596|NCT03520075|581628251|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
161064597|NCT03520075|581628252|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
161064598|NCT03520075|581628253|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
161064599|NCT03520075|581628254|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
161064600|NCT03520075|581628255|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
161282682|NCT05168202|582414970|FG006|Overall Study|Study Terminated by Sponsor|0|||
161282683|NCT04011722|582414974|FG000|30 Days|Death|5|||
161064601|NCT03520075|581628237|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064602|NCT03520075|581628238|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064603|NCT03520075|581628239|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064604|NCT03520075|581628240|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161282684|NCT04011722|582414975|FG001|30 Days|Death|1|||
161282685|NCT04011722|582414974|FG000|1 Year|Death|13|||
161282686|NCT04011722|582414975|FG001|1 Year|Death|5|||
161282687|NCT04011722|582414974|FG000|1 Year|Withdrawal by Subject|8|||
161282688|NCT04011722|582414975|FG001|1 Year|Withdrawal by Subject|2|||
161282689|NCT04011722|582414974|FG000|1 Year|Missed Visit|6|||
161282690|NCT04011722|582414975|FG001|1 Year|Missed Visit|1|||
161282691|NCT04011722|582414974|FG000|1 Year|Pending Visit|0|||
161282692|NCT04011722|582414975|FG001|1 Year|Pending Visit|11|||
161282693|NCT04011722|582414974|FG000|1 Year|Not Yet Due|0|||
161282694|NCT04011722|582414975|FG001|1 Year|Not Yet Due|9|||
161282695|NCT04011722|582414974|FG000|2 Year|Death|16|||
161282696|NCT04011722|582414975|FG001|2 Year|Death|1|||
161282697|NCT04011722|582414974|FG000|2 Year|Withdrawal by Subject|10|||
161282698|NCT04011722|582414975|FG001|2 Year|Withdrawal by Subject|1|||
161282699|NCT04011722|582414974|FG000|2 Year|Missed Visit|9|||
161282700|NCT04011722|582414975|FG001|2 Year|Missed Visit|0|||
161282701|NCT04011722|582414974|FG000|2 Year|Visit Pending|1|||
161282702|NCT04011722|582414975|FG001|2 Year|Visit Pending|3|||
161282703|NCT04011722|582414974|FG000|2 Year|Not Yet Due|43|||
161282704|NCT04011722|582414975|FG001|2 Year|Not Yet Due|54|||
161282705|NCT04011722|582414974|FG000|3 Year|Death|10|||
161282706|NCT04011722|582414975|FG001|3 Year|Death|0|||
161282707|NCT04011722|582414974|FG000|3 Year|Withdrawal by Subject|2|||
161282708|NCT04011722|582414975|FG001|3 Year|Withdrawal by Subject|0|||
161282709|NCT04011722|582414974|FG000|3 Year|Missed Visit|2|||
161282710|NCT04011722|582414975|FG001|3 Year|Missed Visit|0|||
161282711|NCT04011722|582414974|FG000|3 Year|Pending Visit|34|||
161282712|NCT04011722|582414975|FG001|3 Year|Pending Visit|0|||
161282713|NCT04011722|582414974|FG000|3 Year|Not Yet Due|99|||
161282714|NCT04011722|582414975|FG001|3 Year|Not Yet Due|0|||
161282715|NCT05626231|582414978|FG000|Provider Enrollment|Worked part-time|4|||
161282716|NCT05626231|582414978|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
161282717|NCT05626231|582414978|FG000|Provider Enrollment|Non-clinical employee|1|||
161282718|NCT05626231|582414978|FG000|Provider Enrollment|Provider does not see clients|3|||
161282719|NCT05626231|582414978|FG000|Provider Enrollment|Other|5|||
161282720|NCT06195930|582414979|FG000|Overall Study|Adverse Event|4|||
161282721|NCT00233948|582414986|FG000|Overall Study|Adverse Event|1|||
161282722|NCT00233948|582414987|FG001|Overall Study|Adverse Event|0|||
161282723|NCT00233948|582414988|FG002|Overall Study|Adverse Event|0|||
161282724|NCT00233948|582414989|FG003|Overall Study|Adverse Event|0|||
161282725|NCT00233948|582414990|FG004|Overall Study|Adverse Event|0|||
161282726|NCT00233948|582414991|FG005|Overall Study|Adverse Event|0|||
161282727|NCT01567462|582414992|FG000|Overall Study|Withdrawal by Subject|4|||
161282728|NCT01567462|582414993|FG001|Overall Study|Withdrawal by Subject|7|||
161282729|NCT01720225|582414996|FG000|Overall Study|Withdrawal by Subject|0|||
161282730|NCT01720225|582414997|FG001|Overall Study|Withdrawal by Subject|1|||
161282731|NCT01720225|582414996|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
161282732|NCT01720225|582414997|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
161282733|NCT02964312|582414998|FG000|Overall Study|Lost to Follow-up|28|||
161282734|NCT02964312|582414998|FG000|Overall Study|Withdrawal by Subject|11|||
161282735|NCT02964312|582414998|FG000|Overall Study|Lack of Efficacy|10|||
161064605|NCT03520075|581628241|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064606|NCT03520075|581628242|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064607|NCT03520075|581628243|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064608|NCT03520075|581628244|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064609|NCT03520075|581628245|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064610|NCT03520075|581628246|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064611|NCT03520075|581628247|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064612|NCT03520075|581628248|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064613|NCT03520075|581628249|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064614|NCT03520075|581628250|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064615|NCT03520075|581628251|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161064616|NCT03520075|581628252|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161064617|NCT03520075|581628253|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064618|NCT03520075|581628254|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
161064619|NCT03520075|581628255|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
161064620|NCT03520075|581628237|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064621|NCT03520075|581628238|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064622|NCT03520075|581628239|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064623|NCT03520075|581628240|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064624|NCT03520075|581628241|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064625|NCT03520075|581628242|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161154270|NCT02488759|581945598|FG000|Overall Study|Disease progression|73|||
161282736|NCT02964312|582414998|FG000|Overall Study|Did not consent to long-term FU|14|||
161282737|NCT02964312|582414998|FG000|Overall Study|Death|1|||
161282738|NCT03288714|582415005|FG000|Overall Study|Lost to Follow-up|2|||
161282739|NCT03288714|582415006|FG001|Overall Study|Lost to Follow-up|1|||
161282740|NCT03288714|582415005|FG000|Overall Study|Non-compliance with study schedule|2|||
161282741|NCT03288714|582415006|FG001|Overall Study|Non-compliance with study schedule|0|||
161282742|NCT03288714|582415005|FG000|Overall Study|Withdrawal by Subject|3|||
161282743|NCT03288714|582415006|FG001|Overall Study|Withdrawal by Subject|1|||
161064626|NCT03520075|581628243|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064627|NCT03520075|581628244|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064628|NCT03520075|581628245|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064629|NCT03520075|581628246|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064630|NCT03520075|581628247|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064631|NCT03520075|581628248|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064632|NCT03520075|581628249|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064633|NCT03520075|581628250|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
161064634|NCT03520075|581628251|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064635|NCT03520075|581628252|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064636|NCT03520075|581628253|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
161064637|NCT03520075|581628254|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
161064638|NCT03520075|581628255|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
161064639|NCT01432626|581628258|FG000|Overall Study|LV function recovered|2|||
161282744|NCT03288714|582415005|FG000|Overall Study|Clinical Worsening|2|||
161282745|NCT03288714|582415006|FG001|Overall Study|Clinical Worsening|1|||
161282746|NCT03288714|582415005|FG000|Overall Study|Adverse Event|1|||
161282747|NCT03288714|582415006|FG001|Overall Study|Adverse Event|0|||
161282748|NCT03280264|582415007|FG000|Overall Study|Adverse Event|1|||
161282749|NCT03280264|582415007|FG000|Overall Study|Physician Decision|1|||
161282750|NCT03280264|582415007|FG000|Overall Study|Withdrawal by Subject|1|||
161282751|NCT00524420|582415015|FG000|Overall Study|Lack of Efficacy|1|||
161282752|NCT00524420|582415016|FG001|Overall Study|Lack of Efficacy|0|||
161282753|NCT00577863|582415017|FG000|Overall Study|Adverse Event|4|||
161282754|NCT00577863|582415018|FG001|Overall Study|Adverse Event|2|||
161282755|NCT00577863|582415017|FG000|Overall Study|Death|1|||
161282756|NCT00577863|582415018|FG001|Overall Study|Death|0|||
161282757|NCT00577863|582415017|FG000|Overall Study|Lost to Follow-up|2|||
161282758|NCT00577863|582415018|FG001|Overall Study|Lost to Follow-up|2|||
161282759|NCT00577863|582415017|FG000|Overall Study|Entry Criteria Exclusion|1|||
161282760|NCT00577863|582415018|FG001|Overall Study|Entry Criteria Exclusion|0|||
161282761|NCT00577863|582415017|FG000|Overall Study|Withdrawal by Subject|0|||
161282762|NCT00577863|582415018|FG001|Overall Study|Withdrawal by Subject|2|||
161282763|NCT00577863|582415017|FG000|Overall Study|Sponsor Decision|2|||
161282764|NCT00577863|582415018|FG001|Overall Study|Sponsor Decision|7|||
161282765|NCT00577863|582415017|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
161282766|NCT00577863|582415018|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
161282767|NCT02738138|582415022|FG000|Overall Study|Adverse Event|0|||
161282768|NCT02738138|582415023|FG001|Overall Study|Adverse Event|1|||
161282769|NCT02738138|582415022|FG000|Overall Study|Lost to Follow-up|2|||
161282770|NCT02738138|582415023|FG001|Overall Study|Lost to Follow-up|0|||
161282771|NCT02738138|582415022|FG000|Overall Study|Other - not further specified|1|||
161282772|NCT02738138|582415023|FG001|Overall Study|Other - not further specified|0|||
161282773|NCT01960257|582415027|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
161282774|NCT01960257|582415028|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
161282775|NCT01960257|582415029|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
161282776|NCT01960257|582415027|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
161282777|NCT01960257|582415028|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
161282778|NCT01960257|582415029|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
161064640|NCT01432626|581628258|FG000|Overall Study|Withdrawal by Subject|2|||
161064641|NCT01432626|581628258|FG000|Overall Study|Only 1 image competed|2|||
161064642|NCT01432626|581628258|FG000|Overall Study|Imaging agent not available|1|||
161064643|NCT00328562|581628259|FG000|Overall Study|Disease progression|1|||
161064644|NCT03305809|581628260|FG000|Overall Study|Adverse Event|2|||
161064645|NCT03305809|581628261|FG001|Overall Study|Adverse Event|2|||
161064646|NCT03305809|581628262|FG002|Overall Study|Adverse Event|6|||
161064647|NCT03305809|581628263|FG003|Overall Study|Adverse Event|6|||
161064648|NCT03305809|581628260|FG000|Overall Study|Death|0|||
161064649|NCT03305809|581628261|FG001|Overall Study|Death|0|||
161064650|NCT03305809|581628262|FG002|Overall Study|Death|1|||
161064651|NCT03305809|581628263|FG003|Overall Study|Death|1|||
161064652|NCT03305809|581628260|FG000|Overall Study|Lost to Follow-up|1|||
161282779|NCT01960257|582415027|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
161064653|NCT03305809|581628261|FG001|Overall Study|Lost to Follow-up|2|||
161064654|NCT03305809|581628262|FG002|Overall Study|Lost to Follow-up|0|||
161064655|NCT03305809|581628263|FG003|Overall Study|Lost to Follow-up|0|||
161064656|NCT03305809|581628260|FG000|Overall Study|Sponsor Decision|1|||
161064657|NCT03305809|581628261|FG001|Overall Study|Sponsor Decision|0|||
161282780|NCT01960257|582415028|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
161282781|NCT01960257|582415029|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
161282782|NCT02038010|582415030|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161282783|NCT02038010|582415031|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
161282784|NCT02038010|582415032|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161282785|NCT02038010|582415033|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
161064658|NCT03305809|581628262|FG002|Overall Study|Sponsor Decision|1|||
161064659|NCT03305809|581628263|FG003|Overall Study|Sponsor Decision|8|||
161064660|NCT03305809|581628260|FG000|Overall Study|Physician Decision|0|||
161064661|NCT03305809|581628261|FG001|Overall Study|Physician Decision|0|||
161064662|NCT03305809|581628262|FG002|Overall Study|Physician Decision|2|||
161064663|NCT03305809|581628263|FG003|Overall Study|Physician Decision|4|||
161064664|NCT03305809|581628260|FG000|Overall Study|Progressive Disease|0|||
161064665|NCT03305809|581628261|FG001|Overall Study|Progressive Disease|0|||
161064666|NCT03305809|581628262|FG002|Overall Study|Progressive Disease|1|||
161064667|NCT03305809|581628263|FG003|Overall Study|Progressive Disease|0|||
161064668|NCT03305809|581628260|FG000|Overall Study|Protocol Violation|1|||
161064669|NCT03305809|581628261|FG001|Overall Study|Protocol Violation|0|||
161064670|NCT03305809|581628262|FG002|Overall Study|Protocol Violation|2|||
161064671|NCT03305809|581628263|FG003|Overall Study|Protocol Violation|3|||
161064672|NCT03305809|581628260|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
161064673|NCT03305809|581628261|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
161064674|NCT03305809|581628262|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
161064675|NCT03305809|581628263|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
161064676|NCT03305809|581628260|FG000|Overall Study|Withdrawal by Subject|2|||
161064677|NCT03305809|581628261|FG001|Overall Study|Withdrawal by Subject|4|||
161064678|NCT03305809|581628262|FG002|Overall Study|Withdrawal by Subject|5|||
161064679|NCT03305809|581628263|FG003|Overall Study|Withdrawal by Subject|2|||
161064680|NCT03305809|581628260|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
161064681|NCT03305809|581628261|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
161064682|NCT03305809|581628262|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
161064683|NCT03305809|581628263|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
161064684|NCT00816556|581628266|FG000|Overall Study|Adverse Event|1|||
161064685|NCT00816556|581628267|FG001|Overall Study|Adverse Event|1|||
161064686|NCT00816556|581628268|FG002|Overall Study|Adverse Event|1|||
161064687|NCT00816556|581628266|FG000|Overall Study|Withdrawal by Subject|1|||
161064688|NCT00816556|581628267|FG001|Overall Study|Withdrawal by Subject|1|||
161064689|NCT00816556|581628268|FG002|Overall Study|Withdrawal by Subject|1|||
161064690|NCT00816556|581628266|FG000|Overall Study|Lost to Follow-up|0|||
161064691|NCT00816556|581628267|FG001|Overall Study|Lost to Follow-up|0|||
161064692|NCT00816556|581628268|FG002|Overall Study|Lost to Follow-up|1|||
161064693|NCT04014790|581628269|FG000|Overall Study|Death|4|||
161064694|NCT04014790|581628269|FG000|Overall Study|Adverse Event|1|||
161064695|NCT04014790|581628269|FG000|Overall Study|Withdrawal by Subject|1|||
161064696|NCT03546816|581628270|FG000|Overall Study|Adverse Event|5|||
161064697|NCT03546816|581628271|FG001|Overall Study|Adverse Event|3|||
161064698|NCT03546816|581628270|FG000|Overall Study|Lack of Efficacy|2|||
161064699|NCT03546816|581628271|FG001|Overall Study|Lack of Efficacy|4|||
161064700|NCT03546816|581628270|FG000|Overall Study|Pregnancy|1|||
161064701|NCT03546816|581628271|FG001|Overall Study|Pregnancy|0|||
161064702|NCT03546816|581628270|FG000|Overall Study|Physician Decision|2|||
161064703|NCT03546816|581628271|FG001|Overall Study|Physician Decision|0|||
161064704|NCT03546816|581628270|FG000|Overall Study|Withdrawal by Subject|8|||
161064705|NCT03546816|581628271|FG001|Overall Study|Withdrawal by Subject|10|||
161064706|NCT03546816|581628270|FG000|Overall Study|Lost to Follow-up|3|||
161064707|NCT03546816|581628271|FG001|Overall Study|Lost to Follow-up|2|||
161064708|NCT01161446|581628272|FG000|Overall Study|Lost to Follow-up|18|||
161064709|NCT01161446|581628273|FG001|Overall Study|Lost to Follow-up|14|||
161064710|NCT01161446|581628272|FG000|Overall Study|Withdrawal by Subject|0|||
161064711|NCT01161446|581628273|FG001|Overall Study|Withdrawal by Subject|1|||
161064712|NCT00810342|581628274|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
161064713|NCT00810342|581628275|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
161064714|NCT00810342|581628274|FG000|Month 1 Follow-up|Pregnancy|1|||
161064715|NCT00810342|581628275|FG001|Month 1 Follow-up|Pregnancy|0|||
161064716|NCT00810342|581628274|FG000|6-month Follow-up|Lost to Follow-up|18|||
161064717|NCT00810342|581628275|FG001|6-month Follow-up|Lost to Follow-up|6|||
161064718|NCT00810342|581628274|FG000|6-month Follow-up|Pregnancy|6|||
161064719|NCT00810342|581628275|FG001|6-month Follow-up|Pregnancy|2|||
161064720|NCT00810342|581628274|FG000|12-month Followup|Pregnancy|9|||
161064721|NCT00810342|581628275|FG001|12-month Followup|Pregnancy|10|||
161064722|NCT00810342|581628274|FG000|12-month Followup|Lost to Follow-up|3|||
161064723|NCT00810342|581628275|FG001|12-month Followup|Lost to Follow-up|1|||
161154271|NCT02488759|581945599|FG001|Overall Study|Disease progression|111|||
161064724|NCT01010204|581628276|FG000|Overall Study|Lost to Follow-up|2|||
161064725|NCT01010204|581628277|FG001|Overall Study|Lost to Follow-up|2|||
161154272|NCT02488759|581945600|FG002|Overall Study|Disease progression|62|||
161154273|NCT02488759|581945601|FG003|Overall Study|Disease progression|7|||
161154274|NCT02488759|581945602|FG004|Overall Study|Disease progression|4|||
161154275|NCT02488759|581945603|FG005|Overall Study|Disease progression|2|||
161154276|NCT02488759|581945598|FG000|Overall Study|Study drug toxicity|11|||
161064726|NCT01010204|581628276|FG000|Overall Study|Adverse Event|1|||
161064727|NCT01010204|581628277|FG001|Overall Study|Adverse Event|3|||
161154277|NCT02488759|581945599|FG001|Overall Study|Study drug toxicity|33|||
161154278|NCT02488759|581945600|FG002|Overall Study|Study drug toxicity|31|||
161154279|NCT02488759|581945601|FG003|Overall Study|Study drug toxicity|0|||
161282786|NCT02038010|582415030|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
161282787|NCT02038010|582415031|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161064728|NCT01010204|581628276|FG000|Overall Study|Withdrawal by Subject|2|||
161064729|NCT01010204|581628277|FG001|Overall Study|Withdrawal by Subject|3|||
161064730|NCT01010204|581628276|FG000|Overall Study|psychiatric hospitalization|2|||
161064731|NCT01010204|581628277|FG001|Overall Study|psychiatric hospitalization|1|||
161064732|NCT01519778|581628278|FG000|Overall Study|Withdrawal by Subject|3|||
161064733|NCT01519778|581628278|FG000|Overall Study|Lost to Follow-up|10|||
161064734|NCT01519778|581628278|FG000|Overall Study|Physician Decision|1|||
161064735|NCT02270671|581628279|FG000|Overall Study|Withdrawal by Subject|1|||
161064736|NCT02270671|581628280|FG001|Overall Study|Withdrawal by Subject|1|||
161064737|NCT02270671|581628279|FG000|Overall Study|Protocol Violation|0|||
161064738|NCT02270671|581628280|FG001|Overall Study|Protocol Violation|1|||
161064739|NCT02270671|581628279|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
161064740|NCT02270671|581628280|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
161064741|NCT02270671|581628279|FG000|Overall Study|Lost to Follow-up|2|||
161064742|NCT02270671|581628280|FG001|Overall Study|Lost to Follow-up|1|||
161064743|NCT01547117|581628281|FG000|Overall Study|Physician Decision|0|||
161064744|NCT01547117|581628282|FG001|Overall Study|Physician Decision|1|||
161064745|NCT01547117|581628283|FG002|Overall Study|Physician Decision|1|||
161064746|NCT01547117|581628284|FG003|Overall Study|Physician Decision|3|||
161064747|NCT01547117|581628281|FG000|Overall Study|Withdrawal by Subject|1|||
161064748|NCT01547117|581628282|FG001|Overall Study|Withdrawal by Subject|2|||
161064749|NCT01547117|581628283|FG002|Overall Study|Withdrawal by Subject|1|||
161064750|NCT01547117|581628284|FG003|Overall Study|Withdrawal by Subject|2|||
161064751|NCT03927690|581628285|FG000|Overall Study|Withdrawal by Subject|3|||
161064752|NCT03927690|581628286|FG001|Overall Study|Withdrawal by Subject|1|||
161064753|NCT03927690|581628287|FG002|Overall Study|Withdrawal by Subject|1|||
161064754|NCT03927690|581628285|FG000|Overall Study|Adverse Event|1|||
161064755|NCT03927690|581628286|FG001|Overall Study|Adverse Event|0|||
161064756|NCT03927690|581628287|FG002|Overall Study|Adverse Event|0|||
161064757|NCT03927690|581628285|FG000|Overall Study|Death|1|||
161064758|NCT03927690|581628286|FG001|Overall Study|Death|0|||
161064759|NCT03927690|581628287|FG002|Overall Study|Death|0|||
161064760|NCT03927690|581628285|FG000|Overall Study|Lost to Follow-up|2|||
161064761|NCT03927690|581628286|FG001|Overall Study|Lost to Follow-up|2|||
161064762|NCT03927690|581628287|FG002|Overall Study|Lost to Follow-up|1|||
161064763|NCT01657799|581628288|FG000|Overall Study|Adverse Event Related to progression|6|||
161064764|NCT01657799|581628289|FG001|Overall Study|Adverse Event Related to progression|8|||
161064765|NCT01657799|581628290|FG002|Overall Study|Adverse Event Related to progression|12|||
161064766|NCT01657799|581628288|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
161064767|NCT01657799|581628289|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
161064768|NCT01657799|581628290|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
161064769|NCT01657799|581628288|FG000|Overall Study|Withdrawal by Subject|13|||
161064770|NCT01657799|581628289|FG001|Overall Study|Withdrawal by Subject|10|||
161064771|NCT01657799|581628290|FG002|Overall Study|Withdrawal by Subject|10|||
161064772|NCT01657799|581628288|FG000|Overall Study|Lost to Follow-up|1|||
161064773|NCT01657799|581628289|FG001|Overall Study|Lost to Follow-up|0|||
161064774|NCT01657799|581628290|FG002|Overall Study|Lost to Follow-up|1|||
161064775|NCT01657799|581628288|FG000|Overall Study|Disease Progression|2|||
161064776|NCT01657799|581628289|FG001|Overall Study|Disease Progression|4|||
161064777|NCT01657799|581628290|FG002|Overall Study|Disease Progression|4|||
161064778|NCT01657799|581628288|FG000|Overall Study|Progressive Disease Clinical|7|||
161064779|NCT01657799|581628289|FG001|Overall Study|Progressive Disease Clinical|4|||
161064780|NCT01657799|581628290|FG002|Overall Study|Progressive Disease Clinical|7|||
161064781|NCT01657799|581628288|FG000|Overall Study|Radiographic & Clinical Progression|16|||
161064782|NCT01657799|581628289|FG001|Overall Study|Radiographic & Clinical Progression|11|||
161064783|NCT01657799|581628290|FG002|Overall Study|Radiographic & Clinical Progression|15|||
161064784|NCT01657799|581628288|FG000|Overall Study|Other|52|||
161064785|NCT01657799|581628289|FG001|Overall Study|Other|62|||
161064786|NCT01657799|581628290|FG002|Overall Study|Other|49|||
161154280|NCT02488759|581945602|FG004|Overall Study|Study drug toxicity|0|||
161282788|NCT02038010|582415032|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161064787|NCT02229578|581628295|FG000|Overall Study|Withdrawal by Subject|1|||
161064788|NCT02229578|581628296|FG001|Overall Study|Withdrawal by Subject|3|||
161064789|NCT02229578|581628295|FG000|Overall Study|Protocol Violation|2|||
161064790|NCT02229578|581628296|FG001|Overall Study|Protocol Violation|0|||
161064791|NCT03603639|581628298|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161064792|NCT03603639|581628299|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161064793|NCT03603639|581628300|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161064794|NCT03603639|581628301|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
161064795|NCT03603639|581628302|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161064796|NCT03603639|581628303|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
161154281|NCT02488759|581945603|FG005|Overall Study|Study drug toxicity|2|||
161064797|NCT03603639|581628298|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
161064798|NCT03603639|581628299|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
161064799|NCT03603639|581628300|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
161282789|NCT02038010|582415033|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
161282790|NCT02038010|582415030|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161282791|NCT02038010|582415031|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
161282792|NCT02038010|582415032|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161282793|NCT02038010|582415033|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
161064800|NCT03603639|581628301|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
161064801|NCT03603639|581628302|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
161064802|NCT03603639|581628303|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
161064803|NCT00551135|581628306|FG000|Overall Study|Adverse Event|1|||
161064804|NCT00551135|581628307|FG001|Overall Study|Adverse Event|0|||
161064805|NCT00551135|581628308|FG002|Overall Study|Adverse Event|1|||
161064806|NCT00551135|581628309|FG003|Overall Study|Adverse Event|1|||
161064807|NCT00551135|581628306|FG000|Overall Study|Lost to Follow-up|0|||
161064808|NCT00551135|581628307|FG001|Overall Study|Lost to Follow-up|0|||
161064809|NCT00551135|581628308|FG002|Overall Study|Lost to Follow-up|0|||
161064810|NCT00551135|581628309|FG003|Overall Study|Lost to Follow-up|1|||
161064811|NCT00551135|581628306|FG000|Overall Study|Other|3|||
161064812|NCT00551135|581628307|FG001|Overall Study|Other|2|||
161064813|NCT00551135|581628308|FG002|Overall Study|Other|1|||
161064814|NCT00551135|581628309|FG003|Overall Study|Other|2|||
161064815|NCT00551135|581628306|FG000|Overall Study|Withdrawal by Subject|1|||
161064816|NCT00551135|581628307|FG001|Overall Study|Withdrawal by Subject|0|||
161064817|NCT00551135|581628308|FG002|Overall Study|Withdrawal by Subject|3|||
161064818|NCT00551135|581628309|FG003|Overall Study|Withdrawal by Subject|1|||
161064819|NCT02165397|581628312|FG000|Overall Study|Death|7|||
161064820|NCT02165397|581628313|FG001|Overall Study|Death|10|||
161064821|NCT02165397|581628314|FG002|Overall Study|Death|8|||
161064822|NCT02165397|581628312|FG000|Overall Study|Lost to Follow-up|1|||
161064823|NCT02165397|581628313|FG001|Overall Study|Lost to Follow-up|3|||
161064824|NCT02165397|581628314|FG002|Overall Study|Lost to Follow-up|0|||
161064825|NCT02165397|581628312|FG000|Overall Study|Withdrawal by Subject|6|||
161064826|NCT02165397|581628313|FG001|Overall Study|Withdrawal by Subject|6|||
161064827|NCT02165397|581628314|FG002|Overall Study|Withdrawal by Subject|1|||
161064828|NCT02165397|581628312|FG000|Overall Study|Other, Not Specified|0|||
161064829|NCT02165397|581628313|FG001|Overall Study|Other, Not Specified|0|||
161064830|NCT02165397|581628314|FG002|Overall Study|Other, Not Specified|1|||
161064831|NCT01841697|581628317|FG000|Overall Study|Death|0|||
161064832|NCT01841697|581628318|FG001|Overall Study|Death|1|||
161064833|NCT01841697|581628317|FG000|Overall Study|Lost to Follow-up|4|||
161064834|NCT01841697|581628318|FG001|Overall Study|Lost to Follow-up|1|||
161064835|NCT01841697|581628317|FG000|Overall Study|Withdrawal by Subject|16|||
161064836|NCT01841697|581628318|FG001|Overall Study|Withdrawal by Subject|16|||
161064837|NCT03672175|581628321|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
161064838|NCT03672175|581628322|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
161064839|NCT03672175|581628323|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
161064840|NCT03672175|581628321|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
161064841|NCT03672175|581628322|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
161064842|NCT03672175|581628323|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
161064843|NCT03672175|581628321|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
161064844|NCT03672175|581628322|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
161064845|NCT03672175|581628323|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
161064846|NCT03672175|581628321|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
161064847|NCT03672175|581628322|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
161064848|NCT03672175|581628323|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
161064849|NCT03672175|581628321|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
161064850|NCT03672175|581628322|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
161282794|NCT02038010|582415030|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
161282795|NCT02038010|582415031|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
161282796|NCT02038010|582415032|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
161064851|NCT03672175|581628323|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
161064852|NCT03672175|581628321|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
161064853|NCT03672175|581628322|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
161064854|NCT03672175|581628323|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
161282797|NCT02038010|582415033|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
161064855|NCT03672175|581628321|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
161064856|NCT03672175|581628322|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
161064857|NCT03672175|581628323|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
161064858|NCT03672175|581628321|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
161064859|NCT03672175|581628322|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
161345368|NCT01706328|582648940|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
161345369|NCT01706328|582648941|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161064860|NCT03672175|581628323|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
161064861|NCT03672175|581628321|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
161064862|NCT03672175|581628322|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
161064863|NCT03672175|581628323|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
161064864|NCT03672175|581628321|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
161064865|NCT03672175|581628322|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
161064866|NCT03672175|581628323|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
161064867|NCT03672175|581628321|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
161064868|NCT03672175|581628322|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
161064869|NCT03672175|581628323|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
161064870|NCT03672175|581628321|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
161064871|NCT03672175|581628322|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
161064872|NCT03672175|581628323|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
161064873|NCT01129115|581628325|FG000|Overall Study|Adverse Event|1|||
161064874|NCT01129115|581628326|FG001|Overall Study|Adverse Event|2|||
161064875|NCT01129115|581628327|FG002|Overall Study|Adverse Event|3|||
161064876|NCT01129115|581628328|FG003|Overall Study|Adverse Event|3|||
161064877|NCT01129115|581628325|FG000|Overall Study|Withdrawal by Subject|1|||
161064878|NCT01129115|581628326|FG001|Overall Study|Withdrawal by Subject|3|||
161064879|NCT01129115|581628327|FG002|Overall Study|Withdrawal by Subject|1|||
161064880|NCT01129115|581628328|FG003|Overall Study|Withdrawal by Subject|4|||
161064881|NCT01129115|581628325|FG000|Overall Study|Protocol Violation|0|||
161064882|NCT01129115|581628326|FG001|Overall Study|Protocol Violation|2|||
161064883|NCT01129115|581628327|FG002|Overall Study|Protocol Violation|2|||
161064884|NCT01129115|581628328|FG003|Overall Study|Protocol Violation|2|||
161064885|NCT01747837|581628329|FG000|Overall Study|Lost to Follow-up|5|||
161064886|NCT01747837|581628330|FG001|Overall Study|Lost to Follow-up|2|||
161064887|NCT01747837|581628329|FG000|Overall Study|Death|4|||
161064888|NCT01747837|581628330|FG001|Overall Study|Death|4|||
161064889|NCT01121913|581628331|FG000|First Intervention Period|Adverse Event|0|||
161064890|NCT01121913|581628332|FG001|First Intervention Period|Adverse Event|0|||
161064891|NCT01121913|581628333|FG002|First Intervention Period|Adverse Event|1|||
161064892|NCT01121913|581628334|FG003|First Intervention Period|Adverse Event|0|||
161064893|NCT01121913|581628331|FG000|First Washout Period|Withdrawal by Subject|1|||
161064894|NCT01121913|581628332|FG001|First Washout Period|Withdrawal by Subject|0|||
161064895|NCT01121913|581628333|FG002|First Washout Period|Withdrawal by Subject|0|||
161064896|NCT01121913|581628334|FG003|First Washout Period|Withdrawal by Subject|0|||
161064897|NCT01121913|581628331|FG000|Second Intervention Period|Adverse Event|0|||
161064898|NCT01121913|581628332|FG001|Second Intervention Period|Adverse Event|0|||
161064899|NCT01121913|581628333|FG002|Second Intervention Period|Adverse Event|1|||
161064900|NCT01121913|581628334|FG003|Second Intervention Period|Adverse Event|0|||
161064901|NCT01121913|581628331|FG000|Second Washout Period|Withdrawal by Subject|0|||
161064902|NCT01121913|581628332|FG001|Second Washout Period|Withdrawal by Subject|0|||
161064903|NCT01121913|581628333|FG002|Second Washout Period|Withdrawal by Subject|1|||
161064904|NCT01121913|581628334|FG003|Second Washout Period|Withdrawal by Subject|0|||
161064905|NCT01121913|581628331|FG000|Third Washout Period|Adverse Event|1|||
161064906|NCT01121913|581628332|FG001|Third Washout Period|Adverse Event|0|||
161064907|NCT01121913|581628333|FG002|Third Washout Period|Adverse Event|0|||
161064908|NCT01121913|581628334|FG003|Third Washout Period|Adverse Event|0|||
161064909|NCT00690378|581628335|FG000|Overall Study|Adverse Event|1|||
161064910|NCT00690378|581628336|FG001|Overall Study|Adverse Event|0|||
161064911|NCT00690378|581628335|FG000|Overall Study|Withdrawal by Subject|2|||
161064912|NCT00690378|581628336|FG001|Overall Study|Withdrawal by Subject|0|||
161064913|NCT00690378|581628335|FG000|Overall Study|Protocol Violation|1|||
161064914|NCT00690378|581628336|FG001|Overall Study|Protocol Violation|0|||
161064915|NCT00690378|581628335|FG000|Overall Study|Lost to Follow-up|2|||
161064916|NCT00690378|581628336|FG001|Overall Study|Lost to Follow-up|3|||
161064917|NCT00690378|581628335|FG000|Overall Study|Did not meet inc/exc criteria|13|||
161064918|NCT00690378|581628336|FG001|Overall Study|Did not meet inc/exc criteria|11|||
161064919|NCT00690378|581628335|FG000|Overall Study|Social problem|1|||
161064920|NCT00690378|581628336|FG001|Overall Study|Social problem|0|||
161064921|NCT02019641|581628340|FG000|10-Week Follow up|Withdrawal by investigator|2|||
161064922|NCT02019641|581628341|FG001|10-Week Follow up|Withdrawal by investigator|0|||
161064923|NCT02019641|581628342|FG002|10-Week Follow up|Withdrawal by investigator|0|||
161064924|NCT02019641|581628340|FG000|10-Week Follow up|Withdrawal by Subject|1|||
161064925|NCT02019641|581628341|FG001|10-Week Follow up|Withdrawal by Subject|1|||
161064926|NCT02019641|581628342|FG002|10-Week Follow up|Withdrawal by Subject|0|||
161064927|NCT02019641|581628340|FG000|20-Week Follow up|Withdrawal by investigator|0|||
161064928|NCT02019641|581628341|FG001|20-Week Follow up|Withdrawal by investigator|0|||
161064929|NCT02019641|581628342|FG002|20-Week Follow up|Withdrawal by investigator|1|||
161064930|NCT03410108|581628345|FG000|Overall Study|Ongoing|41|||
161154282|NCT02488759|581945598|FG000|Overall Study|Adverse event unrelated to study drug|9|||
161154283|NCT02488759|581945599|FG001|Overall Study|Adverse event unrelated to study drug|11|||
161154284|NCT02488759|581945600|FG002|Overall Study|Adverse event unrelated to study drug|7|||
161154285|NCT02488759|581945601|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161154286|NCT02488759|581945602|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161154287|NCT02488759|581945603|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161154288|NCT02488759|581945598|FG000|Overall Study|Participant request to discontinue study treatment|6|||
161154289|NCT02488759|581945599|FG001|Overall Study|Participant request to discontinue study treatment|8|||
161154290|NCT02488759|581945600|FG002|Overall Study|Participant request to discontinue study treatment|4|||
161154291|NCT02488759|581945601|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161154292|NCT02488759|581945602|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161154293|NCT02488759|581945603|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161154294|NCT02488759|581945598|FG000|Overall Study|Withdrawal by Subject|4|||
161154295|NCT02488759|581945599|FG001|Overall Study|Withdrawal by Subject|0|||
161154296|NCT02488759|581945600|FG002|Overall Study|Withdrawal by Subject|3|||
161154297|NCT02488759|581945601|FG003|Overall Study|Withdrawal by Subject|0|||
161154298|NCT02488759|581945602|FG004|Overall Study|Withdrawal by Subject|0|||
161154299|NCT02488759|581945603|FG005|Overall Study|Withdrawal by Subject|2|||
161154300|NCT02488759|581945598|FG000|Overall Study|Lost to Follow-up|0|||
161154301|NCT02488759|581945599|FG001|Overall Study|Lost to Follow-up|0|||
161154302|NCT02488759|581945600|FG002|Overall Study|Lost to Follow-up|2|||
161154303|NCT02488759|581945601|FG003|Overall Study|Lost to Follow-up|0|||
161154304|NCT02488759|581945602|FG004|Overall Study|Lost to Follow-up|0|||
161154305|NCT02488759|581945603|FG005|Overall Study|Lost to Follow-up|0|||
161154306|NCT02488759|581945598|FG000|Overall Study|Maximum clinical benefit|3|||
161154307|NCT02488759|581945599|FG001|Overall Study|Maximum clinical benefit|0|||
161154308|NCT02488759|581945600|FG002|Overall Study|Maximum clinical benefit|1|||
161154309|NCT02488759|581945601|FG003|Overall Study|Maximum clinical benefit|0|||
161154310|NCT02488759|581945602|FG004|Overall Study|Maximum clinical benefit|0|||
161154311|NCT02488759|581945603|FG005|Overall Study|Maximum clinical benefit|0|||
161154312|NCT02488759|581945598|FG000|Overall Study|Other reasons|7|||
161154313|NCT02488759|581945599|FG001|Overall Study|Other reasons|32|||
161154314|NCT02488759|581945600|FG002|Overall Study|Other reasons|23|||
161154315|NCT02488759|581945601|FG003|Overall Study|Other reasons|1|||
161154316|NCT02488759|581945602|FG004|Overall Study|Other reasons|1|||
161154317|NCT02488759|581945603|FG005|Overall Study|Other reasons|1|||
161154318|NCT03860844|581945604|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
161154319|NCT03860844|581945605|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
161154320|NCT03860844|581945606|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
161154321|NCT03860844|581945604|FG000|Overall Study|Progressive disease|5|||
161154322|NCT03860844|581945605|FG001|Overall Study|Progressive disease|3|||
161154323|NCT03860844|581945606|FG002|Overall Study|Progressive disease|4|||
161154324|NCT03860844|581945604|FG000|Overall Study|Other, Not related to COVID-19|0|||
161154325|NCT03860844|581945605|FG001|Overall Study|Other, Not related to COVID-19|1|||
161154326|NCT03860844|581945606|FG002|Overall Study|Other, Not related to COVID-19|0|||
161154327|NCT01678807|581945614|FG000|Overall Study|Adverse Event|4|||
161154328|NCT01678807|581945615|FG001|Overall Study|Adverse Event|4|||
161154329|NCT01678807|581945616|FG002|Overall Study|Adverse Event|0|||
161154330|NCT01678807|581945614|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
161154331|NCT01678807|581945615|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
161154332|NCT01678807|581945616|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161154333|NCT04038255|581947444|FG000|Overall Study|Lost to Follow-up|0|||
161154334|NCT04038255|581947445|FG001|Overall Study|Lost to Follow-up|9|||
161154335|NCT04038255|581947446|FG002|Overall Study|Lost to Follow-up|5|||
161154336|NCT04038255|581947444|FG000|Overall Study|Withdrawal by Subject|0|||
161154337|NCT04038255|581947445|FG001|Overall Study|Withdrawal by Subject|0|||
161154338|NCT04038255|581947446|FG002|Overall Study|Withdrawal by Subject|1|||
161154339|NCT05183867|581947447|FG000|Overall Study|Withdrawal by Subject|3|||
161154340|NCT05183867|581947448|FG001|Overall Study|Withdrawal by Subject|2|||
161154341|NCT05183867|581947449|FG002|Overall Study|Withdrawal by Subject|0|||
161154342|NCT05306873|581947452|FG000|Stage 2|Study stopped|1|||
161154343|NCT05306873|581947453|FG001|Stage 2|Study stopped|1|||
161154344|NCT05306873|581947454|FG002|Stage 2|Study stopped|0|||
161154345|NCT05306873|581947455|FG003|Stage 2|Study stopped|0|||
161154346|NCT05306873|581947452|FG000|Stage 2|Stage 2 Treatment Failure|2|||
161154347|NCT05306873|581947453|FG001|Stage 2|Stage 2 Treatment Failure|3|||
161154348|NCT05306873|581947454|FG002|Stage 2|Stage 2 Treatment Failure|0|||
161154349|NCT05306873|581947455|FG003|Stage 2|Stage 2 Treatment Failure|0|||
161154350|NCT05306873|581947452|FG000|Stage 2|Logistical issues due to participant moving|1|||
161154351|NCT05306873|581947453|FG001|Stage 2|Logistical issues due to participant moving|0|||
161154352|NCT05306873|581947454|FG002|Stage 2|Logistical issues due to participant moving|0|||
161154353|NCT05306873|581947455|FG003|Stage 2|Logistical issues due to participant moving|0|||
161154354|NCT05306873|581947452|FG000|Stage 3|Stage 3 Treatment Failure|0|||
161282798|NCT02038010|582415030|FG000|Follow Up|Death|4|||
161282799|NCT02038010|582415031|FG001|Follow Up|Death|3|||
161282800|NCT02038010|582415032|FG002|Follow Up|Death|0|||
161282801|NCT02038010|582415033|FG003|Follow Up|Death|0|||
161282802|NCT02038010|582415030|FG000|Follow Up|Other|3|||
161282803|NCT02038010|582415031|FG001|Follow Up|Other|0|||
161282804|NCT02038010|582415032|FG002|Follow Up|Other|0|||
161282805|NCT02038010|582415033|FG003|Follow Up|Other|0|||
161282806|NCT00958828|582415039|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
161282807|NCT00958828|582415040|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
161282808|NCT00958828|582415039|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
161064931|NCT03410108|581628345|FG000|Overall Study|Adverse Event|4|||
161064932|NCT03410108|581628345|FG000|Overall Study|Progressive Disease|58|||
161064933|NCT03410108|581628345|FG000|Overall Study|Withdrawal by Subject|1|||
161064934|NCT01313624|581628347|FG000|Double-Blind Phase|Adverse Event|27|||
161064935|NCT01313624|581628348|FG001|Double-Blind Phase|Adverse Event|4|||
161064936|NCT01313624|581628347|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
161064937|NCT01313624|581628348|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
161064938|NCT01313624|581628347|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161064939|NCT01313624|581628348|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161064940|NCT01313624|581628347|FG000|Double-Blind Phase|Physician Decision|1|||
161064941|NCT01313624|581628348|FG001|Double-Blind Phase|Physician Decision|0|||
161064942|NCT01313624|581628347|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161064943|NCT01313624|581628348|FG001|Double-Blind Phase|Lack of Efficacy|0|||
161064944|NCT01313624|581628347|FG000|Open-Label Phase|Adverse Event|1|||
161064945|NCT01313624|581628348|FG001|Open-Label Phase|Adverse Event|10|||
161064946|NCT01313624|581628347|FG000|Open-Label Phase|Withdrawal by Subject|2|||
161064947|NCT01313624|581628348|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161064948|NCT01313624|581628347|FG000|Open-Label Phase|Lost to Follow-up|1|||
161064949|NCT01313624|581628348|FG001|Open-Label Phase|Lost to Follow-up|1|||
161064950|NCT05043883|581628349|FG000|Overall Study|Minimum required measurements could not be taken|4|||
161064951|NCT02447718|581628352|FG000|Overall Study|Lost to Follow-up|8|||
161064952|NCT02447718|581628353|FG001|Overall Study|Lost to Follow-up|0|||
161064953|NCT02447718|581628352|FG000|Overall Study|Withdrawal by Subject|3|||
161064954|NCT02447718|581628353|FG001|Overall Study|Withdrawal by Subject|0|||
161064955|NCT02447718|581628352|FG000|Overall Study|Screen Failure|1|||
161064956|NCT02447718|581628353|FG001|Overall Study|Screen Failure|0|||
161064957|NCT00468130|581628356|FG000|Overall Study|Adverse Event|2|||
161064958|NCT00468130|581628357|FG001|Overall Study|Adverse Event|1|||
161064959|NCT00468130|581628356|FG000|Overall Study|Withdrawal by Subject|0|||
161064960|NCT00468130|581628357|FG001|Overall Study|Withdrawal by Subject|1|||
161064961|NCT03772613|581628358|FG000|Overall Study|Lost to Follow-up|0|||
161064962|NCT03772613|581628359|FG001|Overall Study|Lost to Follow-up|1|||
161064963|NCT03772613|581628360|FG002|Overall Study|Lost to Follow-up|1|||
161064964|NCT01837797|581628369|FG000|Period 1|Adverse Event|9|||
161064965|NCT01837797|581628370|FG001|Period 1|Adverse Event|0|||
161064966|NCT01837797|581628371|FG002|Period 1|Adverse Event|0|||
161064967|NCT01837797|581628372|FG003|Period 1|Adverse Event|0|||
161064968|NCT01837797|581628373|FG004|Period 1|Adverse Event|0|||
161064969|NCT01837797|581628369|FG000|Period 1|Withdrawal by Subject|6|||
161064970|NCT01837797|581628370|FG001|Period 1|Withdrawal by Subject|0|||
161064971|NCT01837797|581628371|FG002|Period 1|Withdrawal by Subject|0|||
161064972|NCT01837797|581628372|FG003|Period 1|Withdrawal by Subject|0|||
161064973|NCT01837797|581628373|FG004|Period 1|Withdrawal by Subject|0|||
161064974|NCT01837797|581628369|FG000|Period 1|Administrative reasons|76|||
161064975|NCT01837797|581628370|FG001|Period 1|Administrative reasons|0|||
161064976|NCT01837797|581628371|FG002|Period 1|Administrative reasons|0|||
161064977|NCT01837797|581628372|FG003|Period 1|Administrative reasons|0|||
161064978|NCT01837797|581628373|FG004|Period 1|Administrative reasons|0|||
161064979|NCT01837797|581628369|FG000|Period 1|Withdrawal of consent before treatment|1|||
161064980|NCT01837797|581628370|FG001|Period 1|Withdrawal of consent before treatment|0|||
161064981|NCT01837797|581628371|FG002|Period 1|Withdrawal of consent before treatment|0|||
161064982|NCT01837797|581628372|FG003|Period 1|Withdrawal of consent before treatment|0|||
161282809|NCT00958828|582415040|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
161064983|NCT01837797|581628373|FG004|Period 1|Withdrawal of consent before treatment|0|||
161064984|NCT01837797|581628369|FG000|Period 1|Other|10|||
161064985|NCT01837797|581628370|FG001|Period 1|Other|0|||
161064986|NCT01837797|581628371|FG002|Period 1|Other|0|||
161064987|NCT01837797|581628372|FG003|Period 1|Other|0|||
161064988|NCT01837797|581628373|FG004|Period 1|Other|0|||
161064989|NCT01837797|581628369|FG000|Period 2|Administrative or other reasons|0|||
161064990|NCT01837797|581628370|FG001|Period 2|Administrative or other reasons|5|||
161064991|NCT01837797|581628371|FG002|Period 2|Administrative or other reasons|2|||
161064992|NCT01837797|581628372|FG003|Period 2|Administrative or other reasons|4|||
161064993|NCT01837797|581628373|FG004|Period 2|Administrative or other reasons|0|||
161282810|NCT02673775|582415051|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
161282811|NCT02673775|582415052|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
161282812|NCT02673775|582415051|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
161282813|NCT02673775|582415052|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
161064994|NCT01837797|581628369|FG000|Period 2|Adverse Event|0|||
161064995|NCT01837797|581628370|FG001|Period 2|Adverse Event|0|||
161064996|NCT01837797|581628371|FG002|Period 2|Adverse Event|0|||
161064997|NCT01837797|581628372|FG003|Period 2|Adverse Event|1|||
161064998|NCT01837797|581628373|FG004|Period 2|Adverse Event|0|||
161064999|NCT01837797|581628369|FG000|Period 3|Adverse Event|0|||
161065000|NCT01837797|581628370|FG001|Period 3|Adverse Event|0|||
161065001|NCT01837797|581628371|FG002|Period 3|Adverse Event|0|||
161065002|NCT01837797|581628372|FG003|Period 3|Adverse Event|0|||
161065003|NCT01837797|581628373|FG004|Period 3|Adverse Event|1|||
161065004|NCT01837797|581628369|FG000|Period 3|Administrative reasons|0|||
161065005|NCT01837797|581628370|FG001|Period 3|Administrative reasons|0|||
161065006|NCT01837797|581628371|FG002|Period 3|Administrative reasons|0|||
161065007|NCT01837797|581628372|FG003|Period 3|Administrative reasons|0|||
161065008|NCT01837797|581628373|FG004|Period 3|Administrative reasons|20|||
161065009|NCT01837797|581628369|FG000|Period 3|Other|0|||
161065010|NCT01837797|581628370|FG001|Period 3|Other|0|||
161065011|NCT01837797|581628371|FG002|Period 3|Other|0|||
161065012|NCT01837797|581628372|FG003|Period 3|Other|0|||
161065013|NCT01837797|581628373|FG004|Period 3|Other|2|||
161065014|NCT03797989|581628394|FG000|VAC069A|Withdrawal by Subject|0|||
161065015|NCT03797989|581628395|FG001|VAC069A|Withdrawal by Subject|0|||
161065016|NCT03797989|581628396|FG002|VAC069A|Withdrawal by Subject|1|||
161065017|NCT03797989|581628397|FG003|VAC069A|Withdrawal by Subject|0|||
161065018|NCT03797989|581628398|FG004|VAC069A|Withdrawal by Subject|0|||
161065019|NCT03797989|581628399|FG005|VAC069A|Withdrawal by Subject|0|||
161065020|NCT03797989|581628400|FG006|VAC069A|Withdrawal by Subject|0|||
161065021|NCT03797989|581628401|FG007|VAC069A|Withdrawal by Subject|0|||
161065022|NCT03797989|581628402|FG008|VAC069A|Withdrawal by Subject|0|||
161065023|NCT03797989|581628403|FG009|VAC069A|Withdrawal by Subject|0|||
161065024|NCT03797989|581628404|FG010|VAC069A|Withdrawal by Subject|0|||
161065025|NCT03797989|581628405|FG011|VAC069A|Withdrawal by Subject|0|||
161065026|NCT04522778|581628407|FG000|Overall Study|Patient did not want to wear the device|1|||
161065027|NCT04522778|581628408|FG001|Overall Study|Patient did not want to wear the device|0|||
161065028|NCT04522778|581628407|FG000|Overall Study|Lost to Follow-up|0|||
161065029|NCT04522778|581628408|FG001|Overall Study|Lost to Follow-up|1|||
161065030|NCT04052997|581628409|FG000|Overall Study|Withdrawal by Subject|17|||
161065031|NCT04052997|581628409|FG000|Overall Study|Physician Decision|50|||
161065032|NCT04052997|581628409|FG000|Overall Study|Death|43|||
161065033|NCT04052997|581628409|FG000|Overall Study|Lost to Follow-up|5|||
161065034|NCT04052997|581628409|FG000|Overall Study|Progression of Disease|1|||
161065035|NCT00069277|581628410|FG000|Overall Study|Adverse Event|3|||
161065036|NCT00069277|581628410|FG000|Overall Study|Withdrawal by Subject|1|||
161065037|NCT00069277|581628410|FG000|Overall Study|Progressive Disease|15|||
161065038|NCT00069277|581628410|FG000|Overall Study|Physician Decision|2|||
161065039|NCT04594733|581628411|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
161065040|NCT04594733|581628412|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
161065041|NCT04594733|581628411|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
161065042|NCT04594733|581628412|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
161065043|NCT04594733|581628411|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
161065044|NCT04594733|581628412|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
161065045|NCT01225159|581628417|FG000|Overall Study|Change operation|1|||
161065046|NCT01225159|581628418|FG001|Overall Study|Change operation|0|||
161065047|NCT01024036|581628421|FG000|Blinded Treatment|Adverse Event|1|||
161065048|NCT01024036|581628422|FG001|Blinded Treatment|Adverse Event|1|||
161065049|NCT01024036|581628421|FG000|Blinded Treatment|Lack of Efficacy|16|||
161065050|NCT01024036|581628422|FG001|Blinded Treatment|Lack of Efficacy|14|||
161065051|NCT01024036|581628421|FG000|Blinded Treatment|Physician Decision|1|||
161065052|NCT01024036|581628422|FG001|Blinded Treatment|Physician Decision|0|||
161065053|NCT01024036|581628421|FG000|Blinded Treatment|Death|0|||
161065054|NCT01024036|581628422|FG001|Blinded Treatment|Death|2|||
161065055|NCT01024036|581628421|FG000|Blinded Treatment|Withdrawal by Subject|4|||
161065056|NCT01024036|581628422|FG001|Blinded Treatment|Withdrawal by Subject|3|||
161065057|NCT01024036|581628421|FG000|Unblinded Treatment|Adverse Event|0|||
161345370|NCT01706328|582648942|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
161065058|NCT01024036|581628422|FG001|Unblinded Treatment|Adverse Event|1|||
161065059|NCT01024036|581628421|FG000|Unblinded Treatment|Lack of Efficacy|0|||
161065060|NCT01024036|581628422|FG001|Unblinded Treatment|Lack of Efficacy|2|||
161065061|NCT01024036|581628421|FG000|Follow-Up Period|Lost to Follow-up|1|||
161065062|NCT01024036|581628422|FG001|Follow-Up Period|Lost to Follow-up|1|||
161065063|NCT01024036|581628421|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161065064|NCT01024036|581628422|FG001|Follow-Up Period|Withdrawal by Subject|1|||
161065065|NCT01024036|581628421|FG000|Follow-Up Period|Adverse Event|4|||
161065066|NCT01024036|581628422|FG001|Follow-Up Period|Adverse Event|1|||
161065067|NCT01220856|581628423|FG000|Overall Study|graft loss|3|||
161065068|NCT01220856|581628424|FG001|Overall Study|graft loss|3|||
161065069|NCT01220856|581628423|FG000|Overall Study|Lost to Follow-up|1|||
161065070|NCT01220856|581628424|FG001|Overall Study|Lost to Follow-up|0|||
161065071|NCT03512288|581628429|FG000|Overall Study|Adverse Event|1|||
161065072|NCT03512288|581628430|FG001|Overall Study|Adverse Event|0|||
161154355|NCT05306873|581947453|FG001|Stage 3|Stage 3 Treatment Failure|0|||
161154356|NCT05306873|581947454|FG002|Stage 3|Stage 3 Treatment Failure|0|||
161154357|NCT05306873|581947455|FG003|Stage 3|Stage 3 Treatment Failure|1|||
161154358|NCT05306873|581947452|FG000|Stage 3|Study Stopped|0|||
161154359|NCT05306873|581947453|FG001|Stage 3|Study Stopped|0|||
161154360|NCT05306873|581947454|FG002|Stage 3|Study Stopped|1|||
161154361|NCT05306873|581947455|FG003|Stage 3|Study Stopped|0|||
161154362|NCT02614287|581947456|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
161154363|NCT02614287|581947457|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
161154364|NCT02614287|581947456|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
161154365|NCT02614287|581947457|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
161154366|NCT02614287|581947456|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
161154367|NCT02614287|581947457|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
161154368|NCT02614287|581947456|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
161154369|NCT02614287|581947457|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
161154370|NCT02614287|581947456|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
161154371|NCT02614287|581947457|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
161154372|NCT02614287|581947456|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
161154373|NCT02614287|581947457|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
161154374|NCT02614287|581947456|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
161154375|NCT02614287|581947457|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
161154376|NCT02614287|581947456|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
161154377|NCT02614287|581947457|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
161154378|NCT00418834|581947458|FG000|Overall Study|Adverse Event|16|||
161154379|NCT00418834|581947459|FG001|Overall Study|Adverse Event|9|||
161154380|NCT00418834|581947458|FG000|Overall Study|Lost to Follow-up|0|||
161154381|NCT00418834|581947459|FG001|Overall Study|Lost to Follow-up|1|||
161154382|NCT00418834|581947458|FG000|Overall Study|Protocol Violation|4|||
161154383|NCT00418834|581947459|FG001|Overall Study|Protocol Violation|3|||
161154384|NCT00418834|581947458|FG000|Overall Study|Withdrawal by Subject|3|||
161154385|NCT00418834|581947459|FG001|Overall Study|Withdrawal by Subject|7|||
161154386|NCT01953328|581947460|FG000|Overall Study|Withdrawal by Subject|0|||
161154387|NCT01953328|581947461|FG001|Overall Study|Withdrawal by Subject|0|||
161154388|NCT01953328|581947462|FG002|Overall Study|Withdrawal by Subject|0|||
161154389|NCT01953328|581947463|FG003|Overall Study|Withdrawal by Subject|0|||
161154390|NCT01953328|581947464|FG004|Overall Study|Withdrawal by Subject|1|||
161154391|NCT01953328|581947465|FG005|Overall Study|Withdrawal by Subject|0|||
161154392|NCT01953328|581947466|FG006|Overall Study|Withdrawal by Subject|0|||
161154393|NCT01953328|581947467|FG007|Overall Study|Withdrawal by Subject|0|||
161154394|NCT01953328|581947460|FG000|Overall Study|Lost to Follow-up|0|||
161154395|NCT01953328|581947461|FG001|Overall Study|Lost to Follow-up|0|||
161154396|NCT01953328|581947462|FG002|Overall Study|Lost to Follow-up|0|||
161154397|NCT01953328|581947463|FG003|Overall Study|Lost to Follow-up|0|||
161154398|NCT01953328|581947464|FG004|Overall Study|Lost to Follow-up|1|||
161154399|NCT01953328|581947465|FG005|Overall Study|Lost to Follow-up|0|||
161154400|NCT01953328|581947466|FG006|Overall Study|Lost to Follow-up|0|||
161154401|NCT01953328|581947467|FG007|Overall Study|Lost to Follow-up|0|||
161154402|NCT01755195|581947470|FG000|Overall Study|Participant noncompliance|2|||
161154403|NCT01755195|581947470|FG000|Overall Study|Switched to alternative treatment|4|||
161154404|NCT01755195|581947470|FG000|Overall Study|Withdrawal by Subject|1|||
161154405|NCT01755195|581947470|FG000|Overall Study|Participant refused to start treatment|1|||
161154406|NCT01755195|581947470|FG000|Overall Study|Participant has been consented for another trial|1|||
161154407|NCT01755195|581947470|FG000|Overall Study|Refused further treatment|3|||
161154408|NCT01755195|581947470|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
161154409|NCT05113953|581947471|FG000|Overall Study|Adverse Event|5|||
161154410|NCT05113953|581947472|FG001|Overall Study|Adverse Event|0|||
161154411|NCT05113953|581947473|FG002|Overall Study|Adverse Event|3|||
161154412|NCT05113953|581947471|FG000|Overall Study|Lost to Follow-up|3|||
161154413|NCT05113953|581947472|FG001|Overall Study|Lost to Follow-up|4|||
161154414|NCT05113953|581947473|FG002|Overall Study|Lost to Follow-up|2|||
161282814|NCT02673775|582415051|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
161282815|NCT02673775|582415052|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
161282816|NCT02673775|582415051|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
161154415|NCT05113953|581947471|FG000|Overall Study|Non-compliance with Study Drug|1|||
161154416|NCT05113953|581947472|FG001|Overall Study|Non-compliance with Study Drug|0|||
161154417|NCT05113953|581947473|FG002|Overall Study|Non-compliance with Study Drug|0|||
161154418|NCT05113953|581947471|FG000|Overall Study|Withdrawal by Subject|2|||
161154419|NCT05113953|581947472|FG001|Overall Study|Withdrawal by Subject|6|||
161154420|NCT05113953|581947473|FG002|Overall Study|Withdrawal by Subject|4|||
161154421|NCT05113953|581947471|FG000|Overall Study|Reason not Specified|2|||
161154422|NCT05113953|581947472|FG001|Overall Study|Reason not Specified|0|||
161154423|NCT05113953|581947473|FG002|Overall Study|Reason not Specified|0|||
161154424|NCT03470922|581947480|FG000|Overall Study|Death|107|||
161154425|NCT03470922|581947481|FG001|Overall Study|Death|118|||
161154426|NCT03470922|581947480|FG000|Overall Study|Lost to Follow-up|5|||
161065073|NCT03512288|581628429|FG000|Overall Study|Lost to Follow-up|12|||
161065074|NCT03512288|581628430|FG001|Overall Study|Lost to Follow-up|15|||
161065075|NCT03512288|581628429|FG000|Overall Study|Physician Decision|0|||
161065076|NCT03512288|581628430|FG001|Overall Study|Physician Decision|2|||
161065077|NCT03512288|581628429|FG000|Overall Study|Protocol Violation|6|||
161065078|NCT03512288|581628430|FG001|Overall Study|Protocol Violation|4|||
161065079|NCT03512288|581628429|FG000|Overall Study|Medication error without associated adverse event|1|||
161065080|NCT03512288|581628430|FG001|Overall Study|Medication error without associated adverse event|0|||
161065081|NCT03512288|581628429|FG000|Overall Study|No longer met eligibility criteria|5|||
161065082|NCT03512288|581628430|FG001|Overall Study|No longer met eligibility criteria|2|||
161065083|NCT03512288|581628429|FG000|Overall Study|Withdrawal by parent/guardian|14|||
161065084|NCT03512288|581628430|FG001|Overall Study|Withdrawal by parent/guardian|18|||
161065085|NCT03512288|581628429|FG000|Overall Study|Other|1|||
161065086|NCT03512288|581628430|FG001|Overall Study|Other|1|||
161065087|NCT03512288|581628429|FG000|Overall Study|Randomized but not treated|1|||
161065088|NCT03512288|581628430|FG001|Overall Study|Randomized but not treated|1|||
161065089|NCT04814992|581628431|FG000|Overall Study|Withdrawal by Subject|6|||
161065090|NCT04814992|581628432|FG001|Overall Study|Withdrawal by Subject|3|||
161065091|NCT04814992|581628431|FG000|Overall Study|Lost to Follow-up|1|||
161065092|NCT04814992|581628432|FG001|Overall Study|Lost to Follow-up|4|||
161065093|NCT04811339|581628433|FG000|Overall Study|lack of transportation not wanting to return|4|||
161065094|NCT04811339|581628434|FG001|Overall Study|lack of transportation not wanting to return|8|||
161065095|NCT04811339|581628435|FG002|Overall Study|lack of transportation not wanting to return|0|||
161065096|NCT04811339|581628433|FG000|Overall Study|Adverse Event|3|||
161065097|NCT04811339|581628434|FG001|Overall Study|Adverse Event|0|||
161065098|NCT04811339|581628435|FG002|Overall Study|Adverse Event|0|||
161065099|NCT04811339|581628433|FG000|Overall Study|Lost to Follow-up|1|||
161065100|NCT04811339|581628434|FG001|Overall Study|Lost to Follow-up|0|||
161065101|NCT04811339|581628435|FG002|Overall Study|Lost to Follow-up|0|||
161065102|NCT04811339|581628433|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
161065103|NCT04811339|581628434|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
161065104|NCT04811339|581628435|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
161065105|NCT04811339|581628433|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
161065106|NCT04811339|581628434|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
161065107|NCT04811339|581628435|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
161065108|NCT04811339|581628433|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
161065109|NCT04811339|581628434|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
161065110|NCT04811339|581628435|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
161065111|NCT04811339|581628433|FG000|Overall Study|Withdrawal by Subject|0|||
161065112|NCT04811339|581628434|FG001|Overall Study|Withdrawal by Subject|3|||
161065113|NCT04811339|581628435|FG002|Overall Study|Withdrawal by Subject|0|||
161065114|NCT04811339|581628433|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
161065115|NCT04811339|581628434|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
161065116|NCT04811339|581628435|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
161065117|NCT04811339|581628433|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
161065118|NCT04811339|581628434|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
161065119|NCT04811339|581628435|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
161065120|NCT02366143|581630471|FG000|Overall Study|Death|307|||
161065121|NCT02366143|581630472|FG001|Overall Study|Death|278|||
161065122|NCT02366143|581630473|FG002|Overall Study|Death|280|||
161065123|NCT02366143|581630471|FG000|Overall Study|Lost to Follow-up|2|||
161065124|NCT02366143|581630472|FG001|Overall Study|Lost to Follow-up|4|||
161065125|NCT02366143|581630473|FG002|Overall Study|Lost to Follow-up|2|||
161065126|NCT02366143|581630471|FG000|Overall Study|Physician Decision|1|||
161065127|NCT02366143|581630472|FG001|Overall Study|Physician Decision|2|||
161065128|NCT02366143|581630473|FG002|Overall Study|Physician Decision|1|||
161065129|NCT02366143|581630471|FG000|Overall Study|Protocol Violation|0|||
161065130|NCT02366143|581630472|FG001|Overall Study|Protocol Violation|0|||
161065131|NCT02366143|581630473|FG002|Overall Study|Protocol Violation|2|||
161065132|NCT02366143|581630471|FG000|Overall Study|Withdrawal by Subject|16|||
161065133|NCT02366143|581630472|FG001|Overall Study|Withdrawal by Subject|17|||
161065134|NCT02366143|581630473|FG002|Overall Study|Withdrawal by Subject|22|||
161065135|NCT02366143|581630471|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
161065136|NCT02366143|581630472|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
161065137|NCT02366143|581630473|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
161065138|NCT02366143|581630471|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
161065139|NCT02366143|581630472|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
161065140|NCT02366143|581630473|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
161065141|NCT02366143|581630471|FG000|Overall Study|Randomization Error|1|||
161065142|NCT02366143|581630472|FG001|Overall Study|Randomization Error|0|||
161282817|NCT02673775|582415052|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
161065143|NCT02366143|581630473|FG002|Overall Study|Randomization Error|0|||
161065144|NCT02366143|581630471|FG000|Overall Study|PI Move and Site Closure|1|||
161065145|NCT02366143|581630472|FG001|Overall Study|PI Move and Site Closure|0|||
161065146|NCT02366143|581630473|FG002|Overall Study|PI Move and Site Closure|1|||
161065147|NCT02366143|581630471|FG000|Overall Study|Study Terminated By Sponsor|0|||
161065148|NCT02366143|581630472|FG001|Overall Study|Study Terminated By Sponsor|0|||
161065149|NCT02366143|581630473|FG002|Overall Study|Study Terminated By Sponsor|2|||
161065150|NCT02366143|581630471|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
161065151|NCT02366143|581630472|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
161065152|NCT02366143|581630473|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
161065153|NCT02366143|581630471|FG000|Overall Study|Patient moved to roll-over study|1|||
161065154|NCT02366143|581630472|FG001|Overall Study|Patient moved to roll-over study|19|||
161065155|NCT02366143|581630473|FG002|Overall Study|Patient moved to roll-over study|28|||
161065156|NCT02366143|581630471|FG000|Overall Study|Patient moved to commercial stock|0|||
161065157|NCT02366143|581630472|FG001|Overall Study|Patient moved to commercial stock|0|||
161065158|NCT02366143|581630473|FG002|Overall Study|Patient moved to commercial stock|1|||
161065159|NCT02366143|581630471|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
161065160|NCT02366143|581630472|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
161065161|NCT02366143|581630473|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
161065162|NCT02366143|581630471|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
161065163|NCT02366143|581630472|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
161065164|NCT02366143|581630473|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
161065165|NCT02366143|581630471|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
161065166|NCT02366143|581630472|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
161065167|NCT02366143|581630473|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
161065168|NCT02366143|581630471|FG000|Overall Study|Requester's instructions|1|||
161065169|NCT02366143|581630472|FG001|Overall Study|Requester's instructions|1|||
161065170|NCT02366143|581630473|FG002|Overall Study|Requester's instructions|1|||
161065171|NCT02366143|581630471|FG000|Overall Study|Uneligible|0|||
161065172|NCT02366143|581630472|FG001|Overall Study|Uneligible|1|||
161065173|NCT02366143|581630473|FG002|Overall Study|Uneligible|0|||
161065174|NCT02366143|581630471|FG000|Overall Study|Post Trial Migration|0|||
161065175|NCT02366143|581630472|FG001|Overall Study|Post Trial Migration|1|||
161065176|NCT02366143|581630473|FG002|Overall Study|Post Trial Migration|0|||
161065177|NCT02366143|581630471|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
161065178|NCT02366143|581630472|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
161065179|NCT02366143|581630473|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
161065180|NCT02366143|581630471|FG000|Overall Study|Patient switched to PTAP|0|||
161065181|NCT02366143|581630472|FG001|Overall Study|Patient switched to PTAP|1|||
161065182|NCT02366143|581630473|FG002|Overall Study|Patient switched to PTAP|0|||
161065183|NCT02366143|581630471|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
161065184|NCT02366143|581630472|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
161065185|NCT02366143|581630473|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
161065186|NCT01266018|581630474|FG000|Overall Study|Physician Decision|1|||
161065187|NCT01266018|581630475|FG001|Overall Study|Physician Decision|0|||
161065188|NCT01266018|581630474|FG000|Overall Study|Progressive disease|0|||
161065189|NCT01266018|581630475|FG001|Overall Study|Progressive disease|1|||
161065190|NCT03167151|581630476|FG000|Overall Study|Withdrawal by Subject|1|||
161065191|NCT03167151|581630477|FG001|Overall Study|Withdrawal by Subject|0|||
161065192|NCT03167151|581630478|FG002|Overall Study|Withdrawal by Subject|0|||
161065193|NCT03167151|581630476|FG000|Overall Study|No evidence of tumour at surgery|0|||
161065194|NCT03167151|581630477|FG001|Overall Study|No evidence of tumour at surgery|1|||
161065195|NCT03167151|581630478|FG002|Overall Study|No evidence of tumour at surgery|1|||
161065196|NCT01458522|581630479|FG000|Overall Study|Withdrawal by Subject|2|||
161065197|NCT01458522|581630480|FG001|Overall Study|Withdrawal by Subject|2|||
161065198|NCT01458522|581630479|FG000|Overall Study|Physician Decision|1|||
161065199|NCT01458522|581630480|FG001|Overall Study|Physician Decision|9|||
161065200|NCT00516139|581630481|FG000|Overall Study|Adverse Event|27|||
161065201|NCT00516139|581630481|FG000|Overall Study|Lost to Follow-up|1|||
161065202|NCT00516139|581630481|FG000|Overall Study|Protocol Violation|1|||
161065203|NCT00516139|581630481|FG000|Overall Study|Withdrawal by Subject|8|||
161065204|NCT00516139|581630481|FG000|Overall Study|Lack of Efficacy|1|||
161065205|NCT00589303|581630482|FG000|Overall Study|Withdrawal by Subject|2|||
161065206|NCT00589303|581630483|FG001|Overall Study|Withdrawal by Subject|1|||
161065207|NCT00730015|581630484|FG000|Overall Study|Adverse Event|11|||
161065208|NCT00730015|581630485|FG001|Overall Study|Adverse Event|10|||
161065209|NCT00730015|581630486|FG002|Overall Study|Adverse Event|8|||
161065210|NCT00730015|581630484|FG000|Overall Study|Protocol Violation|2|||
161065211|NCT00730015|581630485|FG001|Overall Study|Protocol Violation|6|||
161065212|NCT00730015|581630486|FG002|Overall Study|Protocol Violation|4|||
161065213|NCT00730015|581630484|FG000|Overall Study|Withdrawal by Subject|12|||
161065214|NCT00730015|581630485|FG001|Overall Study|Withdrawal by Subject|12|||
161065215|NCT00730015|581630486|FG002|Overall Study|Withdrawal by Subject|8|||
161065216|NCT00730015|581630484|FG000|Overall Study|Lost to Follow-up|4|||
161065217|NCT00730015|581630485|FG001|Overall Study|Lost to Follow-up|10|||
161065218|NCT00730015|581630486|FG002|Overall Study|Lost to Follow-up|3|||
161065219|NCT00730015|581630484|FG000|Overall Study|Lack of Efficacy|1|||
161065220|NCT00730015|581630485|FG001|Overall Study|Lack of Efficacy|2|||
161065221|NCT00730015|581630486|FG002|Overall Study|Lack of Efficacy|8|||
161065222|NCT00730015|581630484|FG000|Overall Study|Other Reason|1|||
161065223|NCT00730015|581630485|FG001|Overall Study|Other Reason|0|||
161065224|NCT00730015|581630486|FG002|Overall Study|Other Reason|1|||
161065225|NCT03062449|581630487|FG000|Overall Study|Withdrawal by Subject|7|||
161065226|NCT03062449|581630488|FG001|Overall Study|Withdrawal by Subject|1|||
161065227|NCT02370251|581630489|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
161065228|NCT02370251|581630489|FG000|Overall Study|Death|4|||
161065229|NCT04120376|581630490|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
161065230|NCT04120376|581630491|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
161065231|NCT02053610|581630492|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
161065232|NCT02053610|581630493|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
161065233|NCT02053610|581630492|FG000|Overall Study|Withdrew Consent|2|||
161065234|NCT02053610|581630493|FG001|Overall Study|Withdrew Consent|9|||
161065235|NCT02053610|581630492|FG000|Overall Study|Death|5|||
161065236|NCT02053610|581630493|FG001|Overall Study|Death|5|||
161065237|NCT02053610|581630492|FG000|Overall Study|Administrative/Other|1|||
161065238|NCT02053610|581630493|FG001|Overall Study|Administrative/Other|1|||
161065239|NCT02053610|581630492|FG000|Overall Study|Disease Progression|2|||
161065240|NCT02053610|581630493|FG001|Overall Study|Disease Progression|3|||
161065241|NCT02053610|581630492|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
161065242|NCT02053610|581630493|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
161065243|NCT02053610|581630492|FG000|Overall Study|Did not Receive Treatment|4|||
161065244|NCT02053610|581630493|FG001|Overall Study|Did not Receive Treatment|2|||
161065245|NCT02053610|581630492|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161065246|NCT02053610|581630493|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161065247|NCT02053610|581630492|FG000|Overall Study|Violation of Selection Criteria|1|||
161065248|NCT02053610|581630493|FG001|Overall Study|Violation of Selection Criteria|0|||
161065249|NCT01165177|581630494|FG000|Overall Study|Serious Adverse Event|227|||
161065250|NCT01165177|581630495|FG001|Overall Study|Serious Adverse Event|235|||
161065251|NCT01165177|581630494|FG000|Overall Study|Withdrawal by Subject|368|||
161065252|NCT01165177|581630495|FG001|Overall Study|Withdrawal by Subject|354|||
161065253|NCT01165177|581630494|FG000|Overall Study|Protocol Violation|19|||
161065254|NCT01165177|581630495|FG001|Overall Study|Protocol Violation|21|||
161065255|NCT01165177|581630494|FG000|Overall Study|Non-serious adverse event|30|||
161065256|NCT01165177|581630495|FG001|Overall Study|Non-serious adverse event|18|||
161065257|NCT01165177|581630494|FG000|Overall Study|Other unspecified reasons|47|||
161065258|NCT01165177|581630495|FG001|Overall Study|Other unspecified reasons|35|||
161065259|NCT01165177|581630494|FG000|Overall Study|Suspected HZ episode|0|||
161065260|NCT01165177|581630495|FG001|Overall Study|Suspected HZ episode|2|||
161065261|NCT01165177|581630494|FG000|Overall Study|Lost to Follow-up|183|||
161065262|NCT01165177|581630495|FG001|Overall Study|Lost to Follow-up|194|||
161065263|NCT01165177|581630494|FG000|Overall Study|Migrated/ moved from study area|48|||
161065264|NCT01165177|581630495|FG001|Overall Study|Migrated/ moved from study area|43|||
161065265|NCT05499130|581630496|FG000|Overall Study|Adverse Event|2|||
161065266|NCT05499130|581630497|FG001|Overall Study|Adverse Event|0|||
161065267|NCT05499130|581630498|FG002|Overall Study|Adverse Event|1|||
161065268|NCT05499130|581630499|FG003|Overall Study|Adverse Event|0|||
161065269|NCT05499130|581630500|FG004|Overall Study|Adverse Event|1|||
161065270|NCT05499130|581630501|FG005|Overall Study|Adverse Event|4|||
161065271|NCT05499130|581630502|FG006|Overall Study|Adverse Event|1|||
161065272|NCT05499130|581630503|FG007|Overall Study|Adverse Event|0|||
161065273|NCT05499130|581630496|FG000|Overall Study|Lack of Efficacy|1|||
161065274|NCT05499130|581630497|FG001|Overall Study|Lack of Efficacy|0|||
161065275|NCT05499130|581630498|FG002|Overall Study|Lack of Efficacy|0|||
161065276|NCT05499130|581630499|FG003|Overall Study|Lack of Efficacy|0|||
161065277|NCT05499130|581630500|FG004|Overall Study|Lack of Efficacy|5|||
161065278|NCT05499130|581630501|FG005|Overall Study|Lack of Efficacy|0|||
161065279|NCT05499130|581630502|FG006|Overall Study|Lack of Efficacy|1|||
161065280|NCT05499130|581630503|FG007|Overall Study|Lack of Efficacy|0|||
161065281|NCT05499130|581630496|FG000|Overall Study|Withdrawal by Subject|2|||
161065282|NCT05499130|581630497|FG001|Overall Study|Withdrawal by Subject|0|||
161065283|NCT05499130|581630498|FG002|Overall Study|Withdrawal by Subject|0|||
161065284|NCT05499130|581630499|FG003|Overall Study|Withdrawal by Subject|0|||
161065285|NCT05499130|581630500|FG004|Overall Study|Withdrawal by Subject|1|||
161065286|NCT05499130|581630501|FG005|Overall Study|Withdrawal by Subject|2|||
161065287|NCT05499130|581630502|FG006|Overall Study|Withdrawal by Subject|0|||
161065288|NCT05499130|581630503|FG007|Overall Study|Withdrawal by Subject|0|||
161065289|NCT05499130|581630496|FG000|Overall Study|Lost to Follow-up|0|||
161065290|NCT05499130|581630497|FG001|Overall Study|Lost to Follow-up|0|||
161065291|NCT05499130|581630498|FG002|Overall Study|Lost to Follow-up|0|||
161065292|NCT05499130|581630499|FG003|Overall Study|Lost to Follow-up|0|||
161065293|NCT05499130|581630500|FG004|Overall Study|Lost to Follow-up|0|||
161065294|NCT05499130|581630501|FG005|Overall Study|Lost to Follow-up|2|||
161065295|NCT05499130|581630502|FG006|Overall Study|Lost to Follow-up|0|||
161065296|NCT05499130|581630503|FG007|Overall Study|Lost to Follow-up|0|||
161065297|NCT05499130|581630496|FG000|Overall Study|Other Than Specified|0|||
161065298|NCT05499130|581630497|FG001|Overall Study|Other Than Specified|0|||
161065299|NCT05499130|581630498|FG002|Overall Study|Other Than Specified|0|||
161065300|NCT05499130|581630499|FG003|Overall Study|Other Than Specified|0|||
161065301|NCT05499130|581630500|FG004|Overall Study|Other Than Specified|1|||
161065302|NCT05499130|581630501|FG005|Overall Study|Other Than Specified|1|||
161065303|NCT05499130|581630502|FG006|Overall Study|Other Than Specified|2|||
161065304|NCT05499130|581630503|FG007|Overall Study|Other Than Specified|0|||
161065305|NCT05499130|581630496|FG000|Overall Study|Protocol Violation|0|||
161065306|NCT05499130|581630497|FG001|Overall Study|Protocol Violation|0|||
161065307|NCT05499130|581630498|FG002|Overall Study|Protocol Violation|0|||
161065308|NCT05499130|581630499|FG003|Overall Study|Protocol Violation|0|||
161065309|NCT05499130|581630500|FG004|Overall Study|Protocol Violation|1|||
161065310|NCT05499130|581630501|FG005|Overall Study|Protocol Violation|0|||
161065311|NCT05499130|581630502|FG006|Overall Study|Protocol Violation|0|||
161065312|NCT05499130|581630503|FG007|Overall Study|Protocol Violation|0|||
161065313|NCT00781937|581630505|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
161065314|NCT00781937|581630506|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
161065315|NCT00781937|581630505|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
161065316|NCT00781937|581630506|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
161065317|NCT00781937|581630505|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
161065318|NCT00781937|581630506|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
161065319|NCT00781937|581630505|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
161065320|NCT00781937|581630506|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
161065321|NCT00781937|581630505|FG000|Main Trial Period Through Week 56|Unclassified|10|||
161065322|NCT00781937|581630506|FG001|Main Trial Period Through Week 56|Unclassified|15|||
161065323|NCT00781937|581630505|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
161065324|NCT00781937|581630506|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
161065325|NCT00781937|581630505|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
161065326|NCT00781937|581630506|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
161065327|NCT00013611|581630507|FG000|Overall Study|Lost to Follow-up|91|||
161065328|NCT00013611|581630508|FG001|Overall Study|Lost to Follow-up|100|||
161065329|NCT01150045|581630509|FG000|Overall Study|Protocol Violation|0|||
161065330|NCT01150045|581630510|FG001|Overall Study|Protocol Violation|1|||
161065331|NCT01150045|581630511|FG002|Overall Study|Protocol Violation|0|||
161065332|NCT01150045|581630512|FG003|Overall Study|Protocol Violation|1|||
161065333|NCT02330562|581630516|FG000|Overall Study|Adverse Event|0|||
161065334|NCT02330562|581630517|FG001|Overall Study|Adverse Event|0|||
161065335|NCT02330562|581630518|FG002|Overall Study|Adverse Event|3|||
161065336|NCT02330562|581630519|FG003|Overall Study|Adverse Event|0|||
161065337|NCT02330562|581630520|FG004|Overall Study|Adverse Event|3|||
161065338|NCT02330562|581630521|FG005|Overall Study|Adverse Event|1|||
161065339|NCT02330562|581630522|FG006|Overall Study|Adverse Event|0|||
161065340|NCT02330562|581630523|FG007|Overall Study|Adverse Event|0|||
161065341|NCT02330562|581630524|FG008|Overall Study|Adverse Event|0|||
161065342|NCT02330562|581630525|FG009|Overall Study|Adverse Event|1|||
161065343|NCT02330562|581630526|FG010|Overall Study|Adverse Event|1|||
161065344|NCT02330562|581630516|FG000|Overall Study|Participant decision|1|||
161065345|NCT02330562|581630517|FG001|Overall Study|Participant decision|0|||
161065346|NCT02330562|581630518|FG002|Overall Study|Participant decision|4|||
161065347|NCT02330562|581630519|FG003|Overall Study|Participant decision|1|||
161154427|NCT03470922|581947481|FG001|Overall Study|Lost to Follow-up|5|||
161154428|NCT03470922|581947480|FG000|Overall Study|Participant Withdrew Consent|4|||
161154429|NCT03470922|581947481|FG001|Overall Study|Participant Withdrew Consent|9|||
161154430|NCT03470922|581947480|FG000|Overall Study|Other reasons|1|||
161154431|NCT03470922|581947481|FG001|Overall Study|Other reasons|0|||
161154432|NCT03470922|581947480|FG000|Overall Study|Not reported|1|||
161154433|NCT03470922|581947481|FG001|Overall Study|Not reported|0|||
161065348|NCT02330562|581630520|FG004|Overall Study|Participant decision|5|||
161065349|NCT02330562|581630521|FG005|Overall Study|Participant decision|2|||
161065350|NCT02330562|581630522|FG006|Overall Study|Participant decision|0|||
161065351|NCT02330562|581630523|FG007|Overall Study|Participant decision|0|||
161065352|NCT02330562|581630524|FG008|Overall Study|Participant decision|0|||
161065353|NCT02330562|581630525|FG009|Overall Study|Participant decision|3|||
161282818|NCT00535405|582415053|FG000|Overall Study|Adverse Event|6|||
161282819|NCT00535405|582415054|FG001|Overall Study|Adverse Event|8|||
161282820|NCT00535405|582415055|FG002|Overall Study|Adverse Event|3|||
161282821|NCT00535405|582415056|FG003|Overall Study|Adverse Event|8|||
161282822|NCT00535405|582415057|FG004|Overall Study|Adverse Event|6|||
161282823|NCT00535405|582415053|FG000|Overall Study|Lost to Follow-up|1|||
161282824|NCT00535405|582415054|FG001|Overall Study|Lost to Follow-up|3|||
161345371|NCT01706328|582648940|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
161345372|NCT01706328|582648941|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161065354|NCT02330562|581630526|FG010|Overall Study|Participant decision|0|||
161065355|NCT02330562|581630516|FG000|Overall Study|Disease progression|5|||
161065356|NCT02330562|581630517|FG001|Overall Study|Disease progression|3|||
161065357|NCT02330562|581630518|FG002|Overall Study|Disease progression|20|||
161065358|NCT02330562|581630519|FG003|Overall Study|Disease progression|28|||
161065359|NCT02330562|581630520|FG004|Overall Study|Disease progression|23|||
161065360|NCT02330562|581630521|FG005|Overall Study|Disease progression|7|||
161065361|NCT02330562|581630522|FG006|Overall Study|Disease progression|1|||
161065362|NCT02330562|581630523|FG007|Overall Study|Disease progression|1|||
161065363|NCT02330562|581630524|FG008|Overall Study|Disease progression|1|||
161065364|NCT02330562|581630525|FG009|Overall Study|Disease progression|0|||
161065365|NCT02330562|581630526|FG010|Overall Study|Disease progression|5|||
161065366|NCT02330562|581630516|FG000|Overall Study|Other reasons|0|||
161065367|NCT02330562|581630517|FG001|Overall Study|Other reasons|0|||
161065368|NCT02330562|581630518|FG002|Overall Study|Other reasons|0|||
161065369|NCT02330562|581630519|FG003|Overall Study|Other reasons|1|||
161065370|NCT02330562|581630520|FG004|Overall Study|Other reasons|0|||
161065371|NCT02330562|581630521|FG005|Overall Study|Other reasons|0|||
161065372|NCT02330562|581630522|FG006|Overall Study|Other reasons|0|||
161065373|NCT02330562|581630523|FG007|Overall Study|Other reasons|0|||
161065374|NCT02330562|581630524|FG008|Overall Study|Other reasons|0|||
161065375|NCT02330562|581630525|FG009|Overall Study|Other reasons|0|||
161065376|NCT02330562|581630526|FG010|Overall Study|Other reasons|0|||
161065377|NCT02330562|581630516|FG000|Overall Study|Withdrawal by Subject|0|||
161065378|NCT02330562|581630517|FG001|Overall Study|Withdrawal by Subject|0|||
161065379|NCT02330562|581630518|FG002|Overall Study|Withdrawal by Subject|0|||
161065380|NCT02330562|581630519|FG003|Overall Study|Withdrawal by Subject|0|||
161065381|NCT02330562|581630520|FG004|Overall Study|Withdrawal by Subject|0|||
161065382|NCT02330562|581630521|FG005|Overall Study|Withdrawal by Subject|0|||
161065383|NCT02330562|581630522|FG006|Overall Study|Withdrawal by Subject|0|||
161065384|NCT02330562|581630523|FG007|Overall Study|Withdrawal by Subject|0|||
161065385|NCT02330562|581630524|FG008|Overall Study|Withdrawal by Subject|0|||
161065386|NCT02330562|581630525|FG009|Overall Study|Withdrawal by Subject|1|||
161065387|NCT02330562|581630526|FG010|Overall Study|Withdrawal by Subject|0|||
161065388|NCT00126659|581630530|FG000|Overall Study|Adverse Event|0|||
161065389|NCT00126659|581630531|FG001|Overall Study|Adverse Event|0|||
161065390|NCT00126659|581630532|FG002|Overall Study|Adverse Event|2|||
161065391|NCT00174447|581630533|FG000|Overall Study|Adverse Event|19|||
161065392|NCT00174447|581630533|FG000|Overall Study|Withdrawal by Subject|15|||
161065393|NCT00174447|581630533|FG000|Overall Study|Protocol Violation|1|||
161065394|NCT00174447|581630533|FG000|Overall Study|Lack of Efficacy|1|||
161065395|NCT00174447|581630533|FG000|Overall Study|Administrative reason/Other|2|||
161065396|NCT03491215|581630541|FG000|Overall Study|Death|6|||
161065397|NCT03491215|581630542|FG001|Overall Study|Death|2|||
161065398|NCT03491215|581630543|FG002|Overall Study|Death|1|||
161065399|NCT03491215|581630544|FG003|Overall Study|Death|0|||
161065400|NCT03491215|581630541|FG000|Overall Study|Physician Decision|1|||
161065401|NCT03491215|581630542|FG001|Overall Study|Physician Decision|0|||
161065402|NCT03491215|581630543|FG002|Overall Study|Physician Decision|0|||
161065403|NCT03491215|581630544|FG003|Overall Study|Physician Decision|0|||
161065404|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
161065405|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
161065406|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
161065407|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
161065408|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
161065409|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
161065410|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
161065411|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
161154434|NCT02340819|581947482|FG000|Overall Study|Adverse Event|1|||
161345373|NCT01706328|582648942|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161065412|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
161065413|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
161065414|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
161065415|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
161065416|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
161282825|NCT00535405|582415055|FG002|Overall Study|Lost to Follow-up|3|||
161282826|NCT00535405|582415056|FG003|Overall Study|Lost to Follow-up|2|||
161154435|NCT02340819|581947482|FG000|Overall Study|Withdrawal by Subject|2|||
161154436|NCT02340819|581947482|FG000|Overall Study|Discontinued with other reason|1|||
161154437|NCT02626819|581947483|FG000|Overall Study|Lost to Follow-up|3|||
161154438|NCT02626819|581947484|FG001|Overall Study|Lost to Follow-up|2|||
161154439|NCT02626819|581947483|FG000|Overall Study|Withdrawal by Subject|1|||
161154440|NCT02626819|581947484|FG001|Overall Study|Withdrawal by Subject|0|||
161154441|NCT02626819|581947483|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
161154442|NCT02626819|581947484|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
161154443|NCT02361762|581947485|FG000|Overall Study|Withdrawal by Subject|0|||
161154444|NCT02361762|581947486|FG001|Overall Study|Withdrawal by Subject|1|||
161154445|NCT02361762|581947485|FG000|Overall Study|Lost to Follow-up|0|||
161154446|NCT02361762|581947486|FG001|Overall Study|Lost to Follow-up|1|||
161154447|NCT00502307|581947487|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
161282827|NCT00535405|582415057|FG004|Overall Study|Lost to Follow-up|1|||
161282828|NCT00535405|582415053|FG000|Overall Study|Physician Decision|3|||
161282829|NCT00535405|582415054|FG001|Overall Study|Physician Decision|2|||
161282830|NCT00535405|582415055|FG002|Overall Study|Physician Decision|0|||
161282831|NCT00535405|582415056|FG003|Overall Study|Physician Decision|1|||
161282832|NCT00535405|582415057|FG004|Overall Study|Physician Decision|1|||
161154448|NCT00502307|581947488|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
161154449|NCT00502307|581947489|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
161154450|NCT00502307|581947487|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
161154451|NCT00502307|581947488|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
161154452|NCT00502307|581947489|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
161154453|NCT00502307|581947487|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
161154454|NCT00502307|581947488|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
161154455|NCT00502307|581947489|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
161154456|NCT00502307|581947487|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
161154457|NCT00502307|581947488|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
161154458|NCT00502307|581947489|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
161154459|NCT00502307|581947487|FG000|Maintenance Period|Progressive disease|80|||
161154460|NCT00502307|581947488|FG001|Maintenance Period|Progressive disease|0|||
161154461|NCT00502307|581947489|FG002|Maintenance Period|Progressive disease|0|||
161154462|NCT00502307|581947487|FG000|Maintenance Period|Discontinued due to other reasons|68|||
161154463|NCT00502307|581947488|FG001|Maintenance Period|Discontinued due to other reasons|0|||
161154464|NCT00502307|581947489|FG002|Maintenance Period|Discontinued due to other reasons|0|||
161154465|NCT00423085|581947490|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
161154466|NCT00423085|581947491|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
161154467|NCT00423085|581947492|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
161154468|NCT00423085|581947493|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
161154469|NCT00423085|581947490|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
161154470|NCT00423085|581947491|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
161154471|NCT00423085|581947492|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
161154472|NCT00423085|581947493|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161154473|NCT00423085|581947490|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
161154474|NCT00423085|581947491|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
161154475|NCT00423085|581947492|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
161154476|NCT00423085|581947493|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161154477|NCT00423085|581947490|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
161154478|NCT00423085|581947491|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
161154479|NCT00423085|581947492|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
161154480|NCT00423085|581947493|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
161154481|NCT00423085|581947490|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
161154482|NCT00423085|581947491|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
161154483|NCT00423085|581947492|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
161154484|NCT00423085|581947493|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
161154485|NCT00423085|581947490|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
161154486|NCT00423085|581947491|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161154487|NCT00423085|581947492|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161154488|NCT00423085|581947493|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
161154489|NCT00423085|581947490|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
161154490|NCT00423085|581947491|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
161154491|NCT00423085|581947492|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
161282833|NCT00535405|582415053|FG000|Overall Study|Protocol Violation|2|||
161282834|NCT00535405|582415054|FG001|Overall Study|Protocol Violation|2|||
161345374|NCT01706328|582648940|FG000|2-week Run-in Period|Physician Decision|4|||
161282835|NCT00535405|582415055|FG002|Overall Study|Protocol Violation|2|||
161282836|NCT00535405|582415056|FG003|Overall Study|Protocol Violation|1|||
161282837|NCT00535405|582415057|FG004|Overall Study|Protocol Violation|0|||
161154492|NCT00423085|581947493|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
161154493|NCT00423085|581947490|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161154494|NCT00423085|581947491|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161154495|NCT00423085|581947492|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
161154496|NCT00423085|581947493|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
161154497|NCT00423085|581947490|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161154498|NCT00423085|581947491|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161154499|NCT00423085|581947492|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
161154500|NCT00423085|581947493|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
161154501|NCT00423085|581947490|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161154502|NCT00423085|581947491|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161154503|NCT00423085|581947492|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
161154504|NCT00423085|581947493|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
161154505|NCT00423085|581947490|FG000|52-Week Open-Label Extension Phase|Death|0|||
161282838|NCT00535405|582415053|FG000|Overall Study|Withdrawal by Subject|5|||
161282839|NCT00535405|582415054|FG001|Overall Study|Withdrawal by Subject|11|||
161282840|NCT00535405|582415055|FG002|Overall Study|Withdrawal by Subject|10|||
161282841|NCT00535405|582415056|FG003|Overall Study|Withdrawal by Subject|10|||
161282842|NCT00535405|582415057|FG004|Overall Study|Withdrawal by Subject|8|||
161282843|NCT03910673|582415061|FG000|Overall Study|Adverse Event|0|||
161282844|NCT03910673|582415062|FG001|Overall Study|Adverse Event|0|||
161154506|NCT00423085|581947491|FG001|52-Week Open-Label Extension Phase|Death|0|||
161154507|NCT00423085|581947492|FG002|52-Week Open-Label Extension Phase|Death|0|||
161154508|NCT00423085|581947493|FG003|52-Week Open-Label Extension Phase|Death|2|||
161154509|NCT03331666|581947494|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
161154510|NCT03331666|581947495|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
161154511|NCT02326467|581947496|FG000|Overall Study|Withdrawal by Subject|1|||
161154512|NCT00434512|581947497|FG000|Overall Study|Migrated/moved from study area|0|||
161154513|NCT00434512|581947498|FG001|Overall Study|Migrated/moved from study area|0|||
161154514|NCT00434512|581947499|FG002|Overall Study|Migrated/moved from study area|0|||
161154515|NCT00434512|581947500|FG003|Overall Study|Migrated/moved from study area|1|||
161154516|NCT00434512|581947501|FG004|Overall Study|Migrated/moved from study area|1|||
161154517|NCT00434512|581947502|FG005|Overall Study|Migrated/moved from study area|1|||
161154518|NCT00434512|581947497|FG000|Overall Study|Other|0|||
161154519|NCT00434512|581947498|FG001|Overall Study|Other|1|||
161154520|NCT00434512|581947499|FG002|Overall Study|Other|0|||
161154521|NCT00434512|581947500|FG003|Overall Study|Other|0|||
161154522|NCT00434512|581947501|FG004|Overall Study|Other|0|||
161154523|NCT00434512|581947502|FG005|Overall Study|Other|0|||
161154524|NCT02750813|581947506|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
161154525|NCT02750813|581947507|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
161154526|NCT02750813|581947506|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
161154527|NCT02750813|581947507|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
161154528|NCT01998581|581947508|FG000|Overall Study|Refused repeat treatment|20|||
161154529|NCT01998581|581947509|FG001|Overall Study|Refused repeat treatment|4|||
161154530|NCT01998581|581947508|FG000|Overall Study|Protocol Violation|1|||
161154531|NCT01998581|581947509|FG001|Overall Study|Protocol Violation|0|||
161154532|NCT01998581|581947508|FG000|Overall Study|Withdrawal by Subject|8|||
161154533|NCT01998581|581947509|FG001|Overall Study|Withdrawal by Subject|1|||
161154534|NCT01998581|581947508|FG000|Overall Study|Lost to Follow-up|12|||
161154535|NCT01998581|581947509|FG001|Overall Study|Lost to Follow-up|4|||
161154536|NCT01998581|581947508|FG000|Overall Study|Adverse Event|1|||
161154537|NCT01998581|581947509|FG001|Overall Study|Adverse Event|1|||
161154538|NCT01998581|581947508|FG000|Overall Study|Other reasons|3|||
161154539|NCT01998581|581947509|FG001|Overall Study|Other reasons|2|||
161154540|NCT01998581|581947508|FG000|Overall Study|Randomized but withdrew before treatment|1|||
161154541|NCT01998581|581947509|FG001|Overall Study|Randomized but withdrew before treatment|0|||
161154542|NCT00441441|581947510|FG000|Overall Study|Adverse Event|2|||
161154543|NCT00441441|581947511|FG001|Overall Study|Adverse Event|1|||
161154544|NCT00441441|581947510|FG000|Overall Study|Protocol Violation|4|||
161154545|NCT00441441|581947511|FG001|Overall Study|Protocol Violation|6|||
161154546|NCT00441441|581947510|FG000|Overall Study|Exacerbation of asthma|1|||
161154547|NCT00441441|581947511|FG001|Overall Study|Exacerbation of asthma|2|||
161282845|NCT03910673|582415063|FG002|Overall Study|Adverse Event|0|||
161282846|NCT03910673|582415064|FG003|Overall Study|Adverse Event|2|||
161282847|NCT03910673|582415065|FG004|Overall Study|Adverse Event|0|||
161345375|NCT01706328|582648941|FG001|2-week Run-in Period|Physician Decision|0|||
161154548|NCT00441441|581947510|FG000|Overall Study|Withdrawal by Subject|1|||
161154549|NCT00441441|581947511|FG001|Overall Study|Withdrawal by Subject|2|||
161282848|NCT04650204|582415083|FG000|Overall Study|Study was Terminated|2|||
161282849|NCT04650204|582415084|FG001|Overall Study|Study was Terminated|1|||
161282850|NCT03164616|582415085|FG000|Overall Study|Death|250|||
161282851|NCT03164616|582415086|FG001|Overall Study|Death|264|||
161065417|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
161065418|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
161065419|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
161065420|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
161065421|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
161065422|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
161065423|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
161065424|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
161065425|NCT04599855|581630547|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
161065426|NCT04599855|581630548|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
161065427|NCT04599855|581630549|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
161065428|NCT04599855|581630547|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
161065429|NCT04599855|581630548|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
161065430|NCT04599855|581630549|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
161065431|NCT04599855|581630547|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
161065432|NCT04599855|581630548|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
161065433|NCT04599855|581630549|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
161065434|NCT04599855|581630547|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
161065435|NCT04599855|581630548|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
161065436|NCT04599855|581630549|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
161065437|NCT04599855|581630547|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
161065438|NCT04599855|581630548|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
161065439|NCT04599855|581630549|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
161065440|NCT04599855|581630547|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
161065441|NCT04599855|581630548|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
161065442|NCT04599855|581630549|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
161065443|NCT04599855|581630547|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
161065444|NCT04599855|581630548|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
161065445|NCT04599855|581630549|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
161065446|NCT04294667|581630550|FG000|Overall Study|Lack of Efficacy|4|||
161065447|NCT04294667|581630551|FG001|Overall Study|Lack of Efficacy|4|||
161065448|NCT04294667|581630550|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
161065449|NCT04294667|581630551|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
161065450|NCT04294667|581630550|FG000|Overall Study|Patient has a Renal Flare|1|||
161065451|NCT04294667|581630551|FG001|Overall Study|Patient has a Renal Flare|0|||
161065452|NCT04294667|581630550|FG000|Overall Study|SLE Worsening|0|||
161065453|NCT04294667|581630551|FG001|Overall Study|SLE Worsening|1|||
161065454|NCT04294667|581630550|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
161065455|NCT04294667|581630551|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
161065456|NCT04294667|581630550|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
161065457|NCT04294667|581630551|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
161065458|NCT04294667|581630550|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
161065459|NCT04294667|581630551|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
161065460|NCT04294667|581630550|FG000|Overall Study|Subject Moved to Another State|0|||
161065461|NCT04294667|581630551|FG001|Overall Study|Subject Moved to Another State|1|||
161065462|NCT04294667|581630550|FG000|Overall Study|Adverse event, serious fatal|0|||
161065463|NCT04294667|581630551|FG001|Overall Study|Adverse event, serious fatal|1|||
161065464|NCT04294667|581630550|FG000|Overall Study|Adverse event, non-fatal|3|||
161065465|NCT04294667|581630551|FG001|Overall Study|Adverse event, non-fatal|4|||
161065466|NCT00548847|581630552|FG000|Overall Study|Disease progression|7|||
161065467|NCT00727415|581630553|FG000|Phase I|Dose Limiting Toxicity|2|||
161065468|NCT01588366|581630556|FG000|Overall Study|Adverse Event|0|||
161065469|NCT01588366|581630557|FG001|Overall Study|Adverse Event|1|||
161065470|NCT01588366|581630558|FG002|Overall Study|Adverse Event|0|||
161065471|NCT01588366|581630559|FG003|Overall Study|Adverse Event|1|||
161065472|NCT01588366|581630560|FG004|Overall Study|Adverse Event|0|||
161065473|NCT01588366|581630561|FG005|Overall Study|Adverse Event|2|||
161065474|NCT00302159|581630562|FG000|Overall Study|pt declined before treatment started|1|||
161065475|NCT00302159|581630562|FG000|Overall Study|pt started Avastin|1|||
161065476|NCT04962698|581630565|FG000|Motor Imagery|Technical difficulty|1|||
161065477|NCT04962698|581630566|FG001|Motor Imagery|Technical difficulty|0|||
161065478|NCT04962698|581630565|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
161065479|NCT04962698|581630566|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
161065480|NCT04962698|581630565|FG000|Kinesthetic MI|Technical difficulty|1|||
161065481|NCT04962698|581630566|FG001|Kinesthetic MI|Technical difficulty|0|||
161065482|NCT04962698|581630565|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
161065483|NCT04962698|581630566|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
161065484|NCT04962698|581630565|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
161065485|NCT04962698|581630566|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
161154550|NCT00441441|581947510|FG000|Overall Study|Other|3|||
161154551|NCT00441441|581947511|FG001|Overall Study|Other|3|||
161154552|NCT05619172|581947515|FG000|Safety Cohort 1|Death|7|||
161154553|NCT05619172|581947516|FG001|Safety Cohort 1|Death|0|||
161154554|NCT05619172|581947515|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
161154555|NCT05619172|581947516|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
161154556|NCT05619172|581947515|FG000|Safety Cohort 2|Death|0|||
161154557|NCT05619172|581947516|FG001|Safety Cohort 2|Death|1|||
161154558|NCT05619172|581947515|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
161154559|NCT05619172|581947516|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
161154560|NCT04346628|581947519|FG000|Overall Study|Lost to Follow-up|4|||
161154561|NCT04346628|581947520|FG001|Overall Study|Lost to Follow-up|4|||
161154562|NCT04346628|581947519|FG000|Overall Study|Withdrew (had personal reasons)|2|||
161154563|NCT04346628|581947520|FG001|Overall Study|Withdrew (had personal reasons)|5|||
161154564|NCT04346628|581947519|FG000|Overall Study|Withdrew (medication intolerant)|0|||
161154565|NCT04346628|581947520|FG001|Overall Study|Withdrew (medication intolerant)|3|||
161154566|NCT04346628|581947519|FG000|Overall Study|Withdrew (declined intervention)|0|||
161154567|NCT04346628|581947520|FG001|Overall Study|Withdrew (declined intervention)|1|||
161154568|NCT01763905|581947521|FG000|Overall Study|Withdrawal by Subject|1|||
161154569|NCT01763905|581947522|FG001|Overall Study|Withdrawal by Subject|1|||
161154570|NCT01763905|581947523|FG002|Overall Study|Withdrawal by Subject|0|||
161154571|NCT01763905|581947524|FG003|Overall Study|Withdrawal by Subject|1|||
161154572|NCT01763905|581947521|FG000|Overall Study|Decision by sponsor|5|||
161154573|NCT01763905|581947522|FG001|Overall Study|Decision by sponsor|0|||
161154574|NCT01763905|581947523|FG002|Overall Study|Decision by sponsor|8|||
161154575|NCT01763905|581947524|FG003|Overall Study|Decision by sponsor|0|||
161154576|NCT01763905|581947521|FG000|Overall Study|Lost to Follow-up|0|||
161154577|NCT01763905|581947522|FG001|Overall Study|Lost to Follow-up|0|||
161154578|NCT01763905|581947523|FG002|Overall Study|Lost to Follow-up|1|||
161154579|NCT01763905|581947524|FG003|Overall Study|Lost to Follow-up|0|||
161154580|NCT03165721|581947532|FG000|Overall Study|Refused further treatment|3|||
161154581|NCT03165721|581947533|FG001|Overall Study|Refused further treatment|0|||
161154582|NCT03165721|581947534|FG002|Overall Study|Refused further treatment|0|||
161154583|NCT03165721|581947532|FG000|Overall Study|Physician Decision|1|||
161154584|NCT03165721|581947533|FG001|Overall Study|Physician Decision|0|||
161154585|NCT03165721|581947534|FG002|Overall Study|Physician Decision|0|||
161154586|NCT01457118|581947535|FG000|Overall Study|Adverse Event|1|||
161154587|NCT01457118|581947536|FG001|Overall Study|Adverse Event|0|||
161154588|NCT01457118|581947537|FG002|Overall Study|Adverse Event|0|||
161154589|NCT01457118|581947538|FG003|Overall Study|Adverse Event|1|||
161154590|NCT01457118|581947535|FG000|Overall Study|Clinical Progression|0|||
161154591|NCT01457118|581947536|FG001|Overall Study|Clinical Progression|1|||
161154592|NCT01457118|581947537|FG002|Overall Study|Clinical Progression|0|||
161154593|NCT01457118|581947538|FG003|Overall Study|Clinical Progression|1|||
161154594|NCT01457118|581947535|FG000|Overall Study|Physician Decision|2|||
161154595|NCT01457118|581947536|FG001|Overall Study|Physician Decision|0|||
161154596|NCT01457118|581947537|FG002|Overall Study|Physician Decision|0|||
161154597|NCT01457118|581947538|FG003|Overall Study|Physician Decision|0|||
161154598|NCT01457118|581947535|FG000|Overall Study|Progressive Disease by RECIST|12|||
161154599|NCT01457118|581947536|FG001|Overall Study|Progressive Disease by RECIST|3|||
161154600|NCT01457118|581947537|FG002|Overall Study|Progressive Disease by RECIST|1|||
161154601|NCT01457118|581947538|FG003|Overall Study|Progressive Disease by RECIST|0|||
161154602|NCT01457118|581947535|FG000|Overall Study|Withdrawal by Subject|5|||
161154603|NCT01457118|581947536|FG001|Overall Study|Withdrawal by Subject|0|||
161154604|NCT01457118|581947537|FG002|Overall Study|Withdrawal by Subject|0|||
161154605|NCT01457118|581947538|FG003|Overall Study|Withdrawal by Subject|0|||
161154606|NCT02324842|581947539|FG000|Overall Study|Lost to Follow-up|1|||
161154607|NCT02324842|581947540|FG001|Overall Study|Lost to Follow-up|1|||
161154608|NCT02324842|581947541|FG002|Overall Study|Lost to Follow-up|2|||
161154609|NCT03298412|581947544|FG000|Run-in Period|Other, Not Specified|1|||
161154610|NCT03298412|581947544|FG000|Run-in Period|Disease Progression|1|||
161154611|NCT03298412|581947544|FG000|Run-in Period|Ineligibility Determined|1|||
161345376|NCT01706328|582648942|FG002|2-week Run-in Period|Physician Decision|0|||
161154612|NCT03298412|581947544|FG000|Run-in Period|Decision by Sponsor|6|||
161154613|NCT01202227|581947547|FG000|Overall Study|Adverse Event|16|||
161154614|NCT01202227|581947547|FG000|Overall Study|Withdrawal by Subject|2|||
161154615|NCT01202227|581947547|FG000|Overall Study|Lack of Efficacy|1|||
161154616|NCT01894477|581947548|FG000|Overall Study|Protocol Violation|0|||
161154617|NCT01894477|581947549|FG001|Overall Study|Protocol Violation|1|||
161154618|NCT01894477|581947548|FG000|Overall Study|protocol changed due SC changed to cord|0|||
161154619|NCT01894477|581947549|FG001|Overall Study|protocol changed due SC changed to cord|1|||
161345377|NCT01706328|582648940|FG000|2-week Run-in Period|Adverse Event|4|||
161345378|NCT01706328|582648941|FG001|2-week Run-in Period|Adverse Event|0|||
161154620|NCT01727713|581947557|FG000|Overall Study|Lost to Follow-up|5|||
161154621|NCT01727713|581947557|FG000|Overall Study|Adverse Event|10|||
161345379|NCT01706328|582648942|FG002|2-week Run-in Period|Adverse Event|0|||
161154622|NCT01727713|581947557|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
161154623|NCT01727713|581947557|FG000|Overall Study|Withdrawal by Subject|13|||
161154624|NCT01727713|581947557|FG000|Overall Study|Protocol Deviation|2|||
161154625|NCT02389816|581947558|FG000|Overall Study|Randomized but Not Treated|1|||
161154626|NCT02389816|581947559|FG001|Overall Study|Randomized but Not Treated|0|||
161154627|NCT02389816|581947560|FG002|Overall Study|Randomized but Not Treated|0|||
161154628|NCT02389816|581947558|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
161154629|NCT02389816|581947559|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
161154630|NCT02389816|581947560|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
161154631|NCT02389816|581947558|FG000|Overall Study|Major Protocol Deviation|1|||
161154632|NCT02389816|581947559|FG001|Overall Study|Major Protocol Deviation|0|||
161154633|NCT02389816|581947560|FG002|Overall Study|Major Protocol Deviation|0|||
161154634|NCT02389816|581947558|FG000|Overall Study|Lost to Follow-up|1|||
161154635|NCT02389816|581947559|FG001|Overall Study|Lost to Follow-up|0|||
161154636|NCT02389816|581947560|FG002|Overall Study|Lost to Follow-up|0|||
161154637|NCT02389816|581947558|FG000|Overall Study|Withdrawal of Consent|6|||
161154638|NCT02389816|581947559|FG001|Overall Study|Withdrawal of Consent|4|||
161154639|NCT02389816|581947560|FG002|Overall Study|Withdrawal of Consent|4|||
161154640|NCT02389816|581947558|FG000|Overall Study|Lack of Efficacy|1|||
161154641|NCT02389816|581947559|FG001|Overall Study|Lack of Efficacy|0|||
161154642|NCT02389816|581947560|FG002|Overall Study|Lack of Efficacy|0|||
161154643|NCT02389816|581947558|FG000|Overall Study|Non Compliance with Study Drug|1|||
161154644|NCT02389816|581947559|FG001|Overall Study|Non Compliance with Study Drug|1|||
161154645|NCT02389816|581947560|FG002|Overall Study|Non Compliance with Study Drug|1|||
161154646|NCT02389816|581947558|FG000|Overall Study|Reason not Specified|0|||
161154647|NCT02389816|581947559|FG001|Overall Study|Reason not Specified|2|||
161154648|NCT02389816|581947560|FG002|Overall Study|Reason not Specified|0|||
161154649|NCT01842308|581947567|FG000|Overall Study|Withdrawal by Subject|0|||
161154650|NCT01842308|581947568|FG001|Overall Study|Withdrawal by Subject|0|||
161154651|NCT01842308|581947569|FG002|Overall Study|Withdrawal by Subject|0|||
161154652|NCT01842308|581947570|FG003|Overall Study|Withdrawal by Subject|0|||
161154653|NCT01842308|581947571|FG004|Overall Study|Withdrawal by Subject|1|||
161154654|NCT02868216|581947572|FG000|Overall Study|Death|0|||
161154655|NCT02868216|581947573|FG001|Overall Study|Death|1|||
161154656|NCT02868216|581947572|FG000|Overall Study|coronary artery bypass|1|||
161154657|NCT02868216|581947573|FG001|Overall Study|coronary artery bypass|0|||
161154658|NCT02868216|581947572|FG000|Overall Study|Withdrawal by Subject|7|||
161154659|NCT02868216|581947573|FG001|Overall Study|Withdrawal by Subject|5|||
161154660|NCT03161678|581947574|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161154661|NCT03161678|581947575|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161154662|NCT03161678|581947576|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161154663|NCT03161678|581947577|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
161154664|NCT03161678|581947578|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
161154665|NCT03161678|581947579|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
161154666|NCT03161678|581947574|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
161154667|NCT03161678|581947575|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
161154668|NCT03161678|581947576|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
161154669|NCT03161678|581947577|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
161154670|NCT03161678|581947578|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
161154671|NCT03161678|581947579|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
161154672|NCT03161678|581947574|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
161154673|NCT03161678|581947575|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
161154674|NCT03161678|581947576|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
161154675|NCT03161678|581947577|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
161154676|NCT03161678|581947578|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
161154677|NCT03161678|581947579|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
161154678|NCT03161678|581947574|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161154679|NCT03161678|581947575|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161154680|NCT03161678|581947576|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161154681|NCT03161678|581947577|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
161154682|NCT03161678|581947578|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161154683|NCT03161678|581947579|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
161154684|NCT00752609|581947580|FG000|Overall Study|Adverse Event|2|||
161154685|NCT00752609|581947581|FG001|Overall Study|Adverse Event|2|||
161154686|NCT00752609|581947580|FG000|Overall Study|Withdrawal by Subject|3|||
161154687|NCT00752609|581947581|FG001|Overall Study|Withdrawal by Subject|0|||
161282852|NCT03164616|582415087|FG002|Overall Study|Death|279|||
161154688|NCT00752609|581947580|FG000|Overall Study|Physician Decision|1|||
161154689|NCT00752609|581947581|FG001|Overall Study|Physician Decision|0|||
161154690|NCT00752609|581947580|FG000|Overall Study|Death|1|||
161154691|NCT00752609|581947581|FG001|Overall Study|Death|0|||
161154692|NCT00752609|581947580|FG000|Overall Study|Met exclusion criteria|1|||
161154693|NCT00752609|581947581|FG001|Overall Study|Met exclusion criteria|0|||
161154694|NCT00752609|581947580|FG000|Overall Study|Received Aranesp in error|1|||
161154695|NCT00752609|581947581|FG001|Overall Study|Received Aranesp in error|0|||
161154696|NCT00938327|581947582|FG000|Overall Study|Adverse Event|2|||
161154697|NCT00938327|581947582|FG000|Overall Study|Protocol Violation|1|||
161154698|NCT00938327|581947582|FG000|Overall Study|Withdrawal by Subject|4|||
161154699|NCT00938327|581947582|FG000|Overall Study|Lost to Follow-up|37|||
161154700|NCT00938327|581947582|FG000|Overall Study|2nd dose received outside of the study|7|||
161154701|NCT00938327|581947582|FG000|Overall Study|Vaccine not received as out of stock|9|||
161154702|NCT01425190|581947583|FG000|Overall Study|Full dose not consumed.|1|||
161154703|NCT01425190|581947584|FG001|Overall Study|Full dose not consumed.|0|||
161154704|NCT01425190|581947585|FG002|Overall Study|Full dose not consumed.|0|||
161154705|NCT02552355|581947587|FG000|Overall Study|Adverse Event|0|||
161154706|NCT02552355|581947588|FG001|Overall Study|Adverse Event|2|||
161154707|NCT02552355|581947589|FG002|Overall Study|Adverse Event|2|||
161154708|NCT02552355|581947590|FG003|Overall Study|Adverse Event|0|||
161154709|NCT02552355|581947587|FG000|Overall Study|Withdrawal by Subject|0|||
161154710|NCT02552355|581947588|FG001|Overall Study|Withdrawal by Subject|0|||
161154711|NCT02552355|581947589|FG002|Overall Study|Withdrawal by Subject|0|||
161154712|NCT02552355|581947590|FG003|Overall Study|Withdrawal by Subject|1|||
161154713|NCT00850460|581947593|FG000|Overall Study|Lost to Follow-up|4|||
161154714|NCT00850460|581947594|FG001|Overall Study|Lost to Follow-up|4|||
161154715|NCT00001262|581947600|FG000|Overall Study|Death|10|||
161154716|NCT00001262|581947601|FG001|Overall Study|Death|11|||
161154717|NCT00001262|581947602|FG002|Overall Study|Death|0|||
161154718|NCT00001262|581947600|FG000|Overall Study|Withdrawal by Subject|0|||
161154719|NCT00001262|581947601|FG001|Overall Study|Withdrawal by Subject|3|||
161154720|NCT00001262|581947602|FG002|Overall Study|Withdrawal by Subject|0|||
161154721|NCT00783705|581947604|FG000|Overall Study|Adverse Event|2|||
161154722|NCT00783705|581947605|FG001|Overall Study|Adverse Event|0|||
161154723|NCT00783705|581947604|FG000|Overall Study|Withdrawal by Subject|3|||
161154724|NCT00783705|581947605|FG001|Overall Study|Withdrawal by Subject|2|||
161154725|NCT00783705|581947604|FG000|Overall Study|Lost to Follow-up|1|||
161154726|NCT00783705|581947605|FG001|Overall Study|Lost to Follow-up|3|||
161154727|NCT00748540|581947606|FG000|Overall Study|Physician Decision|1|||
161154728|NCT04743635|581947607|FG000|Overall Study|Lost to Follow-up|2|||
161154729|NCT04743635|581947608|FG001|Overall Study|Lost to Follow-up|0|||
161154730|NCT01402284|581947609|FG000|Overall Study|Withdrawal consent|2|||
161154731|NCT01402284|581947609|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
161154732|NCT01402284|581947609|FG000|Overall Study|Physician Decision|1|||
161154733|NCT01402284|581947609|FG000|Overall Study|Disease progression on study|10|||
161154734|NCT05281523|581947611|FG000|Overall Study|Adverse Event|1|||
161154735|NCT05281523|581947612|FG001|Overall Study|Adverse Event|1|||
161154736|NCT05281523|581947611|FG000|Overall Study|Physician Decision|1|||
161154737|NCT05281523|581947612|FG001|Overall Study|Physician Decision|1|||
161154738|NCT05281523|581947611|FG000|Overall Study|Withdrawal by Subject|5|||
161154739|NCT05281523|581947612|FG001|Overall Study|Withdrawal by Subject|15|||
161154740|NCT05281523|581947611|FG000|Overall Study|GCP violations|3|||
161154741|NCT05281523|581947612|FG001|Overall Study|GCP violations|4|||
161154742|NCT04491877|581948954|FG000|Overall Study|Protocol Deviation|1|||
161154743|NCT04491877|581948955|FG001|Overall Study|Protocol Deviation|0|||
161154744|NCT04491877|581948956|FG002|Overall Study|Protocol Deviation|2|||
161154745|NCT04491877|581948957|FG003|Overall Study|Protocol Deviation|0|||
161154746|NCT04491877|581948958|FG004|Overall Study|Protocol Deviation|0|||
161154747|NCT04491877|581948959|FG005|Overall Study|Protocol Deviation|0|||
161154748|NCT04491877|581948960|FG006|Overall Study|Protocol Deviation|1|||
161154749|NCT04491877|581948961|FG007|Overall Study|Protocol Deviation|1|||
161154750|NCT04491877|581948962|FG008|Overall Study|Protocol Deviation|0|||
161154751|NCT04491877|581948954|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161154752|NCT04491877|581948955|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161154753|NCT04491877|581948956|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161154754|NCT04491877|581948957|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
161154755|NCT04491877|581948958|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161154756|NCT04491877|581948959|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
161282853|NCT03164616|582415085|FG000|Overall Study|Lost to Follow-up|2|||
161282854|NCT03164616|582415086|FG001|Overall Study|Lost to Follow-up|2|||
161282855|NCT03164616|582415087|FG002|Overall Study|Lost to Follow-up|2|||
161154757|NCT04491877|581948960|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
161154758|NCT04491877|581948961|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
161154759|NCT04491877|581948962|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
161154760|NCT04491877|581948954|FG000|Overall Study|Lost to Follow-up|0|||
161154761|NCT04491877|581948955|FG001|Overall Study|Lost to Follow-up|2|||
161154762|NCT04491877|581948956|FG002|Overall Study|Lost to Follow-up|0|||
161154763|NCT04491877|581948957|FG003|Overall Study|Lost to Follow-up|0|||
161154764|NCT04491877|581948958|FG004|Overall Study|Lost to Follow-up|0|||
161154765|NCT04491877|581948959|FG005|Overall Study|Lost to Follow-up|0|||
161154766|NCT04491877|581948960|FG006|Overall Study|Lost to Follow-up|2|||
161154767|NCT04491877|581948961|FG007|Overall Study|Lost to Follow-up|1|||
161154768|NCT04491877|581948962|FG008|Overall Study|Lost to Follow-up|1|||
161154769|NCT02429258|581948966|FG000|Overall Study|Withdrawal by Subject|2|||
161154770|NCT02429258|581948967|FG001|Overall Study|Withdrawal by Subject|0|||
161282856|NCT03164616|582415085|FG000|Overall Study|Withdrawal by Subject|6|||
161154771|NCT02429258|581948966|FG000|Overall Study|Protocol Violation|0|||
161154772|NCT02429258|581948967|FG001|Overall Study|Protocol Violation|1|||
161154773|NCT03364335|581948968|FG000|Overall Study|Adverse Event|3|||
161154774|NCT03364335|581948969|FG001|Overall Study|Adverse Event|4|||
161154775|NCT03364335|581948970|FG002|Overall Study|Adverse Event|1|||
161154776|NCT03364335|581948971|FG003|Overall Study|Adverse Event|2|||
161154777|NCT03364335|581948972|FG004|Overall Study|Adverse Event|0|||
161154778|NCT03364335|581948968|FG000|Overall Study|Lost to Follow-up|7|||
161154779|NCT03364335|581948969|FG001|Overall Study|Lost to Follow-up|7|||
161154780|NCT03364335|581948970|FG002|Overall Study|Lost to Follow-up|10|||
161154781|NCT03364335|581948971|FG003|Overall Study|Lost to Follow-up|11|||
161154782|NCT03364335|581948972|FG004|Overall Study|Lost to Follow-up|11|||
161154783|NCT00492856|581948973|FG000|Induction|Adverse Event|2|||
161154784|NCT00492856|581948974|FG001|Induction|Adverse Event|0|||
161154785|NCT00492856|581948975|FG002|Induction|Adverse Event|0|||
161154786|NCT00492856|581948976|FG003|Induction|Adverse Event|0|||
161154787|NCT00492856|581948973|FG000|Induction|Withdrawal by Subject|1|||
161154788|NCT00492856|581948974|FG001|Induction|Withdrawal by Subject|0|||
161154789|NCT00492856|581948975|FG002|Induction|Withdrawal by Subject|0|||
161154790|NCT00492856|581948976|FG003|Induction|Withdrawal by Subject|0|||
161154791|NCT00492856|581948973|FG000|Induction|Death|3|||
161154792|NCT00492856|581948974|FG001|Induction|Death|0|||
161154793|NCT00492856|581948975|FG002|Induction|Death|0|||
161154794|NCT00492856|581948976|FG003|Induction|Death|0|||
161154795|NCT00492856|581948973|FG000|Consolidation|Adverse Event|6|||
161154796|NCT00492856|581948974|FG001|Consolidation|Adverse Event|0|||
161154797|NCT00492856|581948975|FG002|Consolidation|Adverse Event|0|||
161154798|NCT00492856|581948976|FG003|Consolidation|Adverse Event|0|||
161154799|NCT00492856|581948973|FG000|Consolidation|Not protocol specified|2|||
161154800|NCT00492856|581948974|FG001|Consolidation|Not protocol specified|0|||
161154801|NCT00492856|581948975|FG002|Consolidation|Not protocol specified|0|||
161154802|NCT00492856|581948976|FG003|Consolidation|Not protocol specified|0|||
161154803|NCT00492856|581948973|FG000|Consolidation|Lost to Follow-up|1|||
161154804|NCT00492856|581948974|FG001|Consolidation|Lost to Follow-up|0|||
161154805|NCT00492856|581948975|FG002|Consolidation|Lost to Follow-up|0|||
161154806|NCT00492856|581948976|FG003|Consolidation|Lost to Follow-up|0|||
161154807|NCT00492856|581948973|FG000|Post-consolidation|Adverse Event|0|||
161154808|NCT00492856|581948974|FG001|Post-consolidation|Adverse Event|4|||
161154809|NCT00492856|581948975|FG002|Post-consolidation|Adverse Event|0|||
161154810|NCT00492856|581948976|FG003|Post-consolidation|Adverse Event|1|||
161154811|NCT00492856|581948973|FG000|Post-consolidation|Withdrawal by Subject|0|||
161154812|NCT00492856|581948974|FG001|Post-consolidation|Withdrawal by Subject|4|||
161154813|NCT00492856|581948975|FG002|Post-consolidation|Withdrawal by Subject|0|||
161154814|NCT00492856|581948976|FG003|Post-consolidation|Withdrawal by Subject|0|||
161154815|NCT00492856|581948973|FG000|Post-consolidation|Death|0|||
161154816|NCT00492856|581948974|FG001|Post-consolidation|Death|1|||
161154817|NCT00492856|581948975|FG002|Post-consolidation|Death|0|||
161154818|NCT00492856|581948976|FG003|Post-consolidation|Death|0|||
161154819|NCT00492856|581948973|FG000|Post-consolidation|Not protocol specified|0|||
161154820|NCT00492856|581948974|FG001|Post-consolidation|Not protocol specified|1|||
161154821|NCT00492856|581948975|FG002|Post-consolidation|Not protocol specified|0|||
161154822|NCT00492856|581948976|FG003|Post-consolidation|Not protocol specified|0|||
161154823|NCT00492856|581948973|FG000|Post-consolidation|Lost to Follow-up|0|||
161154824|NCT00492856|581948974|FG001|Post-consolidation|Lost to Follow-up|2|||
161154825|NCT00492856|581948975|FG002|Post-consolidation|Lost to Follow-up|0|||
161154826|NCT00492856|581948976|FG003|Post-consolidation|Lost to Follow-up|0|||
161154827|NCT00492856|581948973|FG000|Post-consolidation|Observation Arm|0|||
161154828|NCT00492856|581948974|FG001|Post-consolidation|Observation Arm|0|||
161154829|NCT00492856|581948975|FG002|Post-consolidation|Observation Arm|27|||
161154830|NCT00492856|581948976|FG003|Post-consolidation|Observation Arm|0|||
161154831|NCT03987919|581948977|FG000|Overall Study|Adverse Event|1|||
161154832|NCT03987919|581948978|FG001|Overall Study|Adverse Event|4|||
161154833|NCT03987919|581948979|FG002|Overall Study|Adverse Event|1|||
161154834|NCT03987919|581948980|FG003|Overall Study|Adverse Event|3|||
161154835|NCT03987919|581948977|FG000|Overall Study|Death|4|||
161154836|NCT03987919|581948978|FG001|Overall Study|Death|4|||
161154837|NCT03987919|581948979|FG002|Overall Study|Death|4|||
161154838|NCT03987919|581948980|FG003|Overall Study|Death|1|||
161154839|NCT03987919|581948977|FG000|Overall Study|Lost to Follow-up|5|||
161154840|NCT03987919|581948978|FG001|Overall Study|Lost to Follow-up|6|||
161154841|NCT03987919|581948979|FG002|Overall Study|Lost to Follow-up|8|||
161154842|NCT03987919|581948980|FG003|Overall Study|Lost to Follow-up|12|||
161154843|NCT03987919|581948977|FG000|Overall Study|Physician Decision|0|||
161154844|NCT03987919|581948978|FG001|Overall Study|Physician Decision|2|||
161154845|NCT03987919|581948979|FG002|Overall Study|Physician Decision|0|||
161154846|NCT03987919|581948980|FG003|Overall Study|Physician Decision|4|||
161154847|NCT03987919|581948977|FG000|Overall Study|Pregnancy|1|||
161154848|NCT03987919|581948978|FG001|Overall Study|Pregnancy|0|||
161154849|NCT03987919|581948979|FG002|Overall Study|Pregnancy|1|||
161154850|NCT03987919|581948980|FG003|Overall Study|Pregnancy|1|||
161154851|NCT03987919|581948977|FG000|Overall Study|Protocol Violation|0|||
161154852|NCT03987919|581948978|FG001|Overall Study|Protocol Violation|1|||
161282857|NCT03164616|582415086|FG001|Overall Study|Withdrawal by Subject|7|||
161282858|NCT03164616|582415087|FG002|Overall Study|Withdrawal by Subject|16|||
161282859|NCT01911273|582415090|FG000|Overall Study|Progression of Disease|1|||
161065486|NCT04962698|581630565|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
161065487|NCT04962698|581630566|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
161065488|NCT04962698|581630565|FG000|Virtual-hand Interaction|Technical difficulty|1|||
161065489|NCT04962698|581630566|FG001|Virtual-hand Interaction|Technical difficulty|0|||
161065490|NCT04962698|581630565|FG000|Robotic Action Observation|Technical difficulty|1|||
161065491|NCT04962698|581630566|FG001|Robotic Action Observation|Technical difficulty|0|||
161065492|NCT04962698|581630565|FG000|Rest|Technical difficulty|1|||
161065493|NCT04962698|581630566|FG001|Rest|Technical difficulty|0|||
161065494|NCT04962698|581630565|FG000|Rest|Exclusion criteria met after enrollment|0|||
161065495|NCT04962698|581630566|FG001|Rest|Exclusion criteria met after enrollment|2|||
161065496|NCT00853229|581630567|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
161065497|NCT00853229|581630568|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
161065498|NCT02312206|581630575|FG000|Overall Study|Adverse Event|3|||
161065499|NCT02312206|581630576|FG001|Overall Study|Adverse Event|6|||
161065500|NCT02312206|581630575|FG000|Overall Study|Withdrawal by Subject|6|||
161065501|NCT02312206|581630576|FG001|Overall Study|Withdrawal by Subject|6|||
161065502|NCT02312206|581630575|FG000|Overall Study|Physician Decision|7|||
161065503|NCT02312206|581630576|FG001|Overall Study|Physician Decision|6|||
161065504|NCT02312206|581630575|FG000|Overall Study|Death|31|||
161065505|NCT02312206|581630576|FG001|Overall Study|Death|36|||
161065506|NCT02312206|581630575|FG000|Overall Study|Study Terminated by Sponsor|81|||
161065507|NCT02312206|581630576|FG001|Overall Study|Study Terminated by Sponsor|74|||
161065508|NCT02312206|581630575|FG000|Overall Study|Patient transferred to hospice|0|||
161065509|NCT02312206|581630576|FG001|Overall Study|Patient transferred to hospice|1|||
161065510|NCT02312206|581630575|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
161065511|NCT02312206|581630576|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
161065512|NCT02312206|581630575|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
161065513|NCT02312206|581630576|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
161065514|NCT02312206|581630575|FG000|Overall Study|Disease Progression|1|||
161065515|NCT02312206|581630576|FG001|Overall Study|Disease Progression|0|||
161065516|NCT00585975|581630577|FG000|Overall Study|Withdrawal by Subject|3|||
161065517|NCT00585975|581630578|FG001|Overall Study|Withdrawal by Subject|3|||
161065518|NCT00585975|581630577|FG000|Overall Study|Lost to Follow-up|2|||
161065519|NCT00585975|581630578|FG001|Overall Study|Lost to Follow-up|1|||
161065520|NCT00585975|581630577|FG000|Overall Study|Enrollment met/over-enrolled|10|||
161065521|NCT00585975|581630578|FG001|Overall Study|Enrollment met/over-enrolled|9|||
161065522|NCT03082612|581630581|FG000|Overall Study|Lost to Follow-up|2|||
161065523|NCT03082612|581630582|FG001|Overall Study|Lost to Follow-up|0|||
161065524|NCT01006616|581630583|FG000|Period 1 (6 Months)|Adverse Event|10|||
161065525|NCT01006616|581630584|FG001|Period 1 (6 Months)|Adverse Event|31|||
161065526|NCT01006616|581630585|FG002|Period 1 (6 Months)|Adverse Event|37|||
161065527|NCT01006616|581630586|FG003|Period 1 (6 Months)|Adverse Event|9|||
161065528|NCT01006616|581630583|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
161065529|NCT01006616|581630584|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
161065530|NCT01006616|581630585|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
161065531|NCT01006616|581630586|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
161065532|NCT01006616|581630583|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
161065533|NCT01006616|581630584|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
161065534|NCT01006616|581630585|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
161065535|NCT01006616|581630586|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
161065536|NCT01006616|581630583|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
161065537|NCT01006616|581630584|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
161065538|NCT01006616|581630585|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
161065539|NCT01006616|581630586|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
161065540|NCT01006616|581630583|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
161065541|NCT01006616|581630584|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
161065542|NCT01006616|581630585|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
161065543|NCT01006616|581630586|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
161065544|NCT01006616|581630583|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
161065545|NCT01006616|581630584|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
161065546|NCT01006616|581630585|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
161065547|NCT01006616|581630586|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
161065548|NCT01006616|581630583|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
161065549|NCT01006616|581630584|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
161065550|NCT01006616|581630585|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
161065551|NCT01006616|581630586|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
161065552|NCT01006616|581630583|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
161065553|NCT01006616|581630584|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
161282860|NCT01911273|582415091|FG001|Overall Study|Progression of Disease|0|||
161154853|NCT03987919|581948979|FG002|Overall Study|Protocol Violation|0|||
161154854|NCT03987919|581948980|FG003|Overall Study|Protocol Violation|0|||
161154855|NCT03987919|581948977|FG000|Overall Study|Site terminated by Sponsor|0|||
161154856|NCT03987919|581948978|FG001|Overall Study|Site terminated by Sponsor|0|||
161154857|NCT03987919|581948979|FG002|Overall Study|Site terminated by Sponsor|0|||
161154858|NCT03987919|581948980|FG003|Overall Study|Site terminated by Sponsor|1|||
161154859|NCT03987919|581948977|FG000|Overall Study|Withdrawal by Subject|7|||
161154860|NCT03987919|581948978|FG001|Overall Study|Withdrawal by Subject|7|||
161154861|NCT03987919|581948979|FG002|Overall Study|Withdrawal by Subject|8|||
161154862|NCT03987919|581948980|FG003|Overall Study|Withdrawal by Subject|4|||
161154863|NCT03987919|581948977|FG000|Overall Study|Other - as reported by the investigator|1|||
161154864|NCT03987919|581948978|FG001|Overall Study|Other - as reported by the investigator|3|||
161154865|NCT03987919|581948979|FG002|Overall Study|Other - as reported by the investigator|2|||
161154866|NCT03987919|581948980|FG003|Overall Study|Other - as reported by the investigator|0|||
161154867|NCT03725202|581948983|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
161154868|NCT03725202|581948984|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
161154869|NCT03725202|581948985|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
161154870|NCT03725202|581948986|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161154871|NCT03725202|581948987|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161154872|NCT03725202|581948988|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161154873|NCT03725202|581948989|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161154874|NCT03725202|581948990|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
161154875|NCT03725202|581948983|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
161154876|NCT03725202|581948984|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
161154877|NCT03725202|581948985|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
161154878|NCT03725202|581948986|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161154879|NCT03725202|581948987|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161154880|NCT03725202|581948988|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161154881|NCT03725202|581948989|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161154882|NCT03725202|581948990|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
161154883|NCT03725202|581948983|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
161154884|NCT03725202|581948984|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154885|NCT03725202|581948985|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154886|NCT03725202|581948986|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154887|NCT03725202|581948987|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154888|NCT03725202|581948988|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154889|NCT03725202|581948989|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154890|NCT03725202|581948990|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
161154891|NCT03725202|581948983|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
161154892|NCT03725202|581948984|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154893|NCT03725202|581948985|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154894|NCT03725202|581948986|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154895|NCT03725202|581948987|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154896|NCT03725202|581948988|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154897|NCT03725202|581948989|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154898|NCT03725202|581948990|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
161154899|NCT03725202|581948983|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161154900|NCT03725202|581948984|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161154901|NCT03725202|581948985|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
161154902|NCT03725202|581948986|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161154903|NCT03725202|581948987|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161154904|NCT03725202|581948988|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161154905|NCT03725202|581948989|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161154906|NCT03725202|581948990|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
161154907|NCT03725202|581948983|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154908|NCT03725202|581948984|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154909|NCT03725202|581948985|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
161154910|NCT03725202|581948986|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154911|NCT03725202|581948987|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154912|NCT03725202|581948988|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154913|NCT03725202|581948989|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154914|NCT03725202|581948990|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
161154915|NCT03725202|581948983|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161345380|NCT01706328|582648940|FG000|2-week Run-in Period|Lost to Follow-up|2|||
161345381|NCT01706328|582648941|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161345382|NCT01706328|582648942|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161154916|NCT03725202|581948984|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161154917|NCT03725202|581948985|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
161154918|NCT03725202|581948986|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
161154919|NCT03725202|581948987|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
161154920|NCT03725202|581948988|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
161154921|NCT03725202|581948989|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
161154922|NCT03725202|581948990|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
161154923|NCT03725202|581948983|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161154924|NCT03725202|581948984|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161154925|NCT03725202|581948985|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
161154926|NCT03725202|581948986|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
161154927|NCT03725202|581948987|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
161154928|NCT03725202|581948988|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
161154929|NCT03725202|581948989|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
161154930|NCT03725202|581948990|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
161154931|NCT03725202|581948983|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161154932|NCT03725202|581948984|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161154933|NCT03725202|581948985|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161154934|NCT03725202|581948986|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
161154935|NCT03725202|581948987|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161154936|NCT03725202|581948988|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
161154937|NCT03725202|581948989|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
161154938|NCT03725202|581948990|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
161154939|NCT03725202|581948983|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154940|NCT03725202|581948984|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154941|NCT03725202|581948985|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154942|NCT03725202|581948986|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154943|NCT03725202|581948987|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154944|NCT03725202|581948988|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154945|NCT03725202|581948989|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
161154946|NCT03725202|581948990|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
161154947|NCT03725202|581948983|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161282861|NCT01911273|582415090|FG000|Overall Study|Withdrawal by Subject|0|||
161282862|NCT01911273|582415091|FG001|Overall Study|Withdrawal by Subject|2|||
161282863|NCT02503787|582415096|FG000|Enrollment|Withdrawal by Subject|6|||
161282864|NCT02503787|582415096|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
161282865|NCT02503787|582415096|FG000|Enrollment|Physician Decision|2|||
161282866|NCT02503787|582415096|FG000|Enrollment|Insurance issue|2|||
161282867|NCT02503787|582415096|FG000|Enrollment|Lost to Follow-up|1|||
161282868|NCT02503787|582415096|FG000|Enrollment|Study closure|1|||
161282869|NCT02503787|582415096|FG000|Enrollment|Adverse Event|1|||
161282870|NCT02503787|582415096|FG000|Enrollment|Protocol Violation|1|||
161282871|NCT02503787|582415096|FG000|Enrollment|Inability to implant system|1|||
161282872|NCT02503787|582415096|FG000|Enrollment|Unable to be programmed|1|||
161282873|NCT02503787|582415096|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
161282874|NCT02503787|582415096|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
161282875|NCT02503787|582415096|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
161282876|NCT02503787|582415096|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
161282877|NCT02503787|582415096|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
161282878|NCT02503787|582415096|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
161282879|NCT04787627|582415097|FG000|Overall Study|Withdrawal by Subject|3|||
161282880|NCT04787627|582415098|FG001|Overall Study|Withdrawal by Subject|0|||
161282881|NCT04787627|582415097|FG000|Overall Study|Physician Decision|2|||
161282882|NCT04787627|582415098|FG001|Overall Study|Physician Decision|0|||
161282883|NCT04787627|582415097|FG000|Overall Study|Excluded|0|||
161282884|NCT04787627|582415098|FG001|Overall Study|Excluded|1|||
161282885|NCT00548093|582415099|FG000|Overall Study|Death|33|||
161282886|NCT00548093|582415100|FG001|Overall Study|Death|13|||
161282887|NCT00548093|582415099|FG000|Overall Study|Lost to Follow-up|3|||
161282888|NCT00548093|582415100|FG001|Overall Study|Lost to Follow-up|1|||
161282889|NCT00548093|582415099|FG000|Overall Study|Objective progression or relapse|1|||
161282890|NCT00548093|582415100|FG001|Overall Study|Objective progression or relapse|1|||
161282891|NCT00548093|582415099|FG000|Overall Study|Other|11|||
161282892|NCT00548093|582415100|FG001|Overall Study|Other|1|||
161282893|NCT00548093|582415099|FG000|Overall Study|Withdrawal by Subject|1|||
161282894|NCT00548093|582415100|FG001|Overall Study|Withdrawal by Subject|0|||
161282895|NCT00548093|582415099|FG000|Overall Study|Completed post-treatment follow-up|1|||
161154948|NCT03725202|581948984|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161282896|NCT00548093|582415100|FG001|Overall Study|Completed post-treatment follow-up|0|||
161282897|NCT00174954|582415103|FG000|Overall Study|Adverse Event|2|||
161282898|NCT00174954|582415103|FG000|Overall Study|No tophi found in MRI|1|||
161282899|NCT00174954|582415103|FG000|Overall Study|Physician Decision|1|||
161282900|NCT00839254|582415104|FG000|Overall Study|Protocol Violation|0|||
161154949|NCT03725202|581948985|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161154950|NCT03725202|581948986|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161154951|NCT03725202|581948987|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161154952|NCT03725202|581948988|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
161154953|NCT03725202|581948989|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161154954|NCT03725202|581948990|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
161154955|NCT03725202|581948983|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161154956|NCT03725202|581948984|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161154957|NCT03725202|581948985|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161154958|NCT03725202|581948986|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
161154959|NCT03725202|581948987|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161154960|NCT03725202|581948988|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
161154961|NCT03725202|581948989|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
161154962|NCT03725202|581948990|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
161154963|NCT01520324|581948991|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
161154964|NCT01328249|581948994|FG000|Overall Study|Adverse Event|3|||
161154965|NCT01328249|581948995|FG001|Overall Study|Adverse Event|0|||
161154966|NCT01328249|581948994|FG000|Overall Study|Disease progression|1|||
161154967|NCT01328249|581948995|FG001|Overall Study|Disease progression|0|||
161154968|NCT01328249|581948994|FG000|Overall Study|Withdrawal by Subject|1|||
161154969|NCT01328249|581948995|FG001|Overall Study|Withdrawal by Subject|1|||
161154970|NCT01328249|581948994|FG000|Overall Study|Moved before end of treatment visit|1|||
161154971|NCT01328249|581948995|FG001|Overall Study|Moved before end of treatment visit|0|||
161154972|NCT01328249|581948994|FG000|Overall Study|Subject choice|1|||
161154973|NCT01328249|581948995|FG001|Overall Study|Subject choice|1|||
161154974|NCT01328249|581948994|FG000|Overall Study|Protocol Violation|0|||
161154975|NCT01328249|581948995|FG001|Overall Study|Protocol Violation|1|||
161154976|NCT00748553|581948996|FG000|Overall Study|Adverse Event|0|||
161154977|NCT00748553|581948997|FG001|Overall Study|Adverse Event|1|||
161154978|NCT00748553|581948996|FG000|Overall Study|disease progression|2|||
161154979|NCT00748553|581948997|FG001|Overall Study|disease progression|0|||
161154980|NCT00748553|581948996|FG000|Overall Study|noncompliance|1|||
161154981|NCT00748553|581948997|FG001|Overall Study|noncompliance|0|||
161154982|NCT00495495|581949000|FG000|Overall Study|Protocol Violation|99|||
161154983|NCT02245568|581949001|FG000|Overall Study|Study terminated by Sponsor|346|||
161154984|NCT02245568|581949001|FG000|Overall Study|Adverse Event|144|||
161154985|NCT02245568|581949001|FG000|Overall Study|Lack of Efficacy|98|||
161154986|NCT02245568|581949001|FG000|Overall Study|Withdrawal by Caregiver|85|||
161154987|NCT02245568|581949001|FG000|Overall Study|Withdrawal by Subject|77|||
161154988|NCT02245568|581949001|FG000|Overall Study|Withdrawal by Legal Representative|31|||
161154989|NCT02245568|581949001|FG000|Overall Study|Missing (Site closure)|16|||
161154990|NCT02245568|581949001|FG000|Overall Study|Physician Decision|14|||
161154991|NCT02245568|581949001|FG000|Overall Study|Non-compliance with study drug|11|||
161154992|NCT02245568|581949001|FG000|Overall Study|Death|9|||
161154993|NCT02245568|581949001|FG000|Overall Study|Blue staining|6|||
161154994|NCT02245568|581949001|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
161154995|NCT02245568|581949001|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
161154996|NCT02245568|581949001|FG000|Overall Study|Lost to Follow-up|5|||
161154997|NCT01533935|581949009|FG000|Overall Study|Adverse Event|5|||
161154998|NCT01533935|581949010|FG001|Overall Study|Adverse Event|7|||
161154999|NCT01533935|581949011|FG002|Overall Study|Adverse Event|1|||
161155000|NCT01533935|581949012|FG003|Overall Study|Adverse Event|5|||
161155001|NCT01533935|581949013|FG004|Overall Study|Adverse Event|3|||
161155002|NCT01533935|581949009|FG000|Overall Study|Protocol Violation|0|||
161155003|NCT01533935|581949010|FG001|Overall Study|Protocol Violation|2|||
161155004|NCT01533935|581949011|FG002|Overall Study|Protocol Violation|0|||
161155005|NCT01533935|581949012|FG003|Overall Study|Protocol Violation|0|||
161282901|NCT00839254|582415105|FG001|Overall Study|Protocol Violation|1|||
161282902|NCT00839254|582415106|FG002|Overall Study|Protocol Violation|1|||
161155006|NCT01533935|581949013|FG004|Overall Study|Protocol Violation|0|||
161155007|NCT01533935|581949009|FG000|Overall Study|Lost to Follow-up|0|||
161155008|NCT01533935|581949010|FG001|Overall Study|Lost to Follow-up|0|||
161155009|NCT01533935|581949011|FG002|Overall Study|Lost to Follow-up|1|||
161282903|NCT00839254|582415107|FG003|Overall Study|Protocol Violation|1|||
161282904|NCT00839254|582415108|FG004|Overall Study|Protocol Violation|0|||
161155010|NCT01533935|581949012|FG003|Overall Study|Lost to Follow-up|0|||
161155011|NCT01533935|581949013|FG004|Overall Study|Lost to Follow-up|0|||
161155012|NCT01533935|581949009|FG000|Overall Study|Withdrawal by Subject|0|||
161155013|NCT01533935|581949010|FG001|Overall Study|Withdrawal by Subject|4|||
161155014|NCT01533935|581949011|FG002|Overall Study|Withdrawal by Subject|5|||
161282905|NCT00839254|582415109|FG005|Overall Study|Protocol Violation|0|||
161155015|NCT01533935|581949012|FG003|Overall Study|Withdrawal by Subject|2|||
161155016|NCT01533935|581949013|FG004|Overall Study|Withdrawal by Subject|4|||
161282906|NCT00839254|582415110|FG006|Overall Study|Protocol Violation|1|||
161282907|NCT00839254|582415111|FG007|Overall Study|Protocol Violation|2|||
161155017|NCT01533935|581949009|FG000|Overall Study|Other reason not defined above|1|||
161155018|NCT01533935|581949010|FG001|Overall Study|Other reason not defined above|0|||
161155019|NCT01533935|581949011|FG002|Overall Study|Other reason not defined above|1|||
161155020|NCT01533935|581949012|FG003|Overall Study|Other reason not defined above|0|||
161155021|NCT01533935|581949013|FG004|Overall Study|Other reason not defined above|1|||
161155022|NCT01554956|581949014|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
161155023|NCT01554956|581949015|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
161155024|NCT01554956|581949016|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
161155025|NCT01554956|581949014|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
161155026|NCT01554956|581949015|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
161155027|NCT01554956|581949016|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
161155028|NCT01554956|581949014|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
161155029|NCT01554956|581949015|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
161155030|NCT01554956|581949016|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
161155031|NCT00069095|581949017|FG000|Primary Treatment Phase|Ongoing|0|||
161155032|NCT00069095|581949018|FG001|Primary Treatment Phase|Ongoing|0|||
161155033|NCT00069095|581949019|FG002|Primary Treatment Phase|Ongoing|5|||
161155034|NCT00069095|581949020|FG003|Primary Treatment Phase|Ongoing|7|||
161155035|NCT00069095|581949021|FG004|Primary Treatment Phase|Ongoing|7|||
161155036|NCT00069095|581949022|FG005|Primary Treatment Phase|Ongoing|4|||
161155037|NCT00069095|581949017|FG000|Primary Treatment Phase|Admin/Other|29|||
161155038|NCT00069095|581949018|FG001|Primary Treatment Phase|Admin/Other|38|||
161155039|NCT00069095|581949019|FG002|Primary Treatment Phase|Admin/Other|31|||
161155040|NCT00069095|581949020|FG003|Primary Treatment Phase|Admin/Other|45|||
161155041|NCT00069095|581949021|FG004|Primary Treatment Phase|Admin/Other|48|||
161155042|NCT00069095|581949022|FG005|Primary Treatment Phase|Admin/Other|42|||
161155043|NCT00069095|581949017|FG000|Primary Treatment Phase|Adverse Event|99|||
161155044|NCT00069095|581949018|FG001|Primary Treatment Phase|Adverse Event|92|||
161155045|NCT00069095|581949019|FG002|Primary Treatment Phase|Adverse Event|71|||
161155046|NCT00069095|581949020|FG003|Primary Treatment Phase|Adverse Event|72|||
161155047|NCT00069095|581949021|FG004|Primary Treatment Phase|Adverse Event|109|||
161155048|NCT00069095|581949022|FG005|Primary Treatment Phase|Adverse Event|101|||
161155049|NCT00069095|581949017|FG000|Primary Treatment Phase|Death|14|||
161155050|NCT00069095|581949018|FG001|Primary Treatment Phase|Death|8|||
161155051|NCT00069095|581949019|FG002|Primary Treatment Phase|Death|2|||
161155052|NCT00069095|581949020|FG003|Primary Treatment Phase|Death|5|||
161155053|NCT00069095|581949021|FG004|Primary Treatment Phase|Death|8|||
161155054|NCT00069095|581949022|FG005|Primary Treatment Phase|Death|8|||
161155055|NCT00069095|581949017|FG000|Primary Treatment Phase|Failure to return|5|||
161155056|NCT00069095|581949018|FG001|Primary Treatment Phase|Failure to return|5|||
161155057|NCT00069095|581949019|FG002|Primary Treatment Phase|Failure to return|0|||
161155058|NCT00069095|581949020|FG003|Primary Treatment Phase|Failure to return|0|||
161155059|NCT00069095|581949021|FG004|Primary Treatment Phase|Failure to return|0|||
161155060|NCT00069095|581949022|FG005|Primary Treatment Phase|Failure to return|2|||
161155061|NCT00069095|581949017|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
161155062|NCT00069095|581949018|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
161155063|NCT00069095|581949019|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
161155064|NCT00069095|581949020|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
161155065|NCT00069095|581949021|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
161155066|NCT00069095|581949022|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
161155067|NCT00069095|581949017|FG000|Primary Treatment Phase|Refused treatment|15|||
161155068|NCT00069095|581949018|FG001|Primary Treatment Phase|Refused treatment|26|||
161155069|NCT00069095|581949019|FG002|Primary Treatment Phase|Refused treatment|17|||
161155070|NCT00069095|581949020|FG003|Primary Treatment Phase|Refused treatment|31|||
161155071|NCT00069095|581949021|FG004|Primary Treatment Phase|Refused treatment|24|||
161155072|NCT00069095|581949022|FG005|Primary Treatment Phase|Refused treatment|27|||
161155073|NCT00069095|581949017|FG000|Primary Treatment Phase|Withdrew|2|||
161155074|NCT00069095|581949018|FG001|Primary Treatment Phase|Withdrew|3|||
161155075|NCT00069095|581949019|FG002|Primary Treatment Phase|Withdrew|8|||
161155076|NCT00069095|581949020|FG003|Primary Treatment Phase|Withdrew|2|||
161155077|NCT00069095|581949021|FG004|Primary Treatment Phase|Withdrew|4|||
161155078|NCT00069095|581949022|FG005|Primary Treatment Phase|Withdrew|9|||
161155079|NCT00069095|581949017|FG000|Primary Treatment Phase|Other Violation|0|||
161155080|NCT00069095|581949018|FG001|Primary Treatment Phase|Other Violation|1|||
161155081|NCT00069095|581949019|FG002|Primary Treatment Phase|Other Violation|1|||
161155082|NCT00069095|581949020|FG003|Primary Treatment Phase|Other Violation|1|||
161155083|NCT00069095|581949021|FG004|Primary Treatment Phase|Other Violation|0|||
161155084|NCT00069095|581949022|FG005|Primary Treatment Phase|Other Violation|1|||
161155085|NCT00069095|581949017|FG000|Primary Treatment Phase|Violation criteria|0|||
161155086|NCT00069095|581949018|FG001|Primary Treatment Phase|Violation criteria|2|||
161155087|NCT00069095|581949019|FG002|Primary Treatment Phase|Violation criteria|4|||
161155088|NCT00069095|581949020|FG003|Primary Treatment Phase|Violation criteria|3|||
161155089|NCT00069095|581949021|FG004|Primary Treatment Phase|Violation criteria|1|||
161155090|NCT00069095|581949022|FG005|Primary Treatment Phase|Violation criteria|5|||
161155091|NCT00069095|581949017|FG000|Post-study Treatment Phase|Missing reason|1|||
161155092|NCT00069095|581949018|FG001|Post-study Treatment Phase|Missing reason|3|||
161155093|NCT00069095|581949019|FG002|Post-study Treatment Phase|Missing reason|12|||
161155094|NCT00069095|581949020|FG003|Post-study Treatment Phase|Missing reason|8|||
161155095|NCT00069095|581949021|FG004|Post-study Treatment Phase|Missing reason|18|||
161155096|NCT00069095|581949022|FG005|Post-study Treatment Phase|Missing reason|17|||
161155097|NCT00069095|581949017|FG000|Post-study Treatment Phase|Adverse Event|2|||
161155098|NCT00069095|581949018|FG001|Post-study Treatment Phase|Adverse Event|3|||
161155099|NCT00069095|581949019|FG002|Post-study Treatment Phase|Adverse Event|1|||
161155100|NCT00069095|581949020|FG003|Post-study Treatment Phase|Adverse Event|0|||
161155101|NCT00069095|581949021|FG004|Post-study Treatment Phase|Adverse Event|5|||
161155102|NCT00069095|581949022|FG005|Post-study Treatment Phase|Adverse Event|1|||
161155103|NCT00069095|581949017|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
161155104|NCT00069095|581949018|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
161155105|NCT00069095|581949019|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
161155106|NCT00069095|581949020|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
161155107|NCT00069095|581949021|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
161155108|NCT00069095|581949022|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
161155109|NCT00069095|581949017|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
161155110|NCT00069095|581949018|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
161155111|NCT00069095|581949019|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
161155112|NCT00069095|581949020|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
161155113|NCT00069095|581949021|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
161155114|NCT00069095|581949022|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
161155115|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
161155116|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161155117|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161155118|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161155119|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
161155120|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
161155121|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant had complete response|1|||
161155122|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant had complete response|1|||
161155123|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant had complete response|0|||
161155124|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant had complete response|0|||
161155125|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant had complete response|0|||
161155126|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant had complete response|0|||
161155127|NCT00069095|581949017|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161155128|NCT00069095|581949018|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
161155129|NCT00069095|581949019|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161155130|NCT00069095|581949020|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161155131|NCT00069095|581949021|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161155132|NCT00069095|581949022|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
161155133|NCT00069095|581949017|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161155134|NCT00069095|581949018|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161155135|NCT00069095|581949019|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161155136|NCT00069095|581949020|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161155137|NCT00069095|581949021|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
161155138|NCT00069095|581949022|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
161155139|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
161155140|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
161155141|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
161155142|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
161155143|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
161155144|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
161155145|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
161155146|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
161155147|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
161155148|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
161155149|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
161155150|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
161282908|NCT00839254|582415104|FG000|Overall Study|Physician Decision|0|||
161282909|NCT00839254|582415105|FG001|Overall Study|Physician Decision|1|||
161282910|NCT00839254|582415106|FG002|Overall Study|Physician Decision|0|||
161282911|NCT00839254|582415107|FG003|Overall Study|Physician Decision|0|||
161282912|NCT00839254|582415108|FG004|Overall Study|Physician Decision|0|||
161282913|NCT00839254|582415109|FG005|Overall Study|Physician Decision|0|||
161282914|NCT00839254|582415110|FG006|Overall Study|Physician Decision|0|||
161282915|NCT00839254|582415111|FG007|Overall Study|Physician Decision|1|||
161282916|NCT00839254|582415104|FG000|Overall Study|Wrong treatment number allocation|0|||
161282917|NCT00839254|582415105|FG001|Overall Study|Wrong treatment number allocation|1|||
161282918|NCT00839254|582415106|FG002|Overall Study|Wrong treatment number allocation|0|||
161282919|NCT00839254|582415107|FG003|Overall Study|Wrong treatment number allocation|0|||
161282920|NCT00839254|582415108|FG004|Overall Study|Wrong treatment number allocation|0|||
161282921|NCT00839254|582415109|FG005|Overall Study|Wrong treatment number allocation|1|||
161282922|NCT00839254|582415110|FG006|Overall Study|Wrong treatment number allocation|0|||
161282923|NCT00839254|582415111|FG007|Overall Study|Wrong treatment number allocation|0|||
161065554|NCT01006616|581630585|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
161065555|NCT01006616|581630586|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
161155151|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161155152|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161155153|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161155154|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
161155155|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161155156|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
161155157|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
161155158|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
161155159|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
161155160|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
161155161|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
161155162|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
161155163|NCT00069095|581949017|FG000|Post-study Treatment Phase|Surgery|0|||
161155164|NCT00069095|581949018|FG001|Post-study Treatment Phase|Surgery|0|||
161282924|NCT00839254|582415104|FG000|Overall Study|Adverse Event|12|||
161065556|NCT01006616|581630583|FG000|Period 1 (6 Months)|Not Treated|0|||
161065557|NCT01006616|581630584|FG001|Period 1 (6 Months)|Not Treated|0|||
161065558|NCT01006616|581630585|FG002|Period 1 (6 Months)|Not Treated|1|||
161065559|NCT01006616|581630586|FG003|Period 1 (6 Months)|Not Treated|1|||
161065560|NCT01006616|581630583|FG000|Period 2 (18 Months)|Adverse Event|6|||
161065561|NCT01006616|581630584|FG001|Period 2 (18 Months)|Adverse Event|6|||
161065562|NCT01006616|581630585|FG002|Period 2 (18 Months)|Adverse Event|6|||
161065563|NCT01006616|581630586|FG003|Period 2 (18 Months)|Adverse Event|4|||
161065564|NCT01006616|581630583|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
161065565|NCT01006616|581630584|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
161065566|NCT01006616|581630585|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
161065567|NCT01006616|581630586|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
161065568|NCT01006616|581630583|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
161065569|NCT01006616|581630584|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
161065570|NCT01006616|581630585|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
161065571|NCT01006616|581630586|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
161065572|NCT01006616|581630583|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
161065573|NCT01006616|581630584|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
161065574|NCT01006616|581630585|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
161065575|NCT01006616|581630586|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
161065576|NCT01006616|581630583|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
161065577|NCT01006616|581630584|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
161065578|NCT01006616|581630585|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
161065579|NCT01006616|581630586|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
161065580|NCT01006616|581630583|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
161065581|NCT01006616|581630584|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
161065582|NCT01006616|581630585|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
161065583|NCT01006616|581630586|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
161065584|NCT01006616|581630583|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
161065585|NCT01006616|581630584|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
161065586|NCT01006616|581630585|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
161065587|NCT01006616|581630586|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
161065588|NCT01006616|581630583|FG000|Period 2 (18 Months)|Study Terminated|63|||
161065589|NCT01006616|581630584|FG001|Period 2 (18 Months)|Study Terminated|46|||
161065590|NCT01006616|581630585|FG002|Period 2 (18 Months)|Study Terminated|44|||
161155165|NCT00069095|581949019|FG002|Post-study Treatment Phase|Surgery|0|||
161155166|NCT00069095|581949020|FG003|Post-study Treatment Phase|Surgery|1|||
161155167|NCT00069095|581949021|FG004|Post-study Treatment Phase|Surgery|1|||
161282925|NCT00839254|582415105|FG001|Overall Study|Adverse Event|6|||
161282926|NCT00839254|582415106|FG002|Overall Study|Adverse Event|3|||
161282927|NCT00839254|582415107|FG003|Overall Study|Adverse Event|5|||
161155168|NCT00069095|581949022|FG005|Post-study Treatment Phase|Surgery|0|||
161155169|NCT00069095|581949017|FG000|Post-study Treatment Phase|Death|0|||
161155170|NCT00069095|581949018|FG001|Post-study Treatment Phase|Death|0|||
161155171|NCT00069095|581949019|FG002|Post-study Treatment Phase|Death|0|||
161155172|NCT00069095|581949020|FG003|Post-study Treatment Phase|Death|0|||
161155173|NCT00069095|581949021|FG004|Post-study Treatment Phase|Death|1|||
161155174|NCT00069095|581949022|FG005|Post-study Treatment Phase|Death|0|||
161155175|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
161155176|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
161155177|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
161155178|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
161155179|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
161155180|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
161155181|NCT00069095|581949017|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161282928|NCT00839254|582415108|FG004|Overall Study|Adverse Event|2|||
161282929|NCT00839254|582415109|FG005|Overall Study|Adverse Event|1|||
161282930|NCT00839254|582415110|FG006|Overall Study|Adverse Event|0|||
161282931|NCT00839254|582415111|FG007|Overall Study|Adverse Event|1|||
161282932|NCT00839254|582415104|FG000|Overall Study|Withdrawal by Subject|87|||
161282933|NCT00839254|582415105|FG001|Overall Study|Withdrawal by Subject|53|||
161282934|NCT00839254|582415106|FG002|Overall Study|Withdrawal by Subject|54|||
161282935|NCT00839254|582415107|FG003|Overall Study|Withdrawal by Subject|32|||
161282936|NCT00839254|582415108|FG004|Overall Study|Withdrawal by Subject|27|||
161282937|NCT00839254|582415109|FG005|Overall Study|Withdrawal by Subject|15|||
161282938|NCT00839254|582415110|FG006|Overall Study|Withdrawal by Subject|22|||
161282939|NCT00839254|582415111|FG007|Overall Study|Withdrawal by Subject|9|||
161282940|NCT00839254|582415104|FG000|Overall Study|Wrong group allocation|0|||
161282941|NCT00839254|582415105|FG001|Overall Study|Wrong group allocation|0|||
161282942|NCT00839254|582415106|FG002|Overall Study|Wrong group allocation|0|||
161282943|NCT00839254|582415107|FG003|Overall Study|Wrong group allocation|0|||
161282944|NCT00839254|582415108|FG004|Overall Study|Wrong group allocation|0|||
161282945|NCT00839254|582415109|FG005|Overall Study|Wrong group allocation|0|||
161282946|NCT00839254|582415110|FG006|Overall Study|Wrong group allocation|1|||
161282947|NCT00839254|582415111|FG007|Overall Study|Wrong group allocation|0|||
161282948|NCT00839254|582415104|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
161282949|NCT00839254|582415105|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
161282950|NCT00839254|582415106|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
161282951|NCT00839254|582415107|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
161282952|NCT00839254|582415108|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
161282953|NCT00839254|582415109|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
161282954|NCT00839254|582415110|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
161282955|NCT00839254|582415111|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
161155182|NCT00069095|581949018|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161155183|NCT00069095|581949019|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161282956|NCT00839254|582415104|FG000|Overall Study|Withdrawn due to non-compliance|2|||
161282957|NCT00839254|582415105|FG001|Overall Study|Withdrawn due to non-compliance|0|||
161065591|NCT01006616|581630586|FG003|Period 2 (18 Months)|Study Terminated|70|||
161065592|NCT03414047|581630587|FG000|Overall Study|Adverse Event|0|||
161065593|NCT03414047|581630588|FG001|Overall Study|Adverse Event|0|||
161065594|NCT03414047|581630589|FG002|Overall Study|Adverse Event|1|||
161065595|NCT03414047|581630590|FG003|Overall Study|Adverse Event|1|||
161065596|NCT03414047|581630587|FG000|Overall Study|Physician Decision|1|||
161065597|NCT03414047|581630588|FG001|Overall Study|Physician Decision|0|||
161065598|NCT03414047|581630589|FG002|Overall Study|Physician Decision|0|||
161065599|NCT03414047|581630590|FG003|Overall Study|Physician Decision|1|||
161065600|NCT03414047|581630587|FG000|Overall Study|Withdrawal by Subject|1|||
161065601|NCT03414047|581630588|FG001|Overall Study|Withdrawal by Subject|0|||
161065602|NCT03414047|581630589|FG002|Overall Study|Withdrawal by Subject|2|||
161065603|NCT03414047|581630590|FG003|Overall Study|Withdrawal by Subject|0|||
161065604|NCT03269695|581630594|FG000|Overall Study|Adverse Event|2|||
161065605|NCT03269695|581630595|FG001|Overall Study|Adverse Event|1|||
161065606|NCT03269695|581630594|FG000|Overall Study|Lack of Efficacy|0|||
161065607|NCT03269695|581630595|FG001|Overall Study|Lack of Efficacy|1|||
161065608|NCT03269695|581630594|FG000|Overall Study|Withdrawal by Subject|0|||
161155184|NCT00069095|581949020|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161282958|NCT00839254|582415106|FG002|Overall Study|Withdrawn due to non-compliance|0|||
161065609|NCT03269695|581630595|FG001|Overall Study|Withdrawal by Subject|1|||
161065610|NCT01017263|581630596|FG000|Overall Study|not eligible|12|||
161282959|NCT00839254|582415107|FG003|Overall Study|Withdrawn due to non-compliance|0|||
161282960|NCT00839254|582415108|FG004|Overall Study|Withdrawn due to non-compliance|0|||
161282961|NCT00839254|582415109|FG005|Overall Study|Withdrawn due to non-compliance|0|||
161282962|NCT00839254|582415110|FG006|Overall Study|Withdrawn due to non-compliance|0|||
161282963|NCT00839254|582415111|FG007|Overall Study|Withdrawn due to non-compliance|0|||
161282964|NCT00839254|582415104|FG000|Overall Study|Lost to Follow-up|51|||
161282965|NCT00839254|582415105|FG001|Overall Study|Lost to Follow-up|30|||
161282966|NCT00839254|582415106|FG002|Overall Study|Lost to Follow-up|32|||
161282967|NCT00839254|582415107|FG003|Overall Study|Lost to Follow-up|24|||
161282968|NCT00839254|582415108|FG004|Overall Study|Lost to Follow-up|8|||
161282969|NCT00839254|582415109|FG005|Overall Study|Lost to Follow-up|8|||
161282970|NCT00839254|582415110|FG006|Overall Study|Lost to Follow-up|4|||
161282971|NCT00839254|582415111|FG007|Overall Study|Lost to Follow-up|2|||
161282972|NCT02359994|582415113|FG000|Overall Population Study|Adverse Event|1|||
161282973|NCT02359994|582415114|FG001|Overall Population Study|Adverse Event|1|||
161282974|NCT02359994|582415113|FG000|Overall Population Study|Death|1|||
161065611|NCT00239681|581630597|FG000|Overall Study|Adverse Event|100|||
161065612|NCT00239681|581630598|FG001|Overall Study|Adverse Event|99|||
161065613|NCT00239681|581630597|FG000|Overall Study|Withdrawal by Subject|458|||
161065614|NCT00239681|581630598|FG001|Overall Study|Withdrawal by Subject|489|||
161065615|NCT00239681|581630597|FG000|Overall Study|Lost to Follow-up|28|||
161065616|NCT00239681|581630598|FG001|Overall Study|Lost to Follow-up|22|||
161065617|NCT00239681|581630597|FG000|Overall Study|Protocol Violation|4|||
161065618|NCT00239681|581630598|FG001|Overall Study|Protocol Violation|4|||
161065619|NCT00239681|581630597|FG000|Overall Study|Physician Decision|13|||
161065620|NCT00239681|581630598|FG001|Overall Study|Physician Decision|17|||
161065621|NCT00239681|581630597|FG000|Overall Study|No information chacked on CaseReportForm|90|||
161065622|NCT00239681|581630598|FG001|Overall Study|No information chacked on CaseReportForm|84|||
161345383|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
161065623|NCT00905359|581630601|FG000|Overall Study|Lost to Follow-up|17|||
161065624|NCT00905359|581630602|FG001|Overall Study|Lost to Follow-up|10|||
161065625|NCT00905359|581630601|FG000|Overall Study|Death|2|||
161065626|NCT00905359|581630602|FG001|Overall Study|Death|0|||
161065627|NCT00905359|581630601|FG000|Overall Study|Withdrawal consent|5|||
161065628|NCT00905359|581630602|FG001|Overall Study|Withdrawal consent|6|||
161065629|NCT02654132|581630603|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
161065630|NCT02654132|581630604|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
161065631|NCT02654132|581630603|FG000|Treatment Period|Disease progression|43|||
161065632|NCT02654132|581630604|FG001|Treatment Period|Disease progression|38|||
161065633|NCT02654132|581630603|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
161065634|NCT02654132|581630604|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
161065635|NCT02654132|581630603|FG000|Treatment Period|Other reasons|4|||
161065636|NCT02654132|581630604|FG001|Treatment Period|Other reasons|2|||
161065637|NCT02654132|581630603|FG000|Treatment Period|Study drug toxicity|2|||
161065638|NCT02654132|581630604|FG001|Treatment Period|Study drug toxicity|2|||
161065639|NCT02654132|581630603|FG000|Treatment Period|Withdrawal by Subject|2|||
161065640|NCT02654132|581630604|FG001|Treatment Period|Withdrawal by Subject|1|||
161065641|NCT02654132|581630603|FG000|Treatment Period|Maximum Clinical Benefit|0|||
161065642|NCT02654132|581630604|FG001|Treatment Period|Maximum Clinical Benefit|2|||
161065643|NCT02654132|581630603|FG000|Treatment Period|Participant request to discontinue|2|||
161065644|NCT02654132|581630604|FG001|Treatment Period|Participant request to discontinue|0|||
161065645|NCT02654132|581630603|FG000|Treatment Period|Administrative reasons by sponsor|0|||
161065646|NCT02654132|581630604|FG001|Treatment Period|Administrative reasons by sponsor|1|||
161065647|NCT02654132|581630603|FG000|Treatment Period|Death|1|||
161065648|NCT02654132|581630604|FG001|Treatment Period|Death|0|||
161065649|NCT02485899|581630605|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
161065650|NCT02485899|581630606|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161065651|NCT02485899|581630605|FG000|Overall Study|Withdrawal by Subject|1|||
161065652|NCT02485899|581630606|FG001|Overall Study|Withdrawal by Subject|0|||
161065653|NCT02485899|581630605|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
161065654|NCT02485899|581630606|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
161065655|NCT00623363|581630607|FG000|Overall Study|Adverse Event|2|||
161065656|NCT00623363|581630608|FG001|Overall Study|Adverse Event|2|||
161345384|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
161345385|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
161345386|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
161065657|NCT03713320|581630609|FG000|Randomized Period|Adverse Event|1|||
161065658|NCT03713320|581630610|FG001|Randomized Period|Adverse Event|5|||
161065659|NCT03713320|581630611|FG002|Randomized Period|Adverse Event|0|||
161065660|NCT03713320|581630609|FG000|Randomized Period|Physician Decision|1|||
161345387|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
161065661|NCT03713320|581630610|FG001|Randomized Period|Physician Decision|1|||
161065662|NCT03713320|581630611|FG002|Randomized Period|Physician Decision|0|||
161065663|NCT03713320|581630609|FG000|Randomized Period|Withdrawal by Subject|4|||
161282975|NCT02359994|582415114|FG001|Overall Population Study|Death|5|||
161345388|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
161345389|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
161065664|NCT03713320|581630610|FG001|Randomized Period|Withdrawal by Subject|0|||
161282976|NCT02359994|582415113|FG000|Overall Population Study|Lost to Follow-up|1|||
161282977|NCT02359994|582415114|FG001|Overall Population Study|Lost to Follow-up|1|||
161065665|NCT03713320|581630611|FG002|Randomized Period|Withdrawal by Subject|0|||
161065666|NCT03713320|581630609|FG000|Randomized Period|Participant decision|3|||
161282978|NCT02359994|582415113|FG000|Overall Population Study|Withdrawal by Subject|1|||
161282979|NCT02359994|582415114|FG001|Overall Population Study|Withdrawal by Subject|0|||
161282980|NCT02359994|582415113|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
161282981|NCT02359994|582415114|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
161282982|NCT02359994|582415113|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
161282983|NCT02359994|582415114|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
161282984|NCT02359994|582415113|FG000|Extended Oncology 24-Month Survival|Death|19|||
161282985|NCT02359994|582415114|FG001|Extended Oncology 24-Month Survival|Death|21|||
161282986|NCT02359994|582415113|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
161282987|NCT02359994|582415114|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
161282988|NCT04597632|582415115|FG000|Overall Study|Withdrawal by Subject|10|||
161282989|NCT04597632|582415115|FG000|Overall Study|Lost to Follow-up|1|||
161282990|NCT04597632|582415115|FG000|Overall Study|Death|1|||
161282991|NCT04597632|582415115|FG000|Overall Study|Adverse Event|5|||
161282992|NCT01823835|582415116|FG000|Overall Study|Adverse Event|0|||
161282993|NCT01823835|582415117|FG001|Overall Study|Adverse Event|0|||
161282994|NCT01823835|582415118|FG002|Overall Study|Adverse Event|0|||
161282995|NCT01823835|582415119|FG003|Overall Study|Adverse Event|0|||
161282996|NCT01823835|582415120|FG004|Overall Study|Adverse Event|1|||
161282997|NCT01823835|582415121|FG005|Overall Study|Adverse Event|0|||
161282998|NCT01823835|582415122|FG006|Overall Study|Adverse Event|1|||
161282999|NCT01823835|582415123|FG007|Overall Study|Adverse Event|0|||
161283000|NCT01823835|582415124|FG008|Overall Study|Adverse Event|0|||
161283001|NCT01823835|582415125|FG009|Overall Study|Adverse Event|0|||
161283002|NCT01823835|582415126|FG010|Overall Study|Adverse Event|1|||
161283003|NCT01823835|582415127|FG011|Overall Study|Adverse Event|2|||
161283004|NCT01823835|582415128|FG012|Overall Study|Adverse Event|0|||
161283005|NCT01823835|582415129|FG013|Overall Study|Adverse Event|0|||
161283006|NCT01823835|582415130|FG014|Overall Study|Adverse Event|0|||
161283007|NCT01823835|582415116|FG000|Overall Study|Physician Decision|0|||
161283008|NCT01823835|582415117|FG001|Overall Study|Physician Decision|0|||
161283009|NCT01823835|582415118|FG002|Overall Study|Physician Decision|0|||
161283010|NCT01823835|582415119|FG003|Overall Study|Physician Decision|0|||
161283011|NCT01823835|582415120|FG004|Overall Study|Physician Decision|0|||
161283012|NCT01823835|582415121|FG005|Overall Study|Physician Decision|0|||
161283013|NCT01823835|582415122|FG006|Overall Study|Physician Decision|0|||
161283014|NCT01823835|582415123|FG007|Overall Study|Physician Decision|0|||
161283015|NCT01823835|582415124|FG008|Overall Study|Physician Decision|0|||
161283016|NCT01823835|582415125|FG009|Overall Study|Physician Decision|0|||
161283017|NCT01823835|582415126|FG010|Overall Study|Physician Decision|0|||
161283018|NCT01823835|582415127|FG011|Overall Study|Physician Decision|2|||
161283019|NCT01823835|582415128|FG012|Overall Study|Physician Decision|0|||
161283020|NCT01823835|582415129|FG013|Overall Study|Physician Decision|0|||
161283021|NCT01823835|582415130|FG014|Overall Study|Physician Decision|0|||
161283022|NCT01823835|582415116|FG000|Overall Study|Progressive Disease|3|||
161283023|NCT01823835|582415117|FG001|Overall Study|Progressive Disease|4|||
161283024|NCT01823835|582415118|FG002|Overall Study|Progressive Disease|3|||
161283025|NCT01823835|582415119|FG003|Overall Study|Progressive Disease|6|||
161283026|NCT01823835|582415120|FG004|Overall Study|Progressive Disease|4|||
161283027|NCT01823835|582415121|FG005|Overall Study|Progressive Disease|6|||
161283028|NCT01823835|582415122|FG006|Overall Study|Progressive Disease|5|||
161283029|NCT01823835|582415123|FG007|Overall Study|Progressive Disease|3|||
161065667|NCT03713320|581630610|FG001|Randomized Period|Participant decision|1|||
161065668|NCT03713320|581630611|FG002|Randomized Period|Participant decision|0|||
161065669|NCT03713320|581630609|FG000|Randomized Period|Study terminated by sponsor|6|||
161065670|NCT03713320|581630610|FG001|Randomized Period|Study terminated by sponsor|3|||
161065671|NCT03713320|581630611|FG002|Randomized Period|Study terminated by sponsor|0|||
161065672|NCT03713320|581630609|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
161065673|NCT03713320|581630610|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
161065674|NCT03713320|581630611|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
161065675|NCT03713320|581630609|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
161065676|NCT03713320|581630610|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
161065677|NCT03713320|581630611|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
161065678|NCT04354168|581630612|FG000|Overall Study|Lost to Follow-up|22|||
161283030|NCT01823835|582415124|FG008|Overall Study|Progressive Disease|3|||
161283031|NCT01823835|582415125|FG009|Overall Study|Progressive Disease|18|||
161283032|NCT01823835|582415126|FG010|Overall Study|Progressive Disease|8|||
161283033|NCT01823835|582415127|FG011|Overall Study|Progressive Disease|46|||
161283034|NCT01823835|582415128|FG012|Overall Study|Progressive Disease|18|||
161283035|NCT01823835|582415129|FG013|Overall Study|Progressive Disease|4|||
161283036|NCT01823835|582415130|FG014|Overall Study|Progressive Disease|6|||
161283037|NCT01823835|582415116|FG000|Overall Study|Study Termination|0|||
161283038|NCT01823835|582415117|FG001|Overall Study|Study Termination|0|||
161155185|NCT00069095|581949021|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
161155186|NCT00069095|581949022|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
161155187|NCT00069095|581949017|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161155188|NCT00069095|581949018|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161155189|NCT00069095|581949019|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161155190|NCT00069095|581949020|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161155191|NCT00069095|581949021|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
161155192|NCT00069095|581949022|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
161155193|NCT00069095|581949017|FG000|Post-study Treatment Phase|Investigator decision|0|||
161155194|NCT00069095|581949018|FG001|Post-study Treatment Phase|Investigator decision|0|||
161155195|NCT00069095|581949019|FG002|Post-study Treatment Phase|Investigator decision|0|||
161155196|NCT00069095|581949020|FG003|Post-study Treatment Phase|Investigator decision|0|||
161155197|NCT00069095|581949021|FG004|Post-study Treatment Phase|Investigator decision|0|||
161155198|NCT00069095|581949022|FG005|Post-study Treatment Phase|Investigator decision|1|||
161155199|NCT00069095|581949017|FG000|Follow-up Phase|Death|174|||
161155200|NCT00069095|581949018|FG001|Follow-up Phase|Death|206|||
161155201|NCT00069095|581949019|FG002|Follow-up Phase|Death|120|||
161155202|NCT00069095|581949020|FG003|Follow-up Phase|Death|112|||
161155203|NCT00069095|581949021|FG004|Follow-up Phase|Death|92|||
161155204|NCT00069095|581949022|FG005|Follow-up Phase|Death|101|||
161155205|NCT05610176|581949023|FG000|Overall Study|Death|6|||
161155206|NCT01217190|581949024|FG000|Second Dosing|Withdrawal by Subject|0|||
161155207|NCT01217190|581949025|FG001|Second Dosing|Withdrawal by Subject|2|||
161155208|NCT01594476|581949026|FG000|Overall Study|Protocol Violation|1|||
161155209|NCT01594476|581949027|FG001|Overall Study|Protocol Violation|3|||
161155210|NCT05114590|581949028|FG000|Overall Study|Adverse Event|1|||
161155211|NCT05114590|581949028|FG000|Overall Study|Investigator decision|1|||
161155212|NCT05114590|581949028|FG000|Overall Study|Lost to Follow-up|5|||
161155213|NCT05114590|581949028|FG000|Overall Study|Withdrawal by Subject|5|||
161155214|NCT05114590|581949028|FG000|Overall Study|Other|2|||
161155215|NCT03007953|581949029|FG000|Overall Study|Withdrawal by Subject|5|||
161155216|NCT03007953|581949030|FG001|Overall Study|Withdrawal by Subject|2|||
161155217|NCT03007953|581949029|FG000|Overall Study|Death|5|||
161155218|NCT03007953|581949030|FG001|Overall Study|Death|7|||
161155219|NCT03007953|581949029|FG000|Overall Study|Lost to Follow-up|3|||
161155220|NCT03007953|581949030|FG001|Overall Study|Lost to Follow-up|2|||
161155221|NCT03007953|581949029|FG000|Overall Study|Enrolled in Hospice|3|||
161155222|NCT03007953|581949030|FG001|Overall Study|Enrolled in Hospice|2|||
161155223|NCT02224846|581949031|FG000|Period 1 (Month 3)|Adverse Event|2|||
161155224|NCT02224846|581949032|FG001|Period 1 (Month 3)|Adverse Event|1|||
161155225|NCT02224846|581949031|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
161155226|NCT02224846|581949032|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
161155227|NCT02224846|581949031|FG000|Period 1 (Month 3)|Protocol Violation|4|||
161155228|NCT02224846|581949032|FG001|Period 1 (Month 3)|Protocol Violation|8|||
161155229|NCT02224846|581949031|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
161155230|NCT02224846|581949032|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
161155231|NCT02224846|581949031|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
161155232|NCT02224846|581949032|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
161155233|NCT02224846|581949031|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
161155234|NCT02224846|581949032|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
161155235|NCT02224846|581949031|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
161155236|NCT02224846|581949032|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
161155237|NCT02224846|581949031|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
161155238|NCT02224846|581949032|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
161155239|NCT02224846|581949031|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
161155240|NCT02224846|581949032|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
161155241|NCT02224846|581949031|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
161155242|NCT02224846|581949032|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
161283039|NCT01823835|582415118|FG002|Overall Study|Study Termination|0|||
161283040|NCT01823835|582415119|FG003|Overall Study|Study Termination|0|||
161283041|NCT01823835|582415120|FG004|Overall Study|Study Termination|1|||
161283042|NCT01823835|582415121|FG005|Overall Study|Study Termination|0|||
161283043|NCT01823835|582415122|FG006|Overall Study|Study Termination|0|||
161283044|NCT01823835|582415123|FG007|Overall Study|Study Termination|0|||
161283045|NCT01823835|582415124|FG008|Overall Study|Study Termination|0|||
161155243|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
161155244|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
161155245|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
161155246|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
161283046|NCT01823835|582415125|FG009|Overall Study|Study Termination|0|||
161155247|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
161155248|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
161283047|NCT01823835|582415126|FG010|Overall Study|Study Termination|0|||
161283048|NCT01823835|582415127|FG011|Overall Study|Study Termination|1|||
161283049|NCT01823835|582415128|FG012|Overall Study|Study Termination|0|||
161283050|NCT01823835|582415129|FG013|Overall Study|Study Termination|0|||
161283051|NCT01823835|582415130|FG014|Overall Study|Study Termination|0|||
161283052|NCT01823835|582415116|FG000|Overall Study|Withdrawal by Subject|0|||
161283053|NCT01823835|582415117|FG001|Overall Study|Withdrawal by Subject|0|||
161283054|NCT01823835|582415118|FG002|Overall Study|Withdrawal by Subject|1|||
161283055|NCT01823835|582415119|FG003|Overall Study|Withdrawal by Subject|0|||
161283056|NCT01823835|582415120|FG004|Overall Study|Withdrawal by Subject|0|||
161283057|NCT01823835|582415121|FG005|Overall Study|Withdrawal by Subject|0|||
161065679|NCT01781832|581630613|FG000|Overall Study|Withdrawal by Subject|1|||
161065680|NCT02287233|581630614|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
161065681|NCT02287233|581630615|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
161065682|NCT02287233|581630616|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
161065683|NCT02287233|581630614|FG000|Overall Study|Adverse Event Related to Progression|0|||
161065684|NCT02287233|581630615|FG001|Overall Study|Adverse Event Related to Progression|2|||
161065685|NCT02287233|581630616|FG002|Overall Study|Adverse Event Related to Progression|8|||
161065686|NCT02287233|581630614|FG000|Overall Study|Physician Decision|1|||
161065687|NCT02287233|581630615|FG001|Overall Study|Physician Decision|2|||
161065688|NCT02287233|581630616|FG002|Overall Study|Physician Decision|4|||
161065689|NCT02287233|581630614|FG000|Overall Study|Progressive Disease with Death|0|||
161065690|NCT02287233|581630615|FG001|Overall Study|Progressive Disease with Death|0|||
161065691|NCT02287233|581630616|FG002|Overall Study|Progressive Disease with Death|10|||
161065692|NCT02287233|581630614|FG000|Overall Study|Progressive Disease Without Death|2|||
161065693|NCT02287233|581630615|FG001|Overall Study|Progressive Disease Without Death|3|||
161065694|NCT02287233|581630616|FG002|Overall Study|Progressive Disease Without Death|20|||
161065695|NCT02287233|581630614|FG000|Overall Study|Withdrawal by Subject|1|||
161065696|NCT02287233|581630615|FG001|Overall Study|Withdrawal by Subject|1|||
161065697|NCT02287233|581630616|FG002|Overall Study|Withdrawal by Subject|7|||
161065698|NCT02287233|581630614|FG000|Overall Study|Other|3|||
161065699|NCT02287233|581630615|FG001|Overall Study|Other|0|||
161065700|NCT02287233|581630616|FG002|Overall Study|Other|15|||
161065701|NCT02287233|581630614|FG000|Overall Study|Did Not Receive Treatment|0|||
161065702|NCT02287233|581630615|FG001|Overall Study|Did Not Receive Treatment|0|||
161065703|NCT02287233|581630616|FG002|Overall Study|Did Not Receive Treatment|2|||
161065704|NCT01174264|581630617|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
161065705|NCT01174264|581630618|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
161065706|NCT01174264|581630619|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
161065707|NCT01174264|581630617|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
161065708|NCT01174264|581630618|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
161065709|NCT01174264|581630619|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
161065710|NCT01174264|581630617|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
161065711|NCT01174264|581630618|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
161065712|NCT01174264|581630619|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
161065713|NCT01185171|581630625|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
161065714|NCT01185171|581630625|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
161065715|NCT01185171|581630625|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
161065716|NCT01185171|581630625|FG000|Maintenance|Elevated liver transaminases|3|||
161065717|NCT01185171|581630625|FG000|Maintenance|Rush|2|||
161065718|NCT01185171|581630625|FG000|Maintenance|Diarrhea|1|||
161065719|NCT01185171|581630625|FG000|Maintenance|Xerostomia|1|||
161065720|NCT01185171|581630625|FG000|Maintenance|Nausea|1|||
161065721|NCT01185171|581630625|FG000|Maintenance|Comorbid Illness|2|||
161065722|NCT01185171|581630625|FG000|Maintenance|Withdrawal by Subject|1|||
161065723|NCT01185171|581630625|FG000|Maintenance|Disease Recurrence|1|||
161065724|NCT01482429|581630626|FG000|Care Usual|Protocol Violation|0|||
161065725|NCT01482429|581630627|FG001|Care Usual|Protocol Violation|172|||
161065726|NCT01482429|581630626|FG000|Care Usual|Lost to Follow-up|0|||
161065727|NCT01482429|581630627|FG001|Care Usual|Lost to Follow-up|1|||
161065728|NCT01482429|581630626|FG000|Protocol|Protocol Violation|275|||
161065729|NCT01482429|581630627|FG001|Protocol|Protocol Violation|0|||
161065730|NCT03561597|581630628|FG000|Overall Study|Lost to Follow-up|20|||
161065731|NCT00573651|581630629|FG000|Overall Study|Lost to Follow-up|3|||
161065732|NCT00573651|581630629|FG000|Overall Study|Withdrawal by Subject|1|||
161065733|NCT03049306|581630636|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
161065734|NCT03049306|581630637|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
161283058|NCT01823835|582415122|FG006|Overall Study|Withdrawal by Subject|0|||
161283059|NCT01823835|582415123|FG007|Overall Study|Withdrawal by Subject|0|||
161283060|NCT01823835|582415124|FG008|Overall Study|Withdrawal by Subject|0|||
161283061|NCT01823835|582415125|FG009|Overall Study|Withdrawal by Subject|1|||
161065735|NCT05896696|581630640|FG000|Overall Study|Screening Failure|7|||
161065736|NCT05896696|581630640|FG000|Overall Study|Withdrawal by Subject|2|||
161065737|NCT01639742|581632635|FG000|Overall Study|Study Ongoing|17|||
161065738|NCT01639742|581632635|FG000|Overall Study|Lost to Follow-up|1|||
161065739|NCT04411186|581632636|FG000|Overall Study|Withdrawn due to protocol violation|0|||
161065740|NCT04411186|581632637|FG001|Overall Study|Withdrawn due to protocol violation|1|||
161065741|NCT02172911|581632638|FG000|Overall Study|Serious Adverse Event|0|||
161283062|NCT01823835|582415126|FG010|Overall Study|Withdrawal by Subject|1|||
161283063|NCT01823835|582415127|FG011|Overall Study|Withdrawal by Subject|2|||
161283064|NCT01823835|582415128|FG012|Overall Study|Withdrawal by Subject|1|||
161283065|NCT01823835|582415129|FG013|Overall Study|Withdrawal by Subject|0|||
161283066|NCT01823835|582415130|FG014|Overall Study|Withdrawal by Subject|0|||
161283067|NCT00509795|582415131|FG000|Overall Study|Adverse Event|4|||
161283068|NCT00509795|582415132|FG001|Overall Study|Adverse Event|3|||
161283069|NCT00509795|582415133|FG002|Overall Study|Adverse Event|5|||
161283070|NCT00509795|582415134|FG003|Overall Study|Adverse Event|4|||
161283071|NCT00509795|582415131|FG000|Overall Study|Death|3|||
161283072|NCT00509795|582415132|FG001|Overall Study|Death|1|||
161345390|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
161345391|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
161065742|NCT02172911|581632639|FG001|Overall Study|Serious Adverse Event|1|||
161065743|NCT02172911|581632638|FG000|Overall Study|Progression of Disease|0|||
161065744|NCT02172911|581632639|FG001|Overall Study|Progression of Disease|1|||
161065745|NCT02172911|581632638|FG000|Overall Study|Loss of insurance coverage|1|||
161065746|NCT02172911|581632639|FG001|Overall Study|Loss of insurance coverage|0|||
161065747|NCT00575042|581632642|FG000|Overall Study|Adverse Event|2|||
161065748|NCT00575042|581632642|FG000|Overall Study|Lost to Follow-up|1|||
161065749|NCT04795336|581632643|FG000|Overall Study|Withdrawal by Subject|3|||
161065750|NCT04795336|581632644|FG001|Overall Study|Withdrawal by Subject|4|||
161065751|NCT04795336|581632645|FG002|Overall Study|Withdrawal by Subject|3|||
161065752|NCT04795336|581632646|FG003|Overall Study|Withdrawal by Subject|12|||
161065753|NCT04795336|581632643|FG000|Overall Study|Lost study logs|0|||
161065754|NCT04795336|581632644|FG001|Overall Study|Lost study logs|1|||
161065755|NCT04795336|581632645|FG002|Overall Study|Lost study logs|0|||
161065756|NCT04795336|581632646|FG003|Overall Study|Lost study logs|2|||
161065757|NCT04795336|581632643|FG000|Overall Study|Did not take study medication|2|||
161065758|NCT04795336|581632644|FG001|Overall Study|Did not take study medication|0|||
161065759|NCT04795336|581632645|FG002|Overall Study|Did not take study medication|0|||
161065760|NCT04795336|581632646|FG003|Overall Study|Did not take study medication|0|||
161065761|NCT03021551|581632648|FG000|Overall Study|Equipment Issues|2|||
161065762|NCT03021551|581632648|FG000|Overall Study|Protocol Violation|1|||
161065763|NCT00490945|581632651|FG000|Overall Study|Adverse Event|0|||
161065764|NCT00490945|581632652|FG001|Overall Study|Adverse Event|1|||
161065765|NCT00490945|581632653|FG002|Overall Study|Adverse Event|0|||
161065766|NCT00490945|581632654|FG003|Overall Study|Adverse Event|0|||
161065767|NCT00490945|581632655|FG004|Overall Study|Adverse Event|0|||
161065768|NCT02706951|581632657|FG000|Period 1|Adverse Event|1|||
161065769|NCT02706951|581632658|FG001|Period 1|Adverse Event|5|||
161065770|NCT02706951|581632659|FG002|Period 1|Adverse Event|3|||
161065771|NCT02706951|581632660|FG003|Period 1|Adverse Event|0|||
161065772|NCT02706951|581632661|FG004|Period 1|Adverse Event|0|||
161065773|NCT02706951|581632657|FG000|Period 1|Withdrawal by Subject|10|||
161065774|NCT02706951|581632658|FG001|Period 1|Withdrawal by Subject|6|||
161065775|NCT02706951|581632659|FG002|Period 1|Withdrawal by Subject|6|||
161065776|NCT02706951|581632660|FG003|Period 1|Withdrawal by Subject|0|||
161065777|NCT02706951|581632661|FG004|Period 1|Withdrawal by Subject|0|||
161065778|NCT02706951|581632657|FG000|Period 1|Lost to Follow-up|0|||
161065779|NCT02706951|581632658|FG001|Period 1|Lost to Follow-up|4|||
161065780|NCT02706951|581632659|FG002|Period 1|Lost to Follow-up|1|||
161065781|NCT02706951|581632660|FG003|Period 1|Lost to Follow-up|0|||
161065782|NCT02706951|581632661|FG004|Period 1|Lost to Follow-up|0|||
161065783|NCT02706951|581632657|FG000|Period 1|Other|2|||
161065784|NCT02706951|581632658|FG001|Period 1|Other|1|||
161065785|NCT02706951|581632659|FG002|Period 1|Other|0|||
161065786|NCT02706951|581632660|FG003|Period 1|Other|0|||
161065787|NCT02706951|581632661|FG004|Period 1|Other|0|||
161065788|NCT02706951|581632657|FG000|Period 2|Adverse Event|0|||
161065789|NCT02706951|581632658|FG001|Period 2|Adverse Event|0|||
161065790|NCT02706951|581632659|FG002|Period 2|Adverse Event|0|||
161065791|NCT02706951|581632660|FG003|Period 2|Adverse Event|25|||
161065792|NCT02706951|581632661|FG004|Period 2|Adverse Event|34|||
161065793|NCT02706951|581632657|FG000|Period 2|Withdrawal by Subject|0|||
161065794|NCT02706951|581632658|FG001|Period 2|Withdrawal by Subject|0|||
161065795|NCT02706951|581632659|FG002|Period 2|Withdrawal by Subject|0|||
161065796|NCT02706951|581632660|FG003|Period 2|Withdrawal by Subject|38|||
161065797|NCT02706951|581632661|FG004|Period 2|Withdrawal by Subject|44|||
161065798|NCT02706951|581632657|FG000|Period 2|Lost to Follow-up|0|||
161065799|NCT02706951|581632658|FG001|Period 2|Lost to Follow-up|0|||
161065800|NCT02706951|581632659|FG002|Period 2|Lost to Follow-up|0|||
161065801|NCT02706951|581632660|FG003|Period 2|Lost to Follow-up|17|||
161065802|NCT02706951|581632661|FG004|Period 2|Lost to Follow-up|9|||
161065803|NCT02706951|581632657|FG000|Period 2|COVID-19 Related|0|||
161065804|NCT02706951|581632658|FG001|Period 2|COVID-19 Related|0|||
161065805|NCT02706951|581632659|FG002|Period 2|COVID-19 Related|0|||
161065806|NCT02706951|581632660|FG003|Period 2|COVID-19 Related|1|||
161065807|NCT02706951|581632661|FG004|Period 2|COVID-19 Related|2|||
161065808|NCT02706951|581632657|FG000|Period 2|Other|0|||
161065809|NCT02706951|581632658|FG001|Period 2|Other|0|||
161283073|NCT00509795|582415133|FG002|Overall Study|Death|2|||
161283074|NCT00509795|582415134|FG003|Overall Study|Death|7|||
161283075|NCT00509795|582415131|FG000|Overall Study|Lack of Efficacy|0|||
161283076|NCT00509795|582415132|FG001|Overall Study|Lack of Efficacy|0|||
161283077|NCT00509795|582415133|FG002|Overall Study|Lack of Efficacy|2|||
161283078|NCT00509795|582415134|FG003|Overall Study|Lack of Efficacy|2|||
161283079|NCT00509795|582415131|FG000|Overall Study|Lost to Follow-up|1|||
161065810|NCT02706951|581632659|FG002|Period 2|Other|0|||
161065811|NCT02706951|581632660|FG003|Period 2|Other|37|||
161065812|NCT02706951|581632661|FG004|Period 2|Other|31|||
161065813|NCT03297398|581632666|FG000|Overall Study|Sponsor's decision|6|||
161065814|NCT03297398|581632667|FG001|Overall Study|Sponsor's decision|9|||
161065815|NCT03297398|581632668|FG002|Overall Study|Sponsor's decision|7|||
161065816|NCT03297398|581632666|FG000|Overall Study|Adverse Event|1|||
161065817|NCT03297398|581632667|FG001|Overall Study|Adverse Event|4|||
161065818|NCT03297398|581632668|FG002|Overall Study|Adverse Event|4|||
161065819|NCT03297398|581632666|FG000|Overall Study|Withdrawal by Subject|1|||
161065820|NCT03297398|581632667|FG001|Overall Study|Withdrawal by Subject|2|||
161065821|NCT03297398|581632668|FG002|Overall Study|Withdrawal by Subject|2|||
161065822|NCT03297398|581632666|FG000|Overall Study|Protocol Violation|0|||
161065823|NCT03297398|581632667|FG001|Overall Study|Protocol Violation|2|||
161065824|NCT03297398|581632668|FG002|Overall Study|Protocol Violation|0|||
161065825|NCT03297398|581632666|FG000|Overall Study|Physician Decision|0|||
161065826|NCT03297398|581632667|FG001|Overall Study|Physician Decision|0|||
161065827|NCT03297398|581632668|FG002|Overall Study|Physician Decision|1|||
161065828|NCT03297398|581632666|FG000|Overall Study|Lost to Follow-up|0|||
161065829|NCT03297398|581632667|FG001|Overall Study|Lost to Follow-up|0|||
161065830|NCT03297398|581632668|FG002|Overall Study|Lost to Follow-up|1|||
161065831|NCT00611715|581632671|FG000|Overall Study|Disease Progression|24|||
161065832|NCT00611715|581632672|FG001|Overall Study|Disease Progression|4|||
161065833|NCT00611715|581632671|FG000|Overall Study|Withdrawal by Subject|5|||
161065834|NCT00611715|581632672|FG001|Overall Study|Withdrawal by Subject|1|||
161065835|NCT00611715|581632671|FG000|Overall Study|Adverse Event|9|||
161065836|NCT00611715|581632672|FG001|Overall Study|Adverse Event|1|||
161065837|NCT00611715|581632671|FG000|Overall Study|Death|1|||
161065838|NCT00611715|581632672|FG001|Overall Study|Death|0|||
161065839|NCT00611715|581632671|FG000|Overall Study|two patients are still on treatment|2|||
161065840|NCT00611715|581632672|FG001|Overall Study|two patients are still on treatment|0|||
161065841|NCT03634839|581632674|FG000|First Intervention (2 Hours)|Adverse Event|0|||
161065842|NCT03634839|581632675|FG001|First Intervention (2 Hours)|Adverse Event|2|||
161065843|NCT00233389|581632678|FG000|Overall Study|Adverse Event|5|||
161065844|NCT00233389|581632679|FG001|Overall Study|Adverse Event|5|||
161065845|NCT00233389|581632678|FG000|Overall Study|Lack of Efficacy|11|||
161065846|NCT00233389|581632679|FG001|Overall Study|Lack of Efficacy|8|||
161065847|NCT00233389|581632678|FG000|Overall Study|Lost to Follow-up|1|||
161065848|NCT00233389|581632679|FG001|Overall Study|Lost to Follow-up|1|||
161065849|NCT00233389|581632678|FG000|Overall Study|Physician Decision|1|||
161065850|NCT00233389|581632679|FG001|Overall Study|Physician Decision|0|||
161065851|NCT00233389|581632678|FG000|Overall Study|Protocol Violation|0|||
161065852|NCT00233389|581632679|FG001|Overall Study|Protocol Violation|1|||
161065853|NCT00233389|581632678|FG000|Overall Study|Withdrawal by Subject|0|||
161065854|NCT00233389|581632679|FG001|Overall Study|Withdrawal by Subject|1|||
161065855|NCT00719043|581632685|FG000|Overall Study|Adverse Event|5|||
161065856|NCT00719043|581632686|FG001|Overall Study|Adverse Event|1|||
161065857|NCT00719043|581632687|FG002|Overall Study|Adverse Event|2|||
161065858|NCT00719043|581632688|FG003|Overall Study|Adverse Event|2|||
161065859|NCT00719043|581632689|FG004|Overall Study|Adverse Event|1|||
161065860|NCT00719043|581632690|FG005|Overall Study|Adverse Event|4|||
161065861|NCT00719043|581632691|FG006|Overall Study|Adverse Event|4|||
161065862|NCT00719043|581632685|FG000|Overall Study|Lost to Follow-up|14|||
161065863|NCT00719043|581632686|FG001|Overall Study|Lost to Follow-up|10|||
161065864|NCT00719043|581632687|FG002|Overall Study|Lost to Follow-up|8|||
161065865|NCT00719043|581632688|FG003|Overall Study|Lost to Follow-up|9|||
161065866|NCT00719043|581632689|FG004|Overall Study|Lost to Follow-up|10|||
161065867|NCT00719043|581632690|FG005|Overall Study|Lost to Follow-up|9|||
161065868|NCT00719043|581632691|FG006|Overall Study|Lost to Follow-up|9|||
161065869|NCT00719043|581632685|FG000|Overall Study|Protocol Violation|0|||
161065870|NCT00719043|581632686|FG001|Overall Study|Protocol Violation|0|||
161065871|NCT00719043|581632687|FG002|Overall Study|Protocol Violation|0|||
161065872|NCT00719043|581632688|FG003|Overall Study|Protocol Violation|0|||
161065873|NCT00719043|581632689|FG004|Overall Study|Protocol Violation|0|||
161065874|NCT00719043|581632690|FG005|Overall Study|Protocol Violation|1|||
161065875|NCT00719043|581632691|FG006|Overall Study|Protocol Violation|0|||
161065876|NCT00719043|581632685|FG000|Overall Study|Other|1|||
161065877|NCT00719043|581632686|FG001|Overall Study|Other|0|||
161065878|NCT00719043|581632687|FG002|Overall Study|Other|1|||
161283080|NCT00509795|582415132|FG001|Overall Study|Lost to Follow-up|2|||
161283081|NCT00509795|582415133|FG002|Overall Study|Lost to Follow-up|4|||
161065879|NCT00719043|581632688|FG003|Overall Study|Other|2|||
161065880|NCT00719043|581632689|FG004|Overall Study|Other|0|||
161065881|NCT00719043|581632690|FG005|Overall Study|Other|2|||
161283082|NCT00509795|582415134|FG003|Overall Study|Lost to Follow-up|4|||
161283083|NCT00509795|582415131|FG000|Overall Study|OTHER|1|||
161283084|NCT00509795|582415132|FG001|Overall Study|OTHER|0|||
161283085|NCT00509795|582415133|FG002|Overall Study|OTHER|4|||
161283086|NCT00509795|582415134|FG003|Overall Study|OTHER|1|||
161283087|NCT00509795|582415131|FG000|Overall Study|Protocol Violation|3|||
161283088|NCT00509795|582415132|FG001|Overall Study|Protocol Violation|0|||
161283089|NCT00509795|582415133|FG002|Overall Study|Protocol Violation|3|||
161283090|NCT00509795|582415134|FG003|Overall Study|Protocol Violation|1|||
161283091|NCT00509795|582415131|FG000|Overall Study|Withdrawal by Subject|10|||
161283092|NCT00509795|582415132|FG001|Overall Study|Withdrawal by Subject|5|||
161283093|NCT00509795|582415133|FG002|Overall Study|Withdrawal by Subject|7|||
161283094|NCT00509795|582415134|FG003|Overall Study|Withdrawal by Subject|8|||
161283095|NCT04895982|582415135|FG000|Overall Study|Withdrawal by Subject|0|||
161283096|NCT04895982|582415136|FG001|Overall Study|Withdrawal by Subject|0|||
161283097|NCT04895982|582415137|FG002|Overall Study|Withdrawal by Subject|0|||
161283098|NCT04895982|582415138|FG003|Overall Study|Withdrawal by Subject|0|||
161283099|NCT04895982|582415139|FG004|Overall Study|Withdrawal by Subject|0|||
161283100|NCT04895982|582415140|FG005|Overall Study|Withdrawal by Subject|1|||
161283101|NCT04895982|582415141|FG006|Overall Study|Withdrawal by Subject|1|||
161283102|NCT04895982|582415142|FG007|Overall Study|Withdrawal by Subject|0|||
161283103|NCT04895982|582415143|FG008|Overall Study|Withdrawal by Subject|0|||
161283104|NCT04895982|582415144|FG009|Overall Study|Withdrawal by Subject|1|||
161283105|NCT04895982|582415145|FG010|Overall Study|Withdrawal by Subject|0|||
161283106|NCT04895982|582415146|FG011|Overall Study|Withdrawal by Subject|1|||
161283107|NCT04895982|582415135|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161283108|NCT04895982|582415136|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161283109|NCT04895982|582415137|FG002|Overall Study|Withdrawal by parent/guardian|3|||
161283110|NCT04895982|582415138|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161283111|NCT04895982|582415139|FG004|Overall Study|Withdrawal by parent/guardian|3|||
161283112|NCT04895982|582415140|FG005|Overall Study|Withdrawal by parent/guardian|2|||
161283113|NCT04895982|582415141|FG006|Overall Study|Withdrawal by parent/guardian|1|||
161155249|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
161155250|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
161155251|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
161155252|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
161155253|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
161155254|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
161155255|NCT02224846|581949031|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
161155256|NCT02224846|581949032|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
161155257|NCT03196297|581949033|FG000|Main Period|Withdrawal by Subject|4|||
161155258|NCT03196297|581949033|FG000|Extension Period|Withdrawal by Subject|1|||
161155259|NCT03196297|581949033|FG000|Extension Period|Lack of Efficacy|2|||
161155260|NCT00320385|581949037|FG000|Overall Study|Lost to Follow-up|7|||
161155261|NCT00320385|581949038|FG001|Overall Study|Lost to Follow-up|10|||
161155262|NCT00320385|581949037|FG000|Overall Study|Withdrawal by Subject|6|||
161155263|NCT00320385|581949038|FG001|Overall Study|Withdrawal by Subject|7|||
161155264|NCT00320385|581949037|FG000|Overall Study|Sponsor Terminated Study|2|||
161155265|NCT00320385|581949038|FG001|Overall Study|Sponsor Terminated Study|1|||
161155266|NCT00320385|581949037|FG000|Overall Study|Investigator Decision|0|||
161155267|NCT00320385|581949038|FG001|Overall Study|Investigator Decision|1|||
161155268|NCT00320385|581949037|FG000|Overall Study|Death|1|||
161155269|NCT00320385|581949038|FG001|Overall Study|Death|2|||
161155270|NCT00320385|581949037|FG000|Overall Study|Serious Adverse Event|1|||
161155271|NCT00320385|581949038|FG001|Overall Study|Serious Adverse Event|0|||
161155272|NCT00320385|581949037|FG000|Overall Study|Withdrew Consent|1|||
161155273|NCT00320385|581949038|FG001|Overall Study|Withdrew Consent|0|||
161155274|NCT00320385|581949037|FG000|Overall Study|Adverse Event|0|||
161155275|NCT00320385|581949038|FG001|Overall Study|Adverse Event|1|||
161155276|NCT04370028|581949039|FG000|Overall Study|Withdrawal by Subject|695|||
161155277|NCT04370028|581949039|FG000|Overall Study|Protocol Violation|9|||
161155278|NCT04370028|581949039|FG000|Overall Study|Adverse Event|3|||
161155279|NCT02582749|581949046|FG000|Overall Study|Study terminated by funder|5|||
161155280|NCT02582749|581949047|FG001|Overall Study|Study terminated by funder|10|||
161155281|NCT02582749|581949046|FG000|Overall Study|Withdrawal by Subject|0|||
161155282|NCT02582749|581949047|FG001|Overall Study|Withdrawal by Subject|1|||
161155283|NCT02213198|581949048|FG000|Baseline|No show for intake|7|||
161155284|NCT02213198|581949049|FG001|Baseline|No show for intake|9|||
161155285|NCT02213198|581949048|FG000|Baseline|Withdrawal by Subject|34|||
161155286|NCT02213198|581949049|FG001|Baseline|Withdrawal by Subject|11|||
161283114|NCT04895982|582415142|FG007|Overall Study|Withdrawal by parent/guardian|0|||
161283115|NCT04895982|582415143|FG008|Overall Study|Withdrawal by parent/guardian|3|||
161283116|NCT04895982|582415144|FG009|Overall Study|Withdrawal by parent/guardian|0|||
161283117|NCT04895982|582415145|FG010|Overall Study|Withdrawal by parent/guardian|0|||
161283118|NCT04895982|582415146|FG011|Overall Study|Withdrawal by parent/guardian|0|||
161283119|NCT04895982|582415135|FG000|Overall Study|Other|0|||
161155287|NCT02213198|581949048|FG000|Baseline|transferred out of clinic|7|||
161155288|NCT02213198|581949049|FG001|Baseline|transferred out of clinic|9|||
161155289|NCT02213198|581949048|FG000|Baseline|Lost to Follow-up|40|||
161155290|NCT02213198|581949049|FG001|Baseline|Lost to Follow-up|21|||
161155291|NCT02213198|581949048|FG000|Baseline|incarcerated,violent|0|||
161155292|NCT02213198|581949049|FG001|Baseline|incarcerated,violent|1|||
161155293|NCT02213198|581949048|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
161155294|NCT02213198|581949049|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
161155295|NCT02213198|581949048|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
161155296|NCT02213198|581949049|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
161155297|NCT02213198|581949048|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
161155298|NCT02213198|581949049|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
161155299|NCT02213198|581949048|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
161155300|NCT02213198|581949049|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
161155301|NCT02213198|581949048|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
161155302|NCT02213198|581949049|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
161155303|NCT02213198|581949048|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
161155304|NCT02213198|581949049|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
161155305|NCT01518192|581949050|FG000|Overall Study|Lost to Follow-up|29|||
161155306|NCT01518192|581949051|FG001|Overall Study|Lost to Follow-up|26|||
161155307|NCT01518192|581949052|FG002|Overall Study|Lost to Follow-up|35|||
161155308|NCT01954121|581949053|FG000|Overall Study|Lack of Efficacy|94|||
161155309|NCT01954121|581949054|FG001|Overall Study|Lack of Efficacy|41|||
161155310|NCT01954121|581949053|FG000|Overall Study|Protocol Violation|0|||
161155311|NCT01954121|581949054|FG001|Overall Study|Protocol Violation|2|||
161155312|NCT01954121|581949053|FG000|Overall Study|Lost to Follow-up|5|||
161155313|NCT01954121|581949054|FG001|Overall Study|Lost to Follow-up|6|||
161155314|NCT01954121|581949053|FG000|Overall Study|Withdrawal by Subject|18|||
161155315|NCT01954121|581949054|FG001|Overall Study|Withdrawal by Subject|12|||
161155316|NCT01954121|581949053|FG000|Overall Study|Pregnancy|1|||
161155317|NCT01954121|581949054|FG001|Overall Study|Pregnancy|1|||
161155318|NCT01954121|581949053|FG000|Overall Study|AE, serious fatal|1|||
161155319|NCT01954121|581949054|FG001|Overall Study|AE, serious fatal|0|||
161155320|NCT01954121|581949053|FG000|Overall Study|AE, non-serious non-fatal|5|||
161155321|NCT01954121|581949054|FG001|Overall Study|AE, non-serious non-fatal|22|||
161155322|NCT01954121|581949053|FG000|Overall Study|SAE, non-fatal|1|||
161155323|NCT01954121|581949054|FG001|Overall Study|SAE, non-fatal|4|||
161155324|NCT01954121|581949053|FG000|Overall Study|Non-compliant with study procedures|1|||
161155325|NCT01954121|581949054|FG001|Overall Study|Non-compliant with study procedures|0|||
161155326|NCT01954121|581949053|FG000|Overall Study|Non-compliant patient|1|||
161155327|NCT01954121|581949054|FG001|Overall Study|Non-compliant patient|1|||
161155328|NCT01954121|581949053|FG000|Overall Study|Subject did not follow instructions|0|||
161155329|NCT01954121|581949054|FG001|Overall Study|Subject did not follow instructions|2|||
161155330|NCT00872170|581949056|FG000|Overall Study|Adverse Event|1|||
161155331|NCT00872170|581949057|FG001|Overall Study|Adverse Event|0|||
161155332|NCT00601523|581949058|FG000|Overall Study|Adverse Event|42|||
161155333|NCT00601523|581949059|FG001|Overall Study|Adverse Event|14|||
161155334|NCT00601523|581949058|FG000|Overall Study|Lack of Efficacy|3|||
161155335|NCT00601523|581949059|FG001|Overall Study|Lack of Efficacy|0|||
161155336|NCT00601523|581949058|FG000|Overall Study|Protocol Violation|5|||
161155337|NCT00601523|581949059|FG001|Overall Study|Protocol Violation|1|||
161155338|NCT00601523|581949058|FG000|Overall Study|Lost to Follow-up|0|||
161155339|NCT00601523|581949059|FG001|Overall Study|Lost to Follow-up|1|||
161155340|NCT00601523|581949058|FG000|Overall Study|Withdrawal by Subject|18|||
161155341|NCT00601523|581949059|FG001|Overall Study|Withdrawal by Subject|9|||
161155342|NCT00601523|581949058|FG000|Overall Study|Other|9|||
161155343|NCT00601523|581949059|FG001|Overall Study|Other|1|||
161155344|NCT01617434|581949060|FG000|Overall Study|Adverse Event|12|||
161155345|NCT01617434|581949061|FG001|Overall Study|Adverse Event|3|||
161155346|NCT01617434|581949060|FG000|Overall Study|Protocol Violation|8|||
161155347|NCT01617434|581949061|FG001|Overall Study|Protocol Violation|7|||
161155348|NCT01617434|581949060|FG000|Overall Study|Withdrawal Criteria|12|||
161155349|NCT01617434|581949061|FG001|Overall Study|Withdrawal Criteria|37|||
161155350|NCT01617434|581949060|FG000|Overall Study|Unclassified|3|||
161155351|NCT01617434|581949061|FG001|Overall Study|Unclassified|4|||
161283120|NCT04895982|582415136|FG001|Overall Study|Other|0|||
161155352|NCT01987986|581949062|FG000|Overall Study|Lost to Follow-up|1|||
161155353|NCT01987986|581949063|FG001|Overall Study|Lost to Follow-up|0|||
161155354|NCT01987986|581949064|FG002|Overall Study|Lost to Follow-up|0|||
161155355|NCT01987986|581949065|FG003|Overall Study|Lost to Follow-up|0|||
161155356|NCT01987986|581949062|FG000|Overall Study|Adverse Event|1|||
161283121|NCT04895982|582415137|FG002|Overall Study|Other|1|||
161155357|NCT01987986|581949063|FG001|Overall Study|Adverse Event|0|||
161155358|NCT01987986|581949064|FG002|Overall Study|Adverse Event|2|||
161155359|NCT01987986|581949065|FG003|Overall Study|Adverse Event|0|||
161155360|NCT03342469|581949072|FG000|Overall Study|Withdrawal by Subject|0|||
161283122|NCT04895982|582415138|FG003|Overall Study|Other|1|||
161283123|NCT04895982|582415139|FG004|Overall Study|Other|0|||
161065882|NCT00719043|581632691|FG006|Overall Study|Other|1|||
161065883|NCT00719043|581632685|FG000|Overall Study|Withdrawal by Subject|12|||
161065884|NCT00719043|581632686|FG001|Overall Study|Withdrawal by Subject|14|||
161065885|NCT00719043|581632687|FG002|Overall Study|Withdrawal by Subject|9|||
161065886|NCT00719043|581632688|FG003|Overall Study|Withdrawal by Subject|10|||
161065887|NCT00719043|581632689|FG004|Overall Study|Withdrawal by Subject|16|||
161065888|NCT00719043|581632690|FG005|Overall Study|Withdrawal by Subject|18|||
161065889|NCT00719043|581632691|FG006|Overall Study|Withdrawal by Subject|14|||
161065890|NCT04593823|581632692|FG000|Overall Study|Withdrawal by Subject|1|||
161065891|NCT04593823|581632693|FG001|Overall Study|Withdrawal by Subject|1|||
161065892|NCT04593823|581632692|FG000|Overall Study|Lost to Follow-up|0|||
161065893|NCT04593823|581632693|FG001|Overall Study|Lost to Follow-up|1|||
161065894|NCT00952848|581632700|FG000|Overall Study|Withdrawal by Subject|4|||
161065895|NCT00458393|581632701|FG000|Overall Study|Withdrawal by Subject|67|||
161065896|NCT00458393|581632702|FG001|Overall Study|Withdrawal by Subject|80|||
161065897|NCT00458393|581632701|FG000|Overall Study|Physician Decision|31|||
161065898|NCT00458393|581632702|FG001|Overall Study|Physician Decision|22|||
161065899|NCT00458393|581632701|FG000|Overall Study|Relocated|77|||
161065900|NCT00458393|581632702|FG001|Overall Study|Relocated|81|||
161065901|NCT00458393|581632701|FG000|Overall Study|Lost to Follow-up|115|||
161065902|NCT00458393|581632702|FG001|Overall Study|Lost to Follow-up|92|||
161065903|NCT00458393|581632701|FG000|Overall Study|Sites marked other on the form.|19|||
161065904|NCT00458393|581632702|FG001|Overall Study|Sites marked other on the form.|20|||
161065905|NCT02725567|581632703|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
161065906|NCT02725567|581632704|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
161065907|NCT02725567|581632703|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
161065908|NCT02725567|581632704|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
161065909|NCT02725567|581632703|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
161065910|NCT02725567|581632704|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
161065911|NCT02777242|581632705|FG000|Overall Study|Other|2|||
161065912|NCT02777242|581632705|FG000|Overall Study|Lost to Follow-up|1|||
161065913|NCT02777242|581632705|FG000|Overall Study|Multiple|1|||
161065914|NCT02777242|581632705|FG000|Overall Study|Sponsor's request|1|||
161065915|NCT02777242|581632705|FG000|Overall Study|Withdrawal by Subject|1|||
161065916|NCT01182181|581632714|FG000|First Intervention|Adverse Event|1|||
161065917|NCT01182181|581632715|FG001|First Intervention|Adverse Event|0|||
161065918|NCT01182181|581632714|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
161065919|NCT01182181|581632715|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
161065920|NCT00511797|581632716|FG000|Overall Study|Adverse Event|1|||
161065921|NCT00511797|581632717|FG001|Overall Study|Adverse Event|2|||
161065922|NCT00511797|581632718|FG002|Overall Study|Adverse Event|2|||
161065923|NCT00511797|581632719|FG003|Overall Study|Adverse Event|2|||
161065924|NCT00511797|581632716|FG000|Overall Study|Lost to Follow-up|1|||
161065925|NCT00511797|581632717|FG001|Overall Study|Lost to Follow-up|0|||
161065926|NCT00511797|581632718|FG002|Overall Study|Lost to Follow-up|0|||
161065927|NCT00511797|581632719|FG003|Overall Study|Lost to Follow-up|1|||
161065928|NCT00511797|581632716|FG000|Overall Study|Pregnancy|0|||
161065929|NCT00511797|581632717|FG001|Overall Study|Pregnancy|0|||
161065930|NCT00511797|581632718|FG002|Overall Study|Pregnancy|0|||
161065931|NCT00511797|581632719|FG003|Overall Study|Pregnancy|1|||
161065932|NCT00511797|581632716|FG000|Overall Study|Protocol Violation|0|||
161065933|NCT00511797|581632717|FG001|Overall Study|Protocol Violation|2|||
161065934|NCT00511797|581632718|FG002|Overall Study|Protocol Violation|2|||
161065935|NCT00511797|581632719|FG003|Overall Study|Protocol Violation|3|||
161065936|NCT00511797|581632716|FG000|Overall Study|Withdrawal by Subject|3|||
161065937|NCT00511797|581632717|FG001|Overall Study|Withdrawal by Subject|3|||
161065938|NCT00511797|581632718|FG002|Overall Study|Withdrawal by Subject|4|||
161065939|NCT00511797|581632719|FG003|Overall Study|Withdrawal by Subject|2|||
161065940|NCT00511797|581632716|FG000|Overall Study|Never dispensed|1|||
161065941|NCT00511797|581632717|FG001|Overall Study|Never dispensed|0|||
161065942|NCT00511797|581632718|FG002|Overall Study|Never dispensed|1|||
161065943|NCT00511797|581632719|FG003|Overall Study|Never dispensed|3|||
161065944|NCT00511797|581632716|FG000|Overall Study|Study drug not taken|0|||
161065945|NCT00511797|581632717|FG001|Overall Study|Study drug not taken|1|||
161065946|NCT00511797|581632718|FG002|Overall Study|Study drug not taken|0|||
161065947|NCT00511797|581632719|FG003|Overall Study|Study drug not taken|1|||
161065948|NCT00511797|581632716|FG000|Overall Study|Partially missing diary|0|||
161065949|NCT00511797|581632717|FG001|Overall Study|Partially missing diary|0|||
161065950|NCT00511797|581632718|FG002|Overall Study|Partially missing diary|1|||
161065951|NCT00511797|581632719|FG003|Overall Study|Partially missing diary|0|||
161283124|NCT04895982|582415140|FG005|Overall Study|Other|0|||
161283125|NCT04895982|582415141|FG006|Overall Study|Other|0|||
161065952|NCT00511797|581632716|FG000|Overall Study|Other (moving etc)|1|||
161065953|NCT00511797|581632717|FG001|Overall Study|Other (moving etc)|0|||
161065954|NCT00511797|581632718|FG002|Overall Study|Other (moving etc)|1|||
161065955|NCT00511797|581632719|FG003|Overall Study|Other (moving etc)|2|||
161283126|NCT04895982|582415142|FG007|Overall Study|Other|0|||
161155361|NCT03342469|581949073|FG001|Overall Study|Withdrawal by Subject|1|||
161155362|NCT03342469|581949074|FG002|Overall Study|Withdrawal by Subject|0|||
161155363|NCT03342469|581949075|FG003|Overall Study|Withdrawal by Subject|0|||
161155364|NCT02928406|581949076|FG000|Overall Study|Death|780|||
161155365|NCT02928406|581949076|FG000|Overall Study|Progressive disease|3|||
161155366|NCT02928406|581949076|FG000|Overall Study|Lost to Follow-up|49|||
161155367|NCT02928406|581949076|FG000|Overall Study|Non-compliance|2|||
161155368|NCT02928406|581949076|FG000|Overall Study|Withdrawal by Subject|40|||
161155369|NCT02928406|581949076|FG000|Overall Study|Study terminated by sponsor|57|||
161155370|NCT02928406|581949076|FG000|Overall Study|Physician Decision|1|||
161155371|NCT02928406|581949076|FG000|Overall Study|Various reasons|72|||
161155372|NCT00786838|581949077|FG000|Overall Study|Physician Decision|4|||
161155373|NCT00786838|581949077|FG000|Overall Study|Death|4|||
161155374|NCT00786838|581949077|FG000|Overall Study|Adverse Event|6|||
161155375|NCT00786838|581949077|FG000|Overall Study|Progressive disease|31|||
161155376|NCT00786838|581949077|FG000|Overall Study|Withdrawal by Subject|4|||
161155377|NCT04937816|581949078|FG000|Overall Study|Study drug stopped, reason missing|5|||
161155378|NCT04937816|581949079|FG001|Overall Study|Study drug stopped, reason missing|3|||
161155379|NCT04937816|581949080|FG002|Overall Study|Study drug stopped, reason missing|4|||
161155380|NCT04937816|581949081|FG003|Overall Study|Study drug stopped, reason missing|6|||
161155381|NCT04937816|581949082|FG004|Overall Study|Study drug stopped, reason missing|1|||
161155382|NCT04937816|581949083|FG005|Overall Study|Study drug stopped, reason missing|0|||
161155383|NCT04937816|581949084|FG006|Overall Study|Study drug stopped, reason missing|0|||
161155384|NCT04937816|581949078|FG000|Overall Study|Other than stated below|173|||
161155385|NCT04937816|581949079|FG001|Overall Study|Other than stated below|143|||
161155386|NCT04937816|581949080|FG002|Overall Study|Other than stated below|125|||
161155387|NCT04937816|581949081|FG003|Overall Study|Other than stated below|44|||
161155388|NCT04937816|581949082|FG004|Overall Study|Other than stated below|45|||
161155389|NCT04937816|581949083|FG005|Overall Study|Other than stated below|28|||
161155390|NCT04937816|581949084|FG006|Overall Study|Other than stated below|31|||
161155391|NCT04937816|581949078|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
161155392|NCT04937816|581949079|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
161155393|NCT04937816|581949080|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
161155394|NCT04937816|581949081|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
161155395|NCT04937816|581949082|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
161155396|NCT04937816|581949083|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
161155397|NCT04937816|581949084|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
161155398|NCT04937816|581949078|FG000|Overall Study|Lost to Follow-up|15|||
161155399|NCT04937816|581949079|FG001|Overall Study|Lost to Follow-up|9|||
161155400|NCT04937816|581949080|FG002|Overall Study|Lost to Follow-up|6|||
161155401|NCT04937816|581949081|FG003|Overall Study|Lost to Follow-up|6|||
161155402|NCT04937816|581949082|FG004|Overall Study|Lost to Follow-up|16|||
161155403|NCT04937816|581949083|FG005|Overall Study|Lost to Follow-up|11|||
161155404|NCT04937816|581949084|FG006|Overall Study|Lost to Follow-up|17|||
161155405|NCT04937816|581949078|FG000|Overall Study|Protocol Violation|15|||
161155406|NCT04937816|581949079|FG001|Overall Study|Protocol Violation|15|||
161155407|NCT04937816|581949080|FG002|Overall Study|Protocol Violation|12|||
161155408|NCT04937816|581949081|FG003|Overall Study|Protocol Violation|30|||
161155409|NCT04937816|581949082|FG004|Overall Study|Protocol Violation|24|||
161155410|NCT04937816|581949083|FG005|Overall Study|Protocol Violation|5|||
161155411|NCT04937816|581949084|FG006|Overall Study|Protocol Violation|5|||
161155412|NCT04937816|581949078|FG000|Overall Study|Adverse Event|303|||
161155413|NCT04937816|581949079|FG001|Overall Study|Adverse Event|267|||
161155414|NCT04937816|581949080|FG002|Overall Study|Adverse Event|273|||
161283127|NCT04895982|582415143|FG008|Overall Study|Other|0|||
161283128|NCT04895982|582415144|FG009|Overall Study|Other|1|||
161283129|NCT04895982|582415145|FG010|Overall Study|Other|0|||
161283130|NCT04895982|582415146|FG011|Overall Study|Other|0|||
161283131|NCT04895982|582415135|FG000|Overall Study|Protocol Violation|0|||
161155415|NCT04937816|581949081|FG003|Overall Study|Adverse Event|553|||
161155416|NCT04937816|581949082|FG004|Overall Study|Adverse Event|575|||
161155417|NCT04937816|581949083|FG005|Overall Study|Adverse Event|343|||
161155418|NCT04937816|581949084|FG006|Overall Study|Adverse Event|337|||
161155419|NCT04937816|581949078|FG000|Overall Study|Not treated|4|||
161155420|NCT04937816|581949079|FG001|Overall Study|Not treated|2|||
161155421|NCT04937816|581949080|FG002|Overall Study|Not treated|2|||
161155422|NCT04937816|581949081|FG003|Overall Study|Not treated|2|||
161155423|NCT04937816|581949082|FG004|Overall Study|Not treated|1|||
161155424|NCT04937816|581949083|FG005|Overall Study|Not treated|4|||
161155425|NCT04937816|581949084|FG006|Overall Study|Not treated|0|||
161155426|NCT00436215|581949085|FG000|Overall Study|Refused further treatment|3|||
161155427|NCT00436215|581949085|FG000|Overall Study|Small bowel obstruction|1|||
161155428|NCT05513053|581949086|FG000|Overall Study|Lost to Follow-up|9|||
161155429|NCT05513053|581949087|FG001|Overall Study|Lost to Follow-up|11|||
161155430|NCT05513053|581949086|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161155431|NCT05513053|581949087|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161283132|NCT04895982|582415136|FG001|Overall Study|Protocol Violation|0|||
161283133|NCT04895982|582415137|FG002|Overall Study|Protocol Violation|1|||
161155432|NCT05513053|581949086|FG000|Overall Study|Withdrawal by Subject|2|||
161155433|NCT05513053|581949087|FG001|Overall Study|Withdrawal by Subject|9|||
161155434|NCT05513053|581949086|FG000|Overall Study|Protocol Violation|6|||
161155435|NCT05513053|581949087|FG001|Overall Study|Protocol Violation|3|||
161155436|NCT05513053|581949086|FG000|Overall Study|Adverse Event|0|||
161155437|NCT05513053|581949087|FG001|Overall Study|Adverse Event|2|||
161155438|NCT00948818|581951075|FG000|Overall Study|Adverse Event|10|||
161155439|NCT00948818|581951076|FG001|Overall Study|Adverse Event|32|||
161155440|NCT00948818|581951075|FG000|Overall Study|Protocol Violation|9|||
161155441|NCT00948818|581951076|FG001|Overall Study|Protocol Violation|10|||
161155442|NCT00948818|581951075|FG000|Overall Study|Withdrawal by Subject|25|||
161155443|NCT00948818|581951076|FG001|Overall Study|Withdrawal by Subject|25|||
161155444|NCT00948818|581951075|FG000|Overall Study|Lost to Follow-up|10|||
161155445|NCT00948818|581951076|FG001|Overall Study|Lost to Follow-up|17|||
161155446|NCT00948818|581951075|FG000|Overall Study|Lack of Efficacy|4|||
161155447|NCT00948818|581951076|FG001|Overall Study|Lack of Efficacy|5|||
161155448|NCT00948818|581951075|FG000|Overall Study|Other Reason|4|||
161155449|NCT00948818|581951076|FG001|Overall Study|Other Reason|5|||
161155450|NCT02330549|581951077|FG000|Overall Study|Adverse Event|1|||
161155451|NCT02330549|581951078|FG001|Overall Study|Adverse Event|0|||
161155452|NCT02330549|581951077|FG000|Overall Study|Subject withdrew consent|2|||
161155453|NCT02330549|581951078|FG001|Overall Study|Subject withdrew consent|1|||
161155454|NCT02330549|581951077|FG000|Overall Study|Failure to meet randomization criteria|1|||
161155455|NCT02330549|581951078|FG001|Overall Study|Failure to meet randomization criteria|0|||
161155456|NCT00745368|581951079|FG000|Overall Study|Unable to provide sample|3|||
161155457|NCT02364947|581951082|FG000|Overall Study|Withdrawal by Subject|10|||
161155458|NCT02364947|581951083|FG001|Overall Study|Withdrawal by Subject|8|||
161155459|NCT02364947|581951084|FG002|Overall Study|Withdrawal by Subject|9|||
161155460|NCT02364947|581951082|FG000|Overall Study|Adverse Event|45|||
161155461|NCT02364947|581951083|FG001|Overall Study|Adverse Event|33|||
161155462|NCT02364947|581951084|FG002|Overall Study|Adverse Event|11|||
161155463|NCT02364947|581951082|FG000|Overall Study|Protocol Violation|1|||
161155464|NCT02364947|581951083|FG001|Overall Study|Protocol Violation|1|||
161155465|NCT02364947|581951084|FG002|Overall Study|Protocol Violation|1|||
161155466|NCT02364947|581951082|FG000|Overall Study|Physician Decision|3|||
161155467|NCT02364947|581951083|FG001|Overall Study|Physician Decision|2|||
161155468|NCT02364947|581951084|FG002|Overall Study|Physician Decision|5|||
161155469|NCT02364947|581951082|FG000|Overall Study|Death|0|||
161155470|NCT02364947|581951083|FG001|Overall Study|Death|1|||
161155471|NCT02364947|581951084|FG002|Overall Study|Death|0|||
161155472|NCT02702518|581951088|FG000|Overall Study|Lost to Follow-up|3|||
161155473|NCT02702518|581951089|FG001|Overall Study|Lost to Follow-up|4|||
161155474|NCT00853489|581951090|FG000|Overall Study|Lost to Follow-up|5|||
161155475|NCT00853489|581951091|FG001|Overall Study|Lost to Follow-up|2|||
161155476|NCT05525975|581951092|FG000|Overall Study|Surgery cancellation|4|||
161155477|NCT05525975|581951093|FG001|Overall Study|Surgery cancellation|5|||
161155478|NCT05525975|581951092|FG000|Overall Study|didn't fill prescription|1|||
161155479|NCT05525975|581951093|FG001|Overall Study|didn't fill prescription|0|||
161155480|NCT05525975|581951092|FG000|Overall Study|Withdrawal by Subject|0|||
161155481|NCT05525975|581951093|FG001|Overall Study|Withdrawal by Subject|3|||
161155482|NCT00262080|581951100|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
161155483|NCT00262080|581951101|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
161155484|NCT00262080|581951102|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
161155485|NCT00262080|581951100|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
161155486|NCT00262080|581951101|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
161155487|NCT00262080|581951102|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
161065956|NCT02413593|581632720|FG000|Overall Study|Lost to Follow-up|3|||
161065957|NCT02413593|581632720|FG000|Overall Study|Adverse Event|1|||
161065958|NCT03845075|581632721|FG000|Part 1 - DB|Withdrawal by Subject|1|||
161065959|NCT03845075|581632722|FG001|Part 1 - DB|Withdrawal by Subject|1|||
161065960|NCT03845075|581632723|FG002|Part 1 - DB|Withdrawal by Subject|0|||
161065961|NCT03845075|581632724|FG003|Part 1 - DB|Withdrawal by Subject|0|||
161065962|NCT03845075|581632721|FG000|Part 1 - DB|Adverse Event|0|||
161065963|NCT03845075|581632722|FG001|Part 1 - DB|Adverse Event|1|||
161065964|NCT03845075|581632723|FG002|Part 1 - DB|Adverse Event|0|||
161065965|NCT03845075|581632724|FG003|Part 1 - DB|Adverse Event|0|||
161065966|NCT03845075|581632721|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
161065967|NCT03845075|581632722|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
161065968|NCT03845075|581632723|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
161155488|NCT00262080|581951100|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
161155489|NCT00262080|581951101|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
161155490|NCT00262080|581951102|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
161155491|NCT00262080|581951100|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
161155492|NCT00262080|581951101|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
161155493|NCT00262080|581951102|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
161155494|NCT00262080|581951100|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
161155495|NCT00262080|581951101|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
161155496|NCT00262080|581951102|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
161155497|NCT00262080|581951100|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
161155498|NCT00262080|581951101|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
161155499|NCT00262080|581951102|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
161155500|NCT01051986|581951103|FG000|Overall Study|Death|1|||
161155501|NCT01051986|581951104|FG001|Overall Study|Death|0|||
161155502|NCT01051986|581951103|FG000|Overall Study|Withdrawal by Subject|2|||
161155503|NCT01051986|581951104|FG001|Overall Study|Withdrawal by Subject|1|||
161155504|NCT01051986|581951103|FG000|Overall Study|Protocol Violation|2|||
161155505|NCT01051986|581951104|FG001|Overall Study|Protocol Violation|3|||
161155506|NCT04009096|581951109|FG000|Overall Study|Withdrawal by Subject|0|||
161155507|NCT04009096|581951110|FG001|Overall Study|Withdrawal by Subject|7|||
161155508|NCT04009096|581951111|FG002|Overall Study|Withdrawal by Subject|0|||
161155509|NCT04009096|581951109|FG000|Overall Study|Physician Decision|0|||
161155510|NCT04009096|581951110|FG001|Overall Study|Physician Decision|1|||
161155511|NCT04009096|581951111|FG002|Overall Study|Physician Decision|0|||
161155512|NCT04263142|581951112|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161155513|NCT04263142|581951113|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161155514|NCT04263142|581951114|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161155515|NCT04263142|581951115|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
161155516|NCT04263142|581951116|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
161155517|NCT04263142|581951112|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161155518|NCT04263142|581951113|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161155519|NCT04263142|581951114|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161155520|NCT04263142|581951115|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
161155521|NCT04263142|581951116|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
161155522|NCT00450372|581951117|FG000|Overall Study|Physician Decision|1|||
161155523|NCT00769704|581951118|FG000|Overall Study|Lost to Follow-up|3|||
161155524|NCT00769704|581951119|FG001|Overall Study|Lost to Follow-up|2|||
161155525|NCT00769704|581951118|FG000|Overall Study|Death|95|||
161155526|NCT00769704|581951119|FG001|Overall Study|Death|190|||
161155527|NCT00769704|581951118|FG000|Overall Study|Withdrawal by Subject|12|||
161155528|NCT00769704|581951119|FG001|Overall Study|Withdrawal by Subject|5|||
161155529|NCT00769704|581951118|FG000|Overall Study|Other|1|||
161155530|NCT00769704|581951119|FG001|Overall Study|Other|2|||
161155531|NCT03010423|581951120|FG000|Overall Study|Study termination|8|||
161155532|NCT00520676|581951121|FG000|Overall Study|Death|84|||
161155533|NCT00520676|581951122|FG001|Overall Study|Death|81|||
161155534|NCT00520676|581951121|FG000|Overall Study|Lost to Follow-up|6|||
161155535|NCT00520676|581951122|FG001|Overall Study|Lost to Follow-up|10|||
161155536|NCT00520676|581951121|FG000|Overall Study|Physician Decision|4|||
161155537|NCT00520676|581951122|FG001|Overall Study|Physician Decision|1|||
161155538|NCT00520676|581951121|FG000|Overall Study|Withdrawal by Subject|7|||
161155539|NCT00520676|581951122|FG001|Overall Study|Withdrawal by Subject|11|||
161155540|NCT03439748|581951123|FG000|Overall Study|Withdrawal by Subject|11|||
161155541|NCT03439748|581951124|FG001|Overall Study|Withdrawal by Subject|17|||
161155542|NCT05131451|581951125|FG000|Overall Study|Protocol Violation|1|||
161155543|NCT05131451|581951126|FG001|Overall Study|Protocol Violation|0|||
161155544|NCT01856595|581951128|FG000|Overall Study|Withdrawal by Subject|0|||
161155545|NCT01856595|581951129|FG001|Overall Study|Withdrawal by Subject|1|||
161155546|NCT01856595|581951130|FG002|Overall Study|Withdrawal by Subject|0|||
161155547|NCT01856595|581951131|FG003|Overall Study|Withdrawal by Subject|0|||
161155548|NCT01856595|581951132|FG004|Overall Study|Withdrawal by Subject|0|||
161155549|NCT01856595|581951133|FG005|Overall Study|Withdrawal by Subject|0|||
161155550|NCT01856595|581951134|FG006|Overall Study|Withdrawal by Subject|1|||
161155551|NCT01856595|581951135|FG007|Overall Study|Withdrawal by Subject|0|||
161155552|NCT01856595|581951136|FG008|Overall Study|Withdrawal by Subject|0|||
161155553|NCT04426825|581951137|FG000|Overall Study|Death|17|||
161283134|NCT04895982|582415138|FG003|Overall Study|Protocol Violation|1|||
161283135|NCT04895982|582415139|FG004|Overall Study|Protocol Violation|1|||
161155554|NCT04426825|581951137|FG000|Overall Study|Lost to Follow-up|1|||
161155555|NCT04426825|581951137|FG000|Overall Study|Study terminated by sponsor|5|||
161283136|NCT04895982|582415140|FG005|Overall Study|Protocol Violation|0|||
161283137|NCT04895982|582415141|FG006|Overall Study|Protocol Violation|0|||
161155556|NCT01863849|581951144|FG000|Overall Study|Lost to Follow-up|1|||
161155557|NCT01863849|581951145|FG001|Overall Study|Lost to Follow-up|0|||
161155558|NCT04402008|581951148|FG000|Overall Study|Adverse Event|0|||
161155559|NCT04402008|581951149|FG001|Overall Study|Adverse Event|0|||
161155560|NCT04402008|581951150|FG002|Overall Study|Adverse Event|0|||
161155561|NCT04402008|581951151|FG003|Overall Study|Adverse Event|1|||
161155562|NCT04402008|581951152|FG004|Overall Study|Adverse Event|0|||
161155563|NCT04402008|581951153|FG005|Overall Study|Adverse Event|0|||
161155564|NCT04402008|581951154|FG006|Overall Study|Adverse Event|0|||
161155565|NCT04402008|581951148|FG000|Overall Study|Disease Progression|3|||
161155566|NCT04402008|581951149|FG001|Overall Study|Disease Progression|2|||
161155567|NCT04402008|581951150|FG002|Overall Study|Disease Progression|3|||
161283138|NCT04895982|582415142|FG007|Overall Study|Protocol Violation|1|||
161283139|NCT04895982|582415143|FG008|Overall Study|Protocol Violation|0|||
161065969|NCT03845075|581632724|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
161065970|NCT03599622|581632725|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161065971|NCT03599622|581632726|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
161065972|NCT03599622|581632727|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
161065973|NCT03599622|581632728|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
161065974|NCT03599622|581632725|FG000|Pre-Treatment Period|Other reasons|1|||
161065975|NCT03599622|581632726|FG001|Pre-Treatment Period|Other reasons|1|||
161065976|NCT03599622|581632727|FG002|Pre-Treatment Period|Other reasons|1|||
161065977|NCT03599622|581632728|FG003|Pre-Treatment Period|Other reasons|0|||
161065978|NCT03599622|581632725|FG000|Treatment Period|Adverse Event|11|||
161065979|NCT03599622|581632726|FG001|Treatment Period|Adverse Event|20|||
161065980|NCT03599622|581632727|FG002|Treatment Period|Adverse Event|18|||
161065981|NCT03599622|581632728|FG003|Treatment Period|Adverse Event|2|||
161065982|NCT03599622|581632725|FG000|Treatment Period|Lack of Efficacy|18|||
161065983|NCT03599622|581632726|FG001|Treatment Period|Lack of Efficacy|12|||
161065984|NCT03599622|581632727|FG002|Treatment Period|Lack of Efficacy|13|||
161065985|NCT03599622|581632728|FG003|Treatment Period|Lack of Efficacy|2|||
161065986|NCT03599622|581632725|FG000|Treatment Period|Withdrawal by Subject|5|||
161065987|NCT03599622|581632726|FG001|Treatment Period|Withdrawal by Subject|11|||
161065988|NCT03599622|581632727|FG002|Treatment Period|Withdrawal by Subject|16|||
161065989|NCT03599622|581632728|FG003|Treatment Period|Withdrawal by Subject|1|||
161065990|NCT03599622|581632725|FG000|Treatment Period|Other reasons|4|||
161065991|NCT03599622|581632726|FG001|Treatment Period|Other reasons|6|||
161065992|NCT03599622|581632727|FG002|Treatment Period|Other reasons|7|||
161065993|NCT03599622|581632728|FG003|Treatment Period|Other reasons|0|||
161065994|NCT03599622|581632725|FG000|Treatment Period|Lost to Follow-up|1|||
161065995|NCT03599622|581632726|FG001|Treatment Period|Lost to Follow-up|0|||
161065996|NCT03599622|581632727|FG002|Treatment Period|Lost to Follow-up|0|||
161065997|NCT03599622|581632728|FG003|Treatment Period|Lost to Follow-up|0|||
161065998|NCT03599622|581632725|FG000|Treatment Period|Study terminated by sponsor|7|||
161065999|NCT03599622|581632726|FG001|Treatment Period|Study terminated by sponsor|20|||
161066000|NCT03599622|581632727|FG002|Treatment Period|Study terminated by sponsor|15|||
161066001|NCT03599622|581632728|FG003|Treatment Period|Study terminated by sponsor|0|||
161066002|NCT03599622|581632725|FG000|Treatment Period|Site terminated by sponsor|0|||
161066003|NCT03599622|581632726|FG001|Treatment Period|Site terminated by sponsor|1|||
161066004|NCT03599622|581632727|FG002|Treatment Period|Site terminated by sponsor|0|||
161066005|NCT03599622|581632728|FG003|Treatment Period|Site terminated by sponsor|0|||
161066006|NCT01006889|581632729|FG000|Overall Study|Withdrawal by Subject|3|||
161066007|NCT04706793|581632730|FG000|Treatment|Disease worsening|10|||
161066008|NCT04706793|581632731|FG001|Treatment|Disease worsening|10|||
161066009|NCT04706793|581632730|FG000|Follow-up|Lack of Efficacy|1|||
161066010|NCT04706793|581632731|FG001|Follow-up|Lack of Efficacy|0|||
161066011|NCT04706793|581632730|FG000|Follow-up|Disease worsening|8|||
161066012|NCT04706793|581632731|FG001|Follow-up|Disease worsening|10|||
161066013|NCT04706793|581632730|FG000|Follow-up|Adverse Event|1|||
161066014|NCT04706793|581632731|FG001|Follow-up|Adverse Event|0|||
161066015|NCT00823836|581632732|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
161066016|NCT00823836|581632733|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
161066017|NCT00823836|581632732|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
161066018|NCT00823836|581632733|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
161066019|NCT00823836|581632732|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
161066020|NCT00823836|581632733|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
161066021|NCT00823836|581632732|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
161066022|NCT00823836|581632733|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
161066023|NCT00823836|581632732|FG000|Long-term Phase|Adverse Event|3|||
161066024|NCT00823836|581632733|FG001|Long-term Phase|Adverse Event|2|||
161066025|NCT00823836|581632732|FG000|Long-term Phase|Physician Decision|1|||
161066026|NCT00823836|581632733|FG001|Long-term Phase|Physician Decision|2|||
161066027|NCT00823836|581632732|FG000|Long-term Phase|Withdrawal by Subject|1|||
161066028|NCT00823836|581632733|FG001|Long-term Phase|Withdrawal by Subject|1|||
161066029|NCT01130168|581632734|FG000|Period 1|Withdrawal by Subject|0|||
161066030|NCT01130168|581632735|FG001|Period 1|Withdrawal by Subject|1|||
161066031|NCT01130168|581632736|FG002|Period 1|Withdrawal by Subject|0|||
161066032|NCT01130168|581632737|FG003|Period 1|Withdrawal by Subject|1|||
161066033|NCT01130168|581632738|FG004|Period 1|Withdrawal by Subject|0|||
161066034|NCT01130168|581632739|FG005|Period 1|Withdrawal by Subject|0|||
161066035|NCT01130168|581632734|FG000|Period 1|Discontinued For Other Reason|0|||
161066036|NCT01130168|581632735|FG001|Period 1|Discontinued For Other Reason|0|||
161066037|NCT01130168|581632736|FG002|Period 1|Discontinued For Other Reason|1|||
161066038|NCT01130168|581632737|FG003|Period 1|Discontinued For Other Reason|1|||
161066039|NCT01130168|581632738|FG004|Period 1|Discontinued For Other Reason|0|||
161066040|NCT01130168|581632739|FG005|Period 1|Discontinued For Other Reason|0|||
161066041|NCT01130168|581632734|FG000|Period 1|Adverse Event|0|||
161066042|NCT01130168|581632735|FG001|Period 1|Adverse Event|0|||
161066043|NCT01130168|581632736|FG002|Period 1|Adverse Event|0|||
161155568|NCT04402008|581951151|FG003|Overall Study|Disease Progression|3|||
161155569|NCT04402008|581951152|FG004|Overall Study|Disease Progression|4|||
161155570|NCT04402008|581951153|FG005|Overall Study|Disease Progression|3|||
161155571|NCT04402008|581951154|FG006|Overall Study|Disease Progression|10|||
161155572|NCT04402008|581951148|FG000|Overall Study|Withdrawal by Subject|0|||
161155573|NCT04402008|581951149|FG001|Overall Study|Withdrawal by Subject|1|||
161155574|NCT04402008|581951150|FG002|Overall Study|Withdrawal by Subject|0|||
161155575|NCT04402008|581951151|FG003|Overall Study|Withdrawal by Subject|0|||
161155576|NCT04402008|581951152|FG004|Overall Study|Withdrawal by Subject|1|||
161155577|NCT04402008|581951153|FG005|Overall Study|Withdrawal by Subject|0|||
161155578|NCT04402008|581951154|FG006|Overall Study|Withdrawal by Subject|0|||
161155579|NCT04402008|581951148|FG000|Overall Study|Sponsor Decision|0|||
161155580|NCT04402008|581951149|FG001|Overall Study|Sponsor Decision|0|||
161155581|NCT04402008|581951150|FG002|Overall Study|Sponsor Decision|0|||
161155582|NCT04402008|581951151|FG003|Overall Study|Sponsor Decision|0|||
161155583|NCT04402008|581951152|FG004|Overall Study|Sponsor Decision|0|||
161155584|NCT04402008|581951153|FG005|Overall Study|Sponsor Decision|0|||
161155585|NCT04402008|581951154|FG006|Overall Study|Sponsor Decision|3|||
161155586|NCT04402008|581951148|FG000|Overall Study|Death|0|||
161155587|NCT04402008|581951149|FG001|Overall Study|Death|0|||
161155588|NCT04402008|581951150|FG002|Overall Study|Death|0|||
161155589|NCT04402008|581951151|FG003|Overall Study|Death|0|||
161066044|NCT01130168|581632737|FG003|Period 1|Adverse Event|1|||
161066045|NCT01130168|581632738|FG004|Period 1|Adverse Event|0|||
161066046|NCT01130168|581632739|FG005|Period 1|Adverse Event|0|||
161066047|NCT02725528|581632740|FG000|Overall Study|Lost to Follow-up|1|||
161066048|NCT02725528|581632741|FG001|Overall Study|Lost to Follow-up|4|||
161066049|NCT02725528|581632740|FG000|Overall Study|Withdrawal by Subject|0|||
161066050|NCT02725528|581632741|FG001|Overall Study|Withdrawal by Subject|1|||
161066051|NCT02635386|581632742|FG000|Overall Study|Pregnancy|2|||
161155590|NCT04402008|581951152|FG004|Overall Study|Death|1|||
161155591|NCT04402008|581951153|FG005|Overall Study|Death|0|||
161155592|NCT04402008|581951154|FG006|Overall Study|Death|2|||
161155593|NCT04402008|581951148|FG000|Overall Study|Other|0|||
161155594|NCT04402008|581951149|FG001|Overall Study|Other|0|||
161155595|NCT04402008|581951150|FG002|Overall Study|Other|0|||
161155596|NCT04402008|581951151|FG003|Overall Study|Other|0|||
161155597|NCT04402008|581951152|FG004|Overall Study|Other|0|||
161155598|NCT04402008|581951153|FG005|Overall Study|Other|0|||
161155599|NCT04402008|581951154|FG006|Overall Study|Other|5|||
161155600|NCT00913978|581951155|FG000|Overall Study|Surgeon choice|1|||
161155601|NCT00913978|581951156|FG001|Overall Study|Surgeon choice|3|||
161155602|NCT04716933|581951157|FG000|Overall Study|Sponsor Decision|36|||
161155603|NCT04716933|581951158|FG001|Overall Study|Sponsor Decision|33|||
161155604|NCT04716933|581951157|FG000|Overall Study|Death|65|||
161155605|NCT04716933|581951158|FG001|Overall Study|Death|67|||
161155606|NCT03249792|581951159|FG000|Arms 1, 2, and 4|Death|1|||
161155607|NCT03249792|581951160|FG001|Arms 1, 2, and 4|Death|1|||
161155608|NCT03249792|581951161|FG002|Arms 1, 2, and 4|Death|0|||
161155609|NCT03249792|581951162|FG003|Arms 1, 2, and 4|Death|2|||
161155610|NCT03249792|581951163|FG004|Arms 1, 2, and 4|Death|3|||
161155611|NCT03249792|581951164|FG005|Arms 1, 2, and 4|Death|2|||
161155612|NCT03249792|581951165|FG006|Arms 1, 2, and 4|Death|2|||
161155613|NCT03249792|581951166|FG007|Arms 1, 2, and 4|Death|4|||
161155614|NCT03249792|581951167|FG008|Arms 1, 2, and 4|Death|2|||
161155615|NCT03249792|581951168|FG009|Arms 1, 2, and 4|Death|1|||
161155616|NCT03249792|581951169|FG010|Arms 1, 2, and 4|Death|7|||
161066052|NCT02635386|581632743|FG001|Overall Study|Pregnancy|0|||
161066053|NCT02635386|581632744|FG002|Overall Study|Pregnancy|0|||
161066054|NCT02635386|581632745|FG003|Overall Study|Pregnancy|0|||
161155617|NCT03249792|581951170|FG011|Arms 1, 2, and 4|Death|7|||
161066055|NCT02635386|581632746|FG004|Overall Study|Pregnancy|2|||
161066056|NCT02635386|581632742|FG000|Overall Study|Withdrawal by Subject|1|||
161066057|NCT02635386|581632743|FG001|Overall Study|Withdrawal by Subject|1|||
161066058|NCT02635386|581632744|FG002|Overall Study|Withdrawal by Subject|0|||
161066059|NCT02635386|581632745|FG003|Overall Study|Withdrawal by Subject|1|||
161155618|NCT03249792|581951171|FG012|Arms 1, 2, and 4|Death|12|||
161155619|NCT03249792|581951172|FG013|Arms 1, 2, and 4|Death|7|||
161155620|NCT03249792|581951173|FG014|Arms 1, 2, and 4|Death|0|||
161155621|NCT03249792|581951174|FG015|Arms 1, 2, and 4|Death|4|||
161155622|NCT03249792|581951175|FG016|Arms 1, 2, and 4|Death|4|||
161155623|NCT03249792|581951176|FG017|Arms 1, 2, and 4|Death|12|||
161155624|NCT03249792|581951177|FG018|Arms 1, 2, and 4|Death|6|||
161155625|NCT03249792|581951178|FG019|Arms 1, 2, and 4|Death|4|||
161155626|NCT03249792|581951179|FG020|Arms 1, 2, and 4|Death|2|||
161155627|NCT03249792|581951180|FG021|Arms 1, 2, and 4|Death|3|||
161155628|NCT03249792|581951181|FG022|Arms 1, 2, and 4|Death|1|||
161155629|NCT03249792|581951182|FG023|Arms 1, 2, and 4|Death|1|||
161155630|NCT03249792|581951183|FG024|Arms 1, 2, and 4|Death|4|||
161155631|NCT03249792|581951184|FG025|Arms 1, 2, and 4|Death|0|||
161155632|NCT03249792|581951185|FG026|Arms 1, 2, and 4|Death|0|||
161155633|NCT03249792|581951186|FG027|Arms 1, 2, and 4|Death|0|||
161155634|NCT03249792|581951187|FG028|Arms 1, 2, and 4|Death|0|||
161155635|NCT03249792|581951188|FG029|Arms 1, 2, and 4|Death|0|||
161155636|NCT03249792|581951189|FG030|Arms 1, 2, and 4|Death|0|||
161345392|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
161345393|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
161345394|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
161345395|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
161345396|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
161345397|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
161345398|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
161345399|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
161345400|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
161345401|NCT01706328|582648940|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161345402|NCT01706328|582648941|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
161345403|NCT01706328|582648942|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
161345404|NCT06481579|582648944|FG000|Overall Study|Death|1|||
161345405|NCT06481579|582648945|FG001|Overall Study|Death|0|||
161345406|NCT06481579|582648944|FG000|Overall Study|Withdrawal by Subject|3|||
161345407|NCT06481579|582648945|FG001|Overall Study|Withdrawal by Subject|0|||
161345408|NCT06481579|582648944|FG000|Overall Study|Other|1|||
161345409|NCT06481579|582648945|FG001|Overall Study|Other|1|||
161345410|NCT04817410|582650807|FG000|Overall Study|Withdrawal by Subject|5|||
161345411|NCT04817410|582650807|FG000|Overall Study|Physician Decision|3|||
161345412|NCT03595748|582650808|FG000|Overall Study|Death|11|||
161345413|NCT03595748|582650809|FG001|Overall Study|Death|12|||
161345414|NCT03595748|582650808|FG000|Overall Study|Withdrawal by Subject|28|||
161345415|NCT03595748|582650809|FG001|Overall Study|Withdrawal by Subject|29|||
161066060|NCT02635386|581632746|FG004|Overall Study|Withdrawal by Subject|0|||
161066061|NCT02635386|581632742|FG000|Overall Study|Physician Decision|0|||
161066062|NCT02635386|581632743|FG001|Overall Study|Physician Decision|1|||
161066063|NCT02635386|581632744|FG002|Overall Study|Physician Decision|0|||
161066064|NCT02635386|581632745|FG003|Overall Study|Physician Decision|0|||
161066065|NCT02635386|581632746|FG004|Overall Study|Physician Decision|0|||
161066066|NCT02635386|581632742|FG000|Overall Study|Moved Out of State|0|||
161066067|NCT02635386|581632743|FG001|Overall Study|Moved Out of State|1|||
161066068|NCT02635386|581632744|FG002|Overall Study|Moved Out of State|0|||
161066069|NCT02635386|581632745|FG003|Overall Study|Moved Out of State|0|||
161066070|NCT02635386|581632746|FG004|Overall Study|Moved Out of State|0|||
161066071|NCT02635386|581632742|FG000|Overall Study|Noncompliant|0|||
161066072|NCT02635386|581632743|FG001|Overall Study|Noncompliant|2|||
161066073|NCT02635386|581632744|FG002|Overall Study|Noncompliant|1|||
161066074|NCT02635386|581632745|FG003|Overall Study|Noncompliant|1|||
161066075|NCT02635386|581632746|FG004|Overall Study|Noncompliant|1|||
161066076|NCT02635386|581632742|FG000|Overall Study|side effects|0|||
161066077|NCT02635386|581632743|FG001|Overall Study|side effects|0|||
161066078|NCT02635386|581632744|FG002|Overall Study|side effects|1|||
161066079|NCT02635386|581632745|FG003|Overall Study|side effects|4|||
161066080|NCT02635386|581632746|FG004|Overall Study|side effects|6|||
161066081|NCT02635386|581632742|FG000|Overall Study|needed other major surgery|0|||
161066082|NCT02635386|581632743|FG001|Overall Study|needed other major surgery|1|||
161066083|NCT02635386|581632744|FG002|Overall Study|needed other major surgery|0|||
161066084|NCT02635386|581632745|FG003|Overall Study|needed other major surgery|0|||
161066085|NCT02635386|581632746|FG004|Overall Study|needed other major surgery|0|||
161066086|NCT02635386|581632742|FG000|Overall Study|Other medical problems not drug related|0|||
161066087|NCT02635386|581632743|FG001|Overall Study|Other medical problems not drug related|0|||
161066088|NCT02635386|581632744|FG002|Overall Study|Other medical problems not drug related|0|||
161066089|NCT02635386|581632745|FG003|Overall Study|Other medical problems not drug related|1|||
161066090|NCT02635386|581632746|FG004|Overall Study|Other medical problems not drug related|0|||
161066091|NCT00745498|581632747|FG000|Overall Study|Lost to Follow-up|1|||
161066092|NCT00745498|581632748|FG001|Overall Study|Lost to Follow-up|1|||
161066093|NCT00745498|581632749|FG002|Overall Study|Lost to Follow-up|3|||
161066094|NCT00745498|581632747|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
161066095|NCT00745498|581632748|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
161066096|NCT00745498|581632749|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
161066097|NCT00745498|581632747|FG000|Overall Study|Non-PDR related VH|0|||
161066098|NCT00745498|581632748|FG001|Overall Study|Non-PDR related VH|1|||
161066099|NCT00745498|581632749|FG002|Overall Study|Non-PDR related VH|1|||
161066100|NCT00745498|581632747|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
161066101|NCT00745498|581632748|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
161066102|NCT00745498|581632749|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
161066103|NCT02804399|581632752|FG000|Period 2|Adverse Event|0|||
161066104|NCT02804399|581632753|FG001|Period 2|Adverse Event|1|||
161066105|NCT02706847|581632754|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
161066106|NCT02706847|581632755|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
161066107|NCT02706847|581632756|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
161066108|NCT02706847|581632757|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
161066109|NCT02706847|581632754|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
161155637|NCT03249792|581951190|FG031|Arms 1, 2, and 4|Death|0|||
161155638|NCT03249792|581951191|FG032|Arms 1, 2, and 4|Death|0|||
161155639|NCT03249792|581951159|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155640|NCT03249792|581951160|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155641|NCT03249792|581951161|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161155642|NCT03249792|581951162|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155643|NCT03249792|581951163|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155644|NCT03249792|581951164|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161155645|NCT03249792|581951165|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
161155646|NCT03249792|581951166|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155647|NCT03249792|581951167|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
161155648|NCT03249792|581951168|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161155649|NCT03249792|581951169|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
161155650|NCT03249792|581951170|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161155651|NCT03249792|581951171|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
161155652|NCT03249792|581951172|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161155653|NCT03249792|581951173|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155654|NCT03249792|581951174|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155655|NCT03249792|581951175|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
161155656|NCT03249792|581951176|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155657|NCT03249792|581951177|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161155658|NCT03249792|581951178|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155659|NCT03249792|581951179|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155660|NCT03249792|581951180|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155661|NCT03249792|581951181|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161155662|NCT03249792|581951182|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
161155663|NCT03249792|581951183|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155664|NCT03249792|581951184|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155665|NCT03249792|581951185|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155666|NCT03249792|581951186|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155667|NCT03249792|581951187|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155668|NCT03249792|581951188|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155669|NCT03249792|581951189|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155670|NCT03249792|581951190|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155671|NCT03249792|581951191|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
161155672|NCT03249792|581951159|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
161283140|NCT04895982|582415144|FG009|Overall Study|Protocol Violation|0|||
161283141|NCT04895982|582415145|FG010|Overall Study|Protocol Violation|0|||
161283142|NCT04895982|582415146|FG011|Overall Study|Protocol Violation|0|||
161283143|NCT04895982|582415135|FG000|Overall Study|Lost to Follow-up|0|||
161283144|NCT04895982|582415136|FG001|Overall Study|Lost to Follow-up|0|||
161283145|NCT04895982|582415137|FG002|Overall Study|Lost to Follow-up|1|||
161283146|NCT04895982|582415138|FG003|Overall Study|Lost to Follow-up|0|||
161283147|NCT04895982|582415139|FG004|Overall Study|Lost to Follow-up|0|||
161283148|NCT04895982|582415140|FG005|Overall Study|Lost to Follow-up|1|||
161283149|NCT04895982|582415141|FG006|Overall Study|Lost to Follow-up|0|||
161283150|NCT04895982|582415142|FG007|Overall Study|Lost to Follow-up|0|||
161283151|NCT04895982|582415143|FG008|Overall Study|Lost to Follow-up|1|||
161283152|NCT04895982|582415144|FG009|Overall Study|Lost to Follow-up|0|||
161283153|NCT04895982|582415145|FG010|Overall Study|Lost to Follow-up|0|||
161283154|NCT04895982|582415146|FG011|Overall Study|Lost to Follow-up|0|||
161283155|NCT04895982|582415135|FG000|Overall Study|Refused further study procedures|0|||
161283156|NCT04895982|582415136|FG001|Overall Study|Refused further study procedures|0|||
161283157|NCT04895982|582415137|FG002|Overall Study|Refused further study procedures|1|||
161283158|NCT04895982|582415138|FG003|Overall Study|Refused further study procedures|0|||
161283159|NCT04895982|582415139|FG004|Overall Study|Refused further study procedures|0|||
161283160|NCT04895982|582415140|FG005|Overall Study|Refused further study procedures|0|||
161283161|NCT04895982|582415141|FG006|Overall Study|Refused further study procedures|0|||
161283162|NCT04895982|582415142|FG007|Overall Study|Refused further study procedures|0|||
161283163|NCT04895982|582415143|FG008|Overall Study|Refused further study procedures|0|||
161283164|NCT04895982|582415144|FG009|Overall Study|Refused further study procedures|0|||
161283165|NCT04895982|582415145|FG010|Overall Study|Refused further study procedures|0|||
161283166|NCT04895982|582415146|FG011|Overall Study|Refused further study procedures|0|||
161283167|NCT02517463|582415152|FG000|Overall Study|Lost to Follow-up|5|||
161283168|NCT02517463|582415153|FG001|Overall Study|Lost to Follow-up|2|||
161283169|NCT02296931|582415160|FG000|Overall Study|Protocol Violation|0|||
161283170|NCT02296931|582415161|FG001|Overall Study|Protocol Violation|2|||
161283171|NCT02603146|582417577|FG000|Overall Study|Lost to Follow-up|5|||
161283172|NCT02603146|582417578|FG001|Overall Study|Lost to Follow-up|6|||
161283173|NCT02603146|582417577|FG000|Overall Study|Withdrawal by Subject|8|||
161155673|NCT03249792|581951160|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
161155674|NCT03249792|581951161|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
161155675|NCT03249792|581951162|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
161155676|NCT03249792|581951163|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
161155677|NCT03249792|581951164|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
161155678|NCT03249792|581951165|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
161155679|NCT03249792|581951166|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
161283174|NCT02603146|582417578|FG001|Overall Study|Withdrawal by Subject|10|||
161283175|NCT02603146|582417577|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
161283176|NCT02603146|582417578|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
161066110|NCT02706847|581632755|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
161066111|NCT02706847|581632756|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
161066112|NCT02706847|581632757|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
161066113|NCT02706847|581632754|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
161066114|NCT02706847|581632755|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
161066115|NCT02706847|581632756|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
161066116|NCT02706847|581632757|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
161066117|NCT02706847|581632754|FG000|Period 1: Day 1 to Week 12|Other|4|||
161066118|NCT02706847|581632755|FG001|Period 1: Day 1 to Week 12|Other|4|||
161066119|NCT02706847|581632756|FG002|Period 1: Day 1 to Week 12|Other|2|||
161066120|NCT02706847|581632757|FG003|Period 1: Day 1 to Week 12|Other|2|||
161066121|NCT02706847|581632754|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
161066122|NCT02706847|581632755|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
161066123|NCT02706847|581632756|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
161066124|NCT02706847|581632757|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
161066125|NCT02706847|581632754|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
161066126|NCT02706847|581632755|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
161066127|NCT02706847|581632756|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
161066128|NCT02706847|581632757|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
161066129|NCT02706847|581632754|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
161066130|NCT02706847|581632755|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
161066131|NCT02706847|581632756|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
161066132|NCT02706847|581632757|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
161066133|NCT02706847|581632754|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
161066134|NCT02706847|581632755|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
161066135|NCT02706847|581632756|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
161066136|NCT02706847|581632757|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
161066137|NCT02706847|581632754|FG000|Period 1: Week 12 to Week 24|Other|1|||
161066138|NCT02706847|581632755|FG001|Period 1: Week 12 to Week 24|Other|0|||
161066139|NCT02706847|581632756|FG002|Period 1: Week 12 to Week 24|Other|1|||
161066140|NCT02706847|581632757|FG003|Period 1: Week 12 to Week 24|Other|4|||
161066141|NCT02706847|581632754|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
161066142|NCT02706847|581632755|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
161066143|NCT02706847|581632756|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
161066144|NCT02706847|581632757|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
161066145|NCT02706847|581632754|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
161066146|NCT02706847|581632755|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
161066147|NCT02706847|581632756|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
161066148|NCT02706847|581632757|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
161066149|NCT02706847|581632754|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
161066150|NCT02706847|581632755|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
161066151|NCT02706847|581632756|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
161066152|NCT02706847|581632757|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
161066153|NCT02706847|581632754|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
161066154|NCT02706847|581632755|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
161066155|NCT02706847|581632756|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
161066156|NCT02706847|581632757|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
161066157|NCT02706847|581632754|FG000|Period 2: Week 24 to Week 260|Other|8|||
161066158|NCT02706847|581632755|FG001|Period 2: Week 24 to Week 260|Other|5|||
161066159|NCT02706847|581632756|FG002|Period 2: Week 24 to Week 260|Other|15|||
161066160|NCT02706847|581632757|FG003|Period 2: Week 24 to Week 260|Other|15|||
161066161|NCT03432390|581632758|FG000|Apnea Period|Protocol Violation|2|||
161066162|NCT03432390|581632759|FG001|Apnea Period|Protocol Violation|2|||
161066163|NCT02058836|581632760|FG000|Overall Study|Withdrawal by Subject|1|||
161066164|NCT02058836|581632761|FG001|Overall Study|Withdrawal by Subject|1|||
161066165|NCT01774305|581632763|FG000|Overall Study|Physician Decision|1|||
161066166|NCT01774305|581632764|FG001|Overall Study|Physician Decision|0|||
161066167|NCT00725543|581632771|FG000|Overall Study|Adverse Event|10|||
161066168|NCT00725543|581632771|FG000|Overall Study|Lack of Efficacy|3|||
161066169|NCT00725543|581632771|FG000|Overall Study|Withdrawal by Subject|10|||
161066170|NCT00725543|581632771|FG000|Overall Study|Physician Decision|5|||
161066171|NCT00725543|581632771|FG000|Overall Study|Lost to Follow-up|4|||
161066172|NCT00725543|581632771|FG000|Overall Study|Non-compliance|2|||
161066173|NCT00725543|581632771|FG000|Overall Study|Other|119|||
161066174|NCT01157377|581632772|FG000|Overall Study|Lost to Follow-up|0|||
161066175|NCT01157377|581632773|FG001|Overall Study|Lost to Follow-up|0|||
161066176|NCT01157377|581632774|FG002|Overall Study|Lost to Follow-up|1|||
161066177|NCT01157377|581632775|FG003|Overall Study|Lost to Follow-up|0|||
161283177|NCT02603146|582417577|FG000|Overall Study|Participant moved|2|||
161283178|NCT02603146|582417578|FG001|Overall Study|Participant moved|0|||
161283179|NCT02603146|582417577|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
161283180|NCT02603146|582417578|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
161283181|NCT05221320|582417581|FG000|Overall Study|Lack of Efficacy|3|||
161283182|NCT05221320|582417582|FG001|Overall Study|Lack of Efficacy|7|||
161283183|NCT05221320|582417583|FG002|Overall Study|Lack of Efficacy|10|||
161283184|NCT05221320|582417584|FG003|Overall Study|Lack of Efficacy|1|||
161283185|NCT05221320|582417585|FG004|Overall Study|Lack of Efficacy|0|||
161283186|NCT05221320|582417586|FG005|Overall Study|Lack of Efficacy|0|||
161283187|NCT05221320|582417581|FG000|Overall Study|Physician Decision|1|||
161283188|NCT05221320|582417582|FG001|Overall Study|Physician Decision|0|||
161283189|NCT05221320|582417583|FG002|Overall Study|Physician Decision|3|||
161283190|NCT05221320|582417584|FG003|Overall Study|Physician Decision|1|||
161283191|NCT05221320|582417585|FG004|Overall Study|Physician Decision|0|||
161283192|NCT05221320|582417586|FG005|Overall Study|Physician Decision|0|||
161283193|NCT05221320|582417581|FG000|Overall Study|Withdrawal by Subject|0|||
161283194|NCT05221320|582417582|FG001|Overall Study|Withdrawal by Subject|3|||
161283195|NCT05221320|582417583|FG002|Overall Study|Withdrawal by Subject|1|||
161283196|NCT05221320|582417584|FG003|Overall Study|Withdrawal by Subject|0|||
161283197|NCT05221320|582417585|FG004|Overall Study|Withdrawal by Subject|0|||
161283198|NCT05221320|582417586|FG005|Overall Study|Withdrawal by Subject|0|||
161283199|NCT05221320|582417581|FG000|Overall Study|Death|0|||
161283200|NCT05221320|582417582|FG001|Overall Study|Death|5|||
161283201|NCT05221320|582417583|FG002|Overall Study|Death|6|||
161283202|NCT05221320|582417584|FG003|Overall Study|Death|0|||
161283203|NCT05221320|582417585|FG004|Overall Study|Death|1|||
161283204|NCT05221320|582417586|FG005|Overall Study|Death|0|||
161283205|NCT05016960|582417587|FG000|Overall Study|Withdrawal by Subject|1|||
161283206|NCT05016960|582417588|FG001|Overall Study|Withdrawal by Subject|9|||
161283207|NCT03300817|582417594|FG000|Overall Study|Withdrawal by Subject|1|||
161283208|NCT03300817|582417594|FG000|Overall Study|Adverse Event|1|||
161283209|NCT03300817|582417594|FG000|Overall Study|Subject Found to be Ineligible|2|||
161283210|NCT03729596|582417596|FG000|Overall Study|Death|3|||
161283211|NCT03729596|582417597|FG001|Overall Study|Death|5|||
161283212|NCT03729596|582417598|FG002|Overall Study|Death|4|||
161283213|NCT03729596|582417599|FG003|Overall Study|Death|1|||
161283214|NCT03729596|582417600|FG004|Overall Study|Death|0|||
161283215|NCT03729596|582417601|FG005|Overall Study|Death|34|||
161283216|NCT03729596|582417602|FG006|Overall Study|Death|18|||
161283217|NCT03729596|582417603|FG007|Overall Study|Death|14|||
161283218|NCT03729596|582417604|FG008|Overall Study|Death|19|||
161283219|NCT03729596|582417605|FG009|Overall Study|Death|9|||
161283220|NCT03729596|582417596|FG000|Overall Study|Lost to Follow-up|0|||
161283221|NCT03729596|582417597|FG001|Overall Study|Lost to Follow-up|0|||
161283222|NCT03729596|582417598|FG002|Overall Study|Lost to Follow-up|0|||
161283223|NCT03729596|582417599|FG003|Overall Study|Lost to Follow-up|0|||
161283224|NCT03729596|582417600|FG004|Overall Study|Lost to Follow-up|0|||
161283225|NCT03729596|582417601|FG005|Overall Study|Lost to Follow-up|0|||
161283226|NCT03729596|582417602|FG006|Overall Study|Lost to Follow-up|1|||
161283227|NCT03729596|582417603|FG007|Overall Study|Lost to Follow-up|0|||
161283228|NCT03729596|582417604|FG008|Overall Study|Lost to Follow-up|0|||
161283229|NCT03729596|582417605|FG009|Overall Study|Lost to Follow-up|1|||
161283230|NCT03729596|582417596|FG000|Overall Study|protocol amendment|0|||
161283231|NCT03729596|582417597|FG001|Overall Study|protocol amendment|1|||
161283232|NCT03729596|582417598|FG002|Overall Study|protocol amendment|3|||
161283233|NCT03729596|582417599|FG003|Overall Study|protocol amendment|6|||
161283234|NCT03729596|582417600|FG004|Overall Study|protocol amendment|5|||
161283235|NCT03729596|582417601|FG005|Overall Study|protocol amendment|0|||
161283236|NCT03729596|582417602|FG006|Overall Study|protocol amendment|0|||
161283237|NCT03729596|582417603|FG007|Overall Study|protocol amendment|0|||
161283238|NCT03729596|582417604|FG008|Overall Study|protocol amendment|0|||
161066178|NCT01157377|581632776|FG004|Overall Study|Lost to Follow-up|1|||
161066179|NCT01157377|581632777|FG005|Overall Study|Lost to Follow-up|1|||
161066180|NCT01157377|581632778|FG006|Overall Study|Lost to Follow-up|0|||
161066181|NCT01157377|581632772|FG000|Overall Study|Personal Reasons|2|||
161066182|NCT01157377|581632773|FG001|Overall Study|Personal Reasons|1|||
161066183|NCT01157377|581632774|FG002|Overall Study|Personal Reasons|0|||
161283239|NCT03729596|582417605|FG009|Overall Study|protocol amendment|0|||
161283240|NCT03729596|582417596|FG000|Overall Study|Withdrawal by Subject|0|||
161283241|NCT03729596|582417597|FG001|Overall Study|Withdrawal by Subject|0|||
161283242|NCT03729596|582417598|FG002|Overall Study|Withdrawal by Subject|0|||
161283243|NCT03729596|582417599|FG003|Overall Study|Withdrawal by Subject|0|||
161283244|NCT03729596|582417600|FG004|Overall Study|Withdrawal by Subject|0|||
161283245|NCT03729596|582417601|FG005|Overall Study|Withdrawal by Subject|4|||
161283246|NCT03729596|582417602|FG006|Overall Study|Withdrawal by Subject|2|||
161283247|NCT03729596|582417603|FG007|Overall Study|Withdrawal by Subject|3|||
161066184|NCT01157377|581632775|FG003|Overall Study|Personal Reasons|1|||
161066185|NCT01157377|581632776|FG004|Overall Study|Personal Reasons|0|||
161283248|NCT03729596|582417604|FG008|Overall Study|Withdrawal by Subject|2|||
161283249|NCT03729596|582417605|FG009|Overall Study|Withdrawal by Subject|3|||
161283250|NCT03729596|582417596|FG000|Overall Study|study terminated by sponsor|0|||
161283251|NCT03729596|582417597|FG001|Overall Study|study terminated by sponsor|0|||
161283252|NCT03729596|582417598|FG002|Overall Study|study terminated by sponsor|0|||
161283253|NCT03729596|582417599|FG003|Overall Study|study terminated by sponsor|0|||
161283254|NCT03729596|582417600|FG004|Overall Study|study terminated by sponsor|1|||
161283255|NCT03729596|582417601|FG005|Overall Study|study terminated by sponsor|3|||
161283256|NCT03729596|582417602|FG006|Overall Study|study terminated by sponsor|0|||
161283257|NCT03729596|582417603|FG007|Overall Study|study terminated by sponsor|1|||
161283258|NCT03729596|582417604|FG008|Overall Study|study terminated by sponsor|0|||
161283259|NCT03729596|582417605|FG009|Overall Study|study terminated by sponsor|0|||
161283260|NCT03631199|582417610|FG000|Overall Study|Progressive disease|9|||
161283261|NCT03631199|582417611|FG001|Overall Study|Progressive disease|5|||
161283262|NCT03631199|582417612|FG002|Overall Study|Progressive disease|5|||
161283263|NCT03631199|582417613|FG003|Overall Study|Progressive disease|149|||
161283264|NCT03631199|582417614|FG004|Overall Study|Progressive disease|148|||
161283265|NCT03631199|582417610|FG000|Overall Study|Physician Decision|0|||
161283266|NCT03631199|582417611|FG001|Overall Study|Physician Decision|2|||
161283267|NCT03631199|582417612|FG002|Overall Study|Physician Decision|3|||
161066186|NCT01157377|581632777|FG005|Overall Study|Personal Reasons|0|||
161066187|NCT01157377|581632778|FG006|Overall Study|Personal Reasons|0|||
161066188|NCT01157377|581632772|FG000|Overall Study|Protocol Violation|0|||
161066189|NCT01157377|581632773|FG001|Overall Study|Protocol Violation|0|||
161066190|NCT01157377|581632774|FG002|Overall Study|Protocol Violation|0|||
161066191|NCT01157377|581632775|FG003|Overall Study|Protocol Violation|0|||
161066192|NCT01157377|581632776|FG004|Overall Study|Protocol Violation|0|||
161066193|NCT01157377|581632777|FG005|Overall Study|Protocol Violation|1|||
161066194|NCT01157377|581632778|FG006|Overall Study|Protocol Violation|0|||
161283268|NCT03631199|582417613|FG003|Overall Study|Physician Decision|19|||
161283269|NCT03631199|582417614|FG004|Overall Study|Physician Decision|13|||
161283270|NCT03631199|582417610|FG000|Overall Study|Adverse Event|1|||
161283271|NCT03631199|582417611|FG001|Overall Study|Adverse Event|1|||
161283272|NCT03631199|582417612|FG002|Overall Study|Adverse Event|0|||
161066195|NCT01157377|581632772|FG000|Overall Study|Lack of Efficacy|0|||
161066196|NCT01157377|581632773|FG001|Overall Study|Lack of Efficacy|0|||
161066197|NCT01157377|581632774|FG002|Overall Study|Lack of Efficacy|0|||
161066198|NCT01157377|581632775|FG003|Overall Study|Lack of Efficacy|0|||
161066199|NCT01157377|581632776|FG004|Overall Study|Lack of Efficacy|0|||
161066200|NCT01157377|581632777|FG005|Overall Study|Lack of Efficacy|0|||
161066201|NCT01157377|581632778|FG006|Overall Study|Lack of Efficacy|1|||
161066202|NCT01157377|581632772|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161066203|NCT01157377|581632773|FG001|Overall Study|Other Miscellaneous Reasons|2|||
161066204|NCT01157377|581632774|FG002|Overall Study|Other Miscellaneous Reasons|0|||
161066205|NCT01157377|581632775|FG003|Overall Study|Other Miscellaneous Reasons|0|||
161066206|NCT01157377|581632776|FG004|Overall Study|Other Miscellaneous Reasons|1|||
161066207|NCT01157377|581632777|FG005|Overall Study|Other Miscellaneous Reasons|1|||
161066208|NCT01157377|581632778|FG006|Overall Study|Other Miscellaneous Reasons|1|||
161066209|NCT00087555|581632779|FG000|Overall Study|Adverse Event|3|||
161283273|NCT03631199|582417613|FG003|Overall Study|Adverse Event|28|||
161283274|NCT03631199|582417614|FG004|Overall Study|Adverse Event|29|||
161283275|NCT03631199|582417610|FG000|Overall Study|Death|0|||
161283276|NCT03631199|582417611|FG001|Overall Study|Death|1|||
161066210|NCT00087555|581632780|FG001|Overall Study|Adverse Event|6|||
161066211|NCT00087555|581632781|FG002|Overall Study|Adverse Event|14|||
161066212|NCT00087555|581632779|FG000|Overall Study|Lost to Follow-up|0|||
161066213|NCT00087555|581632780|FG001|Overall Study|Lost to Follow-up|1|||
161066214|NCT00087555|581632781|FG002|Overall Study|Lost to Follow-up|1|||
161066215|NCT00087555|581632779|FG000|Overall Study|Non - Compliance|1|||
161283277|NCT03631199|582417612|FG002|Overall Study|Death|0|||
161066216|NCT00087555|581632780|FG001|Overall Study|Non - Compliance|0|||
161066217|NCT00087555|581632781|FG002|Overall Study|Non - Compliance|0|||
161066218|NCT00087555|581632779|FG000|Overall Study|Protocol Violation|0|||
161066219|NCT00087555|581632780|FG001|Overall Study|Protocol Violation|0|||
161066220|NCT00087555|581632781|FG002|Overall Study|Protocol Violation|2|||
161066221|NCT00087555|581632779|FG000|Overall Study|Screen Failure|1|||
161066222|NCT00087555|581632780|FG001|Overall Study|Screen Failure|1|||
161066223|NCT00087555|581632781|FG002|Overall Study|Screen Failure|0|||
161066224|NCT00087555|581632779|FG000|Overall Study|Pregnancy|0|||
161155680|NCT03249792|581951167|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
161066225|NCT00087555|581632780|FG001|Overall Study|Pregnancy|1|||
161066226|NCT00087555|581632781|FG002|Overall Study|Pregnancy|1|||
161066227|NCT00087555|581632779|FG000|Overall Study|Withdrawal by Subject|3|||
161066228|NCT00087555|581632780|FG001|Overall Study|Withdrawal by Subject|2|||
161066229|NCT00087555|581632781|FG002|Overall Study|Withdrawal by Subject|1|||
161066230|NCT00087555|581632779|FG000|Overall Study|Lack of Efficacy|2|||
161155681|NCT03249792|581951168|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
161155682|NCT03249792|581951169|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
161283278|NCT03631199|582417613|FG003|Overall Study|Death|35|||
161283279|NCT03631199|582417614|FG004|Overall Study|Death|48|||
161283280|NCT03631199|582417610|FG000|Overall Study|Subject decision|0|||
161283281|NCT03631199|582417611|FG001|Overall Study|Subject decision|1|||
161283282|NCT03631199|582417612|FG002|Overall Study|Subject decision|0|||
161066231|NCT00087555|581632780|FG001|Overall Study|Lack of Efficacy|0|||
161066232|NCT00087555|581632781|FG002|Overall Study|Lack of Efficacy|1|||
161066233|NCT00087555|581632779|FG000|Overall Study|Non Compliance|0|||
161066234|NCT00087555|581632780|FG001|Overall Study|Non Compliance|0|||
161066235|NCT00087555|581632781|FG002|Overall Study|Non Compliance|1|||
161066236|NCT00087555|581632779|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
161066237|NCT00087555|581632780|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
161066238|NCT00087555|581632781|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
161066239|NCT00087555|581632779|FG000|Overall Study|Patient wanted to go back on Med|1|||
161066240|NCT00087555|581632780|FG001|Overall Study|Patient wanted to go back on Med|0|||
161066241|NCT00087555|581632781|FG002|Overall Study|Patient wanted to go back on Med|0|||
161066242|NCT01062971|581632782|FG000|Overall Study|Protocol Violation|1|||
161066243|NCT01062971|581632783|FG001|Overall Study|Protocol Violation|3|||
161066244|NCT01062971|581632782|FG000|Overall Study|Lost to Follow-up|3|||
161066245|NCT01062971|581632783|FG001|Overall Study|Lost to Follow-up|4|||
161066246|NCT03738397|581632792|FG000|Overall Study|Adverse Event|3|||
161066247|NCT03738397|581632793|FG001|Overall Study|Adverse Event|7|||
161066248|NCT03738397|581632792|FG000|Overall Study|Withdrawal by Subject|8|||
161066249|NCT03738397|581632793|FG001|Overall Study|Withdrawal by Subject|11|||
161066250|NCT03738397|581632792|FG000|Overall Study|Lost to Follow-up|7|||
161066251|NCT03738397|581632793|FG001|Overall Study|Lost to Follow-up|5|||
161066252|NCT03738397|581632792|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
161066253|NCT03738397|581632793|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161066254|NCT03738397|581632792|FG000|Overall Study|Other|4|||
161066255|NCT03738397|581632793|FG001|Overall Study|Other|6|||
161066256|NCT00904722|581632796|FG000|Overall Study|Physician Decision|1|||
161066257|NCT00661713|581632797|FG000|Overall Study|Death|1|||
161066258|NCT00661713|581632798|FG001|Overall Study|Death|0|||
161066259|NCT00661713|581632799|FG002|Overall Study|Death|0|||
161066260|NCT00661713|581632800|FG003|Overall Study|Death|0|||
161066261|NCT00661713|581632801|FG004|Overall Study|Death|1|||
161066262|NCT00661713|581632802|FG005|Overall Study|Death|0|||
161066263|NCT00661713|581632803|FG006|Overall Study|Death|0|||
161066264|NCT00661713|581632804|FG007|Overall Study|Death|0|||
161066265|NCT00661713|581632797|FG000|Overall Study|Unable to Classify|1|||
161066266|NCT00661713|581632798|FG001|Overall Study|Unable to Classify|0|||
161066267|NCT00661713|581632799|FG002|Overall Study|Unable to Classify|0|||
161066268|NCT00661713|581632800|FG003|Overall Study|Unable to Classify|0|||
161066269|NCT00661713|581632801|FG004|Overall Study|Unable to Classify|0|||
161066270|NCT00661713|581632802|FG005|Overall Study|Unable to Classify|0|||
161066271|NCT00661713|581632803|FG006|Overall Study|Unable to Classify|0|||
161066272|NCT00661713|581632804|FG007|Overall Study|Unable to Classify|0|||
161066273|NCT00661713|581632797|FG000|Overall Study|Protocol Violation|1|||
161066274|NCT00661713|581632798|FG001|Overall Study|Protocol Violation|6|||
161066275|NCT00661713|581632799|FG002|Overall Study|Protocol Violation|3|||
161066276|NCT00661713|581632800|FG003|Overall Study|Protocol Violation|3|||
161066277|NCT00661713|581632801|FG004|Overall Study|Protocol Violation|0|||
161066278|NCT00661713|581632802|FG005|Overall Study|Protocol Violation|2|||
161066279|NCT00661713|581632803|FG006|Overall Study|Protocol Violation|2|||
161066280|NCT00661713|581632804|FG007|Overall Study|Protocol Violation|1|||
161066281|NCT00661713|581632797|FG000|Overall Study|Withdrawal by Subject|11|||
161066282|NCT00661713|581632798|FG001|Overall Study|Withdrawal by Subject|25|||
161066283|NCT00661713|581632799|FG002|Overall Study|Withdrawal by Subject|12|||
161066284|NCT00661713|581632800|FG003|Overall Study|Withdrawal by Subject|21|||
161066285|NCT00661713|581632801|FG004|Overall Study|Withdrawal by Subject|12|||
161066286|NCT00661713|581632802|FG005|Overall Study|Withdrawal by Subject|26|||
161066287|NCT00661713|581632803|FG006|Overall Study|Withdrawal by Subject|45|||
161066288|NCT00661713|581632804|FG007|Overall Study|Withdrawal by Subject|9|||
161066289|NCT00661713|581632797|FG000|Overall Study|Lost to Follow-up|2|||
161066290|NCT00661713|581632798|FG001|Overall Study|Lost to Follow-up|7|||
161066291|NCT00661713|581632799|FG002|Overall Study|Lost to Follow-up|2|||
161066292|NCT00661713|581632800|FG003|Overall Study|Lost to Follow-up|2|||
161066293|NCT00661713|581632801|FG004|Overall Study|Lost to Follow-up|5|||
161066294|NCT00661713|581632802|FG005|Overall Study|Lost to Follow-up|7|||
161066295|NCT00661713|581632803|FG006|Overall Study|Lost to Follow-up|14|||
161066296|NCT00661713|581632804|FG007|Overall Study|Lost to Follow-up|1|||
161066297|NCT00661713|581632797|FG000|Overall Study|Administrative Reason|0|||
161066298|NCT00661713|581632798|FG001|Overall Study|Administrative Reason|1|||
161066299|NCT00661713|581632799|FG002|Overall Study|Administrative Reason|0|||
161066300|NCT00661713|581632800|FG003|Overall Study|Administrative Reason|2|||
161066301|NCT00661713|581632801|FG004|Overall Study|Administrative Reason|2|||
161066302|NCT00661713|581632802|FG005|Overall Study|Administrative Reason|2|||
161066303|NCT00661713|581632803|FG006|Overall Study|Administrative Reason|1|||
161066304|NCT00661713|581632804|FG007|Overall Study|Administrative Reason|0|||
161066305|NCT00661713|581632797|FG000|Overall Study|Adverse Event|0|||
161066306|NCT00661713|581632798|FG001|Overall Study|Adverse Event|0|||
161066307|NCT00661713|581632799|FG002|Overall Study|Adverse Event|0|||
161066308|NCT00661713|581632800|FG003|Overall Study|Adverse Event|0|||
161066309|NCT00661713|581632801|FG004|Overall Study|Adverse Event|0|||
161066310|NCT00661713|581632802|FG005|Overall Study|Adverse Event|0|||
161066311|NCT00661713|581632803|FG006|Overall Study|Adverse Event|1|||
161066312|NCT00661713|581632804|FG007|Overall Study|Adverse Event|0|||
161066313|NCT00661713|581632797|FG000|Overall Study|Inappropriate Enrollment|0|||
161066314|NCT00661713|581632798|FG001|Overall Study|Inappropriate Enrollment|0|||
161066315|NCT00661713|581632799|FG002|Overall Study|Inappropriate Enrollment|0|||
161066316|NCT00661713|581632800|FG003|Overall Study|Inappropriate Enrollment|0|||
161066317|NCT00661713|581632801|FG004|Overall Study|Inappropriate Enrollment|0|||
161066318|NCT00661713|581632802|FG005|Overall Study|Inappropriate Enrollment|0|||
161066319|NCT00661713|581632803|FG006|Overall Study|Inappropriate Enrollment|1|||
161066320|NCT00661713|581632804|FG007|Overall Study|Inappropriate Enrollment|0|||
161066321|NCT01801982|581632805|FG000|Overall Study|Lost to Follow-up|1|||
161066322|NCT00727506|581632808|FG000|Overall Study|Adverse Event|0|||
161066323|NCT00727506|581632809|FG001|Overall Study|Adverse Event|0|||
161066324|NCT00727506|581632810|FG002|Overall Study|Adverse Event|4|||
161066325|NCT00727506|581632811|FG003|Overall Study|Adverse Event|4|||
161066326|NCT00727506|581632812|FG004|Overall Study|Adverse Event|1|||
161066327|NCT00727506|581632813|FG005|Overall Study|Adverse Event|8|||
161066328|NCT00727506|581632808|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161066329|NCT00727506|581632809|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161066330|NCT00727506|581632810|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
161066331|NCT00727506|581632811|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161066332|NCT00727506|581632812|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161066333|NCT00727506|581632813|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
161066334|NCT00727506|581632808|FG000|Overall Study|Progressive disease|4|||
161066335|NCT00727506|581632809|FG001|Overall Study|Progressive disease|7|||
161066336|NCT00727506|581632810|FG002|Overall Study|Progressive disease|9|||
161066337|NCT00727506|581632811|FG003|Overall Study|Progressive disease|28|||
161066338|NCT00727506|581632812|FG004|Overall Study|Progressive disease|38|||
161066339|NCT00727506|581632813|FG005|Overall Study|Progressive disease|28|||
161066340|NCT00727506|581632808|FG000|Overall Study|Refused to continue medication|0|||
161066341|NCT00727506|581632809|FG001|Overall Study|Refused to continue medication|1|||
161066342|NCT00727506|581632810|FG002|Overall Study|Refused to continue medication|2|||
161066343|NCT00727506|581632811|FG003|Overall Study|Refused to continue medication|3|||
161066344|NCT00727506|581632812|FG004|Overall Study|Refused to continue medication|1|||
161066345|NCT00727506|581632813|FG005|Overall Study|Refused to continue medication|2|||
161066346|NCT00727506|581632808|FG000|Overall Study|Other reason not described above|0|||
161066347|NCT00727506|581632809|FG001|Overall Study|Other reason not described above|0|||
161066348|NCT00727506|581632810|FG002|Overall Study|Other reason not described above|1|||
161066349|NCT00727506|581632811|FG003|Overall Study|Other reason not described above|4|||
161066350|NCT00727506|581632812|FG004|Overall Study|Other reason not described above|1|||
161066351|NCT00727506|581632813|FG005|Overall Study|Other reason not described above|1|||
161066352|NCT02650466|581632815|FG000|Overall Study|Physician Decision|1|||
161066353|NCT02650466|581632815|FG000|Overall Study|Withdrawal by Subject|5|||
161066354|NCT02650466|581632815|FG000|Overall Study|Lost to Follow-up|1|||
161066355|NCT01214421|581632819|FG000|Overall Study|Lost to Follow-up|7|||
161066356|NCT01214421|581632820|FG001|Overall Study|Lost to Follow-up|3|||
161066357|NCT01214421|581632821|FG002|Overall Study|Lost to Follow-up|7|||
161066358|NCT01214421|581632822|FG003|Overall Study|Lost to Follow-up|3|||
161066359|NCT01214421|581632819|FG000|Overall Study|Adverse Event|16|||
161066360|NCT01214421|581632820|FG001|Overall Study|Adverse Event|35|||
161066361|NCT01214421|581632821|FG002|Overall Study|Adverse Event|14|||
161066362|NCT01214421|581632822|FG003|Overall Study|Adverse Event|3|||
161066363|NCT01214421|581632819|FG000|Overall Study|Sponsor Discontinued Site|1|||
161066364|NCT01214421|581632820|FG001|Overall Study|Sponsor Discontinued Site|2|||
161066365|NCT01214421|581632821|FG002|Overall Study|Sponsor Discontinued Site|0|||
161066366|NCT01214421|581632822|FG003|Overall Study|Sponsor Discontinued Site|0|||
161066367|NCT01214421|581632819|FG000|Overall Study|Withdrawal Criteria Met|3|||
161066368|NCT01214421|581632820|FG001|Overall Study|Withdrawal Criteria Met|0|||
161066369|NCT01214421|581632821|FG002|Overall Study|Withdrawal Criteria Met|2|||
161066370|NCT01214421|581632822|FG003|Overall Study|Withdrawal Criteria Met|1|||
161066371|NCT01214421|581632819|FG000|Overall Study|Physician Decision|2|||
161066372|NCT01214421|581632820|FG001|Overall Study|Physician Decision|0|||
161066373|NCT01214421|581632821|FG002|Overall Study|Physician Decision|4|||
161066374|NCT01214421|581632822|FG003|Overall Study|Physician Decision|0|||
161066375|NCT01214421|581632819|FG000|Overall Study|Withdrawal by Subject|21|||
161066376|NCT01214421|581632820|FG001|Overall Study|Withdrawal by Subject|18|||
161066377|NCT01214421|581632821|FG002|Overall Study|Withdrawal by Subject|11|||
161066378|NCT01214421|581632822|FG003|Overall Study|Withdrawal by Subject|2|||
161066379|NCT03783689|581632824|FG000|Overall Study|Adverse Event|2|||
161066380|NCT03783689|581632825|FG001|Overall Study|Adverse Event|0|||
161066381|NCT03783689|581632824|FG000|Overall Study|Lost to Follow-up|2|||
161066382|NCT03783689|581632825|FG001|Overall Study|Lost to Follow-up|1|||
161066383|NCT03783689|581632824|FG000|Overall Study|Physician Decision|2|||
161066384|NCT03783689|581632825|FG001|Overall Study|Physician Decision|1|||
161066385|NCT03783689|581632824|FG000|Overall Study|Withdrawal by Subject|3|||
161155683|NCT03249792|581951170|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
161066386|NCT03783689|581632825|FG001|Overall Study|Withdrawal by Subject|3|||
161066387|NCT00691678|581632827|FG000|Overall Study|Adverse Event|5|||
161066388|NCT00691678|581632827|FG000|Overall Study|life events, pain|11|||
161066389|NCT05347485|581632831|FG000|Overall Study|Death|14|||
161066390|NCT05347485|581632831|FG000|Overall Study|Lost to Follow-up|2|||
161066391|NCT05347485|581632831|FG000|Overall Study|Withdrawal by Subject|13|||
161066392|NCT05347485|581632831|FG000|Overall Study|Progressive Disease|1|||
161066393|NCT05347485|581632831|FG000|Overall Study|Study Terminated by Sponsor|49|||
161066394|NCT05347485|581632831|FG000|Overall Study|Other|1|||
161066395|NCT05347485|581632831|FG000|Overall Study|Enrolled (consented) but not treated|4|||
161066396|NCT05347485|581632831|FG000|Overall Study|Disease Relapse|2|||
161066397|NCT03526679|581634300|FG000|Overall Study|still under treatment|2|||
161066398|NCT00903760|581634301|FG000|Overall Study|Disease Progression/Death|8|||
161066399|NCT00903760|581634302|FG001|Overall Study|Disease Progression/Death|6|||
161066400|NCT00903760|581634301|FG000|Overall Study|Stem Cell Transplant|8|||
161066401|NCT00903760|581634302|FG001|Overall Study|Stem Cell Transplant|4|||
161066402|NCT00903760|581634301|FG000|Overall Study|Physician Decision|1|||
161066403|NCT00903760|581634302|FG001|Overall Study|Physician Decision|2|||
161066404|NCT00903760|581634301|FG000|Overall Study|Death|0|||
161066405|NCT00903760|581634302|FG001|Overall Study|Death|1|||
161066406|NCT00903760|581634301|FG000|Overall Study|Lost to Follow-up|1|||
161066407|NCT00903760|581634302|FG001|Overall Study|Lost to Follow-up|0|||
161066408|NCT00903760|581634301|FG000|Overall Study|Withdrawal by Subject|1|||
161066409|NCT00903760|581634302|FG001|Overall Study|Withdrawal by Subject|2|||
161066410|NCT00903760|581634301|FG000|Overall Study|Off treatment for long period|0|||
161066411|NCT00903760|581634302|FG001|Overall Study|Off treatment for long period|1|||
161066412|NCT00487825|581634304|FG000|Overall Study|Adverse Event|2|||
161066413|NCT00487825|581634305|FG001|Overall Study|Adverse Event|2|||
161066414|NCT00487825|581634304|FG000|Overall Study|Lack of Efficacy|1|||
161066415|NCT00487825|581634305|FG001|Overall Study|Lack of Efficacy|1|||
161066416|NCT00487825|581634304|FG000|Overall Study|Other|3|||
161066417|NCT00487825|581634305|FG001|Overall Study|Other|2|||
161066418|NCT01256671|581634306|FG000|Overall Study|Adverse Event|29|||
161066419|NCT01256671|581634306|FG000|Overall Study|Lost to Follow-up|16|||
161066420|NCT01256671|581634306|FG000|Overall Study|Withdrawal by Subject|31|||
161066421|NCT01256671|581634306|FG000|Overall Study|Physician Decision|3|||
161066422|NCT01256671|581634306|FG000|Overall Study|Lack of Efficacy|4|||
161066423|NCT01256671|581634306|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
161066424|NCT01986114|581634307|FG000|Overall Study|Adverse Event|59|||
161066425|NCT01986114|581634307|FG000|Overall Study|Lack of Efficacy|23|||
161066426|NCT01986114|581634307|FG000|Overall Study|Withdrawal by Subject|58|||
161066427|NCT01986114|581634307|FG000|Overall Study|Noncompliance|3|||
161066428|NCT01986114|581634307|FG000|Overall Study|Protocol Violation|1|||
161066429|NCT01986114|581634307|FG000|Overall Study|Lost to Follow-up|5|||
161066430|NCT01986114|581634307|FG000|Overall Study|Other reason|7|||
161066431|NCT01190644|581634308|FG000|Overall Study|Death|2|||
161066432|NCT01190644|581634308|FG000|Overall Study|Disease progression|1|||
161066433|NCT01638390|581634311|FG000|Overall Study|screening failures|21|||
161066434|NCT01536587|581634314|FG000|Overall Study|Adverse Event|2|||
161066435|NCT02666664|581634315|FG000|Overall Study|Physician Decision|0|||
161066436|NCT02666664|581634316|FG001|Overall Study|Physician Decision|1|||
161066437|NCT02666664|581634315|FG000|Overall Study|Protocol Violation|0|||
161066438|NCT02666664|581634316|FG001|Overall Study|Protocol Violation|2|||
161066439|NCT02666664|581634315|FG000|Overall Study|Other|0|||
161066440|NCT02666664|581634316|FG001|Overall Study|Other|1|||
161283283|NCT03631199|582417613|FG003|Overall Study|Subject decision|12|||
161283284|NCT03631199|582417614|FG004|Overall Study|Subject decision|12|||
161066441|NCT02666664|581634315|FG000|Overall Study|Adverse Event|12|||
161283285|NCT03631199|582417610|FG000|Overall Study|No treated|0|||
161283286|NCT03631199|582417611|FG001|Overall Study|No treated|0|||
161283287|NCT03631199|582417612|FG002|Overall Study|No treated|0|||
161283288|NCT03631199|582417613|FG003|Overall Study|No treated|0|||
161283289|NCT03631199|582417614|FG004|Overall Study|No treated|1|||
161283290|NCT03631199|582417610|FG000|Overall Study|Treatment ongoing|0|||
161283291|NCT03631199|582417611|FG001|Overall Study|Treatment ongoing|1|||
161066442|NCT02666664|581634316|FG001|Overall Study|Adverse Event|37|||
161066443|NCT02666664|581634315|FG000|Overall Study|Withdrawal by participant|23|||
161066444|NCT02666664|581634316|FG001|Overall Study|Withdrawal by participant|40|||
161066445|NCT02666664|581634315|FG000|Overall Study|Sponsor decision|0|||
161066446|NCT02666664|581634316|FG001|Overall Study|Sponsor decision|1|||
161066447|NCT02666664|581634315|FG000|Overall Study|Lost to Follow-up|1|||
161066448|NCT02666664|581634316|FG001|Overall Study|Lost to Follow-up|2|||
161066449|NCT04836559|581634317|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161066450|NCT04836559|581634318|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
161066451|NCT04836559|581634319|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
161066452|NCT04836559|581634320|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
161155684|NCT03249792|581951171|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
161283292|NCT03631199|582417612|FG002|Overall Study|Treatment ongoing|1|||
161283293|NCT03631199|582417613|FG003|Overall Study|Treatment ongoing|76|||
161066453|NCT04836559|581634321|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161066454|NCT04836559|581634322|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161066455|NCT04836559|581634323|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161066456|NCT04836559|581634324|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
161066457|NCT04836559|581634317|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161066458|NCT04836559|581634318|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
161066459|NCT04836559|581634319|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
161066460|NCT04836559|581634320|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
161066461|NCT04836559|581634321|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161066462|NCT04836559|581634322|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161066463|NCT04836559|581634323|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161066464|NCT04836559|581634324|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
161066465|NCT04836559|581634317|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
161066466|NCT04836559|581634318|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066467|NCT04836559|581634319|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066468|NCT04836559|581634320|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066469|NCT04836559|581634321|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066470|NCT04836559|581634322|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066471|NCT04836559|581634323|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066472|NCT04836559|581634324|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
161066473|NCT04836559|581634317|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
161066474|NCT04836559|581634318|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066475|NCT04836559|581634319|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066476|NCT04836559|581634320|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066477|NCT04836559|581634321|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066478|NCT04836559|581634322|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066479|NCT04836559|581634323|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066480|NCT04836559|581634324|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
161066481|NCT04836559|581634317|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066482|NCT04836559|581634318|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066483|NCT04836559|581634319|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066484|NCT04836559|581634320|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
161066485|NCT04836559|581634321|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066486|NCT04836559|581634322|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066487|NCT04836559|581634323|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066488|NCT04836559|581634324|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
161066489|NCT04836559|581634317|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161066490|NCT04836559|581634318|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161066491|NCT04836559|581634319|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161066492|NCT04836559|581634320|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
161066493|NCT04836559|581634321|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
161066494|NCT04836559|581634322|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
161066495|NCT04836559|581634323|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
161066496|NCT04836559|581634324|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
161066497|NCT04836559|581634317|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161066498|NCT04836559|581634318|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161066499|NCT04836559|581634319|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161066500|NCT04836559|581634320|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
161066501|NCT04836559|581634321|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
161066502|NCT04836559|581634322|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
161066503|NCT04836559|581634323|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
161066504|NCT04836559|581634324|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
161066505|NCT04836559|581634317|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161066506|NCT04836559|581634318|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161066507|NCT04836559|581634319|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161066508|NCT04836559|581634320|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161066509|NCT04836559|581634321|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
161066510|NCT04836559|581634322|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
161066511|NCT04836559|581634323|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
161066512|NCT04836559|581634324|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
161066513|NCT04836559|581634317|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161283294|NCT03631199|582417614|FG004|Overall Study|Treatment ongoing|71|||
161283295|NCT03631199|582417610|FG000|Overall Study|Guardian decision|0|||
161283296|NCT03631199|582417611|FG001|Overall Study|Guardian decision|0|||
161283297|NCT03631199|582417612|FG002|Overall Study|Guardian decision|0|||
161283298|NCT03631199|582417613|FG003|Overall Study|Guardian decision|1|||
161283299|NCT03631199|582417614|FG004|Overall Study|Guardian decision|1|||
161283300|NCT03999996|582417615|FG000|Prior to Booster|Adverse Event|2|||
161283301|NCT03999996|582417616|FG001|Prior to Booster|Adverse Event|0|||
161283302|NCT03999996|582417617|FG002|Prior to Booster|Adverse Event|0|||
161283303|NCT03999996|582417618|FG003|Prior to Booster|Adverse Event|0|||
161283304|NCT03999996|582417615|FG000|Prior to Booster|Lost to Follow-up|17|||
161283305|NCT03999996|582417616|FG001|Prior to Booster|Lost to Follow-up|22|||
161283306|NCT03999996|582417617|FG002|Prior to Booster|Lost to Follow-up|0|||
161283307|NCT03999996|582417618|FG003|Prior to Booster|Lost to Follow-up|0|||
161283308|NCT03999996|582417615|FG000|Prior to Booster|Withdrawal of Consent|51|||
161283309|NCT03999996|582417616|FG001|Prior to Booster|Withdrawal of Consent|8|||
161283310|NCT03999996|582417617|FG002|Prior to Booster|Withdrawal of Consent|0|||
161283311|NCT03999996|582417618|FG003|Prior to Booster|Withdrawal of Consent|0|||
161283312|NCT03999996|582417615|FG000|Prior to Booster|Death|0|||
161283313|NCT03999996|582417616|FG001|Prior to Booster|Death|1|||
161283314|NCT03999996|582417617|FG002|Prior to Booster|Death|0|||
161283315|NCT03999996|582417618|FG003|Prior to Booster|Death|0|||
161283316|NCT03999996|582417615|FG000|Prior to Booster|Reason Not Specified|27|||
161066514|NCT04836559|581634318|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161066515|NCT04836559|581634319|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161066516|NCT04836559|581634320|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161066517|NCT04836559|581634321|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161066518|NCT04836559|581634322|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161066519|NCT04836559|581634323|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
161066520|NCT04836559|581634324|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
161066521|NCT04978350|581634325|FG000|Overall Study|Lost to Follow-up|6|||
161066522|NCT03865953|581634330|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
161066523|NCT03865953|581634331|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161066524|NCT03865953|581634330|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
161066525|NCT03865953|581634331|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
161066526|NCT03865953|581634330|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
161066527|NCT03865953|581634331|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
161066528|NCT00412880|581634342|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
161066529|NCT00412880|581634342|FG000|Overall Study|Consent withdrawn|1|||
161066530|NCT00412880|581634342|FG000|Overall Study|Adverse Event|1|||
161066531|NCT00412880|581634342|FG000|Overall Study|Progressive disease|20|||
161066532|NCT02232399|581634343|FG000|Overall Study|Adverse Event|1|||
161066533|NCT02232399|581634344|FG001|Overall Study|Adverse Event|0|||
161066534|NCT02232399|581634343|FG000|Overall Study|Withdrawal by Subject|0|||
161066535|NCT02232399|581634344|FG001|Overall Study|Withdrawal by Subject|1|||
161066536|NCT01162135|581634352|FG000|Overall Study|Withdrawal by Subject|1|||
161066537|NCT01162135|581634352|FG000|Overall Study|Severe back pain|1|||
161066538|NCT01162135|581634352|FG000|Overall Study|Ineligible|1|||
161066539|NCT01777334|581634353|FG000|Overall Study|Adverse Event|18|||
161066540|NCT01777334|581634354|FG001|Overall Study|Adverse Event|14|||
161066541|NCT01777334|581634353|FG000|Overall Study|Lack of Efficacy|15|||
161066542|NCT01777334|581634354|FG001|Overall Study|Lack of Efficacy|29|||
161066543|NCT01777334|581634353|FG000|Overall Study|Protocol Violation|3|||
161066544|NCT01777334|581634354|FG001|Overall Study|Protocol Violation|7|||
161066545|NCT01777334|581634353|FG000|Overall Study|Lost to Follow-up|3|||
161066546|NCT01777334|581634354|FG001|Overall Study|Lost to Follow-up|2|||
161066547|NCT01777334|581634353|FG000|Overall Study|Withdrawal by Subject|14|||
161066548|NCT01777334|581634354|FG001|Overall Study|Withdrawal by Subject|11|||
161066549|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
161066550|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
161283317|NCT03999996|582417616|FG001|Prior to Booster|Reason Not Specified|4|||
161283318|NCT03999996|582417617|FG002|Prior to Booster|Reason Not Specified|0|||
161066551|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
161066552|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
161066553|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
161066554|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
161066555|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
161066556|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
161066557|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
161283319|NCT03999996|582417618|FG003|Prior to Booster|Reason Not Specified|0|||
161283320|NCT03999996|582417615|FG000|Booster Phase|Lost to Follow-up|0|||
161283321|NCT03999996|582417616|FG001|Booster Phase|Lost to Follow-up|0|||
161283322|NCT03999996|582417617|FG002|Booster Phase|Lost to Follow-up|3|||
161283323|NCT03999996|582417618|FG003|Booster Phase|Lost to Follow-up|3|||
161283324|NCT03999996|582417615|FG000|Booster Phase|Withdrawal of Consent|0|||
161283325|NCT03999996|582417616|FG001|Booster Phase|Withdrawal of Consent|0|||
161066558|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
161066559|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
161066560|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
161066561|NCT01216072|581634362|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
161066562|NCT01216072|581634363|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
161066563|NCT01216072|581634362|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
161066564|NCT01216072|581634363|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
161066565|NCT01216072|581634362|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
161066566|NCT01216072|581634363|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
161066567|NCT01216072|581634362|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
161066568|NCT01216072|581634363|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
161066569|NCT04799418|581634367|FG000|Overall Study|Death|1|||
161066570|NCT04799418|581634368|FG001|Overall Study|Death|1|||
161066571|NCT04799418|581634367|FG000|Overall Study|Lack of Efficacy|14|||
161066572|NCT04799418|581634368|FG001|Overall Study|Lack of Efficacy|14|||
161066573|NCT04799418|581634367|FG000|Overall Study|Withdrawal by Subject|10|||
161066574|NCT04799418|581634368|FG001|Overall Study|Withdrawal by Subject|7|||
161066575|NCT04799418|581634367|FG000|Overall Study|Adverse Event|3|||
161066576|NCT04799418|581634368|FG001|Overall Study|Adverse Event|2|||
161066577|NCT00107978|581634371|FG000|Overall Study|Adverse Event|1|||
161066578|NCT00107978|581634372|FG001|Overall Study|Adverse Event|5|||
161066579|NCT00107978|581634371|FG000|Overall Study|Death|3|||
161066580|NCT00107978|581634372|FG001|Overall Study|Death|3|||
161066581|NCT00107978|581634371|FG000|Overall Study|Lost to Follow-up|20|||
161066582|NCT00107978|581634372|FG001|Overall Study|Lost to Follow-up|28|||
161066583|NCT00107978|581634371|FG000|Overall Study|Withdrawal by Subject|4|||
161066584|NCT00107978|581634372|FG001|Overall Study|Withdrawal by Subject|9|||
161066585|NCT00107978|581634371|FG000|Overall Study|Protocol Violation|0|||
161066586|NCT00107978|581634372|FG001|Overall Study|Protocol Violation|1|||
161066587|NCT00107978|581634371|FG000|Overall Study|Other|5|||
161066588|NCT00107978|581634372|FG001|Overall Study|Other|4|||
161066589|NCT02669407|581634373|FG000|Overall Study|Physician Decision|3|||
161066590|NCT00350298|581634375|FG000|Overall Study|Death|7|||
161066591|NCT00350298|581634376|FG001|Overall Study|Death|8|||
161066592|NCT00350298|581634375|FG000|Overall Study|Lost to Follow-up|1|||
161066593|NCT00350298|581634376|FG001|Overall Study|Lost to Follow-up|2|||
161066594|NCT00350298|581634375|FG000|Overall Study|Withdrawal by Subject|1|||
161066595|NCT00350298|581634376|FG001|Overall Study|Withdrawal by Subject|3|||
161066596|NCT00822770|581634379|FG000|Overall Study|Not treated|1|||
161066597|NCT00822770|581634380|FG001|Overall Study|Not treated|0|||
161066598|NCT00822770|581634379|FG000|Overall Study|Complication/Incomplete treatment|1|||
161066599|NCT00822770|581634380|FG001|Overall Study|Complication/Incomplete treatment|0|||
161066600|NCT00822770|581634379|FG000|Overall Study|Death|1|||
161066601|NCT00822770|581634380|FG001|Overall Study|Death|1|||
161066602|NCT00992992|581634381|FG000|Overall Study|Lost to Follow-up|3|||
161066603|NCT00992992|581634381|FG000|Overall Study|Death|16|||
161066604|NCT00992992|581634381|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
161066605|NCT00992992|581634381|FG000|Overall Study|Sponsor Closed the Study|4|||
161066606|NCT00217022|581634383|FG000|Overall Study|Withdrawal by Subject|1|||
161066607|NCT00217022|581634384|FG001|Overall Study|Withdrawal by Subject|1|||
161066608|NCT05178979|581634385|FG000|Overall Study|Death|0|||
161066609|NCT05178979|581634386|FG001|Overall Study|Death|5|||
161066610|NCT05178979|581634387|FG002|Overall Study|Death|0|||
161066611|NCT05178979|581634388|FG003|Overall Study|Death|3|||
161066612|NCT05178979|581634385|FG000|Overall Study|Adverse Event|0|||
161066613|NCT05178979|581634386|FG001|Overall Study|Adverse Event|1|||
161066614|NCT05178979|581634387|FG002|Overall Study|Adverse Event|0|||
161066615|NCT05178979|581634388|FG003|Overall Study|Adverse Event|0|||
161066616|NCT05178979|581634385|FG000|Overall Study|Lost to Follow-up|1|||
161066617|NCT05178979|581634386|FG001|Overall Study|Lost to Follow-up|8|||
161066618|NCT05178979|581634387|FG002|Overall Study|Lost to Follow-up|3|||
161066619|NCT05178979|581634388|FG003|Overall Study|Lost to Follow-up|8|||
161066620|NCT00817336|581634389|FG000|Overall Study|Withdrawal by Subject|1|||
161066621|NCT00817336|581634390|FG001|Overall Study|Withdrawal by Subject|1|||
161066622|NCT01253447|581634391|FG000|Overall Study|Adverse Event|2|||
161066623|NCT02299427|581634392|FG000|Overall Study|Withdrawal by Subject|1|||
161066624|NCT02299427|581634393|FG001|Overall Study|Withdrawal by Subject|0|||
161066625|NCT02299427|581634392|FG000|Overall Study|Lost to Follow-up|1|||
161066626|NCT02299427|581634393|FG001|Overall Study|Lost to Follow-up|3|||
161066627|NCT02299427|581634392|FG000|Overall Study|not adherent to dog website use|21|||
161066628|NCT02299427|581634393|FG001|Overall Study|not adherent to dog website use|0|||
161066629|NCT02108652|581634394|FG000|Overall Study|Death|253|||
161066630|NCT02108652|581634394|FG000|Overall Study|Lost to Follow-up|2|||
161066631|NCT02108652|581634394|FG000|Overall Study|Withdrawal by Subject|16|||
161066632|NCT02108652|581634394|FG000|Overall Study|Study Terminated By Sponsor|31|||
161066633|NCT02108652|581634394|FG000|Overall Study|Non-Compliance|1|||
161066634|NCT02108652|581634394|FG000|Overall Study|Physician Decision|6|||
161155685|NCT03249792|581951172|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
161066635|NCT02108652|581634394|FG000|Overall Study|Progression Of Disease|1|||
161066636|NCT01704547|581634395|FG000|Overall Study|Physician Decision|4|||
161066637|NCT01704547|581634395|FG000|Overall Study|Withdrawal by Subject|1|||
161066638|NCT02564718|581634396|FG000|Overall Study|Withdrew from treatment|0|||
161066639|NCT02564718|581634397|FG001|Overall Study|Withdrew from treatment|1|||
161066640|NCT00104637|581634398|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
161066641|NCT00104637|581634399|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
161066642|NCT00409409|581634400|FG000|Overall Study|Adverse Event|7|||
161066643|NCT00409409|581634401|FG001|Overall Study|Adverse Event|2|||
161066644|NCT00409409|581634400|FG000|Overall Study|Withdrawal by Subject|1|||
161066645|NCT00409409|581634401|FG001|Overall Study|Withdrawal by Subject|1|||
161066646|NCT00409409|581634400|FG000|Overall Study|Any other reason not above-mentioned|0|||
161066647|NCT00409409|581634401|FG001|Overall Study|Any other reason not above-mentioned|1|||
161066648|NCT02138253|581634405|FG000|Overall Study|Adverse Event|3|||
161066649|NCT02138253|581634406|FG001|Overall Study|Adverse Event|3|||
161066650|NCT02138253|581634405|FG000|Overall Study|Lost to Follow-up|2|||
161066651|NCT02138253|581634406|FG001|Overall Study|Lost to Follow-up|1|||
161066652|NCT02138253|581634405|FG000|Overall Study|Physician Decision|2|||
161066653|NCT02138253|581634406|FG001|Overall Study|Physician Decision|0|||
161066654|NCT02138253|581634405|FG000|Overall Study|Non compliance|1|||
161066655|NCT02138253|581634406|FG001|Overall Study|Non compliance|0|||
161066656|NCT02138253|581634405|FG000|Overall Study|Withdrawal by Subject|1|||
161066657|NCT02138253|581634406|FG001|Overall Study|Withdrawal by Subject|0|||
161066658|NCT01918371|581634407|FG000|Overall Study|Missing Data|1|||
161066659|NCT01918371|581634408|FG001|Overall Study|Missing Data|1|||
161066660|NCT04211389|581634413|FG000|Overall Study|Adverse Event|1|||
161066661|NCT04211389|581634414|FG001|Overall Study|Adverse Event|2|||
161066662|NCT04211389|581634413|FG000|Overall Study|Lost to Follow-up|15|||
161066663|NCT04211389|581634414|FG001|Overall Study|Lost to Follow-up|7|||
161066664|NCT04211389|581634413|FG000|Overall Study|Protocol Violation|0|||
161066665|NCT04211389|581634414|FG001|Overall Study|Protocol Violation|1|||
161066666|NCT04211389|581634413|FG000|Overall Study|Withdrawal by Subject|10|||
161066667|NCT04211389|581634414|FG001|Overall Study|Withdrawal by Subject|11|||
161066668|NCT00547534|581634418|FG000|Overall Study|Adverse Event|7|||
161066669|NCT00547534|581634418|FG000|Overall Study|Disease Progression|4|||
161066670|NCT02168478|581634422|FG000|Overall Study|Withdrawal by Subject|1|||
161066671|NCT02168478|581634422|FG000|Overall Study|Did Not Consent to Participation|2|||
161066672|NCT02168478|581634422|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
161066673|NCT05523219|581634423|FG000|Overall Study|Wrong inclusion|1|||
161066674|NCT05523219|581634423|FG000|Overall Study|Lost to Follow-up|7|||
161066675|NCT02760485|581634424|FG000|Phase 1|Death|3|||
161066676|NCT02760485|581634425|FG001|Phase 1|Death|6|||
161066677|NCT02760485|581634426|FG002|Phase 1|Death|0|||
161066678|NCT02760485|581634424|FG000|Phase 1|Withdrawal by Subject|2|||
161066679|NCT02760485|581634425|FG001|Phase 1|Withdrawal by Subject|0|||
161066680|NCT02760485|581634426|FG002|Phase 1|Withdrawal by Subject|0|||
161066681|NCT02760485|581634424|FG000|Phase 1|Progressive Disease|1|||
161066682|NCT02760485|581634425|FG001|Phase 1|Progressive Disease|0|||
161066683|NCT02760485|581634426|FG002|Phase 1|Progressive Disease|0|||
161066684|NCT02760485|581634424|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
161066685|NCT02760485|581634425|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
161066686|NCT02760485|581634426|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
161066687|NCT02760485|581634424|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
161066688|NCT02760485|581634425|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
161066689|NCT02760485|581634426|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
161066690|NCT02760485|581634424|FG000|Phase 2|Death|0|||
161066691|NCT02760485|581634425|FG001|Phase 2|Death|0|||
161066692|NCT02760485|581634426|FG002|Phase 2|Death|12|||
161066693|NCT02760485|581634424|FG000|Phase 2|Withdrawal by Subject|0|||
161283326|NCT03999996|582417617|FG002|Booster Phase|Withdrawal of Consent|0|||
161283327|NCT03999996|582417618|FG003|Booster Phase|Withdrawal of Consent|1|||
161283328|NCT03999996|582417615|FG000|Booster Phase|Reason Not Specified|0|||
161283329|NCT03999996|582417616|FG001|Booster Phase|Reason Not Specified|0|||
161283330|NCT03999996|582417617|FG002|Booster Phase|Reason Not Specified|0|||
161283331|NCT03999996|582417618|FG003|Booster Phase|Reason Not Specified|1|||
161066694|NCT02760485|581634425|FG001|Phase 2|Withdrawal by Subject|0|||
161155686|NCT03249792|581951173|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
161066695|NCT02760485|581634426|FG002|Phase 2|Withdrawal by Subject|3|||
161066696|NCT02760485|581634424|FG000|Phase 2|Progressive Disease|0|||
161155687|NCT03249792|581951174|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
161066697|NCT02760485|581634425|FG001|Phase 2|Progressive Disease|0|||
161066698|NCT02760485|581634426|FG002|Phase 2|Progressive Disease|1|||
161066699|NCT02760485|581634424|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
161066700|NCT02760485|581634425|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
161066701|NCT02760485|581634426|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
161066702|NCT01087814|581634427|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
161066703|NCT01087814|581634428|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
161283332|NCT03690388|582417619|FG000|Overall Study|Adverse Event|8|||
161283333|NCT03690388|582417620|FG001|Overall Study|Adverse Event|1|||
161283334|NCT03690388|582417619|FG000|Overall Study|Radiographic Progression|14|||
161283335|NCT03690388|582417620|FG001|Overall Study|Radiographic Progression|29|||
161283336|NCT03690388|582417619|FG000|Overall Study|Clinical deterioration|10|||
161283337|NCT03690388|582417620|FG001|Overall Study|Clinical deterioration|6|||
161283338|NCT03690388|582417619|FG000|Overall Study|Withdrawal by Subject|2|||
161283339|NCT03690388|582417620|FG001|Overall Study|Withdrawal by Subject|0|||
161283340|NCT03690388|582417619|FG000|Overall Study|Lack of Efficacy|1|||
161283341|NCT03690388|582417620|FG001|Overall Study|Lack of Efficacy|0|||
161283342|NCT03690388|582417619|FG000|Overall Study|Lost to Follow-up|1|||
161283343|NCT03690388|582417620|FG001|Overall Study|Lost to Follow-up|0|||
161283344|NCT03765788|582417621|FG000|Overall Study|Subject decision|2|||
161283345|NCT03765788|582417622|FG001|Overall Study|Subject decision|3|||
161283346|NCT03765788|582417621|FG000|Overall Study|Physician Decision|2|||
161283347|NCT03765788|582417622|FG001|Overall Study|Physician Decision|4|||
161283348|NCT03765788|582417621|FG000|Overall Study|Death|0|||
161283349|NCT03765788|582417622|FG001|Overall Study|Death|1|||
161283350|NCT03765788|582417621|FG000|Overall Study|Lost to Follow-up|1|||
161283351|NCT03765788|582417622|FG001|Overall Study|Lost to Follow-up|0|||
161283352|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
161283353|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
161283354|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
161283355|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
161283356|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
161283357|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
161283358|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
161283359|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
161283360|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
161283361|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
161283362|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
161283363|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
161283364|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
161283365|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
161283366|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
161283367|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
161283368|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
161283369|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
161283370|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
161283371|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
161283372|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
161283373|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
161283374|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
161283375|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
161283376|NCT01130532|582417626|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
161283377|NCT01130532|582417627|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
161283378|NCT01130532|582417628|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
161283379|NCT01130532|582417629|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
161283380|NCT01130532|582417626|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
161283381|NCT01130532|582417627|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
161283382|NCT01130532|582417628|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
161283383|NCT01130532|582417629|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
161283384|NCT01130532|582417626|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161283385|NCT01130532|582417627|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161283386|NCT01130532|582417628|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
161066704|NCT01087814|581634427|FG000|Second Intervention (5 Days)|Physician Decision|1|||
161066705|NCT01087814|581634428|FG001|Second Intervention (5 Days)|Physician Decision|0|||
161066706|NCT01427738|581634429|FG000|Overall Study|Death|12|||
161066707|NCT01427738|581634430|FG001|Overall Study|Death|9|||
161283387|NCT01130532|582417629|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
161283388|NCT01130532|582417626|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161283389|NCT01130532|582417627|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161283390|NCT01130532|582417628|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
161283391|NCT01130532|582417629|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
161283392|NCT01130532|582417626|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161283393|NCT01130532|582417627|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161283394|NCT01130532|582417628|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
161283395|NCT01130532|582417629|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
161283396|NCT02656303|582417630|FG000|Overall Study|Adverse Event|3|||
161066708|NCT01427738|581634429|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161283397|NCT02656303|582417631|FG001|Overall Study|Adverse Event|2|||
161283398|NCT02656303|582417632|FG002|Overall Study|Adverse Event|0|||
161283399|NCT02656303|582417630|FG000|Overall Study|Death|12|||
161066709|NCT01427738|581634430|FG001|Overall Study|Severe debilitation, unable to continue|1|||
161066710|NCT01427738|581634429|FG000|Overall Study|Subject unable to get to clinic|5|||
161066711|NCT01427738|581634430|FG001|Overall Study|Subject unable to get to clinic|2|||
161066712|NCT01427738|581634429|FG000|Overall Study|Withdrawal by Subject|0|||
161066713|NCT01427738|581634430|FG001|Overall Study|Withdrawal by Subject|2|||
161066714|NCT01427738|581634429|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
161066715|NCT01427738|581634430|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
161066716|NCT01427738|581634429|FG000|Overall Study|Lost to Follow-up|1|||
161066717|NCT01427738|581634430|FG001|Overall Study|Lost to Follow-up|5|||
161066718|NCT05314374|581634431|FG000|Overall Study|Adverse Event|2|||
161066719|NCT05314374|581634432|FG001|Overall Study|Adverse Event|2|||
161066720|NCT02392104|581634433|FG000|Overall Study|discontinuation of warfarin|3|||
161066721|NCT02392104|581634433|FG000|Overall Study|bleeding event|1|||
161066722|NCT02392104|581634433|FG000|Overall Study|transferred care to another doctor|2|||
161066723|NCT02392104|581634433|FG000|Overall Study|INR goal range changed|1|||
161066724|NCT02392104|581634433|FG000|Overall Study|admitted to skilled nursing facility|3|||
161066725|NCT02392104|581634433|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
161066726|NCT04887506|581634434|FG000|Overall Study|Death|1|||
161066727|NCT04887506|581634435|FG001|Overall Study|Death|1|||
161066728|NCT04887506|581634434|FG000|Overall Study|Withdrawal by Subject|0|||
161066729|NCT04887506|581634435|FG001|Overall Study|Withdrawal by Subject|3|||
161066730|NCT04887506|581634434|FG000|Overall Study|Adverse Event|4|||
161066731|NCT04887506|581634435|FG001|Overall Study|Adverse Event|3|||
161066732|NCT04887506|581634434|FG000|Overall Study|Other - Not Reported|1|||
161066733|NCT04887506|581634435|FG001|Overall Study|Other - Not Reported|1|||
161066734|NCT03783871|581634436|FG000|Overall Study|Withdrawal by Subject|15|||
161066735|NCT03783871|581634436|FG000|Overall Study|Death|13|||
161066736|NCT03783871|581634436|FG000|Overall Study|Lost to Follow-up|2|||
161066737|NCT05990387|581634437|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
161066738|NCT05990387|581634438|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
161066739|NCT03522389|581634439|FG000|Overall Study|Lost to Follow-up|1|||
161066740|NCT03522389|581634440|FG001|Overall Study|Lost to Follow-up|1|||
161066741|NCT03522389|581634441|FG002|Overall Study|Lost to Follow-up|2|||
161066742|NCT03522389|581634439|FG000|Overall Study|had herniated nucleus pulposus|0|||
161066743|NCT03522389|581634440|FG001|Overall Study|had herniated nucleus pulposus|1|||
161066744|NCT03522389|581634441|FG002|Overall Study|had herniated nucleus pulposus|0|||
161066745|NCT03522389|581634439|FG000|Overall Study|go to work in other province|1|||
161066746|NCT03522389|581634440|FG001|Overall Study|go to work in other province|0|||
161066747|NCT03522389|581634441|FG002|Overall Study|go to work in other province|0|||
161066748|NCT00604188|581634442|FG000|Overall Study|Adverse Event|1|||
161066749|NCT00604188|581634443|FG001|Overall Study|Adverse Event|4|||
161066750|NCT00604188|581634442|FG000|Overall Study|Lost to Follow-up|17|||
161066751|NCT00604188|581634443|FG001|Overall Study|Lost to Follow-up|15|||
161066752|NCT00604188|581634442|FG000|Overall Study|Withdrawal by Subject|5|||
161066753|NCT00604188|581634443|FG001|Overall Study|Withdrawal by Subject|1|||
161066754|NCT00604188|581634442|FG000|Overall Study|Non-compliance with protocol|4|||
161066755|NCT00604188|581634443|FG001|Overall Study|Non-compliance with protocol|4|||
161066756|NCT00604188|581634442|FG000|Overall Study|Did not receive study drug|0|||
161066757|NCT00604188|581634443|FG001|Overall Study|Did not receive study drug|1|||
161066758|NCT02242643|581634446|FG000|Overall Study|Protocol Violation|1|||
161066759|NCT02242643|581634447|FG001|Overall Study|Protocol Violation|2|||
161066760|NCT02242643|581634446|FG000|Overall Study|Withdrawal by Subject|15|||
161066761|NCT02242643|581634447|FG001|Overall Study|Withdrawal by Subject|10|||
161066762|NCT02242643|581634446|FG000|Overall Study|Migrated/moved from study area|1|||
161066763|NCT02242643|581634447|FG001|Overall Study|Migrated/moved from study area|3|||
161066764|NCT02242643|581634446|FG000|Overall Study|Lost to Follow-up|54|||
161066765|NCT02242643|581634447|FG001|Overall Study|Lost to Follow-up|61|||
161066766|NCT02242643|581634446|FG000|Overall Study|Child placed in foster care by family|0|||
161066767|NCT02242643|581634447|FG001|Overall Study|Child placed in foster care by family|1|||
161066768|NCT02242643|581634446|FG000|Overall Study|Non-compliance|1|||
161066769|NCT02242643|581634447|FG001|Overall Study|Non-compliance|0|||
161066770|NCT02242643|581634446|FG000|Overall Study|Consent withdrawal by parent|1|||
161066771|NCT02242643|581634447|FG001|Overall Study|Consent withdrawal by parent|0|||
161066772|NCT02242643|581634446|FG000|Overall Study|Protocol requirements not followed|1|||
161066773|NCT02242643|581634447|FG001|Overall Study|Protocol requirements not followed|0|||
161066774|NCT02242643|581634446|FG000|Overall Study|Language barrier|1|||
161066775|NCT02242643|581634447|FG001|Overall Study|Language barrier|0|||
161066776|NCT02242643|581634446|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
161066777|NCT02242643|581634447|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
161066778|NCT00321685|581636022|FG000|Overall Study|Adverse Event|18|||
161066779|NCT00321685|581636022|FG000|Overall Study|Death|2|||
161066780|NCT00321685|581636022|FG000|Overall Study|Withdrawal by Subject|8|||
161066781|NCT00321685|581636022|FG000|Overall Study|Alternative therapy|1|||
161066782|NCT00321685|581636022|FG000|Overall Study|Complicating disese|1|||
161066783|NCT00321685|581636022|FG000|Overall Study|Other|5|||
161066784|NCT00321685|581636022|FG000|Overall Study|Not start protocol therapy|2|||
161066785|NCT00321685|581636022|FG000|Overall Study|Ineligible|2|||
161066786|NCT03616964|581636026|FG000|Overall Study|Adverse Event|15|||
161283400|NCT02656303|582417631|FG001|Overall Study|Death|4|||
161283401|NCT02656303|582417632|FG002|Overall Study|Death|1|||
161283402|NCT02656303|582417630|FG000|Overall Study|Lack of Efficacy|1|||
161283403|NCT02656303|582417631|FG001|Overall Study|Lack of Efficacy|0|||
161283404|NCT02656303|582417632|FG002|Overall Study|Lack of Efficacy|0|||
161283405|NCT02656303|582417630|FG000|Overall Study|Non-Compliance with Study|1|||
161283406|NCT02656303|582417631|FG001|Overall Study|Non-Compliance with Study|1|||
161066787|NCT03616964|581636027|FG001|Overall Study|Adverse Event|10|||
161066788|NCT03616964|581636028|FG002|Overall Study|Adverse Event|16|||
161066789|NCT03616964|581636026|FG000|Overall Study|Death|3|||
161066790|NCT03616964|581636027|FG001|Overall Study|Death|0|||
161066791|NCT03616964|581636028|FG002|Overall Study|Death|4|||
161066792|NCT03616964|581636026|FG000|Overall Study|Lack of Efficacy|4|||
161066793|NCT03616964|581636027|FG001|Overall Study|Lack of Efficacy|8|||
161066794|NCT03616964|581636028|FG002|Overall Study|Lack of Efficacy|8|||
161066795|NCT03616964|581636026|FG000|Overall Study|Lost to Follow-up|2|||
161066796|NCT03616964|581636027|FG001|Overall Study|Lost to Follow-up|1|||
161066797|NCT03616964|581636028|FG002|Overall Study|Lost to Follow-up|3|||
161283407|NCT02656303|582417632|FG002|Overall Study|Non-Compliance with Study|0|||
161283408|NCT02656303|582417630|FG000|Overall Study|Investigator Decision|2|||
161066798|NCT03616964|581636026|FG000|Overall Study|Withdrawal by Subject|18|||
161066799|NCT03616964|581636027|FG001|Overall Study|Withdrawal by Subject|14|||
161066800|NCT03616964|581636028|FG002|Overall Study|Withdrawal by Subject|21|||
161066801|NCT03616964|581636026|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
161066802|NCT03616964|581636027|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
161066803|NCT03616964|581636028|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
161066804|NCT03616964|581636026|FG000|Overall Study|Sponsor's Decision|1|||
161066805|NCT03616964|581636027|FG001|Overall Study|Sponsor's Decision|0|||
161066806|NCT03616964|581636028|FG002|Overall Study|Sponsor's Decision|0|||
161066807|NCT03616964|581636026|FG000|Overall Study|Physician Decision|0|||
161066808|NCT03616964|581636027|FG001|Overall Study|Physician Decision|2|||
161066809|NCT03616964|581636028|FG002|Overall Study|Physician Decision|0|||
161066810|NCT03616964|581636026|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
161066811|NCT03616964|581636027|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
161066812|NCT03616964|581636028|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
161066813|NCT03616964|581636026|FG000|Overall Study|Protocol Violation|0|||
161066814|NCT03616964|581636027|FG001|Overall Study|Protocol Violation|1|||
161066815|NCT03616964|581636028|FG002|Overall Study|Protocol Violation|0|||
161066816|NCT03616964|581636026|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
161066817|NCT03616964|581636027|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
161066818|NCT03616964|581636028|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
161066819|NCT03616964|581636026|FG000|Overall Study|Randomized but Never Treated|1|||
161066820|NCT03616964|581636027|FG001|Overall Study|Randomized but Never Treated|1|||
161066821|NCT03616964|581636028|FG002|Overall Study|Randomized but Never Treated|1|||
161066822|NCT04596995|581636029|FG000|Overall Study|Lack of Efficacy|8|||
161066823|NCT04596995|581636029|FG000|Overall Study|Lost to Follow-up|3|||
161066824|NCT04596995|581636029|FG000|Overall Study|Withdrawal by Subject|12|||
161066825|NCT04596995|581636029|FG000|Overall Study|Sponsor decision|3|||
161066826|NCT04596995|581636029|FG000|Overall Study|Enrolled in managed access program|3|||
161066827|NCT00129935|581636030|FG000|Overall Study|Adverse Event|18|||
161066828|NCT00129935|581636031|FG001|Overall Study|Adverse Event|56|||
161066829|NCT00129935|581636030|FG000|Overall Study|Death|1|||
161066830|NCT00129935|581636031|FG001|Overall Study|Death|1|||
161066831|NCT00129935|581636030|FG000|Overall Study|Withdrawal by Subject|7|||
161066832|NCT00129935|581636031|FG001|Overall Study|Withdrawal by Subject|20|||
161066833|NCT00129935|581636030|FG000|Overall Study|Protocol Violation|0|||
161066834|NCT00129935|581636031|FG001|Overall Study|Protocol Violation|4|||
161066835|NCT00129935|581636030|FG000|Overall Study|Physician Decision|3|||
161066836|NCT00129935|581636031|FG001|Overall Study|Physician Decision|4|||
161066837|NCT00129935|581636030|FG000|Overall Study|Recurrence|1|||
161066838|NCT00129935|581636031|FG001|Overall Study|Recurrence|3|||
161066839|NCT00129935|581636030|FG000|Overall Study|Second primary|0|||
161283409|NCT02656303|582417631|FG001|Overall Study|Investigator Decision|1|||
161283410|NCT02656303|582417632|FG002|Overall Study|Investigator Decision|0|||
161066840|NCT00129935|581636031|FG001|Overall Study|Second primary|1|||
161066841|NCT00129935|581636030|FG000|Overall Study|Other|3|||
161066842|NCT00129935|581636031|FG001|Overall Study|Other|2|||
161066843|NCT00129935|581636030|FG000|Overall Study|Crossed to the other arm|2|||
161283411|NCT02656303|582417630|FG000|Overall Study|Progressive Disease|25|||
161066844|NCT00129935|581636031|FG001|Overall Study|Crossed to the other arm|1|||
161066845|NCT00129935|581636030|FG000|Overall Study|Incorrect study treatment|1|||
161066846|NCT00129935|581636031|FG001|Overall Study|Incorrect study treatment|0|||
161066847|NCT02056626|581636032|FG000|Overall Study|patient did not follow directions|3|||
161283412|NCT02656303|582417631|FG001|Overall Study|Progressive Disease|14|||
161283413|NCT02656303|582417632|FG002|Overall Study|Progressive Disease|10|||
161283414|NCT02656303|582417630|FG000|Overall Study|Study Terminated by Sponsor|20|||
161066848|NCT02056626|581636033|FG001|Overall Study|patient did not follow directions|1|||
161066849|NCT02056626|581636034|FG002|Overall Study|patient did not follow directions|0|||
161066850|NCT02056626|581636035|FG003|Overall Study|patient did not follow directions|0|||
161066851|NCT04916002|581636037|FG000|Overall Study|Adverse Event|0|||
161066852|NCT04916002|581636038|FG001|Overall Study|Adverse Event|1|||
161066853|NCT04916002|581636039|FG002|Overall Study|Adverse Event|0|||
161066854|NCT04916002|581636040|FG003|Overall Study|Adverse Event|1|||
161066855|NCT04916002|581636041|FG004|Overall Study|Adverse Event|0|||
161066856|NCT04916002|581636037|FG000|Overall Study|Withdrawal by Subject|3|||
161066857|NCT04916002|581636038|FG001|Overall Study|Withdrawal by Subject|1|||
161066858|NCT04916002|581636039|FG002|Overall Study|Withdrawal by Subject|0|||
161066859|NCT04916002|581636040|FG003|Overall Study|Withdrawal by Subject|1|||
161066860|NCT04916002|581636041|FG004|Overall Study|Withdrawal by Subject|0|||
161066861|NCT04916002|581636037|FG000|Overall Study|Death|8|||
161066862|NCT04916002|581636038|FG001|Overall Study|Death|7|||
161066863|NCT04916002|581636039|FG002|Overall Study|Death|4|||
161066864|NCT04916002|581636040|FG003|Overall Study|Death|9|||
161066865|NCT04916002|581636041|FG004|Overall Study|Death|0|||
161066866|NCT04916002|581636037|FG000|Overall Study|Study Terminated by Sponsor|11|||
161066867|NCT04916002|581636038|FG001|Overall Study|Study Terminated by Sponsor|10|||
161066868|NCT04916002|581636039|FG002|Overall Study|Study Terminated by Sponsor|8|||
161066869|NCT04916002|581636040|FG003|Overall Study|Study Terminated by Sponsor|5|||
161066870|NCT04916002|581636041|FG004|Overall Study|Study Terminated by Sponsor|4|||
161066871|NCT04916002|581636037|FG000|Overall Study|End of trial|1|||
161066872|NCT04916002|581636038|FG001|Overall Study|End of trial|0|||
161066873|NCT04916002|581636039|FG002|Overall Study|End of trial|0|||
161066874|NCT04916002|581636040|FG003|Overall Study|End of trial|0|||
161066875|NCT04916002|581636041|FG004|Overall Study|End of trial|0|||
161066876|NCT04916002|581636037|FG000|Overall Study|Progressive disease|0|||
161066877|NCT04916002|581636038|FG001|Overall Study|Progressive disease|0|||
161066878|NCT04916002|581636039|FG002|Overall Study|Progressive disease|1|||
161066879|NCT04916002|581636040|FG003|Overall Study|Progressive disease|0|||
161066880|NCT04916002|581636041|FG004|Overall Study|Progressive disease|0|||
161066881|NCT04916002|581636037|FG000|Overall Study|Participant non-compliance|2|||
161066882|NCT04916002|581636038|FG001|Overall Study|Participant non-compliance|0|||
161066883|NCT04916002|581636039|FG002|Overall Study|Participant non-compliance|0|||
161066884|NCT04916002|581636040|FG003|Overall Study|Participant non-compliance|0|||
161066885|NCT04916002|581636041|FG004|Overall Study|Participant non-compliance|0|||
161066886|NCT03210519|581636042|FG000|Overall Study|Adverse Event|2|||
161066887|NCT03210519|581636043|FG001|Overall Study|Adverse Event|0|||
161066888|NCT05147350|581636044|FG000|Overall Study|Death|2|||
161066889|NCT05147350|581636045|FG001|Overall Study|Death|3|||
161066890|NCT05147350|581636046|FG002|Overall Study|Death|3|||
161066891|NCT05147350|581636047|FG003|Overall Study|Death|2|||
161066892|NCT05147350|581636048|FG004|Overall Study|Death|2|||
161066893|NCT05147350|581636049|FG005|Overall Study|Death|1|||
161066894|NCT05147350|581636050|FG006|Overall Study|Death|1|||
161066895|NCT05147350|581636051|FG007|Overall Study|Death|3|||
161066896|NCT05147350|581636044|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
161066897|NCT05147350|581636045|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
161066898|NCT05147350|581636046|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
161066899|NCT05147350|581636047|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
161066900|NCT05147350|581636048|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
161066901|NCT05147350|581636049|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
161066902|NCT05147350|581636050|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
161066903|NCT05147350|581636051|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
161066904|NCT05147350|581636044|FG000|Overall Study|Withdrawal by Subject|0|||
161066905|NCT05147350|581636045|FG001|Overall Study|Withdrawal by Subject|0|||
161066906|NCT05147350|581636046|FG002|Overall Study|Withdrawal by Subject|3|||
161066907|NCT05147350|581636047|FG003|Overall Study|Withdrawal by Subject|1|||
161066908|NCT05147350|581636048|FG004|Overall Study|Withdrawal by Subject|1|||
161066909|NCT05147350|581636049|FG005|Overall Study|Withdrawal by Subject|0|||
161066910|NCT05147350|581636050|FG006|Overall Study|Withdrawal by Subject|1|||
161283415|NCT02656303|582417631|FG001|Overall Study|Study Terminated by Sponsor|7|||
161066911|NCT05147350|581636051|FG007|Overall Study|Withdrawal by Subject|0|||
161066912|NCT05147350|581636044|FG000|Overall Study|Other Reasons|0|||
161066913|NCT05147350|581636045|FG001|Overall Study|Other Reasons|0|||
161066914|NCT05147350|581636046|FG002|Overall Study|Other Reasons|2|||
161066915|NCT05147350|581636047|FG003|Overall Study|Other Reasons|0|||
161283416|NCT02656303|582417632|FG002|Overall Study|Study Terminated by Sponsor|5|||
161283417|NCT02656303|582417630|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
161283418|NCT02656303|582417631|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
161066916|NCT05147350|581636048|FG004|Overall Study|Other Reasons|0|||
161066917|NCT05147350|581636049|FG005|Overall Study|Other Reasons|2|||
161066918|NCT05147350|581636050|FG006|Overall Study|Other Reasons|1|||
161066919|NCT05147350|581636051|FG007|Overall Study|Other Reasons|1|||
161066920|NCT06136897|581636052|FG000|Overall Study|Ineligible|3|||
161066921|NCT06136897|581636052|FG000|Overall Study|Mutation status not confirmed|7|||
161066922|NCT06136897|581636052|FG000|Overall Study|Adverse Event|2|||
161066923|NCT06136897|581636052|FG000|Overall Study|Death|1|||
161066924|NCT06136897|581636052|FG000|Overall Study|Disease progression|18|||
161066925|NCT06136897|581636052|FG000|Overall Study|Other complicating disease|1|||
161066926|NCT06136897|581636052|FG000|Overall Study|Withdrawal by Subject|1|||
161066927|NCT06136897|581636052|FG000|Overall Study|Still on treatment|1|||
161066928|NCT06136897|581636052|FG000|Overall Study|Lost to Follow-up|1|||
161066929|NCT02947100|581636053|FG000|Overall Study|study terminated early|3|||
161066930|NCT02947100|581636053|FG000|Overall Study|did not meet inclusion criteria|1|||
161066931|NCT01296555|581636057|FG000|Overall Study|Adverse Event|0|||
161066932|NCT01296555|581636058|FG001|Overall Study|Adverse Event|0|||
161066933|NCT01296555|581636059|FG002|Overall Study|Adverse Event|1|||
161066934|NCT01296555|581636060|FG003|Overall Study|Adverse Event|1|||
161066935|NCT01296555|581636061|FG004|Overall Study|Adverse Event|2|||
161066936|NCT01296555|581636062|FG005|Overall Study|Adverse Event|4|||
161066937|NCT01296555|581636063|FG006|Overall Study|Adverse Event|1|||
161066938|NCT01296555|581636064|FG007|Overall Study|Adverse Event|4|||
161066939|NCT01296555|581636065|FG008|Overall Study|Adverse Event|3|||
161066940|NCT01296555|581636066|FG009|Overall Study|Adverse Event|1|||
161066941|NCT01296555|581636067|FG010|Overall Study|Adverse Event|0|||
161066942|NCT01296555|581636068|FG011|Overall Study|Adverse Event|4|||
161066943|NCT01296555|581636069|FG012|Overall Study|Adverse Event|1|||
161066944|NCT01296555|581636070|FG013|Overall Study|Adverse Event|4|||
161066945|NCT01296555|581636071|FG014|Overall Study|Adverse Event|0|||
161066946|NCT01296555|581636072|FG015|Overall Study|Adverse Event|0|||
161066947|NCT01296555|581636073|FG016|Overall Study|Adverse Event|0|||
161066948|NCT01296555|581636074|FG017|Overall Study|Adverse Event|0|||
161066949|NCT01296555|581636075|FG018|Overall Study|Adverse Event|0|||
161066950|NCT01296555|581636076|FG019|Overall Study|Adverse Event|1|||
161066951|NCT01296555|581636077|FG020|Overall Study|Adverse Event|0|||
161066952|NCT01296555|581636078|FG021|Overall Study|Adverse Event|0|||
161066953|NCT01296555|581636079|FG022|Overall Study|Adverse Event|0|||
161066954|NCT01296555|581636080|FG023|Overall Study|Adverse Event|0|||
161066955|NCT01296555|581636081|FG024|Overall Study|Adverse Event|0|||
161066956|NCT01296555|581636082|FG025|Overall Study|Adverse Event|0|||
161066957|NCT01296555|581636083|FG026|Overall Study|Adverse Event|0|||
161066958|NCT01296555|581636084|FG027|Overall Study|Adverse Event|0|||
161066959|NCT01296555|581636085|FG028|Overall Study|Adverse Event|0|||
161066960|NCT01296555|581636057|FG000|Overall Study|Reason Not Specified|0|||
161066961|NCT01296555|581636058|FG001|Overall Study|Reason Not Specified|0|||
161066962|NCT01296555|581636059|FG002|Overall Study|Reason Not Specified|0|||
161066963|NCT01296555|581636060|FG003|Overall Study|Reason Not Specified|0|||
161066964|NCT01296555|581636061|FG004|Overall Study|Reason Not Specified|0|||
161066965|NCT01296555|581636062|FG005|Overall Study|Reason Not Specified|0|||
161066966|NCT01296555|581636063|FG006|Overall Study|Reason Not Specified|0|||
161066967|NCT01296555|581636064|FG007|Overall Study|Reason Not Specified|0|||
161066968|NCT01296555|581636065|FG008|Overall Study|Reason Not Specified|0|||
161066969|NCT01296555|581636066|FG009|Overall Study|Reason Not Specified|0|||
161066970|NCT01296555|581636067|FG010|Overall Study|Reason Not Specified|0|||
161066971|NCT01296555|581636068|FG011|Overall Study|Reason Not Specified|0|||
161066972|NCT01296555|581636069|FG012|Overall Study|Reason Not Specified|0|||
161066973|NCT01296555|581636070|FG013|Overall Study|Reason Not Specified|1|||
161066974|NCT01296555|581636071|FG014|Overall Study|Reason Not Specified|2|||
161066975|NCT01296555|581636072|FG015|Overall Study|Reason Not Specified|3|||
161066976|NCT01296555|581636073|FG016|Overall Study|Reason Not Specified|7|||
161066977|NCT01296555|581636074|FG017|Overall Study|Reason Not Specified|4|||
161066978|NCT01296555|581636075|FG018|Overall Study|Reason Not Specified|3|||
161066979|NCT01296555|581636076|FG019|Overall Study|Reason Not Specified|7|||
161066980|NCT01296555|581636077|FG020|Overall Study|Reason Not Specified|11|||
161066981|NCT01296555|581636078|FG021|Overall Study|Reason Not Specified|5|||
161066982|NCT01296555|581636079|FG022|Overall Study|Reason Not Specified|5|||
161066983|NCT01296555|581636080|FG023|Overall Study|Reason Not Specified|7|||
161066984|NCT01296555|581636081|FG024|Overall Study|Reason Not Specified|2|||
161066985|NCT01296555|581636082|FG025|Overall Study|Reason Not Specified|2|||
161066986|NCT01296555|581636083|FG026|Overall Study|Reason Not Specified|19|||
161066987|NCT01296555|581636084|FG027|Overall Study|Reason Not Specified|11|||
161066988|NCT01296555|581636085|FG028|Overall Study|Reason Not Specified|9|||
161066989|NCT01296555|581636057|FG000|Overall Study|Physician Decision|0|||
161066990|NCT01296555|581636058|FG001|Overall Study|Physician Decision|0|||
161066991|NCT01296555|581636059|FG002|Overall Study|Physician Decision|0|||
161066992|NCT01296555|581636060|FG003|Overall Study|Physician Decision|0|||
161066993|NCT01296555|581636061|FG004|Overall Study|Physician Decision|1|||
161066994|NCT01296555|581636062|FG005|Overall Study|Physician Decision|0|||
161066995|NCT01296555|581636063|FG006|Overall Study|Physician Decision|0|||
161066996|NCT01296555|581636064|FG007|Overall Study|Physician Decision|0|||
161066997|NCT01296555|581636065|FG008|Overall Study|Physician Decision|0|||
161345416|NCT03595748|582650808|FG000|Overall Study|Protocol Violation|0|||
161066998|NCT01296555|581636066|FG009|Overall Study|Physician Decision|0|||
161066999|NCT01296555|581636067|FG010|Overall Study|Physician Decision|0|||
161345417|NCT03595748|582650809|FG001|Overall Study|Protocol Violation|1|||
161283419|NCT02656303|582417632|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
161283420|NCT02656303|582417630|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
161283421|NCT02656303|582417631|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
161283422|NCT02656303|582417632|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
161283423|NCT02656303|582417630|FG000|Overall Study|Reason not Specified|1|||
161283424|NCT02656303|582417631|FG001|Overall Study|Reason not Specified|1|||
161283425|NCT02656303|582417632|FG002|Overall Study|Reason not Specified|2|||
161283426|NCT03041311|582417635|FG000|Overall Study|Death|39|||
161283427|NCT03041311|582417636|FG001|Overall Study|Death|42|||
161067000|NCT01296555|581636068|FG011|Overall Study|Physician Decision|0|||
161067001|NCT01296555|581636069|FG012|Overall Study|Physician Decision|0|||
161067002|NCT01296555|581636070|FG013|Overall Study|Physician Decision|1|||
161067003|NCT01296555|581636071|FG014|Overall Study|Physician Decision|0|||
161067004|NCT01296555|581636072|FG015|Overall Study|Physician Decision|0|||
161067005|NCT01296555|581636073|FG016|Overall Study|Physician Decision|0|||
161067006|NCT01296555|581636074|FG017|Overall Study|Physician Decision|0|||
161067007|NCT01296555|581636075|FG018|Overall Study|Physician Decision|0|||
161067008|NCT01296555|581636076|FG019|Overall Study|Physician Decision|1|||
161067009|NCT01296555|581636077|FG020|Overall Study|Physician Decision|0|||
161067010|NCT01296555|581636078|FG021|Overall Study|Physician Decision|0|||
161067011|NCT01296555|581636079|FG022|Overall Study|Physician Decision|0|||
161067012|NCT01296555|581636080|FG023|Overall Study|Physician Decision|0|||
161067013|NCT01296555|581636081|FG024|Overall Study|Physician Decision|0|||
161067014|NCT01296555|581636082|FG025|Overall Study|Physician Decision|0|||
161067015|NCT01296555|581636083|FG026|Overall Study|Physician Decision|0|||
161067016|NCT01296555|581636084|FG027|Overall Study|Physician Decision|0|||
161067017|NCT01296555|581636085|FG028|Overall Study|Physician Decision|0|||
161067018|NCT01296555|581636057|FG000|Overall Study|Progressive Disease|6|||
161067019|NCT01296555|581636058|FG001|Overall Study|Progressive Disease|3|||
161067020|NCT01296555|581636059|FG002|Overall Study|Progressive Disease|3|||
161067021|NCT01296555|581636060|FG003|Overall Study|Progressive Disease|7|||
161067022|NCT01296555|581636061|FG004|Overall Study|Progressive Disease|6|||
161067023|NCT01296555|581636062|FG005|Overall Study|Progressive Disease|16|||
161067024|NCT01296555|581636063|FG006|Overall Study|Progressive Disease|16|||
161067025|NCT01296555|581636064|FG007|Overall Study|Progressive Disease|8|||
161067026|NCT01296555|581636065|FG008|Overall Study|Progressive Disease|7|||
161067027|NCT01296555|581636066|FG009|Overall Study|Progressive Disease|18|||
161067028|NCT01296555|581636067|FG010|Overall Study|Progressive Disease|7|||
161067029|NCT01296555|581636068|FG011|Overall Study|Progressive Disease|14|||
161067030|NCT01296555|581636069|FG012|Overall Study|Progressive Disease|5|||
161067031|NCT01296555|581636070|FG013|Overall Study|Progressive Disease|12|||
161067032|NCT01296555|581636071|FG014|Overall Study|Progressive Disease|1|||
161067033|NCT01296555|581636072|FG015|Overall Study|Progressive Disease|1|||
161067034|NCT01296555|581636073|FG016|Overall Study|Progressive Disease|0|||
161067035|NCT01296555|581636074|FG017|Overall Study|Progressive Disease|0|||
161067036|NCT01296555|581636075|FG018|Overall Study|Progressive Disease|0|||
161067037|NCT01296555|581636076|FG019|Overall Study|Progressive Disease|1|||
161067038|NCT01296555|581636077|FG020|Overall Study|Progressive Disease|0|||
161067039|NCT01296555|581636078|FG021|Overall Study|Progressive Disease|0|||
161067040|NCT01296555|581636079|FG022|Overall Study|Progressive Disease|0|||
161067041|NCT01296555|581636080|FG023|Overall Study|Progressive Disease|0|||
161067042|NCT01296555|581636081|FG024|Overall Study|Progressive Disease|1|||
161067043|NCT01296555|581636082|FG025|Overall Study|Progressive Disease|0|||
161067044|NCT01296555|581636083|FG026|Overall Study|Progressive Disease|5|||
161067045|NCT01296555|581636084|FG027|Overall Study|Progressive Disease|1|||
161067046|NCT01296555|581636085|FG028|Overall Study|Progressive Disease|0|||
161067047|NCT01296555|581636057|FG000|Overall Study|Protocol Violation|0|||
161067048|NCT01296555|581636058|FG001|Overall Study|Protocol Violation|0|||
161067049|NCT01296555|581636059|FG002|Overall Study|Protocol Violation|0|||
161067050|NCT01296555|581636060|FG003|Overall Study|Protocol Violation|0|||
161067051|NCT01296555|581636061|FG004|Overall Study|Protocol Violation|0|||
161283428|NCT03041311|582417635|FG000|Overall Study|Lost to Follow-up|0|||
161067052|NCT01296555|581636062|FG005|Overall Study|Protocol Violation|0|||
161067053|NCT01296555|581636063|FG006|Overall Study|Protocol Violation|0|||
161067054|NCT01296555|581636064|FG007|Overall Study|Protocol Violation|0|||
161067055|NCT01296555|581636065|FG008|Overall Study|Protocol Violation|0|||
161283429|NCT03041311|582417636|FG001|Overall Study|Lost to Follow-up|1|||
161283430|NCT03041311|582417635|FG000|Overall Study|Withdrawal by Subject|8|||
161067056|NCT01296555|581636066|FG009|Overall Study|Protocol Violation|0|||
161067057|NCT01296555|581636067|FG010|Overall Study|Protocol Violation|0|||
161067058|NCT01296555|581636068|FG011|Overall Study|Protocol Violation|0|||
161067059|NCT01296555|581636069|FG012|Overall Study|Protocol Violation|0|||
161067060|NCT01296555|581636070|FG013|Overall Study|Protocol Violation|1|||
161067061|NCT01296555|581636071|FG014|Overall Study|Protocol Violation|0|||
161067062|NCT01296555|581636072|FG015|Overall Study|Protocol Violation|0|||
161067063|NCT01296555|581636073|FG016|Overall Study|Protocol Violation|0|||
161067064|NCT01296555|581636074|FG017|Overall Study|Protocol Violation|0|||
161067065|NCT01296555|581636075|FG018|Overall Study|Protocol Violation|0|||
161067066|NCT01296555|581636076|FG019|Overall Study|Protocol Violation|0|||
161283431|NCT03041311|582417636|FG001|Overall Study|Withdrawal by Subject|5|||
161283432|NCT03041311|582417635|FG000|Overall Study|Sponsor Terminated Study|2|||
161067067|NCT01296555|581636077|FG020|Overall Study|Protocol Violation|0|||
161067068|NCT01296555|581636078|FG021|Overall Study|Protocol Violation|0|||
161067069|NCT01296555|581636079|FG022|Overall Study|Protocol Violation|0|||
161067070|NCT01296555|581636080|FG023|Overall Study|Protocol Violation|0|||
161067071|NCT01296555|581636081|FG024|Overall Study|Protocol Violation|0|||
161067072|NCT01296555|581636082|FG025|Overall Study|Protocol Violation|0|||
161067073|NCT01296555|581636083|FG026|Overall Study|Protocol Violation|0|||
161067074|NCT01296555|581636084|FG027|Overall Study|Protocol Violation|0|||
161067075|NCT01296555|581636085|FG028|Overall Study|Protocol Violation|0|||
161067076|NCT01296555|581636057|FG000|Overall Study|Study Terminated By Sponsor|0|||
161067077|NCT01296555|581636058|FG001|Overall Study|Study Terminated By Sponsor|0|||
161067078|NCT01296555|581636059|FG002|Overall Study|Study Terminated By Sponsor|0|||
161067079|NCT01296555|581636060|FG003|Overall Study|Study Terminated By Sponsor|0|||
161067080|NCT01296555|581636061|FG004|Overall Study|Study Terminated By Sponsor|0|||
161067081|NCT01296555|581636062|FG005|Overall Study|Study Terminated By Sponsor|0|||
161067082|NCT01296555|581636063|FG006|Overall Study|Study Terminated By Sponsor|0|||
161067083|NCT01296555|581636064|FG007|Overall Study|Study Terminated By Sponsor|0|||
161067084|NCT01296555|581636065|FG008|Overall Study|Study Terminated By Sponsor|0|||
161067085|NCT01296555|581636066|FG009|Overall Study|Study Terminated By Sponsor|0|||
161067086|NCT01296555|581636067|FG010|Overall Study|Study Terminated By Sponsor|0|||
161067087|NCT01296555|581636068|FG011|Overall Study|Study Terminated By Sponsor|0|||
161067088|NCT01296555|581636069|FG012|Overall Study|Study Terminated By Sponsor|0|||
161067089|NCT01296555|581636070|FG013|Overall Study|Study Terminated By Sponsor|0|||
161067090|NCT01296555|581636071|FG014|Overall Study|Study Terminated By Sponsor|0|||
161067091|NCT01296555|581636072|FG015|Overall Study|Study Terminated By Sponsor|0|||
161067092|NCT01296555|581636073|FG016|Overall Study|Study Terminated By Sponsor|0|||
161067093|NCT01296555|581636074|FG017|Overall Study|Study Terminated By Sponsor|0|||
161067094|NCT01296555|581636075|FG018|Overall Study|Study Terminated By Sponsor|0|||
161067095|NCT01296555|581636076|FG019|Overall Study|Study Terminated By Sponsor|0|||
161067096|NCT01296555|581636077|FG020|Overall Study|Study Terminated By Sponsor|0|||
161067097|NCT01296555|581636078|FG021|Overall Study|Study Terminated By Sponsor|0|||
161067098|NCT01296555|581636079|FG022|Overall Study|Study Terminated By Sponsor|0|||
161067099|NCT01296555|581636080|FG023|Overall Study|Study Terminated By Sponsor|0|||
161067100|NCT01296555|581636081|FG024|Overall Study|Study Terminated By Sponsor|0|||
161067101|NCT01296555|581636082|FG025|Overall Study|Study Terminated By Sponsor|1|||
161067102|NCT01296555|581636083|FG026|Overall Study|Study Terminated By Sponsor|0|||
161067103|NCT01296555|581636084|FG027|Overall Study|Study Terminated By Sponsor|0|||
161067104|NCT01296555|581636085|FG028|Overall Study|Study Terminated By Sponsor|0|||
161067105|NCT01296555|581636057|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067106|NCT01296555|581636058|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067107|NCT01296555|581636059|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067108|NCT01296555|581636060|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067109|NCT01296555|581636061|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067110|NCT01296555|581636062|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067111|NCT01296555|581636063|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067112|NCT01296555|581636064|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067113|NCT01296555|581636065|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067114|NCT01296555|581636066|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067115|NCT01296555|581636067|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067116|NCT01296555|581636068|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067117|NCT01296555|581636069|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067118|NCT01296555|581636070|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067119|NCT01296555|581636071|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067120|NCT01296555|581636072|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161283433|NCT03041311|582417636|FG001|Overall Study|Sponsor Terminated Study|4|||
161283434|NCT03041311|582417635|FG000|Overall Study|Disease Progression|3|||
161067121|NCT01296555|581636073|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067122|NCT01296555|581636074|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067123|NCT01296555|581636075|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067124|NCT01296555|581636076|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
161067125|NCT01296555|581636077|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067126|NCT01296555|581636078|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067127|NCT01296555|581636079|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161155688|NCT03249792|581951175|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
161155689|NCT03249792|581951176|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
161155690|NCT03249792|581951177|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
161067128|NCT01296555|581636080|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067129|NCT01296555|581636081|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067130|NCT01296555|581636082|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067131|NCT01296555|581636083|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067132|NCT01296555|581636084|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067133|NCT01296555|581636085|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
161067134|NCT01296555|581636057|FG000|Overall Study|Death|0|||
161283435|NCT03041311|582417636|FG001|Overall Study|Disease Progression|1|||
161283436|NCT03041311|582417635|FG000|Overall Study|Randomized in error, did not receive drug|2|||
161283437|NCT03041311|582417636|FG001|Overall Study|Randomized in error, did not receive drug|0|||
161283438|NCT01842438|582417637|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
161283439|NCT01842438|582417638|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
161283440|NCT01842438|582417637|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
161283441|NCT01842438|582417638|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
161345418|NCT02328014|582650810|FG000|Overall Study|Adverse Event|1|||
161345419|NCT02328014|582650811|FG001|Overall Study|Adverse Event|0|||
161345420|NCT02328014|582650812|FG002|Overall Study|Adverse Event|0|||
161345421|NCT02328014|582650813|FG003|Overall Study|Adverse Event|1|||
161345422|NCT02328014|582650810|FG000|Overall Study|Death|0|||
161345423|NCT02328014|582650811|FG001|Overall Study|Death|0|||
161345424|NCT02328014|582650812|FG002|Overall Study|Death|0|||
161345425|NCT02328014|582650813|FG003|Overall Study|Death|4|||
161345426|NCT02328014|582650810|FG000|Overall Study|Physician Decision|0|||
161345427|NCT02328014|582650811|FG001|Overall Study|Physician Decision|0|||
161345428|NCT02328014|582650812|FG002|Overall Study|Physician Decision|0|||
161345429|NCT02328014|582650813|FG003|Overall Study|Physician Decision|1|||
161345430|NCT02328014|582650810|FG000|Overall Study|Disease Progression|1|||
161345431|NCT02328014|582650811|FG001|Overall Study|Disease Progression|0|||
161345432|NCT02328014|582650812|FG002|Overall Study|Disease Progression|1|||
161345433|NCT02328014|582650813|FG003|Overall Study|Disease Progression|3|||
161345434|NCT02328014|582650810|FG000|Overall Study|Study Terminated by Sponsor|4|||
161345435|NCT02328014|582650811|FG001|Overall Study|Study Terminated by Sponsor|1|||
161345436|NCT02328014|582650812|FG002|Overall Study|Study Terminated by Sponsor|1|||
161345437|NCT02328014|582650813|FG003|Overall Study|Study Terminated by Sponsor|0|||
161345438|NCT02328014|582650810|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
161345439|NCT02328014|582650811|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
161345440|NCT02328014|582650812|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
161345441|NCT02328014|582650813|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
161345442|NCT02328014|582650810|FG000|Overall Study|Withdrawal by Subject|0|||
161345443|NCT02328014|582650811|FG001|Overall Study|Withdrawal by Subject|0|||
161345444|NCT02328014|582650812|FG002|Overall Study|Withdrawal by Subject|0|||
161345445|NCT02328014|582650813|FG003|Overall Study|Withdrawal by Subject|1|||
161345446|NCT05028569|582650830|FG000|Double-Blind Phase|Death|0|||
161345447|NCT05028569|582650831|FG001|Double-Blind Phase|Death|0|||
161345448|NCT05028569|582650832|FG002|Double-Blind Phase|Death|0|||
161345449|NCT05028569|582650833|FG003|Double-Blind Phase|Death|1|||
161345450|NCT05028569|582650834|FG004|Double-Blind Phase|Death|0|||
161345451|NCT05028569|582650835|FG005|Double-Blind Phase|Death|0|||
161345452|NCT05028569|582650836|FG006|Double-Blind Phase|Death|0|||
161345453|NCT05028569|582650830|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161345454|NCT05028569|582650831|FG001|Double-Blind Phase|Lost to Follow-up|6|||
161345455|NCT05028569|582650832|FG002|Double-Blind Phase|Lost to Follow-up|3|||
161345456|NCT05028569|582650833|FG003|Double-Blind Phase|Lost to Follow-up|9|||
161345457|NCT05028569|582650834|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161345458|NCT05028569|582650835|FG005|Double-Blind Phase|Lost to Follow-up|0|||
161345459|NCT05028569|582650836|FG006|Double-Blind Phase|Lost to Follow-up|0|||
161345460|NCT05028569|582650830|FG000|Double-Blind Phase|Protocol Deviation|0|||
161345461|NCT05028569|582650831|FG001|Double-Blind Phase|Protocol Deviation|2|||
161345462|NCT05028569|582650832|FG002|Double-Blind Phase|Protocol Deviation|0|||
161345463|NCT05028569|582650833|FG003|Double-Blind Phase|Protocol Deviation|0|||
161345464|NCT05028569|582650834|FG004|Double-Blind Phase|Protocol Deviation|0|||
161345465|NCT05028569|582650835|FG005|Double-Blind Phase|Protocol Deviation|0|||
161345466|NCT05028569|582650836|FG006|Double-Blind Phase|Protocol Deviation|0|||
161345467|NCT05028569|582650830|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161345468|NCT05028569|582650831|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
161345469|NCT05028569|582650832|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
161345470|NCT05028569|582650833|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
161345471|NCT05028569|582650834|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161345472|NCT05028569|582650835|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
161345473|NCT05028569|582650836|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
161345474|NCT05028569|582650830|FG000|Double-Blind Phase|Other, not specified|0|||
161067135|NCT01296555|581636058|FG001|Overall Study|Death|0|||
161067136|NCT01296555|581636059|FG002|Overall Study|Death|0|||
161283442|NCT01842438|582417637|FG000|T2: 6month Follow-up|Death|0|||
161283443|NCT01842438|582417638|FG001|T2: 6month Follow-up|Death|1|||
161345475|NCT05028569|582650831|FG001|Double-Blind Phase|Other, not specified|5|||
161345476|NCT05028569|582650832|FG002|Double-Blind Phase|Other, not specified|4|||
161345477|NCT05028569|582650833|FG003|Double-Blind Phase|Other, not specified|6|||
161345478|NCT05028569|582650834|FG004|Double-Blind Phase|Other, not specified|0|||
161345479|NCT05028569|582650835|FG005|Double-Blind Phase|Other, not specified|0|||
161345480|NCT05028569|582650836|FG006|Double-Blind Phase|Other, not specified|0|||
161345481|NCT05028569|582650830|FG000|Open-Label Phase|Death|0|||
161345482|NCT05028569|582650831|FG001|Open-Label Phase|Death|0|||
161067137|NCT01296555|581636060|FG003|Overall Study|Death|2|||
161067138|NCT01296555|581636061|FG004|Overall Study|Death|1|||
161067139|NCT01296555|581636062|FG005|Overall Study|Death|0|||
161067140|NCT01296555|581636063|FG006|Overall Study|Death|2|||
161067141|NCT01296555|581636064|FG007|Overall Study|Death|0|||
161067142|NCT01296555|581636065|FG008|Overall Study|Death|0|||
161067143|NCT01296555|581636066|FG009|Overall Study|Death|1|||
161067144|NCT01296555|581636067|FG010|Overall Study|Death|0|||
161067145|NCT01296555|581636068|FG011|Overall Study|Death|1|||
161067146|NCT01296555|581636069|FG012|Overall Study|Death|0|||
161067147|NCT01296555|581636070|FG013|Overall Study|Death|2|||
161067148|NCT01296555|581636071|FG014|Overall Study|Death|27|||
161067149|NCT01296555|581636072|FG015|Overall Study|Death|15|||
161067150|NCT01296555|581636073|FG016|Overall Study|Death|11|||
161067151|NCT01296555|581636074|FG017|Overall Study|Death|11|||
161067152|NCT01296555|581636075|FG018|Overall Study|Death|17|||
161067153|NCT01296555|581636076|FG019|Overall Study|Death|12|||
161067154|NCT01296555|581636077|FG020|Overall Study|Death|13|||
161067155|NCT01296555|581636078|FG021|Overall Study|Death|12|||
161067156|NCT01296555|581636079|FG022|Overall Study|Death|12|||
161067157|NCT01296555|581636080|FG023|Overall Study|Death|13|||
161067158|NCT01296555|581636081|FG024|Overall Study|Death|7|||
161067159|NCT01296555|581636082|FG025|Overall Study|Death|7|||
161067160|NCT01296555|581636083|FG026|Overall Study|Death|35|||
161067161|NCT01296555|581636084|FG027|Overall Study|Death|92|||
161067162|NCT01296555|581636085|FG028|Overall Study|Death|44|||
161067163|NCT01296555|581636057|FG000|Overall Study|Lost to Follow-up|0|||
161067164|NCT01296555|581636058|FG001|Overall Study|Lost to Follow-up|0|||
161067165|NCT01296555|581636059|FG002|Overall Study|Lost to Follow-up|0|||
161067166|NCT01296555|581636060|FG003|Overall Study|Lost to Follow-up|0|||
161067167|NCT01296555|581636061|FG004|Overall Study|Lost to Follow-up|0|||
161067168|NCT01296555|581636062|FG005|Overall Study|Lost to Follow-up|0|||
161067169|NCT01296555|581636063|FG006|Overall Study|Lost to Follow-up|0|||
161067170|NCT01296555|581636064|FG007|Overall Study|Lost to Follow-up|0|||
161067171|NCT01296555|581636065|FG008|Overall Study|Lost to Follow-up|0|||
161067172|NCT01296555|581636066|FG009|Overall Study|Lost to Follow-up|0|||
161067173|NCT01296555|581636067|FG010|Overall Study|Lost to Follow-up|0|||
161067174|NCT01296555|581636068|FG011|Overall Study|Lost to Follow-up|0|||
161067175|NCT01296555|581636069|FG012|Overall Study|Lost to Follow-up|0|||
161067176|NCT01296555|581636070|FG013|Overall Study|Lost to Follow-up|0|||
161067177|NCT01296555|581636071|FG014|Overall Study|Lost to Follow-up|2|||
161067178|NCT01296555|581636072|FG015|Overall Study|Lost to Follow-up|1|||
161067179|NCT01296555|581636073|FG016|Overall Study|Lost to Follow-up|0|||
161067180|NCT01296555|581636074|FG017|Overall Study|Lost to Follow-up|2|||
161067181|NCT01296555|581636075|FG018|Overall Study|Lost to Follow-up|0|||
161067182|NCT01296555|581636076|FG019|Overall Study|Lost to Follow-up|2|||
161067183|NCT01296555|581636077|FG020|Overall Study|Lost to Follow-up|3|||
161067184|NCT01296555|581636078|FG021|Overall Study|Lost to Follow-up|2|||
161067185|NCT01296555|581636079|FG022|Overall Study|Lost to Follow-up|0|||
161067186|NCT01296555|581636080|FG023|Overall Study|Lost to Follow-up|0|||
161067187|NCT01296555|581636081|FG024|Overall Study|Lost to Follow-up|0|||
161067188|NCT01296555|581636082|FG025|Overall Study|Lost to Follow-up|0|||
161067189|NCT01296555|581636083|FG026|Overall Study|Lost to Follow-up|3|||
161067190|NCT01296555|581636084|FG027|Overall Study|Lost to Follow-up|13|||
161067191|NCT01296555|581636085|FG028|Overall Study|Lost to Follow-up|5|||
161067192|NCT01296555|581636057|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161067193|NCT01296555|581636058|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161067194|NCT01296555|581636059|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161067195|NCT01296555|581636060|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161067196|NCT01296555|581636061|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161067197|NCT01296555|581636062|FG005|Overall Study|Non-Compliance With Study Drug|0|||
161067198|NCT01296555|581636063|FG006|Overall Study|Non-Compliance With Study Drug|0|||
161067199|NCT01296555|581636064|FG007|Overall Study|Non-Compliance With Study Drug|1|||
161067200|NCT01296555|581636065|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161067201|NCT01296555|581636066|FG009|Overall Study|Non-Compliance With Study Drug|0|||
161067202|NCT01296555|581636067|FG010|Overall Study|Non-Compliance With Study Drug|0|||
161067203|NCT01296555|581636068|FG011|Overall Study|Non-Compliance With Study Drug|0|||
161067204|NCT01296555|581636069|FG012|Overall Study|Non-Compliance With Study Drug|0|||
161067205|NCT01296555|581636070|FG013|Overall Study|Non-Compliance With Study Drug|0|||
161067206|NCT01296555|581636071|FG014|Overall Study|Non-Compliance With Study Drug|0|||
161067207|NCT01296555|581636072|FG015|Overall Study|Non-Compliance With Study Drug|0|||
161067208|NCT01296555|581636073|FG016|Overall Study|Non-Compliance With Study Drug|0|||
161067209|NCT01296555|581636074|FG017|Overall Study|Non-Compliance With Study Drug|0|||
161067210|NCT01296555|581636075|FG018|Overall Study|Non-Compliance With Study Drug|0|||
161067211|NCT01296555|581636076|FG019|Overall Study|Non-Compliance With Study Drug|0|||
161067212|NCT01296555|581636077|FG020|Overall Study|Non-Compliance With Study Drug|0|||
161067213|NCT01296555|581636078|FG021|Overall Study|Non-Compliance With Study Drug|0|||
161067214|NCT01296555|581636079|FG022|Overall Study|Non-Compliance With Study Drug|0|||
161067215|NCT01296555|581636080|FG023|Overall Study|Non-Compliance With Study Drug|0|||
161067216|NCT01296555|581636081|FG024|Overall Study|Non-Compliance With Study Drug|0|||
161283444|NCT04909853|582417639|FG000|Part 1|Assigned but not treated|0|||
161283445|NCT04909853|582417640|FG001|Part 1|Assigned but not treated|0|||
161283446|NCT04909853|582417641|FG002|Part 1|Assigned but not treated|1|||
161283447|NCT04909853|582417642|FG003|Part 1|Assigned but not treated|0|||
161283448|NCT04909853|582417639|FG000|Part 2|Adverse Event|0|||
161283449|NCT04909853|582417640|FG001|Part 2|Adverse Event|0|||
161283450|NCT04909853|582417641|FG002|Part 2|Adverse Event|0|||
161283451|NCT04909853|582417642|FG003|Part 2|Adverse Event|1|||
161283452|NCT02548156|582417645|FG000|Washout Period 1|Lost to Follow-up|0|||
161283453|NCT02548156|582417646|FG001|Washout Period 1|Lost to Follow-up|0|||
161283454|NCT02548156|582417647|FG002|Washout Period 1|Lost to Follow-up|0|||
161283455|NCT02548156|582417648|FG003|Washout Period 1|Lost to Follow-up|0|||
161283456|NCT02548156|582417649|FG004|Washout Period 1|Lost to Follow-up|1|||
161283457|NCT02548156|582417650|FG005|Washout Period 1|Lost to Follow-up|0|||
161283458|NCT00444587|582417651|FG000|Overall Study|Death|2|||
161283459|NCT00444587|582417652|FG001|Overall Study|Death|1|||
161283460|NCT00444587|582417651|FG000|Overall Study|Progression of the disease|73|||
161283461|NCT00444587|582417652|FG001|Overall Study|Progression of the disease|8|||
161283462|NCT00444587|582417651|FG000|Overall Study|Refused treatment/did not cooperate|4|||
161283463|NCT00444587|582417652|FG001|Overall Study|Refused treatment/did not cooperate|1|||
161283464|NCT00444587|582417651|FG000|Overall Study|Investigator decision|3|||
161283465|NCT00444587|582417652|FG001|Overall Study|Investigator decision|0|||
161283466|NCT00444587|582417651|FG000|Overall Study|Protocol Violation|1|||
161283467|NCT00444587|582417652|FG001|Overall Study|Protocol Violation|0|||
161283468|NCT00444587|582417651|FG000|Overall Study|Missing|0|||
161283469|NCT00444587|582417652|FG001|Overall Study|Missing|5|||
161283470|NCT00196326|582417653|FG000|Overall Study|Did not meet protocol requirements|64|||
161283471|NCT00196326|582417653|FG000|Overall Study|Non-compliance with the protocol|81|||
161283472|NCT00196326|582417653|FG000|Overall Study|Physician Decision|3|||
161283473|NCT00196326|582417653|FG000|Overall Study|Withdrawal by Subject|225|||
161283474|NCT00196326|582417653|FG000|Overall Study|Adverse Event|253|||
161283475|NCT00196326|582417653|FG000|Overall Study|Pregnancy|34|||
161283476|NCT00196326|582417653|FG000|Overall Study|Lost to Follow-up|304|||
161283477|NCT00196326|582417653|FG000|Overall Study|Other|22|||
161283478|NCT05223920|582417660|FG000|Overall Study|Adverse Event|6|||
161283479|NCT05223920|582417661|FG001|Overall Study|Adverse Event|3|||
161283480|NCT05223920|582417660|FG000|Overall Study|Death|2|||
161283481|NCT05223920|582417661|FG001|Overall Study|Death|0|||
161283482|NCT05223920|582417660|FG000|Overall Study|Disease Progression|1|||
161283483|NCT05223920|582417661|FG001|Overall Study|Disease Progression|2|||
161283484|NCT05223920|582417660|FG000|Overall Study|Physician Decision|1|||
161283485|NCT05223920|582417661|FG001|Overall Study|Physician Decision|2|||
161283486|NCT05223920|582417660|FG000|Overall Study|Sponsor decision|11|||
161283487|NCT05223920|582417661|FG001|Overall Study|Sponsor decision|9|||
161283488|NCT05223920|582417660|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
161283489|NCT05223920|582417661|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
161283490|NCT05223920|582417660|FG000|Overall Study|Subject decision|1|||
161283491|NCT05223920|582417661|FG001|Overall Study|Subject decision|0|||
161283492|NCT05223920|582417660|FG000|Overall Study|Withdrawal by Subject|1|||
161283493|NCT05223920|582417661|FG001|Overall Study|Withdrawal by Subject|6|||
161283494|NCT00369941|582417662|FG000|Overall Study|Never Treated|1|||
161283495|NCT00369941|582417663|FG001|Overall Study|Never Treated|2|||
161283496|NCT00369941|582417662|FG000|Overall Study|Adverse Event|14|||
161283497|NCT00369941|582417663|FG001|Overall Study|Adverse Event|28|||
161283498|NCT00369941|582417662|FG000|Overall Study|Lack of Efficacy|6|||
161283499|NCT00369941|582417663|FG001|Overall Study|Lack of Efficacy|10|||
161283500|NCT00369941|582417662|FG000|Overall Study|Lost to Follow-up|12|||
161067217|NCT01296555|581636082|FG025|Overall Study|Non-Compliance With Study Drug|0|||
161067218|NCT01296555|581636083|FG026|Overall Study|Non-Compliance With Study Drug|0|||
161067219|NCT01296555|581636084|FG027|Overall Study|Non-Compliance With Study Drug|0|||
161283501|NCT00369941|582417663|FG001|Overall Study|Lost to Follow-up|22|||
161283502|NCT00369941|582417662|FG000|Overall Study|Protocol Violation|5|||
161283503|NCT00369941|582417663|FG001|Overall Study|Protocol Violation|3|||
161283504|NCT00369941|582417662|FG000|Overall Study|Withdrawal by Subject|5|||
161283505|NCT00369941|582417663|FG001|Overall Study|Withdrawal by Subject|18|||
161283506|NCT00369941|582417662|FG000|Overall Study|Pregnancy|4|||
161283507|NCT00369941|582417663|FG001|Overall Study|Pregnancy|2|||
161283508|NCT00369941|582417662|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
161283509|NCT00369941|582417663|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
161283510|NCT00369941|582417662|FG000|Overall Study|Moved|11|||
161283511|NCT00369941|582417663|FG001|Overall Study|Moved|5|||
161283512|NCT00369941|582417662|FG000|Overall Study|Treatment with Prohibited Medication|3|||
161283513|NCT00369941|582417663|FG001|Overall Study|Treatment with Prohibited Medication|1|||
161283514|NCT00369941|582417662|FG000|Overall Study|Employment Interfered with Study Visits|1|||
161283515|NCT00369941|582417663|FG001|Overall Study|Employment Interfered with Study Visits|0|||
161283516|NCT00369941|582417662|FG000|Overall Study|Study Site Terminated|2|||
161283517|NCT00369941|582417663|FG001|Overall Study|Study Site Terminated|0|||
161283518|NCT00369941|582417662|FG000|Overall Study|Miscellaneous|3|||
161283519|NCT00369941|582417663|FG001|Overall Study|Miscellaneous|3|||
161283520|NCT00661193|582417664|FG000|Overall Study|Adverse Event|2|||
161283521|NCT00661193|582417665|FG001|Overall Study|Adverse Event|1|||
161283522|NCT00661193|582417664|FG000|Overall Study|Withdrawal by Subject|3|||
161283523|NCT00661193|582417665|FG001|Overall Study|Withdrawal by Subject|1|||
161283524|NCT00661193|582417664|FG000|Overall Study|Progression|27|||
161283525|NCT00661193|582417665|FG001|Overall Study|Progression|24|||
161283526|NCT00661193|582417664|FG000|Overall Study|Not protocol specified|1|||
161283527|NCT00661193|582417665|FG001|Overall Study|Not protocol specified|0|||
161283528|NCT04882241|582417670|FG000|Overall Study|Ongoing in study|46|||
161283529|NCT04882241|582417671|FG001|Overall Study|Ongoing in study|48|||
161283530|NCT04882241|582417672|FG002|Overall Study|Ongoing in study|0|||
161283531|NCT04882241|582417673|FG003|Overall Study|Ongoing in study|0|||
161283532|NCT04882241|582417670|FG000|Overall Study|Death|13|||
161283533|NCT04882241|582417671|FG001|Overall Study|Death|13|||
161283534|NCT04882241|582417672|FG002|Overall Study|Death|0|||
161067220|NCT01296555|581636085|FG028|Overall Study|Non-Compliance With Study Drug|0|||
161067221|NCT01296555|581636057|FG000|Overall Study|Withdrawal by Subject|0|||
161067222|NCT01296555|581636058|FG001|Overall Study|Withdrawal by Subject|0|||
161067223|NCT01296555|581636059|FG002|Overall Study|Withdrawal by Subject|0|||
161067224|NCT01296555|581636060|FG003|Overall Study|Withdrawal by Subject|0|||
161067225|NCT01296555|581636061|FG004|Overall Study|Withdrawal by Subject|1|||
161067226|NCT01296555|581636062|FG005|Overall Study|Withdrawal by Subject|0|||
161067227|NCT01296555|581636063|FG006|Overall Study|Withdrawal by Subject|1|||
161067228|NCT01296555|581636064|FG007|Overall Study|Withdrawal by Subject|0|||
161067229|NCT01296555|581636065|FG008|Overall Study|Withdrawal by Subject|0|||
161067230|NCT01296555|581636066|FG009|Overall Study|Withdrawal by Subject|0|||
161067231|NCT01296555|581636067|FG010|Overall Study|Withdrawal by Subject|1|||
161067232|NCT01296555|581636068|FG011|Overall Study|Withdrawal by Subject|1|||
161067233|NCT01296555|581636069|FG012|Overall Study|Withdrawal by Subject|0|||
161067234|NCT01296555|581636070|FG013|Overall Study|Withdrawal by Subject|0|||
161067235|NCT01296555|581636071|FG014|Overall Study|Withdrawal by Subject|3|||
161067236|NCT01296555|581636072|FG015|Overall Study|Withdrawal by Subject|0|||
161067237|NCT01296555|581636073|FG016|Overall Study|Withdrawal by Subject|2|||
161067238|NCT01296555|581636074|FG017|Overall Study|Withdrawal by Subject|1|||
161067239|NCT01296555|581636075|FG018|Overall Study|Withdrawal by Subject|0|||
161067240|NCT01296555|581636076|FG019|Overall Study|Withdrawal by Subject|1|||
161067241|NCT01296555|581636077|FG020|Overall Study|Withdrawal by Subject|1|||
161067242|NCT01296555|581636078|FG021|Overall Study|Withdrawal by Subject|1|||
161067243|NCT01296555|581636079|FG022|Overall Study|Withdrawal by Subject|3|||
161067244|NCT01296555|581636080|FG023|Overall Study|Withdrawal by Subject|0|||
161067245|NCT01296555|581636081|FG024|Overall Study|Withdrawal by Subject|0|||
161067246|NCT01296555|581636082|FG025|Overall Study|Withdrawal by Subject|0|||
161067247|NCT01296555|581636083|FG026|Overall Study|Withdrawal by Subject|8|||
161067248|NCT01296555|581636084|FG027|Overall Study|Withdrawal by Subject|4|||
161067249|NCT01296555|581636085|FG028|Overall Study|Withdrawal by Subject|2|||
161067250|NCT00857233|581636087|FG000|Overall Study|Adverse Event|24|||
161067251|NCT00857233|581636087|FG000|Overall Study|Lack of Efficacy|1|||
161067252|NCT00857233|581636087|FG000|Overall Study|Non-compliance|1|||
161067253|NCT00857233|581636087|FG000|Overall Study|Withdrawal of Consent|9|||
161067254|NCT00857233|581636087|FG000|Overall Study|Lost to Follow-up|4|||
161067255|NCT00857233|581636087|FG000|Overall Study|Nursing Home Placement|14|||
161067256|NCT00857233|581636087|FG000|Overall Study|Other Reasons|2|||
161067257|NCT01560871|581636088|FG000|Overall Study|transportation issues|2|||
161067258|NCT01560871|581636089|FG001|Overall Study|transportation issues|1|||
161067259|NCT01560871|581636088|FG000|Overall Study|relocation|1|||
161067260|NCT01560871|581636089|FG001|Overall Study|relocation|0|||
161067261|NCT01560871|581636088|FG000|Overall Study|readmission to a hospital|2|||
161067262|NCT01560871|581636089|FG001|Overall Study|readmission to a hospital|1|||
161067263|NCT01560871|581636088|FG000|Overall Study|Lost to Follow-up|1|||
161067264|NCT01560871|581636089|FG001|Overall Study|Lost to Follow-up|0|||
161283535|NCT04882241|582417673|FG003|Overall Study|Death|0|||
161283536|NCT03639779|582417679|FG000|Overall Study|Lost to Follow-up|1|||
161283537|NCT02932462|582417682|FG000|Overall Study|Adverse Event|1|||
161283538|NCT02932462|582417683|FG001|Overall Study|Adverse Event|2|||
161283539|NCT02932462|582417682|FG000|Overall Study|Lost to Follow-up|4|||
161283540|NCT02932462|582417683|FG001|Overall Study|Lost to Follow-up|1|||
161283541|NCT02932462|582417682|FG000|Overall Study|Protocol Violation|0|||
161283542|NCT02932462|582417683|FG001|Overall Study|Protocol Violation|5|||
161283543|NCT02932462|582417682|FG000|Overall Study|Withdrawal by Subject|1|||
161067265|NCT01587118|581636090|FG000|Overall Study|Adverse Event|3|||
161067266|NCT01587118|581636090|FG000|Overall Study|Lost to Follow-up|2|||
161067267|NCT01587118|581636090|FG000|Overall Study|Relocation|1|||
161067268|NCT01587118|581636090|FG000|Overall Study|nonresponse|1|||
161067269|NCT01278615|581636092|FG000|Overall Study|Withdrawal by Subject|2|||
161067270|NCT00243022|581636093|FG000|Overall Study|Withdrawal by Subject|1|||
161067271|NCT00243022|581636094|FG001|Overall Study|Withdrawal by Subject|0|||
161283544|NCT02932462|582417683|FG001|Overall Study|Withdrawal by Subject|4|||
161283545|NCT02932462|582417682|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161283546|NCT02932462|582417683|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161283547|NCT02932462|582417682|FG000|Overall Study|Progressive Disease|1|||
161283548|NCT02932462|582417683|FG001|Overall Study|Progressive Disease|0|||
161283549|NCT02413229|582417684|FG000|Overall Study|Adverse Event|0|||
161283550|NCT02413229|582417685|FG001|Overall Study|Adverse Event|0|||
161283551|NCT02413229|582417686|FG002|Overall Study|Adverse Event|0|||
161283552|NCT02413229|582417687|FG003|Overall Study|Adverse Event|1|||
161283553|NCT02413229|582417688|FG004|Overall Study|Adverse Event|0|||
161283554|NCT02413229|582417689|FG005|Overall Study|Adverse Event|0|||
161283555|NCT02413229|582417690|FG006|Overall Study|Adverse Event|0|||
161283556|NCT02413229|582417691|FG007|Overall Study|Adverse Event|1|||
161283557|NCT02413229|582417684|FG000|Overall Study|Lost to Follow-up|0|||
161067272|NCT00243022|581636093|FG000|Overall Study|Death|1|||
161067273|NCT00243022|581636094|FG001|Overall Study|Death|0|||
161067274|NCT00243022|581636093|FG000|Overall Study|Difficult Travel Distance|0|||
161067275|NCT00243022|581636094|FG001|Overall Study|Difficult Travel Distance|1|||
161067276|NCT01390441|581636099|FG000|Treatment Period|Protocol Violation|0|||
161067277|NCT01390441|581636100|FG001|Treatment Period|Protocol Violation|1|||
161067278|NCT01390441|581636101|FG002|Treatment Period|Protocol Violation|0|||
161067279|NCT01390441|581636102|FG003|Treatment Period|Protocol Violation|0|||
161067280|NCT01390441|581636103|FG004|Treatment Period|Protocol Violation|0|||
161067281|NCT01390441|581636099|FG000|Treatment Period|Physician Decision|0|||
161067282|NCT01390441|581636100|FG001|Treatment Period|Physician Decision|0|||
161067283|NCT01390441|581636101|FG002|Treatment Period|Physician Decision|0|||
161067284|NCT01390441|581636102|FG003|Treatment Period|Physician Decision|1|||
161067285|NCT01390441|581636103|FG004|Treatment Period|Physician Decision|0|||
161067286|NCT01390441|581636099|FG000|Treatment Period|Lack of Efficacy|0|||
161067287|NCT01390441|581636100|FG001|Treatment Period|Lack of Efficacy|0|||
161067288|NCT01390441|581636101|FG002|Treatment Period|Lack of Efficacy|0|||
161067289|NCT01390441|581636102|FG003|Treatment Period|Lack of Efficacy|0|||
161067290|NCT01390441|581636103|FG004|Treatment Period|Lack of Efficacy|1|||
161067291|NCT01390441|581636099|FG000|Treatment Period|Unknown due to early stopping of study|0|||
161067292|NCT01390441|581636100|FG001|Treatment Period|Unknown due to early stopping of study|0|||
161067293|NCT01390441|581636101|FG002|Treatment Period|Unknown due to early stopping of study|8|||
161067294|NCT01390441|581636102|FG003|Treatment Period|Unknown due to early stopping of study|11|||
161067295|NCT01390441|581636103|FG004|Treatment Period|Unknown due to early stopping of study|7|||
161067296|NCT01390441|581636099|FG000|Treatment Period|Adverse Event|0|||
161067297|NCT01390441|581636100|FG001|Treatment Period|Adverse Event|0|||
161067298|NCT01390441|581636101|FG002|Treatment Period|Adverse Event|1|||
161067299|NCT01390441|581636102|FG003|Treatment Period|Adverse Event|1|||
161067300|NCT01390441|581636103|FG004|Treatment Period|Adverse Event|2|||
161067301|NCT01390441|581636099|FG000|Treatment Period|Withdrawal by Subject|0|||
161067302|NCT01390441|581636100|FG001|Treatment Period|Withdrawal by Subject|0|||
161067303|NCT01390441|581636101|FG002|Treatment Period|Withdrawal by Subject|1|||
161067304|NCT01390441|581636102|FG003|Treatment Period|Withdrawal by Subject|0|||
161067305|NCT01390441|581636103|FG004|Treatment Period|Withdrawal by Subject|1|||
161067306|NCT01390441|581636099|FG000|Treatment Period|Lost to Follow-up|1|||
161067307|NCT01390441|581636100|FG001|Treatment Period|Lost to Follow-up|0|||
161067308|NCT01390441|581636101|FG002|Treatment Period|Lost to Follow-up|0|||
161067309|NCT01390441|581636102|FG003|Treatment Period|Lost to Follow-up|0|||
161067310|NCT01390441|581636103|FG004|Treatment Period|Lost to Follow-up|0|||
161067311|NCT01390441|581636099|FG000|Extension Period|Protocol Violation|3|||
161067312|NCT01390441|581636100|FG001|Extension Period|Protocol Violation|1|||
161067313|NCT01390441|581636101|FG002|Extension Period|Protocol Violation|0|||
161067314|NCT01390441|581636102|FG003|Extension Period|Protocol Violation|1|||
161067315|NCT01390441|581636103|FG004|Extension Period|Protocol Violation|0|||
161067316|NCT03802617|581636104|FG000|Overall Study|Adverse Event|0|||
161067317|NCT03802617|581636105|FG001|Overall Study|Adverse Event|4|||
161067318|NCT03802617|581636106|FG002|Overall Study|Adverse Event|5|||
161067319|NCT03802617|581636107|FG003|Overall Study|Adverse Event|1|||
161067320|NCT03802617|581636104|FG000|Overall Study|Lack of Efficacy|0|||
161067321|NCT03802617|581636105|FG001|Overall Study|Lack of Efficacy|1|||
161067322|NCT03802617|581636106|FG002|Overall Study|Lack of Efficacy|0|||
161283558|NCT02413229|582417685|FG001|Overall Study|Lost to Follow-up|0|||
161283559|NCT02413229|582417686|FG002|Overall Study|Lost to Follow-up|1|||
161283560|NCT02413229|582417687|FG003|Overall Study|Lost to Follow-up|0|||
161283561|NCT02413229|582417688|FG004|Overall Study|Lost to Follow-up|2|||
161283562|NCT02413229|582417689|FG005|Overall Study|Lost to Follow-up|0|||
161283563|NCT02413229|582417690|FG006|Overall Study|Lost to Follow-up|0|||
161067323|NCT03802617|581636107|FG003|Overall Study|Lack of Efficacy|2|||
161067324|NCT03802617|581636104|FG000|Overall Study|Protocol Violation|1|||
161067325|NCT03802617|581636105|FG001|Overall Study|Protocol Violation|1|||
161067326|NCT03802617|581636106|FG002|Overall Study|Protocol Violation|1|||
161067327|NCT03802617|581636107|FG003|Overall Study|Protocol Violation|0|||
161067328|NCT03802617|581636104|FG000|Overall Study|Withdrawal by Subject|1|||
161067329|NCT03802617|581636105|FG001|Overall Study|Withdrawal by Subject|1|||
161283564|NCT02413229|582417691|FG007|Overall Study|Lost to Follow-up|0|||
161283565|NCT02413229|582417684|FG000|Overall Study|Withdrawal by Subject|1|||
161283566|NCT02413229|582417685|FG001|Overall Study|Withdrawal by Subject|1|||
161283567|NCT02413229|582417686|FG002|Overall Study|Withdrawal by Subject|0|||
161283568|NCT02413229|582417687|FG003|Overall Study|Withdrawal by Subject|0|||
161283569|NCT02413229|582417688|FG004|Overall Study|Withdrawal by Subject|1|||
161283570|NCT02413229|582417689|FG005|Overall Study|Withdrawal by Subject|0|||
161283571|NCT02413229|582417690|FG006|Overall Study|Withdrawal by Subject|0|||
161283572|NCT02413229|582417691|FG007|Overall Study|Withdrawal by Subject|2|||
161283573|NCT02413229|582417684|FG000|Overall Study|Progressive Disease|0|||
161283574|NCT02413229|582417685|FG001|Overall Study|Progressive Disease|0|||
161283575|NCT02413229|582417686|FG002|Overall Study|Progressive Disease|0|||
161283576|NCT02413229|582417687|FG003|Overall Study|Progressive Disease|0|||
161283577|NCT02413229|582417688|FG004|Overall Study|Progressive Disease|0|||
161283578|NCT02413229|582417689|FG005|Overall Study|Progressive Disease|0|||
161283579|NCT02413229|582417690|FG006|Overall Study|Progressive Disease|0|||
161283580|NCT02413229|582417691|FG007|Overall Study|Progressive Disease|1|||
161283581|NCT05024747|582417695|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
161283582|NCT05024747|582417696|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
161283583|NCT05024747|582417695|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
161283584|NCT05024747|582417696|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
161283585|NCT05024747|582417695|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
161283586|NCT05024747|582417696|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
161283587|NCT00662649|582417698|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
161283588|NCT00662649|582417699|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
161283589|NCT00662649|582417700|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
161283590|NCT00662649|582417701|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
161283591|NCT00662649|582417702|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
161283592|NCT00662649|582417698|FG000|Core Study (24 Months)|Adverse Event|22|||
161283593|NCT00662649|582417699|FG001|Core Study (24 Months)|Adverse Event|13|||
161283594|NCT00662649|582417700|FG002|Core Study (24 Months)|Adverse Event|18|||
161283595|NCT00662649|582417701|FG003|Core Study (24 Months)|Adverse Event|0|||
161283596|NCT00662649|582417702|FG004|Core Study (24 Months)|Adverse Event|0|||
161283597|NCT00662649|582417698|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
161283598|NCT00662649|582417699|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
161283599|NCT00662649|582417700|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
161283600|NCT00662649|582417701|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
161283601|NCT00662649|582417702|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
161283602|NCT00662649|582417698|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
161283603|NCT00662649|582417699|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
161283604|NCT00662649|582417700|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
161283605|NCT00662649|582417701|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
161283606|NCT00662649|582417702|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
161283607|NCT00662649|582417698|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
161283608|NCT00662649|582417699|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
161283609|NCT00662649|582417700|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
161283610|NCT00662649|582417701|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
161283611|NCT00662649|582417702|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
161283612|NCT00662649|582417698|FG000|Core Study (24 Months)|Protocol Violation|5|||
161067330|NCT03802617|581636106|FG002|Overall Study|Withdrawal by Subject|1|||
161067331|NCT03802617|581636107|FG003|Overall Study|Withdrawal by Subject|0|||
161067332|NCT03802617|581636104|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
161067333|NCT03802617|581636105|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
161067334|NCT03802617|581636106|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
161067335|NCT03802617|581636107|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
161067336|NCT00621192|581636108|FG000|Overall Study|Withdrawal by Subject|0|||
161067337|NCT00621192|581636109|FG001|Overall Study|Withdrawal by Subject|0|||
161067338|NCT00621192|581636110|FG002|Overall Study|Withdrawal by Subject|2|||
161283613|NCT00662649|582417699|FG001|Core Study (24 Months)|Protocol Violation|5|||
161283614|NCT00662649|582417700|FG002|Core Study (24 Months)|Protocol Violation|4|||
161283615|NCT00662649|582417701|FG003|Core Study (24 Months)|Protocol Violation|0|||
161283616|NCT00662649|582417702|FG004|Core Study (24 Months)|Protocol Violation|0|||
161283617|NCT00662649|582417698|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
161283618|NCT00662649|582417699|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
161283619|NCT00662649|582417700|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
161283620|NCT00662649|582417701|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
161283621|NCT00662649|582417702|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
161283622|NCT00662649|582417698|FG000|Core Study (24 Months)|Death|1|||
161283623|NCT00662649|582417699|FG001|Core Study (24 Months)|Death|0|||
161283624|NCT00662649|582417700|FG002|Core Study (24 Months)|Death|2|||
161283625|NCT00662649|582417701|FG003|Core Study (24 Months)|Death|0|||
161283626|NCT00662649|582417702|FG004|Core Study (24 Months)|Death|0|||
161283627|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
161283628|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
161283629|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
161283630|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
161283631|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
161283632|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
161283633|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
161283634|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
161283635|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
161283636|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
161283637|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
161345483|NCT05028569|582650832|FG002|Open-Label Phase|Death|0|||
161067339|NCT00621192|581636111|FG003|Overall Study|Withdrawal by Subject|0|||
161067340|NCT00621192|581636108|FG000|Overall Study|Physician Decision|1|||
161067341|NCT00621192|581636109|FG001|Overall Study|Physician Decision|3|||
161067342|NCT00621192|581636110|FG002|Overall Study|Physician Decision|0|||
161067343|NCT00621192|581636111|FG003|Overall Study|Physician Decision|0|||
161067344|NCT00621192|581636108|FG000|Overall Study|Protocol Violation|1|||
161067345|NCT00621192|581636109|FG001|Overall Study|Protocol Violation|0|||
161067346|NCT00621192|581636110|FG002|Overall Study|Protocol Violation|0|||
161067347|NCT00621192|581636111|FG003|Overall Study|Protocol Violation|1|||
161067348|NCT00621192|581636108|FG000|Overall Study|Adverse Event|0|||
161067349|NCT00621192|581636109|FG001|Overall Study|Adverse Event|1|||
161067350|NCT00621192|581636110|FG002|Overall Study|Adverse Event|0|||
161067351|NCT00621192|581636111|FG003|Overall Study|Adverse Event|1|||
161067352|NCT00621192|581636108|FG000|Overall Study|Death|2|||
161067353|NCT00621192|581636109|FG001|Overall Study|Death|5|||
161067354|NCT00621192|581636110|FG002|Overall Study|Death|0|||
161067355|NCT00621192|581636111|FG003|Overall Study|Death|0|||
161067356|NCT00621192|581636108|FG000|Overall Study|Final Assessments not Completed|0|||
161067357|NCT00621192|581636109|FG001|Overall Study|Final Assessments not Completed|0|||
161067358|NCT00621192|581636110|FG002|Overall Study|Final Assessments not Completed|3|||
161067359|NCT00621192|581636111|FG003|Overall Study|Final Assessments not Completed|1|||
161067360|NCT02569957|581636112|FG000|Overall Study|Withdrawal by Subject|0|||
161067361|NCT02569957|581636113|FG001|Overall Study|Withdrawal by Subject|1|||
161067362|NCT03174782|581636114|FG000|Overall Study|Protocol Violation|1|||
161067363|NCT03174782|581636115|FG001|Overall Study|Protocol Violation|0|||
161067364|NCT03174782|581636114|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
161067365|NCT03174782|581636115|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
161067366|NCT03178045|581636116|FG000|Overall Study|Withdrawal by Subject|5|||
161067367|NCT03178045|581636117|FG001|Overall Study|Withdrawal by Subject|7|||
161067368|NCT03178045|581636116|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
161067369|NCT03178045|581636117|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
161067370|NCT03178045|581636116|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
161067371|NCT03178045|581636117|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
161067372|NCT00267098|581636118|FG000|Overall Study|Death|0|||
161067373|NCT00267098|581636119|FG001|Overall Study|Death|0|||
161067374|NCT00267098|581636120|FG002|Overall Study|Death|57|||
161067375|NCT00267098|581636121|FG003|Overall Study|Death|66|||
161067376|NCT00267098|581636122|FG004|Overall Study|Death|14|||
161067377|NCT00267098|581636123|FG005|Overall Study|Death|23|||
161067378|NCT00267098|581636124|FG006|Overall Study|Death|28|||
161067379|NCT00267098|581636125|FG007|Overall Study|Death|9|||
161067380|NCT00267098|581636118|FG000|Overall Study|Lost to Follow-up|0|||
161067381|NCT00267098|581636119|FG001|Overall Study|Lost to Follow-up|0|||
161067382|NCT00267098|581636120|FG002|Overall Study|Lost to Follow-up|6|||
161067383|NCT00267098|581636121|FG003|Overall Study|Lost to Follow-up|5|||
161067384|NCT00267098|581636122|FG004|Overall Study|Lost to Follow-up|2|||
161067385|NCT00267098|581636123|FG005|Overall Study|Lost to Follow-up|3|||
161067386|NCT00267098|581636124|FG006|Overall Study|Lost to Follow-up|1|||
161067387|NCT00267098|581636125|FG007|Overall Study|Lost to Follow-up|1|||
161067388|NCT00267098|581636118|FG000|Overall Study|Withdrawal by Subject|8|||
161067389|NCT00267098|581636119|FG001|Overall Study|Withdrawal by Subject|0|||
161067390|NCT00267098|581636120|FG002|Overall Study|Withdrawal by Subject|24|||
161067391|NCT00267098|581636121|FG003|Overall Study|Withdrawal by Subject|21|||
161067392|NCT00267098|581636122|FG004|Overall Study|Withdrawal by Subject|12|||
161067393|NCT00267098|581636123|FG005|Overall Study|Withdrawal by Subject|9|||
161067394|NCT00267098|581636124|FG006|Overall Study|Withdrawal by Subject|12|||
161067395|NCT00267098|581636125|FG007|Overall Study|Withdrawal by Subject|5|||
161067396|NCT00267098|581636118|FG000|Overall Study|Physician Decision|5|||
161067397|NCT00267098|581636119|FG001|Overall Study|Physician Decision|0|||
161067398|NCT00267098|581636120|FG002|Overall Study|Physician Decision|7|||
161067399|NCT00267098|581636121|FG003|Overall Study|Physician Decision|11|||
161067400|NCT00267098|581636122|FG004|Overall Study|Physician Decision|5|||
161067401|NCT00267098|581636123|FG005|Overall Study|Physician Decision|4|||
161067402|NCT00267098|581636124|FG006|Overall Study|Physician Decision|3|||
161067403|NCT00267098|581636125|FG007|Overall Study|Physician Decision|0|||
161283638|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
161283639|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
161283640|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
161283641|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
161283642|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
161283643|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
161283644|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
161283645|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
161283646|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
161283647|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
161283648|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
161283649|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
161283650|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
161283651|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
161283652|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
161283653|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
161283654|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161067404|NCT00267098|581636118|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
161067405|NCT00267098|581636119|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161067406|NCT00267098|581636120|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161067407|NCT00267098|581636121|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161067408|NCT00267098|581636122|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
161067409|NCT00267098|581636123|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161067410|NCT00267098|581636124|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161067411|NCT00267098|581636125|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
161067412|NCT00267098|581636118|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067413|NCT00267098|581636119|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
161067414|NCT00267098|581636120|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067415|NCT00267098|581636121|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067416|NCT00267098|581636122|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067417|NCT00267098|581636123|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067418|NCT00267098|581636124|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067419|NCT00267098|581636125|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
161067420|NCT00267098|581636118|FG000|Overall Study|Site closure|0|||
161067421|NCT00267098|581636119|FG001|Overall Study|Site closure|0|||
161067422|NCT00267098|581636120|FG002|Overall Study|Site closure|0|||
161067423|NCT00267098|581636121|FG003|Overall Study|Site closure|1|||
161067424|NCT00267098|581636122|FG004|Overall Study|Site closure|0|||
161067425|NCT00267098|581636123|FG005|Overall Study|Site closure|1|||
161067426|NCT00267098|581636124|FG006|Overall Study|Site closure|1|||
161067427|NCT00267098|581636125|FG007|Overall Study|Site closure|0|||
161067428|NCT00267098|581636118|FG000|Overall Study|Explanted Medtronic device|0|||
161067429|NCT00267098|581636119|FG001|Overall Study|Explanted Medtronic device|0|||
161067430|NCT00267098|581636120|FG002|Overall Study|Explanted Medtronic device|0|||
161067431|NCT00267098|581636121|FG003|Overall Study|Explanted Medtronic device|1|||
161067432|NCT00267098|581636122|FG004|Overall Study|Explanted Medtronic device|0|||
161067433|NCT00267098|581636123|FG005|Overall Study|Explanted Medtronic device|0|||
161067434|NCT00267098|581636124|FG006|Overall Study|Explanted Medtronic device|0|||
161067435|NCT00267098|581636125|FG007|Overall Study|Explanted Medtronic device|0|||
161067436|NCT00267098|581636118|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067437|NCT00267098|581636119|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067438|NCT00267098|581636120|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067439|NCT00267098|581636121|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067440|NCT00267098|581636122|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
161067441|NCT00267098|581636123|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067442|NCT00267098|581636124|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067443|NCT00267098|581636125|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
161067444|NCT00267098|581636118|FG000|Overall Study|Subject listed for heart transplant|0|||
161067445|NCT00267098|581636119|FG001|Overall Study|Subject listed for heart transplant|0|||
161067446|NCT00267098|581636120|FG002|Overall Study|Subject listed for heart transplant|0|||
161067447|NCT00267098|581636121|FG003|Overall Study|Subject listed for heart transplant|0|||
161283655|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161283656|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
161067448|NCT00267098|581636122|FG004|Overall Study|Subject listed for heart transplant|0|||
161067449|NCT00267098|581636123|FG005|Overall Study|Subject listed for heart transplant|0|||
161067450|NCT00267098|581636124|FG006|Overall Study|Subject listed for heart transplant|1|||
161067451|NCT00267098|581636125|FG007|Overall Study|Subject listed for heart transplant|0|||
161067452|NCT00267098|581636118|FG000|Overall Study|Sponsor withdrew subject|0|||
161067453|NCT00267098|581636119|FG001|Overall Study|Sponsor withdrew subject|0|||
161283657|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
161067454|NCT00267098|581636120|FG002|Overall Study|Sponsor withdrew subject|0|||
161067455|NCT00267098|581636121|FG003|Overall Study|Sponsor withdrew subject|1|||
161067456|NCT00267098|581636122|FG004|Overall Study|Sponsor withdrew subject|0|||
161067457|NCT00267098|581636123|FG005|Overall Study|Sponsor withdrew subject|0|||
161067458|NCT00267098|581636124|FG006|Overall Study|Sponsor withdrew subject|0|||
161067459|NCT00267098|581636125|FG007|Overall Study|Sponsor withdrew subject|0|||
161067460|NCT00798304|581636127|FG000|Overall Study|Adverse Event|0|||
161067461|NCT00798304|581636128|FG001|Overall Study|Adverse Event|1|||
161067462|NCT00798304|581636129|FG002|Overall Study|Adverse Event|1|||
161067463|NCT00798304|581636127|FG000|Overall Study|Discontinuation by Sponsor|14|||
161067464|NCT00798304|581636128|FG001|Overall Study|Discontinuation by Sponsor|21|||
161067465|NCT00798304|581636129|FG002|Overall Study|Discontinuation by Sponsor|9|||
161067466|NCT02031536|581636130|FG000|Overall Study|ineligible|1|||
161067467|NCT02031536|581636131|FG001|Overall Study|ineligible|0|||
161067468|NCT04206085|581636134|FG000|Overall Study|Lost to Follow-up|0|||
161067469|NCT04206085|581636135|FG001|Overall Study|Lost to Follow-up|1|||
161067470|NCT04206085|581636136|FG002|Overall Study|Lost to Follow-up|0|||
161067471|NCT04206085|581636134|FG000|Overall Study|Lost to Follow-up|0|||
161067472|NCT04206085|581636135|FG001|Overall Study|Lost to Follow-up|0|||
161067473|NCT04206085|581636136|FG002|Overall Study|Lost to Follow-up|1|||
161067474|NCT03845023|581636137|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
161067475|NCT03845023|581636138|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
161067476|NCT03845023|581636139|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
161067477|NCT03845023|581636140|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
161067478|NCT03845023|581636137|FG000|Follow-Up (14 Days)|Adverse Event|0|||
161067479|NCT03845023|581636138|FG001|Follow-Up (14 Days)|Adverse Event|0|||
161067480|NCT03845023|581636139|FG002|Follow-Up (14 Days)|Adverse Event|1|||
161067481|NCT03845023|581636140|FG003|Follow-Up (14 Days)|Adverse Event|1|||
161067482|NCT01182207|581636141|FG000|First Intervention|Positive Hepatitis Results|0|||
161067483|NCT01182207|581636142|FG001|First Intervention|Positive Hepatitis Results|1|||
161067484|NCT01182207|581636141|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
161067485|NCT01182207|581636142|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
161067486|NCT02658175|581636145|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
161067487|NCT02658175|581636146|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
161067488|NCT02658175|581636147|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
161067489|NCT02658175|581636145|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
161067490|NCT02658175|581636146|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
161067491|NCT02658175|581636147|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
161067492|NCT02658175|581636145|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
161067493|NCT02658175|581636146|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
161067494|NCT02658175|581636147|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
161067495|NCT02658175|581636145|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
161067496|NCT02658175|581636146|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
161067497|NCT02658175|581636147|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
161067498|NCT02658175|581636145|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
161067499|NCT02658175|581636146|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
161067500|NCT02658175|581636147|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
161067501|NCT02658175|581636145|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
161067502|NCT02658175|581636146|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
161067503|NCT02658175|581636147|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
161067504|NCT02658175|581636145|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
161067505|NCT02658175|581636146|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
161067506|NCT02658175|581636147|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
161067507|NCT02658175|581636145|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
161067508|NCT02658175|581636146|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
161067509|NCT02658175|581636147|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
161067510|NCT02658175|581636145|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
161067511|NCT02658175|581636146|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
161067512|NCT02658175|581636147|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
161067513|NCT02658175|581636145|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
161067514|NCT02658175|581636146|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
161067515|NCT02658175|581636147|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
161067516|NCT02918292|581636149|FG000|Study Enrollment Prior to Transplant|Death|1|||
161067517|NCT02918292|581636149|FG000|Study Follow up After Transplant|Death|6|||
161067518|NCT02165826|581636153|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
161067519|NCT02165826|581636154|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
161155691|NCT03249792|581951178|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
161345484|NCT05028569|582650833|FG003|Open-Label Phase|Death|0|||
161345485|NCT05028569|582650834|FG004|Open-Label Phase|Death|0|||
161283658|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
161283659|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
161283660|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
161283661|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
161283662|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161283663|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
161067520|NCT02165826|581636155|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
161067521|NCT02165826|581636153|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
161067522|NCT02165826|581636154|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
161067523|NCT02165826|581636155|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
161067524|NCT02165826|581636153|FG000|Main Treatment Period|Lost to Follow-up|4|||
161067525|NCT02165826|581636154|FG001|Main Treatment Period|Lost to Follow-up|2|||
161067526|NCT02165826|581636155|FG002|Main Treatment Period|Lost to Follow-up|1|||
161283664|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161283665|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161283666|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
161283667|NCT00662649|582417698|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
161283668|NCT00662649|582417699|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
161283669|NCT00662649|582417700|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
161283670|NCT00662649|582417701|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
161283671|NCT00662649|582417702|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
161283672|NCT02009722|582417709|FG000|Overall Study|Protocol Violation|1|||
161345486|NCT05028569|582650835|FG005|Open-Label Phase|Death|0|||
161067527|NCT02165826|581636153|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
161067528|NCT02165826|581636154|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
161067529|NCT02165826|581636155|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
161067530|NCT02165826|581636153|FG000|Main Treatment Period|Lack of Efficacy|2|||
161067531|NCT02165826|581636154|FG001|Main Treatment Period|Lack of Efficacy|0|||
161067532|NCT02165826|581636155|FG002|Main Treatment Period|Lack of Efficacy|0|||
161067533|NCT02165826|581636153|FG000|Main Treatment Period|Reason Not Specified|8|||
161067534|NCT02165826|581636154|FG001|Main Treatment Period|Reason Not Specified|5|||
161067535|NCT02165826|581636155|FG002|Main Treatment Period|Reason Not Specified|16|||
161067536|NCT02165826|581636153|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
161067537|NCT02165826|581636154|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
161067538|NCT02165826|581636155|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
161067539|NCT02165826|581636153|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
161067540|NCT02165826|581636154|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
161067541|NCT02165826|581636155|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
161067542|NCT02165826|581636153|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
161067543|NCT02165826|581636154|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
161067544|NCT02165826|581636155|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
161067545|NCT02165826|581636153|FG000|Down-Titration Period|Reason Not Specified|1|||
161067546|NCT02165826|581636154|FG001|Down-Titration Period|Reason Not Specified|0|||
161067547|NCT02165826|581636155|FG002|Down-Titration Period|Reason Not Specified|2|||
161067548|NCT02636608|581636159|FG000|Overall Study|Failure to Return|4|||
161067549|NCT02636608|581636159|FG000|Overall Study|Insufficient Virological Response|1|||
161067550|NCT02636608|581636159|FG000|Overall Study|Death|3|||
161067551|NCT02636608|581636159|FG000|Overall Study|Other|2|||
161067552|NCT02636608|581636159|FG000|Overall Study|Did Not Receive Treatment|1|||
161067553|NCT04590404|581636161|FG000|Overall Study|Death|16|||
161067554|NCT04590404|581636162|FG001|Overall Study|Death|17|||
161067555|NCT04590404|581636161|FG000|Overall Study|Withdrawal by Subject|7|||
161067556|NCT04590404|581636162|FG001|Overall Study|Withdrawal by Subject|2|||
161067557|NCT03912532|581636163|FG000|Overall Study|Adverse Event|3|||
161067558|NCT03912532|581636164|FG001|Overall Study|Adverse Event|3|||
161067559|NCT03912532|581636165|FG002|Overall Study|Adverse Event|2|||
161067560|NCT03912532|581636166|FG003|Overall Study|Adverse Event|2|||
161067561|NCT03912532|581636163|FG000|Overall Study|Lost to Follow-up|3|||
161067562|NCT03912532|581636164|FG001|Overall Study|Lost to Follow-up|2|||
161067563|NCT03912532|581636165|FG002|Overall Study|Lost to Follow-up|1|||
161067564|NCT03912532|581636166|FG003|Overall Study|Lost to Follow-up|2|||
161067565|NCT03912532|581636163|FG000|Overall Study|Withdrawal by Subject|1|||
161067566|NCT03912532|581636164|FG001|Overall Study|Withdrawal by Subject|1|||
161067567|NCT03912532|581636165|FG002|Overall Study|Withdrawal by Subject|2|||
161067568|NCT03912532|581636166|FG003|Overall Study|Withdrawal by Subject|0|||
161067569|NCT03912532|581636163|FG000|Overall Study|Physician Decision|1|||
161067570|NCT03912532|581636164|FG001|Overall Study|Physician Decision|0|||
161283673|NCT02009722|582417710|FG001|Overall Study|Protocol Violation|2|||
161345487|NCT05028569|582650836|FG006|Open-Label Phase|Death|1|||
161345488|NCT05028569|582650830|FG000|Open-Label Phase|Lost to Follow-up|0|||
161067571|NCT03912532|581636165|FG002|Overall Study|Physician Decision|0|||
161283674|NCT02009722|582417709|FG000|Overall Study|Did not receive intervention|0|||
161067572|NCT03912532|581636166|FG003|Overall Study|Physician Decision|3|||
161067573|NCT03912532|581636163|FG000|Overall Study|Other|0|||
161067574|NCT03912532|581636164|FG001|Overall Study|Other|1|||
161067575|NCT03912532|581636165|FG002|Overall Study|Other|1|||
161067576|NCT03912532|581636166|FG003|Overall Study|Other|0|||
161067577|NCT04913948|581636167|FG000|Overall Study|Withdrawal by Subject|2|||
161067578|NCT04913948|581636167|FG000|Overall Study|Sample processing issues|1|||
161067579|NCT04913948|581636167|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
161067580|NCT05739994|581636173|FG000|Overall Study|Withdrawal by Subject|2|||
161067581|NCT05739994|581636174|FG001|Overall Study|Withdrawal by Subject|2|||
161067582|NCT05739994|581636175|FG002|Overall Study|Withdrawal by Subject|4|||
161067583|NCT00815919|581636176|FG000|Overall Study|Unrelated Fungal Infection|1|||
161067584|NCT00815919|581636176|FG000|Overall Study|AML Relapse|1|||
161067585|NCT00815919|581636176|FG000|Overall Study|Lack of Efficacy|2|||
161067586|NCT04750577|581636177|FG000|Overall Study|Adverse Event|2|||
161067587|NCT04750577|581636178|FG001|Overall Study|Adverse Event|10|||
161067588|NCT04750577|581636179|FG002|Overall Study|Adverse Event|8|||
161067589|NCT04750577|581636180|FG003|Overall Study|Adverse Event|1|||
161067590|NCT04750577|581636177|FG000|Overall Study|Change of residence|0|||
161067591|NCT04750577|581636178|FG001|Overall Study|Change of residence|0|||
161067592|NCT04750577|581636179|FG002|Overall Study|Change of residence|1|||
161067593|NCT04750577|581636180|FG003|Overall Study|Change of residence|0|||
161067594|NCT04750577|581636177|FG000|Overall Study|Burden of study procedures|0|||
161067595|NCT04750577|581636178|FG001|Overall Study|Burden of study procedures|2|||
161067596|NCT04750577|581636179|FG002|Overall Study|Burden of study procedures|2|||
161067597|NCT04750577|581636180|FG003|Overall Study|Burden of study procedures|0|||
161067598|NCT04750577|581636177|FG000|Overall Study|Prematurely discontinued|0|||
161067599|NCT04750577|581636178|FG001|Overall Study|Prematurely discontinued|0|||
161067600|NCT04750577|581636179|FG002|Overall Study|Prematurely discontinued|0|||
161067601|NCT04750577|581636180|FG003|Overall Study|Prematurely discontinued|2|||
161067602|NCT04750577|581636177|FG000|Overall Study|Protocol deviation|1|||
161067603|NCT04750577|581636178|FG001|Overall Study|Protocol deviation|1|||
161067604|NCT04750577|581636179|FG002|Overall Study|Protocol deviation|1|||
161067605|NCT04750577|581636180|FG003|Overall Study|Protocol deviation|1|||
161067606|NCT04750577|581636177|FG000|Overall Study|Other than listed|3|||
161067607|NCT04750577|581636178|FG001|Overall Study|Other than listed|2|||
161067608|NCT04750577|581636179|FG002|Overall Study|Other than listed|2|||
161067609|NCT04750577|581636180|FG003|Overall Study|Other than listed|1|||
161067610|NCT04750577|581636177|FG000|Overall Study|Not treated|0|||
161067611|NCT04750577|581636178|FG001|Overall Study|Not treated|0|||
161067612|NCT04750577|581636179|FG002|Overall Study|Not treated|0|||
161067613|NCT04750577|581636180|FG003|Overall Study|Not treated|2|||
161067614|NCT02473042|581636182|FG000|Overall Study|Withdrawal by Subject|1|||
161067615|NCT02473042|581636183|FG001|Overall Study|Withdrawal by Subject|0|||
161067616|NCT02473042|581636182|FG000|Overall Study|Patient became ineligible after enrollment|2|||
161067617|NCT02473042|581636183|FG001|Overall Study|Patient became ineligible after enrollment|5|||
161067618|NCT02473042|581636182|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
161067619|NCT02473042|581636183|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
161067620|NCT02473042|581636182|FG000|Overall Study|PACU data unable to be collected|3|||
161067621|NCT02473042|581636183|FG001|Overall Study|PACU data unable to be collected|0|||
161067622|NCT04680637|581636186|FG000|Overall Study|Lost to Follow-up|0|||
161067623|NCT04680637|581636187|FG001|Overall Study|Lost to Follow-up|1|||
161067624|NCT04680637|581636188|FG002|Overall Study|Lost to Follow-up|0|||
161067625|NCT04680637|581636189|FG003|Overall Study|Lost to Follow-up|1|||
161067626|NCT04680637|581636186|FG000|Overall Study|Death|1|||
161067627|NCT04680637|581636187|FG001|Overall Study|Death|0|||
161067628|NCT04680637|581636188|FG002|Overall Study|Death|0|||
161067629|NCT04680637|581636189|FG003|Overall Study|Death|0|||
161067630|NCT04680637|581636186|FG000|Overall Study|Withdrawal by Subject|7|||
161067631|NCT04680637|581636187|FG001|Overall Study|Withdrawal by Subject|10|||
161283675|NCT02009722|582417710|FG001|Overall Study|Did not receive intervention|1|||
161283676|NCT02955212|582417711|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
161283677|NCT02955212|582417712|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
161283678|NCT02955212|582417711|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
161283679|NCT02955212|582417712|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
161067632|NCT04680637|581636188|FG002|Overall Study|Withdrawal by Subject|17|||
161067633|NCT04680637|581636189|FG003|Overall Study|Withdrawal by Subject|15|||
161067634|NCT04680637|581636186|FG000|Overall Study|Decision by Sponsor|21|||
161067635|NCT04680637|581636187|FG001|Overall Study|Decision by Sponsor|15|||
161067636|NCT04680637|581636188|FG002|Overall Study|Decision by Sponsor|7|||
161067637|NCT04680637|581636189|FG003|Overall Study|Decision by Sponsor|32|||
161067638|NCT01103232|581636192|FG000|Overall Study|Withdrawal by Subject|1|||
161067639|NCT01103232|581636193|FG001|Overall Study|Withdrawal by Subject|1|||
161283680|NCT02955212|582417711|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
161067640|NCT01103232|581636192|FG000|Overall Study|Protocol Violation|0|||
161067641|NCT01103232|581636193|FG001|Overall Study|Protocol Violation|1|||
161067642|NCT00443599|581636194|FG000|Overall Study|Physician Decision|2|||
161283681|NCT02955212|582417712|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
161283682|NCT02955212|582417711|FG000|Period 1: Double-blind Treatment Period|Other|3|||
161283683|NCT02955212|582417712|FG001|Period 1: Double-blind Treatment Period|Other|2|||
161283684|NCT02955212|582417711|FG000|Period 2: Open-label Extension|Adverse Event|11|||
161283685|NCT02955212|582417712|FG001|Period 2: Open-label Extension|Adverse Event|7|||
161283686|NCT02955212|582417711|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
161283687|NCT02955212|582417712|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
161283688|NCT02955212|582417711|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
161283689|NCT02955212|582417712|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
161283690|NCT02955212|582417711|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
161283691|NCT02955212|582417712|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
161283692|NCT02955212|582417711|FG000|Period 2: Open-label Extension|Other|2|||
161283693|NCT02955212|582417712|FG001|Period 2: Open-label Extension|Other|4|||
161345489|NCT05028569|582650831|FG001|Open-Label Phase|Lost to Follow-up|0|||
161345490|NCT05028569|582650832|FG002|Open-Label Phase|Lost to Follow-up|0|||
161345491|NCT05028569|582650833|FG003|Open-Label Phase|Lost to Follow-up|0|||
161345492|NCT05028569|582650834|FG004|Open-Label Phase|Lost to Follow-up|5|||
161345493|NCT05028569|582650835|FG005|Open-Label Phase|Lost to Follow-up|5|||
161345494|NCT05028569|582650836|FG006|Open-Label Phase|Lost to Follow-up|4|||
161345495|NCT05028569|582650830|FG000|Open-Label Phase|Protocol Deviation|0|||
161345496|NCT05028569|582650831|FG001|Open-Label Phase|Protocol Deviation|0|||
161345497|NCT05028569|582650832|FG002|Open-Label Phase|Protocol Deviation|0|||
161345498|NCT05028569|582650833|FG003|Open-Label Phase|Protocol Deviation|0|||
161345499|NCT05028569|582650834|FG004|Open-Label Phase|Protocol Deviation|1|||
161345500|NCT05028569|582650835|FG005|Open-Label Phase|Protocol Deviation|0|||
161345501|NCT05028569|582650836|FG006|Open-Label Phase|Protocol Deviation|0|||
161345502|NCT05028569|582650830|FG000|Open-Label Phase|Pregnancy|0|||
161345503|NCT05028569|582650831|FG001|Open-Label Phase|Pregnancy|0|||
161345504|NCT05028569|582650832|FG002|Open-Label Phase|Pregnancy|0|||
161345505|NCT05028569|582650833|FG003|Open-Label Phase|Pregnancy|0|||
161345506|NCT05028569|582650834|FG004|Open-Label Phase|Pregnancy|0|||
161345507|NCT05028569|582650835|FG005|Open-Label Phase|Pregnancy|1|||
161345508|NCT05028569|582650836|FG006|Open-Label Phase|Pregnancy|0|||
161067643|NCT00443599|581636195|FG001|Overall Study|Physician Decision|1|||
161067644|NCT00443599|581636194|FG000|Overall Study|Death|1|||
161067645|NCT00443599|581636195|FG001|Overall Study|Death|1|||
161067646|NCT00443599|581636194|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
161067647|NCT00443599|581636195|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
161067648|NCT05093504|581636196|FG000|Overall Study|Death|0|||
161067649|NCT05093504|581636197|FG001|Overall Study|Death|1|||
161067650|NCT03151551|581636198|FG000|Open-Label Treatment Period|Adverse Event|0|||
161067651|NCT03151551|581636199|FG001|Open-Label Treatment Period|Adverse Event|2|||
161067652|NCT03151551|581636198|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
161067653|NCT03151551|581636199|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
161067654|NCT03151551|581636198|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
161067655|NCT03151551|581636199|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
161067656|NCT03151551|581636198|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
161067657|NCT03151551|581636199|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
161067658|NCT03151551|581636198|FG000|Open-Label Treatment Period|Physician Decision|3|||
161067659|NCT03151551|581636199|FG001|Open-Label Treatment Period|Physician Decision|0|||
161067660|NCT03151551|581636198|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
161067661|NCT03151551|581636199|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
161067662|NCT03151551|581636198|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
161067663|NCT03151551|581636199|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
161067664|NCT03151551|581636198|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
161283694|NCT02454933|582417719|FG000|Overall Study|Progressive disease|10|||
161283695|NCT02454933|582417720|FG001|Overall Study|Progressive disease|7|||
161283696|NCT02454933|582417719|FG000|Overall Study|Adverse Event|1|||
161283697|NCT02454933|582417720|FG001|Overall Study|Adverse Event|1|||
161345509|NCT05028569|582650830|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161345510|NCT05028569|582650831|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161345511|NCT05028569|582650832|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161345512|NCT05028569|582650833|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161345513|NCT05028569|582650834|FG004|Open-Label Phase|Withdrawal by Subject|15|||
161067665|NCT03151551|581636199|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
161067666|NCT03151551|581636198|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
161067667|NCT03151551|581636199|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
161067668|NCT03151551|581636198|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
161067669|NCT03151551|581636199|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
161283698|NCT02454933|582417719|FG000|Overall Study|Withdrawal by Subject|0|||
161283699|NCT02454933|582417720|FG001|Overall Study|Withdrawal by Subject|3|||
161283700|NCT02454933|582417719|FG000|Overall Study|Lost to Follow-up|1|||
161067670|NCT01190449|581636200|FG000|Overall Study|Ineligible|0|||
161067671|NCT01190449|581636201|FG001|Overall Study|Ineligible|4|||
161067672|NCT01689363|581637652|FG000|Overall Study|Protocol Violation|0|||
161067673|NCT01689363|581637653|FG001|Overall Study|Protocol Violation|1|||
161067674|NCT01689363|581637654|FG002|Overall Study|Protocol Violation|0|||
161067675|NCT01689363|581637655|FG003|Overall Study|Protocol Violation|0|||
161067676|NCT01689363|581637656|FG004|Overall Study|Protocol Violation|0|||
161067677|NCT01689363|581637657|FG005|Overall Study|Protocol Violation|0|||
161067678|NCT01689363|581637658|FG006|Overall Study|Protocol Violation|0|||
161067679|NCT01689363|581637659|FG007|Overall Study|Protocol Violation|0|||
161067680|NCT05064488|581637660|FG000|Overall Study|Withdrawal by Subject|2|||
161067681|NCT05064488|581637661|FG001|Overall Study|Withdrawal by Subject|0|||
161067682|NCT03023722|581637662|FG000|Overall Study|No follow-up assessment|4|||
161067683|NCT00590564|581637664|FG000|Overall Study|Withdrawal by Subject|4|||
161067684|NCT00590564|581637664|FG000|Overall Study|Lost to Follow-up|6|||
161067685|NCT00590564|581637664|FG000|Overall Study|Protocol Violation|1|||
161067686|NCT00590564|581637664|FG000|Overall Study|Patient Found to be Ineligible|1|||
161067687|NCT00590564|581637664|FG000|Overall Study|Patient Non-compliance|6|||
161067688|NCT01434680|581637669|FG000|Overall Study|Withdrawal by Subject|1|||
161067689|NCT01434680|581637670|FG001|Overall Study|Withdrawal by Subject|0|||
161067690|NCT01434680|581637671|FG002|Overall Study|Withdrawal by Subject|2|||
161067691|NCT01434680|581637672|FG003|Overall Study|Withdrawal by Subject|0|||
161067692|NCT01434680|581637669|FG000|Overall Study|Lost to Follow-up|1|||
161067693|NCT01434680|581637670|FG001|Overall Study|Lost to Follow-up|1|||
161067694|NCT01434680|581637671|FG002|Overall Study|Lost to Follow-up|0|||
161067695|NCT01434680|581637672|FG003|Overall Study|Lost to Follow-up|0|||
161067696|NCT01434680|581637669|FG000|Overall Study|Protocol Violation|1|||
161067697|NCT01434680|581637670|FG001|Overall Study|Protocol Violation|1|||
161067698|NCT01434680|581637671|FG002|Overall Study|Protocol Violation|0|||
161067699|NCT01434680|581637672|FG003|Overall Study|Protocol Violation|0|||
161067700|NCT04090528|581637673|FG000|Overall Study|participants still on study|9|||
161067701|NCT04090528|581637674|FG001|Overall Study|participants still on study|13|||
161067702|NCT05923112|581637677|FG000|Overall Study|Protocol Violation|4|||
161067703|NCT05923112|581637677|FG000|Overall Study|No informed consent on publication of study results|243|||
161067704|NCT04991766|581637678|FG000|Overall Study|Withdrawal by Subject|2|||
161067705|NCT04991766|581637679|FG001|Overall Study|Withdrawal by Subject|0|||
161067706|NCT01952847|581637687|FG000|Overall Study|Ineligible|1|||
161067707|NCT01952847|581637688|FG001|Overall Study|Ineligible|0|||
161067708|NCT01952847|581637689|FG002|Overall Study|Ineligible|0|||
161067709|NCT01952847|581637690|FG003|Overall Study|Ineligible|0|||
161067710|NCT01952847|581637687|FG000|Overall Study|Lack of Insurance Coverage|0|||
161067711|NCT01952847|581637688|FG001|Overall Study|Lack of Insurance Coverage|1|||
161067712|NCT01952847|581637689|FG002|Overall Study|Lack of Insurance Coverage|0|||
161067713|NCT01952847|581637690|FG003|Overall Study|Lack of Insurance Coverage|0|||
161067714|NCT01952847|581637687|FG000|Overall Study|Withdrawal by Subject|1|||
161067715|NCT01952847|581637688|FG001|Overall Study|Withdrawal by Subject|1|||
161067716|NCT01952847|581637689|FG002|Overall Study|Withdrawal by Subject|0|||
161067717|NCT01952847|581637690|FG003|Overall Study|Withdrawal by Subject|1|||
161067718|NCT05382039|581637691|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
161067719|NCT05382039|581637692|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
161067720|NCT05382039|581637693|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
161067721|NCT05382039|581637691|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
161067722|NCT05382039|581637692|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
161067723|NCT05382039|581637693|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
161067724|NCT05382039|581637691|FG000|Overall Study|waiting for confirmation|0|||
161067725|NCT05382039|581637692|FG001|Overall Study|waiting for confirmation|0|||
161067726|NCT05382039|581637693|FG002|Overall Study|waiting for confirmation|1|||
161067727|NCT04464421|581637694|FG000|Overall Study|Lost to Follow-up|2|||
161067728|NCT04464421|581637695|FG001|Overall Study|Lost to Follow-up|2|||
161067729|NCT02577003|581637696|FG000|Overall Study|Adverse Event|2|||
161067730|NCT02577003|581637697|FG001|Overall Study|Adverse Event|4|||
161067731|NCT02577003|581637696|FG000|Overall Study|Withdrawal by Subject|0|||
161067732|NCT02577003|581637697|FG001|Overall Study|Withdrawal by Subject|1|||
161067733|NCT02786004|581637698|FG000|Overall Study|Withdrawal by Subject|0|||
161067734|NCT02786004|581637699|FG001|Overall Study|Withdrawal by Subject|1|||
161067735|NCT01234883|581637700|FG000|Overall Study|Early treatment release|8|||
161283701|NCT02454933|582417720|FG001|Overall Study|Lost to Follow-up|0|||
161067736|NCT01234883|581637701|FG001|Overall Study|Early treatment release|10|||
161283702|NCT02071225|582417726|FG000|Overall Study|Withdrawal of Consent|2|||
161067737|NCT01234883|581637700|FG000|Overall Study|Parent/guardian withdrew consent|1|||
161067738|NCT01234883|581637701|FG001|Overall Study|Parent/guardian withdrew consent|2|||
161283703|NCT02071225|582417726|FG000|Overall Study|Protocol Deviation|1|||
161067739|NCT01234883|581637700|FG000|Overall Study|Technical difficulties with IV infusion|0|||
161155692|NCT03249792|581951179|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
161283704|NCT02071225|582417726|FG000|Overall Study|Lost to Follow-up|2|||
161283705|NCT02071225|582417726|FG000|Overall Study|Death|25|||
161283706|NCT01342081|582417729|FG000|Overall Study|Did not receive allocated intervention|0|||
161283707|NCT01342081|582417730|FG001|Overall Study|Did not receive allocated intervention|0|||
161283708|NCT01342081|582417731|FG002|Overall Study|Did not receive allocated intervention|1|||
161283709|NCT01342081|582417729|FG000|Overall Study|Adverse Event|1|||
161283710|NCT01342081|582417730|FG001|Overall Study|Adverse Event|0|||
161283711|NCT01342081|582417731|FG002|Overall Study|Adverse Event|0|||
161283712|NCT01342081|582417729|FG000|Overall Study|Physician Decision|0|||
161283713|NCT01342081|582417730|FG001|Overall Study|Physician Decision|1|||
161283714|NCT01342081|582417731|FG002|Overall Study|Physician Decision|0|||
161283715|NCT01342081|582417729|FG000|Overall Study|Withdrawal by Subject|1|||
161283716|NCT01342081|582417730|FG001|Overall Study|Withdrawal by Subject|1|||
161283717|NCT01342081|582417731|FG002|Overall Study|Withdrawal by Subject|0|||
161283718|NCT04720053|582417736|FG000|Overall Study|Lost to Follow-up|12|||
161283719|NCT01942993|582417737|FG000|Overall Study|Lost to Follow-up|1|||
161283720|NCT01942993|582417737|FG000|Overall Study|Physician Decision|1|||
161283721|NCT02906670|582417741|FG000|Cohort 1, QW|Radiological Progression|1|||
161283722|NCT02906670|582417742|FG001|Cohort 1, QW|Radiological Progression|0|||
161067740|NCT01234883|581637701|FG001|Overall Study|Technical difficulties with IV infusion|1|||
161067741|NCT01234883|581637700|FG000|Overall Study|Inclusion/exclusion failure|1|||
161067742|NCT01234883|581637701|FG001|Overall Study|Inclusion/exclusion failure|0|||
161067743|NCT01013961|581637702|FG000|Overall Study|Adverse Event|2|||
161067744|NCT01013961|581637703|FG001|Overall Study|Adverse Event|2|||
161067745|NCT01013961|581637702|FG000|Overall Study|Withdrawal by Subject|1|||
161067746|NCT01013961|581637703|FG001|Overall Study|Withdrawal by Subject|0|||
161067747|NCT01013961|581637702|FG000|Overall Study|Physician Decision|0|||
161067748|NCT01013961|581637703|FG001|Overall Study|Physician Decision|1|||
161067749|NCT01271504|581637704|FG000|Overall Study|Death|7|||
161067750|NCT01271504|581637705|FG001|Overall Study|Death|6|||
161067751|NCT01271504|581637706|FG002|Overall Study|Death|32|||
161067752|NCT01271504|581637707|FG003|Overall Study|Death|32|||
161067753|NCT01271504|581637704|FG000|Overall Study|Lost to Follow-up|0|||
161067754|NCT01271504|581637705|FG001|Overall Study|Lost to Follow-up|1|||
161067755|NCT01271504|581637706|FG002|Overall Study|Lost to Follow-up|3|||
161067756|NCT01271504|581637707|FG003|Overall Study|Lost to Follow-up|1|||
161067757|NCT01271504|581637704|FG000|Overall Study|Protocol Violation|0|||
161067758|NCT01271504|581637705|FG001|Overall Study|Protocol Violation|0|||
161067759|NCT01271504|581637706|FG002|Overall Study|Protocol Violation|0|||
161067760|NCT01271504|581637707|FG003|Overall Study|Protocol Violation|2|||
161067761|NCT01271504|581637704|FG000|Overall Study|Administrative Reasons|0|||
161067762|NCT01271504|581637705|FG001|Overall Study|Administrative Reasons|0|||
161067763|NCT01271504|581637706|FG002|Overall Study|Administrative Reasons|6|||
161067764|NCT01271504|581637707|FG003|Overall Study|Administrative Reasons|5|||
161067765|NCT01271504|581637704|FG000|Overall Study|Withdrawal by Subject|0|||
161067766|NCT01271504|581637705|FG001|Overall Study|Withdrawal by Subject|0|||
161067767|NCT01271504|581637706|FG002|Overall Study|Withdrawal by Subject|1|||
161067768|NCT01271504|581637707|FG003|Overall Study|Withdrawal by Subject|3|||
161067769|NCT01271504|581637704|FG000|Overall Study|Other|0|||
161067770|NCT01271504|581637705|FG001|Overall Study|Other|1|||
161067771|NCT01271504|581637706|FG002|Overall Study|Other|2|||
161067772|NCT01271504|581637707|FG003|Overall Study|Other|0|||
161067773|NCT00756457|581637718|FG000|Overall Study|Lost to Follow-up|1|||
161067774|NCT00756457|581637719|FG001|Overall Study|Lost to Follow-up|2|||
161067775|NCT02402322|581637720|FG000|Pretreatment|Withdrawal by Subject|3|||
161067776|NCT02402322|581637721|FG001|Pretreatment|Withdrawal by Subject|1|||
161067777|NCT02402322|581637722|FG002|Pretreatment|Withdrawal by Subject|1|||
161067778|NCT02402322|581637720|FG000|Follow-up|Withdrawal by Subject|6|||
161067779|NCT02402322|581637721|FG001|Follow-up|Withdrawal by Subject|3|||
161067780|NCT02402322|581637722|FG002|Follow-up|Withdrawal by Subject|24|||
161067781|NCT02818998|581637723|FG000|Overall Study|Adverse Event|3|||
161067782|NCT02818998|581637724|FG001|Overall Study|Adverse Event|2|||
161283723|NCT02906670|582417743|FG002|Cohort 1, QW|Radiological Progression|0|||
161283724|NCT02906670|582417744|FG003|Cohort 1, QW|Radiological Progression|0|||
161067783|NCT02818998|581637725|FG002|Overall Study|Adverse Event|1|||
161067784|NCT02818998|581637723|FG000|Overall Study|Lost to Follow-up|4|||
161067785|NCT02818998|581637724|FG001|Overall Study|Lost to Follow-up|1|||
161283725|NCT02906670|582417745|FG004|Cohort 1, QW|Radiological Progression|0|||
161283726|NCT02906670|582417746|FG005|Cohort 1, QW|Radiological Progression|0|||
161345514|NCT05028569|582650835|FG005|Open-Label Phase|Withdrawal by Subject|8|||
161067786|NCT02818998|581637725|FG002|Overall Study|Lost to Follow-up|2|||
161067787|NCT02818998|581637723|FG000|Overall Study|Withdrawal by sponsor|0|||
161283727|NCT02906670|582417747|FG006|Cohort 1, QW|Radiological Progression|0|||
161283728|NCT02906670|582417748|FG007|Cohort 1, QW|Radiological Progression|0|||
161283729|NCT02906670|582417749|FG008|Cohort 1, QW|Radiological Progression|0|||
161067788|NCT02818998|581637724|FG001|Overall Study|Withdrawal by sponsor|1|||
161067789|NCT02818998|581637725|FG002|Overall Study|Withdrawal by sponsor|1|||
161283730|NCT02906670|582417750|FG009|Cohort 1, QW|Radiological Progression|0|||
161067790|NCT02818998|581637723|FG000|Overall Study|Death|3|||
161067791|NCT02818998|581637724|FG001|Overall Study|Death|6|||
161067792|NCT02818998|581637725|FG002|Overall Study|Death|8|||
161067793|NCT02818998|581637723|FG000|Overall Study|Withdrawal by Subject|7|||
161067794|NCT02818998|581637724|FG001|Overall Study|Withdrawal by Subject|6|||
161067795|NCT02818998|581637725|FG002|Overall Study|Withdrawal by Subject|6|||
161067796|NCT02818998|581637723|FG000|Overall Study|Physician Decision|1|||
161067797|NCT02818998|581637724|FG001|Overall Study|Physician Decision|0|||
161067798|NCT02818998|581637725|FG002|Overall Study|Physician Decision|0|||
161067799|NCT02472145|581637726|FG000|Overall Study|Death|10|||
161067800|NCT02472145|581637727|FG001|Overall Study|Death|101|||
161067801|NCT02472145|581637728|FG002|Overall Study|Death|99|||
161067802|NCT02472145|581637726|FG000|Overall Study|Lost to Follow-up|0|||
161067803|NCT02472145|581637727|FG001|Overall Study|Lost to Follow-up|1|||
161067804|NCT02472145|581637728|FG002|Overall Study|Lost to Follow-up|0|||
161067805|NCT02472145|581637726|FG000|Overall Study|Withdrawal by Subject|0|||
161067806|NCT02472145|581637727|FG001|Overall Study|Withdrawal by Subject|9|||
161067807|NCT02472145|581637728|FG002|Overall Study|Withdrawal by Subject|13|||
161067808|NCT02472145|581637726|FG000|Overall Study|Sponsor decision|0|||
161067809|NCT02472145|581637727|FG001|Overall Study|Sponsor decision|3|||
161067810|NCT02472145|581637728|FG002|Overall Study|Sponsor decision|2|||
161067811|NCT02472145|581637726|FG000|Overall Study|Other|0|||
161067812|NCT02472145|581637727|FG001|Overall Study|Other|45|||
161067813|NCT02472145|581637728|FG002|Overall Study|Other|43|||
161067814|NCT01080326|581637729|FG000|Overall Study|Patient deterioration prior to procedure|3|||
161067815|NCT01080326|581637729|FG000|Overall Study|Surgeon decision|1|||
161067816|NCT00632021|581637731|FG000|Overall Study|Withdrawal/death|4|||
161067817|NCT00632021|581637732|FG001|Overall Study|Withdrawal/death|7|||
161067818|NCT02250534|581637735|FG000|Overall Study|Lost to Follow-up|18|||
161067819|NCT02250534|581637736|FG001|Overall Study|Lost to Follow-up|28|||
161067820|NCT02250534|581637737|FG002|Overall Study|Lost to Follow-up|33|||
161067821|NCT02250534|581637735|FG000|Overall Study|Personal reasons|7|||
161067822|NCT02250534|581637736|FG001|Overall Study|Personal reasons|8|||
161067823|NCT02250534|581637737|FG002|Overall Study|Personal reasons|14|||
161067824|NCT02250534|581637735|FG000|Overall Study|Adverse Event|6|||
161067825|NCT02250534|581637736|FG001|Overall Study|Adverse Event|3|||
161067826|NCT02250534|581637737|FG002|Overall Study|Adverse Event|8|||
161067827|NCT02250534|581637735|FG000|Overall Study|incarcerated|2|||
161067828|NCT02250534|581637736|FG001|Overall Study|incarcerated|1|||
161067829|NCT02250534|581637737|FG002|Overall Study|incarcerated|2|||
161067830|NCT02250534|581637735|FG000|Overall Study|Withdrawal by Subject|0|||
161067831|NCT02250534|581637736|FG001|Overall Study|Withdrawal by Subject|1|||
161067832|NCT02250534|581637737|FG002|Overall Study|Withdrawal by Subject|2|||
161067833|NCT02250534|581637735|FG000|Overall Study|Death|0|||
161067834|NCT02250534|581637736|FG001|Overall Study|Death|1|||
161067835|NCT02250534|581637737|FG002|Overall Study|Death|1|||
161067836|NCT02250534|581637735|FG000|Overall Study|Physician Decision|1|||
161067837|NCT02250534|581637736|FG001|Overall Study|Physician Decision|3|||
161067838|NCT02250534|581637737|FG002|Overall Study|Physician Decision|1|||
161067839|NCT02250534|581637735|FG000|Overall Study|Protocol Violation|1|||
161067840|NCT02250534|581637736|FG001|Overall Study|Protocol Violation|0|||
161067841|NCT02250534|581637737|FG002|Overall Study|Protocol Violation|1|||
161067842|NCT02250534|581637735|FG000|Overall Study|Reason unknown|1|||
161067843|NCT02250534|581637736|FG001|Overall Study|Reason unknown|0|||
161067844|NCT02250534|581637737|FG002|Overall Study|Reason unknown|0|||
161067845|NCT01628692|581637740|FG000|Overall Study|Lack of Efficacy|4|||
161067846|NCT01628692|581637741|FG001|Overall Study|Lack of Efficacy|4|||
161067847|NCT01628692|581637742|FG002|Overall Study|Lack of Efficacy|5|||
161067848|NCT01628692|581637743|FG003|Overall Study|Lack of Efficacy|1|||
161067849|NCT01628692|581637744|FG004|Overall Study|Lack of Efficacy|4|||
161067850|NCT01628692|581637745|FG005|Overall Study|Lack of Efficacy|7|||
161067851|NCT01628692|581637740|FG000|Overall Study|Adverse Event|2|||
161283731|NCT02906670|582417741|FG000|Cohort 2, QW|Radiological Progression|0|||
161283732|NCT02906670|582417742|FG001|Cohort 2, QW|Radiological Progression|1|||
161283733|NCT02906670|582417743|FG002|Cohort 2, QW|Radiological Progression|0|||
161283734|NCT02906670|582417744|FG003|Cohort 2, QW|Radiological Progression|0|||
161283735|NCT02906670|582417745|FG004|Cohort 2, QW|Radiological Progression|0|||
161283736|NCT02906670|582417746|FG005|Cohort 2, QW|Radiological Progression|0|||
161283737|NCT02906670|582417747|FG006|Cohort 2, QW|Radiological Progression|0|||
161283738|NCT02906670|582417748|FG007|Cohort 2, QW|Radiological Progression|0|||
161283739|NCT02906670|582417749|FG008|Cohort 2, QW|Radiological Progression|0|||
161067852|NCT01628692|581637741|FG001|Overall Study|Adverse Event|0|||
161067853|NCT01628692|581637742|FG002|Overall Study|Adverse Event|2|||
161067854|NCT01628692|581637743|FG003|Overall Study|Adverse Event|0|||
161067855|NCT01628692|581637744|FG004|Overall Study|Adverse Event|0|||
161067856|NCT01628692|581637745|FG005|Overall Study|Adverse Event|0|||
161067857|NCT01628692|581637740|FG000|Overall Study|Withdrawal by Subject|0|||
161067858|NCT01628692|581637741|FG001|Overall Study|Withdrawal by Subject|1|||
161067859|NCT01628692|581637742|FG002|Overall Study|Withdrawal by Subject|1|||
161067860|NCT01628692|581637743|FG003|Overall Study|Withdrawal by Subject|0|||
161283740|NCT02906670|582417750|FG009|Cohort 2, QW|Radiological Progression|0|||
161283741|NCT02906670|582417741|FG000|Cohort 3, QW|Radiological Progression|0|||
161283742|NCT02906670|582417742|FG001|Cohort 3, QW|Radiological Progression|0|||
161283743|NCT02906670|582417743|FG002|Cohort 3, QW|Radiological Progression|2|||
161283744|NCT02906670|582417744|FG003|Cohort 3, QW|Radiological Progression|0|||
161283745|NCT02906670|582417745|FG004|Cohort 3, QW|Radiological Progression|0|||
161067861|NCT01628692|581637744|FG004|Overall Study|Withdrawal by Subject|0|||
161067862|NCT01628692|581637745|FG005|Overall Study|Withdrawal by Subject|0|||
161067863|NCT01628692|581637740|FG000|Overall Study|Death|0|||
161067864|NCT01628692|581637741|FG001|Overall Study|Death|1|||
161067865|NCT01628692|581637742|FG002|Overall Study|Death|0|||
161067866|NCT01628692|581637743|FG003|Overall Study|Death|0|||
161067867|NCT01628692|581637744|FG004|Overall Study|Death|0|||
161067868|NCT01628692|581637745|FG005|Overall Study|Death|0|||
161067869|NCT01628692|581637740|FG000|Overall Study|Poor compliance/noncompliance|1|||
161067870|NCT01628692|581637741|FG001|Overall Study|Poor compliance/noncompliance|0|||
161067871|NCT01628692|581637742|FG002|Overall Study|Poor compliance/noncompliance|0|||
161067872|NCT01628692|581637743|FG003|Overall Study|Poor compliance/noncompliance|0|||
161067873|NCT01628692|581637744|FG004|Overall Study|Poor compliance/noncompliance|0|||
161067874|NCT01628692|581637745|FG005|Overall Study|Poor compliance/noncompliance|0|||
161067875|NCT01628692|581637740|FG000|Overall Study|Administrative reason by sponsor|0|||
161067876|NCT01628692|581637741|FG001|Overall Study|Administrative reason by sponsor|0|||
161067877|NCT01628692|581637742|FG002|Overall Study|Administrative reason by sponsor|0|||
161067878|NCT01628692|581637743|FG003|Overall Study|Administrative reason by sponsor|0|||
161067879|NCT01628692|581637744|FG004|Overall Study|Administrative reason by sponsor|0|||
161067880|NCT01628692|581637745|FG005|Overall Study|Administrative reason by sponsor|1|||
161067881|NCT01628692|581637740|FG000|Overall Study|Completed 12 Week only|0|||
161067882|NCT01628692|581637741|FG001|Overall Study|Completed 12 Week only|0|||
161067883|NCT01628692|581637742|FG002|Overall Study|Completed 12 Week only|0|||
161067884|NCT01628692|581637743|FG003|Overall Study|Completed 12 Week only|0|||
161067885|NCT01628692|581637744|FG004|Overall Study|Completed 12 Week only|0|||
161067886|NCT01628692|581637745|FG005|Overall Study|Completed 12 Week only|1|||
161067887|NCT02437071|581637746|FG000|Overall Study|Withdrawal by Subject|1|||
161067888|NCT02437071|581637747|FG001|Overall Study|Withdrawal by Subject|0|||
161067889|NCT00537329|581637748|FG000|Overall Study|Death|10|||
161067890|NCT00537329|581637748|FG000|Overall Study|Adverse Event|3|||
161067891|NCT00537329|581637748|FG000|Overall Study|Lack of Efficacy|2|||
161067892|NCT00537329|581637748|FG000|Overall Study|Lost to Follow-up|6|||
161067893|NCT00537329|581637748|FG000|Overall Study|Withdrawal by Subject|4|||
161067894|NCT00537329|581637748|FG000|Overall Study|Other|1|||
161067895|NCT00224029|581637750|FG000|Overall Study|Lost to Follow-up|1|||
161067896|NCT00224029|581637750|FG000|Overall Study|Withdrawal by Subject|4|||
161067897|NCT00224029|581637750|FG000|Overall Study|Other|1|||
161067898|NCT01099579|581637751|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
161067899|NCT01099579|581637752|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
161067900|NCT01099579|581637753|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
161067901|NCT01099579|581637751|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
161067902|NCT01099579|581637752|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
161067903|NCT01099579|581637753|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
161067904|NCT01099579|581637751|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
161067905|NCT01099579|581637752|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
161067906|NCT01099579|581637753|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
161067907|NCT01099579|581637751|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
161067908|NCT01099579|581637752|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
161067909|NCT01099579|581637753|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
161067910|NCT01099579|581637751|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
161067911|NCT01099579|581637752|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
161067912|NCT01099579|581637753|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
161067913|NCT01099579|581637751|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161067914|NCT01099579|581637752|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161067915|NCT01099579|581637753|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
161067916|NCT01099579|581637751|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
161067917|NCT01099579|581637752|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
161283746|NCT02906670|582417746|FG005|Cohort 3, QW|Radiological Progression|0|||
161283747|NCT02906670|582417747|FG006|Cohort 3, QW|Radiological Progression|0|||
161067918|NCT01099579|581637753|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
161067919|NCT01099579|581637751|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
161067920|NCT01099579|581637752|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
161067921|NCT01099579|581637753|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
161067922|NCT01099579|581637751|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
161067923|NCT01099579|581637752|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
161067924|NCT01099579|581637753|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
161067925|NCT01099579|581637751|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
161067926|NCT01099579|581637752|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
161067927|NCT01099579|581637753|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
161067928|NCT04788511|581637756|FG000|Overall Study|Withdrawal by Subject|2|||
161067929|NCT04788511|581637757|FG001|Overall Study|Withdrawal by Subject|1|||
161067930|NCT04788511|581637756|FG000|Overall Study|Lost to Follow-up|2|||
161067931|NCT04788511|581637757|FG001|Overall Study|Lost to Follow-up|7|||
161067932|NCT04788511|581637756|FG000|Overall Study|Death|3|||
161067933|NCT04788511|581637757|FG001|Overall Study|Death|4|||
161067934|NCT00778921|581637758|FG000|Overall Study|Adverse Event|9|||
161067935|NCT00778921|581637759|FG001|Overall Study|Adverse Event|10|||
161067936|NCT00778921|581637760|FG002|Overall Study|Adverse Event|14|||
161067937|NCT00778921|581637758|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
161067938|NCT00778921|581637759|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
161067939|NCT00778921|581637760|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
161067940|NCT00778921|581637758|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
161283748|NCT02906670|582417748|FG007|Cohort 3, QW|Radiological Progression|0|||
161067941|NCT00778921|581637759|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161067942|NCT00778921|581637760|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
161067943|NCT00778921|581637758|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161067944|NCT00778921|581637759|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
161067945|NCT00778921|581637760|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
161067946|NCT00778921|581637758|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
161067947|NCT00778921|581637759|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
161067948|NCT00778921|581637760|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
161067949|NCT00778921|581637758|FG000|Overall Study|Patient withdrew request|3|||
161067950|NCT00778921|581637759|FG001|Overall Study|Patient withdrew request|1|||
161067951|NCT00778921|581637760|FG002|Overall Study|Patient withdrew request|6|||
161067952|NCT00778921|581637758|FG000|Overall Study|Lost to Follow-up|0|||
161067953|NCT00778921|581637759|FG001|Overall Study|Lost to Follow-up|2|||
161067954|NCT00778921|581637760|FG002|Overall Study|Lost to Follow-up|1|||
161283749|NCT02906670|582417749|FG008|Cohort 3, QW|Radiological Progression|0|||
161283750|NCT02906670|582417750|FG009|Cohort 3, QW|Radiological Progression|0|||
161283751|NCT02906670|582417741|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283752|NCT02906670|582417742|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283753|NCT02906670|582417743|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
161283754|NCT02906670|582417744|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283755|NCT02906670|582417745|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283756|NCT02906670|582417746|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283757|NCT02906670|582417747|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283758|NCT02906670|582417748|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283759|NCT02906670|582417749|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283760|NCT02906670|582417750|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
161283761|NCT02906670|582417741|FG000|Cohort 4, Q2W|Radiological Progression|0|||
161283762|NCT02906670|582417742|FG001|Cohort 4, Q2W|Radiological Progression|0|||
161283763|NCT02906670|582417743|FG002|Cohort 4, Q2W|Radiological Progression|0|||
161283764|NCT02906670|582417744|FG003|Cohort 4, Q2W|Radiological Progression|0|||
161283765|NCT02906670|582417745|FG004|Cohort 4, Q2W|Radiological Progression|0|||
161283766|NCT02906670|582417746|FG005|Cohort 4, Q2W|Radiological Progression|1|||
161283767|NCT02906670|582417747|FG006|Cohort 4, Q2W|Radiological Progression|0|||
161283768|NCT02906670|582417748|FG007|Cohort 4, Q2W|Radiological Progression|0|||
161283769|NCT02906670|582417749|FG008|Cohort 4, Q2W|Radiological Progression|0|||
161283770|NCT02906670|582417750|FG009|Cohort 4, Q2W|Radiological Progression|0|||
161283771|NCT02906670|582417741|FG000|Cohort 4, Q2W|Clinical Progression|0|||
161283772|NCT02906670|582417742|FG001|Cohort 4, Q2W|Clinical Progression|0|||
161283773|NCT02906670|582417743|FG002|Cohort 4, Q2W|Clinical Progression|0|||
161283774|NCT02906670|582417744|FG003|Cohort 4, Q2W|Clinical Progression|0|||
161283775|NCT02906670|582417745|FG004|Cohort 4, Q2W|Clinical Progression|0|||
161067955|NCT00778921|581637758|FG000|Overall Study|Administrative Problems|1|||
161067956|NCT00778921|581637759|FG001|Overall Study|Administrative Problems|2|||
161067957|NCT00778921|581637760|FG002|Overall Study|Administrative Problems|0|||
161283776|NCT02906670|582417746|FG005|Cohort 4, Q2W|Clinical Progression|2|||
161283777|NCT02906670|582417747|FG006|Cohort 4, Q2W|Clinical Progression|0|||
161067958|NCT00778921|581637758|FG000|Overall Study|Protocol Violation|3|||
161067959|NCT00778921|581637759|FG001|Overall Study|Protocol Violation|0|||
161067960|NCT00778921|581637760|FG002|Overall Study|Protocol Violation|2|||
161283778|NCT02906670|582417748|FG007|Cohort 4, Q2W|Clinical Progression|0|||
161283779|NCT02906670|582417749|FG008|Cohort 4, Q2W|Clinical Progression|0|||
161283780|NCT02906670|582417750|FG009|Cohort 4, Q2W|Clinical Progression|0|||
161067961|NCT00778921|581637758|FG000|Overall Study|Not treated|0|||
161067962|NCT00778921|581637759|FG001|Overall Study|Not treated|2|||
161067963|NCT00778921|581637760|FG002|Overall Study|Not treated|2|||
161283781|NCT02906670|582417741|FG000|Cohort 5, Q2W|Radiological Progression|0|||
161283782|NCT02906670|582417742|FG001|Cohort 5, Q2W|Radiological Progression|0|||
161067964|NCT00572533|581637761|FG000|Overall Study|Death|4|||
161067965|NCT00572533|581637762|FG001|Overall Study|Death|1|||
161067966|NCT00572533|581637761|FG000|Overall Study|Received Kidney Transplant|2|||
161283783|NCT02906670|582417743|FG002|Cohort 5, Q2W|Radiological Progression|0|||
161067967|NCT00572533|581637762|FG001|Overall Study|Received Kidney Transplant|1|||
161067968|NCT00572533|581637761|FG000|Overall Study|Social Issues|1|||
161067969|NCT00572533|581637762|FG001|Overall Study|Social Issues|0|||
161067970|NCT00572533|581637761|FG000|Overall Study|Transfer out of Facility|0|||
161067971|NCT00572533|581637762|FG001|Overall Study|Transfer out of Facility|1|||
161067972|NCT01078922|581637763|FG000|Overall Study|Adverse Event|1|||
161067973|NCT02353468|581637764|FG000|Overall Study|Study terminated|3|||
161067974|NCT00003477|581637767|FG000|Overall Study|Not evalauable|4|||
161067975|NCT02688530|581637772|FG000|Overall Study|Withdrawal by Subject|0|||
161067976|NCT02688530|581637773|FG001|Overall Study|Withdrawal by Subject|1|||
161067977|NCT02688530|581637774|FG002|Overall Study|Withdrawal by Subject|0|||
161067978|NCT02688530|581637775|FG003|Overall Study|Withdrawal by Subject|0|||
161067979|NCT02688530|581637772|FG000|Overall Study|Lost to Follow-up|0|||
161067980|NCT02688530|581637773|FG001|Overall Study|Lost to Follow-up|0|||
161067981|NCT02688530|581637774|FG002|Overall Study|Lost to Follow-up|2|||
161067982|NCT02688530|581637775|FG003|Overall Study|Lost to Follow-up|0|||
161067983|NCT01658020|581637776|FG000|Overall Study|Adverse Event|3|||
161067984|NCT01658020|581637777|FG001|Overall Study|Adverse Event|3|||
161067985|NCT01658020|581637776|FG000|Overall Study|Lost to Follow-up|1|||
161067986|NCT01658020|581637777|FG001|Overall Study|Lost to Follow-up|0|||
161067987|NCT01658020|581637776|FG000|Overall Study|Withdrawal by Subject|4|||
161067988|NCT01658020|581637777|FG001|Overall Study|Withdrawal by Subject|5|||
161067989|NCT01658020|581637776|FG000|Overall Study|Protocol Violation|0|||
161067990|NCT01658020|581637777|FG001|Overall Study|Protocol Violation|1|||
161067991|NCT01530087|581637784|FG000|Overall Study|Physician Decision|2|||
161067992|NCT02353871|581637785|FG000|Overall Study|Protocol deviation|0|||
161067993|NCT02353871|581637786|FG001|Overall Study|Protocol deviation|1|||
161067994|NCT02353871|581637785|FG000|Overall Study|Consent withdrawn|1|||
161067995|NCT02353871|581637786|FG001|Overall Study|Consent withdrawn|8|||
161067996|NCT02353871|581637785|FG000|Overall Study|Lost to Follow-up|2|||
161067997|NCT02353871|581637786|FG001|Overall Study|Lost to Follow-up|0|||
161067998|NCT02554383|581637789|FG000|Overall Study|Ineligible|3|||
161067999|NCT02554383|581637790|FG001|Overall Study|Ineligible|2|||
161068000|NCT02554383|581637789|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
161068001|NCT02554383|581637790|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
161068002|NCT02554383|581637789|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
161068003|NCT02554383|581637790|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
161068004|NCT02554383|581637789|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
161068005|NCT02554383|581637790|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
161068006|NCT02581059|581637793|FG000|Study Treatment|Disease Progression|1|||
161068007|NCT02581059|581637794|FG001|Study Treatment|Disease Progression|1|||
161068008|NCT02581059|581637793|FG000|Study Treatment|Adverse Event|2|||
161068009|NCT02581059|581637794|FG001|Study Treatment|Adverse Event|1|||
161068010|NCT02581059|581637793|FG000|Study Treatment|Death|1|||
161068011|NCT02581059|581637794|FG001|Study Treatment|Death|1|||
161068012|NCT02581059|581637793|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
161068013|NCT02581059|581637794|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
161068014|NCT02581059|581637793|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
161068015|NCT02581059|581637794|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
161068016|NCT02581059|581637793|FG000|Follow up|Death|1|||
161068017|NCT02581059|581637794|FG001|Follow up|Death|3|||
161068018|NCT02581059|581637793|FG000|Follow up|study terminated|1|||
161068019|NCT02581059|581637794|FG001|Follow up|study terminated|1|||
161068020|NCT02581059|581637793|FG000|Follow up|screen failure|0|||
161068021|NCT02581059|581637794|FG001|Follow up|screen failure|1|||
161068022|NCT02581059|581637793|FG000|Follow up|Patient started new clinical trial|1|||
161068023|NCT02581059|581637794|FG001|Follow up|Patient started new clinical trial|0|||
161068024|NCT03698019|581637795|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
161068025|NCT03698019|581637796|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
161068026|NCT03698019|581637795|FG000|Step 1: Registration|Withdrawal by Subject|7|||
161068027|NCT03698019|581637796|FG001|Step 1: Registration|Withdrawal by Subject|2|||
161068028|NCT03698019|581637795|FG000|Step 1: Registration|Toxicity|0|||
161068029|NCT03698019|581637796|FG001|Step 1: Registration|Toxicity|1|||
161068030|NCT03698019|581637795|FG000|Step 1: Registration|Disease Progression|0|||
161068031|NCT03698019|581637796|FG001|Step 1: Registration|Disease Progression|12|||
161068032|NCT03698019|581637795|FG000|Step 1: Registration|Co-morbidities|0|||
161068033|NCT03698019|581637796|FG001|Step 1: Registration|Co-morbidities|1|||
161068034|NCT03698019|581637795|FG000|Step 1: Registration|Scheduling Issues|1|||
161068035|NCT03698019|581637796|FG001|Step 1: Registration|Scheduling Issues|0|||
161068036|NCT03698019|581637795|FG000|Step 1: Registration|Participant Refusal|0|||
161068037|NCT03698019|581637796|FG001|Step 1: Registration|Participant Refusal|1|||
161068038|NCT03698019|581637795|FG000|Step 2: Surgery|Participant Refusal|2|||
161068039|NCT03698019|581637796|FG001|Step 2: Surgery|Participant Refusal|1|||
161068040|NCT03698019|581637795|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
161068041|NCT03698019|581637796|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
161283784|NCT02906670|582417744|FG003|Cohort 5, Q2W|Radiological Progression|0|||
161283785|NCT02906670|582417745|FG004|Cohort 5, Q2W|Radiological Progression|0|||
161283786|NCT02906670|582417746|FG005|Cohort 5, Q2W|Radiological Progression|0|||
161283787|NCT02906670|582417747|FG006|Cohort 5, Q2W|Radiological Progression|4|||
161283788|NCT02906670|582417748|FG007|Cohort 5, Q2W|Radiological Progression|0|||
161283789|NCT02906670|582417749|FG008|Cohort 5, Q2W|Radiological Progression|0|||
161283790|NCT02906670|582417750|FG009|Cohort 5, Q2W|Radiological Progression|0|||
161283791|NCT02906670|582417741|FG000|Cohort 5, Q2W|Clinical Progression|0|||
161283792|NCT02906670|582417742|FG001|Cohort 5, Q2W|Clinical Progression|0|||
161283793|NCT02906670|582417743|FG002|Cohort 5, Q2W|Clinical Progression|0|||
161283794|NCT02906670|582417744|FG003|Cohort 5, Q2W|Clinical Progression|0|||
161283795|NCT02906670|582417745|FG004|Cohort 5, Q2W|Clinical Progression|0|||
161283796|NCT02906670|582417746|FG005|Cohort 5, Q2W|Clinical Progression|0|||
161283797|NCT02906670|582417747|FG006|Cohort 5, Q2W|Clinical Progression|1|||
161283798|NCT02906670|582417748|FG007|Cohort 5, Q2W|Clinical Progression|0|||
161283799|NCT02906670|582417749|FG008|Cohort 5, Q2W|Clinical Progression|0|||
161283800|NCT02906670|582417750|FG009|Cohort 5, Q2W|Clinical Progression|0|||
161283801|NCT02906670|582417741|FG000|Cohort 5, Q2W|Adverse Event|0|||
161283802|NCT02906670|582417742|FG001|Cohort 5, Q2W|Adverse Event|0|||
161283803|NCT02906670|582417743|FG002|Cohort 5, Q2W|Adverse Event|0|||
161283804|NCT02906670|582417744|FG003|Cohort 5, Q2W|Adverse Event|0|||
161283805|NCT02906670|582417745|FG004|Cohort 5, Q2W|Adverse Event|0|||
161283806|NCT02906670|582417746|FG005|Cohort 5, Q2W|Adverse Event|0|||
161283807|NCT02906670|582417747|FG006|Cohort 5, Q2W|Adverse Event|1|||
161283808|NCT02906670|582417748|FG007|Cohort 5, Q2W|Adverse Event|0|||
161283809|NCT02906670|582417749|FG008|Cohort 5, Q2W|Adverse Event|0|||
161283810|NCT02906670|582417750|FG009|Cohort 5, Q2W|Adverse Event|0|||
161283811|NCT02906670|582417741|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283812|NCT02906670|582417742|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283813|NCT02906670|582417743|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161068042|NCT03698019|581637795|FG000|Step 2: Surgery|Metastatic Disease|16|||
161068043|NCT03698019|581637796|FG001|Step 2: Surgery|Metastatic Disease|9|||
161283814|NCT02906670|582417744|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283815|NCT02906670|582417745|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283816|NCT02906670|582417746|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283817|NCT02906670|582417747|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
161283818|NCT02906670|582417748|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283819|NCT02906670|582417749|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283820|NCT02906670|582417750|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
161283821|NCT02906670|582417741|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
161283822|NCT02906670|582417742|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
161283823|NCT02906670|582417743|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
161283824|NCT02906670|582417744|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
161283825|NCT02906670|582417745|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
161283826|NCT02906670|582417746|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
161283827|NCT02906670|582417747|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
161283828|NCT02906670|582417748|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
161283829|NCT02906670|582417749|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
161283830|NCT02906670|582417750|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
161283831|NCT02906670|582417741|FG000|Cohort 5P, Q2W|Adverse Event|0|||
161283832|NCT02906670|582417742|FG001|Cohort 5P, Q2W|Adverse Event|0|||
161283833|NCT02906670|582417743|FG002|Cohort 5P, Q2W|Adverse Event|0|||
161283834|NCT02906670|582417744|FG003|Cohort 5P, Q2W|Adverse Event|0|||
161068044|NCT03698019|581637795|FG000|Step 2: Surgery|Residual Disease|2|||
161068045|NCT03698019|581637796|FG001|Step 2: Surgery|Residual Disease|1|||
161068046|NCT03698019|581637795|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
161068047|NCT03698019|581637796|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
161068048|NCT03698019|581637795|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
161068049|NCT03698019|581637796|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
161068050|NCT03698019|581637795|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
161068051|NCT03698019|581637796|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
161068052|NCT03698019|581637795|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
161283835|NCT02906670|582417745|FG004|Cohort 5P, Q2W|Adverse Event|0|||
161283836|NCT02906670|582417746|FG005|Cohort 5P, Q2W|Adverse Event|0|||
161283837|NCT02906670|582417747|FG006|Cohort 5P, Q2W|Adverse Event|0|||
161283838|NCT02906670|582417748|FG007|Cohort 5P, Q2W|Adverse Event|1|||
161283839|NCT02906670|582417749|FG008|Cohort 5P, Q2W|Adverse Event|0|||
161283840|NCT02906670|582417750|FG009|Cohort 5P, Q2W|Adverse Event|0|||
161283841|NCT02906670|582417741|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
161283842|NCT02906670|582417742|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
161068053|NCT03698019|581637796|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
161283843|NCT02906670|582417743|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
161283844|NCT02906670|582417744|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
161283845|NCT02906670|582417745|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
161068054|NCT03698019|581637795|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
161283846|NCT02906670|582417746|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
161283847|NCT02906670|582417747|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
161283848|NCT02906670|582417748|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
161283849|NCT02906670|582417749|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
161283850|NCT02906670|582417750|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
161283851|NCT02906670|582417741|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
161283852|NCT02906670|582417742|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
161283853|NCT02906670|582417743|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
161283854|NCT02906670|582417744|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
161283855|NCT02906670|582417745|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
161283856|NCT02906670|582417746|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
161283857|NCT02906670|582417747|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
161283858|NCT02906670|582417748|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
161283859|NCT02906670|582417749|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
161283860|NCT02906670|582417750|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
161283861|NCT02906670|582417741|FG000|Cohort 4P, QW|Radiological Progression|0|||
161283862|NCT02906670|582417742|FG001|Cohort 4P, QW|Radiological Progression|0|||
161283863|NCT02906670|582417743|FG002|Cohort 4P, QW|Radiological Progression|0|||
161283864|NCT02906670|582417744|FG003|Cohort 4P, QW|Radiological Progression|3|||
161283865|NCT02906670|582417745|FG004|Cohort 4P, QW|Radiological Progression|0|||
161283866|NCT02906670|582417746|FG005|Cohort 4P, QW|Radiological Progression|0|||
161283867|NCT02906670|582417747|FG006|Cohort 4P, QW|Radiological Progression|0|||
161283868|NCT02906670|582417748|FG007|Cohort 4P, QW|Radiological Progression|0|||
161283869|NCT02906670|582417749|FG008|Cohort 4P, QW|Radiological Progression|0|||
161283870|NCT02906670|582417750|FG009|Cohort 4P, QW|Radiological Progression|0|||
161283871|NCT02906670|582417741|FG000|Cohort 7P, Q2W|Adverse Event|0|||
161283872|NCT02906670|582417742|FG001|Cohort 7P, Q2W|Adverse Event|0|||
161283873|NCT02906670|582417743|FG002|Cohort 7P, Q2W|Adverse Event|0|||
161283874|NCT02906670|582417744|FG003|Cohort 7P, Q2W|Adverse Event|0|||
161283875|NCT02906670|582417745|FG004|Cohort 7P, Q2W|Adverse Event|0|||
161283876|NCT02906670|582417746|FG005|Cohort 7P, Q2W|Adverse Event|0|||
161283877|NCT02906670|582417747|FG006|Cohort 7P, Q2W|Adverse Event|0|||
161283878|NCT02906670|582417748|FG007|Cohort 7P, Q2W|Adverse Event|0|||
161283879|NCT02906670|582417749|FG008|Cohort 7P, Q2W|Adverse Event|0|||
161283880|NCT02906670|582417750|FG009|Cohort 7P, Q2W|Adverse Event|1|||
161283881|NCT02906670|582417741|FG000|Cohort 7P, Q2W|Physician Decision|0|||
161283882|NCT02906670|582417742|FG001|Cohort 7P, Q2W|Physician Decision|0|||
161283883|NCT02906670|582417743|FG002|Cohort 7P, Q2W|Physician Decision|0|||
161283884|NCT02906670|582417744|FG003|Cohort 7P, Q2W|Physician Decision|0|||
161283885|NCT02906670|582417745|FG004|Cohort 7P, Q2W|Physician Decision|0|||
161283886|NCT02906670|582417746|FG005|Cohort 7P, Q2W|Physician Decision|0|||
161283887|NCT02906670|582417747|FG006|Cohort 7P, Q2W|Physician Decision|0|||
161283888|NCT02906670|582417748|FG007|Cohort 7P, Q2W|Physician Decision|0|||
161283889|NCT02906670|582417749|FG008|Cohort 7P, Q2W|Physician Decision|0|||
161283890|NCT02906670|582417750|FG009|Cohort 7P, Q2W|Physician Decision|1|||
161283891|NCT02906670|582417741|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161283892|NCT02906670|582417742|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161068055|NCT03698019|581637796|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
161068056|NCT03698019|581637795|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
161068057|NCT03698019|581637796|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
161068058|NCT03698019|581637795|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
161068059|NCT03698019|581637796|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
161068060|NCT03698019|581637795|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
161068061|NCT03698019|581637796|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
161068062|NCT04340843|581637799|FG000|Overall Study|Adverse Event|0|||
161068063|NCT04340843|581637800|FG001|Overall Study|Adverse Event|2|||
161068064|NCT04340843|581637799|FG000|Overall Study|Withdrawal by Subject|0|||
161283893|NCT02906670|582417743|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161068065|NCT04340843|581637800|FG001|Overall Study|Withdrawal by Subject|2|||
161068066|NCT04021043|581639878|FG000|Overall Study|Adverse Event|3|||
161068067|NCT04021043|581639879|FG001|Overall Study|Adverse Event|1|||
161283894|NCT02906670|582417744|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161283895|NCT02906670|582417745|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161283896|NCT02906670|582417746|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161345515|NCT05028569|582650836|FG006|Open-Label Phase|Withdrawal by Subject|13|||
161068068|NCT04021043|581639880|FG002|Overall Study|Adverse Event|1|||
161283897|NCT02906670|582417747|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161283898|NCT02906670|582417748|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161283899|NCT02906670|582417749|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
161283900|NCT02906670|582417750|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
161283901|NCT02906670|582417741|FG000|Cohort 5P, QW|Radiological Progression|0|||
161283902|NCT02906670|582417742|FG001|Cohort 5P, QW|Radiological Progression|0|||
161283903|NCT02906670|582417743|FG002|Cohort 5P, QW|Radiological Progression|0|||
161068069|NCT04021043|581639881|FG003|Overall Study|Adverse Event|0|||
161068070|NCT04021043|581639878|FG000|Overall Study|Death|2|||
161068071|NCT04021043|581639879|FG001|Overall Study|Death|3|||
161068072|NCT04021043|581639880|FG002|Overall Study|Death|1|||
161068073|NCT04021043|581639881|FG003|Overall Study|Death|3|||
161068074|NCT04021043|581639878|FG000|Overall Study|Withdrawal by Subject|1|||
161068075|NCT04021043|581639879|FG001|Overall Study|Withdrawal by Subject|1|||
161068076|NCT04021043|581639880|FG002|Overall Study|Withdrawal by Subject|1|||
161068077|NCT04021043|581639881|FG003|Overall Study|Withdrawal by Subject|6|||
161068078|NCT04021043|581639878|FG000|Overall Study|Discontinued due to disease progression|4|||
161068079|NCT04021043|581639879|FG001|Overall Study|Discontinued due to disease progression|5|||
161068080|NCT04021043|581639880|FG002|Overall Study|Discontinued due to disease progression|7|||
161068081|NCT04021043|581639881|FG003|Overall Study|Discontinued due to disease progression|10|||
161068082|NCT00826228|581639882|FG000|Overall Study|Withdrawal by Subject|1|||
161068083|NCT02035696|581639883|FG000|Overall Study|Lost to Follow-up|0|||
161068084|NCT02035696|581639884|FG001|Overall Study|Lost to Follow-up|3|||
161068085|NCT02035696|581639885|FG002|Overall Study|Lost to Follow-up|1|||
161068086|NCT02035696|581639886|FG003|Overall Study|Lost to Follow-up|2|||
161068087|NCT02035696|581639883|FG000|Overall Study|Withdrawal by Subject|3|||
161068088|NCT02035696|581639884|FG001|Overall Study|Withdrawal by Subject|0|||
161068089|NCT02035696|581639885|FG002|Overall Study|Withdrawal by Subject|2|||
161068090|NCT02035696|581639886|FG003|Overall Study|Withdrawal by Subject|1|||
161068091|NCT01246999|581639887|FG000|Overall Study|Lost to Follow-up|0|||
161068092|NCT01246999|581639888|FG001|Overall Study|Lost to Follow-up|1|||
161068093|NCT01246999|581639889|FG002|Overall Study|Lost to Follow-up|0|||
161068094|NCT01246999|581639890|FG003|Overall Study|Lost to Follow-up|0|||
161068095|NCT01246999|581639887|FG000|Overall Study|Withdrawal by Subject|0|||
161068096|NCT01246999|581639888|FG001|Overall Study|Withdrawal by Subject|0|||
161068097|NCT01246999|581639889|FG002|Overall Study|Withdrawal by Subject|0|||
161068098|NCT01246999|581639890|FG003|Overall Study|Withdrawal by Subject|2|||
161068099|NCT01867047|581639891|FG000|Overall Study|Lost to Follow-up|3|||
161068100|NCT01867047|581639892|FG001|Overall Study|Lost to Follow-up|3|||
161068101|NCT01867047|581639891|FG000|Overall Study|Withdrawal by Subject|2|||
161068102|NCT01867047|581639892|FG001|Overall Study|Withdrawal by Subject|0|||
161068103|NCT01867047|581639891|FG000|Overall Study|Physician Decision|2|||
161068104|NCT01867047|581639892|FG001|Overall Study|Physician Decision|0|||
161068105|NCT01867047|581639891|FG000|Overall Study|surgery not indicated in protocol|1|||
161068106|NCT01867047|581639892|FG001|Overall Study|surgery not indicated in protocol|2|||
161068107|NCT00307047|581639893|FG000|Overall Study|Lost to Follow-up|35|||
161068108|NCT00307047|581639894|FG001|Overall Study|Lost to Follow-up|24|||
161068109|NCT00307047|581639893|FG000|Overall Study|Withdrawal by Subject|6|||
161068110|NCT00307047|581639894|FG001|Overall Study|Withdrawal by Subject|6|||
161068111|NCT00307047|581639893|FG000|Overall Study|Physician Decision|1|||
161068112|NCT00307047|581639894|FG001|Overall Study|Physician Decision|2|||
161068113|NCT00307047|581639893|FG000|Overall Study|Lost to follow-up for other reasons|0|||
161068114|NCT00307047|581639894|FG001|Overall Study|Lost to follow-up for other reasons|1|||
161068115|NCT00307047|581639893|FG000|Overall Study|All death, all MI, all Revascularization|27|||
161068116|NCT00307047|581639894|FG001|Overall Study|All death, all MI, all Revascularization|16|||
161068117|NCT00379769|581639895|FG000|Main Study|Death|57|||
161068118|NCT00379769|581639896|FG001|Main Study|Death|67|||
161068119|NCT00379769|581639897|FG002|Main Study|Death|54|||
161068120|NCT00379769|581639898|FG003|Main Study|Death|72|||
161068121|NCT00379769|581639899|FG004|Main Study|Death|0|||
161068122|NCT00379769|581639900|FG005|Main Study|Death|0|||
161068123|NCT00379769|581639895|FG000|Main Study|Adverse Event|5|||
161068124|NCT00379769|581639896|FG001|Main Study|Adverse Event|8|||
161068125|NCT00379769|581639897|FG002|Main Study|Adverse Event|10|||
161068126|NCT00379769|581639898|FG003|Main Study|Adverse Event|11|||
161068127|NCT00379769|581639899|FG004|Main Study|Adverse Event|0|||
161068128|NCT00379769|581639900|FG005|Main Study|Adverse Event|0|||
161068129|NCT00379769|581639895|FG000|Main Study|Lost to Follow-up|29|||
161068130|NCT00379769|581639896|FG001|Main Study|Lost to Follow-up|29|||
161283904|NCT02906670|582417744|FG003|Cohort 5P, QW|Radiological Progression|0|||
161068131|NCT00379769|581639897|FG002|Main Study|Lost to Follow-up|25|||
161068132|NCT00379769|581639898|FG003|Main Study|Lost to Follow-up|26|||
161068133|NCT00379769|581639899|FG004|Main Study|Lost to Follow-up|0|||
161068134|NCT00379769|581639900|FG005|Main Study|Lost to Follow-up|0|||
161068135|NCT00379769|581639895|FG000|Main Study|Withdrawal by Subject|46|||
161068136|NCT00379769|581639896|FG001|Main Study|Withdrawal by Subject|56|||
161068137|NCT00379769|581639897|FG002|Main Study|Withdrawal by Subject|72|||
161068138|NCT00379769|581639898|FG003|Main Study|Withdrawal by Subject|70|||
161068139|NCT00379769|581639899|FG004|Main Study|Withdrawal by Subject|0|||
161068140|NCT00379769|581639900|FG005|Main Study|Withdrawal by Subject|0|||
161068141|NCT00379769|581639895|FG000|Main Study|Moved to survival status follow-up only|27|||
161068142|NCT00379769|581639896|FG001|Main Study|Moved to survival status follow-up only|25|||
161068143|NCT00379769|581639897|FG002|Main Study|Moved to survival status follow-up only|32|||
161068144|NCT00379769|581639898|FG003|Main Study|Moved to survival status follow-up only|36|||
161068145|NCT00379769|581639899|FG004|Main Study|Moved to survival status follow-up only|0|||
161068146|NCT00379769|581639900|FG005|Main Study|Moved to survival status follow-up only|0|||
161283905|NCT02906670|582417745|FG004|Cohort 5P, QW|Radiological Progression|3|||
161283906|NCT02906670|582417746|FG005|Cohort 5P, QW|Radiological Progression|0|||
161283907|NCT02906670|582417747|FG006|Cohort 5P, QW|Radiological Progression|0|||
161283908|NCT02906670|582417748|FG007|Cohort 5P, QW|Radiological Progression|0|||
161283909|NCT02906670|582417749|FG008|Cohort 5P, QW|Radiological Progression|0|||
161283910|NCT02906670|582417750|FG009|Cohort 5P, QW|Radiological Progression|0|||
161283911|NCT01349192|582417751|FG000|Overall Study|Protocol Violation|0|||
161283912|NCT01349192|582417752|FG001|Overall Study|Protocol Violation|1|||
161283913|NCT01349192|582417751|FG000|Overall Study|Withdrawal by Subject|0|||
161283914|NCT01349192|582417752|FG001|Overall Study|Withdrawal by Subject|2|||
161283915|NCT01349192|582417751|FG000|Overall Study|Lost to Follow-up|1|||
161283916|NCT01349192|582417752|FG001|Overall Study|Lost to Follow-up|3|||
161283917|NCT01349192|582417751|FG000|Overall Study|Failure to adhere to Protocol|2|||
161283918|NCT01349192|582417752|FG001|Overall Study|Failure to adhere to Protocol|0|||
161283919|NCT03749330|582417753|FG000|Overall Study|Clinicians left work in the CICU|0|||
161283920|NCT03749330|582417754|FG001|Overall Study|Clinicians left work in the CICU|2|||
161283921|NCT03749330|582417755|FG002|Overall Study|Clinicians left work in the CICU|0|||
161283922|NCT03749330|582417756|FG003|Overall Study|Clinicians left work in the CICU|0|||
161283923|NCT03749330|582417757|FG004|Overall Study|Clinicians left work in the CICU|0|||
161283924|NCT03749330|582417758|FG005|Overall Study|Clinicians left work in the CICU|0|||
161283925|NCT02105467|582417761|FG000|Period 1|Lost to Follow-up|1|||
161283926|NCT02105467|582417762|FG001|Period 1|Lost to Follow-up|0|||
161283927|NCT02105467|582417761|FG000|Period 1|Death|1|||
161283928|NCT02105467|582417762|FG001|Period 1|Death|0|||
161283929|NCT02105467|582417761|FG000|Period 2|Lost to Follow-up|1|||
161283930|NCT02105467|582417762|FG001|Period 2|Lost to Follow-up|0|||
161283931|NCT02105467|582417761|FG000|Period 2|Death|1|||
161283932|NCT02105467|582417762|FG001|Period 2|Death|0|||
161283933|NCT02105467|582417761|FG000|Period 2|Withdrawal by Subject|0|||
161283934|NCT02105467|582417762|FG001|Period 2|Withdrawal by Subject|2|||
161283935|NCT02105467|582417761|FG000|Period 3|Lost to Follow-up|0|||
161283936|NCT02105467|582417762|FG001|Period 3|Lost to Follow-up|1|||
161283937|NCT03908125|582417763|FG000|Overall Study|Withdrawal by Subject|92|||
161283938|NCT03908125|582417763|FG000|Overall Study|Lost to Follow-up|8|||
161283939|NCT02262325|582417764|FG000|Overall Study|Death|16|||
161283940|NCT02262325|582417764|FG000|Overall Study|Lost to Follow-up|1|||
161283941|NCT02815995|582417765|FG000|Overall Study|Disease Progression|3|||
161283942|NCT02815995|582417766|FG001|Overall Study|Disease Progression|7|||
161283943|NCT02815995|582417767|FG002|Overall Study|Disease Progression|2|||
161283944|NCT02815995|582417768|FG003|Overall Study|Disease Progression|4|||
161283945|NCT02815995|582417769|FG004|Overall Study|Disease Progression|3|||
161283946|NCT02815995|582417770|FG005|Overall Study|Disease Progression|9|||
161283947|NCT02815995|582417771|FG006|Overall Study|Disease Progression|3|||
161283948|NCT02815995|582417772|FG007|Overall Study|Disease Progression|1|||
161283949|NCT02815995|582417765|FG000|Overall Study|Adverse Event|1|||
161283950|NCT02815995|582417766|FG001|Overall Study|Adverse Event|2|||
161283951|NCT02815995|582417767|FG002|Overall Study|Adverse Event|2|||
161283952|NCT02815995|582417768|FG003|Overall Study|Adverse Event|0|||
161283953|NCT02815995|582417769|FG004|Overall Study|Adverse Event|0|||
161283954|NCT02815995|582417770|FG005|Overall Study|Adverse Event|1|||
161283955|NCT02815995|582417771|FG006|Overall Study|Adverse Event|0|||
161283956|NCT02815995|582417772|FG007|Overall Study|Adverse Event|0|||
161283957|NCT02815995|582417765|FG000|Overall Study|Pregnancy|0|||
161283958|NCT02815995|582417766|FG001|Overall Study|Pregnancy|0|||
161283959|NCT02815995|582417767|FG002|Overall Study|Pregnancy|0|||
161283960|NCT02815995|582417768|FG003|Overall Study|Pregnancy|0|||
161283961|NCT02815995|582417769|FG004|Overall Study|Pregnancy|0|||
161283962|NCT02815995|582417770|FG005|Overall Study|Pregnancy|0|||
161283963|NCT02815995|582417771|FG006|Overall Study|Pregnancy|1|||
161283964|NCT02815995|582417772|FG007|Overall Study|Pregnancy|0|||
161283965|NCT01071915|582417776|FG000|Overall Study|Adverse Event|3|||
161283966|NCT01071915|582417776|FG000|Overall Study|Physician Decision|2|||
161283967|NCT01071915|582417776|FG000|Overall Study|Withdrawal by Subject|2|||
161283968|NCT01071915|582417776|FG000|Overall Study|Miscellaneous Reasons|2|||
161283969|NCT02016183|582417777|FG000|Overall Study|Case Report Forms Uncollected|13|||
161283970|NCT02016183|582417777|FG000|Overall Study|Protocol Violation|52|||
161283971|NCT00770328|582417778|FG000|Overall Study|Adverse Event|11|||
161283972|NCT00770328|582417779|FG001|Overall Study|Adverse Event|2|||
161283973|NCT00770328|582417778|FG000|Overall Study|Lost to Follow-up|2|||
161345516|NCT05028569|582650830|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
161283974|NCT00770328|582417779|FG001|Overall Study|Lost to Follow-up|2|||
161283975|NCT02286843|582417782|FG000|Overall Study|Not Treated|4|||
161283976|NCT02286843|582417782|FG000|Overall Study|Protocol Violation|1|||
161283977|NCT02286843|582417782|FG000|Overall Study|Withdrawal by Subject|1|||
161283978|NCT02536846|582417783|FG000|Overall Study|Withdrawal by Subject|1|||
161283979|NCT04388553|582417784|FG000|Overall Study|Protocol Violation|1|||
161283980|NCT04388553|582417785|FG001|Overall Study|Protocol Violation|0|||
161283981|NCT04604795|582417786|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
161283982|NCT04604795|582417787|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
161283983|NCT04604795|582417788|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283984|NCT04604795|582417789|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161068147|NCT00379769|581639895|FG000|Main Study|Participant moved|3|||
161068148|NCT00379769|581639896|FG001|Main Study|Participant moved|2|||
161068149|NCT00379769|581639897|FG002|Main Study|Participant moved|3|||
161283985|NCT04604795|582417790|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283986|NCT04604795|582417791|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283987|NCT04604795|582417792|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283988|NCT04604795|582417793|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283989|NCT04604795|582417794|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283990|NCT04604795|582417795|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
161283991|NCT04604795|582417786|FG000|Part B: Up to Day 14|Adverse Event|0|||
161283992|NCT04604795|582417787|FG001|Part B: Up to Day 14|Adverse Event|0|||
161283993|NCT04604795|582417788|FG002|Part B: Up to Day 14|Adverse Event|0|||
161283994|NCT04604795|582417789|FG003|Part B: Up to Day 14|Adverse Event|0|||
161283995|NCT04604795|582417790|FG004|Part B: Up to Day 14|Adverse Event|2|||
161283996|NCT04604795|582417791|FG005|Part B: Up to Day 14|Adverse Event|1|||
161283997|NCT04604795|582417792|FG006|Part B: Up to Day 14|Adverse Event|0|||
161283998|NCT04604795|582417793|FG007|Part B: Up to Day 14|Adverse Event|0|||
161283999|NCT04604795|582417794|FG008|Part B: Up to Day 14|Adverse Event|0|||
161284000|NCT04604795|582417795|FG009|Part B: Up to Day 14|Adverse Event|0|||
161284001|NCT04604795|582417786|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284002|NCT04604795|582417787|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284003|NCT04604795|582417788|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284004|NCT04604795|582417789|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284005|NCT04604795|582417790|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284006|NCT04604795|582417791|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284007|NCT04604795|582417792|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284008|NCT04604795|582417793|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284009|NCT04604795|582417794|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
161284010|NCT04604795|582417795|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
161284011|NCT04604795|582417786|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284012|NCT04604795|582417787|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284013|NCT04604795|582417788|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284014|NCT04604795|582417789|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284015|NCT04604795|582417790|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284016|NCT04604795|582417791|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284017|NCT04604795|582417792|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284018|NCT04604795|582417793|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284019|NCT04604795|582417794|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
161284020|NCT04604795|582417795|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
161284021|NCT04604795|582417786|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284022|NCT04604795|582417787|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284023|NCT04604795|582417788|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284024|NCT04604795|582417789|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284025|NCT04604795|582417790|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284026|NCT04604795|582417791|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284027|NCT04604795|582417792|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284028|NCT04604795|582417793|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284029|NCT04604795|582417794|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
161284030|NCT04604795|582417795|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
161284031|NCT04604795|582417786|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284032|NCT04604795|582417787|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284033|NCT04604795|582417788|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284034|NCT04604795|582417789|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284035|NCT04604795|582417790|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284036|NCT04604795|582417791|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284037|NCT04604795|582417792|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284038|NCT04604795|582417793|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
161284039|NCT04604795|582417794|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
161284040|NCT04604795|582417795|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
161345517|NCT05028569|582650831|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161284041|NCT01590277|582417798|FG000|Overall Study|Withdrawal by Subject|3|||
161284042|NCT01590277|582417798|FG000|Overall Study|Withdrawal by Subject|2|||
161284043|NCT01590277|582417798|FG000|Overall Study|Withdrawal by Subject|1|||
161284044|NCT01590277|582417798|FG000|Overall Study|Withdrawal by Subject|1|||
161284045|NCT04386616|582417799|FG000|Overall Study|Death|22|||
161284046|NCT04386616|582417800|FG001|Overall Study|Death|22|||
161284047|NCT04386616|582417801|FG002|Overall Study|Death|21|||
161284048|NCT04386616|582417799|FG000|Overall Study|Lost to Follow-up|5|||
161284049|NCT04386616|582417800|FG001|Overall Study|Lost to Follow-up|8|||
161284050|NCT04386616|582417801|FG002|Overall Study|Lost to Follow-up|6|||
161284051|NCT04386616|582417799|FG000|Overall Study|Withdrawal by Subject|2|||
161284052|NCT04386616|582417800|FG001|Overall Study|Withdrawal by Subject|4|||
161284053|NCT04386616|582417801|FG002|Overall Study|Withdrawal by Subject|1|||
161284054|NCT04386616|582417799|FG000|Overall Study|Adverse Event|1|||
161284055|NCT04386616|582417800|FG001|Overall Study|Adverse Event|1|||
161284056|NCT04386616|582417801|FG002|Overall Study|Adverse Event|0|||
161284057|NCT01377012|582417802|FG000|Core Study|Study terminated by Sponsor|47|||
161284058|NCT01377012|582417803|FG001|Core Study|Study terminated by Sponsor|54|||
161284059|NCT01377012|582417804|FG002|Core Study|Study terminated by Sponsor|46|||
161284060|NCT01377012|582417802|FG000|Core Study|Technical problems|1|||
161284061|NCT01377012|582417803|FG001|Core Study|Technical problems|0|||
161284062|NCT01377012|582417804|FG002|Core Study|Technical problems|0|||
161284063|NCT01377012|582417802|FG000|Core Study|Withdrawal by Subject|15|||
161284064|NCT01377012|582417803|FG001|Core Study|Withdrawal by Subject|23|||
161284065|NCT01377012|582417804|FG002|Core Study|Withdrawal by Subject|18|||
161284066|NCT01377012|582417802|FG000|Core Study|Protocol Violation|7|||
161284067|NCT01377012|582417803|FG001|Core Study|Protocol Violation|3|||
161068150|NCT00379769|581639898|FG003|Main Study|Participant moved|3|||
161068151|NCT00379769|581639899|FG004|Main Study|Participant moved|0|||
161068152|NCT00379769|581639900|FG005|Main Study|Participant moved|0|||
161284068|NCT01377012|582417804|FG002|Core Study|Protocol Violation|2|||
161068153|NCT00379769|581639895|FG000|Main Study|Poor compliance|3|||
161068154|NCT00379769|581639896|FG001|Main Study|Poor compliance|2|||
161068155|NCT00379769|581639897|FG002|Main Study|Poor compliance|2|||
161068156|NCT00379769|581639898|FG003|Main Study|Poor compliance|1|||
161068157|NCT00379769|581639899|FG004|Main Study|Poor compliance|0|||
161068158|NCT00379769|581639900|FG005|Main Study|Poor compliance|0|||
161068159|NCT00379769|581639895|FG000|Main Study|Prohibited glucose lowering medication|0|||
161068160|NCT00379769|581639896|FG001|Main Study|Prohibited glucose lowering medication|3|||
161068161|NCT00379769|581639897|FG002|Main Study|Prohibited glucose lowering medication|0|||
161068162|NCT00379769|581639898|FG003|Main Study|Prohibited glucose lowering medication|1|||
161068163|NCT00379769|581639899|FG004|Main Study|Prohibited glucose lowering medication|0|||
161068164|NCT00379769|581639900|FG005|Main Study|Prohibited glucose lowering medication|0|||
161068165|NCT00379769|581639895|FG000|Main Study|Site closed|4|||
161068166|NCT00379769|581639896|FG001|Main Study|Site closed|4|||
161068167|NCT00379769|581639897|FG002|Main Study|Site closed|4|||
161068168|NCT00379769|581639898|FG003|Main Study|Site closed|8|||
161068169|NCT00379769|581639899|FG004|Main Study|Site closed|0|||
161068170|NCT00379769|581639900|FG005|Main Study|Site closed|0|||
161068171|NCT00379769|581639895|FG000|Main Study|Entry criteria violation|0|||
161068172|NCT00379769|581639896|FG001|Main Study|Entry criteria violation|0|||
161068173|NCT00379769|581639897|FG002|Main Study|Entry criteria violation|1|||
161068174|NCT00379769|581639898|FG003|Main Study|Entry criteria violation|1|||
161068175|NCT00379769|581639899|FG004|Main Study|Entry criteria violation|0|||
161068176|NCT00379769|581639900|FG005|Main Study|Entry criteria violation|0|||
161068177|NCT00379769|581639895|FG000|Main Study|Participant did not take study drug|0|||
161068178|NCT00379769|581639896|FG001|Main Study|Participant did not take study drug|0|||
161068179|NCT00379769|581639897|FG002|Main Study|Participant did not take study drug|1|||
161068180|NCT00379769|581639898|FG003|Main Study|Participant did not take study drug|0|||
161068181|NCT00379769|581639899|FG004|Main Study|Participant did not take study drug|0|||
161068182|NCT00379769|581639900|FG005|Main Study|Participant did not take study drug|0|||
161068183|NCT00379769|581639895|FG000|Main Study|Physician Decision|2|||
161068184|NCT00379769|581639896|FG001|Main Study|Physician Decision|2|||
161068185|NCT00379769|581639897|FG002|Main Study|Physician Decision|1|||
161068186|NCT00379769|581639898|FG003|Main Study|Physician Decision|1|||
161068187|NCT00379769|581639899|FG004|Main Study|Physician Decision|0|||
161068188|NCT00379769|581639900|FG005|Main Study|Physician Decision|0|||
161068189|NCT00379769|581639895|FG000|Main Study|Participant completed study at visit 27|1|||
161068190|NCT00379769|581639896|FG001|Main Study|Participant completed study at visit 27|0|||
161068191|NCT00379769|581639897|FG002|Main Study|Participant completed study at visit 27|0|||
161068192|NCT00379769|581639898|FG003|Main Study|Participant completed study at visit 27|0|||
161284069|NCT01377012|582417802|FG000|Core Study|Pregnancy|0|||
161068193|NCT00379769|581639899|FG004|Main Study|Participant completed study at visit 27|0|||
161284070|NCT01377012|582417803|FG001|Core Study|Pregnancy|0|||
161284071|NCT01377012|582417804|FG002|Core Study|Pregnancy|1|||
161284072|NCT01377012|582417802|FG000|Core Study|Physician Decision|5|||
161284073|NCT01377012|582417803|FG001|Core Study|Physician Decision|4|||
161284074|NCT01377012|582417804|FG002|Core Study|Physician Decision|10|||
161284075|NCT01377012|582417802|FG000|Core Study|Non-Compliant with study treatment|0|||
161284076|NCT01377012|582417803|FG001|Core Study|Non-Compliant with study treatment|0|||
161284077|NCT01377012|582417804|FG002|Core Study|Non-Compliant with study treatment|1|||
161068194|NCT00379769|581639900|FG005|Main Study|Participant completed study at visit 27|0|||
161068195|NCT00379769|581639895|FG000|Main Study|Personal reasons|1|||
161068196|NCT00379769|581639896|FG001|Main Study|Personal reasons|0|||
161068197|NCT00379769|581639897|FG002|Main Study|Personal reasons|0|||
161068198|NCT00379769|581639898|FG003|Main Study|Personal reasons|0|||
161068199|NCT00379769|581639899|FG004|Main Study|Personal reasons|0|||
161068200|NCT00379769|581639900|FG005|Main Study|Personal reasons|0|||
161068201|NCT00379769|581639895|FG000|Main Study|Risk of heart failure|0|||
161068202|NCT00379769|581639896|FG001|Main Study|Risk of heart failure|1|||
161068203|NCT00379769|581639897|FG002|Main Study|Risk of heart failure|0|||
161068204|NCT00379769|581639898|FG003|Main Study|Risk of heart failure|0|||
161068205|NCT00379769|581639899|FG004|Main Study|Risk of heart failure|0|||
161068206|NCT00379769|581639900|FG005|Main Study|Risk of heart failure|0|||
161068207|NCT00379769|581639895|FG000|Main Study|Investigator refused to log temperature|0|||
161068208|NCT00379769|581639896|FG001|Main Study|Investigator refused to log temperature|0|||
161068209|NCT00379769|581639897|FG002|Main Study|Investigator refused to log temperature|1|||
161068210|NCT00379769|581639898|FG003|Main Study|Investigator refused to log temperature|0|||
161068211|NCT00379769|581639899|FG004|Main Study|Investigator refused to log temperature|0|||
161068212|NCT00379769|581639900|FG005|Main Study|Investigator refused to log temperature|0|||
161068213|NCT00379769|581639895|FG000|Main Study|Reason unspecified|0|||
161068214|NCT00379769|581639896|FG001|Main Study|Reason unspecified|0|||
161068215|NCT00379769|581639897|FG002|Main Study|Reason unspecified|1|||
161068216|NCT00379769|581639898|FG003|Main Study|Reason unspecified|0|||
161068217|NCT00379769|581639899|FG004|Main Study|Reason unspecified|0|||
161068218|NCT00379769|581639900|FG005|Main Study|Reason unspecified|0|||
161068219|NCT00379769|581639895|FG000|Observational Follow-up|Death|0|||
161068220|NCT00379769|581639896|FG001|Observational Follow-up|Death|0|||
161068221|NCT00379769|581639897|FG002|Observational Follow-up|Death|0|||
161068222|NCT00379769|581639898|FG003|Observational Follow-up|Death|0|||
161068223|NCT00379769|581639899|FG004|Observational Follow-up|Death|78|||
161068224|NCT00379769|581639900|FG005|Observational Follow-up|Death|70|||
161068225|NCT00379769|581639895|FG000|Observational Follow-up|Adverse Event|0|||
161068226|NCT00379769|581639896|FG001|Observational Follow-up|Adverse Event|0|||
161068227|NCT00379769|581639897|FG002|Observational Follow-up|Adverse Event|0|||
161068228|NCT00379769|581639898|FG003|Observational Follow-up|Adverse Event|0|||
161068229|NCT00379769|581639899|FG004|Observational Follow-up|Adverse Event|1|||
161068230|NCT00379769|581639900|FG005|Observational Follow-up|Adverse Event|0|||
161068231|NCT00379769|581639895|FG000|Observational Follow-up|Lost to Follow-up|0|||
161068232|NCT00379769|581639896|FG001|Observational Follow-up|Lost to Follow-up|0|||
161068233|NCT00379769|581639897|FG002|Observational Follow-up|Lost to Follow-up|0|||
161068234|NCT00379769|581639898|FG003|Observational Follow-up|Lost to Follow-up|0|||
161068235|NCT00379769|581639899|FG004|Observational Follow-up|Lost to Follow-up|25|||
161068236|NCT00379769|581639900|FG005|Observational Follow-up|Lost to Follow-up|27|||
161068237|NCT00379769|581639895|FG000|Observational Follow-up|Withdrawal by Subject|0|||
161068238|NCT00379769|581639896|FG001|Observational Follow-up|Withdrawal by Subject|0|||
161068239|NCT00379769|581639897|FG002|Observational Follow-up|Withdrawal by Subject|0|||
161068240|NCT00379769|581639898|FG003|Observational Follow-up|Withdrawal by Subject|0|||
161068241|NCT00379769|581639899|FG004|Observational Follow-up|Withdrawal by Subject|12|||
161068242|NCT00379769|581639900|FG005|Observational Follow-up|Withdrawal by Subject|12|||
161068243|NCT00379769|581639895|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
161068244|NCT00379769|581639896|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
161068245|NCT00379769|581639897|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
161068246|NCT00379769|581639898|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
161068247|NCT00379769|581639899|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
161068248|NCT00379769|581639900|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
161068249|NCT00379769|581639895|FG000|Observational Follow-up|Physician Decision|0|||
161068250|NCT00379769|581639896|FG001|Observational Follow-up|Physician Decision|0|||
161068251|NCT00379769|581639897|FG002|Observational Follow-up|Physician Decision|0|||
161068252|NCT00379769|581639898|FG003|Observational Follow-up|Physician Decision|0|||
161068253|NCT00379769|581639899|FG004|Observational Follow-up|Physician Decision|8|||
161068254|NCT00379769|581639900|FG005|Observational Follow-up|Physician Decision|8|||
161068255|NCT00379769|581639895|FG000|Observational Follow-up|Site Closed Early|0|||
161068256|NCT00379769|581639896|FG001|Observational Follow-up|Site Closed Early|0|||
161068257|NCT00379769|581639897|FG002|Observational Follow-up|Site Closed Early|0|||
161068258|NCT00379769|581639898|FG003|Observational Follow-up|Site Closed Early|0|||
161068259|NCT00379769|581639899|FG004|Observational Follow-up|Site Closed Early|6|||
161068260|NCT00379769|581639900|FG005|Observational Follow-up|Site Closed Early|7|||
161068261|NCT00379769|581639895|FG000|Observational Follow-up|Participant Moved|0|||
161068262|NCT00379769|581639896|FG001|Observational Follow-up|Participant Moved|0|||
161068263|NCT00379769|581639897|FG002|Observational Follow-up|Participant Moved|0|||
161068264|NCT00379769|581639898|FG003|Observational Follow-up|Participant Moved|0|||
161068265|NCT00379769|581639899|FG004|Observational Follow-up|Participant Moved|0|||
161068266|NCT00379769|581639900|FG005|Observational Follow-up|Participant Moved|1|||
161068267|NCT00379769|581639895|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
161068268|NCT00379769|581639896|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
161068269|NCT00379769|581639897|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
161068270|NCT00379769|581639898|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
161068271|NCT00379769|581639899|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
161068272|NCT00379769|581639900|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
161068273|NCT02825251|581639901|FG000|Overall Study|Adverse Event|0|||
161068274|NCT02825251|581639902|FG001|Overall Study|Adverse Event|1|||
161068275|NCT02825251|581639901|FG000|Overall Study|Lost to Follow-up|0|||
161068276|NCT02825251|581639902|FG001|Overall Study|Lost to Follow-up|1|||
161068277|NCT02825251|581639901|FG000|Overall Study|Withdrawal by Subject|1|||
161068278|NCT02825251|581639902|FG001|Overall Study|Withdrawal by Subject|4|||
161068279|NCT02825251|581639901|FG000|Overall Study|Unclassified|2|||
161068280|NCT02825251|581639902|FG001|Overall Study|Unclassified|0|||
161068281|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
161068282|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
161068283|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
161068284|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Death|4|||
161068285|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Death|2|||
161068286|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Death|3|||
161068287|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161068288|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161068289|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
161068290|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
161068291|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
161068292|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
161068293|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
161068294|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
161068295|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
161068296|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
161068297|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
161068298|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
161068299|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
161068300|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
161068301|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
161068302|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
161068303|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
161068304|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
161284078|NCT01377012|582417802|FG000|Core Study|No Longer require treatment|0|||
161284079|NCT01377012|582417803|FG001|Core Study|No Longer require treatment|0|||
161284080|NCT01377012|582417804|FG002|Core Study|No Longer require treatment|1|||
161284081|NCT01377012|582417802|FG000|Core Study|Lost to Follow-up|7|||
161284082|NCT01377012|582417803|FG001|Core Study|Lost to Follow-up|5|||
161284083|NCT01377012|582417804|FG002|Core Study|Lost to Follow-up|4|||
161284084|NCT01377012|582417802|FG000|Core Study|Lack of Efficacy|41|||
161284085|NCT01377012|582417803|FG001|Core Study|Lack of Efficacy|28|||
161284086|NCT01377012|582417804|FG002|Core Study|Lack of Efficacy|37|||
161068305|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
161068306|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
161068307|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
161068308|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
161068309|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
161068310|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
161068311|NCT02783573|581639903|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
161068312|NCT02783573|581639904|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
161068313|NCT02783573|581639905|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
161068314|NCT02783573|581639903|FG000|Delayed-Start Period|Sponsor Decision|0|||
161068315|NCT02783573|581639904|FG001|Delayed-Start Period|Sponsor Decision|17|||
161068316|NCT02783573|581639905|FG002|Delayed-Start Period|Sponsor Decision|12|||
161068317|NCT04546217|581639907|FG000|Overall Study|Withdrawal by Subject|2|||
161068318|NCT04546217|581639908|FG001|Overall Study|Withdrawal by Subject|0|||
161068319|NCT04546217|581639907|FG000|Overall Study|Uncontrolled hypertension|1|||
161068320|NCT04546217|581639908|FG001|Overall Study|Uncontrolled hypertension|0|||
161068321|NCT02550938|581639909|FG000|Overall Study|Lost to Follow-up|8|||
161068322|NCT02550938|581639910|FG001|Overall Study|Lost to Follow-up|7|||
161068323|NCT02550938|581639911|FG002|Overall Study|Lost to Follow-up|12|||
161068324|NCT02550938|581639912|FG003|Overall Study|Lost to Follow-up|11|||
161068325|NCT01367847|581639913|FG000|Overall Study|Withdrawal by Subject|2|||
161068326|NCT01367847|581639914|FG001|Overall Study|Withdrawal by Subject|2|||
161068327|NCT02684123|581639915|FG000|Phase 1|Lack of Efficacy|5|||
161284087|NCT01377012|582417802|FG000|Core Study|Death|1|||
161284088|NCT01377012|582417803|FG001|Core Study|Death|1|||
161284089|NCT01377012|582417804|FG002|Core Study|Death|1|||
161284090|NCT01377012|582417802|FG000|Core Study|Adverse Event|10|||
161284091|NCT01377012|582417803|FG001|Core Study|Adverse Event|14|||
161284092|NCT01377012|582417804|FG002|Core Study|Adverse Event|13|||
161068328|NCT02684123|581639916|FG001|Phase 1|Lack of Efficacy|0|||
161068329|NCT02684123|581639915|FG000|Phase 1|Adverse Event|3|||
161068330|NCT02684123|581639916|FG001|Phase 1|Adverse Event|0|||
161068331|NCT02684123|581639915|FG000|Phase 1|Lost to Follow-up|0|||
161068332|NCT02684123|581639916|FG001|Phase 1|Lost to Follow-up|1|||
161068333|NCT02684123|581639915|FG000|Phase 2|Lack of Efficacy|1|||
161068334|NCT02684123|581639916|FG001|Phase 2|Lack of Efficacy|8|||
161068335|NCT01245140|581639921|FG000|Overall Study|Adverse Event|1|||
161068336|NCT01245140|581639922|FG001|Overall Study|Adverse Event|3|||
161068337|NCT01245140|581639921|FG000|Overall Study|Lack of Efficacy|2|||
161068338|NCT01245140|581639922|FG001|Overall Study|Lack of Efficacy|4|||
161068339|NCT01245140|581639921|FG000|Overall Study|Protocol Violation|0|||
161068340|NCT01245140|581639922|FG001|Overall Study|Protocol Violation|1|||
161068341|NCT01245140|581639921|FG000|Overall Study|Withdrawal by Subject|0|||
161068342|NCT01245140|581639922|FG001|Overall Study|Withdrawal by Subject|1|||
161068343|NCT01245140|581639921|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
161068344|NCT01245140|581639922|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
161068345|NCT02037477|581639923|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
161068346|NCT02037477|581639924|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
161068347|NCT02037477|581639925|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
161068348|NCT02037477|581639926|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
161068349|NCT02635360|581639927|FG000|Overall Study|Adverse Event|0|||
161068350|NCT02635360|581639928|FG001|Overall Study|Adverse Event|3|||
161068351|NCT02635360|581639927|FG000|Overall Study|Withdrawal by Subject|2|||
161068352|NCT02635360|581639928|FG001|Overall Study|Withdrawal by Subject|0|||
161068353|NCT02635360|581639927|FG000|Overall Study|Non-Compliance|3|||
161068354|NCT02635360|581639928|FG001|Overall Study|Non-Compliance|1|||
161068355|NCT02635360|581639927|FG000|Overall Study|Disease Progression|0|||
161068356|NCT02635360|581639928|FG001|Overall Study|Disease Progression|2|||
161068357|NCT02635360|581639927|FG000|Overall Study|Lost to Follow-up|1|||
161068358|NCT02635360|581639928|FG001|Overall Study|Lost to Follow-up|1|||
161068359|NCT04082429|581639929|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
161068360|NCT04082429|581639930|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161068361|NCT04082429|581639931|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
161284093|NCT01377012|582417802|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
161284094|NCT01377012|582417803|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
161284095|NCT01377012|582417804|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
161284096|NCT01377012|582417802|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
161284097|NCT01377012|582417803|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
161284098|NCT01377012|582417804|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
161284099|NCT01377012|582417802|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
161284100|NCT01377012|582417803|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
161284101|NCT01377012|582417804|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
161284102|NCT01377012|582417802|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
161284103|NCT01377012|582417803|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
161284104|NCT01377012|582417804|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
161284105|NCT01377012|582417802|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
161284106|NCT01377012|582417803|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
161284107|NCT01377012|582417804|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
161284108|NCT01377012|582417802|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
161284109|NCT01377012|582417803|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
161284110|NCT01377012|582417804|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
161284111|NCT00805961|582417805|FG000|Modality Therapy|Withdrawal by Subject|1|||
161068362|NCT04082429|581639932|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
161068363|NCT04082429|581639933|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
161068364|NCT04082429|581639934|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161068365|NCT04082429|581639935|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161068366|NCT04082429|581639936|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161068367|NCT04082429|581639937|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
161068368|NCT04082429|581639929|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161284112|NCT00805961|582417805|FG000|Modality Therapy|Adverse Event|1|||
161345518|NCT05028569|582650832|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161068369|NCT04082429|581639930|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068370|NCT04082429|581639931|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068371|NCT04082429|581639932|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068372|NCT04082429|581639933|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
161284113|NCT00805961|582417805|FG000|Modality Therapy|Disease Progression|2|||
161284114|NCT00805961|582417805|FG000|Treatment-Free Interval|Adverse Event|3|||
161284115|NCT00805961|582417805|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
161284116|NCT00805961|582417805|FG000|Treatment-Free Interval|Physician Decision|1|||
161345519|NCT05028569|582650833|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
161068373|NCT04082429|581639934|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068374|NCT04082429|581639935|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068375|NCT04082429|581639936|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068376|NCT04082429|581639937|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
161068377|NCT04082429|581639929|FG000|Main Part (After the Treatment Pause)|Death|0|||
161068378|NCT04082429|581639930|FG001|Main Part (After the Treatment Pause)|Death|0|||
161068379|NCT04082429|581639931|FG002|Main Part (After the Treatment Pause)|Death|0|||
161068380|NCT04082429|581639932|FG003|Main Part (After the Treatment Pause)|Death|0|||
161068381|NCT04082429|581639933|FG004|Main Part (After the Treatment Pause)|Death|1|||
161068382|NCT04082429|581639934|FG005|Main Part (After the Treatment Pause)|Death|0|||
161068383|NCT04082429|581639935|FG006|Main Part (After the Treatment Pause)|Death|0|||
161068384|NCT04082429|581639936|FG007|Main Part (After the Treatment Pause)|Death|0|||
161068385|NCT04082429|581639937|FG008|Main Part (After the Treatment Pause)|Death|0|||
161068386|NCT04082429|581639929|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068387|NCT04082429|581639930|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068388|NCT04082429|581639931|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068389|NCT04082429|581639932|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
161068390|NCT04082429|581639933|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068391|NCT04082429|581639934|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
161068392|NCT04082429|581639935|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068393|NCT04082429|581639936|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068394|NCT04082429|581639937|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
161068395|NCT04082429|581639929|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161068396|NCT04082429|581639930|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161068397|NCT04082429|581639931|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
161068398|NCT04082429|581639932|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
161068399|NCT04082429|581639933|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161068400|NCT04082429|581639934|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161068401|NCT04082429|581639935|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
161068402|NCT04082429|581639936|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
161068403|NCT04082429|581639937|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
161068404|NCT04082429|581639929|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
161068405|NCT04082429|581639930|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068406|NCT04082429|581639931|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068407|NCT04082429|581639932|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068408|NCT04082429|581639933|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068409|NCT04082429|581639934|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
161068410|NCT04082429|581639935|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068411|NCT04082429|581639936|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068412|NCT04082429|581639937|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
161068413|NCT04082429|581639929|FG000|Extension Part|Ongoing|0|||
161068414|NCT04082429|581639930|FG001|Extension Part|Ongoing|7|||
161068415|NCT04082429|581639931|FG002|Extension Part|Ongoing|17|||
161068416|NCT04082429|581639932|FG003|Extension Part|Ongoing|6|||
161068417|NCT04082429|581639933|FG004|Extension Part|Ongoing|45|||
161068418|NCT04082429|581639934|FG005|Extension Part|Ongoing|0|||
161068419|NCT04082429|581639935|FG006|Extension Part|Ongoing|10|||
161068420|NCT04082429|581639936|FG007|Extension Part|Ongoing|23|||
161068421|NCT04082429|581639937|FG008|Extension Part|Ongoing|25|||
161068422|NCT00334542|581639938|FG000|Overall Study|Adverse Event|3|||
161068423|NCT00334542|581639938|FG000|Overall Study|Withdrawal by Subject|1|||
161068424|NCT00334542|581639938|FG000|Overall Study|New cancer diagnosis|1|||
161068425|NCT03118050|581639939|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
161068426|NCT03118050|581639940|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
161068427|NCT03118050|581639941|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
161068428|NCT03118050|581639942|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
161068429|NCT03118050|581639943|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
161068430|NCT03118050|581639944|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
161068431|NCT03118050|581639945|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
161068432|NCT01454739|581639947|FG000|Overall Study|Protocol Violation|2|||
161068433|NCT01454739|581639948|FG001|Overall Study|Protocol Violation|3|||
161068434|NCT01454739|581639947|FG000|Overall Study|Withdrawal by Subject|2|||
161284117|NCT00805961|582417805|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
161284118|NCT00805961|582417805|FG000|Maintenance Treatment|Lack of Efficacy|13|||
161068435|NCT01454739|581639948|FG001|Overall Study|Withdrawal by Subject|6|||
161284119|NCT00805961|582417805|FG000|Maintenance Treatment|Intercurrent Illness|7|||
161284120|NCT00805961|582417805|FG000|Maintenance Treatment|Adverse Event|6|||
161284121|NCT00805961|582417805|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
161068436|NCT01454739|581639947|FG000|Overall Study|Other|3|||
161068437|NCT01454739|581639948|FG001|Overall Study|Other|5|||
161068438|NCT01454739|581639947|FG000|Overall Study|Physician Decision|0|||
161068439|NCT01454739|581639948|FG001|Overall Study|Physician Decision|5|||
161068440|NCT01454739|581639947|FG000|Overall Study|Lost to Follow-up|0|||
161068441|NCT01454739|581639948|FG001|Overall Study|Lost to Follow-up|1|||
161068442|NCT01454739|581639947|FG000|Overall Study|Adverse Event|0|||
161068443|NCT01454739|581639948|FG001|Overall Study|Adverse Event|1|||
161068444|NCT05765435|581639949|FG000|Overall Study|Lost to Follow-up|0|||
161068445|NCT05765435|581639950|FG001|Overall Study|Lost to Follow-up|1|||
161068446|NCT05765435|581639951|FG002|Overall Study|Lost to Follow-up|0|||
161068447|NCT05765435|581639949|FG000|Overall Study|Withdrawal by Subject|0|||
161284122|NCT00805961|582417805|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
161068448|NCT05765435|581639950|FG001|Overall Study|Withdrawal by Subject|0|||
161068449|NCT05765435|581639951|FG002|Overall Study|Withdrawal by Subject|1|||
161068450|NCT04351269|581639952|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
161068451|NCT04351269|581639953|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
161068452|NCT04351269|581639954|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
161068453|NCT04351269|581639952|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
161068454|NCT04351269|581639953|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
161068455|NCT04351269|581639954|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
161068456|NCT04351269|581639952|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
161068457|NCT04351269|581639953|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
161068458|NCT04351269|581639954|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
161068459|NCT04351269|581639952|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
161068460|NCT04351269|581639953|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
161068461|NCT04351269|581639954|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
161068462|NCT04351269|581639952|FG000|Overall Study|Lost to Follow-up|1|||
161068463|NCT04351269|581639953|FG001|Overall Study|Lost to Follow-up|3|||
161068464|NCT04351269|581639954|FG002|Overall Study|Lost to Follow-up|0|||
161068465|NCT02980523|581639962|FG000|Overall Study|Lost to Follow-up|1|||
161068466|NCT02980523|581639963|FG001|Overall Study|Lost to Follow-up|4|||
161068467|NCT02980523|581639964|FG002|Overall Study|Lost to Follow-up|1|||
161068468|NCT02980523|581639965|FG003|Overall Study|Lost to Follow-up|2|||
161068469|NCT02980523|581639966|FG004|Overall Study|Lost to Follow-up|1|||
161068470|NCT02980523|581639962|FG000|Overall Study|Excluded from analysis|1|||
161068471|NCT02980523|581639963|FG001|Overall Study|Excluded from analysis|3|||
161068472|NCT02980523|581639964|FG002|Overall Study|Excluded from analysis|1|||
161068473|NCT02980523|581639965|FG003|Overall Study|Excluded from analysis|1|||
161068474|NCT02980523|581639966|FG004|Overall Study|Excluded from analysis|1|||
161068475|NCT02980523|581639962|FG000|Overall Study|Lack of Efficacy|1|||
161068476|NCT02980523|581639963|FG001|Overall Study|Lack of Efficacy|4|||
161068477|NCT02980523|581639964|FG002|Overall Study|Lack of Efficacy|4|||
161068478|NCT02980523|581639965|FG003|Overall Study|Lack of Efficacy|5|||
161068479|NCT02980523|581639966|FG004|Overall Study|Lack of Efficacy|8|||
161068480|NCT02980523|581639962|FG000|Overall Study|Did not receive intervention|0|||
161068481|NCT02980523|581639963|FG001|Overall Study|Did not receive intervention|0|||
161068482|NCT02980523|581639964|FG002|Overall Study|Did not receive intervention|0|||
161068483|NCT02980523|581639965|FG003|Overall Study|Did not receive intervention|1|||
161068484|NCT02980523|581639966|FG004|Overall Study|Did not receive intervention|0|||
161068485|NCT00633945|581639967|FG000|Overall Study|Physician Decision|2|||
161068486|NCT03845140|581639970|FG000|Overall Study|Participant travelled outside study area|0|||
161068487|NCT03845140|581639971|FG001|Overall Study|Participant travelled outside study area|1|||
161068488|NCT03845140|581639972|FG002|Overall Study|Participant travelled outside study area|0|||
161068489|NCT03845140|581639973|FG003|Overall Study|Participant travelled outside study area|0|||
161068490|NCT03845140|581639974|FG004|Overall Study|Participant travelled outside study area|0|||
161068491|NCT03845140|581639975|FG005|Overall Study|Participant travelled outside study area|0|||
161068492|NCT01592045|581639983|FG000|Overall Study|Disease Progression|1|||
161068493|NCT01592045|581639984|FG001|Overall Study|Disease Progression|1|||
161068494|NCT01592045|581639983|FG000|Overall Study|Adverse Event|1|||
161068495|NCT01592045|581639984|FG001|Overall Study|Adverse Event|1|||
161068496|NCT01592045|581639983|FG000|Overall Study|Withdrawal by Subject|1|||
161068497|NCT01592045|581639984|FG001|Overall Study|Withdrawal by Subject|0|||
161068498|NCT01592045|581639983|FG000|Overall Study|Moved out of country|2|||
161068499|NCT01592045|581639984|FG001|Overall Study|Moved out of country|0|||
161068500|NCT01790295|581639987|FG000|Overall Study|Adverse Event|1|||
161068501|NCT01790295|581639987|FG000|Overall Study|Death|4|||
161068502|NCT01790295|581639987|FG000|Overall Study|Lack of Efficacy|2|||
161068503|NCT01790295|581639987|FG000|Overall Study|Study closure|4|||
161068504|NCT03721705|581639988|FG000|Overall Study|Adverse Event|2|||
161068505|NCT03721705|581639989|FG001|Overall Study|Adverse Event|0|||
161284123|NCT00805961|582417805|FG000|Maintenance Treatment|Withdrawn Consent|1|||
161284124|NCT03713593|582419327|FG000|Overall Study|Sponsor Decision|73|||
161068506|NCT03721705|581639988|FG000|Overall Study|Withdrawal by Subject|4|||
161068507|NCT03721705|581639989|FG001|Overall Study|Withdrawal by Subject|10|||
161068508|NCT03721705|581639988|FG000|Overall Study|No Suitable Study Partner|1|||
161068509|NCT03721705|581639989|FG001|Overall Study|No Suitable Study Partner|0|||
161068510|NCT03721705|581639988|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
161068511|NCT03721705|581639989|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
161068512|NCT03721705|581639988|FG000|Overall Study|Death|0|||
161068513|NCT03721705|581639989|FG001|Overall Study|Death|1|||
161068514|NCT01843777|581639990|FG000|Overall Study|Withdrawal by Subject|1|||
161068515|NCT01843777|581639991|FG001|Overall Study|Withdrawal by Subject|0|||
161068516|NCT02599688|581639999|FG000|Overall Study|Lack of Efficacy|1|||
161068517|NCT02599688|581639999|FG000|Overall Study|Withdrawal by Subject|1|||
161068518|NCT02599688|581639999|FG000|Overall Study|Termination by Sponsor|2|||
161068519|NCT01318876|581640001|FG000|Day 8 Survey|email address invalid|96|||
161068520|NCT01318876|581640001|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
161068521|NCT01318876|581640001|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
161068522|NCT01101061|581640004|FG000|Overall Study|Adverse Event|0|||
161068523|NCT01101061|581640005|FG001|Overall Study|Adverse Event|0|||
161068524|NCT01101061|581640006|FG002|Overall Study|Adverse Event|1|||
161068525|NCT01101061|581640007|FG003|Overall Study|Adverse Event|0|||
161068526|NCT01101061|581640008|FG004|Overall Study|Adverse Event|0|||
161068527|NCT01101061|581640009|FG005|Overall Study|Adverse Event|0|||
161068528|NCT02049515|581640010|FG000|Overall Study|Adverse Event|46|||
161068529|NCT02049515|581640011|FG001|Overall Study|Adverse Event|2|||
161068530|NCT02049515|581640010|FG000|Overall Study|Protocol-specified Disease Progression|23|||
161068531|NCT02049515|581640011|FG001|Overall Study|Protocol-specified Disease Progression|2|||
161068532|NCT02049515|581640010|FG000|Overall Study|Death|6|||
161068533|NCT02049515|581640011|FG001|Overall Study|Death|0|||
161068534|NCT02049515|581640010|FG000|Overall Study|Physician Decision|5|||
161068535|NCT02049515|581640011|FG001|Overall Study|Physician Decision|1|||
161068536|NCT02049515|581640010|FG000|Overall Study|Withdrawal by Subject|3|||
161068537|NCT02049515|581640011|FG001|Overall Study|Withdrawal by Subject|0|||
161068538|NCT02049515|581640010|FG000|Overall Study|Termination of the Study by Sponsor|2|||
161068539|NCT02049515|581640011|FG001|Overall Study|Termination of the Study by Sponsor|0|||
161068540|NCT02049515|581640010|FG000|Overall Study|Protocol Violation|1|||
161068541|NCT02049515|581640011|FG001|Overall Study|Protocol Violation|1|||
161068542|NCT02049515|581640010|FG000|Overall Study|Clinical Deterioration|1|||
161068543|NCT02049515|581640011|FG001|Overall Study|Clinical Deterioration|0|||
161068544|NCT02049515|581640010|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
161068545|NCT02049515|581640011|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
161068546|NCT02049515|581640010|FG000|Overall Study|Treatment Interruption >42 Days|1|||
161068547|NCT02049515|581640011|FG001|Overall Study|Treatment Interruption >42 Days|0|||
161068548|NCT02049515|581640010|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
161068549|NCT02049515|581640011|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
161068550|NCT05903183|581640015|FG000|Main Trial Part (365 Days)|Death|1|||
161068551|NCT05903183|581640016|FG001|Main Trial Part (365 Days)|Death|0|||
161068552|NCT05903183|581640017|FG002|Main Trial Part (365 Days)|Death|0|||
161068553|NCT05903183|581640018|FG003|Main Trial Part (365 Days)|Death|0|||
161068554|NCT05903183|581640019|FG004|Main Trial Part (365 Days)|Death|0|||
161068555|NCT05903183|581640015|FG000|Main Trial Part (365 Days)|Other|1|||
161068556|NCT05903183|581640016|FG001|Main Trial Part (365 Days)|Other|2|||
161068557|NCT05903183|581640017|FG002|Main Trial Part (365 Days)|Other|1|||
161068558|NCT05903183|581640018|FG003|Main Trial Part (365 Days)|Other|0|||
161068559|NCT05903183|581640019|FG004|Main Trial Part (365 Days)|Other|0|||
161068560|NCT05903183|581640015|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161068561|NCT05903183|581640016|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161068562|NCT05903183|581640017|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
161068563|NCT05903183|581640018|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161284125|NCT03713593|582419328|FG001|Overall Study|Sponsor Decision|41|||
161284126|NCT03713593|582419327|FG000|Overall Study|Lost to Follow-up|2|||
161284127|NCT03713593|582419328|FG001|Overall Study|Lost to Follow-up|1|||
161068564|NCT05903183|581640019|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
161068565|NCT05903183|581640015|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
161068566|NCT05903183|581640016|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161068567|NCT05903183|581640017|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161068568|NCT05903183|581640018|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161068569|NCT05903183|581640019|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
161068570|NCT05903183|581640015|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
161068571|NCT05903183|581640016|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
161284128|NCT03713593|582419327|FG000|Overall Study|Death|314|||
161284129|NCT03713593|582419328|FG001|Overall Study|Death|349|||
161284130|NCT03713593|582419327|FG000|Overall Study|Withdrawal by Subject|6|||
161068572|NCT05903183|581640017|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
161068573|NCT05903183|581640018|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
161068574|NCT05903183|581640019|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
161068575|NCT02647645|581640020|FG000|Overall Study|Lost to Follow-up|2|||
161068576|NCT02647645|581640021|FG001|Overall Study|Lost to Follow-up|1|||
161284131|NCT03713593|582419328|FG001|Overall Study|Withdrawal by Subject|8|||
161284132|NCT05126693|582419329|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
161284133|NCT05126693|582419330|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
161284134|NCT05126693|582419329|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
161284135|NCT05126693|582419330|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
161284136|NCT05126693|582419329|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
161284137|NCT05126693|582419330|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
161284138|NCT00001521|582419331|FG000|Overall Study|Withdrawal by Subject|3|||
161284139|NCT00001521|582419332|FG001|Overall Study|Withdrawal by Subject|3|||
161284140|NCT00001521|582419331|FG000|Overall Study|Physician Decision|1|||
161284141|NCT00001521|582419332|FG001|Overall Study|Physician Decision|1|||
161284142|NCT00001521|582419331|FG000|Overall Study|Noncompliant|6|||
161284143|NCT00001521|582419332|FG001|Overall Study|Noncompliant|3|||
161284144|NCT01996241|582419338|FG000|Overall Study|Lost to Follow-up|252|||
161284145|NCT01996241|582419339|FG001|Overall Study|Lost to Follow-up|235|||
161284146|NCT01068262|582419342|FG000|Overall Study|Adverse Event|2|||
161345520|NCT05028569|582650834|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
161345521|NCT05028569|582650835|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
161068577|NCT04599907|581640024|FG000|Overall Study|Withdrawal by Subject|1|||
161068578|NCT04599907|581640025|FG001|Overall Study|Withdrawal by Subject|7|||
161068579|NCT04599907|581640026|FG002|Overall Study|Withdrawal by Subject|6|||
161068580|NCT04599907|581640024|FG000|Overall Study|Lost to Follow-up|0|||
161068581|NCT04599907|581640025|FG001|Overall Study|Lost to Follow-up|1|||
161068582|NCT04599907|581640026|FG002|Overall Study|Lost to Follow-up|0|||
161068583|NCT03007732|581640027|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
161068584|NCT03007732|581640028|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
161068585|NCT03007732|581640029|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
161068586|NCT03007732|581640030|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
161068587|NCT03371823|581640031|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
161068588|NCT03371823|581640032|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
161068589|NCT01466790|581640034|FG000|Overall Study|Adverse Event|1|||
161068590|NCT01466790|581640035|FG001|Overall Study|Adverse Event|0|||
161068591|NCT01466790|581640036|FG002|Overall Study|Adverse Event|0|||
161068592|NCT01466790|581640037|FG003|Overall Study|Adverse Event|0|||
161068593|NCT01466790|581640038|FG004|Overall Study|Adverse Event|2|||
161068594|NCT01466790|581640039|FG005|Overall Study|Adverse Event|0|||
161068595|NCT01466790|581640040|FG006|Overall Study|Adverse Event|0|||
161068596|NCT01466790|581640041|FG007|Overall Study|Adverse Event|0|||
161068597|NCT01466790|581640034|FG000|Overall Study|Lost to Follow-up|2|||
161068598|NCT01466790|581640035|FG001|Overall Study|Lost to Follow-up|0|||
161068599|NCT01466790|581640036|FG002|Overall Study|Lost to Follow-up|0|||
161068600|NCT01466790|581640037|FG003|Overall Study|Lost to Follow-up|0|||
161068601|NCT01466790|581640038|FG004|Overall Study|Lost to Follow-up|0|||
161068602|NCT01466790|581640039|FG005|Overall Study|Lost to Follow-up|0|||
161068603|NCT01466790|581640040|FG006|Overall Study|Lost to Follow-up|0|||
161068604|NCT01466790|581640041|FG007|Overall Study|Lost to Follow-up|0|||
161068605|NCT01466790|581640034|FG000|Overall Study|Withdrawal by Subject|1|||
161068606|NCT01466790|581640035|FG001|Overall Study|Withdrawal by Subject|1|||
161068607|NCT01466790|581640036|FG002|Overall Study|Withdrawal by Subject|0|||
161068608|NCT01466790|581640037|FG003|Overall Study|Withdrawal by Subject|0|||
161068609|NCT01466790|581640038|FG004|Overall Study|Withdrawal by Subject|1|||
161068610|NCT01466790|581640039|FG005|Overall Study|Withdrawal by Subject|0|||
161068611|NCT01466790|581640040|FG006|Overall Study|Withdrawal by Subject|1|||
161068612|NCT01466790|581640041|FG007|Overall Study|Withdrawal by Subject|1|||
161068613|NCT03668223|581640042|FG000|Overall Study|Death|10|||
161068614|NCT03668223|581640043|FG001|Overall Study|Death|5|||
161068615|NCT03668223|581640042|FG000|Overall Study|Lost to Follow-up|12|||
161068616|NCT03668223|581640043|FG001|Overall Study|Lost to Follow-up|12|||
161284147|NCT01068262|582419343|FG001|Overall Study|Adverse Event|0|||
161284148|NCT01068262|582419344|FG002|Overall Study|Adverse Event|1|||
161284149|NCT01068262|582419345|FG003|Overall Study|Adverse Event|0|||
161068617|NCT03668223|581640042|FG000|Overall Study|Withdrawal by Subject|8|||
161068618|NCT03668223|581640043|FG001|Overall Study|Withdrawal by Subject|3|||
161068619|NCT05502783|581640044|FG000|Overall Study|Lack of Efficacy|1|||
161068620|NCT04870957|581640045|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161068621|NCT04870957|581640046|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161068622|NCT04870957|581640047|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161068623|NCT04870957|581640048|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161068624|NCT04870957|581640049|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
161284150|NCT01068262|582419342|FG000|Overall Study|Protocol Violation|1|||
161284151|NCT01068262|582419343|FG001|Overall Study|Protocol Violation|0|||
161068625|NCT04870957|581640050|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
161068626|NCT04870957|581640045|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161068627|NCT04870957|581640046|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161068628|NCT04870957|581640047|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161068629|NCT04870957|581640048|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161068630|NCT04870957|581640049|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
161068631|NCT04870957|581640050|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
161068632|NCT04870957|581640045|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161068633|NCT04870957|581640046|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161068634|NCT04870957|581640047|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161068635|NCT04870957|581640048|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161068636|NCT04870957|581640049|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
161068637|NCT04870957|581640050|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
161068638|NCT04870957|581640045|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161068639|NCT04870957|581640046|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161068640|NCT04870957|581640047|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161068641|NCT04870957|581640048|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161068642|NCT04870957|581640049|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
161068643|NCT04870957|581640050|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
161068644|NCT04870957|581640045|FG000|T2 (Randomization) - T3|Adverse Event|1|||
161068645|NCT04870957|581640046|FG001|T2 (Randomization) - T3|Adverse Event|1|||
161068646|NCT04870957|581640047|FG002|T2 (Randomization) - T3|Adverse Event|0|||
161068647|NCT04870957|581640048|FG003|T2 (Randomization) - T3|Adverse Event|0|||
161068648|NCT04870957|581640049|FG004|T2 (Randomization) - T3|Adverse Event|0|||
161068649|NCT04870957|581640050|FG005|T2 (Randomization) - T3|Adverse Event|0|||
161068650|NCT04870957|581640045|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
161068651|NCT04870957|581640046|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
161068652|NCT04870957|581640047|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
161068653|NCT04870957|581640048|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
161068654|NCT04870957|581640049|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
161068655|NCT04870957|581640050|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
161068656|NCT04870957|581640045|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
161068657|NCT04870957|581640046|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
161068658|NCT04870957|581640047|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
161068659|NCT04870957|581640048|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
161068660|NCT04870957|581640049|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
161068661|NCT04870957|581640050|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
161068662|NCT04870957|581640045|FG000|T2 (Randomization) - T3|Physician Decision|0|||
161068663|NCT04870957|581640046|FG001|T2 (Randomization) - T3|Physician Decision|0|||
161068664|NCT04870957|581640047|FG002|T2 (Randomization) - T3|Physician Decision|2|||
161068665|NCT04870957|581640048|FG003|T2 (Randomization) - T3|Physician Decision|1|||
161068666|NCT04870957|581640049|FG004|T2 (Randomization) - T3|Physician Decision|0|||
161068667|NCT04870957|581640050|FG005|T2 (Randomization) - T3|Physician Decision|0|||
161068668|NCT04870957|581640045|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
161068669|NCT04870957|581640046|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
161068670|NCT04870957|581640047|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
161068671|NCT04870957|581640048|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
161068672|NCT04870957|581640049|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
161068673|NCT04870957|581640050|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
161068674|NCT04870957|581640045|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
161068675|NCT04870957|581640046|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
161068676|NCT04870957|581640047|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
161068677|NCT04870957|581640048|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
161068678|NCT04870957|581640049|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
161068679|NCT04870957|581640050|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
161068680|NCT04870957|581640045|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
161068681|NCT04870957|581640046|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
161068682|NCT04870957|581640047|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
161068683|NCT04870957|581640048|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
161284152|NCT01068262|582419344|FG002|Overall Study|Protocol Violation|0|||
161068684|NCT04870957|581640049|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
161284153|NCT01068262|582419345|FG003|Overall Study|Protocol Violation|0|||
161284154|NCT01068262|582419342|FG000|Overall Study|Withdrawal by Subject|0|||
161284155|NCT01068262|582419343|FG001|Overall Study|Withdrawal by Subject|1|||
161284156|NCT01068262|582419344|FG002|Overall Study|Withdrawal by Subject|0|||
161284157|NCT01068262|582419345|FG003|Overall Study|Withdrawal by Subject|0|||
161068685|NCT04870957|581640050|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
161068686|NCT04870957|581640045|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
161068687|NCT04870957|581640046|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
161068688|NCT04870957|581640047|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
161068689|NCT04870957|581640048|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
161068690|NCT04870957|581640049|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
161068691|NCT04870957|581640050|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
161068692|NCT04870957|581640045|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
161068693|NCT04870957|581640046|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
161068694|NCT04870957|581640047|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
161068695|NCT04870957|581640048|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
161068696|NCT04870957|581640049|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
161068697|NCT04870957|581640050|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
161068698|NCT04870957|581640045|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
161068699|NCT04870957|581640046|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
161068700|NCT04870957|581640047|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
161068701|NCT04870957|581640048|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
161068702|NCT04870957|581640049|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
161068703|NCT04870957|581640050|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
161068704|NCT04870957|581640045|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161068705|NCT04870957|581640046|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161068706|NCT04870957|581640047|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161068707|NCT04870957|581640048|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161068708|NCT04870957|581640049|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
161068709|NCT04870957|581640050|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
161068710|NCT04870957|581640045|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161068711|NCT04870957|581640046|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161068712|NCT04870957|581640047|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161068713|NCT04870957|581640048|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161068714|NCT04870957|581640049|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
161068715|NCT04870957|581640050|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
161068716|NCT04870957|581640045|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
161068717|NCT04870957|581640046|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
161068718|NCT04870957|581640047|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
161068719|NCT04870957|581640048|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
161068720|NCT04870957|581640049|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
161068721|NCT04870957|581640050|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
161068722|NCT03733899|581640053|FG000|Period 1|Protocol Violation|0|||
161068723|NCT03733899|581640054|FG001|Period 1|Protocol Violation|0|||
161068724|NCT03733899|581640055|FG002|Period 1|Protocol Violation|0|||
161068725|NCT03733899|581640056|FG003|Period 1|Protocol Violation|0|||
161068726|NCT03733899|581640057|FG004|Period 1|Protocol Violation|0|||
161068727|NCT03733899|581640058|FG005|Period 1|Protocol Violation|1|||
161068728|NCT03733899|581640053|FG000|Period 2|Unscuccessful Treatment|0|||
161068729|NCT03733899|581640054|FG001|Period 2|Unscuccessful Treatment|1|||
161068730|NCT03733899|581640055|FG002|Period 2|Unscuccessful Treatment|0|||
161068731|NCT03733899|581640056|FG003|Period 2|Unscuccessful Treatment|0|||
161068732|NCT03733899|581640057|FG004|Period 2|Unscuccessful Treatment|0|||
161068733|NCT03733899|581640058|FG005|Period 2|Unscuccessful Treatment|0|||
161068734|NCT03733899|581640053|FG000|Period 3|Withdrawal by Subject|1|||
161068735|NCT03733899|581640054|FG001|Period 3|Withdrawal by Subject|0|||
161068736|NCT03733899|581640055|FG002|Period 3|Withdrawal by Subject|0|||
161068737|NCT03733899|581640056|FG003|Period 3|Withdrawal by Subject|0|||
161068738|NCT03733899|581640057|FG004|Period 3|Withdrawal by Subject|0|||
161068739|NCT03733899|581640058|FG005|Period 3|Withdrawal by Subject|0|||
161068740|NCT02859064|581641747|FG000|Overall Study|Progressive Disease|3|||
161068741|NCT02859064|581641747|FG000|Overall Study|Physician Decision|1|||
161068742|NCT02859064|581641747|FG000|Overall Study|Withdrawal by Subject|1|||
161068743|NCT02859064|581641747|FG000|Overall Study|Death|1|||
161068744|NCT00667459|581641751|FG000|Overall Study|Death|0|||
161068745|NCT00667459|581641752|FG001|Overall Study|Death|2|||
161068746|NCT00667459|581641751|FG000|Overall Study|Lost to Follow-up|8|||
161068747|NCT00667459|581641752|FG001|Overall Study|Lost to Follow-up|43|||
161068748|NCT02568397|581641753|FG000|Period 2|Withdrawal by Subject|0|||
161068749|NCT02568397|581641754|FG001|Period 2|Withdrawal by Subject|1|||
161068750|NCT02568397|581641753|FG000|Period 2|Physician Decision|0|||
161068751|NCT02568397|581641754|FG001|Period 2|Physician Decision|1|||
161068752|NCT00078377|581641755|FG000|Overall Study|Adverse Event|2|||
161068753|NCT00078377|581641756|FG001|Overall Study|Adverse Event|5|||
161068754|NCT00078377|581641757|FG002|Overall Study|Adverse Event|1|||
161068755|NCT00078377|581641755|FG000|Overall Study|Lack of Efficacy|2|||
161284158|NCT04182490|582419346|FG000|Overall Study|Withdrawal by Subject|3|||
161284159|NCT04182490|582419347|FG001|Overall Study|Withdrawal by Subject|3|||
161068756|NCT00078377|581641756|FG001|Overall Study|Lack of Efficacy|0|||
161068757|NCT00078377|581641757|FG002|Overall Study|Lack of Efficacy|2|||
161068758|NCT00078377|581641755|FG000|Overall Study|Lost to Follow-up|0|||
161068759|NCT00078377|581641756|FG001|Overall Study|Lost to Follow-up|1|||
161068760|NCT00078377|581641757|FG002|Overall Study|Lost to Follow-up|1|||
161068761|NCT00078377|581641755|FG000|Overall Study|Physician Decision|2|||
161068762|NCT00078377|581641756|FG001|Overall Study|Physician Decision|0|||
161068763|NCT00078377|581641757|FG002|Overall Study|Physician Decision|0|||
161068764|NCT00078377|581641755|FG000|Overall Study|Withdrawal by Subject|3|||
161068765|NCT00078377|581641756|FG001|Overall Study|Withdrawal by Subject|4|||
161068766|NCT00078377|581641757|FG002|Overall Study|Withdrawal by Subject|4|||
161068767|NCT00078377|581641755|FG000|Overall Study|Miscellaneous|2|||
161068768|NCT00078377|581641756|FG001|Overall Study|Miscellaneous|6|||
161068769|NCT00078377|581641757|FG002|Overall Study|Miscellaneous|1|||
161068770|NCT00581893|581641758|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
161068771|NCT00581893|581641759|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
161068772|NCT01381575|581641760|FG000|Overall Study|Serious Adverse Event|1|||
161068773|NCT01381575|581641761|FG001|Overall Study|Serious Adverse Event|0|||
161068774|NCT01381575|581641762|FG002|Overall Study|Serious Adverse Event|0|||
161068775|NCT01381575|581641760|FG000|Overall Study|Non-Serious Adverse Event|0|||
161068776|NCT01381575|581641761|FG001|Overall Study|Non-Serious Adverse Event|0|||
161068777|NCT01381575|581641762|FG002|Overall Study|Non-Serious Adverse Event|1|||
161068778|NCT01381575|581641760|FG000|Overall Study|Protocol Violation|0|||
161068779|NCT01381575|581641761|FG001|Overall Study|Protocol Violation|1|||
161068780|NCT01381575|581641762|FG002|Overall Study|Protocol Violation|1|||
161068781|NCT01381575|581641760|FG000|Overall Study|Withdrawal by Subject|15|||
161068782|NCT01381575|581641761|FG001|Overall Study|Withdrawal by Subject|9|||
161068783|NCT01381575|581641762|FG002|Overall Study|Withdrawal by Subject|7|||
161068784|NCT01381575|581641760|FG000|Overall Study|Migrated/moved from study area|2|||
161068785|NCT01381575|581641761|FG001|Overall Study|Migrated/moved from study area|12|||
161068786|NCT01381575|581641762|FG002|Overall Study|Migrated/moved from study area|2|||
161068787|NCT01381575|581641760|FG000|Overall Study|Lost to Follow-up|8|||
161068788|NCT01381575|581641761|FG001|Overall Study|Lost to Follow-up|17|||
161068789|NCT01381575|581641762|FG002|Overall Study|Lost to Follow-up|9|||
161068790|NCT03020069|581641763|FG000|Overall Study|Lost to Follow-up|0|||
161068791|NCT03020069|581641764|FG001|Overall Study|Lost to Follow-up|1|||
161068792|NCT01920932|581641765|FG000|Overall Study|Death|1|||
161068793|NCT01920932|581641765|FG000|Overall Study|Withdrawal of consent|1|||
161068794|NCT04486313|581641766|FG000|Overall Study|Lost to Follow-up|7|||
161068795|NCT04486313|581641767|FG001|Overall Study|Lost to Follow-up|9|||
161068796|NCT04486313|581641766|FG000|Overall Study|Withdrawal by Subject|8|||
161068797|NCT04486313|581641767|FG001|Overall Study|Withdrawal by Subject|6|||
161068798|NCT04486313|581641766|FG000|Overall Study|Physician Decision|1|||
161068799|NCT04486313|581641767|FG001|Overall Study|Physician Decision|1|||
161068800|NCT04486313|581641766|FG000|Overall Study|Death|2|||
161068801|NCT04486313|581641767|FG001|Overall Study|Death|0|||
161068802|NCT04486313|581641766|FG000|Overall Study|Protocol Violation|1|||
161068803|NCT04486313|581641767|FG001|Overall Study|Protocol Violation|1|||
161068804|NCT00882115|581641770|FG000|Overall Study|Withdrawal by Subject|3|||
161068805|NCT00882115|581641770|FG000|Overall Study|did not respond to DEP challe|6|||
161068806|NCT02552147|581641771|FG000|First Intervention (7 Days)|Protocol Violation|1|||
161068807|NCT02552147|581641772|FG001|First Intervention (7 Days)|Protocol Violation|0|||
161068808|NCT02552147|581641771|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
161068809|NCT02552147|581641772|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
161068810|NCT00940875|581641773|FG000|Treatment Phase|Adverse Event|9|||
161068811|NCT00940875|581641774|FG001|Treatment Phase|Adverse Event|3|||
161068812|NCT00940875|581641773|FG000|Treatment Phase|Death|3|||
161068813|NCT00940875|581641774|FG001|Treatment Phase|Death|5|||
161068814|NCT00940875|581641773|FG000|Treatment Phase|Lack of Efficacy|1|||
161068815|NCT00940875|581641774|FG001|Treatment Phase|Lack of Efficacy|0|||
161068816|NCT00940875|581641773|FG000|Treatment Phase|Withdrawal by Subject|3|||
161068817|NCT00940875|581641774|FG001|Treatment Phase|Withdrawal by Subject|0|||
161068818|NCT00940875|581641773|FG000|Treatment Phase|Disease progression|9|||
161068819|NCT00940875|581641774|FG001|Treatment Phase|Disease progression|11|||
161068820|NCT00940875|581641773|FG000|Treatment Phase|Physician Decision|1|||
161068821|NCT00940875|581641774|FG001|Treatment Phase|Physician Decision|0|||
161068822|NCT00940875|581641773|FG000|Post-Study Treatment|Death|0|||
161068823|NCT00940875|581641774|FG001|Post-Study Treatment|Death|1|||
161068824|NCT00940875|581641773|FG000|Post-Study Treatment|Disease Progression|0|||
161068825|NCT00940875|581641774|FG001|Post-Study Treatment|Disease Progression|2|||
161068826|NCT00943787|581641775|FG000|Overall Study|Physician Decision|4|||
161068827|NCT00943787|581641775|FG000|Overall Study|Withdrawal by Subject|3|||
161068828|NCT01547598|581641776|FG000|Overall Study|Withdrew consent|1|||
161068829|NCT01547598|581641777|FG001|Overall Study|Withdrew consent|1|||
161068830|NCT01547598|581641776|FG000|Overall Study|Lost to Follow-up|1|||
161068831|NCT01547598|581641777|FG001|Overall Study|Lost to Follow-up|1|||
161068832|NCT01547598|581641776|FG000|Overall Study|Adverse Event|1|||
161068833|NCT01547598|581641777|FG001|Overall Study|Adverse Event|1|||
161068834|NCT01547598|581641776|FG000|Overall Study|Protocol Violation|1|||
161068835|NCT01547598|581641777|FG001|Overall Study|Protocol Violation|1|||
161068836|NCT01547598|581641776|FG000|Overall Study|Other Miscellaneous Reasons|2|||
161068837|NCT01547598|581641777|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161068838|NCT00872001|581641781|FG000|Overall Study|Adverse Event|34|||
161068839|NCT00872001|581641782|FG001|Overall Study|Adverse Event|23|||
161068840|NCT00872001|581641781|FG000|Overall Study|Protocol Defined Clinical Event|5|||
161068841|NCT00872001|581641782|FG001|Overall Study|Protocol Defined Clinical Event|7|||
161068842|NCT00872001|581641781|FG000|Overall Study|Lost to Follow-up|13|||
161068843|NCT00872001|581641782|FG001|Overall Study|Lost to Follow-up|12|||
161068844|NCT00872001|581641781|FG000|Overall Study|Withdrawal by Subject|18|||
161068845|NCT00872001|581641782|FG001|Overall Study|Withdrawal by Subject|30|||
161068846|NCT00872001|581641781|FG000|Overall Study|Protocol Violation|5|||
161068847|NCT00872001|581641782|FG001|Overall Study|Protocol Violation|8|||
161068848|NCT00872001|581641781|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
161068849|NCT00872001|581641782|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
161068850|NCT00872001|581641781|FG000|Overall Study|Administrative|23|||
161068851|NCT00872001|581641782|FG001|Overall Study|Administrative|15|||
161068852|NCT04071301|581641783|FG000|Overall Study|Withdrawal by Subject|6|||
161068853|NCT04071301|581641783|FG000|Overall Study|Death|1|||
161068854|NCT02879383|581641784|FG000|First 24 Weeks|Physician Decision|0|||
161068855|NCT02879383|581641785|FG001|First 24 Weeks|Physician Decision|1|||
161068856|NCT02879383|581641786|FG002|First 24 Weeks|Physician Decision|0|||
161068857|NCT02879383|581641787|FG003|First 24 Weeks|Physician Decision|0|||
161068858|NCT02125279|581641788|FG000|Overall Study|Lack of Efficacy|2|||
161068859|NCT02125279|581641788|FG000|Overall Study|Withdrawal by Subject|6|||
161068860|NCT02125279|581641788|FG000|Overall Study|Protocol Violation|1|||
161068861|NCT02125279|581641788|FG000|Overall Study|Lost to Follow-up|4|||
161068862|NCT01850589|581641789|FG000|Overall Study|Withdrawal by Subject|8|||
161068863|NCT01850589|581641790|FG001|Overall Study|Withdrawal by Subject|0|||
161068864|NCT01607879|581641791|FG000|Overall Study|Death|1|||
161068865|NCT01607879|581641792|FG001|Overall Study|Death|0|||
161068866|NCT03912662|581641793|FG000|Overall Study|Adverse Event|3|||
161068867|NCT03912662|581641793|FG000|Overall Study|Adverse Event and Death|1|||
161068868|NCT03912662|581641793|FG000|Overall Study|Death|1|||
161068869|NCT03912662|581641793|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
161068870|NCT03912662|581641793|FG000|Overall Study|Mesh Removal|1|||
161068871|NCT03912662|581641793|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
161068872|NCT03912662|581641793|FG000|Overall Study|Early study termination|20|||
161068873|NCT00420784|581641796|FG000|Overall Study|Adverse Event|11|||
161068874|NCT00420784|581641797|FG001|Overall Study|Adverse Event|29|||
161068875|NCT00420784|581641798|FG002|Overall Study|Adverse Event|10|||
161068876|NCT00420784|581641799|FG003|Overall Study|Adverse Event|5|||
161068877|NCT00420784|581641796|FG000|Overall Study|Withdrawal by Subject|0|||
161068878|NCT00420784|581641797|FG001|Overall Study|Withdrawal by Subject|1|||
161068879|NCT00420784|581641798|FG002|Overall Study|Withdrawal by Subject|0|||
161068880|NCT00420784|581641799|FG003|Overall Study|Withdrawal by Subject|0|||
161068881|NCT00420784|581641796|FG000|Overall Study|Lost to Follow-up|0|||
161068882|NCT00420784|581641797|FG001|Overall Study|Lost to Follow-up|0|||
161068883|NCT00420784|581641798|FG002|Overall Study|Lost to Follow-up|2|||
161068884|NCT00420784|581641799|FG003|Overall Study|Lost to Follow-up|1|||
161284160|NCT04182490|582419346|FG000|Overall Study|Lost to Follow-up|0|||
161284161|NCT04182490|582419347|FG001|Overall Study|Lost to Follow-up|1|||
161284162|NCT04182490|582419346|FG000|Overall Study|Physician Decision|0|||
161068885|NCT00420784|581641796|FG000|Overall Study|Virologic Stopping Rule|17|||
161068886|NCT00420784|581641797|FG001|Overall Study|Virologic Stopping Rule|26|||
161068887|NCT00420784|581641798|FG002|Overall Study|Virologic Stopping Rule|41|||
161068888|NCT00420784|581641799|FG003|Overall Study|Virologic Stopping Rule|67|||
161068889|NCT00420784|581641796|FG000|Overall Study|Other|1|||
161068890|NCT00420784|581641797|FG001|Overall Study|Other|2|||
161068891|NCT00420784|581641798|FG002|Overall Study|Other|0|||
161068892|NCT00420784|581641799|FG003|Overall Study|Other|5|||
161068893|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
161068894|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
161068895|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
161068896|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
161068897|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
161068898|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
161284163|NCT04182490|582419347|FG001|Overall Study|Physician Decision|1|||
161284164|NCT01811472|582419353|FG000|Overall Study|Adverse Event|1|||
161284165|NCT01811472|582419354|FG001|Overall Study|Adverse Event|0|||
161068899|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
161068900|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
161068901|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
161284166|NCT01811472|582419355|FG002|Overall Study|Adverse Event|4|||
161068902|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
161068903|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
161068904|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
161068905|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
161068906|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
161068907|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
161068908|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
161068909|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
161284167|NCT01811472|582419353|FG000|Overall Study|Lost to Follow-up|0|||
161068910|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
161068911|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Missing|2|||
161068912|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Missing|1|||
161068913|NCT00443209|581641802|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
161068914|NCT00443209|581641803|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
161068915|NCT00443209|581641802|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
161068916|NCT00443209|581641803|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
161068917|NCT00443209|581641802|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
161068918|NCT00443209|581641803|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
161068919|NCT00443209|581641802|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
161068920|NCT00443209|581641803|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
161068921|NCT00443209|581641802|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
161068922|NCT00443209|581641803|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
161068923|NCT00443209|581641802|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
161068924|NCT00443209|581641803|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
161068925|NCT00443209|581641802|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
161068926|NCT00443209|581641803|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
161284168|NCT01811472|582419354|FG001|Overall Study|Lost to Follow-up|0|||
161284169|NCT01811472|582419355|FG002|Overall Study|Lost to Follow-up|1|||
161284170|NCT01811472|582419353|FG000|Overall Study|Subject/guardian decision|1|||
161284171|NCT01811472|582419354|FG001|Overall Study|Subject/guardian decision|0|||
161284172|NCT01811472|582419355|FG002|Overall Study|Subject/guardian decision|0|||
161284173|NCT01350271|582419364|FG000|Overall Study|Lost to Follow-up|21|||
161284174|NCT01350271|582419365|FG001|Overall Study|Lost to Follow-up|17|||
161284175|NCT01350271|582419366|FG002|Overall Study|Lost to Follow-up|26|||
161284176|NCT01973439|582419367|FG000|Overall Study|Lost samples from one PK Day|2|||
161284177|NCT01973439|582419367|FG000|Overall Study|Vomiting after commencing once daily|1|||
161284178|NCT01973439|582419367|FG000|Overall Study|PK curve incomplete|2|||
161284179|NCT00344448|582419368|FG000|Screening|Withdrawal by Subject|0|||
161284180|NCT00344448|582419369|FG001|Screening|Withdrawal by Subject|1|||
161284181|NCT00344448|582419368|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
161284182|NCT00344448|582419369|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
161284183|NCT00344448|582419368|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
161284184|NCT00344448|582419369|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
161284185|NCT00344448|582419368|FG000|Open Label|Withdrawal by Subject|1|||
161284186|NCT00344448|582419369|FG001|Open Label|Withdrawal by Subject|1|||
161284187|NCT00344448|582419368|FG000|Open Label|Study terminated|1|||
161284188|NCT00344448|582419369|FG001|Open Label|Study terminated|0|||
161284189|NCT03519087|582419372|FG000|Clinic Evaluation|Physician Decision|15|||
161284190|NCT03519087|582419373|FG001|Clinic Evaluation|Physician Decision|18|||
161284191|NCT03519087|582419374|FG002|Clinic Evaluation|Physician Decision|0|||
161284192|NCT03519087|582419375|FG003|Clinic Evaluation|Physician Decision|0|||
161284193|NCT03519087|582419376|FG004|Clinic Evaluation|Physician Decision|0|||
161284194|NCT03519087|582419372|FG000|Clinic Evaluation|Protocol Violation|1|||
161284195|NCT03519087|582419373|FG001|Clinic Evaluation|Protocol Violation|0|||
161284196|NCT03519087|582419374|FG002|Clinic Evaluation|Protocol Violation|0|||
161284197|NCT03519087|582419375|FG003|Clinic Evaluation|Protocol Violation|0|||
161284198|NCT03519087|582419376|FG004|Clinic Evaluation|Protocol Violation|0|||
161284199|NCT03519087|582419372|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
161284200|NCT03519087|582419373|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
161284201|NCT03519087|582419374|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
161284202|NCT03519087|582419375|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
161284203|NCT03519087|582419376|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
161284204|NCT03519087|582419372|FG000|Re-randomization for Treatment|Not appropriate|2|||
161284205|NCT03519087|582419373|FG001|Re-randomization for Treatment|Not appropriate|3|||
161284206|NCT03519087|582419374|FG002|Re-randomization for Treatment|Not appropriate|0|||
161284207|NCT03519087|582419375|FG003|Re-randomization for Treatment|Not appropriate|0|||
161284208|NCT03519087|582419376|FG004|Re-randomization for Treatment|Not appropriate|0|||
161284209|NCT03519087|582419372|FG000|Laboratory Testing|Lost to Follow-up|0|||
161284210|NCT03519087|582419373|FG001|Laboratory Testing|Lost to Follow-up|0|||
161284211|NCT03519087|582419374|FG002|Laboratory Testing|Lost to Follow-up|2|||
161284212|NCT03519087|582419375|FG003|Laboratory Testing|Lost to Follow-up|3|||
161284213|NCT03519087|582419376|FG004|Laboratory Testing|Lost to Follow-up|6|||
161284214|NCT03519087|582419372|FG000|Laboratory Testing|Protocol Violation|0|||
161284215|NCT03519087|582419373|FG001|Laboratory Testing|Protocol Violation|0|||
161284216|NCT03519087|582419374|FG002|Laboratory Testing|Protocol Violation|0|||
161284217|NCT03519087|582419375|FG003|Laboratory Testing|Protocol Violation|1|||
161284218|NCT03519087|582419376|FG004|Laboratory Testing|Protocol Violation|0|||
161284219|NCT01137071|582419377|FG000|Overall Study|Disease Progression|11|||
161284220|NCT01137071|582419377|FG000|Overall Study|Withdrawal by Subject|2|||
161284221|NCT01137071|582419377|FG000|Overall Study|Wrongly Included|1|||
161284222|NCT04807400|582419380|FG000|Overall Study|Adverse Event|2|||
161284223|NCT04807400|582419381|FG001|Overall Study|Adverse Event|3|||
161284224|NCT04807400|582419382|FG002|Overall Study|Adverse Event|3|||
161284225|NCT04807400|582419380|FG000|Overall Study|Death|2|||
161284226|NCT04807400|582419381|FG001|Overall Study|Death|0|||
161284227|NCT04807400|582419382|FG002|Overall Study|Death|0|||
161284228|NCT04807400|582419380|FG000|Overall Study|Lost to Follow-up|8|||
161284229|NCT04807400|582419381|FG001|Overall Study|Lost to Follow-up|6|||
161068927|NCT03513068|581641804|FG000|Overall Study|Death|1|||
161068928|NCT03513068|581641805|FG001|Overall Study|Death|0|||
161068929|NCT03513068|581641804|FG000|Overall Study|Withdrawal by Subject|4|||
161068930|NCT03513068|581641805|FG001|Overall Study|Withdrawal by Subject|6|||
161068931|NCT03636373|581641806|FG000|Overall Study|Study closure due to Covid-19|1|||
161068932|NCT03636373|581641807|FG001|Overall Study|Study closure due to Covid-19|0|||
161068933|NCT01236352|581641812|FG000|Overall Study|Death|0|||
161068934|NCT01236352|581641813|FG001|Overall Study|Death|0|||
161068935|NCT01236352|581641814|FG002|Overall Study|Death|0|||
161068936|NCT01236352|581641815|FG003|Overall Study|Death|0|||
161068937|NCT01236352|581641816|FG004|Overall Study|Death|0|||
161068938|NCT01236352|581641817|FG005|Overall Study|Death|0|||
161068939|NCT01236352|581641818|FG006|Overall Study|Death|0|||
161068940|NCT01236352|581641819|FG007|Overall Study|Death|1|||
161068941|NCT01236352|581641820|FG008|Overall Study|Death|0|||
161068942|NCT01236352|581641821|FG009|Overall Study|Death|0|||
161068943|NCT01236352|581641822|FG010|Overall Study|Death|0|||
161068944|NCT01236352|581641812|FG000|Overall Study|Withdrawal by Subject|0|||
161068945|NCT01236352|581641813|FG001|Overall Study|Withdrawal by Subject|0|||
161068946|NCT01236352|581641814|FG002|Overall Study|Withdrawal by Subject|0|||
161068947|NCT01236352|581641815|FG003|Overall Study|Withdrawal by Subject|0|||
161068948|NCT01236352|581641816|FG004|Overall Study|Withdrawal by Subject|0|||
161068949|NCT01236352|581641817|FG005|Overall Study|Withdrawal by Subject|0|||
161068950|NCT01236352|581641818|FG006|Overall Study|Withdrawal by Subject|0|||
161068951|NCT01236352|581641819|FG007|Overall Study|Withdrawal by Subject|0|||
161068952|NCT01236352|581641820|FG008|Overall Study|Withdrawal by Subject|0|||
161068953|NCT01236352|581641821|FG009|Overall Study|Withdrawal by Subject|2|||
161068954|NCT01236352|581641822|FG010|Overall Study|Withdrawal by Subject|1|||
161068955|NCT01236352|581641812|FG000|Overall Study|Adverse Event|0|||
161068956|NCT01236352|581641813|FG001|Overall Study|Adverse Event|0|||
161068957|NCT01236352|581641814|FG002|Overall Study|Adverse Event|0|||
161068958|NCT01236352|581641815|FG003|Overall Study|Adverse Event|0|||
161068959|NCT01236352|581641816|FG004|Overall Study|Adverse Event|0|||
161068960|NCT01236352|581641817|FG005|Overall Study|Adverse Event|0|||
161068961|NCT01236352|581641818|FG006|Overall Study|Adverse Event|2|||
161068962|NCT01236352|581641819|FG007|Overall Study|Adverse Event|0|||
161068963|NCT01236352|581641820|FG008|Overall Study|Adverse Event|0|||
161068964|NCT01236352|581641821|FG009|Overall Study|Adverse Event|4|||
161068965|NCT01236352|581641822|FG010|Overall Study|Adverse Event|1|||
161068966|NCT01236352|581641812|FG000|Overall Study|Study drug toxicity|0|||
161068967|NCT01236352|581641813|FG001|Overall Study|Study drug toxicity|0|||
161068968|NCT01236352|581641814|FG002|Overall Study|Study drug toxicity|0|||
161068969|NCT01236352|581641815|FG003|Overall Study|Study drug toxicity|0|||
161068970|NCT01236352|581641816|FG004|Overall Study|Study drug toxicity|0|||
161068971|NCT01236352|581641817|FG005|Overall Study|Study drug toxicity|1|||
161068972|NCT01236352|581641818|FG006|Overall Study|Study drug toxicity|1|||
161068973|NCT01236352|581641819|FG007|Overall Study|Study drug toxicity|0|||
161068974|NCT01236352|581641820|FG008|Overall Study|Study drug toxicity|0|||
161068975|NCT01236352|581641821|FG009|Overall Study|Study drug toxicity|2|||
161068976|NCT01236352|581641822|FG010|Overall Study|Study drug toxicity|2|||
161068977|NCT01236352|581641812|FG000|Overall Study|Disease progression|1|||
161068978|NCT01236352|581641813|FG001|Overall Study|Disease progression|2|||
161068979|NCT01236352|581641814|FG002|Overall Study|Disease progression|1|||
161068980|NCT01236352|581641815|FG003|Overall Study|Disease progression|2|||
161068981|NCT01236352|581641816|FG004|Overall Study|Disease progression|2|||
161068982|NCT01236352|581641817|FG005|Overall Study|Disease progression|2|||
161068983|NCT01236352|581641818|FG006|Overall Study|Disease progression|1|||
161068984|NCT01236352|581641819|FG007|Overall Study|Disease progression|3|||
161068985|NCT01236352|581641820|FG008|Overall Study|Disease progression|2|||
161068986|NCT01236352|581641821|FG009|Overall Study|Disease progression|2|||
161068987|NCT01236352|581641822|FG010|Overall Study|Disease progression|2|||
161068988|NCT01236352|581641812|FG000|Overall Study|Poor/Non-compliance|1|||
161284230|NCT04807400|582419382|FG002|Overall Study|Lost to Follow-up|6|||
161284231|NCT04807400|582419380|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161284232|NCT04807400|582419381|FG001|Overall Study|Non-Compliance With Study Drug|4|||
161068989|NCT01236352|581641813|FG001|Overall Study|Poor/Non-compliance|0|||
161068990|NCT01236352|581641814|FG002|Overall Study|Poor/Non-compliance|0|||
161068991|NCT01236352|581641815|FG003|Overall Study|Poor/Non-compliance|0|||
161068992|NCT01236352|581641816|FG004|Overall Study|Poor/Non-compliance|0|||
161068993|NCT01236352|581641817|FG005|Overall Study|Poor/Non-compliance|0|||
161068994|NCT01236352|581641818|FG006|Overall Study|Poor/Non-compliance|0|||
161068995|NCT01236352|581641819|FG007|Overall Study|Poor/Non-compliance|0|||
161068996|NCT01236352|581641820|FG008|Overall Study|Poor/Non-compliance|0|||
161284233|NCT04807400|582419382|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161284234|NCT04807400|582419380|FG000|Overall Study|Participant Decision|20|||
161284235|NCT04807400|582419381|FG001|Overall Study|Participant Decision|19|||
161284236|NCT04807400|582419382|FG002|Overall Study|Participant Decision|26|||
161284237|NCT04807400|582419380|FG000|Overall Study|Physician Decision|0|||
161284238|NCT04807400|582419381|FG001|Overall Study|Physician Decision|1|||
161284239|NCT04807400|582419382|FG002|Overall Study|Physician Decision|0|||
161284240|NCT04807400|582419380|FG000|Overall Study|Protocol Violation|4|||
161284241|NCT04807400|582419381|FG001|Overall Study|Protocol Violation|3|||
161284242|NCT04807400|582419382|FG002|Overall Study|Protocol Violation|7|||
161284243|NCT04807400|582419380|FG000|Overall Study|Withdrawal by Subject|13|||
161284244|NCT04807400|582419381|FG001|Overall Study|Withdrawal by Subject|9|||
161284245|NCT04807400|582419382|FG002|Overall Study|Withdrawal by Subject|20|||
161284246|NCT04807400|582419380|FG000|Overall Study|Mis-randomized|1|||
161284247|NCT04807400|582419381|FG001|Overall Study|Mis-randomized|0|||
161284248|NCT04807400|582419382|FG002|Overall Study|Mis-randomized|0|||
161284249|NCT04194645|582419383|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284250|NCT04194645|582419384|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161068997|NCT01236352|581641821|FG009|Overall Study|Poor/Non-compliance|0|||
161068998|NCT01236352|581641822|FG010|Overall Study|Poor/Non-compliance|0|||
161068999|NCT01236352|581641812|FG000|Overall Study|Maximum clinical benefit|1|||
161069000|NCT01236352|581641813|FG001|Overall Study|Maximum clinical benefit|1|||
161069001|NCT01236352|581641814|FG002|Overall Study|Maximum clinical benefit|1|||
161069002|NCT01236352|581641815|FG003|Overall Study|Maximum clinical benefit|0|||
161069003|NCT01236352|581641816|FG004|Overall Study|Maximum clinical benefit|2|||
161069004|NCT01236352|581641817|FG005|Overall Study|Maximum clinical benefit|0|||
161069005|NCT01236352|581641818|FG006|Overall Study|Maximum clinical benefit|3|||
161069006|NCT01236352|581641819|FG007|Overall Study|Maximum clinical benefit|1|||
161069007|NCT01236352|581641820|FG008|Overall Study|Maximum clinical benefit|1|||
161069008|NCT01236352|581641821|FG009|Overall Study|Maximum clinical benefit|4|||
161069009|NCT01236352|581641822|FG010|Overall Study|Maximum clinical benefit|2|||
161069010|NCT01236352|581641812|FG000|Overall Study|Subject request to discontinue treatment|0|||
161069011|NCT01236352|581641813|FG001|Overall Study|Subject request to discontinue treatment|0|||
161069012|NCT01236352|581641814|FG002|Overall Study|Subject request to discontinue treatment|1|||
161069013|NCT01236352|581641815|FG003|Overall Study|Subject request to discontinue treatment|1|||
161069014|NCT01236352|581641816|FG004|Overall Study|Subject request to discontinue treatment|0|||
161069015|NCT01236352|581641817|FG005|Overall Study|Subject request to discontinue treatment|1|||
161069016|NCT01236352|581641818|FG006|Overall Study|Subject request to discontinue treatment|0|||
161069017|NCT01236352|581641819|FG007|Overall Study|Subject request to discontinue treatment|0|||
161069018|NCT01236352|581641820|FG008|Overall Study|Subject request to discontinue treatment|0|||
161069019|NCT01236352|581641821|FG009|Overall Study|Subject request to discontinue treatment|1|||
161069020|NCT01236352|581641822|FG010|Overall Study|Subject request to discontinue treatment|4|||
161069021|NCT01236352|581641812|FG000|Overall Study|Subject to receive drug via EAP|1|||
161069022|NCT01236352|581641813|FG001|Overall Study|Subject to receive drug via EAP|1|||
161069023|NCT01236352|581641814|FG002|Overall Study|Subject to receive drug via EAP|1|||
161069024|NCT01236352|581641815|FG003|Overall Study|Subject to receive drug via EAP|0|||
161069025|NCT01236352|581641816|FG004|Overall Study|Subject to receive drug via EAP|0|||
161069026|NCT01236352|581641817|FG005|Overall Study|Subject to receive drug via EAP|0|||
161069027|NCT01236352|581641818|FG006|Overall Study|Subject to receive drug via EAP|0|||
161069028|NCT01236352|581641819|FG007|Overall Study|Subject to receive drug via EAP|2|||
161069029|NCT01236352|581641820|FG008|Overall Study|Subject to receive drug via EAP|0|||
161069030|NCT01236352|581641821|FG009|Overall Study|Subject to receive drug via EAP|4|||
161069031|NCT01236352|581641822|FG010|Overall Study|Subject to receive drug via EAP|0|||
161069032|NCT01236352|581641812|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
161069033|NCT01236352|581641813|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
161069034|NCT01236352|581641814|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
161069035|NCT01236352|581641815|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
161069036|NCT01236352|581641816|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
161069037|NCT01236352|581641817|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
161069038|NCT01236352|581641818|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
161069039|NCT01236352|581641819|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
161069040|NCT01236352|581641820|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
161069041|NCT01236352|581641821|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
161069042|NCT01236352|581641822|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
161069043|NCT01236352|581641812|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069044|NCT01236352|581641813|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069045|NCT01236352|581641814|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161155693|NCT03249792|581951180|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
161284251|NCT04194645|582419385|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284252|NCT04194645|582419386|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284253|NCT04194645|582419387|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284254|NCT04194645|582419388|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284255|NCT04194645|582419389|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161069046|NCT01236352|581641815|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069047|NCT01236352|581641816|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069048|NCT01236352|581641817|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069049|NCT01236352|581641818|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069050|NCT01236352|581641819|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069051|NCT01236352|581641820|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069052|NCT01236352|581641821|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
161069053|NCT01236352|581641822|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
161069054|NCT01236352|581641812|FG000|Overall Study|Lack of response to drug|0|||
161069055|NCT01236352|581641813|FG001|Overall Study|Lack of response to drug|0|||
161069056|NCT01236352|581641814|FG002|Overall Study|Lack of response to drug|0|||
161069057|NCT01236352|581641815|FG003|Overall Study|Lack of response to drug|0|||
161069058|NCT01236352|581641816|FG004|Overall Study|Lack of response to drug|0|||
161069059|NCT01236352|581641817|FG005|Overall Study|Lack of response to drug|0|||
161069060|NCT01236352|581641818|FG006|Overall Study|Lack of response to drug|0|||
161069061|NCT01236352|581641819|FG007|Overall Study|Lack of response to drug|0|||
161069062|NCT01236352|581641820|FG008|Overall Study|Lack of response to drug|0|||
161069063|NCT01236352|581641821|FG009|Overall Study|Lack of response to drug|1|||
161069064|NCT01236352|581641822|FG010|Overall Study|Lack of response to drug|1|||
161069065|NCT01236352|581641812|FG000|Overall Study|Patient transferred to IST|0|||
161069066|NCT01236352|581641813|FG001|Overall Study|Patient transferred to IST|0|||
161069067|NCT01236352|581641814|FG002|Overall Study|Patient transferred to IST|0|||
161069068|NCT01236352|581641815|FG003|Overall Study|Patient transferred to IST|0|||
161069069|NCT01236352|581641816|FG004|Overall Study|Patient transferred to IST|0|||
161069070|NCT01236352|581641817|FG005|Overall Study|Patient transferred to IST|0|||
161069071|NCT01236352|581641818|FG006|Overall Study|Patient transferred to IST|0|||
161069072|NCT01236352|581641819|FG007|Overall Study|Patient transferred to IST|0|||
161069073|NCT01236352|581641820|FG008|Overall Study|Patient transferred to IST|0|||
161069074|NCT01236352|581641821|FG009|Overall Study|Patient transferred to IST|2|||
161069075|NCT01236352|581641822|FG010|Overall Study|Patient transferred to IST|6|||
161069076|NCT01575873|581641823|FG000|Overall Study|Withdrawal by Subject|15|||
161069077|NCT01575873|581641824|FG001|Overall Study|Withdrawal by Subject|20|||
161069078|NCT01575873|581641825|FG002|Overall Study|Withdrawal by Subject|34|||
161069079|NCT01575873|581641826|FG003|Overall Study|Withdrawal by Subject|34|||
161069080|NCT01575873|581641823|FG000|Overall Study|Adverse Event|7|||
161069081|NCT01575873|581641824|FG001|Overall Study|Adverse Event|7|||
161069082|NCT01575873|581641825|FG002|Overall Study|Adverse Event|9|||
161069083|NCT01575873|581641826|FG003|Overall Study|Adverse Event|12|||
161069084|NCT01575873|581641823|FG000|Overall Study|Lost to Follow-up|1|||
161069085|NCT01575873|581641824|FG001|Overall Study|Lost to Follow-up|3|||
161069086|NCT01575873|581641825|FG002|Overall Study|Lost to Follow-up|13|||
161069087|NCT01575873|581641826|FG003|Overall Study|Lost to Follow-up|5|||
161069088|NCT01575873|581641823|FG000|Overall Study|Death|3|||
161069089|NCT01575873|581641824|FG001|Overall Study|Death|2|||
161069090|NCT01575873|581641825|FG002|Overall Study|Death|8|||
161069091|NCT01575873|581641826|FG003|Overall Study|Death|9|||
161069092|NCT01575873|581641823|FG000|Overall Study|Noncompliance|1|||
161069093|NCT01575873|581641824|FG001|Overall Study|Noncompliance|2|||
161069094|NCT01575873|581641825|FG002|Overall Study|Noncompliance|4|||
161069095|NCT01575873|581641826|FG003|Overall Study|Noncompliance|3|||
161069096|NCT01575873|581641823|FG000|Overall Study|Administrative decision|1|||
161069097|NCT01575873|581641824|FG001|Overall Study|Administrative decision|1|||
161069098|NCT01575873|581641825|FG002|Overall Study|Administrative decision|1|||
161069099|NCT01575873|581641826|FG003|Overall Study|Administrative decision|0|||
161069100|NCT01575873|581641823|FG000|Overall Study|Protocol deviation|0|||
161069101|NCT01575873|581641824|FG001|Overall Study|Protocol deviation|1|||
161069102|NCT01575873|581641825|FG002|Overall Study|Protocol deviation|0|||
161069103|NCT01575873|581641826|FG003|Overall Study|Protocol deviation|1|||
161069104|NCT01575873|581641823|FG000|Overall Study|Requirement for Alternative Therapy|0|||
161284256|NCT04194645|582419390|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284257|NCT04194645|582419391|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284258|NCT04194645|582419392|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
161069105|NCT01575873|581641824|FG001|Overall Study|Requirement for Alternative Therapy|0|||
161069106|NCT01575873|581641825|FG002|Overall Study|Requirement for Alternative Therapy|1|||
161069107|NCT01575873|581641826|FG003|Overall Study|Requirement for Alternative Therapy|1|||
161284259|NCT04194645|582419393|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284260|NCT04194645|582419394|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161069108|NCT01575873|581641823|FG000|Overall Study|Other|0|||
161069109|NCT01575873|581641824|FG001|Overall Study|Other|0|||
161069110|NCT01575873|581641825|FG002|Overall Study|Other|4|||
161069111|NCT01575873|581641826|FG003|Overall Study|Other|2|||
161069112|NCT01850030|581641827|FG000|Overall Study|Adverse Event|64|||
161069113|NCT01850030|581641828|FG001|Overall Study|Adverse Event|82|||
161069114|NCT01850030|581641827|FG000|Overall Study|Lack of Efficacy|3|||
161069115|NCT01850030|581641828|FG001|Overall Study|Lack of Efficacy|1|||
161069116|NCT01850030|581641827|FG000|Overall Study|Lost to Follow-up|5|||
161284261|NCT04194645|582419395|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284262|NCT04194645|582419396|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161284263|NCT04194645|582419397|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
161069117|NCT01850030|581641828|FG001|Overall Study|Lost to Follow-up|5|||
161069118|NCT01850030|581641827|FG000|Overall Study|Withdrawal by Subject|3|||
161069119|NCT01850030|581641828|FG001|Overall Study|Withdrawal by Subject|4|||
161069120|NCT01850030|581641827|FG000|Overall Study|Protocol Violation|24|||
161069121|NCT01850030|581641828|FG001|Overall Study|Protocol Violation|28|||
161069122|NCT01850030|581641827|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
161069123|NCT01850030|581641828|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
161069124|NCT00246090|581641829|FG000|Overall Study|Adverse Event|25|||
161069125|NCT00246090|581641829|FG000|Overall Study|Withdrawal by Subject|7|||
161069126|NCT00246090|581641829|FG000|Overall Study|Progressive Disease|212|||
161069127|NCT00246090|581641829|FG000|Overall Study|Clinical Progression|30|||
161069128|NCT00246090|581641829|FG000|Overall Study|Physician Decision|11|||
161069129|NCT00246090|581641829|FG000|Overall Study|Not Otherwise Specified|10|||
161069130|NCT03332784|581641832|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069131|NCT03332784|581641833|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
161069132|NCT03332784|581641834|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069133|NCT03332784|581641835|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069134|NCT03332784|581641836|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069135|NCT03332784|581641837|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069136|NCT03332784|581641838|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069137|NCT03332784|581641839|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069138|NCT03332784|581641840|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069139|NCT03332784|581641841|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069140|NCT03332784|581641842|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069141|NCT03332784|581641843|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069142|NCT03332784|581641844|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069143|NCT03332784|581641845|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069144|NCT03332784|581641846|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
161069145|NCT03332784|581641847|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069146|NCT03332784|581641848|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069147|NCT03332784|581641849|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069148|NCT03332784|581641850|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069149|NCT03332784|581641851|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
161069150|NCT00763451|581641857|FG000|Overall Study|Adverse Event|4|||
161069151|NCT00763451|581641858|FG001|Overall Study|Adverse Event|6|||
161069152|NCT00763451|581641859|FG002|Overall Study|Adverse Event|19|||
161069153|NCT00763451|581641860|FG003|Overall Study|Adverse Event|14|||
161069154|NCT00763451|581641857|FG000|Overall Study|Lack of Efficacy|1|||
161069155|NCT00763451|581641858|FG001|Overall Study|Lack of Efficacy|4|||
161069156|NCT00763451|581641859|FG002|Overall Study|Lack of Efficacy|3|||
161069157|NCT00763451|581641860|FG003|Overall Study|Lack of Efficacy|2|||
161069158|NCT00763451|581641857|FG000|Overall Study|Withdrawal by Subject|1|||
161069159|NCT00763451|581641858|FG001|Overall Study|Withdrawal by Subject|6|||
161069160|NCT00763451|581641859|FG002|Overall Study|Withdrawal by Subject|9|||
161069161|NCT00763451|581641860|FG003|Overall Study|Withdrawal by Subject|7|||
161069162|NCT00763451|581641857|FG000|Overall Study|Protocol Violation|0|||
161069163|NCT00763451|581641858|FG001|Overall Study|Protocol Violation|0|||
161069164|NCT00763451|581641859|FG002|Overall Study|Protocol Violation|1|||
161069165|NCT00763451|581641860|FG003|Overall Study|Protocol Violation|0|||
161069166|NCT00763451|581641857|FG000|Overall Study|Poor Compliance to Protocol|1|||
161069167|NCT00763451|581641858|FG001|Overall Study|Poor Compliance to Protocol|1|||
161069168|NCT00763451|581641859|FG002|Overall Study|Poor Compliance to Protocol|2|||
161069169|NCT00763451|581641860|FG003|Overall Study|Poor Compliance to Protocol|2|||
161069170|NCT00763451|581641857|FG000|Overall Study|Familial and Personal Reasons|5|||
161069171|NCT00763451|581641858|FG001|Overall Study|Familial and Personal Reasons|3|||
161069172|NCT00763451|581641859|FG002|Overall Study|Familial and Personal Reasons|5|||
161069173|NCT00763451|581641860|FG003|Overall Study|Familial and Personal Reasons|4|||
161069174|NCT00763451|581641857|FG000|Overall Study|Randomized but not Treated|1|||
161069175|NCT00763451|581641858|FG001|Overall Study|Randomized but not Treated|1|||
161069176|NCT00763451|581641859|FG002|Overall Study|Randomized but not Treated|0|||
161069177|NCT00763451|581641860|FG003|Overall Study|Randomized but not Treated|0|||
161069178|NCT00763451|581641857|FG000|Overall Study|Study Site Reason|0|||
161069179|NCT00763451|581641858|FG001|Overall Study|Study Site Reason|1|||
161284264|NCT03656744|582419398|FG000|Overall Study|Adverse Event|1|||
161069180|NCT00763451|581641859|FG002|Overall Study|Study Site Reason|1|||
161069181|NCT00763451|581641860|FG003|Overall Study|Study Site Reason|1|||
161069182|NCT02282917|581641863|FG000|Overall Study|Withdrawal by Subject|1|||
161069183|NCT02282917|581641863|FG000|Overall Study|Screen Failure/Not Eligible|1|||
161069184|NCT00115336|581641864|FG000|Overall Study|Hospital discharge before study drug|0|||
161069185|NCT00115336|581641865|FG001|Overall Study|Hospital discharge before study drug|1|||
161069186|NCT00569127|581641874|FG000|Overall Study|Adverse Event|57|||
161069187|NCT00569127|581641875|FG001|Overall Study|Adverse Event|47|||
161069188|NCT00569127|581641874|FG000|Overall Study|Withdrawal by Subject|13|||
161069189|NCT00569127|581641875|FG001|Overall Study|Withdrawal by Subject|27|||
161069190|NCT00569127|581641874|FG000|Overall Study|Progression|99|||
161069191|NCT00569127|581641875|FG001|Overall Study|Progression|100|||
161069192|NCT00569127|581641874|FG000|Overall Study|Death|4|||
161069193|NCT00569127|581641875|FG001|Overall Study|Death|3|||
161069194|NCT00569127|581641874|FG000|Overall Study|Other|20|||
161069195|NCT00569127|581641875|FG001|Overall Study|Other|19|||
161069196|NCT00569127|581641874|FG000|Overall Study|Lost to Follow-up|0|||
161069197|NCT00569127|581641875|FG001|Overall Study|Lost to Follow-up|3|||
161069198|NCT00569127|581641874|FG000|Overall Study|Not Eligible|14|||
161069199|NCT00569127|581641875|FG001|Overall Study|Not Eligible|11|||
161069200|NCT00569127|581641874|FG000|Overall Study|Still on Treatment|7|||
161069201|NCT00569127|581641875|FG001|Overall Study|Still on Treatment|3|||
161069202|NCT03149029|581641890|FG000|Overall Study|Adverse Event|2|||
161069203|NCT03149029|581641891|FG001|Overall Study|Adverse Event|0|||
161069204|NCT00356811|581641892|FG000|Overall Study|Death|35|||
161069205|NCT00356811|581641892|FG000|Overall Study|Lost to Follow-up|2|||
161069206|NCT00356811|581641892|FG000|Overall Study|Withdrawal by Subject|6|||
161069207|NCT00356811|581641892|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
161069208|NCT00356811|581641892|FG000|Overall Study|Study Is Terminating|3|||
161069209|NCT00356811|581641892|FG000|Overall Study|Site Closed during Follow-up|2|||
161069210|NCT01310699|581641893|FG000|Overall Study|Patients did not complete tandem.|4|||
161069211|NCT01310699|581641894|FG001|Overall Study|Patients did not complete tandem.|6|||
161069212|NCT02386839|581641895|FG000|Overall Study|Death|1|||
161069213|NCT02386839|581641896|FG001|Overall Study|Death|0|||
161069214|NCT02386839|581641895|FG000|Overall Study|Withdrawal by Subject|9|||
161069215|NCT02386839|581641896|FG001|Overall Study|Withdrawal by Subject|10|||
161069216|NCT02386839|581641895|FG000|Overall Study|Lost to Follow-up|4|||
161069217|NCT02386839|581641896|FG001|Overall Study|Lost to Follow-up|4|||
161069218|NCT02386839|581641895|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
161069219|NCT02386839|581641896|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
161069220|NCT02386839|581641895|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
161069221|NCT02386839|581641896|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
161069222|NCT02386839|581641895|FG000|Overall Study|Other (unspecified)|1|||
161069223|NCT02386839|581641896|FG001|Overall Study|Other (unspecified)|0|||
161069224|NCT00926575|581641897|FG000|Overall Study|Adverse Event|1|||
161069225|NCT00926575|581641898|FG001|Overall Study|Adverse Event|1|||
161069226|NCT00926575|581641897|FG000|Overall Study|Death|4|||
161069227|NCT00926575|581641898|FG001|Overall Study|Death|4|||
161069228|NCT00926575|581641897|FG000|Overall Study|Lost to Follow-up|1|||
161069229|NCT00926575|581641898|FG001|Overall Study|Lost to Follow-up|1|||
161069230|NCT00926575|581641897|FG000|Overall Study|Physician Decision|1|||
161069231|NCT00926575|581641898|FG001|Overall Study|Physician Decision|2|||
161069232|NCT00926575|581641897|FG000|Overall Study|Protocol Violation|1|||
161069233|NCT00926575|581641898|FG001|Overall Study|Protocol Violation|0|||
161069234|NCT00926575|581641897|FG000|Overall Study|Withdrawal by Subject|8|||
161069235|NCT00926575|581641898|FG001|Overall Study|Withdrawal by Subject|9|||
161069236|NCT00490698|581641899|FG000|Overall Study|Withdrawal by Subject|1|||
161069237|NCT00490698|581641899|FG000|Overall Study|Disease Progression|7|||
161069238|NCT00490698|581641899|FG000|Overall Study|Physician Decision|2|||
161069239|NCT02101983|581641900|FG000|Overall Study|Physician Decision|1|||
161069240|NCT02101983|581641901|FG001|Overall Study|Physician Decision|0|||
161069241|NCT03725605|581641906|FG000|Overall Study|Unsuccessful TIL expansion|2|||
161069242|NCT00469859|581641907|FG000|Overall Study|Inevaluable|0|||
161069243|NCT00469859|581641908|FG001|Overall Study|Inevaluable|2|||
161069244|NCT04124471|581641909|FG000|Overall Study|screen failure|1|||
161069245|NCT01503086|581641910|FG000|Overall Study|Lost to Follow-up|0|||
161069246|NCT01503086|581641911|FG001|Overall Study|Lost to Follow-up|1|||
161069247|NCT01503086|581641912|FG002|Overall Study|Lost to Follow-up|0|||
161069248|NCT01503086|581641910|FG000|Overall Study|Did Not Start Treatment|4|||
161069249|NCT01503086|581641911|FG001|Overall Study|Did Not Start Treatment|3|||
161069250|NCT01503086|581641912|FG002|Overall Study|Did Not Start Treatment|3|||
161069251|NCT01503086|581641910|FG000|Overall Study|Progressive disease|3|||
161069252|NCT01503086|581641911|FG001|Overall Study|Progressive disease|1|||
161069253|NCT01503086|581641912|FG002|Overall Study|Progressive disease|0|||
161069254|NCT01503086|581641910|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
161069255|NCT01503086|581641911|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
161069256|NCT01503086|581641912|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
161069257|NCT01503086|581641910|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
161069258|NCT01503086|581641911|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
161069259|NCT01503086|581641912|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
161069260|NCT05970640|581641915|FG000|Overall Study|Adverse Event|1|||
161069261|NCT05970640|581641916|FG001|Overall Study|Adverse Event|3|||
161069262|NCT05970640|581641917|FG002|Overall Study|Adverse Event|1|||
161069263|NCT05970640|581641918|FG003|Overall Study|Adverse Event|0|||
161069264|NCT05970640|581641915|FG000|Overall Study|Withdrawal by Subject|0|||
161069265|NCT05970640|581641916|FG001|Overall Study|Withdrawal by Subject|0|||
161069266|NCT05970640|581641917|FG002|Overall Study|Withdrawal by Subject|1|||
161069267|NCT05970640|581641918|FG003|Overall Study|Withdrawal by Subject|1|||
161069268|NCT05970640|581641915|FG000|Overall Study|Sponsor decision|0|||
161069269|NCT05970640|581641916|FG001|Overall Study|Sponsor decision|0|||
161284265|NCT03656744|582419399|FG001|Overall Study|Adverse Event|4|||
161284266|NCT03656744|582419400|FG002|Overall Study|Adverse Event|1|||
161284267|NCT03656744|582419398|FG000|Overall Study|Protocol Violation|1|||
161284268|NCT03656744|582419399|FG001|Overall Study|Protocol Violation|0|||
161284269|NCT03656744|582419400|FG002|Overall Study|Protocol Violation|0|||
161284270|NCT03656744|582419398|FG000|Overall Study|Lost to Follow-up|2|||
161284271|NCT03656744|582419399|FG001|Overall Study|Lost to Follow-up|2|||
161284272|NCT03656744|582419400|FG002|Overall Study|Lost to Follow-up|0|||
161284273|NCT03656744|582419398|FG000|Overall Study|Withdrawal by Subject|0|||
161284274|NCT03656744|582419399|FG001|Overall Study|Withdrawal by Subject|1|||
161284275|NCT03656744|582419400|FG002|Overall Study|Withdrawal by Subject|0|||
161284276|NCT03656744|582419398|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
161284277|NCT03656744|582419399|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
161284278|NCT03656744|582419400|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
161284279|NCT03076775|582419401|FG000|Overall Study|Lost to Follow-up|1|||
161284280|NCT03076775|582419402|FG001|Overall Study|Lost to Follow-up|0|||
161284281|NCT01783886|582419403|FG000|Overall Study|Lost to Follow-up|0|||
161284282|NCT01783886|582419404|FG001|Overall Study|Lost to Follow-up|3|||
161284283|NCT01783886|582419405|FG002|Overall Study|Lost to Follow-up|0|||
161284284|NCT01783886|582419403|FG000|Overall Study|Protocol deviation|0|||
161284285|NCT01783886|582419404|FG001|Overall Study|Protocol deviation|0|||
161284286|NCT01783886|582419405|FG002|Overall Study|Protocol deviation|2|||
161284287|NCT01783886|582419403|FG000|Overall Study|Withdrawal of consent by participant|1|||
161284288|NCT01783886|582419404|FG001|Overall Study|Withdrawal of consent by participant|3|||
161284289|NCT01783886|582419405|FG002|Overall Study|Withdrawal of consent by participant|4|||
161284290|NCT01783886|582419403|FG000|Overall Study|Adverse Event|4|||
161069270|NCT05970640|581641917|FG002|Overall Study|Sponsor decision|1|||
161069271|NCT05970640|581641918|FG003|Overall Study|Sponsor decision|1|||
161069272|NCT02394925|581641919|FG000|Overall Study|Adverse Event|1|||
161069273|NCT02394925|581641919|FG000|Overall Study|Lens Discomfort|3|||
161069274|NCT02394925|581641919|FG000|Overall Study|Lens handling difficulities|5|||
161069275|NCT02394925|581641919|FG000|Overall Study|Lost to Follow-up|9|||
161069276|NCT02394925|581641919|FG000|Overall Study|Protocol Violation|5|||
161069277|NCT02394925|581641919|FG000|Overall Study|No longer meet eligibility criteria|1|||
161069278|NCT02394925|581641919|FG000|Overall Study|Unsatisfactory Visual Response|5|||
161069279|NCT02358668|581643379|FG000|Overall Study|Adverse Event|2|||
161069280|NCT02358668|581643380|FG001|Overall Study|Adverse Event|0|||
161069281|NCT02358668|581643381|FG002|Overall Study|Adverse Event|0|||
161069282|NCT02358668|581643379|FG000|Overall Study|Withdrawal by Subject|0|||
161069283|NCT02358668|581643380|FG001|Overall Study|Withdrawal by Subject|1|||
161069284|NCT02358668|581643381|FG002|Overall Study|Withdrawal by Subject|0|||
161069285|NCT02104505|581643382|FG000|First Intervention (14 Days)|Adverse Event|2|||
161069286|NCT02104505|581643383|FG001|First Intervention (14 Days)|Adverse Event|0|||
161069287|NCT02104505|581643382|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
161069288|NCT02104505|581643383|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
161069289|NCT02104505|581643382|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
161069290|NCT02104505|581643383|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
161069291|NCT02104505|581643382|FG000|First Intervention (14 Days)|exclusionary condition|0|||
161069292|NCT02104505|581643383|FG001|First Intervention (14 Days)|exclusionary condition|1|||
161069293|NCT02104505|581643382|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
161069294|NCT02104505|581643383|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
161069295|NCT02104505|581643382|FG000|Second Intervention (14 Days)|Adverse Event|2|||
161069296|NCT02104505|581643383|FG001|Second Intervention (14 Days)|Adverse Event|0|||
161069297|NCT01240551|581643384|FG000|Overall Study|Refused further treatment|3|||
161284291|NCT01783886|582419404|FG001|Overall Study|Adverse Event|5|||
161284292|NCT01783886|582419405|FG002|Overall Study|Adverse Event|4|||
161284293|NCT00940316|582419406|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
161284294|NCT00940316|582419407|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
161284295|NCT00940316|582419408|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
161069298|NCT01240551|581643385|FG001|Overall Study|Refused further treatment|2|||
161069299|NCT01240551|581643384|FG000|Overall Study|Lost to Follow-up|1|||
161069300|NCT01240551|581643385|FG001|Overall Study|Lost to Follow-up|1|||
161069301|NCT01730950|581643388|FG000|Overall Study|Protocol Violation|6|||
161069302|NCT01730950|581643389|FG001|Overall Study|Protocol Violation|6|||
161284296|NCT00940316|582419406|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
161069303|NCT02737826|581643390|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
161069304|NCT02737826|581643391|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
161069305|NCT02737826|581643392|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
161284297|NCT00940316|582419407|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
161284298|NCT00940316|582419408|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
161284299|NCT00940316|582419406|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
161284300|NCT00940316|582419407|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
161284301|NCT00940316|582419408|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
161284302|NCT00940316|582419406|FG000|Treated After Cycle 5|Adverse Event|0|||
161284303|NCT00940316|582419407|FG001|Treated After Cycle 5|Adverse Event|0|||
161284304|NCT00940316|582419408|FG002|Treated After Cycle 5|Adverse Event|1|||
161284305|NCT00940316|582419406|FG000|Treated After Cycle 5|Progressive disease|0|||
161284306|NCT00940316|582419407|FG001|Treated After Cycle 5|Progressive disease|1|||
161284307|NCT00940316|582419408|FG002|Treated After Cycle 5|Progressive disease|0|||
161284308|NCT02290405|582419409|FG000|Overall Study|Withdrawal by Subject|1|||
161284309|NCT02290405|582419410|FG001|Overall Study|Withdrawal by Subject|0|||
161284310|NCT00996489|582419411|FG000|Overall Study|Device failure|45|||
161284311|NCT00996489|582419411|FG000|Overall Study|Discontinued|116|||
161284312|NCT03142191|582419412|FG000|Placebo Controlled Period|Death|0|||
161284313|NCT03142191|582419413|FG001|Placebo Controlled Period|Death|1|||
161284314|NCT03142191|582419414|FG002|Placebo Controlled Period|Death|1|||
161284315|NCT03142191|582419415|FG003|Placebo Controlled Period|Death|0|||
161284316|NCT03142191|582419416|FG004|Placebo Controlled Period|Death|0|||
161284317|NCT03142191|582419412|FG000|Placebo Controlled Period|Adverse Event|4|||
161284318|NCT03142191|582419413|FG001|Placebo Controlled Period|Adverse Event|5|||
161284319|NCT03142191|582419414|FG002|Placebo Controlled Period|Adverse Event|1|||
161284320|NCT03142191|582419415|FG003|Placebo Controlled Period|Adverse Event|0|||
161284321|NCT03142191|582419416|FG004|Placebo Controlled Period|Adverse Event|0|||
161284322|NCT03142191|582419412|FG000|Placebo Controlled Period|Progressive Disease|1|||
161284323|NCT03142191|582419413|FG001|Placebo Controlled Period|Progressive Disease|0|||
161284324|NCT03142191|582419414|FG002|Placebo Controlled Period|Progressive Disease|1|||
161284325|NCT03142191|582419415|FG003|Placebo Controlled Period|Progressive Disease|0|||
161284326|NCT03142191|582419416|FG004|Placebo Controlled Period|Progressive Disease|0|||
161284327|NCT03142191|582419412|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
161284328|NCT03142191|582419413|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
161284329|NCT03142191|582419414|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
161284330|NCT03142191|582419415|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
161284331|NCT03142191|582419416|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
161284332|NCT03142191|582419412|FG000|Placebo Controlled Period|Other Reasons|1|||
161284333|NCT03142191|582419413|FG001|Placebo Controlled Period|Other Reasons|0|||
161284334|NCT03142191|582419414|FG002|Placebo Controlled Period|Other Reasons|0|||
161284335|NCT03142191|582419415|FG003|Placebo Controlled Period|Other Reasons|0|||
161284336|NCT03142191|582419416|FG004|Placebo Controlled Period|Other Reasons|0|||
161284337|NCT03142191|582419412|FG000|Active Treatment Extension Period|Death|2|||
161284338|NCT03142191|582419413|FG001|Active Treatment Extension Period|Death|1|||
161284339|NCT03142191|582419414|FG002|Active Treatment Extension Period|Death|1|||
161284340|NCT03142191|582419415|FG003|Active Treatment Extension Period|Death|1|||
161284341|NCT03142191|582419416|FG004|Active Treatment Extension Period|Death|0|||
161284342|NCT03142191|582419412|FG000|Active Treatment Extension Period|Adverse Event|6|||
161284343|NCT03142191|582419413|FG001|Active Treatment Extension Period|Adverse Event|5|||
161284344|NCT03142191|582419414|FG002|Active Treatment Extension Period|Adverse Event|4|||
161284345|NCT03142191|582419415|FG003|Active Treatment Extension Period|Adverse Event|1|||
161069306|NCT02354651|581643393|FG000|Overall Study|Withdrawal by Subject|2|||
161069307|NCT02354651|581643393|FG000|Overall Study|Physician Decision|1|||
161069308|NCT01317875|581643394|FG000|Overall Study|Other|0|||
161069309|NCT01317875|581643395|FG001|Overall Study|Other|0|||
161069310|NCT01317875|581643396|FG002|Overall Study|Other|1|||
161069311|NCT01317875|581643397|FG003|Overall Study|Other|0|||
161069312|NCT01317875|581643398|FG004|Overall Study|Other|0|||
161069313|NCT01317875|581643399|FG005|Overall Study|Other|0|||
161069314|NCT01317875|581643400|FG006|Overall Study|Other|0|||
161069315|NCT01317875|581643401|FG007|Overall Study|Other|0|||
161069316|NCT01317875|581643402|FG008|Overall Study|Other|0|||
161284346|NCT03142191|582419416|FG004|Active Treatment Extension Period|Adverse Event|0|||
161284347|NCT03142191|582419412|FG000|Active Treatment Extension Period|Progressive Disease|10|||
161284348|NCT03142191|582419413|FG001|Active Treatment Extension Period|Progressive Disease|5|||
161284349|NCT03142191|582419414|FG002|Active Treatment Extension Period|Progressive Disease|4|||
161284350|NCT03142191|582419415|FG003|Active Treatment Extension Period|Progressive Disease|1|||
161284351|NCT03142191|582419416|FG004|Active Treatment Extension Period|Progressive Disease|2|||
161284352|NCT03142191|582419412|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
161284353|NCT03142191|582419413|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
161284354|NCT03142191|582419414|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
161284355|NCT03142191|582419415|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
161284356|NCT03142191|582419416|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
161069317|NCT01317875|581643403|FG009|Overall Study|Other|0|||
161069318|NCT01317875|581643394|FG000|Overall Study|Noncompliance with study drug|0|||
161069319|NCT01317875|581643395|FG001|Overall Study|Noncompliance with study drug|0|||
161069320|NCT01317875|581643396|FG002|Overall Study|Noncompliance with study drug|1|||
161069321|NCT01317875|581643397|FG003|Overall Study|Noncompliance with study drug|0|||
161069322|NCT01317875|581643398|FG004|Overall Study|Noncompliance with study drug|0|||
161069323|NCT01317875|581643399|FG005|Overall Study|Noncompliance with study drug|0|||
161069324|NCT01317875|581643400|FG006|Overall Study|Noncompliance with study drug|0|||
161069325|NCT01317875|581643401|FG007|Overall Study|Noncompliance with study drug|0|||
161069326|NCT01317875|581643402|FG008|Overall Study|Noncompliance with study drug|0|||
161069327|NCT01317875|581643403|FG009|Overall Study|Noncompliance with study drug|0|||
161069328|NCT01317875|581643394|FG000|Overall Study|Progressive Disease|1|||
161069329|NCT01317875|581643395|FG001|Overall Study|Progressive Disease|0|||
161069330|NCT01317875|581643396|FG002|Overall Study|Progressive Disease|2|||
161069331|NCT01317875|581643397|FG003|Overall Study|Progressive Disease|0|||
161069332|NCT01317875|581643398|FG004|Overall Study|Progressive Disease|1|||
161069333|NCT01317875|581643399|FG005|Overall Study|Progressive Disease|0|||
161069334|NCT01317875|581643400|FG006|Overall Study|Progressive Disease|0|||
161069335|NCT01317875|581643401|FG007|Overall Study|Progressive Disease|1|||
161069336|NCT01317875|581643402|FG008|Overall Study|Progressive Disease|0|||
161069337|NCT01317875|581643403|FG009|Overall Study|Progressive Disease|0|||
161069338|NCT01317875|581643394|FG000|Overall Study|Withdrawal by Subject|0|||
161069339|NCT01317875|581643395|FG001|Overall Study|Withdrawal by Subject|0|||
161069340|NCT01317875|581643396|FG002|Overall Study|Withdrawal by Subject|0|||
161069341|NCT01317875|581643397|FG003|Overall Study|Withdrawal by Subject|0|||
161069342|NCT01317875|581643398|FG004|Overall Study|Withdrawal by Subject|1|||
161069343|NCT01317875|581643399|FG005|Overall Study|Withdrawal by Subject|0|||
161069344|NCT01317875|581643400|FG006|Overall Study|Withdrawal by Subject|0|||
161069345|NCT01317875|581643401|FG007|Overall Study|Withdrawal by Subject|3|||
161069346|NCT01317875|581643402|FG008|Overall Study|Withdrawal by Subject|0|||
161069347|NCT01317875|581643403|FG009|Overall Study|Withdrawal by Subject|0|||
161069348|NCT01317875|581643394|FG000|Overall Study|Physician Decision|0|||
161069349|NCT01317875|581643395|FG001|Overall Study|Physician Decision|1|||
161069350|NCT01317875|581643396|FG002|Overall Study|Physician Decision|1|||
161069351|NCT01317875|581643397|FG003|Overall Study|Physician Decision|0|||
161069352|NCT01317875|581643398|FG004|Overall Study|Physician Decision|2|||
161069353|NCT01317875|581643399|FG005|Overall Study|Physician Decision|0|||
161069354|NCT01317875|581643400|FG006|Overall Study|Physician Decision|0|||
161069355|NCT01317875|581643401|FG007|Overall Study|Physician Decision|2|||
161069356|NCT01317875|581643402|FG008|Overall Study|Physician Decision|0|||
161069357|NCT01317875|581643403|FG009|Overall Study|Physician Decision|0|||
161069358|NCT01317875|581643394|FG000|Overall Study|Death|0|||
161069359|NCT01317875|581643395|FG001|Overall Study|Death|0|||
161069360|NCT01317875|581643396|FG002|Overall Study|Death|2|||
161069361|NCT01317875|581643397|FG003|Overall Study|Death|1|||
161069362|NCT01317875|581643398|FG004|Overall Study|Death|0|||
161069363|NCT01317875|581643399|FG005|Overall Study|Death|1|||
161069364|NCT01317875|581643400|FG006|Overall Study|Death|0|||
161069365|NCT01317875|581643401|FG007|Overall Study|Death|4|||
161069366|NCT01317875|581643402|FG008|Overall Study|Death|0|||
161069367|NCT01317875|581643403|FG009|Overall Study|Death|0|||
161069368|NCT01317875|581643394|FG000|Overall Study|Adverse Event|2|||
161069369|NCT01317875|581643395|FG001|Overall Study|Adverse Event|1|||
161069370|NCT01317875|581643396|FG002|Overall Study|Adverse Event|2|||
161069371|NCT01317875|581643397|FG003|Overall Study|Adverse Event|1|||
161069372|NCT01317875|581643398|FG004|Overall Study|Adverse Event|5|||
161069373|NCT01317875|581643399|FG005|Overall Study|Adverse Event|1|||
161069374|NCT01317875|581643400|FG006|Overall Study|Adverse Event|2|||
161069375|NCT01317875|581643401|FG007|Overall Study|Adverse Event|5|||
161069376|NCT01317875|581643402|FG008|Overall Study|Adverse Event|0|||
161069377|NCT01317875|581643403|FG009|Overall Study|Adverse Event|0|||
161069378|NCT01377389|581643404|FG000|Overall Study|Withdrawal by Subject|1|||
161284357|NCT03142191|582419412|FG000|Active Treatment Extension Period|Physician Decision|2|||
161284358|NCT03142191|582419413|FG001|Active Treatment Extension Period|Physician Decision|0|||
161284359|NCT03142191|582419414|FG002|Active Treatment Extension Period|Physician Decision|0|||
161284360|NCT03142191|582419415|FG003|Active Treatment Extension Period|Physician Decision|0|||
161284361|NCT03142191|582419416|FG004|Active Treatment Extension Period|Physician Decision|0|||
161069379|NCT01377389|581643404|FG000|Overall Study|Screen failure|2|||
161069380|NCT02562235|581643411|FG000|Overall Study|Adverse Event|3|||
161069381|NCT00863512|581643415|FG000|Overall Study|Adverse Event|2|||
161069382|NCT00863512|581643416|FG001|Overall Study|Adverse Event|0|||
161069383|NCT00863512|581643415|FG000|Overall Study|Withdrawal by Subject|11|||
161069384|NCT00863512|581643416|FG001|Overall Study|Withdrawal by Subject|0|||
161069385|NCT00863512|581643415|FG000|Overall Study|Physician Decision|1|||
161069386|NCT00863512|581643416|FG001|Overall Study|Physician Decision|0|||
161069387|NCT05274750|581643420|FG000|Overall Study|Adverse Event|0|||
161069388|NCT05274750|581643421|FG001|Overall Study|Adverse Event|1|||
161069389|NCT05274750|581643420|FG000|Overall Study|Lost to Follow-up|2|||
161069390|NCT05274750|581643421|FG001|Overall Study|Lost to Follow-up|3|||
161069391|NCT05274750|581643420|FG000|Overall Study|Physician Decision|3|||
161069392|NCT05274750|581643421|FG001|Overall Study|Physician Decision|0|||
161069393|NCT05274750|581643420|FG000|Overall Study|Withdrawal by Subject|10|||
161069394|NCT05274750|581643421|FG001|Overall Study|Withdrawal by Subject|9|||
161069395|NCT05274750|581643420|FG000|Overall Study|GCP Violation|0|||
161069396|NCT05274750|581643421|FG001|Overall Study|GCP Violation|4|||
161069397|NCT05274750|581643420|FG000|Overall Study|Randomized, not treated|0|||
161069398|NCT05274750|581643421|FG001|Overall Study|Randomized, not treated|1|||
161069399|NCT04328623|581643426|FG000|Overall Study|Protocol Violation|0|||
161069400|NCT04328623|581643427|FG001|Overall Study|Protocol Violation|1|||
161069401|NCT04340947|581643428|FG000|7-day Washout Period|Lost to Follow-up|5|||
161069402|NCT04340947|581643429|FG001|7-day Washout Period|Lost to Follow-up|4|||
161069403|NCT02312557|581643430|FG000|Overall Study|Survival follow-up|4|||
161069404|NCT01437423|581643436|FG000|Overall Study|Lost to Follow-up|12|||
161069405|NCT01437423|581643436|FG000|Overall Study|Off label usage|3|||
161069406|NCT01375751|581643437|FG000|Overall Study|Other|0|||
161069407|NCT01375751|581643438|FG001|Overall Study|Other|1|||
161069408|NCT01375751|581643439|FG002|Overall Study|Other|0|||
161069409|NCT05186311|581643440|FG000|Part A: Serum|Withdrawal by Subject|1|||
161069410|NCT00983853|581643445|FG000|Overall Study|Lost to Follow-up|1|||
161069411|NCT00983853|581643446|FG001|Overall Study|Lost to Follow-up|1|||
161069412|NCT00983853|581643447|FG002|Overall Study|Lost to Follow-up|2|||
161069413|NCT00983853|581643448|FG003|Overall Study|Lost to Follow-up|2|||
161069414|NCT00983853|581643449|FG004|Overall Study|Lost to Follow-up|2|||
161284362|NCT03142191|582419412|FG000|Active Treatment Extension Period|Other Reasons|3|||
161284363|NCT03142191|582419413|FG001|Active Treatment Extension Period|Other Reasons|3|||
161069415|NCT00983853|581643450|FG005|Overall Study|Lost to Follow-up|1|||
161069416|NCT00983853|581643445|FG000|Overall Study|Withdrawal by Subject|0|||
161069417|NCT00983853|581643446|FG001|Overall Study|Withdrawal by Subject|0|||
161069418|NCT00983853|581643447|FG002|Overall Study|Withdrawal by Subject|1|||
161069419|NCT00983853|581643448|FG003|Overall Study|Withdrawal by Subject|0|||
161069420|NCT00983853|581643449|FG004|Overall Study|Withdrawal by Subject|1|||
161069421|NCT00983853|581643450|FG005|Overall Study|Withdrawal by Subject|0|||
161069422|NCT00983853|581643445|FG000|Overall Study|Unable to come to study follow-up visits|0|||
161069423|NCT00983853|581643446|FG001|Overall Study|Unable to come to study follow-up visits|1|||
161069424|NCT00983853|581643447|FG002|Overall Study|Unable to come to study follow-up visits|0|||
161069425|NCT00983853|581643448|FG003|Overall Study|Unable to come to study follow-up visits|0|||
161069426|NCT00983853|581643449|FG004|Overall Study|Unable to come to study follow-up visits|0|||
161069427|NCT00983853|581643450|FG005|Overall Study|Unable to come to study follow-up visits|0|||
161069428|NCT00478205|581643454|FG000|Overall Study|Adverse Event|182|||
161069429|NCT00478205|581643455|FG001|Overall Study|Adverse Event|39|||
161069430|NCT00478205|581643454|FG000|Overall Study|Medication Non-compliance|9|||
161069431|NCT00478205|581643455|FG001|Overall Study|Medication Non-compliance|4|||
161069432|NCT00478205|581643454|FG000|Overall Study|Protocol Violation|15|||
161069433|NCT00478205|581643455|FG001|Overall Study|Protocol Violation|5|||
161069434|NCT00478205|581643454|FG000|Overall Study|Request of Investigator or Sponsor|4|||
161069435|NCT00478205|581643455|FG001|Overall Study|Request of Investigator or Sponsor|5|||
161069436|NCT00478205|581643454|FG000|Overall Study|Withdrawal by Subject|61|||
161069437|NCT00478205|581643455|FG001|Overall Study|Withdrawal by Subject|22|||
161069438|NCT00478205|581643454|FG000|Overall Study|Lack of Efficacy|1|||
161069439|NCT00478205|581643455|FG001|Overall Study|Lack of Efficacy|0|||
161069440|NCT00478205|581643454|FG000|Overall Study|Other|24|||
161069441|NCT00478205|581643455|FG001|Overall Study|Other|12|||
161069442|NCT01791413|581643456|FG000|Overall Study|Lost to Follow-up|5|||
161069443|NCT01791413|581643457|FG001|Overall Study|Lost to Follow-up|1|||
161069444|NCT00825305|581643468|FG000|Overall Study|Adverse Event|1|||
161069445|NCT00825305|581643469|FG001|Overall Study|Adverse Event|1|||
161069446|NCT00825305|581643468|FG000|Overall Study|Withdrawal by Subject|6|||
161069447|NCT00825305|581643469|FG001|Overall Study|Withdrawal by Subject|12|||
161069448|NCT00825305|581643468|FG000|Overall Study|Inappropriate inclusion|1|||
161069449|NCT00825305|581643469|FG001|Overall Study|Inappropriate inclusion|0|||
161069450|NCT00825305|581643468|FG000|Overall Study|Protocol Violation|9|||
161069451|NCT00825305|581643469|FG001|Overall Study|Protocol Violation|9|||
161069452|NCT00825305|581643468|FG000|Overall Study|Can not be classified|0|||
161069453|NCT00825305|581643469|FG001|Overall Study|Can not be classified|1|||
161069454|NCT04016272|581643470|FG000|Overall Study|Withdrawal by Subject|1|||
161069455|NCT04016272|581643471|FG001|Overall Study|Withdrawal by Subject|2|||
161069456|NCT01827046|581643478|FG000|Overall Study|Lost to Follow-up|1|||
161069457|NCT01827046|581643479|FG001|Overall Study|Lost to Follow-up|5|||
161069458|NCT01827046|581643478|FG000|Overall Study|Withdrawal by Subject|0|||
161069459|NCT01827046|581643479|FG001|Overall Study|Withdrawal by Subject|4|||
161069460|NCT05594589|581643481|FG000|Overall Study|Other|0|||
161069461|NCT05594589|581643482|FG001|Overall Study|Other|1|||
161069462|NCT05594589|581643483|FG002|Overall Study|Other|0|||
161069463|NCT00715117|581643487|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
161069464|NCT00715117|581643488|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
161069465|NCT01536171|581643492|FG000|Overall Study|Withdrawal by Subject|1|||
161284364|NCT03142191|582419414|FG002|Active Treatment Extension Period|Other Reasons|3|||
161284365|NCT03142191|582419415|FG003|Active Treatment Extension Period|Other Reasons|8|||
161284366|NCT03142191|582419416|FG004|Active Treatment Extension Period|Other Reasons|3|||
161284367|NCT03142191|582419412|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
161284368|NCT03142191|582419413|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
161284369|NCT03142191|582419414|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
161284370|NCT03142191|582419415|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
161284371|NCT03142191|582419416|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
161284372|NCT01130493|582419421|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
161284373|NCT01130493|582419422|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
161284374|NCT01130493|582419423|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
161284375|NCT01130493|582419421|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
161284376|NCT01130493|582419422|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
161284377|NCT01130493|582419423|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
161284378|NCT01130493|582419421|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
161284379|NCT01130493|582419422|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
161284380|NCT01130493|582419423|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
161284381|NCT01130493|582419421|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
161284382|NCT01130493|582419422|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
161284383|NCT01130493|582419423|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
161069466|NCT01018732|581643493|FG000|Overall Study|Lost to Follow-up|0|||
161069467|NCT01018732|581643494|FG001|Overall Study|Lost to Follow-up|0|||
161069468|NCT01018732|581643495|FG002|Overall Study|Lost to Follow-up|3|||
161069469|NCT01018732|581643493|FG000|Overall Study|Protocol Violation|1|||
161069470|NCT01018732|581643494|FG001|Overall Study|Protocol Violation|1|||
161069471|NCT01018732|581643495|FG002|Overall Study|Protocol Violation|0|||
161069472|NCT01018732|581643493|FG000|Overall Study|Inappropriate Enrollment|0|||
161069473|NCT01018732|581643494|FG001|Overall Study|Inappropriate Enrollment|1|||
161069474|NCT01018732|581643495|FG002|Overall Study|Inappropriate Enrollment|0|||
161069475|NCT01018732|581643493|FG000|Overall Study|Unable to Classify|0|||
161069476|NCT01018732|581643494|FG001|Overall Study|Unable to Classify|0|||
161069477|NCT01018732|581643495|FG002|Overall Study|Unable to Classify|1|||
161069478|NCT01262092|581643496|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
161069479|NCT01262092|581643497|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
161069480|NCT01262092|581643496|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
161069481|NCT01262092|581643497|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
161069482|NCT01262092|581643496|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
161069483|NCT01262092|581643497|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
161069484|NCT01262092|581643496|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
161069485|NCT01262092|581643497|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
161069486|NCT03784820|581643498|FG000|Overall Study|Lost to Follow-up|5|||
161069487|NCT03784820|581643499|FG001|Overall Study|Lost to Follow-up|5|||
161069488|NCT03784820|581643500|FG002|Overall Study|Lost to Follow-up|3|||
161069489|NCT03784820|581643501|FG003|Overall Study|Lost to Follow-up|3|||
161069490|NCT02336425|581643502|FG000|Overall Study|Study terminated.|2|||
161069491|NCT02336425|581643503|FG001|Overall Study|Study terminated.|2|||
161069492|NCT02336425|581643504|FG002|Overall Study|Study terminated.|3|||
161069493|NCT02336425|581643505|FG003|Overall Study|Study terminated.|3|||
161069494|NCT00978562|581643506|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
161069495|NCT02394665|581643507|FG000|Overall Study|Physician Decision|1|||
161069496|NCT02394665|581643508|FG001|Overall Study|Physician Decision|0|||
161069497|NCT02394665|581643509|FG002|Overall Study|Physician Decision|0|||
161069498|NCT03569891|581643510|FG000|Lead-in|Ineligible during lead-in|8|||
161069499|NCT03569891|581643510|FG000|Lead-in|Withdrawal by Subject|3|||
161069500|NCT03569891|581643510|FG000|Lead-in|Risks related to COVID-19|2|||
161069501|NCT03569891|581643510|FG000|AMT-061|Adverse Event|1|||
161069502|NCT03735121|581643513|FG000|Overall Study|Death|3|||
161069503|NCT03735121|581643514|FG001|Overall Study|Death|6|||
161069504|NCT03735121|581643515|FG002|Overall Study|Death|19|||
161069505|NCT03735121|581643516|FG003|Overall Study|Death|97|||
161069506|NCT03735121|581643517|FG004|Overall Study|Death|205|||
161069507|NCT03735121|581643513|FG000|Overall Study|Lost to Follow-up|0|||
161069508|NCT03735121|581643514|FG001|Overall Study|Lost to Follow-up|0|||
161069509|NCT03735121|581643515|FG002|Overall Study|Lost to Follow-up|0|||
161284384|NCT01130493|582419421|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
161345522|NCT05028569|582650836|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
161345523|NCT05028569|582650830|FG000|Open-Label Phase|Other, not specified|0|||
161069510|NCT03735121|581643516|FG003|Overall Study|Lost to Follow-up|2|||
161069511|NCT03735121|581643517|FG004|Overall Study|Lost to Follow-up|3|||
161069512|NCT03735121|581643513|FG000|Overall Study|New Therapy|0|||
161069513|NCT03735121|581643514|FG001|Overall Study|New Therapy|1|||
161069514|NCT03735121|581643515|FG002|Overall Study|New Therapy|0|||
161069515|NCT03735121|581643516|FG003|Overall Study|New Therapy|0|||
161069516|NCT03735121|581643517|FG004|Overall Study|New Therapy|0|||
161345524|NCT05028569|582650831|FG001|Open-Label Phase|Other, not specified|0|||
161069517|NCT03735121|581643513|FG000|Overall Study|Study Ended by Sponsor|1|||
161069518|NCT03735121|581643514|FG001|Overall Study|Study Ended by Sponsor|0|||
161069519|NCT03735121|581643515|FG002|Overall Study|Study Ended by Sponsor|1|||
161069520|NCT03735121|581643516|FG003|Overall Study|Study Ended by Sponsor|17|||
161069521|NCT03735121|581643517|FG004|Overall Study|Study Ended by Sponsor|28|||
161069522|NCT03735121|581643513|FG000|Overall Study|Withdrawal by Subject|1|||
161069523|NCT03735121|581643514|FG001|Overall Study|Withdrawal by Subject|1|||
161069524|NCT03735121|581643515|FG002|Overall Study|Withdrawal by Subject|6|||
161069525|NCT03735121|581643516|FG003|Overall Study|Withdrawal by Subject|8|||
161069526|NCT03735121|581643517|FG004|Overall Study|Withdrawal by Subject|11|||
161069527|NCT02176863|581643518|FG000|Overall Study|Physician Decision|1|||
161069528|NCT02176863|581643519|FG001|Overall Study|Physician Decision|0|||
161069529|NCT02176863|581643520|FG002|Overall Study|Physician Decision|0|||
161069530|NCT02176863|581643521|FG003|Overall Study|Physician Decision|0|||
161069531|NCT02176863|581643522|FG004|Overall Study|Physician Decision|0|||
161069532|NCT02176863|581643518|FG000|Overall Study|Adverse Event|10|||
161069533|NCT02176863|581643519|FG001|Overall Study|Adverse Event|4|||
161069534|NCT02176863|581643520|FG002|Overall Study|Adverse Event|4|||
161069535|NCT02176863|581643521|FG003|Overall Study|Adverse Event|1|||
161069536|NCT02176863|581643522|FG004|Overall Study|Adverse Event|1|||
161069537|NCT02176863|581643518|FG000|Overall Study|Protocol Violation|2|||
161069538|NCT02176863|581643519|FG001|Overall Study|Protocol Violation|0|||
161069539|NCT02176863|581643520|FG002|Overall Study|Protocol Violation|1|||
161069540|NCT02176863|581643521|FG003|Overall Study|Protocol Violation|1|||
161069541|NCT02176863|581643522|FG004|Overall Study|Protocol Violation|0|||
161069542|NCT02176863|581643518|FG000|Overall Study|Withdrawal by Subject|4|||
161069543|NCT02176863|581643519|FG001|Overall Study|Withdrawal by Subject|2|||
161069544|NCT02176863|581643520|FG002|Overall Study|Withdrawal by Subject|2|||
161069545|NCT02176863|581643521|FG003|Overall Study|Withdrawal by Subject|3|||
161069546|NCT02176863|581643522|FG004|Overall Study|Withdrawal by Subject|4|||
161069547|NCT02176863|581643518|FG000|Overall Study|Reason not specified|0|||
161069548|NCT02176863|581643519|FG001|Overall Study|Reason not specified|1|||
161069549|NCT02176863|581643520|FG002|Overall Study|Reason not specified|1|||
161069550|NCT02176863|581643521|FG003|Overall Study|Reason not specified|2|||
161069551|NCT02176863|581643522|FG004|Overall Study|Reason not specified|1|||
161069552|NCT02176863|581643518|FG000|Overall Study|Lost to Follow-up|0|||
161069553|NCT02176863|581643519|FG001|Overall Study|Lost to Follow-up|1|||
161069554|NCT02176863|581643520|FG002|Overall Study|Lost to Follow-up|1|||
161069555|NCT02176863|581643521|FG003|Overall Study|Lost to Follow-up|0|||
161069556|NCT02176863|581643522|FG004|Overall Study|Lost to Follow-up|0|||
161069557|NCT02037256|581643525|FG000|Overall Study|Protocol Violation|0|||
161069558|NCT02037256|581643526|FG001|Overall Study|Protocol Violation|1|||
161069559|NCT02037256|581643525|FG000|Overall Study|Withdrawn prior to Velcade|0|||
161069560|NCT02037256|581643526|FG001|Overall Study|Withdrawn prior to Velcade|2|||
161069561|NCT04650698|581645346|FG000|Overall Study|Protocol Violation|2|||
161069562|NCT04650698|581645347|FG001|Overall Study|Protocol Violation|1|||
161069563|NCT04650698|581645346|FG000|Overall Study|Withdrawal by Subject|0|||
161069564|NCT04650698|581645347|FG001|Overall Study|Withdrawal by Subject|1|||
161069565|NCT02419417|581645349|FG000|Overall Study|Disease progression|5|||
161069566|NCT02419417|581645350|FG001|Overall Study|Disease progression|4|||
161069567|NCT02419417|581645351|FG002|Overall Study|Disease progression|13|||
161069568|NCT02419417|581645352|FG003|Overall Study|Disease progression|10|||
161069569|NCT02419417|581645353|FG004|Overall Study|Disease progression|10|||
161069570|NCT02419417|581645354|FG005|Overall Study|Disease progression|3|||
161069571|NCT02419417|581645355|FG006|Overall Study|Disease progression|4|||
161069572|NCT02419417|581645356|FG007|Overall Study|Disease progression|5|||
161069573|NCT02419417|581645357|FG008|Overall Study|Disease progression|13|||
161069574|NCT02419417|581645358|FG009|Overall Study|Disease progression|9|||
161069575|NCT02419417|581645359|FG010|Overall Study|Disease progression|0|||
161069576|NCT02419417|581645349|FG000|Overall Study|Study drug toxicity|0|||
161069577|NCT02419417|581645350|FG001|Overall Study|Study drug toxicity|0|||
161069578|NCT02419417|581645351|FG002|Overall Study|Study drug toxicity|0|||
161069579|NCT02419417|581645352|FG003|Overall Study|Study drug toxicity|0|||
161069580|NCT02419417|581645353|FG004|Overall Study|Study drug toxicity|1|||
161069581|NCT02419417|581645354|FG005|Overall Study|Study drug toxicity|0|||
161069582|NCT02419417|581645355|FG006|Overall Study|Study drug toxicity|0|||
161069583|NCT02419417|581645356|FG007|Overall Study|Study drug toxicity|0|||
161069584|NCT02419417|581645357|FG008|Overall Study|Study drug toxicity|0|||
161069585|NCT02419417|581645358|FG009|Overall Study|Study drug toxicity|0|||
161069586|NCT02419417|581645359|FG010|Overall Study|Study drug toxicity|0|||
161069587|NCT02419417|581645349|FG000|Overall Study|Adverse event unrelated to study drug|0|||
161069588|NCT02419417|581645350|FG001|Overall Study|Adverse event unrelated to study drug|0|||
161069589|NCT02419417|581645351|FG002|Overall Study|Adverse event unrelated to study drug|0|||
161069590|NCT02419417|581645352|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161069591|NCT02419417|581645353|FG004|Overall Study|Adverse event unrelated to study drug|2|||
161069592|NCT02419417|581645354|FG005|Overall Study|Adverse event unrelated to study drug|1|||
161069593|NCT02419417|581645355|FG006|Overall Study|Adverse event unrelated to study drug|0|||
161155694|NCT03249792|581951181|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
161284385|NCT01130493|582419422|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
161284386|NCT01130493|582419423|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
161284387|NCT01130493|582419421|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
161284388|NCT01130493|582419422|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
161284389|NCT01130493|582419423|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
161284390|NCT01130493|582419421|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
161284391|NCT01130493|582419422|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
161284392|NCT01130493|582419423|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
161284393|NCT01130493|582419421|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
161345525|NCT05028569|582650832|FG002|Open-Label Phase|Other, not specified|0|||
161345526|NCT05028569|582650833|FG003|Open-Label Phase|Other, not specified|0|||
161345527|NCT05028569|582650834|FG004|Open-Label Phase|Other, not specified|6|||
161345528|NCT05028569|582650835|FG005|Open-Label Phase|Other, not specified|5|||
161345529|NCT05028569|582650836|FG006|Open-Label Phase|Other, not specified|7|||
161345530|NCT05028569|582650830|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161345531|NCT05028569|582650831|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161345532|NCT05028569|582650832|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161345533|NCT05028569|582650833|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161345534|NCT05028569|582650834|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161345535|NCT05028569|582650835|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
161345536|NCT05028569|582650836|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
161345537|NCT05028569|582650830|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161345538|NCT05028569|582650831|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161345539|NCT05028569|582650832|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161345540|NCT05028569|582650833|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161345541|NCT05028569|582650834|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161345542|NCT05028569|582650835|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
161345543|NCT05028569|582650836|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
161345544|NCT04609553|582650837|FG000|Overall Study|Lost to Follow-up|27|||
161345545|NCT04609553|582650838|FG001|Overall Study|Lost to Follow-up|31|||
161345546|NCT04609553|582650839|FG002|Overall Study|Lost to Follow-up|24|||
161345547|NCT04609553|582650837|FG000|Overall Study|Discontinued|12|||
161345548|NCT04609553|582650838|FG001|Overall Study|Discontinued|10|||
161345549|NCT04609553|582650839|FG002|Overall Study|Discontinued|9|||
161345550|NCT01240746|582650840|FG000|Overall Study|Adverse Event|2|||
161345551|NCT01240746|582650841|FG001|Overall Study|Adverse Event|0|||
161345552|NCT01240746|582650842|FG002|Overall Study|Adverse Event|10|||
161345553|NCT01240746|582650840|FG000|Overall Study|Lost to Follow-up|23|||
161345554|NCT01240746|582650841|FG001|Overall Study|Lost to Follow-up|20|||
161345555|NCT01240746|582650842|FG002|Overall Study|Lost to Follow-up|102|||
161345556|NCT01240746|582650840|FG000|Overall Study|Protocol Violation|24|||
161345557|NCT01240746|582650841|FG001|Overall Study|Protocol Violation|15|||
161345558|NCT01240746|582650842|FG002|Overall Study|Protocol Violation|72|||
161345559|NCT01240746|582650840|FG000|Overall Study|Withdrawal by Subject|10|||
161345560|NCT01240746|582650841|FG001|Overall Study|Withdrawal by Subject|13|||
161345561|NCT01240746|582650842|FG002|Overall Study|Withdrawal by Subject|59|||
161345562|NCT01136954|582650843|FG000|Overall Study|Adverse Event|3|||
161345563|NCT01136954|582650844|FG001|Overall Study|Adverse Event|2|||
161345564|NCT01136954|582650843|FG000|Overall Study|Withdrawal by Subject|6|||
161345565|NCT01136954|582650844|FG001|Overall Study|Withdrawal by Subject|2|||
161345566|NCT01136954|582650843|FG000|Overall Study|Lack of Efficacy|14|||
161345567|NCT01136954|582650844|FG001|Overall Study|Lack of Efficacy|13|||
161345568|NCT01136954|582650843|FG000|Overall Study|Physician Decision|0|||
161345569|NCT01136954|582650844|FG001|Overall Study|Physician Decision|1|||
161345570|NCT01136954|582650843|FG000|Overall Study|Other|1|||
161345571|NCT01136954|582650844|FG001|Overall Study|Other|3|||
161345572|NCT02362451|582650862|FG000|Overall Study|Withdrawal by Subject|0|||
161345573|NCT02362451|582650863|FG001|Overall Study|Withdrawal by Subject|1|||
161345574|NCT02362451|582650862|FG000|Overall Study|Lack of Efficacy|2|||
161069594|NCT02419417|581645356|FG007|Overall Study|Adverse event unrelated to study drug|1|||
161069595|NCT02419417|581645357|FG008|Overall Study|Adverse event unrelated to study drug|0|||
161069596|NCT02419417|581645358|FG009|Overall Study|Adverse event unrelated to study drug|0|||
161069597|NCT02419417|581645359|FG010|Overall Study|Adverse event unrelated to study drug|0|||
161069598|NCT02419417|581645349|FG000|Overall Study|Participant request to discontinue|0|||
161069599|NCT02419417|581645350|FG001|Overall Study|Participant request to discontinue|0|||
161069600|NCT02419417|581645351|FG002|Overall Study|Participant request to discontinue|0|||
161345575|NCT02362451|582650863|FG001|Overall Study|Lack of Efficacy|0|||
161345576|NCT02362451|582650862|FG000|Overall Study|Progression|1|||
161345577|NCT02362451|582650863|FG001|Overall Study|Progression|0|||
161069601|NCT02419417|581645352|FG003|Overall Study|Participant request to discontinue|0|||
161284394|NCT01130493|582419422|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
161284395|NCT01130493|582419423|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
161284396|NCT01130493|582419421|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
161284397|NCT01130493|582419422|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
161284398|NCT01130493|582419423|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
161284399|NCT01130493|582419421|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
161284400|NCT01130493|582419422|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
161284401|NCT01130493|582419423|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
161069602|NCT02419417|581645353|FG004|Overall Study|Participant request to discontinue|0|||
161069603|NCT02419417|581645354|FG005|Overall Study|Participant request to discontinue|0|||
161069604|NCT02419417|581645355|FG006|Overall Study|Participant request to discontinue|0|||
161069605|NCT02419417|581645356|FG007|Overall Study|Participant request to discontinue|0|||
161069606|NCT02419417|581645357|FG008|Overall Study|Participant request to discontinue|0|||
161069607|NCT02419417|581645358|FG009|Overall Study|Participant request to discontinue|1|||
161069608|NCT02419417|581645359|FG010|Overall Study|Participant request to discontinue|0|||
161069609|NCT02419417|581645349|FG000|Overall Study|Withdrawal by Subject|0|||
161069610|NCT02419417|581645350|FG001|Overall Study|Withdrawal by Subject|0|||
161069611|NCT02419417|581645351|FG002|Overall Study|Withdrawal by Subject|0|||
161069612|NCT02419417|581645352|FG003|Overall Study|Withdrawal by Subject|0|||
161069613|NCT02419417|581645353|FG004|Overall Study|Withdrawal by Subject|0|||
161069614|NCT02419417|581645354|FG005|Overall Study|Withdrawal by Subject|0|||
161069615|NCT02419417|581645355|FG006|Overall Study|Withdrawal by Subject|0|||
161069616|NCT02419417|581645356|FG007|Overall Study|Withdrawal by Subject|0|||
161069617|NCT02419417|581645357|FG008|Overall Study|Withdrawal by Subject|0|||
161069618|NCT02419417|581645358|FG009|Overall Study|Withdrawal by Subject|0|||
161069619|NCT02419417|581645359|FG010|Overall Study|Withdrawal by Subject|1|||
161069620|NCT01385748|581645360|FG000|Overall Study|Withdrawal by Subject|7|||
161069621|NCT01385748|581645361|FG001|Overall Study|Withdrawal by Subject|4|||
161069622|NCT01385748|581645362|FG002|Overall Study|Withdrawal by Subject|5|||
161069623|NCT01385748|581645360|FG000|Overall Study|Noncompliance|3|||
161069624|NCT01385748|581645361|FG001|Overall Study|Noncompliance|1|||
161069625|NCT01385748|581645362|FG002|Overall Study|Noncompliance|6|||
161069626|NCT01385748|581645360|FG000|Overall Study|Other|1|||
161069627|NCT01385748|581645361|FG001|Overall Study|Other|7|||
161069628|NCT01385748|581645362|FG002|Overall Study|Other|1|||
161069629|NCT01385748|581645360|FG000|Overall Study|Adverse Event|4|||
161069630|NCT01385748|581645361|FG001|Overall Study|Adverse Event|2|||
161069631|NCT01385748|581645362|FG002|Overall Study|Adverse Event|1|||
161069632|NCT01200342|581645363|FG000|Overall Study|Disease Progression|1|||
161069633|NCT00121667|581645373|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
161069634|NCT00121667|581645374|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
161069635|NCT00121667|581645375|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
161069636|NCT00121667|581645376|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
161069637|NCT00121667|581645373|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
161069638|NCT00121667|581645374|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
161069639|NCT00121667|581645375|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
161069640|NCT00121667|581645376|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
161069641|NCT00121667|581645373|FG000|Short Term (ST) Period|Adverse Event|5|||
161069642|NCT00121667|581645374|FG001|Short Term (ST) Period|Adverse Event|6|||
161069643|NCT00121667|581645375|FG002|Short Term (ST) Period|Adverse Event|5|||
161069644|NCT00121667|581645376|FG003|Short Term (ST) Period|Adverse Event|3|||
161069645|NCT00121667|581645373|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
161069646|NCT00121667|581645374|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
161069647|NCT00121667|581645375|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
161069648|NCT00121667|581645376|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
161069649|NCT00121667|581645373|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
161069650|NCT00121667|581645374|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
161069651|NCT00121667|581645375|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
161069652|NCT00121667|581645376|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
161069653|NCT00121667|581645373|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
161069654|NCT00121667|581645374|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
161069655|NCT00121667|581645375|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
161069656|NCT00121667|581645376|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
161069657|NCT00121667|581645373|FG000|Short Term (ST) Period|Other Reason|3|||
161284402|NCT01130493|582419421|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
161069658|NCT00121667|581645374|FG001|Short Term (ST) Period|Other Reason|0|||
161069659|NCT00121667|581645375|FG002|Short Term (ST) Period|Other Reason|0|||
161069660|NCT00121667|581645376|FG003|Short Term (ST) Period|Other Reason|0|||
161284403|NCT01130493|582419422|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
161069661|NCT00121667|581645373|FG000|Short Term (ST) Period|Death|0|||
161069662|NCT00121667|581645374|FG001|Short Term (ST) Period|Death|0|||
161069663|NCT00121667|581645375|FG002|Short Term (ST) Period|Death|0|||
161069664|NCT00121667|581645376|FG003|Short Term (ST) Period|Death|1|||
161284404|NCT01130493|582419423|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
161284405|NCT01130493|582419421|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
161069665|NCT00121667|581645373|FG000|Short Term (ST) Period|Pregnancy|0|||
161069666|NCT00121667|581645374|FG001|Short Term (ST) Period|Pregnancy|0|||
161069667|NCT00121667|581645375|FG002|Short Term (ST) Period|Pregnancy|0|||
161069668|NCT00121667|581645376|FG003|Short Term (ST) Period|Pregnancy|1|||
161069669|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
161069670|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
161069671|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
161069672|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
161069673|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
161069674|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
161069675|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
161069676|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
161069677|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
161069678|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
161069679|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
161069680|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
161069681|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
161069682|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
161069683|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
161069684|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
161069685|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
161069686|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
161069687|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
161069688|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
161069689|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
161069690|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
161069691|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
161069692|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
161069693|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
161069694|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
161069695|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
161069696|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
161069697|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
161069698|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
161069699|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
161069700|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
161069701|NCT00121667|581645373|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
161069702|NCT00121667|581645374|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
161069703|NCT00121667|581645375|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
161069704|NCT00121667|581645376|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
161069705|NCT04468230|581645378|FG000|Overall Study|Adverse Event|2|||
161069706|NCT03721172|581645379|FG000|Placebo-controlled Phase|Adverse Event|7|||
161069707|NCT03721172|581645380|FG001|Placebo-controlled Phase|Adverse Event|7|||
161069708|NCT03721172|581645381|FG002|Placebo-controlled Phase|Adverse Event|0|||
161069709|NCT03721172|581645379|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
161069710|NCT03721172|581645380|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
161069711|NCT03721172|581645381|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161069712|NCT03721172|581645379|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
161069713|NCT03721172|581645380|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
161069714|NCT03721172|581645381|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
161069715|NCT03721172|581645379|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
161069716|NCT03721172|581645380|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
161069717|NCT03721172|581645381|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161069718|NCT03721172|581645379|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
161069719|NCT03721172|581645380|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
161155695|NCT03249792|581951182|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
161155696|NCT03249792|581951183|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
161155697|NCT03249792|581951184|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
161155698|NCT03249792|581951185|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
161155699|NCT03249792|581951186|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
161155700|NCT03249792|581951187|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
161155701|NCT03249792|581951188|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
161155702|NCT03249792|581951189|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
161155703|NCT03249792|581951190|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
161155704|NCT03249792|581951191|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
161155705|NCT03249792|581951159|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
161284406|NCT01130493|582419422|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
161069720|NCT03721172|581645381|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161069721|NCT03721172|581645379|FG000|Placebo-controlled Phase|Other|3|||
161069722|NCT03721172|581645380|FG001|Placebo-controlled Phase|Other|0|||
161069723|NCT03721172|581645381|FG002|Placebo-controlled Phase|Other|0|||
161069724|NCT03721172|581645379|FG000|Apremilast Extension Phase|Adverse Event|0|||
161069725|NCT03721172|581645380|FG001|Apremilast Extension Phase|Adverse Event|0|||
161069726|NCT03721172|581645381|FG002|Apremilast Extension Phase|Adverse Event|10|||
161069727|NCT03721172|581645379|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161069728|NCT03721172|581645380|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161069729|NCT03721172|581645381|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
161069730|NCT03721172|581645379|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
161069731|NCT03721172|581645380|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
161069732|NCT03721172|581645381|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
161069733|NCT03721172|581645379|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161069734|NCT03721172|581645380|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161069735|NCT03721172|581645381|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
161069736|NCT03721172|581645379|FG000|Apremilast Extension Phase|Protocol Violation|0|||
161069737|NCT03721172|581645380|FG001|Apremilast Extension Phase|Protocol Violation|0|||
161069738|NCT03721172|581645381|FG002|Apremilast Extension Phase|Protocol Violation|1|||
161069739|NCT03721172|581645379|FG000|Apremilast Extension Phase|Physician Decision|0|||
161069740|NCT03721172|581645380|FG001|Apremilast Extension Phase|Physician Decision|0|||
161069741|NCT03721172|581645381|FG002|Apremilast Extension Phase|Physician Decision|1|||
161069742|NCT03721172|581645379|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161069743|NCT03721172|581645380|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161069744|NCT03721172|581645381|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
161069745|NCT03721172|581645379|FG000|Apremilast Extension Phase|Other|0|||
161069746|NCT03721172|581645380|FG001|Apremilast Extension Phase|Other|0|||
161069747|NCT03721172|581645381|FG002|Apremilast Extension Phase|Other|3|||
161069748|NCT03721172|581645379|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
161069749|NCT03721172|581645380|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
161069750|NCT03721172|581645381|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
161069751|NCT03934099|581645382|FG000|Overall Study|Adverse Event|0|||
161069752|NCT03934099|581645383|FG001|Overall Study|Adverse Event|3|||
161069753|NCT03934099|581645384|FG002|Overall Study|Adverse Event|1|||
161069754|NCT03934099|581645385|FG003|Overall Study|Adverse Event|0|||
161069755|NCT03934099|581645382|FG000|Overall Study|Lost to Follow-up|1|||
161069756|NCT03934099|581645383|FG001|Overall Study|Lost to Follow-up|2|||
161069757|NCT03934099|581645384|FG002|Overall Study|Lost to Follow-up|1|||
161069758|NCT03934099|581645385|FG003|Overall Study|Lost to Follow-up|1|||
161069759|NCT03934099|581645382|FG000|Overall Study|Protocol Violation|1|||
161069760|NCT03934099|581645383|FG001|Overall Study|Protocol Violation|0|||
161069761|NCT03934099|581645384|FG002|Overall Study|Protocol Violation|0|||
161069762|NCT03934099|581645385|FG003|Overall Study|Protocol Violation|0|||
161069763|NCT03934099|581645382|FG000|Overall Study|Withdrawal by Subject|2|||
161069764|NCT03934099|581645383|FG001|Overall Study|Withdrawal by Subject|0|||
161069765|NCT03934099|581645384|FG002|Overall Study|Withdrawal by Subject|1|||
161069766|NCT03934099|581645385|FG003|Overall Study|Withdrawal by Subject|1|||
161069767|NCT03934099|581645382|FG000|Overall Study|Other reasons|0|||
161069768|NCT03934099|581645383|FG001|Overall Study|Other reasons|1|||
161069769|NCT03934099|581645384|FG002|Overall Study|Other reasons|0|||
161069770|NCT03934099|581645385|FG003|Overall Study|Other reasons|0|||
161069771|NCT02417441|581645386|FG000|Overall Study|Inconclusive due to missing data|52|||
161069772|NCT02417441|581645387|FG001|Overall Study|Inconclusive due to missing data|19|||
161069773|NCT05628285|581645388|FG000|Overall Study|Lost to Follow-up|1|||
161069774|NCT02339506|581645389|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
161069775|NCT02339506|581645390|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
161069776|NCT02339506|581645389|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
161069777|NCT02339506|581645390|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
161155706|NCT03249792|581951160|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155707|NCT03249792|581951161|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
161069808|NCT05555615|581645397|FG000|Overall Study|Adverse Event|7|||
161069809|NCT05555615|581645397|FG000|Overall Study|Lack of Efficacy|12|||
161069810|NCT05555615|581645397|FG000|Overall Study|Lost to Follow-up|10|||
161069811|NCT05555615|581645397|FG000|Overall Study|Noncompliance with study drug|5|||
161069812|NCT05555615|581645397|FG000|Overall Study|Physician Decision|2|||
161069813|NCT05555615|581645397|FG000|Overall Study|Study terminated by sponsor|80|||
161069814|NCT05555615|581645397|FG000|Overall Study|Prohibited medication use|2|||
161069815|NCT05555615|581645397|FG000|Overall Study|Withdrawal by Subject|20|||
161069816|NCT05555615|581645397|FG000|Overall Study|Not further specified|4|||
161069817|NCT03016598|581645398|FG000|Overall Study|Lost to Follow-up|0|||
161069818|NCT03016598|581645399|FG001|Overall Study|Lost to Follow-up|2|||
161069819|NCT02872012|581645411|FG000|Overall Study|Withdrawal by Subject|1|||
161069820|NCT02872012|581645412|FG001|Overall Study|Withdrawal by Subject|0|||
161069821|NCT02872012|581645413|FG002|Overall Study|Withdrawal by Subject|0|||
161069822|NCT02872012|581645414|FG003|Overall Study|Withdrawal by Subject|0|||
161069823|NCT02872012|581645415|FG004|Overall Study|Withdrawal by Subject|0|||
161069824|NCT01728623|581645416|FG000|Overall Study|Disease progression|26|||
161069825|NCT01728623|581645416|FG000|Overall Study|Adverse Event|1|||
161069826|NCT01728623|581645416|FG000|Overall Study|Withdrawal by Subject|1|||
161069827|NCT03000348|581645417|FG000|Overall Study|Adverse Event|1|||
161069828|NCT03000348|581645418|FG001|Overall Study|Adverse Event|1|||
161069829|NCT03000348|581645419|FG002|Overall Study|Adverse Event|1|||
161069830|NCT03000348|581645420|FG003|Overall Study|Adverse Event|1|||
161069831|NCT03000348|581645421|FG004|Overall Study|Adverse Event|1|||
161069832|NCT03000348|581645422|FG005|Overall Study|Adverse Event|1|||
161069833|NCT03000348|581645417|FG000|Overall Study|Lost to Follow-up|0|||
161069834|NCT03000348|581645418|FG001|Overall Study|Lost to Follow-up|0|||
161069835|NCT03000348|581645419|FG002|Overall Study|Lost to Follow-up|1|||
161069836|NCT03000348|581645420|FG003|Overall Study|Lost to Follow-up|0|||
161069837|NCT03000348|581645421|FG004|Overall Study|Lost to Follow-up|0|||
161069838|NCT03000348|581645422|FG005|Overall Study|Lost to Follow-up|0|||
161069839|NCT03000348|581645417|FG000|Overall Study|Withdrawal by Subject|0|||
161069840|NCT03000348|581645418|FG001|Overall Study|Withdrawal by Subject|1|||
161069841|NCT03000348|581645419|FG002|Overall Study|Withdrawal by Subject|0|||
161069842|NCT03000348|581645420|FG003|Overall Study|Withdrawal by Subject|0|||
161069843|NCT03000348|581645421|FG004|Overall Study|Withdrawal by Subject|0|||
161069844|NCT03000348|581645422|FG005|Overall Study|Withdrawal by Subject|0|||
161069845|NCT03000348|581645417|FG000|Overall Study|Consent|0|||
161069846|NCT03000348|581645418|FG001|Overall Study|Consent|0|||
161069847|NCT03000348|581645419|FG002|Overall Study|Consent|0|||
161069848|NCT03000348|581645420|FG003|Overall Study|Consent|0|||
161069849|NCT03000348|581645421|FG004|Overall Study|Consent|1|||
161069850|NCT03000348|581645422|FG005|Overall Study|Consent|0|||
161069851|NCT03000348|581645417|FG000|Overall Study|Failure to expectorate sputum|1|||
161069852|NCT03000348|581645418|FG001|Overall Study|Failure to expectorate sputum|0|||
161069853|NCT03000348|581645419|FG002|Overall Study|Failure to expectorate sputum|1|||
161069854|NCT03000348|581645420|FG003|Overall Study|Failure to expectorate sputum|0|||
161069855|NCT03000348|581645421|FG004|Overall Study|Failure to expectorate sputum|1|||
161069856|NCT03000348|581645422|FG005|Overall Study|Failure to expectorate sputum|0|||
161069857|NCT03000348|581645417|FG000|Overall Study|No gram negative|1|||
161069858|NCT03000348|581645418|FG001|Overall Study|No gram negative|2|||
161069859|NCT03000348|581645419|FG002|Overall Study|No gram negative|1|||
161069860|NCT03000348|581645420|FG003|Overall Study|No gram negative|1|||
161069861|NCT03000348|581645421|FG004|Overall Study|No gram negative|1|||
161069862|NCT03000348|581645422|FG005|Overall Study|No gram negative|1|||
161069863|NCT03000348|581645417|FG000|Overall Study|Patient had no transport|0|||
161069864|NCT03000348|581645418|FG001|Overall Study|Patient had no transport|0|||
161069865|NCT03000348|581645419|FG002|Overall Study|Patient had no transport|0|||
161069866|NCT03000348|581645420|FG003|Overall Study|Patient had no transport|1|||
161069867|NCT03000348|581645421|FG004|Overall Study|Patient had no transport|0|||
161069868|NCT03000348|581645422|FG005|Overall Study|Patient had no transport|0|||
161069869|NCT03000348|581645417|FG000|Overall Study|Dosing|0|||
161069870|NCT03000348|581645418|FG001|Overall Study|Dosing|0|||
161155708|NCT03249792|581951162|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155709|NCT03249792|581951163|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155710|NCT03249792|581951164|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155711|NCT03249792|581951165|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155712|NCT03249792|581951166|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155713|NCT03249792|581951167|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
161155714|NCT03249792|581951168|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155715|NCT03249792|581951169|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155716|NCT03249792|581951170|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155717|NCT03249792|581951171|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155718|NCT03249792|581951172|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155719|NCT03249792|581951173|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155720|NCT03249792|581951174|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155721|NCT03249792|581951175|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
161155722|NCT03249792|581951176|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
161155723|NCT03249792|581951177|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155724|NCT03249792|581951178|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
161155725|NCT03249792|581951179|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155726|NCT03249792|581951180|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155727|NCT03249792|581951181|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155728|NCT03249792|581951182|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155729|NCT03249792|581951183|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155730|NCT03249792|581951184|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155731|NCT03249792|581951185|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155732|NCT03249792|581951186|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155733|NCT03249792|581951187|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155734|NCT03249792|581951188|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155735|NCT03249792|581951189|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155736|NCT03249792|581951190|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155737|NCT03249792|581951191|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
161155738|NCT03249792|581951159|FG000|Switch Over Period|Withdrawal by Subject|0|||
161155739|NCT03249792|581951160|FG001|Switch Over Period|Withdrawal by Subject|0|||
161155740|NCT03249792|581951161|FG002|Switch Over Period|Withdrawal by Subject|0|||
161155741|NCT03249792|581951162|FG003|Switch Over Period|Withdrawal by Subject|0|||
161155742|NCT03249792|581951163|FG004|Switch Over Period|Withdrawal by Subject|0|||
161155743|NCT03249792|581951164|FG005|Switch Over Period|Withdrawal by Subject|0|||
161155744|NCT03249792|581951165|FG006|Switch Over Period|Withdrawal by Subject|0|||
161155745|NCT03249792|581951166|FG007|Switch Over Period|Withdrawal by Subject|0|||
161155746|NCT03249792|581951167|FG008|Switch Over Period|Withdrawal by Subject|0|||
161155747|NCT03249792|581951168|FG009|Switch Over Period|Withdrawal by Subject|0|||
161155748|NCT03249792|581951169|FG010|Switch Over Period|Withdrawal by Subject|0|||
161155749|NCT03249792|581951170|FG011|Switch Over Period|Withdrawal by Subject|0|||
161155750|NCT03249792|581951171|FG012|Switch Over Period|Withdrawal by Subject|0|||
161155751|NCT03249792|581951172|FG013|Switch Over Period|Withdrawal by Subject|0|||
161155752|NCT03249792|581951173|FG014|Switch Over Period|Withdrawal by Subject|0|||
161155753|NCT03249792|581951174|FG015|Switch Over Period|Withdrawal by Subject|0|||
161155754|NCT03249792|581951175|FG016|Switch Over Period|Withdrawal by Subject|0|||
161155755|NCT03249792|581951176|FG017|Switch Over Period|Withdrawal by Subject|0|||
161155756|NCT03249792|581951177|FG018|Switch Over Period|Withdrawal by Subject|0|||
161155757|NCT03249792|581951178|FG019|Switch Over Period|Withdrawal by Subject|0|||
161155758|NCT03249792|581951179|FG020|Switch Over Period|Withdrawal by Subject|0|||
161155759|NCT03249792|581951180|FG021|Switch Over Period|Withdrawal by Subject|0|||
161155760|NCT03249792|581951181|FG022|Switch Over Period|Withdrawal by Subject|0|||
161155761|NCT03249792|581951182|FG023|Switch Over Period|Withdrawal by Subject|0|||
161155762|NCT03249792|581951183|FG024|Switch Over Period|Withdrawal by Subject|0|||
161155763|NCT03249792|581951184|FG025|Switch Over Period|Withdrawal by Subject|0|||
161155764|NCT03249792|581951185|FG026|Switch Over Period|Withdrawal by Subject|0|||
161155765|NCT03249792|581951186|FG027|Switch Over Period|Withdrawal by Subject|0|||
161155766|NCT03249792|581951187|FG028|Switch Over Period|Withdrawal by Subject|0|||
161155767|NCT03249792|581951188|FG029|Switch Over Period|Withdrawal by Subject|0|||
161155768|NCT03249792|581951189|FG030|Switch Over Period|Withdrawal by Subject|0|||
161155769|NCT03249792|581951190|FG031|Switch Over Period|Withdrawal by Subject|1|||
161155770|NCT03249792|581951191|FG032|Switch Over Period|Withdrawal by Subject|0|||
161155771|NCT03249792|581951159|FG000|Switch Over Period|Progressive Disease|0|||
161155772|NCT03249792|581951160|FG001|Switch Over Period|Progressive Disease|0|||
161155773|NCT03249792|581951161|FG002|Switch Over Period|Progressive Disease|0|||
161155774|NCT03249792|581951162|FG003|Switch Over Period|Progressive Disease|0|||
161155775|NCT03249792|581951163|FG004|Switch Over Period|Progressive Disease|0|||
161155776|NCT03249792|581951164|FG005|Switch Over Period|Progressive Disease|0|||
161155777|NCT03249792|581951165|FG006|Switch Over Period|Progressive Disease|0|||
161155778|NCT03249792|581951166|FG007|Switch Over Period|Progressive Disease|0|||
161155779|NCT03249792|581951167|FG008|Switch Over Period|Progressive Disease|0|||
161155780|NCT03249792|581951168|FG009|Switch Over Period|Progressive Disease|0|||
161155781|NCT03249792|581951169|FG010|Switch Over Period|Progressive Disease|0|||
161155782|NCT03249792|581951170|FG011|Switch Over Period|Progressive Disease|0|||
161069871|NCT03000348|581645419|FG002|Overall Study|Dosing|0|||
161069872|NCT03000348|581645420|FG003|Overall Study|Dosing|0|||
161069873|NCT03000348|581645421|FG004|Overall Study|Dosing|1|||
161069874|NCT03000348|581645422|FG005|Overall Study|Dosing|0|||
161069875|NCT00723125|581645423|FG000|Overall Study|Met Dx|1|||
161069876|NCT00723125|581645424|FG001|Overall Study|Met Dx|0|||
161069877|NCT00723125|581645423|FG000|Overall Study|Withdrawal by Subject|15|||
161069878|NCT00723125|581645424|FG001|Overall Study|Withdrawal by Subject|6|||
161069879|NCT00723125|581645423|FG000|Overall Study|Adverse Event|2|||
161069880|NCT00723125|581645424|FG001|Overall Study|Adverse Event|0|||
161069881|NCT01667549|581645425|FG000|Overall Study|Withdrawal by Subject|3|||
161069882|NCT01667549|581645426|FG001|Overall Study|Withdrawal by Subject|5|||
161069883|NCT01667549|581645427|FG002|Overall Study|Withdrawal by Subject|7|||
161069884|NCT01667549|581645428|FG003|Overall Study|Withdrawal by Subject|6|||
161069885|NCT01667549|581645429|FG004|Overall Study|Withdrawal by Subject|1|||
161069886|NCT01407276|581645431|FG000|Overall Study|Withdrawal by Subject|0|||
161069887|NCT01407276|581645432|FG001|Overall Study|Withdrawal by Subject|0|||
161069888|NCT01407276|581645433|FG002|Overall Study|Withdrawal by Subject|0|||
161069889|NCT01407276|581645434|FG003|Overall Study|Withdrawal by Subject|0|||
161069890|NCT01407276|581645435|FG004|Overall Study|Withdrawal by Subject|0|||
161069891|NCT01407276|581645436|FG005|Overall Study|Withdrawal by Subject|0|||
161069892|NCT01407276|581645437|FG006|Overall Study|Withdrawal by Subject|0|||
161069893|NCT01407276|581645438|FG007|Overall Study|Withdrawal by Subject|1|||
161069894|NCT01807182|581645440|FG000|Overall Study|Death|1|||
161069895|NCT01807182|581645440|FG000|Overall Study|New therapy|1|||
161069896|NCT01807182|581645440|FG000|Overall Study|Moved to hospice care|1|||
161069897|NCT04092452|581645442|FG000|Overall Study|Adverse Event|1|||
161069898|NCT04092452|581645443|FG001|Overall Study|Adverse Event|3|||
161069899|NCT04092452|581645444|FG002|Overall Study|Adverse Event|3|||
161069900|NCT04092452|581645445|FG003|Overall Study|Adverse Event|7|||
161069901|NCT04092452|581645442|FG000|Overall Study|Lack of Efficacy|1|||
161069902|NCT04092452|581645443|FG001|Overall Study|Lack of Efficacy|1|||
161069903|NCT04092452|581645444|FG002|Overall Study|Lack of Efficacy|1|||
161069904|NCT04092452|581645445|FG003|Overall Study|Lack of Efficacy|0|||
161069905|NCT04092452|581645442|FG000|Overall Study|Lost to Follow-up|4|||
161069906|NCT04092452|581645443|FG001|Overall Study|Lost to Follow-up|3|||
161069907|NCT04092452|581645444|FG002|Overall Study|Lost to Follow-up|5|||
161069908|NCT04092452|581645445|FG003|Overall Study|Lost to Follow-up|1|||
161069909|NCT04092452|581645442|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161069910|NCT04092452|581645443|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161069911|NCT04092452|581645444|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161069912|NCT04092452|581645445|FG003|Overall Study|Non-Compliance With Study Drug|1|||
161069913|NCT04092452|581645442|FG000|Overall Study|Physician Decision|1|||
161069914|NCT04092452|581645443|FG001|Overall Study|Physician Decision|0|||
161069915|NCT04092452|581645444|FG002|Overall Study|Physician Decision|1|||
161069916|NCT04092452|581645445|FG003|Overall Study|Physician Decision|0|||
161069917|NCT04092452|581645442|FG000|Overall Study|Pregnancy|2|||
161069918|NCT04092452|581645443|FG001|Overall Study|Pregnancy|0|||
161069919|NCT04092452|581645444|FG002|Overall Study|Pregnancy|0|||
161069920|NCT04092452|581645445|FG003|Overall Study|Pregnancy|0|||
161069921|NCT04092452|581645442|FG000|Overall Study|Protocol Deviation|1|||
161069922|NCT04092452|581645443|FG001|Overall Study|Protocol Deviation|0|||
161069923|NCT04092452|581645444|FG002|Overall Study|Protocol Deviation|0|||
161069924|NCT04092452|581645445|FG003|Overall Study|Protocol Deviation|0|||
161069925|NCT04092452|581645442|FG000|Overall Study|Withdrawal by Subject|3|||
161069926|NCT04092452|581645443|FG001|Overall Study|Withdrawal by Subject|10|||
161069927|NCT04092452|581645444|FG002|Overall Study|Withdrawal by Subject|3|||
161069928|NCT04092452|581645445|FG003|Overall Study|Withdrawal by Subject|5|||
161069929|NCT04092452|581645442|FG000|Overall Study|Other|0|||
161069930|NCT04092452|581645443|FG001|Overall Study|Other|0|||
161069931|NCT04092452|581645444|FG002|Overall Study|Other|1|||
161069932|NCT04092452|581645445|FG003|Overall Study|Other|2|||
161069933|NCT01012947|581645453|FG000|Overall Study|Lost to Follow-up|131|||
161069934|NCT01012947|581645454|FG001|Overall Study|Lost to Follow-up|135|||
161069935|NCT01012947|581645455|FG002|Overall Study|Lost to Follow-up|130|||
161069936|NCT01012947|581645456|FG003|Overall Study|Lost to Follow-up|118|||
161069937|NCT01012947|581645457|FG004|Overall Study|Lost to Follow-up|142|||
161069938|NCT02127125|581645458|FG000|Overall Study|Lost to Follow-up|0|||
161069939|NCT02127125|581645459|FG001|Overall Study|Lost to Follow-up|0|||
161069940|NCT02127125|581645460|FG002|Overall Study|Lost to Follow-up|0|||
161069941|NCT02127125|581645461|FG003|Overall Study|Lost to Follow-up|0|||
161069942|NCT02127125|581645462|FG004|Overall Study|Lost to Follow-up|2|||
161155783|NCT03249792|581951171|FG012|Switch Over Period|Progressive Disease|0|||
161155784|NCT03249792|581951172|FG013|Switch Over Period|Progressive Disease|0|||
161155785|NCT03249792|581951173|FG014|Switch Over Period|Progressive Disease|0|||
161069943|NCT02127125|581645463|FG005|Overall Study|Lost to Follow-up|1|||
161069944|NCT02127125|581645464|FG006|Overall Study|Lost to Follow-up|0|||
161069945|NCT02127125|581645465|FG007|Overall Study|Lost to Follow-up|0|||
161069946|NCT02127125|581645466|FG008|Overall Study|Lost to Follow-up|0|||
161069947|NCT02127125|581645458|FG000|Overall Study|Withdrawal by Subject|0|||
161069948|NCT02127125|581645459|FG001|Overall Study|Withdrawal by Subject|0|||
161069949|NCT02127125|581645460|FG002|Overall Study|Withdrawal by Subject|0|||
161069950|NCT02127125|581645461|FG003|Overall Study|Withdrawal by Subject|1|||
161069951|NCT02127125|581645462|FG004|Overall Study|Withdrawal by Subject|0|||
161069952|NCT02127125|581645463|FG005|Overall Study|Withdrawal by Subject|0|||
161069953|NCT02127125|581645464|FG006|Overall Study|Withdrawal by Subject|0|||
161069954|NCT02127125|581645465|FG007|Overall Study|Withdrawal by Subject|0|||
161069955|NCT02127125|581645466|FG008|Overall Study|Withdrawal by Subject|0|||
161069956|NCT02127125|581645458|FG000|Overall Study|Physician Decision|0|||
161069957|NCT02127125|581645459|FG001|Overall Study|Physician Decision|0|||
161069958|NCT02127125|581645460|FG002|Overall Study|Physician Decision|1|||
161069959|NCT02127125|581645461|FG003|Overall Study|Physician Decision|0|||
161069960|NCT02127125|581645462|FG004|Overall Study|Physician Decision|1|||
161069961|NCT02127125|581645463|FG005|Overall Study|Physician Decision|2|||
161069962|NCT02127125|581645464|FG006|Overall Study|Physician Decision|0|||
161069963|NCT02127125|581645465|FG007|Overall Study|Physician Decision|0|||
161069964|NCT02127125|581645466|FG008|Overall Study|Physician Decision|0|||
161069965|NCT03566979|581645468|FG000|Overall Study|Withdrawal by Subject|2|||
161069966|NCT03566979|581645469|FG001|Overall Study|Withdrawal by Subject|0|||
161069967|NCT03566979|581645470|FG002|Overall Study|Withdrawal by Subject|1|||
161069968|NCT03566979|581645471|FG003|Overall Study|Withdrawal by Subject|1|||
161069969|NCT03566979|581645468|FG000|Overall Study|Lost to Follow-up|2|||
161069970|NCT03566979|581645469|FG001|Overall Study|Lost to Follow-up|7|||
161069971|NCT03566979|581645470|FG002|Overall Study|Lost to Follow-up|9|||
161069972|NCT03566979|581645471|FG003|Overall Study|Lost to Follow-up|5|||
161069973|NCT03566979|581645468|FG000|Overall Study|Adverse Event|1|||
161069974|NCT03566979|581645469|FG001|Overall Study|Adverse Event|0|||
161069975|NCT03566979|581645470|FG002|Overall Study|Adverse Event|0|||
161069976|NCT03566979|581645471|FG003|Overall Study|Adverse Event|0|||
161069977|NCT01191008|581645472|FG000|Overall Study|Protocol Violation|7|||
161069978|NCT01191008|581645472|FG000|Overall Study|Lost to Follow-up|8|||
161069979|NCT03348631|581645475|FG000|Overall Study|Not Eligible, No treatment|0|||
161069980|NCT03348631|581645476|FG001|Overall Study|Not Eligible, No treatment|1|||
161069981|NCT03348631|581645475|FG000|Overall Study|Not Eligible, Treated|2|||
161069982|NCT03348631|581645476|FG001|Overall Study|Not Eligible, Treated|0|||
161069983|NCT03348631|581645475|FG000|Overall Study|Eligible, No Treatment|1|||
161069984|NCT03348631|581645476|FG001|Overall Study|Eligible, No Treatment|0|||
161069985|NCT01068210|581645477|FG000|Overall Study|Lost to Follow-up|1|||
161069986|NCT01068210|581645478|FG001|Overall Study|Lost to Follow-up|2|||
161069987|NCT01068210|581645479|FG002|Overall Study|Lost to Follow-up|2|||
161069988|NCT01068210|581645480|FG003|Overall Study|Lost to Follow-up|1|||
161069989|NCT01068210|581645477|FG000|Overall Study|Second cancer|0|||
161069990|NCT01068210|581645478|FG001|Overall Study|Second cancer|1|||
161069991|NCT01068210|581645479|FG002|Overall Study|Second cancer|0|||
161069992|NCT01068210|581645480|FG003|Overall Study|Second cancer|0|||
161069993|NCT01068210|581645477|FG000|Overall Study|Disease progression|0|||
161069994|NCT01068210|581645478|FG001|Overall Study|Disease progression|0|||
161069995|NCT01068210|581645479|FG002|Overall Study|Disease progression|0|||
161069996|NCT01068210|581645480|FG003|Overall Study|Disease progression|2|||
161069997|NCT03299959|581645485|FG000|Overall Study|Lost to Follow-up|7|||
161069998|NCT03299959|581645486|FG001|Overall Study|Lost to Follow-up|9|||
161069999|NCT03299959|581645485|FG000|Overall Study|Death|1|||
161070000|NCT03299959|581645486|FG001|Overall Study|Death|0|||
161070001|NCT03299959|581645485|FG000|Overall Study|Withdrawal by Subject|13|||
161070002|NCT03299959|581645486|FG001|Overall Study|Withdrawal by Subject|9|||
161070003|NCT03299959|581645485|FG000|Overall Study|Changes in study team and government regulations|1|||
161070004|NCT03299959|581645486|FG001|Overall Study|Changes in study team and government regulations|1|||
161070005|NCT03299959|581645485|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
161070006|NCT03299959|581645486|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
161070007|NCT02201901|581645488|FG000|Overall Study|Randomized but never treated|0|||
161070008|NCT02201901|581645489|FG001|Overall Study|Randomized but never treated|1|||
161070009|NCT02201901|581645490|FG002|Overall Study|Randomized but never treated|0|||
161070010|NCT02201901|581645488|FG000|Overall Study|Lack of Efficacy|7|||
161070011|NCT02201901|581645489|FG001|Overall Study|Lack of Efficacy|1|||
161070012|NCT02201901|581645490|FG002|Overall Study|Lack of Efficacy|6|||
161345578|NCT02362451|582650862|FG000|Overall Study|Participant chose other therapy.|1|||
161070013|NCT02201901|581645488|FG000|Overall Study|Death|3|||
161345579|NCT02362451|582650863|FG001|Overall Study|Participant chose other therapy.|0|||
161070014|NCT02201901|581645489|FG001|Overall Study|Death|3|||
161070015|NCT02201901|581645490|FG002|Overall Study|Death|3|||
161070016|NCT02201901|581645488|FG000|Overall Study|Lost to Follow-up|2|||
161070017|NCT02201901|581645489|FG001|Overall Study|Lost to Follow-up|3|||
161070018|NCT02201901|581645490|FG002|Overall Study|Lost to Follow-up|2|||
161070019|NCT02201901|581645488|FG000|Overall Study|Withdrew Consent|2|||
161070020|NCT02201901|581645489|FG001|Overall Study|Withdrew Consent|0|||
161070021|NCT02201901|581645490|FG002|Overall Study|Withdrew Consent|2|||
161070022|NCT02201901|581645488|FG000|Overall Study|Adverse Event|1|||
161070023|NCT02201901|581645489|FG001|Overall Study|Adverse Event|1|||
161155786|NCT03249792|581951174|FG015|Switch Over Period|Progressive Disease|0|||
161155787|NCT03249792|581951175|FG016|Switch Over Period|Progressive Disease|0|||
161155788|NCT03249792|581951176|FG017|Switch Over Period|Progressive Disease|0|||
161155789|NCT03249792|581951177|FG018|Switch Over Period|Progressive Disease|0|||
161155790|NCT03249792|581951178|FG019|Switch Over Period|Progressive Disease|0|||
161155791|NCT03249792|581951179|FG020|Switch Over Period|Progressive Disease|0|||
161155792|NCT03249792|581951180|FG021|Switch Over Period|Progressive Disease|0|||
161155793|NCT03249792|581951181|FG022|Switch Over Period|Progressive Disease|0|||
161155794|NCT03249792|581951182|FG023|Switch Over Period|Progressive Disease|0|||
161155795|NCT03249792|581951183|FG024|Switch Over Period|Progressive Disease|0|||
161155796|NCT03249792|581951184|FG025|Switch Over Period|Progressive Disease|0|||
161155797|NCT03249792|581951185|FG026|Switch Over Period|Progressive Disease|1|||
161155798|NCT03249792|581951186|FG027|Switch Over Period|Progressive Disease|0|||
161155799|NCT03249792|581951187|FG028|Switch Over Period|Progressive Disease|1|||
161155800|NCT03249792|581951188|FG029|Switch Over Period|Progressive Disease|2|||
161155801|NCT03249792|581951189|FG030|Switch Over Period|Progressive Disease|1|||
161155802|NCT03249792|581951190|FG031|Switch Over Period|Progressive Disease|0|||
161155803|NCT03249792|581951191|FG032|Switch Over Period|Progressive Disease|1|||
161155804|NCT03249792|581951159|FG000|Switch Over Period|Adverse Event|0|||
161155805|NCT03249792|581951160|FG001|Switch Over Period|Adverse Event|0|||
161070024|NCT02201901|581645490|FG002|Overall Study|Adverse Event|0|||
161070025|NCT01431950|581645493|FG000|Overall Study|Study Site Closed/Terminated|7|||
161070026|NCT01431950|581645494|FG001|Overall Study|Study Site Closed/Terminated|3|||
161070027|NCT01431950|581645493|FG000|Overall Study|Withdrawal by Subject|4|||
161070028|NCT01431950|581645494|FG001|Overall Study|Withdrawal by Subject|3|||
161070029|NCT01431950|581645493|FG000|Overall Study|Protocol Violation|2|||
161070030|NCT01431950|581645494|FG001|Overall Study|Protocol Violation|3|||
161070031|NCT01431950|581645493|FG000|Overall Study|Adverse Event|2|||
161070032|NCT01431950|581645494|FG001|Overall Study|Adverse Event|2|||
161070033|NCT01431950|581645493|FG000|Overall Study|Physician Decision|2|||
161070034|NCT01431950|581645494|FG001|Overall Study|Physician Decision|1|||
161070035|NCT01431950|581645493|FG000|Overall Study|Lack of Efficacy|2|||
161070036|NCT01431950|581645494|FG001|Overall Study|Lack of Efficacy|1|||
161070037|NCT01431950|581645493|FG000|Overall Study|Lost to Follow-up|0|||
161070038|NCT01431950|581645494|FG001|Overall Study|Lost to Follow-up|1|||
161070039|NCT01431950|581645493|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
161070040|NCT01431950|581645494|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
161070041|NCT00738283|581645497|FG000|Overall Study|Death|1|||
161070042|NCT00738283|581645497|FG000|Overall Study|Transfer to another facility|2|||
161070043|NCT00738283|581645497|FG000|Overall Study|Discharge home prior to end of study|1|||
161070044|NCT01210651|581645498|FG000|Overall Study|Lost to Follow-up|1|||
161070045|NCT01210651|581645499|FG001|Overall Study|Lost to Follow-up|1|||
161070046|NCT01210651|581645498|FG000|Overall Study|schedule conflicts|1|||
161070047|NCT01210651|581645499|FG001|Overall Study|schedule conflicts|5|||
161070048|NCT01210651|581645498|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
161070049|NCT01210651|581645499|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
161070050|NCT01210651|581645498|FG000|Overall Study|Withdrawal by Subject|1|||
161070051|NCT01210651|581645499|FG001|Overall Study|Withdrawal by Subject|1|||
161070052|NCT01210651|581645498|FG000|Overall Study|Injury outside study|2|||
161070053|NCT01210651|581645499|FG001|Overall Study|Injury outside study|0|||
161070054|NCT03494985|581645500|FG000|Overall Study|Adverse Event|3|||
161070055|NCT03494985|581645501|FG001|Overall Study|Adverse Event|2|||
161070056|NCT03494985|581645502|FG002|Overall Study|Adverse Event|3|||
161070057|NCT03494985|581645503|FG003|Overall Study|Adverse Event|0|||
161070058|NCT03494985|581645500|FG000|Overall Study|Other (Withdrawal of consent)|2|||
161070059|NCT03494985|581645501|FG001|Overall Study|Other (Withdrawal of consent)|3|||
161070060|NCT03494985|581645502|FG002|Overall Study|Other (Withdrawal of consent)|2|||
161070061|NCT03494985|581645503|FG003|Overall Study|Other (Withdrawal of consent)|5|||
161070062|NCT03494985|581645500|FG000|Overall Study|Other (Not specified)|0|||
161070063|NCT03494985|581645501|FG001|Overall Study|Other (Not specified)|1|||
161070064|NCT03494985|581645502|FG002|Overall Study|Other (Not specified)|1|||
161070065|NCT03494985|581645503|FG003|Overall Study|Other (Not specified)|0|||
161070066|NCT03459846|581645504|FG000|Overall Study|Death|52|||
161070067|NCT03459846|581645505|FG001|Overall Study|Death|46|||
161155806|NCT03249792|581951161|FG002|Switch Over Period|Adverse Event|0|||
161155807|NCT03249792|581951162|FG003|Switch Over Period|Adverse Event|0|||
161155808|NCT03249792|581951163|FG004|Switch Over Period|Adverse Event|0|||
161155809|NCT03249792|581951164|FG005|Switch Over Period|Adverse Event|0|||
161155810|NCT03249792|581951165|FG006|Switch Over Period|Adverse Event|0|||
161070068|NCT03459846|581645504|FG000|Overall Study|Study terminated by sponsor|24|||
161070069|NCT03459846|581645505|FG001|Overall Study|Study terminated by sponsor|28|||
161070070|NCT03459846|581645504|FG000|Overall Study|Withdrawal by Subject|2|||
161070071|NCT03459846|581645505|FG001|Overall Study|Withdrawal by Subject|2|||
161070072|NCT04886518|581645512|FG000|Overall Study|Noncompliance with study drug|1|||
161070073|NCT04886518|581645513|FG001|Overall Study|Noncompliance with study drug|0|||
161155811|NCT03249792|581951166|FG007|Switch Over Period|Adverse Event|0|||
161155812|NCT03249792|581951167|FG008|Switch Over Period|Adverse Event|0|||
161155813|NCT03249792|581951168|FG009|Switch Over Period|Adverse Event|0|||
161155814|NCT03249792|581951169|FG010|Switch Over Period|Adverse Event|0|||
161155815|NCT03249792|581951170|FG011|Switch Over Period|Adverse Event|0|||
161155816|NCT03249792|581951171|FG012|Switch Over Period|Adverse Event|0|||
161155817|NCT03249792|581951172|FG013|Switch Over Period|Adverse Event|0|||
161155818|NCT03249792|581951173|FG014|Switch Over Period|Adverse Event|0|||
161155819|NCT03249792|581951174|FG015|Switch Over Period|Adverse Event|0|||
161155820|NCT03249792|581951175|FG016|Switch Over Period|Adverse Event|0|||
161155821|NCT03249792|581951176|FG017|Switch Over Period|Adverse Event|0|||
161155822|NCT03249792|581951177|FG018|Switch Over Period|Adverse Event|0|||
161155823|NCT03249792|581951178|FG019|Switch Over Period|Adverse Event|0|||
161155824|NCT03249792|581951179|FG020|Switch Over Period|Adverse Event|0|||
161155825|NCT03249792|581951180|FG021|Switch Over Period|Adverse Event|0|||
161155826|NCT03249792|581951181|FG022|Switch Over Period|Adverse Event|0|||
161155827|NCT03249792|581951182|FG023|Switch Over Period|Adverse Event|0|||
161155828|NCT03249792|581951183|FG024|Switch Over Period|Adverse Event|0|||
161155829|NCT03249792|581951184|FG025|Switch Over Period|Adverse Event|1|||
161155830|NCT03249792|581951185|FG026|Switch Over Period|Adverse Event|0|||
161155831|NCT03249792|581951186|FG027|Switch Over Period|Adverse Event|1|||
161155832|NCT03249792|581951187|FG028|Switch Over Period|Adverse Event|0|||
161155833|NCT03249792|581951188|FG029|Switch Over Period|Adverse Event|0|||
161155834|NCT03249792|581951189|FG030|Switch Over Period|Adverse Event|0|||
161155835|NCT03249792|581951190|FG031|Switch Over Period|Adverse Event|0|||
161155836|NCT03249792|581951191|FG032|Switch Over Period|Adverse Event|0|||
161155837|NCT00988559|581951201|FG000|Overall Study|Withdrawal by Subject|1|||
161155838|NCT00988559|581951202|FG001|Overall Study|Withdrawal by Subject|1|||
161155839|NCT00988559|581951203|FG002|Overall Study|Withdrawal by Subject|0|||
161155840|NCT00988559|581951204|FG003|Overall Study|Withdrawal by Subject|1|||
161155841|NCT00988559|581951201|FG000|Overall Study|Pregnancy|0|||
161155842|NCT00988559|581951202|FG001|Overall Study|Pregnancy|1|||
161155843|NCT00988559|581951203|FG002|Overall Study|Pregnancy|1|||
161155844|NCT00988559|581951204|FG003|Overall Study|Pregnancy|0|||
161155845|NCT00988559|581951201|FG000|Overall Study|Lost to Follow-up|0|||
161155846|NCT00988559|581951202|FG001|Overall Study|Lost to Follow-up|0|||
161155847|NCT00988559|581951203|FG002|Overall Study|Lost to Follow-up|1|||
161155848|NCT00988559|581951204|FG003|Overall Study|Lost to Follow-up|0|||
161284407|NCT01130493|582419423|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
161284408|NCT01130493|582419421|FG000|Part 2: OLE|Adverse Event|0|||
161284409|NCT01130493|582419422|FG001|Part 2: OLE|Adverse Event|2|||
161284410|NCT01130493|582419423|FG002|Part 2: OLE|Adverse Event|1|||
161155849|NCT01052012|581951205|FG000|Overall Study|Not treated|2|||
161155850|NCT01052012|581951206|FG001|Overall Study|Not treated|5|||
161155851|NCT01052012|581951207|FG002|Overall Study|Not treated|0|||
161155852|NCT01052012|581951208|FG003|Overall Study|Not treated|0|||
161284411|NCT01130493|582419421|FG000|Part 2: OLE|Withdrawal by Subject|0|||
161284412|NCT01130493|582419422|FG001|Part 2: OLE|Withdrawal by Subject|1|||
161284413|NCT01130493|582419423|FG002|Part 2: OLE|Withdrawal by Subject|4|||
161284414|NCT03541317|582419426|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
161284415|NCT03541317|582419427|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161284416|NCT03541317|582419428|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161284417|NCT03541317|582419429|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161284418|NCT03541317|582419430|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161284419|NCT03541317|582419431|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
161284420|NCT00879086|582419434|FG000|Overall Study|Adverse Event|3|||
161284421|NCT00879086|582419435|FG001|Overall Study|Adverse Event|15|||
161284422|NCT00879086|582419434|FG000|Overall Study|Participant choice|2|||
161284423|NCT00879086|582419435|FG001|Overall Study|Participant choice|2|||
161284424|NCT00879086|582419434|FG000|Overall Study|Progression of disease|40|||
161284425|NCT00879086|582419435|FG001|Overall Study|Progression of disease|26|||
161284426|NCT00879086|582419434|FG000|Overall Study|Withdrawal of consent|2|||
161284427|NCT00879086|582419435|FG001|Overall Study|Withdrawal of consent|1|||
161155853|NCT01052012|581951209|FG004|Overall Study|Not treated|11|||
161155854|NCT01052012|581951210|FG005|Overall Study|Not treated|8|||
161155855|NCT01052012|581951205|FG000|Overall Study|Adverse Event|1|||
161155856|NCT01052012|581951206|FG001|Overall Study|Adverse Event|0|||
161155857|NCT01052012|581951207|FG002|Overall Study|Adverse Event|0|||
161155858|NCT01052012|581951208|FG003|Overall Study|Adverse Event|1|||
161155859|NCT01052012|581951209|FG004|Overall Study|Adverse Event|0|||
161284428|NCT00879086|582419434|FG000|Overall Study|Other|4|||
161284429|NCT00879086|582419435|FG001|Overall Study|Other|6|||
161284430|NCT00879086|582419434|FG000|Overall Study|Death|1|||
161284431|NCT00879086|582419435|FG001|Overall Study|Death|2|||
161155860|NCT01052012|581951210|FG005|Overall Study|Adverse Event|0|||
161155861|NCT01052012|581951205|FG000|Overall Study|Lost to Follow-up|0|||
161155862|NCT01052012|581951206|FG001|Overall Study|Lost to Follow-up|0|||
161155863|NCT01052012|581951207|FG002|Overall Study|Lost to Follow-up|0|||
161155864|NCT01052012|581951208|FG003|Overall Study|Lost to Follow-up|0|||
161155865|NCT01052012|581951209|FG004|Overall Study|Lost to Follow-up|1|||
161155866|NCT01052012|581951210|FG005|Overall Study|Lost to Follow-up|0|||
161284432|NCT04728802|582419436|FG000|Overall Study|Withdrawal by Subject|4|||
161284433|NCT04728802|582419437|FG001|Overall Study|Withdrawal by Subject|20|||
161070074|NCT04886518|581645514|FG002|Overall Study|Noncompliance with study drug|0|||
161070075|NCT04886518|581645512|FG000|Overall Study|Adverse Event|0|||
161070076|NCT04886518|581645513|FG001|Overall Study|Adverse Event|1|||
161070077|NCT04886518|581645514|FG002|Overall Study|Adverse Event|0|||
161070078|NCT04886518|581645512|FG000|Overall Study|Withdrawal by Subject|1|||
161070079|NCT04886518|581645513|FG001|Overall Study|Withdrawal by Subject|0|||
161070080|NCT04886518|581645514|FG002|Overall Study|Withdrawal by Subject|0|||
161070081|NCT01090011|581647840|FG000|Overall Study|Progressive disease|128|||
161070082|NCT01090011|581647840|FG000|Overall Study|Adverse Event|32|||
161070083|NCT01090011|581647840|FG000|Overall Study|Protocol Violation|1|||
161070084|NCT01090011|581647840|FG000|Overall Study|Refusal to start/continue medication|5|||
161070085|NCT01090011|581647840|FG000|Overall Study|Other reason not defined above|5|||
161070086|NCT03778294|581647841|FG000|Overall Study|Death|1|||
161070087|NCT03778294|581647841|FG000|Overall Study|Issues with insurance|1|||
161070088|NCT03778294|581647841|FG000|Overall Study|disease progression before treatment|2|||
161070089|NCT01845805|581647842|FG000|Overall Study|Withdrawal by Subject|1|||
161070090|NCT01845805|581647843|FG001|Overall Study|Withdrawal by Subject|2|||
161070091|NCT01845805|581647842|FG000|Overall Study|Disease Progression|13|||
161070092|NCT01845805|581647843|FG001|Overall Study|Disease Progression|14|||
161070093|NCT01845805|581647842|FG000|Overall Study|Drug-related Toxicity|4|||
161070094|NCT01845805|581647843|FG001|Overall Study|Drug-related Toxicity|0|||
161070095|NCT00127842|581647844|FG000|Overall Study|Adverse Event|15|||
161070096|NCT00127842|581647844|FG000|Overall Study|Withdrawal by Subject|3|||
161070097|NCT00127842|581647844|FG000|Overall Study|Lost to Follow-up|1|||
161070098|NCT00127842|581647844|FG000|Overall Study|Lack of Efficacy|12|||
161070099|NCT00127842|581647844|FG000|Overall Study|Noncompliance|2|||
161070100|NCT00127842|581647844|FG000|Overall Study|Protocol Violation|1|||
161070101|NCT00127842|581647844|FG000|Overall Study|Other|5|||
161070102|NCT01443403|581647845|FG000|Overall Study|Adverse Event|1|||
161070103|NCT01443403|581647846|FG001|Overall Study|Adverse Event|1|||
161070104|NCT01443403|581647847|FG002|Overall Study|Adverse Event|4|||
161070105|NCT01443403|581647848|FG003|Overall Study|Adverse Event|5|||
161070106|NCT01443403|581647845|FG000|Overall Study|Withdrawal by Subject|0|||
161070107|NCT01443403|581647846|FG001|Overall Study|Withdrawal by Subject|1|||
161070108|NCT01443403|581647847|FG002|Overall Study|Withdrawal by Subject|2|||
161070109|NCT01443403|581647848|FG003|Overall Study|Withdrawal by Subject|1|||
161070110|NCT01443403|581647845|FG000|Overall Study|Lost to Follow-up|0|||
161070111|NCT01443403|581647846|FG001|Overall Study|Lost to Follow-up|0|||
161070112|NCT01443403|581647847|FG002|Overall Study|Lost to Follow-up|0|||
161070113|NCT01443403|581647848|FG003|Overall Study|Lost to Follow-up|1|||
161070114|NCT01443403|581647845|FG000|Overall Study|Protocol Violation|2|||
161070115|NCT01443403|581647846|FG001|Overall Study|Protocol Violation|1|||
161070116|NCT01443403|581647847|FG002|Overall Study|Protocol Violation|1|||
161070117|NCT01443403|581647848|FG003|Overall Study|Protocol Violation|1|||
161070118|NCT01443403|581647845|FG000|Overall Study|Use of Prohibited Treatment|2|||
161070119|NCT01443403|581647846|FG001|Overall Study|Use of Prohibited Treatment|3|||
161070120|NCT01443403|581647847|FG002|Overall Study|Use of Prohibited Treatment|0|||
161070121|NCT01443403|581647848|FG003|Overall Study|Use of Prohibited Treatment|0|||
161070122|NCT01443403|581647845|FG000|Overall Study|Other - Miscellaneous|1|||
161070123|NCT01443403|581647846|FG001|Overall Study|Other - Miscellaneous|0|||
161070124|NCT01443403|581647847|FG002|Overall Study|Other - Miscellaneous|0|||
161070125|NCT01443403|581647848|FG003|Overall Study|Other - Miscellaneous|1|||
161070126|NCT03945773|581647849|FG000|Overall Study|Consent Withdrawn|1|||
161070127|NCT03945773|581647850|FG001|Overall Study|Consent Withdrawn|1|||
161070128|NCT03945773|581647849|FG000|Overall Study|Lost to Follow-up|1|||
161070129|NCT03945773|581647850|FG001|Overall Study|Lost to Follow-up|0|||
161070130|NCT03945773|581647849|FG000|Overall Study|Death|46|||
161070131|NCT03945773|581647850|FG001|Overall Study|Death|22|||
161070132|NCT03945773|581647849|FG000|Overall Study|Physician Decision|1|||
161070133|NCT03945773|581647850|FG001|Overall Study|Physician Decision|0|||
161070134|NCT03945773|581647849|FG000|Overall Study|Other|1|||
161070135|NCT03945773|581647850|FG001|Overall Study|Other|0|||
161070136|NCT03945773|581647849|FG000|Overall Study|Ongoing at the time of DCO|4|||
161070137|NCT03945773|581647850|FG001|Overall Study|Ongoing at the time of DCO|3|||
161070138|NCT00725712|581647853|FG000|Overall Study|Withdrawal by Subject|2|||
161070139|NCT00725712|581647854|FG001|Overall Study|Withdrawal by Subject|1|||
161070140|NCT00725712|581647853|FG000|Overall Study|Protocol Violation|1|||
161070141|NCT00725712|581647854|FG001|Overall Study|Protocol Violation|0|||
161070142|NCT00725712|581647853|FG000|Overall Study|Progressive disease|37|||
161070143|NCT00725712|581647854|FG001|Overall Study|Progressive disease|16|||
161070144|NCT00725712|581647853|FG000|Overall Study|Clinical progression not based on RECIST|0|||
161070145|NCT00725712|581647854|FG001|Overall Study|Clinical progression not based on RECIST|3|||
161070146|NCT00725712|581647853|FG000|Overall Study|Adverse Event|5|||
161070147|NCT00725712|581647854|FG001|Overall Study|Adverse Event|5|||
161070148|NCT00725712|581647853|FG000|Overall Study|Death|2|||
161070149|NCT00725712|581647854|FG001|Overall Study|Death|0|||
161155867|NCT01052012|581951205|FG000|Overall Study|Withdrawal by Subject|1|||
161155868|NCT01052012|581951206|FG001|Overall Study|Withdrawal by Subject|1|||
161155869|NCT01052012|581951207|FG002|Overall Study|Withdrawal by Subject|0|||
161155870|NCT01052012|581951208|FG003|Overall Study|Withdrawal by Subject|0|||
161155871|NCT01052012|581951209|FG004|Overall Study|Withdrawal by Subject|3|||
161155872|NCT01052012|581951210|FG005|Overall Study|Withdrawal by Subject|1|||
161155873|NCT01052012|581951205|FG000|Overall Study|Physician Decision|0|||
161155874|NCT01052012|581951206|FG001|Overall Study|Physician Decision|0|||
161155875|NCT01052012|581951207|FG002|Overall Study|Physician Decision|0|||
161155876|NCT01052012|581951208|FG003|Overall Study|Physician Decision|0|||
161155877|NCT01052012|581951209|FG004|Overall Study|Physician Decision|0|||
161155878|NCT01052012|581951210|FG005|Overall Study|Physician Decision|1|||
161155879|NCT01052012|581951205|FG000|Overall Study|Other|0|||
161155880|NCT01052012|581951206|FG001|Overall Study|Other|0|||
161155881|NCT01052012|581951207|FG002|Overall Study|Other|0|||
161155882|NCT01052012|581951208|FG003|Overall Study|Other|0|||
161155883|NCT01052012|581951209|FG004|Overall Study|Other|1|||
161155884|NCT01052012|581951210|FG005|Overall Study|Other|0|||
161155885|NCT02538666|581951214|FG000|Pre-Treatment|Disease progression|1|||
161155886|NCT02538666|581951215|FG001|Pre-Treatment|Disease progression|0|||
161155887|NCT02538666|581951216|FG002|Pre-Treatment|Disease progression|0|||
161155888|NCT02538666|581951214|FG000|Pre-Treatment|no longer meets study criteria|1|||
161155889|NCT02538666|581951215|FG001|Pre-Treatment|no longer meets study criteria|0|||
161155890|NCT02538666|581951216|FG002|Pre-Treatment|no longer meets study criteria|0|||
161155891|NCT02538666|581951214|FG000|Pre-Treatment|Withdrew Consent|0|||
161155892|NCT02538666|581951215|FG001|Pre-Treatment|Withdrew Consent|1|||
161155893|NCT02538666|581951216|FG002|Pre-Treatment|Withdrew Consent|1|||
161155894|NCT02538666|581951214|FG000|Treatment|Disease progression|270|||
161155895|NCT02538666|581951215|FG001|Treatment|Disease progression|227|||
161155896|NCT02538666|581951216|FG002|Treatment|Disease progression|165|||
161155897|NCT02538666|581951214|FG000|Treatment|Study drug toxicity|1|||
161155898|NCT02538666|581951215|FG001|Treatment|Study drug toxicity|29|||
161155899|NCT02538666|581951216|FG002|Treatment|Study drug toxicity|92|||
161155900|NCT02538666|581951214|FG000|Treatment|Death|0|||
161155901|NCT02538666|581951215|FG001|Treatment|Death|2|||
161155902|NCT02538666|581951216|FG002|Treatment|Death|3|||
161155903|NCT02538666|581951214|FG000|Treatment|Adverse event unrelated to study drug|8|||
161155904|NCT02538666|581951215|FG001|Treatment|Adverse event unrelated to study drug|10|||
161155905|NCT02538666|581951216|FG002|Treatment|Adverse event unrelated to study drug|15|||
161155906|NCT02538666|581951214|FG000|Treatment|Participant request to discontinue study treatment|3|||
161155907|NCT02538666|581951215|FG001|Treatment|Participant request to discontinue study treatment|6|||
161155908|NCT02538666|581951216|FG002|Treatment|Participant request to discontinue study treatment|11|||
161155909|NCT02538666|581951214|FG000|Treatment|Participant withdrew consent|2|||
161155910|NCT02538666|581951215|FG001|Treatment|Participant withdrew consent|5|||
161155911|NCT02538666|581951216|FG002|Treatment|Participant withdrew consent|3|||
161155912|NCT02538666|581951214|FG000|Treatment|Lost to Follow-up|0|||
161155913|NCT02538666|581951215|FG001|Treatment|Lost to Follow-up|1|||
161155914|NCT02538666|581951216|FG002|Treatment|Lost to Follow-up|1|||
161155915|NCT02538666|581951214|FG000|Treatment|Maximum clinical benefit|4|||
161155916|NCT02538666|581951215|FG001|Treatment|Maximum clinical benefit|3|||
161155917|NCT02538666|581951216|FG002|Treatment|Maximum clinical benefit|4|||
161155918|NCT02538666|581951214|FG000|Treatment|Poor/non-compliance|0|||
161155919|NCT02538666|581951215|FG001|Treatment|Poor/non-compliance|1|||
161155920|NCT02538666|581951216|FG002|Treatment|Poor/non-compliance|0|||
161155921|NCT02538666|581951214|FG000|Treatment|Participant no longer meets study criteria|0|||
161155922|NCT02538666|581951215|FG001|Treatment|Participant no longer meets study criteria|2|||
161155923|NCT02538666|581951216|FG002|Treatment|Participant no longer meets study criteria|0|||
161155924|NCT02538666|581951214|FG000|Treatment|Administrative reason by sponsor|0|||
161155925|NCT02538666|581951215|FG001|Treatment|Administrative reason by sponsor|0|||
161155926|NCT02538666|581951216|FG002|Treatment|Administrative reason by sponsor|1|||
161155927|NCT02538666|581951214|FG000|Treatment|Other reasons|8|||
161155928|NCT02538666|581951215|FG001|Treatment|Other reasons|15|||
161155929|NCT02538666|581951216|FG002|Treatment|Other reasons|5|||
161155930|NCT02538666|581951214|FG000|Treatment|Not reported|2|||
161155931|NCT02538666|581951215|FG001|Treatment|Not reported|2|||
161155932|NCT02538666|581951216|FG002|Treatment|Not reported|2|||
161155933|NCT00829166|581951217|FG000|Overall Study|Death|305|||
161155934|NCT00829166|581951218|FG001|Overall Study|Death|333|||
161155935|NCT00829166|581951217|FG000|Overall Study|Lost to Follow-up|5|||
161155936|NCT00829166|581951218|FG001|Overall Study|Lost to Follow-up|4|||
161155937|NCT00829166|581951217|FG000|Overall Study|Physician's Decision|4|||
161155938|NCT00829166|581951218|FG001|Overall Study|Physician's Decision|3|||
161155939|NCT00829166|581951217|FG000|Overall Study|Subject's Decision|41|||
161155940|NCT00829166|581951218|FG001|Overall Study|Subject's Decision|55|||
161155941|NCT00829166|581951217|FG000|Overall Study|Sponsor's Decision|137|||
161155942|NCT00829166|581951218|FG001|Overall Study|Sponsor's Decision|98|||
161155943|NCT00829166|581951217|FG000|Overall Study|Reason Not Specified|3|||
161155944|NCT00829166|581951218|FG001|Overall Study|Reason Not Specified|3|||
161155945|NCT04072146|581951223|FG000|Overall Study|Adverse Event|0|||
161155946|NCT04072146|581951224|FG001|Overall Study|Adverse Event|1|||
161155947|NCT02993224|581951225|FG000|Core Phase - Period 1|Adverse Event|4|||
161345580|NCT02239328|582650866|FG000|Overall Study|Benign disease noted at time of surgery|6|||
161345581|NCT02239328|582650866|FG000|Overall Study|Equipment or website malfunction|2|||
161345582|NCT03331562|582650868|FG000|Overall Study|Adverse Event|2|||
161155948|NCT02993224|581951225|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
161155949|NCT02993224|581951225|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
161155950|NCT02993224|581951225|FG000|Core Phase- Period 2|Adverse Event|1|||
161155951|NCT02993224|581951225|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
161155952|NCT02993224|581951225|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
161155953|NCT02993224|581951225|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
161155954|NCT02993224|581951225|FG000|Extension Phase|Adverse Event|3|||
161155955|NCT02993224|581951225|FG000|Extension Phase|Withdrawal by Subject|3|||
161155956|NCT02993224|581951225|FG000|Extension Phase|Lost to Follow-up|2|||
161155957|NCT02993224|581951225|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
161155958|NCT05515601|581951233|FG000|Overall Study|Withdrawal by Subject|1|||
161155959|NCT05515601|581951234|FG001|Overall Study|Withdrawal by Subject|3|||
161155960|NCT05515601|581951235|FG002|Overall Study|Withdrawal by Subject|2|||
161155961|NCT05515601|581951236|FG003|Overall Study|Withdrawal by Subject|1|||
161155962|NCT05515601|581951237|FG004|Overall Study|Withdrawal by Subject|1|||
161155963|NCT05515601|581951238|FG005|Overall Study|Withdrawal by Subject|1|||
161155964|NCT05515601|581951233|FG000|Overall Study|Lost to Follow-up|0|||
161155965|NCT05515601|581951234|FG001|Overall Study|Lost to Follow-up|0|||
161155966|NCT05515601|581951235|FG002|Overall Study|Lost to Follow-up|0|||
161155967|NCT05515601|581951236|FG003|Overall Study|Lost to Follow-up|0|||
161155968|NCT05515601|581951237|FG004|Overall Study|Lost to Follow-up|1|||
161155969|NCT05515601|581951238|FG005|Overall Study|Lost to Follow-up|0|||
161155970|NCT00540436|581951239|FG000|First 12-Week Treatment Period|Adverse Event|1|||
161155971|NCT00540436|581951239|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
161155972|NCT00540436|581951239|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
161155973|NCT00540436|581951239|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
161155974|NCT01515306|581951240|FG000|Overall Study|Adverse Event|3|||
161155975|NCT01515306|581951241|FG001|Overall Study|Adverse Event|2|||
161155976|NCT01515306|581951240|FG000|Overall Study|Progressive Disease|19|||
161155977|NCT01515306|581951241|FG001|Overall Study|Progressive Disease|9|||
161155978|NCT01515306|581951240|FG000|Overall Study|Withdrawal by Subject|1|||
161155979|NCT01515306|581951241|FG001|Overall Study|Withdrawal by Subject|2|||
161155980|NCT01515306|581951240|FG000|Overall Study|Physician Decision|1|||
161155981|NCT01515306|581951241|FG001|Overall Study|Physician Decision|1|||
161155982|NCT02678780|581951243|FG000|Overall Study|Adverse Event|11|||
161155983|NCT02678780|581951244|FG001|Overall Study|Adverse Event|14|||
161155984|NCT02678780|581951243|FG000|Overall Study|Withdrawal by Subject|2|||
161155985|NCT02678780|581951244|FG001|Overall Study|Withdrawal by Subject|1|||
161155986|NCT02678780|581951243|FG000|Overall Study|Sponsor discontinuation|7|||
161155987|NCT02678780|581951244|FG001|Overall Study|Sponsor discontinuation|4|||
161155988|NCT02678780|581951243|FG000|Overall Study|Death|1|||
161155989|NCT02678780|581951244|FG001|Overall Study|Death|1|||
161155990|NCT02678780|581951243|FG000|Overall Study|Other|6|||
161155991|NCT02678780|581951244|FG001|Overall Study|Other|8|||
161155992|NCT01064648|581951257|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
161155993|NCT01064648|581951258|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
161155994|NCT01064648|581951259|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
161155995|NCT01064648|581951260|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
161155996|NCT01064648|581951257|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
161155997|NCT01064648|581951258|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161155998|NCT01064648|581951259|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161155999|NCT01064648|581951260|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
161156000|NCT01064648|581951257|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161156001|NCT01064648|581951258|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
161156002|NCT01064648|581951259|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161156003|NCT01064648|581951260|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
161156004|NCT01064648|581951257|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161156005|NCT01064648|581951258|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
161156006|NCT01064648|581951259|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161156007|NCT01064648|581951260|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
161345583|NCT03331562|582650869|FG001|Overall Study|Adverse Event|0|||
161345584|NCT03331562|582650868|FG000|Overall Study|Death|1|||
161156008|NCT01064648|581951257|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
161156009|NCT01064648|581951258|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
161156010|NCT01064648|581951259|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
161156011|NCT01064648|581951260|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
161156012|NCT01064648|581951257|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161156013|NCT01064648|581951258|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
161156014|NCT01064648|581951259|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161156015|NCT01064648|581951260|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
161156016|NCT01064648|581951257|FG000|Phase II|Adverse Event|0|||
161156017|NCT01064648|581951258|FG001|Phase II|Adverse Event|0|||
161156018|NCT01064648|581951259|FG002|Phase II|Adverse Event|15|||
161156019|NCT01064648|581951260|FG003|Phase II|Adverse Event|8|||
161156020|NCT01064648|581951257|FG000|Phase II|Death|0|||
161156021|NCT01064648|581951258|FG001|Phase II|Death|0|||
161156022|NCT01064648|581951259|FG002|Phase II|Death|4|||
161156023|NCT01064648|581951260|FG003|Phase II|Death|5|||
161156024|NCT01064648|581951257|FG000|Phase II|Withdrawal by Subject|0|||
161156025|NCT01064648|581951258|FG001|Phase II|Withdrawal by Subject|0|||
161156026|NCT01064648|581951259|FG002|Phase II|Withdrawal by Subject|2|||
161156027|NCT01064648|581951260|FG003|Phase II|Withdrawal by Subject|5|||
161156028|NCT01064648|581951257|FG000|Phase II|Progression|0|||
161156029|NCT01064648|581951258|FG001|Phase II|Progression|0|||
161156030|NCT01064648|581951259|FG002|Phase II|Progression|21|||
161156031|NCT01064648|581951260|FG003|Phase II|Progression|27|||
161156032|NCT01064648|581951257|FG000|Phase II|Non-protocol specified|0|||
161156033|NCT01064648|581951258|FG001|Phase II|Non-protocol specified|0|||
161156034|NCT01064648|581951259|FG002|Phase II|Non-protocol specified|5|||
161156035|NCT01064648|581951260|FG003|Phase II|Non-protocol specified|3|||
161156036|NCT01064648|581951257|FG000|Phase II|Under Review|0|||
161156037|NCT01064648|581951258|FG001|Phase II|Under Review|0|||
161156038|NCT01064648|581951259|FG002|Phase II|Under Review|2|||
161156039|NCT01064648|581951260|FG003|Phase II|Under Review|0|||
161156040|NCT05513391|581951261|FG000|Overall Study|Adverse Event|1|||
161156041|NCT05513391|581951262|FG001|Overall Study|Adverse Event|0|||
161156042|NCT05513391|581951261|FG000|Overall Study|Protocol Deviation|0|||
161156043|NCT05513391|581951262|FG001|Overall Study|Protocol Deviation|1|||
161156044|NCT05513391|581951261|FG000|Overall Study|Withdrawal by Subject|3|||
161156045|NCT05513391|581951262|FG001|Overall Study|Withdrawal by Subject|1|||
161156046|NCT05513391|581951261|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161156047|NCT05513391|581951262|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
161156048|NCT05513391|581951261|FG000|Overall Study|Lost to Follow-up|0|||
161156049|NCT05513391|581951262|FG001|Overall Study|Lost to Follow-up|2|||
161156050|NCT02429427|581951263|FG000|Overall Study|Adverse Event|220|||
161156051|NCT02429427|581951264|FG001|Overall Study|Adverse Event|92|||
161156052|NCT02429427|581951263|FG000|Overall Study|Protocol Violation|10|||
161156053|NCT02429427|581951264|FG001|Overall Study|Protocol Violation|6|||
161156054|NCT02429427|581951263|FG000|Overall Study|Lost to Follow-up|15|||
161156055|NCT02429427|581951264|FG001|Overall Study|Lost to Follow-up|6|||
161156056|NCT02429427|581951263|FG000|Overall Study|Withdrawal by Subject|64|||
161156057|NCT02429427|581951264|FG001|Overall Study|Withdrawal by Subject|34|||
161156058|NCT02429427|581951263|FG000|Overall Study|Other|62|||
161156059|NCT02429427|581951264|FG001|Overall Study|Other|41|||
161156060|NCT00719732|581951265|FG000|Overall Study|Lost to Follow-up|20|||
161156061|NCT00719732|581951265|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
161156062|NCT00719732|581951265|FG000|Overall Study|Illness not associated with device|1|||
161156063|NCT00309777|581951270|FG000|Overall Study|Adverse Event|13|||
161156064|NCT00309777|581951271|FG001|Overall Study|Adverse Event|2|||
161156065|NCT00309777|581951272|FG002|Overall Study|Adverse Event|8|||
161156066|NCT00309777|581951273|FG003|Overall Study|Adverse Event|1|||
161156067|NCT00309777|581951270|FG000|Overall Study|Protocol Violation|4|||
161156068|NCT00309777|581951271|FG001|Overall Study|Protocol Violation|1|||
161156069|NCT00309777|581951272|FG002|Overall Study|Protocol Violation|3|||
161156070|NCT00309777|581951273|FG003|Overall Study|Protocol Violation|1|||
161156071|NCT00309777|581951270|FG000|Overall Study|Withdrawal by Subject|6|||
161156072|NCT00309777|581951271|FG001|Overall Study|Withdrawal by Subject|5|||
161156073|NCT00309777|581951272|FG002|Overall Study|Withdrawal by Subject|7|||
161156074|NCT00309777|581951273|FG003|Overall Study|Withdrawal by Subject|2|||
161284434|NCT04728802|582419436|FG000|Overall Study|Physician Decision|7|||
161284435|NCT04728802|582419437|FG001|Overall Study|Physician Decision|7|||
161156075|NCT00309777|581951270|FG000|Overall Study|Lost to Follow-up|0|||
161156076|NCT00309777|581951271|FG001|Overall Study|Lost to Follow-up|0|||
161156077|NCT00309777|581951272|FG002|Overall Study|Lost to Follow-up|1|||
161156078|NCT00309777|581951273|FG003|Overall Study|Lost to Follow-up|0|||
161156079|NCT00309777|581951270|FG000|Overall Study|Death|0|||
161156080|NCT00309777|581951271|FG001|Overall Study|Death|1|||
161156081|NCT00309777|581951272|FG002|Overall Study|Death|0|||
161156082|NCT00309777|581951273|FG003|Overall Study|Death|0|||
161284436|NCT04728802|582419436|FG000|Overall Study|Protocol Violation|10|||
161156083|NCT00683475|581952828|FG000|Overall Study|Withdrawal by Subject|1|||
161156084|NCT00683475|581952829|FG001|Overall Study|Withdrawal by Subject|0|||
161156085|NCT00683475|581952828|FG000|Overall Study|Never Treated: Adverse Event|2|||
161284437|NCT04728802|582419437|FG001|Overall Study|Protocol Violation|4|||
161156086|NCT00683475|581952829|FG001|Overall Study|Never Treated: Adverse Event|3|||
161156087|NCT00683475|581952828|FG000|Overall Study|Never Treated: Progressive Disease|1|||
161156088|NCT00683475|581952829|FG001|Overall Study|Never Treated: Progressive Disease|0|||
161156089|NCT01251276|581952833|FG000|Overall Study|Protocol Violation|1|||
161156090|NCT01251276|581952834|FG001|Overall Study|Protocol Violation|0|||
161156091|NCT01251276|581952833|FG000|Overall Study|Lost to Follow-up|0|||
161156092|NCT01251276|581952834|FG001|Overall Study|Lost to Follow-up|1|||
161156093|NCT01725152|581952835|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
161156094|NCT01725152|581952836|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
161156095|NCT01725152|581952835|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
161156096|NCT01725152|581952836|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
161156097|NCT01725152|581952835|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
161156098|NCT01725152|581952836|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
161156099|NCT01725152|581952835|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
161156100|NCT01725152|581952836|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
161156101|NCT02044159|581952837|FG000|Overall Study|Consent declined (deferred consent)|2|||
161156102|NCT02044159|581952838|FG001|Overall Study|Consent declined (deferred consent)|4|||
161156103|NCT02044159|581952837|FG000|Overall Study|No longer eligible, drug not given|1|||
161156104|NCT02044159|581952838|FG001|Overall Study|No longer eligible, drug not given|0|||
161156105|NCT02044159|581952837|FG000|Overall Study|Nurse declined to give study drug|1|||
161156106|NCT02044159|581952838|FG001|Overall Study|Nurse declined to give study drug|0|||
161156107|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
161156108|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161156109|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161156110|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161156111|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
161156112|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
161156113|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161156114|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161156115|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161156116|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
161156117|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
161156118|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161156119|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161156120|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161156121|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
161156122|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
161156123|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161156124|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161156125|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161156126|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
161156127|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
161156128|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161156129|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161156130|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161156131|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
161156132|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
161156133|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161156134|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161156135|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161156136|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
161156137|NCT01111539|581952841|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
161156138|NCT01111539|581952842|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161156139|NCT01111539|581952843|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161156140|NCT01111539|581952844|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161156141|NCT01111539|581952845|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
161156142|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161156143|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161156144|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161156145|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
161156146|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
161156147|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161156148|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161156149|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
161156150|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
161156151|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
161156152|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
161156153|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
161284438|NCT04728802|582419436|FG000|Overall Study|Transfer|1|||
161284439|NCT04728802|582419437|FG001|Overall Study|Transfer|0|||
161284440|NCT04728802|582419436|FG000|Overall Study|Death|4|||
161284441|NCT04728802|582419437|FG001|Overall Study|Death|5|||
161284442|NCT04728802|582419436|FG000|Overall Study|Other|3|||
161284443|NCT04728802|582419437|FG001|Overall Study|Other|0|||
161284444|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
161284445|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Off-label use|283|||
161284446|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
161156154|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
161156155|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161156156|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
161156157|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161156158|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161156159|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161156160|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
161156161|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
161156162|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161156163|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161156164|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161156165|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
161156166|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
161156167|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161156168|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161156169|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161156170|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
161156171|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
161156172|NCT01111539|581952841|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161156173|NCT01111539|581952842|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161156174|NCT01111539|581952843|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161156175|NCT01111539|581952844|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
161156176|NCT01111539|581952845|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
161156177|NCT03580382|581952850|FG000|Overall Study|Early Termination of Study|0|||
161156178|NCT03580382|581952851|FG001|Overall Study|Early Termination of Study|3|||
161156179|NCT02808312|581952852|FG000|Overall Study|Enrolled but Never Treated|0|||
161156180|NCT02808312|581952853|FG001|Overall Study|Enrolled but Never Treated|0|||
161156181|NCT02808312|581952854|FG002|Overall Study|Enrolled but Never Treated|1|||
161156182|NCT02808312|581952855|FG003|Overall Study|Enrolled but Never Treated|0|||
161156183|NCT02808312|581952856|FG004|Overall Study|Enrolled but Never Treated|0|||
161156184|NCT03628417|581952857|FG000|Overall Study|Death|1|||
161156185|NCT03628417|581952858|FG001|Overall Study|Death|1|||
161156186|NCT02420223|581952859|FG000|Overall Study|Adverse Event|1|||
161156187|NCT02420223|581952860|FG001|Overall Study|Adverse Event|0|||
161156188|NCT02420223|581952859|FG000|Overall Study|Physician Decision|0|||
161156189|NCT02420223|581952860|FG001|Overall Study|Physician Decision|2|||
161156190|NCT01361009|581952861|FG000|Overall Study|Protocol Violation|116|||
161156191|NCT01826422|581952862|FG000|Overall Study|Withdrawal by Subject|1|||
161156192|NCT01826422|581952863|FG001|Overall Study|Withdrawal by Subject|3|||
161156193|NCT03484923|581952870|FG000|Overall Study|Adverse Event|3|||
161156194|NCT03484923|581952871|FG001|Overall Study|Adverse Event|3|||
161156195|NCT03484923|581952872|FG002|Overall Study|Adverse Event|5|||
161156196|NCT03484923|581952873|FG003|Overall Study|Adverse Event|11|||
161156197|NCT03484923|581952874|FG004|Overall Study|Adverse Event|1|||
161156198|NCT03484923|581952870|FG000|Overall Study|Death|2|||
161156199|NCT03484923|581952871|FG001|Overall Study|Death|2|||
161156200|NCT03484923|581952872|FG002|Overall Study|Death|3|||
161156201|NCT03484923|581952873|FG003|Overall Study|Death|0|||
161156202|NCT03484923|581952874|FG004|Overall Study|Death|1|||
161156203|NCT03484923|581952870|FG000|Overall Study|Physician Decision|6|||
161156204|NCT03484923|581952871|FG001|Overall Study|Physician Decision|7|||
161284447|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
161284448|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
161284449|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
161284450|NCT01070953|582419441|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
161284451|NCT01070953|582419441|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
161284452|NCT01070953|582419441|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
161284453|NCT01070953|582419441|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
161284454|NCT04700137|582419442|FG000|Overall Study|Lost to Follow-up|1|||
161284455|NCT04700137|582419443|FG001|Overall Study|Lost to Follow-up|6|||
161156205|NCT03484923|581952872|FG002|Overall Study|Physician Decision|6|||
161156206|NCT03484923|581952873|FG003|Overall Study|Physician Decision|3|||
161156207|NCT03484923|581952874|FG004|Overall Study|Physician Decision|2|||
161284456|NCT04700137|582419444|FG002|Overall Study|Lost to Follow-up|1|||
161070150|NCT00725712|581647853|FG000|Overall Study|Other: Death|1|||
161070151|NCT00725712|581647854|FG001|Overall Study|Other: Death|0|||
161070152|NCT00725712|581647853|FG000|Overall Study|Hospitalized, unable to continue|0|||
161070153|NCT00725712|581647854|FG001|Overall Study|Hospitalized, unable to continue|1|||
161070154|NCT03595124|581647858|FG000|Overall Study|Physician Decision|1|||
161070155|NCT03595124|581647859|FG001|Overall Study|Physician Decision|1|||
161070156|NCT03595124|581647860|FG002|Overall Study|Physician Decision|1|||
161070157|NCT03595124|581647858|FG000|Overall Study|Ineligible|1|||
161070158|NCT03595124|581647859|FG001|Overall Study|Ineligible|1|||
161070159|NCT03595124|581647860|FG002|Overall Study|Ineligible|0|||
161070160|NCT03595124|581647858|FG000|Overall Study|Disease Progression|4|||
161070161|NCT03595124|581647859|FG001|Overall Study|Disease Progression|1|||
161070162|NCT03595124|581647860|FG002|Overall Study|Disease Progression|4|||
161070163|NCT01439867|581647861|FG000|Overall Study|Non-compliance|0|||
161070164|NCT01439867|581647862|FG001|Overall Study|Non-compliance|1|||
161070165|NCT01439867|581647861|FG000|Overall Study|Withdrawal by Subject|1|||
161070166|NCT01439867|581647862|FG001|Overall Study|Withdrawal by Subject|2|||
161070167|NCT01439867|581647861|FG000|Overall Study|Administrative Decision|4|||
161070168|NCT01439867|581647862|FG001|Overall Study|Administrative Decision|5|||
161070169|NCT01439867|581647861|FG000|Overall Study|Protocol-specified Criteria|1|||
161070170|NCT01439867|581647862|FG001|Overall Study|Protocol-specified Criteria|0|||
161070171|NCT03607422|581647863|FG000|Overall Study|Adverse Event|7|||
161070172|NCT03607422|581647864|FG001|Overall Study|Adverse Event|3|||
161070173|NCT03607422|581647865|FG002|Overall Study|Adverse Event|2|||
161070174|NCT03607422|581647866|FG003|Overall Study|Adverse Event|0|||
161070175|NCT03607422|581647867|FG004|Overall Study|Adverse Event|2|||
161070176|NCT03607422|581647868|FG005|Overall Study|Adverse Event|0|||
161070177|NCT03607422|581647863|FG000|Overall Study|Withdrawal by Subject|11|||
161070178|NCT03607422|581647864|FG001|Overall Study|Withdrawal by Subject|3|||
161070179|NCT03607422|581647865|FG002|Overall Study|Withdrawal by Subject|6|||
161070180|NCT03607422|581647866|FG003|Overall Study|Withdrawal by Subject|2|||
161070181|NCT03607422|581647867|FG004|Overall Study|Withdrawal by Subject|0|||
161070182|NCT03607422|581647868|FG005|Overall Study|Withdrawal by Subject|0|||
161070183|NCT03607422|581647863|FG000|Overall Study|Lost to Follow-up|0|||
161070184|NCT03607422|581647864|FG001|Overall Study|Lost to Follow-up|0|||
161070185|NCT03607422|581647865|FG002|Overall Study|Lost to Follow-up|1|||
161070186|NCT03607422|581647866|FG003|Overall Study|Lost to Follow-up|0|||
161070187|NCT03607422|581647867|FG004|Overall Study|Lost to Follow-up|0|||
161070188|NCT03607422|581647868|FG005|Overall Study|Lost to Follow-up|0|||
161070189|NCT03607422|581647863|FG000|Overall Study|Other|12|||
161070190|NCT03607422|581647864|FG001|Overall Study|Other|4|||
161070191|NCT03607422|581647865|FG002|Overall Study|Other|1|||
161070192|NCT03607422|581647866|FG003|Overall Study|Other|2|||
161070193|NCT03607422|581647867|FG004|Overall Study|Other|0|||
161070194|NCT03607422|581647868|FG005|Overall Study|Other|2|||
161070195|NCT03607422|581647863|FG000|Overall Study|Ongoing at Time of Analysis|8|||
161070196|NCT03607422|581647864|FG001|Overall Study|Ongoing at Time of Analysis|0|||
161070197|NCT03607422|581647865|FG002|Overall Study|Ongoing at Time of Analysis|2|||
161070198|NCT03607422|581647866|FG003|Overall Study|Ongoing at Time of Analysis|1|||
161070199|NCT03607422|581647867|FG004|Overall Study|Ongoing at Time of Analysis|1|||
161070200|NCT03607422|581647868|FG005|Overall Study|Ongoing at Time of Analysis|1|||
161070201|NCT03258723|581647871|FG000|Overall Study|COVID Interruption of study|54|||
161070202|NCT03258723|581647871|FG000|Overall Study|Lost to Follow-up|8|||
161070203|NCT04832971|581647872|FG000|Double-Blind (DB) Treatment Period|Death|1|||
161070204|NCT04832971|581647873|FG001|Double-Blind (DB) Treatment Period|Death|0|||
161070205|NCT04832971|581647874|FG002|Double-Blind (DB) Treatment Period|Death|0|||
161070206|NCT04832971|581647875|FG003|Double-Blind (DB) Treatment Period|Death|0|||
161070207|NCT04832971|581647876|FG004|Double-Blind (DB) Treatment Period|Death|0|||
161070208|NCT04832971|581647877|FG005|Double-Blind (DB) Treatment Period|Death|0|||
161070209|NCT04832971|581647878|FG006|Double-Blind (DB) Treatment Period|Death|0|||
161070210|NCT04832971|581647879|FG007|Double-Blind (DB) Treatment Period|Death|0|||
161070211|NCT04832971|581647880|FG008|Double-Blind (DB) Treatment Period|Death|0|||
161070212|NCT04832971|581647881|FG009|Double-Blind (DB) Treatment Period|Death|0|||
161070213|NCT04832971|581647872|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161070214|NCT04832971|581647873|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161070215|NCT04832971|581647874|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
161070216|NCT04832971|581647875|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161070217|NCT04832971|581647876|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161156208|NCT03484923|581952870|FG000|Overall Study|Progressive disease|33|||
161070218|NCT04832971|581647877|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161156209|NCT03484923|581952871|FG001|Overall Study|Progressive disease|28|||
161070219|NCT04832971|581647878|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161070220|NCT04832971|581647879|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161070221|NCT04832971|581647880|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161070222|NCT04832971|581647881|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
161070223|NCT04832971|581647872|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161156210|NCT03484923|581952872|FG002|Overall Study|Progressive disease|26|||
161284457|NCT04700137|582419445|FG003|Overall Study|Lost to Follow-up|1|||
161284458|NCT04700137|582419442|FG000|Overall Study|Withdrawal by Subject|0|||
161284459|NCT04700137|582419443|FG001|Overall Study|Withdrawal by Subject|0|||
161284460|NCT04700137|582419444|FG002|Overall Study|Withdrawal by Subject|1|||
161284461|NCT04700137|582419445|FG003|Overall Study|Withdrawal by Subject|0|||
161284462|NCT04700137|582419442|FG000|Overall Study|Death|0|||
161284463|NCT04700137|582419443|FG001|Overall Study|Death|0|||
161284464|NCT04700137|582419444|FG002|Overall Study|Death|1|||
161284465|NCT04700137|582419445|FG003|Overall Study|Death|0|||
161284466|NCT03449446|582419448|FG000|Overall Study|Randomized but Never Treated|0|||
161284467|NCT03449446|582419449|FG001|Overall Study|Randomized but Never Treated|0|||
161284468|NCT03449446|582419450|FG002|Overall Study|Randomized but Never Treated|1|||
161284469|NCT03449446|582419451|FG003|Overall Study|Randomized but Never Treated|1|||
161284470|NCT03449446|582419452|FG004|Overall Study|Randomized but Never Treated|1|||
161284471|NCT03449446|582419453|FG005|Overall Study|Randomized but Never Treated|0|||
161284472|NCT03449446|582419454|FG006|Overall Study|Randomized but Never Treated|0|||
161284473|NCT03449446|582419448|FG000|Overall Study|Unknown Reason|33|||
161284474|NCT03449446|582419449|FG001|Overall Study|Unknown Reason|1|||
161284475|NCT03449446|582419450|FG002|Overall Study|Unknown Reason|1|||
161284476|NCT03449446|582419451|FG003|Overall Study|Unknown Reason|1|||
161284477|NCT03449446|582419452|FG004|Overall Study|Unknown Reason|2|||
161284478|NCT03449446|582419453|FG005|Overall Study|Unknown Reason|2|||
161284479|NCT03449446|582419454|FG006|Overall Study|Unknown Reason|0|||
161284480|NCT03449446|582419448|FG000|Overall Study|Withdrew Consent|1|||
161284481|NCT03449446|582419449|FG001|Overall Study|Withdrew Consent|3|||
161284482|NCT03449446|582419450|FG002|Overall Study|Withdrew Consent|1|||
161284483|NCT03449446|582419451|FG003|Overall Study|Withdrew Consent|4|||
161284484|NCT03449446|582419452|FG004|Overall Study|Withdrew Consent|4|||
161284485|NCT03449446|582419453|FG005|Overall Study|Withdrew Consent|4|||
161284486|NCT03449446|582419454|FG006|Overall Study|Withdrew Consent|1|||
161284487|NCT03449446|582419448|FG000|Overall Study|Adverse Event|1|||
161284488|NCT03449446|582419449|FG001|Overall Study|Adverse Event|2|||
161284489|NCT03449446|582419450|FG002|Overall Study|Adverse Event|1|||
161284490|NCT03449446|582419451|FG003|Overall Study|Adverse Event|0|||
161284491|NCT03449446|582419452|FG004|Overall Study|Adverse Event|0|||
161284492|NCT03449446|582419453|FG005|Overall Study|Adverse Event|2|||
161284493|NCT03449446|582419454|FG006|Overall Study|Adverse Event|0|||
161284494|NCT03449446|582419448|FG000|Overall Study|Lost to Follow-up|0|||
161284495|NCT03449446|582419449|FG001|Overall Study|Lost to Follow-up|0|||
161284496|NCT03449446|582419450|FG002|Overall Study|Lost to Follow-up|2|||
161284497|NCT03449446|582419451|FG003|Overall Study|Lost to Follow-up|1|||
161284498|NCT03449446|582419452|FG004|Overall Study|Lost to Follow-up|3|||
161284499|NCT03449446|582419453|FG005|Overall Study|Lost to Follow-up|0|||
161284500|NCT03449446|582419454|FG006|Overall Study|Lost to Follow-up|0|||
161284501|NCT03449446|582419448|FG000|Overall Study|Investigator's Discretion|0|||
161284502|NCT03449446|582419449|FG001|Overall Study|Investigator's Discretion|1|||
161284503|NCT03449446|582419450|FG002|Overall Study|Investigator's Discretion|1|||
161284504|NCT03449446|582419451|FG003|Overall Study|Investigator's Discretion|2|||
161284505|NCT03449446|582419452|FG004|Overall Study|Investigator's Discretion|0|||
161284506|NCT03449446|582419453|FG005|Overall Study|Investigator's Discretion|0|||
161284507|NCT03449446|582419454|FG006|Overall Study|Investigator's Discretion|0|||
161284508|NCT03449446|582419448|FG000|Overall Study|Non Compliance with Study Drug|1|||
161284509|NCT03449446|582419449|FG001|Overall Study|Non Compliance with Study Drug|0|||
161284510|NCT03449446|582419450|FG002|Overall Study|Non Compliance with Study Drug|0|||
161284511|NCT03449446|582419451|FG003|Overall Study|Non Compliance with Study Drug|0|||
161284512|NCT03449446|582419452|FG004|Overall Study|Non Compliance with Study Drug|0|||
161284513|NCT03449446|582419453|FG005|Overall Study|Non Compliance with Study Drug|0|||
161284514|NCT03449446|582419454|FG006|Overall Study|Non Compliance with Study Drug|0|||
161284515|NCT03449446|582419448|FG000|Overall Study|Protocol Violation|0|||
161284516|NCT03449446|582419449|FG001|Overall Study|Protocol Violation|0|||
161284517|NCT03449446|582419450|FG002|Overall Study|Protocol Violation|0|||
161345585|NCT03331562|582650869|FG001|Overall Study|Death|0|||
161345586|NCT03718000|582650877|FG000|Overall Study|Relocation|2|||
161070224|NCT04832971|581647873|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161070225|NCT04832971|581647874|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
161070226|NCT04832971|581647875|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
161070227|NCT04832971|581647876|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161070228|NCT04832971|581647877|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161070229|NCT04832971|581647878|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161284518|NCT03449446|582419451|FG003|Overall Study|Protocol Violation|0|||
161284519|NCT03449446|582419452|FG004|Overall Study|Protocol Violation|1|||
161284520|NCT03449446|582419453|FG005|Overall Study|Protocol Violation|1|||
161284521|NCT03449446|582419454|FG006|Overall Study|Protocol Violation|0|||
161284522|NCT03449446|582419448|FG000|Overall Study|Death|0|||
161284523|NCT03449446|582419449|FG001|Overall Study|Death|0|||
161284524|NCT03449446|582419450|FG002|Overall Study|Death|0|||
161284525|NCT03449446|582419451|FG003|Overall Study|Death|0|||
161345587|NCT03718000|582650878|FG001|Overall Study|Relocation|4|||
161156211|NCT03484923|581952873|FG003|Overall Study|Progressive disease|30|||
161156212|NCT03484923|581952874|FG004|Overall Study|Progressive disease|16|||
161156213|NCT03484923|581952870|FG000|Overall Study|Subject Decision|1|||
161156214|NCT03484923|581952871|FG001|Overall Study|Subject Decision|3|||
161156215|NCT03484923|581952872|FG002|Overall Study|Subject Decision|3|||
161156216|NCT03484923|581952873|FG003|Overall Study|Subject Decision|0|||
161156217|NCT03484923|581952874|FG004|Overall Study|Subject Decision|1|||
161156218|NCT01597557|581952877|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
161156219|NCT01597557|581952878|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
161156220|NCT00115349|581952881|FG000|Overall Study|Study closed due to low enrollment.|11|||
161156221|NCT00115349|581952882|FG001|Overall Study|Study closed due to low enrollment.|9|||
161156222|NCT06150573|581952888|FG000|Overall Study|Did not meet study criteria|1|||
161156223|NCT06150573|581952889|FG001|Overall Study|Did not meet study criteria|0|||
161156224|NCT06150573|581952888|FG000|Overall Study|Adverse Event|1|||
161156225|NCT06150573|581952889|FG001|Overall Study|Adverse Event|0|||
161156226|NCT06150573|581952888|FG000|Overall Study|Lost to Follow-up|0|||
161284526|NCT03449446|582419452|FG004|Overall Study|Death|1|||
161284527|NCT03449446|582419453|FG005|Overall Study|Death|0|||
161284528|NCT03449446|582419454|FG006|Overall Study|Death|0|||
161156227|NCT06150573|581952889|FG001|Overall Study|Lost to Follow-up|1|||
161156228|NCT06150573|581952888|FG000|Overall Study|Protocol Violation|0|||
161156229|NCT06150573|581952889|FG001|Overall Study|Protocol Violation|1|||
161156230|NCT06150573|581952888|FG000|Overall Study|Withdrawal by Subject|2|||
161156231|NCT06150573|581952889|FG001|Overall Study|Withdrawal by Subject|0|||
161156232|NCT00210158|581952890|FG000|Overall Study|Protocol Violation|0|||
161156233|NCT00210158|581952891|FG001|Overall Study|Protocol Violation|2|||
161156234|NCT01327651|581952892|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
161156235|NCT01327651|581952893|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
161156236|NCT01327651|581952894|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
161156237|NCT01327651|581952895|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
161156238|NCT01327651|581952896|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
161156239|NCT01327651|581952897|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
161156240|NCT01327651|581952898|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
161156241|NCT01327651|581952899|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
161156242|NCT01327651|581952900|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
161156243|NCT01327651|581952892|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
161156244|NCT01327651|581952893|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156245|NCT01327651|581952894|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156246|NCT01327651|581952895|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156247|NCT01327651|581952896|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156248|NCT01327651|581952897|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156249|NCT01327651|581952898|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156250|NCT01327651|581952899|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156251|NCT01327651|581952900|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
161156252|NCT01327651|581952892|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
161156253|NCT01327651|581952893|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
161156254|NCT01327651|581952894|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
161156255|NCT01327651|581952895|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
161156256|NCT01327651|581952896|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
161156257|NCT01327651|581952897|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
161156258|NCT01327651|581952898|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
161156259|NCT01327651|581952899|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
161156260|NCT01327651|581952900|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
161156261|NCT01327651|581952892|FG000|Post Study Follow-up|Lost to Follow-up|0|||
161156262|NCT01327651|581952893|FG001|Post Study Follow-up|Lost to Follow-up|1|||
161156263|NCT01327651|581952894|FG002|Post Study Follow-up|Lost to Follow-up|1|||
161284529|NCT03180645|582419467|FG000|Overall Study|Adverse Event|0|||
161284530|NCT03180645|582419468|FG001|Overall Study|Adverse Event|1|||
161284531|NCT03180645|582419469|FG002|Overall Study|Adverse Event|2|||
161284532|NCT04208750|582419470|FG000|Overall Study|Lost to Follow-up|16|||
161284533|NCT04208750|582419471|FG001|Overall Study|Lost to Follow-up|15|||
161156264|NCT01327651|581952895|FG003|Post Study Follow-up|Lost to Follow-up|0|||
161156265|NCT01327651|581952896|FG004|Post Study Follow-up|Lost to Follow-up|0|||
161156266|NCT01327651|581952897|FG005|Post Study Follow-up|Lost to Follow-up|0|||
161156267|NCT01327651|581952898|FG006|Post Study Follow-up|Lost to Follow-up|4|||
161156268|NCT01327651|581952899|FG007|Post Study Follow-up|Lost to Follow-up|1|||
161156269|NCT01327651|581952900|FG008|Post Study Follow-up|Lost to Follow-up|2|||
161156270|NCT02284906|581952905|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161156271|NCT02284906|581952906|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161156272|NCT02284906|581952907|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161156273|NCT02284906|581952905|FG000|Overall Study|Major Protocol Deviation|0|||
161284534|NCT02201277|582419472|FG000|Overall Study|Death|3|||
161284535|NCT02201277|582419473|FG001|Overall Study|Death|4|||
161156274|NCT02284906|581952906|FG001|Overall Study|Major Protocol Deviation|1|||
161156275|NCT02284906|581952907|FG002|Overall Study|Major Protocol Deviation|0|||
161156276|NCT02284906|581952905|FG000|Overall Study|Voluntary Withdrawal|2|||
161156277|NCT02284906|581952906|FG001|Overall Study|Voluntary Withdrawal|4|||
161156278|NCT02284906|581952907|FG002|Overall Study|Voluntary Withdrawal|5|||
161156279|NCT02284906|581952905|FG000|Overall Study|Study Termination|0|||
161156280|NCT02284906|581952906|FG001|Overall Study|Study Termination|11|||
161156281|NCT02284906|581952907|FG002|Overall Study|Study Termination|14|||
161156282|NCT02284906|581952905|FG000|Overall Study|Reason not Specified|1|||
161156283|NCT02284906|581952906|FG001|Overall Study|Reason not Specified|1|||
161156284|NCT02284906|581952907|FG002|Overall Study|Reason not Specified|0|||
161156285|NCT01409031|581952908|FG000|Overall Study|transferred to other hosp|1|||
161156286|NCT01409031|581952909|FG001|Overall Study|transferred to other hosp|0|||
161156287|NCT00532948|581952910|FG000|Overall Study|Protocol Violation|1|||
161156288|NCT00532948|581952911|FG001|Overall Study|Protocol Violation|0|||
161156289|NCT00532948|581952912|FG002|Overall Study|Protocol Violation|0|||
161156290|NCT00532948|581952910|FG000|Overall Study|Death|3|||
161156291|NCT00532948|581952911|FG001|Overall Study|Death|3|||
161156292|NCT00532948|581952912|FG002|Overall Study|Death|4|||
161156293|NCT00532948|581952910|FG000|Overall Study|Violation of selection criteria at entry|0|||
161156294|NCT00532948|581952911|FG001|Overall Study|Violation of selection criteria at entry|1|||
161156295|NCT00532948|581952912|FG002|Overall Study|Violation of selection criteria at entry|0|||
161156296|NCT00532948|581952910|FG000|Overall Study|Failure to return|0|||
161284536|NCT02201277|582419472|FG000|Overall Study|Lost to Follow-up|2|||
161284537|NCT02201277|582419473|FG001|Overall Study|Lost to Follow-up|1|||
161284538|NCT02201277|582419472|FG000|Overall Study|Failed retrieval|1|||
161284539|NCT02201277|582419473|FG001|Overall Study|Failed retrieval|0|||
161284540|NCT02201277|582419472|FG000|Overall Study|Physician Decision|1|||
161284541|NCT02201277|582419473|FG001|Overall Study|Physician Decision|0|||
161284542|NCT05022212|582419476|FG000|Overall Study|Lost to Follow-up|0|||
161284543|NCT05022212|582419477|FG001|Overall Study|Lost to Follow-up|2|||
161284544|NCT02905032|582419478|FG000|Overall Study|Withdrawal by Subject|2|||
161284545|NCT02905032|582419479|FG001|Overall Study|Withdrawal by Subject|0|||
161284546|NCT02905032|582419480|FG002|Overall Study|Withdrawal by Subject|0|||
161284547|NCT02905032|582419478|FG000|Overall Study|Protocol Violation|6|||
161284548|NCT02905032|582419479|FG001|Overall Study|Protocol Violation|12|||
161284549|NCT02905032|582419480|FG002|Overall Study|Protocol Violation|0|||
161284550|NCT00739063|582419481|FG000|Overall Study|Screen failures|8|||
161284551|NCT01625091|582419482|FG000|Intervention|Death|1|||
161284552|NCT01625091|582419483|FG001|Intervention|Death|1|||
161284553|NCT01625091|582419482|FG000|Intervention|Withdrawal by Subject|4|||
161284554|NCT01625091|582419483|FG001|Intervention|Withdrawal by Subject|1|||
161284555|NCT01625091|582419482|FG000|Intervention|Adverse Event|0|||
161284556|NCT01625091|582419483|FG001|Intervention|Adverse Event|2|||
161284557|NCT01625091|582419482|FG000|Intervention|Lost to Follow-up|4|||
161284558|NCT01625091|582419483|FG001|Intervention|Lost to Follow-up|4|||
161284559|NCT01625091|582419482|FG000|Intervention|Study termination|2|||
161284560|NCT01625091|582419483|FG001|Intervention|Study termination|3|||
161284561|NCT01625091|582419482|FG000|Post-intervention|Death|0|||
161284562|NCT01625091|582419483|FG001|Post-intervention|Death|1|||
161284563|NCT01625091|582419482|FG000|Post-intervention|Lost to Follow-up|2|||
161284564|NCT01625091|582419483|FG001|Post-intervention|Lost to Follow-up|0|||
161284565|NCT01625091|582419482|FG000|Post-intervention|Study termination|2|||
161284566|NCT01625091|582419483|FG001|Post-intervention|Study termination|1|||
161284567|NCT02163057|582419484|FG000|Overall Study|Participant Refusal to Continue|2|||
161284568|NCT02163057|582419485|FG001|Overall Study|Participant Refusal to Continue|2|||
161284569|NCT02163057|582419484|FG000|Overall Study|Participant Significant Noncompliance|0|||
161284570|NCT02163057|582419485|FG001|Overall Study|Participant Significant Noncompliance|1|||
161284571|NCT02163057|582419484|FG000|Overall Study|Progression of Disease|1|||
161284572|NCT02163057|582419485|FG001|Overall Study|Progression of Disease|2|||
161345588|NCT03718000|582650877|FG000|Overall Study|Pregnancy|0|||
161156297|NCT00532948|581952911|FG001|Overall Study|Failure to return|1|||
161156298|NCT00532948|581952912|FG002|Overall Study|Failure to return|0|||
161156299|NCT00995345|581952913|FG000|Overall Study|Withdrawal by Subject|4|||
161156300|NCT00995345|581952914|FG001|Overall Study|Withdrawal by Subject|2|||
161156301|NCT00995345|581952915|FG002|Overall Study|Withdrawal by Subject|1|||
161156302|NCT00995345|581952916|FG003|Overall Study|Withdrawal by Subject|3|||
161156303|NCT00995345|581952917|FG004|Overall Study|Withdrawal by Subject|1|||
161156304|NCT00995345|581952913|FG000|Overall Study|Adverse Event|3|||
161284573|NCT01547390|582419486|FG000|Overall Study|Withdrawal by Subject|10|||
161284574|NCT01547390|582419487|FG001|Overall Study|Withdrawal by Subject|7|||
161284575|NCT01547390|582419486|FG000|Overall Study|termination of pregnancy|0|||
161284576|NCT01547390|582419487|FG001|Overall Study|termination of pregnancy|1|||
161284577|NCT01547390|582419486|FG000|Overall Study|Lost to Follow-up|0|||
161284578|NCT01547390|582419487|FG001|Overall Study|Lost to Follow-up|2|||
161284579|NCT01547390|582419486|FG000|Overall Study|Adverse Event|3|||
161156305|NCT00995345|581952914|FG001|Overall Study|Adverse Event|1|||
161284580|NCT01547390|582419487|FG001|Overall Study|Adverse Event|0|||
161284581|NCT01260701|582419488|FG000|Overall Study|Adverse Event|9|||
161284582|NCT01260701|582419488|FG000|Overall Study|Withdrawal by Subject|2|||
161284583|NCT01260701|582419488|FG000|Overall Study|Progression|53|||
161284584|NCT01260701|582419488|FG000|Overall Study|Death|2|||
161284585|NCT01260701|582419488|FG000|Overall Study|Not protocol specified|3|||
161284586|NCT01260701|582419488|FG000|Overall Study|Under review|1|||
161070230|NCT04832971|581647879|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161070231|NCT04832971|581647880|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161070232|NCT04832971|581647881|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
161070233|NCT04832971|581647872|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070234|NCT04832971|581647873|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
161070235|NCT04832971|581647874|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070236|NCT04832971|581647875|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070237|NCT04832971|581647876|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070238|NCT04832971|581647877|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070239|NCT04832971|581647878|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070240|NCT04832971|581647879|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070241|NCT04832971|581647880|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070242|NCT04832971|581647881|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
161070243|NCT04832971|581647872|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
161070244|NCT04832971|581647873|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
161070245|NCT04832971|581647874|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
161070246|NCT04832971|581647875|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
161070247|NCT04832971|581647876|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
161070248|NCT04832971|581647877|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
161070249|NCT04832971|581647878|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
161070250|NCT04832971|581647879|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
161070251|NCT04832971|581647880|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
161070252|NCT04832971|581647881|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
161070253|NCT04832971|581647872|FG000|Open-Label Extension (OLE) Period|Death|0|||
161070254|NCT04832971|581647873|FG001|Open-Label Extension (OLE) Period|Death|0|||
161070255|NCT04832971|581647874|FG002|Open-Label Extension (OLE) Period|Death|0|||
161070256|NCT04832971|581647875|FG003|Open-Label Extension (OLE) Period|Death|0|||
161070257|NCT04832971|581647876|FG004|Open-Label Extension (OLE) Period|Death|0|||
161070258|NCT04832971|581647877|FG005|Open-Label Extension (OLE) Period|Death|0|||
161070259|NCT04832971|581647878|FG006|Open-Label Extension (OLE) Period|Death|0|||
161070260|NCT04832971|581647879|FG007|Open-Label Extension (OLE) Period|Death|1|||
161070261|NCT04832971|581647880|FG008|Open-Label Extension (OLE) Period|Death|0|||
161070262|NCT04832971|581647881|FG009|Open-Label Extension (OLE) Period|Death|0|||
161070263|NCT04832971|581647872|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070264|NCT04832971|581647873|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070265|NCT04832971|581647874|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070266|NCT04832971|581647875|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070267|NCT04832971|581647876|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070268|NCT04832971|581647877|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070269|NCT04832971|581647878|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
161070270|NCT04832971|581647879|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
161070271|NCT04832971|581647880|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070272|NCT04832971|581647881|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
161070273|NCT04832971|581647872|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161070274|NCT04832971|581647873|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161070275|NCT04832971|581647874|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161070276|NCT04832971|581647875|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
161070277|NCT04832971|581647876|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
161070278|NCT04832971|581647877|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
161070279|NCT04832971|581647878|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
161070280|NCT04832971|581647879|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
161070281|NCT04832971|581647880|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
161070282|NCT04832971|581647881|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
161070283|NCT04832971|581647872|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161070284|NCT04832971|581647873|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161284587|NCT01260701|582419488|FG000|Overall Study|Ineligible|4|||
161070285|NCT04832971|581647874|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161070286|NCT04832971|581647875|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161070287|NCT04832971|581647876|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161070288|NCT04832971|581647877|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161284588|NCT01260701|582419488|FG000|Overall Study|Did not begin protocol therapy|1|||
161284589|NCT05061134|582421266|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
161284590|NCT05061134|582421267|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
161284591|NCT05061134|582421268|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
161284592|NCT05061134|582421266|FG000|Overall Study|Subject not treated|0|||
161284593|NCT05061134|582421267|FG001|Overall Study|Subject not treated|0|||
161284594|NCT05061134|582421268|FG002|Overall Study|Subject not treated|2|||
161284595|NCT05061134|582421266|FG000|Overall Study|Other|0|||
161284596|NCT05061134|582421267|FG001|Overall Study|Other|0|||
161284597|NCT05061134|582421268|FG002|Overall Study|Other|9|||
161284598|NCT05061134|582421266|FG000|Overall Study|Withdrawal by Subject|9|||
161284599|NCT05061134|582421267|FG001|Overall Study|Withdrawal by Subject|8|||
161284600|NCT05061134|582421268|FG002|Overall Study|Withdrawal by Subject|5|||
161284601|NCT05061134|582421266|FG000|Overall Study|Study Terminated by Sponsor|22|||
161284602|NCT05061134|582421267|FG001|Overall Study|Study Terminated by Sponsor|14|||
161284603|NCT05061134|582421268|FG002|Overall Study|Study Terminated by Sponsor|7|||
161284604|NCT05061134|582421266|FG000|Overall Study|Progressive Disease|1|||
161284605|NCT05061134|582421267|FG001|Overall Study|Progressive Disease|2|||
161284606|NCT05061134|582421268|FG002|Overall Study|Progressive Disease|0|||
161284607|NCT05061134|582421266|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
161284608|NCT05061134|582421267|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
161284609|NCT05061134|582421268|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
161284610|NCT05061134|582421266|FG000|Overall Study|Lost to Follow-up|1|||
161284611|NCT05061134|582421267|FG001|Overall Study|Lost to Follow-up|0|||
161284612|NCT05061134|582421268|FG002|Overall Study|Lost to Follow-up|0|||
161284613|NCT05061134|582421266|FG000|Overall Study|Physician Decision|1|||
161284614|NCT05061134|582421267|FG001|Overall Study|Physician Decision|1|||
161284615|NCT05061134|582421268|FG002|Overall Study|Physician Decision|0|||
161284616|NCT05061134|582421266|FG000|Overall Study|Disease progression|1|||
161284617|NCT05061134|582421267|FG001|Overall Study|Disease progression|0|||
161284618|NCT05061134|582421268|FG002|Overall Study|Disease progression|0|||
161284619|NCT05061134|582421266|FG000|Overall Study|Death|43|||
161284620|NCT05061134|582421267|FG001|Overall Study|Death|23|||
161284621|NCT05061134|582421268|FG002|Overall Study|Death|14|||
161284622|NCT05061134|582421266|FG000|Overall Study|Database lock|2|||
161284623|NCT05061134|582421267|FG001|Overall Study|Database lock|0|||
161284624|NCT05061134|582421268|FG002|Overall Study|Database lock|0|||
161284625|NCT03176134|582421269|FG000|Overall Study|Lost to Follow-up|0|||
161284626|NCT03176134|582421270|FG001|Overall Study|Lost to Follow-up|2|||
161284627|NCT03176134|582421271|FG002|Overall Study|Lost to Follow-up|0|||
161284628|NCT03176134|582421272|FG003|Overall Study|Lost to Follow-up|0|||
161284629|NCT03176134|582421273|FG004|Overall Study|Lost to Follow-up|0|||
161284630|NCT03176134|582421274|FG005|Overall Study|Lost to Follow-up|0|||
161284631|NCT03176134|582421275|FG006|Overall Study|Lost to Follow-up|0|||
161284632|NCT03176134|582421276|FG007|Overall Study|Lost to Follow-up|0|||
161284633|NCT03176134|582421269|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
161284634|NCT03176134|582421270|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161284635|NCT03176134|582421271|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161284636|NCT03176134|582421272|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161284637|NCT03176134|582421273|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161284638|NCT03176134|582421274|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161284639|NCT03176134|582421275|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
161284640|NCT03176134|582421276|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
161284641|NCT03410056|582421281|FG000|Overall Study|Decision by Sponsor|0|||
161284642|NCT03410056|582421282|FG001|Overall Study|Decision by Sponsor|0|||
161284643|NCT03410056|582421283|FG002|Overall Study|Decision by Sponsor|3|||
161284644|NCT03410056|582421284|FG003|Overall Study|Decision by Sponsor|0|||
161284645|NCT03410056|582421285|FG004|Overall Study|Decision by Sponsor|0|||
161284646|NCT03410056|582421286|FG005|Overall Study|Decision by Sponsor|0|||
161284647|NCT03410056|582421287|FG006|Overall Study|Decision by Sponsor|0|||
161284648|NCT03410056|582421281|FG000|Overall Study|Withdrawal by Subject|0|||
161284649|NCT03410056|582421282|FG001|Overall Study|Withdrawal by Subject|2|||
161070289|NCT04832971|581647878|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161070290|NCT04832971|581647879|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161070291|NCT04832971|581647880|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161284650|NCT03410056|582421283|FG002|Overall Study|Withdrawal by Subject|5|||
161284651|NCT03410056|582421284|FG003|Overall Study|Withdrawal by Subject|5|||
161284652|NCT03410056|582421285|FG004|Overall Study|Withdrawal by Subject|0|||
161284653|NCT03410056|582421286|FG005|Overall Study|Withdrawal by Subject|0|||
161284654|NCT03410056|582421287|FG006|Overall Study|Withdrawal by Subject|0|||
161284655|NCT02762929|582421288|FG000|Overall Study|Adverse Event|0|||
161345589|NCT03718000|582650878|FG001|Overall Study|Pregnancy|1|||
161070292|NCT04832971|581647881|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
161284656|NCT02762929|582421289|FG001|Overall Study|Adverse Event|0|||
161284657|NCT02762929|582421290|FG002|Overall Study|Adverse Event|0|||
161284658|NCT02762929|582421291|FG003|Overall Study|Adverse Event|1|||
161284659|NCT02762929|582421292|FG004|Overall Study|Adverse Event|0|||
161284660|NCT02762929|582421293|FG005|Overall Study|Adverse Event|0|||
161284661|NCT02762929|582421288|FG000|Overall Study|Lost to Follow-up|1|||
161070293|NCT04832971|581647872|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070294|NCT04832971|581647873|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070295|NCT04832971|581647874|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070296|NCT04832971|581647875|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070297|NCT04832971|581647876|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070298|NCT04832971|581647877|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070299|NCT04832971|581647878|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
161070300|NCT04832971|581647879|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
161070301|NCT04832971|581647880|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
161070302|NCT04832971|581647881|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
161070303|NCT01107899|581647882|FG000|Overall Study|Physician Decision|5|||
161284662|NCT02762929|582421289|FG001|Overall Study|Lost to Follow-up|2|||
161284663|NCT02762929|582421290|FG002|Overall Study|Lost to Follow-up|0|||
161284664|NCT02762929|582421291|FG003|Overall Study|Lost to Follow-up|1|||
161284665|NCT02762929|582421292|FG004|Overall Study|Lost to Follow-up|0|||
161284666|NCT02762929|582421293|FG005|Overall Study|Lost to Follow-up|0|||
161284667|NCT02762929|582421288|FG000|Overall Study|Withdrawal by Subject|0|||
161284668|NCT02762929|582421289|FG001|Overall Study|Withdrawal by Subject|1|||
161284669|NCT02762929|582421290|FG002|Overall Study|Withdrawal by Subject|0|||
161284670|NCT02762929|582421291|FG003|Overall Study|Withdrawal by Subject|0|||
161284671|NCT02762929|582421292|FG004|Overall Study|Withdrawal by Subject|0|||
161284672|NCT02762929|582421293|FG005|Overall Study|Withdrawal by Subject|0|||
161284673|NCT02762929|582421288|FG000|Overall Study|exclusionary medication disclosed late|0|||
161284674|NCT02762929|582421289|FG001|Overall Study|exclusionary medication disclosed late|0|||
161284675|NCT02762929|582421290|FG002|Overall Study|exclusionary medication disclosed late|0|||
161284676|NCT02762929|582421291|FG003|Overall Study|exclusionary medication disclosed late|1|||
161284677|NCT02762929|582421292|FG004|Overall Study|exclusionary medication disclosed late|0|||
161284678|NCT02762929|582421293|FG005|Overall Study|exclusionary medication disclosed late|0|||
161284679|NCT02366689|582421297|FG000|Overall Study|Withdrawal by Subject|1|||
161284680|NCT02366689|582421298|FG001|Overall Study|Withdrawal by Subject|0|||
161284681|NCT02366689|582421299|FG002|Overall Study|Withdrawal by Subject|1|||
161284682|NCT02366689|582421297|FG000|Overall Study|Lost to Follow-up|3|||
161284683|NCT02366689|582421298|FG001|Overall Study|Lost to Follow-up|2|||
161284684|NCT02366689|582421299|FG002|Overall Study|Lost to Follow-up|0|||
161284685|NCT02366689|582421297|FG000|Overall Study|Pregnancy|0|||
161284686|NCT02366689|582421298|FG001|Overall Study|Pregnancy|1|||
161284687|NCT02366689|582421299|FG002|Overall Study|Pregnancy|1|||
161284688|NCT03718832|582421300|FG000|Analysis Sample|Withdrawal by Subject|18|||
161284689|NCT03718832|582421301|FG001|Analysis Sample|Withdrawal by Subject|15|||
161284690|NCT03718832|582421300|FG000|Analysis Sample|Legal hold on data|1|||
161284691|NCT03718832|582421301|FG001|Analysis Sample|Legal hold on data|0|||
161284692|NCT03718832|582421300|FG000|Analysis Sample|Participant from treated household|0|||
161284693|NCT03718832|582421301|FG001|Analysis Sample|Participant from treated household|1|||
161284694|NCT03718832|582421300|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
161284695|NCT03718832|582421301|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
161284696|NCT04108299|582421305|FG000|Overall Study|Not interested in participating|2|||
161284697|NCT04108299|582421306|FG001|Overall Study|Not interested in participating|1|||
161284698|NCT04108299|582421307|FG002|Overall Study|Not interested in participating|2|||
161284699|NCT04108299|582421308|FG003|Overall Study|Not interested in participating|1|||
161284700|NCT02515331|582421317|FG000|Overall Study|Withdrawal by Subject|0|||
161284701|NCT02515331|582421318|FG001|Overall Study|Withdrawal by Subject|0|||
161284702|NCT02515331|582421319|FG002|Overall Study|Withdrawal by Subject|1|||
161284703|NCT02515331|582421317|FG000|Overall Study|Protocol deviation|0|||
161284704|NCT02515331|582421318|FG001|Overall Study|Protocol deviation|0|||
161284705|NCT02515331|582421319|FG002|Overall Study|Protocol deviation|3|||
161284706|NCT02515331|582421317|FG000|Overall Study|Adverse Event|2|||
161284707|NCT02515331|582421318|FG001|Overall Study|Adverse Event|0|||
161284708|NCT02515331|582421319|FG002|Overall Study|Adverse Event|0|||
161284709|NCT00124748|582421320|FG000|Overall Study|Adverse Event|8|||
161284710|NCT00124748|582421321|FG001|Overall Study|Adverse Event|39|||
161284711|NCT00124748|582421320|FG000|Overall Study|Abnormal laboratory Value|2|||
161284712|NCT00124748|582421321|FG001|Overall Study|Abnormal laboratory Value|2|||
161284713|NCT00124748|582421320|FG000|Overall Study|Abnormal Procedure|0|||
161070304|NCT01107899|581647883|FG001|Overall Study|Physician Decision|0|||
161070305|NCT01107899|581647884|FG002|Overall Study|Physician Decision|3|||
161070306|NCT01107899|581647882|FG000|Overall Study|Withdrawal by Subject|0|||
161070307|NCT01107899|581647883|FG001|Overall Study|Withdrawal by Subject|0|||
161070308|NCT01107899|581647884|FG002|Overall Study|Withdrawal by Subject|1|||
161070309|NCT03584152|581647885|FG000|Overall Study|Discontinued intervention|7|||
161070310|NCT03584152|581647886|FG001|Overall Study|Discontinued intervention|4|||
161284714|NCT00124748|582421321|FG001|Overall Study|Abnormal Procedure|1|||
161284715|NCT00124748|582421320|FG000|Overall Study|Lack of Efficacy|20|||
161284716|NCT00124748|582421321|FG001|Overall Study|Lack of Efficacy|41|||
161284717|NCT00124748|582421320|FG000|Overall Study|No longer requires study drug|1|||
161070311|NCT04024462|581647887|FG000|Overall Study|Withdrawal by Subject|6|||
161070312|NCT04024462|581647888|FG001|Overall Study|Withdrawal by Subject|7|||
161070313|NCT04024462|581647887|FG000|Overall Study|Progressive Disease|0|||
161070314|NCT04024462|581647888|FG001|Overall Study|Progressive Disease|1|||
161070315|NCT04024462|581647887|FG000|Overall Study|Adverse Event|0|||
161070316|NCT04024462|581647888|FG001|Overall Study|Adverse Event|1|||
161070317|NCT04024462|581647887|FG000|Overall Study|Death|0|||
161070318|NCT04024462|581647888|FG001|Overall Study|Death|1|||
161070319|NCT04024462|581647887|FG000|Overall Study|Lost to Follow-up|1|||
161070320|NCT04024462|581647888|FG001|Overall Study|Lost to Follow-up|0|||
161070321|NCT04024462|581647887|FG000|Overall Study|Ongoing in the Study|94|||
161070322|NCT04024462|581647888|FG001|Overall Study|Ongoing in the Study|89|||
161070323|NCT00983749|581647893|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
161070324|NCT00983749|581647894|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
161070325|NCT04292470|581647895|FG000|Overall Study|Withdrawal by Subject|0|||
161070326|NCT04292470|581647896|FG001|Overall Study|Withdrawal by Subject|1|||
161070327|NCT02906020|581647910|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
161070328|NCT02906020|581647911|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
161070329|NCT02906020|581647912|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
161070330|NCT02906020|581647913|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
161070331|NCT02906020|581647914|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
161070332|NCT02906020|581647915|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
161070333|NCT02906020|581647916|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
161070334|NCT02906020|581647917|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
161070335|NCT02906020|581647918|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
161070336|NCT02906020|581647919|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
161070337|NCT02906020|581647920|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
161070338|NCT02906020|581647921|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
161070339|NCT02906020|581647922|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
161070340|NCT02906020|581647923|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
161070341|NCT02906020|581647924|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
161070342|NCT02906020|581647925|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
161070343|NCT02906020|581647910|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070344|NCT02906020|581647911|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070345|NCT02906020|581647912|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070346|NCT02906020|581647913|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070347|NCT02906020|581647914|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070348|NCT02906020|581647915|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070349|NCT02906020|581647916|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070350|NCT02906020|581647917|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070351|NCT02906020|581647918|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
161070352|NCT02906020|581647919|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
161070353|NCT02906020|581647920|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070354|NCT02906020|581647921|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070355|NCT02906020|581647922|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070356|NCT02906020|581647923|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070357|NCT02906020|581647924|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070358|NCT02906020|581647925|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
161070359|NCT02906020|581647910|FG000|Part 2: Double-blind Treatment Period|Other|0|||
161070360|NCT02906020|581647911|FG001|Part 2: Double-blind Treatment Period|Other|0|||
161070361|NCT02906020|581647912|FG002|Part 2: Double-blind Treatment Period|Other|0|||
161070362|NCT02906020|581647913|FG003|Part 2: Double-blind Treatment Period|Other|0|||
161070363|NCT02906020|581647914|FG004|Part 2: Double-blind Treatment Period|Other|0|||
161070364|NCT02906020|581647915|FG005|Part 2: Double-blind Treatment Period|Other|0|||
161070365|NCT02906020|581647916|FG006|Part 2: Double-blind Treatment Period|Other|0|||
161070366|NCT02906020|581647917|FG007|Part 2: Double-blind Treatment Period|Other|0|||
161070367|NCT02906020|581647918|FG008|Part 2: Double-blind Treatment Period|Other|6|||
161070368|NCT02906020|581647919|FG009|Part 2: Double-blind Treatment Period|Other|10|||
161070369|NCT02906020|581647920|FG010|Part 2: Double-blind Treatment Period|Other|0|||
161070370|NCT02906020|581647921|FG011|Part 2: Double-blind Treatment Period|Other|0|||
161070371|NCT02906020|581647922|FG012|Part 2: Double-blind Treatment Period|Other|0|||
161070372|NCT02906020|581647923|FG013|Part 2: Double-blind Treatment Period|Other|0|||
161070373|NCT02906020|581647924|FG014|Part 2: Double-blind Treatment Period|Other|0|||
161070374|NCT02906020|581647925|FG015|Part 2: Double-blind Treatment Period|Other|0|||
161070375|NCT02906020|581647910|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070376|NCT02906020|581647911|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070377|NCT02906020|581647912|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070378|NCT02906020|581647913|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070379|NCT02906020|581647914|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070380|NCT02906020|581647915|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070381|NCT02906020|581647916|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070382|NCT02906020|581647917|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070383|NCT02906020|581647918|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070384|NCT02906020|581647919|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070385|NCT02906020|581647920|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070386|NCT02906020|581647921|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070387|NCT02906020|581647922|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
161070388|NCT02906020|581647923|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
161070389|NCT02906020|581647924|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070390|NCT02906020|581647925|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
161070391|NCT02906020|581647910|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070392|NCT02906020|581647911|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070393|NCT02906020|581647912|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070394|NCT02906020|581647913|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070395|NCT02906020|581647914|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070396|NCT02906020|581647915|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070397|NCT02906020|581647916|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070398|NCT02906020|581647917|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070399|NCT02906020|581647918|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070400|NCT02906020|581647919|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070401|NCT02906020|581647920|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070402|NCT02906020|581647921|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070403|NCT02906020|581647922|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
161070404|NCT02906020|581647923|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
161070405|NCT02906020|581647924|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
161070406|NCT02906020|581647925|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
161070407|NCT02906020|581647910|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070408|NCT02906020|581647911|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070409|NCT02906020|581647912|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070410|NCT02906020|581647913|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070411|NCT02906020|581647914|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070412|NCT02906020|581647915|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070413|NCT02906020|581647916|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070414|NCT02906020|581647917|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070415|NCT02906020|581647918|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070416|NCT02906020|581647919|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070417|NCT02906020|581647920|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070418|NCT02906020|581647921|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070419|NCT02906020|581647922|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
161070420|NCT02906020|581647923|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
161070421|NCT02906020|581647924|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070422|NCT02906020|581647925|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
161070423|NCT02906020|581647910|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070424|NCT02906020|581647911|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070425|NCT02906020|581647912|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070426|NCT02906020|581647913|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070427|NCT02906020|581647914|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070428|NCT02906020|581647915|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070429|NCT02906020|581647916|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070430|NCT02906020|581647917|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070431|NCT02906020|581647918|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070432|NCT02906020|581647919|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070433|NCT02906020|581647920|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070434|NCT02906020|581647921|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070435|NCT02906020|581647922|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
161070436|NCT02906020|581647923|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
161070437|NCT02906020|581647924|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070438|NCT02906020|581647925|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
161070439|NCT02906020|581647910|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070440|NCT02906020|581647911|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070441|NCT02906020|581647912|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070442|NCT02906020|581647913|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161156306|NCT00995345|581952915|FG002|Overall Study|Adverse Event|2|||
161284718|NCT00124748|582421321|FG001|Overall Study|No longer requires study drug|1|||
161284719|NCT00124748|582421320|FG000|Overall Study|Protocol Violation|3|||
161070443|NCT02906020|581647914|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070444|NCT02906020|581647915|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070445|NCT02906020|581647916|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070446|NCT02906020|581647917|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070447|NCT02906020|581647918|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070448|NCT02906020|581647919|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070449|NCT02906020|581647920|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070450|NCT02906020|581647921|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
161070451|NCT02906020|581647922|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
161070452|NCT02906020|581647923|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
161070453|NCT02906020|581647924|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
161070454|NCT02906020|581647925|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
161070455|NCT02906020|581647910|FG000|Part 2: Long-term Follow-up Period|Other|0|||
161070456|NCT02906020|581647911|FG001|Part 2: Long-term Follow-up Period|Other|0|||
161070457|NCT02906020|581647912|FG002|Part 2: Long-term Follow-up Period|Other|0|||
161070458|NCT02906020|581647913|FG003|Part 2: Long-term Follow-up Period|Other|0|||
161070459|NCT02906020|581647914|FG004|Part 2: Long-term Follow-up Period|Other|0|||
161070460|NCT02906020|581647915|FG005|Part 2: Long-term Follow-up Period|Other|0|||
161070461|NCT02906020|581647916|FG006|Part 2: Long-term Follow-up Period|Other|0|||
161070462|NCT02906020|581647917|FG007|Part 2: Long-term Follow-up Period|Other|0|||
161070463|NCT02906020|581647918|FG008|Part 2: Long-term Follow-up Period|Other|0|||
161070464|NCT02906020|581647919|FG009|Part 2: Long-term Follow-up Period|Other|0|||
161070465|NCT02906020|581647920|FG010|Part 2: Long-term Follow-up Period|Other|0|||
161070466|NCT02906020|581647921|FG011|Part 2: Long-term Follow-up Period|Other|0|||
161070467|NCT02906020|581647922|FG012|Part 2: Long-term Follow-up Period|Other|13|||
161070468|NCT02906020|581647923|FG013|Part 2: Long-term Follow-up Period|Other|8|||
161070469|NCT02906020|581647924|FG014|Part 2: Long-term Follow-up Period|Other|3|||
161070470|NCT02906020|581647925|FG015|Part 2: Long-term Follow-up Period|Other|2|||
161070471|NCT01375673|581647931|FG000|Overall Study|Withdrawal by Subject|0|||
161070472|NCT01375673|581647932|FG001|Overall Study|Withdrawal by Subject|1|||
161070473|NCT04698915|581647937|FG000|Overall Study|Adverse Event|2|||
161070474|NCT04698915|581647938|FG001|Overall Study|Adverse Event|0|||
161070475|NCT04698915|581647937|FG000|Overall Study|Death|23|||
161070476|NCT04698915|581647938|FG001|Overall Study|Death|20|||
161070477|NCT04698915|581647937|FG000|Overall Study|Physician Decision|1|||
161070478|NCT04698915|581647938|FG001|Overall Study|Physician Decision|1|||
161070479|NCT04698915|581647937|FG000|Overall Study|Lost to Follow-up|1|||
161070480|NCT04698915|581647938|FG001|Overall Study|Lost to Follow-up|0|||
161070481|NCT04698915|581647937|FG000|Overall Study|Study Terminated by Sponsor|55|||
161070482|NCT04698915|581647938|FG001|Overall Study|Study Terminated by Sponsor|60|||
161070483|NCT04698915|581647937|FG000|Overall Study|Withdrawal by Subject|2|||
161070484|NCT04698915|581647938|FG001|Overall Study|Withdrawal by Subject|3|||
161070485|NCT01907906|581647939|FG000|Overall Study|Withdrawal by Subject|1|||
161070486|NCT01907906|581647940|FG001|Overall Study|Withdrawal by Subject|0|||
161070487|NCT01907906|581647939|FG000|Overall Study|Physician Decision|3|||
161070488|NCT01907906|581647940|FG001|Overall Study|Physician Decision|1|||
161070489|NCT00979953|581647941|FG000|Overall Study|Adverse Event|5|||
161070490|NCT00979953|581647942|FG001|Overall Study|Adverse Event|2|||
161070491|NCT00979953|581647943|FG002|Overall Study|Adverse Event|17|||
161070492|NCT00979953|581647944|FG003|Overall Study|Adverse Event|4|||
161070493|NCT00979953|581647941|FG000|Overall Study|Lack of Efficacy|1|||
161070494|NCT00979953|581647942|FG001|Overall Study|Lack of Efficacy|2|||
161070495|NCT00979953|581647943|FG002|Overall Study|Lack of Efficacy|0|||
161070496|NCT00979953|581647944|FG003|Overall Study|Lack of Efficacy|0|||
161070497|NCT00979953|581647941|FG000|Overall Study|Lost to Follow-up|1|||
161070498|NCT00979953|581647942|FG001|Overall Study|Lost to Follow-up|1|||
161070499|NCT00979953|581647943|FG002|Overall Study|Lost to Follow-up|1|||
161070500|NCT00979953|581647944|FG003|Overall Study|Lost to Follow-up|0|||
161070501|NCT00979953|581647941|FG000|Overall Study|Withdrawal by Subject|0|||
161070502|NCT00979953|581647942|FG001|Overall Study|Withdrawal by Subject|0|||
161070503|NCT00979953|581647943|FG002|Overall Study|Withdrawal by Subject|2|||
161070504|NCT00979953|581647944|FG003|Overall Study|Withdrawal by Subject|1|||
161070505|NCT00979953|581647941|FG000|Overall Study|Protocol Violation|1|||
161070506|NCT00979953|581647942|FG001|Overall Study|Protocol Violation|0|||
161345590|NCT00716417|582650879|FG000|Overall Study|Adverse Event|0|||
161070507|NCT00979953|581647943|FG002|Overall Study|Protocol Violation|2|||
161070508|NCT00979953|581647944|FG003|Overall Study|Protocol Violation|2|||
161070509|NCT01124097|581647945|FG000|Overall Study|Withdrawal by Subject|4|||
161070510|NCT01124097|581647946|FG001|Overall Study|Withdrawal by Subject|3|||
161070511|NCT01124097|581647947|FG002|Overall Study|Withdrawal by Subject|2|||
161070512|NCT01124097|581647948|FG003|Overall Study|Withdrawal by Subject|3|||
161070513|NCT01124097|581647945|FG000|Overall Study|Lack of Efficacy|2|||
161070514|NCT01124097|581647946|FG001|Overall Study|Lack of Efficacy|3|||
161070515|NCT01124097|581647947|FG002|Overall Study|Lack of Efficacy|1|||
161070516|NCT01124097|581647948|FG003|Overall Study|Lack of Efficacy|3|||
161156307|NCT00995345|581952916|FG003|Overall Study|Adverse Event|0|||
161156308|NCT00995345|581952917|FG004|Overall Study|Adverse Event|1|||
161156309|NCT00995345|581952913|FG000|Overall Study|Lost to Follow-up|2|||
161156310|NCT00995345|581952914|FG001|Overall Study|Lost to Follow-up|2|||
161156311|NCT00995345|581952915|FG002|Overall Study|Lost to Follow-up|2|||
161156312|NCT00995345|581952916|FG003|Overall Study|Lost to Follow-up|1|||
161156313|NCT00995345|581952917|FG004|Overall Study|Lost to Follow-up|0|||
161156314|NCT00995345|581952913|FG000|Overall Study|all other reasons combined|2|||
161156315|NCT00995345|581952914|FG001|Overall Study|all other reasons combined|2|||
161156316|NCT00995345|581952915|FG002|Overall Study|all other reasons combined|2|||
161156317|NCT00995345|581952916|FG003|Overall Study|all other reasons combined|1|||
161156318|NCT00995345|581952917|FG004|Overall Study|all other reasons combined|3|||
161156319|NCT03885726|581952919|FG000|Overall Study|Staffing issues/lost interest|1|||
161156320|NCT03885726|581952919|FG000|Overall Study|Early discharge from hospital|3|||
161156321|NCT02509598|581952928|FG000|Overall Study|Withdrawal by Subject|1|||
161156322|NCT01201798|581952929|FG000|Overall Study|Adverse Event|2|||
161156323|NCT01201798|581952930|FG001|Overall Study|Adverse Event|0|||
161156324|NCT01201798|581952929|FG000|Overall Study|Lost to Follow-up|3|||
161156325|NCT01201798|581952930|FG001|Overall Study|Lost to Follow-up|5|||
161156326|NCT01201798|581952929|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
161156327|NCT01201798|581952930|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
161156328|NCT01201798|581952929|FG000|Overall Study|Noncompliance|1|||
161156329|NCT01201798|581952930|FG001|Overall Study|Noncompliance|0|||
161156330|NCT01201798|581952929|FG000|Overall Study|Protocol Violation|1|||
161156331|NCT01201798|581952930|FG001|Overall Study|Protocol Violation|1|||
161156332|NCT01201798|581952929|FG000|Overall Study|Treatment Failure|1|||
161156333|NCT01201798|581952930|FG001|Overall Study|Treatment Failure|8|||
161156334|NCT05692154|581952931|FG000|Overall Study|Adverse Event|0|||
161156335|NCT05692154|581952932|FG001|Overall Study|Adverse Event|1|||
161156336|NCT03609359|581952935|FG000|Overall Study|Progression of primary disease (PD)|25|||
161156337|NCT03609359|581952935|FG000|Overall Study|Patient's refusal|1|||
161156338|NCT03609359|581952935|FG000|Overall Study|Physician Decision|1|||
161156339|NCT03609359|581952935|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
161156340|NCT01912729|581952936|FG000|Overall Study|Withdrawal by Subject|0|||
161156341|NCT01912729|581952937|FG001|Overall Study|Withdrawal by Subject|1|||
161156342|NCT01952834|581952940|FG000|Overall Study|Adverse Event|1|||
161156343|NCT01975272|581952943|FG000|Overall Study|Excluded after protocol amendment|1|||
161156344|NCT01975272|581952944|FG001|Overall Study|Excluded after protocol amendment|1|||
161156345|NCT01975272|581952945|FG002|Overall Study|Excluded after protocol amendment|2|||
161156346|NCT00740779|581952952|FG000|Overall Study|Adverse Event|4|||
161156347|NCT00740779|581952953|FG001|Overall Study|Adverse Event|6|||
161156348|NCT00740779|581952954|FG002|Overall Study|Adverse Event|3|||
161156349|NCT00740779|581952952|FG000|Overall Study|Protocol Violation|1|||
161156350|NCT00740779|581952953|FG001|Overall Study|Protocol Violation|1|||
161156351|NCT00740779|581952954|FG002|Overall Study|Protocol Violation|1|||
161156352|NCT00740779|581952952|FG000|Overall Study|Lack of Efficacy|0|||
161156353|NCT00740779|581952953|FG001|Overall Study|Lack of Efficacy|0|||
161156354|NCT00740779|581952954|FG002|Overall Study|Lack of Efficacy|2|||
161156355|NCT00740779|581952952|FG000|Overall Study|Withdrawal by Subject|2|||
161156356|NCT00740779|581952953|FG001|Overall Study|Withdrawal by Subject|4|||
161156357|NCT00740779|581952954|FG002|Overall Study|Withdrawal by Subject|2|||
161156358|NCT00740779|581952952|FG000|Overall Study|Lost to Follow-up|2|||
161156359|NCT00740779|581952953|FG001|Overall Study|Lost to Follow-up|3|||
161156360|NCT00740779|581952954|FG002|Overall Study|Lost to Follow-up|5|||
161156361|NCT03280550|581952958|FG000|Overall Study|Withdrawal by Subject|2|||
161156362|NCT03280550|581952959|FG001|Overall Study|Withdrawal by Subject|2|||
161156363|NCT03280550|581952958|FG000|Overall Study|Physician Decision|0|||
161156364|NCT03280550|581952959|FG001|Overall Study|Physician Decision|1|||
161284720|NCT00124748|582421321|FG001|Overall Study|Protocol Violation|1|||
161284721|NCT00124748|582421320|FG000|Overall Study|Withdrawal by Subject|5|||
161284722|NCT00124748|582421321|FG001|Overall Study|Withdrawal by Subject|15|||
161284723|NCT00124748|582421320|FG000|Overall Study|Lost to Follow-up|2|||
161284724|NCT00124748|582421321|FG001|Overall Study|Lost to Follow-up|7|||
161284725|NCT00124748|582421320|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
161284726|NCT00124748|582421321|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
161284727|NCT00124748|582421320|FG000|Overall Study|Death|1|||
161284728|NCT00124748|582421321|FG001|Overall Study|Death|3|||
161156365|NCT01465178|581952960|FG000|Overall Study|Withdrawal by Subject|1|||
161284729|NCT00322712|582421322|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
161156366|NCT01465178|581952961|FG001|Overall Study|Withdrawal by Subject|0|||
161156367|NCT01930799|581952962|FG000|Overall Study|Withdrawal by Subject|3|||
161284730|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
161156368|NCT01930799|581952962|FG000|Overall Study|Lost to Follow-up|5|||
161156369|NCT00875017|581952963|FG000|First Intervention|Withdrawal by Subject|1|||
161156370|NCT00875017|581952964|FG001|First Intervention|Withdrawal by Subject|0|||
161284731|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
161156371|NCT00875017|581952965|FG002|First Intervention|Withdrawal by Subject|1|||
161284732|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
161284733|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284734|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
161284735|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
161070517|NCT01124097|581647945|FG000|Overall Study|Adverse Event|24|||
161070518|NCT01124097|581647946|FG001|Overall Study|Adverse Event|15|||
161070519|NCT01124097|581647947|FG002|Overall Study|Adverse Event|15|||
161070520|NCT01124097|581647948|FG003|Overall Study|Adverse Event|7|||
161070521|NCT01124097|581647945|FG000|Overall Study|Protocol Violation|2|||
161070522|NCT01124097|581647946|FG001|Overall Study|Protocol Violation|0|||
161070523|NCT01124097|581647947|FG002|Overall Study|Protocol Violation|2|||
161070524|NCT01124097|581647948|FG003|Overall Study|Protocol Violation|1|||
161070525|NCT01124097|581647945|FG000|Overall Study|Physician Decision|2|||
161070526|NCT01124097|581647946|FG001|Overall Study|Physician Decision|1|||
161070527|NCT01124097|581647947|FG002|Overall Study|Physician Decision|0|||
161070528|NCT01124097|581647948|FG003|Overall Study|Physician Decision|0|||
161070529|NCT05687032|581647949|FG000|Treatment Phase|Adverse Event|13|||
161070530|NCT05687032|581647949|FG000|Treatment Phase|Death|1|||
161070531|NCT05687032|581647949|FG000|Treatment Phase|Physician Decision|3|||
161070532|NCT05687032|581647949|FG000|Treatment Phase|Progressive disease|9|||
161070533|NCT05687032|581647949|FG000|Treatment Phase|Withdrawal by Subject|5|||
161070534|NCT05687032|581647949|FG000|Follow-Up Phase|Death|16|||
161070535|NCT05687032|581647949|FG000|Follow-Up Phase|Ongoing|26|||
161070536|NCT04829747|581647953|FG000|Overall Study|Protocol Violation|1|||
161070537|NCT02367352|581647956|FG000|Overall Study|Progressive disease|7|||
161070538|NCT02367352|581647957|FG001|Overall Study|Progressive disease|0|||
161070539|NCT02367352|581647958|FG002|Overall Study|Progressive disease|0|||
161070540|NCT02367352|581647956|FG000|Overall Study|Participant Received Alternative Therapy|1|||
161070541|NCT02367352|581647957|FG001|Overall Study|Participant Received Alternative Therapy|0|||
161070542|NCT02367352|581647958|FG002|Overall Study|Participant Received Alternative Therapy|0|||
161070543|NCT02367352|581647956|FG000|Overall Study|Adverse Event|1|||
161070544|NCT02367352|581647957|FG001|Overall Study|Adverse Event|0|||
161070545|NCT02367352|581647958|FG002|Overall Study|Adverse Event|0|||
161070546|NCT05878873|581647959|FG000|Overall Study|Lost to Follow-up|2|||
161070547|NCT05878873|581647960|FG001|Overall Study|Lost to Follow-up|0|||
161070548|NCT02375347|581647962|FG000|Overall Study|Protocol Violation|1|||
161070549|NCT00425607|581647963|FG000|Overall Study|Death|1|||
161070550|NCT00425607|581647963|FG000|Overall Study|Withdrawal by Subject|1|||
161070551|NCT00193479|581647964|FG000|Induction Chemotherapy|Adverse Event|2|||
161070552|NCT00193479|581647964|FG000|Induction Chemotherapy|Disease Progression|1|||
161070553|NCT00193479|581647964|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
161070554|NCT00193479|581647964|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
161070555|NCT00079339|581647965|FG000|Overall Study|Adverse Event|1|||
161070556|NCT00079339|581647966|FG001|Overall Study|Adverse Event|7|||
161070557|NCT00079339|581647967|FG002|Overall Study|Adverse Event|2|||
161070558|NCT00079339|581647965|FG000|Overall Study|Death|1|||
161070559|NCT00079339|581647966|FG001|Overall Study|Death|0|||
161070560|NCT00079339|581647967|FG002|Overall Study|Death|0|||
161070561|NCT00079339|581647965|FG000|Overall Study|Non-compliance|0|||
161070562|NCT00079339|581647966|FG001|Overall Study|Non-compliance|0|||
161070563|NCT00079339|581647967|FG002|Overall Study|Non-compliance|1|||
161070564|NCT00079339|581647965|FG000|Overall Study|Withdrawal by Subject|0|||
161070565|NCT00079339|581647966|FG001|Overall Study|Withdrawal by Subject|4|||
161070566|NCT00079339|581647967|FG002|Overall Study|Withdrawal by Subject|1|||
161070567|NCT00079339|581647965|FG000|Overall Study|Disease progression|3|||
161070568|NCT00079339|581647966|FG001|Overall Study|Disease progression|28|||
161070569|NCT00079339|581647967|FG002|Overall Study|Disease progression|2|||
161070570|NCT02563548|581647969|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
161070571|NCT02563548|581647970|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161070572|NCT02563548|581647971|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161070573|NCT02563548|581647972|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
161070574|NCT02563548|581647973|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161070575|NCT02563548|581647974|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
161070576|NCT02563548|581647969|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
161070577|NCT02563548|581647970|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
161070578|NCT02563548|581647971|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
161070579|NCT02563548|581647972|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
161070580|NCT02563548|581647973|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
161070581|NCT02563548|581647974|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
161070582|NCT02563548|581647969|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161156372|NCT00875017|581952966|FG003|First Intervention|Withdrawal by Subject|0|||
161070583|NCT02563548|581647970|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161070584|NCT02563548|581647971|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
161070585|NCT02563548|581647972|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161070586|NCT02563548|581647973|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161070587|NCT02563548|581647974|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
161070588|NCT02563548|581647969|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161070589|NCT02563548|581647970|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161070590|NCT02563548|581647971|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
161070591|NCT02563548|581647972|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
161070592|NCT02563548|581647973|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161070593|NCT02563548|581647974|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
161070594|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161070595|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161070596|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161070597|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
161070598|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
161070599|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
161070600|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161070601|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161070602|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161070603|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
161070604|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
161070605|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
161070606|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161070607|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161070608|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161070609|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161070610|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
161070611|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
161070612|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161070613|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161070614|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161070615|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
161070616|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
161070617|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
161070618|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161070619|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161070620|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161070621|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161070622|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
161070623|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
161070624|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161070625|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161070626|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161070627|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161070628|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
161070629|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
161070630|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161070631|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161070632|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161070633|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161070634|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
161070635|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
161070636|NCT02563548|581647969|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161070637|NCT02563548|581647970|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161070638|NCT02563548|581647971|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161070639|NCT02563548|581647972|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161070640|NCT02563548|581647973|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
161070641|NCT02563548|581647974|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
161070642|NCT00559377|581647975|FG000|Overall Study|Withdrawal by Subject|9|||
161070643|NCT00203047|581647981|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
161070644|NCT00203047|581647982|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
161070645|NCT00203047|581647981|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
161070646|NCT00203047|581647982|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
161070647|NCT00203047|581647981|FG000|Overall Study|Withdrawal by Subject|13|||
161070648|NCT00203047|581647982|FG001|Overall Study|Withdrawal by Subject|47|||
161070649|NCT00203047|581647981|FG000|Overall Study|Teva requested participant withdrawal|1|||
161070650|NCT00203047|581647982|FG001|Overall Study|Teva requested participant withdrawal|1|||
161070651|NCT00203047|581647981|FG000|Overall Study|Physician Decision|8|||
161156373|NCT00875017|581952967|FG004|First Intervention|Withdrawal by Subject|0|||
161070652|NCT00203047|581647982|FG001|Overall Study|Physician Decision|7|||
161070653|NCT00203047|581647981|FG000|Overall Study|Non-compliance|4|||
161070654|NCT00203047|581647982|FG001|Overall Study|Non-compliance|8|||
161070655|NCT00203047|581647981|FG000|Overall Study|Protocol Violation|1|||
161070656|NCT00203047|581647982|FG001|Overall Study|Protocol Violation|0|||
161070657|NCT00203047|581647981|FG000|Overall Study|Lost to Follow-up|11|||
161070658|NCT00203047|581647982|FG001|Overall Study|Lost to Follow-up|5|||
161070659|NCT00203047|581647981|FG000|Overall Study|Adverse Event|8|||
161070660|NCT00203047|581647982|FG001|Overall Study|Adverse Event|18|||
161070661|NCT00203047|581647981|FG000|Overall Study|Death|1|||
161070662|NCT00203047|581647982|FG001|Overall Study|Death|2|||
161070663|NCT00203047|581647981|FG000|Overall Study|Pregnancy|3|||
161070664|NCT00203047|581647982|FG001|Overall Study|Pregnancy|0|||
161070665|NCT00203047|581647981|FG000|Overall Study|Other|5|||
161070666|NCT00203047|581647982|FG001|Overall Study|Other|5|||
161070667|NCT02229227|581647983|FG000|Overall Study|Adverse Event|14|||
161070668|NCT02229227|581647984|FG001|Overall Study|Adverse Event|9|||
161070669|NCT02229227|581647983|FG000|Overall Study|Lack of Efficacy|3|||
161070670|NCT02229227|581647984|FG001|Overall Study|Lack of Efficacy|3|||
161070671|NCT02229227|581647983|FG000|Overall Study|Protocol Violation|6|||
161070672|NCT02229227|581647984|FG001|Overall Study|Protocol Violation|8|||
161070673|NCT02229227|581647983|FG000|Overall Study|Protocol defined stopping criteria|1|||
161070674|NCT02229227|581647984|FG001|Overall Study|Protocol defined stopping criteria|3|||
161070675|NCT02229227|581647983|FG000|Overall Study|Lost to Follow-up|3|||
161070676|NCT02229227|581647984|FG001|Overall Study|Lost to Follow-up|3|||
161070677|NCT02229227|581647983|FG000|Overall Study|Study terminated by sponsor|11|||
161070678|NCT02229227|581647984|FG001|Overall Study|Study terminated by sponsor|11|||
161070679|NCT02229227|581647983|FG000|Overall Study|Withdrawal by Subject|8|||
161070680|NCT02229227|581647984|FG001|Overall Study|Withdrawal by Subject|12|||
161070681|NCT02229227|581647983|FG000|Overall Study|Other|0|||
161070682|NCT02229227|581647984|FG001|Overall Study|Other|1|||
161070683|NCT02229227|581647983|FG000|Overall Study|Physician Decision|5|||
161070684|NCT02229227|581647984|FG001|Overall Study|Physician Decision|12|||
161070685|NCT00340704|581647987|FG000|PK Study|Adverse Event|0|||
161070686|NCT00340704|581647988|FG001|PK Study|Adverse Event|1|||
161070687|NCT00340704|581647989|FG002|PK Study|Adverse Event|0|||
161070688|NCT00340704|581647990|FG003|PK Study|Adverse Event|0|||
161070689|NCT00340704|581647991|FG004|PK Study|Adverse Event|0|||
161070690|NCT00340704|581647992|FG005|PK Study|Adverse Event|0|||
161070691|NCT00340704|581647993|FG006|PK Study|Adverse Event|0|||
161070692|NCT00340704|581647994|FG007|PK Study|Adverse Event|0|||
161070693|NCT00340704|581647995|FG008|PK Study|Adverse Event|0|||
161070694|NCT00340704|581647987|FG000|PK Study|Not treated|0|||
161070695|NCT00340704|581647988|FG001|PK Study|Not treated|0|||
161070696|NCT00340704|581647989|FG002|PK Study|Not treated|1|||
161070697|NCT00340704|581647990|FG003|PK Study|Not treated|0|||
161070698|NCT00340704|581647991|FG004|PK Study|Not treated|0|||
161070699|NCT00340704|581647992|FG005|PK Study|Not treated|0|||
161070700|NCT00340704|581647993|FG006|PK Study|Not treated|0|||
161070701|NCT00340704|581647994|FG007|PK Study|Not treated|0|||
161070702|NCT00340704|581647995|FG008|PK Study|Not treated|0|||
161070703|NCT00340704|581647987|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161070704|NCT00340704|581647988|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161070705|NCT00340704|581647989|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161070706|NCT00340704|581647990|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
161070707|NCT00340704|581647991|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
161070708|NCT00340704|581647992|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161070709|NCT00340704|581647993|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
161070710|NCT00340704|581647994|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
161070711|NCT00340704|581647995|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
161070712|NCT00340704|581647987|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070713|NCT00340704|581647988|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070714|NCT00340704|581647989|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070715|NCT00340704|581647990|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070716|NCT00340704|581647991|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070717|NCT00340704|581647992|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
161070718|NCT00340704|581647993|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070719|NCT00340704|581647994|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070720|NCT00340704|581647995|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
161070721|NCT00340704|581647987|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070722|NCT00340704|581647988|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070723|NCT00340704|581647989|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070724|NCT00340704|581647990|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070725|NCT00340704|581647991|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
161070726|NCT00340704|581647992|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
161345591|NCT00716417|582650880|FG001|Overall Study|Adverse Event|0|||
161070727|NCT00340704|581647993|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070728|NCT00340704|581647994|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070729|NCT00340704|581647995|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
161070730|NCT00340704|581647987|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161070731|NCT00340704|581647988|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161070732|NCT00340704|581647989|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161070733|NCT00340704|581647990|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161070734|NCT00340704|581647991|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
161070735|NCT00340704|581647992|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
161070736|NCT00340704|581647993|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
161070737|NCT00340704|581647994|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
161070738|NCT00340704|581647995|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
161070739|NCT01453023|581647996|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
161070740|NCT01453023|581647997|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
161070741|NCT01453023|581647996|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
161070742|NCT01453023|581647997|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
161070743|NCT01453023|581647996|FG000|Treatment Period 2|Protocol Violation|0|||
161070744|NCT01453023|581647997|FG001|Treatment Period 2|Protocol Violation|1|||
161070745|NCT02869867|581648010|FG000|Overall Study|Protocol Violation|1|||
161070746|NCT02869867|581648011|FG001|Overall Study|Protocol Violation|0|||
161070747|NCT02869867|581648010|FG000|Overall Study|Lost to Follow-up|5|||
161070748|NCT02869867|581648011|FG001|Overall Study|Lost to Follow-up|5|||
161070749|NCT02498236|581648019|FG000|Overall Study|Did not show for testing|1|||
161070750|NCT02498236|581648020|FG001|Overall Study|Did not show for testing|0|||
161070751|NCT02498236|581648021|FG002|Overall Study|Did not show for testing|0|||
161070752|NCT02498236|581648022|FG003|Overall Study|Did not show for testing|0|||
161070753|NCT02498236|581648023|FG004|Overall Study|Did not show for testing|0|||
161070754|NCT02498236|581648024|FG005|Overall Study|Did not show for testing|0|||
161070755|NCT02498236|581648025|FG006|Overall Study|Did not show for testing|0|||
161070756|NCT02498236|581648026|FG007|Overall Study|Did not show for testing|1|||
161070757|NCT02498236|581648019|FG000|Overall Study|Equipment failure|0|||
161070758|NCT02498236|581648020|FG001|Overall Study|Equipment failure|0|||
161070759|NCT02498236|581648021|FG002|Overall Study|Equipment failure|0|||
161070760|NCT02498236|581648022|FG003|Overall Study|Equipment failure|0|||
161070761|NCT02498236|581648023|FG004|Overall Study|Equipment failure|0|||
161070762|NCT02498236|581648024|FG005|Overall Study|Equipment failure|0|||
161070763|NCT02498236|581648025|FG006|Overall Study|Equipment failure|1|||
161070764|NCT02498236|581648026|FG007|Overall Study|Equipment failure|0|||
161070765|NCT02498236|581648019|FG000|Overall Study|Withdrawal by Subject|0|||
161070766|NCT02498236|581648020|FG001|Overall Study|Withdrawal by Subject|0|||
161070767|NCT02498236|581648021|FG002|Overall Study|Withdrawal by Subject|0|||
161070768|NCT02498236|581648022|FG003|Overall Study|Withdrawal by Subject|0|||
161070769|NCT02498236|581648023|FG004|Overall Study|Withdrawal by Subject|1|||
161070770|NCT02498236|581648024|FG005|Overall Study|Withdrawal by Subject|0|||
161070771|NCT02498236|581648025|FG006|Overall Study|Withdrawal by Subject|0|||
161070772|NCT02498236|581648026|FG007|Overall Study|Withdrawal by Subject|0|||
161070773|NCT01255761|581648027|FG000|Overall Study|Adverse Event|29|||
161070774|NCT01255761|581648028|FG001|Overall Study|Adverse Event|43|||
161070775|NCT01255761|581648027|FG000|Overall Study|Lack of Efficacy|86|||
161070776|NCT01255761|581648028|FG001|Overall Study|Lack of Efficacy|74|||
161070777|NCT01255761|581648027|FG000|Overall Study|Protocol Violation|9|||
161070778|NCT01255761|581648028|FG001|Overall Study|Protocol Violation|5|||
161070779|NCT01255761|581648027|FG000|Overall Study|Lost to Follow-up|10|||
161070780|NCT01255761|581648028|FG001|Overall Study|Lost to Follow-up|8|||
161070781|NCT01255761|581648027|FG000|Overall Study|Withdrawal by Subject|11|||
161070782|NCT01255761|581648028|FG001|Overall Study|Withdrawal by Subject|27|||
161070783|NCT01255761|581648027|FG000|Overall Study|Other Reasons|37|||
161070784|NCT01255761|581648028|FG001|Overall Study|Other Reasons|18|||
161070785|NCT00658606|581648029|FG000|Overall Study|Adverse Event|2|||
161070786|NCT00658606|581648030|FG001|Overall Study|Adverse Event|1|||
161070787|NCT00658606|581648029|FG000|Overall Study|Lack of Efficacy|6|||
161070788|NCT00658606|581648030|FG001|Overall Study|Lack of Efficacy|3|||
161070789|NCT00658606|581648029|FG000|Overall Study|Lost to Follow-up|1|||
161070790|NCT00658606|581648030|FG001|Overall Study|Lost to Follow-up|0|||
161070791|NCT00658606|581648029|FG000|Overall Study|Withdrawal by Subject|7|||
161070792|NCT00658606|581648030|FG001|Overall Study|Withdrawal by Subject|16|||
161070793|NCT00658606|581648029|FG000|Overall Study|Lack of Compliance|0|||
161345592|NCT00716417|582650881|FG002|Overall Study|Adverse Event|2|||
161070794|NCT00658606|581648030|FG001|Overall Study|Lack of Compliance|3|||
161070795|NCT00486252|581648035|FG000|Overall Study|Adverse Event|7|||
161070796|NCT00486252|581648035|FG000|Overall Study|Lack of Efficacy|9|||
161070797|NCT00486252|581648035|FG000|Overall Study|Lost to Follow-up|24|||
161070798|NCT00486252|581648035|FG000|Overall Study|Other|18|||
161070799|NCT02559310|581648036|FG000|Overall Study|Death|4|||
161284736|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284737|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284738|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284739|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284740|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284741|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284742|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284743|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161070800|NCT02559310|581648037|FG001|Overall Study|Death|3|||
161070801|NCT02559310|581648036|FG000|Overall Study|Lost to Follow-up|5|||
161070802|NCT02559310|581648037|FG001|Overall Study|Lost to Follow-up|3|||
161070803|NCT02559310|581648036|FG000|Overall Study|Physician Decision|2|||
161070804|NCT02559310|581648037|FG001|Overall Study|Physician Decision|1|||
161070805|NCT02559310|581648036|FG000|Overall Study|Withdrawal by Subject|13|||
161070806|NCT02559310|581648037|FG001|Overall Study|Withdrawal by Subject|9|||
161070807|NCT02559310|581648036|FG000|Overall Study|Sponsor Decision|0|||
161070808|NCT02559310|581648037|FG001|Overall Study|Sponsor Decision|1|||
161070809|NCT02559310|581648036|FG000|Overall Study|Randomized but not treated|3|||
161070810|NCT02559310|581648037|FG001|Overall Study|Randomized but not treated|2|||
161070811|NCT02633397|581648038|FG000|Overall Study|Adverse Event|8|||
161070812|NCT02633397|581648039|FG001|Overall Study|Adverse Event|8|||
161070813|NCT02633397|581648038|FG000|Overall Study|Study Burden|4|||
161070814|NCT02633397|581648039|FG001|Overall Study|Study Burden|1|||
161070815|NCT02633397|581648038|FG000|Overall Study|Treatment interruption|2|||
161070816|NCT02633397|581648039|FG001|Overall Study|Treatment interruption|5|||
161070817|NCT02633397|581648038|FG000|Overall Study|Death|2|||
161070818|NCT02633397|581648039|FG001|Overall Study|Death|2|||
161070819|NCT02633397|581648038|FG000|Overall Study|Physician Decision|0|||
161070820|NCT02633397|581648039|FG001|Overall Study|Physician Decision|1|||
161070821|NCT03595878|581648040|FG000|Overall Study|Death|2|||
161070822|NCT03595878|581648041|FG001|Overall Study|Death|1|||
161070823|NCT03595878|581648042|FG002|Overall Study|Death|0|||
161070824|NCT03595878|581648040|FG000|Overall Study|Disease progression|2|||
161070825|NCT03595878|581648041|FG001|Overall Study|Disease progression|1|||
161070826|NCT03595878|581648042|FG002|Overall Study|Disease progression|2|||
161070827|NCT03036124|581648045|FG000|Overall Study|Lost to Follow-up|0|||
161070828|NCT03036124|581648046|FG001|Overall Study|Lost to Follow-up|2|||
161070829|NCT03036124|581648045|FG000|Overall Study|Withdrawal by Subject|5|||
161070830|NCT03036124|581648046|FG001|Overall Study|Withdrawal by Subject|4|||
161070831|NCT02282059|581648047|FG000|Overall Study|Other|15|||
161070832|NCT02282059|581648048|FG001|Overall Study|Other|3|||
161070833|NCT02282059|581648047|FG000|Overall Study|Participant refused further follow-up|8|||
161070834|NCT02282059|581648048|FG001|Overall Study|Participant refused further follow-up|4|||
161070835|NCT02282059|581648047|FG000|Overall Study|Lost to Follow-up|19|||
161070836|NCT02282059|581648048|FG001|Overall Study|Lost to Follow-up|3|||
161070837|NCT02282059|581648047|FG000|Overall Study|Death|40|||
161070838|NCT02282059|581648048|FG001|Overall Study|Death|8|||
161070839|NCT04949802|581649592|FG000|Overall Study|Lost to Follow-up|3|||
161070840|NCT01020877|581649595|FG000|Second Intervention|Withdrawal by Subject|1|||
161070841|NCT01020877|581649596|FG001|Second Intervention|Withdrawal by Subject|0|||
161070842|NCT00433511|581649597|FG000|Step 1|Adverse Event|50|||
161070843|NCT00433511|581649598|FG001|Step 1|Adverse Event|157|||
161070844|NCT00433511|581649599|FG002|Step 1|Adverse Event|153|||
161070845|NCT00433511|581649597|FG000|Step 1|Withdrawal by Subject|45|||
161070846|NCT00433511|581649598|FG001|Step 1|Withdrawal by Subject|143|||
161070847|NCT00433511|581649599|FG002|Step 1|Withdrawal by Subject|154|||
161070848|NCT00433511|581649597|FG000|Step 1|Death|3|||
161070849|NCT00433511|581649598|FG001|Step 1|Death|1|||
161156374|NCT00875017|581952968|FG005|First Intervention|Withdrawal by Subject|0|||
161284744|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284745|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161070850|NCT00433511|581649599|FG002|Step 1|Death|1|||
161070851|NCT00433511|581649597|FG000|Step 1|Physician Decision|1|||
161070852|NCT00433511|581649598|FG001|Step 1|Physician Decision|4|||
161070853|NCT00433511|581649599|FG002|Step 1|Physician Decision|3|||
161070854|NCT00433511|581649597|FG000|Step 1|Never started protocol therapy|28|||
161070855|NCT00433511|581649598|FG001|Step 1|Never started protocol therapy|64|||
161070856|NCT00433511|581649599|FG002|Step 1|Never started protocol therapy|66|||
161070857|NCT00433511|581649597|FG000|Step 1|Alternative therapy|2|||
161070858|NCT00433511|581649598|FG001|Step 1|Alternative therapy|1|||
161070859|NCT00433511|581649599|FG002|Step 1|Alternative therapy|3|||
161070860|NCT00433511|581649597|FG000|Step 1|Disease progression, relapse|5|||
161070861|NCT00433511|581649598|FG001|Step 1|Disease progression, relapse|3|||
161070862|NCT00433511|581649599|FG002|Step 1|Disease progression, relapse|3|||
161070863|NCT00433511|581649597|FG000|Step 1|Other complicating disease|2|||
161156375|NCT00875017|581952963|FG000|First Intervention|Adverse Event|0|||
161070864|NCT00433511|581649598|FG001|Step 1|Other complicating disease|6|||
161070865|NCT00433511|581649599|FG002|Step 1|Other complicating disease|3|||
161070866|NCT00433511|581649597|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
161284746|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
161284747|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161284748|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284749|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
161284750|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161284751|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
161284752|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
161284753|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284754|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284755|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284756|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284757|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284758|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284759|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284760|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284761|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284762|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284763|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
161284764|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
161284765|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161284766|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161284767|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
161284768|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
161284769|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
161284770|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284771|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284772|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284773|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284774|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284775|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284776|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284777|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284778|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284779|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284780|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
161284781|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284782|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
161284783|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
161284784|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284785|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
161284786|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
161284787|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284788|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284789|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284790|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284791|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284792|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284793|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284794|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284795|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284796|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284797|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
161284798|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284799|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284800|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
161284801|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
161284802|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284803|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284804|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284805|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284806|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284807|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284808|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284809|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284810|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284811|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284812|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284813|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161070867|NCT00433511|581649598|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
161070868|NCT00433511|581649599|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
161070869|NCT00433511|581649597|FG000|Step 1|Suspected recurrence|0|||
161070870|NCT00433511|581649598|FG001|Step 1|Suspected recurrence|1|||
161070871|NCT00433511|581649599|FG002|Step 1|Suspected recurrence|0|||
161070872|NCT00433511|581649597|FG000|Step 1|Insurance/drug distribution issues|0|||
161070873|NCT00433511|581649598|FG001|Step 1|Insurance/drug distribution issues|1|||
161070874|NCT00433511|581649599|FG002|Step 1|Insurance/drug distribution issues|2|||
161070875|NCT00433511|581649597|FG000|Step 1|Patient moved|0|||
161070876|NCT00433511|581649598|FG001|Step 1|Patient moved|0|||
161070877|NCT00433511|581649599|FG002|Step 1|Patient moved|1|||
161070878|NCT00433511|581649597|FG000|Step 2 (Arm D)|Adverse Event|0|||
161070879|NCT00433511|581649598|FG001|Step 2 (Arm D)|Adverse Event|0|||
161070880|NCT00433511|581649599|FG002|Step 2 (Arm D)|Adverse Event|135|||
161070881|NCT00433511|581649597|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
161070882|NCT00433511|581649598|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
161070883|NCT00433511|581649599|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
161070884|NCT00433511|581649597|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
161070885|NCT00433511|581649598|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
161070886|NCT00433511|581649599|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
161070887|NCT00433511|581649597|FG000|Step 2 (Arm D)|Physician Decision|0|||
161070888|NCT00433511|581649598|FG001|Step 2 (Arm D)|Physician Decision|0|||
161070889|NCT00433511|581649599|FG002|Step 2 (Arm D)|Physician Decision|9|||
161070890|NCT00433511|581649597|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
161070891|NCT00433511|581649598|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
161070892|NCT00433511|581649599|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
161070893|NCT00433511|581649597|FG000|Step 2 (Arm D)|Other complicating disease|0|||
161070894|NCT00433511|581649598|FG001|Step 2 (Arm D)|Other complicating disease|0|||
161070895|NCT00433511|581649599|FG002|Step 2 (Arm D)|Other complicating disease|3|||
161070896|NCT00433511|581649597|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
161070897|NCT00433511|581649598|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
161070898|NCT00433511|581649599|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
161070899|NCT00433511|581649597|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
161070900|NCT00433511|581649598|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
161070901|NCT00433511|581649599|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
161070902|NCT00433511|581649597|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
161070903|NCT00433511|581649598|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
161070904|NCT00433511|581649599|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
161070905|NCT00433511|581649597|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
161070906|NCT00433511|581649598|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
161070907|NCT00433511|581649599|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
161070908|NCT01784523|581649600|FG000|Overall Study|Study closed early|7|||
161070909|NCT01784523|581649601|FG001|Overall Study|Study closed early|4|||
161070910|NCT03377361|581649610|FG000|Pre-Treatment|Subject withdrew consent|0|||
161070911|NCT03377361|581649611|FG001|Pre-Treatment|Subject withdrew consent|0|||
161070912|NCT03377361|581649612|FG002|Pre-Treatment|Subject withdrew consent|0|||
161070913|NCT03377361|581649613|FG003|Pre-Treatment|Subject withdrew consent|0|||
161070914|NCT03377361|581649614|FG004|Pre-Treatment|Subject withdrew consent|0|||
161070915|NCT03377361|581649615|FG005|Pre-Treatment|Subject withdrew consent|0|||
161070916|NCT03377361|581649616|FG006|Pre-Treatment|Subject withdrew consent|0|||
161070917|NCT03377361|581649617|FG007|Pre-Treatment|Subject withdrew consent|3|||
161070918|NCT03377361|581649618|FG008|Pre-Treatment|Subject withdrew consent|1|||
161070919|NCT03377361|581649619|FG009|Pre-Treatment|Subject withdrew consent|0|||
161070920|NCT03377361|581649610|FG000|Pre-Treatment|Not Reported|0|||
161070921|NCT03377361|581649611|FG001|Pre-Treatment|Not Reported|0|||
161070922|NCT03377361|581649612|FG002|Pre-Treatment|Not Reported|0|||
161070923|NCT03377361|581649613|FG003|Pre-Treatment|Not Reported|0|||
161070924|NCT03377361|581649614|FG004|Pre-Treatment|Not Reported|0|||
161070925|NCT03377361|581649615|FG005|Pre-Treatment|Not Reported|0|||
161070926|NCT03377361|581649616|FG006|Pre-Treatment|Not Reported|0|||
161070927|NCT03377361|581649617|FG007|Pre-Treatment|Not Reported|0|||
161070928|NCT03377361|581649618|FG008|Pre-Treatment|Not Reported|3|||
161070929|NCT03377361|581649619|FG009|Pre-Treatment|Not Reported|0|||
161156376|NCT00875017|581952964|FG001|First Intervention|Adverse Event|0|||
161156377|NCT00875017|581952965|FG002|First Intervention|Adverse Event|0|||
161284814|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
161284815|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284816|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284817|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284818|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284819|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
161070930|NCT03377361|581649610|FG000|Treatment Period|Disease Progression|3|||
161284820|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161070931|NCT03377361|581649611|FG001|Treatment Period|Disease Progression|2|||
161070932|NCT03377361|581649612|FG002|Treatment Period|Disease Progression|5|||
161070933|NCT03377361|581649613|FG003|Treatment Period|Disease Progression|3|||
161070934|NCT03377361|581649614|FG004|Treatment Period|Disease Progression|3|||
161070935|NCT03377361|581649615|FG005|Treatment Period|Disease Progression|3|||
161070936|NCT03377361|581649616|FG006|Treatment Period|Disease Progression|6|||
161070937|NCT03377361|581649617|FG007|Treatment Period|Disease Progression|106|||
161070938|NCT03377361|581649618|FG008|Treatment Period|Disease Progression|48|||
161070939|NCT03377361|581649619|FG009|Treatment Period|Disease Progression|59|||
161070940|NCT03377361|581649610|FG000|Treatment Period|Study Drug Toxicity|0|||
161070941|NCT03377361|581649611|FG001|Treatment Period|Study Drug Toxicity|0|||
161070942|NCT03377361|581649612|FG002|Treatment Period|Study Drug Toxicity|0|||
161070943|NCT03377361|581649613|FG003|Treatment Period|Study Drug Toxicity|1|||
161070944|NCT03377361|581649614|FG004|Treatment Period|Study Drug Toxicity|0|||
161070945|NCT03377361|581649615|FG005|Treatment Period|Study Drug Toxicity|0|||
161070946|NCT03377361|581649616|FG006|Treatment Period|Study Drug Toxicity|0|||
161070947|NCT03377361|581649617|FG007|Treatment Period|Study Drug Toxicity|7|||
161070948|NCT03377361|581649618|FG008|Treatment Period|Study Drug Toxicity|2|||
161070949|NCT03377361|581649619|FG009|Treatment Period|Study Drug Toxicity|16|||
161070950|NCT03377361|581649610|FG000|Treatment Period|Death|0|||
161070951|NCT03377361|581649611|FG001|Treatment Period|Death|0|||
161070952|NCT03377361|581649612|FG002|Treatment Period|Death|1|||
161070953|NCT03377361|581649613|FG003|Treatment Period|Death|0|||
161070954|NCT03377361|581649614|FG004|Treatment Period|Death|0|||
161070955|NCT03377361|581649615|FG005|Treatment Period|Death|0|||
161070956|NCT03377361|581649616|FG006|Treatment Period|Death|0|||
161070957|NCT03377361|581649617|FG007|Treatment Period|Death|2|||
161070958|NCT03377361|581649618|FG008|Treatment Period|Death|1|||
161070959|NCT03377361|581649619|FG009|Treatment Period|Death|3|||
161070960|NCT03377361|581649610|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070961|NCT03377361|581649611|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070962|NCT03377361|581649612|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070963|NCT03377361|581649613|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070964|NCT03377361|581649614|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070965|NCT03377361|581649615|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070966|NCT03377361|581649616|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
161070967|NCT03377361|581649617|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
161070968|NCT03377361|581649618|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
161070969|NCT03377361|581649619|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
161070970|NCT03377361|581649610|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
161070971|NCT03377361|581649611|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
161070972|NCT03377361|581649612|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
161070973|NCT03377361|581649613|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
161070974|NCT03377361|581649614|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
161070975|NCT03377361|581649615|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
161070976|NCT03377361|581649616|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
161070977|NCT03377361|581649617|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
161070978|NCT03377361|581649618|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
161070979|NCT03377361|581649619|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
161070980|NCT03377361|581649610|FG000|Treatment Period|Subject Withdrew Consent|0|||
161070981|NCT03377361|581649611|FG001|Treatment Period|Subject Withdrew Consent|0|||
161070982|NCT03377361|581649612|FG002|Treatment Period|Subject Withdrew Consent|0|||
161070983|NCT03377361|581649613|FG003|Treatment Period|Subject Withdrew Consent|0|||
161070984|NCT03377361|581649614|FG004|Treatment Period|Subject Withdrew Consent|0|||
161070985|NCT03377361|581649615|FG005|Treatment Period|Subject Withdrew Consent|0|||
161070986|NCT03377361|581649616|FG006|Treatment Period|Subject Withdrew Consent|0|||
161070987|NCT03377361|581649617|FG007|Treatment Period|Subject Withdrew Consent|0|||
161070988|NCT03377361|581649618|FG008|Treatment Period|Subject Withdrew Consent|2|||
161070989|NCT03377361|581649619|FG009|Treatment Period|Subject Withdrew Consent|1|||
161070990|NCT03377361|581649610|FG000|Treatment Period|No longer meets study criteria|0|||
161070991|NCT03377361|581649611|FG001|Treatment Period|No longer meets study criteria|1|||
161070992|NCT03377361|581649612|FG002|Treatment Period|No longer meets study criteria|0|||
161345593|NCT00716417|582650882|FG003|Overall Study|Adverse Event|1|||
161345594|NCT00716417|582650883|FG004|Overall Study|Adverse Event|0|||
161345595|NCT00716417|582650884|FG005|Overall Study|Adverse Event|0|||
161345596|NCT00716417|582650885|FG006|Overall Study|Adverse Event|3|||
161070993|NCT03377361|581649613|FG003|Treatment Period|No longer meets study criteria|0|||
161070994|NCT03377361|581649614|FG004|Treatment Period|No longer meets study criteria|0|||
161070995|NCT03377361|581649615|FG005|Treatment Period|No longer meets study criteria|0|||
161070996|NCT03377361|581649616|FG006|Treatment Period|No longer meets study criteria|0|||
161070997|NCT03377361|581649617|FG007|Treatment Period|No longer meets study criteria|1|||
161156378|NCT00875017|581952966|FG003|First Intervention|Adverse Event|1|||
161156379|NCT00875017|581952967|FG004|First Intervention|Adverse Event|0|||
161156380|NCT00875017|581952968|FG005|First Intervention|Adverse Event|0|||
161345597|NCT00716417|582650886|FG007|Overall Study|Adverse Event|1|||
161284821|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284822|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284823|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284824|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284825|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284826|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284827|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284828|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284829|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284830|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284831|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
161284832|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284833|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
161284834|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284835|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284836|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284837|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284838|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284839|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284840|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284841|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284842|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284843|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284844|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284845|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284846|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284847|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161345598|NCT00716417|582650887|FG008|Overall Study|Adverse Event|0|||
161345599|NCT00716417|582650888|FG009|Overall Study|Adverse Event|3|||
161284848|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
161284849|NCT00758524|582421325|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284850|NCT00758524|582421326|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
161284851|NCT00758524|582421327|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284852|NCT00758524|582421328|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284853|NCT00758524|582421329|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284854|NCT00758524|582421330|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284855|NCT00758524|582421331|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284856|NCT00758524|582421332|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284857|NCT00758524|582421333|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284858|NCT00758524|582421334|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284859|NCT00758524|582421335|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284860|NCT00758524|582421336|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284861|NCT00758524|582421337|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284862|NCT00758524|582421338|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284863|NCT00758524|582421339|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284864|NCT00758524|582421340|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284865|NCT00758524|582421341|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
161284866|NCT00758524|582421325|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284867|NCT00758524|582421326|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284868|NCT00758524|582421327|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284869|NCT00758524|582421328|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284870|NCT00758524|582421329|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284871|NCT00758524|582421330|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284872|NCT00758524|582421331|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284873|NCT00758524|582421332|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284874|NCT00758524|582421333|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
161284875|NCT00758524|582421334|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161345600|NCT00716417|582650879|FG000|Overall Study|Withdrawal by Subject|0|||
161345601|NCT00716417|582650880|FG001|Overall Study|Withdrawal by Subject|1|||
161345602|NCT00716417|582650881|FG002|Overall Study|Withdrawal by Subject|0|||
161345603|NCT00716417|582650882|FG003|Overall Study|Withdrawal by Subject|2|||
161070998|NCT03377361|581649618|FG008|Treatment Period|No longer meets study criteria|0|||
161345604|NCT00716417|582650883|FG004|Overall Study|Withdrawal by Subject|0|||
161345605|NCT00716417|582650884|FG005|Overall Study|Withdrawal by Subject|0|||
161070999|NCT03377361|581649619|FG009|Treatment Period|No longer meets study criteria|0|||
161071000|NCT03377361|581649610|FG000|Treatment Period|Other Reasons|0|||
161071001|NCT03377361|581649611|FG001|Treatment Period|Other Reasons|0|||
161071002|NCT03377361|581649612|FG002|Treatment Period|Other Reasons|0|||
161071003|NCT03377361|581649613|FG003|Treatment Period|Other Reasons|3|||
161071004|NCT03377361|581649614|FG004|Treatment Period|Other Reasons|0|||
161071005|NCT03377361|581649615|FG005|Treatment Period|Other Reasons|0|||
161071006|NCT03377361|581649616|FG006|Treatment Period|Other Reasons|0|||
161071007|NCT03377361|581649617|FG007|Treatment Period|Other Reasons|2|||
161071008|NCT03377361|581649618|FG008|Treatment Period|Other Reasons|0|||
161071009|NCT03377361|581649619|FG009|Treatment Period|Other Reasons|1|||
161071010|NCT00742326|581649620|FG000|Overall Study|Physician Decision|0|||
161071011|NCT00742326|581649621|FG001|Overall Study|Physician Decision|1|||
161071012|NCT03698994|581649625|FG000|Overall Study|Adverse Event|2|||
161071013|NCT03698994|581649625|FG000|Overall Study|Death|1|||
161071014|NCT03698994|581649625|FG000|Overall Study|Physician Decision|1|||
161071015|NCT03698994|581649625|FG000|Overall Study|Withdrawal by Subject|3|||
161071016|NCT03698994|581649625|FG000|Overall Study|Progressive Disease|12|||
161071017|NCT03635086|581649628|FG000|Overall Study|Withdrawal of consent|0|||
161071018|NCT03635086|581649629|FG001|Overall Study|Withdrawal of consent|0|||
161071019|NCT03635086|581649630|FG002|Overall Study|Withdrawal of consent|1|||
161071020|NCT03635086|581649631|FG003|Overall Study|Withdrawal of consent|0|||
161071021|NCT03635086|581649632|FG004|Overall Study|Withdrawal of consent|0|||
161071022|NCT03635086|581649628|FG000|Overall Study|Adverse Event|0|||
161071023|NCT03635086|581649629|FG001|Overall Study|Adverse Event|1|||
161071024|NCT03635086|581649630|FG002|Overall Study|Adverse Event|0|||
161071025|NCT03635086|581649631|FG003|Overall Study|Adverse Event|0|||
161071026|NCT03635086|581649632|FG004|Overall Study|Adverse Event|0|||
161284876|NCT00758524|582421335|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284877|NCT00758524|582421336|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284878|NCT00758524|582421337|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284879|NCT00758524|582421338|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284880|NCT00758524|582421339|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284881|NCT00758524|582421340|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284882|NCT00758524|582421341|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
161284883|NCT00758524|582421325|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284884|NCT00758524|582421326|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284885|NCT00758524|582421327|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284886|NCT00758524|582421328|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284887|NCT00758524|582421329|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284888|NCT00758524|582421330|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284889|NCT00758524|582421331|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
161071027|NCT03635086|581649628|FG000|Overall Study|Lost to Follow-up|1|||
161071028|NCT03635086|581649629|FG001|Overall Study|Lost to Follow-up|0|||
161071029|NCT03635086|581649630|FG002|Overall Study|Lost to Follow-up|0|||
161071030|NCT03635086|581649631|FG003|Overall Study|Lost to Follow-up|0|||
161071031|NCT03635086|581649632|FG004|Overall Study|Lost to Follow-up|0|||
161071032|NCT02196077|581649633|FG000|Overall Study|Adverse Event|4|||
161071033|NCT02196077|581649633|FG000|Overall Study|Lack of Efficacy|1|||
161071034|NCT02196077|581649633|FG000|Overall Study|Withdrawal by Subject|14|||
161071035|NCT02196077|581649633|FG000|Overall Study|Physician Decision|1|||
161071036|NCT02196077|581649633|FG000|Overall Study|Lost to Follow-up|3|||
161071037|NCT02196077|581649633|FG000|Overall Study|Protocol Violation|24|||
161071038|NCT00732992|581649634|FG000|Overall Study|Adverse Event|1|||
161071039|NCT00732992|581649635|FG001|Overall Study|Adverse Event|1|||
161071040|NCT00732992|581649634|FG000|Overall Study|Objective Progression or Relapse|3|||
161071041|NCT00732992|581649635|FG001|Overall Study|Objective Progression or Relapse|5|||
161071042|NCT00732992|581649634|FG000|Overall Study|Global Deterioration of Health Status|1|||
161071043|NCT00732992|581649635|FG001|Overall Study|Global Deterioration of Health Status|0|||
161071044|NCT00732992|581649634|FG000|Overall Study|Withdrawal by Subject|1|||
161071045|NCT00732992|581649635|FG001|Overall Study|Withdrawal by Subject|0|||
161071046|NCT03482752|581649640|FG000|Overall Study|Withdrawal by Subject|2|||
161071047|NCT03482752|581649640|FG000|Overall Study|Lost to Follow-up|1|||
161071048|NCT03482752|581649640|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
161071049|NCT02844777|581649641|FG000|Overall Study|Withdrawal by Subject|2|||
161156381|NCT00875017|581952963|FG000|First Intervention|Problems collecting rectal effluent|1|||
161156382|NCT00875017|581952964|FG001|First Intervention|Problems collecting rectal effluent|0|||
161071050|NCT02844777|581649642|FG001|Overall Study|Withdrawal by Subject|0|||
161071051|NCT02844777|581649643|FG002|Overall Study|Withdrawal by Subject|0|||
161071052|NCT01776008|581649644|FG000|Overall Study|ineligible|2|||
161071053|NCT00150618|581649645|FG000|Overall Study|Adverse Event|2|||
161071054|NCT00150618|581649646|FG001|Overall Study|Adverse Event|2|||
161071055|NCT00150618|581649647|FG002|Overall Study|Adverse Event|6|||
161071056|NCT00150618|581649648|FG003|Overall Study|Adverse Event|9|||
161071057|NCT00150618|581649649|FG004|Overall Study|Adverse Event|5|||
161071058|NCT00150618|581649645|FG000|Overall Study|Withdrawal by Subject|6|||
161071059|NCT00150618|581649646|FG001|Overall Study|Withdrawal by Subject|8|||
161071060|NCT00150618|581649647|FG002|Overall Study|Withdrawal by Subject|8|||
161071061|NCT00150618|581649648|FG003|Overall Study|Withdrawal by Subject|4|||
161071062|NCT00150618|581649649|FG004|Overall Study|Withdrawal by Subject|5|||
161071063|NCT00150618|581649645|FG000|Overall Study|Lost to Follow-up|4|||
161071064|NCT00150618|581649646|FG001|Overall Study|Lost to Follow-up|1|||
161071065|NCT00150618|581649647|FG002|Overall Study|Lost to Follow-up|5|||
161071066|NCT00150618|581649648|FG003|Overall Study|Lost to Follow-up|8|||
161071067|NCT00150618|581649649|FG004|Overall Study|Lost to Follow-up|4|||
161071068|NCT00150618|581649645|FG000|Overall Study|Protocol Violation|1|||
161071069|NCT00150618|581649646|FG001|Overall Study|Protocol Violation|0|||
161071070|NCT00150618|581649647|FG002|Overall Study|Protocol Violation|0|||
161071071|NCT00150618|581649648|FG003|Overall Study|Protocol Violation|0|||
161071072|NCT00150618|581649649|FG004|Overall Study|Protocol Violation|1|||
161071073|NCT00150618|581649645|FG000|Overall Study|Lack of Efficacy|1|||
161071074|NCT00150618|581649646|FG001|Overall Study|Lack of Efficacy|4|||
161071075|NCT00150618|581649647|FG002|Overall Study|Lack of Efficacy|7|||
161071076|NCT00150618|581649648|FG003|Overall Study|Lack of Efficacy|4|||
161071077|NCT00150618|581649649|FG004|Overall Study|Lack of Efficacy|6|||
161071078|NCT00150618|581649645|FG000|Overall Study|No study meds|0|||
161071079|NCT00150618|581649646|FG001|Overall Study|No study meds|0|||
161071080|NCT00150618|581649647|FG002|Overall Study|No study meds|0|||
161071081|NCT00150618|581649648|FG003|Overall Study|No study meds|0|||
161071082|NCT00150618|581649649|FG004|Overall Study|No study meds|2|||
161156383|NCT00875017|581952965|FG002|First Intervention|Problems collecting rectal effluent|0|||
161156384|NCT00875017|581952966|FG003|First Intervention|Problems collecting rectal effluent|0|||
161156385|NCT00875017|581952967|FG004|First Intervention|Problems collecting rectal effluent|0|||
161156386|NCT00875017|581952968|FG005|First Intervention|Problems collecting rectal effluent|0|||
161156387|NCT00875017|581952963|FG000|First Intervention|Intolerance to nasogastric tube|0|||
161156388|NCT00875017|581952964|FG001|First Intervention|Intolerance to nasogastric tube|0|||
161156389|NCT00875017|581952965|FG002|First Intervention|Intolerance to nasogastric tube|0|||
161156390|NCT00875017|581952966|FG003|First Intervention|Intolerance to nasogastric tube|0|||
161156391|NCT00875017|581952967|FG004|First Intervention|Intolerance to nasogastric tube|1|||
161156392|NCT00875017|581952968|FG005|First Intervention|Intolerance to nasogastric tube|0|||
161156393|NCT00875017|581952963|FG000|Washout|Problem collecting rectal effluent|0|||
161156394|NCT00875017|581952964|FG001|Washout|Problem collecting rectal effluent|0|||
161156395|NCT00875017|581952965|FG002|Washout|Problem collecting rectal effluent|1|||
161156396|NCT00875017|581952966|FG003|Washout|Problem collecting rectal effluent|0|||
161156397|NCT00875017|581952967|FG004|Washout|Problem collecting rectal effluent|0|||
161156398|NCT00875017|581952968|FG005|Washout|Problem collecting rectal effluent|0|||
161156399|NCT00875017|581952963|FG000|Second Intervention|Adverse Event|0|||
161156400|NCT00875017|581952964|FG001|Second Intervention|Adverse Event|0|||
161156401|NCT00875017|581952965|FG002|Second Intervention|Adverse Event|0|||
161156402|NCT00875017|581952966|FG003|Second Intervention|Adverse Event|1|||
161156403|NCT00875017|581952967|FG004|Second Intervention|Adverse Event|0|||
161156404|NCT00875017|581952968|FG005|Second Intervention|Adverse Event|0|||
161156405|NCT00875017|581952963|FG000|Washout|Problems collecting rectal effluent|0|||
161156406|NCT00875017|581952964|FG001|Washout|Problems collecting rectal effluent|1|||
161156407|NCT00875017|581952965|FG002|Washout|Problems collecting rectal effluent|0|||
161156408|NCT00875017|581952966|FG003|Washout|Problems collecting rectal effluent|0|||
161156409|NCT00875017|581952967|FG004|Washout|Problems collecting rectal effluent|0|||
161156410|NCT00875017|581952968|FG005|Washout|Problems collecting rectal effluent|0|||
161156411|NCT00875017|581952963|FG000|Third Intervention|Adverse Event|0|||
161156412|NCT00875017|581952964|FG001|Third Intervention|Adverse Event|1|||
161156413|NCT00875017|581952965|FG002|Third Intervention|Adverse Event|1|||
161156414|NCT00875017|581952966|FG003|Third Intervention|Adverse Event|0|||
161156415|NCT00875017|581952967|FG004|Third Intervention|Adverse Event|0|||
161156416|NCT00875017|581952968|FG005|Third Intervention|Adverse Event|0|||
161156417|NCT00875017|581952963|FG000|Washout|Withdrawal by Subject|0|||
161284890|NCT00758524|582421332|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284891|NCT00758524|582421333|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161156418|NCT00875017|581952964|FG001|Washout|Withdrawal by Subject|0|||
161284892|NCT00758524|582421334|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161071083|NCT00150618|581649645|FG000|Overall Study|Physician Decision|0|||
161071084|NCT00150618|581649646|FG001|Overall Study|Physician Decision|2|||
161071085|NCT00150618|581649647|FG002|Overall Study|Physician Decision|0|||
161071086|NCT00150618|581649648|FG003|Overall Study|Physician Decision|0|||
161071087|NCT00150618|581649649|FG004|Overall Study|Physician Decision|1|||
161071088|NCT00150618|581649645|FG000|Overall Study|Lack of compliance|2|||
161156419|NCT00875017|581952965|FG002|Washout|Withdrawal by Subject|0|||
161156420|NCT00875017|581952966|FG003|Washout|Withdrawal by Subject|0|||
161156421|NCT00875017|581952967|FG004|Washout|Withdrawal by Subject|1|||
161071089|NCT00150618|581649646|FG001|Overall Study|Lack of compliance|1|||
161284893|NCT00758524|582421335|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284894|NCT00758524|582421336|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284895|NCT00758524|582421337|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284896|NCT00758524|582421338|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284897|NCT00758524|582421339|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284898|NCT00758524|582421340|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284899|NCT00758524|582421341|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
161284900|NCT04176250|582421342|FG000|Overall Study|Adverse Event|0|||
161284901|NCT04176250|582421343|FG001|Overall Study|Adverse Event|1|||
161284902|NCT04176250|582421344|FG002|Overall Study|Adverse Event|0|||
161284903|NCT04176250|582421345|FG003|Overall Study|Adverse Event|1|||
161284904|NCT04176250|582421346|FG004|Overall Study|Adverse Event|0|||
161284905|NCT04176250|582421347|FG005|Overall Study|Adverse Event|1|||
161284906|NCT04176250|582421342|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161284907|NCT04176250|582421343|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161284908|NCT04176250|582421344|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
161284909|NCT04176250|582421345|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
161284910|NCT04176250|582421346|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161284911|NCT04176250|582421347|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
161284912|NCT04176250|582421342|FG000|Overall Study|Withdrawal by Subject|0|||
161284913|NCT04176250|582421343|FG001|Overall Study|Withdrawal by Subject|0|||
161284914|NCT04176250|582421344|FG002|Overall Study|Withdrawal by Subject|0|||
161284915|NCT04176250|582421345|FG003|Overall Study|Withdrawal by Subject|0|||
161284916|NCT04176250|582421346|FG004|Overall Study|Withdrawal by Subject|0|||
161284917|NCT04176250|582421347|FG005|Overall Study|Withdrawal by Subject|1|||
161284918|NCT04176250|582421342|FG000|Overall Study|Randomized in error|0|||
161284919|NCT04176250|582421343|FG001|Overall Study|Randomized in error|0|||
161284920|NCT04176250|582421344|FG002|Overall Study|Randomized in error|0|||
161284921|NCT04176250|582421345|FG003|Overall Study|Randomized in error|0|||
161284922|NCT04176250|582421346|FG004|Overall Study|Randomized in error|1|||
161284923|NCT04176250|582421347|FG005|Overall Study|Randomized in error|0|||
161284924|NCT04688671|582421348|FG000|Overall Study|Adverse Event|3|||
161284925|NCT04688671|582421349|FG001|Overall Study|Adverse Event|1|||
161284926|NCT04688671|582421348|FG000|Overall Study|Withdrawal by Subject|3|||
161284927|NCT04688671|582421349|FG001|Overall Study|Withdrawal by Subject|1|||
161284928|NCT04688671|582421348|FG000|Overall Study|Lack of Efficacy|1|||
161284929|NCT04688671|582421349|FG001|Overall Study|Lack of Efficacy|1|||
161284930|NCT04688671|582421348|FG000|Overall Study|Protocol Violation|1|||
161284931|NCT04688671|582421349|FG001|Overall Study|Protocol Violation|0|||
161284932|NCT04688671|582421348|FG000|Overall Study|Lost to Follow-up|0|||
161284933|NCT04688671|582421349|FG001|Overall Study|Lost to Follow-up|1|||
161284934|NCT02676882|582421354|FG000|Overall Study|Adverse Event|1|||
161284935|NCT02676882|582421355|FG001|Overall Study|Adverse Event|0|||
161284936|NCT02676882|582421354|FG000|Overall Study|Lost to Follow-up|1|||
161284937|NCT02676882|582421355|FG001|Overall Study|Lost to Follow-up|0|||
161284938|NCT02676882|582421354|FG000|Overall Study|Withdrawal by Subject|1|||
161284939|NCT02676882|582421355|FG001|Overall Study|Withdrawal by Subject|2|||
161284940|NCT00811733|582421357|FG000|Overall Study|Investigator Discretion|10|||
161284941|NCT00811733|582421358|FG001|Overall Study|Investigator Discretion|8|||
161284942|NCT00811733|582421357|FG000|Overall Study|Withdrawal by Subject|1|||
161284943|NCT00811733|582421358|FG001|Overall Study|Withdrawal by Subject|2|||
161284944|NCT00793871|582421359|FG000|Overall Study|Death|50|||
161284945|NCT00793871|582421359|FG000|Overall Study|Lost to Follow-up|3|||
161284946|NCT00793871|582421359|FG000|Overall Study|Study terminated by the Sponsor|7|||
161284947|NCT02500589|582421360|FG000|Overall Study|Withdrawal by Subject|11|||
161284948|NCT02500589|582421361|FG001|Overall Study|Withdrawal by Subject|14|||
161284949|NCT02500589|582421360|FG000|Overall Study|Lost to Follow-up|10|||
161284950|NCT02500589|582421361|FG001|Overall Study|Lost to Follow-up|12|||
161284951|NCT02500589|582421360|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
161284952|NCT02500589|582421361|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
161284953|NCT02500589|582421360|FG000|Overall Study|Death|7|||
161284954|NCT02500589|582421361|FG001|Overall Study|Death|5|||
161284955|NCT00245466|582421362|FG000|Overall Study|Adverse Event|2|||
161284956|NCT00245466|582421363|FG001|Overall Study|Adverse Event|8|||
161284957|NCT00245466|582421364|FG002|Overall Study|Adverse Event|4|||
161284958|NCT00245466|582421362|FG000|Overall Study|Low prostate specific antigen suppr|16|||
161284959|NCT00245466|582421363|FG001|Overall Study|Low prostate specific antigen suppr|14|||
161284960|NCT00245466|582421364|FG002|Overall Study|Low prostate specific antigen suppr|5|||
161284961|NCT00245466|582421362|FG000|Overall Study|Insufficient testosterone suppr|12|||
161284962|NCT00245466|582421363|FG001|Overall Study|Insufficient testosterone suppr|12|||
161284963|NCT00245466|582421364|FG002|Overall Study|Insufficient testosterone suppr|21|||
161284964|NCT00245466|582421362|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
161284965|NCT00245466|582421363|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
161284966|NCT00245466|582421364|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
161284967|NCT00245466|582421362|FG000|Overall Study|Withdrawal by Subject|2|||
161284968|NCT00245466|582421363|FG001|Overall Study|Withdrawal by Subject|2|||
161284969|NCT00245466|582421364|FG002|Overall Study|Withdrawal by Subject|1|||
161284970|NCT00245466|582421362|FG000|Overall Study|Lost to Follow-up|3|||
161284971|NCT00245466|582421363|FG001|Overall Study|Lost to Follow-up|0|||
161284972|NCT00245466|582421364|FG002|Overall Study|Lost to Follow-up|0|||
161284973|NCT00245466|582421362|FG000|Overall Study|Disease progression|0|||
161284974|NCT00245466|582421363|FG001|Overall Study|Disease progression|3|||
161284975|NCT00245466|582421364|FG002|Overall Study|Disease progression|1|||
161284976|NCT00245466|582421362|FG000|Overall Study|Protocol Violation|1|||
161345606|NCT00716417|582650885|FG006|Overall Study|Withdrawal by Subject|1|||
161345607|NCT00716417|582650886|FG007|Overall Study|Withdrawal by Subject|0|||
161071090|NCT00150618|581649647|FG002|Overall Study|Lack of compliance|1|||
161071091|NCT00150618|581649648|FG003|Overall Study|Lack of compliance|0|||
161071092|NCT00150618|581649649|FG004|Overall Study|Lack of compliance|1|||
161071093|NCT00150618|581649645|FG000|Overall Study|Abnormal ECG|1|||
161071094|NCT00150618|581649646|FG001|Overall Study|Abnormal ECG|0|||
161071095|NCT00150618|581649647|FG002|Overall Study|Abnormal ECG|0|||
161071096|NCT00150618|581649648|FG003|Overall Study|Abnormal ECG|0|||
161071097|NCT00150618|581649649|FG004|Overall Study|Abnormal ECG|0|||
161071098|NCT00150618|581649645|FG000|Overall Study|Sponsor's decision|0|||
161071099|NCT00150618|581649646|FG001|Overall Study|Sponsor's decision|0|||
161071100|NCT00150618|581649647|FG002|Overall Study|Sponsor's decision|0|||
161071101|NCT00150618|581649648|FG003|Overall Study|Sponsor's decision|1|||
161071102|NCT00150618|581649649|FG004|Overall Study|Sponsor's decision|0|||
161071103|NCT02493946|581649650|FG000|DB Period|Withdrawal by Subject|8|||
161071104|NCT02493946|581649651|FG001|DB Period|Withdrawal by Subject|5|||
161071105|NCT02493946|581649652|FG002|DB Period|Withdrawal by Subject|0|||
161071106|NCT02493946|581649650|FG000|Open Label Period|Withdrawal by Subject|0|||
161071107|NCT02493946|581649651|FG001|Open Label Period|Withdrawal by Subject|0|||
161071108|NCT02493946|581649652|FG002|Open Label Period|Withdrawal by Subject|74|||
161071109|NCT02493946|581649650|FG000|Open Label Period|Adverse Event|0|||
161071110|NCT02493946|581649651|FG001|Open Label Period|Adverse Event|0|||
161071111|NCT02493946|581649652|FG002|Open Label Period|Adverse Event|4|||
161071112|NCT02493946|581649650|FG000|Open Label Period|Lost to Follow-up|0|||
161071113|NCT02493946|581649651|FG001|Open Label Period|Lost to Follow-up|0|||
161071114|NCT02493946|581649652|FG002|Open Label Period|Lost to Follow-up|1|||
161071115|NCT02493946|581649650|FG000|Open Label Period|Investigator decision, non-compliance|0|||
161071116|NCT02493946|581649651|FG001|Open Label Period|Investigator decision, non-compliance|0|||
161071117|NCT02493946|581649652|FG002|Open Label Period|Investigator decision, non-compliance|2|||
161071118|NCT02493946|581649650|FG000|Open Label Period|Investigator decision, non-availability|0|||
161071119|NCT02493946|581649651|FG001|Open Label Period|Investigator decision, non-availability|0|||
161071120|NCT02493946|581649652|FG002|Open Label Period|Investigator decision, non-availability|1|||
161071121|NCT02493946|581649650|FG000|Open Label Period|Pregnancy|0|||
161071122|NCT02493946|581649651|FG001|Open Label Period|Pregnancy|0|||
161071123|NCT02493946|581649652|FG002|Open Label Period|Pregnancy|3|||
161071124|NCT02493946|581649650|FG000|Open Label Period|Site error|0|||
161071125|NCT02493946|581649651|FG001|Open Label Period|Site error|0|||
161071126|NCT02493946|581649652|FG002|Open Label Period|Site error|1|||
161071127|NCT00965497|581649653|FG000|Overall Study|Physician Decision|1|||
161071128|NCT02689453|581649654|FG000|Overall Study|Progressive disease|0|||
161071129|NCT02689453|581649655|FG001|Overall Study|Progressive disease|1|||
161071130|NCT02689453|581649656|FG002|Overall Study|Progressive disease|1|||
161071131|NCT01162486|581649657|FG000|Overall Study|low ANC|1|||
161071132|NCT01162486|581649658|FG001|Overall Study|low ANC|0|||
161071133|NCT01162486|581649659|FG002|Overall Study|low ANC|0|||
161071134|NCT01162486|581649660|FG003|Overall Study|low ANC|0|||
161071135|NCT01162486|581649661|FG004|Overall Study|low ANC|0|||
161071136|NCT01162486|581649657|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
161071137|NCT01162486|581649658|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161071138|NCT01162486|581649659|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161284977|NCT00245466|582421363|FG001|Overall Study|Protocol Violation|2|||
161071139|NCT01162486|581649660|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161071140|NCT01162486|581649661|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
161071141|NCT01162486|581649657|FG000|Overall Study|elevated LFTs|0|||
161345608|NCT00716417|582650887|FG008|Overall Study|Withdrawal by Subject|0|||
161071142|NCT01162486|581649658|FG001|Overall Study|elevated LFTs|0|||
161071143|NCT01162486|581649659|FG002|Overall Study|elevated LFTs|1|||
161071144|NCT01162486|581649660|FG003|Overall Study|elevated LFTs|0|||
161284978|NCT00245466|582421364|FG002|Overall Study|Protocol Violation|2|||
161284979|NCT00245466|582421362|FG000|Overall Study|Death|0|||
161071145|NCT01162486|581649661|FG004|Overall Study|elevated LFTs|0|||
161071146|NCT01162486|581649657|FG000|Overall Study|Pregnancy|0|||
161071147|NCT01162486|581649658|FG001|Overall Study|Pregnancy|0|||
161071148|NCT01162486|581649659|FG002|Overall Study|Pregnancy|0|||
161156422|NCT00875017|581952968|FG005|Washout|Withdrawal by Subject|0|||
161156423|NCT00875017|581952963|FG000|Fourth Intervention|Inability to comply with fasting|0|||
161156424|NCT00875017|581952964|FG001|Fourth Intervention|Inability to comply with fasting|0|||
161156425|NCT00875017|581952965|FG002|Fourth Intervention|Inability to comply with fasting|0|||
161156426|NCT00875017|581952966|FG003|Fourth Intervention|Inability to comply with fasting|0|||
161156427|NCT00875017|581952967|FG004|Fourth Intervention|Inability to comply with fasting|0|||
161156428|NCT00875017|581952968|FG005|Fourth Intervention|Inability to comply with fasting|1|||
161156429|NCT01477892|581952969|FG000|Overall Study|Withdrawal by Subject|0|||
161156430|NCT01477892|581952970|FG001|Overall Study|Withdrawal by Subject|2|||
161156431|NCT00364845|581952973|FG000|Overall Study|Adverse Event|1|||
161156432|NCT00364845|581952974|FG001|Overall Study|Adverse Event|0|||
161156433|NCT00364845|581952973|FG000|Overall Study|Withdrawal by Subject|2|||
161156434|NCT00364845|581952974|FG001|Overall Study|Withdrawal by Subject|1|||
161156435|NCT00364845|581952973|FG000|Overall Study|Physician Decision|8|||
161156436|NCT00364845|581952974|FG001|Overall Study|Physician Decision|8|||
161156437|NCT00364845|581952973|FG000|Overall Study|Lost to Follow-up|0|||
161156438|NCT00364845|581952974|FG001|Overall Study|Lost to Follow-up|1|||
161156439|NCT00364845|581952973|FG000|Overall Study|Death|0|||
161156440|NCT00364845|581952974|FG001|Overall Study|Death|1|||
161156441|NCT03255291|581952977|FG000|Overall Study|Determined to be ineligible|10|||
161156442|NCT03255291|581952978|FG001|Overall Study|Determined to be ineligible|12|||
161156443|NCT03255291|581952979|FG002|Overall Study|Determined to be ineligible|6|||
161156444|NCT03255291|581952980|FG003|Overall Study|Determined to be ineligible|6|||
161156445|NCT03255291|581952981|FG004|Overall Study|Determined to be ineligible|5|||
161156446|NCT03255291|581952982|FG005|Overall Study|Determined to be ineligible|10|||
161156447|NCT03255291|581952977|FG000|Overall Study|Baseline data collection issues|3|||
161156448|NCT03255291|581952978|FG001|Overall Study|Baseline data collection issues|0|||
161156449|NCT03255291|581952979|FG002|Overall Study|Baseline data collection issues|0|||
161156450|NCT03255291|581952980|FG003|Overall Study|Baseline data collection issues|0|||
161156451|NCT03255291|581952981|FG004|Overall Study|Baseline data collection issues|2|||
161156452|NCT03255291|581952982|FG005|Overall Study|Baseline data collection issues|0|||
161156453|NCT01423617|581952983|FG000|Overall Study|Lost to Follow-up|0|||
161156454|NCT01423617|581952984|FG001|Overall Study|Lost to Follow-up|1|||
161156455|NCT01204658|581952986|FG000|Primary Phase|Adverse Event|0|||
161156456|NCT01204658|581952987|FG001|Primary Phase|Adverse Event|0|||
161156457|NCT01204658|581952988|FG002|Primary Phase|Adverse Event|1|||
161156458|NCT01204658|581952989|FG003|Primary Phase|Adverse Event|0|||
161156459|NCT04594239|581952994|FG000|Overall Study|Withdrawal by Subject|3|||
161156460|NCT04594239|581952995|FG001|Overall Study|Withdrawal by Subject|4|||
161156461|NCT04594239|581952996|FG002|Overall Study|Withdrawal by Subject|2|||
161156462|NCT04594239|581952997|FG003|Overall Study|Withdrawal by Subject|4|||
161156463|NCT04594239|581952994|FG000|Overall Study|Lost to Follow-up|8|||
161156464|NCT04594239|581952995|FG001|Overall Study|Lost to Follow-up|5|||
161156465|NCT04594239|581952996|FG002|Overall Study|Lost to Follow-up|4|||
161156466|NCT04594239|581952997|FG003|Overall Study|Lost to Follow-up|6|||
161156467|NCT04594239|581952994|FG000|Overall Study|Subject relocated|0|||
161156468|NCT04594239|581952995|FG001|Overall Study|Subject relocated|0|||
161156469|NCT04594239|581952996|FG002|Overall Study|Subject relocated|0|||
161156470|NCT04594239|581952997|FG003|Overall Study|Subject relocated|1|||
161156471|NCT03050359|581955064|FG000|Overall Study|Randomized But Not Treated|2|||
161156472|NCT03050359|581955065|FG001|Overall Study|Randomized But Not Treated|0|||
161156473|NCT03050359|581955064|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
161156474|NCT03050359|581955065|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
161156475|NCT03050359|581955064|FG000|Overall Study|Significant Protocol Deviation|2|||
161156476|NCT03050359|581955065|FG001|Overall Study|Significant Protocol Deviation|3|||
161156477|NCT03050359|581955064|FG000|Overall Study|Lost to Follow-up|2|||
161284980|NCT00245466|582421363|FG001|Overall Study|Death|2|||
161284981|NCT00245466|582421364|FG002|Overall Study|Death|0|||
161284982|NCT00245466|582421362|FG000|Overall Study|Administrative reasons|0|||
161284983|NCT00245466|582421363|FG001|Overall Study|Administrative reasons|1|||
161156478|NCT03050359|581955065|FG001|Overall Study|Lost to Follow-up|1|||
161156479|NCT03050359|581955064|FG000|Overall Study|Voluntary Withdrawal|4|||
161156480|NCT03050359|581955065|FG001|Overall Study|Voluntary Withdrawal|6|||
161156481|NCT03050359|581955064|FG000|Overall Study|Pregnancy|1|||
161156482|NCT03050359|581955065|FG001|Overall Study|Pregnancy|0|||
161156483|NCT03050359|581955064|FG000|Overall Study|Reason Not Specified|1|||
161156484|NCT03050359|581955065|FG001|Overall Study|Reason Not Specified|0|||
161156485|NCT02020031|581955066|FG000|Overall Study|Physician Decision|1|||
161156486|NCT02020031|581955067|FG001|Overall Study|Physician Decision|1|||
161156487|NCT00755846|581955070|FG000|Overall Study|Adverse Event|0|||
161156488|NCT00755846|581955071|FG001|Overall Study|Adverse Event|0|||
161156489|NCT00755846|581955072|FG002|Overall Study|Adverse Event|0|||
161156490|NCT00755846|581955073|FG003|Overall Study|Adverse Event|1|||
161156491|NCT00755846|581955074|FG004|Overall Study|Adverse Event|3|||
161156492|NCT00755846|581955075|FG005|Overall Study|Adverse Event|2|||
161156493|NCT00755846|581955070|FG000|Overall Study|Protocol Violation|1|||
161284984|NCT00245466|582421364|FG002|Overall Study|Administrative reasons|0|||
161071149|NCT01162486|581649660|FG003|Overall Study|Pregnancy|1|||
161071150|NCT01162486|581649661|FG004|Overall Study|Pregnancy|0|||
161071151|NCT00794924|581649662|FG000|Overall Study|Lost to Follow-up|6|||
161071152|NCT00794924|581649663|FG001|Overall Study|Lost to Follow-up|8|||
161071153|NCT00794924|581649662|FG000|Overall Study|Withdrawal by Subject|48|||
161071154|NCT00794924|581649663|FG001|Overall Study|Withdrawal by Subject|60|||
161071155|NCT00794924|581649662|FG000|Overall Study|Adverse Event|6|||
161071156|NCT00794924|581649663|FG001|Overall Study|Adverse Event|2|||
161071157|NCT00953615|581649664|FG000|Overall Study|Adverse Event|1|||
161071158|NCT02296892|581649669|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
161071159|NCT02296892|581649670|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
161071160|NCT02296892|581649671|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
161071161|NCT02296892|581649669|FG000|Overall Study|Lost to Follow-up|5|||
161071162|NCT02296892|581649670|FG001|Overall Study|Lost to Follow-up|0|||
161071163|NCT02296892|581649671|FG002|Overall Study|Lost to Follow-up|1|||
161071164|NCT00383123|581649674|FG000|Overall Study|Adverse Event|1|||
161071165|NCT00383123|581649675|FG001|Overall Study|Adverse Event|0|||
161071166|NCT00383123|581649674|FG000|Overall Study|Lost to Follow-up|68|||
161071167|NCT00383123|581649675|FG001|Overall Study|Lost to Follow-up|61|||
161071168|NCT00383123|581649674|FG000|Overall Study|Protocol Violation|5|||
161071169|NCT00383123|581649675|FG001|Overall Study|Protocol Violation|1|||
161071170|NCT00383123|581649674|FG000|Overall Study|Withdrawal by Subject|27|||
161071171|NCT00383123|581649675|FG001|Overall Study|Withdrawal by Subject|18|||
161071172|NCT00383123|581649674|FG000|Overall Study|Other reason|10|||
161071173|NCT00383123|581649675|FG001|Overall Study|Other reason|6|||
161071174|NCT00250432|581649678|FG000|Overall Study|Adverse Event|25|||
161071175|NCT00250432|581649679|FG001|Overall Study|Adverse Event|29|||
161071176|NCT00250432|581649678|FG000|Overall Study|Lack of Efficacy|2|||
161071177|NCT00250432|581649679|FG001|Overall Study|Lack of Efficacy|1|||
161071178|NCT00250432|581649678|FG000|Overall Study|Lost to Follow-up|6|||
161071179|NCT00250432|581649679|FG001|Overall Study|Lost to Follow-up|5|||
161071180|NCT00250432|581649678|FG000|Overall Study|Patient Moved|0|||
161071181|NCT00250432|581649679|FG001|Overall Study|Patient Moved|1|||
161071182|NCT00250432|581649678|FG000|Overall Study|Protocol Violation|0|||
161071183|NCT00250432|581649679|FG001|Overall Study|Protocol Violation|3|||
161071184|NCT00250432|581649678|FG000|Overall Study|Withdrawal by Subject|6|||
161071185|NCT00250432|581649679|FG001|Overall Study|Withdrawal by Subject|2|||
161071186|NCT00250432|581649678|FG000|Overall Study|Pt died out of posttherapy report period|6|||
161071187|NCT00250432|581649679|FG001|Overall Study|Pt died out of posttherapy report period|5|||
161071188|NCT00250432|581649678|FG000|Overall Study|Pt was considered untreatable|0|||
161071189|NCT00250432|581649679|FG001|Overall Study|Pt was considered untreatable|1|||
161071190|NCT04147858|581649680|FG000|Overall Study|Adverse Event|6|||
161071191|NCT04147858|581649681|FG001|Overall Study|Adverse Event|6|||
161071192|NCT04147858|581649682|FG002|Overall Study|Adverse Event|6|||
161071193|NCT04147858|581649680|FG000|Overall Study|Lack of Efficacy|3|||
161071194|NCT04147858|581649681|FG001|Overall Study|Lack of Efficacy|3|||
161071195|NCT04147858|581649682|FG002|Overall Study|Lack of Efficacy|1|||
161071196|NCT04147858|581649680|FG000|Overall Study|Lost to Follow-up|1|||
161071197|NCT04147858|581649681|FG001|Overall Study|Lost to Follow-up|6|||
161071198|NCT04147858|581649682|FG002|Overall Study|Lost to Follow-up|2|||
161071199|NCT04147858|581649680|FG000|Overall Study|Withdrawal by Subject|3|||
161071200|NCT04147858|581649681|FG001|Overall Study|Withdrawal by Subject|4|||
161071201|NCT04147858|581649682|FG002|Overall Study|Withdrawal by Subject|10|||
161071202|NCT04147858|581649680|FG000|Overall Study|Subject Noncompliance, Other|4|||
161071203|NCT04147858|581649681|FG001|Overall Study|Subject Noncompliance, Other|3|||
161071204|NCT04147858|581649682|FG002|Overall Study|Subject Noncompliance, Other|1|||
161071205|NCT01056263|581649685|FG000|Overall Study|Adverse Event|12|||
161071206|NCT01056263|581649685|FG000|Overall Study|Death|1|||
161071207|NCT01056263|581649685|FG000|Overall Study|Withdrawal by Subject|1|||
161071208|NCT01056263|581649685|FG000|Overall Study|Lack of Efficacy|29|||
161071209|NCT01056263|581649685|FG000|Overall Study|Progressive disease|2|||
161071210|NCT01056263|581649685|FG000|Overall Study|Neoplasm progression|1|||
161071211|NCT01056263|581649685|FG000|Overall Study|Objective progression or relapse|1|||
161345609|NCT00716417|582650888|FG009|Overall Study|Withdrawal by Subject|0|||
161071212|NCT01056263|581649685|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
161071213|NCT03375320|581649690|FG000|Overall Study|Adverse Event|34|||
161071214|NCT03375320|581649691|FG001|Overall Study|Adverse Event|9|||
161071215|NCT03375320|581649692|FG002|Overall Study|Adverse Event|10|||
161071216|NCT03375320|581649693|FG003|Overall Study|Adverse Event|0|||
161071217|NCT03375320|581649690|FG000|Overall Study|Death|6|||
161071218|NCT03375320|581649691|FG001|Overall Study|Death|3|||
161071219|NCT03375320|581649692|FG002|Overall Study|Death|0|||
161071220|NCT03375320|581649693|FG003|Overall Study|Death|0|||
161071221|NCT03375320|581649690|FG000|Overall Study|Withdrawal by Subject|7|||
161071222|NCT03375320|581649691|FG001|Overall Study|Withdrawal by Subject|4|||
161071223|NCT03375320|581649692|FG002|Overall Study|Withdrawal by Subject|5|||
161071224|NCT03375320|581649693|FG003|Overall Study|Withdrawal by Subject|4|||
161071225|NCT03375320|581649690|FG000|Overall Study|Progressive disease|55|||
161284985|NCT03885661|582421365|FG000|Overall Study|Withdrawal by Subject|0|||
161284986|NCT03885661|582421366|FG001|Overall Study|Withdrawal by Subject|1|||
161284987|NCT03885661|582421365|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
161284988|NCT03885661|582421366|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
161284989|NCT00856193|582421367|FG000|Period 2|Abnormal test procedure results|0|||
161284990|NCT00856193|582421368|FG001|Period 2|Abnormal test procedure results|1|||
161284991|NCT00856193|582421367|FG000|Period 2|Lost to Follow-up|0|||
161071226|NCT03375320|581649691|FG001|Overall Study|Progressive disease|41|||
161071227|NCT03375320|581649692|FG002|Overall Study|Progressive disease|29|||
161071228|NCT03375320|581649693|FG003|Overall Study|Progressive disease|24|||
161071229|NCT03375320|581649690|FG000|Overall Study|Alternative treatment|6|||
161071230|NCT03375320|581649691|FG001|Overall Study|Alternative treatment|1|||
161071231|NCT03375320|581649692|FG002|Overall Study|Alternative treatment|1|||
161071232|NCT03375320|581649693|FG003|Overall Study|Alternative treatment|0|||
161071233|NCT03375320|581649690|FG000|Overall Study|Other disease|1|||
161071234|NCT03375320|581649691|FG001|Overall Study|Other disease|1|||
161071235|NCT03375320|581649692|FG002|Overall Study|Other disease|3|||
161071236|NCT03375320|581649693|FG003|Overall Study|Other disease|0|||
161071237|NCT03375320|581649690|FG000|Overall Study|Withdrawal prior to initiation|2|||
161071238|NCT03375320|581649691|FG001|Overall Study|Withdrawal prior to initiation|2|||
161071239|NCT03375320|581649692|FG002|Overall Study|Withdrawal prior to initiation|1|||
161071240|NCT03375320|581649693|FG003|Overall Study|Withdrawal prior to initiation|0|||
161071241|NCT03375320|581649690|FG000|Overall Study|Physician Decision|1|||
161071242|NCT03375320|581649691|FG001|Overall Study|Physician Decision|1|||
161071243|NCT03375320|581649692|FG002|Overall Study|Physician Decision|1|||
161071244|NCT03375320|581649693|FG003|Overall Study|Physician Decision|1|||
161071245|NCT03375320|581649690|FG000|Overall Study|Non-compliance|1|||
161071246|NCT03375320|581649691|FG001|Overall Study|Non-compliance|0|||
161071247|NCT03375320|581649692|FG002|Overall Study|Non-compliance|0|||
161071248|NCT03375320|581649693|FG003|Overall Study|Non-compliance|0|||
161071249|NCT00365547|581649696|FG000|Overall Study|Insurance did not cover Avastin|1|||
161071250|NCT00365547|581649696|FG000|Overall Study|Screen failure|1|||
161071251|NCT00365547|581649696|FG000|Overall Study|Withdrawal by Subject|1|||
161071252|NCT03692052|581649697|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
161071253|NCT03692052|581649697|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
161071254|NCT03692052|581649697|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
161071255|NCT03692052|581649697|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
161071256|NCT03170518|581649698|FG000|Overall Study|Lost to Follow-up|4|||
161071257|NCT03170518|581649699|FG001|Overall Study|Lost to Follow-up|1|||
161071258|NCT03170518|581649700|FG002|Overall Study|Lost to Follow-up|0|||
161071259|NCT03170518|581649698|FG000|Overall Study|Physician Decision|1|||
161071260|NCT03170518|581649699|FG001|Overall Study|Physician Decision|0|||
161071261|NCT03170518|581649700|FG002|Overall Study|Physician Decision|0|||
161071262|NCT03170518|581649698|FG000|Overall Study|Withdrawal by Subject|4|||
161071263|NCT03170518|581649699|FG001|Overall Study|Withdrawal by Subject|5|||
161071264|NCT03170518|581649700|FG002|Overall Study|Withdrawal by Subject|2|||
161071265|NCT03170518|581649698|FG000|Overall Study|Site terminated by sponsor|0|||
161071266|NCT03170518|581649699|FG001|Overall Study|Site terminated by sponsor|1|||
161071267|NCT03170518|581649700|FG002|Overall Study|Site terminated by sponsor|0|||
161071268|NCT03170518|581649698|FG000|Overall Study|Non-compliance with study drug|1|||
161071269|NCT03170518|581649699|FG001|Overall Study|Non-compliance with study drug|0|||
161071270|NCT03170518|581649700|FG002|Overall Study|Non-compliance with study drug|1|||
161071271|NCT03170518|581649698|FG000|Overall Study|Withdrawal by parent/guardian|2|||
161071272|NCT03170518|581649699|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161071273|NCT03170518|581649700|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161071274|NCT00546078|581649701|FG000|Overall Study|Lost to Follow-up|1|||
161071275|NCT00546078|581649702|FG001|Overall Study|Lost to Follow-up|3|||
161071276|NCT00546078|581649701|FG000|Overall Study|Withdrawal by Subject|2|||
161071277|NCT00546078|581649702|FG001|Overall Study|Withdrawal by Subject|3|||
161071278|NCT00546078|581649701|FG000|Overall Study|Other reason|1|||
161071279|NCT00546078|581649702|FG001|Overall Study|Other reason|1|||
161284992|NCT00856193|582421368|FG001|Period 2|Lost to Follow-up|1|||
161071280|NCT03512197|581649703|FG000|Overall Study|Guardian decision|1|||
161071281|NCT03512197|581649704|FG001|Overall Study|Guardian decision|1|||
161071282|NCT03512197|581649703|FG000|Overall Study|Lack of Efficacy|19|||
161071283|NCT03512197|581649704|FG001|Overall Study|Lack of Efficacy|11|||
161071284|NCT03512197|581649703|FG000|Overall Study|New Therapy for Study Indication|16|||
161284993|NCT05064397|582421369|FG000|Overall Study|Adverse Event|4|||
161284994|NCT05064397|582421369|FG000|Overall Study|Lack of Efficacy|12|||
161071285|NCT03512197|581649704|FG001|Overall Study|New Therapy for Study Indication|16|||
161071286|NCT03512197|581649703|FG000|Overall Study|Physician Decision|60|||
161071287|NCT03512197|581649704|FG001|Overall Study|Physician Decision|60|||
161284995|NCT05064397|582421369|FG000|Overall Study|Withdrawal by Subject|3|||
161071288|NCT03512197|581649703|FG000|Overall Study|Protocol Violation|0|||
161071289|NCT03512197|581649704|FG001|Overall Study|Protocol Violation|2|||
161071290|NCT03512197|581649703|FG000|Overall Study|Terminated by Sponsored|46|||
161071291|NCT03512197|581649704|FG001|Overall Study|Terminated by Sponsored|50|||
161071292|NCT03512197|581649703|FG000|Overall Study|Subject Decision|15|||
161071293|NCT03512197|581649704|FG001|Overall Study|Subject Decision|12|||
161071294|NCT03512197|581649703|FG000|Overall Study|Withdrawal of informed consent|20|||
161071295|NCT03512197|581649704|FG001|Overall Study|Withdrawal of informed consent|14|||
161071296|NCT03512197|581649703|FG000|Overall Study|Adverse Event|30|||
161071297|NCT03512197|581649704|FG001|Overall Study|Adverse Event|34|||
161071298|NCT03512197|581649703|FG000|Overall Study|Death|14|||
161071299|NCT03512197|581649704|FG001|Overall Study|Death|9|||
161071300|NCT03512197|581649703|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
161071301|NCT03512197|581649704|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
161071302|NCT03512197|581649703|FG000|Overall Study|Missing|3|||
161071303|NCT03512197|581649704|FG001|Overall Study|Missing|13|||
161071304|NCT03842436|581649705|FG000|Overall Study|Lost to Follow-up|1|||
161071305|NCT01806389|581649706|FG000|Overall Study|Withdrawal by Subject|4|||
161071306|NCT01948076|581649707|FG000|Overall Study|Withdrawal by Subject|0|||
161071307|NCT01948076|581649708|FG001|Overall Study|Withdrawal by Subject|1|||
161071308|NCT00936598|581649714|FG000|Overall Study|Withdrawal by Subject|1|||
161071309|NCT00936598|581649715|FG001|Overall Study|Withdrawal by Subject|0|||
161071310|NCT00936598|581649714|FG000|Overall Study|Ineligible after consent|1|||
161071311|NCT00936598|581649715|FG001|Overall Study|Ineligible after consent|0|||
161071312|NCT03358238|581649716|FG000|Overall Study|Withdrawal by Subject|0|||
161071313|NCT03358238|581649717|FG001|Overall Study|Withdrawal by Subject|1|||
161071314|NCT04596540|581649718|FG000|Overall Study|Withdrawal by Subject|9|||
161071315|NCT04596540|581649719|FG001|Overall Study|Withdrawal by Subject|8|||
161071316|NCT04596540|581649720|FG002|Overall Study|Withdrawal by Subject|5|||
161071317|NCT04596540|581649718|FG000|Overall Study|Lost to Follow-up|1|||
161071318|NCT04596540|581649719|FG001|Overall Study|Lost to Follow-up|2|||
161071319|NCT04596540|581649720|FG002|Overall Study|Lost to Follow-up|1|||
161071320|NCT04596540|581649718|FG000|Overall Study|Sponsor Decision|2|||
161071321|NCT04596540|581649719|FG001|Overall Study|Sponsor Decision|0|||
161071322|NCT04596540|581649720|FG002|Overall Study|Sponsor Decision|0|||
161071323|NCT04596540|581649718|FG000|Overall Study|Physician Decision|0|||
161071324|NCT04596540|581649719|FG001|Overall Study|Physician Decision|1|||
161071325|NCT04596540|581649720|FG002|Overall Study|Physician Decision|1|||
161071326|NCT04596540|581649718|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
161071327|NCT04596540|581649719|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161071328|NCT04596540|581649720|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161071329|NCT04596540|581649718|FG000|Overall Study|Other Than Specified|5|||
161071330|NCT04596540|581649719|FG001|Overall Study|Other Than Specified|5|||
161071331|NCT04596540|581649720|FG002|Overall Study|Other Than Specified|2|||
161071332|NCT04526665|581649721|FG000|Overall Study|Withdrawal by Subject|6|||
161071333|NCT04526665|581649722|FG001|Overall Study|Withdrawal by Subject|3|||
161071334|NCT04526665|581649721|FG000|Overall Study|Adverse Event|4|||
161071335|NCT04526665|581649722|FG001|Overall Study|Adverse Event|1|||
161071336|NCT04526665|581649721|FG000|Overall Study|Physician Decision|2|||
161071337|NCT04526665|581649722|FG001|Overall Study|Physician Decision|2|||
161071338|NCT04526665|581649721|FG000|Overall Study|Death|2|||
161071339|NCT04526665|581649722|FG001|Overall Study|Death|0|||
161071340|NCT04526665|581649721|FG000|Overall Study|Other|0|||
161071341|NCT04526665|581649722|FG001|Overall Study|Other|1|||
161071342|NCT02113124|581651339|FG000|Overall Study|Unable to retrieve blood sample|1|||
161071343|NCT02113124|581651340|FG001|Overall Study|Unable to retrieve blood sample|1|||
161071344|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161071345|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
161071346|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161071347|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
161071348|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
161071349|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
161071350|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
161071351|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
161071352|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
161071353|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
161071354|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
161071355|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
161071356|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
161071357|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
161071358|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161071359|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161071360|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161071361|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161071362|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161071363|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
161071364|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
161071365|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161071366|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161071367|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
161071368|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161071369|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
161071370|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
161071371|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
161071372|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161071373|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161071374|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161071375|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161071376|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
161071377|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161071378|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
161071379|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161071380|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
161071381|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161071382|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161156494|NCT00755846|581955071|FG001|Overall Study|Protocol Violation|1|||
161156495|NCT00755846|581955072|FG002|Overall Study|Protocol Violation|1|||
161156496|NCT00755846|581955073|FG003|Overall Study|Protocol Violation|1|||
161156497|NCT00755846|581955074|FG004|Overall Study|Protocol Violation|1|||
161156498|NCT00755846|581955075|FG005|Overall Study|Protocol Violation|1|||
161156499|NCT00755846|581955070|FG000|Overall Study|Lost to Follow-up|0|||
161284996|NCT05064397|582421369|FG000|Overall Study|Lost to Follow-up|1|||
161284997|NCT05064397|582421369|FG000|Overall Study|Other reasons|3|||
161284998|NCT02324582|582421372|FG000|Overall Study|Screen Failures|0|||
161284999|NCT02324582|582421373|FG001|Overall Study|Screen Failures|5|||
161285000|NCT00129545|582421377|FG000|Overall Study|Death|5|||
161285001|NCT00129545|582421378|FG001|Overall Study|Death|60|||
161285002|NCT00129545|582421379|FG002|Overall Study|Death|44|||
161285003|NCT00129545|582421377|FG000|Overall Study|Withdrawal by Subject|3|||
161285004|NCT00129545|582421378|FG001|Overall Study|Withdrawal by Subject|18|||
161285005|NCT00129545|582421379|FG002|Overall Study|Withdrawal by Subject|44|||
161285006|NCT00129545|582421377|FG000|Overall Study|Lost to Follow-up|2|||
161285007|NCT00129545|582421378|FG001|Overall Study|Lost to Follow-up|22|||
161285008|NCT00129545|582421379|FG002|Overall Study|Lost to Follow-up|13|||
161285009|NCT00129545|582421377|FG000|Overall Study|Physician Decision|0|||
161285010|NCT00129545|582421378|FG001|Overall Study|Physician Decision|3|||
161285011|NCT00129545|582421379|FG002|Overall Study|Physician Decision|10|||
161285012|NCT00129545|582421377|FG000|Overall Study|Device not implanted|16|||
161285013|NCT00129545|582421378|FG001|Overall Study|Device not implanted|61|||
161285014|NCT00129545|582421379|FG002|Overall Study|Device not implanted|0|||
161285015|NCT04660331|582421380|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
161285016|NCT04660331|582421381|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
161285017|NCT04660331|582421382|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
161285018|NCT00111241|582421391|FG000|Overall Study|Lost to Follow-up|1|||
161285019|NCT00111241|582421392|FG001|Overall Study|Lost to Follow-up|0|||
161285020|NCT00111241|582421391|FG000|Overall Study|Withdrawal by Subject|4|||
161285021|NCT00111241|582421392|FG001|Overall Study|Withdrawal by Subject|0|||
161285022|NCT00111241|582421391|FG000|Overall Study|Protocol Violation|9|||
161285023|NCT00111241|582421392|FG001|Overall Study|Protocol Violation|8|||
161285024|NCT00111241|582421391|FG000|Overall Study|Adverse Event|1|||
161285025|NCT00111241|582421392|FG001|Overall Study|Adverse Event|0|||
161285026|NCT02096744|582421403|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
161285027|NCT02096744|582421404|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
161285028|NCT02096744|582421403|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
161285029|NCT02096744|582421404|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
161285030|NCT02096744|582421403|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
161285031|NCT02096744|582421404|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
161285032|NCT05724589|582421410|FG000|Overall Study|Lost to Follow-up|1|||
161285033|NCT00786409|582421411|FG000|Overall Study|Withdrawal by Subject|2|||
161285034|NCT00786409|582421411|FG000|Overall Study|Adverse Event|2|||
161285035|NCT00786409|582421411|FG000|Overall Study|Pregnancy|2|||
161285036|NCT00786409|582421411|FG000|Overall Study|Lost to Follow-up|1|||
161285037|NCT00610129|582421412|FG000|Overall Study|Not treated since patients ineligible|3|||
161285038|NCT00866359|582421416|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
161285039|NCT00866359|582421417|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
161285040|NCT00866359|582421418|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
161285041|NCT00866359|582421419|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
161285042|NCT00866359|582421416|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
161285043|NCT00866359|582421417|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161285044|NCT00866359|582421418|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161285045|NCT00866359|582421419|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
161285046|NCT00866359|582421416|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
161285047|NCT00866359|582421417|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161285048|NCT00866359|582421418|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161285049|NCT00866359|582421419|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
161285050|NCT00866359|582421416|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
161285051|NCT00866359|582421417|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
161285052|NCT00866359|582421418|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
161285053|NCT00866359|582421419|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
161285054|NCT00866359|582421416|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
161285055|NCT00866359|582421417|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
161285056|NCT00866359|582421418|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
161285057|NCT00866359|582421419|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
161285058|NCT00866359|582421416|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
161285059|NCT00866359|582421417|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
161285060|NCT00866359|582421418|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
161285061|NCT00866359|582421419|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
161285062|NCT04917861|582421430|FG000|Main Study (196 Days)|Adverse Event|0|||
161285063|NCT04917861|582421431|FG001|Main Study (196 Days)|Adverse Event|1|||
161285064|NCT04917861|582421432|FG002|Main Study (196 Days)|Adverse Event|0|||
161285065|NCT04917861|582421433|FG003|Main Study (196 Days)|Adverse Event|0|||
161285066|NCT04917861|582421430|FG000|Main Study (196 Days)|Death|0|||
161285067|NCT04917861|582421431|FG001|Main Study (196 Days)|Death|0|||
161285068|NCT04917861|582421432|FG002|Main Study (196 Days)|Death|0|||
161285069|NCT04917861|582421433|FG003|Main Study (196 Days)|Death|1|||
161285070|NCT04917861|582421430|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
161285071|NCT04917861|582421431|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
161285072|NCT04917861|582421432|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
161285073|NCT04917861|582421433|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
161071383|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161285074|NCT04917861|582421430|FG000|Main Study (196 Days)|Physician Decision|0|||
161285075|NCT04917861|582421431|FG001|Main Study (196 Days)|Physician Decision|0|||
161285076|NCT04917861|582421432|FG002|Main Study (196 Days)|Physician Decision|0|||
161285077|NCT04917861|582421433|FG003|Main Study (196 Days)|Physician Decision|1|||
161071384|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161071385|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
161071386|NCT01888874|581651341|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161071387|NCT01888874|581651342|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
161071388|NCT01888874|581651343|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161071389|NCT01888874|581651344|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161071390|NCT01888874|581651345|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161071391|NCT01888874|581651346|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
161071392|NCT01888874|581651347|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
161071393|NCT01888874|581651341|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
161071394|NCT01888874|581651342|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
161071395|NCT01888874|581651343|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
161071396|NCT01888874|581651344|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161071397|NCT01888874|581651345|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
161071398|NCT01888874|581651346|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161071399|NCT01888874|581651347|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
161071400|NCT01888874|581651341|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161071401|NCT01888874|581651342|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161071402|NCT01888874|581651343|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161071403|NCT01888874|581651344|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161071404|NCT01888874|581651345|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
161071405|NCT01888874|581651346|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161071406|NCT01888874|581651347|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
161071407|NCT01888874|581651341|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161071408|NCT01888874|581651342|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161071409|NCT01888874|581651343|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
161071410|NCT01888874|581651344|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161071411|NCT01888874|581651345|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161071412|NCT01888874|581651346|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
161071413|NCT01888874|581651347|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
161071414|NCT01888874|581651341|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161071415|NCT01888874|581651342|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161345610|NCT00716417|582650879|FG000|Overall Study|Progressive disease|3|||
161285078|NCT04917861|582421430|FG000|Main Study (196 Days)|Pregnancy|1|||
161285079|NCT04917861|582421431|FG001|Main Study (196 Days)|Pregnancy|1|||
161285080|NCT04917861|582421432|FG002|Main Study (196 Days)|Pregnancy|0|||
161285081|NCT04917861|582421433|FG003|Main Study (196 Days)|Pregnancy|0|||
161285082|NCT04917861|582421430|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
161285083|NCT04917861|582421431|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
161285084|NCT04917861|582421432|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
161285085|NCT04917861|582421433|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
161285086|NCT04917861|582421430|FG000|Main Study (196 Days)|Other Than Specified|1|||
161071416|NCT01888874|581651343|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
161071417|NCT01888874|581651344|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161071418|NCT01888874|581651345|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161071419|NCT01888874|581651346|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161071420|NCT01888874|581651347|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
161071421|NCT01888874|581651341|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161071422|NCT01888874|581651342|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
161071423|NCT01888874|581651343|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161071424|NCT01888874|581651344|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
161071425|NCT01888874|581651345|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
161071426|NCT01888874|581651346|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
161071427|NCT01888874|581651347|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
161071428|NCT01888874|581651341|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161071429|NCT01888874|581651342|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
161071430|NCT01888874|581651343|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161071431|NCT01888874|581651344|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161071432|NCT01888874|581651345|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161071433|NCT01888874|581651346|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
161071434|NCT01888874|581651347|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
161071435|NCT02763215|581651348|FG000|Overall Study|Participants withdrew from study|3|||
161071436|NCT02763215|581651348|FG000|Overall Study|Missed visit|1|||
161071437|NCT02763215|581651348|FG000|Overall Study|Visit outside visit-window|1|||
161071438|NCT02763215|581651348|FG000|Overall Study|Death|1|||
161071439|NCT02763215|581651348|FG000|Overall Study|Lost to Follow-up|1|||
161071440|NCT02963090|581651349|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
161071441|NCT02963090|581651350|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
161071442|NCT00709228|581651351|FG000|Overall Study|Not treated|14|||
161071443|NCT00709228|581651351|FG000|Overall Study|Eligibility criteria not met|281|||
161071444|NCT00709228|581651351|FG000|Overall Study|Adverse events|2|||
161071445|NCT00709228|581651351|FG000|Overall Study|Discontinued treatment|14|||
161071446|NCT00709228|581651351|FG000|Overall Study|Did not enter follow-up|4|||
161071447|NCT00709228|581651351|FG000|Overall Study|Discontinued follow-up|5|||
161071448|NCT00709228|581651351|FG000|Overall Study|Disease progression|1|||
161071449|NCT00709228|581651351|FG000|Overall Study|Lost to Follow-up|6|||
161071450|NCT00709228|581651351|FG000|Overall Study|Non-compliance|5|||
161071451|NCT02179177|581651354|FG000|Overall Study|Lost to Follow-up|1|||
161071452|NCT02179177|581651355|FG001|Overall Study|Lost to Follow-up|1|||
161071453|NCT02179177|581651354|FG000|Overall Study|Withdrawal by Subject|1|||
161071454|NCT02179177|581651355|FG001|Overall Study|Withdrawal by Subject|1|||
161071455|NCT00022659|581651356|FG000|Overall Study|Ineligible: wrong primary|1|||
161071456|NCT00022659|581651356|FG000|Overall Study|Never treated|1|||
161071457|NCT00884650|581651359|FG000|Overall Study|Did not return complete pain diaries|7|||
161071458|NCT00884650|581651360|FG001|Overall Study|Did not return complete pain diaries|7|||
161071459|NCT00884650|581651359|FG000|Overall Study|Admitted Post-Op|1|||
161071460|NCT00884650|581651360|FG001|Overall Study|Admitted Post-Op|0|||
161071461|NCT00884650|581651359|FG000|Overall Study|Femoral Stress Fracture|1|||
161071462|NCT00884650|581651360|FG001|Overall Study|Femoral Stress Fracture|0|||
161071463|NCT00884650|581651359|FG000|Overall Study|Pain Pump Complication|0|||
161071464|NCT00884650|581651360|FG001|Overall Study|Pain Pump Complication|1|||
161071465|NCT04052425|581651363|FG000|24-Week Double-blind Period|Adverse Event|0|||
161071466|NCT04052425|581651364|FG001|24-Week Double-blind Period|Adverse Event|1|||
161071467|NCT04052425|581651365|FG002|24-Week Double-blind Period|Adverse Event|0|||
161071468|NCT04052425|581651366|FG003|24-Week Double-blind Period|Adverse Event|0|||
161071469|NCT04052425|581651363|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
161071470|NCT04052425|581651364|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
161285087|NCT04917861|582421431|FG001|Main Study (196 Days)|Other Than Specified|0|||
161071471|NCT04052425|581651365|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
161071472|NCT04052425|581651366|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
161071473|NCT04052425|581651363|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
161071474|NCT04052425|581651364|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
161071475|NCT04052425|581651365|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
161071476|NCT04052425|581651366|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
161285088|NCT04917861|582421432|FG002|Main Study (196 Days)|Other Than Specified|1|||
161285089|NCT04917861|582421433|FG003|Main Study (196 Days)|Other Than Specified|2|||
161156500|NCT00755846|581955071|FG001|Overall Study|Lost to Follow-up|2|||
161156501|NCT00755846|581955072|FG002|Overall Study|Lost to Follow-up|1|||
161156502|NCT00755846|581955073|FG003|Overall Study|Lost to Follow-up|0|||
161156503|NCT00755846|581955074|FG004|Overall Study|Lost to Follow-up|4|||
161156504|NCT00755846|581955075|FG005|Overall Study|Lost to Follow-up|2|||
161156505|NCT00755846|581955070|FG000|Overall Study|Withdrawal by Subject|2|||
161156506|NCT00755846|581955071|FG001|Overall Study|Withdrawal by Subject|3|||
161156507|NCT00755846|581955072|FG002|Overall Study|Withdrawal by Subject|5|||
161156508|NCT00755846|581955073|FG003|Overall Study|Withdrawal by Subject|2|||
161156509|NCT00755846|581955074|FG004|Overall Study|Withdrawal by Subject|0|||
161156510|NCT00755846|581955075|FG005|Overall Study|Withdrawal by Subject|1|||
161156511|NCT00755846|581955070|FG000|Overall Study|Hyperglycemic Rescue|21|||
161156512|NCT00755846|581955071|FG001|Overall Study|Hyperglycemic Rescue|7|||
161156513|NCT00755846|581955072|FG002|Overall Study|Hyperglycemic Rescue|5|||
161156514|NCT00755846|581955073|FG003|Overall Study|Hyperglycemic Rescue|8|||
161156515|NCT00755846|581955074|FG004|Overall Study|Hyperglycemic Rescue|8|||
161156516|NCT00755846|581955075|FG005|Overall Study|Hyperglycemic Rescue|7|||
161156517|NCT00755846|581955070|FG000|Overall Study|Physician Decision|1|||
161156518|NCT00755846|581955071|FG001|Overall Study|Physician Decision|3|||
161156519|NCT00755846|581955072|FG002|Overall Study|Physician Decision|0|||
161156520|NCT00755846|581955073|FG003|Overall Study|Physician Decision|1|||
161156521|NCT00755846|581955074|FG004|Overall Study|Physician Decision|0|||
161156522|NCT00755846|581955075|FG005|Overall Study|Physician Decision|1|||
161156523|NCT00755846|581955070|FG000|Overall Study|Administrative Error|0|||
161156524|NCT00755846|581955071|FG001|Overall Study|Administrative Error|1|||
161156525|NCT00755846|581955072|FG002|Overall Study|Administrative Error|0|||
161156526|NCT00755846|581955073|FG003|Overall Study|Administrative Error|0|||
161156527|NCT00755846|581955074|FG004|Overall Study|Administrative Error|0|||
161156528|NCT00755846|581955075|FG005|Overall Study|Administrative Error|0|||
161156529|NCT00755846|581955070|FG000|Overall Study|Participant Non-compliance|0|||
161156530|NCT00755846|581955071|FG001|Overall Study|Participant Non-compliance|0|||
161156531|NCT00755846|581955072|FG002|Overall Study|Participant Non-compliance|0|||
161156532|NCT00755846|581955073|FG003|Overall Study|Participant Non-compliance|0|||
161156533|NCT00755846|581955074|FG004|Overall Study|Participant Non-compliance|1|||
161156534|NCT00755846|581955075|FG005|Overall Study|Participant Non-compliance|0|||
161156535|NCT00111475|581955085|FG000|Overall Study|Lost to Follow-up|0|||
161156536|NCT00111475|581955086|FG001|Overall Study|Lost to Follow-up|0|||
161156537|NCT00111475|581955087|FG002|Overall Study|Lost to Follow-up|0|||
161156538|NCT00111475|581955088|FG003|Overall Study|Lost to Follow-up|0|||
161156539|NCT00111475|581955089|FG004|Overall Study|Lost to Follow-up|0|||
161156540|NCT00111475|581955090|FG005|Overall Study|Lost to Follow-up|1|||
161156541|NCT00111475|581955091|FG006|Overall Study|Lost to Follow-up|0|||
161156542|NCT00111475|581955092|FG007|Overall Study|Lost to Follow-up|0|||
161156543|NCT00111475|581955093|FG008|Overall Study|Lost to Follow-up|0|||
161156544|NCT00111475|581955094|FG009|Overall Study|Lost to Follow-up|0|||
161156545|NCT03303092|581955095|FG000|Overall Study|Adverse Event|1|||
161156546|NCT03303092|581955096|FG001|Overall Study|Adverse Event|0|||
161156547|NCT03303092|581955097|FG002|Overall Study|Adverse Event|1|||
161156548|NCT03303092|581955095|FG000|Overall Study|Protocol Violation|1|||
161156549|NCT03303092|581955096|FG001|Overall Study|Protocol Violation|5|||
161285090|NCT04917861|582421430|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
161156550|NCT03303092|581955097|FG002|Overall Study|Protocol Violation|1|||
161156551|NCT03303092|581955095|FG000|Overall Study|Withdrawal by Subject|1|||
161156552|NCT03303092|581955096|FG001|Overall Study|Withdrawal by Subject|1|||
161285091|NCT04917861|582421431|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
161285092|NCT04917861|582421432|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
161285093|NCT04917861|582421433|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
161285094|NCT04917861|582421430|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161285095|NCT04917861|582421431|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
161285096|NCT04917861|582421432|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161285097|NCT04917861|582421433|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
161285098|NCT04917861|582421430|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161156553|NCT03303092|581955097|FG002|Overall Study|Withdrawal by Subject|3|||
161285099|NCT04917861|582421431|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
161285100|NCT04917861|582421432|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161156554|NCT01995136|581955100|FG000|Overall Study|Change in residence|1|||
161156555|NCT01830543|581955101|FG000|Overall Study|Subject Decision|19|||
161156556|NCT01830543|581955102|FG001|Overall Study|Subject Decision|21|||
161156557|NCT01830543|581955103|FG002|Overall Study|Subject Decision|57|||
161156558|NCT01830543|581955101|FG000|Overall Study|Adverse Event|91|||
161156559|NCT01830543|581955102|FG001|Overall Study|Adverse Event|77|||
161156560|NCT01830543|581955103|FG002|Overall Study|Adverse Event|76|||
161285101|NCT04917861|582421433|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
161156561|NCT01830543|581955101|FG000|Overall Study|Death|20|||
161156562|NCT01830543|581955102|FG001|Overall Study|Death|22|||
161156563|NCT01830543|581955103|FG002|Overall Study|Death|22|||
161156564|NCT01830543|581955101|FG000|Overall Study|Protocol Violation|3|||
161156565|NCT01830543|581955102|FG001|Overall Study|Protocol Violation|7|||
161156566|NCT01830543|581955103|FG002|Overall Study|Protocol Violation|7|||
161156567|NCT01830543|581955101|FG000|Overall Study|Physician Decision|11|||
161156568|NCT01830543|581955102|FG001|Overall Study|Physician Decision|5|||
161156569|NCT01830543|581955103|FG002|Overall Study|Physician Decision|12|||
161156570|NCT01830543|581955101|FG000|Overall Study|Withdrawal by consent|3|||
161156571|NCT01830543|581955102|FG001|Overall Study|Withdrawal by consent|3|||
161156572|NCT01830543|581955103|FG002|Overall Study|Withdrawal by consent|3|||
161156573|NCT01830543|581955101|FG000|Overall Study|Other|12|||
161156574|NCT01830543|581955102|FG001|Overall Study|Other|17|||
161156575|NCT01830543|581955103|FG002|Overall Study|Other|37|||
161156576|NCT01028651|581955106|FG000|Overall Study|Death|2|||
161156577|NCT01028651|581955106|FG000|Overall Study|Adverse Event|1|||
161071477|NCT04052425|581651363|FG000|24-Week Double-blind Period|Physician Decision|1|||
161071478|NCT04052425|581651364|FG001|24-Week Double-blind Period|Physician Decision|0|||
161071479|NCT04052425|581651365|FG002|24-Week Double-blind Period|Physician Decision|0|||
161071480|NCT04052425|581651366|FG003|24-Week Double-blind Period|Physician Decision|0|||
161071481|NCT04052425|581651363|FG000|24-Week Double-blind Period|Protocol Violation|1|||
161071482|NCT04052425|581651364|FG001|24-Week Double-blind Period|Protocol Violation|0|||
161071483|NCT04052425|581651365|FG002|24-Week Double-blind Period|Protocol Violation|0|||
161071484|NCT04052425|581651366|FG003|24-Week Double-blind Period|Protocol Violation|0|||
161071485|NCT04052425|581651363|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
161071486|NCT04052425|581651364|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
161071487|NCT04052425|581651365|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
161071488|NCT04052425|581651366|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
161071489|NCT04052425|581651363|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
161071490|NCT04052425|581651364|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
161071491|NCT04052425|581651365|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
161071492|NCT04052425|581651366|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
161071493|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
161071494|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
161071495|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
161071496|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
161071497|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
161071498|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
161071499|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
161071500|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
161071501|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161071502|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
161071503|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
161071504|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
161071505|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
161071506|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
161071507|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
161071508|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
161071509|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161071510|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
161071511|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
161071512|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
161071513|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
161071514|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
161071515|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
161071516|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
161071517|NCT04052425|581651363|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
161071518|NCT04052425|581651364|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
161071519|NCT04052425|581651365|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
161071520|NCT04052425|581651366|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
161071521|NCT04334278|581651367|FG000|Overall Study|Lost to Follow-up|0|||
161071522|NCT04334278|581651368|FG001|Overall Study|Lost to Follow-up|3|||
161071523|NCT04334278|581651367|FG000|Overall Study|Withdrawal by Subject|4|||
161071524|NCT04334278|581651368|FG001|Overall Study|Withdrawal by Subject|2|||
161071525|NCT01732549|581651371|FG000|Overall Study|Adverse Event|13|||
161071526|NCT01732549|581651372|FG001|Overall Study|Adverse Event|3|||
161071527|NCT01732549|581651371|FG000|Overall Study|Consent withdrawn|13|||
161156578|NCT00390416|581955108|FG000|Overall Study|Withdrawal by Subject|1|||
161156579|NCT00390416|581955108|FG000|Overall Study|Not treated|3|||
161156580|NCT01592409|581955109|FG000|Overall Study|Withdrawal by Subject|0|||
161071528|NCT01732549|581651372|FG001|Overall Study|Consent withdrawn|6|||
161071529|NCT01732549|581651371|FG000|Overall Study|Disease progression|37|||
161156581|NCT01592409|581955110|FG001|Overall Study|Withdrawal by Subject|1|||
161156582|NCT01728584|581955111|FG000|Overall Study|Adverse Event|1|||
161156583|NCT01728584|581955112|FG001|Overall Study|Adverse Event|0|||
161156584|NCT01728584|581955113|FG002|Overall Study|Adverse Event|0|||
161156585|NCT01728584|581955114|FG003|Overall Study|Adverse Event|0|||
161156586|NCT01728584|581955111|FG000|Overall Study|Physician Decision|4|||
161156587|NCT01728584|581955112|FG001|Overall Study|Physician Decision|0|||
161156588|NCT01728584|581955113|FG002|Overall Study|Physician Decision|1|||
161156589|NCT01728584|581955114|FG003|Overall Study|Physician Decision|0|||
161156590|NCT01728584|581955111|FG000|Overall Study|Withdrawal by Subject|1|||
161156591|NCT01728584|581955112|FG001|Overall Study|Withdrawal by Subject|0|||
161156592|NCT01728584|581955113|FG002|Overall Study|Withdrawal by Subject|0|||
161156593|NCT01728584|581955114|FG003|Overall Study|Withdrawal by Subject|0|||
161285102|NCT04917861|582421430|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
161156594|NCT01728584|581955111|FG000|Overall Study|Screen failure|1|||
161156595|NCT01728584|581955112|FG001|Overall Study|Screen failure|0|||
161156596|NCT01728584|581955113|FG002|Overall Study|Screen failure|0|||
161156597|NCT01728584|581955114|FG003|Overall Study|Screen failure|0|||
161156598|NCT01728584|581955111|FG000|Overall Study|Other reason (not specified)|1|||
161156599|NCT01728584|581955112|FG001|Overall Study|Other reason (not specified)|0|||
161156600|NCT01728584|581955113|FG002|Overall Study|Other reason (not specified)|0|||
161156601|NCT01728584|581955114|FG003|Overall Study|Other reason (not specified)|1|||
161156602|NCT02935634|581955115|FG000|Randomization|Participant withdrew consent|0|||
161156603|NCT02935634|581955116|FG001|Randomization|Participant withdrew consent|1|||
161156604|NCT02935634|581955117|FG002|Randomization|Participant withdrew consent|0|||
161156605|NCT02935634|581955118|FG003|Randomization|Participant withdrew consent|0|||
161156606|NCT02935634|581955119|FG004|Randomization|Participant withdrew consent|0|||
161156607|NCT02935634|581955120|FG005|Randomization|Participant withdrew consent|0|||
161156608|NCT02935634|581955115|FG000|Randomization|Death|2|||
161156609|NCT02935634|581955116|FG001|Randomization|Death|1|||
161156610|NCT02935634|581955117|FG002|Randomization|Death|1|||
161156611|NCT02935634|581955118|FG003|Randomization|Death|0|||
161156612|NCT02935634|581955119|FG004|Randomization|Death|0|||
161156613|NCT02935634|581955120|FG005|Randomization|Death|0|||
161156614|NCT02935634|581955115|FG000|Randomization|Other reasons|0|||
161156615|NCT02935634|581955116|FG001|Randomization|Other reasons|2|||
161156616|NCT02935634|581955117|FG002|Randomization|Other reasons|2|||
161156617|NCT02935634|581955118|FG003|Randomization|Other reasons|0|||
161156618|NCT02935634|581955119|FG004|Randomization|Other reasons|0|||
161156619|NCT02935634|581955120|FG005|Randomization|Other reasons|0|||
161156620|NCT02935634|581955115|FG000|Treatment: Track 1|Disease progression|15|||
161156621|NCT02935634|581955116|FG001|Treatment: Track 1|Disease progression|17|||
161156622|NCT02935634|581955117|FG002|Treatment: Track 1|Disease progression|28|||
161156623|NCT02935634|581955118|FG003|Treatment: Track 1|Disease progression|4|||
161156624|NCT02935634|581955119|FG004|Treatment: Track 1|Disease progression|6|||
161156625|NCT02935634|581955120|FG005|Treatment: Track 1|Disease progression|2|||
161156626|NCT02935634|581955115|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
161156627|NCT02935634|581955116|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
161156628|NCT02935634|581955117|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
161156629|NCT02935634|581955118|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
161156630|NCT02935634|581955119|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
161156631|NCT02935634|581955120|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
161156632|NCT02935634|581955115|FG000|Treatment: Track 1|Lost to Follow-up|1|||
161156633|NCT02935634|581955116|FG001|Treatment: Track 1|Lost to Follow-up|0|||
161156634|NCT02935634|581955117|FG002|Treatment: Track 1|Lost to Follow-up|0|||
161156635|NCT02935634|581955118|FG003|Treatment: Track 1|Lost to Follow-up|0|||
161156636|NCT02935634|581955119|FG004|Treatment: Track 1|Lost to Follow-up|0|||
161156637|NCT02935634|581955120|FG005|Treatment: Track 1|Lost to Follow-up|0|||
161156638|NCT02935634|581955115|FG000|Treatment: Track 1|Study drug toxicity|2|||
161285103|NCT04917861|582421431|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
161285104|NCT04917861|582421432|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
161285105|NCT04917861|582421433|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
161285106|NCT04917861|582421430|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161156639|NCT02935634|581955116|FG001|Treatment: Track 1|Study drug toxicity|1|||
161156640|NCT02935634|581955117|FG002|Treatment: Track 1|Study drug toxicity|3|||
161156641|NCT02935634|581955118|FG003|Treatment: Track 1|Study drug toxicity|0|||
161156642|NCT02935634|581955119|FG004|Treatment: Track 1|Study drug toxicity|0|||
161156643|NCT02935634|581955120|FG005|Treatment: Track 1|Study drug toxicity|1|||
161156644|NCT02935634|581955115|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
161156645|NCT02935634|581955116|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
161156646|NCT02935634|581955117|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
161285107|NCT04917861|582421431|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
161156647|NCT02935634|581955118|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
161156648|NCT02935634|581955119|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
161156649|NCT02935634|581955120|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
161156650|NCT02935634|581955115|FG000|Treatment: Track 1|Participant withdrew consent|2|||
161156651|NCT02935634|581955116|FG001|Treatment: Track 1|Participant withdrew consent|0|||
161156652|NCT02935634|581955117|FG002|Treatment: Track 1|Participant withdrew consent|1|||
161156653|NCT02935634|581955118|FG003|Treatment: Track 1|Participant withdrew consent|0|||
161156654|NCT02935634|581955119|FG004|Treatment: Track 1|Participant withdrew consent|1|||
161071530|NCT01732549|581651372|FG001|Overall Study|Disease progression|50|||
161071531|NCT01732549|581651371|FG000|Overall Study|Other|8|||
161071532|NCT01732549|581651372|FG001|Overall Study|Other|14|||
161071533|NCT01516749|581651373|FG000|Active Therapy|Lost to Follow-up|1|||
161071534|NCT01516749|581651373|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
161071535|NCT03994731|581651375|FG000|Pegloticase + IMM Period|Death|2|||
161071536|NCT03994731|581651376|FG001|Pegloticase + IMM Period|Death|0|||
161071537|NCT03994731|581651375|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
161071538|NCT03994731|581651376|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
161071539|NCT03994731|581651375|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
161071540|NCT03994731|581651376|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
161071541|NCT00447590|581651379|FG000|Overall Study|Withdrawal by Subject|26|||
161071542|NCT00447590|581651379|FG000|Overall Study|Lost to Follow-up|24|||
161071543|NCT00447590|581651379|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
161071544|NCT03880019|581651380|FG000|Overall Study|Competing disease|1|||
161071545|NCT01163474|581651388|FG000|Overall Study|Withdrawal by Subject|1|||
161071546|NCT01163474|581651388|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
161071547|NCT01163474|581651388|FG000|Overall Study|Lost to Follow-up|3|||
161071548|NCT02878603|581651389|FG000|Overall Study|Lost to Follow-up|4|||
161071549|NCT02878603|581651390|FG001|Overall Study|Lost to Follow-up|1|||
161071550|NCT02878603|581651389|FG000|Overall Study|Withdrawal by Subject|1|||
161071551|NCT02878603|581651390|FG001|Overall Study|Withdrawal by Subject|1|||
161071552|NCT02878603|581651389|FG000|Overall Study|Death|1|||
161071553|NCT02878603|581651390|FG001|Overall Study|Death|0|||
161071554|NCT02878603|581651389|FG000|Overall Study|Physician Decision|0|||
161071555|NCT02878603|581651390|FG001|Overall Study|Physician Decision|3|||
161071556|NCT03274895|581651391|FG000|Overall Study|Lack of Efficacy|1|||
161071557|NCT03274895|581651392|FG001|Overall Study|Lack of Efficacy|0|||
161071558|NCT03274895|581651391|FG000|Overall Study|Adverse Event|8|||
161071559|NCT03274895|581651392|FG001|Overall Study|Adverse Event|7|||
161071560|NCT03274895|581651391|FG000|Overall Study|Lost to Follow-up|1|||
161071561|NCT03274895|581651392|FG001|Overall Study|Lost to Follow-up|0|||
161071562|NCT03274895|581651391|FG000|Overall Study|Diagnosis not confirmed|3|||
161071563|NCT03274895|581651392|FG001|Overall Study|Diagnosis not confirmed|4|||
161071564|NCT01969851|581651397|FG000|Overall Study|Adverse Event|0|||
161071565|NCT01969851|581651398|FG001|Overall Study|Adverse Event|0|||
161071566|NCT01969851|581651399|FG002|Overall Study|Adverse Event|3|||
161071567|NCT01969851|581651397|FG000|Overall Study|Lack of Efficacy|0|||
161071568|NCT01969851|581651398|FG001|Overall Study|Lack of Efficacy|3|||
161071569|NCT01969851|581651399|FG002|Overall Study|Lack of Efficacy|1|||
161071570|NCT01969851|581651397|FG000|Overall Study|Withdrawal by Subject|1|||
161071571|NCT01969851|581651398|FG001|Overall Study|Withdrawal by Subject|0|||
161071572|NCT01969851|581651399|FG002|Overall Study|Withdrawal by Subject|1|||
161071573|NCT01969851|581651397|FG000|Overall Study|No effective dose in Titration period|0|||
161071574|NCT01969851|581651398|FG001|Overall Study|No effective dose in Titration period|0|||
161071575|NCT01969851|581651399|FG002|Overall Study|No effective dose in Titration period|1|||
161071576|NCT01969851|581651397|FG000|Overall Study|Sponsor decision|0|||
161071577|NCT01969851|581651398|FG001|Overall Study|Sponsor decision|0|||
161071578|NCT01969851|581651399|FG002|Overall Study|Sponsor decision|1|||
161071579|NCT01294436|581651400|FG000|Overall Study|Adverse Event|10|||
161071580|NCT01294436|581651401|FG001|Overall Study|Adverse Event|17|||
161071581|NCT01294436|581651400|FG000|Overall Study|Withdrawal by Subject|11|||
161071582|NCT01294436|581651401|FG001|Overall Study|Withdrawal by Subject|28|||
161071583|NCT01294436|581651400|FG000|Overall Study|subject no longer meets study criteria|5|||
161071584|NCT01294436|581651401|FG001|Overall Study|subject no longer meets study criteria|20|||
161071585|NCT01294436|581651400|FG000|Overall Study|poor/non-compliance|2|||
161071586|NCT01294436|581651401|FG001|Overall Study|poor/non-compliance|5|||
161071587|NCT02389764|581651402|FG000|Overall Study|Lack of Efficacy|9|||
161071588|NCT00585078|581651405|FG000|Overall Study|Withdrawal by Subject|4|||
161071589|NCT00585078|581651405|FG000|Overall Study|Poor performance status|1|||
161071590|NCT00585078|581651405|FG000|Overall Study|Disease Progression|24|||
161071591|NCT00585078|581651405|FG000|Overall Study|Adverse Event|10|||
161071592|NCT00585078|581651405|FG000|Overall Study|Death|1|||
161071593|NCT01814072|581651408|FG000|Overall Study|Lost to Follow-up|2|||
161071594|NCT01814072|581651409|FG001|Overall Study|Lost to Follow-up|2|||
161071595|NCT01814072|581651410|FG002|Overall Study|Lost to Follow-up|2|||
161071596|NCT01814072|581651411|FG003|Overall Study|Lost to Follow-up|0|||
161071597|NCT01814072|581651412|FG004|Overall Study|Lost to Follow-up|2|||
161071598|NCT01814072|581651413|FG005|Overall Study|Lost to Follow-up|3|||
161071599|NCT01814072|581651414|FG006|Overall Study|Lost to Follow-up|3|||
161071600|NCT01814072|581651415|FG007|Overall Study|Lost to Follow-up|1|||
161071601|NCT01814072|581651416|FG008|Overall Study|Lost to Follow-up|2|||
161071602|NCT01814072|581651417|FG009|Overall Study|Lost to Follow-up|3|||
161071603|NCT01814072|581651418|FG010|Overall Study|Lost to Follow-up|1|||
161071604|NCT01814072|581651419|FG011|Overall Study|Lost to Follow-up|2|||
161071605|NCT01814072|581651420|FG012|Overall Study|Lost to Follow-up|2|||
161071606|NCT01814072|581651421|FG013|Overall Study|Lost to Follow-up|1|||
161071607|NCT01814072|581651422|FG014|Overall Study|Lost to Follow-up|2|||
161071608|NCT01814072|581651423|FG015|Overall Study|Lost to Follow-up|1|||
161071609|NCT01814072|581651424|FG016|Overall Study|Lost to Follow-up|3|||
161071610|NCT01814072|581651425|FG017|Overall Study|Lost to Follow-up|1|||
161071611|NCT01814072|581651426|FG018|Overall Study|Lost to Follow-up|3|||
161071612|NCT01814072|581651427|FG019|Overall Study|Lost to Follow-up|3|||
161071613|NCT01814072|581651428|FG020|Overall Study|Lost to Follow-up|2|||
161071614|NCT01814072|581651429|FG021|Overall Study|Lost to Follow-up|1|||
161071615|NCT01814072|581651430|FG022|Overall Study|Lost to Follow-up|3|||
161071616|NCT01814072|581651431|FG023|Overall Study|Lost to Follow-up|1|||
161071617|NCT01814072|581651432|FG024|Overall Study|Lost to Follow-up|4|||
161071618|NCT01814072|581651433|FG025|Overall Study|Lost to Follow-up|1|||
161071619|NCT01814072|581651434|FG026|Overall Study|Lost to Follow-up|1|||
161071620|NCT01814072|581651435|FG027|Overall Study|Lost to Follow-up|2|||
161071621|NCT01814072|581651436|FG028|Overall Study|Lost to Follow-up|3|||
161071622|NCT01814072|581651437|FG029|Overall Study|Lost to Follow-up|3|||
161071623|NCT01814072|581651438|FG030|Overall Study|Lost to Follow-up|2|||
161071624|NCT01814072|581651439|FG031|Overall Study|Lost to Follow-up|0|||
161071625|NCT01814072|581651408|FG000|Overall Study|Withdrawal by Subject|2|||
161071626|NCT01814072|581651409|FG001|Overall Study|Withdrawal by Subject|0|||
161071627|NCT01814072|581651410|FG002|Overall Study|Withdrawal by Subject|1|||
161071628|NCT01814072|581651411|FG003|Overall Study|Withdrawal by Subject|0|||
161071629|NCT01814072|581651412|FG004|Overall Study|Withdrawal by Subject|2|||
161071630|NCT01814072|581651413|FG005|Overall Study|Withdrawal by Subject|3|||
161071631|NCT01814072|581651414|FG006|Overall Study|Withdrawal by Subject|1|||
161071632|NCT01814072|581651415|FG007|Overall Study|Withdrawal by Subject|0|||
161071633|NCT01814072|581651416|FG008|Overall Study|Withdrawal by Subject|1|||
161071634|NCT01814072|581651417|FG009|Overall Study|Withdrawal by Subject|2|||
161071635|NCT01814072|581651418|FG010|Overall Study|Withdrawal by Subject|0|||
161071636|NCT01814072|581651419|FG011|Overall Study|Withdrawal by Subject|0|||
161071637|NCT01814072|581651420|FG012|Overall Study|Withdrawal by Subject|1|||
161071638|NCT01814072|581651421|FG013|Overall Study|Withdrawal by Subject|1|||
161071639|NCT01814072|581651422|FG014|Overall Study|Withdrawal by Subject|1|||
161071640|NCT01814072|581651423|FG015|Overall Study|Withdrawal by Subject|1|||
161071641|NCT01814072|581651424|FG016|Overall Study|Withdrawal by Subject|0|||
161071642|NCT01814072|581651425|FG017|Overall Study|Withdrawal by Subject|0|||
161071643|NCT01814072|581651426|FG018|Overall Study|Withdrawal by Subject|0|||
161071644|NCT01814072|581651427|FG019|Overall Study|Withdrawal by Subject|2|||
161071645|NCT01814072|581651428|FG020|Overall Study|Withdrawal by Subject|0|||
161071646|NCT01814072|581651429|FG021|Overall Study|Withdrawal by Subject|0|||
161071647|NCT01814072|581651430|FG022|Overall Study|Withdrawal by Subject|1|||
161071648|NCT01814072|581651431|FG023|Overall Study|Withdrawal by Subject|0|||
161071649|NCT01814072|581651432|FG024|Overall Study|Withdrawal by Subject|2|||
161071650|NCT01814072|581651433|FG025|Overall Study|Withdrawal by Subject|1|||
161071651|NCT01814072|581651434|FG026|Overall Study|Withdrawal by Subject|1|||
161071652|NCT01814072|581651435|FG027|Overall Study|Withdrawal by Subject|2|||
161071653|NCT01814072|581651436|FG028|Overall Study|Withdrawal by Subject|1|||
161071654|NCT01814072|581651437|FG029|Overall Study|Withdrawal by Subject|0|||
161071655|NCT01814072|581651438|FG030|Overall Study|Withdrawal by Subject|0|||
161071656|NCT01814072|581651439|FG031|Overall Study|Withdrawal by Subject|0|||
161071657|NCT02781311|581651440|FG000|Overall Study|Adverse Event|2|||
161071658|NCT02781311|581651441|FG001|Overall Study|Adverse Event|6|||
161071659|NCT02781311|581651442|FG002|Overall Study|Adverse Event|1|||
161071660|NCT02781311|581651440|FG000|Overall Study|Withdrawal of Consent|11|||
161071661|NCT02781311|581651441|FG001|Overall Study|Withdrawal of Consent|12|||
161071662|NCT02781311|581651442|FG002|Overall Study|Withdrawal of Consent|2|||
161071663|NCT02781311|581651440|FG000|Overall Study|Lost to Follow-up|11|||
161071664|NCT02781311|581651441|FG001|Overall Study|Lost to Follow-up|8|||
161071665|NCT02781311|581651442|FG002|Overall Study|Lost to Follow-up|1|||
161071666|NCT02781311|581651440|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161071667|NCT02781311|581651441|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161071668|NCT02781311|581651442|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161156655|NCT02935634|581955120|FG005|Treatment: Track 1|Participant withdrew consent|0|||
161156656|NCT02935634|581955115|FG000|Treatment: Track 1|Other reasons|0|||
161071669|NCT01011868|581651447|FG000|After Week 18 Follow-up|Adverse Event|8|||
161071670|NCT01011868|581651448|FG001|After Week 18 Follow-up|Adverse Event|6|||
161071671|NCT01011868|581651449|FG002|After Week 18 Follow-up|Adverse Event|13|||
161071672|NCT01011868|581651447|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
161071673|NCT01011868|581651448|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
161071674|NCT01011868|581651449|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
161071675|NCT01011868|581651447|FG000|After Week 18 Follow-up|Protocol Violation|1|||
161285108|NCT04917861|582421432|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161071676|NCT01011868|581651448|FG001|After Week 18 Follow-up|Protocol Violation|1|||
161071677|NCT01011868|581651449|FG002|After Week 18 Follow-up|Protocol Violation|1|||
161071678|NCT01011868|581651447|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
161071679|NCT01011868|581651448|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
161071680|NCT01011868|581651449|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
161071681|NCT01011868|581651447|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
161071682|NCT01011868|581651448|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
161071683|NCT01011868|581651449|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
161071684|NCT01011868|581651447|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
161071685|NCT01011868|581651448|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
161071686|NCT01011868|581651449|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
161071687|NCT01011868|581651447|FG000|After Week 78 Follow-up|Adverse Event|14|||
161071688|NCT01011868|581651448|FG001|After Week 78 Follow-up|Adverse Event|18|||
161071689|NCT01011868|581651449|FG002|After Week 78 Follow-up|Adverse Event|21|||
161071690|NCT01011868|581651447|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
161071691|NCT01011868|581651448|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
161071692|NCT01011868|581651449|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
161071693|NCT01011868|581651447|FG000|After Week 78 Follow-up|Protocol Violation|9|||
161071694|NCT01011868|581651448|FG001|After Week 78 Follow-up|Protocol Violation|1|||
161071695|NCT01011868|581651449|FG002|After Week 78 Follow-up|Protocol Violation|2|||
161071696|NCT01011868|581651447|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
161071697|NCT01011868|581651448|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
161071698|NCT01011868|581651449|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
161071699|NCT01011868|581651447|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
161071700|NCT01011868|581651448|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
161071701|NCT01011868|581651449|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
161071702|NCT01011868|581651447|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
161071703|NCT01011868|581651448|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
161071704|NCT01011868|581651449|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
161071705|NCT02615938|581651450|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
161071706|NCT02615938|581651451|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
161071707|NCT02615938|581651452|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161071708|NCT02615938|581651453|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161071709|NCT02615938|581651450|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
161071710|NCT02615938|581651451|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
161071711|NCT02615938|581651452|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
161071712|NCT02615938|581651453|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
161071713|NCT02615938|581651450|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161071714|NCT02615938|581651451|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161071715|NCT02615938|581651452|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
161071716|NCT02615938|581651453|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
161071717|NCT04905849|581651455|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
161071718|NCT04905849|581651456|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
161071719|NCT04199052|581651464|FG000|Overall Study|Lost to Follow-up|11|||
161071720|NCT04199052|581651465|FG001|Overall Study|Lost to Follow-up|18|||
161071721|NCT01358331|581651466|FG000|Overall Study|Lost to Follow-up|0|||
161071722|NCT01358331|581651467|FG001|Overall Study|Lost to Follow-up|0|||
161071723|NCT01358331|581651468|FG002|Overall Study|Lost to Follow-up|0|||
161071724|NCT01358331|581651469|FG003|Overall Study|Lost to Follow-up|1|||
161071725|NCT01358331|581651470|FG004|Overall Study|Lost to Follow-up|0|||
161071726|NCT01358331|581651471|FG005|Overall Study|Lost to Follow-up|0|||
161071727|NCT01358331|581651466|FG000|Overall Study|Withdrawal by Subject|0|||
161071728|NCT01358331|581651467|FG001|Overall Study|Withdrawal by Subject|0|||
161071729|NCT01358331|581651468|FG002|Overall Study|Withdrawal by Subject|0|||
161071730|NCT01358331|581651469|FG003|Overall Study|Withdrawal by Subject|1|||
161071731|NCT01358331|581651470|FG004|Overall Study|Withdrawal by Subject|1|||
161071732|NCT01358331|581651471|FG005|Overall Study|Withdrawal by Subject|1|||
161071733|NCT01358331|581651466|FG000|Overall Study|Adverse Events|1|||
161071734|NCT01358331|581651467|FG001|Overall Study|Adverse Events|1|||
161071735|NCT01358331|581651468|FG002|Overall Study|Adverse Events|1|||
161156657|NCT02935634|581955116|FG001|Treatment: Track 1|Other reasons|0|||
161156658|NCT02935634|581955117|FG002|Treatment: Track 1|Other reasons|2|||
161071736|NCT01358331|581651469|FG003|Overall Study|Adverse Events|0|||
161156659|NCT02935634|581955118|FG003|Treatment: Track 1|Other reasons|0|||
161071737|NCT01358331|581651470|FG004|Overall Study|Adverse Events|1|||
161071738|NCT01358331|581651471|FG005|Overall Study|Adverse Events|5|||
161071739|NCT01358331|581651466|FG000|Overall Study|Symptomatic Deterioration|0|||
161071740|NCT01358331|581651467|FG001|Overall Study|Symptomatic Deterioration|0|||
161071741|NCT01358331|581651468|FG002|Overall Study|Symptomatic Deterioration|0|||
161285109|NCT04917861|582421433|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
161156660|NCT02935634|581955119|FG004|Treatment: Track 1|Other reasons|0|||
161156661|NCT02935634|581955120|FG005|Treatment: Track 1|Other reasons|0|||
161156662|NCT02935634|581955115|FG000|Treatment: Track 2|Disease progression|13|||
161156663|NCT02935634|581955116|FG001|Treatment: Track 2|Disease progression|26|||
161156664|NCT02935634|581955117|FG002|Treatment: Track 2|Disease progression|20|||
161156665|NCT02935634|581955118|FG003|Treatment: Track 2|Disease progression|5|||
161156666|NCT02935634|581955119|FG004|Treatment: Track 2|Disease progression|1|||
161156667|NCT02935634|581955120|FG005|Treatment: Track 2|Disease progression|4|||
161156668|NCT02935634|581955115|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
161156669|NCT02935634|581955116|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
161156670|NCT02935634|581955117|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161156671|NCT02935634|581955118|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161156672|NCT02935634|581955119|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161156673|NCT02935634|581955120|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
161156674|NCT02935634|581955115|FG000|Treatment: Track 2|Study drug toxicity|7|||
161156675|NCT02935634|581955116|FG001|Treatment: Track 2|Study drug toxicity|3|||
161156676|NCT02935634|581955117|FG002|Treatment: Track 2|Study drug toxicity|0|||
161156677|NCT02935634|581955118|FG003|Treatment: Track 2|Study drug toxicity|0|||
161156678|NCT02935634|581955119|FG004|Treatment: Track 2|Study drug toxicity|0|||
161156679|NCT02935634|581955120|FG005|Treatment: Track 2|Study drug toxicity|0|||
161156680|NCT02935634|581955115|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
161156681|NCT02935634|581955116|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
161156682|NCT02935634|581955117|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
161156683|NCT02935634|581955118|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
161156684|NCT02935634|581955119|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
161156685|NCT02935634|581955120|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
161156686|NCT02935634|581955115|FG000|Treatment: Track 2|Participant withdrew consent|0|||
161156687|NCT02935634|581955116|FG001|Treatment: Track 2|Participant withdrew consent|1|||
161156688|NCT02935634|581955117|FG002|Treatment: Track 2|Participant withdrew consent|1|||
161156689|NCT02935634|581955118|FG003|Treatment: Track 2|Participant withdrew consent|0|||
161156690|NCT02935634|581955119|FG004|Treatment: Track 2|Participant withdrew consent|1|||
161156691|NCT02935634|581955120|FG005|Treatment: Track 2|Participant withdrew consent|0|||
161156692|NCT05132569|581955122|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
161156693|NCT05132569|581955123|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
161156694|NCT05132569|581955122|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
161156695|NCT05132569|581955123|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
161156696|NCT05132569|581955122|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
161156697|NCT05132569|581955123|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
161156698|NCT02864940|581955124|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
161156699|NCT02864940|581955125|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
161156700|NCT02232087|581955126|FG000|Overall Study|Withdrawal by Subject|2|||
161156701|NCT02232087|581955127|FG001|Overall Study|Withdrawal by Subject|0|||
161156702|NCT02232087|581955128|FG002|Overall Study|Withdrawal by Subject|0|||
161156703|NCT02232087|581955129|FG003|Overall Study|Withdrawal by Subject|0|||
161156704|NCT02232087|581955130|FG004|Overall Study|Withdrawal by Subject|0|||
161156705|NCT02232087|581955131|FG005|Overall Study|Withdrawal by Subject|1|||
161156706|NCT02232087|581955126|FG000|Overall Study|poor inhalation technique|0|||
161156707|NCT02232087|581955127|FG001|Overall Study|poor inhalation technique|1|||
161156708|NCT02232087|581955128|FG002|Overall Study|poor inhalation technique|0|||
161156709|NCT02232087|581955129|FG003|Overall Study|poor inhalation technique|0|||
161156710|NCT02232087|581955130|FG004|Overall Study|poor inhalation technique|0|||
161156711|NCT02232087|581955131|FG005|Overall Study|poor inhalation technique|2|||
161156712|NCT02232087|581955126|FG000|Overall Study|protocol stop criteria|0|||
161156713|NCT02232087|581955127|FG001|Overall Study|protocol stop criteria|1|||
161285110|NCT04917861|582421430|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
161285111|NCT04917861|582421431|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
161285112|NCT04917861|582421432|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
161285113|NCT04917861|582421433|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
161285114|NCT00720382|582421434|FG000|Overall Study|Adverse Event|54|||
161285115|NCT00720382|582421435|FG001|Overall Study|Adverse Event|17|||
161285116|NCT00720382|582421434|FG000|Overall Study|Lack of Efficacy|18|||
161285117|NCT00720382|582421435|FG001|Overall Study|Lack of Efficacy|7|||
161285118|NCT00720382|582421434|FG000|Overall Study|Non-Compliance|15|||
161285119|NCT00720382|582421435|FG001|Overall Study|Non-Compliance|5|||
161156714|NCT02232087|581955128|FG002|Overall Study|protocol stop criteria|0|||
161156715|NCT02232087|581955129|FG003|Overall Study|protocol stop criteria|1|||
161156716|NCT02232087|581955130|FG004|Overall Study|protocol stop criteria|0|||
161156717|NCT02232087|581955131|FG005|Overall Study|protocol stop criteria|0|||
161285120|NCT00720382|582421434|FG000|Overall Study|Withdrawal by Subject|47|||
161285121|NCT00720382|582421435|FG001|Overall Study|Withdrawal by Subject|11|||
161285122|NCT00720382|582421434|FG000|Overall Study|Lost to Follow-up|28|||
161285123|NCT00720382|582421435|FG001|Overall Study|Lost to Follow-up|14|||
161285124|NCT00720382|582421434|FG000|Overall Study|administrative|14|||
161285125|NCT00720382|582421435|FG001|Overall Study|administrative|5|||
161285126|NCT05192889|582421437|FG000|Block 1: All Eligible Patients|Death|2|||
161285127|NCT05192889|582421438|FG001|Block 1: All Eligible Patients|Death|0|||
161285128|NCT05192889|582421439|FG002|Block 1: All Eligible Patients|Death|0|||
161285129|NCT05192889|582421437|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
161285130|NCT05192889|582421438|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
161285131|NCT05192889|582421439|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
161285132|NCT05192889|582421437|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
161285133|NCT05192889|582421438|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
161285134|NCT05192889|582421439|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
161285135|NCT04075487|582423364|FG000|Overall Study|Withdrawal by Subject|1|||
161071742|NCT01358331|581651469|FG003|Overall Study|Symptomatic Deterioration|0|||
161071743|NCT01358331|581651470|FG004|Overall Study|Symptomatic Deterioration|1|||
161071744|NCT01358331|581651471|FG005|Overall Study|Symptomatic Deterioration|0|||
161071745|NCT01358331|581651466|FG000|Overall Study|Participants did not wish to continue|0|||
161071746|NCT01358331|581651467|FG001|Overall Study|Participants did not wish to continue|0|||
161071747|NCT01358331|581651468|FG002|Overall Study|Participants did not wish to continue|0|||
161071748|NCT01358331|581651469|FG003|Overall Study|Participants did not wish to continue|0|||
161071749|NCT01358331|581651470|FG004|Overall Study|Participants did not wish to continue|1|||
161071750|NCT01358331|581651471|FG005|Overall Study|Participants did not wish to continue|0|||
161071751|NCT01358331|581651466|FG000|Overall Study|Progress of disease under investigation|1|||
161071752|NCT01358331|581651467|FG001|Overall Study|Progress of disease under investigation|2|||
161071753|NCT01358331|581651468|FG002|Overall Study|Progress of disease under investigation|3|||
161071754|NCT01358331|581651469|FG003|Overall Study|Progress of disease under investigation|1|||
161071755|NCT01358331|581651470|FG004|Overall Study|Progress of disease under investigation|3|||
161071756|NCT01358331|581651471|FG005|Overall Study|Progress of disease under investigation|0|||
161071757|NCT04946942|581651472|FG000|Overall Study|Lost to Follow-up|6|||
161071758|NCT04946942|581651473|FG001|Overall Study|Lost to Follow-up|2|||
161071759|NCT04946942|581651474|FG002|Overall Study|Lost to Follow-up|0|||
161071760|NCT04907357|581651475|FG000|Overall Study|Death|0|||
161071761|NCT04907357|581651476|FG001|Overall Study|Death|1|||
161071762|NCT04907357|581651475|FG000|Overall Study|Lost to Follow-up|9|||
161071763|NCT04907357|581651476|FG001|Overall Study|Lost to Follow-up|18|||
161071764|NCT04907357|581651475|FG000|Overall Study|Physician Decision|1|||
161071765|NCT04907357|581651476|FG001|Overall Study|Physician Decision|0|||
161071766|NCT04907357|581651475|FG000|Overall Study|Withdrawal by Subject|0|||
161071767|NCT04907357|581651476|FG001|Overall Study|Withdrawal by Subject|1|||
161071768|NCT04907357|581651475|FG000|Overall Study|Unable to attend visits|1|||
161071769|NCT04907357|581651476|FG001|Overall Study|Unable to attend visits|0|||
161071770|NCT04907357|581651475|FG000|Overall Study|Incarcerated|1|||
161071771|NCT04907357|581651476|FG001|Overall Study|Incarcerated|1|||
161071772|NCT05226130|581651482|FG000|Overall Study|Lost to Follow-up|0|||
161071773|NCT05226130|581651483|FG001|Overall Study|Lost to Follow-up|1|||
161071774|NCT05226130|581651482|FG000|Overall Study|Not treatment adherent|0|||
161071775|NCT05226130|581651483|FG001|Overall Study|Not treatment adherent|2|||
161071776|NCT03358472|581651484|FG000|Overall Study|Death|6|||
161071777|NCT03358472|581651485|FG001|Overall Study|Death|3|||
161071778|NCT03358472|581651486|FG002|Overall Study|Death|10|||
161071779|NCT03358472|581651484|FG000|Overall Study|Physician Decision|0|||
161071780|NCT03358472|581651485|FG001|Overall Study|Physician Decision|1|||
161071781|NCT03358472|581651486|FG002|Overall Study|Physician Decision|0|||
161071782|NCT03358472|581651484|FG000|Overall Study|Withdrawal by Subject|0|||
161071783|NCT03358472|581651485|FG001|Overall Study|Withdrawal by Subject|0|||
161071784|NCT03358472|581651486|FG002|Overall Study|Withdrawal by Subject|1|||
161071785|NCT03358472|581651484|FG000|Overall Study|On-going at clinical cut off date|9|||
161071786|NCT03358472|581651485|FG001|Overall Study|On-going at clinical cut off date|6|||
161071787|NCT03358472|581651486|FG002|Overall Study|On-going at clinical cut off date|5|||
161071788|NCT03974022|581651487|FG000|Overall Study|Death|0|||
161071789|NCT03974022|581651488|FG001|Overall Study|Death|1|||
161071790|NCT03974022|581651489|FG002|Overall Study|Death|0|||
161071791|NCT03974022|581651490|FG003|Overall Study|Death|2|||
161071792|NCT03974022|581651491|FG004|Overall Study|Death|0|||
161071793|NCT03974022|581651492|FG005|Overall Study|Death|1|||
161071794|NCT03974022|581651493|FG006|Overall Study|Death|0|||
161071795|NCT03974022|581651494|FG007|Overall Study|Death|2|||
161071796|NCT03974022|581651495|FG008|Overall Study|Death|1|||
161071797|NCT03974022|581651496|FG009|Overall Study|Death|4|||
161071798|NCT03974022|581651497|FG010|Overall Study|Death|0|||
161071799|NCT03974022|581651498|FG011|Overall Study|Death|0|||
161156718|NCT02232087|581955126|FG000|Overall Study|Adverse Event|0|||
161285136|NCT00265759|582423367|FG000|Overall Study|Withdrawal by Subject|0|||
161285137|NCT00265759|582423368|FG001|Overall Study|Withdrawal by Subject|1|||
161285138|NCT00265759|582423369|FG002|Overall Study|Withdrawal by Subject|2|||
161071800|NCT03974022|581651499|FG012|Overall Study|Death|0|||
161071801|NCT03974022|581651500|FG013|Overall Study|Death|33|||
161156719|NCT02232087|581955127|FG001|Overall Study|Adverse Event|0|||
161156720|NCT02232087|581955128|FG002|Overall Study|Adverse Event|0|||
161156721|NCT02232087|581955129|FG003|Overall Study|Adverse Event|0|||
161156722|NCT02232087|581955130|FG004|Overall Study|Adverse Event|1|||
161156723|NCT02232087|581955131|FG005|Overall Study|Adverse Event|0|||
161156724|NCT01958125|581955132|FG000|Overall Study|Missing diary data|2|||
161156725|NCT01958125|581955133|FG001|Overall Study|Missing diary data|6|||
161156726|NCT01958125|581955132|FG000|Overall Study|No headache attacks|0|||
161156727|NCT01958125|581955133|FG001|Overall Study|No headache attacks|2|||
161156728|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
161156729|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
161156730|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
161156731|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
161156732|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
161156733|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
161156734|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
161156735|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
161156736|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
161156737|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
161156738|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
161156739|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
161156740|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
161156741|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
161156742|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
161156743|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
161156744|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
161156745|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
161156746|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
161156747|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
161156748|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
161156749|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161156750|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161156751|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161156752|NCT01106625|581955134|FG000|Core Period: Baseline to Week 26|Other|8|||
161156753|NCT01106625|581955135|FG001|Core Period: Baseline to Week 26|Other|7|||
161156754|NCT01106625|581955136|FG002|Core Period: Baseline to Week 26|Other|4|||
161156755|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161156756|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
161156757|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
161156758|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
161156759|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
161156760|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161156761|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161156762|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
161156763|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
161156764|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161156765|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161156766|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161156767|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
161156768|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161156769|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161156770|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
161156771|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
161156772|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
161156773|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161156774|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
161071802|NCT03974022|581651501|FG014|Overall Study|Death|40|||
161071803|NCT03974022|581651487|FG000|Overall Study|Withdrawal by Subject|0|||
161071804|NCT03974022|581651488|FG001|Overall Study|Withdrawal by Subject|0|||
161071805|NCT03974022|581651489|FG002|Overall Study|Withdrawal by Subject|0|||
161071806|NCT03974022|581651490|FG003|Overall Study|Withdrawal by Subject|0|||
161071807|NCT03974022|581651491|FG004|Overall Study|Withdrawal by Subject|0|||
161071808|NCT03974022|581651492|FG005|Overall Study|Withdrawal by Subject|4|||
161071809|NCT03974022|581651493|FG006|Overall Study|Withdrawal by Subject|4|||
161071810|NCT03974022|581651494|FG007|Overall Study|Withdrawal by Subject|2|||
161071811|NCT03974022|581651495|FG008|Overall Study|Withdrawal by Subject|2|||
161071812|NCT03974022|581651496|FG009|Overall Study|Withdrawal by Subject|3|||
161156775|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161156776|NCT01106625|581955134|FG000|Extension Period: Week 26 to Week 52|Other|5|||
161156777|NCT01106625|581955135|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161156778|NCT01106625|581955136|FG002|Extension Period: Week 26 to Week 52|Other|4|||
161156779|NCT01864018|581955140|FG000|Overall Study|Ineligible|3|||
161156780|NCT01864018|581955141|FG001|Overall Study|Ineligible|1|||
161156781|NCT02702193|581955142|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
161156782|NCT02702193|581955143|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
161156783|NCT02702193|581955142|FG000|4 Month Follow up|Withdrawal by Subject|1|||
161156784|NCT02702193|581955143|FG001|4 Month Follow up|Withdrawal by Subject|0|||
161156785|NCT02702193|581955142|FG000|4 Month Follow up|Lost to Follow-up|17|||
161156786|NCT02702193|581955143|FG001|4 Month Follow up|Lost to Follow-up|18|||
161156787|NCT02702193|581955142|FG000|8 Month Follow up|Withdrawal by Subject|1|||
161156788|NCT02702193|581955143|FG001|8 Month Follow up|Withdrawal by Subject|0|||
161156789|NCT02702193|581955142|FG000|8 Month Follow up|Lost to Follow-up|14|||
161156790|NCT02702193|581955143|FG001|8 Month Follow up|Lost to Follow-up|18|||
161156791|NCT02702193|581955142|FG000|12 Month Follow up|Withdrawal by Subject|1|||
161156792|NCT02702193|581955143|FG001|12 Month Follow up|Withdrawal by Subject|0|||
161156793|NCT02702193|581955142|FG000|12 Month Follow up|Lost to Follow-up|16|||
161156794|NCT02702193|581955143|FG001|12 Month Follow up|Lost to Follow-up|18|||
161156795|NCT04056455|581955145|FG000|Overall Study|Adverse Event|1|||
161156796|NCT04056455|581955146|FG001|Overall Study|Adverse Event|0|||
161156797|NCT02512068|581955147|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
161156798|NCT02512068|581955148|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
161156799|NCT02512068|581955147|FG000|Overall Study|Major Protocol Deviation|1|||
161156800|NCT02512068|581955148|FG001|Overall Study|Major Protocol Deviation|0|||
161156801|NCT02512068|581955147|FG000|Overall Study|Voluntary Withdrawal|0|||
161156802|NCT02512068|581955148|FG001|Overall Study|Voluntary Withdrawal|1|||
161156803|NCT02512068|581955147|FG000|Overall Study|Lack of Efficacy|0|||
161156804|NCT02512068|581955148|FG001|Overall Study|Lack of Efficacy|1|||
161156805|NCT02512068|581955147|FG000|Overall Study|Reason Not Specified|3|||
161156806|NCT02512068|581955148|FG001|Overall Study|Reason Not Specified|5|||
161156807|NCT03521687|581955150|FG000|Overall Study|Adverse Event|4|||
161156808|NCT03521687|581955150|FG000|Overall Study|Physician Decision|1|||
161156809|NCT01276457|581955157|FG000|Core Study|Adverse Event|6|||
161156810|NCT01276457|581955158|FG001|Core Study|Adverse Event|3|||
161156811|NCT01276457|581955157|FG000|Core Study|Lost to Follow-up|1|||
161156812|NCT01276457|581955158|FG001|Core Study|Lost to Follow-up|2|||
161156813|NCT01276457|581955157|FG000|Core Study|Administrative problems|1|||
161156814|NCT01276457|581955158|FG001|Core Study|Administrative problems|1|||
161156815|NCT01276457|581955157|FG000|Core Study|Death|2|||
161156816|NCT01276457|581955158|FG001|Core Study|Death|2|||
161156817|NCT01276457|581955157|FG000|Core Study|Lack of Efficacy|3|||
161156818|NCT01276457|581955158|FG001|Core Study|Lack of Efficacy|12|||
161156819|NCT01276457|581955157|FG000|Extension Study|Lost to Follow-up|3|||
161156820|NCT01276457|581955158|FG001|Extension Study|Lost to Follow-up|0|||
161156821|NCT01276457|581955157|FG000|Extension Study|Death|0|||
161156822|NCT01276457|581955158|FG001|Extension Study|Death|1|||
161156823|NCT01276457|581955157|FG000|Extension Study|Lack of Efficacy|3|||
161156824|NCT01276457|581955158|FG001|Extension Study|Lack of Efficacy|1|||
161156825|NCT04891770|581955162|FG000|Overall Study|Withdrew consent|1|||
161156826|NCT04891770|581955163|FG001|Overall Study|Withdrew consent|3|||
161156827|NCT04891770|581955164|FG002|Overall Study|Withdrew consent|0|||
161156828|NCT04891770|581955162|FG000|Overall Study|Enrolled but never treated|0|||
161156829|NCT04891770|581955163|FG001|Overall Study|Enrolled but never treated|0|||
161156830|NCT04891770|581955164|FG002|Overall Study|Enrolled but never treated|1|||
161156831|NCT04891770|581955162|FG000|Overall Study|Investigator's discretion|0|||
161156832|NCT04891770|581955163|FG001|Overall Study|Investigator's discretion|1|||
161156833|NCT04891770|581955164|FG002|Overall Study|Investigator's discretion|0|||
161156834|NCT05122650|581955165|FG000|Overall Study|Adverse Event|4|||
161156835|NCT05122650|581955166|FG001|Overall Study|Adverse Event|16|||
161156836|NCT05122650|581955167|FG002|Overall Study|Adverse Event|11|||
161156837|NCT05122650|581955168|FG003|Overall Study|Adverse Event|12|||
161285139|NCT00265759|582423370|FG003|Overall Study|Withdrawal by Subject|2|||
161285140|NCT00265759|582423367|FG000|Overall Study|Cancel|0|||
161285141|NCT00265759|582423368|FG001|Overall Study|Cancel|0|||
161156838|NCT05122650|581955165|FG000|Overall Study|Lack of Efficacy|0|||
161156839|NCT05122650|581955166|FG001|Overall Study|Lack of Efficacy|1|||
161156840|NCT05122650|581955167|FG002|Overall Study|Lack of Efficacy|1|||
161156841|NCT05122650|581955168|FG003|Overall Study|Lack of Efficacy|2|||
161156842|NCT05122650|581955165|FG000|Overall Study|Lost to Follow-up|1|||
161156843|NCT05122650|581955166|FG001|Overall Study|Lost to Follow-up|1|||
161156844|NCT05122650|581955167|FG002|Overall Study|Lost to Follow-up|3|||
161285142|NCT00265759|582423369|FG002|Overall Study|Cancel|0|||
161156845|NCT05122650|581955168|FG003|Overall Study|Lost to Follow-up|0|||
161156846|NCT05122650|581955165|FG000|Overall Study|Non-compliance with study intervention|0|||
161156847|NCT05122650|581955166|FG001|Overall Study|Non-compliance with study intervention|0|||
161285143|NCT00265759|582423370|FG003|Overall Study|Cancel|3|||
161285144|NCT00265759|582423367|FG000|Overall Study|Ineligible|0|||
161285145|NCT00265759|582423368|FG001|Overall Study|Ineligible|0|||
161285146|NCT00265759|582423369|FG002|Overall Study|Ineligible|0|||
161285147|NCT00265759|582423370|FG003|Overall Study|Ineligible|1|||
161285148|NCT00265759|582423367|FG000|Overall Study|Bilateral disease|0|||
161285149|NCT00265759|582423368|FG001|Overall Study|Bilateral disease|0|||
161285150|NCT00265759|582423369|FG002|Overall Study|Bilateral disease|0|||
161285151|NCT00265759|582423370|FG003|Overall Study|Bilateral disease|2|||
161071813|NCT03974022|581651497|FG010|Overall Study|Withdrawal by Subject|0|||
161285152|NCT00265759|582423367|FG000|Overall Study|Discontinued due to intolerability|0|||
161285153|NCT00265759|582423368|FG001|Overall Study|Discontinued due to intolerability|0|||
161285154|NCT00265759|582423369|FG002|Overall Study|Discontinued due to intolerability|0|||
161285155|NCT00265759|582423370|FG003|Overall Study|Discontinued due to intolerability|1|||
161285156|NCT04467840|582423371|FG000|Overall Study|Death|35|||
161285157|NCT04467840|582423372|FG001|Overall Study|Death|39|||
161285158|NCT04467840|582423371|FG000|Overall Study|Withdrawal by Subject|8|||
161285159|NCT04467840|582423372|FG001|Overall Study|Withdrawal by Subject|4|||
161285160|NCT04467840|582423371|FG000|Overall Study|Adverse Event|2|||
161285161|NCT04467840|582423372|FG001|Overall Study|Adverse Event|0|||
161285162|NCT04467840|582423371|FG000|Overall Study|Lost to Follow-up|1|||
161285163|NCT04467840|582423372|FG001|Overall Study|Lost to Follow-up|3|||
161285164|NCT04467840|582423371|FG000|Overall Study|Physician Decision|1|||
161071814|NCT03974022|581651498|FG011|Overall Study|Withdrawal by Subject|1|||
161071815|NCT03974022|581651499|FG012|Overall Study|Withdrawal by Subject|0|||
161071816|NCT03974022|581651500|FG013|Overall Study|Withdrawal by Subject|3|||
161071817|NCT03974022|581651501|FG014|Overall Study|Withdrawal by Subject|9|||
161071818|NCT03974022|581651487|FG000|Overall Study|Lost to Follow-up|0|||
161071819|NCT03974022|581651488|FG001|Overall Study|Lost to Follow-up|0|||
161071820|NCT03974022|581651489|FG002|Overall Study|Lost to Follow-up|0|||
161071821|NCT03974022|581651490|FG003|Overall Study|Lost to Follow-up|0|||
161071822|NCT03974022|581651491|FG004|Overall Study|Lost to Follow-up|0|||
161071823|NCT03974022|581651492|FG005|Overall Study|Lost to Follow-up|0|||
161071824|NCT03974022|581651493|FG006|Overall Study|Lost to Follow-up|1|||
161071825|NCT03974022|581651494|FG007|Overall Study|Lost to Follow-up|0|||
161071826|NCT03974022|581651495|FG008|Overall Study|Lost to Follow-up|0|||
161071827|NCT03974022|581651496|FG009|Overall Study|Lost to Follow-up|0|||
161071828|NCT03974022|581651497|FG010|Overall Study|Lost to Follow-up|0|||
161071829|NCT03974022|581651498|FG011|Overall Study|Lost to Follow-up|0|||
161071830|NCT03974022|581651499|FG012|Overall Study|Lost to Follow-up|0|||
161071831|NCT03974022|581651500|FG013|Overall Study|Lost to Follow-up|1|||
161071832|NCT03974022|581651501|FG014|Overall Study|Lost to Follow-up|1|||
161071833|NCT03974022|581651487|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
161071834|NCT03974022|581651488|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
161071835|NCT03974022|581651489|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
161071836|NCT03974022|581651490|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
161071837|NCT03974022|581651491|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
161071838|NCT03974022|581651492|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
161071839|NCT03974022|581651493|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
161071840|NCT03974022|581651494|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
161071841|NCT03974022|581651495|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
161071842|NCT03974022|581651496|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
161071843|NCT03974022|581651497|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
161071844|NCT03974022|581651498|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
161071845|NCT03974022|581651499|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
161071846|NCT03974022|581651500|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
161071847|NCT03974022|581651501|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
161071848|NCT02520310|581651502|FG000|At 6 Months Clinical Follow-up|Death|1|||
161071849|NCT02520310|581651502|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
161071850|NCT02520310|581651502|FG000|AT 3 Year Clinical Follow-up|Death|2|||
161071851|NCT02520310|581651502|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
161071852|NCT02520310|581651502|FG000|AT 4 Year Clinical Follow-up|Death|1|||
161071853|NCT02520310|581651502|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
161071854|NCT01340014|581651503|FG000|Period 1, First 7 Days|Adverse Event|1|||
161071855|NCT01340014|581651504|FG001|Period 1, First 7 Days|Adverse Event|0|||
161071856|NCT01340014|581651503|FG000|Period 1, First 7 Days|Personal Reasons|1|||
161071857|NCT01340014|581651504|FG001|Period 1, First 7 Days|Personal Reasons|0|||
161071858|NCT01340014|581651503|FG000|Period 2, Second 7 Days|Adverse Event|0|||
161071859|NCT01340014|581651504|FG001|Period 2, Second 7 Days|Adverse Event|1|||
161071860|NCT05101993|581651511|FG000|Overall Study|Withdrawal by Subject|1|||
161071861|NCT04577573|581651512|FG000|Overall Study|Technical - invalid protocol|0|||
161071862|NCT04577573|581651513|FG001|Overall Study|Technical - invalid protocol|2|||
161285165|NCT04467840|582423372|FG001|Overall Study|Physician Decision|0|||
161285166|NCT04467840|582423371|FG000|Overall Study|Other|1|||
161285167|NCT04467840|582423372|FG001|Overall Study|Other|5|||
161285168|NCT04467840|582423371|FG000|Overall Study|Missing study completion status|3|||
161285169|NCT04467840|582423372|FG001|Overall Study|Missing study completion status|1|||
161285170|NCT00696423|582423379|FG000|Overall Study|Lost to Follow-up|0|||
161285171|NCT00696423|582423380|FG001|Overall Study|Lost to Follow-up|5|||
161285172|NCT03989102|582423381|FG000|Year 1|Withdrawal by Subject|6|||
161285173|NCT03989102|582423382|FG001|Year 1|Withdrawal by Subject|2|||
161285174|NCT03989102|582423383|FG002|Year 1|Withdrawal by Subject|7|||
161285175|NCT03989102|582423381|FG000|Year 1|Lost to Follow-up|5|||
161285176|NCT03989102|582423382|FG001|Year 1|Lost to Follow-up|2|||
161285177|NCT03989102|582423383|FG002|Year 1|Lost to Follow-up|5|||
161285178|NCT03989102|582423381|FG000|Year 1|Subject met withdrawal criteria|1|||
161285179|NCT03989102|582423382|FG001|Year 1|Subject met withdrawal criteria|0|||
161285180|NCT03989102|582423383|FG002|Year 1|Subject met withdrawal criteria|1|||
161285181|NCT03989102|582423381|FG000|Year 2|Lost to Follow-up|7|||
161285182|NCT03989102|582423382|FG001|Year 2|Lost to Follow-up|3|||
161285183|NCT03989102|582423383|FG002|Year 2|Lost to Follow-up|4|||
161285184|NCT03989102|582423381|FG000|Year 2|Withdrawal by Subject|3|||
161285185|NCT03989102|582423382|FG001|Year 2|Withdrawal by Subject|1|||
161285186|NCT03989102|582423383|FG002|Year 2|Withdrawal by Subject|2|||
161285187|NCT03989102|582423381|FG000|Year 2|Subject non-compliant|3|||
161285188|NCT03989102|582423382|FG001|Year 2|Subject non-compliant|2|||
161285189|NCT03989102|582423383|FG002|Year 2|Subject non-compliant|0|||
161285190|NCT03989102|582423381|FG000|Year 2|Travel|1|||
161285191|NCT03989102|582423382|FG001|Year 2|Travel|0|||
161285192|NCT03989102|582423383|FG002|Year 2|Travel|1|||
161285193|NCT03989102|582423381|FG000|Year 2|P16 missing|4|||
161285194|NCT03989102|582423382|FG001|Year 2|P16 missing|2|||
161285195|NCT03989102|582423383|FG002|Year 2|P16 missing|1|||
161285196|NCT03989102|582423381|FG000|Year 2|P11 missing|1|||
161285197|NCT03989102|582423382|FG001|Year 2|P11 missing|3|||
161285198|NCT03989102|582423383|FG002|Year 2|P11 missing|7|||
161285199|NCT03989102|582423381|FG000|Year 2|Definitive displacement outside the study site|0|||
161285200|NCT03989102|582423382|FG001|Year 2|Definitive displacement outside the study site|1|||
161285201|NCT03989102|582423383|FG002|Year 2|Definitive displacement outside the study site|0|||
161285202|NCT03989102|582423381|FG000|Year 2|Subject missed last study visit|0|||
161285203|NCT03989102|582423382|FG001|Year 2|Subject missed last study visit|1|||
161285204|NCT03989102|582423383|FG002|Year 2|Subject missed last study visit|0|||
161285205|NCT03989102|582423381|FG000|Year 2|Death|0|||
161285206|NCT03989102|582423382|FG001|Year 2|Death|1|||
161285207|NCT03989102|582423383|FG002|Year 2|Death|0|||
161285208|NCT03989102|582423381|FG000|Year 2|Subject not reachable|0|||
161285209|NCT03989102|582423382|FG001|Year 2|Subject not reachable|0|||
161285210|NCT03989102|582423383|FG002|Year 2|Subject not reachable|1|||
161285211|NCT03989102|582423381|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
161071863|NCT04577573|581651514|FG002|Overall Study|Technical - invalid protocol|0|||
161071864|NCT02065882|581651518|FG000|Part I: PK/PD|Screening failure|5|||
161071865|NCT02065882|581651518|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
161071866|NCT02065882|581651518|FG000|Part I: PK/PD|Adverse Event|1|||
161071867|NCT02065882|581651518|FG000|Part II: Clinical Efficacy|Screening failure|7|||
161071868|NCT02065882|581651518|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
161071869|NCT02065882|581651518|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
161071870|NCT02065882|581651518|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
161071871|NCT02065882|581651518|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
161071872|NCT02065882|581651518|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
161071873|NCT00945672|581652908|FG000|Overall Study|Withdrawal by Subject|0|||
161071874|NCT00945672|581652909|FG001|Overall Study|Withdrawal by Subject|0|||
161071875|NCT00945672|581652910|FG002|Overall Study|Withdrawal by Subject|0|||
161071876|NCT00945672|581652911|FG003|Overall Study|Withdrawal by Subject|1|||
161071877|NCT01681992|581652916|FG000|Overall Study|Adverse Event|3|||
161071878|NCT01681992|581652917|FG001|Overall Study|Adverse Event|2|||
161071879|NCT01681992|581652918|FG002|Overall Study|Adverse Event|3|||
161071880|NCT01681992|581652916|FG000|Overall Study|Lost to Follow-up|36|||
161071881|NCT01681992|581652917|FG001|Overall Study|Lost to Follow-up|38|||
161071882|NCT01681992|581652918|FG002|Overall Study|Lost to Follow-up|53|||
161071883|NCT01681992|581652916|FG000|Overall Study|As Per Sponsor Decision|0|||
161071884|NCT01681992|581652917|FG001|Overall Study|As Per Sponsor Decision|0|||
161071885|NCT01681992|581652918|FG002|Overall Study|As Per Sponsor Decision|1|||
161071886|NCT01681992|581652916|FG000|Overall Study|Protocol Violation|0|||
161071887|NCT01681992|581652917|FG001|Overall Study|Protocol Violation|0|||
161071888|NCT01681992|581652918|FG002|Overall Study|Protocol Violation|1|||
161285212|NCT03989102|582423382|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
161285213|NCT03989102|582423383|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
161285214|NCT03989102|582423381|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161285215|NCT03989102|582423382|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161285216|NCT03989102|582423383|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
161285217|NCT03989102|582423381|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
161285218|NCT03989102|582423382|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
161285219|NCT03989102|582423383|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
161156848|NCT05122650|581955167|FG002|Overall Study|Non-compliance with study intervention|0|||
161156849|NCT05122650|581955168|FG003|Overall Study|Non-compliance with study intervention|2|||
161285220|NCT03989102|582423381|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
161285221|NCT03989102|582423382|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
161285222|NCT03989102|582423383|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
161285223|NCT03989102|582423381|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
161285224|NCT03989102|582423382|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
161285225|NCT03989102|582423383|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
161285226|NCT03989102|582423381|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
161285227|NCT03989102|582423382|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
161285228|NCT03989102|582423383|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
161285229|NCT04054765|582423384|FG000|Baseline|Withdrawal by Subject|5|||
161285230|NCT04054765|582423385|FG001|Baseline|Withdrawal by Subject|3|||
161285231|NCT04054765|582423384|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
161285232|NCT04054765|582423385|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
161285233|NCT04054765|582423384|FG000|3-month Follow up|Withdrawal by Subject|0|||
161285234|NCT04054765|582423385|FG001|3-month Follow up|Withdrawal by Subject|3|||
161285235|NCT04054765|582423384|FG000|6-month Follow up|Lost to Follow-up|32|||
161285236|NCT04054765|582423385|FG001|6-month Follow up|Lost to Follow-up|32|||
161285237|NCT01290068|582423386|FG000|Overall Study|Adverse Event|1|||
161285238|NCT01290068|582423387|FG001|Overall Study|Adverse Event|3|||
161285239|NCT01290068|582423386|FG000|Overall Study|Lost to Follow-up|3|||
161285240|NCT01290068|582423387|FG001|Overall Study|Lost to Follow-up|0|||
161285241|NCT01290068|582423386|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
161285242|NCT01290068|582423387|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
161285243|NCT01290068|582423386|FG000|Overall Study|Other|3|||
161285244|NCT01290068|582423387|FG001|Overall Study|Other|1|||
161285245|NCT02719184|582423390|FG000|Overall Study|Other than listed|1|||
161285246|NCT02719184|582423391|FG001|Overall Study|Other than listed|12|||
161285247|NCT02719184|582423392|FG002|Overall Study|Other than listed|13|||
161285248|NCT02719184|582423393|FG003|Overall Study|Other than listed|22|||
161285249|NCT02719184|582423394|FG004|Overall Study|Other than listed|9|||
161285250|NCT02719184|582423390|FG000|Overall Study|Withdrawal by Subject|5|||
161285251|NCT02719184|582423391|FG001|Overall Study|Withdrawal by Subject|3|||
161285252|NCT02719184|582423392|FG002|Overall Study|Withdrawal by Subject|6|||
161285253|NCT02719184|582423393|FG003|Overall Study|Withdrawal by Subject|6|||
161285254|NCT02719184|582423394|FG004|Overall Study|Withdrawal by Subject|0|||
161285255|NCT02719184|582423390|FG000|Overall Study|Lost to Follow-up|0|||
161285256|NCT02719184|582423391|FG001|Overall Study|Lost to Follow-up|4|||
161285257|NCT02719184|582423392|FG002|Overall Study|Lost to Follow-up|1|||
161285258|NCT02719184|582423393|FG003|Overall Study|Lost to Follow-up|3|||
161285259|NCT02719184|582423394|FG004|Overall Study|Lost to Follow-up|0|||
161285260|NCT02719184|582423390|FG000|Overall Study|Protocol Violation|0|||
161156850|NCT05122650|581955165|FG000|Overall Study|Protocol Violation|0|||
161156851|NCT05122650|581955166|FG001|Overall Study|Protocol Violation|1|||
161156852|NCT05122650|581955167|FG002|Overall Study|Protocol Violation|0|||
161156853|NCT05122650|581955168|FG003|Overall Study|Protocol Violation|1|||
161156854|NCT05122650|581955165|FG000|Overall Study|Randomized by mistake|0|||
161156855|NCT05122650|581955166|FG001|Overall Study|Randomized by mistake|0|||
161156856|NCT05122650|581955167|FG002|Overall Study|Randomized by mistake|3|||
161156857|NCT05122650|581955168|FG003|Overall Study|Randomized by mistake|2|||
161156858|NCT05122650|581955165|FG000|Overall Study|Sponsor request|0|||
161156859|NCT05122650|581955166|FG001|Overall Study|Sponsor request|1|||
161156860|NCT05122650|581955167|FG002|Overall Study|Sponsor request|1|||
161156861|NCT05122650|581955168|FG003|Overall Study|Sponsor request|2|||
161156862|NCT05122650|581955165|FG000|Overall Study|Withdrawal by Subject|3|||
161156863|NCT05122650|581955166|FG001|Overall Study|Withdrawal by Subject|7|||
161285261|NCT02719184|582423391|FG001|Overall Study|Protocol Violation|3|||
161285262|NCT02719184|582423392|FG002|Overall Study|Protocol Violation|0|||
161285263|NCT02719184|582423393|FG003|Overall Study|Protocol Violation|2|||
161156864|NCT05122650|581955167|FG002|Overall Study|Withdrawal by Subject|4|||
161156865|NCT05122650|581955168|FG003|Overall Study|Withdrawal by Subject|8|||
161156866|NCT05122650|581955165|FG000|Overall Study|Other|5|||
161285264|NCT02719184|582423394|FG004|Overall Study|Protocol Violation|0|||
161285265|NCT02719184|582423390|FG000|Overall Study|Adverse Event|0|||
161285266|NCT02719184|582423391|FG001|Overall Study|Adverse Event|0|||
161285267|NCT02719184|582423392|FG002|Overall Study|Adverse Event|0|||
161285268|NCT02719184|582423393|FG003|Overall Study|Adverse Event|3|||
161156867|NCT05122650|581955166|FG001|Overall Study|Other|0|||
161156868|NCT05122650|581955167|FG002|Overall Study|Other|0|||
161156869|NCT05122650|581955168|FG003|Overall Study|Other|0|||
161156870|NCT05372575|581955175|FG000|Overall Study|Protocol Violation|7|||
161156871|NCT05372575|581955176|FG001|Overall Study|Protocol Violation|16|||
161156872|NCT03345836|581955177|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
161285269|NCT02719184|582423394|FG004|Overall Study|Adverse Event|0|||
161285270|NCT04428034|582423397|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
161071889|NCT01681992|581652916|FG000|Overall Study|Withdrawal by Subject|27|||
161071890|NCT01681992|581652917|FG001|Overall Study|Withdrawal by Subject|30|||
161071891|NCT01681992|581652918|FG002|Overall Study|Withdrawal by Subject|25|||
161071892|NCT04042077|581652919|FG000|Overall Study|Adverse Event|0|||
161071893|NCT04042077|581652920|FG001|Overall Study|Adverse Event|1|||
161071894|NCT04042077|581652919|FG000|Overall Study|Death|2|||
161071895|NCT04042077|581652920|FG001|Overall Study|Death|1|||
161071896|NCT04042077|581652919|FG000|Overall Study|Physician Decision|2|||
161071897|NCT04042077|581652920|FG001|Overall Study|Physician Decision|0|||
161071898|NCT04042077|581652919|FG000|Overall Study|Withdrawal by Subject|3|||
161071899|NCT04042077|581652920|FG001|Overall Study|Withdrawal by Subject|2|||
161071900|NCT04042077|581652919|FG000|Overall Study|Lack of Efficacy|0|||
161071901|NCT04042077|581652920|FG001|Overall Study|Lack of Efficacy|1|||
161071902|NCT01080300|581652921|FG000|Overall Study|Adverse Event|49|||
161071903|NCT01080300|581652922|FG001|Overall Study|Adverse Event|35|||
161071904|NCT01080300|581652921|FG000|Overall Study|Lack of Efficacy|12|||
161071905|NCT01080300|581652922|FG001|Overall Study|Lack of Efficacy|15|||
161071906|NCT01080300|581652921|FG000|Overall Study|Protocol Violation|7|||
161071907|NCT01080300|581652922|FG001|Overall Study|Protocol Violation|13|||
161071908|NCT01080300|581652921|FG000|Overall Study|Lost to Follow-up|10|||
161071909|NCT01080300|581652922|FG001|Overall Study|Lost to Follow-up|6|||
161071910|NCT01080300|581652921|FG000|Overall Study|Death|0|||
161071911|NCT01080300|581652922|FG001|Overall Study|Death|1|||
161071912|NCT01080300|581652921|FG000|Overall Study|Withdrawal by Subject|12|||
161071913|NCT01080300|581652922|FG001|Overall Study|Withdrawal by Subject|28|||
161071914|NCT01080300|581652921|FG000|Overall Study|Reasons not specified|4|||
161071915|NCT01080300|581652922|FG001|Overall Study|Reasons not specified|6|||
161071916|NCT02269423|581652928|FG000|Overall Study|Discontinued due to change in residence|0|||
161071917|NCT02269423|581652929|FG001|Overall Study|Discontinued due to change in residence|1|||
161071918|NCT02269423|581652930|FG002|Overall Study|Discontinued due to change in residence|0|||
161071919|NCT02269423|581652931|FG003|Overall Study|Discontinued due to change in residence|1|||
161071920|NCT01305239|581652932|FG000|Overall Study|Adverse Event|22|||
161071921|NCT01305239|581652932|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
161071922|NCT01754753|581652934|FG000|Overall Study|Study close|43|||
161071923|NCT01754753|581652935|FG001|Overall Study|Study close|44|||
161071924|NCT01754753|581652934|FG000|Overall Study|Lost to Follow-up|9|||
161071925|NCT01754753|581652935|FG001|Overall Study|Lost to Follow-up|5|||
161071926|NCT03229486|581652936|FG000|Overall Study|Protocol Violation|0|||
161071927|NCT03229486|581652937|FG001|Overall Study|Protocol Violation|1|||
161071928|NCT00856245|581652938|FG000|Overall Study|Was not transplanted|5|||
161071929|NCT04547023|581652943|FG000|Overall Study|Did Not Receive Intervention|3|||
161071930|NCT04547023|581652944|FG001|Overall Study|Did Not Receive Intervention|2|||
161071931|NCT04547023|581652943|FG000|Overall Study|Lost to Follow-up|1|||
161071932|NCT04547023|581652944|FG001|Overall Study|Lost to Follow-up|1|||
161071933|NCT01782690|581652947|FG000|Overall Study|Not reported|7|||
161071934|NCT01782690|581652947|FG000|Overall Study|Toxicity of gemcitabine|1|||
161071935|NCT01782690|581652947|FG000|Overall Study|Toxicity of erlotinib|1|||
161071936|NCT01782690|581652947|FG000|Overall Study|Lost to Follow-up|31|||
161071937|NCT01782690|581652947|FG000|Overall Study|Withdrawal of informed consent|2|||
161071938|NCT01782690|581652947|FG000|Overall Study|Absent rash|9|||
161071939|NCT01782690|581652947|FG000|Overall Study|Physician Decision|13|||
161071940|NCT01782690|581652947|FG000|Overall Study|Patient's wish|21|||
161071941|NCT01782690|581652947|FG000|Overall Study|Tumor progression|74|||
161071942|NCT01782690|581652947|FG000|Overall Study|Death|133|||
161071943|NCT01782690|581652947|FG000|Overall Study|Study completion unknown|7|||
161071944|NCT01637077|581652952|FG000|Overall Study|Cancel|1|||
161071945|NCT01637077|581652953|FG001|Overall Study|Cancel|1|||
161071946|NCT01637077|581652952|FG000|Overall Study|Withdrawal by Subject|1|||
161071947|NCT01637077|581652953|FG001|Overall Study|Withdrawal by Subject|0|||
161071948|NCT01637077|581652952|FG000|Overall Study|No cycle 1 questionnaire data|2|||
161071949|NCT01637077|581652953|FG001|Overall Study|No cycle 1 questionnaire data|0|||
161071950|NCT02638103|581652955|FG000|Overall Study|Adverse Event|13|||
161071951|NCT02638103|581652956|FG001|Overall Study|Adverse Event|12|||
161071952|NCT02638103|581652957|FG002|Overall Study|Adverse Event|19|||
161071953|NCT02638103|581652958|FG003|Overall Study|Adverse Event|12|||
161071954|NCT02638103|581652955|FG000|Overall Study|Withdrawal by Subject|43|||
161071955|NCT02638103|581652956|FG001|Overall Study|Withdrawal by Subject|53|||
161071956|NCT02638103|581652957|FG002|Overall Study|Withdrawal by Subject|30|||
161071957|NCT02638103|581652958|FG003|Overall Study|Withdrawal by Subject|61|||
161285271|NCT02556801|582423400|FG000|Overall Study|Lost to Follow-up|1|||
161285272|NCT02556801|582423401|FG001|Overall Study|Lost to Follow-up|0|||
161285273|NCT02556801|582423402|FG002|Overall Study|Lost to Follow-up|2|||
161285274|NCT02556801|582423403|FG003|Overall Study|Lost to Follow-up|0|||
161071958|NCT02638103|581652955|FG000|Overall Study|Protocol Violation|1|||
161071959|NCT02638103|581652956|FG001|Overall Study|Protocol Violation|2|||
161071960|NCT02638103|581652957|FG002|Overall Study|Protocol Violation|1|||
161071961|NCT02638103|581652958|FG003|Overall Study|Protocol Violation|4|||
161071962|NCT02638103|581652955|FG000|Overall Study|Pregnancy|2|||
161345611|NCT00716417|582650880|FG001|Overall Study|Progressive disease|5|||
161071963|NCT02638103|581652956|FG001|Overall Study|Pregnancy|3|||
161071964|NCT02638103|581652957|FG002|Overall Study|Pregnancy|0|||
161071965|NCT02638103|581652958|FG003|Overall Study|Pregnancy|1|||
161071966|NCT02638103|581652955|FG000|Overall Study|Non-compliance to Study Procedures|2|||
161071967|NCT02638103|581652956|FG001|Overall Study|Non-compliance to Study Procedures|1|||
161071968|NCT02638103|581652957|FG002|Overall Study|Non-compliance to Study Procedures|1|||
161071969|NCT02638103|581652958|FG003|Overall Study|Non-compliance to Study Procedures|1|||
161285275|NCT02556801|582423400|FG000|Overall Study|Withdrawal by Subject|1|||
161285276|NCT02556801|582423401|FG001|Overall Study|Withdrawal by Subject|1|||
161285277|NCT02556801|582423402|FG002|Overall Study|Withdrawal by Subject|1|||
161285278|NCT02556801|582423403|FG003|Overall Study|Withdrawal by Subject|0|||
161285279|NCT02556801|582423400|FG000|Overall Study|Protocol Violation|0|||
161285280|NCT02556801|582423401|FG001|Overall Study|Protocol Violation|3|||
161285281|NCT02556801|582423402|FG002|Overall Study|Protocol Violation|1|||
161285282|NCT02556801|582423403|FG003|Overall Study|Protocol Violation|1|||
161285283|NCT02556801|582423400|FG000|Overall Study|Adverse Event|0|||
161285284|NCT02556801|582423401|FG001|Overall Study|Adverse Event|2|||
161285285|NCT02556801|582423402|FG002|Overall Study|Adverse Event|0|||
161285286|NCT02556801|582423403|FG003|Overall Study|Adverse Event|3|||
161285287|NCT02556801|582423400|FG000|Overall Study|Pregnancy|0|||
161285288|NCT02556801|582423401|FG001|Overall Study|Pregnancy|1|||
161285289|NCT02556801|582423402|FG002|Overall Study|Pregnancy|0|||
161285290|NCT02556801|582423403|FG003|Overall Study|Pregnancy|0|||
161285291|NCT02556801|582423400|FG000|Overall Study|Personal reasons patient|0|||
161285292|NCT02556801|582423401|FG001|Overall Study|Personal reasons patient|0|||
161285293|NCT02556801|582423402|FG002|Overall Study|Personal reasons patient|0|||
161285294|NCT02556801|582423403|FG003|Overall Study|Personal reasons patient|1|||
161285295|NCT01431079|582423413|FG000|Overall Study|Lost to Follow-up|35|||
161285296|NCT01431079|582423414|FG001|Overall Study|Lost to Follow-up|39|||
161285297|NCT04747470|582423415|FG000|Overall Study|Death|0|||
161285298|NCT04747470|582423416|FG001|Overall Study|Death|3|||
161285299|NCT04747470|582423417|FG002|Overall Study|Death|2|||
161285300|NCT04747470|582423418|FG003|Overall Study|Death|2|||
161285301|NCT04747470|582423419|FG004|Overall Study|Death|2|||
161285302|NCT04747470|582423420|FG005|Overall Study|Death|0|||
161285303|NCT04747470|582423421|FG006|Overall Study|Death|0|||
161285304|NCT04747470|582423422|FG007|Overall Study|Death|0|||
161285305|NCT04747470|582423423|FG008|Overall Study|Death|0|||
161285306|NCT04747470|582423424|FG009|Overall Study|Death|0|||
161285307|NCT04747470|582423425|FG010|Overall Study|Death|0|||
161285308|NCT04747470|582423415|FG000|Overall Study|Withdrew Consent|0|||
161285309|NCT04747470|582423416|FG001|Overall Study|Withdrew Consent|0|||
161285310|NCT04747470|582423417|FG002|Overall Study|Withdrew Consent|0|||
161285311|NCT04747470|582423418|FG003|Overall Study|Withdrew Consent|1|||
161285312|NCT04747470|582423419|FG004|Overall Study|Withdrew Consent|0|||
161285313|NCT04747470|582423420|FG005|Overall Study|Withdrew Consent|0|||
161285314|NCT04747470|582423421|FG006|Overall Study|Withdrew Consent|0|||
161285315|NCT04747470|582423422|FG007|Overall Study|Withdrew Consent|0|||
161285316|NCT04747470|582423423|FG008|Overall Study|Withdrew Consent|0|||
161285317|NCT04747470|582423424|FG009|Overall Study|Withdrew Consent|0|||
161285318|NCT04747470|582423425|FG010|Overall Study|Withdrew Consent|0|||
161285319|NCT04747470|582423415|FG000|Overall Study|Study Terminated by Sponsor|0|||
161285320|NCT04747470|582423416|FG001|Overall Study|Study Terminated by Sponsor|0|||
161285321|NCT04747470|582423417|FG002|Overall Study|Study Terminated by Sponsor|1|||
161285322|NCT04747470|582423418|FG003|Overall Study|Study Terminated by Sponsor|0|||
161285323|NCT04747470|582423419|FG004|Overall Study|Study Terminated by Sponsor|2|||
161285324|NCT04747470|582423420|FG005|Overall Study|Study Terminated by Sponsor|0|||
161285325|NCT04747470|582423421|FG006|Overall Study|Study Terminated by Sponsor|0|||
161285326|NCT04747470|582423422|FG007|Overall Study|Study Terminated by Sponsor|0|||
161285327|NCT04747470|582423423|FG008|Overall Study|Study Terminated by Sponsor|0|||
161285328|NCT04747470|582423424|FG009|Overall Study|Study Terminated by Sponsor|0|||
161285329|NCT04747470|582423425|FG010|Overall Study|Study Terminated by Sponsor|0|||
161285330|NCT02790437|582423426|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
161285331|NCT02790437|582423427|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
161285332|NCT02790437|582423426|FG000|Overall Study|Adverse Event|1|||
161285333|NCT02790437|582423427|FG001|Overall Study|Adverse Event|0|||
161285334|NCT02790437|582423426|FG000|Overall Study|Withdrawal by Subject|1|||
161285335|NCT02790437|582423427|FG001|Overall Study|Withdrawal by Subject|0|||
161285336|NCT01202175|582423428|FG000|Overall Study|Lost to Follow-up|2|||
161285337|NCT01202175|582423428|FG000|Overall Study|Withdrawal by Subject|1|||
161156873|NCT03345836|581955178|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
161285338|NCT01202175|582423428|FG000|Overall Study|Adverse Event|2|||
161071970|NCT02638103|581652955|FG000|Overall Study|Lost to Follow-up|26|||
161071971|NCT02638103|581652956|FG001|Overall Study|Lost to Follow-up|33|||
161285339|NCT01626690|582423431|FG000|Overall Study|Protocol Violation|1|||
161285340|NCT01626690|582423432|FG001|Overall Study|Protocol Violation|0|||
161285341|NCT01626690|582423431|FG000|Overall Study|Adverse Event|1|||
161285342|NCT01626690|582423432|FG001|Overall Study|Adverse Event|0|||
161285343|NCT01125189|582423433|FG000|Treatment Period|Lack of Efficacy|15|||
161285344|NCT01125189|582423434|FG001|Treatment Period|Lack of Efficacy|18|||
161285345|NCT01125189|582423435|FG002|Treatment Period|Lack of Efficacy|25|||
161285346|NCT01125189|582423433|FG000|Treatment Period|Adverse Event|7|||
161285347|NCT01125189|582423434|FG001|Treatment Period|Adverse Event|8|||
161285348|NCT01125189|582423435|FG002|Treatment Period|Adverse Event|8|||
161285349|NCT01125189|582423433|FG000|Treatment Period|Withdrawal by Subject|3|||
161285350|NCT01125189|582423434|FG001|Treatment Period|Withdrawal by Subject|1|||
161285351|NCT01125189|582423435|FG002|Treatment Period|Withdrawal by Subject|1|||
161285352|NCT01125189|582423433|FG000|Treatment Period|Death|1|||
161285353|NCT01125189|582423434|FG001|Treatment Period|Death|0|||
161285354|NCT01125189|582423435|FG002|Treatment Period|Death|0|||
161285355|NCT01125189|582423433|FG000|Treatment Period|Lost to Follow-up|1|||
161285356|NCT01125189|582423434|FG001|Treatment Period|Lost to Follow-up|2|||
161285357|NCT01125189|582423435|FG002|Treatment Period|Lost to Follow-up|1|||
161285358|NCT01125189|582423433|FG000|Treatment Period|Poor compliance/noncompliance|0|||
161285359|NCT01125189|582423434|FG001|Treatment Period|Poor compliance/noncompliance|1|||
161285360|NCT01125189|582423435|FG002|Treatment Period|Poor compliance/noncompliance|0|||
161285361|NCT01125189|582423433|FG000|Treatment Period|Participants requested to discontinue|1|||
161285362|NCT01125189|582423434|FG001|Treatment Period|Participants requested to discontinue|3|||
161285363|NCT01125189|582423435|FG002|Treatment Period|Participants requested to discontinue|4|||
161285364|NCT01125189|582423433|FG000|Treatment Period|Other reasons|1|||
161285365|NCT01125189|582423434|FG001|Treatment Period|Other reasons|1|||
161285366|NCT01125189|582423435|FG002|Treatment Period|Other reasons|0|||
161285367|NCT01125189|582423433|FG000|Treatment Period|Completed 24 week treatment period only|2|||
161285368|NCT01125189|582423434|FG001|Treatment Period|Completed 24 week treatment period only|1|||
161285369|NCT01125189|582423435|FG002|Treatment Period|Completed 24 week treatment period only|2|||
161285370|NCT01125189|582423433|FG000|Follow up Period|Withdrawal by Subject|3|||
161285371|NCT01125189|582423434|FG001|Follow up Period|Withdrawal by Subject|2|||
161285372|NCT01125189|582423435|FG002|Follow up Period|Withdrawal by Subject|5|||
161285373|NCT01125189|582423433|FG000|Follow up Period|Death|1|||
161285374|NCT01125189|582423434|FG001|Follow up Period|Death|0|||
161285375|NCT01125189|582423435|FG002|Follow up Period|Death|0|||
161285376|NCT01125189|582423433|FG000|Follow up Period|Lost to Follow-up|12|||
161285377|NCT01125189|582423434|FG001|Follow up Period|Lost to Follow-up|9|||
161285378|NCT01125189|582423435|FG002|Follow up Period|Lost to Follow-up|6|||
161285379|NCT01125189|582423433|FG000|Follow up Period|Other reasons|4|||
161285380|NCT01125189|582423434|FG001|Follow up Period|Other reasons|4|||
161285381|NCT01125189|582423435|FG002|Follow up Period|Other reasons|5|||
161285382|NCT00114140|582423436|FG000|Overall Study|Protocol Violation|7|||
161285383|NCT00110396|582423441|FG000|Overall Study|Adverse Event|15|||
161285384|NCT00110396|582423441|FG000|Overall Study|Lost to Follow-up|1|||
161285385|NCT00110396|582423441|FG000|Overall Study|Administration of plasmapheresis|1|||
161285386|NCT00110396|582423441|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
161285387|NCT00110396|582423441|FG000|Overall Study|Lack of Efficacy|1|||
161285388|NCT00110396|582423441|FG000|Overall Study|Decided not to continue treatment|1|||
161285389|NCT00110396|582423441|FG000|Overall Study|Patient non-compliance|1|||
161285390|NCT00110396|582423441|FG000|Overall Study|Patient refused to continue|1|||
161285391|NCT00110396|582423441|FG000|Overall Study|Patient refused to participate|1|||
161285392|NCT00110396|582423441|FG000|Overall Study|Patient will|1|||
161285393|NCT00110396|582423441|FG000|Overall Study|Patient's decision|1|||
161285394|NCT00110396|582423441|FG000|Overall Study|Participation in MS vaccine study|1|||
161285395|NCT00110396|582423441|FG000|Overall Study|Pregnancy|1|||
161285396|NCT00110396|582423441|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
161285397|NCT00110396|582423441|FG000|Overall Study|Protocol Violation|2|||
161285398|NCT00110396|582423441|FG000|Overall Study|Patient refused to come back|1|||
161285399|NCT00110396|582423441|FG000|Overall Study|The patient has refused|2|||
161285400|NCT00110396|582423441|FG000|Overall Study|The patient has refused to visit site|1|||
161285401|NCT00110396|582423441|FG000|Overall Study|Patient is to be administered copaxone|1|||
161285402|NCT02414958|582423442|FG000|Overall Study|Adverse Event|6|||
161285403|NCT02414958|582423443|FG001|Overall Study|Adverse Event|6|||
161285404|NCT02414958|582423444|FG002|Overall Study|Adverse Event|3|||
161285405|NCT02414958|582423442|FG000|Overall Study|Protocol Violation|10|||
161285406|NCT02414958|582423443|FG001|Overall Study|Protocol Violation|3|||
161285407|NCT02414958|582423444|FG002|Overall Study|Protocol Violation|1|||
161285408|NCT02414958|582423442|FG000|Overall Study|Lost to Follow-up|7|||
161285409|NCT02414958|582423443|FG001|Overall Study|Lost to Follow-up|4|||
161285410|NCT02414958|582423444|FG002|Overall Study|Lost to Follow-up|0|||
161285411|NCT02414958|582423442|FG000|Overall Study|Withdrawal by Subject|5|||
161285412|NCT02414958|582423443|FG001|Overall Study|Withdrawal by Subject|3|||
161285413|NCT02414958|582423444|FG002|Overall Study|Withdrawal by Subject|5|||
161285414|NCT02414958|582423442|FG000|Overall Study|Other than specified|4|||
161285415|NCT02414958|582423443|FG001|Overall Study|Other than specified|4|||
161285416|NCT02414958|582423444|FG002|Overall Study|Other than specified|5|||
161285417|NCT01269918|582423445|FG000|Overall Study|Did not receive study drug|0|||
161285418|NCT01269918|582423446|FG001|Overall Study|Did not receive study drug|3|||
161285419|NCT04542057|582423450|FG000|Overall Study|Death|3|||
161285420|NCT04542057|582423451|FG001|Overall Study|Death|1|||
161345612|NCT00716417|582650881|FG002|Overall Study|Progressive disease|3|||
161285421|NCT04542057|582423450|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
161285422|NCT04542057|582423451|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
161285423|NCT04542057|582423450|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
161285424|NCT04542057|582423451|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
161285425|NCT04542057|582423450|FG000|Overall Study|Adverse Event|15|||
161285426|NCT04542057|582423451|FG001|Overall Study|Adverse Event|6|||
161285427|NCT04542057|582423450|FG000|Overall Study|COVID-19 adverse event|6|||
161285428|NCT04542057|582423451|FG001|Overall Study|COVID-19 adverse event|4|||
161285429|NCT04542057|582423450|FG000|Overall Study|Lack of Efficacy|2|||
161285430|NCT04542057|582423451|FG001|Overall Study|Lack of Efficacy|5|||
161285431|NCT04542057|582423450|FG000|Overall Study|Study terminated by sponsor|1|||
161285432|NCT04542057|582423451|FG001|Overall Study|Study terminated by sponsor|0|||
161285433|NCT04542057|582423450|FG000|Overall Study|Investigator discretion|2|||
161285434|NCT04542057|582423451|FG001|Overall Study|Investigator discretion|1|||
161285435|NCT04542057|582423450|FG000|Overall Study|Withdrawal by Subject|52|||
161285436|NCT04542057|582423451|FG001|Overall Study|Withdrawal by Subject|30|||
161285437|NCT04542057|582423450|FG000|Overall Study|Lost to Follow-up|8|||
161285438|NCT04542057|582423451|FG001|Overall Study|Lost to Follow-up|11|||
161285439|NCT04542057|582423450|FG000|Overall Study|Other|2|||
161285440|NCT04542057|582423451|FG001|Overall Study|Other|2|||
161285441|NCT00838526|582423452|FG000|Overall Study|Adverse Event|3|||
161285442|NCT00838526|582423453|FG001|Overall Study|Adverse Event|12|||
161285443|NCT00838526|582423452|FG000|Overall Study|Lost to Follow-up|4|||
161285444|NCT00838526|582423453|FG001|Overall Study|Lost to Follow-up|12|||
161285445|NCT00838526|582423452|FG000|Overall Study|Withdrawal by Subject|4|||
161285446|NCT00838526|582423453|FG001|Overall Study|Withdrawal by Subject|5|||
161285447|NCT00838526|582423452|FG000|Overall Study|Lack of Efficacy|2|||
161285448|NCT00838526|582423453|FG001|Overall Study|Lack of Efficacy|3|||
161285449|NCT00838526|582423452|FG000|Overall Study|Other|11|||
161285450|NCT00838526|582423453|FG001|Overall Study|Other|7|||
161285451|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
161285452|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
161285453|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
161285454|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
161285455|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
161285456|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
161285457|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
161285458|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
161285459|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
161285460|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
161285461|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
161285462|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
161285463|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
161285464|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
161285465|NCT04338022|582423454|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
161285466|NCT04338022|582423455|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
161285467|NCT04338022|582423454|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
161285468|NCT04338022|582423455|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
161285469|NCT04338022|582423454|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
161285470|NCT04338022|582423455|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
161285471|NCT04338022|582423454|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
161285472|NCT04338022|582423455|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
161285473|NCT04338022|582423454|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
161285474|NCT04338022|582423455|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
161285475|NCT04338022|582423454|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
161285476|NCT04338022|582423455|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
161285477|NCT04338022|582423454|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
161285478|NCT04338022|582423455|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
161285479|NCT02273388|582423457|FG000|Overall Study|Adverse Event|0|||
161285480|NCT02273388|582423458|FG001|Overall Study|Adverse Event|0|||
161285481|NCT02273388|582423459|FG002|Overall Study|Adverse Event|0|||
161285482|NCT02273388|582423460|FG003|Overall Study|Adverse Event|0|||
161285483|NCT02273388|582423461|FG004|Overall Study|Adverse Event|0|||
161285484|NCT02273388|582423462|FG005|Overall Study|Adverse Event|0|||
161285485|NCT02273388|582423463|FG006|Overall Study|Adverse Event|1|||
161285486|NCT02273388|582423464|FG007|Overall Study|Adverse Event|2|||
161285487|NCT02273388|582423465|FG008|Overall Study|Adverse Event|0|||
161285488|NCT02273388|582423466|FG009|Overall Study|Adverse Event|0|||
161285489|NCT02273388|582423467|FG010|Overall Study|Adverse Event|0|||
161285490|NCT02273388|582423468|FG011|Overall Study|Adverse Event|0|||
161285491|NCT02273388|582423457|FG000|Overall Study|Adverse Event study disease worse|4|||
161071972|NCT02638103|581652957|FG002|Overall Study|Lost to Follow-up|20|||
161071973|NCT02638103|581652958|FG003|Overall Study|Lost to Follow-up|37|||
161156874|NCT03345836|581955179|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
161156875|NCT03345836|581955180|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161156876|NCT03345836|581955181|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161156877|NCT03345836|581955182|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
161156878|NCT03345836|581955177|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
161156879|NCT03345836|581955178|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
161156880|NCT03345836|581955179|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
161156881|NCT03345836|581955180|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161156882|NCT03345836|581955181|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161156883|NCT03345836|581955182|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
161156884|NCT03345836|581955177|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161156885|NCT03345836|581955178|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
161156886|NCT03345836|581955179|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161156887|NCT03345836|581955180|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161156888|NCT03345836|581955181|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161156889|NCT03345836|581955182|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
161156890|NCT03345836|581955177|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
161156891|NCT03345836|581955178|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
161156892|NCT03345836|581955179|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161156893|NCT03345836|581955180|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161156894|NCT03345836|581955181|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161156895|NCT03345836|581955182|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
161156896|NCT03345836|581955177|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
161156897|NCT03345836|581955178|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
161156898|NCT03345836|581955179|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
161156899|NCT03345836|581955180|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161156900|NCT03345836|581955181|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161156901|NCT03345836|581955182|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
161156902|NCT03345836|581955177|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161156903|NCT03345836|581955178|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161156904|NCT03345836|581955179|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161156905|NCT03345836|581955180|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
161156906|NCT03345836|581955181|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
161156907|NCT03345836|581955182|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
161156908|NCT03345836|581955177|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161156909|NCT03345836|581955178|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161156910|NCT03345836|581955179|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161156911|NCT03345836|581955180|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
161156912|NCT03345836|581955181|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
161156913|NCT03345836|581955182|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
161156914|NCT03345836|581955177|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161156915|NCT03345836|581955178|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161156916|NCT03345836|581955179|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161156917|NCT03345836|581955180|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161156918|NCT03345836|581955181|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
161156919|NCT03345836|581955182|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
161156920|NCT03345836|581955177|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161156921|NCT03345836|581955178|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161156922|NCT03345836|581955179|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
161156923|NCT03345836|581955180|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
161156924|NCT03345836|581955181|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
161156925|NCT03345836|581955182|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
161156926|NCT03345836|581955177|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161156927|NCT03345836|581955178|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161156928|NCT03345836|581955179|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161156929|NCT03345836|581955180|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161156930|NCT03345836|581955181|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
161285492|NCT02273388|582423458|FG001|Overall Study|Adverse Event study disease worse|3|||
161285493|NCT02273388|582423459|FG002|Overall Study|Adverse Event study disease worse|3|||
161285494|NCT02273388|582423460|FG003|Overall Study|Adverse Event study disease worse|2|||
161285495|NCT02273388|582423461|FG004|Overall Study|Adverse Event study disease worse|4|||
161285496|NCT02273388|582423462|FG005|Overall Study|Adverse Event study disease worse|3|||
161285497|NCT02273388|582423463|FG006|Overall Study|Adverse Event study disease worse|14|||
161345613|NCT00716417|582650882|FG003|Overall Study|Progressive disease|8|||
161285498|NCT02273388|582423464|FG007|Overall Study|Adverse Event study disease worse|6|||
161285499|NCT02273388|582423465|FG008|Overall Study|Adverse Event study disease worse|6|||
161285500|NCT02273388|582423466|FG009|Overall Study|Adverse Event study disease worse|5|||
161285501|NCT02273388|582423467|FG010|Overall Study|Adverse Event study disease worse|10|||
161285502|NCT02273388|582423468|FG011|Overall Study|Adverse Event study disease worse|1|||
161285503|NCT02273388|582423457|FG000|Overall Study|Sponsor decision|0|||
161285504|NCT02273388|582423458|FG001|Overall Study|Sponsor decision|0|||
161285505|NCT02273388|582423459|FG002|Overall Study|Sponsor decision|0|||
161285506|NCT02273388|582423460|FG003|Overall Study|Sponsor decision|0|||
161285507|NCT02273388|582423461|FG004|Overall Study|Sponsor decision|0|||
161071974|NCT02638103|581652955|FG000|Overall Study|Lack of Efficacy|14|||
161071975|NCT02638103|581652956|FG001|Overall Study|Lack of Efficacy|10|||
161071976|NCT02638103|581652957|FG002|Overall Study|Lack of Efficacy|12|||
161071977|NCT02638103|581652958|FG003|Overall Study|Lack of Efficacy|22|||
161071978|NCT02638103|581652955|FG000|Overall Study|Other than specified|5|||
161071979|NCT02638103|581652956|FG001|Overall Study|Other than specified|4|||
161071980|NCT02638103|581652957|FG002|Overall Study|Other than specified|2|||
161071981|NCT02638103|581652958|FG003|Overall Study|Other than specified|4|||
161071982|NCT00838929|581652961|FG000|Overall Study|Protocol Violation|0|||
161071983|NCT00838929|581652962|FG001|Overall Study|Protocol Violation|1|||
161071984|NCT00838929|581652963|FG002|Overall Study|Protocol Violation|0|||
161071985|NCT00838929|581652961|FG000|Overall Study|Disease progression|0|||
161071986|NCT00838929|581652962|FG001|Overall Study|Disease progression|2|||
161071987|NCT00838929|581652963|FG002|Overall Study|Disease progression|1|||
161071988|NCT00699842|581652967|FG000|Overall Study|Death|0|||
161071989|NCT00699842|581652968|FG001|Overall Study|Death|1|||
161071990|NCT00699842|581652969|FG002|Overall Study|Death|0|||
161071991|NCT03342196|581652970|FG000|Overall Study|Physician Decision|1|||
161071992|NCT02257918|581652971|FG000|Overall Study|Lost to Follow-up|4|||
161071993|NCT02257918|581652972|FG001|Overall Study|Lost to Follow-up|1|||
161071994|NCT02257918|581652973|FG002|Overall Study|Lost to Follow-up|0|||
161071995|NCT02257918|581652971|FG000|Overall Study|Withdrawal by Subject|0|||
161071996|NCT02257918|581652972|FG001|Overall Study|Withdrawal by Subject|0|||
161071997|NCT02257918|581652973|FG002|Overall Study|Withdrawal by Subject|1|||
161071998|NCT02257918|581652971|FG000|Overall Study|Pregnancy|0|||
161071999|NCT02257918|581652972|FG001|Overall Study|Pregnancy|0|||
161072000|NCT02257918|581652973|FG002|Overall Study|Pregnancy|1|||
161072001|NCT03023423|581652976|FG000|Overall Study|Death|5|||
161072002|NCT03023423|581652977|FG001|Overall Study|Death|12|||
161072003|NCT03023423|581652978|FG002|Overall Study|Death|20|||
161072004|NCT03023423|581652976|FG000|Overall Study|Other|0|||
161072005|NCT03023423|581652977|FG001|Overall Study|Other|2|||
161072006|NCT03023423|581652978|FG002|Overall Study|Other|2|||
161072007|NCT03023423|581652976|FG000|Overall Study|Ongoing|2|||
161072008|NCT03023423|581652977|FG001|Overall Study|Ongoing|32|||
161072009|NCT03023423|581652978|FG002|Overall Study|Ongoing|24|||
161072010|NCT01151423|581652979|FG000|Overall Study|Study terminated by Sponsor|9|||
161072011|NCT01151423|581652980|FG001|Overall Study|Study terminated by Sponsor|10|||
161072012|NCT01151423|581652979|FG000|Overall Study|Protocol Violation|0|||
161072013|NCT01151423|581652980|FG001|Overall Study|Protocol Violation|1|||
161072014|NCT01151423|581652979|FG000|Overall Study|Physician Decision|1|||
161072015|NCT01151423|581652980|FG001|Overall Study|Physician Decision|1|||
161072016|NCT01151423|581652979|FG000|Overall Study|Pregnancy|0|||
161072017|NCT01151423|581652980|FG001|Overall Study|Pregnancy|1|||
161072018|NCT01151423|581652979|FG000|Overall Study|Death|0|||
161072019|NCT01151423|581652980|FG001|Overall Study|Death|1|||
161072020|NCT01151423|581652979|FG000|Overall Study|Adverse Event|3|||
161072021|NCT01151423|581652980|FG001|Overall Study|Adverse Event|0|||
161072022|NCT01151423|581652979|FG000|Overall Study|Withdrawal by Subject|1|||
161072023|NCT01151423|581652980|FG001|Overall Study|Withdrawal by Subject|3|||
161072024|NCT01151423|581652979|FG000|Overall Study|Lost to Follow-up|1|||
161072025|NCT01151423|581652980|FG001|Overall Study|Lost to Follow-up|0|||
161072026|NCT01151423|581652979|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
161072027|NCT01151423|581652980|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
161072028|NCT01151423|581652979|FG000|Overall Study|Participated in other clinical trial|1|||
161072029|NCT01151423|581652980|FG001|Overall Study|Participated in other clinical trial|0|||
161072030|NCT01263054|581652981|FG000|Overall Study|Death|1|||
161072031|NCT01263054|581652982|FG001|Overall Study|Death|0|||
161072032|NCT01263054|581652981|FG000|Overall Study|Lost to Follow-up|2|||
161072033|NCT01263054|581652982|FG001|Overall Study|Lost to Follow-up|2|||
161072034|NCT01263054|581652981|FG000|Overall Study|Withdrawal by Subject|1|||
161072035|NCT01263054|581652982|FG001|Overall Study|Withdrawal by Subject|3|||
161072036|NCT01263054|581652981|FG000|Overall Study|Qualification Violation|1|||
161072037|NCT01263054|581652982|FG001|Overall Study|Qualification Violation|0|||
161072038|NCT01263054|581652981|FG000|Overall Study|Other|0|||
161072039|NCT01263054|581652982|FG001|Overall Study|Other|1|||
161072040|NCT00681668|581652983|FG000|Overall Study|Protocol Violation|1|||
161072041|NCT00681668|581652983|FG000|Overall Study|Withdrawal by Subject|1|||
161072042|NCT04277507|581652987|FG000|Overall Study|Lost to Follow-up|17|||
161072043|NCT04277507|581652987|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
161156931|NCT03345836|581955182|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
161156932|NCT03345836|581955177|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161156933|NCT03345836|581955178|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161156934|NCT03345836|581955179|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
161156935|NCT03345836|581955180|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161156936|NCT03345836|581955181|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161156937|NCT03345836|581955182|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
161156938|NCT03510663|581955183|FG000|Overall Study|Withdrawal by Subject|0|||
161156939|NCT03510663|581955184|FG001|Overall Study|Withdrawal by Subject|1|||
161156940|NCT03510663|581955185|FG002|Overall Study|Withdrawal by Subject|0|||
161156941|NCT03510663|581955186|FG003|Overall Study|Withdrawal by Subject|0|||
161156942|NCT03510663|581955187|FG004|Overall Study|Withdrawal by Subject|0|||
161156943|NCT03510663|581955188|FG005|Overall Study|Withdrawal by Subject|0|||
161156944|NCT03510663|581955189|FG006|Overall Study|Withdrawal by Subject|0|||
161156945|NCT03510663|581955190|FG007|Overall Study|Withdrawal by Subject|0|||
161156946|NCT00222729|581955193|FG000|Overall Study|Adverse Event|3|||
161156947|NCT01915849|581955196|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
161156948|NCT01915849|581955197|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161156949|NCT01915849|581955198|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161156950|NCT01915849|581955199|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
161156951|NCT01915849|581955196|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161156952|NCT01915849|581955197|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161156953|NCT01915849|581955198|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161156954|NCT01915849|581955199|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161156955|NCT01798706|581955200|FG000|Overall Study|Adverse Event|15|||
161156956|NCT01798706|581955201|FG001|Overall Study|Adverse Event|10|||
161156957|NCT01798706|581955200|FG000|Overall Study|Lack of Efficacy|0|||
161156958|NCT01798706|581955201|FG001|Overall Study|Lack of Efficacy|2|||
161156959|NCT01798706|581955200|FG000|Overall Study|Poor compliance to protocol|1|||
161156960|NCT01798706|581955201|FG001|Overall Study|Poor compliance to protocol|0|||
161156961|NCT01798706|581955200|FG000|Overall Study|Other than specified above|5|||
161156962|NCT01798706|581955201|FG001|Overall Study|Other than specified above|9|||
161156963|NCT02775864|581955202|FG000|Overall Study|Data ended end of 2010|1764|||
161156964|NCT02775864|581955203|FG001|Overall Study|Data ended end of 2010|2880|||
161156965|NCT02775864|581955204|FG002|Overall Study|Data ended end of 2010|1140|||
161156966|NCT02775864|581955205|FG003|Overall Study|Data ended end of 2010|1194|||
161156967|NCT02775864|581955202|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
161156968|NCT02775864|581955203|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
161156969|NCT02775864|581955204|FG002|Overall Study|Medicaid eligibility discontinued|720|||
161156970|NCT02775864|581955205|FG003|Overall Study|Medicaid eligibility discontinued|890|||
161156971|NCT05896761|581955206|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
161156972|NCT05896761|581955207|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
161156973|NCT05896761|581955206|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
161156974|NCT05896761|581955207|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
161156975|NCT01318083|581955208|FG000|Overall Study|Adverse Event|4|||
161156976|NCT01318083|581955209|FG001|Overall Study|Adverse Event|1|||
161156977|NCT01318083|581955210|FG002|Overall Study|Adverse Event|2|||
161156978|NCT01318083|581955208|FG000|Overall Study|Withdrawal by Subject|1|||
161156979|NCT01318083|581955209|FG001|Overall Study|Withdrawal by Subject|0|||
161156980|NCT01318083|581955210|FG002|Overall Study|Withdrawal by Subject|2|||
161156981|NCT01318083|581955208|FG000|Overall Study|Lack of Efficacy|0|||
161156982|NCT01318083|581955209|FG001|Overall Study|Lack of Efficacy|0|||
161156983|NCT01318083|581955210|FG002|Overall Study|Lack of Efficacy|1|||
161072044|NCT04277507|581652987|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
161072045|NCT04277507|581652987|FG000|Overall Study|Withdrawal by Subject|3|||
161072046|NCT04277507|581652987|FG000|Overall Study|Death due to COVID-19|1|||
161072047|NCT04277507|581652987|FG000|Overall Study|Data missing for full evaluation|5|||
161072048|NCT00583947|581652991|FG000|Cross-over Period|Adverse Event|2|||
161072049|NCT00583947|581652992|FG001|Cross-over Period|Adverse Event|0|||
161072050|NCT00583947|581652991|FG000|Cross-over Period|Withdrawal by Subject|2|||
161072051|NCT00583947|581652992|FG001|Cross-over Period|Withdrawal by Subject|0|||
161072052|NCT00583947|581652991|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
161072053|NCT00583947|581652992|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
161072054|NCT00583947|581652991|FG000|Cross-over Period|Other|1|||
161072055|NCT00583947|581652992|FG001|Cross-over Period|Other|1|||
161072056|NCT01261247|581652994|FG000|Overall Study|Ineligible|2|||
161072057|NCT01740154|581652995|FG000|Overall Study|Adverse Event|1|||
161072058|NCT04013971|581652998|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
161156984|NCT01318083|581955208|FG000|Overall Study|Treatment Complications|1|||
161156985|NCT01318083|581955209|FG001|Overall Study|Treatment Complications|0|||
161156986|NCT01318083|581955210|FG002|Overall Study|Treatment Complications|0|||
161156987|NCT01318083|581955208|FG000|Overall Study|Lack of Study Medication Compliance|0|||
161285508|NCT02273388|582423462|FG005|Overall Study|Sponsor decision|0|||
161285509|NCT02273388|582423463|FG006|Overall Study|Sponsor decision|0|||
161285510|NCT02273388|582423464|FG007|Overall Study|Sponsor decision|0|||
161285511|NCT02273388|582423465|FG008|Overall Study|Sponsor decision|0|||
161285512|NCT02273388|582423466|FG009|Overall Study|Sponsor decision|0|||
161285513|NCT02273388|582423467|FG010|Overall Study|Sponsor decision|0|||
161285514|NCT02273388|582423468|FG011|Overall Study|Sponsor decision|1|||
161285515|NCT04331808|582423471|FG000|Overall Study|Withdrew consent|1|||
161285516|NCT04331808|582423472|FG001|Overall Study|Withdrew consent|0|||
161285517|NCT04331808|582423473|FG002|Overall Study|Withdrew consent|2|||
161285518|NCT04331808|582423474|FG003|Overall Study|Withdrew consent|3|||
161285519|NCT02445963|582423475|FG000|Overall Study|Lost to Follow-up|1|||
161285520|NCT02445963|582423476|FG001|Overall Study|Lost to Follow-up|0|||
161285521|NCT02445963|582423477|FG002|Overall Study|Lost to Follow-up|0|||
161285522|NCT02445963|582423478|FG003|Overall Study|Lost to Follow-up|0|||
161285523|NCT02445963|582423475|FG000|Overall Study|Change in employment|1|||
161285524|NCT02445963|582423476|FG001|Overall Study|Change in employment|0|||
161285525|NCT02445963|582423477|FG002|Overall Study|Change in employment|0|||
161285526|NCT02445963|582423478|FG003|Overall Study|Change in employment|0|||
161285527|NCT02445963|582423475|FG000|Overall Study|Symptoms post-vaccination|0|||
161285528|NCT02445963|582423476|FG001|Overall Study|Symptoms post-vaccination|0|||
161285529|NCT02445963|582423477|FG002|Overall Study|Symptoms post-vaccination|1|||
161285530|NCT02445963|582423478|FG003|Overall Study|Symptoms post-vaccination|0|||
161285531|NCT01957176|582423482|FG000|Overall Study|Adverse Event|2|||
161285532|NCT01957176|582423483|FG001|Overall Study|Adverse Event|0|||
161285533|NCT01957176|582423482|FG000|Overall Study|Physician Decision|2|||
161285534|NCT01957176|582423483|FG001|Overall Study|Physician Decision|1|||
161285535|NCT01957176|582423482|FG000|Overall Study|Withdrawal by Subject|1|||
161285536|NCT01957176|582423483|FG001|Overall Study|Withdrawal by Subject|0|||
161285537|NCT00952731|582423484|FG000|Overall Study|Drug supply expired|1|||
161285538|NCT00952731|582423485|FG001|Overall Study|Drug supply expired|0|||
161285539|NCT01449812|582423486|FG000|Overall Study|Migrated/moved from study area|1|||
161285540|NCT01449812|582423487|FG001|Overall Study|Migrated/moved from study area|0|||
161285541|NCT01449812|582423488|FG002|Overall Study|Migrated/moved from study area|0|||
161285542|NCT01449812|582423486|FG000|Overall Study|Withdrawal by Subject|0|||
161285543|NCT01449812|582423487|FG001|Overall Study|Withdrawal by Subject|0|||
161285544|NCT01449812|582423488|FG002|Overall Study|Withdrawal by Subject|1|||
161285545|NCT01449812|582423486|FG000|Overall Study|Lost to Follow-up|1|||
161285546|NCT01449812|582423487|FG001|Overall Study|Lost to Follow-up|0|||
161285547|NCT01449812|582423488|FG002|Overall Study|Lost to Follow-up|0|||
161285548|NCT00625872|582423489|FG000|Overall Study|Withdrawal by Subject|1|||
161285549|NCT00625872|582423490|FG001|Overall Study|Withdrawal by Subject|0|||
161285550|NCT00625872|582423489|FG000|Overall Study|Does not meet inclusion criteria|1|||
161285551|NCT00625872|582423490|FG001|Overall Study|Does not meet inclusion criteria|0|||
161285552|NCT00625872|582423489|FG000|Overall Study|Terminated by sponsor|2|||
161285553|NCT00625872|582423490|FG001|Overall Study|Terminated by sponsor|5|||
161285554|NCT00625872|582423489|FG000|Overall Study|Randomized but not treated|0|||
161285555|NCT00625872|582423490|FG001|Overall Study|Randomized but not treated|1|||
161285556|NCT01512160|582423494|FG000|Overall Study|Lost to Follow-up|1|||
161285557|NCT01512160|582423495|FG001|Overall Study|Lost to Follow-up|0|||
161285558|NCT01512160|582423496|FG002|Overall Study|Lost to Follow-up|0|||
161285559|NCT01512160|582423497|FG003|Overall Study|Lost to Follow-up|0|||
161285560|NCT01512160|582423494|FG000|Overall Study|Withdrawal by Subject|1|||
161285561|NCT01512160|582423495|FG001|Overall Study|Withdrawal by Subject|0|||
161285562|NCT01512160|582423496|FG002|Overall Study|Withdrawal by Subject|0|||
161285563|NCT01512160|582423497|FG003|Overall Study|Withdrawal by Subject|1|||
161285564|NCT02729909|582423498|FG000|Overall Study|Lost to Follow-up|0|||
161285565|NCT02729909|582423499|FG001|Overall Study|Lost to Follow-up|1|||
161285566|NCT02729909|582423498|FG000|Overall Study|Lack of Efficacy|0|||
161285567|NCT02729909|582423499|FG001|Overall Study|Lack of Efficacy|2|||
161072059|NCT04013971|581652999|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
161072060|NCT04013971|581652998|FG000|Overall Study|Missing biomechanical data|0|||
161072061|NCT04013971|581652999|FG001|Overall Study|Missing biomechanical data|1|||
161072062|NCT05032066|581653002|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
161072063|NCT05032066|581653003|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
161072064|NCT05032066|581653004|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
161285568|NCT02729909|582423498|FG000|Overall Study|Significant Protocol Deviation|0|||
161285569|NCT02729909|582423499|FG001|Overall Study|Significant Protocol Deviation|2|||
161285570|NCT02729909|582423498|FG000|Overall Study|Voluntary Withdrawal|1|||
161072065|NCT05032066|581653002|FG000|Part 1: Core Phase|Physician Decision|0|||
161285571|NCT02729909|582423499|FG001|Overall Study|Voluntary Withdrawal|0|||
161285572|NCT01128179|582423500|FG000|Overall Study|Death|1|||
161285573|NCT01128179|582423501|FG001|Overall Study|Death|0|||
161285574|NCT01128179|582423500|FG000|Overall Study|Protocol Violation|1|||
161285575|NCT01128179|582423501|FG001|Overall Study|Protocol Violation|0|||
161285576|NCT06082843|582425578|FG000|Overall Study|Withdrawal by Subject|0|||
161285577|NCT06082843|582425579|FG001|Overall Study|Withdrawal by Subject|2|||
161072066|NCT05032066|581653003|FG001|Part 1: Core Phase|Physician Decision|1|||
161072067|NCT05032066|581653004|FG002|Part 1: Core Phase|Physician Decision|1|||
161072068|NCT05032066|581653002|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
161072069|NCT05032066|581653003|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
161072070|NCT05032066|581653004|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
161072071|NCT05032066|581653002|FG000|Part 1: Core Phase|Death|3|||
161072072|NCT05032066|581653003|FG001|Part 1: Core Phase|Death|4|||
161072073|NCT05032066|581653004|FG002|Part 1: Core Phase|Death|2|||
161072074|NCT05032066|581653002|FG000|Part 1: Core Phase|Adverse Event|2|||
161072075|NCT05032066|581653003|FG001|Part 1: Core Phase|Adverse Event|3|||
161072076|NCT05032066|581653004|FG002|Part 1: Core Phase|Adverse Event|0|||
161072077|NCT05032066|581653002|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
161072078|NCT05032066|581653003|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
161072079|NCT05032066|581653004|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
161072080|NCT05032066|581653002|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
161072081|NCT05032066|581653003|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
161072082|NCT05032066|581653004|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
161072083|NCT05032066|581653002|FG000|Part 2: Extension Phase|Physician Decision|1|||
161072084|NCT05032066|581653003|FG001|Part 2: Extension Phase|Physician Decision|2|||
161072085|NCT05032066|581653004|FG002|Part 2: Extension Phase|Physician Decision|0|||
161072086|NCT05032066|581653002|FG000|Part 2: Extension Phase|Death|2|||
161072087|NCT05032066|581653003|FG001|Part 2: Extension Phase|Death|4|||
161072088|NCT05032066|581653004|FG002|Part 2: Extension Phase|Death|5|||
161072089|NCT01124838|581653005|FG000|Overall Study|Miscellaneous|4|||
161072090|NCT01124838|581653006|FG001|Overall Study|Miscellaneous|2|||
161072091|NCT01124838|581653005|FG000|Overall Study|Adverse Event|7|||
161072092|NCT01124838|581653006|FG001|Overall Study|Adverse Event|11|||
161072093|NCT01124838|581653005|FG000|Overall Study|Lack of Efficacy|2|||
161072094|NCT01124838|581653006|FG001|Overall Study|Lack of Efficacy|0|||
161072095|NCT01124838|581653005|FG000|Overall Study|Withdrawal by Subject|3|||
161072096|NCT01124838|581653006|FG001|Overall Study|Withdrawal by Subject|2|||
161072097|NCT01124838|581653005|FG000|Overall Study|Lost to Follow-up|2|||
161072098|NCT01124838|581653006|FG001|Overall Study|Lost to Follow-up|0|||
161072099|NCT06719986|581653007|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
161072100|NCT06719986|581653008|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
161072101|NCT06719986|581653009|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
161072102|NCT06719986|581653007|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
161072103|NCT06719986|581653008|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
161072104|NCT06719986|581653009|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
161072105|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
161072106|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
161072107|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
161072108|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
161072109|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
161072110|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
161072111|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
161072112|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
161072113|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
161072114|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
161072115|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
161072116|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
161072117|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
161072118|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
161072119|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
161072120|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
161072121|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
161072122|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
161072123|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
161285578|NCT06082843|582425578|FG000|Overall Study|Study terminated by sponsor|12|||
161285579|NCT06082843|582425579|FG001|Overall Study|Study terminated by sponsor|8|||
161285580|NCT04358081|582425588|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
161285581|NCT04358081|582425589|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
161072124|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
161072125|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
161072126|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
161072127|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
161072128|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
161072129|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
161072130|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
161072131|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
161156988|NCT01318083|581955209|FG001|Overall Study|Lack of Study Medication Compliance|1|||
161156989|NCT01318083|581955210|FG002|Overall Study|Lack of Study Medication Compliance|0|||
161156990|NCT02028338|581955213|FG000|Overall Study|Withdrawal by Subject|3|||
161156991|NCT02028338|581955214|FG001|Overall Study|Withdrawal by Subject|1|||
161156992|NCT02028338|581955213|FG000|Overall Study|Unable to contact participant|1|||
161156993|NCT02028338|581955214|FG001|Overall Study|Unable to contact participant|0|||
161156994|NCT03552549|581955216|FG000|Overall Study|Disease progression|25|||
161156995|NCT03552549|581955217|FG001|Overall Study|Disease progression|17|||
161156996|NCT03552549|581955216|FG000|Overall Study|Adverse event in first 12 months|12|||
161156997|NCT03552549|581955217|FG001|Overall Study|Adverse event in first 12 months|8|||
161156998|NCT03552549|581955216|FG000|Overall Study|Withdrawal by Subject|7|||
161156999|NCT03552549|581955217|FG001|Overall Study|Withdrawal by Subject|7|||
161157000|NCT03552549|581955216|FG000|Overall Study|Unknown (no reason provided)|4|||
161157001|NCT03552549|581955217|FG001|Overall Study|Unknown (no reason provided)|2|||
161157002|NCT03552549|581955216|FG000|Overall Study|Not in participant's best interest|2|||
161157003|NCT03552549|581955217|FG001|Overall Study|Not in participant's best interest|1|||
161157004|NCT03552549|581955216|FG000|Overall Study|Did not complete study treatment|2|||
161157005|NCT03552549|581955217|FG001|Overall Study|Did not complete study treatment|3|||
161157006|NCT03552549|581955216|FG000|Overall Study|Did not meet eligibility criteria|1|||
161157007|NCT03552549|581955217|FG001|Overall Study|Did not meet eligibility criteria|0|||
161157008|NCT03552549|581955216|FG000|Overall Study|Administrative|0|||
161157009|NCT03552549|581955217|FG001|Overall Study|Administrative|14|||
161157010|NCT02761993|581955226|FG000|Overall Study|Adverse Event|0|||
161157011|NCT02761993|581955227|FG001|Overall Study|Adverse Event|2|||
161157012|NCT02761993|581955228|FG002|Overall Study|Adverse Event|0|||
161157013|NCT02761993|581955226|FG000|Overall Study|Lost to Follow-up|1|||
161157014|NCT02761993|581955227|FG001|Overall Study|Lost to Follow-up|3|||
161157015|NCT02761993|581955228|FG002|Overall Study|Lost to Follow-up|2|||
161157016|NCT02761993|581955226|FG000|Overall Study|Withdrawal by Subject|1|||
161157017|NCT02761993|581955227|FG001|Overall Study|Withdrawal by Subject|1|||
161157018|NCT02761993|581955228|FG002|Overall Study|Withdrawal by Subject|2|||
161157019|NCT00256867|581955229|FG000|Overall Study|Adverse Event|0|||
161157020|NCT00256867|581955230|FG001|Overall Study|Adverse Event|1|||
161157021|NCT00256867|581955231|FG002|Overall Study|Adverse Event|1|||
161157022|NCT00256867|581955232|FG003|Overall Study|Adverse Event|1|||
161157023|NCT00256867|581955233|FG004|Overall Study|Adverse Event|2|||
161157024|NCT00256867|581955234|FG005|Overall Study|Adverse Event|2|||
161157025|NCT00256867|581955235|FG006|Overall Study|Adverse Event|1|||
161157026|NCT00256867|581955236|FG007|Overall Study|Adverse Event|4|||
161157027|NCT00256867|581955229|FG000|Overall Study|Lost to Follow-up|2|||
161157028|NCT00256867|581955230|FG001|Overall Study|Lost to Follow-up|2|||
161157029|NCT00256867|581955231|FG002|Overall Study|Lost to Follow-up|2|||
161157030|NCT00256867|581955232|FG003|Overall Study|Lost to Follow-up|3|||
161157031|NCT00256867|581955233|FG004|Overall Study|Lost to Follow-up|2|||
161157032|NCT00256867|581955234|FG005|Overall Study|Lost to Follow-up|0|||
161157033|NCT00256867|581955235|FG006|Overall Study|Lost to Follow-up|1|||
161157034|NCT00256867|581955236|FG007|Overall Study|Lost to Follow-up|2|||
161157035|NCT00256867|581955229|FG000|Overall Study|Protocol Violation|0|||
161157036|NCT00256867|581955230|FG001|Overall Study|Protocol Violation|0|||
161157037|NCT00256867|581955231|FG002|Overall Study|Protocol Violation|0|||
161157038|NCT00256867|581955232|FG003|Overall Study|Protocol Violation|1|||
161157039|NCT00256867|581955233|FG004|Overall Study|Protocol Violation|0|||
161157040|NCT00256867|581955234|FG005|Overall Study|Protocol Violation|1|||
161157041|NCT00256867|581955235|FG006|Overall Study|Protocol Violation|0|||
161157042|NCT00256867|581955236|FG007|Overall Study|Protocol Violation|1|||
161157043|NCT00256867|581955229|FG000|Overall Study|Withdrawal by Subject|0|||
161157044|NCT00256867|581955230|FG001|Overall Study|Withdrawal by Subject|0|||
161157045|NCT00256867|581955231|FG002|Overall Study|Withdrawal by Subject|1|||
161157046|NCT00256867|581955232|FG003|Overall Study|Withdrawal by Subject|1|||
161157047|NCT00256867|581955233|FG004|Overall Study|Withdrawal by Subject|2|||
161157048|NCT00256867|581955234|FG005|Overall Study|Withdrawal by Subject|2|||
161157049|NCT00256867|581955235|FG006|Overall Study|Withdrawal by Subject|3|||
161157050|NCT00256867|581955236|FG007|Overall Study|Withdrawal by Subject|2|||
161157051|NCT00256867|581955229|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157052|NCT00256867|581955230|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
161157053|NCT00256867|581955231|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157054|NCT00256867|581955232|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157055|NCT00256867|581955233|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157056|NCT00256867|581955234|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157057|NCT00256867|581955235|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157058|NCT00256867|581955236|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
161157059|NCT00256867|581955229|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161157060|NCT00256867|581955230|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161157061|NCT00256867|581955231|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161157062|NCT00256867|581955232|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161345614|NCT00716417|582650883|FG004|Overall Study|Progressive disease|0|||
161285582|NCT04358081|582425590|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
161285583|NCT04358081|582425588|FG000|Treatment Phase of Study|Adverse Event|1|||
161285584|NCT04358081|582425589|FG001|Treatment Phase of Study|Adverse Event|0|||
161285585|NCT04358081|582425590|FG002|Treatment Phase of Study|Adverse Event|1|||
161285586|NCT04358081|582425588|FG000|Treatment Phase of Study|Physician Decision|2|||
161285587|NCT04358081|582425589|FG001|Treatment Phase of Study|Physician Decision|0|||
161285588|NCT04358081|582425590|FG002|Treatment Phase of Study|Physician Decision|1|||
161285589|NCT04358081|582425588|FG000|Treatment Phase of Study|Protocol Violation|1|||
161285590|NCT04358081|582425589|FG001|Treatment Phase of Study|Protocol Violation|0|||
161285591|NCT04358081|582425590|FG002|Treatment Phase of Study|Protocol Violation|0|||
161285592|NCT04358081|582425588|FG000|Study Completion Phase|Death|0|||
161285593|NCT04358081|582425589|FG001|Study Completion Phase|Death|0|||
161285594|NCT04358081|582425590|FG002|Study Completion Phase|Death|1|||
161285595|NCT04358081|582425588|FG000|Study Completion Phase|Lost to Follow-up|1|||
161285596|NCT04358081|582425589|FG001|Study Completion Phase|Lost to Follow-up|0|||
161285597|NCT04358081|582425590|FG002|Study Completion Phase|Lost to Follow-up|1|||
161285598|NCT03283566|582425591|FG000|Overall Study|Lost to Follow-up|1|||
161285599|NCT03283566|582425592|FG001|Overall Study|Lost to Follow-up|2|||
161285600|NCT04515147|582425593|FG000|Overall Study|Withdrawal by Subject|1|||
161285601|NCT04515147|582425594|FG001|Overall Study|Withdrawal by Subject|0|||
161285602|NCT04515147|582425595|FG002|Overall Study|Withdrawal by Subject|10|||
161285603|NCT04515147|582425596|FG003|Overall Study|Withdrawal by Subject|18|||
161285604|NCT04515147|582425597|FG004|Overall Study|Withdrawal by Subject|1|||
161285605|NCT04515147|582425598|FG005|Overall Study|Withdrawal by Subject|8|||
161285606|NCT04515147|582425593|FG000|Overall Study|Lost to Follow-up|0|||
161285607|NCT04515147|582425594|FG001|Overall Study|Lost to Follow-up|1|||
161285608|NCT04515147|582425595|FG002|Overall Study|Lost to Follow-up|5|||
161285609|NCT04515147|582425596|FG003|Overall Study|Lost to Follow-up|6|||
161285610|NCT04515147|582425597|FG004|Overall Study|Lost to Follow-up|2|||
161285611|NCT04515147|582425598|FG005|Overall Study|Lost to Follow-up|1|||
161285612|NCT04515147|582425593|FG000|Overall Study|Adverse Event|0|||
161285613|NCT04515147|582425594|FG001|Overall Study|Adverse Event|0|||
161285614|NCT04515147|582425595|FG002|Overall Study|Adverse Event|0|||
161285615|NCT04515147|582425596|FG003|Overall Study|Adverse Event|2|||
161285616|NCT04515147|582425597|FG004|Overall Study|Adverse Event|0|||
161285617|NCT04515147|582425598|FG005|Overall Study|Adverse Event|0|||
161285618|NCT04515147|582425593|FG000|Overall Study|Miscellaneous|0|||
161285619|NCT04515147|582425594|FG001|Overall Study|Miscellaneous|0|||
161285620|NCT04515147|582425595|FG002|Overall Study|Miscellaneous|0|||
161285621|NCT04515147|582425596|FG003|Overall Study|Miscellaneous|1|||
161285622|NCT04515147|582425597|FG004|Overall Study|Miscellaneous|0|||
161285623|NCT04515147|582425598|FG005|Overall Study|Miscellaneous|1|||
161285624|NCT04123405|582425599|FG000|Overall Study|Adverse Event|1|||
161285625|NCT04123405|582425600|FG001|Overall Study|Adverse Event|2|||
161285626|NCT04123405|582425601|FG002|Overall Study|Adverse Event|3|||
161285627|NCT04123405|582425602|FG003|Overall Study|Adverse Event|3|||
161285628|NCT04123405|582425599|FG000|Overall Study|Exclusion criteria met|1|||
161285629|NCT04123405|582425600|FG001|Overall Study|Exclusion criteria met|2|||
161285630|NCT04123405|582425601|FG002|Overall Study|Exclusion criteria met|0|||
161285631|NCT04123405|582425602|FG003|Overall Study|Exclusion criteria met|2|||
161285632|NCT04123405|582425599|FG000|Overall Study|Withdrawal by Subject|1|||
161285633|NCT04123405|582425600|FG001|Overall Study|Withdrawal by Subject|3|||
161285634|NCT04123405|582425601|FG002|Overall Study|Withdrawal by Subject|0|||
161285635|NCT04123405|582425602|FG003|Overall Study|Withdrawal by Subject|2|||
161285636|NCT04123405|582425599|FG000|Overall Study|Contact to subject lost|0|||
161285637|NCT04123405|582425600|FG001|Overall Study|Contact to subject lost|0|||
161285638|NCT04123405|582425601|FG002|Overall Study|Contact to subject lost|0|||
161285639|NCT04123405|582425602|FG003|Overall Study|Contact to subject lost|1|||
161285640|NCT04123405|582425599|FG000|Overall Study|screening failure|1|||
161285641|NCT04123405|582425600|FG001|Overall Study|screening failure|0|||
161285642|NCT04123405|582425601|FG002|Overall Study|screening failure|0|||
161285643|NCT04123405|582425602|FG003|Overall Study|screening failure|0|||
161285644|NCT01050530|582425603|FG000|Overall Study|Adverse Event|6|||
161345615|NCT00716417|582650884|FG005|Overall Study|Progressive disease|3|||
161345616|NCT00716417|582650885|FG006|Overall Study|Progressive disease|3|||
161285645|NCT01050530|582425604|FG001|Overall Study|Adverse Event|3|||
161285646|NCT01050530|582425603|FG000|Overall Study|Lack of Efficacy|1|||
161285647|NCT01050530|582425604|FG001|Overall Study|Lack of Efficacy|4|||
161345617|NCT00716417|582650886|FG007|Overall Study|Progressive disease|1|||
161345618|NCT00716417|582650887|FG008|Overall Study|Progressive disease|5|||
161285648|NCT01050530|582425603|FG000|Overall Study|Withdrawal by Subject|0|||
161285649|NCT01050530|582425604|FG001|Overall Study|Withdrawal by Subject|3|||
161345619|NCT00716417|582650888|FG009|Overall Study|Progressive disease|0|||
161285650|NCT01050530|582425603|FG000|Overall Study|Protocol Violation|1|||
161285651|NCT01050530|582425604|FG001|Overall Study|Protocol Violation|0|||
161285652|NCT00545714|582425605|FG000|Induction Phase (6 Months)|Physician Decision|3|||
161285653|NCT00545714|582425605|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
161345620|NCT00716417|582650879|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
161072132|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
161072133|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161072134|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161072135|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
161072136|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
161072137|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
161072138|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
161072139|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
161072140|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
161072141|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
161072142|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
161072143|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
161072144|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
161072145|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
161072146|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
161072147|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
161072148|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
161072149|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
161072150|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
161072151|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
161072152|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
161072153|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
161072154|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
161072155|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
161072156|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
161072157|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
161072158|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
161072159|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
161072160|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
161072161|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
161072162|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
161072163|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
161072164|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
161072165|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
161072166|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
161072167|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
161072168|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
161072169|NCT00217737|581653010|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
161072170|NCT00217737|581653011|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
161072171|NCT00217737|581653012|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
161072172|NCT00217737|581653013|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
161072173|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
161072174|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
161072175|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
161072176|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
161072177|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
161072178|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
161072179|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
161072180|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
161072181|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Study suspension|0|||
161072182|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Study suspension|45|||
161072183|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Study suspension|0|||
161072184|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Study suspension|0|||
161072185|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
161072186|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
161072187|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
161072188|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
161072189|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Death|2|||
161072190|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Death|3|||
161072191|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Death|0|||
161072192|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Death|0|||
161072193|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
161072194|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
161072195|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
161072196|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
161072197|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
161285654|NCT00545714|582425605|FG000|Induction Phase (6 Months)|Disease Progression|1|||
161285655|NCT00545714|582425605|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
161285656|NCT00545714|582425605|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
161285657|NCT00545714|582425605|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
161285658|NCT00545714|582425605|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
161285659|NCT00545714|582425605|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
161285660|NCT00545714|582425605|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
161285661|NCT00545714|582425605|FG000|Maintenance Phase (36 Months)|Death|2|||
161285662|NCT00116779|582425606|FG000|Overall Study|Adverse Event|4|||
161285663|NCT00116779|582425607|FG001|Overall Study|Adverse Event|2|||
161285664|NCT00116779|582425606|FG000|Overall Study|Protocol Violation|1|||
161285665|NCT00116779|582425607|FG001|Overall Study|Protocol Violation|4|||
161285666|NCT00116779|582425606|FG000|Overall Study|Withdrawal by Subject|4|||
161285667|NCT00116779|582425607|FG001|Overall Study|Withdrawal by Subject|1|||
161285668|NCT00116779|582425606|FG000|Overall Study|Inadequate testosterone suppression|7|||
161285669|NCT00116779|582425607|FG001|Overall Study|Inadequate testosterone suppression|9|||
161285670|NCT00116779|582425606|FG000|Overall Study|Physician Decision|3|||
161285671|NCT00116779|582425607|FG001|Overall Study|Physician Decision|1|||
161285672|NCT00116779|582425606|FG000|Overall Study|Elevated PSA levels|2|||
161285673|NCT00116779|582425607|FG001|Overall Study|Elevated PSA levels|2|||
161285674|NCT03934541|582425619|FG000|Overall Study|Study Terminated by Sponsor|0|||
161345621|NCT00716417|582650880|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
161072198|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
161072199|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
161157063|NCT00256867|581955233|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161157064|NCT00256867|581955234|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161072200|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
161072201|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
161072202|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
161072203|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
161072204|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
161072205|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
161072206|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
161072207|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
161157065|NCT00256867|581955235|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
161157066|NCT00256867|581955236|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
161157067|NCT00256867|581955229|FG000|Overall Study|Investigator's Decision|0|||
161157068|NCT00256867|581955230|FG001|Overall Study|Investigator's Decision|0|||
161157069|NCT00256867|581955231|FG002|Overall Study|Investigator's Decision|0|||
161157070|NCT00256867|581955232|FG003|Overall Study|Investigator's Decision|0|||
161157071|NCT00256867|581955233|FG004|Overall Study|Investigator's Decision|1|||
161157072|NCT00256867|581955234|FG005|Overall Study|Investigator's Decision|0|||
161157073|NCT00256867|581955235|FG006|Overall Study|Investigator's Decision|0|||
161157074|NCT00256867|581955236|FG007|Overall Study|Investigator's Decision|0|||
161157075|NCT00256867|581955229|FG000|Overall Study|Non-compliance with study medication|0|||
161157076|NCT00256867|581955230|FG001|Overall Study|Non-compliance with study medication|0|||
161157077|NCT00256867|581955231|FG002|Overall Study|Non-compliance with study medication|0|||
161157078|NCT00256867|581955232|FG003|Overall Study|Non-compliance with study medication|0|||
161157079|NCT00256867|581955233|FG004|Overall Study|Non-compliance with study medication|0|||
161157080|NCT00256867|581955234|FG005|Overall Study|Non-compliance with study medication|0|||
161157081|NCT00256867|581955235|FG006|Overall Study|Non-compliance with study medication|0|||
161157082|NCT00256867|581955236|FG007|Overall Study|Non-compliance with study medication|1|||
161157083|NCT00256867|581955229|FG000|Overall Study|Participant travelled Overseas|0|||
161157084|NCT00256867|581955230|FG001|Overall Study|Participant travelled Overseas|1|||
161157085|NCT00256867|581955231|FG002|Overall Study|Participant travelled Overseas|0|||
161157086|NCT00256867|581955232|FG003|Overall Study|Participant travelled Overseas|0|||
161157087|NCT00256867|581955233|FG004|Overall Study|Participant travelled Overseas|0|||
161157088|NCT00256867|581955234|FG005|Overall Study|Participant travelled Overseas|0|||
161157089|NCT00256867|581955235|FG006|Overall Study|Participant travelled Overseas|0|||
161157090|NCT00256867|581955236|FG007|Overall Study|Participant travelled Overseas|0|||
161157091|NCT00256867|581955229|FG000|Overall Study|Participant out of assessment window|0|||
161157092|NCT00256867|581955230|FG001|Overall Study|Participant out of assessment window|0|||
161157093|NCT00256867|581955231|FG002|Overall Study|Participant out of assessment window|1|||
161157094|NCT00256867|581955232|FG003|Overall Study|Participant out of assessment window|0|||
161157095|NCT00256867|581955233|FG004|Overall Study|Participant out of assessment window|0|||
161157096|NCT00256867|581955234|FG005|Overall Study|Participant out of assessment window|0|||
161285675|NCT03934541|582425620|FG001|Overall Study|Study Terminated by Sponsor|1|||
161285676|NCT03934541|582425621|FG002|Overall Study|Study Terminated by Sponsor|0|||
161345622|NCT00716417|582650881|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
161072208|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
161072209|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
161072210|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
161072211|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
161072212|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
161072213|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
161072214|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
161072215|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
161072216|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
161072217|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
161072218|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
161072219|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
161072220|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
161072221|NCT00217737|581653010|FG000|Step 2 Randomization/Registration|Other|1|||
161072222|NCT00217737|581653011|FG001|Step 2 Randomization/Registration|Other|2|||
161072223|NCT00217737|581653012|FG002|Step 2 Randomization/Registration|Other|0|||
161072224|NCT00217737|581653013|FG003|Step 2 Randomization/Registration|Other|0|||
161072225|NCT01667926|581654637|FG000|Overall Study|Withdrawal by Subject|1|||
161072226|NCT01667926|581654638|FG001|Overall Study|Withdrawal by Subject|2|||
161072227|NCT01667926|581654639|FG002|Overall Study|Withdrawal by Subject|2|||
161072228|NCT01667926|581654637|FG000|Overall Study|Physician Decision|0|||
161072229|NCT01667926|581654638|FG001|Overall Study|Physician Decision|0|||
161072230|NCT01667926|581654639|FG002|Overall Study|Physician Decision|1|||
161072231|NCT01667926|581654637|FG000|Overall Study|Time committment|0|||
161072232|NCT01667926|581654638|FG001|Overall Study|Time committment|0|||
161072233|NCT01667926|581654639|FG002|Overall Study|Time committment|2|||
161072234|NCT01667926|581654637|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
161072235|NCT01667926|581654638|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161072236|NCT01667926|581654639|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
161072237|NCT01667926|581654637|FG000|Overall Study|Lost to Follow-up|1|||
161072238|NCT01667926|581654638|FG001|Overall Study|Lost to Follow-up|2|||
161072239|NCT01667926|581654639|FG002|Overall Study|Lost to Follow-up|1|||
161072240|NCT01667926|581654637|FG000|Overall Study|Side effects|3|||
161072241|NCT01667926|581654638|FG001|Overall Study|Side effects|0|||
161072242|NCT01667926|581654639|FG002|Overall Study|Side effects|0|||
161072243|NCT01411241|581654643|FG000|Overall Study|Protocol Violation|0|||
161072244|NCT01411241|581654644|FG001|Overall Study|Protocol Violation|5|||
161072245|NCT01411241|581654643|FG000|Overall Study|Withdrawal by Subject|9|||
161072246|NCT01411241|581654644|FG001|Overall Study|Withdrawal by Subject|10|||
161072247|NCT01411241|581654643|FG000|Overall Study|Serious Adverse Event|0|||
161072248|NCT01411241|581654644|FG001|Overall Study|Serious Adverse Event|3|||
161072249|NCT01411241|581654643|FG000|Overall Study|Lost to Follow-up|2|||
161072250|NCT01411241|581654644|FG001|Overall Study|Lost to Follow-up|4|||
161072251|NCT02980042|581654647|FG000|Overall Study|Lost to Follow-up|5|||
161072252|NCT02980042|581654648|FG001|Overall Study|Lost to Follow-up|0|||
161072253|NCT02980042|581654647|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
161072254|NCT02980042|581654648|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
161072255|NCT00699153|581654649|FG000|Overall Study|Lost to Follow-up|1|||
161072256|NCT00699153|581654650|FG001|Overall Study|Lost to Follow-up|0|||
161072257|NCT00699153|581654649|FG000|Overall Study|Adverse Event|0|||
161072258|NCT00699153|581654650|FG001|Overall Study|Adverse Event|2|||
161072259|NCT00699153|581654649|FG000|Overall Study|Protocol Violation|1|||
161072260|NCT00699153|581654650|FG001|Overall Study|Protocol Violation|0|||
161072261|NCT00699153|581654649|FG000|Overall Study|Travel Problem|1|||
161072262|NCT00699153|581654650|FG001|Overall Study|Travel Problem|0|||
161072263|NCT02521363|581654652|FG000|Overall Study|Withdrawal by Subject|1|||
161072264|NCT02521363|581654653|FG001|Overall Study|Withdrawal by Subject|2|||
161072265|NCT00953771|581654657|FG000|Overall Study|Death|1|||
161072266|NCT00953771|581654658|FG001|Overall Study|Death|0|||
161072267|NCT00974259|581654659|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
161072268|NCT00974259|581654660|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
161072269|NCT04201288|581654666|FG000|Overall Study|Death|1|||
161072270|NCT04201288|581654667|FG001|Overall Study|Death|1|||
161072271|NCT04201288|581654666|FG000|Overall Study|Lost to Follow-up|5|||
161157097|NCT00256867|581955235|FG006|Overall Study|Participant out of assessment window|0|||
161285677|NCT03934541|582425622|FG003|Overall Study|Study Terminated by Sponsor|0|||
161072272|NCT04201288|581654667|FG001|Overall Study|Lost to Follow-up|3|||
161072273|NCT04201288|581654666|FG000|Overall Study|Withdrawal by Subject|1|||
161072274|NCT04201288|581654667|FG001|Overall Study|Withdrawal by Subject|0|||
161285678|NCT01928472|582425625|FG000|Overall Study|Death|0|||
161072275|NCT00592293|581654668|FG000|Overall Study|Withdrawal by Subject|1|||
161072276|NCT01606319|581654671|FG000|Overall Study|Lost to Follow-up|17|||
161072277|NCT01606319|581654672|FG001|Overall Study|Lost to Follow-up|14|||
161285679|NCT01928472|582425626|FG001|Overall Study|Death|0|||
161072278|NCT01606319|581654671|FG000|Overall Study|Withdrawal by Subject|9|||
161072279|NCT01606319|581654672|FG001|Overall Study|Withdrawal by Subject|12|||
161072280|NCT01606319|581654671|FG000|Overall Study|Physician Decision|1|||
161072281|NCT01606319|581654672|FG001|Overall Study|Physician Decision|2|||
161072282|NCT01606319|581654671|FG000|Overall Study|Lack of Efficacy|6|||
161072283|NCT01606319|581654672|FG001|Overall Study|Lack of Efficacy|8|||
161072284|NCT01606319|581654671|FG000|Overall Study|Adverse Event|1|||
161072285|NCT01606319|581654672|FG001|Overall Study|Adverse Event|4|||
161072286|NCT01270828|581654673|FG000|Pregabalin CR SB|Reason Unspecified|0|||
161072287|NCT01270828|581654674|FG001|Pregabalin CR SB|Reason Unspecified|0|||
161072288|NCT01270828|581654675|FG002|Pregabalin CR SB|Reason Unspecified|8|||
161072289|NCT01270828|581654673|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
161072290|NCT01270828|581654674|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
161072291|NCT01270828|581654675|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
161072292|NCT01270828|581654673|FG000|Pregabalin CR SB|Related adverse event|0|||
161072293|NCT01270828|581654674|FG001|Pregabalin CR SB|Related adverse event|0|||
161072294|NCT01270828|581654675|FG002|Pregabalin CR SB|Related adverse event|46|||
161072295|NCT01270828|581654673|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
161072296|NCT01270828|581654674|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
161072297|NCT01270828|581654675|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
161072298|NCT01270828|581654673|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
161072299|NCT01270828|581654674|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
161072300|NCT01270828|581654675|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
161072301|NCT01270828|581654673|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
161072302|NCT01270828|581654674|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
161072303|NCT01270828|581654675|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
161072304|NCT01270828|581654673|FG000|Pregabalin CR SB|Unrelated AE|0|||
161072305|NCT01270828|581654674|FG001|Pregabalin CR SB|Unrelated AE|0|||
161072306|NCT01270828|581654675|FG002|Pregabalin CR SB|Unrelated AE|8|||
161072307|NCT01270828|581654673|FG000|Pregabalin CR SB|Protocol Violation|0|||
161072308|NCT01270828|581654674|FG001|Pregabalin CR SB|Protocol Violation|0|||
161072309|NCT01270828|581654675|FG002|Pregabalin CR SB|Protocol Violation|8|||
161072310|NCT01270828|581654673|FG000|Double Blind Phase|Death|0|||
161072311|NCT01270828|581654674|FG001|Double Blind Phase|Death|1|||
161072312|NCT01270828|581654675|FG002|Double Blind Phase|Death|0|||
161072313|NCT01270828|581654673|FG000|Double Blind Phase|Protocol Violation|0|||
161072314|NCT01270828|581654674|FG001|Double Blind Phase|Protocol Violation|1|||
161072315|NCT01270828|581654675|FG002|Double Blind Phase|Protocol Violation|0|||
161072316|NCT01270828|581654673|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
161072317|NCT01270828|581654674|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
161072318|NCT01270828|581654675|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
161072319|NCT01270828|581654673|FG000|Double Blind Phase|Reason Unspecified|7|||
161072320|NCT01270828|581654674|FG001|Double Blind Phase|Reason Unspecified|4|||
161072321|NCT01270828|581654675|FG002|Double Blind Phase|Reason Unspecified|0|||
161072322|NCT01270828|581654673|FG000|Double Blind Phase|Withdrawal by Subject|6|||
161072323|NCT01270828|581654674|FG001|Double Blind Phase|Withdrawal by Subject|15|||
161072324|NCT01270828|581654675|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161072325|NCT01270828|581654673|FG000|Double Blind Phase|Lost to Follow-up|1|||
161072326|NCT01270828|581654674|FG001|Double Blind Phase|Lost to Follow-up|2|||
161072327|NCT01270828|581654675|FG002|Double Blind Phase|Lost to Follow-up|0|||
161072328|NCT01270828|581654673|FG000|Double Blind Phase|Lack of Efficacy|2|||
161072329|NCT01270828|581654674|FG001|Double Blind Phase|Lack of Efficacy|11|||
161072330|NCT01270828|581654675|FG002|Double Blind Phase|Lack of Efficacy|0|||
161072331|NCT01270828|581654673|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
161072332|NCT01270828|581654674|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
161072333|NCT01270828|581654675|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
161072334|NCT01270828|581654673|FG000|Double Blind Phase|Adverse event related to study drug|5|||
161072335|NCT01270828|581654674|FG001|Double Blind Phase|Adverse event related to study drug|7|||
161072336|NCT01270828|581654675|FG002|Double Blind Phase|Adverse event related to study drug|0|||
161072337|NCT02870972|581654679|FG000|Overall Study|Adverse Event|1|||
161072338|NCT02870972|581654680|FG001|Overall Study|Adverse Event|0|||
161072339|NCT02870972|581654681|FG002|Overall Study|Adverse Event|0|||
161285680|NCT01928472|582425627|FG002|Overall Study|Death|1|||
161285681|NCT01928472|582425628|FG003|Overall Study|Death|0|||
161285682|NCT01928472|582425625|FG000|Overall Study|Withdrawal by Subject|4|||
161285683|NCT01928472|582425626|FG001|Overall Study|Withdrawal by Subject|4|||
161285684|NCT01928472|582425627|FG002|Overall Study|Withdrawal by Subject|1|||
161285685|NCT01928472|582425628|FG003|Overall Study|Withdrawal by Subject|2|||
161285686|NCT01928472|582425625|FG000|Overall Study|Lost to Follow-up|2|||
161072340|NCT02870972|581654682|FG003|Overall Study|Adverse Event|0|||
161072341|NCT02870972|581654683|FG004|Overall Study|Adverse Event|0|||
161072342|NCT01821937|581654688|FG000|Overall Study|Adverse Event|0|||
161072343|NCT01821937|581654689|FG001|Overall Study|Adverse Event|3|||
161072344|NCT02615509|581654690|FG000|Overall Study|Lost to Follow-up|134|||
161072345|NCT02615509|581654690|FG000|Overall Study|Death|4|||
161285687|NCT01928472|582425626|FG001|Overall Study|Lost to Follow-up|3|||
161157098|NCT00256867|581955236|FG007|Overall Study|Participant out of assessment window|0|||
161157099|NCT00256867|581955229|FG000|Overall Study|Withdrawal by participant|0|||
161157100|NCT00256867|581955230|FG001|Overall Study|Withdrawal by participant|0|||
161157101|NCT00256867|581955231|FG002|Overall Study|Withdrawal by participant|0|||
161157102|NCT00256867|581955232|FG003|Overall Study|Withdrawal by participant|0|||
161157103|NCT00256867|581955233|FG004|Overall Study|Withdrawal by participant|0|||
161157104|NCT00256867|581955234|FG005|Overall Study|Withdrawal by participant|1|||
161157105|NCT00256867|581955235|FG006|Overall Study|Withdrawal by participant|0|||
161157106|NCT00256867|581955236|FG007|Overall Study|Withdrawal by participant|0|||
161157107|NCT00527111|581955239|FG000|Overall Study|Adverse Event|14|||
161157108|NCT00527111|581955240|FG001|Overall Study|Adverse Event|13|||
161157109|NCT00527111|581955239|FG000|Overall Study|Death|0|||
161157110|NCT00527111|581955240|FG001|Overall Study|Death|1|||
161157111|NCT00527111|581955239|FG000|Overall Study|Investigator Request|2|||
161157112|NCT00527111|581955240|FG001|Overall Study|Investigator Request|1|||
161157113|NCT00527111|581955239|FG000|Overall Study|Patient Request|2|||
161157114|NCT00527111|581955240|FG001|Overall Study|Patient Request|5|||
161157115|NCT00527111|581955239|FG000|Overall Study|Other|2|||
161157116|NCT00527111|581955240|FG001|Overall Study|Other|2|||
161157117|NCT02689219|581955246|FG000|Overall Study|Death|1|||
161157118|NCT02689219|581955247|FG001|Overall Study|Death|1|||
161072346|NCT02615509|581654690|FG000|Overall Study|Withdrawal by Subject|8|||
161072347|NCT03334253|581654691|FG000|Overall Study|Withdrawal by Subject|1|||
161072348|NCT03334253|581654692|FG001|Overall Study|Withdrawal by Subject|0|||
161072349|NCT03334253|581654691|FG000|Overall Study|Lost to Follow-up|4|||
161072350|NCT03334253|581654692|FG001|Overall Study|Lost to Follow-up|3|||
161072351|NCT03334253|581654691|FG000|Overall Study|Moved residence|2|||
161072352|NCT03334253|581654692|FG001|Overall Study|Moved residence|2|||
161072353|NCT00968526|581654693|FG000|Overall Study|Adverse Event|2|||
161072354|NCT00968526|581654694|FG001|Overall Study|Adverse Event|0|||
161072355|NCT00968526|581654693|FG000|Overall Study|Migrated/moved from study area|1|||
161072356|NCT00968526|581654694|FG001|Overall Study|Migrated/moved from study area|0|||
161072357|NCT02030002|581654698|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
161072358|NCT02030002|581654698|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
161072359|NCT02030002|581654698|FG000|Follow-up|Lost to Follow-up|2|||
161072360|NCT00609947|581654699|FG000|Overall Study|Death|1|||
161072361|NCT00504075|581654700|FG000|Overall Study|Adverse Event|1|||
161072362|NCT00504075|581654700|FG000|Overall Study|Lost to Follow-up|5|||
161072363|NCT00504075|581654700|FG000|Overall Study|Withdrawal by Subject|1|||
161072364|NCT00504075|581654700|FG000|Overall Study|Required other therapeutic intervention|1|||
161072365|NCT02406248|581654701|FG000|Overall Study|Death|7|||
161072366|NCT02406248|581654701|FG000|Overall Study|Withdrawal by Subject|2|||
161072367|NCT01689857|581654703|FG000|Overall Study|Lost to Follow-up|5|||
161072368|NCT01689857|581654704|FG001|Overall Study|Lost to Follow-up|2|||
161072369|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
161072370|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
161072371|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
161072372|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
161072373|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
161072374|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
161072375|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
161072376|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
161072377|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
161072378|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
161072379|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
161072380|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
161072381|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
161072382|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
161072383|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
161072384|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
161072385|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
161072386|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
161072387|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
161072388|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
161072389|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
161072390|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
161157119|NCT02689219|581955246|FG000|Overall Study|Disease Progression|10|||
161157120|NCT02689219|581955247|FG001|Overall Study|Disease Progression|6|||
161157121|NCT01921257|581955250|FG000|Overall Study|Adverse Event|1|||
161157122|NCT01921257|581955250|FG000|Overall Study|Protocol Violation|1|||
161157123|NCT01921257|581955250|FG000|Overall Study|Withdrawal by Subject|1|||
161157124|NCT02426658|581955251|FG000|Overall Study|Withdrawal by Subject|1|||
161285688|NCT01928472|582425627|FG002|Overall Study|Lost to Follow-up|4|||
161345623|NCT00716417|582650882|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
161345624|NCT00716417|582650883|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
161345625|NCT00716417|582650884|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
161345626|NCT00716417|582650885|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
161345627|NCT00716417|582650886|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
161345628|NCT00716417|582650887|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
161345629|NCT00716417|582650888|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
161345630|NCT00716417|582650879|FG000|Overall Study|On patient request due to toxicities|0|||
161345631|NCT00716417|582650880|FG001|Overall Study|On patient request due to toxicities|0|||
161345632|NCT00716417|582650881|FG002|Overall Study|On patient request due to toxicities|0|||
161345633|NCT00716417|582650882|FG003|Overall Study|On patient request due to toxicities|0|||
161345634|NCT00716417|582650883|FG004|Overall Study|On patient request due to toxicities|0|||
161345635|NCT00716417|582650884|FG005|Overall Study|On patient request due to toxicities|0|||
161345636|NCT00716417|582650885|FG006|Overall Study|On patient request due to toxicities|0|||
161345637|NCT00716417|582650886|FG007|Overall Study|On patient request due to toxicities|1|||
161345638|NCT00716417|582650887|FG008|Overall Study|On patient request due to toxicities|0|||
161345639|NCT00716417|582650888|FG009|Overall Study|On patient request due to toxicities|0|||
161345640|NCT03881371|582650889|FG000|Overall Study|Adverse Event|8|||
161345641|NCT03881371|582650890|FG001|Overall Study|Adverse Event|9|||
161345642|NCT03881371|582650889|FG000|Overall Study|Death|1|||
161345643|NCT03881371|582650890|FG001|Overall Study|Death|0|||
161345644|NCT03881371|582650889|FG000|Overall Study|Lost to Follow-up|1|||
161345645|NCT03881371|582650890|FG001|Overall Study|Lost to Follow-up|0|||
161072391|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
161072392|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
161072393|NCT00479882|581654711|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
161072394|NCT00479882|581654712|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
161072395|NCT00479882|581654713|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
161072396|NCT00479882|581654714|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
161072397|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
161072398|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
161072399|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
161072400|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
161072401|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
161072402|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
161072403|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
161072404|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
161072405|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
161072406|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
161072407|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
161072408|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
161072409|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
161072410|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
161072411|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
161072412|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
161072413|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
161072414|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
161072415|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
161072416|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
161072417|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
161072418|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
161072419|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
161072420|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
161072421|NCT00479882|581654711|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
161072422|NCT00479882|581654712|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
161072423|NCT00479882|581654713|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
161072424|NCT00479882|581654714|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
161072425|NCT03812029|581654715|FG000|Overall Study|Protocol Violation|1|||
161072426|NCT03812029|581654716|FG001|Overall Study|Protocol Violation|0|||
161072427|NCT03812029|581654717|FG002|Overall Study|Protocol Violation|0|||
161072428|NCT03812029|581654718|FG003|Overall Study|Protocol Violation|1|||
161072429|NCT03812029|581654719|FG004|Overall Study|Protocol Violation|0|||
161072430|NCT03812029|581654715|FG000|Overall Study|Withdrawal by Subject|1|||
161072431|NCT03812029|581654716|FG001|Overall Study|Withdrawal by Subject|0|||
161072432|NCT03812029|581654717|FG002|Overall Study|Withdrawal by Subject|0|||
161072433|NCT03812029|581654718|FG003|Overall Study|Withdrawal by Subject|2|||
161072434|NCT03812029|581654719|FG004|Overall Study|Withdrawal by Subject|2|||
161157125|NCT02426658|581955251|FG000|Overall Study|Patient expired before treatment|2|||
161157126|NCT00634244|581955252|FG000|Overall Study|Never started treatment|0|||
161157127|NCT00634244|581955253|FG001|Overall Study|Never started treatment|1|||
161157128|NCT00634244|581955254|FG002|Overall Study|Never started treatment|0|||
161157129|NCT00634244|581955252|FG000|Overall Study|Death|1|||
161157130|NCT00634244|581955253|FG001|Overall Study|Death|6|||
161157131|NCT00634244|581955254|FG002|Overall Study|Death|0|||
161157132|NCT00634244|581955252|FG000|Overall Study|Adverse Event|0|||
161157133|NCT00634244|581955253|FG001|Overall Study|Adverse Event|2|||
161157134|NCT00634244|581955254|FG002|Overall Study|Adverse Event|0|||
161157135|NCT00634244|581955252|FG000|Overall Study|Withdrawal by Subject|0|||
161157136|NCT00634244|581955253|FG001|Overall Study|Withdrawal by Subject|1|||
161157137|NCT00634244|581955254|FG002|Overall Study|Withdrawal by Subject|0|||
161157138|NCT00634244|581955252|FG000|Overall Study|Physician Decision|0|||
161157139|NCT00634244|581955253|FG001|Overall Study|Physician Decision|1|||
161157140|NCT00634244|581955254|FG002|Overall Study|Physician Decision|0|||
161157141|NCT00634244|581955252|FG000|Overall Study|Disease progression/relapse|0|||
161157142|NCT00634244|581955253|FG001|Overall Study|Disease progression/relapse|1|||
161285689|NCT01928472|582425628|FG003|Overall Study|Lost to Follow-up|0|||
161285690|NCT01928472|582425625|FG000|Overall Study|Administrative Reason|2|||
161285691|NCT01928472|582425626|FG001|Overall Study|Administrative Reason|1|||
161285692|NCT01928472|582425627|FG002|Overall Study|Administrative Reason|0|||
161285693|NCT01928472|582425628|FG003|Overall Study|Administrative Reason|0|||
161285694|NCT01928472|582425625|FG000|Overall Study|Unclassified|0|||
161285695|NCT01928472|582425626|FG001|Overall Study|Unclassified|0|||
161285696|NCT01928472|582425627|FG002|Overall Study|Unclassified|1|||
161285697|NCT01928472|582425628|FG003|Overall Study|Unclassified|0|||
161285698|NCT03624192|582425630|FG000|Overall Study|Lost to Follow-up|1|||
161285699|NCT03624192|582425631|FG001|Overall Study|Lost to Follow-up|1|||
161285700|NCT01640249|582425632|FG000|Period 1|Withdrawal by Subject|1|||
161285701|NCT01640249|582425633|FG001|Period 1|Withdrawal by Subject|0|||
161285702|NCT01640249|582425634|FG002|Period 1|Withdrawal by Subject|0|||
161285703|NCT01640249|582425635|FG003|Period 1|Withdrawal by Subject|0|||
161285704|NCT01640249|582425636|FG004|Period 1|Withdrawal by Subject|0|||
161285705|NCT01640249|582425637|FG005|Period 1|Withdrawal by Subject|1|||
161285706|NCT01640249|582425638|FG006|Period 1|Withdrawal by Subject|0|||
161285707|NCT00065156|582425639|FG000|Overall Study|Adverse Event|37|||
161285708|NCT00065156|582425639|FG000|Overall Study|Lack of Efficacy|52|||
161285709|NCT00065156|582425639|FG000|Overall Study|Withdrawal by Subject|8|||
161285710|NCT00065156|582425639|FG000|Overall Study|Lost to Follow-up|1|||
161285711|NCT00065156|582425639|FG000|Overall Study|Death|11|||
161285712|NCT00065156|582425639|FG000|Overall Study|Study Closed by Sponsor|2|||
161285713|NCT00065156|582425639|FG000|Overall Study|Disease Progression|7|||
161285714|NCT00065156|582425639|FG000|Overall Study|Investigator Decision|2|||
161285715|NCT00065156|582425639|FG000|Overall Study|Non-Compliance|2|||
161285716|NCT00065156|582425639|FG000|Overall Study|Loss of Response|1|||
161285717|NCT00065156|582425639|FG000|Overall Study|Secondary Malign Disease|1|||
161285718|NCT00312338|582425640|FG000|Overall Study|Adverse Event|7|||
161285719|NCT00312338|582425641|FG001|Overall Study|Adverse Event|2|||
161285720|NCT00312338|582425640|FG000|Overall Study|Lost to Follow-up|9|||
161285721|NCT00312338|582425641|FG001|Overall Study|Lost to Follow-up|1|||
161285722|NCT00312338|582425640|FG000|Overall Study|Withdrawal by Subject|4|||
161285723|NCT00312338|582425641|FG001|Overall Study|Withdrawal by Subject|0|||
161285724|NCT00312338|582425640|FG000|Overall Study|Subsequent infection|2|||
161285725|NCT00312338|582425641|FG001|Overall Study|Subsequent infection|0|||
161285726|NCT00100828|582425642|FG000|Overall Study|Physician Decision|6|||
161285727|NCT01176513|582425643|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
161285728|NCT04583735|582425644|FG000|Double-masked Treatment Period|Adverse Event|0|||
161285729|NCT04583735|582425645|FG001|Double-masked Treatment Period|Adverse Event|1|||
161285730|NCT04583735|582425644|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
161285731|NCT04583735|582425645|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
161285732|NCT04583735|582425644|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
161285733|NCT04583735|582425645|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
161285734|NCT04583735|582425644|FG000|Open-label Treatment Period|Adverse Event|1|||
161285735|NCT04583735|582425645|FG001|Open-label Treatment Period|Adverse Event|1|||
161345646|NCT03881371|582650889|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161285736|NCT04583735|582425644|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
161285737|NCT04583735|582425645|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161285738|NCT04583735|582425644|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161285739|NCT04583735|582425645|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
161157143|NCT00634244|581955254|FG002|Overall Study|Disease progression/relapse|0|||
161157144|NCT00634244|581955252|FG000|Overall Study|Other complicating disease|0|||
161285740|NCT01215136|582425646|FG000|Overall Study|Adverse Event|2|||
161285741|NCT01215136|582425647|FG001|Overall Study|Adverse Event|9|||
161285742|NCT01215136|582425646|FG000|Overall Study|Disease Progression|3|||
161285743|NCT01215136|582425647|FG001|Overall Study|Disease Progression|14|||
161157145|NCT00634244|581955253|FG001|Overall Study|Other complicating disease|1|||
161157146|NCT00634244|581955254|FG002|Overall Study|Other complicating disease|0|||
161345647|NCT03881371|582650890|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161345648|NCT03881371|582650889|FG000|Overall Study|Physician Decision|3|||
161072435|NCT03812029|581654715|FG000|Overall Study|Stopping rules|0|||
161072436|NCT03812029|581654716|FG001|Overall Study|Stopping rules|1|||
161072437|NCT03812029|581654717|FG002|Overall Study|Stopping rules|0|||
161072438|NCT03812029|581654718|FG003|Overall Study|Stopping rules|0|||
161072439|NCT03812029|581654719|FG004|Overall Study|Stopping rules|0|||
161072440|NCT03812029|581654715|FG000|Overall Study|Adverse Event|0|||
161072441|NCT03812029|581654716|FG001|Overall Study|Adverse Event|9|||
161072442|NCT03812029|581654717|FG002|Overall Study|Adverse Event|0|||
161072443|NCT03812029|581654718|FG003|Overall Study|Adverse Event|3|||
161072444|NCT03812029|581654719|FG004|Overall Study|Adverse Event|5|||
161072445|NCT03812029|581654715|FG000|Overall Study|Lost to Follow-up|0|||
161072446|NCT03812029|581654716|FG001|Overall Study|Lost to Follow-up|0|||
161072447|NCT03812029|581654717|FG002|Overall Study|Lost to Follow-up|0|||
161072448|NCT03812029|581654718|FG003|Overall Study|Lost to Follow-up|0|||
161072449|NCT03812029|581654719|FG004|Overall Study|Lost to Follow-up|3|||
161072450|NCT03106753|581654720|FG000|Overall Study|Withdrawal by Subject|0|||
161072451|NCT03106753|581654721|FG001|Overall Study|Withdrawal by Subject|1|||
161072452|NCT01643044|581654723|FG000|Overall Study|Lost to Follow-up|1|||
161072453|NCT01643044|581654724|FG001|Overall Study|Lost to Follow-up|1|||
161072454|NCT01643044|581654723|FG000|Overall Study|Miscarried baby|2|||
161072455|NCT01643044|581654724|FG001|Overall Study|Miscarried baby|2|||
161072456|NCT01643044|581654723|FG000|Overall Study|Delivered outside of hospital|1|||
161072457|NCT01643044|581654724|FG001|Overall Study|Delivered outside of hospital|2|||
161072458|NCT03149042|581654725|FG000|Overall Study|Invasive FFR not performed|21|||
161072459|NCT03149042|581654725|FG000|Overall Study|Poor CT Image Quality|1|||
161072460|NCT03149042|581654725|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
161072461|NCT01023958|581654728|FG000|Overall Study|Progressive disease|48|||
161072462|NCT01023958|581654728|FG000|Overall Study|Other adverse event|1|||
161072463|NCT01023958|581654728|FG000|Overall Study|Refused to continue medication|1|||
161072464|NCT02362503|581654729|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
161072465|NCT02362503|581654730|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
161072466|NCT02362503|581654731|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
161072467|NCT02362503|581654729|FG000|Double-blind Period-Up to 8 Days|Death|1|||
161072468|NCT02362503|581654730|FG001|Double-blind Period-Up to 8 Days|Death|0|||
161072469|NCT02362503|581654731|FG002|Double-blind Period-Up to 8 Days|Death|0|||
161072470|NCT02362503|581654729|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
161072471|NCT02362503|581654730|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
161072472|NCT02362503|581654731|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
161072473|NCT02362503|581654729|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
161072474|NCT02362503|581654730|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
161072475|NCT02362503|581654731|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
161072476|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
161072477|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
161072478|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
161072479|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
161072480|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
161072481|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
161072482|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
161072483|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
161072484|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
161072485|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
161072486|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
161072487|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
161072488|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
161072489|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
161072490|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
161157147|NCT04369430|581955262|FG000|Overall Study|Adverse Event|2|||
161157148|NCT04369430|581955263|FG001|Overall Study|Adverse Event|3|||
161157149|NCT04369430|581955262|FG000|Overall Study|Death|1|||
161072491|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
161072492|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
161072493|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
161157150|NCT04369430|581955263|FG001|Overall Study|Death|0|||
161157151|NCT04369430|581955262|FG000|Overall Study|Withdrawal by Subject|4|||
161072494|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
161072495|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
161072496|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
161072497|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
161072498|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
161072499|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
161072500|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
161157152|NCT04369430|581955263|FG001|Overall Study|Withdrawal by Subject|3|||
161157153|NCT04369430|581955262|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
161157154|NCT04369430|581955263|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
161157155|NCT04369430|581955262|FG000|Overall Study|Lost to Follow-up|0|||
161157156|NCT04369430|581955263|FG001|Overall Study|Lost to Follow-up|1|||
161157157|NCT04737031|581955264|FG000|Overall Study|Patients who did not have a treatment visit|0|||
161157158|NCT04737031|581955265|FG001|Overall Study|Patients who did not have a treatment visit|31|||
161157159|NCT04737031|581955266|FG002|Overall Study|Patients who did not have a treatment visit|93|||
161157160|NCT04737031|581955267|FG003|Overall Study|Patients who did not have a treatment visit|227|||
161157161|NCT02723604|581957080|FG000|Overall Study|ineligible|1|||
161157162|NCT02723604|581957080|FG000|Overall Study|never received treatment|1|||
161157163|NCT00762372|581957081|FG000|Overall Study|Adverse Event|1|||
161157164|NCT00762372|581957082|FG001|Overall Study|Adverse Event|0|||
161157165|NCT00762372|581957083|FG002|Overall Study|Adverse Event|0|||
161157166|NCT02616185|581957084|FG000|Overall Study|Death|0|||
161157167|NCT02616185|581957085|FG001|Overall Study|Death|0|||
161157168|NCT02616185|581957086|FG002|Overall Study|Death|0|||
161157169|NCT02616185|581957087|FG003|Overall Study|Death|1|||
161157170|NCT02616185|581957088|FG004|Overall Study|Death|2|||
161157171|NCT02616185|581957089|FG005|Overall Study|Death|0|||
161157172|NCT02616185|581957090|FG006|Overall Study|Death|0|||
161157173|NCT02616185|581957091|FG007|Overall Study|Death|2|||
161157174|NCT02616185|581957092|FG008|Overall Study|Death|1|||
161157175|NCT02616185|581957084|FG000|Overall Study|Study terminated by sponsor|0|||
161157176|NCT02616185|581957085|FG001|Overall Study|Study terminated by sponsor|0|||
161157177|NCT02616185|581957086|FG002|Overall Study|Study terminated by sponsor|1|||
161157178|NCT02616185|581957087|FG003|Overall Study|Study terminated by sponsor|0|||
161157179|NCT02616185|581957088|FG004|Overall Study|Study terminated by sponsor|0|||
161157180|NCT02616185|581957089|FG005|Overall Study|Study terminated by sponsor|0|||
161157181|NCT02616185|581957090|FG006|Overall Study|Study terminated by sponsor|5|||
161157182|NCT02616185|581957091|FG007|Overall Study|Study terminated by sponsor|2|||
161157183|NCT02616185|581957092|FG008|Overall Study|Study terminated by sponsor|0|||
161285744|NCT01215136|582425646|FG000|Overall Study|Symptomatic Deterioration|1|||
161285745|NCT01215136|582425647|FG001|Overall Study|Symptomatic Deterioration|1|||
161285746|NCT01215136|582425646|FG000|Overall Study|Death|0|||
161285747|NCT01215136|582425647|FG001|Overall Study|Death|2|||
161285748|NCT01215136|582425646|FG000|Overall Study|Withdrawal by Subject|0|||
161285749|NCT01215136|582425647|FG001|Overall Study|Withdrawal by Subject|1|||
161285750|NCT01125917|582425652|FG000|Overall Study|Adverse Event|43|||
161285751|NCT01125917|582425652|FG000|Overall Study|Lost to Follow-up|23|||
161285752|NCT01125917|582425652|FG000|Overall Study|Withdrawal by Subject|31|||
161285753|NCT01125917|582425652|FG000|Overall Study|Administrative|223|||
161285754|NCT01125917|582425652|FG000|Overall Study|Lack of Efficacy|19|||
161285755|NCT04421131|582425653|FG000|Overall Study|Lost to Follow-up|1|||
161285756|NCT04421131|582425653|FG000|Overall Study|Protocol Violation|2|||
161285757|NCT04421131|582425653|FG000|Overall Study|App crashed|5|||
161285758|NCT02501928|582425658|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161285759|NCT02501928|582425659|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161285760|NCT02501928|582425660|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
161072501|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
161072502|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
161072503|NCT02362503|581654729|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
161072504|NCT02362503|581654730|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
161072505|NCT02362503|581654731|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
161072506|NCT00762476|581654732|FG000|Overall Study|Adverse Event|7|||
161072507|NCT00762476|581654733|FG001|Overall Study|Adverse Event|1|||
161072508|NCT00762476|581654732|FG000|Overall Study|Lost to Follow-up|2|||
161072509|NCT00762476|581654733|FG001|Overall Study|Lost to Follow-up|0|||
161072510|NCT00762476|581654732|FG000|Overall Study|Protocol Violation|5|||
161072511|NCT00762476|581654733|FG001|Overall Study|Protocol Violation|6|||
161072512|NCT00762476|581654732|FG000|Overall Study|Physician Decision|2|||
161072513|NCT00762476|581654733|FG001|Overall Study|Physician Decision|14|||
161072514|NCT00762476|581654732|FG000|Overall Study|Withdrawal by Subject|6|||
161072515|NCT00762476|581654733|FG001|Overall Study|Withdrawal by Subject|12|||
161072516|NCT00762476|581654732|FG000|Overall Study|antibiotic use|0|||
161072517|NCT00762476|581654733|FG001|Overall Study|antibiotic use|1|||
161072518|NCT00762476|581654732|FG000|Overall Study|non-compliance with study visits|0|||
161072519|NCT00762476|581654733|FG001|Overall Study|non-compliance with study visits|2|||
161072520|NCT00762476|581654732|FG000|Overall Study|Seasonal allergies|1|||
161072521|NCT00762476|581654733|FG001|Overall Study|Seasonal allergies|0|||
161157184|NCT02616185|581957084|FG000|Overall Study|Participant refused further follow-up|1|||
161157185|NCT02616185|581957085|FG001|Overall Study|Participant refused further follow-up|1|||
161157186|NCT02616185|581957086|FG002|Overall Study|Participant refused further follow-up|2|||
161072522|NCT02838134|581654734|FG000|Overall Study|Lost to Follow-up|1|||
161157187|NCT02616185|581957087|FG003|Overall Study|Participant refused further follow-up|3|||
161285761|NCT02501928|582425661|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
161285762|NCT02501928|582425662|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
161285763|NCT02501928|582425663|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
161285764|NCT01197911|582425664|FG000|Overall Study|Adverse Event|0|||
161285765|NCT01197911|582425665|FG001|Overall Study|Adverse Event|0|||
161285766|NCT01197911|582425666|FG002|Overall Study|Adverse Event|1|||
161285767|NCT02123446|582425667|FG000|Washout Period (1 Day)|Physician Decision|1|||
161285768|NCT02123446|582425668|FG001|Washout Period (1 Day)|Physician Decision|0|||
161285769|NCT02553772|582425670|FG000|Overall Study|Adverse Event|2|||
161285770|NCT02553772|582425671|FG001|Overall Study|Adverse Event|3|||
161285771|NCT02553772|582425670|FG000|Overall Study|Lost to Follow-up|2|||
161285772|NCT02553772|582425671|FG001|Overall Study|Lost to Follow-up|1|||
161285773|NCT02553772|582425670|FG000|Overall Study|Withdrawal of Consent|1|||
161285774|NCT02553772|582425671|FG001|Overall Study|Withdrawal of Consent|1|||
161285775|NCT02553772|582425670|FG000|Overall Study|Lack of Efficacy|1|||
161285776|NCT02553772|582425671|FG001|Overall Study|Lack of Efficacy|0|||
161285777|NCT02553772|582425670|FG000|Overall Study|Other Miscellaneous Reasons|0|||
161285778|NCT02553772|582425671|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161285779|NCT02466321|582425672|FG000|Overall Study|Death|26|||
161285780|NCT02466321|582425672|FG000|Overall Study|Revision|6|||
161285781|NCT02466321|582425672|FG000|Overall Study|Lost to Follow-up|60|||
161285782|NCT02466321|582425672|FG000|Overall Study|Did not receive study device|1|||
161285783|NCT04233073|582425673|FG000|Overall Study|Death|5|||
161285784|NCT03172494|582425674|FG000|Overall Study|Adverse Event|5|||
161345649|NCT03881371|582650890|FG001|Overall Study|Physician Decision|3|||
161072523|NCT02838134|581654735|FG001|Overall Study|Lost to Follow-up|2|||
161072524|NCT02838134|581654734|FG000|Overall Study|logistic problems|1|||
161072525|NCT02838134|581654735|FG001|Overall Study|logistic problems|1|||
161072526|NCT01912404|581654739|FG000|Overall Study|Due to personal reasons|1|||
161072527|NCT01912404|581654740|FG001|Overall Study|Due to personal reasons|0|||
161072528|NCT01430468|581654741|FG000|Overall Study|Physician Decision|2|||
161072529|NCT01430468|581654742|FG001|Overall Study|Physician Decision|1|||
161072530|NCT01430468|581654741|FG000|Overall Study|Withdrawal by Subject|5|||
161072531|NCT01430468|581654742|FG001|Overall Study|Withdrawal by Subject|5|||
161072532|NCT01281839|581654743|FG000|Overall Study|Lost to Follow-up|6|||
161072533|NCT01281839|581654744|FG001|Overall Study|Lost to Follow-up|3|||
161072534|NCT01281839|581654743|FG000|Overall Study|Withdrawal by Subject|4|||
161072535|NCT01281839|581654744|FG001|Overall Study|Withdrawal by Subject|10|||
161072536|NCT01281839|581654743|FG000|Overall Study|Reason not specified|0|||
161072537|NCT01281839|581654744|FG001|Overall Study|Reason not specified|1|||
161072538|NCT01443923|581654745|FG000|Overall Study|Adverse Event|1|||
161072539|NCT01443923|581654746|FG001|Overall Study|Adverse Event|0|||
161072540|NCT01245374|581654747|FG000|Overall Study|Protocol Violation|1|||
161072541|NCT01245374|581654747|FG000|Overall Study|Withdrawal by Subject|3|||
161072542|NCT04674189|581654748|FG000|Overall Study|Adverse Event|0|||
161072543|NCT04674189|581654749|FG001|Overall Study|Adverse Event|0|||
161072544|NCT04674189|581654750|FG002|Overall Study|Adverse Event|1|||
161072545|NCT04674189|581654748|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
161072546|NCT04674189|581654749|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
161072547|NCT04674189|581654750|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
161072548|NCT04674189|581654748|FG000|Overall Study|Physician Decision|1|||
161072549|NCT04674189|581654749|FG001|Overall Study|Physician Decision|0|||
161072550|NCT04674189|581654750|FG002|Overall Study|Physician Decision|0|||
161072551|NCT04674189|581654748|FG000|Overall Study|Withdrawal by Participant|83|||
161072552|NCT04674189|581654749|FG001|Overall Study|Withdrawal by Participant|71|||
161072553|NCT04674189|581654750|FG002|Overall Study|Withdrawal by Participant|142|||
161072554|NCT04674189|581654748|FG000|Overall Study|Lost to Follow-up|55|||
161072555|NCT04674189|581654749|FG001|Overall Study|Lost to Follow-up|53|||
161072556|NCT04674189|581654750|FG002|Overall Study|Lost to Follow-up|44|||
161072557|NCT04674189|581654748|FG000|Overall Study|Miscellaneous|27|||
161072558|NCT04674189|581654749|FG001|Overall Study|Miscellaneous|23|||
161072559|NCT04674189|581654750|FG002|Overall Study|Miscellaneous|207|||
161072560|NCT04674189|581654748|FG000|Overall Study|Did Not Receive Treatment|3|||
161072561|NCT04674189|581654749|FG001|Overall Study|Did Not Receive Treatment|1|||
161072562|NCT04674189|581654750|FG002|Overall Study|Did Not Receive Treatment|2|||
161072563|NCT02600897|581654755|FG000|Overall Study|Death|1|||
161072564|NCT02600897|581654756|FG001|Overall Study|Death|2|||
161072565|NCT02600897|581654757|FG002|Overall Study|Death|1|||
161072566|NCT02600897|581654758|FG003|Overall Study|Death|2|||
161072567|NCT02600897|581654759|FG004|Overall Study|Death|3|||
161072568|NCT02600897|581654760|FG005|Overall Study|Death|2|||
161072569|NCT02600897|581654761|FG006|Overall Study|Death|10|||
161072570|NCT02600897|581654762|FG007|Overall Study|Death|7|||
161072571|NCT02600897|581654763|FG008|Overall Study|Death|20|||
161072572|NCT02600897|581654755|FG000|Overall Study|Lost to Follow-up|1|||
161072573|NCT02600897|581654756|FG001|Overall Study|Lost to Follow-up|0|||
161285785|NCT03172494|582425675|FG001|Overall Study|Adverse Event|1|||
161285786|NCT03172494|582425676|FG002|Overall Study|Adverse Event|15|||
161285787|NCT03172494|582425674|FG000|Overall Study|Protocol Violation|3|||
161285788|NCT03172494|582425675|FG001|Overall Study|Protocol Violation|2|||
161157188|NCT02616185|581957088|FG004|Overall Study|Participant refused further follow-up|4|||
161157189|NCT02616185|581957089|FG005|Overall Study|Participant refused further follow-up|0|||
161157190|NCT02616185|581957090|FG006|Overall Study|Participant refused further follow-up|3|||
161157191|NCT02616185|581957091|FG007|Overall Study|Participant refused further follow-up|4|||
161157192|NCT02616185|581957092|FG008|Overall Study|Participant refused further follow-up|3|||
161157193|NCT02616185|581957084|FG000|Overall Study|Not reported|0|||
161157194|NCT02616185|581957085|FG001|Overall Study|Not reported|0|||
161157195|NCT02616185|581957086|FG002|Overall Study|Not reported|0|||
161157196|NCT02616185|581957087|FG003|Overall Study|Not reported|1|||
161157197|NCT02616185|581957088|FG004|Overall Study|Not reported|3|||
161157198|NCT02616185|581957089|FG005|Overall Study|Not reported|1|||
161157199|NCT02616185|581957090|FG006|Overall Study|Not reported|0|||
161157200|NCT02616185|581957091|FG007|Overall Study|Not reported|5|||
161157201|NCT02616185|581957092|FG008|Overall Study|Not reported|2|||
161157202|NCT00833248|581957099|FG000|Overall Study|Adverse Event|3|||
161157203|NCT00833248|581957100|FG001|Overall Study|Adverse Event|0|||
161157204|NCT00833248|581957099|FG000|Overall Study|Protocol Violation|1|||
161157205|NCT00833248|581957100|FG001|Overall Study|Protocol Violation|2|||
161157206|NCT00833248|581957099|FG000|Overall Study|Withdrawal by Subject|0|||
161157207|NCT00833248|581957100|FG001|Overall Study|Withdrawal by Subject|1|||
161157208|NCT01030458|581957105|FG000|Overall Study|Lost to Follow-up|9|||
161157209|NCT01030458|581957106|FG001|Overall Study|Lost to Follow-up|10|||
161157210|NCT01030458|581957105|FG000|Overall Study|Withdrawal by Subject|2|||
161157211|NCT01030458|581957106|FG001|Overall Study|Withdrawal by Subject|3|||
161157212|NCT01030458|581957105|FG000|Overall Study|Logistical reasons|9|||
161157213|NCT01030458|581957106|FG001|Overall Study|Logistical reasons|5|||
161157214|NCT01030458|581957105|FG000|Overall Study|Moved or changed job|6|||
161157215|NCT01030458|581957106|FG001|Overall Study|Moved or changed job|13|||
161157216|NCT01030458|581957105|FG000|Overall Study|Side effect of medication|1|||
161157217|NCT01030458|581957106|FG001|Overall Study|Side effect of medication|1|||
161157218|NCT00839423|581957109|FG000|Overall Study|Adverse Event|4|||
161157219|NCT00839423|581957110|FG001|Overall Study|Adverse Event|3|||
161157220|NCT00839423|581957111|FG002|Overall Study|Adverse Event|7|||
161157221|NCT00839423|581957112|FG003|Overall Study|Adverse Event|16|||
161157222|NCT00839423|581957109|FG000|Overall Study|Lack of Efficacy|6|||
161157223|NCT00839423|581957110|FG001|Overall Study|Lack of Efficacy|6|||
161157224|NCT00839423|581957111|FG002|Overall Study|Lack of Efficacy|3|||
161157225|NCT00839423|581957112|FG003|Overall Study|Lack of Efficacy|2|||
161157226|NCT00839423|581957109|FG000|Overall Study|Non-compliance|0|||
161157227|NCT00839423|581957110|FG001|Overall Study|Non-compliance|0|||
161157228|NCT00839423|581957111|FG002|Overall Study|Non-compliance|0|||
161157229|NCT00839423|581957112|FG003|Overall Study|Non-compliance|1|||
161157230|NCT00839423|581957109|FG000|Overall Study|Protocol Violation|0|||
161157231|NCT00839423|581957110|FG001|Overall Study|Protocol Violation|1|||
161157232|NCT00839423|581957111|FG002|Overall Study|Protocol Violation|2|||
161157233|NCT00839423|581957112|FG003|Overall Study|Protocol Violation|0|||
161072574|NCT02600897|581654757|FG002|Overall Study|Lost to Follow-up|0|||
161072575|NCT02600897|581654758|FG003|Overall Study|Lost to Follow-up|0|||
161072576|NCT02600897|581654759|FG004|Overall Study|Lost to Follow-up|0|||
161072577|NCT02600897|581654760|FG005|Overall Study|Lost to Follow-up|0|||
161072578|NCT02600897|581654761|FG006|Overall Study|Lost to Follow-up|0|||
161072579|NCT02600897|581654762|FG007|Overall Study|Lost to Follow-up|1|||
161072580|NCT02600897|581654763|FG008|Overall Study|Lost to Follow-up|0|||
161072581|NCT02600897|581654755|FG000|Overall Study|Withdrawal by Subject|0|||
161072582|NCT02600897|581654756|FG001|Overall Study|Withdrawal by Subject|0|||
161072583|NCT02600897|581654757|FG002|Overall Study|Withdrawal by Subject|0|||
161072584|NCT02600897|581654758|FG003|Overall Study|Withdrawal by Subject|0|||
161072585|NCT02600897|581654759|FG004|Overall Study|Withdrawal by Subject|0|||
161072586|NCT02600897|581654760|FG005|Overall Study|Withdrawal by Subject|0|||
161072587|NCT02600897|581654761|FG006|Overall Study|Withdrawal by Subject|0|||
161072588|NCT02600897|581654762|FG007|Overall Study|Withdrawal by Subject|4|||
161072589|NCT02600897|581654763|FG008|Overall Study|Withdrawal by Subject|2|||
161072590|NCT02600897|581654755|FG000|Overall Study|Reason Not Specified|0|||
161072591|NCT02600897|581654756|FG001|Overall Study|Reason Not Specified|0|||
161072592|NCT02600897|581654757|FG002|Overall Study|Reason Not Specified|0|||
161157234|NCT00839423|581957109|FG000|Overall Study|Withdrawal of consent|4|||
161157235|NCT00839423|581957110|FG001|Overall Study|Withdrawal of consent|0|||
161157236|NCT00839423|581957111|FG002|Overall Study|Withdrawal of consent|4|||
161157237|NCT00839423|581957112|FG003|Overall Study|Withdrawal of consent|1|||
161157238|NCT00839423|581957109|FG000|Overall Study|Lost to Follow-up|1|||
161157239|NCT00839423|581957110|FG001|Overall Study|Lost to Follow-up|0|||
161157240|NCT00839423|581957111|FG002|Overall Study|Lost to Follow-up|1|||
161072593|NCT02600897|581654758|FG003|Overall Study|Reason Not Specified|0|||
161072594|NCT02600897|581654759|FG004|Overall Study|Reason Not Specified|0|||
161157241|NCT00839423|581957112|FG003|Overall Study|Lost to Follow-up|0|||
161157242|NCT00839423|581957109|FG000|Overall Study|Administrative or other reasons|3|||
161157243|NCT00839423|581957110|FG001|Overall Study|Administrative or other reasons|0|||
161285789|NCT03172494|582425676|FG002|Overall Study|Protocol Violation|1|||
161285790|NCT03172494|582425674|FG000|Overall Study|Lack of Efficacy|0|||
161285791|NCT03172494|582425675|FG001|Overall Study|Lack of Efficacy|0|||
161285792|NCT03172494|582425676|FG002|Overall Study|Lack of Efficacy|4|||
161285793|NCT03172494|582425674|FG000|Overall Study|Pregnancy|0|||
161285794|NCT03172494|582425675|FG001|Overall Study|Pregnancy|1|||
161285795|NCT03172494|582425676|FG002|Overall Study|Pregnancy|0|||
161285796|NCT03172494|582425674|FG000|Overall Study|Withdrawal by Subject|10|||
161285797|NCT03172494|582425675|FG001|Overall Study|Withdrawal by Subject|8|||
161285798|NCT03172494|582425676|FG002|Overall Study|Withdrawal by Subject|8|||
161285799|NCT03172494|582425674|FG000|Overall Study|Severe hypoglycaemic episode|0|||
161285800|NCT03172494|582425675|FG001|Overall Study|Severe hypoglycaemic episode|0|||
161285801|NCT03172494|582425676|FG002|Overall Study|Severe hypoglycaemic episode|1|||
161285802|NCT03172494|582425674|FG000|Overall Study|Non-compliance towards treatment|2|||
161285803|NCT03172494|582425675|FG001|Overall Study|Non-compliance towards treatment|0|||
161285804|NCT03172494|582425676|FG002|Overall Study|Non-compliance towards treatment|0|||
161285805|NCT00243412|582425677|FG000|Overall Study|Death|0|||
161285806|NCT00243412|582425678|FG001|Overall Study|Death|1|||
161285807|NCT00243412|582425677|FG000|Overall Study|Adverse Event|4|||
161285808|NCT00243412|582425678|FG001|Overall Study|Adverse Event|2|||
161285809|NCT00243412|582425677|FG000|Overall Study|Lost to Follow-up|0|||
161285810|NCT00243412|582425678|FG001|Overall Study|Lost to Follow-up|1|||
161285811|NCT00243412|582425677|FG000|Overall Study|Physician Decision|1|||
161285812|NCT00243412|582425678|FG001|Overall Study|Physician Decision|1|||
161285813|NCT00243412|582425677|FG000|Overall Study|Withdrawal by Subject|4|||
161285814|NCT00243412|582425678|FG001|Overall Study|Withdrawal by Subject|5|||
161285815|NCT00243412|582425677|FG000|Overall Study|Other|1|||
161285816|NCT00243412|582425678|FG001|Overall Study|Other|1|||
161285817|NCT00143390|582425679|FG000|Overall Study|Death|2|||
161285818|NCT00143390|582425680|FG001|Overall Study|Death|0|||
161285819|NCT00143390|582425679|FG000|Overall Study|Not meeting entry criteria|2|||
161285820|NCT00143390|582425680|FG001|Overall Study|Not meeting entry criteria|5|||
161285821|NCT00143390|582425679|FG000|Overall Study|Withdrawal by Subject|4|||
161285822|NCT00143390|582425680|FG001|Overall Study|Withdrawal by Subject|4|||
161285823|NCT00143390|582425679|FG000|Overall Study|Progressive disease|119|||
161285824|NCT00143390|582425680|FG001|Overall Study|Progressive disease|115|||
161285825|NCT00143390|582425679|FG000|Overall Study|Protocol Violation|2|||
161285826|NCT00143390|582425680|FG001|Overall Study|Protocol Violation|0|||
161285827|NCT00143390|582425679|FG000|Overall Study|Study termination|10|||
161285828|NCT00143390|582425680|FG001|Overall Study|Study termination|15|||
161285829|NCT00143390|582425679|FG000|Overall Study|Adverse Event|9|||
161285830|NCT00143390|582425680|FG001|Overall Study|Adverse Event|8|||
161285831|NCT00143390|582425679|FG000|Overall Study|Other|1|||
161285832|NCT00143390|582425680|FG001|Overall Study|Other|2|||
161285833|NCT00041132|582425682|FG000|Overall Study|Adverse Event|19|||
161285834|NCT00041132|582425682|FG000|Overall Study|Death|1|||
161285835|NCT00041132|582425682|FG000|Overall Study|Not Eligible|7|||
161285836|NCT00041132|582425682|FG000|Overall Study|Withdrawal by Subject|1|||
161285837|NCT00041132|582425682|FG000|Overall Study|Physician Decision|2|||
161285838|NCT02764151|582425686|FG000|Overall Study|Subject refused further follow-up|0|||
161285839|NCT02764151|582425687|FG001|Overall Study|Subject refused further follow-up|0|||
161285840|NCT02764151|582425688|FG002|Overall Study|Subject refused further follow-up|0|||
161285841|NCT02764151|582425689|FG003|Overall Study|Subject refused further follow-up|1|||
161285842|NCT02764151|582425686|FG000|Overall Study|Other|0|||
161285843|NCT02764151|582425687|FG001|Overall Study|Other|0|||
161285844|NCT02764151|582425688|FG002|Overall Study|Other|0|||
161285845|NCT02764151|582425689|FG003|Overall Study|Other|2|||
161285846|NCT01450683|582425690|FG000|Overall Study|Adverse Event|2|||
161285847|NCT05101343|582425695|FG000|Overall Study|Withdrawal by Subject|2|||
161285848|NCT05101343|582425696|FG001|Overall Study|Withdrawal by Subject|1|||
161285849|NCT04779879|582425697|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161285850|NCT04779879|582425698|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161285851|NCT04779879|582425699|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161285852|NCT04779879|582425700|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
161285853|NCT04779879|582425701|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161285854|NCT04779879|582425702|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
161285855|NCT04779879|582425697|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
161285856|NCT04779879|582425698|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
161285857|NCT04779879|582425699|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
161285858|NCT04779879|582425700|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
161285859|NCT04779879|582425701|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
161285860|NCT04779879|582425702|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
161285861|NCT04779879|582425697|FG000|Part C: Up to Week 36|Death|0|||
161285862|NCT04779879|582425698|FG001|Part C: Up to Week 36|Death|0|||
161285863|NCT04779879|582425699|FG002|Part C: Up to Week 36|Death|0|||
161285864|NCT04779879|582425700|FG003|Part C: Up to Week 36|Death|0|||
161285865|NCT04779879|582425701|FG004|Part C: Up to Week 36|Death|0|||
161285866|NCT04779879|582425702|FG005|Part C: Up to Week 36|Death|1|||
161157244|NCT00839423|581957111|FG002|Overall Study|Administrative or other reasons|1|||
161157245|NCT00839423|581957112|FG003|Overall Study|Administrative or other reasons|0|||
161157246|NCT01071096|581957113|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
161157247|NCT01071096|581957114|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
161157248|NCT02585999|581957115|FG000|Overall Study|Lost to Follow-up|1|||
161157249|NCT02585999|581957115|FG000|Overall Study|Protocol Violation|1|||
161157250|NCT00288860|581957116|FG000|Overall Study|Did not complete intake|4|||
161157251|NCT00288860|581957117|FG001|Overall Study|Did not complete intake|8|||
161157252|NCT00288860|581957116|FG000|Overall Study|Death|4|||
161157253|NCT00288860|581957117|FG001|Overall Study|Death|3|||
161157254|NCT00288860|581957116|FG000|Overall Study|Withdrawal by Subject|20|||
161157255|NCT00288860|581957117|FG001|Overall Study|Withdrawal by Subject|15|||
161157256|NCT00288860|581957116|FG000|Overall Study|Lost to Follow-up|74|||
161157257|NCT00288860|581957117|FG001|Overall Study|Lost to Follow-up|71|||
161157258|NCT05142332|581957118|FG000|Overall Study|Withdrawal by Subject|0|||
161157259|NCT05142332|581957119|FG001|Overall Study|Withdrawal by Subject|1|||
161157260|NCT05142332|581957120|FG002|Overall Study|Withdrawal by Subject|2|||
161157261|NCT05142332|581957121|FG003|Overall Study|Withdrawal by Subject|0|||
161157262|NCT05142332|581957122|FG004|Overall Study|Withdrawal by Subject|0|||
161157263|NCT05142332|581957123|FG005|Overall Study|Withdrawal by Subject|2|||
161157264|NCT05142332|581957124|FG006|Overall Study|Withdrawal by Subject|6|||
161157265|NCT05142332|581957118|FG000|Overall Study|Left ED|3|||
161285867|NCT04779879|582425697|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
161285868|NCT04779879|582425698|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
161285869|NCT04779879|582425699|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
161285870|NCT04779879|582425700|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
161072595|NCT02600897|581654760|FG005|Overall Study|Reason Not Specified|0|||
161072596|NCT02600897|581654761|FG006|Overall Study|Reason Not Specified|0|||
161072597|NCT02600897|581654762|FG007|Overall Study|Reason Not Specified|0|||
161072598|NCT02600897|581654763|FG008|Overall Study|Reason Not Specified|1|||
161072599|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Adverse Event|10|||
161072600|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Adverse Event|9|||
161072601|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Adverse Event|7|||
161072602|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
161072603|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
161072604|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
161072605|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
161072606|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
161072607|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
161072608|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Physician Decision|7|||
161072609|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Physician Decision|3|||
161072610|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Physician Decision|2|||
161072611|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Pregnancy|2|||
161072612|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Pregnancy|1|||
161072613|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Pregnancy|3|||
161072614|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
161072615|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
161072616|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
161072617|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
161072618|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
161072619|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
161072620|NCT02614183|581654764|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
161072621|NCT02614183|581654765|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
161072622|NCT02614183|581654766|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
161072623|NCT02614183|581654764|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
161072624|NCT02614183|581654765|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
161072625|NCT02614183|581654766|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
161072626|NCT02614183|581654764|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
161072627|NCT02614183|581654765|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
161072628|NCT02614183|581654766|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
161072629|NCT02614183|581654764|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
161072630|NCT02614183|581654765|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
161072631|NCT02614183|581654766|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
161072632|NCT02614183|581654764|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
161072633|NCT02614183|581654765|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
161072634|NCT02614183|581654766|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
161072635|NCT03213704|581654768|FG000|Overall Study|Physician Decision|3|||
161072636|NCT03213704|581654768|FG000|Overall Study|Protocol Violation|1|||
161072637|NCT03213704|581654768|FG000|Overall Study|Progressive disease|4|||
161157266|NCT05142332|581957119|FG001|Overall Study|Left ED|0|||
161157267|NCT05142332|581957120|FG002|Overall Study|Left ED|4|||
161157268|NCT05142332|581957121|FG003|Overall Study|Left ED|6|||
161285871|NCT04779879|582425701|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
161285872|NCT04779879|582425702|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
161285873|NCT02854527|582425703|FG000|Overall Study|Adverse Event|0|||
161285874|NCT02854527|582425704|FG001|Overall Study|Adverse Event|0|||
161285875|NCT02854527|582425705|FG002|Overall Study|Adverse Event|0|||
161285876|NCT02854527|582425706|FG003|Overall Study|Adverse Event|0|||
161285877|NCT02854527|582425707|FG004|Overall Study|Adverse Event|1|||
161285878|NCT02854527|582425708|FG005|Overall Study|Adverse Event|0|||
161285879|NCT02854527|582425709|FG006|Overall Study|Adverse Event|0|||
161285880|NCT02854527|582425710|FG007|Overall Study|Adverse Event|0|||
161285881|NCT02854527|582425711|FG008|Overall Study|Adverse Event|0|||
161285882|NCT02854527|582425712|FG009|Overall Study|Adverse Event|0|||
161285883|NCT02854527|582425703|FG000|Overall Study|Lost to Follow-up|0|||
161285884|NCT02854527|582425704|FG001|Overall Study|Lost to Follow-up|0|||
161157269|NCT05142332|581957122|FG004|Overall Study|Left ED|1|||
161157270|NCT05142332|581957123|FG005|Overall Study|Left ED|2|||
161157271|NCT05142332|581957124|FG006|Overall Study|Left ED|6|||
161157272|NCT05142332|581957118|FG000|Overall Study|Physician Decision|0|||
161157273|NCT05142332|581957119|FG001|Overall Study|Physician Decision|0|||
161157274|NCT05142332|581957120|FG002|Overall Study|Physician Decision|2|||
161157275|NCT05142332|581957121|FG003|Overall Study|Physician Decision|1|||
161157276|NCT05142332|581957122|FG004|Overall Study|Physician Decision|0|||
161157277|NCT05142332|581957123|FG005|Overall Study|Physician Decision|0|||
161157278|NCT05142332|581957124|FG006|Overall Study|Physician Decision|3|||
161157279|NCT05142332|581957118|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
161157280|NCT05142332|581957119|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161157281|NCT05142332|581957120|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
161157282|NCT05142332|581957121|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
161157283|NCT05142332|581957122|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161157284|NCT05142332|581957123|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
161157285|NCT05142332|581957124|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
161157286|NCT00937560|581957130|FG000|Initial Treatment|Death|6|||
161157287|NCT00937560|581957130|FG000|Initial Treatment|Withdraw consent|3|||
161157288|NCT00937560|581957130|FG000|Initial Treatment|Adverse Event|1|||
161157289|NCT00937560|581957130|FG000|Initial Treatment|Lost to Follow-up|1|||
161157290|NCT00937560|581957130|FG000|Initial Treatment|No end of study page|10|||
161157291|NCT00937560|581957130|FG000|Maintenance Treatment|Death|12|||
161157292|NCT00937560|581957130|FG000|Maintenance Treatment|Withdraw consent|5|||
161157293|NCT00937560|581957130|FG000|Maintenance Treatment|According to protocol|1|||
161157294|NCT00411788|581957131|FG000|Overall Study|Protocol Violation|1|||
161157295|NCT00411788|581957131|FG000|Overall Study|Adverse Event|1|||
161157296|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
161157297|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
161157298|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
161157299|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
161157300|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
161157301|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
161157302|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
161157303|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
161157304|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
161157305|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
161157306|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
161157307|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
161157308|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
161157309|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
161157310|NCT00848549|581957132|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
161157311|NCT00848549|581957133|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
161157312|NCT00848549|581957132|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
161157313|NCT00848549|581957133|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
161157314|NCT00848549|581957132|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
161157315|NCT00848549|581957133|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
161285885|NCT02854527|582425705|FG002|Overall Study|Lost to Follow-up|0|||
161285886|NCT02854527|582425706|FG003|Overall Study|Lost to Follow-up|1|||
161285887|NCT02854527|582425707|FG004|Overall Study|Lost to Follow-up|0|||
161285888|NCT02854527|582425708|FG005|Overall Study|Lost to Follow-up|0|||
161285889|NCT02854527|582425709|FG006|Overall Study|Lost to Follow-up|0|||
161285890|NCT02854527|582425710|FG007|Overall Study|Lost to Follow-up|0|||
161285891|NCT02854527|582425711|FG008|Overall Study|Lost to Follow-up|0|||
161285892|NCT02854527|582425712|FG009|Overall Study|Lost to Follow-up|0|||
161157316|NCT00848549|581957132|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
161285893|NCT01959295|582425713|FG000|Overall Study|Adverse Event|2|||
161285894|NCT01959295|582425714|FG001|Overall Study|Adverse Event|0|||
161285895|NCT01959295|582425713|FG000|Overall Study|Lost to Follow-up|0|||
161157317|NCT00848549|581957133|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
161157318|NCT00848549|581957132|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
161157319|NCT00848549|581957133|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
161157320|NCT00848549|581957132|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
161157321|NCT00848549|581957133|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
161157322|NCT00848549|581957132|FG000|E2090-E044-314 (Extension Study)|Other|5|||
161157323|NCT00848549|581957133|FG001|E2090-E044-314 (Extension Study)|Other|6|||
161157324|NCT02561299|581957134|FG000|Overall Study|Death|2|||
161157325|NCT02561299|581957135|FG001|Overall Study|Death|4|||
161157326|NCT02561299|581957134|FG000|Overall Study|Lost to Follow-up|1|||
161157327|NCT02561299|581957135|FG001|Overall Study|Lost to Follow-up|0|||
161157328|NCT02561299|581957134|FG000|Overall Study|Withdrawal by Subject|2|||
161157329|NCT02561299|581957135|FG001|Overall Study|Withdrawal by Subject|2|||
161157330|NCT05631548|581957136|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
161157331|NCT05631548|581957137|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
161157332|NCT01219959|581957138|FG000|Overall Study|Adverse Event|6|||
161157333|NCT01219959|581957139|FG001|Overall Study|Adverse Event|14|||
161157334|NCT01219959|581957138|FG000|Overall Study|Physician Decision|0|||
161157335|NCT01219959|581957139|FG001|Overall Study|Physician Decision|4|||
161157336|NCT01219959|581957138|FG000|Overall Study|Withdrawal by Subject|0|||
161157337|NCT01219959|581957139|FG001|Overall Study|Withdrawal by Subject|2|||
161157338|NCT01219959|581957138|FG000|Overall Study|Renal Transplantation|0|||
161157339|NCT01219959|581957139|FG001|Overall Study|Renal Transplantation|3|||
161157340|NCT01219959|581957138|FG000|Overall Study|Other|1|||
161157341|NCT01219959|581957139|FG001|Overall Study|Other|0|||
161157342|NCT05906732|581957140|FG000|Overall Study|Withdrawal by Subject|1|||
161157343|NCT05906732|581957141|FG001|Overall Study|Withdrawal by Subject|0|||
161157344|NCT05906732|581957142|FG002|Overall Study|Withdrawal by Subject|0|||
161157345|NCT05906732|581957143|FG003|Overall Study|Withdrawal by Subject|0|||
161157346|NCT05906732|581957140|FG000|Overall Study|Physician Decision|2|||
161157347|NCT05906732|581957141|FG001|Overall Study|Physician Decision|4|||
161157348|NCT05906732|581957142|FG002|Overall Study|Physician Decision|0|||
161157349|NCT05906732|581957143|FG003|Overall Study|Physician Decision|0|||
161157350|NCT01248130|581957144|FG000|Overall Study|Protocol Violation|1|||
161157351|NCT01248130|581957145|FG001|Overall Study|Protocol Violation|0|||
161157352|NCT01248130|581957144|FG000|Overall Study|Ineligible|1|||
161157353|NCT01248130|581957145|FG001|Overall Study|Ineligible|0|||
161157354|NCT02052778|581957146|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161157355|NCT02052778|581957147|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161157356|NCT02052778|581957148|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161157357|NCT02052778|581957149|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
161157358|NCT02052778|581957150|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
161157359|NCT02052778|581957151|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
161157360|NCT02052778|581957152|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157361|NCT02052778|581957153|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
161285896|NCT01959295|582425714|FG001|Overall Study|Lost to Follow-up|2|||
161285897|NCT01959295|582425713|FG000|Overall Study|Physician Decision|2|||
161285898|NCT01959295|582425714|FG001|Overall Study|Physician Decision|3|||
161285899|NCT01959295|582425713|FG000|Overall Study|Protocol Violation|16|||
161285900|NCT01959295|582425714|FG001|Overall Study|Protocol Violation|5|||
161072638|NCT04680533|581654769|FG000|Overall Study|Screen failure|1|||
161072639|NCT01183390|581656655|FG000|First Intervention|Adverse Event|0|||
161072640|NCT01183390|581656656|FG001|First Intervention|Adverse Event|1|||
161072641|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Adverse Event|2|||
161072642|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Adverse Event|0|||
161072643|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Adverse Event|0|||
161072644|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Adverse Event|0|||
161072645|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
161072646|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
161072647|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
161072648|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
161072649|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
161072650|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
161072651|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
161072652|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
161072653|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Physician Decision|1|||
161072654|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Physician Decision|0|||
161072655|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Physician Decision|0|||
161072656|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Physician Decision|0|||
161072657|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Pregnancy|1|||
161072658|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Pregnancy|0|||
161285901|NCT01959295|582425713|FG000|Overall Study|Withdrawal by Subject|3|||
161285902|NCT01959295|582425714|FG001|Overall Study|Withdrawal by Subject|1|||
161285903|NCT01959295|582425713|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
161285904|NCT01959295|582425714|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
161285905|NCT01682811|582425715|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161285906|NCT01682811|582425716|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161072659|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Pregnancy|0|||
161072660|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Pregnancy|0|||
161072661|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
161072662|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
161072663|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161072664|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
161072665|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
161072666|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
161072667|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
161072668|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
161072669|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
161072670|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
161072671|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
161072672|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
161072673|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
161072674|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
161072675|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
161072676|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
161072677|NCT04057573|581656659|FG000|24-Week Double-Blind Period|Not Treated|1|||
161072678|NCT04057573|581656660|FG001|24-Week Double-Blind Period|Not Treated|0|||
161072679|NCT04057573|581656661|FG002|24-Week Double-Blind Period|Not Treated|0|||
161072680|NCT04057573|581656662|FG003|24-Week Double-Blind Period|Not Treated|0|||
161072681|NCT04057573|581656659|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
161072682|NCT04057573|581656660|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
161072683|NCT04057573|581656661|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
161072684|NCT04057573|581656662|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
161072685|NCT04057573|581656659|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
161072686|NCT04057573|581656660|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
161072687|NCT04057573|581656661|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
161072688|NCT04057573|581656662|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
161072689|NCT04057573|581656659|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
161072690|NCT04057573|581656660|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
161072691|NCT04057573|581656661|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
161072692|NCT04057573|581656662|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
161072693|NCT04057573|581656659|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
161072694|NCT04057573|581656660|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
161072695|NCT04057573|581656661|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
161072696|NCT04057573|581656662|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
161072697|NCT04057573|581656659|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
161072698|NCT04057573|581656660|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
161072699|NCT04057573|581656661|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
161072700|NCT04057573|581656662|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
161072701|NCT04991753|581656663|FG000|Overall Study|Withdrawal by Subject|0|||
161072702|NCT04991753|581656664|FG001|Overall Study|Withdrawal by Subject|1|||
161072703|NCT00233480|581656667|FG000|Overall Study|Underwent status II heart transplant|0|||
161072704|NCT00233480|581656668|FG001|Overall Study|Underwent status II heart transplant|1|||
161072705|NCT00474526|581656671|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
161072706|NCT00474526|581656672|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
161072707|NCT00474526|581656673|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
161072708|NCT00474526|581656674|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
161072709|NCT00474526|581656675|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
161072710|NCT00474526|581656676|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
161072711|NCT00474526|581656677|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
161072712|NCT00474526|581656678|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
161072713|NCT00474526|581656679|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
161072714|NCT00474526|581656680|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
161072715|NCT00474526|581656681|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
161072716|NCT00474526|581656682|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
161072717|NCT00474526|581656683|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
161072718|NCT00474526|581656684|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
161072719|NCT00474526|581656685|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
161072720|NCT00474526|581656686|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
161285907|NCT01682811|582425717|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161072721|NCT00474526|581656687|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
161072722|NCT00474526|581656671|FG000|Overall Study|Adverse Event|2|||
161072723|NCT00474526|581656672|FG001|Overall Study|Adverse Event|0|||
161072724|NCT00474526|581656673|FG002|Overall Study|Adverse Event|2|||
161072725|NCT00474526|581656674|FG003|Overall Study|Adverse Event|4|||
161072726|NCT00474526|581656675|FG004|Overall Study|Adverse Event|2|||
161072727|NCT00474526|581656676|FG005|Overall Study|Adverse Event|1|||
161072728|NCT00474526|581656677|FG006|Overall Study|Adverse Event|1|||
161072729|NCT00474526|581656678|FG007|Overall Study|Adverse Event|0|||
161072730|NCT00474526|581656679|FG008|Overall Study|Adverse Event|0|||
161072731|NCT00474526|581656680|FG009|Overall Study|Adverse Event|0|||
161072732|NCT00474526|581656681|FG010|Overall Study|Adverse Event|0|||
161072733|NCT00474526|581656682|FG011|Overall Study|Adverse Event|0|||
161072734|NCT00474526|581656683|FG012|Overall Study|Adverse Event|0|||
161072735|NCT00474526|581656684|FG013|Overall Study|Adverse Event|0|||
161072736|NCT00474526|581656685|FG014|Overall Study|Adverse Event|1|||
161072737|NCT00474526|581656686|FG015|Overall Study|Adverse Event|1|||
161072738|NCT00474526|581656687|FG016|Overall Study|Adverse Event|0|||
161072739|NCT00474526|581656671|FG000|Overall Study|Death|0|||
161072740|NCT00474526|581656672|FG001|Overall Study|Death|0|||
161072741|NCT00474526|581656673|FG002|Overall Study|Death|0|||
161072742|NCT00474526|581656674|FG003|Overall Study|Death|0|||
161072743|NCT00474526|581656675|FG004|Overall Study|Death|0|||
161072744|NCT00474526|581656676|FG005|Overall Study|Death|0|||
161072745|NCT00474526|581656677|FG006|Overall Study|Death|0|||
161072746|NCT00474526|581656678|FG007|Overall Study|Death|0|||
161072747|NCT00474526|581656679|FG008|Overall Study|Death|0|||
161072748|NCT00474526|581656680|FG009|Overall Study|Death|0|||
161072749|NCT00474526|581656681|FG010|Overall Study|Death|0|||
161072750|NCT00474526|581656682|FG011|Overall Study|Death|0|||
161072751|NCT00474526|581656683|FG012|Overall Study|Death|0|||
161072752|NCT00474526|581656684|FG013|Overall Study|Death|3|||
161072753|NCT00474526|581656685|FG014|Overall Study|Death|0|||
161072754|NCT00474526|581656686|FG015|Overall Study|Death|0|||
161072755|NCT00474526|581656687|FG016|Overall Study|Death|0|||
161072756|NCT00474526|581656671|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072757|NCT00474526|581656672|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
161072758|NCT00474526|581656673|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072759|NCT00474526|581656674|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
161072760|NCT00474526|581656675|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
161072761|NCT00474526|581656676|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072762|NCT00474526|581656677|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072763|NCT00474526|581656678|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072764|NCT00474526|581656679|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072765|NCT00474526|581656680|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161285908|NCT01682811|582425718|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161285909|NCT01682811|582425719|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
161285910|NCT01682811|582425720|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161285911|NCT01682811|582425721|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
161285912|NCT01682811|582425715|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
161285913|NCT01682811|582425716|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
161285914|NCT01682811|582425717|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
161285915|NCT01682811|582425718|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
161285916|NCT01682811|582425719|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
161285917|NCT01682811|582425720|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
161285918|NCT01682811|582425721|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
161285919|NCT01682811|582425715|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
161285920|NCT01682811|582425716|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
161285921|NCT01682811|582425717|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
161285922|NCT01682811|582425718|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
161285923|NCT01682811|582425719|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
161285924|NCT01682811|582425720|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
161285925|NCT01682811|582425721|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
161285926|NCT01682811|582425715|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
161285927|NCT01682811|582425716|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
161285928|NCT01682811|582425717|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
161285929|NCT01682811|582425718|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
161285930|NCT01682811|582425719|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
161285931|NCT01682811|582425720|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
161285932|NCT01682811|582425721|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
161285933|NCT02694328|582425726|FG000|Overall Study|Adverse Event|27|||
161285934|NCT02694328|582425727|FG001|Overall Study|Adverse Event|33|||
161285935|NCT02694328|582425726|FG000|Overall Study|Withdrawal by Subject|27|||
161285936|NCT02694328|582425727|FG001|Overall Study|Withdrawal by Subject|23|||
161285937|NCT02694328|582425726|FG000|Overall Study|Lost to Follow-up|26|||
161072766|NCT00474526|581656681|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161285938|NCT02694328|582425727|FG001|Overall Study|Lost to Follow-up|22|||
161072767|NCT00474526|581656682|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072768|NCT00474526|581656683|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072769|NCT00474526|581656684|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
161072770|NCT00474526|581656685|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
161072771|NCT00474526|581656686|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072772|NCT00474526|581656687|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
161072773|NCT00474526|581656671|FG000|Overall Study|Lost to Follow-up|8|||
161072774|NCT00474526|581656672|FG001|Overall Study|Lost to Follow-up|6|||
161072775|NCT00474526|581656673|FG002|Overall Study|Lost to Follow-up|13|||
161072776|NCT00474526|581656674|FG003|Overall Study|Lost to Follow-up|29|||
161072777|NCT00474526|581656675|FG004|Overall Study|Lost to Follow-up|11|||
161072778|NCT00474526|581656676|FG005|Overall Study|Lost to Follow-up|5|||
161072779|NCT00474526|581656677|FG006|Overall Study|Lost to Follow-up|8|||
161072780|NCT00474526|581656678|FG007|Overall Study|Lost to Follow-up|1|||
161072781|NCT00474526|581656679|FG008|Overall Study|Lost to Follow-up|0|||
161072782|NCT00474526|581656680|FG009|Overall Study|Lost to Follow-up|6|||
161072783|NCT00474526|581656681|FG010|Overall Study|Lost to Follow-up|2|||
161072784|NCT00474526|581656682|FG011|Overall Study|Lost to Follow-up|4|||
161072785|NCT00474526|581656683|FG012|Overall Study|Lost to Follow-up|6|||
161072786|NCT00474526|581656684|FG013|Overall Study|Lost to Follow-up|74|||
161072787|NCT00474526|581656685|FG014|Overall Study|Lost to Follow-up|29|||
161072788|NCT00474526|581656686|FG015|Overall Study|Lost to Follow-up|4|||
161072789|NCT00474526|581656687|FG016|Overall Study|Lost to Follow-up|5|||
161072790|NCT00474526|581656671|FG000|Overall Study|Protocol Violation|2|||
161072791|NCT00474526|581656672|FG001|Overall Study|Protocol Violation|6|||
161072792|NCT00474526|581656673|FG002|Overall Study|Protocol Violation|4|||
161072793|NCT00474526|581656674|FG003|Overall Study|Protocol Violation|12|||
161072794|NCT00474526|581656675|FG004|Overall Study|Protocol Violation|3|||
161072795|NCT00474526|581656676|FG005|Overall Study|Protocol Violation|1|||
161072796|NCT00474526|581656677|FG006|Overall Study|Protocol Violation|3|||
161072797|NCT00474526|581656678|FG007|Overall Study|Protocol Violation|0|||
161072798|NCT00474526|581656679|FG008|Overall Study|Protocol Violation|0|||
161072799|NCT00474526|581656680|FG009|Overall Study|Protocol Violation|4|||
161072800|NCT00474526|581656681|FG010|Overall Study|Protocol Violation|2|||
161072801|NCT00474526|581656682|FG011|Overall Study|Protocol Violation|2|||
161072802|NCT00474526|581656683|FG012|Overall Study|Protocol Violation|4|||
161072803|NCT00474526|581656684|FG013|Overall Study|Protocol Violation|19|||
161072804|NCT00474526|581656685|FG014|Overall Study|Protocol Violation|9|||
161072805|NCT00474526|581656686|FG015|Overall Study|Protocol Violation|6|||
161072806|NCT00474526|581656687|FG016|Overall Study|Protocol Violation|2|||
161072807|NCT00474526|581656671|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
161072808|NCT00474526|581656672|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
161072809|NCT00474526|581656673|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
161072810|NCT00474526|581656674|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
161072811|NCT00474526|581656675|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
161072812|NCT00474526|581656676|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
161072813|NCT00474526|581656677|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
161072814|NCT00474526|581656678|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
161072815|NCT00474526|581656679|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
161072816|NCT00474526|581656680|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
161072817|NCT00474526|581656681|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
161072818|NCT00474526|581656682|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
161072819|NCT00474526|581656683|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
161072820|NCT00474526|581656684|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
161072821|NCT00474526|581656685|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
161072822|NCT00474526|581656686|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
161072823|NCT00474526|581656687|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
161072824|NCT00474526|581656671|FG000|Overall Study|Withdrawal by Subject|9|||
161072825|NCT00474526|581656672|FG001|Overall Study|Withdrawal by Subject|24|||
161072826|NCT00474526|581656673|FG002|Overall Study|Withdrawal by Subject|21|||
161072827|NCT00474526|581656674|FG003|Overall Study|Withdrawal by Subject|52|||
161072828|NCT00474526|581656675|FG004|Overall Study|Withdrawal by Subject|38|||
161072829|NCT00474526|581656676|FG005|Overall Study|Withdrawal by Subject|6|||
161072830|NCT00474526|581656677|FG006|Overall Study|Withdrawal by Subject|12|||
161072831|NCT00474526|581656678|FG007|Overall Study|Withdrawal by Subject|4|||
161072832|NCT00474526|581656679|FG008|Overall Study|Withdrawal by Subject|4|||
161072833|NCT00474526|581656680|FG009|Overall Study|Withdrawal by Subject|13|||
161072834|NCT00474526|581656681|FG010|Overall Study|Withdrawal by Subject|5|||
161072835|NCT00474526|581656682|FG011|Overall Study|Withdrawal by Subject|4|||
161285939|NCT02694328|582425726|FG000|Overall Study|Noncompliant with study drug|11|||
161285940|NCT02694328|582425727|FG001|Overall Study|Noncompliant with study drug|8|||
161072836|NCT00474526|581656683|FG012|Overall Study|Withdrawal by Subject|4|||
161072837|NCT00474526|581656684|FG013|Overall Study|Withdrawal by Subject|37|||
161072838|NCT00474526|581656685|FG014|Overall Study|Withdrawal by Subject|22|||
161072839|NCT00474526|581656686|FG015|Overall Study|Withdrawal by Subject|1|||
161072840|NCT00474526|581656687|FG016|Overall Study|Withdrawal by Subject|1|||
161072841|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
161072842|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
161072843|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
161072844|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
161157362|NCT02052778|581957154|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
161157363|NCT02052778|581957155|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161157364|NCT02052778|581957156|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
161157365|NCT02052778|581957157|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
161157366|NCT02052778|581957158|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
161157367|NCT02052778|581957159|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
161157368|NCT02052778|581957160|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157369|NCT02052778|581957161|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157370|NCT02052778|581957162|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157371|NCT02052778|581957163|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157372|NCT02052778|581957164|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161285941|NCT02694328|582425726|FG000|Overall Study|Incarceration|1|||
161285942|NCT02694328|582425727|FG001|Overall Study|Incarceration|1|||
161285943|NCT02694328|582425726|FG000|Overall Study|Lack of Efficacy|1|||
161285944|NCT02694328|582425727|FG001|Overall Study|Lack of Efficacy|2|||
161285945|NCT02694328|582425726|FG000|Overall Study|Pregnancy|1|||
161285946|NCT02694328|582425727|FG001|Overall Study|Pregnancy|1|||
161285947|NCT02694328|582425726|FG000|Overall Study|Protocol Violation|6|||
161285948|NCT02694328|582425727|FG001|Overall Study|Protocol Violation|5|||
161285949|NCT02694328|582425726|FG000|Overall Study|Abnormal Laboratory Value|0|||
161285950|NCT02694328|582425727|FG001|Overall Study|Abnormal Laboratory Value|3|||
161285951|NCT04653454|582427956|FG000|Overall Study|Withdrawal by Subject|1|||
161285952|NCT04653454|582427956|FG000|Overall Study|Physician Decision|40|||
161285953|NCT05525520|582427957|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
161285954|NCT05525520|582427958|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
161285955|NCT05525520|582427957|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
161285956|NCT05525520|582427958|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
161285957|NCT05878093|582427959|FG000|Overall Study|Withdrawal by Subject|3|||
161285958|NCT05878093|582427960|FG001|Overall Study|Withdrawal by Subject|1|||
161285959|NCT02721732|582427961|FG000|Overall Study|Adverse Event|2|||
161285960|NCT02721732|582427962|FG001|Overall Study|Adverse Event|0|||
161285961|NCT02721732|582427963|FG002|Overall Study|Adverse Event|2|||
161285962|NCT02721732|582427964|FG003|Overall Study|Adverse Event|0|||
161285963|NCT02721732|582427965|FG004|Overall Study|Adverse Event|1|||
161285964|NCT02721732|582427966|FG005|Overall Study|Adverse Event|0|||
161285965|NCT02721732|582427967|FG006|Overall Study|Adverse Event|1|||
161285966|NCT02721732|582427968|FG007|Overall Study|Adverse Event|0|||
161285967|NCT02721732|582427969|FG008|Overall Study|Adverse Event|1|||
161285968|NCT02721732|582427970|FG009|Overall Study|Adverse Event|1|||
161285969|NCT02721732|582427961|FG000|Overall Study|Death|0|||
161285970|NCT02721732|582427962|FG001|Overall Study|Death|0|||
161285971|NCT02721732|582427963|FG002|Overall Study|Death|0|||
161285972|NCT02721732|582427964|FG003|Overall Study|Death|0|||
161285973|NCT02721732|582427965|FG004|Overall Study|Death|1|||
161285974|NCT02721732|582427966|FG005|Overall Study|Death|0|||
161285975|NCT02721732|582427967|FG006|Overall Study|Death|1|||
161285976|NCT02721732|582427968|FG007|Overall Study|Death|0|||
161285977|NCT02721732|582427969|FG008|Overall Study|Death|0|||
161285978|NCT02721732|582427970|FG009|Overall Study|Death|1|||
161285979|NCT02721732|582427961|FG000|Overall Study|Lack of Efficacy|12|||
161285980|NCT02721732|582427962|FG001|Overall Study|Lack of Efficacy|11|||
161285981|NCT02721732|582427963|FG002|Overall Study|Lack of Efficacy|18|||
161285982|NCT02721732|582427964|FG003|Overall Study|Lack of Efficacy|5|||
161285983|NCT02721732|582427965|FG004|Overall Study|Lack of Efficacy|21|||
161157373|NCT02052778|581957165|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157374|NCT02052778|581957166|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157375|NCT02052778|581957167|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157376|NCT02052778|581957168|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
161157377|NCT02052778|581957146|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161157378|NCT02052778|581957147|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161285984|NCT02721732|582427966|FG005|Overall Study|Lack of Efficacy|2|||
161285985|NCT02721732|582427967|FG006|Overall Study|Lack of Efficacy|8|||
161285986|NCT02721732|582427968|FG007|Overall Study|Lack of Efficacy|11|||
161285987|NCT02721732|582427969|FG008|Overall Study|Lack of Efficacy|10|||
161285988|NCT02721732|582427970|FG009|Overall Study|Lack of Efficacy|20|||
161285989|NCT02721732|582427961|FG000|Overall Study|Physician Decision|0|||
161285990|NCT02721732|582427962|FG001|Overall Study|Physician Decision|0|||
161285991|NCT02721732|582427963|FG002|Overall Study|Physician Decision|1|||
161285992|NCT02721732|582427964|FG003|Overall Study|Physician Decision|0|||
161285993|NCT02721732|582427965|FG004|Overall Study|Physician Decision|0|||
161285994|NCT02721732|582427966|FG005|Overall Study|Physician Decision|0|||
161285995|NCT02721732|582427967|FG006|Overall Study|Physician Decision|0|||
161285996|NCT02721732|582427968|FG007|Overall Study|Physician Decision|0|||
161285997|NCT02721732|582427969|FG008|Overall Study|Physician Decision|0|||
161345650|NCT03881371|582650889|FG000|Overall Study|Withdrawal by Subject|2|||
161157379|NCT02052778|581957148|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161157380|NCT02052778|581957149|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161157381|NCT02052778|581957150|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161157382|NCT02052778|581957151|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161157383|NCT02052778|581957152|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
161157384|NCT02052778|581957153|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161157385|NCT02052778|581957154|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
161157386|NCT02052778|581957155|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157387|NCT02052778|581957156|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157388|NCT02052778|581957157|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161157389|NCT02052778|581957158|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
161157390|NCT02052778|581957159|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
161157391|NCT02052778|581957160|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157392|NCT02052778|581957161|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157393|NCT02052778|581957162|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157394|NCT02052778|581957163|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157395|NCT02052778|581957164|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157396|NCT02052778|581957165|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157397|NCT02052778|581957166|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157398|NCT02052778|581957167|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157399|NCT02052778|581957168|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
161157400|NCT02052778|581957146|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157401|NCT02052778|581957147|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157402|NCT02052778|581957148|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157403|NCT02052778|581957149|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157404|NCT02052778|581957150|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157405|NCT02052778|581957151|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157406|NCT02052778|581957152|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157407|NCT02052778|581957153|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157408|NCT02052778|581957154|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157409|NCT02052778|581957155|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157410|NCT02052778|581957156|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157411|NCT02052778|581957157|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157412|NCT02052778|581957158|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157413|NCT02052778|581957159|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
161157414|NCT02052778|581957160|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157415|NCT02052778|581957161|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157416|NCT02052778|581957162|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157417|NCT02052778|581957163|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157418|NCT02052778|581957164|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157419|NCT02052778|581957165|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157420|NCT02052778|581957166|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157421|NCT02052778|581957167|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157422|NCT02052778|581957168|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
161157423|NCT02052778|581957146|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
161157424|NCT02052778|581957147|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
161157425|NCT02052778|581957148|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
161157426|NCT02052778|581957149|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
161157427|NCT02052778|581957150|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
161157428|NCT02052778|581957151|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
161157429|NCT02052778|581957152|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
161157430|NCT02052778|581957153|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
161157431|NCT02052778|581957154|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
161157432|NCT02052778|581957155|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
161157433|NCT02052778|581957156|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
161157434|NCT02052778|581957157|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
161157435|NCT02052778|581957158|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
161157436|NCT02052778|581957159|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
161157437|NCT02052778|581957160|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
161157438|NCT02052778|581957161|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
161157439|NCT02052778|581957162|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
161157440|NCT02052778|581957163|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
161157441|NCT02052778|581957164|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
161345651|NCT03881371|582650890|FG001|Overall Study|Withdrawal by Subject|10|||
161285998|NCT02721732|582427970|FG009|Overall Study|Physician Decision|0|||
161285999|NCT02721732|582427961|FG000|Overall Study|Withdrawal by Subject|1|||
161286000|NCT02721732|582427962|FG001|Overall Study|Withdrawal by Subject|0|||
161286001|NCT02721732|582427963|FG002|Overall Study|Withdrawal by Subject|0|||
161286002|NCT02721732|582427964|FG003|Overall Study|Withdrawal by Subject|0|||
161072845|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
161072846|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
161072847|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
161072848|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
161072849|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
161072850|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
161072851|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
161072852|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
161072853|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
161072854|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
161072855|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
161072856|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
161072857|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
161072858|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
161072859|NCT00132678|581656692|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
161072860|NCT00132678|581656693|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
161072861|NCT00132678|581656694|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
161072862|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Death|2|||
161072863|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Death|0|||
161072864|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Death|0|||
161072865|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
161072866|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
161072867|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
161072868|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
161072869|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
161072870|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
161072871|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
161072872|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
161072873|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
161286003|NCT02721732|582427965|FG004|Overall Study|Withdrawal by Subject|3|||
161286004|NCT02721732|582427966|FG005|Overall Study|Withdrawal by Subject|0|||
161286005|NCT02721732|582427967|FG006|Overall Study|Withdrawal by Subject|1|||
161286006|NCT02721732|582427968|FG007|Overall Study|Withdrawal by Subject|1|||
161286007|NCT02721732|582427969|FG008|Overall Study|Withdrawal by Subject|0|||
161286008|NCT02721732|582427970|FG009|Overall Study|Withdrawal by Subject|1|||
161286009|NCT02721732|582427961|FG000|Overall Study|Participant Choice|1|||
161286010|NCT02721732|582427962|FG001|Overall Study|Participant Choice|0|||
161286011|NCT02721732|582427963|FG002|Overall Study|Participant Choice|0|||
161286012|NCT02721732|582427964|FG003|Overall Study|Participant Choice|0|||
161286013|NCT02721732|582427965|FG004|Overall Study|Participant Choice|0|||
161286014|NCT02721732|582427966|FG005|Overall Study|Participant Choice|0|||
161345652|NCT03881371|582650889|FG000|Overall Study|Discontinuation from Study|1|||
161072874|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
161072875|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
161072876|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
161072877|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
161072878|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
161072879|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
161072880|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
161072881|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
161072882|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
161072883|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
161072884|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
161072885|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
161072886|NCT00132678|581656692|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
161072887|NCT00132678|581656693|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
161072888|NCT00132678|581656694|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
161072889|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
161072890|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
161286015|NCT02721732|582427967|FG006|Overall Study|Participant Choice|0|||
161286016|NCT02721732|582427968|FG007|Overall Study|Participant Choice|0|||
161286017|NCT02721732|582427969|FG008|Overall Study|Participant Choice|0|||
161345653|NCT03881371|582650890|FG001|Overall Study|Discontinuation from Study|0|||
161157442|NCT02052778|581957165|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
161157443|NCT02052778|581957166|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
161157444|NCT02052778|581957167|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
161157445|NCT02052778|581957168|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
161157446|NCT02052778|581957146|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157447|NCT02052778|581957147|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157448|NCT02052778|581957148|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157449|NCT02052778|581957149|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157450|NCT02052778|581957150|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157451|NCT02052778|581957151|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157452|NCT02052778|581957152|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157453|NCT02052778|581957153|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157454|NCT02052778|581957154|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
161157455|NCT02052778|581957155|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157456|NCT02052778|581957156|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157457|NCT02052778|581957157|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157458|NCT02052778|581957158|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157459|NCT02052778|581957159|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
161157460|NCT02052778|581957160|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157461|NCT02052778|581957161|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157462|NCT02052778|581957162|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157463|NCT02052778|581957163|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157464|NCT02052778|581957164|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157465|NCT02052778|581957165|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157466|NCT02052778|581957166|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157467|NCT02052778|581957167|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157468|NCT02052778|581957168|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
161157469|NCT02052778|581957146|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157470|NCT02052778|581957147|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157471|NCT02052778|581957148|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157472|NCT02052778|581957149|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157473|NCT02052778|581957150|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157474|NCT02052778|581957151|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
161157475|NCT02052778|581957152|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161286018|NCT02721732|582427970|FG009|Overall Study|Participant Choice|1|||
161286019|NCT02721732|582427961|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161072891|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
161072892|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
161072893|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
161072894|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
161072895|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
161072896|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
161072897|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
161072898|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
161072899|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
161072900|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
161072901|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
161072902|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
161072903|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
161072904|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
161072905|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
161072906|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
161072907|NCT00132678|581656692|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
161072908|NCT00132678|581656693|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
161072909|NCT00132678|581656694|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
161072910|NCT00953147|581656695|FG000|Overall Study|Adverse Event|8|||
161072911|NCT00953147|581656696|FG001|Overall Study|Adverse Event|16|||
161072912|NCT00953147|581656697|FG002|Overall Study|Adverse Event|6|||
161072913|NCT00953147|581656695|FG000|Overall Study|Protocol Violation|2|||
161072914|NCT00953147|581656696|FG001|Overall Study|Protocol Violation|8|||
161072915|NCT00953147|581656697|FG002|Overall Study|Protocol Violation|4|||
161072916|NCT00953147|581656695|FG000|Overall Study|Withdrawal by Subject|13|||
161072917|NCT00953147|581656696|FG001|Overall Study|Withdrawal by Subject|15|||
161072918|NCT00953147|581656697|FG002|Overall Study|Withdrawal by Subject|12|||
161072919|NCT00953147|581656695|FG000|Overall Study|Lost to Follow-up|8|||
161072920|NCT00953147|581656696|FG001|Overall Study|Lost to Follow-up|9|||
161072921|NCT00953147|581656697|FG002|Overall Study|Lost to Follow-up|4|||
161072922|NCT00953147|581656695|FG000|Overall Study|Physician Decision|2|||
161072923|NCT00953147|581656696|FG001|Overall Study|Physician Decision|7|||
161072924|NCT00953147|581656697|FG002|Overall Study|Physician Decision|3|||
161072925|NCT00953147|581656695|FG000|Overall Study|Other|4|||
161072926|NCT00953147|581656696|FG001|Overall Study|Other|11|||
161072927|NCT00953147|581656697|FG002|Overall Study|Other|13|||
161072928|NCT01484431|581656698|FG000|Period 1: High Dose|Physician Decision|0|||
161072929|NCT01484431|581656699|FG001|Period 1: High Dose|Physician Decision|1|||
161072930|NCT01484431|581656700|FG002|Period 1: High Dose|Physician Decision|0|||
161072931|NCT01484431|581656698|FG000|Period 2|Death|0|||
161072932|NCT01484431|581656699|FG001|Period 2|Death|1|||
161072933|NCT01484431|581656700|FG002|Period 2|Death|1|||
161072934|NCT01484431|581656698|FG000|Period 2|Physician Decision|0|||
161072935|NCT01484431|581656699|FG001|Period 2|Physician Decision|0|||
161072936|NCT01484431|581656700|FG002|Period 2|Physician Decision|1|||
161072937|NCT01484431|581656698|FG000|Period 2|Non-Compliance with Study Drug|1|||
161072938|NCT01484431|581656699|FG001|Period 2|Non-Compliance with Study Drug|0|||
161072939|NCT01484431|581656700|FG002|Period 2|Non-Compliance with Study Drug|0|||
161072940|NCT01251770|581656701|FG000|Overall Study|Protocol Violation|13|||
161072941|NCT01251770|581656702|FG001|Overall Study|Protocol Violation|7|||
161072942|NCT02514239|581656703|FG000|Overall Study|Refused to continue trial medication|0|||
161072943|NCT02514239|581656704|FG001|Overall Study|Refused to continue trial medication|0|||
161072944|NCT02514239|581656705|FG002|Overall Study|Refused to continue trial medication|0|||
161072945|NCT02514239|581656706|FG003|Overall Study|Refused to continue trial medication|0|||
161072946|NCT02514239|581656707|FG004|Overall Study|Refused to continue trial medication|0|||
161072947|NCT02514239|581656708|FG005|Overall Study|Refused to continue trial medication|0|||
161072948|NCT02514239|581656709|FG006|Overall Study|Refused to continue trial medication|0|||
161072949|NCT02514239|581656710|FG007|Overall Study|Refused to continue trial medication|0|||
161072950|NCT02514239|581656711|FG008|Overall Study|Refused to continue trial medication|0|||
161072951|NCT02514239|581656712|FG009|Overall Study|Refused to continue trial medication|1|||
161072952|NCT02514239|581656703|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072953|NCT02514239|581656704|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072954|NCT02514239|581656705|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072955|NCT02514239|581656706|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072956|NCT02514239|581656707|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072957|NCT02514239|581656708|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072958|NCT02514239|581656709|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072959|NCT02514239|581656710|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
161072960|NCT02514239|581656711|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
161072961|NCT02514239|581656712|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
161072962|NCT02514239|581656703|FG000|Overall Study|Not treated|0|||
161072963|NCT02514239|581656704|FG001|Overall Study|Not treated|1|||
161072964|NCT02514239|581656705|FG002|Overall Study|Not treated|0|||
161072965|NCT02514239|581656706|FG003|Overall Study|Not treated|0|||
161072966|NCT02514239|581656707|FG004|Overall Study|Not treated|0|||
161072967|NCT02514239|581656708|FG005|Overall Study|Not treated|0|||
161072968|NCT02514239|581656709|FG006|Overall Study|Not treated|0|||
161072969|NCT02514239|581656710|FG007|Overall Study|Not treated|0|||
161072970|NCT02514239|581656711|FG008|Overall Study|Not treated|0|||
161072971|NCT02514239|581656712|FG009|Overall Study|Not treated|0|||
161072972|NCT02514239|581656703|FG000|Overall Study|Other Adverse Events|2|||
161072973|NCT02514239|581656704|FG001|Overall Study|Other Adverse Events|0|||
161072974|NCT02514239|581656705|FG002|Overall Study|Other Adverse Events|0|||
161072975|NCT02514239|581656706|FG003|Overall Study|Other Adverse Events|1|||
161072976|NCT02514239|581656707|FG004|Overall Study|Other Adverse Events|0|||
161072977|NCT02514239|581656708|FG005|Overall Study|Other Adverse Events|1|||
161072978|NCT02514239|581656709|FG006|Overall Study|Other Adverse Events|0|||
161072979|NCT02514239|581656710|FG007|Overall Study|Other Adverse Events|1|||
161072980|NCT02514239|581656711|FG008|Overall Study|Other Adverse Events|2|||
161072981|NCT02514239|581656712|FG009|Overall Study|Other Adverse Events|0|||
161072982|NCT02514239|581656703|FG000|Overall Study|Progressive disease|3|||
161072983|NCT02514239|581656704|FG001|Overall Study|Progressive disease|3|||
161072984|NCT02514239|581656705|FG002|Overall Study|Progressive disease|2|||
161072985|NCT02514239|581656706|FG003|Overall Study|Progressive disease|2|||
161072986|NCT02514239|581656707|FG004|Overall Study|Progressive disease|3|||
161072987|NCT02514239|581656708|FG005|Overall Study|Progressive disease|3|||
161072988|NCT02514239|581656709|FG006|Overall Study|Progressive disease|4|||
161072989|NCT02514239|581656710|FG007|Overall Study|Progressive disease|2|||
161072990|NCT02514239|581656711|FG008|Overall Study|Progressive disease|5|||
161072991|NCT02514239|581656712|FG009|Overall Study|Progressive disease|0|||
161072992|NCT03299049|581656713|FG000|Overall Study|On-going|486|||
161072993|NCT03299049|581656714|FG001|Overall Study|On-going|481|||
161072994|NCT03299049|581656713|FG000|Overall Study|Withdrawal by Subject|6|||
161157476|NCT02052778|581957153|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157477|NCT02052778|581957154|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157478|NCT02052778|581957155|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157479|NCT02052778|581957156|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157480|NCT02052778|581957157|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157481|NCT02052778|581957158|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
161157482|NCT02052778|581957159|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157483|NCT02052778|581957160|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157484|NCT02052778|581957161|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157485|NCT02052778|581957162|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157486|NCT02052778|581957163|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157487|NCT02052778|581957164|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157488|NCT02052778|581957165|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157489|NCT02052778|581957166|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157490|NCT02052778|581957167|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157491|NCT02052778|581957168|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
161157492|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157493|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157494|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157495|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157496|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157497|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157498|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157499|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157500|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157501|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157502|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157503|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157504|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157505|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157506|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
161157507|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
161157508|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
161157509|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
161157510|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
161157511|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
161157512|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
161157513|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
161157514|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
161157515|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157516|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157517|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157518|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157519|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157520|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157521|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157522|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157523|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157524|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157525|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157526|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157527|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157528|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157529|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
161157530|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
161157531|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157532|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
161157533|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
161157534|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
161157535|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
161286020|NCT02721732|582427962|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161072995|NCT03299049|581656714|FG001|Overall Study|Withdrawal by Subject|21|||
161072996|NCT03299049|581656713|FG000|Overall Study|Physician Decision|5|||
161072997|NCT03299049|581656714|FG001|Overall Study|Physician Decision|1|||
161072998|NCT03299049|581656713|FG000|Overall Study|Lost to Follow-up|2|||
161072999|NCT03299049|581656714|FG001|Overall Study|Lost to Follow-up|0|||
161073000|NCT03299049|581656713|FG000|Overall Study|Pregnancy|1|||
161073001|NCT03299049|581656714|FG001|Overall Study|Pregnancy|3|||
161073002|NCT03299049|581656713|FG000|Overall Study|Protocol Violation|1|||
161073003|NCT03299049|581656714|FG001|Overall Study|Protocol Violation|1|||
161073004|NCT03299049|581656713|FG000|Overall Study|Lack of Efficacy|9|||
161073005|NCT03299049|581656714|FG001|Overall Study|Lack of Efficacy|3|||
161073006|NCT03299049|581656713|FG000|Overall Study|Adverse Event|12|||
161073007|NCT03299049|581656714|FG001|Overall Study|Adverse Event|13|||
161073008|NCT01901419|581656715|FG000|Overall Study|Protocol Violation|2|||
161073009|NCT01901419|581656716|FG001|Overall Study|Protocol Violation|6|||
161073010|NCT01901419|581656715|FG000|Overall Study|unavailable researchers|6|||
161157536|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
161157537|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
161157538|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157539|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157540|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157541|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157542|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157543|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157544|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157545|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157546|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157547|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157548|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157549|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157550|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157551|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157552|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
161157553|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161157554|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
161157555|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157556|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
161157557|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
161157558|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157559|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157560|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
161157561|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157562|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157563|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157564|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157565|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157566|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157567|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157568|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157569|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157570|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157571|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157572|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157573|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157574|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157575|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
161157576|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
161157577|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157578|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157579|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157580|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161073011|NCT01901419|581656716|FG001|Overall Study|unavailable researchers|3|||
161073012|NCT00475644|581656717|FG000|Overall Study|Protocol Violation|13|||
161073013|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
161073014|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
161073015|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
161157581|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157582|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157583|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
161157584|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157585|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157586|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157587|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157588|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157589|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157590|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157591|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157592|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157593|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157594|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157595|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157596|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157597|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157598|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
161157599|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
161157600|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157601|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157602|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157603|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
161157604|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157605|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157606|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
161157607|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
161157608|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
161157609|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
161157610|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
161157611|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
161157612|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
161157613|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
161157614|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
161157615|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
161157616|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
161157617|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
161157618|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
161157619|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
161157620|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
161157621|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
161157622|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
161157623|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
161157624|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
161157625|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
161157626|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
161157627|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
161157628|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
161157629|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
161157630|NCT02052778|581957146|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157631|NCT02052778|581957147|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157632|NCT02052778|581957148|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157633|NCT02052778|581957149|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157634|NCT02052778|581957150|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157635|NCT02052778|581957151|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157636|NCT02052778|581957152|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157637|NCT02052778|581957153|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157638|NCT02052778|581957154|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161286021|NCT02721732|582427963|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
161157639|NCT02052778|581957155|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161286022|NCT02721732|582427964|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161286023|NCT02721732|582427965|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161286024|NCT02721732|582427966|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161286025|NCT02721732|582427967|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161073016|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
161073017|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
161073018|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
161073019|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
161073020|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
161073021|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
161073022|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
161073023|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
161073024|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
161073025|NCT00790400|581656724|FG000|Double-blind Period (Core Phase)|Death|1|||
161073026|NCT00790400|581656725|FG001|Double-blind Period (Core Phase)|Death|0|||
161073027|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
161073028|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
161073029|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
161073030|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
161073031|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
161073032|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
161073033|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
161073034|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
161073035|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
161073036|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
161073037|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Death|1|||
161073038|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Death|0|||
161073039|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
161073040|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
161073041|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
161073042|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
161073043|NCT00790400|581656724|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
161073044|NCT00790400|581656725|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
161073045|NCT02412735|581656728|FG000|Overall Study|Adverse Event|0|||
161073046|NCT02412735|581656729|FG001|Overall Study|Adverse Event|1|||
161073047|NCT02412735|581656730|FG002|Overall Study|Adverse Event|2|||
161073048|NCT02412735|581656728|FG000|Overall Study|Withdrawal by Subject|23|||
161073049|NCT02412735|581656729|FG001|Overall Study|Withdrawal by Subject|27|||
161073050|NCT02412735|581656730|FG002|Overall Study|Withdrawal by Subject|22|||
161073051|NCT02412735|581656728|FG000|Overall Study|Investigator Decision|3|||
161073052|NCT02412735|581656729|FG001|Overall Study|Investigator Decision|3|||
161073053|NCT02412735|581656730|FG002|Overall Study|Investigator Decision|2|||
161073054|NCT02412735|581656728|FG000|Overall Study|Lost to Follow-up|17|||
161073055|NCT02412735|581656729|FG001|Overall Study|Lost to Follow-up|11|||
161073056|NCT02412735|581656730|FG002|Overall Study|Lost to Follow-up|18|||
161073057|NCT02412735|581656728|FG000|Overall Study|Reason not Specified|3|||
161073058|NCT02412735|581656729|FG001|Overall Study|Reason not Specified|2|||
161073059|NCT02412735|581656730|FG002|Overall Study|Reason not Specified|2|||
161073060|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
161073061|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
161073062|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
161073063|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
161073064|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Death|13|||
161073065|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Death|12|||
161073066|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Progression|257|||
161073067|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Progression|218|||
161073068|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
161073069|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
161073070|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
161073071|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
161073072|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
161073073|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
161073074|NCT01006980|581656731|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
161073075|NCT01006980|581656732|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
161073076|NCT01006980|581656731|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
161073077|NCT01006980|581656732|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
161073078|NCT01006980|581656731|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
161073079|NCT01006980|581656732|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
161073080|NCT01006980|581656731|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
161073081|NCT01006980|581656732|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
161073082|NCT01006980|581656731|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
161073083|NCT01006980|581656732|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
161073084|NCT01006980|581656731|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
161073085|NCT01006980|581656732|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
161073086|NCT00078338|581656733|FG000|Overall Study|Adverse Event|31|||
161073087|NCT00078338|581656734|FG001|Overall Study|Adverse Event|24|||
161073088|NCT00078338|581656733|FG000|Overall Study|Lost to Follow-up|17|||
161073089|NCT00078338|581656734|FG001|Overall Study|Lost to Follow-up|2|||
161073090|NCT00078338|581656733|FG000|Overall Study|Protocol Violation|2|||
161073091|NCT00078338|581656734|FG001|Overall Study|Protocol Violation|2|||
161073092|NCT00078338|581656733|FG000|Overall Study|Disease Progression|4|||
161073093|NCT00078338|581656734|FG001|Overall Study|Disease Progression|7|||
161073094|NCT00078338|581656733|FG000|Overall Study|Other|28|||
161073095|NCT00078338|581656734|FG001|Overall Study|Other|16|||
161073096|NCT00078338|581656733|FG000|Overall Study|Subjects randomized, but not treated|3|||
161073097|NCT00078338|581656734|FG001|Overall Study|Subjects randomized, but not treated|3|||
161073098|NCT02124811|581656735|FG000|Overall Study|Early termination|2|||
161073099|NCT02124811|581656736|FG001|Overall Study|Early termination|2|||
161073100|NCT02124811|581656735|FG000|Overall Study|Withdrawal by Subject|1|||
161073101|NCT02124811|581656736|FG001|Overall Study|Withdrawal by Subject|0|||
161073102|NCT03445533|581656739|FG000|Overall Study|Progressive Disease|48|||
161073103|NCT03445533|581656740|FG001|Overall Study|Progressive Disease|81|||
161073104|NCT03445533|581656739|FG000|Overall Study|Adverse Event|60|||
161073105|NCT03445533|581656740|FG001|Overall Study|Adverse Event|64|||
161073106|NCT03445533|581656739|FG000|Overall Study|Death|9|||
161073107|NCT03445533|581656740|FG001|Overall Study|Death|19|||
161073108|NCT03445533|581656739|FG000|Overall Study|Miscellaneous|0|||
161073109|NCT03445533|581656740|FG001|Overall Study|Miscellaneous|16|||
161073110|NCT03445533|581656739|FG000|Overall Study|Withdrawal by Subject|3|||
161073111|NCT03445533|581656740|FG001|Overall Study|Withdrawal by Subject|4|||
161073112|NCT03445533|581656739|FG000|Overall Study|Physician Decision|1|||
161073113|NCT03445533|581656740|FG001|Overall Study|Physician Decision|3|||
161073114|NCT03445533|581656739|FG000|Overall Study|Sponsor Decision|0|||
161073115|NCT03445533|581656740|FG001|Overall Study|Sponsor Decision|1|||
161073116|NCT03445533|581656739|FG000|Overall Study|Lost to Follow-up|0|||
161073117|NCT03445533|581656740|FG001|Overall Study|Lost to Follow-up|1|||
161073118|NCT03445533|581656739|FG000|Overall Study|Never Received any Study Treatment|7|||
161073119|NCT03445533|581656740|FG001|Overall Study|Never Received any Study Treatment|4|||
161073120|NCT03274453|581656741|FG000|Overall Study|Lost to Follow-up|2|||
161073121|NCT03274453|581656742|FG001|Overall Study|Lost to Follow-up|5|||
161073122|NCT03274453|581656743|FG002|Overall Study|Lost to Follow-up|4|||
161073123|NCT03274453|581656744|FG003|Overall Study|Lost to Follow-up|1|||
161073124|NCT03274453|581656741|FG000|Overall Study|Physician Decision|2|||
161073125|NCT03274453|581656742|FG001|Overall Study|Physician Decision|0|||
161073126|NCT03274453|581656743|FG002|Overall Study|Physician Decision|0|||
161073127|NCT03274453|581656744|FG003|Overall Study|Physician Decision|3|||
161073128|NCT03274453|581656741|FG000|Overall Study|Surgery Cancelled|0|||
161073129|NCT03274453|581656742|FG001|Overall Study|Surgery Cancelled|1|||
161073130|NCT03274453|581656743|FG002|Overall Study|Surgery Cancelled|0|||
161073131|NCT03274453|581656744|FG003|Overall Study|Surgery Cancelled|0|||
161073132|NCT01294397|581656745|FG000|Overall Study|Withdrawal by Subject|1|||
161073133|NCT01294397|581656745|FG000|Overall Study|Administrative Decision|1|||
161073134|NCT01967069|581656747|FG000|Overall Study|Adverse Event|2|||
161073135|NCT01967069|581656748|FG001|Overall Study|Adverse Event|2|||
161073136|NCT01967069|581656747|FG000|Overall Study|Lost to Follow-up|5|||
161073137|NCT01967069|581656748|FG001|Overall Study|Lost to Follow-up|2|||
161073138|NCT01967069|581656747|FG000|Overall Study|Withdrawal by Subject|1|||
161073139|NCT01967069|581656748|FG001|Overall Study|Withdrawal by Subject|3|||
161073140|NCT01967069|581656747|FG000|Overall Study|Lack of Efficacy|0|||
161073141|NCT01967069|581656748|FG001|Overall Study|Lack of Efficacy|1|||
161073142|NCT05569421|581656749|FG000|Overall Study|Withdrawal by Subject|1|||
161073143|NCT05569421|581656750|FG001|Overall Study|Withdrawal by Subject|0|||
161073144|NCT05569421|581656751|FG002|Overall Study|Withdrawal by Subject|0|||
161073145|NCT02643628|581656760|FG000|Overall Study|Lost to Follow-up|1|||
161073146|NCT02643628|581656761|FG001|Overall Study|Lost to Follow-up|4|||
161073147|NCT02643628|581656760|FG000|Overall Study|Withdrawal by Subject|0|||
161073148|NCT02643628|581656761|FG001|Overall Study|Withdrawal by Subject|1|||
161073149|NCT02643628|581656760|FG000|Overall Study|Relocated out of state|0|||
161073150|NCT02643628|581656761|FG001|Overall Study|Relocated out of state|1|||
161073151|NCT04805073|581656765|FG000|Overall Study|study personnel not available|2|||
161073152|NCT04805073|581656766|FG001|Overall Study|study personnel not available|0|||
161073153|NCT04805073|581656765|FG000|Overall Study|spinal anesthesia failure|0|||
161073154|NCT04805073|581656766|FG001|Overall Study|spinal anesthesia failure|1|||
161073155|NCT04805073|581656765|FG000|Overall Study|Lost to Follow-up|0|||
161073156|NCT04805073|581656766|FG001|Overall Study|Lost to Follow-up|2|||
161073157|NCT00422734|581656770|FG000|Overall Study|Physician Decision|1|||
161073158|NCT00422734|581656771|FG001|Overall Study|Physician Decision|1|||
161073159|NCT00422734|581656770|FG000|Overall Study|Protocol Violation|1|||
161073160|NCT00422734|581656771|FG001|Overall Study|Protocol Violation|6|||
161073161|NCT00422734|581656770|FG000|Overall Study|Withdrawal by Subject|12|||
161073162|NCT00422734|581656771|FG001|Overall Study|Withdrawal by Subject|8|||
161286026|NCT02721732|582427968|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161286027|NCT02721732|582427969|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161286028|NCT02721732|582427970|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
161286029|NCT02721732|582427961|FG000|Overall Study|Progression and withdrew consent|1|||
161286030|NCT02721732|582427962|FG001|Overall Study|Progression and withdrew consent|1|||
161286031|NCT02721732|582427963|FG002|Overall Study|Progression and withdrew consent|0|||
161286032|NCT02721732|582427964|FG003|Overall Study|Progression and withdrew consent|0|||
161286033|NCT02721732|582427965|FG004|Overall Study|Progression and withdrew consent|0|||
161286034|NCT02721732|582427966|FG005|Overall Study|Progression and withdrew consent|0|||
161286035|NCT02721732|582427967|FG006|Overall Study|Progression and withdrew consent|0|||
161286036|NCT02721732|582427968|FG007|Overall Study|Progression and withdrew consent|0|||
161286037|NCT02721732|582427969|FG008|Overall Study|Progression and withdrew consent|0|||
161286038|NCT02721732|582427970|FG009|Overall Study|Progression and withdrew consent|1|||
161286039|NCT02721732|582427961|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
161286040|NCT02721732|582427962|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
161286041|NCT02721732|582427963|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
161286042|NCT02721732|582427964|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
161286043|NCT02721732|582427965|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
161286044|NCT02721732|582427966|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
161286045|NCT02721732|582427967|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
161286046|NCT02721732|582427968|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
161286047|NCT02721732|582427969|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
161286048|NCT02721732|582427970|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
161286049|NCT04100018|582427971|FG000|Pre-Treatment Period|Not Reported|0|||
161286050|NCT04100018|582427972|FG001|Pre-Treatment Period|Not Reported|4|||
161286051|NCT04100018|582427971|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
161286052|NCT04100018|582427972|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
161286053|NCT04100018|582427971|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
161286054|NCT04100018|582427972|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
161286055|NCT04100018|582427971|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
161286056|NCT04100018|582427972|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161286057|NCT04100018|582427971|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
161286058|NCT04100018|582427972|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
161286059|NCT04100018|582427971|FG000|Treatment Period|Ongoing Treatment|1|||
161286060|NCT04100018|582427972|FG001|Treatment Period|Ongoing Treatment|0|||
161286061|NCT04100018|582427971|FG000|Treatment Period|Other Reason|26|||
161286062|NCT04100018|582427972|FG001|Treatment Period|Other Reason|37|||
161286063|NCT04100018|582427971|FG000|Treatment Period|Completed treatment as per protocol|1|||
161286064|NCT04100018|582427972|FG001|Treatment Period|Completed treatment as per protocol|2|||
161286065|NCT04100018|582427971|FG000|Treatment Period|Maximum clinical benefit|3|||
161286066|NCT04100018|582427972|FG001|Treatment Period|Maximum clinical benefit|0|||
161286067|NCT04100018|582427971|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
161286068|NCT04100018|582427972|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
161286069|NCT04100018|582427971|FG000|Treatment Period|Study drug toxicity|67|||
161286070|NCT04100018|582427972|FG001|Treatment Period|Study drug toxicity|28|||
161286071|NCT04100018|582427971|FG000|Treatment Period|Disease Progression|284|||
161286072|NCT04100018|582427972|FG001|Treatment Period|Disease Progression|327|||
161286073|NCT04100018|582427971|FG000|Treatment Period|Administrative reasons by sponsor|16|||
161286074|NCT04100018|582427972|FG001|Treatment Period|Administrative reasons by sponsor|30|||
161073163|NCT00422734|581656770|FG000|Overall Study|Adverse Event|0|||
161073164|NCT00422734|581656771|FG001|Overall Study|Adverse Event|3|||
161073165|NCT00422734|581656770|FG000|Overall Study|Partner Decision|0|||
161073166|NCT00422734|581656771|FG001|Overall Study|Partner Decision|3|||
161073167|NCT02975102|581656774|FG000|Overall Study|Adverse Event|2|||
161073168|NCT02975102|581656775|FG001|Overall Study|Adverse Event|1|||
161073169|NCT04148651|581656776|FG000|Overall Study|Lost to Follow-up|2|||
161073170|NCT02609672|581656777|FG000|Overall Study|Lost to Follow-up|3|||
161073171|NCT02609672|581656778|FG001|Overall Study|Lost to Follow-up|1|||
161073172|NCT03392168|581656779|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
161073173|NCT03392168|581656780|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
161073174|NCT03392168|581656781|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
161073175|NCT03392168|581656782|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
161073176|NCT03392168|581656779|FG000|Period 2: Cohort 2|Other|0|||
161073177|NCT03392168|581656780|FG001|Period 2: Cohort 2|Other|1|||
161073178|NCT03392168|581656781|FG002|Period 2: Cohort 2|Other|0|||
161073179|NCT03392168|581656782|FG003|Period 2: Cohort 2|Other|0|||
161073180|NCT01441635|581656784|FG000|Overall Study|Adverse Event|4|||
161073181|NCT01441635|581656785|FG001|Overall Study|Adverse Event|3|||
161286075|NCT04100018|582427971|FG000|Treatment Period|Poor/Non-Compliance|1|||
161286076|NCT04100018|582427972|FG001|Treatment Period|Poor/Non-Compliance|0|||
161286077|NCT04100018|582427971|FG000|Treatment Period|Lost to Follow-up|2|||
161073182|NCT01441635|581656786|FG002|Overall Study|Adverse Event|1|||
161073183|NCT01441635|581656787|FG003|Overall Study|Adverse Event|5|||
161073184|NCT01441635|581656788|FG004|Overall Study|Adverse Event|1|||
161073185|NCT01441635|581656789|FG005|Overall Study|Adverse Event|2|||
161073186|NCT01441635|581656790|FG006|Overall Study|Adverse Event|2|||
161073187|NCT01441635|581656791|FG007|Overall Study|Adverse Event|2|||
161073188|NCT01441635|581656792|FG008|Overall Study|Adverse Event|1|||
161073189|NCT01441635|581656793|FG009|Overall Study|Adverse Event|0|||
161073190|NCT01441635|581656784|FG000|Overall Study|Withdrawal by Subject|1|||
161073191|NCT01441635|581656785|FG001|Overall Study|Withdrawal by Subject|1|||
161073192|NCT01441635|581656786|FG002|Overall Study|Withdrawal by Subject|0|||
161073193|NCT01441635|581656787|FG003|Overall Study|Withdrawal by Subject|1|||
161073194|NCT01441635|581656788|FG004|Overall Study|Withdrawal by Subject|0|||
161073195|NCT01441635|581656789|FG005|Overall Study|Withdrawal by Subject|0|||
161073196|NCT01441635|581656790|FG006|Overall Study|Withdrawal by Subject|2|||
161073197|NCT01441635|581656791|FG007|Overall Study|Withdrawal by Subject|0|||
161073198|NCT01441635|581656792|FG008|Overall Study|Withdrawal by Subject|1|||
161073199|NCT01441635|581656793|FG009|Overall Study|Withdrawal by Subject|1|||
161073200|NCT01441635|581656784|FG000|Overall Study|Lost to Follow-up|0|||
161073201|NCT01441635|581656785|FG001|Overall Study|Lost to Follow-up|1|||
161073202|NCT01441635|581656786|FG002|Overall Study|Lost to Follow-up|1|||
161073203|NCT01441635|581656787|FG003|Overall Study|Lost to Follow-up|1|||
161073204|NCT01441635|581656788|FG004|Overall Study|Lost to Follow-up|1|||
161073205|NCT01441635|581656789|FG005|Overall Study|Lost to Follow-up|3|||
161073206|NCT01441635|581656790|FG006|Overall Study|Lost to Follow-up|1|||
161073207|NCT01441635|581656791|FG007|Overall Study|Lost to Follow-up|1|||
161073208|NCT01441635|581656792|FG008|Overall Study|Lost to Follow-up|0|||
161073209|NCT01441635|581656793|FG009|Overall Study|Lost to Follow-up|1|||
161073210|NCT01441635|581656784|FG000|Overall Study|Noncompliance|0|||
161073211|NCT01441635|581656785|FG001|Overall Study|Noncompliance|1|||
161073212|NCT01441635|581656786|FG002|Overall Study|Noncompliance|0|||
161073213|NCT01441635|581656787|FG003|Overall Study|Noncompliance|0|||
161073214|NCT01441635|581656788|FG004|Overall Study|Noncompliance|0|||
161073215|NCT01441635|581656789|FG005|Overall Study|Noncompliance|0|||
161073216|NCT01441635|581656790|FG006|Overall Study|Noncompliance|1|||
161073217|NCT01441635|581656791|FG007|Overall Study|Noncompliance|0|||
161073218|NCT01441635|581656792|FG008|Overall Study|Noncompliance|0|||
161073219|NCT01441635|581656793|FG009|Overall Study|Noncompliance|0|||
161073220|NCT01441635|581656784|FG000|Overall Study|Surgery or Invasive Intervention|0|||
161073221|NCT01441635|581656785|FG001|Overall Study|Surgery or Invasive Intervention|0|||
161073222|NCT01441635|581656786|FG002|Overall Study|Surgery or Invasive Intervention|1|||
161073223|NCT01441635|581656787|FG003|Overall Study|Surgery or Invasive Intervention|0|||
161073224|NCT01441635|581656788|FG004|Overall Study|Surgery or Invasive Intervention|0|||
161073225|NCT01441635|581656789|FG005|Overall Study|Surgery or Invasive Intervention|0|||
161073226|NCT01441635|581656790|FG006|Overall Study|Surgery or Invasive Intervention|0|||
161073227|NCT01441635|581656791|FG007|Overall Study|Surgery or Invasive Intervention|0|||
161073228|NCT01441635|581656792|FG008|Overall Study|Surgery or Invasive Intervention|0|||
161073229|NCT01441635|581656793|FG009|Overall Study|Surgery or Invasive Intervention|0|||
161073230|NCT01441635|581656784|FG000|Overall Study|Received Exclusionary Medication|1|||
161073231|NCT01441635|581656785|FG001|Overall Study|Received Exclusionary Medication|0|||
161073232|NCT01441635|581656786|FG002|Overall Study|Received Exclusionary Medication|0|||
161073233|NCT01441635|581656787|FG003|Overall Study|Received Exclusionary Medication|0|||
161073234|NCT01441635|581656788|FG004|Overall Study|Received Exclusionary Medication|0|||
161073235|NCT01441635|581656789|FG005|Overall Study|Received Exclusionary Medication|0|||
161073236|NCT01441635|581656790|FG006|Overall Study|Received Exclusionary Medication|0|||
161073237|NCT01441635|581656791|FG007|Overall Study|Received Exclusionary Medication|0|||
161073238|NCT01441635|581656792|FG008|Overall Study|Received Exclusionary Medication|0|||
161073239|NCT01441635|581656793|FG009|Overall Study|Received Exclusionary Medication|0|||
161073240|NCT01441635|581656784|FG000|Overall Study|Other|0|||
161073241|NCT01441635|581656785|FG001|Overall Study|Other|0|||
161073242|NCT01441635|581656786|FG002|Overall Study|Other|0|||
161073243|NCT01441635|581656787|FG003|Overall Study|Other|0|||
161073244|NCT01441635|581656788|FG004|Overall Study|Other|0|||
161073245|NCT01441635|581656789|FG005|Overall Study|Other|0|||
161073246|NCT01441635|581656790|FG006|Overall Study|Other|0|||
161073247|NCT01441635|581656791|FG007|Overall Study|Other|1|||
161073248|NCT01441635|581656792|FG008|Overall Study|Other|0|||
161073249|NCT01441635|581656793|FG009|Overall Study|Other|0|||
161073250|NCT02637323|581656795|FG000|Overall Study|Lost to Follow-up|2|||
161073251|NCT02637323|581656796|FG001|Overall Study|Lost to Follow-up|0|||
161073252|NCT02637323|581656795|FG000|Overall Study|Protocol Violation|0|||
161073253|NCT02637323|581656796|FG001|Overall Study|Protocol Violation|1|||
161073254|NCT01154140|581656797|FG000|Overall Study|Death|71|||
161073255|NCT01154140|581656798|FG001|Overall Study|Death|81|||
161073256|NCT01154140|581656797|FG000|Overall Study|Lost to Follow-up|4|||
161073257|NCT01154140|581656798|FG001|Overall Study|Lost to Follow-up|5|||
161073258|NCT01154140|581656797|FG000|Overall Study|Withdrawal by Subject|12|||
161073259|NCT01154140|581656798|FG001|Overall Study|Withdrawal by Subject|13|||
161073260|NCT01154140|581656797|FG000|Overall Study|Other|3|||
161073261|NCT01154140|581656798|FG001|Overall Study|Other|1|||
161073262|NCT01154140|581656797|FG000|Overall Study|Randomized but not treated|1|||
161073263|NCT01154140|581656798|FG001|Overall Study|Randomized but not treated|2|||
161073264|NCT00358644|581656799|FG000|Overall Study|Progressive Disease|21|||
161073265|NCT00358644|581656799|FG000|Overall Study|Adverse Event|7|||
161073266|NCT00358644|581656799|FG000|Overall Study|Death|11|||
161073267|NCT00358644|581656799|FG000|Overall Study|Withdrawal by Subject|4|||
161073268|NCT00358644|581656799|FG000|Overall Study|Physician Decision|6|||
161073269|NCT00358644|581656799|FG000|Overall Study|Patient not eligible for study|1|||
161073270|NCT03327831|581656800|FG000|Overall Study|Lost to Follow-up|2|||
161073271|NCT00368875|581656801|FG000|Overall Study|Adverse Event|0|||
161073272|NCT00368875|581656802|FG001|Overall Study|Adverse Event|12|||
161073273|NCT00368875|581656801|FG000|Overall Study|Progressive disease|3|||
161073274|NCT00368875|581656802|FG001|Overall Study|Progressive disease|27|||
161073275|NCT00368875|581656801|FG000|Overall Study|Withdrawal by Subject|2|||
161073276|NCT00368875|581656802|FG001|Overall Study|Withdrawal by Subject|6|||
161073277|NCT00368875|581656801|FG000|Overall Study|Other Reason|0|||
161073278|NCT00368875|581656802|FG001|Overall Study|Other Reason|2|||
161073279|NCT00368875|581656801|FG000|Overall Study|Alternative Therapy|1|||
161073280|NCT00368875|581656802|FG001|Overall Study|Alternative Therapy|1|||
161073281|NCT02595372|581656803|FG000|Overall Study|Adverse Event|6|||
161073282|NCT02595372|581656803|FG000|Overall Study|Physician Decision|2|||
161073283|NCT02595372|581656803|FG000|Overall Study|Disease Progression|1|||
161073284|NCT00401258|581656806|FG000|Overall Study|Adverse Event|7|||
161073285|NCT04297618|581656816|FG000|Overall Study|Adverse Event|1|||
161073286|NCT04297618|581656816|FG000|Overall Study|Withdrawal by Subject|1|||
161073287|NCT04704219|581656817|FG000|Overall Study|Screen Failure|1|||
161073288|NCT04704219|581656817|FG000|Overall Study|Withdrawal by Subject|1|||
161073289|NCT04704219|581656817|FG000|Overall Study|Death|78|||
161073290|NCT04704219|581656817|FG000|Overall Study|Participants Ongoing|80|||
161073291|NCT03816761|581658369|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161073292|NCT03816761|581658370|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161073293|NCT03816761|581658371|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161073294|NCT03816761|581658372|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161073295|NCT03816761|581658373|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
161073296|NCT03816761|581658374|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
161073297|NCT03816761|581658369|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
161073298|NCT03816761|581658370|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
161073299|NCT03816761|581658371|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
161073300|NCT03816761|581658372|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
161073301|NCT03816761|581658373|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
161073302|NCT03816761|581658374|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
161073303|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
161073304|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
161073305|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
161073306|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
161073307|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161073308|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
161073309|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
161073310|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
161073311|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
161073312|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161073313|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
161073314|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161073315|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
161073316|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
161073317|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161073318|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
161073319|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
161073320|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
161286078|NCT04100018|582427972|FG001|Treatment Period|Lost to Follow-up|2|||
161286079|NCT04100018|582427971|FG000|Treatment Period|Death|16|||
161286080|NCT04100018|582427972|FG001|Treatment Period|Death|11|||
161073321|NCT00603525|581658384|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
161073322|NCT00603525|581658385|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
161073323|NCT00603525|581658386|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
161073324|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161073325|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
161286081|NCT04100018|582427971|FG000|Treatment Period|Participant withdrew consent|10|||
161073326|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
161073327|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161073328|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
161157640|NCT02052778|581957156|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157641|NCT02052778|581957157|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157642|NCT02052778|581957158|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157643|NCT02052778|581957159|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157644|NCT02052778|581957160|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161157645|NCT02052778|581957161|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161157646|NCT02052778|581957162|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161157647|NCT02052778|581957163|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157648|NCT02052778|581957164|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
161157649|NCT02052778|581957165|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157650|NCT02052778|581957166|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157651|NCT02052778|581957167|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157652|NCT02052778|581957168|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
161157653|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157654|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157655|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157656|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157657|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157658|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157659|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157660|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157661|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157662|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157663|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157664|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157665|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157666|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157667|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157668|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157669|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157670|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157671|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157672|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157673|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157674|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
161157675|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
161157676|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157677|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157678|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157679|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157680|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157681|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157682|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157683|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157684|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157685|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157686|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157687|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157688|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157689|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157690|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157691|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157692|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157693|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157694|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157695|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157696|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157697|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
161157698|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
161157699|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157700|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157701|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157702|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157703|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157704|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157705|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157706|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157707|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157708|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157709|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157710|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157711|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157712|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157713|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157714|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157715|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157716|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157717|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157718|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157719|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157720|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
161157721|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
161157722|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157723|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157724|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157725|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157726|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157727|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157728|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157729|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157730|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157731|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157732|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157733|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157734|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157735|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157736|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157737|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157738|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157739|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157740|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157741|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157742|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157743|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
161157744|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
161157745|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157746|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157747|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157748|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157749|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157750|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157751|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157752|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157753|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157754|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157755|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157756|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157757|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157758|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157759|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157760|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157761|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157762|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157763|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157764|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157765|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157766|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
161157767|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
161345654|NCT00963235|582650893|FG000|Overall Study|Withdrawal by Subject|22|||
161157768|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
161157769|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
161157770|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
161157771|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
161157772|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
161157773|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
161157774|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
161157775|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
161286082|NCT04100018|582427972|FG001|Treatment Period|Participant withdrew consent|10|||
161157776|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
161157777|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
161157778|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
161157779|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
161157780|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
161157781|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
161157782|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
161157783|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
161157784|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
161157785|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
161157786|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
161157787|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
161157788|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
161157789|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
161157790|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
161157791|NCT02052778|581957146|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157792|NCT02052778|581957147|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157793|NCT02052778|581957148|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157794|NCT02052778|581957149|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157795|NCT02052778|581957150|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157796|NCT02052778|581957151|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157797|NCT02052778|581957152|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157798|NCT02052778|581957153|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157799|NCT02052778|581957154|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157800|NCT02052778|581957155|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157801|NCT02052778|581957156|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157802|NCT02052778|581957157|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157803|NCT02052778|581957158|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157804|NCT02052778|581957159|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157805|NCT02052778|581957160|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157806|NCT02052778|581957161|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157807|NCT02052778|581957162|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157808|NCT02052778|581957163|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157809|NCT02052778|581957164|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157810|NCT02052778|581957165|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157811|NCT02052778|581957166|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157812|NCT02052778|581957167|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
161157813|NCT02052778|581957168|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
161157814|NCT02345252|581957183|FG000|Double-Blind Phase|Adverse Event|2|||
161157815|NCT02345252|581957184|FG001|Double-Blind Phase|Adverse Event|3|||
161157816|NCT02345252|581957183|FG000|Double-Blind Phase|Death|1|||
161286083|NCT04100018|582427971|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
161286084|NCT04100018|582427972|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
161286085|NCT04100018|582427971|FG000|Treatment Period|Adverse Event|14|||
161286086|NCT04100018|582427972|FG001|Treatment Period|Adverse Event|6|||
161286087|NCT04100018|582427971|FG000|Treatment Period|Lack of Efficacy|4|||
161286088|NCT04100018|582427972|FG001|Treatment Period|Lack of Efficacy|2|||
161286089|NCT02848001|582427973|FG000|Overall Study|other reasons|0|||
161286090|NCT02848001|582427974|FG001|Overall Study|other reasons|0|||
161286091|NCT02848001|582427975|FG002|Overall Study|other reasons|1|||
161286092|NCT02848001|582427976|FG003|Overall Study|other reasons|0|||
161286093|NCT02848001|582427977|FG004|Overall Study|other reasons|4|||
161286094|NCT02848001|582427978|FG005|Overall Study|other reasons|1|||
161157817|NCT02345252|581957184|FG001|Double-Blind Phase|Death|2|||
161157818|NCT02345252|581957183|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161157819|NCT02345252|581957184|FG001|Double-Blind Phase|Lack of Efficacy|0|||
161157820|NCT02345252|581957183|FG000|Double-Blind Phase|Investigator's Discretion|4|||
161157821|NCT02345252|581957184|FG001|Double-Blind Phase|Investigator's Discretion|6|||
161157822|NCT02345252|581957183|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
161286095|NCT02848001|582427979|FG006|Overall Study|other reasons|0|||
161286096|NCT02848001|582427980|FG007|Overall Study|other reasons|2|||
161286097|NCT02848001|582427981|FG008|Overall Study|other reasons|2|||
161286098|NCT02848001|582427982|FG009|Overall Study|other reasons|3|||
161157823|NCT02345252|581957184|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
161157824|NCT02345252|581957183|FG000|Double-Blind Phase|Protocol Violation|2|||
161157825|NCT02345252|581957184|FG001|Double-Blind Phase|Protocol Violation|1|||
161157826|NCT02345252|581957183|FG000|Double-Blind Phase|Withdrew Consent|21|||
161157827|NCT02345252|581957184|FG001|Double-Blind Phase|Withdrew Consent|23|||
161157828|NCT02345252|581957183|FG000|Double-Blind Phase|Lost to Follow-up|8|||
161157829|NCT02345252|581957184|FG001|Double-Blind Phase|Lost to Follow-up|10|||
161157830|NCT02345252|581957183|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
161157831|NCT02345252|581957184|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
161157832|NCT00471536|581957195|FG000|Overall Study|Withdrawal by Subject|1|||
161157833|NCT01188564|581957198|FG000|Double-blind Phase|randomized not treated|1|||
161157834|NCT01188564|581957199|FG001|Double-blind Phase|randomized not treated|0|||
161157835|NCT01094730|581957202|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
161157836|NCT01094730|581957203|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
161157837|NCT01094730|581957202|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
161157838|NCT01094730|581957203|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
161157839|NCT01094730|581957202|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
161157840|NCT01094730|581957203|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
161157841|NCT01094730|581957202|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
161157842|NCT01094730|581957203|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
161157843|NCT01094730|581957202|FG000|Period 2 (14 Days)|Protocol Violation|2|||
161157844|NCT01094730|581957203|FG001|Period 2 (14 Days)|Protocol Violation|0|||
161157845|NCT01094730|581957202|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
161157846|NCT01094730|581957203|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
161157847|NCT01094730|581957202|FG000|Period 2 (14 Days)|Adverse Event|0|||
161157848|NCT01094730|581957203|FG001|Period 2 (14 Days)|Adverse Event|1|||
161157849|NCT01094730|581957202|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
161157850|NCT01094730|581957203|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
161157851|NCT04171037|581957204|FG000|Overall Study|Lost to Follow-up|1|||
161157852|NCT04171037|581957205|FG001|Overall Study|Lost to Follow-up|0|||
161157853|NCT04171037|581957204|FG000|Overall Study|Physician Decision|3|||
161157854|NCT04171037|581957205|FG001|Overall Study|Physician Decision|3|||
161157855|NCT01934894|581957206|FG000|Overall Study|Adverse Event|1|||
161157856|NCT01934894|581957207|FG001|Overall Study|Adverse Event|2|||
161157857|NCT01934894|581957206|FG000|Overall Study|Death|2|||
161157858|NCT01934894|581957207|FG001|Overall Study|Death|0|||
161157859|NCT01934894|581957206|FG000|Overall Study|Withdrawal by Subject|0|||
161157860|NCT01934894|581957207|FG001|Overall Study|Withdrawal by Subject|1|||
161157861|NCT01934894|581957206|FG000|Overall Study|Progressive Disease|3|||
161157862|NCT01934894|581957207|FG001|Overall Study|Progressive Disease|2|||
161157863|NCT01954251|581957208|FG000|Overall Study|Adverse Event|5|||
161157864|NCT01954251|581957209|FG001|Overall Study|Adverse Event|7|||
161157865|NCT01954251|581957208|FG000|Overall Study|Lost to Follow-up|6|||
161157866|NCT01954251|581957209|FG001|Overall Study|Lost to Follow-up|6|||
161157867|NCT01954251|581957208|FG000|Overall Study|Withdrawal by Subject|2|||
161157868|NCT01954251|581957209|FG001|Overall Study|Withdrawal by Subject|6|||
161157869|NCT04096326|581957210|FG000|Overall Study|Withdrawal by Subject|0|||
161157870|NCT04096326|581957211|FG001|Overall Study|Withdrawal by Subject|0|||
161157871|NCT04096326|581957212|FG002|Overall Study|Withdrawal by Subject|0|||
161157872|NCT04096326|581957213|FG003|Overall Study|Withdrawal by Subject|0|||
161157873|NCT04096326|581957214|FG004|Overall Study|Withdrawal by Subject|0|||
161157874|NCT04096326|581957215|FG005|Overall Study|Withdrawal by Subject|0|||
161157875|NCT04096326|581957216|FG006|Overall Study|Withdrawal by Subject|1|||
161157876|NCT04096326|581957217|FG007|Overall Study|Withdrawal by Subject|0|||
161157877|NCT04096326|581957218|FG008|Overall Study|Withdrawal by Subject|0|||
161157878|NCT04096326|581957219|FG009|Overall Study|Withdrawal by Subject|0|||
161157879|NCT04096326|581957210|FG000|Overall Study|Lost to Follow-up|0|||
161157880|NCT04096326|581957211|FG001|Overall Study|Lost to Follow-up|1|||
161157881|NCT04096326|581957212|FG002|Overall Study|Lost to Follow-up|0|||
161157882|NCT04096326|581957213|FG003|Overall Study|Lost to Follow-up|0|||
161157883|NCT04096326|581957214|FG004|Overall Study|Lost to Follow-up|0|||
161157884|NCT04096326|581957215|FG005|Overall Study|Lost to Follow-up|0|||
161157885|NCT04096326|581957216|FG006|Overall Study|Lost to Follow-up|0|||
161157886|NCT04096326|581957217|FG007|Overall Study|Lost to Follow-up|0|||
161157887|NCT04096326|581957218|FG008|Overall Study|Lost to Follow-up|0|||
161345655|NCT00963235|582650893|FG000|Overall Study|Lost to Follow-up|14|||
161157888|NCT04096326|581957219|FG009|Overall Study|Lost to Follow-up|0|||
161157889|NCT04096326|581957210|FG000|Overall Study|COVID-19-related reasons|0|||
161157890|NCT04096326|581957211|FG001|Overall Study|COVID-19-related reasons|0|||
161157891|NCT04096326|581957212|FG002|Overall Study|COVID-19-related reasons|0|||
161157892|NCT04096326|581957213|FG003|Overall Study|COVID-19-related reasons|0|||
161157893|NCT04096326|581957214|FG004|Overall Study|COVID-19-related reasons|1|||
161157894|NCT04096326|581957215|FG005|Overall Study|COVID-19-related reasons|5|||
161157895|NCT04096326|581957216|FG006|Overall Study|COVID-19-related reasons|0|||
161157896|NCT04096326|581957217|FG007|Overall Study|COVID-19-related reasons|0|||
161157897|NCT04096326|581957218|FG008|Overall Study|COVID-19-related reasons|0|||
161157898|NCT04096326|581957219|FG009|Overall Study|COVID-19-related reasons|0|||
161157899|NCT04804033|581957220|FG000|Period 1: DBT Phase|Adverse Event|1|||
161073329|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
161073330|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161073331|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
161073332|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
161073333|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161073334|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
161073335|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
161073336|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161073337|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
161073338|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
161073339|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161073340|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
161073341|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
161073342|NCT00603525|581658384|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161073343|NCT00603525|581658385|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
161073344|NCT00603525|581658386|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
161073345|NCT00603525|581658384|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
161073346|NCT00603525|581658385|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
161073347|NCT00603525|581658386|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
161073348|NCT01483144|581658387|FG000|Overall Study|Adverse Event|9|||
161073349|NCT01483144|581658388|FG001|Overall Study|Adverse Event|4|||
161073350|NCT01483144|581658389|FG002|Overall Study|Adverse Event|6|||
161073351|NCT01483144|581658387|FG000|Overall Study|Withdrawal by Subject|0|||
161073352|NCT01483144|581658388|FG001|Overall Study|Withdrawal by Subject|2|||
161073353|NCT01483144|581658389|FG002|Overall Study|Withdrawal by Subject|5|||
161073354|NCT01483144|581658387|FG000|Overall Study|Physician Decision|1|||
161073355|NCT01483144|581658388|FG001|Overall Study|Physician Decision|0|||
161073356|NCT01483144|581658389|FG002|Overall Study|Physician Decision|0|||
161073357|NCT01483144|581658387|FG000|Overall Study|Lost to Follow-up|2|||
161073358|NCT01483144|581658388|FG001|Overall Study|Lost to Follow-up|4|||
161073359|NCT01483144|581658389|FG002|Overall Study|Lost to Follow-up|1|||
161073360|NCT01483144|581658387|FG000|Overall Study|Protocol Violation|3|||
161073361|NCT01483144|581658388|FG001|Overall Study|Protocol Violation|3|||
161073362|NCT01483144|581658389|FG002|Overall Study|Protocol Violation|3|||
161073363|NCT04043143|581658390|FG000|Overall Study|Lost to Follow-up|5|||
161073364|NCT04043143|581658391|FG001|Overall Study|Lost to Follow-up|5|||
161073365|NCT04043143|581658390|FG000|Overall Study|screen failure|1|||
161073366|NCT04043143|581658391|FG001|Overall Study|screen failure|0|||
161073367|NCT05543174|581658392|FG000|Overall Study|Ongoing|7|||
161073368|NCT03374488|581658393|FG000|Overall Study|Death|13|||
161073369|NCT03374488|581658394|FG001|Overall Study|Death|13|||
161073370|NCT03374488|581658393|FG000|Overall Study|Withdrawal by Subject|3|||
161073371|NCT03374488|581658394|FG001|Overall Study|Withdrawal by Subject|1|||
161073372|NCT03374488|581658393|FG000|Overall Study|Physician Decision|3|||
161073373|NCT03374488|581658394|FG001|Overall Study|Physician Decision|0|||
161073374|NCT03104075|581658395|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
161073375|NCT03104075|581658396|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
161073376|NCT04896008|581658397|FG000|Overall Study|Ongoing|70|||
161073377|NCT04896008|581658398|FG001|Overall Study|Ongoing|38|||
161073378|NCT04896008|581658397|FG000|Overall Study|Adverse Event|0|||
161073379|NCT04896008|581658398|FG001|Overall Study|Adverse Event|2|||
161073380|NCT04896008|581658397|FG000|Overall Study|Death|5|||
161073381|NCT04896008|581658398|FG001|Overall Study|Death|10|||
161073382|NCT04896008|581658397|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
161073383|NCT04896008|581658398|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
161073384|NCT04896008|581658397|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
161073385|NCT04896008|581658398|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
161073386|NCT04896008|581658397|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
161073387|NCT04896008|581658398|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
161073388|NCT04896008|581658397|FG000|Overall Study|Withdrawal by Subject|1|||
161073389|NCT04896008|581658398|FG001|Overall Study|Withdrawal by Subject|4|||
161073390|NCT04896008|581658397|FG000|Overall Study|Investigator Decision|2|||
161073391|NCT04896008|581658398|FG001|Overall Study|Investigator Decision|0|||
161073392|NCT04896008|581658397|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
161073393|NCT04896008|581658398|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
161073394|NCT00944229|581658401|FG000|Overall Study|Withdrawal by Subject|11|||
161073395|NCT00944229|581658401|FG000|Overall Study|Physician Decision|14|||
161073396|NCT01810939|581658404|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
161073397|NCT01810939|581658405|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
161073398|NCT01810939|581658406|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
161073399|NCT01810939|581658404|FG000|Part A Treatment Period|Protocol Violation|2|||
161073400|NCT01810939|581658405|FG001|Part A Treatment Period|Protocol Violation|0|||
161073401|NCT01810939|581658406|FG002|Part A Treatment Period|Protocol Violation|0|||
161073402|NCT01810939|581658404|FG000|Part A Treatment Period|Adverse Event|10|||
161073403|NCT01810939|581658405|FG001|Part A Treatment Period|Adverse Event|0|||
161073404|NCT01810939|581658406|FG002|Part A Treatment Period|Adverse Event|0|||
161073405|NCT01810939|581658404|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
161073406|NCT01810939|581658405|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
161073407|NCT01810939|581658406|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
161073408|NCT01810939|581658404|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
161073409|NCT01810939|581658405|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
161073410|NCT01810939|581658406|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
161073411|NCT01810939|581658404|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
161073412|NCT01810939|581658405|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
161073413|NCT01810939|581658406|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
161073414|NCT01810939|581658404|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
161073415|NCT01810939|581658405|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
161073416|NCT01810939|581658406|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
161073417|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
161073418|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
161073419|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
161073420|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
161073421|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
161073422|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
161073423|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
161073424|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
161073425|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
161073426|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
161073427|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
161073428|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
161073429|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
161073430|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
161073431|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
161073432|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
161073433|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
161073434|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
161073435|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
161073436|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
161073437|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
161073438|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
161073439|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
161073440|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
161073441|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
161073442|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
161073443|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
161073444|NCT01810939|581658404|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
161073445|NCT01810939|581658405|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
161073446|NCT01810939|581658406|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
161073447|NCT04400487|581658409|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161073448|NCT04400487|581658409|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
161073449|NCT04400487|581658409|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
161073450|NCT03322540|581658415|FG000|Overall Study|Death|21|||
161073451|NCT03322540|581658416|FG001|Overall Study|Death|28|||
161073452|NCT03322540|581658415|FG000|Overall Study|Lost to Follow-up|0|||
161073453|NCT03322540|581658416|FG001|Overall Study|Lost to Follow-up|1|||
161073454|NCT03322540|581658415|FG000|Overall Study|Physician Decision|7|||
161073455|NCT03322540|581658416|FG001|Overall Study|Physician Decision|6|||
161073456|NCT03322540|581658415|FG000|Overall Study|Withdrawal by Subject|3|||
161073457|NCT03322540|581658416|FG001|Overall Study|Withdrawal by Subject|1|||
161073458|NCT03322540|581658415|FG000|Overall Study|Study terminated by sponsor|0|||
161286099|NCT02848001|582427983|FG010|Overall Study|other reasons|0|||
161073459|NCT03322540|581658416|FG001|Overall Study|Study terminated by sponsor|1|||
161073460|NCT01594827|581658419|FG000|Overall Study|Adverse Event|1|||
161073461|NCT01594827|581658420|FG001|Overall Study|Adverse Event|0|||
161073462|NCT01594827|581658419|FG000|Overall Study|Physician Decision|3|||
161073463|NCT01594827|581658420|FG001|Overall Study|Physician Decision|0|||
161073464|NCT01677299|581658421|FG000|Overall Study|Adverse Event|0|||
161286100|NCT02848001|582427984|FG011|Overall Study|other reasons|1|||
161073465|NCT01677299|581658422|FG001|Overall Study|Adverse Event|2|||
161073466|NCT01677299|581658423|FG002|Overall Study|Adverse Event|1|||
161073467|NCT01677299|581658424|FG003|Overall Study|Adverse Event|0|||
161073468|NCT01677299|581658421|FG000|Overall Study|Withdrawal by Subject|0|||
161073469|NCT01677299|581658422|FG001|Overall Study|Withdrawal by Subject|1|||
161073470|NCT01677299|581658423|FG002|Overall Study|Withdrawal by Subject|0|||
161073471|NCT01677299|581658424|FG003|Overall Study|Withdrawal by Subject|1|||
161073472|NCT02153905|581658425|FG000|Overall Study|Death|1|||
161073473|NCT02153905|581658426|FG001|Overall Study|Death|0|||
161073474|NCT00520845|581658427|FG000|Overall Study|Death|3|||
161073475|NCT00520845|581658427|FG000|Overall Study|Adverse Event|4|||
161073476|NCT00520845|581658427|FG000|Overall Study|Disease Progression, relapse|13|||
161073477|NCT00520845|581658427|FG000|Overall Study|Withdrawal by Subject|1|||
161073478|NCT00520845|581658427|FG000|Overall Study|Alternative Therapy|1|||
161073479|NCT00351377|581658428|FG000|Overall Study|Adverse Event|5|||
161073480|NCT00351377|581658428|FG000|Overall Study|Death|1|||
161073481|NCT00351377|581658428|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161073482|NCT02493062|581658430|FG000|Overall Study|Physician Decision|12|||
161073483|NCT01327612|581658431|FG000|Overall Study|Withdrawal by Subject|0|||
161073484|NCT01327612|581658432|FG001|Overall Study|Withdrawal by Subject|0|||
161073485|NCT01327612|581658433|FG002|Overall Study|Withdrawal by Subject|0|||
161073486|NCT01327612|581658434|FG003|Overall Study|Withdrawal by Subject|0|||
161073487|NCT01327612|581658435|FG004|Overall Study|Withdrawal by Subject|0|||
161073488|NCT01327612|581658436|FG005|Overall Study|Withdrawal by Subject|1|||
161073489|NCT01327612|581658437|FG006|Overall Study|Withdrawal by Subject|0|||
161073490|NCT01327612|581658431|FG000|Overall Study|Disease Progression|1|||
161073491|NCT01327612|581658432|FG001|Overall Study|Disease Progression|1|||
161073492|NCT01327612|581658433|FG002|Overall Study|Disease Progression|1|||
161073493|NCT01327612|581658434|FG003|Overall Study|Disease Progression|0|||
161073494|NCT01327612|581658435|FG004|Overall Study|Disease Progression|1|||
161073495|NCT01327612|581658436|FG005|Overall Study|Disease Progression|2|||
161073496|NCT01327612|581658437|FG006|Overall Study|Disease Progression|2|||
161073497|NCT01327612|581658431|FG000|Overall Study|Administrative Decision|0|||
161073498|NCT01327612|581658432|FG001|Overall Study|Administrative Decision|0|||
161073499|NCT01327612|581658433|FG002|Overall Study|Administrative Decision|0|||
161073500|NCT01327612|581658434|FG003|Overall Study|Administrative Decision|1|||
161073501|NCT01327612|581658435|FG004|Overall Study|Administrative Decision|0|||
161073502|NCT01327612|581658436|FG005|Overall Study|Administrative Decision|0|||
161073503|NCT01327612|581658437|FG006|Overall Study|Administrative Decision|0|||
161073504|NCT01327612|581658431|FG000|Overall Study|Death|0|||
161073505|NCT01327612|581658432|FG001|Overall Study|Death|0|||
161073506|NCT01327612|581658433|FG002|Overall Study|Death|0|||
161073507|NCT01327612|581658434|FG003|Overall Study|Death|0|||
161073508|NCT01327612|581658435|FG004|Overall Study|Death|1|||
161073509|NCT01327612|581658436|FG005|Overall Study|Death|0|||
161073510|NCT01327612|581658437|FG006|Overall Study|Death|0|||
161073511|NCT01661205|581658438|FG000|Overall Study|Physician Decision|2|||
161073512|NCT00874731|581658440|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
161073513|NCT00874731|581658441|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
161073514|NCT00874731|581658442|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
161073515|NCT00874731|581658440|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
161073516|NCT00874731|581658441|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
161073517|NCT00874731|581658442|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
161073518|NCT00874731|581658440|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
161073519|NCT00874731|581658441|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
161073520|NCT00874731|581658442|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
161073521|NCT00955708|581658443|FG000|Overall Study|Death|269|||
161073522|NCT00955708|581658443|FG000|Overall Study|Lost to Follow-up|72|||
161073523|NCT00955708|581658443|FG000|Overall Study|Physician Decision|36|||
161286101|NCT02848001|582427985|FG012|Overall Study|other reasons|1|||
161286102|NCT02848001|582427986|FG013|Overall Study|other reasons|0|||
161286103|NCT02848001|582427987|FG014|Overall Study|other reasons|0|||
161073524|NCT00955708|581658443|FG000|Overall Study|Protocol Violation|134|||
161073525|NCT00955708|581658443|FG000|Overall Study|Registry Conclusion|186|||
161073526|NCT00955708|581658443|FG000|Overall Study|Product removed from service|94|||
161073527|NCT00955708|581658443|FG000|Overall Study|Patient Refused to participate further|116|||
161073528|NCT00955708|581658443|FG000|Overall Study|Closure of study location|60|||
161073529|NCT00955708|581658443|FG000|Overall Study|Patient changed care provider/moved|91|||
161073530|NCT05105087|581658444|FG000|Overall Study|Withdrawal by Subject|2|||
161073531|NCT05105087|581658444|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
161073532|NCT01736540|581658447|FG000|Overall Study|Did not complete scan within 45 days|2|||
161073533|NCT01736540|581658447|FG000|Overall Study|Death|1|||
161073534|NCT01736540|581658447|FG000|Overall Study|Abnormal test procedure|1|||
161073535|NCT01736540|581658447|FG000|Overall Study|Withdrawal by Subject|5|||
161073536|NCT01736540|581658447|FG000|Overall Study|Protocol Violation|1|||
161286104|NCT02848001|582427988|FG015|Overall Study|other reasons|2|||
161073537|NCT01736540|581658447|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
161286105|NCT02848001|582427989|FG016|Overall Study|other reasons|1|||
161286106|NCT02848001|582427973|FG000|Overall Study|Lack of Efficacy|0|||
161286107|NCT02848001|582427974|FG001|Overall Study|Lack of Efficacy|1|||
161073538|NCT01736540|581658447|FG000|Overall Study|No show for MRI appointment|1|||
161073539|NCT01736540|581658447|FG000|Overall Study|Unable to make MRI appointment|3|||
161073540|NCT00581477|581658450|FG000|Overall Study|Physician Decision|2|||
161073541|NCT01735175|581658453|FG000|Overall Study|Withdrawal by Subject|9|||
161073542|NCT01735175|581658454|FG001|Overall Study|Withdrawal by Subject|2|||
161073543|NCT01735175|581658453|FG000|Overall Study|Lost to Follow-up|4|||
161073544|NCT01735175|581658454|FG001|Overall Study|Lost to Follow-up|2|||
161073545|NCT01735175|581658453|FG000|Overall Study|Death|3|||
161073546|NCT01735175|581658454|FG001|Overall Study|Death|2|||
161073547|NCT01735175|581658453|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
161073548|NCT01735175|581658454|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
161073549|NCT00790205|581658455|FG000|Overall Study|Lost to Follow-up|61|||
161073550|NCT00790205|581658456|FG001|Overall Study|Lost to Follow-up|71|||
161073551|NCT00790205|581658455|FG000|Overall Study|Withdrawal by Subject|299|||
161073552|NCT00790205|581658456|FG001|Overall Study|Withdrawal by Subject|363|||
161073553|NCT01031628|581658457|FG000|Overall Study|Study terminated early|0|||
161073554|NCT01031628|581658458|FG001|Overall Study|Study terminated early|1|||
161073555|NCT01031628|581658459|FG002|Overall Study|Study terminated early|3|||
161073556|NCT01031628|581658460|FG003|Overall Study|Study terminated early|0|||
161073557|NCT00755417|581658463|FG000|Overall Study|Adverse Event|28|||
161073558|NCT00755417|581658464|FG001|Overall Study|Adverse Event|20|||
161073559|NCT00755417|581658465|FG002|Overall Study|Adverse Event|7|||
161073560|NCT00755417|581658463|FG000|Overall Study|Lack of Efficacy|8|||
161073561|NCT00755417|581658464|FG001|Overall Study|Lack of Efficacy|4|||
161073562|NCT00755417|581658465|FG002|Overall Study|Lack of Efficacy|9|||
161073563|NCT00755417|581658463|FG000|Overall Study|Protocol Violation|2|||
161073564|NCT00755417|581658464|FG001|Overall Study|Protocol Violation|1|||
161073565|NCT00755417|581658465|FG002|Overall Study|Protocol Violation|1|||
161073566|NCT00755417|581658463|FG000|Overall Study|Lost to Follow-up|3|||
161073567|NCT00755417|581658464|FG001|Overall Study|Lost to Follow-up|0|||
161073568|NCT00755417|581658465|FG002|Overall Study|Lost to Follow-up|1|||
161073569|NCT00755417|581658463|FG000|Overall Study|Withdrawal by Subject|12|||
161073570|NCT00755417|581658464|FG001|Overall Study|Withdrawal by Subject|12|||
161073571|NCT00755417|581658465|FG002|Overall Study|Withdrawal by Subject|12|||
161073572|NCT00755417|581658463|FG000|Overall Study|Not specified or missing data|9|||
161073573|NCT00755417|581658464|FG001|Overall Study|Not specified or missing data|18|||
161073574|NCT00755417|581658465|FG002|Overall Study|Not specified or missing data|12|||
161073575|NCT02803593|581658466|FG000|Overall Study|Lost to Follow-up|17|||
161073576|NCT02803593|581658467|FG001|Overall Study|Lost to Follow-up|35|||
161073577|NCT05143138|581658468|FG000|Overall Study|Death|5|||
161073578|NCT05143138|581658469|FG001|Overall Study|Death|35|||
161073579|NCT05143138|581658470|FG002|Overall Study|Death|1|||
161073580|NCT05143138|581658468|FG000|Overall Study|Lost to Follow-up|2|||
161073581|NCT05143138|581658469|FG001|Overall Study|Lost to Follow-up|4|||
161073582|NCT05143138|581658470|FG002|Overall Study|Lost to Follow-up|0|||
161073583|NCT05143138|581658468|FG000|Overall Study|withdrawal|1|||
161073584|NCT05143138|581658469|FG001|Overall Study|withdrawal|1|||
161073585|NCT05143138|581658470|FG002|Overall Study|withdrawal|0|||
161073586|NCT04245345|581658473|FG000|Overall Study|Death|1|||
161073587|NCT04245345|581658473|FG000|Overall Study|Exited prior to implant|5|||
161073588|NCT04245345|581658473|FG000|Overall Study|Exited prior to 1-month|9|||
161073589|NCT04245345|581658473|FG000|Overall Study|Missed 1-month visit|3|||
161073590|NCT04245345|581658473|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
161073591|NCT04245345|581658473|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
161073592|NCT03933462|581658474|FG000|Overall Study|Adverse Event|2|||
161073593|NCT03933462|581658475|FG001|Overall Study|Adverse Event|0|||
161073594|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
161073595|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
161073596|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
161073597|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
161073598|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
161073599|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
161073600|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
161073601|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
161073602|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
161073603|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
161073604|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
161073605|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
161073606|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
161073607|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
161073608|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
161073609|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
161073610|NCT04210843|581658476|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
161073611|NCT04210843|581658477|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
161073612|NCT04210843|581658476|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
161073613|NCT04210843|581658477|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
161073614|NCT04210843|581658476|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
161073615|NCT04210843|581658477|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
161073616|NCT04210843|581658476|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
161073617|NCT04210843|581658477|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
161073618|NCT04210843|581658476|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
161073619|NCT04210843|581658477|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
161073620|NCT04210843|581658476|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
161073621|NCT04210843|581658477|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
161073622|NCT04210843|581658476|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
161073623|NCT04210843|581658477|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
161073624|NCT04210843|581658476|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
161073625|NCT04210843|581658477|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
161073626|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
161073627|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
161073628|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
161073629|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
161073630|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
161073631|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
161073632|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
161073633|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
161073634|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
161073635|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
161073636|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
161073637|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
161073638|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
161073639|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
161073640|NCT04210843|581658476|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
161073641|NCT04210843|581658477|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
161073642|NCT01485120|581658486|FG000|Overall Study|Withdrawal by Subject|2|||
161073643|NCT00848484|581658487|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
161073644|NCT00848484|581658488|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
161073645|NCT00848484|581658487|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
161073646|NCT00848484|581658488|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
161073647|NCT00848484|581658487|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
161073648|NCT00848484|581658488|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
161073649|NCT00848484|581658487|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
161073650|NCT00848484|581658488|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
161073651|NCT00848484|581658487|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
161073652|NCT00848484|581658488|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
161073653|NCT01081886|581658489|FG000|Overall Study|Study termination|11|||
161286108|NCT02848001|582427975|FG002|Overall Study|Lack of Efficacy|1|||
161286109|NCT02848001|582427976|FG003|Overall Study|Lack of Efficacy|2|||
161073654|NCT01081886|581658490|FG001|Overall Study|Study termination|13|||
161073655|NCT03017742|581658492|FG000|Overall Study|Protocol Violation|36|||
161073656|NCT03017742|581658492|FG000|Overall Study|Withdrawal by Subject|37|||
161073657|NCT05262751|581658495|FG000|Washout Period 2|Adverse Event|1|||
161073658|NCT05262751|581658496|FG001|Washout Period 2|Adverse Event|0|||
161073659|NCT05262751|581658497|FG002|Washout Period 2|Adverse Event|0|||
161073660|NCT05262751|581658498|FG003|Washout Period 2|Adverse Event|0|||
161073661|NCT05262751|581658499|FG004|Washout Period 2|Adverse Event|0|||
161073662|NCT05262751|581658500|FG005|Washout Period 2|Adverse Event|0|||
161073663|NCT05262751|581658495|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
161073664|NCT05262751|581658496|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
161073665|NCT05262751|581658497|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
161073666|NCT05262751|581658498|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
161073667|NCT05262751|581658499|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
161073668|NCT05262751|581658500|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
161073669|NCT03690427|581658503|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
161073670|NCT03690427|581658504|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
161073671|NCT03519204|581658507|FG000|Overall Study|Lost to Follow-up|3|||
161073672|NCT03519204|581658508|FG001|Overall Study|Lost to Follow-up|8|||
161073673|NCT03519204|581658507|FG000|Overall Study|Withdrawal by Subject|9|||
161286110|NCT02848001|582427977|FG004|Overall Study|Lack of Efficacy|3|||
161286111|NCT02848001|582427978|FG005|Overall Study|Lack of Efficacy|0|||
161073674|NCT03519204|581658508|FG001|Overall Study|Withdrawal by Subject|7|||
161073675|NCT03519204|581658507|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161073676|NCT03519204|581658508|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161073677|NCT02956837|581658509|FG000|Overall Study|Serious Adverse Events|0|||
161073678|NCT02956837|581658510|FG001|Overall Study|Serious Adverse Events|1|||
161073679|NCT02956837|581658511|FG002|Overall Study|Serious Adverse Events|0|||
161073680|NCT02956837|581658512|FG003|Overall Study|Serious Adverse Events|0|||
161073681|NCT02956837|581658509|FG000|Overall Study|Withdrawal by Subject|0|||
161073682|NCT02956837|581658510|FG001|Overall Study|Withdrawal by Subject|1|||
161073683|NCT02956837|581658511|FG002|Overall Study|Withdrawal by Subject|0|||
161073684|NCT02956837|581658512|FG003|Overall Study|Withdrawal by Subject|3|||
161073685|NCT02956837|581658509|FG000|Overall Study|Lost to Follow-up|0|||
161073686|NCT02956837|581658510|FG001|Overall Study|Lost to Follow-up|1|||
161073687|NCT02956837|581658511|FG002|Overall Study|Lost to Follow-up|2|||
161073688|NCT02956837|581658512|FG003|Overall Study|Lost to Follow-up|0|||
161073689|NCT02597712|581658513|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
161073690|NCT02597712|581658514|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
161073691|NCT02597712|581658513|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
161073692|NCT02597712|581658514|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
161073693|NCT02597712|581658513|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
161073694|NCT02597712|581658514|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
161073695|NCT01727505|581658519|FG000|First 24 Hours|Adverse Event|0|||
161073696|NCT01727505|581658520|FG001|First 24 Hours|Adverse Event|1|||
161073697|NCT01727505|581658519|FG000|Second 24 Hours|Missing data|0|||
161073698|NCT01727505|581658520|FG001|Second 24 Hours|Missing data|1|||
161073699|NCT00513708|581658524|FG000|Overall Study|Lost to Follow-up|4|||
161073700|NCT00513708|581658525|FG001|Overall Study|Lost to Follow-up|4|||
161073701|NCT00513708|581658526|FG002|Overall Study|Lost to Follow-up|4|||
161073702|NCT01564277|581658527|FG000|Overall Study|Protocol Violation|0|||
161073703|NCT01564277|581658528|FG001|Overall Study|Protocol Violation|1|||
161073704|NCT01564277|581658527|FG000|Overall Study|Physician Decision|1|||
161073705|NCT01564277|581658528|FG001|Overall Study|Physician Decision|0|||
161073706|NCT01594970|581658529|FG000|Overall Study|Non-Adverse Event Related|4|||
161073707|NCT01594970|581658530|FG001|Overall Study|Non-Adverse Event Related|5|||
161073708|NCT01594970|581658531|FG002|Overall Study|Non-Adverse Event Related|6|||
161073709|NCT01594970|581658529|FG000|Overall Study|Adverse Event|17|||
161073710|NCT01594970|581658530|FG001|Overall Study|Adverse Event|23|||
161073711|NCT01594970|581658531|FG002|Overall Study|Adverse Event|23|||
161073712|NCT01594970|581658529|FG000|Overall Study|Lost to Follow-up|54|||
161073713|NCT01594970|581658530|FG001|Overall Study|Lost to Follow-up|54|||
161073714|NCT01594970|581658531|FG002|Overall Study|Lost to Follow-up|37|||
161073715|NCT02460575|581660950|FG000|Overall Study|Lost to Follow-up|1|||
161073716|NCT02460575|581660951|FG001|Overall Study|Lost to Follow-up|0|||
161073717|NCT04307940|581660952|FG000|Overall Study|Adverse Event|1|||
161073718|NCT04307940|581660953|FG001|Overall Study|Adverse Event|0|||
161073719|NCT04307940|581660954|FG002|Overall Study|Adverse Event|0|||
161073720|NCT04307940|581660952|FG000|Overall Study|Withdrawal by Subject|2|||
161073721|NCT04307940|581660953|FG001|Overall Study|Withdrawal by Subject|3|||
161073722|NCT04307940|581660954|FG002|Overall Study|Withdrawal by Subject|1|||
161073723|NCT04307940|581660952|FG000|Overall Study|Lost to Follow-up|2|||
161073724|NCT04307940|581660953|FG001|Overall Study|Lost to Follow-up|0|||
161073725|NCT04307940|581660954|FG002|Overall Study|Lost to Follow-up|1|||
161073726|NCT04624243|581660958|FG000|Overall Study|Death|0|||
161073727|NCT04624243|581660959|FG001|Overall Study|Death|1|||
161073728|NCT04624243|581660960|FG002|Overall Study|Death|0|||
161073729|NCT04624243|581660961|FG003|Overall Study|Death|0|||
161073730|NCT04624243|581660962|FG004|Overall Study|Death|0|||
161073731|NCT04624243|581660958|FG000|Overall Study|Lost to Follow-up|2|||
161073732|NCT04624243|581660959|FG001|Overall Study|Lost to Follow-up|3|||
161073733|NCT04624243|581660960|FG002|Overall Study|Lost to Follow-up|7|||
161073734|NCT04624243|581660961|FG003|Overall Study|Lost to Follow-up|1|||
161073735|NCT04624243|581660962|FG004|Overall Study|Lost to Follow-up|3|||
161073736|NCT04624243|581660958|FG000|Overall Study|Physician Decision|3|||
161073737|NCT04624243|581660959|FG001|Overall Study|Physician Decision|8|||
161073738|NCT04624243|581660960|FG002|Overall Study|Physician Decision|15|||
161073739|NCT04624243|581660961|FG003|Overall Study|Physician Decision|2|||
161286112|NCT02848001|582427979|FG006|Overall Study|Lack of Efficacy|1|||
161286113|NCT02848001|582427980|FG007|Overall Study|Lack of Efficacy|0|||
161073740|NCT04624243|581660962|FG004|Overall Study|Physician Decision|11|||
161286114|NCT02848001|582427981|FG008|Overall Study|Lack of Efficacy|0|||
161073741|NCT04624243|581660958|FG000|Overall Study|Withdrawal by Subject|19|||
161073742|NCT04624243|581660959|FG001|Overall Study|Withdrawal by Subject|44|||
161157900|NCT04804033|581957221|FG001|Period 1: DBT Phase|Adverse Event|5|||
161073743|NCT04624243|581660960|FG002|Overall Study|Withdrawal by Subject|40|||
161073744|NCT04624243|581660961|FG003|Overall Study|Withdrawal by Subject|21|||
161073745|NCT04624243|581660962|FG004|Overall Study|Withdrawal by Subject|39|||
161073746|NCT04624243|581660958|FG000|Overall Study|Miscellaneous|3|||
161073747|NCT04624243|581660959|FG001|Overall Study|Miscellaneous|12|||
161073748|NCT04624243|581660960|FG002|Overall Study|Miscellaneous|9|||
161073749|NCT04624243|581660961|FG003|Overall Study|Miscellaneous|4|||
161073750|NCT04624243|581660962|FG004|Overall Study|Miscellaneous|6|||
161073751|NCT04996004|581660963|FG000|Phase I|Death|1|||
161073752|NCT04996004|581660964|FG001|Phase I|Death|2|||
161073753|NCT04996004|581660965|FG002|Phase I|Death|1|||
161286115|NCT02848001|582427982|FG009|Overall Study|Lack of Efficacy|1|||
161286116|NCT02848001|582427983|FG010|Overall Study|Lack of Efficacy|0|||
161286117|NCT02848001|582427984|FG011|Overall Study|Lack of Efficacy|2|||
161073754|NCT04996004|581660966|FG003|Phase I|Death|0|||
161073755|NCT04996004|581660967|FG004|Phase I|Death|0|||
161073756|NCT04996004|581660968|FG005|Phase I|Death|0|||
161073757|NCT04996004|581660963|FG000|Phase I|Study terminated by sponsor|2|||
161073758|NCT04996004|581660964|FG001|Phase I|Study terminated by sponsor|1|||
161073759|NCT04996004|581660965|FG002|Phase I|Study terminated by sponsor|2|||
161073760|NCT04996004|581660966|FG003|Phase I|Study terminated by sponsor|0|||
161073761|NCT04996004|581660967|FG004|Phase I|Study terminated by sponsor|0|||
161073762|NCT04996004|581660968|FG005|Phase I|Study terminated by sponsor|0|||
161073763|NCT04996004|581660963|FG000|Phase II|Study terminated by sponsor|0|||
161073764|NCT04996004|581660964|FG001|Phase II|Study terminated by sponsor|0|||
161073765|NCT04996004|581660965|FG002|Phase II|Study terminated by sponsor|0|||
161073766|NCT04996004|581660966|FG003|Phase II|Study terminated by sponsor|20|||
161073767|NCT04996004|581660967|FG004|Phase II|Study terminated by sponsor|10|||
161073768|NCT04996004|581660968|FG005|Phase II|Study terminated by sponsor|10|||
161073769|NCT04996004|581660963|FG000|Phase II|Withdrawal by Subject|0|||
161073770|NCT04996004|581660964|FG001|Phase II|Withdrawal by Subject|0|||
161073771|NCT04996004|581660965|FG002|Phase II|Withdrawal by Subject|0|||
161073772|NCT04996004|581660966|FG003|Phase II|Withdrawal by Subject|0|||
161073773|NCT04996004|581660967|FG004|Phase II|Withdrawal by Subject|1|||
161073774|NCT04996004|581660968|FG005|Phase II|Withdrawal by Subject|2|||
161073775|NCT04996004|581660963|FG000|Phase II|Death|0|||
161073776|NCT04996004|581660964|FG001|Phase II|Death|0|||
161073777|NCT04996004|581660965|FG002|Phase II|Death|0|||
161073778|NCT04996004|581660966|FG003|Phase II|Death|12|||
161073779|NCT04996004|581660967|FG004|Phase II|Death|2|||
161073780|NCT04996004|581660968|FG005|Phase II|Death|9|||
161073781|NCT04996004|581660963|FG000|Phase II|Other|0|||
161073782|NCT04996004|581660964|FG001|Phase II|Other|0|||
161073783|NCT04996004|581660965|FG002|Phase II|Other|0|||
161073784|NCT04996004|581660966|FG003|Phase II|Other|0|||
161073785|NCT04996004|581660967|FG004|Phase II|Other|0|||
161073786|NCT04996004|581660968|FG005|Phase II|Other|1|||
161073787|NCT04497389|581660969|FG000|Overall Study|Withdrawal by Subject|1|||
161073788|NCT04497389|581660970|FG001|Overall Study|Withdrawal by Subject|0|||
161073789|NCT03926195|581660972|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
161073790|NCT03926195|581660973|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
161073791|NCT03926195|581660972|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
161073792|NCT03926195|581660973|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
161073793|NCT03926195|581660972|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
161073794|NCT03926195|581660973|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
161073795|NCT03926195|581660972|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
161073796|NCT03926195|581660973|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
161073797|NCT03926195|581660972|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
161073798|NCT03926195|581660973|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
161073799|NCT03926195|581660972|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
161073800|NCT03926195|581660973|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
161073801|NCT03054337|581660974|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
161073802|NCT03054337|581660975|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
161073803|NCT03054337|581660976|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
161073804|NCT03054337|581660977|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
161073805|NCT03054337|581660978|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
161286118|NCT02848001|582427985|FG012|Overall Study|Lack of Efficacy|0|||
161286119|NCT02848001|582427986|FG013|Overall Study|Lack of Efficacy|2|||
161073806|NCT03054337|581660979|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
161073807|NCT03443414|581660982|FG000|Overall Study|Adverse Event|6|||
161073808|NCT03443414|581660983|FG001|Overall Study|Adverse Event|0|||
161073809|NCT03443414|581660984|FG002|Overall Study|Adverse Event|4|||
161073810|NCT03443414|581660985|FG003|Overall Study|Adverse Event|2|||
161286120|NCT02848001|582427987|FG014|Overall Study|Lack of Efficacy|2|||
161286121|NCT02848001|582427988|FG015|Overall Study|Lack of Efficacy|0|||
161073811|NCT03443414|581660986|FG004|Overall Study|Adverse Event|3|||
161073812|NCT03443414|581660982|FG000|Overall Study|Withdrawal by Subject|3|||
161073813|NCT03443414|581660983|FG001|Overall Study|Withdrawal by Subject|2|||
161073814|NCT03443414|581660984|FG002|Overall Study|Withdrawal by Subject|2|||
161073815|NCT03443414|581660985|FG003|Overall Study|Withdrawal by Subject|2|||
161073816|NCT03443414|581660986|FG004|Overall Study|Withdrawal by Subject|1|||
161073817|NCT03443414|581660982|FG000|Overall Study|Death|0|||
161073818|NCT03443414|581660983|FG001|Overall Study|Death|1|||
161073819|NCT03443414|581660984|FG002|Overall Study|Death|0|||
161073820|NCT03443414|581660985|FG003|Overall Study|Death|1|||
161073821|NCT03443414|581660986|FG004|Overall Study|Death|0|||
161073822|NCT03443414|581660982|FG000|Overall Study|Reason not specified|2|||
161073823|NCT03443414|581660983|FG001|Overall Study|Reason not specified|0|||
161073824|NCT03443414|581660984|FG002|Overall Study|Reason not specified|0|||
161073825|NCT03443414|581660985|FG003|Overall Study|Reason not specified|0|||
161073826|NCT03443414|581660986|FG004|Overall Study|Reason not specified|1|||
161073827|NCT02522728|581660989|FG000|Overall Study|Withdrawal by Subject|6|||
161073828|NCT02522728|581660990|FG001|Overall Study|Withdrawal by Subject|6|||
161073829|NCT02522728|581660989|FG000|Overall Study|Death|4|||
161073830|NCT02522728|581660990|FG001|Overall Study|Death|3|||
161073831|NCT02522728|581660989|FG000|Overall Study|Adverse Event|2|||
161073832|NCT02522728|581660990|FG001|Overall Study|Adverse Event|1|||
161073833|NCT02522728|581660989|FG000|Overall Study|Did not receive randomized study device|0|||
161073834|NCT02522728|581660990|FG001|Overall Study|Did not receive randomized study device|1|||
161073835|NCT01099917|581660992|FG000|Overall Study|Adverse Event|3|||
161073836|NCT01099917|581660992|FG000|Overall Study|Not Treated|24|||
161073837|NCT01266161|581660993|FG000|Overall Study|Ineligible|1|||
161073838|NCT01266161|581660994|FG001|Overall Study|Ineligible|0|||
161073839|NCT01266161|581660993|FG000|Overall Study|Lack of Efficacy|0|||
161073840|NCT01266161|581660994|FG001|Overall Study|Lack of Efficacy|1|||
161073841|NCT01266161|581660993|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
161073842|NCT01266161|581660994|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
161073843|NCT01436305|581660995|FG000|Overall Study|Death|1|||
161073844|NCT01436305|581660996|FG001|Overall Study|Death|0|||
161073845|NCT01436305|581660997|FG002|Overall Study|Death|0|||
161073846|NCT01436305|581660995|FG000|Overall Study|Lost to Follow-up|0|||
161073847|NCT01436305|581660996|FG001|Overall Study|Lost to Follow-up|1|||
161073848|NCT01436305|581660997|FG002|Overall Study|Lost to Follow-up|0|||
161073849|NCT01436305|581660995|FG000|Overall Study|Withdrawal by Subject|1|||
161073850|NCT01436305|581660996|FG001|Overall Study|Withdrawal by Subject|3|||
161073851|NCT01436305|581660997|FG002|Overall Study|Withdrawal by Subject|0|||
161073852|NCT02344342|581660998|FG000|Overall Study|Industry partner dropped out|11|||
161073853|NCT02344342|581660999|FG001|Overall Study|Industry partner dropped out|9|||
161073854|NCT02344342|581661000|FG002|Overall Study|Industry partner dropped out|14|||
161073855|NCT02344342|581661001|FG003|Overall Study|Industry partner dropped out|10|||
161073856|NCT03355209|581661003|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
161073857|NCT03355209|581661004|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
161073858|NCT03355209|581661005|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
161073859|NCT03355209|581661006|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
161073860|NCT03355209|581661007|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
161073861|NCT03355209|581661008|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
161073862|NCT03355209|581661003|FG000|Part 1: Double-Blind Period|Death|0|||
161073863|NCT03355209|581661004|FG001|Part 1: Double-Blind Period|Death|0|||
161073864|NCT03355209|581661005|FG002|Part 1: Double-Blind Period|Death|1|||
161157901|NCT04804033|581957222|FG002|Period 1: DBT Phase|Adverse Event|3|||
161157902|NCT04804033|581957223|FG003|Period 1: DBT Phase|Adverse Event|4|||
161157903|NCT04804033|581957220|FG000|Period 1: DBT Phase|Death|1|||
161157904|NCT04804033|581957221|FG001|Period 1: DBT Phase|Death|0|||
161157905|NCT04804033|581957222|FG002|Period 1: DBT Phase|Death|0|||
161157906|NCT04804033|581957223|FG003|Period 1: DBT Phase|Death|0|||
161157907|NCT04804033|581957220|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
161157908|NCT04804033|581957221|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
161157909|NCT04804033|581957222|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
161157910|NCT04804033|581957223|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
161073865|NCT03355209|581661006|FG003|Part 1: Double-Blind Period|Death|0|||
161073866|NCT03355209|581661007|FG004|Part 1: Double-Blind Period|Death|0|||
161073867|NCT03355209|581661008|FG005|Part 1: Double-Blind Period|Death|0|||
161073868|NCT03355209|581661003|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
161073869|NCT03355209|581661004|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
161073870|NCT03355209|581661005|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
161073871|NCT03355209|581661006|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
161073872|NCT03355209|581661007|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
161073873|NCT03355209|581661008|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
161073874|NCT03355209|581661003|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
161073875|NCT03355209|581661004|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
161073876|NCT03355209|581661005|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
161073877|NCT03355209|581661006|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161073878|NCT03355209|581661007|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161073879|NCT03355209|581661008|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
161073880|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
161157911|NCT04804033|581957220|FG000|Period 1: DBT Phase|Non-compliance|1|||
161157912|NCT04804033|581957221|FG001|Period 1: DBT Phase|Non-compliance|0|||
161157913|NCT04804033|581957222|FG002|Period 1: DBT Phase|Non-compliance|1|||
161073881|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
161157914|NCT04804033|581957223|FG003|Period 1: DBT Phase|Non-compliance|2|||
161073882|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
161073883|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
161073884|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
161073885|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
161073886|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161073887|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
161073888|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161073889|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161073890|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161073891|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
161073892|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
161073893|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
161073894|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
161073895|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
161073896|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
161073897|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
161073898|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
161073899|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
161073900|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
161157915|NCT04804033|581957220|FG000|Period 1: DBT Phase|Other|0|||
161157916|NCT04804033|581957221|FG001|Period 1: DBT Phase|Other|1|||
161157917|NCT04804033|581957222|FG002|Period 1: DBT Phase|Other|0|||
161157918|NCT04804033|581957223|FG003|Period 1: DBT Phase|Other|0|||
161157919|NCT04804033|581957220|FG000|Period 1: DBT Phase|Pregnancy|2|||
161157920|NCT04804033|581957221|FG001|Period 1: DBT Phase|Pregnancy|0|||
161157921|NCT04804033|581957222|FG002|Period 1: DBT Phase|Pregnancy|0|||
161157922|NCT04804033|581957223|FG003|Period 1: DBT Phase|Pregnancy|0|||
161157923|NCT04804033|581957220|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
161157924|NCT04804033|581957221|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
161157925|NCT04804033|581957222|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
161157926|NCT04804033|581957223|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
161157927|NCT04804033|581957220|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
161157928|NCT04804033|581957221|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
161157929|NCT04804033|581957222|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
161157930|NCT04804033|581957223|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
161157931|NCT04804033|581957220|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
161157932|NCT04804033|581957221|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
161157933|NCT04804033|581957222|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
161157934|NCT04804033|581957223|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
161157935|NCT04804033|581957220|FG000|Period 2: OLE Phase|Adverse Event|3|||
161157936|NCT04804033|581957221|FG001|Period 2: OLE Phase|Adverse Event|4|||
161157937|NCT04804033|581957222|FG002|Period 2: OLE Phase|Adverse Event|2|||
161157938|NCT04804033|581957223|FG003|Period 2: OLE Phase|Adverse Event|0|||
161157939|NCT04804033|581957220|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
161157940|NCT04804033|581957221|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
161157941|NCT04804033|581957222|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
161157942|NCT04804033|581957223|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
161157943|NCT04804033|581957220|FG000|Period 2: OLE Phase|Non-compliance|2|||
161157944|NCT04804033|581957221|FG001|Period 2: OLE Phase|Non-compliance|2|||
161157945|NCT04804033|581957222|FG002|Period 2: OLE Phase|Non-compliance|0|||
161157946|NCT04804033|581957223|FG003|Period 2: OLE Phase|Non-compliance|1|||
161157947|NCT04804033|581957220|FG000|Period 2: OLE Phase|Other|0|||
161157948|NCT04804033|581957221|FG001|Period 2: OLE Phase|Other|2|||
161345656|NCT00963235|582650893|FG000|Overall Study|Failed to return|9|||
161073901|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
161157949|NCT04804033|581957222|FG002|Period 2: OLE Phase|Other|0|||
161157950|NCT04804033|581957223|FG003|Period 2: OLE Phase|Other|0|||
161157951|NCT04804033|581957220|FG000|Period 2: OLE Phase|Physician Decision|1|||
161157952|NCT04804033|581957221|FG001|Period 2: OLE Phase|Physician Decision|1|||
161157953|NCT04804033|581957222|FG002|Period 2: OLE Phase|Physician Decision|0|||
161157954|NCT04804033|581957223|FG003|Period 2: OLE Phase|Physician Decision|0|||
161157955|NCT04804033|581957220|FG000|Period 2: OLE Phase|Pregnancy|0|||
161157956|NCT04804033|581957221|FG001|Period 2: OLE Phase|Pregnancy|0|||
161157957|NCT04804033|581957222|FG002|Period 2: OLE Phase|Pregnancy|2|||
161157958|NCT04804033|581957223|FG003|Period 2: OLE Phase|Pregnancy|0|||
161157959|NCT04804033|581957220|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
161157960|NCT04804033|581957221|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
161157961|NCT04804033|581957222|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
161157962|NCT04804033|581957223|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
161157963|NCT04804033|581957220|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
161157964|NCT04804033|581957221|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
161157965|NCT04804033|581957222|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
161157966|NCT04804033|581957223|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
161157967|NCT04804033|581957220|FG000|Period 2: OLE Phase|Not reported|0|||
161157968|NCT04804033|581957221|FG001|Period 2: OLE Phase|Not reported|2|||
161157969|NCT04804033|581957222|FG002|Period 2: OLE Phase|Not reported|0|||
161157970|NCT04804033|581957223|FG003|Period 2: OLE Phase|Not reported|0|||
161157971|NCT04804033|581957220|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
161157972|NCT04804033|581957221|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
161157973|NCT04804033|581957222|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161157974|NCT04804033|581957223|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
161157975|NCT04804033|581957220|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
161157976|NCT04804033|581957221|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
161157977|NCT04804033|581957222|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
161157978|NCT04804033|581957223|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
161157979|NCT04804033|581957220|FG000|Period 3: Follow-up Phase|Other|0|||
161157980|NCT04804033|581957221|FG001|Period 3: Follow-up Phase|Other|1|||
161157981|NCT04804033|581957222|FG002|Period 3: Follow-up Phase|Other|2|||
161157982|NCT04804033|581957223|FG003|Period 3: Follow-up Phase|Other|1|||
161157983|NCT04804033|581957220|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
161157984|NCT04804033|581957221|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
161157985|NCT04804033|581957222|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
161157986|NCT04804033|581957223|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
161157987|NCT04804033|581957220|FG000|Period 3: Follow-up Phase|Not reported|18|||
161157988|NCT04804033|581957221|FG001|Period 3: Follow-up Phase|Not reported|15|||
161286122|NCT02848001|582427989|FG016|Overall Study|Lack of Efficacy|0|||
161286123|NCT02848001|582427973|FG000|Overall Study|Progressive Disease|2|||
161286124|NCT02848001|582427974|FG001|Overall Study|Progressive Disease|1|||
161286125|NCT02848001|582427975|FG002|Overall Study|Progressive Disease|0|||
161286126|NCT02848001|582427976|FG003|Overall Study|Progressive Disease|4|||
161286127|NCT02848001|582427977|FG004|Overall Study|Progressive Disease|3|||
161286128|NCT02848001|582427978|FG005|Overall Study|Progressive Disease|0|||
161286129|NCT02848001|582427979|FG006|Overall Study|Progressive Disease|4|||
161345657|NCT00963235|582650893|FG000|Overall Study|Protocol Violation|7|||
161073902|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
161073903|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
161073904|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
161073905|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
161073906|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
161073907|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161073908|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161073909|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161073910|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161073911|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161073912|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161073913|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
161073914|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
161073915|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
161073916|NCT03355209|581661003|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
161073917|NCT03355209|581661004|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161073918|NCT03355209|581661005|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
161073919|NCT03355209|581661006|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161073920|NCT03355209|581661007|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161073921|NCT03355209|581661008|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
161073922|NCT02567708|581661009|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
161073923|NCT02567708|581661010|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
161073924|NCT02567708|581661009|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
161073925|NCT02567708|581661010|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
161073926|NCT02567708|581661009|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
161073927|NCT02567708|581661010|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
161073928|NCT02567708|581661009|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
161073929|NCT02567708|581661010|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
161073930|NCT00706654|581661011|FG000|Conversion Phase|Lost to Follow-up|4|||
161073931|NCT00706654|581661012|FG001|Conversion Phase|Lost to Follow-up|0|||
161073932|NCT00706654|581661013|FG002|Conversion Phase|Lost to Follow-up|0|||
161073933|NCT00706654|581661014|FG003|Conversion Phase|Lost to Follow-up|0|||
161157989|NCT04804033|581957222|FG002|Period 3: Follow-up Phase|Not reported|1|||
161157990|NCT04804033|581957223|FG003|Period 3: Follow-up Phase|Not reported|4|||
161157991|NCT02496585|581957226|FG000|Overall Study|Death|3|||
161286130|NCT02848001|582427980|FG007|Overall Study|Progressive Disease|1|||
161286131|NCT02848001|582427981|FG008|Overall Study|Progressive Disease|0|||
161286132|NCT02848001|582427982|FG009|Overall Study|Progressive Disease|2|||
161157992|NCT02496585|581957227|FG001|Overall Study|Death|0|||
161157993|NCT02496585|581957226|FG000|Overall Study|Lost to Follow-up|2|||
161157994|NCT02496585|581957227|FG001|Overall Study|Lost to Follow-up|0|||
161157995|NCT02496585|581957226|FG000|Overall Study|Withdrawal by Subject|1|||
161157996|NCT02496585|581957227|FG001|Overall Study|Withdrawal by Subject|2|||
161157997|NCT02496585|581957226|FG000|Overall Study|Progression of Malignancy|4|||
161157998|NCT02496585|581957227|FG001|Overall Study|Progression of Malignancy|1|||
161157999|NCT00830037|581957231|FG000|Overall Study|Withdrawal by Subject|2|||
161158000|NCT00830037|581957232|FG001|Overall Study|Withdrawal by Subject|3|||
161158001|NCT00830037|581957231|FG000|Overall Study|Lost to Follow-up|1|||
161158002|NCT00830037|581957232|FG001|Overall Study|Lost to Follow-up|2|||
161158003|NCT00830037|581957231|FG000|Overall Study|Active when terminated by DSMB|15|||
161158004|NCT00830037|581957232|FG001|Overall Study|Active when terminated by DSMB|14|||
161158005|NCT01401010|581957233|FG000|Overall Study|Could not interpret assay results|1|||
161158006|NCT01401010|581957234|FG001|Overall Study|Could not interpret assay results|0|||
161158007|NCT02399813|581957235|FG000|Overall Study|Progressive Disease-Radiographic|2|||
161158008|NCT02399813|581957235|FG000|Overall Study|Death|20|||
161158009|NCT02399813|581957235|FG000|Overall Study|Withdrawal by Subject|3|||
161158010|NCT02399813|581957235|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
161158011|NCT02399813|581957235|FG000|Overall Study|Lost to Follow-up|2|||
161158012|NCT02399813|581957235|FG000|Overall Study|Other than specified|5|||
161158013|NCT03591146|581957242|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161158014|NCT03591146|581957243|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161158015|NCT03591146|581957244|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161158016|NCT03591146|581957245|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
161158017|NCT03591146|581957246|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
161158018|NCT03591146|581957242|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161158019|NCT03591146|581957243|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
161158020|NCT03591146|581957244|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161158021|NCT03591146|581957245|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161158022|NCT03591146|581957246|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
161158023|NCT03591146|581957242|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161158024|NCT03591146|581957243|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161158025|NCT03591146|581957244|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161158026|NCT03591146|581957245|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
161158027|NCT03591146|581957246|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
161158028|NCT03591146|581957242|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161158029|NCT03591146|581957243|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161158030|NCT03591146|581957244|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
161158031|NCT03591146|581957245|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
161158032|NCT03591146|581957246|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
161073934|NCT00706654|581661011|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
161073935|NCT00706654|581661012|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
161073936|NCT00706654|581661013|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
161073937|NCT00706654|581661014|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
161073938|NCT00706654|581661011|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
161073939|NCT00706654|581661012|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
161073940|NCT00706654|581661013|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
161073941|NCT00706654|581661014|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
161073942|NCT00706654|581661011|FG000|Conversion Phase|Withdrawn by Investigator|14|||
161073943|NCT00706654|581661012|FG001|Conversion Phase|Withdrawn by Investigator|0|||
161073944|NCT00706654|581661013|FG002|Conversion Phase|Withdrawn by Investigator|0|||
161073945|NCT00706654|581661014|FG003|Conversion Phase|Withdrawn by Investigator|0|||
161073946|NCT00706654|581661011|FG000|Conversion Phase|Withdrew Consent|38|||
161073947|NCT00706654|581661012|FG001|Conversion Phase|Withdrew Consent|0|||
161073948|NCT00706654|581661013|FG002|Conversion Phase|Withdrew Consent|0|||
161073949|NCT00706654|581661014|FG003|Conversion Phase|Withdrew Consent|0|||
161073950|NCT00706654|581661011|FG000|Conversion Phase|Adverse Event|18|||
161073951|NCT00706654|581661012|FG001|Conversion Phase|Adverse Event|0|||
161158033|NCT03453151|581957247|FG000|Overall Study|Withdrawal by Subject|1|||
161158034|NCT03453151|581957247|FG000|Overall Study|Physician Decision|3|||
161158035|NCT00142519|581957248|FG000|Overall Study|Not Treated|7|||
161286133|NCT02848001|582427983|FG010|Overall Study|Progressive Disease|3|||
161286134|NCT02848001|582427984|FG011|Overall Study|Progressive Disease|2|||
161073952|NCT00706654|581661013|FG002|Conversion Phase|Adverse Event|0|||
161073953|NCT00706654|581661014|FG003|Conversion Phase|Adverse Event|0|||
161073954|NCT00706654|581661011|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
161073955|NCT00706654|581661012|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161158036|NCT00142519|581957249|FG001|Overall Study|Not Treated|9|||
161158037|NCT00142519|581957248|FG000|Overall Study|Protocol Violation|1|||
161158038|NCT00142519|581957249|FG001|Overall Study|Protocol Violation|0|||
161158039|NCT00142519|581957248|FG000|Overall Study|Withdrawal by Subject|10|||
161286135|NCT02848001|582427985|FG012|Overall Study|Progressive Disease|1|||
161286136|NCT02848001|582427986|FG013|Overall Study|Progressive Disease|0|||
161073956|NCT00706654|581661013|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161073957|NCT00706654|581661014|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
161073958|NCT00706654|581661011|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
161073959|NCT00706654|581661012|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161073960|NCT00706654|581661013|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161073961|NCT00706654|581661014|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
161073962|NCT00706654|581661011|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
161073963|NCT00706654|581661012|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
161073964|NCT00706654|581661013|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
161073965|NCT00706654|581661014|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
161073966|NCT00706654|581661011|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
161073967|NCT00706654|581661012|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
161073968|NCT00706654|581661013|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
161073969|NCT00706654|581661014|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
161073970|NCT00706654|581661011|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
161073971|NCT00706654|581661012|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161073972|NCT00706654|581661013|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161073973|NCT00706654|581661014|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
161073974|NCT00706654|581661011|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
161073975|NCT00706654|581661012|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161073976|NCT00706654|581661013|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161073977|NCT00706654|581661014|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
161073978|NCT00706654|581661011|FG000|Oral Stabilization Phase|Withdrew consent|55|||
161073979|NCT00706654|581661012|FG001|Oral Stabilization Phase|Withdrew consent|0|||
161073980|NCT00706654|581661013|FG002|Oral Stabilization Phase|Withdrew consent|0|||
161073981|NCT00706654|581661014|FG003|Oral Stabilization Phase|Withdrew consent|0|||
161073982|NCT00706654|581661011|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
161073983|NCT00706654|581661012|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
161073984|NCT00706654|581661013|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
161073985|NCT00706654|581661014|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
161073986|NCT00706654|581661011|FG000|Oral Stabilization Phase|Adverse Event|21|||
161073987|NCT00706654|581661012|FG001|Oral Stabilization Phase|Adverse Event|0|||
161073988|NCT00706654|581661013|FG002|Oral Stabilization Phase|Adverse Event|0|||
161073989|NCT00706654|581661014|FG003|Oral Stabilization Phase|Adverse Event|0|||
161073990|NCT00706654|581661011|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
161073991|NCT00706654|581661012|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161073992|NCT00706654|581661013|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161073993|NCT00706654|581661014|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
161073994|NCT00706654|581661011|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
161073995|NCT00706654|581661012|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161073996|NCT00706654|581661013|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161073997|NCT00706654|581661014|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
161073998|NCT00706654|581661011|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
161073999|NCT00706654|581661012|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
161286137|NCT02848001|582427987|FG014|Overall Study|Progressive Disease|2|||
161286138|NCT02848001|582427988|FG015|Overall Study|Progressive Disease|4|||
161286139|NCT02848001|582427989|FG016|Overall Study|Progressive Disease|0|||
161286140|NCT02848001|582427973|FG000|Overall Study|Adverse Event|0|||
161286141|NCT02848001|582427974|FG001|Overall Study|Adverse Event|0|||
161286142|NCT02848001|582427975|FG002|Overall Study|Adverse Event|0|||
161286143|NCT02848001|582427976|FG003|Overall Study|Adverse Event|0|||
161286144|NCT02848001|582427977|FG004|Overall Study|Adverse Event|2|||
161286145|NCT02848001|582427978|FG005|Overall Study|Adverse Event|0|||
161286146|NCT02848001|582427979|FG006|Overall Study|Adverse Event|0|||
161286147|NCT02848001|582427980|FG007|Overall Study|Adverse Event|0|||
161286148|NCT02848001|582427981|FG008|Overall Study|Adverse Event|0|||
161286149|NCT02848001|582427982|FG009|Overall Study|Adverse Event|1|||
161286150|NCT02848001|582427983|FG010|Overall Study|Adverse Event|0|||
161286151|NCT02848001|582427984|FG011|Overall Study|Adverse Event|1|||
161286152|NCT02848001|582427985|FG012|Overall Study|Adverse Event|1|||
161286153|NCT02848001|582427986|FG013|Overall Study|Adverse Event|0|||
161286154|NCT02848001|582427987|FG014|Overall Study|Adverse Event|2|||
161286155|NCT02848001|582427988|FG015|Overall Study|Adverse Event|0|||
161286156|NCT02848001|582427989|FG016|Overall Study|Adverse Event|0|||
161286157|NCT02848001|582427973|FG000|Overall Study|Death|0|||
161286158|NCT02848001|582427974|FG001|Overall Study|Death|0|||
161286159|NCT02848001|582427975|FG002|Overall Study|Death|0|||
161286160|NCT02848001|582427976|FG003|Overall Study|Death|1|||
161286161|NCT02848001|582427977|FG004|Overall Study|Death|3|||
161286162|NCT02848001|582427978|FG005|Overall Study|Death|1|||
161286163|NCT02848001|582427979|FG006|Overall Study|Death|2|||
161286164|NCT02848001|582427980|FG007|Overall Study|Death|3|||
161286165|NCT02848001|582427981|FG008|Overall Study|Death|4|||
161074000|NCT00706654|581661013|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
161074001|NCT00706654|581661014|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
161074002|NCT00706654|581661011|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
161074003|NCT00706654|581661012|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
161074004|NCT00706654|581661013|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
161074005|NCT00706654|581661014|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
161074006|NCT00706654|581661011|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
161074007|NCT00706654|581661012|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161074008|NCT00706654|581661013|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
161074009|NCT00706654|581661014|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
161074010|NCT00706654|581661011|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
161074011|NCT00706654|581661012|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
161074012|NCT00706654|581661013|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
161074013|NCT00706654|581661014|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
161074014|NCT00706654|581661011|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
161074015|NCT00706654|581661012|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
161074016|NCT00706654|581661013|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
161074017|NCT00706654|581661014|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
161074018|NCT00706654|581661011|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
161074019|NCT00706654|581661012|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
161074020|NCT00706654|581661013|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
161074021|NCT00706654|581661014|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
161074022|NCT00706654|581661011|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
161074023|NCT00706654|581661012|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
161074024|NCT00706654|581661013|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
161074025|NCT00706654|581661014|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
161074026|NCT00706654|581661011|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
161074027|NCT00706654|581661012|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
161074028|NCT00706654|581661013|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
161074029|NCT00706654|581661014|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
161074030|NCT01001390|581661015|FG000|Overall Study|Failure to wear AFO device|2|||
161074031|NCT01001390|581661016|FG001|Overall Study|Failure to wear AFO device|0|||
161074032|NCT01151215|581661017|FG000|Overall Study|Worsening of condition under study|1|||
161074033|NCT01151215|581661018|FG001|Overall Study|Worsening of condition under study|1|||
161074034|NCT01151215|581661019|FG002|Overall Study|Worsening of condition under study|1|||
161286166|NCT02848001|582427982|FG009|Overall Study|Death|1|||
161286167|NCT02848001|582427983|FG010|Overall Study|Death|0|||
161286168|NCT02848001|582427984|FG011|Overall Study|Death|1|||
161286169|NCT02848001|582427985|FG012|Overall Study|Death|3|||
161286170|NCT02848001|582427986|FG013|Overall Study|Death|0|||
161286171|NCT02848001|582427987|FG014|Overall Study|Death|2|||
161286172|NCT02848001|582427988|FG015|Overall Study|Death|3|||
161286173|NCT02848001|582427989|FG016|Overall Study|Death|0|||
161286174|NCT02848001|582427973|FG000|Overall Study|Physician Decision|0|||
161286175|NCT02848001|582427974|FG001|Overall Study|Physician Decision|0|||
161286176|NCT02848001|582427975|FG002|Overall Study|Physician Decision|0|||
161286177|NCT02848001|582427976|FG003|Overall Study|Physician Decision|0|||
161345658|NCT00963235|582650893|FG000|Overall Study|Adverse Event|5|||
161074035|NCT01151215|581661017|FG000|Overall Study|Death|16|||
161074036|NCT01151215|581661018|FG001|Overall Study|Death|20|||
161074037|NCT01151215|581661019|FG002|Overall Study|Death|11|||
161074038|NCT01151215|581661017|FG000|Overall Study|Lost to Follow-up|0|||
161074039|NCT01151215|581661018|FG001|Overall Study|Lost to Follow-up|0|||
161074040|NCT01151215|581661019|FG002|Overall Study|Lost to Follow-up|3|||
161074041|NCT01151215|581661017|FG000|Overall Study|Withdrawal by Subject|3|||
161074042|NCT01151215|581661018|FG001|Overall Study|Withdrawal by Subject|1|||
161074043|NCT01151215|581661019|FG002|Overall Study|Withdrawal by Subject|2|||
161074044|NCT01151215|581661017|FG000|Overall Study|Disease progression|0|||
161074045|NCT01151215|581661018|FG001|Overall Study|Disease progression|1|||
161074046|NCT01151215|581661019|FG002|Overall Study|Disease progression|1|||
161074047|NCT01151215|581661017|FG000|Overall Study|Safety as judged by the investigator|0|||
161074048|NCT01151215|581661018|FG001|Overall Study|Safety as judged by the investigator|0|||
161074049|NCT01151215|581661019|FG002|Overall Study|Safety as judged by the investigator|1|||
161074050|NCT04276051|581661025|FG000|Overall Study|Lost to Follow-up|0|||
161074051|NCT04276051|581661026|FG001|Overall Study|Lost to Follow-up|1|||
161158040|NCT00142519|581957249|FG001|Overall Study|Withdrawal by Subject|7|||
161286178|NCT02848001|582427977|FG004|Overall Study|Physician Decision|0|||
161286179|NCT02848001|582427978|FG005|Overall Study|Physician Decision|0|||
161074052|NCT04276051|581661025|FG000|Overall Study|Physician Decision|0|||
161074053|NCT04276051|581661026|FG001|Overall Study|Physician Decision|1|||
161286180|NCT02848001|582427979|FG006|Overall Study|Physician Decision|0|||
161286181|NCT02848001|582427980|FG007|Overall Study|Physician Decision|0|||
161286182|NCT02848001|582427981|FG008|Overall Study|Physician Decision|1|||
161286183|NCT02848001|582427982|FG009|Overall Study|Physician Decision|1|||
161286184|NCT02848001|582427983|FG010|Overall Study|Physician Decision|0|||
161074054|NCT04276051|581661025|FG000|Overall Study|Withdrawal by Subject|1|||
161074055|NCT04276051|581661026|FG001|Overall Study|Withdrawal by Subject|1|||
161286185|NCT02848001|582427984|FG011|Overall Study|Physician Decision|0|||
161286186|NCT02848001|582427985|FG012|Overall Study|Physician Decision|2|||
161286187|NCT02848001|582427986|FG013|Overall Study|Physician Decision|0|||
161286188|NCT02848001|582427987|FG014|Overall Study|Physician Decision|0|||
161286189|NCT02848001|582427988|FG015|Overall Study|Physician Decision|0|||
161286190|NCT02848001|582427989|FG016|Overall Study|Physician Decision|0|||
161074056|NCT01299480|581661027|FG000|Overall Study|No longer willing to participate|19|||
161074057|NCT01299480|581661028|FG001|Overall Study|No longer willing to participate|17|||
161074058|NCT01299480|581661029|FG002|Overall Study|No longer willing to participate|14|||
161074059|NCT01299480|581661030|FG003|Overall Study|No longer willing to participate|13|||
161074060|NCT01299480|581661031|FG004|Overall Study|No longer willing to participate|10|||
161074061|NCT01299480|581661027|FG000|Overall Study|Protocol Violation|7|||
161074062|NCT01299480|581661028|FG001|Overall Study|Protocol Violation|5|||
161074063|NCT01299480|581661029|FG002|Overall Study|Protocol Violation|8|||
161074064|NCT01299480|581661030|FG003|Overall Study|Protocol Violation|1|||
161074065|NCT01299480|581661031|FG004|Overall Study|Protocol Violation|1|||
161286191|NCT02848001|582427973|FG000|Overall Study|Withdrawal by Subject|0|||
161286192|NCT02848001|582427974|FG001|Overall Study|Withdrawal by Subject|0|||
161286193|NCT02848001|582427975|FG002|Overall Study|Withdrawal by Subject|0|||
161286194|NCT02848001|582427976|FG003|Overall Study|Withdrawal by Subject|0|||
161074066|NCT01299480|581661027|FG000|Overall Study|Withdrawal by Subject|3|||
161074067|NCT01299480|581661028|FG001|Overall Study|Withdrawal by Subject|4|||
161286195|NCT02848001|582427977|FG004|Overall Study|Withdrawal by Subject|0|||
161286196|NCT02848001|582427978|FG005|Overall Study|Withdrawal by Subject|1|||
161286197|NCT02848001|582427979|FG006|Overall Study|Withdrawal by Subject|1|||
161286198|NCT02848001|582427980|FG007|Overall Study|Withdrawal by Subject|1|||
161286199|NCT02848001|582427981|FG008|Overall Study|Withdrawal by Subject|0|||
161286200|NCT02848001|582427982|FG009|Overall Study|Withdrawal by Subject|0|||
161286201|NCT02848001|582427983|FG010|Overall Study|Withdrawal by Subject|0|||
161286202|NCT02848001|582427984|FG011|Overall Study|Withdrawal by Subject|0|||
161286203|NCT02848001|582427985|FG012|Overall Study|Withdrawal by Subject|0|||
161286204|NCT02848001|582427986|FG013|Overall Study|Withdrawal by Subject|0|||
161286205|NCT02848001|582427987|FG014|Overall Study|Withdrawal by Subject|0|||
161286206|NCT02848001|582427988|FG015|Overall Study|Withdrawal by Subject|0|||
161286207|NCT02848001|582427989|FG016|Overall Study|Withdrawal by Subject|0|||
161286208|NCT00725283|582427993|FG000|Overall Study|Missing Code|3|||
161286209|NCT00725283|582427993|FG000|Overall Study|Death|5|||
161286210|NCT00725283|582427993|FG000|Overall Study|Other|6|||
161286211|NCT00725283|582427993|FG000|Overall Study|Withdrawal by Subject|10|||
161286212|NCT03103087|582427994|FG000|Overall Study|Did not receive any study drug|1|||
161286213|NCT03103087|582427995|FG001|Overall Study|Did not receive any study drug|0|||
161286214|NCT03103087|582427996|FG002|Overall Study|Did not receive any study drug|0|||
161286215|NCT03103087|582427994|FG000|Overall Study|Protocol Violation|1|||
161286216|NCT03103087|582427995|FG001|Overall Study|Protocol Violation|2|||
161286217|NCT03103087|582427996|FG002|Overall Study|Protocol Violation|1|||
161286218|NCT03103087|582427994|FG000|Overall Study|Lack of Efficacy|2|||
161286219|NCT03103087|582427995|FG001|Overall Study|Lack of Efficacy|1|||
161286220|NCT03103087|582427996|FG002|Overall Study|Lack of Efficacy|1|||
161345659|NCT00963235|582650893|FG000|Overall Study|Physician Decision|2|||
161074068|NCT01299480|581661029|FG002|Overall Study|Withdrawal by Subject|7|||
161074069|NCT01299480|581661030|FG003|Overall Study|Withdrawal by Subject|3|||
161074070|NCT01299480|581661031|FG004|Overall Study|Withdrawal by Subject|4|||
161074071|NCT01299480|581661027|FG000|Overall Study|Adverse Event|6|||
161074072|NCT01299480|581661028|FG001|Overall Study|Adverse Event|4|||
161074073|NCT01299480|581661029|FG002|Overall Study|Adverse Event|5|||
161074074|NCT01299480|581661030|FG003|Overall Study|Adverse Event|4|||
161074075|NCT01299480|581661031|FG004|Overall Study|Adverse Event|0|||
161074076|NCT01299480|581661027|FG000|Overall Study|Withdrawal due to pregnancy|0|||
161074077|NCT01299480|581661028|FG001|Overall Study|Withdrawal due to pregnancy|1|||
161074078|NCT01299480|581661029|FG002|Overall Study|Withdrawal due to pregnancy|1|||
161074079|NCT01299480|581661030|FG003|Overall Study|Withdrawal due to pregnancy|0|||
161074080|NCT01299480|581661031|FG004|Overall Study|Withdrawal due to pregnancy|0|||
161074081|NCT01299480|581661027|FG000|Overall Study|Physician Decision|1|||
161074082|NCT01299480|581661028|FG001|Overall Study|Physician Decision|1|||
161286221|NCT03103087|582427994|FG000|Overall Study|Pregnancy|0|||
161286222|NCT03103087|582427995|FG001|Overall Study|Pregnancy|0|||
161286223|NCT03103087|582427996|FG002|Overall Study|Pregnancy|1|||
161286224|NCT03103087|582427994|FG000|Overall Study|Adverse Event|2|||
161074083|NCT01299480|581661029|FG002|Overall Study|Physician Decision|0|||
161074084|NCT01299480|581661030|FG003|Overall Study|Physician Decision|2|||
161286225|NCT03103087|582427995|FG001|Overall Study|Adverse Event|15|||
161286226|NCT03103087|582427996|FG002|Overall Study|Adverse Event|6|||
161286227|NCT03103087|582427994|FG000|Overall Study|Withdrawal by Subject|13|||
161286228|NCT03103087|582427995|FG001|Overall Study|Withdrawal by Subject|6|||
161286229|NCT03103087|582427996|FG002|Overall Study|Withdrawal by Subject|6|||
161074085|NCT01299480|581661031|FG004|Overall Study|Physician Decision|0|||
161074086|NCT01299480|581661027|FG000|Overall Study|Lost to Follow-up|3|||
161074087|NCT01299480|581661028|FG001|Overall Study|Lost to Follow-up|1|||
161074088|NCT01299480|581661029|FG002|Overall Study|Lost to Follow-up|2|||
161074089|NCT01299480|581661030|FG003|Overall Study|Lost to Follow-up|1|||
161074090|NCT01299480|581661031|FG004|Overall Study|Lost to Follow-up|2|||
161074091|NCT01299480|581661027|FG000|Overall Study|Other|3|||
161074092|NCT01299480|581661028|FG001|Overall Study|Other|2|||
161074093|NCT01299480|581661029|FG002|Overall Study|Other|3|||
161074094|NCT01299480|581661030|FG003|Overall Study|Other|0|||
161074095|NCT01299480|581661031|FG004|Overall Study|Other|3|||
161074096|NCT01299480|581661027|FG000|Overall Study|Started, but not vaccinated|0|||
161074097|NCT01299480|581661028|FG001|Overall Study|Started, but not vaccinated|0|||
161074098|NCT01299480|581661029|FG002|Overall Study|Started, but not vaccinated|1|||
161074099|NCT01299480|581661030|FG003|Overall Study|Started, but not vaccinated|1|||
161158041|NCT01468909|581957250|FG000|Overall Study|Never Treated|2|||
161158042|NCT01468909|581957251|FG001|Overall Study|Never Treated|2|||
161158043|NCT01511419|581957257|FG000|Dose 2|Physician Decision|1|||
161158044|NCT01511419|581957258|FG001|Dose 2|Physician Decision|0|||
161158045|NCT00937768|581957259|FG000|Overall Study|Refused Further Treatment|3|||
161158046|NCT00937768|581957260|FG001|Overall Study|Refused Further Treatment|2|||
161158047|NCT00937768|581957259|FG000|Overall Study|Disease Progression|1|||
161158048|NCT00937768|581957260|FG001|Overall Study|Disease Progression|1|||
161158049|NCT00937768|581957259|FG000|Overall Study|Alternate Treatment|0|||
161158050|NCT00937768|581957260|FG001|Overall Study|Alternate Treatment|1|||
161158051|NCT00937768|581957259|FG000|Overall Study|No Further Funding|4|||
161158052|NCT00937768|581957260|FG001|Overall Study|No Further Funding|4|||
161158053|NCT03229759|581957261|FG000|Overall Study|Screen Failure|30|||
161158054|NCT02669862|581959012|FG000|Overall Study|Lost to Follow-up|0|||
161158055|NCT02669862|581959013|FG001|Overall Study|Lost to Follow-up|2|||
161158056|NCT02669862|581959014|FG002|Overall Study|Lost to Follow-up|1|||
161158057|NCT02669862|581959012|FG000|Overall Study|Withdrawal by Subject|2|||
161345660|NCT00963235|582650893|FG000|Overall Study|Other|1|||
161345661|NCT01756235|582650894|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
161345662|NCT05376358|582650895|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
161345663|NCT05376358|582650896|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
161345664|NCT05376358|582650895|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
161345665|NCT05376358|582650896|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
161345666|NCT05376358|582650895|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
161345667|NCT05376358|582650896|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
161345668|NCT05376358|582650895|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
161345669|NCT05376358|582650896|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
161345670|NCT05376358|582650895|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
161345671|NCT05376358|582650896|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
161345672|NCT05376358|582650895|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
161345673|NCT05376358|582650896|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
161345674|NCT04225832|582650897|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
161345675|NCT04225832|582650898|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
161345676|NCT04225832|582650897|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
161345677|NCT04225832|582650898|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
161345678|NCT02452190|582650901|FG000|Overall Study|Withdrawal by Sponsor|1|||
161345679|NCT02452190|582650902|FG001|Overall Study|Withdrawal by Sponsor|3|||
161345680|NCT02452190|582650901|FG000|Overall Study|Pregnancy|1|||
161345681|NCT02452190|582650902|FG001|Overall Study|Pregnancy|0|||
161345682|NCT02452190|582650901|FG000|Overall Study|Investigator's Decision|2|||
161345683|NCT02452190|582650902|FG001|Overall Study|Investigator's Decision|0|||
161345684|NCT02452190|582650901|FG000|Overall Study|Lack of Efficacy|3|||
161074100|NCT01299480|581661031|FG004|Overall Study|Started, but not vaccinated|0|||
161074101|NCT00604708|581661037|FG000|Overall Study|Withdrawal by Subject|9|||
161158058|NCT02669862|581959013|FG001|Overall Study|Withdrawal by Subject|2|||
161158059|NCT02669862|581959014|FG002|Overall Study|Withdrawal by Subject|3|||
161158060|NCT02669862|581959012|FG000|Overall Study|moved|0|||
161074102|NCT00604708|581661038|FG001|Overall Study|Withdrawal by Subject|10|||
161074103|NCT00604708|581661037|FG000|Overall Study|Protocol Violation|2|||
161074104|NCT00604708|581661038|FG001|Overall Study|Protocol Violation|8|||
161158061|NCT02669862|581959013|FG001|Overall Study|moved|1|||
161158062|NCT02669862|581959014|FG002|Overall Study|moved|0|||
161158063|NCT02669862|581959012|FG000|Overall Study|Protocol Violation|0|||
161158064|NCT02669862|581959013|FG001|Overall Study|Protocol Violation|0|||
161158065|NCT02669862|581959014|FG002|Overall Study|Protocol Violation|1|||
161286230|NCT03103087|582427994|FG000|Overall Study|Lost to Follow-up|4|||
161286231|NCT03103087|582427995|FG001|Overall Study|Lost to Follow-up|2|||
161286232|NCT03103087|582427996|FG002|Overall Study|Lost to Follow-up|7|||
161286233|NCT03103087|582427994|FG000|Overall Study|Other reason not reported|1|||
161286234|NCT03103087|582427995|FG001|Overall Study|Other reason not reported|3|||
161286235|NCT03103087|582427996|FG002|Overall Study|Other reason not reported|5|||
161286236|NCT00118157|582427997|FG000|Overall Study|Adverse Event|2|||
161286237|NCT00118157|582427997|FG000|Overall Study|Death|8|||
161286238|NCT00118157|582427997|FG000|Overall Study|Withdrawal by Subject|2|||
161286239|NCT01495000|582427998|FG000|Overall Study|Lost to Follow-up|2|||
161286240|NCT01495000|582427999|FG001|Overall Study|Lost to Follow-up|2|||
161286241|NCT01495000|582427998|FG000|Overall Study|Protocol Violation|1|||
161286242|NCT01495000|582427999|FG001|Overall Study|Protocol Violation|0|||
161286243|NCT01495000|582427998|FG000|Overall Study|Withdrawal by Subject|10|||
161286244|NCT01495000|582427999|FG001|Overall Study|Withdrawal by Subject|10|||
161074105|NCT00604708|581661037|FG000|Overall Study|Lost to Follow-up|5|||
161074106|NCT00604708|581661038|FG001|Overall Study|Lost to Follow-up|5|||
161286245|NCT02070965|582428000|FG000|Overall Study|Lost to Follow-up|0|||
161286246|NCT02070965|582428001|FG001|Overall Study|Lost to Follow-up|1|||
161286247|NCT02070965|582428002|FG002|Overall Study|Lost to Follow-up|0|||
161286248|NCT02070965|582428000|FG000|Overall Study|Withdrawal by Subject|1|||
161286249|NCT02070965|582428001|FG001|Overall Study|Withdrawal by Subject|1|||
161286250|NCT02070965|582428002|FG002|Overall Study|Withdrawal by Subject|1|||
161074107|NCT00604708|581661037|FG000|Overall Study|administrative reasons|9|||
161074108|NCT00604708|581661038|FG001|Overall Study|administrative reasons|11|||
161074109|NCT00604708|581661037|FG000|Overall Study|Adverse Event|6|||
161074110|NCT00604708|581661038|FG001|Overall Study|Adverse Event|6|||
161074111|NCT01277887|581661040|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
161074112|NCT01277887|581661041|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
161074113|NCT01277887|581661040|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
161074114|NCT01277887|581661041|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
161074115|NCT01277887|581661040|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
161074116|NCT01277887|581661041|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
161074117|NCT00415051|581661042|FG000|Overall Study|Protocol Violation|1|||
161074118|NCT04916730|581661044|FG000|Overall Study|Withdrawal by Subject|4|||
161074119|NCT04916730|581661045|FG001|Overall Study|Withdrawal by Subject|2|||
161074120|NCT04916730|581661044|FG000|Overall Study|Lost to Follow-up|0|||
161074121|NCT04916730|581661045|FG001|Overall Study|Lost to Follow-up|2|||
161074122|NCT04916730|581661044|FG000|Overall Study|Physician Decision|1|||
161074123|NCT04916730|581661045|FG001|Overall Study|Physician Decision|0|||
161074124|NCT00617929|581661048|FG000|Overall Study|Physician Decision|1|||
161074125|NCT00760747|581661058|FG000|Study Period II|Adverse Event|3|||
161074126|NCT00760747|581661059|FG001|Study Period II|Adverse Event|4|||
161074127|NCT00760747|581661058|FG000|Study Period II|Lack of Efficacy|0|||
161074128|NCT00760747|581661059|FG001|Study Period II|Lack of Efficacy|6|||
161074129|NCT00760747|581661058|FG000|Study Period II|Parent/Caregiver Decision|3|||
161074130|NCT00760747|581661059|FG001|Study Period II|Parent/Caregiver Decision|0|||
161074131|NCT00760747|581661058|FG000|Study Period II|Protocol Violation|6|||
161074132|NCT00760747|581661059|FG001|Study Period II|Protocol Violation|3|||
161074133|NCT00760747|581661058|FG000|Study Period II|Withdrawal by Subject|1|||
161074134|NCT00760747|581661059|FG001|Study Period II|Withdrawal by Subject|0|||
161074135|NCT00760747|581661058|FG000|Study Period II|No drug administered|0|||
161074136|NCT00760747|581661059|FG001|Study Period II|No drug administered|1|||
161074137|NCT00760747|581661058|FG000|Study Period III|Adverse Event|1|||
161074138|NCT00760747|581661059|FG001|Study Period III|Adverse Event|0|||
161074139|NCT00760747|581661058|FG000|Study Period III|Lack of Efficacy|1|||
161074140|NCT00760747|581661059|FG001|Study Period III|Lack of Efficacy|0|||
161074141|NCT00760747|581661058|FG000|Study Period III|Parent/Caregiver Decision|0|||
161074142|NCT00760747|581661059|FG001|Study Period III|Parent/Caregiver Decision|1|||
161074143|NCT00760747|581661058|FG000|Study Period III|Protocol Violation|1|||
161074144|NCT00760747|581661059|FG001|Study Period III|Protocol Violation|1|||
161074145|NCT00760747|581661058|FG000|Study Period III|Physician Decision|0|||
161074146|NCT00760747|581661059|FG001|Study Period III|Physician Decision|1|||
161074147|NCT04160988|581661060|FG000|Overall Study|poor image quality|28|||
161074148|NCT00844597|581661061|FG000|Overall Study|Adverse Event|0|||
161074149|NCT00844597|581661062|FG001|Overall Study|Adverse Event|0|||
161074150|NCT00844597|581661063|FG002|Overall Study|Adverse Event|0|||
161286251|NCT02070965|582428000|FG000|Overall Study|Subject moved|1|||
161074151|NCT00844597|581661064|FG003|Overall Study|Adverse Event|1|||
161074152|NCT00844597|581661065|FG004|Overall Study|Adverse Event|0|||
161074153|NCT00844597|581661066|FG005|Overall Study|Adverse Event|0|||
161074154|NCT01250509|581661067|FG000|Overall Study|Lost to Follow-up|5|||
161074155|NCT01250509|581661068|FG001|Overall Study|Lost to Follow-up|2|||
161286252|NCT02070965|582428001|FG001|Overall Study|Subject moved|0|||
161286253|NCT02070965|582428002|FG002|Overall Study|Subject moved|0|||
161286254|NCT03889886|582428003|FG000|Overall Study|Other|0|||
161286255|NCT03889886|582428004|FG001|Overall Study|Other|1|||
161286256|NCT03889886|582428005|FG002|Overall Study|Other|0|||
161158066|NCT01194804|581959015|FG000|Overall Study|Withdrawal by Subject|1|||
161158067|NCT02670915|581959016|FG000|Overall Study|Withdrawal by Subject|0|||
161158068|NCT02670915|581959017|FG001|Overall Study|Withdrawal by Subject|1|||
161158069|NCT02670915|581959018|FG002|Overall Study|Withdrawal by Subject|4|||
161158070|NCT02670915|581959016|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161158071|NCT02670915|581959017|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161158072|NCT02670915|581959018|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161158073|NCT02670915|581959016|FG000|Overall Study|Unclassified|0|||
161158074|NCT02670915|581959017|FG001|Overall Study|Unclassified|3|||
161158075|NCT02670915|581959018|FG002|Overall Study|Unclassified|0|||
161158076|NCT00818207|581959019|FG000|Overall Study|Adverse Event|6|||
161158077|NCT00818207|581959020|FG001|Overall Study|Adverse Event|0|||
161158078|NCT00818207|581959019|FG000|Overall Study|Lost to Follow-up|160|||
161158079|NCT00818207|581959020|FG001|Overall Study|Lost to Follow-up|146|||
161158080|NCT00818207|581959019|FG000|Overall Study|Multiple reasons|11|||
161158081|NCT00818207|581959020|FG001|Overall Study|Multiple reasons|12|||
161158082|NCT00818207|581959019|FG000|Overall Study|Withdrawal by Subject|42|||
161158083|NCT00818207|581959020|FG001|Overall Study|Withdrawal by Subject|104|||
161158084|NCT00818207|581959019|FG000|Overall Study|Death|3|||
161158085|NCT00818207|581959020|FG001|Overall Study|Death|5|||
161158086|NCT01303380|581959021|FG000|Overall Study|Lack of compliance to study procedures|1|||
161158087|NCT00487084|581959022|FG000|Overall Study|Did not receive intervention|4|||
161158088|NCT00487084|581959023|FG001|Overall Study|Did not receive intervention|3|||
161158089|NCT00487084|581959024|FG002|Overall Study|Did not receive intervention|5|||
161158090|NCT01697267|581959025|FG000|Overall Study|Death|3|||
161158091|NCT01697267|581959026|FG001|Overall Study|Death|1|||
161158092|NCT01697267|581959025|FG000|Overall Study|Withdrawal by Subject|5|||
161158093|NCT01697267|581959026|FG001|Overall Study|Withdrawal by Subject|5|||
161158094|NCT01697267|581959025|FG000|Overall Study|Adverse Event|2|||
161158095|NCT01697267|581959026|FG001|Overall Study|Adverse Event|1|||
161158096|NCT01697267|581959025|FG000|Overall Study|Lost to Follow-up|2|||
161158097|NCT01697267|581959026|FG001|Overall Study|Lost to Follow-up|4|||
161158098|NCT01697267|581959025|FG000|Overall Study|Physician Decision|2|||
161158099|NCT01697267|581959026|FG001|Overall Study|Physician Decision|4|||
161158100|NCT02796391|581959029|FG000|Overall Study|Lost to Follow-up|2|||
161158101|NCT02796391|581959030|FG001|Overall Study|Lost to Follow-up|2|||
161158102|NCT02796391|581959031|FG002|Overall Study|Lost to Follow-up|13|||
161158103|NCT02796391|581959032|FG003|Overall Study|Lost to Follow-up|8|||
161158104|NCT02796391|581959033|FG004|Overall Study|Lost to Follow-up|14|||
161158105|NCT02796391|581959034|FG005|Overall Study|Lost to Follow-up|13|||
161158106|NCT02796391|581959029|FG000|Overall Study|COVID|0|||
161158107|NCT02796391|581959030|FG001|Overall Study|COVID|0|||
161158108|NCT02796391|581959031|FG002|Overall Study|COVID|5|||
161158109|NCT02796391|581959032|FG003|Overall Study|COVID|5|||
161158110|NCT02796391|581959033|FG004|Overall Study|COVID|2|||
161158111|NCT02796391|581959034|FG005|Overall Study|COVID|4|||
161158112|NCT02796391|581959029|FG000|Overall Study|Participant did not like study cigarettes|0|||
161158113|NCT02796391|581959030|FG001|Overall Study|Participant did not like study cigarettes|0|||
161158114|NCT02796391|581959031|FG002|Overall Study|Participant did not like study cigarettes|3|||
161158115|NCT02796391|581959032|FG003|Overall Study|Participant did not like study cigarettes|0|||
161158116|NCT02796391|581959033|FG004|Overall Study|Participant did not like study cigarettes|0|||
161158117|NCT02796391|581959034|FG005|Overall Study|Participant did not like study cigarettes|0|||
161158118|NCT02796391|581959029|FG000|Overall Study|Withdrawal by Subject|1|||
161158119|NCT02796391|581959030|FG001|Overall Study|Withdrawal by Subject|1|||
161158120|NCT02796391|581959031|FG002|Overall Study|Withdrawal by Subject|4|||
161158121|NCT02796391|581959032|FG003|Overall Study|Withdrawal by Subject|3|||
161158122|NCT02796391|581959033|FG004|Overall Study|Withdrawal by Subject|4|||
161158123|NCT02796391|581959034|FG005|Overall Study|Withdrawal by Subject|3|||
161158124|NCT02796391|581959029|FG000|Overall Study|Adverse Event|0|||
161158125|NCT02796391|581959030|FG001|Overall Study|Adverse Event|0|||
161345685|NCT02452190|582650902|FG001|Overall Study|Lack of Efficacy|1|||
161158126|NCT02796391|581959031|FG002|Overall Study|Adverse Event|0|||
161158127|NCT02796391|581959032|FG003|Overall Study|Adverse Event|1|||
161158128|NCT02796391|581959033|FG004|Overall Study|Adverse Event|0|||
161158129|NCT02796391|581959034|FG005|Overall Study|Adverse Event|0|||
161158130|NCT02796391|581959029|FG000|Overall Study|Protocol Violation|0|||
161158131|NCT02796391|581959030|FG001|Overall Study|Protocol Violation|0|||
161158132|NCT02796391|581959031|FG002|Overall Study|Protocol Violation|0|||
161345686|NCT02452190|582650901|FG000|Overall Study|Lost to Follow-up|4|||
161158133|NCT02796391|581959032|FG003|Overall Study|Protocol Violation|1|||
161158134|NCT02796391|581959033|FG004|Overall Study|Protocol Violation|0|||
161158135|NCT02796391|581959034|FG005|Overall Study|Protocol Violation|0|||
161158136|NCT02681055|581959035|FG000|Weeks 5-12|Adverse Event|1|||
161158137|NCT00377611|581959036|FG000|Overall Study|Adverse Event|2|||
161158138|NCT00377611|581959037|FG001|Overall Study|Adverse Event|9|||
161158139|NCT00377611|581959036|FG000|Overall Study|Protocol Violation|2|||
161158140|NCT00377611|581959037|FG001|Overall Study|Protocol Violation|0|||
161158141|NCT00377611|581959036|FG000|Overall Study|Withdrawal by Subject|0|||
161286257|NCT03889886|582428006|FG003|Overall Study|Other|1|||
161074156|NCT01228175|581661073|FG000|Overall Study|Lost to Follow-up|64|||
161074157|NCT01228175|581661074|FG001|Overall Study|Lost to Follow-up|50|||
161074158|NCT01228175|581661073|FG000|Overall Study|Withdrawal by Subject|1|||
161074159|NCT01228175|581661074|FG001|Overall Study|Withdrawal by Subject|2|||
161074160|NCT01228175|581661073|FG000|Overall Study|Physician Decision|1|||
161074161|NCT01228175|581661074|FG001|Overall Study|Physician Decision|1|||
161074162|NCT00108745|581661075|FG000|Overall Study|Withdrawal by Subject|19|||
161074163|NCT00108745|581661076|FG001|Overall Study|Withdrawal by Subject|12|||
161074164|NCT00108745|581661077|FG002|Overall Study|Withdrawal by Subject|12|||
161074165|NCT00108745|581661075|FG000|Overall Study|Never Treated|8|||
161074166|NCT00108745|581661076|FG001|Overall Study|Never Treated|10|||
161074167|NCT00108745|581661077|FG002|Overall Study|Never Treated|12|||
161074168|NCT00108745|581661075|FG000|Overall Study|Ineligible|7|||
161074169|NCT00108745|581661076|FG001|Overall Study|Ineligible|13|||
161074170|NCT00108745|581661077|FG002|Overall Study|Ineligible|13|||
161074171|NCT00243074|581661080|FG000|Overall Study|Ineligible|6|||
161074172|NCT00243074|581661080|FG000|Overall Study|Adverse Event|6|||
161074173|NCT00243074|581661080|FG000|Overall Study|Withdrawal by Subject|2|||
161074174|NCT00243074|581661080|FG000|Overall Study|Lack of Efficacy|36|||
161074175|NCT00243074|581661080|FG000|Overall Study|Death|2|||
161074176|NCT00243074|581661080|FG000|Overall Study|not protocol specified|1|||
161074177|NCT00243074|581661080|FG000|Overall Study|Did not receive any treatment|1|||
161074178|NCT00402051|581661085|FG000|Overall Study|Progressive Disease|13|||
161074179|NCT00402051|581661086|FG001|Overall Study|Progressive Disease|20|||
161074180|NCT00402051|581661085|FG000|Overall Study|Adverse Event|11|||
161074181|NCT00402051|581661086|FG001|Overall Study|Adverse Event|4|||
161074182|NCT00402051|581661085|FG000|Overall Study|Physician Decision|7|||
161074183|NCT00402051|581661086|FG001|Overall Study|Physician Decision|3|||
161074184|NCT00402051|581661085|FG000|Overall Study|Withdrawal by Subject|3|||
161074185|NCT00402051|581661086|FG001|Overall Study|Withdrawal by Subject|3|||
161074186|NCT00402051|581661085|FG000|Overall Study|Death - Related to Study Drug|1|||
161074187|NCT00402051|581661086|FG001|Overall Study|Death - Related to Study Drug|2|||
161074188|NCT00402051|581661085|FG000|Overall Study|Death Due to Study Disease|2|||
161074189|NCT00402051|581661086|FG001|Overall Study|Death Due to Study Disease|1|||
161074190|NCT00402051|581661085|FG000|Overall Study|Death Due to Adverse Event|0|||
161074191|NCT00402051|581661086|FG001|Overall Study|Death Due to Adverse Event|2|||
161074192|NCT00402051|581661085|FG000|Overall Study|Lost to Follow-up|1|||
161074193|NCT00402051|581661086|FG001|Overall Study|Lost to Follow-up|0|||
161074194|NCT04463680|581661089|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
161074195|NCT04463680|581661089|FG000|Overall Study|Not eligible due to implant duration of use|1|||
161074196|NCT04463680|581661089|FG000|Overall Study|Withdrawal by Subject|3|||
161074197|NCT05239598|581661094|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
161074198|NCT05239598|581661095|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
161074199|NCT05239598|581661094|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
161074200|NCT05239598|581661095|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
161074201|NCT02592707|581661096|FG000|Overall Study|Consent Withdrawn|0|||
161074202|NCT02592707|581661097|FG001|Overall Study|Consent Withdrawn|1|||
161074203|NCT02592707|581661098|FG002|Overall Study|Consent Withdrawn|2|||
161074204|NCT02592707|581661099|FG003|Overall Study|Consent Withdrawn|0|||
161074205|NCT02592707|581661096|FG000|Overall Study|Death|1|||
161074206|NCT02592707|581661097|FG001|Overall Study|Death|0|||
161074207|NCT02592707|581661098|FG002|Overall Study|Death|0|||
161074208|NCT02592707|581661099|FG003|Overall Study|Death|0|||
161074209|NCT02592707|581661096|FG000|Overall Study|Progressive Disease|4|||
161074210|NCT02592707|581661097|FG001|Overall Study|Progressive Disease|4|||
161074211|NCT02592707|581661098|FG002|Overall Study|Progressive Disease|3|||
161074212|NCT02592707|581661099|FG003|Overall Study|Progressive Disease|3|||
161074213|NCT02592707|581661096|FG000|Overall Study|Other|0|||
161074214|NCT02592707|581661097|FG001|Overall Study|Other|0|||
161074215|NCT02592707|581661098|FG002|Overall Study|Other|1|||
161074216|NCT02592707|581661099|FG003|Overall Study|Other|2|||
161074217|NCT02592707|581661096|FG000|Overall Study|Never entered LTFU period|1|||
161074218|NCT02592707|581661097|FG001|Overall Study|Never entered LTFU period|0|||
161074219|NCT02592707|581661098|FG002|Overall Study|Never entered LTFU period|0|||
161074220|NCT02592707|581661099|FG003|Overall Study|Never entered LTFU period|2|||
161074221|NCT02998476|581661102|FG000|Overall Study|Lost to Follow-up|1|||
161074222|NCT02998476|581661103|FG001|Overall Study|Lost to Follow-up|0|||
161074223|NCT02998476|581661102|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
161074224|NCT02998476|581661103|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
161074225|NCT02998476|581661102|FG000|Overall Study|Withdrawal by Subject|1|||
161074226|NCT02998476|581661103|FG001|Overall Study|Withdrawal by Subject|2|||
161074227|NCT02998476|581661102|FG000|Overall Study|Death|45|||
161074228|NCT02998476|581661103|FG001|Overall Study|Death|2|||
161074229|NCT02998476|581661102|FG000|Overall Study|Other|6|||
161074230|NCT02998476|581661103|FG001|Overall Study|Other|1|||
161074231|NCT04855734|581661104|FG000|Overall Study|Lost to Follow-up|2|||
161074232|NCT04855734|581661105|FG001|Overall Study|Lost to Follow-up|2|||
161074233|NCT03832595|581661106|FG000|Overall Study|Death|142|||
161074234|NCT03832595|581661107|FG001|Overall Study|Death|130|||
161074235|NCT03832595|581661106|FG000|Overall Study|Medical management without dialysis|37|||
161074236|NCT03832595|581661107|FG001|Overall Study|Medical management without dialysis|1|||
161074237|NCT00344032|581661110|FG000|Overall Study|Adverse Event|0|||
161074238|NCT00344032|581661111|FG001|Overall Study|Adverse Event|1|||
161074239|NCT00344032|581661110|FG000|Overall Study|Withdrawal by Subject|6|||
161074240|NCT00344032|581661111|FG001|Overall Study|Withdrawal by Subject|2|||
161074241|NCT00344032|581661110|FG000|Overall Study|Lost to Follow-up|4|||
161074242|NCT00344032|581661111|FG001|Overall Study|Lost to Follow-up|6|||
161074243|NCT00344032|581661110|FG000|Overall Study|Physician Decision|4|||
161074244|NCT00344032|581661111|FG001|Overall Study|Physician Decision|1|||
161074245|NCT05131477|581661114|FG000|PART 1|Withdrawal by Subject|2|||
161074246|NCT05131477|581661115|FG001|PART 1|Withdrawal by Subject|9|||
161074247|NCT05131477|581661116|FG002|PART 1|Withdrawal by Subject|6|||
161074248|NCT05131477|581661117|FG003|PART 1|Withdrawal by Subject|2|||
161074249|NCT05131477|581661118|FG004|PART 1|Withdrawal by Subject|8|||
161074250|NCT05131477|581661119|FG005|PART 1|Withdrawal by Subject|0|||
161074251|NCT05131477|581661120|FG006|PART 1|Withdrawal by Subject|0|||
161074252|NCT05131477|581661121|FG007|PART 1|Withdrawal by Subject|0|||
161074253|NCT05131477|581661122|FG008|PART 1|Withdrawal by Subject|0|||
161074254|NCT05131477|581661123|FG009|PART 1|Withdrawal by Subject|0|||
161074255|NCT05131477|581661124|FG010|PART 1|Withdrawal by Subject|0|||
161074256|NCT05131477|581661125|FG011|PART 1|Withdrawal by Subject|0|||
161074257|NCT05131477|581661126|FG012|PART 1|Withdrawal by Subject|0|||
161074258|NCT05131477|581661127|FG013|PART 1|Withdrawal by Subject|0|||
161074259|NCT05131477|581661114|FG000|PART 1|Physician Decision|1|||
161074260|NCT05131477|581661115|FG001|PART 1|Physician Decision|0|||
161074261|NCT05131477|581661116|FG002|PART 1|Physician Decision|0|||
161074262|NCT05131477|581661117|FG003|PART 1|Physician Decision|0|||
161074263|NCT05131477|581661118|FG004|PART 1|Physician Decision|0|||
161074264|NCT05131477|581661119|FG005|PART 1|Physician Decision|0|||
161074265|NCT05131477|581661120|FG006|PART 1|Physician Decision|0|||
161074266|NCT05131477|581661121|FG007|PART 1|Physician Decision|0|||
161074267|NCT05131477|581661122|FG008|PART 1|Physician Decision|0|||
161074268|NCT05131477|581661123|FG009|PART 1|Physician Decision|0|||
161074269|NCT05131477|581661124|FG010|PART 1|Physician Decision|0|||
161074270|NCT05131477|581661125|FG011|PART 1|Physician Decision|0|||
161074271|NCT05131477|581661126|FG012|PART 1|Physician Decision|0|||
161074272|NCT05131477|581661127|FG013|PART 1|Physician Decision|0|||
161074273|NCT05131477|581661114|FG000|PART 1|Adverse Event|3|||
161074274|NCT05131477|581661115|FG001|PART 1|Adverse Event|5|||
161074275|NCT05131477|581661116|FG002|PART 1|Adverse Event|1|||
161286258|NCT03889886|582428003|FG000|Overall Study|Withdrawal by Subject|0|||
161286259|NCT03889886|582428004|FG001|Overall Study|Withdrawal by Subject|0|||
161074276|NCT05131477|581661117|FG003|PART 1|Adverse Event|6|||
161074277|NCT05131477|581661118|FG004|PART 1|Adverse Event|4|||
161074278|NCT05131477|581661119|FG005|PART 1|Adverse Event|0|||
161074279|NCT05131477|581661120|FG006|PART 1|Adverse Event|0|||
161074280|NCT05131477|581661121|FG007|PART 1|Adverse Event|0|||
161074281|NCT05131477|581661122|FG008|PART 1|Adverse Event|0|||
161074282|NCT05131477|581661123|FG009|PART 1|Adverse Event|0|||
161074283|NCT05131477|581661124|FG010|PART 1|Adverse Event|0|||
161074284|NCT05131477|581661125|FG011|PART 1|Adverse Event|0|||
161074285|NCT05131477|581661126|FG012|PART 1|Adverse Event|0|||
161074286|NCT05131477|581661127|FG013|PART 1|Adverse Event|0|||
161074287|NCT05131477|581661114|FG000|PART 1|unclassified|1|||
161074288|NCT05131477|581661115|FG001|PART 1|unclassified|1|||
161074289|NCT05131477|581661116|FG002|PART 1|unclassified|0|||
161074290|NCT05131477|581661117|FG003|PART 1|unclassified|0|||
161074291|NCT05131477|581661118|FG004|PART 1|unclassified|4|||
161074292|NCT05131477|581661119|FG005|PART 1|unclassified|0|||
161074293|NCT05131477|581661120|FG006|PART 1|unclassified|0|||
161074294|NCT05131477|581661121|FG007|PART 1|unclassified|0|||
161074295|NCT05131477|581661122|FG008|PART 1|unclassified|0|||
161074296|NCT05131477|581661123|FG009|PART 1|unclassified|0|||
161074297|NCT05131477|581661124|FG010|PART 1|unclassified|0|||
161074298|NCT05131477|581661125|FG011|PART 1|unclassified|0|||
161074299|NCT05131477|581661126|FG012|PART 1|unclassified|0|||
161074300|NCT05131477|581661127|FG013|PART 1|unclassified|0|||
161074301|NCT05131477|581661114|FG000|PART 1|Randomized and not treated|0|||
161074302|NCT05131477|581661115|FG001|PART 1|Randomized and not treated|0|||
161074303|NCT05131477|581661116|FG002|PART 1|Randomized and not treated|0|||
161074304|NCT05131477|581661117|FG003|PART 1|Randomized and not treated|1|||
161074305|NCT05131477|581661118|FG004|PART 1|Randomized and not treated|1|||
161074306|NCT05131477|581661119|FG005|PART 1|Randomized and not treated|0|||
161074307|NCT05131477|581661120|FG006|PART 1|Randomized and not treated|0|||
161074308|NCT05131477|581661121|FG007|PART 1|Randomized and not treated|0|||
161074309|NCT05131477|581661122|FG008|PART 1|Randomized and not treated|0|||
161074310|NCT05131477|581661123|FG009|PART 1|Randomized and not treated|0|||
161074311|NCT05131477|581661124|FG010|PART 1|Randomized and not treated|0|||
161074312|NCT05131477|581661125|FG011|PART 1|Randomized and not treated|0|||
161074313|NCT05131477|581661126|FG012|PART 1|Randomized and not treated|0|||
161074314|NCT05131477|581661127|FG013|PART 1|Randomized and not treated|0|||
161074315|NCT05131477|581661114|FG000|PART 1|Protocol Violation|2|||
161074316|NCT05131477|581661115|FG001|PART 1|Protocol Violation|0|||
161074317|NCT05131477|581661116|FG002|PART 1|Protocol Violation|0|||
161074318|NCT05131477|581661117|FG003|PART 1|Protocol Violation|1|||
161074319|NCT05131477|581661118|FG004|PART 1|Protocol Violation|0|||
161074320|NCT05131477|581661119|FG005|PART 1|Protocol Violation|0|||
161074321|NCT05131477|581661120|FG006|PART 1|Protocol Violation|0|||
161074322|NCT05131477|581661121|FG007|PART 1|Protocol Violation|0|||
161074323|NCT05131477|581661122|FG008|PART 1|Protocol Violation|0|||
161074324|NCT05131477|581661123|FG009|PART 1|Protocol Violation|0|||
161074325|NCT05131477|581661124|FG010|PART 1|Protocol Violation|0|||
161074326|NCT05131477|581661125|FG011|PART 1|Protocol Violation|0|||
161074327|NCT05131477|581661126|FG012|PART 1|Protocol Violation|0|||
161074328|NCT05131477|581661127|FG013|PART 1|Protocol Violation|0|||
161074329|NCT05131477|581661114|FG000|PART 1|Lack of Efficacy|0|||
161074330|NCT05131477|581661115|FG001|PART 1|Lack of Efficacy|1|||
161074331|NCT05131477|581661116|FG002|PART 1|Lack of Efficacy|1|||
161074332|NCT05131477|581661117|FG003|PART 1|Lack of Efficacy|2|||
161074333|NCT05131477|581661118|FG004|PART 1|Lack of Efficacy|5|||
161074334|NCT05131477|581661119|FG005|PART 1|Lack of Efficacy|0|||
161074335|NCT05131477|581661120|FG006|PART 1|Lack of Efficacy|0|||
161074336|NCT05131477|581661121|FG007|PART 1|Lack of Efficacy|0|||
161074337|NCT05131477|581661122|FG008|PART 1|Lack of Efficacy|0|||
161074338|NCT05131477|581661123|FG009|PART 1|Lack of Efficacy|0|||
161074339|NCT05131477|581661124|FG010|PART 1|Lack of Efficacy|0|||
161074340|NCT05131477|581661125|FG011|PART 1|Lack of Efficacy|0|||
161074341|NCT05131477|581661126|FG012|PART 1|Lack of Efficacy|0|||
161074342|NCT05131477|581661127|FG013|PART 1|Lack of Efficacy|0|||
161074343|NCT05131477|581661114|FG000|PART 2|Withdrawal by Subject|0|||
161074344|NCT05131477|581661115|FG001|PART 2|Withdrawal by Subject|0|||
161074345|NCT05131477|581661116|FG002|PART 2|Withdrawal by Subject|0|||
161074346|NCT05131477|581661117|FG003|PART 2|Withdrawal by Subject|0|||
161074347|NCT05131477|581661118|FG004|PART 2|Withdrawal by Subject|0|||
161074348|NCT05131477|581661119|FG005|PART 2|Withdrawal by Subject|0|||
161074349|NCT05131477|581661120|FG006|PART 2|Withdrawal by Subject|2|||
161074350|NCT05131477|581661121|FG007|PART 2|Withdrawal by Subject|0|||
161074351|NCT05131477|581661122|FG008|PART 2|Withdrawal by Subject|0|||
161074352|NCT05131477|581661123|FG009|PART 2|Withdrawal by Subject|0|||
161074353|NCT05131477|581661124|FG010|PART 2|Withdrawal by Subject|2|||
161074354|NCT05131477|581661125|FG011|PART 2|Withdrawal by Subject|0|||
161074355|NCT05131477|581661126|FG012|PART 2|Withdrawal by Subject|2|||
161074356|NCT05131477|581661127|FG013|PART 2|Withdrawal by Subject|2|||
161074357|NCT05131477|581661114|FG000|PART 2|Other|0|||
161074358|NCT05131477|581661115|FG001|PART 2|Other|0|||
161074359|NCT05131477|581661116|FG002|PART 2|Other|0|||
161074360|NCT05131477|581661117|FG003|PART 2|Other|0|||
161074361|NCT05131477|581661118|FG004|PART 2|Other|0|||
161074362|NCT05131477|581661119|FG005|PART 2|Other|0|||
161074363|NCT05131477|581661120|FG006|PART 2|Other|0|||
161074364|NCT05131477|581661121|FG007|PART 2|Other|0|||
161074365|NCT05131477|581661122|FG008|PART 2|Other|1|||
161074366|NCT05131477|581661123|FG009|PART 2|Other|1|||
161074367|NCT05131477|581661124|FG010|PART 2|Other|0|||
161074368|NCT05131477|581661125|FG011|PART 2|Other|0|||
161074369|NCT05131477|581661126|FG012|PART 2|Other|1|||
161074370|NCT05131477|581661127|FG013|PART 2|Other|0|||
161074371|NCT05131477|581661114|FG000|PART 2|Lack of Efficacy|0|||
161074372|NCT05131477|581661115|FG001|PART 2|Lack of Efficacy|0|||
161074373|NCT05131477|581661116|FG002|PART 2|Lack of Efficacy|0|||
161074374|NCT05131477|581661117|FG003|PART 2|Lack of Efficacy|0|||
161074375|NCT05131477|581661118|FG004|PART 2|Lack of Efficacy|0|||
161074376|NCT05131477|581661119|FG005|PART 2|Lack of Efficacy|1|||
161074377|NCT05131477|581661120|FG006|PART 2|Lack of Efficacy|1|||
161074378|NCT05131477|581661121|FG007|PART 2|Lack of Efficacy|0|||
161074379|NCT05131477|581661122|FG008|PART 2|Lack of Efficacy|3|||
161074380|NCT05131477|581661123|FG009|PART 2|Lack of Efficacy|0|||
161074381|NCT05131477|581661124|FG010|PART 2|Lack of Efficacy|1|||
161074382|NCT05131477|581661125|FG011|PART 2|Lack of Efficacy|0|||
161074383|NCT05131477|581661126|FG012|PART 2|Lack of Efficacy|2|||
161074384|NCT05131477|581661127|FG013|PART 2|Lack of Efficacy|0|||
161074385|NCT05131477|581661114|FG000|PART 2|Unclassified|0|||
161074386|NCT05131477|581661115|FG001|PART 2|Unclassified|0|||
161074387|NCT05131477|581661116|FG002|PART 2|Unclassified|0|||
161074388|NCT05131477|581661117|FG003|PART 2|Unclassified|0|||
161074389|NCT05131477|581661118|FG004|PART 2|Unclassified|0|||
161074390|NCT05131477|581661119|FG005|PART 2|Unclassified|0|||
161074391|NCT05131477|581661120|FG006|PART 2|Unclassified|0|||
161074392|NCT05131477|581661121|FG007|PART 2|Unclassified|0|||
161074393|NCT05131477|581661122|FG008|PART 2|Unclassified|0|||
161074394|NCT05131477|581661123|FG009|PART 2|Unclassified|0|||
161074395|NCT05131477|581661124|FG010|PART 2|Unclassified|1|||
161074396|NCT05131477|581661125|FG011|PART 2|Unclassified|0|||
161074397|NCT05131477|581661126|FG012|PART 2|Unclassified|0|||
161074398|NCT05131477|581661127|FG013|PART 2|Unclassified|0|||
161074399|NCT05131477|581661114|FG000|PART 2|Re-randomized and not treated|0|||
161074400|NCT05131477|581661115|FG001|PART 2|Re-randomized and not treated|0|||
161074401|NCT05131477|581661116|FG002|PART 2|Re-randomized and not treated|0|||
161074402|NCT05131477|581661117|FG003|PART 2|Re-randomized and not treated|0|||
161345687|NCT02452190|582650902|FG001|Overall Study|Lost to Follow-up|3|||
161074403|NCT05131477|581661118|FG004|PART 2|Re-randomized and not treated|0|||
161074404|NCT05131477|581661119|FG005|PART 2|Re-randomized and not treated|0|||
161074405|NCT05131477|581661120|FG006|PART 2|Re-randomized and not treated|0|||
161074406|NCT05131477|581661121|FG007|PART 2|Re-randomized and not treated|1|||
161074407|NCT05131477|581661122|FG008|PART 2|Re-randomized and not treated|0|||
161074408|NCT05131477|581661123|FG009|PART 2|Re-randomized and not treated|0|||
161074409|NCT05131477|581661124|FG010|PART 2|Re-randomized and not treated|1|||
161074410|NCT05131477|581661125|FG011|PART 2|Re-randomized and not treated|0|||
161074411|NCT05131477|581661126|FG012|PART 2|Re-randomized and not treated|1|||
161074412|NCT05131477|581661127|FG013|PART 2|Re-randomized and not treated|1|||
161074413|NCT02194829|581661128|FG000|Overall Study|Adverse Event|2|||
161074414|NCT02194829|581661129|FG001|Overall Study|Adverse Event|2|||
161074415|NCT02194829|581661128|FG000|Overall Study|Death|0|||
161074416|NCT02194829|581661129|FG001|Overall Study|Death|1|||
161074417|NCT02194829|581661128|FG000|Overall Study|Disease progression|0|||
161074418|NCT02194829|581661129|FG001|Overall Study|Disease progression|1|||
161074419|NCT02194829|581661128|FG000|Overall Study|Withdrawal by Subject|0|||
161074420|NCT02194829|581661129|FG001|Overall Study|Withdrawal by Subject|1|||
161074421|NCT02194829|581661128|FG000|Overall Study|Never started protocol therapy|0|||
161074422|NCT02194829|581661129|FG001|Overall Study|Never started protocol therapy|1|||
161074423|NCT06840769|581661131|FG000|Overall Study|Withdrawal by Subject|1|||
161074424|NCT06840769|581661132|FG001|Overall Study|Withdrawal by Subject|0|||
161074425|NCT06840769|581661133|FG002|Overall Study|Withdrawal by Subject|0|||
161074426|NCT06840769|581661134|FG003|Overall Study|Withdrawal by Subject|0|||
161074427|NCT06840769|581661135|FG004|Overall Study|Withdrawal by Subject|0|||
161074428|NCT05992922|581661136|FG000|Overall Study|Adverse Event|6|||
161074429|NCT05992922|581661137|FG001|Overall Study|Adverse Event|0|||
161074430|NCT05992922|581661136|FG000|Overall Study|Sponsor Termination of Study|14|||
161074431|NCT05992922|581661137|FG001|Overall Study|Sponsor Termination of Study|20|||
161074432|NCT03939689|581662367|FG000|Overall Study|Radiographic progression|14|||
161074433|NCT03939689|581662368|FG001|Overall Study|Radiographic progression|17|||
161074434|NCT03939689|581662367|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
161074435|NCT03939689|581662368|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
161074436|NCT03939689|581662367|FG000|Overall Study|Adverse Event|1|||
161074437|NCT03939689|581662368|FG001|Overall Study|Adverse Event|8|||
161074438|NCT03939689|581662367|FG000|Overall Study|Unequivocal clinical progression|2|||
161074439|NCT03939689|581662368|FG001|Overall Study|Unequivocal clinical progression|5|||
161074440|NCT03939689|581662367|FG000|Overall Study|Other|1|||
161074441|NCT03939689|581662368|FG001|Overall Study|Other|4|||
161074442|NCT03939689|581662367|FG000|Overall Study|Death|0|||
161074443|NCT03939689|581662368|FG001|Overall Study|Death|3|||
161074444|NCT03939689|581662367|FG000|Overall Study|Participant decision|0|||
161074445|NCT03939689|581662368|FG001|Overall Study|Participant decision|3|||
161074446|NCT03939689|581662367|FG000|Overall Study|Withdrawal of consent|2|||
161074447|NCT03939689|581662368|FG001|Overall Study|Withdrawal of consent|1|||
161074448|NCT03939689|581662367|FG000|Overall Study|Investigator decision|1|||
161074449|NCT03939689|581662368|FG001|Overall Study|Investigator decision|0|||
161074450|NCT04427280|581662369|FG000|Overall Study|Withdrawal by Subject|0|||
161074451|NCT04427280|581662370|FG001|Overall Study|Withdrawal by Subject|2|||
161074452|NCT02473965|581662372|FG000|Overall Study|Adverse Event|6|||
161074453|NCT02473965|581662373|FG001|Overall Study|Adverse Event|4|||
161074454|NCT02473965|581662372|FG000|Overall Study|MG worsening|4|||
161074455|NCT02473965|581662373|FG001|Overall Study|MG worsening|1|||
161074456|NCT02473965|581662372|FG000|Overall Study|Withdrawal by Subject|2|||
161074457|NCT02473965|581662373|FG001|Overall Study|Withdrawal by Subject|3|||
161074458|NCT02473965|581662372|FG000|Overall Study|Physician Decision|0|||
161074459|NCT02473965|581662373|FG001|Overall Study|Physician Decision|2|||
161286260|NCT03889886|582428005|FG002|Overall Study|Withdrawal by Subject|1|||
161286261|NCT03889886|582428006|FG003|Overall Study|Withdrawal by Subject|0|||
161286262|NCT03889886|582428003|FG000|Overall Study|Adverse Event|0|||
161286263|NCT03889886|582428004|FG001|Overall Study|Adverse Event|0|||
161286264|NCT03889886|582428005|FG002|Overall Study|Adverse Event|0|||
161286265|NCT03889886|582428006|FG003|Overall Study|Adverse Event|6|||
161074460|NCT01920477|581662376|FG000|Overall Study|Adverse Event|0|||
161074461|NCT01920477|581662377|FG001|Overall Study|Adverse Event|1|||
161074462|NCT01920477|581662376|FG000|Overall Study|Lack of Efficacy|1|||
161074463|NCT01920477|581662377|FG001|Overall Study|Lack of Efficacy|0|||
161074464|NCT01920477|581662376|FG000|Overall Study|Study closed/terminated|14|||
161074465|NCT01920477|581662377|FG001|Overall Study|Study closed/terminated|15|||
161074466|NCT01920477|581662376|FG000|Overall Study|Withdrawal by Subject|0|||
161074467|NCT01920477|581662377|FG001|Overall Study|Withdrawal by Subject|1|||
161074468|NCT01681277|581662378|FG000|Overall Study|Adverse Event|1|||
161074469|NCT01681277|581662379|FG001|Overall Study|Adverse Event|0|||
161074470|NCT01681277|581662380|FG002|Overall Study|Adverse Event|0|||
161074471|NCT01681277|581662381|FG003|Overall Study|Adverse Event|0|||
161074472|NCT01681277|581662382|FG004|Overall Study|Adverse Event|0|||
161074473|NCT03838731|581662387|FG000|Overall Study|Pregnancy|0|||
161074474|NCT03838731|581662388|FG001|Overall Study|Pregnancy|1|||
161074475|NCT03838731|581662387|FG000|Overall Study|Withdrawal of consent|1|||
161074476|NCT03838731|581662388|FG001|Overall Study|Withdrawal of consent|0|||
161074477|NCT02706405|581662397|FG000|Overall Study|Death|3|||
161074478|NCT02706405|581662398|FG001|Overall Study|Death|2|||
161074479|NCT02706405|581662399|FG002|Overall Study|Death|0|||
161074480|NCT02706405|581662400|FG003|Overall Study|Death|1|||
161074481|NCT02706405|581662401|FG004|Overall Study|Death|0|||
161074482|NCT02706405|581662402|FG005|Overall Study|Death|0|||
161074483|NCT02706405|581662403|FG006|Overall Study|Death|3|||
161074484|NCT02706405|581662404|FG007|Overall Study|Death|4|||
161074485|NCT02706405|581662397|FG000|Overall Study|Disease progression|0|||
161074486|NCT02706405|581662398|FG001|Overall Study|Disease progression|0|||
161074487|NCT02706405|581662399|FG002|Overall Study|Disease progression|0|||
161074488|NCT02706405|581662400|FG003|Overall Study|Disease progression|0|||
161074489|NCT02706405|581662401|FG004|Overall Study|Disease progression|0|||
161074490|NCT02706405|581662402|FG005|Overall Study|Disease progression|0|||
161074491|NCT02706405|581662403|FG006|Overall Study|Disease progression|0|||
161074492|NCT02706405|581662404|FG007|Overall Study|Disease progression|1|||
161074493|NCT02706405|581662397|FG000|Overall Study|Pt moved to new therapy|0|||
161074494|NCT02706405|581662398|FG001|Overall Study|Pt moved to new therapy|0|||
161074495|NCT02706405|581662399|FG002|Overall Study|Pt moved to new therapy|0|||
161074496|NCT02706405|581662400|FG003|Overall Study|Pt moved to new therapy|0|||
161074497|NCT02706405|581662401|FG004|Overall Study|Pt moved to new therapy|0|||
161074498|NCT02706405|581662402|FG005|Overall Study|Pt moved to new therapy|1|||
161074499|NCT02706405|581662403|FG006|Overall Study|Pt moved to new therapy|0|||
161074500|NCT02706405|581662404|FG007|Overall Study|Pt moved to new therapy|1|||
161074501|NCT02706405|581662397|FG000|Overall Study|Physician Decision|1|||
161074502|NCT02706405|581662398|FG001|Overall Study|Physician Decision|0|||
161074503|NCT02706405|581662399|FG002|Overall Study|Physician Decision|0|||
161074504|NCT02706405|581662400|FG003|Overall Study|Physician Decision|0|||
161074505|NCT02706405|581662401|FG004|Overall Study|Physician Decision|0|||
161074506|NCT02706405|581662402|FG005|Overall Study|Physician Decision|0|||
161074507|NCT02706405|581662403|FG006|Overall Study|Physician Decision|0|||
161074508|NCT02706405|581662404|FG007|Overall Study|Physician Decision|0|||
161074509|NCT02304705|581662409|FG000|Overall Study|Withdrawal by Subject|2|||
161074510|NCT02304705|581662410|FG001|Overall Study|Withdrawal by Subject|0|||
161074511|NCT02304705|581662409|FG000|Overall Study|Physician Decision|2|||
161074512|NCT02304705|581662410|FG001|Overall Study|Physician Decision|4|||
161074513|NCT02304705|581662409|FG000|Overall Study|Death|0|||
161074514|NCT02304705|581662410|FG001|Overall Study|Death|1|||
161074515|NCT02304705|581662409|FG000|Overall Study|Lost to Follow-up|0|||
161074516|NCT02304705|581662410|FG001|Overall Study|Lost to Follow-up|2|||
161074517|NCT02038842|581662411|FG000|Overall Study|Withdrawal by Subject|2|||
161074518|NCT02038842|581662412|FG001|Overall Study|Withdrawal by Subject|2|||
161074519|NCT02038842|581662413|FG002|Overall Study|Withdrawal by Subject|0|||
161074520|NCT02038842|581662414|FG003|Overall Study|Withdrawal by Subject|0|||
161074521|NCT02038842|581662411|FG000|Overall Study|Participant decision|0|||
161074522|NCT02038842|581662412|FG001|Overall Study|Participant decision|0|||
161074523|NCT02038842|581662413|FG002|Overall Study|Participant decision|2|||
161074524|NCT02038842|581662414|FG003|Overall Study|Participant decision|1|||
161074525|NCT02038842|581662411|FG000|Overall Study|Adverse Event|0|||
161074526|NCT02038842|581662412|FG001|Overall Study|Adverse Event|0|||
161074527|NCT02038842|581662413|FG002|Overall Study|Adverse Event|3|||
161074528|NCT02038842|581662414|FG003|Overall Study|Adverse Event|1|||
161074529|NCT02038842|581662411|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
161074530|NCT02038842|581662412|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
161074531|NCT02038842|581662413|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
161074532|NCT02038842|581662414|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
161074533|NCT00789360|581662419|FG000|Overall Study|Protocol Violation|3|||
161074534|NCT00789360|581662420|FG001|Overall Study|Protocol Violation|1|||
161074535|NCT03559062|581662421|FG000|Overall Study|Other|0|||
161074536|NCT03559062|581662422|FG001|Overall Study|Other|1|||
161074537|NCT03559062|581662423|FG002|Overall Study|Other|0|||
161074538|NCT01757197|581662424|FG000|Overall Study|Death|2|||
161074539|NCT00847626|581662428|FG000|Overall Study|Adverse Event|10|||
161074540|NCT00847626|581662429|FG001|Overall Study|Adverse Event|10|||
161074541|NCT00847626|581662430|FG002|Overall Study|Adverse Event|6|||
161074542|NCT00847626|581662431|FG003|Overall Study|Adverse Event|19|||
161074543|NCT00847626|581662432|FG004|Overall Study|Adverse Event|11|||
161074544|NCT00847626|581662433|FG005|Overall Study|Adverse Event|22|||
161074545|NCT00847626|581662434|FG006|Overall Study|Adverse Event|4|||
161074546|NCT00847626|581662435|FG007|Overall Study|Adverse Event|6|||
161074547|NCT00847626|581662436|FG008|Overall Study|Adverse Event|3|||
161074548|NCT00847626|581662437|FG009|Overall Study|Adverse Event|6|||
161074549|NCT00847626|581662438|FG010|Overall Study|Adverse Event|6|||
161074550|NCT00847626|581662428|FG000|Overall Study|Protocol Violation|2|||
161074551|NCT00847626|581662429|FG001|Overall Study|Protocol Violation|1|||
161074552|NCT00847626|581662430|FG002|Overall Study|Protocol Violation|2|||
161074553|NCT00847626|581662431|FG003|Overall Study|Protocol Violation|1|||
161286266|NCT00276484|582428008|FG000|Overall Study|Adverse Event|4|||
161286267|NCT00276484|582428009|FG001|Overall Study|Adverse Event|7|||
161286268|NCT00276484|582428008|FG000|Overall Study|Lost to Follow-up|1|||
161286269|NCT00276484|582428009|FG001|Overall Study|Lost to Follow-up|1|||
161286270|NCT00276484|582428008|FG000|Overall Study|Protocol Violation|0|||
161286271|NCT00276484|582428009|FG001|Overall Study|Protocol Violation|1|||
161286272|NCT00276484|582428008|FG000|Overall Study|Withdrawal by Subject|4|||
161286273|NCT00276484|582428009|FG001|Overall Study|Withdrawal by Subject|3|||
161286274|NCT00276484|582428008|FG000|Overall Study|Could not take time off work|0|||
161286275|NCT00276484|582428009|FG001|Overall Study|Could not take time off work|1|||
161286276|NCT00942357|582428023|FG000|Overall Study|Ineligible|37|||
161286277|NCT00942357|582428024|FG001|Overall Study|Ineligible|40|||
161286278|NCT03347110|582428025|FG000|Overall Study|Other (Participant is incarcerated)|1|||
161286279|NCT03347110|582428025|FG000|Overall Study|Withdrawal by Subject|9|||
161286280|NCT03347110|582428025|FG000|Overall Study|Lost to Follow-up|1|||
161286281|NCT03347110|582428025|FG000|Overall Study|Lack of Efficacy|2|||
161286282|NCT03347110|582428025|FG000|Overall Study|Adverse Event, non-fatal|9|||
161286283|NCT01321879|582428026|FG000|Overall Study|Lack of Efficacy|5|||
161286284|NCT01321879|582428026|FG000|Overall Study|Adverse Event|5|||
161286285|NCT01321879|582428026|FG000|Overall Study|Death|3|||
161286286|NCT01321879|582428026|FG000|Overall Study|Withdrawal by Subject|1|||
161286287|NCT02687451|582428027|FG000|Overall Study|Withdrawal by Subject|1|||
161286288|NCT02687451|582428028|FG001|Overall Study|Withdrawal by Subject|0|||
161286289|NCT02687451|582428029|FG002|Overall Study|Withdrawal by Subject|0|||
161286290|NCT02687451|582428030|FG003|Overall Study|Withdrawal by Subject|0|||
161286291|NCT02687451|582428031|FG004|Overall Study|Withdrawal by Subject|0|||
161286292|NCT02687451|582428032|FG005|Overall Study|Withdrawal by Subject|1|||
161074554|NCT00847626|581662432|FG004|Overall Study|Protocol Violation|1|||
161074555|NCT00847626|581662433|FG005|Overall Study|Protocol Violation|1|||
161074556|NCT00847626|581662434|FG006|Overall Study|Protocol Violation|1|||
161074557|NCT00847626|581662435|FG007|Overall Study|Protocol Violation|1|||
161074558|NCT00847626|581662436|FG008|Overall Study|Protocol Violation|0|||
161074559|NCT00847626|581662437|FG009|Overall Study|Protocol Violation|1|||
161074560|NCT00847626|581662438|FG010|Overall Study|Protocol Violation|1|||
161074561|NCT00847626|581662428|FG000|Overall Study|Lost to Follow-up|0|||
161074562|NCT00847626|581662429|FG001|Overall Study|Lost to Follow-up|1|||
161074563|NCT00847626|581662430|FG002|Overall Study|Lost to Follow-up|1|||
161074564|NCT00847626|581662431|FG003|Overall Study|Lost to Follow-up|1|||
161074565|NCT00847626|581662432|FG004|Overall Study|Lost to Follow-up|0|||
161074566|NCT00847626|581662433|FG005|Overall Study|Lost to Follow-up|3|||
161074567|NCT00847626|581662434|FG006|Overall Study|Lost to Follow-up|1|||
161074568|NCT00847626|581662435|FG007|Overall Study|Lost to Follow-up|3|||
161074569|NCT00847626|581662436|FG008|Overall Study|Lost to Follow-up|1|||
161074570|NCT00847626|581662437|FG009|Overall Study|Lost to Follow-up|0|||
161074571|NCT00847626|581662438|FG010|Overall Study|Lost to Follow-up|1|||
161074572|NCT00847626|581662428|FG000|Overall Study|Withdrawal by Subject|5|||
161074573|NCT00847626|581662429|FG001|Overall Study|Withdrawal by Subject|5|||
161074574|NCT00847626|581662430|FG002|Overall Study|Withdrawal by Subject|3|||
161074575|NCT00847626|581662431|FG003|Overall Study|Withdrawal by Subject|8|||
161074576|NCT00847626|581662432|FG004|Overall Study|Withdrawal by Subject|12|||
161074577|NCT00847626|581662433|FG005|Overall Study|Withdrawal by Subject|9|||
161074578|NCT00847626|581662434|FG006|Overall Study|Withdrawal by Subject|8|||
161074579|NCT00847626|581662435|FG007|Overall Study|Withdrawal by Subject|4|||
161074580|NCT00847626|581662436|FG008|Overall Study|Withdrawal by Subject|4|||
161074581|NCT00847626|581662437|FG009|Overall Study|Withdrawal by Subject|5|||
161074582|NCT00847626|581662438|FG010|Overall Study|Withdrawal by Subject|2|||
161074583|NCT00847626|581662428|FG000|Overall Study|Lack of Efficacy|3|||
161074584|NCT00847626|581662429|FG001|Overall Study|Lack of Efficacy|1|||
161074585|NCT00847626|581662430|FG002|Overall Study|Lack of Efficacy|0|||
161074586|NCT00847626|581662431|FG003|Overall Study|Lack of Efficacy|1|||
161074587|NCT00847626|581662432|FG004|Overall Study|Lack of Efficacy|2|||
161074588|NCT00847626|581662433|FG005|Overall Study|Lack of Efficacy|0|||
161074589|NCT00847626|581662434|FG006|Overall Study|Lack of Efficacy|6|||
161074590|NCT00847626|581662435|FG007|Overall Study|Lack of Efficacy|2|||
161074591|NCT00847626|581662436|FG008|Overall Study|Lack of Efficacy|5|||
161074592|NCT00847626|581662437|FG009|Overall Study|Lack of Efficacy|1|||
161074593|NCT00847626|581662438|FG010|Overall Study|Lack of Efficacy|7|||
161074594|NCT00847626|581662428|FG000|Overall Study|Other|1|||
161074595|NCT00847626|581662429|FG001|Overall Study|Other|5|||
161074596|NCT00847626|581662430|FG002|Overall Study|Other|4|||
161074597|NCT00847626|581662431|FG003|Overall Study|Other|1|||
161074598|NCT00847626|581662432|FG004|Overall Study|Other|2|||
161074599|NCT00847626|581662433|FG005|Overall Study|Other|2|||
161158142|NCT00377611|581959037|FG001|Overall Study|Withdrawal by Subject|5|||
161286293|NCT00707239|582428033|FG000|Overall Study|Adverse Event|5|||
161286294|NCT00707239|582428034|FG001|Overall Study|Adverse Event|3|||
161286295|NCT00707239|582428035|FG002|Overall Study|Adverse Event|2|||
161286296|NCT00707239|582428033|FG000|Overall Study|Death|3|||
161286297|NCT00707239|582428034|FG001|Overall Study|Death|1|||
161286298|NCT00707239|582428035|FG002|Overall Study|Death|3|||
161158143|NCT00377611|581959036|FG000|Overall Study|Lost to Follow-up|18|||
161158144|NCT00377611|581959037|FG001|Overall Study|Lost to Follow-up|16|||
161158145|NCT00377611|581959036|FG000|Overall Study|Other|0|||
161158146|NCT00377611|581959037|FG001|Overall Study|Other|3|||
161158147|NCT03446651|581959041|FG000|Overall Study|Lost to Follow-up|4|||
161158148|NCT03446651|581959042|FG001|Overall Study|Lost to Follow-up|0|||
161158149|NCT03446651|581959041|FG000|Overall Study|Open Label Participants|5|||
161158150|NCT03446651|581959042|FG001|Overall Study|Open Label Participants|0|||
161158151|NCT01332019|581959047|FG000|Overall Study|Was Not Dosed|1|||
161158152|NCT01332019|581959048|FG001|Overall Study|Was Not Dosed|0|||
161158153|NCT01332019|581959047|FG000|Overall Study|Other|16|||
161158154|NCT01332019|581959048|FG001|Overall Study|Other|18|||
161158155|NCT01332019|581959047|FG000|Overall Study|Death|2|||
161158156|NCT01332019|581959048|FG001|Overall Study|Death|1|||
161158157|NCT01332019|581959047|FG000|Overall Study|Physician Decision|4|||
161158158|NCT01332019|581959048|FG001|Overall Study|Physician Decision|3|||
161158159|NCT01332019|581959047|FG000|Overall Study|Withdrawal by Subject|73|||
161158160|NCT01332019|581959048|FG001|Overall Study|Withdrawal by Subject|71|||
161158161|NCT01332019|581959047|FG000|Overall Study|Lost to Follow-up|4|||
161158162|NCT01332019|581959048|FG001|Overall Study|Lost to Follow-up|7|||
161158163|NCT01332019|581959047|FG000|Overall Study|Adverse Event|13|||
161158164|NCT01332019|581959048|FG001|Overall Study|Adverse Event|22|||
161158165|NCT01369849|581959051|FG000|Overall Study|Ineligible prior to treatment|0|||
161158166|NCT01369849|581959052|FG001|Overall Study|Ineligible prior to treatment|0|||
161158167|NCT01369849|581959053|FG002|Overall Study|Ineligible prior to treatment|1|||
161158168|NCT01369849|581959051|FG000|Overall Study|Ineligible after receiving treatment|0|||
161158169|NCT01369849|581959052|FG001|Overall Study|Ineligible after receiving treatment|1|||
161158170|NCT01369849|581959053|FG002|Overall Study|Ineligible after receiving treatment|0|||
161158171|NCT00756886|581959057|FG000|Overall Study|Lost to Follow-up|1|||
161158172|NCT00756886|581959058|FG001|Overall Study|Lost to Follow-up|0|||
161158173|NCT00756886|581959057|FG000|Overall Study|Adverse Event|0|||
161158174|NCT00756886|581959058|FG001|Overall Study|Adverse Event|3|||
161158175|NCT00756886|581959057|FG000|Overall Study|Lack of Efficacy|1|||
161158176|NCT00756886|581959058|FG001|Overall Study|Lack of Efficacy|0|||
161158177|NCT00756886|581959057|FG000|Overall Study|Ineligible|9|||
161158178|NCT00756886|581959058|FG001|Overall Study|Ineligible|4|||
161158179|NCT00871377|581959060|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161158180|NCT00871377|581959061|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161158181|NCT00871377|581959062|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
161158182|NCT00871377|581959063|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161158183|NCT00871377|581959064|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161158184|NCT00871377|581959065|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
161158185|NCT00871377|581959060|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161158186|NCT00871377|581959061|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161158187|NCT00871377|581959062|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161158188|NCT00871377|581959063|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161158189|NCT00871377|581959064|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
161158190|NCT00871377|581959065|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
161158191|NCT00871377|581959060|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
161158192|NCT00871377|581959061|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158193|NCT00871377|581959062|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158194|NCT00871377|581959063|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158195|NCT00871377|581959064|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158196|NCT00871377|581959065|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158197|NCT00871377|581959060|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158198|NCT00871377|581959061|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158199|NCT00871377|581959062|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158200|NCT00871377|581959063|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158201|NCT00871377|581959064|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
161158202|NCT00871377|581959065|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
161158203|NCT00871377|581959060|FG000|Third Intervention (10 Weeks)|Death|0|||
161158204|NCT00871377|581959061|FG001|Third Intervention (10 Weeks)|Death|0|||
161158205|NCT00871377|581959062|FG002|Third Intervention (10 Weeks)|Death|0|||
161158206|NCT00871377|581959063|FG003|Third Intervention (10 Weeks)|Death|1|||
161158207|NCT00871377|581959064|FG004|Third Intervention (10 Weeks)|Death|0|||
161158208|NCT00871377|581959065|FG005|Third Intervention (10 Weeks)|Death|0|||
161158209|NCT04348656|581959066|FG000|Overall Study|Withdrawal by Subject|2|||
161158210|NCT04348656|581959067|FG001|Overall Study|Withdrawal by Subject|0|||
161158211|NCT04348656|581959066|FG000|Overall Study|Lost to Follow-up|11|||
161158212|NCT04348656|581959067|FG001|Overall Study|Lost to Follow-up|6|||
161158213|NCT02116660|581959076|FG000|Overall Study|Deteriorating renal function|0|||
161158214|NCT02116660|581959077|FG001|Overall Study|Deteriorating renal function|1|||
161158215|NCT02116660|581959076|FG000|Overall Study|Adverse Event|1|||
161158216|NCT02116660|581959077|FG001|Overall Study|Adverse Event|1|||
161158217|NCT02116660|581959076|FG000|Overall Study|Withdrawal by Subject|0|||
161158218|NCT02116660|581959077|FG001|Overall Study|Withdrawal by Subject|2|||
161074600|NCT00847626|581662434|FG006|Overall Study|Other|2|||
161074601|NCT00847626|581662435|FG007|Overall Study|Other|3|||
161074602|NCT00847626|581662436|FG008|Overall Study|Other|1|||
161074603|NCT00847626|581662437|FG009|Overall Study|Other|1|||
161074604|NCT00847626|581662438|FG010|Overall Study|Other|3|||
161074605|NCT02138786|581662444|FG000|Overall Study|Adverse Event|0|||
161074606|NCT02138786|581662445|FG001|Overall Study|Adverse Event|2|||
161074607|NCT02138786|581662446|FG002|Overall Study|Adverse Event|1|||
161074608|NCT02138786|581662444|FG000|Overall Study|Death|1|||
161074609|NCT02138786|581662445|FG001|Overall Study|Death|7|||
161074610|NCT02138786|581662446|FG002|Overall Study|Death|2|||
161074611|NCT02138786|581662444|FG000|Overall Study|Disease Progression|1|||
161074612|NCT02138786|581662445|FG001|Overall Study|Disease Progression|1|||
161074613|NCT02138786|581662446|FG002|Overall Study|Disease Progression|3|||
161074614|NCT02138786|581662444|FG000|Overall Study|Withdrawal by Subject|1|||
161074615|NCT02138786|581662445|FG001|Overall Study|Withdrawal by Subject|2|||
161074616|NCT02138786|581662446|FG002|Overall Study|Withdrawal by Subject|0|||
161074617|NCT02138786|581662444|FG000|Overall Study|Patient's Wish|0|||
161074618|NCT02138786|581662445|FG001|Overall Study|Patient's Wish|2|||
161074619|NCT02138786|581662446|FG002|Overall Study|Patient's Wish|0|||
161074620|NCT02138786|581662444|FG000|Overall Study|Sponsor Terminated Study|0|||
161074621|NCT02138786|581662445|FG001|Overall Study|Sponsor Terminated Study|1|||
161074622|NCT02138786|581662446|FG002|Overall Study|Sponsor Terminated Study|1|||
161074623|NCT02138786|581662444|FG000|Overall Study|Non-Compliance|0|||
161074624|NCT02138786|581662445|FG001|Overall Study|Non-Compliance|0|||
161074625|NCT02138786|581662446|FG002|Overall Study|Non-Compliance|1|||
161074626|NCT02088957|581662447|FG000|Overall Study|Lack of Efficacy|1|||
161074627|NCT02088957|581662448|FG001|Overall Study|Lack of Efficacy|0|||
161074628|NCT00426127|581662449|FG000|Overall Study|Adverse Event|1|||
161074629|NCT00426127|581662449|FG000|Overall Study|Removed due to disease progression|1|||
161074630|NCT03111095|581662450|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
161074631|NCT03111095|581662451|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
161074632|NCT03111095|581662450|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
161074633|NCT03111095|581662451|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
161074634|NCT04638660|581662457|FG000|Overall Study|Withdrawal by Subject|2|||
161074635|NCT04638660|581662458|FG001|Overall Study|Withdrawal by Subject|0|||
161074636|NCT04638660|581662457|FG000|Overall Study|Lost to Follow-up|1|||
161074637|NCT04638660|581662458|FG001|Overall Study|Lost to Follow-up|0|||
161074638|NCT04076943|581662463|FG000|Overall Study|Withdrawal by Subject|12|||
161074639|NCT04076943|581662463|FG000|Overall Study|Adverse Event|1|||
161074640|NCT04076943|581662463|FG000|Overall Study|Progressive Disease|2|||
161074641|NCT04076943|581662463|FG000|Overall Study|Death|13|||
161074642|NCT04076943|581662463|FG000|Overall Study|Other than specified|6|||
161074643|NCT03080493|581662464|FG000|Overall Study|Did not provide NRS pain results|1|||
161074644|NCT03080493|581662465|FG001|Overall Study|Did not provide NRS pain results|0|||
161074645|NCT03080493|581662464|FG000|Overall Study|Adverse Event|0|||
161074646|NCT03080493|581662465|FG001|Overall Study|Adverse Event|1|||
161074647|NCT03080493|581662464|FG000|Overall Study|Randomization error (parity group)|0|||
161074648|NCT03080493|581662465|FG001|Overall Study|Randomization error (parity group)|1|||
161074649|NCT01602510|581662466|FG000|Open Label Phase|Adverse Event|46|||
161074650|NCT01602510|581662467|FG001|Open Label Phase|Adverse Event|0|||
161074651|NCT01602510|581662468|FG002|Open Label Phase|Adverse Event|0|||
161074652|NCT01602510|581662466|FG000|Open Label Phase|Lack of Efficacy|22|||
161074653|NCT01602510|581662467|FG001|Open Label Phase|Lack of Efficacy|0|||
161074654|NCT01602510|581662468|FG002|Open Label Phase|Lack of Efficacy|0|||
161074655|NCT01602510|581662466|FG000|Open Label Phase|Protocol Violation|15|||
161074656|NCT01602510|581662467|FG001|Open Label Phase|Protocol Violation|0|||
161074657|NCT01602510|581662468|FG002|Open Label Phase|Protocol Violation|0|||
161074658|NCT01602510|581662466|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
161074659|NCT01602510|581662467|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
161074660|NCT01602510|581662468|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
161074661|NCT01602510|581662466|FG000|Open Label Phase|Lost to Follow-up|22|||
161074662|NCT01602510|581662467|FG001|Open Label Phase|Lost to Follow-up|0|||
161074663|NCT01602510|581662468|FG002|Open Label Phase|Lost to Follow-up|0|||
161074664|NCT01602510|581662466|FG000|Open Label Phase|Physician Decision|19|||
161074665|NCT01602510|581662467|FG001|Open Label Phase|Physician Decision|0|||
161074666|NCT01602510|581662468|FG002|Open Label Phase|Physician Decision|0|||
161286299|NCT00707239|582428033|FG000|Overall Study|Physician Decision|1|||
161074667|NCT01602510|581662466|FG000|Open Label Phase|Withdrawal by Subject|57|||
161074668|NCT01602510|581662467|FG001|Open Label Phase|Withdrawal by Subject|0|||
161074669|NCT01602510|581662468|FG002|Open Label Phase|Withdrawal by Subject|0|||
161074670|NCT01602510|581662466|FG000|Randomized Phase|Adverse Event|0|||
161074671|NCT01602510|581662467|FG001|Randomized Phase|Adverse Event|2|||
161074672|NCT01602510|581662468|FG002|Randomized Phase|Adverse Event|6|||
161074673|NCT01602510|581662466|FG000|Randomized Phase|Lack of Efficacy|0|||
161074674|NCT01602510|581662467|FG001|Randomized Phase|Lack of Efficacy|4|||
161074675|NCT01602510|581662468|FG002|Randomized Phase|Lack of Efficacy|4|||
161074676|NCT01602510|581662466|FG000|Randomized Phase|Protocol Violation|0|||
161074677|NCT01602510|581662467|FG001|Randomized Phase|Protocol Violation|3|||
161074678|NCT01602510|581662468|FG002|Randomized Phase|Protocol Violation|3|||
161074679|NCT01602510|581662466|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
161074680|NCT01602510|581662467|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
161074681|NCT01602510|581662468|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
161074682|NCT01602510|581662466|FG000|Randomized Phase|Lost to Follow-up|0|||
161074683|NCT01602510|581662467|FG001|Randomized Phase|Lost to Follow-up|1|||
161074684|NCT01602510|581662468|FG002|Randomized Phase|Lost to Follow-up|3|||
161074685|NCT01602510|581662466|FG000|Randomized Phase|Physician Decision|0|||
161074686|NCT01602510|581662467|FG001|Randomized Phase|Physician Decision|0|||
161074687|NCT01602510|581662468|FG002|Randomized Phase|Physician Decision|2|||
161074688|NCT01602510|581662466|FG000|Randomized Phase|Withdrawal by Subject|0|||
161074689|NCT01602510|581662467|FG001|Randomized Phase|Withdrawal by Subject|6|||
161074690|NCT01602510|581662468|FG002|Randomized Phase|Withdrawal by Subject|7|||
161074691|NCT01261000|581662469|FG000|Overall Study|Screen failure|1|||
161074692|NCT01825577|581662470|FG000|Overall Study|Physician Decision|2|||
161074693|NCT01825577|581662470|FG000|Overall Study|Withdrawal by Subject|1|||
161074694|NCT01825577|581662470|FG000|Overall Study|Withdrawn by family members|2|||
161074695|NCT01825577|581662470|FG000|Overall Study|Lack of Efficacy|3|||
161074696|NCT01427725|581662475|FG000|Overall Study|Lost to Follow-up|17|||
161074697|NCT01427725|581662475|FG000|Overall Study|Protocol Violation|1|||
161074698|NCT01427725|581662475|FG000|Overall Study|Drug not administered|1|||
161074699|NCT01427725|581662475|FG000|Overall Study|Failure to visit|7|||
161074700|NCT01427725|581662475|FG000|Overall Study|Adverse Event|46|||
161074701|NCT01427725|581662475|FG000|Overall Study|Failure to visit after administration|40|||
161074702|NCT01427725|581662475|FG000|Overall Study|Patient's rejection|27|||
161074703|NCT01427725|581662475|FG000|Overall Study|Transfer to a different hospital|17|||
161074704|NCT01427725|581662475|FG000|Overall Study|Lack of Efficacy|8|||
161074705|NCT01427725|581662475|FG000|Overall Study|Death|7|||
161074706|NCT01427725|581662475|FG000|Overall Study|Symptom improvement|6|||
161074707|NCT01427725|581662475|FG000|Overall Study|AE and Patient's rejection|5|||
161074708|NCT01427725|581662475|FG000|Overall Study|Physician Decision|5|||
161074709|NCT01427725|581662475|FG000|Overall Study|Exacerbation of underlying disease|5|||
161074710|NCT01427725|581662475|FG000|Overall Study|Oral feeding difficulty|5|||
161074711|NCT01427725|581662475|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
161074712|NCT01427725|581662475|FG000|Overall Study|Forgetting prescription|1|||
161074713|NCT01427725|581662475|FG000|Overall Study|Other|2|||
161074714|NCT01374568|581662476|FG000|Overall Study|Lab unable to analyze BTM|0|||
161074715|NCT01374568|581662477|FG001|Overall Study|Lab unable to analyze BTM|2|||
161074716|NCT04230122|581662478|FG000|Overall Study|Lost to Follow-up|1|||
161074717|NCT04230122|581662479|FG001|Overall Study|Lost to Follow-up|0|||
161074718|NCT00277095|581662481|FG000|Overall Study|Death|2|||
161074719|NCT00277095|581662481|FG000|Overall Study|Explanted|7|||
161074720|NCT00277095|581662481|FG000|Overall Study|Lost to Follow-up|2|||
161074721|NCT00277095|581662481|FG000|Overall Study|Missed Follow-up|9|||
161074722|NCT00277095|581662481|FG000|Overall Study|Physician Decision|1|||
161074723|NCT05415748|581662485|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
161074724|NCT05415748|581662486|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
161074725|NCT05415748|581662487|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
161074726|NCT05415748|581662488|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
161074727|NCT05415748|581662485|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
161074728|NCT05415748|581662486|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
161074729|NCT05415748|581662487|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
161074730|NCT05415748|581662488|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
161074731|NCT01447576|581662489|FG000|Overall Study|Lost to Follow-up|52|||
161074732|NCT01447576|581662489|FG000|Overall Study|Adverse Event|127|||
161074733|NCT01447576|581662489|FG000|Overall Study|Participant met withdrawal criteria|40|||
161074734|NCT01447576|581662489|FG000|Overall Study|Withdrawal by Subject|100|||
161074735|NCT01447576|581662489|FG000|Overall Study|Protocol deviation|83|||
161074736|NCT01447576|581662489|FG000|Overall Study|Lack of Efficacy|68|||
161074737|NCT01447576|581662489|FG000|Overall Study|Physician Decision|6|||
161074738|NCT03128671|581662490|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
161074739|NCT03128671|581662491|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
161074740|NCT03128671|581662490|FG000|Allocation|Death|1|||
161074741|NCT03128671|581662491|FG001|Allocation|Death|0|||
161074742|NCT03128671|581662490|FG000|Allocation|Withdrawal by Subject|4|||
161074743|NCT03128671|581662491|FG001|Allocation|Withdrawal by Subject|0|||
161074744|NCT03128671|581662490|FG000|Intervention|Withdrawal by Subject|11|||
161074745|NCT03128671|581662491|FG001|Intervention|Withdrawal by Subject|10|||
161074746|NCT03128671|581662490|FG000|Intervention|Palliative/hospice care initiated|9|||
161074747|NCT03128671|581662491|FG001|Intervention|Palliative/hospice care initiated|10|||
161074748|NCT03128671|581662490|FG000|Intervention|Death|13|||
161074749|NCT03128671|581662491|FG001|Intervention|Death|11|||
161074750|NCT03128671|581662490|FG000|Intervention|Interrupted by hurricane|1|||
161074751|NCT03128671|581662491|FG001|Intervention|Interrupted by hurricane|0|||
161074752|NCT03128671|581662490|FG000|Intervention|Physician Decision|2|||
161074753|NCT03128671|581662491|FG001|Intervention|Physician Decision|3|||
161074754|NCT04641962|581662492|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
161074755|NCT04641962|581662493|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
161074756|NCT04641962|581662494|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
161074757|NCT04641962|581662495|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
161074758|NCT04641962|581662496|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
161074759|NCT04641962|581662492|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161074760|NCT04641962|581662493|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161074761|NCT04641962|581662494|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161074762|NCT04641962|581662495|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
161074763|NCT04641962|581662496|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
161074764|NCT04641962|581662492|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
161074765|NCT04641962|581662493|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
161074766|NCT04641962|581662494|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
161074767|NCT04641962|581662495|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
161074768|NCT04641962|581662496|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
161074769|NCT04641962|581662492|FG000|DBT Period: Up to 52 Weeks|Death|1|||
161074770|NCT04641962|581662493|FG001|DBT Period: Up to 52 Weeks|Death|0|||
161074771|NCT04641962|581662494|FG002|DBT Period: Up to 52 Weeks|Death|0|||
161074772|NCT04641962|581662495|FG003|DBT Period: Up to 52 Weeks|Death|0|||
161074773|NCT04641962|581662496|FG004|DBT Period: Up to 52 Weeks|Death|0|||
161074774|NCT04641962|581662492|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
161074775|NCT04641962|581662493|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
161074776|NCT04641962|581662494|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
161074777|NCT04641962|581662495|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
161074778|NCT04641962|581662496|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
161074779|NCT04641962|581662492|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
161074780|NCT04641962|581662493|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
161074781|NCT04641962|581662494|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
161074782|NCT04641962|581662495|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
161074783|NCT04641962|581662496|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
161074784|NCT04641962|581662492|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161074785|NCT04641962|581662493|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161074786|NCT04641962|581662494|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
161074787|NCT04641962|581662495|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161074788|NCT04641962|581662496|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
161074789|NCT03277352|581662497|FG000|Overall Study|Study Terminated By Sponsor|2|||
161074790|NCT03277352|581662497|FG000|Overall Study|Withdrawal by Subject|4|||
161074791|NCT03277352|581662497|FG000|Overall Study|Death|4|||
161074792|NCT02726945|581662504|FG000|Overall Study|Withdrawal by Subject|0|||
161074793|NCT02726945|581662505|FG001|Overall Study|Withdrawal by Subject|0|||
161074794|NCT02726945|581662506|FG002|Overall Study|Withdrawal by Subject|1|||
161074795|NCT02726945|581662504|FG000|Overall Study|Elected to have total knee replacement|0|||
161074796|NCT02726945|581662505|FG001|Overall Study|Elected to have total knee replacement|1|||
161074797|NCT02726945|581662506|FG002|Overall Study|Elected to have total knee replacement|0|||
161074798|NCT02271984|581664600|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074799|NCT02271984|581664601|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074800|NCT02271984|581664602|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074801|NCT02271984|581664603|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074802|NCT02271984|581664604|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074803|NCT02271984|581664605|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
161074804|NCT02271984|581664606|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074805|NCT02271984|581664607|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
161074806|NCT02271984|581664608|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074807|NCT02271984|581664609|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074808|NCT02271984|581664610|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074809|NCT02271984|581664611|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
161074810|NCT01088984|581664612|FG000|Phase 1|Death|2|||
161074811|NCT01088984|581664613|FG001|Phase 1|Death|1|||
161074812|NCT01088984|581664612|FG000|Phase 1|Disease Progression|2|||
161074813|NCT01088984|581664613|FG001|Phase 1|Disease Progression|4|||
161074814|NCT01088984|581664612|FG000|Phase 1|Other|1|||
161074815|NCT01088984|581664613|FG001|Phase 1|Other|1|||
161074816|NCT01088984|581664612|FG000|Phase 2|Death|0|||
161158219|NCT02116660|581959076|FG000|Overall Study|Organization reason|1|||
161158220|NCT02116660|581959077|FG001|Overall Study|Organization reason|0|||
161158221|NCT02651194|581959082|FG000|Overall Study|Lost to Follow-up|3|||
161158222|NCT02651194|581959082|FG000|Overall Study|Other|2|||
161074817|NCT01088984|581664613|FG001|Phase 2|Death|5|||
161074818|NCT01088984|581664612|FG000|Phase 2|Withdrawal by Subject|0|||
161074819|NCT01088984|581664613|FG001|Phase 2|Withdrawal by Subject|1|||
161074820|NCT01088984|581664612|FG000|Phase 2|DIsease Progression|0|||
161074821|NCT01088984|581664613|FG001|Phase 2|DIsease Progression|25|||
161074822|NCT01088984|581664612|FG000|Phase 2|Other|0|||
161074823|NCT01088984|581664613|FG001|Phase 2|Other|1|||
161074824|NCT05602727|581664624|FG000|Overall Study|Physician Decision|0|||
161074825|NCT05602727|581664625|FG001|Overall Study|Physician Decision|1|||
161074826|NCT05602727|581664626|FG002|Overall Study|Physician Decision|0|||
161074827|NCT05602727|581664624|FG000|Overall Study|Randomized by mistake without study medication|1|||
161074828|NCT05602727|581664625|FG001|Overall Study|Randomized by mistake without study medication|0|||
161074829|NCT05602727|581664626|FG002|Overall Study|Randomized by mistake without study medication|0|||
161074830|NCT05602727|581664624|FG000|Overall Study|Study termination by Sponsor|18|||
161074831|NCT05602727|581664625|FG001|Overall Study|Study termination by Sponsor|15|||
161074832|NCT05602727|581664626|FG002|Overall Study|Study termination by Sponsor|19|||
161074833|NCT05602727|581664624|FG000|Overall Study|Withdrawal by Subject|2|||
161074834|NCT05602727|581664625|FG001|Overall Study|Withdrawal by Subject|1|||
161074835|NCT05602727|581664626|FG002|Overall Study|Withdrawal by Subject|1|||
161074836|NCT05602727|581664624|FG000|Overall Study|Various reasons|1|||
161074837|NCT05602727|581664625|FG001|Overall Study|Various reasons|6|||
161074838|NCT05602727|581664626|FG002|Overall Study|Various reasons|1|||
161074839|NCT03412773|581664629|FG000|Overall Study|Lost to Follow-up|0|||
161074840|NCT03412773|581664630|FG001|Overall Study|Lost to Follow-up|7|||
161074841|NCT03412773|581664631|FG002|Overall Study|Lost to Follow-up|6|||
161074842|NCT03412773|581664629|FG000|Overall Study|Withdrawal by Subject|0|||
161074843|NCT03412773|581664630|FG001|Overall Study|Withdrawal by Subject|15|||
161074844|NCT03412773|581664631|FG002|Overall Study|Withdrawal by Subject|19|||
161074845|NCT03412773|581664629|FG000|Overall Study|Study Closed By Sponsor|3|||
161074846|NCT03412773|581664630|FG001|Overall Study|Study Closed By Sponsor|46|||
161074847|NCT03412773|581664631|FG002|Overall Study|Study Closed By Sponsor|33|||
161074848|NCT03412773|581664629|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
161074849|NCT03412773|581664630|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
161074850|NCT03412773|581664631|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
161074851|NCT03412773|581664629|FG000|Overall Study|Death|7|||
161074852|NCT03412773|581664630|FG001|Overall Study|Death|259|||
161074853|NCT03412773|581664631|FG002|Overall Study|Death|273|||
161158223|NCT01980706|581959083|FG000|Overall Study|Withdrawal by Subject|9|||
161158224|NCT01980706|581959084|FG001|Overall Study|Withdrawal by Subject|6|||
161158225|NCT01980706|581959085|FG002|Overall Study|Withdrawal by Subject|2|||
161158226|NCT01980706|581959083|FG000|Overall Study|Adverse Event|1|||
161158227|NCT01980706|581959084|FG001|Overall Study|Adverse Event|2|||
161158228|NCT01980706|581959085|FG002|Overall Study|Adverse Event|5|||
161158229|NCT01980706|581959083|FG000|Overall Study|Lost to Follow-up|3|||
161158230|NCT01980706|581959084|FG001|Overall Study|Lost to Follow-up|4|||
161158231|NCT01980706|581959085|FG002|Overall Study|Lost to Follow-up|3|||
161158232|NCT01980706|581959083|FG000|Overall Study|miscellaneous|4|||
161158233|NCT01980706|581959084|FG001|Overall Study|miscellaneous|5|||
161158234|NCT01980706|581959085|FG002|Overall Study|miscellaneous|3|||
161158235|NCT02546674|581959086|FG000|Overall Study|Adverse Event|19|||
161158236|NCT02546674|581959086|FG000|Overall Study|Death|1|||
161158237|NCT02546674|581959086|FG000|Overall Study|Lost to Follow-up|1|||
161158238|NCT02546674|581959086|FG000|Overall Study|Physician Decision|13|||
161158239|NCT02546674|581959086|FG000|Overall Study|Pregnancy|1|||
161158240|NCT02546674|581959086|FG000|Overall Study|Progressive Disease|2|||
161158241|NCT02546674|581959086|FG000|Overall Study|Protocol Deviation|2|||
161158242|NCT02546674|581959086|FG000|Overall Study|Subject/Guardian Decision|6|||
161158243|NCT02546674|581959086|FG000|Overall Study|Withdrawal of Informed Consent|3|||
161158244|NCT02208024|581959087|FG000|Overall Study|Withdrawal by Subject|1|||
161158245|NCT04285346|581959090|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
161158246|NCT04285346|581959091|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
161158247|NCT04285346|581959090|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
161158248|NCT04285346|581959091|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161158249|NCT04285346|581959090|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
161158250|NCT04285346|581959091|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161158251|NCT00610935|581959092|FG000|Overall Study|Lost to Follow-up|0|||
161158252|NCT00610935|581959093|FG001|Overall Study|Lost to Follow-up|1|||
161158253|NCT00610935|581959092|FG000|Overall Study|Withdrawal by Subject|0|||
161158254|NCT00610935|581959093|FG001|Overall Study|Withdrawal by Subject|2|||
161158255|NCT00610935|581959092|FG000|Overall Study|Sponsor Discontinuation|1|||
161158256|NCT00610935|581959093|FG001|Overall Study|Sponsor Discontinuation|0|||
161158257|NCT04360187|581959096|FG000|Double-Blind Treatment|Adverse Event|9|||
161158258|NCT04360187|581959097|FG001|Double-Blind Treatment|Adverse Event|11|||
161158259|NCT04360187|581959096|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
161158260|NCT04360187|581959097|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
161158261|NCT04360187|581959096|FG000|Double-Blind Treatment|Physician Decision|1|||
161158262|NCT04360187|581959097|FG001|Double-Blind Treatment|Physician Decision|0|||
161074854|NCT03412773|581664629|FG000|Overall Study|Physician Decision|0|||
161074855|NCT03412773|581664630|FG001|Overall Study|Physician Decision|0|||
161074856|NCT03412773|581664631|FG002|Overall Study|Physician Decision|1|||
161074857|NCT02643303|581664634|FG000|Overall Study|Progressive Disease|4|||
161158263|NCT04360187|581959096|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
161074858|NCT02643303|581664635|FG001|Overall Study|Progressive Disease|4|||
161074859|NCT02643303|581664636|FG002|Overall Study|Progressive Disease|1|||
161074860|NCT02643303|581664637|FG003|Overall Study|Progressive Disease|12|||
161074861|NCT02643303|581664638|FG004|Overall Study|Progressive Disease|6|||
161286300|NCT00707239|582428034|FG001|Overall Study|Physician Decision|1|||
161286301|NCT00707239|582428035|FG002|Overall Study|Physician Decision|2|||
161074862|NCT02643303|581664639|FG005|Overall Study|Progressive Disease|4|||
161074863|NCT02643303|581664640|FG006|Overall Study|Progressive Disease|8|||
161074864|NCT02643303|581664641|FG007|Overall Study|Progressive Disease|2|||
161074865|NCT02643303|581664642|FG008|Overall Study|Progressive Disease|6|||
161074866|NCT02643303|581664634|FG000|Overall Study|Adverse Event|0|||
161074867|NCT02643303|581664635|FG001|Overall Study|Adverse Event|1|||
161074868|NCT02643303|581664636|FG002|Overall Study|Adverse Event|0|||
161074869|NCT02643303|581664637|FG003|Overall Study|Adverse Event|0|||
161074870|NCT02643303|581664638|FG004|Overall Study|Adverse Event|1|||
161074871|NCT02643303|581664639|FG005|Overall Study|Adverse Event|0|||
161074872|NCT02643303|581664640|FG006|Overall Study|Adverse Event|0|||
161286302|NCT00707239|582428033|FG000|Overall Study|Protocol Violation|0|||
161074873|NCT02643303|581664641|FG007|Overall Study|Adverse Event|0|||
161074874|NCT02643303|581664642|FG008|Overall Study|Adverse Event|0|||
161074875|NCT02643303|581664634|FG000|Overall Study|Withdrawal by Subject|0|||
161074876|NCT02643303|581664635|FG001|Overall Study|Withdrawal by Subject|0|||
161074877|NCT02643303|581664636|FG002|Overall Study|Withdrawal by Subject|0|||
161074878|NCT02643303|581664637|FG003|Overall Study|Withdrawal by Subject|1|||
161074879|NCT02643303|581664638|FG004|Overall Study|Withdrawal by Subject|0|||
161074880|NCT02643303|581664639|FG005|Overall Study|Withdrawal by Subject|0|||
161074881|NCT02643303|581664640|FG006|Overall Study|Withdrawal by Subject|1|||
161074882|NCT02643303|581664641|FG007|Overall Study|Withdrawal by Subject|1|||
161074883|NCT02643303|581664642|FG008|Overall Study|Withdrawal by Subject|1|||
161074884|NCT05332912|581664645|FG000|Overall Study|Withdrawal by Subject|0|||
161074885|NCT05332912|581664646|FG001|Overall Study|Withdrawal by Subject|1|||
161074886|NCT05332912|581664647|FG002|Overall Study|Withdrawal by Subject|2|||
161074887|NCT05332912|581664648|FG003|Overall Study|Withdrawal by Subject|0|||
161074888|NCT05332912|581664645|FG000|Overall Study|Lost to Follow-up|0|||
161074889|NCT05332912|581664646|FG001|Overall Study|Lost to Follow-up|0|||
161074890|NCT05332912|581664647|FG002|Overall Study|Lost to Follow-up|1|||
161074891|NCT05332912|581664648|FG003|Overall Study|Lost to Follow-up|0|||
161074892|NCT01174446|581664649|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
161074893|NCT01174446|581664650|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
161074894|NCT01174446|581664651|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
161074895|NCT01174446|581664652|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
161074896|NCT01174446|581664649|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
161074897|NCT01174446|581664650|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
161074898|NCT01174446|581664651|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
161074899|NCT01174446|581664652|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
161074900|NCT01174446|581664649|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
161074901|NCT01174446|581664650|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161074902|NCT01174446|581664651|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161074903|NCT01174446|581664652|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
161074904|NCT01174446|581664649|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
161074905|NCT01174446|581664650|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
161074906|NCT01174446|581664651|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
161074907|NCT01174446|581664652|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
161074908|NCT03057847|581664653|FG000|Overall Study|Lost to Follow-up|16|||
161074909|NCT04517669|581664654|FG000|Overall Study|Lost to Follow-up|2|||
161074910|NCT04517669|581664654|FG000|Overall Study|Withdrawal by Subject|3|||
161074911|NCT04517669|581664654|FG000|Overall Study|Drug withdrawn|44|||
161074912|NCT04517669|581664654|FG000|Overall Study|Other|1|||
161074913|NCT04517669|581664654|FG000|Overall Study|Eligibility criteria not met|4|||
161074914|NCT04517669|581664654|FG000|Overall Study|Did not receive treatment|3|||
161074915|NCT01923662|581664655|FG000|Overall Study|Withdrawal by Subject|1|||
161074916|NCT01199068|581664656|FG000|Overall Study|Unacceptable toxicity|0|||
161074917|NCT01199068|581664657|FG001|Overall Study|Unacceptable toxicity|0|||
161074918|NCT01199068|581664658|FG002|Overall Study|Unacceptable toxicity|2|||
161074919|NCT01199068|581664656|FG000|Overall Study|Progressive disease|3|||
161074920|NCT01199068|581664657|FG001|Overall Study|Progressive disease|3|||
161074921|NCT01199068|581664658|FG002|Overall Study|Progressive disease|6|||
161074922|NCT01199068|581664656|FG000|Overall Study|Withdrawal by Subject|0|||
161074923|NCT01199068|581664657|FG001|Overall Study|Withdrawal by Subject|0|||
161074924|NCT01199068|581664658|FG002|Overall Study|Withdrawal by Subject|1|||
161074925|NCT01250925|581664659|FG000|Overall Study|Lost to Follow-up|1|||
161074926|NCT01250925|581664660|FG001|Overall Study|Lost to Follow-up|1|||
161074927|NCT01250925|581664661|FG002|Overall Study|Lost to Follow-up|0|||
161286303|NCT00707239|582428034|FG001|Overall Study|Protocol Violation|0|||
161286304|NCT00707239|582428035|FG002|Overall Study|Protocol Violation|1|||
161074928|NCT01250925|581664659|FG000|Overall Study|Withdrawal by Subject|2|||
161074929|NCT01250925|581664660|FG001|Overall Study|Withdrawal by Subject|0|||
161074930|NCT01250925|581664661|FG002|Overall Study|Withdrawal by Subject|0|||
161074931|NCT01250925|581664659|FG000|Overall Study|Protocol Violation|2|||
161074932|NCT01250925|581664660|FG001|Overall Study|Protocol Violation|0|||
161074933|NCT01250925|581664661|FG002|Overall Study|Protocol Violation|0|||
161074934|NCT01250925|581664659|FG000|Overall Study|Physician Decision|0|||
161074935|NCT01250925|581664660|FG001|Overall Study|Physician Decision|2|||
161074936|NCT01250925|581664661|FG002|Overall Study|Physician Decision|1|||
161074937|NCT01250925|581664659|FG000|Overall Study|Adverse Event|0|||
161074938|NCT01250925|581664660|FG001|Overall Study|Adverse Event|0|||
161074939|NCT01250925|581664661|FG002|Overall Study|Adverse Event|1|||
161074940|NCT01016262|581664672|FG000|Double-blind Phase|Adverse Event|0|||
161074941|NCT01016262|581664673|FG001|Double-blind Phase|Adverse Event|0|||
161074942|NCT01016262|581664674|FG002|Double-blind Phase|Adverse Event|1|||
161074943|NCT01016262|581664675|FG003|Double-blind Phase|Adverse Event|0|||
161074944|NCT01016262|581664676|FG004|Double-blind Phase|Adverse Event|0|||
161074945|NCT01016262|581664677|FG005|Double-blind Phase|Adverse Event|0|||
161074946|NCT01016262|581664672|FG000|Double-blind Phase|Lack of Efficacy|1|||
161074947|NCT01016262|581664673|FG001|Double-blind Phase|Lack of Efficacy|0|||
161074948|NCT01016262|581664674|FG002|Double-blind Phase|Lack of Efficacy|5|||
161074949|NCT01016262|581664675|FG003|Double-blind Phase|Lack of Efficacy|0|||
161074950|NCT01016262|581664676|FG004|Double-blind Phase|Lack of Efficacy|0|||
161074951|NCT01016262|581664677|FG005|Double-blind Phase|Lack of Efficacy|0|||
161074952|NCT01016262|581664672|FG000|Double-blind Phase|Disease Progression|0|||
161074953|NCT01016262|581664673|FG001|Double-blind Phase|Disease Progression|1|||
161074954|NCT01016262|581664674|FG002|Double-blind Phase|Disease Progression|2|||
161074955|NCT01016262|581664675|FG003|Double-blind Phase|Disease Progression|0|||
161074956|NCT01016262|581664676|FG004|Double-blind Phase|Disease Progression|0|||
161074957|NCT01016262|581664677|FG005|Double-blind Phase|Disease Progression|0|||
161074958|NCT01016262|581664672|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
161074959|NCT01016262|581664673|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
161074960|NCT01016262|581664674|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
161074961|NCT01016262|581664675|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
161074962|NCT01016262|581664676|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
161074963|NCT01016262|581664677|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
161074964|NCT01016262|581664672|FG000|Open-Label Phase|Adverse Event|0|||
161074965|NCT01016262|581664673|FG001|Open-Label Phase|Adverse Event|0|||
161074966|NCT01016262|581664674|FG002|Open-Label Phase|Adverse Event|0|||
161074967|NCT01016262|581664675|FG003|Open-Label Phase|Adverse Event|1|||
161074968|NCT01016262|581664676|FG004|Open-Label Phase|Adverse Event|0|||
161074969|NCT01016262|581664677|FG005|Open-Label Phase|Adverse Event|0|||
161074970|NCT01016262|581664672|FG000|Open-Label Phase|Lost to Follow-up|0|||
161074971|NCT01016262|581664673|FG001|Open-Label Phase|Lost to Follow-up|0|||
161074972|NCT01016262|581664674|FG002|Open-Label Phase|Lost to Follow-up|0|||
161074973|NCT01016262|581664675|FG003|Open-Label Phase|Lost to Follow-up|0|||
161074974|NCT01016262|581664676|FG004|Open-Label Phase|Lost to Follow-up|1|||
161074975|NCT01016262|581664677|FG005|Open-Label Phase|Lost to Follow-up|0|||
161074976|NCT01016262|581664672|FG000|Open-Label Phase|Lack of Efficacy|0|||
161074977|NCT01016262|581664673|FG001|Open-Label Phase|Lack of Efficacy|0|||
161074978|NCT01016262|581664674|FG002|Open-Label Phase|Lack of Efficacy|0|||
161074979|NCT01016262|581664675|FG003|Open-Label Phase|Lack of Efficacy|1|||
161158264|NCT04360187|581959097|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
161286305|NCT00707239|582428033|FG000|Overall Study|Lack of Efficacy|1|||
161286306|NCT00707239|582428034|FG001|Overall Study|Lack of Efficacy|2|||
161074980|NCT01016262|581664676|FG004|Open-Label Phase|Lack of Efficacy|0|||
161074981|NCT01016262|581664677|FG005|Open-Label Phase|Lack of Efficacy|0|||
161074982|NCT01016262|581664672|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
161074983|NCT01016262|581664673|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
161074984|NCT01016262|581664674|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
161074985|NCT01016262|581664675|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
161074986|NCT01016262|581664676|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
161074987|NCT01016262|581664677|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
161074988|NCT03738475|581664678|FG000|Overall Study|Participant Non-Compliance|1|||
161074989|NCT03738475|581664679|FG001|Overall Study|Participant Non-Compliance|0|||
161074990|NCT00677534|581664680|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
161074991|NCT00677534|581664680|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
161074992|NCT00677534|581664680|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
161074993|NCT00667394|581664681|FG000|Overall Study|Adverse Event|3|||
161074994|NCT00667394|581664682|FG001|Overall Study|Adverse Event|0|||
161074995|NCT00667394|581664681|FG000|Overall Study|Progressive disease|1|||
161074996|NCT00667394|581664682|FG001|Overall Study|Progressive disease|0|||
161074997|NCT02224703|581664688|FG000|Overall Study|Adverse Event|0|||
161158265|NCT04360187|581959096|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
161074998|NCT02224703|581664689|FG001|Overall Study|Adverse Event|5|||
161286307|NCT00707239|582428035|FG002|Overall Study|Lack of Efficacy|0|||
161286308|NCT00707239|582428033|FG000|Overall Study|Randomized, but not treated|1|||
161074999|NCT02224703|581664690|FG002|Overall Study|Adverse Event|0|||
161075000|NCT02224703|581664688|FG000|Overall Study|Withdrawn by investigator|1|||
161075001|NCT02224703|581664689|FG001|Overall Study|Withdrawn by investigator|0|||
161075002|NCT02224703|581664690|FG002|Overall Study|Withdrawn by investigator|0|||
161075003|NCT02224703|581664688|FG000|Overall Study|Advised by medical monitor|1|||
161075004|NCT02224703|581664689|FG001|Overall Study|Advised by medical monitor|0|||
161075005|NCT02224703|581664690|FG002|Overall Study|Advised by medical monitor|0|||
161075006|NCT02224703|581664688|FG000|Overall Study|Withdrawn by parent/guardian|0|||
161075007|NCT02224703|581664689|FG001|Overall Study|Withdrawn by parent/guardian|1|||
161075008|NCT02224703|581664690|FG002|Overall Study|Withdrawn by parent/guardian|0|||
161075009|NCT02224703|581664688|FG000|Overall Study|Lack of Efficacy|1|||
161075010|NCT02224703|581664689|FG001|Overall Study|Lack of Efficacy|0|||
161075011|NCT02224703|581664690|FG002|Overall Study|Lack of Efficacy|0|||
161075012|NCT02922023|581664693|FG000|Overall Study|Lost to Follow-up|2|||
161075013|NCT02922023|581664694|FG001|Overall Study|Lost to Follow-up|0|||
161075014|NCT00863681|581664695|FG000|Overall Study|Other|2|||
161075015|NCT00863681|581664696|FG001|Overall Study|Other|0|||
161075016|NCT00863681|581664697|FG002|Overall Study|Other|0|||
161075017|NCT00863681|581664695|FG000|Overall Study|Missing|1|||
161075018|NCT00863681|581664696|FG001|Overall Study|Missing|0|||
161075019|NCT00863681|581664697|FG002|Overall Study|Missing|0|||
161075020|NCT00863681|581664695|FG000|Overall Study|Death|40|||
161075021|NCT00863681|581664696|FG001|Overall Study|Death|23|||
161075022|NCT00863681|581664697|FG002|Overall Study|Death|6|||
161075023|NCT00863681|581664695|FG000|Overall Study|Withdrawal by Subject|12|||
161075024|NCT00863681|581664696|FG001|Overall Study|Withdrawal by Subject|5|||
161075025|NCT00863681|581664697|FG002|Overall Study|Withdrawal by Subject|2|||
161075026|NCT00863681|581664695|FG000|Overall Study|Protocol Violation|2|||
161075027|NCT00863681|581664696|FG001|Overall Study|Protocol Violation|0|||
161075028|NCT00863681|581664697|FG002|Overall Study|Protocol Violation|0|||
161075029|NCT00863681|581664695|FG000|Overall Study|Lost to Follow-up|3|||
161075030|NCT00863681|581664696|FG001|Overall Study|Lost to Follow-up|0|||
161075031|NCT00863681|581664697|FG002|Overall Study|Lost to Follow-up|3|||
161075032|NCT00863681|581664695|FG000|Overall Study|Adverse Event|28|||
161075033|NCT00863681|581664696|FG001|Overall Study|Adverse Event|10|||
161075034|NCT00863681|581664697|FG002|Overall Study|Adverse Event|6|||
161075035|NCT00863681|581664695|FG000|Overall Study|Lack of Efficacy|2|||
161075036|NCT00863681|581664696|FG001|Overall Study|Lack of Efficacy|2|||
161075037|NCT00863681|581664697|FG002|Overall Study|Lack of Efficacy|1|||
161075038|NCT00863681|581664695|FG000|Overall Study|Non-compliance with study drug|1|||
161075039|NCT00863681|581664696|FG001|Overall Study|Non-compliance with study drug|3|||
161075040|NCT00863681|581664697|FG002|Overall Study|Non-compliance with study drug|0|||
161075049|NCT01304498|581664701|FG000|Overall Study|Adverse Event|1|||
161075050|NCT01304498|581664702|FG001|Overall Study|Adverse Event|1|||
161075051|NCT01304498|581664701|FG000|Overall Study|Withdrawal by Subject|2|||
161075052|NCT01304498|581664702|FG001|Overall Study|Withdrawal by Subject|3|||
161075053|NCT01304498|581664701|FG000|Overall Study|Protocol Violation|1|||
161075054|NCT01304498|581664702|FG001|Overall Study|Protocol Violation|0|||
161075055|NCT01304498|581664701|FG000|Overall Study|Lost to Follow-up|2|||
161075056|NCT01304498|581664702|FG001|Overall Study|Lost to Follow-up|1|||
161075057|NCT03325777|581664703|FG000|Overall Study|Lost to Follow-up|9|||
161075058|NCT03325777|581664704|FG001|Overall Study|Lost to Follow-up|12|||
161075059|NCT03004404|581664706|FG000|Period 2|Adverse Event|0|||
161075060|NCT03004404|581664707|FG001|Period 2|Adverse Event|0|||
161075061|NCT03004404|581664708|FG002|Period 2|Adverse Event|0|||
161075062|NCT03004404|581664709|FG003|Period 2|Adverse Event|0|||
161075063|NCT03004404|581664710|FG004|Period 2|Adverse Event|0|||
161075064|NCT03004404|581664711|FG005|Period 2|Adverse Event|0|||
161075065|NCT03004404|581664712|FG006|Period 2|Adverse Event|0|||
161075066|NCT03004404|581664713|FG007|Period 2|Adverse Event|0|||
161075067|NCT03004404|581664714|FG008|Period 2|Adverse Event|1|||
161075068|NCT03004404|581664715|FG009|Period 2|Adverse Event|0|||
161075069|NCT03004404|581664716|FG010|Period 2|Adverse Event|0|||
161075070|NCT03004404|581664717|FG011|Period 2|Adverse Event|0|||
161075071|NCT03004404|581664718|FG012|Period 2|Adverse Event|0|||
161075072|NCT03004404|581664719|FG013|Period 2|Adverse Event|0|||
161075073|NCT03004404|581664720|FG014|Period 2|Adverse Event|0|||
161075074|NCT03004404|581664721|FG015|Period 2|Adverse Event|1|||
161075075|NCT02990468|581664725|FG000|Phase 2: MTD|Change in treatment|0|||
161075076|NCT02990468|581664726|FG001|Phase 2: MTD|Change in treatment|0|||
161075077|NCT02990468|581664727|FG002|Phase 2: MTD|Change in treatment|1|||
161075078|NCT01721954|581664732|FG000|Overall Study|Death|58|||
161075079|NCT01721954|581664733|FG001|Overall Study|Death|64|||
161345688|NCT02452190|582650901|FG000|Overall Study|Adverse Event|2|||
161075080|NCT01721954|581664732|FG000|Overall Study|Withdrawal by Subject|8|||
161075081|NCT01721954|581664733|FG001|Overall Study|Withdrawal by Subject|4|||
161075082|NCT01721954|581664732|FG000|Overall Study|Adverse Event|2|||
161075083|NCT01721954|581664733|FG001|Overall Study|Adverse Event|0|||
161075084|NCT01721954|581664732|FG000|Overall Study|Lost to Follow-up|2|||
161075085|NCT01721954|581664733|FG001|Overall Study|Lost to Follow-up|1|||
161075086|NCT01195623|581664734|FG000|Overall Study|Lost to Follow-up|35|||
161075087|NCT01195623|581664735|FG001|Overall Study|Lost to Follow-up|37|||
161075088|NCT00534495|581664737|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
161075089|NCT00534495|581664738|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
161075090|NCT00534495|581664739|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
161075091|NCT00534495|581664737|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
161075092|NCT00534495|581664738|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
161075093|NCT00534495|581664739|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
161075094|NCT00534495|581664737|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
161075095|NCT00534495|581664738|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
161075096|NCT00534495|581664739|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
161075097|NCT00534495|581664737|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
161075098|NCT00534495|581664738|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
161075099|NCT00534495|581664739|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
161075100|NCT00534495|581664737|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
161075101|NCT00534495|581664738|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
161075102|NCT00534495|581664739|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
161075103|NCT00534495|581664737|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
161075104|NCT00534495|581664738|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
161075105|NCT00534495|581664739|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
161075106|NCT00534495|581664737|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
161075107|NCT00534495|581664738|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
161075108|NCT00534495|581664739|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
161075109|NCT00534495|581664737|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
161075110|NCT00534495|581664738|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
161075111|NCT00534495|581664739|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
161075112|NCT00534495|581664737|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
161075113|NCT00534495|581664738|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
161075114|NCT00534495|581664739|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
161075115|NCT02920970|581664742|FG000|First Intervention|Protocol Violation|0|||
161075116|NCT02920970|581664743|FG001|First Intervention|Protocol Violation|1|||
161075117|NCT02920970|581664742|FG000|First Intervention|Adverse Event|0|||
161075118|NCT02920970|581664743|FG001|First Intervention|Adverse Event|1|||
161075119|NCT02920970|581664742|FG000|Second Intervention|Poor Lens Fit|1|||
161075120|NCT02920970|581664743|FG001|Second Intervention|Poor Lens Fit|0|||
161075121|NCT01711853|581664744|FG000|Overall Study|Not treated|3|||
161075122|NCT04191616|581664745|FG000|Pre-assignment Period|Did not receive study treatment|2|||
161075123|NCT04191616|581664745|FG000|Treatment Period|Death|37|||
161075124|NCT04191616|581664745|FG000|Treatment Period|Sponsor decision|11|||
161075125|NCT04191616|581664745|FG000|Treatment Period|Withdrawal by Subject|4|||
161075126|NCT01361594|581664746|FG000|Overall Study|Withdrawal by Subject|1|||
161075127|NCT01361594|581664747|FG001|Overall Study|Withdrawal by Subject|2|||
161075128|NCT02670122|581664751|FG000|Overall Study|Lost to Follow-up|4|||
161075129|NCT02762903|581664753|FG000|Overall Study|Lost to Follow-up|0|||
161075130|NCT02762903|581664754|FG001|Overall Study|Lost to Follow-up|1|||
161075131|NCT00632502|581664757|FG000|Overall Study|Adverse Event|0|||
161075132|NCT00632502|581664758|FG001|Overall Study|Adverse Event|1|||
161075133|NCT00632502|581664757|FG000|Overall Study|Randomized not treated|3|||
161075134|NCT00632502|581664758|FG001|Overall Study|Randomized not treated|0|||
161075135|NCT00570908|581664759|FG000|Overall Study|Adverse Event|5|||
161075136|NCT00570908|581664759|FG000|Overall Study|Withdrawal by Subject|2|||
161075137|NCT01213524|581664760|FG000|Baseline|Withdrawal by Subject|5|||
161075138|NCT01213524|581664760|FG000|Baseline|high breath alcohol levels|1|||
161075139|NCT01213524|581664760|FG000|Baseline|Physician Decision|1|||
161075140|NCT01213524|581664760|FG000|Session 2|Withdrawal by Subject|5|||
161075141|NCT01213524|581664760|FG000|Session 3|Withdrawal by Subject|4|||
161075142|NCT01213524|581664760|FG000|Session 4|Physician Decision|1|||
161075143|NCT01213524|581664760|FG000|Session 4|Withdrawal by Subject|2|||
161075144|NCT00975676|581664764|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
161158266|NCT04360187|581959097|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
161075145|NCT00975676|581664765|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
161075146|NCT02209181|581664766|FG000|Overall Study|Adverse Event|1|||
161075147|NCT02209181|581664767|FG001|Overall Study|Adverse Event|0|||
161075148|NCT02209181|581664768|FG002|Overall Study|Adverse Event|1|||
161075149|NCT02209181|581664769|FG003|Overall Study|Adverse Event|0|||
161075150|NCT02209181|581664766|FG000|Overall Study|Withdrawal by Subject|0|||
161075151|NCT02209181|581664767|FG001|Overall Study|Withdrawal by Subject|1|||
161075152|NCT02209181|581664768|FG002|Overall Study|Withdrawal by Subject|0|||
161075153|NCT02209181|581664769|FG003|Overall Study|Withdrawal by Subject|0|||
161075154|NCT02548078|581664770|FG000|Overall Study|Serious adverse event/Adverse event|1|||
161075155|NCT02548078|581664771|FG001|Overall Study|Serious adverse event/Adverse event|0|||
161075156|NCT02548078|581664770|FG000|Overall Study|Moved from study area|3|||
161075157|NCT02548078|581664771|FG001|Overall Study|Moved from study area|3|||
161075158|NCT02548078|581664770|FG000|Overall Study|Lost to Follow-up|1|||
161075159|NCT02548078|581664771|FG001|Overall Study|Lost to Follow-up|3|||
161075160|NCT02579772|581664772|FG000|Overall Study|Withdrawal by Subject|0|||
161075161|NCT02579772|581664773|FG001|Overall Study|Withdrawal by Subject|1|||
161075162|NCT02579772|581664772|FG000|Overall Study|Usage of additional antioxidants|1|||
161075163|NCT02579772|581664773|FG001|Overall Study|Usage of additional antioxidants|0|||
161075164|NCT02579772|581664772|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
161075165|NCT02579772|581664773|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
161075166|NCT01040169|581664774|FG000|Overall Study|Lost to Follow-up|3|||
161075167|NCT01040169|581664775|FG001|Overall Study|Lost to Follow-up|8|||
161075168|NCT00350727|581664776|FG000|Phase I: Dose Escalation|Adverse Event|4|||
161075169|NCT00350727|581664777|FG001|Phase I: Dose Escalation|Adverse Event|0|||
161075170|NCT00350727|581664778|FG002|Phase I: Dose Escalation|Adverse Event|0|||
161075171|NCT00350727|581664776|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
161075172|NCT00350727|581664777|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
161075173|NCT00350727|581664778|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
161075174|NCT00350727|581664776|FG000|Phase I: Dose Escalation|Death|1|||
161075175|NCT00350727|581664777|FG001|Phase I: Dose Escalation|Death|0|||
161075176|NCT00350727|581664778|FG002|Phase I: Dose Escalation|Death|0|||
161075177|NCT00350727|581664776|FG000|Phase I: Dose Escalation|Physician Decision|1|||
161075178|NCT00350727|581664777|FG001|Phase I: Dose Escalation|Physician Decision|0|||
161075179|NCT00350727|581664778|FG002|Phase I: Dose Escalation|Physician Decision|0|||
161075180|NCT00350727|581664776|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
161075181|NCT00350727|581664777|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
161075182|NCT00350727|581664778|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
161075183|NCT00350727|581664776|FG000|Phase II|Disease Progression|0|||
161075184|NCT00350727|581664777|FG001|Phase II|Disease Progression|15|||
161075185|NCT00350727|581664778|FG002|Phase II|Disease Progression|16|||
161075186|NCT00350727|581664776|FG000|Phase II|Clinical Deterioration|0|||
161075187|NCT00350727|581664777|FG001|Phase II|Clinical Deterioration|1|||
161075188|NCT00350727|581664778|FG002|Phase II|Clinical Deterioration|0|||
161075189|NCT00350727|581664776|FG000|Phase II|Withdrawal by Subject|0|||
161075190|NCT00350727|581664777|FG001|Phase II|Withdrawal by Subject|2|||
161075191|NCT00350727|581664778|FG002|Phase II|Withdrawal by Subject|1|||
161075192|NCT00350727|581664776|FG000|Phase II|Adverse Event|0|||
161075193|NCT00350727|581664777|FG001|Phase II|Adverse Event|1|||
161075194|NCT00350727|581664778|FG002|Phase II|Adverse Event|1|||
161075195|NCT00350727|581664776|FG000|Phase II|Death|0|||
161075196|NCT00350727|581664777|FG001|Phase II|Death|0|||
161075197|NCT00350727|581664778|FG002|Phase II|Death|2|||
161075198|NCT00350727|581664776|FG000|Phase II|Sponsor Terminated Study|0|||
161075199|NCT00350727|581664777|FG001|Phase II|Sponsor Terminated Study|0|||
161075200|NCT00350727|581664778|FG002|Phase II|Sponsor Terminated Study|1|||
161075201|NCT00350727|581664776|FG000|Phase II|Enrolled in Rollover Study|0|||
161075202|NCT00350727|581664777|FG001|Phase II|Enrolled in Rollover Study|0|||
161075203|NCT00350727|581664778|FG002|Phase II|Enrolled in Rollover Study|1|||
161075204|NCT00862836|581664779|FG000|Overall Study|Withdrawal by Subject|1|||
161075205|NCT04535544|581664782|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
161075206|NCT04535544|581664783|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
161075207|NCT04535544|581664784|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
161075208|NCT04535544|581664785|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
161075209|NCT04535544|581664782|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
161075210|NCT04535544|581664783|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
161075211|NCT04535544|581664784|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
161075212|NCT04535544|581664785|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
161075213|NCT04535544|581664782|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
161075214|NCT04535544|581664783|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
161075215|NCT04535544|581664784|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
161075216|NCT04535544|581664785|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
161158267|NCT04360187|581959096|FG000|Follow-Up|Lost to Follow-up|1|||
161158268|NCT04360187|581959097|FG001|Follow-Up|Lost to Follow-up|0|||
161158269|NCT02203838|581959098|FG000|Overall Study|Lack of Efficacy|7|||
161075217|NCT04535544|581664782|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
161075218|NCT04535544|581664783|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
161075219|NCT04535544|581664784|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
161075220|NCT04535544|581664785|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
161075221|NCT04535544|581664782|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
161075222|NCT04535544|581664783|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
161075223|NCT04535544|581664784|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
161075224|NCT04535544|581664785|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
161075225|NCT04535544|581664782|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
161075226|NCT04535544|581664783|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
161075227|NCT04535544|581664784|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
161075228|NCT04535544|581664785|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
161075229|NCT04535544|581664782|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
161075230|NCT04535544|581664783|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
161075231|NCT04535544|581664784|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
161075232|NCT04535544|581664785|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
161075233|NCT04535544|581664782|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
161075234|NCT04535544|581664783|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
161075235|NCT04535544|581664784|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
161075236|NCT04535544|581664785|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
161075237|NCT01228318|581667091|FG000|Overall Study|Clinic no show to receive intervention|1|||
161075238|NCT01228318|581667092|FG001|Overall Study|Clinic no show to receive intervention|0|||
161075239|NCT01228318|581667091|FG000|Overall Study|Unable to contact|2|||
161075240|NCT01228318|581667092|FG001|Overall Study|Unable to contact|5|||
161075241|NCT01228318|581667091|FG000|Overall Study|Moved|0|||
161075242|NCT01228318|581667092|FG001|Overall Study|Moved|2|||
161075243|NCT01228318|581667091|FG000|Overall Study|Incarcerated|1|||
161075244|NCT01228318|581667092|FG001|Overall Study|Incarcerated|0|||
161075245|NCT00770029|581667093|FG000|Overall Study|Lost to Follow-up|2|||
161075246|NCT00770029|581667094|FG001|Overall Study|Lost to Follow-up|0|||
161075247|NCT00770029|581667093|FG000|Overall Study|Withdrawal by Subject|3|||
161075248|NCT00770029|581667094|FG001|Overall Study|Withdrawal by Subject|3|||
161075249|NCT00770029|581667093|FG000|Overall Study|Adverse Event|1|||
161075250|NCT00770029|581667094|FG001|Overall Study|Adverse Event|0|||
161075251|NCT03140280|581667095|FG000|Overall Study|Physician Decision|5|||
161075252|NCT05620108|581667096|FG000|Overall Study|Physician Decision|1|||
161075253|NCT05620108|581667097|FG001|Overall Study|Physician Decision|2|||
161075254|NCT00626197|581667103|FG000|Overall Study|Did not cooperate|2|||
161075255|NCT00626197|581667104|FG001|Overall Study|Did not cooperate|6|||
161075256|NCT00626197|581667105|FG002|Overall Study|Did not cooperate|1|||
161075257|NCT00626197|581667103|FG000|Overall Study|Failure to return|6|||
161075258|NCT00626197|581667104|FG001|Overall Study|Failure to return|5|||
161075259|NCT00626197|581667105|FG002|Overall Study|Failure to return|6|||
161075260|NCT00626197|581667103|FG000|Overall Study|Adverse event, serious fatal|3|||
161075261|NCT00626197|581667104|FG001|Overall Study|Adverse event, serious fatal|6|||
161075262|NCT00626197|581667105|FG002|Overall Study|Adverse event, serious fatal|6|||
161075263|NCT00626197|581667103|FG000|Overall Study|Adverse Event|1|||
161075264|NCT00626197|581667104|FG001|Overall Study|Adverse Event|1|||
161075265|NCT00626197|581667105|FG002|Overall Study|Adverse Event|2|||
161075266|NCT00626197|581667103|FG000|Overall Study|Withdrawal by Subject|17|||
161075267|NCT00626197|581667104|FG001|Overall Study|Withdrawal by Subject|17|||
161075268|NCT00626197|581667105|FG002|Overall Study|Withdrawal by Subject|7|||
161075269|NCT00626197|581667103|FG000|Overall Study|Administrative reasons|15|||
161075270|NCT00626197|581667104|FG001|Overall Study|Administrative reasons|19|||
161075271|NCT00626197|581667105|FG002|Overall Study|Administrative reasons|55|||
161075272|NCT05282121|581667110|FG000|Overall Study|Adverse Event|1|||
161075273|NCT05282121|581667111|FG001|Overall Study|Adverse Event|1|||
161075274|NCT05282121|581667112|FG002|Overall Study|Adverse Event|4|||
161075275|NCT05282121|581667113|FG003|Overall Study|Adverse Event|1|||
161075276|NCT05282121|581667110|FG000|Overall Study|Study Terminated by Sponsor|1|||
161075277|NCT05282121|581667111|FG001|Overall Study|Study Terminated by Sponsor|2|||
161075278|NCT05282121|581667112|FG002|Overall Study|Study Terminated by Sponsor|2|||
161075279|NCT05282121|581667113|FG003|Overall Study|Study Terminated by Sponsor|2|||
161075280|NCT05282121|581667110|FG000|Overall Study|Other than listed|0|||
161075281|NCT05282121|581667111|FG001|Overall Study|Other than listed|0|||
161075282|NCT05282121|581667112|FG002|Overall Study|Other than listed|1|||
161075283|NCT05282121|581667113|FG003|Overall Study|Other than listed|0|||
161075284|NCT05282121|581667110|FG000|Overall Study|No reason available|0|||
161075285|NCT05282121|581667111|FG001|Overall Study|No reason available|0|||
161075286|NCT05282121|581667112|FG002|Overall Study|No reason available|1|||
161075287|NCT05282121|581667113|FG003|Overall Study|No reason available|0|||
161158270|NCT02203838|581959099|FG001|Overall Study|Lack of Efficacy|0|||
161158271|NCT02203838|581959100|FG002|Overall Study|Lack of Efficacy|1|||
161075288|NCT03301155|581667116|FG000|Overall Study|Сompliance with exclusion criteria|8|||
161075289|NCT03301155|581667117|FG001|Overall Study|Сompliance with exclusion criteria|7|||
161075290|NCT03510455|581667118|FG000|Overall Study|Physician Decision|1|||
161075291|NCT00384189|581667119|FG000|Overall Study|Reason Not Specified|50|||
161075292|NCT00384189|581667120|FG001|Overall Study|Reason Not Specified|57|||
161075293|NCT00384189|581667121|FG002|Overall Study|Reason Not Specified|58|||
161075294|NCT00384189|581667122|FG003|Overall Study|Reason Not Specified|40|||
161075295|NCT04958642|581667123|FG000|Overall Study|Transferred to OLEX program|3|||
161075296|NCT04958642|581667124|FG001|Overall Study|Transferred to OLEX program|0|||
161075297|NCT04958642|581667125|FG002|Overall Study|Transferred to OLEX program|5|||
161286309|NCT00707239|582428034|FG001|Overall Study|Randomized, but not treated|1|||
161286310|NCT00707239|582428035|FG002|Overall Study|Randomized, but not treated|1|||
161286311|NCT00707239|582428033|FG000|Overall Study|Other|8|||
161286312|NCT00707239|582428034|FG001|Overall Study|Other|3|||
161286313|NCT00707239|582428035|FG002|Overall Study|Other|5|||
161075298|NCT04958642|581667123|FG000|Overall Study|Death|0|||
161286314|NCT01518322|582428036|FG000|Overall Study|FeNO measurement was missing|13|||
161286315|NCT01958437|582428037|FG000|Overall Study|Incidental MRI findings|0|||
161075299|NCT04958642|581667124|FG001|Overall Study|Death|0|||
161075300|NCT04958642|581667125|FG002|Overall Study|Death|1|||
161075301|NCT04958642|581667123|FG000|Overall Study|Withdrawal by Subject|4|||
161075302|NCT04958642|581667124|FG001|Overall Study|Withdrawal by Subject|9|||
161075303|NCT04958642|581667125|FG002|Overall Study|Withdrawal by Subject|13|||
161075304|NCT04958642|581667123|FG000|Overall Study|Investigator's Decision|0|||
161075305|NCT04958642|581667124|FG001|Overall Study|Investigator's Decision|0|||
161075306|NCT04958642|581667125|FG002|Overall Study|Investigator's Decision|1|||
161075307|NCT04958642|581667123|FG000|Overall Study|Adverse Event|1|||
161075308|NCT04958642|581667124|FG001|Overall Study|Adverse Event|0|||
161075309|NCT04958642|581667125|FG002|Overall Study|Adverse Event|1|||
161075310|NCT04958642|581667123|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
161075311|NCT04958642|581667124|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
161075312|NCT04958642|581667125|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
161075313|NCT04958642|581667123|FG000|Overall Study|Lost to Follow-up|1|||
161075314|NCT04958642|581667124|FG001|Overall Study|Lost to Follow-up|0|||
161075315|NCT04958642|581667125|FG002|Overall Study|Lost to Follow-up|0|||
161075316|NCT04958642|581667123|FG000|Overall Study|Transferred to EAP following study termination|0|||
161075317|NCT04958642|581667124|FG001|Overall Study|Transferred to EAP following study termination|0|||
161075318|NCT04958642|581667125|FG002|Overall Study|Transferred to EAP following study termination|1|||
161075319|NCT04958642|581667123|FG000|Overall Study|Transferred to Expanded Access Program|1|||
161075320|NCT04958642|581667124|FG001|Overall Study|Transferred to Expanded Access Program|0|||
161075321|NCT04958642|581667125|FG002|Overall Study|Transferred to Expanded Access Program|0|||
161075322|NCT02942004|581667126|FG000|Overall Study|Withdrawal by Subject|0|||
161075323|NCT02942004|581667127|FG001|Overall Study|Withdrawal by Subject|2|||
161075324|NCT02942004|581667128|FG002|Overall Study|Withdrawal by Subject|3|||
161075325|NCT02942004|581667126|FG000|Overall Study|Lost to Follow-up|1|||
161075326|NCT02942004|581667127|FG001|Overall Study|Lost to Follow-up|1|||
161075327|NCT02942004|581667128|FG002|Overall Study|Lost to Follow-up|2|||
161075328|NCT02942004|581667126|FG000|Overall Study|Randomized but not dosed|3|||
161075329|NCT02942004|581667127|FG001|Overall Study|Randomized but not dosed|9|||
161075330|NCT02942004|581667128|FG002|Overall Study|Randomized but not dosed|4|||
161075331|NCT05627258|581667129|FG000|Overall Study|Lost to Follow-up|1|||
161075332|NCT05627258|581667130|FG001|Overall Study|Lost to Follow-up|0|||
161075333|NCT05627258|581667131|FG002|Overall Study|Lost to Follow-up|0|||
161075334|NCT05627258|581667132|FG003|Overall Study|Lost to Follow-up|0|||
161075335|NCT05627258|581667133|FG004|Overall Study|Lost to Follow-up|0|||
161075336|NCT05627258|581667134|FG005|Overall Study|Lost to Follow-up|0|||
161075337|NCT05627258|581667129|FG000|Overall Study|Withdrawal by Subject|0|||
161075338|NCT05627258|581667130|FG001|Overall Study|Withdrawal by Subject|0|||
161075339|NCT05627258|581667131|FG002|Overall Study|Withdrawal by Subject|0|||
161075340|NCT05627258|581667132|FG003|Overall Study|Withdrawal by Subject|0|||
161075341|NCT05627258|581667133|FG004|Overall Study|Withdrawal by Subject|2|||
161075342|NCT05627258|581667134|FG005|Overall Study|Withdrawal by Subject|0|||
161075343|NCT05627258|581667129|FG000|Overall Study|Enrolled, but product not administered|1|||
161075344|NCT05627258|581667130|FG001|Overall Study|Enrolled, but product not administered|0|||
161075345|NCT05627258|581667131|FG002|Overall Study|Enrolled, but product not administered|0|||
161075346|NCT05627258|581667132|FG003|Overall Study|Enrolled, but product not administered|0|||
161075347|NCT05627258|581667133|FG004|Overall Study|Enrolled, but product not administered|0|||
161075348|NCT05627258|581667134|FG005|Overall Study|Enrolled, but product not administered|0|||
161075349|NCT05627258|581667129|FG000|Overall Study|Other subject illness/injury|1|||
161075350|NCT05627258|581667130|FG001|Overall Study|Other subject illness/injury|0|||
161075351|NCT05627258|581667131|FG002|Overall Study|Other subject illness/injury|0|||
161075352|NCT05627258|581667132|FG003|Overall Study|Other subject illness/injury|0|||
161075353|NCT05627258|581667133|FG004|Overall Study|Other subject illness/injury|0|||
161075354|NCT05627258|581667134|FG005|Overall Study|Other subject illness/injury|0|||
161075355|NCT05627258|581667129|FG000|Overall Study|Subject moved from area|0|||
161075356|NCT05627258|581667130|FG001|Overall Study|Subject moved from area|0|||
161286316|NCT01958437|582428038|FG001|Overall Study|Incidental MRI findings|0|||
161286317|NCT01958437|582428039|FG002|Overall Study|Incidental MRI findings|1|||
161075357|NCT05627258|581667131|FG002|Overall Study|Subject moved from area|1|||
161075358|NCT05627258|581667132|FG003|Overall Study|Subject moved from area|0|||
161158272|NCT02203838|581959101|FG003|Overall Study|Lack of Efficacy|1|||
161286318|NCT01958437|582428040|FG003|Overall Study|Incidental MRI findings|1|||
161345689|NCT02452190|582650902|FG001|Overall Study|Adverse Event|5|||
161345690|NCT02452190|582650901|FG000|Overall Study|Withdrawal by Subject|20|||
161345691|NCT02452190|582650902|FG001|Overall Study|Withdrawal by Subject|11|||
161345692|NCT02452190|582650901|FG000|Overall Study|Noncompliance with study drug|1|||
161075359|NCT05627258|581667133|FG004|Overall Study|Subject moved from area|0|||
161075360|NCT05627258|581667134|FG005|Overall Study|Subject moved from area|0|||
161075361|NCT00678301|581667135|FG000|Overall Study|Non-compliance with study procedures|0|||
161075362|NCT00678301|581667136|FG001|Overall Study|Non-compliance with study procedures|1|||
161075363|NCT00678301|581667135|FG000|Overall Study|Adverse Event|1|||
161075364|NCT00678301|581667136|FG001|Overall Study|Adverse Event|0|||
161075365|NCT00678301|581667135|FG000|Overall Study|Withdrawal by Subject|4|||
161075366|NCT00678301|581667136|FG001|Overall Study|Withdrawal by Subject|0|||
161075367|NCT00678301|581667135|FG000|Overall Study|Lost to Follow-up|3|||
161075368|NCT00678301|581667136|FG001|Overall Study|Lost to Follow-up|1|||
161075369|NCT02476175|581667137|FG000|Overall Study|Adverse Event|2|||
161075370|NCT05048238|581667138|FG000|Overall Study|Withdrawal by Subject|1|||
161075371|NCT00335140|581667144|FG000|Overall Study|Ineligible|1|||
161075372|NCT00737477|581667148|FG000|Overall Study|Adverse Event|9|||
161075373|NCT00737477|581667148|FG000|Overall Study|Death|9|||
161075374|NCT00737477|581667148|FG000|Overall Study|Treatment Refusal|1|||
161075375|NCT00737477|581667148|FG000|Overall Study|Withdrawal by Subject|1|||
161075376|NCT00737477|581667148|FG000|Overall Study|Renal Transplantation|10|||
161075377|NCT00737477|581667148|FG000|Overall Study|Other|4|||
161075378|NCT01132820|581667149|FG000|Overall Study|Ineligible: wrong cell type|1|||
161075379|NCT01132820|581667149|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
161075380|NCT01132820|581667149|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
161075381|NCT01132820|581667149|FG000|Overall Study|Never treated|1|||
161075382|NCT01132820|581667149|FG000|Overall Study|Inadequate data|1|||
161075383|NCT01370655|581667150|FG000|Period 1|Adverse Event|2|||
161075384|NCT01370655|581667151|FG001|Period 1|Adverse Event|0|||
161075385|NCT01370655|581667152|FG002|Period 1|Adverse Event|0|||
161075386|NCT01370655|581667153|FG003|Period 1|Adverse Event|0|||
161075387|NCT01370655|581667154|FG004|Period 1|Adverse Event|0|||
161075388|NCT01370655|581667155|FG005|Period 1|Adverse Event|0|||
161075389|NCT01370655|581667156|FG006|Period 1|Adverse Event|1|||
161075390|NCT01370655|581667157|FG007|Period 1|Adverse Event|0|||
161075391|NCT01370655|581667158|FG008|Period 1|Adverse Event|0|||
161075392|NCT01370655|581667159|FG009|Period 1|Adverse Event|0|||
161075393|NCT01370655|581667160|FG010|Period 1|Adverse Event|0|||
161075394|NCT01370655|581667161|FG011|Period 1|Adverse Event|0|||
161075395|NCT01370655|581667150|FG000|Period 2|Adverse Event|0|||
161075396|NCT01370655|581667151|FG001|Period 2|Adverse Event|0|||
161075397|NCT01370655|581667152|FG002|Period 2|Adverse Event|1|||
161075398|NCT01370655|581667153|FG003|Period 2|Adverse Event|0|||
161075399|NCT01370655|581667154|FG004|Period 2|Adverse Event|1|||
161075400|NCT01370655|581667155|FG005|Period 2|Adverse Event|0|||
161075401|NCT01370655|581667156|FG006|Period 2|Adverse Event|0|||
161075402|NCT01370655|581667157|FG007|Period 2|Adverse Event|1|||
161075403|NCT01370655|581667158|FG008|Period 2|Adverse Event|0|||
161075404|NCT01370655|581667159|FG009|Period 2|Adverse Event|0|||
161075405|NCT01370655|581667160|FG010|Period 2|Adverse Event|0|||
161075406|NCT01370655|581667161|FG011|Period 2|Adverse Event|0|||
161075407|NCT01370655|581667150|FG000|Period 2|met protocol specified stopping criteria|0|||
161075408|NCT01370655|581667151|FG001|Period 2|met protocol specified stopping criteria|0|||
161075409|NCT01370655|581667152|FG002|Period 2|met protocol specified stopping criteria|1|||
161075410|NCT01370655|581667153|FG003|Period 2|met protocol specified stopping criteria|0|||
161075411|NCT01370655|581667154|FG004|Period 2|met protocol specified stopping criteria|0|||
161075412|NCT01370655|581667155|FG005|Period 2|met protocol specified stopping criteria|0|||
161075413|NCT01370655|581667156|FG006|Period 2|met protocol specified stopping criteria|1|||
161075414|NCT01370655|581667157|FG007|Period 2|met protocol specified stopping criteria|0|||
161075415|NCT01370655|581667158|FG008|Period 2|met protocol specified stopping criteria|1|||
161075416|NCT01370655|581667159|FG009|Period 2|met protocol specified stopping criteria|0|||
161075417|NCT01370655|581667160|FG010|Period 2|met protocol specified stopping criteria|1|||
161075418|NCT01370655|581667161|FG011|Period 2|met protocol specified stopping criteria|0|||
161075419|NCT01370655|581667150|FG000|Period 2|Withdrawal by Subject|0|||
161075420|NCT01370655|581667151|FG001|Period 2|Withdrawal by Subject|0|||
161345693|NCT02452190|582650902|FG001|Overall Study|Noncompliance with study drug|0|||
161345694|NCT02452190|582650901|FG000|Overall Study|Participant traveled abroad|1|||
161075421|NCT01370655|581667152|FG002|Period 2|Withdrawal by Subject|0|||
161075422|NCT01370655|581667153|FG003|Period 2|Withdrawal by Subject|0|||
161075423|NCT01370655|581667154|FG004|Period 2|Withdrawal by Subject|0|||
161075424|NCT01370655|581667155|FG005|Period 2|Withdrawal by Subject|0|||
161075425|NCT01370655|581667156|FG006|Period 2|Withdrawal by Subject|0|||
161075426|NCT01370655|581667157|FG007|Period 2|Withdrawal by Subject|0|||
161075427|NCT01370655|581667158|FG008|Period 2|Withdrawal by Subject|1|||
161075428|NCT01370655|581667159|FG009|Period 2|Withdrawal by Subject|0|||
161075429|NCT01370655|581667160|FG010|Period 2|Withdrawal by Subject|0|||
161075430|NCT01370655|581667161|FG011|Period 2|Withdrawal by Subject|0|||
161075431|NCT01730378|581667162|FG000|Overall Study|Lost to Follow-up|1|||
161286319|NCT02394600|582428043|FG000|Overall Study|Adverse Event|3|||
161075432|NCT01730378|581667163|FG001|Overall Study|Lost to Follow-up|0|||
161075433|NCT02687035|581667164|FG000|Overall Study|Withdrawal by Subject|1|||
161075434|NCT02687035|581667164|FG000|Overall Study|Death|87|||
161075435|NCT02687035|581667164|FG000|Overall Study|Lost to Follow-up|1|||
161075436|NCT02687035|581667164|FG000|Overall Study|Missed Visit|87|||
161075437|NCT02687035|581667164|FG000|Overall Study|Did not receive Study Device|8|||
161075438|NCT05000216|581667168|FG000|Stage 1|Lost to Follow-up|0|||
161075439|NCT05000216|581667169|FG001|Stage 1|Lost to Follow-up|0|||
161075440|NCT05000216|581667170|FG002|Stage 1|Lost to Follow-up|0|||
161075441|NCT05000216|581667171|FG003|Stage 1|Lost to Follow-up|0|||
161075442|NCT05000216|581667172|FG004|Stage 1|Lost to Follow-up|0|||
161075443|NCT05000216|581667173|FG005|Stage 1|Lost to Follow-up|0|||
161075444|NCT05000216|581667174|FG006|Stage 1|Lost to Follow-up|1|||
161075445|NCT05000216|581667175|FG007|Stage 1|Lost to Follow-up|1|||
161075446|NCT05000216|581667176|FG008|Stage 1|Lost to Follow-up|0|||
161075447|NCT05000216|581667177|FG009|Stage 1|Lost to Follow-up|2|||
161075448|NCT05000216|581667178|FG010|Stage 1|Lost to Follow-up|3|||
161075449|NCT05000216|581667179|FG011|Stage 1|Lost to Follow-up|0|||
161075450|NCT05000216|581667180|FG012|Stage 1|Lost to Follow-up|0|||
161075451|NCT05000216|581667181|FG013|Stage 1|Lost to Follow-up|0|||
161075452|NCT05000216|581667182|FG014|Stage 1|Lost to Follow-up|0|||
161075453|NCT05000216|581667183|FG015|Stage 1|Lost to Follow-up|0|||
161075454|NCT05000216|581667184|FG016|Stage 1|Lost to Follow-up|0|||
161075455|NCT05000216|581667185|FG017|Stage 1|Lost to Follow-up|0|||
161075456|NCT05000216|581667186|FG018|Stage 1|Lost to Follow-up|0|||
161075457|NCT05000216|581667187|FG019|Stage 1|Lost to Follow-up|0|||
161075458|NCT05000216|581667188|FG020|Stage 1|Lost to Follow-up|0|||
161075459|NCT05000216|581667189|FG021|Stage 1|Lost to Follow-up|0|||
161075460|NCT05000216|581667168|FG000|Stage 1|Physician Decision|0|||
161075461|NCT05000216|581667169|FG001|Stage 1|Physician Decision|0|||
161075462|NCT05000216|581667170|FG002|Stage 1|Physician Decision|0|||
161075463|NCT05000216|581667171|FG003|Stage 1|Physician Decision|0|||
161075464|NCT05000216|581667172|FG004|Stage 1|Physician Decision|0|||
161075465|NCT05000216|581667173|FG005|Stage 1|Physician Decision|0|||
161075466|NCT05000216|581667174|FG006|Stage 1|Physician Decision|0|||
161075467|NCT05000216|581667175|FG007|Stage 1|Physician Decision|1|||
161075468|NCT05000216|581667176|FG008|Stage 1|Physician Decision|1|||
161075469|NCT05000216|581667177|FG009|Stage 1|Physician Decision|0|||
161075470|NCT05000216|581667178|FG010|Stage 1|Physician Decision|0|||
161075471|NCT05000216|581667179|FG011|Stage 1|Physician Decision|0|||
161075472|NCT05000216|581667180|FG012|Stage 1|Physician Decision|0|||
161075473|NCT05000216|581667181|FG013|Stage 1|Physician Decision|0|||
161075474|NCT05000216|581667182|FG014|Stage 1|Physician Decision|0|||
161075475|NCT05000216|581667183|FG015|Stage 1|Physician Decision|0|||
161075476|NCT05000216|581667184|FG016|Stage 1|Physician Decision|0|||
161075477|NCT05000216|581667185|FG017|Stage 1|Physician Decision|0|||
161075478|NCT05000216|581667186|FG018|Stage 1|Physician Decision|0|||
161075479|NCT05000216|581667187|FG019|Stage 1|Physician Decision|0|||
161075480|NCT05000216|581667188|FG020|Stage 1|Physician Decision|0|||
161075481|NCT05000216|581667189|FG021|Stage 1|Physician Decision|0|||
161075482|NCT05000216|581667168|FG000|Stage 1|Withdrawal by Subject|0|||
161075483|NCT05000216|581667169|FG001|Stage 1|Withdrawal by Subject|1|||
161075484|NCT05000216|581667170|FG002|Stage 1|Withdrawal by Subject|0|||
161075485|NCT05000216|581667171|FG003|Stage 1|Withdrawal by Subject|0|||
161075486|NCT05000216|581667172|FG004|Stage 1|Withdrawal by Subject|0|||
161075487|NCT05000216|581667173|FG005|Stage 1|Withdrawal by Subject|0|||
161075488|NCT05000216|581667174|FG006|Stage 1|Withdrawal by Subject|0|||
161075489|NCT05000216|581667175|FG007|Stage 1|Withdrawal by Subject|0|||
161075490|NCT05000216|581667176|FG008|Stage 1|Withdrawal by Subject|0|||
161075491|NCT05000216|581667177|FG009|Stage 1|Withdrawal by Subject|3|||
161075492|NCT05000216|581667178|FG010|Stage 1|Withdrawal by Subject|10|||
161075493|NCT05000216|581667179|FG011|Stage 1|Withdrawal by Subject|0|||
161075494|NCT05000216|581667180|FG012|Stage 1|Withdrawal by Subject|0|||
161075495|NCT05000216|581667181|FG013|Stage 1|Withdrawal by Subject|0|||
161075496|NCT05000216|581667182|FG014|Stage 1|Withdrawal by Subject|0|||
161075497|NCT05000216|581667183|FG015|Stage 1|Withdrawal by Subject|0|||
161286320|NCT02394600|582428044|FG001|Overall Study|Adverse Event|0|||
161075498|NCT05000216|581667184|FG016|Stage 1|Withdrawal by Subject|0|||
161075499|NCT05000216|581667185|FG017|Stage 1|Withdrawal by Subject|0|||
161075500|NCT05000216|581667186|FG018|Stage 1|Withdrawal by Subject|0|||
161286321|NCT02394600|582428043|FG000|Overall Study|Lost to Follow-up|0|||
161075501|NCT05000216|581667187|FG019|Stage 1|Withdrawal by Subject|0|||
161075502|NCT05000216|581667188|FG020|Stage 1|Withdrawal by Subject|0|||
161075503|NCT05000216|581667189|FG021|Stage 1|Withdrawal by Subject|0|||
161075504|NCT05000216|581667168|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
161075505|NCT05000216|581667169|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
161075506|NCT05000216|581667170|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
161075507|NCT05000216|581667171|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
161075508|NCT05000216|581667172|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
161075509|NCT05000216|581667173|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
161075510|NCT05000216|581667174|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
161075511|NCT05000216|581667175|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
161075512|NCT05000216|581667176|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
161075513|NCT05000216|581667177|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
161075514|NCT05000216|581667178|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
161075515|NCT05000216|581667179|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
161075516|NCT05000216|581667180|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
161075517|NCT05000216|581667181|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
161075518|NCT05000216|581667182|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
161075519|NCT05000216|581667183|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
161075520|NCT05000216|581667184|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
161075521|NCT05000216|581667185|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
161075522|NCT05000216|581667186|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
161075523|NCT05000216|581667187|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
161075524|NCT05000216|581667188|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
161075525|NCT05000216|581667189|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
161075526|NCT05000216|581667168|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075527|NCT05000216|581667169|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075528|NCT05000216|581667170|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075529|NCT05000216|581667171|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075530|NCT05000216|581667172|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075531|NCT05000216|581667173|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075532|NCT05000216|581667174|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075533|NCT05000216|581667175|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075534|NCT05000216|581667176|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
161075535|NCT05000216|581667177|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075536|NCT05000216|581667178|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075537|NCT05000216|581667179|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075538|NCT05000216|581667180|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075539|NCT05000216|581667181|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075540|NCT05000216|581667182|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075541|NCT05000216|581667183|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075542|NCT05000216|581667184|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075543|NCT05000216|581667185|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075544|NCT05000216|581667186|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075545|NCT05000216|581667187|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075546|NCT05000216|581667188|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075547|NCT05000216|581667189|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
161075548|NCT05000216|581667168|FG000|Stage 1|Other|0|||
161075549|NCT05000216|581667169|FG001|Stage 1|Other|0|||
161075550|NCT05000216|581667170|FG002|Stage 1|Other|0|||
161075551|NCT05000216|581667171|FG003|Stage 1|Other|0|||
161075552|NCT05000216|581667172|FG004|Stage 1|Other|1|||
161075553|NCT05000216|581667173|FG005|Stage 1|Other|0|||
161075554|NCT05000216|581667174|FG006|Stage 1|Other|0|||
161075555|NCT05000216|581667175|FG007|Stage 1|Other|2|||
161075556|NCT05000216|581667176|FG008|Stage 1|Other|0|||
161075557|NCT05000216|581667177|FG009|Stage 1|Other|0|||
161075558|NCT05000216|581667178|FG010|Stage 1|Other|1|||
161075559|NCT05000216|581667179|FG011|Stage 1|Other|1|||
161075560|NCT05000216|581667180|FG012|Stage 1|Other|0|||
161075561|NCT05000216|581667181|FG013|Stage 1|Other|0|||
161075562|NCT05000216|581667182|FG014|Stage 1|Other|0|||
161075563|NCT05000216|581667183|FG015|Stage 1|Other|0|||
161075564|NCT05000216|581667184|FG016|Stage 1|Other|0|||
161075565|NCT05000216|581667185|FG017|Stage 1|Other|0|||
161075566|NCT05000216|581667186|FG018|Stage 1|Other|0|||
161075567|NCT05000216|581667187|FG019|Stage 1|Other|0|||
161075568|NCT05000216|581667188|FG020|Stage 1|Other|0|||
161286322|NCT02394600|582428044|FG001|Overall Study|Lost to Follow-up|1|||
161286323|NCT02394600|582428043|FG000|Overall Study|Withdrawal by Subject|0|||
161286324|NCT02394600|582428044|FG001|Overall Study|Withdrawal by Subject|1|||
161286325|NCT02394600|582428043|FG000|Overall Study|Protocol Violation|1|||
161075569|NCT05000216|581667189|FG021|Stage 1|Other|0|||
161075570|NCT05000216|581667168|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
161075571|NCT05000216|581667169|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
161075572|NCT05000216|581667170|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
161075573|NCT05000216|581667171|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
161075574|NCT05000216|581667172|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
161075575|NCT05000216|581667173|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
161075576|NCT05000216|581667174|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
161075577|NCT05000216|581667175|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
161075578|NCT05000216|581667176|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
161075579|NCT05000216|581667177|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
161075580|NCT05000216|581667178|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
161075581|NCT05000216|581667179|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
161075582|NCT05000216|581667180|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
161075583|NCT05000216|581667181|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
161286326|NCT02394600|582428044|FG001|Overall Study|Protocol Violation|0|||
161075584|NCT05000216|581667182|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
161075585|NCT05000216|581667183|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
161075586|NCT05000216|581667184|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
161075587|NCT05000216|581667185|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
161075588|NCT05000216|581667186|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
161075589|NCT05000216|581667187|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
161075590|NCT05000216|581667188|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
161075591|NCT05000216|581667189|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
161075592|NCT05000216|581667168|FG000|Stage 2|Lost to Follow-up|0|||
161075593|NCT05000216|581667169|FG001|Stage 2|Lost to Follow-up|0|||
161075594|NCT05000216|581667170|FG002|Stage 2|Lost to Follow-up|0|||
161075595|NCT05000216|581667171|FG003|Stage 2|Lost to Follow-up|0|||
161075596|NCT05000216|581667172|FG004|Stage 2|Lost to Follow-up|0|||
161075597|NCT05000216|581667173|FG005|Stage 2|Lost to Follow-up|0|||
161075598|NCT05000216|581667174|FG006|Stage 2|Lost to Follow-up|0|||
161075599|NCT05000216|581667175|FG007|Stage 2|Lost to Follow-up|0|||
161075600|NCT05000216|581667176|FG008|Stage 2|Lost to Follow-up|0|||
161075601|NCT05000216|581667177|FG009|Stage 2|Lost to Follow-up|0|||
161075602|NCT05000216|581667178|FG010|Stage 2|Lost to Follow-up|0|||
161075603|NCT05000216|581667179|FG011|Stage 2|Lost to Follow-up|0|||
161075604|NCT05000216|581667180|FG012|Stage 2|Lost to Follow-up|0|||
161075605|NCT05000216|581667181|FG013|Stage 2|Lost to Follow-up|0|||
161075606|NCT05000216|581667182|FG014|Stage 2|Lost to Follow-up|0|||
161075607|NCT05000216|581667183|FG015|Stage 2|Lost to Follow-up|0|||
161075608|NCT05000216|581667184|FG016|Stage 2|Lost to Follow-up|4|||
161075609|NCT05000216|581667185|FG017|Stage 2|Lost to Follow-up|0|||
161075610|NCT05000216|581667186|FG018|Stage 2|Lost to Follow-up|0|||
161158273|NCT02203838|581959098|FG000|Overall Study|Adverse Event|46|||
161158274|NCT02203838|581959099|FG001|Overall Study|Adverse Event|6|||
161075611|NCT05000216|581667187|FG019|Stage 2|Lost to Follow-up|0|||
161158275|NCT02203838|581959100|FG002|Overall Study|Adverse Event|3|||
161158276|NCT02203838|581959101|FG003|Overall Study|Adverse Event|2|||
161158277|NCT02203838|581959098|FG000|Overall Study|Lost to Follow-up|39|||
161158278|NCT02203838|581959099|FG001|Overall Study|Lost to Follow-up|3|||
161158279|NCT02203838|581959100|FG002|Overall Study|Lost to Follow-up|2|||
161158280|NCT02203838|581959101|FG003|Overall Study|Lost to Follow-up|1|||
161158281|NCT02203838|581959098|FG000|Overall Study|Protocol Violation|7|||
161158282|NCT02203838|581959099|FG001|Overall Study|Protocol Violation|3|||
161158283|NCT02203838|581959100|FG002|Overall Study|Protocol Violation|0|||
161158284|NCT02203838|581959101|FG003|Overall Study|Protocol Violation|0|||
161158285|NCT02203838|581959098|FG000|Overall Study|Withdrawal by Subject|83|||
161158286|NCT02203838|581959099|FG001|Overall Study|Withdrawal by Subject|10|||
161158287|NCT02203838|581959100|FG002|Overall Study|Withdrawal by Subject|8|||
161158288|NCT02203838|581959101|FG003|Overall Study|Withdrawal by Subject|11|||
161158289|NCT02203838|581959098|FG000|Overall Study|Physician Decision|27|||
161158290|NCT02203838|581959099|FG001|Overall Study|Physician Decision|0|||
161158291|NCT02203838|581959100|FG002|Overall Study|Physician Decision|2|||
161158292|NCT02203838|581959101|FG003|Overall Study|Physician Decision|3|||
161158293|NCT02203838|581959098|FG000|Overall Study|Other|1|||
161286327|NCT02569801|582428045|FG000|Overall Study|Withdrawal by Subject|9|||
161286328|NCT02569801|582428046|FG001|Overall Study|Withdrawal by Subject|9|||
161286329|NCT02569801|582428045|FG000|Overall Study|Sponsor Decision|13|||
161075612|NCT05000216|581667188|FG020|Stage 2|Lost to Follow-up|0|||
161075613|NCT05000216|581667189|FG021|Stage 2|Lost to Follow-up|0|||
161075614|NCT05000216|581667168|FG000|Stage 2|Physician Decision|0|||
161075615|NCT05000216|581667169|FG001|Stage 2|Physician Decision|0|||
161075616|NCT05000216|581667170|FG002|Stage 2|Physician Decision|0|||
161075617|NCT05000216|581667171|FG003|Stage 2|Physician Decision|0|||
161286330|NCT02569801|582428046|FG001|Overall Study|Sponsor Decision|14|||
161286331|NCT02569801|582428045|FG000|Overall Study|Progressive Disease|2|||
161286332|NCT02569801|582428046|FG001|Overall Study|Progressive Disease|7|||
161286333|NCT02569801|582428045|FG000|Overall Study|Lost to Follow-up|0|||
161075618|NCT05000216|581667172|FG004|Stage 2|Physician Decision|0|||
161075619|NCT05000216|581667173|FG005|Stage 2|Physician Decision|0|||
161075620|NCT05000216|581667174|FG006|Stage 2|Physician Decision|0|||
161075621|NCT05000216|581667175|FG007|Stage 2|Physician Decision|0|||
161158294|NCT02203838|581959099|FG001|Overall Study|Other|0|||
161158295|NCT02203838|581959100|FG002|Overall Study|Other|0|||
161075622|NCT05000216|581667176|FG008|Stage 2|Physician Decision|0|||
161158296|NCT02203838|581959101|FG003|Overall Study|Other|0|||
161158297|NCT05091060|581959102|FG000|Overall Study|Lost to Follow-up|1|||
161286334|NCT02569801|582428046|FG001|Overall Study|Lost to Follow-up|1|||
161075623|NCT05000216|581667177|FG009|Stage 2|Physician Decision|0|||
161075624|NCT05000216|581667178|FG010|Stage 2|Physician Decision|0|||
161075625|NCT05000216|581667179|FG011|Stage 2|Physician Decision|0|||
161075626|NCT05000216|581667180|FG012|Stage 2|Physician Decision|1|||
161075627|NCT05000216|581667181|FG013|Stage 2|Physician Decision|0|||
161075628|NCT05000216|581667182|FG014|Stage 2|Physician Decision|0|||
161075629|NCT05000216|581667183|FG015|Stage 2|Physician Decision|0|||
161075630|NCT05000216|581667184|FG016|Stage 2|Physician Decision|0|||
161075631|NCT05000216|581667185|FG017|Stage 2|Physician Decision|0|||
161286335|NCT02569801|582428045|FG000|Overall Study|Death|12|||
161075632|NCT05000216|581667186|FG018|Stage 2|Physician Decision|0|||
161075633|NCT05000216|581667187|FG019|Stage 2|Physician Decision|0|||
161075634|NCT05000216|581667188|FG020|Stage 2|Physician Decision|0|||
161075635|NCT05000216|581667189|FG021|Stage 2|Physician Decision|0|||
161075636|NCT05000216|581667168|FG000|Stage 2|Withdrawal by Subject|0|||
161075637|NCT05000216|581667169|FG001|Stage 2|Withdrawal by Subject|0|||
161075638|NCT05000216|581667170|FG002|Stage 2|Withdrawal by Subject|0|||
161075639|NCT05000216|581667171|FG003|Stage 2|Withdrawal by Subject|0|||
161075640|NCT05000216|581667172|FG004|Stage 2|Withdrawal by Subject|0|||
161075641|NCT05000216|581667173|FG005|Stage 2|Withdrawal by Subject|0|||
161075642|NCT05000216|581667174|FG006|Stage 2|Withdrawal by Subject|0|||
161075643|NCT05000216|581667175|FG007|Stage 2|Withdrawal by Subject|0|||
161075644|NCT05000216|581667176|FG008|Stage 2|Withdrawal by Subject|0|||
161075645|NCT05000216|581667177|FG009|Stage 2|Withdrawal by Subject|0|||
161075646|NCT05000216|581667178|FG010|Stage 2|Withdrawal by Subject|0|||
161075647|NCT05000216|581667179|FG011|Stage 2|Withdrawal by Subject|0|||
161075648|NCT05000216|581667180|FG012|Stage 2|Withdrawal by Subject|0|||
161075649|NCT05000216|581667181|FG013|Stage 2|Withdrawal by Subject|0|||
161075650|NCT05000216|581667182|FG014|Stage 2|Withdrawal by Subject|2|||
161075651|NCT05000216|581667183|FG015|Stage 2|Withdrawal by Subject|0|||
161075652|NCT05000216|581667184|FG016|Stage 2|Withdrawal by Subject|9|||
161075653|NCT05000216|581667185|FG017|Stage 2|Withdrawal by Subject|0|||
161075654|NCT05000216|581667186|FG018|Stage 2|Withdrawal by Subject|0|||
161075655|NCT05000216|581667187|FG019|Stage 2|Withdrawal by Subject|0|||
161075656|NCT05000216|581667188|FG020|Stage 2|Withdrawal by Subject|0|||
161075657|NCT05000216|581667189|FG021|Stage 2|Withdrawal by Subject|0|||
161075658|NCT05000216|581667168|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
161075659|NCT05000216|581667169|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
161075660|NCT05000216|581667170|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
161075661|NCT05000216|581667171|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
161075662|NCT05000216|581667172|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
161075663|NCT05000216|581667173|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
161075664|NCT05000216|581667174|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
161075665|NCT05000216|581667175|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
161075666|NCT05000216|581667176|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
161075667|NCT05000216|581667177|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
161075668|NCT05000216|581667178|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
161075669|NCT05000216|581667179|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
161075670|NCT05000216|581667180|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
161075671|NCT05000216|581667181|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
161075672|NCT05000216|581667182|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
161075673|NCT05000216|581667183|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
161075674|NCT05000216|581667184|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
161075675|NCT05000216|581667185|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
161075676|NCT05000216|581667186|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
161075677|NCT05000216|581667187|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
161075678|NCT05000216|581667188|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
161075679|NCT05000216|581667189|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
161075680|NCT05000216|581667168|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075681|NCT05000216|581667169|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075682|NCT05000216|581667170|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075683|NCT05000216|581667171|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075684|NCT05000216|581667172|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075685|NCT05000216|581667173|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075686|NCT05000216|581667174|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075687|NCT05000216|581667175|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075688|NCT05000216|581667176|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075689|NCT05000216|581667177|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075690|NCT05000216|581667178|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075691|NCT05000216|581667179|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075692|NCT05000216|581667180|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075693|NCT05000216|581667181|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075694|NCT05000216|581667182|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
161075695|NCT05000216|581667183|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075696|NCT05000216|581667184|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
161075697|NCT05000216|581667185|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075698|NCT05000216|581667186|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075699|NCT05000216|581667187|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075700|NCT05000216|581667188|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075701|NCT05000216|581667189|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
161075702|NCT05000216|581667168|FG000|Stage 2|Other reason|0|||
161158298|NCT02739594|581959103|FG000|Overall Study|Undesired Event|3|||
161075703|NCT05000216|581667169|FG001|Stage 2|Other reason|0|||
161075704|NCT05000216|581667170|FG002|Stage 2|Other reason|0|||
161075705|NCT05000216|581667171|FG003|Stage 2|Other reason|0|||
161075706|NCT05000216|581667172|FG004|Stage 2|Other reason|0|||
161075707|NCT05000216|581667173|FG005|Stage 2|Other reason|0|||
161075708|NCT05000216|581667174|FG006|Stage 2|Other reason|0|||
161075709|NCT05000216|581667175|FG007|Stage 2|Other reason|0|||
161075710|NCT05000216|581667176|FG008|Stage 2|Other reason|0|||
161075711|NCT05000216|581667177|FG009|Stage 2|Other reason|0|||
161075712|NCT05000216|581667178|FG010|Stage 2|Other reason|0|||
161075713|NCT05000216|581667179|FG011|Stage 2|Other reason|0|||
161075714|NCT05000216|581667180|FG012|Stage 2|Other reason|0|||
161075715|NCT05000216|581667181|FG013|Stage 2|Other reason|0|||
161075716|NCT05000216|581667182|FG014|Stage 2|Other reason|0|||
161075717|NCT05000216|581667183|FG015|Stage 2|Other reason|0|||
161075718|NCT05000216|581667184|FG016|Stage 2|Other reason|1|||
161075719|NCT05000216|581667185|FG017|Stage 2|Other reason|0|||
161075720|NCT05000216|581667186|FG018|Stage 2|Other reason|0|||
161075721|NCT05000216|581667187|FG019|Stage 2|Other reason|0|||
161075722|NCT05000216|581667188|FG020|Stage 2|Other reason|0|||
161075723|NCT05000216|581667189|FG021|Stage 2|Other reason|0|||
161075724|NCT05000216|581667168|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
161075725|NCT05000216|581667169|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
161075726|NCT05000216|581667170|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
161075727|NCT05000216|581667171|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
161075728|NCT05000216|581667172|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
161075729|NCT05000216|581667173|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
161075730|NCT05000216|581667174|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
161075731|NCT05000216|581667175|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
161075732|NCT05000216|581667176|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
161075733|NCT05000216|581667177|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
161075734|NCT05000216|581667178|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
161075735|NCT05000216|581667179|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
161075736|NCT05000216|581667180|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
161075737|NCT05000216|581667181|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
161075738|NCT05000216|581667182|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
161075739|NCT05000216|581667183|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
161075740|NCT05000216|581667184|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
161075741|NCT05000216|581667185|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
161075742|NCT05000216|581667186|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
161075743|NCT05000216|581667187|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
161075744|NCT05000216|581667188|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
161075745|NCT05000216|581667189|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
161075746|NCT05000216|581667168|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075747|NCT05000216|581667169|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075748|NCT05000216|581667170|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075749|NCT05000216|581667171|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075750|NCT05000216|581667172|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075751|NCT05000216|581667173|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075752|NCT05000216|581667174|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075753|NCT05000216|581667175|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075754|NCT05000216|581667176|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075755|NCT05000216|581667177|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075756|NCT05000216|581667178|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075757|NCT05000216|581667179|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075758|NCT05000216|581667180|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075759|NCT05000216|581667181|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075760|NCT05000216|581667182|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075761|NCT05000216|581667183|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
161075762|NCT05000216|581667184|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075763|NCT05000216|581667185|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075764|NCT05000216|581667186|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075765|NCT05000216|581667187|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075766|NCT05000216|581667188|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075767|NCT05000216|581667189|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
161075768|NCT05000216|581667168|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075769|NCT05000216|581667169|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075770|NCT05000216|581667170|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075771|NCT05000216|581667171|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075772|NCT05000216|581667172|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075773|NCT05000216|581667173|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075774|NCT05000216|581667174|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075775|NCT05000216|581667175|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075776|NCT05000216|581667176|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075777|NCT05000216|581667177|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075778|NCT05000216|581667178|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075779|NCT05000216|581667179|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075780|NCT05000216|581667180|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075781|NCT05000216|581667181|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
161075782|NCT05000216|581667182|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075783|NCT05000216|581667183|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
161075784|NCT05000216|581667184|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075785|NCT05000216|581667185|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075786|NCT05000216|581667186|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
161075787|NCT05000216|581667187|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075788|NCT05000216|581667188|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075789|NCT05000216|581667189|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
161075790|NCT04481373|581667190|FG000|Overall Study|Protocol Violation|1|||
161075791|NCT04481373|581667191|FG001|Overall Study|Protocol Violation|0|||
161075792|NCT04481373|581667190|FG000|Overall Study|Viral load in hospital not over 1000|2|||
161075793|NCT04481373|581667191|FG001|Overall Study|Viral load in hospital not over 1000|1|||
161075794|NCT04481373|581667190|FG000|Overall Study|Death before hospital discharge|1|||
161075795|NCT04481373|581667191|FG001|Overall Study|Death before hospital discharge|0|||
161075796|NCT02057575|581667193|FG000|Overall Study|Adverse Event|0|||
161075797|NCT02057575|581667194|FG001|Overall Study|Adverse Event|2|||
161075798|NCT02057575|581667195|FG002|Overall Study|Adverse Event|0|||
161075799|NCT02057575|581667196|FG003|Overall Study|Adverse Event|1|||
161075800|NCT02057575|581667193|FG000|Overall Study|Withdrawal by Subject|1|||
161075801|NCT02057575|581667194|FG001|Overall Study|Withdrawal by Subject|0|||
161075802|NCT02057575|581667195|FG002|Overall Study|Withdrawal by Subject|0|||
161075803|NCT02057575|581667196|FG003|Overall Study|Withdrawal by Subject|0|||
161075804|NCT02057575|581667193|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
161075805|NCT02057575|581667194|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
161075806|NCT02057575|581667195|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
161075807|NCT02057575|581667196|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
161075808|NCT02057575|581667193|FG000|Overall Study|Protocol Violation|0|||
161075809|NCT02057575|581667194|FG001|Overall Study|Protocol Violation|1|||
161075810|NCT02057575|581667195|FG002|Overall Study|Protocol Violation|0|||
161075811|NCT02057575|581667196|FG003|Overall Study|Protocol Violation|0|||
161075812|NCT00332462|581667197|FG000|Overall Study|Adverse Event|5|||
161075813|NCT00332462|581667197|FG000|Overall Study|Abnormal Lab Value|1|||
161075814|NCT00332462|581667197|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161075815|NCT00332462|581667197|FG000|Overall Study|no longer requires study drug|1|||
161075816|NCT00332462|581667197|FG000|Overall Study|Death|3|||
161075817|NCT00332462|581667197|FG000|Overall Study|Graft Loss|2|||
161075818|NCT02979249|581667201|FG000|Overall Study|Lost to Follow-up|2|||
161075819|NCT02979249|581667201|FG000|Overall Study|Withdrawal by Subject|4|||
161075820|NCT01125046|581667202|FG000|First 6 Months of Treatment|Death|1|||
161075821|NCT01125046|581667202|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
161075822|NCT01125046|581667202|FG000|First 6 Months of Treatment|Non-compliance|1|||
161075823|NCT01125046|581667202|FG000|First 6 Months of Treatment|Surgery|1|||
161075824|NCT01125046|581667202|FG000|First 6 Months of Treatment|Progressive Disease|7|||
161075825|NCT01125046|581667202|FG000|First 6 Months of Treatment|Adverse Event|2|||
161075826|NCT01125046|581667202|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
161075827|NCT01125046|581667202|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
161075828|NCT01125046|581667202|FG000|Follow-up/Data Cut Off Point|Death|29|||
161075829|NCT01125046|581667202|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
161075830|NCT01685229|581667203|FG000|Overall Study|Subjects missing Study Exit form|3|||
161075831|NCT01685229|581667204|FG001|Overall Study|Subjects missing Study Exit form|1|||
161075832|NCT01685229|581667203|FG000|Overall Study|Lost to Follow-up|16|||
161075833|NCT01685229|581667204|FG001|Overall Study|Lost to Follow-up|10|||
161075834|NCT01685229|581667203|FG000|Overall Study|Withdrawal by Subject|6|||
161075835|NCT01685229|581667204|FG001|Overall Study|Withdrawal by Subject|5|||
161075836|NCT01685229|581667203|FG000|Overall Study|Death|1|||
161075837|NCT01685229|581667204|FG001|Overall Study|Death|0|||
161075838|NCT01853475|581667219|FG000|Overall Study|Withdrawal by Subject|0|||
161075839|NCT01853475|581667220|FG001|Overall Study|Withdrawal by Subject|1|||
161075840|NCT01853475|581667221|FG002|Overall Study|Withdrawal by Subject|0|||
161075841|NCT00659880|581667222|FG000|Overall Study|Lost to Follow-up|5|||
161075842|NCT02159040|581667223|FG000|Overall Study|Death|1|||
161075843|NCT02766777|581667227|FG000|Overall Study|Adverse Event|12|||
161075844|NCT02766777|581667227|FG000|Overall Study|Lost to Follow-up|16|||
161075845|NCT02766777|581667227|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161075846|NCT02766777|581667227|FG000|Overall Study|Protocol Violation|1|||
161075847|NCT02766777|581667227|FG000|Overall Study|Withdrawal by Subject|4|||
161075848|NCT01886287|581667228|FG000|Overall Study|Radiographic disease progression|1|||
161075849|NCT01886287|581667228|FG000|Overall Study|Clinical progression due to disease|1|||
161075850|NCT02964325|581667229|FG000|Overall Study|Lost to Follow-up|3|||
161075851|NCT02964325|581667230|FG001|Overall Study|Lost to Follow-up|3|||
161075852|NCT02964325|581667229|FG000|Overall Study|Physician Decision|5|||
161075853|NCT02964325|581667230|FG001|Overall Study|Physician Decision|4|||
161075854|NCT02964325|581667229|FG000|Overall Study|Death|1|||
161075855|NCT02964325|581667230|FG001|Overall Study|Death|3|||
161075856|NCT02964325|581667229|FG000|Overall Study|Withdrawal by Subject|2|||
161075857|NCT02964325|581667230|FG001|Overall Study|Withdrawal by Subject|1|||
161075858|NCT02964325|581667229|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
161075859|NCT02964325|581667230|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
161075860|NCT03596762|581667231|FG000|Overall Study|Protocol Violation|0|||
161075861|NCT03596762|581667232|FG001|Overall Study|Protocol Violation|0|||
161075862|NCT03596762|581667233|FG002|Overall Study|Protocol Violation|0|||
161075863|NCT03596762|581667234|FG003|Overall Study|Protocol Violation|0|||
161075864|NCT03596762|581667235|FG004|Overall Study|Protocol Violation|1|||
161075865|NCT03596762|581667231|FG000|Overall Study|Adverse Event|2|||
161075866|NCT03596762|581667232|FG001|Overall Study|Adverse Event|0|||
161075867|NCT03596762|581667233|FG002|Overall Study|Adverse Event|1|||
161075868|NCT03596762|581667234|FG003|Overall Study|Adverse Event|0|||
161075869|NCT03596762|581667235|FG004|Overall Study|Adverse Event|5|||
161075870|NCT03596762|581667231|FG000|Overall Study|Withdrawal by Subject|2|||
161075871|NCT03596762|581667232|FG001|Overall Study|Withdrawal by Subject|1|||
161075872|NCT03596762|581667233|FG002|Overall Study|Withdrawal by Subject|0|||
161075873|NCT03596762|581667234|FG003|Overall Study|Withdrawal by Subject|1|||
161075874|NCT03596762|581667235|FG004|Overall Study|Withdrawal by Subject|1|||
161075875|NCT02510040|581667236|FG000|Overall Study|Deemed no longer eligible|18|||
161075876|NCT02510040|581667237|FG001|Overall Study|Deemed no longer eligible|3|||
161075877|NCT02510040|581667238|FG002|Overall Study|Deemed no longer eligible|1|||
161075878|NCT03842228|581667239|FG000|Overall Study|Adverse Event|1|||
161075879|NCT03842228|581667240|FG001|Overall Study|Adverse Event|1|||
161075880|NCT03842228|581667241|FG002|Overall Study|Adverse Event|1|||
161075881|NCT03842228|581667242|FG003|Overall Study|Adverse Event|0|||
161075882|NCT03842228|581667243|FG004|Overall Study|Adverse Event|0|||
161075883|NCT03842228|581667244|FG005|Overall Study|Adverse Event|0|||
161075884|NCT03842228|581667245|FG006|Overall Study|Adverse Event|0|||
161075885|NCT03842228|581667239|FG000|Overall Study|Death|0|||
161075886|NCT03842228|581667240|FG001|Overall Study|Death|1|||
161075887|NCT03842228|581667241|FG002|Overall Study|Death|0|||
161075888|NCT03842228|581667242|FG003|Overall Study|Death|0|||
161075889|NCT03842228|581667243|FG004|Overall Study|Death|0|||
161075890|NCT03842228|581667244|FG005|Overall Study|Death|0|||
161075891|NCT03842228|581667245|FG006|Overall Study|Death|0|||
161075892|NCT03842228|581667239|FG000|Overall Study|Withdrawal by Subject|0|||
161075893|NCT03842228|581667240|FG001|Overall Study|Withdrawal by Subject|0|||
161075894|NCT03842228|581667241|FG002|Overall Study|Withdrawal by Subject|2|||
161075895|NCT03842228|581667242|FG003|Overall Study|Withdrawal by Subject|1|||
161075896|NCT03842228|581667243|FG004|Overall Study|Withdrawal by Subject|0|||
161075897|NCT03842228|581667244|FG005|Overall Study|Withdrawal by Subject|0|||
161075898|NCT03842228|581667245|FG006|Overall Study|Withdrawal by Subject|2|||
161075899|NCT03842228|581667239|FG000|Overall Study|Progression|8|||
161075900|NCT03842228|581667240|FG001|Overall Study|Progression|1|||
161075901|NCT03842228|581667241|FG002|Overall Study|Progression|7|||
161075902|NCT03842228|581667242|FG003|Overall Study|Progression|5|||
161075903|NCT03842228|581667243|FG004|Overall Study|Progression|4|||
161075904|NCT03842228|581667244|FG005|Overall Study|Progression|2|||
161075905|NCT03842228|581667245|FG006|Overall Study|Progression|3|||
161075906|NCT01889069|581667258|FG000|Overall Study|Death|18|||
161075907|NCT01889069|581667258|FG000|Overall Study|Progression of Disease|14|||
161075908|NCT01889069|581667258|FG000|Overall Study|Lost to Follow-up|6|||
161075909|NCT01889069|581667258|FG000|Overall Study|Other|4|||
161075910|NCT01889069|581667258|FG000|Overall Study|Consent Withdrawal|3|||
161075911|NCT01426347|581667262|FG000|Overall Study|Lost to Follow-up|0|||
161075912|NCT01426347|581667263|FG001|Overall Study|Lost to Follow-up|3|||
161075913|NCT01426347|581667262|FG000|Overall Study|Protocol Violation|2|||
161075914|NCT01426347|581667263|FG001|Overall Study|Protocol Violation|0|||
161075915|NCT01426347|581667262|FG000|Overall Study|Withdrawal by Subject|5|||
161075916|NCT01426347|581667263|FG001|Overall Study|Withdrawal by Subject|0|||
161075917|NCT00455741|581667264|FG000|Overall Study|Physician Decision|0|||
161075918|NCT00455741|581667265|FG001|Overall Study|Physician Decision|1|||
161075919|NCT03041792|581667266|FG000|Overall Study|Adverse Event|4|||
161345695|NCT02452190|582650902|FG001|Overall Study|Participant traveled abroad|0|||
161345696|NCT02452190|582650901|FG000|Overall Study|Death|0|||
161345697|NCT02452190|582650902|FG001|Overall Study|Death|1|||
161075920|NCT03041792|581667267|FG001|Overall Study|Adverse Event|0|||
161075921|NCT03041792|581667266|FG000|Overall Study|Death in the family|0|||
161075922|NCT03041792|581667267|FG001|Overall Study|Death in the family|2|||
161075923|NCT03041792|581667266|FG000|Overall Study|Randomized but not treated|0|||
161075924|NCT03041792|581667267|FG001|Overall Study|Randomized but not treated|1|||
161075925|NCT04978090|581667268|FG000|Overall Study|unable to adequately fit device|2|||
161075926|NCT02227992|581667271|FG000|Overall Study|Lost to Follow-up|1|||
161075927|NCT02227992|581667272|FG001|Overall Study|Lost to Follow-up|1|||
161075928|NCT01509547|581667273|FG000|Overall Study|Lost to Follow-up|24|||
161075929|NCT01509547|581667274|FG001|Overall Study|Lost to Follow-up|14|||
161075930|NCT01509547|581667273|FG000|Overall Study|Withdrawal by Subject|11|||
161075931|NCT01509547|581667274|FG001|Overall Study|Withdrawal by Subject|24|||
161075932|NCT01509547|581667273|FG000|Overall Study|Physician Decision|0|||
161075933|NCT01509547|581667274|FG001|Overall Study|Physician Decision|1|||
161075934|NCT01371708|581667279|FG000|Overall Study|Insufficient clinical response|3|||
161075935|NCT01371708|581667280|FG001|Overall Study|Insufficient clinical response|2|||
161075936|NCT01371708|581667281|FG002|Overall Study|Insufficient clinical response|0|||
161075937|NCT01371708|581667279|FG000|Overall Study|Lost to Follow-up|5|||
161075938|NCT01371708|581667280|FG001|Overall Study|Lost to Follow-up|9|||
161075939|NCT01371708|581667281|FG002|Overall Study|Lost to Follow-up|7|||
161075940|NCT01371708|581667279|FG000|Overall Study|Protocol Violation|2|||
161075941|NCT01371708|581667280|FG001|Overall Study|Protocol Violation|1|||
161075942|NCT01371708|581667281|FG002|Overall Study|Protocol Violation|2|||
161075943|NCT01371708|581667279|FG000|Overall Study|No longer willing to participate|7|||
161075944|NCT01371708|581667280|FG001|Overall Study|No longer willing to participate|7|||
161075945|NCT01371708|581667281|FG002|Overall Study|No longer willing to participate|13|||
161075946|NCT01371708|581667279|FG000|Overall Study|Medication error/not related to AE|0|||
161075947|NCT01371708|581667280|FG001|Overall Study|Medication error/not related to AE|1|||
161075948|NCT01371708|581667281|FG002|Overall Study|Medication error/not related to AE|0|||
161075949|NCT01371708|581667279|FG000|Overall Study|Other|3|||
161075950|NCT01371708|581667280|FG001|Overall Study|Other|2|||
161075951|NCT01371708|581667281|FG002|Overall Study|Other|4|||
161075952|NCT01371708|581667279|FG000|Overall Study|Adverse Event|5|||
161075953|NCT01371708|581667280|FG001|Overall Study|Adverse Event|8|||
161075954|NCT01371708|581667281|FG002|Overall Study|Adverse Event|12|||
161075955|NCT01371708|581667279|FG000|Overall Study|Started but did not receive treatment|1|||
161075956|NCT01371708|581667280|FG001|Overall Study|Started but did not receive treatment|0|||
161075957|NCT01371708|581667281|FG002|Overall Study|Started but did not receive treatment|1|||
161075958|NCT02514551|581667282|FG000|Overall Study|Lost to Follow-up|0|||
161075959|NCT02514551|581667283|FG001|Overall Study|Lost to Follow-up|1|||
161075960|NCT02514551|581667282|FG000|Overall Study|Participant Never Treated|0|||
161075961|NCT02514551|581667283|FG001|Overall Study|Participant Never Treated|2|||
161075962|NCT00996606|581667294|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
161075963|NCT00996606|581667294|FG000|Overall Study|Insufficient Therapeutic Response|2|||
161075964|NCT00996606|581667294|FG000|Overall Study|Protocol Violation|1|||
161075965|NCT00996606|581667294|FG000|Overall Study|Withdrawal by Subject|3|||
161075966|NCT03197766|581667295|FG000|Overall Study|Withdrawal by Subject|2|||
161075967|NCT03197766|581667296|FG001|Overall Study|Withdrawal by Subject|0|||
161075968|NCT03554629|581669366|FG000|Overall Study|Inadequate data|6|||
161075969|NCT01182441|581669369|FG000|Overall Study|Patient Still in Follow-up|152|||
161075970|NCT01182441|581669370|FG001|Overall Study|Patient Still in Follow-up|72|||
161075971|NCT01182441|581669369|FG000|Overall Study|Death|37|||
161075972|NCT01182441|581669370|FG001|Overall Study|Death|25|||
161075973|NCT01182441|581669369|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
161075974|NCT01182441|581669370|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
161075975|NCT01182441|581669369|FG000|Overall Study|Lost to Follow-up|5|||
161075976|NCT01182441|581669370|FG001|Overall Study|Lost to Follow-up|8|||
161075977|NCT01182441|581669369|FG000|Overall Study|Withdrawal by Subject|6|||
161075978|NCT01182441|581669370|FG001|Overall Study|Withdrawal by Subject|13|||
161075979|NCT01182441|581669369|FG000|Overall Study|Implant Not Attempted|4|||
161075980|NCT01182441|581669370|FG001|Overall Study|Implant Not Attempted|0|||
161075981|NCT01182441|581669369|FG000|Overall Study|Adverse Event|2|||
161075982|NCT01182441|581669370|FG001|Overall Study|Adverse Event|0|||
161075983|NCT01182441|581669369|FG000|Overall Study|Physician Decision|1|||
161075984|NCT01182441|581669370|FG001|Overall Study|Physician Decision|1|||
161075985|NCT03480932|581669371|FG000|Overall Study|Death|1|||
161075986|NCT03480932|581669372|FG001|Overall Study|Death|1|||
161075987|NCT03480932|581669373|FG002|Overall Study|Death|0|||
161075988|NCT03480932|581669371|FG000|Overall Study|Lost to Follow-up|0|||
161075989|NCT03480932|581669372|FG001|Overall Study|Lost to Follow-up|2|||
161075990|NCT03480932|581669373|FG002|Overall Study|Lost to Follow-up|3|||
161075991|NCT03480932|581669371|FG000|Overall Study|Incarcerated|2|||
161075992|NCT03480932|581669372|FG001|Overall Study|Incarcerated|2|||
161075993|NCT03480932|581669373|FG002|Overall Study|Incarcerated|2|||
161075994|NCT00663702|581669374|FG000|Overall Study|Adverse Event|8|||
161075995|NCT00663702|581669375|FG001|Overall Study|Adverse Event|4|||
161075996|NCT00663702|581669374|FG000|Overall Study|Withdrawal by Subject|3|||
161075997|NCT00663702|581669375|FG001|Overall Study|Withdrawal by Subject|1|||
161075998|NCT00663702|581669374|FG000|Overall Study|Pregnancy|0|||
161075999|NCT00663702|581669375|FG001|Overall Study|Pregnancy|1|||
161076000|NCT00663702|581669374|FG000|Overall Study|Lost to Follow-up|3|||
161158299|NCT02739594|581959104|FG001|Overall Study|Undesired Event|4|||
161076001|NCT00663702|581669375|FG001|Overall Study|Lost to Follow-up|0|||
161076002|NCT00663702|581669374|FG000|Overall Study|Death|1|||
161158300|NCT02739594|581959103|FG000|Overall Study|Violation of Eligibility Criteria|1|||
161158301|NCT02739594|581959104|FG001|Overall Study|Violation of Eligibility Criteria|2|||
161158302|NCT02739594|581959103|FG000|Overall Study|Protocol Violation|5|||
161158303|NCT02739594|581959104|FG001|Overall Study|Protocol Violation|6|||
161076003|NCT00663702|581669375|FG001|Overall Study|Death|1|||
161158304|NCT02739594|581959103|FG000|Overall Study|Death|4|||
161076004|NCT00663702|581669374|FG000|Overall Study|Lack of Efficacy|3|||
161076005|NCT00663702|581669375|FG001|Overall Study|Lack of Efficacy|3|||
161158305|NCT02739594|581959104|FG001|Overall Study|Death|2|||
161076006|NCT03056300|581669376|FG000|Overall Study|Surgical reason per study protocol|3|||
161286336|NCT02569801|582428046|FG001|Overall Study|Death|4|||
161286337|NCT03442751|582428050|FG000|Overall Study|Withdrawal by Subject|3|||
161286338|NCT03442751|582428051|FG001|Overall Study|Withdrawal by Subject|1|||
161286339|NCT03442751|582428050|FG000|Overall Study|Lost to Follow-up|3|||
161286340|NCT03442751|582428051|FG001|Overall Study|Lost to Follow-up|0|||
161286341|NCT01308424|582428055|FG000|Baseline Eligibility|Screen Failures|71|||
161286342|NCT01308424|582428056|FG001|Baseline Eligibility|Screen Failures|0|||
161286343|NCT01308424|582428057|FG002|Baseline Eligibility|Screen Failures|0|||
161286344|NCT01308424|582428055|FG000|Randomization|Adverse Event|0|||
161286345|NCT01308424|582428056|FG001|Randomization|Adverse Event|1|||
161286346|NCT01308424|582428057|FG002|Randomization|Adverse Event|1|||
161286347|NCT01308424|582428055|FG000|Randomization|Lost to Follow-up|0|||
161286348|NCT01308424|582428056|FG001|Randomization|Lost to Follow-up|1|||
161286349|NCT01308424|582428057|FG002|Randomization|Lost to Follow-up|0|||
161286350|NCT01308424|582428055|FG000|Randomization|Physician Decision|0|||
161286351|NCT01308424|582428056|FG001|Randomization|Physician Decision|1|||
161286352|NCT01308424|582428057|FG002|Randomization|Physician Decision|1|||
161286353|NCT00948155|582428058|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
161286354|NCT00948155|582428059|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
161286355|NCT00948155|582428058|FG000|Washout 14 Days|Lost to Follow-up|1|||
161286356|NCT00948155|582428059|FG001|Washout 14 Days|Lost to Follow-up|2|||
161286357|NCT04620746|582428060|FG000|Overall Study|Adverse Event|2|||
161286358|NCT04620746|582428061|FG001|Overall Study|Adverse Event|0|||
161286359|NCT04620746|582428060|FG000|Overall Study|Uniterpretable skin test|1|||
161286360|NCT04620746|582428061|FG001|Overall Study|Uniterpretable skin test|0|||
161286361|NCT04620746|582428060|FG000|Overall Study|Withdrawal by Subject|0|||
161286362|NCT04620746|582428061|FG001|Overall Study|Withdrawal by Subject|1|||
161286363|NCT05767905|582428066|FG000|Overall Study|Adverse Event|0|||
161286364|NCT05767905|582428067|FG001|Overall Study|Adverse Event|0|||
161286365|NCT05767905|582428068|FG002|Overall Study|Adverse Event|1|||
161286366|NCT03404674|582428074|FG000|Overall Study|Inability to Attend Future Visits|0|||
161286367|NCT03404674|582428075|FG001|Overall Study|Inability to Attend Future Visits|1|||
161286368|NCT03404674|582428076|FG002|Overall Study|Inability to Attend Future Visits|1|||
161286369|NCT03404674|582428077|FG003|Overall Study|Inability to Attend Future Visits|0|||
161286370|NCT03404674|582428078|FG004|Overall Study|Inability to Attend Future Visits|0|||
161286371|NCT03404674|582428079|FG005|Overall Study|Inability to Attend Future Visits|0|||
161286372|NCT03404674|582428074|FG000|Overall Study|Behavioral Problems|0|||
161286373|NCT03404674|582428075|FG001|Overall Study|Behavioral Problems|0|||
161286374|NCT03404674|582428076|FG002|Overall Study|Behavioral Problems|1|||
161286375|NCT03404674|582428077|FG003|Overall Study|Behavioral Problems|0|||
161286376|NCT03404674|582428078|FG004|Overall Study|Behavioral Problems|0|||
161286377|NCT03404674|582428079|FG005|Overall Study|Behavioral Problems|0|||
161286378|NCT03404674|582428074|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
161286379|NCT03404674|582428075|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
161286380|NCT03404674|582428076|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
161286381|NCT03404674|582428077|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
161286382|NCT03404674|582428078|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
161286383|NCT03404674|582428079|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
161286384|NCT01841593|582428084|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
161286385|NCT01841593|582428085|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
161286386|NCT01841593|582428084|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
161286387|NCT01841593|582428085|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
161286388|NCT02635984|582428086|FG000|Overall Study|Lost to Follow-up|2|||
161286389|NCT02635984|582428087|FG001|Overall Study|Lost to Follow-up|4|||
161286390|NCT02635984|582428086|FG000|Overall Study|Study Arm Closed|1|||
161286391|NCT02635984|582428087|FG001|Overall Study|Study Arm Closed|0|||
161286392|NCT00307086|582428090|FG000|Overall Study|ineligible|5|||
161286393|NCT01487525|582428091|FG000|Overall Study|Withdrawal by Subject|0|||
161286394|NCT01487525|582428092|FG001|Overall Study|Withdrawal by Subject|1|||
161286395|NCT03518008|582428093|FG000|Period 2, Second Week of Wear|Family emergency|0|||
161286396|NCT03518008|582428094|FG001|Period 2, Second Week of Wear|Family emergency|1|||
161286397|NCT02308124|582428096|FG000|Overall Study|Lost to Follow-up|6|||
161286398|NCT02308124|582428097|FG001|Overall Study|Lost to Follow-up|6|||
161286399|NCT02308124|582428098|FG002|Overall Study|Lost to Follow-up|6|||
161286400|NCT02308124|582428096|FG000|Overall Study|Adverse Event|0|||
161286401|NCT02308124|582428097|FG001|Overall Study|Adverse Event|2|||
161286402|NCT02308124|582428098|FG002|Overall Study|Adverse Event|2|||
161286403|NCT01526057|582428102|FG000|Overall Study|Withdrawal by Subject|3|||
161286404|NCT01526057|582428103|FG001|Overall Study|Withdrawal by Subject|2|||
161286405|NCT01526057|582428104|FG002|Overall Study|Withdrawal by Subject|2|||
161286406|NCT01526057|582428102|FG000|Overall Study|Adverse Event|3|||
161286407|NCT01526057|582428103|FG001|Overall Study|Adverse Event|1|||
161286408|NCT01526057|582428104|FG002|Overall Study|Adverse Event|1|||
161286409|NCT01526057|582428102|FG000|Overall Study|Death|1|||
161286410|NCT01526057|582428103|FG001|Overall Study|Death|0|||
161286411|NCT01526057|582428104|FG002|Overall Study|Death|0|||
161076007|NCT05262517|581669383|FG000|Overall Study|Randomized but not treated|5|||
161286412|NCT01526057|582428102|FG000|Overall Study|Lost to Follow-up|1|||
161076008|NCT05262517|581669384|FG001|Overall Study|Randomized but not treated|11|||
161076009|NCT05577715|581669385|FG000|Overall Study|Withdrawal by Subject|1|||
161076010|NCT05577715|581669385|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
161076011|NCT05577715|581669385|FG000|Overall Study|Lost to Follow-up|1|||
161076012|NCT05577715|581669385|FG000|Overall Study|Death|6|||
161076013|NCT02195479|581669390|FG000|Overall Study|Lost to Follow-up|18|||
161076014|NCT02195479|581669391|FG001|Overall Study|Lost to Follow-up|15|||
161076015|NCT02195479|581669390|FG000|Overall Study|Death|217|||
161076016|NCT02195479|581669391|FG001|Overall Study|Death|171|||
161076017|NCT02195479|581669390|FG000|Overall Study|Physician Decision|1|||
161076018|NCT02195479|581669391|FG001|Overall Study|Physician Decision|0|||
161076019|NCT02195479|581669390|FG000|Overall Study|Withdrawal by Subject|30|||
161076020|NCT02195479|581669391|FG001|Overall Study|Withdrawal by Subject|30|||
161076021|NCT02195479|581669390|FG000|Overall Study|Other|3|||
161076022|NCT02195479|581669391|FG001|Overall Study|Other|4|||
161076023|NCT02195479|581669390|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
161076024|NCT02195479|581669391|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
161076025|NCT01834586|581669392|FG000|Overall Study|Adverse Event|1|||
161076026|NCT01263509|581669393|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
161076027|NCT01263509|581669394|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
161076028|NCT01263509|581669395|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
161076029|NCT01263509|581669396|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
161076030|NCT01263509|581669393|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161076031|NCT01263509|581669394|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
161076032|NCT01263509|581669395|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
161076033|NCT01263509|581669396|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
161076034|NCT01263509|581669393|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
161076035|NCT01263509|581669394|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
161076036|NCT01263509|581669395|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161076037|NCT01263509|581669396|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
161076038|NCT01263509|581669393|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
161076039|NCT01263509|581669394|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
161076040|NCT01263509|581669395|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161076041|NCT01263509|581669396|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
161076042|NCT01263509|581669393|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
161076043|NCT01263509|581669394|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
161076044|NCT01263509|581669395|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
161076045|NCT01263509|581669396|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
161076046|NCT01371825|581669404|FG000|Overall Study|Death|4|||
161076047|NCT00895895|581669405|FG000|Period 1|Adverse Event|7|||
161076048|NCT00895895|581669406|FG001|Period 1|Adverse Event|6|||
161076049|NCT00895895|581669407|FG002|Period 1|Adverse Event|4|||
161076050|NCT00895895|581669408|FG003|Period 1|Adverse Event|6|||
161076051|NCT00895895|581669409|FG004|Period 1|Adverse Event|7|||
161076052|NCT00895895|581669405|FG000|Period 1|Death|0|||
161076053|NCT00895895|581669406|FG001|Period 1|Death|0|||
161076054|NCT00895895|581669407|FG002|Period 1|Death|0|||
161076055|NCT00895895|581669408|FG003|Period 1|Death|0|||
161076056|NCT00895895|581669409|FG004|Period 1|Death|1|||
161076057|NCT00895895|581669405|FG000|Period 1|discontinued by sponsor|2|||
161076058|NCT00895895|581669406|FG001|Period 1|discontinued by sponsor|1|||
161076059|NCT00895895|581669407|FG002|Period 1|discontinued by sponsor|2|||
161076060|NCT00895895|581669408|FG003|Period 1|discontinued by sponsor|1|||
161076061|NCT00895895|581669409|FG004|Period 1|discontinued by sponsor|1|||
161076062|NCT00895895|581669405|FG000|Period 1|failed to return|0|||
161076063|NCT00895895|581669406|FG001|Period 1|failed to return|0|||
161076064|NCT00895895|581669407|FG002|Period 1|failed to return|1|||
161076065|NCT00895895|581669408|FG003|Period 1|failed to return|0|||
161076066|NCT00895895|581669409|FG004|Period 1|failed to return|1|||
161076067|NCT00895895|581669405|FG000|Period 1|investigator request|0|||
161076068|NCT00895895|581669406|FG001|Period 1|investigator request|1|||
161076069|NCT00895895|581669407|FG002|Period 1|investigator request|0|||
161076070|NCT00895895|581669408|FG003|Period 1|investigator request|0|||
161076071|NCT00895895|581669409|FG004|Period 1|investigator request|0|||
161076072|NCT00895895|581669405|FG000|Period 1|Lost to Follow-up|2|||
161076073|NCT00895895|581669406|FG001|Period 1|Lost to Follow-up|1|||
161286413|NCT01526057|582428103|FG001|Overall Study|Lost to Follow-up|0|||
161286414|NCT01526057|582428104|FG002|Overall Study|Lost to Follow-up|1|||
161076074|NCT00895895|581669407|FG002|Period 1|Lost to Follow-up|3|||
161076075|NCT00895895|581669408|FG003|Period 1|Lost to Follow-up|2|||
161076076|NCT00895895|581669409|FG004|Period 1|Lost to Follow-up|3|||
161076077|NCT00895895|581669405|FG000|Period 1|Other|1|||
161076078|NCT00895895|581669406|FG001|Period 1|Other|2|||
161076079|NCT00895895|581669407|FG002|Period 1|Other|1|||
161286415|NCT01526057|582428102|FG000|Overall Study|Other|1|||
161158306|NCT02739594|581959103|FG000|Overall Study|Renal Insufficiency|4|||
161158307|NCT02739594|581959104|FG001|Overall Study|Renal Insufficiency|6|||
161158308|NCT02739594|581959103|FG000|Overall Study|Administrative Reasons|1|||
161158309|NCT02739594|581959104|FG001|Overall Study|Administrative Reasons|3|||
161158310|NCT02739594|581959103|FG000|Overall Study|Withdrawal by Subject|1|||
161158311|NCT02739594|581959104|FG001|Overall Study|Withdrawal by Subject|1|||
161158312|NCT02739594|581959103|FG000|Overall Study|Lost to Follow-up|0|||
161158313|NCT02739594|581959104|FG001|Overall Study|Lost to Follow-up|1|||
161158314|NCT02739594|581959103|FG000|Overall Study|Elevated Serum Creatinine|0|||
161158315|NCT02739594|581959104|FG001|Overall Study|Elevated Serum Creatinine|1|||
161158316|NCT02739594|581959103|FG000|Overall Study|Other|6|||
161158317|NCT02739594|581959104|FG001|Overall Study|Other|2|||
161158318|NCT00952289|581959105|FG000|All Participants|Death|9|||
161158319|NCT00952289|581959106|FG001|All Participants|Death|9|||
161158320|NCT00952289|581959105|FG000|All Participants|Adverse Event|8|||
161158321|NCT00952289|581959106|FG001|All Participants|Adverse Event|8|||
161158322|NCT00952289|581959105|FG000|All Participants|Disease progression|3|||
161158323|NCT00952289|581959106|FG001|All Participants|Disease progression|12|||
161158324|NCT00952289|581959105|FG000|All Participants|Withdrawal by Subject|1|||
161158325|NCT00952289|581959106|FG001|All Participants|Withdrawal by Subject|10|||
161158326|NCT00952289|581959105|FG000|All Participants|Data lost during site relocation|0|||
161158327|NCT00952289|581959106|FG001|All Participants|Data lost during site relocation|1|||
161158328|NCT00952289|581959105|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
161158329|NCT00952289|581959106|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
161158330|NCT00952289|581959105|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
161158331|NCT00952289|581959106|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
161158332|NCT00952289|581959105|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
161158333|NCT00952289|581959106|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
161158334|NCT00952289|581959105|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
161158335|NCT00952289|581959106|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
161158336|NCT00952289|581959105|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
161158337|NCT00952289|581959106|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
161158338|NCT03259334|581959107|FG000|Overall Study|Adverse Event|3|||
161158339|NCT03259334|581959108|FG001|Overall Study|Adverse Event|8|||
161158340|NCT03259334|581959109|FG002|Overall Study|Adverse Event|5|||
161158341|NCT03259334|581959107|FG000|Overall Study|Withdrawal by Subject|4|||
161158342|NCT03259334|581959108|FG001|Overall Study|Withdrawal by Subject|2|||
161158343|NCT03259334|581959109|FG002|Overall Study|Withdrawal by Subject|4|||
161158344|NCT03259334|581959107|FG000|Overall Study|Physician Decision|1|||
161158345|NCT03259334|581959108|FG001|Overall Study|Physician Decision|0|||
161158346|NCT03259334|581959109|FG002|Overall Study|Physician Decision|0|||
161158347|NCT03259334|581959107|FG000|Overall Study|Lost to Follow-up|0|||
161158348|NCT03259334|581959108|FG001|Overall Study|Lost to Follow-up|2|||
161158349|NCT03259334|581959109|FG002|Overall Study|Lost to Follow-up|1|||
161158350|NCT03259334|581959107|FG000|Overall Study|Protocol Deviation|0|||
161158351|NCT03259334|581959108|FG001|Overall Study|Protocol Deviation|3|||
161076080|NCT00895895|581669408|FG003|Period 1|Other|1|||
161076081|NCT00895895|581669409|FG004|Period 1|Other|1|||
161076082|NCT00895895|581669405|FG000|Period 1|Protocol Violation|0|||
161076083|NCT00895895|581669406|FG001|Period 1|Protocol Violation|1|||
161076084|NCT00895895|581669407|FG002|Period 1|Protocol Violation|0|||
161076085|NCT00895895|581669408|FG003|Period 1|Protocol Violation|0|||
161076086|NCT00895895|581669409|FG004|Period 1|Protocol Violation|0|||
161076087|NCT00895895|581669405|FG000|Period 1|Withdrawal by Subject|6|||
161076088|NCT00895895|581669406|FG001|Period 1|Withdrawal by Subject|6|||
161076089|NCT00895895|581669407|FG002|Period 1|Withdrawal by Subject|8|||
161076090|NCT00895895|581669408|FG003|Period 1|Withdrawal by Subject|2|||
161076091|NCT00895895|581669409|FG004|Period 1|Withdrawal by Subject|4|||
161076092|NCT00895895|581669405|FG000|Period 1|unsatisfactory response-efficacy|2|||
161076093|NCT00895895|581669406|FG001|Period 1|unsatisfactory response-efficacy|0|||
161076094|NCT00895895|581669407|FG002|Period 1|unsatisfactory response-efficacy|0|||
161076095|NCT00895895|581669408|FG003|Period 1|unsatisfactory response-efficacy|0|||
161076096|NCT00895895|581669409|FG004|Period 1|unsatisfactory response-efficacy|0|||
161076097|NCT00895895|581669405|FG000|Period 1|randomized and not treated|1|||
161286416|NCT01526057|582428103|FG001|Overall Study|Other|0|||
161286417|NCT01526057|582428104|FG002|Overall Study|Other|1|||
161286418|NCT01526057|582428102|FG000|Overall Study|Protocol Violation|0|||
161076098|NCT00895895|581669406|FG001|Period 1|randomized and not treated|3|||
161286419|NCT01526057|582428103|FG001|Overall Study|Protocol Violation|0|||
161076099|NCT00895895|581669407|FG002|Period 1|randomized and not treated|1|||
161076100|NCT00895895|581669408|FG003|Period 1|randomized and not treated|1|||
161158352|NCT03259334|581959109|FG002|Overall Study|Protocol Deviation|2|||
161158353|NCT03259334|581959107|FG000|Overall Study|Lack of Efficacy|2|||
161158354|NCT03259334|581959108|FG001|Overall Study|Lack of Efficacy|0|||
161158355|NCT03259334|581959109|FG002|Overall Study|Lack of Efficacy|1|||
161076101|NCT00895895|581669409|FG004|Period 1|randomized and not treated|2|||
161345698|NCT03112603|582650905|FG000|End of Randomization Period|Lost to Follow-up|3|||
161345699|NCT03112603|582650906|FG001|End of Randomization Period|Lost to Follow-up|0|||
161345700|NCT03112603|582650907|FG002|End of Randomization Period|Lost to Follow-up|0|||
161345701|NCT03112603|582650905|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
161345702|NCT03112603|582650906|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
161345703|NCT03112603|582650907|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
161345704|NCT03112603|582650905|FG000|End of Randomization Period|Physician Decision|43|||
161345705|NCT03112603|582650906|FG001|End of Randomization Period|Physician Decision|18|||
161345706|NCT03112603|582650907|FG002|End of Randomization Period|Physician Decision|0|||
161345707|NCT03112603|582650905|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
161345708|NCT03112603|582650906|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
161345709|NCT03112603|582650907|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
161345710|NCT03112603|582650905|FG000|End of Randomization Period|Death|10|||
161345711|NCT03112603|582650906|FG001|End of Randomization Period|Death|7|||
161345712|NCT03112603|582650907|FG002|End of Randomization Period|Death|0|||
161345713|NCT03112603|582650905|FG000|End of Randomization Period|Disease Relapse|12|||
161345714|NCT03112603|582650906|FG001|End of Randomization Period|Disease Relapse|7|||
161345715|NCT03112603|582650907|FG002|End of Randomization Period|Disease Relapse|0|||
161345716|NCT03112603|582650905|FG000|End of Randomization Period|Lack of Efficacy|25|||
161345717|NCT03112603|582650906|FG001|End of Randomization Period|Lack of Efficacy|77|||
161345718|NCT03112603|582650907|FG002|End of Randomization Period|Lack of Efficacy|0|||
161345719|NCT03112603|582650905|FG000|End of Randomization Period|Adverse Event|32|||
161345720|NCT03112603|582650906|FG001|End of Randomization Period|Adverse Event|12|||
161345721|NCT03112603|582650907|FG002|End of Randomization Period|Adverse Event|0|||
161345722|NCT03112603|582650905|FG000|End of Cross Over Period|Death|0|||
161345723|NCT03112603|582650906|FG001|End of Cross Over Period|Death|0|||
161345724|NCT03112603|582650907|FG002|End of Cross Over Period|Death|2|||
161345725|NCT03112603|582650905|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
161345726|NCT03112603|582650906|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
161345727|NCT03112603|582650907|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
161345728|NCT03112603|582650905|FG000|End of Cross Over Period|Physician Decision|0|||
161345729|NCT03112603|582650906|FG001|End of Cross Over Period|Physician Decision|0|||
161345730|NCT03112603|582650907|FG002|End of Cross Over Period|Physician Decision|29|||
161345731|NCT03112603|582650905|FG000|End of Cross Over Period|Lack of Efficacy|0|||
161345732|NCT03112603|582650906|FG001|End of Cross Over Period|Lack of Efficacy|0|||
161345733|NCT03112603|582650907|FG002|End of Cross Over Period|Lack of Efficacy|8|||
161345734|NCT03112603|582650905|FG000|End of Cross Over Period|Adverse Event|0|||
161345735|NCT03112603|582650906|FG001|End of Cross Over Period|Adverse Event|0|||
161345736|NCT03112603|582650907|FG002|End of Cross Over Period|Adverse Event|6|||
161345737|NCT03112603|582650905|FG000|End of Cross Over Period|Disease Relapse|0|||
161345738|NCT03112603|582650906|FG001|End of Cross Over Period|Disease Relapse|0|||
161286420|NCT01526057|582428104|FG002|Overall Study|Protocol Violation|1|||
161286421|NCT02860546|582428105|FG000|Overall Study|Clinical Progression|6|||
161286422|NCT02860546|582428105|FG000|Overall Study|Radiological Progression|12|||
161286423|NCT01329900|582428109|FG000|Overall Study|Elevated creatinine/renal function|1|||
161286424|NCT01855828|582428110|FG000|Overall Study|Adverse Event|1|||
161286425|NCT01855828|582428110|FG000|Overall Study|Withdrawal by Subject|1|||
161286426|NCT01866098|582428111|FG000|Overall Study|Lost to Follow-up|11|||
161286427|NCT01866098|582428112|FG001|Overall Study|Lost to Follow-up|18|||
161286428|NCT01866098|582428113|FG002|Overall Study|Lost to Follow-up|13|||
161286429|NCT01866098|582428111|FG000|Overall Study|Physician Decision|0|||
161286430|NCT01866098|582428112|FG001|Overall Study|Physician Decision|1|||
161286431|NCT01866098|582428113|FG002|Overall Study|Physician Decision|2|||
161286432|NCT01866098|582428111|FG000|Overall Study|Adverse Event|1|||
161286433|NCT01866098|582428112|FG001|Overall Study|Adverse Event|5|||
161286434|NCT01866098|582428113|FG002|Overall Study|Adverse Event|4|||
161286435|NCT01866098|582428111|FG000|Overall Study|Protocol Violation|1|||
161286436|NCT01866098|582428112|FG001|Overall Study|Protocol Violation|0|||
161286437|NCT01866098|582428113|FG002|Overall Study|Protocol Violation|0|||
161345739|NCT03112603|582650907|FG002|End of Cross Over Period|Disease Relapse|2|||
161345740|NCT02802228|582650908|FG000|Overall Study|Withdrawal by Subject|2|||
161345741|NCT02802228|582650909|FG001|Overall Study|Withdrawal by Subject|0|||
161345742|NCT02802228|582650908|FG000|Overall Study|Lost to Follow-up|1|||
161345743|NCT02802228|582650909|FG001|Overall Study|Lost to Follow-up|0|||
161345744|NCT02802228|582650908|FG000|Overall Study|Adverse Event|1|||
161345745|NCT02802228|582650909|FG001|Overall Study|Adverse Event|0|||
161286438|NCT01866098|582428111|FG000|Overall Study|Withdrawal by Subject|1|||
161345746|NCT02802228|582650908|FG000|Overall Study|Physician Decision|1|||
161286439|NCT01866098|582428112|FG001|Overall Study|Withdrawal by Subject|2|||
161286440|NCT01866098|582428113|FG002|Overall Study|Withdrawal by Subject|0|||
161345747|NCT02802228|582650909|FG001|Overall Study|Physician Decision|0|||
161286441|NCT01866098|582428111|FG000|Overall Study|Unrelated Hospitalization|2|||
161286442|NCT01866098|582428112|FG001|Overall Study|Unrelated Hospitalization|0|||
161286443|NCT01866098|582428113|FG002|Overall Study|Unrelated Hospitalization|1|||
161158356|NCT03259334|581959107|FG000|Overall Study|Randomized but never treated|0|||
161158357|NCT03259334|581959108|FG001|Overall Study|Randomized but never treated|2|||
161158358|NCT03259334|581959109|FG002|Overall Study|Randomized but never treated|0|||
161158359|NCT03375112|581959110|FG000|Overall Study|Withdrawal by Subject|3|||
161158360|NCT03375112|581959111|FG001|Overall Study|Withdrawal by Subject|0|||
161158361|NCT03599141|581959112|FG000|Overall Study|Lost to Follow-up|3|||
161158362|NCT03599141|581959113|FG001|Overall Study|Lost to Follow-up|1|||
161158363|NCT00777491|581959114|FG000|Overall Study|Protocol Violation|0|||
161158364|NCT00777491|581959115|FG001|Overall Study|Protocol Violation|2|||
161158365|NCT00777491|581959114|FG000|Overall Study|Did not receive any protocol treatment|2|||
161158366|NCT00777491|581959115|FG001|Overall Study|Did not receive any protocol treatment|0|||
161158367|NCT01689207|581959116|FG000|Overall Study|Adverse Event|0|||
161158368|NCT01689207|581959117|FG001|Overall Study|Adverse Event|1|||
161158369|NCT01689207|581959118|FG002|Overall Study|Adverse Event|0|||
161158370|NCT01689207|581959119|FG003|Overall Study|Adverse Event|0|||
161158371|NCT01689207|581959120|FG004|Overall Study|Adverse Event|2|||
161158372|NCT01689207|581959121|FG005|Overall Study|Adverse Event|1|||
161158373|NCT01689207|581959122|FG006|Overall Study|Adverse Event|0|||
161158374|NCT01689207|581959123|FG007|Overall Study|Adverse Event|0|||
161158375|NCT01689207|581959124|FG008|Overall Study|Adverse Event|1|||
161158376|NCT01689207|581959125|FG009|Overall Study|Adverse Event|0|||
161158377|NCT01689207|581959126|FG010|Overall Study|Adverse Event|0|||
161158378|NCT01912768|581959127|FG000|Overall Study|Adverse Event|2|||
161158379|NCT01912768|581959128|FG001|Overall Study|Adverse Event|0|||
161158380|NCT01912768|581959127|FG000|Overall Study|Lost to Follow-up|2|||
161158381|NCT01912768|581959128|FG001|Overall Study|Lost to Follow-up|1|||
161158382|NCT01912768|581959127|FG000|Overall Study|Withdrawal by Subject|5|||
161158383|NCT01912768|581959128|FG001|Overall Study|Withdrawal by Subject|3|||
161158384|NCT01912768|581959127|FG000|Overall Study|Randomized in error|1|||
161158385|NCT01912768|581959128|FG001|Overall Study|Randomized in error|0|||
161158386|NCT00524316|581959129|FG000|Overall Study|Withdrawal by Subject|2|||
161158387|NCT00524316|581959129|FG000|Overall Study|Adverse Event|7|||
161158388|NCT00524316|581959129|FG000|Overall Study|Disease Progression|7|||
161158389|NCT01199263|581959130|FG000|Overall Study|Ineligible|0|||
161158390|NCT01199263|581959131|FG001|Overall Study|Ineligible|2|||
161158391|NCT01199263|581959130|FG000|Overall Study|Never Treated|6|||
161158392|NCT01199263|581959131|FG001|Overall Study|Never Treated|0|||
161158393|NCT01687413|581959136|FG000|Overall Study|Withdrawal by Subject|0|||
161158394|NCT01687413|581959137|FG001|Overall Study|Withdrawal by Subject|2|||
161158395|NCT01687413|581959136|FG000|Overall Study|Not eligible|0|||
161158396|NCT01687413|581959137|FG001|Overall Study|Not eligible|2|||
161158397|NCT01687413|581959136|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
161158398|NCT01687413|581959137|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
161158399|NCT04973228|581959140|FG000|Overall Study|Adverse Event|2|||
161158400|NCT04973228|581959141|FG001|Overall Study|Adverse Event|3|||
161158401|NCT04973228|581959140|FG000|Overall Study|Lack of Efficacy|1|||
161158402|NCT04973228|581959141|FG001|Overall Study|Lack of Efficacy|3|||
161158403|NCT04973228|581959140|FG000|Overall Study|Lost to Follow-up|12|||
161158404|NCT04973228|581959141|FG001|Overall Study|Lost to Follow-up|4|||
161286444|NCT01866098|582428111|FG000|Overall Study|Non-compliance|1|||
161286445|NCT01866098|582428112|FG001|Overall Study|Non-compliance|0|||
161076102|NCT00895895|581669405|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
161076103|NCT00895895|581669406|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
161076104|NCT00895895|581669407|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
161076105|NCT00895895|581669408|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
161076106|NCT00895895|581669409|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
161076107|NCT00895895|581669405|FG000|After Period 1, Prior to Period 2|Other|0|||
161076108|NCT00895895|581669406|FG001|After Period 1, Prior to Period 2|Other|0|||
161076109|NCT00895895|581669407|FG002|After Period 1, Prior to Period 2|Other|1|||
161076110|NCT00895895|581669408|FG003|After Period 1, Prior to Period 2|Other|0|||
161076111|NCT00895895|581669409|FG004|After Period 1, Prior to Period 2|Other|0|||
161076112|NCT00895895|581669405|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
161076113|NCT00895895|581669406|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
161158405|NCT04973228|581959140|FG000|Overall Study|Withdrawal by Subject|11|||
161158406|NCT04973228|581959141|FG001|Overall Study|Withdrawal by Subject|4|||
161158407|NCT04973228|581959140|FG000|Overall Study|Did not tolerate application|1|||
161158408|NCT04973228|581959141|FG001|Overall Study|Did not tolerate application|0|||
161158409|NCT04973228|581959140|FG000|Overall Study|Wanted to early terminate and use own product|0|||
161158410|NCT04973228|581959141|FG001|Overall Study|Wanted to early terminate and use own product|1|||
161158411|NCT04973228|581959140|FG000|Overall Study|Missed visits due to new work schedule|1|||
161076114|NCT00895895|581669407|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
161158412|NCT04973228|581959141|FG001|Overall Study|Missed visits due to new work schedule|0|||
161076115|NCT00895895|581669408|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
161158413|NCT00091390|581959147|FG000|Overall Study|Protocol Violation|1|||
161158414|NCT00091390|581959147|FG000|Overall Study|No protocol treatment|3|||
161076116|NCT00895895|581669409|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
161076117|NCT00895895|581669405|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161076118|NCT00895895|581669406|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161076119|NCT00895895|581669407|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161076120|NCT00895895|581669408|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
161076121|NCT00895895|581669409|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
161076122|NCT00895895|581669405|FG000|Period 2|Adverse Event|3|||
161076123|NCT00895895|581669406|FG001|Period 2|Adverse Event|3|||
161076124|NCT00895895|581669407|FG002|Period 2|Adverse Event|5|||
161076125|NCT00895895|581669408|FG003|Period 2|Adverse Event|2|||
161076126|NCT00895895|581669409|FG004|Period 2|Adverse Event|5|||
161076127|NCT00895895|581669405|FG000|Period 2|Death|0|||
161076128|NCT00895895|581669406|FG001|Period 2|Death|0|||
161076129|NCT00895895|581669407|FG002|Period 2|Death|1|||
161076130|NCT00895895|581669408|FG003|Period 2|Death|0|||
161076131|NCT00895895|581669409|FG004|Period 2|Death|0|||
161076132|NCT00895895|581669405|FG000|Period 2|discontinued by sponsor|44|||
161076133|NCT00895895|581669406|FG001|Period 2|discontinued by sponsor|44|||
161076134|NCT00895895|581669407|FG002|Period 2|discontinued by sponsor|38|||
161076135|NCT00895895|581669408|FG003|Period 2|discontinued by sponsor|46|||
161076136|NCT00895895|581669409|FG004|Period 2|discontinued by sponsor|37|||
161076137|NCT00895895|581669405|FG000|Period 2|failed to return|2|||
161076138|NCT00895895|581669406|FG001|Period 2|failed to return|0|||
161076139|NCT00895895|581669407|FG002|Period 2|failed to return|0|||
161076140|NCT00895895|581669408|FG003|Period 2|failed to return|0|||
161076141|NCT00895895|581669409|FG004|Period 2|failed to return|0|||
161076142|NCT00895895|581669405|FG000|Period 2|investigator request|2|||
161076143|NCT00895895|581669406|FG001|Period 2|investigator request|0|||
161076144|NCT00895895|581669407|FG002|Period 2|investigator request|0|||
161076145|NCT00895895|581669408|FG003|Period 2|investigator request|0|||
161076146|NCT00895895|581669409|FG004|Period 2|investigator request|0|||
161076147|NCT00895895|581669405|FG000|Period 2|Lost to Follow-up|1|||
161076148|NCT00895895|581669406|FG001|Period 2|Lost to Follow-up|2|||
161076149|NCT00895895|581669407|FG002|Period 2|Lost to Follow-up|1|||
161076150|NCT00895895|581669408|FG003|Period 2|Lost to Follow-up|1|||
161076151|NCT00895895|581669409|FG004|Period 2|Lost to Follow-up|0|||
161076152|NCT00895895|581669405|FG000|Period 2|Other|1|||
161076153|NCT00895895|581669406|FG001|Period 2|Other|1|||
161076154|NCT00895895|581669407|FG002|Period 2|Other|3|||
161076155|NCT00895895|581669408|FG003|Period 2|Other|1|||
161076156|NCT00895895|581669409|FG004|Period 2|Other|1|||
161076157|NCT00895895|581669405|FG000|Period 2|Protocol Violation|1|||
161076158|NCT00895895|581669406|FG001|Period 2|Protocol Violation|0|||
161076159|NCT00895895|581669407|FG002|Period 2|Protocol Violation|1|||
161076160|NCT00895895|581669408|FG003|Period 2|Protocol Violation|1|||
161076161|NCT00895895|581669409|FG004|Period 2|Protocol Violation|1|||
161076162|NCT00895895|581669405|FG000|Period 2|Withdrawal by Subject|0|||
161076163|NCT00895895|581669406|FG001|Period 2|Withdrawal by Subject|2|||
161076164|NCT00895895|581669407|FG002|Period 2|Withdrawal by Subject|0|||
161076165|NCT00895895|581669408|FG003|Period 2|Withdrawal by Subject|3|||
161076166|NCT00895895|581669409|FG004|Period 2|Withdrawal by Subject|5|||
161076167|NCT00895895|581669405|FG000|Period 2|unsatisfactory response-efficacy|2|||
161076168|NCT00895895|581669406|FG001|Period 2|unsatisfactory response-efficacy|1|||
161076169|NCT00895895|581669407|FG002|Period 2|unsatisfactory response-efficacy|0|||
161076170|NCT00895895|581669408|FG003|Period 2|unsatisfactory response-efficacy|0|||
161076171|NCT00895895|581669409|FG004|Period 2|unsatisfactory response-efficacy|0|||
161076172|NCT03019640|581669410|FG000|Overall Study|Screen Failures|4|||
161076173|NCT03019640|581669410|FG000|Overall Study|Adverse Event|3|||
161076174|NCT03019640|581669410|FG000|Overall Study|Participant Relapsed|1|||
161076175|NCT01818531|581669416|FG000|Overall Study|Withdrawn for case delay after block|1|||
161076176|NCT01818531|581669417|FG001|Overall Study|Withdrawn for case delay after block|0|||
161076177|NCT01818531|581669416|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
161076178|NCT01818531|581669417|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
161076179|NCT01818531|581669416|FG000|Overall Study|Withdrawn for failure to place block|0|||
161076180|NCT01818531|581669417|FG001|Overall Study|Withdrawn for failure to place block|1|||
161076181|NCT00214019|581669418|FG000|Overall Study|Lost to Follow-up|11|||
161076182|NCT00214019|581669418|FG000|Overall Study|Withdrawal by Subject|2|||
161076183|NCT00214019|581669418|FG000|Overall Study|Screen Failed prior to randomization|17|||
161076184|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
161076185|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
161076186|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
161076187|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
161076188|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
161076189|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
161076190|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
161076191|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
161076192|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
161076193|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
161076194|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161076195|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161076196|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
161076197|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
161076198|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161076199|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161076200|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161076201|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
161076202|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
161076203|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076204|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076205|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076206|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
161076207|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076208|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076209|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076210|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
161076211|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
161076212|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
161076213|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
161076214|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
161076215|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
161076216|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161076217|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161076218|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161076219|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
161076220|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
161076221|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
161076222|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
161076223|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
161076224|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
161076225|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161076226|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161076227|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161076228|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
161076229|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
161076230|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
161076231|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
161076232|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
161076233|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
161076234|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
161076235|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
161076236|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
161076237|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
161076238|NCT00477490|581669419|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
161076239|NCT00477490|581669420|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
161076240|NCT00477490|581669421|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
161076241|NCT00477490|581669422|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
161076242|NCT00477490|581669423|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
161076243|NCT00477490|581669424|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
161076244|NCT00477490|581669425|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
161076245|NCT00477490|581669426|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
161076246|NCT00477490|581669427|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
161076247|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
161076248|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
161076249|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
161076250|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
161076251|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
161076252|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
161076253|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
161076254|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
161076255|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
161076256|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
161076257|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
161076258|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
161076259|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161076260|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161076261|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161076262|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161158415|NCT00406640|581959152|FG000|Acute Phase|Adverse Event|18|||
161158416|NCT00406640|581959153|FG001|Acute Phase|Adverse Event|13|||
161076263|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
161076264|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
161076265|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161076266|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
161076267|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
161076268|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161076269|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
161076270|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161076271|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
161076272|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161076273|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
161076274|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161076275|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161076276|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161076277|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161076278|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
161076279|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161076280|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
161076281|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
161076282|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
161076283|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076284|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
161076285|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076286|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076287|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076288|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076289|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076290|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076291|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
161076292|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
161076293|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
161076294|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
161076295|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
161076296|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
161076297|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
161076298|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
161076299|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
161076300|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
161076301|NCT00477490|581669419|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161076302|NCT00477490|581669420|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
161076303|NCT00477490|581669421|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
161076304|NCT00477490|581669422|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161076305|NCT00477490|581669423|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
161076306|NCT00477490|581669424|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161076307|NCT00477490|581669425|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161076308|NCT00477490|581669426|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161076309|NCT00477490|581669427|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
161076310|NCT01465763|581669430|FG000|Overall Study|Withdrawal by Subject|4|||
161076311|NCT01465763|581669431|FG001|Overall Study|Withdrawal by Subject|0|||
161076312|NCT01465763|581669432|FG002|Overall Study|Withdrawal by Subject|1|||
161076313|NCT01465763|581669430|FG000|Overall Study|Insufficient Clinical Response|11|||
161076314|NCT01465763|581669431|FG001|Overall Study|Insufficient Clinical Response|0|||
161076315|NCT01465763|581669432|FG002|Overall Study|Insufficient Clinical Response|1|||
161076316|NCT01465763|581669430|FG000|Overall Study|Adverse Event|9|||
161076317|NCT01465763|581669431|FG001|Overall Study|Adverse Event|0|||
161076318|NCT01465763|581669432|FG002|Overall Study|Adverse Event|1|||
161076319|NCT01465763|581669430|FG000|Overall Study|Other|2|||
161076320|NCT01465763|581669431|FG001|Overall Study|Other|0|||
161076321|NCT01465763|581669432|FG002|Overall Study|Other|0|||
161076322|NCT01465763|581669430|FG000|Overall Study|Protocol Violation|4|||
161076323|NCT01465763|581669431|FG001|Overall Study|Protocol Violation|1|||
161076324|NCT01465763|581669432|FG002|Overall Study|Protocol Violation|1|||
161076325|NCT01465763|581669430|FG000|Overall Study|Death|1|||
161076326|NCT01465763|581669431|FG001|Overall Study|Death|0|||
161076327|NCT01465763|581669432|FG002|Overall Study|Death|0|||
161076328|NCT01646177|581669433|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
161076329|NCT01646177|581669434|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
161076330|NCT01646177|581669435|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
161286446|NCT01866098|582428113|FG002|Overall Study|Non-compliance|1|||
161286447|NCT01866098|582428111|FG000|Overall Study|Pregnancy|2|||
161286448|NCT01866098|582428112|FG001|Overall Study|Pregnancy|0|||
161286449|NCT01866098|582428113|FG002|Overall Study|Pregnancy|0|||
161286450|NCT01866098|582428111|FG000|Overall Study|Death|0|||
161286451|NCT01866098|582428112|FG001|Overall Study|Death|1|||
161076331|NCT01646177|581669436|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
161076332|NCT01646177|581669437|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076333|NCT01646177|581669438|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076334|NCT01646177|581669439|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076335|NCT01646177|581669440|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076336|NCT01646177|581669441|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076337|NCT01646177|581669442|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076338|NCT01646177|581669443|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076339|NCT01646177|581669444|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
161076340|NCT01646177|581669433|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
161076341|NCT01646177|581669434|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
161076342|NCT01646177|581669435|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
161076343|NCT01646177|581669436|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
161076344|NCT01646177|581669437|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076345|NCT01646177|581669438|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076346|NCT01646177|581669439|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076347|NCT01646177|581669440|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076348|NCT01646177|581669441|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076349|NCT01646177|581669442|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076350|NCT01646177|581669443|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076351|NCT01646177|581669444|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
161076352|NCT01646177|581669433|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
161076353|NCT01646177|581669434|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
161076354|NCT01646177|581669435|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
161076355|NCT01646177|581669436|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
161076356|NCT01646177|581669437|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076357|NCT01646177|581669438|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076358|NCT01646177|581669439|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076359|NCT01646177|581669440|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076360|NCT01646177|581669441|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076361|NCT01646177|581669442|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076362|NCT01646177|581669443|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076363|NCT01646177|581669444|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
161076364|NCT01646177|581669433|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
161076365|NCT01646177|581669434|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
161076366|NCT01646177|581669435|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
161076367|NCT01646177|581669436|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
161076368|NCT01646177|581669437|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076369|NCT01646177|581669438|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076370|NCT01646177|581669439|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076371|NCT01646177|581669440|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076372|NCT01646177|581669441|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076373|NCT01646177|581669442|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076374|NCT01646177|581669443|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076375|NCT01646177|581669444|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
161076376|NCT01646177|581669433|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076377|NCT01646177|581669434|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076378|NCT01646177|581669435|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
161076379|NCT01646177|581669436|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
161076380|NCT01646177|581669437|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076381|NCT01646177|581669438|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076382|NCT01646177|581669439|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076383|NCT01646177|581669440|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076384|NCT01646177|581669441|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076385|NCT01646177|581669442|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161076386|NCT01646177|581669443|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161286452|NCT01866098|582428113|FG002|Overall Study|Death|0|||
161076387|NCT01646177|581669444|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
161286453|NCT04239027|582428121|FG000|Overall Study|Adverse Event|4|||
161286454|NCT04239027|582428121|FG000|Overall Study|Withdrawal by Subject|9|||
161158417|NCT00406640|581959152|FG000|Acute Phase|Failed to Return|5|||
161158418|NCT00406640|581959153|FG001|Acute Phase|Failed to Return|1|||
161158419|NCT00406640|581959152|FG000|Acute Phase|Physician Decision|0|||
161158420|NCT00406640|581959153|FG001|Acute Phase|Physician Decision|1|||
161158421|NCT00406640|581959152|FG000|Acute Phase|Lost to Follow-up|7|||
161158422|NCT00406640|581959153|FG001|Acute Phase|Lost to Follow-up|4|||
161158423|NCT00406640|581959152|FG000|Acute Phase|Protocol deviation|4|||
161158424|NCT00406640|581959153|FG001|Acute Phase|Protocol deviation|10|||
161076388|NCT01646177|581669433|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
161076389|NCT01646177|581669434|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
161076390|NCT01646177|581669435|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
161076391|NCT01646177|581669436|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076392|NCT01646177|581669437|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076393|NCT01646177|581669438|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076394|NCT01646177|581669439|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161158425|NCT00406640|581959152|FG000|Acute Phase|Protocol Violation|3|||
161158426|NCT00406640|581959153|FG001|Acute Phase|Protocol Violation|2|||
161158427|NCT00406640|581959152|FG000|Acute Phase|Withdrawal by Subject|11|||
161158428|NCT00406640|581959153|FG001|Acute Phase|Withdrawal by Subject|9|||
161158429|NCT00406640|581959152|FG000|Acute Phase|Lack of Efficacy|3|||
161158430|NCT00406640|581959153|FG001|Acute Phase|Lack of Efficacy|3|||
161158431|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
161158432|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
161158433|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Death|1|||
161158434|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Death|0|||
161158435|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
161158436|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
161158437|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
161158438|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
161158439|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
161158440|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
161158441|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|non-compliance|7|||
161158442|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|non-compliance|5|||
161158443|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
161158444|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
161158445|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
161158446|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
161158447|NCT00406640|581959152|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
161158448|NCT00406640|581959153|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
161158449|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
161158450|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
161158451|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
161158452|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
161158453|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
161158454|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
161158455|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
161158456|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
161158457|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
161158458|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
161158459|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
161158460|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
161158461|NCT00406640|581959152|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
161158462|NCT00406640|581959153|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
161158463|NCT00311181|581961047|FG000|Overall Study|Final DFTs were not obtained|96|||
161158464|NCT02294318|581961048|FG000|Overall Study|Worsening of drinking|3|||
161158465|NCT02294318|581961049|FG001|Overall Study|Worsening of drinking|0|||
161158466|NCT02294318|581961048|FG000|Overall Study|Not exposed to intervention|0|||
161158467|NCT02294318|581961049|FG001|Overall Study|Not exposed to intervention|2|||
161158468|NCT01694420|581961053|FG000|Overall Study|Lost to Follow-up|3|||
161158469|NCT00506948|581961054|FG000|Overall Study|Death|4|||
161158470|NCT00506948|581961054|FG000|Overall Study|Adverse Event|5|||
161158471|NCT00506948|581961054|FG000|Overall Study|Physician Decision|1|||
161158472|NCT02395653|581961055|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
161076395|NCT01646177|581669440|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161158473|NCT02395653|581961055|FG000|Overall Study|Consent Withdrawn at Screening|1|||
161158474|NCT02395653|581961055|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
161158475|NCT02395653|581961055|FG000|Overall Study|Investigator Decision at Screening|1|||
161158476|NCT02395653|581961055|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
161158477|NCT02395653|581961055|FG000|Overall Study|Withdrawal by Subject|1|||
161158478|NCT02395653|581961055|FG000|Overall Study|Lost to Follow-up|1|||
161158479|NCT02494778|581961056|FG000|Overall Study|Death|3|||
161076396|NCT01646177|581669441|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076397|NCT01646177|581669442|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076398|NCT01646177|581669443|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076399|NCT01646177|581669444|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
161076400|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076401|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076402|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076403|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076404|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
161076405|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
161076406|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
161076407|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
161076408|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076409|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076410|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076411|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
161076412|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076413|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076414|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076415|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076416|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
161076417|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
161076418|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
161076419|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
161076420|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076421|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076422|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076423|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
161076424|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076425|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076426|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076427|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076428|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
161076429|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
161076430|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
161076431|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
161076432|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076433|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076434|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076435|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
161076436|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076437|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076438|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076439|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076440|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
161076441|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
161076442|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
161076443|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
161076444|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076445|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076446|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076447|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
161076448|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076449|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076450|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076451|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076452|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
161158480|NCT02494778|581961056|FG000|Overall Study|Other|173|||
161286455|NCT04239027|582428121|FG000|Overall Study|Death|1|||
161286456|NCT04239027|582428121|FG000|Overall Study|Physician Decision|9|||
161286457|NCT04239027|582428121|FG000|Overall Study|Lost to Follow-up|2|||
161286458|NCT04239027|582428121|FG000|Overall Study|Lack of Efficacy|1|||
161286459|NCT01184079|582428128|FG000|Overall Study|Lost to Follow-up|14|||
161286460|NCT01184079|582428129|FG001|Overall Study|Lost to Follow-up|2|||
161286461|NCT01523002|582428140|FG000|Period 1|Withdrawal by Subject|1|||
161076453|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
161076454|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
161076455|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
161076456|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076457|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076458|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076459|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
161076460|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076461|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076462|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076463|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076464|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
161076465|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
161076466|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076467|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
161076468|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076469|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076470|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076471|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
161076472|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076473|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076474|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076475|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076476|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
161076477|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161076478|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161076479|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
161076480|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076481|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076482|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076483|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
161076484|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
161076485|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
161076486|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
161076487|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
161076488|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
161076489|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
161076490|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
161076491|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
161076492|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
161076493|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
161076494|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
161076495|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
161076496|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076497|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076498|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076499|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076500|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
161076501|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
161076502|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
161076503|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
161076504|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076505|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076506|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076507|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
161076508|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076509|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076510|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076511|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076512|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076513|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076514|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076515|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
161158481|NCT02494778|581961056|FG000|Overall Study|Lack of Efficacy|4|||
161345748|NCT00695019|582650910|FG000|Overall Study|Withdrawal by Subject|8|||
161345749|NCT00695019|582650911|FG001|Overall Study|Withdrawal by Subject|6|||
161345750|NCT00695019|582650912|FG002|Overall Study|Withdrawal by Subject|4|||
161345751|NCT00695019|582650910|FG000|Overall Study|Protocol Violation|1|||
161345752|NCT00695019|582650911|FG001|Overall Study|Protocol Violation|3|||
161076516|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076517|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076518|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076519|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
161076520|NCT01646177|581669433|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076521|NCT01646177|581669434|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076522|NCT01646177|581669435|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076523|NCT01646177|581669436|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076524|NCT01646177|581669437|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076525|NCT01646177|581669438|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
161076526|NCT01646177|581669439|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
161076527|NCT01646177|581669440|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
161076528|NCT01646177|581669441|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076529|NCT01646177|581669442|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076530|NCT01646177|581669443|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076531|NCT01646177|581669444|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
161076532|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076533|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076534|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076535|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076536|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076537|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076538|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076539|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
161076540|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
161076541|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
161076542|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
161076543|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
161076544|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076545|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076546|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076547|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076548|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076549|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076550|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076551|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
161076552|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
161076553|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
161076554|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
161076555|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
161076556|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076557|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076558|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076559|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076560|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076561|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076562|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076563|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
161076564|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
161076565|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
161076566|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
161076567|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
161076568|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076569|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076570|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076571|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161345753|NCT00695019|582650912|FG002|Overall Study|Protocol Violation|1|||
161345754|NCT00695019|582650910|FG000|Overall Study|Lack of Efficacy|0|||
161345755|NCT00695019|582650911|FG001|Overall Study|Lack of Efficacy|0|||
161345756|NCT00695019|582650912|FG002|Overall Study|Lack of Efficacy|1|||
161158482|NCT02494778|581961056|FG000|Overall Study|Adverse Event|18|||
161158483|NCT02494778|581961056|FG000|Overall Study|Withdrawal by Subject|20|||
161158484|NCT02494778|581961056|FG000|Overall Study|Lost to Follow-up|2|||
161158485|NCT02494778|581961056|FG000|Overall Study|Noncompliant with study drug admin.|1|||
161158486|NCT03621943|581961057|FG000|First Randomized Intervention|Lost to Follow-up|51|||
161158487|NCT03621943|581961058|FG001|First Randomized Intervention|Lost to Follow-up|54|||
161158488|NCT03621943|581961057|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
161158489|NCT03621943|581961058|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
161158490|NCT03621943|581961057|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
161158491|NCT03621943|581961058|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
161158492|NCT03621943|581961057|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
161158493|NCT03621943|581961058|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
161158494|NCT00967226|581961059|FG000|Overall Study|Adverse Event|0|||
161158495|NCT00967226|581961060|FG001|Overall Study|Adverse Event|5|||
161158496|NCT00967226|581961059|FG000|Overall Study|Protocol Violation|2|||
161158497|NCT00967226|581961060|FG001|Overall Study|Protocol Violation|0|||
161158498|NCT00967226|581961059|FG000|Overall Study|Physician Decision|0|||
161158499|NCT00967226|581961060|FG001|Overall Study|Physician Decision|1|||
161158500|NCT02174861|581961061|FG000|Overall Study|Decision by sponsor|8|||
161158501|NCT02174861|581961061|FG000|Overall Study|Withdrawal by Subject|124|||
161158502|NCT02174861|581961061|FG000|Overall Study|Lost to Follow-up|26|||
161158503|NCT01215734|581961062|FG000|Overall Study|Death|0|||
161158504|NCT01215734|581961063|FG001|Overall Study|Death|1|||
161158505|NCT00315705|581961064|FG000|Phase 1|Refused further treatment|1|||
161158506|NCT00315705|581961064|FG000|Phase 1|Failure to achieve response|8|||
161158507|NCT00315705|581961064|FG000|Phase 1|Disease relapse|4|||
161158508|NCT00315705|581961064|FG000|Phase 1|Scheduled for transplant|9|||
161158509|NCT00315705|581961064|FG000|Phase 1|Death|3|||
161158510|NCT00315705|581961064|FG000|Phase 2|Physician Decision|4|||
161158511|NCT00315705|581961064|FG000|Phase 2|Adverse Event|1|||
161158512|NCT00315705|581961064|FG000|Phase 2|Failure to achieve response|3|||
161158513|NCT00315705|581961064|FG000|Phase 2|Disease relapse|1|||
161158514|NCT00315705|581961064|FG000|Phase 2|Scheduled for transplant|8|||
161158515|NCT00315705|581961064|FG000|Phase 2|Other|1|||
161158516|NCT00315705|581961064|FG000|Phase 2|Death|7|||
161158517|NCT01346371|581961065|FG000|Overall Study|Lost to Follow-up|2|||
161158518|NCT01346371|581961066|FG001|Overall Study|Lost to Follow-up|0|||
161158519|NCT01716533|581961067|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
161158520|NCT01716533|581961068|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
161158521|NCT01716533|581961069|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
161158522|NCT01716533|581961070|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
161158523|NCT01716533|581961067|FG000|Overall Study|Withdrawal by Subject|0|||
161158524|NCT01716533|581961068|FG001|Overall Study|Withdrawal by Subject|0|||
161158525|NCT01716533|581961069|FG002|Overall Study|Withdrawal by Subject|0|||
161158526|NCT01716533|581961070|FG003|Overall Study|Withdrawal by Subject|5|||
161158527|NCT01716533|581961067|FG000|Overall Study|Death|0|||
161158528|NCT01716533|581961068|FG001|Overall Study|Death|0|||
161076572|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076573|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076574|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076575|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
161076576|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
161076577|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
161076578|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
161076579|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
161076580|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076581|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076582|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076583|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076584|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161158529|NCT01716533|581961069|FG002|Overall Study|Death|0|||
161158530|NCT01716533|581961070|FG003|Overall Study|Death|2|||
161158531|NCT01716533|581961067|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
161158532|NCT01716533|581961068|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
161158533|NCT01716533|581961069|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
161158534|NCT01716533|581961070|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
161158535|NCT01670656|581961080|FG000|Overall Study|Non-compliance with study drug|0|||
161158536|NCT01670656|581961081|FG001|Overall Study|Non-compliance with study drug|0|||
161158537|NCT01670656|581961082|FG002|Overall Study|Non-compliance with study drug|3|||
161158538|NCT01670656|581961083|FG003|Overall Study|Non-compliance with study drug|0|||
161158539|NCT01670656|581961084|FG004|Overall Study|Non-compliance with study drug|1|||
161076585|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076586|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076587|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
161076588|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
161076589|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
161076590|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
161076591|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
161076592|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076593|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076594|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076595|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076596|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076597|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076598|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076599|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
161076600|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
161076601|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
161076602|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
161076603|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
161076604|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076605|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076606|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076607|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076608|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076609|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076610|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076611|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076612|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
161076613|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
161076614|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
161076615|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
161076616|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076617|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076618|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076619|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076620|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076621|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076622|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076623|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076624|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
161076625|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
161076626|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
161076627|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
161076628|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076629|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076630|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076631|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076632|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076633|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076634|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076635|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076636|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
161076637|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
161076638|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
161076639|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
161076640|NCT01646177|581669433|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076641|NCT01646177|581669434|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076642|NCT01646177|581669435|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076643|NCT01646177|581669436|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076644|NCT01646177|581669437|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076645|NCT01646177|581669438|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076646|NCT01646177|581669439|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076647|NCT01646177|581669440|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076648|NCT01646177|581669441|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076649|NCT01646177|581669442|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
161076650|NCT01646177|581669443|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
161286462|NCT01523002|582428141|FG001|Period 1|Withdrawal by Subject|3|||
161286463|NCT01523002|582428140|FG000|Period 1|Lost to Follow-up|1|||
161076651|NCT01646177|581669444|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
161076652|NCT01038427|581669447|FG000|Overall Study|Lost to follow up|1|||
161076653|NCT01038427|581669448|FG001|Overall Study|Lost to follow up|1|||
161076654|NCT01038427|581669449|FG002|Overall Study|Lost to follow up|0|||
161076655|NCT01038427|581669447|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161076656|NCT01038427|581669448|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
161076657|NCT01038427|581669449|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
161076658|NCT01038427|581669447|FG000|Overall Study|Withdrew consent|0|||
161076659|NCT01038427|581669448|FG001|Overall Study|Withdrew consent|0|||
161076660|NCT01038427|581669449|FG002|Overall Study|Withdrew consent|1|||
161076661|NCT01038427|581669447|FG000|Overall Study|Adverse Event|2|||
161076662|NCT01038427|581669448|FG001|Overall Study|Adverse Event|2|||
161076663|NCT01038427|581669449|FG002|Overall Study|Adverse Event|1|||
161076664|NCT01038427|581669447|FG000|Overall Study|Enrolled in error|0|||
161076665|NCT01038427|581669448|FG001|Overall Study|Enrolled in error|1|||
161076666|NCT01038427|581669449|FG002|Overall Study|Enrolled in error|1|||
161076667|NCT01038427|581669447|FG000|Overall Study|Other|0|||
161076668|NCT01038427|581669448|FG001|Overall Study|Other|2|||
161076669|NCT01038427|581669449|FG002|Overall Study|Other|0|||
161076670|NCT02992691|581669450|FG000|Overall Study|Adverse Event|2|||
161076671|NCT02992691|581669450|FG000|Overall Study|Withdrawal by Subject|1|||
161076672|NCT00588692|581669451|FG000|Overall Study|Withdrawal by Subject|4|||
161076673|NCT00588692|581669452|FG001|Overall Study|Withdrawal by Subject|2|||
161076674|NCT00588692|581669451|FG000|Overall Study|Hip Surgery|0|||
161076675|NCT00588692|581669452|FG001|Overall Study|Hip Surgery|1|||
161076676|NCT00588692|581669451|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
161076677|NCT00588692|581669452|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
161076678|NCT00588692|581669451|FG000|Overall Study|Cancer|1|||
161076679|NCT00588692|581669452|FG001|Overall Study|Cancer|0|||
161076680|NCT00588692|581669451|FG000|Overall Study|Death|1|||
161076681|NCT00588692|581669452|FG001|Overall Study|Death|0|||
161076682|NCT00820170|581669454|FG000|Overall Study|Adverse Event|0|||
161076683|NCT00820170|581669455|FG001|Overall Study|Adverse Event|0|||
161076684|NCT00820170|581669456|FG002|Overall Study|Adverse Event|0|||
161076685|NCT00820170|581669457|FG003|Overall Study|Adverse Event|0|||
161076686|NCT00820170|581669458|FG004|Overall Study|Adverse Event|2|||
161076687|NCT00820170|581669454|FG000|Overall Study|Progressive Disease|0|||
161076688|NCT00820170|581669455|FG001|Overall Study|Progressive Disease|0|||
161076689|NCT00820170|581669456|FG002|Overall Study|Progressive Disease|0|||
161076690|NCT00820170|581669457|FG003|Overall Study|Progressive Disease|0|||
161076691|NCT00820170|581669458|FG004|Overall Study|Progressive Disease|2|||
161076692|NCT03538938|581669459|FG000|Overall Study|Death|0|||
161076693|NCT03538938|581669460|FG001|Overall Study|Death|0|||
161076694|NCT03538938|581669461|FG002|Overall Study|Death|2|||
161076695|NCT03538938|581669462|FG003|Overall Study|Death|0|||
161076696|NCT03538938|581669463|FG004|Overall Study|Death|0|||
161076697|NCT03538938|581669464|FG005|Overall Study|Death|1|||
161076698|NCT03538938|581669465|FG006|Overall Study|Death|0|||
161076699|NCT03538938|581669466|FG007|Overall Study|Death|1|||
161076700|NCT03538938|581669467|FG008|Overall Study|Death|1|||
161076701|NCT03538938|581669468|FG009|Overall Study|Death|1|||
161076702|NCT03538938|581669469|FG010|Overall Study|Death|0|||
161076703|NCT03538938|581669470|FG011|Overall Study|Death|0|||
161076704|NCT03538938|581669471|FG012|Overall Study|Death|1|||
161076705|NCT03538938|581669472|FG013|Overall Study|Death|1|||
161076706|NCT03538938|581669473|FG014|Overall Study|Death|0|||
161076707|NCT03538938|581669474|FG015|Overall Study|Death|1|||
161076708|NCT03538938|581669459|FG000|Overall Study|Withdrawal by Subject|4|||
161076709|NCT03538938|581669460|FG001|Overall Study|Withdrawal by Subject|6|||
161076710|NCT03538938|581669461|FG002|Overall Study|Withdrawal by Subject|5|||
161076711|NCT03538938|581669462|FG003|Overall Study|Withdrawal by Subject|3|||
161076712|NCT03538938|581669463|FG004|Overall Study|Withdrawal by Subject|0|||
161076713|NCT03538938|581669464|FG005|Overall Study|Withdrawal by Subject|0|||
161076714|NCT03538938|581669465|FG006|Overall Study|Withdrawal by Subject|3|||
161076715|NCT03538938|581669466|FG007|Overall Study|Withdrawal by Subject|1|||
161076716|NCT03538938|581669467|FG008|Overall Study|Withdrawal by Subject|5|||
161076717|NCT03538938|581669468|FG009|Overall Study|Withdrawal by Subject|1|||
161076718|NCT03538938|581669469|FG010|Overall Study|Withdrawal by Subject|2|||
161076719|NCT03538938|581669470|FG011|Overall Study|Withdrawal by Subject|1|||
161286464|NCT01523002|582428141|FG001|Period 1|Lost to Follow-up|0|||
161076720|NCT03538938|581669471|FG012|Overall Study|Withdrawal by Subject|3|||
161076721|NCT03538938|581669472|FG013|Overall Study|Withdrawal by Subject|0|||
161286465|NCT01523002|582428140|FG000|Period 1|Adverse Event|0|||
161286466|NCT01523002|582428141|FG001|Period 1|Adverse Event|8|||
161076722|NCT03538938|581669473|FG014|Overall Study|Withdrawal by Subject|2|||
161158540|NCT01670656|581961080|FG000|Overall Study|Pregnancy|0|||
161286467|NCT01523002|582428140|FG000|Period 2|Withdrawal by Subject|4|||
161076723|NCT03538938|581669474|FG015|Overall Study|Withdrawal by Subject|4|||
161076724|NCT03538938|581669459|FG000|Overall Study|Incarcerated|0|||
161076725|NCT03538938|581669460|FG001|Overall Study|Incarcerated|0|||
161076726|NCT03538938|581669461|FG002|Overall Study|Incarcerated|0|||
161076727|NCT03538938|581669462|FG003|Overall Study|Incarcerated|0|||
161076728|NCT03538938|581669463|FG004|Overall Study|Incarcerated|0|||
161076729|NCT03538938|581669464|FG005|Overall Study|Incarcerated|0|||
161076730|NCT03538938|581669465|FG006|Overall Study|Incarcerated|0|||
161076731|NCT03538938|581669466|FG007|Overall Study|Incarcerated|0|||
161076732|NCT03538938|581669467|FG008|Overall Study|Incarcerated|0|||
161076733|NCT03538938|581669468|FG009|Overall Study|Incarcerated|0|||
161076734|NCT03538938|581669469|FG010|Overall Study|Incarcerated|0|||
161076735|NCT03538938|581669470|FG011|Overall Study|Incarcerated|1|||
161076736|NCT03538938|581669471|FG012|Overall Study|Incarcerated|0|||
161076737|NCT03538938|581669472|FG013|Overall Study|Incarcerated|0|||
161076738|NCT03538938|581669473|FG014|Overall Study|Incarcerated|0|||
161076739|NCT03538938|581669474|FG015|Overall Study|Incarcerated|0|||
161076740|NCT00755105|581669475|FG000|Overall Study|Withdrawal by Subject|9|||
161076741|NCT00755105|581669476|FG001|Overall Study|Withdrawal by Subject|11|||
161076742|NCT00755105|581669477|FG002|Overall Study|Withdrawal by Subject|4|||
161076743|NCT03995316|581669478|FG000|Overall Study|Lost to Follow-up|10|||
161076744|NCT03995316|581669479|FG001|Overall Study|Lost to Follow-up|3|||
161076745|NCT02180243|581669480|FG000|Overall Study|Withdrawal by Subject|12|||
161076746|NCT02180243|581669481|FG001|Overall Study|Withdrawal by Subject|12|||
161076747|NCT02180243|581669480|FG000|Overall Study|Lost to Follow-up|12|||
161076748|NCT02180243|581669481|FG001|Overall Study|Lost to Follow-up|2|||
161076749|NCT02202785|581669482|FG000|Overall Study|Study Terminated by Sponsor|1|||
161076750|NCT02202785|581669483|FG001|Overall Study|Study Terminated by Sponsor|6|||
161076751|NCT02202785|581669484|FG002|Overall Study|Study Terminated by Sponsor|4|||
161076752|NCT02202785|581669482|FG000|Overall Study|Withdrawal by Subject|0|||
161076753|NCT02202785|581669483|FG001|Overall Study|Withdrawal by Subject|1|||
161076754|NCT02202785|581669484|FG002|Overall Study|Withdrawal by Subject|0|||
161076755|NCT02202785|581669482|FG000|Overall Study|Lost to Follow-up|0|||
161076756|NCT02202785|581669483|FG001|Overall Study|Lost to Follow-up|1|||
161076757|NCT02202785|581669484|FG002|Overall Study|Lost to Follow-up|0|||
161076758|NCT02202785|581669482|FG000|Overall Study|Reason not Specified|10|||
161076759|NCT02202785|581669483|FG001|Overall Study|Reason not Specified|7|||
161076760|NCT02202785|581669484|FG002|Overall Study|Reason not Specified|13|||
161076761|NCT01137578|581669485|FG000|Overall Study|Participant requested to Discontinue|3|||
161076762|NCT01137578|581669486|FG001|Overall Study|Participant requested to Discontinue|0|||
161076763|NCT01137578|581669487|FG002|Overall Study|Participant requested to Discontinue|0|||
161076764|NCT01137578|581669485|FG000|Overall Study|Withdrawal by Subject|1|||
161076765|NCT01137578|581669486|FG001|Overall Study|Withdrawal by Subject|0|||
161076766|NCT01137578|581669487|FG002|Overall Study|Withdrawal by Subject|0|||
161076767|NCT01137578|581669485|FG000|Overall Study|Other|12|||
161076768|NCT01137578|581669486|FG001|Overall Study|Other|2|||
161076769|NCT01137578|581669487|FG002|Overall Study|Other|6|||
161076770|NCT03651700|581669488|FG000|Overall Study|Withdrawal by Subject|1|||
161076771|NCT03651700|581669489|FG001|Overall Study|Withdrawal by Subject|0|||
161076772|NCT05479734|581669490|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
161076773|NCT05479734|581669491|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
161076774|NCT05479734|581669490|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
161076775|NCT05479734|581669491|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
161076776|NCT05479734|581669490|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
161076777|NCT05479734|581669491|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
161076778|NCT05479734|581669490|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
161076779|NCT05479734|581669491|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
161076780|NCT00664534|581669492|FG000|Overall Study|Adverse Event|2|||
161076781|NCT00664534|581669493|FG001|Overall Study|Adverse Event|3|||
161076782|NCT00664534|581669492|FG000|Overall Study|Lost to Follow-up|6|||
161076783|NCT00664534|581669493|FG001|Overall Study|Lost to Follow-up|10|||
161076784|NCT00664534|581669492|FG000|Overall Study|Protocol Violation|10|||
161076785|NCT00664534|581669493|FG001|Overall Study|Protocol Violation|8|||
161076786|NCT00664534|581669492|FG000|Overall Study|Withdrawal by Subject|7|||
161076787|NCT00664534|581669493|FG001|Overall Study|Withdrawal by Subject|6|||
161076788|NCT00664534|581669492|FG000|Overall Study|Physician Decision|8|||
161076789|NCT00664534|581669493|FG001|Overall Study|Physician Decision|0|||
161076790|NCT00664534|581669492|FG000|Overall Study|Sponsor decision|8|||
161076791|NCT00664534|581669493|FG001|Overall Study|Sponsor decision|6|||
161076792|NCT00935532|581669498|FG000|Overall Study|Adverse Event|11|||
161076793|NCT00935532|581669499|FG001|Overall Study|Adverse Event|6|||
161076794|NCT00935532|581669498|FG000|Overall Study|Death|1|||
161076795|NCT00935532|581669499|FG001|Overall Study|Death|0|||
161076796|NCT00935532|581669498|FG000|Overall Study|Lost to Follow-up|1|||
161076797|NCT00935532|581669499|FG001|Overall Study|Lost to Follow-up|0|||
161076798|NCT00935532|581669498|FG000|Overall Study|Physician Decision|1|||
161076799|NCT00935532|581669499|FG001|Overall Study|Physician Decision|2|||
161076800|NCT00935532|581669498|FG000|Overall Study|Protocol Violation|2|||
161076801|NCT00935532|581669499|FG001|Overall Study|Protocol Violation|1|||
161076802|NCT00935532|581669498|FG000|Overall Study|Subject Decision|2|||
161076803|NCT00935532|581669499|FG001|Overall Study|Subject Decision|1|||
161076804|NCT00935532|581669498|FG000|Overall Study|Sponsor Decision|0|||
161076805|NCT00935532|581669499|FG001|Overall Study|Sponsor Decision|1|||
161076806|NCT00935532|581669498|FG000|Overall Study|Loss Glucose Control|4|||
161076807|NCT00935532|581669499|FG001|Overall Study|Loss Glucose Control|0|||
161076808|NCT01399918|581669500|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
161076809|NCT01436253|581669502|FG000|Overall Study|Lost to Follow-up|182|||
161076810|NCT01436253|581669502|FG000|Overall Study|Not meeting all eligibility criteria|117|||
161076811|NCT03083665|581669504|FG000|Double-Blind Period|Adverse Event|5|||
161076812|NCT03083665|581669505|FG001|Double-Blind Period|Adverse Event|4|||
161076813|NCT03083665|581669506|FG002|Double-Blind Period|Adverse Event|5|||
161076814|NCT03083665|581669507|FG003|Double-Blind Period|Adverse Event|0|||
161076815|NCT03083665|581669508|FG004|Double-Blind Period|Adverse Event|0|||
161076816|NCT03083665|581669509|FG005|Double-Blind Period|Adverse Event|0|||
161076817|NCT03083665|581669504|FG000|Double-Blind Period|Lack of Efficacy|0|||
161076818|NCT03083665|581669505|FG001|Double-Blind Period|Lack of Efficacy|0|||
161076819|NCT03083665|581669506|FG002|Double-Blind Period|Lack of Efficacy|1|||
161076820|NCT03083665|581669507|FG003|Double-Blind Period|Lack of Efficacy|0|||
161076821|NCT03083665|581669508|FG004|Double-Blind Period|Lack of Efficacy|0|||
161076822|NCT03083665|581669509|FG005|Double-Blind Period|Lack of Efficacy|0|||
161076823|NCT03083665|581669504|FG000|Double-Blind Period|Protocol Violation|1|||
161076824|NCT03083665|581669505|FG001|Double-Blind Period|Protocol Violation|0|||
161076825|NCT03083665|581669506|FG002|Double-Blind Period|Protocol Violation|1|||
161076826|NCT03083665|581669507|FG003|Double-Blind Period|Protocol Violation|0|||
161076827|NCT03083665|581669508|FG004|Double-Blind Period|Protocol Violation|0|||
161076828|NCT03083665|581669509|FG005|Double-Blind Period|Protocol Violation|0|||
161076829|NCT03083665|581669504|FG000|Double-Blind Period|Lost to Follow-up|1|||
161076830|NCT03083665|581669505|FG001|Double-Blind Period|Lost to Follow-up|0|||
161076831|NCT03083665|581669506|FG002|Double-Blind Period|Lost to Follow-up|1|||
161076832|NCT03083665|581669507|FG003|Double-Blind Period|Lost to Follow-up|0|||
161076833|NCT03083665|581669508|FG004|Double-Blind Period|Lost to Follow-up|0|||
161076834|NCT03083665|581669509|FG005|Double-Blind Period|Lost to Follow-up|0|||
161076835|NCT03083665|581669504|FG000|Double-Blind Period|Withdrawal by Subject|3|||
161076836|NCT03083665|581669505|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161076837|NCT03083665|581669506|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161076838|NCT03083665|581669507|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161076839|NCT03083665|581669508|FG004|Double-Blind Period|Withdrawal by Subject|0|||
161076840|NCT03083665|581669509|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161076841|NCT03083665|581669504|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
161076842|NCT03083665|581669505|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161076843|NCT03083665|581669506|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161076844|NCT03083665|581669507|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161076845|NCT03083665|581669508|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161076846|NCT03083665|581669509|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
161076847|NCT03083665|581669504|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
161076848|NCT03083665|581669505|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
161076849|NCT03083665|581669506|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
161076850|NCT03083665|581669507|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
161076851|NCT03083665|581669508|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
161076852|NCT03083665|581669509|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
161076853|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161076854|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161076855|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161076856|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
161076857|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161076858|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
161076859|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161076860|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161076861|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161076862|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161076863|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
161076864|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
161076865|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
161076866|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
161076867|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
161076868|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
161076869|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
161076870|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
161076871|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161076872|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161158541|NCT01670656|581961081|FG001|Overall Study|Pregnancy|0|||
161158542|NCT01670656|581961082|FG002|Overall Study|Pregnancy|0|||
161158543|NCT01670656|581961083|FG003|Overall Study|Pregnancy|0|||
161158544|NCT01670656|581961084|FG004|Overall Study|Pregnancy|1|||
161158545|NCT01670656|581961080|FG000|Overall Study|Withdrawal by Subject|1|||
161158546|NCT01670656|581961081|FG001|Overall Study|Withdrawal by Subject|1|||
161158547|NCT01670656|581961082|FG002|Overall Study|Withdrawal by Subject|0|||
161158548|NCT01670656|581961083|FG003|Overall Study|Withdrawal by Subject|0|||
161158549|NCT01670656|581961084|FG004|Overall Study|Withdrawal by Subject|0|||
161158550|NCT01670656|581961080|FG000|Overall Study|Non-compliance with protocol|0|||
161158551|NCT01670656|581961081|FG001|Overall Study|Non-compliance with protocol|3|||
161158552|NCT01670656|581961082|FG002|Overall Study|Non-compliance with protocol|1|||
161158553|NCT01670656|581961083|FG003|Overall Study|Non-compliance with protocol|1|||
161158554|NCT01670656|581961084|FG004|Overall Study|Non-compliance with protocol|2|||
161158555|NCT01670656|581961080|FG000|Overall Study|Adverse Event|2|||
161158556|NCT01670656|581961081|FG001|Overall Study|Adverse Event|2|||
161158557|NCT01670656|581961082|FG002|Overall Study|Adverse Event|2|||
161158558|NCT01670656|581961083|FG003|Overall Study|Adverse Event|3|||
161158559|NCT01670656|581961084|FG004|Overall Study|Adverse Event|3|||
161158560|NCT01670656|581961080|FG000|Overall Study|Subject withdrew consent|0|||
161158561|NCT01670656|581961081|FG001|Overall Study|Subject withdrew consent|1|||
161158562|NCT01670656|581961082|FG002|Overall Study|Subject withdrew consent|2|||
161158563|NCT01670656|581961083|FG003|Overall Study|Subject withdrew consent|1|||
161158564|NCT01670656|581961084|FG004|Overall Study|Subject withdrew consent|1|||
161158565|NCT01670656|581961080|FG000|Overall Study|Lost to Follow-up|0|||
161158566|NCT01670656|581961081|FG001|Overall Study|Lost to Follow-up|0|||
161158567|NCT01670656|581961082|FG002|Overall Study|Lost to Follow-up|0|||
161158568|NCT01670656|581961083|FG003|Overall Study|Lost to Follow-up|0|||
161158569|NCT01670656|581961084|FG004|Overall Study|Lost to Follow-up|3|||
161158570|NCT01670656|581961080|FG000|Overall Study|Subject moved|0|||
161158571|NCT01670656|581961081|FG001|Overall Study|Subject moved|0|||
161158572|NCT01670656|581961082|FG002|Overall Study|Subject moved|0|||
161158573|NCT01670656|581961083|FG003|Overall Study|Subject moved|1|||
161158574|NCT01670656|581961084|FG004|Overall Study|Subject moved|0|||
161158575|NCT00165841|581961085|FG000|Overall Study|Adverse Event|2|||
161158576|NCT00165841|581961086|FG001|Overall Study|Adverse Event|3|||
161158577|NCT00165841|581961085|FG000|Overall Study|Lack of Efficacy|6|||
161158578|NCT00165841|581961086|FG001|Overall Study|Lack of Efficacy|33|||
161158579|NCT00165841|581961085|FG000|Overall Study|Lost to Follow-up|4|||
161158580|NCT00165841|581961086|FG001|Overall Study|Lost to Follow-up|4|||
161158581|NCT00165841|581961085|FG000|Overall Study|Withdrawal by Subject|7|||
161158582|NCT00165841|581961086|FG001|Overall Study|Withdrawal by Subject|8|||
161158583|NCT00165841|581961085|FG000|Overall Study|Physician Decision|1|||
161158584|NCT00165841|581961086|FG001|Overall Study|Physician Decision|0|||
161158585|NCT00165841|581961085|FG000|Overall Study|Protocol Violation|6|||
161158586|NCT00165841|581961086|FG001|Overall Study|Protocol Violation|8|||
161158587|NCT00165841|581961085|FG000|Overall Study|Other|3|||
161158588|NCT00165841|581961086|FG001|Overall Study|Other|5|||
161158589|NCT00165841|581961085|FG000|Overall Study|Medication Noncompliance|1|||
161158590|NCT00165841|581961086|FG001|Overall Study|Medication Noncompliance|1|||
161158591|NCT00789958|581961087|FG000|Overall Study|Adverse Event|3|||
161158592|NCT00789958|581961087|FG000|Overall Study|Withdrawal by Subject|4|||
161158593|NCT00789958|581961087|FG000|Overall Study|Progression|3|||
161158594|NCT00789958|581961087|FG000|Overall Study|not protocol specified|1|||
161158595|NCT00789958|581961087|FG000|Overall Study|Not eligible/not analyzable|26|||
161158596|NCT02622724|581961088|FG000|Overall Study|Death|51|||
161158597|NCT02622724|581961089|FG001|Overall Study|Death|53|||
161158598|NCT02622724|581961088|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
161158599|NCT02622724|581961089|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
161158600|NCT02622724|581961088|FG000|Overall Study|Early termination of study|38|||
161158601|NCT02622724|581961089|FG001|Overall Study|Early termination of study|43|||
161158602|NCT00254293|581961090|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161158603|NCT00254293|581961091|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
161158604|NCT00254293|581961092|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161158605|NCT00254293|581961093|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
161158606|NCT00254293|581961094|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161158607|NCT00254293|581961095|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161158608|NCT00254293|581961096|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
161158609|NCT00254293|581961090|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161158610|NCT00254293|581961091|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161158611|NCT00254293|581961092|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
161158612|NCT00254293|581961093|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161158613|NCT00254293|581961094|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161158614|NCT00254293|581961095|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161158615|NCT00254293|581961096|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
161286468|NCT01523002|582428141|FG001|Period 2|Withdrawal by Subject|1|||
161076873|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161076874|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161076875|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
161076876|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
161076877|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161076878|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161076879|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161076880|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
161076881|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161076882|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
161076883|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161076884|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161076885|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161076886|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161076887|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
161076888|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
161076889|NCT03083665|581669504|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161076890|NCT03083665|581669505|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161076891|NCT03083665|581669506|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161076892|NCT03083665|581669507|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161076893|NCT03083665|581669508|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
161076894|NCT03083665|581669509|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
161076895|NCT02519348|581669510|FG000|Overall Study|Death|31|||
161076896|NCT02519348|581669511|FG001|Overall Study|Death|74|||
161076897|NCT02519348|581669512|FG002|Overall Study|Death|47|||
161076898|NCT02519348|581669513|FG003|Overall Study|Death|54|||
161076899|NCT02519348|581669514|FG004|Overall Study|Death|63|||
161076900|NCT02519348|581669515|FG005|Overall Study|Death|18|||
161076901|NCT02519348|581669516|FG006|Overall Study|Death|2|||
161076902|NCT02519348|581669517|FG007|Overall Study|Death|5|||
161076903|NCT02519348|581669518|FG008|Overall Study|Death|5|||
161076904|NCT02519348|581669510|FG000|Overall Study|Withdrawal by Subject|4|||
161076905|NCT02519348|581669511|FG001|Overall Study|Withdrawal by Subject|7|||
161076906|NCT02519348|581669512|FG002|Overall Study|Withdrawal by Subject|4|||
161076907|NCT02519348|581669513|FG003|Overall Study|Withdrawal by Subject|3|||
161076908|NCT02519348|581669514|FG004|Overall Study|Withdrawal by Subject|3|||
161076909|NCT02519348|581669515|FG005|Overall Study|Withdrawal by Subject|2|||
161076910|NCT02519348|581669516|FG006|Overall Study|Withdrawal by Subject|0|||
161076911|NCT02519348|581669517|FG007|Overall Study|Withdrawal by Subject|0|||
161076912|NCT02519348|581669518|FG008|Overall Study|Withdrawal by Subject|1|||
161076913|NCT02519348|581669510|FG000|Overall Study|Lost to Follow-up|0|||
161076914|NCT02519348|581669511|FG001|Overall Study|Lost to Follow-up|0|||
161076915|NCT02519348|581669512|FG002|Overall Study|Lost to Follow-up|1|||
161076916|NCT02519348|581669513|FG003|Overall Study|Lost to Follow-up|0|||
161076917|NCT02519348|581669514|FG004|Overall Study|Lost to Follow-up|2|||
161076918|NCT02519348|581669515|FG005|Overall Study|Lost to Follow-up|1|||
161076919|NCT02519348|581669516|FG006|Overall Study|Lost to Follow-up|1|||
161076920|NCT02519348|581669517|FG007|Overall Study|Lost to Follow-up|0|||
161076921|NCT02519348|581669518|FG008|Overall Study|Lost to Follow-up|0|||
161076922|NCT02519348|581669510|FG000|Overall Study|Other|0|||
161076923|NCT02519348|581669511|FG001|Overall Study|Other|3|||
161076924|NCT02519348|581669512|FG002|Overall Study|Other|0|||
161076925|NCT02519348|581669513|FG003|Overall Study|Other|0|||
161076926|NCT02519348|581669514|FG004|Overall Study|Other|1|||
161076927|NCT02519348|581669515|FG005|Overall Study|Other|0|||
161076928|NCT02519348|581669516|FG006|Overall Study|Other|0|||
161076929|NCT02519348|581669517|FG007|Overall Study|Other|0|||
161076930|NCT02519348|581669518|FG008|Overall Study|Other|0|||
161076931|NCT02519348|581669510|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
161076932|NCT02519348|581669511|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
161076933|NCT02519348|581669512|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
161076934|NCT02519348|581669513|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
161076935|NCT02519348|581669514|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
161076936|NCT02519348|581669515|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
161076937|NCT02519348|581669516|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
161076938|NCT02519348|581669517|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
161286469|NCT01523002|582428140|FG000|Period 2|Adverse Event|2|||
161076939|NCT02519348|581669518|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
161286470|NCT01523002|582428141|FG001|Period 2|Adverse Event|5|||
161286471|NCT01523002|582428140|FG000|Period 3|Withdrawal by Subject|1|||
161286472|NCT01523002|582428141|FG001|Period 3|Withdrawal by Subject|0|||
161286473|NCT01523002|582428140|FG000|Period 3|Adverse Event|3|||
161286474|NCT01523002|582428141|FG001|Period 3|Adverse Event|0|||
161286475|NCT01256502|582428142|FG000|Overall Study|Had scaffold removed|4|||
161286476|NCT01256502|582428142|FG000|Overall Study|Personal reasons|5|||
161076940|NCT04103892|581669524|FG000|Overall Study|Adverse Event|0|||
161076941|NCT04103892|581669525|FG001|Overall Study|Adverse Event|0|||
161076942|NCT04103892|581669526|FG002|Overall Study|Adverse Event|0|||
161076943|NCT04103892|581669527|FG003|Overall Study|Adverse Event|3|||
161076944|NCT04103892|581669524|FG000|Overall Study|Lost to Follow-up|0|||
161076945|NCT04103892|581669525|FG001|Overall Study|Lost to Follow-up|0|||
161076946|NCT04103892|581669526|FG002|Overall Study|Lost to Follow-up|2|||
161076947|NCT04103892|581669527|FG003|Overall Study|Lost to Follow-up|0|||
161076948|NCT04103892|581669524|FG000|Overall Study|Protocol Violation|0|||
161076949|NCT04103892|581669525|FG001|Overall Study|Protocol Violation|0|||
161076950|NCT04103892|581669526|FG002|Overall Study|Protocol Violation|1|||
161076951|NCT04103892|581669527|FG003|Overall Study|Protocol Violation|1|||
161076952|NCT04103892|581669524|FG000|Overall Study|Withdrawal by Subject|1|||
161076953|NCT04103892|581669525|FG001|Overall Study|Withdrawal by Subject|0|||
161076954|NCT04103892|581669526|FG002|Overall Study|Withdrawal by Subject|2|||
161076955|NCT04103892|581669527|FG003|Overall Study|Withdrawal by Subject|5|||
161076956|NCT04103892|581669524|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
161076957|NCT04103892|581669525|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
161076958|NCT04103892|581669526|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
161076959|NCT04103892|581669527|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
161076960|NCT05576662|581669528|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
161076961|NCT05576662|581669529|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
161076962|NCT05576662|581669528|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
161076963|NCT05576662|581669529|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
161076964|NCT05576662|581669528|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
161076965|NCT05576662|581669529|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
161076966|NCT05576662|581669528|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
161076967|NCT05576662|581669529|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
161076968|NCT00281320|581669532|FG000|Overall Study|Adverse Event|12|||
161076969|NCT00281320|581669533|FG001|Overall Study|Adverse Event|9|||
161076970|NCT00281320|581669532|FG000|Overall Study|Lack of Efficacy|4|||
161076971|NCT00281320|581669533|FG001|Overall Study|Lack of Efficacy|3|||
161076972|NCT00281320|581669532|FG000|Overall Study|Withdrawal by Subject|5|||
161076973|NCT00281320|581669533|FG001|Overall Study|Withdrawal by Subject|6|||
161076974|NCT00281320|581669532|FG000|Overall Study|Lost to Follow-up|1|||
161076975|NCT00281320|581669533|FG001|Overall Study|Lost to Follow-up|2|||
161076976|NCT00281320|581669532|FG000|Overall Study|Other|3|||
161076977|NCT00281320|581669533|FG001|Overall Study|Other|1|||
161076978|NCT03008005|581669534|FG000|Overall Study|Physician Decision|1|||
161076979|NCT03008005|581669535|FG001|Overall Study|Physician Decision|0|||
161076980|NCT03008005|581669536|FG002|Overall Study|Physician Decision|0|||
161076981|NCT03008005|581669534|FG000|Overall Study|Withdrawal by Subject|1|||
161076982|NCT03008005|581669535|FG001|Overall Study|Withdrawal by Subject|0|||
161076983|NCT03008005|581669536|FG002|Overall Study|Withdrawal by Subject|0|||
161076984|NCT03008005|581669534|FG000|Overall Study|Ineligible|0|||
161076985|NCT03008005|581669535|FG001|Overall Study|Ineligible|1|||
161076986|NCT03008005|581669536|FG002|Overall Study|Ineligible|0|||
161076987|NCT00475228|581669538|FG000|Overall Study|Lost to Follow-up|17|||
161076988|NCT00475228|581669539|FG001|Overall Study|Lost to Follow-up|17|||
161076989|NCT03633799|581669547|FG000|Overall Study|Adverse Event|349|||
161076990|NCT03633799|581669547|FG000|Overall Study|Withdrawal by Subject|288|||
161076991|NCT03633799|581669547|FG000|Overall Study|Lost to Follow-up|97|||
161076992|NCT03633799|581669547|FG000|Overall Study|Physician Decision|9|||
161076993|NCT03633799|581669547|FG000|Overall Study|Protocol Violation|4|||
161076994|NCT03633799|581669547|FG000|Overall Study|Pregnancy|20|||
161076995|NCT03633799|581669547|FG000|Overall Study|other|39|||
161286477|NCT01256502|582428142|FG000|Overall Study|Protocol deviation|1|||
161076996|NCT03633799|581669547|FG000|Overall Study|ongoing within third year of study|106|||
161076997|NCT03633799|581669547|FG000|Overall Study|unsuccessful study drug placement|19|||
161076998|NCT05855967|581669548|FG000|Overall Study|Withdrawal by Subject|7|||
161076999|NCT05855967|581669549|FG001|Overall Study|Withdrawal by Subject|5|||
161077000|NCT05855967|581669548|FG000|Overall Study|Lost to Follow-up|2|||
161077001|NCT05855967|581669549|FG001|Overall Study|Lost to Follow-up|1|||
161077002|NCT02446821|581669550|FG000|Overall Study|Adverse Event|28|||
161077003|NCT02446821|581669550|FG000|Overall Study|Withdrawal by Subject|6|||
161077004|NCT02446821|581669550|FG000|Overall Study|Lost to Follow-up|22|||
161077005|NCT02446821|581669550|FG000|Overall Study|other|9|||
161077006|NCT02446821|581669550|FG000|Overall Study|insertion failure|3|||
161077007|NCT02284009|581669554|FG000|Overall Study|Adverse Event|3|||
161286478|NCT03953612|582428143|FG000|Overall Study|Randomized but did not start|1|||
161286479|NCT03953612|582428144|FG001|Overall Study|Randomized but did not start|1|||
161345757|NCT00695019|582650910|FG000|Overall Study|Various|4|||
161345758|NCT00695019|582650911|FG001|Overall Study|Various|5|||
161345759|NCT00695019|582650912|FG002|Overall Study|Various|4|||
161345760|NCT01564407|582650921|FG000|Overall Study|Lost to Follow-up|0|||
161345761|NCT01564407|582650922|FG001|Overall Study|Lost to Follow-up|1|||
161345762|NCT01564407|582650923|FG002|Overall Study|Lost to Follow-up|0|||
161345763|NCT01564407|582650924|FG003|Overall Study|Lost to Follow-up|0|||
161345764|NCT01564407|582650925|FG004|Overall Study|Lost to Follow-up|0|||
161345765|NCT01564407|582650921|FG000|Overall Study|Withdrawal by Subject|0|||
161345766|NCT01564407|582650922|FG001|Overall Study|Withdrawal by Subject|1|||
161345767|NCT01564407|582650923|FG002|Overall Study|Withdrawal by Subject|0|||
161345768|NCT01564407|582650924|FG003|Overall Study|Withdrawal by Subject|0|||
161345769|NCT01564407|582650925|FG004|Overall Study|Withdrawal by Subject|0|||
161345770|NCT01564407|582650921|FG000|Overall Study|funding lost, study ended|0|||
161345771|NCT01564407|582650922|FG001|Overall Study|funding lost, study ended|0|||
161345772|NCT01564407|582650923|FG002|Overall Study|funding lost, study ended|0|||
161345773|NCT01564407|582650924|FG003|Overall Study|funding lost, study ended|1|||
161345774|NCT01564407|582650925|FG004|Overall Study|funding lost, study ended|0|||
161345775|NCT01723774|582650927|FG000|Neoadjuvant|Ki67 > 10%|4|||
161345776|NCT01723774|582650928|FG001|Neoadjuvant|Ki67 > 10%|0|||
161345777|NCT01723774|582650929|FG002|Neoadjuvant|Ki67 > 10%|10|||
161345778|NCT01723774|582650930|FG003|Neoadjuvant|Ki67 > 10%|0|||
161345779|NCT01723774|582650927|FG000|Neoadjuvant|Withdrawal by Subject|3|||
161345780|NCT01723774|582650928|FG001|Neoadjuvant|Withdrawal by Subject|1|||
161345781|NCT01723774|582650929|FG002|Neoadjuvant|Withdrawal by Subject|0|||
161345782|NCT01723774|582650930|FG003|Neoadjuvant|Withdrawal by Subject|0|||
161345783|NCT01723774|582650927|FG000|Neoadjuvant|Disease progression|0|||
161345784|NCT01723774|582650928|FG001|Neoadjuvant|Disease progression|1|||
161345785|NCT01723774|582650929|FG002|Neoadjuvant|Disease progression|1|||
161345786|NCT01723774|582650930|FG003|Neoadjuvant|Disease progression|0|||
161345787|NCT01723774|582650927|FG000|Neoadjuvant|Adverse Event|0|||
161345788|NCT01723774|582650928|FG001|Neoadjuvant|Adverse Event|1|||
161345789|NCT01723774|582650929|FG002|Neoadjuvant|Adverse Event|2|||
161345790|NCT01723774|582650930|FG003|Neoadjuvant|Adverse Event|0|||
161345791|NCT01723774|582650927|FG000|Neoadjuvant|High estradiol|0|||
161345792|NCT01723774|582650928|FG001|Neoadjuvant|High estradiol|1|||
161345793|NCT01723774|582650929|FG002|Neoadjuvant|High estradiol|0|||
161345794|NCT01723774|582650930|FG003|Neoadjuvant|High estradiol|0|||
161345795|NCT04967222|582650933|FG000|Randomized|Lost to Follow-up|0|||
161286480|NCT03953612|582428145|FG002|Overall Study|Randomized but did not start|1|||
161286481|NCT03953612|582428143|FG000|Overall Study|Withdrawal by Subject|2|||
161286482|NCT03953612|582428144|FG001|Overall Study|Withdrawal by Subject|1|||
161286483|NCT03953612|582428145|FG002|Overall Study|Withdrawal by Subject|0|||
161286484|NCT00489255|582428146|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
161286485|NCT00489255|582428147|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
161286486|NCT00489255|582428146|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
161286487|NCT00489255|582428147|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
161286488|NCT00489255|582428146|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
161286489|NCT00489255|582428147|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
161345796|NCT04967222|582650934|FG001|Randomized|Lost to Follow-up|1|||
161345797|NCT04967222|582650935|FG002|Randomized|Lost to Follow-up|1|||
161345798|NCT04967222|582650933|FG000|Randomized|Physician Decision|0|||
161345799|NCT04967222|582650934|FG001|Randomized|Physician Decision|0|||
161345800|NCT04967222|582650935|FG002|Randomized|Physician Decision|1|||
161345801|NCT04967222|582650933|FG000|Randomized|Withdrawal by Subject|0|||
161286490|NCT00489255|582428146|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
161286491|NCT00489255|582428147|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
161345802|NCT04967222|582650934|FG001|Randomized|Withdrawal by Subject|0|||
161345803|NCT04967222|582650935|FG002|Randomized|Withdrawal by Subject|2|||
161345804|NCT04967222|582650933|FG000|Randomized|abnormal finding in MRI|0|||
161345805|NCT04967222|582650934|FG001|Randomized|abnormal finding in MRI|2|||
161345806|NCT04967222|582650935|FG002|Randomized|abnormal finding in MRI|0|||
161345807|NCT02629159|582650936|FG000|Overall Study|Adverse Event|17|||
161345808|NCT02629159|582650937|FG001|Overall Study|Adverse Event|20|||
161345809|NCT02629159|582650938|FG002|Overall Study|Adverse Event|22|||
161345810|NCT02629159|582650936|FG000|Overall Study|Withdrawal by Subject|22|||
161345811|NCT02629159|582650937|FG001|Overall Study|Withdrawal by Subject|11|||
161345812|NCT02629159|582650938|FG002|Overall Study|Withdrawal by Subject|15|||
161345813|NCT02629159|582650936|FG000|Overall Study|Lost to Follow-up|7|||
161345814|NCT02629159|582650937|FG001|Overall Study|Lost to Follow-up|4|||
161345815|NCT02629159|582650938|FG002|Overall Study|Lost to Follow-up|5|||
161345816|NCT02629159|582650936|FG000|Overall Study|Lack of Efficacy|4|||
161345817|NCT02629159|582650937|FG001|Overall Study|Lack of Efficacy|0|||
161345818|NCT02629159|582650938|FG002|Overall Study|Lack of Efficacy|1|||
161345819|NCT02629159|582650936|FG000|Overall Study|Other|6|||
161345820|NCT02629159|582650937|FG001|Overall Study|Other|4|||
161345821|NCT02629159|582650938|FG002|Overall Study|Other|8|||
161345822|NCT05722015|582650940|FG000|Overall Study|Death|57|||
161345823|NCT05722015|582650941|FG001|Overall Study|Death|37|||
161077008|NCT02284009|581669555|FG001|Overall Study|Adverse Event|0|||
161077009|NCT02284009|581669554|FG000|Overall Study|Lost to Follow-up|1|||
161077010|NCT02284009|581669555|FG001|Overall Study|Lost to Follow-up|3|||
161077011|NCT02284009|581669554|FG000|Overall Study|Physician Decision|0|||
161077012|NCT02284009|581669555|FG001|Overall Study|Physician Decision|2|||
161077013|NCT02284009|581669554|FG000|Overall Study|Withdrawal by Subject|2|||
161077014|NCT02284009|581669555|FG001|Overall Study|Withdrawal by Subject|5|||
161077015|NCT04147195|581669556|FG000|Overall Study|Adverse Event|0|||
161077016|NCT04147195|581669557|FG001|Overall Study|Adverse Event|3|||
161077017|NCT04147195|581669556|FG000|Overall Study|Study Terminated by Sponsor|4|||
161077018|NCT04147195|581669557|FG001|Overall Study|Study Terminated by Sponsor|2|||
161077019|NCT04147195|581669556|FG000|Overall Study|Withdrawal by Subject|0|||
161077020|NCT04147195|581669557|FG001|Overall Study|Withdrawal by Subject|1|||
161077021|NCT03841526|581669558|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
161077022|NCT03841526|581669559|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161077023|NCT03841526|581669560|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161077024|NCT03841526|581669561|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
161077025|NCT03841526|581669562|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161077026|NCT03841526|581669563|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
161077027|NCT03841526|581669558|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
161077028|NCT03841526|581669559|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
161077029|NCT03841526|581669560|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
161077030|NCT03841526|581669561|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
161077031|NCT03841526|581669562|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
161077032|NCT03841526|581669563|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
161077033|NCT03841526|581669558|FG000|Outpatient Phase Treatment|Physician Decision|0|||
161077034|NCT03841526|581669559|FG001|Outpatient Phase Treatment|Physician Decision|1|||
161077035|NCT03841526|581669560|FG002|Outpatient Phase Treatment|Physician Decision|0|||
161077036|NCT03841526|581669561|FG003|Outpatient Phase Treatment|Physician Decision|0|||
161077037|NCT03841526|581669562|FG004|Outpatient Phase Treatment|Physician Decision|0|||
161077038|NCT03841526|581669563|FG005|Outpatient Phase Treatment|Physician Decision|0|||
161077039|NCT03841526|581669558|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161077040|NCT03841526|581669559|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161077041|NCT03841526|581669560|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
161286492|NCT00489255|582428146|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
161286493|NCT00489255|582428147|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
161286494|NCT00489255|582428146|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
161286495|NCT00489255|582428147|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
161286496|NCT00489255|582428146|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
161286497|NCT00489255|582428147|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
161286498|NCT00489255|582428146|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
161286499|NCT00489255|582428147|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
161077042|NCT03841526|581669561|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161077043|NCT03841526|581669562|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
161077044|NCT03841526|581669563|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
161077045|NCT01876082|581671947|FG000|Overall Study|Withdrawal by Subject|0|||
161077046|NCT01876082|581671948|FG001|Overall Study|Withdrawal by Subject|2|||
161077047|NCT01876082|581671947|FG000|Overall Study|Protocol Violation|1|||
161077048|NCT01876082|581671948|FG001|Overall Study|Protocol Violation|0|||
161077049|NCT01876082|581671947|FG000|Overall Study|Adverse Event|1|||
161077050|NCT01876082|581671948|FG001|Overall Study|Adverse Event|1|||
161077051|NCT01876082|581671947|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
161077052|NCT01876082|581671948|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
161077053|NCT03829501|581671959|FG000|Overall Study|Withdrawal of Consent|2|||
161077054|NCT03829501|581671960|FG001|Overall Study|Withdrawal of Consent|0|||
161077055|NCT03829501|581671961|FG002|Overall Study|Withdrawal of Consent|3|||
161077056|NCT03829501|581671962|FG003|Overall Study|Withdrawal of Consent|0|||
161077057|NCT03829501|581671963|FG004|Overall Study|Withdrawal of Consent|1|||
161077058|NCT03829501|581671964|FG005|Overall Study|Withdrawal of Consent|1|||
161077059|NCT03829501|581671965|FG006|Overall Study|Withdrawal of Consent|0|||
161077060|NCT03829501|581671966|FG007|Overall Study|Withdrawal of Consent|10|||
161077061|NCT03829501|581671967|FG008|Overall Study|Withdrawal of Consent|10|||
161077062|NCT03829501|581671968|FG009|Overall Study|Withdrawal of Consent|3|||
161077063|NCT03829501|581671969|FG010|Overall Study|Withdrawal of Consent|4|||
161077064|NCT03829501|581671970|FG011|Overall Study|Withdrawal of Consent|4|||
161077065|NCT03829501|581671971|FG012|Overall Study|Withdrawal of Consent|4|||
161077066|NCT03829501|581671972|FG013|Overall Study|Withdrawal of Consent|0|||
161077067|NCT03829501|581671973|FG014|Overall Study|Withdrawal of Consent|3|||
161077068|NCT03829501|581671974|FG015|Overall Study|Withdrawal of Consent|0|||
161077069|NCT03829501|581671975|FG016|Overall Study|Withdrawal of Consent|1|||
161077070|NCT03829501|581671976|FG017|Overall Study|Withdrawal of Consent|1|||
161077071|NCT03829501|581671977|FG018|Overall Study|Withdrawal of Consent|0|||
161077072|NCT03829501|581671978|FG019|Overall Study|Withdrawal of Consent|0|||
161345824|NCT05722015|582650940|FG000|Overall Study|Lost to Follow-up|1|||
161345825|NCT05722015|582650941|FG001|Overall Study|Lost to Follow-up|0|||
161345826|NCT05722015|582650940|FG000|Overall Study|Withdrawal by Subject|5|||
161345827|NCT05722015|582650941|FG001|Overall Study|Withdrawal by Subject|1|||
161345828|NCT05722015|582650940|FG000|Overall Study|Participants Ongoing|188|||
161345829|NCT05722015|582650941|FG001|Overall Study|Participants Ongoing|88|||
161345830|NCT01802281|582650944|FG000|Overall Study|Death|1|||
161345831|NCT01802281|582650945|FG001|Overall Study|Death|2|||
161345832|NCT01802281|582650944|FG000|Overall Study|Withdrawal by Subject|2|||
161345833|NCT01802281|582650945|FG001|Overall Study|Withdrawal by Subject|1|||
161345834|NCT01802281|582650944|FG000|Overall Study|Ineligible|5|||
161345835|NCT01802281|582650945|FG001|Overall Study|Ineligible|3|||
161345836|NCT02685735|582650946|FG000|Overall Study|Surgery Cancelled|4|||
161345837|NCT02685735|582650947|FG001|Overall Study|Surgery Cancelled|9|||
161345838|NCT02685735|582650946|FG000|Overall Study|Adverse Event|10|||
161345839|NCT02685735|582650947|FG001|Overall Study|Adverse Event|3|||
161345840|NCT02685735|582650946|FG000|Overall Study|Preop testing found to be incomplete|2|||
161345841|NCT02685735|582650947|FG001|Overall Study|Preop testing found to be incomplete|2|||
161345842|NCT02685735|582650946|FG000|Overall Study|Withdrawal by Subject|1|||
161345843|NCT02685735|582650947|FG001|Overall Study|Withdrawal by Subject|2|||
161345844|NCT02685735|582650946|FG000|Overall Study|Death|1|||
161345845|NCT02685735|582650947|FG001|Overall Study|Death|0|||
161345846|NCT05020743|582650948|FG000|Overall Study|Enrollment in Interventional Study|2|||
161345847|NCT05020743|582650949|FG001|Overall Study|Enrollment in Interventional Study|9|||
161345848|NCT05020743|582650950|FG002|Overall Study|Enrollment in Interventional Study|0|||
161345849|NCT05020743|582650948|FG000|Overall Study|Withdrawal by Subject|0|||
161345850|NCT05020743|582650949|FG001|Overall Study|Withdrawal by Subject|3|||
161345851|NCT05020743|582650950|FG002|Overall Study|Withdrawal by Subject|1|||
161345852|NCT05020743|582650948|FG000|Overall Study|Lost to Follow-up|1|||
161345853|NCT05020743|582650949|FG001|Overall Study|Lost to Follow-up|0|||
161345854|NCT05020743|582650950|FG002|Overall Study|Lost to Follow-up|0|||
161345855|NCT05020743|582650948|FG000|Overall Study|Study Termination by Sponsor|10|||
161345856|NCT05020743|582650949|FG001|Overall Study|Study Termination by Sponsor|11|||
161345857|NCT05020743|582650950|FG002|Overall Study|Study Termination by Sponsor|10|||
161345858|NCT03488524|582650951|FG000|Overall Study|Withdrawal by Subject|51|||
161345859|NCT03488524|582650951|FG000|Overall Study|Death|19|||
161345860|NCT03488524|582650951|FG000|Overall Study|Study Sponsor|11|||
161345861|NCT03488524|582650951|FG000|Overall Study|Physician Decision|4|||
161345862|NCT03488524|582650951|FG000|Overall Study|Lost to Follow-up|3|||
161345863|NCT02003924|582650952|FG000|Double-blind Phase|Lost to Follow-up|2|||
161345864|NCT02003924|582650953|FG001|Double-blind Phase|Lost to Follow-up|1|||
161345865|NCT02003924|582650954|FG002|Double-blind Phase|Lost to Follow-up|0|||
161345866|NCT02003924|582650952|FG000|Double-blind Phase|Protocol Violation|1|||
161345867|NCT02003924|582650953|FG001|Double-blind Phase|Protocol Violation|2|||
161345868|NCT02003924|582650954|FG002|Double-blind Phase|Protocol Violation|0|||
161345869|NCT02003924|582650952|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
161345870|NCT02003924|582650953|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
161345871|NCT02003924|582650954|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
161345872|NCT02003924|582650952|FG000|Double-blind Phase|Disease Progression|229|||
161345873|NCT02003924|582650953|FG001|Double-blind Phase|Disease Progression|247|||
161345874|NCT02003924|582650954|FG002|Double-blind Phase|Disease Progression|0|||
161345875|NCT02003924|582650952|FG000|Double-blind Phase|Adverse Event|120|||
161345876|NCT02003924|582650953|FG001|Double-blind Phase|Adverse Event|31|||
161345877|NCT02003924|582650954|FG002|Double-blind Phase|Adverse Event|0|||
161345878|NCT02003924|582650952|FG000|Double-blind Phase|Randomized But not Treated|3|||
161345879|NCT02003924|582650953|FG001|Double-blind Phase|Randomized But not Treated|3|||
161345880|NCT02003924|582650954|FG002|Double-blind Phase|Randomized But not Treated|0|||
161345881|NCT02003924|582650952|FG000|Double-blind Phase|Other|29|||
161345882|NCT02003924|582650953|FG001|Double-blind Phase|Other|50|||
161345883|NCT02003924|582650954|FG002|Double-blind Phase|Other|0|||
161345884|NCT02003924|582650952|FG000|Open-label Phase|Lost to Follow-up|0|||
161345885|NCT02003924|582650953|FG001|Open-label Phase|Lost to Follow-up|0|||
161345886|NCT02003924|582650954|FG002|Open-label Phase|Lost to Follow-up|1|||
161345887|NCT02003924|582650952|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
161345888|NCT02003924|582650953|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
161345889|NCT02003924|582650954|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
161345890|NCT02003924|582650952|FG000|Open-label Phase|Disease Progression|59|||
161345891|NCT02003924|582650953|FG001|Open-label Phase|Disease Progression|0|||
161345892|NCT02003924|582650954|FG002|Open-label Phase|Disease Progression|5|||
161345893|NCT02003924|582650952|FG000|Open-label Phase|Adverse Event|25|||
161345894|NCT02003924|582650953|FG001|Open-label Phase|Adverse Event|0|||
161345895|NCT02003924|582650954|FG002|Open-label Phase|Adverse Event|10|||
161345896|NCT02003924|582650952|FG000|Open-label Phase|Other|7|||
161345897|NCT02003924|582650953|FG001|Open-label Phase|Other|0|||
161345898|NCT02003924|582650954|FG002|Open-label Phase|Other|0|||
161345899|NCT02003924|582650952|FG000|Long-term Follow-up Phase|Death|288|||
161286500|NCT00489255|582428146|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
161286501|NCT00489255|582428147|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
161286502|NCT00489255|582428146|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
161286503|NCT00489255|582428147|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
161286504|NCT03485352|582428148|FG000|Overall Study|Lost to Follow-up|9|||
161077073|NCT03829501|581671979|FG020|Overall Study|Withdrawal of Consent|3|||
161077074|NCT03829501|581671980|FG021|Overall Study|Withdrawal of Consent|0|||
161077075|NCT03829501|581671981|FG022|Overall Study|Withdrawal of Consent|1|||
161077076|NCT03829501|581671959|FG000|Overall Study|PD|0|||
161077077|NCT03829501|581671960|FG001|Overall Study|PD|0|||
161077078|NCT03829501|581671961|FG002|Overall Study|PD|0|||
161077079|NCT03829501|581671962|FG003|Overall Study|PD|2|||
161077080|NCT03829501|581671963|FG004|Overall Study|PD|0|||
161077081|NCT03829501|581671964|FG005|Overall Study|PD|0|||
161077082|NCT03829501|581671965|FG006|Overall Study|PD|0|||
161077083|NCT03829501|581671966|FG007|Overall Study|PD|0|||
161077084|NCT03829501|581671967|FG008|Overall Study|PD|0|||
161077085|NCT03829501|581671968|FG009|Overall Study|PD|0|||
161077086|NCT03829501|581671969|FG010|Overall Study|PD|0|||
161077087|NCT03829501|581671970|FG011|Overall Study|PD|0|||
161077088|NCT03829501|581671971|FG012|Overall Study|PD|0|||
161077089|NCT03829501|581671972|FG013|Overall Study|PD|0|||
161077090|NCT03829501|581671973|FG014|Overall Study|PD|0|||
161077091|NCT03829501|581671974|FG015|Overall Study|PD|1|||
161077092|NCT03829501|581671975|FG016|Overall Study|PD|0|||
161077093|NCT03829501|581671976|FG017|Overall Study|PD|0|||
161077094|NCT03829501|581671977|FG018|Overall Study|PD|0|||
161077095|NCT03829501|581671978|FG019|Overall Study|PD|0|||
161077096|NCT03829501|581671979|FG020|Overall Study|PD|1|||
161077097|NCT03829501|581671980|FG021|Overall Study|PD|0|||
161077098|NCT03829501|581671981|FG022|Overall Study|PD|0|||
161077099|NCT03829501|581671959|FG000|Overall Study|Study Terminated by Sponsor|0|||
161077100|NCT03829501|581671960|FG001|Overall Study|Study Terminated by Sponsor|0|||
161077101|NCT03829501|581671961|FG002|Overall Study|Study Terminated by Sponsor|0|||
161077102|NCT03829501|581671962|FG003|Overall Study|Study Terminated by Sponsor|0|||
161077103|NCT03829501|581671963|FG004|Overall Study|Study Terminated by Sponsor|0|||
161077104|NCT03829501|581671964|FG005|Overall Study|Study Terminated by Sponsor|0|||
161077105|NCT03829501|581671965|FG006|Overall Study|Study Terminated by Sponsor|0|||
161077106|NCT03829501|581671966|FG007|Overall Study|Study Terminated by Sponsor|3|||
161077107|NCT03829501|581671967|FG008|Overall Study|Study Terminated by Sponsor|1|||
161077108|NCT03829501|581671968|FG009|Overall Study|Study Terminated by Sponsor|0|||
161077109|NCT03829501|581671969|FG010|Overall Study|Study Terminated by Sponsor|0|||
161077110|NCT03829501|581671970|FG011|Overall Study|Study Terminated by Sponsor|0|||
161077111|NCT03829501|581671971|FG012|Overall Study|Study Terminated by Sponsor|0|||
161077112|NCT03829501|581671972|FG013|Overall Study|Study Terminated by Sponsor|0|||
161077113|NCT03829501|581671973|FG014|Overall Study|Study Terminated by Sponsor|3|||
161077114|NCT03829501|581671974|FG015|Overall Study|Study Terminated by Sponsor|2|||
161077115|NCT03829501|581671975|FG016|Overall Study|Study Terminated by Sponsor|2|||
161077116|NCT03829501|581671976|FG017|Overall Study|Study Terminated by Sponsor|0|||
161077117|NCT03829501|581671977|FG018|Overall Study|Study Terminated by Sponsor|0|||
161077118|NCT03829501|581671978|FG019|Overall Study|Study Terminated by Sponsor|0|||
161077119|NCT03829501|581671979|FG020|Overall Study|Study Terminated by Sponsor|1|||
161077120|NCT03829501|581671980|FG021|Overall Study|Study Terminated by Sponsor|0|||
161077121|NCT03829501|581671981|FG022|Overall Study|Study Terminated by Sponsor|3|||
161077122|NCT03829501|581671959|FG000|Overall Study|Lost to Follow Up|0|||
161077123|NCT03829501|581671960|FG001|Overall Study|Lost to Follow Up|0|||
161077124|NCT03829501|581671961|FG002|Overall Study|Lost to Follow Up|0|||
161077125|NCT03829501|581671962|FG003|Overall Study|Lost to Follow Up|0|||
161077126|NCT03829501|581671963|FG004|Overall Study|Lost to Follow Up|1|||
161077127|NCT03829501|581671964|FG005|Overall Study|Lost to Follow Up|0|||
161077128|NCT03829501|581671965|FG006|Overall Study|Lost to Follow Up|0|||
161077129|NCT03829501|581671966|FG007|Overall Study|Lost to Follow Up|2|||
161077130|NCT03829501|581671967|FG008|Overall Study|Lost to Follow Up|2|||
161077131|NCT03829501|581671968|FG009|Overall Study|Lost to Follow Up|0|||
161077132|NCT03829501|581671969|FG010|Overall Study|Lost to Follow Up|2|||
161077133|NCT03829501|581671970|FG011|Overall Study|Lost to Follow Up|1|||
161077134|NCT03829501|581671971|FG012|Overall Study|Lost to Follow Up|0|||
161077135|NCT03829501|581671972|FG013|Overall Study|Lost to Follow Up|1|||
161077136|NCT03829501|581671973|FG014|Overall Study|Lost to Follow Up|1|||
161077137|NCT03829501|581671974|FG015|Overall Study|Lost to Follow Up|0|||
161286505|NCT05655546|582429754|FG000|Overall Study|Withdrawal by Subject|2|||
161077138|NCT03829501|581671975|FG016|Overall Study|Lost to Follow Up|0|||
161077139|NCT03829501|581671976|FG017|Overall Study|Lost to Follow Up|0|||
161077140|NCT03829501|581671977|FG018|Overall Study|Lost to Follow Up|0|||
161077141|NCT03829501|581671978|FG019|Overall Study|Lost to Follow Up|0|||
161077142|NCT03829501|581671979|FG020|Overall Study|Lost to Follow Up|0|||
161077143|NCT03829501|581671980|FG021|Overall Study|Lost to Follow Up|0|||
161077144|NCT03829501|581671981|FG022|Overall Study|Lost to Follow Up|1|||
161077145|NCT03829501|581671959|FG000|Overall Study|Death|2|||
161077146|NCT03829501|581671960|FG001|Overall Study|Death|4|||
161077147|NCT03829501|581671961|FG002|Overall Study|Death|5|||
161077148|NCT03829501|581671962|FG003|Overall Study|Death|6|||
161077149|NCT03829501|581671963|FG004|Overall Study|Death|5|||
161158616|NCT00254293|581961090|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161158617|NCT00254293|581961091|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161286506|NCT05655546|582429755|FG001|Overall Study|Withdrawal by Subject|4|||
161286507|NCT03493685|582429756|FG000|Overall Study|Death|4|||
161286508|NCT03493685|582429757|FG001|Overall Study|Death|3|||
161286509|NCT03493685|582429756|FG000|Overall Study|Lost to Follow-up|3|||
161286510|NCT03493685|582429757|FG001|Overall Study|Lost to Follow-up|2|||
161286511|NCT03493685|582429756|FG000|Overall Study|Physician Decision|2|||
161286512|NCT03493685|582429757|FG001|Overall Study|Physician Decision|0|||
161286513|NCT03493685|582429756|FG000|Overall Study|Withdrawal by Subject|7|||
161286514|NCT03493685|582429757|FG001|Overall Study|Withdrawal by Subject|11|||
161286515|NCT04452669|582429758|FG000|Overall Study|Death|1|||
161286516|NCT04452669|582429759|FG001|Overall Study|Death|4|||
161286517|NCT04576507|582429763|FG000|Overall Study|Adverse Event|4|||
161286518|NCT04576507|582429763|FG000|Overall Study|Withdrawal by Subject|1|||
161286519|NCT00413699|582429764|FG000|Initial Period|Death|25|||
161286520|NCT00413699|582429765|FG001|Initial Period|Death|30|||
161286521|NCT00413699|582429766|FG002|Initial Period|Death|0|||
161286522|NCT00413699|582429764|FG000|Initial Period|Lack of Efficacy|59|||
161286523|NCT00413699|582429765|FG001|Initial Period|Lack of Efficacy|115|||
161286524|NCT00413699|582429766|FG002|Initial Period|Lack of Efficacy|0|||
161286525|NCT00413699|582429764|FG000|Initial Period|Lost to Follow-up|31|||
161286526|NCT00413699|582429765|FG001|Initial Period|Lost to Follow-up|101|||
161286527|NCT00413699|582429766|FG002|Initial Period|Lost to Follow-up|0|||
161286528|NCT00413699|582429764|FG000|Initial Period|Protocol Violation|38|||
161286529|NCT00413699|582429765|FG001|Initial Period|Protocol Violation|89|||
161286530|NCT00413699|582429766|FG002|Initial Period|Protocol Violation|0|||
161286531|NCT00413699|582429764|FG000|Initial Period|Pregnancy|10|||
161286532|NCT00413699|582429765|FG001|Initial Period|Pregnancy|8|||
161286533|NCT00413699|582429766|FG002|Initial Period|Pregnancy|0|||
161286534|NCT00413699|582429764|FG000|Initial Period|Did not meet entrance criteria|2|||
161286535|NCT00413699|582429765|FG001|Initial Period|Did not meet entrance criteria|2|||
161286536|NCT00413699|582429766|FG002|Initial Period|Did not meet entrance criteria|0|||
161286537|NCT00413699|582429764|FG000|Initial Period|Medication error without adverse event|0|||
161286538|NCT00413699|582429765|FG001|Initial Period|Medication error without adverse event|1|||
161286539|NCT00413699|582429766|FG002|Initial Period|Medication error without adverse event|0|||
161286540|NCT00413699|582429764|FG000|Initial Period|Study terminated by Sponsor|0|||
161286541|NCT00413699|582429765|FG001|Initial Period|Study terminated by Sponsor|1|||
161286542|NCT00413699|582429766|FG002|Initial Period|Study terminated by Sponsor|0|||
161286543|NCT00413699|582429764|FG000|Initial Period|Other|67|||
161286544|NCT00413699|582429765|FG001|Initial Period|Other|211|||
161286545|NCT00413699|582429766|FG002|Initial Period|Other|0|||
161286546|NCT00413699|582429764|FG000|Initial Period|Adverse event related to study drug|178|||
161286547|NCT00413699|582429765|FG001|Initial Period|Adverse event related to study drug|527|||
161286548|NCT00413699|582429766|FG002|Initial Period|Adverse event related to study drug|0|||
161286549|NCT00413699|582429764|FG000|Initial Period|Adverse event not related to study drug|113|||
161286550|NCT00413699|582429765|FG001|Initial Period|Adverse event not related to study drug|248|||
161286551|NCT00413699|582429766|FG002|Initial Period|Adverse event not related to study drug|0|||
161286552|NCT00413699|582429764|FG000|Initial Period|Missing end of study page|0|||
161286553|NCT00413699|582429765|FG001|Initial Period|Missing end of study page|4|||
161286554|NCT00413699|582429766|FG002|Initial Period|Missing end of study page|0|||
161286555|NCT00413699|582429764|FG000|Initial Period|No longer willing to participate|116|||
161286556|NCT00413699|582429765|FG001|Initial Period|No longer willing to participate|368|||
161286557|NCT00413699|582429766|FG002|Initial Period|No longer willing to participate|0|||
161286558|NCT00413699|582429764|FG000|Extension Period|No Longer Willing to Participate|0|||
161286559|NCT00413699|582429765|FG001|Extension Period|No Longer Willing to Participate|0|||
161286560|NCT00413699|582429766|FG002|Extension Period|No Longer Willing to Participate|2|||
161286561|NCT00413699|582429764|FG000|Extension Period|Protocol Violation|0|||
161286562|NCT00413699|582429765|FG001|Extension Period|Protocol Violation|0|||
161286563|NCT00413699|582429766|FG002|Extension Period|Protocol Violation|1|||
161286564|NCT00413699|582429764|FG000|Extension Period|Adverse Event|0|||
161286565|NCT00413699|582429765|FG001|Extension Period|Adverse Event|0|||
161286566|NCT00413699|582429766|FG002|Extension Period|Adverse Event|2|||
161158618|NCT00254293|581961092|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
161286567|NCT02115269|582429768|FG000|Overall Study|Lost to Follow-up|43|||
161286568|NCT02115269|582429768|FG000|Overall Study|Did not complete patient diary|3|||
161286569|NCT02115269|582429768|FG000|Overall Study|Moved to another city|7|||
161286570|NCT02115269|582429768|FG000|Overall Study|Withdrawal by Subject|2|||
161286571|NCT02115269|582429768|FG000|Overall Study|Didn't take study drug|2|||
161286572|NCT05989672|582429769|FG000|Overall Study|Adverse Event|3|||
161286573|NCT05989672|582429770|FG001|Overall Study|Adverse Event|0|||
161286574|NCT05989672|582429771|FG002|Overall Study|Adverse Event|0|||
161286575|NCT03511105|582429772|FG000|Overall Study|Adverse Event|1|||
161286576|NCT03511105|582429773|FG001|Overall Study|Adverse Event|0|||
161286577|NCT03511105|582429772|FG000|Overall Study|Withdrew consent|1|||
161286578|NCT03511105|582429773|FG001|Overall Study|Withdrew consent|0|||
161077150|NCT03829501|581671964|FG005|Overall Study|Death|4|||
161077151|NCT03829501|581671965|FG006|Overall Study|Death|5|||
161077152|NCT03829501|581671966|FG007|Overall Study|Death|24|||
161077153|NCT03829501|581671967|FG008|Overall Study|Death|22|||
161077154|NCT03829501|581671968|FG009|Overall Study|Death|6|||
161077155|NCT03829501|581671969|FG010|Overall Study|Death|3|||
161077156|NCT03829501|581671970|FG011|Overall Study|Death|10|||
161077157|NCT03829501|581671971|FG012|Overall Study|Death|10|||
161077158|NCT03829501|581671972|FG013|Overall Study|Death|5|||
161077159|NCT03829501|581671973|FG014|Overall Study|Death|7|||
161077160|NCT03829501|581671974|FG015|Overall Study|Death|2|||
161077161|NCT03829501|581671975|FG016|Overall Study|Death|2|||
161077162|NCT03829501|581671976|FG017|Overall Study|Death|1|||
161077163|NCT03829501|581671977|FG018|Overall Study|Death|1|||
161077164|NCT03829501|581671978|FG019|Overall Study|Death|1|||
161077165|NCT03829501|581671979|FG020|Overall Study|Death|1|||
161077166|NCT03829501|581671980|FG021|Overall Study|Death|2|||
161077167|NCT03829501|581671981|FG022|Overall Study|Death|3|||
161077168|NCT03829501|581671959|FG000|Overall Study|Miscellaneous|0|||
161077169|NCT03829501|581671960|FG001|Overall Study|Miscellaneous|0|||
161077170|NCT03829501|581671961|FG002|Overall Study|Miscellaneous|1|||
161077171|NCT03829501|581671962|FG003|Overall Study|Miscellaneous|0|||
161077172|NCT03829501|581671963|FG004|Overall Study|Miscellaneous|0|||
161077173|NCT03829501|581671964|FG005|Overall Study|Miscellaneous|0|||
161077174|NCT03829501|581671965|FG006|Overall Study|Miscellaneous|0|||
161077175|NCT03829501|581671966|FG007|Overall Study|Miscellaneous|1|||
161077176|NCT03829501|581671967|FG008|Overall Study|Miscellaneous|0|||
161077177|NCT03829501|581671968|FG009|Overall Study|Miscellaneous|0|||
161077178|NCT03829501|581671969|FG010|Overall Study|Miscellaneous|0|||
161077179|NCT03829501|581671970|FG011|Overall Study|Miscellaneous|0|||
161077180|NCT03829501|581671971|FG012|Overall Study|Miscellaneous|0|||
161077181|NCT03829501|581671972|FG013|Overall Study|Miscellaneous|0|||
161077182|NCT03829501|581671973|FG014|Overall Study|Miscellaneous|0|||
161077183|NCT03829501|581671974|FG015|Overall Study|Miscellaneous|0|||
161077184|NCT03829501|581671975|FG016|Overall Study|Miscellaneous|0|||
161077185|NCT03829501|581671976|FG017|Overall Study|Miscellaneous|0|||
161077186|NCT03829501|581671977|FG018|Overall Study|Miscellaneous|0|||
161077187|NCT03829501|581671978|FG019|Overall Study|Miscellaneous|0|||
161077188|NCT03829501|581671979|FG020|Overall Study|Miscellaneous|0|||
161077189|NCT03829501|581671980|FG021|Overall Study|Miscellaneous|0|||
161077190|NCT03829501|581671981|FG022|Overall Study|Miscellaneous|1|||
161077191|NCT02964013|581671982|FG000|Overall Study|Death|58|||
161077192|NCT02964013|581671983|FG001|Overall Study|Death|239|||
161077193|NCT02964013|581671984|FG002|Overall Study|Death|38|||
161077194|NCT02964013|581671985|FG003|Overall Study|Death|10|||
161077195|NCT02964013|581671986|FG004|Overall Study|Death|33|||
161077196|NCT02964013|581671982|FG000|Overall Study|Lost to Follow-up|1|||
161077197|NCT02964013|581671983|FG001|Overall Study|Lost to Follow-up|4|||
161077198|NCT02964013|581671984|FG002|Overall Study|Lost to Follow-up|2|||
161077199|NCT02964013|581671985|FG003|Overall Study|Lost to Follow-up|0|||
161077200|NCT02964013|581671986|FG004|Overall Study|Lost to Follow-up|0|||
161077201|NCT02964013|581671982|FG000|Overall Study|Physician Decision|0|||
161077202|NCT02964013|581671983|FG001|Overall Study|Physician Decision|1|||
161077203|NCT02964013|581671984|FG002|Overall Study|Physician Decision|0|||
161077204|NCT02964013|581671985|FG003|Overall Study|Physician Decision|0|||
161077205|NCT02964013|581671986|FG004|Overall Study|Physician Decision|0|||
161077206|NCT02964013|581671982|FG000|Overall Study|Sponsor Decision|3|||
161077207|NCT02964013|581671983|FG001|Overall Study|Sponsor Decision|22|||
161077208|NCT02964013|581671984|FG002|Overall Study|Sponsor Decision|11|||
161077209|NCT02964013|581671985|FG003|Overall Study|Sponsor Decision|0|||
161077210|NCT02964013|581671986|FG004|Overall Study|Sponsor Decision|7|||
161077211|NCT02964013|581671982|FG000|Overall Study|Withdrawal by Subject|6|||
161077212|NCT02964013|581671983|FG001|Overall Study|Withdrawal by Subject|27|||
161077213|NCT02964013|581671984|FG002|Overall Study|Withdrawal by Subject|9|||
161077214|NCT02964013|581671985|FG003|Overall Study|Withdrawal by Subject|0|||
161077215|NCT02964013|581671986|FG004|Overall Study|Withdrawal by Subject|0|||
161077216|NCT02964013|581671982|FG000|Overall Study|Not Treated|0|||
161077217|NCT02964013|581671983|FG001|Overall Study|Not Treated|2|||
161077218|NCT02964013|581671984|FG002|Overall Study|Not Treated|0|||
161077219|NCT02964013|581671985|FG003|Overall Study|Not Treated|1|||
161077220|NCT02964013|581671986|FG004|Overall Study|Not Treated|0|||
161077221|NCT01123070|581671987|FG000|Part B Double Blind Period|Protocol Violation|0|||
161077222|NCT01123070|581671988|FG001|Part B Double Blind Period|Protocol Violation|0|||
161077223|NCT01123070|581671989|FG002|Part B Double Blind Period|Protocol Violation|0|||
161077224|NCT01123070|581671990|FG003|Part B Double Blind Period|Protocol Violation|1|||
161077225|NCT01123070|581671987|FG000|Part B Double Blind Period|Adverse Event|0|||
161077226|NCT01123070|581671988|FG001|Part B Double Blind Period|Adverse Event|0|||
161077227|NCT01123070|581671989|FG002|Part B Double Blind Period|Adverse Event|2|||
161077228|NCT01123070|581671990|FG003|Part B Double Blind Period|Adverse Event|0|||
161077229|NCT01123070|581671987|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
161077230|NCT01123070|581671988|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
161077231|NCT01123070|581671989|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
161158619|NCT00254293|581961093|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161158620|NCT00254293|581961094|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161158621|NCT00254293|581961095|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161158622|NCT00254293|581961096|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
161158623|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Death|0|||
161158624|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Death|0|||
161158625|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Death|1|||
161158626|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Death|0|||
161158627|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Death|0|||
161158628|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Death|0|||
161158629|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Death|0|||
161158630|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
161158631|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161158632|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
161158633|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161158634|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
161158635|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161158636|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
161158637|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
161158638|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161158639|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
161158640|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161158641|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
161158642|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161158643|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
161158644|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161158645|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161158646|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
161158647|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161158648|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161158649|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161158650|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
161158651|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161158652|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161158653|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
161158654|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161158655|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161158656|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161158657|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
161158658|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161158659|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161158660|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
161158661|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161158662|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161158663|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161158664|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
161158665|NCT00254293|581961090|FG000|LTE Open Label Variable SC Dosing|Other|0|||
161158666|NCT00254293|581961091|FG001|LTE Open Label Variable SC Dosing|Other|0|||
161158667|NCT00254293|581961092|FG002|LTE Open Label Variable SC Dosing|Other|2|||
161158668|NCT00254293|581961093|FG003|LTE Open Label Variable SC Dosing|Other|0|||
161158669|NCT00254293|581961094|FG004|LTE Open Label Variable SC Dosing|Other|0|||
161158670|NCT00254293|581961095|FG005|LTE Open Label Variable SC Dosing|Other|0|||
161158671|NCT00254293|581961096|FG006|LTE Open Label Variable SC Dosing|Other|0|||
161158672|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Death|0|||
161158673|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Death|0|||
161158674|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Death|0|||
161158675|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Death|0|||
161158676|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Death|0|||
161158677|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Death|0|||
161158678|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Death|3|||
161158679|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
161158680|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
161158681|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
161158682|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
161158683|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
161286579|NCT02810457|582429774|FG000|Overall Study|Randomised but no treatment received|2|||
161286580|NCT02810457|582429775|FG001|Overall Study|Randomised but no treatment received|1|||
161286581|NCT02810457|582429774|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
161286582|NCT02810457|582429775|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
161286583|NCT02810457|582429774|FG000|Overall Study|Adverse Event|37|||
161286584|NCT02810457|582429775|FG001|Overall Study|Adverse Event|43|||
161286585|NCT02810457|582429774|FG000|Overall Study|Patient decision|31|||
161286586|NCT02810457|582429775|FG001|Overall Study|Patient decision|35|||
161286587|NCT02810457|582429774|FG000|Overall Study|Patient lost to follow-up|2|||
161286588|NCT02810457|582429775|FG001|Overall Study|Patient lost to follow-up|2|||
161286589|NCT02810457|582429774|FG000|Overall Study|Death|39|||
161286590|NCT02810457|582429775|FG001|Overall Study|Death|28|||
161286591|NCT02810457|582429774|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
161286592|NCT02810457|582429775|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
161286593|NCT02810457|582429774|FG000|Overall Study|Clinical progression|15|||
161286594|NCT02810457|582429775|FG001|Overall Study|Clinical progression|16|||
161286595|NCT02810457|582429774|FG000|Overall Study|Investigator decision|3|||
161286596|NCT02810457|582429775|FG001|Overall Study|Investigator decision|2|||
161286597|NCT02810457|582429774|FG000|Overall Study|Patient ineligibility|3|||
161286598|NCT02810457|582429775|FG001|Overall Study|Patient ineligibility|0|||
161286599|NCT02810457|582429774|FG000|Overall Study|Miscalculated PD|1|||
161286600|NCT02810457|582429775|FG001|Overall Study|Miscalculated PD|0|||
161286601|NCT02810457|582429774|FG000|Overall Study|Physician Decision|0|||
161286602|NCT02810457|582429775|FG001|Overall Study|Physician Decision|1|||
161286603|NCT04179838|582429776|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161286604|NCT04179838|582429777|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
161286605|NCT04179838|582429776|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
161286606|NCT04179838|582429777|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
161286607|NCT02750618|582429778|FG000|Overall Study|Withdrawal by Subject|1|||
161286608|NCT02763046|582429785|FG000|Overall Study|Adverse Event|5|||
161286609|NCT02763046|582429786|FG001|Overall Study|Adverse Event|4|||
161286610|NCT02763046|582429787|FG002|Overall Study|Adverse Event|0|||
161286611|NCT02763046|582429785|FG000|Overall Study|Lack of Efficacy|1|||
161286612|NCT02763046|582429786|FG001|Overall Study|Lack of Efficacy|1|||
161286613|NCT02763046|582429787|FG002|Overall Study|Lack of Efficacy|3|||
161286614|NCT02763046|582429785|FG000|Overall Study|Physician Decision|1|||
161077232|NCT01123070|581671990|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
161077233|NCT04942366|581671991|FG000|Overall Study|Withdrawal by Subject|5|||
161077234|NCT04942366|581671992|FG001|Overall Study|Withdrawal by Subject|5|||
161077235|NCT00747227|581671999|FG000|Overall Study|Death|3|||
161077236|NCT00747227|581672000|FG001|Overall Study|Death|1|||
161077237|NCT00747227|581671999|FG000|Overall Study|Withdrawal by Subject|1|||
161077238|NCT00747227|581672000|FG001|Overall Study|Withdrawal by Subject|0|||
161077239|NCT00747227|581671999|FG000|Overall Study|Lost to Follow-up|1|||
161077240|NCT00747227|581672000|FG001|Overall Study|Lost to Follow-up|2|||
161077241|NCT00747227|581671999|FG000|Overall Study|Illness|1|||
161077242|NCT00747227|581672000|FG001|Overall Study|Illness|1|||
161077243|NCT03284229|581672001|FG000|Overall Study|Lost to Follow-up|3|||
161077244|NCT00918879|581672003|FG000|Overall Study|Withdrawal by Subject|4|||
161077245|NCT00918879|581672004|FG001|Overall Study|Withdrawal by Subject|4|||
161077246|NCT00918879|581672003|FG000|Overall Study|Lost to Follow-up|1|||
161077247|NCT00918879|581672004|FG001|Overall Study|Lost to Follow-up|1|||
161077248|NCT00918879|581672003|FG000|Overall Study|Severe non-compliance to protocol|1|||
161077249|NCT00918879|581672004|FG001|Overall Study|Severe non-compliance to protocol|1|||
161077250|NCT04707664|581672005|FG000|Overall Study|Adverse Event|2|||
161077251|NCT04707664|581672006|FG001|Overall Study|Adverse Event|0|||
161077252|NCT04707664|581672005|FG000|Overall Study|Death|1|||
161077253|NCT04707664|581672006|FG001|Overall Study|Death|2|||
161077254|NCT04707664|581672005|FG000|Overall Study|Withdrawal by Subject|13|||
161077255|NCT04707664|581672006|FG001|Overall Study|Withdrawal by Subject|21|||
161077256|NCT04707664|581672005|FG000|Overall Study|Lost to Follow-up|11|||
161077257|NCT04707664|581672006|FG001|Overall Study|Lost to Follow-up|13|||
161077258|NCT04707664|581672005|FG000|Overall Study|Not treated|2|||
161077259|NCT04707664|581672006|FG001|Overall Study|Not treated|0|||
161077260|NCT00357110|581672007|FG000|Overall Study|Early study termination|5|||
161077261|NCT00357110|581672008|FG001|Overall Study|Early study termination|5|||
161077262|NCT03339245|581672016|FG000|Overall Study|Adverse Event|1|||
161077263|NCT03339245|581672017|FG001|Overall Study|Adverse Event|1|||
161077264|NCT03339245|581672016|FG000|Overall Study|Withdrawal by Subject|1|||
161077265|NCT03339245|581672017|FG001|Overall Study|Withdrawal by Subject|0|||
161077266|NCT00288639|581672025|FG000|Overall Study|Adverse Event|5|||
161077267|NCT00288639|581672025|FG000|Overall Study|Lack of Efficacy|4|||
161158684|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
161345900|NCT02003924|582650953|FG001|Long-term Follow-up Phase|Death|174|||
161077268|NCT00288639|581672025|FG000|Overall Study|Withdrawal by Subject|2|||
161077269|NCT00288639|581672025|FG000|Overall Study|Other|1|||
161286615|NCT02763046|582429786|FG001|Overall Study|Physician Decision|0|||
161286616|NCT02763046|582429787|FG002|Overall Study|Physician Decision|1|||
161286617|NCT02763046|582429785|FG000|Overall Study|Subject/guardian decision|2|||
161286618|NCT02763046|582429786|FG001|Overall Study|Subject/guardian decision|0|||
161286619|NCT02763046|582429787|FG002|Overall Study|Subject/guardian decision|4|||
161286620|NCT00818766|582429792|FG000|Overall Study|Could not be Contacted on Day 28|11|||
161158685|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
161158686|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161158687|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161158688|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161158689|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161158690|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161158691|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
161158692|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
161158693|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161158694|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161158695|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161158696|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161158697|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161158698|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
161158699|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
161158700|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161158701|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161158702|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161158703|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161158704|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161158705|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
161158706|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
161158707|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161158708|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161158709|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161158710|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161158711|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161158712|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
161158713|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
161158714|NCT00254293|581961090|FG000|LTE Open Label Fixed Dosing|Other|0|||
161158715|NCT00254293|581961091|FG001|LTE Open Label Fixed Dosing|Other|0|||
161158716|NCT00254293|581961092|FG002|LTE Open Label Fixed Dosing|Other|0|||
161158717|NCT00254293|581961093|FG003|LTE Open Label Fixed Dosing|Other|0|||
161158718|NCT00254293|581961094|FG004|LTE Open Label Fixed Dosing|Other|0|||
161158719|NCT00254293|581961095|FG005|LTE Open Label Fixed Dosing|Other|0|||
161158720|NCT00254293|581961096|FG006|LTE Open Label Fixed Dosing|Other|1|||
161158721|NCT01575197|581961097|FG000|Overall Study|Migration out of study area|1|||
161158722|NCT01575197|581961098|FG001|Overall Study|Migration out of study area|5|||
161158723|NCT01575197|581961099|FG002|Overall Study|Migration out of study area|4|||
161158724|NCT01575197|581961097|FG000|Overall Study|SAE|0|||
161158725|NCT01575197|581961098|FG001|Overall Study|SAE|1|||
161158726|NCT01575197|581961099|FG002|Overall Study|SAE|0|||
161158727|NCT01575197|581961097|FG000|Overall Study|Lost to Follow-up|0|||
161158728|NCT01575197|581961098|FG001|Overall Study|Lost to Follow-up|1|||
161158729|NCT01575197|581961099|FG002|Overall Study|Lost to Follow-up|0|||
161158730|NCT01575197|581961097|FG000|Overall Study|Withdrawal by Subject|0|||
161158731|NCT01575197|581961098|FG001|Overall Study|Withdrawal by Subject|1|||
161158732|NCT01575197|581961099|FG002|Overall Study|Withdrawal by Subject|1|||
161158733|NCT01575197|581961097|FG000|Overall Study|Protocol Violation|2|||
161158734|NCT01575197|581961098|FG001|Overall Study|Protocol Violation|1|||
161158735|NCT01575197|581961099|FG002|Overall Study|Protocol Violation|1|||
161158736|NCT01000727|581961100|FG000|Overall Study|Lost to Follow-up|41|||
161158737|NCT01000727|581961101|FG001|Overall Study|Lost to Follow-up|43|||
161158738|NCT01000727|581961100|FG000|Overall Study|Withdrawal by Subject|111|||
161158739|NCT01000727|581961101|FG001|Overall Study|Withdrawal by Subject|109|||
161158740|NCT01000727|581961100|FG000|Overall Study|Study closed/terminated|23|||
161158741|NCT01000727|581961101|FG001|Overall Study|Study closed/terminated|24|||
161158742|NCT03196193|581961102|FG000|Overall Study|Adverse Event|1|||
161158743|NCT03196193|581961103|FG001|Overall Study|Adverse Event|0|||
161158744|NCT03196193|581961102|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
161158745|NCT03196193|581961103|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
161158746|NCT02709083|581961107|FG000|Overall Study|Original PI left institution|7|||
161158747|NCT01026389|581961108|FG000|Overall Study|Withdrawal by Subject|1|||
161158748|NCT01026389|581961109|FG001|Overall Study|Withdrawal by Subject|3|||
161286621|NCT00818766|582429793|FG001|Overall Study|Could not be Contacted on Day 28|10|||
161286622|NCT00818766|582429792|FG000|Overall Study|Death|1|||
161286623|NCT00818766|582429793|FG001|Overall Study|Death|0|||
161286624|NCT00818766|582429792|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
161158749|NCT01026389|581961108|FG000|Overall Study|change of treatment, patient moved|4|||
161286625|NCT00818766|582429793|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
161286626|NCT00086684|582429794|FG000|Overall Study|Adverse Event|12|||
161158750|NCT01026389|581961109|FG001|Overall Study|change of treatment, patient moved|2|||
161158751|NCT03544268|581961110|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
161286627|NCT00086684|582429795|FG001|Overall Study|Adverse Event|17|||
161345901|NCT02003924|582650954|FG002|Long-term Follow-up Phase|Death|4|||
161345902|NCT02003924|582650952|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
161345903|NCT02003924|582650953|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
161345904|NCT02003924|582650954|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
161345905|NCT02003924|582650952|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
161345906|NCT02003924|582650953|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
161345907|NCT02003924|582650954|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
161345908|NCT02003924|582650952|FG000|Long-term Follow-up Phase|Other|5|||
161345909|NCT02003924|582650953|FG001|Long-term Follow-up Phase|Other|2|||
161345910|NCT02003924|582650954|FG002|Long-term Follow-up Phase|Other|1|||
161345911|NCT00315445|582650955|FG000|Overall Study|Adverse Event|7|||
161345912|NCT00315445|582650956|FG001|Overall Study|Adverse Event|12|||
161345913|NCT00315445|582650957|FG002|Overall Study|Adverse Event|15|||
161345914|NCT00315445|582650955|FG000|Overall Study|Lack of Efficacy|16|||
161345915|NCT00315445|582650956|FG001|Overall Study|Lack of Efficacy|1|||
161345916|NCT00315445|582650957|FG002|Overall Study|Lack of Efficacy|7|||
161345917|NCT00315445|582650955|FG000|Overall Study|Lost to Follow-up|1|||
161345918|NCT00315445|582650956|FG001|Overall Study|Lost to Follow-up|0|||
161345919|NCT00315445|582650957|FG002|Overall Study|Lost to Follow-up|1|||
161345920|NCT00315445|582650955|FG000|Overall Study|Protocol Violation|2|||
161345921|NCT00315445|582650956|FG001|Overall Study|Protocol Violation|0|||
161345922|NCT00315445|582650957|FG002|Overall Study|Protocol Violation|1|||
161345923|NCT00315445|582650955|FG000|Overall Study|Other|1|||
161345924|NCT00315445|582650956|FG001|Overall Study|Other|3|||
161345925|NCT00315445|582650957|FG002|Overall Study|Other|0|||
161345926|NCT01299909|582650958|FG000|Overall Study|Lost to Follow-up|22|||
161345927|NCT01299909|582650959|FG001|Overall Study|Lost to Follow-up|18|||
161345928|NCT01299909|582650960|FG002|Overall Study|Lost to Follow-up|17|||
161345929|NCT01811238|582650961|FG000|Overall Study|Withdrawal by Subject|42|||
161345930|NCT01811238|582650961|FG000|Overall Study|Adverse Event|25|||
161345931|NCT01811238|582650961|FG000|Overall Study|Protocol Violation|4|||
161345932|NCT01811238|582650961|FG000|Overall Study|Lack of Efficacy|4|||
161345933|NCT01811238|582650961|FG000|Overall Study|subject refused study medication|6|||
161345934|NCT01155570|582650962|FG000|Overall Study|Adverse Event|39|||
161345935|NCT01155570|582650962|FG000|Overall Study|Lack of Efficacy|46|||
161345936|NCT01155570|582650962|FG000|Overall Study|Participant's Economic Reasons|17|||
161345937|NCT01155570|582650962|FG000|Overall Study|No Hospital Visits|7|||
161345938|NCT01155570|582650962|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
161345939|NCT01155570|582650962|FG000|Overall Study|Adverse Event + Other Reasons|7|||
161345940|NCT01155570|582650962|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
161345941|NCT01155570|582650962|FG000|Overall Study|Other Reasons|23|||
161345942|NCT01922934|582650963|FG000|Eligible Patients|Death|0|||
161345943|NCT01922934|582650964|FG001|Eligible Patients|Death|7|||
161345944|NCT01922934|582650963|FG000|Eligible Patients|Physician Decision|17|||
161345945|NCT01922934|582650964|FG001|Eligible Patients|Physician Decision|0|||
161345946|NCT01922934|582650963|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
161345947|NCT01922934|582650964|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
161345948|NCT01922934|582650963|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
161345949|NCT01922934|582650964|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
161345950|NCT01922934|582650963|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
161345951|NCT01922934|582650964|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
161345952|NCT01922934|582650963|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
161345953|NCT01922934|582650964|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
161345954|NCT02774889|582650967|FG000|Overall Study|Lost to Follow-up|2|||
161345955|NCT02774889|582650968|FG001|Overall Study|Lost to Follow-up|1|||
161345956|NCT00724945|582650969|FG000|Period 1|non-compliance|1|||
161345957|NCT00724945|582650970|FG001|Period 1|non-compliance|0|||
161345958|NCT00724945|582650969|FG000|Period 1|Adverse Event|1|||
161345959|NCT00724945|582650970|FG001|Period 1|Adverse Event|1|||
161345960|NCT00724945|582650969|FG000|Period 1|Lost to Follow-up|1|||
161345961|NCT00724945|582650970|FG001|Period 1|Lost to Follow-up|0|||
161077270|NCT01195948|581672026|FG000|Overall Study|Lost to Follow-up|0|||
161077271|NCT01195948|581672027|FG001|Overall Study|Lost to Follow-up|1|||
161077272|NCT01195948|581672028|FG002|Overall Study|Lost to Follow-up|2|||
161077273|NCT01498887|581672031|FG000|Overall Study|Administrative problems|1|||
161077274|NCT01498887|581672032|FG001|Overall Study|Administrative problems|0|||
161077275|NCT01498887|581672031|FG000|Overall Study|Lost to Follow-up|1|||
161077276|NCT01498887|581672032|FG001|Overall Study|Lost to Follow-up|1|||
161077277|NCT01498887|581672031|FG000|Overall Study|Withdrawal by Subject|1|||
161345962|NCT00724945|582650969|FG000|Period 2|lens comfort issue|3|||
161345963|NCT00724945|582650970|FG001|Period 2|lens comfort issue|0|||
161077278|NCT01498887|581672032|FG001|Overall Study|Withdrawal by Subject|0|||
161077279|NCT01498887|581672031|FG000|Overall Study|Protocol Violation|1|||
161077280|NCT01498887|581672032|FG001|Overall Study|Protocol Violation|3|||
161345964|NCT00724945|582650969|FG000|Period 2|lens physiology issue|1|||
161345965|NCT00724945|582650970|FG001|Period 2|lens physiology issue|0|||
161077281|NCT01498887|581672031|FG000|Overall Study|Lack of Efficacy|5|||
161077282|NCT01498887|581672032|FG001|Overall Study|Lack of Efficacy|3|||
161077283|NCT01498887|581672031|FG000|Overall Study|Abnormal result from test procedure|1|||
161077284|NCT01498887|581672032|FG001|Overall Study|Abnormal result from test procedure|1|||
161077285|NCT01498887|581672031|FG000|Overall Study|Abnormal laboratory value|2|||
161077286|NCT01498887|581672032|FG001|Overall Study|Abnormal laboratory value|2|||
161077287|NCT01498887|581672031|FG000|Overall Study|Adverse Event|4|||
161077288|NCT01498887|581672032|FG001|Overall Study|Adverse Event|1|||
161077289|NCT04079868|581672033|FG000|Overall Study|Lost to Follow-up|100|||
161077290|NCT04079868|581672034|FG001|Overall Study|Lost to Follow-up|200|||
161077291|NCT04079868|581672033|FG000|Overall Study|Physician Decision|100|||
161077292|NCT04079868|581672034|FG001|Overall Study|Physician Decision|0|||
161077293|NCT04335591|581672035|FG000|Overall Study|Adverse Event|5|||
161077294|NCT04335591|581672036|FG001|Overall Study|Adverse Event|2|||
161077295|NCT04335591|581672037|FG002|Overall Study|Adverse Event|3|||
161077296|NCT04335591|581672038|FG003|Overall Study|Adverse Event|2|||
161077297|NCT04335591|581672035|FG000|Overall Study|Protocol Violation|1|||
161077298|NCT04335591|581672036|FG001|Overall Study|Protocol Violation|0|||
161077299|NCT04335591|581672037|FG002|Overall Study|Protocol Violation|0|||
161077300|NCT04335591|581672038|FG003|Overall Study|Protocol Violation|0|||
161077301|NCT04335591|581672035|FG000|Overall Study|Withdrawal by Subject|8|||
161077302|NCT04335591|581672036|FG001|Overall Study|Withdrawal by Subject|4|||
161077303|NCT04335591|581672037|FG002|Overall Study|Withdrawal by Subject|4|||
161077304|NCT04335591|581672038|FG003|Overall Study|Withdrawal by Subject|5|||
161077305|NCT04335591|581672035|FG000|Overall Study|Subject planning pregnancy|0|||
161077306|NCT04335591|581672036|FG001|Overall Study|Subject planning pregnancy|1|||
161077307|NCT04335591|581672037|FG002|Overall Study|Subject planning pregnancy|0|||
161077308|NCT04335591|581672038|FG003|Overall Study|Subject planning pregnancy|0|||
161077309|NCT04335591|581672035|FG000|Overall Study|Ukrainian Russian war conflict|4|||
161077310|NCT04335591|581672036|FG001|Overall Study|Ukrainian Russian war conflict|5|||
161077311|NCT04335591|581672037|FG002|Overall Study|Ukrainian Russian war conflict|2|||
161077312|NCT04335591|581672038|FG003|Overall Study|Ukrainian Russian war conflict|0|||
161077313|NCT01077128|581672048|FG000|Overall Study|Adverse Event|8|||
161077314|NCT01077128|581672048|FG000|Overall Study|Lack of Efficacy|1|||
161077315|NCT01077128|581672048|FG000|Overall Study|Disease exacerbation|1|||
161077316|NCT01077128|581672048|FG000|Overall Study|Adverse event and consent withdrawal|1|||
161077317|NCT01077128|581672048|FG000|Overall Study|Adverse event and disease exacerbation|1|||
161077318|NCT01077128|581672048|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
161077319|NCT01077128|581672048|FG000|Overall Study|Other|54|||
161077320|NCT03338296|581672056|FG000|Overall Study|Adverse Event|0|||
161077321|NCT03338296|581672057|FG001|Overall Study|Adverse Event|1|||
161077322|NCT03338296|581672056|FG000|Overall Study|Withdrawal by Subject|14|||
161077323|NCT03338296|581672057|FG001|Overall Study|Withdrawal by Subject|13|||
161077324|NCT03338296|581672056|FG000|Overall Study|Lost to Follow-up|10|||
161077325|NCT03338296|581672057|FG001|Overall Study|Lost to Follow-up|10|||
161077326|NCT03338296|581672056|FG000|Overall Study|Study Terminated by Sponsor|77|||
161077327|NCT03338296|581672057|FG001|Overall Study|Study Terminated by Sponsor|76|||
161077328|NCT03338296|581672056|FG000|Overall Study|Other|2|||
161077329|NCT03338296|581672057|FG001|Overall Study|Other|7|||
161077330|NCT03338296|581672056|FG000|Overall Study|Missing|0|||
161077331|NCT03338296|581672057|FG001|Overall Study|Missing|1|||
161077332|NCT01939353|581672058|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
161077333|NCT01939353|581672058|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
161077334|NCT01939353|581672058|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
161077335|NCT01939353|581672058|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161077336|NCT01939353|581672058|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
161077337|NCT04421950|581672062|FG000|Overall Study|Dropped or lost to follow up|4|||
161077338|NCT04421950|581672063|FG001|Overall Study|Dropped or lost to follow up|2|||
161077339|NCT04546425|581672064|FG000|Overall Study|Protocol Violation|1|||
161158752|NCT03544268|581961111|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
161158753|NCT04410198|581961112|FG000|Overall Study|Death|10|||
161077340|NCT04546425|581672065|FG001|Overall Study|Protocol Violation|1|||
161077341|NCT04546425|581672066|FG002|Overall Study|Protocol Violation|0|||
161158754|NCT04410198|581961112|FG000|Overall Study|Withdrawal by Subject|7|||
161286628|NCT00086684|582429796|FG002|Overall Study|Adverse Event|14|||
161286629|NCT00086684|582429794|FG000|Overall Study|Lack of Efficacy|6|||
161077342|NCT04546425|581672067|FG003|Overall Study|Protocol Violation|0|||
161077343|NCT04546425|581672064|FG000|Overall Study|Adverse Event|3|||
161077344|NCT04546425|581672065|FG001|Overall Study|Adverse Event|0|||
161077345|NCT04546425|581672066|FG002|Overall Study|Adverse Event|0|||
161077346|NCT04546425|581672067|FG003|Overall Study|Adverse Event|0|||
161077347|NCT04546425|581672064|FG000|Overall Study|Lost to Follow-up|5|||
161077348|NCT04546425|581672065|FG001|Overall Study|Lost to Follow-up|4|||
161077349|NCT04546425|581672066|FG002|Overall Study|Lost to Follow-up|0|||
161077350|NCT04546425|581672067|FG003|Overall Study|Lost to Follow-up|0|||
161077351|NCT04546425|581672064|FG000|Overall Study|No Longer met eligibility criteria|3|||
161286630|NCT00086684|582429795|FG001|Overall Study|Lack of Efficacy|6|||
161158755|NCT04410198|581961112|FG000|Overall Study|Transferred/Relocation|4|||
161158756|NCT04410198|581961112|FG000|Overall Study|Kidney Transplant|9|||
161158757|NCT04410198|581961112|FG000|Overall Study|Adverse Event|4|||
161158758|NCT04410198|581961112|FG000|Overall Study|Physician Decision|2|||
161158759|NCT04410198|581961112|FG000|Overall Study|Other than specified|1|||
161158760|NCT01626352|581961116|FG000|Overall Study|Disease Progression|3|||
161158761|NCT01626352|581961116|FG000|Overall Study|Intercurrent Illness|2|||
161158762|NCT01626352|581961116|FG000|Overall Study|Death|2|||
161158763|NCT01626352|581961116|FG000|Overall Study|Withdrawal by Subject|1|||
161158764|NCT01626352|581961116|FG000|Overall Study|Non-Compliance|1|||
161158765|NCT01626352|581961116|FG000|Overall Study|Never Treated|1|||
161158766|NCT03583372|581961119|FG000|Overall Study|Withdrawal by Subject|6|||
161158767|NCT03583372|581961120|FG001|Overall Study|Withdrawal by Subject|11|||
161158768|NCT03583372|581961121|FG002|Overall Study|Withdrawal by Subject|7|||
161158769|NCT03583372|581961122|FG003|Overall Study|Withdrawal by Subject|8|||
161158770|NCT03583372|581961119|FG000|Overall Study|Lost to Follow-up|4|||
161158771|NCT03583372|581961120|FG001|Overall Study|Lost to Follow-up|6|||
161158772|NCT03583372|581961121|FG002|Overall Study|Lost to Follow-up|3|||
161158773|NCT03583372|581961122|FG003|Overall Study|Lost to Follow-up|2|||
161158774|NCT03583372|581961119|FG000|Overall Study|Adverse Event|1|||
161158775|NCT03583372|581961120|FG001|Overall Study|Adverse Event|3|||
161158776|NCT03583372|581961121|FG002|Overall Study|Adverse Event|4|||
161158777|NCT03583372|581961122|FG003|Overall Study|Adverse Event|4|||
161158778|NCT03583372|581961119|FG000|Overall Study|Physician Decision|0|||
161158779|NCT03583372|581961120|FG001|Overall Study|Physician Decision|1|||
161158780|NCT03583372|581961121|FG002|Overall Study|Physician Decision|1|||
161158781|NCT03583372|581961122|FG003|Overall Study|Physician Decision|1|||
161158782|NCT03583372|581961119|FG000|Overall Study|Lack of Efficacy|0|||
161158783|NCT03583372|581961120|FG001|Overall Study|Lack of Efficacy|1|||
161158784|NCT03583372|581961121|FG002|Overall Study|Lack of Efficacy|0|||
161158785|NCT03583372|581961122|FG003|Overall Study|Lack of Efficacy|1|||
161158786|NCT03583372|581961119|FG000|Overall Study|Death|1|||
161158787|NCT03583372|581961120|FG001|Overall Study|Death|0|||
161158788|NCT03583372|581961121|FG002|Overall Study|Death|0|||
161158789|NCT03583372|581961122|FG003|Overall Study|Death|0|||
161158790|NCT03583372|581961119|FG000|Overall Study|Protocol Violation|0|||
161158791|NCT03583372|581961120|FG001|Overall Study|Protocol Violation|1|||
161158792|NCT03583372|581961121|FG002|Overall Study|Protocol Violation|0|||
161158793|NCT03583372|581961122|FG003|Overall Study|Protocol Violation|0|||
161158794|NCT03583372|581961119|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
161158795|NCT03583372|581961120|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
161158796|NCT03583372|581961121|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
161158797|NCT03583372|581961122|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
161158798|NCT03583372|581961119|FG000|Overall Study|Did Not Receive Study Drug|0|||
161158799|NCT03583372|581961120|FG001|Overall Study|Did Not Receive Study Drug|1|||
161158800|NCT03583372|581961121|FG002|Overall Study|Did Not Receive Study Drug|0|||
161158801|NCT03583372|581961122|FG003|Overall Study|Did Not Receive Study Drug|0|||
161158802|NCT03583372|581961119|FG000|Overall Study|Captured as Other in the Database|1|||
161158803|NCT03583372|581961120|FG001|Overall Study|Captured as Other in the Database|2|||
161158804|NCT03583372|581961121|FG002|Overall Study|Captured as Other in the Database|4|||
161158805|NCT03583372|581961122|FG003|Overall Study|Captured as Other in the Database|1|||
161158806|NCT02695524|581961123|FG000|Overall Study|Lost to Follow-up|3|||
161158807|NCT02695524|581961124|FG001|Overall Study|Lost to Follow-up|2|||
161158808|NCT02695524|581961123|FG000|Overall Study|Death|0|||
161158809|NCT02695524|581961124|FG001|Overall Study|Death|1|||
161158810|NCT00798655|581961131|FG000|Overall Study|Did not receive at least one dose of pan|2|||
161158811|NCT00343291|581961132|FG000|Overall Study|Adverse Event|13|||
161158812|NCT00343291|581961133|FG001|Overall Study|Adverse Event|13|||
161158813|NCT00343291|581961132|FG000|Overall Study|Death|3|||
161158814|NCT00343291|581961133|FG001|Overall Study|Death|2|||
161158815|NCT00343291|581961132|FG000|Overall Study|Progressive disease|33|||
161158816|NCT00343291|581961133|FG001|Overall Study|Progressive disease|34|||
161158817|NCT00343291|581961132|FG000|Overall Study|Withdrawal by Subject|0|||
161158818|NCT00343291|581961133|FG001|Overall Study|Withdrawal by Subject|2|||
161158819|NCT00343291|581961132|FG000|Overall Study|Other|8|||
161158820|NCT00343291|581961133|FG001|Overall Study|Other|5|||
161158821|NCT04831515|581961134|FG000|First Intervention|Adverse Event|0|||
161286631|NCT00086684|582429796|FG002|Overall Study|Lack of Efficacy|5|||
161158822|NCT04831515|581961135|FG001|First Intervention|Adverse Event|1|||
161158823|NCT03712345|581961136|FG000|Overall Study|Failure to meet randomization criteria|0|||
161286632|NCT00086684|582429794|FG000|Overall Study|Lost to Follow-up|15|||
161158824|NCT03712345|581961137|FG001|Overall Study|Failure to meet randomization criteria|0|||
161158825|NCT03712345|581961138|FG002|Overall Study|Failure to meet randomization criteria|1|||
161286633|NCT00086684|582429795|FG001|Overall Study|Lost to Follow-up|8|||
161158826|NCT00960934|581961139|FG000|Overall Study|Adverse Event|2|||
161286634|NCT00086684|582429796|FG002|Overall Study|Lost to Follow-up|10|||
161158827|NCT00960934|581961140|FG001|Overall Study|Adverse Event|3|||
161158828|NCT00960934|581961141|FG002|Overall Study|Adverse Event|3|||
161286635|NCT00086684|582429794|FG000|Overall Study|Protocol Violation|8|||
161077352|NCT04546425|581672065|FG001|Overall Study|No Longer met eligibility criteria|3|||
161077353|NCT04546425|581672066|FG002|Overall Study|No Longer met eligibility criteria|1|||
161077354|NCT04546425|581672067|FG003|Overall Study|No Longer met eligibility criteria|1|||
161077355|NCT04546425|581672064|FG000|Overall Study|Withdrawal by parent/guardian|6|||
161077356|NCT04546425|581672065|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161077357|NCT04546425|581672066|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161077358|NCT04546425|581672067|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161077359|NCT03435692|581672068|FG000|Overall Study|Lack of Efficacy|2|||
161077360|NCT03435692|581672069|FG001|Overall Study|Lack of Efficacy|2|||
161077361|NCT03435692|581672070|FG002|Overall Study|Lack of Efficacy|0|||
161077362|NCT00967005|581672071|FG000|Overall Study|Lost to Follow-up|7|||
161077363|NCT00967005|581672072|FG001|Overall Study|Lost to Follow-up|10|||
161077364|NCT02593123|581672073|FG000|Overall Study|Physician Decision|2|||
161077365|NCT02593123|581672074|FG001|Overall Study|Physician Decision|1|||
161077366|NCT02593123|581672073|FG000|Overall Study|Relapse|1|||
161077367|NCT02593123|581672074|FG001|Overall Study|Relapse|1|||
161077368|NCT05071053|581672075|FG000|Overall Study|Progressive disease|30|||
161077369|NCT05071053|581672075|FG000|Overall Study|Adverse Event|5|||
161077370|NCT03945825|581672083|FG000|Overall Study|Enrolled but treatment not administered|0|||
161077371|NCT03945825|581672084|FG001|Overall Study|Enrolled but treatment not administered|0|||
161077372|NCT03945825|581672085|FG002|Overall Study|Enrolled but treatment not administered|0|||
161077373|NCT03945825|581672086|FG003|Overall Study|Enrolled but treatment not administered|0|||
161077374|NCT03945825|581672087|FG004|Overall Study|Enrolled but treatment not administered|1|||
161077375|NCT03945825|581672088|FG005|Overall Study|Enrolled but treatment not administered|0|||
161077376|NCT03945825|581672083|FG000|Overall Study|Lost to Follow-up|1|||
161077377|NCT03945825|581672084|FG001|Overall Study|Lost to Follow-up|5|||
161077378|NCT03945825|581672085|FG002|Overall Study|Lost to Follow-up|0|||
161077379|NCT03945825|581672086|FG003|Overall Study|Lost to Follow-up|1|||
161077380|NCT03945825|581672087|FG004|Overall Study|Lost to Follow-up|2|||
161077381|NCT03945825|581672088|FG005|Overall Study|Lost to Follow-up|2|||
161077382|NCT03945825|581672083|FG000|Overall Study|Withdrawal by Subject|1|||
161077383|NCT03945825|581672084|FG001|Overall Study|Withdrawal by Subject|0|||
161077384|NCT03945825|581672085|FG002|Overall Study|Withdrawal by Subject|1|||
161077385|NCT03945825|581672086|FG003|Overall Study|Withdrawal by Subject|1|||
161077386|NCT03945825|581672087|FG004|Overall Study|Withdrawal by Subject|0|||
161077387|NCT03945825|581672088|FG005|Overall Study|Withdrawal by Subject|1|||
161077388|NCT01461005|581672089|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
161077389|NCT00203268|581672090|FG000|Early Treatment|only treated one headache|2|||
161077390|NCT00203268|581672090|FG000|Early Treatment|Lost to Follow-up|1|||
161077391|NCT00203268|581672090|FG000|Early Treatment|Withdrawal by Subject|1|||
161077392|NCT00600613|581672091|FG000|Overall Study|Protocol Deviation|1|||
161077393|NCT00846807|581672095|FG000|Overall Study|Adverse Event|270|||
161077394|NCT00846807|581672095|FG000|Overall Study|Lost to Follow-up|94|||
161077395|NCT00846807|581672095|FG000|Overall Study|Withdrawal by Subject|56|||
161077396|NCT00846807|581672095|FG000|Overall Study|Non compliant with European label|7|||
161077397|NCT00846807|581672095|FG000|Overall Study|Switch to other anticoagulants|89|||
161077398|NCT00846807|581672095|FG000|Overall Study|No prescription after hospital discharge|56|||
161077399|NCT00846807|581672095|FG000|Overall Study|Other|60|||
161077400|NCT00245960|581672096|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
161077401|NCT00245960|581672097|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
161077402|NCT00245960|581672096|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
161077403|NCT00245960|581672097|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
161077404|NCT00245960|581672096|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
161077405|NCT00245960|581672097|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
161077406|NCT00245960|581672096|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
161077407|NCT00245960|581672097|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
161077408|NCT00245960|581672096|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
161077409|NCT00245960|581672097|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
161077410|NCT00245960|581672096|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
161077411|NCT00245960|581672097|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
161077412|NCT00245960|581672096|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
161077413|NCT00245960|581672097|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
161077414|NCT00245960|581672096|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
161286636|NCT00086684|582429795|FG001|Overall Study|Protocol Violation|3|||
161286637|NCT00086684|582429796|FG002|Overall Study|Protocol Violation|0|||
161077415|NCT00245960|581672097|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
161077416|NCT00245960|581672096|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
161077417|NCT00245960|581672097|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
161077418|NCT00245960|581672096|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
161077419|NCT00245960|581672097|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
161077420|NCT00245960|581672096|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
161158829|NCT00960934|581961142|FG003|Overall Study|Adverse Event|2|||
161286638|NCT00086684|582429794|FG000|Overall Study|Withdrawal by Subject|0|||
161286639|NCT00086684|582429795|FG001|Overall Study|Withdrawal by Subject|4|||
161286640|NCT00086684|582429796|FG002|Overall Study|Withdrawal by Subject|10|||
161286641|NCT00086684|582429794|FG000|Overall Study|NONCOMPLIANCE|5|||
161286642|NCT00086684|582429795|FG001|Overall Study|NONCOMPLIANCE|7|||
161286643|NCT00086684|582429796|FG002|Overall Study|NONCOMPLIANCE|6|||
161286644|NCT00086684|582429794|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161286645|NCT00086684|582429795|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
161286646|NCT00086684|582429796|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
161286647|NCT00086684|582429794|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
161286648|NCT00086684|582429795|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
161286649|NCT00086684|582429796|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
161286650|NCT00086684|582429794|FG000|Overall Study|Other|4|||
161286651|NCT00086684|582429795|FG001|Overall Study|Other|2|||
161286652|NCT00086684|582429796|FG002|Overall Study|Other|3|||
161286653|NCT01103180|582429799|FG000|Overall Study|Withdrawal by Subject|8|||
161286654|NCT01103180|582429800|FG001|Overall Study|Withdrawal by Subject|13|||
161286655|NCT01103180|582429799|FG000|Overall Study|Lost to Follow-up|13|||
161286656|NCT01103180|582429800|FG001|Overall Study|Lost to Follow-up|7|||
161286657|NCT01103180|582429799|FG000|Overall Study|Physician Decision|1|||
161286658|NCT01103180|582429800|FG001|Overall Study|Physician Decision|0|||
161286659|NCT01103180|582429799|FG000|Overall Study|Protocol Violation|0|||
161286660|NCT01103180|582429800|FG001|Overall Study|Protocol Violation|1|||
161286661|NCT01067105|582429801|FG000|Overall Study|Adverse Event|14|||
161286662|NCT01067105|582429801|FG000|Overall Study|Protocol Violation|48|||
161286663|NCT01067105|582429801|FG000|Overall Study|Withdrawal by Subject|36|||
161286664|NCT01067105|582429801|FG000|Overall Study|Lost to Follow-up|6|||
161286665|NCT01067105|582429801|FG000|Overall Study|Physician Decision|6|||
161286666|NCT01067105|582429801|FG000|Overall Study|Other|31|||
161286667|NCT02760004|582429802|FG000|Overall Study|Lost to Follow-up|13|||
161286668|NCT02760004|582429803|FG001|Overall Study|Lost to Follow-up|22|||
161286669|NCT02094300|582429806|FG000|Overall Study|Death|7|||
161286670|NCT02094300|582429806|FG000|Overall Study|Lost to Follow-up|10|||
161286671|NCT02094300|582429806|FG000|Overall Study|Still be eligible for follow-up|3|||
161286672|NCT00725491|582429813|FG000|Overall Study|Adverse Event|3|||
161286673|NCT00725491|582429814|FG001|Overall Study|Adverse Event|2|||
161286674|NCT00725491|582429813|FG000|Overall Study|Pregnancy|0|||
161286675|NCT00725491|582429814|FG001|Overall Study|Pregnancy|3|||
161286676|NCT00725491|582429813|FG000|Overall Study|Risk for hyperstimulation|2|||
161286677|NCT00725491|582429814|FG001|Overall Study|Risk for hyperstimulation|9|||
161286678|NCT00725491|582429813|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
161286679|NCT00725491|582429814|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
161286680|NCT00725491|582429813|FG000|Overall Study|Fertilization failure|0|||
161286681|NCT00725491|582429814|FG001|Overall Study|Fertilization failure|1|||
161345966|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
161077421|NCT00245960|581672097|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
161077422|NCT00245960|581672096|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
161077423|NCT00245960|581672097|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
161077424|NCT00737698|581672098|FG000|Overall Study|Withdrawal by Subject|6|||
161077425|NCT00737698|581672099|FG001|Overall Study|Withdrawal by Subject|5|||
161077426|NCT00737698|581672100|FG002|Overall Study|Withdrawal by Subject|3|||
161077427|NCT00737698|581672098|FG000|Overall Study|Death|0|||
161077428|NCT00737698|581672099|FG001|Overall Study|Death|0|||
161077429|NCT00737698|581672100|FG002|Overall Study|Death|1|||
161077430|NCT01110408|581672103|FG000|Overall Study|Protocol Violation|1|||
161077431|NCT01110408|581672104|FG001|Overall Study|Protocol Violation|0|||
161077432|NCT00669877|581672105|FG000|Overall Study|Disease Progression/Death|4|||
161077433|NCT04844879|581672106|FG000|Overall Study|Death|1|||
161077434|NCT04844879|581672106|FG000|Overall Study|Withdrawal by Subject|1|||
161077435|NCT04844879|581672106|FG000|Overall Study|Adverse Event|1|||
161077436|NCT03551691|581672126|FG000|Overall Study|Withdrawal by Subject|3|||
161077437|NCT03551691|581672127|FG001|Overall Study|Withdrawal by Subject|3|||
161077438|NCT02367040|581672128|FG000|Overall Study|Lost to Follow-up|1|||
161077439|NCT02367040|581672129|FG001|Overall Study|Lost to Follow-up|1|||
161077440|NCT02367040|581672128|FG000|Overall Study|Lack of Efficacy|1|||
161158830|NCT00960934|581961143|FG004|Overall Study|Adverse Event|4|||
161286682|NCT00725491|582429813|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
161286683|NCT00725491|582429814|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
161345967|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
161286684|NCT01641640|582429817|FG000|Overall Study|Enrolled but not treated|1|||
161286685|NCT01641640|582429817|FG000|Overall Study|Efficacy failure|29|||
161286686|NCT01641640|582429817|FG000|Overall Study|Lost to Follow-up|3|||
161286687|NCT01641640|582429817|FG000|Overall Study|Withdrawal by Subject|2|||
161077441|NCT02367040|581672129|FG001|Overall Study|Lack of Efficacy|0|||
161077442|NCT02367040|581672128|FG000|Overall Study|Additional primary malignancy|1|||
161077443|NCT02367040|581672129|FG001|Overall Study|Additional primary malignancy|1|||
161077444|NCT02367040|581672128|FG000|Overall Study|AE not associated with clinical disease progression|117|||
161158831|NCT00960934|581961144|FG005|Overall Study|Adverse Event|3|||
161158832|NCT00960934|581961139|FG000|Overall Study|Lack of Efficacy|1|||
161158833|NCT00960934|581961140|FG001|Overall Study|Lack of Efficacy|0|||
161158834|NCT00960934|581961141|FG002|Overall Study|Lack of Efficacy|0|||
161158835|NCT00960934|581961142|FG003|Overall Study|Lack of Efficacy|0|||
161158836|NCT00960934|581961143|FG004|Overall Study|Lack of Efficacy|0|||
161158837|NCT00960934|581961144|FG005|Overall Study|Lack of Efficacy|0|||
161158838|NCT00960934|581961139|FG000|Overall Study|Lost to Follow-up|0|||
161158839|NCT00960934|581961140|FG001|Overall Study|Lost to Follow-up|1|||
161158840|NCT00960934|581961141|FG002|Overall Study|Lost to Follow-up|0|||
161158841|NCT00960934|581961142|FG003|Overall Study|Lost to Follow-up|0|||
161158842|NCT00960934|581961143|FG004|Overall Study|Lost to Follow-up|0|||
161158843|NCT00960934|581961144|FG005|Overall Study|Lost to Follow-up|0|||
161158844|NCT00960934|581961139|FG000|Overall Study|Other|2|||
161158845|NCT00960934|581961140|FG001|Overall Study|Other|1|||
161158846|NCT00960934|581961141|FG002|Overall Study|Other|5|||
161158847|NCT00960934|581961142|FG003|Overall Study|Other|4|||
161158848|NCT00960934|581961143|FG004|Overall Study|Other|2|||
161158849|NCT00960934|581961144|FG005|Overall Study|Other|2|||
161158850|NCT00960934|581961139|FG000|Overall Study|Physician Decision|0|||
161158851|NCT00960934|581961140|FG001|Overall Study|Physician Decision|1|||
161158852|NCT00960934|581961141|FG002|Overall Study|Physician Decision|0|||
161158853|NCT00960934|581961142|FG003|Overall Study|Physician Decision|0|||
161158854|NCT00960934|581961143|FG004|Overall Study|Physician Decision|0|||
161158855|NCT00960934|581961144|FG005|Overall Study|Physician Decision|0|||
161158856|NCT00960934|581961139|FG000|Overall Study|Progressive Disease|1|||
161158857|NCT00960934|581961140|FG001|Overall Study|Progressive Disease|1|||
161158858|NCT00960934|581961141|FG002|Overall Study|Progressive Disease|0|||
161158859|NCT00960934|581961142|FG003|Overall Study|Progressive Disease|0|||
161158860|NCT00960934|581961143|FG004|Overall Study|Progressive Disease|1|||
161158861|NCT00960934|581961144|FG005|Overall Study|Progressive Disease|1|||
161158862|NCT00960934|581961139|FG000|Overall Study|Protocol Violation|3|||
161158863|NCT00960934|581961140|FG001|Overall Study|Protocol Violation|4|||
161158864|NCT00960934|581961141|FG002|Overall Study|Protocol Violation|0|||
161158865|NCT00960934|581961142|FG003|Overall Study|Protocol Violation|3|||
161158866|NCT00960934|581961143|FG004|Overall Study|Protocol Violation|3|||
161158867|NCT00960934|581961144|FG005|Overall Study|Protocol Violation|2|||
161286688|NCT01641640|582429817|FG000|Overall Study|Adverse Event|1|||
161286689|NCT01778530|582429821|FG000|Overall Study|Progression on study|1|||
161286690|NCT01778530|582429821|FG000|Overall Study|Adverse event/side effect|1|||
161286691|NCT01199939|582429822|FG000|Overall Study|Adverse Event|4|||
161286692|NCT01199939|582429822|FG000|Overall Study|Protocol Violation|3|||
161286693|NCT01199939|582429822|FG000|Overall Study|Lost to Follow-up|2|||
161286694|NCT01199939|582429822|FG000|Overall Study|Reached a virologic endpoint|4|||
161345968|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
161077445|NCT02367040|581672129|FG001|Overall Study|AE not associated with clinical disease progression|12|||
161158868|NCT00960934|581961139|FG000|Overall Study|Withdrawal by Subject|5|||
161286695|NCT03472014|582429823|FG000|Overall Study|Lost to Follow-up|4|||
161286696|NCT02792517|582429831|FG000|Overall Study|Withdrawal by Subject|10|||
161286697|NCT02792517|582429831|FG000|Overall Study|Decision by Sponsor|7|||
161077446|NCT02367040|581672128|FG000|Overall Study|AE associated with clinical disease progression|1|||
161077447|NCT02367040|581672129|FG001|Overall Study|AE associated with clinical disease progression|4|||
161077448|NCT02367040|581672128|FG000|Overall Study|Physician Decision|2|||
161077449|NCT02367040|581672129|FG001|Overall Study|Physician Decision|8|||
161077450|NCT02367040|581672128|FG000|Overall Study|Non-compliance to study drug|1|||
161077451|NCT02367040|581672129|FG001|Overall Study|Non-compliance to study drug|0|||
161077452|NCT02367040|581672128|FG000|Overall Study|Failure to meet continuation criteria|1|||
161077453|NCT02367040|581672129|FG001|Overall Study|Failure to meet continuation criteria|0|||
161077454|NCT02367040|581672128|FG000|Overall Study|Switching to other therapy|2|||
161077455|NCT02367040|581672129|FG001|Overall Study|Switching to other therapy|0|||
161158869|NCT00960934|581961140|FG001|Overall Study|Withdrawal by Subject|6|||
161158870|NCT00960934|581961141|FG002|Overall Study|Withdrawal by Subject|4|||
161158871|NCT00960934|581961142|FG003|Overall Study|Withdrawal by Subject|5|||
161158872|NCT00960934|581961143|FG004|Overall Study|Withdrawal by Subject|5|||
161286698|NCT02792517|582429831|FG000|Overall Study|Lost to Follow-up|3|||
161286699|NCT00882518|582429832|FG000|Overall Study|Adverse Event|9|||
161286700|NCT00882518|582429833|FG001|Overall Study|Adverse Event|18|||
161158873|NCT00960934|581961144|FG005|Overall Study|Withdrawal by Subject|7|||
161345969|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
161158874|NCT00960934|581961139|FG000|Overall Study|Study Terminated by Sponsor|50|||
161158875|NCT00960934|581961140|FG001|Overall Study|Study Terminated by Sponsor|46|||
161158876|NCT00960934|581961141|FG002|Overall Study|Study Terminated by Sponsor|52|||
161158877|NCT00960934|581961142|FG003|Overall Study|Study Terminated by Sponsor|50|||
161158878|NCT00960934|581961143|FG004|Overall Study|Study Terminated by Sponsor|49|||
161286701|NCT00882518|582429832|FG000|Overall Study|Withdrawal by Subject|9|||
161286702|NCT00882518|582429833|FG001|Overall Study|Withdrawal by Subject|13|||
161158879|NCT00960934|581961144|FG005|Overall Study|Study Terminated by Sponsor|49|||
161158880|NCT02338492|581961157|FG000|Overall Study|Death|32|||
161158881|NCT02338492|581961157|FG000|Overall Study|Adverse Event|3|||
161158882|NCT02338492|581961157|FG000|Overall Study|Lost to Follow-up|4|||
161158883|NCT02338492|581961157|FG000|Overall Study|Reason not captured above|6|||
161158884|NCT04281030|581961158|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
161158885|NCT04281030|581961159|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
161158886|NCT04281030|581961158|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
161158887|NCT04281030|581961159|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
161158888|NCT01395368|581961160|FG000|Overall Study|Physician Decision|14|||
161158889|NCT01395368|581961160|FG000|Overall Study|Withdrawal by Subject|2|||
161158890|NCT00310388|581961161|FG000|Primary Reporting Phase|Adverse Event|101|||
161158891|NCT00310388|581961162|FG001|Primary Reporting Phase|Adverse Event|0|||
161158892|NCT00310388|581961161|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
161158893|NCT00310388|581961162|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
161158894|NCT00310388|581961161|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
161158895|NCT00310388|581961162|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
161158896|NCT00310388|581961161|FG000|Primary Reporting Phase|Protocol Violation|10|||
161158897|NCT00310388|581961162|FG001|Primary Reporting Phase|Protocol Violation|0|||
161158898|NCT00310388|581961161|FG000|Primary Reporting Phase|Pregnancy|3|||
161158899|NCT00310388|581961162|FG001|Primary Reporting Phase|Pregnancy|0|||
161158900|NCT00310388|581961161|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
161158901|NCT00310388|581961162|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
161158902|NCT00310388|581961161|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
161158903|NCT00310388|581961162|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
161158904|NCT00310388|581961161|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
161158905|NCT00310388|581961162|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
161158906|NCT00310388|581961161|FG000|Primary Reporting Phase|Physician Decision|2|||
161158907|NCT00310388|581961162|FG001|Primary Reporting Phase|Physician Decision|0|||
161158908|NCT00310388|581961161|FG000|Primary Reporting Phase|Request of the sponsor|19|||
161158909|NCT00310388|581961162|FG001|Primary Reporting Phase|Request of the sponsor|0|||
161158910|NCT00310388|581961161|FG000|Primary Reporting Phase|Failed to return|8|||
161158911|NCT00310388|581961162|FG001|Primary Reporting Phase|Failed to return|0|||
161158912|NCT00310388|581961161|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
161158913|NCT00310388|581961162|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
161158914|NCT00310388|581961161|FG000|Primary Reporting Phase|Participant request|2|||
161158915|NCT00310388|581961162|FG001|Primary Reporting Phase|Participant request|0|||
161158916|NCT00310388|581961161|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
161158917|NCT00310388|581961162|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
161158918|NCT00310388|581961161|FG000|Primary Reporting Phase|Discontinuation of study|1|||
161158919|NCT00310388|581961162|FG001|Primary Reporting Phase|Discontinuation of study|0|||
161158920|NCT00310388|581961161|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
161158921|NCT00310388|581961162|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
161158922|NCT00310388|581961161|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
161158923|NCT00310388|581961162|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
161158924|NCT00310388|581961161|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
161158925|NCT00310388|581961162|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
161158926|NCT00310388|581961161|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
161158927|NCT00310388|581961162|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
161158928|NCT00310388|581961161|FG000|Primary Reporting Phase|Participant passed away|1|||
161158929|NCT00310388|581961162|FG001|Primary Reporting Phase|Participant passed away|0|||
161158930|NCT00310388|581961161|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
161158931|NCT00310388|581961162|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
161158932|NCT00310388|581961161|FG000|Primary Reporting Phase|Missing|1|||
161158933|NCT00310388|581961162|FG001|Primary Reporting Phase|Missing|0|||
161158934|NCT00310388|581961161|FG000|Primary Reporting Phase|Other|1|||
161158935|NCT00310388|581961162|FG001|Primary Reporting Phase|Other|0|||
161158936|NCT00310388|581961161|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
161158937|NCT00310388|581961162|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
161158938|NCT00310388|581961161|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
161158939|NCT00310388|581961162|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
161158940|NCT00310388|581961161|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
161158941|NCT00310388|581961162|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
161158942|NCT00310388|581961161|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
161158943|NCT00310388|581961162|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
161158944|NCT02179515|581961167|FG000|Overall Study|switched to alternative treatment|0|||
161345970|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
161345971|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
161345972|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
161158945|NCT02179515|581961168|FG001|Overall Study|switched to alternative treatment|1|||
161286703|NCT00882518|582429832|FG000|Overall Study|Lack of Efficacy|12|||
161077456|NCT02367040|581672128|FG000|Overall Study|Withdrawal by Subject|51|||
161077457|NCT02367040|581672129|FG001|Overall Study|Withdrawal by Subject|16|||
161077458|NCT02367040|581672128|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
161077459|NCT02367040|581672129|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161077460|NCT02367040|581672128|FG000|Overall Study|Patient decision|40|||
161077461|NCT02367040|581672129|FG001|Overall Study|Patient decision|14|||
161077462|NCT02367040|581672128|FG000|Overall Study|Required procedure failed|1|||
161077463|NCT02367040|581672129|FG001|Overall Study|Required procedure failed|0|||
161077464|NCT02367040|581672128|FG000|Overall Study|Randomized by mistake with study treatment|1|||
161077465|NCT02367040|581672129|FG001|Overall Study|Randomized by mistake with study treatment|0|||
161077466|NCT02367040|581672128|FG000|Overall Study|Protocol Violation|1|||
161077467|NCT02367040|581672129|FG001|Overall Study|Protocol Violation|0|||
161077468|NCT02367040|581672128|FG000|Overall Study|Progressive disease - radiological progression|54|||
161077469|NCT02367040|581672129|FG001|Overall Study|Progressive disease - radiological progression|80|||
161077470|NCT02367040|581672128|FG000|Overall Study|Progressive disease - clinical progression|6|||
161077471|NCT02367040|581672129|FG001|Overall Study|Progressive disease - clinical progression|6|||
161077472|NCT02367040|581672128|FG000|Overall Study|Drug not administered|3|||
161077473|NCT02367040|581672129|FG001|Overall Study|Drug not administered|2|||
161077474|NCT02367040|581672128|FG000|Overall Study|Progressive disease|0|||
161077475|NCT02367040|581672129|FG001|Overall Study|Progressive disease|1|||
161077476|NCT02367040|581672128|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
161077477|NCT02367040|581672129|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
161077478|NCT02367040|581672128|FG000|Overall Study|Death|2|||
161077479|NCT02367040|581672129|FG001|Overall Study|Death|0|||
161077480|NCT02367040|581672128|FG000|Overall Study|Study terminated by sponsor|19|||
161077481|NCT02367040|581672129|FG001|Overall Study|Study terminated by sponsor|2|||
161077482|NCT02477618|581672130|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
161077483|NCT02477618|581672131|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
161077484|NCT02477618|581672130|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
161077485|NCT02477618|581672131|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
161077486|NCT02477618|581672130|FG000|Overall Study|Adverse Event|1|||
161077487|NCT02477618|581672131|FG001|Overall Study|Adverse Event|1|||
161077488|NCT02477618|581672130|FG000|Overall Study|Transferred Away from Study Site|1|||
161158946|NCT02179515|581961169|FG002|Overall Study|switched to alternative treatment|1|||
161158947|NCT02179515|581961167|FG000|Overall Study|Death|0|||
161158948|NCT02179515|581961168|FG001|Overall Study|Death|1|||
161158949|NCT02179515|581961169|FG002|Overall Study|Death|1|||
161158950|NCT02179515|581961167|FG000|Overall Study|refused further treatment|0|||
161158951|NCT02179515|581961168|FG001|Overall Study|refused further treatment|3|||
161158952|NCT02179515|581961169|FG002|Overall Study|refused further treatment|4|||
161158953|NCT02179515|581961167|FG000|Overall Study|Disease progression on study|2|||
161158954|NCT02179515|581961168|FG001|Overall Study|Disease progression on study|11|||
161158955|NCT02179515|581961169|FG002|Overall Study|Disease progression on study|8|||
161158956|NCT00782418|581961170|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
161158957|NCT00782418|581961171|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161158958|NCT00782418|581961172|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161158959|NCT00782418|581961173|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161158960|NCT00782418|581961174|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161158961|NCT00782418|581961175|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161158962|NCT00782418|581961176|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
161158963|NCT00782418|581961170|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161158964|NCT00782418|581961171|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161158965|NCT00782418|581961172|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161158966|NCT00782418|581961173|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161158967|NCT00782418|581961174|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161158968|NCT00782418|581961175|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
161158969|NCT00782418|581961176|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
161158970|NCT01718509|581961177|FG000|Overall Study|Lost to Follow-up|18|||
161158971|NCT01718509|581961178|FG001|Overall Study|Lost to Follow-up|15|||
161077489|NCT02477618|581672131|FG001|Overall Study|Transferred Away from Study Site|0|||
161077490|NCT02477618|581672130|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
161158972|NCT01718509|581961177|FG000|Overall Study|Withdrawal by Subject|7|||
161077491|NCT02477618|581672131|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
161077492|NCT03007420|581672132|FG000|Overall Study|Withdrawal by Subject|0|||
161286704|NCT00882518|582429833|FG001|Overall Study|Lack of Efficacy|9|||
161077493|NCT03007420|581672133|FG001|Overall Study|Withdrawal by Subject|2|||
161077494|NCT03007420|581672132|FG000|Overall Study|Physician Decision|0|||
161158973|NCT01718509|581961178|FG001|Overall Study|Withdrawal by Subject|13|||
161077495|NCT03007420|581672133|FG001|Overall Study|Physician Decision|1|||
161158974|NCT01718509|581961177|FG000|Overall Study|Adverse Event|5|||
161158975|NCT01718509|581961178|FG001|Overall Study|Adverse Event|7|||
161158976|NCT01718509|581961177|FG000|Overall Study|Other|13|||
161158977|NCT01718509|581961178|FG001|Overall Study|Other|11|||
161158978|NCT01718509|581961177|FG000|Overall Study|Protocol Violation|4|||
161158979|NCT01718509|581961178|FG001|Overall Study|Protocol Violation|2|||
161158980|NCT01718509|581961177|FG000|Overall Study|Lack of Efficacy|1|||
161158981|NCT01718509|581961178|FG001|Overall Study|Lack of Efficacy|0|||
161158982|NCT00882999|581961181|FG000|Overall Study|Adverse Event|0|||
161158983|NCT00882999|581961182|FG001|Overall Study|Adverse Event|0|||
161158984|NCT00882999|581961183|FG002|Overall Study|Adverse Event|0|||
161158985|NCT00882999|581961184|FG003|Overall Study|Adverse Event|0|||
161158986|NCT00882999|581961185|FG004|Overall Study|Adverse Event|1|||
161286705|NCT00882518|582429832|FG000|Overall Study|Severe non-compliance to protocol|3|||
161286706|NCT00882518|582429833|FG001|Overall Study|Severe non-compliance to protocol|1|||
161286707|NCT00882518|582429832|FG000|Overall Study|Incorrect enrolment|4|||
161286708|NCT00882518|582429833|FG001|Overall Study|Incorrect enrolment|2|||
161286709|NCT00882518|582429832|FG000|Overall Study|Central lab closure for National day|1|||
161286710|NCT00882518|582429833|FG001|Overall Study|Central lab closure for National day|0|||
161286711|NCT00882518|582429832|FG000|Overall Study|Allocating random number by mistake|0|||
161286712|NCT00882518|582429833|FG001|Overall Study|Allocating random number by mistake|1|||
161286713|NCT03238651|582429834|FG000|Overall Study|Other|0|||
161286714|NCT03238651|582429835|FG001|Overall Study|Other|0|||
161286715|NCT03238651|582429836|FG002|Overall Study|Other|0|||
161286716|NCT03238651|582429837|FG003|Overall Study|Other|0|||
161286717|NCT03238651|582429838|FG004|Overall Study|Other|1|||
161286718|NCT03238651|582429834|FG000|Overall Study|Progressive Disease|2|||
161286719|NCT03238651|582429835|FG001|Overall Study|Progressive Disease|2|||
161286720|NCT03238651|582429836|FG002|Overall Study|Progressive Disease|2|||
161286721|NCT03238651|582429837|FG003|Overall Study|Progressive Disease|2|||
161286722|NCT03238651|582429838|FG004|Overall Study|Progressive Disease|0|||
161286723|NCT03238651|582429834|FG000|Overall Study|Withdrawal by Subject|0|||
161286724|NCT03238651|582429835|FG001|Overall Study|Withdrawal by Subject|1|||
161286725|NCT03238651|582429836|FG002|Overall Study|Withdrawal by Subject|0|||
161286726|NCT03238651|582429837|FG003|Overall Study|Withdrawal by Subject|1|||
161286727|NCT03238651|582429838|FG004|Overall Study|Withdrawal by Subject|0|||
161286728|NCT03238651|582429834|FG000|Overall Study|Adverse Event|1|||
161286729|NCT03238651|582429835|FG001|Overall Study|Adverse Event|3|||
161286730|NCT03238651|582429836|FG002|Overall Study|Adverse Event|2|||
161286731|NCT03238651|582429837|FG003|Overall Study|Adverse Event|0|||
161286732|NCT03238651|582429838|FG004|Overall Study|Adverse Event|0|||
161286733|NCT00711087|582429839|FG000|Overall Study|Lost to Follow-up|1|||
161286734|NCT00711087|582429840|FG001|Overall Study|Lost to Follow-up|0|||
161286735|NCT03652051|582429841|FG000|Stage 1|Adverse Event|0|||
161286736|NCT03652051|582429842|FG001|Stage 1|Adverse Event|5|||
161286737|NCT03652051|582429843|FG002|Stage 1|Adverse Event|7|||
161286738|NCT03652051|582429844|FG003|Stage 1|Adverse Event|1|||
161286739|NCT03652051|582429841|FG000|Stage 1|Withdrawal by Subject|0|||
161286740|NCT03652051|582429842|FG001|Stage 1|Withdrawal by Subject|0|||
161286741|NCT03652051|582429843|FG002|Stage 1|Withdrawal by Subject|1|||
161286742|NCT03652051|582429844|FG003|Stage 1|Withdrawal by Subject|0|||
161286743|NCT03652051|582429841|FG000|Stage 2|Adverse Event|0|||
161286744|NCT03652051|582429842|FG001|Stage 2|Adverse Event|2|||
161158987|NCT00882999|581961186|FG005|Overall Study|Adverse Event|0|||
161158988|NCT00882999|581961187|FG006|Overall Study|Adverse Event|0|||
161286745|NCT03652051|582429843|FG002|Stage 2|Adverse Event|1|||
161286746|NCT03652051|582429844|FG003|Stage 2|Adverse Event|0|||
161286747|NCT03652051|582429841|FG000|Stage 2|Protocol Violation|0|||
161286748|NCT03652051|582429842|FG001|Stage 2|Protocol Violation|1|||
161286749|NCT03652051|582429843|FG002|Stage 2|Protocol Violation|6|||
161286750|NCT03652051|582429844|FG003|Stage 2|Protocol Violation|0|||
161286751|NCT03652051|582429841|FG000|Stage 2|Lost to Follow-up|0|||
161158989|NCT00882999|581961181|FG000|Overall Study|Death|0|||
161158990|NCT00882999|581961182|FG001|Overall Study|Death|1|||
161286752|NCT03652051|582429842|FG001|Stage 2|Lost to Follow-up|2|||
161286753|NCT03652051|582429843|FG002|Stage 2|Lost to Follow-up|0|||
161286754|NCT03652051|582429844|FG003|Stage 2|Lost to Follow-up|3|||
161286755|NCT03652051|582429841|FG000|Stage 2|Withdrawal by Subject|0|||
161286756|NCT03652051|582429842|FG001|Stage 2|Withdrawal by Subject|11|||
161286757|NCT03652051|582429843|FG002|Stage 2|Withdrawal by Subject|9|||
161286758|NCT03652051|582429844|FG003|Stage 2|Withdrawal by Subject|3|||
161286759|NCT01930162|582429845|FG000|Overall Study|Abnormal test procedure result(s)|4|||
161286760|NCT01930162|582429845|FG000|Overall Study|Death|1|||
161286761|NCT02603887|582429846|FG000|Stage 1|Adverse Event|4|||
161286762|NCT02603887|582429846|FG000|Stage 1|Disease progression|1|||
161158991|NCT00882999|581961183|FG002|Overall Study|Death|0|||
161158992|NCT00882999|581961184|FG003|Overall Study|Death|0|||
161158993|NCT00882999|581961185|FG004|Overall Study|Death|0|||
161286763|NCT02603887|582429846|FG000|Stage 2|FDA guidance|1|||
161286764|NCT03535740|582429847|FG000|Overall Study|Death|44|||
161286765|NCT03535740|582429847|FG000|Overall Study|Lost to Follow-up|1|||
161286766|NCT03535740|582429847|FG000|Overall Study|Withdrawal by Subject|13|||
161158994|NCT00882999|581961186|FG005|Overall Study|Death|0|||
161158995|NCT00882999|581961187|FG006|Overall Study|Death|0|||
161158996|NCT00882999|581961181|FG000|Overall Study|Withdrawal by Subject|7|||
161158997|NCT00882999|581961182|FG001|Overall Study|Withdrawal by Subject|6|||
161158998|NCT00882999|581961183|FG002|Overall Study|Withdrawal by Subject|3|||
161158999|NCT00882999|581961184|FG003|Overall Study|Withdrawal by Subject|3|||
161159000|NCT00882999|581961185|FG004|Overall Study|Withdrawal by Subject|6|||
161159001|NCT00882999|581961186|FG005|Overall Study|Withdrawal by Subject|5|||
161159002|NCT00882999|581961187|FG006|Overall Study|Withdrawal by Subject|5|||
161159003|NCT00882999|581961181|FG000|Overall Study|Lost to Follow-up|0|||
161159004|NCT00882999|581961182|FG001|Overall Study|Lost to Follow-up|1|||
161159005|NCT00882999|581961183|FG002|Overall Study|Lost to Follow-up|1|||
161159006|NCT00882999|581961184|FG003|Overall Study|Lost to Follow-up|2|||
161159007|NCT00882999|581961185|FG004|Overall Study|Lost to Follow-up|1|||
161159008|NCT00882999|581961186|FG005|Overall Study|Lost to Follow-up|1|||
161159009|NCT00882999|581961187|FG006|Overall Study|Lost to Follow-up|2|||
161159010|NCT00882999|581961181|FG000|Overall Study|Physician Decision|1|||
161159011|NCT00882999|581961182|FG001|Overall Study|Physician Decision|0|||
161159012|NCT00882999|581961183|FG002|Overall Study|Physician Decision|0|||
161159013|NCT00882999|581961184|FG003|Overall Study|Physician Decision|0|||
161159014|NCT00882999|581961185|FG004|Overall Study|Physician Decision|0|||
161159015|NCT00882999|581961186|FG005|Overall Study|Physician Decision|1|||
161159016|NCT00882999|581961187|FG006|Overall Study|Physician Decision|1|||
161159017|NCT01757405|581961190|FG000|Overall Study|Lost to Follow-up|1|||
161159018|NCT01757405|581961191|FG001|Overall Study|Lost to Follow-up|1|||
161159019|NCT01757405|581961190|FG000|Overall Study|Withdrawal by Subject|0|||
161159020|NCT01757405|581961191|FG001|Overall Study|Withdrawal by Subject|1|||
161159021|NCT00082758|581961192|FG000|Overall Study|Adverse Event|0|||
161159022|NCT00082758|581961193|FG001|Overall Study|Adverse Event|2|||
161159023|NCT00082758|581961194|FG002|Overall Study|Adverse Event|0|||
161159024|NCT00082758|581961192|FG000|Overall Study|Lack of Efficacy|12|||
161286767|NCT03535740|582429847|FG000|Overall Study|Site terminated by Sponsor|45|||
161286768|NCT01870778|582429851|FG000|Overall Study|Withdrawal by Subject|8|||
161286769|NCT01870778|582429852|FG001|Overall Study|Withdrawal by Subject|7|||
161286770|NCT01870778|582429851|FG000|Overall Study|Lost to Follow-up|0|||
161077496|NCT01435772|581672136|FG000|Overall Study|Adverse Event|1|||
161077497|NCT01435772|581672137|FG001|Overall Study|Adverse Event|0|||
161077498|NCT01435772|581672138|FG002|Overall Study|Adverse Event|2|||
161077499|NCT01435772|581672136|FG000|Overall Study|Withdrawal by Subject|0|||
161077500|NCT01435772|581672137|FG001|Overall Study|Withdrawal by Subject|1|||
161077501|NCT01435772|581672138|FG002|Overall Study|Withdrawal by Subject|3|||
161077502|NCT01435772|581672136|FG000|Overall Study|Other - study termination|2|||
161077503|NCT01435772|581672137|FG001|Overall Study|Other - study termination|2|||
161077504|NCT01435772|581672138|FG002|Overall Study|Other - study termination|10|||
161286771|NCT01870778|582429852|FG001|Overall Study|Lost to Follow-up|2|||
161286772|NCT01169350|582429855|FG000|Overall Study|Physician Decision|3|||
161286773|NCT01169350|582429855|FG000|Overall Study|Lost to Follow-up|2|||
161286774|NCT04870710|582429857|FG000|Overall Study|Lost to Follow-up|3|||
161286775|NCT01876446|582429858|FG000|Overall Study|Death|0|||
161286776|NCT01876446|582429859|FG001|Overall Study|Death|1|||
161077505|NCT03238963|581672139|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
161077506|NCT03238963|581672140|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
161077507|NCT03238963|581672139|FG000|Overall Study|Withdrawal by Subject|1|||
161077508|NCT03238963|581672140|FG001|Overall Study|Withdrawal by Subject|1|||
161077509|NCT03238963|581672139|FG000|Overall Study|Lost to Follow-up|1|||
161077510|NCT03238963|581672140|FG001|Overall Study|Lost to Follow-up|0|||
161077511|NCT03238963|581672139|FG000|Overall Study|Protocol Violation|1|||
161077512|NCT03238963|581672140|FG001|Overall Study|Protocol Violation|1|||
161077513|NCT03238963|581672139|FG000|Overall Study|Adverse Event|1|||
161159025|NCT00082758|581961193|FG001|Overall Study|Lack of Efficacy|13|||
161286777|NCT01876446|582429858|FG000|Overall Study|Withdrawal by Subject|1|||
161286778|NCT01876446|582429859|FG001|Overall Study|Withdrawal by Subject|2|||
161286779|NCT01876446|582429858|FG000|Overall Study|Physician Decision|1|||
161286780|NCT01876446|582429859|FG001|Overall Study|Physician Decision|3|||
161159026|NCT00082758|581961194|FG002|Overall Study|Lack of Efficacy|0|||
161159027|NCT00082758|581961192|FG000|Overall Study|Physician Decision|0|||
161159028|NCT00082758|581961193|FG001|Overall Study|Physician Decision|1|||
161159029|NCT00082758|581961194|FG002|Overall Study|Physician Decision|0|||
161159030|NCT00082758|581961192|FG000|Overall Study|Withdrawal by Subject|3|||
161159031|NCT00082758|581961193|FG001|Overall Study|Withdrawal by Subject|0|||
161159032|NCT00082758|581961194|FG002|Overall Study|Withdrawal by Subject|0|||
161159033|NCT00082758|581961192|FG000|Overall Study|Protocol Violation|0|||
161286781|NCT02108912|582429860|FG000|Overall Study|Lost to Follow-up|1|||
161286782|NCT02108912|582429861|FG001|Overall Study|Lost to Follow-up|1|||
161286783|NCT02108912|582429860|FG000|Overall Study|lack of transportation|1|||
161159034|NCT00082758|581961193|FG001|Overall Study|Protocol Violation|1|||
161159035|NCT00082758|581961194|FG002|Overall Study|Protocol Violation|0|||
161159036|NCT00238303|581961195|FG000|Overall Study|Withdrawal by Subject|11|||
161077514|NCT03238963|581672140|FG001|Overall Study|Adverse Event|0|||
161077515|NCT05823012|581672141|FG000|Titration Period|Adverse Event|1|||
161077516|NCT05823012|581672141|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
161077517|NCT05823012|581672141|FG000|Maintenance Period|Adverse Event|1|||
161077518|NCT05823012|581672141|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
161077519|NCT05823012|581672141|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
161077520|NCT01424813|581672142|FG000|Overall Study|Withdrawal by Subject|3|||
161077521|NCT01424813|581672143|FG001|Overall Study|Withdrawal by Subject|0|||
161077522|NCT01424813|581672142|FG000|Overall Study|Protocol Violation|1|||
161077523|NCT01424813|581672143|FG001|Overall Study|Protocol Violation|0|||
161077524|NCT01424813|581672142|FG000|Overall Study|Other|1|||
161077525|NCT01424813|581672143|FG001|Overall Study|Other|2|||
161077526|NCT07149155|581672144|FG000|Overall Study|Lost to Follow-up|10|||
161077527|NCT00515671|581673713|FG000|Overall Study|Lost to Follow-up|13|||
161077528|NCT00515671|581673714|FG001|Overall Study|Lost to Follow-up|10|||
161077529|NCT00515671|581673713|FG000|Overall Study|Withdrawal by Subject|3|||
161077530|NCT00515671|581673714|FG001|Overall Study|Withdrawal by Subject|5|||
161077531|NCT00515671|581673713|FG000|Overall Study|incarcerated|1|||
161077532|NCT00515671|581673714|FG001|Overall Study|incarcerated|2|||
161077533|NCT02942277|581673721|FG000|Year 1|Withdrawal by Subject|0|||
161077534|NCT02942277|581673722|FG001|Year 1|Withdrawal by Subject|0|||
161077535|NCT02942277|581673723|FG002|Year 1|Withdrawal by Subject|0|||
161077536|NCT02942277|581673724|FG003|Year 1|Withdrawal by Subject|0|||
161077537|NCT02942277|581673725|FG004|Year 1|Withdrawal by Subject|1|||
161077538|NCT02942277|581673726|FG005|Year 1|Withdrawal by Subject|3|||
161077539|NCT02942277|581673727|FG006|Year 1|Withdrawal by Subject|0|||
161077540|NCT02942277|581673728|FG007|Year 1|Withdrawal by Subject|1|||
161077541|NCT02942277|581673729|FG008|Year 1|Withdrawal by Subject|0|||
161077542|NCT02942277|581673730|FG009|Year 1|Withdrawal by Subject|0|||
161077543|NCT02942277|581673731|FG010|Year 1|Withdrawal by Subject|3|||
161077544|NCT02942277|581673721|FG000|Year 1|Travel|0|||
161077545|NCT02942277|581673722|FG001|Year 1|Travel|1|||
161077546|NCT02942277|581673723|FG002|Year 1|Travel|0|||
161077547|NCT02942277|581673724|FG003|Year 1|Travel|0|||
161077548|NCT02942277|581673725|FG004|Year 1|Travel|4|||
161077549|NCT02942277|581673726|FG005|Year 1|Travel|5|||
161077550|NCT02942277|581673727|FG006|Year 1|Travel|0|||
161077551|NCT02942277|581673728|FG007|Year 1|Travel|0|||
161077552|NCT02942277|581673729|FG008|Year 1|Travel|0|||
161077553|NCT02942277|581673730|FG009|Year 1|Travel|0|||
161077554|NCT02942277|581673731|FG010|Year 1|Travel|8|||
161077555|NCT02942277|581673721|FG000|Year 1|Joined Army|0|||
161077556|NCT02942277|581673722|FG001|Year 1|Joined Army|1|||
161077557|NCT02942277|581673723|FG002|Year 1|Joined Army|0|||
161077558|NCT02942277|581673724|FG003|Year 1|Joined Army|0|||
161077559|NCT02942277|581673725|FG004|Year 1|Joined Army|0|||
161077560|NCT02942277|581673726|FG005|Year 1|Joined Army|0|||
161077561|NCT02942277|581673727|FG006|Year 1|Joined Army|0|||
161077562|NCT02942277|581673728|FG007|Year 1|Joined Army|0|||
161077563|NCT02942277|581673729|FG008|Year 1|Joined Army|0|||
161077564|NCT02942277|581673730|FG009|Year 1|Joined Army|0|||
161077565|NCT02942277|581673731|FG010|Year 1|Joined Army|0|||
161077566|NCT02942277|581673721|FG000|Year 1|Subject met withdrawal criteria|0|||
161077567|NCT02942277|581673722|FG001|Year 1|Subject met withdrawal criteria|0|||
161077568|NCT02942277|581673723|FG002|Year 1|Subject met withdrawal criteria|0|||
161077569|NCT02942277|581673724|FG003|Year 1|Subject met withdrawal criteria|1|||
161077570|NCT02942277|581673725|FG004|Year 1|Subject met withdrawal criteria|0|||
161077571|NCT02942277|581673726|FG005|Year 1|Subject met withdrawal criteria|0|||
161077572|NCT02942277|581673727|FG006|Year 1|Subject met withdrawal criteria|0|||
161077573|NCT02942277|581673728|FG007|Year 1|Subject met withdrawal criteria|0|||
161077574|NCT02942277|581673729|FG008|Year 1|Subject met withdrawal criteria|0|||
161077575|NCT02942277|581673730|FG009|Year 1|Subject met withdrawal criteria|0|||
161077576|NCT02942277|581673731|FG010|Year 1|Subject met withdrawal criteria|0|||
161077577|NCT02942277|581673721|FG000|Year 1|Lost to Follow-up|0|||
161077578|NCT02942277|581673722|FG001|Year 1|Lost to Follow-up|0|||
161077579|NCT02942277|581673723|FG002|Year 1|Lost to Follow-up|0|||
161077580|NCT02942277|581673724|FG003|Year 1|Lost to Follow-up|0|||
161077581|NCT02942277|581673725|FG004|Year 1|Lost to Follow-up|1|||
161077582|NCT02942277|581673726|FG005|Year 1|Lost to Follow-up|0|||
161077583|NCT02942277|581673727|FG006|Year 1|Lost to Follow-up|0|||
161159037|NCT00238303|581961196|FG001|Overall Study|Withdrawal by Subject|1|||
161077584|NCT02942277|581673728|FG007|Year 1|Lost to Follow-up|0|||
161077585|NCT02942277|581673729|FG008|Year 1|Lost to Follow-up|0|||
161077586|NCT02942277|581673730|FG009|Year 1|Lost to Follow-up|0|||
161159038|NCT00238303|581961197|FG002|Overall Study|Withdrawal by Subject|2|||
161077587|NCT02942277|581673731|FG010|Year 1|Lost to Follow-up|2|||
161077588|NCT02942277|581673721|FG000|Year 1|Protocol Violation|0|||
161077589|NCT02942277|581673722|FG001|Year 1|Protocol Violation|0|||
161077590|NCT02942277|581673723|FG002|Year 1|Protocol Violation|0|||
161077591|NCT02942277|581673724|FG003|Year 1|Protocol Violation|0|||
161077592|NCT02942277|581673725|FG004|Year 1|Protocol Violation|1|||
161077593|NCT02942277|581673726|FG005|Year 1|Protocol Violation|1|||
161077594|NCT02942277|581673727|FG006|Year 1|Protocol Violation|0|||
161159039|NCT00238303|581961195|FG000|Overall Study|Death|1|||
161159040|NCT00238303|581961196|FG001|Overall Study|Death|0|||
161159041|NCT00238303|581961197|FG002|Overall Study|Death|1|||
161159042|NCT00238303|581961195|FG000|Overall Study|Other Medical Problems|2|||
161159043|NCT00238303|581961196|FG001|Overall Study|Other Medical Problems|0|||
161159044|NCT00238303|581961197|FG002|Overall Study|Other Medical Problems|2|||
161159045|NCT00238303|581961195|FG000|Overall Study|Poor tolerance of study treatment|1|||
161159046|NCT00238303|581961196|FG001|Overall Study|Poor tolerance of study treatment|0|||
161159047|NCT00238303|581961197|FG002|Overall Study|Poor tolerance of study treatment|1|||
161159048|NCT00238303|581961195|FG000|Overall Study|Adverse Event|0|||
161159049|NCT00238303|581961196|FG001|Overall Study|Adverse Event|1|||
161159050|NCT00238303|581961197|FG002|Overall Study|Adverse Event|3|||
161159051|NCT01994226|581961201|FG000|Overall Study|Protocol Violation|13|||
161159052|NCT01994226|581961202|FG001|Overall Study|Protocol Violation|10|||
161159053|NCT01994226|581961201|FG000|Overall Study|Early Cessation of treatment|6|||
161159054|NCT01994226|581961202|FG001|Overall Study|Early Cessation of treatment|11|||
161159055|NCT02488551|581961203|FG000|Overall Study|Lost to Follow-up|4|||
161159056|NCT02488551|581961204|FG001|Overall Study|Lost to Follow-up|7|||
161159057|NCT02488551|581961205|FG002|Overall Study|Lost to Follow-up|0|||
161159058|NCT02488551|581961206|FG003|Overall Study|Lost to Follow-up|0|||
161077595|NCT02942277|581673728|FG007|Year 1|Protocol Violation|0|||
161077596|NCT02942277|581673729|FG008|Year 1|Protocol Violation|0|||
161077597|NCT02942277|581673730|FG009|Year 1|Protocol Violation|0|||
161077598|NCT02942277|581673731|FG010|Year 1|Protocol Violation|2|||
161077599|NCT02942277|581673721|FG000|Year 1|Pregnancy|0|||
161077600|NCT02942277|581673722|FG001|Year 1|Pregnancy|0|||
161077601|NCT02942277|581673723|FG002|Year 1|Pregnancy|0|||
161077602|NCT02942277|581673724|FG003|Year 1|Pregnancy|0|||
161077603|NCT02942277|581673725|FG004|Year 1|Pregnancy|0|||
161077604|NCT02942277|581673726|FG005|Year 1|Pregnancy|1|||
161077605|NCT02942277|581673727|FG006|Year 1|Pregnancy|0|||
161077606|NCT02942277|581673728|FG007|Year 1|Pregnancy|0|||
161077607|NCT02942277|581673729|FG008|Year 1|Pregnancy|0|||
161077608|NCT02942277|581673730|FG009|Year 1|Pregnancy|0|||
161077609|NCT02942277|581673731|FG010|Year 1|Pregnancy|0|||
161077610|NCT02942277|581673721|FG000|Year 2|Lost to Follow-up|0|||
161077611|NCT02942277|581673722|FG001|Year 2|Lost to Follow-up|0|||
161077612|NCT02942277|581673723|FG002|Year 2|Lost to Follow-up|0|||
161077613|NCT02942277|581673724|FG003|Year 2|Lost to Follow-up|0|||
161077614|NCT02942277|581673725|FG004|Year 2|Lost to Follow-up|2|||
161077615|NCT02942277|581673726|FG005|Year 2|Lost to Follow-up|1|||
161077616|NCT02942277|581673727|FG006|Year 2|Lost to Follow-up|0|||
161077617|NCT02942277|581673728|FG007|Year 2|Lost to Follow-up|0|||
161077618|NCT02942277|581673729|FG008|Year 2|Lost to Follow-up|0|||
161077619|NCT02942277|581673730|FG009|Year 2|Lost to Follow-up|0|||
161077620|NCT02942277|581673731|FG010|Year 2|Lost to Follow-up|0|||
161077621|NCT02942277|581673721|FG000|Year 2|Did not rescreen|0|||
161077622|NCT02942277|581673722|FG001|Year 2|Did not rescreen|0|||
161077623|NCT02942277|581673723|FG002|Year 2|Did not rescreen|1|||
161077624|NCT02942277|581673724|FG003|Year 2|Did not rescreen|1|||
161077625|NCT02942277|581673725|FG004|Year 2|Did not rescreen|9|||
161077626|NCT02942277|581673726|FG005|Year 2|Did not rescreen|6|||
161077627|NCT02942277|581673727|FG006|Year 2|Did not rescreen|0|||
161077628|NCT02942277|581673728|FG007|Year 2|Did not rescreen|1|||
161077629|NCT02942277|581673729|FG008|Year 2|Did not rescreen|0|||
161077630|NCT02942277|581673730|FG009|Year 2|Did not rescreen|0|||
161077631|NCT02942277|581673731|FG010|Year 2|Did not rescreen|21|||
161077632|NCT02942277|581673721|FG000|Year 2|Met withdrawal criteria|0|||
161077633|NCT02942277|581673722|FG001|Year 2|Met withdrawal criteria|0|||
161159059|NCT02488551|581961203|FG000|Overall Study|Military Deployment|1|||
161159060|NCT02488551|581961204|FG001|Overall Study|Military Deployment|1|||
161286784|NCT02108912|582429861|FG001|Overall Study|lack of transportation|0|||
161286785|NCT02108912|582429860|FG000|Overall Study|high blood pressure|1|||
161286786|NCT02108912|582429861|FG001|Overall Study|high blood pressure|0|||
161286787|NCT01808573|582429862|FG000|Overall Study|Death|212|||
161077634|NCT02942277|581673723|FG002|Year 2|Met withdrawal criteria|0|||
161077635|NCT02942277|581673724|FG003|Year 2|Met withdrawal criteria|0|||
161077636|NCT02942277|581673725|FG004|Year 2|Met withdrawal criteria|1|||
161077637|NCT02942277|581673726|FG005|Year 2|Met withdrawal criteria|2|||
161159061|NCT02488551|581961205|FG002|Overall Study|Military Deployment|0|||
161159062|NCT02488551|581961206|FG003|Overall Study|Military Deployment|0|||
161159063|NCT00436566|581961207|FG000|Overall Study|Withdrawal by Subject|2|||
161159064|NCT00436566|581961207|FG000|Overall Study|Protocol Violation|1|||
161159065|NCT01860534|581961208|FG000|ROP #1|Needed treatment for ROP|0|||
161159066|NCT01860534|581961209|FG001|ROP #1|Needed treatment for ROP|1|||
161159067|NCT01860534|581961208|FG000|ROP #2|discharged prior to ROP #2|1|||
161286788|NCT01808573|582429863|FG001|Overall Study|Death|240|||
161077638|NCT02942277|581673727|FG006|Year 2|Met withdrawal criteria|0|||
161077639|NCT02942277|581673728|FG007|Year 2|Met withdrawal criteria|0|||
161077640|NCT02942277|581673729|FG008|Year 2|Met withdrawal criteria|0|||
161077641|NCT02942277|581673730|FG009|Year 2|Met withdrawal criteria|0|||
161077642|NCT02942277|581673731|FG010|Year 2|Met withdrawal criteria|1|||
161077643|NCT02942277|581673721|FG000|Year 2|Travel|0|||
161077644|NCT02942277|581673722|FG001|Year 2|Travel|1|||
161077645|NCT02942277|581673723|FG002|Year 2|Travel|0|||
161077646|NCT02942277|581673724|FG003|Year 2|Travel|0|||
161077647|NCT02942277|581673725|FG004|Year 2|Travel|0|||
161077648|NCT02942277|581673726|FG005|Year 2|Travel|1|||
161077649|NCT02942277|581673727|FG006|Year 2|Travel|0|||
161077650|NCT02942277|581673728|FG007|Year 2|Travel|0|||
161077651|NCT02942277|581673729|FG008|Year 2|Travel|0|||
161077652|NCT02942277|581673730|FG009|Year 2|Travel|1|||
161077653|NCT02942277|581673731|FG010|Year 2|Travel|3|||
161077654|NCT02942277|581673721|FG000|Year 2|Non-compliant|0|||
161077655|NCT02942277|581673722|FG001|Year 2|Non-compliant|0|||
161077656|NCT02942277|581673723|FG002|Year 2|Non-compliant|0|||
161077657|NCT02942277|581673724|FG003|Year 2|Non-compliant|0|||
161077658|NCT02942277|581673725|FG004|Year 2|Non-compliant|1|||
161077659|NCT02942277|581673726|FG005|Year 2|Non-compliant|1|||
161077660|NCT02942277|581673727|FG006|Year 2|Non-compliant|0|||
161077661|NCT02942277|581673728|FG007|Year 2|Non-compliant|0|||
161077662|NCT02942277|581673729|FG008|Year 2|Non-compliant|0|||
161077663|NCT02942277|581673730|FG009|Year 2|Non-compliant|0|||
161077664|NCT02942277|581673731|FG010|Year 2|Non-compliant|0|||
161077665|NCT02942277|581673721|FG000|Year 2|Withdrawal by Subject|0|||
161077666|NCT02942277|581673722|FG001|Year 2|Withdrawal by Subject|0|||
161077667|NCT02942277|581673723|FG002|Year 2|Withdrawal by Subject|0|||
161077668|NCT02942277|581673724|FG003|Year 2|Withdrawal by Subject|0|||
161077669|NCT02942277|581673725|FG004|Year 2|Withdrawal by Subject|0|||
161077670|NCT02942277|581673726|FG005|Year 2|Withdrawal by Subject|0|||
161077671|NCT02942277|581673727|FG006|Year 2|Withdrawal by Subject|1|||
161077672|NCT02942277|581673728|FG007|Year 2|Withdrawal by Subject|0|||
161077673|NCT02942277|581673729|FG008|Year 2|Withdrawal by Subject|0|||
161077674|NCT02942277|581673730|FG009|Year 2|Withdrawal by Subject|0|||
161077675|NCT02942277|581673731|FG010|Year 2|Withdrawal by Subject|0|||
161077676|NCT01706705|581673732|FG000|Overall Study|Death|1|||
161077677|NCT01706705|581673732|FG000|Overall Study|Lack of Efficacy|13|||
161077678|NCT01706705|581673732|FG000|Overall Study|Non-clinical|6|||
161077679|NCT01252355|581673735|FG000|Overall Study|Adverse Event|9|||
161077680|NCT01252355|581673736|FG001|Overall Study|Adverse Event|17|||
161077681|NCT01252355|581673737|FG002|Overall Study|Adverse Event|22|||
161077682|NCT01252355|581673735|FG000|Overall Study|Lack of Efficacy|6|||
161077683|NCT01252355|581673736|FG001|Overall Study|Lack of Efficacy|4|||
161077684|NCT01252355|581673737|FG002|Overall Study|Lack of Efficacy|2|||
161077685|NCT01252355|581673735|FG000|Overall Study|Lost to Follow-up|0|||
161077686|NCT01252355|581673736|FG001|Overall Study|Lost to Follow-up|0|||
161077687|NCT01252355|581673737|FG002|Overall Study|Lost to Follow-up|1|||
161077688|NCT01252355|581673735|FG000|Overall Study|Poor Compliance to Protocol|1|||
161077689|NCT01252355|581673736|FG001|Overall Study|Poor Compliance to Protocol|1|||
161077690|NCT01252355|581673737|FG002|Overall Study|Poor Compliance to Protocol|1|||
161077691|NCT01252355|581673735|FG000|Overall Study|Progressive Disease|2|||
161077692|NCT01252355|581673736|FG001|Overall Study|Progressive Disease|0|||
161077693|NCT01252355|581673737|FG002|Overall Study|Progressive Disease|0|||
161077694|NCT01252355|581673735|FG000|Overall Study|Sponsor Early Termination of Study|149|||
161077695|NCT01252355|581673736|FG001|Overall Study|Sponsor Early Termination of Study|149|||
161077696|NCT01252355|581673737|FG002|Overall Study|Sponsor Early Termination of Study|146|||
161077697|NCT01252355|581673735|FG000|Overall Study|Randomized but not Treated|2|||
161077698|NCT01252355|581673736|FG001|Overall Study|Randomized but not Treated|0|||
161077699|NCT01252355|581673737|FG002|Overall Study|Randomized but not Treated|0|||
161077700|NCT01252355|581673735|FG000|Overall Study|Other Than Above|8|||
161077701|NCT01252355|581673736|FG001|Overall Study|Other Than Above|7|||
161077702|NCT01252355|581673737|FG002|Overall Study|Other Than Above|7|||
161077703|NCT02175641|581673739|FG000|Overall Study|Death|3|||
161077704|NCT02175641|581673740|FG001|Overall Study|Death|4|||
161077705|NCT02175641|581673739|FG000|Overall Study|Lost to Follow-up|4|||
161077706|NCT02175641|581673740|FG001|Overall Study|Lost to Follow-up|4|||
161077707|NCT02175641|581673739|FG000|Overall Study|Withdrawal by Subject|7|||
161077708|NCT02175641|581673740|FG001|Overall Study|Withdrawal by Subject|4|||
161077709|NCT02175641|581673739|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
161077710|NCT02175641|581673740|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
161077711|NCT02175641|581673739|FG000|Overall Study|Developed Contraindicated Condition|8|||
161077712|NCT02175641|581673740|FG001|Overall Study|Developed Contraindicated Condition|0|||
161077713|NCT02242097|581673745|FG000|Ibrutinib Treatment|Adverse Event|16|||
161077714|NCT02242097|581673745|FG000|Ibrutinib Treatment|Physician Decision|1|||
161077715|NCT02242097|581673745|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
161077716|NCT02242097|581673745|FG000|Ibrutinib Treatment|Death|1|||
161077717|NCT02242097|581673745|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
161077718|NCT02242097|581673745|FG000|Post Therapy Follow Up|Death|3|||
161077719|NCT02242097|581673745|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
161077720|NCT03031496|581673747|FG000|Period 1|Adverse Event|2|||
161077721|NCT03031496|581673748|FG001|Period 1|Adverse Event|0|||
161077722|NCT03031496|581673747|FG000|Period 1|Withdrawal by Subject|0|||
161077723|NCT03031496|581673748|FG001|Period 1|Withdrawal by Subject|2|||
161077724|NCT03868787|581673750|FG000|Overall Study|Withdrawal by Subject|2|||
161077725|NCT03868787|581673751|FG001|Overall Study|Withdrawal by Subject|1|||
161077726|NCT01399697|581673752|FG000|Overall Study|Adverse Event|13|||
161077727|NCT01399697|581673753|FG001|Overall Study|Adverse Event|3|||
161077728|NCT01399697|581673754|FG002|Overall Study|Adverse Event|1|||
161077729|NCT01399697|581673752|FG000|Overall Study|Lost to Follow-up|2|||
161077730|NCT01399697|581673753|FG001|Overall Study|Lost to Follow-up|0|||
161077731|NCT01399697|581673754|FG002|Overall Study|Lost to Follow-up|0|||
161077732|NCT01399697|581673752|FG000|Overall Study|Withdrawal by Subject|8|||
161077733|NCT01399697|581673753|FG001|Overall Study|Withdrawal by Subject|0|||
161077734|NCT01399697|581673754|FG002|Overall Study|Withdrawal by Subject|0|||
161077735|NCT01399697|581673752|FG000|Overall Study|Investigator Decisión|1|||
161077736|NCT01399697|581673753|FG001|Overall Study|Investigator Decisión|0|||
161077737|NCT01399697|581673754|FG002|Overall Study|Investigator Decisión|2|||
161077738|NCT01399697|581673752|FG000|Overall Study|Lack of Efficacy|9|||
161077739|NCT01399697|581673753|FG001|Overall Study|Lack of Efficacy|0|||
161077740|NCT01399697|581673754|FG002|Overall Study|Lack of Efficacy|1|||
161077741|NCT01399697|581673752|FG000|Overall Study|Protocol Violation|2|||
161077742|NCT01399697|581673753|FG001|Overall Study|Protocol Violation|0|||
161077743|NCT01399697|581673754|FG002|Overall Study|Protocol Violation|0|||
161077744|NCT01399697|581673752|FG000|Overall Study|Non-Compliant|1|||
161077745|NCT01399697|581673753|FG001|Overall Study|Non-Compliant|0|||
161077746|NCT01399697|581673754|FG002|Overall Study|Non-Compliant|0|||
161077747|NCT01399697|581673752|FG000|Overall Study|Inclusion Error|2|||
161077748|NCT01399697|581673753|FG001|Overall Study|Inclusion Error|0|||
161077749|NCT01399697|581673754|FG002|Overall Study|Inclusion Error|0|||
161077750|NCT01399697|581673752|FG000|Overall Study|Positive result for hepatitis B|1|||
161077751|NCT01399697|581673753|FG001|Overall Study|Positive result for hepatitis B|0|||
161077752|NCT01399697|581673754|FG002|Overall Study|Positive result for hepatitis B|0|||
161077753|NCT01399697|581673752|FG000|Overall Study|Clinical RA remission|1|||
161077754|NCT01399697|581673753|FG001|Overall Study|Clinical RA remission|0|||
161159068|NCT01860534|581961209|FG001|ROP #2|discharged prior to ROP #2|0|||
161159069|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
161159070|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159071|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159072|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159073|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159074|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159075|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159076|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159077|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161159078|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
161159079|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159080|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159081|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159082|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159083|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159084|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159085|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159086|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161159087|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
161159088|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159089|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159090|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159091|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159092|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159093|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159094|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159095|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161159096|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
161159097|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161159098|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161159099|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161159100|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161077755|NCT01399697|581673754|FG002|Overall Study|Clinical RA remission|0|||
161077756|NCT01399697|581673752|FG000|Overall Study|Sponsor Decision|1|||
161077757|NCT01399697|581673753|FG001|Overall Study|Sponsor Decision|0|||
161077758|NCT01399697|581673754|FG002|Overall Study|Sponsor Decision|0|||
161077759|NCT01712061|581673755|FG000|Overall Study|Adverse Event|4|||
161077760|NCT01712061|581673756|FG001|Overall Study|Adverse Event|9|||
161159101|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161077761|NCT01712061|581673757|FG002|Overall Study|Adverse Event|5|||
161077762|NCT01712061|581673755|FG000|Overall Study|Death|0|||
161077763|NCT01712061|581673756|FG001|Overall Study|Death|0|||
161077764|NCT01712061|581673757|FG002|Overall Study|Death|1|||
161159102|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
161159103|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
161159104|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
161159105|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
161159106|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159107|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159108|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159109|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159110|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159111|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159112|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159113|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161159114|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
161159115|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159116|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159117|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159118|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159119|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159120|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159121|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159122|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161159123|NCT02175771|581961214|FG000|Run-In Period (Pre-assignment)|Other|8|||
161159124|NCT02175771|581961215|FG001|Run-In Period (Pre-assignment)|Other|0|||
161159125|NCT02175771|581961216|FG002|Run-In Period (Pre-assignment)|Other|0|||
161159126|NCT02175771|581961217|FG003|Run-In Period (Pre-assignment)|Other|0|||
161159127|NCT02175771|581961218|FG004|Run-In Period (Pre-assignment)|Other|0|||
161159128|NCT02175771|581961219|FG005|Run-In Period (Pre-assignment)|Other|0|||
161159129|NCT02175771|581961220|FG006|Run-In Period (Pre-assignment)|Other|0|||
161159130|NCT02175771|581961221|FG007|Run-In Period (Pre-assignment)|Other|0|||
161159131|NCT02175771|581961222|FG008|Run-In Period (Pre-assignment)|Other|0|||
161159132|NCT02175771|581961214|FG000|Treatment Period|Adverse Event|0|||
161159133|NCT02175771|581961215|FG001|Treatment Period|Adverse Event|2|||
161159134|NCT02175771|581961216|FG002|Treatment Period|Adverse Event|1|||
161159135|NCT02175771|581961217|FG003|Treatment Period|Adverse Event|1|||
161159136|NCT02175771|581961218|FG004|Treatment Period|Adverse Event|1|||
161159137|NCT02175771|581961219|FG005|Treatment Period|Adverse Event|3|||
161159138|NCT02175771|581961220|FG006|Treatment Period|Adverse Event|2|||
161159139|NCT02175771|581961221|FG007|Treatment Period|Adverse Event|0|||
161159140|NCT02175771|581961222|FG008|Treatment Period|Adverse Event|1|||
161159141|NCT02175771|581961214|FG000|Treatment Period|Withdrawal by Subject|0|||
161159142|NCT02175771|581961215|FG001|Treatment Period|Withdrawal by Subject|9|||
161159143|NCT02175771|581961216|FG002|Treatment Period|Withdrawal by Subject|3|||
161159144|NCT02175771|581961217|FG003|Treatment Period|Withdrawal by Subject|6|||
161159145|NCT02175771|581961218|FG004|Treatment Period|Withdrawal by Subject|2|||
161159146|NCT02175771|581961219|FG005|Treatment Period|Withdrawal by Subject|4|||
161159147|NCT02175771|581961220|FG006|Treatment Period|Withdrawal by Subject|2|||
161159148|NCT02175771|581961221|FG007|Treatment Period|Withdrawal by Subject|9|||
161159149|NCT02175771|581961222|FG008|Treatment Period|Withdrawal by Subject|2|||
161286789|NCT01808573|582429862|FG000|Overall Study|Withdrawal by Subject|12|||
161286790|NCT01808573|582429863|FG001|Overall Study|Withdrawal by Subject|10|||
161286791|NCT01808573|582429862|FG000|Overall Study|Lost to Follow-up|3|||
161286792|NCT01808573|582429863|FG001|Overall Study|Lost to Follow-up|0|||
161286793|NCT01808573|582429862|FG000|Overall Study|Discontinuation of study by sponsor|79|||
161286794|NCT01808573|582429863|FG001|Overall Study|Discontinuation of study by sponsor|64|||
161286795|NCT01808573|582429862|FG000|Overall Study|Randomized in Error|1|||
161286796|NCT01808573|582429863|FG001|Overall Study|Randomized in Error|0|||
161286797|NCT00852202|582429874|FG000|Overall Study|Adverse Event|2|||
161286798|NCT00852202|582429875|FG001|Overall Study|Adverse Event|3|||
161286799|NCT00852202|582429876|FG002|Overall Study|Adverse Event|7|||
161286800|NCT00852202|582429874|FG000|Overall Study|Lack of Efficacy|4|||
161286801|NCT00852202|582429875|FG001|Overall Study|Lack of Efficacy|1|||
161286802|NCT00852202|582429876|FG002|Overall Study|Lack of Efficacy|2|||
161159150|NCT02175771|581961214|FG000|Treatment Period|Noncompliance|0|||
161159151|NCT02175771|581961215|FG001|Treatment Period|Noncompliance|1|||
161159152|NCT02175771|581961216|FG002|Treatment Period|Noncompliance|2|||
161159153|NCT02175771|581961217|FG003|Treatment Period|Noncompliance|0|||
161159154|NCT02175771|581961218|FG004|Treatment Period|Noncompliance|0|||
161159155|NCT02175771|581961219|FG005|Treatment Period|Noncompliance|0|||
161159156|NCT02175771|581961220|FG006|Treatment Period|Noncompliance|0|||
161286803|NCT00852202|582429874|FG000|Overall Study|Protocol Violation|2|||
161159157|NCT02175771|581961221|FG007|Treatment Period|Noncompliance|0|||
161159158|NCT02175771|581961222|FG008|Treatment Period|Noncompliance|1|||
161159159|NCT02175771|581961214|FG000|Treatment Period|Protocol Violation|0|||
161159160|NCT02175771|581961215|FG001|Treatment Period|Protocol Violation|0|||
161286804|NCT00852202|582429875|FG001|Overall Study|Protocol Violation|2|||
161159161|NCT02175771|581961216|FG002|Treatment Period|Protocol Violation|0|||
161159162|NCT02175771|581961217|FG003|Treatment Period|Protocol Violation|0|||
161159163|NCT02175771|581961218|FG004|Treatment Period|Protocol Violation|0|||
161159164|NCT02175771|581961219|FG005|Treatment Period|Protocol Violation|0|||
161159165|NCT02175771|581961220|FG006|Treatment Period|Protocol Violation|0|||
161159166|NCT02175771|581961221|FG007|Treatment Period|Protocol Violation|1|||
161159167|NCT02175771|581961222|FG008|Treatment Period|Protocol Violation|0|||
161159168|NCT02175771|581961214|FG000|Treatment Period|Disease progression|0|||
161159169|NCT02175771|581961215|FG001|Treatment Period|Disease progression|0|||
161159170|NCT02175771|581961216|FG002|Treatment Period|Disease progression|0|||
161159171|NCT02175771|581961217|FG003|Treatment Period|Disease progression|0|||
161159172|NCT02175771|581961218|FG004|Treatment Period|Disease progression|0|||
161159173|NCT02175771|581961219|FG005|Treatment Period|Disease progression|0|||
161159174|NCT02175771|581961220|FG006|Treatment Period|Disease progression|0|||
161159175|NCT02175771|581961221|FG007|Treatment Period|Disease progression|2|||
161159176|NCT02175771|581961222|FG008|Treatment Period|Disease progression|0|||
161159177|NCT02175771|581961214|FG000|Treatment Period|Lost to Follow-up|0|||
161159178|NCT02175771|581961215|FG001|Treatment Period|Lost to Follow-up|3|||
161159179|NCT02175771|581961216|FG002|Treatment Period|Lost to Follow-up|1|||
161159180|NCT02175771|581961217|FG003|Treatment Period|Lost to Follow-up|3|||
161159181|NCT02175771|581961218|FG004|Treatment Period|Lost to Follow-up|1|||
161159182|NCT02175771|581961219|FG005|Treatment Period|Lost to Follow-up|2|||
161159183|NCT02175771|581961220|FG006|Treatment Period|Lost to Follow-up|1|||
161159184|NCT02175771|581961221|FG007|Treatment Period|Lost to Follow-up|2|||
161159185|NCT02175771|581961222|FG008|Treatment Period|Lost to Follow-up|2|||
161159186|NCT02175771|581961214|FG000|Treatment Period|Lack of Efficacy|0|||
161159187|NCT02175771|581961215|FG001|Treatment Period|Lack of Efficacy|0|||
161159188|NCT02175771|581961216|FG002|Treatment Period|Lack of Efficacy|0|||
161159189|NCT02175771|581961217|FG003|Treatment Period|Lack of Efficacy|0|||
161159190|NCT02175771|581961218|FG004|Treatment Period|Lack of Efficacy|0|||
161159191|NCT02175771|581961219|FG005|Treatment Period|Lack of Efficacy|1|||
161159192|NCT02175771|581961220|FG006|Treatment Period|Lack of Efficacy|0|||
161159193|NCT02175771|581961221|FG007|Treatment Period|Lack of Efficacy|1|||
161159194|NCT02175771|581961222|FG008|Treatment Period|Lack of Efficacy|0|||
161159195|NCT02175771|581961214|FG000|Treatment Period|Other|0|||
161159196|NCT02175771|581961215|FG001|Treatment Period|Other|1|||
161159197|NCT02175771|581961216|FG002|Treatment Period|Other|0|||
161159198|NCT02175771|581961217|FG003|Treatment Period|Other|3|||
161159199|NCT02175771|581961218|FG004|Treatment Period|Other|1|||
161159200|NCT02175771|581961219|FG005|Treatment Period|Other|0|||
161159201|NCT02175771|581961220|FG006|Treatment Period|Other|0|||
161159202|NCT02175771|581961221|FG007|Treatment Period|Other|2|||
161159203|NCT02175771|581961222|FG008|Treatment Period|Other|0|||
161159204|NCT00779324|581961223|FG000|Overall Study|Lost to Follow-up|2|||
161159205|NCT00779324|581961224|FG001|Overall Study|Lost to Follow-up|1|||
161159206|NCT00779324|581961223|FG000|Overall Study|Withdrawal by Subject|4|||
161159207|NCT00779324|581961224|FG001|Overall Study|Withdrawal by Subject|2|||
161159208|NCT00779324|581961223|FG000|Overall Study|Missed visit|1|||
161159209|NCT00779324|581961224|FG001|Overall Study|Missed visit|1|||
161159210|NCT02207556|581961225|FG000|Overall Study|Physician Decision|1|||
161159211|NCT02207556|581961226|FG001|Overall Study|Physician Decision|0|||
161159212|NCT02207556|581961225|FG000|Overall Study|Withdrawal by Subject|1|||
161159213|NCT02207556|581961226|FG001|Overall Study|Withdrawal by Subject|0|||
161159214|NCT02207556|581961225|FG000|Overall Study|Death|0|||
161159215|NCT02207556|581961226|FG001|Overall Study|Death|5|||
161159216|NCT03558555|581961227|FG000|Overall Study|Lost to Follow-up|2|||
161286805|NCT00852202|582429876|FG002|Overall Study|Protocol Violation|7|||
161286806|NCT00852202|582429874|FG000|Overall Study|Withdrawal by Subject|3|||
161286807|NCT00852202|582429875|FG001|Overall Study|Withdrawal by Subject|1|||
161286808|NCT00852202|582429876|FG002|Overall Study|Withdrawal by Subject|2|||
161286809|NCT00852202|582429874|FG000|Overall Study|Lost to Follow-up|5|||
161159217|NCT03558555|581961228|FG001|Overall Study|Lost to Follow-up|1|||
161159218|NCT02841787|581961238|FG000|Overall Study|Lost to Follow-up|1|||
161159219|NCT02841787|581961239|FG001|Overall Study|Lost to Follow-up|0|||
161286810|NCT00852202|582429875|FG001|Overall Study|Lost to Follow-up|5|||
161286811|NCT00852202|582429876|FG002|Overall Study|Lost to Follow-up|6|||
161286812|NCT00852202|582429874|FG000|Overall Study|pregnancy,moving away and surgery|1|||
161159220|NCT02841787|581961240|FG002|Overall Study|Lost to Follow-up|0|||
161159221|NCT02841787|581961238|FG000|Overall Study|Symptoms dropped below threshold|1|||
161159222|NCT02841787|581961239|FG001|Overall Study|Symptoms dropped below threshold|0|||
161159223|NCT02841787|581961240|FG002|Overall Study|Symptoms dropped below threshold|0|||
161159224|NCT02841787|581961238|FG000|Overall Study|Withdrawal by Subject|1|||
161345973|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
161159225|NCT02841787|581961239|FG001|Overall Study|Withdrawal by Subject|4|||
161159226|NCT02841787|581961240|FG002|Overall Study|Withdrawal by Subject|0|||
161159227|NCT01474746|581961241|FG000|Overall Study|Lost to Follow-up|1|||
161159228|NCT01474746|581961242|FG001|Overall Study|Lost to Follow-up|1|||
161286813|NCT00852202|582429875|FG001|Overall Study|pregnancy,moving away and surgery|0|||
161345974|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
161345975|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
161345976|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
161345977|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
161345978|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
161345979|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
161345980|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
161345981|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
161345982|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
161345983|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
161345984|NCT01069939|582650971|FG000|Randomised and Included in the Analyses|Removal|1|||
161345985|NCT01069939|582650972|FG001|Randomised and Included in the Analyses|Removal|0|||
161345986|NCT05166876|582650973|FG000|Overall Study|Withdrawal by Subject|1|||
161345987|NCT05166876|582650974|FG001|Overall Study|Withdrawal by Subject|0|||
161345988|NCT05166876|582650975|FG002|Overall Study|Withdrawal by Subject|0|||
161345989|NCT00658528|582650976|FG000|Overall Study|Adverse Event|5|||
161345990|NCT00658528|582650977|FG001|Overall Study|Adverse Event|7|||
161345991|NCT00658528|582650976|FG000|Overall Study|Lost to Follow-up|14|||
161345992|NCT00658528|582650977|FG001|Overall Study|Lost to Follow-up|22|||
161345993|NCT00658528|582650976|FG000|Overall Study|Withdrawal by Subject|8|||
161345994|NCT00658528|582650977|FG001|Overall Study|Withdrawal by Subject|6|||
161345995|NCT00658528|582650976|FG000|Overall Study|Withdrawal of consent|5|||
161345996|NCT00658528|582650977|FG001|Overall Study|Withdrawal of consent|6|||
161345997|NCT00658528|582650976|FG000|Overall Study|Other|8|||
161345998|NCT00658528|582650977|FG001|Overall Study|Other|4|||
161345999|NCT01147458|582650984|FG000|First Intervention|Study terminated by sponsor|8|||
161346000|NCT01147458|582650985|FG001|First Intervention|Study terminated by sponsor|8|||
161346001|NCT01147458|582650986|FG002|First Intervention|Study terminated by sponsor|7|||
161346002|NCT01147458|582650987|FG003|First Intervention|Study terminated by sponsor|8|||
161346003|NCT01147458|582650984|FG000|First Intervention|Protocol Violation|2|||
161346004|NCT01147458|582650985|FG001|First Intervention|Protocol Violation|3|||
161346005|NCT01147458|582650986|FG002|First Intervention|Protocol Violation|2|||
161346006|NCT01147458|582650987|FG003|First Intervention|Protocol Violation|3|||
161346007|NCT01147458|582650984|FG000|First Intervention|Withdrawal by Subject|3|||
161346008|NCT01147458|582650985|FG001|First Intervention|Withdrawal by Subject|0|||
161346009|NCT01147458|582650986|FG002|First Intervention|Withdrawal by Subject|1|||
161346010|NCT01147458|582650987|FG003|First Intervention|Withdrawal by Subject|0|||
161346011|NCT01147458|582650984|FG000|First Intervention|Adverse Event|0|||
161346012|NCT01147458|582650985|FG001|First Intervention|Adverse Event|3|||
161346013|NCT01147458|582650986|FG002|First Intervention|Adverse Event|2|||
161346014|NCT01147458|582650987|FG003|First Intervention|Adverse Event|3|||
161346015|NCT01147458|582650984|FG000|First Intervention|Other|1|||
161346016|NCT01147458|582650985|FG001|First Intervention|Other|2|||
161346017|NCT01147458|582650986|FG002|First Intervention|Other|0|||
161077765|NCT01712061|581673755|FG000|Overall Study|Lost to Follow-up|1|||
161077766|NCT01712061|581673756|FG001|Overall Study|Lost to Follow-up|0|||
161077767|NCT01712061|581673757|FG002|Overall Study|Lost to Follow-up|1|||
161077768|NCT01712061|581673755|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
161077769|NCT01712061|581673756|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
161077770|NCT01712061|581673757|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
161077771|NCT01712061|581673755|FG000|Overall Study|Medication Error Without Associated AE|0|||
161077772|NCT01712061|581673756|FG001|Overall Study|Medication Error Without Associated AE|1|||
161077773|NCT01712061|581673757|FG002|Overall Study|Medication Error Without Associated AE|0|||
161077774|NCT01712061|581673755|FG000|Overall Study|Withdrawal by Subject|1|||
161077775|NCT01712061|581673756|FG001|Overall Study|Withdrawal by Subject|7|||
161077776|NCT01712061|581673757|FG002|Overall Study|Withdrawal by Subject|1|||
161077777|NCT01712061|581673755|FG000|Overall Study|Other|0|||
161077778|NCT01712061|581673756|FG001|Overall Study|Other|3|||
161077779|NCT01712061|581673757|FG002|Overall Study|Other|0|||
161077780|NCT00504777|581673762|FG000|Overall Study|Adverse Event|1|||
161077781|NCT04868539|581673766|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
161077782|NCT04868539|581673767|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
161077783|NCT01572740|581673768|FG000|Overall Study|Adverse Event|1|||
161077784|NCT01572740|581673769|FG001|Overall Study|Adverse Event|1|||
161077785|NCT01572740|581673768|FG000|Overall Study|Withdrawal by Subject|1|||
161346018|NCT01147458|582650987|FG003|First Intervention|Other|0|||
161346019|NCT01147458|582650984|FG000|Second Intervention|Study terminated by sponsor|7|||
161346020|NCT01147458|582650985|FG001|Second Intervention|Study terminated by sponsor|5|||
161346021|NCT01147458|582650986|FG002|Second Intervention|Study terminated by sponsor|5|||
161346022|NCT01147458|582650987|FG003|Second Intervention|Study terminated by sponsor|3|||
161077786|NCT01572740|581673769|FG001|Overall Study|Withdrawal by Subject|1|||
161077787|NCT01572740|581673768|FG000|Overall Study|unclassified|4|||
161077788|NCT01572740|581673769|FG001|Overall Study|unclassified|3|||
161286814|NCT00852202|582429876|FG002|Overall Study|pregnancy,moving away and surgery|2|||
161286815|NCT03629184|582429882|FG000|Overall Study|Withdrawal by Subject|2|||
161286816|NCT03629184|582429883|FG001|Overall Study|Withdrawal by Subject|1|||
161286817|NCT03629184|582429882|FG000|Overall Study|Physician Decision|1|||
161286818|NCT03629184|582429883|FG001|Overall Study|Physician Decision|0|||
161286819|NCT01461538|582429884|FG000|Overall Study|Death|15|||
161286820|NCT01461538|582429885|FG001|Overall Study|Death|6|||
161286821|NCT01461538|582429886|FG002|Overall Study|Death|2|||
161286822|NCT01461538|582429884|FG000|Overall Study|Study Stopped by Sponsor|2|||
161286823|NCT01461538|582429885|FG001|Overall Study|Study Stopped by Sponsor|1|||
161286824|NCT01461538|582429886|FG002|Overall Study|Study Stopped by Sponsor|0|||
161286825|NCT01461538|582429884|FG000|Overall Study|Withdrawal by Subject|1|||
161286826|NCT01461538|582429885|FG001|Overall Study|Withdrawal by Subject|1|||
161286827|NCT01461538|582429886|FG002|Overall Study|Withdrawal by Subject|0|||
161286828|NCT00141778|582429887|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
161286829|NCT00141778|582429888|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
161286830|NCT00141778|582429889|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
161286831|NCT00141778|582429887|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
161286832|NCT00141778|582429888|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
161286833|NCT00141778|582429889|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
161286834|NCT00141778|582429887|FG000|Started Study Medication|Withdrawal by Subject|0|||
161159229|NCT01474746|581961241|FG000|Overall Study|Withdrawal by Subject|2|||
161159230|NCT01474746|581961242|FG001|Overall Study|Withdrawal by Subject|1|||
161159231|NCT00786032|581963025|FG000|Overall Study|Death|4|||
161159232|NCT00786032|581963025|FG000|Overall Study|Withdrawal by Subject|14|||
161159233|NCT00786032|581963025|FG000|Overall Study|Did not complete in the timeframe|6|||
161159234|NCT02457182|581963026|FG000|Overall Study|Lost to Follow-up|1|||
161159235|NCT02457182|581963027|FG001|Overall Study|Lost to Follow-up|0|||
161159236|NCT01116687|581963030|FG000|Overall Study|Withdrawal by Subject|4|||
161159237|NCT00424528|581963031|FG000|Overall Study|Adverse Event|2|||
161159238|NCT00424528|581963032|FG001|Overall Study|Adverse Event|1|||
161159239|NCT00424528|581963033|FG002|Overall Study|Adverse Event|2|||
161159240|NCT00424528|581963031|FG000|Overall Study|Protocol Violation|1|||
161159241|NCT00424528|581963032|FG001|Overall Study|Protocol Violation|1|||
161159242|NCT00424528|581963033|FG002|Overall Study|Protocol Violation|0|||
161159243|NCT00424528|581963031|FG000|Overall Study|Lost to Follow-up|0|||
161159244|NCT00424528|581963032|FG001|Overall Study|Lost to Follow-up|1|||
161159245|NCT00424528|581963033|FG002|Overall Study|Lost to Follow-up|0|||
161159246|NCT00424528|581963031|FG000|Overall Study|noncompliance with study requirements|2|||
161159247|NCT00424528|581963032|FG001|Overall Study|noncompliance with study requirements|1|||
161159248|NCT00424528|581963033|FG002|Overall Study|noncompliance with study requirements|2|||
161159249|NCT01009983|581963037|FG000|Overall Study|necessary scans not completed|1|||
161159250|NCT03497429|581963038|FG000|Overall Study|Progressive disease|3|||
161159251|NCT03497429|581963039|FG001|Overall Study|Progressive disease|4|||
161159252|NCT03497429|581963038|FG000|Overall Study|Adverse Event|0|||
161159253|NCT03497429|581963039|FG001|Overall Study|Adverse Event|2|||
161159254|NCT00174785|581963047|FG000|Overall Study|Adverse Event|293|||
161159255|NCT00174785|581963048|FG001|Overall Study|Adverse Event|191|||
161159256|NCT00174785|581963047|FG000|Overall Study|Protocol Violation|14|||
161159257|NCT00174785|581963048|FG001|Overall Study|Protocol Violation|14|||
161159258|NCT00174785|581963047|FG000|Overall Study|Withdrawal by Subject|173|||
161159259|NCT00174785|581963048|FG001|Overall Study|Withdrawal by Subject|175|||
161159260|NCT00174785|581963047|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
161159261|NCT00174785|581963048|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
161159262|NCT00174785|581963047|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
161286835|NCT00141778|582429888|FG001|Started Study Medication|Withdrawal by Subject|2|||
161286836|NCT00141778|582429889|FG002|Started Study Medication|Withdrawal by Subject|0|||
161286837|NCT00141778|582429887|FG000|Started Study Medication|Difficulty Swallowing|0|||
161286838|NCT00141778|582429888|FG001|Started Study Medication|Difficulty Swallowing|1|||
161286839|NCT00141778|582429889|FG002|Started Study Medication|Difficulty Swallowing|0|||
161286840|NCT00141778|582429887|FG000|Started Study Medication|Chest Discomfort|0|||
161159263|NCT00174785|581963048|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
161159264|NCT00174785|581963047|FG000|Overall Study|Other prohibited medication|5|||
161159265|NCT00174785|581963048|FG001|Overall Study|Other prohibited medication|3|||
161159266|NCT00174785|581963047|FG000|Overall Study|Family request|6|||
161159267|NCT00174785|581963048|FG001|Overall Study|Family request|8|||
161159268|NCT00174785|581963047|FG000|Overall Study|Not pre-specified/Not coded|56|||
161159269|NCT00174785|581963048|FG001|Overall Study|Not pre-specified/Not coded|70|||
161159270|NCT00120289|581963049|FG000|Overall Study|Death|96|||
161159271|NCT00120289|581963050|FG001|Overall Study|Death|82|||
161159272|NCT00120289|581963049|FG000|Overall Study|Lost to Follow-up|11|||
161286841|NCT00141778|582429888|FG001|Started Study Medication|Chest Discomfort|0|||
161159273|NCT00120289|581963050|FG001|Overall Study|Lost to Follow-up|14|||
161159274|NCT00120289|581963049|FG000|Overall Study|Withdrawal by Subject|14|||
161159275|NCT00120289|581963050|FG001|Overall Study|Withdrawal by Subject|13|||
161159276|NCT04507867|581963057|FG000|Overall Study|Death|7|||
161159277|NCT04507867|581963058|FG001|Overall Study|Death|1|||
161159278|NCT03364673|581963062|FG000|Overall Study|Withdrawal by Subject|2|||
161159279|NCT03364673|581963062|FG000|Overall Study|Injury unrelated to study|3|||
161159280|NCT00194025|581963064|FG000|Overall Study|Adverse Event|1|||
161159281|NCT00194025|581963064|FG000|Overall Study|non-adherence with study medication|4|||
161159282|NCT00543569|581963065|FG000|Overall Study|Death|2|||
161159283|NCT00543569|581963066|FG001|Overall Study|Death|2|||
161159284|NCT00543569|581963067|FG002|Overall Study|Death|3|||
161159285|NCT00543569|581963068|FG003|Overall Study|Death|1|||
161159286|NCT00543569|581963065|FG000|Overall Study|Lost to Follow-up|0|||
161159287|NCT00543569|581963066|FG001|Overall Study|Lost to Follow-up|0|||
161159288|NCT00543569|581963067|FG002|Overall Study|Lost to Follow-up|1|||
161159289|NCT00543569|581963068|FG003|Overall Study|Lost to Follow-up|1|||
161159290|NCT00543569|581963065|FG000|Overall Study|Miscellaneous Reasons|7|||
161159291|NCT00543569|581963066|FG001|Overall Study|Miscellaneous Reasons|3|||
161159292|NCT00543569|581963067|FG002|Overall Study|Miscellaneous Reasons|11|||
161159293|NCT00543569|581963068|FG003|Overall Study|Miscellaneous Reasons|4|||
161159294|NCT00543569|581963065|FG000|Overall Study|Randomized but never received study drug|3|||
161159295|NCT00543569|581963066|FG001|Overall Study|Randomized but never received study drug|3|||
161159296|NCT00543569|581963067|FG002|Overall Study|Randomized but never received study drug|5|||
161159297|NCT00543569|581963068|FG003|Overall Study|Randomized but never received study drug|3|||
161159298|NCT00862849|581963069|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161159299|NCT00862849|581963070|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
161159300|NCT00862849|581963071|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161159301|NCT00862849|581963072|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161159302|NCT00862849|581963073|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161159303|NCT00862849|581963074|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
161159304|NCT00862849|581963069|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161159305|NCT00862849|581963070|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
161159306|NCT00862849|581963071|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161159307|NCT00862849|581963072|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161159308|NCT00862849|581963073|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161159309|NCT00862849|581963074|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
161159310|NCT02124707|581963080|FG000|Overall Study|Adverse Event|5|||
161159311|NCT02124707|581963080|FG000|Overall Study|Physician Decision|1|||
161159312|NCT02124707|581963080|FG000|Overall Study|Death|1|||
161159313|NCT01766336|581963084|FG000|Overall Study|Adverse Event|11|||
161159314|NCT01766336|581963085|FG001|Overall Study|Adverse Event|8|||
161159315|NCT01766336|581963084|FG000|Overall Study|Death|4|||
161159316|NCT01766336|581963085|FG001|Overall Study|Death|3|||
161159317|NCT01766336|581963084|FG000|Overall Study|Lost to Follow-up|1|||
161159318|NCT01766336|581963085|FG001|Overall Study|Lost to Follow-up|3|||
161159319|NCT01766336|581963084|FG000|Overall Study|Physician Decision|4|||
161159320|NCT01766336|581963085|FG001|Overall Study|Physician Decision|2|||
161159321|NCT01766336|581963084|FG000|Overall Study|Protocol Violation|0|||
161159322|NCT01766336|581963085|FG001|Overall Study|Protocol Violation|1|||
161159323|NCT01766336|581963084|FG000|Overall Study|Sponsor Decision|52|||
161159324|NCT01766336|581963085|FG001|Overall Study|Sponsor Decision|43|||
161159325|NCT01766336|581963084|FG000|Overall Study|Withdrawal by Subject|18|||
161159326|NCT01766336|581963085|FG001|Overall Study|Withdrawal by Subject|15|||
161159327|NCT03029650|581963086|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
161159328|NCT03029650|581963087|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
161159329|NCT03029650|581963086|FG000|Washout (1 Week)|Physician Decision|0|||
161159330|NCT03029650|581963087|FG001|Washout (1 Week)|Physician Decision|1|||
161159331|NCT04544709|581963088|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
161159332|NCT03135028|581963089|FG000|Overall Study|Death|6|||
161159333|NCT03135028|581963089|FG000|Overall Study|Study Terminated by Sponsor|2|||
161159334|NCT03135028|581963089|FG000|Overall Study|Withdrew Consent|1|||
161286842|NCT00141778|582429889|FG002|Started Study Medication|Chest Discomfort|1|||
161286843|NCT01982955|582429890|FG000|Overall Study|Randomized but not treated|0|||
161286844|NCT01982955|582429891|FG001|Overall Study|Randomized but not treated|0|||
161286845|NCT01982955|582429892|FG002|Overall Study|Randomized but not treated|0|||
161286846|NCT01982955|582429893|FG003|Overall Study|Randomized but not treated|1|||
161159335|NCT00496873|581963090|FG000|Overall Study|Ineligible|2|||
161159336|NCT00496873|581963090|FG000|Overall Study|Death|2|||
161159337|NCT00496873|581963090|FG000|Overall Study|Withdrawal by Subject|3|||
161159338|NCT02065869|581963091|FG000|Overall Study|Death|7|||
161159339|NCT02065869|581963091|FG000|Overall Study|Disease relapse|16|||
161159340|NCT02065869|581963091|FG000|Overall Study|Lost to Follow-up|4|||
161159341|NCT02065869|581963091|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
161159342|NCT02065869|581963091|FG000|Overall Study|Withdrawal by Subject|1|||
161159343|NCT01842620|581963092|FG000|Period 1|Withdrawal by Subject|1|||
161159344|NCT01842620|581963093|FG001|Period 1|Withdrawal by Subject|0|||
161159345|NCT01814800|581963096|FG000|Overall Study|Adverse Event|2|||
161286847|NCT01982955|582429894|FG004|Overall Study|Randomized but not treated|0|||
161286848|NCT02548143|582429899|FG000|Overall Study|Adverse Event|1|||
161286849|NCT02548143|582429900|FG001|Overall Study|Adverse Event|0|||
161286850|NCT02548143|582429899|FG000|Overall Study|Withdrawal by Subject|0|||
161286851|NCT02548143|582429900|FG001|Overall Study|Withdrawal by Subject|1|||
161286852|NCT04796961|582431493|FG000|Overall Study|Lost to Follow-up|10|||
161286853|NCT04796961|582431493|FG000|Overall Study|Withdrawal by Subject|3|||
161286854|NCT04796961|582431493|FG000|Overall Study|Left Organization|10|||
161286855|NCT01557504|582431498|FG000|Overall Study|Physician Decision|1|||
161286856|NCT01557504|582431499|FG001|Overall Study|Physician Decision|0|||
161286857|NCT01962103|582431503|FG000|Phase 1|Adverse Event|4|||
161286858|NCT01962103|582431504|FG001|Phase 1|Adverse Event|0|||
161286859|NCT01962103|582431505|FG002|Phase 1|Adverse Event|2|||
161286860|NCT01962103|582431506|FG003|Phase 1|Adverse Event|1|||
161286861|NCT01962103|582431507|FG004|Phase 1|Adverse Event|2|||
161286862|NCT01962103|582431508|FG005|Phase 1|Adverse Event|2|||
161286863|NCT01962103|582431509|FG006|Phase 1|Adverse Event|0|||
161286864|NCT01962103|582431510|FG007|Phase 1|Adverse Event|0|||
161286865|NCT01962103|582431511|FG008|Phase 1|Adverse Event|0|||
161286866|NCT01962103|582431503|FG000|Phase 1|Progressive Disease|8|||
161286867|NCT01962103|582431504|FG001|Phase 1|Progressive Disease|6|||
161286868|NCT01962103|582431505|FG002|Phase 1|Progressive Disease|8|||
161286869|NCT01962103|582431506|FG003|Phase 1|Progressive Disease|4|||
161286870|NCT01962103|582431507|FG004|Phase 1|Progressive Disease|5|||
161286871|NCT01962103|582431508|FG005|Phase 1|Progressive Disease|4|||
161286872|NCT01962103|582431509|FG006|Phase 1|Progressive Disease|0|||
161286873|NCT01962103|582431510|FG007|Phase 1|Progressive Disease|0|||
161286874|NCT01962103|582431511|FG008|Phase 1|Progressive Disease|0|||
161286875|NCT01962103|582431503|FG000|Phase 1|Withdrawal by Subject|0|||
161286876|NCT01962103|582431504|FG001|Phase 1|Withdrawal by Subject|0|||
161286877|NCT01962103|582431505|FG002|Phase 1|Withdrawal by Subject|0|||
161286878|NCT01962103|582431506|FG003|Phase 1|Withdrawal by Subject|2|||
161286879|NCT01962103|582431507|FG004|Phase 1|Withdrawal by Subject|0|||
161286880|NCT01962103|582431508|FG005|Phase 1|Withdrawal by Subject|0|||
161286881|NCT01962103|582431509|FG006|Phase 1|Withdrawal by Subject|0|||
161286882|NCT01962103|582431510|FG007|Phase 1|Withdrawal by Subject|0|||
161286883|NCT01962103|582431511|FG008|Phase 1|Withdrawal by Subject|0|||
161286884|NCT01962103|582431503|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
161286885|NCT01962103|582431504|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
161286886|NCT01962103|582431505|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
161286887|NCT01962103|582431506|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
161286888|NCT01962103|582431507|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
161286889|NCT01962103|582431508|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
161286890|NCT01962103|582431509|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
161286891|NCT01962103|582431510|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
161286892|NCT01962103|582431511|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
161286893|NCT01962103|582431503|FG000|Phase 1|Physician Decision|0|||
161286894|NCT01962103|582431504|FG001|Phase 1|Physician Decision|0|||
161286895|NCT01962103|582431505|FG002|Phase 1|Physician Decision|0|||
161286896|NCT01962103|582431506|FG003|Phase 1|Physician Decision|1|||
161286897|NCT01962103|582431507|FG004|Phase 1|Physician Decision|0|||
161286898|NCT01962103|582431508|FG005|Phase 1|Physician Decision|0|||
161286899|NCT01962103|582431509|FG006|Phase 1|Physician Decision|0|||
161286900|NCT01962103|582431510|FG007|Phase 1|Physician Decision|0|||
161286901|NCT01962103|582431511|FG008|Phase 1|Physician Decision|0|||
161159346|NCT01814800|581963096|FG000|Overall Study|Pregnancy|1|||
161159347|NCT01814800|581963096|FG000|Overall Study|Sponsor decision|1|||
161159348|NCT01814800|581963096|FG000|Overall Study|Subject relocation|1|||
161159349|NCT02402218|581963097|FG000|Overall Study|Did not pickup study medication|12|||
161159350|NCT02402218|581963098|FG001|Overall Study|Did not pickup study medication|9|||
161159351|NCT02402218|581963099|FG002|Overall Study|Did not pickup study medication|13|||
161159352|NCT02402218|581963097|FG000|Overall Study|Lack of Efficacy|0|||
161159353|NCT02402218|581963098|FG001|Overall Study|Lack of Efficacy|1|||
161159354|NCT02402218|581963099|FG002|Overall Study|Lack of Efficacy|1|||
161159355|NCT02402218|581963097|FG000|Overall Study|Death|1|||
161159356|NCT02402218|581963098|FG001|Overall Study|Death|0|||
161159357|NCT02402218|581963099|FG002|Overall Study|Death|0|||
161286902|NCT01962103|582431503|FG000|Phase 1|Symptomatic Deterioration|3|||
161286903|NCT01962103|582431504|FG001|Phase 1|Symptomatic Deterioration|2|||
161286904|NCT01962103|582431505|FG002|Phase 1|Symptomatic Deterioration|2|||
161286905|NCT01962103|582431506|FG003|Phase 1|Symptomatic Deterioration|2|||
161286906|NCT01962103|582431507|FG004|Phase 1|Symptomatic Deterioration|1|||
161286907|NCT01962103|582431508|FG005|Phase 1|Symptomatic Deterioration|1|||
161286908|NCT01962103|582431509|FG006|Phase 1|Symptomatic Deterioration|0|||
161286909|NCT01962103|582431510|FG007|Phase 1|Symptomatic Deterioration|0|||
161286910|NCT01962103|582431511|FG008|Phase 1|Symptomatic Deterioration|0|||
161286911|NCT01962103|582431503|FG000|Phase 1|Miscellaneous|1|||
161286912|NCT01962103|582431504|FG001|Phase 1|Miscellaneous|0|||
161286913|NCT01962103|582431505|FG002|Phase 1|Miscellaneous|0|||
161159358|NCT02402218|581963097|FG000|Overall Study|Reinfection|0|||
161159359|NCT02402218|581963098|FG001|Overall Study|Reinfection|0|||
161286914|NCT01962103|582431506|FG003|Phase 1|Miscellaneous|0|||
161286915|NCT01962103|582431507|FG004|Phase 1|Miscellaneous|0|||
161286916|NCT01962103|582431508|FG005|Phase 1|Miscellaneous|0|||
161286917|NCT01962103|582431509|FG006|Phase 1|Miscellaneous|0|||
161286918|NCT01962103|582431510|FG007|Phase 1|Miscellaneous|0|||
161286919|NCT01962103|582431511|FG008|Phase 1|Miscellaneous|0|||
161286920|NCT01962103|582431503|FG000|Phase 2|Adverse Event|0|||
161286921|NCT01962103|582431504|FG001|Phase 2|Adverse Event|0|||
161286922|NCT01962103|582431505|FG002|Phase 2|Adverse Event|0|||
161286923|NCT01962103|582431506|FG003|Phase 2|Adverse Event|0|||
161286924|NCT01962103|582431507|FG004|Phase 2|Adverse Event|0|||
161286925|NCT01962103|582431508|FG005|Phase 2|Adverse Event|0|||
161286926|NCT01962103|582431509|FG006|Phase 2|Adverse Event|1|||
161286927|NCT01962103|582431510|FG007|Phase 2|Adverse Event|0|||
161286928|NCT01962103|582431511|FG008|Phase 2|Adverse Event|3|||
161286929|NCT01962103|582431503|FG000|Phase 2|Progressive Disease|0|||
161286930|NCT01962103|582431504|FG001|Phase 2|Progressive Disease|0|||
161286931|NCT01962103|582431505|FG002|Phase 2|Progressive Disease|0|||
161286932|NCT01962103|582431506|FG003|Phase 2|Progressive Disease|0|||
161286933|NCT01962103|582431507|FG004|Phase 2|Progressive Disease|0|||
161286934|NCT01962103|582431508|FG005|Phase 2|Progressive Disease|0|||
161286935|NCT01962103|582431509|FG006|Phase 2|Progressive Disease|11|||
161286936|NCT01962103|582431510|FG007|Phase 2|Progressive Disease|12|||
161286937|NCT01962103|582431511|FG008|Phase 2|Progressive Disease|11|||
161286938|NCT01962103|582431503|FG000|Phase 2|Symptomatic Deterioration|0|||
161286939|NCT01962103|582431504|FG001|Phase 2|Symptomatic Deterioration|0|||
161286940|NCT01962103|582431505|FG002|Phase 2|Symptomatic Deterioration|0|||
161286941|NCT01962103|582431506|FG003|Phase 2|Symptomatic Deterioration|0|||
161077789|NCT01401153|581673770|FG000|First Test Day|Learning disabilities; illness|1|||
161077790|NCT01401153|581673771|FG001|First Test Day|Learning disabilities; illness|10|||
161077791|NCT01401153|581673770|FG000|Second Test Day|illness|0|||
161077792|NCT01401153|581673771|FG001|Second Test Day|illness|5|||
161077793|NCT01677767|581673774|FG000|Overall Study|Adverse Event|1|||
161077794|NCT01677767|581673774|FG000|Overall Study|Death|4|||
161077795|NCT01677767|581673774|FG000|Overall Study|Protocol Violation|4|||
161286942|NCT01962103|582431507|FG004|Phase 2|Symptomatic Deterioration|0|||
161286943|NCT01962103|582431508|FG005|Phase 2|Symptomatic Deterioration|0|||
161286944|NCT01962103|582431509|FG006|Phase 2|Symptomatic Deterioration|2|||
161286945|NCT01962103|582431510|FG007|Phase 2|Symptomatic Deterioration|2|||
161286946|NCT01962103|582431511|FG008|Phase 2|Symptomatic Deterioration|0|||
161286947|NCT01321749|582431514|FG000|Overall Study|Lost to Follow-up|4|||
161286948|NCT01321749|582431515|FG001|Overall Study|Lost to Follow-up|11|||
161286949|NCT01321749|582431514|FG000|Overall Study|Protocol Violation|4|||
161286950|NCT01321749|582431515|FG001|Overall Study|Protocol Violation|7|||
161286951|NCT01321749|582431514|FG000|Overall Study|Withdrawal by Subject|5|||
161286952|NCT01321749|582431515|FG001|Overall Study|Withdrawal by Subject|4|||
161286953|NCT01173523|582431519|FG000|Overall Study|Clinical Progression|1|||
161286954|NCT01173523|582431520|FG001|Overall Study|Clinical Progression|1|||
161286955|NCT01173523|582431519|FG000|Overall Study|Progressive Disease|10|||
161286956|NCT01173523|582431520|FG001|Overall Study|Progressive Disease|8|||
161286957|NCT01173523|582431519|FG000|Overall Study|Other|2|||
161286958|NCT01173523|582431520|FG001|Overall Study|Other|3|||
161286959|NCT00853099|582431521|FG000|Double-blind Period|Adverse Event|7|||
161286960|NCT00853099|582431522|FG001|Double-blind Period|Adverse Event|9|||
161286961|NCT00853099|582431523|FG002|Double-blind Period|Adverse Event|13|||
161286962|NCT00853099|582431524|FG003|Double-blind Period|Adverse Event|0|||
161286963|NCT00853099|582431521|FG000|Double-blind Period|Withdrawal by Subject|2|||
161286964|NCT00853099|582431522|FG001|Double-blind Period|Withdrawal by Subject|3|||
161286965|NCT00853099|582431523|FG002|Double-blind Period|Withdrawal by Subject|0|||
161286966|NCT00853099|582431524|FG003|Double-blind Period|Withdrawal by Subject|0|||
161286967|NCT00853099|582431521|FG000|Double-blind Period|Lack of Efficacy|14|||
161286968|NCT00853099|582431522|FG001|Double-blind Period|Lack of Efficacy|17|||
161286969|NCT00853099|582431523|FG002|Double-blind Period|Lack of Efficacy|16|||
161286970|NCT00853099|582431524|FG003|Double-blind Period|Lack of Efficacy|0|||
161286971|NCT00853099|582431521|FG000|Double-blind Period|Other|0|||
161286972|NCT00853099|582431522|FG001|Double-blind Period|Other|0|||
161286973|NCT00853099|582431523|FG002|Double-blind Period|Other|1|||
161286974|NCT00853099|582431524|FG003|Double-blind Period|Other|0|||
161286975|NCT00853099|582431521|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
161077796|NCT01677767|581673774|FG000|Overall Study|Withdrawal by Subject|10|||
161077797|NCT01677767|581673774|FG000|Overall Study|Non-compliance by the participants|3|||
161077798|NCT00842244|581673775|FG000|Overall Study|Death|3|||
161077799|NCT00842244|581673775|FG000|Overall Study|Withdrawal by Subject|1|||
161077800|NCT00842244|581673775|FG000|Overall Study|Other|17|||
161077801|NCT01068665|581673780|FG000|Overall Study|Adverse Event|5|||
161077802|NCT01068665|581673781|FG001|Overall Study|Adverse Event|4|||
161077803|NCT01068665|581673780|FG000|Overall Study|Lack of Efficacy|0|||
161286976|NCT00853099|582431522|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
161286977|NCT00853099|582431523|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
161286978|NCT00853099|582431524|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
161286979|NCT00853099|582431521|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161286980|NCT00853099|582431522|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161286981|NCT00853099|582431523|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
161286982|NCT00853099|582431524|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
161286983|NCT00853099|582431521|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
161286984|NCT00853099|582431522|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
161286985|NCT00853099|582431523|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
161286986|NCT00853099|582431524|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
161159360|NCT02402218|581963099|FG002|Overall Study|Reinfection|1|||
161159361|NCT02402218|581963097|FG000|Overall Study|Adverse Event|0|||
161159362|NCT02402218|581963098|FG001|Overall Study|Adverse Event|2|||
161159363|NCT02402218|581963099|FG002|Overall Study|Adverse Event|1|||
161159364|NCT02402218|581963097|FG000|Overall Study|Withdrawal by Subject|1|||
161159365|NCT02402218|581963098|FG001|Overall Study|Withdrawal by Subject|1|||
161159366|NCT02402218|581963099|FG002|Overall Study|Withdrawal by Subject|1|||
161159367|NCT03827473|581963100|FG000|Overall Study|Withdrawal by Subject|1|||
161159368|NCT03827473|581963101|FG001|Overall Study|Withdrawal by Subject|0|||
161159369|NCT04436822|581963102|FG000|Overall Study|Physician Decision|2|||
161159370|NCT04436822|581963103|FG001|Overall Study|Physician Decision|0|||
161159371|NCT04436822|581963102|FG000|Overall Study|Sponsor request|1|||
161159372|NCT04436822|581963103|FG001|Overall Study|Sponsor request|0|||
161159373|NCT04436822|581963102|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161159374|NCT04436822|581963103|FG001|Overall Study|Withdrawal by parent/guardian|3|||
161159375|NCT04436822|581963102|FG000|Overall Study|Unsuccessful procedure|0|||
161159376|NCT04436822|581963103|FG001|Overall Study|Unsuccessful procedure|1|||
161159377|NCT04436822|581963102|FG000|Overall Study|Withdrawal due to Covid-19|8|||
161159378|NCT04436822|581963103|FG001|Overall Study|Withdrawal due to Covid-19|1|||
161159379|NCT04436822|581963102|FG000|Overall Study|Withdrawal by Subject|1|||
161159380|NCT04436822|581963103|FG001|Overall Study|Withdrawal by Subject|0|||
161159381|NCT04436822|581963102|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
161159382|NCT04436822|581963103|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
161159383|NCT03807739|581963104|FG000|Overall Study|Adverse Event|1|||
161159384|NCT03807739|581963105|FG001|Overall Study|Adverse Event|0|||
161159385|NCT03807739|581963106|FG002|Overall Study|Adverse Event|0|||
161159386|NCT03807739|581963107|FG003|Overall Study|Adverse Event|0|||
161159387|NCT03807739|581963104|FG000|Overall Study|Withdrawal by Subject|1|||
161159388|NCT03807739|581963105|FG001|Overall Study|Withdrawal by Subject|0|||
161159389|NCT03807739|581963106|FG002|Overall Study|Withdrawal by Subject|0|||
161159390|NCT03807739|581963107|FG003|Overall Study|Withdrawal by Subject|0|||
161159391|NCT02371759|581963108|FG000|Overall Study|Protocol Violation|3|||
161159392|NCT02371759|581963109|FG001|Overall Study|Protocol Violation|1|||
161159393|NCT02371759|581963110|FG002|Overall Study|Protocol Violation|1|||
161159394|NCT02371759|581963111|FG003|Overall Study|Protocol Violation|0|||
161159395|NCT02371759|581963112|FG004|Overall Study|Protocol Violation|3|||
161159396|NCT02371759|581963113|FG005|Overall Study|Protocol Violation|1|||
161159397|NCT02371759|581963114|FG006|Overall Study|Protocol Violation|0|||
161159398|NCT02371759|581963115|FG007|Overall Study|Protocol Violation|3|||
161159399|NCT02371759|581963108|FG000|Overall Study|Withdrawal by Subject|0|||
161159400|NCT02371759|581963109|FG001|Overall Study|Withdrawal by Subject|0|||
161159401|NCT02371759|581963110|FG002|Overall Study|Withdrawal by Subject|0|||
161159402|NCT02371759|581963111|FG003|Overall Study|Withdrawal by Subject|0|||
161159403|NCT02371759|581963112|FG004|Overall Study|Withdrawal by Subject|0|||
161159404|NCT02371759|581963113|FG005|Overall Study|Withdrawal by Subject|0|||
161159405|NCT02371759|581963114|FG006|Overall Study|Withdrawal by Subject|0|||
161159406|NCT02371759|581963115|FG007|Overall Study|Withdrawal by Subject|1|||
161159407|NCT03136185|581963123|FG000|Overall Study|Adverse Event|0|||
161159408|NCT03136185|581963124|FG001|Overall Study|Adverse Event|1|||
161159409|NCT03136185|581963125|FG002|Overall Study|Adverse Event|3|||
161159410|NCT03136185|581963126|FG003|Overall Study|Adverse Event|1|||
161159411|NCT03136185|581963127|FG004|Overall Study|Adverse Event|2|||
161159412|NCT03136185|581963128|FG005|Overall Study|Adverse Event|2|||
161159413|NCT03136185|581963129|FG006|Overall Study|Adverse Event|5|||
161286987|NCT00853099|582431521|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161286988|NCT00853099|582431522|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161159414|NCT03136185|581963130|FG007|Overall Study|Adverse Event|1|||
161159415|NCT03136185|581963131|FG008|Overall Study|Adverse Event|1|||
161159416|NCT03136185|581963123|FG000|Overall Study|Death|0|||
161159417|NCT03136185|581963124|FG001|Overall Study|Death|0|||
161159418|NCT03136185|581963125|FG002|Overall Study|Death|0|||
161159419|NCT03136185|581963126|FG003|Overall Study|Death|1|||
161159420|NCT03136185|581963127|FG004|Overall Study|Death|1|||
161159421|NCT03136185|581963128|FG005|Overall Study|Death|0|||
161159422|NCT03136185|581963129|FG006|Overall Study|Death|1|||
161159423|NCT03136185|581963130|FG007|Overall Study|Death|0|||
161159424|NCT03136185|581963131|FG008|Overall Study|Death|0|||
161159425|NCT03136185|581963123|FG000|Overall Study|Physician Decision|3|||
161159426|NCT03136185|581963124|FG001|Overall Study|Physician Decision|1|||
161159427|NCT03136185|581963125|FG002|Overall Study|Physician Decision|1|||
161159428|NCT03136185|581963126|FG003|Overall Study|Physician Decision|2|||
161286989|NCT00853099|582431523|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
161286990|NCT00853099|582431524|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
161286991|NCT00853099|582431521|FG000|Double-blind + Open-label Periods|Other|0|||
161286992|NCT00853099|582431522|FG001|Double-blind + Open-label Periods|Other|0|||
161286993|NCT00853099|582431523|FG002|Double-blind + Open-label Periods|Other|0|||
161286994|NCT00853099|582431524|FG003|Double-blind + Open-label Periods|Other|6|||
161286995|NCT00970593|582431526|FG000|Overall Study|Adverse Event|1|||
161286996|NCT00970593|582431527|FG001|Overall Study|Adverse Event|1|||
161286997|NCT00970593|582431528|FG002|Overall Study|Adverse Event|0|||
161286998|NCT00970593|582431529|FG003|Overall Study|Adverse Event|0|||
161286999|NCT00970593|582431530|FG004|Overall Study|Adverse Event|0|||
161287000|NCT00970593|582431531|FG005|Overall Study|Adverse Event|0|||
161287001|NCT00970593|582431532|FG006|Overall Study|Adverse Event|0|||
161287002|NCT00970593|582431526|FG000|Overall Study|Discontinuation of study by sponsor|0|||
161287003|NCT00970593|582431527|FG001|Overall Study|Discontinuation of study by sponsor|0|||
161287004|NCT00970593|582431528|FG002|Overall Study|Discontinuation of study by sponsor|5|||
161287005|NCT00970593|582431529|FG003|Overall Study|Discontinuation of study by sponsor|0|||
161287006|NCT00970593|582431530|FG004|Overall Study|Discontinuation of study by sponsor|0|||
161287007|NCT00970593|582431531|FG005|Overall Study|Discontinuation of study by sponsor|0|||
161287008|NCT00970593|582431532|FG006|Overall Study|Discontinuation of study by sponsor|2|||
161287009|NCT00970593|582431526|FG000|Overall Study|Withdrawal by Subject|0|||
161287010|NCT00970593|582431527|FG001|Overall Study|Withdrawal by Subject|0|||
161287011|NCT00970593|582431528|FG002|Overall Study|Withdrawal by Subject|1|||
161287012|NCT00970593|582431529|FG003|Overall Study|Withdrawal by Subject|0|||
161287013|NCT00970593|582431530|FG004|Overall Study|Withdrawal by Subject|0|||
161287014|NCT00970593|582431531|FG005|Overall Study|Withdrawal by Subject|0|||
161287015|NCT00970593|582431532|FG006|Overall Study|Withdrawal by Subject|0|||
161287016|NCT02203357|582431533|FG000|Overall Study|Lost to Follow-up|58|||
161287017|NCT02203357|582431534|FG001|Overall Study|Lost to Follow-up|66|||
161287018|NCT02203357|582431535|FG002|Overall Study|Lost to Follow-up|70|||
161287019|NCT02439216|582431536|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
161287020|NCT02439216|582431537|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287021|NCT02439216|582431538|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287022|NCT02439216|582431539|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287023|NCT02439216|582431540|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287024|NCT02439216|582431541|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287025|NCT02439216|582431542|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287026|NCT02439216|582431543|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287027|NCT02439216|582431544|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
161287028|NCT02439216|582431536|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287029|NCT02439216|582431537|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287030|NCT02439216|582431538|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287031|NCT02439216|582431539|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287032|NCT02439216|582431540|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287033|NCT02439216|582431541|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287034|NCT02439216|582431542|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287035|NCT02439216|582431543|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
161287036|NCT02439216|582431544|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
161287037|NCT02439216|582431536|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161287038|NCT02439216|582431537|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161287039|NCT02439216|582431538|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161346023|NCT01147458|582650984|FG000|Second Intervention|Protocol Violation|0|||
161346024|NCT01147458|582650985|FG001|Second Intervention|Protocol Violation|1|||
161346025|NCT01147458|582650986|FG002|Second Intervention|Protocol Violation|1|||
161287040|NCT02439216|582431539|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161287041|NCT02439216|582431540|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161287042|NCT02439216|582431541|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161287043|NCT02439216|582431542|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
161287044|NCT02439216|582431543|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
161287045|NCT02439216|582431544|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
161287046|NCT02439216|582431536|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161346026|NCT01147458|582650987|FG003|Second Intervention|Protocol Violation|0|||
161287047|NCT02439216|582431537|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161287048|NCT02439216|582431538|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161287049|NCT02439216|582431539|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161287050|NCT02439216|582431540|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161287051|NCT02439216|582431541|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161287052|NCT02439216|582431542|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161346027|NCT01147458|582650984|FG000|Second Intervention|Withdrawal by Subject|0|||
161159429|NCT03136185|581963127|FG004|Overall Study|Physician Decision|1|||
161159430|NCT03136185|581963128|FG005|Overall Study|Physician Decision|2|||
161159431|NCT03136185|581963129|FG006|Overall Study|Physician Decision|1|||
161159432|NCT03136185|581963130|FG007|Overall Study|Physician Decision|0|||
161159433|NCT03136185|581963131|FG008|Overall Study|Physician Decision|1|||
161159434|NCT03136185|581963123|FG000|Overall Study|Protocol Defined Disease Progression|0|||
161159435|NCT03136185|581963124|FG001|Overall Study|Protocol Defined Disease Progression|0|||
161159436|NCT03136185|581963125|FG002|Overall Study|Protocol Defined Disease Progression|1|||
161159437|NCT03136185|581963126|FG003|Overall Study|Protocol Defined Disease Progression|0|||
161159438|NCT03136185|581963127|FG004|Overall Study|Protocol Defined Disease Progression|0|||
161159439|NCT03136185|581963128|FG005|Overall Study|Protocol Defined Disease Progression|1|||
161159440|NCT03136185|581963129|FG006|Overall Study|Protocol Defined Disease Progression|0|||
161159441|NCT03136185|581963130|FG007|Overall Study|Protocol Defined Disease Progression|1|||
161159442|NCT03136185|581963131|FG008|Overall Study|Protocol Defined Disease Progression|1|||
161159443|NCT03136185|581963123|FG000|Overall Study|Withdrawal by Subject|1|||
161159444|NCT03136185|581963124|FG001|Overall Study|Withdrawal by Subject|0|||
161159445|NCT03136185|581963125|FG002|Overall Study|Withdrawal by Subject|1|||
161159446|NCT03136185|581963126|FG003|Overall Study|Withdrawal by Subject|1|||
161159447|NCT03136185|581963127|FG004|Overall Study|Withdrawal by Subject|1|||
161159448|NCT03136185|581963128|FG005|Overall Study|Withdrawal by Subject|1|||
161159449|NCT03136185|581963129|FG006|Overall Study|Withdrawal by Subject|2|||
161159450|NCT03136185|581963130|FG007|Overall Study|Withdrawal by Subject|3|||
161159451|NCT03136185|581963131|FG008|Overall Study|Withdrawal by Subject|3|||
161159452|NCT03136185|581963123|FG000|Overall Study|Not Reported|4|||
161159453|NCT03136185|581963124|FG001|Overall Study|Not Reported|1|||
161159454|NCT03136185|581963125|FG002|Overall Study|Not Reported|0|||
161159455|NCT03136185|581963126|FG003|Overall Study|Not Reported|1|||
161159456|NCT03136185|581963127|FG004|Overall Study|Not Reported|0|||
161159457|NCT03136185|581963128|FG005|Overall Study|Not Reported|2|||
161159458|NCT03136185|581963129|FG006|Overall Study|Not Reported|1|||
161159459|NCT03136185|581963130|FG007|Overall Study|Not Reported|1|||
161159460|NCT03136185|581963131|FG008|Overall Study|Not Reported|0|||
161159461|NCT05118386|581963140|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161159462|NCT05118386|581963141|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161159463|NCT05118386|581963142|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161159464|NCT05118386|581963143|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
161159465|NCT05118386|581963144|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161159466|NCT05118386|581963145|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
161159467|NCT05118386|581963140|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161159468|NCT05118386|581963141|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161159469|NCT05118386|581963142|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161159470|NCT05118386|581963143|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161159471|NCT05118386|581963144|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
161159472|NCT05118386|581963145|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
161159473|NCT00488033|581963146|FG000|Overall Study|Withdrawal by Subject|1|||
161159474|NCT00488033|581963147|FG001|Overall Study|Withdrawal by Subject|0|||
161159475|NCT00369668|581963148|FG000|Overall Study|Lack of Efficacy|4|||
161159476|NCT00369668|581963149|FG001|Overall Study|Lack of Efficacy|5|||
161159477|NCT00369668|581963150|FG002|Overall Study|Lack of Efficacy|7|||
161159478|NCT00303108|581963153|FG000|Overall Study|Adverse Event|5|||
161159479|NCT00303108|581963154|FG001|Overall Study|Adverse Event|6|||
161159480|NCT00303108|581963155|FG002|Overall Study|Adverse Event|7|||
161159481|NCT00303108|581963153|FG000|Overall Study|Patient Request|4|||
161159482|NCT00303108|581963154|FG001|Overall Study|Patient Request|2|||
161159483|NCT00303108|581963155|FG002|Overall Study|Patient Request|8|||
161159484|NCT00303108|581963153|FG000|Overall Study|Failed Entry|1|||
161159485|NCT00303108|581963154|FG001|Overall Study|Failed Entry|0|||
161159486|NCT00303108|581963155|FG002|Overall Study|Failed Entry|1|||
161159487|NCT00303108|581963153|FG000|Overall Study|ineligible|2|||
161159488|NCT00303108|581963154|FG001|Overall Study|ineligible|1|||
161159489|NCT00303108|581963155|FG002|Overall Study|ineligible|0|||
161159490|NCT00894413|581963156|FG000|Overall Study|Physician Decision|0|||
161159491|NCT00894413|581963157|FG001|Overall Study|Physician Decision|2|||
161159492|NCT00894413|581963156|FG000|Overall Study|Adverse Event|0|||
161159493|NCT00894413|581963157|FG001|Overall Study|Adverse Event|2|||
161287053|NCT02439216|582431543|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
161287054|NCT02439216|582431544|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
161287055|NCT02439216|582431536|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161287056|NCT02439216|582431537|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161159494|NCT00894413|581963156|FG000|Overall Study|Withdrawal by Subject|0|||
161159495|NCT00894413|581963157|FG001|Overall Study|Withdrawal by Subject|4|||
161159496|NCT03855137|581963162|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
161159497|NCT03855137|581963163|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
161159498|NCT03855137|581963164|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
161159499|NCT03855137|581963162|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
161159500|NCT03855137|581963163|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
161159501|NCT03855137|581963164|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
161159502|NCT03855137|581963162|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
161159503|NCT03855137|581963163|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
161159504|NCT03855137|581963164|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
161159505|NCT03855137|581963162|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
161159506|NCT03855137|581963163|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
161159507|NCT03855137|581963164|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
161159508|NCT03855137|581963162|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
161159509|NCT03855137|581963163|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
161159510|NCT03855137|581963164|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
161159511|NCT03855137|581963162|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
161159512|NCT03855137|581963163|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161159513|NCT03855137|581963164|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
161159514|NCT03855137|581963162|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
161159515|NCT03855137|581963163|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
161159516|NCT03855137|581963164|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
161159517|NCT03855137|581963162|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
161159518|NCT03855137|581963163|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
161159519|NCT03855137|581963164|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
161159520|NCT03855137|581963162|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
161159521|NCT03855137|581963163|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
161159522|NCT03855137|581963164|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
161159523|NCT03855137|581963162|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
161159524|NCT03855137|581963163|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
161159525|NCT03855137|581963164|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
161159526|NCT02427477|581963167|FG000|Period 1|Adverse Event|1|||
161159527|NCT02427477|581963168|FG001|Period 1|Adverse Event|0|||
161159528|NCT02435277|581963169|FG000|Overall Study|Adverse Event|1|||
161159529|NCT02435277|581963170|FG001|Overall Study|Adverse Event|1|||
161159530|NCT02435277|581963171|FG002|Overall Study|Adverse Event|0|||
161159531|NCT02435277|581963172|FG003|Overall Study|Adverse Event|0|||
161159532|NCT02435277|581963169|FG000|Overall Study|Withdrawal by Subject|1|||
161159533|NCT02435277|581963170|FG001|Overall Study|Withdrawal by Subject|0|||
161159534|NCT02435277|581963171|FG002|Overall Study|Withdrawal by Subject|0|||
161159535|NCT02435277|581963172|FG003|Overall Study|Withdrawal by Subject|0|||
161159536|NCT01067508|581963173|FG000|Overall Study|Physician Decision|0|||
161159537|NCT01067508|581963174|FG001|Overall Study|Physician Decision|1|||
161159538|NCT01067508|581963173|FG000|Overall Study|Withdrawal by Subject|0|||
161159539|NCT01067508|581963174|FG001|Overall Study|Withdrawal by Subject|1|||
161159540|NCT00444626|581963177|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
161159541|NCT00444626|581963177|FG000|Initial Treatment Period|Adverse Event|1|||
161159542|NCT00444626|581963177|FG000|Initial Treatment Period|Lost to Follow-up|9|||
161159543|NCT00008138|581963178|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
161159544|NCT00008138|581963178|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
161159545|NCT00008138|581963178|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
161159546|NCT00008138|581963178|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
161159547|NCT00008138|581963178|FG000|Interval Debulking|Withdrawal by Subject|2|||
161159548|NCT00008138|581963178|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
161159549|NCT00008138|581963178|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
161159550|NCT00008138|581963178|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
161159551|NCT03213626|581963179|FG000|Overall Study|Adverse Event|1|||
161159552|NCT03213626|581963179|FG000|Overall Study|Progressive Disease|6|||
161159553|NCT01005732|581963183|FG000|Overall Study|Lost to Follow-up|10|||
161159554|NCT01005732|581963183|FG000|Overall Study|Death|1|||
161287057|NCT02439216|582431538|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161287058|NCT02439216|582431539|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161159555|NCT02635737|581963184|FG000|Overall Study|Protocol Violation|1|||
161159556|NCT01552928|581963185|FG000|Period 3|Adverse Event|0|||
161159557|NCT01552928|581963186|FG001|Period 3|Adverse Event|0|||
161159558|NCT01552928|581963187|FG002|Period 3|Adverse Event|1|||
161159559|NCT01552928|581963188|FG003|Period 3|Adverse Event|0|||
161159560|NCT00632463|581963190|FG000|Overall Study|Adverse Event|0|||
161159561|NCT00632463|581963191|FG001|Overall Study|Adverse Event|1|||
161159562|NCT00632463|581963192|FG002|Overall Study|Adverse Event|0|||
161159563|NCT02065622|581963193|FG000|Induction Study|Adverse Event|13|||
161159564|NCT02065622|581963194|FG001|Induction Study|Adverse Event|19|||
161159565|NCT02065622|581963195|FG002|Induction Study|Adverse Event|0|||
161159566|NCT02065622|581963196|FG003|Induction Study|Adverse Event|0|||
161287059|NCT02439216|582431540|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161287060|NCT02439216|582431541|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161287061|NCT02439216|582431542|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
161287062|NCT02439216|582431543|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
161287063|NCT02439216|582431544|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
161287064|NCT00470535|582431548|FG000|Overall Study|Disease Progression|13|||
161287065|NCT00470535|582431548|FG000|Overall Study|Withdrawal by Subject|1|||
161346028|NCT01147458|582650985|FG001|Second Intervention|Withdrawal by Subject|1|||
161346029|NCT01147458|582650986|FG002|Second Intervention|Withdrawal by Subject|0|||
161346030|NCT01147458|582650987|FG003|Second Intervention|Withdrawal by Subject|0|||
161077804|NCT01068665|581673781|FG001|Overall Study|Lack of Efficacy|2|||
161077805|NCT01068665|581673780|FG000|Overall Study|Protocol Violation|5|||
161077806|NCT01068665|581673781|FG001|Overall Study|Protocol Violation|2|||
161077807|NCT01068665|581673780|FG000|Overall Study|Withdrawal Criteria|3|||
161077808|NCT01068665|581673781|FG001|Overall Study|Withdrawal Criteria|9|||
161077809|NCT01068665|581673780|FG000|Overall Study|Other|17|||
161077810|NCT01068665|581673781|FG001|Overall Study|Other|12|||
161077811|NCT02807272|581673782|FG000|Overall Study|Death|9|||
161077812|NCT02807272|581673783|FG001|Overall Study|Death|5|||
161077813|NCT02807272|581673784|FG002|Overall Study|Death|2|||
161077814|NCT02807272|581673785|FG003|Overall Study|Death|0|||
161077815|NCT02807272|581673786|FG004|Overall Study|Death|1|||
161077816|NCT02807272|581673782|FG000|Overall Study|Lost to Follow-up|1|||
161077817|NCT02807272|581673783|FG001|Overall Study|Lost to Follow-up|0|||
161077818|NCT02807272|581673784|FG002|Overall Study|Lost to Follow-up|0|||
161077819|NCT02807272|581673785|FG003|Overall Study|Lost to Follow-up|0|||
161077820|NCT02807272|581673786|FG004|Overall Study|Lost to Follow-up|0|||
161077821|NCT02807272|581673782|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
161077822|NCT02807272|581673783|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
161077823|NCT02807272|581673784|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
161077824|NCT02807272|581673785|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
161077825|NCT02807272|581673786|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
161077826|NCT02807272|581673782|FG000|Overall Study|Protocol-defined Disease Progression|0|||
161077827|NCT02807272|581673783|FG001|Overall Study|Protocol-defined Disease Progression|1|||
161077828|NCT02807272|581673784|FG002|Overall Study|Protocol-defined Disease Progression|0|||
161077829|NCT02807272|581673785|FG003|Overall Study|Protocol-defined Disease Progression|0|||
161077830|NCT02807272|581673786|FG004|Overall Study|Protocol-defined Disease Progression|1|||
161077831|NCT02807272|581673782|FG000|Overall Study|Study Terminated by Sponsor|1|||
161077832|NCT02807272|581673783|FG001|Overall Study|Study Terminated by Sponsor|0|||
161077833|NCT02807272|581673784|FG002|Overall Study|Study Terminated by Sponsor|0|||
161077834|NCT02807272|581673785|FG003|Overall Study|Study Terminated by Sponsor|1|||
161077835|NCT02807272|581673786|FG004|Overall Study|Study Terminated by Sponsor|0|||
161077836|NCT02807272|581673782|FG000|Overall Study|Other|1|||
161077837|NCT02807272|581673783|FG001|Overall Study|Other|0|||
161077838|NCT02807272|581673784|FG002|Overall Study|Other|0|||
161077839|NCT02807272|581673785|FG003|Overall Study|Other|0|||
161077840|NCT02807272|581673786|FG004|Overall Study|Other|1|||
161077841|NCT01162863|581673790|FG000|Overall Study|Lack of Efficacy|1|||
161077842|NCT01162863|581673791|FG001|Overall Study|Lack of Efficacy|0|||
161077843|NCT01162863|581673792|FG002|Overall Study|Lack of Efficacy|0|||
161077844|NCT01162863|581673790|FG000|Overall Study|Adverse Event|0|||
161077845|NCT01162863|581673791|FG001|Overall Study|Adverse Event|1|||
161077846|NCT01162863|581673792|FG002|Overall Study|Adverse Event|0|||
161077847|NCT00392925|581673793|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
161077848|NCT00392925|581673794|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161077849|NCT00392925|581673795|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161287066|NCT00470535|582431548|FG000|Overall Study|Adverse Event|1|||
161346031|NCT01147458|582650984|FG000|Second Intervention|Adverse Event|2|||
161346032|NCT01147458|582650985|FG001|Second Intervention|Adverse Event|0|||
161346033|NCT01147458|582650986|FG002|Second Intervention|Adverse Event|1|||
161346034|NCT01147458|582650987|FG003|Second Intervention|Adverse Event|1|||
161077850|NCT00392925|581673796|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
161287067|NCT00470535|582431548|FG000|Overall Study|Death|1|||
161287068|NCT00470535|582431548|FG000|Overall Study|Other|2|||
161287069|NCT02968576|582431549|FG000|Overall Study|Pregnancy|0|||
161287070|NCT02968576|582431550|FG001|Overall Study|Pregnancy|1|||
161287071|NCT02002221|582431551|FG000|Overall Study|Adverse Event|2|||
161287072|NCT02002221|582431552|FG001|Overall Study|Adverse Event|1|||
161287073|NCT02002221|582431551|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161346035|NCT01147458|582650984|FG000|Second Intervention|Other|0|||
161077851|NCT00392925|581673793|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
161077852|NCT00392925|581673794|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
161159567|NCT02065622|581963197|FG004|Induction Study|Adverse Event|0|||
161287074|NCT02002221|582431552|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161287075|NCT02002221|582431551|FG000|Overall Study|Patient withdrew consent|0|||
161346036|NCT01147458|582650985|FG001|Second Intervention|Other|0|||
161287076|NCT02002221|582431552|FG001|Overall Study|Patient withdrew consent|1|||
161287077|NCT01998919|582431553|FG000|Overall Study|Death|2|||
161287078|NCT01998919|582431554|FG001|Overall Study|Death|2|||
161287079|NCT01998919|582431553|FG000|Overall Study|Adverse Event|0|||
161287080|NCT01998919|582431554|FG001|Overall Study|Adverse Event|5|||
161287081|NCT01998919|582431553|FG000|Overall Study|Disease progression|31|||
161287082|NCT01998919|582431554|FG001|Overall Study|Disease progression|22|||
161287083|NCT01998919|582431553|FG000|Overall Study|Withdrawal by Subject|2|||
161077853|NCT00392925|581673795|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
161077854|NCT00392925|581673796|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
161077855|NCT00392925|581673793|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
161077856|NCT00392925|581673794|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
161077857|NCT00392925|581673795|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
161077858|NCT00392925|581673796|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
161077859|NCT00392925|581673793|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
161077860|NCT00392925|581673794|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
161077861|NCT00392925|581673795|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
161077862|NCT00392925|581673796|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
161077863|NCT00392925|581673793|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
161077864|NCT00392925|581673794|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
161077865|NCT00392925|581673795|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
161077866|NCT00392925|581673796|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
161077867|NCT00392925|581673793|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
161077868|NCT00392925|581673794|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
161077869|NCT00392925|581673795|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
161077870|NCT00392925|581673796|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
161077871|NCT00392925|581673793|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
161077872|NCT00392925|581673794|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
161077873|NCT00392925|581673795|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
161077874|NCT00392925|581673796|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
161077875|NCT00392925|581673793|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
161077876|NCT00392925|581673794|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
161077877|NCT00392925|581673795|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
161077878|NCT00392925|581673796|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
161077879|NCT00392925|581673793|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
161077880|NCT00392925|581673794|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
161077881|NCT00392925|581673795|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
161077882|NCT00392925|581673796|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
161077883|NCT03552523|581673797|FG000|Overall Study|Withdrawal by Subject|1|||
161077884|NCT03552523|581673798|FG001|Overall Study|Withdrawal by Subject|1|||
161077885|NCT04145700|581673799|FG000|Overall Study|Withdrawal by Subject|8|||
161077886|NCT04145700|581673800|FG001|Overall Study|Withdrawal by Subject|3|||
161077887|NCT00780559|581673803|FG000|Overall Study|Lost to Follow-up|2|||
161077888|NCT00780559|581673804|FG001|Overall Study|Lost to Follow-up|7|||
161077889|NCT00780559|581673803|FG000|Overall Study|Death|1|||
161077890|NCT00780559|581673804|FG001|Overall Study|Death|0|||
161077891|NCT01840410|581673806|FG000|Overall Study|Physician Decision|1|||
161077892|NCT01840410|581673807|FG001|Overall Study|Physician Decision|2|||
161077893|NCT01840410|581673806|FG000|Overall Study|Pregnancy|1|||
161077894|NCT01840410|581673807|FG001|Overall Study|Pregnancy|0|||
161077895|NCT01840410|581673806|FG000|Overall Study|Protocol deviation|1|||
161077896|NCT01840410|581673807|FG001|Overall Study|Protocol deviation|0|||
161077897|NCT01840410|581673806|FG000|Overall Study|Lost to Follow-up|1|||
161077898|NCT01840410|581673807|FG001|Overall Study|Lost to Follow-up|0|||
161077899|NCT01840410|581673806|FG000|Overall Study|Withdrawal by Subject|2|||
161077900|NCT01840410|581673807|FG001|Overall Study|Withdrawal by Subject|1|||
161077901|NCT01840410|581673806|FG000|Overall Study|Adverse Event|1|||
161077902|NCT01840410|581673807|FG001|Overall Study|Adverse Event|1|||
161077903|NCT00839956|581673808|FG000|Overall Study|Adverse Event|2|||
161077904|NCT00839956|581673808|FG000|Overall Study|Lack of Efficacy|6|||
161077905|NCT00839956|581673808|FG000|Overall Study|Physician Decision|1|||
161077906|NCT00839956|581673808|FG000|Overall Study|Withdrawal by Subject|3|||
161077907|NCT00594880|581673809|FG000|Overall Study|Withdrawal by Subject|1|||
161077908|NCT00594880|581673810|FG001|Overall Study|Withdrawal by Subject|1|||
161077909|NCT00594880|581673809|FG000|Overall Study|Lost to Follow-up|1|||
161077910|NCT00594880|581673810|FG001|Overall Study|Lost to Follow-up|0|||
161077911|NCT02206061|581673811|FG000|Overall Study|Withdrawal by Subject|4|||
161077912|NCT02206061|581673812|FG001|Overall Study|Withdrawal by Subject|7|||
161077913|NCT02206061|581673813|FG002|Overall Study|Withdrawal by Subject|1|||
161077914|NCT02206061|581673811|FG000|Overall Study|Lost to Follow-up|14|||
161077915|NCT02206061|581673812|FG001|Overall Study|Lost to Follow-up|7|||
161287084|NCT01998919|582431554|FG001|Overall Study|Withdrawal by Subject|4|||
161159568|NCT02065622|581963193|FG000|Induction Study|Withdrawal by Subject|3|||
161159569|NCT02065622|581963194|FG001|Induction Study|Withdrawal by Subject|5|||
161159570|NCT02065622|581963195|FG002|Induction Study|Withdrawal by Subject|0|||
161159571|NCT02065622|581963196|FG003|Induction Study|Withdrawal by Subject|0|||
161159572|NCT02065622|581963197|FG004|Induction Study|Withdrawal by Subject|0|||
161159573|NCT02065622|581963193|FG000|Induction Study|Lost to Follow-up|1|||
161159574|NCT02065622|581963194|FG001|Induction Study|Lost to Follow-up|0|||
161159575|NCT02065622|581963195|FG002|Induction Study|Lost to Follow-up|0|||
161159576|NCT02065622|581963196|FG003|Induction Study|Lost to Follow-up|0|||
161159577|NCT02065622|581963197|FG004|Induction Study|Lost to Follow-up|0|||
161159578|NCT02065622|581963193|FG000|Induction Study|Lack of Efficacy|22|||
161159579|NCT02065622|581963194|FG001|Induction Study|Lack of Efficacy|27|||
161159580|NCT02065622|581963195|FG002|Induction Study|Lack of Efficacy|0|||
161159581|NCT02065622|581963196|FG003|Induction Study|Lack of Efficacy|0|||
161159582|NCT02065622|581963197|FG004|Induction Study|Lack of Efficacy|0|||
161159583|NCT02065622|581963193|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
161159584|NCT02065622|581963194|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
161159585|NCT02065622|581963195|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161159586|NCT02065622|581963196|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161159587|NCT02065622|581963197|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
161159588|NCT02065622|581963193|FG000|Induction Study|Subject Noncompliance|1|||
161159589|NCT02065622|581963194|FG001|Induction Study|Subject Noncompliance|1|||
161159590|NCT02065622|581963195|FG002|Induction Study|Subject Noncompliance|0|||
161159591|NCT02065622|581963196|FG003|Induction Study|Subject Noncompliance|0|||
161159592|NCT02065622|581963197|FG004|Induction Study|Subject Noncompliance|0|||
161159593|NCT02065622|581963193|FG000|Induction Study|Other, Not Specified|3|||
161159594|NCT02065622|581963194|FG001|Induction Study|Other, Not Specified|2|||
161159595|NCT02065622|581963195|FG002|Induction Study|Other, Not Specified|0|||
161159596|NCT02065622|581963196|FG003|Induction Study|Other, Not Specified|0|||
161159597|NCT02065622|581963197|FG004|Induction Study|Other, Not Specified|0|||
161159598|NCT02065622|581963193|FG000|Maintenance Study|Adverse Event|0|||
161159599|NCT02065622|581963194|FG001|Maintenance Study|Adverse Event|0|||
161159600|NCT02065622|581963195|FG002|Maintenance Study|Adverse Event|25|||
161159601|NCT02065622|581963196|FG003|Maintenance Study|Adverse Event|22|||
161159602|NCT02065622|581963197|FG004|Maintenance Study|Adverse Event|11|||
161159603|NCT02065622|581963193|FG000|Maintenance Study|Withdrawal by Subject|0|||
161159604|NCT02065622|581963194|FG001|Maintenance Study|Withdrawal by Subject|0|||
161159605|NCT02065622|581963195|FG002|Maintenance Study|Withdrawal by Subject|11|||
161159606|NCT02065622|581963196|FG003|Maintenance Study|Withdrawal by Subject|5|||
161159607|NCT02065622|581963197|FG004|Maintenance Study|Withdrawal by Subject|7|||
161159608|NCT02065622|581963193|FG000|Maintenance Study|Lost to Follow-up|0|||
161159609|NCT02065622|581963194|FG001|Maintenance Study|Lost to Follow-up|0|||
161159610|NCT02065622|581963195|FG002|Maintenance Study|Lost to Follow-up|4|||
161159611|NCT02065622|581963196|FG003|Maintenance Study|Lost to Follow-up|1|||
161159612|NCT02065622|581963197|FG004|Maintenance Study|Lost to Follow-up|1|||
161159613|NCT02065622|581963193|FG000|Maintenance Study|Lack of Efficacy|0|||
161159614|NCT02065622|581963194|FG001|Maintenance Study|Lack of Efficacy|0|||
161159615|NCT02065622|581963195|FG002|Maintenance Study|Lack of Efficacy|70|||
161159616|NCT02065622|581963196|FG003|Maintenance Study|Lack of Efficacy|55|||
161159617|NCT02065622|581963197|FG004|Maintenance Study|Lack of Efficacy|19|||
161159618|NCT02065622|581963193|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
161159619|NCT02065622|581963194|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
161159620|NCT02065622|581963195|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
161159621|NCT02065622|581963196|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
161159622|NCT02065622|581963197|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
161159623|NCT02065622|581963193|FG000|Maintenance Study|Subject Non-Compliance|0|||
161159624|NCT02065622|581963194|FG001|Maintenance Study|Subject Non-Compliance|0|||
161159625|NCT02065622|581963195|FG002|Maintenance Study|Subject Non-Compliance|1|||
161159626|NCT02065622|581963196|FG003|Maintenance Study|Subject Non-Compliance|3|||
161159627|NCT02065622|581963197|FG004|Maintenance Study|Subject Non-Compliance|2|||
161159628|NCT02065622|581963193|FG000|Maintenance Study|Other, Not Specified|0|||
161159629|NCT02065622|581963194|FG001|Maintenance Study|Other, Not Specified|0|||
161159630|NCT02065622|581963195|FG002|Maintenance Study|Other, Not Specified|6|||
161159631|NCT02065622|581963196|FG003|Maintenance Study|Other, Not Specified|14|||
161159632|NCT02065622|581963197|FG004|Maintenance Study|Other, Not Specified|2|||
161159633|NCT02065622|581963193|FG000|Maintenance Study|Unknown Reason|0|||
161159634|NCT02065622|581963194|FG001|Maintenance Study|Unknown Reason|0|||
161159635|NCT02065622|581963195|FG002|Maintenance Study|Unknown Reason|0|||
161159636|NCT02065622|581963196|FG003|Maintenance Study|Unknown Reason|1|||
161159637|NCT02065622|581963197|FG004|Maintenance Study|Unknown Reason|0|||
161159638|NCT02349789|581965057|FG000|Overall Study|Withdrawal by Subject|2|||
161159639|NCT03137121|581965066|FG000|Overall Study|Withdrawal by Subject|0|||
161159640|NCT03137121|581965067|FG001|Overall Study|Withdrawal by Subject|1|||
161159641|NCT02871401|581965068|FG000|Overall Study|Adverse Event|1|||
161159642|NCT02871401|581965069|FG001|Overall Study|Adverse Event|0|||
161287085|NCT01998919|582431553|FG000|Overall Study|Lost to Follow-up|2|||
161287086|NCT01998919|582431554|FG001|Overall Study|Lost to Follow-up|0|||
161077916|NCT02206061|581673813|FG002|Overall Study|Lost to Follow-up|20|||
161077917|NCT00694109|581673814|FG000|Overall Study|Physician Decision|3|||
161077918|NCT00694109|581673814|FG000|Overall Study|Adverse Event|74|||
161077919|NCT00694109|581673814|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
161077920|NCT00694109|581673814|FG000|Overall Study|Lack of Efficacy|2|||
161077921|NCT00694109|581673814|FG000|Overall Study|Withdrawal by Subject|13|||
161077922|NCT00694109|581673814|FG000|Overall Study|Pregnancy|1|||
161077923|NCT00694109|581673814|FG000|Overall Study|Enrolled but not treated|1|||
161077924|NCT00694109|581673814|FG000|Overall Study|Other|2|||
161077925|NCT00694109|581673814|FG000|Overall Study|Consented but no additional treatment|3|||
161077926|NCT01067846|581673815|FG000|Overall Study|Lost to Follow-up|17|||
161077927|NCT01067846|581673816|FG001|Overall Study|Lost to Follow-up|19|||
161077928|NCT01067846|581673815|FG000|Overall Study|Withdrawal by Subject|1|||
161077929|NCT01067846|581673816|FG001|Overall Study|Withdrawal by Subject|0|||
161077930|NCT01067846|581673815|FG000|Overall Study|participation in other tx study|1|||
161077931|NCT01067846|581673816|FG001|Overall Study|participation in other tx study|0|||
161077932|NCT02817906|581673817|FG000|Overall Study|Adverse Event|3|||
161077933|NCT02817906|581673818|FG001|Overall Study|Adverse Event|0|||
161077934|NCT02817906|581673817|FG000|Overall Study|Lack of Efficacy|1|||
161077935|NCT02817906|581673818|FG001|Overall Study|Lack of Efficacy|0|||
161077936|NCT02817906|581673817|FG000|Overall Study|Protocol Violation|1|||
161077937|NCT02817906|581673818|FG001|Overall Study|Protocol Violation|1|||
161077938|NCT02817906|581673817|FG000|Overall Study|Study Terminated by Sponsor|2|||
161077939|NCT02817906|581673818|FG001|Overall Study|Study Terminated by Sponsor|2|||
161077940|NCT02817906|581673817|FG000|Overall Study|Withdrawal by Subject|7|||
161077941|NCT02817906|581673818|FG001|Overall Study|Withdrawal by Subject|0|||
161077942|NCT02817906|581673817|FG000|Overall Study|Other|2|||
161077943|NCT02817906|581673818|FG001|Overall Study|Other|2|||
161077944|NCT03686423|581673827|FG000|Overall Study|Withdrawal by Subject|9|||
161077945|NCT03686423|581673827|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
161077946|NCT04954326|581673828|FG000|Overall Study|Protocol Violation|0|||
161077947|NCT04954326|581673829|FG001|Overall Study|Protocol Violation|1|||
161077948|NCT04954326|581673828|FG000|Overall Study|Death|0|||
161077949|NCT04954326|581673829|FG001|Overall Study|Death|2|||
161077950|NCT04954326|581673828|FG000|Overall Study|Physician Decision|0|||
161077951|NCT04954326|581673829|FG001|Overall Study|Physician Decision|1|||
161077952|NCT01495598|581673834|FG000|Overall Study|Death during follow up period|2|||
161077953|NCT01495598|581673834|FG000|Overall Study|Death on study|1|||
161077954|NCT01495598|581673834|FG000|Overall Study|Lost to Follow-up|3|||
161077955|NCT01495598|581673834|FG000|Overall Study|Physician Decision|8|||
161077956|NCT03635099|581673835|FG000|Period 1|Adverse Event|1|||
161077957|NCT03635099|581673836|FG001|Period 1|Adverse Event|0|||
161077958|NCT03635099|581673837|FG002|Period 1|Adverse Event|0|||
161077959|NCT03635099|581673838|FG003|Period 1|Adverse Event|1|||
161077960|NCT03635099|581673839|FG004|Period 1|Adverse Event|0|||
161077961|NCT03635099|581673840|FG005|Period 1|Adverse Event|0|||
161077962|NCT03635099|581673841|FG006|Period 1|Adverse Event|0|||
161077963|NCT03635099|581673842|FG007|Period 1|Adverse Event|0|||
161077964|NCT03635099|581673835|FG000|Period 1|Protocol Violation|0|||
161077965|NCT03635099|581673836|FG001|Period 1|Protocol Violation|0|||
161077966|NCT03635099|581673837|FG002|Period 1|Protocol Violation|1|||
161077967|NCT03635099|581673838|FG003|Period 1|Protocol Violation|0|||
161077968|NCT03635099|581673839|FG004|Period 1|Protocol Violation|0|||
161077969|NCT03635099|581673840|FG005|Period 1|Protocol Violation|0|||
161077970|NCT03635099|581673841|FG006|Period 1|Protocol Violation|0|||
161077971|NCT03635099|581673842|FG007|Period 1|Protocol Violation|0|||
161077972|NCT03635099|581673835|FG000|Period 1|Lost to Follow-up|0|||
161077973|NCT03635099|581673836|FG001|Period 1|Lost to Follow-up|0|||
161077974|NCT03635099|581673837|FG002|Period 1|Lost to Follow-up|1|||
161077975|NCT03635099|581673838|FG003|Period 1|Lost to Follow-up|2|||
161077976|NCT03635099|581673839|FG004|Period 1|Lost to Follow-up|1|||
161077977|NCT03635099|581673840|FG005|Period 1|Lost to Follow-up|0|||
161077978|NCT03635099|581673841|FG006|Period 1|Lost to Follow-up|1|||
161077979|NCT03635099|581673842|FG007|Period 1|Lost to Follow-up|2|||
161077980|NCT03635099|581673835|FG000|Period 1|Withdrawal by Subject|3|||
161077981|NCT03635099|581673836|FG001|Period 1|Withdrawal by Subject|3|||
161077982|NCT03635099|581673837|FG002|Period 1|Withdrawal by Subject|5|||
161077983|NCT03635099|581673838|FG003|Period 1|Withdrawal by Subject|2|||
161077984|NCT03635099|581673839|FG004|Period 1|Withdrawal by Subject|2|||
161077985|NCT03635099|581673840|FG005|Period 1|Withdrawal by Subject|0|||
161077986|NCT03635099|581673841|FG006|Period 1|Withdrawal by Subject|3|||
161077987|NCT03635099|581673842|FG007|Period 1|Withdrawal by Subject|0|||
161077988|NCT03635099|581673835|FG000|Period 1|History of suicidal ideation|0|||
161077989|NCT03635099|581673836|FG001|Period 1|History of suicidal ideation|0|||
161077990|NCT03635099|581673837|FG002|Period 1|History of suicidal ideation|1|||
161077991|NCT03635099|581673838|FG003|Period 1|History of suicidal ideation|0|||
161077992|NCT03635099|581673839|FG004|Period 1|History of suicidal ideation|0|||
161077993|NCT03635099|581673840|FG005|Period 1|History of suicidal ideation|0|||
161159643|NCT02282982|581965070|FG000|Overall Study|Lost to Follow-up|15|||
161159644|NCT02282982|581965070|FG000|Overall Study|Withdrew consent|2|||
161159645|NCT02282982|581965070|FG000|Overall Study|Death|4|||
161159646|NCT02282982|581965070|FG000|Overall Study|Lack of product|156|||
161159647|NCT02282982|581965070|FG000|Overall Study|Palivizumab is ended|11|||
161159648|NCT02282982|581965070|FG000|Overall Study|Other, not specified|18|||
161159649|NCT02006667|581965071|FG000|Overall Study|Adverse Event|3|||
161159650|NCT02006667|581965071|FG000|Overall Study|Death|2|||
161159651|NCT02006667|581965071|FG000|Overall Study|Withdrawal by Subject|1|||
161159652|NCT02939937|581965072|FG000|Overall Study|Adverse Event|5|||
161159653|NCT02939937|581965073|FG001|Overall Study|Adverse Event|0|||
161159654|NCT02939937|581965072|FG000|Overall Study|Lost to Follow-up|1|||
161159655|NCT02939937|581965073|FG001|Overall Study|Lost to Follow-up|3|||
161159656|NCT00568958|581965075|FG000|Allocation|Withdrawal by Subject|7|||
161159657|NCT00568958|581965076|FG001|Allocation|Withdrawal by Subject|3|||
161159658|NCT00568958|581965075|FG000|Allocation|Physician Decision|2|||
161159659|NCT00568958|581965076|FG001|Allocation|Physician Decision|0|||
161159660|NCT00568958|581965075|FG000|Follow-Up|Withdrawal by Subject|6|||
161159661|NCT00568958|581965076|FG001|Follow-Up|Withdrawal by Subject|6|||
161159662|NCT00568958|581965075|FG000|Follow-Up|Physician Decision|1|||
161159663|NCT00568958|581965076|FG001|Follow-Up|Physician Decision|1|||
161159664|NCT00568958|581965075|FG000|Follow-Up|Family Emergency|1|||
161159665|NCT00568958|581965076|FG001|Follow-Up|Family Emergency|0|||
161159666|NCT00568958|581965075|FG000|Follow-Up|Adverse Event|1|||
161159667|NCT00568958|581965076|FG001|Follow-Up|Adverse Event|0|||
161159668|NCT05254613|581965080|FG000|Overall Study|Lost to Follow-up|0|||
161159669|NCT05254613|581965081|FG001|Overall Study|Lost to Follow-up|0|||
161159670|NCT05254613|581965082|FG002|Overall Study|Lost to Follow-up|1|||
161159671|NCT02387372|581965083|FG000|Overall Study|Not Treated|1|||
161159672|NCT02387372|581965084|FG001|Overall Study|Not Treated|0|||
161159673|NCT01911845|581965086|FG000|Overall Study|Adverse Event|2|||
161159674|NCT01911845|581965086|FG000|Overall Study|Lost to Follow-up|1|||
161159675|NCT01911845|581965086|FG000|Overall Study|Other (not specified)|3|||
161159676|NCT01576016|581965087|FG000|Lead Safety|Death|132|||
161159677|NCT01576016|581965088|FG001|Lead Safety|Death|0|||
161159678|NCT01576016|581965087|FG000|Lead Safety|Withdrawal by Subject|81|||
161159679|NCT01576016|581965088|FG001|Lead Safety|Withdrawal by Subject|0|||
161159680|NCT01576016|581965087|FG000|Lead Safety|System Explanted without Replacement|24|||
161159681|NCT01576016|581965088|FG001|Lead Safety|System Explanted without Replacement|0|||
161159682|NCT01576016|581965087|FG000|Lead Safety|Physician Decision|14|||
161159683|NCT01576016|581965088|FG001|Lead Safety|Physician Decision|0|||
161159684|NCT01576016|581965087|FG000|Lead Safety|Lost to Follow-up|13|||
161159685|NCT01576016|581965088|FG001|Lead Safety|Lost to Follow-up|0|||
161159686|NCT01576016|581965087|FG000|Lead Safety|Unsuccessful implant|2|||
161159687|NCT01576016|581965088|FG001|Lead Safety|Unsuccessful implant|0|||
161159688|NCT01576016|581965087|FG000|Lead Safety|Sponsor request|1|||
161159689|NCT01576016|581965088|FG001|Lead Safety|Sponsor request|0|||
161159690|NCT01576016|581965087|FG000|Lead Safety|Device replaced with CRT-D|1|||
161159691|NCT01576016|581965088|FG001|Lead Safety|Device replaced with CRT-D|0|||
161159692|NCT01576016|581965087|FG000|Lead Safety|Patient on Palliative Care|1|||
161159693|NCT01576016|581965088|FG001|Lead Safety|Patient on Palliative Care|0|||
161159694|NCT01576016|581965087|FG000|Lead Safety|Patient noncompliance|1|||
161159695|NCT01576016|581965088|FG001|Lead Safety|Patient noncompliance|0|||
161159696|NCT01576016|581965087|FG000|Lead Safety|Too far from study site|1|||
161346037|NCT01147458|582650986|FG002|Second Intervention|Other|1|||
161346038|NCT01147458|582650987|FG003|Second Intervention|Other|0|||
161346039|NCT02811159|582650999|FG000|Treatment Course 1|Lost to Follow-up|1|||
161346040|NCT04603066|582651000|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
161159697|NCT01576016|581965088|FG001|Lead Safety|Too far from study site|0|||
161159698|NCT01576016|581965087|FG000|Lead Safety|System deactivated|1|||
161159699|NCT01576016|581965088|FG001|Lead Safety|System deactivated|0|||
161159700|NCT01576016|581965087|FG000|Lead Safety|Patient no longer followed by study PI|1|||
161159701|NCT01576016|581965088|FG001|Lead Safety|Patient no longer followed by study PI|0|||
161159702|NCT01576016|581965087|FG000|MRI Safety|Withdrawal by Subject|0|||
161346041|NCT04603066|582651001|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
161346042|NCT04409002|582651002|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
161159703|NCT01576016|581965088|FG001|MRI Safety|Withdrawal by Subject|10|||
161159704|NCT01576016|581965087|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
161159705|NCT01576016|581965088|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
161159706|NCT01576016|581965087|FG000|MRI Safety|Has not yet completed MRI scan|0|||
161159707|NCT01576016|581965088|FG001|MRI Safety|Has not yet completed MRI scan|56|||
161159708|NCT01576016|581965087|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
161159709|NCT01576016|581965088|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
161159710|NCT01774344|581965089|FG000|Overall Study|Withdrawal by Subject|3|||
161159711|NCT01774344|581965090|FG001|Overall Study|Withdrawal by Subject|10|||
161346043|NCT04190225|582653218|FG000|Overall Study|Lost to Follow-up|2|||
161159712|NCT01774344|581965089|FG000|Overall Study|Protocol Violation|0|||
161159713|NCT01774344|581965090|FG001|Overall Study|Protocol Violation|1|||
161159714|NCT01774344|581965089|FG000|Overall Study|Lost to Follow-up|4|||
161287087|NCT01998919|582431553|FG000|Overall Study|Other|5|||
161287088|NCT01998919|582431554|FG001|Overall Study|Other|2|||
161287089|NCT00897715|582431558|FG000|Overall Study|Lost to Follow-up|0|||
161287090|NCT00897715|582431559|FG001|Overall Study|Lost to Follow-up|1|||
161287091|NCT00897715|582431558|FG000|Overall Study|Physician Decision|1|||
161287092|NCT00897715|582431559|FG001|Overall Study|Physician Decision|0|||
161287093|NCT00897715|582431558|FG000|Overall Study|increased risk of infection|1|||
161287094|NCT00897715|582431559|FG001|Overall Study|increased risk of infection|0|||
161287095|NCT00927589|582431561|FG000|Overall Study|Death|1|||
161287096|NCT00927589|582431561|FG000|Overall Study|Physician Decision|1|||
161287097|NCT00927589|582431561|FG000|Overall Study|Withdrawal by Subject|3|||
161287098|NCT00927589|582431561|FG000|Overall Study|Adverse Event|2|||
161287099|NCT00927589|582431561|FG000|Overall Study|Disease Progression|8|||
161287100|NCT00927589|582431561|FG000|Overall Study|Non-compliance|1|||
161287101|NCT03875508|582431562|FG000|Overall Study|Adverse Event|1|||
161287102|NCT03875508|582431562|FG000|Overall Study|Lost to Follow-up|8|||
161287103|NCT03875508|582431562|FG000|Overall Study|Lack of Efficacy|1|||
161287104|NCT03875508|582431562|FG000|Overall Study|Other, not specified|2|||
161287105|NCT03743051|582431563|FG000|Overall Study|Adverse Event|5|||
161287106|NCT03743051|582431564|FG001|Overall Study|Adverse Event|9|||
161287107|NCT03743051|582431563|FG000|Overall Study|Death|27|||
161287108|NCT03743051|582431564|FG001|Overall Study|Death|26|||
161287109|NCT03743051|582431563|FG000|Overall Study|Lost to Follow-up|4|||
161287110|NCT03743051|582431564|FG001|Overall Study|Lost to Follow-up|8|||
161287111|NCT03743051|582431563|FG000|Overall Study|Withdrawal by Subject|32|||
161287112|NCT03743051|582431564|FG001|Overall Study|Withdrawal by Subject|19|||
161287113|NCT03743051|582431563|FG000|Overall Study|Physician Decision|10|||
161287114|NCT03743051|582431564|FG001|Overall Study|Physician Decision|15|||
161287115|NCT03743051|582431563|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
161287116|NCT03743051|582431564|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
161287117|NCT02137252|582431565|FG000|Overall Study|trial terminated early|2|||
161287118|NCT02137252|582431566|FG001|Overall Study|trial terminated early|1|||
161287119|NCT02550561|582431570|FG000|Overall Study|Lost to Follow-up|5|||
161287120|NCT02550561|582431570|FG000|Overall Study|Withdrawal by Subject|1|||
161287121|NCT00428246|582431571|FG000|Overall Study|Withdrawal by Subject|0|||
161287122|NCT00428246|582431572|FG001|Overall Study|Withdrawal by Subject|0|||
161287123|NCT00428246|582431573|FG002|Overall Study|Withdrawal by Subject|1|||
161287124|NCT00428246|582431571|FG000|Overall Study|Adverse Event|1|||
161287125|NCT00428246|582431572|FG001|Overall Study|Adverse Event|0|||
161287126|NCT00428246|582431573|FG002|Overall Study|Adverse Event|0|||
161287127|NCT05198518|582431575|FG000|Screening Visit|Deemed unable to participate|58|||
161287128|NCT05198518|582431576|FG001|Screening Visit|Deemed unable to participate|0|||
161287129|NCT05198518|582431577|FG002|Screening Visit|Deemed unable to participate|0|||
161287130|NCT05317312|582431584|FG000|Overall Study|Withdrawal by Subject|0|||
161287131|NCT05317312|582431585|FG001|Overall Study|Withdrawal by Subject|1|||
161287132|NCT05317312|582431586|FG002|Overall Study|Withdrawal by Subject|0|||
161287133|NCT05317312|582431587|FG003|Overall Study|Withdrawal by Subject|0|||
161287134|NCT05317312|582431584|FG000|Overall Study|Lost to Follow-up|0|||
161287135|NCT05317312|582431585|FG001|Overall Study|Lost to Follow-up|0|||
161287136|NCT05317312|582431586|FG002|Overall Study|Lost to Follow-up|0|||
161287137|NCT05317312|582431587|FG003|Overall Study|Lost to Follow-up|1|||
161287138|NCT05317312|582431584|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
161287139|NCT05317312|582431585|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
161287140|NCT05317312|582431586|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
161287141|NCT05317312|582431587|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
161287142|NCT00262028|582431588|FG000|Overall Study|Withdrawal by Subject|6|||
161287143|NCT00262028|582431589|FG001|Overall Study|Withdrawal by Subject|3|||
161287144|NCT00262028|582431590|FG002|Overall Study|Withdrawal by Subject|6|||
161287145|NCT00262028|582431591|FG003|Overall Study|Withdrawal by Subject|5|||
161287146|NCT00262028|582431592|FG004|Overall Study|Withdrawal by Subject|2|||
161346044|NCT04190225|582653219|FG001|Overall Study|Lost to Follow-up|3|||
161346045|NCT04190225|582653218|FG000|Overall Study|Withdrawal by Subject|3|||
161159715|NCT01774344|581965090|FG001|Overall Study|Lost to Follow-up|10|||
161287147|NCT00262028|582431593|FG005|Overall Study|Withdrawal by Subject|3|||
161287148|NCT00262028|582431594|FG006|Overall Study|Withdrawal by Subject|5|||
161287149|NCT00262028|582431595|FG007|Overall Study|Withdrawal by Subject|7|||
161287150|NCT00262028|582431596|FG008|Overall Study|Withdrawal by Subject|2|||
161287151|NCT00262028|582431588|FG000|Overall Study|Lost to Follow-up|7|||
161287152|NCT00262028|582431589|FG001|Overall Study|Lost to Follow-up|7|||
161287153|NCT00262028|582431590|FG002|Overall Study|Lost to Follow-up|5|||
161287154|NCT00262028|582431591|FG003|Overall Study|Lost to Follow-up|5|||
161287155|NCT00262028|582431592|FG004|Overall Study|Lost to Follow-up|4|||
161287156|NCT00262028|582431593|FG005|Overall Study|Lost to Follow-up|3|||
161287157|NCT00262028|582431594|FG006|Overall Study|Lost to Follow-up|3|||
161287158|NCT00262028|582431595|FG007|Overall Study|Lost to Follow-up|5|||
161287159|NCT00262028|582431596|FG008|Overall Study|Lost to Follow-up|6|||
161287160|NCT00262028|582431588|FG000|Overall Study|Administrative Reason|11|||
161159716|NCT01774344|581965089|FG000|Overall Study|End of survival follow-up not available|2|||
161159717|NCT01774344|581965090|FG001|Overall Study|End of survival follow-up not available|2|||
161159718|NCT01774344|581965089|FG000|Overall Study|Data collection finished|4|||
161159719|NCT01774344|581965090|FG001|Overall Study|Data collection finished|14|||
161159720|NCT01774344|581965089|FG000|Overall Study|Other|0|||
161159721|NCT01774344|581965090|FG001|Overall Study|Other|1|||
161159722|NCT01774344|581965089|FG000|Overall Study|Did not enter Survival Follow up|49|||
161159723|NCT01774344|581965090|FG001|Overall Study|Did not enter Survival Follow up|83|||
161159724|NCT00502320|581965099|FG000|Overall Study|Lost to Follow-up|1|||
161287161|NCT00262028|582431589|FG001|Overall Study|Administrative Reason|14|||
161287162|NCT00262028|582431590|FG002|Overall Study|Administrative Reason|9|||
161287163|NCT00262028|582431591|FG003|Overall Study|Administrative Reason|12|||
161287164|NCT00262028|582431592|FG004|Overall Study|Administrative Reason|6|||
161287165|NCT00262028|582431593|FG005|Overall Study|Administrative Reason|7|||
161287166|NCT00262028|582431594|FG006|Overall Study|Administrative Reason|4|||
161287167|NCT00262028|582431595|FG007|Overall Study|Administrative Reason|6|||
161287168|NCT00262028|582431596|FG008|Overall Study|Administrative Reason|10|||
161287169|NCT00262028|582431588|FG000|Overall Study|Protocol Violation|0|||
161287170|NCT00262028|582431589|FG001|Overall Study|Protocol Violation|0|||
161287171|NCT00262028|582431590|FG002|Overall Study|Protocol Violation|0|||
161287172|NCT00262028|582431591|FG003|Overall Study|Protocol Violation|1|||
161287173|NCT00262028|582431592|FG004|Overall Study|Protocol Violation|0|||
161287174|NCT00262028|582431593|FG005|Overall Study|Protocol Violation|0|||
161287175|NCT00262028|582431594|FG006|Overall Study|Protocol Violation|0|||
161287176|NCT00262028|582431595|FG007|Overall Study|Protocol Violation|0|||
161287177|NCT00262028|582431596|FG008|Overall Study|Protocol Violation|0|||
161287178|NCT00262028|582431588|FG000|Overall Study|Unable to classify|0|||
161287179|NCT00262028|582431589|FG001|Overall Study|Unable to classify|3|||
161287180|NCT00262028|582431590|FG002|Overall Study|Unable to classify|0|||
161287181|NCT00262028|582431591|FG003|Overall Study|Unable to classify|0|||
161077994|NCT03635099|581673841|FG006|Period 1|History of suicidal ideation|0|||
161077995|NCT03635099|581673842|FG007|Period 1|History of suicidal ideation|0|||
161077996|NCT03635099|581673835|FG000|Period 1|pursue other treatment options|0|||
161077997|NCT03635099|581673836|FG001|Period 1|pursue other treatment options|0|||
161077998|NCT03635099|581673837|FG002|Period 1|pursue other treatment options|0|||
161077999|NCT03635099|581673838|FG003|Period 1|pursue other treatment options|0|||
161078000|NCT03635099|581673839|FG004|Period 1|pursue other treatment options|0|||
161078001|NCT03635099|581673840|FG005|Period 1|pursue other treatment options|1|||
161078002|NCT03635099|581673841|FG006|Period 1|pursue other treatment options|0|||
161078003|NCT03635099|581673842|FG007|Period 1|pursue other treatment options|0|||
161078004|NCT03635099|581673835|FG000|Not Eligible for Period 2|Pregnancy|0|||
161078005|NCT03635099|581673836|FG001|Not Eligible for Period 2|Pregnancy|0|||
161078006|NCT03635099|581673837|FG002|Not Eligible for Period 2|Pregnancy|0|||
161078007|NCT03635099|581673838|FG003|Not Eligible for Period 2|Pregnancy|1|||
161078008|NCT03635099|581673839|FG004|Not Eligible for Period 2|Pregnancy|0|||
161078009|NCT03635099|581673840|FG005|Not Eligible for Period 2|Pregnancy|0|||
161078010|NCT03635099|581673841|FG006|Not Eligible for Period 2|Pregnancy|0|||
161078011|NCT03635099|581673842|FG007|Not Eligible for Period 2|Pregnancy|0|||
161078012|NCT03635099|581673835|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
161078013|NCT03635099|581673836|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078014|NCT03635099|581673837|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078015|NCT03635099|581673838|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078016|NCT03635099|581673839|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078017|NCT03635099|581673840|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078018|NCT03635099|581673841|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078019|NCT03635099|581673842|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
161078020|NCT03635099|581673835|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161078021|NCT03635099|581673836|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161078022|NCT03635099|581673837|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161078023|NCT03635099|581673838|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161078024|NCT03635099|581673839|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
161159725|NCT00502320|581965100|FG001|Overall Study|Lost to Follow-up|1|||
161159726|NCT00502320|581965099|FG000|Overall Study|Withdrew Consent|1|||
161287182|NCT00262028|582431592|FG004|Overall Study|Unable to classify|0|||
161287183|NCT00262028|582431593|FG005|Overall Study|Unable to classify|0|||
161287184|NCT00262028|582431594|FG006|Overall Study|Unable to classify|0|||
161287185|NCT00262028|582431595|FG007|Overall Study|Unable to classify|0|||
161078025|NCT03635099|581673840|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
161159727|NCT00502320|581965100|FG001|Overall Study|Withdrew Consent|0|||
161287186|NCT00262028|582431596|FG008|Overall Study|Unable to classify|1|||
161287187|NCT00124917|582431597|FG000|Overall Study|Physician Decision|3|||
161287188|NCT03164551|582431598|FG000|Overall Study|Imaging discontinued prior completion|8|||
161287189|NCT03164551|582431599|FG001|Overall Study|Imaging discontinued prior completion|0|||
161287190|NCT03164551|582431598|FG000|Overall Study|Participant was non-compliant|1|||
161346046|NCT04190225|582653219|FG001|Overall Study|Withdrawal by Subject|2|||
161346047|NCT04190225|582653218|FG000|Overall Study|Unrelated health condition|2|||
161346048|NCT04190225|582653219|FG001|Overall Study|Unrelated health condition|0|||
161346049|NCT01732783|582653220|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
161346050|NCT01732783|582653221|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
161346051|NCT01732783|582653222|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
161346052|NCT01732783|582653220|FG000|Overall Study|Death|13|||
161346053|NCT01732783|582653221|FG001|Overall Study|Death|4|||
161346054|NCT01732783|582653222|FG002|Overall Study|Death|1|||
161346055|NCT01732783|582653220|FG000|Overall Study|Lost to Follow-up|7|||
161346056|NCT01732783|582653221|FG001|Overall Study|Lost to Follow-up|1|||
161346057|NCT01732783|582653222|FG002|Overall Study|Lost to Follow-up|1|||
161346058|NCT01732783|582653220|FG000|Overall Study|Administrative Decision|8|||
161287191|NCT03164551|582431599|FG001|Overall Study|Participant was non-compliant|0|||
161287192|NCT03164551|582431598|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
161287193|NCT03164551|582431599|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
161287194|NCT03164551|582431598|FG000|Overall Study|Other|8|||
161287195|NCT03164551|582431599|FG001|Overall Study|Other|2|||
161287196|NCT01515423|582431600|FG000|Open Label Phase|Adverse Event|57|||
161287197|NCT01515423|582431601|FG001|Open Label Phase|Adverse Event|0|||
161287198|NCT01515423|582431602|FG002|Open Label Phase|Adverse Event|0|||
161287199|NCT01515423|582431600|FG000|Open Label Phase|Death|2|||
161287200|NCT01515423|582431601|FG001|Open Label Phase|Death|0|||
161287201|NCT01515423|582431602|FG002|Open Label Phase|Death|0|||
161287202|NCT01515423|582431600|FG000|Open Label Phase|Lack of Efficacy|117|||
161287203|NCT01515423|582431601|FG001|Open Label Phase|Lack of Efficacy|0|||
161287204|NCT01515423|582431602|FG002|Open Label Phase|Lack of Efficacy|0|||
161287205|NCT01515423|582431600|FG000|Open Label Phase|Lost to Follow-up|21|||
161287206|NCT01515423|582431601|FG001|Open Label Phase|Lost to Follow-up|0|||
161287207|NCT01515423|582431602|FG002|Open Label Phase|Lost to Follow-up|0|||
161287208|NCT01515423|582431600|FG000|Open Label Phase|Withdrawal by Subject|118|||
161287209|NCT01515423|582431601|FG001|Open Label Phase|Withdrawal by Subject|0|||
161287210|NCT01515423|582431602|FG002|Open Label Phase|Withdrawal by Subject|0|||
161287211|NCT01515423|582431600|FG000|Open Label Phase|excluded from DB Phase|70|||
161287212|NCT01515423|582431601|FG001|Open Label Phase|excluded from DB Phase|0|||
161287213|NCT01515423|582431602|FG002|Open Label Phase|excluded from DB Phase|0|||
161287214|NCT01515423|582431600|FG000|Open Label Phase|Other|28|||
161287215|NCT01515423|582431601|FG001|Open Label Phase|Other|0|||
161287216|NCT01515423|582431602|FG002|Open Label Phase|Other|0|||
161287217|NCT01515423|582431600|FG000|DOUBLE BLIND|Adverse Event|0|||
161287218|NCT01515423|582431601|FG001|DOUBLE BLIND|Adverse Event|15|||
161287219|NCT01515423|582431602|FG002|DOUBLE BLIND|Adverse Event|13|||
161287220|NCT01515423|582431600|FG000|DOUBLE BLIND|Death|0|||
161287221|NCT01515423|582431601|FG001|DOUBLE BLIND|Death|1|||
161287222|NCT01515423|582431602|FG002|DOUBLE BLIND|Death|2|||
161287223|NCT01515423|582431600|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
161287224|NCT01515423|582431601|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
161287225|NCT01515423|582431602|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
161287226|NCT01515423|582431600|FG000|DOUBLE BLIND|Pregnancy|0|||
161287227|NCT01515423|582431601|FG001|DOUBLE BLIND|Pregnancy|2|||
161287228|NCT01515423|582431602|FG002|DOUBLE BLIND|Pregnancy|0|||
161287229|NCT01515423|582431600|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
161287230|NCT01515423|582431601|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
161287231|NCT01515423|582431602|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
161346059|NCT01732783|582653221|FG001|Overall Study|Administrative Decision|2|||
161346060|NCT01732783|582653222|FG002|Overall Study|Administrative Decision|1|||
161346061|NCT01732783|582653220|FG000|Overall Study|Withdrawal by Subject|1|||
161346062|NCT01732783|582653221|FG001|Overall Study|Withdrawal by Subject|0|||
161346063|NCT01732783|582653222|FG002|Overall Study|Withdrawal by Subject|0|||
161078026|NCT03635099|581673841|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
161078027|NCT03635099|581673842|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
161078028|NCT03635099|581673835|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
161287232|NCT01515423|582431600|FG000|DOUBLE BLIND|Other|0|||
161346064|NCT04429971|582653223|FG000|Overall Study|Lost to Follow-up|7|||
161346065|NCT04429971|582653224|FG001|Overall Study|Lost to Follow-up|8|||
161346066|NCT05522751|582653230|FG000|Overall Study|Adverse Event|1|||
161346067|NCT04044690|582653232|FG000|Period 1|Lack of Efficacy|1|||
161287233|NCT01515423|582431601|FG001|DOUBLE BLIND|Other|6|||
161287234|NCT01515423|582431602|FG002|DOUBLE BLIND|Other|12|||
161287235|NCT01515423|582431600|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
161287236|NCT01515423|582431601|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
161287237|NCT01515423|582431602|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
161287238|NCT01422213|582431607|FG000|Overall Study|Adverse Event|8|||
161287239|NCT01422213|582431608|FG001|Overall Study|Adverse Event|7|||
161287240|NCT01422213|582431609|FG002|Overall Study|Adverse Event|11|||
161287241|NCT01422213|582431607|FG000|Overall Study|Lack of Efficacy|10|||
161287242|NCT01422213|582431608|FG001|Overall Study|Lack of Efficacy|2|||
161287243|NCT01422213|582431609|FG002|Overall Study|Lack of Efficacy|2|||
161346068|NCT04044690|582653233|FG001|Period 1|Lack of Efficacy|1|||
161078029|NCT03635099|581673836|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
161078030|NCT03635099|581673837|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
161078031|NCT03635099|581673838|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
161078032|NCT03635099|581673839|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161078033|NCT03635099|581673840|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161078034|NCT03635099|581673841|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161078035|NCT03635099|581673842|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
161078036|NCT03635099|581673835|FG000|Period 2|Adverse Event|0|||
161078037|NCT03635099|581673836|FG001|Period 2|Adverse Event|0|||
161078038|NCT03635099|581673837|FG002|Period 2|Adverse Event|1|||
161078039|NCT03635099|581673838|FG003|Period 2|Adverse Event|0|||
161078040|NCT03635099|581673839|FG004|Period 2|Adverse Event|1|||
161078041|NCT03635099|581673840|FG005|Period 2|Adverse Event|0|||
161078042|NCT03635099|581673841|FG006|Period 2|Adverse Event|0|||
161078043|NCT03635099|581673842|FG007|Period 2|Adverse Event|0|||
161078044|NCT03635099|581673835|FG000|Period 2|Lost to Follow-up|0|||
161078045|NCT03635099|581673836|FG001|Period 2|Lost to Follow-up|0|||
161078046|NCT03635099|581673837|FG002|Period 2|Lost to Follow-up|1|||
161078047|NCT03635099|581673838|FG003|Period 2|Lost to Follow-up|0|||
161078048|NCT03635099|581673839|FG004|Period 2|Lost to Follow-up|4|||
161078049|NCT03635099|581673840|FG005|Period 2|Lost to Follow-up|0|||
161078050|NCT03635099|581673841|FG006|Period 2|Lost to Follow-up|0|||
161078051|NCT03635099|581673842|FG007|Period 2|Lost to Follow-up|0|||
161078052|NCT03635099|581673835|FG000|Period 2|Withdrawal by Subject|0|||
161078053|NCT03635099|581673836|FG001|Period 2|Withdrawal by Subject|0|||
161078054|NCT03635099|581673837|FG002|Period 2|Withdrawal by Subject|7|||
161078055|NCT03635099|581673838|FG003|Period 2|Withdrawal by Subject|4|||
161078056|NCT03635099|581673839|FG004|Period 2|Withdrawal by Subject|7|||
161078057|NCT03635099|581673840|FG005|Period 2|Withdrawal by Subject|0|||
161078058|NCT03635099|581673841|FG006|Period 2|Withdrawal by Subject|0|||
161078059|NCT03635099|581673842|FG007|Period 2|Withdrawal by Subject|0|||
161078060|NCT01289210|581673843|FG000|Overall Study|Adverse Event|1|||
161078061|NCT06285240|581673844|FG000|Overall Study|Withdrawal by Subject|2|||
161078062|NCT06285240|581673845|FG001|Overall Study|Withdrawal by Subject|0|||
161078063|NCT06285240|581673846|FG002|Overall Study|Withdrawal by Subject|0|||
161078064|NCT06285240|581673847|FG003|Overall Study|Withdrawal by Subject|0|||
161078065|NCT06285240|581673844|FG000|Overall Study|Serious Adverse Event|0|||
161078066|NCT06285240|581673845|FG001|Overall Study|Serious Adverse Event|0|||
161078067|NCT06285240|581673846|FG002|Overall Study|Serious Adverse Event|1|||
161078068|NCT06285240|581673847|FG003|Overall Study|Serious Adverse Event|0|||
161078069|NCT05140915|581673850|FG000|Overall Study|Lost to Follow-up|2|||
161078070|NCT05140915|581673851|FG001|Overall Study|Lost to Follow-up|1|||
161078071|NCT04520659|581673852|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
161078072|NCT04520659|581673853|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
161078073|NCT04520659|581673854|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
161078074|NCT04520659|581673855|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
161078075|NCT04485611|581673860|FG000|Prehabilitation|Physician Decision|1|||
161078076|NCT04879849|581673861|FG000|Overall Study|Lost to Follow-up|0|||
161078077|NCT04879849|581673862|FG001|Overall Study|Lost to Follow-up|0|||
161078078|NCT04879849|581673863|FG002|Overall Study|Lost to Follow-up|0|||
161078079|NCT04879849|581673864|FG003|Overall Study|Lost to Follow-up|1|||
161078080|NCT04879849|581673865|FG004|Overall Study|Lost to Follow-up|0|||
161078081|NCT04879849|581673866|FG005|Overall Study|Lost to Follow-up|0|||
161078082|NCT04879849|581673867|FG006|Overall Study|Lost to Follow-up|0|||
161078083|NCT04879849|581673868|FG007|Overall Study|Lost to Follow-up|0|||
161078084|NCT04879849|581673861|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
161078085|NCT04879849|581673862|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
161078086|NCT04879849|581673863|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
161078087|NCT04879849|581673864|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
161078088|NCT04879849|581673865|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
161078089|NCT04879849|581673866|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
161078090|NCT04879849|581673867|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
161078091|NCT04879849|581673868|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
161078092|NCT04879849|581673861|FG000|Overall Study|Withdrawal by Subject|0|||
161078093|NCT04879849|581673862|FG001|Overall Study|Withdrawal by Subject|0|||
161078094|NCT04879849|581673863|FG002|Overall Study|Withdrawal by Subject|0|||
161078095|NCT04879849|581673864|FG003|Overall Study|Withdrawal by Subject|0|||
161078096|NCT04879849|581673865|FG004|Overall Study|Withdrawal by Subject|2|||
161078097|NCT04879849|581673866|FG005|Overall Study|Withdrawal by Subject|0|||
161078098|NCT04879849|581673867|FG006|Overall Study|Withdrawal by Subject|1|||
161078099|NCT04879849|581673868|FG007|Overall Study|Withdrawal by Subject|0|||
161078100|NCT04879849|581673861|FG000|Overall Study|Progressive Disease|0|||
161078101|NCT04879849|581673862|FG001|Overall Study|Progressive Disease|0|||
161078102|NCT04879849|581673863|FG002|Overall Study|Progressive Disease|1|||
161159728|NCT00502320|581965099|FG000|Overall Study|No longer met criteria|1|||
161159729|NCT00502320|581965100|FG001|Overall Study|No longer met criteria|0|||
161159730|NCT00502320|581965099|FG000|Overall Study|Screen Failure|0|||
161159731|NCT00502320|581965100|FG001|Overall Study|Screen Failure|1|||
161159732|NCT00502320|581965099|FG000|Overall Study|Adverse Event|3|||
161159733|NCT00502320|581965100|FG001|Overall Study|Adverse Event|5|||
161159734|NCT00617409|581965104|FG000|Overall Study|Withdrawal by Subject|4|||
161159735|NCT00617409|581965105|FG001|Overall Study|Withdrawal by Subject|1|||
161159736|NCT00617409|581965106|FG002|Overall Study|Withdrawal by Subject|2|||
161159737|NCT00617409|581965104|FG000|Overall Study|Adverse Event|0|||
161159738|NCT00617409|581965105|FG001|Overall Study|Adverse Event|2|||
161159739|NCT00617409|581965106|FG002|Overall Study|Adverse Event|3|||
161159740|NCT00617409|581965104|FG000|Overall Study|Disease Progression|8|||
161159741|NCT00617409|581965105|FG001|Overall Study|Disease Progression|8|||
161159742|NCT00617409|581965106|FG002|Overall Study|Disease Progression|18|||
161159743|NCT00617409|581965104|FG000|Overall Study|Death|3|||
161159744|NCT00617409|581965105|FG001|Overall Study|Death|5|||
161159745|NCT00617409|581965106|FG002|Overall Study|Death|4|||
161159746|NCT00617409|581965104|FG000|Overall Study|Alternative Therapy|1|||
161159747|NCT00617409|581965105|FG001|Overall Study|Alternative Therapy|2|||
161159748|NCT00617409|581965106|FG002|Overall Study|Alternative Therapy|0|||
161159749|NCT01363713|581965120|FG000|Overall Study|Adverse Event|1|||
161159750|NCT01363713|581965120|FG000|Overall Study|Protocol Violation|3|||
161159751|NCT01363713|581965120|FG000|Overall Study|Withdrawal by Subject|2|||
161159752|NCT01199055|581965121|FG000|Overall Study|Death|0|||
161159753|NCT01199055|581965122|FG001|Overall Study|Death|1|||
161159754|NCT01199055|581965123|FG002|Overall Study|Death|0|||
161159755|NCT01199055|581965121|FG000|Overall Study|Physician Decision|0|||
161159756|NCT01199055|581965122|FG001|Overall Study|Physician Decision|1|||
161159757|NCT01199055|581965123|FG002|Overall Study|Physician Decision|1|||
161159758|NCT01199055|581965121|FG000|Overall Study|Progressive disease|2|||
161159759|NCT01199055|581965122|FG001|Overall Study|Progressive disease|1|||
161159760|NCT01199055|581965123|FG002|Overall Study|Progressive disease|2|||
161159761|NCT01199055|581965121|FG000|Overall Study|Withdrawal by Subject|0|||
161159762|NCT01199055|581965122|FG001|Overall Study|Withdrawal by Subject|0|||
161159763|NCT01199055|581965123|FG002|Overall Study|Withdrawal by Subject|1|||
161159764|NCT00511342|581965124|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
161159765|NCT00511342|581965125|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
161159766|NCT00511342|581965124|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
161159767|NCT00511342|581965125|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
161159768|NCT00511342|581965124|FG000|Overall Study|Pregnancy|0|||
161159769|NCT00511342|581965125|FG001|Overall Study|Pregnancy|1|||
161159770|NCT00511342|581965124|FG000|Overall Study|Pregnancy wish|0|||
161159771|NCT00511342|581965125|FG001|Overall Study|Pregnancy wish|1|||
161159772|NCT00511342|581965124|FG000|Overall Study|Lost to Follow-up|1|||
161159773|NCT00511342|581965125|FG001|Overall Study|Lost to Follow-up|5|||
161159774|NCT00511342|581965124|FG000|Overall Study|Other Reason|2|||
161159775|NCT00511342|581965125|FG001|Overall Study|Other Reason|2|||
161159776|NCT02432040|581965126|FG000|Overall Study|Lack of Efficacy|3|||
161159777|NCT02432040|581965127|FG001|Overall Study|Lack of Efficacy|0|||
161159778|NCT02432040|581965126|FG000|Overall Study|Lost to Follow-up|4|||
161159779|NCT02432040|581965127|FG001|Overall Study|Lost to Follow-up|5|||
161159780|NCT02432040|581965126|FG000|Overall Study|Physician Decision|1|||
161159781|NCT02432040|581965127|FG001|Overall Study|Physician Decision|1|||
161159782|NCT03198754|581965134|FG000|Overall Study|Withdrawal by Subject|5|||
161159783|NCT03198754|581965135|FG001|Overall Study|Withdrawal by Subject|4|||
161159784|NCT03198754|581965134|FG000|Overall Study|Lost to Follow-up|4|||
161159785|NCT03198754|581965135|FG001|Overall Study|Lost to Follow-up|3|||
161159786|NCT03198754|581965134|FG000|Overall Study|Ineligible|2|||
161159787|NCT03198754|581965135|FG001|Overall Study|Ineligible|1|||
161159788|NCT03247413|581965136|FG000|Overall Study|Lost to Follow-up|28|||
161159789|NCT00668200|581965137|FG000|Overall Study|Withdrawal by Subject|2|||
161159790|NCT00668200|581965137|FG000|Overall Study|Lost to Follow-up|1|||
161159791|NCT00642746|581965138|FG000|Overall Study|Patient unevaluable|1|||
161159792|NCT00642746|581965139|FG001|Overall Study|Patient unevaluable|0|||
161159793|NCT01496430|581965143|FG000|Overall Study|Adverse Event|0|||
161159794|NCT01496430|581965144|FG001|Overall Study|Adverse Event|0|||
161159795|NCT01496430|581965145|FG002|Overall Study|Adverse Event|1|||
161159796|NCT01496430|581965143|FG000|Overall Study|Major Protocol Deviation|0|||
161159797|NCT01496430|581965144|FG001|Overall Study|Major Protocol Deviation|0|||
161159798|NCT01496430|581965145|FG002|Overall Study|Major Protocol Deviation|1|||
161159799|NCT01496430|581965143|FG000|Overall Study|Lost to Follow-up|2|||
161159800|NCT01496430|581965144|FG001|Overall Study|Lost to Follow-up|3|||
161287244|NCT01422213|582431607|FG000|Overall Study|Non-compliance with study drug|0|||
161159801|NCT01496430|581965145|FG002|Overall Study|Lost to Follow-up|1|||
161159802|NCT01496430|581965143|FG000|Overall Study|Voluntary Withdrawal|2|||
161159803|NCT01496430|581965144|FG001|Overall Study|Voluntary Withdrawal|1|||
161159804|NCT01496430|581965145|FG002|Overall Study|Voluntary Withdrawal|6|||
161159805|NCT01496430|581965143|FG000|Overall Study|Principal Investigator Discretion|0|||
161287245|NCT01422213|582431608|FG001|Overall Study|Non-compliance with study drug|1|||
161287246|NCT01422213|582431609|FG002|Overall Study|Non-compliance with study drug|0|||
161078103|NCT04879849|581673864|FG003|Overall Study|Progressive Disease|0|||
161078104|NCT04879849|581673865|FG004|Overall Study|Progressive Disease|0|||
161078105|NCT04879849|581673866|FG005|Overall Study|Progressive Disease|0|||
161078106|NCT04879849|581673867|FG006|Overall Study|Progressive Disease|0|||
161078107|NCT04879849|581673868|FG007|Overall Study|Progressive Disease|0|||
161078108|NCT04879849|581673861|FG000|Overall Study|Death|0|||
161078109|NCT04879849|581673862|FG001|Overall Study|Death|0|||
161078110|NCT04879849|581673863|FG002|Overall Study|Death|1|||
161078111|NCT04879849|581673864|FG003|Overall Study|Death|1|||
161078112|NCT04879849|581673865|FG004|Overall Study|Death|1|||
161078113|NCT04879849|581673866|FG005|Overall Study|Death|2|||
161078114|NCT04879849|581673867|FG006|Overall Study|Death|1|||
161078115|NCT04879849|581673868|FG007|Overall Study|Death|2|||
161078116|NCT04879849|581673861|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
161078117|NCT04879849|581673862|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
161078118|NCT04879849|581673863|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
161078119|NCT04879849|581673864|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
161078120|NCT04879849|581673865|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
161078121|NCT04879849|581673866|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
161078122|NCT04879849|581673867|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
161078123|NCT04879849|581673868|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
161078124|NCT04879849|581673861|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078125|NCT04879849|581673862|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078126|NCT04879849|581673863|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078127|NCT04879849|581673864|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078128|NCT04879849|581673865|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078129|NCT04879849|581673866|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078130|NCT04879849|581673867|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
161078131|NCT04879849|581673868|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
161078132|NCT04879849|581673861|FG000|Overall Study|Reason Not Specified|1|||
161078133|NCT04879849|581673862|FG001|Overall Study|Reason Not Specified|0|||
161078134|NCT04879849|581673863|FG002|Overall Study|Reason Not Specified|0|||
161078135|NCT04879849|581673864|FG003|Overall Study|Reason Not Specified|0|||
161078136|NCT04879849|581673865|FG004|Overall Study|Reason Not Specified|0|||
161078137|NCT04879849|581673866|FG005|Overall Study|Reason Not Specified|0|||
161078138|NCT04879849|581673867|FG006|Overall Study|Reason Not Specified|0|||
161078139|NCT04879849|581673868|FG007|Overall Study|Reason Not Specified|0|||
161078140|NCT05292586|581673869|FG000|Overall Study|Withdrawal by Subject|3|||
161078141|NCT05292586|581673870|FG001|Overall Study|Withdrawal by Subject|10|||
161078142|NCT05292586|581673869|FG000|Overall Study|Randomization error|3|||
161078143|NCT05292586|581673870|FG001|Overall Study|Randomization error|7|||
161078144|NCT05292586|581673869|FG000|Overall Study|Adverse Event|3|||
161078145|NCT05292586|581673870|FG001|Overall Study|Adverse Event|0|||
161078146|NCT05292586|581673869|FG000|Overall Study|Lost to Follow-up|0|||
161078147|NCT05292586|581673870|FG001|Overall Study|Lost to Follow-up|1|||
161078148|NCT05292586|581673869|FG000|Overall Study|Patient refused treatment|1|||
161078149|NCT05292586|581673870|FG001|Overall Study|Patient refused treatment|0|||
161078150|NCT05292586|581673869|FG000|Overall Study|Patient could not travel to the study site|1|||
161078151|NCT05292586|581673870|FG001|Overall Study|Patient could not travel to the study site|0|||
161078152|NCT05292586|581673869|FG000|Overall Study|Technical issues with the masterscope|0|||
161078153|NCT05292586|581673870|FG001|Overall Study|Technical issues with the masterscope|3|||
161078154|NCT05292586|581673869|FG000|Overall Study|Patient moved to a different state|0|||
161078155|NCT05292586|581673870|FG001|Overall Study|Patient moved to a different state|1|||
161078156|NCT03345576|581673872|FG000|Overall Study|Withdrawal by Subject|2|||
161078157|NCT03345576|581673873|FG001|Overall Study|Withdrawal by Subject|2|||
161078158|NCT03345576|581673872|FG000|Overall Study|Adverse Event|1|||
161078159|NCT03345576|581673873|FG001|Overall Study|Adverse Event|0|||
161078160|NCT05718466|581675212|FG000|Overall Study|Withdrawal by Subject|1|||
161078161|NCT05718466|581675213|FG001|Overall Study|Withdrawal by Subject|2|||
161078162|NCT05718466|581675212|FG000|Overall Study|Death|0|||
161078163|NCT05718466|581675213|FG001|Overall Study|Death|1|||
161078164|NCT01253135|581675214|FG000|Original Protocol|Protocol Amendment|15|||
161078165|NCT01253135|581675214|FG000|Amended Protocol|Non-compliance|1|||
161078166|NCT00833261|581675221|FG000|Overall Study|Withdrawal by Subject|4|||
161078167|NCT01255631|581675225|FG000|Overall Study|poor enrollment, no data analyzed|9|||
161078168|NCT01255631|581675226|FG001|Overall Study|poor enrollment, no data analyzed|6|||
161287247|NCT01422213|582431607|FG000|Overall Study|Protocol Violation|0|||
161287248|NCT01422213|582431608|FG001|Overall Study|Protocol Violation|2|||
161346069|NCT04044690|582653232|FG000|Period 1|Adverse Event|4|||
161346070|NCT04044690|582653233|FG001|Period 1|Adverse Event|2|||
161346071|NCT04044690|582653232|FG000|Period 1|Physician Decision|0|||
161346072|NCT04044690|582653233|FG001|Period 1|Physician Decision|1|||
161346073|NCT04044690|582653232|FG000|Period 1|Withdrawal by Subject|2|||
161346074|NCT04044690|582653233|FG001|Period 1|Withdrawal by Subject|5|||
161346075|NCT04044690|582653232|FG000|Period 1|Protocol Deviation|2|||
161346076|NCT04044690|582653233|FG001|Period 1|Protocol Deviation|0|||
161346077|NCT04044690|582653232|FG000|Period 1|Site Terminated by Sponsor|0|||
161346078|NCT04044690|582653233|FG001|Period 1|Site Terminated by Sponsor|1|||
161346079|NCT04044690|582653232|FG000|Period 1|Study Terminated by Sponsor|0|||
161346080|NCT04044690|582653233|FG001|Period 1|Study Terminated by Sponsor|1|||
161346081|NCT04044690|582653232|FG000|Period 1|Death|1|||
161346082|NCT04044690|582653233|FG001|Period 1|Death|1|||
161346083|NCT04044690|582653232|FG000|Period 1|Other: Unspecified|1|||
161346084|NCT04044690|582653233|FG001|Period 1|Other: Unspecified|0|||
161346085|NCT04044690|582653232|FG000|Period 2|Lack of Efficacy|0|||
161346086|NCT04044690|582653233|FG001|Period 2|Lack of Efficacy|1|||
161346087|NCT04044690|582653232|FG000|Period 2|Adverse Event|0|||
161346088|NCT04044690|582653233|FG001|Period 2|Adverse Event|1|||
161346089|NCT04044690|582653232|FG000|Period 2|Physician Decision|0|||
161346090|NCT04044690|582653233|FG001|Period 2|Physician Decision|2|||
161346091|NCT04044690|582653232|FG000|Period 2|Withdrawal by Subject|5|||
161346092|NCT04044690|582653233|FG001|Period 2|Withdrawal by Subject|5|||
161346093|NCT04044690|582653232|FG000|Period 2|Lost to Follow-up|0|||
161346094|NCT04044690|582653233|FG001|Period 2|Lost to Follow-up|1|||
161346095|NCT04044690|582653232|FG000|Period 2|Site Terminated by Sponsor|1|||
161346096|NCT04044690|582653233|FG001|Period 2|Site Terminated by Sponsor|3|||
161346097|NCT04044690|582653232|FG000|Period 2|Study Terminated by Sponsor|8|||
161346098|NCT04044690|582653233|FG001|Period 2|Study Terminated by Sponsor|3|||
161346099|NCT04044690|582653232|FG000|Period 2|Death|1|||
161346100|NCT04044690|582653233|FG001|Period 2|Death|0|||
161346101|NCT04044690|582653232|FG000|Period 2|Other: Unspecified|1|||
161346102|NCT04044690|582653233|FG001|Period 2|Other: Unspecified|1|||
161346103|NCT04044690|582653232|FG000|Period 3|Site Terminated by Sponsor|1|||
161346104|NCT04044690|582653233|FG001|Period 3|Site Terminated by Sponsor|2|||
161346105|NCT04044690|582653232|FG000|Period 3|Study Terminated by Sponsor|24|||
161346106|NCT04044690|582653233|FG001|Period 3|Study Terminated by Sponsor|18|||
161346107|NCT04044690|582653232|FG000|Period 3|Missing|0|||
161346108|NCT04044690|582653233|FG001|Period 3|Missing|2|||
161346109|NCT01582451|582653239|FG000|Overall Study|Adverse Event|1|||
161346110|NCT01582451|582653240|FG001|Overall Study|Adverse Event|3|||
161346111|NCT01582451|582653239|FG000|Overall Study|Death|3|||
161346112|NCT01582451|582653240|FG001|Overall Study|Death|3|||
161346113|NCT01582451|582653239|FG000|Overall Study|Lost to Follow-up|0|||
161346114|NCT01582451|582653240|FG001|Overall Study|Lost to Follow-up|2|||
161346115|NCT01582451|582653239|FG000|Overall Study|Protocol Violation|11|||
161346116|NCT01582451|582653240|FG001|Overall Study|Protocol Violation|3|||
161346117|NCT01582451|582653239|FG000|Overall Study|Withdrawal by Subject|13|||
161346118|NCT01582451|582653240|FG001|Overall Study|Withdrawal by Subject|9|||
161346119|NCT01582451|582653239|FG000|Overall Study|Physician Decision|3|||
161346120|NCT01582451|582653240|FG001|Overall Study|Physician Decision|0|||
161346121|NCT01582451|582653239|FG000|Overall Study|Sponsor Decision|1|||
161346122|NCT01582451|582653240|FG001|Overall Study|Sponsor Decision|0|||
161346123|NCT00487188|582653243|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
161346124|NCT00487188|582653244|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
161346125|NCT00487188|582653245|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
161346126|NCT00487188|582653243|FG000|Induction Phase|Adverse Event|5|||
161346127|NCT00487188|582653244|FG001|Induction Phase|Adverse Event|0|||
161346128|NCT00487188|582653245|FG002|Induction Phase|Adverse Event|0|||
161346129|NCT00487188|582653243|FG000|Induction Phase|Lack of Efficacy|0|||
161346130|NCT00487188|582653244|FG001|Induction Phase|Lack of Efficacy|1|||
161346131|NCT00487188|582653245|FG002|Induction Phase|Lack of Efficacy|0|||
161346132|NCT00487188|582653243|FG000|Induction Phase|Protocol Violation|1|||
161078169|NCT00264303|581675234|FG000|Overall Study|Adverse Event|4|||
161078170|NCT00264303|581675235|FG001|Overall Study|Adverse Event|3|||
161078171|NCT00264303|581675234|FG000|Overall Study|Lack of Efficacy|10|||
161078172|NCT00264303|581675235|FG001|Overall Study|Lack of Efficacy|13|||
161078173|NCT00264303|581675234|FG000|Overall Study|Lost to Follow-up|3|||
161078174|NCT00264303|581675235|FG001|Overall Study|Lost to Follow-up|3|||
161078175|NCT00264303|581675234|FG000|Overall Study|Withdrawal by Subject|2|||
161078176|NCT00264303|581675235|FG001|Overall Study|Withdrawal by Subject|3|||
161078177|NCT00264303|581675234|FG000|Overall Study|Various reasons listed in study report|6|||
161346133|NCT00487188|582653244|FG001|Induction Phase|Protocol Violation|0|||
161078178|NCT00264303|581675235|FG001|Overall Study|Various reasons listed in study report|7|||
161078179|NCT02815579|581675236|FG000|Overall Study|Non-payment of loan down-payment|16|||
161078180|NCT02815579|581675237|FG001|Overall Study|Non-payment of loan down-payment|0|||
161078181|NCT02815579|581675236|FG000|Overall Study|Withdrawal by Subject|7|||
161346134|NCT00487188|582653245|FG002|Induction Phase|Protocol Violation|0|||
161346135|NCT00487188|582653243|FG000|Induction Phase|Refused Treatment|1|||
161159806|NCT01496430|581965144|FG001|Overall Study|Principal Investigator Discretion|1|||
161159807|NCT01496430|581965145|FG002|Overall Study|Principal Investigator Discretion|1|||
161159808|NCT01496430|581965143|FG000|Overall Study|Other|2|||
161159809|NCT01496430|581965144|FG001|Overall Study|Other|0|||
161159810|NCT01496430|581965145|FG002|Overall Study|Other|0|||
161159811|NCT01100307|581965146|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
161159812|NCT01100307|581965147|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
161159813|NCT01100307|581965146|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
161159814|NCT01100307|581965147|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
161159815|NCT01100307|581965146|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
161287249|NCT01422213|582431609|FG002|Overall Study|Protocol Violation|4|||
161287250|NCT01422213|582431607|FG000|Overall Study|Withdrawal of Consent|7|||
161287251|NCT01422213|582431608|FG001|Overall Study|Withdrawal of Consent|3|||
161287252|NCT01422213|582431609|FG002|Overall Study|Withdrawal of Consent|5|||
161287253|NCT01422213|582431607|FG000|Overall Study|Lost to Follow-up|3|||
161287254|NCT01422213|582431608|FG001|Overall Study|Lost to Follow-up|3|||
161159816|NCT01100307|581965147|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
161159817|NCT01100307|581965146|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
161159818|NCT01100307|581965147|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
161159819|NCT01100307|581965146|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
161159820|NCT01100307|581965147|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
161159821|NCT01100307|581965146|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
161159822|NCT01100307|581965147|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
161159823|NCT00718666|581965148|FG000|Booster Phase Year 5|No active participation request|0|||
161159824|NCT00718666|581965149|FG001|Booster Phase Year 5|No active participation request|0|||
161159825|NCT00718666|581965150|FG002|Booster Phase Year 5|No active participation request|1|||
161159826|NCT00718666|581965148|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
161159827|NCT00718666|581965149|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
161159828|NCT00718666|581965150|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
161159829|NCT00718666|581965148|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
161159830|NCT00718666|581965149|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
161159831|NCT00718666|581965150|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
161159832|NCT00718666|581965148|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
161159833|NCT00718666|581965149|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
161159834|NCT00718666|581965150|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
161159835|NCT00997321|581965151|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
161159836|NCT00997321|581965152|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
161159837|NCT02196038|581965155|FG000|Overall Study|Death|16|||
161159838|NCT02196038|581965156|FG001|Overall Study|Death|21|||
161159839|NCT02196038|581965155|FG000|Overall Study|Withdrawal by Subject|0|||
161159840|NCT02196038|581965156|FG001|Overall Study|Withdrawal by Subject|1|||
161159841|NCT02196038|581965155|FG000|Overall Study|Lost to Follow-up|1|||
161159842|NCT02196038|581965156|FG001|Overall Study|Lost to Follow-up|0|||
161159843|NCT01151579|581965172|FG000|Overall Study|Physician Decision|3|||
161159844|NCT01151579|581965173|FG001|Overall Study|Physician Decision|1|||
161159845|NCT01151579|581965172|FG000|Overall Study|Withdrawal by Subject|3|||
161159846|NCT01151579|581965173|FG001|Overall Study|Withdrawal by Subject|2|||
161159847|NCT01151579|581965172|FG000|Overall Study|Not meet inclusion criteria|6|||
161159848|NCT01151579|581965173|FG001|Overall Study|Not meet inclusion criteria|4|||
161159849|NCT00608530|581965174|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
161287255|NCT01422213|582431609|FG002|Overall Study|Lost to Follow-up|5|||
161287256|NCT01422213|582431607|FG000|Overall Study|Administrative or Other Reason(s)|5|||
161287257|NCT01422213|582431608|FG001|Overall Study|Administrative or Other Reason(s)|4|||
161287258|NCT01422213|582431609|FG002|Overall Study|Administrative or Other Reason(s)|2|||
161287259|NCT00613171|582431614|FG000|Overall Study|Adverse Event|7|||
161287260|NCT00613171|582431614|FG000|Overall Study|Withdrawal by Subject|3|||
161287261|NCT00613171|582431614|FG000|Overall Study|Reason not Specified|4|||
161287262|NCT00951496|582431619|FG000|Overall Study|Did not initiate study treatment|10|||
161287263|NCT00951496|582431620|FG001|Overall Study|Did not initiate study treatment|8|||
161287264|NCT00951496|582431621|FG002|Overall Study|Did not initiate study treatment|13|||
161346136|NCT00487188|582653244|FG001|Induction Phase|Refused Treatment|2|||
161287265|NCT00995774|582431624|FG000|Training Period 2|Withdrawal by Subject|2|||
161346137|NCT00487188|582653245|FG002|Induction Phase|Refused Treatment|0|||
161159850|NCT00608530|581965175|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
161159851|NCT00608530|581965176|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
161159852|NCT00608530|581965177|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
161159853|NCT00608530|581965174|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
161159854|NCT00608530|581965175|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
161287266|NCT00995774|582431625|FG001|Training Period 2|Withdrawal by Subject|0|||
161287267|NCT01998841|582431632|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
161287268|NCT01998841|582431633|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
161346138|NCT00487188|582653243|FG000|Induction Phase|Lost to Follow-up|2|||
161287269|NCT01998841|582431634|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
161287270|NCT01998841|582431635|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161287271|NCT01998841|582431636|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161287272|NCT01998841|582431632|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161078182|NCT02815579|581675237|FG001|Overall Study|Withdrawal by Subject|1|||
161078183|NCT02815579|581675236|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
161078184|NCT02815579|581675237|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
161078185|NCT02815579|581675236|FG000|Overall Study|Lost to Follow-up|7|||
161078186|NCT02815579|581675237|FG001|Overall Study|Lost to Follow-up|4|||
161078187|NCT02815579|581675236|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
161078188|NCT02815579|581675237|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
161078189|NCT02815579|581675236|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
161078190|NCT02815579|581675237|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
161078191|NCT02815579|581675236|FG000|Overall Study|Death|5|||
161078192|NCT02815579|581675237|FG001|Overall Study|Death|4|||
161078193|NCT02815579|581675236|FG000|Overall Study|Imprisoned|0|||
161078194|NCT02815579|581675237|FG001|Overall Study|Imprisoned|2|||
161078195|NCT02815579|581675236|FG000|Overall Study|Did not meet enrollment criteria|0|||
161078196|NCT02815579|581675237|FG001|Overall Study|Did not meet enrollment criteria|1|||
161078197|NCT00818168|581675241|FG000|Overall Study|Lack of Efficacy|18|||
161078198|NCT00818168|581675241|FG000|Overall Study|Pregnancy|2|||
161078199|NCT00818168|581675241|FG000|Overall Study|Withdrawal by Subject|16|||
161078200|NCT00818168|581675241|FG000|Overall Study|Lost to Follow-up|7|||
161078201|NCT00818168|581675241|FG000|Overall Study|Adverse Event|19|||
161078202|NCT00818168|581675241|FG000|Overall Study|Reason for Non-completion Not reported|6|||
161078203|NCT00818168|581675241|FG000|Overall Study|Participant Moved|2|||
161078204|NCT02993406|581675246|FG000|Overall Study|Withdrawal by Subject|170|||
161078205|NCT02993406|581675247|FG001|Overall Study|Withdrawal by Subject|196|||
161078206|NCT02993406|581675246|FG000|Overall Study|Physician Decision|3|||
161078207|NCT02993406|581675247|FG001|Overall Study|Physician Decision|5|||
161078208|NCT02993406|581675246|FG000|Overall Study|Lost to Follow-up|12|||
161078209|NCT02993406|581675247|FG001|Overall Study|Lost to Follow-up|13|||
161078210|NCT02993406|581675246|FG000|Overall Study|Unclassifiable Response|105|||
161078211|NCT02993406|581675247|FG001|Overall Study|Unclassifiable Response|139|||
161078212|NCT02993406|581675246|FG000|Overall Study|Administrative decision|1|||
161078213|NCT02993406|581675247|FG001|Overall Study|Administrative decision|0|||
161078214|NCT02993406|581675246|FG000|Overall Study|Sponsor decision|4|||
161078215|NCT02993406|581675247|FG001|Overall Study|Sponsor decision|5|||
161078216|NCT04325282|581675248|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
161078217|NCT04325282|581675249|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
161078218|NCT04325282|581675248|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
161078219|NCT04325282|581675249|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
161078220|NCT04020185|581675254|FG000|Overall Study|Death|0|||
161078221|NCT04020185|581675255|FG001|Overall Study|Death|0|||
161078222|NCT04020185|581675256|FG002|Overall Study|Death|1|||
161078223|NCT04020185|581675257|FG003|Overall Study|Death|2|||
161078224|NCT04020185|581675258|FG004|Overall Study|Death|1|||
161078225|NCT04020185|581675259|FG005|Overall Study|Death|0|||
161078226|NCT04020185|581675260|FG006|Overall Study|Death|1|||
161078227|NCT04020185|581675261|FG007|Overall Study|Death|0|||
161078228|NCT04020185|581675254|FG000|Overall Study|Consent withdrawn|1|||
161078229|NCT04020185|581675255|FG001|Overall Study|Consent withdrawn|0|||
161078230|NCT04020185|581675256|FG002|Overall Study|Consent withdrawn|0|||
161078231|NCT04020185|581675257|FG003|Overall Study|Consent withdrawn|0|||
161078232|NCT04020185|581675258|FG004|Overall Study|Consent withdrawn|2|||
161078233|NCT04020185|581675259|FG005|Overall Study|Consent withdrawn|0|||
161078234|NCT04020185|581675260|FG006|Overall Study|Consent withdrawn|1|||
161078235|NCT04020185|581675261|FG007|Overall Study|Consent withdrawn|1|||
161078236|NCT04020185|581675254|FG000|Overall Study|Patient in hospice|0|||
161078237|NCT04020185|581675255|FG001|Overall Study|Patient in hospice|1|||
161078238|NCT04020185|581675256|FG002|Overall Study|Patient in hospice|0|||
161078239|NCT04020185|581675257|FG003|Overall Study|Patient in hospice|0|||
161078240|NCT04020185|581675258|FG004|Overall Study|Patient in hospice|0|||
161078241|NCT04020185|581675259|FG005|Overall Study|Patient in hospice|0|||
161078242|NCT04020185|581675260|FG006|Overall Study|Patient in hospice|0|||
161078243|NCT04020185|581675261|FG007|Overall Study|Patient in hospice|0|||
161078244|NCT04020185|581675254|FG000|Overall Study|Continuing on expanded access|0|||
161078245|NCT04020185|581675255|FG001|Overall Study|Continuing on expanded access|0|||
161078246|NCT04020185|581675256|FG002|Overall Study|Continuing on expanded access|0|||
161078247|NCT04020185|581675257|FG003|Overall Study|Continuing on expanded access|0|||
161078248|NCT04020185|581675258|FG004|Overall Study|Continuing on expanded access|0|||
161159855|NCT00608530|581965176|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
161078249|NCT04020185|581675259|FG005|Overall Study|Continuing on expanded access|0|||
161078250|NCT04020185|581675260|FG006|Overall Study|Continuing on expanded access|1|||
161078251|NCT04020185|581675261|FG007|Overall Study|Continuing on expanded access|1|||
161159856|NCT00608530|581965177|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
161159857|NCT00608530|581965174|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
161159858|NCT00608530|581965175|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
161159859|NCT00608530|581965176|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
161159860|NCT00608530|581965177|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
161159861|NCT00608530|581965174|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161159862|NCT00608530|581965175|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161159863|NCT00608530|581965176|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
161159864|NCT00608530|581965177|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
161159865|NCT00608530|581965174|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
161159866|NCT00608530|581965175|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
161159867|NCT00608530|581965176|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
161159868|NCT00608530|581965177|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
161159869|NCT00608530|581965174|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161159870|NCT00608530|581965175|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161159871|NCT00608530|581965176|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
161159872|NCT00608530|581965177|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
161159873|NCT00077610|581965178|FG000|Overall Study|Adverse Event|9|||
161159874|NCT00077610|581965179|FG001|Overall Study|Adverse Event|7|||
161159875|NCT00077610|581965180|FG002|Overall Study|Adverse Event|1|||
161159876|NCT00077610|581965178|FG000|Overall Study|Lost to Follow-up|0|||
161159877|NCT00077610|581965179|FG001|Overall Study|Lost to Follow-up|1|||
161159878|NCT00077610|581965180|FG002|Overall Study|Lost to Follow-up|2|||
161159879|NCT00077610|581965178|FG000|Overall Study|Withdrawal by Subject|4|||
161159880|NCT00077610|581965179|FG001|Overall Study|Withdrawal by Subject|10|||
161159881|NCT00077610|581965180|FG002|Overall Study|Withdrawal by Subject|6|||
161159882|NCT00077610|581965178|FG000|Overall Study|Death|17|||
161159883|NCT00077610|581965179|FG001|Overall Study|Death|13|||
161159884|NCT00077610|581965180|FG002|Overall Study|Death|13|||
161159885|NCT00077610|581965178|FG000|Overall Study|Renal transplant|12|||
161159886|NCT00077610|581965179|FG001|Overall Study|Renal transplant|15|||
161159887|NCT00077610|581965180|FG002|Overall Study|Renal transplant|11|||
161159888|NCT00077610|581965178|FG000|Overall Study|Withdrew from dialysis care|5|||
161159889|NCT00077610|581965179|FG001|Overall Study|Withdrew from dialysis care|0|||
161159890|NCT00077610|581965180|FG002|Overall Study|Withdrew from dialysis care|3|||
161159891|NCT00077610|581965178|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161159892|NCT00077610|581965179|FG001|Overall Study|Insufficient Therapeutic Response|0|||
161159893|NCT00077610|581965180|FG002|Overall Study|Insufficient Therapeutic Response|0|||
161159894|NCT00077610|581965178|FG000|Overall Study|Multiple blood transfusions|0|||
161159895|NCT00077610|581965179|FG001|Overall Study|Multiple blood transfusions|0|||
161159896|NCT00077610|581965180|FG002|Overall Study|Multiple blood transfusions|1|||
161159897|NCT00077610|581965178|FG000|Overall Study|Principal Investigator's decision|1|||
161159898|NCT00077610|581965179|FG001|Overall Study|Principal Investigator's decision|0|||
161159899|NCT00077610|581965180|FG002|Overall Study|Principal Investigator's decision|1|||
161159900|NCT00077610|581965178|FG000|Overall Study|Worsening of health condition|1|||
161159901|NCT00077610|581965179|FG001|Overall Study|Worsening of health condition|1|||
161159902|NCT00077610|581965180|FG002|Overall Study|Worsening of health condition|0|||
161159903|NCT00077610|581965178|FG000|Overall Study|Given Epogen in hospital|1|||
161159904|NCT00077610|581965179|FG001|Overall Study|Given Epogen in hospital|0|||
161159905|NCT00077610|581965180|FG002|Overall Study|Given Epogen in hospital|0|||
161159906|NCT00077610|581965178|FG000|Overall Study|Transferred to other unit|0|||
161159907|NCT00077610|581965179|FG001|Overall Study|Transferred to other unit|0|||
161159908|NCT00077610|581965180|FG002|Overall Study|Transferred to other unit|1|||
161159909|NCT00077610|581965178|FG000|Overall Study|Transferred to nursing home|0|||
161159910|NCT00077610|581965179|FG001|Overall Study|Transferred to nursing home|0|||
161159911|NCT00077610|581965180|FG002|Overall Study|Transferred to nursing home|1|||
161159912|NCT00077610|581965178|FG000|Overall Study|Transfer to satellite unit|1|||
161159913|NCT00077610|581965179|FG001|Overall Study|Transfer to satellite unit|0|||
161159914|NCT00077610|581965180|FG002|Overall Study|Transfer to satellite unit|0|||
161159915|NCT00077610|581965178|FG000|Overall Study|Transfer to other center for surgery|1|||
161159916|NCT00077610|581965179|FG001|Overall Study|Transfer to other center for surgery|0|||
161159917|NCT00077610|581965180|FG002|Overall Study|Transfer to other center for surgery|0|||
161159918|NCT00077610|581965178|FG000|Overall Study|Change in dialysis modality|1|||
161159919|NCT00077610|581965179|FG001|Overall Study|Change in dialysis modality|0|||
161159920|NCT00077610|581965180|FG002|Overall Study|Change in dialysis modality|0|||
161159921|NCT00077610|581965178|FG000|Overall Study|Relocation|0|||
161159922|NCT00077610|581965179|FG001|Overall Study|Relocation|8|||
161159923|NCT00077610|581965180|FG002|Overall Study|Relocation|5|||
161159924|NCT00077610|581965178|FG000|Overall Study|Financial issues|0|||
161159925|NCT00077610|581965179|FG001|Overall Study|Financial issues|1|||
161159926|NCT00077610|581965180|FG002|Overall Study|Financial issues|0|||
161159927|NCT00077610|581965178|FG000|Overall Study|Sponsors decision to withdraw|0|||
161159928|NCT00077610|581965179|FG001|Overall Study|Sponsors decision to withdraw|0|||
161287273|NCT01998841|582431633|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161287274|NCT01998841|582431634|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
161287275|NCT01998841|582431635|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
161287276|NCT01998841|582431636|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
161287277|NCT00972595|582431637|FG000|Period 1|Adverse Event|1|||
161287278|NCT00972595|582431638|FG001|Period 1|Adverse Event|0|||
161287279|NCT02552121|582431639|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
161287280|NCT02552121|582431640|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161287281|NCT02552121|582431641|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161287282|NCT02552121|582431642|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161287283|NCT02552121|582431643|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161287284|NCT02552121|582431644|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161287285|NCT02552121|582431645|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161078252|NCT00527787|581675263|FG000|Overall Study|Adverse Event|14|||
161078253|NCT00527787|581675264|FG001|Overall Study|Adverse Event|24|||
161078254|NCT00527787|581675263|FG000|Overall Study|Withdrawal by Subject|13|||
161078255|NCT00527787|581675264|FG001|Overall Study|Withdrawal by Subject|25|||
161078256|NCT00527787|581675263|FG000|Overall Study|Lost to Follow-up|5|||
161078257|NCT00527787|581675264|FG001|Overall Study|Lost to Follow-up|2|||
161078258|NCT00527787|581675263|FG000|Overall Study|Duodenal Ulcer|1|||
161078259|NCT00527787|581675264|FG001|Overall Study|Duodenal Ulcer|10|||
161078260|NCT00527787|581675263|FG000|Overall Study|misc|5|||
161078261|NCT00527787|581675264|FG001|Overall Study|misc|2|||
161078262|NCT00608868|581675269|FG000|Overall Study|Withdrawal by Subject|7|||
161078263|NCT00608868|581675269|FG000|Overall Study|Protocol Violation|3|||
161078264|NCT00608868|581675269|FG000|Overall Study|Lost to Follow-up|2|||
161078265|NCT00608868|581675269|FG000|Overall Study|Adverse Event|1|||
161078266|NCT00608868|581675269|FG000|Overall Study|Physician Decision|2|||
161078267|NCT00702962|581675270|FG000|Overall Study|Progressive disease|0|||
161078268|NCT00702962|581675271|FG001|Overall Study|Progressive disease|1|||
161078269|NCT00702962|581675270|FG000|Overall Study|Hospitalized for other health disorder|1|||
161078270|NCT00702962|581675271|FG001|Overall Study|Hospitalized for other health disorder|0|||
161078271|NCT01876901|581675272|FG000|Overall Study|Protocol Violation|10|||
161078272|NCT01876901|581675273|FG001|Overall Study|Protocol Violation|2|||
161078273|NCT01876901|581675272|FG000|Overall Study|No or other surgical intervention|7|||
161078274|NCT01876901|581675273|FG001|Overall Study|No or other surgical intervention|5|||
161078275|NCT04313608|581675274|FG000|Overall Study|Death|12|||
161078276|NCT04313608|581675275|FG001|Overall Study|Death|3|||
161078277|NCT01867333|581675277|FG000|Overall Study|Withdrawal by Subject|1|||
161078278|NCT01867333|581675278|FG001|Overall Study|Withdrawal by Subject|0|||
161078279|NCT01867333|581675277|FG000|Overall Study|Adverse Event|1|||
161078280|NCT01867333|581675278|FG001|Overall Study|Adverse Event|0|||
161078281|NCT01867333|581675277|FG000|Overall Study|Participant choice|1|||
161078282|NCT01867333|581675278|FG001|Overall Study|Participant choice|2|||
161078283|NCT01867333|581675277|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
161078284|NCT01867333|581675278|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
161078285|NCT01867333|581675277|FG000|Overall Study|Death|0|||
161078286|NCT01867333|581675278|FG001|Overall Study|Death|1|||
161078287|NCT01867333|581675277|FG000|Overall Study|Physician Decision|3|||
161078288|NCT01867333|581675278|FG001|Overall Study|Physician Decision|2|||
161078289|NCT01867333|581675277|FG000|Overall Study|Switched to alternative treatment|1|||
161078290|NCT01867333|581675278|FG001|Overall Study|Switched to alternative treatment|0|||
161078291|NCT01145898|581675279|FG000|3-year Treatment|medication change by treating physician|3|||
161078292|NCT01145898|581675280|FG001|3-year Treatment|medication change by treating physician|16|||
161078293|NCT00879775|581675281|FG000|Overall Study|Lost to Follow-up|2|||
161078294|NCT00879775|581675282|FG001|Overall Study|Lost to Follow-up|1|||
161078295|NCT02833077|581675284|FG000|Overall Study|Adverse Event|1|||
161078296|NCT02833077|581675285|FG001|Overall Study|Adverse Event|2|||
161078297|NCT02833077|581675284|FG000|Overall Study|Lost to Follow-up|10|||
161078298|NCT02833077|581675285|FG001|Overall Study|Lost to Follow-up|1|||
161078299|NCT02833077|581675284|FG000|Overall Study|Personal Reasons|6|||
161078300|NCT02833077|581675285|FG001|Overall Study|Personal Reasons|4|||
161078301|NCT02833077|581675284|FG000|Overall Study|Protocol Deviation|0|||
161078302|NCT02833077|581675285|FG001|Overall Study|Protocol Deviation|1|||
161078303|NCT04608773|581675286|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
161078304|NCT04608773|581675287|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
161078305|NCT04608773|581675286|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
161078306|NCT04608773|581675287|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161078307|NCT04608773|581675286|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
161078308|NCT04608773|581675287|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
161078309|NCT04608773|581675286|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
161078310|NCT04608773|581675287|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
161078311|NCT04608773|581675286|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
161159929|NCT00077610|581965180|FG002|Overall Study|Sponsors decision to withdraw|1|||
161287286|NCT02552121|582431646|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
161159930|NCT00305253|581965182|FG000|Overall Study|Withdrawal by Subject|0|||
161159931|NCT00305253|581965183|FG001|Overall Study|Withdrawal by Subject|1|||
161159932|NCT01357915|581965184|FG000|Overall Study|Lost to Follow-up|3|||
161159933|NCT01357915|581965185|FG001|Overall Study|Lost to Follow-up|0|||
161159934|NCT01153763|581965188|FG000|Overall Study|Study Closed|16|||
161159935|NCT01153763|581965188|FG000|Overall Study|Lost to Follow-up|1|||
161159936|NCT01153763|581965188|FG000|Overall Study|Physician Decision|2|||
161159937|NCT01153763|581965188|FG000|Overall Study|Withdrawal by Subject|2|||
161159938|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
161159939|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
161159940|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Death|2|||
161159941|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Death|1|||
161159942|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
161159943|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
161159944|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
161159945|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
161159946|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
161159947|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
161159948|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
161159949|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
161159950|NCT03633227|581965193|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
161159951|NCT03633227|581965194|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
161159952|NCT03633227|581965193|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
161159953|NCT03633227|581965194|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
161159954|NCT03633227|581965193|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
161159955|NCT03633227|581965194|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
161159956|NCT03633227|581965193|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
161159957|NCT03633227|581965194|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
161159958|NCT03633227|581965193|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
161159959|NCT03633227|581965194|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
161159960|NCT03633227|581965193|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
161159961|NCT03633227|581965194|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
161159962|NCT03491553|581965195|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
161159963|NCT03491553|581965196|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
161159964|NCT03491553|581965197|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
161159965|NCT03491553|581965198|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
161159966|NCT03491553|581965199|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
161159967|NCT03491553|581965200|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
161159968|NCT03491553|581965195|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
161159969|NCT03491553|581965196|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
161159970|NCT03491553|581965197|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
161159971|NCT03491553|581965198|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
161159972|NCT03491553|581965199|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
161159973|NCT03491553|581965200|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
161159974|NCT00488618|581965208|FG000|Overall Study|Adverse Event|13|||
161159975|NCT00488618|581965209|FG001|Overall Study|Adverse Event|17|||
161159976|NCT00488618|581965208|FG000|Overall Study|Insufficient Therapeutic Response|18|||
161159977|NCT00488618|581965209|FG001|Overall Study|Insufficient Therapeutic Response|11|||
161159978|NCT00488618|581965208|FG000|Overall Study|Protocol Violation|0|||
161159979|NCT00488618|581965209|FG001|Overall Study|Protocol Violation|2|||
161159980|NCT00488618|581965208|FG000|Overall Study|Withdrawal of Consent|15|||
161159981|NCT00488618|581965209|FG001|Overall Study|Withdrawal of Consent|13|||
161346139|NCT00487188|582653244|FG001|Induction Phase|Lost to Follow-up|2|||
161346140|NCT00487188|582653245|FG002|Induction Phase|Lost to Follow-up|0|||
161346141|NCT00487188|582653243|FG000|Induction Phase|Administrative|0|||
161346142|NCT00487188|582653244|FG001|Induction Phase|Administrative|1|||
161346143|NCT00487188|582653245|FG002|Induction Phase|Administrative|0|||
161346144|NCT00487188|582653243|FG000|Maintenance Phase|Adverse Event|1|||
161346145|NCT00487188|582653244|FG001|Maintenance Phase|Adverse Event|0|||
161346146|NCT00487188|582653245|FG002|Maintenance Phase|Adverse Event|0|||
161346147|NCT00487188|582653243|FG000|Maintenance Phase|Death|1|||
161159982|NCT00488618|581965208|FG000|Overall Study|Lost to Follow-up|1|||
161159983|NCT00488618|581965209|FG001|Overall Study|Lost to Follow-up|0|||
161159984|NCT00992446|581965210|FG000|Overall Study|Disease Progression|1|||
161159985|NCT00992446|581965210|FG000|Overall Study|Withdrawal by Subject|2|||
161159986|NCT00992446|581965210|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
161159987|NCT02198651|581966821|FG000|Lead-in Period|Withdrew consent|13|||
161346148|NCT00487188|582653244|FG001|Maintenance Phase|Death|0|||
161346149|NCT00487188|582653245|FG002|Maintenance Phase|Death|0|||
161346150|NCT00487188|582653243|FG000|Maintenance Phase|Lost to Follow-up|1|||
161346151|NCT00487188|582653244|FG001|Maintenance Phase|Lost to Follow-up|0|||
161346152|NCT00487188|582653245|FG002|Maintenance Phase|Lost to Follow-up|0|||
161346153|NCT00487188|582653243|FG000|Maintenance Phase|Administrative|0|||
161346154|NCT00487188|582653244|FG001|Maintenance Phase|Administrative|0|||
161346155|NCT00487188|582653245|FG002|Maintenance Phase|Administrative|1|||
161346156|NCT01838876|582653246|FG000|Overall Study|Adverse Event|49|||
161346157|NCT01838876|582653246|FG000|Overall Study|Insufficient Therapeutic Response|10|||
161346158|NCT01838876|582653246|FG000|Overall Study|Protocol Violation|34|||
161346159|NCT01838876|582653246|FG000|Overall Study|Withdrawal of Consent|33|||
161346160|NCT01838876|582653246|FG000|Overall Study|Lost to Follow-up|21|||
161346161|NCT01838876|582653246|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
161346162|NCT01838876|582653246|FG000|Overall Study|Reason not Specified|7|||
161346163|NCT01838876|582653246|FG000|Overall Study|Did not meet eligibility criteria|78|||
161346164|NCT01682031|582653247|FG000|Overall Study|Withdrawal by Subject|0|||
161346165|NCT01682031|582653248|FG001|Overall Study|Withdrawal by Subject|1|||
161159988|NCT02198651|581966822|FG001|Lead-in Period|Withdrew consent|0|||
161159989|NCT02198651|581966823|FG002|Lead-in Period|Withdrew consent|0|||
161159990|NCT02198651|581966824|FG003|Lead-in Period|Withdrew consent|0|||
161159991|NCT02198651|581966825|FG004|Lead-in Period|Withdrew consent|0|||
161159992|NCT02198651|581966821|FG000|Lead-in Period|Adverse Event|2|||
161159993|NCT02198651|581966822|FG001|Lead-in Period|Adverse Event|0|||
161159994|NCT02198651|581966823|FG002|Lead-in Period|Adverse Event|0|||
161159995|NCT02198651|581966824|FG003|Lead-in Period|Adverse Event|0|||
161159996|NCT02198651|581966825|FG004|Lead-in Period|Adverse Event|0|||
161159997|NCT02198651|581966821|FG000|Lead-in Period|Other, not specified|22|||
161159998|NCT02198651|581966822|FG001|Lead-in Period|Other, not specified|0|||
161159999|NCT02198651|581966823|FG002|Lead-in Period|Other, not specified|0|||
161160000|NCT02198651|581966824|FG003|Lead-in Period|Other, not specified|0|||
161160001|NCT02198651|581966825|FG004|Lead-in Period|Other, not specified|0|||
161160002|NCT02198651|581966821|FG000|Double-blind Period|Withdrew consent|0|||
161160003|NCT02198651|581966822|FG001|Double-blind Period|Withdrew consent|4|||
161160004|NCT02198651|581966823|FG002|Double-blind Period|Withdrew consent|0|||
161160005|NCT02198651|581966824|FG003|Double-blind Period|Withdrew consent|0|||
161160006|NCT02198651|581966825|FG004|Double-blind Period|Withdrew consent|0|||
161160007|NCT02198651|581966821|FG000|Double-blind Period|Adverse Event|0|||
161160008|NCT02198651|581966822|FG001|Double-blind Period|Adverse Event|1|||
161160009|NCT02198651|581966823|FG002|Double-blind Period|Adverse Event|0|||
161160010|NCT02198651|581966824|FG003|Double-blind Period|Adverse Event|0|||
161160011|NCT02198651|581966825|FG004|Double-blind Period|Adverse Event|0|||
161160012|NCT02198651|581966821|FG000|Double-blind Period|Other, not specified|0|||
161160013|NCT02198651|581966822|FG001|Double-blind Period|Other, not specified|4|||
161160014|NCT02198651|581966823|FG002|Double-blind Period|Other, not specified|1|||
161160015|NCT02198651|581966824|FG003|Double-blind Period|Other, not specified|0|||
161160016|NCT02198651|581966825|FG004|Double-blind Period|Other, not specified|0|||
161160017|NCT02198651|581966821|FG000|Open-label Rescue Period|Withdrew consent|0|||
161160018|NCT02198651|581966822|FG001|Open-label Rescue Period|Withdrew consent|0|||
161160019|NCT02198651|581966823|FG002|Open-label Rescue Period|Withdrew consent|0|||
161160020|NCT02198651|581966824|FG003|Open-label Rescue Period|Withdrew consent|2|||
161160021|NCT02198651|581966825|FG004|Open-label Rescue Period|Withdrew consent|0|||
161160022|NCT02198651|581966821|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161160023|NCT02198651|581966822|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161160024|NCT02198651|581966823|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161160025|NCT02198651|581966824|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
161160026|NCT02198651|581966825|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
161160027|NCT02922634|581966828|FG000|Overall Study|Withdrawal by Subject|5|||
161160028|NCT02922634|581966828|FG000|Overall Study|Did not have their surgery|5|||
161160029|NCT02625324|581966829|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
161160030|NCT02625324|581966829|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
161160031|NCT02625324|581966829|FG000|6-Month Follow-up Subject Accountability|Death|5|||
161160032|NCT02625324|581966829|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
161160033|NCT02625324|581966829|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
161160034|NCT02625324|581966829|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
161160035|NCT02625324|581966829|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
161160036|NCT02625324|581966829|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
161160037|NCT02625324|581966829|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
161160038|NCT02625324|581966829|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
161160039|NCT02625324|581966829|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
161160040|NCT02625324|581966829|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
161346166|NCT01682031|582653247|FG000|Overall Study|Adverse Event|0|||
161346167|NCT01682031|582653248|FG001|Overall Study|Adverse Event|2|||
161346168|NCT01682031|582653247|FG000|Overall Study|MRI results indicate increased nodul|0|||
161346169|NCT01682031|582653248|FG001|Overall Study|MRI results indicate increased nodul|1|||
161346170|NCT01682031|582653247|FG000|Overall Study|Patient could not swallow tablets|1|||
161346171|NCT01682031|582653248|FG001|Overall Study|Patient could not swallow tablets|0|||
161346172|NCT01682031|582653247|FG000|Overall Study|Patient stopped selenium on his own|0|||
161160041|NCT02625324|581966829|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
161160042|NCT02625324|581966829|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
161160043|NCT02625324|581966829|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161160044|NCT02625324|581966829|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
161160045|NCT02625324|581966829|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
161160046|NCT00352755|581966830|FG000|Overall Study|Physician Decision|1|||
161160047|NCT00352755|581966830|FG000|Overall Study|Adverse Event|1|||
161160048|NCT02397694|581966833|FG000|Double-Blinded Phase|Adverse Event|1|||
161160049|NCT02397694|581966834|FG001|Double-Blinded Phase|Adverse Event|0|||
161160050|NCT02397694|581966833|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
161160051|NCT02397694|581966834|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
161160052|NCT02397694|581966833|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
161160053|NCT02397694|581966834|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
161160054|NCT02397694|581966833|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
161160055|NCT02397694|581966834|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
161160056|NCT02397694|581966833|FG000|Open Label Extension Phase|Protocol Violation|1|||
161160057|NCT02397694|581966834|FG001|Open Label Extension Phase|Protocol Violation|0|||
161160058|NCT02397694|581966833|FG000|Open Label Extension Phase|Withdrew Consent|3|||
161160059|NCT02397694|581966834|FG001|Open Label Extension Phase|Withdrew Consent|1|||
161160060|NCT02397694|581966833|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
161160061|NCT02397694|581966834|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
161160062|NCT02115113|581966835|FG000|Participants in Run-in Period|Death|0|||
161160063|NCT02115113|581966836|FG001|Participants in Run-in Period|Death|0|||
161160064|NCT02115113|581966837|FG002|Participants in Run-in Period|Death|1|||
161160065|NCT02115113|581966835|FG000|Participants in Run-in Period|Administrative problems|0|||
161160066|NCT02115113|581966836|FG001|Participants in Run-in Period|Administrative problems|0|||
161160067|NCT02115113|581966837|FG002|Participants in Run-in Period|Administrative problems|1|||
161160068|NCT02115113|581966835|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
161160069|NCT02115113|581966836|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
161160070|NCT02115113|581966837|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
161160071|NCT02115113|581966835|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
161160072|NCT02115113|581966836|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
161160073|NCT02115113|581966837|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
161160074|NCT02115113|581966835|FG000|Participants Randomized|Lost to Follow-up|1|||
161160075|NCT02115113|581966836|FG001|Participants Randomized|Lost to Follow-up|0|||
161160076|NCT02115113|581966837|FG002|Participants Randomized|Lost to Follow-up|0|||
161160077|NCT02115113|581966835|FG000|Participants Randomized|Death|1|||
161160078|NCT02115113|581966836|FG001|Participants Randomized|Death|0|||
161160079|NCT02115113|581966837|FG002|Participants Randomized|Death|0|||
161160080|NCT00789191|581966839|FG000|Overall Study|Adverse Event|2|||
161160081|NCT00789191|581966840|FG001|Overall Study|Adverse Event|4|||
161160082|NCT00789191|581966839|FG000|Overall Study|Lack of Efficacy|0|||
161160083|NCT00789191|581966840|FG001|Overall Study|Lack of Efficacy|5|||
161160084|NCT00789191|581966839|FG000|Overall Study|Protocol Violation|5|||
161160085|NCT00789191|581966840|FG001|Overall Study|Protocol Violation|3|||
161160086|NCT00789191|581966839|FG000|Overall Study|Withdrawal Criteria|2|||
161160087|NCT00789191|581966840|FG001|Overall Study|Withdrawal Criteria|4|||
161160088|NCT00789191|581966839|FG000|Overall Study|Unclassified|5|||
161160089|NCT00789191|581966840|FG001|Overall Study|Unclassified|3|||
161160090|NCT00296725|581966846|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
161160091|NCT00296725|581966846|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
161160092|NCT00296725|581966846|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
161160093|NCT00356863|581966847|FG000|Overall Study|Death|16|||
161160094|NCT00356863|581966848|FG001|Overall Study|Death|32|||
161160095|NCT00356863|581966847|FG000|Overall Study|Lost to Follow-up|76|||
161160096|NCT00356863|581966848|FG001|Overall Study|Lost to Follow-up|43|||
161160097|NCT00836277|581966856|FG000|Overall Study|Not evaluable for response|6|||
161160098|NCT00280150|581966857|FG000|Overall Study|Adverse Event|0|||
161160099|NCT00280150|581966858|FG001|Overall Study|Adverse Event|1|||
161160100|NCT00280150|581966859|FG002|Overall Study|Adverse Event|2|||
161160101|NCT00280150|581966860|FG003|Overall Study|Adverse Event|3|||
161160102|NCT00280150|581966857|FG000|Overall Study|Lack of Efficacy|0|||
161160103|NCT00280150|581966858|FG001|Overall Study|Lack of Efficacy|0|||
161160104|NCT00280150|581966859|FG002|Overall Study|Lack of Efficacy|0|||
161160105|NCT00280150|581966860|FG003|Overall Study|Lack of Efficacy|3|||
161160106|NCT00280150|581966857|FG000|Overall Study|Physician Decision|0|||
161160107|NCT00280150|581966858|FG001|Overall Study|Physician Decision|0|||
161160108|NCT00280150|581966859|FG002|Overall Study|Physician Decision|0|||
161160109|NCT00280150|581966860|FG003|Overall Study|Physician Decision|1|||
161160110|NCT00280150|581966857|FG000|Overall Study|Protocol Violation|0|||
161160111|NCT00280150|581966858|FG001|Overall Study|Protocol Violation|0|||
161160112|NCT00280150|581966859|FG002|Overall Study|Protocol Violation|0|||
161160113|NCT00280150|581966860|FG003|Overall Study|Protocol Violation|1|||
161160114|NCT00280150|581966857|FG000|Overall Study|Withdrawal by Subject|0|||
161160115|NCT00280150|581966858|FG001|Overall Study|Withdrawal by Subject|0|||
161160116|NCT00280150|581966859|FG002|Overall Study|Withdrawal by Subject|0|||
161287287|NCT02552121|582431639|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
161287288|NCT02552121|582431640|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287289|NCT02552121|582431641|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287290|NCT02552121|582431642|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287291|NCT02552121|582431643|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287292|NCT02552121|582431644|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287293|NCT02552121|582431645|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287294|NCT02552121|582431646|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
161287295|NCT02552121|582431639|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161287296|NCT02552121|582431640|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
161287297|NCT02552121|582431641|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161287298|NCT02552121|582431642|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161287299|NCT02552121|582431643|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161287300|NCT02552121|582431644|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161160117|NCT00280150|581966860|FG003|Overall Study|Withdrawal by Subject|1|||
161160118|NCT00280150|581966857|FG000|Overall Study|Did not get consolidation therapy|3|||
161160119|NCT00280150|581966858|FG001|Overall Study|Did not get consolidation therapy|0|||
161160120|NCT00280150|581966859|FG002|Overall Study|Did not get consolidation therapy|3|||
161160121|NCT00280150|581966860|FG003|Overall Study|Did not get consolidation therapy|0|||
161160122|NCT00280150|581966857|FG000|Overall Study|Declining Performance Status|0|||
161160123|NCT00280150|581966858|FG001|Overall Study|Declining Performance Status|0|||
161160124|NCT00280150|581966859|FG002|Overall Study|Declining Performance Status|0|||
161160125|NCT00280150|581966860|FG003|Overall Study|Declining Performance Status|1|||
161160126|NCT01944969|581966870|FG000|Overall Study|Adverse Event|1|||
161160127|NCT01944969|581966870|FG000|Overall Study|Lack of Efficacy|1|||
161160128|NCT01944969|581966870|FG000|Overall Study|Non-compliance with IMP|1|||
161160129|NCT01944969|581966870|FG000|Overall Study|Administrative or other reasons|23|||
161160130|NCT00424294|581966873|FG000|Overall Study|Adverse Event|4|||
161160131|NCT00424294|581966874|FG001|Overall Study|Adverse Event|10|||
161160132|NCT00424294|581966873|FG000|Overall Study|Lack of Efficacy|2|||
161160133|NCT00424294|581966874|FG001|Overall Study|Lack of Efficacy|1|||
161160134|NCT00424294|581966873|FG000|Overall Study|Withdrawal by Subject|1|||
161160135|NCT00424294|581966874|FG001|Overall Study|Withdrawal by Subject|2|||
161160136|NCT00424294|581966873|FG000|Overall Study|Other|0|||
161160137|NCT00424294|581966874|FG001|Overall Study|Other|2|||
161160138|NCT00424294|581966873|FG000|Overall Study|Randomized but not Treated|1|||
161160139|NCT00424294|581966874|FG001|Overall Study|Randomized but not Treated|0|||
161160140|NCT02108951|581966875|FG000|Overall Study|Lost to Follow-up|1|||
161160141|NCT02108951|581966875|FG000|Overall Study|Patient's/guardian's decision|1|||
161160142|NCT02108951|581966875|FG000|Overall Study|Study Terminated by Sponsor|14|||
161160143|NCT01098461|581966880|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
161160144|NCT01098461|581966881|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
161160145|NCT01098461|581966882|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
161160146|NCT01098461|581966883|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
161160147|NCT01098461|581966880|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
161160148|NCT01098461|581966881|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
161160149|NCT01098461|581966882|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
161160150|NCT01098461|581966883|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
161160151|NCT01098461|581966880|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
161160152|NCT01098461|581966881|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
161160153|NCT01098461|581966882|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
161160154|NCT01098461|581966883|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
161160155|NCT01098461|581966880|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161160156|NCT01098461|581966881|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
161160157|NCT01098461|581966882|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161160158|NCT01098461|581966883|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
161160159|NCT01098461|581966880|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161160160|NCT01098461|581966881|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
161160161|NCT01098461|581966882|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161160162|NCT01098461|581966883|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
161160163|NCT01098461|581966880|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161160164|NCT01098461|581966881|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
161160165|NCT01098461|581966882|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161160166|NCT01098461|581966883|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
161160167|NCT01098461|581966880|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161160168|NCT01098461|581966881|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
161287301|NCT02552121|582431645|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161287302|NCT02552121|582431646|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
161160169|NCT01098461|581966882|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
161160170|NCT01098461|581966883|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
161160171|NCT02662985|581966884|FG000|Treatment Period 1|Adverse Event|0|||
161160172|NCT02662985|581966885|FG001|Treatment Period 1|Adverse Event|2|||
161160173|NCT02662985|581966884|FG000|Treatment Period 1|Protocol Violation|0|||
161160174|NCT02662985|581966885|FG001|Treatment Period 1|Protocol Violation|1|||
161160175|NCT02662985|581966884|FG000|Treatment Period 1|Physician Decision|1|||
161160176|NCT02662985|581966885|FG001|Treatment Period 1|Physician Decision|0|||
161160177|NCT02662985|581966884|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161160178|NCT02662985|581966885|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161160179|NCT02662985|581966884|FG000|Treatment Period 2|Lack of Efficacy|0|||
161160180|NCT02662985|581966885|FG001|Treatment Period 2|Lack of Efficacy|1|||
161160181|NCT02662985|581966884|FG000|Treatment Period 2|Lost to Follow-up|1|||
161160182|NCT02662985|581966885|FG001|Treatment Period 2|Lost to Follow-up|0|||
161160183|NCT02662985|581966884|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
161160184|NCT02662985|581966885|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
161160185|NCT02662985|581966884|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
161160186|NCT02662985|581966885|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
161160187|NCT02662985|581966884|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
161160188|NCT02662985|581966885|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
161160189|NCT02662985|581966884|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
161160190|NCT02662985|581966885|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
161160191|NCT02662985|581966884|FG000|Treatment Period 3 (Extension Period)|Death|0|||
161160192|NCT02662985|581966885|FG001|Treatment Period 3 (Extension Period)|Death|1|||
161160193|NCT05373706|581966886|FG000|Overall Study|Lost to Follow-up|2|||
161160194|NCT05373706|581966887|FG001|Overall Study|Lost to Follow-up|2|||
161160195|NCT01486784|581966888|FG000|Overall Study|Withdrawal by Subject|0|||
161160196|NCT01486784|581966889|FG001|Overall Study|Withdrawal by Subject|0|||
161160197|NCT01486784|581966890|FG002|Overall Study|Withdrawal by Subject|1|||
161160198|NCT01486784|581966891|FG003|Overall Study|Withdrawal by Subject|0|||
161160199|NCT01486784|581966892|FG004|Overall Study|Withdrawal by Subject|1|||
161160200|NCT01486784|581966893|FG005|Overall Study|Withdrawal by Subject|2|||
161160201|NCT01486784|581966888|FG000|Overall Study|Subject did not meet entry criteria|0|||
161160202|NCT01486784|581966889|FG001|Overall Study|Subject did not meet entry criteria|0|||
161160203|NCT01486784|581966890|FG002|Overall Study|Subject did not meet entry criteria|0|||
161160204|NCT01486784|581966891|FG003|Overall Study|Subject did not meet entry criteria|0|||
161160205|NCT01486784|581966892|FG004|Overall Study|Subject did not meet entry criteria|1|||
161160206|NCT01486784|581966893|FG005|Overall Study|Subject did not meet entry criteria|0|||
161160207|NCT01486784|581966888|FG000|Overall Study|Death|0|||
161160208|NCT01486784|581966889|FG001|Overall Study|Death|0|||
161160209|NCT01486784|581966890|FG002|Overall Study|Death|0|||
161160210|NCT01486784|581966891|FG003|Overall Study|Death|0|||
161160211|NCT01486784|581966892|FG004|Overall Study|Death|0|||
161160212|NCT01486784|581966893|FG005|Overall Study|Death|1|||
161160213|NCT01479374|581966901|FG000|Overall Study|Adverse Event|2|||
161160214|NCT01479374|581966902|FG001|Overall Study|Adverse Event|1|||
161160215|NCT01479374|581966903|FG002|Overall Study|Adverse Event|0|||
161160216|NCT01479374|581966901|FG000|Overall Study|Lost to Follow-up|1|||
161160217|NCT01479374|581966902|FG001|Overall Study|Lost to Follow-up|2|||
161160218|NCT01479374|581966903|FG002|Overall Study|Lost to Follow-up|0|||
161160219|NCT01479374|581966901|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
161160220|NCT01479374|581966902|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
161160221|NCT01479374|581966903|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
161160222|NCT01479374|581966901|FG000|Overall Study|Other|0|||
161160223|NCT01479374|581966902|FG001|Overall Study|Other|4|||
161160224|NCT01479374|581966903|FG002|Overall Study|Other|5|||
161160225|NCT01606761|581966904|FG000|Prior to Week 24|Lost to Follow-up|0|||
161160226|NCT01606761|581966905|FG001|Prior to Week 24|Lost to Follow-up|3|||
161160227|NCT01606761|581966906|FG002|Prior to Week 24|Lost to Follow-up|2|||
161160228|NCT01606761|581966907|FG003|Prior to Week 24|Lost to Follow-up|0|||
161160229|NCT01606761|581966908|FG004|Prior to Week 24|Lost to Follow-up|0|||
161160230|NCT01606761|581966904|FG000|Prior to Week 24|Withdrawal by Subject|12|||
161160231|NCT01606761|581966905|FG001|Prior to Week 24|Withdrawal by Subject|10|||
161160232|NCT01606761|581966906|FG002|Prior to Week 24|Withdrawal by Subject|9|||
161160233|NCT01606761|581966907|FG003|Prior to Week 24|Withdrawal by Subject|0|||
161160234|NCT01606761|581966908|FG004|Prior to Week 24|Withdrawal by Subject|0|||
161160235|NCT01606761|581966904|FG000|Prior to Week 24|Adverse Event|11|||
161160236|NCT01606761|581966905|FG001|Prior to Week 24|Adverse Event|18|||
161160237|NCT01606761|581966906|FG002|Prior to Week 24|Adverse Event|22|||
161160238|NCT01606761|581966907|FG003|Prior to Week 24|Adverse Event|0|||
161160239|NCT01606761|581966908|FG004|Prior to Week 24|Adverse Event|0|||
161160240|NCT01606761|581966904|FG000|Prior to Week 24|Lack of Efficacy|15|||
161160241|NCT01606761|581966905|FG001|Prior to Week 24|Lack of Efficacy|14|||
161160242|NCT01606761|581966906|FG002|Prior to Week 24|Lack of Efficacy|8|||
161160243|NCT01606761|581966907|FG003|Prior to Week 24|Lack of Efficacy|0|||
161287303|NCT02552121|582431639|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287304|NCT02552121|582431640|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
161287305|NCT02552121|582431641|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287306|NCT02552121|582431642|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287307|NCT02552121|582431643|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287308|NCT02552121|582431644|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287309|NCT02552121|582431645|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287310|NCT02552121|582431646|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
161287311|NCT02552121|582431639|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287312|NCT02552121|582431640|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
161287313|NCT02552121|582431641|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287314|NCT02552121|582431642|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287315|NCT02552121|582431643|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287316|NCT02552121|582431644|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287317|NCT02552121|582431645|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287318|NCT02552121|582431646|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
161287319|NCT02552121|582431639|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287320|NCT02552121|582431640|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
161287321|NCT02552121|582431641|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287322|NCT02552121|582431642|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287323|NCT02552121|582431643|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287324|NCT02552121|582431644|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287325|NCT02552121|582431645|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287326|NCT02552121|582431646|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
161287327|NCT02552121|582431639|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
161287328|NCT02552121|582431640|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
161287329|NCT02552121|582431641|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
161287330|NCT02552121|582431642|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
161287331|NCT02552121|582431643|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
161287332|NCT02552121|582431644|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
161287333|NCT02552121|582431645|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
161287334|NCT02552121|582431646|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
161287335|NCT02552121|582431639|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
161287336|NCT02552121|582431640|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
161287337|NCT02552121|582431641|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
161287338|NCT02552121|582431642|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
161287339|NCT02552121|582431643|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
161287340|NCT02552121|582431644|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
161287341|NCT02552121|582431645|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
161287342|NCT02552121|582431646|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
161287343|NCT02552121|582431639|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
161287344|NCT02552121|582431640|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
161287345|NCT02552121|582431641|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
161287346|NCT02552121|582431642|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
161287347|NCT02552121|582431643|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
161287348|NCT02552121|582431644|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
161287349|NCT02552121|582431645|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
161287350|NCT02552121|582431646|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
161287351|NCT02552121|582431639|FG000|Part 2: Cohort Expansion|Death|0|||
161287352|NCT02552121|582431640|FG001|Part 2: Cohort Expansion|Death|0|||
161287353|NCT02552121|582431641|FG002|Part 2: Cohort Expansion|Death|1|||
161287354|NCT02552121|582431642|FG003|Part 2: Cohort Expansion|Death|0|||
161287355|NCT02552121|582431643|FG004|Part 2: Cohort Expansion|Death|0|||
161287356|NCT02552121|582431644|FG005|Part 2: Cohort Expansion|Death|0|||
161287357|NCT02552121|582431645|FG006|Part 2: Cohort Expansion|Death|0|||
161287358|NCT02552121|582431646|FG007|Part 2: Cohort Expansion|Death|0|||
161287359|NCT01406574|582431649|FG000|Overall Study|Adverse Event|0|||
161287360|NCT01406574|582431650|FG001|Overall Study|Adverse Event|0|||
161287361|NCT01406574|582431651|FG002|Overall Study|Adverse Event|1|||
161287362|NCT01406574|582431652|FG003|Overall Study|Adverse Event|3|||
161287363|NCT01406574|582431649|FG000|Overall Study|Physician Decision|0|||
161287364|NCT01406574|582431650|FG001|Overall Study|Physician Decision|0|||
161287365|NCT01406574|582431651|FG002|Overall Study|Physician Decision|0|||
161287366|NCT01406574|582431652|FG003|Overall Study|Physician Decision|1|||
161287367|NCT01406574|582431649|FG000|Overall Study|Withdrawal by Subject|0|||
161287368|NCT01406574|582431650|FG001|Overall Study|Withdrawal by Subject|1|||
161287369|NCT01406574|582431651|FG002|Overall Study|Withdrawal by Subject|0|||
161287370|NCT01406574|582431652|FG003|Overall Study|Withdrawal by Subject|0|||
161287371|NCT01406574|582431649|FG000|Overall Study|Definite progression of primary disease|1|||
161287372|NCT01406574|582431650|FG001|Overall Study|Definite progression of primary disease|0|||
161287373|NCT01406574|582431651|FG002|Overall Study|Definite progression of primary disease|0|||
161078312|NCT04608773|581675287|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
161287374|NCT01406574|582431652|FG003|Overall Study|Definite progression of primary disease|0|||
161287375|NCT03447743|582431653|FG000|Overall Study|Withdrawal by Subject|2|||
161287376|NCT03447743|582431653|FG000|Overall Study|Lost to Follow-up|3|||
161287377|NCT03447743|582431653|FG000|Overall Study|Adverse Event|1|||
161287378|NCT03447743|582431653|FG000|Overall Study|Did not meet criteria to continue|1|||
161287379|NCT01112059|582431654|FG000|Overall Study|Withdrawal by Subject|1|||
161287380|NCT01112059|582431655|FG001|Overall Study|Withdrawal by Subject|0|||
161287381|NCT00768248|582431658|FG000|Overall Study|Research coordinator didn't collect data|1|||
161287382|NCT00768248|582431659|FG001|Overall Study|Research coordinator didn't collect data|1|||
161287383|NCT04211831|582431660|FG000|Overall Study|Withdrawal by Subject|4|||
161287384|NCT04211831|582431661|FG001|Overall Study|Withdrawal by Subject|1|||
161287385|NCT04211831|582431662|FG002|Overall Study|Withdrawal by Subject|1|||
161287386|NCT04211831|582431660|FG000|Overall Study|Protocol Violation|0|||
161287387|NCT04211831|582431661|FG001|Overall Study|Protocol Violation|0|||
161287388|NCT04211831|582431662|FG002|Overall Study|Protocol Violation|1|||
161287389|NCT04211831|582431660|FG000|Overall Study|Adverse Event|0|||
161287390|NCT04211831|582431661|FG001|Overall Study|Adverse Event|1|||
161287391|NCT04211831|582431662|FG002|Overall Study|Adverse Event|0|||
161287392|NCT04211831|582431660|FG000|Overall Study|Lack of Efficacy|0|||
161287393|NCT04211831|582431661|FG001|Overall Study|Lack of Efficacy|0|||
161287394|NCT04211831|582431662|FG002|Overall Study|Lack of Efficacy|1|||
161287395|NCT04211831|582431660|FG000|Overall Study|Lost to Follow-up|0|||
161287396|NCT04211831|582431661|FG001|Overall Study|Lost to Follow-up|0|||
161287397|NCT04211831|582431662|FG002|Overall Study|Lost to Follow-up|2|||
161287398|NCT04211831|582431660|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
161287399|NCT04211831|582431661|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
161287400|NCT04211831|582431662|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
161287401|NCT04211831|582431660|FG000|Overall Study|Other|0|||
161287402|NCT04211831|582431661|FG001|Overall Study|Other|1|||
161287403|NCT04211831|582431662|FG002|Overall Study|Other|0|||
161287404|NCT00967330|582431663|FG000|Overall Study|Protocol Violation|3|||
161287405|NCT00967330|582431664|FG001|Overall Study|Protocol Violation|4|||
161287406|NCT00967330|582431663|FG000|Overall Study|Regular|10|||
161287407|NCT00967330|582431664|FG001|Overall Study|Regular|3|||
161287408|NCT00967330|582431663|FG000|Overall Study|Withdrawal by Subject|6|||
161287409|NCT00967330|582431664|FG001|Overall Study|Withdrawal by Subject|0|||
161287410|NCT00967330|582431663|FG000|Overall Study|Lost to Follow-up|1|||
161078313|NCT00972322|581675290|FG000|Overall Study|Adverse Event|2|||
161078314|NCT00972322|581675291|FG001|Overall Study|Adverse Event|1|||
161078315|NCT00972322|581675290|FG000|Overall Study|Positive drug screen|0|||
161078316|NCT00972322|581675291|FG001|Overall Study|Positive drug screen|1|||
161078317|NCT00972322|581675290|FG000|Overall Study|Lost to Follow-up|0|||
161078318|NCT00972322|581675291|FG001|Overall Study|Lost to Follow-up|1|||
161078319|NCT00972322|581675290|FG000|Overall Study|Consistently high glucose values|1|||
161078320|NCT00972322|581675291|FG001|Overall Study|Consistently high glucose values|0|||
161078321|NCT01077518|581675292|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
161078322|NCT01077518|581675293|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
161078323|NCT01077518|581675294|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
161078324|NCT01077518|581675292|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
161078325|NCT01077518|581675293|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
161078326|NCT01077518|581675294|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
161078327|NCT01077518|581675292|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
161078328|NCT01077518|581675293|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
161078329|NCT01077518|581675294|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
161078330|NCT01077518|581675292|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
161078331|NCT01077518|581675293|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
161078332|NCT01077518|581675294|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
161078333|NCT01077518|581675292|FG000|Optional Ofa Phase|Physician Decision|0|||
161078334|NCT01077518|581675293|FG001|Optional Ofa Phase|Physician Decision|0|||
161078335|NCT01077518|581675294|FG002|Optional Ofa Phase|Physician Decision|1|||
161078336|NCT01077518|581675292|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
161078337|NCT01077518|581675293|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
161078338|NCT01077518|581675294|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
161078339|NCT01077518|581675292|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
161078340|NCT01077518|581675293|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
161078341|NCT01077518|581675294|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
161078342|NCT04958200|581675295|FG000|Overall Study|Withdrawal by Subject|0|||
161078343|NCT04958200|581675296|FG001|Overall Study|Withdrawal by Subject|2|||
161078344|NCT04958200|581675295|FG000|Overall Study|Lost to Follow-up|3|||
161078345|NCT04958200|581675296|FG001|Overall Study|Lost to Follow-up|2|||
161078346|NCT00316017|581675299|FG000|Overall Study|Protocol Violation|11|||
161078347|NCT00316017|581675300|FG001|Overall Study|Protocol Violation|13|||
161078348|NCT00316017|581675301|FG002|Overall Study|Protocol Violation|19|||
161160244|NCT01606761|581966908|FG004|Prior to Week 24|Lack of Efficacy|0|||
161287411|NCT00967330|582431664|FG001|Overall Study|Lost to Follow-up|1|||
161287412|NCT00967330|582431663|FG000|Overall Study|Death|102|||
161078349|NCT04157400|581675302|FG000|Overall Study|Withdrawal by Subject|1|||
161078350|NCT04157400|581675302|FG000|Overall Study|Lost to Follow-up|3|||
161078351|NCT02671500|581675310|FG000|Overall Study|Lack of Efficacy|12|||
161078352|NCT02671500|581675310|FG000|Overall Study|Lost to Follow-up|2|||
161078353|NCT05235269|581675312|FG000|Overall Study|Adverse Event|1|||
161078354|NCT05235269|581675312|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
161078355|NCT05235269|581675312|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
161078356|NCT03361865|581675313|FG000|Overall Study|Death|17|||
161078357|NCT03361865|581675314|FG001|Overall Study|Death|18|||
161078358|NCT03361865|581675313|FG000|Overall Study|Physician Decision|1|||
161078359|NCT03361865|581675314|FG001|Overall Study|Physician Decision|9|||
161078360|NCT03361865|581675313|FG000|Overall Study|Withdrawal by Subject|1|||
161078361|NCT03361865|581675314|FG001|Overall Study|Withdrawal by Subject|0|||
161078362|NCT03852719|581675316|FG000|Overall Study|Withdrawal of consent|8|||
161078363|NCT03852719|581675317|FG001|Overall Study|Withdrawal of consent|8|||
161078364|NCT03852719|581675318|FG002|Overall Study|Withdrawal of consent|9|||
161078365|NCT03852719|581675316|FG000|Overall Study|Physician Decision|5|||
161078366|NCT03852719|581675317|FG001|Overall Study|Physician Decision|4|||
161078367|NCT03852719|581675318|FG002|Overall Study|Physician Decision|1|||
161078368|NCT03852719|581675316|FG000|Overall Study|Pregnancy|2|||
161078369|NCT03852719|581675317|FG001|Overall Study|Pregnancy|1|||
161078370|NCT03852719|581675318|FG002|Overall Study|Pregnancy|0|||
161078371|NCT03852719|581675316|FG000|Overall Study|Death|1|||
161078372|NCT03852719|581675317|FG001|Overall Study|Death|0|||
161078373|NCT03852719|581675318|FG002|Overall Study|Death|0|||
161078374|NCT03852719|581675316|FG000|Overall Study|Reason not Specified|3|||
161078375|NCT03852719|581675317|FG001|Overall Study|Reason not Specified|3|||
161078376|NCT03852719|581675318|FG002|Overall Study|Reason not Specified|5|||
161078377|NCT03852719|581675316|FG000|Overall Study|Adverse Event|2|||
161078378|NCT03852719|581675317|FG001|Overall Study|Adverse Event|1|||
161078379|NCT03852719|581675318|FG002|Overall Study|Adverse Event|4|||
161078380|NCT03852719|581675316|FG000|Overall Study|Progressive disease|1|||
161078381|NCT03852719|581675317|FG001|Overall Study|Progressive disease|4|||
161078382|NCT03852719|581675318|FG002|Overall Study|Progressive disease|1|||
161078383|NCT03852719|581675316|FG000|Overall Study|Lost to Follow-up|1|||
161078384|NCT03852719|581675317|FG001|Overall Study|Lost to Follow-up|0|||
161078385|NCT03852719|581675318|FG002|Overall Study|Lost to Follow-up|0|||
161078386|NCT01647542|581675320|FG000|Overall Study|Major Protocol Deviation|1|||
161078387|NCT01647542|581675321|FG001|Overall Study|Major Protocol Deviation|0|||
161078388|NCT01647542|581675322|FG002|Overall Study|Major Protocol Deviation|0|||
161078389|NCT01647542|581675320|FG000|Overall Study|Adverse Event|4|||
161078390|NCT01647542|581675321|FG001|Overall Study|Adverse Event|5|||
161078391|NCT01647542|581675322|FG002|Overall Study|Adverse Event|4|||
161078392|NCT01647542|581675320|FG000|Overall Study|Lost to Follow-up|0|||
161078393|NCT01647542|581675321|FG001|Overall Study|Lost to Follow-up|2|||
161078394|NCT01647542|581675322|FG002|Overall Study|Lost to Follow-up|2|||
161078395|NCT01647542|581675320|FG000|Overall Study|Withdrawal by Subject|6|||
161078396|NCT01647542|581675321|FG001|Overall Study|Withdrawal by Subject|4|||
161078397|NCT01647542|581675322|FG002|Overall Study|Withdrawal by Subject|0|||
161078398|NCT01647542|581675320|FG000|Overall Study|Study Termination|64|||
161078399|NCT01647542|581675321|FG001|Overall Study|Study Termination|61|||
161078400|NCT01647542|581675322|FG002|Overall Study|Study Termination|65|||
161078401|NCT01647542|581675320|FG000|Overall Study|Lack of Efficacy|1|||
161078402|NCT01647542|581675321|FG001|Overall Study|Lack of Efficacy|1|||
161078403|NCT01647542|581675322|FG002|Overall Study|Lack of Efficacy|0|||
161078404|NCT01647542|581675320|FG000|Overall Study|Death|0|||
161078405|NCT01647542|581675321|FG001|Overall Study|Death|0|||
161078406|NCT01647542|581675322|FG002|Overall Study|Death|1|||
161078407|NCT02819024|581675323|FG000|Overall Study|Withdrawal by Subject|1|||
161078408|NCT05217641|581675327|FG000|Overall Study|Lost to Follow-up|1|||
161160245|NCT01606761|581966904|FG000|Prior to Week 24|Physician Decision|0|||
161078409|NCT05217641|581675328|FG001|Overall Study|Lost to Follow-up|1|||
161078410|NCT05217641|581675329|FG002|Overall Study|Lost to Follow-up|0|||
161078411|NCT05217641|581675330|FG003|Overall Study|Lost to Follow-up|1|||
161078412|NCT05217641|581675331|FG004|Overall Study|Lost to Follow-up|1|||
161078413|NCT05217641|581675332|FG005|Overall Study|Lost to Follow-up|0|||
161078414|NCT05217641|581675327|FG000|Overall Study|Withdrawal by Subject|0|||
161078415|NCT05217641|581675328|FG001|Overall Study|Withdrawal by Subject|0|||
161078416|NCT05217641|581675329|FG002|Overall Study|Withdrawal by Subject|0|||
161078417|NCT05217641|581675330|FG003|Overall Study|Withdrawal by Subject|3|||
161078418|NCT05217641|581675331|FG004|Overall Study|Withdrawal by Subject|1|||
161078419|NCT05217641|581675332|FG005|Overall Study|Withdrawal by Subject|0|||
161078420|NCT05217641|581675327|FG000|Overall Study|Other: participant did not specify reason|0|||
161078421|NCT05217641|581675328|FG001|Overall Study|Other: participant did not specify reason|0|||
161078422|NCT05217641|581675329|FG002|Overall Study|Other: participant did not specify reason|0|||
161287413|NCT00967330|582431664|FG001|Overall Study|Death|51|||
161346173|NCT01682031|582653248|FG001|Overall Study|Patient stopped selenium on his own|1|||
161346174|NCT00311168|582653256|FG000|First Intervention|Withdrawal by Subject|2|||
161346175|NCT00311168|582653257|FG001|First Intervention|Withdrawal by Subject|2|||
161346176|NCT00311168|582653256|FG000|First Intervention|Lost to Follow-up|1|||
161346177|NCT00311168|582653257|FG001|First Intervention|Lost to Follow-up|1|||
161346178|NCT00311168|582653256|FG000|First Intervention|Protocol Violation|1|||
161346179|NCT00311168|582653257|FG001|First Intervention|Protocol Violation|1|||
161346180|NCT00311168|582653256|FG000|First Intervention|Adverse Event|1|||
161346181|NCT00311168|582653257|FG001|First Intervention|Adverse Event|0|||
161346182|NCT00311168|582653256|FG000|First Intervention|Other|2|||
161346183|NCT00311168|582653257|FG001|First Intervention|Other|2|||
161346184|NCT00311168|582653256|FG000|Second Intervention|Lost to Follow-up|9|||
161346185|NCT00311168|582653257|FG001|Second Intervention|Lost to Follow-up|2|||
161346186|NCT00311168|582653256|FG000|Second Intervention|Withdrawal by Subject|0|||
161346187|NCT00311168|582653257|FG001|Second Intervention|Withdrawal by Subject|1|||
161346188|NCT00311168|582653256|FG000|Second Intervention|Other|1|||
161346189|NCT00311168|582653257|FG001|Second Intervention|Other|1|||
161346190|NCT05472142|582653258|FG000|Total Participants|Lost to Follow-up|312|||
161346191|NCT05472142|582653259|FG001|Total Participants|Lost to Follow-up|0|||
161346192|NCT05472142|582653258|FG000|Clinic Patients|Lost to Follow-up|312|||
161346193|NCT05472142|582653259|FG001|Clinic Patients|Lost to Follow-up|0|||
161346194|NCT02327078|582653262|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161346195|NCT02327078|582653263|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161346196|NCT02327078|582653264|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
161346197|NCT02327078|582653265|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161346198|NCT02327078|582653266|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
161346199|NCT02327078|582653267|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161346200|NCT02327078|582653268|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
161346201|NCT02327078|582653269|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
161346202|NCT02327078|582653270|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
161346203|NCT02327078|582653262|FG000|Overall Study|Death|2|||
161346204|NCT02327078|582653263|FG001|Overall Study|Death|4|||
161346205|NCT02327078|582653264|FG002|Overall Study|Death|10|||
161346206|NCT02327078|582653265|FG003|Overall Study|Death|6|||
161346207|NCT02327078|582653266|FG004|Overall Study|Death|4|||
161346208|NCT02327078|582653267|FG005|Overall Study|Death|3|||
161346209|NCT02327078|582653268|FG006|Overall Study|Death|2|||
161346210|NCT02327078|582653269|FG007|Overall Study|Death|51|||
161346211|NCT02327078|582653270|FG008|Overall Study|Death|97|||
161346212|NCT02327078|582653262|FG000|Overall Study|Lost to Follow-up|0|||
161346213|NCT02327078|582653263|FG001|Overall Study|Lost to Follow-up|1|||
161346214|NCT02327078|582653264|FG002|Overall Study|Lost to Follow-up|1|||
161346215|NCT02327078|582653265|FG003|Overall Study|Lost to Follow-up|0|||
161346216|NCT02327078|582653266|FG004|Overall Study|Lost to Follow-up|0|||
161346217|NCT02327078|582653267|FG005|Overall Study|Lost to Follow-up|0|||
161346218|NCT02327078|582653268|FG006|Overall Study|Lost to Follow-up|0|||
161346219|NCT02327078|582653269|FG007|Overall Study|Lost to Follow-up|2|||
161346220|NCT02327078|582653270|FG008|Overall Study|Lost to Follow-up|5|||
161346221|NCT02327078|582653262|FG000|Overall Study|Site Terminated by Sponsor|1|||
161346222|NCT02327078|582653263|FG001|Overall Study|Site Terminated by Sponsor|0|||
161346223|NCT02327078|582653264|FG002|Overall Study|Site Terminated by Sponsor|1|||
161346224|NCT02327078|582653265|FG003|Overall Study|Site Terminated by Sponsor|4|||
161346225|NCT02327078|582653266|FG004|Overall Study|Site Terminated by Sponsor|0|||
161346226|NCT02327078|582653267|FG005|Overall Study|Site Terminated by Sponsor|0|||
161346227|NCT02327078|582653268|FG006|Overall Study|Site Terminated by Sponsor|0|||
161346228|NCT02327078|582653269|FG007|Overall Study|Site Terminated by Sponsor|11|||
161346229|NCT02327078|582653270|FG008|Overall Study|Site Terminated by Sponsor|25|||
161346230|NCT02327078|582653262|FG000|Overall Study|Physician Decision|0|||
161346231|NCT02327078|582653263|FG001|Overall Study|Physician Decision|0|||
161346232|NCT02327078|582653264|FG002|Overall Study|Physician Decision|0|||
161346233|NCT02327078|582653265|FG003|Overall Study|Physician Decision|1|||
161346234|NCT02327078|582653266|FG004|Overall Study|Physician Decision|0|||
161346235|NCT02327078|582653267|FG005|Overall Study|Physician Decision|0|||
161346236|NCT02327078|582653268|FG006|Overall Study|Physician Decision|0|||
161346237|NCT02327078|582653269|FG007|Overall Study|Physician Decision|0|||
161346238|NCT02327078|582653270|FG008|Overall Study|Physician Decision|1|||
161346239|NCT02327078|582653262|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161346240|NCT02327078|582653263|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161346241|NCT02327078|582653264|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161346242|NCT02327078|582653265|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161346243|NCT02327078|582653266|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161078423|NCT05217641|581675330|FG003|Overall Study|Other: participant did not specify reason|0|||
161346244|NCT02327078|582653267|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
161346245|NCT02327078|582653268|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
161346246|NCT02327078|582653269|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
161346247|NCT02327078|582653270|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
161346248|NCT02327078|582653262|FG000|Overall Study|Reason not Specified|0|||
161346249|NCT02327078|582653263|FG001|Overall Study|Reason not Specified|0|||
161346250|NCT02327078|582653264|FG002|Overall Study|Reason not Specified|0|||
161346251|NCT02327078|582653265|FG003|Overall Study|Reason not Specified|0|||
161346252|NCT02327078|582653266|FG004|Overall Study|Reason not Specified|0|||
161346253|NCT02327078|582653267|FG005|Overall Study|Reason not Specified|0|||
161346254|NCT02327078|582653268|FG006|Overall Study|Reason not Specified|0|||
161346255|NCT02327078|582653269|FG007|Overall Study|Reason not Specified|5|||
161346256|NCT02327078|582653270|FG008|Overall Study|Reason not Specified|12|||
161346257|NCT06001021|582653271|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
161346258|NCT06001021|582653272|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161346259|NCT06001021|582653273|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161346260|NCT06001021|582653274|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
161346261|NCT06001021|582653275|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
161346262|NCT06001021|582653276|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
161346263|NCT06001021|582653277|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
161346264|NCT06001021|582653271|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
161346265|NCT06001021|582653272|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161346266|NCT06001021|582653273|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161346267|NCT06001021|582653274|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
161346268|NCT06001021|582653275|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
161287414|NCT00967330|582431663|FG000|Overall Study|Severe protocol deviation|0|||
161287415|NCT00967330|582431664|FG001|Overall Study|Severe protocol deviation|1|||
161287416|NCT04563754|582433602|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
161287417|NCT04563754|582433603|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
161287418|NCT04563754|582433604|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
161287419|NCT04563754|582433602|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
161287420|NCT04563754|582433603|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
161287421|NCT04563754|582433604|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
161287422|NCT04563754|582433602|FG000|Follow up|Lost to Follow-up|61|||
161287423|NCT04563754|582433603|FG001|Follow up|Lost to Follow-up|23|||
161287424|NCT04563754|582433604|FG002|Follow up|Lost to Follow-up|5|||
161287425|NCT04563754|582433602|FG000|Follow up|Death|0|||
161287426|NCT04563754|582433603|FG001|Follow up|Death|2|||
161287427|NCT04563754|582433604|FG002|Follow up|Death|0|||
161287428|NCT04563754|582433602|FG000|Follow up|Ongoing|0|||
161287429|NCT04563754|582433603|FG001|Follow up|Ongoing|28|||
161287430|NCT04563754|582433604|FG002|Follow up|Ongoing|0|||
161287431|NCT00070564|582433605|FG000|Overall Study|Progression|2|||
161287432|NCT00070564|582433606|FG001|Overall Study|Progression|4|||
161287433|NCT00070564|582433607|FG002|Overall Study|Progression|7|||
161287434|NCT00070564|582433608|FG003|Overall Study|Progression|7|||
161287435|NCT00070564|582433609|FG004|Overall Study|Progression|1|||
161287436|NCT00070564|582433610|FG005|Overall Study|Progression|0|||
161287437|NCT00070564|582433605|FG000|Overall Study|Delinquent|1|||
161287438|NCT00070564|582433606|FG001|Overall Study|Delinquent|4|||
161287439|NCT00070564|582433607|FG002|Overall Study|Delinquent|2|||
161287440|NCT00070564|582433608|FG003|Overall Study|Delinquent|0|||
161287441|NCT00070564|582433609|FG004|Overall Study|Delinquent|0|||
161287442|NCT00070564|582433610|FG005|Overall Study|Delinquent|0|||
161287443|NCT00070564|582433605|FG000|Overall Study|Adverse Event|150|||
161287444|NCT00070564|582433606|FG001|Overall Study|Adverse Event|142|||
161287445|NCT00070564|582433607|FG002|Overall Study|Adverse Event|120|||
161287446|NCT00070564|582433608|FG003|Overall Study|Adverse Event|108|||
161287447|NCT00070564|582433609|FG004|Overall Study|Adverse Event|63|||
161287448|NCT00070564|582433610|FG005|Overall Study|Adverse Event|36|||
161287449|NCT00070564|582433605|FG000|Overall Study|Death|4|||
161287450|NCT00070564|582433606|FG001|Overall Study|Death|1|||
161287451|NCT00070564|582433607|FG002|Overall Study|Death|5|||
161287452|NCT00070564|582433608|FG003|Overall Study|Death|3|||
161287453|NCT00070564|582433609|FG004|Overall Study|Death|0|||
161287454|NCT00070564|582433610|FG005|Overall Study|Death|1|||
161287455|NCT00070564|582433605|FG000|Overall Study|Other, not protocol specified|17|||
161287456|NCT00070564|582433606|FG001|Overall Study|Other, not protocol specified|15|||
161346269|NCT06001021|582653276|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161346270|NCT06001021|582653277|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
161346271|NCT04092777|582653279|FG000|Overall Study|Lost to Follow-up|28|||
161346272|NCT04092777|582653280|FG001|Overall Study|Lost to Follow-up|46|||
161346273|NCT04092777|582653279|FG000|Overall Study|Withdrawal by Subject|8|||
161346274|NCT04092777|582653280|FG001|Overall Study|Withdrawal by Subject|5|||
161346275|NCT03330197|582653283|FG000|Overall Study|Adverse Event|0|||
161287457|NCT00070564|582433607|FG002|Overall Study|Other, not protocol specified|14|||
161287458|NCT00070564|582433608|FG003|Overall Study|Other, not protocol specified|19|||
161346276|NCT03330197|582653284|FG001|Overall Study|Adverse Event|1|||
161346277|NCT03330197|582653283|FG000|Overall Study|Withdrawal by Subject|0|||
161346278|NCT03330197|582653284|FG001|Overall Study|Withdrawal by Subject|1|||
161346279|NCT03765073|582653285|FG000|Stage 1|Lost to Follow-up|1|||
161346280|NCT03765073|582653286|FG001|Stage 1|Lost to Follow-up|0|||
161346281|NCT03765073|582653287|FG002|Stage 1|Lost to Follow-up|0|||
161346282|NCT03765073|582653288|FG003|Stage 1|Lost to Follow-up|0|||
161346283|NCT03765073|582653289|FG004|Stage 1|Lost to Follow-up|0|||
161346284|NCT03765073|582653290|FG005|Stage 1|Lost to Follow-up|0|||
161346285|NCT03765073|582653291|FG006|Stage 1|Lost to Follow-up|0|||
161346286|NCT03765073|582653292|FG007|Stage 1|Lost to Follow-up|0|||
161346287|NCT03765073|582653293|FG008|Stage 1|Lost to Follow-up|0|||
161346288|NCT03765073|582653294|FG009|Stage 1|Lost to Follow-up|0|||
161346289|NCT03765073|582653295|FG010|Stage 1|Lost to Follow-up|0|||
161346290|NCT03765073|582653296|FG011|Stage 1|Lost to Follow-up|0|||
161346291|NCT03765073|582653297|FG012|Stage 1|Lost to Follow-up|0|||
161346292|NCT03765073|582653298|FG013|Stage 1|Lost to Follow-up|0|||
161346293|NCT03765073|582653299|FG014|Stage 1|Lost to Follow-up|0|||
161346294|NCT03765073|582653300|FG015|Stage 1|Lost to Follow-up|0|||
161346295|NCT03765073|582653301|FG016|Stage 1|Lost to Follow-up|0|||
161346296|NCT03765073|582653302|FG017|Stage 1|Lost to Follow-up|0|||
161346297|NCT03765073|582653303|FG018|Stage 1|Lost to Follow-up|0|||
161346298|NCT03765073|582653304|FG019|Stage 1|Lost to Follow-up|0|||
161346299|NCT03765073|582653305|FG020|Stage 1|Lost to Follow-up|0|||
161346300|NCT03765073|582653285|FG000|Stage 1|Withdrawal by participant|0|||
161346301|NCT03765073|582653286|FG001|Stage 1|Withdrawal by participant|1|||
161346302|NCT03765073|582653287|FG002|Stage 1|Withdrawal by participant|0|||
161346303|NCT03765073|582653288|FG003|Stage 1|Withdrawal by participant|0|||
161346304|NCT03765073|582653289|FG004|Stage 1|Withdrawal by participant|0|||
161346305|NCT03765073|582653290|FG005|Stage 1|Withdrawal by participant|0|||
161346306|NCT03765073|582653291|FG006|Stage 1|Withdrawal by participant|0|||
161346307|NCT03765073|582653292|FG007|Stage 1|Withdrawal by participant|0|||
161346308|NCT03765073|582653293|FG008|Stage 1|Withdrawal by participant|0|||
161346309|NCT03765073|582653294|FG009|Stage 1|Withdrawal by participant|0|||
161346310|NCT03765073|582653295|FG010|Stage 1|Withdrawal by participant|0|||
161346311|NCT03765073|582653296|FG011|Stage 1|Withdrawal by participant|0|||
161346312|NCT03765073|582653297|FG012|Stage 1|Withdrawal by participant|0|||
161346313|NCT03765073|582653298|FG013|Stage 1|Withdrawal by participant|0|||
161346314|NCT03765073|582653299|FG014|Stage 1|Withdrawal by participant|0|||
161346315|NCT03765073|582653300|FG015|Stage 1|Withdrawal by participant|0|||
161346316|NCT03765073|582653301|FG016|Stage 1|Withdrawal by participant|0|||
161346317|NCT03765073|582653302|FG017|Stage 1|Withdrawal by participant|0|||
161346318|NCT03765073|582653303|FG018|Stage 1|Withdrawal by participant|0|||
161346319|NCT03765073|582653304|FG019|Stage 1|Withdrawal by participant|0|||
161346320|NCT03765073|582653305|FG020|Stage 1|Withdrawal by participant|0|||
161346321|NCT03765073|582653285|FG000|Stage 2|Death|0|||
161346322|NCT03765073|582653286|FG001|Stage 2|Death|0|||
161078424|NCT05217641|581675331|FG004|Overall Study|Other: participant did not specify reason|1|||
161078425|NCT05217641|581675332|FG005|Overall Study|Other: participant did not specify reason|0|||
161078426|NCT05217641|581675327|FG000|Overall Study|Extended Follow up|1|||
161078427|NCT05217641|581675328|FG001|Overall Study|Extended Follow up|1|||
161078428|NCT05217641|581675329|FG002|Overall Study|Extended Follow up|0|||
161078429|NCT05217641|581675330|FG003|Overall Study|Extended Follow up|0|||
161078430|NCT05217641|581675331|FG004|Overall Study|Extended Follow up|1|||
161078431|NCT05217641|581675332|FG005|Overall Study|Extended Follow up|0|||
161078432|NCT02994069|581675333|FG000|Overall Study|Death|7|||
161078433|NCT02994069|581675334|FG001|Overall Study|Death|13|||
161078434|NCT02994069|581675333|FG000|Overall Study|Adverse Event|1|||
161078435|NCT02994069|581675334|FG001|Overall Study|Adverse Event|0|||
161078436|NCT02994069|581675333|FG000|Overall Study|Other|2|||
161078437|NCT02994069|581675334|FG001|Overall Study|Other|0|||
161078438|NCT02994069|581675333|FG000|Overall Study|still on follow up/treatment|5|||
161078439|NCT02994069|581675334|FG001|Overall Study|still on follow up/treatment|6|||
161346323|NCT03765073|582653287|FG002|Stage 2|Death|0|||
161078440|NCT02389452|581676973|FG000|Overall Study|Lost to Follow-up|13|||
161078441|NCT02389452|581676973|FG000|Overall Study|Adverse Event|1|||
161078442|NCT02389452|581676973|FG000|Overall Study|Withdrawal by Subject|5|||
161346324|NCT03765073|582653288|FG003|Stage 2|Death|0|||
161346325|NCT03765073|582653289|FG004|Stage 2|Death|0|||
161346326|NCT03765073|582653290|FG005|Stage 2|Death|0|||
161346327|NCT03765073|582653291|FG006|Stage 2|Death|0|||
161346328|NCT03765073|582653292|FG007|Stage 2|Death|0|||
161346329|NCT03765073|582653293|FG008|Stage 2|Death|0|||
161346330|NCT03765073|582653294|FG009|Stage 2|Death|1|||
161346331|NCT03765073|582653295|FG010|Stage 2|Death|0|||
161346332|NCT03765073|582653296|FG011|Stage 2|Death|1|||
161346333|NCT03765073|582653297|FG012|Stage 2|Death|0|||
161346334|NCT03765073|582653298|FG013|Stage 2|Death|0|||
161346335|NCT03765073|582653299|FG014|Stage 2|Death|0|||
161346336|NCT03765073|582653300|FG015|Stage 2|Death|0|||
161078443|NCT02389452|581676973|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
161346337|NCT03765073|582653301|FG016|Stage 2|Death|2|||
161346338|NCT03765073|582653302|FG017|Stage 2|Death|0|||
161346339|NCT03765073|582653303|FG018|Stage 2|Death|0|||
161346340|NCT03765073|582653304|FG019|Stage 2|Death|0|||
161287459|NCT00070564|582433609|FG004|Overall Study|Other, not protocol specified|6|||
161287460|NCT00070564|582433610|FG005|Overall Study|Other, not protocol specified|7|||
161287461|NCT00070564|582433605|FG000|Overall Study|Withdrawal by Subject|26|||
161287462|NCT00070564|582433606|FG001|Overall Study|Withdrawal by Subject|37|||
161287463|NCT00070564|582433607|FG002|Overall Study|Withdrawal by Subject|23|||
161346341|NCT03765073|582653305|FG020|Stage 2|Death|0|||
161346342|NCT03765073|582653285|FG000|Stage 2|Lost to Follow-up|0|||
161346343|NCT03765073|582653286|FG001|Stage 2|Lost to Follow-up|0|||
161346344|NCT03765073|582653287|FG002|Stage 2|Lost to Follow-up|0|||
161346345|NCT03765073|582653288|FG003|Stage 2|Lost to Follow-up|5|||
161346346|NCT03765073|582653289|FG004|Stage 2|Lost to Follow-up|1|||
161346347|NCT03765073|582653290|FG005|Stage 2|Lost to Follow-up|0|||
161346348|NCT03765073|582653291|FG006|Stage 2|Lost to Follow-up|3|||
161346349|NCT03765073|582653292|FG007|Stage 2|Lost to Follow-up|3|||
161346350|NCT03765073|582653293|FG008|Stage 2|Lost to Follow-up|1|||
161346351|NCT03765073|582653294|FG009|Stage 2|Lost to Follow-up|6|||
161346352|NCT03765073|582653295|FG010|Stage 2|Lost to Follow-up|5|||
161346353|NCT03765073|582653296|FG011|Stage 2|Lost to Follow-up|1|||
161346354|NCT03765073|582653297|FG012|Stage 2|Lost to Follow-up|1|||
161346355|NCT03765073|582653298|FG013|Stage 2|Lost to Follow-up|3|||
161346356|NCT03765073|582653299|FG014|Stage 2|Lost to Follow-up|3|||
161346357|NCT03765073|582653300|FG015|Stage 2|Lost to Follow-up|1|||
161346358|NCT03765073|582653301|FG016|Stage 2|Lost to Follow-up|6|||
161346359|NCT03765073|582653302|FG017|Stage 2|Lost to Follow-up|0|||
161346360|NCT03765073|582653303|FG018|Stage 2|Lost to Follow-up|0|||
161287464|NCT00070564|582433608|FG003|Overall Study|Withdrawal by Subject|30|||
161287465|NCT00070564|582433609|FG004|Overall Study|Withdrawal by Subject|8|||
161287466|NCT00070564|582433610|FG005|Overall Study|Withdrawal by Subject|8|||
161287467|NCT00070564|582433605|FG000|Overall Study|Not reported|0|||
161287468|NCT00070564|582433606|FG001|Overall Study|Not reported|0|||
161287469|NCT00070564|582433607|FG002|Overall Study|Not reported|0|||
161287470|NCT00070564|582433608|FG003|Overall Study|Not reported|0|||
161078444|NCT02311673|581676974|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
161078445|NCT02311673|581676975|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
161078446|NCT02311673|581676976|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
161078447|NCT02311673|581676977|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
161078448|NCT00414908|581676980|FG000|Overall Study|Protocol Violation|1|||
161078449|NCT00414908|581676981|FG001|Overall Study|Protocol Violation|1|||
161078450|NCT01076153|581676982|FG000|Overall Study|Symptoms improved/resolved|10|||
161078451|NCT01076153|581676982|FG000|Overall Study|Adverse Event|1|||
161078452|NCT04165031|581676983|FG000|Overall Study|Adverse Event|1|||
161078453|NCT04165031|581676984|FG001|Overall Study|Adverse Event|1|||
161078454|NCT04165031|581676985|FG002|Overall Study|Adverse Event|0|||
161078455|NCT04165031|581676986|FG003|Overall Study|Adverse Event|0|||
161078456|NCT04165031|581676987|FG004|Overall Study|Adverse Event|0|||
161078457|NCT04165031|581676988|FG005|Overall Study|Adverse Event|0|||
161078458|NCT04165031|581676983|FG000|Overall Study|Withdrawal by Subject|0|||
161078459|NCT04165031|581676984|FG001|Overall Study|Withdrawal by Subject|0|||
161078460|NCT04165031|581676985|FG002|Overall Study|Withdrawal by Subject|1|||
161078461|NCT04165031|581676986|FG003|Overall Study|Withdrawal by Subject|0|||
161078462|NCT04165031|581676987|FG004|Overall Study|Withdrawal by Subject|0|||
161078463|NCT04165031|581676988|FG005|Overall Study|Withdrawal by Subject|0|||
161078464|NCT01977677|581676989|FG000|Overall Study|Unrelated Adverse Event|0|||
161078465|NCT01977677|581676990|FG001|Overall Study|Unrelated Adverse Event|0|||
161078466|NCT01977677|581676991|FG002|Overall Study|Unrelated Adverse Event|1|||
161078467|NCT00667225|581676992|FG000|Overall Study|Subject had no more lesions to treat.|1|||
161078468|NCT00667225|581676993|FG001|Overall Study|Subject had no more lesions to treat.|0|||
161078469|NCT00667225|581676992|FG000|Overall Study|Lost to Follow-up|0|||
161078470|NCT00667225|581676993|FG001|Overall Study|Lost to Follow-up|1|||
161078471|NCT03563157|581676998|FG000|Overall Study|Progressive Disease|2|||
161078472|NCT02248818|581676999|FG000|Screening|Protocol Violation|0|||
161078473|NCT02248818|581677000|FG001|Screening|Protocol Violation|0|||
161078474|NCT02248818|581677001|FG002|Screening|Protocol Violation|0|||
161078475|NCT02248818|581677002|FG003|Screening|Protocol Violation|0|||
161078476|NCT02248818|581677003|FG004|Screening|Protocol Violation|0|||
161078477|NCT02248818|581677004|FG005|Screening|Protocol Violation|0|||
161346361|NCT03765073|582653304|FG019|Stage 2|Lost to Follow-up|0|||
161346362|NCT03765073|582653305|FG020|Stage 2|Lost to Follow-up|0|||
161346363|NCT03765073|582653285|FG000|Stage 2|Other|0|||
161346364|NCT03765073|582653286|FG001|Stage 2|Other|0|||
161346365|NCT03765073|582653287|FG002|Stage 2|Other|0|||
161078478|NCT02248818|581677005|FG006|Screening|Protocol Violation|0|||
161078479|NCT02248818|581677006|FG007|Screening|Protocol Violation|0|||
161160246|NCT01606761|581966905|FG001|Prior to Week 24|Physician Decision|3|||
161287471|NCT00070564|582433609|FG004|Overall Study|Not reported|1|||
161346366|NCT03765073|582653288|FG003|Stage 2|Other|0|||
161346367|NCT03765073|582653289|FG004|Stage 2|Other|0|||
161346368|NCT03765073|582653290|FG005|Stage 2|Other|0|||
161346369|NCT03765073|582653291|FG006|Stage 2|Other|0|||
161346370|NCT03765073|582653292|FG007|Stage 2|Other|1|||
161160247|NCT01606761|581966906|FG002|Prior to Week 24|Physician Decision|1|||
161160248|NCT01606761|581966907|FG003|Prior to Week 24|Physician Decision|0|||
161160249|NCT01606761|581966908|FG004|Prior to Week 24|Physician Decision|0|||
161160250|NCT01606761|581966904|FG000|Prior to Week 24|Other|4|||
161160251|NCT01606761|581966905|FG001|Prior to Week 24|Other|7|||
161160252|NCT01606761|581966906|FG002|Prior to Week 24|Other|5|||
161160253|NCT01606761|581966907|FG003|Prior to Week 24|Other|0|||
161160254|NCT01606761|581966908|FG004|Prior to Week 24|Other|0|||
161160255|NCT01606761|581966904|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
161160256|NCT01606761|581966905|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
161160257|NCT01606761|581966906|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
161160258|NCT01606761|581966907|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
161160259|NCT01606761|581966908|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
161160260|NCT01606761|581966904|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
161160261|NCT01606761|581966905|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
161160262|NCT01606761|581966906|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
161160263|NCT01606761|581966907|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
161160264|NCT01606761|581966908|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
161160265|NCT01606761|581966904|FG000|Week 24 to Week 52|Adverse Event|0|||
161160266|NCT01606761|581966905|FG001|Week 24 to Week 52|Adverse Event|11|||
161160267|NCT01606761|581966906|FG002|Week 24 to Week 52|Adverse Event|14|||
161160268|NCT01606761|581966907|FG003|Week 24 to Week 52|Adverse Event|3|||
161160269|NCT01606761|581966908|FG004|Week 24 to Week 52|Adverse Event|15|||
161160270|NCT01606761|581966904|FG000|Week 24 to Week 52|Death|0|||
161160271|NCT01606761|581966905|FG001|Week 24 to Week 52|Death|0|||
161160272|NCT01606761|581966906|FG002|Week 24 to Week 52|Death|2|||
161160273|NCT01606761|581966907|FG003|Week 24 to Week 52|Death|1|||
161160274|NCT01606761|581966908|FG004|Week 24 to Week 52|Death|0|||
161160275|NCT01606761|581966904|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
161160276|NCT01606761|581966905|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
161160277|NCT01606761|581966906|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
161160278|NCT01606761|581966907|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
161160279|NCT01606761|581966908|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
161160280|NCT01606761|581966904|FG000|Week 24 to Week 52|Physician Decision|0|||
161160281|NCT01606761|581966905|FG001|Week 24 to Week 52|Physician Decision|1|||
161160282|NCT01606761|581966906|FG002|Week 24 to Week 52|Physician Decision|1|||
161160283|NCT01606761|581966907|FG003|Week 24 to Week 52|Physician Decision|0|||
161160284|NCT01606761|581966908|FG004|Week 24 to Week 52|Physician Decision|0|||
161160285|NCT01606761|581966904|FG000|Week 24 to Week 52|Other|0|||
161160286|NCT01606761|581966905|FG001|Week 24 to Week 52|Other|1|||
161160287|NCT01606761|581966906|FG002|Week 24 to Week 52|Other|5|||
161160288|NCT01606761|581966907|FG003|Week 24 to Week 52|Other|2|||
161160289|NCT01606761|581966908|FG004|Week 24 to Week 52|Other|2|||
161160290|NCT01606761|581966904|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
161160291|NCT01606761|581966905|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
161160292|NCT01606761|581966906|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
161160293|NCT01606761|581966907|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
161160294|NCT01606761|581966908|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
161160295|NCT01606761|581966904|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
161160296|NCT01606761|581966905|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
161160297|NCT01606761|581966906|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
161160298|NCT01606761|581966907|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
161160299|NCT01606761|581966908|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
161160300|NCT01606761|581966904|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
161160301|NCT01606761|581966905|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
161160302|NCT01606761|581966906|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
161160303|NCT01606761|581966907|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
161160304|NCT01606761|581966908|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
161160305|NCT01606761|581966904|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
161160306|NCT01606761|581966905|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
161287472|NCT00070564|582433610|FG005|Overall Study|Not reported|0|||
161287473|NCT04510090|582433615|FG000|FE-HS|Withdrawal by Subject|0|||
161287474|NCT04510090|582433616|FG001|FE-HS|Withdrawal by Subject|0|||
161160307|NCT01606761|581966906|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
161287475|NCT04510090|582433617|FG002|FE-HS|Withdrawal by Subject|0|||
161160308|NCT01606761|581966907|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
161160309|NCT01606761|581966908|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
161160310|NCT05086289|581966909|FG000|Overall Study|Adverse Event|4|||
161160311|NCT05086289|581966910|FG001|Overall Study|Adverse Event|2|||
161160312|NCT05086289|581966909|FG000|Overall Study|Lost to Follow-up|2|||
161160313|NCT05086289|581966910|FG001|Overall Study|Lost to Follow-up|0|||
161160314|NCT05086289|581966909|FG000|Overall Study|Non-compliance with study drug|2|||
161160315|NCT05086289|581966910|FG001|Overall Study|Non-compliance with study drug|1|||
161160316|NCT05086289|581966909|FG000|Overall Study|Physician Decision|2|||
161160317|NCT05086289|581966910|FG001|Overall Study|Physician Decision|0|||
161287476|NCT04510090|582433618|FG003|FE-HS|Withdrawal by Subject|0|||
161160318|NCT05086289|581966909|FG000|Overall Study|Withdrawal by Subject|5|||
161160319|NCT05086289|581966910|FG001|Overall Study|Withdrawal by Subject|2|||
161160320|NCT03628508|581966916|FG000|Overall Study|Lost to Follow-up|1|||
161160321|NCT01996748|581966917|FG000|Overall Study|Personal reason|1|||
161160322|NCT01996748|581966918|FG001|Overall Study|Personal reason|0|||
161160323|NCT01996748|581966917|FG000|Overall Study|Physician Decision|2|||
161160324|NCT01996748|581966918|FG001|Overall Study|Physician Decision|0|||
161160325|NCT01996748|581966917|FG000|Overall Study|Adverse Event|1|||
161160326|NCT01996748|581966918|FG001|Overall Study|Adverse Event|4|||
161160327|NCT01996748|581966917|FG000|Overall Study|Withdrawal by Subject|0|||
161160328|NCT01996748|581966918|FG001|Overall Study|Withdrawal by Subject|1|||
161160329|NCT01996748|581966917|FG000|Overall Study|Lost to Follow-up|4|||
161160330|NCT01996748|581966918|FG001|Overall Study|Lost to Follow-up|1|||
161078480|NCT02248818|581677007|FG008|Screening|Protocol Violation|7|||
161078481|NCT02248818|581676999|FG000|Screening|Study fully enrolled|0|||
161078482|NCT02248818|581677000|FG001|Screening|Study fully enrolled|0|||
161078483|NCT02248818|581677001|FG002|Screening|Study fully enrolled|0|||
161078484|NCT02248818|581677002|FG003|Screening|Study fully enrolled|0|||
161078485|NCT02248818|581677003|FG004|Screening|Study fully enrolled|0|||
161078486|NCT02248818|581677004|FG005|Screening|Study fully enrolled|0|||
161160331|NCT03238235|581966919|FG000|Overall Study|Adverse Event|2|||
161160332|NCT03238235|581966920|FG001|Overall Study|Adverse Event|0|||
161160333|NCT03238235|581966919|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
161160334|NCT03238235|581966920|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
161160335|NCT00243230|581966925|FG000|Double-Blind Period|Adverse Event|0|||
161160336|NCT00243230|581966926|FG001|Double-Blind Period|Adverse Event|2|||
161160337|NCT00243230|581966927|FG002|Double-Blind Period|Adverse Event|2|||
161160338|NCT00243230|581966928|FG003|Double-Blind Period|Adverse Event|0|||
161160339|NCT00243230|581966925|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161160340|NCT00243230|581966926|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161160341|NCT00243230|581966927|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161160342|NCT00243230|581966928|FG003|Double-Blind Period|Withdrawal by Subject|0|||
161160343|NCT00243230|581966925|FG000|Double-Blind Period|Protocol Violation|0|||
161160344|NCT00243230|581966926|FG001|Double-Blind Period|Protocol Violation|0|||
161160345|NCT00243230|581966927|FG002|Double-Blind Period|Protocol Violation|1|||
161160346|NCT00243230|581966928|FG003|Double-Blind Period|Protocol Violation|0|||
161160347|NCT00243230|581966925|FG000|Double-Blind Period|Randomized but Not Treated|0|||
161160348|NCT00243230|581966926|FG001|Double-Blind Period|Randomized but Not Treated|0|||
161160349|NCT00243230|581966927|FG002|Double-Blind Period|Randomized but Not Treated|2|||
161160350|NCT00243230|581966928|FG003|Double-Blind Period|Randomized but Not Treated|0|||
161160351|NCT00243230|581966925|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
161160352|NCT00243230|581966926|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
161160353|NCT00243230|581966927|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
161160354|NCT00243230|581966928|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
161160355|NCT00243230|581966925|FG000|Open Label Period|Adverse Event|0|||
161160356|NCT00243230|581966926|FG001|Open Label Period|Adverse Event|0|||
161160357|NCT00243230|581966927|FG002|Open Label Period|Adverse Event|0|||
161160358|NCT00243230|581966928|FG003|Open Label Period|Adverse Event|2|||
161160359|NCT00243230|581966925|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
161160360|NCT00243230|581966926|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
161160361|NCT00243230|581966927|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
161160362|NCT00243230|581966928|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
161160363|NCT00243230|581966925|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161160364|NCT00243230|581966926|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161160365|NCT00243230|581966927|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
161160366|NCT00243230|581966928|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
161160367|NCT00243230|581966925|FG000|Open Label Period|Lost to Follow-up|0|||
161160368|NCT00243230|581966926|FG001|Open Label Period|Lost to Follow-up|0|||
161160369|NCT00243230|581966927|FG002|Open Label Period|Lost to Follow-up|0|||
161287477|NCT04510090|582433619|FG004|FE-HS|Withdrawal by Subject|1|||
161287478|NCT04510090|582433620|FG005|FE-HS|Withdrawal by Subject|0|||
161287479|NCT04510090|582433621|FG006|FE-HS|Withdrawal by Subject|0|||
161078487|NCT02248818|581677005|FG006|Screening|Study fully enrolled|0|||
161078488|NCT02248818|581677006|FG007|Screening|Study fully enrolled|0|||
161160370|NCT00243230|581966928|FG003|Open Label Period|Lost to Follow-up|2|||
161160371|NCT00243230|581966925|FG000|Open Label Period|Withdrawal by Subject|0|||
161160372|NCT00243230|581966926|FG001|Open Label Period|Withdrawal by Subject|0|||
161160373|NCT00243230|581966927|FG002|Open Label Period|Withdrawal by Subject|0|||
161160374|NCT00243230|581966928|FG003|Open Label Period|Withdrawal by Subject|2|||
161160375|NCT00243230|581966925|FG000|Open Label Period|Protocol Violation|0|||
161160376|NCT00243230|581966926|FG001|Open Label Period|Protocol Violation|0|||
161160377|NCT00243230|581966927|FG002|Open Label Period|Protocol Violation|0|||
161287480|NCT04510090|582433622|FG007|FE-HS|Withdrawal by Subject|0|||
161078489|NCT02248818|581677007|FG008|Screening|Study fully enrolled|14|||
161287481|NCT01127256|582433623|FG000|Overall Study|Adverse Event|13|||
161287482|NCT01127256|582433624|FG001|Overall Study|Adverse Event|13|||
161287483|NCT01127256|582433623|FG000|Overall Study|Lack of Efficacy|4|||
161287484|NCT01127256|582433624|FG001|Overall Study|Lack of Efficacy|0|||
161287485|NCT01127256|582433623|FG000|Overall Study|Lost to Follow-up|16|||
161287486|NCT01127256|582433624|FG001|Overall Study|Lost to Follow-up|17|||
161287487|NCT01127256|582433623|FG000|Overall Study|Withdrawal by Subject|5|||
161287488|NCT01127256|582433624|FG001|Overall Study|Withdrawal by Subject|9|||
161287489|NCT01127256|582433623|FG000|Overall Study|Protocol Violation|1|||
161287490|NCT01127256|582433624|FG001|Overall Study|Protocol Violation|0|||
161287491|NCT01922037|582433625|FG000|Overall Study|Withdrawal by Subject|2|||
161287492|NCT01922037|582433626|FG001|Overall Study|Withdrawal by Subject|44|||
161287493|NCT01922037|582433625|FG000|Overall Study|Adverse Event|1|||
161287494|NCT01922037|582433626|FG001|Overall Study|Adverse Event|7|||
161287495|NCT01922037|582433625|FG000|Overall Study|Death|0|||
161287496|NCT01922037|582433626|FG001|Overall Study|Death|5|||
161287497|NCT01922037|582433625|FG000|Overall Study|Pregnancy|0|||
161287498|NCT01922037|582433626|FG001|Overall Study|Pregnancy|2|||
161287499|NCT01922037|582433625|FG000|Overall Study|Participant non-compliance|4|||
161287500|NCT01922037|582433626|FG001|Overall Study|Participant non-compliance|46|||
161287501|NCT01922037|582433625|FG000|Overall Study|Investigator/Sponsor decision|1|||
161287502|NCT01922037|582433626|FG001|Overall Study|Investigator/Sponsor decision|4|||
161287503|NCT01922037|582433625|FG000|Overall Study|Other unspecified|2|||
161287504|NCT01922037|582433626|FG001|Overall Study|Other unspecified|66|||
161287505|NCT00679211|582433627|FG000|Overall Study|Progressive disease|82|||
161287506|NCT00679211|582433627|FG000|Overall Study|Adverse Event|7|||
161287507|NCT00679211|582433627|FG000|Overall Study|Withdrawal by Subject|2|||
161287508|NCT00679211|582433627|FG000|Overall Study|Physician Decision|5|||
161287509|NCT00679211|582433627|FG000|Overall Study|Refused to undergo protocol procedures|1|||
161287510|NCT00679211|582433627|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
161287511|NCT00679211|582433627|FG000|Overall Study|Other|1|||
161287512|NCT01866826|582433634|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
161287513|NCT01866826|582433635|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
161287514|NCT01866826|582433634|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
161287515|NCT01866826|582433635|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
161287516|NCT01866826|582433634|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
161287517|NCT01866826|582433635|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
161287518|NCT02288312|582433636|FG000|Overall Study|Pregnancy|1|||
161287519|NCT02288312|582433637|FG001|Overall Study|Pregnancy|0|||
161287520|NCT02288312|582433638|FG002|Overall Study|Pregnancy|0|||
161287521|NCT01276041|582433639|FG000|Overall Study|Adverse Event|2|||
161287522|NCT01276041|582433639|FG000|Overall Study|Protocol Violation|1|||
161287523|NCT02058069|582433642|FG000|Overall Study|Exclusion due to implant size|5|||
161287524|NCT02058069|582433642|FG000|Overall Study|Withdrawal by Subject|6|||
161287525|NCT02222922|582433643|FG000|Overall Study|Death|0|||
161287526|NCT02222922|582433644|FG001|Overall Study|Death|0|||
161287527|NCT02222922|582433645|FG002|Overall Study|Death|0|||
161287528|NCT02222922|582433646|FG003|Overall Study|Death|0|||
161287529|NCT02222922|582433647|FG004|Overall Study|Death|13|||
161287530|NCT02222922|582433648|FG005|Overall Study|Death|0|||
161287531|NCT02222922|582433649|FG006|Overall Study|Death|0|||
161287532|NCT02222922|582433650|FG007|Overall Study|Death|0|||
161287533|NCT02222922|582433651|FG008|Overall Study|Death|2|||
161287534|NCT02222922|582433643|FG000|Overall Study|Lost to Follow-up|0|||
161287535|NCT02222922|582433644|FG001|Overall Study|Lost to Follow-up|0|||
161287536|NCT02222922|582433645|FG002|Overall Study|Lost to Follow-up|1|||
161287537|NCT02222922|582433646|FG003|Overall Study|Lost to Follow-up|0|||
161287538|NCT02222922|582433647|FG004|Overall Study|Lost to Follow-up|9|||
161287539|NCT02222922|582433648|FG005|Overall Study|Lost to Follow-up|1|||
161287540|NCT02222922|582433649|FG006|Overall Study|Lost to Follow-up|0|||
161287541|NCT02222922|582433650|FG007|Overall Study|Lost to Follow-up|0|||
161287542|NCT02222922|582433651|FG008|Overall Study|Lost to Follow-up|0|||
161287543|NCT02222922|582433643|FG000|Overall Study|Other|0|||
161287544|NCT02222922|582433644|FG001|Overall Study|Other|0|||
161287545|NCT02222922|582433645|FG002|Overall Study|Other|0|||
161287546|NCT02222922|582433646|FG003|Overall Study|Other|2|||
161287547|NCT02222922|582433647|FG004|Overall Study|Other|10|||
161287548|NCT02222922|582433648|FG005|Overall Study|Other|2|||
161287549|NCT02222922|582433649|FG006|Overall Study|Other|2|||
161287550|NCT02222922|582433650|FG007|Overall Study|Other|4|||
161287551|NCT02222922|582433651|FG008|Overall Study|Other|1|||
161287552|NCT02222922|582433643|FG000|Overall Study|Participant refused further follow-up|1|||
161287553|NCT02222922|582433644|FG001|Overall Study|Participant refused further follow-up|0|||
161287554|NCT02222922|582433645|FG002|Overall Study|Participant refused further follow-up|0|||
161287555|NCT02222922|582433646|FG003|Overall Study|Participant refused further follow-up|1|||
161287556|NCT02222922|582433647|FG004|Overall Study|Participant refused further follow-up|6|||
161287557|NCT02222922|582433648|FG005|Overall Study|Participant refused further follow-up|0|||
161287558|NCT02222922|582433649|FG006|Overall Study|Participant refused further follow-up|0|||
161160378|NCT00243230|581966928|FG003|Open Label Period|Protocol Violation|2|||
161160379|NCT00243230|581966925|FG000|Open Label Period|Administrative Reason|0|||
161160380|NCT00243230|581966926|FG001|Open Label Period|Administrative Reason|0|||
161160381|NCT00243230|581966927|FG002|Open Label Period|Administrative Reason|0|||
161160382|NCT00243230|581966928|FG003|Open Label Period|Administrative Reason|63|||
161160383|NCT03011840|581966930|FG000|Overall Study|Not received PIL in post PIL phase|0|||
161160384|NCT03011840|581966931|FG001|Overall Study|Not received PIL in post PIL phase|21|||
161160385|NCT03201198|581966937|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
161160386|NCT03201198|581966938|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
161160387|NCT03201198|581966937|FG000|Overall Study|Withdrawal by Subject|2|||
161160388|NCT03201198|581966938|FG001|Overall Study|Withdrawal by Subject|3|||
161160389|NCT00471445|581966939|FG000|Overall Study|Withdrawal by Subject|1|||
161160390|NCT00471445|581966940|FG001|Overall Study|Withdrawal by Subject|1|||
161160391|NCT00471445|581966939|FG000|Overall Study|Ineligible|1|||
161160392|NCT00471445|581966940|FG001|Overall Study|Ineligible|0|||
161160393|NCT00471445|581966939|FG000|Overall Study|Protocol Violation|0|||
161160394|NCT00471445|581966940|FG001|Overall Study|Protocol Violation|1|||
161160395|NCT04715230|581966941|FG000|Overall Study|Withdrawal by Subject|1|||
161160396|NCT04715230|581966942|FG001|Overall Study|Withdrawal by Subject|0|||
161160397|NCT04715230|581966943|FG002|Overall Study|Withdrawal by Subject|0|||
161160398|NCT04715230|581966941|FG000|Overall Study|Lost to Follow-up|0|||
161160399|NCT04715230|581966942|FG001|Overall Study|Lost to Follow-up|5|||
161160400|NCT04715230|581966943|FG002|Overall Study|Lost to Follow-up|1|||
161160401|NCT00586924|581966946|FG000|Overall Study|Adverse event/serious adverse event|0|||
161160402|NCT00586924|581966947|FG001|Overall Study|Adverse event/serious adverse event|0|||
161160403|NCT00586924|581966948|FG002|Overall Study|Adverse event/serious adverse event|0|||
161160404|NCT00586924|581966949|FG003|Overall Study|Adverse event/serious adverse event|1|||
161160405|NCT00586924|581966950|FG004|Overall Study|Adverse event/serious adverse event|0|||
161160406|NCT00586924|581966951|FG005|Overall Study|Adverse event/serious adverse event|2|||
161160407|NCT00586924|581966946|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
161160408|NCT00586924|581966947|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
161160409|NCT00586924|581966948|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
161160410|NCT00586924|581966949|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
161160411|NCT00586924|581966950|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
161160412|NCT00586924|581966951|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
161160413|NCT00586924|581966946|FG000|Overall Study|Disease progression|0|||
161160414|NCT00586924|581966947|FG001|Overall Study|Disease progression|0|||
161160415|NCT00586924|581966948|FG002|Overall Study|Disease progression|0|||
161160416|NCT00586924|581966949|FG003|Overall Study|Disease progression|1|||
161160417|NCT00586924|581966950|FG004|Overall Study|Disease progression|1|||
161160418|NCT00586924|581966951|FG005|Overall Study|Disease progression|0|||
161160419|NCT00586924|581966946|FG000|Overall Study|Development of neutralizing antibodies|2|||
161160420|NCT00586924|581966947|FG001|Overall Study|Development of neutralizing antibodies|2|||
161160421|NCT00586924|581966948|FG002|Overall Study|Development of neutralizing antibodies|2|||
161160422|NCT00586924|581966949|FG003|Overall Study|Development of neutralizing antibodies|0|||
161160423|NCT00586924|581966950|FG004|Overall Study|Development of neutralizing antibodies|0|||
161160424|NCT00586924|581966951|FG005|Overall Study|Development of neutralizing antibodies|22|||
161160425|NCT00586924|581966946|FG000|Overall Study|Complete response|0|||
161160426|NCT00586924|581966947|FG001|Overall Study|Complete response|1|||
161287559|NCT02222922|582433650|FG007|Overall Study|Participant refused further follow-up|0|||
161287560|NCT02222922|582433651|FG008|Overall Study|Participant refused further follow-up|3|||
161287561|NCT01068860|582433652|FG000|Overall Study|Withdrawal by Subject|0|||
161287562|NCT01068860|582433653|FG001|Overall Study|Withdrawal by Subject|0|||
161287563|NCT01068860|582433654|FG002|Overall Study|Withdrawal by Subject|0|||
161287564|NCT01068860|582433655|FG003|Overall Study|Withdrawal by Subject|0|||
161287565|NCT01068860|582433656|FG004|Overall Study|Withdrawal by Subject|0|||
161287566|NCT01068860|582433657|FG005|Overall Study|Withdrawal by Subject|2|||
161287567|NCT01068860|582433658|FG006|Overall Study|Withdrawal by Subject|0|||
161287568|NCT01068860|582433659|FG007|Overall Study|Withdrawal by Subject|0|||
161287569|NCT01068860|582433660|FG008|Overall Study|Withdrawal by Subject|0|||
161287570|NCT01068860|582433661|FG009|Overall Study|Withdrawal by Subject|3|||
161287571|NCT01068860|582433652|FG000|Overall Study|Administrative problems; misrandomized|0|||
161287572|NCT01068860|582433653|FG001|Overall Study|Administrative problems; misrandomized|0|||
161287573|NCT01068860|582433654|FG002|Overall Study|Administrative problems; misrandomized|0|||
161287574|NCT01068860|582433655|FG003|Overall Study|Administrative problems; misrandomized|1|||
161346371|NCT03765073|582653293|FG008|Stage 2|Other|1|||
161160427|NCT00586924|581966948|FG002|Overall Study|Complete response|0|||
161346372|NCT03765073|582653294|FG009|Stage 2|Other|3|||
161160428|NCT00586924|581966949|FG003|Overall Study|Complete response|0|||
161160429|NCT00586924|581966950|FG004|Overall Study|Complete response|2|||
161160430|NCT00586924|581966951|FG005|Overall Study|Complete response|2|||
161160431|NCT00586924|581966946|FG000|Overall Study|Other|1|||
161160432|NCT00586924|581966947|FG001|Overall Study|Other|0|||
161160433|NCT00586924|581966948|FG002|Overall Study|Other|1|||
161287575|NCT01068860|582433656|FG004|Overall Study|Administrative problems; misrandomized|0|||
161287576|NCT01068860|582433657|FG005|Overall Study|Administrative problems; misrandomized|0|||
161287577|NCT01068860|582433658|FG006|Overall Study|Administrative problems; misrandomized|0|||
161287578|NCT01068860|582433659|FG007|Overall Study|Administrative problems; misrandomized|0|||
161287579|NCT01068860|582433660|FG008|Overall Study|Administrative problems; misrandomized|0|||
161287580|NCT01068860|582433661|FG009|Overall Study|Administrative problems; misrandomized|1|||
161287581|NCT01068860|582433652|FG000|Overall Study|Lost to Follow-up|0|||
161287582|NCT01068860|582433653|FG001|Overall Study|Lost to Follow-up|1|||
161287583|NCT01068860|582433654|FG002|Overall Study|Lost to Follow-up|0|||
161287584|NCT01068860|582433655|FG003|Overall Study|Lost to Follow-up|0|||
161287585|NCT01068860|582433656|FG004|Overall Study|Lost to Follow-up|0|||
161287586|NCT01068860|582433657|FG005|Overall Study|Lost to Follow-up|0|||
161287587|NCT01068860|582433658|FG006|Overall Study|Lost to Follow-up|0|||
161287588|NCT01068860|582433659|FG007|Overall Study|Lost to Follow-up|0|||
161287589|NCT01068860|582433660|FG008|Overall Study|Lost to Follow-up|0|||
161287590|NCT01068860|582433661|FG009|Overall Study|Lost to Follow-up|0|||
161287591|NCT02568072|582433662|FG000|Overall Study|Unavailable for appointment|23|||
161287592|NCT02568072|582433662|FG000|Overall Study|Unable to contact|3|||
161287593|NCT02568072|582433662|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
161287594|NCT02568072|582433662|FG000|Overall Study|Withdrawal by Subject|1|||
161287595|NCT02568072|582433662|FG000|Overall Study|Sustained injury, marathon not run|24|||
161287596|NCT05263908|582433663|FG000|Overall Study|No informed consent for publication of study results|397|||
161287597|NCT05263908|582433663|FG000|Overall Study|CRF not collected|1|||
161160434|NCT00586924|581966949|FG003|Overall Study|Other|1|||
161160435|NCT00586924|581966950|FG004|Overall Study|Other|1|||
161160436|NCT00586924|581966951|FG005|Overall Study|Other|6|||
161160437|NCT01767194|581966954|FG000|Overall Study|Adverse Event|1|||
161160438|NCT01767194|581966955|FG001|Overall Study|Adverse Event|1|||
161160439|NCT01767194|581966954|FG000|Overall Study|Death|0|||
161160440|NCT01767194|581966955|FG001|Overall Study|Death|1|||
161160441|NCT01767194|581966954|FG000|Overall Study|Lack of Efficacy|12|||
161160442|NCT01767194|581966955|FG001|Overall Study|Lack of Efficacy|11|||
161160443|NCT01767194|581966954|FG000|Overall Study|Physician Decision|2|||
161160444|NCT01767194|581966955|FG001|Overall Study|Physician Decision|23|||
161160445|NCT01767194|581966954|FG000|Overall Study|Withdrawal by Subject|0|||
161160446|NCT01767194|581966955|FG001|Overall Study|Withdrawal by Subject|1|||
161160447|NCT01767194|581966954|FG000|Overall Study|Ineligible|1|||
161160448|NCT01767194|581966955|FG001|Overall Study|Ineligible|1|||
161160449|NCT01767194|581966954|FG000|Overall Study|Refusal by patient/parent|2|||
161287598|NCT02714218|582433664|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161287599|NCT02714218|582433665|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
161287600|NCT02714218|582433666|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
161287601|NCT02714218|582433664|FG000|Pre-Treatment Period|Other reasons|0|||
161287602|NCT02714218|582433665|FG001|Pre-Treatment Period|Other reasons|1|||
161287603|NCT02714218|582433666|FG002|Pre-Treatment Period|Other reasons|0|||
161287604|NCT02714218|582433664|FG000|Treatment Period|Disease Progression|55|||
161287605|NCT02714218|582433665|FG001|Treatment Period|Disease Progression|52|||
161287606|NCT02714218|582433666|FG002|Treatment Period|Disease Progression|14|||
161287607|NCT02714218|582433664|FG000|Treatment Period|Study drug toxicity|46|||
161287608|NCT02714218|582433665|FG001|Treatment Period|Study drug toxicity|70|||
161287609|NCT02714218|582433666|FG002|Treatment Period|Study drug toxicity|6|||
161287610|NCT02714218|582433664|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
161287611|NCT02714218|582433665|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
161287612|NCT02714218|582433666|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
161287613|NCT02714218|582433664|FG000|Treatment Period|Request to discontinue treatment|1|||
161287614|NCT02714218|582433665|FG001|Treatment Period|Request to discontinue treatment|4|||
161287615|NCT02714218|582433666|FG002|Treatment Period|Request to discontinue treatment|1|||
161287616|NCT02714218|582433664|FG000|Treatment Period|Participant withdrew consent|2|||
161287617|NCT02714218|582433665|FG001|Treatment Period|Participant withdrew consent|2|||
161287618|NCT02714218|582433666|FG002|Treatment Period|Participant withdrew consent|0|||
161287619|NCT02714218|582433664|FG000|Treatment Period|Maximum clinical benefit|4|||
161287620|NCT02714218|582433665|FG001|Treatment Period|Maximum clinical benefit|2|||
161160450|NCT01767194|581966955|FG001|Overall Study|Refusal by patient/parent|4|||
161287621|NCT02714218|582433666|FG002|Treatment Period|Maximum clinical benefit|0|||
161287622|NCT02714218|582433664|FG000|Treatment Period|Administrative reason by sponsor|2|||
161287623|NCT02714218|582433665|FG001|Treatment Period|Administrative reason by sponsor|1|||
161287624|NCT02714218|582433666|FG002|Treatment Period|Administrative reason by sponsor|0|||
161287625|NCT02714218|582433664|FG000|Treatment Period|Other reasons|6|||
161287626|NCT02714218|582433665|FG001|Treatment Period|Other reasons|6|||
161160451|NCT01767194|581966954|FG000|Overall Study|Criteria not met on time for next cycle|0|||
161160452|NCT01767194|581966955|FG001|Overall Study|Criteria not met on time for next cycle|1|||
161160453|NCT00605722|581968752|FG000|Overall Study|Adverse Event|6|||
161160454|NCT00605722|581968752|FG000|Overall Study|Insufficient therapeutic response|44|||
161287627|NCT02714218|582433666|FG002|Treatment Period|Other reasons|0|||
161287628|NCT02714218|582433664|FG000|Treatment Period|Completed treatment as per protocol|36|||
161287629|NCT02714218|582433665|FG001|Treatment Period|Completed treatment as per protocol|27|||
161287630|NCT02714218|582433666|FG002|Treatment Period|Completed treatment as per protocol|3|||
161287631|NCT02714218|582433664|FG000|Treatment Period|Not reported|9|||
161287632|NCT02714218|582433665|FG001|Treatment Period|Not reported|6|||
161287633|NCT02714218|582433666|FG002|Treatment Period|Not reported|0|||
161287634|NCT00840749|582433667|FG000|Overall Study|Death|1|||
161287635|NCT00840749|582433668|FG001|Overall Study|Death|2|||
161287636|NCT00840749|582433667|FG000|Overall Study|not treated on study arm|11|||
161287637|NCT00840749|582433668|FG001|Overall Study|not treated on study arm|11|||
161287638|NCT00840749|582433667|FG000|Overall Study|study closed|19|||
161287639|NCT00840749|582433668|FG001|Overall Study|study closed|14|||
161287640|NCT01113892|582433673|FG000|Overall Study|Lost to Follow-up|2|||
161287641|NCT01113892|582433674|FG001|Overall Study|Lost to Follow-up|2|||
161287642|NCT01113892|582433673|FG000|Overall Study|Withdrawal by Subject|1|||
161287643|NCT01113892|582433674|FG001|Overall Study|Withdrawal by Subject|1|||
161287644|NCT01113892|582433673|FG000|Overall Study|Death|2|||
161287645|NCT01113892|582433674|FG001|Overall Study|Death|4|||
161287646|NCT01113892|582433673|FG000|Overall Study|Graft no longer evaluable|9|||
161287647|NCT01113892|582433674|FG001|Overall Study|Graft no longer evaluable|9|||
161287648|NCT00789854|582433677|FG000|Overall Study|Adverse Event|28|||
161287649|NCT00789854|582433678|FG001|Overall Study|Adverse Event|23|||
161287650|NCT00789854|582433679|FG002|Overall Study|Adverse Event|18|||
161287651|NCT00789854|582433677|FG000|Overall Study|Lost to Follow-up|1|||
161287652|NCT00789854|582433678|FG001|Overall Study|Lost to Follow-up|1|||
161287653|NCT00789854|582433679|FG002|Overall Study|Lost to Follow-up|4|||
161287654|NCT00789854|582433677|FG000|Overall Study|Withdrawal by Subject|9|||
161287655|NCT00789854|582433678|FG001|Overall Study|Withdrawal by Subject|6|||
161287656|NCT00789854|582433679|FG002|Overall Study|Withdrawal by Subject|17|||
161287657|NCT00789854|582433677|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161287658|NCT00789854|582433678|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
161287659|NCT00789854|582433679|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
161287660|NCT00789854|582433677|FG000|Overall Study|Severe non-compliance to the protocol|3|||
161287661|NCT00789854|582433678|FG001|Overall Study|Severe non-compliance to the protocol|0|||
161287662|NCT00789854|582433679|FG002|Overall Study|Severe non-compliance to the protocol|0|||
161287663|NCT00789854|582433677|FG000|Overall Study|Safety reasons|0|||
161287664|NCT00789854|582433678|FG001|Overall Study|Safety reasons|0|||
161287665|NCT00789854|582433679|FG002|Overall Study|Safety reasons|2|||
161287666|NCT00789854|582433677|FG000|Overall Study|Other|6|||
161287667|NCT00789854|582433678|FG001|Overall Study|Other|0|||
161287668|NCT00789854|582433679|FG002|Overall Study|Other|5|||
161287669|NCT03473925|582433680|FG000|Overall Study|Death|48|||
161287670|NCT03473925|582433681|FG001|Overall Study|Death|44|||
161287671|NCT03473925|582433680|FG000|Overall Study|Sponsor Decision|2|||
161287672|NCT03473925|582433681|FG001|Overall Study|Sponsor Decision|7|||
161287673|NCT03473925|582433680|FG000|Overall Study|Withdrawal by Subject|1|||
161287674|NCT03473925|582433681|FG001|Overall Study|Withdrawal by Subject|3|||
161287675|NCT03473925|582433680|FG000|Overall Study|Not Treated|1|||
161287676|NCT03473925|582433681|FG001|Overall Study|Not Treated|1|||
161287677|NCT03411863|582433682|FG000|Overall Study|Withdrawal by Subject|3|||
161287678|NCT03411863|582433683|FG001|Overall Study|Withdrawal by Subject|1|||
161287679|NCT03411863|582433682|FG000|Overall Study|Physician Decision|0|||
161287680|NCT03411863|582433683|FG001|Overall Study|Physician Decision|1|||
161287681|NCT02766335|582433685|FG000|Initial Registration|Adverse Event|6|||
161287682|NCT02766335|582433686|FG001|Initial Registration|Adverse Event|3|||
161287683|NCT02766335|582433687|FG002|Initial Registration|Adverse Event|0|||
161287684|NCT02766335|582433685|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
161287685|NCT02766335|582433686|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
161287686|NCT02766335|582433687|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
161287687|NCT02766335|582433685|FG000|Initial Registration|Progression/relapse|49|||
161287688|NCT02766335|582433686|FG001|Initial Registration|Progression/relapse|15|||
161287689|NCT02766335|582433687|FG002|Initial Registration|Progression/relapse|0|||
161287690|NCT02766335|582433685|FG000|Initial Registration|Death|1|||
161287691|NCT02766335|582433686|FG001|Initial Registration|Death|3|||
161287692|NCT02766335|582433687|FG002|Initial Registration|Death|0|||
161287693|NCT02766335|582433685|FG000|Initial Registration|not protocol specified|1|||
161287694|NCT02766335|582433686|FG001|Initial Registration|not protocol specified|9|||
161287695|NCT02766335|582433687|FG002|Initial Registration|not protocol specified|0|||
161287696|NCT02766335|582433685|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
161287697|NCT02766335|582433686|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
161287698|NCT02766335|582433687|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
161078490|NCT02248818|581676999|FG000|Screening|Physician Decision|0|||
161078491|NCT02248818|581677000|FG001|Screening|Physician Decision|0|||
161287699|NCT02766335|582433685|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
161287700|NCT02766335|582433686|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
161160455|NCT00605722|581968752|FG000|Overall Study|Failure to return|1|||
161160456|NCT00333619|581968759|FG000|Overall Study|Death|12|||
161160457|NCT00333619|581968760|FG001|Overall Study|Death|6|||
161160458|NCT00333619|581968759|FG000|Overall Study|Withdrawal by Subject|6|||
161160459|NCT00333619|581968760|FG001|Overall Study|Withdrawal by Subject|1|||
161160460|NCT00333619|581968759|FG000|Overall Study|Lost to Follow-up|3|||
161160461|NCT00333619|581968760|FG001|Overall Study|Lost to Follow-up|3|||
161160462|NCT01120379|581968769|FG000|One Year Timepoint|Withdrawal by Subject|41|||
161160463|NCT01120379|581968769|FG000|One Year Timepoint|Lost to Follow-up|115|||
161160464|NCT01120379|581968769|FG000|One Year Timepoint|Death|108|||
161160465|NCT01120379|581968769|FG000|One Year Timepoint|Physician Decision|9|||
161160466|NCT01120379|581968769|FG000|One Year Timepoint|Any other reason for early termination|5|||
161160467|NCT01120379|581968769|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
161160468|NCT01120379|581968769|FG000|Two Year Timepoint|Lost to Follow-up|87|||
161160469|NCT01120379|581968769|FG000|Two Year Timepoint|Death|123|||
161160470|NCT01120379|581968769|FG000|Two Year Timepoint|Physician Decision|12|||
161160471|NCT01120379|581968769|FG000|Two Year Timepoint|Any other reason for early termination|4|||
161160472|NCT01120379|581968769|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
161160473|NCT01120379|581968769|FG000|Three Year Timepoint|Lost to Follow-up|43|||
161160474|NCT01120379|581968769|FG000|Three Year Timepoint|Death|120|||
161160475|NCT01120379|581968769|FG000|Three Year Timepoint|Physician Decision|9|||
161160476|NCT01120379|581968769|FG000|Three Year Timepoint|Any other reason for early termination|17|||
161160477|NCT01120379|581968769|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
161160478|NCT01120379|581968769|FG000|Four Year Timepoint|Lost to Follow-up|10|||
161160479|NCT01120379|581968769|FG000|Four Year Timepoint|Death|131|||
161160480|NCT01120379|581968769|FG000|Four Year Timepoint|Physician Decision|5|||
161160481|NCT01120379|581968769|FG000|Four Year Timepoint|Any other reason for early termination|217|||
161160482|NCT03162055|581968770|FG000|Overall Study|Adverse Event|6|||
161160483|NCT03162055|581968771|FG001|Overall Study|Adverse Event|5|||
161160484|NCT03162055|581968770|FG000|Overall Study|Death|3|||
161160485|NCT03162055|581968771|FG001|Overall Study|Death|3|||
161160486|NCT03162055|581968770|FG000|Overall Study|Lost to Follow-up|0|||
161160487|NCT03162055|581968771|FG001|Overall Study|Lost to Follow-up|1|||
161160488|NCT03162055|581968770|FG000|Overall Study|Study-specific withdrawal criteria|22|||
161160489|NCT03162055|581968771|FG001|Overall Study|Study-specific withdrawal criteria|14|||
161160490|NCT03162055|581968770|FG000|Overall Study|Withdrawal by Subject|17|||
161160491|NCT03162055|581968771|FG001|Overall Study|Withdrawal by Subject|2|||
161160492|NCT03162055|581968770|FG000|Overall Study|Did not receive treatment|2|||
161160493|NCT03162055|581968771|FG001|Overall Study|Did not receive treatment|0|||
161160494|NCT03162055|581968770|FG000|Overall Study|Incorrect randomization|4|||
161160495|NCT03162055|581968771|FG001|Overall Study|Incorrect randomization|3|||
161160496|NCT03162055|581968770|FG000|Overall Study|Other|8|||
161160497|NCT03162055|581968771|FG001|Overall Study|Other|15|||
161160498|NCT04031404|581968772|FG000|Baseline|Lost to Follow-up|0|||
161160499|NCT04031404|581968773|FG001|Baseline|Lost to Follow-up|1|||
161160500|NCT04031404|581968772|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
161160501|NCT04031404|581968773|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
161160502|NCT04031404|581968772|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
161160503|NCT04031404|581968773|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
161160504|NCT04031404|581968772|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
161160505|NCT04031404|581968773|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
161160506|NCT04031404|581968772|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
161160507|NCT04031404|581968773|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
161160508|NCT01993615|581968777|FG000|Overall Study|Death|1|||
161287701|NCT02766335|582433687|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
161287702|NCT02756611|582433689|FG000|Overall Study|Death|70|||
161287703|NCT02756611|582433689|FG000|Overall Study|Withdrawal by Subject|2|||
161287704|NCT02756611|582433689|FG000|Overall Study|Lost to Follow-up|3|||
161287705|NCT02756611|582433689|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
161287706|NCT02756611|582433689|FG000|Overall Study|Other|10|||
161287707|NCT03125798|582433691|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
161160509|NCT01993615|581968778|FG001|Overall Study|Death|0|||
161287708|NCT03125798|582433692|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
161287709|NCT03125798|582433691|FG000|Overall Study|Conversion to thoracotomy|7|||
161287710|NCT03125798|582433692|FG001|Overall Study|Conversion to thoracotomy|7|||
161287711|NCT00476190|582433707|FG000|Overall Study|Ineligible|1|||
161160510|NCT01354353|581968787|FG000|Overall Study|Adverse Event|1|||
161160511|NCT01354353|581968788|FG001|Overall Study|Adverse Event|0|||
161160512|NCT01354353|581968789|FG002|Overall Study|Adverse Event|0|||
161160513|NCT01354353|581968790|FG003|Overall Study|Adverse Event|4|||
161160514|NCT01354353|581968791|FG004|Overall Study|Adverse Event|0|||
161160515|NCT01354353|581968792|FG005|Overall Study|Adverse Event|5|||
161160516|NCT01354353|581968787|FG000|Overall Study|Entry Criteria Not Met|0|||
161160517|NCT01354353|581968788|FG001|Overall Study|Entry Criteria Not Met|0|||
161160518|NCT01354353|581968789|FG002|Overall Study|Entry Criteria Not Met|0|||
161160519|NCT01354353|581968790|FG003|Overall Study|Entry Criteria Not Met|1|||
161160520|NCT01354353|581968791|FG004|Overall Study|Entry Criteria Not Met|1|||
161160521|NCT01354353|581968792|FG005|Overall Study|Entry Criteria Not Met|0|||
161160522|NCT01354353|581968787|FG000|Overall Study|Physician Decision|0|||
161160523|NCT01354353|581968788|FG001|Overall Study|Physician Decision|1|||
161160524|NCT01354353|581968789|FG002|Overall Study|Physician Decision|1|||
161160525|NCT01354353|581968790|FG003|Overall Study|Physician Decision|0|||
161160526|NCT01354353|581968791|FG004|Overall Study|Physician Decision|0|||
161160527|NCT01354353|581968792|FG005|Overall Study|Physician Decision|0|||
161160528|NCT01354353|581968787|FG000|Overall Study|Withdrawal by Subject|2|||
161160529|NCT01354353|581968788|FG001|Overall Study|Withdrawal by Subject|0|||
161160530|NCT01354353|581968789|FG002|Overall Study|Withdrawal by Subject|1|||
161160531|NCT01354353|581968790|FG003|Overall Study|Withdrawal by Subject|0|||
161160532|NCT01354353|581968791|FG004|Overall Study|Withdrawal by Subject|0|||
161160533|NCT01354353|581968792|FG005|Overall Study|Withdrawal by Subject|1|||
161160534|NCT00831441|581968793|FG000|Randomized|Death|82|||
161160535|NCT00831441|581968794|FG001|Randomized|Death|81|||
161160536|NCT00831441|581968793|FG000|Randomized|Adverse Event|248|||
161160537|NCT00831441|581968794|FG001|Randomized|Adverse Event|321|||
161160538|NCT00831441|581968793|FG000|Randomized|Emergency procedure|2|||
161160539|NCT00831441|581968794|FG001|Randomized|Emergency procedure|2|||
161160540|NCT00831441|581968793|FG000|Randomized|Elective procedure|26|||
161160541|NCT00831441|581968794|FG001|Randomized|Elective procedure|25|||
161160542|NCT00831441|581968793|FG000|Randomized|Physician Decision|26|||
161160543|NCT00831441|581968794|FG001|Randomized|Physician Decision|35|||
161160544|NCT00831441|581968793|FG000|Randomized|No longer met criteria|13|||
161160545|NCT00831441|581968794|FG001|Randomized|No longer met criteria|19|||
161160546|NCT00831441|581968793|FG000|Randomized|Withdrawal by Subject|178|||
161160547|NCT00831441|581968794|FG001|Randomized|Withdrawal by Subject|212|||
161160548|NCT00831441|581968793|FG000|Randomized|Lost to Follow-up|26|||
161160549|NCT00831441|581968794|FG001|Randomized|Lost to Follow-up|35|||
161160550|NCT00831441|581968793|FG000|Randomized|Administrative reason by sponsor|2780|||
161160551|NCT00831441|581968794|FG001|Randomized|Administrative reason by sponsor|2671|||
161160552|NCT00831441|581968793|FG000|Randomized|poor/non-compliance|30|||
161160553|NCT00831441|581968794|FG001|Randomized|poor/non-compliance|38|||
161160554|NCT00831441|581968793|FG000|Randomized|non-specified|276|||
161160555|NCT00831441|581968794|FG001|Randomized|non-specified|266|||
161160556|NCT00831441|581968793|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
161160557|NCT00831441|581968794|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
161160558|NCT00831441|581968793|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
161160559|NCT00831441|581968794|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
161160560|NCT00831441|581968793|FG000|Follow Up (30 Days)|Death|63|||
161160561|NCT00831441|581968794|FG001|Follow Up (30 Days)|Death|86|||
161160562|NCT00831441|581968793|FG000|Follow Up (30 Days)|non-specified|16|||
161160563|NCT00831441|581968794|FG001|Follow Up (30 Days)|non-specified|26|||
161160564|NCT00831441|581968793|FG000|Follow Up (30 Days)|missing end of study status|0|||
161160565|NCT00831441|581968794|FG001|Follow Up (30 Days)|missing end of study status|1|||
161160566|NCT05674344|581968795|FG000|Overall Study|Screen Fail|21|||
161160567|NCT05674344|581968795|FG000|Overall Study|Incomplete study procedures|3|||
161160568|NCT00111917|581968796|FG000|Overall Study|Withdrawal by Subject|1|||
161160569|NCT00111917|581968797|FG001|Overall Study|Withdrawal by Subject|1|||
161160570|NCT01640925|581968798|FG000|Overall Study|Withdrawal by Subject|1|||
161160571|NCT01640925|581968799|FG001|Overall Study|Withdrawal by Subject|0|||
161160572|NCT01640925|581968798|FG000|Overall Study|Previously enrolled in this trial|13|||
161160573|NCT01640925|581968799|FG001|Overall Study|Previously enrolled in this trial|11|||
161160574|NCT02156492|581968800|FG000|Period 1|No Reason Given|0|||
161160575|NCT02156492|581968801|FG001|Period 1|No Reason Given|1|||
161160576|NCT02156492|581968802|FG002|Period 1|No Reason Given|0|||
161160577|NCT02156492|581968800|FG000|Period 3|Adverse Event|0|||
161160578|NCT02156492|581968801|FG001|Period 3|Adverse Event|1|||
161160579|NCT02156492|581968802|FG002|Period 3|Adverse Event|0|||
161160580|NCT00485589|581968811|FG000|Overall Study|Death|2|||
161160581|NCT00485589|581968812|FG001|Overall Study|Death|2|||
161287712|NCT00476190|582433708|FG001|Overall Study|Ineligible|1|||
161160582|NCT00485589|581968813|FG002|Overall Study|Death|0|||
161160583|NCT00485589|581968811|FG000|Overall Study|Failure to return|6|||
161287713|NCT00476190|582433707|FG000|Overall Study|Induction Death|2|||
161160584|NCT00485589|581968812|FG001|Overall Study|Failure to return|5|||
161160585|NCT00485589|581968813|FG002|Overall Study|Failure to return|1|||
161160586|NCT00485589|581968811|FG000|Overall Study|Protocol Violation|1|||
161160587|NCT00485589|581968812|FG001|Overall Study|Protocol Violation|0|||
161160588|NCT00485589|581968813|FG002|Overall Study|Protocol Violation|0|||
161160589|NCT00485589|581968811|FG000|Overall Study|Violation of selection criteria at entry|0|||
161160590|NCT00485589|581968812|FG001|Overall Study|Violation of selection criteria at entry|3|||
161160591|NCT00485589|581968813|FG002|Overall Study|Violation of selection criteria at entry|1|||
161160592|NCT00485589|581968811|FG000|Overall Study|Administrative/Other|1|||
161160593|NCT00485589|581968812|FG001|Overall Study|Administrative/Other|2|||
161160594|NCT00485589|581968813|FG002|Overall Study|Administrative/Other|1|||
161160595|NCT00485589|581968811|FG000|Overall Study|Insufficient therapeutic response|10|||
161160596|NCT00485589|581968812|FG001|Overall Study|Insufficient therapeutic response|3|||
161287714|NCT00476190|582433708|FG001|Overall Study|Induction Death|0|||
161287715|NCT00476190|582433707|FG000|Overall Study|Induction Failure|2|||
161287716|NCT00476190|582433708|FG001|Overall Study|Induction Failure|4|||
161078492|NCT02248818|581677001|FG002|Screening|Physician Decision|0|||
161078493|NCT02248818|581677002|FG003|Screening|Physician Decision|0|||
161078494|NCT02248818|581677003|FG004|Screening|Physician Decision|0|||
161078495|NCT02248818|581677004|FG005|Screening|Physician Decision|0|||
161078496|NCT02248818|581677005|FG006|Screening|Physician Decision|0|||
161078497|NCT02248818|581677006|FG007|Screening|Physician Decision|0|||
161078498|NCT02248818|581677007|FG008|Screening|Physician Decision|73|||
161078499|NCT02248818|581676999|FG000|Screening|Withdrawal by Subject|0|||
161078500|NCT02248818|581677000|FG001|Screening|Withdrawal by Subject|0|||
161078501|NCT02248818|581677001|FG002|Screening|Withdrawal by Subject|0|||
161078502|NCT02248818|581677002|FG003|Screening|Withdrawal by Subject|0|||
161078503|NCT02248818|581677003|FG004|Screening|Withdrawal by Subject|0|||
161078504|NCT02248818|581677004|FG005|Screening|Withdrawal by Subject|0|||
161078505|NCT02248818|581677005|FG006|Screening|Withdrawal by Subject|0|||
161078506|NCT02248818|581677006|FG007|Screening|Withdrawal by Subject|0|||
161078507|NCT02248818|581677007|FG008|Screening|Withdrawal by Subject|6|||
161078508|NCT02248818|581676999|FG000|Screening|Lost to Follow-up|0|||
161078509|NCT02248818|581677000|FG001|Screening|Lost to Follow-up|0|||
161078510|NCT02248818|581677001|FG002|Screening|Lost to Follow-up|0|||
161078511|NCT02248818|581677002|FG003|Screening|Lost to Follow-up|0|||
161078512|NCT02248818|581677003|FG004|Screening|Lost to Follow-up|0|||
161078513|NCT02248818|581677004|FG005|Screening|Lost to Follow-up|0|||
161078514|NCT02248818|581677005|FG006|Screening|Lost to Follow-up|0|||
161078515|NCT02248818|581677006|FG007|Screening|Lost to Follow-up|0|||
161078516|NCT02248818|581677007|FG008|Screening|Lost to Follow-up|7|||
161078517|NCT02248818|581676999|FG000|Randomised Study|Administrative - randomization error|0|||
161078518|NCT02248818|581677000|FG001|Randomised Study|Administrative - randomization error|0|||
161078519|NCT02248818|581677001|FG002|Randomised Study|Administrative - randomization error|0|||
161078520|NCT02248818|581677002|FG003|Randomised Study|Administrative - randomization error|0|||
161078521|NCT02248818|581677003|FG004|Randomised Study|Administrative - randomization error|0|||
161078522|NCT02248818|581677004|FG005|Randomised Study|Administrative - randomization error|8|||
161078523|NCT02248818|581677005|FG006|Randomised Study|Administrative - randomization error|0|||
161078524|NCT02248818|581677006|FG007|Randomised Study|Administrative - randomization error|0|||
161078525|NCT02248818|581677007|FG008|Randomised Study|Administrative - randomization error|0|||
161078526|NCT02187159|581677010|FG000|Overall Study|Protocol Violation|4|||
161078527|NCT02187159|581677011|FG001|Overall Study|Protocol Violation|6|||
161078528|NCT02187159|581677012|FG002|Overall Study|Protocol Violation|3|||
161078529|NCT02187159|581677013|FG003|Overall Study|Protocol Violation|4|||
161078530|NCT02187159|581677010|FG000|Overall Study|Lack of Efficacy|10|||
161078531|NCT02187159|581677011|FG001|Overall Study|Lack of Efficacy|5|||
161078532|NCT02187159|581677012|FG002|Overall Study|Lack of Efficacy|4|||
161078533|NCT02187159|581677013|FG003|Overall Study|Lack of Efficacy|7|||
161078534|NCT02187159|581677010|FG000|Overall Study|Adverse Event|28|||
161078535|NCT02187159|581677011|FG001|Overall Study|Adverse Event|33|||
161078536|NCT02187159|581677012|FG002|Overall Study|Adverse Event|42|||
161078537|NCT02187159|581677013|FG003|Overall Study|Adverse Event|50|||
161078538|NCT02187159|581677010|FG000|Overall Study|Withdrawal by Subject|24|||
161078539|NCT02187159|581677011|FG001|Overall Study|Withdrawal by Subject|28|||
161078540|NCT02187159|581677012|FG002|Overall Study|Withdrawal by Subject|25|||
161078541|NCT02187159|581677013|FG003|Overall Study|Withdrawal by Subject|26|||
161078542|NCT02187159|581677010|FG000|Overall Study|Other|3|||
161078543|NCT02187159|581677011|FG001|Overall Study|Other|7|||
161078544|NCT02187159|581677012|FG002|Overall Study|Other|3|||
161078545|NCT02187159|581677013|FG003|Overall Study|Other|9|||
161078546|NCT01283152|581677014|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
161078547|NCT01283152|581677015|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
161078548|NCT01283152|581677014|FG000|Overall Study|Refused HESA|1|||
161078549|NCT01283152|581677015|FG001|Overall Study|Refused HESA|0|||
161078550|NCT03482466|581677016|FG000|Overall Study|Protocol Violation|2|||
161078551|NCT04833127|581677017|FG000|Overall Study|Lost to Follow-up|1|||
161078552|NCT04833127|581677018|FG001|Overall Study|Lost to Follow-up|1|||
161078553|NCT01736189|581677019|FG000|Overall Study|Violation of registration criteria|41|||
161078554|NCT01736189|581677019|FG000|Overall Study|Protocol Violation|4|||
161078555|NCT01736189|581677019|FG000|Overall Study|Criteria and protocol violations|1|||
161078556|NCT01499303|581677020|FG000|Overall Study|Ongoing|2|||
161078557|NCT01499303|581677021|FG001|Overall Study|Ongoing|1|||
161078558|NCT01499303|581677020|FG000|Overall Study|Withdrawal by Subject|0|||
161078559|NCT01499303|581677021|FG001|Overall Study|Withdrawal by Subject|1|||
161078560|NCT01499303|581677020|FG000|Overall Study|Adverse Event|1|||
161078561|NCT01499303|581677021|FG001|Overall Study|Adverse Event|4|||
161078562|NCT01499303|581677020|FG000|Overall Study|Other|0|||
161078563|NCT01499303|581677021|FG001|Overall Study|Other|1|||
161078564|NCT00461981|581677022|FG000|Overall Study|Lost to Follow-up|9|||
161078565|NCT00461981|581677023|FG001|Overall Study|Lost to Follow-up|6|||
161078566|NCT00461981|581677022|FG000|Overall Study|Withdrawal by Subject|2|||
161346373|NCT03765073|582653295|FG010|Stage 2|Other|0|||
161346374|NCT03765073|582653296|FG011|Stage 2|Other|0|||
161346375|NCT03765073|582653297|FG012|Stage 2|Other|0|||
161346376|NCT03765073|582653298|FG013|Stage 2|Other|0|||
161346377|NCT03765073|582653299|FG014|Stage 2|Other|0|||
161346378|NCT03765073|582653300|FG015|Stage 2|Other|1|||
161346379|NCT03765073|582653301|FG016|Stage 2|Other|2|||
161346380|NCT03765073|582653302|FG017|Stage 2|Other|0|||
161346381|NCT03765073|582653303|FG018|Stage 2|Other|0|||
161346382|NCT03765073|582653304|FG019|Stage 2|Other|0|||
161346383|NCT03765073|582653305|FG020|Stage 2|Other|0|||
161346384|NCT03765073|582653285|FG000|Stage 2|Withdrawal by parent/guardian|0|||
161346385|NCT03765073|582653286|FG001|Stage 2|Withdrawal by parent/guardian|0|||
161346386|NCT03765073|582653287|FG002|Stage 2|Withdrawal by parent/guardian|0|||
161346387|NCT03765073|582653288|FG003|Stage 2|Withdrawal by parent/guardian|0|||
161346388|NCT03765073|582653289|FG004|Stage 2|Withdrawal by parent/guardian|0|||
161346389|NCT03765073|582653290|FG005|Stage 2|Withdrawal by parent/guardian|0|||
161346390|NCT03765073|582653291|FG006|Stage 2|Withdrawal by parent/guardian|0|||
161346391|NCT03765073|582653292|FG007|Stage 2|Withdrawal by parent/guardian|0|||
161346392|NCT03765073|582653293|FG008|Stage 2|Withdrawal by parent/guardian|0|||
161346393|NCT03765073|582653294|FG009|Stage 2|Withdrawal by parent/guardian|0|||
161346394|NCT03765073|582653295|FG010|Stage 2|Withdrawal by parent/guardian|3|||
161346395|NCT03765073|582653296|FG011|Stage 2|Withdrawal by parent/guardian|3|||
161346396|NCT03765073|582653297|FG012|Stage 2|Withdrawal by parent/guardian|3|||
161346397|NCT03765073|582653298|FG013|Stage 2|Withdrawal by parent/guardian|1|||
161346398|NCT03765073|582653299|FG014|Stage 2|Withdrawal by parent/guardian|1|||
161346399|NCT03765073|582653300|FG015|Stage 2|Withdrawal by parent/guardian|0|||
161346400|NCT03765073|582653301|FG016|Stage 2|Withdrawal by parent/guardian|3|||
161346401|NCT03765073|582653302|FG017|Stage 2|Withdrawal by parent/guardian|0|||
161346402|NCT03765073|582653303|FG018|Stage 2|Withdrawal by parent/guardian|0|||
161346403|NCT03765073|582653304|FG019|Stage 2|Withdrawal by parent/guardian|0|||
161346404|NCT03765073|582653305|FG020|Stage 2|Withdrawal by parent/guardian|0|||
161346405|NCT03765073|582653285|FG000|Stage 2|Withdrawal by Subject|0|||
161346406|NCT03765073|582653286|FG001|Stage 2|Withdrawal by Subject|0|||
161346407|NCT03765073|582653287|FG002|Stage 2|Withdrawal by Subject|0|||
161346408|NCT03765073|582653288|FG003|Stage 2|Withdrawal by Subject|3|||
161346409|NCT03765073|582653289|FG004|Stage 2|Withdrawal by Subject|3|||
161346410|NCT03765073|582653290|FG005|Stage 2|Withdrawal by Subject|3|||
161346411|NCT03765073|582653291|FG006|Stage 2|Withdrawal by Subject|0|||
161346412|NCT03765073|582653292|FG007|Stage 2|Withdrawal by Subject|1|||
161346413|NCT03765073|582653293|FG008|Stage 2|Withdrawal by Subject|0|||
161346414|NCT03765073|582653294|FG009|Stage 2|Withdrawal by Subject|5|||
161346415|NCT03765073|582653295|FG010|Stage 2|Withdrawal by Subject|0|||
161346416|NCT03765073|582653296|FG011|Stage 2|Withdrawal by Subject|0|||
161346417|NCT03765073|582653297|FG012|Stage 2|Withdrawal by Subject|0|||
161346418|NCT03765073|582653298|FG013|Stage 2|Withdrawal by Subject|0|||
161346419|NCT03765073|582653299|FG014|Stage 2|Withdrawal by Subject|0|||
161346420|NCT03765073|582653300|FG015|Stage 2|Withdrawal by Subject|0|||
161346421|NCT03765073|582653301|FG016|Stage 2|Withdrawal by Subject|0|||
161346422|NCT03765073|582653302|FG017|Stage 2|Withdrawal by Subject|0|||
161346423|NCT03765073|582653303|FG018|Stage 2|Withdrawal by Subject|0|||
161346424|NCT03765073|582653304|FG019|Stage 2|Withdrawal by Subject|0|||
161346425|NCT03765073|582653305|FG020|Stage 2|Withdrawal by Subject|0|||
161078567|NCT00461981|581677023|FG001|Overall Study|Withdrawal by Subject|3|||
161078568|NCT01240915|581677028|FG000|Overall Study|Adverse Event|0|||
161078569|NCT01240915|581677029|FG001|Overall Study|Adverse Event|0|||
161078570|NCT01240915|581677030|FG002|Overall Study|Adverse Event|0|||
161078571|NCT01240915|581677031|FG003|Overall Study|Adverse Event|1|||
161078572|NCT01240915|581677032|FG004|Overall Study|Adverse Event|0|||
161078573|NCT01240915|581677033|FG005|Overall Study|Adverse Event|2|||
161078574|NCT01240915|581677034|FG006|Overall Study|Adverse Event|0|||
161078575|NCT01240915|581677035|FG007|Overall Study|Adverse Event|0|||
161078576|NCT01240915|581677036|FG008|Overall Study|Adverse Event|1|||
161078577|NCT01240915|581677028|FG000|Overall Study|Lost to Follow-up|0|||
161078578|NCT01240915|581677029|FG001|Overall Study|Lost to Follow-up|0|||
161078579|NCT01240915|581677030|FG002|Overall Study|Lost to Follow-up|0|||
161078580|NCT01240915|581677031|FG003|Overall Study|Lost to Follow-up|0|||
161346426|NCT03765073|582653285|FG000|Stage 3|Adverse Event|0|||
161346427|NCT03765073|582653286|FG001|Stage 3|Adverse Event|0|||
161346428|NCT03765073|582653287|FG002|Stage 3|Adverse Event|0|||
161346429|NCT03765073|582653288|FG003|Stage 3|Adverse Event|0|||
161346430|NCT03765073|582653289|FG004|Stage 3|Adverse Event|0|||
161346431|NCT03765073|582653290|FG005|Stage 3|Adverse Event|0|||
161346432|NCT03765073|582653291|FG006|Stage 3|Adverse Event|0|||
161346433|NCT03765073|582653292|FG007|Stage 3|Adverse Event|0|||
161346434|NCT03765073|582653293|FG008|Stage 3|Adverse Event|0|||
161346435|NCT03765073|582653294|FG009|Stage 3|Adverse Event|0|||
161346436|NCT03765073|582653295|FG010|Stage 3|Adverse Event|0|||
161078581|NCT01240915|581677032|FG004|Overall Study|Lost to Follow-up|1|||
161346437|NCT03765073|582653296|FG011|Stage 3|Adverse Event|0|||
161346438|NCT03765073|582653297|FG012|Stage 3|Adverse Event|0|||
161346439|NCT03765073|582653298|FG013|Stage 3|Adverse Event|0|||
161160597|NCT00485589|581968813|FG002|Overall Study|Insufficient therapeutic response|1|||
161160598|NCT00485589|581968811|FG000|Overall Study|Refused treatment/did not cooperate|1|||
161160599|NCT00485589|581968812|FG001|Overall Study|Refused treatment/did not cooperate|0|||
161160600|NCT00485589|581968813|FG002|Overall Study|Refused treatment/did not cooperate|2|||
161160601|NCT00485589|581968811|FG000|Overall Study|Withdrawal by Subject|3|||
161160602|NCT00485589|581968812|FG001|Overall Study|Withdrawal by Subject|2|||
161160603|NCT00485589|581968813|FG002|Overall Study|Withdrawal by Subject|2|||
161160604|NCT00485589|581968811|FG000|Overall Study|Adverse Event|3|||
161160605|NCT00485589|581968812|FG001|Overall Study|Adverse Event|3|||
161160606|NCT00485589|581968813|FG002|Overall Study|Adverse Event|10|||
161160607|NCT02924688|581968816|FG000|Overall Study|Adverse Event|9|||
161160608|NCT02924688|581968817|FG001|Overall Study|Adverse Event|3|||
161160609|NCT02924688|581968818|FG002|Overall Study|Adverse Event|2|||
161160610|NCT02924688|581968819|FG003|Overall Study|Adverse Event|2|||
161078582|NCT01240915|581677033|FG005|Overall Study|Lost to Follow-up|1|||
161078583|NCT01240915|581677034|FG006|Overall Study|Lost to Follow-up|0|||
161078584|NCT01240915|581677035|FG007|Overall Study|Lost to Follow-up|1|||
161078585|NCT01240915|581677036|FG008|Overall Study|Lost to Follow-up|1|||
161160611|NCT02924688|581968820|FG004|Overall Study|Adverse Event|3|||
161160612|NCT02924688|581968821|FG005|Overall Study|Adverse Event|2|||
161160613|NCT02924688|581968816|FG000|Overall Study|Lack of Efficacy|2|||
161160614|NCT02924688|581968817|FG001|Overall Study|Lack of Efficacy|3|||
161160615|NCT02924688|581968818|FG002|Overall Study|Lack of Efficacy|4|||
161160616|NCT02924688|581968819|FG003|Overall Study|Lack of Efficacy|2|||
161160617|NCT02924688|581968820|FG004|Overall Study|Lack of Efficacy|1|||
161287717|NCT00476190|582433707|FG000|Overall Study|Lost to Follow-up|1|||
161287718|NCT00476190|582433708|FG001|Overall Study|Lost to Follow-up|0|||
161287719|NCT00476190|582433707|FG000|Overall Study|Relapse/Progression|5|||
161287720|NCT00476190|582433708|FG001|Overall Study|Relapse/Progression|2|||
161287721|NCT00476190|582433707|FG000|Overall Study|Remission Death|0|||
161287722|NCT00476190|582433708|FG001|Overall Study|Remission Death|1|||
161287723|NCT00476190|582433707|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
161287724|NCT00476190|582433708|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
161287725|NCT00476190|582433707|FG000|Overall Study|Withdrawal by Subject|6|||
161287726|NCT00476190|582433708|FG001|Overall Study|Withdrawal by Subject|2|||
161287727|NCT00476190|582433707|FG000|Overall Study|Other|9|||
161287728|NCT00476190|582433708|FG001|Overall Study|Other|10|||
161287729|NCT04782076|582433709|FG000|Overall Study|Family Emergency|1|||
161287730|NCT01042093|582433713|FG000|Overall Study|Protocol Violation|2|||
161287731|NCT01042093|582433714|FG001|Overall Study|Protocol Violation|2|||
161287732|NCT01042093|582433715|FG002|Overall Study|Protocol Violation|2|||
161287733|NCT01042093|582433716|FG003|Overall Study|Protocol Violation|3|||
161078586|NCT01240915|581677028|FG000|Overall Study|Withdrawal by Subject|2|||
161078587|NCT01240915|581677029|FG001|Overall Study|Withdrawal by Subject|1|||
161078588|NCT01240915|581677030|FG002|Overall Study|Withdrawal by Subject|0|||
161078589|NCT01240915|581677031|FG003|Overall Study|Withdrawal by Subject|2|||
161078590|NCT01240915|581677032|FG004|Overall Study|Withdrawal by Subject|0|||
161078591|NCT01240915|581677033|FG005|Overall Study|Withdrawal by Subject|4|||
161078592|NCT01240915|581677034|FG006|Overall Study|Withdrawal by Subject|2|||
161078593|NCT01240915|581677035|FG007|Overall Study|Withdrawal by Subject|3|||
161078594|NCT01240915|581677036|FG008|Overall Study|Withdrawal by Subject|3|||
161078595|NCT01240915|581677028|FG000|Overall Study|Other|0|||
161078596|NCT01240915|581677029|FG001|Overall Study|Other|0|||
161078597|NCT01240915|581677030|FG002|Overall Study|Other|0|||
161078598|NCT01240915|581677031|FG003|Overall Study|Other|0|||
161078599|NCT01240915|581677032|FG004|Overall Study|Other|2|||
161078600|NCT01240915|581677033|FG005|Overall Study|Other|0|||
161078601|NCT01240915|581677034|FG006|Overall Study|Other|0|||
161078602|NCT01240915|581677035|FG007|Overall Study|Other|0|||
161078603|NCT01240915|581677036|FG008|Overall Study|Other|0|||
161078604|NCT01240915|581677028|FG000|Overall Study|Insufficient Clinical Response|0|||
161078605|NCT01240915|581677029|FG001|Overall Study|Insufficient Clinical Response|0|||
161078606|NCT01240915|581677030|FG002|Overall Study|Insufficient Clinical Response|0|||
161078607|NCT01240915|581677031|FG003|Overall Study|Insufficient Clinical Response|0|||
161078608|NCT01240915|581677032|FG004|Overall Study|Insufficient Clinical Response|1|||
161078609|NCT01240915|581677033|FG005|Overall Study|Insufficient Clinical Response|3|||
161078610|NCT01240915|581677034|FG006|Overall Study|Insufficient Clinical Response|6|||
161078611|NCT01240915|581677035|FG007|Overall Study|Insufficient Clinical Response|0|||
161160618|NCT02924688|581968821|FG005|Overall Study|Lack of Efficacy|1|||
161287734|NCT01042093|582433713|FG000|Overall Study|Withdrawal by Subject|0|||
161287735|NCT01042093|582433714|FG001|Overall Study|Withdrawal by Subject|0|||
161287736|NCT01042093|582433715|FG002|Overall Study|Withdrawal by Subject|0|||
161160619|NCT02924688|581968816|FG000|Overall Study|Protocol Violation|3|||
161160620|NCT02924688|581968817|FG001|Overall Study|Protocol Violation|7|||
161160621|NCT02924688|581968818|FG002|Overall Study|Protocol Violation|5|||
161078612|NCT01240915|581677036|FG008|Overall Study|Insufficient Clinical Response|3|||
161160622|NCT02924688|581968819|FG003|Overall Study|Protocol Violation|6|||
161287737|NCT01042093|582433716|FG003|Overall Study|Withdrawal by Subject|1|||
161160623|NCT02924688|581968820|FG004|Overall Study|Protocol Violation|2|||
161160624|NCT02924688|581968821|FG005|Overall Study|Protocol Violation|2|||
161160625|NCT02924688|581968816|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
161160626|NCT02924688|581968817|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
161160627|NCT02924688|581968818|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
161160628|NCT02924688|581968819|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
161160629|NCT02924688|581968820|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
161160630|NCT02924688|581968821|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
161160631|NCT02924688|581968816|FG000|Overall Study|Lost to Follow-up|2|||
161160632|NCT02924688|581968817|FG001|Overall Study|Lost to Follow-up|4|||
161160633|NCT02924688|581968818|FG002|Overall Study|Lost to Follow-up|2|||
161160634|NCT02924688|581968819|FG003|Overall Study|Lost to Follow-up|4|||
161160635|NCT02924688|581968820|FG004|Overall Study|Lost to Follow-up|2|||
161160636|NCT02924688|581968821|FG005|Overall Study|Lost to Follow-up|4|||
161160637|NCT02924688|581968816|FG000|Overall Study|Physician Decision|2|||
161160638|NCT02924688|581968817|FG001|Overall Study|Physician Decision|1|||
161160639|NCT02924688|581968818|FG002|Overall Study|Physician Decision|0|||
161160640|NCT02924688|581968819|FG003|Overall Study|Physician Decision|1|||
161160641|NCT02924688|581968820|FG004|Overall Study|Physician Decision|1|||
161160642|NCT02924688|581968821|FG005|Overall Study|Physician Decision|1|||
161160643|NCT02924688|581968816|FG000|Overall Study|Withdrawal by Subject|14|||
161160644|NCT02924688|581968817|FG001|Overall Study|Withdrawal by Subject|13|||
161160645|NCT02924688|581968818|FG002|Overall Study|Withdrawal by Subject|9|||
161160646|NCT02924688|581968819|FG003|Overall Study|Withdrawal by Subject|12|||
161160647|NCT02924688|581968820|FG004|Overall Study|Withdrawal by Subject|13|||
161160648|NCT02924688|581968821|FG005|Overall Study|Withdrawal by Subject|14|||
161160649|NCT03072719|581968822|FG000|Overall Study|Adverse Event|1|||
161160650|NCT03072719|581968823|FG001|Overall Study|Adverse Event|1|||
161160651|NCT01104584|581968826|FG000|Overall Study|Study drug never administered|21|||
161160652|NCT01104584|581968826|FG000|Overall Study|Study prematurely discontinued|2|||
161160653|NCT02370498|581968827|FG000|Overall Study|Adverse Event|10|||
161160654|NCT02370498|581968828|FG001|Overall Study|Adverse Event|8|||
161160655|NCT02370498|581968827|FG000|Overall Study|Death|263|||
161160656|NCT02370498|581968828|FG001|Overall Study|Death|265|||
161160657|NCT02370498|581968827|FG000|Overall Study|Protocol Violation|1|||
161160658|NCT02370498|581968828|FG001|Overall Study|Protocol Violation|2|||
161160659|NCT02370498|581968827|FG000|Overall Study|Withdrawal by Subject|7|||
161160660|NCT02370498|581968828|FG001|Overall Study|Withdrawal by Subject|12|||
161160661|NCT02370498|581968827|FG000|Overall Study|Sponsor's decision|15|||
161160662|NCT02370498|581968828|FG001|Overall Study|Sponsor's decision|9|||
161160663|NCT04017442|581968829|FG000|Overall Study|Withdrawal by Subject|0|||
161160664|NCT04017442|581968830|FG001|Overall Study|Withdrawal by Subject|3|||
161160665|NCT04017442|581968829|FG000|Overall Study|Lost to Follow-up|21|||
161160666|NCT04017442|581968830|FG001|Overall Study|Lost to Follow-up|19|||
161160667|NCT03225716|581968834|FG000|Overall Study|Withdrawal by Subject|2|||
161160668|NCT03225716|581968835|FG001|Overall Study|Withdrawal by Subject|2|||
161160669|NCT03225716|581968836|FG002|Overall Study|Withdrawal by Subject|0|||
161160670|NCT03225716|581968834|FG000|Overall Study|Lack of Efficacy|1|||
161160671|NCT03225716|581968835|FG001|Overall Study|Lack of Efficacy|0|||
161160672|NCT03225716|581968836|FG002|Overall Study|Lack of Efficacy|0|||
161160673|NCT03225716|581968834|FG000|Overall Study|Adverse Event|2|||
161160674|NCT03225716|581968835|FG001|Overall Study|Adverse Event|0|||
161160675|NCT03225716|581968836|FG002|Overall Study|Adverse Event|1|||
161160676|NCT03225716|581968834|FG000|Overall Study|Study early termination by Sponsor|0|||
161160677|NCT03225716|581968835|FG001|Overall Study|Study early termination by Sponsor|0|||
161160678|NCT03225716|581968836|FG002|Overall Study|Study early termination by Sponsor|2|||
161160679|NCT00848250|581968837|FG000|Overall Study|surgery was completed without cardiopulm|0|||
161346440|NCT03765073|582653299|FG014|Stage 3|Adverse Event|0|||
161346441|NCT03765073|582653300|FG015|Stage 3|Adverse Event|0|||
161160680|NCT00848250|581968838|FG001|Overall Study|surgery was completed without cardiopulm|1|||
161160681|NCT02226146|581968849|FG000|Overall Study|Received rescue therapy|1|||
161346442|NCT03765073|582653301|FG016|Stage 3|Adverse Event|0|||
161160682|NCT02226146|581968849|FG000|Overall Study|Withdrawal by Subject|2|||
161160683|NCT05464836|581968850|FG000|Overall Study|Progression of Disease|1|||
161160684|NCT05464836|581968850|FG000|Overall Study|Physician Decision|1|||
161160685|NCT01522976|581968851|FG000|Overall Study|Ineligible|4|||
161160686|NCT01522976|581968852|FG001|Overall Study|Ineligible|0|||
161160687|NCT01522976|581968853|FG002|Overall Study|Ineligible|1|||
161160688|NCT01522976|581968851|FG000|Overall Study|Death|7|||
161160689|NCT01522976|581968852|FG001|Overall Study|Death|6|||
161160690|NCT01522976|581968853|FG002|Overall Study|Death|2|||
161160691|NCT01522976|581968851|FG000|Overall Study|Still on treatment|9|||
161160692|NCT01522976|581968852|FG001|Overall Study|Still on treatment|9|||
161160693|NCT01522976|581968853|FG002|Overall Study|Still on treatment|6|||
161160694|NCT01522976|581968851|FG000|Overall Study|Disease progression|28|||
161160695|NCT01522976|581968852|FG001|Overall Study|Disease progression|30|||
161160696|NCT01522976|581968853|FG002|Overall Study|Disease progression|25|||
161160697|NCT01522976|581968851|FG000|Overall Study|Adverse Event|17|||
161160698|NCT01522976|581968852|FG001|Overall Study|Adverse Event|7|||
161346443|NCT03765073|582653302|FG017|Stage 3|Adverse Event|0|||
161346444|NCT03765073|582653303|FG018|Stage 3|Adverse Event|1|||
161346445|NCT03765073|582653304|FG019|Stage 3|Adverse Event|0|||
161346446|NCT03765073|582653305|FG020|Stage 3|Adverse Event|0|||
161346447|NCT03765073|582653285|FG000|Stage 3|Death|0|||
161346448|NCT03765073|582653286|FG001|Stage 3|Death|0|||
161346449|NCT03765073|582653287|FG002|Stage 3|Death|0|||
161346450|NCT03765073|582653288|FG003|Stage 3|Death|0|||
161346451|NCT03765073|582653289|FG004|Stage 3|Death|0|||
161346452|NCT03765073|582653290|FG005|Stage 3|Death|0|||
161346453|NCT03765073|582653291|FG006|Stage 3|Death|0|||
161346454|NCT03765073|582653292|FG007|Stage 3|Death|0|||
161346455|NCT03765073|582653293|FG008|Stage 3|Death|0|||
161346456|NCT03765073|582653294|FG009|Stage 3|Death|0|||
161346457|NCT03765073|582653295|FG010|Stage 3|Death|0|||
161346458|NCT03765073|582653296|FG011|Stage 3|Death|0|||
161346459|NCT03765073|582653297|FG012|Stage 3|Death|0|||
161346460|NCT03765073|582653298|FG013|Stage 3|Death|0|||
161346461|NCT03765073|582653299|FG014|Stage 3|Death|0|||
161346462|NCT03765073|582653300|FG015|Stage 3|Death|0|||
161346463|NCT03765073|582653301|FG016|Stage 3|Death|0|||
161346464|NCT03765073|582653302|FG017|Stage 3|Death|0|||
161346465|NCT03765073|582653303|FG018|Stage 3|Death|0|||
161346466|NCT03765073|582653304|FG019|Stage 3|Death|3|||
161346467|NCT03765073|582653305|FG020|Stage 3|Death|2|||
161346468|NCT03765073|582653285|FG000|Stage 3|Lost to Follow-up|0|||
161346469|NCT03765073|582653286|FG001|Stage 3|Lost to Follow-up|0|||
161346470|NCT03765073|582653287|FG002|Stage 3|Lost to Follow-up|0|||
161346471|NCT03765073|582653288|FG003|Stage 3|Lost to Follow-up|0|||
161346472|NCT03765073|582653289|FG004|Stage 3|Lost to Follow-up|0|||
161346473|NCT03765073|582653290|FG005|Stage 3|Lost to Follow-up|0|||
161346474|NCT03765073|582653291|FG006|Stage 3|Lost to Follow-up|0|||
161346475|NCT03765073|582653292|FG007|Stage 3|Lost to Follow-up|0|||
161346476|NCT03765073|582653293|FG008|Stage 3|Lost to Follow-up|0|||
161346477|NCT03765073|582653294|FG009|Stage 3|Lost to Follow-up|0|||
161346478|NCT03765073|582653295|FG010|Stage 3|Lost to Follow-up|0|||
161346479|NCT03765073|582653296|FG011|Stage 3|Lost to Follow-up|0|||
161346480|NCT03765073|582653297|FG012|Stage 3|Lost to Follow-up|0|||
161346481|NCT03765073|582653298|FG013|Stage 3|Lost to Follow-up|0|||
161346482|NCT03765073|582653299|FG014|Stage 3|Lost to Follow-up|0|||
161346483|NCT03765073|582653300|FG015|Stage 3|Lost to Follow-up|0|||
161346484|NCT03765073|582653301|FG016|Stage 3|Lost to Follow-up|0|||
161346485|NCT03765073|582653302|FG017|Stage 3|Lost to Follow-up|8|||
161346486|NCT03765073|582653303|FG018|Stage 3|Lost to Follow-up|5|||
161346487|NCT03765073|582653304|FG019|Stage 3|Lost to Follow-up|7|||
161160699|NCT01522976|581968853|FG002|Overall Study|Adverse Event|18|||
161160700|NCT01522976|581968851|FG000|Overall Study|Refusal unrelated to adverse event|10|||
161160701|NCT01522976|581968852|FG001|Overall Study|Refusal unrelated to adverse event|13|||
161160702|NCT01522976|581968853|FG002|Overall Study|Refusal unrelated to adverse event|14|||
161160703|NCT01522976|581968851|FG000|Overall Study|Not protocol specified|22|||
161160704|NCT01522976|581968852|FG001|Overall Study|Not protocol specified|27|||
161160705|NCT01522976|581968853|FG002|Overall Study|Not protocol specified|27|||
161160706|NCT02883049|581968854|FG000|Induction|Adverse Event|52|||
161160707|NCT02883049|581968855|FG001|Induction|Adverse Event|2|||
161160708|NCT02883049|581968856|FG002|Induction|Adverse Event|0|||
161160709|NCT02883049|581968857|FG003|Induction|Adverse Event|0|||
161160710|NCT02883049|581968858|FG004|Induction|Adverse Event|0|||
161346488|NCT03765073|582653305|FG020|Stage 3|Lost to Follow-up|4|||
161346489|NCT03765073|582653285|FG000|Stage 3|No longer meets eligibility criteria|0|||
161346490|NCT03765073|582653286|FG001|Stage 3|No longer meets eligibility criteria|0|||
161160711|NCT02883049|581968859|FG005|Induction|Adverse Event|0|||
161346491|NCT03765073|582653287|FG002|Stage 3|No longer meets eligibility criteria|0|||
161160712|NCT02883049|581968860|FG006|Induction|Adverse Event|0|||
161160713|NCT02883049|581968861|FG007|Induction|Adverse Event|0|||
161160714|NCT02883049|581968862|FG008|Induction|Adverse Event|0|||
161160715|NCT02883049|581968863|FG009|Induction|Adverse Event|0|||
161160716|NCT02883049|581968864|FG010|Induction|Adverse Event|0|||
161346492|NCT03765073|582653288|FG003|Stage 3|No longer meets eligibility criteria|0|||
161160717|NCT02883049|581968865|FG011|Induction|Adverse Event|0|||
161160718|NCT02883049|581968866|FG012|Induction|Adverse Event|0|||
161346493|NCT03765073|582653289|FG004|Stage 3|No longer meets eligibility criteria|0|||
161346494|NCT03765073|582653290|FG005|Stage 3|No longer meets eligibility criteria|0|||
161346495|NCT03765073|582653291|FG006|Stage 3|No longer meets eligibility criteria|0|||
161346496|NCT03765073|582653292|FG007|Stage 3|No longer meets eligibility criteria|0|||
161160719|NCT02883049|581968867|FG013|Induction|Adverse Event|0|||
161160720|NCT02883049|581968868|FG014|Induction|Adverse Event|0|||
161160721|NCT02883049|581968869|FG015|Induction|Adverse Event|0|||
161346497|NCT03765073|582653293|FG008|Stage 3|No longer meets eligibility criteria|0|||
161346498|NCT03765073|582653294|FG009|Stage 3|No longer meets eligibility criteria|0|||
161346499|NCT03765073|582653295|FG010|Stage 3|No longer meets eligibility criteria|0|||
161346500|NCT03765073|582653296|FG011|Stage 3|No longer meets eligibility criteria|0|||
161346501|NCT03765073|582653297|FG012|Stage 3|No longer meets eligibility criteria|0|||
161346502|NCT03765073|582653298|FG013|Stage 3|No longer meets eligibility criteria|0|||
161346503|NCT03765073|582653299|FG014|Stage 3|No longer meets eligibility criteria|0|||
161160722|NCT02883049|581968854|FG000|Induction|Death|76|||
161160723|NCT02883049|581968855|FG001|Induction|Death|8|||
161160724|NCT02883049|581968856|FG002|Induction|Death|0|||
161160725|NCT02883049|581968857|FG003|Induction|Death|0|||
161160726|NCT02883049|581968858|FG004|Induction|Death|0|||
161160727|NCT02883049|581968859|FG005|Induction|Death|0|||
161160728|NCT02883049|581968860|FG006|Induction|Death|0|||
161160729|NCT02883049|581968861|FG007|Induction|Death|0|||
161160730|NCT02883049|581968862|FG008|Induction|Death|0|||
161160731|NCT02883049|581968863|FG009|Induction|Death|0|||
161160732|NCT02883049|581968864|FG010|Induction|Death|0|||
161160733|NCT02883049|581968865|FG011|Induction|Death|0|||
161160734|NCT02883049|581968866|FG012|Induction|Death|0|||
161160735|NCT02883049|581968867|FG013|Induction|Death|0|||
161160736|NCT02883049|581968868|FG014|Induction|Death|0|||
161160737|NCT02883049|581968869|FG015|Induction|Death|0|||
161160738|NCT02883049|581968854|FG000|Induction|Lost to Follow-up|2|||
161160739|NCT02883049|581968855|FG001|Induction|Lost to Follow-up|0|||
161160740|NCT02883049|581968856|FG002|Induction|Lost to Follow-up|0|||
161160741|NCT02883049|581968857|FG003|Induction|Lost to Follow-up|0|||
161160742|NCT02883049|581968858|FG004|Induction|Lost to Follow-up|0|||
161160743|NCT02883049|581968859|FG005|Induction|Lost to Follow-up|0|||
161160744|NCT02883049|581968860|FG006|Induction|Lost to Follow-up|0|||
161160745|NCT02883049|581968861|FG007|Induction|Lost to Follow-up|0|||
161160746|NCT02883049|581968862|FG008|Induction|Lost to Follow-up|0|||
161160747|NCT02883049|581968863|FG009|Induction|Lost to Follow-up|0|||
161160748|NCT02883049|581968864|FG010|Induction|Lost to Follow-up|0|||
161160749|NCT02883049|581968865|FG011|Induction|Lost to Follow-up|0|||
161160750|NCT02883049|581968866|FG012|Induction|Lost to Follow-up|0|||
161160751|NCT02883049|581968867|FG013|Induction|Lost to Follow-up|0|||
161160752|NCT02883049|581968868|FG014|Induction|Lost to Follow-up|0|||
161160753|NCT02883049|581968869|FG015|Induction|Lost to Follow-up|0|||
161160754|NCT02883049|581968854|FG000|Induction|Physician Decision|1407|||
161160755|NCT02883049|581968855|FG001|Induction|Physician Decision|8|||
161160756|NCT02883049|581968856|FG002|Induction|Physician Decision|0|||
161160757|NCT02883049|581968857|FG003|Induction|Physician Decision|0|||
161160758|NCT02883049|581968858|FG004|Induction|Physician Decision|0|||
161160759|NCT02883049|581968859|FG005|Induction|Physician Decision|0|||
161160760|NCT02883049|581968860|FG006|Induction|Physician Decision|0|||
161160761|NCT02883049|581968861|FG007|Induction|Physician Decision|0|||
161160762|NCT02883049|581968862|FG008|Induction|Physician Decision|0|||
161160763|NCT02883049|581968863|FG009|Induction|Physician Decision|0|||
161160764|NCT02883049|581968864|FG010|Induction|Physician Decision|0|||
161160765|NCT02883049|581968865|FG011|Induction|Physician Decision|0|||
161160766|NCT02883049|581968866|FG012|Induction|Physician Decision|0|||
161160767|NCT02883049|581968867|FG013|Induction|Physician Decision|0|||
161160768|NCT02883049|581968868|FG014|Induction|Physician Decision|0|||
161160769|NCT02883049|581968869|FG015|Induction|Physician Decision|0|||
161160770|NCT02883049|581968854|FG000|Induction|Protocol Violation|6|||
161160771|NCT02883049|581968855|FG001|Induction|Protocol Violation|0|||
161160772|NCT02883049|581968856|FG002|Induction|Protocol Violation|0|||
161160773|NCT02883049|581968857|FG003|Induction|Protocol Violation|0|||
161160774|NCT02883049|581968858|FG004|Induction|Protocol Violation|0|||
161160775|NCT02883049|581968859|FG005|Induction|Protocol Violation|0|||
161160776|NCT02883049|581968860|FG006|Induction|Protocol Violation|0|||
161160777|NCT02883049|581968861|FG007|Induction|Protocol Violation|0|||
161160778|NCT02883049|581968862|FG008|Induction|Protocol Violation|0|||
161160779|NCT02883049|581968863|FG009|Induction|Protocol Violation|0|||
161160780|NCT02883049|581968864|FG010|Induction|Protocol Violation|0|||
161160781|NCT02883049|581968865|FG011|Induction|Protocol Violation|0|||
161160782|NCT02883049|581968866|FG012|Induction|Protocol Violation|0|||
161160783|NCT02883049|581968867|FG013|Induction|Protocol Violation|0|||
161160784|NCT02883049|581968868|FG014|Induction|Protocol Violation|0|||
161160785|NCT02883049|581968869|FG015|Induction|Protocol Violation|0|||
161160786|NCT02883049|581968854|FG000|Induction|Withdrawal by Subject|6|||
161160787|NCT02883049|581968855|FG001|Induction|Withdrawal by Subject|0|||
161160788|NCT02883049|581968856|FG002|Induction|Withdrawal by Subject|0|||
161160789|NCT02883049|581968857|FG003|Induction|Withdrawal by Subject|0|||
161160790|NCT02883049|581968858|FG004|Induction|Withdrawal by Subject|0|||
161160791|NCT02883049|581968859|FG005|Induction|Withdrawal by Subject|0|||
161160792|NCT02883049|581968860|FG006|Induction|Withdrawal by Subject|0|||
161160793|NCT02883049|581968861|FG007|Induction|Withdrawal by Subject|0|||
161160794|NCT02883049|581968862|FG008|Induction|Withdrawal by Subject|0|||
161160795|NCT02883049|581968863|FG009|Induction|Withdrawal by Subject|0|||
161160796|NCT02883049|581968864|FG010|Induction|Withdrawal by Subject|0|||
161160797|NCT02883049|581968865|FG011|Induction|Withdrawal by Subject|0|||
161160798|NCT02883049|581968866|FG012|Induction|Withdrawal by Subject|0|||
161160799|NCT02883049|581968867|FG013|Induction|Withdrawal by Subject|0|||
161160800|NCT02883049|581968868|FG014|Induction|Withdrawal by Subject|0|||
161160801|NCT02883049|581968869|FG015|Induction|Withdrawal by Subject|0|||
161160802|NCT02883049|581968854|FG000|Induction|Ineligible|35|||
161160803|NCT02883049|581968855|FG001|Induction|Ineligible|1|||
161160804|NCT02883049|581968856|FG002|Induction|Ineligible|0|||
161160805|NCT02883049|581968857|FG003|Induction|Ineligible|0|||
161160806|NCT02883049|581968858|FG004|Induction|Ineligible|0|||
161160807|NCT02883049|581968859|FG005|Induction|Ineligible|0|||
161160808|NCT02883049|581968860|FG006|Induction|Ineligible|0|||
161160809|NCT02883049|581968861|FG007|Induction|Ineligible|0|||
161160810|NCT02883049|581968862|FG008|Induction|Ineligible|0|||
161160811|NCT02883049|581968863|FG009|Induction|Ineligible|0|||
161160812|NCT02883049|581968864|FG010|Induction|Ineligible|0|||
161160813|NCT02883049|581968865|FG011|Induction|Ineligible|0|||
161160814|NCT02883049|581968866|FG012|Induction|Ineligible|0|||
161160815|NCT02883049|581968867|FG013|Induction|Ineligible|0|||
161160816|NCT02883049|581968868|FG014|Induction|Ineligible|0|||
161160817|NCT02883049|581968869|FG015|Induction|Ineligible|0|||
161160818|NCT02883049|581968854|FG000|Induction|Refusal of further protocol therapy|466|||
161160819|NCT02883049|581968855|FG001|Induction|Refusal of further protocol therapy|2|||
161160820|NCT02883049|581968856|FG002|Induction|Refusal of further protocol therapy|0|||
161160821|NCT02883049|581968857|FG003|Induction|Refusal of further protocol therapy|0|||
161160822|NCT02883049|581968858|FG004|Induction|Refusal of further protocol therapy|0|||
161160823|NCT02883049|581968859|FG005|Induction|Refusal of further protocol therapy|0|||
161160824|NCT02883049|581968860|FG006|Induction|Refusal of further protocol therapy|0|||
161160825|NCT02883049|581968861|FG007|Induction|Refusal of further protocol therapy|0|||
161160826|NCT02883049|581968862|FG008|Induction|Refusal of further protocol therapy|0|||
161160827|NCT02883049|581968863|FG009|Induction|Refusal of further protocol therapy|0|||
161160828|NCT02883049|581968864|FG010|Induction|Refusal of further protocol therapy|0|||
161160829|NCT02883049|581968865|FG011|Induction|Refusal of further protocol therapy|0|||
161160830|NCT02883049|581968866|FG012|Induction|Refusal of further protocol therapy|0|||
161160831|NCT02883049|581968867|FG013|Induction|Refusal of further protocol therapy|0|||
161160832|NCT02883049|581968868|FG014|Induction|Refusal of further protocol therapy|0|||
161160833|NCT02883049|581968869|FG015|Induction|Refusal of further protocol therapy|0|||
161160834|NCT02883049|581968854|FG000|Induction|Identified as Ph+ patients|279|||
161160835|NCT02883049|581968855|FG001|Induction|Identified as Ph+ patients|1|||
161160836|NCT02883049|581968856|FG002|Induction|Identified as Ph+ patients|0|||
161160837|NCT02883049|581968857|FG003|Induction|Identified as Ph+ patients|0|||
161160838|NCT02883049|581968858|FG004|Induction|Identified as Ph+ patients|0|||
161160839|NCT02883049|581968859|FG005|Induction|Identified as Ph+ patients|0|||
161160840|NCT02883049|581968860|FG006|Induction|Identified as Ph+ patients|0|||
161160841|NCT02883049|581968861|FG007|Induction|Identified as Ph+ patients|0|||
161160842|NCT02883049|581968862|FG008|Induction|Identified as Ph+ patients|0|||
161160843|NCT02883049|581968863|FG009|Induction|Identified as Ph+ patients|0|||
161160844|NCT02883049|581968864|FG010|Induction|Identified as Ph+ patients|0|||
161160845|NCT02883049|581968865|FG011|Induction|Identified as Ph+ patients|0|||
161160846|NCT02883049|581968866|FG012|Induction|Identified as Ph+ patients|0|||
161160847|NCT02883049|581968867|FG013|Induction|Identified as Ph+ patients|0|||
161160848|NCT02883049|581968868|FG014|Induction|Identified as Ph+ patients|0|||
161160849|NCT02883049|581968869|FG015|Induction|Identified as Ph+ patients|0|||
161160850|NCT02883049|581968854|FG000|Induction|M3 Marrow at Day29|8|||
161160851|NCT02883049|581968855|FG001|Induction|M3 Marrow at Day29|1|||
161160852|NCT02883049|581968856|FG002|Induction|M3 Marrow at Day29|0|||
161160853|NCT02883049|581968857|FG003|Induction|M3 Marrow at Day29|0|||
161160854|NCT02883049|581968858|FG004|Induction|M3 Marrow at Day29|0|||
161160855|NCT02883049|581968859|FG005|Induction|M3 Marrow at Day29|0|||
161160856|NCT02883049|581968860|FG006|Induction|M3 Marrow at Day29|0|||
161160857|NCT02883049|581968861|FG007|Induction|M3 Marrow at Day29|0|||
161160858|NCT02883049|581968862|FG008|Induction|M3 Marrow at Day29|0|||
161160859|NCT02883049|581968863|FG009|Induction|M3 Marrow at Day29|0|||
161160860|NCT02883049|581968864|FG010|Induction|M3 Marrow at Day29|0|||
161160861|NCT02883049|581968865|FG011|Induction|M3 Marrow at Day29|0|||
161160862|NCT02883049|581968866|FG012|Induction|M3 Marrow at Day29|0|||
161160863|NCT02883049|581968867|FG013|Induction|M3 Marrow at Day29|0|||
161160864|NCT02883049|581968868|FG014|Induction|M3 Marrow at Day29|0|||
161160865|NCT02883049|581968869|FG015|Induction|M3 Marrow at Day29|0|||
161160866|NCT02883049|581968854|FG000|Induction|Inevaluable|33|||
161160867|NCT02883049|581968855|FG001|Induction|Inevaluable|1|||
161160868|NCT02883049|581968856|FG002|Induction|Inevaluable|0|||
161160869|NCT02883049|581968857|FG003|Induction|Inevaluable|0|||
161160870|NCT02883049|581968858|FG004|Induction|Inevaluable|0|||
161346504|NCT03765073|582653300|FG015|Stage 3|No longer meets eligibility criteria|0|||
161346505|NCT03765073|582653301|FG016|Stage 3|No longer meets eligibility criteria|0|||
161160871|NCT02883049|581968859|FG005|Induction|Inevaluable|0|||
161160872|NCT02883049|581968860|FG006|Induction|Inevaluable|0|||
161160873|NCT02883049|581968861|FG007|Induction|Inevaluable|0|||
161160874|NCT02883049|581968862|FG008|Induction|Inevaluable|0|||
161160875|NCT02883049|581968863|FG009|Induction|Inevaluable|0|||
161160876|NCT02883049|581968864|FG010|Induction|Inevaluable|0|||
161160877|NCT02883049|581968865|FG011|Induction|Inevaluable|0|||
161160878|NCT02883049|581968866|FG012|Induction|Inevaluable|0|||
161160879|NCT02883049|581968867|FG013|Induction|Inevaluable|0|||
161160880|NCT02883049|581968868|FG014|Induction|Inevaluable|0|||
161346506|NCT03765073|582653302|FG017|Stage 3|No longer meets eligibility criteria|0|||
161160881|NCT02883049|581968869|FG015|Induction|Inevaluable|0|||
161287738|NCT02189837|582433717|FG000|Overall Study|Withdrawal by Subject|2|||
161287739|NCT02189837|582433718|FG001|Overall Study|Withdrawal by Subject|1|||
161287740|NCT02189837|582433719|FG002|Overall Study|Withdrawal by Subject|3|||
161287741|NCT02189837|582433720|FG003|Overall Study|Withdrawal by Subject|1|||
161287742|NCT02189837|582433717|FG000|Overall Study|Sponsor Decision|0|||
161287743|NCT02189837|582433718|FG001|Overall Study|Sponsor Decision|0|||
161287744|NCT02189837|582433719|FG002|Overall Study|Sponsor Decision|0|||
161287745|NCT02189837|582433720|FG003|Overall Study|Sponsor Decision|1|||
161287746|NCT04052620|582433721|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
161287747|NCT04052620|582433722|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
161287748|NCT04052620|582433721|FG000|Overall Study|Withdrawal by Subject|1|||
161287749|NCT04052620|582433722|FG001|Overall Study|Withdrawal by Subject|0|||
161287750|NCT04052620|582433721|FG000|Overall Study|Lost to Follow-up|1|||
161287751|NCT04052620|582433722|FG001|Overall Study|Lost to Follow-up|1|||
161287752|NCT04052620|582433721|FG000|Overall Study|Adverse Event|1|||
161287753|NCT04052620|582433722|FG001|Overall Study|Adverse Event|0|||
161287754|NCT04052620|582433721|FG000|Overall Study|Subject did not meet study Criteria|0|||
161287755|NCT04052620|582433722|FG001|Overall Study|Subject did not meet study Criteria|1|||
161287756|NCT04052620|582433721|FG000|Overall Study|Screened failure, randomized by mistake|0|||
161287757|NCT04052620|582433722|FG001|Overall Study|Screened failure, randomized by mistake|1|||
161287758|NCT04052620|582433721|FG000|Overall Study|Personal reasons|2|||
161287759|NCT04052620|582433722|FG001|Overall Study|Personal reasons|4|||
161287760|NCT04052620|582433721|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
161287761|NCT04052620|582433722|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
161287762|NCT03552380|582433724|FG000|Study Treatment|Disease Progression|3|||
161287763|NCT03552380|582433725|FG001|Study Treatment|Disease Progression|4|||
161287764|NCT03552380|582433724|FG000|Study Treatment|Adverse Event|2|||
161287765|NCT03552380|582433725|FG001|Study Treatment|Adverse Event|2|||
161287766|NCT03552380|582433724|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
161287767|NCT03552380|582433725|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
161287768|NCT03552380|582433724|FG000|Follow up|Death|3|||
161287769|NCT03552380|582433725|FG001|Follow up|Death|4|||
161287770|NCT03552380|582433724|FG000|Follow up|Site IRB terminated|0|||
161287771|NCT03552380|582433725|FG001|Follow up|Site IRB terminated|1|||
161287772|NCT01245283|582433726|FG000|Overall Study|Lost to Follow-up|14|||
161287773|NCT01245283|582433727|FG001|Overall Study|Lost to Follow-up|11|||
161287774|NCT01245283|582433728|FG002|Overall Study|Lost to Follow-up|11|||
161287775|NCT03567980|582433737|FG000|Overall Study|Adverse Event|1|||
161287776|NCT01610492|582433738|FG000|Overall Study|Adverse Event|1|||
161287777|NCT01610492|582433738|FG000|Overall Study|Lack of Efficacy|3|||
161287778|NCT01610492|582433738|FG000|Overall Study|Other: Reached stopping criteria|1|||
161287779|NCT01610492|582433738|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
161287780|NCT03093259|582433742|FG000|Overall Study|Adverse Event|1|||
161287781|NCT03093259|582433743|FG001|Overall Study|Adverse Event|0|||
161287782|NCT03093259|582433742|FG000|Overall Study|Withdrawal by Subject|1|||
161287783|NCT03093259|582433743|FG001|Overall Study|Withdrawal by Subject|0|||
161287784|NCT02575833|582433744|FG000|Overall Study|Withdrawal by Subject|0|||
161287785|NCT02575833|582433745|FG001|Overall Study|Withdrawal by Subject|1|||
161287786|NCT02575833|582433744|FG000|Overall Study|Lost to Follow-up|1|||
161287787|NCT02575833|582433745|FG001|Overall Study|Lost to Follow-up|0|||
161287788|NCT01757275|582433746|FG000|Overall Study|Lost to Follow-up|1|||
161287789|NCT01757275|582433747|FG001|Overall Study|Lost to Follow-up|2|||
161287790|NCT01757275|582433746|FG000|Overall Study|Adverse Event|3|||
161287791|NCT01757275|582433747|FG001|Overall Study|Adverse Event|3|||
161287792|NCT01757275|582433746|FG000|Overall Study|Withdrawal by Subject|2|||
161287793|NCT01757275|582433747|FG001|Overall Study|Withdrawal by Subject|4|||
161287794|NCT01757275|582433746|FG000|Overall Study|Not treated|3|||
161287795|NCT01757275|582433747|FG001|Overall Study|Not treated|4|||
161287796|NCT01821807|582433748|FG000|Overall Study|Lost to Follow-up|3|||
161287797|NCT01821807|582433749|FG001|Overall Study|Lost to Follow-up|1|||
161287798|NCT02633787|582433752|FG000|Overall Study|Withdrawal by Subject|1|||
161287799|NCT00550459|582433753|FG000|Overall Study|Adverse Event|0|||
161287800|NCT00550459|582433754|FG001|Overall Study|Adverse Event|2|||
161287801|NCT00550459|582433753|FG000|Overall Study|Withdrawal by Subject|1|||
161287802|NCT00550459|582433754|FG001|Overall Study|Withdrawal by Subject|1|||
161346507|NCT03765073|582653303|FG018|Stage 3|No longer meets eligibility criteria|1|||
161287803|NCT01401452|582433755|FG000|Overall Study|Adverse reaction|9|||
161287804|NCT01401452|582433755|FG000|Overall Study|Lost to Follow-up|12|||
161287805|NCT01401452|582433755|FG000|Overall Study|Lack of Efficacy|30|||
161287806|NCT01401452|582433755|FG000|Overall Study|Participant developed breast cancer|1|||
161287807|NCT01401452|582433755|FG000|Overall Study|Tx stopped due to financial reasons|1|||
161287808|NCT01401452|582433755|FG000|Overall Study|Tx stopped by psychiatrist|1|||
161287809|NCT01401452|582433755|FG000|Overall Study|No more visits within the 36 wk followup|4|||
161287810|NCT01401452|582433755|FG000|Overall Study|Subject did not come to follow up visits|2|||
161287811|NCT01401452|582433755|FG000|Overall Study|Subject didn't return for routine visits|1|||
161160882|NCT02883049|581968854|FG000|Induction|Identified as VHR at end of Induction|244|||
161160883|NCT02883049|581968855|FG001|Induction|Identified as VHR at end of Induction|0|||
161160884|NCT02883049|581968856|FG002|Induction|Identified as VHR at end of Induction|0|||
161160885|NCT02883049|581968857|FG003|Induction|Identified as VHR at end of Induction|0|||
161160886|NCT02883049|581968858|FG004|Induction|Identified as VHR at end of Induction|0|||
161160887|NCT02883049|581968859|FG005|Induction|Identified as VHR at end of Induction|0|||
161160888|NCT02883049|581968860|FG006|Induction|Identified as VHR at end of Induction|0|||
161160889|NCT02883049|581968861|FG007|Induction|Identified as VHR at end of Induction|0|||
161160890|NCT02883049|581968862|FG008|Induction|Identified as VHR at end of Induction|0|||
161160891|NCT02883049|581968863|FG009|Induction|Identified as VHR at end of Induction|0|||
161160892|NCT02883049|581968864|FG010|Induction|Identified as VHR at end of Induction|0|||
161160893|NCT02883049|581968865|FG011|Induction|Identified as VHR at end of Induction|0|||
161160894|NCT02883049|581968866|FG012|Induction|Identified as VHR at end of Induction|0|||
161160895|NCT02883049|581968867|FG013|Induction|Identified as VHR at end of Induction|0|||
161160896|NCT02883049|581968868|FG014|Induction|Identified as VHR at end of Induction|0|||
161160897|NCT02883049|581968869|FG015|Induction|Identified as VHR at end of Induction|0|||
161160898|NCT02883049|581968854|FG000|Induction|Moved to another non-COG institution|3|||
161160899|NCT02883049|581968855|FG001|Induction|Moved to another non-COG institution|0|||
161160900|NCT02883049|581968856|FG002|Induction|Moved to another non-COG institution|0|||
161160901|NCT02883049|581968857|FG003|Induction|Moved to another non-COG institution|0|||
161160902|NCT02883049|581968858|FG004|Induction|Moved to another non-COG institution|0|||
161160903|NCT02883049|581968859|FG005|Induction|Moved to another non-COG institution|0|||
161160904|NCT02883049|581968860|FG006|Induction|Moved to another non-COG institution|0|||
161160905|NCT02883049|581968861|FG007|Induction|Moved to another non-COG institution|0|||
161160906|NCT02883049|581968862|FG008|Induction|Moved to another non-COG institution|0|||
161160907|NCT02883049|581968863|FG009|Induction|Moved to another non-COG institution|0|||
161160908|NCT02883049|581968864|FG010|Induction|Moved to another non-COG institution|0|||
161160909|NCT02883049|581968865|FG011|Induction|Moved to another non-COG institution|0|||
161160910|NCT02883049|581968866|FG012|Induction|Moved to another non-COG institution|0|||
161160911|NCT02883049|581968867|FG013|Induction|Moved to another non-COG institution|0|||
161160912|NCT02883049|581968868|FG014|Induction|Moved to another non-COG institution|0|||
161160913|NCT02883049|581968869|FG015|Induction|Moved to another non-COG institution|0|||
161160914|NCT02883049|581968854|FG000|Induction|Randomization closed|41|||
161160915|NCT02883049|581968855|FG001|Induction|Randomization closed|0|||
161160916|NCT02883049|581968856|FG002|Induction|Randomization closed|0|||
161160917|NCT02883049|581968857|FG003|Induction|Randomization closed|0|||
161160918|NCT02883049|581968858|FG004|Induction|Randomization closed|0|||
161160919|NCT02883049|581968859|FG005|Induction|Randomization closed|0|||
161160920|NCT02883049|581968860|FG006|Induction|Randomization closed|0|||
161160921|NCT02883049|581968861|FG007|Induction|Randomization closed|0|||
161160922|NCT02883049|581968862|FG008|Induction|Randomization closed|0|||
161160923|NCT02883049|581968863|FG009|Induction|Randomization closed|0|||
161160924|NCT02883049|581968864|FG010|Induction|Randomization closed|0|||
161160925|NCT02883049|581968865|FG011|Induction|Randomization closed|0|||
161160926|NCT02883049|581968866|FG012|Induction|Randomization closed|0|||
161160927|NCT02883049|581968867|FG013|Induction|Randomization closed|0|||
161160928|NCT02883049|581968868|FG014|Induction|Randomization closed|0|||
161160929|NCT02883049|581968869|FG015|Induction|Randomization closed|0|||
161160930|NCT02883049|581968854|FG000|Induction|MRD negative|36|||
161160931|NCT02883049|581968855|FG001|Induction|MRD negative|0|||
161160932|NCT02883049|581968856|FG002|Induction|MRD negative|0|||
161160933|NCT02883049|581968857|FG003|Induction|MRD negative|0|||
161160934|NCT02883049|581968858|FG004|Induction|MRD negative|0|||
161160935|NCT02883049|581968859|FG005|Induction|MRD negative|0|||
161160936|NCT02883049|581968860|FG006|Induction|MRD negative|0|||
161160937|NCT02883049|581968861|FG007|Induction|MRD negative|0|||
161160938|NCT02883049|581968862|FG008|Induction|MRD negative|0|||
161160939|NCT02883049|581968863|FG009|Induction|MRD negative|0|||
161160940|NCT02883049|581968864|FG010|Induction|MRD negative|0|||
161160941|NCT02883049|581968865|FG011|Induction|MRD negative|0|||
161160942|NCT02883049|581968866|FG012|Induction|MRD negative|0|||
161160943|NCT02883049|581968867|FG013|Induction|MRD negative|0|||
161160944|NCT02883049|581968868|FG014|Induction|MRD negative|0|||
161160945|NCT02883049|581968869|FG015|Induction|MRD negative|0|||
161160946|NCT02883049|581968854|FG000|Induction|Identified as HR patients|165|||
161160947|NCT02883049|581968855|FG001|Induction|Identified as HR patients|0|||
161160948|NCT02883049|581968856|FG002|Induction|Identified as HR patients|0|||
161160949|NCT02883049|581968857|FG003|Induction|Identified as HR patients|0|||
161160950|NCT02883049|581968858|FG004|Induction|Identified as HR patients|0|||
161160951|NCT02883049|581968859|FG005|Induction|Identified as HR patients|0|||
161160952|NCT02883049|581968860|FG006|Induction|Identified as HR patients|0|||
161160953|NCT02883049|581968861|FG007|Induction|Identified as HR patients|0|||
161160954|NCT02883049|581968862|FG008|Induction|Identified as HR patients|0|||
161160955|NCT02883049|581968863|FG009|Induction|Identified as HR patients|0|||
161160956|NCT02883049|581968864|FG010|Induction|Identified as HR patients|0|||
161160957|NCT02883049|581968865|FG011|Induction|Identified as HR patients|0|||
161160958|NCT02883049|581968866|FG012|Induction|Identified as HR patients|0|||
161160959|NCT02883049|581968867|FG013|Induction|Identified as HR patients|0|||
161160960|NCT02883049|581968868|FG014|Induction|Identified as HR patients|0|||
161160961|NCT02883049|581968869|FG015|Induction|Identified as HR patients|0|||
161160962|NCT02883049|581968854|FG000|Induction|Developed SMN|0|||
161160963|NCT02883049|581968855|FG001|Induction|Developed SMN|1|||
161160964|NCT02883049|581968856|FG002|Induction|Developed SMN|0|||
161160965|NCT02883049|581968857|FG003|Induction|Developed SMN|0|||
161160966|NCT02883049|581968858|FG004|Induction|Developed SMN|0|||
161160967|NCT02883049|581968859|FG005|Induction|Developed SMN|0|||
161160968|NCT02883049|581968860|FG006|Induction|Developed SMN|0|||
161160969|NCT02883049|581968861|FG007|Induction|Developed SMN|0|||
161160970|NCT02883049|581968862|FG008|Induction|Developed SMN|0|||
161160971|NCT02883049|581968863|FG009|Induction|Developed SMN|0|||
161160972|NCT02883049|581968864|FG010|Induction|Developed SMN|0|||
161160973|NCT02883049|581968865|FG011|Induction|Developed SMN|0|||
161160974|NCT02883049|581968866|FG012|Induction|Developed SMN|0|||
161160975|NCT02883049|581968867|FG013|Induction|Developed SMN|0|||
161160976|NCT02883049|581968868|FG014|Induction|Developed SMN|0|||
161160977|NCT02883049|581968869|FG015|Induction|Developed SMN|0|||
161160978|NCT02883049|581968854|FG000|Induction|Enrolled onto another COG study|72|||
161160979|NCT02883049|581968855|FG001|Induction|Enrolled onto another COG study|0|||
161160980|NCT02883049|581968856|FG002|Induction|Enrolled onto another COG study|0|||
161160981|NCT02883049|581968857|FG003|Induction|Enrolled onto another COG study|0|||
161160982|NCT02883049|581968858|FG004|Induction|Enrolled onto another COG study|0|||
161160983|NCT02883049|581968859|FG005|Induction|Enrolled onto another COG study|0|||
161160984|NCT02883049|581968860|FG006|Induction|Enrolled onto another COG study|0|||
161160985|NCT02883049|581968861|FG007|Induction|Enrolled onto another COG study|0|||
161160986|NCT02883049|581968862|FG008|Induction|Enrolled onto another COG study|0|||
161160987|NCT02883049|581968863|FG009|Induction|Enrolled onto another COG study|0|||
161160988|NCT02883049|581968864|FG010|Induction|Enrolled onto another COG study|0|||
161160989|NCT02883049|581968865|FG011|Induction|Enrolled onto another COG study|0|||
161160990|NCT02883049|581968866|FG012|Induction|Enrolled onto another COG study|0|||
161160991|NCT02883049|581968867|FG013|Induction|Enrolled onto another COG study|0|||
161160992|NCT02883049|581968868|FG014|Induction|Enrolled onto another COG study|0|||
161160993|NCT02883049|581968869|FG015|Induction|Enrolled onto another COG study|0|||
161160994|NCT02883049|581968854|FG000|Induction|Incomplete induction data|17|||
161160995|NCT02883049|581968855|FG001|Induction|Incomplete induction data|0|||
161160996|NCT02883049|581968856|FG002|Induction|Incomplete induction data|0|||
161160997|NCT02883049|581968857|FG003|Induction|Incomplete induction data|0|||
161160998|NCT02883049|581968858|FG004|Induction|Incomplete induction data|0|||
161160999|NCT02883049|581968859|FG005|Induction|Incomplete induction data|0|||
161161000|NCT02883049|581968860|FG006|Induction|Incomplete induction data|0|||
161161001|NCT02883049|581968861|FG007|Induction|Incomplete induction data|0|||
161161002|NCT02883049|581968862|FG008|Induction|Incomplete induction data|0|||
161161003|NCT02883049|581968863|FG009|Induction|Incomplete induction data|0|||
161161004|NCT02883049|581968864|FG010|Induction|Incomplete induction data|0|||
161161005|NCT02883049|581968865|FG011|Induction|Incomplete induction data|0|||
161161006|NCT02883049|581968866|FG012|Induction|Incomplete induction data|0|||
161287812|NCT01401452|582433755|FG000|Overall Study|Subject moved to another city|1|||
161287813|NCT01401452|582433755|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
161287814|NCT01401452|582433755|FG000|Overall Study|Psoriatic arthritis|1|||
161287815|NCT01401452|582433755|FG000|Overall Study|Participant stopped Tx|2|||
161287816|NCT01401452|582433755|FG000|Overall Study|Discontinuation for personal reasons|1|||
161287817|NCT01401452|582433755|FG000|Overall Study|Treatment failure|1|||
161287818|NCT01401452|582433755|FG000|Overall Study|Unsatisfactory output|1|||
161287819|NCT01401452|582433755|FG000|Overall Study|Subject withdrew because of Tx success|1|||
161287820|NCT01401452|582433755|FG000|Overall Study|Subject chose to discontinue treatment|1|||
161287821|NCT01401452|582433755|FG000|Overall Study|Participant withdrew consent|1|||
161287822|NCT00584454|582433756|FG000|Overall Study|Adverse Event|1|||
161287823|NCT00584454|582433756|FG000|Overall Study|Relocation|1|||
161287824|NCT00584454|582433756|FG000|Overall Study|Clinical Hold|2|||
161161007|NCT02883049|581968867|FG013|Induction|Incomplete induction data|0|||
161161008|NCT02883049|581968868|FG014|Induction|Incomplete induction data|0|||
161161009|NCT02883049|581968869|FG015|Induction|Incomplete induction data|0|||
161161010|NCT02883049|581968854|FG000|Post Induction|Adverse Event|0|||
161161011|NCT02883049|581968855|FG001|Post Induction|Adverse Event|0|||
161161012|NCT02883049|581968856|FG002|Post Induction|Adverse Event|0|||
161161013|NCT02883049|581968857|FG003|Post Induction|Adverse Event|7|||
161161014|NCT02883049|581968858|FG004|Post Induction|Adverse Event|8|||
161287825|NCT01742897|582433757|FG000|Overall Study|Adverse Event|3|||
161287826|NCT01742897|582433757|FG000|Overall Study|Withdrawal by Subject|1|||
161287827|NCT01742897|582433757|FG000|Overall Study|Other|1|||
161161015|NCT02883049|581968859|FG005|Post Induction|Adverse Event|3|||
161161016|NCT02883049|581968860|FG006|Post Induction|Adverse Event|4|||
161161017|NCT02883049|581968861|FG007|Post Induction|Adverse Event|5|||
161161018|NCT02883049|581968862|FG008|Post Induction|Adverse Event|6|||
161161019|NCT02883049|581968863|FG009|Post Induction|Adverse Event|7|||
161078613|NCT02574845|581677038|FG000|Overall Study|Consent withdrawn further participation|0|||
161078614|NCT02574845|581677039|FG001|Overall Study|Consent withdrawn further participation|0|||
161078615|NCT02574845|581677040|FG002|Overall Study|Consent withdrawn further participation|0|||
161078616|NCT02574845|581677041|FG003|Overall Study|Consent withdrawn further participation|0|||
161078617|NCT02574845|581677042|FG004|Overall Study|Consent withdrawn further participation|1|||
161078618|NCT02574845|581677043|FG005|Overall Study|Consent withdrawn further participation|0|||
161078619|NCT02574845|581677038|FG000|Overall Study|Adverse Event|0|||
161078620|NCT02574845|581677039|FG001|Overall Study|Adverse Event|1|||
161078621|NCT02574845|581677040|FG002|Overall Study|Adverse Event|0|||
161078622|NCT02574845|581677041|FG003|Overall Study|Adverse Event|0|||
161078623|NCT02574845|581677042|FG004|Overall Study|Adverse Event|0|||
161078624|NCT02574845|581677043|FG005|Overall Study|Adverse Event|1|||
161078625|NCT02440425|581677046|FG000|Overall Study|Death likely due to disease progression|1|||
161078626|NCT02440425|581677046|FG000|Overall Study|Withdrawal by Subject|2|||
161078627|NCT02440425|581677046|FG000|Overall Study|Adverse Event|1|||
161078628|NCT02440425|581677046|FG000|Overall Study|Adverse Event/Ineligible|1|||
161078629|NCT03101462|581677047|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
161078630|NCT03101462|581677048|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
161078631|NCT00831129|581677050|FG000|Overall Study|Adverse Event|0|||
161078632|NCT00831129|581677051|FG001|Overall Study|Adverse Event|1|||
161078633|NCT00831129|581677050|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
161078634|NCT00831129|581677051|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
161078635|NCT01669577|581677053|FG000|Overall Study|Death|22|||
161078636|NCT01669577|581677053|FG000|Overall Study|Lost to Follow-up|78|||
161078637|NCT01669577|581677053|FG000|Overall Study|Physician Decision|34|||
161078638|NCT00818779|581677054|FG000|Overall Study|Protocol Violation|1|||
161078639|NCT00818779|581677055|FG001|Overall Study|Protocol Violation|0|||
161078640|NCT00818779|581677054|FG000|Overall Study|Lost to Follow-up|1|||
161078641|NCT00818779|581677055|FG001|Overall Study|Lost to Follow-up|0|||
161078642|NCT00818779|581677054|FG000|Overall Study|Adverse Event|4|||
161078643|NCT00818779|581677055|FG001|Overall Study|Adverse Event|1|||
161078644|NCT01518153|581677056|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
161078645|NCT01518153|581677057|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
161078646|NCT01518153|581677058|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
161078647|NCT01518153|581677056|FG000|Stem Cell Transplant|Death|2|||
161078648|NCT01518153|581677057|FG001|Stem Cell Transplant|Death|0|||
161078649|NCT01518153|581677058|FG002|Stem Cell Transplant|Death|0|||
161078650|NCT01518153|581677056|FG000|Stem Cell Transplant|Secondary graft failure|1|||
161078651|NCT01518153|581677057|FG001|Stem Cell Transplant|Secondary graft failure|0|||
161078652|NCT01518153|581677058|FG002|Stem Cell Transplant|Secondary graft failure|0|||
161078653|NCT01518153|581677056|FG000|Stem Cell Transplant|Adverse Event|1|||
161078654|NCT01518153|581677057|FG001|Stem Cell Transplant|Adverse Event|0|||
161078655|NCT01518153|581677058|FG002|Stem Cell Transplant|Adverse Event|0|||
161078656|NCT01518153|581677056|FG000|Donor Lymphocyte Infusion|Death|0|||
161078657|NCT01518153|581677057|FG001|Donor Lymphocyte Infusion|Death|2|||
161078658|NCT01518153|581677058|FG002|Donor Lymphocyte Infusion|Death|1|||
161078659|NCT03309813|581677059|FG000|Main Randomized Study|Withdrawal by Subject|1|||
161078660|NCT03309813|581677060|FG001|Main Randomized Study|Withdrawal by Subject|0|||
161078661|NCT01327846|581677061|FG000|Core Phase|Subject decision (vital status: missing)|1|||
161078662|NCT01327846|581677062|FG001|Core Phase|Subject decision (vital status: missing)|2|||
161078663|NCT01327846|581677063|FG002|Core Phase|Subject decision (vital status: missing)|2|||
161078664|NCT01327846|581677064|FG003|Core Phase|Subject decision (vital status: missing)|1|||
161078665|NCT01327846|581677061|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
161078666|NCT01327846|581677062|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
161078667|NCT01327846|581677063|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
161078668|NCT01327846|581677064|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
161078669|NCT01327846|581677061|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
161078670|NCT01327846|581677062|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
161078671|NCT01327846|581677063|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
161078672|NCT01327846|581677064|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
161078673|NCT01327846|581677061|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
161078674|NCT01327846|581677062|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
161078675|NCT01327846|581677063|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
161078676|NCT01327846|581677064|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
161078677|NCT01327846|581677061|FG000|Core Phase|Lost to Follow-up|3|||
161078678|NCT01327846|581677062|FG001|Core Phase|Lost to Follow-up|3|||
161078679|NCT01327846|581677063|FG002|Core Phase|Lost to Follow-up|4|||
161078680|NCT01327846|581677064|FG003|Core Phase|Lost to Follow-up|5|||
161078681|NCT01327846|581677061|FG000|Extension Phase|Study terminated by sponsor|1073|||
161078682|NCT01327846|581677062|FG001|Extension Phase|Study terminated by sponsor|1124|||
161078683|NCT01327846|581677063|FG002|Extension Phase|Study terminated by sponsor|1067|||
161078684|NCT01327846|581677064|FG003|Extension Phase|Study terminated by sponsor|1660|||
161078685|NCT01327846|581677061|FG000|Extension Phase|Withdrawal by Subject|20|||
161161020|NCT02883049|581968864|FG010|Post Induction|Adverse Event|2|||
161161021|NCT02883049|581968865|FG011|Post Induction|Adverse Event|2|||
161161022|NCT02883049|581968866|FG012|Post Induction|Adverse Event|0|||
161161023|NCT02883049|581968867|FG013|Post Induction|Adverse Event|0|||
161161024|NCT02883049|581968868|FG014|Post Induction|Adverse Event|5|||
161161025|NCT02883049|581968869|FG015|Post Induction|Adverse Event|2|||
161161026|NCT02883049|581968854|FG000|Post Induction|Death|0|||
161161027|NCT02883049|581968855|FG001|Post Induction|Death|0|||
161161028|NCT02883049|581968856|FG002|Post Induction|Death|0|||
161161029|NCT02883049|581968857|FG003|Post Induction|Death|9|||
161161030|NCT02883049|581968858|FG004|Post Induction|Death|9|||
161161031|NCT02883049|581968859|FG005|Post Induction|Death|0|||
161161032|NCT02883049|581968860|FG006|Post Induction|Death|1|||
161161033|NCT02883049|581968861|FG007|Post Induction|Death|6|||
161161034|NCT02883049|581968862|FG008|Post Induction|Death|5|||
161161035|NCT02883049|581968863|FG009|Post Induction|Death|3|||
161161036|NCT02883049|581968864|FG010|Post Induction|Death|1|||
161161037|NCT02883049|581968865|FG011|Post Induction|Death|0|||
161161038|NCT02883049|581968866|FG012|Post Induction|Death|1|||
161161039|NCT02883049|581968867|FG013|Post Induction|Death|1|||
161161040|NCT02883049|581968868|FG014|Post Induction|Death|10|||
161161041|NCT02883049|581968869|FG015|Post Induction|Death|2|||
161161042|NCT02883049|581968854|FG000|Post Induction|Lost to Follow-up|0|||
161161043|NCT02883049|581968855|FG001|Post Induction|Lost to Follow-up|0|||
161161044|NCT02883049|581968856|FG002|Post Induction|Lost to Follow-up|0|||
161161045|NCT02883049|581968857|FG003|Post Induction|Lost to Follow-up|0|||
161161046|NCT02883049|581968858|FG004|Post Induction|Lost to Follow-up|1|||
161161047|NCT02883049|581968859|FG005|Post Induction|Lost to Follow-up|1|||
161161048|NCT02883049|581968860|FG006|Post Induction|Lost to Follow-up|0|||
161161049|NCT02883049|581968861|FG007|Post Induction|Lost to Follow-up|0|||
161161050|NCT02883049|581968862|FG008|Post Induction|Lost to Follow-up|3|||
161161051|NCT02883049|581968863|FG009|Post Induction|Lost to Follow-up|0|||
161161052|NCT02883049|581968864|FG010|Post Induction|Lost to Follow-up|1|||
161161053|NCT02883049|581968865|FG011|Post Induction|Lost to Follow-up|0|||
161161054|NCT02883049|581968866|FG012|Post Induction|Lost to Follow-up|0|||
161161055|NCT02883049|581968867|FG013|Post Induction|Lost to Follow-up|0|||
161161056|NCT02883049|581968868|FG014|Post Induction|Lost to Follow-up|0|||
161161057|NCT02883049|581968869|FG015|Post Induction|Lost to Follow-up|0|||
161161058|NCT02883049|581968854|FG000|Post Induction|Physician Decision|0|||
161161059|NCT02883049|581968855|FG001|Post Induction|Physician Decision|0|||
161161060|NCT02883049|581968856|FG002|Post Induction|Physician Decision|0|||
161161061|NCT02883049|581968857|FG003|Post Induction|Physician Decision|27|||
161161062|NCT02883049|581968858|FG004|Post Induction|Physician Decision|27|||
161161063|NCT02883049|581968859|FG005|Post Induction|Physician Decision|23|||
161161064|NCT02883049|581968860|FG006|Post Induction|Physician Decision|30|||
161161065|NCT02883049|581968861|FG007|Post Induction|Physician Decision|56|||
161161066|NCT02883049|581968862|FG008|Post Induction|Physician Decision|85|||
161161067|NCT02883049|581968863|FG009|Post Induction|Physician Decision|12|||
161161068|NCT02883049|581968864|FG010|Post Induction|Physician Decision|5|||
161161069|NCT02883049|581968865|FG011|Post Induction|Physician Decision|14|||
161161070|NCT02883049|581968866|FG012|Post Induction|Physician Decision|1|||
161161071|NCT02883049|581968867|FG013|Post Induction|Physician Decision|11|||
161161072|NCT02883049|581968868|FG014|Post Induction|Physician Decision|19|||
161161073|NCT02883049|581968869|FG015|Post Induction|Physician Decision|5|||
161161074|NCT02883049|581968854|FG000|Post Induction|Protocol Violation|0|||
161161075|NCT02883049|581968855|FG001|Post Induction|Protocol Violation|0|||
161161076|NCT02883049|581968856|FG002|Post Induction|Protocol Violation|0|||
161161077|NCT02883049|581968857|FG003|Post Induction|Protocol Violation|0|||
161161078|NCT02883049|581968858|FG004|Post Induction|Protocol Violation|0|||
161161079|NCT02883049|581968859|FG005|Post Induction|Protocol Violation|0|||
161161080|NCT02883049|581968860|FG006|Post Induction|Protocol Violation|0|||
161161081|NCT02883049|581968861|FG007|Post Induction|Protocol Violation|1|||
161161082|NCT02883049|581968862|FG008|Post Induction|Protocol Violation|0|||
161161083|NCT02883049|581968863|FG009|Post Induction|Protocol Violation|0|||
161161084|NCT02883049|581968864|FG010|Post Induction|Protocol Violation|0|||
161161085|NCT02883049|581968865|FG011|Post Induction|Protocol Violation|0|||
161161086|NCT02883049|581968866|FG012|Post Induction|Protocol Violation|0|||
161161087|NCT02883049|581968867|FG013|Post Induction|Protocol Violation|0|||
161161088|NCT02883049|581968868|FG014|Post Induction|Protocol Violation|0|||
161161089|NCT02883049|581968869|FG015|Post Induction|Protocol Violation|0|||
161287828|NCT02404805|582433758|FG000|Overall Study|Withdrawal by Subject|1|||
161161090|NCT02883049|581968854|FG000|Post Induction|Withdrawal by Subject|0|||
161161091|NCT02883049|581968855|FG001|Post Induction|Withdrawal by Subject|0|||
161161092|NCT02883049|581968856|FG002|Post Induction|Withdrawal by Subject|0|||
161161093|NCT02883049|581968857|FG003|Post Induction|Withdrawal by Subject|5|||
161161094|NCT02883049|581968858|FG004|Post Induction|Withdrawal by Subject|2|||
161161095|NCT02883049|581968859|FG005|Post Induction|Withdrawal by Subject|1|||
161161096|NCT02883049|581968860|FG006|Post Induction|Withdrawal by Subject|0|||
161161097|NCT02883049|581968861|FG007|Post Induction|Withdrawal by Subject|0|||
161161098|NCT02883049|581968862|FG008|Post Induction|Withdrawal by Subject|2|||
161161099|NCT02883049|581968863|FG009|Post Induction|Withdrawal by Subject|0|||
161161100|NCT02883049|581968864|FG010|Post Induction|Withdrawal by Subject|1|||
161161101|NCT02883049|581968865|FG011|Post Induction|Withdrawal by Subject|1|||
161161102|NCT02883049|581968866|FG012|Post Induction|Withdrawal by Subject|0|||
161161103|NCT02883049|581968867|FG013|Post Induction|Withdrawal by Subject|0|||
161161104|NCT02883049|581968868|FG014|Post Induction|Withdrawal by Subject|1|||
161161105|NCT02883049|581968869|FG015|Post Induction|Withdrawal by Subject|0|||
161161106|NCT02883049|581968854|FG000|Post Induction|Ineligible|0|||
161161107|NCT02883049|581968855|FG001|Post Induction|Ineligible|0|||
161161108|NCT02883049|581968856|FG002|Post Induction|Ineligible|2|||
161161109|NCT02883049|581968857|FG003|Post Induction|Ineligible|0|||
161161110|NCT02883049|581968858|FG004|Post Induction|Ineligible|0|||
161161111|NCT02883049|581968859|FG005|Post Induction|Ineligible|0|||
161161112|NCT02883049|581968860|FG006|Post Induction|Ineligible|1|||
161161113|NCT02883049|581968861|FG007|Post Induction|Ineligible|0|||
161161114|NCT02883049|581968862|FG008|Post Induction|Ineligible|0|||
161161115|NCT02883049|581968863|FG009|Post Induction|Ineligible|0|||
161161116|NCT02883049|581968864|FG010|Post Induction|Ineligible|1|||
161161117|NCT02883049|581968865|FG011|Post Induction|Ineligible|0|||
161161118|NCT02883049|581968866|FG012|Post Induction|Ineligible|0|||
161161119|NCT02883049|581968867|FG013|Post Induction|Ineligible|0|||
161161120|NCT02883049|581968868|FG014|Post Induction|Ineligible|0|||
161161121|NCT02883049|581968869|FG015|Post Induction|Ineligible|1|||
161161122|NCT02883049|581968854|FG000|Post Induction|Refusal of further protocol therapy|0|||
161161123|NCT02883049|581968855|FG001|Post Induction|Refusal of further protocol therapy|0|||
161161124|NCT02883049|581968856|FG002|Post Induction|Refusal of further protocol therapy|0|||
161161125|NCT02883049|581968857|FG003|Post Induction|Refusal of further protocol therapy|11|||
161161126|NCT02883049|581968858|FG004|Post Induction|Refusal of further protocol therapy|15|||
161161127|NCT02883049|581968859|FG005|Post Induction|Refusal of further protocol therapy|9|||
161161128|NCT02883049|581968860|FG006|Post Induction|Refusal of further protocol therapy|13|||
161161129|NCT02883049|581968861|FG007|Post Induction|Refusal of further protocol therapy|5|||
161161130|NCT02883049|581968862|FG008|Post Induction|Refusal of further protocol therapy|21|||
161161131|NCT02883049|581968863|FG009|Post Induction|Refusal of further protocol therapy|7|||
161161132|NCT02883049|581968864|FG010|Post Induction|Refusal of further protocol therapy|0|||
161161133|NCT02883049|581968865|FG011|Post Induction|Refusal of further protocol therapy|7|||
161161134|NCT02883049|581968866|FG012|Post Induction|Refusal of further protocol therapy|3|||
161161135|NCT02883049|581968867|FG013|Post Induction|Refusal of further protocol therapy|0|||
161161136|NCT02883049|581968868|FG014|Post Induction|Refusal of further protocol therapy|4|||
161161137|NCT02883049|581968869|FG015|Post Induction|Refusal of further protocol therapy|1|||
161161138|NCT02883049|581968854|FG000|Post Induction|Inevaluable|0|||
161161139|NCT02883049|581968855|FG001|Post Induction|Inevaluable|0|||
161161140|NCT02883049|581968856|FG002|Post Induction|Inevaluable|0|||
161161141|NCT02883049|581968857|FG003|Post Induction|Inevaluable|1|||
161161142|NCT02883049|581968858|FG004|Post Induction|Inevaluable|1|||
161161143|NCT02883049|581968859|FG005|Post Induction|Inevaluable|2|||
161161144|NCT02883049|581968860|FG006|Post Induction|Inevaluable|7|||
161161145|NCT02883049|581968861|FG007|Post Induction|Inevaluable|6|||
161161146|NCT02883049|581968862|FG008|Post Induction|Inevaluable|4|||
161161147|NCT02883049|581968863|FG009|Post Induction|Inevaluable|4|||
161161148|NCT02883049|581968864|FG010|Post Induction|Inevaluable|1|||
161161149|NCT02883049|581968865|FG011|Post Induction|Inevaluable|1|||
161161150|NCT02883049|581968866|FG012|Post Induction|Inevaluable|2|||
161161151|NCT02883049|581968867|FG013|Post Induction|Inevaluable|0|||
161161152|NCT02883049|581968868|FG014|Post Induction|Inevaluable|0|||
161161153|NCT02883049|581968869|FG015|Post Induction|Inevaluable|1|||
161161154|NCT02883049|581968854|FG000|Post Induction|Moved to another non-COG institution|0|||
161161155|NCT02883049|581968855|FG001|Post Induction|Moved to another non-COG institution|0|||
161161156|NCT02883049|581968856|FG002|Post Induction|Moved to another non-COG institution|0|||
161161157|NCT02883049|581968857|FG003|Post Induction|Moved to another non-COG institution|0|||
161161158|NCT02883049|581968858|FG004|Post Induction|Moved to another non-COG institution|0|||
161161159|NCT02883049|581968859|FG005|Post Induction|Moved to another non-COG institution|0|||
161161160|NCT02883049|581968860|FG006|Post Induction|Moved to another non-COG institution|0|||
161161161|NCT02883049|581968861|FG007|Post Induction|Moved to another non-COG institution|2|||
161161162|NCT02883049|581968862|FG008|Post Induction|Moved to another non-COG institution|2|||
161161163|NCT02883049|581968863|FG009|Post Induction|Moved to another non-COG institution|0|||
161161164|NCT02883049|581968864|FG010|Post Induction|Moved to another non-COG institution|0|||
161161165|NCT02883049|581968865|FG011|Post Induction|Moved to another non-COG institution|1|||
161161166|NCT02883049|581968866|FG012|Post Induction|Moved to another non-COG institution|0|||
161161167|NCT02883049|581968867|FG013|Post Induction|Moved to another non-COG institution|0|||
161161168|NCT02883049|581968868|FG014|Post Induction|Moved to another non-COG institution|0|||
161161169|NCT02883049|581968869|FG015|Post Induction|Moved to another non-COG institution|0|||
161161170|NCT02883049|581968854|FG000|Post Induction|Randomization closed|0|||
161161171|NCT02883049|581968855|FG001|Post Induction|Randomization closed|0|||
161161172|NCT02883049|581968856|FG002|Post Induction|Randomization closed|0|||
161161173|NCT02883049|581968857|FG003|Post Induction|Randomization closed|0|||
161161174|NCT02883049|581968858|FG004|Post Induction|Randomization closed|0|||
161161175|NCT02883049|581968859|FG005|Post Induction|Randomization closed|0|||
161161176|NCT02883049|581968860|FG006|Post Induction|Randomization closed|0|||
161161177|NCT02883049|581968861|FG007|Post Induction|Randomization closed|20|||
161161178|NCT02883049|581968862|FG008|Post Induction|Randomization closed|0|||
161161179|NCT02883049|581968863|FG009|Post Induction|Randomization closed|0|||
161161180|NCT02883049|581968864|FG010|Post Induction|Randomization closed|0|||
161161181|NCT02883049|581968865|FG011|Post Induction|Randomization closed|0|||
161161182|NCT02883049|581968866|FG012|Post Induction|Randomization closed|0|||
161161183|NCT02883049|581968867|FG013|Post Induction|Randomization closed|0|||
161161184|NCT02883049|581968868|FG014|Post Induction|Randomization closed|0|||
161161185|NCT02883049|581968869|FG015|Post Induction|Randomization closed|0|||
161161186|NCT02883049|581968854|FG000|Post Induction|MRD negative|0|||
161161187|NCT02883049|581968855|FG001|Post Induction|MRD negative|0|||
161161188|NCT02883049|581968856|FG002|Post Induction|MRD negative|0|||
161161189|NCT02883049|581968857|FG003|Post Induction|MRD negative|0|||
161161190|NCT02883049|581968858|FG004|Post Induction|MRD negative|0|||
161161191|NCT02883049|581968859|FG005|Post Induction|MRD negative|0|||
161161192|NCT02883049|581968860|FG006|Post Induction|MRD negative|0|||
161161193|NCT02883049|581968861|FG007|Post Induction|MRD negative|11|||
161161194|NCT02883049|581968862|FG008|Post Induction|MRD negative|0|||
161161195|NCT02883049|581968863|FG009|Post Induction|MRD negative|0|||
161161196|NCT02883049|581968864|FG010|Post Induction|MRD negative|0|||
161161197|NCT02883049|581968865|FG011|Post Induction|MRD negative|0|||
161161198|NCT02883049|581968866|FG012|Post Induction|MRD negative|0|||
161161199|NCT02883049|581968867|FG013|Post Induction|MRD negative|0|||
161161200|NCT02883049|581968868|FG014|Post Induction|MRD negative|0|||
161161201|NCT02883049|581968869|FG015|Post Induction|MRD negative|0|||
161161202|NCT02883049|581968854|FG000|Post Induction|Developed SMN|0|||
161161203|NCT02883049|581968855|FG001|Post Induction|Developed SMN|0|||
161161204|NCT02883049|581968856|FG002|Post Induction|Developed SMN|0|||
161161205|NCT02883049|581968857|FG003|Post Induction|Developed SMN|0|||
161161206|NCT02883049|581968858|FG004|Post Induction|Developed SMN|1|||
161161207|NCT02883049|581968859|FG005|Post Induction|Developed SMN|0|||
161161208|NCT02883049|581968860|FG006|Post Induction|Developed SMN|1|||
161161209|NCT02883049|581968861|FG007|Post Induction|Developed SMN|0|||
161161210|NCT02883049|581968862|FG008|Post Induction|Developed SMN|0|||
161161211|NCT02883049|581968863|FG009|Post Induction|Developed SMN|0|||
161161212|NCT02883049|581968864|FG010|Post Induction|Developed SMN|1|||
161161213|NCT02883049|581968865|FG011|Post Induction|Developed SMN|1|||
161161214|NCT02883049|581968866|FG012|Post Induction|Developed SMN|0|||
161161215|NCT02883049|581968867|FG013|Post Induction|Developed SMN|0|||
161161216|NCT02883049|581968868|FG014|Post Induction|Developed SMN|1|||
161161217|NCT02883049|581968869|FG015|Post Induction|Developed SMN|0|||
161161218|NCT02883049|581968854|FG000|Post Induction|Enrolled onto another COG study|0|||
161161219|NCT02883049|581968855|FG001|Post Induction|Enrolled onto another COG study|0|||
161161220|NCT02883049|581968856|FG002|Post Induction|Enrolled onto another COG study|0|||
161161221|NCT02883049|581968857|FG003|Post Induction|Enrolled onto another COG study|1|||
161161222|NCT02883049|581968858|FG004|Post Induction|Enrolled onto another COG study|1|||
161161223|NCT02883049|581968859|FG005|Post Induction|Enrolled onto another COG study|0|||
161161224|NCT02883049|581968860|FG006|Post Induction|Enrolled onto another COG study|0|||
161161225|NCT02883049|581968861|FG007|Post Induction|Enrolled onto another COG study|4|||
161161226|NCT02883049|581968862|FG008|Post Induction|Enrolled onto another COG study|0|||
161161227|NCT02883049|581968863|FG009|Post Induction|Enrolled onto another COG study|0|||
161161228|NCT02883049|581968864|FG010|Post Induction|Enrolled onto another COG study|0|||
161161229|NCT02883049|581968865|FG011|Post Induction|Enrolled onto another COG study|2|||
161161230|NCT02883049|581968866|FG012|Post Induction|Enrolled onto another COG study|0|||
161161231|NCT02883049|581968867|FG013|Post Induction|Enrolled onto another COG study|1|||
161161232|NCT02883049|581968868|FG014|Post Induction|Enrolled onto another COG study|0|||
161287829|NCT02404805|582433759|FG001|Overall Study|Withdrawal by Subject|0|||
161287830|NCT02404805|582433760|FG002|Overall Study|Withdrawal by Subject|0|||
161161233|NCT02883049|581968869|FG015|Post Induction|Enrolled onto another COG study|0|||
161161234|NCT02883049|581968854|FG000|Post Induction|Recurrent leukemia|0|||
161161235|NCT02883049|581968855|FG001|Post Induction|Recurrent leukemia|0|||
161161236|NCT02883049|581968856|FG002|Post Induction|Recurrent leukemia|0|||
161161237|NCT02883049|581968857|FG003|Post Induction|Recurrent leukemia|17|||
161287831|NCT02404805|582433761|FG003|Overall Study|Withdrawal by Subject|0|||
161287832|NCT02404805|582433762|FG004|Overall Study|Withdrawal by Subject|0|||
161161238|NCT02883049|581968858|FG004|Post Induction|Recurrent leukemia|12|||
161161239|NCT02883049|581968859|FG005|Post Induction|Recurrent leukemia|4|||
161161240|NCT02883049|581968860|FG006|Post Induction|Recurrent leukemia|1|||
161161241|NCT02883049|581968861|FG007|Post Induction|Recurrent leukemia|13|||
161287833|NCT02404805|582433763|FG005|Overall Study|Withdrawal by Subject|0|||
161161242|NCT02883049|581968862|FG008|Post Induction|Recurrent leukemia|27|||
161161243|NCT02883049|581968863|FG009|Post Induction|Recurrent leukemia|5|||
161161244|NCT02883049|581968864|FG010|Post Induction|Recurrent leukemia|3|||
161161245|NCT02883049|581968865|FG011|Post Induction|Recurrent leukemia|12|||
161161246|NCT02883049|581968866|FG012|Post Induction|Recurrent leukemia|1|||
161161247|NCT02883049|581968867|FG013|Post Induction|Recurrent leukemia|1|||
161161248|NCT02883049|581968868|FG014|Post Induction|Recurrent leukemia|9|||
161161249|NCT02883049|581968869|FG015|Post Induction|Recurrent leukemia|3|||
161161250|NCT02883049|581968854|FG000|Post Induction|Induction Failure|0|||
161161251|NCT02883049|581968855|FG001|Post Induction|Induction Failure|0|||
161161252|NCT02883049|581968856|FG002|Post Induction|Induction Failure|0|||
161161253|NCT02883049|581968857|FG003|Post Induction|Induction Failure|0|||
161161254|NCT02883049|581968858|FG004|Post Induction|Induction Failure|0|||
161161255|NCT02883049|581968859|FG005|Post Induction|Induction Failure|0|||
161161256|NCT02883049|581968860|FG006|Post Induction|Induction Failure|0|||
161161257|NCT02883049|581968861|FG007|Post Induction|Induction Failure|2|||
161161258|NCT02883049|581968862|FG008|Post Induction|Induction Failure|2|||
161161259|NCT02883049|581968863|FG009|Post Induction|Induction Failure|0|||
161161260|NCT02883049|581968864|FG010|Post Induction|Induction Failure|0|||
161161261|NCT02883049|581968865|FG011|Post Induction|Induction Failure|0|||
161161262|NCT02883049|581968866|FG012|Post Induction|Induction Failure|0|||
161161263|NCT02883049|581968867|FG013|Post Induction|Induction Failure|2|||
161161264|NCT02883049|581968868|FG014|Post Induction|Induction Failure|0|||
161161265|NCT02883049|581968869|FG015|Post Induction|Induction Failure|0|||
161161266|NCT03421964|581968872|FG000|Overall Study|Lost to Follow-up|11|||
161161267|NCT03421964|581968873|FG001|Overall Study|Lost to Follow-up|21|||
161161268|NCT03421964|581968872|FG000|Overall Study|Withdrawal by Subject|9|||
161161269|NCT03421964|581968873|FG001|Overall Study|Withdrawal by Subject|3|||
161161270|NCT03421964|581968872|FG000|Overall Study|Incarcerated|1|||
161161271|NCT03421964|581968873|FG001|Overall Study|Incarcerated|0|||
161161272|NCT03421964|581968872|FG000|Overall Study|Inpt Treatment Facility|1|||
161161273|NCT03421964|581968873|FG001|Overall Study|Inpt Treatment Facility|1|||
161161274|NCT03421964|581968872|FG000|Overall Study|Virtual Platform Issues|1|||
161161275|NCT03421964|581968873|FG001|Overall Study|Virtual Platform Issues|1|||
161161276|NCT02938585|581968874|FG000|Overall Study|Withdrawal by parent or guardian|0|||
161161277|NCT02938585|581968875|FG001|Overall Study|Withdrawal by parent or guardian|1|||
161161278|NCT02938585|581968876|FG002|Overall Study|Withdrawal by parent or guardian|0|||
161161279|NCT02938585|581968877|FG003|Overall Study|Withdrawal by parent or guardian|0|||
161161280|NCT02938585|581968874|FG000|Overall Study|Withdrawal by Subject|0|||
161161281|NCT02938585|581968875|FG001|Overall Study|Withdrawal by Subject|0|||
161161282|NCT02938585|581968876|FG002|Overall Study|Withdrawal by Subject|0|||
161161283|NCT02938585|581968877|FG003|Overall Study|Withdrawal by Subject|5|||
161161284|NCT02106455|581968885|FG000|Overall Study|Case Report Form Uncollected|6|||
161161285|NCT02106455|581968885|FG000|Overall Study|Protocol Deviation|2|||
161161286|NCT03364608|581968886|FG000|Overall Study|Withdrawal by Subject|4|||
161161287|NCT03364608|581968886|FG000|Overall Study|Protocol Violation|2|||
161161288|NCT03364608|581968886|FG000|Overall Study|Lost to Follow-up|2|||
161161289|NCT03888391|581968889|FG000|Overall Study|Lost to Follow-up|15|||
161161290|NCT02504268|581968892|FG000|Overall Study|Adverse Event|18|||
161161291|NCT02504268|581968893|FG001|Overall Study|Adverse Event|8|||
161161292|NCT02504268|581968894|FG002|Overall Study|Adverse Event|14|||
161161293|NCT02504268|581968895|FG003|Overall Study|Adverse Event|0|||
161161294|NCT02504268|581968896|FG004|Overall Study|Adverse Event|0|||
161161295|NCT02504268|581968897|FG005|Overall Study|Adverse Event|0|||
161161296|NCT02504268|581968898|FG006|Overall Study|Adverse Event|0|||
161161297|NCT02504268|581968899|FG007|Overall Study|Adverse Event|0|||
161161298|NCT02504268|581968900|FG008|Overall Study|Adverse Event|0|||
161161299|NCT02504268|581968892|FG000|Overall Study|Withdrawal of Consent|11|||
161161300|NCT02504268|581968893|FG001|Overall Study|Withdrawal of Consent|10|||
161161301|NCT02504268|581968894|FG002|Overall Study|Withdrawal of Consent|3|||
161161302|NCT02504268|581968895|FG003|Overall Study|Withdrawal of Consent|0|||
161161303|NCT02504268|581968896|FG004|Overall Study|Withdrawal of Consent|0|||
161161304|NCT02504268|581968897|FG005|Overall Study|Withdrawal of Consent|0|||
161287834|NCT01459783|582433767|FG000|Baseline to 6 Months|Death|1|||
161161305|NCT02504268|581968898|FG006|Overall Study|Withdrawal of Consent|0|||
161161306|NCT02504268|581968899|FG007|Overall Study|Withdrawal of Consent|0|||
161161307|NCT02504268|581968900|FG008|Overall Study|Withdrawal of Consent|0|||
161161308|NCT02504268|581968892|FG000|Overall Study|Pregnancy|2|||
161161309|NCT02504268|581968893|FG001|Overall Study|Pregnancy|0|||
161161310|NCT02504268|581968894|FG002|Overall Study|Pregnancy|0|||
161161311|NCT02504268|581968895|FG003|Overall Study|Pregnancy|0|||
161161312|NCT02504268|581968896|FG004|Overall Study|Pregnancy|0|||
161161313|NCT02504268|581968897|FG005|Overall Study|Pregnancy|0|||
161161314|NCT02504268|581968898|FG006|Overall Study|Pregnancy|0|||
161161315|NCT02504268|581968899|FG007|Overall Study|Pregnancy|0|||
161161316|NCT02504268|581968900|FG008|Overall Study|Pregnancy|0|||
161161317|NCT02504268|581968892|FG000|Overall Study|Lost to Follow-up|3|||
161161318|NCT02504268|581968893|FG001|Overall Study|Lost to Follow-up|6|||
161161319|NCT02504268|581968894|FG002|Overall Study|Lost to Follow-up|4|||
161161320|NCT02504268|581968895|FG003|Overall Study|Lost to Follow-up|0|||
161161321|NCT02504268|581968896|FG004|Overall Study|Lost to Follow-up|0|||
161161322|NCT02504268|581968897|FG005|Overall Study|Lost to Follow-up|0|||
161161323|NCT02504268|581968898|FG006|Overall Study|Lost to Follow-up|0|||
161287835|NCT01459783|582433768|FG001|Baseline to 6 Months|Death|0|||
161287836|NCT01459783|582433767|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
161287837|NCT01459783|582433768|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
161161324|NCT02504268|581968899|FG007|Overall Study|Lost to Follow-up|0|||
161161325|NCT02504268|581968900|FG008|Overall Study|Lost to Follow-up|0|||
161161326|NCT02504268|581968892|FG000|Overall Study|Death|1|||
161161327|NCT02504268|581968893|FG001|Overall Study|Death|1|||
161161328|NCT02504268|581968894|FG002|Overall Study|Death|0|||
161161329|NCT02504268|581968895|FG003|Overall Study|Death|0|||
161161330|NCT02504268|581968896|FG004|Overall Study|Death|0|||
161161331|NCT02504268|581968897|FG005|Overall Study|Death|0|||
161161332|NCT02504268|581968898|FG006|Overall Study|Death|0|||
161161333|NCT02504268|581968899|FG007|Overall Study|Death|0|||
161161334|NCT02504268|581968900|FG008|Overall Study|Death|0|||
161161335|NCT02504268|581968892|FG000|Overall Study|Subject Request to Discontinue|11|||
161161336|NCT02504268|581968893|FG001|Overall Study|Subject Request to Discontinue|3|||
161161337|NCT02504268|581968894|FG002|Overall Study|Subject Request to Discontinue|6|||
161161338|NCT02504268|581968895|FG003|Overall Study|Subject Request to Discontinue|0|||
161161339|NCT02504268|581968896|FG004|Overall Study|Subject Request to Discontinue|0|||
161161340|NCT02504268|581968897|FG005|Overall Study|Subject Request to Discontinue|0|||
161161341|NCT02504268|581968898|FG006|Overall Study|Subject Request to Discontinue|0|||
161161342|NCT02504268|581968899|FG007|Overall Study|Subject Request to Discontinue|0|||
161161343|NCT02504268|581968900|FG008|Overall Study|Subject Request to Discontinue|0|||
161161344|NCT02504268|581968892|FG000|Overall Study|No Longer Meets Study Criteria|2|||
161161345|NCT02504268|581968893|FG001|Overall Study|No Longer Meets Study Criteria|3|||
161161346|NCT02504268|581968894|FG002|Overall Study|No Longer Meets Study Criteria|0|||
161161347|NCT02504268|581968895|FG003|Overall Study|No Longer Meets Study Criteria|0|||
161161348|NCT02504268|581968896|FG004|Overall Study|No Longer Meets Study Criteria|0|||
161161349|NCT02504268|581968897|FG005|Overall Study|No Longer Meets Study Criteria|0|||
161161350|NCT02504268|581968898|FG006|Overall Study|No Longer Meets Study Criteria|0|||
161161351|NCT02504268|581968899|FG007|Overall Study|No Longer Meets Study Criteria|0|||
161161352|NCT02504268|581968900|FG008|Overall Study|No Longer Meets Study Criteria|0|||
161161353|NCT02504268|581968892|FG000|Overall Study|Lack of Efficacy|11|||
161161354|NCT02504268|581968893|FG001|Overall Study|Lack of Efficacy|35|||
161161355|NCT02504268|581968894|FG002|Overall Study|Lack of Efficacy|9|||
161161356|NCT02504268|581968895|FG003|Overall Study|Lack of Efficacy|0|||
161161357|NCT02504268|581968896|FG004|Overall Study|Lack of Efficacy|0|||
161161358|NCT02504268|581968897|FG005|Overall Study|Lack of Efficacy|0|||
161161359|NCT02504268|581968898|FG006|Overall Study|Lack of Efficacy|0|||
161161360|NCT02504268|581968899|FG007|Overall Study|Lack of Efficacy|0|||
161161361|NCT02504268|581968900|FG008|Overall Study|Lack of Efficacy|0|||
161161362|NCT02504268|581968892|FG000|Overall Study|Poor/Non-Compliance|3|||
161161363|NCT02504268|581968893|FG001|Overall Study|Poor/Non-Compliance|2|||
161161364|NCT02504268|581968894|FG002|Overall Study|Poor/Non-Compliance|3|||
161161365|NCT02504268|581968895|FG003|Overall Study|Poor/Non-Compliance|0|||
161161366|NCT02504268|581968896|FG004|Overall Study|Poor/Non-Compliance|0|||
161161367|NCT02504268|581968897|FG005|Overall Study|Poor/Non-Compliance|0|||
161161368|NCT02504268|581968898|FG006|Overall Study|Poor/Non-Compliance|0|||
161161369|NCT02504268|581968899|FG007|Overall Study|Poor/Non-Compliance|0|||
161161370|NCT02504268|581968900|FG008|Overall Study|Poor/Non-Compliance|0|||
161161371|NCT02504268|581968892|FG000|Overall Study|Not Disclosed|1|||
161161372|NCT02504268|581968893|FG001|Overall Study|Not Disclosed|0|||
161161373|NCT02504268|581968894|FG002|Overall Study|Not Disclosed|2|||
161161374|NCT02504268|581968895|FG003|Overall Study|Not Disclosed|0|||
161161375|NCT02504268|581968896|FG004|Overall Study|Not Disclosed|0|||
161161376|NCT02504268|581968897|FG005|Overall Study|Not Disclosed|0|||
161161377|NCT02504268|581968898|FG006|Overall Study|Not Disclosed|0|||
161161378|NCT02504268|581968899|FG007|Overall Study|Not Disclosed|0|||
161161379|NCT02504268|581968900|FG008|Overall Study|Not Disclosed|0|||
161161380|NCT03025217|581968901|FG000|Overall Study|Pregnancy|1|||
161161381|NCT03025217|581968901|FG000|Overall Study|Lost to Follow-up|1|||
161161382|NCT03025217|581968901|FG000|Overall Study|Not eligible, poor English|2|||
161287838|NCT01459783|582433767|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
161287839|NCT01459783|582433768|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
161161383|NCT03654755|581968907|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
161161384|NCT03654755|581968908|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
161161385|NCT03654755|581968909|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
161161386|NCT03654755|581968907|FG000|Overall Study|Withdrawal by Subject|2|||
161287840|NCT01459783|582433767|FG000|6 Months to 12 Months|Death|0|||
161287841|NCT01459783|582433768|FG001|6 Months to 12 Months|Death|1|||
161287842|NCT01459783|582433767|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
161161387|NCT03654755|581968908|FG001|Overall Study|Withdrawal by Subject|4|||
161161388|NCT03654755|581968909|FG002|Overall Study|Withdrawal by Subject|8|||
161161389|NCT03654755|581968907|FG000|Overall Study|Lost to Follow-up|1|||
161161390|NCT03654755|581968908|FG001|Overall Study|Lost to Follow-up|3|||
161287843|NCT01459783|582433768|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
161161391|NCT03654755|581968909|FG002|Overall Study|Lost to Follow-up|7|||
161161392|NCT03654755|581968907|FG000|Overall Study|Physician Decision|0|||
161161393|NCT03654755|581968908|FG001|Overall Study|Physician Decision|1|||
161161394|NCT03654755|581968909|FG002|Overall Study|Physician Decision|0|||
161161395|NCT03654755|581968907|FG000|Overall Study|Adverse Event|0|||
161161396|NCT03654755|581968908|FG001|Overall Study|Adverse Event|0|||
161161397|NCT03654755|581968909|FG002|Overall Study|Adverse Event|4|||
161161398|NCT03654755|581968907|FG000|Overall Study|Lack of Efficacy|0|||
161161399|NCT03654755|581968908|FG001|Overall Study|Lack of Efficacy|0|||
161161400|NCT03654755|581968909|FG002|Overall Study|Lack of Efficacy|1|||
161161401|NCT00992784|581968911|FG000|Overall Study|Adverse Event|2|||
161161402|NCT00992784|581968912|FG001|Overall Study|Adverse Event|1|||
161161403|NCT00992784|581968913|FG002|Overall Study|Adverse Event|0|||
161161404|NCT00992784|581968911|FG000|Overall Study|Withdrawal by Subject|1|||
161161405|NCT00992784|581968912|FG001|Overall Study|Withdrawal by Subject|1|||
161161406|NCT00992784|581968913|FG002|Overall Study|Withdrawal by Subject|1|||
161161407|NCT00781599|581968914|FG000|Overall Study|Lost to Follow-up|7|||
161161408|NCT00781599|581968915|FG001|Overall Study|Lost to Follow-up|4|||
161161409|NCT01088438|581968916|FG000|Overall Study|Withdrawal by Subject|11|||
161161410|NCT01088438|581968917|FG001|Overall Study|Withdrawal by Subject|6|||
161161411|NCT01088438|581968916|FG000|Overall Study|Lost to Follow-up|18|||
161161412|NCT01088438|581968917|FG001|Overall Study|Lost to Follow-up|30|||
161161413|NCT03442829|581968920|FG000|Overall Study|Scheduling clash|3|||
161161414|NCT03442829|581968921|FG001|Overall Study|Scheduling clash|1|||
161161415|NCT03442829|581968920|FG000|Overall Study|Illness unrelated to study|1|||
161161416|NCT03442829|581968921|FG001|Overall Study|Illness unrelated to study|1|||
161161417|NCT02596711|581968926|FG000|Overall Study|Lost to Follow-up|1|||
161161418|NCT02596711|581968927|FG001|Overall Study|Lost to Follow-up|2|||
161161419|NCT02596711|581968928|FG002|Overall Study|Lost to Follow-up|3|||
161161420|NCT02112994|581968930|FG000|Overall Study|Progressive Disease|0|||
161161421|NCT02112994|581968931|FG001|Overall Study|Progressive Disease|0|||
161161422|NCT02112994|581968932|FG002|Overall Study|Progressive Disease|1|||
161161423|NCT02112994|581968930|FG000|Overall Study|Pregnancy|0|||
161161424|NCT02112994|581968931|FG001|Overall Study|Pregnancy|1|||
161161425|NCT02112994|581968932|FG002|Overall Study|Pregnancy|1|||
161161426|NCT02112994|581968930|FG000|Overall Study|Liver Transplant|0|||
161161427|NCT02112994|581968931|FG001|Overall Study|Liver Transplant|1|||
161161428|NCT02112994|581968932|FG002|Overall Study|Liver Transplant|0|||
161161429|NCT02112994|581968930|FG000|Overall Study|Withdrawal by Subject|0|||
161161430|NCT02112994|581968931|FG001|Overall Study|Withdrawal by Subject|0|||
161161431|NCT02112994|581968932|FG002|Overall Study|Withdrawal by Subject|1|||
161161432|NCT04191577|581968936|FG000|Overall Study|Withdrawal by Subject|2|||
161161433|NCT04191577|581968937|FG001|Overall Study|Withdrawal by Subject|2|||
161161434|NCT04191577|581968938|FG002|Overall Study|Withdrawal by Subject|1|||
161161435|NCT04191577|581968936|FG000|Overall Study|Physician Decision|1|||
161161436|NCT04191577|581968937|FG001|Overall Study|Physician Decision|1|||
161161437|NCT04191577|581968938|FG002|Overall Study|Physician Decision|0|||
161161438|NCT04191577|581968936|FG000|Overall Study|Adverse Event|0|||
161161439|NCT04191577|581968937|FG001|Overall Study|Adverse Event|0|||
161161440|NCT04191577|581968938|FG002|Overall Study|Adverse Event|1|||
161161441|NCT04191577|581968936|FG000|Overall Study|Death|0|||
161161442|NCT04191577|581968937|FG001|Overall Study|Death|0|||
161161443|NCT04191577|581968938|FG002|Overall Study|Death|1|||
161161444|NCT01683071|581968939|FG000|Part 1|Lack of Efficacy|1|||
161161445|NCT01683071|581968940|FG001|Part 1|Lack of Efficacy|0|||
161161446|NCT01683071|581968941|FG002|Part 1|Lack of Efficacy|0|||
161161447|NCT01683071|581968942|FG003|Part 1|Lack of Efficacy|3|||
161161448|NCT01683071|581968943|FG004|Part 1|Lack of Efficacy|0|||
161161449|NCT01683071|581968944|FG005|Part 1|Lack of Efficacy|0|||
161287844|NCT01459783|582433767|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
161287845|NCT01459783|582433768|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
161287846|NCT01459783|582433767|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
161287847|NCT01459783|582433768|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
161161450|NCT01683071|581968939|FG000|Part 1|Withdrawal by Subject|1|||
161161451|NCT01683071|581968940|FG001|Part 1|Withdrawal by Subject|2|||
161287848|NCT02601014|582433769|FG000|Overall Study|Adverse Event|3|||
161161452|NCT01683071|581968941|FG002|Part 1|Withdrawal by Subject|2|||
161161453|NCT01683071|581968942|FG003|Part 1|Withdrawal by Subject|1|||
161161454|NCT01683071|581968943|FG004|Part 1|Withdrawal by Subject|0|||
161161455|NCT01683071|581968944|FG005|Part 1|Withdrawal by Subject|0|||
161161456|NCT01683071|581968939|FG000|Part 1|Surgery Cancelled|1|||
161161457|NCT01683071|581968940|FG001|Part 1|Surgery Cancelled|0|||
161161458|NCT01683071|581968941|FG002|Part 1|Surgery Cancelled|0|||
161161459|NCT01683071|581968942|FG003|Part 1|Surgery Cancelled|0|||
161161460|NCT01683071|581968943|FG004|Part 1|Surgery Cancelled|0|||
161161461|NCT01683071|581968944|FG005|Part 1|Surgery Cancelled|0|||
161161462|NCT01683071|581968939|FG000|Part 1|Did not receive study drug|1|||
161161463|NCT01683071|581968940|FG001|Part 1|Did not receive study drug|0|||
161161464|NCT01683071|581968941|FG002|Part 1|Did not receive study drug|0|||
161161465|NCT01683071|581968942|FG003|Part 1|Did not receive study drug|1|||
161161466|NCT01683071|581968943|FG004|Part 1|Did not receive study drug|0|||
161161467|NCT01683071|581968944|FG005|Part 1|Did not receive study drug|0|||
161161468|NCT01683071|581968939|FG000|Part 1|Early termination; met exclusion criteria|0|||
161287849|NCT02601014|582433770|FG001|Overall Study|Adverse Event|3|||
161287850|NCT02601014|582433769|FG000|Overall Study|Death|3|||
161287851|NCT02601014|582433770|FG001|Overall Study|Death|1|||
161287852|NCT02601014|582433769|FG000|Overall Study|Disease progression|4|||
161287853|NCT02601014|582433770|FG001|Overall Study|Disease progression|8|||
161287854|NCT02698163|582433771|FG000|Overall Study|Lost to Follow-up|0|||
161287855|NCT02698163|582433772|FG001|Overall Study|Lost to Follow-up|1|||
161287856|NCT01133067|582433773|FG000|Overall Study|Death|136|||
161287857|NCT01133067|582433773|FG000|Overall Study|Lost to Follow-up|3|||
161287858|NCT00752128|582433774|FG000|Overall Study|Withdrawal by Subject|4|||
161287859|NCT00349973|582433775|FG000|Overall Study|Adverse Event|3|||
161287860|NCT00349973|582433776|FG001|Overall Study|Adverse Event|3|||
161287861|NCT00349973|582433775|FG000|Overall Study|Withdrawal by Subject|1|||
161287862|NCT00349973|582433776|FG001|Overall Study|Withdrawal by Subject|0|||
161287863|NCT04135937|582433777|FG000|Overall Study|Lost to Follow-up|2|||
161287864|NCT04135937|582433777|FG000|Overall Study|Withdrawal by Subject|1|||
161287865|NCT05620082|582433778|FG000|Overall Study|Discharged before study end|1|||
161287866|NCT05620082|582433779|FG001|Overall Study|Discharged before study end|4|||
161287867|NCT05620082|582433780|FG002|Overall Study|Discharged before study end|0|||
161287868|NCT05620082|582433778|FG000|Overall Study|Moved to a different ward|1|||
161287869|NCT05620082|582433779|FG001|Overall Study|Moved to a different ward|0|||
161287870|NCT05620082|582433780|FG002|Overall Study|Moved to a different ward|0|||
161287871|NCT05620082|582433778|FG000|Overall Study|Feeling too unwell|1|||
161287872|NCT05620082|582433779|FG001|Overall Study|Feeling too unwell|0|||
161287873|NCT05620082|582433780|FG002|Overall Study|Feeling too unwell|0|||
161287874|NCT01490086|582436094|FG000|Overall Study|Consent withdrawn|4|||
161287875|NCT01490086|582436095|FG001|Overall Study|Consent withdrawn|4|||
161287876|NCT01490086|582436096|FG002|Overall Study|Consent withdrawn|3|||
161287877|NCT01490086|582436097|FG003|Overall Study|Consent withdrawn|0|||
161287878|NCT01490086|582436098|FG004|Overall Study|Consent withdrawn|1|||
161287879|NCT01490086|582436094|FG000|Overall Study|Non-compliance|0|||
161287880|NCT01490086|582436095|FG001|Overall Study|Non-compliance|1|||
161287881|NCT01490086|582436096|FG002|Overall Study|Non-compliance|0|||
161287882|NCT01490086|582436097|FG003|Overall Study|Non-compliance|0|||
161287883|NCT01490086|582436098|FG004|Overall Study|Non-compliance|0|||
161287884|NCT01490086|582436094|FG000|Overall Study|Abnormal laboratory findings|1|||
161287885|NCT01490086|582436095|FG001|Overall Study|Abnormal laboratory findings|0|||
161287886|NCT01490086|582436096|FG002|Overall Study|Abnormal laboratory findings|0|||
161287887|NCT01490086|582436097|FG003|Overall Study|Abnormal laboratory findings|0|||
161287888|NCT01490086|582436098|FG004|Overall Study|Abnormal laboratory findings|0|||
161287889|NCT01490086|582436094|FG000|Overall Study|Lost to Follow-up|0|||
161287890|NCT01490086|582436095|FG001|Overall Study|Lost to Follow-up|0|||
161287891|NCT01490086|582436096|FG002|Overall Study|Lost to Follow-up|0|||
161287892|NCT01490086|582436097|FG003|Overall Study|Lost to Follow-up|0|||
161287893|NCT01490086|582436098|FG004|Overall Study|Lost to Follow-up|1|||
161287894|NCT01490086|582436094|FG000|Overall Study|Physician Decision|3|||
161287895|NCT01490086|582436095|FG001|Overall Study|Physician Decision|4|||
161287896|NCT01490086|582436096|FG002|Overall Study|Physician Decision|2|||
161287897|NCT01490086|582436097|FG003|Overall Study|Physician Decision|3|||
161287898|NCT01490086|582436098|FG004|Overall Study|Physician Decision|1|||
161287899|NCT01490086|582436094|FG000|Overall Study|Adverse Event|0|||
161287900|NCT01490086|582436095|FG001|Overall Study|Adverse Event|0|||
161287901|NCT01490086|582436096|FG002|Overall Study|Adverse Event|1|||
161287902|NCT01490086|582436097|FG003|Overall Study|Adverse Event|2|||
161287903|NCT01490086|582436098|FG004|Overall Study|Adverse Event|0|||
161287904|NCT01490086|582436094|FG000|Overall Study|Lack of Efficacy|0|||
161287905|NCT01490086|582436095|FG001|Overall Study|Lack of Efficacy|3|||
161287906|NCT01490086|582436096|FG002|Overall Study|Lack of Efficacy|1|||
161287907|NCT01490086|582436097|FG003|Overall Study|Lack of Efficacy|0|||
161161469|NCT01683071|581968940|FG001|Part 1|Early termination; met exclusion criteria|2|||
161161470|NCT01683071|581968941|FG002|Part 1|Early termination; met exclusion criteria|1|||
161161471|NCT01683071|581968942|FG003|Part 1|Early termination; met exclusion criteria|0|||
161161472|NCT01683071|581968943|FG004|Part 1|Early termination; met exclusion criteria|0|||
161161473|NCT01683071|581968944|FG005|Part 1|Early termination; met exclusion criteria|0|||
161161474|NCT01683071|581968939|FG000|Part 2|Lack of Efficacy|0|||
161287908|NCT01490086|582436098|FG004|Overall Study|Lack of Efficacy|8|||
161287909|NCT01490086|582436094|FG000|Overall Study|Worsening of symptoms|0|||
161287910|NCT01490086|582436095|FG001|Overall Study|Worsening of symptoms|1|||
161287911|NCT01490086|582436096|FG002|Overall Study|Worsening of symptoms|0|||
161161475|NCT01683071|581968940|FG001|Part 2|Lack of Efficacy|0|||
161287912|NCT01490086|582436097|FG003|Overall Study|Worsening of symptoms|1|||
161287913|NCT01490086|582436098|FG004|Overall Study|Worsening of symptoms|0|||
161287914|NCT01490086|582436094|FG000|Overall Study|Subject uncontrollable and abusive|0|||
161287915|NCT01490086|582436095|FG001|Overall Study|Subject uncontrollable and abusive|1|||
161287916|NCT01490086|582436096|FG002|Overall Study|Subject uncontrollable and abusive|0|||
161287917|NCT01490086|582436097|FG003|Overall Study|Subject uncontrollable and abusive|0|||
161287918|NCT01490086|582436098|FG004|Overall Study|Subject uncontrollable and abusive|0|||
161287919|NCT01490086|582436094|FG000|Overall Study|Subject left hospital|0|||
161161476|NCT01683071|581968941|FG002|Part 2|Lack of Efficacy|0|||
161161477|NCT01683071|581968942|FG003|Part 2|Lack of Efficacy|0|||
161161478|NCT01683071|581968943|FG004|Part 2|Lack of Efficacy|3|||
161161479|NCT01683071|581968944|FG005|Part 2|Lack of Efficacy|4|||
161161480|NCT01683071|581968939|FG000|Part 2|Lost to Follow-up|0|||
161161481|NCT01683071|581968940|FG001|Part 2|Lost to Follow-up|0|||
161161482|NCT01683071|581968941|FG002|Part 2|Lost to Follow-up|0|||
161161483|NCT01683071|581968942|FG003|Part 2|Lost to Follow-up|0|||
161161484|NCT01683071|581968943|FG004|Part 2|Lost to Follow-up|2|||
161161485|NCT01683071|581968944|FG005|Part 2|Lost to Follow-up|0|||
161161486|NCT01683071|581968939|FG000|Part 2|Withdrawal by Subject|0|||
161161487|NCT01683071|581968940|FG001|Part 2|Withdrawal by Subject|0|||
161161488|NCT01683071|581968941|FG002|Part 2|Withdrawal by Subject|0|||
161161489|NCT01683071|581968942|FG003|Part 2|Withdrawal by Subject|0|||
161161490|NCT01683071|581968943|FG004|Part 2|Withdrawal by Subject|3|||
161161491|NCT01683071|581968944|FG005|Part 2|Withdrawal by Subject|3|||
161161492|NCT01683071|581968939|FG000|Part 2|Surgery cancelled|0|||
161161493|NCT01683071|581968940|FG001|Part 2|Surgery cancelled|0|||
161161494|NCT01683071|581968941|FG002|Part 2|Surgery cancelled|0|||
161161495|NCT01683071|581968942|FG003|Part 2|Surgery cancelled|0|||
161161496|NCT01683071|581968943|FG004|Part 2|Surgery cancelled|4|||
161161497|NCT01683071|581968944|FG005|Part 2|Surgery cancelled|2|||
161161498|NCT01683071|581968939|FG000|Part 2|Did not receive study drug|0|||
161161499|NCT01683071|581968940|FG001|Part 2|Did not receive study drug|0|||
161161500|NCT01683071|581968941|FG002|Part 2|Did not receive study drug|0|||
161161501|NCT01683071|581968942|FG003|Part 2|Did not receive study drug|0|||
161161502|NCT01683071|581968943|FG004|Part 2|Did not receive study drug|2|||
161161503|NCT01683071|581968944|FG005|Part 2|Did not receive study drug|1|||
161161504|NCT01683071|581968939|FG000|Part 2|Met exclusion criterion|0|||
161161505|NCT01683071|581968940|FG001|Part 2|Met exclusion criterion|0|||
161161506|NCT01683071|581968941|FG002|Part 2|Met exclusion criterion|0|||
161161507|NCT01683071|581968942|FG003|Part 2|Met exclusion criterion|0|||
161161508|NCT01683071|581968943|FG004|Part 2|Met exclusion criterion|1|||
161161509|NCT01683071|581968944|FG005|Part 2|Met exclusion criterion|1|||
161161510|NCT01683071|581968939|FG000|Part 2|Protocol deviation|0|||
161287920|NCT01490086|582436095|FG001|Overall Study|Subject left hospital|1|||
161287921|NCT01490086|582436096|FG002|Overall Study|Subject left hospital|0|||
161287922|NCT01490086|582436097|FG003|Overall Study|Subject left hospital|1|||
161287923|NCT01490086|582436098|FG004|Overall Study|Subject left hospital|0|||
161287924|NCT05825404|582436099|FG000|First Intervention (Weeks 2-5)|Death|0|||
161287925|NCT05825404|582436100|FG001|First Intervention (Weeks 2-5)|Death|1|||
161287926|NCT05825404|582436099|FG000|Second Intervention (Weeks 8-11)|Death|0|||
161287927|NCT05825404|582436100|FG001|Second Intervention (Weeks 8-11)|Death|1|||
161287928|NCT00931528|582436101|FG000|Overall Study|Protocol Violation|9|||
161287929|NCT00931528|582436102|FG001|Overall Study|Protocol Violation|12|||
161287930|NCT00931528|582436101|FG000|Overall Study|Withdrawal by Subject|4|||
161287931|NCT00931528|582436102|FG001|Overall Study|Withdrawal by Subject|12|||
161287932|NCT00931528|582436101|FG000|Overall Study|Lost to Follow-up|6|||
161287933|NCT00931528|582436102|FG001|Overall Study|Lost to Follow-up|13|||
161287934|NCT00931528|582436101|FG000|Overall Study|Assessment outside of Time Frame|22|||
161287935|NCT00931528|582436102|FG001|Overall Study|Assessment outside of Time Frame|23|||
161287936|NCT01470248|582436103|FG000|Overall Study|Withdrawal by Subject|1|||
161287937|NCT02243605|582436106|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
161287938|NCT02243605|582436107|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
161287939|NCT02243605|582436106|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
161287940|NCT02243605|582436107|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
161287941|NCT02243605|582436106|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
161287942|NCT02243605|582436107|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
161287943|NCT02243605|582436106|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
161287944|NCT02243605|582436107|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
161287945|NCT02243605|582436106|FG000|Stage 2 - Final Analysis Population|Progression|0|||
161287946|NCT02243605|582436107|FG001|Stage 2 - Final Analysis Population|Progression|1|||
161287947|NCT05842967|582436108|FG000|Period 1: SSA|Adverse Event|1|||
161287948|NCT05842967|582436109|FG001|Period 1: SSA|Adverse Event|1|||
161287949|NCT05842967|582436110|FG002|Period 1: SSA|Adverse Event|0|||
161287950|NCT05842967|582436111|FG003|Period 1: SSA|Adverse Event|0|||
161287951|NCT05842967|582436108|FG000|Period 1: SSA|Death|1|||
161161511|NCT01683071|581968940|FG001|Part 2|Protocol deviation|0|||
161161512|NCT01683071|581968941|FG002|Part 2|Protocol deviation|0|||
161161513|NCT01683071|581968942|FG003|Part 2|Protocol deviation|0|||
161161514|NCT01683071|581968943|FG004|Part 2|Protocol deviation|1|||
161287952|NCT05842967|582436109|FG001|Period 1: SSA|Death|0|||
161287953|NCT05842967|582436110|FG002|Period 1: SSA|Death|0|||
161287954|NCT05842967|582436111|FG003|Period 1: SSA|Death|0|||
161287955|NCT05842967|582436108|FG000|Period 1: SSA|Lost to Follow-up|16|||
161287956|NCT05842967|582436109|FG001|Period 1: SSA|Lost to Follow-up|4|||
161287957|NCT05842967|582436110|FG002|Period 1: SSA|Lost to Follow-up|0|||
161161515|NCT01683071|581968944|FG005|Part 2|Protocol deviation|2|||
161161516|NCT01683071|581968939|FG000|Part 2|Withdrawal by investigator decision|0|||
161161517|NCT01683071|581968940|FG001|Part 2|Withdrawal by investigator decision|0|||
161161518|NCT01683071|581968941|FG002|Part 2|Withdrawal by investigator decision|0|||
161161519|NCT01683071|581968942|FG003|Part 2|Withdrawal by investigator decision|0|||
161161520|NCT01683071|581968943|FG004|Part 2|Withdrawal by investigator decision|1|||
161161521|NCT01683071|581968944|FG005|Part 2|Withdrawal by investigator decision|2|||
161161522|NCT01927744|581970198|FG000|Overall Study|Death|2|||
161161523|NCT01927744|581970199|FG001|Overall Study|Death|9|||
161161524|NCT00369967|581970200|FG000|Overall Study|Lost to Follow-up|23|||
161161525|NCT00369967|581970201|FG001|Overall Study|Lost to Follow-up|12|||
161161526|NCT03073213|581970202|FG000|Multiple Dose Period|Protocol Violation|0|||
161161527|NCT03073213|581970203|FG001|Multiple Dose Period|Protocol Violation|0|||
161161528|NCT03073213|581970204|FG002|Multiple Dose Period|Protocol Violation|1|||
161161529|NCT02064205|581970205|FG000|Overall Study|Withdrawal by Subject|1|||
161161530|NCT02586233|581970207|FG000|Overall Study|Randomized but did not receive treatment|0|||
161161531|NCT02586233|581970208|FG001|Overall Study|Randomized but did not receive treatment|1|||
161161532|NCT02586233|581970209|FG002|Overall Study|Randomized but did not receive treatment|0|||
161161533|NCT02586233|581970210|FG003|Overall Study|Randomized but did not receive treatment|0|||
161161534|NCT02586233|581970211|FG004|Overall Study|Randomized but did not receive treatment|0|||
161161535|NCT02586233|581970212|FG005|Overall Study|Randomized but did not receive treatment|2|||
161161536|NCT02586233|581970213|FG006|Overall Study|Randomized but did not receive treatment|2|||
161161537|NCT02586233|581970207|FG000|Overall Study|Death|0|||
161161538|NCT02586233|581970208|FG001|Overall Study|Death|1|||
161161539|NCT02586233|581970209|FG002|Overall Study|Death|0|||
161161540|NCT02586233|581970210|FG003|Overall Study|Death|0|||
161161541|NCT02586233|581970211|FG004|Overall Study|Death|2|||
161161542|NCT02586233|581970212|FG005|Overall Study|Death|0|||
161161543|NCT02586233|581970213|FG006|Overall Study|Death|0|||
161161544|NCT01205451|581970214|FG000|Overall Study|Lost to Follow-up|1|||
161161545|NCT01205451|581970215|FG001|Overall Study|Lost to Follow-up|1|||
161161546|NCT01205451|581970214|FG000|Overall Study|Withdrawal by Subject|5|||
161161547|NCT01205451|581970215|FG001|Overall Study|Withdrawal by Subject|9|||
161161548|NCT01708941|581970218|FG000|Overall Study|Adverse Event|4|||
161161549|NCT01708941|581970219|FG001|Overall Study|Adverse Event|6|||
161161550|NCT01708941|581970220|FG002|Overall Study|Adverse Event|1|||
161161551|NCT01708941|581970221|FG003|Overall Study|Adverse Event|0|||
161161552|NCT01708941|581970218|FG000|Overall Study|Death|1|||
161161553|NCT01708941|581970219|FG001|Overall Study|Death|1|||
161161554|NCT01708941|581970220|FG002|Overall Study|Death|2|||
161161555|NCT01708941|581970221|FG003|Overall Study|Death|14|||
161161556|NCT01708941|581970218|FG000|Overall Study|Withdrawal by Subject|1|||
161161557|NCT01708941|581970219|FG001|Overall Study|Withdrawal by Subject|0|||
161161558|NCT01708941|581970220|FG002|Overall Study|Withdrawal by Subject|3|||
161161559|NCT01708941|581970221|FG003|Overall Study|Withdrawal by Subject|4|||
161161560|NCT01708941|581970218|FG000|Overall Study|Disease progression|9|||
161161561|NCT01708941|581970219|FG001|Overall Study|Disease progression|10|||
161161562|NCT01708941|581970220|FG002|Overall Study|Disease progression|8|||
161161563|NCT01708941|581970221|FG003|Overall Study|Disease progression|0|||
161161564|NCT01708941|581970218|FG000|Overall Study|Alternative therapy|0|||
161161565|NCT01708941|581970219|FG001|Overall Study|Alternative therapy|0|||
161161566|NCT01708941|581970220|FG002|Overall Study|Alternative therapy|2|||
161161567|NCT01708941|581970221|FG003|Overall Study|Alternative therapy|0|||
161161568|NCT01708941|581970218|FG000|Overall Study|Ineligible and never started treatment|1|||
161161569|NCT01708941|581970219|FG001|Overall Study|Ineligible and never started treatment|0|||
161161570|NCT01708941|581970220|FG002|Overall Study|Ineligible and never started treatment|1|||
161161571|NCT01708941|581970221|FG003|Overall Study|Ineligible and never started treatment|0|||
161161572|NCT01708941|581970218|FG000|Overall Study|Never started treatment|2|||
161161573|NCT01708941|581970219|FG001|Overall Study|Never started treatment|1|||
161161574|NCT01708941|581970220|FG002|Overall Study|Never started treatment|0|||
161161575|NCT01708941|581970221|FG003|Overall Study|Never started treatment|0|||
161161576|NCT01708941|581970218|FG000|Overall Study|Ineligible|0|||
161161577|NCT01708941|581970219|FG001|Overall Study|Ineligible|0|||
161161578|NCT01708941|581970220|FG002|Overall Study|Ineligible|2|||
161161579|NCT01708941|581970221|FG003|Overall Study|Ineligible|0|||
161161580|NCT00229203|581970222|FG000|Overall Study|Progressive disease|18|||
161161581|NCT00229203|581970223|FG001|Overall Study|Progressive disease|9|||
161161582|NCT00229203|581970222|FG000|Overall Study|Toxicity|6|||
161161583|NCT00229203|581970223|FG001|Overall Study|Toxicity|1|||
161161584|NCT00229203|581970222|FG000|Overall Study|Death|4|||
161161585|NCT00229203|581970223|FG001|Overall Study|Death|2|||
161161586|NCT00229203|581970222|FG000|Overall Study|Other|3|||
161287958|NCT05842967|582436111|FG003|Period 1: SSA|Lost to Follow-up|0|||
161161587|NCT00229203|581970223|FG001|Overall Study|Other|3|||
161161588|NCT00229203|581970222|FG000|Overall Study|Withdrawal by Subject|1|||
161161589|NCT00229203|581970223|FG001|Overall Study|Withdrawal by Subject|4|||
161161590|NCT03457103|581970224|FG000|Overall Study|illness/hospitalization|4|||
161161591|NCT03457103|581970225|FG001|Overall Study|illness/hospitalization|2|||
161161592|NCT03457103|581970224|FG000|Overall Study|Lost to Follow-up|2|||
161161593|NCT03457103|581970225|FG001|Overall Study|Lost to Follow-up|1|||
161161594|NCT03457103|581970224|FG000|Overall Study|Withdrawal by Subject|1|||
161161595|NCT03457103|581970225|FG001|Overall Study|Withdrawal by Subject|2|||
161161596|NCT03457103|581970224|FG000|Overall Study|financial/ insurance issues|1|||
161161597|NCT03457103|581970225|FG001|Overall Study|financial/ insurance issues|1|||
161161598|NCT00213980|581970226|FG000|Overall Study|Withdrawal by Subject|3|||
161161599|NCT00213980|581970227|FG001|Overall Study|Withdrawal by Subject|1|||
161161600|NCT00213980|581970226|FG000|Overall Study|Adverse Event|1|||
161161601|NCT00213980|581970227|FG001|Overall Study|Adverse Event|1|||
161161602|NCT00213980|581970226|FG000|Overall Study|Disease progression|0|||
161161603|NCT00213980|581970227|FG001|Overall Study|Disease progression|2|||
161161604|NCT00213980|581970226|FG000|Overall Study|Developed ovarian cancer|1|||
161161605|NCT00213980|581970227|FG001|Overall Study|Developed ovarian cancer|0|||
161161606|NCT00213980|581970226|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
161161607|NCT00213980|581970227|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
161161608|NCT03607838|581970228|FG000|Overall Study|Lack of Efficacy|14|||
161161609|NCT03607838|581970229|FG001|Overall Study|Lack of Efficacy|20|||
161161610|NCT03607838|581970228|FG000|Overall Study|Withdrawal by Subject|13|||
161161611|NCT03607838|581970229|FG001|Overall Study|Withdrawal by Subject|8|||
161161612|NCT03607838|581970228|FG000|Overall Study|Lost to Follow-up|6|||
161161613|NCT03607838|581970229|FG001|Overall Study|Lost to Follow-up|11|||
161161614|NCT03607838|581970228|FG000|Overall Study|Adverse Event|2|||
161161615|NCT03607838|581970229|FG001|Overall Study|Adverse Event|2|||
161161616|NCT03607838|581970228|FG000|Overall Study|Physician Decision|2|||
161161617|NCT03607838|581970229|FG001|Overall Study|Physician Decision|0|||
161161618|NCT03607838|581970228|FG000|Overall Study|Failure to meet randomization criteria|1|||
161161619|NCT03607838|581970229|FG001|Overall Study|Failure to meet randomization criteria|2|||
161161620|NCT03607838|581970228|FG000|Overall Study|Pregnancy|1|||
161161621|NCT03607838|581970229|FG001|Overall Study|Pregnancy|0|||
161161622|NCT03607838|581970228|FG000|Overall Study|Protocol Violation|1|||
161161623|NCT03607838|581970229|FG001|Overall Study|Protocol Violation|0|||
161161624|NCT03607838|581970228|FG000|Overall Study|Due to work|1|||
161161625|NCT03607838|581970229|FG001|Overall Study|Due to work|0|||
161161626|NCT03607838|581970228|FG000|Overall Study|Litigation|0|||
161161627|NCT03607838|581970229|FG001|Overall Study|Litigation|1|||
161161628|NCT03607838|581970228|FG000|Overall Study|Temperature excursion for study drug|0|||
161161629|NCT03607838|581970229|FG001|Overall Study|Temperature excursion for study drug|1|||
161161630|NCT03607838|581970228|FG000|Overall Study|Change of mind|0|||
161161631|NCT03607838|581970229|FG001|Overall Study|Change of mind|1|||
161161632|NCT02411201|581970230|FG000|Overall Study|Adverse Event|2|||
161161633|NCT02411201|581970230|FG000|Overall Study|Withdrawal by Subject|2|||
161161634|NCT02411201|581970230|FG000|Overall Study|Age group completed|2|||
161161635|NCT01260467|581970231|FG000|Overall Study|Withdrawal by Subject|2|||
161161636|NCT00798694|581970232|FG000|Overall Study|Lost to Follow-up|1|||
161161637|NCT00798694|581970233|FG001|Overall Study|Lost to Follow-up|1|||
161161638|NCT00798694|581970232|FG000|Overall Study|Physician Decision|1|||
161161639|NCT00798694|581970233|FG001|Overall Study|Physician Decision|0|||
161161640|NCT01163253|581970239|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
161161641|NCT01163253|581970240|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
161161642|NCT01163253|581970239|FG000|Overall Study|Study Terminated by Sponsor|978|||
161161643|NCT01163253|581970240|FG001|Overall Study|Study Terminated by Sponsor|349|||
161161644|NCT01163253|581970239|FG000|Overall Study|Protocol Violation|43|||
161161645|NCT01163253|581970240|FG001|Overall Study|Protocol Violation|12|||
161161646|NCT01163253|581970239|FG000|Overall Study|Withdrawal by Subject|199|||
161161647|NCT01163253|581970240|FG001|Overall Study|Withdrawal by Subject|50|||
161161648|NCT01163253|581970239|FG000|Overall Study|Medication Error|1|||
161161649|NCT01163253|581970240|FG001|Overall Study|Medication Error|0|||
161161650|NCT01163253|581970239|FG000|Overall Study|Lost to Follow-up|125|||
161161651|NCT01163253|581970240|FG001|Overall Study|Lost to Follow-up|23|||
161161652|NCT01163253|581970239|FG000|Overall Study|Insufficient Clinical Response|423|||
161161653|NCT01163253|581970240|FG001|Overall Study|Insufficient Clinical Response|29|||
161161654|NCT01163253|581970239|FG000|Overall Study|Adverse Event|300|||
161161655|NCT01163253|581970240|FG001|Overall Study|Adverse Event|78|||
161161656|NCT01163253|581970239|FG000|Overall Study|Death|17|||
161161657|NCT01163253|581970240|FG001|Overall Study|Death|5|||
161161658|NCT01163253|581970239|FG000|Overall Study|Ongoing|13|||
161161659|NCT01163253|581970240|FG001|Overall Study|Ongoing|4|||
161161660|NCT01163253|581970239|FG000|Overall Study|Other Unspecified|170|||
161161661|NCT01163253|581970240|FG001|Overall Study|Other Unspecified|34|||
161161662|NCT00423735|581970241|FG000|Overall Study|Ineligible / No protocol treatment|8|||
161161663|NCT00423735|581970242|FG001|Overall Study|Ineligible / No protocol treatment|6|||
161161664|NCT00423735|581970243|FG002|Overall Study|Ineligible / No protocol treatment|0|||
161161665|NCT02394808|581970247|FG000|Period 1|Unsatisfactory lens fitting|0|||
161287959|NCT05842967|582436108|FG000|Period 1: SSA|Physician Decision|1|||
161161666|NCT02394808|581970248|FG001|Period 1|Unsatisfactory lens fitting|1|||
161161667|NCT02394808|581970247|FG000|Period 2|Lost to Follow-up|1|||
161161668|NCT02394808|581970248|FG001|Period 2|Lost to Follow-up|0|||
161161669|NCT00289185|581970249|FG000|Overall Study|Withdrawal by Subject|4|||
161161670|NCT00289185|581970250|FG001|Overall Study|Withdrawal by Subject|8|||
161161671|NCT00289185|581970249|FG000|Overall Study|Lost to Follow-up|23|||
161161672|NCT00289185|581970250|FG001|Overall Study|Lost to Follow-up|17|||
161161673|NCT00289185|581970249|FG000|Overall Study|Death|1|||
161161674|NCT00289185|581970250|FG001|Overall Study|Death|1|||
161161675|NCT03337152|581970255|FG000|Overall Study|Physician Decision|1|||
161161676|NCT03337152|581970256|FG001|Overall Study|Physician Decision|0|||
161161677|NCT03337152|581970255|FG000|Overall Study|Lost to Follow-up|1|||
161161678|NCT03337152|581970256|FG001|Overall Study|Lost to Follow-up|3|||
161161679|NCT03337152|581970255|FG000|Overall Study|Adverse Event|3|||
161161680|NCT03337152|581970256|FG001|Overall Study|Adverse Event|1|||
161161681|NCT03337152|581970255|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
161161682|NCT03337152|581970256|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
161161683|NCT00421343|581970257|FG000|Overall Study|Death|1|||
161161684|NCT00421343|581970257|FG000|Overall Study|Withdrawal by Subject|2|||
161161685|NCT00421343|581970257|FG000|Overall Study|Lost to Follow-up|3|||
161161686|NCT00678587|581970258|FG000|Overall Study|Adverse Event|3|||
161161687|NCT00678587|581970259|FG001|Overall Study|Adverse Event|3|||
161161688|NCT00678587|581970258|FG000|Overall Study|Lack of Efficacy|1|||
161161689|NCT00678587|581970259|FG001|Overall Study|Lack of Efficacy|0|||
161161690|NCT00678587|581970258|FG000|Overall Study|Protocol Violation|2|||
161161691|NCT00678587|581970259|FG001|Overall Study|Protocol Violation|1|||
161161692|NCT00678587|581970258|FG000|Overall Study|Study Closed/Terminated|1|||
161161693|NCT00678587|581970259|FG001|Overall Study|Study Closed/Terminated|0|||
161161694|NCT00678587|581970258|FG000|Overall Study|Lost to Follow-up|3|||
161161695|NCT00678587|581970259|FG001|Overall Study|Lost to Follow-up|5|||
161161696|NCT00678587|581970258|FG000|Overall Study|Investigator Discretion|2|||
161161697|NCT00678587|581970259|FG001|Overall Study|Investigator Discretion|6|||
161161698|NCT00678587|581970258|FG000|Overall Study|Withdrew Consent|8|||
161161699|NCT00678587|581970259|FG001|Overall Study|Withdrew Consent|3|||
161161700|NCT01952730|581970262|FG000|Overall Study|FDA shut down core lab used by study|1|||
161161701|NCT00976950|581970266|FG000|Overall Study|Adverse Event|3|||
161161702|NCT00976950|581970266|FG000|Overall Study|Events with no relationship to Aptivus|3|||
161161703|NCT01514188|581970268|FG000|Overall Study|Adverse Event|3|||
161161704|NCT01514188|581970269|FG001|Overall Study|Adverse Event|5|||
161161705|NCT01514188|581970268|FG000|Overall Study|Withdrawal by Subject|2|||
161161706|NCT01514188|581970269|FG001|Overall Study|Withdrawal by Subject|4|||
161161707|NCT01514188|581970268|FG000|Overall Study|Protocol Violation|2|||
161161708|NCT01514188|581970269|FG001|Overall Study|Protocol Violation|4|||
161161709|NCT01514188|581970268|FG000|Overall Study|Physician Decision|0|||
161161710|NCT01514188|581970269|FG001|Overall Study|Physician Decision|2|||
161161711|NCT01514188|581970268|FG000|Overall Study|Disease Progression|13|||
161161712|NCT01514188|581970269|FG001|Overall Study|Disease Progression|14|||
161161713|NCT01514188|581970268|FG000|Overall Study|Death|1|||
161161714|NCT01514188|581970269|FG001|Overall Study|Death|3|||
161161715|NCT01514188|581970268|FG000|Overall Study|Other|2|||
161161716|NCT01514188|581970269|FG001|Overall Study|Other|1|||
161161717|NCT01019486|581970270|FG000|Overall Study|Withdrawal by Subject|1|||
161161718|NCT01019486|581970271|FG001|Overall Study|Withdrawal by Subject|1|||
161161719|NCT01019486|581970272|FG002|Overall Study|Withdrawal by Subject|1|||
161161720|NCT02932332|581970273|FG000|Overall Study|Withdrawal by Subject|1|||
161161721|NCT02932332|581970274|FG001|Overall Study|Withdrawal by Subject|1|||
161161722|NCT02932332|581970275|FG002|Overall Study|Withdrawal by Subject|0|||
161161723|NCT02932332|581970276|FG003|Overall Study|Withdrawal by Subject|1|||
161161724|NCT02932332|581970273|FG000|Overall Study|Chest pain|0|||
161161725|NCT02932332|581970274|FG001|Overall Study|Chest pain|0|||
161161726|NCT02932332|581970275|FG002|Overall Study|Chest pain|0|||
161161727|NCT02932332|581970276|FG003|Overall Study|Chest pain|1|||
161161728|NCT02932332|581970273|FG000|Overall Study|Not Dyspneic cough|1|||
161161729|NCT02932332|581970274|FG001|Overall Study|Not Dyspneic cough|2|||
161161730|NCT02932332|581970275|FG002|Overall Study|Not Dyspneic cough|1|||
161161731|NCT02932332|581970276|FG003|Overall Study|Not Dyspneic cough|0|||
161161732|NCT01069523|581970278|FG000|Overall Study|Withdrawal by Subject|4|||
161161733|NCT01069523|581970279|FG001|Overall Study|Withdrawal by Subject|7|||
161161734|NCT02605447|581970284|FG000|Overall Study|Death|66|||
161161735|NCT02605447|581970284|FG000|Overall Study|Physician Decision|1|||
161287960|NCT05842967|582436109|FG001|Period 1: SSA|Physician Decision|0|||
161287961|NCT05842967|582436110|FG002|Period 1: SSA|Physician Decision|0|||
161161736|NCT02605447|581970284|FG000|Overall Study|Lost to Follow-up|24|||
161161737|NCT02605447|581970284|FG000|Overall Study|Withdrawal by Subject|10|||
161161738|NCT02605447|581970284|FG000|Overall Study|Not disclosed|1|||
161161739|NCT02237157|581970285|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
161161740|NCT02237157|581970286|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161161741|NCT02237157|581970287|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161161742|NCT02237157|581970288|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
161161743|NCT02237157|581970285|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
161287962|NCT05842967|582436111|FG003|Period 1: SSA|Physician Decision|0|||
161161744|NCT02237157|581970286|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161161745|NCT02237157|581970287|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161161746|NCT02237157|581970288|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
161161747|NCT04533815|581970293|FG000|Overall Study|Adverse Event|2|||
161161748|NCT04533815|581970293|FG000|Overall Study|Site withdrew|5|||
161161749|NCT02045212|581970294|FG000|Overall Study|Adverse Event|0|||
161161750|NCT02045212|581970295|FG001|Overall Study|Adverse Event|1|||
161161751|NCT02045212|581970294|FG000|Overall Study|Withdrawal by Subject|1|||
161161752|NCT02045212|581970295|FG001|Overall Study|Withdrawal by Subject|0|||
161161753|NCT02045212|581970294|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
161161754|NCT02045212|581970295|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
161161755|NCT00488592|581970296|FG000|Overall Study|Withdrawal by Subject|1|||
161161756|NCT00488592|581970296|FG000|Overall Study|Disease progression|1|||
161161757|NCT00488592|581970296|FG000|Overall Study|Enrolled but not treated|1|||
161161758|NCT00441103|581970297|FG000|Overall Study|Adverse Event|2|||
161161759|NCT00441103|581970298|FG001|Overall Study|Adverse Event|1|||
161161760|NCT00441103|581970297|FG000|Overall Study|Death|1|||
161161761|NCT00441103|581970298|FG001|Overall Study|Death|0|||
161161762|NCT00441103|581970297|FG000|Overall Study|Disease Progression|2|||
161161763|NCT00441103|581970298|FG001|Overall Study|Disease Progression|0|||
161161764|NCT00441103|581970297|FG000|Overall Study|Lost to Follow-up|1|||
161161765|NCT00441103|581970298|FG001|Overall Study|Lost to Follow-up|0|||
161161766|NCT00441103|581970297|FG000|Overall Study|Protocol Violation|1|||
161161767|NCT00441103|581970298|FG001|Overall Study|Protocol Violation|0|||
161161768|NCT00441103|581970297|FG000|Overall Study|Participant unable to use Rebiject II|1|||
161161769|NCT00441103|581970298|FG001|Overall Study|Participant unable to use Rebiject II|0|||
161161770|NCT00441103|581970297|FG000|Overall Study|Participant refused MRI|1|||
161161771|NCT00441103|581970298|FG001|Overall Study|Participant refused MRI|0|||
161161772|NCT00441103|581970297|FG000|Overall Study|Inclusion criteria absent|1|||
161161773|NCT00441103|581970298|FG001|Overall Study|Inclusion criteria absent|0|||
161161774|NCT00441103|581970297|FG000|Overall Study|Non-compliant|0|||
161161775|NCT00441103|581970298|FG001|Overall Study|Non-compliant|1|||
161161776|NCT00441103|581970297|FG000|Overall Study|Participant decided to withdraw|1|||
161161777|NCT00441103|581970298|FG001|Overall Study|Participant decided to withdraw|0|||
161161778|NCT00441103|581970297|FG000|Overall Study|Participant's reason|0|||
161161779|NCT00441103|581970298|FG001|Overall Study|Participant's reason|1|||
161161780|NCT00441103|581970297|FG000|Overall Study|Participant decided to stop|0|||
161161781|NCT00441103|581970298|FG001|Overall Study|Participant decided to stop|1|||
161161782|NCT00515008|581970299|FG000|Overall Study|Lost to Follow-up|1|||
161161783|NCT00515008|581970300|FG001|Overall Study|Lost to Follow-up|0|||
161161784|NCT00515008|581970299|FG000|Overall Study|Declined|0|||
161161785|NCT00515008|581970300|FG001|Overall Study|Declined|3|||
161161786|NCT00515008|581970299|FG000|Overall Study|Left the Boston Area|1|||
161161787|NCT00515008|581970300|FG001|Overall Study|Left the Boston Area|1|||
161161788|NCT00515008|581970299|FG000|Overall Study|Scheduling conflict|1|||
161161789|NCT00515008|581970300|FG001|Overall Study|Scheduling conflict|0|||
161161790|NCT05836818|581970301|FG000|Overall Study|Physician Decision|1|||
161161791|NCT05836818|581970302|FG001|Overall Study|Physician Decision|1|||
161161792|NCT05836818|581970303|FG002|Overall Study|Physician Decision|0|||
161161793|NCT05836818|581970301|FG000|Overall Study|Withdrawal by Subject|0|||
161161794|NCT05836818|581970302|FG001|Overall Study|Withdrawal by Subject|0|||
161161795|NCT05836818|581970303|FG002|Overall Study|Withdrawal by Subject|1|||
161161796|NCT05836818|581970301|FG000|Overall Study|Later found to be previously vaccinated|0|||
161161797|NCT05836818|581970302|FG001|Overall Study|Later found to be previously vaccinated|1|||
161161798|NCT05836818|581970303|FG002|Overall Study|Later found to be previously vaccinated|3|||
161161799|NCT05836818|581970301|FG000|Overall Study|Pregnancy|0|||
161161800|NCT05836818|581970302|FG001|Overall Study|Pregnancy|1|||
161161801|NCT05836818|581970303|FG002|Overall Study|Pregnancy|0|||
161161802|NCT05836818|581970301|FG000|Overall Study|Allergic to vaccines|0|||
161161803|NCT05836818|581970302|FG001|Overall Study|Allergic to vaccines|1|||
161161804|NCT05836818|581970303|FG002|Overall Study|Allergic to vaccines|0|||
161161805|NCT03738566|581970304|FG000|Initial Study Phase|Withdrawal by Subject|1|||
161161806|NCT03738566|581970305|FG001|Initial Study Phase|Withdrawal by Subject|1|||
161161807|NCT03738566|581970306|FG002|Initial Study Phase|Withdrawal by Subject|2|||
161161808|NCT03738566|581970307|FG003|Initial Study Phase|Withdrawal by Subject|0|||
161161809|NCT03738566|581970304|FG000|Initial Study Phase|Death|0|||
161161810|NCT03738566|581970305|FG001|Initial Study Phase|Death|1|||
161161811|NCT03738566|581970306|FG002|Initial Study Phase|Death|0|||
161161812|NCT03738566|581970307|FG003|Initial Study Phase|Death|0|||
161161813|NCT03738566|581970304|FG000|Initial Study Phase|Treatment failure|5|||
161161814|NCT03738566|581970305|FG001|Initial Study Phase|Treatment failure|0|||
161161815|NCT03738566|581970306|FG002|Initial Study Phase|Treatment failure|0|||
161161816|NCT03738566|581970307|FG003|Initial Study Phase|Treatment failure|0|||
161161817|NCT03738566|581970304|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161161818|NCT03738566|581970305|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161161819|NCT03738566|581970306|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
161161820|NCT03738566|581970307|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
161161821|NCT03126539|581970316|FG000|Overall Study|Lost to Follow-up|1|||
161161822|NCT03126539|581970317|FG001|Overall Study|Lost to Follow-up|1|||
161161823|NCT03126539|581970318|FG002|Overall Study|Lost to Follow-up|1|||
161346508|NCT03765073|582653304|FG019|Stage 3|No longer meets eligibility criteria|0|||
161346509|NCT03765073|582653305|FG020|Stage 3|No longer meets eligibility criteria|1|||
161346510|NCT03765073|582653285|FG000|Stage 3|Other|0|||
161346511|NCT03765073|582653286|FG001|Stage 3|Other|0|||
161346512|NCT03765073|582653287|FG002|Stage 3|Other|0|||
161346513|NCT03765073|582653288|FG003|Stage 3|Other|0|||
161346514|NCT03765073|582653289|FG004|Stage 3|Other|0|||
161346515|NCT03765073|582653290|FG005|Stage 3|Other|0|||
161346516|NCT03765073|582653291|FG006|Stage 3|Other|0|||
161346517|NCT03765073|582653292|FG007|Stage 3|Other|0|||
161346518|NCT03765073|582653293|FG008|Stage 3|Other|0|||
161346519|NCT03765073|582653294|FG009|Stage 3|Other|0|||
161346520|NCT03765073|582653295|FG010|Stage 3|Other|0|||
161346521|NCT03765073|582653296|FG011|Stage 3|Other|0|||
161346522|NCT03765073|582653297|FG012|Stage 3|Other|0|||
161346523|NCT03765073|582653298|FG013|Stage 3|Other|0|||
161346524|NCT03765073|582653299|FG014|Stage 3|Other|0|||
161346525|NCT03765073|582653300|FG015|Stage 3|Other|0|||
161346526|NCT03765073|582653301|FG016|Stage 3|Other|0|||
161346527|NCT03765073|582653302|FG017|Stage 3|Other|1|||
161346528|NCT03765073|582653303|FG018|Stage 3|Other|2|||
161346529|NCT03765073|582653304|FG019|Stage 3|Other|2|||
161346530|NCT03765073|582653305|FG020|Stage 3|Other|2|||
161346531|NCT03765073|582653285|FG000|Stage 3|Withdrawal by parent/guardian|0|||
161346532|NCT03765073|582653286|FG001|Stage 3|Withdrawal by parent/guardian|0|||
161346533|NCT03765073|582653287|FG002|Stage 3|Withdrawal by parent/guardian|0|||
161078686|NCT01327846|581677062|FG001|Extension Phase|Withdrawal by Subject|13|||
161078687|NCT01327846|581677063|FG002|Extension Phase|Withdrawal by Subject|19|||
161078688|NCT01327846|581677064|FG003|Extension Phase|Withdrawal by Subject|37|||
161078689|NCT01327846|581677061|FG000|Extension Phase|Lost to Follow-up|4|||
161078690|NCT01327846|581677062|FG001|Extension Phase|Lost to Follow-up|3|||
161078691|NCT01327846|581677063|FG002|Extension Phase|Lost to Follow-up|4|||
161078692|NCT01327846|581677064|FG003|Extension Phase|Lost to Follow-up|7|||
161078693|NCT01327846|581677061|FG000|Extension Phase|Technical Problems|2|||
161078694|NCT01327846|581677062|FG001|Extension Phase|Technical Problems|4|||
161078695|NCT01327846|581677063|FG002|Extension Phase|Technical Problems|2|||
161078696|NCT01327846|581677064|FG003|Extension Phase|Technical Problems|2|||
161078697|NCT04662931|581677067|FG000|Overall Study|Withdrawal by Subject|17|||
161078698|NCT04662931|581677067|FG000|Overall Study|Death|3|||
161078699|NCT04662931|581677067|FG000|Overall Study|Lost to Follow-up|3|||
161078700|NCT04662931|581677067|FG000|Overall Study|Guardian Decision|1|||
161078701|NCT04343976|581677071|FG000|Overall Study|Withdrawal by Subject|0|||
161078702|NCT04343976|581677072|FG001|Overall Study|Withdrawal by Subject|1|||
161078703|NCT02807883|581677073|FG000|Overall Study|Withdrawal by Subject|2|||
161078704|NCT00623805|581677074|FG000|Overall Study|Adverse Event|9|||
161078705|NCT00623805|581677075|FG001|Overall Study|Adverse Event|6|||
161078706|NCT00623805|581677074|FG000|Overall Study|Death|2|||
161078707|NCT00623805|581677075|FG001|Overall Study|Death|0|||
161078708|NCT00623805|581677074|FG000|Overall Study|Lack of Efficacy|3|||
161078709|NCT00623805|581677075|FG001|Overall Study|Lack of Efficacy|7|||
161078710|NCT00623805|581677074|FG000|Overall Study|Lost to Follow-up|2|||
161078711|NCT00623805|581677075|FG001|Overall Study|Lost to Follow-up|2|||
161078712|NCT00623805|581677074|FG000|Overall Study|Protocol Violation|1|||
161078713|NCT00623805|581677075|FG001|Overall Study|Protocol Violation|1|||
161078714|NCT00623805|581677074|FG000|Overall Study|Reason not Specified|3|||
161078715|NCT00623805|581677075|FG001|Overall Study|Reason not Specified|6|||
161078716|NCT03810235|581677079|FG000|Overall Study|Withdrawal by Subject|2|||
161078717|NCT03810235|581677080|FG001|Overall Study|Withdrawal by Subject|0|||
161078718|NCT04201262|581677081|FG000|Primary Treatment Period|Adverse Event|1|||
161078719|NCT04201262|581677082|FG001|Primary Treatment Period|Adverse Event|2|||
161078720|NCT04201262|581677081|FG000|Primary Treatment Period|Physician Decision|1|||
161078721|NCT04201262|581677082|FG001|Primary Treatment Period|Physician Decision|1|||
161078722|NCT04201262|581677081|FG000|Long-term Extension Period|Death|1|||
161078723|NCT04201262|581677082|FG001|Long-term Extension Period|Death|0|||
161078724|NCT03682185|581677083|FG000|Overall Study|Lost to Follow-up|4|||
161078725|NCT03682185|581677084|FG001|Overall Study|Lost to Follow-up|7|||
161078726|NCT03682185|581677085|FG002|Overall Study|Lost to Follow-up|4|||
161078727|NCT03682185|581677086|FG003|Overall Study|Lost to Follow-up|7|||
161078728|NCT03682185|581677087|FG004|Overall Study|Lost to Follow-up|1|||
161078729|NCT03682185|581677083|FG000|Overall Study|Withdrawal by Subject|7|||
161078730|NCT03682185|581677084|FG001|Overall Study|Withdrawal by Subject|3|||
161078731|NCT03682185|581677085|FG002|Overall Study|Withdrawal by Subject|7|||
161078732|NCT03682185|581677086|FG003|Overall Study|Withdrawal by Subject|3|||
161078733|NCT03682185|581677087|FG004|Overall Study|Withdrawal by Subject|0|||
161346534|NCT03765073|582653288|FG003|Stage 3|Withdrawal by parent/guardian|0|||
161346535|NCT03765073|582653289|FG004|Stage 3|Withdrawal by parent/guardian|0|||
161346536|NCT03765073|582653290|FG005|Stage 3|Withdrawal by parent/guardian|0|||
161078734|NCT03548220|581677089|FG000|Overall Study|Lost to Follow-up|1|||
161346537|NCT03765073|582653291|FG006|Stage 3|Withdrawal by parent/guardian|0|||
161346538|NCT03765073|582653292|FG007|Stage 3|Withdrawal by parent/guardian|0|||
161346539|NCT03765073|582653293|FG008|Stage 3|Withdrawal by parent/guardian|0|||
161346540|NCT03765073|582653294|FG009|Stage 3|Withdrawal by parent/guardian|0|||
161161824|NCT03126539|581970319|FG003|Overall Study|Lost to Follow-up|0|||
161161825|NCT03126539|581970320|FG004|Overall Study|Lost to Follow-up|0|||
161161826|NCT01627067|581970321|FG000|Overall Study|Screen Failure|1|||
161161827|NCT00926796|581970322|FG000|Overall Study|Did not receive randomized treatment|4|||
161161828|NCT00926796|581970323|FG001|Overall Study|Did not receive randomized treatment|7|||
161161829|NCT00926796|581970322|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
161161830|NCT00926796|581970323|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
161161831|NCT00926796|581970322|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
161161832|NCT00926796|581970323|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
161161833|NCT00926796|581970322|FG000|Overall Study|Adverse Event|7|||
161161834|NCT00926796|581970323|FG001|Overall Study|Adverse Event|14|||
161161835|NCT00926796|581970322|FG000|Overall Study|Lost to Follow-up|22|||
161161836|NCT00926796|581970323|FG001|Overall Study|Lost to Follow-up|13|||
161161837|NCT00926796|581970322|FG000|Overall Study|Protocol Violation|15|||
161161838|NCT00926796|581970323|FG001|Overall Study|Protocol Violation|11|||
161161839|NCT00926796|581970322|FG000|Overall Study|Withdrawal by Subject|1|||
161161840|NCT00926796|581970323|FG001|Overall Study|Withdrawal by Subject|0|||
161161841|NCT01072539|581970327|FG000|Overall Study|Treated prior to the Site Initiation|1|||
161161842|NCT01072539|581970327|FG000|Overall Study|Protocol Violation|2|||
161161843|NCT00946530|581970328|FG000|Overall Study|Withdrawal by Subject|0|||
161161844|NCT00946530|581970329|FG001|Overall Study|Withdrawal by Subject|3|||
161161845|NCT00946530|581970330|FG002|Overall Study|Withdrawal by Subject|0|||
161161846|NCT00946530|581970331|FG003|Overall Study|Withdrawal by Subject|3|||
161161847|NCT00946530|581970328|FG000|Overall Study|Physician Decision|1|||
161161848|NCT00946530|581970329|FG001|Overall Study|Physician Decision|1|||
161161849|NCT00946530|581970330|FG002|Overall Study|Physician Decision|1|||
161161850|NCT00946530|581970331|FG003|Overall Study|Physician Decision|1|||
161161851|NCT00417976|581970332|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
161161852|NCT00417976|581970332|FG000|Overall Study|Treatment -related toxicity|2|||
161161853|NCT02358369|581970333|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
161161854|NCT02358369|581970334|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161161855|NCT02358369|581970335|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161161856|NCT02358369|581970336|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161161857|NCT02358369|581970337|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
161161858|NCT02358369|581970333|FG000|Treatment Period A/B|Adverse Event|0|||
161161859|NCT02358369|581970334|FG001|Treatment Period A/B|Adverse Event|0|||
161161860|NCT02358369|581970335|FG002|Treatment Period A/B|Adverse Event|1|||
161161861|NCT02358369|581970336|FG003|Treatment Period A/B|Adverse Event|2|||
161161862|NCT02358369|581970337|FG004|Treatment Period A/B|Adverse Event|0|||
161161863|NCT02358369|581970333|FG000|Treatment Period A/B|Death|0|||
161161864|NCT02358369|581970334|FG001|Treatment Period A/B|Death|0|||
161161865|NCT02358369|581970335|FG002|Treatment Period A/B|Death|1|||
161161866|NCT02358369|581970336|FG003|Treatment Period A/B|Death|0|||
161161867|NCT02358369|581970337|FG004|Treatment Period A/B|Death|0|||
161161868|NCT02358369|581970333|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
161161869|NCT02358369|581970334|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
161161870|NCT02358369|581970335|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
161161871|NCT02358369|581970336|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
161161872|NCT02358369|581970337|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
161161873|NCT02358369|581970333|FG000|Treatment Period C|Adverse Event|0|||
161161874|NCT02358369|581970334|FG001|Treatment Period C|Adverse Event|0|||
161161875|NCT02358369|581970335|FG002|Treatment Period C|Adverse Event|0|||
161161876|NCT02358369|581970336|FG003|Treatment Period C|Adverse Event|0|||
161161877|NCT02358369|581970337|FG004|Treatment Period C|Adverse Event|7|||
161161878|NCT03655717|581970338|FG000|Overall Study|Withdrawal by Subject|4|||
161161879|NCT03655717|581970339|FG001|Overall Study|Withdrawal by Subject|8|||
161161880|NCT03655717|581970340|FG002|Overall Study|Withdrawal by Subject|1|||
161161881|NCT03655717|581970341|FG003|Overall Study|Withdrawal by Subject|0|||
161161882|NCT03655717|581970342|FG004|Overall Study|Withdrawal by Subject|0|||
161161883|NCT03655717|581970343|FG005|Overall Study|Withdrawal by Subject|1|||
161161884|NCT03655717|581970344|FG006|Overall Study|Withdrawal by Subject|3|||
161161885|NCT03655717|581970345|FG007|Overall Study|Withdrawal by Subject|1|||
161161886|NCT03655717|581970346|FG008|Overall Study|Withdrawal by Subject|2|||
161161887|NCT03655717|581970347|FG009|Overall Study|Withdrawal by Subject|0|||
161161888|NCT03655717|581970348|FG010|Overall Study|Withdrawal by Subject|0|||
161161889|NCT03655717|581970349|FG011|Overall Study|Withdrawal by Subject|1|||
161161890|NCT03655717|581970350|FG012|Overall Study|Withdrawal by Subject|0|||
161161891|NCT03655717|581970351|FG013|Overall Study|Withdrawal by Subject|3|||
161161892|NCT03655717|581970352|FG014|Overall Study|Withdrawal by Subject|0|||
161161893|NCT03655717|581970353|FG015|Overall Study|Withdrawal by Subject|1|||
161161894|NCT03655717|581970354|FG016|Overall Study|Withdrawal by Subject|0|||
161161895|NCT03655717|581970355|FG017|Overall Study|Withdrawal by Subject|0|||
161287963|NCT05842967|582436108|FG000|Period 1: SSA|Withdrawal by Subject|2|||
161287964|NCT05842967|582436109|FG001|Period 1: SSA|Withdrawal by Subject|2|||
161161896|NCT03655717|581970356|FG018|Overall Study|Withdrawal by Subject|1|||
161161897|NCT03655717|581970357|FG019|Overall Study|Withdrawal by Subject|0|||
161161898|NCT03655717|581970358|FG020|Overall Study|Withdrawal by Subject|0|||
161161899|NCT03655717|581970359|FG021|Overall Study|Withdrawal by Subject|1|||
161161900|NCT03655717|581970360|FG022|Overall Study|Withdrawal by Subject|2|||
161161901|NCT03655717|581970361|FG023|Overall Study|Withdrawal by Subject|1|||
161161902|NCT03655717|581970362|FG024|Overall Study|Withdrawal by Subject|1|||
161161903|NCT03655717|581970363|FG025|Overall Study|Withdrawal by Subject|0|||
161161904|NCT03655717|581970338|FG000|Overall Study|Physician Decision|3|||
161161905|NCT03655717|581970339|FG001|Overall Study|Physician Decision|3|||
161161906|NCT03655717|581970340|FG002|Overall Study|Physician Decision|0|||
161161907|NCT03655717|581970341|FG003|Overall Study|Physician Decision|0|||
161161908|NCT03655717|581970342|FG004|Overall Study|Physician Decision|0|||
161161909|NCT03655717|581970343|FG005|Overall Study|Physician Decision|0|||
161161910|NCT03655717|581970344|FG006|Overall Study|Physician Decision|0|||
161161911|NCT03655717|581970345|FG007|Overall Study|Physician Decision|0|||
161161912|NCT03655717|581970346|FG008|Overall Study|Physician Decision|0|||
161161913|NCT03655717|581970347|FG009|Overall Study|Physician Decision|1|||
161161914|NCT03655717|581970348|FG010|Overall Study|Physician Decision|0|||
161161915|NCT03655717|581970349|FG011|Overall Study|Physician Decision|0|||
161161916|NCT03655717|581970350|FG012|Overall Study|Physician Decision|0|||
161161917|NCT03655717|581970351|FG013|Overall Study|Physician Decision|0|||
161161918|NCT03655717|581970352|FG014|Overall Study|Physician Decision|0|||
161161919|NCT03655717|581970353|FG015|Overall Study|Physician Decision|0|||
161161920|NCT03655717|581970354|FG016|Overall Study|Physician Decision|0|||
161161921|NCT03655717|581970355|FG017|Overall Study|Physician Decision|0|||
161161922|NCT03655717|581970356|FG018|Overall Study|Physician Decision|0|||
161161923|NCT03655717|581970357|FG019|Overall Study|Physician Decision|1|||
161161924|NCT03655717|581970358|FG020|Overall Study|Physician Decision|0|||
161161925|NCT03655717|581970359|FG021|Overall Study|Physician Decision|0|||
161161926|NCT03655717|581970360|FG022|Overall Study|Physician Decision|0|||
161161927|NCT03655717|581970361|FG023|Overall Study|Physician Decision|1|||
161161928|NCT03655717|581970362|FG024|Overall Study|Physician Decision|0|||
161161929|NCT03655717|581970363|FG025|Overall Study|Physician Decision|0|||
161161930|NCT03655717|581970338|FG000|Overall Study|Lost to Follow-up|3|||
161161931|NCT03655717|581970339|FG001|Overall Study|Lost to Follow-up|1|||
161161932|NCT03655717|581970340|FG002|Overall Study|Lost to Follow-up|0|||
161161933|NCT03655717|581970341|FG003|Overall Study|Lost to Follow-up|1|||
161161934|NCT03655717|581970342|FG004|Overall Study|Lost to Follow-up|0|||
161161935|NCT03655717|581970343|FG005|Overall Study|Lost to Follow-up|1|||
161161936|NCT03655717|581970344|FG006|Overall Study|Lost to Follow-up|0|||
161161937|NCT03655717|581970345|FG007|Overall Study|Lost to Follow-up|0|||
161161938|NCT03655717|581970346|FG008|Overall Study|Lost to Follow-up|0|||
161161939|NCT03655717|581970347|FG009|Overall Study|Lost to Follow-up|0|||
161161940|NCT03655717|581970348|FG010|Overall Study|Lost to Follow-up|0|||
161161941|NCT03655717|581970349|FG011|Overall Study|Lost to Follow-up|1|||
161161942|NCT03655717|581970350|FG012|Overall Study|Lost to Follow-up|0|||
161161943|NCT03655717|581970351|FG013|Overall Study|Lost to Follow-up|0|||
161161944|NCT03655717|581970352|FG014|Overall Study|Lost to Follow-up|0|||
161161945|NCT03655717|581970353|FG015|Overall Study|Lost to Follow-up|0|||
161161946|NCT03655717|581970354|FG016|Overall Study|Lost to Follow-up|0|||
161161947|NCT03655717|581970355|FG017|Overall Study|Lost to Follow-up|0|||
161161948|NCT03655717|581970356|FG018|Overall Study|Lost to Follow-up|0|||
161161949|NCT03655717|581970357|FG019|Overall Study|Lost to Follow-up|0|||
161161950|NCT03655717|581970358|FG020|Overall Study|Lost to Follow-up|0|||
161161951|NCT03655717|581970359|FG021|Overall Study|Lost to Follow-up|0|||
161161952|NCT03655717|581970360|FG022|Overall Study|Lost to Follow-up|0|||
161161953|NCT03655717|581970361|FG023|Overall Study|Lost to Follow-up|0|||
161161954|NCT03655717|581970362|FG024|Overall Study|Lost to Follow-up|0|||
161161955|NCT03655717|581970363|FG025|Overall Study|Lost to Follow-up|0|||
161161956|NCT01973452|581970364|FG000|Overall Study|Lack of Efficacy|0|||
161161957|NCT01973452|581970365|FG001|Overall Study|Lack of Efficacy|1|||
161161958|NCT01973452|581970364|FG000|Overall Study|Lost to Follow-up|1|||
161161959|NCT01973452|581970365|FG001|Overall Study|Lost to Follow-up|0|||
161161960|NCT01973452|581970364|FG000|Overall Study|Withdrawal by Subject|10|||
161161961|NCT01973452|581970365|FG001|Overall Study|Withdrawal by Subject|9|||
161161962|NCT01973452|581970364|FG000|Overall Study|Ineligible|1|||
161161963|NCT01973452|581970365|FG001|Overall Study|Ineligible|1|||
161161964|NCT01973452|581970364|FG000|Overall Study|Surgery canceled by participant|5|||
161161965|NCT01973452|581970365|FG001|Overall Study|Surgery canceled by participant|3|||
161161966|NCT01454401|581970370|FG000|Overall Study|Death|1|||
161161967|NCT01454401|581970370|FG000|Overall Study|hospitalised|1|||
161161968|NCT01454401|581970370|FG000|Overall Study|osteomyelitis|2|||
161161969|NCT01454401|581970370|FG000|Overall Study|non-adherence|1|||
161161970|NCT03675737|581970371|FG000|Overall Study|Death|593|||
161161971|NCT03675737|581970372|FG001|Overall Study|Death|660|||
161161972|NCT03675737|581970371|FG000|Overall Study|Lost to Follow-up|1|||
161161973|NCT03675737|581970372|FG001|Overall Study|Lost to Follow-up|5|||
161161974|NCT03675737|581970371|FG000|Overall Study|Physician Decision|1|||
161161975|NCT03675737|581970372|FG001|Overall Study|Physician Decision|0|||
161161976|NCT03675737|581970371|FG000|Overall Study|Withdrawal by Subject|14|||
161161977|NCT03675737|581970372|FG001|Overall Study|Withdrawal by Subject|12|||
161161978|NCT03675737|581970371|FG000|Overall Study|Ongoing in Study|181|||
161161979|NCT03675737|581970372|FG001|Overall Study|Ongoing in Study|112|||
161161980|NCT01274338|581972104|FG000|Overall Study|Lack of Efficacy|72|||
161161981|NCT01274338|581972105|FG001|Overall Study|Lack of Efficacy|108|||
161161982|NCT01274338|581972106|FG002|Overall Study|Lack of Efficacy|116|||
161161983|NCT01274338|581972107|FG003|Overall Study|Lack of Efficacy|0|||
161287965|NCT05842967|582436110|FG002|Period 1: SSA|Withdrawal by Subject|0|||
161287966|NCT05842967|582436111|FG003|Period 1: SSA|Withdrawal by Subject|0|||
161287967|NCT05842967|582436108|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
161287968|NCT05842967|582436109|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
161287969|NCT05842967|582436110|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
161287970|NCT05842967|582436111|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
161287971|NCT05842967|582436108|FG000|Period 2: SSB|Adverse Event|0|||
161287972|NCT05842967|582436109|FG001|Period 2: SSB|Adverse Event|0|||
161287973|NCT05842967|582436110|FG002|Period 2: SSB|Adverse Event|2|||
161287974|NCT05842967|582436111|FG003|Period 2: SSB|Adverse Event|0|||
161287975|NCT05842967|582436108|FG000|Period 2: SSB|Lost to Follow-up|0|||
161287976|NCT05842967|582436109|FG001|Period 2: SSB|Lost to Follow-up|0|||
161287977|NCT05842967|582436110|FG002|Period 2: SSB|Lost to Follow-up|4|||
161287978|NCT05842967|582436111|FG003|Period 2: SSB|Lost to Follow-up|3|||
161287979|NCT05842967|582436108|FG000|Period 2: SSB|Withdrawal by Subject|0|||
161287980|NCT05842967|582436109|FG001|Period 2: SSB|Withdrawal by Subject|0|||
161287981|NCT05842967|582436110|FG002|Period 2: SSB|Withdrawal by Subject|1|||
161287982|NCT05842967|582436111|FG003|Period 2: SSB|Withdrawal by Subject|0|||
161287983|NCT05842967|582436108|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
161287984|NCT05842967|582436109|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
161287985|NCT05842967|582436110|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
161287986|NCT05842967|582436111|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
161287987|NCT05842967|582436108|FG000|Period 2: SSB|Protocol Violation|0|||
161287988|NCT05842967|582436109|FG001|Period 2: SSB|Protocol Violation|0|||
161287989|NCT05842967|582436110|FG002|Period 2: SSB|Protocol Violation|0|||
161287990|NCT05842967|582436111|FG003|Period 2: SSB|Protocol Violation|1|||
161287991|NCT03657797|582436117|FG000|Overall Study|Lost to Follow-up|0|||
161287992|NCT03657797|582436118|FG001|Overall Study|Lost to Follow-up|1|||
161287993|NCT03657797|582436119|FG002|Overall Study|Lost to Follow-up|1|||
161287994|NCT03657797|582436120|FG003|Overall Study|Lost to Follow-up|0|||
161287995|NCT03657797|582436117|FG000|Overall Study|Physician Decision|0|||
161287996|NCT03657797|582436118|FG001|Overall Study|Physician Decision|1|||
161287997|NCT03657797|582436119|FG002|Overall Study|Physician Decision|0|||
161287998|NCT03657797|582436120|FG003|Overall Study|Physician Decision|0|||
161287999|NCT03657797|582436117|FG000|Overall Study|Withdrawal by Subject|0|||
161288000|NCT03657797|582436118|FG001|Overall Study|Withdrawal by Subject|1|||
161288001|NCT03657797|582436119|FG002|Overall Study|Withdrawal by Subject|2|||
161288002|NCT03657797|582436120|FG003|Overall Study|Withdrawal by Subject|0|||
161288003|NCT03657797|582436117|FG000|Overall Study|Adverse Event|0|||
161288004|NCT03657797|582436118|FG001|Overall Study|Adverse Event|0|||
161288005|NCT03657797|582436119|FG002|Overall Study|Adverse Event|2|||
161288006|NCT03657797|582436120|FG003|Overall Study|Adverse Event|0|||
161288007|NCT00711243|582436123|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
161288008|NCT00711243|582436124|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
161288009|NCT00711243|582436125|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
161288010|NCT00711243|582436126|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
161288011|NCT00711243|582436127|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
161288012|NCT00711243|582436128|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
161288013|NCT00711243|582436123|FG000|Reached First Response/4 Cycles|Death|0|||
161288014|NCT00711243|582436124|FG001|Reached First Response/4 Cycles|Death|0|||
161288015|NCT00711243|582436125|FG002|Reached First Response/4 Cycles|Death|0|||
161288016|NCT00711243|582436126|FG003|Reached First Response/4 Cycles|Death|0|||
161288017|NCT00711243|582436127|FG004|Reached First Response/4 Cycles|Death|0|||
161288018|NCT00711243|582436128|FG005|Reached First Response/4 Cycles|Death|2|||
161288019|NCT00711243|582436123|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
161288020|NCT00711243|582436124|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
161288021|NCT00711243|582436125|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
161288022|NCT00711243|582436126|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
161288023|NCT00711243|582436127|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
161288024|NCT00711243|582436128|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
161288025|NCT00711243|582436123|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
161161984|NCT01274338|581972108|FG004|Overall Study|Lack of Efficacy|0|||
161161985|NCT01274338|581972109|FG005|Overall Study|Lack of Efficacy|0|||
161288026|NCT00711243|582436124|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
161288027|NCT00711243|582436125|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
161288028|NCT00711243|582436126|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
161161986|NCT01274338|581972104|FG000|Overall Study|Adverse Event|272|||
161346541|NCT03765073|582653295|FG010|Stage 3|Withdrawal by parent/guardian|0|||
161346542|NCT03765073|582653296|FG011|Stage 3|Withdrawal by parent/guardian|0|||
161161987|NCT01274338|581972105|FG001|Overall Study|Adverse Event|105|||
161161988|NCT01274338|581972106|FG002|Overall Study|Adverse Event|180|||
161161989|NCT01274338|581972107|FG003|Overall Study|Adverse Event|1|||
161161990|NCT01274338|581972108|FG004|Overall Study|Adverse Event|0|||
161161991|NCT01274338|581972109|FG005|Overall Study|Adverse Event|0|||
161161992|NCT01274338|581972104|FG000|Overall Study|Death|8|||
161161993|NCT01274338|581972105|FG001|Overall Study|Death|1|||
161161994|NCT01274338|581972106|FG002|Overall Study|Death|0|||
161161995|NCT01274338|581972107|FG003|Overall Study|Death|0|||
161161996|NCT01274338|581972108|FG004|Overall Study|Death|0|||
161161997|NCT01274338|581972109|FG005|Overall Study|Death|0|||
161161998|NCT01274338|581972104|FG000|Overall Study|Withdrawal by Subject|27|||
161161999|NCT01274338|581972105|FG001|Overall Study|Withdrawal by Subject|99|||
161162000|NCT01274338|581972106|FG002|Overall Study|Withdrawal by Subject|17|||
161162001|NCT01274338|581972107|FG003|Overall Study|Withdrawal by Subject|0|||
161162002|NCT01274338|581972108|FG004|Overall Study|Withdrawal by Subject|0|||
161162003|NCT01274338|581972109|FG005|Overall Study|Withdrawal by Subject|0|||
161162004|NCT01274338|581972104|FG000|Overall Study|Did not start treatment|8|||
161162005|NCT01274338|581972105|FG001|Overall Study|Did not start treatment|116|||
161162006|NCT01274338|581972106|FG002|Overall Study|Did not start treatment|7|||
161162007|NCT01274338|581972107|FG003|Overall Study|Did not start treatment|0|||
161162008|NCT01274338|581972108|FG004|Overall Study|Did not start treatment|0|||
161162009|NCT01274338|581972109|FG005|Overall Study|Did not start treatment|0|||
161162010|NCT01274338|581972104|FG000|Overall Study|Alternative therapy|0|||
161162011|NCT01274338|581972105|FG001|Overall Study|Alternative therapy|1|||
161162012|NCT01274338|581972106|FG002|Overall Study|Alternative therapy|0|||
161162013|NCT01274338|581972107|FG003|Overall Study|Alternative therapy|0|||
161162014|NCT01274338|581972108|FG004|Overall Study|Alternative therapy|0|||
161162015|NCT01274338|581972109|FG005|Overall Study|Alternative therapy|0|||
161162016|NCT01274338|581972104|FG000|Overall Study|Other complicating diseases|0|||
161162017|NCT01274338|581972105|FG001|Overall Study|Other complicating diseases|3|||
161162018|NCT01274338|581972106|FG002|Overall Study|Other complicating diseases|1|||
161162019|NCT01274338|581972107|FG003|Overall Study|Other complicating diseases|0|||
161162020|NCT01274338|581972108|FG004|Overall Study|Other complicating diseases|0|||
161162021|NCT01274338|581972109|FG005|Overall Study|Other complicating diseases|0|||
161162022|NCT01274338|581972104|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
161162023|NCT01274338|581972105|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
161162024|NCT01274338|581972106|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
161162025|NCT01274338|581972107|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
161162026|NCT01274338|581972108|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
161162027|NCT01274338|581972109|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
161162028|NCT01274338|581972104|FG000|Overall Study|Pregnancy|0|||
161162029|NCT01274338|581972105|FG001|Overall Study|Pregnancy|0|||
161162030|NCT01274338|581972106|FG002|Overall Study|Pregnancy|1|||
161162031|NCT01274338|581972107|FG003|Overall Study|Pregnancy|0|||
161162032|NCT01274338|581972108|FG004|Overall Study|Pregnancy|0|||
161162033|NCT01274338|581972109|FG005|Overall Study|Pregnancy|0|||
161162034|NCT01274338|581972104|FG000|Overall Study|Reason not reported|12|||
161162035|NCT01274338|581972105|FG001|Overall Study|Reason not reported|21|||
161162036|NCT01274338|581972106|FG002|Overall Study|Reason not reported|3|||
161162037|NCT01274338|581972107|FG003|Overall Study|Reason not reported|0|||
161162038|NCT01274338|581972108|FG004|Overall Study|Reason not reported|1|||
161162039|NCT01274338|581972109|FG005|Overall Study|Reason not reported|0|||
161162040|NCT03004469|581972110|FG000|Overall Study|Adverse Event|6|||
161162041|NCT03004469|581972111|FG001|Overall Study|Adverse Event|4|||
161162042|NCT03004469|581972112|FG002|Overall Study|Adverse Event|6|||
161346543|NCT03765073|582653297|FG012|Stage 3|Withdrawal by parent/guardian|0|||
161346544|NCT03765073|582653298|FG013|Stage 3|Withdrawal by parent/guardian|0|||
161346545|NCT03765073|582653299|FG014|Stage 3|Withdrawal by parent/guardian|0|||
161162043|NCT03004469|581972110|FG000|Overall Study|Lack of Efficacy|1|||
161162044|NCT03004469|581972111|FG001|Overall Study|Lack of Efficacy|0|||
161162045|NCT03004469|581972112|FG002|Overall Study|Lack of Efficacy|1|||
161162046|NCT03004469|581972110|FG000|Overall Study|Lost to Follow-up|23|||
161162047|NCT03004469|581972111|FG001|Overall Study|Lost to Follow-up|14|||
161162048|NCT03004469|581972112|FG002|Overall Study|Lost to Follow-up|6|||
161162049|NCT03004469|581972110|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161162050|NCT03004469|581972111|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161162051|NCT03004469|581972112|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161162052|NCT03004469|581972110|FG000|Overall Study|Protocol Violation|0|||
161162053|NCT03004469|581972111|FG001|Overall Study|Protocol Violation|0|||
161162054|NCT03004469|581972112|FG002|Overall Study|Protocol Violation|1|||
161162055|NCT03004469|581972110|FG000|Overall Study|Withdrawal by Subject|29|||
161162056|NCT03004469|581972111|FG001|Overall Study|Withdrawal by Subject|27|||
161162057|NCT03004469|581972112|FG002|Overall Study|Withdrawal by Subject|10|||
161346546|NCT03765073|582653300|FG015|Stage 3|Withdrawal by parent/guardian|0|||
161162058|NCT03004469|581972110|FG000|Overall Study|Other unspecified reason|0|||
161162059|NCT03004469|581972111|FG001|Overall Study|Other unspecified reason|4|||
161162060|NCT03004469|581972112|FG002|Overall Study|Other unspecified reason|1|||
161162061|NCT01397552|581972113|FG000|Overall Study|Adverse Event|1|||
161162062|NCT01397552|581972114|FG001|Overall Study|Adverse Event|0|||
161162063|NCT01397552|581972113|FG000|Overall Study|Withdrawal by Subject|2|||
161162064|NCT01397552|581972114|FG001|Overall Study|Withdrawal by Subject|1|||
161162065|NCT00579501|581972117|FG000|Overall Study|Death|1|||
161162066|NCT00579501|581972117|FG000|Overall Study|End of neoadjuvant therapy|25|||
161162067|NCT00579501|581972117|FG000|Overall Study|toxicity|1|||
161162068|NCT00579501|581972117|FG000|Overall Study|Secondary lesion|1|||
161162069|NCT00579501|581972117|FG000|Overall Study|Radiation therapy before surgery|1|||
161162070|NCT00190983|581972118|FG000|Overall Study|Inevaluable (never treated)|2|||
161162071|NCT02287402|581972119|FG000|Treatment Period|Adverse Event|17|||
161162072|NCT02287402|581972119|FG000|Treatment Period|Voluntary Withdrawal|10|||
161162073|NCT02287402|581972119|FG000|Follow-up|Lost to Follow-up|1|||
161162074|NCT02287402|581972119|FG000|Follow-up|Voluntary Withdrawal|2|||
161162075|NCT04247815|581972120|FG000|Overall Study|Adverse Event|1|||
161162076|NCT04247815|581972121|FG001|Overall Study|Adverse Event|0|||
161162077|NCT04247815|581972120|FG000|Overall Study|Withdrawal by Subject|1|||
161162078|NCT04247815|581972121|FG001|Overall Study|Withdrawal by Subject|0|||
161162079|NCT04247815|581972120|FG000|Overall Study|Protocol Violation|0|||
161162080|NCT04247815|581972121|FG001|Overall Study|Protocol Violation|1|||
161162081|NCT03150095|581972122|FG000|Overall Study|Death|0|||
161162082|NCT03150095|581972123|FG001|Overall Study|Death|1|||
161162083|NCT03150095|581972122|FG000|Overall Study|Lost to Follow-up|1|||
161162084|NCT03150095|581972123|FG001|Overall Study|Lost to Follow-up|1|||
161162085|NCT03150095|581972122|FG000|Overall Study|Withdrawal by Subject|4|||
161162086|NCT03150095|581972123|FG001|Overall Study|Withdrawal by Subject|0|||
161162087|NCT03150095|581972122|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
161162088|NCT03150095|581972123|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
161162089|NCT04032171|581972125|FG000|Overall Study|Study Termination|1|||
161162090|NCT04032171|581972126|FG001|Overall Study|Study Termination|0|||
161162091|NCT00089479|581972136|FG000|Overall Study|Death|108|||
161162092|NCT00089479|581972137|FG001|Overall Study|Death|75|||
161162093|NCT00089479|581972136|FG000|Overall Study|Withdrawal by Subject|86|||
161162094|NCT00089479|581972137|FG001|Overall Study|Withdrawal by Subject|107|||
161162095|NCT00089479|581972136|FG000|Overall Study|Lost to Follow-up|137|||
161162096|NCT00089479|581972137|FG001|Overall Study|Lost to Follow-up|107|||
161162097|NCT03943953|581972138|FG000|Trial of ITG 1|Lost to Follow-up|19|||
161162098|NCT03943953|581972139|FG001|Trial of ITG 1|Lost to Follow-up|1|||
161162099|NCT03943953|581972138|FG000|Trial of ITG 2|Lost to Follow-up|8|||
161162100|NCT03943953|581972139|FG001|Trial of ITG 2|Lost to Follow-up|0|||
161162101|NCT03943953|581972138|FG000|Trial of ITG 3|Lost to Follow-up|2|||
161162102|NCT03943953|581972139|FG001|Trial of ITG 3|Lost to Follow-up|0|||
161162103|NCT03943953|581972138|FG000|Trial of ITG 4|Lost to Follow-up|2|||
161162104|NCT03943953|581972139|FG001|Trial of ITG 4|Lost to Follow-up|0|||
161162105|NCT01124448|581972142|FG000|Overall Study|Lost to Follow-up|0|||
161162106|NCT01124448|581972143|FG001|Overall Study|Lost to Follow-up|3|||
161162107|NCT01124448|581972142|FG000|Overall Study|Protocol Violation|2|||
161162108|NCT01124448|581972143|FG001|Overall Study|Protocol Violation|0|||
161162109|NCT03471767|581972144|FG000|Overall Study|Withdrawal by Subject|3|||
161162110|NCT03471767|581972145|FG001|Overall Study|Withdrawal by Subject|1|||
161162111|NCT03471767|581972144|FG000|Overall Study|Adverse Event|1|||
161162112|NCT03471767|581972145|FG001|Overall Study|Adverse Event|0|||
161162113|NCT03471767|581972144|FG000|Overall Study|Lost to Follow-up|1|||
161162114|NCT03471767|581972145|FG001|Overall Study|Lost to Follow-up|0|||
161162115|NCT03471767|581972144|FG000|Overall Study|PI Withdrawal|1|||
161162116|NCT03471767|581972145|FG001|Overall Study|PI Withdrawal|3|||
161162117|NCT01875367|581972148|FG000|Overall Study|Not complete at least 2 questionaries|4|||
161162118|NCT01875367|581972149|FG001|Overall Study|Not complete at least 2 questionaries|2|||
161288029|NCT00711243|582436127|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
161288030|NCT00711243|582436128|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
161288031|NCT00711243|582436123|FG000|Treated Cycle 5 After First Response|Death|0|||
161288032|NCT00711243|582436124|FG001|Treated Cycle 5 After First Response|Death|0|||
161288033|NCT00711243|582436125|FG002|Treated Cycle 5 After First Response|Death|0|||
161288034|NCT00711243|582436126|FG003|Treated Cycle 5 After First Response|Death|0|||
161288035|NCT00711243|582436127|FG004|Treated Cycle 5 After First Response|Death|0|||
161288036|NCT00711243|582436128|FG005|Treated Cycle 5 After First Response|Death|2|||
161288037|NCT00711243|582436123|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
161346547|NCT03765073|582653301|FG016|Stage 3|Withdrawal by parent/guardian|0|||
161162119|NCT01875367|581972148|FG000|Overall Study|Not receive study treatment|1|||
161162120|NCT01875367|581972149|FG001|Overall Study|Not receive study treatment|0|||
161162121|NCT02951988|581972150|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
161162122|NCT02951988|581972151|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161162123|NCT02951988|581972152|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161162124|NCT02951988|581972153|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
161078735|NCT03548220|581677090|FG001|Overall Study|Lost to Follow-up|0|||
161078736|NCT03548220|581677091|FG002|Overall Study|Lost to Follow-up|0|||
161078737|NCT03548220|581677092|FG003|Overall Study|Lost to Follow-up|0|||
161078738|NCT02397447|581677093|FG000|Overall Study|Lost to Follow-up|2|||
161078739|NCT02397447|581677094|FG001|Overall Study|Lost to Follow-up|2|||
161078740|NCT06926673|581677097|FG000|Overall Study|Lost to Follow-up|0|||
161078741|NCT06926673|581677098|FG001|Overall Study|Lost to Follow-up|0|||
161078742|NCT06926673|581677099|FG002|Overall Study|Lost to Follow-up|0|||
161078743|NCT06926673|581677100|FG003|Overall Study|Lost to Follow-up|1|||
161078744|NCT06926673|581677101|FG004|Overall Study|Lost to Follow-up|0|||
161078745|NCT06926673|581677102|FG005|Overall Study|Lost to Follow-up|0|||
161078746|NCT06926673|581677103|FG006|Overall Study|Lost to Follow-up|0|||
161078747|NCT06926673|581677097|FG000|Overall Study|Physician Decision|0|||
161078748|NCT06926673|581677098|FG001|Overall Study|Physician Decision|0|||
161078749|NCT06926673|581677099|FG002|Overall Study|Physician Decision|0|||
161078750|NCT06926673|581677100|FG003|Overall Study|Physician Decision|0|||
161078751|NCT06926673|581677101|FG004|Overall Study|Physician Decision|0|||
161078752|NCT06926673|581677102|FG005|Overall Study|Physician Decision|0|||
161078753|NCT06926673|581677103|FG006|Overall Study|Physician Decision|1|||
161078754|NCT06926673|581677097|FG000|Overall Study|Withdrawal by Subject|0|||
161078755|NCT06926673|581677098|FG001|Overall Study|Withdrawal by Subject|3|||
161078756|NCT06926673|581677099|FG002|Overall Study|Withdrawal by Subject|2|||
161078757|NCT06926673|581677100|FG003|Overall Study|Withdrawal by Subject|1|||
161078758|NCT06926673|581677101|FG004|Overall Study|Withdrawal by Subject|0|||
161078759|NCT06926673|581677102|FG005|Overall Study|Withdrawal by Subject|2|||
161078760|NCT06926673|581677103|FG006|Overall Study|Withdrawal by Subject|0|||
161078762|NCT01967147|581678617|FG000|Overall Study|Adverse Event|5|||
161078763|NCT01967147|581678618|FG001|Overall Study|Adverse Event|2|||
161078764|NCT01967147|581678617|FG000|Overall Study|Lack of Efficacy|1|||
161078765|NCT01967147|581678618|FG001|Overall Study|Lack of Efficacy|4|||
161078766|NCT01967147|581678617|FG000|Overall Study|Lost to Follow-up|1|||
161078767|NCT01967147|581678618|FG001|Overall Study|Lost to Follow-up|2|||
161078768|NCT01967147|581678617|FG000|Overall Study|Withdrawal by Subject|2|||
161078769|NCT01967147|581678618|FG001|Overall Study|Withdrawal by Subject|4|||
161078770|NCT01967147|581678617|FG000|Overall Study|Non-compliance with Study Drug|0|||
161078771|NCT01967147|581678618|FG001|Overall Study|Non-compliance with Study Drug|3|||
161078772|NCT01967147|581678617|FG000|Overall Study|Other|4|||
161078773|NCT01967147|581678618|FG001|Overall Study|Other|5|||
161078774|NCT00387426|581678619|FG000|Overall Study|Lack of Response|7|||
161078775|NCT00387426|581678619|FG000|Overall Study|Toxicities|4|||
161078776|NCT00387426|581678619|FG000|Overall Study|Disease Progression|3|||
161078777|NCT03203473|581678620|FG000|Induction Phase|Never started primary treatment|2|||
161078778|NCT03203473|581678621|FG001|Induction Phase|Never started primary treatment|0|||
161078779|NCT03203473|581678622|FG002|Induction Phase|Never started primary treatment|0|||
161078780|NCT03203473|581678620|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
161078781|NCT03203473|581678621|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
161078782|NCT03203473|581678622|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
161078783|NCT03203473|581678620|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
161078784|NCT03203473|581678621|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
161078785|NCT03203473|581678622|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
161078786|NCT03203473|581678620|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
161078787|NCT03203473|581678621|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
161078788|NCT03203473|581678622|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
161078789|NCT03203473|581678620|FG000|Arm Allocation Phase|started salvage therapy|0|||
161078790|NCT03203473|581678621|FG001|Arm Allocation Phase|started salvage therapy|5|||
161078791|NCT03203473|581678622|FG002|Arm Allocation Phase|started salvage therapy|0|||
161078792|NCT03203473|581678620|FG000|Arm Allocation Phase|Disease progression|0|||
161078793|NCT03203473|581678621|FG001|Arm Allocation Phase|Disease progression|0|||
161078794|NCT03203473|581678622|FG002|Arm Allocation Phase|Disease progression|37|||
161078795|NCT03203473|581678620|FG000|Arm Allocation Phase|Adverse Event|0|||
161078796|NCT03203473|581678621|FG001|Arm Allocation Phase|Adverse Event|0|||
161319386|NCT00592592|582555299|FG000|Overall Study|Patient found ineligible upon chart review|1|||
161078797|NCT03203473|581678622|FG002|Arm Allocation Phase|Adverse Event|11|||
161078798|NCT03203473|581678620|FG000|Arm Allocation Phase|Physician Decision|0|||
161078799|NCT03203473|581678621|FG001|Arm Allocation Phase|Physician Decision|0|||
161078800|NCT03203473|581678622|FG002|Arm Allocation Phase|Physician Decision|3|||
161078801|NCT03203473|581678620|FG000|Arm Allocation Phase|Death|0|||
161078802|NCT03203473|581678621|FG001|Arm Allocation Phase|Death|0|||
161078803|NCT03203473|581678622|FG002|Arm Allocation Phase|Death|1|||
161078804|NCT03203473|581678620|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
161078805|NCT03203473|581678621|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
161078806|NCT03203473|581678622|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
161078807|NCT03203473|581678620|FG000|Arm Allocation Phase|Intercurrent illness|0|||
161078808|NCT03203473|581678621|FG001|Arm Allocation Phase|Intercurrent illness|0|||
161078809|NCT03203473|581678622|FG002|Arm Allocation Phase|Intercurrent illness|1|||
161288038|NCT00711243|582436124|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
161288039|NCT00711243|582436125|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
161288040|NCT00711243|582436126|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
161288041|NCT00711243|582436127|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
161288042|NCT00711243|582436128|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
161288043|NCT00711243|582436123|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161288044|NCT00711243|582436124|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161288045|NCT00711243|582436125|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161288046|NCT00711243|582436126|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161288047|NCT00711243|582436127|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
161288048|NCT00711243|582436128|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
161288049|NCT01402570|582436129|FG000|Overall Study|Adverse Event|1|||
161288050|NCT03642262|582436132|FG000|Period 1|Withdrawal by Subject|1|||
161288051|NCT03642262|582436133|FG001|Period 1|Withdrawal by Subject|1|||
161288052|NCT03642262|582436132|FG000|Period 1|Adverse Event|0|||
161288053|NCT03642262|582436133|FG001|Period 1|Adverse Event|1|||
161288054|NCT02572570|582436134|FG000|Overall Study|Study Terminated|27|||
161288055|NCT02019472|582436135|FG000|Overall Study|Adverse Event|14|||
161288056|NCT02019472|582436136|FG001|Overall Study|Adverse Event|23|||
161288057|NCT02019472|582436137|FG002|Overall Study|Adverse Event|17|||
161288058|NCT02019472|582436135|FG000|Overall Study|Death|0|||
161288059|NCT02019472|582436136|FG001|Overall Study|Death|1|||
161288060|NCT02019472|582436137|FG002|Overall Study|Death|1|||
161288061|NCT02019472|582436135|FG000|Overall Study|Lack of Efficacy|7|||
161288062|NCT02019472|582436136|FG001|Overall Study|Lack of Efficacy|4|||
161288063|NCT02019472|582436137|FG002|Overall Study|Lack of Efficacy|4|||
161288064|NCT02019472|582436135|FG000|Overall Study|Lost to Follow-up|0|||
161288065|NCT02019472|582436136|FG001|Overall Study|Lost to Follow-up|2|||
161288066|NCT02019472|582436137|FG002|Overall Study|Lost to Follow-up|1|||
161288067|NCT02019472|582436135|FG000|Overall Study|Physician Decision|1|||
161288068|NCT02019472|582436136|FG001|Overall Study|Physician Decision|2|||
161288069|NCT02019472|582436137|FG002|Overall Study|Physician Decision|0|||
161288070|NCT02019472|582436135|FG000|Overall Study|Pregnancy|1|||
161288071|NCT02019472|582436136|FG001|Overall Study|Pregnancy|2|||
161288072|NCT02019472|582436137|FG002|Overall Study|Pregnancy|2|||
161288073|NCT02019472|582436135|FG000|Overall Study|Withdrawal by Subject|11|||
161288074|NCT02019472|582436136|FG001|Overall Study|Withdrawal by Subject|10|||
161288075|NCT02019472|582436137|FG002|Overall Study|Withdrawal by Subject|11|||
161288076|NCT02019472|582436135|FG000|Overall Study|Other|3|||
161288077|NCT02019472|582436136|FG001|Overall Study|Other|8|||
161288078|NCT02019472|582436137|FG002|Overall Study|Other|6|||
161288079|NCT00513695|582436138|FG000|Overall Study|Discontinued therapy|2|||
161288080|NCT00513695|582436138|FG000|Overall Study|Progression prior to surgery|3|||
161288081|NCT02157935|582436141|FG000|Overall Study|Withdrawal by Subject|25|||
161288082|NCT02157935|582436142|FG001|Overall Study|Withdrawal by Subject|39|||
161288083|NCT02157935|582436141|FG000|Overall Study|Screen failure|1|||
161288084|NCT02157935|582436142|FG001|Overall Study|Screen failure|2|||
161288085|NCT02157935|582436141|FG000|Overall Study|Protocol Violation|1|||
161288086|NCT02157935|582436142|FG001|Overall Study|Protocol Violation|0|||
161288087|NCT02157935|582436141|FG000|Overall Study|Progressive disease|0|||
161288088|NCT02157935|582436142|FG001|Overall Study|Progressive disease|2|||
161288089|NCT02157935|582436141|FG000|Overall Study|Other|5|||
161288090|NCT02157935|582436142|FG001|Overall Study|Other|12|||
161288091|NCT02157935|582436141|FG000|Overall Study|Lack of Efficacy|0|||
161288092|NCT02157935|582436142|FG001|Overall Study|Lack of Efficacy|1|||
161288093|NCT02157935|582436141|FG000|Overall Study|Death|4|||
161288094|NCT02157935|582436142|FG001|Overall Study|Death|4|||
161288095|NCT02157935|582436141|FG000|Overall Study|Adverse Event|3|||
161288096|NCT02157935|582436142|FG001|Overall Study|Adverse Event|5|||
161288097|NCT01417156|582436143|FG000|Overall Study|Adverse Event|12|||
161288098|NCT01417156|582436143|FG000|Overall Study|Protocol Violation|2|||
161288099|NCT03192488|582436144|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
161288100|NCT03192488|582436145|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
161288101|NCT03192488|582436146|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
161288102|NCT03192488|582436147|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
161288103|NCT03192488|582436148|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
161288104|NCT03192488|582436149|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
161288105|NCT03192488|582436144|FG000|Third Intervention (d1)|Adverse Event|0|||
161288106|NCT03192488|582436145|FG001|Third Intervention (d1)|Adverse Event|0|||
161288107|NCT03192488|582436146|FG002|Third Intervention (d1)|Adverse Event|0|||
161288108|NCT03192488|582436147|FG003|Third Intervention (d1)|Adverse Event|0|||
161288109|NCT03192488|582436148|FG004|Third Intervention (d1)|Adverse Event|1|||
161288110|NCT03192488|582436149|FG005|Third Intervention (d1)|Adverse Event|0|||
161288111|NCT00611923|582436151|FG000|Overall Study|Withdrawal by Subject|2|||
161288112|NCT00611923|582436152|FG001|Overall Study|Withdrawal by Subject|2|||
161288113|NCT02302833|582436166|FG000|Overall Study|Lost to Follow-up|3|||
161288114|NCT04429503|582436167|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
161162125|NCT02951988|581972150|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
161162126|NCT02951988|581972151|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
161162127|NCT02951988|581972152|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
161162128|NCT02951988|581972153|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
161162129|NCT02951988|581972150|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
161162130|NCT02951988|581972151|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161162131|NCT02951988|581972152|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161162132|NCT02951988|581972153|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
161162133|NCT02951988|581972150|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
161162134|NCT02951988|581972151|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
161162135|NCT02951988|581972152|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
161162136|NCT02951988|581972153|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
161162137|NCT02951988|581972150|FG000|Open-Label Treatment Period|Protocol Violation|22|||
161162138|NCT02951988|581972151|FG001|Open-Label Treatment Period|Protocol Violation|0|||
161162139|NCT02951988|581972152|FG002|Open-Label Treatment Period|Protocol Violation|0|||
161162140|NCT02951988|581972153|FG003|Open-Label Treatment Period|Protocol Violation|0|||
161162141|NCT02951988|581972150|FG000|Open-Label Treatment Period|Pregnancy|2|||
161162142|NCT02951988|581972151|FG001|Open-Label Treatment Period|Pregnancy|0|||
161162143|NCT02951988|581972152|FG002|Open-Label Treatment Period|Pregnancy|0|||
161162144|NCT02951988|581972153|FG003|Open-Label Treatment Period|Pregnancy|0|||
161162145|NCT02951988|581972150|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
161162146|NCT02951988|581972151|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
161162147|NCT02951988|581972152|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
161162148|NCT02951988|581972153|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
161162149|NCT02951988|581972150|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
161162150|NCT02951988|581972151|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
161162151|NCT02951988|581972152|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
161162152|NCT02951988|581972153|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
161162153|NCT02951988|581972150|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
161162154|NCT02951988|581972151|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
161162155|NCT02951988|581972152|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
161162156|NCT02951988|581972153|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
161162157|NCT02951988|581972150|FG000|Open-Label Treatment Period|Adverse Event|45|||
161162158|NCT02951988|581972151|FG001|Open-Label Treatment Period|Adverse Event|0|||
161162159|NCT02951988|581972152|FG002|Open-Label Treatment Period|Adverse Event|0|||
161162160|NCT02951988|581972153|FG003|Open-Label Treatment Period|Adverse Event|0|||
161162161|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
161162162|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
161162163|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
161162164|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
161288115|NCT04429503|582436168|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
161288116|NCT04429503|582436169|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161078810|NCT03203473|581678620|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
161078811|NCT03203473|581678621|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
161078812|NCT03203473|581678622|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
161078813|NCT04396366|581678625|FG000|Overall Study|Adverse Event|1|||
161078814|NCT04396366|581678626|FG001|Overall Study|Adverse Event|0|||
161078815|NCT01531673|581678627|FG000|Overall Study|Non-Compliance|0|||
161078816|NCT01531673|581678628|FG001|Overall Study|Non-Compliance|0|||
161078817|NCT01531673|581678629|FG002|Overall Study|Non-Compliance|0|||
161078818|NCT01531673|581678630|FG003|Overall Study|Non-Compliance|0|||
161078819|NCT01531673|581678631|FG004|Overall Study|Non-Compliance|0|||
161078820|NCT01531673|581678632|FG005|Overall Study|Non-Compliance|1|||
161078821|NCT01531673|581678633|FG006|Overall Study|Non-Compliance|0|||
161078822|NCT01531673|581678634|FG007|Overall Study|Non-Compliance|0|||
161078823|NCT01531673|581678635|FG008|Overall Study|Non-Compliance|0|||
161078824|NCT01531673|581678636|FG009|Overall Study|Non-Compliance|0|||
161078825|NCT01531673|581678637|FG010|Overall Study|Non-Compliance|0|||
161078826|NCT01531673|581678638|FG011|Overall Study|Non-Compliance|0|||
161078827|NCT01531673|581678639|FG012|Overall Study|Non-Compliance|0|||
161078828|NCT01531673|581678627|FG000|Overall Study|Adverse Event|0|||
161078829|NCT01531673|581678628|FG001|Overall Study|Adverse Event|1|||
161078830|NCT01531673|581678629|FG002|Overall Study|Adverse Event|0|||
161078831|NCT01531673|581678630|FG003|Overall Study|Adverse Event|0|||
161078832|NCT01531673|581678631|FG004|Overall Study|Adverse Event|0|||
161078833|NCT01531673|581678632|FG005|Overall Study|Adverse Event|0|||
161078834|NCT01531673|581678633|FG006|Overall Study|Adverse Event|0|||
161078835|NCT01531673|581678634|FG007|Overall Study|Adverse Event|0|||
161078836|NCT01531673|581678635|FG008|Overall Study|Adverse Event|0|||
161078837|NCT01531673|581678636|FG009|Overall Study|Adverse Event|0|||
161162165|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
161162166|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
161078838|NCT01531673|581678637|FG010|Overall Study|Adverse Event|0|||
161078839|NCT01531673|581678638|FG011|Overall Study|Adverse Event|0|||
161078840|NCT01531673|581678639|FG012|Overall Study|Adverse Event|0|||
161078841|NCT01531673|581678627|FG000|Overall Study|Lost to Follow-up|0|||
161078842|NCT01531673|581678628|FG001|Overall Study|Lost to Follow-up|0|||
161078843|NCT01531673|581678629|FG002|Overall Study|Lost to Follow-up|0|||
161078844|NCT01531673|581678630|FG003|Overall Study|Lost to Follow-up|0|||
161078845|NCT01531673|581678631|FG004|Overall Study|Lost to Follow-up|1|||
161078846|NCT01531673|581678632|FG005|Overall Study|Lost to Follow-up|0|||
161078847|NCT01531673|581678633|FG006|Overall Study|Lost to Follow-up|0|||
161078848|NCT01531673|581678634|FG007|Overall Study|Lost to Follow-up|0|||
161078849|NCT01531673|581678635|FG008|Overall Study|Lost to Follow-up|0|||
161078850|NCT01531673|581678636|FG009|Overall Study|Lost to Follow-up|0|||
161078851|NCT01531673|581678637|FG010|Overall Study|Lost to Follow-up|0|||
161078852|NCT01531673|581678638|FG011|Overall Study|Lost to Follow-up|0|||
161078853|NCT01531673|581678639|FG012|Overall Study|Lost to Follow-up|0|||
161078854|NCT01531673|581678627|FG000|Overall Study|Other|0|||
161078855|NCT01531673|581678628|FG001|Overall Study|Other|0|||
161078856|NCT01531673|581678629|FG002|Overall Study|Other|0|||
161078857|NCT01531673|581678630|FG003|Overall Study|Other|1|||
161078858|NCT01531673|581678631|FG004|Overall Study|Other|0|||
161078859|NCT01531673|581678632|FG005|Overall Study|Other|0|||
161078860|NCT01531673|581678633|FG006|Overall Study|Other|0|||
161078861|NCT01531673|581678634|FG007|Overall Study|Other|0|||
161078862|NCT01531673|581678635|FG008|Overall Study|Other|0|||
161078863|NCT01531673|581678636|FG009|Overall Study|Other|1|||
161078864|NCT01531673|581678637|FG010|Overall Study|Other|0|||
161078865|NCT01531673|581678638|FG011|Overall Study|Other|0|||
161078866|NCT01531673|581678639|FG012|Overall Study|Other|0|||
161078867|NCT01014208|581678643|FG000|Overall Study|Lost to Follow-up|2|||
161078868|NCT01014208|581678644|FG001|Overall Study|Lost to Follow-up|5|||
161078869|NCT01014208|581678643|FG000|Overall Study|Participant Withdrew Consent|12|||
161078870|NCT01014208|581678644|FG001|Overall Study|Participant Withdrew Consent|12|||
161078871|NCT01014208|581678643|FG000|Overall Study|Did Not Receive Study Drug|2|||
161078872|NCT01014208|581678644|FG001|Overall Study|Did Not Receive Study Drug|0|||
161078873|NCT01014208|581678643|FG000|Overall Study|Study Closed/terminated|78|||
161078874|NCT01014208|581678644|FG001|Overall Study|Study Closed/terminated|83|||
161078875|NCT01262677|581678647|FG000|Overall Study|Does not meet entrance criteria|0|||
161078876|NCT01262677|581678648|FG001|Overall Study|Does not meet entrance criteria|2|||
161078877|NCT01262677|581678649|FG002|Overall Study|Does not meet entrance criteria|0|||
161078878|NCT01262677|581678647|FG000|Overall Study|Insufficient clinical response|0|||
161078879|NCT01262677|581678648|FG001|Overall Study|Insufficient clinical response|0|||
161078880|NCT01262677|581678649|FG002|Overall Study|Insufficient clinical response|1|||
161078881|NCT01262677|581678647|FG000|Overall Study|Lost to Follow-up|1|||
161078882|NCT01262677|581678648|FG001|Overall Study|Lost to Follow-up|0|||
161078883|NCT01262677|581678649|FG002|Overall Study|Lost to Follow-up|2|||
161078884|NCT01262677|581678647|FG000|Overall Study|No longer willing to participate|3|||
161078885|NCT01262677|581678648|FG001|Overall Study|No longer willing to participate|3|||
161078886|NCT01262677|581678649|FG002|Overall Study|No longer willing to participate|2|||
161078887|NCT01262677|581678647|FG000|Overall Study|Reason not provided|2|||
161078888|NCT01262677|581678648|FG001|Overall Study|Reason not provided|1|||
161078889|NCT01262677|581678649|FG002|Overall Study|Reason not provided|3|||
161078890|NCT01262677|581678647|FG000|Overall Study|Protocol Violation|0|||
161078891|NCT01262677|581678648|FG001|Overall Study|Protocol Violation|1|||
161078892|NCT01262677|581678649|FG002|Overall Study|Protocol Violation|1|||
161078893|NCT01262677|581678647|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
161078894|NCT01262677|581678648|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
161078895|NCT01262677|581678649|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
161078896|NCT02787044|581678652|FG000|Overall Study|Lost to Follow-up|15|||
161078897|NCT02787044|581678653|FG001|Overall Study|Lost to Follow-up|19|||
161078898|NCT00567567|581678654|FG000|Overall Study|Adverse Event|0|||
161078899|NCT00567567|581678655|FG001|Overall Study|Adverse Event|2|||
161078900|NCT00567567|581678656|FG002|Overall Study|Adverse Event|5|||
161078901|NCT00567567|581678654|FG000|Overall Study|Death|8|||
161078902|NCT00567567|581678655|FG001|Overall Study|Death|1|||
161078903|NCT00567567|581678656|FG002|Overall Study|Death|5|||
161078904|NCT00567567|581678654|FG000|Overall Study|Lack of Efficacy|16|||
161078905|NCT00567567|581678655|FG001|Overall Study|Lack of Efficacy|17|||
161078906|NCT00567567|581678656|FG002|Overall Study|Lack of Efficacy|48|||
161078907|NCT00567567|581678654|FG000|Overall Study|Lost to Follow-up|0|||
161078908|NCT00567567|581678655|FG001|Overall Study|Lost to Follow-up|0|||
161078909|NCT00567567|581678656|FG002|Overall Study|Lost to Follow-up|1|||
161078910|NCT00567567|581678654|FG000|Overall Study|Physician Decision|16|||
161078911|NCT00567567|581678655|FG001|Overall Study|Physician Decision|18|||
161078912|NCT00567567|581678656|FG002|Overall Study|Physician Decision|84|||
161078913|NCT00567567|581678654|FG000|Overall Study|Withdrawal by Subject|0|||
161078914|NCT00567567|581678655|FG001|Overall Study|Withdrawal by Subject|0|||
161078915|NCT00567567|581678656|FG002|Overall Study|Withdrawal by Subject|2|||
161078916|NCT00567567|581678654|FG000|Overall Study|Ineligible|4|||
161078917|NCT00567567|581678655|FG001|Overall Study|Ineligible|0|||
161162167|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
161162168|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
161162169|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
161162170|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
161162171|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
161162172|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
161162173|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
161162174|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
161162175|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
161162176|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
161162177|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Pregnancy|0|||
161162178|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Pregnancy|1|||
161162179|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Pregnancy|1|||
161162180|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Pregnancy|0|||
161162181|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161162182|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
161162183|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
161162184|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
161162185|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161162186|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
161162187|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
161162188|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
161162189|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Adverse Event|0|||
161162190|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Adverse Event|8|||
161162191|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Adverse Event|3|||
161162192|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Adverse Event|6|||
161162193|NCT02951988|581972150|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
161162194|NCT02951988|581972151|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
161162195|NCT02951988|581972152|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
161162196|NCT02951988|581972153|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
161162197|NCT03352414|581972157|FG000|Overall Study|Ineligible by operative criteria|12|||
161162198|NCT03352414|581972158|FG001|Overall Study|Ineligible by operative criteria|10|||
161162199|NCT00516269|581972159|FG000|Overall Study|Adverse Event|2|||
161162200|NCT00516269|581972160|FG001|Overall Study|Adverse Event|1|||
161162201|NCT00516269|581972159|FG000|Overall Study|Lost to Follow-up|0|||
161162202|NCT00516269|581972160|FG001|Overall Study|Lost to Follow-up|1|||
161162203|NCT00516269|581972159|FG000|Overall Study|Protocol Violation|0|||
161162204|NCT00516269|581972160|FG001|Overall Study|Protocol Violation|1|||
161162205|NCT04570657|581972162|FG000|Overall Study|Adverse Event|0|||
161162206|NCT04570657|581972163|FG001|Overall Study|Adverse Event|0|||
161162207|NCT04570657|581972164|FG002|Overall Study|Adverse Event|1|||
161162208|NCT04570657|581972162|FG000|Overall Study|Lost to Follow-up|0|||
161162209|NCT04570657|581972163|FG001|Overall Study|Lost to Follow-up|0|||
161162210|NCT04570657|581972164|FG002|Overall Study|Lost to Follow-up|1|||
161162211|NCT04570657|581972162|FG000|Overall Study|Physician Decision|0|||
161162212|NCT04570657|581972163|FG001|Overall Study|Physician Decision|1|||
161162213|NCT04570657|581972164|FG002|Overall Study|Physician Decision|0|||
161162214|NCT04570657|581972162|FG000|Overall Study|Withdrawal by Subject|1|||
161162215|NCT04570657|581972163|FG001|Overall Study|Withdrawal by Subject|2|||
161162216|NCT04570657|581972164|FG002|Overall Study|Withdrawal by Subject|2|||
161162217|NCT01079962|581972165|FG000|Overall Study|Adverse Event|2|||
161162218|NCT01079962|581972166|FG001|Overall Study|Adverse Event|2|||
161162219|NCT01079962|581972165|FG000|Overall Study|Withdrawal by Subject|5|||
161162220|NCT01079962|581972166|FG001|Overall Study|Withdrawal by Subject|7|||
161162221|NCT01079962|581972165|FG000|Overall Study|Protocol Violation|2|||
161162222|NCT01079962|581972166|FG001|Overall Study|Protocol Violation|2|||
161162223|NCT01079962|581972165|FG000|Overall Study|No blood pressure (BP) control|3|||
161162224|NCT01079962|581972166|FG001|Overall Study|No blood pressure (BP) control|0|||
161162225|NCT01079962|581972165|FG000|Overall Study|Inclusion/exclusion criteria|1|||
161162226|NCT01079962|581972166|FG001|Overall Study|Inclusion/exclusion criteria|3|||
161162227|NCT01079962|581972165|FG000|Overall Study|Participant not returning for next visit|1|||
161162228|NCT01079962|581972166|FG001|Overall Study|Participant not returning for next visit|0|||
161162229|NCT01079962|581972165|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
161162230|NCT01079962|581972166|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
161162231|NCT01331239|581972167|FG000|Part II: Core Study|Adverse Event|0|||
161162232|NCT01331239|581972168|FG001|Part II: Core Study|Adverse Event|3|||
161162233|NCT01331239|581972169|FG002|Part II: Core Study|Adverse Event|0|||
161162234|NCT01331239|581972167|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
161162235|NCT01331239|581972168|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
161162236|NCT01331239|581972169|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
161162237|NCT01331239|581972167|FG000|Part II: Core Study|Withdrawal by Subject|0|||
161319387|NCT01134263|582555300|FG000|Overall Study|Serious adverse event|2|||
161162238|NCT01331239|581972168|FG001|Part II: Core Study|Withdrawal by Subject|2|||
161162239|NCT01331239|581972169|FG002|Part II: Core Study|Withdrawal by Subject|0|||
161162240|NCT01331239|581972167|FG000|Part II: Core Study|Administrative problems|0|||
161162241|NCT01331239|581972168|FG001|Part II: Core Study|Administrative problems|1|||
161162242|NCT01331239|581972169|FG002|Part II: Core Study|Administrative problems|0|||
161162243|NCT01008995|581972170|FG000|Controlled Period|Adverse Event|1|||
161162244|NCT01008995|581972171|FG001|Controlled Period|Adverse Event|2|||
161162245|NCT01008995|581972172|FG002|Controlled Period|Adverse Event|0|||
161162246|NCT01008995|581972173|FG003|Controlled Period|Adverse Event|0|||
161162247|NCT01008995|581972170|FG000|Controlled Period|Other|2|||
161162248|NCT01008995|581972171|FG001|Controlled Period|Other|1|||
161162249|NCT01008995|581972172|FG002|Controlled Period|Other|0|||
161162250|NCT01008995|581972173|FG003|Controlled Period|Other|0|||
161162251|NCT01008995|581972170|FG000|After Controlled Period|Adverse Event|0|||
161162252|NCT01008995|581972171|FG001|After Controlled Period|Adverse Event|0|||
161162253|NCT01008995|581972172|FG002|After Controlled Period|Adverse Event|1|||
161162254|NCT01008995|581972173|FG003|After Controlled Period|Adverse Event|1|||
161162255|NCT01008995|581972170|FG000|After Controlled Period|Other|0|||
161162256|NCT01008995|581972171|FG001|After Controlled Period|Other|0|||
161162257|NCT01008995|581972172|FG002|After Controlled Period|Other|1|||
161162258|NCT01008995|581972173|FG003|After Controlled Period|Other|0|||
161162259|NCT04167306|581972174|FG000|Overall Study|Lost to Follow-up|2|||
161162260|NCT04167306|581972175|FG001|Overall Study|Lost to Follow-up|2|||
161162261|NCT04167306|581972176|FG002|Overall Study|Lost to Follow-up|5|||
161162262|NCT04167306|581972177|FG003|Overall Study|Lost to Follow-up|5|||
161162263|NCT04167306|581972174|FG000|Overall Study|Adverse Event|13|||
161162264|NCT04167306|581972175|FG001|Overall Study|Adverse Event|14|||
161162265|NCT04167306|581972176|FG002|Overall Study|Adverse Event|5|||
161162266|NCT04167306|581972177|FG003|Overall Study|Adverse Event|4|||
161162267|NCT04167306|581972174|FG000|Overall Study|Withdrawal by Subject|4|||
161162268|NCT04167306|581972175|FG001|Overall Study|Withdrawal by Subject|6|||
161162269|NCT04167306|581972176|FG002|Overall Study|Withdrawal by Subject|8|||
161162270|NCT04167306|581972177|FG003|Overall Study|Withdrawal by Subject|3|||
161162271|NCT04167306|581972174|FG000|Overall Study|covid|1|||
161162272|NCT04167306|581972175|FG001|Overall Study|covid|1|||
161162273|NCT04167306|581972176|FG002|Overall Study|covid|2|||
161162274|NCT04167306|581972177|FG003|Overall Study|covid|1|||
161162275|NCT04167306|581972174|FG000|Overall Study|concomitant medication|0|||
161162276|NCT04167306|581972175|FG001|Overall Study|concomitant medication|0|||
161162277|NCT04167306|581972176|FG002|Overall Study|concomitant medication|0|||
161162278|NCT04167306|581972177|FG003|Overall Study|concomitant medication|1|||
161162279|NCT04167306|581972174|FG000|Overall Study|Alcohol treatment|0|||
161162280|NCT04167306|581972175|FG001|Overall Study|Alcohol treatment|4|||
161162281|NCT04167306|581972176|FG002|Overall Study|Alcohol treatment|3|||
161162282|NCT04167306|581972177|FG003|Overall Study|Alcohol treatment|2|||
161162283|NCT04167306|581972174|FG000|Overall Study|non-compliance|0|||
161162284|NCT04167306|581972175|FG001|Overall Study|non-compliance|0|||
161162285|NCT04167306|581972176|FG002|Overall Study|non-compliance|1|||
161162286|NCT04167306|581972177|FG003|Overall Study|non-compliance|0|||
161162287|NCT04167306|581972174|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
161162288|NCT04167306|581972175|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
161162289|NCT04167306|581972176|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
161162290|NCT04167306|581972177|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
161162291|NCT00115804|581972180|FG000|Overall Study|Adverse Event|2|||
161162292|NCT00621855|581972181|FG000|Overall Study|Adverse Event|32|||
161162293|NCT00621855|581972182|FG001|Overall Study|Adverse Event|31|||
161162294|NCT00621855|581972183|FG002|Overall Study|Adverse Event|48|||
161162295|NCT00621855|581972184|FG003|Overall Study|Adverse Event|34|||
161162296|NCT00621855|581972185|FG004|Overall Study|Adverse Event|31|||
161162297|NCT00621855|581972181|FG000|Overall Study|Lost to Follow-up|0|||
161162298|NCT00621855|581972182|FG001|Overall Study|Lost to Follow-up|1|||
161162299|NCT00621855|581972183|FG002|Overall Study|Lost to Follow-up|3|||
161162300|NCT00621855|581972184|FG003|Overall Study|Lost to Follow-up|4|||
161162301|NCT00621855|581972185|FG004|Overall Study|Lost to Follow-up|1|||
161162302|NCT00621855|581972181|FG000|Overall Study|Protocol Violation|16|||
161162303|NCT00621855|581972182|FG001|Overall Study|Protocol Violation|8|||
161162304|NCT00621855|581972183|FG002|Overall Study|Protocol Violation|6|||
161162305|NCT00621855|581972184|FG003|Overall Study|Protocol Violation|7|||
161162306|NCT00621855|581972185|FG004|Overall Study|Protocol Violation|8|||
161162307|NCT00621855|581972181|FG000|Overall Study|Withdrawal by Subject|16|||
161162308|NCT00621855|581972182|FG001|Overall Study|Withdrawal by Subject|11|||
161162309|NCT00621855|581972183|FG002|Overall Study|Withdrawal by Subject|13|||
161162310|NCT00621855|581972184|FG003|Overall Study|Withdrawal by Subject|13|||
161162311|NCT00621855|581972185|FG004|Overall Study|Withdrawal by Subject|9|||
161162312|NCT00621855|581972181|FG000|Overall Study|Other|9|||
161162313|NCT00621855|581972182|FG001|Overall Study|Other|7|||
161162314|NCT00621855|581972183|FG002|Overall Study|Other|6|||
161162315|NCT00621855|581972184|FG003|Overall Study|Other|5|||
161162316|NCT00621855|581972185|FG004|Overall Study|Other|4|||
161162317|NCT00621855|581972181|FG000|Overall Study|Patients did not receive study drug|3|||
161162318|NCT00621855|581972182|FG001|Overall Study|Patients did not receive study drug|3|||
161162319|NCT00621855|581972183|FG002|Overall Study|Patients did not receive study drug|5|||
161162320|NCT00621855|581972184|FG003|Overall Study|Patients did not receive study drug|4|||
161162321|NCT00621855|581972185|FG004|Overall Study|Patients did not receive study drug|2|||
161162322|NCT03731364|581972186|FG000|Overall Study|Adverse Event|0|||
161162323|NCT03731364|581972187|FG001|Overall Study|Adverse Event|0|||
161162324|NCT03731364|581972188|FG002|Overall Study|Adverse Event|1|||
161162325|NCT03731364|581972189|FG003|Overall Study|Adverse Event|2|||
161162326|NCT03731364|581972190|FG004|Overall Study|Adverse Event|1|||
161162327|NCT00403559|581972191|FG000|Overall Study|Adverse Event|0|||
161162328|NCT00403559|581972192|FG001|Overall Study|Adverse Event|1|||
161162329|NCT00403559|581972191|FG000|Overall Study|Lost to Follow-up|3|||
161162330|NCT00403559|581972192|FG001|Overall Study|Lost to Follow-up|3|||
161162331|NCT00403559|581972191|FG000|Overall Study|Withdrawal by Subject|1|||
161162332|NCT00403559|581972192|FG001|Overall Study|Withdrawal by Subject|0|||
161162333|NCT00547378|581972193|FG000|Randomized Cohort|Withdrawal by Subject|7|||
161162334|NCT00547378|581972194|FG001|Randomized Cohort|Withdrawal by Subject|5|||
161162335|NCT00547378|581972195|FG002|Randomized Cohort|Withdrawal by Subject|0|||
161162336|NCT00547378|581972193|FG000|Randomized Cohort|Death|0|||
161162337|NCT00547378|581972194|FG001|Randomized Cohort|Death|1|||
161162338|NCT00547378|581972195|FG002|Randomized Cohort|Death|0|||
161162339|NCT00547378|581972193|FG000|Randomized Cohort|Lost to Follow-up|1|||
161162340|NCT00547378|581972194|FG001|Randomized Cohort|Lost to Follow-up|0|||
161162341|NCT00547378|581972195|FG002|Randomized Cohort|Lost to Follow-up|0|||
161162342|NCT00547378|581972193|FG000|Randomized Cohort|Adverse Event|1|||
161162343|NCT00547378|581972194|FG001|Randomized Cohort|Adverse Event|0|||
161162344|NCT00547378|581972195|FG002|Randomized Cohort|Adverse Event|0|||
161162345|NCT00547378|581972193|FG000|Randomized Cohort|Other reasons|2|||
161162346|NCT00547378|581972194|FG001|Randomized Cohort|Other reasons|0|||
161162347|NCT00547378|581972195|FG002|Randomized Cohort|Other reasons|0|||
161162348|NCT00547378|581972193|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
161162349|NCT00547378|581972194|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
161162350|NCT00547378|581972195|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
161162351|NCT00547378|581972193|FG000|All Implanted Cohort|Adverse Event|4|||
161162352|NCT00547378|581972194|FG001|All Implanted Cohort|Adverse Event|10|||
161162353|NCT00547378|581972195|FG002|All Implanted Cohort|Adverse Event|17|||
161162354|NCT00547378|581972193|FG000|All Implanted Cohort|Lost to Follow-up|0|||
161162355|NCT00547378|581972194|FG001|All Implanted Cohort|Lost to Follow-up|1|||
161162356|NCT00547378|581972195|FG002|All Implanted Cohort|Lost to Follow-up|14|||
161162357|NCT00547378|581972193|FG000|All Implanted Cohort|Death|3|||
161162358|NCT00547378|581972194|FG001|All Implanted Cohort|Death|1|||
161162359|NCT00547378|581972195|FG002|All Implanted Cohort|Death|4|||
161162360|NCT00547378|581972193|FG000|All Implanted Cohort|Physician Decision|0|||
161162361|NCT00547378|581972194|FG001|All Implanted Cohort|Physician Decision|2|||
161162362|NCT00547378|581972195|FG002|All Implanted Cohort|Physician Decision|6|||
161162363|NCT00547378|581972193|FG000|All Implanted Cohort|Site closure|2|||
161162364|NCT00547378|581972194|FG001|All Implanted Cohort|Site closure|0|||
161162365|NCT00547378|581972195|FG002|All Implanted Cohort|Site closure|1|||
161162366|NCT00547378|581972193|FG000|All Implanted Cohort|Other reasons|1|||
161162367|NCT00547378|581972194|FG001|All Implanted Cohort|Other reasons|0|||
161162368|NCT00547378|581972195|FG002|All Implanted Cohort|Other reasons|1|||
161162369|NCT04387136|581972196|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
161162370|NCT04387136|581972197|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
161162371|NCT01982773|581972198|FG000|Overall Study|Withdrawal by Subject|1|||
161162372|NCT01982773|581972199|FG001|Overall Study|Withdrawal by Subject|3|||
161162373|NCT01982773|581972198|FG000|Overall Study|Lost to Follow-up|7|||
161162374|NCT01982773|581972199|FG001|Overall Study|Lost to Follow-up|1|||
161162375|NCT01029886|581972202|FG000|Overall Study|Adverse Event|12|||
161162376|NCT01029886|581972203|FG001|Overall Study|Adverse Event|25|||
161162377|NCT01029886|581972202|FG000|Overall Study|Lost to Follow-up|1|||
161162378|NCT01029886|581972203|FG001|Overall Study|Lost to Follow-up|0|||
161162379|NCT01029886|581972202|FG000|Overall Study|Physician Decision|2|||
161162380|NCT01029886|581972203|FG001|Overall Study|Physician Decision|6|||
161346548|NCT03765073|582653302|FG017|Stage 3|Withdrawal by parent/guardian|0|||
161346549|NCT03765073|582653303|FG018|Stage 3|Withdrawal by parent/guardian|0|||
161162381|NCT01029886|581972202|FG000|Overall Study|Protocol Violation|17|||
161162382|NCT01029886|581972203|FG001|Overall Study|Protocol Violation|5|||
161162383|NCT01029886|581972202|FG000|Overall Study|Withdrawal by Subject|8|||
161162384|NCT01029886|581972203|FG001|Overall Study|Withdrawal by Subject|18|||
161162385|NCT01029886|581972202|FG000|Overall Study|Entry Criteria Not Met|13|||
161162386|NCT01029886|581972203|FG001|Overall Study|Entry Criteria Not Met|5|||
161162387|NCT01029886|581972202|FG000|Overall Study|Sponsor Decision|1|||
161162388|NCT01029886|581972203|FG001|Overall Study|Sponsor Decision|0|||
161162389|NCT01029886|581972202|FG000|Overall Study|Loss Glucose Control|7|||
161162390|NCT01029886|581972203|FG001|Overall Study|Loss Glucose Control|1|||
161346550|NCT03765073|582653304|FG019|Stage 3|Withdrawal by parent/guardian|6|||
161346551|NCT03765073|582653305|FG020|Stage 3|Withdrawal by parent/guardian|9|||
161346552|NCT03765073|582653285|FG000|Stage 3|Withdrawal by Subject|0|||
161346553|NCT03765073|582653286|FG001|Stage 3|Withdrawal by Subject|0|||
161346554|NCT03765073|582653287|FG002|Stage 3|Withdrawal by Subject|0|||
161346555|NCT03765073|582653288|FG003|Stage 3|Withdrawal by Subject|0|||
161346556|NCT03765073|582653289|FG004|Stage 3|Withdrawal by Subject|0|||
161346557|NCT03765073|582653290|FG005|Stage 3|Withdrawal by Subject|0|||
161346558|NCT03765073|582653291|FG006|Stage 3|Withdrawal by Subject|0|||
161346559|NCT03765073|582653292|FG007|Stage 3|Withdrawal by Subject|0|||
161346560|NCT03765073|582653293|FG008|Stage 3|Withdrawal by Subject|0|||
161346561|NCT03765073|582653294|FG009|Stage 3|Withdrawal by Subject|0|||
161346562|NCT03765073|582653295|FG010|Stage 3|Withdrawal by Subject|0|||
161346563|NCT03765073|582653296|FG011|Stage 3|Withdrawal by Subject|0|||
161288117|NCT04429503|582436170|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161288118|NCT04429503|582436171|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161288119|NCT04429503|582436172|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
161288120|NCT04429503|582436167|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
161288121|NCT04429503|582436168|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
161288122|NCT04429503|582436169|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
161288123|NCT04429503|582436170|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
161288124|NCT04429503|582436171|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
161288125|NCT04429503|582436172|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
161288126|NCT04429503|582436167|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
161288127|NCT04429503|582436168|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
161346564|NCT03765073|582653297|FG012|Stage 3|Withdrawal by Subject|0|||
161346565|NCT03765073|582653298|FG013|Stage 3|Withdrawal by Subject|0|||
161346566|NCT03765073|582653299|FG014|Stage 3|Withdrawal by Subject|0|||
161346567|NCT03765073|582653300|FG015|Stage 3|Withdrawal by Subject|0|||
161346568|NCT03765073|582653301|FG016|Stage 3|Withdrawal by Subject|0|||
161346569|NCT03765073|582653302|FG017|Stage 3|Withdrawal by Subject|8|||
161346570|NCT03765073|582653303|FG018|Stage 3|Withdrawal by Subject|11|||
161346571|NCT03765073|582653304|FG019|Stage 3|Withdrawal by Subject|0|||
161346572|NCT03765073|582653305|FG020|Stage 3|Withdrawal by Subject|0|||
161346573|NCT00580840|582653312|FG000|Run-in|Adverse Event|17|||
161346574|NCT00580840|582653313|FG001|Run-in|Adverse Event|0|||
161162391|NCT03294681|581972204|FG000|Overall Study|Withdrawal by Subject|1|||
161288128|NCT04429503|582436169|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
161288129|NCT04429503|582436170|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161288130|NCT04429503|582436171|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161288131|NCT04429503|582436172|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
161288132|NCT04429503|582436167|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
161288133|NCT04429503|582436168|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
161288134|NCT04429503|582436169|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
161288135|NCT04429503|582436170|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161288136|NCT04429503|582436171|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161288137|NCT04429503|582436172|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
161288138|NCT04429503|582436167|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
161288139|NCT04429503|582436168|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
161288140|NCT04429503|582436169|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
161288141|NCT04429503|582436170|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161288142|NCT04429503|582436171|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161288143|NCT04429503|582436172|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
161162392|NCT02720016|581972207|FG000|Overall Study|Separation of couple|6|||
161162393|NCT02720016|581972208|FG001|Overall Study|Separation of couple|8|||
161162394|NCT02720016|581972209|FG002|Overall Study|Separation of couple|2|||
161162395|NCT02720016|581972207|FG000|Overall Study|Withdrawal by Subject|6|||
161162396|NCT02720016|581972208|FG001|Overall Study|Withdrawal by Subject|6|||
161162397|NCT02720016|581972209|FG002|Overall Study|Withdrawal by Subject|4|||
161162398|NCT02720016|581972207|FG000|Overall Study|Scheduling issues|2|||
161162399|NCT02720016|581972208|FG001|Overall Study|Scheduling issues|4|||
161162400|NCT02720016|581972209|FG002|Overall Study|Scheduling issues|7|||
161288144|NCT04429503|582436167|FG000|Main Study (Up to Wk 96)|Death|9|||
161288145|NCT04429503|582436168|FG001|Main Study (Up to Wk 96)|Death|18|||
161288146|NCT04429503|582436169|FG002|Main Study (Up to Wk 96)|Death|5|||
161288147|NCT04429503|582436170|FG003|Main Study (Up to Wk 96)|Death|0|||
161346575|NCT00580840|582653314|FG002|Run-in|Adverse Event|0|||
161346576|NCT00580840|582653315|FG003|Run-in|Adverse Event|0|||
161288148|NCT04429503|582436171|FG004|Main Study (Up to Wk 96)|Death|0|||
161346577|NCT00580840|582653312|FG000|Run-in|Lack of Efficacy|93|||
161346578|NCT00580840|582653313|FG001|Run-in|Lack of Efficacy|0|||
161346579|NCT00580840|582653314|FG002|Run-in|Lack of Efficacy|0|||
161346580|NCT00580840|582653315|FG003|Run-in|Lack of Efficacy|0|||
161346581|NCT00580840|582653312|FG000|Run-in|Loss of Efficacy|1|||
161346582|NCT00580840|582653313|FG001|Run-in|Loss of Efficacy|0|||
161162401|NCT02720016|581972207|FG000|Overall Study|Childcare|2|||
161288149|NCT04429503|582436172|FG005|Main Study (Up to Wk 96)|Death|0|||
161288150|NCT04429503|582436167|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161288151|NCT04429503|582436168|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161288152|NCT04429503|582436169|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161288153|NCT04429503|582436170|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
161288154|NCT04429503|582436171|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161288155|NCT04429503|582436172|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
161288156|NCT04429503|582436167|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161288157|NCT04429503|582436168|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161288158|NCT04429503|582436169|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
161288159|NCT04429503|582436170|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161078918|NCT00567567|581678656|FG002|Overall Study|Ineligible|9|||
161078919|NCT00567567|581678654|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
161078920|NCT00567567|581678655|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
161078921|NCT00567567|581678656|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
161078922|NCT00567567|581678654|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
161078923|NCT00567567|581678655|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
161078924|NCT00567567|581678656|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
161078925|NCT00567567|581678654|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
161078926|NCT00567567|581678655|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
161078927|NCT00567567|581678656|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
161078928|NCT03433677|581678657|FG000|Period 1|Protocol Violation|1|||
161078929|NCT03433677|581678658|FG001|Period 1|Protocol Violation|0|||
161078930|NCT03433677|581678657|FG000|Period 2|Withdrawal by Subject|1|||
161078931|NCT03433677|581678658|FG001|Period 2|Withdrawal by Subject|1|||
161078932|NCT03330405|581678659|FG000|Overall Study|Other|1|||
161078933|NCT03330405|581678660|FG001|Overall Study|Other|3|||
161078934|NCT03330405|581678661|FG002|Overall Study|Other|1|||
161078935|NCT03330405|581678662|FG003|Overall Study|Other|0|||
161078936|NCT03330405|581678663|FG004|Overall Study|Other|2|||
161078937|NCT03330405|581678664|FG005|Overall Study|Other|0|||
161078938|NCT03330405|581678665|FG006|Overall Study|Other|1|||
161078939|NCT03330405|581678666|FG007|Overall Study|Other|0|||
161078940|NCT03330405|581678667|FG008|Overall Study|Other|0|||
161078941|NCT03330405|581678668|FG009|Overall Study|Other|0|||
161078942|NCT03330405|581678669|FG010|Overall Study|Other|0|||
161078943|NCT03330405|581678659|FG000|Overall Study|Progressive disease|8|||
161078944|NCT03330405|581678660|FG001|Overall Study|Progressive disease|27|||
161078945|NCT03330405|581678661|FG002|Overall Study|Progressive disease|4|||
161078946|NCT03330405|581678662|FG003|Overall Study|Progressive disease|18|||
161078947|NCT03330405|581678663|FG004|Overall Study|Progressive disease|16|||
161078948|NCT03330405|581678664|FG005|Overall Study|Progressive disease|14|||
161078949|NCT03330405|581678665|FG006|Overall Study|Progressive disease|7|||
161078950|NCT03330405|581678666|FG007|Overall Study|Progressive disease|29|||
161078951|NCT03330405|581678667|FG008|Overall Study|Progressive disease|9|||
161078952|NCT03330405|581678668|FG009|Overall Study|Progressive disease|11|||
161078953|NCT03330405|581678669|FG010|Overall Study|Progressive disease|5|||
161078954|NCT03330405|581678659|FG000|Overall Study|Withdrawal by Subject|1|||
161078955|NCT03330405|581678660|FG001|Overall Study|Withdrawal by Subject|4|||
161078956|NCT03330405|581678661|FG002|Overall Study|Withdrawal by Subject|0|||
161078957|NCT03330405|581678662|FG003|Overall Study|Withdrawal by Subject|1|||
161078958|NCT03330405|581678663|FG004|Overall Study|Withdrawal by Subject|1|||
161078959|NCT03330405|581678664|FG005|Overall Study|Withdrawal by Subject|1|||
161078960|NCT03330405|581678665|FG006|Overall Study|Withdrawal by Subject|0|||
161078961|NCT03330405|581678666|FG007|Overall Study|Withdrawal by Subject|2|||
161078962|NCT03330405|581678667|FG008|Overall Study|Withdrawal by Subject|2|||
161078963|NCT03330405|581678668|FG009|Overall Study|Withdrawal by Subject|1|||
161078964|NCT03330405|581678669|FG010|Overall Study|Withdrawal by Subject|1|||
161078965|NCT03330405|581678659|FG000|Overall Study|Global deterioration of health status|2|||
161078966|NCT03330405|581678660|FG001|Overall Study|Global deterioration of health status|3|||
161078967|NCT03330405|581678661|FG002|Overall Study|Global deterioration of health status|0|||
161078968|NCT03330405|581678662|FG003|Overall Study|Global deterioration of health status|2|||
161078969|NCT03330405|581678663|FG004|Overall Study|Global deterioration of health status|3|||
161078970|NCT03330405|581678664|FG005|Overall Study|Global deterioration of health status|3|||
161078971|NCT03330405|581678665|FG006|Overall Study|Global deterioration of health status|0|||
161078972|NCT03330405|581678666|FG007|Overall Study|Global deterioration of health status|2|||
161078973|NCT03330405|581678667|FG008|Overall Study|Global deterioration of health status|8|||
161078974|NCT03330405|581678668|FG009|Overall Study|Global deterioration of health status|4|||
161078975|NCT03330405|581678669|FG010|Overall Study|Global deterioration of health status|1|||
161078976|NCT03330405|581678659|FG000|Overall Study|Adverse Event|0|||
161078977|NCT03330405|581678660|FG001|Overall Study|Adverse Event|1|||
161078978|NCT03330405|581678661|FG002|Overall Study|Adverse Event|0|||
161078979|NCT03330405|581678662|FG003|Overall Study|Adverse Event|1|||
161288160|NCT04429503|582436171|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161162402|NCT02720016|581972208|FG001|Overall Study|Childcare|0|||
161162403|NCT02720016|581972209|FG002|Overall Study|Childcare|2|||
161162404|NCT02720016|581972207|FG000|Overall Study|Withdrawal by PI|2|||
161162405|NCT02720016|581972208|FG001|Overall Study|Withdrawal by PI|2|||
161162406|NCT02720016|581972209|FG002|Overall Study|Withdrawal by PI|0|||
161162407|NCT02720016|581972207|FG000|Overall Study|Moved away|2|||
161162408|NCT02720016|581972208|FG001|Overall Study|Moved away|0|||
161162409|NCT02720016|581972209|FG002|Overall Study|Moved away|0|||
161162410|NCT02720016|581972207|FG000|Overall Study|Not Primary Health Concern|0|||
161162411|NCT02720016|581972208|FG001|Overall Study|Not Primary Health Concern|0|||
161162412|NCT02720016|581972209|FG002|Overall Study|Not Primary Health Concern|2|||
161162413|NCT02720016|581972207|FG000|Overall Study|Transportation issues|0|||
161162414|NCT02720016|581972208|FG001|Overall Study|Transportation issues|0|||
161162415|NCT02720016|581972209|FG002|Overall Study|Transportation issues|1|||
161162416|NCT02720016|581972207|FG000|Overall Study|Other|0|||
161162417|NCT02720016|581972208|FG001|Overall Study|Other|0|||
161162418|NCT02720016|581972209|FG002|Overall Study|Other|2|||
161162419|NCT04501679|581972210|FG000|Overall Study|Pregnancy|0|||
161162420|NCT04501679|581972211|FG001|Overall Study|Pregnancy|1|||
161162421|NCT04501679|581972210|FG000|Overall Study|Adverse Event|4|||
161162422|NCT04501679|581972211|FG001|Overall Study|Adverse Event|2|||
161162423|NCT04501679|581972210|FG000|Overall Study|Withdrawal by Subject|2|||
161162424|NCT04501679|581972211|FG001|Overall Study|Withdrawal by Subject|0|||
161162425|NCT04501679|581972210|FG000|Overall Study|Physician Decision|1|||
161162426|NCT04501679|581972211|FG001|Overall Study|Physician Decision|0|||
161162427|NCT04501679|581972210|FG000|Overall Study|Lost to Follow-up|2|||
161162428|NCT04501679|581972211|FG001|Overall Study|Lost to Follow-up|0|||
161162429|NCT02121756|581972215|FG000|Overall Study|Adverse Event|3|||
161162430|NCT02121756|581972216|FG001|Overall Study|Adverse Event|0|||
161162431|NCT02121756|581972215|FG000|Overall Study|Protocol Violation|1|||
161162432|NCT02121756|581972216|FG001|Overall Study|Protocol Violation|1|||
161162433|NCT02121756|581972215|FG000|Overall Study|Physician Decision|2|||
161162434|NCT02121756|581972216|FG001|Overall Study|Physician Decision|1|||
161162435|NCT05319080|581972217|FG000|Overall Study|Withdrawal by Subject|2|||
161162436|NCT05319080|581972217|FG000|Overall Study|Physician Decision|4|||
161162437|NCT00751114|581972218|FG000|Overall Study|Adverse Event|2|||
161162438|NCT00751114|581972219|FG001|Overall Study|Adverse Event|4|||
161162439|NCT00751114|581972218|FG000|Overall Study|Protocol Violation|8|||
161162440|NCT00751114|581972219|FG001|Overall Study|Protocol Violation|9|||
161162441|NCT00751114|581972218|FG000|Overall Study|Withdrawal by Subject|9|||
161162442|NCT00751114|581972219|FG001|Overall Study|Withdrawal by Subject|4|||
161162443|NCT00751114|581972218|FG000|Overall Study|Lost to Follow-up|4|||
161162444|NCT00751114|581972219|FG001|Overall Study|Lost to Follow-up|7|||
161162445|NCT00751114|581972218|FG000|Overall Study|Lack of Efficacy|0|||
161162446|NCT00751114|581972219|FG001|Overall Study|Lack of Efficacy|7|||
161162447|NCT00751114|581972218|FG000|Overall Study|Not Treated|13|||
161162448|NCT00751114|581972219|FG001|Overall Study|Not Treated|1|||
161162449|NCT00751114|581972218|FG000|Overall Study|Out of country for 2 months|1|||
161162450|NCT00751114|581972219|FG001|Overall Study|Out of country for 2 months|0|||
161162451|NCT00751114|581972218|FG000|Overall Study|Move to another city|1|||
161162452|NCT00751114|581972219|FG001|Overall Study|Move to another city|0|||
161162453|NCT03095521|581972220|FG000|Overall Study|Withdrawal by Subject|0|||
161162454|NCT03095521|581972221|FG001|Overall Study|Withdrawal by Subject|1|||
161162455|NCT03095521|581972220|FG000|Overall Study|Lost to Follow-up|0|||
161162456|NCT03095521|581972221|FG001|Overall Study|Lost to Follow-up|1|||
161162457|NCT01536119|581972224|FG000|Overall Study|Lost to Follow-up|17|||
161162458|NCT01536119|581972225|FG001|Overall Study|Lost to Follow-up|14|||
161162459|NCT00448916|581972226|FG000|Overall Study|Adverse Event|2|||
161162460|NCT00448916|581972227|FG001|Overall Study|Adverse Event|2|||
161162461|NCT00448916|581972228|FG002|Overall Study|Adverse Event|3|||
161162462|NCT00448916|581972229|FG003|Overall Study|Adverse Event|2|||
161162463|NCT00448916|581972226|FG000|Overall Study|Lack of Efficacy|1|||
161162464|NCT00448916|581972227|FG001|Overall Study|Lack of Efficacy|0|||
161162465|NCT00448916|581972228|FG002|Overall Study|Lack of Efficacy|2|||
161162466|NCT00448916|581972229|FG003|Overall Study|Lack of Efficacy|1|||
161162467|NCT00448916|581972226|FG000|Overall Study|Withdrawal by Subject|3|||
161162468|NCT00448916|581972227|FG001|Overall Study|Withdrawal by Subject|3|||
161162469|NCT00448916|581972228|FG002|Overall Study|Withdrawal by Subject|1|||
161162470|NCT00448916|581972229|FG003|Overall Study|Withdrawal by Subject|1|||
161162471|NCT00448916|581972226|FG000|Overall Study|Other|1|||
161162472|NCT00448916|581972227|FG001|Overall Study|Other|0|||
161162473|NCT00448916|581972228|FG002|Overall Study|Other|0|||
161162474|NCT00448916|581972229|FG003|Overall Study|Other|0|||
161162475|NCT00448916|581972226|FG000|Overall Study|Lost to Follow-up|0|||
161162476|NCT00448916|581972227|FG001|Overall Study|Lost to Follow-up|1|||
161162477|NCT00448916|581972228|FG002|Overall Study|Lost to Follow-up|0|||
161162478|NCT00448916|581972229|FG003|Overall Study|Lost to Follow-up|1|||
161162479|NCT00448916|581972226|FG000|Overall Study|Protocol Violation|0|||
161162480|NCT00448916|581972227|FG001|Overall Study|Protocol Violation|0|||
161162481|NCT00448916|581972228|FG002|Overall Study|Protocol Violation|0|||
161162482|NCT00448916|581972229|FG003|Overall Study|Protocol Violation|1|||
161162483|NCT02365584|581972230|FG000|Overall Study|Adverse Event|2|||
161162484|NCT02365584|581972231|FG001|Overall Study|Adverse Event|2|||
161162485|NCT02365584|581972230|FG000|Overall Study|Withdrawal by Subject|1|||
161162486|NCT02365584|581972231|FG001|Overall Study|Withdrawal by Subject|0|||
161162487|NCT02365584|581972230|FG000|Overall Study|Disease Progression|9|||
161162488|NCT02365584|581972231|FG001|Overall Study|Disease Progression|12|||
161162489|NCT01185249|581972232|FG000|Overall Study|Patients discharged or change in status|42|||
161162490|NCT03521193|581972234|FG000|Overall Study|Withdrawal by Subject|8|||
161162491|NCT03521193|581972235|FG001|Overall Study|Withdrawal by Subject|0|||
161162492|NCT03521193|581972234|FG000|Overall Study|non compliant to ASA treatment|8|||
161162493|NCT03521193|581972235|FG001|Overall Study|non compliant to ASA treatment|0|||
161162494|NCT00064350|581972236|FG000|Induction Treatment|Disease Progression|5|||
161162495|NCT00064350|581972237|FG001|Induction Treatment|Disease Progression|1|||
161162496|NCT00064350|581972238|FG002|Induction Treatment|Disease Progression|110|||
161162497|NCT00064350|581972236|FG000|Induction Treatment|Adverse Event|0|||
161162498|NCT00064350|581972237|FG001|Induction Treatment|Adverse Event|2|||
161162499|NCT00064350|581972238|FG002|Induction Treatment|Adverse Event|49|||
161162500|NCT00064350|581972236|FG000|Induction Treatment|Death|0|||
161162501|NCT00064350|581972237|FG001|Induction Treatment|Death|0|||
161162502|NCT00064350|581972238|FG002|Induction Treatment|Death|9|||
161162503|NCT00064350|581972236|FG000|Induction Treatment|Withdrawal by Subject|0|||
161162504|NCT00064350|581972237|FG001|Induction Treatment|Withdrawal by Subject|0|||
161162505|NCT00064350|581972238|FG002|Induction Treatment|Withdrawal by Subject|21|||
161162506|NCT00064350|581972236|FG000|Induction Treatment|Ineligible or never started treatment|3|||
161162507|NCT00064350|581972237|FG001|Induction Treatment|Ineligible or never started treatment|6|||
161162508|NCT00064350|581972238|FG002|Induction Treatment|Ineligible or never started treatment|34|||
161162509|NCT00064350|581972236|FG000|Induction Treatment|Other|0|||
161162510|NCT00064350|581972237|FG001|Induction Treatment|Other|0|||
161162511|NCT00064350|581972238|FG002|Induction Treatment|Other|13|||
161162512|NCT00064350|581972236|FG000|Randomization|Adverse Event|8|||
161162513|NCT00064350|581972237|FG001|Randomization|Adverse Event|3|||
161162514|NCT00064350|581972238|FG002|Randomization|Adverse Event|0|||
161162515|NCT00064350|581972236|FG000|Randomization|Death|3|||
161162516|NCT00064350|581972237|FG001|Randomization|Death|0|||
161162517|NCT00064350|581972238|FG002|Randomization|Death|0|||
161162518|NCT00064350|581972236|FG000|Randomization|Withdrawal by Subject|1|||
161162519|NCT00064350|581972237|FG001|Randomization|Withdrawal by Subject|0|||
161162520|NCT00064350|581972238|FG002|Randomization|Withdrawal by Subject|0|||
161162521|NCT00064350|581972236|FG000|Randomization|Ineligible or never started treatment|9|||
161162522|NCT00064350|581972237|FG001|Randomization|Ineligible or never started treatment|15|||
161162523|NCT00064350|581972238|FG002|Randomization|Ineligible or never started treatment|0|||
161162524|NCT00064350|581972236|FG000|Randomization|Other|5|||
161162525|NCT00064350|581972237|FG001|Randomization|Other|0|||
161162526|NCT00064350|581972238|FG002|Randomization|Other|0|||
161162527|NCT00064350|581972236|FG000|Cross-Over|Adverse Event|0|||
161162528|NCT00064350|581972237|FG001|Cross-Over|Adverse Event|1|||
161162529|NCT00064350|581972238|FG002|Cross-Over|Adverse Event|0|||
161162530|NCT00064350|581972236|FG000|Cross-Over|Death|1|||
161162531|NCT00064350|581972237|FG001|Cross-Over|Death|3|||
161162532|NCT00064350|581972238|FG002|Cross-Over|Death|0|||
161162533|NCT00064350|581972236|FG000|Cross-Over|Withdrawal by Subject|2|||
161162534|NCT00064350|581972237|FG001|Cross-Over|Withdrawal by Subject|2|||
161162535|NCT00064350|581972238|FG002|Cross-Over|Withdrawal by Subject|0|||
161162536|NCT00064350|581972236|FG000|Cross-Over|Ineligible or never started treatment|3|||
161162537|NCT00064350|581972237|FG001|Cross-Over|Ineligible or never started treatment|6|||
161288161|NCT04429503|582436172|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
161288162|NCT04429503|582436167|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161288163|NCT04429503|582436168|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161288164|NCT04429503|582436169|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161288165|NCT04429503|582436170|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
161288166|NCT04429503|582436171|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
161288167|NCT04429503|582436172|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
161288168|NCT04429503|582436167|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161288169|NCT04429503|582436168|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161288170|NCT04429503|582436169|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
161162538|NCT00064350|581972238|FG002|Cross-Over|Ineligible or never started treatment|0|||
161162539|NCT00064350|581972236|FG000|Cross-Over|Other|0|||
161162540|NCT00064350|581972237|FG001|Cross-Over|Other|2|||
161162541|NCT00064350|581972238|FG002|Cross-Over|Other|0|||
161162542|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
161162543|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
161162544|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
161162545|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
161162546|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
161162547|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
161346583|NCT00580840|582653314|FG002|Run-in|Loss of Efficacy|0|||
161162548|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
161162549|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161162550|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
161162551|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
161162552|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
161162553|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
161162554|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
161162555|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
161162556|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
161162557|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
161162558|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Missing|3|||
161162559|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Missing|1|||
161162560|NCT00838916|581972239|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
161162561|NCT00838916|581972240|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161162562|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
161162563|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
161162564|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
161162565|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
161162566|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
161162567|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
161162568|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
161288171|NCT04429503|582436170|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
161288172|NCT04429503|582436171|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
161288173|NCT04429503|582436172|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
161288174|NCT04429503|582436167|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161162569|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
161162570|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
161162571|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
161162572|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
161162573|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
161162574|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
161162575|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
161162576|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
161162577|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
161162578|NCT00838916|581972239|FG000|Follow-up Period (8 Weeks)|Missing|3|||
161162579|NCT00838916|581972240|FG001|Follow-up Period (8 Weeks)|Missing|0|||
161162580|NCT01927419|581972241|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
161162581|NCT01927419|581972242|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
161162582|NCT01927419|581972241|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
161162583|NCT01927419|581972242|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
161162584|NCT01927419|581972241|FG000|Treatment Period|Disease progression|17|||
161162585|NCT01927419|581972242|FG001|Treatment Period|Disease progression|20|||
161162586|NCT01927419|581972241|FG000|Treatment Period|Study drug toxicity|48|||
161162587|NCT01927419|581972242|FG001|Treatment Period|Study drug toxicity|10|||
161162588|NCT01927419|581972241|FG000|Treatment Period|Death|0|||
161162589|NCT01927419|581972242|FG001|Treatment Period|Death|1|||
161162590|NCT01927419|581972241|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
161162591|NCT01927419|581972242|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
161162592|NCT01927419|581972241|FG000|Treatment Period|Participant request to discontinue|12|||
161162593|NCT01927419|581972242|FG001|Treatment Period|Participant request to discontinue|4|||
161162594|NCT01927419|581972241|FG000|Treatment Period|Withdrawal by Subject|1|||
161162595|NCT01927419|581972242|FG001|Treatment Period|Withdrawal by Subject|1|||
161162596|NCT01927419|581972241|FG000|Treatment Period|Maximum Clinical Benefit|6|||
161162597|NCT01927419|581972242|FG001|Treatment Period|Maximum Clinical Benefit|2|||
161162598|NCT01927419|581972241|FG000|Treatment Period|Other reasons|3|||
161162599|NCT01927419|581972242|FG001|Treatment Period|Other reasons|4|||
161162600|NCT01927419|581972241|FG000|Treatment Period|Not Reported|1|||
161162601|NCT01927419|581972242|FG001|Treatment Period|Not Reported|1|||
161162602|NCT00115765|581972243|FG000|Overall Study|Withdrawal by Subject|22|||
161162603|NCT00115765|581972244|FG001|Overall Study|Withdrawal by Subject|53|||
161162604|NCT00115765|581972245|FG002|Overall Study|Withdrawal by Subject|76|||
161288175|NCT04429503|582436168|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161162605|NCT00115765|581972246|FG003|Overall Study|Withdrawal by Subject|15|||
161162606|NCT00115765|581972243|FG000|Overall Study|Physician Decision|4|||
161162607|NCT00115765|581972244|FG001|Overall Study|Physician Decision|15|||
161162608|NCT00115765|581972245|FG002|Overall Study|Physician Decision|18|||
161162609|NCT00115765|581972246|FG003|Overall Study|Physician Decision|13|||
161162610|NCT00115765|581972243|FG000|Overall Study|Lost to Follow-up|3|||
161162611|NCT00115765|581972244|FG001|Overall Study|Lost to Follow-up|20|||
161162612|NCT00115765|581972245|FG002|Overall Study|Lost to Follow-up|18|||
161162613|NCT00115765|581972246|FG003|Overall Study|Lost to Follow-up|1|||
161288176|NCT04429503|582436169|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
161078980|NCT03330405|581678663|FG004|Overall Study|Adverse Event|1|||
161078981|NCT03330405|581678664|FG005|Overall Study|Adverse Event|1|||
161078982|NCT03330405|581678665|FG006|Overall Study|Adverse Event|3|||
161078983|NCT03330405|581678666|FG007|Overall Study|Adverse Event|4|||
161078984|NCT03330405|581678667|FG008|Overall Study|Adverse Event|2|||
161078985|NCT03330405|581678668|FG009|Overall Study|Adverse Event|2|||
161078986|NCT03330405|581678669|FG010|Overall Study|Adverse Event|2|||
161078987|NCT03330405|581678659|FG000|Overall Study|Death|0|||
161078988|NCT03330405|581678660|FG001|Overall Study|Death|4|||
161078989|NCT03330405|581678661|FG002|Overall Study|Death|0|||
161078990|NCT03330405|581678662|FG003|Overall Study|Death|0|||
161078991|NCT03330405|581678663|FG004|Overall Study|Death|0|||
161078992|NCT03330405|581678664|FG005|Overall Study|Death|1|||
161078993|NCT03330405|581678665|FG006|Overall Study|Death|0|||
161078994|NCT03330405|581678666|FG007|Overall Study|Death|2|||
161078995|NCT03330405|581678667|FG008|Overall Study|Death|0|||
161078996|NCT03330405|581678668|FG009|Overall Study|Death|0|||
161078997|NCT03330405|581678669|FG010|Overall Study|Death|0|||
161078998|NCT03330405|581678659|FG000|Overall Study|Physician Decision|0|||
161078999|NCT03330405|581678660|FG001|Overall Study|Physician Decision|0|||
161079000|NCT03330405|581678661|FG002|Overall Study|Physician Decision|0|||
161079001|NCT03330405|581678662|FG003|Overall Study|Physician Decision|0|||
161079002|NCT03330405|581678663|FG004|Overall Study|Physician Decision|0|||
161079003|NCT03330405|581678664|FG005|Overall Study|Physician Decision|0|||
161079004|NCT03330405|581678665|FG006|Overall Study|Physician Decision|0|||
161079005|NCT03330405|581678666|FG007|Overall Study|Physician Decision|1|||
161079006|NCT03330405|581678667|FG008|Overall Study|Physician Decision|0|||
161079007|NCT03330405|581678668|FG009|Overall Study|Physician Decision|0|||
161079008|NCT03330405|581678669|FG010|Overall Study|Physician Decision|0|||
161079009|NCT03889704|581678671|FG000|Overall Study|Study terminated due to pandemic|1|||
161079010|NCT01896557|581678678|FG000|Clopidogrel Alone|Adverse Event|1|||
161079011|NCT01896557|581678679|FG001|Clopidogrel Alone|Adverse Event|0|||
161079012|NCT01896557|581678678|FG000|Clopidogrel + GI Protector|low adherence|1|||
161079013|NCT01896557|581678679|FG001|Clopidogrel + GI Protector|low adherence|1|||
161079014|NCT01896557|581678678|FG000|Clopidogrel + GI Protector|Reading error|1|||
161079015|NCT01896557|581678679|FG001|Clopidogrel + GI Protector|Reading error|3|||
161079016|NCT02383940|581678680|FG000|Overall Study|Adverse Event|1|||
161079017|NCT02383940|581678681|FG001|Overall Study|Adverse Event|0|||
161079018|NCT02383940|581678680|FG000|Overall Study|Lost to Follow-up|2|||
161079019|NCT02383940|581678681|FG001|Overall Study|Lost to Follow-up|2|||
161079020|NCT02383940|581678680|FG000|Overall Study|Physician Decision|2|||
161079021|NCT02383940|581678681|FG001|Overall Study|Physician Decision|0|||
161079022|NCT02383940|581678680|FG000|Overall Study|Withdrawal by Subject|1|||
161079023|NCT02383940|581678681|FG001|Overall Study|Withdrawal by Subject|1|||
161079024|NCT02383940|581678680|FG000|Overall Study|Randomized but not treated|2|||
161079025|NCT02383940|581678681|FG001|Overall Study|Randomized but not treated|0|||
161079026|NCT02383940|581678680|FG000|Overall Study|Other than specified above|1|||
161079027|NCT02383940|581678681|FG001|Overall Study|Other than specified above|0|||
161079028|NCT01517295|581678682|FG000|Overall Study|Physician Decision|1|||
161079029|NCT01517295|581678683|FG001|Overall Study|Physician Decision|0|||
161079030|NCT00565773|581678684|FG000|Overall Study|Withdrawal by Subject|1|||
161079031|NCT00565773|581678684|FG000|Overall Study|Physician Decision|1|||
161079032|NCT03853551|581678685|FG000|Overall Study|Death|2|||
161079033|NCT03853551|581678685|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
161079034|NCT01923467|581678686|FG000|Overall Study|Lost to Follow-up|62|||
161079035|NCT01923467|581678686|FG000|Overall Study|Subject non-interest|479|||
161079036|NCT01075958|581678687|FG000|Overall Study|Blood sample could not be obtained|44|||
161079037|NCT01696045|581678692|FG000|Overall Study|Study drug toxicity|1|||
161079038|NCT01696045|581678693|FG001|Overall Study|Study drug toxicity|5|||
161079039|NCT01696045|581678692|FG000|Overall Study|Disease progression|2|||
161079040|NCT01696045|581678693|FG001|Overall Study|Disease progression|2|||
161079041|NCT01559129|581678694|FG000|Treatment Phase|Adverse Event|0|||
161079042|NCT01559129|581678695|FG001|Treatment Phase|Adverse Event|2|||
161079043|NCT01559129|581678694|FG000|Treatment Phase|Progressive Disease|1|||
161079044|NCT01559129|581678695|FG001|Treatment Phase|Progressive Disease|1|||
161079045|NCT01559129|581678694|FG000|Treatment Phase|Lack of Efficacy|0|||
161079046|NCT01559129|581678695|FG001|Treatment Phase|Lack of Efficacy|1|||
161079047|NCT01559129|581678694|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
161079048|NCT01559129|581678695|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
161079049|NCT01559129|581678694|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
161079050|NCT01559129|581678695|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
161079051|NCT01559129|581678694|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
161079052|NCT01559129|581678695|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
161079053|NCT01559129|581678694|FG000|Open-label Extension Period|Adverse Event|1|||
161079054|NCT01559129|581678695|FG001|Open-label Extension Period|Adverse Event|0|||
161079055|NCT01559129|581678694|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
161079056|NCT01559129|581678695|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
161079057|NCT03525392|581678696|FG000|Overall Study|Adverse Event|1|||
161079058|NCT03525392|581678697|FG001|Overall Study|Adverse Event|0|||
161079059|NCT03525392|581678698|FG002|Overall Study|Adverse Event|2|||
161079060|NCT03525392|581678699|FG003|Overall Study|Adverse Event|0|||
161079061|NCT03525392|581678700|FG004|Overall Study|Adverse Event|0|||
161079062|NCT03525392|581678696|FG000|Overall Study|Progressive disease|0|||
161079063|NCT03525392|581678697|FG001|Overall Study|Progressive disease|1|||
161079064|NCT03525392|581678698|FG002|Overall Study|Progressive disease|1|||
161079065|NCT03525392|581678699|FG003|Overall Study|Progressive disease|3|||
161079066|NCT03525392|581678700|FG004|Overall Study|Progressive disease|1|||
161079067|NCT04462289|581678705|FG000|Overall Study|Lost to Follow-up|4|||
161079068|NCT04462289|581678706|FG001|Overall Study|Lost to Follow-up|5|||
161079069|NCT04462289|581678705|FG000|Overall Study|Death|0|||
161079070|NCT04462289|581678706|FG001|Overall Study|Death|3|||
161079071|NCT04462289|581678705|FG000|Overall Study|Withdrawal by Subject|1|||
161079072|NCT04462289|581678706|FG001|Overall Study|Withdrawal by Subject|3|||
161079073|NCT00132873|581678707|FG000|Overall Study|Adverse Event|3|||
161079074|NCT00132873|581678707|FG000|Overall Study|Lost to Follow-up|1|||
161079075|NCT00132873|581678707|FG000|Overall Study|Lack of Efficacy|1|||
161079076|NCT00132873|581678707|FG000|Overall Study|Withdrawal by Subject|3|||
161079077|NCT00132873|581678707|FG000|Overall Study|Planned Pregnancy|1|||
161079078|NCT04276415|581678708|FG000|Overall Study|Adverse Event|0|||
161079079|NCT04276415|581678709|FG001|Overall Study|Adverse Event|0|||
161079080|NCT04276415|581678710|FG002|Overall Study|Adverse Event|0|||
161079081|NCT04276415|581678711|FG003|Overall Study|Adverse Event|3|||
161079082|NCT04276415|581678712|FG004|Overall Study|Adverse Event|0|||
161079083|NCT04276415|581678713|FG005|Overall Study|Adverse Event|0|||
161079084|NCT04276415|581678708|FG000|Overall Study|Clinical progression|1|||
161079085|NCT04276415|581678709|FG001|Overall Study|Clinical progression|1|||
161079086|NCT04276415|581678710|FG002|Overall Study|Clinical progression|0|||
161079087|NCT04276415|581678711|FG003|Overall Study|Clinical progression|0|||
161079088|NCT04276415|581678712|FG004|Overall Study|Clinical progression|1|||
161079089|NCT04276415|581678713|FG005|Overall Study|Clinical progression|0|||
161079090|NCT04276415|581678708|FG000|Overall Study|Other|0|||
161079091|NCT04276415|581678709|FG001|Overall Study|Other|0|||
161079092|NCT04276415|581678710|FG002|Overall Study|Other|0|||
161079093|NCT04276415|581678711|FG003|Overall Study|Other|1|||
161079094|NCT04276415|581678712|FG004|Overall Study|Other|0|||
161079095|NCT04276415|581678713|FG005|Overall Study|Other|0|||
161079096|NCT04276415|581678708|FG000|Overall Study|Physician Decision|0|||
161079097|NCT04276415|581678709|FG001|Overall Study|Physician Decision|0|||
161079098|NCT04276415|581678710|FG002|Overall Study|Physician Decision|1|||
161079099|NCT04276415|581678711|FG003|Overall Study|Physician Decision|3|||
161079100|NCT04276415|581678712|FG004|Overall Study|Physician Decision|2|||
161079101|NCT04276415|581678713|FG005|Overall Study|Physician Decision|0|||
161079102|NCT04276415|581678708|FG000|Overall Study|Progressive disease|3|||
161079103|NCT04276415|581678709|FG001|Overall Study|Progressive disease|3|||
161079104|NCT04276415|581678710|FG002|Overall Study|Progressive disease|4|||
161079105|NCT04276415|581678711|FG003|Overall Study|Progressive disease|5|||
161079106|NCT04276415|581678712|FG004|Overall Study|Progressive disease|1|||
161079107|NCT04276415|581678713|FG005|Overall Study|Progressive disease|2|||
161079108|NCT04276415|581678708|FG000|Overall Study|Withdrawal by patient|0|||
161079109|NCT04276415|581678709|FG001|Overall Study|Withdrawal by patient|0|||
161079110|NCT04276415|581678710|FG002|Overall Study|Withdrawal by patient|0|||
161079111|NCT04276415|581678711|FG003|Overall Study|Withdrawal by patient|1|||
161079112|NCT04276415|581678712|FG004|Overall Study|Withdrawal by patient|2|||
161079113|NCT04276415|581678713|FG005|Overall Study|Withdrawal by patient|0|||
161079114|NCT02406677|581678714|FG000|Overall Study|Death|16|||
161079115|NCT02406677|581678715|FG001|Overall Study|Death|8|||
161079116|NCT02406677|581678714|FG000|Overall Study|Discharged without P2Y12|1|||
161079117|NCT02406677|581678715|FG001|Overall Study|Discharged without P2Y12|3|||
161079118|NCT02406677|581678714|FG000|Overall Study|Discharged on prasugrel|283|||
161079119|NCT02406677|581678715|FG001|Overall Study|Discharged on prasugrel|587|||
161079120|NCT02406677|581678714|FG000|Overall Study|Withdrawal by Subject|1|||
161079121|NCT02406677|581678715|FG001|Overall Study|Withdrawal by Subject|0|||
161079122|NCT02145468|581678718|FG000|Overall Study|Withdrawal by Subject|5|||
161079123|NCT02145468|581678719|FG001|Overall Study|Withdrawal by Subject|8|||
161079124|NCT01803282|581678722|FG000|Overall Study|Progressive Disease|4|||
161079125|NCT01803282|581678723|FG001|Overall Study|Progressive Disease|3|||
161079126|NCT01803282|581678724|FG002|Overall Study|Progressive Disease|6|||
161079127|NCT01803282|581678725|FG003|Overall Study|Progressive Disease|22|||
161079128|NCT01803282|581678726|FG004|Overall Study|Progressive Disease|5|||
161079129|NCT01803282|581678727|FG005|Overall Study|Progressive Disease|8|||
161079130|NCT01803282|581678728|FG006|Overall Study|Progressive Disease|23|||
161079131|NCT01803282|581678729|FG007|Overall Study|Progressive Disease|24|||
161079132|NCT01803282|581678730|FG008|Overall Study|Progressive Disease|3|||
161079133|NCT01803282|581678731|FG009|Overall Study|Progressive Disease|29|||
161162614|NCT00115765|581972243|FG000|Overall Study|Other|6|||
161162615|NCT00115765|581972244|FG001|Overall Study|Other|12|||
161162616|NCT00115765|581972245|FG002|Overall Study|Other|9|||
161162617|NCT00115765|581972246|FG003|Overall Study|Other|2|||
161162618|NCT03707158|581972247|FG000|Midtreatment|Lost to Follow-up|16|||
161162619|NCT03707158|581972248|FG001|Midtreatment|Lost to Follow-up|7|||
161162620|NCT03707158|581972247|FG000|Midtreatment|Withdrawal by Subject|28|||
161162621|NCT03707158|581972248|FG001|Midtreatment|Withdrawal by Subject|19|||
161162622|NCT03707158|581972247|FG000|Posttreatment|Lost to Follow-up|0|||
161162623|NCT03707158|581972248|FG001|Posttreatment|Lost to Follow-up|5|||
161162624|NCT03707158|581972247|FG000|Follow-up|Lost to Follow-up|19|||
161162625|NCT03707158|581972248|FG001|Follow-up|Lost to Follow-up|18|||
161162626|NCT03707158|581972247|FG000|Follow-up|Withdrawal by Subject|13|||
161162627|NCT03707158|581972248|FG001|Follow-up|Withdrawal by Subject|6|||
161162628|NCT01968187|581972252|FG000|Overall Study|Adverse Event|0|||
161162629|NCT01968187|581972253|FG001|Overall Study|Adverse Event|1|||
161162630|NCT01968187|581972252|FG000|Overall Study|Randomized but not treated|1|||
161162631|NCT01968187|581972253|FG001|Overall Study|Randomized but not treated|0|||
161162632|NCT00430521|581972254|FG000|Overall Study|Adverse Event|0|||
161162633|NCT00430521|581972255|FG001|Overall Study|Adverse Event|0|||
161162634|NCT00430521|581972256|FG002|Overall Study|Adverse Event|0|||
161162635|NCT00430521|581972257|FG003|Overall Study|Adverse Event|0|||
161162636|NCT00430521|581972258|FG004|Overall Study|Adverse Event|0|||
161162637|NCT00430521|581972259|FG005|Overall Study|Adverse Event|2|||
161162638|NCT00430521|581972260|FG006|Overall Study|Adverse Event|1|||
161162639|NCT00430521|581972261|FG007|Overall Study|Adverse Event|0|||
161162640|NCT00430521|581972254|FG000|Overall Study|Lost to Follow-up|7|||
161162641|NCT00430521|581972255|FG001|Overall Study|Lost to Follow-up|8|||
161162642|NCT00430521|581972256|FG002|Overall Study|Lost to Follow-up|3|||
161162643|NCT00430521|581972257|FG003|Overall Study|Lost to Follow-up|5|||
161162644|NCT00430521|581972258|FG004|Overall Study|Lost to Follow-up|5|||
161162645|NCT00430521|581972259|FG005|Overall Study|Lost to Follow-up|2|||
161162646|NCT00430521|581972260|FG006|Overall Study|Lost to Follow-up|8|||
161162647|NCT00430521|581972261|FG007|Overall Study|Lost to Follow-up|10|||
161162648|NCT00430521|581972254|FG000|Overall Study|Pregnancy|0|||
161162649|NCT00430521|581972255|FG001|Overall Study|Pregnancy|0|||
161162650|NCT00430521|581972256|FG002|Overall Study|Pregnancy|0|||
161162651|NCT00430521|581972257|FG003|Overall Study|Pregnancy|0|||
161162652|NCT00430521|581972258|FG004|Overall Study|Pregnancy|0|||
161162653|NCT00430521|581972259|FG005|Overall Study|Pregnancy|0|||
161162654|NCT00430521|581972260|FG006|Overall Study|Pregnancy|1|||
161162655|NCT00430521|581972261|FG007|Overall Study|Pregnancy|0|||
161162656|NCT00430521|581972254|FG000|Overall Study|Vaccine Expired|0|||
161162657|NCT00430521|581972255|FG001|Overall Study|Vaccine Expired|0|||
161162658|NCT00430521|581972256|FG002|Overall Study|Vaccine Expired|0|||
161162659|NCT00430521|581972257|FG003|Overall Study|Vaccine Expired|0|||
161162660|NCT00430521|581972258|FG004|Overall Study|Vaccine Expired|0|||
161162661|NCT00430521|581972259|FG005|Overall Study|Vaccine Expired|1|||
161162662|NCT00430521|581972260|FG006|Overall Study|Vaccine Expired|0|||
161162663|NCT00430521|581972261|FG007|Overall Study|Vaccine Expired|0|||
161162664|NCT00430521|581972254|FG000|Overall Study|Protocol Violation|1|||
161162665|NCT00430521|581972255|FG001|Overall Study|Protocol Violation|0|||
161162666|NCT00430521|581972256|FG002|Overall Study|Protocol Violation|0|||
161162667|NCT00430521|581972257|FG003|Overall Study|Protocol Violation|0|||
161162668|NCT00430521|581972258|FG004|Overall Study|Protocol Violation|0|||
161162669|NCT00430521|581972259|FG005|Overall Study|Protocol Violation|0|||
161162670|NCT00430521|581972260|FG006|Overall Study|Protocol Violation|0|||
161162671|NCT00430521|581972261|FG007|Overall Study|Protocol Violation|0|||
161162672|NCT00430521|581972254|FG000|Overall Study|Withdrawal by Subject|3|||
161162673|NCT00430521|581972255|FG001|Overall Study|Withdrawal by Subject|1|||
161162674|NCT00430521|581972256|FG002|Overall Study|Withdrawal by Subject|0|||
161162675|NCT00430521|581972257|FG003|Overall Study|Withdrawal by Subject|3|||
161162676|NCT00430521|581972258|FG004|Overall Study|Withdrawal by Subject|0|||
161162677|NCT00430521|581972259|FG005|Overall Study|Withdrawal by Subject|0|||
161162678|NCT00430521|581972260|FG006|Overall Study|Withdrawal by Subject|0|||
161162679|NCT00430521|581972261|FG007|Overall Study|Withdrawal by Subject|2|||
161162680|NCT03422133|581972262|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
161162681|NCT03422133|581972263|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
161162682|NCT05195359|581974188|FG000|Overall Study|Lost to Follow-up|124|||
161162683|NCT05195359|581974189|FG001|Overall Study|Lost to Follow-up|34|||
161162684|NCT01146951|581974190|FG000|Overall Study|Adverse Event|4|||
161162685|NCT01146951|581974191|FG001|Overall Study|Adverse Event|1|||
161162686|NCT01747811|581974192|FG000|Overall Study|Lack of Efficacy|2|||
161162687|NCT01747811|581974193|FG001|Overall Study|Lack of Efficacy|4|||
161162688|NCT02492997|581974194|FG000|Overall Study|Withdrawal by Subject|1|||
161162689|NCT02492997|581974195|FG001|Overall Study|Withdrawal by Subject|0|||
161162690|NCT02492997|581974194|FG000|Overall Study|Gained Weight|1|||
161162691|NCT02492997|581974195|FG001|Overall Study|Gained Weight|0|||
161162692|NCT02492997|581974194|FG000|Overall Study|Lost to Follow-up|0|||
161162693|NCT02492997|581974195|FG001|Overall Study|Lost to Follow-up|1|||
161162694|NCT01089582|581974196|FG000|Overall Study|Death|2|||
161162695|NCT01089582|581974196|FG000|Overall Study|Adverse Event|15|||
161162696|NCT01089582|581974196|FG000|Overall Study|Lost to Follow-up|8|||
161162697|NCT01089582|581974196|FG000|Overall Study|Other|4|||
161162698|NCT01089582|581974196|FG000|Overall Study|Withdrawal by Subject|1|||
161162699|NCT04069156|581974197|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
161162700|NCT04069156|581974198|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
161162701|NCT04069156|581974197|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
161162702|NCT04069156|581974198|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
161162703|NCT04069156|581974197|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
161162704|NCT04069156|581974198|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
161162705|NCT04069156|581974197|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
161162706|NCT04069156|581974198|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
161162707|NCT02130427|581974202|FG000|Overall Study|Imaging results not interpretable|30|||
161162708|NCT02108600|581974203|FG000|Overall Study|Withdrawal by Subject|2|||
161162709|NCT02108600|581974204|FG001|Overall Study|Withdrawal by Subject|0|||
161162710|NCT02108600|581974203|FG000|Overall Study|Lost to Follow-up|1|||
161162711|NCT02108600|581974204|FG001|Overall Study|Lost to Follow-up|1|||
161162712|NCT01295580|581974207|FG000|Overall Study|Protocol Violation|4|||
161162713|NCT01295580|581974208|FG001|Overall Study|Protocol Violation|2|||
161162714|NCT01295580|581974207|FG000|Overall Study|Withdrawal by Subject|1|||
161162715|NCT01295580|581974208|FG001|Overall Study|Withdrawal by Subject|4|||
161162716|NCT01295580|581974207|FG000|Overall Study|Adverse Event|2|||
161162717|NCT01295580|581974208|FG001|Overall Study|Adverse Event|1|||
161162718|NCT01295580|581974207|FG000|Overall Study|Lost to Follow-up|1|||
161162719|NCT01295580|581974208|FG001|Overall Study|Lost to Follow-up|0|||
161162720|NCT01295580|581974207|FG000|Overall Study|Lack of Efficacy|1|||
161162721|NCT01295580|581974208|FG001|Overall Study|Lack of Efficacy|0|||
161162722|NCT01295580|581974207|FG000|Overall Study|Other: inconvenience|1|||
161162723|NCT01295580|581974208|FG001|Overall Study|Other: inconvenience|0|||
161162724|NCT01295580|581974207|FG000|Overall Study|Other: family objection|0|||
161162725|NCT01295580|581974208|FG001|Overall Study|Other: family objection|1|||
161162726|NCT01742078|581974209|FG000|Overall Study|Withdrawal by Subject|0|||
161162727|NCT01742078|581974210|FG001|Overall Study|Withdrawal by Subject|0|||
161162728|NCT01742078|581974211|FG002|Overall Study|Withdrawal by Subject|0|||
161162729|NCT01742078|581974212|FG003|Overall Study|Withdrawal by Subject|1|||
161162730|NCT01742078|581974213|FG004|Overall Study|Withdrawal by Subject|0|||
161162731|NCT01742078|581974214|FG005|Overall Study|Withdrawal by Subject|0|||
161162732|NCT01742078|581974215|FG006|Overall Study|Withdrawal by Subject|0|||
161162733|NCT01742078|581974216|FG007|Overall Study|Withdrawal by Subject|0|||
161162734|NCT01742078|581974217|FG008|Overall Study|Withdrawal by Subject|0|||
161162735|NCT05025787|581974220|FG000|Overall Study|Lack of Efficacy|0|||
161162736|NCT05025787|581974221|FG001|Overall Study|Lack of Efficacy|1|||
161162737|NCT05025787|581974220|FG000|Overall Study|Adverse Event|2|||
161162738|NCT05025787|581974221|FG001|Overall Study|Adverse Event|4|||
161162739|NCT05025787|581974220|FG000|Overall Study|Non compliance|0|||
161162740|NCT05025787|581974221|FG001|Overall Study|Non compliance|1|||
161162741|NCT05025787|581974220|FG000|Overall Study|Protocol Violation|3|||
161162742|NCT05025787|581974221|FG001|Overall Study|Protocol Violation|1|||
161162743|NCT05025787|581974220|FG000|Overall Study|Stopping criteria met|1|||
161162744|NCT05025787|581974221|FG001|Overall Study|Stopping criteria met|1|||
161162745|NCT05025787|581974220|FG000|Overall Study|Withdrawal by Subject|3|||
161162746|NCT05025787|581974221|FG001|Overall Study|Withdrawal by Subject|1|||
161162747|NCT03806179|581974222|FG000|Overall Study|Progressive disease|0|||
161162748|NCT03806179|581974223|FG001|Overall Study|Progressive disease|2|||
161288177|NCT04429503|582436170|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
161288178|NCT04429503|582436171|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
161288179|NCT04429503|582436172|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
161288180|NCT04429503|582436167|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161288181|NCT04429503|582436168|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161288182|NCT04429503|582436169|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
161288183|NCT04429503|582436170|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
161288184|NCT04429503|582436171|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
161162749|NCT05600309|581974224|FG000|Overall Study|Death|41|||
161162750|NCT05600309|581974225|FG001|Overall Study|Death|38|||
161162751|NCT05600309|581974224|FG000|Overall Study|Sponsor Decision|9|||
161162752|NCT05600309|581974225|FG001|Overall Study|Sponsor Decision|6|||
161162753|NCT05822830|581974226|FG000|Overall Study|Adverse Event|6|||
161162754|NCT05822830|581974227|FG001|Overall Study|Adverse Event|6|||
161162755|NCT05822830|581974226|FG000|Overall Study|Assigned Treatment by Mistake|5|||
161162756|NCT05822830|581974227|FG001|Overall Study|Assigned Treatment by Mistake|3|||
161162757|NCT05822830|581974226|FG000|Overall Study|Lost to Follow-up|16|||
161162758|NCT05822830|581974227|FG001|Overall Study|Lost to Follow-up|18|||
161162759|NCT05822830|581974226|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161162760|NCT05822830|581974227|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161288185|NCT04429503|582436172|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
161162761|NCT05822830|581974226|FG000|Overall Study|Participant was Out of the Country|0|||
161162762|NCT05822830|581974227|FG001|Overall Study|Participant was Out of the Country|1|||
161162763|NCT05822830|581974226|FG000|Overall Study|Pregnancy|1|||
161162764|NCT05822830|581974227|FG001|Overall Study|Pregnancy|2|||
161162765|NCT05822830|581974226|FG000|Overall Study|Withdrawal by Subject|27|||
161162766|NCT05822830|581974227|FG001|Overall Study|Withdrawal by Subject|26|||
161162767|NCT03368664|581974234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
161162768|NCT03368664|581974234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
161162769|NCT03368664|581974234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
161162770|NCT03368664|581974234|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
161162771|NCT05441592|581974235|FG000|Overall Study|Lost to Follow-up|1|||
161162772|NCT05441592|581974236|FG001|Overall Study|Lost to Follow-up|5|||
161162773|NCT01021852|581974237|FG000|Treatment Period 1|Adverse Event|3|||
161162774|NCT01021852|581974238|FG001|Treatment Period 1|Adverse Event|1|||
161162775|NCT01021852|581974239|FG002|Treatment Period 1|Adverse Event|1|||
161162776|NCT01021852|581974240|FG003|Treatment Period 1|Adverse Event|0|||
161162777|NCT01021852|581974241|FG004|Treatment Period 1|Adverse Event|2|||
161162778|NCT01021852|581974242|FG005|Treatment Period 1|Adverse Event|2|||
161162779|NCT01021852|581974243|FG006|Treatment Period 1|Adverse Event|0|||
161162780|NCT01021852|581974244|FG007|Treatment Period 1|Adverse Event|0|||
161162781|NCT01021852|581974237|FG000|Treatment Period 1|Pregnancy|0|||
161162782|NCT01021852|581974238|FG001|Treatment Period 1|Pregnancy|0|||
161162783|NCT01021852|581974239|FG002|Treatment Period 1|Pregnancy|1|||
161162784|NCT01021852|581974240|FG003|Treatment Period 1|Pregnancy|0|||
161162785|NCT01021852|581974241|FG004|Treatment Period 1|Pregnancy|0|||
161162786|NCT01021852|581974242|FG005|Treatment Period 1|Pregnancy|0|||
161162787|NCT01021852|581974243|FG006|Treatment Period 1|Pregnancy|0|||
161162788|NCT01021852|581974244|FG007|Treatment Period 1|Pregnancy|0|||
161162789|NCT01021852|581974237|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161162790|NCT01021852|581974238|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161162791|NCT01021852|581974239|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161162792|NCT01021852|581974240|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161162793|NCT01021852|581974241|FG004|Treatment Period 1|Withdrawal by Subject|1|||
161162794|NCT01021852|581974242|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161162795|NCT01021852|581974243|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161162796|NCT01021852|581974244|FG007|Treatment Period 1|Withdrawal by Subject|1|||
161162797|NCT01021852|581974237|FG000|Treatment Period 1|Not Treated|0|||
161162798|NCT01021852|581974238|FG001|Treatment Period 1|Not Treated|0|||
161162799|NCT01021852|581974239|FG002|Treatment Period 1|Not Treated|0|||
161162800|NCT01021852|581974240|FG003|Treatment Period 1|Not Treated|2|||
161162801|NCT01021852|581974241|FG004|Treatment Period 1|Not Treated|0|||
161162802|NCT01021852|581974242|FG005|Treatment Period 1|Not Treated|0|||
161162803|NCT01021852|581974243|FG006|Treatment Period 1|Not Treated|0|||
161162804|NCT01021852|581974244|FG007|Treatment Period 1|Not Treated|0|||
161162805|NCT01021852|581974237|FG000|Washout Period-Placebo|Adverse Event|0|||
161162806|NCT01021852|581974238|FG001|Washout Period-Placebo|Adverse Event|0|||
161162807|NCT01021852|581974239|FG002|Washout Period-Placebo|Adverse Event|0|||
161162808|NCT01021852|581974240|FG003|Washout Period-Placebo|Adverse Event|1|||
161162809|NCT01021852|581974241|FG004|Washout Period-Placebo|Adverse Event|0|||
161162810|NCT01021852|581974242|FG005|Washout Period-Placebo|Adverse Event|1|||
161162811|NCT01021852|581974243|FG006|Washout Period-Placebo|Adverse Event|0|||
161162812|NCT01021852|581974244|FG007|Washout Period-Placebo|Adverse Event|0|||
161162813|NCT01021852|581974237|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
161162814|NCT01021852|581974238|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
161162815|NCT01021852|581974239|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
161162816|NCT01021852|581974240|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
161162817|NCT01021852|581974241|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
161288186|NCT05516108|582436173|FG000|Overall Study|Time Commitment|3|||
161288187|NCT05516108|582436174|FG001|Overall Study|Time Commitment|1|||
161288188|NCT05516108|582436173|FG000|Overall Study|Reason Unknown|2|||
161288189|NCT05516108|582436174|FG001|Overall Study|Reason Unknown|4|||
161288190|NCT03664232|582436175|FG000|Overall Study|Withdrawal by Subject|0|||
161162818|NCT01021852|581974242|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
161162819|NCT01021852|581974243|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
161162820|NCT01021852|581974244|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
161162821|NCT01021852|581974237|FG000|Washout Period-Placebo|Protocol Violation|0|||
161162822|NCT01021852|581974238|FG001|Washout Period-Placebo|Protocol Violation|0|||
161162823|NCT01021852|581974239|FG002|Washout Period-Placebo|Protocol Violation|0|||
161162824|NCT01021852|581974240|FG003|Washout Period-Placebo|Protocol Violation|0|||
161162825|NCT01021852|581974241|FG004|Washout Period-Placebo|Protocol Violation|0|||
161162826|NCT01021852|581974242|FG005|Washout Period-Placebo|Protocol Violation|0|||
161162827|NCT01021852|581974243|FG006|Washout Period-Placebo|Protocol Violation|1|||
161162828|NCT01021852|581974244|FG007|Washout Period-Placebo|Protocol Violation|0|||
161162829|NCT01021852|581974237|FG000|Washout Period-No Drug|Adverse Event|1|||
161288191|NCT03664232|582436176|FG001|Overall Study|Withdrawal by Subject|1|||
161288192|NCT03664232|582436177|FG002|Overall Study|Withdrawal by Subject|0|||
161162830|NCT01021852|581974238|FG001|Washout Period-No Drug|Adverse Event|0|||
161162831|NCT01021852|581974239|FG002|Washout Period-No Drug|Adverse Event|0|||
161162832|NCT01021852|581974240|FG003|Washout Period-No Drug|Adverse Event|0|||
161162833|NCT01021852|581974241|FG004|Washout Period-No Drug|Adverse Event|0|||
161162834|NCT01021852|581974242|FG005|Washout Period-No Drug|Adverse Event|1|||
161162835|NCT01021852|581974243|FG006|Washout Period-No Drug|Adverse Event|0|||
161162836|NCT01021852|581974244|FG007|Washout Period-No Drug|Adverse Event|0|||
161162837|NCT01021852|581974237|FG000|Treatment Period 2|Adverse Event|0|||
161162838|NCT01021852|581974238|FG001|Treatment Period 2|Adverse Event|1|||
161162839|NCT01021852|581974239|FG002|Treatment Period 2|Adverse Event|0|||
161162840|NCT01021852|581974240|FG003|Treatment Period 2|Adverse Event|0|||
161162841|NCT01021852|581974241|FG004|Treatment Period 2|Adverse Event|1|||
161162842|NCT01021852|581974242|FG005|Treatment Period 2|Adverse Event|0|||
161162843|NCT01021852|581974243|FG006|Treatment Period 2|Adverse Event|1|||
161162844|NCT01021852|581974244|FG007|Treatment Period 2|Adverse Event|0|||
161162845|NCT01021852|581974237|FG000|Treatment Period 2|Lack of Efficacy|0|||
161162846|NCT01021852|581974238|FG001|Treatment Period 2|Lack of Efficacy|0|||
161162847|NCT01021852|581974239|FG002|Treatment Period 2|Lack of Efficacy|0|||
161162848|NCT01021852|581974240|FG003|Treatment Period 2|Lack of Efficacy|0|||
161162849|NCT01021852|581974241|FG004|Treatment Period 2|Lack of Efficacy|0|||
161162850|NCT01021852|581974242|FG005|Treatment Period 2|Lack of Efficacy|1|||
161162851|NCT01021852|581974243|FG006|Treatment Period 2|Lack of Efficacy|0|||
161162852|NCT01021852|581974244|FG007|Treatment Period 2|Lack of Efficacy|0|||
161162853|NCT01021852|581974237|FG000|Treatment Period 2|Physician Decision|0|||
161162854|NCT01021852|581974238|FG001|Treatment Period 2|Physician Decision|0|||
161162855|NCT01021852|581974239|FG002|Treatment Period 2|Physician Decision|1|||
161162856|NCT01021852|581974240|FG003|Treatment Period 2|Physician Decision|0|||
161162857|NCT01021852|581974241|FG004|Treatment Period 2|Physician Decision|0|||
161162858|NCT01021852|581974242|FG005|Treatment Period 2|Physician Decision|0|||
161162859|NCT01021852|581974243|FG006|Treatment Period 2|Physician Decision|0|||
161162860|NCT01021852|581974244|FG007|Treatment Period 2|Physician Decision|0|||
161162861|NCT01021852|581974237|FG000|Treatment Period 2|Protocol Violation|0|||
161162862|NCT01021852|581974238|FG001|Treatment Period 2|Protocol Violation|0|||
161162863|NCT01021852|581974239|FG002|Treatment Period 2|Protocol Violation|0|||
161162864|NCT01021852|581974240|FG003|Treatment Period 2|Protocol Violation|0|||
161162865|NCT01021852|581974241|FG004|Treatment Period 2|Protocol Violation|1|||
161162866|NCT01021852|581974242|FG005|Treatment Period 2|Protocol Violation|0|||
161162867|NCT01021852|581974243|FG006|Treatment Period 2|Protocol Violation|1|||
161162868|NCT01021852|581974244|FG007|Treatment Period 2|Protocol Violation|0|||
161162869|NCT01021852|581974237|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161162870|NCT01021852|581974238|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161162871|NCT01021852|581974239|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161288193|NCT03664232|582436178|FG003|Overall Study|Withdrawal by Subject|1|||
161288194|NCT03664232|582436175|FG000|Overall Study|Adverse Event|0|||
161288195|NCT03664232|582436176|FG001|Overall Study|Adverse Event|0|||
161288196|NCT03664232|582436177|FG002|Overall Study|Adverse Event|1|||
161288197|NCT03664232|582436178|FG003|Overall Study|Adverse Event|0|||
161288198|NCT03664232|582436175|FG000|Overall Study|Other-Non-compliance with study drug|0|||
161288199|NCT03664232|582436176|FG001|Overall Study|Other-Non-compliance with study drug|1|||
161288200|NCT03664232|582436177|FG002|Overall Study|Other-Non-compliance with study drug|0|||
161288201|NCT03664232|582436178|FG003|Overall Study|Other-Non-compliance with study drug|2|||
161288202|NCT03664232|582436175|FG000|Overall Study|Other-Unspecified|0|||
161288203|NCT03664232|582436176|FG001|Overall Study|Other-Unspecified|3|||
161288204|NCT03664232|582436177|FG002|Overall Study|Other-Unspecified|0|||
161162872|NCT01021852|581974240|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161162873|NCT01021852|581974241|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161162874|NCT01021852|581974242|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161288205|NCT03664232|582436178|FG003|Overall Study|Other-Unspecified|1|||
161288206|NCT03664232|582436175|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
161288207|NCT03664232|582436176|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
161288208|NCT03664232|582436177|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
161288209|NCT03664232|582436178|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
161162875|NCT01021852|581974243|FG006|Treatment Period 2|Withdrawal by Subject|1|||
161288210|NCT02717507|582436179|FG000|Overall Study|Lost to Follow-up|5|||
161162876|NCT01021852|581974244|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161162877|NCT02493426|581974245|FG000|Overall Study|Withdrawal by Subject|0|||
161162878|NCT02493426|581974246|FG001|Overall Study|Withdrawal by Subject|1|||
161162879|NCT01025817|581974248|FG000|Completed Study Medication|Adverse Event|66|||
161162880|NCT01025817|581974249|FG001|Completed Study Medication|Adverse Event|39|||
161162881|NCT01025817|581974248|FG000|Completed Study Medication|Protocol Deviation|9|||
161288211|NCT02717507|582436180|FG001|Overall Study|Lost to Follow-up|8|||
161288212|NCT02717507|582436179|FG000|Overall Study|Pregnancy|1|||
161288213|NCT02717507|582436180|FG001|Overall Study|Pregnancy|1|||
161162882|NCT01025817|581974249|FG001|Completed Study Medication|Protocol Deviation|8|||
161162883|NCT01025817|581974248|FG000|Completed Study Medication|Withdrawal by Subject|8|||
161162884|NCT01025817|581974249|FG001|Completed Study Medication|Withdrawal by Subject|9|||
161079134|NCT01803282|581678732|FG010|Overall Study|Progressive Disease|6|||
161079135|NCT01803282|581678733|FG011|Overall Study|Progressive Disease|11|||
161079136|NCT01803282|581678722|FG000|Overall Study|Death|0|||
161079137|NCT01803282|581678723|FG001|Overall Study|Death|0|||
161079138|NCT01803282|581678724|FG002|Overall Study|Death|0|||
161079139|NCT01803282|581678725|FG003|Overall Study|Death|0|||
161079140|NCT01803282|581678726|FG004|Overall Study|Death|2|||
161079141|NCT01803282|581678727|FG005|Overall Study|Death|1|||
161079142|NCT01803282|581678728|FG006|Overall Study|Death|1|||
161079143|NCT01803282|581678729|FG007|Overall Study|Death|5|||
161079144|NCT01803282|581678730|FG008|Overall Study|Death|1|||
161079145|NCT01803282|581678731|FG009|Overall Study|Death|1|||
161079146|NCT01803282|581678732|FG010|Overall Study|Death|0|||
161079147|NCT01803282|581678733|FG011|Overall Study|Death|0|||
161079148|NCT01803282|581678722|FG000|Overall Study|Withdrew Consent|0|||
161079149|NCT01803282|581678723|FG001|Overall Study|Withdrew Consent|0|||
161079150|NCT01803282|581678724|FG002|Overall Study|Withdrew Consent|0|||
161079151|NCT01803282|581678725|FG003|Overall Study|Withdrew Consent|6|||
161079152|NCT01803282|581678726|FG004|Overall Study|Withdrew Consent|1|||
161079153|NCT01803282|581678727|FG005|Overall Study|Withdrew Consent|0|||
161079154|NCT01803282|581678728|FG006|Overall Study|Withdrew Consent|8|||
161079155|NCT01803282|581678729|FG007|Overall Study|Withdrew Consent|3|||
161079156|NCT01803282|581678730|FG008|Overall Study|Withdrew Consent|1|||
161079157|NCT01803282|581678731|FG009|Overall Study|Withdrew Consent|5|||
161079158|NCT01803282|581678732|FG010|Overall Study|Withdrew Consent|0|||
161079159|NCT01803282|581678733|FG011|Overall Study|Withdrew Consent|1|||
161079160|NCT01803282|581678722|FG000|Overall Study|Investigator's Discretion|0|||
161079161|NCT01803282|581678723|FG001|Overall Study|Investigator's Discretion|0|||
161079162|NCT01803282|581678724|FG002|Overall Study|Investigator's Discretion|0|||
161079163|NCT01803282|581678725|FG003|Overall Study|Investigator's Discretion|7|||
161079164|NCT01803282|581678726|FG004|Overall Study|Investigator's Discretion|2|||
161079165|NCT01803282|581678727|FG005|Overall Study|Investigator's Discretion|1|||
161079166|NCT01803282|581678728|FG006|Overall Study|Investigator's Discretion|7|||
161079167|NCT01803282|581678729|FG007|Overall Study|Investigator's Discretion|10|||
161079168|NCT01803282|581678730|FG008|Overall Study|Investigator's Discretion|6|||
161079169|NCT01803282|581678731|FG009|Overall Study|Investigator's Discretion|7|||
161079170|NCT01803282|581678732|FG010|Overall Study|Investigator's Discretion|1|||
161079171|NCT01803282|581678733|FG011|Overall Study|Investigator's Discretion|0|||
161079172|NCT01803282|581678722|FG000|Overall Study|Adverse Event|0|||
161079173|NCT01803282|581678723|FG001|Overall Study|Adverse Event|0|||
161079174|NCT01803282|581678724|FG002|Overall Study|Adverse Event|0|||
161079175|NCT01803282|581678725|FG003|Overall Study|Adverse Event|0|||
161079176|NCT01803282|581678726|FG004|Overall Study|Adverse Event|0|||
161079177|NCT01803282|581678727|FG005|Overall Study|Adverse Event|0|||
161079178|NCT01803282|581678728|FG006|Overall Study|Adverse Event|1|||
161079179|NCT01803282|581678729|FG007|Overall Study|Adverse Event|2|||
161079180|NCT01803282|581678730|FG008|Overall Study|Adverse Event|0|||
161079181|NCT01803282|581678731|FG009|Overall Study|Adverse Event|1|||
161079182|NCT01803282|581678732|FG010|Overall Study|Adverse Event|0|||
161079183|NCT01803282|581678733|FG011|Overall Study|Adverse Event|3|||
161079184|NCT01803282|581678722|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161079185|NCT01803282|581678723|FG001|Overall Study|Non-Compliance with Study Drug|0|||
161079186|NCT01803282|581678724|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161079187|NCT01803282|581678725|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161079188|NCT01803282|581678726|FG004|Overall Study|Non-Compliance with Study Drug|0|||
161079189|NCT01803282|581678727|FG005|Overall Study|Non-Compliance with Study Drug|0|||
161079190|NCT01803282|581678728|FG006|Overall Study|Non-Compliance with Study Drug|0|||
161079191|NCT01803282|581678729|FG007|Overall Study|Non-Compliance with Study Drug|0|||
161079192|NCT01803282|581678730|FG008|Overall Study|Non-Compliance with Study Drug|0|||
161079193|NCT01803282|581678731|FG009|Overall Study|Non-Compliance with Study Drug|0|||
161079194|NCT01803282|581678732|FG010|Overall Study|Non-Compliance with Study Drug|0|||
161079195|NCT01803282|581678733|FG011|Overall Study|Non-Compliance with Study Drug|0|||
161079196|NCT01803282|581678722|FG000|Overall Study|Unknown Reason|0|||
161079197|NCT01803282|581678723|FG001|Overall Study|Unknown Reason|0|||
161079198|NCT01803282|581678724|FG002|Overall Study|Unknown Reason|0|||
161079199|NCT01803282|581678725|FG003|Overall Study|Unknown Reason|0|||
161079200|NCT01803282|581678726|FG004|Overall Study|Unknown Reason|0|||
161079201|NCT01803282|581678727|FG005|Overall Study|Unknown Reason|0|||
161079202|NCT01803282|581678728|FG006|Overall Study|Unknown Reason|0|||
161079203|NCT01803282|581678729|FG007|Overall Study|Unknown Reason|1|||
161079204|NCT01803282|581678730|FG008|Overall Study|Unknown Reason|0|||
161079205|NCT01803282|581678731|FG009|Overall Study|Unknown Reason|0|||
161079206|NCT01803282|581678732|FG010|Overall Study|Unknown Reason|0|||
161079207|NCT01803282|581678733|FG011|Overall Study|Unknown Reason|0|||
161079208|NCT01803282|581678722|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
161079209|NCT01803282|581678723|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
161079210|NCT01803282|581678724|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
161079211|NCT01803282|581678725|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
161288214|NCT02717507|582436179|FG000|Overall Study|Protocol Violation|2|||
161162885|NCT01025817|581974248|FG000|Completed Study Medication|Administrative problems|7|||
161162886|NCT01025817|581974249|FG001|Completed Study Medication|Administrative problems|5|||
161162887|NCT01025817|581974248|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
161162888|NCT01025817|581974249|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
161162889|NCT01025817|581974248|FG000|Completed Study Medication|Abnormal test procedure|4|||
161162890|NCT01025817|581974249|FG001|Completed Study Medication|Abnormal test procedure|0|||
161162891|NCT01025817|581974248|FG000|Completed Study Medication|Graft loss|2|||
161162892|NCT01025817|581974249|FG001|Completed Study Medication|Graft loss|5|||
161162893|NCT01025817|581974248|FG000|Completed Study Medication|Death|2|||
161162894|NCT01025817|581974249|FG001|Completed Study Medication|Death|2|||
161162895|NCT01025817|581974248|FG000|Completed Study Medication|Abnormal lab values|0|||
161162896|NCT01025817|581974249|FG001|Completed Study Medication|Abnormal lab values|2|||
161162897|NCT01025817|581974248|FG000|Completed Study Medication|Subject no longer required study drug|0|||
161162898|NCT01025817|581974249|FG001|Completed Study Medication|Subject no longer required study drug|1|||
161162899|NCT01025817|581974248|FG000|Completed Study Medication|Lost to Follow-up|0|||
161162900|NCT01025817|581974249|FG001|Completed Study Medication|Lost to Follow-up|1|||
161162901|NCT01025817|581974248|FG000|Completed Study|Withdrawal by Subject|8|||
161162902|NCT01025817|581974249|FG001|Completed Study|Withdrawal by Subject|16|||
161162903|NCT01025817|581974248|FG000|Completed Study|Death|6|||
161162904|NCT01025817|581974249|FG001|Completed Study|Death|5|||
161162905|NCT01025817|581974248|FG000|Completed Study|Missing|2|||
161162906|NCT01025817|581974249|FG001|Completed Study|Missing|0|||
161162907|NCT01025817|581974248|FG000|Completed Study|Lost to Follow-up|0|||
161162908|NCT01025817|581974249|FG001|Completed Study|Lost to Follow-up|1|||
161162909|NCT00807846|581974252|FG000|Overall Study|Adverse Event|5|||
161162910|NCT00807846|581974253|FG001|Overall Study|Adverse Event|0|||
161162911|NCT00807846|581974252|FG000|Overall Study|Lack of Efficacy|2|||
161162912|NCT00807846|581974253|FG001|Overall Study|Lack of Efficacy|0|||
161162913|NCT00807846|581974252|FG000|Overall Study|Protocol Violation|2|||
161162914|NCT00807846|581974253|FG001|Overall Study|Protocol Violation|1|||
161162915|NCT00807846|581974252|FG000|Overall Study|Withdrawal by Subject|2|||
161162916|NCT00807846|581974253|FG001|Overall Study|Withdrawal by Subject|1|||
161162917|NCT00807846|581974252|FG000|Overall Study|Other|1|||
161162918|NCT00807846|581974253|FG001|Overall Study|Other|2|||
161162919|NCT01081873|581974254|FG000|Overall Study|Death|86|||
161162920|NCT01081873|581974254|FG000|Overall Study|Withdrawal by Subject|10|||
161162921|NCT01081873|581974254|FG000|Overall Study|Lost to Follow-up|142|||
161162922|NCT01081873|581974254|FG000|Overall Study|Progression of prostate cancer|13|||
161162923|NCT01081873|581974254|FG000|Overall Study|Other|47|||
161162924|NCT01165021|581974256|FG000|Overall Study|Death|1|||
161162925|NCT02491073|581974257|FG000|Overall Study|screen failure|1|||
161162926|NCT02491073|581974258|FG001|Overall Study|screen failure|0|||
161162927|NCT03977727|581974259|FG000|Second Treatment|Lost to Follow-up|0|||
161162928|NCT03977727|581974260|FG001|Second Treatment|Lost to Follow-up|3|||
161162929|NCT01419665|581974261|FG000|Combination Treatment|Adverse Event|7|||
161162930|NCT01419665|581974262|FG001|Combination Treatment|Adverse Event|10|||
161162931|NCT01419665|581974261|FG000|Combination Treatment|Physician Decision|5|||
161162932|NCT01419665|581974262|FG001|Combination Treatment|Physician Decision|8|||
161162933|NCT01419665|581974261|FG000|Combination Treatment|Protocol Violation|6|||
161162934|NCT01419665|581974262|FG001|Combination Treatment|Protocol Violation|2|||
161162935|NCT01419665|581974261|FG000|Combination Treatment|disease progression|10|||
161162936|NCT01419665|581974262|FG001|Combination Treatment|disease progression|9|||
161162937|NCT01419665|581974261|FG000|Combination Treatment|Death|5|||
161162938|NCT01419665|581974262|FG001|Combination Treatment|Death|7|||
161162939|NCT01419665|581974261|FG000|Combination Treatment|administrative problems|0|||
161162940|NCT01419665|581974262|FG001|Combination Treatment|administrative problems|1|||
161162941|NCT01419665|581974261|FG000|Combination Treatment|Withdrawal by Subject|5|||
161162942|NCT01419665|581974262|FG001|Combination Treatment|Withdrawal by Subject|4|||
161162943|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
161162944|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
161162945|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
161162946|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
161162947|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
161162948|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
161162949|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
161162950|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
161162951|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
161162952|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
161162953|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
161162954|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
161162955|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|Death|1|||
161162956|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|Death|2|||
161162957|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
161162958|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
161162959|NCT01419665|581974261|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
161162960|NCT01419665|581974262|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
161162961|NCT01419665|581974261|FG000|Open Label Phase|Death|1|||
161162962|NCT01419665|581974262|FG001|Open Label Phase|Death|0|||
161162963|NCT01419665|581974261|FG000|Open Label Phase|disease progression|0|||
161162964|NCT01419665|581974262|FG001|Open Label Phase|disease progression|1|||
161162965|NCT01655823|581974264|FG000|Overall Study|Lost to Follow-up|0|||
161162966|NCT01655823|581974265|FG001|Overall Study|Lost to Follow-up|1|||
161162967|NCT01655823|581974266|FG002|Overall Study|Lost to Follow-up|0|||
161162968|NCT01655823|581974267|FG003|Overall Study|Lost to Follow-up|0|||
161162969|NCT01655823|581974268|FG004|Overall Study|Lost to Follow-up|1|||
161162970|NCT01655823|581974264|FG000|Overall Study|Withdrawal by Subject|0|||
161162971|NCT01655823|581974265|FG001|Overall Study|Withdrawal by Subject|1|||
161162972|NCT01655823|581974266|FG002|Overall Study|Withdrawal by Subject|0|||
161162973|NCT01655823|581974267|FG003|Overall Study|Withdrawal by Subject|1|||
161162974|NCT01655823|581974268|FG004|Overall Study|Withdrawal by Subject|0|||
161162975|NCT02683525|581974269|FG000|Overall Study|Lost to Follow-up|1|||
161162976|NCT02683525|581974269|FG000|Overall Study|Physician Decision|1|||
161162977|NCT02683525|581974269|FG000|Overall Study|Disease Progression|6|||
161162978|NCT02632110|581974274|FG000|Overall Study|Withdrawal by Subject|1|||
161162979|NCT02632110|581974275|FG001|Overall Study|Withdrawal by Subject|1|||
161162980|NCT02632110|581974276|FG002|Overall Study|Withdrawal by Subject|0|||
161162981|NCT02632110|581974277|FG003|Overall Study|Withdrawal by Subject|0|||
161162982|NCT02632110|581974278|FG004|Overall Study|Withdrawal by Subject|1|||
161162983|NCT02632110|581974279|FG005|Overall Study|Withdrawal by Subject|1|||
161162984|NCT02632110|581974280|FG006|Overall Study|Withdrawal by Subject|3|||
161162985|NCT02632110|581974281|FG007|Overall Study|Withdrawal by Subject|3|||
161162986|NCT02632110|581974282|FG008|Overall Study|Withdrawal by Subject|1|||
161162987|NCT02632110|581974283|FG009|Overall Study|Withdrawal by Subject|1|||
161162988|NCT01935336|581974289|FG000|Overall Study|Adverse Event|1|||
161162989|NCT01935336|581974290|FG001|Overall Study|Adverse Event|0|||
161162990|NCT01935336|581974291|FG002|Overall Study|Adverse Event|0|||
161162991|NCT01935336|581974292|FG003|Overall Study|Adverse Event|0|||
161162992|NCT01935336|581974289|FG000|Overall Study|Progressive disease|5|||
161162993|NCT01935336|581974290|FG001|Overall Study|Progressive disease|3|||
161162994|NCT01935336|581974291|FG002|Overall Study|Progressive disease|47|||
161162995|NCT01935336|581974292|FG003|Overall Study|Progressive disease|66|||
161162996|NCT02773238|581974293|FG000|Overall Study|Lack of Efficacy|4|||
161162997|NCT03260205|581974294|FG000|Overall Study|Adverse Event|2|||
161162998|NCT03260205|581974295|FG001|Overall Study|Adverse Event|0|||
161162999|NCT03260205|581974296|FG002|Overall Study|Adverse Event|2|||
161163000|NCT03260205|581974297|FG003|Overall Study|Adverse Event|2|||
161163001|NCT03260205|581974298|FG004|Overall Study|Adverse Event|4|||
161163002|NCT03260205|581974294|FG000|Overall Study|Lost to Follow-up|2|||
161163003|NCT03260205|581974295|FG001|Overall Study|Lost to Follow-up|2|||
161163004|NCT03260205|581974296|FG002|Overall Study|Lost to Follow-up|1|||
161163005|NCT03260205|581974297|FG003|Overall Study|Lost to Follow-up|1|||
161163006|NCT03260205|581974298|FG004|Overall Study|Lost to Follow-up|5|||
161163007|NCT03260205|581974294|FG000|Overall Study|Protocol Violation|0|||
161163008|NCT03260205|581974295|FG001|Overall Study|Protocol Violation|0|||
161163009|NCT03260205|581974296|FG002|Overall Study|Protocol Violation|2|||
161163010|NCT03260205|581974297|FG003|Overall Study|Protocol Violation|0|||
161163011|NCT03260205|581974298|FG004|Overall Study|Protocol Violation|1|||
161163012|NCT03260205|581974294|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
161163013|NCT03260205|581974295|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
161163014|NCT03260205|581974296|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
161163015|NCT03260205|581974297|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
161163016|NCT03260205|581974298|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
161163017|NCT03260205|581974294|FG000|Overall Study|Other: Unspecified|0|||
161163018|NCT03260205|581974295|FG001|Overall Study|Other: Unspecified|0|||
161163019|NCT03260205|581974296|FG002|Overall Study|Other: Unspecified|3|||
161163020|NCT03260205|581974297|FG003|Overall Study|Other: Unspecified|1|||
161163021|NCT03260205|581974298|FG004|Overall Study|Other: Unspecified|1|||
161163022|NCT03260205|581974294|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
161163023|NCT03260205|581974295|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
161163024|NCT03260205|581974296|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
161163025|NCT03260205|581974297|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
161163026|NCT03260205|581974298|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
161163027|NCT01877382|581974299|FG000|Dose Escalation|Progressive disease|2|||
161163028|NCT01877382|581974300|FG001|Dose Escalation|Progressive disease|0|||
161163029|NCT01877382|581974301|FG002|Dose Escalation|Progressive disease|1|||
161163030|NCT01877382|581974302|FG003|Dose Escalation|Progressive disease|6|||
161163031|NCT01877382|581974303|FG004|Dose Escalation|Progressive disease|1|||
161163032|NCT01877382|581974304|FG005|Dose Escalation|Progressive disease|0|||
161163033|NCT01877382|581974305|FG006|Dose Escalation|Progressive disease|3|||
161163034|NCT01877382|581974306|FG007|Dose Escalation|Progressive disease|10|||
161163035|NCT01877382|581974307|FG008|Dose Escalation|Progressive disease|4|||
161163036|NCT01877382|581974308|FG009|Dose Escalation|Progressive disease|2|||
161163037|NCT01877382|581974309|FG010|Dose Escalation|Progressive disease|3|||
161163038|NCT01877382|581974310|FG011|Dose Escalation|Progressive disease|3|||
161163039|NCT01877382|581974311|FG012|Dose Escalation|Progressive disease|13|||
161163040|NCT01877382|581974312|FG013|Dose Escalation|Progressive disease|1|||
161163041|NCT01877382|581974313|FG014|Dose Escalation|Progressive disease|0|||
161163042|NCT01877382|581974299|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161163043|NCT01877382|581974300|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163044|NCT01877382|581974301|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163045|NCT01877382|581974302|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161163046|NCT01877382|581974303|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163047|NCT01877382|581974304|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163048|NCT01877382|581974305|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161163049|NCT01877382|581974306|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163050|NCT01877382|581974307|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163051|NCT01877382|581974308|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163052|NCT01877382|581974309|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163053|NCT01877382|581974310|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163054|NCT01877382|581974311|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163055|NCT01877382|581974312|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163056|NCT01877382|581974313|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163057|NCT01877382|581974299|FG000|Dose Escalation|Clinical progression|0|||
161163058|NCT01877382|581974300|FG001|Dose Escalation|Clinical progression|1|||
161163059|NCT01877382|581974301|FG002|Dose Escalation|Clinical progression|0|||
161163060|NCT01877382|581974302|FG003|Dose Escalation|Clinical progression|2|||
161163061|NCT01877382|581974303|FG004|Dose Escalation|Clinical progression|0|||
161163062|NCT01877382|581974304|FG005|Dose Escalation|Clinical progression|0|||
161163063|NCT01877382|581974305|FG006|Dose Escalation|Clinical progression|1|||
161163064|NCT01877382|581974306|FG007|Dose Escalation|Clinical progression|0|||
161163065|NCT01877382|581974307|FG008|Dose Escalation|Clinical progression|0|||
161163066|NCT01877382|581974308|FG009|Dose Escalation|Clinical progression|1|||
161163067|NCT01877382|581974309|FG010|Dose Escalation|Clinical progression|0|||
161163068|NCT01877382|581974310|FG011|Dose Escalation|Clinical progression|0|||
161163069|NCT01877382|581974311|FG012|Dose Escalation|Clinical progression|2|||
161163070|NCT01877382|581974312|FG013|Dose Escalation|Clinical progression|1|||
161163071|NCT01877382|581974313|FG014|Dose Escalation|Clinical progression|0|||
161163072|NCT01877382|581974299|FG000|Dose Escalation|Adverse Event|0|||
161163073|NCT01877382|581974300|FG001|Dose Escalation|Adverse Event|0|||
161163074|NCT01877382|581974301|FG002|Dose Escalation|Adverse Event|0|||
161163075|NCT01877382|581974302|FG003|Dose Escalation|Adverse Event|4|||
161163076|NCT01877382|581974303|FG004|Dose Escalation|Adverse Event|1|||
161163077|NCT01877382|581974304|FG005|Dose Escalation|Adverse Event|2|||
161163078|NCT01877382|581974305|FG006|Dose Escalation|Adverse Event|1|||
161163079|NCT01877382|581974306|FG007|Dose Escalation|Adverse Event|2|||
161163080|NCT01877382|581974307|FG008|Dose Escalation|Adverse Event|0|||
161163081|NCT01877382|581974308|FG009|Dose Escalation|Adverse Event|0|||
161163082|NCT01877382|581974309|FG010|Dose Escalation|Adverse Event|0|||
161163083|NCT01877382|581974310|FG011|Dose Escalation|Adverse Event|0|||
161163084|NCT01877382|581974311|FG012|Dose Escalation|Adverse Event|1|||
161163085|NCT01877382|581974312|FG013|Dose Escalation|Adverse Event|0|||
161163086|NCT01877382|581974313|FG014|Dose Escalation|Adverse Event|0|||
161163087|NCT01877382|581974299|FG000|Dose Escalation|Withdrawal by Subject|0|||
161163088|NCT01877382|581974300|FG001|Dose Escalation|Withdrawal by Subject|0|||
161163089|NCT01877382|581974301|FG002|Dose Escalation|Withdrawal by Subject|0|||
161163090|NCT01877382|581974302|FG003|Dose Escalation|Withdrawal by Subject|0|||
161163091|NCT01877382|581974303|FG004|Dose Escalation|Withdrawal by Subject|0|||
161163092|NCT01877382|581974304|FG005|Dose Escalation|Withdrawal by Subject|3|||
161163093|NCT01877382|581974305|FG006|Dose Escalation|Withdrawal by Subject|2|||
161163094|NCT01877382|581974306|FG007|Dose Escalation|Withdrawal by Subject|1|||
161163095|NCT01877382|581974307|FG008|Dose Escalation|Withdrawal by Subject|1|||
161163096|NCT01877382|581974308|FG009|Dose Escalation|Withdrawal by Subject|0|||
161163097|NCT01877382|581974309|FG010|Dose Escalation|Withdrawal by Subject|0|||
161163098|NCT01877382|581974310|FG011|Dose Escalation|Withdrawal by Subject|0|||
161163099|NCT01877382|581974311|FG012|Dose Escalation|Withdrawal by Subject|0|||
161163100|NCT01877382|581974312|FG013|Dose Escalation|Withdrawal by Subject|0|||
161163101|NCT01877382|581974313|FG014|Dose Escalation|Withdrawal by Subject|0|||
161163102|NCT01877382|581974299|FG000|Dose Escalation|Protocol Violation|0|||
161163103|NCT01877382|581974300|FG001|Dose Escalation|Protocol Violation|0|||
161163104|NCT01877382|581974301|FG002|Dose Escalation|Protocol Violation|0|||
161163105|NCT01877382|581974302|FG003|Dose Escalation|Protocol Violation|0|||
161163106|NCT01877382|581974303|FG004|Dose Escalation|Protocol Violation|0|||
161163107|NCT01877382|581974304|FG005|Dose Escalation|Protocol Violation|0|||
161163108|NCT01877382|581974305|FG006|Dose Escalation|Protocol Violation|1|||
161163109|NCT01877382|581974306|FG007|Dose Escalation|Protocol Violation|0|||
161163110|NCT01877382|581974307|FG008|Dose Escalation|Protocol Violation|0|||
161163111|NCT01877382|581974308|FG009|Dose Escalation|Protocol Violation|0|||
161163112|NCT01877382|581974309|FG010|Dose Escalation|Protocol Violation|0|||
161163113|NCT01877382|581974310|FG011|Dose Escalation|Protocol Violation|0|||
161163114|NCT01877382|581974311|FG012|Dose Escalation|Protocol Violation|0|||
161163115|NCT01877382|581974312|FG013|Dose Escalation|Protocol Violation|0|||
161163116|NCT01877382|581974313|FG014|Dose Escalation|Protocol Violation|0|||
161163117|NCT01877382|581974299|FG000|Dose Escalation|Study terminated by sponsor|0|||
161163118|NCT01877382|581974300|FG001|Dose Escalation|Study terminated by sponsor|0|||
161163119|NCT01877382|581974301|FG002|Dose Escalation|Study terminated by sponsor|0|||
161163120|NCT01877382|581974302|FG003|Dose Escalation|Study terminated by sponsor|0|||
161163121|NCT01877382|581974303|FG004|Dose Escalation|Study terminated by sponsor|0|||
161163122|NCT01877382|581974304|FG005|Dose Escalation|Study terminated by sponsor|0|||
161163123|NCT01877382|581974305|FG006|Dose Escalation|Study terminated by sponsor|0|||
161163124|NCT01877382|581974306|FG007|Dose Escalation|Study terminated by sponsor|1|||
161163125|NCT01877382|581974307|FG008|Dose Escalation|Study terminated by sponsor|1|||
161163126|NCT01877382|581974308|FG009|Dose Escalation|Study terminated by sponsor|0|||
161163127|NCT01877382|581974309|FG010|Dose Escalation|Study terminated by sponsor|0|||
161163128|NCT01877382|581974310|FG011|Dose Escalation|Study terminated by sponsor|0|||
161163129|NCT01877382|581974311|FG012|Dose Escalation|Study terminated by sponsor|3|||
161163130|NCT01877382|581974312|FG013|Dose Escalation|Study terminated by sponsor|0|||
161163131|NCT01877382|581974313|FG014|Dose Escalation|Study terminated by sponsor|0|||
161163132|NCT01877382|581974299|FG000|Dose Escalation|Death|0|||
161163133|NCT01877382|581974300|FG001|Dose Escalation|Death|0|||
161163134|NCT01877382|581974301|FG002|Dose Escalation|Death|0|||
161163135|NCT01877382|581974302|FG003|Dose Escalation|Death|0|||
161163136|NCT01877382|581974303|FG004|Dose Escalation|Death|0|||
161163137|NCT01877382|581974304|FG005|Dose Escalation|Death|0|||
161163138|NCT01877382|581974305|FG006|Dose Escalation|Death|0|||
161163139|NCT01877382|581974306|FG007|Dose Escalation|Death|1|||
161163140|NCT01877382|581974307|FG008|Dose Escalation|Death|0|||
161163141|NCT01877382|581974308|FG009|Dose Escalation|Death|0|||
161163142|NCT01877382|581974309|FG010|Dose Escalation|Death|0|||
161163143|NCT01877382|581974310|FG011|Dose Escalation|Death|0|||
161163144|NCT01877382|581974311|FG012|Dose Escalation|Death|1|||
161163145|NCT01877382|581974312|FG013|Dose Escalation|Death|1|||
161163146|NCT01877382|581974313|FG014|Dose Escalation|Death|0|||
161163147|NCT01877382|581974299|FG000|Dose Expansion|Progressive disease|0|||
161163148|NCT01877382|581974300|FG001|Dose Expansion|Progressive disease|0|||
161163149|NCT01877382|581974301|FG002|Dose Expansion|Progressive disease|0|||
161163150|NCT01877382|581974302|FG003|Dose Expansion|Progressive disease|0|||
161163151|NCT01877382|581974303|FG004|Dose Expansion|Progressive disease|0|||
161163152|NCT01877382|581974304|FG005|Dose Expansion|Progressive disease|0|||
161163153|NCT01877382|581974305|FG006|Dose Expansion|Progressive disease|0|||
161163154|NCT01877382|581974306|FG007|Dose Expansion|Progressive disease|0|||
161163155|NCT01877382|581974307|FG008|Dose Expansion|Progressive disease|0|||
161163156|NCT01877382|581974308|FG009|Dose Expansion|Progressive disease|0|||
161163157|NCT01877382|581974309|FG010|Dose Expansion|Progressive disease|0|||
161163158|NCT01877382|581974310|FG011|Dose Expansion|Progressive disease|0|||
161163159|NCT01877382|581974311|FG012|Dose Expansion|Progressive disease|0|||
161163160|NCT01877382|581974312|FG013|Dose Expansion|Progressive disease|0|||
161163161|NCT01877382|581974313|FG014|Dose Expansion|Progressive disease|11|||
161288215|NCT02717507|582436180|FG001|Overall Study|Protocol Violation|2|||
161288216|NCT02717507|582436179|FG000|Overall Study|Withdrawal by Subject|20|||
161288217|NCT02717507|582436180|FG001|Overall Study|Withdrawal by Subject|20|||
161288218|NCT02717507|582436179|FG000|Overall Study|Relapse|1|||
161288219|NCT02717507|582436180|FG001|Overall Study|Relapse|1|||
161288220|NCT02717507|582436179|FG000|Overall Study|Cardiac Event|2|||
161288221|NCT02717507|582436180|FG001|Overall Study|Cardiac Event|6|||
161163162|NCT01877382|581974299|FG000|Dose Expansion|Clinical progression|0|||
161163163|NCT01877382|581974300|FG001|Dose Expansion|Clinical progression|0|||
161163164|NCT01877382|581974301|FG002|Dose Expansion|Clinical progression|0|||
161163165|NCT01877382|581974302|FG003|Dose Expansion|Clinical progression|0|||
161163166|NCT01877382|581974303|FG004|Dose Expansion|Clinical progression|0|||
161163167|NCT01877382|581974304|FG005|Dose Expansion|Clinical progression|0|||
161163168|NCT01877382|581974305|FG006|Dose Expansion|Clinical progression|0|||
161163169|NCT01877382|581974306|FG007|Dose Expansion|Clinical progression|0|||
161163170|NCT01877382|581974307|FG008|Dose Expansion|Clinical progression|0|||
161163171|NCT01877382|581974308|FG009|Dose Expansion|Clinical progression|0|||
161163172|NCT01877382|581974309|FG010|Dose Expansion|Clinical progression|0|||
161163173|NCT01877382|581974310|FG011|Dose Expansion|Clinical progression|0|||
161288222|NCT05017246|582436181|FG000|Overall Study|Withdrawal by Subject|5|||
161288223|NCT05017246|582436182|FG001|Overall Study|Withdrawal by Subject|3|||
161288224|NCT05017246|582436181|FG000|Overall Study|Determined to be ineligible|0|||
161288225|NCT05017246|582436182|FG001|Overall Study|Determined to be ineligible|1|||
161288226|NCT05017246|582436181|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
161288227|NCT05017246|582436182|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
161288228|NCT05017246|582436181|FG000|Overall Study|Technical failure|1|||
161288229|NCT05017246|582436182|FG001|Overall Study|Technical failure|3|||
161288230|NCT02493660|582436185|FG000|Overall Study|Physician Decision|0|||
161288231|NCT02493660|582436186|FG001|Overall Study|Physician Decision|1|||
161288232|NCT02493660|582436185|FG000|Overall Study|Adverse Event|4|||
161288233|NCT02493660|582436186|FG001|Overall Study|Adverse Event|2|||
161288234|NCT02493660|582436185|FG000|Overall Study|Withdrawal by Subject|2|||
161288235|NCT02493660|582436186|FG001|Overall Study|Withdrawal by Subject|3|||
161288236|NCT02493660|582436185|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
161288237|NCT02493660|582436186|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
161288238|NCT02493660|582436185|FG000|Overall Study|Protocol Violation|0|||
161288239|NCT02493660|582436186|FG001|Overall Study|Protocol Violation|1|||
161288240|NCT02493660|582436185|FG000|Overall Study|Death|0|||
161288241|NCT02493660|582436186|FG001|Overall Study|Death|1|||
161288242|NCT02493660|582436185|FG000|Overall Study|Lost to Follow-up|2|||
161288243|NCT02493660|582436186|FG001|Overall Study|Lost to Follow-up|4|||
161288244|NCT00709995|582436187|FG000|Overall Study|Adverse Event|4|||
161288245|NCT00709995|582436188|FG001|Overall Study|Adverse Event|2|||
161288246|NCT00709995|582436187|FG000|Overall Study|Withdrawal by Subject|1|||
161288247|NCT00709995|582436188|FG001|Overall Study|Withdrawal by Subject|3|||
161288248|NCT00638508|582436189|FG000|Overall Study|Physician Decision|5|||
161288249|NCT00638508|582436190|FG001|Overall Study|Physician Decision|2|||
161288250|NCT03500198|582436191|FG000|Overall Study|Lost to Follow-up|0|||
161288251|NCT03500198|582436192|FG001|Overall Study|Lost to Follow-up|1|||
161288252|NCT00654095|582436193|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
161288253|NCT00654095|582436193|FG000|Overall Study|Elevated triglyceride level (2)|1|||
161288254|NCT00654095|582436193|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
161288255|NCT00654095|582436193|FG000|Overall Study|Adverse Event|11|||
161288256|NCT00654095|582436193|FG000|Overall Study|Withdrawal by Subject|5|||
161288257|NCT00654095|582436193|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
161288258|NCT00654095|582436193|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
161288259|NCT00654095|582436193|FG000|Overall Study|Did not meet inclusion criteria|1|||
161288260|NCT00595621|582436199|FG000|Open Label Run in|Adverse Event|1|||
161288261|NCT00595621|582436200|FG001|Open Label Run in|Adverse Event|0|||
161288262|NCT00595621|582436199|FG000|Open Label Run in|Physician Decision|1|||
161288263|NCT00595621|582436200|FG001|Open Label Run in|Physician Decision|0|||
161288264|NCT00595621|582436199|FG000|Open Label Run in|Withdrawal by Subject|1|||
161288265|NCT00595621|582436200|FG001|Open Label Run in|Withdrawal by Subject|0|||
161288266|NCT00595621|582436199|FG000|Randomization and Study|Adverse Event|2|||
161288267|NCT00595621|582436200|FG001|Randomization and Study|Adverse Event|0|||
161288268|NCT00595621|582436199|FG000|Randomization and Study|Withdrawal by Subject|0|||
161288269|NCT00595621|582436200|FG001|Randomization and Study|Withdrawal by Subject|1|||
161288270|NCT02440464|582436201|FG000|Overall Study|Withdrawal by Subject|3|||
161288271|NCT02440464|582436202|FG001|Overall Study|Withdrawal by Subject|2|||
161288272|NCT00324987|582436203|FG000|Overall Study|Adverse Event|2|||
161288273|NCT00324987|582436204|FG001|Overall Study|Adverse Event|1|||
161288274|NCT00324987|582436203|FG000|Overall Study|Withdrawal by Subject|1|||
161288275|NCT00324987|582436204|FG001|Overall Study|Withdrawal by Subject|1|||
161288276|NCT00324987|582436203|FG000|Overall Study|Progression|1|||
161288277|NCT00324987|582436204|FG001|Overall Study|Progression|1|||
161288278|NCT00324987|582436203|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
161288279|NCT00324987|582436204|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
161288280|NCT03565900|582436206|FG000|Overall Study|Disposition Unknown|4|||
161288281|NCT03565900|582436207|FG001|Overall Study|Disposition Unknown|1|||
161288282|NCT03565900|582436206|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161288283|NCT03565900|582436207|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
161288284|NCT03565900|582436206|FG000|Overall Study|Withdrawal by Subject|4|||
161288285|NCT03565900|582436207|FG001|Overall Study|Withdrawal by Subject|5|||
161288286|NCT03565900|582436206|FG000|Overall Study|Randomized By Mistake|0|||
161288287|NCT03565900|582436207|FG001|Overall Study|Randomized By Mistake|2|||
161288288|NCT03565900|582436206|FG000|Overall Study|Physician Decision|7|||
161288289|NCT03565900|582436207|FG001|Overall Study|Physician Decision|11|||
161288290|NCT03565900|582436206|FG000|Overall Study|Death|9|||
161288291|NCT03565900|582436207|FG001|Overall Study|Death|7|||
161288292|NCT01254643|582436208|FG000|Overall Study|Withdrawal by Subject|1|||
161288293|NCT03359850|582436211|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
161288294|NCT03359850|582436212|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
161288295|NCT03359850|582436211|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
161288296|NCT03359850|582436212|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
161288297|NCT03359850|582436211|FG000|Extension Phase (Up to 28 Months)|Death|2|||
161288298|NCT03359850|582436212|FG001|Extension Phase (Up to 28 Months)|Death|4|||
161288299|NCT03359850|582436211|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
161288300|NCT03359850|582436212|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
161288301|NCT03359850|582436211|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
161288302|NCT03359850|582436212|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
161288303|NCT01037218|582436226|FG000|Overall Study|Adverse Event|4|||
161288304|NCT01037218|582436227|FG001|Overall Study|Adverse Event|2|||
161288305|NCT01037218|582436228|FG002|Overall Study|Adverse Event|2|||
161288306|NCT01037218|582436229|FG003|Overall Study|Adverse Event|1|||
161288307|NCT01037218|582436226|FG000|Overall Study|Lack of Efficacy|0|||
161288308|NCT01037218|582436227|FG001|Overall Study|Lack of Efficacy|2|||
161288309|NCT01037218|582436228|FG002|Overall Study|Lack of Efficacy|1|||
161288310|NCT01037218|582436229|FG003|Overall Study|Lack of Efficacy|5|||
161288311|NCT01037218|582436226|FG000|Overall Study|Lost to Follow-up|3|||
161288312|NCT01037218|582436227|FG001|Overall Study|Lost to Follow-up|5|||
161288313|NCT01037218|582436228|FG002|Overall Study|Lost to Follow-up|4|||
161288314|NCT01037218|582436229|FG003|Overall Study|Lost to Follow-up|2|||
161288315|NCT01037218|582436226|FG000|Overall Study|Withdrawal by Subject|6|||
161288316|NCT01037218|582436227|FG001|Overall Study|Withdrawal by Subject|7|||
161288317|NCT01037218|582436228|FG002|Overall Study|Withdrawal by Subject|7|||
161288318|NCT01037218|582436229|FG003|Overall Study|Withdrawal by Subject|4|||
161288319|NCT01037218|582436226|FG000|Overall Study|Partner Withdrew Consent|0|||
161288320|NCT01037218|582436227|FG001|Overall Study|Partner Withdrew Consent|3|||
161288321|NCT01037218|582436228|FG002|Overall Study|Partner Withdrew Consent|2|||
161288322|NCT01037218|582436229|FG003|Overall Study|Partner Withdrew Consent|1|||
161288323|NCT01037218|582436226|FG000|Overall Study|Protocol Violation|0|||
161288324|NCT01037218|582436227|FG001|Overall Study|Protocol Violation|0|||
161288325|NCT01037218|582436228|FG002|Overall Study|Protocol Violation|2|||
161288326|NCT01037218|582436229|FG003|Overall Study|Protocol Violation|2|||
161288327|NCT01037218|582436226|FG000|Overall Study|Various|3|||
161288328|NCT01037218|582436227|FG001|Overall Study|Various|2|||
161288329|NCT01037218|582436228|FG002|Overall Study|Various|3|||
161288330|NCT01037218|582436229|FG003|Overall Study|Various|1|||
161288331|NCT00513240|582436231|FG000|Overall Study|Did not have intended surgery|3|||
161288332|NCT00513240|582436232|FG001|Overall Study|Did not have intended surgery|0|||
161288333|NCT00513240|582436231|FG000|Overall Study|Death|3|||
161288334|NCT00513240|582436232|FG001|Overall Study|Death|3|||
161288335|NCT00513240|582436231|FG000|Overall Study|Withdrawal by Subject|7|||
161288336|NCT00513240|582436232|FG001|Overall Study|Withdrawal by Subject|4|||
161288337|NCT00729937|582436237|FG000|Overall Study|Lost to Follow-up|49|||
161288338|NCT00729937|582436238|FG001|Overall Study|Lost to Follow-up|58|||
161288339|NCT00729937|582436239|FG002|Overall Study|Lost to Follow-up|18|||
161288340|NCT00729937|582436240|FG003|Overall Study|Lost to Follow-up|33|||
161288341|NCT00729937|582436241|FG004|Overall Study|Lost to Follow-up|18|||
161288342|NCT00729937|582436242|FG005|Overall Study|Lost to Follow-up|23|||
161288343|NCT00729937|582436237|FG000|Overall Study|Physician Decision|7|||
161288344|NCT00729937|582436238|FG001|Overall Study|Physician Decision|16|||
161288345|NCT00729937|582436239|FG002|Overall Study|Physician Decision|2|||
161288346|NCT00729937|582436240|FG003|Overall Study|Physician Decision|0|||
161288347|NCT00729937|582436241|FG004|Overall Study|Physician Decision|5|||
161288348|NCT00729937|582436242|FG005|Overall Study|Physician Decision|8|||
161288349|NCT00729937|582436237|FG000|Overall Study|Death|1|||
161288350|NCT00729937|582436238|FG001|Overall Study|Death|0|||
161288351|NCT00729937|582436239|FG002|Overall Study|Death|1|||
161288352|NCT00729937|582436240|FG003|Overall Study|Death|0|||
161288353|NCT00729937|582436241|FG004|Overall Study|Death|0|||
161288354|NCT00729937|582436242|FG005|Overall Study|Death|1|||
161288355|NCT00729937|582436237|FG000|Overall Study|Withdrawal by Subject|3|||
161288356|NCT00729937|582436238|FG001|Overall Study|Withdrawal by Subject|5|||
161288357|NCT00729937|582436239|FG002|Overall Study|Withdrawal by Subject|6|||
161288358|NCT00729937|582436240|FG003|Overall Study|Withdrawal by Subject|0|||
161288359|NCT00729937|582436241|FG004|Overall Study|Withdrawal by Subject|4|||
161288360|NCT00729937|582436242|FG005|Overall Study|Withdrawal by Subject|2|||
161288361|NCT00729937|582436237|FG000|Overall Study|Randomized but not treated|12|||
161079212|NCT01803282|581678726|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
161079213|NCT01803282|581678727|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
161079214|NCT01803282|581678728|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
161079215|NCT01803282|581678729|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
161288362|NCT00729937|582436238|FG001|Overall Study|Randomized but not treated|6|||
161288363|NCT00729937|582436239|FG002|Overall Study|Randomized but not treated|1|||
161288364|NCT00729937|582436240|FG003|Overall Study|Randomized but not treated|0|||
161288365|NCT00729937|582436241|FG004|Overall Study|Randomized but not treated|1|||
161079216|NCT01803282|581678730|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
161288366|NCT00729937|582436242|FG005|Overall Study|Randomized but not treated|3|||
161288367|NCT00729937|582436237|FG000|Overall Study|Did not meet eligibility criteria|2|||
161288368|NCT00729937|582436238|FG001|Overall Study|Did not meet eligibility criteria|1|||
161288369|NCT00729937|582436239|FG002|Overall Study|Did not meet eligibility criteria|0|||
161288370|NCT00729937|582436240|FG003|Overall Study|Did not meet eligibility criteria|0|||
161288371|NCT00729937|582436241|FG004|Overall Study|Did not meet eligibility criteria|0|||
161288372|NCT00729937|582436242|FG005|Overall Study|Did not meet eligibility criteria|0|||
161288373|NCT00729937|582436237|FG000|Overall Study|Incarcerated|0|||
161288374|NCT00729937|582436238|FG001|Overall Study|Incarcerated|2|||
161288375|NCT00729937|582436239|FG002|Overall Study|Incarcerated|1|||
161288376|NCT00729937|582436240|FG003|Overall Study|Incarcerated|1|||
161288377|NCT00729937|582436241|FG004|Overall Study|Incarcerated|0|||
161288378|NCT00729937|582436242|FG005|Overall Study|Incarcerated|0|||
161288379|NCT02198963|582436246|FG000|Overall Study|Adverse Event|1|||
161288380|NCT02198963|582436246|FG000|Overall Study|Withdrawal by Subject|6|||
161288381|NCT00683657|582436247|FG000|Overall Study|Adverse Event|0|||
161288382|NCT00683657|582436248|FG001|Overall Study|Adverse Event|1|||
161288383|NCT00683657|582436247|FG000|Overall Study|Subject Withdrew Consent|1|||
161288384|NCT00683657|582436248|FG001|Overall Study|Subject Withdrew Consent|0|||
161288385|NCT02586155|582436252|FG000|Overall Study|Adverse Event|2|||
161288386|NCT02586155|582436253|FG001|Overall Study|Adverse Event|3|||
161288387|NCT02586155|582436252|FG000|Overall Study|Withdrawal by Subject|31|||
161288388|NCT02586155|582436253|FG001|Overall Study|Withdrawal by Subject|24|||
161288389|NCT02586155|582436252|FG000|Overall Study|Lost to Follow-up|7|||
161288390|NCT02586155|582436253|FG001|Overall Study|Lost to Follow-up|13|||
161288391|NCT02586155|582436252|FG000|Overall Study|Death|61|||
161288392|NCT02586155|582436253|FG001|Overall Study|Death|72|||
161288393|NCT02586155|582436252|FG000|Overall Study|Other reasons|26|||
161288394|NCT02586155|582436253|FG001|Overall Study|Other reasons|15|||
161288395|NCT02461160|582436254|FG000|Overall Study|Lost to Follow-up|0|||
161288396|NCT02461160|582436255|FG001|Overall Study|Lost to Follow-up|0|||
161288397|NCT02461160|582436256|FG002|Overall Study|Lost to Follow-up|0|||
161288398|NCT02461160|582436257|FG003|Overall Study|Lost to Follow-up|0|||
161288399|NCT02461160|582436258|FG004|Overall Study|Lost to Follow-up|0|||
161288400|NCT02461160|582436259|FG005|Overall Study|Lost to Follow-up|0|||
161288401|NCT02461160|582436260|FG006|Overall Study|Lost to Follow-up|0|||
161288402|NCT02461160|582436261|FG007|Overall Study|Lost to Follow-up|1|||
161288403|NCT02461160|582436262|FG008|Overall Study|Lost to Follow-up|0|||
161288404|NCT02461160|582436263|FG009|Overall Study|Lost to Follow-up|0|||
161288405|NCT02461160|582436264|FG010|Overall Study|Lost to Follow-up|0|||
161288406|NCT02461160|582436265|FG011|Overall Study|Lost to Follow-up|0|||
161288407|NCT02461160|582436266|FG012|Overall Study|Lost to Follow-up|0|||
161288408|NCT00193050|582436267|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
161288409|NCT00193050|582436267|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
161288410|NCT00193050|582436267|FG000|Neoadjuvant Treatment|Physician Decision|2|||
161288411|NCT00193050|582436267|FG000|Neoadjuvant Treatment|Adverse Event|2|||
161288412|NCT00193050|582436267|FG000|Adjuvant|Physician Decision|5|||
161288413|NCT00193050|582436267|FG000|Adjuvant|Intercurrent Hospitalization|3|||
161288414|NCT00193050|582436267|FG000|Adjuvant|Lack of Efficacy|2|||
161288415|NCT00916383|582436268|FG000|Overall Study|Adverse Event|1|||
161288416|NCT00916383|582436268|FG000|Overall Study|Death|1|||
161288417|NCT00916383|582436268|FG000|Overall Study|Protocol Violation|1|||
161288418|NCT00258960|582436269|FG000|Overall Study|Death|2|||
161288419|NCT00258960|582436269|FG000|Overall Study|Disease Progression|7|||
161288420|NCT00258960|582436269|FG000|Overall Study|Adverse Event|4|||
161288421|NCT00258960|582436269|FG000|Overall Study|Physician Decision|1|||
161288422|NCT00258960|582436269|FG000|Overall Study|Withdrawal by Subject|1|||
161163174|NCT01877382|581974311|FG012|Dose Expansion|Clinical progression|0|||
161163175|NCT01877382|581974312|FG013|Dose Expansion|Clinical progression|0|||
161163176|NCT01877382|581974313|FG014|Dose Expansion|Clinical progression|6|||
161163177|NCT01877382|581974299|FG000|Dose Expansion|Adverse Event|0|||
161163178|NCT01877382|581974300|FG001|Dose Expansion|Adverse Event|0|||
161163179|NCT01877382|581974301|FG002|Dose Expansion|Adverse Event|0|||
161163180|NCT01877382|581974302|FG003|Dose Expansion|Adverse Event|0|||
161163181|NCT01877382|581974303|FG004|Dose Expansion|Adverse Event|0|||
161163182|NCT01877382|581974304|FG005|Dose Expansion|Adverse Event|0|||
161288423|NCT00258960|582436269|FG000|Overall Study|Mistake|2|||
161288424|NCT02899962|582436270|FG000|Open-label Phase|Adverse Event|2|||
161288425|NCT02899962|582436271|FG001|Open-label Phase|Adverse Event|0|||
161288426|NCT02899962|582436272|FG002|Open-label Phase|Adverse Event|0|||
161288427|NCT02899962|582436270|FG000|Open-label Phase|Lost to Follow-up|9|||
161163183|NCT01877382|581974305|FG006|Dose Expansion|Adverse Event|0|||
161163184|NCT01877382|581974306|FG007|Dose Expansion|Adverse Event|0|||
161288428|NCT02899962|582436271|FG001|Open-label Phase|Lost to Follow-up|0|||
161288429|NCT02899962|582436272|FG002|Open-label Phase|Lost to Follow-up|0|||
161288430|NCT02899962|582436270|FG000|Open-label Phase|Other reasons|9|||
161163185|NCT01877382|581974307|FG008|Dose Expansion|Adverse Event|0|||
161163186|NCT01877382|581974308|FG009|Dose Expansion|Adverse Event|0|||
161288431|NCT02899962|582436271|FG001|Open-label Phase|Other reasons|0|||
161288432|NCT02899962|582436272|FG002|Open-label Phase|Other reasons|0|||
161288433|NCT02899962|582436270|FG000|Open-label Phase|Withdrawal by Subject|7|||
161288434|NCT02899962|582436271|FG001|Open-label Phase|Withdrawal by Subject|0|||
161288435|NCT02899962|582436272|FG002|Open-label Phase|Withdrawal by Subject|0|||
161288436|NCT02899962|582436270|FG000|Maintenance Phase|Adverse Event|0|||
161288437|NCT02899962|582436271|FG001|Maintenance Phase|Adverse Event|2|||
161163187|NCT01877382|581974309|FG010|Dose Expansion|Adverse Event|0|||
161288438|NCT02899962|582436272|FG002|Maintenance Phase|Adverse Event|1|||
161288439|NCT02899962|582436270|FG000|Maintenance Phase|Death|0|||
161288440|NCT02899962|582436271|FG001|Maintenance Phase|Death|0|||
161288441|NCT02899962|582436272|FG002|Maintenance Phase|Death|1|||
161288442|NCT02899962|582436270|FG000|Maintenance Phase|Lack of Efficacy|0|||
161288443|NCT02899962|582436271|FG001|Maintenance Phase|Lack of Efficacy|20|||
161288444|NCT02899962|582436272|FG002|Maintenance Phase|Lack of Efficacy|16|||
161288445|NCT02899962|582436270|FG000|Maintenance Phase|Lost to Follow-up|0|||
161288446|NCT02899962|582436271|FG001|Maintenance Phase|Lost to Follow-up|12|||
161288447|NCT02899962|582436272|FG002|Maintenance Phase|Lost to Follow-up|14|||
161288448|NCT02899962|582436270|FG000|Maintenance Phase|Other reasons|0|||
161288449|NCT02899962|582436271|FG001|Maintenance Phase|Other reasons|9|||
161288450|NCT02899962|582436272|FG002|Maintenance Phase|Other reasons|13|||
161288451|NCT02899962|582436270|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
161288452|NCT02899962|582436271|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
161288453|NCT02899962|582436272|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
161288454|NCT02899962|582436270|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
161288455|NCT02899962|582436271|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
161288456|NCT02899962|582436272|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
161288457|NCT02899962|582436270|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161288458|NCT02899962|582436271|FG001|Maintenance Phase|Withdrawal by Subject|30|||
161288459|NCT02899962|582436272|FG002|Maintenance Phase|Withdrawal by Subject|36|||
161288460|NCT00473590|582436273|FG000|Overall Study|Adverse Event|3|||
161288461|NCT00473590|582436274|FG001|Overall Study|Adverse Event|3|||
161288462|NCT00473590|582436273|FG000|Overall Study|Death|4|||
161288463|NCT00473590|582436274|FG001|Overall Study|Death|2|||
161288464|NCT00473590|582436273|FG000|Overall Study|Progression not resulting in death|24|||
161288465|NCT00473590|582436274|FG001|Overall Study|Progression not resulting in death|20|||
161288466|NCT00473590|582436273|FG000|Overall Study|Non-protocol-specified therapy|7|||
161288467|NCT00473590|582436274|FG001|Overall Study|Non-protocol-specified therapy|5|||
161288468|NCT00473590|582436273|FG000|Overall Study|Physician Decision|2|||
161288469|NCT00473590|582436274|FG001|Overall Study|Physician Decision|4|||
161288470|NCT00473590|582436273|FG000|Overall Study|Withdrawal by Subject|5|||
161288471|NCT00473590|582436274|FG001|Overall Study|Withdrawal by Subject|3|||
161288472|NCT00473590|582436273|FG000|Overall Study|Other|0|||
161288473|NCT00473590|582436274|FG001|Overall Study|Other|1|||
161079217|NCT01803282|581678731|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
161079218|NCT01803282|581678732|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
161079219|NCT01803282|581678733|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
161079220|NCT01803282|581678722|FG000|Overall Study|Enrolled but Never Treated|0|||
161079221|NCT01803282|581678723|FG001|Overall Study|Enrolled but Never Treated|0|||
161079222|NCT01803282|581678724|FG002|Overall Study|Enrolled but Never Treated|0|||
161079223|NCT01803282|581678725|FG003|Overall Study|Enrolled but Never Treated|0|||
161079224|NCT01803282|581678726|FG004|Overall Study|Enrolled but Never Treated|1|||
161079225|NCT01803282|581678727|FG005|Overall Study|Enrolled but Never Treated|0|||
161079226|NCT01803282|581678728|FG006|Overall Study|Enrolled but Never Treated|1|||
161079227|NCT01803282|581678729|FG007|Overall Study|Enrolled but Never Treated|1|||
161079228|NCT01803282|581678730|FG008|Overall Study|Enrolled but Never Treated|0|||
161079229|NCT01803282|581678731|FG009|Overall Study|Enrolled but Never Treated|1|||
161079230|NCT01803282|581678732|FG010|Overall Study|Enrolled but Never Treated|0|||
161079231|NCT01803282|581678733|FG011|Overall Study|Enrolled but Never Treated|0|||
161079232|NCT00798434|581678734|FG000|Double-Blind|Adverse Event|22|||
161079233|NCT00798434|581678735|FG001|Double-Blind|Adverse Event|46|||
161079234|NCT00798434|581678734|FG000|Double-Blind|Death|0|||
161079235|NCT00798434|581678735|FG001|Double-Blind|Death|1|||
161079236|NCT00798434|581678734|FG000|Double-Blind|Lost to Follow-up|1|||
161079237|NCT00798434|581678735|FG001|Double-Blind|Lost to Follow-up|0|||
161079238|NCT00798434|581678734|FG000|Double-Blind|Lack of Efficacy|8|||
161079239|NCT00798434|581678735|FG001|Double-Blind|Lack of Efficacy|12|||
161079240|NCT00798434|581678734|FG000|Double-Blind|Withdrawal by Subject|17|||
161079241|NCT00798434|581678735|FG001|Double-Blind|Withdrawal by Subject|14|||
161079242|NCT00798434|581678734|FG000|Double-Blind|Protocol Violation|1|||
161079243|NCT00798434|581678735|FG001|Double-Blind|Protocol Violation|4|||
161079244|NCT00798434|581678734|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
161079245|NCT00798434|581678735|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
161079246|NCT00798434|581678734|FG000|Double-Blind|Other|1|||
161288474|NCT03367819|582436278|FG000|Overall Study|Adverse Event|4|||
161288475|NCT03367819|582436279|FG001|Overall Study|Adverse Event|4|||
161288476|NCT03367819|582436278|FG000|Overall Study|Progressive Disease|15|||
161288477|NCT03367819|582436279|FG001|Overall Study|Progressive Disease|13|||
161288478|NCT03367819|582436278|FG000|Overall Study|Withdrawal by Subject|1|||
161288479|NCT03367819|582436279|FG001|Overall Study|Withdrawal by Subject|0|||
161288480|NCT03367819|582436278|FG000|Overall Study|Other|4|||
161079247|NCT00798434|581678735|FG001|Double-Blind|Other|0|||
161079248|NCT00798434|581678734|FG000|Double-Blind|Not Treated|3|||
161079249|NCT00798434|581678735|FG001|Double-Blind|Not Treated|6|||
161079250|NCT00798434|581678734|FG000|Open-Label|Adverse Event|33|||
161079251|NCT00798434|581678735|FG001|Open-Label|Adverse Event|11|||
161079252|NCT00798434|581678734|FG000|Open-Label|Lack of Efficacy|5|||
161079253|NCT00798434|581678735|FG001|Open-Label|Lack of Efficacy|11|||
161079254|NCT00798434|581678734|FG000|Open-Label|Withdrawal by Subject|2|||
161079255|NCT00798434|581678735|FG001|Open-Label|Withdrawal by Subject|7|||
161079256|NCT00798434|581678734|FG000|Open-Label|Protocol Violation|1|||
161079257|NCT00798434|581678735|FG001|Open-Label|Protocol Violation|0|||
161079258|NCT00798434|581678734|FG000|Open-Label|Other|1|||
161079259|NCT00798434|581678735|FG001|Open-Label|Other|2|||
161079260|NCT00798434|581678734|FG000|Open-Label|Not Treated|0|||
161079261|NCT00798434|581678735|FG001|Open-Label|Not Treated|1|||
161079262|NCT01217437|581678739|FG000|Overall Study|Adverse Event|0|||
161079263|NCT01217437|581678740|FG001|Overall Study|Adverse Event|8|||
161079264|NCT01217437|581678739|FG000|Overall Study|Death|5|||
161079265|NCT01217437|581678740|FG001|Overall Study|Death|0|||
161079266|NCT01217437|581678739|FG000|Overall Study|Lack of Efficacy|29|||
161079267|NCT01217437|581678740|FG001|Overall Study|Lack of Efficacy|25|||
161079268|NCT01217437|581678739|FG000|Overall Study|Physician Decision|8|||
161079269|NCT01217437|581678740|FG001|Overall Study|Physician Decision|5|||
161079270|NCT01217437|581678739|FG000|Overall Study|Withdrawal by Subject|0|||
161079271|NCT01217437|581678740|FG001|Overall Study|Withdrawal by Subject|2|||
161079272|NCT01217437|581678739|FG000|Overall Study|Ineligible|1|||
161079273|NCT01217437|581678740|FG001|Overall Study|Ineligible|1|||
161079274|NCT04908631|581678743|FG000|Overall Study|Lost to Follow-up|1|||
161079275|NCT04908631|581678743|FG000|Overall Study|Physician Decision|1|||
161079276|NCT04908631|581678743|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
161079277|NCT03578887|581678747|FG000|Overall Study|Withdrawal by Subject|7|||
161079278|NCT03578887|581678748|FG001|Overall Study|Withdrawal by Subject|2|||
161079279|NCT03578887|581678749|FG002|Overall Study|Withdrawal by Subject|1|||
161079280|NCT03578887|581678747|FG000|Overall Study|Lost to Follow-up|13|||
161079281|NCT03578887|581678748|FG001|Overall Study|Lost to Follow-up|1|||
161079282|NCT03578887|581678749|FG002|Overall Study|Lost to Follow-up|4|||
161079283|NCT03578887|581678747|FG000|Overall Study|Physician Decision|0|||
161079284|NCT03578887|581678748|FG001|Overall Study|Physician Decision|1|||
161079285|NCT03578887|581678749|FG002|Overall Study|Physician Decision|1|||
161079286|NCT03843554|581680417|FG000|Overall Study|Physician Decision|0|||
161079287|NCT03843554|581680418|FG001|Overall Study|Physician Decision|2|||
161079288|NCT02218606|581680420|FG000|Overall Study|Adverse Event|1|||
161079289|NCT02218606|581680421|FG001|Overall Study|Adverse Event|1|||
161079290|NCT02218606|581680420|FG000|Overall Study|Death|15|||
161079291|NCT02218606|581680421|FG001|Overall Study|Death|28|||
161079292|NCT02218606|581680420|FG000|Overall Study|Physician Decision|0|||
161079293|NCT02218606|581680421|FG001|Overall Study|Physician Decision|1|||
161079294|NCT02218606|581680420|FG000|Overall Study|Withdrawal by Subject|4|||
161079295|NCT02218606|581680421|FG001|Overall Study|Withdrawal by Subject|0|||
161079296|NCT02218606|581680420|FG000|Overall Study|Noncompliance|1|||
161079297|NCT02218606|581680421|FG001|Overall Study|Noncompliance|0|||
161079298|NCT02218606|581680420|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
161079299|NCT02218606|581680421|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
161079300|NCT02218606|581680420|FG000|Overall Study|Other|2|||
161079301|NCT02218606|581680421|FG001|Overall Study|Other|1|||
161079302|NCT02218606|581680420|FG000|Overall Study|Never started treatment|0|||
161079303|NCT02218606|581680421|FG001|Overall Study|Never started treatment|1|||
161079304|NCT00890695|581680422|FG000|Overall Study|Protocol Violation|1|||
161079305|NCT00890695|581680423|FG001|Overall Study|Protocol Violation|0|||
161079306|NCT01008410|581680426|FG000|Overall Study|Adverse Event|13|||
161079307|NCT01008410|581680427|FG001|Overall Study|Adverse Event|7|||
161079308|NCT01008410|581680426|FG000|Overall Study|Withdrawal by Subject|6|||
161079309|NCT01008410|581680427|FG001|Overall Study|Withdrawal by Subject|2|||
161079310|NCT01008410|581680426|FG000|Overall Study|Lost to Follow-up|1|||
161079311|NCT01008410|581680427|FG001|Overall Study|Lost to Follow-up|0|||
161079312|NCT01008410|581680426|FG000|Overall Study|Noncompliance|1|||
161079313|NCT01008410|581680427|FG001|Overall Study|Noncompliance|0|||
161079314|NCT01008410|581680426|FG000|Overall Study|Low Cortisol|2|||
161079315|NCT01008410|581680427|FG001|Overall Study|Low Cortisol|0|||
161079316|NCT01008410|581680426|FG000|Overall Study|Lack of Efficacy|2|||
161079317|NCT01008410|581680427|FG001|Overall Study|Lack of Efficacy|6|||
161079318|NCT01008410|581680426|FG000|Overall Study|Met Exclusion Criterion|0|||
161079319|NCT01008410|581680427|FG001|Overall Study|Met Exclusion Criterion|1|||
161079320|NCT00297427|581680428|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
161079321|NCT00297427|581680429|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
161079322|NCT00297427|581680428|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
161079323|NCT00297427|581680429|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
161079324|NCT00297427|581680428|FG000|Phase 1: Initial Intervention|Death|0|||
161079325|NCT00297427|581680429|FG001|Phase 1: Initial Intervention|Death|1|||
161079326|NCT00297427|581680428|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
161079327|NCT00297427|581680429|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
161079328|NCT00297427|581680428|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
161163188|NCT01877382|581974310|FG011|Dose Expansion|Adverse Event|0|||
161163189|NCT01877382|581974311|FG012|Dose Expansion|Adverse Event|0|||
161163190|NCT01877382|581974312|FG013|Dose Expansion|Adverse Event|0|||
161346584|NCT00580840|582653315|FG003|Run-in|Loss of Efficacy|0|||
161079329|NCT00297427|581680429|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
161079330|NCT00297427|581680428|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
161079331|NCT00297427|581680429|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
161079332|NCT00297427|581680428|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
161079333|NCT00297427|581680429|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
161079334|NCT00297427|581680428|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
161079335|NCT00297427|581680429|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
161079336|NCT01127893|581680430|FG000|Overall Study|Study Termination by the Sponsor|1|||
161079337|NCT00574873|581680431|FG000|Overall Study|Withdrawal by Subject|18|||
161079338|NCT00574873|581680432|FG001|Overall Study|Withdrawal by Subject|19|||
161079339|NCT00574873|581680431|FG000|Overall Study|Investigator request|18|||
161079340|NCT00574873|581680432|FG001|Overall Study|Investigator request|8|||
161079341|NCT00574873|581680431|FG000|Overall Study|Death|15|||
161079342|NCT00574873|581680432|FG001|Overall Study|Death|14|||
161079343|NCT00574873|581680431|FG000|Overall Study|Lost to Follow-up|14|||
161079344|NCT00574873|581680432|FG001|Overall Study|Lost to Follow-up|5|||
161079345|NCT00574873|581680431|FG000|Overall Study|Other|40|||
161079346|NCT00574873|581680432|FG001|Overall Study|Other|4|||
161079347|NCT00574873|581680431|FG000|Overall Study|Discontinuation of study by sponsor|5|||
161079348|NCT00574873|581680432|FG001|Overall Study|Discontinuation of study by sponsor|199|||
161079349|NCT00574873|581680431|FG000|Overall Study|Blank, site closed per local regulations|2|||
161079350|NCT00574873|581680432|FG001|Overall Study|Blank, site closed per local regulations|2|||
161079351|NCT00574873|581680431|FG000|Overall Study|Extension Study|126|||
161079352|NCT00574873|581680432|FG001|Overall Study|Extension Study|0|||
161079353|NCT01638429|581680433|FG000|Overall Study|Withdrawal by Subject|1|||
161079354|NCT04552899|581680434|FG000|Overall Study|Adverse Event|4|||
161079355|NCT04552899|581680435|FG001|Overall Study|Adverse Event|3|||
161079356|NCT04552899|581680434|FG000|Overall Study|Death|4|||
161079357|NCT04552899|581680435|FG001|Overall Study|Death|4|||
161079358|NCT04552899|581680434|FG000|Overall Study|Lost to Follow-up|8|||
161079359|NCT04552899|581680435|FG001|Overall Study|Lost to Follow-up|13|||
161079360|NCT04552899|581680434|FG000|Overall Study|Lung Transplant|4|||
161079361|NCT04552899|581680435|FG001|Overall Study|Lung Transplant|3|||
161079362|NCT04552899|581680434|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
161079363|NCT04552899|581680435|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
161079364|NCT04552899|581680434|FG000|Overall Study|Physician Decision|3|||
161079365|NCT04552899|581680435|FG001|Overall Study|Physician Decision|4|||
161079366|NCT04552899|581680434|FG000|Overall Study|Study Terminated By Sponsor|237|||
161079367|NCT04552899|581680435|FG001|Overall Study|Study Terminated By Sponsor|239|||
161079368|NCT04552899|581680434|FG000|Overall Study|Withdrawal by Subject|15|||
161079369|NCT04552899|581680435|FG001|Overall Study|Withdrawal by Subject|17|||
161079370|NCT02591953|581680436|FG000|Overall Study|Lost to Follow-up|6|||
161079371|NCT02591953|581680437|FG001|Overall Study|Lost to Follow-up|6|||
161079372|NCT02060370|581680438|FG000|Overall Study|Physician Decision|1|||
161079373|NCT00731133|581680439|FG000|Overall Study|Withdrawal by Subject|10|||
161079374|NCT00943852|581680440|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079375|NCT00943852|581680441|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079376|NCT00943852|581680442|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079377|NCT00943852|581680443|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
161079378|NCT00943852|581680444|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079379|NCT00943852|581680445|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079380|NCT00943852|581680446|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079381|NCT00943852|581680447|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079382|NCT00943852|581680448|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079383|NCT00943852|581680449|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
161079384|NCT00943852|581680440|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079385|NCT00943852|581680441|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079386|NCT00943852|581680442|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079387|NCT00943852|581680443|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079388|NCT00943852|581680444|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079389|NCT00943852|581680445|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
161079390|NCT00943852|581680446|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161163191|NCT01877382|581974313|FG014|Dose Expansion|Adverse Event|1|||
161079391|NCT00943852|581680447|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079392|NCT00943852|581680448|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161163192|NCT01877382|581974299|FG000|Dose Expansion|Death|0|||
161163193|NCT01877382|581974300|FG001|Dose Expansion|Death|0|||
161163194|NCT01877382|581974301|FG002|Dose Expansion|Death|0|||
161163195|NCT01877382|581974302|FG003|Dose Expansion|Death|0|||
161163196|NCT01877382|581974303|FG004|Dose Expansion|Death|0|||
161163197|NCT01877382|581974304|FG005|Dose Expansion|Death|0|||
161163198|NCT01877382|581974305|FG006|Dose Expansion|Death|0|||
161163199|NCT01877382|581974306|FG007|Dose Expansion|Death|0|||
161163200|NCT01877382|581974307|FG008|Dose Expansion|Death|0|||
161163201|NCT01877382|581974308|FG009|Dose Expansion|Death|0|||
161163202|NCT01877382|581974309|FG010|Dose Expansion|Death|0|||
161163203|NCT01877382|581974310|FG011|Dose Expansion|Death|0|||
161163204|NCT01877382|581974311|FG012|Dose Expansion|Death|0|||
161163205|NCT01877382|581974312|FG013|Dose Expansion|Death|0|||
161163206|NCT01877382|581974313|FG014|Dose Expansion|Death|1|||
161163207|NCT01877382|581974299|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163208|NCT01877382|581974300|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163209|NCT01877382|581974301|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163210|NCT01877382|581974302|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163211|NCT01877382|581974303|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163212|NCT01877382|581974304|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163213|NCT01877382|581974305|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163214|NCT01877382|581974306|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163215|NCT01877382|581974307|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163216|NCT01877382|581974308|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163217|NCT01877382|581974309|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163218|NCT01877382|581974310|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163219|NCT01877382|581974311|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163220|NCT01877382|581974312|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
161163221|NCT01877382|581974313|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
161163222|NCT03423979|581974314|FG000|Overall Study|Death|5|||
161163223|NCT03423979|581974314|FG000|Overall Study|Adverse Event|4|||
161163224|NCT03423979|581974314|FG000|Overall Study|Withdrawal by Subject|3|||
161163225|NCT03423979|581974314|FG000|Overall Study|Lost to Follow-up|16|||
161163226|NCT00808249|581974317|FG000|Overall Study|Adverse Event|4|||
161163227|NCT00808249|581974318|FG001|Overall Study|Adverse Event|7|||
161163228|NCT00808249|581974319|FG002|Overall Study|Adverse Event|10|||
161163229|NCT00808249|581974320|FG003|Overall Study|Adverse Event|6|||
161163230|NCT00808249|581974317|FG000|Overall Study|Lost to Follow-up|2|||
161163231|NCT00808249|581974318|FG001|Overall Study|Lost to Follow-up|3|||
161163232|NCT00808249|581974319|FG002|Overall Study|Lost to Follow-up|3|||
161163233|NCT00808249|581974320|FG003|Overall Study|Lost to Follow-up|5|||
161163234|NCT00808249|581974317|FG000|Overall Study|Withdrawal by Subject|4|||
161163235|NCT00808249|581974318|FG001|Overall Study|Withdrawal by Subject|0|||
161163236|NCT00808249|581974319|FG002|Overall Study|Withdrawal by Subject|2|||
161163237|NCT00808249|581974320|FG003|Overall Study|Withdrawal by Subject|4|||
161163238|NCT00808249|581974317|FG000|Overall Study|Protocol Violation|3|||
161163239|NCT00808249|581974318|FG001|Overall Study|Protocol Violation|3|||
161163240|NCT00808249|581974319|FG002|Overall Study|Protocol Violation|3|||
161163241|NCT00808249|581974320|FG003|Overall Study|Protocol Violation|0|||
161163242|NCT00808249|581974317|FG000|Overall Study|Lack of Efficacy|1|||
161163243|NCT00808249|581974318|FG001|Overall Study|Lack of Efficacy|1|||
161163244|NCT00808249|581974319|FG002|Overall Study|Lack of Efficacy|0|||
161288481|NCT03367819|582436279|FG001|Overall Study|Other|2|||
161288482|NCT00445146|582436283|FG000|Overall Study|Withdrew Consent|29|||
161288483|NCT00445146|582436283|FG000|Overall Study|Lack of Efficacy|28|||
161288484|NCT00445146|582436283|FG000|Overall Study|Investigator's Discretion|22|||
161079393|NCT00943852|581680449|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
161079394|NCT00943852|581680440|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079395|NCT00943852|581680441|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079396|NCT00943852|581680442|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079397|NCT00943852|581680443|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079398|NCT00943852|581680444|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079399|NCT00943852|581680445|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079400|NCT00943852|581680446|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
161079401|NCT00943852|581680447|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079402|NCT00943852|581680448|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079403|NCT00943852|581680449|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
161079404|NCT00943852|581680440|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079405|NCT00943852|581680441|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161163245|NCT00808249|581974320|FG003|Overall Study|Lack of Efficacy|0|||
161163246|NCT00808249|581974317|FG000|Overall Study|study specific discontinuation criteria|1|||
161163247|NCT00808249|581974318|FG001|Overall Study|study specific discontinuation criteria|0|||
161163248|NCT00808249|581974319|FG002|Overall Study|study specific discontinuation criteria|1|||
161163249|NCT00808249|581974320|FG003|Overall Study|study specific discontinuation criteria|0|||
161163250|NCT00808249|581974317|FG000|Overall Study|All other reasons|2|||
161163251|NCT00808249|581974318|FG001|Overall Study|All other reasons|1|||
161163252|NCT00808249|581974319|FG002|Overall Study|All other reasons|3|||
161163253|NCT00808249|581974320|FG003|Overall Study|All other reasons|1|||
161163254|NCT05108805|581974324|FG000|Overall Study|T-cell expansion was not successful.|5|||
161163255|NCT04095286|581974325|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163256|NCT04095286|581974326|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
161163257|NCT04095286|581974327|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163258|NCT04095286|581974328|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163259|NCT04095286|581974329|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163260|NCT04095286|581974330|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163261|NCT04095286|581974325|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
161163262|NCT04095286|581974326|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161163263|NCT04095286|581974327|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161163264|NCT04095286|581974328|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161163265|NCT04095286|581974329|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161163266|NCT04095286|581974330|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
161163267|NCT04095286|581974325|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161163268|NCT04095286|581974326|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161163269|NCT04095286|581974327|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
161163270|NCT04095286|581974328|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161163271|NCT04095286|581974329|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161163272|NCT04095286|581974330|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
161163273|NCT04095286|581974325|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163274|NCT04095286|581974326|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163275|NCT04095286|581974327|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
161163276|NCT04095286|581974328|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163277|NCT04095286|581974329|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163278|NCT04095286|581974330|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
161163279|NCT04095286|581974325|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161163280|NCT04095286|581974326|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161163281|NCT04095286|581974327|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161163282|NCT04095286|581974328|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161163283|NCT04095286|581974329|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
161163284|NCT04095286|581974330|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
161163285|NCT00479557|581974331|FG000|Overall Study|Death|0|||
161163286|NCT00479557|581974332|FG001|Overall Study|Death|0|||
161163287|NCT00479557|581974333|FG002|Overall Study|Death|0|||
161163288|NCT00479557|581974334|FG003|Overall Study|Death|0|||
161163289|NCT00479557|581974335|FG004|Overall Study|Death|0|||
161163290|NCT00479557|581974336|FG005|Overall Study|Death|1|||
161163291|NCT00479557|581974337|FG006|Overall Study|Death|0|||
161163292|NCT00479557|581974331|FG000|Overall Study|Lack of Efficacy|1|||
161163293|NCT00479557|581974332|FG001|Overall Study|Lack of Efficacy|0|||
161163294|NCT00479557|581974333|FG002|Overall Study|Lack of Efficacy|0|||
161163295|NCT00479557|581974334|FG003|Overall Study|Lack of Efficacy|0|||
161163296|NCT00479557|581974335|FG004|Overall Study|Lack of Efficacy|0|||
161163297|NCT00479557|581974336|FG005|Overall Study|Lack of Efficacy|0|||
161163298|NCT00479557|581974337|FG006|Overall Study|Lack of Efficacy|0|||
161163299|NCT00479557|581974331|FG000|Overall Study|Lost to Follow-up|0|||
161163300|NCT00479557|581974332|FG001|Overall Study|Lost to Follow-up|2|||
161163301|NCT00479557|581974333|FG002|Overall Study|Lost to Follow-up|0|||
161163302|NCT00479557|581974334|FG003|Overall Study|Lost to Follow-up|2|||
161163303|NCT00479557|581974335|FG004|Overall Study|Lost to Follow-up|0|||
161163304|NCT00479557|581974336|FG005|Overall Study|Lost to Follow-up|0|||
161163305|NCT00479557|581974337|FG006|Overall Study|Lost to Follow-up|0|||
161163306|NCT00479557|581974331|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161163307|NCT00479557|581974332|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161163308|NCT00479557|581974333|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
161163309|NCT00479557|581974334|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
161163310|NCT00479557|581974335|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161163311|NCT00479557|581974336|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
161163312|NCT00479557|581974337|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
161163313|NCT00479557|581974331|FG000|Overall Study|AE not related to Study Drug|1|||
161288485|NCT00445146|582436283|FG000|Overall Study|Adverse Event|13|||
161163314|NCT00479557|581974332|FG001|Overall Study|AE not related to Study Drug|3|||
161163315|NCT00479557|581974333|FG002|Overall Study|AE not related to Study Drug|0|||
161163316|NCT00479557|581974334|FG003|Overall Study|AE not related to Study Drug|0|||
161163317|NCT00479557|581974335|FG004|Overall Study|AE not related to Study Drug|2|||
161163318|NCT00479557|581974336|FG005|Overall Study|AE not related to Study Drug|2|||
161163319|NCT00479557|581974337|FG006|Overall Study|AE not related to Study Drug|1|||
161163320|NCT00479557|581974331|FG000|Overall Study|Caregiver Request|2|||
161163321|NCT00479557|581974332|FG001|Overall Study|Caregiver Request|2|||
161163322|NCT00479557|581974333|FG002|Overall Study|Caregiver Request|2|||
161163323|NCT00479557|581974334|FG003|Overall Study|Caregiver Request|0|||
161163324|NCT00479557|581974335|FG004|Overall Study|Caregiver Request|1|||
161163325|NCT00479557|581974336|FG005|Overall Study|Caregiver Request|2|||
161163326|NCT00479557|581974337|FG006|Overall Study|Caregiver Request|0|||
161163327|NCT00479557|581974331|FG000|Overall Study|Investigator Request|0|||
161163328|NCT00479557|581974332|FG001|Overall Study|Investigator Request|0|||
161163329|NCT00479557|581974333|FG002|Overall Study|Investigator Request|1|||
161163330|NCT00479557|581974334|FG003|Overall Study|Investigator Request|0|||
161163331|NCT00479557|581974335|FG004|Overall Study|Investigator Request|0|||
161163332|NCT00479557|581974336|FG005|Overall Study|Investigator Request|0|||
161163333|NCT00479557|581974337|FG006|Overall Study|Investigator Request|0|||
161163334|NCT00479557|581974331|FG000|Overall Study|Subject Request|3|||
161163335|NCT00479557|581974332|FG001|Overall Study|Subject Request|0|||
161163336|NCT00479557|581974333|FG002|Overall Study|Subject Request|1|||
161163337|NCT00479557|581974334|FG003|Overall Study|Subject Request|1|||
161163338|NCT00479557|581974335|FG004|Overall Study|Subject Request|1|||
161163339|NCT00479557|581974336|FG005|Overall Study|Subject Request|4|||
161163340|NCT00479557|581974337|FG006|Overall Study|Subject Request|1|||
161163341|NCT00479557|581974331|FG000|Overall Study|Other|2|||
161163342|NCT00479557|581974332|FG001|Overall Study|Other|3|||
161163343|NCT00479557|581974333|FG002|Overall Study|Other|1|||
161163344|NCT00479557|581974334|FG003|Overall Study|Other|0|||
161163345|NCT00479557|581974335|FG004|Overall Study|Other|0|||
161163346|NCT00479557|581974336|FG005|Overall Study|Other|3|||
161163347|NCT00479557|581974337|FG006|Overall Study|Other|0|||
161163348|NCT01511107|581974340|FG000|Overall Study|Ineligible|3|||
161163349|NCT01511107|581974341|FG001|Overall Study|Ineligible|2|||
161163350|NCT01511107|581974340|FG000|Overall Study|Lost to Follow-up|10|||
161163351|NCT01511107|581974341|FG001|Overall Study|Lost to Follow-up|19|||
161163352|NCT01511107|581974340|FG000|Overall Study|Withdrawal by Subject|9|||
161163353|NCT01511107|581974341|FG001|Overall Study|Withdrawal by Subject|20|||
161163354|NCT05371912|581974342|FG000|Overall Study|Lost to Follow-up|3|||
161163355|NCT05371912|581974343|FG001|Overall Study|Lost to Follow-up|2|||
161163356|NCT04752189|581974344|FG000|Overall Study|Withdrawal by Subject|0|||
161163357|NCT04752189|581974345|FG001|Overall Study|Withdrawal by Subject|150|||
161163358|NCT04752189|581974344|FG000|Overall Study|Lost to Follow-up|261|||
161163359|NCT04752189|581974345|FG001|Overall Study|Lost to Follow-up|126|||
161163360|NCT00975195|581974346|FG000|Overall Study|Adverse Event|108|||
161163361|NCT00975195|581974347|FG001|Overall Study|Adverse Event|101|||
161163362|NCT00975195|581974346|FG000|Overall Study|Lack of Efficacy|6|||
161163363|NCT00975195|581974347|FG001|Overall Study|Lack of Efficacy|6|||
161163364|NCT00975195|581974346|FG000|Overall Study|Protocol Violation|27|||
161163365|NCT00975195|581974347|FG001|Overall Study|Protocol Violation|23|||
161163366|NCT00975195|581974346|FG000|Overall Study|Lost to Follow-up|9|||
161163367|NCT00975195|581974347|FG001|Overall Study|Lost to Follow-up|7|||
161163368|NCT00975195|581974346|FG000|Overall Study|Withdrawal by Subject|48|||
161163369|NCT00975195|581974347|FG001|Overall Study|Withdrawal by Subject|61|||
161163370|NCT00975195|581974346|FG000|Overall Study|Other reason not defined above|29|||
161163371|NCT00975195|581974347|FG001|Overall Study|Other reason not defined above|33|||
161163372|NCT00975195|581974346|FG000|Overall Study|Not treated|1|||
161163373|NCT00975195|581974347|FG001|Overall Study|Not treated|2|||
161163374|NCT03003403|581974352|FG000|Overall Study|Ineligible|8|||
161163375|NCT03003403|581974353|FG001|Overall Study|Ineligible|7|||
161163376|NCT03003403|581974352|FG000|Overall Study|Withdrawal by Subject|3|||
161163377|NCT03003403|581974353|FG001|Overall Study|Withdrawal by Subject|1|||
161163378|NCT02180724|581975717|FG000|Overall Study|Death|26|||
161163379|NCT02180724|581975718|FG001|Overall Study|Death|1|||
161163380|NCT02180724|581975717|FG000|Overall Study|Lost to Follow-up|3|||
161163381|NCT02180724|581975718|FG001|Overall Study|Lost to Follow-up|1|||
161163382|NCT02180724|581975717|FG000|Overall Study|Withdrawal by Subject|4|||
161163383|NCT02180724|581975718|FG001|Overall Study|Withdrawal by Subject|2|||
161163384|NCT02180724|581975717|FG000|Overall Study|PI Decision|5|||
161163385|NCT02180724|581975718|FG001|Overall Study|PI Decision|2|||
161163386|NCT02180724|581975717|FG000|Overall Study|Study terminated by sponsor|54|||
161163387|NCT02180724|581975718|FG001|Overall Study|Study terminated by sponsor|8|||
161163388|NCT04580394|581975729|FG000|First Intervention|Incorrectly Randomized|1|||
161163389|NCT04580394|581975729|FG000|First Intervention|Physician Decision|1|||
161163390|NCT04580394|581975729|FG000|First Intervention|Lost to Follow-up|1|||
161163391|NCT04580394|581975729|FG000|Washout (One Week)|Withdrawal by Subject|1|||
161163392|NCT04580394|581975729|FG000|Washout (One Week)|Adverse Event|1|||
161163393|NCT04580394|581975729|FG000|Washout (One Week)|Withdrawal by Subject|2|||
161163394|NCT04580394|581975729|FG000|Third Intervention|Adverse Event|1|||
161163395|NCT04580394|581975729|FG000|Third Intervention|Withdrawal by Subject|1|||
161163396|NCT04580394|581975729|FG000|Washout (One Week)|Withdrawal by Subject|2|||
161163397|NCT03201965|581975734|FG000|Overall Study|Death|5|||
161163398|NCT03201965|581975735|FG001|Overall Study|Death|65|||
161163399|NCT03201965|581975736|FG002|Overall Study|Death|47|||
161163400|NCT03201965|581975734|FG000|Overall Study|Lost to Follow-up|0|||
161163401|NCT03201965|581975735|FG001|Overall Study|Lost to Follow-up|6|||
161163402|NCT03201965|581975736|FG002|Overall Study|Lost to Follow-up|0|||
161163403|NCT03201965|581975734|FG000|Overall Study|Withdrawal by Subject|3|||
161163404|NCT03201965|581975735|FG001|Overall Study|Withdrawal by Subject|23|||
161163405|NCT03201965|581975736|FG002|Overall Study|Withdrawal by Subject|8|||
161163406|NCT03201965|581975734|FG000|Overall Study|Sponsor's Decision|20|||
161163407|NCT03201965|581975735|FG001|Overall Study|Sponsor's Decision|99|||
161163408|NCT03201965|581975736|FG002|Overall Study|Sponsor's Decision|140|||
161163409|NCT03589326|581975737|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
161163410|NCT03589326|581975738|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
161163411|NCT03589326|581975737|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
161163412|NCT03589326|581975738|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
161163413|NCT03589326|581975737|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
161163414|NCT03589326|581975738|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
161163415|NCT03589326|581975737|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
161163416|NCT03589326|581975738|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
161163417|NCT03589326|581975737|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
161163418|NCT03589326|581975738|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
161163419|NCT01371981|581975741|FG000|Overall Study|Adverse Event|12|||
161163420|NCT01371981|581975742|FG001|Overall Study|Adverse Event|17|||
161163421|NCT01371981|581975743|FG002|Overall Study|Adverse Event|0|||
161163422|NCT01371981|581975744|FG003|Overall Study|Adverse Event|4|||
161163423|NCT01371981|581975745|FG004|Overall Study|Adverse Event|1|||
161163424|NCT01371981|581975746|FG005|Overall Study|Adverse Event|0|||
161163425|NCT01371981|581975741|FG000|Overall Study|Death|22|||
161163426|NCT01371981|581975742|FG001|Overall Study|Death|16|||
161163427|NCT01371981|581975743|FG002|Overall Study|Death|0|||
161163428|NCT01371981|581975744|FG003|Overall Study|Death|0|||
161163429|NCT01371981|581975745|FG004|Overall Study|Death|2|||
161163430|NCT01371981|581975746|FG005|Overall Study|Death|2|||
161163431|NCT01371981|581975741|FG000|Overall Study|Lack of Efficacy|69|||
161163432|NCT01371981|581975742|FG001|Overall Study|Lack of Efficacy|61|||
161163433|NCT01371981|581975743|FG002|Overall Study|Lack of Efficacy|4|||
161163434|NCT01371981|581975744|FG003|Overall Study|Lack of Efficacy|8|||
161163435|NCT01371981|581975745|FG004|Overall Study|Lack of Efficacy|5|||
161163436|NCT01371981|581975746|FG005|Overall Study|Lack of Efficacy|0|||
161163437|NCT01371981|581975741|FG000|Overall Study|Physician Decision|48|||
161163438|NCT01371981|581975742|FG001|Overall Study|Physician Decision|63|||
161163439|NCT01371981|581975743|FG002|Overall Study|Physician Decision|1|||
161163440|NCT01371981|581975744|FG003|Overall Study|Physician Decision|7|||
161163441|NCT01371981|581975745|FG004|Overall Study|Physician Decision|14|||
161163442|NCT01371981|581975746|FG005|Overall Study|Physician Decision|3|||
161163443|NCT01371981|581975741|FG000|Overall Study|Withdrawal by Subject|12|||
161163444|NCT01371981|581975742|FG001|Overall Study|Withdrawal by Subject|19|||
161163445|NCT01371981|581975743|FG002|Overall Study|Withdrawal by Subject|1|||
161163446|NCT01371981|581975744|FG003|Overall Study|Withdrawal by Subject|2|||
161163447|NCT01371981|581975745|FG004|Overall Study|Withdrawal by Subject|10|||
161163448|NCT01371981|581975746|FG005|Overall Study|Withdrawal by Subject|3|||
161163449|NCT01371981|581975741|FG000|Overall Study|Ineligible|19|||
161163450|NCT01371981|581975742|FG001|Overall Study|Ineligible|13|||
161163451|NCT01371981|581975743|FG002|Overall Study|Ineligible|0|||
161163452|NCT01371981|581975744|FG003|Overall Study|Ineligible|0|||
161163453|NCT01371981|581975745|FG004|Overall Study|Ineligible|0|||
161163454|NCT01371981|581975746|FG005|Overall Study|Ineligible|4|||
161163455|NCT01371981|581975741|FG000|Overall Study|Did not start treatment|2|||
161163456|NCT01371981|581975742|FG001|Overall Study|Did not start treatment|3|||
161163457|NCT01371981|581975743|FG002|Overall Study|Did not start treatment|0|||
161163458|NCT01371981|581975744|FG003|Overall Study|Did not start treatment|0|||
161163459|NCT01371981|581975745|FG004|Overall Study|Did not start treatment|0|||
161163460|NCT01371981|581975746|FG005|Overall Study|Did not start treatment|2|||
161163461|NCT01153893|581975747|FG000|Overall Study|Adverse Event|1|||
161163462|NCT01153893|581975748|FG001|Overall Study|Adverse Event|0|||
161163463|NCT04799405|581975749|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
161163464|NCT00603980|581975750|FG000|Study Qualification|Protocol Violation|3|||
161163465|NCT00603980|581975750|FG000|Study Qualification|Inconsistent data reporting|13|||
161163466|NCT00603980|581975750|FG000|Main Study|14th subject completed trial|1|||
161163467|NCT01029002|581975751|FG000|Overall Study|Lost to Follow-up|2|||
161163468|NCT01029002|581975752|FG001|Overall Study|Lost to Follow-up|4|||
161163469|NCT01341652|581975753|FG000|Overall Study|Incorrect Random Assignment|0|||
161163470|NCT01341652|581975754|FG001|Overall Study|Incorrect Random Assignment|1|||
161163471|NCT01341652|581975753|FG000|Overall Study|ineligible; presence metastatic disease|0|||
161163472|NCT01341652|581975754|FG001|Overall Study|ineligible; presence metastatic disease|1|||
161163473|NCT02618928|581975757|FG000|Overall Study|Failure to Return|28|||
161163474|NCT02618928|581975757|FG000|Overall Study|Insufficient Virological Response|1|||
161163475|NCT02618928|581975757|FG000|Overall Study|Withdrawal by Subject|2|||
161163476|NCT02618928|581975757|FG000|Overall Study|Death|3|||
161163477|NCT02618928|581975757|FG000|Overall Study|Other|11|||
161163478|NCT02618928|581975757|FG000|Overall Study|Missing|6|||
161163479|NCT02618928|581975757|FG000|Overall Study|Treatment Never Started|7|||
161163480|NCT02998554|581975758|FG000|Overall Study|Adverse Event|8|||
161163481|NCT02998554|581975759|FG001|Overall Study|Adverse Event|3|||
161163482|NCT02998554|581975758|FG000|Overall Study|Protocol deviation|1|||
161163483|NCT02998554|581975759|FG001|Overall Study|Protocol deviation|0|||
161163484|NCT02998554|581975758|FG000|Overall Study|Withdrawal by Subject|2|||
161163485|NCT02998554|581975759|FG001|Overall Study|Withdrawal by Subject|6|||
161163486|NCT02998554|581975758|FG000|Overall Study|Lost to Follow-up|0|||
161163487|NCT02998554|581975759|FG001|Overall Study|Lost to Follow-up|1|||
161163488|NCT02998554|581975758|FG000|Overall Study|Lack of Efficacy|0|||
161163489|NCT02998554|581975759|FG001|Overall Study|Lack of Efficacy|1|||
161163490|NCT00118482|581975760|FG000|Overall Study|Lost to Follow-up|7|||
161163491|NCT00118482|581975761|FG001|Overall Study|Lost to Follow-up|7|||
161163492|NCT00118482|581975760|FG000|Overall Study|Withdrawal by Subject|23|||
161163493|NCT00118482|581975761|FG001|Overall Study|Withdrawal by Subject|22|||
161163494|NCT02953782|581975766|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
161163495|NCT02953782|581975767|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
161163496|NCT02953782|581975768|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
161163497|NCT02953782|581975769|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
161163498|NCT02953782|581975770|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
161163499|NCT02953782|581975771|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161163500|NCT02953782|581975772|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161163501|NCT02953782|581975773|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
161163502|NCT02953782|581975766|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
161163503|NCT02953782|581975767|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161163504|NCT02953782|581975768|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
161163505|NCT02953782|581975769|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161163506|NCT02953782|581975770|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
161163507|NCT02953782|581975771|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161163508|NCT02953782|581975772|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161163509|NCT02953782|581975773|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
161163510|NCT02953782|581975766|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161163511|NCT02953782|581975767|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161163512|NCT02953782|581975768|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161163513|NCT02953782|581975769|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161163514|NCT02953782|581975770|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
161163515|NCT02953782|581975771|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161163516|NCT02953782|581975772|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161163517|NCT02953782|581975773|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
161163518|NCT02953782|581975766|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161163519|NCT02953782|581975767|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161163520|NCT02953782|581975768|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
161163521|NCT02953782|581975769|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
161163522|NCT02953782|581975770|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161163523|NCT02953782|581975771|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161163524|NCT02953782|581975772|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161163525|NCT02953782|581975773|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
161163526|NCT02953782|581975766|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161163527|NCT02953782|581975767|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161163528|NCT02953782|581975768|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161163529|NCT02953782|581975769|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161163530|NCT02953782|581975770|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
161163531|NCT02953782|581975771|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
161163532|NCT02953782|581975772|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
161163533|NCT02953782|581975773|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
161163534|NCT02953782|581975766|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161163535|NCT02953782|581975767|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161163536|NCT02953782|581975768|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161288486|NCT00445146|582436283|FG000|Overall Study|Lost to Follow-up|13|||
161288487|NCT00445146|582436283|FG000|Overall Study|Death|9|||
161288488|NCT00445146|582436283|FG000|Overall Study|Protocol Violation|4|||
161079406|NCT00943852|581680442|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079407|NCT00943852|581680443|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079408|NCT00943852|581680444|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079409|NCT00943852|581680445|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079410|NCT00943852|581680446|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079411|NCT00943852|581680447|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
161079412|NCT00943852|581680448|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079413|NCT00943852|581680449|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
161079414|NCT00943852|581680440|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161079415|NCT00943852|581680441|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161079416|NCT00943852|581680442|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161079417|NCT00943852|581680443|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161079418|NCT00943852|581680444|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161079419|NCT00943852|581680445|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161079420|NCT00943852|581680446|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
161079421|NCT00943852|581680447|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161079422|NCT00943852|581680448|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161079423|NCT00943852|581680449|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
161079424|NCT01353859|581680454|FG000|Overall Study|Adverse Event|3|||
161079425|NCT01353859|581680454|FG000|Overall Study|Lack of Efficacy|1|||
161079426|NCT02672852|581680455|FG000|Part A1|Disease Worsening|1|||
161079427|NCT02672852|581680456|FG001|Part A1|Disease Worsening|0|||
161079428|NCT02672852|581680457|FG002|Part A1|Disease Worsening|0|||
161079429|NCT02672852|581680458|FG003|Part A1|Disease Worsening|0|||
161079430|NCT02672852|581680459|FG004|Part A1|Disease Worsening|0|||
161079431|NCT02672852|581680460|FG005|Part A1|Disease Worsening|0|||
161079432|NCT02672852|581680461|FG006|Part A1|Disease Worsening|0|||
161079433|NCT02672852|581680455|FG000|Part A1|Adverse Event|0|||
161079434|NCT02672852|581680456|FG001|Part A1|Adverse Event|1|||
161079435|NCT02672852|581680457|FG002|Part A1|Adverse Event|0|||
161079436|NCT02672852|581680458|FG003|Part A1|Adverse Event|0|||
161079437|NCT02672852|581680459|FG004|Part A1|Adverse Event|0|||
161079438|NCT02672852|581680460|FG005|Part A1|Adverse Event|0|||
161079439|NCT02672852|581680461|FG006|Part A1|Adverse Event|0|||
161079440|NCT02672852|581680455|FG000|Part A1|Lost to Follow-up|1|||
161079441|NCT02672852|581680456|FG001|Part A1|Lost to Follow-up|2|||
161079442|NCT02672852|581680457|FG002|Part A1|Lost to Follow-up|0|||
161079443|NCT02672852|581680458|FG003|Part A1|Lost to Follow-up|0|||
161079444|NCT02672852|581680459|FG004|Part A1|Lost to Follow-up|0|||
161079445|NCT02672852|581680460|FG005|Part A1|Lost to Follow-up|0|||
161079446|NCT02672852|581680461|FG006|Part A1|Lost to Follow-up|0|||
161079447|NCT02672852|581680455|FG000|Part A1|Withdrawal by Subject|1|||
161079448|NCT02672852|581680456|FG001|Part A1|Withdrawal by Subject|1|||
161079449|NCT02672852|581680457|FG002|Part A1|Withdrawal by Subject|0|||
161079450|NCT02672852|581680458|FG003|Part A1|Withdrawal by Subject|0|||
161079451|NCT02672852|581680459|FG004|Part A1|Withdrawal by Subject|0|||
161079452|NCT02672852|581680460|FG005|Part A1|Withdrawal by Subject|0|||
161079453|NCT02672852|581680461|FG006|Part A1|Withdrawal by Subject|0|||
161079454|NCT02672852|581680455|FG000|Part A2|Disease worsening|0|||
161079455|NCT02672852|581680456|FG001|Part A2|Disease worsening|0|||
161079456|NCT02672852|581680457|FG002|Part A2|Disease worsening|1|||
161079457|NCT02672852|581680458|FG003|Part A2|Disease worsening|0|||
161079458|NCT02672852|581680459|FG004|Part A2|Disease worsening|0|||
161079459|NCT02672852|581680460|FG005|Part A2|Disease worsening|0|||
161079460|NCT02672852|581680461|FG006|Part A2|Disease worsening|0|||
161079461|NCT02672852|581680455|FG000|Part A2|Adverse Event|0|||
161079462|NCT02672852|581680456|FG001|Part A2|Adverse Event|0|||
161079463|NCT02672852|581680457|FG002|Part A2|Adverse Event|3|||
161079464|NCT02672852|581680458|FG003|Part A2|Adverse Event|0|||
161079465|NCT02672852|581680459|FG004|Part A2|Adverse Event|0|||
161079466|NCT02672852|581680460|FG005|Part A2|Adverse Event|0|||
161079467|NCT02672852|581680461|FG006|Part A2|Adverse Event|0|||
161079468|NCT02672852|581680455|FG000|Part A2|Lost to Follow-up|0|||
161079469|NCT02672852|581680456|FG001|Part A2|Lost to Follow-up|0|||
161079470|NCT02672852|581680457|FG002|Part A2|Lost to Follow-up|2|||
161079471|NCT02672852|581680458|FG003|Part A2|Lost to Follow-up|0|||
161079472|NCT02672852|581680459|FG004|Part A2|Lost to Follow-up|0|||
161079473|NCT02672852|581680460|FG005|Part A2|Lost to Follow-up|0|||
161079474|NCT02672852|581680461|FG006|Part A2|Lost to Follow-up|0|||
161079475|NCT02672852|581680455|FG000|Part A2|Withdrawal by Subject|0|||
161079476|NCT02672852|581680456|FG001|Part A2|Withdrawal by Subject|0|||
161079477|NCT02672852|581680457|FG002|Part A2|Withdrawal by Subject|1|||
161288489|NCT00445146|582436283|FG000|Overall Study|Pregnancy|1|||
161288490|NCT02623725|582436285|FG000|Overall Study|Non compliance with protocol|9|||
161288491|NCT02623725|582436286|FG001|Overall Study|Non compliance with protocol|3|||
161288492|NCT02623725|582436285|FG000|Overall Study|Serious adverse event|0|||
161288493|NCT02623725|582436286|FG001|Overall Study|Serious adverse event|2|||
161079478|NCT02672852|581680458|FG003|Part A2|Withdrawal by Subject|0|||
161079479|NCT02672852|581680459|FG004|Part A2|Withdrawal by Subject|0|||
161163537|NCT02953782|581975769|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161163538|NCT02953782|581975770|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
161163539|NCT02953782|581975771|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
161163540|NCT02953782|581975772|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
161163541|NCT02953782|581975773|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
161163542|NCT02953782|581975766|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161163543|NCT02953782|581975767|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161163544|NCT02953782|581975768|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161163545|NCT02953782|581975769|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161163546|NCT02953782|581975770|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
161163547|NCT02953782|581975771|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
161163548|NCT02953782|581975772|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
161163549|NCT02953782|581975773|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
161163550|NCT02953782|581975766|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163551|NCT02953782|581975767|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163552|NCT02953782|581975768|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163553|NCT02953782|581975769|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163554|NCT02953782|581975770|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163555|NCT02953782|581975771|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163556|NCT02953782|581975772|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
161163557|NCT02953782|581975773|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
161163558|NCT01934192|581975776|FG000|Overall Study|Protocol Violation|0|||
161163559|NCT01934192|581975777|FG001|Overall Study|Protocol Violation|0|||
161163560|NCT01934192|581975778|FG002|Overall Study|Protocol Violation|0|||
161079480|NCT02672852|581680460|FG005|Part A2|Withdrawal by Subject|0|||
161079481|NCT02672852|581680461|FG006|Part A2|Withdrawal by Subject|0|||
161079482|NCT02672852|581680455|FG000|Part A2|Other|0|||
161079483|NCT02672852|581680456|FG001|Part A2|Other|0|||
161079484|NCT02672852|581680457|FG002|Part A2|Other|3|||
161079485|NCT02672852|581680458|FG003|Part A2|Other|0|||
161079486|NCT02672852|581680459|FG004|Part A2|Other|0|||
161079487|NCT02672852|581680460|FG005|Part A2|Other|0|||
161079488|NCT02672852|581680461|FG006|Part A2|Other|0|||
161079489|NCT02672852|581680455|FG000|Part A2|Not entered in Part B|0|||
161079490|NCT02672852|581680456|FG001|Part A2|Not entered in Part B|0|||
161079491|NCT02672852|581680457|FG002|Part A2|Not entered in Part B|0|||
161079492|NCT02672852|581680458|FG003|Part A2|Not entered in Part B|4|||
161079493|NCT02672852|581680459|FG004|Part A2|Not entered in Part B|0|||
161079494|NCT02672852|581680460|FG005|Part A2|Not entered in Part B|0|||
161079495|NCT02672852|581680461|FG006|Part A2|Not entered in Part B|0|||
161079496|NCT02672852|581680455|FG000|Part B|Disease worsening|0|||
161079497|NCT02672852|581680456|FG001|Part B|Disease worsening|0|||
161079498|NCT02672852|581680457|FG002|Part B|Disease worsening|0|||
161079499|NCT02672852|581680458|FG003|Part B|Disease worsening|0|||
161079500|NCT02672852|581680459|FG004|Part B|Disease worsening|1|||
161079501|NCT02672852|581680460|FG005|Part B|Disease worsening|0|||
161079502|NCT02672852|581680461|FG006|Part B|Disease worsening|1|||
161079503|NCT02672852|581680455|FG000|Part B|Worsening pre-existing condition|0|||
161079504|NCT02672852|581680456|FG001|Part B|Worsening pre-existing condition|0|||
161079505|NCT02672852|581680457|FG002|Part B|Worsening pre-existing condition|0|||
161079506|NCT02672852|581680458|FG003|Part B|Worsening pre-existing condition|0|||
161079507|NCT02672852|581680459|FG004|Part B|Worsening pre-existing condition|0|||
161079508|NCT02672852|581680460|FG005|Part B|Worsening pre-existing condition|1|||
161079509|NCT02672852|581680461|FG006|Part B|Worsening pre-existing condition|0|||
161079510|NCT02672852|581680455|FG000|Part B|Other adverse event|0|||
161079511|NCT02672852|581680456|FG001|Part B|Other adverse event|0|||
161079512|NCT02672852|581680457|FG002|Part B|Other adverse event|0|||
161079513|NCT02672852|581680458|FG003|Part B|Other adverse event|0|||
161079514|NCT02672852|581680459|FG004|Part B|Other adverse event|3|||
161079515|NCT02672852|581680460|FG005|Part B|Other adverse event|5|||
161079516|NCT02672852|581680461|FG006|Part B|Other adverse event|1|||
161079517|NCT02672852|581680455|FG000|Part B|Lost to Follow-up|0|||
161079518|NCT02672852|581680456|FG001|Part B|Lost to Follow-up|0|||
161079519|NCT02672852|581680457|FG002|Part B|Lost to Follow-up|0|||
161079520|NCT02672852|581680458|FG003|Part B|Lost to Follow-up|0|||
161079521|NCT02672852|581680459|FG004|Part B|Lost to Follow-up|3|||
161079522|NCT02672852|581680460|FG005|Part B|Lost to Follow-up|4|||
161079523|NCT02672852|581680461|FG006|Part B|Lost to Follow-up|1|||
161079524|NCT02672852|581680455|FG000|Part B|Withdrawal by Subject|0|||
161079525|NCT02672852|581680456|FG001|Part B|Withdrawal by Subject|0|||
161079526|NCT02672852|581680457|FG002|Part B|Withdrawal by Subject|0|||
161079527|NCT02672852|581680458|FG003|Part B|Withdrawal by Subject|0|||
161288494|NCT02623725|582436285|FG000|Overall Study|Withdrawal by Subject|7|||
161288495|NCT02623725|582436286|FG001|Overall Study|Withdrawal by Subject|1|||
161288496|NCT02456740|582436287|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161288497|NCT02456740|582436288|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161288498|NCT02456740|582436289|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
161288499|NCT02456740|582436290|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161288500|NCT02456740|582436291|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161288501|NCT02456740|582436292|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161288502|NCT02456740|582436293|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161288503|NCT02456740|582436294|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161288504|NCT02456740|582436295|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
161288505|NCT02456740|582436287|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
161288506|NCT02456740|582436288|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
161288507|NCT02456740|582436289|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
161288508|NCT02456740|582436290|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161288509|NCT02456740|582436291|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161288510|NCT02456740|582436292|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161288511|NCT02456740|582436293|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161288512|NCT02456740|582436294|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161288513|NCT02456740|582436295|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
161288514|NCT02456740|582436287|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
161288515|NCT02456740|582436288|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
161288516|NCT02456740|582436289|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
161288517|NCT02456740|582436290|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161288518|NCT02456740|582436291|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161288519|NCT02456740|582436292|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161288520|NCT02456740|582436293|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161288521|NCT02456740|582436294|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161288522|NCT02456740|582436295|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
161288523|NCT02456740|582436287|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161288524|NCT02456740|582436288|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161288525|NCT02456740|582436289|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161288526|NCT02456740|582436290|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
161288527|NCT02456740|582436291|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
161288528|NCT02456740|582436292|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161288529|NCT02456740|582436293|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161288530|NCT02456740|582436294|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
161288531|NCT02456740|582436295|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
161288532|NCT02456740|582436287|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161288533|NCT02456740|582436288|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161288534|NCT02456740|582436289|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
161288535|NCT02456740|582436290|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
161288536|NCT02456740|582436291|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
161288537|NCT02456740|582436292|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
161288538|NCT02456740|582436293|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
161288539|NCT02456740|582436294|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
161288540|NCT02456740|582436295|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
161288541|NCT02456740|582436287|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288542|NCT02456740|582436288|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288543|NCT02456740|582436289|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288544|NCT02456740|582436290|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288545|NCT02456740|582436291|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288546|NCT02456740|582436292|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288547|NCT02456740|582436293|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288548|NCT02456740|582436294|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
161288549|NCT02456740|582436295|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
161288550|NCT02456740|582436287|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161288551|NCT02456740|582436288|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161288552|NCT02456740|582436289|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
161288553|NCT02456740|582436290|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
161288554|NCT02456740|582436291|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
161079528|NCT02672852|581680459|FG004|Part B|Withdrawal by Subject|5|||
161079529|NCT02672852|581680460|FG005|Part B|Withdrawal by Subject|0|||
161079530|NCT02672852|581680461|FG006|Part B|Withdrawal by Subject|7|||
161288555|NCT02456740|582436292|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
161288556|NCT02456740|582436293|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
161288557|NCT02456740|582436294|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
161288558|NCT02456740|582436295|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
161288559|NCT03918629|582436296|FG000|Overall Study|Adverse Event|19|||
161288560|NCT03918629|582436297|FG001|Overall Study|Adverse Event|20|||
161288561|NCT03918629|582436296|FG000|Overall Study|Death|14|||
161288562|NCT03918629|582436297|FG001|Overall Study|Death|7|||
161288563|NCT03918629|582436296|FG000|Overall Study|Lost to Follow-up|36|||
161288564|NCT03918629|582436297|FG001|Overall Study|Lost to Follow-up|28|||
161288565|NCT03918629|582436296|FG000|Overall Study|Physician Decision|1|||
161288566|NCT03918629|582436297|FG001|Overall Study|Physician Decision|0|||
161288567|NCT03918629|582436296|FG000|Overall Study|Protocol Violation|7|||
161288568|NCT03918629|582436297|FG001|Overall Study|Protocol Violation|4|||
161288569|NCT03918629|582436296|FG000|Overall Study|Withdrawal by Subject|47|||
161288570|NCT03918629|582436297|FG001|Overall Study|Withdrawal by Subject|47|||
161288571|NCT03918629|582436296|FG000|Overall Study|Other|7|||
161288572|NCT03918629|582436297|FG001|Overall Study|Other|11|||
161288573|NCT03918629|582436296|FG000|Overall Study|Randomized but not vaccinated|2|||
161288574|NCT03918629|582436297|FG001|Overall Study|Randomized but not vaccinated|1|||
161288575|NCT01891864|582436300|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
161288576|NCT01891864|582436301|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
161288577|NCT01891864|582436302|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161288578|NCT01891864|582436303|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161288579|NCT01891864|582436304|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161288580|NCT01891864|582436305|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
161288581|NCT01891864|582436300|FG000|Treatment Period 1|Physician Decision|0|||
161288582|NCT01891864|582436301|FG001|Treatment Period 1|Physician Decision|1|||
161288583|NCT01891864|582436302|FG002|Treatment Period 1|Physician Decision|0|||
161288584|NCT01891864|582436303|FG003|Treatment Period 1|Physician Decision|0|||
161288585|NCT01891864|582436304|FG004|Treatment Period 1|Physician Decision|0|||
161288586|NCT01891864|582436305|FG005|Treatment Period 1|Physician Decision|0|||
161288587|NCT01891864|582436300|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161288588|NCT01891864|582436301|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
161288589|NCT01891864|582436302|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161288590|NCT01891864|582436303|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161288591|NCT01891864|582436304|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161079531|NCT02672852|581680455|FG000|Part B|Other|0|||
161079532|NCT02672852|581680456|FG001|Part B|Other|0|||
161079533|NCT02672852|581680457|FG002|Part B|Other|0|||
161079534|NCT02672852|581680458|FG003|Part B|Other|0|||
161079535|NCT02672852|581680459|FG004|Part B|Other|4|||
161079536|NCT02672852|581680460|FG005|Part B|Other|1|||
161079537|NCT02672852|581680461|FG006|Part B|Other|2|||
161079538|NCT01725126|581680464|FG000|Overall Study|Protocol Violation|0|||
161079539|NCT01725126|581680465|FG001|Overall Study|Protocol Violation|1|||
161079540|NCT01725126|581680466|FG002|Overall Study|Protocol Violation|0|||
161079541|NCT01725126|581680467|FG003|Overall Study|Protocol Violation|0|||
161079542|NCT01725126|581680468|FG004|Overall Study|Protocol Violation|0|||
161079543|NCT01725126|581680469|FG005|Overall Study|Protocol Violation|0|||
161079544|NCT01725126|581680464|FG000|Overall Study|Withdrawal by Subject|0|||
161079545|NCT01725126|581680465|FG001|Overall Study|Withdrawal by Subject|0|||
161079546|NCT01725126|581680466|FG002|Overall Study|Withdrawal by Subject|0|||
161079547|NCT01725126|581680467|FG003|Overall Study|Withdrawal by Subject|1|||
161079548|NCT01725126|581680468|FG004|Overall Study|Withdrawal by Subject|0|||
161079549|NCT01725126|581680469|FG005|Overall Study|Withdrawal by Subject|0|||
161079550|NCT02530970|581680485|FG000|Overall Study|Adverse Event|8|||
161079551|NCT02530970|581680485|FG000|Overall Study|Lost to Follow-up|88|||
161079552|NCT02530970|581680485|FG000|Overall Study|Physician Decision|5|||
161079553|NCT02530970|581680485|FG000|Overall Study|Withdrawal by Subject|14|||
161079554|NCT02530970|581680485|FG000|Overall Study|Death|6|||
161079555|NCT02530970|581680485|FG000|Overall Study|Hospitalization|1|||
161079556|NCT02530970|581680485|FG000|Overall Study|Insurance|2|||
161079557|NCT02530970|581680485|FG000|Overall Study|Explant|2|||
161079558|NCT02530970|581680485|FG000|Overall Study|Change in Provider|5|||
161079559|NCT02530970|581680485|FG000|Overall Study|Relocation|3|||
161163561|NCT01934192|581975779|FG003|Overall Study|Protocol Violation|1|||
161079560|NCT02636725|581680489|FG000|Overall Study|Adverse Event|1|||
161079561|NCT00743431|581680498|FG000|Overall Study|Toxicity|6|||
161079562|NCT00743431|581680498|FG000|Overall Study|Tumor progression|56|||
161163562|NCT01934192|581975776|FG000|Overall Study|Other: reached stopping criteria|6|||
161079563|NCT00743431|581680498|FG000|Overall Study|Withdrawal by Subject|13|||
161079564|NCT00743431|581680498|FG000|Overall Study|Death|9|||
161079565|NCT00743431|581680498|FG000|Overall Study|Reason for discontinuation not specified|29|||
161079566|NCT00743431|581680498|FG000|Overall Study|No documentation available|13|||
161288592|NCT01891864|582436305|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
161288593|NCT01891864|582436300|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
161288594|NCT01891864|582436301|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
161288595|NCT01891864|582436302|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161288596|NCT01891864|582436303|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161288597|NCT01891864|582436304|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161288598|NCT01891864|582436305|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
161288599|NCT01891864|582436300|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161288600|NCT01891864|582436301|FG001|Treatment Period 1|Withdrawal by Subject|5|||
161288601|NCT01891864|582436302|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161288602|NCT01891864|582436303|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161288603|NCT01891864|582436304|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161288604|NCT01891864|582436305|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161288605|NCT01891864|582436300|FG000|Treatment Period 1|Lost to Follow-up|1|||
161288606|NCT01891864|582436301|FG001|Treatment Period 1|Lost to Follow-up|0|||
161288607|NCT01891864|582436302|FG002|Treatment Period 1|Lost to Follow-up|0|||
161288608|NCT01891864|582436303|FG003|Treatment Period 1|Lost to Follow-up|0|||
161288609|NCT01891864|582436304|FG004|Treatment Period 1|Lost to Follow-up|0|||
161288610|NCT01891864|582436305|FG005|Treatment Period 1|Lost to Follow-up|0|||
161288611|NCT01891864|582436300|FG000|Treatment Period 2|Protocol Violation|0|||
161288612|NCT01891864|582436301|FG001|Treatment Period 2|Protocol Violation|0|||
161288613|NCT01891864|582436302|FG002|Treatment Period 2|Protocol Violation|0|||
161288614|NCT01891864|582436303|FG003|Treatment Period 2|Protocol Violation|1|||
161288615|NCT01891864|582436304|FG004|Treatment Period 2|Protocol Violation|0|||
161288616|NCT01891864|582436305|FG005|Treatment Period 2|Protocol Violation|0|||
161288617|NCT01891864|582436300|FG000|Treatment Period 2|Physician Decision|0|||
161288618|NCT01891864|582436301|FG001|Treatment Period 2|Physician Decision|0|||
161288619|NCT01891864|582436302|FG002|Treatment Period 2|Physician Decision|1|||
161288620|NCT01891864|582436303|FG003|Treatment Period 2|Physician Decision|0|||
161288621|NCT01891864|582436304|FG004|Treatment Period 2|Physician Decision|0|||
161288622|NCT01891864|582436305|FG005|Treatment Period 2|Physician Decision|0|||
161288623|NCT01891864|582436300|FG000|Treatment Period 2|Site Termination|0|||
161079567|NCT03291288|581680499|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
161079568|NCT03291288|581680500|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
161079569|NCT03291288|581680499|FG000|Drug-drug Interaction Phase|Disease progression|1|||
161079570|NCT03291288|581680500|FG001|Drug-drug Interaction Phase|Disease progression|0|||
161079571|NCT03291288|581680499|FG000|Drug-drug Interaction Phase|Other|3|||
161079572|NCT03291288|581680500|FG001|Drug-drug Interaction Phase|Other|0|||
161079573|NCT03291288|581680499|FG000|Pexidartinib Only|Ongoing|0|||
161079574|NCT03291288|581680500|FG001|Pexidartinib Only|Ongoing|2|||
161079575|NCT04978493|581680501|FG000|Overall Study|No reason available|0|||
161079576|NCT04978493|581680502|FG001|Overall Study|No reason available|1|||
161079577|NCT04978493|581680501|FG000|Overall Study|Adverse Event|1|||
161079578|NCT04978493|581680502|FG001|Overall Study|Adverse Event|0|||
161079579|NCT01896726|581680503|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
161079580|NCT01896726|581680503|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
161079581|NCT01128114|581680504|FG000|Overall Study|Treatment Withdrawn|6|||
161079582|NCT01128114|581680504|FG000|Overall Study|Screening Failed|2|||
161079583|NCT00208325|581680505|FG000|Overall Study|Death|18|||
161079584|NCT00208325|581680506|FG001|Overall Study|Death|19|||
161079585|NCT00208325|581680507|FG002|Overall Study|Death|7|||
161079586|NCT00208325|581680508|FG003|Overall Study|Death|5|||
161079587|NCT00208325|581680505|FG000|Overall Study|Withdrawal by Subject|0|||
161079588|NCT00208325|581680506|FG001|Overall Study|Withdrawal by Subject|1|||
161079589|NCT00208325|581680507|FG002|Overall Study|Withdrawal by Subject|0|||
161079590|NCT00208325|581680508|FG003|Overall Study|Withdrawal by Subject|0|||
161079591|NCT00208325|581680505|FG000|Overall Study|Revision|4|||
161079592|NCT00208325|581680506|FG001|Overall Study|Revision|1|||
161079593|NCT00208325|581680507|FG002|Overall Study|Revision|0|||
161079594|NCT00208325|581680508|FG003|Overall Study|Revision|4|||
161079595|NCT00208325|581680505|FG000|Overall Study|Lost to Follow-up|1|||
161079596|NCT00208325|581680506|FG001|Overall Study|Lost to Follow-up|0|||
161079597|NCT00208325|581680507|FG002|Overall Study|Lost to Follow-up|2|||
161079598|NCT00208325|581680508|FG003|Overall Study|Lost to Follow-up|0|||
161079599|NCT00208325|581680505|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
161079600|NCT00208325|581680506|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
161079601|NCT00208325|581680507|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
161079602|NCT00208325|581680508|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
161079603|NCT00208325|581680505|FG000|Overall Study|Does not wish to Continue in Study|5|||
161079604|NCT00208325|581680506|FG001|Overall Study|Does not wish to Continue in Study|8|||
161079605|NCT00208325|581680507|FG002|Overall Study|Does not wish to Continue in Study|3|||
161079606|NCT00208325|581680508|FG003|Overall Study|Does not wish to Continue in Study|2|||
161079607|NCT00208325|581680505|FG000|Overall Study|Other|2|||
161079608|NCT00208325|581680506|FG001|Overall Study|Other|1|||
161079609|NCT00208325|581680507|FG002|Overall Study|Other|1|||
161079610|NCT00208325|581680508|FG003|Overall Study|Other|0|||
161079611|NCT00208325|581680505|FG000|Overall Study|Mis-Randomized|17|||
161288624|NCT01891864|582436301|FG001|Treatment Period 2|Site Termination|0|||
161163563|NCT01934192|581975777|FG001|Overall Study|Other: reached stopping criteria|5|||
161163564|NCT01934192|581975778|FG002|Overall Study|Other: reached stopping criteria|1|||
161163565|NCT01934192|581975779|FG003|Overall Study|Other: reached stopping criteria|0|||
161163566|NCT01934192|581975776|FG000|Overall Study|Physician Decision|3|||
161163567|NCT01934192|581975777|FG001|Overall Study|Physician Decision|2|||
161163568|NCT01934192|581975778|FG002|Overall Study|Physician Decision|0|||
161163569|NCT01934192|581975779|FG003|Overall Study|Physician Decision|0|||
161163570|NCT01737840|581975780|FG000|Overall Study|Diagnosed with an other pathology|2|||
161163571|NCT01737840|581975781|FG001|Overall Study|Diagnosed with an other pathology|2|||
161163572|NCT01189435|581975782|FG000|Overall Study|Withdrawal by Subject|1|||
161163573|NCT01189435|581975782|FG000|Overall Study|Physician Decision|1|||
161163574|NCT02357849|581975785|FG000|Overall Study|Withdrawal by Subject|2|||
161163575|NCT02357849|581975786|FG001|Overall Study|Withdrawal by Subject|3|||
161163576|NCT03105700|581975789|FG000|Overall Study|screen fail|3|||
161163577|NCT03105700|581975789|FG000|Overall Study|Lost to Follow-up|4|||
161163578|NCT04105244|581975790|FG000|Overall Study|Withdrawal by Subject|10|||
161163579|NCT04105244|581975791|FG001|Overall Study|Withdrawal by Subject|12|||
161163580|NCT04105244|581975790|FG000|Overall Study|Lost to Follow-up|20|||
161163581|NCT04105244|581975791|FG001|Overall Study|Lost to Follow-up|15|||
161163582|NCT04105244|581975790|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
161163583|NCT04105244|581975791|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
161163584|NCT04105244|581975790|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
161163585|NCT04105244|581975791|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
161163586|NCT01449682|581975792|FG000|Overall Study|Death|0|||
161163587|NCT01449682|581975793|FG001|Overall Study|Death|1|||
161163588|NCT01449682|581975792|FG000|Overall Study|Adverse Event|1|||
161163589|NCT01449682|581975793|FG001|Overall Study|Adverse Event|0|||
161163590|NCT02768194|581975794|FG000|Period 1|Adverse Event|0|||
161163591|NCT02768194|581975795|FG001|Period 1|Adverse Event|0|||
161163592|NCT02768194|581975796|FG002|Period 1|Adverse Event|0|||
161163593|NCT02768194|581975797|FG003|Period 1|Adverse Event|1|||
161163594|NCT02768194|581975798|FG004|Period 1|Adverse Event|0|||
161163595|NCT02768194|581975799|FG005|Period 1|Adverse Event|0|||
161163596|NCT02768194|581975794|FG000|Period 2|Other (Reason not specified)|1|||
161163597|NCT02768194|581975795|FG001|Period 2|Other (Reason not specified)|0|||
161163598|NCT02768194|581975796|FG002|Period 2|Other (Reason not specified)|0|||
161163599|NCT02768194|581975797|FG003|Period 2|Other (Reason not specified)|0|||
161163600|NCT02768194|581975798|FG004|Period 2|Other (Reason not specified)|0|||
161163601|NCT02768194|581975799|FG005|Period 2|Other (Reason not specified)|0|||
161163602|NCT02768194|581975794|FG000|Period 3|Other (Reason not specified)|0|||
161163603|NCT02768194|581975795|FG001|Period 3|Other (Reason not specified)|1|||
161163604|NCT02768194|581975796|FG002|Period 3|Other (Reason not specified)|0|||
161163605|NCT02768194|581975797|FG003|Period 3|Other (Reason not specified)|0|||
161163606|NCT02768194|581975798|FG004|Period 3|Other (Reason not specified)|0|||
161163607|NCT02768194|581975799|FG005|Period 3|Other (Reason not specified)|0|||
161163608|NCT04863014|581975800|FG000|Overall Study|Lost to Follow-up|3|||
161163609|NCT04863014|581975801|FG001|Overall Study|Lost to Follow-up|2|||
161163610|NCT04863014|581975800|FG000|Overall Study|Subject Decision|0|||
161163611|NCT04863014|581975801|FG001|Overall Study|Subject Decision|4|||
161163612|NCT04633473|581975806|FG000|Overall Study|Withdrawal by Subject|6|||
161163613|NCT01822691|581975808|FG000|Overall Study|Withdrawal by Subject|2|||
161163614|NCT01553916|581975809|FG000|Overall Study|Withdrawal by Subject|2|||
161163615|NCT01553916|581975809|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
161163616|NCT03089216|581975810|FG000|Overall Study|Adverse Event|0|||
161163617|NCT03089216|581975811|FG001|Overall Study|Adverse Event|0|||
161163618|NCT03089216|581975812|FG002|Overall Study|Adverse Event|0|||
161163619|NCT03089216|581975813|FG003|Overall Study|Adverse Event|1|||
161163620|NCT03259490|581975814|FG000|Period 1|Withdrawal by Subject|0|||
161163621|NCT03259490|581975815|FG001|Period 1|Withdrawal by Subject|1|||
161163622|NCT03259490|581975814|FG000|Period 2|Protocol Violation|1|||
161163623|NCT03259490|581975815|FG001|Period 2|Protocol Violation|0|||
161163624|NCT00819585|581975818|FG000|Core Study|Adverse Event|2|||
161163625|NCT00819585|581975819|FG001|Core Study|Adverse Event|1|||
161163626|NCT00819585|581975820|FG002|Core Study|Adverse Event|1|||
161163627|NCT00819585|581975821|FG003|Core Study|Adverse Event|4|||
161163628|NCT00819585|581975822|FG004|Core Study|Adverse Event|1|||
161163629|NCT00819585|581975823|FG005|Core Study|Adverse Event|0|||
161163630|NCT00819585|581975824|FG006|Core Study|Adverse Event|2|||
161163631|NCT00819585|581975825|FG007|Core Study|Adverse Event|0|||
161163632|NCT00819585|581975826|FG008|Core Study|Adverse Event|0|||
161163633|NCT00819585|581975827|FG009|Core Study|Adverse Event|0|||
161163634|NCT00819585|581975828|FG010|Core Study|Adverse Event|0|||
161163635|NCT00819585|581975818|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
161163636|NCT00819585|581975819|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
161163637|NCT00819585|581975820|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
161163638|NCT00819585|581975821|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
161163639|NCT00819585|581975822|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
161163640|NCT00819585|581975823|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
161163641|NCT00819585|581975824|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
161163642|NCT00819585|581975825|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
161163643|NCT00819585|581975826|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
161163644|NCT00819585|581975827|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
161163645|NCT00819585|581975828|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
161163646|NCT00819585|581975818|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163647|NCT00819585|581975819|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
161163648|NCT00819585|581975820|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163649|NCT00819585|581975821|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163650|NCT00819585|581975822|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163651|NCT00819585|581975823|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163652|NCT00819585|581975824|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
161163653|NCT00819585|581975825|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163654|NCT00819585|581975826|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163655|NCT00819585|581975827|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163656|NCT00819585|581975828|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
161163657|NCT00819585|581975818|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
161163658|NCT00819585|581975819|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
161163659|NCT00819585|581975820|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
161163660|NCT00819585|581975821|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
161163661|NCT00819585|581975822|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
161163662|NCT00819585|581975823|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
161163663|NCT00819585|581975824|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
161163664|NCT00819585|581975825|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
161163665|NCT00819585|581975826|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
161163666|NCT00819585|581975827|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
161163667|NCT00819585|581975828|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
161163668|NCT00819585|581975818|FG000|Core Study|Subject Withdrew Consent|0|||
161163669|NCT00819585|581975819|FG001|Core Study|Subject Withdrew Consent|3|||
161163670|NCT00819585|581975820|FG002|Core Study|Subject Withdrew Consent|2|||
161163671|NCT00819585|581975821|FG003|Core Study|Subject Withdrew Consent|1|||
161163672|NCT00819585|581975822|FG004|Core Study|Subject Withdrew Consent|0|||
161163673|NCT00819585|581975823|FG005|Core Study|Subject Withdrew Consent|0|||
161163674|NCT00819585|581975824|FG006|Core Study|Subject Withdrew Consent|3|||
161163675|NCT00819585|581975825|FG007|Core Study|Subject Withdrew Consent|0|||
161163676|NCT00819585|581975826|FG008|Core Study|Subject Withdrew Consent|0|||
161163677|NCT00819585|581975827|FG009|Core Study|Subject Withdrew Consent|0|||
161163678|NCT00819585|581975828|FG010|Core Study|Subject Withdrew Consent|0|||
161163679|NCT00819585|581975818|FG000|Core Study|Lost to Follow-up|2|||
161163680|NCT00819585|581975819|FG001|Core Study|Lost to Follow-up|1|||
161163681|NCT00819585|581975820|FG002|Core Study|Lost to Follow-up|2|||
161163682|NCT00819585|581975821|FG003|Core Study|Lost to Follow-up|0|||
161163683|NCT00819585|581975822|FG004|Core Study|Lost to Follow-up|1|||
161163684|NCT00819585|581975823|FG005|Core Study|Lost to Follow-up|1|||
161163685|NCT00819585|581975824|FG006|Core Study|Lost to Follow-up|1|||
161163686|NCT00819585|581975825|FG007|Core Study|Lost to Follow-up|0|||
161163687|NCT00819585|581975826|FG008|Core Study|Lost to Follow-up|0|||
161163688|NCT00819585|581975827|FG009|Core Study|Lost to Follow-up|0|||
161163689|NCT00819585|581975828|FG010|Core Study|Lost to Follow-up|0|||
161163690|NCT00819585|581975818|FG000|Core Study|Administrative Problems|0|||
161163691|NCT00819585|581975819|FG001|Core Study|Administrative Problems|0|||
161163692|NCT00819585|581975820|FG002|Core Study|Administrative Problems|0|||
161163693|NCT00819585|581975821|FG003|Core Study|Administrative Problems|0|||
161163694|NCT00819585|581975822|FG004|Core Study|Administrative Problems|0|||
161163695|NCT00819585|581975823|FG005|Core Study|Administrative Problems|0|||
161163696|NCT00819585|581975824|FG006|Core Study|Administrative Problems|2|||
161163697|NCT00819585|581975825|FG007|Core Study|Administrative Problems|0|||
161163698|NCT00819585|581975826|FG008|Core Study|Administrative Problems|0|||
161163699|NCT00819585|581975827|FG009|Core Study|Administrative Problems|0|||
161163700|NCT00819585|581975828|FG010|Core Study|Administrative Problems|0|||
161163701|NCT00819585|581975818|FG000|Core Study|Death|0|||
161163702|NCT00819585|581975819|FG001|Core Study|Death|0|||
161163703|NCT00819585|581975820|FG002|Core Study|Death|0|||
161163704|NCT00819585|581975821|FG003|Core Study|Death|0|||
161163705|NCT00819585|581975822|FG004|Core Study|Death|0|||
161163706|NCT00819585|581975823|FG005|Core Study|Death|0|||
161163707|NCT00819585|581975824|FG006|Core Study|Death|1|||
161163708|NCT00819585|581975825|FG007|Core Study|Death|0|||
161163709|NCT00819585|581975826|FG008|Core Study|Death|0|||
161163710|NCT00819585|581975827|FG009|Core Study|Death|0|||
161163711|NCT00819585|581975828|FG010|Core Study|Death|0|||
161163712|NCT00819585|581975818|FG000|Core Study|Protocol Violation|0|||
161163713|NCT00819585|581975819|FG001|Core Study|Protocol Violation|0|||
161163714|NCT00819585|581975820|FG002|Core Study|Protocol Violation|1|||
161163715|NCT00819585|581975821|FG003|Core Study|Protocol Violation|0|||
161163716|NCT00819585|581975822|FG004|Core Study|Protocol Violation|0|||
161163717|NCT00819585|581975823|FG005|Core Study|Protocol Violation|1|||
161163718|NCT00819585|581975824|FG006|Core Study|Protocol Violation|3|||
161163719|NCT00819585|581975825|FG007|Core Study|Protocol Violation|0|||
161163720|NCT00819585|581975826|FG008|Core Study|Protocol Violation|0|||
161163721|NCT00819585|581975827|FG009|Core Study|Protocol Violation|0|||
161163722|NCT00819585|581975828|FG010|Core Study|Protocol Violation|0|||
161163723|NCT00819585|581975818|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
161163724|NCT00819585|581975819|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
161163725|NCT00819585|581975820|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
161163726|NCT00819585|581975821|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
161163727|NCT00819585|581975822|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
161163728|NCT00819585|581975823|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
161163729|NCT00819585|581975824|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
161163730|NCT00819585|581975825|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
161163731|NCT00819585|581975826|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
161163732|NCT00819585|581975827|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
161163733|NCT00819585|581975828|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
161163734|NCT00819585|581975818|FG000|Extension Study|Subject Withdrew Consent|0|||
161163735|NCT00819585|581975819|FG001|Extension Study|Subject Withdrew Consent|0|||
161163736|NCT00819585|581975820|FG002|Extension Study|Subject Withdrew Consent|0|||
161163737|NCT00819585|581975821|FG003|Extension Study|Subject Withdrew Consent|0|||
161163738|NCT00819585|581975822|FG004|Extension Study|Subject Withdrew Consent|0|||
161163739|NCT00819585|581975823|FG005|Extension Study|Subject Withdrew Consent|0|||
161163740|NCT00819585|581975824|FG006|Extension Study|Subject Withdrew Consent|0|||
161163741|NCT00819585|581975825|FG007|Extension Study|Subject Withdrew Consent|0|||
161163742|NCT00819585|581975826|FG008|Extension Study|Subject Withdrew Consent|3|||
161163743|NCT00819585|581975827|FG009|Extension Study|Subject Withdrew Consent|0|||
161163744|NCT00819585|581975828|FG010|Extension Study|Subject Withdrew Consent|1|||
161163745|NCT00819585|581975818|FG000|Extension Study|Lost to Follow-up|0|||
161163746|NCT00819585|581975819|FG001|Extension Study|Lost to Follow-up|0|||
161163747|NCT00819585|581975820|FG002|Extension Study|Lost to Follow-up|0|||
161163748|NCT00819585|581975821|FG003|Extension Study|Lost to Follow-up|0|||
161163749|NCT00819585|581975822|FG004|Extension Study|Lost to Follow-up|0|||
161163750|NCT00819585|581975823|FG005|Extension Study|Lost to Follow-up|0|||
161163751|NCT00819585|581975824|FG006|Extension Study|Lost to Follow-up|0|||
161163752|NCT00819585|581975825|FG007|Extension Study|Lost to Follow-up|0|||
161288625|NCT01891864|582436302|FG002|Treatment Period 2|Site Termination|1|||
161288626|NCT01891864|582436303|FG003|Treatment Period 2|Site Termination|2|||
161288627|NCT01891864|582436304|FG004|Treatment Period 2|Site Termination|0|||
161288628|NCT01891864|582436305|FG005|Treatment Period 2|Site Termination|0|||
161288629|NCT01891864|582436300|FG000|Treatment Period 2|Lack of Efficacy|0|||
161288630|NCT01891864|582436301|FG001|Treatment Period 2|Lack of Efficacy|0|||
161288631|NCT01891864|582436302|FG002|Treatment Period 2|Lack of Efficacy|1|||
161288632|NCT01891864|582436303|FG003|Treatment Period 2|Lack of Efficacy|0|||
161288633|NCT01891864|582436304|FG004|Treatment Period 2|Lack of Efficacy|1|||
161288634|NCT01891864|582436305|FG005|Treatment Period 2|Lack of Efficacy|0|||
161288635|NCT01891864|582436300|FG000|Treatment Period 2|Adverse Event|0|||
161288636|NCT01891864|582436301|FG001|Treatment Period 2|Adverse Event|0|||
161288637|NCT01891864|582436302|FG002|Treatment Period 2|Adverse Event|1|||
161288638|NCT01891864|582436303|FG003|Treatment Period 2|Adverse Event|2|||
161288639|NCT01891864|582436304|FG004|Treatment Period 2|Adverse Event|0|||
161288640|NCT01891864|582436305|FG005|Treatment Period 2|Adverse Event|4|||
161288641|NCT01891864|582436300|FG000|Treatment Period 2|Termination of Site|0|||
161288642|NCT01891864|582436301|FG001|Treatment Period 2|Termination of Site|0|||
161288643|NCT01891864|582436302|FG002|Treatment Period 2|Termination of Site|0|||
161288644|NCT01891864|582436303|FG003|Treatment Period 2|Termination of Site|0|||
161288645|NCT01891864|582436304|FG004|Treatment Period 2|Termination of Site|2|||
161288646|NCT01891864|582436305|FG005|Treatment Period 2|Termination of Site|0|||
161288647|NCT01891864|582436300|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161288648|NCT01891864|582436301|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161288649|NCT01891864|582436302|FG002|Treatment Period 2|Withdrawal by Subject|3|||
161288650|NCT01891864|582436303|FG003|Treatment Period 2|Withdrawal by Subject|4|||
161288651|NCT01891864|582436304|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161288652|NCT01891864|582436305|FG005|Treatment Period 2|Withdrawal by Subject|1|||
161288653|NCT01891864|582436300|FG000|Extension Period|Lack of Efficacy|0|||
161288654|NCT01891864|582436301|FG001|Extension Period|Lack of Efficacy|0|||
161288655|NCT01891864|582436302|FG002|Extension Period|Lack of Efficacy|0|||
161288656|NCT01891864|582436303|FG003|Extension Period|Lack of Efficacy|1|||
161288657|NCT01891864|582436304|FG004|Extension Period|Lack of Efficacy|1|||
161288658|NCT01891864|582436305|FG005|Extension Period|Lack of Efficacy|0|||
161288659|NCT01891864|582436300|FG000|Extension Period|Pregnancy|0|||
161288660|NCT01891864|582436301|FG001|Extension Period|Pregnancy|0|||
161288661|NCT01891864|582436302|FG002|Extension Period|Pregnancy|1|||
161163753|NCT00819585|581975826|FG008|Extension Study|Lost to Follow-up|2|||
161163754|NCT00819585|581975827|FG009|Extension Study|Lost to Follow-up|1|||
161163755|NCT00819585|581975828|FG010|Extension Study|Lost to Follow-up|1|||
161288662|NCT01891864|582436303|FG003|Extension Period|Pregnancy|0|||
161288663|NCT01891864|582436304|FG004|Extension Period|Pregnancy|0|||
161288664|NCT01891864|582436305|FG005|Extension Period|Pregnancy|0|||
161288665|NCT01891864|582436300|FG000|Extension Period|Adverse Event|0|||
161288666|NCT01891864|582436301|FG001|Extension Period|Adverse Event|0|||
161288667|NCT01891864|582436302|FG002|Extension Period|Adverse Event|4|||
161288668|NCT01891864|582436303|FG003|Extension Period|Adverse Event|2|||
161288669|NCT01891864|582436304|FG004|Extension Period|Adverse Event|2|||
161288670|NCT01891864|582436305|FG005|Extension Period|Adverse Event|0|||
161288671|NCT01891864|582436300|FG000|Extension Period|Withdrawal by Subject|0|||
161288672|NCT01891864|582436301|FG001|Extension Period|Withdrawal by Subject|0|||
161288673|NCT01891864|582436302|FG002|Extension Period|Withdrawal by Subject|1|||
161288674|NCT01891864|582436303|FG003|Extension Period|Withdrawal by Subject|2|||
161288675|NCT01891864|582436304|FG004|Extension Period|Withdrawal by Subject|4|||
161288676|NCT01891864|582436305|FG005|Extension Period|Withdrawal by Subject|0|||
161288677|NCT01891864|582436300|FG000|Extension Period|Lost to Follow-up|0|||
161288678|NCT01891864|582436301|FG001|Extension Period|Lost to Follow-up|0|||
161288679|NCT01891864|582436302|FG002|Extension Period|Lost to Follow-up|2|||
161288680|NCT01891864|582436303|FG003|Extension Period|Lost to Follow-up|0|||
161288681|NCT01891864|582436304|FG004|Extension Period|Lost to Follow-up|0|||
161288682|NCT01891864|582436305|FG005|Extension Period|Lost to Follow-up|0|||
161288683|NCT04199104|582438200|FG000|Overall Study|Death|148|||
161288684|NCT04199104|582438201|FG001|Overall Study|Death|134|||
161288685|NCT04199104|582438200|FG000|Overall Study|Lost to Follow-up|1|||
161288686|NCT04199104|582438201|FG001|Overall Study|Lost to Follow-up|1|||
161288687|NCT04199104|582438200|FG000|Overall Study|Withdrawal by Subject|4|||
161288688|NCT04199104|582438201|FG001|Overall Study|Withdrawal by Subject|4|||
161288689|NCT04199104|582438200|FG000|Overall Study|Participants Ongoing|103|||
161288690|NCT04199104|582438201|FG001|Overall Study|Participants Ongoing|116|||
161288691|NCT04023396|582438205|FG000|Overall Study|Adverse Event|16|||
161288692|NCT04023396|582438205|FG000|Overall Study|Death|1|||
161288693|NCT04023396|582438205|FG000|Overall Study|Lost to Follow-up|1|||
161288694|NCT04023396|582438205|FG000|Overall Study|Withdrawal by Subject|14|||
161288695|NCT04023396|582438205|FG000|Overall Study|Pregnancy|4|||
161288696|NCT04023396|582438205|FG000|Overall Study|Lack of Efficacy|3|||
161288697|NCT04023396|582438205|FG000|Overall Study|Physician Decision|4|||
161288698|NCT04023396|582438205|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
161288699|NCT02325973|582438210|FG000|Overall Study|Death|5|||
161288700|NCT02325973|582438210|FG000|Overall Study|Withdrawal by subject or investigator|16|||
161288701|NCT04075825|582438211|FG000|Overall Study|Withdrawal by Subject|6|||
161288702|NCT04075825|582438212|FG001|Overall Study|Withdrawal by Subject|8|||
161288703|NCT04075825|582438211|FG000|Overall Study|Physician Decision|3|||
161288704|NCT04075825|582438212|FG001|Overall Study|Physician Decision|1|||
161288705|NCT04075825|582438211|FG000|Overall Study|Lost to Follow-up|5|||
161288706|NCT04075825|582438212|FG001|Overall Study|Lost to Follow-up|1|||
161288707|NCT04075825|582438211|FG000|Overall Study|Participation in New Clinical Trial|1|||
161288708|NCT04075825|582438212|FG001|Overall Study|Participation in New Clinical Trial|1|||
161288709|NCT04075825|582438211|FG000|Overall Study|Reason Not Specified|2|||
161288710|NCT04075825|582438212|FG001|Overall Study|Reason Not Specified|2|||
161288711|NCT01168232|582438213|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
161288712|NCT01168232|582438213|FG000|Overall Study|Ineligible- Wrong cell type|6|||
161288713|NCT01168232|582438213|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
161288714|NCT03879135|582438219|FG000|Overall Study|Physician Decision|0|||
161079612|NCT00208325|581680506|FG001|Overall Study|Mis-Randomized|20|||
161079613|NCT00208325|581680507|FG002|Overall Study|Mis-Randomized|0|||
161079614|NCT00208325|581680508|FG003|Overall Study|Mis-Randomized|0|||
161079615|NCT01254747|581680509|FG000|Overall Study|Unacceptable subjective vision|0|||
161079616|NCT01254747|581680510|FG001|Overall Study|Unacceptable subjective vision|0|||
161079617|NCT01254747|581680511|FG002|Overall Study|Unacceptable subjective vision|0|||
161079618|NCT01254747|581680512|FG003|Overall Study|Unacceptable subjective vision|2|||
161079619|NCT01254747|581680509|FG000|Overall Study|Difficult removal handling|0|||
161079620|NCT01254747|581680510|FG001|Overall Study|Difficult removal handling|0|||
161079621|NCT01254747|581680511|FG002|Overall Study|Difficult removal handling|1|||
161079622|NCT01254747|581680512|FG003|Overall Study|Difficult removal handling|0|||
161079623|NCT01254747|581680509|FG000|Overall Study|Symptoms and problems|0|||
161079624|NCT01254747|581680510|FG001|Overall Study|Symptoms and problems|2|||
161288715|NCT03879135|582438220|FG001|Overall Study|Physician Decision|0|||
161288716|NCT03879135|582438221|FG002|Overall Study|Physician Decision|0|||
161079625|NCT01254747|581680511|FG002|Overall Study|Symptoms and problems|1|||
161079626|NCT01254747|581680512|FG003|Overall Study|Symptoms and problems|0|||
161288717|NCT03879135|582438222|FG003|Overall Study|Physician Decision|1|||
161288718|NCT03879135|582438223|FG004|Overall Study|Physician Decision|0|||
161079627|NCT01254747|581680509|FG000|Overall Study|Lost to Follow-up|0|||
161288719|NCT03879135|582438224|FG005|Overall Study|Physician Decision|0|||
161288720|NCT03879135|582438219|FG000|Overall Study|Withdrawal by Subject|0|||
161288721|NCT03879135|582438220|FG001|Overall Study|Withdrawal by Subject|0|||
161288722|NCT03879135|582438221|FG002|Overall Study|Withdrawal by Subject|0|||
161288723|NCT03879135|582438222|FG003|Overall Study|Withdrawal by Subject|0|||
161288724|NCT03879135|582438223|FG004|Overall Study|Withdrawal by Subject|0|||
161079628|NCT01254747|581680510|FG001|Overall Study|Lost to Follow-up|0|||
161079629|NCT01254747|581680511|FG002|Overall Study|Lost to Follow-up|1|||
161079630|NCT01254747|581680512|FG003|Overall Study|Lost to Follow-up|0|||
161079631|NCT01254747|581680509|FG000|Overall Study|Biomicroscopy|0|||
161079632|NCT01254747|581680510|FG001|Overall Study|Biomicroscopy|0|||
161079633|NCT01254747|581680511|FG002|Overall Study|Biomicroscopy|1|||
161079634|NCT01254747|581680512|FG003|Overall Study|Biomicroscopy|0|||
161079635|NCT01254747|581680509|FG000|Overall Study|Discomfort|0|||
161079636|NCT01254747|581680510|FG001|Overall Study|Discomfort|4|||
161288725|NCT03879135|582438224|FG005|Overall Study|Withdrawal by Subject|1|||
161288726|NCT03879135|582438219|FG000|Overall Study|Site Closed by Sponsor|0|||
161288727|NCT03879135|582438220|FG001|Overall Study|Site Closed by Sponsor|0|||
161288728|NCT03879135|582438221|FG002|Overall Study|Site Closed by Sponsor|0|||
161288729|NCT03879135|582438222|FG003|Overall Study|Site Closed by Sponsor|1|||
161288730|NCT03879135|582438223|FG004|Overall Study|Site Closed by Sponsor|1|||
161288731|NCT03879135|582438224|FG005|Overall Study|Site Closed by Sponsor|0|||
161288732|NCT05201794|582438225|FG000|Overall Study|Withdrawal by Subject|13|||
161288733|NCT05201794|582438226|FG001|Overall Study|Withdrawal by Subject|12|||
161288734|NCT05201794|582438227|FG002|Overall Study|Withdrawal by Subject|14|||
161288735|NCT05201794|582438228|FG003|Overall Study|Withdrawal by Subject|0|||
161288736|NCT05201794|582438225|FG000|Overall Study|Adverse Event|5|||
161288737|NCT05201794|582438226|FG001|Overall Study|Adverse Event|5|||
161288738|NCT05201794|582438227|FG002|Overall Study|Adverse Event|4|||
161288739|NCT05201794|582438228|FG003|Overall Study|Adverse Event|0|||
161288740|NCT05201794|582438225|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
161288741|NCT05201794|582438226|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161288742|NCT05201794|582438227|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
161288743|NCT05201794|582438228|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161288744|NCT05201794|582438225|FG000|Overall Study|Non-Compliance With Study Drug|2|||
161288745|NCT05201794|582438226|FG001|Overall Study|Non-Compliance With Study Drug|3|||
161288746|NCT05201794|582438227|FG002|Overall Study|Non-Compliance With Study Drug|3|||
161288747|NCT05201794|582438228|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161288748|NCT05201794|582438225|FG000|Overall Study|Physician Decision|1|||
161288749|NCT05201794|582438226|FG001|Overall Study|Physician Decision|3|||
161288750|NCT05201794|582438227|FG002|Overall Study|Physician Decision|2|||
161288751|NCT05201794|582438228|FG003|Overall Study|Physician Decision|0|||
161288752|NCT05201794|582438225|FG000|Overall Study|Lost to Follow-up|2|||
161288753|NCT05201794|582438226|FG001|Overall Study|Lost to Follow-up|2|||
161288754|NCT05201794|582438227|FG002|Overall Study|Lost to Follow-up|0|||
161288755|NCT05201794|582438228|FG003|Overall Study|Lost to Follow-up|0|||
161288756|NCT05201794|582438225|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
161288757|NCT05201794|582438226|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
161288758|NCT05201794|582438227|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
161288759|NCT05201794|582438228|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
161288760|NCT05201794|582438225|FG000|Overall Study|Protocol Violation|2|||
161288761|NCT05201794|582438226|FG001|Overall Study|Protocol Violation|0|||
161288762|NCT05201794|582438227|FG002|Overall Study|Protocol Violation|1|||
161288763|NCT05201794|582438228|FG003|Overall Study|Protocol Violation|0|||
161288764|NCT05201794|582438225|FG000|Overall Study|Death|1|||
161288765|NCT05201794|582438226|FG001|Overall Study|Death|0|||
161288766|NCT05201794|582438227|FG002|Overall Study|Death|0|||
161288767|NCT05201794|582438228|FG003|Overall Study|Death|0|||
161288768|NCT05201794|582438225|FG000|Overall Study|Site Terminated By Sponsor|0|||
161288769|NCT05201794|582438226|FG001|Overall Study|Site Terminated By Sponsor|1|||
161288770|NCT05201794|582438227|FG002|Overall Study|Site Terminated By Sponsor|0|||
161288771|NCT05201794|582438228|FG003|Overall Study|Site Terminated By Sponsor|0|||
161288772|NCT05201794|582438225|FG000|Overall Study|Other|3|||
161288773|NCT05201794|582438226|FG001|Overall Study|Other|3|||
161288774|NCT05201794|582438227|FG002|Overall Study|Other|3|||
161288775|NCT05201794|582438228|FG003|Overall Study|Other|0|||
161288776|NCT05201794|582438225|FG000|Overall Study|Randomized But Not Treated|1|||
161288777|NCT05201794|582438226|FG001|Overall Study|Randomized But Not Treated|2|||
161288778|NCT05201794|582438227|FG002|Overall Study|Randomized But Not Treated|1|||
161288779|NCT05201794|582438228|FG003|Overall Study|Randomized But Not Treated|0|||
161288780|NCT03428958|582438229|FG000|Overall Study|Adverse Event|0|||
161288781|NCT03428958|582438230|FG001|Overall Study|Adverse Event|0|||
161288782|NCT03428958|582438231|FG002|Overall Study|Adverse Event|0|||
161288783|NCT03428958|582438232|FG003|Overall Study|Adverse Event|1|||
161288784|NCT03428958|582438233|FG004|Overall Study|Adverse Event|0|||
161079637|NCT01254747|581680511|FG002|Overall Study|Discomfort|0|||
161079638|NCT01254747|581680512|FG003|Overall Study|Discomfort|0|||
161079639|NCT04531098|581680515|FG000|Stage I|Adverse Event|0|||
161079640|NCT04531098|581680516|FG001|Stage I|Adverse Event|0|||
161288785|NCT03428958|582438234|FG005|Overall Study|Adverse Event|2|||
161288786|NCT03428958|582438235|FG006|Overall Study|Adverse Event|1|||
161288787|NCT03428958|582438236|FG007|Overall Study|Adverse Event|0|||
161288788|NCT03428958|582438237|FG008|Overall Study|Adverse Event|0|||
161288789|NCT03428958|582438238|FG009|Overall Study|Adverse Event|0|||
161288790|NCT03428958|582438239|FG010|Overall Study|Adverse Event|0|||
161163756|NCT00819585|581975818|FG000|Extension Study|Death|0|||
161163757|NCT00819585|581975819|FG001|Extension Study|Death|0|||
161163758|NCT00819585|581975820|FG002|Extension Study|Death|0|||
161163759|NCT00819585|581975821|FG003|Extension Study|Death|0|||
161163760|NCT00819585|581975822|FG004|Extension Study|Death|0|||
161163761|NCT00819585|581975823|FG005|Extension Study|Death|0|||
161163762|NCT00819585|581975824|FG006|Extension Study|Death|0|||
161163763|NCT00819585|581975825|FG007|Extension Study|Death|0|||
161163764|NCT00819585|581975826|FG008|Extension Study|Death|2|||
161163765|NCT00819585|581975827|FG009|Extension Study|Death|0|||
161163766|NCT00819585|581975828|FG010|Extension Study|Death|0|||
161163767|NCT00406783|581975829|FG000|Overall Study|Adverse Event|4|||
161163768|NCT00406783|581975830|FG001|Overall Study|Adverse Event|4|||
161163769|NCT00406783|581975829|FG000|Overall Study|Treatment Failure|2|||
161163770|NCT00406783|581975830|FG001|Overall Study|Treatment Failure|3|||
161163771|NCT00406783|581975829|FG000|Overall Study|Lost to Follow-up|3|||
161163772|NCT00406783|581975830|FG001|Overall Study|Lost to Follow-up|0|||
161163773|NCT00406783|581975829|FG000|Overall Study|Withdrawal by Subject|1|||
161163774|NCT00406783|581975830|FG001|Overall Study|Withdrawal by Subject|4|||
161163775|NCT00406783|581975829|FG000|Overall Study|Protocol Violation|4|||
161163776|NCT00406783|581975830|FG001|Overall Study|Protocol Violation|4|||
161163777|NCT00675103|581975831|FG000|Overall Study|Lack of Efficacy|2|||
161163778|NCT00675103|581975831|FG000|Overall Study|Adverse Event|1|||
161163779|NCT01810042|581975834|FG000|Overall Study|Lost to Follow-up|10|||
161163780|NCT01208038|581975837|FG000|Overall Study|Withdrawal by Subject|1|||
161163781|NCT02509494|581975840|FG000|Overall Study|Lost to Follow-up|8|||
161163782|NCT02509494|581975841|FG001|Overall Study|Lost to Follow-up|47|||
161163783|NCT02509494|581975842|FG002|Overall Study|Lost to Follow-up|19|||
161163784|NCT02509494|581975843|FG003|Overall Study|Lost to Follow-up|6|||
161163785|NCT02509494|581975844|FG004|Overall Study|Lost to Follow-up|3|||
161163786|NCT02509494|581975845|FG005|Overall Study|Lost to Follow-up|3|||
161163787|NCT02509494|581975846|FG006|Overall Study|Lost to Follow-up|1|||
161163788|NCT02509494|581975847|FG007|Overall Study|Lost to Follow-up|3|||
161163789|NCT02509494|581975848|FG008|Overall Study|Lost to Follow-up|1|||
161163790|NCT02509494|581975840|FG000|Overall Study|Physician Decision|2|||
161163791|NCT02509494|581975841|FG001|Overall Study|Physician Decision|1|||
161163792|NCT02509494|581975842|FG002|Overall Study|Physician Decision|0|||
161163793|NCT02509494|581975843|FG003|Overall Study|Physician Decision|0|||
161163794|NCT02509494|581975844|FG004|Overall Study|Physician Decision|0|||
161163795|NCT02509494|581975845|FG005|Overall Study|Physician Decision|0|||
161163796|NCT02509494|581975846|FG006|Overall Study|Physician Decision|0|||
161163797|NCT02509494|581975847|FG007|Overall Study|Physician Decision|0|||
161163798|NCT02509494|581975848|FG008|Overall Study|Physician Decision|0|||
161163799|NCT02509494|581975840|FG000|Overall Study|Withdrawal by Subject|4|||
161163800|NCT02509494|581975841|FG001|Overall Study|Withdrawal by Subject|17|||
161163801|NCT02509494|581975842|FG002|Overall Study|Withdrawal by Subject|7|||
161163802|NCT02509494|581975843|FG003|Overall Study|Withdrawal by Subject|5|||
161163803|NCT02509494|581975844|FG004|Overall Study|Withdrawal by Subject|0|||
161288791|NCT03428958|582438240|FG011|Overall Study|Adverse Event|0|||
161079641|NCT04531098|581680517|FG002|Stage I|Adverse Event|3|||
161079642|NCT04531098|581680515|FG000|Stage I|Protocol Violation|0|||
161079643|NCT04531098|581680516|FG001|Stage I|Protocol Violation|0|||
161079644|NCT04531098|581680517|FG002|Stage I|Protocol Violation|5|||
161079645|NCT04531098|581680515|FG000|Stage I|Withdrawal by Subject|0|||
161079646|NCT04531098|581680516|FG001|Stage I|Withdrawal by Subject|5|||
161079647|NCT04531098|581680517|FG002|Stage I|Withdrawal by Subject|10|||
161079648|NCT04531098|581680515|FG000|Stage II|Adverse Event|1|||
161079649|NCT04531098|581680516|FG001|Stage II|Adverse Event|2|||
161079650|NCT04531098|581680517|FG002|Stage II|Adverse Event|0|||
161079651|NCT04531098|581680515|FG000|Stage II|Protocol Violation|1|||
161079652|NCT04531098|581680516|FG001|Stage II|Protocol Violation|2|||
161079653|NCT04531098|581680517|FG002|Stage II|Protocol Violation|0|||
161079654|NCT04531098|581680515|FG000|Stage II|Withdrawal by Subject|3|||
161079655|NCT04531098|581680516|FG001|Stage II|Withdrawal by Subject|1|||
161079656|NCT04531098|581680517|FG002|Stage II|Withdrawal by Subject|0|||
161079657|NCT04531098|581680515|FG000|Stage II|Moved from study area|8|||
161079658|NCT04531098|581680516|FG001|Stage II|Moved from study area|5|||
161079659|NCT04531098|581680517|FG002|Stage II|Moved from study area|0|||
161163804|NCT02509494|581975845|FG005|Overall Study|Withdrawal by Subject|6|||
161163805|NCT02509494|581975846|FG006|Overall Study|Withdrawal by Subject|1|||
161163806|NCT02509494|581975847|FG007|Overall Study|Withdrawal by Subject|2|||
161163807|NCT02509494|581975848|FG008|Overall Study|Withdrawal by Subject|1|||
161163808|NCT02509494|581975840|FG000|Overall Study|Death|0|||
161163809|NCT02509494|581975841|FG001|Overall Study|Death|1|||
161163810|NCT02509494|581975842|FG002|Overall Study|Death|0|||
161163811|NCT02509494|581975843|FG003|Overall Study|Death|0|||
161163812|NCT02509494|581975844|FG004|Overall Study|Death|1|||
161163813|NCT02509494|581975845|FG005|Overall Study|Death|0|||
161163814|NCT02509494|581975846|FG006|Overall Study|Death|0|||
161163815|NCT02509494|581975847|FG007|Overall Study|Death|1|||
161163816|NCT02509494|581975848|FG008|Overall Study|Death|0|||
161163817|NCT02509494|581975840|FG000|Overall Study|Other|0|||
161288792|NCT03428958|582438241|FG012|Overall Study|Adverse Event|0|||
161163818|NCT02509494|581975841|FG001|Overall Study|Other|4|||
161163819|NCT02509494|581975842|FG002|Overall Study|Other|5|||
161163820|NCT02509494|581975843|FG003|Overall Study|Other|0|||
161163821|NCT02509494|581975844|FG004|Overall Study|Other|0|||
161163822|NCT02509494|581975845|FG005|Overall Study|Other|0|||
161163823|NCT02509494|581975846|FG006|Overall Study|Other|0|||
161163824|NCT02509494|581975847|FG007|Overall Study|Other|0|||
161163825|NCT02509494|581975848|FG008|Overall Study|Other|0|||
161163826|NCT02509494|581975840|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161163827|NCT02509494|581975841|FG001|Overall Study|Non-Compliance With Study Drug|11|||
161163828|NCT02509494|581975842|FG002|Overall Study|Non-Compliance With Study Drug|7|||
161163829|NCT02509494|581975843|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161163830|NCT02509494|581975844|FG004|Overall Study|Non-Compliance With Study Drug|1|||
161163831|NCT02509494|581975845|FG005|Overall Study|Non-Compliance With Study Drug|2|||
161163832|NCT02509494|581975846|FG006|Overall Study|Non-Compliance With Study Drug|1|||
161163833|NCT02509494|581975847|FG007|Overall Study|Non-Compliance With Study Drug|1|||
161163834|NCT02509494|581975848|FG008|Overall Study|Non-Compliance With Study Drug|0|||
161163835|NCT05084053|581977743|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
161163836|NCT05084053|581977744|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161163837|NCT05084053|581977745|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161163838|NCT05084053|581977746|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
161163839|NCT05084053|581977743|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
161163840|NCT05084053|581977744|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
161163841|NCT05084053|581977745|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
161163842|NCT05084053|581977746|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
161163843|NCT05084053|581977743|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
161163844|NCT05084053|581977744|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
161163845|NCT05084053|581977745|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
161163846|NCT05084053|581977746|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
161163847|NCT01255306|581977750|FG000|Overall Study|Physician Decision|1|||
161163848|NCT01255306|581977751|FG001|Overall Study|Physician Decision|1|||
161163849|NCT01617655|581977757|FG000|Overall Study|Adverse Event|2|||
161163850|NCT01617655|581977758|FG001|Overall Study|Adverse Event|3|||
161163851|NCT01617655|581977757|FG000|Overall Study|Poor compliance to protocol|1|||
161163852|NCT01617655|581977758|FG001|Overall Study|Poor compliance to protocol|4|||
161163853|NCT01617655|581977757|FG000|Overall Study|Participants moved|0|||
161163854|NCT01617655|581977758|FG001|Overall Study|Participants moved|4|||
161163855|NCT01617655|581977757|FG000|Overall Study|Consent withdrawn by participant|1|||
161163856|NCT01617655|581977758|FG001|Overall Study|Consent withdrawn by participant|1|||
161163857|NCT01617655|581977757|FG000|Overall Study|Last visit outside protocol visit window|1|||
161163858|NCT01617655|581977758|FG001|Overall Study|Last visit outside protocol visit window|10|||
161163859|NCT01617655|581977757|FG000|Overall Study|Site closure|3|||
161163860|NCT01617655|581977758|FG001|Overall Study|Site closure|5|||
161163861|NCT01617655|581977757|FG000|Overall Study|Other than specified above|1|||
161163862|NCT01617655|581977758|FG001|Overall Study|Other than specified above|2|||
161163863|NCT01175213|581977761|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
161163864|NCT01175213|581977762|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
161163865|NCT01175213|581977761|FG000|IGSC, 10%/rHuPH20|Death|1|||
161163866|NCT01175213|581977762|FG001|IGSC, 10%/rHuPH20|Death|0|||
161163867|NCT01175213|581977761|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
161163868|NCT01175213|581977762|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
161163869|NCT01175213|581977761|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
161163870|NCT01175213|581977762|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
161163871|NCT01175213|581977761|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
161163872|NCT01175213|581977762|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
161163873|NCT01175213|581977761|FG000|Safety Follow-up|Adverse Event|1|||
161163874|NCT01175213|581977762|FG001|Safety Follow-up|Adverse Event|0|||
161163875|NCT01517412|581977768|FG000|Overall Study|Adverse Event|10|||
161163876|NCT01517412|581977769|FG001|Overall Study|Adverse Event|11|||
161288793|NCT03428958|582438242|FG013|Overall Study|Adverse Event|0|||
161288794|NCT03428958|582438243|FG014|Overall Study|Adverse Event|0|||
161288795|NCT03428958|582438244|FG015|Overall Study|Adverse Event|0|||
161288796|NCT03428958|582438245|FG016|Overall Study|Adverse Event|0|||
161288797|NCT03428958|582438229|FG000|Overall Study|Clinical Progression|2|||
161163877|NCT01517412|581977768|FG000|Overall Study|Lack of Efficacy|10|||
161163878|NCT01517412|581977769|FG001|Overall Study|Lack of Efficacy|5|||
161163879|NCT01517412|581977768|FG000|Overall Study|Poor compliance to protocol|8|||
161163880|NCT01517412|581977769|FG001|Overall Study|Poor compliance to protocol|3|||
161163881|NCT01517412|581977768|FG000|Overall Study|Other than specified above|8|||
161163882|NCT01517412|581977769|FG001|Overall Study|Other than specified above|5|||
161163883|NCT01253187|581977770|FG000|Period 2|Withdrawal by Subject|0|||
161163884|NCT01253187|581977771|FG001|Period 2|Withdrawal by Subject|0|||
161163885|NCT01253187|581977772|FG002|Period 2|Withdrawal by Subject|0|||
161163886|NCT01253187|581977773|FG003|Period 2|Withdrawal by Subject|0|||
161163887|NCT01253187|581977774|FG004|Period 2|Withdrawal by Subject|1|||
161346585|NCT00580840|582653312|FG000|Run-in|Lost to Follow-up|4|||
161346586|NCT00580840|582653313|FG001|Run-in|Lost to Follow-up|0|||
161346587|NCT00580840|582653314|FG002|Run-in|Lost to Follow-up|0|||
161346588|NCT00580840|582653315|FG003|Run-in|Lost to Follow-up|0|||
161346589|NCT00580840|582653312|FG000|Run-in|Withdrawal by Subject|5|||
161346590|NCT00580840|582653313|FG001|Run-in|Withdrawal by Subject|0|||
161346591|NCT00580840|582653314|FG002|Run-in|Withdrawal by Subject|0|||
161346592|NCT00580840|582653315|FG003|Run-in|Withdrawal by Subject|0|||
161163888|NCT01253187|581977775|FG005|Period 2|Withdrawal by Subject|0|||
161163889|NCT01253187|581977770|FG000|Period 3|Pregnancy|1|||
161163890|NCT01253187|581977771|FG001|Period 3|Pregnancy|0|||
161163891|NCT01253187|581977772|FG002|Period 3|Pregnancy|0|||
161163892|NCT01253187|581977773|FG003|Period 3|Pregnancy|0|||
161163893|NCT01253187|581977774|FG004|Period 3|Pregnancy|0|||
161163894|NCT01253187|581977775|FG005|Period 3|Pregnancy|0|||
161163895|NCT01253187|581977770|FG000|Period 3|difficulty with blood sampling|0|||
161163896|NCT01253187|581977771|FG001|Period 3|difficulty with blood sampling|1|||
161163897|NCT01253187|581977772|FG002|Period 3|difficulty with blood sampling|0|||
161163898|NCT01253187|581977773|FG003|Period 3|difficulty with blood sampling|0|||
161163899|NCT01253187|581977774|FG004|Period 3|difficulty with blood sampling|0|||
161163900|NCT01253187|581977775|FG005|Period 3|difficulty with blood sampling|0|||
161163901|NCT01253187|581977770|FG000|Period 3|non-compliance|0|||
161163902|NCT01253187|581977771|FG001|Period 3|non-compliance|0|||
161163903|NCT01253187|581977772|FG002|Period 3|non-compliance|0|||
161163904|NCT01253187|581977773|FG003|Period 3|non-compliance|0|||
161163905|NCT01253187|581977774|FG004|Period 3|non-compliance|1|||
161163906|NCT01253187|581977775|FG005|Period 3|non-compliance|0|||
161288798|NCT03428958|582438230|FG001|Overall Study|Clinical Progression|3|||
161288799|NCT03428958|582438231|FG002|Overall Study|Clinical Progression|2|||
161288800|NCT03428958|582438232|FG003|Overall Study|Clinical Progression|1|||
161288801|NCT03428958|582438233|FG004|Overall Study|Clinical Progression|0|||
161288802|NCT03428958|582438234|FG005|Overall Study|Clinical Progression|2|||
161288803|NCT03428958|582438235|FG006|Overall Study|Clinical Progression|0|||
161288804|NCT03428958|582438236|FG007|Overall Study|Clinical Progression|0|||
161288805|NCT03428958|582438237|FG008|Overall Study|Clinical Progression|0|||
161288806|NCT03428958|582438238|FG009|Overall Study|Clinical Progression|0|||
161288807|NCT03428958|582438239|FG010|Overall Study|Clinical Progression|0|||
161288808|NCT03428958|582438240|FG011|Overall Study|Clinical Progression|0|||
161288809|NCT03428958|582438241|FG012|Overall Study|Clinical Progression|0|||
161288810|NCT03428958|582438242|FG013|Overall Study|Clinical Progression|0|||
161288811|NCT03428958|582438243|FG014|Overall Study|Clinical Progression|0|||
161288812|NCT03428958|582438244|FG015|Overall Study|Clinical Progression|0|||
161288813|NCT03428958|582438245|FG016|Overall Study|Clinical Progression|0|||
161288814|NCT03428958|582438229|FG000|Overall Study|Progression per RECIST|6|||
161288815|NCT03428958|582438230|FG001|Overall Study|Progression per RECIST|6|||
161288816|NCT03428958|582438231|FG002|Overall Study|Progression per RECIST|7|||
161288817|NCT03428958|582438232|FG003|Overall Study|Progression per RECIST|4|||
161288818|NCT03428958|582438233|FG004|Overall Study|Progression per RECIST|0|||
161288819|NCT03428958|582438234|FG005|Overall Study|Progression per RECIST|7|||
161288820|NCT03428958|582438235|FG006|Overall Study|Progression per RECIST|8|||
161288821|NCT03428958|582438236|FG007|Overall Study|Progression per RECIST|0|||
161288822|NCT03428958|582438237|FG008|Overall Study|Progression per RECIST|0|||
161288823|NCT03428958|582438238|FG009|Overall Study|Progression per RECIST|0|||
161288824|NCT03428958|582438239|FG010|Overall Study|Progression per RECIST|0|||
161288825|NCT03428958|582438240|FG011|Overall Study|Progression per RECIST|0|||
161288826|NCT03428958|582438241|FG012|Overall Study|Progression per RECIST|1|||
161288827|NCT03428958|582438242|FG013|Overall Study|Progression per RECIST|0|||
161288828|NCT03428958|582438243|FG014|Overall Study|Progression per RECIST|0|||
161288829|NCT03428958|582438244|FG015|Overall Study|Progression per RECIST|0|||
161288830|NCT03428958|582438245|FG016|Overall Study|Progression per RECIST|0|||
161288831|NCT03428958|582438229|FG000|Overall Study|Death|2|||
161288832|NCT03428958|582438230|FG001|Overall Study|Death|2|||
161346593|NCT00580840|582653312|FG000|Run-in|Other: Per Sponsor Request|2|||
161346594|NCT00580840|582653313|FG001|Run-in|Other: Per Sponsor Request|0|||
161163907|NCT03569449|581977776|FG000|Overall Study|Lost to Follow-up|0|||
161288833|NCT03428958|582438231|FG002|Overall Study|Death|0|||
161288834|NCT03428958|582438232|FG003|Overall Study|Death|0|||
161288835|NCT03428958|582438233|FG004|Overall Study|Death|0|||
161288836|NCT03428958|582438234|FG005|Overall Study|Death|7|||
161346595|NCT00580840|582653314|FG002|Run-in|Other: Per Sponsor Request|0|||
161288837|NCT03428958|582438235|FG006|Overall Study|Death|9|||
161346596|NCT00580840|582653315|FG003|Run-in|Other: Per Sponsor Request|0|||
161346597|NCT00580840|582653312|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
161346598|NCT00580840|582653313|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161163908|NCT03569449|581977777|FG001|Overall Study|Lost to Follow-up|1|||
161163909|NCT03569449|581977778|FG002|Overall Study|Lost to Follow-up|0|||
161163910|NCT03569449|581977779|FG003|Overall Study|Lost to Follow-up|2|||
161163911|NCT03569449|581977780|FG004|Overall Study|Lost to Follow-up|0|||
161163912|NCT03569449|581977781|FG005|Overall Study|Lost to Follow-up|0|||
161163913|NCT03569449|581977782|FG006|Overall Study|Lost to Follow-up|0|||
161163914|NCT03569449|581977783|FG007|Overall Study|Lost to Follow-up|0|||
161163915|NCT03569449|581977784|FG008|Overall Study|Lost to Follow-up|0|||
161163916|NCT03569449|581977785|FG009|Overall Study|Lost to Follow-up|0|||
161163917|NCT03569449|581977786|FG010|Overall Study|Lost to Follow-up|0|||
161163918|NCT03569449|581977787|FG011|Overall Study|Lost to Follow-up|0|||
161163919|NCT03569449|581977788|FG012|Overall Study|Lost to Follow-up|0|||
161163920|NCT03569449|581977789|FG013|Overall Study|Lost to Follow-up|0|||
161163921|NCT03569449|581977790|FG014|Overall Study|Lost to Follow-up|1|||
161163922|NCT03569449|581977791|FG015|Overall Study|Lost to Follow-up|0|||
161163923|NCT03569449|581977776|FG000|Overall Study|Withdrawal by Subject|0|||
161163924|NCT03569449|581977777|FG001|Overall Study|Withdrawal by Subject|1|||
161163925|NCT03569449|581977778|FG002|Overall Study|Withdrawal by Subject|0|||
161163926|NCT03569449|581977779|FG003|Overall Study|Withdrawal by Subject|0|||
161163927|NCT03569449|581977780|FG004|Overall Study|Withdrawal by Subject|1|||
161163928|NCT03569449|581977781|FG005|Overall Study|Withdrawal by Subject|0|||
161163929|NCT03569449|581977782|FG006|Overall Study|Withdrawal by Subject|0|||
161163930|NCT03569449|581977783|FG007|Overall Study|Withdrawal by Subject|0|||
161163931|NCT03569449|581977784|FG008|Overall Study|Withdrawal by Subject|0|||
161163932|NCT03569449|581977785|FG009|Overall Study|Withdrawal by Subject|0|||
161163933|NCT03569449|581977786|FG010|Overall Study|Withdrawal by Subject|0|||
161163934|NCT03569449|581977787|FG011|Overall Study|Withdrawal by Subject|0|||
161163935|NCT03569449|581977788|FG012|Overall Study|Withdrawal by Subject|0|||
161163936|NCT03569449|581977789|FG013|Overall Study|Withdrawal by Subject|0|||
161163937|NCT03569449|581977790|FG014|Overall Study|Withdrawal by Subject|0|||
161163938|NCT03569449|581977791|FG015|Overall Study|Withdrawal by Subject|0|||
161163939|NCT04124692|581977792|FG000|Overall Study|Medical reason|0|||
161163940|NCT04124692|581977793|FG001|Overall Study|Medical reason|1|||
161163941|NCT04124692|581977792|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
161163942|NCT04124692|581977793|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
161163943|NCT04124692|581977792|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
161163944|NCT04124692|581977793|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
161163945|NCT04124692|581977792|FG000|Overall Study|Lost to Follow-up|2|||
161163946|NCT04124692|581977793|FG001|Overall Study|Lost to Follow-up|4|||
161163947|NCT04124692|581977792|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
161163948|NCT04124692|581977793|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
161163949|NCT05279898|581977805|FG000|Overall Study|Withdrawal by Subject|1|||
161163950|NCT05279898|581977806|FG001|Overall Study|Withdrawal by Subject|0|||
161163951|NCT05279898|581977805|FG000|Overall Study|Physician Decision|1|||
161163952|NCT05279898|581977806|FG001|Overall Study|Physician Decision|1|||
161163953|NCT05136170|581977807|FG000|Overall Study|Withdrawal by Subject|2|||
161163954|NCT05136170|581977808|FG001|Overall Study|Withdrawal by Subject|2|||
161163955|NCT05136170|581977807|FG000|Overall Study|Can no longer make office visits|1|||
161163956|NCT05136170|581977808|FG001|Overall Study|Can no longer make office visits|0|||
161163957|NCT04393038|581977809|FG000|Overall Study|Adverse Event|11|||
161163958|NCT04393038|581977810|FG001|Overall Study|Adverse Event|2|||
161163959|NCT04393038|581977809|FG000|Overall Study|Protocol Violation|1|||
161163960|NCT04393038|581977810|FG001|Overall Study|Protocol Violation|0|||
161163961|NCT04393038|581977809|FG000|Overall Study|Death|6|||
161163962|NCT04393038|581977810|FG001|Overall Study|Death|4|||
161163963|NCT04393038|581977809|FG000|Overall Study|Withdrawal by Subject|24|||
161163964|NCT04393038|581977810|FG001|Overall Study|Withdrawal by Subject|8|||
161163965|NCT04393038|581977809|FG000|Overall Study|Lost to Follow-up|5|||
161163966|NCT04393038|581977810|FG001|Overall Study|Lost to Follow-up|4|||
161163967|NCT04393038|581977809|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
161163968|NCT04393038|581977810|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
161163969|NCT04393038|581977809|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
161163970|NCT04393038|581977810|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
161163971|NCT05168813|581977811|FG000|Part A (Open-label)|Lost to Follow-up|21|||
161288838|NCT03428958|582438236|FG007|Overall Study|Death|6|||
161288839|NCT03428958|582438237|FG008|Overall Study|Death|0|||
161288840|NCT03428958|582438238|FG009|Overall Study|Death|0|||
161288841|NCT03428958|582438239|FG010|Overall Study|Death|3|||
161163972|NCT05168813|581977812|FG001|Part A (Open-label)|Lost to Follow-up|39|||
161288842|NCT03428958|582438240|FG011|Overall Study|Death|0|||
161288843|NCT03428958|582438241|FG012|Overall Study|Death|4|||
161163973|NCT05168813|581977813|FG002|Part A (Open-label)|Lost to Follow-up|8|||
161288844|NCT03428958|582438242|FG013|Overall Study|Death|0|||
161288845|NCT03428958|582438243|FG014|Overall Study|Death|0|||
161288846|NCT03428958|582438244|FG015|Overall Study|Death|0|||
161163974|NCT05168813|581977814|FG003|Part A (Open-label)|Lost to Follow-up|26|||
161163975|NCT05168813|581977815|FG004|Part A (Open-label)|Lost to Follow-up|0|||
161163976|NCT05168813|581977816|FG005|Part A (Open-label)|Lost to Follow-up|0|||
161163977|NCT05168813|581977811|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
161288847|NCT03428958|582438245|FG016|Overall Study|Death|0|||
161288848|NCT03428958|582438229|FG000|Overall Study|Lost to Follow-up|0|||
161346599|NCT00580840|582653314|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161346600|NCT00580840|582653315|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
161346601|NCT00580840|582653312|FG000|Run-in|Other: Exclusionary Lab Value|1|||
161163978|NCT05168813|581977812|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
161163979|NCT05168813|581977813|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
161163980|NCT05168813|581977814|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
161163981|NCT05168813|581977815|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
161163982|NCT05168813|581977816|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
161163983|NCT05168813|581977811|FG000|Part A (Open-label)|Death|23|||
161163984|NCT05168813|581977812|FG001|Part A (Open-label)|Death|28|||
161163985|NCT05168813|581977813|FG002|Part A (Open-label)|Death|1|||
161163986|NCT05168813|581977814|FG003|Part A (Open-label)|Death|9|||
161346602|NCT00580840|582653313|FG001|Run-in|Other: Exclusionary Lab Value|0|||
161346603|NCT00580840|582653314|FG002|Run-in|Other: Exclusionary Lab Value|0|||
161346604|NCT00580840|582653315|FG003|Run-in|Other: Exclusionary Lab Value|0|||
161163987|NCT05168813|581977815|FG004|Part A (Open-label)|Death|0|||
161163988|NCT05168813|581977816|FG005|Part A (Open-label)|Death|0|||
161163989|NCT05168813|581977811|FG000|Part A (Open-label)|Physician Decision|0|||
161163990|NCT05168813|581977812|FG001|Part A (Open-label)|Physician Decision|1|||
161163991|NCT05168813|581977813|FG002|Part A (Open-label)|Physician Decision|0|||
161163992|NCT05168813|581977814|FG003|Part A (Open-label)|Physician Decision|2|||
161163993|NCT05168813|581977815|FG004|Part A (Open-label)|Physician Decision|0|||
161163994|NCT05168813|581977816|FG005|Part A (Open-label)|Physician Decision|0|||
161163995|NCT05168813|581977811|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
161163996|NCT05168813|581977812|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
161346605|NCT00580840|582653312|FG000|Double-Blind|Adverse Event|0|||
161346606|NCT00580840|582653313|FG001|Double-Blind|Adverse Event|3|||
161346607|NCT00580840|582653314|FG002|Double-Blind|Adverse Event|4|||
161346608|NCT00580840|582653315|FG003|Double-Blind|Adverse Event|1|||
161346609|NCT00580840|582653312|FG000|Double-Blind|Loss of Efficacy|0|||
161346610|NCT00580840|582653313|FG001|Double-Blind|Loss of Efficacy|1|||
161346611|NCT00580840|582653314|FG002|Double-Blind|Loss of Efficacy|2|||
161346612|NCT00580840|582653315|FG003|Double-Blind|Loss of Efficacy|10|||
161346613|NCT00580840|582653312|FG000|Double-Blind|Lost to Follow-up|0|||
161346614|NCT00580840|582653313|FG001|Double-Blind|Lost to Follow-up|1|||
161346615|NCT00580840|582653314|FG002|Double-Blind|Lost to Follow-up|0|||
161346616|NCT00580840|582653315|FG003|Double-Blind|Lost to Follow-up|2|||
161346617|NCT00580840|582653312|FG000|Double-Blind|Withdrawal by Subject|0|||
161346618|NCT00580840|582653313|FG001|Double-Blind|Withdrawal by Subject|1|||
161346619|NCT00580840|582653314|FG002|Double-Blind|Withdrawal by Subject|2|||
161346620|NCT00580840|582653315|FG003|Double-Blind|Withdrawal by Subject|2|||
161346621|NCT00580840|582653312|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
161346622|NCT00580840|582653313|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
161346623|NCT00580840|582653314|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
161346624|NCT00580840|582653315|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
161346625|NCT00580840|582653312|FG000|Double-Blind|Other: Forbidden Medication|0|||
161346626|NCT00580840|582653313|FG001|Double-Blind|Other: Forbidden Medication|0|||
161346627|NCT00580840|582653314|FG002|Double-Blind|Other: Forbidden Medication|1|||
161346628|NCT00580840|582653315|FG003|Double-Blind|Other: Forbidden Medication|0|||
161346629|NCT04435626|582653318|FG000|Overall Study|Lost to Follow-up|1|||
161346630|NCT04435626|582653319|FG001|Overall Study|Lost to Follow-up|5|||
161346631|NCT04435626|582653318|FG000|Overall Study|Withdrawal by Subject|6|||
161346632|NCT04435626|582653319|FG001|Overall Study|Withdrawal by Subject|7|||
161163997|NCT05168813|581977813|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161163998|NCT05168813|581977814|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
161163999|NCT05168813|581977815|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161164000|NCT05168813|581977816|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
161164001|NCT05168813|581977811|FG000|Part A (Open-label)|Protocol Violation|0|||
161164002|NCT05168813|581977812|FG001|Part A (Open-label)|Protocol Violation|1|||
161164003|NCT05168813|581977813|FG002|Part A (Open-label)|Protocol Violation|0|||
161164004|NCT05168813|581977814|FG003|Part A (Open-label)|Protocol Violation|0|||
161346633|NCT04435626|582653318|FG000|Overall Study|major GCP violations|8|||
161346634|NCT04435626|582653319|FG001|Overall Study|major GCP violations|7|||
161346635|NCT01160614|582653327|FG000|Overall Study|Withdrawal by Subject|0|||
161346636|NCT01160614|582653328|FG001|Overall Study|Withdrawal by Subject|2|||
161346637|NCT00984399|582653329|FG000|Overall Study|Adverse Event|0|||
161346638|NCT00984399|582653330|FG001|Overall Study|Adverse Event|1|||
161346639|NCT00984399|582653329|FG000|Overall Study|Physician Decision|1|||
161346640|NCT00984399|582653330|FG001|Overall Study|Physician Decision|0|||
161346641|NCT00984399|582653329|FG000|Overall Study|Withdrawal by Subject|1|||
161164005|NCT05168813|581977815|FG004|Part A (Open-label)|Protocol Violation|0|||
161164006|NCT05168813|581977816|FG005|Part A (Open-label)|Protocol Violation|0|||
161164007|NCT05168813|581977811|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
161164008|NCT05168813|581977812|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
161164009|NCT05168813|581977813|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
161288849|NCT03428958|582438230|FG001|Overall Study|Lost to Follow-up|0|||
161288850|NCT03428958|582438231|FG002|Overall Study|Lost to Follow-up|0|||
161288851|NCT03428958|582438232|FG003|Overall Study|Lost to Follow-up|0|||
161288852|NCT03428958|582438233|FG004|Overall Study|Lost to Follow-up|0|||
161288853|NCT03428958|582438234|FG005|Overall Study|Lost to Follow-up|1|||
161079660|NCT05543707|581680527|FG000|Overall Study|Study drug non-compliance/|5|||
161079661|NCT05543707|581680528|FG001|Overall Study|Study drug non-compliance/|0|||
161079662|NCT05543707|581680527|FG000|Overall Study|Withdrawal by Subject|1|||
161079663|NCT05543707|581680528|FG001|Overall Study|Withdrawal by Subject|1|||
161079664|NCT05543707|581680527|FG000|Overall Study|Adverse Event|1|||
161079665|NCT05543707|581680528|FG001|Overall Study|Adverse Event|0|||
161079666|NCT05543707|581680527|FG000|Overall Study|concurrent illness|0|||
161079667|NCT05543707|581680528|FG001|Overall Study|concurrent illness|1|||
161079668|NCT05543707|581680527|FG000|Overall Study|Pregnancy|1|||
161079669|NCT05543707|581680528|FG001|Overall Study|Pregnancy|1|||
161079670|NCT05511038|581680529|FG000|Overall|Withdrawal by Subject|5|||
161079671|NCT05511038|581680530|FG001|Overall|Withdrawal by Subject|3|||
161079672|NCT05511038|581680529|FG000|Overall|Screen Failure|20|||
161079673|NCT05511038|581680530|FG001|Overall|Screen Failure|1|||
161079674|NCT05511038|581680529|FG000|Overall|Physician Decision|3|||
161079675|NCT05511038|581680530|FG001|Overall|Physician Decision|0|||
161079676|NCT05511038|581680529|FG000|Overall|Lost to Follow-up|3|||
161079677|NCT05511038|581680530|FG001|Overall|Lost to Follow-up|0|||
161079678|NCT05511038|581680529|FG000|Overall|Death|1|||
161079679|NCT05511038|581680530|FG001|Overall|Death|0|||
161079680|NCT05511038|581680529|FG000|Screening|Withdrawal by Subject|1|||
161079681|NCT05511038|581680530|FG001|Screening|Withdrawal by Subject|0|||
161079682|NCT05511038|581680529|FG000|Screening|Lost to Follow Up (1 participant)|1|||
161079683|NCT05511038|581680530|FG001|Screening|Lost to Follow Up (1 participant)|0|||
161079684|NCT05511038|581680529|FG000|Screening|Screen Failure|3|||
161079685|NCT05511038|581680530|FG001|Screening|Screen Failure|0|||
161079686|NCT05511038|581680529|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
161079687|NCT05511038|581680530|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
161079688|NCT05511038|581680529|FG000|Treatment|Withdrawal by Subject|5|||
161079689|NCT05511038|581680530|FG001|Treatment|Withdrawal by Subject|3|||
161079690|NCT05511038|581680529|FG000|Treatment|Physician Decision|4|||
161079691|NCT05511038|581680530|FG001|Treatment|Physician Decision|0|||
161079692|NCT05511038|581680529|FG000|Treatment|Lost to Follow-up|2|||
161079693|NCT05511038|581680530|FG001|Treatment|Lost to Follow-up|0|||
161079694|NCT05511038|581680529|FG000|Treatment|Death|1|||
161079695|NCT05511038|581680530|FG001|Treatment|Death|0|||
161079696|NCT05511038|581680529|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
161079697|NCT05511038|581680530|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
161079698|NCT05511038|581680529|FG000|Treatment|Refuse by subject|1|||
161079699|NCT05511038|581680530|FG001|Treatment|Refuse by subject|0|||
161079700|NCT05511038|581680529|FG000|Treatment|Subject did not go to the site for visit|1|||
161079701|NCT05511038|581680530|FG001|Treatment|Subject did not go to the site for visit|0|||
161079702|NCT02108964|581680531|FG000|Overall Study|Progressive disease|15|||
161079703|NCT02108964|581680532|FG001|Overall Study|Progressive disease|31|||
161079704|NCT02108964|581680533|FG002|Overall Study|Progressive disease|54|||
161079705|NCT02108964|581680534|FG003|Overall Study|Progressive disease|7|||
161079706|NCT02108964|581680535|FG004|Overall Study|Progressive disease|20|||
161079707|NCT02108964|581680536|FG005|Overall Study|Progressive disease|4|||
161079708|NCT02108964|581680537|FG006|Overall Study|Progressive disease|6|||
161079709|NCT02108964|581680538|FG007|Overall Study|Progressive disease|33|||
161079710|NCT02108964|581680531|FG000|Overall Study|Physician Decision|1|||
161079711|NCT02108964|581680532|FG001|Overall Study|Physician Decision|5|||
161079712|NCT02108964|581680533|FG002|Overall Study|Physician Decision|7|||
161079713|NCT02108964|581680534|FG003|Overall Study|Physician Decision|1|||
161079714|NCT02108964|581680535|FG004|Overall Study|Physician Decision|2|||
161079715|NCT02108964|581680536|FG005|Overall Study|Physician Decision|1|||
161079716|NCT02108964|581680537|FG006|Overall Study|Physician Decision|1|||
161079717|NCT02108964|581680538|FG007|Overall Study|Physician Decision|3|||
161288854|NCT03428958|582438235|FG006|Overall Study|Lost to Follow-up|1|||
161288855|NCT03428958|582438236|FG007|Overall Study|Lost to Follow-up|0|||
161288856|NCT03428958|582438237|FG008|Overall Study|Lost to Follow-up|0|||
161079718|NCT02108964|581680531|FG000|Overall Study|Adverse Event|0|||
161079719|NCT02108964|581680532|FG001|Overall Study|Adverse Event|0|||
161079720|NCT02108964|581680533|FG002|Overall Study|Adverse Event|4|||
161079721|NCT02108964|581680534|FG003|Overall Study|Adverse Event|0|||
161079722|NCT02108964|581680535|FG004|Overall Study|Adverse Event|1|||
161079723|NCT02108964|581680536|FG005|Overall Study|Adverse Event|0|||
161288857|NCT03428958|582438238|FG009|Overall Study|Lost to Follow-up|0|||
161079724|NCT02108964|581680537|FG006|Overall Study|Adverse Event|3|||
161079725|NCT02108964|581680538|FG007|Overall Study|Adverse Event|2|||
161079726|NCT02108964|581680531|FG000|Overall Study|Death|1|||
161079727|NCT02108964|581680532|FG001|Overall Study|Death|1|||
161079728|NCT02108964|581680533|FG002|Overall Study|Death|4|||
161079729|NCT02108964|581680534|FG003|Overall Study|Death|0|||
161079730|NCT02108964|581680535|FG004|Overall Study|Death|3|||
161288858|NCT03428958|582438239|FG010|Overall Study|Lost to Follow-up|0|||
161288859|NCT03428958|582438240|FG011|Overall Study|Lost to Follow-up|0|||
161288860|NCT03428958|582438241|FG012|Overall Study|Lost to Follow-up|0|||
161288861|NCT03428958|582438242|FG013|Overall Study|Lost to Follow-up|0|||
161288862|NCT03428958|582438243|FG014|Overall Study|Lost to Follow-up|0|||
161288863|NCT03428958|582438244|FG015|Overall Study|Lost to Follow-up|0|||
161288864|NCT03428958|582438245|FG016|Overall Study|Lost to Follow-up|0|||
161288865|NCT03428958|582438229|FG000|Overall Study|Physician/Sponsor Decision|1|||
161288866|NCT03428958|582438230|FG001|Overall Study|Physician/Sponsor Decision|0|||
161288867|NCT03428958|582438231|FG002|Overall Study|Physician/Sponsor Decision|1|||
161288868|NCT03428958|582438232|FG003|Overall Study|Physician/Sponsor Decision|0|||
161288869|NCT03428958|582438233|FG004|Overall Study|Physician/Sponsor Decision|0|||
161288870|NCT03428958|582438234|FG005|Overall Study|Physician/Sponsor Decision|2|||
161288871|NCT03428958|582438235|FG006|Overall Study|Physician/Sponsor Decision|2|||
161288872|NCT03428958|582438236|FG007|Overall Study|Physician/Sponsor Decision|2|||
161288873|NCT03428958|582438237|FG008|Overall Study|Physician/Sponsor Decision|0|||
161288874|NCT03428958|582438238|FG009|Overall Study|Physician/Sponsor Decision|0|||
161288875|NCT03428958|582438239|FG010|Overall Study|Physician/Sponsor Decision|2|||
161288876|NCT03428958|582438240|FG011|Overall Study|Physician/Sponsor Decision|0|||
161288877|NCT03428958|582438241|FG012|Overall Study|Physician/Sponsor Decision|4|||
161288878|NCT03428958|582438242|FG013|Overall Study|Physician/Sponsor Decision|0|||
161288879|NCT03428958|582438243|FG014|Overall Study|Physician/Sponsor Decision|0|||
161288880|NCT03428958|582438244|FG015|Overall Study|Physician/Sponsor Decision|0|||
161288881|NCT03428958|582438245|FG016|Overall Study|Physician/Sponsor Decision|0|||
161288882|NCT03428958|582438229|FG000|Overall Study|Withdrawal by Subject|0|||
161288883|NCT03428958|582438230|FG001|Overall Study|Withdrawal by Subject|0|||
161288884|NCT03428958|582438231|FG002|Overall Study|Withdrawal by Subject|2|||
161288885|NCT03428958|582438232|FG003|Overall Study|Withdrawal by Subject|0|||
161288886|NCT03428958|582438233|FG004|Overall Study|Withdrawal by Subject|0|||
161288887|NCT03428958|582438234|FG005|Overall Study|Withdrawal by Subject|2|||
161288888|NCT03428958|582438235|FG006|Overall Study|Withdrawal by Subject|4|||
161288889|NCT03428958|582438236|FG007|Overall Study|Withdrawal by Subject|1|||
161288890|NCT03428958|582438237|FG008|Overall Study|Withdrawal by Subject|0|||
161288891|NCT03428958|582438238|FG009|Overall Study|Withdrawal by Subject|0|||
161288892|NCT03428958|582438239|FG010|Overall Study|Withdrawal by Subject|0|||
161288893|NCT03428958|582438240|FG011|Overall Study|Withdrawal by Subject|0|||
161288894|NCT03428958|582438241|FG012|Overall Study|Withdrawal by Subject|0|||
161288895|NCT03428958|582438242|FG013|Overall Study|Withdrawal by Subject|0|||
161288896|NCT03428958|582438243|FG014|Overall Study|Withdrawal by Subject|0|||
161288897|NCT03428958|582438244|FG015|Overall Study|Withdrawal by Subject|0|||
161288898|NCT03428958|582438245|FG016|Overall Study|Withdrawal by Subject|0|||
161288899|NCT03874117|582438246|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
161288900|NCT03874117|582438247|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
161288901|NCT03874117|582438246|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
161288902|NCT03874117|582438247|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
161288903|NCT03874117|582438246|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161288904|NCT03874117|582438247|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161288905|NCT03874117|582438246|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
161288906|NCT03874117|582438247|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
161288907|NCT03874117|582438246|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161288908|NCT03874117|582438247|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161288909|NCT05012098|582438248|FG000|Overall Study|Disease progression|5|||
161288910|NCT05012098|582438249|FG001|Overall Study|Disease progression|2|||
161288911|NCT05012098|582438248|FG000|Overall Study|Adverse Event|1|||
161288912|NCT05012098|582438249|FG001|Overall Study|Adverse Event|0|||
161288913|NCT05012098|582438248|FG000|Overall Study|Withdrawal by Subject|1|||
161288914|NCT05012098|582438249|FG001|Overall Study|Withdrawal by Subject|0|||
161288915|NCT05012098|582438248|FG000|Overall Study|Discontinuation per protocol|1|||
161288916|NCT05012098|582438249|FG001|Overall Study|Discontinuation per protocol|0|||
161288917|NCT01749826|582438253|FG000|Overall Study|Study Terminated|20|||
161288918|NCT01749826|582438254|FG001|Overall Study|Study Terminated|0|||
161288919|NCT05085834|582438255|FG000|Overall Study|Lost to Follow-up|9|||
161164010|NCT05168813|581977814|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
161288920|NCT05085834|582438256|FG001|Overall Study|Lost to Follow-up|2|||
161164011|NCT05168813|581977815|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
161164012|NCT05168813|581977816|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
161164013|NCT05168813|581977811|FG000|Part A (Open-label)|Other|0|||
161164014|NCT05168813|581977812|FG001|Part A (Open-label)|Other|1|||
161288921|NCT05085834|582438255|FG000|Overall Study|Adverse Event|6|||
161288922|NCT05085834|582438256|FG001|Overall Study|Adverse Event|0|||
161288923|NCT05085834|582438255|FG000|Overall Study|Death|1|||
161288924|NCT05085834|582438256|FG001|Overall Study|Death|0|||
161288925|NCT05085834|582438255|FG000|Overall Study|Inability to swallow the pill|0|||
161288926|NCT05085834|582438256|FG001|Overall Study|Inability to swallow the pill|1|||
161288927|NCT04565145|582438261|FG000|Overall Study|Withdrawal by Subject|1|||
161288928|NCT04565145|582438262|FG001|Overall Study|Withdrawal by Subject|1|||
161288929|NCT00742209|582438275|FG000|Overall Study|Adverse Event|11|||
161288930|NCT00742209|582438276|FG001|Overall Study|Adverse Event|4|||
161288931|NCT00742209|582438277|FG002|Overall Study|Adverse Event|17|||
161288932|NCT00742209|582438278|FG003|Overall Study|Adverse Event|16|||
161288933|NCT00742209|582438279|FG004|Overall Study|Adverse Event|13|||
161288934|NCT00742209|582438275|FG000|Overall Study|Participant Withdrew Consent|8|||
161288935|NCT00742209|582438276|FG001|Overall Study|Participant Withdrew Consent|4|||
161288936|NCT00742209|582438277|FG002|Overall Study|Participant Withdrew Consent|14|||
161288937|NCT00742209|582438278|FG003|Overall Study|Participant Withdrew Consent|7|||
161288938|NCT00742209|582438279|FG004|Overall Study|Participant Withdrew Consent|4|||
161288939|NCT00742209|582438275|FG000|Overall Study|Protocol Violation|6|||
161288940|NCT00742209|582438276|FG001|Overall Study|Protocol Violation|5|||
161288941|NCT00742209|582438277|FG002|Overall Study|Protocol Violation|4|||
161288942|NCT00742209|582438278|FG003|Overall Study|Protocol Violation|5|||
161288943|NCT00742209|582438279|FG004|Overall Study|Protocol Violation|3|||
161288944|NCT00742209|582438275|FG000|Overall Study|Lost to Follow-up|3|||
161288945|NCT00742209|582438276|FG001|Overall Study|Lost to Follow-up|4|||
161288946|NCT00742209|582438277|FG002|Overall Study|Lost to Follow-up|5|||
161288947|NCT00742209|582438278|FG003|Overall Study|Lost to Follow-up|5|||
161288948|NCT00742209|582438279|FG004|Overall Study|Lost to Follow-up|3|||
161288949|NCT00742209|582438275|FG000|Overall Study|Lack of Efficacy|6|||
161288950|NCT00742209|582438276|FG001|Overall Study|Lack of Efficacy|1|||
161288951|NCT00742209|582438277|FG002|Overall Study|Lack of Efficacy|1|||
161288952|NCT00742209|582438278|FG003|Overall Study|Lack of Efficacy|3|||
161288953|NCT00742209|582438279|FG004|Overall Study|Lack of Efficacy|1|||
161288954|NCT00742209|582438275|FG000|Overall Study|Investigator Discretion|0|||
161288955|NCT00742209|582438276|FG001|Overall Study|Investigator Discretion|0|||
161288956|NCT00742209|582438277|FG002|Overall Study|Investigator Discretion|5|||
161288957|NCT00742209|582438278|FG003|Overall Study|Investigator Discretion|1|||
161288958|NCT00742209|582438279|FG004|Overall Study|Investigator Discretion|1|||
161288959|NCT02003209|582438280|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
161288960|NCT02003209|582438281|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
161288961|NCT00485264|582438284|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
161288962|NCT00485264|582438285|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
161288963|NCT00485264|582438286|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
161288964|NCT00485264|582438287|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
161288965|NCT00485264|582438288|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
161288966|NCT00485264|582438289|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
161288967|NCT00485264|582438284|FG000|Overall Study|Death|1|||
161288968|NCT00485264|582438285|FG001|Overall Study|Death|0|||
161288969|NCT00485264|582438286|FG002|Overall Study|Death|0|||
161288970|NCT00485264|582438287|FG003|Overall Study|Death|0|||
161288971|NCT00485264|582438288|FG004|Overall Study|Death|1|||
161288972|NCT00485264|582438289|FG005|Overall Study|Death|0|||
161288973|NCT00485264|582438284|FG000|Overall Study|Adverse Event|1|||
161288974|NCT00485264|582438285|FG001|Overall Study|Adverse Event|0|||
161288975|NCT00485264|582438286|FG002|Overall Study|Adverse Event|2|||
161288976|NCT00485264|582438287|FG003|Overall Study|Adverse Event|3|||
161288977|NCT00485264|582438288|FG004|Overall Study|Adverse Event|1|||
161288978|NCT00485264|582438289|FG005|Overall Study|Adverse Event|3|||
161288979|NCT00485264|582438284|FG000|Overall Study|Pregnancy|4|||
161288980|NCT00485264|582438285|FG001|Overall Study|Pregnancy|0|||
161288981|NCT00485264|582438286|FG002|Overall Study|Pregnancy|0|||
161288982|NCT00485264|582438287|FG003|Overall Study|Pregnancy|0|||
161288983|NCT00485264|582438288|FG004|Overall Study|Pregnancy|0|||
161288984|NCT00485264|582438289|FG005|Overall Study|Pregnancy|0|||
161288985|NCT00485264|582438284|FG000|Overall Study|Disallowed Medication|0|||
161288986|NCT00485264|582438285|FG001|Overall Study|Disallowed Medication|0|||
161288987|NCT00485264|582438286|FG002|Overall Study|Disallowed Medication|0|||
161288988|NCT00485264|582438287|FG003|Overall Study|Disallowed Medication|0|||
161288989|NCT00485264|582438288|FG004|Overall Study|Disallowed Medication|0|||
161288990|NCT00485264|582438289|FG005|Overall Study|Disallowed Medication|1|||
161288991|NCT00485264|582438284|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
161288992|NCT00485264|582438285|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
161288993|NCT00485264|582438286|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
161288994|NCT00485264|582438287|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
161288995|NCT00485264|582438288|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
161288996|NCT00485264|582438289|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
161288997|NCT00485264|582438284|FG000|Overall Study|Lack of Efficacy|0|||
161288998|NCT00485264|582438285|FG001|Overall Study|Lack of Efficacy|1|||
161288999|NCT00485264|582438286|FG002|Overall Study|Lack of Efficacy|0|||
161289000|NCT00485264|582438287|FG003|Overall Study|Lack of Efficacy|0|||
161289001|NCT00485264|582438288|FG004|Overall Study|Lack of Efficacy|0|||
161289002|NCT00485264|582438289|FG005|Overall Study|Lack of Efficacy|0|||
161289003|NCT00485264|582438284|FG000|Overall Study|Guardian Consent Withdrawn|1|||
161289004|NCT00485264|582438285|FG001|Overall Study|Guardian Consent Withdrawn|0|||
161346642|NCT00984399|582653330|FG001|Overall Study|Withdrawal by Subject|1|||
161346643|NCT00984399|582653329|FG000|Overall Study|Protocol Violation|0|||
161346644|NCT00984399|582653330|FG001|Overall Study|Protocol Violation|1|||
161346645|NCT00984399|582653329|FG000|Overall Study|Pts did not start treatment|2|||
161346646|NCT00984399|582653330|FG001|Overall Study|Pts did not start treatment|2|||
161346647|NCT05248386|582653332|FG000|Overall Study|Technical problems|0|||
161346648|NCT05248386|582653333|FG001|Overall Study|Technical problems|1|||
161346649|NCT05248386|582653332|FG000|Overall Study|Withdrawal by Subject|15|||
161346650|NCT05248386|582653333|FG001|Overall Study|Withdrawal by Subject|10|||
161346651|NCT05248386|582653332|FG000|Overall Study|Physician Decision|0|||
161346652|NCT05248386|582653333|FG001|Overall Study|Physician Decision|1|||
161346653|NCT05248386|582653332|FG000|Overall Study|Adverse Event|2|||
161346654|NCT05248386|582653333|FG001|Overall Study|Adverse Event|4|||
161346655|NCT05248386|582653332|FG000|Overall Study|Other|1|||
161346656|NCT05248386|582653333|FG001|Overall Study|Other|0|||
161346657|NCT05248386|582653332|FG000|Overall Study|Lack of Efficacy|14|||
161346658|NCT05248386|582653333|FG001|Overall Study|Lack of Efficacy|12|||
161346659|NCT01910441|582653334|FG000|Overall Study|Sponsor decision|0|||
161079731|NCT02108964|581680536|FG005|Overall Study|Death|0|||
161079732|NCT02108964|581680537|FG006|Overall Study|Death|0|||
161079733|NCT02108964|581680538|FG007|Overall Study|Death|2|||
161079734|NCT02108964|581680531|FG000|Overall Study|Subject/Guardian decision|0|||
161079735|NCT02108964|581680532|FG001|Overall Study|Subject/Guardian decision|1|||
161079736|NCT02108964|581680533|FG002|Overall Study|Subject/Guardian decision|4|||
161079737|NCT02108964|581680534|FG003|Overall Study|Subject/Guardian decision|0|||
161079738|NCT02108964|581680535|FG004|Overall Study|Subject/Guardian decision|2|||
161079739|NCT02108964|581680536|FG005|Overall Study|Subject/Guardian decision|0|||
161079740|NCT02108964|581680537|FG006|Overall Study|Subject/Guardian decision|1|||
161079741|NCT02108964|581680538|FG007|Overall Study|Subject/Guardian decision|2|||
161079742|NCT02108964|581680531|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079743|NCT02108964|581680532|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079744|NCT02108964|581680533|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079745|NCT02108964|581680534|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079746|NCT02108964|581680535|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079747|NCT02108964|581680536|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079748|NCT02108964|581680537|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
161079749|NCT02108964|581680538|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
161079750|NCT02336451|581680541|FG000|Overall Study|Adverse Event|1|||
161079751|NCT02336451|581680542|FG001|Overall Study|Adverse Event|2|||
161079752|NCT02336451|581680543|FG002|Overall Study|Adverse Event|0|||
161079753|NCT02336451|581680544|FG003|Overall Study|Adverse Event|6|||
161079754|NCT02336451|581680545|FG004|Overall Study|Adverse Event|4|||
161079755|NCT02336451|581680541|FG000|Overall Study|Death|6|||
161079756|NCT02336451|581680542|FG001|Overall Study|Death|2|||
161079757|NCT02336451|581680543|FG002|Overall Study|Death|3|||
161079758|NCT02336451|581680544|FG003|Overall Study|Death|6|||
161079759|NCT02336451|581680545|FG004|Overall Study|Death|6|||
161079760|NCT02336451|581680541|FG000|Overall Study|Physician Decision|9|||
161079761|NCT02336451|581680542|FG001|Overall Study|Physician Decision|6|||
161079762|NCT02336451|581680543|FG002|Overall Study|Physician Decision|7|||
161079763|NCT02336451|581680544|FG003|Overall Study|Physician Decision|16|||
161079764|NCT02336451|581680545|FG004|Overall Study|Physician Decision|3|||
161079765|NCT02336451|581680541|FG000|Overall Study|Progressive disease|23|||
161079766|NCT02336451|581680542|FG001|Overall Study|Progressive disease|26|||
161079767|NCT02336451|581680543|FG002|Overall Study|Progressive disease|2|||
161079768|NCT02336451|581680544|FG003|Overall Study|Progressive disease|14|||
161079769|NCT02336451|581680545|FG004|Overall Study|Progressive disease|4|||
161079770|NCT02336451|581680541|FG000|Overall Study|Protocol Violation|1|||
161079771|NCT02336451|581680542|FG001|Overall Study|Protocol Violation|0|||
161079772|NCT02336451|581680543|FG002|Overall Study|Protocol Violation|0|||
161079773|NCT02336451|581680544|FG003|Overall Study|Protocol Violation|0|||
161079774|NCT02336451|581680545|FG004|Overall Study|Protocol Violation|0|||
161079775|NCT02336451|581680541|FG000|Overall Study|Patient/guardian decision|2|||
161079776|NCT02336451|581680542|FG001|Overall Study|Patient/guardian decision|4|||
161079777|NCT02336451|581680543|FG002|Overall Study|Patient/guardian decision|0|||
161079778|NCT02336451|581680544|FG003|Overall Study|Patient/guardian decision|2|||
161079779|NCT02336451|581680545|FG004|Overall Study|Patient/guardian decision|1|||
161079780|NCT06655558|581680548|FG000|Overall Study|Protocol Violation|1|||
161079781|NCT04998812|581680555|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
161079782|NCT04998812|581680556|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
161079783|NCT04998812|581680555|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
161346660|NCT01910441|582653335|FG001|Overall Study|Sponsor decision|2|||
161346661|NCT01910441|582653334|FG000|Overall Study|Lost to Follow-up|6|||
161079784|NCT04998812|581680556|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
161079785|NCT04998812|581680555|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
161079786|NCT04998812|581680556|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
161079787|NCT04998812|581680555|FG000|Vaccination Period|Ongoing in study|23|||
161079788|NCT04998812|581680556|FG001|Vaccination Period|Ongoing in study|23|||
161079789|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
161079790|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
161079791|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
161079792|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
161079793|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
161079794|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
161079795|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
161079796|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
161079797|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
161079798|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
161079799|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
161079800|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
161079801|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161079802|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
161079803|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161079804|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161079805|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161079806|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
161079807|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161079808|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
161079809|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161079810|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161079811|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161079812|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
161079813|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161079814|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161079815|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
161079816|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161079817|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161079818|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
161079819|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161079820|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
161079821|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
161079822|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161079823|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161079824|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
161079825|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
161079826|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
161079827|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
161079828|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
161079829|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
161079830|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
161079831|NCT03524092|581680562|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
161079832|NCT03524092|581680563|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
161079833|NCT03524092|581680564|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
161079834|NCT03524092|581680565|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
161079835|NCT03524092|581680566|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
161079836|NCT03524092|581680567|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
161079837|NCT03524092|581680562|FG000|Loss of Response Rescue Period|Adverse Event|0|||
161079838|NCT03524092|581680563|FG001|Loss of Response Rescue Period|Adverse Event|0|||
161079839|NCT03524092|581680564|FG002|Loss of Response Rescue Period|Adverse Event|0|||
161079840|NCT03524092|581680565|FG003|Loss of Response Rescue Period|Adverse Event|2|||
161079841|NCT03524092|581680566|FG004|Loss of Response Rescue Period|Adverse Event|0|||
161079842|NCT03524092|581680567|FG005|Loss of Response Rescue Period|Adverse Event|0|||
161079843|NCT03524092|581680562|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
161079844|NCT03524092|581680563|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
161079845|NCT03524092|581680564|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
161079846|NCT03524092|581680565|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
161079847|NCT03524092|581680566|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
161079848|NCT03524092|581680567|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
161079849|NCT03524092|581680562|FG000|Loss of Response Rescue Period|Pregnancy|0|||
161079850|NCT03524092|581680563|FG001|Loss of Response Rescue Period|Pregnancy|0|||
161079851|NCT03524092|581680564|FG002|Loss of Response Rescue Period|Pregnancy|0|||
161079852|NCT03524092|581680565|FG003|Loss of Response Rescue Period|Pregnancy|1|||
161079853|NCT03524092|581680566|FG004|Loss of Response Rescue Period|Pregnancy|0|||
161079854|NCT03524092|581680567|FG005|Loss of Response Rescue Period|Pregnancy|0|||
161079855|NCT03524092|581680562|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161079856|NCT03524092|581680563|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161079857|NCT03524092|581680564|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161079858|NCT03524092|581680565|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
161079859|NCT03524092|581680566|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161079860|NCT03524092|581680567|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
161079861|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161079862|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161079863|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161079864|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161079865|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
161079866|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
161079867|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161079868|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161079869|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161079870|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161079871|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
161079872|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
161079873|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161079874|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161079875|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161079876|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161079877|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
161079878|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
161079879|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161079880|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161079881|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161079882|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161079883|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
161079884|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
161079885|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161079886|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161079887|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161079888|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161079889|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
161079890|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
161079891|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161079892|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161079893|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161079894|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161079895|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
161079896|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
161079897|NCT03524092|581680562|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161079898|NCT03524092|581680563|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161079899|NCT03524092|581680564|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161079900|NCT03524092|581680565|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161079901|NCT03524092|581680566|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
161079902|NCT03524092|581680567|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
161079903|NCT03524092|581680562|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161079904|NCT03524092|581680563|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161079905|NCT03524092|581680564|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161079906|NCT03524092|581680565|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161079907|NCT03524092|581680566|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
161079908|NCT03524092|581680567|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
161079909|NCT03524092|581680562|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161346662|NCT01910441|582653335|FG001|Overall Study|Lost to Follow-up|5|||
161346663|NCT01910441|582653334|FG000|Overall Study|Withdrawal by Subject|0|||
161346664|NCT01910441|582653335|FG001|Overall Study|Withdrawal by Subject|1|||
161079910|NCT03524092|581680563|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161079911|NCT03524092|581680564|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161079912|NCT03524092|581680565|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161079913|NCT03524092|581680566|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
161079914|NCT03524092|581680567|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
161079915|NCT03524092|581680562|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161079916|NCT03524092|581680563|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161079917|NCT03524092|581680564|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161079918|NCT03524092|581680565|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161079919|NCT03524092|581680566|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
161079920|NCT03524092|581680567|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
161079921|NCT03524092|581680562|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161079922|NCT03524092|581680563|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161079923|NCT03524092|581680564|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161079924|NCT03524092|581680565|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161079925|NCT03524092|581680566|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
161079926|NCT03524092|581680567|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
161079927|NCT04303780|581680568|FG000|Overall Study|Death|104|||
161079928|NCT04303780|581680569|FG001|Overall Study|Death|85|||
161079929|NCT04303780|581680568|FG000|Overall Study|Lost to Follow-up|5|||
161079930|NCT04303780|581680569|FG001|Overall Study|Lost to Follow-up|2|||
161079931|NCT04303780|581680568|FG000|Overall Study|Withdrawal by Subject|12|||
161079932|NCT04303780|581680569|FG001|Overall Study|Withdrawal by Subject|39|||
161079933|NCT04303780|581680568|FG000|Overall Study|Ongoing in study|50|||
161079934|NCT04303780|581680569|FG001|Overall Study|Ongoing in study|45|||
161079935|NCT03826030|581680570|FG000|Overall Study|Withdrawal by Subject|2|||
161079936|NCT03826030|581680571|FG001|Overall Study|Withdrawal by Subject|0|||
161079937|NCT03826030|581680572|FG002|Overall Study|Withdrawal by Subject|1|||
161079938|NCT03826030|581680570|FG000|Overall Study|Lost to Follow-up|1|||
161079939|NCT03826030|581680571|FG001|Overall Study|Lost to Follow-up|1|||
161079940|NCT03826030|581680572|FG002|Overall Study|Lost to Follow-up|1|||
161079941|NCT03826030|581680570|FG000|Overall Study|Too busy to return for visits|1|||
161079942|NCT03826030|581680571|FG001|Overall Study|Too busy to return for visits|0|||
161079943|NCT03826030|581680572|FG002|Overall Study|Too busy to return for visits|0|||
161079944|NCT04893460|581680573|FG000|Overall Study|Lost to Follow-up|18|||
161079945|NCT01099215|581682259|FG000|Overall Study|Withdrawal by Subject|1|||
161079946|NCT01099215|581682260|FG001|Overall Study|Withdrawal by Subject|0|||
161079947|NCT01099215|581682259|FG000|Overall Study|Adverse Event|0|||
161079948|NCT01099215|581682260|FG001|Overall Study|Adverse Event|1|||
161079949|NCT03333876|581682263|FG000|Screening Period|Screen Failure|4|||
161079950|NCT03333876|581682263|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
161079951|NCT03333876|581682263|FG000|Mandibular Advancement|Adverse Event|2|||
161079952|NCT03333876|581682263|FG000|Mandibular Advancement|Product Damage|2|||
161079953|NCT00095498|581682267|FG000|Overall Study|Physician Decision|9|||
161079954|NCT00095498|581682268|FG001|Overall Study|Physician Decision|10|||
161079955|NCT00095498|581682269|FG002|Overall Study|Physician Decision|8|||
161079956|NCT00095498|581682267|FG000|Overall Study|Adverse Event|1|||
161079957|NCT00095498|581682268|FG001|Overall Study|Adverse Event|0|||
161079958|NCT00095498|581682269|FG002|Overall Study|Adverse Event|1|||
161079959|NCT00095498|581682267|FG000|Overall Study|Withdrawal by Subject|15|||
161079960|NCT00095498|581682268|FG001|Overall Study|Withdrawal by Subject|16|||
161079961|NCT00095498|581682269|FG002|Overall Study|Withdrawal by Subject|15|||
161079962|NCT00095498|581682267|FG000|Overall Study|Disease progression|0|||
161079963|NCT00095498|581682268|FG001|Overall Study|Disease progression|1|||
161079964|NCT00095498|581682269|FG002|Overall Study|Disease progression|1|||
161079965|NCT00095498|581682267|FG000|Overall Study|Ineligibility determined|3|||
161079966|NCT00095498|581682268|FG001|Overall Study|Ineligibility determined|0|||
161079967|NCT00095498|581682269|FG002|Overall Study|Ineligibility determined|2|||
161079968|NCT00095498|581682267|FG000|Overall Study|Lost to Follow-up|1|||
161079969|NCT00095498|581682268|FG001|Overall Study|Lost to Follow-up|1|||
161079970|NCT00095498|581682269|FG002|Overall Study|Lost to Follow-up|2|||
161079971|NCT00095498|581682267|FG000|Overall Study|Noncompliance|1|||
161079972|NCT00095498|581682268|FG001|Overall Study|Noncompliance|0|||
161079973|NCT00095498|581682269|FG002|Overall Study|Noncompliance|1|||
161079974|NCT00095498|581682267|FG000|Overall Study|Other|6|||
161079975|NCT00095498|581682268|FG001|Overall Study|Other|7|||
161079976|NCT00095498|581682269|FG002|Overall Study|Other|6|||
161079977|NCT00095498|581682267|FG000|Overall Study|Protocol Violation|0|||
161079978|NCT00095498|581682268|FG001|Overall Study|Protocol Violation|0|||
161079979|NCT00095498|581682269|FG002|Overall Study|Protocol Violation|1|||
161079980|NCT00095498|581682267|FG000|Overall Study|Requirement for alternative therapy|1|||
161079981|NCT00095498|581682268|FG001|Overall Study|Requirement for alternative therapy|0|||
161079982|NCT00095498|581682269|FG002|Overall Study|Requirement for alternative therapy|2|||
161079983|NCT05020327|581682271|FG000|Overall Study|Physician Decision|3|||
161289005|NCT00485264|582438286|FG002|Overall Study|Guardian Consent Withdrawn|0|||
161289006|NCT00485264|582438287|FG003|Overall Study|Guardian Consent Withdrawn|0|||
161289007|NCT00485264|582438288|FG004|Overall Study|Guardian Consent Withdrawn|1|||
161289008|NCT00485264|582438289|FG005|Overall Study|Guardian Consent Withdrawn|0|||
161289009|NCT00485264|582438284|FG000|Overall Study|Physician Decision|0|||
161289010|NCT00485264|582438285|FG001|Overall Study|Physician Decision|2|||
161289011|NCT00485264|582438286|FG002|Overall Study|Physician Decision|0|||
161289012|NCT00485264|582438287|FG003|Overall Study|Physician Decision|0|||
161289013|NCT00485264|582438288|FG004|Overall Study|Physician Decision|0|||
161289014|NCT00485264|582438289|FG005|Overall Study|Physician Decision|0|||
161289015|NCT00485264|582438284|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161289016|NCT00485264|582438285|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161289017|NCT00485264|582438286|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
161289018|NCT00485264|582438287|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161289019|NCT00485264|582438288|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161289020|NCT00485264|582438289|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
161289021|NCT00485264|582438284|FG000|Overall Study|Not Able to Attend Clinic|5|||
161289022|NCT00485264|582438285|FG001|Overall Study|Not Able to Attend Clinic|0|||
161289023|NCT00485264|582438286|FG002|Overall Study|Not Able to Attend Clinic|0|||
161289024|NCT00485264|582438287|FG003|Overall Study|Not Able to Attend Clinic|1|||
161289025|NCT00485264|582438288|FG004|Overall Study|Not Able to Attend Clinic|1|||
161289026|NCT00485264|582438289|FG005|Overall Study|Not Able to Attend Clinic|2|||
161289027|NCT00485264|582438284|FG000|Overall Study|Non-Compliant|17|||
161289028|NCT00485264|582438285|FG001|Overall Study|Non-Compliant|2|||
161289029|NCT00485264|582438286|FG002|Overall Study|Non-Compliant|1|||
161289030|NCT00485264|582438287|FG003|Overall Study|Non-Compliant|0|||
161289031|NCT00485264|582438288|FG004|Overall Study|Non-Compliant|1|||
161289032|NCT00485264|582438289|FG005|Overall Study|Non-Compliant|0|||
161289033|NCT00485264|582438284|FG000|Overall Study|Lost to Follow-up|2|||
161289034|NCT00485264|582438285|FG001|Overall Study|Lost to Follow-up|1|||
161289035|NCT00485264|582438286|FG002|Overall Study|Lost to Follow-up|1|||
161289036|NCT00485264|582438287|FG003|Overall Study|Lost to Follow-up|0|||
161289037|NCT00485264|582438288|FG004|Overall Study|Lost to Follow-up|0|||
161289038|NCT00485264|582438289|FG005|Overall Study|Lost to Follow-up|1|||
161289039|NCT00485264|582438284|FG000|Overall Study|Other Reason|3|||
161289040|NCT00485264|582438285|FG001|Overall Study|Other Reason|0|||
161289041|NCT00485264|582438286|FG002|Overall Study|Other Reason|0|||
161289042|NCT00485264|582438287|FG003|Overall Study|Other Reason|0|||
161289043|NCT00485264|582438288|FG004|Overall Study|Other Reason|0|||
161289044|NCT00485264|582438289|FG005|Overall Study|Other Reason|0|||
161289045|NCT01514461|582438290|FG000|Overall Study|Adverse Event|2|||
161289046|NCT01514461|582438291|FG001|Overall Study|Adverse Event|1|||
161289047|NCT01514461|582438292|FG002|Overall Study|Adverse Event|3|||
161289048|NCT01514461|582438290|FG000|Overall Study|Physician Decision|1|||
161289049|NCT01514461|582438291|FG001|Overall Study|Physician Decision|1|||
161289050|NCT01514461|582438292|FG002|Overall Study|Physician Decision|0|||
161289051|NCT01514461|582438290|FG000|Overall Study|Patient/guardian decision|1|||
161289052|NCT01514461|582438291|FG001|Overall Study|Patient/guardian decision|1|||
161289053|NCT01514461|582438292|FG002|Overall Study|Patient/guardian decision|1|||
161289054|NCT01514461|582438290|FG000|Overall Study|Death|1|||
161289055|NCT01514461|582438291|FG001|Overall Study|Death|0|||
161289056|NCT01514461|582438292|FG002|Overall Study|Death|0|||
161289057|NCT02548832|582438293|FG000|Overall Study|Lost to Follow-up|2|||
161289058|NCT02548832|582438294|FG001|Overall Study|Lost to Follow-up|2|||
161289059|NCT02548832|582438295|FG002|Overall Study|Lost to Follow-up|2|||
161289060|NCT03817125|582438303|FG000|Overall Study|Adverse Event|1|||
161289061|NCT03817125|582438304|FG001|Overall Study|Adverse Event|0|||
161289062|NCT03817125|582438303|FG000|Overall Study|Physician Decision|0|||
161289063|NCT03817125|582438304|FG001|Overall Study|Physician Decision|1|||
161289064|NCT03817125|582438303|FG000|Overall Study|Lack of Efficacy|1|||
161289065|NCT03817125|582438304|FG001|Overall Study|Lack of Efficacy|5|||
161289066|NCT00942084|582438305|FG000|Overall Study|Death|2|||
161289067|NCT01062425|582438306|FG000|Overall Study|Protocol Violation|3|||
161289068|NCT01062425|582438307|FG001|Overall Study|Protocol Violation|6|||
161289069|NCT05366010|582438308|FG000|Overall Study|Withdrawal by Subject|1|||
161289070|NCT05366010|582438308|FG000|Overall Study|Protocol Violation|1|||
161289071|NCT05366010|582438308|FG000|Overall Study|Lost to Follow-up|2|||
161079984|NCT05020327|581682272|FG001|Overall Study|Physician Decision|0|||
161079985|NCT05020327|581682273|FG002|Overall Study|Physician Decision|0|||
161079986|NCT05020327|581682271|FG000|Overall Study|Withdrawal by Subject|1|||
161079987|NCT05020327|581682272|FG001|Overall Study|Withdrawal by Subject|1|||
161079988|NCT05020327|581682273|FG002|Overall Study|Withdrawal by Subject|0|||
161079989|NCT05020327|581682271|FG000|Overall Study|personal/cultural, ineligible|12|||
161079990|NCT05020327|581682272|FG001|Overall Study|personal/cultural, ineligible|0|||
161289072|NCT05366010|582438308|FG000|Overall Study|Screen Failure|2|||
161289073|NCT02857816|582438311|FG000|Overall Study|Screen Failure|33|||
161289074|NCT02857816|582438311|FG000|Overall Study|Withdrawal by Subject|4|||
161079991|NCT05020327|581682273|FG002|Overall Study|personal/cultural, ineligible|0|||
161289075|NCT02857816|582438311|FG000|Overall Study|Lost to Follow-up|1|||
161079992|NCT03002220|581682275|FG000|Overall Study|Lack of Efficacy|2|||
161079993|NCT03002220|581682275|FG000|Overall Study|Withdrawal by Subject|3|||
161079994|NCT03002220|581682275|FG000|Overall Study|Adverse Event|2|||
161079995|NCT03002220|581682275|FG000|Overall Study|Disease progression|13|||
161079996|NCT03002220|581682275|FG000|Overall Study|Physician Decision|1|||
161079997|NCT01015560|581682278|FG000|Overall Study|Adverse Event|1|||
161289076|NCT01949662|582438312|FG000|Overall Study|Death|9|||
161079998|NCT01015560|581682278|FG000|Overall Study|Not protocol specified|1|||
161079999|NCT01015560|581682278|FG000|Overall Study|Withdrawal by Subject|1|||
161080000|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
161080001|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
161080002|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
161080003|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
161080004|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
161080005|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
161080006|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
161080007|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161080008|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161289077|NCT01949662|582438313|FG001|Overall Study|Death|7|||
161289078|NCT01949662|582438312|FG000|Overall Study|Discharged before an agitation event|8|||
161289079|NCT01949662|582438313|FG001|Overall Study|Discharged before an agitation event|3|||
161289080|NCT01949662|582438312|FG000|Overall Study|Dropped out|1|||
161289081|NCT01949662|582438313|FG001|Overall Study|Dropped out|3|||
161289082|NCT01949662|582438312|FG000|Overall Study|Ineligible|0|||
161080009|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161080010|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161080011|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
161080012|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Death|1|||
161080013|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Death|2|||
161080014|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Death|2|||
161080015|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Death|0|||
161080016|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Death|0|||
161080017|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Death|0|||
161080018|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161080019|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
161080020|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
161080021|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161080022|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161080023|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
161080024|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
161080025|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161080026|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161080027|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161080028|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161080029|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
161080030|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
161080031|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161080032|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161080033|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161080034|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161080035|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
161080036|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
161080037|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161080038|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161080039|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161080040|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161080041|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
161080042|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161080043|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
161080044|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161080045|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161080046|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161080047|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
161289083|NCT01949662|582438313|FG001|Overall Study|Ineligible|1|||
161346665|NCT01910441|582653334|FG000|Overall Study|Non-compliance|0|||
161346666|NCT01910441|582653335|FG001|Overall Study|Non-compliance|1|||
161346667|NCT01910441|582653334|FG000|Overall Study|Adverse Event|1|||
161346668|NCT01910441|582653335|FG001|Overall Study|Adverse Event|0|||
161346669|NCT01910441|582653334|FG000|Overall Study|Physician Decision|0|||
161346670|NCT01910441|582653335|FG001|Overall Study|Physician Decision|1|||
161346671|NCT02964182|582653336|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161346672|NCT02964182|582653337|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
161346673|NCT02964182|582653338|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161346674|NCT02964182|582653339|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161346675|NCT02964182|582653340|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161346676|NCT02964182|582653341|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
161346677|NCT02964182|582653342|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161346678|NCT02964182|582653343|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
161346679|NCT02964182|582653336|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346680|NCT02964182|582653337|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346681|NCT02964182|582653338|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346682|NCT02964182|582653339|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346683|NCT02964182|582653340|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346684|NCT02964182|582653341|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
161346685|NCT02964182|582653342|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346686|NCT02964182|582653343|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
161346687|NCT02964182|582653336|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161346688|NCT02964182|582653337|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
161346689|NCT02964182|582653338|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161346690|NCT02964182|582653339|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161346691|NCT02964182|582653340|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161346692|NCT02964182|582653341|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
161346693|NCT02964182|582653342|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161346694|NCT02964182|582653343|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
161346695|NCT02964182|582653336|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161346696|NCT02964182|582653337|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161346697|NCT02964182|582653338|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
161346698|NCT02964182|582653339|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
161346699|NCT02964182|582653340|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161346700|NCT02964182|582653341|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161346701|NCT02964182|582653342|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
161346702|NCT02964182|582653343|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
161346703|NCT02964182|582653336|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161346704|NCT02964182|582653337|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161346705|NCT02964182|582653338|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
161346706|NCT02964182|582653339|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
161346707|NCT02964182|582653340|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161346708|NCT02964182|582653341|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161346709|NCT02964182|582653342|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
161346710|NCT02964182|582653343|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
161346711|NCT02964182|582653336|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161346712|NCT02964182|582653337|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161346713|NCT02964182|582653338|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
161346714|NCT02964182|582653339|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
161346715|NCT02964182|582653340|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161346716|NCT02964182|582653341|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161346717|NCT02964182|582653342|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161346718|NCT02964182|582653343|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
161346719|NCT02964182|582653336|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161346720|NCT02964182|582653337|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161346721|NCT02964182|582653338|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
161346722|NCT02964182|582653339|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
161346723|NCT02964182|582653340|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161346724|NCT02964182|582653341|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161346725|NCT02964182|582653342|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
161346726|NCT02964182|582653343|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
161346727|NCT03636477|582653345|FG000|Overall Study|Adverse Event|0|||
161346728|NCT03636477|582653346|FG001|Overall Study|Adverse Event|0|||
161346729|NCT03636477|582653347|FG002|Overall Study|Adverse Event|1|||
161346730|NCT02382380|582653349|FG000|Overall Study|Withdrawal by Subject|2|||
161346731|NCT02382380|582653350|FG001|Overall Study|Withdrawal by Subject|2|||
161346732|NCT02382380|582653349|FG000|Overall Study|Lost to Follow-up|0|||
161346733|NCT02382380|582653350|FG001|Overall Study|Lost to Follow-up|1|||
161346734|NCT01295944|582653351|FG000|Overall Study|Switched to alternative treatment|1|||
161346735|NCT01295944|582653351|FG000|Overall Study|Ineligible|9|||
161346736|NCT01295944|582653351|FG000|Overall Study|Withdrawal by Subject|1|||
161346737|NCT01295944|582653351|FG000|Overall Study|Participant chose to be treated in Peru|1|||
161346738|NCT01295944|582653351|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
161164015|NCT05168813|581977813|FG002|Part A (Open-label)|Other|0|||
161080048|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
161080049|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
161080050|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
161080051|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
161080052|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
161080053|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
161080054|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161164016|NCT05168813|581977814|FG003|Part A (Open-label)|Other|0|||
161164017|NCT05168813|581977815|FG004|Part A (Open-label)|Other|0|||
161164018|NCT05168813|581977816|FG005|Part A (Open-label)|Other|0|||
161164019|NCT05168813|581977811|FG000|Part B (Blinded)|Lost to Follow-up|0|||
161164020|NCT05168813|581977812|FG001|Part B (Blinded)|Lost to Follow-up|0|||
161164021|NCT05168813|581977813|FG002|Part B (Blinded)|Lost to Follow-up|0|||
161164022|NCT05168813|581977814|FG003|Part B (Blinded)|Lost to Follow-up|0|||
161164023|NCT05168813|581977815|FG004|Part B (Blinded)|Lost to Follow-up|219|||
161164024|NCT05168813|581977816|FG005|Part B (Blinded)|Lost to Follow-up|88|||
161164025|NCT05168813|581977811|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
161164026|NCT05168813|581977812|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
161164027|NCT05168813|581977813|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
161164028|NCT05168813|581977814|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
161164029|NCT05168813|581977815|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
161164030|NCT05168813|581977816|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
161164031|NCT05168813|581977811|FG000|Part B (Blinded)|Death|0|||
161164032|NCT05168813|581977812|FG001|Part B (Blinded)|Death|0|||
161164033|NCT05168813|581977813|FG002|Part B (Blinded)|Death|0|||
161164034|NCT05168813|581977814|FG003|Part B (Blinded)|Death|0|||
161164035|NCT05168813|581977815|FG004|Part B (Blinded)|Death|63|||
161164036|NCT05168813|581977816|FG005|Part B (Blinded)|Death|19|||
161164037|NCT05168813|581977811|FG000|Part B (Blinded)|Physician Decision|0|||
161164038|NCT05168813|581977812|FG001|Part B (Blinded)|Physician Decision|0|||
161164039|NCT05168813|581977813|FG002|Part B (Blinded)|Physician Decision|0|||
161164040|NCT05168813|581977814|FG003|Part B (Blinded)|Physician Decision|0|||
161164041|NCT05168813|581977815|FG004|Part B (Blinded)|Physician Decision|6|||
161164042|NCT05168813|581977816|FG005|Part B (Blinded)|Physician Decision|1|||
161164043|NCT05168813|581977811|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161164044|NCT05168813|581977812|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161164045|NCT05168813|581977813|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161289084|NCT02291237|582438314|FG000|Overall Study|Study Terminated by Sponsor|72|||
161164046|NCT05168813|581977814|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
161164047|NCT05168813|581977815|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
161164048|NCT05168813|581977816|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
161164049|NCT05168813|581977811|FG000|Part B (Blinded)|Pregnancy|0|||
161164050|NCT05168813|581977812|FG001|Part B (Blinded)|Pregnancy|0|||
161164051|NCT05168813|581977813|FG002|Part B (Blinded)|Pregnancy|0|||
161164052|NCT05168813|581977814|FG003|Part B (Blinded)|Pregnancy|0|||
161164053|NCT05168813|581977815|FG004|Part B (Blinded)|Pregnancy|1|||
161164054|NCT05168813|581977816|FG005|Part B (Blinded)|Pregnancy|0|||
161164055|NCT05168813|581977811|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
161164056|NCT05168813|581977812|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
161164057|NCT05168813|581977813|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
161164058|NCT05168813|581977814|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
161164059|NCT05168813|581977815|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
161164060|NCT05168813|581977816|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
161164061|NCT05168813|581977811|FG000|Part B (Blinded)|Other|0|||
161164062|NCT05168813|581977812|FG001|Part B (Blinded)|Other|0|||
161164063|NCT05168813|581977813|FG002|Part B (Blinded)|Other|0|||
161164064|NCT05168813|581977814|FG003|Part B (Blinded)|Other|0|||
161164065|NCT05168813|581977815|FG004|Part B (Blinded)|Other|41|||
161164066|NCT05168813|581977816|FG005|Part B (Blinded)|Other|27|||
161164067|NCT01754922|581977818|FG000|Overall Study|Adverse Event|0|||
161164068|NCT01754922|581977819|FG001|Overall Study|Adverse Event|1|||
161289085|NCT02291237|582438315|FG001|Overall Study|Study Terminated by Sponsor|67|||
161289086|NCT02291237|582438314|FG000|Overall Study|Adverse Event|1|||
161289087|NCT02291237|582438315|FG001|Overall Study|Adverse Event|3|||
161289088|NCT02291237|582438314|FG000|Overall Study|Investigator's Discretion|0|||
161164069|NCT01207388|581977822|FG000|Overall Study|Death|67|||
161164070|NCT01207388|581977822|FG000|Overall Study|Withdrawal by Subject|1|||
161164071|NCT02680587|581977823|FG000|Overall Study|Withdrawal by Subject|1|||
161164072|NCT02680587|581977824|FG001|Overall Study|Withdrawal by Subject|0|||
161164073|NCT00571688|581977828|FG000|Overall Study|Lost to Follow-up|3|||
161164074|NCT00571688|581977829|FG001|Overall Study|Lost to Follow-up|6|||
161289089|NCT02291237|582438315|FG001|Overall Study|Investigator's Discretion|3|||
161289090|NCT02291237|582438314|FG000|Overall Study|Withdrew Consent|11|||
161289091|NCT02291237|582438315|FG001|Overall Study|Withdrew Consent|11|||
161289092|NCT02291237|582438314|FG000|Overall Study|Lost to Follow-up|0|||
161289093|NCT02291237|582438315|FG001|Overall Study|Lost to Follow-up|2|||
161164075|NCT00571688|581977828|FG000|Overall Study|subject did not tolerate Consta|1|||
161164076|NCT00571688|581977829|FG001|Overall Study|subject did not tolerate Consta|0|||
161164077|NCT00571688|581977828|FG000|Overall Study|subject moved out of the area|1|||
161164078|NCT00571688|581977829|FG001|Overall Study|subject moved out of the area|0|||
161164079|NCT00259740|581977830|FG000|Overall Study|Physician Decision|1|||
161164080|NCT00259740|581977831|FG001|Overall Study|Physician Decision|1|||
161164081|NCT00259740|581977830|FG000|Overall Study|Adverse Event|0|||
161164082|NCT00259740|581977831|FG001|Overall Study|Adverse Event|2|||
161164083|NCT00259740|581977830|FG000|Overall Study|Withdrawal by Subject|2|||
161164084|NCT00259740|581977831|FG001|Overall Study|Withdrawal by Subject|6|||
161164085|NCT00259740|581977830|FG000|Overall Study|Death|1|||
161164086|NCT00259740|581977831|FG001|Overall Study|Death|1|||
161164087|NCT00259740|581977830|FG000|Overall Study|Disease progression|19|||
161164088|NCT00259740|581977831|FG001|Overall Study|Disease progression|36|||
161164089|NCT00259740|581977830|FG000|Overall Study|Ongoing|17|||
161164090|NCT00259740|581977831|FG001|Overall Study|Ongoing|3|||
161164091|NCT00259740|581977830|FG000|Overall Study|Other|3|||
161164092|NCT00259740|581977831|FG001|Overall Study|Other|0|||
161164093|NCT00259740|581977830|FG000|Overall Study|Requirement for alternative therapy|0|||
161164094|NCT00259740|581977831|FG001|Overall Study|Requirement for alternative therapy|4|||
161289094|NCT02291237|582438314|FG000|Overall Study|Subject Required Prohibited Medication|2|||
161289095|NCT02291237|582438315|FG001|Overall Study|Subject Required Prohibited Medication|0|||
161289096|NCT00281957|582438316|FG000|Overall Study|Adverse Event|7|||
161289097|NCT00281957|582438317|FG001|Overall Study|Adverse Event|2|||
161289098|NCT00281957|582438316|FG000|Overall Study|Death|1|||
161289099|NCT00281957|582438317|FG001|Overall Study|Death|0|||
161289100|NCT00281957|582438316|FG000|Overall Study|Progression/relapse|47|||
161289101|NCT00281957|582438317|FG001|Overall Study|Progression/relapse|35|||
161289102|NCT00281957|582438316|FG000|Overall Study|Not protocol specified|8|||
161289103|NCT00281957|582438317|FG001|Overall Study|Not protocol specified|1|||
161289104|NCT00281957|582438316|FG000|Overall Study|Not eligible|1|||
161289105|NCT00281957|582438317|FG001|Overall Study|Not eligible|2|||
161289106|NCT00281957|582438316|FG000|Overall Study|Did not start treatment|3|||
161289107|NCT00281957|582438317|FG001|Overall Study|Did not start treatment|1|||
161289108|NCT00281957|582438316|FG000|Overall Study|Refusal unrelated to adverse events|0|||
161289109|NCT00281957|582438317|FG001|Overall Study|Refusal unrelated to adverse events|1|||
161289110|NCT03281876|582438326|FG000|Overall Study|Adverse Event|4|||
161289111|NCT03281876|582438327|FG001|Overall Study|Adverse Event|15|||
161289112|NCT03281876|582438326|FG000|Overall Study|Lost to Follow-up|1|||
161289113|NCT03281876|582438327|FG001|Overall Study|Lost to Follow-up|4|||
161289114|NCT03281876|582438326|FG000|Overall Study|Withdrawal by Subject|11|||
161289115|NCT03281876|582438327|FG001|Overall Study|Withdrawal by Subject|15|||
161289116|NCT03281876|582438326|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
161289117|NCT03281876|582438327|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161289118|NCT03281876|582438326|FG000|Overall Study|OTHER|5|||
161289119|NCT03281876|582438327|FG001|Overall Study|OTHER|5|||
161289120|NCT02208089|582438328|FG000|Overall Study|Withdrawal by Subject|1|||
161289121|NCT02208089|582438329|FG001|Overall Study|Withdrawal by Subject|0|||
161289122|NCT02208089|582438328|FG000|Overall Study|Lost to Follow-up|6|||
161289123|NCT02208089|582438329|FG001|Overall Study|Lost to Follow-up|0|||
161289124|NCT00456300|582438330|FG000|Overall Study|Adverse Event|1|||
161289125|NCT00456300|582438331|FG001|Overall Study|Adverse Event|0|||
161289126|NCT01478373|582438334|FG000|Treatment Phase|Protocol Violation|1|||
161289127|NCT01478373|582438334|FG000|Survival Phase|Adverse Event|8|||
161289128|NCT01478373|582438334|FG000|Survival Phase|Protocol Violation|1|||
161289129|NCT01478373|582438334|FG000|Survival Phase|crossover to another study|2|||
161289130|NCT01478373|582438334|FG000|Survival Phase|Progressive Disease|27|||
161289131|NCT01074944|582438342|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
161289132|NCT01074944|582438343|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161289133|NCT01074944|582438344|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161289134|NCT01074944|582438345|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161289135|NCT01074944|582438346|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
161289136|NCT01074944|582438342|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
161289137|NCT01074944|582438343|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161289138|NCT01074944|582438344|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161289139|NCT01074944|582438345|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161289140|NCT01074944|582438346|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
161289141|NCT01074944|582438342|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
161346739|NCT01295944|582653351|FG000|Overall Study|Physician Decision|1|||
161289142|NCT01074944|582438343|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161289143|NCT01074944|582438344|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161289144|NCT01074944|582438345|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161164095|NCT01844830|581977836|FG000|Overall Study|Withdrawal by Subject|1|||
161164096|NCT01844830|581977837|FG001|Overall Study|Withdrawal by Subject|0|||
161164097|NCT04735393|581977841|FG000|Overall Study|Lost to Follow-up|46|||
161164098|NCT04735393|581977842|FG001|Overall Study|Lost to Follow-up|24|||
161164099|NCT04735393|581977841|FG000|Overall Study|Physician Decision|2|||
161164100|NCT04735393|581977842|FG001|Overall Study|Physician Decision|1|||
161164101|NCT04735393|581977841|FG000|Overall Study|Not Detailed|1|||
161164102|NCT04735393|581977842|FG001|Overall Study|Not Detailed|2|||
161164103|NCT04735393|581977841|FG000|Overall Study|Withdrawal by Subject|71|||
161164104|NCT04735393|581977842|FG001|Overall Study|Withdrawal by Subject|28|||
161164105|NCT04735393|581977841|FG000|Overall Study|Adverse Event|56|||
161164106|NCT04735393|581977842|FG001|Overall Study|Adverse Event|7|||
161164107|NCT04735393|581977841|FG000|Overall Study|Protocol Violation|6|||
161164108|NCT04735393|581977842|FG001|Overall Study|Protocol Violation|1|||
161164109|NCT04735393|581977841|FG000|Overall Study|Trial terminated by Sponsor|49|||
161164110|NCT04735393|581977842|FG001|Overall Study|Trial terminated by Sponsor|29|||
161164111|NCT00209170|581977843|FG000|Overall Study|Adverse Event|0|||
161164112|NCT00209170|581977844|FG001|Overall Study|Adverse Event|1|||
161164113|NCT00209170|581977843|FG000|Overall Study|Withdrawal by Subject|2|||
161164114|NCT00209170|581977844|FG001|Overall Study|Withdrawal by Subject|1|||
161164115|NCT00209170|581977843|FG000|Overall Study|Lack of Efficacy|0|||
161164116|NCT00209170|581977844|FG001|Overall Study|Lack of Efficacy|1|||
161164117|NCT03224104|581977848|FG000|Overall Study|Lack of Efficacy|2|||
161164118|NCT03224104|581977849|FG001|Overall Study|Lack of Efficacy|6|||
161164119|NCT03224104|581977850|FG002|Overall Study|Lack of Efficacy|3|||
161164120|NCT03224104|581977851|FG003|Overall Study|Lack of Efficacy|4|||
161164121|NCT03224104|581977852|FG004|Overall Study|Lack of Efficacy|42|||
161164122|NCT03224104|581977848|FG000|Overall Study|Withdrawal by Subject|0|||
161164123|NCT03224104|581977849|FG001|Overall Study|Withdrawal by Subject|2|||
161164124|NCT03224104|581977850|FG002|Overall Study|Withdrawal by Subject|0|||
161164125|NCT03224104|581977851|FG003|Overall Study|Withdrawal by Subject|1|||
161164126|NCT03224104|581977852|FG004|Overall Study|Withdrawal by Subject|3|||
161164127|NCT03224104|581977848|FG000|Overall Study|Death|0|||
161164128|NCT03224104|581977849|FG001|Overall Study|Death|1|||
161164129|NCT03224104|581977850|FG002|Overall Study|Death|0|||
161164130|NCT03224104|581977851|FG003|Overall Study|Death|0|||
161164131|NCT03224104|581977852|FG004|Overall Study|Death|0|||
161164132|NCT03224104|581977848|FG000|Overall Study|Adverse Event|1|||
161164133|NCT03224104|581977849|FG001|Overall Study|Adverse Event|0|||
161164134|NCT03224104|581977850|FG002|Overall Study|Adverse Event|0|||
161164135|NCT03224104|581977851|FG003|Overall Study|Adverse Event|1|||
161164136|NCT03224104|581977852|FG004|Overall Study|Adverse Event|3|||
161164137|NCT03224104|581977848|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
161164138|NCT03224104|581977849|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
161164139|NCT03224104|581977850|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
161164140|NCT03224104|581977851|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
161164141|NCT03224104|581977852|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
161164142|NCT03224104|581977848|FG000|Overall Study|Treatment ongoing|0|||
161164143|NCT03224104|581977849|FG001|Overall Study|Treatment ongoing|0|||
161164144|NCT03224104|581977850|FG002|Overall Study|Treatment ongoing|0|||
161164145|NCT03224104|581977851|FG003|Overall Study|Treatment ongoing|0|||
161164146|NCT03224104|581977852|FG004|Overall Study|Treatment ongoing|1|||
161164147|NCT04397718|581977853|FG000|Overall Study|Death|7|||
161164148|NCT04397718|581977854|FG001|Overall Study|Death|11|||
161164149|NCT04397718|581977853|FG000|Overall Study|Lost to Follow-up|0|||
161164150|NCT04397718|581977854|FG001|Overall Study|Lost to Follow-up|4|||
161164151|NCT06087328|581977855|FG000|28-Day Treatment|Lost to Follow-up|7|||
161164152|NCT06087328|581977856|FG001|28-Day Treatment|Lost to Follow-up|3|||
161164153|NCT06087328|581977857|FG002|28-Day Treatment|Lost to Follow-up|4|||
161164154|NCT06087328|581977855|FG000|1-month Follow-up|Lost to Follow-up|0|||
161164155|NCT06087328|581977856|FG001|1-month Follow-up|Lost to Follow-up|1|||
161164156|NCT06087328|581977857|FG002|1-month Follow-up|Lost to Follow-up|1|||
161164157|NCT01577160|581977858|FG000|Overall Study|Adverse Event|9|||
161164158|NCT01577160|581977858|FG000|Overall Study|Lack of Efficacy|15|||
161164159|NCT01577160|581977858|FG000|Overall Study|Lost to Follow-up|40|||
161164160|NCT01577160|581977858|FG000|Overall Study|Withdrawal by Subject|18|||
161164161|NCT01577160|581977858|FG000|Overall Study|Subject Uncooperative|7|||
161164162|NCT01577160|581977858|FG000|Overall Study|Other|9|||
161164163|NCT01096849|581977863|FG000|Overall Study|Consent Withdrawn|1|||
161164164|NCT01096849|581977864|FG001|Overall Study|Consent Withdrawn|4|||
161164165|NCT01096849|581977865|FG002|Overall Study|Consent Withdrawn|2|||
161164166|NCT01096849|581977863|FG000|Overall Study|Lack of Efficacy|0|||
161164167|NCT01096849|581977864|FG001|Overall Study|Lack of Efficacy|2|||
161164168|NCT01096849|581977865|FG002|Overall Study|Lack of Efficacy|0|||
161164169|NCT01096849|581977863|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
161164170|NCT01096849|581977864|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
161164171|NCT01096849|581977865|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
161164172|NCT01096849|581977863|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
161164173|NCT01096849|581977864|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
161164174|NCT01096849|581977865|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
161164175|NCT01096849|581977863|FG000|Overall Study|Administrative Reasons|0|||
161164176|NCT01096849|581977864|FG001|Overall Study|Administrative Reasons|1|||
161164177|NCT01096849|581977865|FG002|Overall Study|Administrative Reasons|2|||
161164178|NCT01096849|581977863|FG000|Overall Study|Lost to Follow-up|1|||
161164179|NCT01096849|581977864|FG001|Overall Study|Lost to Follow-up|3|||
161164180|NCT01096849|581977865|FG002|Overall Study|Lost to Follow-up|1|||
161164181|NCT04146467|581977866|FG000|Overall Study|Adverse Event|0|||
161164182|NCT04146467|581977867|FG001|Overall Study|Adverse Event|1|||
161164183|NCT04146467|581977866|FG000|Overall Study|Lost to Follow-up|0|||
161164184|NCT04146467|581977867|FG001|Overall Study|Lost to Follow-up|2|||
161164185|NCT02128763|581977870|FG000|Overall Study|Death|1|||
161164186|NCT02128763|581977871|FG001|Overall Study|Death|0|||
161164187|NCT02128763|581977870|FG000|Overall Study|Lost to Follow-up|19|||
161164188|NCT02128763|581977871|FG001|Overall Study|Lost to Follow-up|16|||
161164189|NCT01253421|581977872|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
161164190|NCT01253421|581977873|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
161164191|NCT01253421|581977874|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
161164192|NCT01253421|581977875|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
161164193|NCT01253421|581977876|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
161164194|NCT01253421|581977872|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
161164195|NCT01253421|581977873|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
161164196|NCT01253421|581977874|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
161164197|NCT01253421|581977875|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
161164198|NCT01253421|581977876|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
161164199|NCT01253421|581977872|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
161164200|NCT01253421|581977873|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
161164201|NCT01253421|581977874|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
161164202|NCT01253421|581977875|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
161164203|NCT01253421|581977876|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
161164204|NCT01253421|581977872|FG000|Assessment and Scheduling|Physician Decision|1|||
161164205|NCT01253421|581977873|FG001|Assessment and Scheduling|Physician Decision|0|||
161164206|NCT01253421|581977874|FG002|Assessment and Scheduling|Physician Decision|0|||
161164207|NCT01253421|581977875|FG003|Assessment and Scheduling|Physician Decision|0|||
161164208|NCT01253421|581977876|FG004|Assessment and Scheduling|Physician Decision|0|||
161164209|NCT01253421|581977872|FG000|Drug+Scanning Visit|Physician Decision|0|||
161164210|NCT01253421|581977873|FG001|Drug+Scanning Visit|Physician Decision|0|||
161164211|NCT01253421|581977874|FG002|Drug+Scanning Visit|Physician Decision|0|||
161164212|NCT01253421|581977875|FG003|Drug+Scanning Visit|Physician Decision|0|||
161164213|NCT01253421|581977876|FG004|Drug+Scanning Visit|Physician Decision|1|||
161164214|NCT01608724|581977878|FG000|Overall Study|Withdrawal by Subject|131|||
161164215|NCT01608724|581977878|FG000|Overall Study|Lost to Follow-up|41|||
161164216|NCT01608724|581977878|FG000|Overall Study|Study-specific discontinuation criteria|32|||
161164217|NCT01608724|581977878|FG000|Overall Study|Adverse Event|29|||
161164218|NCT01608724|581977878|FG000|Overall Study|Protocol Violation|6|||
161164219|NCT01608724|581977878|FG000|Overall Study|bood sugar too high, etc.|3|||
161164220|NCT01608724|581977878|FG000|Overall Study|Safety reasons|1|||
161164221|NCT00099359|581977879|FG000|Overall Study|Death|11|||
161164222|NCT00099359|581977880|FG001|Overall Study|Death|15|||
161164223|NCT00099359|581977881|FG002|Overall Study|Death|17|||
161289145|NCT01074944|582438346|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
161289146|NCT01074944|582438342|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
161289147|NCT01074944|582438343|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161289148|NCT01074944|582438344|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161080055|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161080056|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
161080057|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161080058|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161080059|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
161080060|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Site closure|0|||
161080061|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Site closure|0|||
161164224|NCT00099359|581977879|FG000|Overall Study|Withdrawal by Subject|19|||
161164225|NCT00099359|581977880|FG001|Overall Study|Withdrawal by Subject|19|||
161164226|NCT00099359|581977881|FG002|Overall Study|Withdrawal by Subject|23|||
161164227|NCT00099359|581977879|FG000|Overall Study|Lost to Follow-up|15|||
161164228|NCT00099359|581977880|FG001|Overall Study|Lost to Follow-up|24|||
161164229|NCT00099359|581977881|FG002|Overall Study|Lost to Follow-up|24|||
161164230|NCT00099359|581977879|FG000|Overall Study|moved out of area|9|||
161164231|NCT00099359|581977880|FG001|Overall Study|moved out of area|7|||
161164232|NCT00099359|581977881|FG002|Overall Study|moved out of area|4|||
161164233|NCT00717366|581977882|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
161164234|NCT00717366|581977883|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
161164235|NCT00717366|581977882|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
161289149|NCT01074944|582438345|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161289150|NCT01074944|582438346|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
161289151|NCT01074944|582438342|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161289152|NCT01074944|582438343|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
161289153|NCT01074944|582438344|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
161289154|NCT01074944|582438345|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161289155|NCT01074944|582438346|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
161289156|NCT01074944|582438342|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161289157|NCT01074944|582438343|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
161289158|NCT01074944|582438344|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
161289159|NCT01074944|582438345|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161289160|NCT01074944|582438346|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
161289161|NCT01074944|582438342|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161346740|NCT01295944|582653351|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
161346741|NCT01295944|582653351|FG000|Overall Study|Disease progression|4|||
161346742|NCT01295944|582653351|FG000|Overall Study|Transferred care before starting new treatment|1|||
161346743|NCT03785366|582653359|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
161346744|NCT03785366|582653360|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
161346745|NCT03785366|582653359|FG000|Overall Study|Lost to Follow-up|1|||
161346746|NCT03785366|582653360|FG001|Overall Study|Lost to Follow-up|0|||
161080062|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Site closure|1|||
161080063|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Site closure|0|||
161080064|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Site closure|0|||
161080065|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Site closure|0|||
161080066|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
161080067|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
161080068|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
161080069|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
161080070|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
161080071|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
161080072|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
161080073|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
161080074|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
161080075|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
161080076|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
161080077|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
161080078|NCT03439254|581682279|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
161080079|NCT03439254|581682280|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
161080080|NCT03439254|581682281|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
161080081|NCT03439254|581682282|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
161080082|NCT03439254|581682283|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
161080083|NCT03439254|581682284|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
161080084|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
161080085|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
161080086|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
161080087|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
161080088|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
161080089|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
161080090|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161080091|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161080092|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161080093|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
161080094|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
161080095|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
161080096|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161080097|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161080098|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161080099|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161080100|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
161080101|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
161080102|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161080103|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161080104|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161080105|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161080106|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
161080107|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
161080108|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161164236|NCT00717366|581977883|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
161164237|NCT00717366|581977882|FG000|Core Study Period (20 Weeks)|Death|0|||
161164238|NCT00717366|581977883|FG001|Core Study Period (20 Weeks)|Death|1|||
161164239|NCT00717366|581977882|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
161164240|NCT00717366|581977883|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
161164241|NCT00717366|581977882|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
161164242|NCT00717366|581977883|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
161164243|NCT00717366|581977882|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
161164244|NCT00717366|581977883|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
161164245|NCT00717366|581977882|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
161164246|NCT00717366|581977883|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
161164247|NCT02104804|581977886|FG000|Overall Study|Did not take study medication|0|||
161164248|NCT02104804|581977887|FG001|Overall Study|Did not take study medication|1|||
161164249|NCT02104804|581977886|FG000|Overall Study|Study specific discontinuation criteria|6|||
161164250|NCT02104804|581977887|FG001|Overall Study|Study specific discontinuation criteria|1|||
161164251|NCT02104804|581977886|FG000|Overall Study|Other listed|2|||
161164252|NCT02104804|581977887|FG001|Overall Study|Other listed|1|||
161164253|NCT02104804|581977886|FG000|Overall Study|Protocol Violation|0|||
161164254|NCT02104804|581977887|FG001|Overall Study|Protocol Violation|1|||
161289162|NCT01074944|582438343|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
161289163|NCT01074944|582438344|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
161289164|NCT01074944|582438345|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161289165|NCT01074944|582438346|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
161289166|NCT01074944|582438342|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161164255|NCT02104804|581977886|FG000|Overall Study|Adverse Event|4|||
161164256|NCT02104804|581977887|FG001|Overall Study|Adverse Event|3|||
161164257|NCT02104804|581977886|FG000|Overall Study|Withdrawal by Subject|4|||
161164258|NCT02104804|581977887|FG001|Overall Study|Withdrawal by Subject|12|||
161164259|NCT01364233|581977888|FG000|Overall Study|Lost to Follow-up|1|||
161164260|NCT00438399|581977889|FG000|Overall Study|Lost to Follow-up|2|||
161164261|NCT00438399|581977890|FG001|Overall Study|Lost to Follow-up|2|||
161164262|NCT00438399|581977891|FG002|Overall Study|Lost to Follow-up|1|||
161164263|NCT00438399|581977892|FG003|Overall Study|Lost to Follow-up|1|||
161164264|NCT00438399|581977893|FG004|Overall Study|Lost to Follow-up|1|||
161164265|NCT00438399|581977894|FG005|Overall Study|Lost to Follow-up|1|||
161289167|NCT01074944|582438343|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
161289168|NCT01074944|582438344|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161289169|NCT01074944|582438345|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161289170|NCT01074944|582438346|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
161289171|NCT01074944|582438342|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161289172|NCT01074944|582438343|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
161289173|NCT01074944|582438344|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
161289174|NCT01074944|582438345|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161289175|NCT01074944|582438346|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
161289176|NCT01074944|582438342|FG000|Long Term Treatment|Adverse Event|0|||
161289177|NCT01074944|582438343|FG001|Long Term Treatment|Adverse Event|0|||
161289178|NCT01074944|582438344|FG002|Long Term Treatment|Adverse Event|0|||
161289179|NCT01074944|582438345|FG003|Long Term Treatment|Adverse Event|3|||
161289180|NCT01074944|582438346|FG004|Long Term Treatment|Adverse Event|0|||
161289181|NCT01074944|582438342|FG000|Long Term Treatment|Lost to Follow-up|0|||
161289182|NCT01074944|582438343|FG001|Long Term Treatment|Lost to Follow-up|0|||
161289183|NCT01074944|582438344|FG002|Long Term Treatment|Lost to Follow-up|0|||
161289184|NCT01074944|582438345|FG003|Long Term Treatment|Lost to Follow-up|2|||
161289185|NCT01074944|582438346|FG004|Long Term Treatment|Lost to Follow-up|0|||
161289186|NCT01074944|582438342|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161289187|NCT01074944|582438343|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161289188|NCT01074944|582438344|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161289189|NCT01074944|582438345|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
161289190|NCT01074944|582438346|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
161289191|NCT01074944|582438342|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
161289192|NCT01074944|582438343|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
161289193|NCT01074944|582438344|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
161164266|NCT00438399|581977889|FG000|Overall Study|Adverse Event|0|||
161164267|NCT00438399|581977890|FG001|Overall Study|Adverse Event|0|||
161164268|NCT00438399|581977891|FG002|Overall Study|Adverse Event|1|||
161164269|NCT00438399|581977892|FG003|Overall Study|Adverse Event|1|||
161164270|NCT00438399|581977893|FG004|Overall Study|Adverse Event|0|||
161289194|NCT01074944|582438345|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
161289195|NCT01074944|582438346|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
161289196|NCT01074944|582438342|FG000|Long Term Treatment|Withdrawal by Subject|0|||
161164271|NCT00438399|581977894|FG005|Overall Study|Adverse Event|1|||
161164272|NCT00438399|581977889|FG000|Overall Study|Withdrawal by Subject|5|||
161164273|NCT00438399|581977890|FG001|Overall Study|Withdrawal by Subject|6|||
161164274|NCT00438399|581977891|FG002|Overall Study|Withdrawal by Subject|3|||
161164275|NCT00438399|581977892|FG003|Overall Study|Withdrawal by Subject|2|||
161164276|NCT00438399|581977893|FG004|Overall Study|Withdrawal by Subject|2|||
161164277|NCT00438399|581977894|FG005|Overall Study|Withdrawal by Subject|2|||
161164278|NCT00438399|581977889|FG000|Overall Study|Protocol Violation|0|||
161164279|NCT00438399|581977890|FG001|Overall Study|Protocol Violation|0|||
161164280|NCT00438399|581977891|FG002|Overall Study|Protocol Violation|1|||
161289197|NCT01074944|582438343|FG001|Long Term Treatment|Withdrawal by Subject|0|||
161289198|NCT01074944|582438344|FG002|Long Term Treatment|Withdrawal by Subject|0|||
161289199|NCT01074944|582438345|FG003|Long Term Treatment|Withdrawal by Subject|2|||
161080109|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161080110|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161080111|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161080112|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
161080113|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
161080114|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161080115|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161080116|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161080117|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161080118|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
161080119|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
161080120|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161080121|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161080122|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161080123|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
161080124|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161080125|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
161080126|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161080127|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161080128|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161080129|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
161080130|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
161080131|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
161080132|NCT03439254|581682279|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
161080133|NCT03439254|581682280|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
161080134|NCT03439254|581682281|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
161080135|NCT03439254|581682282|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
161080136|NCT03439254|581682283|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
161080137|NCT03439254|581682284|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
161080138|NCT00128102|581682287|FG000|Overall Study|Site Discontinued|3|||
161080139|NCT00128102|581682288|FG001|Overall Study|Site Discontinued|6|||
161080140|NCT00128102|581682287|FG000|Overall Study|Other|0|||
161080141|NCT00128102|581682288|FG001|Overall Study|Other|1|||
161080142|NCT00128102|581682287|FG000|Overall Study|Progressive Disease|255|||
161080143|NCT00128102|581682288|FG001|Overall Study|Progressive Disease|285|||
161080144|NCT00128102|581682287|FG000|Overall Study|Adverse Event|34|||
161080145|NCT00128102|581682288|FG001|Overall Study|Adverse Event|11|||
161080146|NCT00128102|581682287|FG000|Overall Study|Death|12|||
161080147|NCT00128102|581682288|FG001|Overall Study|Death|13|||
161080148|NCT00128102|581682287|FG000|Overall Study|Physician Decision|3|||
161080149|NCT00128102|581682288|FG001|Overall Study|Physician Decision|3|||
161080150|NCT00128102|581682287|FG000|Overall Study|Withdrawal by Subject|19|||
161080151|NCT00128102|581682288|FG001|Overall Study|Withdrawal by Subject|11|||
161080152|NCT00128102|581682287|FG000|Overall Study|Protocol Violation|2|||
161080153|NCT00128102|581682288|FG001|Overall Study|Protocol Violation|2|||
161080154|NCT00568178|581682289|FG000|Double Blind Base Study|Adverse Event|0|||
161080155|NCT00568178|581682290|FG001|Double Blind Base Study|Adverse Event|2|||
161080156|NCT00568178|581682291|FG002|Double Blind Base Study|Adverse Event|1|||
161080157|NCT00568178|581682292|FG003|Double Blind Base Study|Adverse Event|2|||
161080158|NCT00568178|581682293|FG004|Double Blind Base Study|Adverse Event|0|||
161080159|NCT00568178|581682294|FG005|Double Blind Base Study|Adverse Event|0|||
161080160|NCT00568178|581682289|FG000|Double Blind Base Study|Lost to Follow-up|1|||
161080161|NCT00568178|581682290|FG001|Double Blind Base Study|Lost to Follow-up|0|||
161080162|NCT00568178|581682291|FG002|Double Blind Base Study|Lost to Follow-up|0|||
161080163|NCT00568178|581682292|FG003|Double Blind Base Study|Lost to Follow-up|1|||
161080164|NCT00568178|581682293|FG004|Double Blind Base Study|Lost to Follow-up|0|||
161080165|NCT00568178|581682294|FG005|Double Blind Base Study|Lost to Follow-up|0|||
161164281|NCT00438399|581977892|FG003|Overall Study|Protocol Violation|0|||
161289200|NCT01074944|582438346|FG004|Long Term Treatment|Withdrawal by Subject|0|||
161164282|NCT00438399|581977893|FG004|Overall Study|Protocol Violation|0|||
161164283|NCT00438399|581977894|FG005|Overall Study|Protocol Violation|1|||
161164284|NCT00438399|581977889|FG000|Overall Study|Subje stopped study|0|||
161164285|NCT00438399|581977890|FG001|Overall Study|Subje stopped study|0|||
161164286|NCT00438399|581977891|FG002|Overall Study|Subje stopped study|1|||
161164287|NCT00438399|581977892|FG003|Overall Study|Subje stopped study|0|||
161164288|NCT00438399|581977893|FG004|Overall Study|Subje stopped study|0|||
161164289|NCT00438399|581977894|FG005|Overall Study|Subje stopped study|0|||
161164290|NCT00438399|581977889|FG000|Overall Study|Pregnancy|0|||
161164291|NCT00438399|581977890|FG001|Overall Study|Pregnancy|0|||
161164292|NCT00438399|581977891|FG002|Overall Study|Pregnancy|0|||
161164293|NCT00438399|581977892|FG003|Overall Study|Pregnancy|0|||
161164294|NCT00438399|581977893|FG004|Overall Study|Pregnancy|0|||
161164295|NCT00438399|581977894|FG005|Overall Study|Pregnancy|1|||
161164296|NCT00438399|581977889|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
161164297|NCT00438399|581977890|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
161164298|NCT00438399|581977891|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
161164299|NCT00438399|581977892|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
161164300|NCT00438399|581977893|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
161164301|NCT00438399|581977894|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
161164302|NCT03334396|581977896|FG000|Overall Study|Adverse Event|1|||
161164303|NCT03334396|581977897|FG001|Overall Study|Adverse Event|0|||
161164304|NCT03334396|581977898|FG002|Overall Study|Adverse Event|1|||
161164305|NCT03334396|581977899|FG003|Overall Study|Adverse Event|0|||
161164306|NCT03334396|581977900|FG004|Overall Study|Adverse Event|0|||
161164307|NCT03334396|581977901|FG005|Overall Study|Adverse Event|0|||
161164308|NCT03334396|581977902|FG006|Overall Study|Adverse Event|0|||
161164309|NCT03334396|581977903|FG007|Overall Study|Adverse Event|0|||
161164310|NCT03334396|581977896|FG000|Overall Study|Lack of Efficacy|10|||
161164311|NCT03334396|581977897|FG001|Overall Study|Lack of Efficacy|4|||
161164312|NCT03334396|581977898|FG002|Overall Study|Lack of Efficacy|1|||
161164313|NCT03334396|581977899|FG003|Overall Study|Lack of Efficacy|3|||
161164314|NCT03334396|581977900|FG004|Overall Study|Lack of Efficacy|1|||
161164315|NCT03334396|581977901|FG005|Overall Study|Lack of Efficacy|0|||
161164316|NCT03334396|581977902|FG006|Overall Study|Lack of Efficacy|0|||
161164317|NCT03334396|581977903|FG007|Overall Study|Lack of Efficacy|1|||
161164318|NCT03334396|581977896|FG000|Overall Study|Lost to Follow-up|0|||
161164319|NCT03334396|581977897|FG001|Overall Study|Lost to Follow-up|0|||
161164320|NCT03334396|581977898|FG002|Overall Study|Lost to Follow-up|1|||
161164321|NCT03334396|581977899|FG003|Overall Study|Lost to Follow-up|0|||
161164322|NCT03334396|581977900|FG004|Overall Study|Lost to Follow-up|0|||
161164323|NCT03334396|581977901|FG005|Overall Study|Lost to Follow-up|0|||
161164324|NCT03334396|581977902|FG006|Overall Study|Lost to Follow-up|1|||
161164325|NCT03334396|581977903|FG007|Overall Study|Lost to Follow-up|0|||
161164326|NCT03334396|581977896|FG000|Overall Study|Physician Decision|1|||
161164327|NCT03334396|581977897|FG001|Overall Study|Physician Decision|0|||
161164328|NCT03334396|581977898|FG002|Overall Study|Physician Decision|0|||
161164329|NCT03334396|581977899|FG003|Overall Study|Physician Decision|0|||
161164330|NCT03334396|581977900|FG004|Overall Study|Physician Decision|0|||
161164331|NCT03334396|581977901|FG005|Overall Study|Physician Decision|0|||
161164332|NCT03334396|581977902|FG006|Overall Study|Physician Decision|0|||
161164333|NCT03334396|581977903|FG007|Overall Study|Physician Decision|0|||
161164334|NCT03334396|581977896|FG000|Overall Study|Withdrawal by Subject|10|||
161164335|NCT03334396|581977897|FG001|Overall Study|Withdrawal by Subject|5|||
161164336|NCT03334396|581977898|FG002|Overall Study|Withdrawal by Subject|7|||
161164337|NCT03334396|581977899|FG003|Overall Study|Withdrawal by Subject|2|||
161164338|NCT03334396|581977900|FG004|Overall Study|Withdrawal by Subject|2|||
161164339|NCT03334396|581977901|FG005|Overall Study|Withdrawal by Subject|1|||
161164340|NCT03334396|581977902|FG006|Overall Study|Withdrawal by Subject|2|||
161164341|NCT03334396|581977903|FG007|Overall Study|Withdrawal by Subject|0|||
161164342|NCT03334396|581977896|FG000|Overall Study|Pregnancy|0|||
161164343|NCT03334396|581977897|FG001|Overall Study|Pregnancy|1|||
161164344|NCT03334396|581977898|FG002|Overall Study|Pregnancy|0|||
161164345|NCT03334396|581977899|FG003|Overall Study|Pregnancy|0|||
161164346|NCT03334396|581977900|FG004|Overall Study|Pregnancy|0|||
161164347|NCT03334396|581977901|FG005|Overall Study|Pregnancy|0|||
161164348|NCT03334396|581977902|FG006|Overall Study|Pregnancy|0|||
161164349|NCT03334396|581977903|FG007|Overall Study|Pregnancy|0|||
161164350|NCT03334396|581977896|FG000|Overall Study|Ineligible|0|||
161164351|NCT03334396|581977897|FG001|Overall Study|Ineligible|1|||
161164352|NCT03334396|581977898|FG002|Overall Study|Ineligible|0|||
161164353|NCT03334396|581977899|FG003|Overall Study|Ineligible|0|||
161164354|NCT03334396|581977900|FG004|Overall Study|Ineligible|0|||
161164355|NCT03334396|581977901|FG005|Overall Study|Ineligible|0|||
161164356|NCT03334396|581977902|FG006|Overall Study|Ineligible|0|||
161164357|NCT03334396|581977903|FG007|Overall Study|Ineligible|0|||
161164358|NCT03334396|581977896|FG000|Overall Study|Started New Job|1|||
161164359|NCT03334396|581977897|FG001|Overall Study|Started New Job|0|||
161164360|NCT03334396|581977898|FG002|Overall Study|Started New Job|0|||
161164361|NCT03334396|581977899|FG003|Overall Study|Started New Job|0|||
161164362|NCT03334396|581977900|FG004|Overall Study|Started New Job|0|||
161289201|NCT01074944|582438342|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161289202|NCT01074944|582438343|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161289203|NCT01074944|582438344|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161289204|NCT01074944|582438345|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
161289205|NCT01074944|582438346|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
161289206|NCT01074944|582438342|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161289207|NCT01074944|582438343|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161289208|NCT01074944|582438344|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161289209|NCT01074944|582438345|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
161289210|NCT01074944|582438346|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
161289211|NCT03200717|582438352|FG000|Overall Study|Progressive disease|24|||
161289212|NCT03200717|582438353|FG001|Overall Study|Progressive disease|5|||
161289213|NCT03200717|582438352|FG000|Overall Study|Adverse Event|11|||
161289214|NCT03200717|582438353|FG001|Overall Study|Adverse Event|8|||
161289215|NCT03200717|582438352|FG000|Overall Study|Physician Decision|3|||
161289216|NCT03200717|582438353|FG001|Overall Study|Physician Decision|2|||
161289217|NCT03200717|582438352|FG000|Overall Study|Death|2|||
161289218|NCT03200717|582438353|FG001|Overall Study|Death|0|||
161289219|NCT03200717|582438352|FG000|Overall Study|Subject/Guardian Decision|1|||
161289220|NCT03200717|582438353|FG001|Overall Study|Subject/Guardian Decision|0|||
161289221|NCT01522456|582438354|FG000|Overall Study|Adverse Event|2|||
161289222|NCT01522456|582438354|FG000|Overall Study|Lost to Follow-up|2|||
161289223|NCT01522456|582438354|FG000|Overall Study|Withdrawal by Subject|2|||
161289224|NCT01522456|582438354|FG000|Overall Study|Pregnancy|1|||
161289225|NCT01522456|582438354|FG000|Overall Study|Tolerability Assessment|1|||
161289226|NCT02201784|582438355|FG000|Overall Study|Failure to achieve adequate block|2|||
161289227|NCT02201784|582438356|FG001|Overall Study|Failure to achieve adequate block|0|||
161289228|NCT02046603|582438357|FG000|Overall Study|Other|11|||
161289229|NCT02046603|582438358|FG001|Overall Study|Other|66|||
161289230|NCT02046603|582438357|FG000|Overall Study|Protocol Violation|0|||
161289231|NCT02046603|582438358|FG001|Overall Study|Protocol Violation|1|||
161289232|NCT02046603|582438357|FG000|Overall Study|Participant/legal guardian decision|1|||
161289233|NCT02046603|582438358|FG001|Overall Study|Participant/legal guardian decision|3|||
161289234|NCT02046603|582438357|FG000|Overall Study|Physician Decision|2|||
161289235|NCT02046603|582438358|FG001|Overall Study|Physician Decision|1|||
161289236|NCT02046603|582438357|FG000|Overall Study|Lost to Follow-up|1|||
161289237|NCT02046603|582438358|FG001|Overall Study|Lost to Follow-up|2|||
161289238|NCT02046603|582438357|FG000|Overall Study|Death|0|||
161289239|NCT02046603|582438358|FG001|Overall Study|Death|1|||
161289240|NCT02046603|582438357|FG000|Overall Study|Adverse Event|0|||
161289241|NCT02046603|582438358|FG001|Overall Study|Adverse Event|1|||
161289242|NCT02072980|582438359|FG000|Period 2, Second Wear|Adverse Event|0|||
161289243|NCT02072980|582438360|FG001|Period 2, Second Wear|Adverse Event|1|||
161289244|NCT02431364|582438361|FG000|Overall Study|Adverse Event|0|||
161289245|NCT02431364|582438362|FG001|Overall Study|Adverse Event|1|||
161289246|NCT02431364|582438363|FG002|Overall Study|Adverse Event|0|||
161289247|NCT02431364|582438364|FG003|Overall Study|Adverse Event|0|||
161289248|NCT02431364|582438365|FG004|Overall Study|Adverse Event|0|||
161289249|NCT02431364|582438361|FG000|Overall Study|Randomized but never treated|0|||
161289250|NCT02431364|582438362|FG001|Overall Study|Randomized but never treated|0|||
161289251|NCT02431364|582438363|FG002|Overall Study|Randomized but never treated|0|||
161289252|NCT02431364|582438364|FG003|Overall Study|Randomized but never treated|1|||
161289253|NCT02431364|582438365|FG004|Overall Study|Randomized but never treated|0|||
161289254|NCT00061932|582438366|FG000|Overall Study|Withdrawal by Subject|13|||
161289255|NCT00061932|582438367|FG001|Overall Study|Withdrawal by Subject|4|||
161080166|NCT00568178|581682289|FG000|Double Blind Base Study|Physician Decision|1|||
161080167|NCT00568178|581682290|FG001|Double Blind Base Study|Physician Decision|1|||
161289256|NCT04720105|582438370|FG000|Overall Study|Lack of Efficacy|1|||
161289257|NCT04720105|582438370|FG000|Overall Study|Lost to Follow-up|1|||
161289258|NCT04720105|582438370|FG000|Overall Study|Withdrawal by Subject|3|||
161289259|NCT00625820|582438372|FG000|Overall Study|Withdrawal by Subject|1|||
161289260|NCT02141438|582440525|FG000|Overall Study|Death|1308|||
161289261|NCT02141438|582440525|FG000|Overall Study|Lost to Follow-up|84|||
161289262|NCT02141438|582440525|FG000|Overall Study|Withdrawal by Subject|52|||
161080168|NCT00568178|581682291|FG002|Double Blind Base Study|Physician Decision|0|||
161080169|NCT00568178|581682292|FG003|Double Blind Base Study|Physician Decision|1|||
161080170|NCT00568178|581682293|FG004|Double Blind Base Study|Physician Decision|0|||
161080171|NCT00568178|581682294|FG005|Double Blind Base Study|Physician Decision|0|||
161289263|NCT02141438|582440525|FG000|Overall Study|Physician Decision|1|||
161289264|NCT02141438|582440525|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
161289265|NCT02546986|582440528|FG000|Treatment Period|Progressive Disease|20|||
161289266|NCT02546986|582440529|FG001|Treatment Period|Progressive Disease|22|||
161289267|NCT02546986|582440528|FG000|Treatment Period|Adverse Event|14|||
161289268|NCT02546986|582440529|FG001|Treatment Period|Adverse Event|6|||
161080172|NCT00568178|581682289|FG000|Double Blind Base Study|Protocol Violation|3|||
161080173|NCT00568178|581682290|FG001|Double Blind Base Study|Protocol Violation|2|||
161080174|NCT00568178|581682291|FG002|Double Blind Base Study|Protocol Violation|0|||
161080175|NCT00568178|581682292|FG003|Double Blind Base Study|Protocol Violation|0|||
161080176|NCT00568178|581682293|FG004|Double Blind Base Study|Protocol Violation|0|||
161080177|NCT00568178|581682294|FG005|Double Blind Base Study|Protocol Violation|0|||
161080178|NCT00568178|581682289|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
161080179|NCT00568178|581682290|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
161080180|NCT00568178|581682291|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
161080181|NCT00568178|581682292|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
161080182|NCT00568178|581682293|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
161080183|NCT00568178|581682294|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
161080184|NCT00568178|581682289|FG000|Double Blind Base Study|Progressive Disease|0|||
161080185|NCT00568178|581682290|FG001|Double Blind Base Study|Progressive Disease|0|||
161080186|NCT00568178|581682291|FG002|Double Blind Base Study|Progressive Disease|0|||
161080187|NCT00568178|581682292|FG003|Double Blind Base Study|Progressive Disease|1|||
161080188|NCT00568178|581682293|FG004|Double Blind Base Study|Progressive Disease|0|||
161080189|NCT00568178|581682294|FG005|Double Blind Base Study|Progressive Disease|0|||
161080190|NCT00568178|581682289|FG000|Open Label Extension|Adverse Event|0|||
161080191|NCT00568178|581682290|FG001|Open Label Extension|Adverse Event|0|||
161080192|NCT00568178|581682291|FG002|Open Label Extension|Adverse Event|0|||
161080193|NCT00568178|581682292|FG003|Open Label Extension|Adverse Event|0|||
161080194|NCT00568178|581682293|FG004|Open Label Extension|Adverse Event|11|||
161080195|NCT00568178|581682294|FG005|Open Label Extension|Adverse Event|8|||
161080196|NCT00568178|581682289|FG000|Open Label Extension|Protocol Violation|0|||
161080197|NCT00568178|581682290|FG001|Open Label Extension|Protocol Violation|0|||
161080198|NCT00568178|581682291|FG002|Open Label Extension|Protocol Violation|0|||
161080199|NCT00568178|581682292|FG003|Open Label Extension|Protocol Violation|0|||
161080200|NCT00568178|581682293|FG004|Open Label Extension|Protocol Violation|1|||
161080201|NCT00568178|581682294|FG005|Open Label Extension|Protocol Violation|0|||
161080202|NCT00568178|581682289|FG000|Open Label Extension|Lost to Follow-up|0|||
161080203|NCT00568178|581682290|FG001|Open Label Extension|Lost to Follow-up|0|||
161080204|NCT00568178|581682291|FG002|Open Label Extension|Lost to Follow-up|0|||
161080205|NCT00568178|581682292|FG003|Open Label Extension|Lost to Follow-up|0|||
161080206|NCT00568178|581682293|FG004|Open Label Extension|Lost to Follow-up|6|||
161080207|NCT00568178|581682294|FG005|Open Label Extension|Lost to Follow-up|11|||
161080208|NCT00568178|581682289|FG000|Open Label Extension|Physician Decision|0|||
161080209|NCT00568178|581682290|FG001|Open Label Extension|Physician Decision|0|||
161080210|NCT00568178|581682291|FG002|Open Label Extension|Physician Decision|0|||
161080211|NCT00568178|581682292|FG003|Open Label Extension|Physician Decision|0|||
161080212|NCT00568178|581682293|FG004|Open Label Extension|Physician Decision|9|||
161080213|NCT00568178|581682294|FG005|Open Label Extension|Physician Decision|8|||
161080214|NCT00568178|581682289|FG000|Open Label Extension|Pregnancy|0|||
161080215|NCT00568178|581682290|FG001|Open Label Extension|Pregnancy|0|||
161080216|NCT00568178|581682291|FG002|Open Label Extension|Pregnancy|0|||
161080217|NCT00568178|581682292|FG003|Open Label Extension|Pregnancy|0|||
161080218|NCT00568178|581682293|FG004|Open Label Extension|Pregnancy|0|||
161080219|NCT00568178|581682294|FG005|Open Label Extension|Pregnancy|1|||
161080220|NCT00568178|581682289|FG000|Open Label Extension|Progressive Disease|0|||
161080221|NCT00568178|581682290|FG001|Open Label Extension|Progressive Disease|0|||
161080222|NCT00568178|581682291|FG002|Open Label Extension|Progressive Disease|0|||
161080223|NCT00568178|581682292|FG003|Open Label Extension|Progressive Disease|0|||
161080224|NCT00568178|581682293|FG004|Open Label Extension|Progressive Disease|3|||
161080225|NCT00568178|581682294|FG005|Open Label Extension|Progressive Disease|1|||
161080226|NCT00568178|581682289|FG000|Open Label Extension|Termination of Trial|0|||
161080227|NCT00568178|581682290|FG001|Open Label Extension|Termination of Trial|0|||
161080228|NCT00568178|581682291|FG002|Open Label Extension|Termination of Trial|0|||
161080229|NCT00568178|581682292|FG003|Open Label Extension|Termination of Trial|0|||
161080230|NCT00568178|581682293|FG004|Open Label Extension|Termination of Trial|45|||
161080231|NCT00568178|581682294|FG005|Open Label Extension|Termination of Trial|47|||
161080232|NCT00568178|581682289|FG000|Open Label Extension|Withdrawal by Subject|0|||
161080233|NCT00568178|581682290|FG001|Open Label Extension|Withdrawal by Subject|0|||
161080234|NCT00568178|581682291|FG002|Open Label Extension|Withdrawal by Subject|0|||
161080235|NCT00568178|581682292|FG003|Open Label Extension|Withdrawal by Subject|0|||
161080236|NCT00568178|581682293|FG004|Open Label Extension|Withdrawal by Subject|4|||
161080237|NCT00568178|581682294|FG005|Open Label Extension|Withdrawal by Subject|4|||
161080238|NCT01332630|581682295|FG000|Overall Study|Withdrawal by Subject|3|||
161080239|NCT04476251|581682298|FG000|Overall Study|Not treated|1|||
161080240|NCT01008553|581682299|FG000|Period 1 (Titration Period)|Physician Decision|2|||
161289269|NCT02546986|582440528|FG000|Treatment Period|Symptomatic Deterioration|4|||
161289270|NCT02546986|582440529|FG001|Treatment Period|Symptomatic Deterioration|3|||
161080241|NCT01008553|581682300|FG001|Period 1 (Titration Period)|Physician Decision|0|||
161080242|NCT01008553|581682301|FG002|Period 1 (Titration Period)|Physician Decision|0|||
161080243|NCT01008553|581682299|FG000|Period 1 (Titration Period)|Adverse Event|33|||
161289271|NCT02546986|582440528|FG000|Treatment Period|Death|3|||
161289272|NCT02546986|582440529|FG001|Treatment Period|Death|4|||
161289273|NCT02546986|582440528|FG000|Treatment Period|Physician Decision|1|||
161289274|NCT02546986|582440529|FG001|Treatment Period|Physician Decision|2|||
161289275|NCT02546986|582440528|FG000|Treatment Period|Protocol Violation|1|||
161289276|NCT02546986|582440529|FG001|Treatment Period|Protocol Violation|0|||
161289277|NCT02546986|582440528|FG000|Treatment Period|Withdrawal by Subject|1|||
161289278|NCT02546986|582440529|FG001|Treatment Period|Withdrawal by Subject|1|||
161080244|NCT01008553|581682300|FG001|Period 1 (Titration Period)|Adverse Event|0|||
161080245|NCT01008553|581682301|FG002|Period 1 (Titration Period)|Adverse Event|0|||
161080246|NCT01008553|581682299|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
161080247|NCT01008553|581682300|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161080248|NCT01008553|581682301|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
161080249|NCT01008553|581682299|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
161080250|NCT01008553|581682300|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
161080251|NCT01008553|581682301|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
161080252|NCT01008553|581682299|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
161080253|NCT01008553|581682300|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161080254|NCT01008553|581682301|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
161080255|NCT01008553|581682299|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
161080256|NCT01008553|581682300|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
161080257|NCT01008553|581682301|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
161080258|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
161080259|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
161080260|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
161080261|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
161080262|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
161080263|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
161080264|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
161080265|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
161080266|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
161080267|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
161080268|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
161080269|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
161080270|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
161080271|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
161080272|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
161080273|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
161080274|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
161080275|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
161080276|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161080277|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
161080278|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
161080279|NCT01008553|581682299|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
161080280|NCT01008553|581682300|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
161080281|NCT01008553|581682301|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
161080282|NCT00581555|581682304|FG000|Overall Study|Adverse Event|4|||
161080283|NCT00581555|581682305|FG001|Overall Study|Adverse Event|3|||
161080284|NCT00581555|581682304|FG000|Overall Study|Physician Decision|3|||
161080285|NCT00581555|581682305|FG001|Overall Study|Physician Decision|2|||
161080286|NCT00581555|581682304|FG000|Overall Study|Withdrawal by Subject|18|||
161080287|NCT00581555|581682305|FG001|Overall Study|Withdrawal by Subject|9|||
161080288|NCT00581555|581682304|FG000|Overall Study|Lost to Follow-up|2|||
161080289|NCT00581555|581682305|FG001|Overall Study|Lost to Follow-up|2|||
161080290|NCT00581555|581682304|FG000|Overall Study|Other reasons|16|||
161080291|NCT00581555|581682305|FG001|Overall Study|Other reasons|4|||
161080292|NCT05816330|581682311|FG000|Overall Study|Withdrawal by Subject|4|||
161080293|NCT05816330|581682312|FG001|Overall Study|Withdrawal by Subject|1|||
161080294|NCT00201643|581682313|FG000|Overall Study|Withdrawal by Subject|5|||
161080295|NCT00201643|581682314|FG001|Overall Study|Withdrawal by Subject|4|||
161080296|NCT03446781|581682315|FG000|Overall Study|Lost to Follow-up|11|||
161080297|NCT03446781|581682316|FG001|Overall Study|Lost to Follow-up|5|||
161080298|NCT03446781|581682315|FG000|Overall Study|Withdrawal by Subject|9|||
161080299|NCT03446781|581682316|FG001|Overall Study|Withdrawal by Subject|7|||
161080300|NCT03446781|581682315|FG000|Overall Study|Adverse Event|8|||
161080301|NCT03446781|581682316|FG001|Overall Study|Adverse Event|2|||
161289279|NCT02546986|582440528|FG000|Treatment Period|Non-compliance with Study Drug|0|||
161080302|NCT03446781|581682315|FG000|Overall Study|Protocol Violation|0|||
161289280|NCT02546986|582440529|FG001|Treatment Period|Non-compliance with Study Drug|1|||
161080303|NCT03446781|581682316|FG001|Overall Study|Protocol Violation|3|||
161080304|NCT02898077|581682323|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
161080305|NCT02898077|581682324|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
161080306|NCT02898077|581682323|FG000|Overall Study|Lost to Follow-up|4|||
161080307|NCT02898077|581682324|FG001|Overall Study|Lost to Follow-up|3|||
161080308|NCT02898077|581682323|FG000|Overall Study|Physician Decision|0|||
161080309|NCT02898077|581682324|FG001|Overall Study|Physician Decision|2|||
161080310|NCT02898077|581682323|FG000|Overall Study|Sponsor Decision|32|||
161080311|NCT02898077|581682324|FG001|Overall Study|Sponsor Decision|13|||
161080312|NCT02898077|581682323|FG000|Overall Study|Withdrawal by Subject|6|||
161080313|NCT02898077|581682324|FG001|Overall Study|Withdrawal by Subject|3|||
161080314|NCT02898077|581682323|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
161080315|NCT02898077|581682324|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
161080316|NCT02898077|581682323|FG000|Overall Study|Ended extension period|3|||
161080317|NCT02898077|581682324|FG001|Overall Study|Ended extension period|0|||
161080318|NCT02040584|581682325|FG000|Overall Study|Adverse Event|13|||
161080319|NCT02040584|581682326|FG001|Overall Study|Adverse Event|6|||
161080320|NCT02040584|581682325|FG000|Overall Study|Protocol Violation|9|||
161080321|NCT02040584|581682326|FG001|Overall Study|Protocol Violation|11|||
161080322|NCT02040584|581682325|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161080323|NCT02040584|581682326|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161080324|NCT02040584|581682325|FG000|Overall Study|Death|6|||
161080325|NCT02040584|581682326|FG001|Overall Study|Death|3|||
161080326|NCT02040584|581682325|FG000|Overall Study|Transplant rejection/retransplant|0|||
161080327|NCT02040584|581682326|FG001|Overall Study|Transplant rejection/retransplant|1|||
161080328|NCT02040584|581682325|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
161080329|NCT02040584|581682326|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
161080330|NCT00996476|581682327|FG000|Overall Study|Withdrawal by Subject|1|||
161080331|NCT00996476|581682328|FG001|Overall Study|Withdrawal by Subject|2|||
161080332|NCT00996476|581682329|FG002|Overall Study|Withdrawal by Subject|1|||
161080333|NCT00996476|581682330|FG003|Overall Study|Withdrawal by Subject|0|||
161080334|NCT00996476|581682331|FG004|Overall Study|Withdrawal by Subject|1|||
161080335|NCT00996476|581682327|FG000|Overall Study|Adverse Event|0|||
161080336|NCT00996476|581682328|FG001|Overall Study|Adverse Event|1|||
161080337|NCT00996476|581682329|FG002|Overall Study|Adverse Event|0|||
161080338|NCT00996476|581682330|FG003|Overall Study|Adverse Event|0|||
161080339|NCT00996476|581682331|FG004|Overall Study|Adverse Event|1|||
161080340|NCT01940939|581682332|FG000|Overall Study|Withdrawal by Subject|2|||
161080341|NCT01940939|581682333|FG001|Overall Study|Withdrawal by Subject|8|||
161080342|NCT01470001|581682334|FG000|Overall Study|Lost to Follow-up|1|||
161080343|NCT01470001|581682335|FG001|Overall Study|Lost to Follow-up|1|||
161080344|NCT01470001|581682334|FG000|Overall Study|Physician Decision|2|||
161080345|NCT01470001|581682335|FG001|Overall Study|Physician Decision|0|||
161080346|NCT01470001|581682334|FG000|Overall Study|Withdrawal by Subject|2|||
161080347|NCT01470001|581682335|FG001|Overall Study|Withdrawal by Subject|1|||
161080348|NCT04939701|581682339|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
161080349|NCT04939701|581682340|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
161080350|NCT04939701|581682341|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
161080351|NCT04939701|581682339|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
161080352|NCT04939701|581682340|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
161080353|NCT04939701|581682341|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
161080354|NCT04939701|581682339|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
161080355|NCT04939701|581682340|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
161080356|NCT04939701|581682341|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
161080357|NCT04939701|581682339|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
161080358|NCT04939701|581682340|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
161080359|NCT04939701|581682341|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
161080360|NCT04939701|581682339|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
161080361|NCT04939701|581682340|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
161080362|NCT04939701|581682341|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
161080363|NCT04939701|581682339|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
161080364|NCT04939701|581682340|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
161080365|NCT04939701|581682341|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
161080366|NCT04939701|581682339|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
161080367|NCT04939701|581682340|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
161080368|NCT04939701|581682341|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
161080369|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
161164363|NCT03334396|581977901|FG005|Overall Study|Started New Job|0|||
161080370|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
161080371|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
161080372|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
161080373|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
161080374|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
161346747|NCT03785366|582653359|FG000|Overall Study|Partial IUD Expulsion|0|||
161346748|NCT03785366|582653360|FG001|Overall Study|Partial IUD Expulsion|2|||
161346749|NCT03785366|582653359|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
161346750|NCT03785366|582653360|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
161346751|NCT05168800|582653361|FG000|Time 1 Survey|Did not start T1 survey|182|||
161346752|NCT05168800|582653362|FG001|Time 1 Survey|Did not start T1 survey|150|||
161346753|NCT05168800|582653363|FG002|Time 1 Survey|Did not start T1 survey|140|||
161346754|NCT05168800|582653361|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
161346755|NCT05168800|582653362|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
161346756|NCT05168800|582653363|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
161346757|NCT05168800|582653361|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
161346758|NCT05168800|582653362|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
161346759|NCT05168800|582653363|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
161346760|NCT05168800|582653361|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
161346761|NCT05168800|582653362|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
161346762|NCT05168800|582653363|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
161346763|NCT05168800|582653361|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
161346764|NCT05168800|582653362|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
161346765|NCT05168800|582653363|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
161346766|NCT05168800|582653361|FG000|Time 1 Survey|Withdrawal by Subject|6|||
161346767|NCT05168800|582653362|FG001|Time 1 Survey|Withdrawal by Subject|3|||
161346768|NCT05168800|582653363|FG002|Time 1 Survey|Withdrawal by Subject|2|||
161346769|NCT05168800|582653361|FG000|Time 2 Survey|Already excluded at Time 1|228|||
161346770|NCT05168800|582653362|FG001|Time 2 Survey|Already excluded at Time 1|202|||
161346771|NCT05168800|582653363|FG002|Time 2 Survey|Already excluded at Time 1|173|||
161346772|NCT05168800|582653361|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
161346773|NCT05168800|582653362|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
161346774|NCT05168800|582653363|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
161346775|NCT05168800|582653361|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
161346776|NCT05168800|582653362|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
161346777|NCT05168800|582653363|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
161346778|NCT05168800|582653361|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
161346779|NCT05168800|582653362|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
161346780|NCT05168800|582653363|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
161346781|NCT05168800|582653361|FG000|Time 2 Survey|Withdrawal by Subject|1|||
161346782|NCT05168800|582653362|FG001|Time 2 Survey|Withdrawal by Subject|0|||
161346783|NCT05168800|582653363|FG002|Time 2 Survey|Withdrawal by Subject|1|||
161346784|NCT05168800|582653361|FG000|Time 3 Survey|Already excluded at Time 1|228|||
161346785|NCT05168800|582653362|FG001|Time 3 Survey|Already excluded at Time 1|200|||
161346786|NCT05168800|582653363|FG002|Time 3 Survey|Already excluded at Time 1|173|||
161346787|NCT05168800|582653361|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
161346788|NCT05168800|582653362|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
161346789|NCT05168800|582653363|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
161346790|NCT05168800|582653361|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
161346791|NCT05168800|582653362|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
161346792|NCT05168800|582653363|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
161346793|NCT05168800|582653361|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
161346794|NCT05168800|582653362|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
161346795|NCT05168800|582653363|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
161346796|NCT04958707|582653364|FG000|Post Intervention|Withdrawal by Subject|1|||
161346797|NCT04958707|582653365|FG001|Post Intervention|Withdrawal by Subject|0|||
161346798|NCT04958707|582653366|FG002|Post Intervention|Withdrawal by Subject|0|||
161346799|NCT04958707|582653364|FG000|3 Months Follow- up|Lost to Follow-up|0|||
161346800|NCT04958707|582653365|FG001|3 Months Follow- up|Lost to Follow-up|3|||
161346801|NCT04958707|582653366|FG002|3 Months Follow- up|Lost to Follow-up|0|||
161346802|NCT04958707|582653364|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
161346803|NCT04958707|582653365|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
161346804|NCT04958707|582653366|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
161346805|NCT04279522|582653369|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
161346806|NCT04279522|582653370|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
161346807|NCT04279522|582653369|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
161346808|NCT04279522|582653370|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
161346809|NCT04279522|582653369|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
161346810|NCT04279522|582653370|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
161346811|NCT04279522|582653369|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
161346812|NCT04279522|582653370|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
161346813|NCT04279522|582653369|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
161346814|NCT04279522|582653370|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
161346815|NCT04279522|582653369|FG000|Period 2: Open Label Phase|Physician Decision|0|||
161164364|NCT03334396|581977902|FG006|Overall Study|Started New Job|0|||
161346816|NCT04279522|582653370|FG001|Period 2: Open Label Phase|Physician Decision|3|||
161346817|NCT04279522|582653369|FG000|Period 2: Open Label Phase|Adverse Event|0|||
161346818|NCT04279522|582653370|FG001|Period 2: Open Label Phase|Adverse Event|1|||
161346819|NCT04279522|582653369|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
161080375|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
161289281|NCT02546986|582440528|FG000|Treatment Period|Study Terminated by Sponsor|0|||
161289282|NCT02546986|582440529|FG001|Treatment Period|Study Terminated by Sponsor|1|||
161289283|NCT02546986|582440528|FG000|Treatment Period|Miscellaneous|7|||
161289284|NCT02546986|582440529|FG001|Treatment Period|Miscellaneous|9|||
161289285|NCT02546986|582440528|FG000|Survival Follow-Up Phase|Missing Status|3|||
161289286|NCT02546986|582440529|FG001|Survival Follow-Up Phase|Missing Status|5|||
161289287|NCT02546986|582440528|FG000|Survival Follow-Up Phase|Death|18|||
161289288|NCT02546986|582440529|FG001|Survival Follow-Up Phase|Death|12|||
161289289|NCT02546986|582440528|FG000|Survival Follow-Up Phase|Alive|13|||
161289290|NCT02546986|582440529|FG001|Survival Follow-Up Phase|Alive|16|||
161289291|NCT02546986|582440528|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
161289292|NCT02546986|582440529|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
161289293|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
161289294|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161289295|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161289296|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
161289297|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
161289298|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161289299|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161289300|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
161289301|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
161289302|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161289303|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161289304|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
161289305|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
161289306|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161289307|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161289308|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
161289309|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
161289310|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161289311|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161289312|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
161289313|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
161289314|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161289315|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161289316|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
161289317|NCT02513160|582440530|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
161289318|NCT02513160|582440531|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161346820|NCT04279522|582653370|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
161080376|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
161080377|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
161080378|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
161080379|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Adverse Event|0|||
161080380|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Adverse Event|0|||
161080381|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Adverse Event|3|||
161080382|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Adverse Event|2|||
161080383|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Adverse Event|13|||
161080384|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
161080385|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
161080386|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
161080387|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
161080388|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
161080389|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Patient's wish|0|||
161080390|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Patient's wish|0|||
161080391|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Patient's wish|19|||
161080392|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Patient's wish|9|||
161080393|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Patient's wish|20|||
161080394|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
161289319|NCT02513160|582440532|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161289320|NCT02513160|582440533|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
161289321|NCT02513160|582440530|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
161346821|NCT02783274|582653383|FG000|Overall Study|Withdrawal by Subject|16|||
161289322|NCT02513160|582440531|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
161289323|NCT02513160|582440532|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
161289324|NCT02513160|582440533|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
161289325|NCT02513160|582440530|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
161289326|NCT02513160|582440531|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161289327|NCT02513160|582440532|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161289328|NCT02513160|582440533|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
161289329|NCT02513160|582440530|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
161289330|NCT02513160|582440531|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161289331|NCT02513160|582440532|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161080395|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
161080396|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
161080397|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
161080398|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
161080399|NCT00444275|581682345|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
161080400|NCT00444275|581682346|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
161080401|NCT00444275|581682347|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
161080402|NCT00444275|581682348|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
161080403|NCT00444275|581682349|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
161080404|NCT04187326|581682350|FG000|Overall Study|Lost to Follow-up|2|||
161080405|NCT04187326|581682351|FG001|Overall Study|Lost to Follow-up|1|||
161080406|NCT04187326|581682350|FG000|Overall Study|Computer error- task was only partially completed.|0|||
161080407|NCT04187326|581682351|FG001|Overall Study|Computer error- task was only partially completed.|1|||
161080408|NCT02387970|581682352|FG000|Overall Study|Did not complete 1-year follow up|1|||
161080409|NCT02387970|581682353|FG001|Overall Study|Did not complete 1-year follow up|2|||
161080410|NCT02628028|581682354|FG000|Dosing Period|Withdrawal by Subject|0|||
161080411|NCT02628028|581682355|FG001|Dosing Period|Withdrawal by Subject|0|||
161080412|NCT02628028|581682356|FG002|Dosing Period|Withdrawal by Subject|1|||
161080413|NCT02628028|581682357|FG003|Dosing Period|Withdrawal by Subject|0|||
161080414|NCT02628028|581682358|FG004|Dosing Period|Withdrawal by Subject|2|||
161080415|NCT02628028|581682359|FG005|Dosing Period|Withdrawal by Subject|4|||
161080416|NCT02628028|581682360|FG006|Dosing Period|Withdrawal by Subject|1|||
161080417|NCT02628028|581682361|FG007|Dosing Period|Withdrawal by Subject|1|||
161080418|NCT02628028|581682354|FG000|Dosing Period|Adverse Event|0|||
161080419|NCT02628028|581682355|FG001|Dosing Period|Adverse Event|0|||
161080420|NCT02628028|581682356|FG002|Dosing Period|Adverse Event|0|||
161080421|NCT02628028|581682357|FG003|Dosing Period|Adverse Event|0|||
161080422|NCT02628028|581682358|FG004|Dosing Period|Adverse Event|2|||
161080423|NCT02628028|581682359|FG005|Dosing Period|Adverse Event|1|||
161080424|NCT02628028|581682360|FG006|Dosing Period|Adverse Event|3|||
161080425|NCT02628028|581682361|FG007|Dosing Period|Adverse Event|2|||
161080426|NCT02628028|581682354|FG000|Dosing Period|Death|0|||
161080427|NCT02628028|581682355|FG001|Dosing Period|Death|0|||
161080428|NCT02628028|581682356|FG002|Dosing Period|Death|0|||
161080429|NCT02628028|581682357|FG003|Dosing Period|Death|0|||
161080430|NCT02628028|581682358|FG004|Dosing Period|Death|0|||
161080431|NCT02628028|581682359|FG005|Dosing Period|Death|0|||
161080432|NCT02628028|581682360|FG006|Dosing Period|Death|0|||
161080433|NCT02628028|581682361|FG007|Dosing Period|Death|1|||
161080434|NCT02628028|581682354|FG000|Dosing Period|Lack of Efficacy|0|||
161080435|NCT02628028|581682355|FG001|Dosing Period|Lack of Efficacy|0|||
161080436|NCT02628028|581682356|FG002|Dosing Period|Lack of Efficacy|0|||
161080437|NCT02628028|581682357|FG003|Dosing Period|Lack of Efficacy|0|||
161080438|NCT02628028|581682358|FG004|Dosing Period|Lack of Efficacy|3|||
161080439|NCT02628028|581682359|FG005|Dosing Period|Lack of Efficacy|0|||
161080440|NCT02628028|581682360|FG006|Dosing Period|Lack of Efficacy|1|||
161080441|NCT02628028|581682361|FG007|Dosing Period|Lack of Efficacy|0|||
161080442|NCT02628028|581682354|FG000|Dosing Period|Study Terminated by Sponsor|0|||
161080443|NCT02628028|581682355|FG001|Dosing Period|Study Terminated by Sponsor|0|||
161080444|NCT02628028|581682356|FG002|Dosing Period|Study Terminated by Sponsor|0|||
161080445|NCT02628028|581682357|FG003|Dosing Period|Study Terminated by Sponsor|0|||
161080446|NCT02628028|581682358|FG004|Dosing Period|Study Terminated by Sponsor|7|||
161080447|NCT02628028|581682359|FG005|Dosing Period|Study Terminated by Sponsor|6|||
161080448|NCT02628028|581682360|FG006|Dosing Period|Study Terminated by Sponsor|7|||
161080449|NCT02628028|581682361|FG007|Dosing Period|Study Terminated by Sponsor|7|||
161080450|NCT02628028|581682354|FG000|Dosing Period|Physician Decision|0|||
161289332|NCT02513160|582440533|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
161080451|NCT02628028|581682355|FG001|Dosing Period|Physician Decision|0|||
161080452|NCT02628028|581682356|FG002|Dosing Period|Physician Decision|0|||
161080453|NCT02628028|581682357|FG003|Dosing Period|Physician Decision|0|||
161080454|NCT02628028|581682358|FG004|Dosing Period|Physician Decision|0|||
161080455|NCT02628028|581682359|FG005|Dosing Period|Physician Decision|1|||
161080456|NCT02628028|581682360|FG006|Dosing Period|Physician Decision|0|||
161080457|NCT02628028|581682361|FG007|Dosing Period|Physician Decision|0|||
161080458|NCT02628028|581682354|FG000|Dosing Period|Site Terminated by Sponsor|0|||
161080459|NCT02628028|581682355|FG001|Dosing Period|Site Terminated by Sponsor|0|||
161164365|NCT03334396|581977903|FG007|Overall Study|Started New Job|0|||
161164366|NCT02034474|581977904|FG000|Overall Study|Adverse Event|3|||
161164367|NCT02034474|581977905|FG001|Overall Study|Adverse Event|2|||
161164368|NCT02034474|581977904|FG000|Overall Study|Withdrawal by Subject|1|||
161164369|NCT02034474|581977905|FG001|Overall Study|Withdrawal by Subject|2|||
161164370|NCT01391819|581977906|FG000|Overall Study|Withdrawal by Subject|56|||
161164371|NCT01391819|581977906|FG000|Overall Study|Migrated/moved from study area|82|||
161164372|NCT01391819|581977906|FG000|Overall Study|Lost to Follow-up|252|||
161164373|NCT01391819|581977906|FG000|Overall Study|Death|3|||
161164374|NCT01391819|581977906|FG000|Overall Study|Other|9|||
161164375|NCT03488251|581977908|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
161164376|NCT03488251|581977909|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161164377|NCT03488251|581977910|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161164378|NCT03488251|581977911|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
161164379|NCT03488251|581977908|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
161164380|NCT03488251|581977909|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161164381|NCT03488251|581977910|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161164382|NCT03488251|581977911|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
161164383|NCT03488251|581977908|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
161164384|NCT03488251|581977909|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161164385|NCT03488251|581977910|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161164386|NCT03488251|581977911|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
161164387|NCT03488251|581977908|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
161164388|NCT03488251|581977909|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161164389|NCT03488251|581977910|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161164390|NCT03488251|581977911|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
161164391|NCT03488251|581977908|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
161164392|NCT03488251|581977909|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161164393|NCT03488251|581977910|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161164394|NCT03488251|581977911|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
161164395|NCT00995670|581977912|FG000|Overall Study|Failed arterial cannulation|1|||
161164396|NCT00995670|581977913|FG001|Overall Study|Failed arterial cannulation|0|||
161164397|NCT00995670|581977914|FG002|Overall Study|Failed arterial cannulation|3|||
161164398|NCT03600714|581977915|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
161164399|NCT00592553|581977917|FG000|Overall Study|Protocol Noncompliance|1|||
161164400|NCT00592553|581977918|FG001|Overall Study|Protocol Noncompliance|0|||
161164401|NCT00592553|581977919|FG002|Overall Study|Protocol Noncompliance|0|||
161164402|NCT03829332|581977920|FG000|Overall Study|Death|225|||
161164403|NCT03829332|581977921|FG001|Overall Study|Death|230|||
161164404|NCT03829332|581977920|FG000|Overall Study|Lost to Follow-up|1|||
161164405|NCT03829332|581977921|FG001|Overall Study|Lost to Follow-up|3|||
161164406|NCT03829332|581977920|FG000|Overall Study|Physician Decision|1|||
161164407|NCT03829332|581977921|FG001|Overall Study|Physician Decision|0|||
161164408|NCT03829332|581977920|FG000|Overall Study|Sponsor Decision|71|||
161164409|NCT03829332|581977921|FG001|Overall Study|Sponsor Decision|72|||
161164410|NCT03829332|581977920|FG000|Overall Study|Withdrawal by Subject|11|||
161164411|NCT03829332|581977921|FG001|Overall Study|Withdrawal by Subject|9|||
161164412|NCT01179347|581980551|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
161164413|NCT01179347|581980552|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
161164414|NCT01179347|581980551|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
161164415|NCT01179347|581980552|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
161164416|NCT01179347|581980551|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
161164417|NCT01179347|581980552|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
161164418|NCT01179347|581980551|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
161164419|NCT01179347|581980552|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
161164420|NCT01179347|581980551|FG000|Double-blind Period (12 Weeks)|Other|2|||
161164421|NCT01179347|581980552|FG001|Double-blind Period (12 Weeks)|Other|4|||
161164422|NCT01179347|581980551|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
161164423|NCT01179347|581980552|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
161164424|NCT01179347|581980551|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
161164425|NCT01179347|581980552|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
161164426|NCT01179347|581980551|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
161164427|NCT01179347|581980552|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
161289333|NCT02513160|582440530|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
161289334|NCT02513160|582440531|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161289335|NCT02513160|582440532|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161164428|NCT01179347|581980551|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
161164429|NCT01179347|581980552|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
161164430|NCT01179347|581980551|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
161346822|NCT02783274|582653383|FG000|Overall Study|Physician Decision|6|||
161346823|NCT02783274|582653383|FG000|Overall Study|Death|9|||
161346824|NCT02783274|582653383|FG000|Overall Study|Lost to Follow-up|22|||
161346825|NCT02783274|582653383|FG000|Overall Study|Other|22|||
161346826|NCT05523297|582653384|FG000|Overall Study|Death|7|||
161346827|NCT05523297|582653385|FG001|Overall Study|Death|8|||
161346828|NCT05523297|582653384|FG000|Overall Study|Lost to Follow-up|2|||
161346829|NCT05523297|582653385|FG001|Overall Study|Lost to Follow-up|1|||
161346830|NCT02246777|582653386|FG000|Overall Study|Adverse Event|2|||
161346831|NCT02246777|582653386|FG000|Overall Study|Change of residence|1|||
161346832|NCT00927472|582653387|FG000|Overall Study|Withdrawal by Subject|10|||
161346833|NCT00927472|582653388|FG001|Overall Study|Withdrawal by Subject|11|||
161346834|NCT00927472|582653387|FG000|Overall Study|Lost to Follow-up|1|||
161346835|NCT00927472|582653388|FG001|Overall Study|Lost to Follow-up|6|||
161346836|NCT00927472|582653387|FG000|Overall Study|Protocol Violation|0|||
161346837|NCT00927472|582653388|FG001|Overall Study|Protocol Violation|1|||
161346838|NCT00927472|582653387|FG000|Overall Study|Post treatment Assessment out of window|0|||
161346839|NCT00927472|582653388|FG001|Overall Study|Post treatment Assessment out of window|4|||
161346840|NCT00433537|582653389|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
161346841|NCT00433537|582653390|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
161346842|NCT00433537|582653391|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
161346843|NCT00433537|582653389|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
161346844|NCT00433537|582653390|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
161346845|NCT00433537|582653391|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
161346846|NCT00433537|582653389|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
161346847|NCT00433537|582653390|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
161346848|NCT00433537|582653391|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
161346849|NCT00433537|582653389|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
161346850|NCT00433537|582653390|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
161346851|NCT00433537|582653391|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
161346852|NCT00433537|582653389|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
161346853|NCT00433537|582653390|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
161346854|NCT00433537|582653391|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
161080460|NCT02628028|581682356|FG002|Dosing Period|Site Terminated by Sponsor|0|||
161080461|NCT02628028|581682357|FG003|Dosing Period|Site Terminated by Sponsor|0|||
161080462|NCT02628028|581682358|FG004|Dosing Period|Site Terminated by Sponsor|0|||
161080463|NCT02628028|581682359|FG005|Dosing Period|Site Terminated by Sponsor|1|||
161080464|NCT02628028|581682360|FG006|Dosing Period|Site Terminated by Sponsor|1|||
161080465|NCT02628028|581682361|FG007|Dosing Period|Site Terminated by Sponsor|0|||
161080466|NCT02628028|581682354|FG000|Dosing Period|Lost to Follow-up|0|||
161080467|NCT02628028|581682355|FG001|Dosing Period|Lost to Follow-up|0|||
161080468|NCT02628028|581682356|FG002|Dosing Period|Lost to Follow-up|0|||
161080469|NCT02628028|581682357|FG003|Dosing Period|Lost to Follow-up|0|||
161080470|NCT02628028|581682358|FG004|Dosing Period|Lost to Follow-up|0|||
161080471|NCT02628028|581682359|FG005|Dosing Period|Lost to Follow-up|0|||
161080472|NCT02628028|581682360|FG006|Dosing Period|Lost to Follow-up|1|||
161080473|NCT02628028|581682361|FG007|Dosing Period|Lost to Follow-up|0|||
161080474|NCT02628028|581682354|FG000|Dosing Period|Other|0|||
161080475|NCT02628028|581682355|FG001|Dosing Period|Other|0|||
161289336|NCT02513160|582440533|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
161289337|NCT02513160|582440530|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161289338|NCT02513160|582440531|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
161289339|NCT02513160|582440532|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161289340|NCT02513160|582440533|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
161289341|NCT02861586|582440539|FG000|Overall Study|Withdrawal by Subject|1|||
161289342|NCT02861586|582440540|FG001|Overall Study|Withdrawal by Subject|2|||
161289343|NCT02861586|582440541|FG002|Overall Study|Withdrawal by Subject|0|||
161289344|NCT02861586|582440542|FG003|Overall Study|Withdrawal by Subject|0|||
161289345|NCT02861586|582440543|FG004|Overall Study|Withdrawal by Subject|0|||
161289346|NCT02861586|582440544|FG005|Overall Study|Withdrawal by Subject|1|||
161289347|NCT02861586|582440545|FG006|Overall Study|Withdrawal by Subject|1|||
161289348|NCT02861586|582440546|FG007|Overall Study|Withdrawal by Subject|0|||
161289349|NCT02861586|582440539|FG000|Overall Study|Lost to Follow-up|3|||
161289350|NCT02861586|582440540|FG001|Overall Study|Lost to Follow-up|1|||
161289351|NCT02861586|582440541|FG002|Overall Study|Lost to Follow-up|1|||
161289352|NCT02861586|582440542|FG003|Overall Study|Lost to Follow-up|0|||
161289353|NCT02861586|582440543|FG004|Overall Study|Lost to Follow-up|0|||
161346855|NCT00433537|582653389|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
161080476|NCT02628028|581682356|FG002|Dosing Period|Other|0|||
161080477|NCT02628028|581682357|FG003|Dosing Period|Other|0|||
161080478|NCT02628028|581682358|FG004|Dosing Period|Other|2|||
161080479|NCT02628028|581682359|FG005|Dosing Period|Other|1|||
161080480|NCT02628028|581682360|FG006|Dosing Period|Other|2|||
161080481|NCT02628028|581682361|FG007|Dosing Period|Other|4|||
161080482|NCT02628028|581682354|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
161164431|NCT01179347|581980552|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
161164432|NCT01179347|581980551|FG000|Open-label Period (12 Weeks)|Other|7|||
161164433|NCT01179347|581980552|FG001|Open-label Period (12 Weeks)|Other|4|||
161164434|NCT04092816|581980553|FG000|Overall Study|Lost to Follow-up|1|||
161164435|NCT04092816|581980554|FG001|Overall Study|Lost to Follow-up|2|||
161164436|NCT01677624|581980555|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
161164437|NCT01337167|581980559|FG000|Infant Series|Adverse Event|1|||
161164438|NCT01337167|581980560|FG001|Infant Series|Adverse Event|1|||
161164439|NCT01337167|581980559|FG000|Infant Series|Death|1|||
161164440|NCT01337167|581980560|FG001|Infant Series|Death|1|||
161164441|NCT01337167|581980559|FG000|Infant Series|Lost to Follow-up|13|||
161164442|NCT01337167|581980560|FG001|Infant Series|Lost to Follow-up|7|||
161164443|NCT01337167|581980559|FG000|Infant Series|Non-compliance with study drug|2|||
161164444|NCT01337167|581980560|FG001|Infant Series|Non-compliance with study drug|1|||
161164445|NCT01337167|581980559|FG000|Infant Series|Physician Decision|3|||
161164446|NCT01337167|581980560|FG001|Infant Series|Physician Decision|1|||
161164447|NCT01337167|581980559|FG000|Infant Series|Protocol Violation|22|||
161164448|NCT01337167|581980560|FG001|Infant Series|Protocol Violation|9|||
161080483|NCT02628028|581682355|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
161080484|NCT02628028|581682356|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
161080485|NCT02628028|581682357|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
161080486|NCT02628028|581682358|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
161080487|NCT02628028|581682359|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
161080488|NCT02628028|581682360|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
161080489|NCT02628028|581682361|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
161080490|NCT02628028|581682354|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161080491|NCT02628028|581682355|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161080492|NCT02628028|581682356|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161080493|NCT02628028|581682357|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161080494|NCT02628028|581682358|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161080495|NCT02628028|581682359|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
161080496|NCT02628028|581682360|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
161080497|NCT02628028|581682361|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
161080498|NCT02628028|581682354|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161080499|NCT02628028|581682355|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161080500|NCT02628028|581682356|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161080501|NCT02628028|581682357|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161080502|NCT02628028|581682358|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
161080503|NCT02628028|581682359|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
161080504|NCT02628028|581682360|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
161080505|NCT02628028|581682361|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
161080506|NCT02628028|581682354|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161080507|NCT02628028|581682355|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161080508|NCT02628028|581682356|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161080509|NCT02628028|581682357|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161080510|NCT02628028|581682358|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
161080511|NCT02628028|581682359|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
161080512|NCT02628028|581682360|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
161080513|NCT02628028|581682361|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
161080514|NCT02628028|581682354|FG000|Long-term Extension (LTE) Period|Other|0|||
161080515|NCT02628028|581682355|FG001|Long-term Extension (LTE) Period|Other|0|||
161080516|NCT02628028|581682356|FG002|Long-term Extension (LTE) Period|Other|0|||
161080517|NCT02628028|581682357|FG003|Long-term Extension (LTE) Period|Other|0|||
161080518|NCT02628028|581682358|FG004|Long-term Extension (LTE) Period|Other|0|||
161080519|NCT02628028|581682359|FG005|Long-term Extension (LTE) Period|Other|3|||
161080520|NCT02628028|581682360|FG006|Long-term Extension (LTE) Period|Other|4|||
161080521|NCT02628028|581682361|FG007|Long-term Extension (LTE) Period|Other|3|||
161080522|NCT00586612|581682362|FG000|Primary Phase|Protocol Violation|1|||
161289354|NCT02861586|582440544|FG005|Overall Study|Lost to Follow-up|3|||
161289355|NCT02861586|582440545|FG006|Overall Study|Lost to Follow-up|0|||
161080523|NCT00586612|581682363|FG001|Primary Phase|Protocol Violation|0|||
161080524|NCT00586612|581682362|FG000|Primary Phase|Lost to Follow-up|0|||
161080525|NCT00586612|581682363|FG001|Primary Phase|Lost to Follow-up|1|||
161164449|NCT01337167|581980559|FG000|Infant Series|Withdrawal by Subject|15|||
161080526|NCT00586612|581682362|FG000|Primary Phase|Withdrawal by Subject|0|||
161080527|NCT00586612|581682363|FG001|Primary Phase|Withdrawal by Subject|2|||
161164450|NCT01337167|581980560|FG001|Infant Series|Withdrawal by Subject|4|||
161164451|NCT01337167|581980559|FG000|Infant Series|Randomized but not vaccinated|5|||
161164452|NCT01337167|581980560|FG001|Infant Series|Randomized but not vaccinated|3|||
161164453|NCT01337167|581980559|FG000|Interim Period|Lost to Follow-up|51|||
161164454|NCT01337167|581980560|FG001|Interim Period|Lost to Follow-up|23|||
161164455|NCT01337167|581980559|FG000|Interim Period|Non-compliance with study drug|1|||
161164456|NCT01337167|581980560|FG001|Interim Period|Non-compliance with study drug|0|||
161164457|NCT01337167|581980559|FG000|Interim Period|Physician Decision|6|||
161164458|NCT01337167|581980560|FG001|Interim Period|Physician Decision|3|||
161164459|NCT01337167|581980559|FG000|Interim Period|Protocol Violation|5|||
161164460|NCT01337167|581980560|FG001|Interim Period|Protocol Violation|3|||
161164461|NCT01337167|581980559|FG000|Interim Period|Withdrawal by Subject|18|||
161164462|NCT01337167|581980560|FG001|Interim Period|Withdrawal by Subject|10|||
161164463|NCT01337167|581980559|FG000|Interim Period|Other protocol criterion not met|0|||
161164464|NCT01337167|581980560|FG001|Interim Period|Other protocol criterion not met|1|||
161164465|NCT01337167|581980559|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
161164466|NCT01337167|581980560|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
161164467|NCT01337167|581980559|FG000|Toddler Vaccinations|Protocol Violation|0|||
161164468|NCT01337167|581980560|FG001|Toddler Vaccinations|Protocol Violation|1|||
161164469|NCT01337167|581980559|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
161164470|NCT01337167|581980560|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
161164471|NCT03833817|581980561|FG000|Overall Study|Withdrawal by Subject|3|||
161164472|NCT03833817|581980562|FG001|Overall Study|Withdrawal by Subject|3|||
161164473|NCT03833817|581980561|FG000|Overall Study|Lost to Follow-up|3|||
161164474|NCT03833817|581980562|FG001|Overall Study|Lost to Follow-up|3|||
161164475|NCT02126670|581980567|FG000|Overall Study|Withdrawal by Subject|1|||
161164476|NCT02126670|581980568|FG001|Overall Study|Withdrawal by Subject|0|||
161164477|NCT02126670|581980569|FG002|Overall Study|Withdrawal by Subject|0|||
161164478|NCT02126670|581980570|FG003|Overall Study|Withdrawal by Subject|1|||
161164479|NCT03363919|581980573|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
161164480|NCT03363919|581980574|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
161164481|NCT03363919|581980573|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
161164482|NCT03363919|581980574|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
161164483|NCT01975246|581980575|FG000|Overall Study|Adverse Event|2|||
161164484|NCT01975246|581980576|FG001|Overall Study|Adverse Event|1|||
161164485|NCT01975246|581980575|FG000|Overall Study|Lack of Efficacy|1|||
161164486|NCT01975246|581980576|FG001|Overall Study|Lack of Efficacy|0|||
161164487|NCT01975246|581980575|FG000|Overall Study|Protocol Violation|1|||
161164488|NCT01975246|581980576|FG001|Overall Study|Protocol Violation|0|||
161164489|NCT01975246|581980575|FG000|Overall Study|Other than stated|0|||
161164490|NCT01975246|581980576|FG001|Overall Study|Other than stated|1|||
161164491|NCT01646398|581980577|FG000|Overall Study|Withdrawal by Subject|1|||
161164492|NCT01646398|581980578|FG001|Overall Study|Withdrawal by Subject|0|||
161164493|NCT01263093|581980579|FG000|Washout|Physician Decision|1|||
161164494|NCT01263093|581980580|FG001|Washout|Physician Decision|0|||
161164495|NCT01263093|581980579|FG000|Period 2|Adverse Event|1|||
161164496|NCT01263093|581980580|FG001|Period 2|Adverse Event|0|||
161164497|NCT01827319|581980581|FG000|Overall Study|Lost to Follow-up|3|||
161164498|NCT00571519|581980582|FG000|Overall Study|Subject withdrew consent|0|||
161164499|NCT00571519|581980583|FG001|Overall Study|Subject withdrew consent|1|||
161164500|NCT00571519|581980584|FG002|Overall Study|Subject withdrew consent|0|||
161164501|NCT00571519|581980585|FG003|Overall Study|Subject withdrew consent|2|||
161164502|NCT00571519|581980586|FG004|Overall Study|Subject withdrew consent|1|||
161164503|NCT00571519|581980587|FG005|Overall Study|Subject withdrew consent|1|||
161164504|NCT00571519|581980588|FG006|Overall Study|Subject withdrew consent|2|||
161164505|NCT00571519|581980582|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161164506|NCT00571519|581980583|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161164507|NCT00571519|581980584|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161164508|NCT00571519|581980585|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
161164509|NCT00571519|581980586|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161164510|NCT00571519|581980587|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161164511|NCT00571519|581980588|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
161164512|NCT00571519|581980582|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
161164513|NCT00571519|581980583|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
161164514|NCT00571519|581980584|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
161164515|NCT00571519|581980585|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
161164516|NCT00571519|581980586|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
161164517|NCT00571519|581980587|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
161289356|NCT02861586|582440546|FG007|Overall Study|Lost to Follow-up|0|||
161289357|NCT02861586|582440539|FG000|Overall Study|Adverse Event|0|||
161289358|NCT02861586|582440540|FG001|Overall Study|Adverse Event|0|||
161289359|NCT02861586|582440541|FG002|Overall Study|Adverse Event|0|||
161289360|NCT02861586|582440542|FG003|Overall Study|Adverse Event|0|||
161289361|NCT02861586|582440543|FG004|Overall Study|Adverse Event|0|||
161289362|NCT02861586|582440544|FG005|Overall Study|Adverse Event|1|||
161164518|NCT00571519|581980588|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
161164519|NCT00571519|581980582|FG000|Overall Study|Termination of study by Sponsor|2|||
161289363|NCT02861586|582440545|FG006|Overall Study|Adverse Event|0|||
161164520|NCT00571519|581980583|FG001|Overall Study|Termination of study by Sponsor|7|||
161164521|NCT00571519|581980584|FG002|Overall Study|Termination of study by Sponsor|10|||
161164522|NCT00571519|581980585|FG003|Overall Study|Termination of study by Sponsor|24|||
161164523|NCT00571519|581980586|FG004|Overall Study|Termination of study by Sponsor|8|||
161164524|NCT00571519|581980587|FG005|Overall Study|Termination of study by Sponsor|9|||
161164525|NCT00571519|581980588|FG006|Overall Study|Termination of study by Sponsor|22|||
161164526|NCT00571519|581980582|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161164527|NCT00571519|581980583|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161164528|NCT00571519|581980584|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
161164529|NCT00571519|581980585|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161164530|NCT00571519|581980586|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161164531|NCT00571519|581980587|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161164532|NCT00571519|581980588|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
161164533|NCT02499575|581980590|FG000|Overall Study|Protocol Violation|0|||
161164534|NCT02499575|581980591|FG001|Overall Study|Protocol Violation|1|||
161164535|NCT05458011|581980593|FG000|DB Period (12 Weeks)|Adverse Event|2|||
161164536|NCT05458011|581980594|FG001|DB Period (12 Weeks)|Adverse Event|1|||
161164537|NCT05458011|581980595|FG002|DB Period (12 Weeks)|Adverse Event|1|||
161164538|NCT05458011|581980593|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
161164539|NCT05458011|581980594|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
161164540|NCT05458011|581980595|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
161164541|NCT05458011|581980593|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
161164542|NCT05458011|581980594|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
161164543|NCT05458011|581980595|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
161164544|NCT05458011|581980593|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
161164545|NCT05458011|581980594|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
161164546|NCT05458011|581980595|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
161164547|NCT05458011|581980593|FG000|OL Period (12 Weeks)|Adverse Event|1|||
161164548|NCT05458011|581980594|FG001|OL Period (12 Weeks)|Adverse Event|2|||
161164549|NCT05458011|581980595|FG002|OL Period (12 Weeks)|Adverse Event|1|||
161164550|NCT05458011|581980593|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
161164551|NCT05458011|581980594|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
161164552|NCT05458011|581980595|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
161164553|NCT00574119|581980597|FG000|Overall Study|Adverse Event|1|||
161164554|NCT00574119|581980597|FG000|Overall Study|Protocol Violation|1|||
161164555|NCT00574119|581980597|FG000|Overall Study|Withdrawal by Subject|1|||
161164556|NCT00574119|581980597|FG000|Overall Study|Physician Decision|1|||
161164557|NCT02690207|581980601|FG000|Overall Study|Lost to Follow-up|48|||
161164558|NCT02690207|581980601|FG000|Overall Study|Withdrawal by Subject|46|||
161164559|NCT02690207|581980601|FG000|Overall Study|Protocol Violation|2|||
161164560|NCT02690207|581980601|FG000|Overall Study|Serious adverse event|110|||
161164561|NCT02690207|581980601|FG000|Overall Study|Non-serious Adverse Event|18|||
161164562|NCT02690207|581980601|FG000|Overall Study|Migrated/moved from study area|5|||
161164563|NCT02690207|581980601|FG000|Overall Study|Suspected HZ Episode|1|||
161164564|NCT02690207|581980601|FG000|Overall Study|Other reasons for withdrawal|23|||
161164565|NCT04656418|581980604|FG000|Overall Study|Withdrawal by Subject|1|||
161164566|NCT04656418|581980605|FG001|Overall Study|Withdrawal by Subject|3|||
161164567|NCT03287245|581980606|FG000|Overall Study|Study terminated by sponsor|3|||
161164568|NCT03287245|581980607|FG001|Overall Study|Study terminated by sponsor|0|||
161164569|NCT03287245|581980608|FG002|Overall Study|Study terminated by sponsor|3|||
161164570|NCT03287245|581980609|FG003|Overall Study|Study terminated by sponsor|1|||
161164571|NCT03287245|581980606|FG000|Overall Study|Adverse Event|1|||
161164572|NCT03287245|581980607|FG001|Overall Study|Adverse Event|0|||
161164573|NCT03287245|581980608|FG002|Overall Study|Adverse Event|0|||
161164574|NCT03287245|581980609|FG003|Overall Study|Adverse Event|0|||
161164575|NCT03287245|581980606|FG000|Overall Study|Withdrawal by Subject|8|||
161164576|NCT03287245|581980607|FG001|Overall Study|Withdrawal by Subject|3|||
161164577|NCT03287245|581980608|FG002|Overall Study|Withdrawal by Subject|3|||
161289364|NCT02861586|582440546|FG007|Overall Study|Adverse Event|0|||
161289365|NCT00803790|582440547|FG000|Period 1|Adverse Event|0|||
161289366|NCT00803790|582440548|FG001|Period 1|Adverse Event|1|||
161289367|NCT00803790|582440549|FG002|Period 1|Adverse Event|0|||
161289368|NCT00803790|582440550|FG003|Period 1|Adverse Event|0|||
161289369|NCT00803790|582440547|FG000|Period 1|Lost to Follow-up|1|||
161289370|NCT00803790|582440548|FG001|Period 1|Lost to Follow-up|2|||
161164578|NCT03287245|581980609|FG003|Overall Study|Withdrawal by Subject|0|||
161164579|NCT03287245|581980606|FG000|Overall Study|Physician Decision|3|||
161164580|NCT03287245|581980607|FG001|Overall Study|Physician Decision|2|||
161164581|NCT03287245|581980608|FG002|Overall Study|Physician Decision|0|||
161164582|NCT03287245|581980609|FG003|Overall Study|Physician Decision|0|||
161164583|NCT02586077|581980610|FG000|Overall Study|Withdrawal by Subject|1|||
161164584|NCT02586077|581980610|FG000|Overall Study|Physician Decision|4|||
161164585|NCT02586077|581980610|FG000|Overall Study|Lost to Follow-up|3|||
161164586|NCT02701192|581980611|FG000|Overall Study|Protocol Violation|2|||
161164587|NCT02701192|581980611|FG000|Overall Study|Lost to Follow-up|4|||
161164588|NCT02862548|581980612|FG000|Randomized Phase (Up to Week 48)|Death|0|||
161164589|NCT02862548|581980613|FG001|Randomized Phase (Up to Week 48)|Death|1|||
161164590|NCT02862548|581980612|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
161164591|NCT02862548|581980613|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
161164592|NCT02862548|581980612|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
161164593|NCT02862548|581980613|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
161164594|NCT02862548|581980612|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
161164595|NCT02862548|581980613|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
161164596|NCT00880763|581980614|FG000|Extension Period (Part 2)|Adverse Event|0|||
161164597|NCT00880763|581980615|FG001|Extension Period (Part 2)|Adverse Event|0|||
161164598|NCT00880763|581980616|FG002|Extension Period (Part 2)|Adverse Event|1|||
161164599|NCT00880763|581980617|FG003|Extension Period (Part 2)|Adverse Event|1|||
161164600|NCT00880763|581980614|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
161164601|NCT00880763|581980615|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
161164602|NCT00880763|581980616|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
161164603|NCT00880763|581980617|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
161164604|NCT00880763|581980614|FG000|Extension Period (Part 2)|Physician Decision|0|||
161164605|NCT00880763|581980615|FG001|Extension Period (Part 2)|Physician Decision|1|||
161164606|NCT00880763|581980616|FG002|Extension Period (Part 2)|Physician Decision|1|||
161164607|NCT00880763|581980617|FG003|Extension Period (Part 2)|Physician Decision|0|||
161164608|NCT00880763|581980614|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
161164609|NCT00880763|581980615|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
161164610|NCT00880763|581980616|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
161164611|NCT00880763|581980617|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
161164612|NCT01245764|581980618|FG000|Study Phase A|Other|3|||
161164613|NCT01245764|581980619|FG001|Study Phase A|Other|2|||
161164614|NCT01245764|581980620|FG002|Study Phase A|Other|3|||
161164615|NCT01245764|581980621|FG003|Study Phase A|Other|1|||
161164616|NCT01245764|581980618|FG000|Study Phase A|Protocol Violation|6|||
161164617|NCT01245764|581980619|FG001|Study Phase A|Protocol Violation|3|||
161164618|NCT01245764|581980620|FG002|Study Phase A|Protocol Violation|2|||
161164619|NCT01245764|581980621|FG003|Study Phase A|Protocol Violation|2|||
161164620|NCT01245764|581980618|FG000|Study Phase A|Lost to Follow-up|0|||
161164621|NCT01245764|581980619|FG001|Study Phase A|Lost to Follow-up|0|||
161164622|NCT01245764|581980620|FG002|Study Phase A|Lost to Follow-up|5|||
161164623|NCT01245764|581980621|FG003|Study Phase A|Lost to Follow-up|0|||
161164624|NCT00003476|581980622|FG000|Overall Study|Not evaluable|1|||
161164625|NCT02475850|581980623|FG000|Overall Study|Death|155|||
161164626|NCT02475850|581980624|FG001|Overall Study|Death|141|||
161164627|NCT02475850|581980623|FG000|Overall Study|Lost to Follow-up|217|||
161164628|NCT02475850|581980624|FG001|Overall Study|Lost to Follow-up|188|||
161164629|NCT02475850|581980623|FG000|Overall Study|Withdrawal by Subject|221|||
161164630|NCT02475850|581980624|FG001|Overall Study|Withdrawal by Subject|155|||
161164631|NCT02667457|581980627|FG000|Overall Study|Withdrawal by Subject|1|||
161164632|NCT02667457|581980628|FG001|Overall Study|Withdrawal by Subject|0|||
161164633|NCT02667457|581980627|FG000|Overall Study|Other Reason|0|||
161164634|NCT02667457|581980628|FG001|Overall Study|Other Reason|2|||
161164635|NCT03097614|581980630|FG000|Overall Study|Adverse Event|3|||
161164636|NCT03057951|581980636|FG000|Overall Study|Adverse Event|553|||
161164637|NCT03057951|581980637|FG001|Overall Study|Adverse Event|575|||
161164638|NCT03057951|581980636|FG000|Overall Study|Protocol Violation|30|||
161164639|NCT03057951|581980637|FG001|Overall Study|Protocol Violation|24|||
161164640|NCT03057951|581980636|FG000|Overall Study|Lost to Follow-up|6|||
161164641|NCT03057951|581980637|FG001|Overall Study|Lost to Follow-up|16|||
161164642|NCT03057951|581980636|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
161164643|NCT03057951|581980637|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
161289371|NCT00803790|582440549|FG002|Period 1|Lost to Follow-up|0|||
161289372|NCT00803790|582440550|FG003|Period 1|Lost to Follow-up|0|||
161289373|NCT00803790|582440547|FG000|Period 1|Withdrawal by Subject|8|||
161289374|NCT00803790|582440548|FG001|Period 1|Withdrawal by Subject|6|||
161164644|NCT03057951|581980636|FG000|Overall Study|Study drug stopped, reason missing|6|||
161164645|NCT03057951|581980637|FG001|Overall Study|Study drug stopped, reason missing|1|||
161289375|NCT00803790|582440549|FG002|Period 1|Withdrawal by Subject|0|||
161164646|NCT03057951|581980636|FG000|Overall Study|Medical advice|6|||
161289376|NCT00803790|582440550|FG003|Period 1|Withdrawal by Subject|0|||
161289377|NCT00803790|582440547|FG000|Period 1|positive drug screen or personal reasons|0|||
161289378|NCT00803790|582440548|FG001|Period 1|positive drug screen or personal reasons|3|||
161164647|NCT03057951|581980637|FG001|Overall Study|Medical advice|2|||
161164648|NCT03057951|581980636|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
161164649|NCT03057951|581980637|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
161164650|NCT03057951|581980636|FG000|Overall Study|Investigator decision|2|||
161164651|NCT03057951|581980637|FG001|Overall Study|Investigator decision|0|||
161164652|NCT03057951|581980636|FG000|Overall Study|Patient decision|5|||
161164653|NCT03057951|581980637|FG001|Overall Study|Patient decision|2|||
161164654|NCT03057951|581980636|FG000|Overall Study|Not attending study visits|3|||
161164655|NCT03057951|581980637|FG001|Overall Study|Not attending study visits|0|||
161289379|NCT00803790|582440549|FG002|Period 1|positive drug screen or personal reasons|0|||
161289380|NCT00803790|582440550|FG003|Period 1|positive drug screen or personal reasons|4|||
161289381|NCT00803790|582440547|FG000|Period 1|Protocol Violation|0|||
161289382|NCT00803790|582440548|FG001|Period 1|Protocol Violation|0|||
161289383|NCT00803790|582440549|FG002|Period 1|Protocol Violation|1|||
161289384|NCT00803790|582440550|FG003|Period 1|Protocol Violation|0|||
161080528|NCT00586612|581682362|FG000|Booster Phase|Lost to Follow-up|3|||
161080529|NCT00586612|581682363|FG001|Booster Phase|Lost to Follow-up|1|||
161080530|NCT00186888|581682364|FG000|Overall Study|Toxicity|0|||
161080531|NCT00186888|581682365|FG001|Overall Study|Toxicity|1|||
161080532|NCT00186888|581682366|FG002|Overall Study|Toxicity|0|||
161080533|NCT00186888|581682364|FG000|Overall Study|Relapse or progression of disease|4|||
161080534|NCT00186888|581682365|FG001|Overall Study|Relapse or progression of disease|2|||
161080535|NCT00186888|581682366|FG002|Overall Study|Relapse or progression of disease|0|||
161080536|NCT04777864|581682367|FG000|Overall Study|Lost to Follow-up|8|||
161080537|NCT04777864|581682368|FG001|Overall Study|Lost to Follow-up|19|||
161080538|NCT03086655|581682369|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
161080539|NCT03086655|581682370|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
161080540|NCT03086655|581682369|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
161080541|NCT03086655|581682370|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
161080542|NCT03086655|581682369|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
161080543|NCT03086655|581682370|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
161080544|NCT03086655|581682369|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
161080545|NCT03086655|581682370|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
161080546|NCT03086655|581682369|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
161080547|NCT03086655|581682370|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
161080548|NCT03086655|581682369|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
161080549|NCT03086655|581682370|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
161080550|NCT03086655|581682369|FG000|12 Month Follow-up = Final Assessment|Death|0|||
161080551|NCT03086655|581682370|FG001|12 Month Follow-up = Final Assessment|Death|1|||
161080552|NCT00384397|581682371|FG000|Overall Study|Adverse Event|0|||
161080553|NCT00384397|581682372|FG001|Overall Study|Adverse Event|1|||
161080554|NCT00384397|581682373|FG002|Overall Study|Adverse Event|2|||
161080555|NCT00384397|581682371|FG000|Overall Study|Protocol Violation|7|||
161080556|NCT00384397|581682372|FG001|Overall Study|Protocol Violation|15|||
161080557|NCT00384397|581682373|FG002|Overall Study|Protocol Violation|13|||
161080558|NCT00384397|581682371|FG000|Overall Study|Lost to Follow-up|11|||
161080559|NCT00384397|581682372|FG001|Overall Study|Lost to Follow-up|13|||
161080560|NCT00384397|581682373|FG002|Overall Study|Lost to Follow-up|3|||
161080561|NCT00384397|581682371|FG000|Overall Study|Withdrawal by Subject|14|||
161080562|NCT00384397|581682372|FG001|Overall Study|Withdrawal by Subject|17|||
161080563|NCT00384397|581682373|FG002|Overall Study|Withdrawal by Subject|15|||
161080564|NCT06748729|581682375|FG000|Overall Study|Withdrawal by Subject|1|||
161080565|NCT01732822|581684373|FG000|Overall Study|Withdrawal by Subject|123|||
161080566|NCT01732822|581684374|FG001|Overall Study|Withdrawal by Subject|113|||
161080567|NCT02314780|581684375|FG000|Overall Study|organizational reasons|0|||
161080568|NCT02314780|581684376|FG001|Overall Study|organizational reasons|2|||
161080569|NCT02314780|581684377|FG002|Overall Study|organizational reasons|0|||
161080570|NCT02314780|581684375|FG000|Overall Study|Adverse Event|0|||
161080571|NCT02314780|581684376|FG001|Overall Study|Adverse Event|1|||
161080572|NCT02314780|581684377|FG002|Overall Study|Adverse Event|0|||
161080573|NCT01901432|581684378|FG000|Overall Study|Adverse Event|0|||
161080574|NCT01901432|581684379|FG001|Overall Study|Adverse Event|1|||
161080575|NCT01901432|581684380|FG002|Overall Study|Adverse Event|1|||
161080576|NCT01901432|581684381|FG003|Overall Study|Adverse Event|0|||
161080577|NCT01901432|581684382|FG004|Overall Study|Adverse Event|1|||
161080578|NCT01901432|581684378|FG000|Overall Study|Withdrawal by Subject|0|||
161080579|NCT01901432|581684379|FG001|Overall Study|Withdrawal by Subject|0|||
161080580|NCT01901432|581684380|FG002|Overall Study|Withdrawal by Subject|1|||
161080581|NCT01901432|581684381|FG003|Overall Study|Withdrawal by Subject|0|||
161080582|NCT01901432|581684382|FG004|Overall Study|Withdrawal by Subject|5|||
161080583|NCT01901432|581684378|FG000|Overall Study|Physician Decision|0|||
161080584|NCT01901432|581684379|FG001|Overall Study|Physician Decision|0|||
161080585|NCT01901432|581684380|FG002|Overall Study|Physician Decision|0|||
161080586|NCT01901432|581684381|FG003|Overall Study|Physician Decision|0|||
161080587|NCT01901432|581684382|FG004|Overall Study|Physician Decision|2|||
161080588|NCT01901432|581684378|FG000|Overall Study|Patient decision to stop study drug|0|||
161080589|NCT01901432|581684379|FG001|Overall Study|Patient decision to stop study drug|0|||
161080590|NCT01901432|581684380|FG002|Overall Study|Patient decision to stop study drug|0|||
161080591|NCT01901432|581684381|FG003|Overall Study|Patient decision to stop study drug|0|||
161080592|NCT01901432|581684382|FG004|Overall Study|Patient decision to stop study drug|1|||
161080593|NCT01077271|581684388|FG000|Overall Study|Parental desire|8|||
161080594|NCT01077271|581684388|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
161289385|NCT00803790|582440547|FG000|Period 2|Adverse Event|0|||
161289386|NCT00803790|582440548|FG001|Period 2|Adverse Event|0|||
161289387|NCT00803790|582440549|FG002|Period 2|Adverse Event|1|||
161346856|NCT00433537|582653390|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
161346857|NCT00433537|582653391|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
161346858|NCT00433537|582653389|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
161346859|NCT00433537|582653390|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
161346860|NCT00433537|582653391|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
161346861|NCT00433537|582653389|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
161080595|NCT01077271|581684388|FG000|Overall Study|Noncompliance|2|||
161080596|NCT01077271|581684388|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
161080597|NCT01077271|581684388|FG000|Overall Study|Changed doctors|2|||
161289388|NCT00803790|582440550|FG003|Period 2|Adverse Event|1|||
161289389|NCT00803790|582440547|FG000|Period 2|Withdrawal by Subject|1|||
161289390|NCT00803790|582440548|FG001|Period 2|Withdrawal by Subject|0|||
161289391|NCT00803790|582440549|FG002|Period 2|Withdrawal by Subject|0|||
161289392|NCT00803790|582440550|FG003|Period 2|Withdrawal by Subject|0|||
161289393|NCT00803790|582440547|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
161289394|NCT00803790|582440548|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
161289395|NCT00803790|582440549|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
161080598|NCT01077271|581684388|FG000|Overall Study|Parents thought too many injections|2|||
161080599|NCT01077271|581684388|FG000|Overall Study|End of RSV season nearly reached|1|||
161080600|NCT01077271|581684388|FG000|Overall Study|Mother unconvinced of the necessity|1|||
161080601|NCT00379288|581684389|FG000|Overall Study|Adverse Event|5|||
161080602|NCT00379288|581684390|FG001|Overall Study|Adverse Event|6|||
161080603|NCT00379288|581684391|FG002|Overall Study|Adverse Event|2|||
161080604|NCT00379288|581684392|FG003|Overall Study|Adverse Event|0|||
161080605|NCT00379288|581684389|FG000|Overall Study|Treatment Failure|0|||
161080606|NCT00379288|581684390|FG001|Overall Study|Treatment Failure|1|||
161080607|NCT00379288|581684391|FG002|Overall Study|Treatment Failure|0|||
161080608|NCT00379288|581684392|FG003|Overall Study|Treatment Failure|1|||
161080609|NCT00379288|581684389|FG000|Overall Study|Lost to Follow-up|3|||
161080610|NCT00379288|581684390|FG001|Overall Study|Lost to Follow-up|3|||
161080611|NCT00379288|581684391|FG002|Overall Study|Lost to Follow-up|2|||
161080612|NCT00379288|581684392|FG003|Overall Study|Lost to Follow-up|0|||
161080613|NCT00379288|581684389|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
161080614|NCT00379288|581684390|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
161080615|NCT00379288|581684391|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
161289396|NCT00803790|582440550|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
161289397|NCT04710576|582440551|FG000|Overall Study|Participants still in the study|73|||
161289398|NCT04710576|582440552|FG001|Overall Study|Participants still in the study|70|||
161289399|NCT04710576|582440553|FG002|Overall Study|Participants still in the study|60|||
161289400|NCT04710576|582440551|FG000|Overall Study|Death|2|||
161289401|NCT04710576|582440552|FG001|Overall Study|Death|7|||
161289402|NCT04710576|582440553|FG002|Overall Study|Death|12|||
161289403|NCT04710576|582440551|FG000|Overall Study|Withdrawal by Subject|4|||
161289404|NCT04710576|582440552|FG001|Overall Study|Withdrawal by Subject|3|||
161289405|NCT04710576|582440553|FG002|Overall Study|Withdrawal by Subject|7|||
161289406|NCT04710576|582440551|FG000|Overall Study|Sponsor decision|1|||
161289407|NCT04710576|582440552|FG001|Overall Study|Sponsor decision|0|||
161289408|NCT04710576|582440553|FG002|Overall Study|Sponsor decision|0|||
161289409|NCT04581824|582440554|FG000|Overall Study|Lost to Follow-up|1|||
161289410|NCT04581824|582440555|FG001|Overall Study|Lost to Follow-up|0|||
161289411|NCT04581824|582440554|FG000|Overall Study|Withdrawal by Subject|2|||
161289412|NCT04581824|582440555|FG001|Overall Study|Withdrawal by Subject|7|||
161289413|NCT04581824|582440554|FG000|Overall Study|Study terminated by sponsor|37|||
161289414|NCT04581824|582440555|FG001|Overall Study|Study terminated by sponsor|23|||
161289415|NCT04796909|582440556|FG000|Overall Study|Withdrawal by Subject|1|||
161289416|NCT04796909|582440557|FG001|Overall Study|Withdrawal by Subject|1|||
161289417|NCT00437021|582440558|FG000|Overall Study|Adverse Event|0|||
161289418|NCT00437021|582440559|FG001|Overall Study|Adverse Event|0|||
161289419|NCT00437021|582440560|FG002|Overall Study|Adverse Event|0|||
161289420|NCT00437021|582440561|FG003|Overall Study|Adverse Event|0|||
161289421|NCT00437021|582440562|FG004|Overall Study|Adverse Event|0|||
161289422|NCT00437021|582440563|FG005|Overall Study|Adverse Event|0|||
161289423|NCT00437021|582440564|FG006|Overall Study|Adverse Event|1|||
161289424|NCT00437021|582440565|FG007|Overall Study|Adverse Event|0|||
161289425|NCT00437021|582440566|FG008|Overall Study|Adverse Event|0|||
161289426|NCT00437021|582440567|FG009|Overall Study|Adverse Event|0|||
161289427|NCT00437021|582440568|FG010|Overall Study|Adverse Event|0|||
161289428|NCT00437021|582440569|FG011|Overall Study|Adverse Event|0|||
161289429|NCT00437021|582440558|FG000|Overall Study|Lost to Follow-up|0|||
161289430|NCT00437021|582440559|FG001|Overall Study|Lost to Follow-up|3|||
161289431|NCT00437021|582440560|FG002|Overall Study|Lost to Follow-up|0|||
161289432|NCT00437021|582440561|FG003|Overall Study|Lost to Follow-up|0|||
161289433|NCT00437021|582440562|FG004|Overall Study|Lost to Follow-up|0|||
161289434|NCT00437021|582440563|FG005|Overall Study|Lost to Follow-up|2|||
161080616|NCT00379288|581684392|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
161289435|NCT00437021|582440564|FG006|Overall Study|Lost to Follow-up|0|||
161289436|NCT00437021|582440565|FG007|Overall Study|Lost to Follow-up|1|||
161289437|NCT00437021|582440566|FG008|Overall Study|Lost to Follow-up|0|||
161289438|NCT00437021|582440567|FG009|Overall Study|Lost to Follow-up|0|||
161289439|NCT00437021|582440568|FG010|Overall Study|Lost to Follow-up|0|||
161289440|NCT00437021|582440569|FG011|Overall Study|Lost to Follow-up|0|||
161289441|NCT00437021|582440558|FG000|Overall Study|Withdrawal by Subject|2|||
161289442|NCT00437021|582440559|FG001|Overall Study|Withdrawal by Subject|1|||
161289443|NCT00437021|582440560|FG002|Overall Study|Withdrawal by Subject|0|||
161289444|NCT00437021|582440561|FG003|Overall Study|Withdrawal by Subject|0|||
161289445|NCT00437021|582440562|FG004|Overall Study|Withdrawal by Subject|0|||
161289446|NCT00437021|582440563|FG005|Overall Study|Withdrawal by Subject|0|||
161289447|NCT00437021|582440564|FG006|Overall Study|Withdrawal by Subject|0|||
161289448|NCT00437021|582440565|FG007|Overall Study|Withdrawal by Subject|0|||
161289449|NCT00437021|582440566|FG008|Overall Study|Withdrawal by Subject|0|||
161289450|NCT00437021|582440567|FG009|Overall Study|Withdrawal by Subject|0|||
161289451|NCT00437021|582440568|FG010|Overall Study|Withdrawal by Subject|0|||
161289452|NCT00437021|582440569|FG011|Overall Study|Withdrawal by Subject|0|||
161289453|NCT04162847|582440570|FG000|Overall Study|Withdrawal by Subject|7|||
161289454|NCT04162847|582440571|FG001|Overall Study|Withdrawal by Subject|1|||
161164656|NCT03057951|581980636|FG000|Overall Study|Patient moved away|3|||
161164657|NCT03057951|581980637|FG001|Overall Study|Patient moved away|4|||
161164658|NCT03057951|581980636|FG000|Overall Study|Other reason than stated above|23|||
161164659|NCT03057951|581980637|FG001|Overall Study|Other reason than stated above|29|||
161164660|NCT03057951|581980636|FG000|Overall Study|Not treated|2|||
161164661|NCT03057951|581980637|FG001|Overall Study|Not treated|1|||
161164662|NCT02700919|581980638|FG000|Overall Study|Physician Decision|1|||
161164663|NCT02700919|581980639|FG001|Overall Study|Physician Decision|0|||
161164664|NCT02700919|581980640|FG002|Overall Study|Physician Decision|0|||
161164665|NCT02700919|581980638|FG000|Overall Study|Protocol Violation|1|||
161164666|NCT02700919|581980639|FG001|Overall Study|Protocol Violation|0|||
161164667|NCT02700919|581980640|FG002|Overall Study|Protocol Violation|0|||
161164668|NCT02700919|581980638|FG000|Overall Study|Adverse Event|1|||
161164669|NCT02700919|581980639|FG001|Overall Study|Adverse Event|3|||
161164670|NCT02700919|581980640|FG002|Overall Study|Adverse Event|1|||
161164671|NCT02700919|581980638|FG000|Overall Study|Withdrawal by Subject|5|||
161164672|NCT02700919|581980639|FG001|Overall Study|Withdrawal by Subject|8|||
161164673|NCT02700919|581980640|FG002|Overall Study|Withdrawal by Subject|2|||
161164674|NCT02700919|581980638|FG000|Overall Study|Lost to Follow-up|2|||
161164675|NCT02700919|581980639|FG001|Overall Study|Lost to Follow-up|0|||
161164676|NCT02700919|581980640|FG002|Overall Study|Lost to Follow-up|0|||
161164677|NCT02700919|581980638|FG000|Overall Study|Other|2|||
161164678|NCT02700919|581980639|FG001|Overall Study|Other|1|||
161164679|NCT02700919|581980640|FG002|Overall Study|Other|1|||
161164680|NCT03434418|581980641|FG000|Overall Study|Disease Progression|11|||
161164681|NCT03434418|581980641|FG000|Overall Study|Adverse Event|2|||
161164682|NCT03434418|581980641|FG000|Overall Study|Physician Decision|1|||
161164683|NCT03434418|581980641|FG000|Overall Study|Decline in Performance Status (PS)|1|||
161164684|NCT00696436|581980643|FG000|Overall Study|Adverse Event|7|||
161164685|NCT00696436|581980644|FG001|Overall Study|Adverse Event|9|||
161164686|NCT00696436|581980645|FG002|Overall Study|Adverse Event|8|||
161164687|NCT00696436|581980646|FG003|Overall Study|Adverse Event|6|||
161164688|NCT00696436|581980647|FG004|Overall Study|Adverse Event|4|||
161164689|NCT00696436|581980643|FG000|Overall Study|Protocol Violation|3|||
161164690|NCT00696436|581980644|FG001|Overall Study|Protocol Violation|2|||
161164691|NCT00696436|581980645|FG002|Overall Study|Protocol Violation|2|||
161164692|NCT00696436|581980646|FG003|Overall Study|Protocol Violation|0|||
161164693|NCT00696436|581980647|FG004|Overall Study|Protocol Violation|1|||
161164694|NCT00696436|581980643|FG000|Overall Study|Lost to Follow-up|1|||
161164695|NCT00696436|581980644|FG001|Overall Study|Lost to Follow-up|6|||
161164696|NCT00696436|581980645|FG002|Overall Study|Lost to Follow-up|2|||
161164697|NCT00696436|581980646|FG003|Overall Study|Lost to Follow-up|4|||
161164698|NCT00696436|581980647|FG004|Overall Study|Lost to Follow-up|3|||
161164699|NCT00696436|581980643|FG000|Overall Study|Withdrawal by Subject|4|||
161289455|NCT03985800|582440572|FG000|Overall Study|Death|1|||
161289456|NCT03985800|582440573|FG001|Overall Study|Death|2|||
161289457|NCT03985800|582440572|FG000|Overall Study|Withdrawal by Subject|3|||
161289458|NCT03985800|582440573|FG001|Overall Study|Withdrawal by Subject|6|||
161289459|NCT03985800|582440572|FG000|Overall Study|Protocol Violation|2|||
161289460|NCT03985800|582440573|FG001|Overall Study|Protocol Violation|0|||
161289461|NCT05258773|582440574|FG000|Overall Study|Screen Failure|1|||
161164700|NCT00696436|581980644|FG001|Overall Study|Withdrawal by Subject|11|||
161164701|NCT00696436|581980645|FG002|Overall Study|Withdrawal by Subject|5|||
161164702|NCT00696436|581980646|FG003|Overall Study|Withdrawal by Subject|7|||
161164703|NCT00696436|581980647|FG004|Overall Study|Withdrawal by Subject|1|||
161164704|NCT00696436|581980643|FG000|Overall Study|Lack of Efficacy|3|||
161164705|NCT00696436|581980644|FG001|Overall Study|Lack of Efficacy|1|||
161164706|NCT00696436|581980645|FG002|Overall Study|Lack of Efficacy|5|||
161164707|NCT00696436|581980646|FG003|Overall Study|Lack of Efficacy|2|||
161289462|NCT05258773|582440575|FG001|Overall Study|Screen Failure|1|||
161164708|NCT00696436|581980647|FG004|Overall Study|Lack of Efficacy|4|||
161164709|NCT00696436|581980643|FG000|Overall Study|Participant Unavailability|2|||
161164710|NCT00696436|581980644|FG001|Overall Study|Participant Unavailability|0|||
161164711|NCT00696436|581980645|FG002|Overall Study|Participant Unavailability|2|||
161164712|NCT00696436|581980646|FG003|Overall Study|Participant Unavailability|1|||
161164713|NCT00696436|581980647|FG004|Overall Study|Participant Unavailability|0|||
161164714|NCT00696436|581980643|FG000|Overall Study|Administrative Error|2|||
161164715|NCT00696436|581980644|FG001|Overall Study|Administrative Error|0|||
161164716|NCT00696436|581980645|FG002|Overall Study|Administrative Error|2|||
161164717|NCT00696436|581980646|FG003|Overall Study|Administrative Error|0|||
161164718|NCT00696436|581980647|FG004|Overall Study|Administrative Error|0|||
161164719|NCT00696436|581980643|FG000|Overall Study|Participant Non-compliance|0|||
161164720|NCT00696436|581980644|FG001|Overall Study|Participant Non-compliance|0|||
161164721|NCT00696436|581980645|FG002|Overall Study|Participant Non-compliance|1|||
161164722|NCT00696436|581980646|FG003|Overall Study|Participant Non-compliance|2|||
161164723|NCT00696436|581980647|FG004|Overall Study|Participant Non-compliance|0|||
161164724|NCT00696436|581980643|FG000|Overall Study|Administrative Decision|1|||
161164725|NCT00696436|581980644|FG001|Overall Study|Administrative Decision|0|||
161164726|NCT00696436|581980645|FG002|Overall Study|Administrative Decision|0|||
161164727|NCT00696436|581980646|FG003|Overall Study|Administrative Decision|0|||
161164728|NCT00696436|581980647|FG004|Overall Study|Administrative Decision|0|||
161164729|NCT00696436|581980643|FG000|Overall Study|Missing|0|||
161164730|NCT00696436|581980644|FG001|Overall Study|Missing|1|||
161164731|NCT00696436|581980645|FG002|Overall Study|Missing|1|||
161164732|NCT00696436|581980646|FG003|Overall Study|Missing|0|||
161164733|NCT00696436|581980647|FG004|Overall Study|Missing|0|||
161164734|NCT03039738|581980649|FG000|Overall Study|Incomplete data sets|54|||
161164735|NCT03039738|581980650|FG001|Overall Study|Incomplete data sets|0|||
161164736|NCT01293006|581980652|FG000|Period 2|Lost to Follow-up|1|||
161164737|NCT01293006|581980653|FG001|Period 2|Lost to Follow-up|0|||
161164738|NCT01293006|581980654|FG002|Period 2|Lost to Follow-up|0|||
161164739|NCT01293006|581980655|FG003|Period 2|Lost to Follow-up|0|||
161164740|NCT01494987|581980656|FG000|Overall Study|Adverse Event|6|||
161164741|NCT01494987|581980657|FG001|Overall Study|Adverse Event|5|||
161164742|NCT01494987|581980656|FG000|Overall Study|Hyperglycemia|6|||
161164743|NCT01494987|581980657|FG001|Overall Study|Hyperglycemia|4|||
161164744|NCT01494987|581980656|FG000|Overall Study|Investigator's Discretion|1|||
161164745|NCT01494987|581980657|FG001|Overall Study|Investigator's Discretion|2|||
161164746|NCT01494987|581980656|FG000|Overall Study|Lost to Follow-up|1|||
161164747|NCT01494987|581980657|FG001|Overall Study|Lost to Follow-up|1|||
161164748|NCT01494987|581980656|FG000|Overall Study|Protocol Violation|3|||
161164749|NCT01494987|581980657|FG001|Overall Study|Protocol Violation|3|||
161164750|NCT01494987|581980656|FG000|Overall Study|Subject Non-Compliance|9|||
161164751|NCT01494987|581980657|FG001|Overall Study|Subject Non-Compliance|10|||
161164752|NCT01494987|581980656|FG000|Overall Study|Subject Withdrew Consent|2|||
161164753|NCT01494987|581980657|FG001|Overall Study|Subject Withdrew Consent|3|||
161164754|NCT00205699|581980665|FG000|Overall Study|Lost to Follow-up|1|||
161164755|NCT00205699|581980666|FG001|Overall Study|Lost to Follow-up|3|||
161164756|NCT00205699|581980667|FG002|Overall Study|Lost to Follow-up|5|||
161164757|NCT00205699|581980665|FG000|Overall Study|Adverse Event|1|||
161164758|NCT00205699|581980666|FG001|Overall Study|Adverse Event|0|||
161164759|NCT00205699|581980667|FG002|Overall Study|Adverse Event|0|||
161164760|NCT00205699|581980665|FG000|Overall Study|Withdrawal by Subject|1|||
161164761|NCT00205699|581980666|FG001|Overall Study|Withdrawal by Subject|2|||
161164762|NCT00205699|581980667|FG002|Overall Study|Withdrawal by Subject|1|||
161164763|NCT00205699|581980665|FG000|Overall Study|Lack of Efficacy|0|||
161164764|NCT00205699|581980666|FG001|Overall Study|Lack of Efficacy|1|||
161164765|NCT00205699|581980667|FG002|Overall Study|Lack of Efficacy|0|||
161164766|NCT01885078|581980668|FG000|Treatment Period|Adverse Event|52|||
161164767|NCT01885078|581980669|FG001|Treatment Period|Adverse Event|136|||
161164768|NCT01885078|581980670|FG002|Treatment Period|Adverse Event|30|||
161289463|NCT05258773|582440574|FG000|Overall Study|Adverse Event|1|||
161289464|NCT05258773|582440575|FG001|Overall Study|Adverse Event|0|||
161289465|NCT05258773|582440574|FG000|Overall Study|Withdrawal by Subject|0|||
161289466|NCT05258773|582440575|FG001|Overall Study|Withdrawal by Subject|1|||
161289467|NCT03018288|582440578|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
161164769|NCT01885078|581980671|FG003|Treatment Period|Adverse Event|73|||
161164770|NCT01885078|581980672|FG004|Treatment Period|Adverse Event|17|||
161289468|NCT03018288|582440579|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
161289469|NCT03018288|582440580|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
161164771|NCT01885078|581980673|FG005|Treatment Period|Adverse Event|72|||
161289470|NCT03018288|582440581|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
161164772|NCT01885078|581980674|FG006|Treatment Period|Adverse Event|24|||
161164773|NCT01885078|581980675|FG007|Treatment Period|Adverse Event|5|||
161164774|NCT01885078|581980676|FG008|Treatment Period|Adverse Event|0|||
161164775|NCT01885078|581980677|FG009|Treatment Period|Adverse Event|0|||
161164776|NCT01885078|581980668|FG000|Treatment Period|Death|13|||
161164777|NCT01885078|581980669|FG001|Treatment Period|Death|33|||
161164778|NCT01885078|581980670|FG002|Treatment Period|Death|5|||
161164779|NCT01885078|581980671|FG003|Treatment Period|Death|9|||
161164780|NCT01885078|581980672|FG004|Treatment Period|Death|2|||
161164781|NCT01885078|581980673|FG005|Treatment Period|Death|10|||
161164782|NCT01885078|581980674|FG006|Treatment Period|Death|3|||
161164783|NCT01885078|581980675|FG007|Treatment Period|Death|2|||
161164784|NCT01885078|581980676|FG008|Treatment Period|Death|0|||
161164785|NCT01885078|581980677|FG009|Treatment Period|Death|0|||
161164786|NCT01885078|581980668|FG000|Treatment Period|Lack of Efficacy|12|||
161164787|NCT01885078|581980669|FG001|Treatment Period|Lack of Efficacy|33|||
161164788|NCT01885078|581980670|FG002|Treatment Period|Lack of Efficacy|10|||
161164789|NCT01885078|581980671|FG003|Treatment Period|Lack of Efficacy|23|||
161164790|NCT01885078|581980672|FG004|Treatment Period|Lack of Efficacy|24|||
161164791|NCT01885078|581980673|FG005|Treatment Period|Lack of Efficacy|58|||
161164792|NCT01885078|581980674|FG006|Treatment Period|Lack of Efficacy|9|||
161164793|NCT01885078|581980675|FG007|Treatment Period|Lack of Efficacy|5|||
161164794|NCT01885078|581980676|FG008|Treatment Period|Lack of Efficacy|0|||
161164795|NCT01885078|581980677|FG009|Treatment Period|Lack of Efficacy|0|||
161164796|NCT01885078|581980668|FG000|Treatment Period|Lost to Follow-up|16|||
161164797|NCT01885078|581980669|FG001|Treatment Period|Lost to Follow-up|19|||
161164798|NCT01885078|581980670|FG002|Treatment Period|Lost to Follow-up|7|||
161164799|NCT01885078|581980671|FG003|Treatment Period|Lost to Follow-up|9|||
161164800|NCT01885078|581980672|FG004|Treatment Period|Lost to Follow-up|2|||
161164801|NCT01885078|581980673|FG005|Treatment Period|Lost to Follow-up|8|||
161164802|NCT01885078|581980674|FG006|Treatment Period|Lost to Follow-up|2|||
161164803|NCT01885078|581980675|FG007|Treatment Period|Lost to Follow-up|0|||
161164804|NCT01885078|581980676|FG008|Treatment Period|Lost to Follow-up|0|||
161164805|NCT01885078|581980677|FG009|Treatment Period|Lost to Follow-up|0|||
161164806|NCT01885078|581980668|FG000|Treatment Period|Physician Decision|19|||
161164807|NCT01885078|581980669|FG001|Treatment Period|Physician Decision|21|||
161164808|NCT01885078|581980670|FG002|Treatment Period|Physician Decision|5|||
161164809|NCT01885078|581980671|FG003|Treatment Period|Physician Decision|12|||
161164810|NCT01885078|581980672|FG004|Treatment Period|Physician Decision|9|||
161164811|NCT01885078|581980673|FG005|Treatment Period|Physician Decision|24|||
161164812|NCT01885078|581980674|FG006|Treatment Period|Physician Decision|4|||
161164813|NCT01885078|581980675|FG007|Treatment Period|Physician Decision|3|||
161164814|NCT01885078|581980676|FG008|Treatment Period|Physician Decision|0|||
161164815|NCT01885078|581980677|FG009|Treatment Period|Physician Decision|0|||
161164816|NCT01885078|581980668|FG000|Treatment Period|Protocol Violation|3|||
161164817|NCT01885078|581980669|FG001|Treatment Period|Protocol Violation|5|||
161164818|NCT01885078|581980670|FG002|Treatment Period|Protocol Violation|0|||
161164819|NCT01885078|581980671|FG003|Treatment Period|Protocol Violation|3|||
161164820|NCT01885078|581980672|FG004|Treatment Period|Protocol Violation|1|||
161164821|NCT01885078|581980673|FG005|Treatment Period|Protocol Violation|6|||
161164822|NCT01885078|581980674|FG006|Treatment Period|Protocol Violation|0|||
161164823|NCT01885078|581980675|FG007|Treatment Period|Protocol Violation|0|||
161164824|NCT01885078|581980676|FG008|Treatment Period|Protocol Violation|0|||
161164825|NCT01885078|581980677|FG009|Treatment Period|Protocol Violation|0|||
161164826|NCT01885078|581980668|FG000|Treatment Period|Sponsor Decision|245|||
161164827|NCT01885078|581980669|FG001|Treatment Period|Sponsor Decision|648|||
161164828|NCT01885078|581980670|FG002|Treatment Period|Sponsor Decision|49|||
161164829|NCT01885078|581980671|FG003|Treatment Period|Sponsor Decision|90|||
161164830|NCT01885078|581980672|FG004|Treatment Period|Sponsor Decision|20|||
161164831|NCT01885078|581980673|FG005|Treatment Period|Sponsor Decision|38|||
161164832|NCT01885078|581980674|FG006|Treatment Period|Sponsor Decision|162|||
161164833|NCT01885078|581980675|FG007|Treatment Period|Sponsor Decision|3|||
161164834|NCT01885078|581980676|FG008|Treatment Period|Sponsor Decision|0|||
161164835|NCT01885078|581980677|FG009|Treatment Period|Sponsor Decision|0|||
161164836|NCT01885078|581980668|FG000|Treatment Period|Withdrawal by Subject|72|||
161164837|NCT01885078|581980669|FG001|Treatment Period|Withdrawal by Subject|132|||
161164838|NCT01885078|581980670|FG002|Treatment Period|Withdrawal by Subject|25|||
161164839|NCT01885078|581980671|FG003|Treatment Period|Withdrawal by Subject|63|||
161164840|NCT01885078|581980672|FG004|Treatment Period|Withdrawal by Subject|15|||
161164841|NCT01885078|581980673|FG005|Treatment Period|Withdrawal by Subject|34|||
161164842|NCT01885078|581980674|FG006|Treatment Period|Withdrawal by Subject|17|||
161164843|NCT01885078|581980675|FG007|Treatment Period|Withdrawal by Subject|10|||
161164844|NCT01885078|581980676|FG008|Treatment Period|Withdrawal by Subject|0|||
161164845|NCT01885078|581980677|FG009|Treatment Period|Withdrawal by Subject|0|||
161164846|NCT01885078|581980668|FG000|Treatment Period|Other|0|||
161164847|NCT01885078|581980669|FG001|Treatment Period|Other|0|||
161164848|NCT01885078|581980670|FG002|Treatment Period|Other|0|||
161346862|NCT00433537|582653390|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
161164849|NCT01885078|581980671|FG003|Treatment Period|Other|1|||
161164850|NCT01885078|581980672|FG004|Treatment Period|Other|0|||
161164851|NCT01885078|581980673|FG005|Treatment Period|Other|0|||
161164852|NCT01885078|581980674|FG006|Treatment Period|Other|0|||
161164853|NCT01885078|581980675|FG007|Treatment Period|Other|0|||
161164854|NCT01885078|581980676|FG008|Treatment Period|Other|0|||
161289471|NCT03018288|582440578|FG000|Overall Study|Participant withdrew consent.|0|||
161289472|NCT03018288|582440579|FG001|Overall Study|Participant withdrew consent.|0|||
161289473|NCT03018288|582440580|FG002|Overall Study|Participant withdrew consent.|1|||
161289474|NCT03018288|582440581|FG003|Overall Study|Participant withdrew consent.|0|||
161289475|NCT03018288|582440578|FG000|Overall Study|Switched to alternative treatment.|0|||
161289476|NCT03018288|582440579|FG001|Overall Study|Switched to alternative treatment.|0|||
161289477|NCT03018288|582440580|FG002|Overall Study|Switched to alternative treatment.|1|||
161289478|NCT03018288|582440581|FG003|Overall Study|Switched to alternative treatment.|0|||
161289479|NCT03018288|582440578|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
161289480|NCT03018288|582440579|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
161289481|NCT03018288|582440580|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
161289482|NCT03018288|582440581|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
161289483|NCT03018288|582440578|FG000|Overall Study|Screen failures|0|||
161289484|NCT03018288|582440579|FG001|Overall Study|Screen failures|0|||
161289485|NCT03018288|582440580|FG002|Overall Study|Screen failures|0|||
161289486|NCT03018288|582440581|FG003|Overall Study|Screen failures|51|||
161289487|NCT03018288|582440578|FG000|Overall Study|Chose treatment outside of UNC|0|||
161289488|NCT03018288|582440579|FG001|Overall Study|Chose treatment outside of UNC|0|||
161289489|NCT03018288|582440580|FG002|Overall Study|Chose treatment outside of UNC|0|||
161289490|NCT03018288|582440581|FG003|Overall Study|Chose treatment outside of UNC|1|||
161289491|NCT03018288|582440578|FG000|Overall Study|Unable to comply with protocol requirements|1|||
161289492|NCT03018288|582440579|FG001|Overall Study|Unable to comply with protocol requirements|1|||
161289493|NCT03018288|582440580|FG002|Overall Study|Unable to comply with protocol requirements|0|||
161289494|NCT03018288|582440581|FG003|Overall Study|Unable to comply with protocol requirements|1|||
161289495|NCT03018288|582440578|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
161289496|NCT03018288|582440579|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
161289497|NCT03018288|582440580|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
161289498|NCT03018288|582440581|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
161289499|NCT03018288|582440578|FG000|Overall Study|Physician Decision|0|||
161289500|NCT03018288|582440579|FG001|Overall Study|Physician Decision|0|||
161289501|NCT03018288|582440580|FG002|Overall Study|Physician Decision|0|||
161289502|NCT03018288|582440581|FG003|Overall Study|Physician Decision|1|||
161289503|NCT05573464|582440582|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
161289504|NCT05573464|582440583|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
161289505|NCT05573464|582440582|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
161289506|NCT05573464|582440583|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
161289507|NCT05573464|582440582|FG000|12-week Treatment Period|Protocol Violation|3|||
161289508|NCT05573464|582440583|FG001|12-week Treatment Period|Protocol Violation|1|||
161289509|NCT05573464|582440582|FG000|12-week Treatment Period|Physician Decision|1|||
161289510|NCT05573464|582440583|FG001|12-week Treatment Period|Physician Decision|2|||
161289511|NCT05573464|582440582|FG000|12-week Treatment Period|Lost to Follow-up|2|||
161289512|NCT05573464|582440583|FG001|12-week Treatment Period|Lost to Follow-up|0|||
161289513|NCT05573464|582440582|FG000|12-week Treatment Period|Adverse Event|20|||
161080617|NCT00379288|581684389|FG000|Overall Study|Subject withdrew-related to study drug|1|||
161080618|NCT00379288|581684390|FG001|Overall Study|Subject withdrew-related to study drug|0|||
161080619|NCT00379288|581684391|FG002|Overall Study|Subject withdrew-related to study drug|0|||
161080620|NCT00379288|581684392|FG003|Overall Study|Subject withdrew-related to study drug|1|||
161080621|NCT00379288|581684389|FG000|Overall Study|Noncompliance with protocol|8|||
161080622|NCT00379288|581684390|FG001|Overall Study|Noncompliance with protocol|6|||
161080623|NCT00379288|581684391|FG002|Overall Study|Noncompliance with protocol|2|||
161080624|NCT00379288|581684392|FG003|Overall Study|Noncompliance with protocol|1|||
161080625|NCT00379288|581684389|FG000|Overall Study|Did not meet protocol eligibility|0|||
161080626|NCT00379288|581684390|FG001|Overall Study|Did not meet protocol eligibility|1|||
161080627|NCT00379288|581684391|FG002|Overall Study|Did not meet protocol eligibility|0|||
161080628|NCT00379288|581684392|FG003|Overall Study|Did not meet protocol eligibility|2|||
161080629|NCT00379288|581684389|FG000|Overall Study|Administrative|2|||
161080630|NCT00379288|581684390|FG001|Overall Study|Administrative|2|||
161080631|NCT00379288|581684391|FG002|Overall Study|Administrative|0|||
161080632|NCT00379288|581684392|FG003|Overall Study|Administrative|1|||
161080633|NCT00215137|581684393|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
161080634|NCT00215137|581684394|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
161080635|NCT00215137|581684395|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
161080636|NCT00215137|581684393|FG000|Randomization Period|Lost to Follow-up|0|||
161289514|NCT05573464|582440583|FG001|12-week Treatment Period|Adverse Event|9|||
161289515|NCT05573464|582440582|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
161289516|NCT05573464|582440583|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
161289517|NCT05573464|582440582|FG000|12-week Treatment Period|Randomised, not treated|0|||
161080637|NCT00215137|581684394|FG001|Randomization Period|Lost to Follow-up|1|||
161080638|NCT00215137|581684395|FG002|Randomization Period|Lost to Follow-up|0|||
161080639|NCT00215137|581684393|FG000|Randomization Period|Withdrawal by Subject|0|||
161080640|NCT00215137|581684394|FG001|Randomization Period|Withdrawal by Subject|1|||
161080641|NCT00215137|581684395|FG002|Randomization Period|Withdrawal by Subject|0|||
161080642|NCT00166712|581684396|FG000|Overall Study|Death|0|||
161080643|NCT00166712|581684397|FG001|Overall Study|Death|1|||
161080644|NCT00166712|581684396|FG000|Overall Study|Adverse Event|1|||
161080645|NCT00166712|581684397|FG001|Overall Study|Adverse Event|0|||
161080646|NCT00166712|581684396|FG000|Overall Study|Withdrawal by Subject|1|||
161080647|NCT00166712|581684397|FG001|Overall Study|Withdrawal by Subject|2|||
161080648|NCT00166712|581684396|FG000|Overall Study|Physician Decision|0|||
161080649|NCT00166712|581684397|FG001|Overall Study|Physician Decision|2|||
161080650|NCT04684394|581684398|FG000|Overall Study|Death|1|||
161080651|NCT04684394|581684399|FG001|Overall Study|Death|2|||
161080652|NCT04684394|581684398|FG000|Overall Study|Lost to Follow-up|1|||
161080653|NCT04684394|581684399|FG001|Overall Study|Lost to Follow-up|0|||
161080654|NCT04684394|581684398|FG000|Overall Study|Withdrawal by Subject|2|||
161080655|NCT04684394|581684399|FG001|Overall Study|Withdrawal by Subject|0|||
161080656|NCT04684394|581684398|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
161080657|NCT04684394|581684399|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
161080658|NCT03986944|581684400|FG000|Overall Study|Adverse Event|1|||
161080659|NCT03986944|581684401|FG001|Overall Study|Adverse Event|2|||
161080660|NCT03986944|581684402|FG002|Overall Study|Adverse Event|3|||
161080661|NCT03986944|581684400|FG000|Overall Study|Protocol Violation|0|||
161080662|NCT03986944|581684401|FG001|Overall Study|Protocol Violation|1|||
161080663|NCT03986944|581684402|FG002|Overall Study|Protocol Violation|1|||
161080664|NCT03986944|581684400|FG000|Overall Study|Withdrawal by Subject|3|||
161080665|NCT03986944|581684401|FG001|Overall Study|Withdrawal by Subject|5|||
161080666|NCT03986944|581684402|FG002|Overall Study|Withdrawal by Subject|5|||
161080667|NCT03986944|581684400|FG000|Overall Study|Study termination|10|||
161080668|NCT03986944|581684401|FG001|Overall Study|Study termination|10|||
161080669|NCT03986944|581684402|FG002|Overall Study|Study termination|10|||
161080670|NCT03986944|581684400|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
161080671|NCT03986944|581684401|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
161080672|NCT03986944|581684402|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
161080673|NCT03986944|581684400|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
161080674|NCT03986944|581684401|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
161080675|NCT03986944|581684402|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
161080676|NCT00095056|581684406|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
161080677|NCT00095056|581684407|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
161080678|NCT00095056|581684406|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
161080679|NCT00095056|581684407|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
161080680|NCT00095056|581684406|FG000|Phase A (Weeks 0-12)|Death|1|||
161080681|NCT00095056|581684407|FG001|Phase A (Weeks 0-12)|Death|0|||
161080682|NCT00095056|581684406|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
161080683|NCT00095056|581684407|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
161080684|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
161080685|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
161080686|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
161080687|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
161080688|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
161080689|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
161080690|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
161080691|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
161080692|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Death|3|||
161080693|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Death|1|||
161080694|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
161080695|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
161080696|NCT00095056|581684406|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
161080697|NCT00095056|581684407|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
161080698|NCT02735577|581684411|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
161080699|NCT02735577|581684411|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
161080700|NCT00833833|581684412|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161080701|NCT00833833|581684413|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161080702|NCT00833833|581684414|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
161080703|NCT00833833|581684415|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
161080704|NCT00833833|581684416|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161080705|NCT00833833|581684417|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
161080706|NCT00833833|581684412|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
161080707|NCT00833833|581684413|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
161080708|NCT00833833|581684414|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
161080709|NCT00833833|581684415|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
161080710|NCT00833833|581684416|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
161080711|NCT00833833|581684417|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
161080712|NCT00833833|581684412|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
161080713|NCT00833833|581684413|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
161080714|NCT00833833|581684414|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
161080715|NCT00833833|581684415|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
161080716|NCT00833833|581684416|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
161080717|NCT00833833|581684417|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
161080718|NCT00833833|581684412|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
161080719|NCT00833833|581684413|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
161080720|NCT00833833|581684414|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
161080721|NCT00833833|581684415|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
161080722|NCT00833833|581684416|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
161080723|NCT00833833|581684417|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
161080724|NCT00833833|581684412|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
161080725|NCT00833833|581684413|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080726|NCT00833833|581684414|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
161080727|NCT00833833|581684415|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080728|NCT00833833|581684416|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080729|NCT00833833|581684417|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080730|NCT00833833|581684412|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
161080731|NCT00833833|581684413|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
161080732|NCT00833833|581684414|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
161080733|NCT00833833|581684415|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
161080734|NCT00833833|581684416|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
161080735|NCT00833833|581684417|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
161080736|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161080737|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161080738|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161080739|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
161080740|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
161080741|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
161080742|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161080743|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161080744|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161080745|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
161080746|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
161080747|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
161080748|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
161080749|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
161080750|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
161080751|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
161080752|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
161080753|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
161080754|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080755|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080756|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080757|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
161080758|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
161080759|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
161080760|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161080761|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161080762|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161080763|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
161080764|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
161080765|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
161080766|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
161080767|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
161080768|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
161080769|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
161080770|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
161080771|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
161080772|NCT00833833|581684412|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161080773|NCT00833833|581684413|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161080774|NCT00833833|581684414|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161080775|NCT00833833|581684415|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161080776|NCT00833833|581684416|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
161289518|NCT05573464|582440583|FG001|12-week Treatment Period|Randomised, not treated|1|||
161164855|NCT01885078|581980677|FG009|Treatment Period|Other|0|||
161289519|NCT05573464|582440582|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
161289520|NCT05573464|582440583|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
161289521|NCT05573464|582440582|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
161289522|NCT05573464|582440583|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
161289523|NCT05573464|582440582|FG000|52-week Treatment Period|Protocol Violation|1|||
161289524|NCT05573464|582440583|FG001|52-week Treatment Period|Protocol Violation|1|||
161289525|NCT05573464|582440582|FG000|52-week Treatment Period|Physician Decision|2|||
161289526|NCT05573464|582440583|FG001|52-week Treatment Period|Physician Decision|2|||
161080777|NCT00833833|581684417|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
161080778|NCT02040259|581684418|FG000|Overall Study|Death|280|||
161080779|NCT02040259|581684418|FG000|Overall Study|Lost to Follow-up|76|||
161080780|NCT02040259|581684418|FG000|Overall Study|Assessment not completed|3|||
161080781|NCT02040259|581684418|FG000|Overall Study|Withdrawal by Subject|4|||
161080782|NCT00316602|581684428|FG000|Overall Study|Withdrawal by Subject|3|||
161080783|NCT00316602|581684429|FG001|Overall Study|Withdrawal by Subject|2|||
161080784|NCT00316602|581684428|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
161080785|NCT00316602|581684429|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
161080786|NCT00316602|581684428|FG000|Overall Study|Adverse Event|1|||
161080787|NCT00316602|581684429|FG001|Overall Study|Adverse Event|0|||
161080788|NCT00316602|581684428|FG000|Overall Study|Other|3|||
161080789|NCT00316602|581684429|FG001|Overall Study|Other|6|||
161080790|NCT01142232|581684430|FG000|Overall Study|Adverse Event|1|||
161080791|NCT01142232|581684431|FG001|Overall Study|Adverse Event|2|||
161080792|NCT01142232|581684432|FG002|Overall Study|Adverse Event|1|||
161080793|NCT01142232|581684433|FG003|Overall Study|Adverse Event|0|||
161080794|NCT01142232|581684434|FG004|Overall Study|Adverse Event|4|||
161080795|NCT01142232|581684430|FG000|Overall Study|Death|0|||
161080796|NCT01142232|581684431|FG001|Overall Study|Death|0|||
161080797|NCT01142232|581684432|FG002|Overall Study|Death|0|||
161080798|NCT01142232|581684433|FG003|Overall Study|Death|0|||
161080799|NCT01142232|581684434|FG004|Overall Study|Death|1|||
161080800|NCT01142232|581684430|FG000|Overall Study|Disease Progression|2|||
161080801|NCT01142232|581684431|FG001|Overall Study|Disease Progression|0|||
161080802|NCT01142232|581684432|FG002|Overall Study|Disease Progression|1|||
161080803|NCT01142232|581684433|FG003|Overall Study|Disease Progression|2|||
161080804|NCT01142232|581684434|FG004|Overall Study|Disease Progression|12|||
161080805|NCT01142232|581684430|FG000|Overall Study|Withdrawal by Subject|0|||
161080806|NCT01142232|581684431|FG001|Overall Study|Withdrawal by Subject|0|||
161080807|NCT01142232|581684432|FG002|Overall Study|Withdrawal by Subject|0|||
161080808|NCT01142232|581684433|FG003|Overall Study|Withdrawal by Subject|1|||
161080809|NCT01142232|581684434|FG004|Overall Study|Withdrawal by Subject|3|||
161080810|NCT01142232|581684430|FG000|Overall Study|Physician Decision|0|||
161080811|NCT01142232|581684431|FG001|Overall Study|Physician Decision|1|||
161080812|NCT01142232|581684432|FG002|Overall Study|Physician Decision|0|||
161080813|NCT01142232|581684433|FG003|Overall Study|Physician Decision|2|||
161080814|NCT01142232|581684434|FG004|Overall Study|Physician Decision|10|||
161080815|NCT01142232|581684430|FG000|Overall Study|Alternative Therapy|0|||
161080816|NCT01142232|581684431|FG001|Overall Study|Alternative Therapy|1|||
161080817|NCT01142232|581684432|FG002|Overall Study|Alternative Therapy|1|||
161080818|NCT01142232|581684433|FG003|Overall Study|Alternative Therapy|0|||
161080819|NCT01142232|581684434|FG004|Overall Study|Alternative Therapy|1|||
161080820|NCT01142232|581684430|FG000|Overall Study|Off Trt for other complicating disease|0|||
161080821|NCT01142232|581684431|FG001|Overall Study|Off Trt for other complicating disease|0|||
161080822|NCT01142232|581684432|FG002|Overall Study|Off Trt for other complicating disease|0|||
161080823|NCT01142232|581684433|FG003|Overall Study|Off Trt for other complicating disease|0|||
161080824|NCT01142232|581684434|FG004|Overall Study|Off Trt for other complicating disease|1|||
161080825|NCT01142232|581684430|FG000|Overall Study|Noncompliance|0|||
161080826|NCT01142232|581684431|FG001|Overall Study|Noncompliance|0|||
161080827|NCT01142232|581684432|FG002|Overall Study|Noncompliance|0|||
161080828|NCT01142232|581684433|FG003|Overall Study|Noncompliance|0|||
161080829|NCT01142232|581684434|FG004|Overall Study|Noncompliance|2|||
161080830|NCT00626990|581684435|FG000|Overall Study|Lack of Efficacy|6|||
161080831|NCT00626990|581684436|FG001|Overall Study|Lack of Efficacy|7|||
161080832|NCT00626990|581684437|FG002|Overall Study|Lack of Efficacy|49|||
161080833|NCT00626990|581684438|FG003|Overall Study|Lack of Efficacy|40|||
161080834|NCT00626990|581684435|FG000|Overall Study|Adverse Event|1|||
161080835|NCT00626990|581684436|FG001|Overall Study|Adverse Event|7|||
161080836|NCT00626990|581684437|FG002|Overall Study|Adverse Event|14|||
161164856|NCT01885078|581980668|FG000|Step-down Period|Sponsor Decision|0|||
161080837|NCT00626990|581684438|FG003|Overall Study|Adverse Event|28|||
161080838|NCT00626990|581684435|FG000|Overall Study|Death|0|||
161080839|NCT00626990|581684436|FG001|Overall Study|Death|1|||
161080840|NCT00626990|581684437|FG002|Overall Study|Death|0|||
161080841|NCT00626990|581684438|FG003|Overall Study|Death|0|||
161080842|NCT00626990|581684435|FG000|Overall Study|Withdrawal by Subject|3|||
161080843|NCT00626990|581684436|FG001|Overall Study|Withdrawal by Subject|1|||
161289527|NCT05573464|582440582|FG000|52-week Treatment Period|Lost to Follow-up|1|||
161164857|NCT01885078|581980669|FG001|Step-down Period|Sponsor Decision|0|||
161164858|NCT01885078|581980670|FG002|Step-down Period|Sponsor Decision|0|||
161164859|NCT01885078|581980671|FG003|Step-down Period|Sponsor Decision|0|||
161164860|NCT01885078|581980672|FG004|Step-down Period|Sponsor Decision|0|||
161164861|NCT01885078|581980673|FG005|Step-down Period|Sponsor Decision|0|||
161164862|NCT01885078|581980674|FG006|Step-down Period|Sponsor Decision|0|||
161164863|NCT01885078|581980675|FG007|Step-down Period|Sponsor Decision|0|||
161164864|NCT01885078|581980676|FG008|Step-down Period|Sponsor Decision|1|||
161164865|NCT01885078|581980677|FG009|Step-down Period|Sponsor Decision|1|||
161164866|NCT01885078|581980668|FG000|Step-down Period|Adverse Event|0|||
161164867|NCT01885078|581980669|FG001|Step-down Period|Adverse Event|0|||
161164868|NCT01885078|581980670|FG002|Step-down Period|Adverse Event|0|||
161164869|NCT01885078|581980671|FG003|Step-down Period|Adverse Event|0|||
161164870|NCT01885078|581980672|FG004|Step-down Period|Adverse Event|0|||
161164871|NCT01885078|581980673|FG005|Step-down Period|Adverse Event|0|||
161164872|NCT01885078|581980674|FG006|Step-down Period|Adverse Event|0|||
161164873|NCT01885078|581980675|FG007|Step-down Period|Adverse Event|0|||
161164874|NCT01885078|581980676|FG008|Step-down Period|Adverse Event|29|||
161164875|NCT01885078|581980677|FG009|Step-down Period|Adverse Event|38|||
161164876|NCT01885078|581980668|FG000|Step-down Period|Withdrawal by Subject|0|||
161164877|NCT01885078|581980669|FG001|Step-down Period|Withdrawal by Subject|0|||
161164878|NCT01885078|581980670|FG002|Step-down Period|Withdrawal by Subject|0|||
161164879|NCT01885078|581980671|FG003|Step-down Period|Withdrawal by Subject|0|||
161164880|NCT01885078|581980672|FG004|Step-down Period|Withdrawal by Subject|0|||
161164881|NCT01885078|581980673|FG005|Step-down Period|Withdrawal by Subject|0|||
161164882|NCT01885078|581980674|FG006|Step-down Period|Withdrawal by Subject|0|||
161164883|NCT01885078|581980675|FG007|Step-down Period|Withdrawal by Subject|0|||
161164884|NCT01885078|581980676|FG008|Step-down Period|Withdrawal by Subject|25|||
161164885|NCT01885078|581980677|FG009|Step-down Period|Withdrawal by Subject|15|||
161164886|NCT01885078|581980668|FG000|Step-down Period|Physician Decision|0|||
161164887|NCT01885078|581980669|FG001|Step-down Period|Physician Decision|0|||
161164888|NCT01885078|581980670|FG002|Step-down Period|Physician Decision|0|||
161164889|NCT01885078|581980671|FG003|Step-down Period|Physician Decision|0|||
161164890|NCT01885078|581980672|FG004|Step-down Period|Physician Decision|0|||
161164891|NCT01885078|581980673|FG005|Step-down Period|Physician Decision|0|||
161164892|NCT01885078|581980674|FG006|Step-down Period|Physician Decision|0|||
161164893|NCT01885078|581980675|FG007|Step-down Period|Physician Decision|0|||
161164894|NCT01885078|581980676|FG008|Step-down Period|Physician Decision|7|||
161164895|NCT01885078|581980677|FG009|Step-down Period|Physician Decision|2|||
161164896|NCT01885078|581980668|FG000|Step-down Period|Death|0|||
161164897|NCT01885078|581980669|FG001|Step-down Period|Death|0|||
161164898|NCT01885078|581980670|FG002|Step-down Period|Death|0|||
161164899|NCT01885078|581980671|FG003|Step-down Period|Death|0|||
161164900|NCT01885078|581980672|FG004|Step-down Period|Death|0|||
161164901|NCT01885078|581980673|FG005|Step-down Period|Death|0|||
161164902|NCT01885078|581980674|FG006|Step-down Period|Death|0|||
161164903|NCT01885078|581980675|FG007|Step-down Period|Death|0|||
161164904|NCT01885078|581980676|FG008|Step-down Period|Death|4|||
161164905|NCT01885078|581980677|FG009|Step-down Period|Death|3|||
161164906|NCT01885078|581980668|FG000|Step-down Period|Lost to Follow-up|0|||
161164907|NCT01885078|581980669|FG001|Step-down Period|Lost to Follow-up|0|||
161164908|NCT01885078|581980670|FG002|Step-down Period|Lost to Follow-up|0|||
161164909|NCT01885078|581980671|FG003|Step-down Period|Lost to Follow-up|0|||
161164910|NCT01885078|581980672|FG004|Step-down Period|Lost to Follow-up|0|||
161164911|NCT01885078|581980673|FG005|Step-down Period|Lost to Follow-up|0|||
161164912|NCT01885078|581980674|FG006|Step-down Period|Lost to Follow-up|0|||
161164913|NCT01885078|581980675|FG007|Step-down Period|Lost to Follow-up|0|||
161164914|NCT01885078|581980676|FG008|Step-down Period|Lost to Follow-up|1|||
161164915|NCT01885078|581980677|FG009|Step-down Period|Lost to Follow-up|1|||
161164916|NCT01885078|581980668|FG000|Step-down Period|Lack of Efficacy|0|||
161164917|NCT01885078|581980669|FG001|Step-down Period|Lack of Efficacy|0|||
161164918|NCT01885078|581980670|FG002|Step-down Period|Lack of Efficacy|0|||
161164919|NCT01885078|581980671|FG003|Step-down Period|Lack of Efficacy|0|||
161164920|NCT01885078|581980672|FG004|Step-down Period|Lack of Efficacy|0|||
161164921|NCT01885078|581980673|FG005|Step-down Period|Lack of Efficacy|0|||
161164922|NCT01885078|581980674|FG006|Step-down Period|Lack of Efficacy|0|||
161164923|NCT01885078|581980675|FG007|Step-down Period|Lack of Efficacy|0|||
161164924|NCT01885078|581980676|FG008|Step-down Period|Lack of Efficacy|1|||
161164925|NCT01885078|581980677|FG009|Step-down Period|Lack of Efficacy|0|||
161164926|NCT01885078|581980668|FG000|Step-down Period|Protocol Violation|0|||
161164927|NCT01885078|581980669|FG001|Step-down Period|Protocol Violation|0|||
161164928|NCT01885078|581980670|FG002|Step-down Period|Protocol Violation|0|||
161164929|NCT01885078|581980671|FG003|Step-down Period|Protocol Violation|0|||
161164930|NCT01885078|581980672|FG004|Step-down Period|Protocol Violation|0|||
161164931|NCT01885078|581980673|FG005|Step-down Period|Protocol Violation|0|||
161164932|NCT01885078|581980674|FG006|Step-down Period|Protocol Violation|0|||
161164933|NCT01885078|581980675|FG007|Step-down Period|Protocol Violation|0|||
161164934|NCT01885078|581980676|FG008|Step-down Period|Protocol Violation|1|||
161164935|NCT01885078|581980677|FG009|Step-down Period|Protocol Violation|1|||
161080844|NCT00626990|581684437|FG002|Overall Study|Withdrawal by Subject|5|||
161080845|NCT00626990|581684438|FG003|Overall Study|Withdrawal by Subject|11|||
161080846|NCT00626990|581684435|FG000|Overall Study|Protocol Violation|0|||
161080847|NCT00626990|581684436|FG001|Overall Study|Protocol Violation|1|||
161080848|NCT00626990|581684437|FG002|Overall Study|Protocol Violation|1|||
161080849|NCT00626990|581684438|FG003|Overall Study|Protocol Violation|0|||
161080850|NCT00626990|581684435|FG000|Overall Study|Various different reasons/missing|4|||
161080851|NCT00626990|581684436|FG001|Overall Study|Various different reasons/missing|8|||
161080852|NCT00626990|581684437|FG002|Overall Study|Various different reasons/missing|8|||
161080853|NCT00626990|581684438|FG003|Overall Study|Various different reasons/missing|16|||
161080854|NCT01802567|581684441|FG000|Overall Study|Withdrawal by Subject|2|||
161080855|NCT01802567|581684441|FG000|Overall Study|Physician Decision|1|||
161080856|NCT01802567|581684441|FG000|Overall Study|Lack of Efficacy|7|||
161080857|NCT01802567|581684441|FG000|Overall Study|Consented but did not start therapy|7|||
161080858|NCT01802567|581684441|FG000|Overall Study|Protocol Violation|1|||
161080859|NCT01895101|581684442|FG000|Overall Study|OPCAB procedure|1|||
161080860|NCT01895101|581684443|FG001|Overall Study|OPCAB procedure|1|||
161080861|NCT01895101|581684444|FG002|Overall Study|OPCAB procedure|3|||
161080862|NCT01895101|581684442|FG000|Overall Study|Withdrawal by Subject|0|||
161080863|NCT01895101|581684443|FG001|Overall Study|Withdrawal by Subject|1|||
161080864|NCT01895101|581684444|FG002|Overall Study|Withdrawal by Subject|2|||
161080865|NCT01895101|581684442|FG000|Overall Study|another study, enrolled in other study|0|||
161080866|NCT01895101|581684443|FG001|Overall Study|another study, enrolled in other study|1|||
161080867|NCT01895101|581684444|FG002|Overall Study|another study, enrolled in other study|0|||
161080868|NCT01895101|581684442|FG000|Overall Study|Death|0|||
161080869|NCT01895101|581684443|FG001|Overall Study|Death|1|||
161080870|NCT01895101|581684444|FG002|Overall Study|Death|0|||
161080871|NCT01895101|581684442|FG000|Overall Study|coagulation disorder|0|||
161080872|NCT01895101|581684443|FG001|Overall Study|coagulation disorder|1|||
161080873|NCT01895101|581684444|FG002|Overall Study|coagulation disorder|0|||
161080874|NCT03268603|581684445|FG000|Overall Study|Withdrawal by Subject|6|||
161080875|NCT03268603|581684445|FG000|Overall Study|Physician Decision|1|||
161080876|NCT03268603|581684445|FG000|Overall Study|Withdrawn due to disease progression|2|||
161080877|NCT03248882|581684446|FG000|Overall Study|Adverse Event|3|||
161080878|NCT03248882|581684447|FG001|Overall Study|Adverse Event|3|||
161080879|NCT03248882|581684448|FG002|Overall Study|Adverse Event|2|||
161080880|NCT03248882|581684449|FG003|Overall Study|Adverse Event|6|||
161080881|NCT03248882|581684450|FG004|Overall Study|Adverse Event|9|||
161080882|NCT03248882|581684446|FG000|Overall Study|Lost to Follow-up|0|||
161080883|NCT03248882|581684447|FG001|Overall Study|Lost to Follow-up|0|||
161080884|NCT03248882|581684448|FG002|Overall Study|Lost to Follow-up|0|||
161080885|NCT03248882|581684449|FG003|Overall Study|Lost to Follow-up|0|||
161080886|NCT03248882|581684450|FG004|Overall Study|Lost to Follow-up|1|||
161080887|NCT03248882|581684446|FG000|Overall Study|Protocol Violation|2|||
161080888|NCT03248882|581684447|FG001|Overall Study|Protocol Violation|0|||
161080889|NCT03248882|581684448|FG002|Overall Study|Protocol Violation|2|||
161080890|NCT03248882|581684449|FG003|Overall Study|Protocol Violation|0|||
161080891|NCT03248882|581684450|FG004|Overall Study|Protocol Violation|1|||
161080892|NCT03248882|581684446|FG000|Overall Study|Withdrawal by Subject|2|||
161080893|NCT03248882|581684447|FG001|Overall Study|Withdrawal by Subject|2|||
161080894|NCT03248882|581684448|FG002|Overall Study|Withdrawal by Subject|3|||
161080895|NCT03248882|581684449|FG003|Overall Study|Withdrawal by Subject|4|||
161080896|NCT03248882|581684450|FG004|Overall Study|Withdrawal by Subject|2|||
161080897|NCT02182947|581684451|FG000|Overall Study|Withdrawal by Subject|7|||
161080898|NCT02182947|581684451|FG000|Overall Study|Lost to Follow-up|3|||
161080899|NCT02182947|581684451|FG000|Overall Study|Failed screening activities|8|||
161080900|NCT04308590|581684452|FG000|Overall Study|Adverse Event|12|||
161080901|NCT04308590|581684453|FG001|Overall Study|Adverse Event|2|||
161080902|NCT04308590|581684452|FG000|Overall Study|Withdrawal by Subject|10|||
161080903|NCT04308590|581684453|FG001|Overall Study|Withdrawal by Subject|4|||
161080904|NCT04308590|581684452|FG000|Overall Study|Death|1|||
161080905|NCT04308590|581684453|FG001|Overall Study|Death|0|||
161080906|NCT04308590|581684452|FG000|Overall Study|Lost to Follow-up|1|||
161080907|NCT04308590|581684453|FG001|Overall Study|Lost to Follow-up|1|||
161164936|NCT01194869|581980678|FG000|Overall Study|Disease Progression|2|||
161164937|NCT01194869|581980678|FG000|Overall Study|Toxicity|2|||
161080908|NCT04308590|581684452|FG000|Overall Study|Physician Decision|1|||
161080909|NCT04308590|581684453|FG001|Overall Study|Physician Decision|0|||
161080910|NCT04308590|581684452|FG000|Overall Study|Subject does not want to continue with Pi|0|||
161080911|NCT04308590|581684453|FG001|Overall Study|Subject does not want to continue with Pi|1|||
161080912|NCT01156376|581684455|FG000|Overall Study|Adverse Event|1|||
161080913|NCT01156376|581684456|FG001|Overall Study|Adverse Event|0|||
161080914|NCT01156376|581684457|FG002|Overall Study|Adverse Event|1|||
161080915|NCT01156376|581684455|FG000|Overall Study|Withdrawal by Subject|0|||
161080916|NCT01156376|581684456|FG001|Overall Study|Withdrawal by Subject|0|||
161080917|NCT01156376|581684457|FG002|Overall Study|Withdrawal by Subject|3|||
161080918|NCT01493427|581684458|FG000|Overall Study|Adverse Event|10|||
161164938|NCT01778127|581980684|FG000|Overall Study|Lost to Follow-up|5|||
161164939|NCT01778127|581980685|FG001|Overall Study|Lost to Follow-up|1|||
161164940|NCT01778127|581980686|FG002|Overall Study|Lost to Follow-up|2|||
161164941|NCT01778127|581980684|FG000|Overall Study|Withdrawal by Subject|3|||
161164942|NCT01778127|581980685|FG001|Overall Study|Withdrawal by Subject|1|||
161164943|NCT01778127|581980686|FG002|Overall Study|Withdrawal by Subject|4|||
161164944|NCT01348425|581980687|FG000|Overall Study|Imaging was not taken.|1|||
161164945|NCT01348425|581980688|FG001|Overall Study|Imaging was not taken.|1|||
161164946|NCT01968954|581980698|FG000|Overall Study|Adverse Event|6|||
161164947|NCT01968954|581980699|FG001|Overall Study|Adverse Event|3|||
161164948|NCT01968954|581980698|FG000|Overall Study|Death|1|||
161164949|NCT01968954|581980699|FG001|Overall Study|Death|2|||
161164950|NCT01968954|581980698|FG000|Overall Study|Lost to Follow-up|6|||
161164951|NCT01968954|581980699|FG001|Overall Study|Lost to Follow-up|4|||
161164952|NCT01968954|581980698|FG000|Overall Study|Withdrawal by Subject|20|||
161164953|NCT01968954|581980699|FG001|Overall Study|Withdrawal by Subject|23|||
161164954|NCT01968954|581980698|FG000|Overall Study|Other|7|||
161164955|NCT01968954|581980699|FG001|Overall Study|Other|8|||
161164956|NCT01968954|581980698|FG000|Overall Study|Protocol Violation|0|||
161164957|NCT01968954|581980699|FG001|Overall Study|Protocol Violation|1|||
161164958|NCT01968954|581980698|FG000|Overall Study|Did not met inclusion criteria|0|||
161164959|NCT01968954|581980699|FG001|Overall Study|Did not met inclusion criteria|2|||
161164960|NCT00645567|581980700|FG000|Overall Study|Adverse Event|1|||
161164961|NCT00434122|581980705|FG000|Overall Study|Non-compliance with protocol|0|||
161164962|NCT00434122|581980706|FG001|Overall Study|Non-compliance with protocol|1|||
161164963|NCT00434122|581980705|FG000|Overall Study|loss of subject contact|1|||
161164964|NCT00434122|581980706|FG001|Overall Study|loss of subject contact|1|||
161164965|NCT00434122|581980705|FG000|Overall Study|Personal reasons|1|||
161164966|NCT00434122|581980706|FG001|Overall Study|Personal reasons|1|||
161164967|NCT00434122|581980705|FG000|Overall Study|Large follicle size|2|||
161164968|NCT00434122|581980706|FG001|Overall Study|Large follicle size|2|||
161164969|NCT00434122|581980705|FG000|Overall Study|Low follicular response.|1|||
161164970|NCT00434122|581980706|FG001|Overall Study|Low follicular response.|2|||
161164971|NCT00434122|581980705|FG000|Overall Study|Travelling of subject.|1|||
161164972|NCT00434122|581980706|FG001|Overall Study|Travelling of subject.|0|||
161164973|NCT00255086|581980708|FG000|Overall Study|Adverse Event|1|||
161164974|NCT00255086|581980709|FG001|Overall Study|Adverse Event|1|||
161164975|NCT00255086|581980708|FG000|Overall Study|Protocol Violation|1|||
161164976|NCT00255086|581980709|FG001|Overall Study|Protocol Violation|1|||
161164977|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
161164978|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161164979|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
161164980|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
161164981|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161164982|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
161164983|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161164984|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
161164985|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
161164986|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
161164987|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161164988|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
161164989|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161164990|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161164991|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
161164992|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161164993|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161164994|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
161164995|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161164996|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161164997|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
161164998|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
161164999|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161165000|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
161165001|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
161165002|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
161165003|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
161165004|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
161165005|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
161165006|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
161165007|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161165008|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161165009|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161165010|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
161165011|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161165012|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
161165013|NCT01963208|581980710|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161165014|NCT01963208|581980711|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161165015|NCT01963208|581980712|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161165016|NCT01963208|581980713|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
161165017|NCT01963208|581980714|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161165018|NCT01963208|581980715|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
161165019|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161165020|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161165021|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161165022|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
161165023|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
161165024|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
161165025|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161165026|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161165027|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161165028|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
161165029|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
161165030|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
161165031|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161165032|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161165033|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161165034|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161165035|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
161165036|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
161165037|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161165038|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161165039|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161165040|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161165041|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
161165042|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
161165043|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
161165044|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
161165045|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
161165046|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
161165047|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
161165048|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
161165049|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161165050|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161165051|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161165052|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
161165053|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
161165054|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
161165055|NCT01963208|581980710|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
161165056|NCT01963208|581980711|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
161165057|NCT01963208|581980712|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
161165058|NCT01963208|581980713|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
161165059|NCT01963208|581980714|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
161165060|NCT01963208|581980715|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
161165061|NCT00349752|581980717|FG000|Overall Study|Adverse Event|8|||
161165062|NCT00349752|581980718|FG001|Overall Study|Adverse Event|12|||
161165063|NCT00349752|581980717|FG000|Overall Study|Lack of Efficacy|37|||
161165064|NCT00349752|581980718|FG001|Overall Study|Lack of Efficacy|42|||
161165065|NCT00349752|581980717|FG000|Overall Study|Lost to Follow-up|4|||
161165066|NCT00349752|581980718|FG001|Overall Study|Lost to Follow-up|2|||
161165067|NCT00349752|581980717|FG000|Overall Study|Personal reasons|6|||
161165068|NCT00349752|581980718|FG001|Overall Study|Personal reasons|5|||
161165069|NCT00349752|581980717|FG000|Overall Study|Other: Required exclusionary medication|0|||
161165070|NCT00349752|581980718|FG001|Overall Study|Other: Required exclusionary medication|1|||
161165071|NCT00349752|581980717|FG000|Overall Study|Other: Non compliance|0|||
161289528|NCT05573464|582440583|FG001|52-week Treatment Period|Lost to Follow-up|1|||
161289529|NCT05573464|582440582|FG000|52-week Treatment Period|Adverse Event|11|||
161289530|NCT05573464|582440583|FG001|52-week Treatment Period|Adverse Event|8|||
161289531|NCT05573464|582440582|FG000|52-week Treatment Period|Death|1|||
161289532|NCT05573464|582440583|FG001|52-week Treatment Period|Death|1|||
161289533|NCT05734157|582440584|FG000|Overall Study|Death|3|||
161289534|NCT05734157|582440584|FG000|Overall Study|Withdrawal by Subject|2|||
161289535|NCT05734157|582440584|FG000|Overall Study|Lost to Follow-up|1|||
161289536|NCT05734157|582440584|FG000|Overall Study|Telephone call|3|||
161289537|NCT04815083|582440585|FG000|Overall Study|Physician Decision|1|||
161289538|NCT04815083|582440585|FG000|Overall Study|Study pause|2|||
161165072|NCT00349752|581980718|FG001|Overall Study|Other: Non compliance|1|||
161165073|NCT00349752|581980717|FG000|Overall Study|Other: Patient stopped steroids|0|||
161165074|NCT00349752|581980718|FG001|Overall Study|Other: Patient stopped steroids|1|||
161165075|NCT00349752|581980717|FG000|Overall Study|Other: Patient's steroid use|1|||
161165076|NCT00349752|581980718|FG001|Overall Study|Other: Patient's steroid use|0|||
161165077|NCT00349752|581980717|FG000|Overall Study|Other: Ineligible|1|||
161165078|NCT00349752|581980718|FG001|Overall Study|Other: Ineligible|0|||
161165079|NCT00349752|581980717|FG000|Overall Study|Other: Inadvertently unblinded|1|||
161165080|NCT00349752|581980718|FG001|Overall Study|Other: Inadvertently unblinded|0|||
161165081|NCT00349752|581980717|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
161165082|NCT00349752|581980718|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
161165083|NCT05294211|581980721|FG000|Overall Study|Withdrawal by Subject|3|||
161165084|NCT05294211|581980721|FG000|Overall Study|Physician Decision|2|||
161165085|NCT05294211|581980721|FG000|Overall Study|Progressed to active labor|1|||
161165086|NCT05294211|581980721|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
161165087|NCT05294211|581980721|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
161165088|NCT01842607|581980723|FG000|Overall Study|Adverse Event|11|||
161165089|NCT01842607|581980723|FG000|Overall Study|Lack of Efficacy|19|||
161165090|NCT01842607|581980723|FG000|Overall Study|Protocol Violation|8|||
161165091|NCT01842607|581980723|FG000|Overall Study|Protocol defined stopping criteria|2|||
161165092|NCT01842607|581980723|FG000|Overall Study|Lost to Follow-up|3|||
161165093|NCT01842607|581980723|FG000|Overall Study|Physician Decision|9|||
161165094|NCT01842607|581980723|FG000|Overall Study|Withdrawal by Subject|14|||
161165095|NCT00012012|581980724|FG000|Overall Study|Protocol Violation|1|||
161165096|NCT00012012|581980725|FG001|Overall Study|Protocol Violation|1|||
161165097|NCT00012012|581980724|FG000|Overall Study|Withdrawal by Subject|0|||
161165098|NCT00012012|581980725|FG001|Overall Study|Withdrawal by Subject|2|||
161165099|NCT02159469|581980726|FG000|Overall Study|Missing Completion status|1|||
161165100|NCT02159469|581980726|FG000|Overall Study|Adverse Event|5|||
161165101|NCT02159469|581980726|FG000|Overall Study|Non-compliance|2|||
161165102|NCT02159469|581980726|FG000|Overall Study|Withdrawal by Subject|9|||
161165103|NCT02159469|581980726|FG000|Overall Study|Lost to Follow-up|1|||
161165104|NCT02159469|581980726|FG000|Overall Study|Sponsor's request|2|||
161165105|NCT02159469|581980726|FG000|Overall Study|Met Stopping Criteria|3|||
161165106|NCT02159469|581980726|FG000|Overall Study|Other|1|||
161165107|NCT02159469|581980726|FG000|Overall Study|Multiple|29|||
161165108|NCT03629041|581980727|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161165109|NCT03629041|581980728|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
161165110|NCT03629041|581980729|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161165111|NCT03629041|581980730|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
161165112|NCT03730194|581980731|FG000|First Stage Treatment|Withdrawal by Subject|1|||
161165113|NCT03730194|581980732|FG001|First Stage Treatment|Withdrawal by Subject|1|||
161165114|NCT03730194|581980733|FG002|First Stage Treatment|Withdrawal by Subject|0|||
161165115|NCT03730194|581980734|FG003|First Stage Treatment|Withdrawal by Subject|0|||
161165116|NCT03730194|581980735|FG004|First Stage Treatment|Withdrawal by Subject|0|||
161165117|NCT03730194|581980736|FG005|First Stage Treatment|Withdrawal by Subject|0|||
161165118|NCT03730194|581980731|FG000|First Stage Treatment|Protocol Violation|3|||
161165119|NCT03730194|581980732|FG001|First Stage Treatment|Protocol Violation|3|||
161165120|NCT03730194|581980733|FG002|First Stage Treatment|Protocol Violation|0|||
161165121|NCT03730194|581980734|FG003|First Stage Treatment|Protocol Violation|0|||
161165122|NCT03730194|581980735|FG004|First Stage Treatment|Protocol Violation|0|||
161165123|NCT03730194|581980736|FG005|First Stage Treatment|Protocol Violation|0|||
161165124|NCT01283997|581982862|FG000|Overall Study|Physician Decision|8|||
161165125|NCT01283997|581982863|FG001|Overall Study|Physician Decision|10|||
161165126|NCT01283997|581982862|FG000|Overall Study|Withdrawal by Subject|3|||
161165127|NCT01283997|581982863|FG001|Overall Study|Withdrawal by Subject|2|||
161165128|NCT01283997|581982862|FG000|Overall Study|Physically unable to continue|0|||
161165129|NCT01283997|581982863|FG001|Overall Study|Physically unable to continue|1|||
161165130|NCT01283997|581982862|FG000|Overall Study|Progressive disease|1|||
161165131|NCT01283997|581982863|FG001|Overall Study|Progressive disease|0|||
161165132|NCT01283997|581982862|FG000|Overall Study|Other|4|||
161165133|NCT01283997|581982863|FG001|Overall Study|Other|4|||
161165134|NCT02109744|581982864|FG000|Overall Study|Death|1|||
161165135|NCT02109744|581982865|FG001|Overall Study|Death|1|||
161165136|NCT02109744|581982864|FG000|Overall Study|no marrow exam|1|||
161165137|NCT02109744|581982865|FG001|Overall Study|no marrow exam|0|||
161165138|NCT04095442|581982869|FG000|Overall Study|Lost to Follow-up|0|||
161165139|NCT04095442|581982870|FG001|Overall Study|Lost to Follow-up|1|||
161165140|NCT04095442|581982869|FG000|Overall Study|Screen failure|1|||
161165141|NCT04095442|581982870|FG001|Overall Study|Screen failure|0|||
161165142|NCT00884221|581982875|FG000|Overall Study|Withdrawal by Subject|0|||
161165143|NCT00884221|581982876|FG001|Overall Study|Withdrawal by Subject|3|||
161165144|NCT00884221|581982875|FG000|Overall Study|Adverse Event|6|||
161165145|NCT00884221|581982876|FG001|Overall Study|Adverse Event|3|||
161165146|NCT00884221|581982875|FG000|Overall Study|Protocol Violation|16|||
161165147|NCT00884221|581982876|FG001|Overall Study|Protocol Violation|13|||
161165148|NCT00884221|581982875|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
161165149|NCT00884221|581982876|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
161165150|NCT00255034|581982877|FG000|Overall Study|Withdrawal by Subject|15|||
161165151|NCT00255034|581982878|FG001|Overall Study|Withdrawal by Subject|38|||
161165152|NCT00424346|581982879|FG000|Core Study|Adverse Event|5|||
161165153|NCT00424346|581982880|FG001|Core Study|Adverse Event|3|||
161165154|NCT00424346|581982881|FG002|Core Study|Adverse Event|1|||
161165155|NCT00424346|581982882|FG003|Core Study|Adverse Event|1|||
161165156|NCT00424346|581982879|FG000|Core Study|Abnormal Laboratory Values|0|||
161165157|NCT00424346|581982880|FG001|Core Study|Abnormal Laboratory Values|1|||
161165158|NCT00424346|581982881|FG002|Core Study|Abnormal Laboratory Values|0|||
161165159|NCT00424346|581982882|FG003|Core Study|Abnormal Laboratory Values|0|||
161165160|NCT00424346|581982879|FG000|Core Study|Lack of Efficacy|1|||
161165161|NCT00424346|581982880|FG001|Core Study|Lack of Efficacy|3|||
161165162|NCT00424346|581982881|FG002|Core Study|Lack of Efficacy|0|||
161165163|NCT00424346|581982882|FG003|Core Study|Lack of Efficacy|4|||
161165164|NCT00424346|581982879|FG000|Core Study|Withdrawal by Subject|1|||
161165165|NCT00424346|581982880|FG001|Core Study|Withdrawal by Subject|0|||
161165166|NCT00424346|581982881|FG002|Core Study|Withdrawal by Subject|0|||
161165167|NCT00424346|581982882|FG003|Core Study|Withdrawal by Subject|2|||
161165168|NCT00424346|581982879|FG000|Core Study|Lost to Follow-up|1|||
161165169|NCT00424346|581982880|FG001|Core Study|Lost to Follow-up|1|||
161165170|NCT00424346|581982881|FG002|Core Study|Lost to Follow-up|0|||
161165171|NCT00424346|581982882|FG003|Core Study|Lost to Follow-up|0|||
161165172|NCT00424346|581982879|FG000|Core Study|Administrative Problems|1|||
161165173|NCT00424346|581982880|FG001|Core Study|Administrative Problems|0|||
161165174|NCT00424346|581982881|FG002|Core Study|Administrative Problems|1|||
161165175|NCT00424346|581982882|FG003|Core Study|Administrative Problems|0|||
161165176|NCT00424346|581982879|FG000|Core Study|Protocol Violation|0|||
161165177|NCT00424346|581982880|FG001|Core Study|Protocol Violation|0|||
161165178|NCT00424346|581982881|FG002|Core Study|Protocol Violation|2|||
161165179|NCT00424346|581982882|FG003|Core Study|Protocol Violation|0|||
161165180|NCT00424346|581982879|FG000|Extension Phase|Adverse Event|0|||
161165181|NCT00424346|581982880|FG001|Extension Phase|Adverse Event|9|||
161165182|NCT00424346|581982881|FG002|Extension Phase|Adverse Event|5|||
161165183|NCT00424346|581982882|FG003|Extension Phase|Adverse Event|4|||
161165184|NCT00424346|581982879|FG000|Extension Phase|Lack of Efficacy|0|||
161165185|NCT00424346|581982880|FG001|Extension Phase|Lack of Efficacy|16|||
161165186|NCT00424346|581982881|FG002|Extension Phase|Lack of Efficacy|14|||
161165187|NCT00424346|581982882|FG003|Extension Phase|Lack of Efficacy|11|||
161165188|NCT00424346|581982879|FG000|Extension Phase|Withdrawal by Subject|0|||
161165189|NCT00424346|581982880|FG001|Extension Phase|Withdrawal by Subject|5|||
161165190|NCT00424346|581982881|FG002|Extension Phase|Withdrawal by Subject|3|||
161165191|NCT00424346|581982882|FG003|Extension Phase|Withdrawal by Subject|4|||
161165192|NCT00424346|581982879|FG000|Extension Phase|Lost to Follow-up|0|||
161165193|NCT00424346|581982880|FG001|Extension Phase|Lost to Follow-up|2|||
161165194|NCT00424346|581982881|FG002|Extension Phase|Lost to Follow-up|0|||
161165195|NCT00424346|581982882|FG003|Extension Phase|Lost to Follow-up|0|||
161165196|NCT00424346|581982879|FG000|Extension Phase|Administrative Problems|0|||
161165197|NCT00424346|581982880|FG001|Extension Phase|Administrative Problems|69|||
161165198|NCT00424346|581982881|FG002|Extension Phase|Administrative Problems|32|||
161165199|NCT00424346|581982882|FG003|Extension Phase|Administrative Problems|35|||
161165200|NCT00424346|581982879|FG000|Extension Phase|Death|0|||
161165201|NCT00424346|581982880|FG001|Extension Phase|Death|0|||
161165202|NCT00424346|581982881|FG002|Extension Phase|Death|0|||
161165203|NCT00424346|581982882|FG003|Extension Phase|Death|1|||
161165204|NCT00424346|581982879|FG000|Extension Phase|Protocol Violation|0|||
161165205|NCT00424346|581982880|FG001|Extension Phase|Protocol Violation|1|||
161165206|NCT00424346|581982881|FG002|Extension Phase|Protocol Violation|1|||
161165207|NCT00424346|581982882|FG003|Extension Phase|Protocol Violation|0|||
161165208|NCT03947255|581982883|FG000|Overall Study|Study Closure by Sponsor|2|||
161165209|NCT03947255|581982884|FG001|Overall Study|Study Closure by Sponsor|2|||
161165210|NCT03947255|581982883|FG000|Overall Study|Withdrawal by Subject|2|||
161165211|NCT03947255|581982884|FG001|Overall Study|Withdrawal by Subject|2|||
161165212|NCT03947255|581982883|FG000|Overall Study|Lost to Follow-up|2|||
161165213|NCT03947255|581982884|FG001|Overall Study|Lost to Follow-up|0|||
161165214|NCT03947255|581982883|FG000|Overall Study|Death|0|||
161165215|NCT03947255|581982884|FG001|Overall Study|Death|2|||
161165216|NCT00781963|581982889|FG000|Overall Study|Death|3|||
161165217|NCT00781963|581982890|FG001|Overall Study|Death|0|||
161165218|NCT00781963|581982889|FG000|Overall Study|Lost to Follow-up|2|||
161165219|NCT00781963|581982890|FG001|Overall Study|Lost to Follow-up|1|||
161165220|NCT00781963|581982889|FG000|Overall Study|Withdrawal by Subject|3|||
161165221|NCT00781963|581982890|FG001|Overall Study|Withdrawal by Subject|1|||
161165222|NCT00781963|581982889|FG000|Overall Study|Refused follow-up|9|||
161165223|NCT00781963|581982890|FG001|Overall Study|Refused follow-up|0|||
161165224|NCT03297216|581982891|FG000|Overall Study|Death|0|||
161165225|NCT03297216|581982892|FG001|Overall Study|Death|1|||
161165226|NCT03297216|581982891|FG000|Overall Study|Miscarriage|0|||
161289539|NCT04815083|582440585|FG000|Overall Study|Screening failure|4|||
161289540|NCT06025721|582440586|FG000|Overall Study|Physician Decision|1|||
161289541|NCT06025721|582440586|FG000|Overall Study|Protocol Violation|1|||
161289542|NCT06025721|582440586|FG000|Overall Study|Incarceration|1|||
161289543|NCT01730053|582440589|FG000|Overall Study|Participant moved|0|||
161289544|NCT01730053|582440590|FG001|Overall Study|Participant moved|0|||
161289545|NCT01730053|582440591|FG002|Overall Study|Participant moved|1|||
161289546|NCT01730053|582440592|FG003|Overall Study|Participant moved|0|||
161289547|NCT01730053|582440593|FG004|Overall Study|Participant moved|0|||
161289548|NCT01730053|582440594|FG005|Overall Study|Participant moved|0|||
161289549|NCT01730053|582440589|FG000|Overall Study|Physician Decision|0|||
161289550|NCT01730053|582440590|FG001|Overall Study|Physician Decision|0|||
161289551|NCT01730053|582440591|FG002|Overall Study|Physician Decision|0|||
161289552|NCT01730053|582440592|FG003|Overall Study|Physician Decision|1|||
161289553|NCT01730053|582440593|FG004|Overall Study|Physician Decision|0|||
161289554|NCT01730053|582440594|FG005|Overall Study|Physician Decision|0|||
161289555|NCT01730053|582440589|FG000|Overall Study|Adverse Event|2|||
161289556|NCT01730053|582440590|FG001|Overall Study|Adverse Event|6|||
161289557|NCT01730053|582440591|FG002|Overall Study|Adverse Event|3|||
161289558|NCT01730053|582440592|FG003|Overall Study|Adverse Event|3|||
161289559|NCT01730053|582440593|FG004|Overall Study|Adverse Event|2|||
161289560|NCT01730053|582440594|FG005|Overall Study|Adverse Event|2|||
161289561|NCT01730053|582440589|FG000|Overall Study|Poor compliance to protocol|1|||
161289562|NCT01730053|582440590|FG001|Overall Study|Poor compliance to protocol|2|||
161289563|NCT01730053|582440591|FG002|Overall Study|Poor compliance to protocol|2|||
161289564|NCT01730053|582440592|FG003|Overall Study|Poor compliance to protocol|0|||
161289565|NCT01730053|582440593|FG004|Overall Study|Poor compliance to protocol|0|||
161289566|NCT01730053|582440594|FG005|Overall Study|Poor compliance to protocol|2|||
161289567|NCT01730053|582440589|FG000|Overall Study|Other than specified|2|||
161289568|NCT01730053|582440590|FG001|Overall Study|Other than specified|6|||
161289569|NCT01730053|582440591|FG002|Overall Study|Other than specified|5|||
161289570|NCT01730053|582440592|FG003|Overall Study|Other than specified|4|||
161289571|NCT01730053|582440593|FG004|Overall Study|Other than specified|7|||
161289572|NCT01730053|582440594|FG005|Overall Study|Other than specified|9|||
161289573|NCT02068508|582440595|FG000|Overall Study|Case report forms uncollected|27|||
161289574|NCT02068508|582440595|FG000|Overall Study|Patient did not visit the study site|1|||
161289575|NCT02068508|582440595|FG000|Overall Study|Protocol Violation|4|||
161289576|NCT00813150|582440596|FG000|Treatment Period|Adverse Event|16|||
161289577|NCT00813150|582440597|FG001|Treatment Period|Adverse Event|15|||
161289578|NCT00813150|582440596|FG000|Treatment Period|Death|2|||
161289579|NCT00813150|582440597|FG001|Treatment Period|Death|0|||
161289580|NCT00813150|582440596|FG000|Treatment Period|Progressive disease|1|||
161289581|NCT00813150|582440597|FG001|Treatment Period|Progressive disease|0|||
161289582|NCT00813150|582440596|FG000|Treatment Period|Complete response|0|||
161289583|NCT00813150|582440597|FG001|Treatment Period|Complete response|1|||
161289584|NCT00813150|582440596|FG000|Treatment Period|Stable disease|1|||
161289585|NCT00813150|582440597|FG001|Treatment Period|Stable disease|2|||
161289586|NCT00813150|582440596|FG000|Treatment Period|Protocol Violation|3|||
161289587|NCT00813150|582440597|FG001|Treatment Period|Protocol Violation|4|||
161289588|NCT00813150|582440596|FG000|Treatment Period|Withdrawal by Subject|5|||
161289589|NCT00813150|582440597|FG001|Treatment Period|Withdrawal by Subject|3|||
161289590|NCT00813150|582440596|FG000|Treatment Period|Non compliance|0|||
161289591|NCT00813150|582440597|FG001|Treatment Period|Non compliance|1|||
161289592|NCT00813150|582440596|FG000|Treatment Period|Reason not specified|3|||
161289593|NCT00813150|582440597|FG001|Treatment Period|Reason not specified|4|||
161289594|NCT00813150|582440596|FG000|Treatment Period|Data not available|1|||
161289595|NCT00813150|582440597|FG001|Treatment Period|Data not available|2|||
161289596|NCT00813150|582440596|FG000|Long Term Follow-up|Death|0|||
161289597|NCT00813150|582440597|FG001|Long Term Follow-up|Death|4|||
161289598|NCT00813150|582440596|FG000|Long Term Follow-up|Other|0|||
161289599|NCT00813150|582440597|FG001|Long Term Follow-up|Other|3|||
161289600|NCT00813150|582440596|FG000|Long Term Follow-up|Lost to Follow-up|2|||
161080919|NCT01493427|581684458|FG000|Overall Study|Personal Reasons|4|||
161080920|NCT01493427|581684458|FG000|Overall Study|Lost to Follow-up|2|||
161289601|NCT00813150|582440597|FG001|Long Term Follow-up|Lost to Follow-up|0|||
161346863|NCT00433537|582653391|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
161289602|NCT00813150|582440596|FG000|Long Term Follow-up|Progression/Relapse|22|||
161289603|NCT00813150|582440597|FG001|Long Term Follow-up|Progression/Relapse|24|||
161289604|NCT00075816|582440605|FG000|Overall Study|Did not undergo transplantation|14|||
161080921|NCT01493427|581684458|FG000|Overall Study|Inability to Follow Instructions|2|||
161289605|NCT00075816|582440606|FG001|Overall Study|Did not undergo transplantation|11|||
161289606|NCT01823328|582440607|FG000|Overall Study|Withdrawal by Subject|8|||
161289607|NCT01823328|582440608|FG001|Overall Study|Withdrawal by Subject|6|||
161289608|NCT04173507|582440609|FG000|Overall Study|On Treatment|3|||
161289609|NCT04173507|582440609|FG000|Overall Study|Adverse Event|3|||
161289610|NCT04173507|582440609|FG000|Overall Study|Progression/Relapse|34|||
161289611|NCT04173507|582440609|FG000|Overall Study|Death|2|||
161289612|NCT02832687|582440610|FG000|Overall Study|Adverse Event|0|||
161165227|NCT03297216|581982892|FG001|Overall Study|Miscarriage|2|||
161165228|NCT03297216|581982891|FG000|Overall Study|Lost to Follow-up|3|||
161165229|NCT03297216|581982892|FG001|Overall Study|Lost to Follow-up|2|||
161165230|NCT00912340|581982896|FG000|Overall Study|Adverse Event|2|||
161165231|NCT00912340|581982897|FG001|Overall Study|Adverse Event|4|||
161165232|NCT00912340|581982898|FG002|Overall Study|Adverse Event|0|||
161165233|NCT00912340|581982896|FG000|Overall Study|Protocol revised to remove arm|0|||
161165234|NCT00912340|581982897|FG001|Overall Study|Protocol revised to remove arm|0|||
161165235|NCT00912340|581982898|FG002|Overall Study|Protocol revised to remove arm|4|||
161165236|NCT00953225|581982903|FG000|Overall Study|Withdrawal by Subject|2|||
161165237|NCT00953225|581982904|FG001|Overall Study|Withdrawal by Subject|0|||
161165238|NCT02254551|581982905|FG000|Dose Escalation|Physician Decision|1|||
161165239|NCT02254551|581982905|FG000|Dose Escalation|Dose-limiting toxicity|2|||
161165240|NCT04058158|581982906|FG000|Period 1|Death|1|||
161165241|NCT04058158|581982907|FG001|Period 1|Death|0|||
161165242|NCT04058158|581982906|FG000|Period 1|Adverse Event|1|||
161165243|NCT04058158|581982907|FG001|Period 1|Adverse Event|1|||
161165244|NCT04058158|581982906|FG000|Period 1|Pregnancy|0|||
161165245|NCT04058158|581982907|FG001|Period 1|Pregnancy|1|||
161165246|NCT01634113|581982908|FG000|Overall Study|Not treated|0|||
161165247|NCT01634113|581982909|FG001|Overall Study|Not treated|0|||
161165248|NCT01634113|581982910|FG002|Overall Study|Not treated|1|||
161165249|NCT00520299|581982913|FG000|Overall Study|Withdrawal by Subject|0|||
161165250|NCT00520299|581982914|FG001|Overall Study|Withdrawal by Subject|0|||
161165251|NCT00520299|581982915|FG002|Overall Study|Withdrawal by Subject|2|||
161165252|NCT00520299|581982913|FG000|Overall Study|Progressive disease|0|||
161165253|NCT00520299|581982914|FG001|Overall Study|Progressive disease|3|||
161165254|NCT00520299|581982915|FG002|Overall Study|Progressive disease|4|||
161165255|NCT01352845|581982916|FG000|Overall Study|Lost to Follow-up|313|||
161165256|NCT01352845|581982917|FG001|Overall Study|Lost to Follow-up|92|||
161165257|NCT01352845|581982916|FG000|Overall Study|No Longer Willing to Participate|205|||
161165258|NCT01352845|581982917|FG001|Overall Study|No Longer Willing to Participate|58|||
161165259|NCT01352845|581982916|FG000|Overall Study|Withdrawal by Subject|48|||
161165260|NCT01352845|581982917|FG001|Overall Study|Withdrawal by Subject|16|||
161165261|NCT01352845|581982916|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
161165262|NCT01352845|581982917|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
161165263|NCT01352845|581982916|FG000|Overall Study|Pregnancy|27|||
161165264|NCT01352845|581982917|FG001|Overall Study|Pregnancy|7|||
161165265|NCT01352845|581982916|FG000|Overall Study|Adverse Event|22|||
161165266|NCT01352845|581982917|FG001|Overall Study|Adverse Event|6|||
161165267|NCT01352845|581982916|FG000|Overall Study|Other|17|||
161165268|NCT01352845|581982917|FG001|Overall Study|Other|7|||
161165269|NCT01352845|581982916|FG000|Overall Study|Protocol Violation|12|||
161165270|NCT01352845|581982917|FG001|Overall Study|Protocol Violation|6|||
161165271|NCT01352845|581982916|FG000|Overall Study|Death|3|||
161165272|NCT01352845|581982917|FG001|Overall Study|Death|0|||
161165273|NCT02062463|581982918|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
161165274|NCT02062463|581982919|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
161165275|NCT02062463|581982920|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
161165276|NCT02062463|581982921|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
161165277|NCT02062463|581982918|FG000|Stage 2|Adverse Event|0|||
161165278|NCT02062463|581982919|FG001|Stage 2|Adverse Event|0|||
161165279|NCT02062463|581982920|FG002|Stage 2|Adverse Event|12|||
161165280|NCT02062463|581982921|FG003|Stage 2|Adverse Event|20|||
161165281|NCT02062463|581982918|FG000|Stage 2|Lack of Efficacy|0|||
161165282|NCT02062463|581982919|FG001|Stage 2|Lack of Efficacy|0|||
161165283|NCT02062463|581982920|FG002|Stage 2|Lack of Efficacy|3|||
161165284|NCT02062463|581982921|FG003|Stage 2|Lack of Efficacy|4|||
161165285|NCT02062463|581982918|FG000|Stage 2|Lost to Follow-up|0|||
161165286|NCT02062463|581982919|FG001|Stage 2|Lost to Follow-up|0|||
161165287|NCT02062463|581982920|FG002|Stage 2|Lost to Follow-up|20|||
161289613|NCT02832687|582440611|FG001|Overall Study|Adverse Event|2|||
161289614|NCT04231825|582440612|FG000|Overall Study|Protocol Violation|3|||
161289615|NCT04231825|582440613|FG001|Overall Study|Protocol Violation|3|||
161289616|NCT04231825|582440612|FG000|Overall Study|Lost to Follow-up|0|||
161165288|NCT02062463|581982921|FG003|Stage 2|Lost to Follow-up|20|||
161165289|NCT02062463|581982918|FG000|Stage 2|Non-Compliance|0|||
161165290|NCT02062463|581982919|FG001|Stage 2|Non-Compliance|0|||
161165291|NCT02062463|581982920|FG002|Stage 2|Non-Compliance|0|||
161165292|NCT02062463|581982921|FG003|Stage 2|Non-Compliance|1|||
161165293|NCT02062463|581982918|FG000|Stage 2|Other than specified|0|||
161165294|NCT02062463|581982919|FG001|Stage 2|Other than specified|0|||
161289617|NCT04231825|582440613|FG001|Overall Study|Lost to Follow-up|1|||
161165295|NCT02062463|581982920|FG002|Stage 2|Other than specified|3|||
161165296|NCT02062463|581982921|FG003|Stage 2|Other than specified|1|||
161165297|NCT02062463|581982918|FG000|Stage 2|Withdrawal by Subject|0|||
161165298|NCT02062463|581982919|FG001|Stage 2|Withdrawal by Subject|0|||
161165299|NCT02062463|581982920|FG002|Stage 2|Withdrawal by Subject|15|||
161165300|NCT02062463|581982921|FG003|Stage 2|Withdrawal by Subject|10|||
161165301|NCT01956240|581982930|FG000|Overall Study|Lost to Follow-up|6|||
161165302|NCT01956240|581982931|FG001|Overall Study|Lost to Follow-up|20|||
161165303|NCT01956240|581982930|FG000|Overall Study|Adverse Event|17|||
161165304|NCT01956240|581982931|FG001|Overall Study|Adverse Event|4|||
161165305|NCT00600028|581982934|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161165306|NCT00600028|581982935|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
161165307|NCT00600028|581982934|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
161165308|NCT00600028|581982935|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
161165309|NCT00600028|581982934|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
161165310|NCT00600028|581982935|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
161165311|NCT01830816|581982936|FG000|Overall Study|Progressive Disease|12|||
161165312|NCT01830816|581982937|FG001|Overall Study|Progressive Disease|7|||
161165313|NCT01830816|581982938|FG002|Overall Study|Progressive Disease|7|||
161165314|NCT01830816|581982936|FG000|Overall Study|Adverse Event|3|||
161165315|NCT01830816|581982937|FG001|Overall Study|Adverse Event|4|||
161165316|NCT01830816|581982938|FG002|Overall Study|Adverse Event|0|||
161165317|NCT01830816|581982936|FG000|Overall Study|Study Terminated by Sponsor|1|||
161165318|NCT01830816|581982937|FG001|Overall Study|Study Terminated by Sponsor|1|||
161165319|NCT01830816|581982938|FG002|Overall Study|Study Terminated by Sponsor|0|||
161165320|NCT01830816|581982936|FG000|Overall Study|Withdrawal by Subject|1|||
161165321|NCT01830816|581982937|FG001|Overall Study|Withdrawal by Subject|1|||
161165322|NCT01830816|581982938|FG002|Overall Study|Withdrawal by Subject|0|||
161165323|NCT01830816|581982936|FG000|Overall Study|Lost to Follow-up|0|||
161165324|NCT01830816|581982937|FG001|Overall Study|Lost to Follow-up|1|||
161165325|NCT01830816|581982938|FG002|Overall Study|Lost to Follow-up|0|||
161165326|NCT01830816|581982936|FG000|Overall Study|Symptomatic Deterioration|1|||
161165327|NCT01830816|581982937|FG001|Overall Study|Symptomatic Deterioration|0|||
161165328|NCT01830816|581982938|FG002|Overall Study|Symptomatic Deterioration|0|||
161165329|NCT01830816|581982936|FG000|Overall Study|Reason not Specified|2|||
161165330|NCT01830816|581982937|FG001|Overall Study|Reason not Specified|0|||
161165331|NCT01830816|581982938|FG002|Overall Study|Reason not Specified|0|||
161289618|NCT01662635|582440614|FG000|Overall Study|scarce samples for evaluation|30|||
161289619|NCT01217112|582440615|FG000|Overall Study|Adverse Event|0|||
161289620|NCT01217112|582440616|FG001|Overall Study|Adverse Event|2|||
161289621|NCT01217112|582440617|FG002|Overall Study|Adverse Event|0|||
161289622|NCT01217112|582440618|FG003|Overall Study|Adverse Event|2|||
161289623|NCT01217112|582440619|FG004|Overall Study|Adverse Event|0|||
161289624|NCT01217112|582440615|FG000|Overall Study|Withdrawal by Subject|0|||
161080922|NCT01493427|581684458|FG000|Overall Study|Other|2|||
161080923|NCT00939822|581684459|FG000|Overall Study|Lost to Follow-up|1|||
161080924|NCT00939822|581684460|FG001|Overall Study|Lost to Follow-up|0|||
161080925|NCT00939822|581684459|FG000|Overall Study|withdrew from study due to busy schedule|1|||
161080926|NCT00939822|581684460|FG001|Overall Study|withdrew from study due to busy schedule|1|||
161080927|NCT00939822|581684459|FG000|Overall Study|Mental health issues|0|||
161080928|NCT00939822|581684460|FG001|Overall Study|Mental health issues|2|||
161080929|NCT03733314|581684465|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
161080930|NCT03733314|581684466|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
161080931|NCT03733314|581684465|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
161080932|NCT03733314|581684466|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
161080933|NCT03733314|581684465|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
161080934|NCT03733314|581684466|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
161080935|NCT03733314|581684465|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
161080936|NCT03733314|581684466|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
161080937|NCT03733314|581684465|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
161080938|NCT03733314|581684466|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
161080939|NCT03733314|581684465|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
161080940|NCT03733314|581684466|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
161080941|NCT01598662|581684467|FG000|Overall Study|Lost to Follow-up|10|||
161080942|NCT01598662|581684468|FG001|Overall Study|Lost to Follow-up|17|||
161080943|NCT01598662|581684467|FG000|Overall Study|Physician Decision|1|||
161080944|NCT01598662|581684468|FG001|Overall Study|Physician Decision|2|||
161080945|NCT01598662|581684467|FG000|Overall Study|IUD expelled before month 6|0|||
161080946|NCT01598662|581684468|FG001|Overall Study|IUD expelled before month 6|2|||
161080947|NCT00910039|581684469|FG000|Overall Study|Physician Decision|1|||
161080948|NCT04514510|581684473|FG000|Overall Study|Lost to Follow-up|0|||
161080949|NCT04514510|581684474|FG001|Overall Study|Lost to Follow-up|1|||
161165332|NCT02716194|581982939|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
161165333|NCT02716194|581982940|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
161165334|NCT02716194|581982941|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
161080950|NCT04514510|581684473|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
161080951|NCT04514510|581684474|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
161165335|NCT03587584|581982945|FG000|Overall Study|SOC deviations|4|||
161289625|NCT01217112|582440616|FG001|Overall Study|Withdrawal by Subject|0|||
161080952|NCT02075073|581684475|FG000|Overall Study|Withdrawal by Subject|0|||
161080953|NCT02075073|581684476|FG001|Overall Study|Withdrawal by Subject|1|||
161289626|NCT01217112|582440617|FG002|Overall Study|Withdrawal by Subject|1|||
161289627|NCT01217112|582440618|FG003|Overall Study|Withdrawal by Subject|0|||
161289628|NCT01217112|582440619|FG004|Overall Study|Withdrawal by Subject|0|||
161289629|NCT01217112|582440615|FG000|Overall Study|Physician Decision|0|||
161080954|NCT02075073|581684477|FG002|Overall Study|Withdrawal by Subject|0|||
161080955|NCT02683785|581684478|FG000|Overall Study|Withdrawal by Subject|1|||
161080956|NCT02683785|581684479|FG001|Overall Study|Withdrawal by Subject|1|||
161080957|NCT02683785|581684478|FG000|Overall Study|Lost to Follow-up|0|||
161080958|NCT02683785|581684479|FG001|Overall Study|Lost to Follow-up|1|||
161080959|NCT02683785|581684478|FG000|Overall Study|Adverse Event|0|||
161080960|NCT02683785|581684479|FG001|Overall Study|Adverse Event|2|||
161080961|NCT01305408|581684482|FG000|Overall Study|Adverse Event|10|||
161080962|NCT01305408|581684483|FG001|Overall Study|Adverse Event|7|||
161080963|NCT01305408|581684482|FG000|Overall Study|Lack of Efficacy|3|||
161080964|NCT01305408|581684483|FG001|Overall Study|Lack of Efficacy|4|||
161080965|NCT01305408|581684482|FG000|Overall Study|Withdrawal by Subject|9|||
161080966|NCT01305408|581684483|FG001|Overall Study|Withdrawal by Subject|9|||
161080967|NCT01305408|581684482|FG000|Overall Study|Protocol Violation|4|||
161080968|NCT01305408|581684483|FG001|Overall Study|Protocol Violation|6|||
161080969|NCT01305408|581684482|FG000|Overall Study|Lost to Follow-up|5|||
161080970|NCT01305408|581684483|FG001|Overall Study|Lost to Follow-up|3|||
161080971|NCT01305408|581684482|FG000|Overall Study|Noncompliance with study medication|0|||
161080972|NCT01305408|581684483|FG001|Overall Study|Noncompliance with study medication|1|||
161080973|NCT01305408|581684482|FG000|Overall Study|Noncompliance with study procedures|0|||
161080974|NCT01305408|581684483|FG001|Overall Study|Noncompliance with study procedures|1|||
161080975|NCT01305408|581684482|FG000|Overall Study|Other|1|||
161080976|NCT01305408|581684483|FG001|Overall Study|Other|0|||
161080977|NCT02770612|581684484|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
161080978|NCT02233803|581684485|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
161080979|NCT02233803|581684486|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
161080980|NCT02233803|581684485|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
161080981|NCT02233803|581684486|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
161080982|NCT02233803|581684485|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
161080983|NCT02233803|581684486|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
161080984|NCT02233803|581684485|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
161080985|NCT02233803|581684486|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
161080986|NCT02233803|581684485|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
161080987|NCT02233803|581684486|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
161080988|NCT02233803|581684485|FG000|Washout Period (4-Wks)|Physician Decision|1|||
161080989|NCT02233803|581684486|FG001|Washout Period (4-Wks)|Physician Decision|0|||
161080990|NCT02233803|581684485|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
161080991|NCT02233803|581684486|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
161080992|NCT02233803|581684485|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
161080993|NCT02233803|581684486|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
161080994|NCT02233803|581684485|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
161080995|NCT02233803|581684486|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
161080996|NCT03846453|581684487|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
161080997|NCT03846453|581684488|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
161080998|NCT03846453|581684489|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
161080999|NCT03846453|581684487|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
161081000|NCT03846453|581684488|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
161081001|NCT03846453|581684489|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
161081002|NCT03846453|581684487|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
161081003|NCT03846453|581684488|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
161081004|NCT03846453|581684489|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
161081005|NCT03846453|581684487|FG000|Placebo Run-in (14 Days)|Other|2|||
161081006|NCT03846453|581684488|FG001|Placebo Run-in (14 Days)|Other|0|||
161165336|NCT03587584|581982946|FG001|Overall Study|SOC deviations|6|||
161165337|NCT03587584|581982945|FG000|Overall Study|Incomplete data|0|||
161165338|NCT03587584|581982946|FG001|Overall Study|Incomplete data|3|||
161165339|NCT00830115|581982947|FG000|Overall Study|Adverse Event|2|||
161289630|NCT01217112|582440616|FG001|Overall Study|Physician Decision|0|||
161289631|NCT01217112|582440617|FG002|Overall Study|Physician Decision|0|||
161081007|NCT03846453|581684489|FG002|Placebo Run-in (14 Days)|Other|0|||
161081008|NCT03846453|581684487|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
161081009|NCT03846453|581684488|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
161081010|NCT03846453|581684489|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
161081011|NCT03846453|581684487|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
161081012|NCT03846453|581684488|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
161081013|NCT03846453|581684489|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
161081014|NCT03846453|581684487|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
161081015|NCT03846453|581684488|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
161165340|NCT00830115|581982947|FG000|Overall Study|Improvement/recovery|1|||
161289632|NCT01217112|582440618|FG003|Overall Study|Physician Decision|0|||
161289633|NCT01217112|582440619|FG004|Overall Study|Physician Decision|1|||
161289634|NCT01401361|582440620|FG000|Overall Study|Withdrawal by Subject|16|||
161289635|NCT01401361|582440620|FG000|Overall Study|Lack of Efficacy|6|||
161289636|NCT01401361|582440620|FG000|Overall Study|Physician Decision|1|||
161289637|NCT01401361|582440620|FG000|Overall Study|Lost to Follow-up|3|||
161289638|NCT01401361|582440620|FG000|Overall Study|Subject/family decision post procedure|2|||
161289639|NCT00595920|582440623|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
161289640|NCT00351468|582440624|FG000|Overall Study|Adverse Event|42|||
161289641|NCT00351468|582440624|FG000|Overall Study|Withdrawal by Subject|39|||
161289642|NCT00351468|582440624|FG000|Overall Study|Various -follow up w clinical team|39|||
161289643|NCT00351468|582440624|FG000|Overall Study|Lack of Efficacy|32|||
161289644|NCT00351468|582440624|FG000|Overall Study|Non-compliance|8|||
161289645|NCT00351468|582440624|FG000|Overall Study|Lost to Follow-up|4|||
161289646|NCT00351468|582440624|FG000|Overall Study|Protocol Violation|3|||
161289647|NCT03588910|582440625|FG000|Overall Study|Withdrawal by Subject|1|||
161289648|NCT03588910|582440626|FG001|Overall Study|Withdrawal by Subject|0|||
161289649|NCT03588910|582440625|FG000|Overall Study|Allergy|2|||
161289650|NCT03588910|582440626|FG001|Overall Study|Allergy|0|||
161289651|NCT03588910|582440625|FG000|Overall Study|Protocol Violation|0|||
161289652|NCT03588910|582440626|FG001|Overall Study|Protocol Violation|3|||
161289653|NCT03588910|582440625|FG000|Overall Study|Did not complete Day 1 Survey|5|||
161289654|NCT03588910|582440626|FG001|Overall Study|Did not complete Day 1 Survey|10|||
161289655|NCT03588910|582440625|FG000|Overall Study|Did not complete Day 7 Survey|5|||
161289656|NCT03588910|582440626|FG001|Overall Study|Did not complete Day 7 Survey|2|||
161289657|NCT03096314|582440627|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
161289658|NCT03096314|582440628|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
161289659|NCT00471822|582440629|FG000|Overall Study|Protocol Violation|2|||
161289660|NCT02547428|582440630|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
161289661|NCT02547428|582440631|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
161289662|NCT02547428|582440630|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
161289663|NCT02547428|582440631|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
161289664|NCT02547428|582440630|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
161289665|NCT02547428|582440631|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
161289666|NCT02547428|582440630|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
161289667|NCT02547428|582440631|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
161289668|NCT02547428|582440630|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
161289669|NCT02547428|582440631|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
161289670|NCT02547428|582440630|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
161289671|NCT02547428|582440631|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
161289672|NCT02547428|582440630|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
161289673|NCT02547428|582440631|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
161289674|NCT02547428|582440630|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
161289675|NCT02547428|582440631|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
161289676|NCT03318861|582440632|FG000|Overall Study|Death|2|||
161289677|NCT03318861|582440633|FG001|Overall Study|Death|3|||
161289678|NCT03318861|582440634|FG002|Overall Study|Death|3|||
161289679|NCT03318861|582440635|FG003|Overall Study|Death|2|||
161289680|NCT03318861|582440636|FG004|Overall Study|Death|2|||
161289681|NCT03318861|582440632|FG000|Overall Study|Enrolled But Never Treated|0|||
161081016|NCT03846453|581684489|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
161081017|NCT03846453|581684487|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
161081018|NCT03846453|581684488|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
161081019|NCT03846453|581684489|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
161081020|NCT03846453|581684487|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
161081021|NCT03846453|581684488|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
161081022|NCT03846453|581684489|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
161081023|NCT00886795|581684490|FG000|Overall Study|Lack of Efficacy|1|||
161081024|NCT01877239|581684493|FG000|Overall Study|Adverse Event|4|||
161081025|NCT01877239|581684493|FG000|Overall Study|Disease Remission|1|||
161081026|NCT01877239|581684493|FG000|Overall Study|Withdrawal by Subject|4|||
161081027|NCT01877239|581684493|FG000|Overall Study|Other|2|||
161081028|NCT01877239|581684493|FG000|Overall Study|Lack of Efficacy|4|||
161081029|NCT01877239|581684493|FG000|Overall Study|Data not available|35|||
161081030|NCT01283516|581684497|FG000|Overall Study|Adverse Event|0|||
161081031|NCT01283516|581684498|FG001|Overall Study|Adverse Event|0|||
161081032|NCT01283516|581684499|FG002|Overall Study|Adverse Event|0|||
161081033|NCT01283516|581684500|FG003|Overall Study|Adverse Event|0|||
161081034|NCT01283516|581684501|FG004|Overall Study|Adverse Event|0|||
161081035|NCT01283516|581684502|FG005|Overall Study|Adverse Event|0|||
161081036|NCT01283516|581684503|FG006|Overall Study|Adverse Event|2|||
161081037|NCT01283516|581684504|FG007|Overall Study|Adverse Event|0|||
161081038|NCT01283516|581684505|FG008|Overall Study|Adverse Event|28|||
161081039|NCT01283516|581684497|FG000|Overall Study|Death|0|||
161165341|NCT01107405|581982959|FG000|Overall Study|Adverse Event|1|||
161165342|NCT01107405|581982960|FG001|Overall Study|Adverse Event|1|||
161165343|NCT01107405|581982961|FG002|Overall Study|Adverse Event|0|||
161165344|NCT01107405|581982962|FG003|Overall Study|Adverse Event|0|||
161165345|NCT01107405|581982963|FG004|Overall Study|Adverse Event|2|||
161165346|NCT01107405|581982959|FG000|Overall Study|Withdrawal by Subject|1|||
161165347|NCT01107405|581982960|FG001|Overall Study|Withdrawal by Subject|0|||
161165348|NCT01107405|581982961|FG002|Overall Study|Withdrawal by Subject|1|||
161165349|NCT01107405|581982962|FG003|Overall Study|Withdrawal by Subject|2|||
161165350|NCT01107405|581982963|FG004|Overall Study|Withdrawal by Subject|1|||
161165351|NCT01107405|581982959|FG000|Overall Study|Protocol Violation|0|||
161165352|NCT01107405|581982960|FG001|Overall Study|Protocol Violation|0|||
161165353|NCT01107405|581982961|FG002|Overall Study|Protocol Violation|1|||
161165354|NCT01107405|581982962|FG003|Overall Study|Protocol Violation|1|||
161165355|NCT01107405|581982963|FG004|Overall Study|Protocol Violation|0|||
161165356|NCT01895452|581982970|FG000|Overall Study|Adverse Event|1|||
161165357|NCT01895452|581982971|FG001|Overall Study|Adverse Event|4|||
161165358|NCT01895452|581982970|FG000|Overall Study|Lost to Follow-up|1|||
161165359|NCT01895452|581982971|FG001|Overall Study|Lost to Follow-up|5|||
161165360|NCT01895452|581982970|FG000|Overall Study|Pregnancy|0|||
161165361|NCT01895452|581982971|FG001|Overall Study|Pregnancy|1|||
161165362|NCT01895452|581982970|FG000|Overall Study|Withdrawal by Subject|2|||
161165363|NCT01895452|581982971|FG001|Overall Study|Withdrawal by Subject|14|||
161165364|NCT01895452|581982970|FG000|Overall Study|Underlying disease|0|||
161165365|NCT01895452|581982971|FG001|Overall Study|Underlying disease|3|||
161165366|NCT01895452|581982970|FG000|Overall Study|Noncompliance with study drug|0|||
161165367|NCT01895452|581982971|FG001|Overall Study|Noncompliance with study drug|1|||
161165368|NCT01653158|581982972|FG000|Overall Study|Death|0|||
161165369|NCT01653158|581982973|FG001|Overall Study|Death|0|||
161165370|NCT01653158|581982974|FG002|Overall Study|Death|0|||
161165371|NCT01653158|581982975|FG003|Overall Study|Death|1|||
161165372|NCT01653158|581982976|FG004|Overall Study|Death|0|||
161165373|NCT01653158|581982977|FG005|Overall Study|Death|0|||
161165374|NCT01653158|581982978|FG006|Overall Study|Death|0|||
161165375|NCT01653158|581982979|FG007|Overall Study|Death|2|||
161165376|NCT01653158|581982972|FG000|Overall Study|Adverse Event|0|||
161165377|NCT01653158|581982973|FG001|Overall Study|Adverse Event|0|||
161165378|NCT01653158|581982974|FG002|Overall Study|Adverse Event|0|||
161165379|NCT01653158|581982975|FG003|Overall Study|Adverse Event|1|||
161165380|NCT01653158|581982976|FG004|Overall Study|Adverse Event|0|||
161165381|NCT01653158|581982977|FG005|Overall Study|Adverse Event|0|||
161165382|NCT01653158|581982978|FG006|Overall Study|Adverse Event|0|||
161165383|NCT01653158|581982979|FG007|Overall Study|Adverse Event|3|||
161165384|NCT01653158|581982972|FG000|Overall Study|Other|0|||
161165385|NCT01653158|581982973|FG001|Overall Study|Other|0|||
161165386|NCT01653158|581982974|FG002|Overall Study|Other|0|||
161165387|NCT01653158|581982975|FG003|Overall Study|Other|0|||
161165388|NCT01653158|581982976|FG004|Overall Study|Other|0|||
161165389|NCT01653158|581982977|FG005|Overall Study|Other|0|||
161165390|NCT01653158|581982978|FG006|Overall Study|Other|0|||
161165391|NCT01653158|581982979|FG007|Overall Study|Other|1|||
161165392|NCT01653158|581982972|FG000|Overall Study|Progressive disease|0|||
161165393|NCT01653158|581982973|FG001|Overall Study|Progressive disease|0|||
161165394|NCT01653158|581982974|FG002|Overall Study|Progressive disease|0|||
161165395|NCT01653158|581982975|FG003|Overall Study|Progressive disease|0|||
161165396|NCT01653158|581982976|FG004|Overall Study|Progressive disease|1|||
161165397|NCT01653158|581982977|FG005|Overall Study|Progressive disease|1|||
161165398|NCT01653158|581982978|FG006|Overall Study|Progressive disease|2|||
161165399|NCT01653158|581982979|FG007|Overall Study|Progressive disease|9|||
161165400|NCT01653158|581982972|FG000|Overall Study|Withdrawal by Subject|1|||
161165401|NCT01653158|581982973|FG001|Overall Study|Withdrawal by Subject|0|||
161165402|NCT01653158|581982974|FG002|Overall Study|Withdrawal by Subject|0|||
161165403|NCT01653158|581982975|FG003|Overall Study|Withdrawal by Subject|0|||
161165404|NCT01653158|581982976|FG004|Overall Study|Withdrawal by Subject|0|||
161165405|NCT01653158|581982977|FG005|Overall Study|Withdrawal by Subject|0|||
161165406|NCT01653158|581982978|FG006|Overall Study|Withdrawal by Subject|0|||
161165407|NCT01653158|581982979|FG007|Overall Study|Withdrawal by Subject|0|||
161165408|NCT06964165|581982986|FG000|Overall Study|Death|4|||
161165409|NCT06964165|581982987|FG001|Overall Study|Death|4|||
161165410|NCT06964165|581982986|FG000|Overall Study|Physician Decision|1|||
161165411|NCT06964165|581982987|FG001|Overall Study|Physician Decision|1|||
161165412|NCT06964165|581982986|FG000|Overall Study|Withdrawal by Subject|0|||
161165413|NCT06964165|581982987|FG001|Overall Study|Withdrawal by Subject|2|||
161165414|NCT06964165|581982986|FG000|Overall Study|Study terminated by sponsor|12|||
161165415|NCT06964165|581982987|FG001|Overall Study|Study terminated by sponsor|10|||
161165416|NCT06964165|581982986|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
161165417|NCT06964165|581982987|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
161165418|NCT06964165|581982986|FG000|Overall Study|Participant removed due to non-compliance|0|||
161165419|NCT06964165|581982987|FG001|Overall Study|Participant removed due to non-compliance|1|||
161165420|NCT01551758|581982988|FG000|Overall Study|Adverse Event|29|||
161165421|NCT01551758|581982989|FG001|Overall Study|Adverse Event|43|||
161165422|NCT01551758|581982988|FG000|Overall Study|Lack of Efficacy|0|||
161165423|NCT01551758|581982989|FG001|Overall Study|Lack of Efficacy|1|||
161165424|NCT01551758|581982988|FG000|Overall Study|Protocol Violation|5|||
161165425|NCT01551758|581982989|FG001|Overall Study|Protocol Violation|6|||
161165426|NCT01551758|581982988|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
161165427|NCT01551758|581982989|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
161165428|NCT01551758|581982988|FG000|Overall Study|Lost to Follow-up|29|||
161165429|NCT01551758|581982989|FG001|Overall Study|Lost to Follow-up|25|||
161165430|NCT01551758|581982988|FG000|Overall Study|Physician Decision|9|||
161165431|NCT01551758|581982989|FG001|Overall Study|Physician Decision|3|||
161165432|NCT01551758|581982988|FG000|Overall Study|Withdrawal by Subject|14|||
161165433|NCT01551758|581982989|FG001|Overall Study|Withdrawal by Subject|17|||
161165434|NCT01586156|581982991|FG000|Overall Study|Pregnancy|0|||
161165435|NCT01586156|581982992|FG001|Overall Study|Pregnancy|1|||
161165436|NCT01586156|581982993|FG002|Overall Study|Pregnancy|0|||
161165437|NCT04465396|581982996|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
161165438|NCT04465396|581982997|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
161165439|NCT04465396|581982998|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
161165440|NCT04465396|581982999|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
161165441|NCT01766817|581983007|FG000|Overall Study|Drug-related adverse event|1|||
161165442|NCT01766817|581983008|FG001|Overall Study|Drug-related adverse event|2|||
161165443|NCT01766817|581983009|FG002|Overall Study|Drug-related adverse event|1|||
161165444|NCT01766817|581983007|FG000|Overall Study|Drug-unrelated adverse event|3|||
161165445|NCT01766817|581983008|FG001|Overall Study|Drug-unrelated adverse event|3|||
161165446|NCT01766817|581983009|FG002|Overall Study|Drug-unrelated adverse event|3|||
161165447|NCT01766817|581983007|FG000|Overall Study|Death|1|||
161165448|NCT01766817|581983008|FG001|Overall Study|Death|1|||
161165449|NCT01766817|581983009|FG002|Overall Study|Death|0|||
161165450|NCT01766817|581983007|FG000|Overall Study|Unable to take study drug|0|||
161165451|NCT01766817|581983008|FG001|Overall Study|Unable to take study drug|1|||
161165452|NCT01766817|581983009|FG002|Overall Study|Unable to take study drug|0|||
161165453|NCT01766817|581983007|FG000|Overall Study|Withdrawal by Subject|2|||
161165454|NCT01766817|581983008|FG001|Overall Study|Withdrawal by Subject|0|||
161165455|NCT01766817|581983009|FG002|Overall Study|Withdrawal by Subject|3|||
161165456|NCT01766817|581983007|FG000|Overall Study|Subject non-compliance|0|||
161165457|NCT01766817|581983008|FG001|Overall Study|Subject non-compliance|1|||
161165458|NCT01766817|581983009|FG002|Overall Study|Subject non-compliance|2|||
161165459|NCT01766817|581983007|FG000|Overall Study|Physician Decision|3|||
161165460|NCT01766817|581983008|FG001|Overall Study|Physician Decision|3|||
161165461|NCT01766817|581983009|FG002|Overall Study|Physician Decision|4|||
161081040|NCT01283516|581684498|FG001|Overall Study|Death|0|||
161081041|NCT01283516|581684499|FG002|Overall Study|Death|0|||
161081042|NCT01283516|581684500|FG003|Overall Study|Death|0|||
161081043|NCT01283516|581684501|FG004|Overall Study|Death|0|||
161081044|NCT01283516|581684502|FG005|Overall Study|Death|1|||
161081045|NCT01283516|581684503|FG006|Overall Study|Death|0|||
161081046|NCT01283516|581684504|FG007|Overall Study|Death|1|||
161081047|NCT01283516|581684505|FG008|Overall Study|Death|12|||
161081048|NCT01283516|581684497|FG000|Overall Study|Disease Progression|2|||
161081049|NCT01283516|581684498|FG001|Overall Study|Disease Progression|2|||
161081050|NCT01283516|581684499|FG002|Overall Study|Disease Progression|3|||
161081051|NCT01283516|581684500|FG003|Overall Study|Disease Progression|3|||
161081052|NCT01283516|581684501|FG004|Overall Study|Disease Progression|13|||
161081053|NCT01283516|581684502|FG005|Overall Study|Disease Progression|8|||
161081054|NCT01283516|581684503|FG006|Overall Study|Disease Progression|6|||
161081055|NCT01283516|581684504|FG007|Overall Study|Disease Progression|3|||
161081056|NCT01283516|581684505|FG008|Overall Study|Disease Progression|139|||
161081057|NCT01283516|581684497|FG000|Overall Study|Withdrawal by Subject|0|||
161081058|NCT01283516|581684498|FG001|Overall Study|Withdrawal by Subject|0|||
161081059|NCT01283516|581684499|FG002|Overall Study|Withdrawal by Subject|0|||
161081060|NCT01283516|581684500|FG003|Overall Study|Withdrawal by Subject|0|||
161081061|NCT01283516|581684501|FG004|Overall Study|Withdrawal by Subject|1|||
161081062|NCT01283516|581684502|FG005|Overall Study|Withdrawal by Subject|0|||
161165462|NCT01766817|581983007|FG000|Overall Study|Other|1|||
161289682|NCT03318861|582440633|FG001|Overall Study|Enrolled But Never Treated|1|||
161081063|NCT01283516|581684503|FG006|Overall Study|Withdrawal by Subject|1|||
161081064|NCT01283516|581684504|FG007|Overall Study|Withdrawal by Subject|0|||
161081065|NCT01283516|581684505|FG008|Overall Study|Withdrawal by Subject|36|||
161165463|NCT01766817|581983008|FG001|Overall Study|Other|0|||
161289683|NCT03318861|582440634|FG002|Overall Study|Enrolled But Never Treated|0|||
161081066|NCT01283516|581684497|FG000|Overall Study|Administrative problems|0|||
161081067|NCT01283516|581684498|FG001|Overall Study|Administrative problems|0|||
161081068|NCT01283516|581684499|FG002|Overall Study|Administrative problems|0|||
161081069|NCT01283516|581684500|FG003|Overall Study|Administrative problems|0|||
161165464|NCT01766817|581983009|FG002|Overall Study|Other|0|||
161165465|NCT03814590|581983010|FG000|Overall Study|Adverse Event|0|||
161165466|NCT03814590|581983011|FG001|Overall Study|Adverse Event|0|||
161346864|NCT00433537|582653389|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
161346865|NCT00433537|582653390|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
161081070|NCT01283516|581684501|FG004|Overall Study|Administrative problems|0|||
161081071|NCT01283516|581684502|FG005|Overall Study|Administrative problems|1|||
161081072|NCT01283516|581684503|FG006|Overall Study|Administrative problems|1|||
161081073|NCT01283516|581684504|FG007|Overall Study|Administrative problems|1|||
161081074|NCT01283516|581684505|FG008|Overall Study|Administrative problems|39|||
161081075|NCT01283516|581684497|FG000|Overall Study|Lost to Follow-up|0|||
161081076|NCT01283516|581684498|FG001|Overall Study|Lost to Follow-up|0|||
161081077|NCT01283516|581684499|FG002|Overall Study|Lost to Follow-up|0|||
161081078|NCT01283516|581684500|FG003|Overall Study|Lost to Follow-up|0|||
161081079|NCT01283516|581684501|FG004|Overall Study|Lost to Follow-up|0|||
161081080|NCT01283516|581684502|FG005|Overall Study|Lost to Follow-up|0|||
161081081|NCT01283516|581684503|FG006|Overall Study|Lost to Follow-up|0|||
161081082|NCT01283516|581684504|FG007|Overall Study|Lost to Follow-up|0|||
161081083|NCT01283516|581684505|FG008|Overall Study|Lost to Follow-up|1|||
161081084|NCT01989169|581684508|FG000|Period 2|Adverse Event|0|||
161081085|NCT01989169|581684509|FG001|Period 2|Adverse Event|1|||
161081086|NCT01114880|581684510|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
161081087|NCT01114880|581684511|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
161081088|NCT01114880|581684510|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
161081089|NCT01114880|581684511|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
161081090|NCT01114880|581684510|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
161081091|NCT01114880|581684511|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
161081092|NCT01114880|581684510|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
161081093|NCT01114880|581684511|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
161081094|NCT01114880|581684510|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
161081095|NCT01114880|581684511|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
161081096|NCT01114880|581684510|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
161081097|NCT01114880|581684511|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
161081098|NCT04531904|581684513|FG000|Overall Study|Lost to Follow-up|1|||
161081099|NCT04531904|581684513|FG000|Overall Study|Death|14|||
161081100|NCT00283244|581684514|FG000|Overall Study|Adverse Event|0|||
161081101|NCT00283244|581684515|FG001|Overall Study|Adverse Event|8|||
161081102|NCT00283244|581684516|FG002|Overall Study|Adverse Event|11|||
161081103|NCT00283244|581684514|FG000|Overall Study|Death|4|||
161081104|NCT00283244|581684515|FG001|Overall Study|Death|3|||
161081105|NCT00283244|581684516|FG002|Overall Study|Death|2|||
161081106|NCT00283244|581684514|FG000|Overall Study|Lack of Efficacy|8|||
161081107|NCT00283244|581684515|FG001|Overall Study|Lack of Efficacy|32|||
161081108|NCT00283244|581684516|FG002|Overall Study|Lack of Efficacy|26|||
161081109|NCT00283244|581684514|FG000|Overall Study|Withdrawal by Subject|1|||
161081110|NCT00283244|581684515|FG001|Overall Study|Withdrawal by Subject|2|||
161081111|NCT00283244|581684516|FG002|Overall Study|Withdrawal by Subject|2|||
161081112|NCT00283244|581684514|FG000|Overall Study|Physician Decision|0|||
161081113|NCT00283244|581684515|FG001|Overall Study|Physician Decision|0|||
161081114|NCT00283244|581684516|FG002|Overall Study|Physician Decision|1|||
161081115|NCT00283244|581684514|FG000|Overall Study|Medical illness (other complicating dz)|4|||
161081116|NCT00283244|581684515|FG001|Overall Study|Medical illness (other complicating dz)|3|||
161081117|NCT00283244|581684516|FG002|Overall Study|Medical illness (other complicating dz)|6|||
161081118|NCT00283244|581684514|FG000|Overall Study|Clinical deterioration|1|||
161081119|NCT00283244|581684515|FG001|Overall Study|Clinical deterioration|3|||
161081120|NCT00283244|581684516|FG002|Overall Study|Clinical deterioration|3|||
161081121|NCT02738853|581684519|FG000|Enrollment|Inclusion/Exclusion not met|21|||
161081122|NCT02738853|581684519|FG000|Enrollment|Withdrawal by Subject|3|||
161081123|NCT02738853|581684519|FG000|Enrollment|Subject treated with commercially available device|6|||
161081124|NCT02738853|581684519|FG000|Enrollment|Study Enrollment Closed|3|||
161081125|NCT02738853|581684519|FG000|Procedure|Death|1|||
161081126|NCT02738853|581684519|FG000|1 Month|Death|2|||
161081127|NCT02738853|581684519|FG000|6 Month|Death|4|||
161081128|NCT02738853|581684519|FG000|6 Month|Withdrawal by Subject|2|||
161081129|NCT02738853|581684519|FG000|1 Year|Death|6|||
161081130|NCT02738853|581684519|FG000|1 Year|Withdrawal by Subject|1|||
161081131|NCT02738853|581684519|FG000|2 Year|Death|2|||
161081132|NCT02738853|581684519|FG000|2 Year|Lost to Follow-up|1|||
161081133|NCT02738853|581684519|FG000|3 Year|Death|2|||
161081134|NCT02738853|581684519|FG000|3 Year|Withdrawal by Subject|1|||
161081135|NCT02738853|581684519|FG000|4 Year|Death|9|||
161081136|NCT02738853|581684519|FG000|5 Year|Lost to Follow-up|4|||
161081137|NCT01743989|581684520|FG000|Treatment Phase|Unstable MR4.0|0|||
161081138|NCT01743989|581684521|FG001|Treatment Phase|Unstable MR4.0|6|||
161081139|NCT01743989|581684522|FG002|Treatment Phase|Unstable MR4.0|263|||
161081140|NCT01743989|581684520|FG000|Treatment Phase|Adverse Event|0|||
161081141|NCT01743989|581684521|FG001|Treatment Phase|Adverse Event|4|||
161081142|NCT01743989|581684522|FG002|Treatment Phase|Adverse Event|67|||
161081143|NCT01743989|581684520|FG000|Treatment Phase|Withdrawal by Subject|1|||
161081144|NCT01743989|581684521|FG001|Treatment Phase|Withdrawal by Subject|3|||
161081145|NCT01743989|581684522|FG002|Treatment Phase|Withdrawal by Subject|28|||
161346866|NCT00433537|582653391|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
161346867|NCT00830765|582653399|FG000|Overall Study|Protocol Violation|3|||
161346868|NCT00830765|582653400|FG001|Overall Study|Protocol Violation|2|||
161346869|NCT02390284|582653401|FG000|Overall Study|Physician Decision|0|||
161346870|NCT02390284|582653402|FG001|Overall Study|Physician Decision|0|||
161346871|NCT02390284|582653403|FG002|Overall Study|Physician Decision|9|||
161346872|NCT01977846|582653404|FG000|Total Study - Prospective|Death|0|||
161346873|NCT01977846|582653405|FG001|Total Study - Prospective|Death|1|||
161346874|NCT01977846|582653404|FG000|Total Study - Prospective|Lost to Follow-up|0|||
161346875|NCT01977846|582653405|FG001|Total Study - Prospective|Lost to Follow-up|8|||
161346876|NCT01977846|582653404|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
161346877|NCT01977846|582653405|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
161346878|NCT01977846|582653404|FG000|Total Study - Prospective|Not available at time of visit|0|||
161346879|NCT01977846|582653405|FG001|Total Study - Prospective|Not available at time of visit|5|||
161346880|NCT01977846|582653404|FG000|Total Study - Prospective|No show|0|||
161346881|NCT01977846|582653405|FG001|Total Study - Prospective|No show|1|||
161346882|NCT01977846|582653404|FG000|Total Study - Prospective|Protocol Violation|0|||
161346883|NCT01977846|582653405|FG001|Total Study - Prospective|Protocol Violation|1|||
161346884|NCT00143507|582654676|FG000|Overall Study|Death|572|||
161346885|NCT00143507|582654677|FG001|Overall Study|Death|547|||
161081146|NCT01743989|581684520|FG000|Treatment Phase|Death|0|||
161081147|NCT01743989|581684521|FG001|Treatment Phase|Death|1|||
161081148|NCT01743989|581684522|FG002|Treatment Phase|Death|3|||
161081149|NCT01743989|581684520|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
161081150|NCT01743989|581684521|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
161081151|NCT01743989|581684522|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
161081152|NCT01743989|581684520|FG000|Treatment Phase|Protocol deviation|0|||
161081153|NCT01743989|581684521|FG001|Treatment Phase|Protocol deviation|0|||
161081154|NCT01743989|581684522|FG002|Treatment Phase|Protocol deviation|3|||
161081155|NCT01743989|581684520|FG000|Treatment Phase|Pregnancy|0|||
161081156|NCT01743989|581684521|FG001|Treatment Phase|Pregnancy|0|||
161081157|NCT01743989|581684522|FG002|Treatment Phase|Pregnancy|2|||
161081158|NCT01743989|581684520|FG000|Treatment Phase|Lost to Follow-up|0|||
161081159|NCT01743989|581684521|FG001|Treatment Phase|Lost to Follow-up|0|||
161081160|NCT01743989|581684522|FG002|Treatment Phase|Lost to Follow-up|2|||
161081161|NCT01743989|581684520|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
161081162|NCT01743989|581684521|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
161081163|NCT01743989|581684522|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
161081164|NCT01743989|581684520|FG000|Treatment Phase|Administrative problems|0|||
161081165|NCT01743989|581684521|FG001|Treatment Phase|Administrative problems|0|||
161081166|NCT01743989|581684522|FG002|Treatment Phase|Administrative problems|1|||
161081167|NCT01743989|581684520|FG000|Treatment Phase|New cancer (CML) therapy|0|||
161081168|NCT01743989|581684521|FG001|Treatment Phase|New cancer (CML) therapy|1|||
161081169|NCT01743989|581684522|FG002|Treatment Phase|New cancer (CML) therapy|0|||
161081170|NCT01743989|581684520|FG000|Treatment Phase|Physician Decision|0|||
161081171|NCT01743989|581684521|FG001|Treatment Phase|Physician Decision|0|||
161081172|NCT01743989|581684522|FG002|Treatment Phase|Physician Decision|3|||
161081173|NCT01743989|581684520|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
161081174|NCT01743989|581684521|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
161081175|NCT01743989|581684522|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
161081176|NCT01743989|581684520|FG000|Treatment Phase|Not randomized by mistake|0|||
161081177|NCT01743989|581684521|FG001|Treatment Phase|Not randomized by mistake|0|||
161081178|NCT01743989|581684522|FG002|Treatment Phase|Not randomized by mistake|1|||
161081179|NCT01743989|581684520|FG000|Treatment Phase|Included by mistake|0|||
161081180|NCT01743989|581684521|FG001|Treatment Phase|Included by mistake|0|||
161081181|NCT01743989|581684522|FG002|Treatment Phase|Included by mistake|1|||
161081182|NCT01743989|581684520|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
161081183|NCT01743989|581684521|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
161081184|NCT01743989|581684522|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
161081185|NCT01743989|581684520|FG000|TFR Phase|Adverse Event|0|||
161081186|NCT01743989|581684521|FG001|TFR Phase|Adverse Event|1|||
161081187|NCT01743989|581684522|FG002|TFR Phase|Adverse Event|0|||
161081188|NCT01743989|581684520|FG000|TFR Phase|Lost to Follow-up|0|||
161081189|NCT01743989|581684521|FG001|TFR Phase|Lost to Follow-up|2|||
161081190|NCT01743989|581684522|FG002|TFR Phase|Lost to Follow-up|0|||
161081191|NCT01743989|581684520|FG000|TFR Phase|Physician Decision|0|||
161081192|NCT01743989|581684521|FG001|TFR Phase|Physician Decision|1|||
161081193|NCT01743989|581684522|FG002|TFR Phase|Physician Decision|0|||
161081194|NCT01743989|581684520|FG000|TFR Phase|Logistical problems|0|||
161081195|NCT01743989|581684521|FG001|TFR Phase|Logistical problems|2|||
161081196|NCT01743989|581684522|FG002|TFR Phase|Logistical problems|0|||
161081197|NCT01743989|581684520|FG000|TFR Phase|Protocol deviation|0|||
161346886|NCT00143507|582654676|FG000|Overall Study|Withdrawal by Subject|114|||
161346887|NCT00143507|582654677|FG001|Overall Study|Withdrawal by Subject|102|||
161081198|NCT01743989|581684521|FG001|TFR Phase|Protocol deviation|1|||
161346888|NCT00143507|582654676|FG000|Overall Study|Lost to Follow-up|1|||
161289684|NCT03318861|582440635|FG003|Overall Study|Enrolled But Never Treated|1|||
161289685|NCT03318861|582440636|FG004|Overall Study|Enrolled But Never Treated|1|||
161081199|NCT01743989|581684522|FG002|TFR Phase|Protocol deviation|0|||
161081200|NCT01743989|581684520|FG000|TFR Phase|Withdrawal by Subject|0|||
161081201|NCT01743989|581684521|FG001|TFR Phase|Withdrawal by Subject|2|||
161081202|NCT01743989|581684522|FG002|TFR Phase|Withdrawal by Subject|0|||
161081203|NCT01743989|581684520|FG000|Re-treatment Phase|Adverse Event|8|||
161081204|NCT01743989|581684521|FG001|Re-treatment Phase|Adverse Event|4|||
161081205|NCT01743989|581684522|FG002|Re-treatment Phase|Adverse Event|0|||
161081206|NCT01743989|581684520|FG000|Re-treatment Phase|Death|1|||
161081207|NCT01743989|581684521|FG001|Re-treatment Phase|Death|1|||
161081208|NCT01743989|581684522|FG002|Re-treatment Phase|Death|0|||
161081209|NCT01743989|581684520|FG000|Re-treatment Phase|Administrative problems|1|||
161081210|NCT01743989|581684521|FG001|Re-treatment Phase|Administrative problems|1|||
161081211|NCT01743989|581684522|FG002|Re-treatment Phase|Administrative problems|0|||
161081212|NCT01743989|581684520|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
161081213|NCT01743989|581684521|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
161081214|NCT01743989|581684522|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
161081215|NCT01743989|581684520|FG000|Re-treatment Phase|Unstable MR|1|||
161081216|NCT01743989|581684521|FG001|Re-treatment Phase|Unstable MR|0|||
161081217|NCT01743989|581684522|FG002|Re-treatment Phase|Unstable MR|0|||
161081218|NCT01743989|581684520|FG000|Re-treatment Phase|Physician Decision|0|||
161081219|NCT01743989|581684521|FG001|Re-treatment Phase|Physician Decision|1|||
161081220|NCT01743989|581684522|FG002|Re-treatment Phase|Physician Decision|0|||
161081221|NCT01743989|581684520|FG000|Re-treatment Phase|Lost to Follow-up|0|||
161081222|NCT01743989|581684521|FG001|Re-treatment Phase|Lost to Follow-up|1|||
161081223|NCT01743989|581684522|FG002|Re-treatment Phase|Lost to Follow-up|0|||
161081224|NCT02235311|581684525|FG000|Overall Study|Lost to Follow-up|0|||
161081225|NCT02235311|581684526|FG001|Overall Study|Lost to Follow-up|1|||
161081226|NCT02235311|581684525|FG000|Overall Study|Protocol Violation|0|||
161081227|NCT02235311|581684526|FG001|Overall Study|Protocol Violation|1|||
161081228|NCT04655027|581684527|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
161081229|NCT04655027|581684528|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
161081230|NCT00658788|581684529|FG000|Overall Study|Adverse Event|11|||
161081231|NCT00658788|581684529|FG000|Overall Study|Withdrawal by Subject|13|||
161081232|NCT00658788|581684529|FG000|Overall Study|Lost to Follow-up|18|||
161081233|NCT00658788|581684529|FG000|Overall Study|Treatment Discontinuation|32|||
161081234|NCT00653523|581684530|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
161081235|NCT00653523|581684530|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
161081236|NCT00653523|581684530|FG000|Overall Study|Adverse Event|7|||
161081237|NCT00653523|581684530|FG000|Overall Study|Withdrawal by Subject|6|||
161081238|NCT00653523|581684530|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
161081239|NCT00653523|581684530|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
161081240|NCT03519997|581684531|FG000|Overall Study|Adverse Event|4|||
161081241|NCT03519997|581684531|FG000|Overall Study|Withdrawal by Subject|2|||
161081242|NCT03519997|581684531|FG000|Overall Study|Protocol Violation|1|||
161081243|NCT03361605|581684532|FG000|Overall Study|Analyzable data not available|3|||
161081244|NCT03006848|581684535|FG000|Overall Study|Adverse Event|1|||
161081245|NCT03006848|581684535|FG000|Overall Study|Physician Decision|1|||
161081246|NCT03006848|581684535|FG000|Overall Study|Lack of Efficacy|16|||
161081247|NCT05543187|581684536|FG000|Overall Study|Ongoing|3|||
161081248|NCT05543187|581684537|FG001|Overall Study|Ongoing|2|||
161081249|NCT03520712|581684538|FG000|Overall Study|Early termination of the study by Sponsor|2|||
161081250|NCT04531982|581684539|FG000|Overall Study|Withdrawal by Subject|10|||
161081251|NCT04531982|581684540|FG001|Overall Study|Withdrawal by Subject|11|||
161081252|NCT04531982|581684539|FG000|Overall Study|Adverse Event|6|||
161081253|NCT04531982|581684540|FG001|Overall Study|Adverse Event|14|||
161081254|NCT04531982|581684539|FG000|Overall Study|Protocol Violation|6|||
161081255|NCT04531982|581684540|FG001|Overall Study|Protocol Violation|9|||
161081256|NCT04531982|581684539|FG000|Overall Study|Non-compliance with study drug|3|||
161081257|NCT04531982|581684540|FG001|Overall Study|Non-compliance with study drug|2|||
161081258|NCT04531982|581684539|FG000|Overall Study|Use of prohibited medication|2|||
161081259|NCT04531982|581684540|FG001|Overall Study|Use of prohibited medication|0|||
161081260|NCT04531982|581684539|FG000|Overall Study|Lost to Follow-up|0|||
161081261|NCT04531982|581684540|FG001|Overall Study|Lost to Follow-up|1|||
161081262|NCT04531982|581684539|FG000|Overall Study|Geopolitical conflict|2|||
161081263|NCT04531982|581684540|FG001|Overall Study|Geopolitical conflict|0|||
161289686|NCT03318861|582440632|FG000|Overall Study|Informed Consent Withdraw|0|||
161081264|NCT04531982|581684539|FG000|Overall Study|Lack of Efficacy|3|||
161081265|NCT04531982|581684540|FG001|Overall Study|Lack of Efficacy|1|||
161081266|NCT04372121|581684541|FG000|Overall Study|Lost to Follow-up|0|||
161081267|NCT04372121|581684542|FG001|Overall Study|Lost to Follow-up|0|||
161081268|NCT04372121|581684543|FG002|Overall Study|Lost to Follow-up|0|||
161081269|NCT04372121|581684544|FG003|Overall Study|Lost to Follow-up|1|||
161081270|NCT04372121|581684541|FG000|Overall Study|Protocol Violation|0|||
161081271|NCT04372121|581684542|FG001|Overall Study|Protocol Violation|0|||
161081272|NCT04372121|581684543|FG002|Overall Study|Protocol Violation|1|||
161165467|NCT03814590|581983012|FG002|Overall Study|Adverse Event|0|||
161165468|NCT03814590|581983013|FG003|Overall Study|Adverse Event|0|||
161165469|NCT03814590|581983014|FG004|Overall Study|Adverse Event|0|||
161165470|NCT03814590|581983015|FG005|Overall Study|Adverse Event|1|||
161165471|NCT03814590|581983016|FG006|Overall Study|Adverse Event|1|||
161165472|NCT03814590|581983017|FG007|Overall Study|Adverse Event|1|||
161165473|NCT03814590|581983018|FG008|Overall Study|Adverse Event|0|||
161165474|NCT03814590|581983019|FG009|Overall Study|Adverse Event|0|||
161165475|NCT03814590|581983020|FG010|Overall Study|Adverse Event|1|||
161165476|NCT03814590|581983021|FG011|Overall Study|Adverse Event|0|||
161165477|NCT03814590|581983022|FG012|Overall Study|Adverse Event|3|||
161165478|NCT03814590|581983023|FG013|Overall Study|Adverse Event|0|||
161165479|NCT03814590|581983010|FG000|Overall Study|Lost to Follow-up|0|||
161165480|NCT03814590|581983011|FG001|Overall Study|Lost to Follow-up|2|||
161165481|NCT03814590|581983012|FG002|Overall Study|Lost to Follow-up|1|||
161165482|NCT03814590|581983013|FG003|Overall Study|Lost to Follow-up|0|||
161165483|NCT03814590|581983014|FG004|Overall Study|Lost to Follow-up|1|||
161165484|NCT03814590|581983015|FG005|Overall Study|Lost to Follow-up|1|||
161165485|NCT03814590|581983016|FG006|Overall Study|Lost to Follow-up|1|||
161165486|NCT03814590|581983017|FG007|Overall Study|Lost to Follow-up|1|||
161165487|NCT03814590|581983018|FG008|Overall Study|Lost to Follow-up|0|||
161165488|NCT03814590|581983019|FG009|Overall Study|Lost to Follow-up|0|||
161165489|NCT03814590|581983020|FG010|Overall Study|Lost to Follow-up|1|||
161165490|NCT03814590|581983021|FG011|Overall Study|Lost to Follow-up|0|||
161165491|NCT03814590|581983022|FG012|Overall Study|Lost to Follow-up|0|||
161165492|NCT03814590|581983023|FG013|Overall Study|Lost to Follow-up|1|||
161165493|NCT03814590|581983010|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165494|NCT03814590|581983011|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165495|NCT03814590|581983012|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161289687|NCT03318861|582440633|FG001|Overall Study|Informed Consent Withdraw|0|||
161289688|NCT03318861|582440634|FG002|Overall Study|Informed Consent Withdraw|0|||
161289689|NCT03318861|582440635|FG003|Overall Study|Informed Consent Withdraw|1|||
161289690|NCT03318861|582440636|FG004|Overall Study|Informed Consent Withdraw|0|||
161289691|NCT03318861|582440632|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
161289692|NCT03318861|582440633|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161289693|NCT03318861|582440634|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161289694|NCT03318861|582440635|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161289695|NCT03318861|582440636|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
161289696|NCT02088177|582440639|FG000|Overall Study|Lost to Follow-up|3|||
161289697|NCT01234350|582440640|FG000|Overall Study|Adverse Event|277|||
161289698|NCT01234350|582440641|FG001|Overall Study|Adverse Event|92|||
161289699|NCT01234350|582440640|FG000|Overall Study|Withdrawal by Subject|61|||
161289700|NCT01234350|582440641|FG001|Overall Study|Withdrawal by Subject|36|||
161289701|NCT01234350|582440640|FG000|Overall Study|Lost to Follow-up|115|||
161289702|NCT01234350|582440641|FG001|Overall Study|Lost to Follow-up|47|||
161289703|NCT01234350|582440640|FG000|Overall Study|Covers a diverse set of reasons|234|||
161289704|NCT01234350|582440641|FG001|Overall Study|Covers a diverse set of reasons|92|||
161289705|NCT00289848|582440642|FG000|Overall Study|Adverse Event|6|||
161289706|NCT00289848|582440643|FG001|Overall Study|Adverse Event|4|||
161289707|NCT00289848|582440642|FG000|Overall Study|Death|1|||
161289708|NCT00289848|582440643|FG001|Overall Study|Death|0|||
161289709|NCT00289848|582440642|FG000|Overall Study|Lack of Efficacy|20|||
161289710|NCT00289848|582440643|FG001|Overall Study|Lack of Efficacy|24|||
161289711|NCT00289848|582440642|FG000|Overall Study|Lost to Follow-up|3|||
161289712|NCT00289848|582440643|FG001|Overall Study|Lost to Follow-up|1|||
161289713|NCT00289848|582440642|FG000|Overall Study|Protocol Violation|5|||
161289714|NCT00289848|582440643|FG001|Overall Study|Protocol Violation|2|||
161289715|NCT00289848|582440642|FG000|Overall Study|Withdrawal by Subject|5|||
161289716|NCT00289848|582440643|FG001|Overall Study|Withdrawal by Subject|11|||
161289717|NCT00289848|582440642|FG000|Overall Study|Patient Moved|6|||
161289718|NCT00289848|582440643|FG001|Overall Study|Patient Moved|2|||
161289719|NCT00289848|582440642|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
161289720|NCT00289848|582440643|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
161289721|NCT01433471|582440646|FG000|Overall Study|Withdrawal by Subject|0|||
161289722|NCT01433471|582440647|FG001|Overall Study|Withdrawal by Subject|1|||
161289723|NCT03428152|582440652|FG000|Overall Study|Physician Decision|4|||
161289724|NCT03428152|582440653|FG001|Overall Study|Physician Decision|2|||
161289725|NCT03428152|582440652|FG000|Overall Study|Protocol Violation|3|||
161289726|NCT03428152|582440653|FG001|Overall Study|Protocol Violation|5|||
161289727|NCT03428152|582440652|FG000|Overall Study|Lack of Efficacy|0|||
161289728|NCT03428152|582440653|FG001|Overall Study|Lack of Efficacy|4|||
161165496|NCT03814590|581983013|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165497|NCT03814590|581983014|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165498|NCT03814590|581983015|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161289729|NCT00395629|582440654|FG000|Core Study|Adverse Event|0|||
161289730|NCT00395629|582440655|FG001|Core Study|Adverse Event|3|||
161165499|NCT03814590|581983016|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165500|NCT03814590|581983017|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165501|NCT03814590|581983018|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165502|NCT03814590|581983019|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
161165503|NCT03814590|581983020|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165504|NCT03814590|581983021|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165505|NCT03814590|581983022|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165506|NCT03814590|581983023|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
161165507|NCT03814590|581983010|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161165508|NCT03814590|581983011|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161165509|NCT03814590|581983012|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161165510|NCT03814590|581983013|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161165511|NCT03814590|581983014|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161165512|NCT03814590|581983015|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
161165513|NCT03814590|581983016|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161165514|NCT03814590|581983017|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
161165515|NCT03814590|581983018|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161165516|NCT03814590|581983019|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
161165517|NCT03814590|581983020|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161165518|NCT03814590|581983021|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
161289731|NCT00395629|582440656|FG002|Core Study|Adverse Event|4|||
161289732|NCT00395629|582440654|FG000|Core Study|Abnormal laboratory value(s)|0|||
161289733|NCT00395629|582440655|FG001|Core Study|Abnormal laboratory value(s)|0|||
161289734|NCT00395629|582440656|FG002|Core Study|Abnormal laboratory value(s)|1|||
161289735|NCT00395629|582440654|FG000|Core Study|Protocol Violation|1|||
161289736|NCT00395629|582440655|FG001|Core Study|Protocol Violation|0|||
161289737|NCT00395629|582440656|FG002|Core Study|Protocol Violation|0|||
161289738|NCT00395629|582440654|FG000|Core Study|Withdrawal by Subject|0|||
161289739|NCT00395629|582440655|FG001|Core Study|Withdrawal by Subject|1|||
161289740|NCT00395629|582440656|FG002|Core Study|Withdrawal by Subject|1|||
161289741|NCT00395629|582440654|FG000|Core Study|Lost to Follow-up|0|||
161289742|NCT00395629|582440655|FG001|Core Study|Lost to Follow-up|0|||
161289743|NCT00395629|582440656|FG002|Core Study|Lost to Follow-up|1|||
161289744|NCT00395629|582440654|FG000|Extension Study|Adverse Event|0|||
161289745|NCT00395629|582440655|FG001|Extension Study|Adverse Event|0|||
161289746|NCT00395629|582440656|FG002|Extension Study|Adverse Event|2|||
161289747|NCT00395629|582440654|FG000|Extension Study|Administrative problems|0|||
161289748|NCT00395629|582440655|FG001|Extension Study|Administrative problems|0|||
161289749|NCT00395629|582440656|FG002|Extension Study|Administrative problems|1|||
161289750|NCT01686373|582440657|FG000|Overall Study|Lost to Follow-up|3|||
161289751|NCT01686373|582440658|FG001|Overall Study|Lost to Follow-up|0|||
161289752|NCT01686373|582440657|FG000|Overall Study|Withdrawal by Subject|0|||
161289753|NCT01686373|582440658|FG001|Overall Study|Withdrawal by Subject|1|||
161289754|NCT01686373|582440657|FG000|Overall Study|Adverse Event|0|||
161289755|NCT01686373|582440658|FG001|Overall Study|Adverse Event|1|||
161289756|NCT01836471|582440665|FG000|Overall Study|Pregnancy|1|||
161289757|NCT01836471|582440666|FG001|Overall Study|Pregnancy|0|||
161289758|NCT01836471|582440667|FG002|Overall Study|Pregnancy|0|||
161289759|NCT01836471|582440668|FG003|Overall Study|Pregnancy|0|||
161289760|NCT01836471|582440669|FG004|Overall Study|Pregnancy|0|||
161289761|NCT01836471|582440665|FG000|Overall Study|Withdrawal by Subject|3|||
161289762|NCT01836471|582440666|FG001|Overall Study|Withdrawal by Subject|4|||
161289763|NCT01836471|582440667|FG002|Overall Study|Withdrawal by Subject|1|||
161289764|NCT01836471|582440668|FG003|Overall Study|Withdrawal by Subject|0|||
161289765|NCT01836471|582440669|FG004|Overall Study|Withdrawal by Subject|2|||
161289766|NCT01836471|582440665|FG000|Overall Study|Physician Decision|0|||
161289767|NCT01836471|582440666|FG001|Overall Study|Physician Decision|1|||
161289768|NCT01836471|582440667|FG002|Overall Study|Physician Decision|0|||
161289769|NCT01836471|582440668|FG003|Overall Study|Physician Decision|0|||
161289770|NCT01836471|582440669|FG004|Overall Study|Physician Decision|0|||
161289771|NCT01836471|582440665|FG000|Overall Study|Lost to Follow-up|0|||
161289772|NCT01836471|582440666|FG001|Overall Study|Lost to Follow-up|0|||
161289773|NCT01836471|582440667|FG002|Overall Study|Lost to Follow-up|0|||
161289774|NCT01836471|582440668|FG003|Overall Study|Lost to Follow-up|1|||
161289775|NCT01836471|582440669|FG004|Overall Study|Lost to Follow-up|1|||
161289776|NCT01836471|582440665|FG000|Overall Study|Adverse Event|6|||
161289777|NCT01836471|582440666|FG001|Overall Study|Adverse Event|3|||
161289778|NCT01836471|582440667|FG002|Overall Study|Adverse Event|1|||
161289779|NCT01836471|582440668|FG003|Overall Study|Adverse Event|1|||
161289780|NCT01836471|582440669|FG004|Overall Study|Adverse Event|2|||
161165519|NCT03814590|581983022|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
161165520|NCT03814590|581983023|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
161165521|NCT03814590|581983010|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165522|NCT03814590|581983011|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165523|NCT03814590|581983012|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165524|NCT03814590|581983013|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165525|NCT03814590|581983014|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165526|NCT03814590|581983015|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165527|NCT03814590|581983016|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165528|NCT03814590|581983017|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161165529|NCT03814590|581983018|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165530|NCT03814590|581983019|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161165531|NCT03814590|581983020|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165532|NCT03814590|581983021|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165533|NCT03814590|581983022|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165534|NCT03814590|581983023|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161165535|NCT03814590|581983010|FG000|Overall Study|UNKNOWN REASON|0|||
161165536|NCT03814590|581983011|FG001|Overall Study|UNKNOWN REASON|0|||
161165537|NCT03814590|581983012|FG002|Overall Study|UNKNOWN REASON|0|||
161165538|NCT03814590|581983013|FG003|Overall Study|UNKNOWN REASON|0|||
161165539|NCT03814590|581983014|FG004|Overall Study|UNKNOWN REASON|0|||
161165540|NCT03814590|581983015|FG005|Overall Study|UNKNOWN REASON|0|||
161165541|NCT03814590|581983016|FG006|Overall Study|UNKNOWN REASON|0|||
161165542|NCT03814590|581983017|FG007|Overall Study|UNKNOWN REASON|1|||
161165543|NCT03814590|581983018|FG008|Overall Study|UNKNOWN REASON|0|||
161165544|NCT03814590|581983019|FG009|Overall Study|UNKNOWN REASON|0|||
161165545|NCT03814590|581983020|FG010|Overall Study|UNKNOWN REASON|0|||
161165546|NCT03814590|581983021|FG011|Overall Study|UNKNOWN REASON|0|||
161165547|NCT03814590|581983022|FG012|Overall Study|UNKNOWN REASON|0|||
161165548|NCT03814590|581983023|FG013|Overall Study|UNKNOWN REASON|0|||
161165549|NCT03519516|581983024|FG000|Overall Study|Adverse Event|0|||
161165550|NCT03519516|581983025|FG001|Overall Study|Adverse Event|1|||
161165551|NCT01244191|581983026|FG000|Overall Study|Progressive disease|295|||
161165552|NCT01244191|581983027|FG001|Overall Study|Progressive disease|350|||
161165553|NCT01244191|581983026|FG000|Overall Study|Clinical disease progression|54|||
161165554|NCT01244191|581983027|FG001|Overall Study|Clinical disease progression|36|||
161165555|NCT01244191|581983026|FG000|Overall Study|Adverse Event|65|||
161165556|NCT01244191|581983027|FG001|Overall Study|Adverse Event|48|||
161165557|NCT01244191|581983026|FG000|Overall Study|Death|22|||
161165558|NCT01244191|581983027|FG001|Overall Study|Death|29|||
161165559|NCT01244191|581983026|FG000|Overall Study|Lost to Follow-up|0|||
161165560|NCT01244191|581983027|FG001|Overall Study|Lost to Follow-up|2|||
161165561|NCT01244191|581983026|FG000|Overall Study|Protocol Violation|1|||
161165562|NCT01244191|581983027|FG001|Overall Study|Protocol Violation|2|||
161165563|NCT01244191|581983026|FG000|Overall Study|Withdrawal by Subject|31|||
161165564|NCT01244191|581983027|FG001|Overall Study|Withdrawal by Subject|23|||
161165565|NCT01244191|581983026|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
161165566|NCT01244191|581983027|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
161165567|NCT01752842|581983028|FG000|Overall Study|Adverse Event|3|||
161165568|NCT01752842|581983029|FG001|Overall Study|Adverse Event|0|||
161165569|NCT01752842|581983028|FG000|Overall Study|Withdrawal by Subject|0|||
161165570|NCT01752842|581983029|FG001|Overall Study|Withdrawal by Subject|2|||
161165571|NCT02164513|581983030|FG000|Overall Study|Adverse Event|162|||
161165572|NCT02164513|581983031|FG001|Overall Study|Adverse Event|180|||
161165573|NCT02164513|581983032|FG002|Overall Study|Adverse Event|111|||
161165574|NCT02164513|581983030|FG000|Overall Study|Other: Study Closed or terminated|5|||
161165575|NCT02164513|581983031|FG001|Overall Study|Other: Study Closed or terminated|2|||
161165576|NCT02164513|581983032|FG002|Overall Study|Other: Study Closed or terminated|4|||
161165577|NCT02164513|581983030|FG000|Overall Study|Lost to Follow-up|30|||
161289781|NCT01836471|582440665|FG000|Overall Study|Non compliance with tx|1|||
161289782|NCT01836471|582440666|FG001|Overall Study|Non compliance with tx|1|||
161289783|NCT01836471|582440667|FG002|Overall Study|Non compliance with tx|0|||
161289784|NCT01836471|582440668|FG003|Overall Study|Non compliance with tx|0|||
161165578|NCT02164513|581983031|FG001|Overall Study|Lost to Follow-up|36|||
161165579|NCT02164513|581983032|FG002|Overall Study|Lost to Follow-up|22|||
161165580|NCT02164513|581983030|FG000|Overall Study|Physician Decision|47|||
161165581|NCT02164513|581983031|FG001|Overall Study|Physician Decision|57|||
161165582|NCT02164513|581983032|FG002|Overall Study|Physician Decision|28|||
161165583|NCT02164513|581983030|FG000|Overall Study|Withdrawal by Subject|192|||
161165584|NCT02164513|581983031|FG001|Overall Study|Withdrawal by Subject|261|||
161165585|NCT02164513|581983032|FG002|Overall Study|Withdrawal by Subject|130|||
161165586|NCT02164513|581983030|FG000|Overall Study|Other: Reason not provided by site|1|||
161289785|NCT01836471|582440669|FG004|Overall Study|Non compliance with tx|0|||
161289786|NCT01960413|582440673|FG000|Overall Study|Withdrawal by Subject|1|||
161081273|NCT04372121|581684544|FG003|Overall Study|Protocol Violation|0|||
161081274|NCT04372121|581684541|FG000|Overall Study|Withdrawal by Subject|3|||
161081275|NCT04372121|581684542|FG001|Overall Study|Withdrawal by Subject|1|||
161081276|NCT04372121|581684543|FG002|Overall Study|Withdrawal by Subject|0|||
161081277|NCT04372121|581684544|FG003|Overall Study|Withdrawal by Subject|0|||
161081278|NCT04372121|581684541|FG000|Overall Study|Study termination|6|||
161081279|NCT04372121|581684542|FG001|Overall Study|Study termination|5|||
161081280|NCT04372121|581684543|FG002|Overall Study|Study termination|1|||
161081281|NCT04372121|581684544|FG003|Overall Study|Study termination|1|||
161081282|NCT04372121|581684541|FG000|Overall Study|Hysterectomy planned|1|||
161081283|NCT04372121|581684542|FG001|Overall Study|Hysterectomy planned|0|||
161081284|NCT04372121|581684543|FG002|Overall Study|Hysterectomy planned|0|||
161081285|NCT04372121|581684544|FG003|Overall Study|Hysterectomy planned|0|||
161081286|NCT02344290|581684548|FG000|Overall Study|Withdrawal by Subject|315|||
161081287|NCT02344290|581684549|FG001|Overall Study|Withdrawal by Subject|324|||
161081288|NCT02344290|581684548|FG000|Overall Study|Lost to Follow-up|258|||
161081289|NCT02344290|581684549|FG001|Overall Study|Lost to Follow-up|249|||
161081290|NCT02344290|581684548|FG000|Overall Study|Unable to get to clinic|69|||
161081291|NCT02344290|581684549|FG001|Overall Study|Unable to get to clinic|60|||
161081292|NCT02344290|581684548|FG000|Overall Study|Physician Decision|25|||
161081293|NCT02344290|581684549|FG001|Overall Study|Physician Decision|25|||
161081294|NCT02344290|581684548|FG000|Overall Study|Site Closure|15|||
161081295|NCT02344290|581684549|FG001|Overall Study|Site Closure|19|||
161081296|NCT02344290|581684548|FG000|Overall Study|Other|5|||
161081297|NCT02344290|581684549|FG001|Overall Study|Other|3|||
161081298|NCT00591370|581686472|FG000|Overall Study|Not Treated|2|||
161081299|NCT01183260|581686473|FG000|Overall Study|Intraop screen failure|2|||
161081300|NCT01183260|581686474|FG001|Overall Study|Intraop screen failure|0|||
161081301|NCT01183260|581686473|FG000|Overall Study|Withdrawal by Subject|1|||
161081302|NCT01183260|581686474|FG001|Overall Study|Withdrawal by Subject|1|||
161081303|NCT01183260|581686473|FG000|Overall Study|Revised within 30 days|0|||
161081304|NCT01183260|581686474|FG001|Overall Study|Revised within 30 days|1|||
161081305|NCT01183260|581686473|FG000|Overall Study|Death|1|||
161081306|NCT01183260|581686474|FG001|Overall Study|Death|0|||
161081307|NCT01202903|581686476|FG000|Overall Study|Administrative Probelms|1|||
161081308|NCT01202903|581686477|FG001|Overall Study|Administrative Probelms|4|||
161081309|NCT01202903|581686476|FG000|Overall Study|Protocol Violation|0|||
161081310|NCT01202903|581686477|FG001|Overall Study|Protocol Violation|1|||
161081311|NCT01202903|581686476|FG000|Overall Study|Death|1|||
161081312|NCT01202903|581686477|FG001|Overall Study|Death|0|||
161081313|NCT01202903|581686476|FG000|Overall Study|Lost to Follow-up|1|||
161081314|NCT01202903|581686477|FG001|Overall Study|Lost to Follow-up|1|||
161081315|NCT01202903|581686476|FG000|Overall Study|Lack of Efficacy|1|||
161081316|NCT01202903|581686477|FG001|Overall Study|Lack of Efficacy|3|||
161081317|NCT01202903|581686476|FG000|Overall Study|Adverse Event|3|||
161081318|NCT01202903|581686477|FG001|Overall Study|Adverse Event|3|||
161081319|NCT01202903|581686476|FG000|Overall Study|Withdrawal by Subject|4|||
161081320|NCT01202903|581686477|FG001|Overall Study|Withdrawal by Subject|4|||
161081321|NCT01302080|581686478|FG000|Overall Study|Withdrew Consent|92|||
161081322|NCT01302080|581686479|FG001|Overall Study|Withdrew Consent|39|||
161081323|NCT01302080|581686478|FG000|Overall Study|Patient/Family Moved|28|||
161081324|NCT01302080|581686479|FG001|Overall Study|Patient/Family Moved|3|||
161081325|NCT01302080|581686478|FG000|Overall Study|Lost to Follow-up|192|||
161081326|NCT01302080|581686479|FG001|Overall Study|Lost to Follow-up|93|||
161081327|NCT01302080|581686478|FG000|Overall Study|Death|1|||
161081328|NCT01302080|581686479|FG001|Overall Study|Death|0|||
161081329|NCT01302080|581686478|FG000|Overall Study|Other|52|||
161081330|NCT01302080|581686479|FG001|Overall Study|Other|8|||
161081331|NCT01302080|581686478|FG000|Overall Study|Reason Missing For Discontinuation|1|||
161081332|NCT01302080|581686479|FG001|Overall Study|Reason Missing For Discontinuation|0|||
161081333|NCT00837694|581686480|FG000|Overall Study|Lost to Follow-up|2|||
161081334|NCT00837694|581686481|FG001|Overall Study|Lost to Follow-up|0|||
161081335|NCT00837694|581686482|FG002|Overall Study|Lost to Follow-up|2|||
161081336|NCT00837694|581686483|FG003|Overall Study|Lost to Follow-up|1|||
161081337|NCT00837694|581686484|FG004|Overall Study|Lost to Follow-up|1|||
161081338|NCT00837694|581686485|FG005|Overall Study|Lost to Follow-up|1|||
161081339|NCT00306670|581686486|FG000|Overall Study|patients recruited; Genentech, the st|0|||
161081340|NCT00306670|581686487|FG001|Overall Study|patients recruited; Genentech, the st|2|||
161081341|NCT00503139|581686488|FG000|Overall Study|Case Report Forms were not collected|4|||
161081342|NCT00503139|581686488|FG000|Overall Study|Protocol Violation|4|||
161081343|NCT00091169|581686492|FG000|Overall Study|Disease progression|3|||
161081344|NCT00091169|581686493|FG001|Overall Study|Disease progression|1|||
161081345|NCT00091169|581686492|FG000|Overall Study|Adverse Event|11|||
161081346|NCT00091169|581686493|FG001|Overall Study|Adverse Event|17|||
161081347|NCT00091169|581686492|FG000|Overall Study|Death|4|||
161081348|NCT00091169|581686493|FG001|Overall Study|Death|1|||
161081349|NCT00091169|581686492|FG000|Overall Study|Withdrawal by Subject|10|||
161081350|NCT00091169|581686493|FG001|Overall Study|Withdrawal by Subject|13|||
161081351|NCT00091169|581686492|FG000|Overall Study|Other|3|||
161165587|NCT02164513|581983031|FG001|Overall Study|Other: Reason not provided by site|0|||
161165588|NCT02164513|581983032|FG002|Overall Study|Other: Reason not provided by site|0|||
161165589|NCT05301322|581983033|FG000|Overall Study|Adverse Event|7|||
161165590|NCT05301322|581983034|FG001|Overall Study|Adverse Event|3|||
161165591|NCT05301322|581983033|FG000|Overall Study|Death|0|||
161165592|NCT05301322|581983034|FG001|Overall Study|Death|1|||
161165593|NCT05301322|581983033|FG000|Overall Study|Lost to Follow-up|2|||
161165594|NCT05301322|581983034|FG001|Overall Study|Lost to Follow-up|1|||
161165595|NCT05301322|581983033|FG000|Overall Study|Protocol Violation|3|||
161165596|NCT05301322|581983034|FG001|Overall Study|Protocol Violation|1|||
161165597|NCT05301322|581983033|FG000|Overall Study|Withdrawal by Subject|3|||
161165598|NCT05301322|581983034|FG001|Overall Study|Withdrawal by Subject|0|||
161165599|NCT05301322|581983033|FG000|Overall Study|Other|4|||
161165600|NCT05301322|581983034|FG001|Overall Study|Other|0|||
161165601|NCT04971785|581983035|FG000|Overall Study|Withdrew Consent|5|||
161165602|NCT04971785|581983036|FG001|Overall Study|Withdrew Consent|5|||
161165603|NCT04971785|581983037|FG002|Overall Study|Withdrew Consent|17|||
161165604|NCT04971785|581983038|FG003|Overall Study|Withdrew Consent|7|||
161165605|NCT04971785|581983035|FG000|Overall Study|Adverse Event|7|||
161165606|NCT04971785|581983036|FG001|Overall Study|Adverse Event|8|||
161165607|NCT04971785|581983037|FG002|Overall Study|Adverse Event|6|||
161165608|NCT04971785|581983038|FG003|Overall Study|Adverse Event|3|||
161165609|NCT04971785|581983035|FG000|Overall Study|Lost to Follow-up|2|||
161165610|NCT04971785|581983036|FG001|Overall Study|Lost to Follow-up|1|||
161165611|NCT04971785|581983037|FG002|Overall Study|Lost to Follow-up|6|||
161165612|NCT04971785|581983038|FG003|Overall Study|Lost to Follow-up|7|||
161165613|NCT04971785|581983035|FG000|Overall Study|Protocol Violation|3|||
161165614|NCT04971785|581983036|FG001|Overall Study|Protocol Violation|1|||
161165615|NCT04971785|581983037|FG002|Overall Study|Protocol Violation|1|||
161165616|NCT04971785|581983038|FG003|Overall Study|Protocol Violation|2|||
161165617|NCT04971785|581983035|FG000|Overall Study|Investigator's Discretion|3|||
161165618|NCT04971785|581983036|FG001|Overall Study|Investigator's Discretion|1|||
161165619|NCT04971785|581983037|FG002|Overall Study|Investigator's Discretion|1|||
161165620|NCT04971785|581983038|FG003|Overall Study|Investigator's Discretion|0|||
161165621|NCT04971785|581983035|FG000|Overall Study|Randomized but Never Treated|1|||
161165622|NCT04971785|581983036|FG001|Overall Study|Randomized but Never Treated|2|||
161165623|NCT04971785|581983037|FG002|Overall Study|Randomized but Never Treated|0|||
161165624|NCT04971785|581983038|FG003|Overall Study|Randomized but Never Treated|1|||
161165625|NCT04971785|581983035|FG000|Overall Study|Death|0|||
161165626|NCT04971785|581983036|FG001|Overall Study|Death|1|||
161165627|NCT04971785|581983037|FG002|Overall Study|Death|1|||
161165628|NCT04971785|581983038|FG003|Overall Study|Death|0|||
161165629|NCT04971785|581983035|FG000|Overall Study|Site Terminated by Sponsor|1|||
161165630|NCT04971785|581983036|FG001|Overall Study|Site Terminated by Sponsor|1|||
161165631|NCT04971785|581983037|FG002|Overall Study|Site Terminated by Sponsor|0|||
161165632|NCT04971785|581983038|FG003|Overall Study|Site Terminated by Sponsor|0|||
161165633|NCT00436982|581984229|FG000|Overall Study|Withdrawal by Subject|3|||
161165634|NCT00436982|581984230|FG001|Overall Study|Withdrawal by Subject|1|||
161165635|NCT00436982|581984229|FG000|Overall Study|Did not receive allocated intervention|0|||
161165636|NCT00436982|581984230|FG001|Overall Study|Did not receive allocated intervention|1|||
161165637|NCT00436982|581984229|FG000|Overall Study|no RSA data|1|||
161165638|NCT00436982|581984230|FG001|Overall Study|no RSA data|2|||
161165639|NCT02215616|581984234|FG000|Overall Study|Sponsor requested to stop study drug|0|||
161165640|NCT02215616|581984235|FG001|Overall Study|Sponsor requested to stop study drug|0|||
161165641|NCT02215616|581984236|FG002|Overall Study|Sponsor requested to stop study drug|1|||
161165642|NCT02215616|581984237|FG003|Overall Study|Sponsor requested to stop study drug|4|||
161165643|NCT02215616|581984234|FG000|Overall Study|Death|1|||
161165644|NCT02215616|581984235|FG001|Overall Study|Death|0|||
161165645|NCT02215616|581984236|FG002|Overall Study|Death|0|||
161165646|NCT02215616|581984237|FG003|Overall Study|Death|0|||
161165647|NCT02215616|581984234|FG000|Overall Study|Adverse Event|7|||
161165648|NCT02215616|581984235|FG001|Overall Study|Adverse Event|4|||
161165649|NCT02215616|581984236|FG002|Overall Study|Adverse Event|9|||
161165650|NCT02215616|581984237|FG003|Overall Study|Adverse Event|2|||
161165651|NCT02215616|581984234|FG000|Overall Study|Withdrawal by Subject|1|||
161165652|NCT02215616|581984235|FG001|Overall Study|Withdrawal by Subject|8|||
161165653|NCT02215616|581984236|FG002|Overall Study|Withdrawal by Subject|2|||
161165654|NCT02215616|581984237|FG003|Overall Study|Withdrawal by Subject|5|||
161165655|NCT02215616|581984234|FG000|Overall Study|Non-compliance|0|||
161165656|NCT02215616|581984235|FG001|Overall Study|Non-compliance|2|||
161165657|NCT02215616|581984236|FG002|Overall Study|Non-compliance|1|||
161165658|NCT02215616|581984237|FG003|Overall Study|Non-compliance|0|||
161165659|NCT02215616|581984234|FG000|Overall Study|Protocol Violation|0|||
161165660|NCT02215616|581984235|FG001|Overall Study|Protocol Violation|2|||
161165661|NCT02215616|581984236|FG002|Overall Study|Protocol Violation|0|||
161165662|NCT02215616|581984237|FG003|Overall Study|Protocol Violation|0|||
161165663|NCT02215616|581984234|FG000|Overall Study|Lost to Follow-up|1|||
161165664|NCT02215616|581984235|FG001|Overall Study|Lost to Follow-up|1|||
161165665|NCT02215616|581984236|FG002|Overall Study|Lost to Follow-up|0|||
161165666|NCT02215616|581984237|FG003|Overall Study|Lost to Follow-up|1|||
161165667|NCT02215616|581984234|FG000|Overall Study|Other than specified|1|||
161165668|NCT02215616|581984235|FG001|Overall Study|Other than specified|0|||
161165669|NCT02215616|581984236|FG002|Overall Study|Other than specified|1|||
161165670|NCT02215616|581984237|FG003|Overall Study|Other than specified|1|||
161165671|NCT03172481|581984241|FG000|Double-blind|Withdrawal by Subject|1|||
161165672|NCT03172481|581984242|FG001|Double-blind|Withdrawal by Subject|0|||
161165673|NCT00363051|581984243|FG000|Overall Study|Adminstrative problems|1|||
161165674|NCT00363051|581984244|FG001|Overall Study|Adminstrative problems|1|||
161165675|NCT00363051|581984243|FG000|Overall Study|Adverse Event|21|||
161165676|NCT00363051|581984244|FG001|Overall Study|Adverse Event|12|||
161165677|NCT00363051|581984243|FG000|Overall Study|New Cancer Therapy|2|||
161165678|NCT00363051|581984244|FG001|Overall Study|New Cancer Therapy|1|||
161165679|NCT00363051|581984243|FG000|Overall Study|Withdrawal by Subject|11|||
161165680|NCT00363051|581984244|FG001|Overall Study|Withdrawal by Subject|3|||
161165681|NCT00363051|581984243|FG000|Overall Study|Lost to Follow-up|0|||
161165682|NCT00363051|581984244|FG001|Overall Study|Lost to Follow-up|1|||
161165683|NCT00363051|581984243|FG000|Overall Study|Protocol Violation|0|||
161165684|NCT00363051|581984244|FG001|Overall Study|Protocol Violation|2|||
161165685|NCT00363051|581984243|FG000|Overall Study|Death|3|||
161165686|NCT00363051|581984244|FG001|Overall Study|Death|2|||
161165687|NCT02759562|581984245|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
161165688|NCT02759562|581984246|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
161165689|NCT02759562|581984245|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
161165690|NCT02759562|581984246|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
161165691|NCT02293993|581984247|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
161165692|NCT02293993|581984248|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
161165693|NCT02293993|581984249|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
161165694|NCT02293993|581984250|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
161165695|NCT02293993|581984247|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
161289787|NCT01960413|582440674|FG001|Overall Study|Withdrawal by Subject|1|||
161289788|NCT01960413|582440673|FG000|Overall Study|Physician Decision|1|||
161289789|NCT01960413|582440674|FG001|Overall Study|Physician Decision|0|||
161289790|NCT01960413|582440673|FG000|Overall Study|Lost to Follow-up|2|||
161289791|NCT01960413|582440674|FG001|Overall Study|Lost to Follow-up|0|||
161289792|NCT02285361|582440675|FG000|Overall Study|Protocol Violation|43|||
161081352|NCT00091169|581686493|FG001|Overall Study|Other|4|||
161081353|NCT00091169|581686492|FG000|Overall Study|Not start protocol therapy|26|||
161081354|NCT00091169|581686493|FG001|Overall Study|Not start protocol therapy|17|||
161081355|NCT04138576|581686498|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
161081356|NCT04410523|581686502|FG000|Overall Study|Study terminated by sponsor|1|||
161081357|NCT04410523|581686503|FG001|Overall Study|Study terminated by sponsor|3|||
161081358|NCT04410523|581686504|FG002|Overall Study|Study terminated by sponsor|2|||
161081359|NCT04410523|581686505|FG003|Overall Study|Study terminated by sponsor|6|||
161081360|NCT04410523|581686506|FG004|Overall Study|Study terminated by sponsor|3|||
161081361|NCT04410523|581686507|FG005|Overall Study|Study terminated by sponsor|4|||
161081362|NCT04410523|581686502|FG000|Overall Study|Adverse Event|1|||
161081363|NCT04410523|581686503|FG001|Overall Study|Adverse Event|0|||
161081364|NCT04410523|581686504|FG002|Overall Study|Adverse Event|0|||
161081365|NCT04410523|581686505|FG003|Overall Study|Adverse Event|0|||
161081366|NCT04410523|581686506|FG004|Overall Study|Adverse Event|0|||
161081367|NCT04410523|581686507|FG005|Overall Study|Adverse Event|2|||
161081368|NCT04410523|581686502|FG000|Overall Study|Lost to Follow-up|0|||
161081369|NCT04410523|581686503|FG001|Overall Study|Lost to Follow-up|1|||
161081370|NCT04410523|581686504|FG002|Overall Study|Lost to Follow-up|0|||
161081371|NCT04410523|581686505|FG003|Overall Study|Lost to Follow-up|0|||
161081372|NCT04410523|581686506|FG004|Overall Study|Lost to Follow-up|0|||
161081373|NCT04410523|581686507|FG005|Overall Study|Lost to Follow-up|0|||
161081374|NCT04410523|581686502|FG000|Overall Study|Physician Decision|0|||
161081375|NCT04410523|581686503|FG001|Overall Study|Physician Decision|1|||
161081376|NCT04410523|581686504|FG002|Overall Study|Physician Decision|0|||
161081377|NCT04410523|581686505|FG003|Overall Study|Physician Decision|0|||
161081378|NCT04410523|581686506|FG004|Overall Study|Physician Decision|0|||
161081379|NCT04410523|581686507|FG005|Overall Study|Physician Decision|0|||
161165696|NCT02293993|581984248|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
161165697|NCT02293993|581984249|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
161289793|NCT02285361|582440675|FG000|Overall Study|Lost to Follow-up|5|||
161289794|NCT02285361|582440675|FG000|Overall Study|Not taken GIOTRIF|2|||
161081380|NCT04410523|581686502|FG000|Overall Study|Pregnancy|0|||
161081381|NCT04410523|581686503|FG001|Overall Study|Pregnancy|0|||
161081382|NCT04410523|581686504|FG002|Overall Study|Pregnancy|0|||
161081383|NCT04410523|581686505|FG003|Overall Study|Pregnancy|0|||
161081384|NCT04410523|581686506|FG004|Overall Study|Pregnancy|0|||
161081385|NCT04410523|581686507|FG005|Overall Study|Pregnancy|1|||
161081386|NCT04410523|581686502|FG000|Overall Study|Protocol deviation|0|||
161081387|NCT04410523|581686503|FG001|Overall Study|Protocol deviation|0|||
161081388|NCT04410523|581686504|FG002|Overall Study|Protocol deviation|0|||
161081389|NCT04410523|581686505|FG003|Overall Study|Protocol deviation|0|||
161081390|NCT04410523|581686506|FG004|Overall Study|Protocol deviation|0|||
161081391|NCT04410523|581686507|FG005|Overall Study|Protocol deviation|2|||
161081392|NCT04410523|581686502|FG000|Overall Study|Subject decision|2|||
161081393|NCT04410523|581686503|FG001|Overall Study|Subject decision|0|||
161081394|NCT04410523|581686504|FG002|Overall Study|Subject decision|0|||
161081395|NCT04410523|581686505|FG003|Overall Study|Subject decision|1|||
161081396|NCT04410523|581686506|FG004|Overall Study|Subject decision|0|||
161081397|NCT04410523|581686507|FG005|Overall Study|Subject decision|1|||
161081398|NCT00490490|581686508|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
161081399|NCT00490490|581686508|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
161081400|NCT00772330|581686509|FG000|Overall Study|Lost to Follow-up|3|||
161081401|NCT00734591|581686510|FG000|Screening for Prospective Period|Site did not participate|1604|||
161081402|NCT00734591|581686511|FG001|Screening for Prospective Period|Site did not participate|1488|||
161081403|NCT00734591|581686510|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
161081404|NCT00734591|581686511|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
161081405|NCT00734591|581686510|FG000|Prospective Period|Withdrawal by Subject|11|||
161081406|NCT00734591|581686511|FG001|Prospective Period|Withdrawal by Subject|9|||
161081407|NCT00734591|581686510|FG000|Prospective Period|Lost to Follow-up|37|||
161081408|NCT00734591|581686511|FG001|Prospective Period|Lost to Follow-up|33|||
161081409|NCT00734591|581686510|FG000|Prospective Period|Study Terminated|1|||
161081410|NCT00734591|581686511|FG001|Prospective Period|Study Terminated|0|||
161081411|NCT00734591|581686510|FG000|Prospective Period|Other|2|||
161165698|NCT02293993|581984250|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
161165699|NCT02293993|581984247|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161165700|NCT02293993|581984248|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161165701|NCT02293993|581984249|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
161165702|NCT02293993|581984250|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
161165703|NCT02293993|581984247|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
161165704|NCT02293993|581984248|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
161165705|NCT02293993|581984249|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
161165706|NCT02293993|581984250|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
161165707|NCT02293993|581984247|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161165708|NCT02293993|581984248|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
161081412|NCT00734591|581686511|FG001|Prospective Period|Other|2|||
161081413|NCT01656200|581686514|FG000|Overall Study|Withdrawal by Subject|1|||
161081414|NCT02236988|581686515|FG000|Overall Study|Lost to Follow-up|0|||
161081415|NCT02236988|581686516|FG001|Overall Study|Lost to Follow-up|0|||
161081416|NCT02236988|581686517|FG002|Overall Study|Lost to Follow-up|0|||
161081417|NCT02236988|581686518|FG003|Overall Study|Lost to Follow-up|1|||
161165709|NCT02293993|581984249|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161165710|NCT02293993|581984250|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
161165711|NCT01957709|581984251|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
161165712|NCT01061736|581984253|FG000|Overall Study|Dose regimen not selected|0|||
161165713|NCT01061736|581984254|FG001|Overall Study|Dose regimen not selected|0|||
161165714|NCT01061736|581984255|FG002|Overall Study|Dose regimen not selected|0|||
161165715|NCT01061736|581984256|FG003|Overall Study|Dose regimen not selected|0|||
161165716|NCT01061736|581984257|FG004|Overall Study|Dose regimen not selected|0|||
161165717|NCT01061736|581984258|FG005|Overall Study|Dose regimen not selected|0|||
161165718|NCT01061736|581984259|FG006|Overall Study|Dose regimen not selected|79|||
161165719|NCT01061736|581984260|FG007|Overall Study|Dose regimen not selected|0|||
161165720|NCT01061736|581984261|FG008|Overall Study|Dose regimen not selected|0|||
161165721|NCT01061736|581984262|FG009|Overall Study|Dose regimen not selected|0|||
161165722|NCT01061736|581984253|FG000|Overall Study|Adverse Event|13|||
161165723|NCT01061736|581984254|FG001|Overall Study|Adverse Event|1|||
161165724|NCT01061736|581984255|FG002|Overall Study|Adverse Event|3|||
161165725|NCT01061736|581984256|FG003|Overall Study|Adverse Event|2|||
161289795|NCT02285361|582440675|FG000|Overall Study|Consented prior to the contract date|1|||
161289796|NCT02059135|582440676|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
161289797|NCT02059135|582440677|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
161081418|NCT02236988|581686515|FG000|Overall Study|Unable to Comply with Study Visits|0|||
161081419|NCT02236988|581686516|FG001|Overall Study|Unable to Comply with Study Visits|0|||
161081420|NCT02236988|581686517|FG002|Overall Study|Unable to Comply with Study Visits|0|||
161081421|NCT02236988|581686518|FG003|Overall Study|Unable to Comply with Study Visits|2|||
161081422|NCT05775991|581686519|FG000|Overall Study|Withdrawal by Subject|0|||
161081423|NCT05775991|581686520|FG001|Overall Study|Withdrawal by Subject|0|||
161081424|NCT05775991|581686521|FG002|Overall Study|Withdrawal by Subject|2|||
161165726|NCT01061736|581984257|FG004|Overall Study|Adverse Event|4|||
161165727|NCT01061736|581984258|FG005|Overall Study|Adverse Event|1|||
161165728|NCT01061736|581984259|FG006|Overall Study|Adverse Event|4|||
161165729|NCT01061736|581984260|FG007|Overall Study|Adverse Event|63|||
161165730|NCT01061736|581984261|FG008|Overall Study|Adverse Event|67|||
161165731|NCT01061736|581984262|FG009|Overall Study|Adverse Event|34|||
161165732|NCT01061736|581984253|FG000|Overall Study|Lack of Efficacy|0|||
161165733|NCT01061736|581984254|FG001|Overall Study|Lack of Efficacy|2|||
161165734|NCT01061736|581984255|FG002|Overall Study|Lack of Efficacy|1|||
161165735|NCT01061736|581984256|FG003|Overall Study|Lack of Efficacy|1|||
161165736|NCT01061736|581984257|FG004|Overall Study|Lack of Efficacy|1|||
161165737|NCT01061736|581984258|FG005|Overall Study|Lack of Efficacy|2|||
161165738|NCT01061736|581984259|FG006|Overall Study|Lack of Efficacy|1|||
161165739|NCT01061736|581984260|FG007|Overall Study|Lack of Efficacy|9|||
161165740|NCT01061736|581984261|FG008|Overall Study|Lack of Efficacy|9|||
161165741|NCT01061736|581984262|FG009|Overall Study|Lack of Efficacy|10|||
161165742|NCT01061736|581984253|FG000|Overall Study|Poor compliance to protocol|0|||
161165743|NCT01061736|581984254|FG001|Overall Study|Poor compliance to protocol|0|||
161165744|NCT01061736|581984255|FG002|Overall Study|Poor compliance to protocol|0|||
161165745|NCT01061736|581984256|FG003|Overall Study|Poor compliance to protocol|0|||
161165746|NCT01061736|581984257|FG004|Overall Study|Poor compliance to protocol|0|||
161165747|NCT01061736|581984258|FG005|Overall Study|Poor compliance to protocol|0|||
161165748|NCT01061736|581984259|FG006|Overall Study|Poor compliance to protocol|0|||
161165749|NCT01061736|581984260|FG007|Overall Study|Poor compliance to protocol|2|||
161165750|NCT01061736|581984261|FG008|Overall Study|Poor compliance to protocol|5|||
161165751|NCT01061736|581984262|FG009|Overall Study|Poor compliance to protocol|9|||
161165752|NCT01061736|581984253|FG000|Overall Study|Not treated|0|||
161165753|NCT01061736|581984254|FG001|Overall Study|Not treated|0|||
161165754|NCT01061736|581984255|FG002|Overall Study|Not treated|0|||
161165755|NCT01061736|581984256|FG003|Overall Study|Not treated|0|||
161165756|NCT01061736|581984257|FG004|Overall Study|Not treated|1|||
161165757|NCT01061736|581984258|FG005|Overall Study|Not treated|0|||
161165758|NCT01061736|581984259|FG006|Overall Study|Not treated|0|||
161165759|NCT01061736|581984260|FG007|Overall Study|Not treated|2|||
161165760|NCT01061736|581984261|FG008|Overall Study|Not treated|1|||
161165761|NCT01061736|581984262|FG009|Overall Study|Not treated|0|||
161165762|NCT01061736|581984253|FG000|Overall Study|Other than specified above|0|||
161165763|NCT01061736|581984254|FG001|Overall Study|Other than specified above|1|||
161165764|NCT01061736|581984255|FG002|Overall Study|Other than specified above|2|||
161165765|NCT01061736|581984256|FG003|Overall Study|Other than specified above|0|||
161165766|NCT01061736|581984257|FG004|Overall Study|Other than specified above|1|||
161165767|NCT01061736|581984258|FG005|Overall Study|Other than specified above|0|||
161165768|NCT01061736|581984259|FG006|Overall Study|Other than specified above|0|||
161081425|NCT01461811|581686524|FG000|Overall Study|Adverse Event|2|||
161081426|NCT01461811|581686525|FG001|Overall Study|Adverse Event|1|||
161081427|NCT01461811|581686524|FG000|Overall Study|Subject decision unrelated to an AE|1|||
161081428|NCT01461811|581686525|FG001|Overall Study|Subject decision unrelated to an AE|1|||
161081429|NCT01461811|581686524|FG000|Overall Study|Noncompliance|1|||
161081430|NCT01461811|581686525|FG001|Overall Study|Noncompliance|1|||
161081431|NCT03015129|581686526|FG000|Overall Study|Death|2|||
161081432|NCT03015129|581686527|FG001|Overall Study|Death|2|||
161081433|NCT03015129|581686526|FG000|Overall Study|Lost to Follow-up|0|||
161081434|NCT03015129|581686527|FG001|Overall Study|Lost to Follow-up|1|||
161165769|NCT01061736|581984260|FG007|Overall Study|Other than specified above|18|||
161165770|NCT01061736|581984261|FG008|Overall Study|Other than specified above|15|||
161165771|NCT01061736|581984262|FG009|Overall Study|Other than specified above|21|||
161289798|NCT02059135|582440676|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
161081435|NCT03015129|581686526|FG000|Overall Study|Progression of disease|38|||
161081436|NCT03015129|581686527|FG001|Overall Study|Progression of disease|33|||
161081437|NCT03015129|581686526|FG000|Overall Study|Adverse Event|0|||
161081438|NCT03015129|581686527|FG001|Overall Study|Adverse Event|4|||
161081439|NCT01072630|581686528|FG000|Overall Study|Adverse Event|11|||
161081440|NCT01072630|581686529|FG001|Overall Study|Adverse Event|19|||
161081441|NCT01072630|581686530|FG002|Overall Study|Adverse Event|2|||
161165772|NCT01925612|581984263|FG000|Overall Study|Progressive Disease|1|||
161165773|NCT01925612|581984264|FG001|Overall Study|Progressive Disease|1|||
161165774|NCT01925612|581984265|FG002|Overall Study|Progressive Disease|1|||
161165775|NCT01925612|581984266|FG003|Overall Study|Progressive Disease|0|||
161165776|NCT01925612|581984267|FG004|Overall Study|Progressive Disease|0|||
161289799|NCT02059135|582440677|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
161081442|NCT01072630|581686528|FG000|Overall Study|Lack of Efficacy|10|||
161081443|NCT01072630|581686529|FG001|Overall Study|Lack of Efficacy|10|||
161081444|NCT01072630|581686530|FG002|Overall Study|Lack of Efficacy|1|||
161081445|NCT01072630|581686528|FG000|Overall Study|Withdrawal by Subject|8|||
161081446|NCT01072630|581686529|FG001|Overall Study|Withdrawal by Subject|7|||
161165777|NCT01925612|581984263|FG000|Overall Study|Adverse Event|3|||
161165778|NCT01925612|581984264|FG001|Overall Study|Adverse Event|3|||
161165779|NCT01925612|581984265|FG002|Overall Study|Adverse Event|0|||
161165780|NCT01925612|581984266|FG003|Overall Study|Adverse Event|1|||
161165781|NCT01925612|581984267|FG004|Overall Study|Adverse Event|2|||
161165782|NCT00980343|581984269|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
161165783|NCT00980343|581984270|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
161165784|NCT02310906|581984275|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161165785|NCT02310906|581984276|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161165786|NCT02310906|581984277|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
161165787|NCT02310906|581984278|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
161165788|NCT02310906|581984275|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
161165789|NCT02310906|581984276|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
161165790|NCT02310906|581984277|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
161165791|NCT02310906|581984278|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
161165792|NCT02310906|581984275|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161165793|NCT02310906|581984276|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161165794|NCT02310906|581984277|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
161165795|NCT02310906|581984278|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
161165796|NCT02310906|581984275|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161165797|NCT02310906|581984276|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161165798|NCT02310906|581984277|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
161081447|NCT01072630|581686530|FG002|Overall Study|Withdrawal by Subject|2|||
161081448|NCT01072630|581686528|FG000|Overall Study|Protocol Violation|10|||
161081449|NCT01072630|581686529|FG001|Overall Study|Protocol Violation|8|||
161081450|NCT01072630|581686530|FG002|Overall Study|Protocol Violation|4|||
161081451|NCT01072630|581686528|FG000|Overall Study|Lost to Follow-up|11|||
161081452|NCT01072630|581686529|FG001|Overall Study|Lost to Follow-up|11|||
161081453|NCT01072630|581686530|FG002|Overall Study|Lost to Follow-up|1|||
161081454|NCT01072630|581686528|FG000|Overall Study|Noncompliance with study medication|1|||
161081455|NCT01072630|581686529|FG001|Overall Study|Noncompliance with study medication|1|||
161081456|NCT01072630|581686530|FG002|Overall Study|Noncompliance with study medication|1|||
161081457|NCT01072630|581686528|FG000|Overall Study|Noncompliance with study procedures|1|||
161081458|NCT01072630|581686529|FG001|Overall Study|Noncompliance with study procedures|2|||
161081459|NCT01072630|581686530|FG002|Overall Study|Noncompliance with study procedures|1|||
161081460|NCT01072630|581686528|FG000|Overall Study|Other|3|||
161081461|NCT01072630|581686529|FG001|Overall Study|Other|2|||
161081462|NCT01072630|581686530|FG002|Overall Study|Other|1|||
161081463|NCT05032872|581686531|FG000|Overall Study|Adverse Event|1|||
161081464|NCT05032872|581686532|FG001|Overall Study|Adverse Event|0|||
161081465|NCT05032872|581686531|FG000|Overall Study|Lost to Follow-up|2|||
161081466|NCT05032872|581686532|FG001|Overall Study|Lost to Follow-up|4|||
161081467|NCT05032872|581686531|FG000|Overall Study|Withdrawal by Subject|4|||
161081468|NCT05032872|581686532|FG001|Overall Study|Withdrawal by Subject|3|||
161081469|NCT00338962|581686533|FG000|Overall Study|Lost to Follow-up|3|||
161081470|NCT00338962|581686534|FG001|Overall Study|Lost to Follow-up|3|||
161081471|NCT00338962|581686535|FG002|Overall Study|Lost to Follow-up|2|||
161081472|NCT00338962|581686536|FG003|Overall Study|Lost to Follow-up|3|||
161081473|NCT00338962|581686533|FG000|Overall Study|Withdrawal by Subject|1|||
161165799|NCT02310906|581984278|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
161165800|NCT00433446|581984279|FG000|Overall Study|Adverse Event|4|||
161165801|NCT00433446|581984279|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
161165802|NCT00433446|581984279|FG000|Overall Study|Progression|44|||
161165803|NCT00433446|581984279|FG000|Overall Study|Other - Not Protocol specified|3|||
161165804|NCT00433446|581984279|FG000|Overall Study|Ineligible|9|||
161165805|NCT01188538|581984280|FG000|Overall Study|Lost to Follow-up|0|||
161165806|NCT01188538|581984281|FG001|Overall Study|Lost to Follow-up|1|||
161165807|NCT02899377|581984282|FG000|Overall Study|Adverse Event|1|||
161165808|NCT02899377|581984283|FG001|Overall Study|Adverse Event|0|||
161165809|NCT01231607|581984287|FG000|Overall Study|Adverse Event|0|||
161165810|NCT01231607|581984288|FG001|Overall Study|Adverse Event|8|||
161165811|NCT01231607|581984289|FG002|Overall Study|Adverse Event|4|||
161289800|NCT02059135|582440676|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
161289801|NCT02059135|582440677|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
161289802|NCT02059135|582440676|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
161289803|NCT02059135|582440677|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
161289804|NCT02059135|582440676|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
161081474|NCT00338962|581686534|FG001|Overall Study|Withdrawal by Subject|0|||
161165812|NCT01231607|581984290|FG003|Overall Study|Adverse Event|4|||
161081475|NCT00338962|581686535|FG002|Overall Study|Withdrawal by Subject|0|||
161081476|NCT00338962|581686536|FG003|Overall Study|Withdrawal by Subject|0|||
161081477|NCT00338962|581686533|FG000|Overall Study|No Transportation|2|||
161081478|NCT00338962|581686534|FG001|Overall Study|No Transportation|0|||
161081479|NCT00338962|581686535|FG002|Overall Study|No Transportation|0|||
161081480|NCT00338962|581686536|FG003|Overall Study|No Transportation|0|||
161081481|NCT00338962|581686533|FG000|Overall Study|Time Constraint|2|||
161289805|NCT02059135|582440677|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
161289806|NCT02059135|582440676|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
161081482|NCT00338962|581686534|FG001|Overall Study|Time Constraint|0|||
161081483|NCT00338962|581686535|FG002|Overall Study|Time Constraint|0|||
161081484|NCT00338962|581686536|FG003|Overall Study|Time Constraint|0|||
161081485|NCT00338962|581686533|FG000|Overall Study|Moved|0|||
161081486|NCT00338962|581686534|FG001|Overall Study|Moved|1|||
161081487|NCT00338962|581686535|FG002|Overall Study|Moved|0|||
161081488|NCT00338962|581686536|FG003|Overall Study|Moved|0|||
161081489|NCT00338962|581686533|FG000|Overall Study|Adverse Event|0|||
161081490|NCT00338962|581686534|FG001|Overall Study|Adverse Event|0|||
161081491|NCT00338962|581686535|FG002|Overall Study|Adverse Event|2|||
161081492|NCT00338962|581686536|FG003|Overall Study|Adverse Event|0|||
161081493|NCT00338962|581686533|FG000|Overall Study|Poor Compliance|0|||
161081494|NCT00338962|581686534|FG001|Overall Study|Poor Compliance|0|||
161081495|NCT00338962|581686535|FG002|Overall Study|Poor Compliance|2|||
161081496|NCT00338962|581686536|FG003|Overall Study|Poor Compliance|0|||
161081497|NCT04155047|581686538|FG000|Overall Study|Adverse Event|1|||
161081498|NCT04155047|581686539|FG001|Overall Study|Adverse Event|0|||
161081499|NCT04155047|581686538|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
161081500|NCT04155047|581686539|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
161081501|NCT00821587|581686540|FG000|Overall Study|Physician Decision|0|||
161081502|NCT00821587|581686541|FG001|Overall Study|Physician Decision|1|||
161081503|NCT02781090|581686544|FG000|3-Month Follow-Up|Missed Visit|20|||
161081504|NCT02781090|581686545|FG001|3-Month Follow-Up|Missed Visit|20|||
161081505|NCT02781090|581686544|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
161081506|NCT02781090|581686545|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
161081507|NCT02781090|581686544|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
161081508|NCT02781090|581686545|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
161081509|NCT02781090|581686544|FG000|3-Month Follow-Up|Death|1|||
161081510|NCT02781090|581686545|FG001|3-Month Follow-Up|Death|0|||
161081511|NCT02781090|581686544|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
161081512|NCT02781090|581686545|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
161081513|NCT02781090|581686544|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
161081514|NCT02781090|581686545|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
161081515|NCT02781090|581686544|FG000|6-Month Follow-Up|Death|0|||
161081516|NCT02781090|581686545|FG001|6-Month Follow-Up|Death|1|||
161081517|NCT00643617|581686546|FG000|Overall Study|Death|6|||
161081518|NCT00643617|581686547|FG001|Overall Study|Death|9|||
161081519|NCT00643617|581686546|FG000|Overall Study|Lost to Follow-up|42|||
161081520|NCT00643617|581686547|FG001|Overall Study|Lost to Follow-up|51|||
161081521|NCT01208103|581686554|FG000|Overall Study|Adverse Event|1|||
161081522|NCT01208103|581686554|FG000|Overall Study|Withdrawal by Subject|1|||
161081523|NCT00416195|581686557|FG000|Overall Study|Adverse Event|1|||
161081524|NCT00416195|581686558|FG001|Overall Study|Adverse Event|2|||
161081525|NCT00416195|581686557|FG000|Overall Study|Protocol Violation|1|||
161081526|NCT00416195|581686558|FG001|Overall Study|Protocol Violation|1|||
161081527|NCT00416195|581686557|FG000|Overall Study|Other|0|||
161081528|NCT00416195|581686558|FG001|Overall Study|Other|1|||
161081529|NCT00468143|581686561|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
161081530|NCT00468143|581686562|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
161081531|NCT00468143|581686561|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
161081532|NCT00468143|581686562|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
161081533|NCT01606670|581686565|FG000|Overall Study|Adverse Event|6|||
161081534|NCT01606670|581686565|FG000|Overall Study|Lack of Efficacy|2|||
161081535|NCT01606670|581686565|FG000|Overall Study|Lost to Follow-up|3|||
161081536|NCT01606670|581686565|FG000|Overall Study|Withdrawal by Subject|3|||
161081537|NCT01606670|581686565|FG000|Overall Study|Other Reason|2|||
161081538|NCT03192475|581686576|FG000|Overall Study|Death|0|||
161081539|NCT03192475|581686577|FG001|Overall Study|Death|1|||
161081540|NCT03192475|581686576|FG000|Overall Study|Lost to Follow-up|13|||
161081541|NCT03192475|581686577|FG001|Overall Study|Lost to Follow-up|8|||
161081542|NCT00798590|581686578|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
161081543|NCT00798590|581686579|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
161081544|NCT03653208|581686584|FG000|Overall Study|Withdrawal by Subject|0|||
161081545|NCT03653208|581686585|FG001|Overall Study|Withdrawal by Subject|0|||
161081546|NCT03653208|581686586|FG002|Overall Study|Withdrawal by Subject|0|||
161081547|NCT03653208|581686587|FG003|Overall Study|Withdrawal by Subject|0|||
161081548|NCT03653208|581686588|FG004|Overall Study|Withdrawal by Subject|1|||
161081549|NCT03653208|581686589|FG005|Overall Study|Withdrawal by Subject|0|||
161081550|NCT03653208|581686590|FG006|Overall Study|Withdrawal by Subject|0|||
161081551|NCT03653208|581686591|FG007|Overall Study|Withdrawal by Subject|1|||
161081552|NCT03653208|581686592|FG008|Overall Study|Withdrawal by Subject|1|||
161081553|NCT00368927|581686593|FG000|Overall Study|Lost to Follow-up|2|||
161081554|NCT00368927|581686594|FG001|Overall Study|Lost to Follow-up|0|||
161081555|NCT00368927|581686593|FG000|Overall Study|Adverse Event|1|||
161081556|NCT00368927|581686594|FG001|Overall Study|Adverse Event|1|||
161081557|NCT00368927|581686593|FG000|Overall Study|Withdrawal by Subject|1|||
161346889|NCT00143507|582654677|FG001|Overall Study|Lost to Follow-up|0|||
161081558|NCT00368927|581686594|FG001|Overall Study|Withdrawal by Subject|2|||
161081559|NCT00368927|581686593|FG000|Overall Study|Physician Decision|1|||
161081560|NCT00368927|581686594|FG001|Overall Study|Physician Decision|0|||
161081561|NCT01204710|581686595|FG000|Randomization Treatment|Lost to Follow-up|1|||
161081562|NCT01204710|581686596|FG001|Randomization Treatment|Lost to Follow-up|0|||
161081563|NCT01204710|581686595|FG000|Randomization Treatment|Withdrawal by Subject|6|||
161081564|NCT01204710|581686596|FG001|Randomization Treatment|Withdrawal by Subject|5|||
161081565|NCT01204710|581686595|FG000|Randomization Treatment|Physician Decision|3|||
161081566|NCT01204710|581686596|FG001|Randomization Treatment|Physician Decision|2|||
161081567|NCT01204710|581686595|FG000|Randomization Treatment|Entry criteria not met|0|||
161081568|NCT01204710|581686596|FG001|Randomization Treatment|Entry criteria not met|1|||
161081569|NCT01204710|581686595|FG000|Randomization Treatment|Adverse Event|4|||
161081570|NCT01204710|581686596|FG001|Randomization Treatment|Adverse Event|2|||
161081571|NCT01204710|581686595|FG000|Randomization Treatment|Sponsor Decision|0|||
161081572|NCT01204710|581686596|FG001|Randomization Treatment|Sponsor Decision|1|||
161081573|NCT01204710|581686595|FG000|Randomization Treatment|Worsening of General condition|0|||
161081574|NCT01204710|581686596|FG001|Randomization Treatment|Worsening of General condition|1|||
161081575|NCT01204710|581686595|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
161081576|NCT01204710|581686596|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
161081577|NCT01204710|581686595|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
161081578|NCT01204710|581686596|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
161081579|NCT01204710|581686595|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
161081580|NCT01204710|581686596|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
161081581|NCT01204710|581686595|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
161081582|NCT01204710|581686596|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
161081583|NCT03898167|581686597|FG000|Overall Study|Terminated phone call early|7|||
161081584|NCT03898167|581686598|FG001|Overall Study|Terminated phone call early|0|||
161081585|NCT03898167|581686599|FG002|Overall Study|Terminated phone call early|0|||
161081586|NCT03898167|581686597|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
161081587|NCT03898167|581686598|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
161081588|NCT03898167|581686599|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
161081589|NCT02906007|581686602|FG000|Overall Study|Physician Decision|0|||
161081590|NCT02906007|581686603|FG001|Overall Study|Physician Decision|0|||
161081591|NCT02906007|581686604|FG002|Overall Study|Physician Decision|1|||
161081592|NCT02906007|581686602|FG000|Overall Study|Died|1|||
161081593|NCT02906007|581686603|FG001|Overall Study|Died|0|||
161081594|NCT02906007|581686604|FG002|Overall Study|Died|0|||
161081595|NCT04696653|581686605|FG000|Overall Study|left organization|18|||
161081596|NCT04696653|581686605|FG000|Overall Study|Lost to Follow-up|3|||
161081597|NCT04047862|581686611|FG000|Overall Study|Death|0|||
161081598|NCT04047862|581686612|FG001|Overall Study|Death|0|||
161081599|NCT04047862|581686613|FG002|Overall Study|Death|4|||
161081600|NCT04047862|581686614|FG003|Overall Study|Death|7|||
161081601|NCT04047862|581686615|FG004|Overall Study|Death|2|||
161081602|NCT04047862|581686616|FG005|Overall Study|Death|4|||
161081603|NCT04047862|581686617|FG006|Overall Study|Death|3|||
161081604|NCT04047862|581686618|FG007|Overall Study|Death|24|||
161081605|NCT04047862|581686619|FG008|Overall Study|Death|24|||
161081606|NCT04047862|581686620|FG009|Overall Study|Death|22|||
161165813|NCT01231607|581984291|FG004|Overall Study|Adverse Event|5|||
161165814|NCT01231607|581984287|FG000|Overall Study|Lost to Follow-up|13|||
161165815|NCT01231607|581984288|FG001|Overall Study|Lost to Follow-up|11|||
161165816|NCT01231607|581984289|FG002|Overall Study|Lost to Follow-up|10|||
161165817|NCT01231607|581984290|FG003|Overall Study|Lost to Follow-up|10|||
161165818|NCT01231607|581984291|FG004|Overall Study|Lost to Follow-up|4|||
161165819|NCT01231607|581984287|FG000|Overall Study|Physician Decision|4|||
161165820|NCT01231607|581984288|FG001|Overall Study|Physician Decision|4|||
161165821|NCT01231607|581984289|FG002|Overall Study|Physician Decision|3|||
161165822|NCT01231607|581984290|FG003|Overall Study|Physician Decision|5|||
161165823|NCT01231607|581984291|FG004|Overall Study|Physician Decision|4|||
161165824|NCT01231607|581984287|FG000|Overall Study|Protocol Violation|3|||
161165825|NCT01231607|581984288|FG001|Overall Study|Protocol Violation|2|||
161165826|NCT01231607|581984289|FG002|Overall Study|Protocol Violation|0|||
161165827|NCT01231607|581984290|FG003|Overall Study|Protocol Violation|2|||
161165828|NCT01231607|581984291|FG004|Overall Study|Protocol Violation|2|||
161165829|NCT01231607|581984287|FG000|Overall Study|Withdrawal by Subject|9|||
161165830|NCT01231607|581984288|FG001|Overall Study|Withdrawal by Subject|9|||
161165831|NCT01231607|581984289|FG002|Overall Study|Withdrawal by Subject|14|||
161165832|NCT01231607|581984290|FG003|Overall Study|Withdrawal by Subject|17|||
161165833|NCT01231607|581984291|FG004|Overall Study|Withdrawal by Subject|9|||
161165834|NCT01170702|581984294|FG000|Overall Study|Exclusion criteria met after consent|1|||
161346890|NCT00143507|582654676|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
161081607|NCT04047862|581686621|FG010|Overall Study|Death|35|||
161081608|NCT04047862|581686622|FG011|Overall Study|Death|18|||
161081609|NCT04047862|581686623|FG012|Overall Study|Death|14|||
161081610|NCT04047862|581686624|FG013|Overall Study|Death|6|||
161081611|NCT04047862|581686625|FG014|Overall Study|Death|19|||
161081612|NCT04047862|581686626|FG015|Overall Study|Death|42|||
161081613|NCT04047862|581686627|FG016|Overall Study|Death|9|||
161081614|NCT04047862|581686628|FG017|Overall Study|Death|8|||
161081615|NCT04047862|581686629|FG018|Overall Study|Death|10|||
161081616|NCT04047862|581686611|FG000|Overall Study|Withdrawal by Subject|0|||
161081617|NCT04047862|581686612|FG001|Overall Study|Withdrawal by Subject|0|||
161081618|NCT04047862|581686613|FG002|Overall Study|Withdrawal by Subject|0|||
161081619|NCT04047862|581686614|FG003|Overall Study|Withdrawal by Subject|5|||
161081620|NCT04047862|581686615|FG004|Overall Study|Withdrawal by Subject|2|||
161081621|NCT04047862|581686616|FG005|Overall Study|Withdrawal by Subject|0|||
161081622|NCT04047862|581686617|FG006|Overall Study|Withdrawal by Subject|1|||
161081623|NCT04047862|581686618|FG007|Overall Study|Withdrawal by Subject|0|||
161081624|NCT04047862|581686619|FG008|Overall Study|Withdrawal by Subject|4|||
161081625|NCT04047862|581686620|FG009|Overall Study|Withdrawal by Subject|4|||
161081626|NCT04047862|581686621|FG010|Overall Study|Withdrawal by Subject|4|||
161081627|NCT04047862|581686622|FG011|Overall Study|Withdrawal by Subject|2|||
161081628|NCT04047862|581686623|FG012|Overall Study|Withdrawal by Subject|3|||
161081629|NCT04047862|581686624|FG013|Overall Study|Withdrawal by Subject|0|||
161081630|NCT04047862|581686625|FG014|Overall Study|Withdrawal by Subject|9|||
161081631|NCT04047862|581686626|FG015|Overall Study|Withdrawal by Subject|5|||
161081632|NCT04047862|581686627|FG016|Overall Study|Withdrawal by Subject|1|||
161081633|NCT04047862|581686628|FG017|Overall Study|Withdrawal by Subject|3|||
161081634|NCT04047862|581686629|FG018|Overall Study|Withdrawal by Subject|1|||
161081635|NCT04047862|581686611|FG000|Overall Study|Lost to Follow-up|0|||
161081636|NCT04047862|581686612|FG001|Overall Study|Lost to Follow-up|0|||
161081637|NCT04047862|581686613|FG002|Overall Study|Lost to Follow-up|1|||
161081638|NCT04047862|581686614|FG003|Overall Study|Lost to Follow-up|0|||
161081639|NCT04047862|581686615|FG004|Overall Study|Lost to Follow-up|0|||
161081640|NCT04047862|581686616|FG005|Overall Study|Lost to Follow-up|0|||
161081641|NCT04047862|581686617|FG006|Overall Study|Lost to Follow-up|0|||
161081642|NCT04047862|581686618|FG007|Overall Study|Lost to Follow-up|1|||
161081643|NCT04047862|581686619|FG008|Overall Study|Lost to Follow-up|0|||
161081644|NCT04047862|581686620|FG009|Overall Study|Lost to Follow-up|1|||
161081645|NCT04047862|581686621|FG010|Overall Study|Lost to Follow-up|0|||
161081646|NCT04047862|581686622|FG011|Overall Study|Lost to Follow-up|3|||
161081647|NCT04047862|581686623|FG012|Overall Study|Lost to Follow-up|0|||
161081648|NCT04047862|581686624|FG013|Overall Study|Lost to Follow-up|0|||
161081649|NCT04047862|581686625|FG014|Overall Study|Lost to Follow-up|2|||
161081650|NCT04047862|581686626|FG015|Overall Study|Lost to Follow-up|2|||
161081651|NCT04047862|581686627|FG016|Overall Study|Lost to Follow-up|1|||
161081652|NCT04047862|581686628|FG017|Overall Study|Lost to Follow-up|0|||
161081653|NCT04047862|581686629|FG018|Overall Study|Lost to Follow-up|0|||
161081654|NCT04047862|581686611|FG000|Overall Study|Physician Decision|0|||
161081655|NCT04047862|581686612|FG001|Overall Study|Physician Decision|0|||
161081656|NCT04047862|581686613|FG002|Overall Study|Physician Decision|0|||
161081657|NCT04047862|581686614|FG003|Overall Study|Physician Decision|1|||
161081658|NCT04047862|581686615|FG004|Overall Study|Physician Decision|0|||
161081659|NCT04047862|581686616|FG005|Overall Study|Physician Decision|0|||
161081660|NCT04047862|581686617|FG006|Overall Study|Physician Decision|0|||
161081661|NCT04047862|581686618|FG007|Overall Study|Physician Decision|0|||
161081662|NCT04047862|581686619|FG008|Overall Study|Physician Decision|0|||
161081663|NCT04047862|581686620|FG009|Overall Study|Physician Decision|0|||
161081664|NCT04047862|581686621|FG010|Overall Study|Physician Decision|0|||
161081665|NCT04047862|581686622|FG011|Overall Study|Physician Decision|0|||
161081666|NCT04047862|581686623|FG012|Overall Study|Physician Decision|0|||
161081667|NCT04047862|581686624|FG013|Overall Study|Physician Decision|0|||
161081668|NCT04047862|581686625|FG014|Overall Study|Physician Decision|1|||
161081669|NCT04047862|581686626|FG015|Overall Study|Physician Decision|0|||
161081670|NCT04047862|581686627|FG016|Overall Study|Physician Decision|1|||
161165835|NCT01170702|581984295|FG001|Overall Study|Exclusion criteria met after consent|2|||
161165836|NCT01170702|581984296|FG002|Overall Study|Exclusion criteria met after consent|0|||
161165837|NCT01170702|581984297|FG003|Overall Study|Exclusion criteria met after consent|2|||
161165838|NCT01677507|581984298|FG000|Initial Assignment|Adverse Event|0|||
161081671|NCT04047862|581686628|FG017|Overall Study|Physician Decision|0|||
161165839|NCT01677507|581984299|FG001|Initial Assignment|Adverse Event|1|||
161165840|NCT01677507|581984298|FG000|Initial Assignment|Protocol Violation|0|||
161165841|NCT01677507|581984299|FG001|Initial Assignment|Protocol Violation|1|||
161165842|NCT01677507|581984298|FG000|Second Assigment|Withdrawal by Subject|2|||
161165843|NCT01677507|581984299|FG001|Second Assigment|Withdrawal by Subject|2|||
161081672|NCT04047862|581686629|FG018|Overall Study|Physician Decision|0|||
161081673|NCT04047862|581686611|FG000|Overall Study|Completed all Assessments|1|||
161081674|NCT04047862|581686612|FG001|Overall Study|Completed all Assessments|3|||
161081675|NCT04047862|581686613|FG002|Overall Study|Completed all Assessments|1|||
161081676|NCT04047862|581686614|FG003|Overall Study|Completed all Assessments|3|||
161081677|NCT04047862|581686615|FG004|Overall Study|Completed all Assessments|2|||
161081678|NCT04047862|581686616|FG005|Overall Study|Completed all Assessments|5|||
161081679|NCT04047862|581686617|FG006|Overall Study|Completed all Assessments|7|||
161165844|NCT01677507|581984298|FG000|Second Assigment|Adverse Event|1|||
161165845|NCT01677507|581984299|FG001|Second Assigment|Adverse Event|3|||
161165846|NCT00469209|581984300|FG000|Overall Study|Adverse Event|1|||
161165847|NCT00469209|581984301|FG001|Overall Study|Adverse Event|0|||
161165848|NCT00469209|581984302|FG002|Overall Study|Adverse Event|1|||
161081680|NCT04047862|581686618|FG007|Overall Study|Completed all Assessments|0|||
161081681|NCT04047862|581686619|FG008|Overall Study|Completed all Assessments|0|||
161081682|NCT04047862|581686620|FG009|Overall Study|Completed all Assessments|0|||
161081683|NCT04047862|581686621|FG010|Overall Study|Completed all Assessments|0|||
161081684|NCT04047862|581686622|FG011|Overall Study|Completed all Assessments|0|||
161081685|NCT04047862|581686623|FG012|Overall Study|Completed all Assessments|0|||
161081686|NCT04047862|581686624|FG013|Overall Study|Completed all Assessments|0|||
161081687|NCT04047862|581686625|FG014|Overall Study|Completed all Assessments|0|||
161081688|NCT04047862|581686626|FG015|Overall Study|Completed all Assessments|0|||
161165849|NCT04999969|581984305|FG000|Overall Study|Death|76|||
161165850|NCT04999969|581984305|FG000|Overall Study|Progressive Disease|1|||
161165851|NCT04999969|581984305|FG000|Overall Study|Withdrawal by Subject|8|||
161165852|NCT03779334|581984307|FG000|Overall Study|Withdrawal by Subject|3|||
161165853|NCT03779334|581984308|FG001|Overall Study|Withdrawal by Subject|0|||
161165854|NCT03779334|581984309|FG002|Overall Study|Withdrawal by Subject|0|||
161165855|NCT03779334|581984307|FG000|Overall Study|Ongoing in Study|5|||
161165856|NCT03779334|581984308|FG001|Overall Study|Ongoing in Study|13|||
161165857|NCT03779334|581984309|FG002|Overall Study|Ongoing in Study|5|||
161165858|NCT04321252|581984316|FG000|Overall Study|Withdrawal by Subject|0|||
161165859|NCT04321252|581984317|FG001|Overall Study|Withdrawal by Subject|0|||
161165860|NCT04321252|581984318|FG002|Overall Study|Withdrawal by Subject|0|||
161165861|NCT04321252|581984319|FG003|Overall Study|Withdrawal by Subject|0|||
161165862|NCT04321252|581984320|FG004|Overall Study|Withdrawal by Subject|0|||
161165863|NCT04321252|581984321|FG005|Overall Study|Withdrawal by Subject|1|||
161165864|NCT04321252|581984322|FG006|Overall Study|Withdrawal by Subject|0|||
161165865|NCT04321252|581984323|FG007|Overall Study|Withdrawal by Subject|0|||
161165866|NCT04321252|581984324|FG008|Overall Study|Withdrawal by Subject|0|||
161165867|NCT06245044|581984325|FG000|No MI help|Technical issues|18|||
161165868|NCT01082367|581984328|FG000|Double-blind Period|Administrative problems|0|||
161165869|NCT01082367|581984329|FG001|Double-blind Period|Administrative problems|1|||
161165870|NCT01082367|581984328|FG000|Double-blind Period|Lack of Efficacy|5|||
161165871|NCT01082367|581984329|FG001|Double-blind Period|Lack of Efficacy|11|||
161165872|NCT01082367|581984328|FG000|Double-blind Period|Adverse Event|0|||
161165873|NCT01082367|581984329|FG001|Double-blind Period|Adverse Event|1|||
161165874|NCT01082367|581984328|FG000|Follow-up (F-U) Period|Administrative problems|1|||
161165875|NCT01082367|581984329|FG001|Follow-up (F-U) Period|Administrative problems|0|||
161165876|NCT01082367|581984328|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
161165877|NCT01082367|581984329|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
161165878|NCT01082367|581984328|FG000|Follow-up (F-U) Period|Adverse Event|0|||
161165879|NCT01082367|581984329|FG001|Follow-up (F-U) Period|Adverse Event|1|||
161165880|NCT00085917|581984333|FG000|Overall Study|Adverse Event|4|||
161165881|NCT00085917|581984334|FG001|Overall Study|Adverse Event|3|||
161165882|NCT01658579|581984335|FG000|Treatment Period A|Other|0|||
161165883|NCT01658579|581984336|FG001|Treatment Period A|Other|0|||
161165884|NCT01658579|581984337|FG002|Treatment Period A|Other|1|||
161165885|NCT01658579|581984338|FG003|Treatment Period A|Other|1|||
161165886|NCT01658579|581984335|FG000|Treatment Period A|Adverse Event|1|||
161165887|NCT01658579|581984336|FG001|Treatment Period A|Adverse Event|0|||
161165888|NCT01658579|581984337|FG002|Treatment Period A|Adverse Event|0|||
161165889|NCT01658579|581984338|FG003|Treatment Period A|Adverse Event|0|||
161165890|NCT01658579|581984335|FG000|Treatment Period B|Other|0|||
161165891|NCT01658579|581984336|FG001|Treatment Period B|Other|0|||
161165892|NCT01658579|581984337|FG002|Treatment Period B|Other|0|||
161165893|NCT01658579|581984338|FG003|Treatment Period B|Other|1|||
161165894|NCT05590767|581984339|FG000|Overall Study|Protocol Violation|1|||
161165895|NCT05590767|581984339|FG000|Overall Study|surgery canceled|1|||
161165896|NCT05590767|581984339|FG000|Overall Study|interscalene brachial block not performed|1|||
161165897|NCT01464788|581984340|FG000|Overall Study|Lost to Follow-up|0|||
161165898|NCT01464788|581984341|FG001|Overall Study|Lost to Follow-up|1|||
161165899|NCT01464788|581984342|FG002|Overall Study|Lost to Follow-up|0|||
161165900|NCT01464788|581984340|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
161165901|NCT01464788|581984341|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
161165902|NCT01464788|581984342|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
161165903|NCT00125190|581984351|FG000|Overall Study|Subject/Parent Decision|7|||
161165904|NCT00125190|581984351|FG000|Overall Study|Non-compliance|2|||
161165905|NCT00125190|581984351|FG000|Overall Study|Adverse Event|1|||
161165906|NCT00125190|581984351|FG000|Overall Study|Other|1|||
161165907|NCT00125190|581984351|FG000|Overall Study|Lost to Follow-up|4|||
161165908|NCT00363246|581984353|FG000|Overall Study|Death|40|||
161081689|NCT04047862|581686627|FG016|Overall Study|Completed all Assessments|0|||
161081690|NCT04047862|581686628|FG017|Overall Study|Completed all Assessments|0|||
161081691|NCT04047862|581686629|FG018|Overall Study|Completed all Assessments|0|||
161165909|NCT00363246|581984353|FG000|Overall Study|Withdrawal by Subject|19|||
161165910|NCT00363246|581984353|FG000|Overall Study|Lost to Follow-up|14|||
161165911|NCT00363246|581984353|FG000|Overall Study|Bad health|6|||
161081692|NCT04047862|581686611|FG000|Overall Study|Sponsor Decision|0|||
161081693|NCT04047862|581686612|FG001|Overall Study|Sponsor Decision|0|||
161081694|NCT04047862|581686613|FG002|Overall Study|Sponsor Decision|0|||
161081695|NCT04047862|581686614|FG003|Overall Study|Sponsor Decision|0|||
161081696|NCT04047862|581686615|FG004|Overall Study|Sponsor Decision|0|||
161081697|NCT04047862|581686616|FG005|Overall Study|Sponsor Decision|0|||
161081698|NCT04047862|581686617|FG006|Overall Study|Sponsor Decision|0|||
161081699|NCT04047862|581686618|FG007|Overall Study|Sponsor Decision|13|||
161081700|NCT04047862|581686619|FG008|Overall Study|Sponsor Decision|10|||
161081701|NCT04047862|581686620|FG009|Overall Study|Sponsor Decision|18|||
161081702|NCT04047862|581686621|FG010|Overall Study|Sponsor Decision|3|||
161081703|NCT04047862|581686622|FG011|Overall Study|Sponsor Decision|3|||
161081704|NCT04047862|581686623|FG012|Overall Study|Sponsor Decision|4|||
161081705|NCT04047862|581686624|FG013|Overall Study|Sponsor Decision|0|||
161081706|NCT04047862|581686625|FG014|Overall Study|Sponsor Decision|7|||
161081707|NCT04047862|581686626|FG015|Overall Study|Sponsor Decision|8|||
161081708|NCT04047862|581686627|FG016|Overall Study|Sponsor Decision|9|||
161081709|NCT04047862|581686628|FG017|Overall Study|Sponsor Decision|7|||
161081710|NCT04047862|581686629|FG018|Overall Study|Sponsor Decision|8|||
161081711|NCT04047862|581686611|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081712|NCT04047862|581686612|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081713|NCT04047862|581686613|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081714|NCT04047862|581686614|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081715|NCT04047862|581686615|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081716|NCT04047862|581686616|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081717|NCT04047862|581686617|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081718|NCT04047862|581686618|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
161081719|NCT04047862|581686619|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
161081720|NCT04047862|581686620|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081721|NCT04047862|581686621|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
161081722|NCT04047862|581686622|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081723|NCT04047862|581686623|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081724|NCT04047862|581686624|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
161081725|NCT04047862|581686625|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
161165912|NCT00363246|581984353|FG000|Overall Study|Stopped using wheelchair|11|||
161165913|NCT00363246|581984353|FG000|Overall Study|Subject expressed security concerns|2|||
161165914|NCT00363246|581984353|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
161165915|NCT00264849|581984354|FG000|Overall Study|Adverse Event|7|||
161165916|NCT00264849|581984355|FG001|Overall Study|Adverse Event|2|||
161289807|NCT02059135|582440677|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
161289808|NCT02059135|582440676|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
161289809|NCT02059135|582440677|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
161289810|NCT02059135|582440676|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
161289811|NCT02059135|582440677|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
161289812|NCT00191477|582440678|FG000|Overall Study|Tumor Recurrence|49|||
161081726|NCT04047862|581686626|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
161081727|NCT04047862|581686627|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
161081728|NCT04047862|581686628|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
161081729|NCT04047862|581686629|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
161081730|NCT04047862|581686611|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081731|NCT04047862|581686612|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081732|NCT04047862|581686613|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081733|NCT04047862|581686614|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081734|NCT04047862|581686615|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081735|NCT04047862|581686616|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081736|NCT04047862|581686617|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081737|NCT04047862|581686618|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081738|NCT04047862|581686619|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081739|NCT04047862|581686620|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081740|NCT04047862|581686621|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081741|NCT04047862|581686622|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161165917|NCT00264849|581984354|FG000|Overall Study|Withdrawal by Subject|7|||
161165918|NCT00264849|581984355|FG001|Overall Study|Withdrawal by Subject|11|||
161165919|NCT00264849|581984354|FG000|Overall Study|Protocol Violation|5|||
161165920|NCT00264849|581984355|FG001|Overall Study|Protocol Violation|3|||
161289813|NCT00191477|582440679|FG001|Overall Study|Tumor Recurrence|48|||
161289814|NCT00191477|582440678|FG000|Overall Study|Death, Study Disease|1|||
161081742|NCT04047862|581686623|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081743|NCT04047862|581686624|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081744|NCT04047862|581686625|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081745|NCT04047862|581686626|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
161081746|NCT04047862|581686627|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081747|NCT04047862|581686628|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
161081748|NCT04047862|581686629|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
161081749|NCT04047862|581686611|FG000|Overall Study|Other|0|||
161081750|NCT04047862|581686612|FG001|Overall Study|Other|0|||
161081751|NCT04047862|581686613|FG002|Overall Study|Other|0|||
161081752|NCT04047862|581686614|FG003|Overall Study|Other|0|||
161081753|NCT04047862|581686615|FG004|Overall Study|Other|0|||
161081754|NCT04047862|581686616|FG005|Overall Study|Other|0|||
161081755|NCT04047862|581686617|FG006|Overall Study|Other|0|||
161081756|NCT04047862|581686618|FG007|Overall Study|Other|0|||
161081757|NCT04047862|581686619|FG008|Overall Study|Other|0|||
161081758|NCT04047862|581686620|FG009|Overall Study|Other|0|||
161081759|NCT04047862|581686621|FG010|Overall Study|Other|0|||
161081760|NCT04047862|581686622|FG011|Overall Study|Other|0|||
161081761|NCT04047862|581686623|FG012|Overall Study|Other|0|||
161081762|NCT04047862|581686624|FG013|Overall Study|Other|0|||
161081763|NCT04047862|581686625|FG014|Overall Study|Other|2|||
161081764|NCT04047862|581686626|FG015|Overall Study|Other|1|||
161081765|NCT04047862|581686627|FG016|Overall Study|Other|1|||
161081766|NCT04047862|581686628|FG017|Overall Study|Other|1|||
161081767|NCT04047862|581686629|FG018|Overall Study|Other|0|||
161081768|NCT00640133|581688381|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
161081769|NCT00640133|581688382|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
161081770|NCT00640133|581688381|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
161081771|NCT00640133|581688382|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
161081772|NCT00640133|581688381|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
161081773|NCT00640133|581688382|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
161081774|NCT01994837|581688384|FG000|Overall Study|Progressive disease per protocol|23|||
161081775|NCT01994837|581688384|FG000|Overall Study|Adv event related to progressive disease|3|||
161081776|NCT01994837|581688384|FG000|Overall Study|Fatal progressive disease|2|||
161081777|NCT01994837|581688384|FG000|Overall Study|Adverse event not related to progression|1|||
161081778|NCT01994837|581688384|FG000|Overall Study|Chose palliative care|1|||
161081779|NCT01994837|581688384|FG000|Overall Study|Proceeded to transplant|1|||
161081780|NCT01994837|581688384|FG000|Overall Study|Removed from study due to no response|1|||
161081781|NCT03900416|581688386|FG000|Six Week Follow-up|Lost to Follow-up|1|||
161081782|NCT03900416|581688387|FG001|Six Week Follow-up|Lost to Follow-up|0|||
161081783|NCT03900416|581688386|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
161081784|NCT03900416|581688387|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
161081785|NCT03900416|581688386|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
161081786|NCT03900416|581688387|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
161081787|NCT03900416|581688386|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
161081788|NCT03900416|581688387|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
161081789|NCT03900416|581688386|FG000|Twelve Week Follow-up|Adverse Event|1|||
161081790|NCT03900416|581688387|FG001|Twelve Week Follow-up|Adverse Event|1|||
161081791|NCT03900416|581688386|FG000|Six Month Follow-up|Lost to Follow-up|4|||
161081792|NCT03900416|581688387|FG001|Six Month Follow-up|Lost to Follow-up|3|||
161081793|NCT03900416|581688386|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
161081794|NCT03900416|581688387|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
161081795|NCT03207451|581688390|FG000|Overall Study|scheduling conflict|1|||
161081796|NCT03207451|581688391|FG001|Overall Study|scheduling conflict|0|||
161081797|NCT03207451|581688392|FG002|Overall Study|scheduling conflict|2|||
161081798|NCT03207451|581688393|FG003|Overall Study|scheduling conflict|2|||
161081799|NCT03207451|581688390|FG000|Overall Study|Adverse Event|0|||
161346891|NCT00143507|582654677|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
161346892|NCT00177671|582654678|FG000|Overall Study|Withdrawal by Subject|5|||
161346893|NCT00177671|582654679|FG001|Overall Study|Withdrawal by Subject|6|||
161081800|NCT03207451|581688391|FG001|Overall Study|Adverse Event|0|||
161346894|NCT00177671|582654678|FG000|Overall Study|medical complications|2|||
161346895|NCT00177671|582654679|FG001|Overall Study|medical complications|0|||
161346896|NCT00177671|582654678|FG000|Overall Study|Adverse Event|6|||
161346897|NCT00177671|582654679|FG001|Overall Study|Adverse Event|0|||
161346898|NCT00177671|582654678|FG000|Overall Study|Physician Decision|12|||
161346899|NCT00177671|582654679|FG001|Overall Study|Physician Decision|8|||
161081801|NCT03207451|581688392|FG002|Overall Study|Adverse Event|0|||
161081802|NCT03207451|581688393|FG003|Overall Study|Adverse Event|1|||
161081803|NCT03896152|581688394|FG000|Overall Study|Patient/guardian decision|1|||
161081804|NCT03896152|581688395|FG001|Overall Study|Patient/guardian decision|1|||
161081805|NCT03896152|581688394|FG000|Overall Study|Adverse Event|0|||
161081806|NCT03896152|581688395|FG001|Overall Study|Adverse Event|1|||
161081807|NCT03896152|581688394|FG000|Overall Study|Physician Decision|1|||
161081808|NCT03896152|581688395|FG001|Overall Study|Physician Decision|0|||
161081809|NCT03896152|581688394|FG000|Overall Study|Technical problems|1|||
161081810|NCT03896152|581688395|FG001|Overall Study|Technical problems|0|||
161081811|NCT00436852|581688396|FG000|Overall Study|Death|23|||
161081812|NCT00436852|581688397|FG001|Overall Study|Death|34|||
161081813|NCT00436852|581688396|FG000|Overall Study|Lack of Efficacy|9|||
161081814|NCT00436852|581688397|FG001|Overall Study|Lack of Efficacy|7|||
161081815|NCT00436852|581688396|FG000|Overall Study|Withdrawal by Subject|2|||
161081816|NCT00436852|581688397|FG001|Overall Study|Withdrawal by Subject|4|||
161081817|NCT00436852|581688396|FG000|Overall Study|Ineligible|1|||
161081818|NCT00436852|581688397|FG001|Overall Study|Ineligible|0|||
161081819|NCT00370682|581688398|FG000|Overall Study|Moved from area|0|||
161081820|NCT00370682|581688399|FG001|Overall Study|Moved from area|2|||
161081821|NCT00370682|581688400|FG002|Overall Study|Moved from area|0|||
161081822|NCT00370682|581688398|FG000|Overall Study|Lost to Follow-up|0|||
161081823|NCT00370682|581688399|FG001|Overall Study|Lost to Follow-up|1|||
161081824|NCT00370682|581688400|FG002|Overall Study|Lost to Follow-up|1|||
161081825|NCT03167359|581688401|FG000|Overall Study|Physician Decision|1|||
161081826|NCT03167359|581688401|FG000|Overall Study|Lost to Follow-up|1|||
161081827|NCT03339583|581688402|FG000|First Intervention (14 Days)|Adverse Event|1|||
161081828|NCT03339583|581688403|FG001|First Intervention (14 Days)|Adverse Event|0|||
161081829|NCT03339583|581688402|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
161081830|NCT03339583|581688403|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
161081831|NCT03339583|581688402|FG000|Second Intervention (14 Days)|Adverse Event|0|||
161081832|NCT03339583|581688403|FG001|Second Intervention (14 Days)|Adverse Event|1|||
161081833|NCT03339583|581688402|FG000|Follow-up (14 Days)|Physician Decision|6|||
161081834|NCT03339583|581688403|FG001|Follow-up (14 Days)|Physician Decision|3|||
161081835|NCT02141620|581688404|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
161081836|NCT02141620|581688405|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
161081837|NCT03651622|581688406|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
161081838|NCT03651622|581688407|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
161081839|NCT03651622|581688408|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
161081840|NCT03651622|581688406|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
161081841|NCT03651622|581688407|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
161081842|NCT03651622|581688408|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
161081843|NCT03651622|581688406|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
161081844|NCT03651622|581688407|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
161081845|NCT03651622|581688408|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
161081846|NCT03651622|581688406|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
161081847|NCT03651622|581688407|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
161081848|NCT03651622|581688408|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
161081849|NCT03651622|581688406|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
161081850|NCT03651622|581688407|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
161081851|NCT03651622|581688408|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
161081852|NCT01519089|581688409|FG000|Overall Study|Adverse Event|4|||
161081853|NCT01519089|581688410|FG001|Overall Study|Adverse Event|4|||
161081854|NCT01519089|581688409|FG000|Overall Study|Lack of Efficacy|0|||
161081855|NCT01519089|581688410|FG001|Overall Study|Lack of Efficacy|2|||
161081856|NCT01519089|581688409|FG000|Overall Study|Lost to Follow-up|1|||
161081857|NCT01519089|581688410|FG001|Overall Study|Lost to Follow-up|0|||
161081858|NCT01519089|581688409|FG000|Overall Study|Withdrawal by Subject|0|||
161081859|NCT01519089|581688410|FG001|Overall Study|Withdrawal by Subject|2|||
161081860|NCT01519089|581688409|FG000|Overall Study|Other|2|||
161081861|NCT01519089|581688410|FG001|Overall Study|Other|6|||
161081862|NCT01519089|581688409|FG000|Overall Study|Not received study drug|0|||
161081863|NCT01519089|581688410|FG001|Overall Study|Not received study drug|1|||
161081864|NCT00307684|581688411|FG000|Open Label Phase|Lack of Efficacy|0|||
161081865|NCT00307684|581688412|FG001|Open Label Phase|Lack of Efficacy|0|||
161081866|NCT00307684|581688413|FG002|Open Label Phase|Lack of Efficacy|3|||
161081867|NCT00307684|581688411|FG000|Open Label Phase|Adverse Event|0|||
161081868|NCT00307684|581688412|FG001|Open Label Phase|Adverse Event|0|||
161081869|NCT00307684|581688413|FG002|Open Label Phase|Adverse Event|16|||
161081870|NCT00307684|581688411|FG000|Open Label Phase|Withdrawal by Subject|0|||
161165921|NCT00264849|581984354|FG000|Overall Study|Lack of Efficacy|1|||
161081871|NCT00307684|581688412|FG001|Open Label Phase|Withdrawal by Subject|0|||
161081872|NCT00307684|581688413|FG002|Open Label Phase|Withdrawal by Subject|15|||
161081873|NCT00307684|581688411|FG000|Open Label Phase|Lost to Follow-up|0|||
161081874|NCT00307684|581688412|FG001|Open Label Phase|Lost to Follow-up|0|||
161081875|NCT00307684|581688413|FG002|Open Label Phase|Lost to Follow-up|11|||
161081876|NCT00307684|581688411|FG000|Open Label Phase|non compliance|0|||
161081877|NCT00307684|581688412|FG001|Open Label Phase|non compliance|0|||
161081878|NCT00307684|581688413|FG002|Open Label Phase|non compliance|5|||
161081879|NCT00307684|581688411|FG000|Open Label Phase|other|0|||
161081880|NCT00307684|581688412|FG001|Open Label Phase|other|0|||
161081881|NCT00307684|581688413|FG002|Open Label Phase|other|6|||
161081882|NCT00307684|581688411|FG000|Double Blind Phase|Lack of Efficacy|2|||
161081883|NCT00307684|581688412|FG001|Double Blind Phase|Lack of Efficacy|5|||
161081884|NCT00307684|581688413|FG002|Double Blind Phase|Lack of Efficacy|0|||
161081885|NCT00224887|581688414|FG000|Overall Study|Pregnancy|6|||
161081886|NCT00224887|581688415|FG001|Overall Study|Pregnancy|6|||
161081887|NCT00730275|581688416|FG000|Overall Study|Withdrawal by Subject|0|||
161081888|NCT00730275|581688417|FG001|Overall Study|Withdrawal by Subject|0|||
161081889|NCT00730275|581688418|FG002|Overall Study|Withdrawal by Subject|0|||
161081890|NCT00730275|581688419|FG003|Overall Study|Withdrawal by Subject|1|||
161081891|NCT00356408|581688420|FG000|Overall Study|Adverse Event|9|||
161081892|NCT00356408|581688420|FG000|Overall Study|Lack of Efficacy|36|||
161081893|NCT00356408|581688420|FG000|Overall Study|Lost to Follow-up|2|||
161081894|NCT00356408|581688420|FG000|Overall Study|Withdrawal by Subject|6|||
161081895|NCT00356408|581688420|FG000|Overall Study|Other: Principal investigator discretion|3|||
161081896|NCT00356408|581688420|FG000|Overall Study|Other: Sponsor request|1|||
161081897|NCT00356408|581688420|FG000|Overall Study|Other: Azathioprine stopped|1|||
161081898|NCT00356408|581688420|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
161081899|NCT00356408|581688420|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
161081900|NCT05487586|581688425|FG000|Overall Study|Death|22|||
161081901|NCT05487586|581688425|FG000|Overall Study|Physician Decision|1|||
161081902|NCT05487586|581688425|FG000|Overall Study|Transfer to another hospital|4|||
161081903|NCT05487586|581688425|FG000|Overall Study|Other|1|||
161081904|NCT03921723|581688426|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
161081905|NCT03921723|581688426|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
161081906|NCT03046121|581688428|FG000|Overall Study|Death|32|||
161289815|NCT00191477|582440679|FG001|Overall Study|Death, Study Disease|1|||
161289816|NCT00191477|582440678|FG000|Overall Study|Death, Other Cause|3|||
161081907|NCT03046121|581688429|FG001|Overall Study|Death|60|||
161081908|NCT03046121|581688428|FG000|Overall Study|Withdrawal by Subject|14|||
161081909|NCT03046121|581688429|FG001|Overall Study|Withdrawal by Subject|12|||
161081910|NCT03214640|581688430|FG000|Overall Study|Protocol Violation|1|||
161081911|NCT03214640|581688431|FG001|Overall Study|Protocol Violation|2|||
161081912|NCT03214640|581688432|FG002|Overall Study|Protocol Violation|1|||
161081913|NCT03214640|581688433|FG003|Overall Study|Protocol Violation|4|||
161081914|NCT00406692|581688441|FG000|Overall Study|Withdrawal by Subject|4|||
161081915|NCT00406692|581688441|FG000|Overall Study|Physician Decision|1|||
161081916|NCT00406692|581688441|FG000|Overall Study|Adverse Event|1|||
161081917|NCT00406692|581688441|FG000|Overall Study|Lack of Efficacy|1|||
161081918|NCT04488770|581688442|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081919|NCT04488770|581688443|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081920|NCT04488770|581688444|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081921|NCT04488770|581688445|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
161081922|NCT04488770|581688446|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081923|NCT04488770|581688447|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081924|NCT04488770|581688448|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081925|NCT04488770|581688449|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081926|NCT04488770|581688450|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081927|NCT04488770|581688451|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081928|NCT04488770|581688452|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081929|NCT04488770|581688453|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081930|NCT04488770|581688454|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
161081931|NCT04488770|581688442|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
161081932|NCT04488770|581688443|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081933|NCT04488770|581688444|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081934|NCT04488770|581688445|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081935|NCT04488770|581688446|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081936|NCT04488770|581688447|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081937|NCT04488770|581688448|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081938|NCT04488770|581688449|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081939|NCT04488770|581688450|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081940|NCT04488770|581688451|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081941|NCT04488770|581688452|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081942|NCT04488770|581688453|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081943|NCT04488770|581688454|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
161081944|NCT04488770|581688442|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081945|NCT04488770|581688443|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081946|NCT04488770|581688444|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081947|NCT04488770|581688445|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081948|NCT04488770|581688446|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081949|NCT04488770|581688447|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
161081950|NCT04488770|581688448|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
161081951|NCT04488770|581688449|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161165922|NCT00264849|581984355|FG001|Overall Study|Lack of Efficacy|6|||
161081952|NCT04488770|581688450|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081953|NCT04488770|581688451|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081954|NCT04488770|581688452|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081955|NCT04488770|581688453|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081956|NCT04488770|581688454|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
161081957|NCT04488770|581688442|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081958|NCT04488770|581688443|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081959|NCT04488770|581688444|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081960|NCT04488770|581688445|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081961|NCT04488770|581688446|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
161081962|NCT04488770|581688447|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081963|NCT04488770|581688448|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081964|NCT04488770|581688449|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081965|NCT04488770|581688450|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081966|NCT04488770|581688451|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081967|NCT04488770|581688452|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081968|NCT04488770|581688453|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081969|NCT04488770|581688454|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
161081970|NCT03547739|581688455|FG000|Overall Study|Death|0|||
161081971|NCT03547739|581688456|FG001|Overall Study|Death|1|||
161081972|NCT03547739|581688457|FG002|Overall Study|Death|5|||
161081973|NCT03547739|581688455|FG000|Overall Study|Adverse Event|24|||
161081974|NCT03547739|581688456|FG001|Overall Study|Adverse Event|11|||
161081975|NCT03547739|581688457|FG002|Overall Study|Adverse Event|13|||
161081976|NCT03547739|581688455|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
161081977|NCT03547739|581688456|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
161081978|NCT03547739|581688457|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
161081979|NCT03547739|581688455|FG000|Overall Study|Lost to Follow-up|80|||
161081980|NCT03547739|581688456|FG001|Overall Study|Lost to Follow-up|84|||
161081981|NCT03547739|581688457|FG002|Overall Study|Lost to Follow-up|116|||
161081982|NCT01696955|581688458|FG000|Main Study|Protocol Violation|1|||
161081983|NCT01696955|581688459|FG001|Main Study|Protocol Violation|0|||
161081984|NCT01696955|581688458|FG000|Main Study|Withdrawal by Subject|1|||
161081985|NCT01696955|581688459|FG001|Main Study|Withdrawal by Subject|1|||
161081986|NCT01641159|581688460|FG000|Overall Study|Lost to Follow-up|2|||
161081987|NCT01641159|581688461|FG001|Overall Study|Lost to Follow-up|1|||
161081988|NCT01641159|581688460|FG000|Overall Study|Withdrawal by Subject|0|||
161081989|NCT01641159|581688461|FG001|Overall Study|Withdrawal by Subject|1|||
161081990|NCT03980808|581688462|FG000|Overall Study|Lost to Follow-up|2|||
161081991|NCT03980808|581688463|FG001|Overall Study|Lost to Follow-up|2|||
161081992|NCT05330676|581688464|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
161081993|NCT05330676|581688465|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
161081994|NCT00573859|581688470|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
161081995|NCT00573859|581688470|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
161081996|NCT05384938|581688471|FG000|Overall Study|Withdrawal by Subject|8|||
161081997|NCT05384938|581688471|FG000|Overall Study|Lost to Follow-up|6|||
161081998|NCT05384938|581688471|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
161081999|NCT02626455|581688472|FG000|Overall Study|Other|1|||
161082000|NCT02626455|581688473|FG001|Overall Study|Other|1|||
161082001|NCT02626455|581688474|FG002|Overall Study|Other|0|||
161082002|NCT02626455|581688475|FG003|Overall Study|Other|0|||
161082003|NCT02626455|581688476|FG004|Overall Study|Other|0|||
161082004|NCT02626455|581688477|FG005|Overall Study|Other|17|||
161082005|NCT02626455|581688478|FG006|Overall Study|Other|23|||
161082006|NCT02626455|581688472|FG000|Overall Study|Withdrawal by Subject|1|||
161082007|NCT02626455|581688473|FG001|Overall Study|Withdrawal by Subject|0|||
161082008|NCT02626455|581688474|FG002|Overall Study|Withdrawal by Subject|0|||
161082009|NCT02626455|581688475|FG003|Overall Study|Withdrawal by Subject|0|||
161082010|NCT02626455|581688476|FG004|Overall Study|Withdrawal by Subject|0|||
161082011|NCT02626455|581688477|FG005|Overall Study|Withdrawal by Subject|10|||
161082012|NCT02626455|581688478|FG006|Overall Study|Withdrawal by Subject|6|||
161082013|NCT02626455|581688472|FG000|Overall Study|Physician Decision|0|||
161082014|NCT02626455|581688473|FG001|Overall Study|Physician Decision|2|||
161082015|NCT02626455|581688474|FG002|Overall Study|Physician Decision|2|||
161082016|NCT02626455|581688475|FG003|Overall Study|Physician Decision|2|||
161082017|NCT02626455|581688476|FG004|Overall Study|Physician Decision|1|||
161082018|NCT02626455|581688477|FG005|Overall Study|Physician Decision|10|||
161082019|NCT02626455|581688478|FG006|Overall Study|Physician Decision|3|||
161082020|NCT02626455|581688472|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161082021|NCT02626455|581688473|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161082022|NCT02626455|581688474|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161082023|NCT02626455|581688475|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161082024|NCT02626455|581688476|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161082025|NCT02626455|581688477|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
161082026|NCT02626455|581688478|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
161082027|NCT02626455|581688472|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161082028|NCT02626455|581688473|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161082029|NCT02626455|581688474|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161082030|NCT02626455|581688475|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161082031|NCT02626455|581688476|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161082032|NCT02626455|581688477|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
161082033|NCT02626455|581688478|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
161082034|NCT02626455|581688472|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161082035|NCT02626455|581688473|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161082036|NCT02626455|581688474|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161082037|NCT02626455|581688475|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161082038|NCT02626455|581688476|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
161082039|NCT02626455|581688477|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
161082040|NCT02626455|581688478|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
161082041|NCT02626455|581688472|FG000|Overall Study|Patient decision|0|||
161082042|NCT02626455|581688473|FG001|Overall Study|Patient decision|1|||
161082043|NCT02626455|581688474|FG002|Overall Study|Patient decision|0|||
161082044|NCT02626455|581688475|FG003|Overall Study|Patient decision|0|||
161082045|NCT02626455|581688476|FG004|Overall Study|Patient decision|1|||
161082046|NCT02626455|581688477|FG005|Overall Study|Patient decision|36|||
161082047|NCT02626455|581688478|FG006|Overall Study|Patient decision|22|||
161082048|NCT02626455|581688472|FG000|Overall Study|Protocol Violation|0|||
161082049|NCT02626455|581688473|FG001|Overall Study|Protocol Violation|0|||
161082050|NCT02626455|581688474|FG002|Overall Study|Protocol Violation|0|||
161082051|NCT02626455|581688475|FG003|Overall Study|Protocol Violation|0|||
161082052|NCT02626455|581688476|FG004|Overall Study|Protocol Violation|0|||
161082053|NCT02626455|581688477|FG005|Overall Study|Protocol Violation|0|||
161082054|NCT02626455|581688478|FG006|Overall Study|Protocol Violation|1|||
161082055|NCT02626455|581688472|FG000|Overall Study|Progressive disease - radiological progression|0|||
161082056|NCT02626455|581688473|FG001|Overall Study|Progressive disease - radiological progression|0|||
161082057|NCT02626455|581688474|FG002|Overall Study|Progressive disease - radiological progression|0|||
161082058|NCT02626455|581688475|FG003|Overall Study|Progressive disease - radiological progression|0|||
161082059|NCT02626455|581688476|FG004|Overall Study|Progressive disease - radiological progression|0|||
161082060|NCT02626455|581688477|FG005|Overall Study|Progressive disease - radiological progression|11|||
161082061|NCT02626455|581688478|FG006|Overall Study|Progressive disease - radiological progression|22|||
161082062|NCT02626455|581688472|FG000|Overall Study|Progressive disease - clinical progression|0|||
161082063|NCT02626455|581688473|FG001|Overall Study|Progressive disease - clinical progression|0|||
161082064|NCT02626455|581688474|FG002|Overall Study|Progressive disease - clinical progression|0|||
161082065|NCT02626455|581688475|FG003|Overall Study|Progressive disease - clinical progression|0|||
161082066|NCT02626455|581688476|FG004|Overall Study|Progressive disease - clinical progression|0|||
161082067|NCT02626455|581688477|FG005|Overall Study|Progressive disease - clinical progression|1|||
161082068|NCT02626455|581688478|FG006|Overall Study|Progressive disease - clinical progression|2|||
161082069|NCT02626455|581688472|FG000|Overall Study|Lost to Follow-up|0|||
161082070|NCT02626455|581688473|FG001|Overall Study|Lost to Follow-up|0|||
161082071|NCT02626455|581688474|FG002|Overall Study|Lost to Follow-up|0|||
161082072|NCT02626455|581688475|FG003|Overall Study|Lost to Follow-up|0|||
161082073|NCT02626455|581688476|FG004|Overall Study|Lost to Follow-up|0|||
161346900|NCT00690898|582654680|FG000|SCREENING|Screen failure|18|||
161346901|NCT00690898|582654680|FG000|TREATMENT|Adverse Event|3|||
161346902|NCT00690898|582654680|FG000|TREATMENT|Lack of Efficacy|18|||
161082074|NCT02626455|581688477|FG005|Overall Study|Lost to Follow-up|1|||
161082075|NCT02626455|581688478|FG006|Overall Study|Lost to Follow-up|0|||
161082076|NCT02626455|581688472|FG000|Overall Study|AE not associated with clinical disease progression|1|||
161082077|NCT02626455|581688473|FG001|Overall Study|AE not associated with clinical disease progression|1|||
161082078|NCT02626455|581688474|FG002|Overall Study|AE not associated with clinical disease progression|0|||
161082079|NCT02626455|581688475|FG003|Overall Study|AE not associated with clinical disease progression|2|||
161082080|NCT02626455|581688476|FG004|Overall Study|AE not associated with clinical disease progression|1|||
161082081|NCT02626455|581688477|FG005|Overall Study|AE not associated with clinical disease progression|65|||
161082082|NCT02626455|581688478|FG006|Overall Study|AE not associated with clinical disease progression|21|||
161082083|NCT02626455|581688472|FG000|Overall Study|AE associated with clinical disease progression|0|||
161082084|NCT02626455|581688473|FG001|Overall Study|AE associated with clinical disease progression|0|||
161082085|NCT02626455|581688474|FG002|Overall Study|AE associated with clinical disease progression|0|||
161082086|NCT02626455|581688475|FG003|Overall Study|AE associated with clinical disease progression|0|||
161082087|NCT02626455|581688476|FG004|Overall Study|AE associated with clinical disease progression|0|||
161082088|NCT02626455|581688477|FG005|Overall Study|AE associated with clinical disease progression|1|||
161082089|NCT02626455|581688478|FG006|Overall Study|AE associated with clinical disease progression|2|||
161082090|NCT02626455|581688472|FG000|Overall Study|Study intervention never administered|0|||
161082091|NCT02626455|581688473|FG001|Overall Study|Study intervention never administered|0|||
161082092|NCT02626455|581688474|FG002|Overall Study|Study intervention never administered|0|||
161082093|NCT02626455|581688475|FG003|Overall Study|Study intervention never administered|0|||
161082094|NCT02626455|581688476|FG004|Overall Study|Study intervention never administered|0|||
161082095|NCT02626455|581688477|FG005|Overall Study|Study intervention never administered|1|||
161082096|NCT02626455|581688478|FG006|Overall Study|Study intervention never administered|3|||
161082097|NCT00151281|581688480|FG000|Overall Study|Not evaluable|3|||
161082098|NCT04349631|581688493|FG000|Overall Study|Lost to Follow-up|3|||
161082099|NCT04349631|581688493|FG000|Overall Study|Withdrawal by Subject|7|||
161082100|NCT00775463|581689860|FG000|Overall Study|Withdrawal by Subject|0|||
161082101|NCT00775463|581689861|FG001|Overall Study|Withdrawal by Subject|1|||
161082102|NCT00775463|581689860|FG000|Overall Study|Adverse Event|7|||
161082103|NCT00775463|581689861|FG001|Overall Study|Adverse Event|9|||
161082104|NCT00775463|581689860|FG000|Overall Study|Protocol Violation|2|||
161082105|NCT00775463|581689861|FG001|Overall Study|Protocol Violation|2|||
161082106|NCT00775463|581689860|FG000|Overall Study|Lost to Follow-up|1|||
161082107|NCT00775463|581689861|FG001|Overall Study|Lost to Follow-up|0|||
161082108|NCT00775463|581689860|FG000|Overall Study|Lack of Efficacy|1|||
161082109|NCT00775463|581689861|FG001|Overall Study|Lack of Efficacy|1|||
161082110|NCT04032613|581689862|FG000|Overall Study|Did not complete post-program assessment|5|||
161082111|NCT04032613|581689863|FG001|Overall Study|Did not complete post-program assessment|2|||
161082112|NCT01659853|581689864|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
161082113|NCT01659853|581689865|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
161082114|NCT01659853|581689864|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
161082115|NCT01659853|581689865|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
161082116|NCT01744392|581689869|FG000|Overall Study|Physician Decision|1|||
161082117|NCT00299494|581689870|FG000|Overall Study|Withdrawal by Subject|0|||
161082118|NCT00299494|581689871|FG001|Overall Study|Withdrawal by Subject|0|||
161082119|NCT00299494|581689872|FG002|Overall Study|Withdrawal by Subject|0|||
161082120|NCT00299494|581689873|FG003|Overall Study|Withdrawal by Subject|3|||
161082121|NCT00299494|581689874|FG004|Overall Study|Withdrawal by Subject|1|||
161082122|NCT00299494|581689875|FG005|Overall Study|Withdrawal by Subject|4|||
161082123|NCT00299494|581689870|FG000|Overall Study|Physician Decision|0|||
161082124|NCT00299494|581689871|FG001|Overall Study|Physician Decision|0|||
161082125|NCT00299494|581689872|FG002|Overall Study|Physician Decision|0|||
161082126|NCT00299494|581689873|FG003|Overall Study|Physician Decision|0|||
161082127|NCT00299494|581689874|FG004|Overall Study|Physician Decision|1|||
161082128|NCT00299494|581689875|FG005|Overall Study|Physician Decision|0|||
161082129|NCT00299494|581689870|FG000|Overall Study|Death|3|||
161082130|NCT00299494|581689871|FG001|Overall Study|Death|1|||
161082131|NCT00299494|581689872|FG002|Overall Study|Death|4|||
161082132|NCT00299494|581689873|FG003|Overall Study|Death|6|||
161082133|NCT00299494|581689874|FG004|Overall Study|Death|18|||
161082134|NCT00299494|581689875|FG005|Overall Study|Death|19|||
161082135|NCT00299494|581689870|FG000|Overall Study|Lost to Follow-up|0|||
161082136|NCT00299494|581689871|FG001|Overall Study|Lost to Follow-up|0|||
161082137|NCT00299494|581689872|FG002|Overall Study|Lost to Follow-up|0|||
161082138|NCT00299494|581689873|FG003|Overall Study|Lost to Follow-up|0|||
161082139|NCT00299494|581689874|FG004|Overall Study|Lost to Follow-up|3|||
161082140|NCT00299494|581689875|FG005|Overall Study|Lost to Follow-up|1|||
161289817|NCT00191477|582440679|FG001|Overall Study|Death, Other Cause|6|||
161289818|NCT00191477|582440678|FG000|Overall Study|Lost to Follow-up|23|||
161289819|NCT00191477|582440679|FG001|Overall Study|Lost to Follow-up|21|||
161289820|NCT00191477|582440678|FG000|Overall Study|Protocol Violation|1|||
161289821|NCT00191477|582440679|FG001|Overall Study|Protocol Violation|1|||
161289822|NCT00191477|582440678|FG000|Overall Study|Treatment Change|2|||
161289823|NCT00191477|582440679|FG001|Overall Study|Treatment Change|0|||
161082141|NCT00299494|581689870|FG000|Overall Study|Other - Unspecified|0|||
161082142|NCT00299494|581689871|FG001|Overall Study|Other - Unspecified|0|||
161082143|NCT00299494|581689872|FG002|Overall Study|Other - Unspecified|0|||
161082144|NCT00299494|581689873|FG003|Overall Study|Other - Unspecified|0|||
161082145|NCT00299494|581689874|FG004|Overall Study|Other - Unspecified|3|||
161082146|NCT00299494|581689875|FG005|Overall Study|Other - Unspecified|1|||
161082147|NCT00299494|581689870|FG000|Overall Study|Other - site closure|0|||
161082148|NCT00299494|581689871|FG001|Overall Study|Other - site closure|0|||
161082149|NCT00299494|581689872|FG002|Overall Study|Other - site closure|0|||
161082150|NCT00299494|581689873|FG003|Overall Study|Other - site closure|1|||
161082151|NCT00299494|581689874|FG004|Overall Study|Other - site closure|1|||
161082152|NCT00299494|581689875|FG005|Overall Study|Other - site closure|1|||
161082153|NCT01365481|581689884|FG000|Overall Study|Adverse Event|6|||
161289824|NCT00191477|582440678|FG000|Overall Study|Withdrawal by Subject|2|||
161082154|NCT01365481|581689885|FG001|Overall Study|Adverse Event|9|||
161082155|NCT01365481|581689886|FG002|Overall Study|Adverse Event|0|||
161082156|NCT01365481|581689887|FG003|Overall Study|Adverse Event|2|||
161082157|NCT01365481|581689884|FG000|Overall Study|Withdrawal by Subject|0|||
161082158|NCT01365481|581689885|FG001|Overall Study|Withdrawal by Subject|2|||
161082159|NCT01365481|581689886|FG002|Overall Study|Withdrawal by Subject|1|||
161082160|NCT01365481|581689887|FG003|Overall Study|Withdrawal by Subject|1|||
161082161|NCT01365481|581689884|FG000|Overall Study|Lost to Follow-up|1|||
161082162|NCT01365481|581689885|FG001|Overall Study|Lost to Follow-up|1|||
161082163|NCT01365481|581689886|FG002|Overall Study|Lost to Follow-up|2|||
161082164|NCT01365481|581689887|FG003|Overall Study|Lost to Follow-up|3|||
161082165|NCT01365481|581689884|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161082166|NCT01365481|581689885|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161082167|NCT01365481|581689886|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161082168|NCT01365481|581689887|FG003|Overall Study|Abnormal laboratory value(s)|0|||
161082169|NCT01365481|581689884|FG000|Overall Study|Administrative problems|0|||
161082170|NCT01365481|581689885|FG001|Overall Study|Administrative problems|1|||
161082171|NCT01365481|581689886|FG002|Overall Study|Administrative problems|0|||
161082172|NCT01365481|581689887|FG003|Overall Study|Administrative problems|0|||
161082173|NCT01365481|581689884|FG000|Overall Study|Protocol deviation|0|||
161082174|NCT01365481|581689885|FG001|Overall Study|Protocol deviation|1|||
161165923|NCT00264849|581984354|FG000|Overall Study|Lost to Follow-up|0|||
161165924|NCT00264849|581984355|FG001|Overall Study|Lost to Follow-up|2|||
161165925|NCT00264849|581984354|FG000|Overall Study|Death|0|||
161165926|NCT00264849|581984355|FG001|Overall Study|Death|1|||
161165927|NCT00264849|581984354|FG000|Overall Study|Administrative Problems|2|||
161165928|NCT00264849|581984355|FG001|Overall Study|Administrative Problems|0|||
161165929|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
161165930|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
161165931|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
161165932|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
161165933|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
161165934|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
161165935|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161165936|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
161165937|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
161165938|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
161165939|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161165940|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
161165941|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
161165942|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
161165943|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
161165944|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
161165945|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
161165946|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
161165947|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
161165948|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
161165949|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
161165950|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
161165951|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
161165952|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
161165953|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
161165954|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
161165955|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
161165956|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
161165957|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
161165958|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
161165959|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
161165960|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
161165961|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
161165962|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
161165963|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
161165964|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
161165965|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
161165966|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
161165967|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
161165968|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
161165969|NCT00383721|581984356|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
161165970|NCT00383721|581984357|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
161165971|NCT00383721|581984358|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
161082175|NCT01365481|581689886|FG002|Overall Study|Protocol deviation|0|||
161082176|NCT01365481|581689887|FG003|Overall Study|Protocol deviation|1|||
161082177|NCT01365481|581689884|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161082178|NCT01365481|581689885|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161082179|NCT01365481|581689886|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
161082180|NCT01365481|581689887|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
161082181|NCT00635661|581689892|FG000|Overall Study|Withdrawal by Subject|4|||
161082182|NCT00403767|581689898|FG000|Overall Study|Adverse Event|993|||
161082183|NCT00403767|581689899|FG001|Overall Study|Adverse Event|919|||
161082184|NCT00403767|581689898|FG000|Overall Study|Non-compliant with study medication|134|||
161082185|NCT00403767|581689899|FG001|Overall Study|Non-compliant with study medication|164|||
161082186|NCT00403767|581689898|FG000|Overall Study|Consent withdrawn|671|||
161082187|NCT00403767|581689899|FG001|Overall Study|Consent withdrawn|673|||
161082188|NCT00403767|581689898|FG000|Overall Study|Investigator dec./not protocol-related|191|||
161082189|NCT00403767|581689899|FG001|Overall Study|Investigator dec./not protocol-related|178|||
161082190|NCT00403767|581689898|FG000|Overall Study|Lost to Follow-up|6|||
161082191|NCT00403767|581689899|FG001|Overall Study|Lost to Follow-up|8|||
161082192|NCT00403767|581689898|FG000|Overall Study|Protocol Violation|142|||
161082193|NCT00403767|581689899|FG001|Overall Study|Protocol Violation|124|||
161082194|NCT00403767|581689898|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
161082195|NCT00403767|581689899|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
161082196|NCT00403767|581689898|FG000|Overall Study|Study terminated by sponsor|82|||
161082197|NCT00403767|581689899|FG001|Overall Study|Study terminated by sponsor|69|||
161082198|NCT00403767|581689898|FG000|Overall Study|Missing/incomplete data|1|||
161082199|NCT00403767|581689899|FG001|Overall Study|Missing/incomplete data|1|||
161082200|NCT00436605|581689900|FG000|Overall Study|Protocol Violation|3|||
161082201|NCT02416453|581689901|FG000|Overall Study|Adverse Event|0|||
161082202|NCT02416453|581689902|FG001|Overall Study|Adverse Event|0|||
161082203|NCT02416453|581689903|FG002|Overall Study|Adverse Event|0|||
161082204|NCT02416453|581689904|FG003|Overall Study|Adverse Event|2|||
161082205|NCT02416453|581689905|FG004|Overall Study|Adverse Event|0|||
161082206|NCT02416453|581689906|FG005|Overall Study|Adverse Event|1|||
161082207|NCT02416453|581689907|FG006|Overall Study|Adverse Event|0|||
161082208|NCT02416453|581689908|FG007|Overall Study|Adverse Event|0|||
161082209|NCT02416453|581689909|FG008|Overall Study|Adverse Event|0|||
161082210|NCT02416453|581689910|FG009|Overall Study|Adverse Event|0|||
161082211|NCT02416453|581689911|FG010|Overall Study|Adverse Event|0|||
161082212|NCT02416453|581689901|FG000|Overall Study|Lost to Follow-up|1|||
161082213|NCT02416453|581689902|FG001|Overall Study|Lost to Follow-up|3|||
161082214|NCT02416453|581689903|FG002|Overall Study|Lost to Follow-up|0|||
161082215|NCT02416453|581689904|FG003|Overall Study|Lost to Follow-up|8|||
161082216|NCT02416453|581689905|FG004|Overall Study|Lost to Follow-up|0|||
161082217|NCT02416453|581689906|FG005|Overall Study|Lost to Follow-up|5|||
161082218|NCT02416453|581689907|FG006|Overall Study|Lost to Follow-up|1|||
161082219|NCT02416453|581689908|FG007|Overall Study|Lost to Follow-up|3|||
161082220|NCT02416453|581689909|FG008|Overall Study|Lost to Follow-up|1|||
161082221|NCT02416453|581689910|FG009|Overall Study|Lost to Follow-up|0|||
161082222|NCT02416453|581689911|FG010|Overall Study|Lost to Follow-up|0|||
161082223|NCT02416453|581689901|FG000|Overall Study|Physician Decision|0|||
161082224|NCT02416453|581689902|FG001|Overall Study|Physician Decision|0|||
161082225|NCT02416453|581689903|FG002|Overall Study|Physician Decision|0|||
161082226|NCT02416453|581689904|FG003|Overall Study|Physician Decision|0|||
161082227|NCT02416453|581689905|FG004|Overall Study|Physician Decision|0|||
161082228|NCT02416453|581689906|FG005|Overall Study|Physician Decision|1|||
161082229|NCT02416453|581689907|FG006|Overall Study|Physician Decision|1|||
161082230|NCT02416453|581689908|FG007|Overall Study|Physician Decision|1|||
161082231|NCT02416453|581689909|FG008|Overall Study|Physician Decision|0|||
161082232|NCT02416453|581689910|FG009|Overall Study|Physician Decision|0|||
161082233|NCT02416453|581689911|FG010|Overall Study|Physician Decision|0|||
161082234|NCT02416453|581689901|FG000|Overall Study|Withdrawal by Subject|2|||
161082235|NCT02416453|581689902|FG001|Overall Study|Withdrawal by Subject|0|||
161082236|NCT02416453|581689903|FG002|Overall Study|Withdrawal by Subject|0|||
161082237|NCT02416453|581689904|FG003|Overall Study|Withdrawal by Subject|5|||
161082238|NCT02416453|581689905|FG004|Overall Study|Withdrawal by Subject|1|||
161082239|NCT02416453|581689906|FG005|Overall Study|Withdrawal by Subject|8|||
161082240|NCT02416453|581689907|FG006|Overall Study|Withdrawal by Subject|0|||
161082241|NCT02416453|581689908|FG007|Overall Study|Withdrawal by Subject|8|||
161082242|NCT02416453|581689909|FG008|Overall Study|Withdrawal by Subject|4|||
161082243|NCT02416453|581689910|FG009|Overall Study|Withdrawal by Subject|0|||
161082244|NCT02416453|581689911|FG010|Overall Study|Withdrawal by Subject|0|||
161082245|NCT02416453|581689901|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082246|NCT02416453|581689902|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082247|NCT02416453|581689903|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
161082248|NCT02416453|581689904|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082249|NCT02416453|581689905|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082250|NCT02416453|581689906|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161346903|NCT00690898|582654680|FG000|TREATMENT|Withdrawal by Subject|4|||
161082251|NCT02416453|581689907|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082252|NCT02416453|581689908|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082253|NCT02416453|581689909|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082254|NCT02416453|581689910|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082255|NCT02416453|581689911|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
161082256|NCT02416453|581689901|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082257|NCT02416453|581689902|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082258|NCT02416453|581689903|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082259|NCT02416453|581689904|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082260|NCT02416453|581689905|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082261|NCT02416453|581689906|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
161082262|NCT02416453|581689907|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082263|NCT02416453|581689908|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082264|NCT02416453|581689909|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082265|NCT02416453|581689910|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082266|NCT02416453|581689911|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
161082267|NCT01152814|581689912|FG000|Overall Study|Lost to Follow-up|2|||
161082268|NCT00992225|581689917|FG000|Overall Study|Entry Criteria Not Met|8|||
161082269|NCT00992225|581689917|FG000|Overall Study|Adverse Event|2|||
161082270|NCT03466073|581689918|FG000|Overall Study|Death|1|||
161082271|NCT03466073|581689919|FG001|Overall Study|Death|0|||
161082272|NCT03466073|581689920|FG002|Overall Study|Death|0|||
161289825|NCT00191477|582440679|FG001|Overall Study|Withdrawal by Subject|0|||
161289826|NCT00191477|582440678|FG000|Overall Study|Other|2|||
161289827|NCT00191477|582440679|FG001|Overall Study|Other|0|||
161289828|NCT00191477|582440678|FG000|Overall Study|Not Eligible|41|||
161289829|NCT00191477|582440679|FG001|Overall Study|Not Eligible|38|||
161289830|NCT00191477|582440678|FG000|Overall Study|Pathological Specimen Lost|1|||
161289831|NCT00191477|582440679|FG001|Overall Study|Pathological Specimen Lost|0|||
161289832|NCT00191477|582440678|FG000|Overall Study|Discontinued Prior to Instillation|13|||
161289833|NCT00191477|582440679|FG001|Overall Study|Discontinued Prior to Instillation|14|||
161289834|NCT02411656|582440680|FG000|Overall Study|Adverse Event|4|||
161082273|NCT03466073|581689921|FG003|Overall Study|Death|0|||
161082274|NCT03466073|581689922|FG004|Overall Study|Death|0|||
161082275|NCT03466073|581689923|FG005|Overall Study|Death|1|||
161082276|NCT00532493|581689924|FG000|Overall Study|Death|1|||
161082277|NCT00532493|581689925|FG001|Overall Study|Death|1|||
161082278|NCT00532493|581689924|FG000|Overall Study|Lost to Follow-up|10|||
161082279|NCT00532493|581689925|FG001|Overall Study|Lost to Follow-up|7|||
161082280|NCT00532493|581689924|FG000|Overall Study|Withdrawal by Subject|7|||
161082281|NCT00532493|581689925|FG001|Overall Study|Withdrawal by Subject|9|||
161289835|NCT02411656|582440680|FG000|Overall Study|Clinical Progression|33|||
161289836|NCT06481709|582440681|FG000|Overall Study|Withdrawal by Subject|0|||
161289837|NCT06481709|582440682|FG001|Overall Study|Withdrawal by Subject|0|||
161289838|NCT06481709|582440683|FG002|Overall Study|Withdrawal by Subject|2|||
161289839|NCT06481709|582440684|FG003|Overall Study|Withdrawal by Subject|0|||
161289840|NCT02224157|582440686|FG000|Overall Study|Severe non-compliance to protocol|2|||
161289841|NCT02224157|582440687|FG001|Overall Study|Severe non-compliance to protocol|2|||
161289842|NCT02224157|582440686|FG000|Overall Study|Other|13|||
161289843|NCT02224157|582440687|FG001|Overall Study|Other|10|||
161289844|NCT02224157|582440686|FG000|Overall Study|Subject decision|58|||
161289845|NCT02224157|582440687|FG001|Overall Study|Subject decision|50|||
161289846|NCT02224157|582440686|FG000|Overall Study|Prematurely closed site|4|||
161289847|NCT02224157|582440687|FG001|Overall Study|Prematurely closed site|2|||
161289848|NCT02224157|582440686|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
161289849|NCT02224157|582440687|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
161289850|NCT02224157|582440686|FG000|Overall Study|Lost to Follow-up|27|||
161082282|NCT00532493|581689924|FG000|Overall Study|Physician Decision|1|||
161082283|NCT00532493|581689925|FG001|Overall Study|Physician Decision|6|||
161082284|NCT00532493|581689924|FG000|Overall Study|Adverse Event|6|||
161082285|NCT00532493|581689925|FG001|Overall Study|Adverse Event|5|||
161082286|NCT00532493|581689924|FG000|Overall Study|Protocol Deviation|1|||
161082287|NCT00532493|581689925|FG001|Overall Study|Protocol Deviation|0|||
161082288|NCT00532493|581689924|FG000|Overall Study|Subject Moved Away|3|||
161082289|NCT00532493|581689925|FG001|Overall Study|Subject Moved Away|1|||
161082290|NCT00532493|581689924|FG000|Overall Study|Contraindicative Medication|1|||
161082291|NCT00532493|581689925|FG001|Overall Study|Contraindicative Medication|0|||
161082292|NCT02153073|581689926|FG000|Overall Study|Case Report Forms Uncollected|230|||
161082293|NCT02153073|581689926|FG000|Overall Study|Protocol Deviation|68|||
161082294|NCT03189745|581689927|FG000|Overall Study|Conflict in work schedule of participant|1|||
161289851|NCT02224157|582440687|FG001|Overall Study|Lost to Follow-up|35|||
161289852|NCT02224157|582440686|FG000|Overall Study|Death|1|||
161289853|NCT02224157|582440687|FG001|Overall Study|Death|1|||
161289854|NCT02224157|582440686|FG000|Overall Study|Adverse Event|1|||
161289855|NCT02224157|582440687|FG001|Overall Study|Adverse Event|3|||
161289856|NCT05906628|582440688|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
161289857|NCT05906628|582440689|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
161082295|NCT03189745|581689928|FG001|Overall Study|Conflict in work schedule of participant|1|||
161082296|NCT03702231|581689929|FG000|Overall Study|Withdrawal by Subject|1|||
161082297|NCT03702231|581689930|FG001|Overall Study|Withdrawal by Subject|0|||
161082298|NCT03702231|581689931|FG002|Overall Study|Withdrawal by Subject|0|||
161082299|NCT03702231|581689929|FG000|Overall Study|Protocol Violation|0|||
161082300|NCT03702231|581689930|FG001|Overall Study|Protocol Violation|0|||
161082301|NCT03702231|581689931|FG002|Overall Study|Protocol Violation|1|||
161082302|NCT03702231|581689929|FG000|Overall Study|Change in CLL Treatment|0|||
161289858|NCT05906628|582440688|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
161289859|NCT05906628|582440689|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
161289860|NCT05906628|582440688|FG000|16-Week DBVC Period|Protocol Violation|4|||
161289861|NCT05906628|582440689|FG001|16-Week DBVC Period|Protocol Violation|2|||
161289862|NCT05906628|582440688|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
161289863|NCT05906628|582440689|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
161289864|NCT05906628|582440688|FG000|16-Week OLE Period|Death|1|||
161289865|NCT05906628|582440689|FG001|16-Week OLE Period|Death|0|||
161289866|NCT05906628|582440688|FG000|16-Week OLE Period|Lost to Follow-up|1|||
161289867|NCT05906628|582440689|FG001|16-Week OLE Period|Lost to Follow-up|1|||
161289868|NCT05906628|582440688|FG000|16-Week OLE Period|Protocol Violation|0|||
161289869|NCT05906628|582440689|FG001|16-Week OLE Period|Protocol Violation|1|||
161289870|NCT05906628|582440688|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
161289871|NCT05906628|582440689|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
161289872|NCT01108718|582440690|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
161289873|NCT01108718|582440691|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
161289874|NCT02443740|582440692|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289875|NCT02443740|582440693|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289876|NCT02443740|582440694|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289877|NCT02443740|582440695|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289878|NCT02443740|582440696|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289879|NCT02443740|582440697|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
161289880|NCT02443740|582440698|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289881|NCT02443740|582440699|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289882|NCT02443740|582440700|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289883|NCT02443740|582440701|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289884|NCT02443740|582440702|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
161289885|NCT02443740|582440692|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
161289886|NCT02443740|582440693|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289887|NCT02443740|582440694|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289888|NCT02443740|582440695|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289889|NCT02443740|582440696|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289890|NCT02443740|582440697|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289891|NCT02443740|582440698|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
161289892|NCT02443740|582440699|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289893|NCT02443740|582440700|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289894|NCT02443740|582440701|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289895|NCT02443740|582440702|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
161289896|NCT02443740|582440692|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289897|NCT02443740|582440693|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289898|NCT02443740|582440694|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289899|NCT02443740|582440695|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289900|NCT02443740|582440696|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289901|NCT02443740|582440697|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
161289902|NCT02443740|582440698|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289903|NCT02443740|582440699|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289904|NCT02443740|582440700|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161082303|NCT03702231|581689930|FG001|Overall Study|Change in CLL Treatment|0|||
161082304|NCT03702231|581689931|FG002|Overall Study|Change in CLL Treatment|1|||
161082305|NCT03702231|581689929|FG000|Overall Study|COVID Pandemic|1|||
161082306|NCT03702231|581689930|FG001|Overall Study|COVID Pandemic|4|||
161082307|NCT03702231|581689931|FG002|Overall Study|COVID Pandemic|1|||
161289905|NCT02443740|582440701|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289906|NCT02443740|582440702|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
161289907|NCT05373108|582440703|FG000|Overall Study|Withdrawal by Subject|2|||
161289908|NCT02892331|582440704|FG000|Overall Study|Withdrawal by Subject|0|||
161289909|NCT02892331|582440705|FG001|Overall Study|Withdrawal by Subject|1|||
161289910|NCT02892331|582440706|FG002|Overall Study|Withdrawal by Subject|1|||
161289911|NCT02892331|582440704|FG000|Overall Study|Sick family member|0|||
161289912|NCT02892331|582440705|FG001|Overall Study|Sick family member|0|||
161289913|NCT02892331|582440706|FG002|Overall Study|Sick family member|1|||
161289914|NCT02892331|582440704|FG000|Overall Study|Corona virus pandemic|1|||
161289915|NCT02892331|582440705|FG001|Overall Study|Corona virus pandemic|0|||
161289916|NCT02892331|582440706|FG002|Overall Study|Corona virus pandemic|1|||
161346904|NCT00690898|582654680|FG000|TREATMENT|Other (not otherwise specified)|1|||
161346905|NCT00356590|582654681|FG000|Overall Study|Adverse Event|54|||
161346906|NCT00356590|582654681|FG000|Overall Study|Death|10|||
161346907|NCT00356590|582654681|FG000|Overall Study|Lost to Follow-up|35|||
161346908|NCT00356590|582654681|FG000|Overall Study|Physician Decision|46|||
161346909|NCT00356590|582654681|FG000|Overall Study|Withdrawal by Subject|41|||
161346910|NCT00356590|582654681|FG000|Overall Study|Completed month 12 only|2|||
161346911|NCT00356590|582654681|FG000|Overall Study|Protocol issues|6|||
161346912|NCT00356590|582654681|FG000|Overall Study|Response status|28|||
161346913|NCT00356590|582654681|FG000|Overall Study|Other|52|||
161346914|NCT00712920|582654682|FG000|Overall Study|Adverse Event|3|||
161346915|NCT00712920|582654683|FG001|Overall Study|Adverse Event|4|||
161346916|NCT00712920|582654684|FG002|Overall Study|Adverse Event|7|||
161346917|NCT00712920|582654682|FG000|Overall Study|Withdrawal by Subject|4|||
161346918|NCT00712920|582654683|FG001|Overall Study|Withdrawal by Subject|2|||
161346919|NCT00712920|582654684|FG002|Overall Study|Withdrawal by Subject|1|||
161346920|NCT00712920|582654682|FG000|Overall Study|Lost to Follow-up|1|||
161346921|NCT00712920|582654683|FG001|Overall Study|Lost to Follow-up|4|||
161346922|NCT00712920|582654684|FG002|Overall Study|Lost to Follow-up|0|||
161346923|NCT00712920|582654682|FG000|Overall Study|Lack of Efficacy|1|||
161346924|NCT00712920|582654683|FG001|Overall Study|Lack of Efficacy|0|||
161346925|NCT00712920|582654684|FG002|Overall Study|Lack of Efficacy|1|||
161346926|NCT00712920|582654682|FG000|Overall Study|Other|5|||
161346927|NCT00712920|582654683|FG001|Overall Study|Other|7|||
161346928|NCT00712920|582654684|FG002|Overall Study|Other|3|||
161346929|NCT00712920|582654682|FG000|Overall Study|Non-compliance|3|||
161346930|NCT00712920|582654683|FG001|Overall Study|Non-compliance|0|||
161346931|NCT00712920|582654684|FG002|Overall Study|Non-compliance|0|||
161346932|NCT02550795|582654687|FG000|Overall Study|Physician Decision|0|||
161346933|NCT02550795|582654688|FG001|Overall Study|Physician Decision|1|||
161346934|NCT02550795|582654689|FG002|Overall Study|Physician Decision|0|||
161346935|NCT03240874|582654692|FG000|Overall Study|Lost to Follow-up|0|||
161346936|NCT03240874|582654693|FG001|Overall Study|Lost to Follow-up|2|||
161346937|NCT03240874|582654694|FG002|Overall Study|Lost to Follow-up|4|||
161346938|NCT03240874|582654695|FG003|Overall Study|Lost to Follow-up|1|||
161346939|NCT05567172|582654699|FG000|Overall Study|Death|3|||
161346940|NCT03168672|582654702|FG000|Overall Study|Withdrawal by Subject|13|||
161346941|NCT03168672|582654702|FG000|Overall Study|Death|3|||
161346942|NCT03168672|582654702|FG000|Overall Study|Investigator's Decision|137|||
161346943|NCT03168672|582654702|FG000|Overall Study|Adverse Event|1|||
161346944|NCT03168672|582654702|FG000|Overall Study|Other|2|||
161346945|NCT03168672|582654702|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
161346946|NCT05317546|582654703|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
161346947|NCT05317546|582654704|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
161346948|NCT04707469|582654705|FG000|Overall Study|Site closure|0|||
161346949|NCT04707469|582654706|FG001|Overall Study|Site closure|2|||
161346950|NCT04707469|582654707|FG002|Overall Study|Site closure|0|||
161346951|NCT04707469|582654705|FG000|Overall Study|Physician Decision|2|||
161346952|NCT04707469|582654706|FG001|Overall Study|Physician Decision|2|||
161346953|NCT04707469|582654707|FG002|Overall Study|Physician Decision|2|||
161346954|NCT04707469|582654705|FG000|Overall Study|Death|1|||
161346955|NCT04707469|582654706|FG001|Overall Study|Death|6|||
161346956|NCT04707469|582654707|FG002|Overall Study|Death|2|||
161346957|NCT04707469|582654705|FG000|Overall Study|Lost to Follow-up|9|||
161346958|NCT04707469|582654706|FG001|Overall Study|Lost to Follow-up|19|||
161346959|NCT04707469|582654707|FG002|Overall Study|Lost to Follow-up|14|||
161346960|NCT04707469|582654705|FG000|Overall Study|Withdrawal by Subject|17|||
161346961|NCT04707469|582654706|FG001|Overall Study|Withdrawal by Subject|16|||
161346962|NCT04707469|582654707|FG002|Overall Study|Withdrawal by Subject|12|||
161346963|NCT04635423|582654720|FG000|Overall Study|Ongoing|493|||
161082308|NCT03702231|581689929|FG000|Overall Study|Non-compliance|0|||
161346964|NCT04635423|582654721|FG001|Overall Study|Ongoing|501|||
161346965|NCT04635423|582654720|FG000|Overall Study|Withdrawal by Subject|36|||
161346966|NCT04635423|582654721|FG001|Overall Study|Withdrawal by Subject|29|||
161346967|NCT05556057|582654722|FG000|Overall Study|Lost to Follow-up|5|||
161346968|NCT05556057|582654723|FG001|Overall Study|Lost to Follow-up|4|||
161346969|NCT05556057|582654722|FG000|Overall Study|Withdrawal by Subject|0|||
161346970|NCT05556057|582654723|FG001|Overall Study|Withdrawal by Subject|2|||
161346971|NCT04364646|582654731|FG000|Overall Study|Lost to Follow-up|1|||
161346972|NCT04364646|582654732|FG001|Overall Study|Lost to Follow-up|0|||
161346973|NCT04364646|582654731|FG000|Overall Study|Withdrawal by Subject|7|||
161346974|NCT04364646|582654732|FG001|Overall Study|Withdrawal by Subject|14|||
161346975|NCT04364646|582654731|FG000|Overall Study|Protocol Violation|4|||
161346976|NCT04364646|582654732|FG001|Overall Study|Protocol Violation|5|||
161346977|NCT02555878|582654746|FG000|Overall Study|Lost to Follow-up|2|||
161346978|NCT02555878|582654747|FG001|Overall Study|Lost to Follow-up|3|||
161346979|NCT02555878|582654746|FG000|Overall Study|Withdrawal by Subject|48|||
161346980|NCT02555878|582654747|FG001|Overall Study|Withdrawal by Subject|48|||
161346981|NCT02555878|582654746|FG000|Overall Study|Adverse Event|12|||
161346982|NCT02555878|582654747|FG001|Overall Study|Adverse Event|8|||
161082309|NCT03702231|581689930|FG001|Overall Study|Non-compliance|0|||
161082310|NCT03702231|581689931|FG002|Overall Study|Non-compliance|1|||
161082311|NCT01276379|581689932|FG000|Overall Study|Screening failure|40|||
161082312|NCT01278173|581689933|FG000|Overall Study|Lack of Efficacy|13|||
161082313|NCT01278173|581689933|FG000|Overall Study|Adverse Event|8|||
161082314|NCT01278173|581689933|FG000|Overall Study|Administrative or other reason|4|||
161082315|NCT01278173|581689933|FG000|Overall Study|Protocol Violation|1|||
161082316|NCT01278173|581689933|FG000|Overall Study|Withdrawal by Subject|1|||
161082317|NCT02729831|581689935|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
161082318|NCT02729831|581689936|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
161082319|NCT02729831|581689937|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
161082320|NCT02729831|581689938|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
161082321|NCT02729831|581689935|FG000|1 Week Post-visit|Lost to Follow-up|43|||
161082322|NCT02729831|581689936|FG001|1 Week Post-visit|Lost to Follow-up|40|||
161082323|NCT02729831|581689937|FG002|1 Week Post-visit|Lost to Follow-up|38|||
161082324|NCT02729831|581689938|FG003|1 Week Post-visit|Lost to Follow-up|36|||
161082325|NCT02729831|581689935|FG000|6 Month Follow-up|Lost to Follow-up|54|||
161082326|NCT02729831|581689936|FG001|6 Month Follow-up|Lost to Follow-up|51|||
161082327|NCT02729831|581689937|FG002|6 Month Follow-up|Lost to Follow-up|48|||
161082328|NCT02729831|581689938|FG003|6 Month Follow-up|Lost to Follow-up|42|||
161082329|NCT02729831|581689935|FG000|6 Month Follow-up|Death|1|||
161082330|NCT02729831|581689936|FG001|6 Month Follow-up|Death|3|||
161082331|NCT02729831|581689937|FG002|6 Month Follow-up|Death|0|||
161082332|NCT02729831|581689938|FG003|6 Month Follow-up|Death|1|||
161082333|NCT00864253|581689939|FG000|Overall Study|Adverse Event|56|||
161082334|NCT00864253|581689940|FG001|Overall Study|Adverse Event|11|||
161082335|NCT00864253|581689939|FG000|Overall Study|Unrelated Adverse Event|3|||
161082336|NCT00864253|581689940|FG001|Overall Study|Unrelated Adverse Event|1|||
161082337|NCT00864253|581689939|FG000|Overall Study|Physician Decision|11|||
161082338|NCT00864253|581689940|FG001|Overall Study|Physician Decision|15|||
161082339|NCT00864253|581689939|FG000|Overall Study|Protocol Violation|0|||
161082340|NCT00864253|581689940|FG001|Overall Study|Protocol Violation|2|||
161082341|NCT00864253|581689939|FG000|Overall Study|Lost to Follow-up|1|||
161082342|NCT00864253|581689940|FG001|Overall Study|Lost to Follow-up|1|||
161082343|NCT00864253|581689939|FG000|Overall Study|Withdrawal by Subject|18|||
161082344|NCT00864253|581689940|FG001|Overall Study|Withdrawal by Subject|18|||
161082345|NCT00864253|581689939|FG000|Overall Study|Death|1|||
161082346|NCT00864253|581689940|FG001|Overall Study|Death|0|||
161082347|NCT00864253|581689939|FG000|Overall Study|Ongoing|2|||
161082348|NCT00864253|581689940|FG001|Overall Study|Ongoing|3|||
161082349|NCT00864253|581689939|FG000|Overall Study|Untreated|7|||
161082350|NCT00864253|581689940|FG001|Overall Study|Untreated|7|||
161082351|NCT01111240|581689942|FG000|Overall Study|Adverse Event|190|||
161082352|NCT01111240|581689942|FG000|Overall Study|Lack of Efficacy|545|||
161082353|NCT01111240|581689942|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
161082354|NCT01111240|581689942|FG000|Overall Study|Other|312|||
161082355|NCT01747551|581689944|FG000|Overall Study|Progressive Disease|24|||
161082356|NCT01747551|581689945|FG001|Overall Study|Progressive Disease|17|||
161082357|NCT01747551|581689944|FG000|Overall Study|Death|3|||
161082358|NCT01747551|581689945|FG001|Overall Study|Death|1|||
161082359|NCT01747551|581689944|FG000|Overall Study|Adverse Event|7|||
161082360|NCT01747551|581689945|FG001|Overall Study|Adverse Event|1|||
161082361|NCT01747551|581689944|FG000|Overall Study|Prolonged Treatment Delay|2|||
161082362|NCT01747551|581689945|FG001|Overall Study|Prolonged Treatment Delay|0|||
161082363|NCT01747551|581689944|FG000|Overall Study|Withdrawal by Subject|3|||
161082364|NCT01747551|581689945|FG001|Overall Study|Withdrawal by Subject|1|||
161082365|NCT01747551|581689944|FG000|Overall Study|Physician Decision|2|||
161082366|NCT01747551|581689945|FG001|Overall Study|Physician Decision|1|||
161082367|NCT01747551|581689944|FG000|Overall Study|Other|2|||
161082368|NCT01747551|581689945|FG001|Overall Study|Other|0|||
161082369|NCT01609062|581689946|FG000|Extension Phase|Terminated by Sponsor|14|||
161082370|NCT01609062|581689947|FG001|Extension Phase|Terminated by Sponsor|9|||
161082371|NCT01609062|581689946|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
161082372|NCT01609062|581689947|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
161082373|NCT01609062|581689946|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
161082374|NCT01609062|581689947|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
161082375|NCT00680992|581689948|FG000|Overall Study|Complete Resection (as per protocol)|25|||
161082376|NCT00680992|581689949|FG001|Overall Study|Complete Resection (as per protocol)|121|||
161082377|NCT00680992|581689950|FG002|Overall Study|Complete Resection (as per protocol)|0|||
161082378|NCT00680992|581689948|FG000|Overall Study|Administrative Decision|83|||
161082379|NCT00680992|581689949|FG001|Overall Study|Administrative Decision|42|||
161082380|NCT00680992|581689950|FG002|Overall Study|Administrative Decision|5|||
161082381|NCT00680992|581689948|FG000|Overall Study|End of Trial|32|||
161082382|NCT00680992|581689949|FG001|Overall Study|End of Trial|12|||
161082383|NCT00680992|581689950|FG002|Overall Study|End of Trial|3|||
161082384|NCT00680992|581689948|FG000|Overall Study|Withdrawal by Subject|33|||
161082385|NCT00680992|581689949|FG001|Overall Study|Withdrawal by Subject|11|||
161082386|NCT00680992|581689950|FG002|Overall Study|Withdrawal by Subject|1|||
161082387|NCT00680992|581689948|FG000|Overall Study|Adverse Event|21|||
161082388|NCT00680992|581689949|FG001|Overall Study|Adverse Event|19|||
161082389|NCT00680992|581689950|FG002|Overall Study|Adverse Event|1|||
161082390|NCT00680992|581689948|FG000|Overall Study|Other|19|||
161082391|NCT00680992|581689949|FG001|Overall Study|Other|14|||
161082392|NCT00680992|581689950|FG002|Overall Study|Other|1|||
161082393|NCT00680992|581689948|FG000|Overall Study|Disease Progression|21|||
161082394|NCT00680992|581689949|FG001|Overall Study|Disease Progression|9|||
161082395|NCT00680992|581689950|FG002|Overall Study|Disease Progression|0|||
161082396|NCT00680992|581689948|FG000|Overall Study|Lost to Follow-up|12|||
161082397|NCT00680992|581689949|FG001|Overall Study|Lost to Follow-up|14|||
161082398|NCT00680992|581689950|FG002|Overall Study|Lost to Follow-up|0|||
161082399|NCT00680992|581689948|FG000|Overall Study|Noncompliance|4|||
161082400|NCT00680992|581689949|FG001|Overall Study|Noncompliance|6|||
161082401|NCT00680992|581689950|FG002|Overall Study|Noncompliance|0|||
161082402|NCT00680992|581689948|FG000|Overall Study|Requirement for Alternative Therapy|8|||
161082403|NCT00680992|581689949|FG001|Overall Study|Requirement for Alternative Therapy|2|||
161082404|NCT00680992|581689950|FG002|Overall Study|Requirement for Alternative Therapy|0|||
161082405|NCT00680992|581689948|FG000|Overall Study|Pregnancy|5|||
161082406|NCT00680992|581689949|FG001|Overall Study|Pregnancy|0|||
161082407|NCT00680992|581689950|FG002|Overall Study|Pregnancy|1|||
161082408|NCT00680992|581689948|FG000|Overall Study|Death|5|||
161082409|NCT00680992|581689949|FG001|Overall Study|Death|1|||
161082410|NCT00680992|581689950|FG002|Overall Study|Death|0|||
161082411|NCT00680992|581689948|FG000|Overall Study|Ineligibility Determined|0|||
161082412|NCT00680992|581689949|FG001|Overall Study|Ineligibility Determined|1|||
161082413|NCT00680992|581689950|FG002|Overall Study|Ineligibility Determined|0|||
161082414|NCT03842358|581689955|FG000|Overall Study|Poor DOT probe contact with breast|2|||
161082415|NCT03842358|581689955|FG000|Overall Study|DOT system problem|1|||
161082416|NCT03842358|581689955|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
161082417|NCT03842358|581689955|FG000|Overall Study|No biopsy after physician review|4|||
161082418|NCT03842358|581689955|FG000|Overall Study|Patient withdrew|2|||
161082419|NCT06665919|581689956|FG000|Overall Study|Withdrawal by Subject|4|||
161082420|NCT06665919|581689957|FG001|Overall Study|Withdrawal by Subject|4|||
161082421|NCT06665919|581689958|FG002|Overall Study|Withdrawal by Subject|4|||
161082422|NCT06665919|581689956|FG000|Overall Study|Non-compliance to Treatment|4|||
161082423|NCT06665919|581689957|FG001|Overall Study|Non-compliance to Treatment|1|||
161082424|NCT06665919|581689958|FG002|Overall Study|Non-compliance to Treatment|6|||
161082425|NCT06665919|581689956|FG000|Overall Study|Lost to Follow-up|3|||
161082426|NCT06665919|581689957|FG001|Overall Study|Lost to Follow-up|0|||
161082427|NCT06665919|581689958|FG002|Overall Study|Lost to Follow-up|2|||
161082428|NCT06665919|581689956|FG000|Overall Study|Physician Decision|4|||
161082429|NCT06665919|581689957|FG001|Overall Study|Physician Decision|0|||
161082430|NCT06665919|581689958|FG002|Overall Study|Physician Decision|1|||
161082431|NCT05148962|581689959|FG000|Overall Study|Withdrawal by Subject|1|||
161082432|NCT05148962|581689960|FG001|Overall Study|Withdrawal by Subject|1|||
161082433|NCT05148962|581689961|FG002|Overall Study|Withdrawal by Subject|0|||
161082434|NCT05148962|581689962|FG003|Overall Study|Withdrawal by Subject|1|||
161082435|NCT05148962|581689963|FG004|Overall Study|Withdrawal by Subject|0|||
161082436|NCT05148962|581689959|FG000|Overall Study|Participant was early terminated per protocol|0|||
161082437|NCT05148962|581689960|FG001|Overall Study|Participant was early terminated per protocol|0|||
161082438|NCT05148962|581689961|FG002|Overall Study|Participant was early terminated per protocol|3|||
161082439|NCT05148962|581689962|FG003|Overall Study|Participant was early terminated per protocol|5|||
161082440|NCT05148962|581689963|FG004|Overall Study|Participant was early terminated per protocol|2|||
161082441|NCT05148962|581689959|FG000|Overall Study|Miscellaneous|0|||
161082442|NCT05148962|581689960|FG001|Overall Study|Miscellaneous|0|||
161082443|NCT05148962|581689961|FG002|Overall Study|Miscellaneous|0|||
161082444|NCT05148962|581689962|FG003|Overall Study|Miscellaneous|1|||
161082445|NCT05148962|581689963|FG004|Overall Study|Miscellaneous|0|||
161082446|NCT01200290|581689964|FG000|Treatment Period|Adverse Event|1|||
161082447|NCT01200290|581689964|FG000|Post-Treatment Follow-Up Period|Death|2|||
161082448|NCT01525238|581689965|FG000|Overall Study|Withdrawal by Subject|1|||
161082449|NCT01525238|581689966|FG001|Overall Study|Withdrawal by Subject|0|||
161082450|NCT01525238|581689967|FG002|Overall Study|Withdrawal by Subject|0|||
161082451|NCT00607724|581689968|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
161082452|NCT00607724|581689969|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
161082453|NCT00607724|581689970|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
161082454|NCT00607724|581689971|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161082455|NCT00607724|581689972|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161082456|NCT00607724|581689973|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161082457|NCT00607724|581689974|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
161082458|NCT00607724|581689968|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
161082459|NCT00607724|581689969|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
161082460|NCT00607724|581689970|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
161165972|NCT00383721|581984359|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
161165973|NCT00383721|581984360|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
161165974|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
161082461|NCT00607724|581689971|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
161082462|NCT00607724|581689972|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
161082463|NCT00607724|581689973|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
161082464|NCT00607724|581689974|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
161082465|NCT00607724|581689968|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
161082466|NCT00607724|581689969|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
161082467|NCT00607724|581689970|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
161082468|NCT00607724|581689971|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
161082469|NCT00607724|581689972|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
161082470|NCT00607724|581689973|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
161082471|NCT00607724|581689974|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
161082472|NCT00607724|581689968|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
161082473|NCT00607724|581689969|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
161082474|NCT00607724|581689970|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
161082475|NCT00607724|581689971|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
161082476|NCT00607724|581689972|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
161082477|NCT00607724|581689973|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
161082478|NCT00607724|581689974|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
161082479|NCT00607724|581689968|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161082480|NCT00607724|581689969|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161082481|NCT00607724|581689970|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161082482|NCT00607724|581689971|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
161082483|NCT00607724|581689972|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161082484|NCT00607724|581689973|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161082485|NCT00607724|581689974|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
161082486|NCT01133418|581689975|FG000|Overall Study|Lost to Follow-up|5|||
161082487|NCT01133418|581689976|FG001|Overall Study|Lost to Follow-up|6|||
161082488|NCT04150068|581689982|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
161082489|NCT04150068|581689983|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
161082490|NCT04150068|581689984|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
161082491|NCT04150068|581689982|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
161082492|NCT04150068|581689983|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
161082493|NCT04150068|581689984|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
161082494|NCT05316701|581689985|FG000|Overall Study|Adverse Event|0|||
161082495|NCT05316701|581689986|FG001|Overall Study|Adverse Event|1|||
161082496|NCT05316701|581689985|FG000|Overall Study|Death|3|||
161082497|NCT05316701|581689986|FG001|Overall Study|Death|9|||
161082498|NCT05316701|581689985|FG000|Overall Study|Lost to Follow-up|1|||
161082499|NCT05316701|581689986|FG001|Overall Study|Lost to Follow-up|0|||
161082500|NCT05316701|581689985|FG000|Overall Study|Physician Decision|1|||
161082501|NCT05316701|581689986|FG001|Overall Study|Physician Decision|4|||
161082502|NCT05316701|581689985|FG000|Overall Study|Withdrawal by Subject|3|||
161082503|NCT05316701|581689986|FG001|Overall Study|Withdrawal by Subject|5|||
161082504|NCT05316701|581689985|FG000|Overall Study|Progression/Relapse|14|||
161082505|NCT05316701|581689986|FG001|Overall Study|Progression/Relapse|9|||
161082506|NCT05316701|581689985|FG000|Overall Study|Received Standard of Care|1|||
161082507|NCT05316701|581689986|FG001|Overall Study|Received Standard of Care|0|||
161082508|NCT05316701|581689985|FG000|Overall Study|Ongoing|70|||
161082509|NCT05316701|581689986|FG001|Overall Study|Ongoing|64|||
161082510|NCT04679935|581689987|FG000|Overall Study|Death|0|||
161082511|NCT04679935|581689988|FG001|Overall Study|Death|1|||
161082512|NCT02980731|581691613|FG000|Overall Study|Death|63|||
161082513|NCT02980731|581691613|FG000|Overall Study|Withdrawal by Subject|6|||
161082514|NCT02980731|581691613|FG000|Overall Study|Lost to Follow-up|5|||
161082515|NCT02980731|581691613|FG000|Overall Study|Study terminated by Sponsor|4|||
161082516|NCT02980731|581691613|FG000|Overall Study|Completed survival follow-up period|65|||
161082517|NCT02980731|581691613|FG000|Overall Study|COVID-19 infection|1|||
161082518|NCT02980731|581691613|FG000|Overall Study|Other, not specified|66|||
161082519|NCT03037931|581691614|FG000|Overall Study|Death|354|||
161082520|NCT03037931|581691615|FG001|Overall Study|Death|367|||
161082521|NCT03037931|581691614|FG000|Overall Study|Lost to Follow-up|7|||
161165975|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
161165976|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
161165977|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
161082522|NCT03037931|581691615|FG001|Overall Study|Lost to Follow-up|4|||
161082523|NCT03037931|581691614|FG000|Overall Study|Withdrawal by Subject|48|||
161082524|NCT03037931|581691615|FG001|Overall Study|Withdrawal by Subject|41|||
161082525|NCT01789567|581691616|FG000|Overall Study|Death|6|||
161082526|NCT01850446|581691617|FG000|Overall Study|Lack of Efficacy|1|||
161082527|NCT01850446|581691618|FG001|Overall Study|Lack of Efficacy|0|||
161082528|NCT01850446|581691617|FG000|Overall Study|Withdrawal by Subject|4|||
161165978|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
161165979|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161165980|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
161165981|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
161165982|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
161165983|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
161165984|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
161165985|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161165986|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161165987|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
161165988|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
161165989|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
161165990|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
161165991|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
161165992|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
161165993|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
161165994|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161289917|NCT02892331|582440704|FG000|Overall Study|Lost to Follow-up|1|||
161289918|NCT02892331|582440705|FG001|Overall Study|Lost to Follow-up|0|||
161165995|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161165996|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161165997|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
161165998|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
161165999|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
161166000|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161166001|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
161166002|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
161166003|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
161166004|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161166005|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161166006|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161166007|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
161166008|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
161166009|NCT00383721|581984356|FG000|26-Week Treatment Safety Extension|Administrative|1|||
161166010|NCT00383721|581984357|FG001|26-Week Treatment Safety Extension|Administrative|2|||
161082529|NCT01850446|581691618|FG001|Overall Study|Withdrawal by Subject|0|||
161082530|NCT01850446|581691617|FG000|Overall Study|Protocol Violation|0|||
161082531|NCT01850446|581691618|FG001|Overall Study|Protocol Violation|2|||
161082532|NCT00591721|581691619|FG000|Overall Study|Withdrawal by Subject|10|||
161082533|NCT00591721|581691620|FG001|Overall Study|Withdrawal by Subject|10|||
161082534|NCT00591721|581691619|FG000|Overall Study|Lost to Follow-up|1|||
161082535|NCT00591721|581691620|FG001|Overall Study|Lost to Follow-up|4|||
161166011|NCT00383721|581984358|FG002|26-Week Treatment Safety Extension|Administrative|3|||
161289919|NCT02892331|582440706|FG002|Overall Study|Lost to Follow-up|1|||
161289920|NCT02892331|582440704|FG000|Overall Study|Blood pressure was too elevated|0|||
161289921|NCT02892331|582440705|FG001|Overall Study|Blood pressure was too elevated|1|||
161289922|NCT02892331|582440706|FG002|Overall Study|Blood pressure was too elevated|0|||
161289923|NCT02892331|582440704|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
161346983|NCT02555878|582654746|FG000|Overall Study|Death|74|||
161082536|NCT00591721|581691619|FG000|Overall Study|Intervention not received|10|||
161082537|NCT00591721|581691620|FG001|Overall Study|Intervention not received|8|||
161082538|NCT03527550|581691627|FG000|Overall Study|Lost to Follow-up|4|||
161082539|NCT03527550|581691628|FG001|Overall Study|Lost to Follow-up|2|||
161082540|NCT03527550|581691627|FG000|Overall Study|Withdrawal by Subject|4|||
161082541|NCT03527550|581691628|FG001|Overall Study|Withdrawal by Subject|1|||
161082542|NCT03527550|581691627|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
161082543|NCT03527550|581691628|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
161082544|NCT02683876|581691630|FG000|Overall Study|samples damaged during shipping|2|||
161082545|NCT02683876|581691631|FG001|Overall Study|samples damaged during shipping|0|||
161082546|NCT01232738|581691632|FG000|Overall Study|Death|3|||
161082547|NCT01232738|581691632|FG000|Overall Study|Physician Decision|2|||
161082548|NCT01232738|581691632|FG000|Overall Study|Lost to Follow-up|1|||
161082549|NCT01232738|581691632|FG000|Overall Study|Withdrawal by Subject|2|||
161082550|NCT01232738|581691632|FG000|Overall Study|Adverse Event|5|||
161082551|NCT00859222|581691637|FG000|Overall Study|Adverse Event|2|||
161082552|NCT00859222|581691638|FG001|Overall Study|Adverse Event|3|||
161082553|NCT00859222|581691639|FG002|Overall Study|Adverse Event|6|||
161082554|NCT00859222|581691640|FG003|Overall Study|Adverse Event|24|||
161082555|NCT00859222|581691641|FG004|Overall Study|Adverse Event|15|||
161082556|NCT00859222|581691637|FG000|Overall Study|DLT|1|||
161082557|NCT00859222|581691638|FG001|Overall Study|DLT|0|||
161082558|NCT00859222|581691639|FG002|Overall Study|DLT|0|||
161082559|NCT00859222|581691640|FG003|Overall Study|DLT|0|||
161082560|NCT00859222|581691641|FG004|Overall Study|DLT|0|||
161082561|NCT00488475|581691642|FG000|Overall Study|Other|1754|||
161082562|NCT00400725|581691653|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
161166012|NCT00383721|581984359|FG003|26-Week Treatment Safety Extension|Administrative|1|||
161166013|NCT00383721|581984360|FG004|26-Week Treatment Safety Extension|Administrative|0|||
161166014|NCT05584202|581984365|FG000|Overall Study|Withdrawal of Consent|3|||
161166015|NCT05584202|581984366|FG001|Overall Study|Withdrawal of Consent|2|||
161166016|NCT05584202|581984365|FG000|Overall Study|Lost to Follow-up|2|||
161166017|NCT05584202|581984366|FG001|Overall Study|Lost to Follow-up|1|||
161166018|NCT05584202|581984365|FG000|Overall Study|Death|0|||
161166019|NCT05584202|581984366|FG001|Overall Study|Death|1|||
161166020|NCT00646113|581985776|FG000|Overall Study|Lost to Follow-up|5|||
161166021|NCT00646113|581985776|FG000|Overall Study|Adverse Event|3|||
161166022|NCT00603733|581985779|FG000|Active Phase ITT|Adverse Event|8|||
161166023|NCT00603733|581985780|FG001|Active Phase ITT|Adverse Event|7|||
161166024|NCT00603733|581985779|FG000|Active Phase ITT|Withdrawal by Subject|0|||
161166025|NCT00603733|581985780|FG001|Active Phase ITT|Withdrawal by Subject|3|||
161166026|NCT00603733|581985779|FG000|Active Phase ITT|Lost to Follow-up|0|||
161166027|NCT00603733|581985780|FG001|Active Phase ITT|Lost to Follow-up|1|||
161166028|NCT00603733|581985779|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
161166029|NCT00603733|581985780|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
161166030|NCT00603733|581985779|FG000|Active Phase ITT|Lack of Efficacy|1|||
161166031|NCT00603733|581985780|FG001|Active Phase ITT|Lack of Efficacy|2|||
161166032|NCT00603733|581985779|FG000|Active Phase ITT|Subject moved, site closed|1|||
161082563|NCT00400725|581691654|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
161082564|NCT00400725|581691655|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
161082565|NCT00400725|581691653|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
161082566|NCT00400725|581691654|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
161082567|NCT00400725|581691655|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
161082568|NCT00400725|581691653|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
161082569|NCT00400725|581691654|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
161082570|NCT00400725|581691655|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
161166033|NCT00603733|581985780|FG001|Active Phase ITT|Subject moved, site closed|1|||
161166034|NCT00603733|581985779|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
161166035|NCT00603733|581985780|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
161166036|NCT00603733|581985779|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
161166037|NCT00603733|581985780|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
161166038|NCT00603733|581985779|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
161166039|NCT00603733|581985780|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
161166040|NCT00603733|581985779|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
161166041|NCT00603733|581985780|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
161166042|NCT00603733|581985779|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
161166043|NCT00603733|581985780|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
161289924|NCT02892331|582440705|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
161289925|NCT02892331|582440706|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
161289926|NCT04871776|582440707|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
161289927|NCT04871776|582440708|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
161289928|NCT04871776|582440709|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
161082571|NCT00400725|581691653|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
161082572|NCT00400725|581691654|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
161082573|NCT00400725|581691655|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
161289929|NCT04871776|582440707|FG000|Overall Study|Did not meet eligibility criteria|1|||
161289930|NCT04871776|582440708|FG001|Overall Study|Did not meet eligibility criteria|1|||
161289931|NCT04871776|582440709|FG002|Overall Study|Did not meet eligibility criteria|1|||
161082574|NCT00400725|581691653|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
161082575|NCT00400725|581691654|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
161082576|NCT00400725|581691655|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
161166044|NCT00603733|581985779|FG000|Maintenance Phase ITT|Adverse Event|3|||
161166045|NCT00603733|581985780|FG001|Maintenance Phase ITT|Adverse Event|6|||
161166046|NCT00603733|581985779|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
161166047|NCT00603733|581985780|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
161166048|NCT00603733|581985779|FG000|Maintenance Phase ITT|Protocol Violation|1|||
161166049|NCT00603733|581985780|FG001|Maintenance Phase ITT|Protocol Violation|1|||
161166050|NCT00603733|581985779|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
161289932|NCT04021914|582442591|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
161289933|NCT02844543|582442592|FG000|Overall Study|Withdrawal by Subject|4|||
161289934|NCT02844543|582442592|FG000|Overall Study|Did not meet eligibility criteria|1|||
161082577|NCT00400725|581691653|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
161082578|NCT00400725|581691654|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
161082579|NCT00400725|581691655|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
161082580|NCT00400725|581691653|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
161082581|NCT00400725|581691654|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
161082582|NCT00400725|581691655|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
161082583|NCT00400725|581691653|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
161082584|NCT00400725|581691654|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
161082585|NCT00400725|581691655|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
161082586|NCT00400725|581691653|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
161346984|NCT02555878|582654747|FG001|Overall Study|Death|59|||
161346985|NCT02555878|582654746|FG000|Overall Study|Protocol Violation|1|||
161346986|NCT02555878|582654747|FG001|Overall Study|Protocol Violation|2|||
161346987|NCT02555878|582654746|FG000|Overall Study|Physician Decision|12|||
161346988|NCT02555878|582654747|FG001|Overall Study|Physician Decision|13|||
161346989|NCT02555878|582654746|FG000|Overall Study|Other|17|||
161346990|NCT02555878|582654747|FG001|Overall Study|Other|17|||
161082587|NCT00400725|581691654|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
161082588|NCT00400725|581691655|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
161082589|NCT02797080|581691659|FG000|Overall Study|Lost to Follow-up|1|||
161082590|NCT02797080|581691659|FG000|Overall Study|Withdrawal by Subject|1|||
161082591|NCT01417104|581691662|FG000|Overall Study|Withdrawal by Subject|5|||
161166051|NCT00603733|581985780|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
161166052|NCT00603733|581985779|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
161166053|NCT00603733|581985780|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
161166054|NCT00603733|581985779|FG000|Maintenance Phase ITT|Physician Decision|0|||
161166055|NCT00603733|581985780|FG001|Maintenance Phase ITT|Physician Decision|1|||
161166056|NCT00603733|581985779|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
161166057|NCT00603733|581985780|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
161166058|NCT01093755|581985781|FG000|Overall Study|Withdrawal by Subject|3|||
161166059|NCT01093755|581985782|FG001|Overall Study|Withdrawal by Subject|4|||
161166060|NCT03115112|581985783|FG000|Overall Study|Adverse Event|5|||
161166061|NCT03115112|581985784|FG001|Overall Study|Adverse Event|1|||
161166062|NCT03115112|581985783|FG000|Overall Study|Withdrawal by Subject|4|||
161166063|NCT03115112|581985784|FG001|Overall Study|Withdrawal by Subject|2|||
161166064|NCT03115112|581985783|FG000|Overall Study|Lost to Follow-up|0|||
161166065|NCT03115112|581985784|FG001|Overall Study|Lost to Follow-up|1|||
161166066|NCT03115112|581985783|FG000|Overall Study|Death|1|||
161166067|NCT03115112|581985784|FG001|Overall Study|Death|0|||
161346991|NCT00765076|582654748|FG000|Overall Study|Adverse Event|1|||
161082592|NCT01417104|581691663|FG001|Overall Study|Withdrawal by Subject|1|||
161082593|NCT01417104|581691662|FG000|Overall Study|Failure to make contact|0|||
161082594|NCT01417104|581691663|FG001|Overall Study|Failure to make contact|1|||
161082595|NCT01417104|581691662|FG000|Overall Study|Adverse Event|1|||
161082596|NCT01417104|581691663|FG001|Overall Study|Adverse Event|0|||
161082597|NCT00757627|581691664|FG000|Overall Study|Adverse Event|15|||
161082598|NCT00757627|581691664|FG000|Overall Study|Lack of Efficacy|10|||
161082599|NCT00757627|581691664|FG000|Overall Study|Lost to Follow-up|28|||
161082600|NCT00757627|581691664|FG000|Overall Study|Withdrawal by Subject|27|||
161082601|NCT00757627|581691664|FG000|Overall Study|Other|1|||
161082602|NCT03014011|581691665|FG000|First Intervention|Withdrawal by Subject|1|||
161082603|NCT03014011|581691666|FG001|First Intervention|Withdrawal by Subject|0|||
161082604|NCT03014011|581691665|FG000|Washout|Withdrawal by Subject|1|||
161082605|NCT03014011|581691666|FG001|Washout|Withdrawal by Subject|0|||
161082606|NCT02755818|581691667|FG000|Overall Study|Withdrawal by Subject|0|||
161082607|NCT02755818|581691668|FG001|Overall Study|Withdrawal by Subject|0|||
161082608|NCT02755818|581691669|FG002|Overall Study|Withdrawal by Subject|0|||
161082609|NCT02755818|581691670|FG003|Overall Study|Withdrawal by Subject|2|||
161082610|NCT02755818|581691667|FG000|Overall Study|withdrawal by PI|0|||
161082611|NCT02755818|581691668|FG001|Overall Study|withdrawal by PI|0|||
161082612|NCT02755818|581691669|FG002|Overall Study|withdrawal by PI|1|||
161082613|NCT02755818|581691670|FG003|Overall Study|withdrawal by PI|1|||
161082614|NCT03223662|581691677|FG000|Overall Study|Physician Decision|1|||
161082615|NCT03223662|581691677|FG000|Overall Study|Study closure|1|||
161346992|NCT00765076|582654749|FG001|Overall Study|Adverse Event|0|||
161346993|NCT00765076|582654750|FG002|Overall Study|Adverse Event|0|||
161082616|NCT01280357|581691678|FG000|Overall Study|Excluded no internal monitoring|14|||
161082617|NCT01280357|581691678|FG000|Overall Study|IInsufficient data/No data supplied|12|||
161082618|NCT02229851|581691679|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
161082619|NCT02229851|581691680|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
161082620|NCT02229851|581691681|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
161082621|NCT02229851|581691682|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
161082622|NCT02229851|581691683|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
161346994|NCT00765076|582654748|FG000|Overall Study|Withdrawal by Subject|0|||
161166068|NCT03115112|581985783|FG000|Overall Study|Pregnancy|1|||
161346995|NCT00765076|582654749|FG001|Overall Study|Withdrawal by Subject|0|||
161289935|NCT03349060|582442593|FG000|Overall Study|Adverse Event|9|||
161289936|NCT03349060|582442594|FG001|Overall Study|Adverse Event|9|||
161082623|NCT02229851|581691684|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
161082624|NCT02229851|581691685|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
161082625|NCT02229851|581691679|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161082626|NCT02229851|581691680|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
161082627|NCT02229851|581691681|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161082628|NCT02229851|581691682|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161082629|NCT02229851|581691683|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161082630|NCT02229851|581691684|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161082631|NCT02229851|581691685|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
161082632|NCT02229851|581691679|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
161082633|NCT02229851|581691680|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
161082634|NCT02229851|581691681|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
161082635|NCT02229851|581691682|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161082636|NCT02229851|581691683|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161082637|NCT02229851|581691684|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161082638|NCT02229851|581691685|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
161082639|NCT02229851|581691679|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161082640|NCT02229851|581691680|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161082641|NCT02229851|581691681|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
161082642|NCT02229851|581691682|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161082643|NCT02229851|581691683|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161082644|NCT02229851|581691684|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161082645|NCT02229851|581691685|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
161082646|NCT02229851|581691679|FG000|Main Phase (Double-blind Phase)|Death|1|||
161082647|NCT02229851|581691680|FG001|Main Phase (Double-blind Phase)|Death|1|||
161082648|NCT02229851|581691681|FG002|Main Phase (Double-blind Phase)|Death|0|||
161082649|NCT02229851|581691682|FG003|Main Phase (Double-blind Phase)|Death|0|||
161082650|NCT02229851|581691683|FG004|Main Phase (Double-blind Phase)|Death|0|||
161082651|NCT02229851|581691684|FG005|Main Phase (Double-blind Phase)|Death|0|||
161082652|NCT02229851|581691685|FG006|Main Phase (Double-blind Phase)|Death|0|||
161082653|NCT02229851|581691679|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161082654|NCT02229851|581691680|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161082655|NCT02229851|581691681|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161082656|NCT02229851|581691682|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
161082657|NCT02229851|581691683|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
161082658|NCT02229851|581691684|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
161082659|NCT02229851|581691685|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
161082660|NCT02229851|581691679|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
161082661|NCT02229851|581691680|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
161082662|NCT02229851|581691681|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
161082663|NCT02229851|581691682|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
161082664|NCT02229851|581691683|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
161082665|NCT02229851|581691684|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
161082666|NCT02229851|581691685|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
161082667|NCT02229851|581691679|FG000|Extension Phase (Open-label Phase)|Death|0|||
161082668|NCT02229851|581691680|FG001|Extension Phase (Open-label Phase)|Death|0|||
161082669|NCT02229851|581691681|FG002|Extension Phase (Open-label Phase)|Death|0|||
161082670|NCT02229851|581691682|FG003|Extension Phase (Open-label Phase)|Death|1|||
161082671|NCT02229851|581691683|FG004|Extension Phase (Open-label Phase)|Death|0|||
161082672|NCT02229851|581691684|FG005|Extension Phase (Open-label Phase)|Death|1|||
161082673|NCT02229851|581691685|FG006|Extension Phase (Open-label Phase)|Death|1|||
161082674|NCT03284203|581691686|FG000|Overall Study|Lost to Follow-up|3|||
161082675|NCT00528931|581691687|FG000|Overall Study|Lost to Follow-up|1|||
161082676|NCT03122223|581691690|FG000|Overall Study|Withdrawal by Subject|2|||
161082677|NCT03122223|581691691|FG001|Overall Study|Withdrawal by Subject|2|||
161082678|NCT03122223|581691692|FG002|Overall Study|Withdrawal by Subject|1|||
161082679|NCT03122223|581691693|FG003|Overall Study|Withdrawal by Subject|0|||
161082680|NCT03122223|581691690|FG000|Overall Study|Lost to Follow-up|0|||
161082681|NCT03122223|581691691|FG001|Overall Study|Lost to Follow-up|2|||
161082682|NCT03122223|581691692|FG002|Overall Study|Lost to Follow-up|2|||
161082683|NCT03122223|581691693|FG003|Overall Study|Lost to Follow-up|0|||
161082684|NCT03122223|581691690|FG000|Overall Study|Participant unable to adhere|1|||
161082685|NCT03122223|581691691|FG001|Overall Study|Participant unable to adhere|1|||
161289937|NCT03349060|582442595|FG002|Overall Study|Adverse Event|7|||
161082686|NCT03122223|581691692|FG002|Overall Study|Participant unable to adhere|1|||
161289938|NCT03349060|582442593|FG000|Overall Study|Lack of Efficacy|1|||
161289939|NCT03349060|582442594|FG001|Overall Study|Lack of Efficacy|0|||
161289940|NCT03349060|582442595|FG002|Overall Study|Lack of Efficacy|2|||
161289941|NCT03349060|582442593|FG000|Overall Study|Lost to Follow-up|2|||
161082687|NCT03122223|581691693|FG003|Overall Study|Participant unable to adhere|0|||
161082688|NCT03682302|581691694|FG000|Overall Study|Lost to Follow-up|1|||
161082689|NCT03682302|581691695|FG001|Overall Study|Lost to Follow-up|2|||
161082690|NCT03682302|581691696|FG002|Overall Study|Lost to Follow-up|0|||
161082691|NCT03682302|581691697|FG003|Overall Study|Lost to Follow-up|1|||
161082692|NCT03682302|581691694|FG000|Overall Study|Study drug was not administered|0|||
161082693|NCT03682302|581691695|FG001|Overall Study|Study drug was not administered|0|||
161082694|NCT03682302|581691696|FG002|Overall Study|Study drug was not administered|1|||
161082695|NCT03682302|581691697|FG003|Overall Study|Study drug was not administered|1|||
161082696|NCT01489891|581691700|FG000|Overall Study|Endoscopy failure|1|||
161082697|NCT01489891|581691701|FG001|Overall Study|Endoscopy failure|0|||
161082698|NCT02045875|581691705|FG000|Overall Study|Lost to Follow-up|3|||
161082699|NCT02045875|581691706|FG001|Overall Study|Lost to Follow-up|0|||
161166069|NCT03115112|581985784|FG001|Overall Study|Pregnancy|0|||
161166070|NCT03115112|581985783|FG000|Overall Study|Site closure|1|||
161166071|NCT03115112|581985784|FG001|Overall Study|Site closure|1|||
161166072|NCT01610076|581985785|FG000|Overall Study|Technical issue with video|0|||
161166073|NCT01610076|581985786|FG001|Overall Study|Technical issue with video|1|||
161166074|NCT01610076|581985785|FG000|Overall Study|Lost to Follow-up|3|||
161166075|NCT01610076|581985786|FG001|Overall Study|Lost to Follow-up|4|||
161166076|NCT02168803|581985787|FG000|Overall Study|Lost to Follow-up|1|||
161166077|NCT02168803|581985788|FG001|Overall Study|Lost to Follow-up|0|||
161166078|NCT02168803|581985789|FG002|Overall Study|Lost to Follow-up|1|||
161166079|NCT02168803|581985787|FG000|Overall Study|Withdrawal by Subject|1|||
161166080|NCT02168803|581985788|FG001|Overall Study|Withdrawal by Subject|1|||
161166081|NCT02168803|581985789|FG002|Overall Study|Withdrawal by Subject|2|||
161166082|NCT02168803|581985787|FG000|Overall Study|Physician Decision|0|||
161166083|NCT02168803|581985788|FG001|Overall Study|Physician Decision|1|||
161166084|NCT02168803|581985789|FG002|Overall Study|Physician Decision|0|||
161166085|NCT02168803|581985787|FG000|Overall Study|Adverse Event|0|||
161166086|NCT02168803|581985788|FG001|Overall Study|Adverse Event|1|||
161166087|NCT02168803|581985789|FG002|Overall Study|Adverse Event|1|||
161166088|NCT02168803|581985787|FG000|Overall Study|Death|0|||
161166089|NCT02168803|581985788|FG001|Overall Study|Death|0|||
161166090|NCT02168803|581985789|FG002|Overall Study|Death|1|||
161166091|NCT02168803|581985787|FG000|Overall Study|Sponsor Decision|0|||
161166092|NCT02168803|581985788|FG001|Overall Study|Sponsor Decision|0|||
161166093|NCT02168803|581985789|FG002|Overall Study|Sponsor Decision|1|||
161166094|NCT00098020|581985799|FG000|Overall Study|Adverse Event|2|||
161166095|NCT00098020|581985799|FG000|Overall Study|Lost to Follow-up|1|||
161166096|NCT00098020|581985799|FG000|Overall Study|elevated liver enzymes|1|||
161166097|NCT00098020|581985799|FG000|Overall Study|Low urine PCR|1|||
161166098|NCT00098020|581985799|FG000|Overall Study|Low epidermal growth factor receptor|1|||
161166099|NCT00865189|581985805|FG000|Overall Study|Other|1|||
161166100|NCT00865189|581985806|FG001|Overall Study|Other|2|||
161166101|NCT00865189|581985805|FG000|Overall Study|Death|4|||
161166102|NCT00865189|581985806|FG001|Overall Study|Death|11|||
161166103|NCT00865189|581985805|FG000|Overall Study|Lost to Follow-up|6|||
161166104|NCT00865189|581985806|FG001|Overall Study|Lost to Follow-up|6|||
161166105|NCT00865189|581985805|FG000|Overall Study|Withdrawal by Subject|1|||
161166106|NCT00865189|581985806|FG001|Overall Study|Withdrawal by Subject|0|||
161166107|NCT00084929|581985808|FG000|Overall Study|ineligible - medical contraindication|1|||
161166108|NCT00084929|581985808|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
161166109|NCT00084929|581985808|FG000|Overall Study|Ineligible - Medical history|6|||
161166110|NCT00084929|581985808|FG000|Overall Study|Withdrawal by Subject|10|||
161166111|NCT00084929|581985808|FG000|Overall Study|Missing/incomplete CTC exam|9|||
161166112|NCT00084929|581985808|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
161082700|NCT02045875|581691705|FG000|Overall Study|Withdrawal by Subject|4|||
161082701|NCT02045875|581691706|FG001|Overall Study|Withdrawal by Subject|3|||
161166113|NCT00664209|581985809|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
161166114|NCT00664209|581985809|FG000|Study Treatment Period|Physician Decision|4|||
161166115|NCT00664209|581985809|FG000|Study Treatment Period|Withdrawal by Subject|2|||
161166116|NCT02767856|581985820|FG000|Overall Study|Lost to Follow-up|9|||
161166117|NCT02767856|581985821|FG001|Overall Study|Lost to Follow-up|1|||
161166118|NCT02767856|581985820|FG000|Overall Study|Withdrawal by Subject|2|||
161166119|NCT02767856|581985821|FG001|Overall Study|Withdrawal by Subject|1|||
161166120|NCT00091026|581985824|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
161166121|NCT00091026|581985825|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
161166122|NCT00091026|581985824|FG000|Overall Study|Patient withdrew and never received trea|0|||
161166123|NCT00091026|581985825|FG001|Overall Study|Patient withdrew and never received trea|2|||
161166124|NCT00091026|581985824|FG000|Overall Study|Unknown-never received treatment|0|||
161166125|NCT00091026|581985825|FG001|Overall Study|Unknown-never received treatment|1|||
161166126|NCT00418379|581985828|FG000|Year 1|Adverse Event|9|||
161082702|NCT01769326|581691712|FG000|Overall Study|Lost to Follow-up|1|||
161082703|NCT01769326|581691713|FG001|Overall Study|Lost to Follow-up|2|||
161082704|NCT01769326|581691714|FG002|Overall Study|Lost to Follow-up|0|||
161166127|NCT00418379|581985829|FG001|Year 1|Adverse Event|15|||
161166128|NCT00418379|581985830|FG002|Year 1|Adverse Event|3|||
161166129|NCT00418379|581985828|FG000|Year 1|Withdrawal by Subject|7|||
161166130|NCT00418379|581985829|FG001|Year 1|Withdrawal by Subject|8|||
161166131|NCT00418379|581985830|FG002|Year 1|Withdrawal by Subject|5|||
161166132|NCT00418379|581985828|FG000|Year 1|Any other reason not above-mentioned|2|||
161166133|NCT00418379|581985829|FG001|Year 1|Any other reason not above-mentioned|5|||
161166134|NCT00418379|581985830|FG002|Year 1|Any other reason not above-mentioned|7|||
161166135|NCT00418379|581985828|FG000|Year 2|Adverse Event|5|||
161166136|NCT00418379|581985829|FG001|Year 2|Adverse Event|2|||
161166137|NCT00418379|581985830|FG002|Year 2|Adverse Event|1|||
161166138|NCT00418379|581985828|FG000|Year 2|Withdrawal by Subject|1|||
161166139|NCT00418379|581985829|FG001|Year 2|Withdrawal by Subject|1|||
161166140|NCT00418379|581985830|FG002|Year 2|Withdrawal by Subject|3|||
161166141|NCT00418379|581985828|FG000|Year 2|Any other reason not above-mentioned|2|||
161166142|NCT00418379|581985829|FG001|Year 2|Any other reason not above-mentioned|1|||
161166143|NCT00418379|581985830|FG002|Year 2|Any other reason not above-mentioned|6|||
161166144|NCT00418379|581985828|FG000|Year 3|Withdrawal by Subject|1|||
161166145|NCT00418379|581985829|FG001|Year 3|Withdrawal by Subject|1|||
161166146|NCT00418379|581985830|FG002|Year 3|Withdrawal by Subject|2|||
161166147|NCT00418379|581985828|FG000|Year 3|Any other reason not above-mentioned|2|||
161166148|NCT00418379|581985829|FG001|Year 3|Any other reason not above-mentioned|1|||
161166149|NCT00418379|581985830|FG002|Year 3|Any other reason not above-mentioned|1|||
161166150|NCT00418379|581985828|FG000|Year 4|Adverse Event|0|||
161166151|NCT00418379|581985829|FG001|Year 4|Adverse Event|1|||
161166152|NCT00418379|581985830|FG002|Year 4|Adverse Event|0|||
161166153|NCT00418379|581985828|FG000|Year 4|Withdrawal by Subject|2|||
161166154|NCT00418379|581985829|FG001|Year 4|Withdrawal by Subject|3|||
161166155|NCT00418379|581985830|FG002|Year 4|Withdrawal by Subject|2|||
161166156|NCT00418379|581985828|FG000|Year 4|Any other reason not above-mentioned|1|||
161166157|NCT00418379|581985829|FG001|Year 4|Any other reason not above-mentioned|1|||
161166158|NCT00418379|581985830|FG002|Year 4|Any other reason not above-mentioned|0|||
161166159|NCT00418379|581985828|FG000|Year 5|Adverse Event|0|||
161166160|NCT00418379|581985829|FG001|Year 5|Adverse Event|1|||
161166161|NCT00418379|581985830|FG002|Year 5|Adverse Event|0|||
161166162|NCT00418379|581985828|FG000|Year 5|Any other reason not above-mentioned|2|||
161166163|NCT00418379|581985829|FG001|Year 5|Any other reason not above-mentioned|4|||
161166164|NCT00418379|581985830|FG002|Year 5|Any other reason not above-mentioned|3|||
161166165|NCT00843843|581985831|FG000|Overall Study|Physician Decision|1|||
161166166|NCT00843843|581985832|FG001|Overall Study|Physician Decision|1|||
161166167|NCT00843843|581985831|FG000|Overall Study|Protocol Violation|1|||
161166168|NCT00843843|581985832|FG001|Overall Study|Protocol Violation|1|||
161166169|NCT01797965|581985833|FG000|Overall Study|Adverse Event|104|||
161166170|NCT01797965|581985834|FG001|Overall Study|Adverse Event|129|||
161166171|NCT01797965|581985835|FG002|Overall Study|Adverse Event|4|||
161166172|NCT01797965|581985836|FG003|Overall Study|Adverse Event|21|||
161166173|NCT01797965|581985833|FG000|Overall Study|Lost to Follow-up|9|||
161166174|NCT01797965|581985834|FG001|Overall Study|Lost to Follow-up|8|||
161166175|NCT01797965|581985835|FG002|Overall Study|Lost to Follow-up|1|||
161166176|NCT01797965|581985836|FG003|Overall Study|Lost to Follow-up|2|||
161166177|NCT01797965|581985833|FG000|Overall Study|Consent withdrawn|130|||
161166178|NCT01797965|581985834|FG001|Overall Study|Consent withdrawn|117|||
161166179|NCT01797965|581985835|FG002|Overall Study|Consent withdrawn|3|||
161166180|NCT01797965|581985836|FG003|Overall Study|Consent withdrawn|35|||
161166181|NCT01797965|581985833|FG000|Overall Study|Investigator decision|21|||
161166182|NCT01797965|581985834|FG001|Overall Study|Investigator decision|15|||
161166183|NCT01797965|581985835|FG002|Overall Study|Investigator decision|0|||
161166184|NCT01797965|581985836|FG003|Overall Study|Investigator decision|0|||
161166185|NCT01797965|581985833|FG000|Overall Study|Death|2|||
161166186|NCT01797965|581985834|FG001|Overall Study|Death|4|||
161166187|NCT01797965|581985835|FG002|Overall Study|Death|0|||
161166188|NCT01797965|581985836|FG003|Overall Study|Death|0|||
161166189|NCT01797965|581985833|FG000|Overall Study|Disease progression, defined by protocol|3|||
161166190|NCT01797965|581985834|FG001|Overall Study|Disease progression, defined by protocol|1|||
161166191|NCT01797965|581985835|FG002|Overall Study|Disease progression, defined by protocol|0|||
161166192|NCT01797965|581985836|FG003|Overall Study|Disease progression, defined by protocol|0|||
161166193|NCT01797965|581985833|FG000|Overall Study|Reason Not Specified|280|||
161166194|NCT01797965|581985834|FG001|Overall Study|Reason Not Specified|295|||
161166195|NCT01797965|581985835|FG002|Overall Study|Reason Not Specified|0|||
161166196|NCT01797965|581985836|FG003|Overall Study|Reason Not Specified|15|||
161166197|NCT01764256|581985837|FG000|Received All Vaccinations|Adverse Event|1|||
161166198|NCT01764256|581985838|FG001|Received All Vaccinations|Adverse Event|1|||
161166199|NCT01764256|581985839|FG002|Received All Vaccinations|Adverse Event|0|||
161166200|NCT01764256|581985840|FG003|Received All Vaccinations|Adverse Event|0|||
161166201|NCT01764256|581985837|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
161166202|NCT01764256|581985838|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
161166203|NCT01764256|581985839|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
161166204|NCT01764256|581985840|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
161166205|NCT01764256|581985837|FG000|Received All Vaccinations|Lost to Follow-up|1|||
161166206|NCT01764256|581985838|FG001|Received All Vaccinations|Lost to Follow-up|0|||
161166207|NCT01764256|581985839|FG002|Received All Vaccinations|Lost to Follow-up|0|||
161166208|NCT01764256|581985840|FG003|Received All Vaccinations|Lost to Follow-up|0|||
161082705|NCT01769326|581691715|FG003|Overall Study|Lost to Follow-up|0|||
161082706|NCT01769326|581691712|FG000|Overall Study|unrelated injry|1|||
161082707|NCT01769326|581691713|FG001|Overall Study|unrelated injry|1|||
161082708|NCT01769326|581691714|FG002|Overall Study|unrelated injry|0|||
161082709|NCT01769326|581691715|FG003|Overall Study|unrelated injry|0|||
161082710|NCT01769326|581691712|FG000|Overall Study|got a job|0|||
161082711|NCT01769326|581691713|FG001|Overall Study|got a job|1|||
161166209|NCT01764256|581985837|FG000|Completed Study|Lost to Follow-up|0|||
161166210|NCT01764256|581985838|FG001|Completed Study|Lost to Follow-up|0|||
161166211|NCT01764256|581985839|FG002|Completed Study|Lost to Follow-up|0|||
161166212|NCT01764256|581985840|FG003|Completed Study|Lost to Follow-up|1|||
161166213|NCT00304915|581985841|FG000|Overall Study|Lost to Follow-up|11|||
161289942|NCT03349060|582442594|FG001|Overall Study|Lost to Follow-up|1|||
161289943|NCT03349060|582442595|FG002|Overall Study|Lost to Follow-up|1|||
161289944|NCT03349060|582442593|FG000|Overall Study|Protocol Violation|2|||
161289945|NCT03349060|582442594|FG001|Overall Study|Protocol Violation|2|||
161166214|NCT00304915|581985842|FG001|Overall Study|Lost to Follow-up|11|||
161166215|NCT00304915|581985841|FG000|Overall Study|Death|4|||
161166216|NCT00304915|581985842|FG001|Overall Study|Death|5|||
161166217|NCT00304915|581985841|FG000|Overall Study|Withdrawal by Subject|3|||
161166218|NCT00304915|581985842|FG001|Overall Study|Withdrawal by Subject|0|||
161166219|NCT00565058|581985843|FG000|Overall Study|Adverse Event|1|||
161166220|NCT00565058|581985844|FG001|Overall Study|Adverse Event|0|||
161166221|NCT02029638|581985845|FG000|Overall Study|Death|0|||
161166222|NCT02029638|581985846|FG001|Overall Study|Death|0|||
161166223|NCT02029638|581985847|FG002|Overall Study|Death|1|||
161166224|NCT02029638|581985845|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
161166225|NCT02029638|581985846|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
161166226|NCT02029638|581985847|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
161166227|NCT05489081|581985849|FG000|Overall Study|student left classroom|0|||
161166228|NCT05489081|581985850|FG001|Overall Study|student left classroom|1|||
161166229|NCT05489081|581985849|FG000|Overall Study|teacher left school|0|||
161166230|NCT05489081|581985850|FG001|Overall Study|teacher left school|2|||
161166231|NCT00973921|581985853|FG000|Overall Study|IVUS results were not available|9|||
161166232|NCT02670330|581985864|FG000|Overall Study|Protocol Deviation|1|||
161166233|NCT02670330|581985865|FG001|Overall Study|Protocol Deviation|0|||
161166234|NCT02670330|581985864|FG000|Overall Study|Study Terminated By Sponsor|36|||
161166235|NCT02670330|581985865|FG001|Overall Study|Study Terminated By Sponsor|43|||
161166236|NCT02670330|581985864|FG000|Overall Study|Adverse Event|1|||
161166237|NCT02670330|581985865|FG001|Overall Study|Adverse Event|3|||
161166238|NCT02670330|581985864|FG000|Overall Study|Withdrawal by Subject|34|||
161166239|NCT02670330|581985865|FG001|Overall Study|Withdrawal by Subject|29|||
161166240|NCT02670330|581985864|FG000|Overall Study|Lost to Follow-up|3|||
161166241|NCT02670330|581985865|FG001|Overall Study|Lost to Follow-up|2|||
161166242|NCT00634114|581985866|FG000|Overall Study|Adverse Event|6|||
161166243|NCT00634114|581985867|FG001|Overall Study|Adverse Event|8|||
161166244|NCT00634114|581985868|FG002|Overall Study|Adverse Event|3|||
161166245|NCT00634114|581985866|FG000|Overall Study|Withdrawal by Subject|9|||
161166246|NCT00634114|581985867|FG001|Overall Study|Withdrawal by Subject|6|||
161166247|NCT00634114|581985868|FG002|Overall Study|Withdrawal by Subject|11|||
161166248|NCT00634114|581985866|FG000|Overall Study|Lost to Follow-up|0|||
161166249|NCT00634114|581985867|FG001|Overall Study|Lost to Follow-up|0|||
161166250|NCT00634114|581985868|FG002|Overall Study|Lost to Follow-up|1|||
161166251|NCT00634114|581985866|FG000|Overall Study|Protocol Violation|3|||
161166252|NCT00634114|581985867|FG001|Overall Study|Protocol Violation|3|||
161166253|NCT00634114|581985868|FG002|Overall Study|Protocol Violation|1|||
161166254|NCT00634114|581985866|FG000|Overall Study|Pregnancy|1|||
161289946|NCT03349060|582442595|FG002|Overall Study|Protocol Violation|1|||
161289947|NCT03349060|582442593|FG000|Overall Study|Withdrawal by Subject|5|||
161166255|NCT00634114|581985867|FG001|Overall Study|Pregnancy|0|||
161166256|NCT00634114|581985868|FG002|Overall Study|Pregnancy|0|||
161166257|NCT00634114|581985866|FG000|Overall Study|Incorrect enrolment|0|||
161289948|NCT03349060|582442594|FG001|Overall Study|Withdrawal by Subject|3|||
161166258|NCT00634114|581985867|FG001|Overall Study|Incorrect enrolment|1|||
161166259|NCT00634114|581985868|FG002|Overall Study|Incorrect enrolment|0|||
161166260|NCT00634114|581985866|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
161166261|NCT00634114|581985867|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
161289949|NCT03349060|582442595|FG002|Overall Study|Withdrawal by Subject|4|||
161289950|NCT03349060|582442593|FG000|Overall Study|Medication error,no linked adverse event|0|||
161082712|NCT01769326|581691714|FG002|Overall Study|got a job|0|||
161082713|NCT01769326|581691715|FG003|Overall Study|got a job|0|||
161166262|NCT00634114|581985868|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
161166263|NCT00634114|581985866|FG000|Overall Study|Difficult to continue|3|||
161166264|NCT00634114|581985867|FG001|Overall Study|Difficult to continue|1|||
161166265|NCT00634114|581985868|FG002|Overall Study|Difficult to continue|1|||
161166266|NCT00634114|581985866|FG000|Overall Study|Other reason|1|||
161166267|NCT00634114|581985867|FG001|Overall Study|Other reason|1|||
161166268|NCT00634114|581985868|FG002|Overall Study|Other reason|1|||
161166269|NCT01599754|581985869|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
161166270|NCT01599754|581985870|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
161166271|NCT01599754|581985869|FG000|Overall Study|Participant noncompliance|4|||
161166272|NCT01599754|581985870|FG001|Overall Study|Participant noncompliance|4|||
161082714|NCT01769326|581691712|FG000|Overall Study|Got sick and could not complete study|0|||
161082715|NCT01769326|581691713|FG001|Overall Study|Got sick and could not complete study|0|||
161082716|NCT01769326|581691714|FG002|Overall Study|Got sick and could not complete study|1|||
161082717|NCT01769326|581691715|FG003|Overall Study|Got sick and could not complete study|0|||
161082718|NCT01036438|581691716|FG000|Overall Study|Adverse Event|7|||
161082719|NCT01036438|581691717|FG001|Overall Study|Adverse Event|8|||
161082720|NCT01036438|581691716|FG000|Overall Study|Death|0|||
161082721|NCT01036438|581691717|FG001|Overall Study|Death|1|||
161082722|NCT01036438|581691716|FG000|Overall Study|No effect of study treatment|3|||
161082723|NCT01036438|581691717|FG001|Overall Study|No effect of study treatment|1|||
161082724|NCT00888927|581691718|FG000|Overall Study|Adverse Event|0|||
161082725|NCT00888927|581691719|FG001|Overall Study|Adverse Event|0|||
161082726|NCT00888927|581691720|FG002|Overall Study|Adverse Event|0|||
161082727|NCT00888927|581691721|FG003|Overall Study|Adverse Event|1|||
161082728|NCT00888927|581691718|FG000|Overall Study|Withdrawal of consent|0|||
161082729|NCT00888927|581691719|FG001|Overall Study|Withdrawal of consent|0|||
161082730|NCT00888927|581691720|FG002|Overall Study|Withdrawal of consent|0|||
161082731|NCT00888927|581691721|FG003|Overall Study|Withdrawal of consent|1|||
161082732|NCT03459443|581691722|FG000|Overall Study|Lack of Efficacy|3|||
161082733|NCT03459443|581691722|FG000|Overall Study|Adverse Event|1|||
161082734|NCT03459443|581691722|FG000|Overall Study|Sponsor's decision to close the study|18|||
161082735|NCT01607476|581691723|FG000|Overall Study|Withdrawal by Subject|1|||
161082736|NCT01607476|581691724|FG001|Overall Study|Withdrawal by Subject|0|||
161082737|NCT01607476|581691725|FG002|Overall Study|Withdrawal by Subject|1|||
161082738|NCT01607476|581691723|FG000|Overall Study|Lost to Follow-up|0|||
161082739|NCT01607476|581691724|FG001|Overall Study|Lost to Follow-up|0|||
161082740|NCT01607476|581691725|FG002|Overall Study|Lost to Follow-up|2|||
161082741|NCT04445987|581691726|FG000|Overall Study|Adverse Event|0|||
161082742|NCT04445987|581691727|FG001|Overall Study|Adverse Event|0|||
161082743|NCT04445987|581691728|FG002|Overall Study|Adverse Event|1|||
161082744|NCT04445987|581691729|FG003|Overall Study|Adverse Event|0|||
161082745|NCT04445987|581691730|FG004|Overall Study|Adverse Event|4|||
161082746|NCT04445987|581691731|FG005|Overall Study|Adverse Event|0|||
161082747|NCT04445987|581691726|FG000|Overall Study|Lost to Follow-up|4|||
161082748|NCT04445987|581691727|FG001|Overall Study|Lost to Follow-up|3|||
161082749|NCT04445987|581691728|FG002|Overall Study|Lost to Follow-up|1|||
161082750|NCT04445987|581691729|FG003|Overall Study|Lost to Follow-up|1|||
161082751|NCT04445987|581691730|FG004|Overall Study|Lost to Follow-up|29|||
161082752|NCT04445987|581691731|FG005|Overall Study|Lost to Follow-up|0|||
161082753|NCT04445987|581691726|FG000|Overall Study|Physician Decision|0|||
161082754|NCT04445987|581691727|FG001|Overall Study|Physician Decision|0|||
161082755|NCT04445987|581691728|FG002|Overall Study|Physician Decision|0|||
161082756|NCT04445987|581691729|FG003|Overall Study|Physician Decision|0|||
161082757|NCT04445987|581691730|FG004|Overall Study|Physician Decision|1|||
161082758|NCT04445987|581691731|FG005|Overall Study|Physician Decision|0|||
161082759|NCT04445987|581691726|FG000|Overall Study|Protocol Violation|1|||
161082760|NCT04445987|581691727|FG001|Overall Study|Protocol Violation|0|||
161082761|NCT04445987|581691728|FG002|Overall Study|Protocol Violation|0|||
161082762|NCT04445987|581691729|FG003|Overall Study|Protocol Violation|0|||
161082763|NCT04445987|581691730|FG004|Overall Study|Protocol Violation|2|||
161082764|NCT04445987|581691731|FG005|Overall Study|Protocol Violation|0|||
161082765|NCT04445987|581691726|FG000|Overall Study|Withdrawal by Subject|4|||
161082766|NCT04445987|581691727|FG001|Overall Study|Withdrawal by Subject|0|||
161082767|NCT04445987|581691728|FG002|Overall Study|Withdrawal by Subject|1|||
161082768|NCT04445987|581691729|FG003|Overall Study|Withdrawal by Subject|0|||
161082769|NCT04445987|581691730|FG004|Overall Study|Withdrawal by Subject|18|||
161082770|NCT04445987|581691731|FG005|Overall Study|Withdrawal by Subject|1|||
161082771|NCT04445987|581691726|FG000|Overall Study|Other reason|0|||
161082772|NCT04445987|581691727|FG001|Overall Study|Other reason|0|||
161082773|NCT04445987|581691728|FG002|Overall Study|Other reason|1|||
161082774|NCT04445987|581691729|FG003|Overall Study|Other reason|0|||
161082775|NCT04445987|581691730|FG004|Overall Study|Other reason|2|||
161082776|NCT04445987|581691731|FG005|Overall Study|Other reason|0|||
161166273|NCT01599754|581985869|FG000|Overall Study|Lost to Follow-up|13|||
161166274|NCT01599754|581985870|FG001|Overall Study|Lost to Follow-up|6|||
161082777|NCT03772587|581691737|FG000|Overall Study|COVID-19|0|||
161082778|NCT03772587|581691738|FG001|Overall Study|COVID-19|0|||
161082779|NCT03772587|581691739|FG002|Overall Study|COVID-19|1|||
161082780|NCT03772587|581691740|FG003|Overall Study|COVID-19|1|||
161082781|NCT03772587|581691741|FG004|Overall Study|COVID-19|0|||
161289951|NCT03349060|582442594|FG001|Overall Study|Medication error,no linked adverse event|0|||
161289952|NCT03349060|582442595|FG002|Overall Study|Medication error,no linked adverse event|1|||
161289953|NCT03349060|582442593|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
161289954|NCT03349060|582442594|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
161289955|NCT03349060|582442595|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
161289956|NCT03349060|582442593|FG000|Overall Study|Other|2|||
161289957|NCT03349060|582442594|FG001|Overall Study|Other|1|||
161289958|NCT03349060|582442595|FG002|Overall Study|Other|0|||
161082782|NCT03772587|581691737|FG000|Overall Study|Withdrawal by Subject|1|||
161082783|NCT03772587|581691738|FG001|Overall Study|Withdrawal by Subject|0|||
161082784|NCT03772587|581691739|FG002|Overall Study|Withdrawal by Subject|0|||
161082785|NCT03772587|581691740|FG003|Overall Study|Withdrawal by Subject|0|||
161082786|NCT03772587|581691741|FG004|Overall Study|Withdrawal by Subject|0|||
161082787|NCT02297139|581691742|FG000|Overall Study|Disease progression|0|||
161082788|NCT02297139|581691743|FG001|Overall Study|Disease progression|1|||
161082789|NCT02297139|581691742|FG000|Overall Study|Study drug toxicity|0|||
161082790|NCT02297139|581691743|FG001|Overall Study|Study drug toxicity|4|||
161082791|NCT02297139|581691742|FG000|Overall Study|Participant request to discontinue study treatment|0|||
161082792|NCT02297139|581691743|FG001|Overall Study|Participant request to discontinue study treatment|1|||
161082793|NCT02297139|581691742|FG000|Overall Study|Maximum clinical benefit|1|||
161082794|NCT02297139|581691743|FG001|Overall Study|Maximum clinical benefit|0|||
161082795|NCT02297139|581691742|FG000|Overall Study|Administrative reason by sponsor|0|||
161082796|NCT02297139|581691743|FG001|Overall Study|Administrative reason by sponsor|2|||
161082797|NCT02297139|581691742|FG000|Overall Study|Other reasons|0|||
161082798|NCT02297139|581691743|FG001|Overall Study|Other reasons|8|||
161082799|NCT05051462|581691749|FG000|Overall Study|Lost to Follow-up|1|||
161082800|NCT05051462|581691750|FG001|Overall Study|Lost to Follow-up|8|||
161082801|NCT05051462|581691749|FG000|Overall Study|Withdrawal by Subject|1|||
161082802|NCT05051462|581691750|FG001|Overall Study|Withdrawal by Subject|0|||
161082803|NCT05051462|581691749|FG000|Overall Study|Protocol Violation|0|||
161082804|NCT05051462|581691750|FG001|Overall Study|Protocol Violation|2|||
161082805|NCT02425904|581691751|FG000|Overall Study|Lost to Follow-up|1|||
161082806|NCT02425904|581691752|FG001|Overall Study|Lost to Follow-up|0|||
161082807|NCT02425904|581691751|FG000|Overall Study|Withdrawal by Subject|2|||
161082808|NCT02425904|581691752|FG001|Overall Study|Withdrawal by Subject|0|||
161082809|NCT02425904|581691751|FG000|Overall Study|Death|0|||
161082810|NCT02425904|581691752|FG001|Overall Study|Death|3|||
161082811|NCT05260021|581691753|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
161082812|NCT05260021|581691754|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
161082813|NCT05260021|581691755|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
161082814|NCT05260021|581691753|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
161082815|NCT05260021|581691754|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
161082816|NCT05260021|581691755|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
161082817|NCT05260021|581691753|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
161082818|NCT05260021|581691754|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
161082819|NCT05260021|581691755|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
161082820|NCT05260021|581691753|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
161082821|NCT05260021|581691754|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
161082822|NCT05260021|581691755|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
161082823|NCT05260021|581691753|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
161082824|NCT05260021|581691754|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
161082825|NCT05260021|581691755|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
161082826|NCT05597787|581691756|FG000|Overall Study|Withdrawal by Subject|0|||
161082827|NCT05597787|581691757|FG001|Overall Study|Withdrawal by Subject|0|||
161082828|NCT05597787|581691758|FG002|Overall Study|Withdrawal by Subject|1|||
161082829|NCT01144377|581691759|FG000|52 Week Treatment Period|Adverse Event|0|||
161082830|NCT01144377|581691760|FG001|52 Week Treatment Period|Adverse Event|0|||
161082831|NCT01144377|581691761|FG002|52 Week Treatment Period|Adverse Event|3|||
161082832|NCT01144377|581691762|FG003|52 Week Treatment Period|Adverse Event|2|||
161082833|NCT01144377|581691763|FG004|52 Week Treatment Period|Adverse Event|1|||
161082834|NCT01144377|581691759|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
161082835|NCT01144377|581691760|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
161082836|NCT01144377|581691761|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
161082837|NCT01144377|581691762|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
161082838|NCT01144377|581691763|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
161082839|NCT01144377|581691759|FG000|52 Week Treatment Period|Protocol Violation|0|||
161289959|NCT02844933|582442596|FG000|Overall Study|Discontinued due to premature termination of study|3|||
161289960|NCT02844933|582442597|FG001|Overall Study|Discontinued due to premature termination of study|2|||
161289961|NCT01479465|582442598|FG000|Overall Study|Disease Progression|9|||
161082840|NCT01144377|581691760|FG001|52 Week Treatment Period|Protocol Violation|0|||
161082841|NCT01144377|581691761|FG002|52 Week Treatment Period|Protocol Violation|0|||
161082842|NCT01144377|581691762|FG003|52 Week Treatment Period|Protocol Violation|0|||
161346996|NCT00765076|582654750|FG002|Overall Study|Withdrawal by Subject|1|||
161346997|NCT01164475|582654751|FG000|Overall Study|Lack of Efficacy|1|||
161346998|NCT01164475|582654752|FG001|Overall Study|Lack of Efficacy|0|||
161346999|NCT01164475|582654751|FG000|Overall Study|Other|0|||
161082843|NCT01144377|581691763|FG004|52 Week Treatment Period|Protocol Violation|1|||
161082844|NCT01144377|581691759|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
161082845|NCT01144377|581691760|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
161082846|NCT01144377|581691761|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
161347000|NCT01164475|582654752|FG001|Overall Study|Other|1|||
161347001|NCT01164475|582654751|FG000|Overall Study|Progressive disease|0|||
161347002|NCT01164475|582654752|FG001|Overall Study|Progressive disease|1|||
161347003|NCT01164475|582654751|FG000|Overall Study|Protocol Violation|1|||
161347004|NCT01164475|582654752|FG001|Overall Study|Protocol Violation|0|||
161347005|NCT02335944|582654753|FG000|Treatment Phase|Progressive Disease|2|||
161347006|NCT02335944|582654754|FG001|Treatment Phase|Progressive Disease|5|||
161347007|NCT02335944|582654755|FG002|Treatment Phase|Progressive Disease|2|||
161347008|NCT02335944|582654756|FG003|Treatment Phase|Progressive Disease|11|||
161347009|NCT02335944|582654757|FG004|Treatment Phase|Progressive Disease|4|||
161082847|NCT01144377|581691762|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
161082848|NCT01144377|581691763|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
161082849|NCT01144377|581691759|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
161082850|NCT01144377|581691760|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
161082851|NCT01144377|581691761|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
161082852|NCT01144377|581691762|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
161082853|NCT01144377|581691763|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
161082854|NCT01144377|581691759|FG000|52 Week Treatment Period|Sponsor Decision|0|||
161082855|NCT01144377|581691760|FG001|52 Week Treatment Period|Sponsor Decision|0|||
161082856|NCT01144377|581691761|FG002|52 Week Treatment Period|Sponsor Decision|0|||
161082857|NCT01144377|581691762|FG003|52 Week Treatment Period|Sponsor Decision|0|||
161082858|NCT01144377|581691763|FG004|52 Week Treatment Period|Sponsor Decision|1|||
161082859|NCT01144377|581691759|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
161082860|NCT01144377|581691760|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
161082861|NCT01144377|581691761|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
161082862|NCT01144377|581691762|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
161082863|NCT01144377|581691763|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
161082864|NCT01144377|581691759|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161082865|NCT01144377|581691760|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161082866|NCT01144377|581691761|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161082867|NCT01144377|581691762|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
161082868|NCT01144377|581691763|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
161082869|NCT01144377|581691759|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
161082870|NCT01144377|581691760|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161082871|NCT01144377|581691761|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161082872|NCT01144377|581691762|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161082873|NCT01144377|581691763|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
161082874|NCT01241604|581691765|FG000|Screening Period|Screen Failure|3|||
161082875|NCT01241604|581691766|FG001|Screening Period|Screen Failure|0|||
161082876|NCT01241604|581691767|FG002|Screening Period|Screen Failure|0|||
161082877|NCT01593787|581691768|FG000|Overall Study|Adverse Event|1|||
161082878|NCT01593787|581691769|FG001|Overall Study|Adverse Event|0|||
161082879|NCT01593787|581691770|FG002|Overall Study|Adverse Event|0|||
161082880|NCT01946529|581691773|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
161082881|NCT01946529|581691774|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
161082882|NCT01946529|581691775|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
161082883|NCT01946529|581691773|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
161082884|NCT01946529|581691774|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
161082885|NCT01946529|581691775|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
161082886|NCT02075476|581693550|FG000|Overall Study|Death|2|||
161082887|NCT02075476|581693551|FG001|Overall Study|Death|2|||
161082888|NCT02075476|581693550|FG000|Overall Study|Lost to Follow-up|1|||
161347010|NCT02335944|582654758|FG005|Treatment Phase|Progressive Disease|25|||
161082889|NCT02075476|581693551|FG001|Overall Study|Lost to Follow-up|3|||
161082890|NCT02914275|581693557|FG000|Overall Study|Lost to Follow-up|84|||
161082891|NCT02914275|581693558|FG001|Overall Study|Lost to Follow-up|29|||
161082892|NCT02914275|581693557|FG000|Overall Study|Withdrawal by Subject|26|||
161082893|NCT02914275|581693558|FG001|Overall Study|Withdrawal by Subject|10|||
161082894|NCT02914275|581693557|FG000|Overall Study|Protocol Violation|1|||
161082895|NCT02914275|581693558|FG001|Overall Study|Protocol Violation|1|||
161082896|NCT02914275|581693557|FG000|Overall Study|Physician Decision|3|||
161082897|NCT02914275|581693558|FG001|Overall Study|Physician Decision|1|||
161347011|NCT02335944|582654759|FG006|Treatment Phase|Progressive Disease|2|||
161347012|NCT02335944|582654760|FG007|Treatment Phase|Progressive Disease|30|||
161347013|NCT02335944|582654761|FG008|Treatment Phase|Progressive Disease|27|||
161082898|NCT02914275|581693557|FG000|Overall Study|Other|4|||
161082899|NCT02914275|581693558|FG001|Overall Study|Other|1|||
161082900|NCT02914275|581693557|FG000|Overall Study|Excluded due to invalid informed consent|3|||
161082901|NCT02914275|581693558|FG001|Overall Study|Excluded due to invalid informed consent|0|||
161082902|NCT02731690|581693559|FG000|Overall Study|Adverse Event|1|||
161082903|NCT02731690|581693559|FG000|Overall Study|Withdrawal by Subject|3|||
161082904|NCT02731690|581693559|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
161082905|NCT00872989|581693560|FG000|Overall Study|Adverse Event|7|||
161082906|NCT00872989|581693561|FG001|Overall Study|Adverse Event|15|||
161082907|NCT00872989|581693560|FG000|Overall Study|Withdrawal by Subject|8|||
161082908|NCT00872989|581693561|FG001|Overall Study|Withdrawal by Subject|5|||
161082909|NCT00872989|581693560|FG000|Overall Study|Progression/relapse|47|||
161082910|NCT00872989|581693561|FG001|Overall Study|Progression/relapse|35|||
161082911|NCT00872989|581693560|FG000|Overall Study|Not protocol specified|3|||
161082912|NCT00872989|581693561|FG001|Overall Study|Not protocol specified|8|||
161082913|NCT02407990|581693562|FG000|Overall Study|Death|2|||
161082914|NCT02407990|581693563|FG001|Overall Study|Death|22|||
161082915|NCT02407990|581693564|FG002|Overall Study|Death|23|||
161082916|NCT02407990|581693565|FG003|Overall Study|Death|7|||
161082917|NCT02407990|581693566|FG004|Overall Study|Death|17|||
161082918|NCT02407990|581693567|FG005|Overall Study|Death|16|||
161082919|NCT02407990|581693568|FG006|Overall Study|Death|10|||
161082920|NCT02407990|581693569|FG007|Overall Study|Death|248|||
161166275|NCT01599754|581985869|FG000|Overall Study|Death|31|||
161166276|NCT01599754|581985870|FG001|Overall Study|Death|33|||
161166277|NCT01599754|581985869|FG000|Overall Study|Adverse Event|3|||
161166278|NCT01599754|581985870|FG001|Overall Study|Adverse Event|2|||
161082921|NCT02407990|581693562|FG000|Overall Study|Lost to Follow-up|0|||
161082922|NCT02407990|581693563|FG001|Overall Study|Lost to Follow-up|1|||
161082923|NCT02407990|581693564|FG002|Overall Study|Lost to Follow-up|0|||
161082924|NCT02407990|581693565|FG003|Overall Study|Lost to Follow-up|0|||
161082925|NCT02407990|581693566|FG004|Overall Study|Lost to Follow-up|0|||
161082926|NCT02407990|581693567|FG005|Overall Study|Lost to Follow-up|0|||
161082927|NCT02407990|581693568|FG006|Overall Study|Lost to Follow-up|0|||
161082928|NCT02407990|581693569|FG007|Overall Study|Lost to Follow-up|17|||
161082929|NCT02407990|581693562|FG000|Overall Study|Progressive Disease|0|||
161082930|NCT02407990|581693563|FG001|Overall Study|Progressive Disease|0|||
161082931|NCT02407990|581693564|FG002|Overall Study|Progressive Disease|0|||
161082932|NCT02407990|581693565|FG003|Overall Study|Progressive Disease|0|||
161082933|NCT02407990|581693566|FG004|Overall Study|Progressive Disease|0|||
161082934|NCT02407990|581693567|FG005|Overall Study|Progressive Disease|0|||
161082935|NCT02407990|581693568|FG006|Overall Study|Progressive Disease|0|||
161082936|NCT02407990|581693569|FG007|Overall Study|Progressive Disease|1|||
161082937|NCT02407990|581693562|FG000|Overall Study|Withdrawal by Subject|0|||
161082938|NCT02407990|581693563|FG001|Overall Study|Withdrawal by Subject|0|||
161082939|NCT02407990|581693564|FG002|Overall Study|Withdrawal by Subject|0|||
161082940|NCT02407990|581693565|FG003|Overall Study|Withdrawal by Subject|0|||
161082941|NCT02407990|581693566|FG004|Overall Study|Withdrawal by Subject|1|||
161082942|NCT02407990|581693567|FG005|Overall Study|Withdrawal by Subject|0|||
161082943|NCT02407990|581693568|FG006|Overall Study|Withdrawal by Subject|0|||
161082944|NCT02407990|581693569|FG007|Overall Study|Withdrawal by Subject|30|||
161082945|NCT02407990|581693562|FG000|Overall Study|Study Terminated by Sponsor|1|||
161082946|NCT02407990|581693563|FG001|Overall Study|Study Terminated by Sponsor|3|||
161082947|NCT02407990|581693564|FG002|Overall Study|Study Terminated by Sponsor|3|||
161082948|NCT02407990|581693565|FG003|Overall Study|Study Terminated by Sponsor|0|||
161082949|NCT02407990|581693566|FG004|Overall Study|Study Terminated by Sponsor|3|||
161082950|NCT02407990|581693567|FG005|Overall Study|Study Terminated by Sponsor|4|||
161082951|NCT02407990|581693568|FG006|Overall Study|Study Terminated by Sponsor|3|||
161082952|NCT02407990|581693569|FG007|Overall Study|Study Terminated by Sponsor|37|||
161166279|NCT01599754|581985869|FG000|Overall Study|Investigator decision|1|||
161166280|NCT01599754|581985870|FG001|Overall Study|Investigator decision|3|||
161082953|NCT02407990|581693562|FG000|Overall Study|Logistics|0|||
161082954|NCT02407990|581693563|FG001|Overall Study|Logistics|0|||
161082955|NCT02407990|581693564|FG002|Overall Study|Logistics|0|||
161082956|NCT02407990|581693565|FG003|Overall Study|Logistics|0|||
161082957|NCT02407990|581693566|FG004|Overall Study|Logistics|0|||
161082958|NCT02407990|581693567|FG005|Overall Study|Logistics|0|||
161082959|NCT02407990|581693568|FG006|Overall Study|Logistics|0|||
161082960|NCT02407990|581693569|FG007|Overall Study|Logistics|1|||
161082961|NCT02407990|581693562|FG000|Overall Study|Rolled into long-term extension study|0|||
161082962|NCT02407990|581693563|FG001|Overall Study|Rolled into long-term extension study|0|||
161082963|NCT02407990|581693564|FG002|Overall Study|Rolled into long-term extension study|0|||
161082964|NCT02407990|581693565|FG003|Overall Study|Rolled into long-term extension study|0|||
161082965|NCT02407990|581693566|FG004|Overall Study|Rolled into long-term extension study|0|||
161082966|NCT02407990|581693567|FG005|Overall Study|Rolled into long-term extension study|0|||
161082967|NCT02407990|581693568|FG006|Overall Study|Rolled into long-term extension study|0|||
161082968|NCT02407990|581693569|FG007|Overall Study|Rolled into long-term extension study|1|||
161289962|NCT01479465|582442599|FG001|Overall Study|Disease Progression|61|||
161082969|NCT00923260|581693570|FG000|Overall Study|Lost to Follow-up|1|||
161082970|NCT00923260|581693571|FG001|Overall Study|Lost to Follow-up|1|||
161082971|NCT01238900|581693576|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
161082972|NCT01238900|581693576|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
161082973|NCT03241927|581693577|FG000|Overall Study|study terminated|1|||
161082974|NCT03241927|581693578|FG001|Overall Study|study terminated|0|||
161082975|NCT03573583|581693579|FG000|Overall Study|Lost to Follow-up|1|||
161082976|NCT03573583|581693580|FG001|Overall Study|Lost to Follow-up|0|||
161082977|NCT03573583|581693579|FG000|Overall Study|Withdrawal by Subject|1|||
161082978|NCT03573583|581693580|FG001|Overall Study|Withdrawal by Subject|1|||
161082979|NCT01198756|581693581|FG000|Overall Study|Adverse Event|0|||
161082980|NCT01198756|581693582|FG001|Overall Study|Adverse Event|0|||
161082981|NCT01198756|581693583|FG002|Overall Study|Adverse Event|0|||
161082982|NCT01198756|581693584|FG003|Overall Study|Adverse Event|1|||
161082983|NCT01198756|581693581|FG000|Overall Study|Protocol Violation|0|||
161082984|NCT01198756|581693582|FG001|Overall Study|Protocol Violation|0|||
161082985|NCT01198756|581693583|FG002|Overall Study|Protocol Violation|0|||
161082986|NCT01198756|581693584|FG003|Overall Study|Protocol Violation|2|||
161082987|NCT01198756|581693581|FG000|Overall Study|Withdrawal by Subject|9|||
161082988|NCT01198756|581693582|FG001|Overall Study|Withdrawal by Subject|4|||
161082989|NCT01198756|581693583|FG002|Overall Study|Withdrawal by Subject|7|||
161082990|NCT01198756|581693584|FG003|Overall Study|Withdrawal by Subject|5|||
161082991|NCT01198756|581693581|FG000|Overall Study|Lost to Follow-up|29|||
161289963|NCT01479465|582442600|FG002|Overall Study|Disease Progression|65|||
161289964|NCT01479465|582442601|FG003|Overall Study|Disease Progression|70|||
161289965|NCT01479465|582442598|FG000|Overall Study|Study Discontinued by Sponsor|0|||
161289966|NCT01479465|582442599|FG001|Overall Study|Study Discontinued by Sponsor|7|||
161082992|NCT01198756|581693582|FG001|Overall Study|Lost to Follow-up|36|||
161082993|NCT01198756|581693583|FG002|Overall Study|Lost to Follow-up|23|||
161082994|NCT01198756|581693584|FG003|Overall Study|Lost to Follow-up|18|||
161082995|NCT02915302|581693587|FG000|Overall Study|Adverse Event|3|||
161082996|NCT02915302|581693588|FG001|Overall Study|Adverse Event|0|||
161082997|NCT02915302|581693587|FG000|Overall Study|Protocol Violation|20|||
161082998|NCT02915302|581693588|FG001|Overall Study|Protocol Violation|27|||
161082999|NCT02915302|581693587|FG000|Overall Study|Lost to Follow-up|19|||
161083000|NCT02915302|581693588|FG001|Overall Study|Lost to Follow-up|22|||
161083001|NCT02915302|581693587|FG000|Overall Study|Withdrawal by Subject|22|||
161083002|NCT02915302|581693588|FG001|Overall Study|Withdrawal by Subject|29|||
161083003|NCT02915302|581693587|FG000|Overall Study|Other|1|||
161083004|NCT02915302|581693588|FG001|Overall Study|Other|0|||
161083005|NCT04343872|581693591|FG000|Overall Study|Lost to Follow-up|6|||
161083006|NCT04343872|581693592|FG001|Overall Study|Lost to Follow-up|3|||
161083007|NCT02134977|581693593|FG000|Overall Study|Protocol Deviation|102|||
161083008|NCT03507777|581693594|FG000|Overall Study|Lost to Follow-up|5|||
161083009|NCT03507777|581693595|FG001|Overall Study|Lost to Follow-up|7|||
161166281|NCT01599754|581985869|FG000|Overall Study|Withdrawal by Subject|24|||
161166282|NCT01599754|581985870|FG001|Overall Study|Withdrawal by Subject|25|||
161166283|NCT01599754|581985869|FG000|Overall Study|Study terminated by sponsor|282|||
161166284|NCT01599754|581985870|FG001|Overall Study|Study terminated by sponsor|285|||
161083010|NCT03507777|581693594|FG000|Overall Study|Withdrawal by Subject|6|||
161083011|NCT03507777|581693595|FG001|Overall Study|Withdrawal by Subject|11|||
161083012|NCT03507777|581693594|FG000|Overall Study|Death|30|||
161083013|NCT03507777|581693595|FG001|Overall Study|Death|44|||
161083014|NCT03507777|581693594|FG000|Overall Study|Other Reasons|3|||
161083015|NCT03507777|581693595|FG001|Overall Study|Other Reasons|8|||
161083016|NCT01879722|581693597|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161166285|NCT03670641|581985875|FG000|Overall Study|Lost to Follow-up|3|||
161289967|NCT01479465|582442600|FG002|Overall Study|Study Discontinued by Sponsor|5|||
161083017|NCT01879722|581693598|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
161083018|NCT01879722|581693599|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161083019|NCT01879722|581693600|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
161083020|NCT01879722|581693601|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
161083021|NCT01879722|581693602|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
161083022|NCT01879722|581693603|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
161083023|NCT01879722|581693604|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
161083024|NCT01879722|581693605|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
161083025|NCT01879722|581693606|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
161083026|NCT01879722|581693597|FG000|Overall Study|Voluntary Withdrawal|0|||
161083027|NCT01879722|581693598|FG001|Overall Study|Voluntary Withdrawal|0|||
161083028|NCT01879722|581693599|FG002|Overall Study|Voluntary Withdrawal|0|||
161083029|NCT01879722|581693600|FG003|Overall Study|Voluntary Withdrawal|0|||
161083030|NCT01879722|581693601|FG004|Overall Study|Voluntary Withdrawal|0|||
161083031|NCT01879722|581693602|FG005|Overall Study|Voluntary Withdrawal|0|||
161289968|NCT01479465|582442601|FG003|Overall Study|Study Discontinued by Sponsor|3|||
161083032|NCT01879722|581693603|FG006|Overall Study|Voluntary Withdrawal|0|||
161083033|NCT01879722|581693604|FG007|Overall Study|Voluntary Withdrawal|0|||
161166286|NCT00916370|581985881|FG000|Overall Study|Death|3|||
161083034|NCT01879722|581693605|FG008|Overall Study|Voluntary Withdrawal|1|||
161083035|NCT01879722|581693606|FG009|Overall Study|Voluntary Withdrawal|0|||
161083036|NCT00037830|581693607|FG000|Overall Study|Adverse Event|2|||
161083037|NCT00037830|581693608|FG001|Overall Study|Adverse Event|0|||
161083038|NCT00037830|581693609|FG002|Overall Study|Adverse Event|0|||
161083039|NCT00037830|581693607|FG000|Overall Study|Withdrawal by Subject|4|||
161289969|NCT01479465|582442598|FG000|Overall Study|Adverse Event|0|||
161289970|NCT01479465|582442599|FG001|Overall Study|Adverse Event|3|||
161289971|NCT01479465|582442600|FG002|Overall Study|Adverse Event|6|||
161289972|NCT01479465|582442601|FG003|Overall Study|Adverse Event|4|||
161289973|NCT01479465|582442598|FG000|Overall Study|Investigator Discretion|1|||
161289974|NCT01479465|582442599|FG001|Overall Study|Investigator Discretion|4|||
161289975|NCT01479465|582442600|FG002|Overall Study|Investigator Discretion|2|||
161289976|NCT01479465|582442601|FG003|Overall Study|Investigator Discretion|4|||
161083040|NCT00037830|581693608|FG001|Overall Study|Withdrawal by Subject|5|||
161083041|NCT00037830|581693609|FG002|Overall Study|Withdrawal by Subject|1|||
161083042|NCT00037830|581693607|FG000|Overall Study|Protocol Violation|2|||
161083043|NCT00037830|581693608|FG001|Overall Study|Protocol Violation|2|||
161083044|NCT00037830|581693609|FG002|Overall Study|Protocol Violation|0|||
161083045|NCT00037830|581693607|FG000|Overall Study|Unrelated Medical Problem|2|||
161083046|NCT00037830|581693608|FG001|Overall Study|Unrelated Medical Problem|0|||
161083047|NCT00037830|581693609|FG002|Overall Study|Unrelated Medical Problem|0|||
161083048|NCT00127205|581693610|FG000|Overall Study|Adverse Event|228|||
161083049|NCT00127205|581693611|FG001|Overall Study|Adverse Event|387|||
161083050|NCT00127205|581693612|FG002|Overall Study|Adverse Event|273|||
161083051|NCT00127205|581693610|FG000|Overall Study|Death|8|||
161083052|NCT00127205|581693611|FG001|Overall Study|Death|6|||
161083053|NCT00127205|581693612|FG002|Overall Study|Death|5|||
161083054|NCT00127205|581693610|FG000|Overall Study|Withdrawal by Subject|318|||
161083055|NCT00127205|581693611|FG001|Overall Study|Withdrawal by Subject|310|||
161083056|NCT00127205|581693612|FG002|Overall Study|Withdrawal by Subject|172|||
161083057|NCT00127205|581693610|FG000|Overall Study|Other-non protocol specified|142|||
161083058|NCT00127205|581693611|FG001|Overall Study|Other-non protocol specified|129|||
161083059|NCT00127205|581693612|FG002|Overall Study|Other-non protocol specified|77|||
161083060|NCT00127205|581693610|FG000|Overall Study|Data not reported|6|||
161083061|NCT00127205|581693611|FG001|Overall Study|Data not reported|10|||
161083062|NCT00127205|581693612|FG002|Overall Study|Data not reported|1|||
161083063|NCT00127205|581693610|FG000|Overall Study|Progression|127|||
161083064|NCT00127205|581693611|FG001|Overall Study|Progression|131|||
161083065|NCT00127205|581693612|FG002|Overall Study|Progression|84|||
161083066|NCT01327495|581693613|FG000|Overall Study|Adverse Event|2|||
161083067|NCT01327495|581693614|FG001|Overall Study|Adverse Event|1|||
161083068|NCT01327495|581693615|FG002|Overall Study|Adverse Event|1|||
161083069|NCT01327495|581693616|FG003|Overall Study|Adverse Event|0|||
161083070|NCT01327495|581693617|FG004|Overall Study|Adverse Event|0|||
161083071|NCT01327495|581693618|FG005|Overall Study|Adverse Event|2|||
161083072|NCT01327495|581693613|FG000|Overall Study|Withdrawal by Subject|0|||
161289977|NCT01479465|582442598|FG000|Overall Study|Subject Request|1|||
161289978|NCT01479465|582442599|FG001|Overall Study|Subject Request|3|||
161289979|NCT01479465|582442600|FG002|Overall Study|Subject Request|4|||
161083073|NCT01327495|581693614|FG001|Overall Study|Withdrawal by Subject|1|||
161083074|NCT01327495|581693615|FG002|Overall Study|Withdrawal by Subject|1|||
161083075|NCT01327495|581693616|FG003|Overall Study|Withdrawal by Subject|0|||
161083076|NCT01327495|581693617|FG004|Overall Study|Withdrawal by Subject|1|||
161083077|NCT01327495|581693618|FG005|Overall Study|Withdrawal by Subject|0|||
161083078|NCT01327495|581693613|FG000|Overall Study|Physician Decision|0|||
161083079|NCT01327495|581693614|FG001|Overall Study|Physician Decision|0|||
161083080|NCT01327495|581693615|FG002|Overall Study|Physician Decision|0|||
161083081|NCT01327495|581693616|FG003|Overall Study|Physician Decision|0|||
161083082|NCT01327495|581693617|FG004|Overall Study|Physician Decision|2|||
161083083|NCT01327495|581693618|FG005|Overall Study|Physician Decision|0|||
161083084|NCT03377699|581693622|FG000|Overall Study|Withdrawal by Subject|2|||
161083085|NCT03377699|581693623|FG001|Overall Study|Withdrawal by Subject|9|||
161083086|NCT03377699|581693622|FG000|Overall Study|Lost to Follow-up|1|||
161083087|NCT03377699|581693623|FG001|Overall Study|Lost to Follow-up|1|||
161083088|NCT03377699|581693622|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
161083089|NCT03377699|581693623|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
161083090|NCT03377699|581693622|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
161083091|NCT03377699|581693623|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
161289980|NCT01479465|582442601|FG003|Overall Study|Subject Request|2|||
161289981|NCT01479465|582442598|FG000|Overall Study|Subject Withdrew Consent|0|||
161289982|NCT01479465|582442599|FG001|Overall Study|Subject Withdrew Consent|5|||
161289983|NCT01479465|582442600|FG002|Overall Study|Subject Withdrew Consent|2|||
161289984|NCT01479465|582442601|FG003|Overall Study|Subject Withdrew Consent|1|||
161083092|NCT03377699|581693622|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
161091280|NCT02054520|581723867|FG005|Overall Study|Study terminated by Sponsor|0|||
161083093|NCT03377699|581693623|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
161083094|NCT03377699|581693622|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
161083095|NCT03377699|581693623|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
161289985|NCT01479465|582442598|FG000|Overall Study|Protocol Violation|0|||
161083096|NCT02580305|581693624|FG000|Overall Study|Adverse Event|15|||
161083097|NCT02580305|581693625|FG001|Overall Study|Adverse Event|19|||
161083098|NCT02580305|581693626|FG002|Overall Study|Adverse Event|10|||
161083099|NCT02580305|581693624|FG000|Overall Study|Lack of Efficacy|5|||
161083100|NCT02580305|581693625|FG001|Overall Study|Lack of Efficacy|0|||
161083101|NCT02580305|581693626|FG002|Overall Study|Lack of Efficacy|2|||
161083102|NCT02580305|581693624|FG000|Overall Study|Protocol Violation|4|||
161083103|NCT02580305|581693625|FG001|Overall Study|Protocol Violation|9|||
161083104|NCT02580305|581693626|FG002|Overall Study|Protocol Violation|6|||
161083105|NCT02580305|581693624|FG000|Overall Study|Lost to Follow-up|4|||
161083106|NCT02580305|581693625|FG001|Overall Study|Lost to Follow-up|4|||
161083107|NCT02580305|581693626|FG002|Overall Study|Lost to Follow-up|2|||
161083108|NCT02580305|581693624|FG000|Overall Study|Withdrawal by Subject|11|||
161083109|NCT02580305|581693625|FG001|Overall Study|Withdrawal by Subject|9|||
161083110|NCT02580305|581693626|FG002|Overall Study|Withdrawal by Subject|7|||
161083111|NCT02580305|581693624|FG000|Overall Study|Randomized in error and never treated|4|||
161083112|NCT02580305|581693625|FG001|Overall Study|Randomized in error and never treated|8|||
161083113|NCT02580305|581693626|FG002|Overall Study|Randomized in error and never treated|5|||
161083114|NCT03582943|581693627|FG000|Allocated to Groups|Withdrawal by Subject|1|||
161083115|NCT03582943|581693628|FG001|Allocated to Groups|Withdrawal by Subject|1|||
161083116|NCT03582943|581693627|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
161083117|NCT03582943|581693628|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
161083118|NCT03582943|581693627|FG000|Analyzed|Protocol Violation|4|||
161083119|NCT03582943|581693628|FG001|Analyzed|Protocol Violation|1|||
161083120|NCT03053518|581693634|FG000|Overall Study|Withdrawal by Subject|3|||
161083121|NCT03053518|581693634|FG000|Overall Study|Lost to Follow-up|2|||
161083122|NCT03053518|581693634|FG000|Overall Study|Ineligible|5|||
161083123|NCT05560243|581693635|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
161083124|NCT05870228|581693637|FG000|Overall Study|Lost to Follow-up|2|||
161083125|NCT05870228|581693638|FG001|Overall Study|Lost to Follow-up|0|||
161083126|NCT05870228|581693637|FG000|Overall Study|Withdrawal by Subject|1|||
161083127|NCT05870228|581693638|FG001|Overall Study|Withdrawal by Subject|0|||
161083128|NCT03231800|581693639|FG000|Overall Study|Lost to Follow-up|0|||
161083129|NCT03231800|581693640|FG001|Overall Study|Lost to Follow-up|2|||
161083130|NCT03231800|581693639|FG000|Overall Study|Protocol Violation|1|||
161083131|NCT03231800|581693640|FG001|Overall Study|Protocol Violation|1|||
161083132|NCT03231800|581693639|FG000|Overall Study|reason not provided|2|||
161083133|NCT03231800|581693640|FG001|Overall Study|reason not provided|0|||
161083134|NCT03500159|581693646|FG000|Overall Study|Study Terminated|2|||
161083135|NCT03500159|581693647|FG001|Overall Study|Study Terminated|1|||
161083136|NCT04075994|581693650|FG000|Overall Study|Withdrawal by Subject|8|||
161083137|NCT04075994|581693651|FG001|Overall Study|Withdrawal by Subject|9|||
161083138|NCT04075994|581693650|FG000|Overall Study|Adverse Event|2|||
161083139|NCT04075994|581693651|FG001|Overall Study|Adverse Event|2|||
161083140|NCT04075994|581693650|FG000|Overall Study|Investigator withdrew|3|||
161083141|NCT04075994|581693651|FG001|Overall Study|Investigator withdrew|1|||
161083142|NCT00252577|581693657|FG000|Overall Study|Lost to Follow-up|20|||
161083143|NCT00560066|581693658|FG000|Overall Study|Death|2|||
161083144|NCT00560066|581693659|FG001|Overall Study|Death|1|||
161083145|NCT00560066|581693658|FG000|Overall Study|Withdrawal by Subject|0|||
161083146|NCT00560066|581693659|FG001|Overall Study|Withdrawal by Subject|3|||
161083147|NCT00560066|581693658|FG000|Overall Study|Lost to Follow-up|4|||
161083148|NCT00560066|581693659|FG001|Overall Study|Lost to Follow-up|10|||
161083149|NCT00560066|581693658|FG000|Overall Study|Protocol Violation|0|||
161083150|NCT00560066|581693659|FG001|Overall Study|Protocol Violation|1|||
161083151|NCT00560066|581693658|FG000|Overall Study|Administrative reason|0|||
161083152|NCT00560066|581693659|FG001|Overall Study|Administrative reason|5|||
161083153|NCT00560066|581693658|FG000|Overall Study|Missing primary reason|0|||
161083154|NCT00560066|581693659|FG001|Overall Study|Missing primary reason|2|||
161083155|NCT04035499|581693660|FG000|Overall Study|Death|2|||
161083156|NCT04035499|581693660|FG000|Overall Study|Withdrawal by Subject|1|||
161083157|NCT00951015|581693661|FG000|Randomization Phase 96 Week|Adverse Event|1|||
161083158|NCT00951015|581693662|FG001|Randomization Phase 96 Week|Adverse Event|1|||
161083159|NCT00951015|581693663|FG002|Randomization Phase 96 Week|Adverse Event|2|||
161083160|NCT00951015|581693664|FG003|Randomization Phase 96 Week|Adverse Event|5|||
161083161|NCT00951015|581693665|FG004|Randomization Phase 96 Week|Adverse Event|0|||
161083162|NCT00951015|581693661|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
161083163|NCT00951015|581693662|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
161289986|NCT01479465|582442599|FG001|Overall Study|Protocol Violation|1|||
161289987|NCT01479465|582442600|FG002|Overall Study|Protocol Violation|1|||
161083164|NCT00951015|581693663|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
161091281|NCT01272804|581723868|FG000|Overall Study|Adverse Event|1|||
161083165|NCT00951015|581693664|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
161083166|NCT00951015|581693665|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
161083167|NCT00951015|581693661|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
161083168|NCT00951015|581693662|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
161083169|NCT00951015|581693663|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
161083170|NCT00951015|581693664|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
161083171|NCT00951015|581693665|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
161083172|NCT00951015|581693661|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161083173|NCT00951015|581693662|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161083174|NCT00951015|581693663|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161083175|NCT00951015|581693664|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
161083176|NCT00951015|581693665|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
161083177|NCT00951015|581693661|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
161083178|NCT00951015|581693662|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
161083179|NCT00951015|581693663|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
161083180|NCT00951015|581693664|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
161083181|NCT00951015|581693665|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
161083182|NCT00951015|581693661|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
161083183|NCT00951015|581693662|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
161083184|NCT00951015|581693663|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
161083185|NCT00951015|581693664|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
161083186|NCT00951015|581693665|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
161347014|NCT02335944|582654762|FG009|Treatment Phase|Progressive Disease|0|||
161083187|NCT00951015|581693661|FG000|Open-label Phase|Adverse Event|0|||
161083188|NCT00951015|581693662|FG001|Open-label Phase|Adverse Event|0|||
161083189|NCT00951015|581693663|FG002|Open-label Phase|Adverse Event|0|||
161083190|NCT00951015|581693664|FG003|Open-label Phase|Adverse Event|0|||
161083191|NCT00951015|581693665|FG004|Open-label Phase|Adverse Event|3|||
161083192|NCT00951015|581693661|FG000|Open-label Phase|Lack of Efficacy|0|||
161083193|NCT00951015|581693662|FG001|Open-label Phase|Lack of Efficacy|0|||
161083194|NCT00951015|581693663|FG002|Open-label Phase|Lack of Efficacy|0|||
161083195|NCT00951015|581693664|FG003|Open-label Phase|Lack of Efficacy|0|||
161083196|NCT00951015|581693665|FG004|Open-label Phase|Lack of Efficacy|1|||
161083197|NCT00951015|581693661|FG000|Open-label Phase|Protocol Violation|0|||
161083198|NCT00951015|581693662|FG001|Open-label Phase|Protocol Violation|0|||
161083199|NCT00951015|581693663|FG002|Open-label Phase|Protocol Violation|0|||
161083200|NCT00951015|581693664|FG003|Open-label Phase|Protocol Violation|0|||
161083201|NCT00951015|581693665|FG004|Open-label Phase|Protocol Violation|12|||
161083202|NCT00951015|581693661|FG000|Open-label Phase|Lost to Follow-up|0|||
161083203|NCT00951015|581693662|FG001|Open-label Phase|Lost to Follow-up|0|||
161083204|NCT00951015|581693663|FG002|Open-label Phase|Lost to Follow-up|0|||
161083205|NCT00951015|581693664|FG003|Open-label Phase|Lost to Follow-up|0|||
161083206|NCT00951015|581693665|FG004|Open-label Phase|Lost to Follow-up|12|||
161083207|NCT00951015|581693661|FG000|Open-label Phase|Withdrawal by Subject|0|||
161083208|NCT00951015|581693662|FG001|Open-label Phase|Withdrawal by Subject|0|||
161083209|NCT00951015|581693663|FG002|Open-label Phase|Withdrawal by Subject|0|||
161083210|NCT00951015|581693664|FG003|Open-label Phase|Withdrawal by Subject|0|||
161083211|NCT00951015|581693665|FG004|Open-label Phase|Withdrawal by Subject|14|||
161083212|NCT00951015|581693661|FG000|Open-label Phase|Physician Decision|0|||
161083213|NCT00951015|581693662|FG001|Open-label Phase|Physician Decision|0|||
161083214|NCT00951015|581693663|FG002|Open-label Phase|Physician Decision|0|||
161083215|NCT00951015|581693664|FG003|Open-label Phase|Physician Decision|0|||
161083216|NCT00951015|581693665|FG004|Open-label Phase|Physician Decision|8|||
161083217|NCT01416389|581693666|FG000|Overall Study|Lost to Follow-up|1|||
161083218|NCT01416389|581693667|FG001|Overall Study|Lost to Follow-up|0|||
161083219|NCT01416389|581693666|FG000|Overall Study|Started New Therapy|2|||
161083220|NCT01416389|581693667|FG001|Overall Study|Started New Therapy|0|||
161083221|NCT00958841|581693668|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161083222|NCT00958841|581693668|FG000|Overall Study|Abnormal test procedure result(s)|3|||
161083223|NCT00958841|581693668|FG000|Overall Study|Administrative problems|1|||
161083224|NCT00958841|581693668|FG000|Overall Study|Adverse Event|8|||
161083225|NCT00958841|581693668|FG000|Overall Study|New cancer therapy|5|||
161083226|NCT00958841|581693668|FG000|Overall Study|Withdrawal by Subject|1|||
161083227|NCT00958841|581693668|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
161083228|NCT00958841|581693668|FG000|Overall Study|Completed M6/did not enter extension|27|||
161083229|NCT00958841|581693668|FG000|Overall Study|Discontinued prior to M*|28|||
161083230|NCT02535091|581693675|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
161083231|NCT02535091|581693676|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
161083232|NCT02535091|581693677|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
161083233|NCT02535091|581693675|FG000|Overall Study|Withdrawal by Subject|14|||
161083234|NCT02535091|581693676|FG001|Overall Study|Withdrawal by Subject|5|||
161347015|NCT02335944|582654753|FG000|Treatment Phase|Adverse Event|2|||
161083235|NCT02535091|581693677|FG002|Overall Study|Withdrawal by Subject|121|||
161166287|NCT00916370|581985882|FG001|Overall Study|Death|1|||
161166288|NCT00916370|581985881|FG000|Overall Study|Withdrawal by Subject|2|||
161166289|NCT00916370|581985882|FG001|Overall Study|Withdrawal by Subject|0|||
161166290|NCT00916370|581985881|FG000|Overall Study|Physician Decision|0|||
161166291|NCT00916370|581985882|FG001|Overall Study|Physician Decision|1|||
161166292|NCT00414960|581985883|FG000|Overall Study|Adverse Event|4|||
161166293|NCT00414960|581985884|FG001|Overall Study|Adverse Event|0|||
161166294|NCT00414960|581985883|FG000|Overall Study|Withdrawal by Subject|3|||
161166295|NCT00414960|581985884|FG001|Overall Study|Withdrawal by Subject|0|||
161166296|NCT00414960|581985883|FG000|Overall Study|Physician Decision|0|||
161166297|NCT00414960|581985884|FG001|Overall Study|Physician Decision|1|||
161166298|NCT03550131|581985885|FG000|Overall Study|Lost to Follow-up|16|||
161166299|NCT03550131|581985886|FG001|Overall Study|Lost to Follow-up|24|||
161166300|NCT03550131|581985885|FG000|Overall Study|Withdrawal by Subject|36|||
161166301|NCT03550131|581985886|FG001|Overall Study|Withdrawal by Subject|28|||
161166302|NCT03550131|581985885|FG000|Overall Study|Illness of dyad member|10|||
161166303|NCT03550131|581985886|FG001|Overall Study|Illness of dyad member|2|||
161166304|NCT03550131|581985885|FG000|Overall Study|Death of person with dementia|4|||
161166305|NCT03550131|581985886|FG001|Overall Study|Death of person with dementia|8|||
161166306|NCT01318512|581985887|FG000|Maintenance Period (6 Months)|Death|2|||
161166307|NCT01318512|581985887|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
161166308|NCT02756650|581985890|FG000|Overall Study|Physician Decision|1|||
161166309|NCT02756650|581985890|FG000|Overall Study|Adverse Event|1|||
161166310|NCT04348591|581985895|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
161166311|NCT04348591|581985896|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
161166312|NCT04348591|581985895|FG000|Imaging Session (120 Min)|Physician Decision|0|||
161166313|NCT04348591|581985896|FG001|Imaging Session (120 Min)|Physician Decision|1|||
161166314|NCT04348591|581985895|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
161166315|NCT04348591|581985896|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
161166316|NCT03722784|581985900|FG000|Overall Study|Withdrawal by Subject|1|||
161166317|NCT03722784|581985901|FG001|Overall Study|Withdrawal by Subject|0|||
161166318|NCT03722784|581985900|FG000|Overall Study|Physician Decision|1|||
161166319|NCT03722784|581985901|FG001|Overall Study|Physician Decision|1|||
161166320|NCT03722784|581985900|FG000|Overall Study|Protocol Violation|0|||
161166321|NCT03722784|581985901|FG001|Overall Study|Protocol Violation|1|||
161166322|NCT00910429|581985904|FG000|Overall Study|Death|18|||
161166323|NCT00910429|581985905|FG001|Overall Study|Death|12|||
161166324|NCT00910429|581985904|FG000|Overall Study|Withdrawal by Subject|3|||
161166325|NCT00910429|581985905|FG001|Overall Study|Withdrawal by Subject|2|||
161166326|NCT00910429|581985904|FG000|Overall Study|Protocol Violation|1|||
161166327|NCT00910429|581985905|FG001|Overall Study|Protocol Violation|0|||
161166328|NCT00910429|581985904|FG000|Overall Study|Lost to Follow-up|2|||
161166329|NCT00910429|581985905|FG001|Overall Study|Lost to Follow-up|1|||
161166330|NCT00910429|581985904|FG000|Overall Study|Adverse Event|10|||
161166331|NCT00910429|581985905|FG001|Overall Study|Adverse Event|5|||
161166332|NCT00910429|581985904|FG000|Overall Study|Drug non-compliance|1|||
161166333|NCT00910429|581985905|FG001|Overall Study|Drug non-compliance|0|||
161166334|NCT00910429|581985904|FG000|Overall Study|Lack of Efficacy|4|||
161166335|NCT00910429|581985905|FG001|Overall Study|Lack of Efficacy|1|||
161166336|NCT01317615|581985906|FG000|Overall Study|Disease progression|25|||
161166337|NCT01317615|581985906|FG000|Overall Study|New cancer therapy|5|||
161166338|NCT01317615|581985906|FG000|Overall Study|Death|6|||
161166339|NCT01317615|581985906|FG000|Overall Study|Withdrawal by Subject|5|||
161166340|NCT01317615|581985906|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161166341|NCT01317615|581985906|FG000|Overall Study|Adverse Event|7|||
161166342|NCT05757427|581985912|FG000|Overall Study|Adverse Event|1|||
161166343|NCT05757427|581985912|FG000|Overall Study|Device deficiency|1|||
161289988|NCT01479465|582442601|FG003|Overall Study|Protocol Violation|0|||
161289989|NCT01479465|582442598|FG000|Overall Study|Death|0|||
161289990|NCT01479465|582442599|FG001|Overall Study|Death|0|||
161289991|NCT01479465|582442600|FG002|Overall Study|Death|0|||
161166344|NCT05757427|581985912|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
161289992|NCT01479465|582442601|FG003|Overall Study|Death|1|||
161166345|NCT05757427|581985912|FG000|Overall Study|MWBI scan of only 1 breast|3|||
161166346|NCT05757427|581985912|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
161166347|NCT00949910|581987879|FG000|Overall Study|Progressive Disease|3750|||
161166348|NCT00949910|581987879|FG000|Overall Study|Symptomatic Deterioration|1088|||
161166349|NCT00949910|581987879|FG000|Overall Study|Lost to Follow-up|100|||
161166350|NCT00949910|581987879|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
161289993|NCT01479465|582442598|FG000|Overall Study|Lost to Follow-up|0|||
161347016|NCT02335944|582654754|FG001|Treatment Phase|Adverse Event|0|||
161289994|NCT01479465|582442599|FG001|Overall Study|Lost to Follow-up|0|||
161289995|NCT01479465|582442600|FG002|Overall Study|Lost to Follow-up|1|||
161289996|NCT01479465|582442601|FG003|Overall Study|Lost to Follow-up|0|||
161166351|NCT00949910|581987879|FG000|Overall Study|Participant Refusal|390|||
161166352|NCT00949910|581987879|FG000|Overall Study|Death Due to Malignant Disease|456|||
161166353|NCT00949910|581987879|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
161289997|NCT01892501|582442602|FG000|Overall Study|Protocol Violation|2|||
161289998|NCT01892501|582442602|FG000|Overall Study|Puncture not carried out|9|||
161289999|NCT01892501|582442602|FG000|Overall Study|Radiological monitoring not carried out|5|||
161290000|NCT01892501|582442602|FG000|Overall Study|Non-contributory histological result|12|||
161290001|NCT04335123|582442606|FG000|Overall Study|Withdrawal by Subject|2|||
161290002|NCT04335123|582442607|FG001|Overall Study|Withdrawal by Subject|0|||
161290003|NCT04335123|582442606|FG000|Overall Study|Physician Decision|2|||
161290004|NCT04335123|582442607|FG001|Overall Study|Physician Decision|0|||
161290005|NCT01439802|582442608|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
161290006|NCT01439802|582442608|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
161290007|NCT03499067|582442612|FG000|First Intervention|Physician Decision|2|||
161290008|NCT03499067|582442613|FG001|First Intervention|Physician Decision|1|||
161290009|NCT03499067|582442612|FG000|First Intervention|Withdrawal by Subject|3|||
161290010|NCT03499067|582442613|FG001|First Intervention|Withdrawal by Subject|6|||
161290011|NCT02502149|582442614|FG000|Intermediate|Discontinued prematurely|1|||
161290012|NCT02502149|582442615|FG001|Intermediate|Discontinued prematurely|0|||
161290013|NCT02502149|582442616|FG002|Intermediate|Discontinued prematurely|0|||
161290014|NCT02502149|582442617|FG003|Intermediate|Discontinued prematurely|0|||
161290015|NCT02502149|582442618|FG004|Intermediate|Discontinued prematurely|0|||
161290016|NCT02383017|582442626|FG000|Overall Study|Injury Sustained Outside Study|1|||
161290017|NCT02383017|582442627|FG001|Overall Study|Injury Sustained Outside Study|0|||
161290018|NCT02383017|582442626|FG000|Overall Study|Compliance|3|||
161290019|NCT02383017|582442627|FG001|Overall Study|Compliance|2|||
161290020|NCT02383017|582442626|FG000|Overall Study|Found to be Hypogonadal|1|||
161290021|NCT02383017|582442627|FG001|Overall Study|Found to be Hypogonadal|0|||
161166354|NCT00949910|581987879|FG000|Overall Study|Death Due to Adverse Event|115|||
161166355|NCT00949910|581987879|FG000|Overall Study|Death Due to Toxicity|3|||
161166356|NCT00949910|581987879|FG000|Overall Study|Death from Unknown Cause|5|||
161166357|NCT00949910|581987879|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
161166358|NCT00949910|581987879|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
161166359|NCT00949910|581987879|FG000|Overall Study|Switched to Commercial Treatment|4|||
161166360|NCT00949910|581987879|FG000|Overall Study|Violation of Eligibility|23|||
161166361|NCT00949910|581987879|FG000|Overall Study|Logistical Reasons|13|||
161166362|NCT00949910|581987879|FG000|Overall Study|Non-Compliance|10|||
161166363|NCT00949910|581987879|FG000|Overall Study|Prolonged Dosing Interruption|4|||
161166364|NCT00949910|581987879|FG000|Overall Study|Adverse Event|83|||
161166365|NCT00949910|581987879|FG000|Overall Study|Serious Adverse Event|6|||
161166366|NCT00949910|581987879|FG000|Overall Study|Physician/Participant Decision|7|||
161166367|NCT00949910|581987879|FG000|Overall Study|Other|4|||
161166368|NCT00949910|581987879|FG000|Overall Study|No Data|9|||
161166369|NCT00971425|581987880|FG000|Overall Study|Adverse Event|1|||
161166370|NCT00971425|581987881|FG001|Overall Study|Adverse Event|1|||
161166371|NCT00971425|581987880|FG000|Overall Study|Withdrawal by Subject|0|||
161166372|NCT00971425|581987881|FG001|Overall Study|Withdrawal by Subject|1|||
161166373|NCT00132314|581987882|FG000|Overall Study|Lost to Follow-up|70|||
161166374|NCT00132314|581987883|FG001|Overall Study|Lost to Follow-up|62|||
161166375|NCT00132314|581987882|FG000|Overall Study|Lacked SSN|1|||
161166376|NCT00132314|581987883|FG001|Overall Study|Lacked SSN|3|||
161166377|NCT00132314|581987882|FG000|Overall Study|Refused intervention at baseline|2|||
161166378|NCT00132314|581987883|FG001|Overall Study|Refused intervention at baseline|7|||
161166379|NCT04019795|581987898|FG000|Overall Study|Withdrawal by Subject|1|||
161166380|NCT04019795|581987899|FG001|Overall Study|Withdrawal by Subject|2|||
161166381|NCT04019795|581987900|FG002|Overall Study|Withdrawal by Subject|2|||
161166382|NCT04019795|581987901|FG003|Overall Study|Withdrawal by Subject|1|||
161166383|NCT04019795|581987898|FG000|Overall Study|Lost to Follow-up|0|||
161166384|NCT04019795|581987899|FG001|Overall Study|Lost to Follow-up|1|||
161166385|NCT04019795|581987900|FG002|Overall Study|Lost to Follow-up|1|||
161166386|NCT04019795|581987901|FG003|Overall Study|Lost to Follow-up|2|||
161166387|NCT04019795|581987898|FG000|Overall Study|Treatment non-compliance|3|||
161166388|NCT04019795|581987899|FG001|Overall Study|Treatment non-compliance|1|||
161166389|NCT04019795|581987900|FG002|Overall Study|Treatment non-compliance|2|||
161166390|NCT04019795|581987901|FG003|Overall Study|Treatment non-compliance|0|||
161166391|NCT04019795|581987898|FG000|Overall Study|Physician Decision|0|||
161166392|NCT04019795|581987899|FG001|Overall Study|Physician Decision|0|||
161166393|NCT04019795|581987900|FG002|Overall Study|Physician Decision|1|||
161166394|NCT04019795|581987901|FG003|Overall Study|Physician Decision|0|||
161290022|NCT03871543|582442628|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
161290023|NCT03871543|582442628|FG000|Period 1|Investigator Error|1|||
161290024|NCT03871543|582442628|FG000|Period 1|Protocol Violation|2|||
161290025|NCT03871543|582442628|FG000|Period 1|COVID-19 Related|1|||
161290026|NCT03871543|582442628|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
161290027|NCT03871543|582442628|FG000|Period 1|Withdrawal by Subject|10|||
161290028|NCT03871543|582442628|FG000|Period 2|Adverse Event|1|||
161290029|NCT03871543|582442628|FG000|Period 2|Withdrawal by Subject|1|||
161290030|NCT01894919|582442629|FG000|Overall Study|Withdrawal by Subject|1|||
161166395|NCT04019795|581987898|FG000|Overall Study|Adverse Event|1|||
161166396|NCT04019795|581987899|FG001|Overall Study|Adverse Event|0|||
161290031|NCT01894919|582442630|FG001|Overall Study|Withdrawal by Subject|0|||
161083236|NCT02535091|581693675|FG000|Overall Study|Adverse Event|9|||
161083237|NCT02535091|581693676|FG001|Overall Study|Adverse Event|4|||
161083238|NCT02535091|581693677|FG002|Overall Study|Adverse Event|170|||
161083239|NCT02535091|581693675|FG000|Overall Study|Other|4|||
161083240|NCT02535091|581693676|FG001|Overall Study|Other|3|||
161083241|NCT02535091|581693677|FG002|Overall Study|Other|81|||
161083242|NCT02535091|581693675|FG000|Overall Study|Lost to Follow-up|0|||
161083243|NCT02535091|581693676|FG001|Overall Study|Lost to Follow-up|1|||
161083244|NCT02535091|581693677|FG002|Overall Study|Lost to Follow-up|19|||
161083245|NCT02535091|581693675|FG000|Overall Study|Protocol Violation|0|||
161083246|NCT02535091|581693676|FG001|Overall Study|Protocol Violation|1|||
161083247|NCT02535091|581693677|FG002|Overall Study|Protocol Violation|11|||
161083248|NCT02535091|581693675|FG000|Overall Study|Pregnancy|0|||
161083249|NCT02535091|581693676|FG001|Overall Study|Pregnancy|0|||
161083250|NCT02535091|581693677|FG002|Overall Study|Pregnancy|7|||
161083251|NCT01259089|581693682|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161083252|NCT01259089|581693683|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161083253|NCT01259089|581693684|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161083254|NCT01259089|581693685|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161083255|NCT01259089|581693686|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
161083256|NCT01259089|581693687|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
161083257|NCT01259089|581693682|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
161083258|NCT01259089|581693683|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
161083259|NCT01259089|581693684|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
161083260|NCT01259089|581693685|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
161083261|NCT01259089|581693686|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
161083262|NCT01259089|581693687|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
161083263|NCT01259089|581693682|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161083264|NCT01259089|581693683|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161083265|NCT01259089|581693684|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161083266|NCT01259089|581693685|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161083267|NCT01259089|581693686|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
161083268|NCT01259089|581693687|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
161083269|NCT01259089|581693682|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
161083270|NCT01259089|581693683|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
161083271|NCT01259089|581693684|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
161083272|NCT01259089|581693685|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
161083273|NCT01259089|581693686|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
161083274|NCT01259089|581693687|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
161083275|NCT01259089|581693682|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
161083276|NCT01259089|581693683|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
161083277|NCT01259089|581693684|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
161083278|NCT01259089|581693685|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
161083279|NCT01259089|581693686|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
161083280|NCT01259089|581693687|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
161083281|NCT01259089|581693682|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
161083282|NCT01259089|581693683|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161083283|NCT01259089|581693684|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161083284|NCT01259089|581693685|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161083285|NCT01259089|581693686|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161083286|NCT01259089|581693687|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
161083287|NCT01259089|581693682|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
161083288|NCT01259089|581693683|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
161083289|NCT01259089|581693684|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
161083290|NCT01259089|581693685|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
161083291|NCT01259089|581693686|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
161083292|NCT01259089|581693687|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
161083293|NCT01259089|581693682|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
161083294|NCT01259089|581693683|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
161083295|NCT01259089|581693684|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
161083296|NCT01259089|581693685|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
161083297|NCT01259089|581693686|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
161083298|NCT01259089|581693687|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
161083299|NCT01259089|581693682|FG000|Survival Follow up for Two Years|Death|3|||
161083300|NCT01259089|581693683|FG001|Survival Follow up for Two Years|Death|2|||
161083301|NCT01259089|581693684|FG002|Survival Follow up for Two Years|Death|2|||
161083302|NCT01259089|581693685|FG003|Survival Follow up for Two Years|Death|3|||
161083303|NCT01259089|581693686|FG004|Survival Follow up for Two Years|Death|6|||
161083304|NCT01259089|581693687|FG005|Survival Follow up for Two Years|Death|13|||
161083305|NCT01259089|581693682|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
161166397|NCT04019795|581987900|FG002|Overall Study|Adverse Event|0|||
161166398|NCT04019795|581987901|FG003|Overall Study|Adverse Event|0|||
161166399|NCT03625141|581987902|FG000|Overall Study|Adverse Event|0|||
161166400|NCT03625141|581987903|FG001|Overall Study|Adverse Event|2|||
161166401|NCT03625141|581987902|FG000|Overall Study|Study Terminated By Sponsor|1|||
161166402|NCT03625141|581987903|FG001|Overall Study|Study Terminated By Sponsor|13|||
161166403|NCT03625141|581987902|FG000|Overall Study|Withdrawal by Subject|3|||
161166404|NCT03625141|581987903|FG001|Overall Study|Withdrawal by Subject|0|||
161166405|NCT03625141|581987902|FG000|Overall Study|Withdrawal Of Consent|0|||
161166406|NCT03625141|581987903|FG001|Overall Study|Withdrawal Of Consent|1|||
161166407|NCT03625141|581987902|FG000|Overall Study|Death|11|||
161166408|NCT03625141|581987903|FG001|Overall Study|Death|47|||
161166409|NCT03625141|581987902|FG000|Overall Study|Progressive Disease|0|||
161166410|NCT03625141|581987903|FG001|Overall Study|Progressive Disease|2|||
161166411|NCT03250377|581987904|FG000|Overall Study|Adverse Event|2|||
161166412|NCT03250377|581987905|FG001|Overall Study|Adverse Event|4|||
161166413|NCT03250377|581987906|FG002|Overall Study|Adverse Event|0|||
161166414|NCT03250377|581987907|FG003|Overall Study|Adverse Event|4|||
161166415|NCT03250377|581987904|FG000|Overall Study|Lack of Efficacy|5|||
161166416|NCT03250377|581987905|FG001|Overall Study|Lack of Efficacy|14|||
161166417|NCT03250377|581987906|FG002|Overall Study|Lack of Efficacy|1|||
161166418|NCT03250377|581987907|FG003|Overall Study|Lack of Efficacy|3|||
161166419|NCT03250377|581987904|FG000|Overall Study|Protocol Violation|0|||
161166420|NCT03250377|581987905|FG001|Overall Study|Protocol Violation|2|||
161290032|NCT01894919|582442631|FG002|Overall Study|Withdrawal by Subject|0|||
161290033|NCT01894919|582442632|FG003|Overall Study|Withdrawal by Subject|0|||
161166421|NCT03250377|581987906|FG002|Overall Study|Protocol Violation|0|||
161166422|NCT03250377|581987907|FG003|Overall Study|Protocol Violation|1|||
161166423|NCT03250377|581987904|FG000|Overall Study|Lost to Follow-up|0|||
161166424|NCT03250377|581987905|FG001|Overall Study|Lost to Follow-up|1|||
161166425|NCT03250377|581987906|FG002|Overall Study|Lost to Follow-up|0|||
161166426|NCT03250377|581987907|FG003|Overall Study|Lost to Follow-up|0|||
161166427|NCT03250377|581987904|FG000|Overall Study|Withdrawal by Subject|7|||
161166428|NCT03250377|581987905|FG001|Overall Study|Withdrawal by Subject|7|||
161166429|NCT03250377|581987906|FG002|Overall Study|Withdrawal by Subject|0|||
161166430|NCT03250377|581987907|FG003|Overall Study|Withdrawal by Subject|4|||
161166431|NCT03250377|581987904|FG000|Overall Study|Investigator's Judgment|1|||
161166432|NCT03250377|581987905|FG001|Overall Study|Investigator's Judgment|0|||
161166433|NCT03250377|581987906|FG002|Overall Study|Investigator's Judgment|0|||
161166434|NCT03250377|581987907|FG003|Overall Study|Investigator's Judgment|0|||
161166435|NCT03250377|581987904|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
161166436|NCT03250377|581987905|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
161166437|NCT03250377|581987906|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
161166438|NCT03250377|581987907|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
161166439|NCT03250377|581987904|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
161166440|NCT03250377|581987905|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
161166441|NCT03250377|581987906|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
161166442|NCT03250377|581987907|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
161290034|NCT01894919|582442633|FG004|Overall Study|Withdrawal by Subject|1|||
161290035|NCT01894919|582442634|FG005|Overall Study|Withdrawal by Subject|0|||
161290036|NCT01894919|582442635|FG006|Overall Study|Withdrawal by Subject|0|||
161290037|NCT01894919|582442636|FG007|Overall Study|Withdrawal by Subject|0|||
161290038|NCT01894919|582442637|FG008|Overall Study|Withdrawal by Subject|0|||
161290039|NCT01894919|582442638|FG009|Overall Study|Withdrawal by Subject|1|||
161290040|NCT01894919|582442639|FG010|Overall Study|Withdrawal by Subject|1|||
161290041|NCT01894919|582442640|FG011|Overall Study|Withdrawal by Subject|0|||
161290042|NCT01894919|582442641|FG012|Overall Study|Withdrawal by Subject|0|||
161290043|NCT01894919|582442629|FG000|Overall Study|Adverse Event|0|||
161347017|NCT02335944|582654755|FG002|Treatment Phase|Adverse Event|0|||
161166443|NCT03250377|581987904|FG000|Overall Study|Epilepsy Surgery|0|||
161166444|NCT03250377|581987905|FG001|Overall Study|Epilepsy Surgery|1|||
161166445|NCT03250377|581987906|FG002|Overall Study|Epilepsy Surgery|2|||
161166446|NCT03250377|581987907|FG003|Overall Study|Epilepsy Surgery|0|||
161166447|NCT03250377|581987904|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161166448|NCT03250377|581987905|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
161166449|NCT03250377|581987906|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161166450|NCT03250377|581987907|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
161166451|NCT03250377|581987904|FG000|Overall Study|Request From The Sponsor|0|||
161166452|NCT03250377|581987905|FG001|Overall Study|Request From The Sponsor|1|||
161347018|NCT02335944|582654756|FG003|Treatment Phase|Adverse Event|2|||
161347019|NCT02335944|582654757|FG004|Treatment Phase|Adverse Event|1|||
161347020|NCT02335944|582654758|FG005|Treatment Phase|Adverse Event|15|||
161347021|NCT02335944|582654759|FG006|Treatment Phase|Adverse Event|0|||
161347022|NCT02335944|582654760|FG007|Treatment Phase|Adverse Event|5|||
161347023|NCT02335944|582654761|FG008|Treatment Phase|Adverse Event|7|||
161347024|NCT02335944|582654762|FG009|Treatment Phase|Adverse Event|0|||
161166453|NCT03250377|581987906|FG002|Overall Study|Request From The Sponsor|0|||
161166454|NCT03250377|581987907|FG003|Overall Study|Request From The Sponsor|0|||
161166455|NCT03250377|581987904|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
161166456|NCT03250377|581987905|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
161166457|NCT03250377|581987906|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
161166458|NCT03250377|581987907|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
161166459|NCT03250377|581987904|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
161166460|NCT03250377|581987905|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
161166461|NCT03250377|581987906|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
161166462|NCT03250377|581987907|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
161166463|NCT03250377|581987904|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
161166464|NCT03250377|581987905|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
161166465|NCT03250377|581987906|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
161166466|NCT03250377|581987907|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
161166467|NCT03250377|581987904|FG000|Overall Study|Pregnancy Event|0|||
161166468|NCT03250377|581987905|FG001|Overall Study|Pregnancy Event|1|||
161166469|NCT03250377|581987906|FG002|Overall Study|Pregnancy Event|0|||
161166470|NCT03250377|581987907|FG003|Overall Study|Pregnancy Event|0|||
161166471|NCT03250377|581987904|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161166472|NCT03250377|581987905|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
161166473|NCT03250377|581987906|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161166474|NCT03250377|581987907|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
161166475|NCT03250377|581987904|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161166476|NCT03250377|581987905|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
161166477|NCT03250377|581987906|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161166478|NCT03250377|581987907|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
161166479|NCT03250377|581987904|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161166480|NCT03250377|581987905|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
161083306|NCT01259089|581693683|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
161083307|NCT01259089|581693684|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
161083308|NCT01259089|581693685|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
161083309|NCT01259089|581693686|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
161083310|NCT01259089|581693687|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
161083311|NCT01259089|581693682|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161083312|NCT01259089|581693683|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161083313|NCT01259089|581693684|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161083314|NCT01259089|581693685|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161083315|NCT01259089|581693686|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
161083316|NCT01259089|581693687|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
161083317|NCT00688870|581693688|FG000|Infant Series|Parent or legal guardian request|4|||
161083318|NCT00688870|581693689|FG001|Infant Series|Parent or legal guardian request|0|||
161083319|NCT01151410|581693690|FG000|Overall Study|Withdrawal by Subject|3|||
161083320|NCT01151410|581693691|FG001|Overall Study|Withdrawal by Subject|5|||
161083321|NCT01151410|581693690|FG000|Overall Study|Lost to Follow-up|3|||
161083322|NCT01151410|581693691|FG001|Overall Study|Lost to Follow-up|4|||
161083323|NCT01151410|581693690|FG000|Overall Study|Adverse Event|1|||
161083324|NCT01151410|581693691|FG001|Overall Study|Adverse Event|2|||
161083325|NCT01151410|581693690|FG000|Overall Study|Protocol deviation|2|||
161083326|NCT01151410|581693691|FG001|Overall Study|Protocol deviation|1|||
161083327|NCT01151410|581693690|FG000|Overall Study|Administrative problems|1|||
161083328|NCT01151410|581693691|FG001|Overall Study|Administrative problems|1|||
161083329|NCT01151410|581693690|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161083330|NCT01151410|581693691|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
161083331|NCT01151410|581693690|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161083332|NCT01151410|581693691|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161083333|NCT01253018|581693692|FG000|Overall Study|Lost to Follow-up|1|||
161083334|NCT01253018|581693693|FG001|Overall Study|Lost to Follow-up|1|||
161083335|NCT01253018|581693692|FG000|Overall Study|Robot Repair Issues|2|||
161083336|NCT01253018|581693693|FG001|Overall Study|Robot Repair Issues|0|||
161083337|NCT01253018|581693692|FG000|Overall Study|Withdrawal by Subject|1|||
161083338|NCT01253018|581693693|FG001|Overall Study|Withdrawal by Subject|1|||
161166481|NCT03250377|581987906|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161290044|NCT01894919|582442630|FG001|Overall Study|Adverse Event|0|||
161290045|NCT01894919|582442631|FG002|Overall Study|Adverse Event|0|||
161083339|NCT00744757|581693694|FG000|Overall Study|Objective disease progression|7|||
161083340|NCT00744757|581693694|FG000|Overall Study|Physician Decision|5|||
161083341|NCT00744757|581693694|FG000|Overall Study|Withdrawal by Subject|1|||
161083342|NCT00744757|581693694|FG000|Overall Study|Death|6|||
161166482|NCT03250377|581987907|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
161166483|NCT03250377|581987904|FG000|Overall Study|Patient requested to change hospital|0|||
161166484|NCT03250377|581987905|FG001|Overall Study|Patient requested to change hospital|0|||
161166485|NCT03250377|581987906|FG002|Overall Study|Patient requested to change hospital|0|||
161166486|NCT03250377|581987907|FG003|Overall Study|Patient requested to change hospital|1|||
161166487|NCT03250377|581987904|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
161166488|NCT03250377|581987905|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
161166489|NCT03250377|581987906|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
161166490|NCT03250377|581987907|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
161166491|NCT01114373|581987908|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
161166492|NCT01114373|581987909|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
161166493|NCT01114373|581987908|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
161166494|NCT01114373|581987909|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
161166495|NCT01114373|581987908|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
161166496|NCT01114373|581987909|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
161166497|NCT01114373|581987908|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
161166498|NCT01114373|581987909|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
161166499|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161166500|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161166501|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
161166502|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
161166503|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161166504|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
161166505|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
161166506|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
161166507|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
161166508|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161166509|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161166510|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
161166511|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
161166512|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
161166513|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
161166514|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161166515|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161166516|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
161166517|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
161166518|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
161166519|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161166520|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161166521|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161166522|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
161166523|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
161166524|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
161166525|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161166526|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161166527|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161166528|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
161166529|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
161166530|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161166531|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161166532|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161166533|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161166534|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
161166535|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
161166536|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
161166537|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
161166538|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
161166539|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
161166540|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
161166541|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
161166542|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
161166543|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161166544|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161290046|NCT01894919|582442632|FG003|Overall Study|Adverse Event|0|||
161290047|NCT01894919|582442633|FG004|Overall Study|Adverse Event|0|||
161290048|NCT01894919|582442634|FG005|Overall Study|Adverse Event|0|||
161290049|NCT01894919|582442635|FG006|Overall Study|Adverse Event|0|||
161166545|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161166546|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
161166547|NCT03444870|581987910|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
161166548|NCT03444870|581987911|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161166549|NCT03444870|581987912|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161166550|NCT03444870|581987913|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161166551|NCT03444870|581987914|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161166552|NCT03444870|581987915|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
161166553|NCT03444870|581987910|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161166554|NCT03444870|581987911|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161166555|NCT03444870|581987912|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161166556|NCT03444870|581987913|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
161166557|NCT03444870|581987914|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
161166558|NCT03444870|581987915|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
161166559|NCT03444870|581987910|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
161166560|NCT03444870|581987911|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
161166561|NCT03444870|581987912|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
161166562|NCT03444870|581987913|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
161166563|NCT03444870|581987914|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
161166564|NCT03444870|581987915|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
161166565|NCT03444870|581987910|FG000|Open-Label Extension (OLE) Period|Death|0|||
161166566|NCT03444870|581987911|FG001|Open-Label Extension (OLE) Period|Death|0|||
161166567|NCT03444870|581987912|FG002|Open-Label Extension (OLE) Period|Death|0|||
161166568|NCT03444870|581987913|FG003|Open-Label Extension (OLE) Period|Death|0|||
161166569|NCT03444870|581987914|FG004|Open-Label Extension (OLE) Period|Death|1|||
161166570|NCT03444870|581987915|FG005|Open-Label Extension (OLE) Period|Death|0|||
161166571|NCT02034552|581987916|FG000|Overall Study|Never treated|3|||
161166572|NCT02034552|581987917|FG001|Overall Study|Never treated|2|||
161166573|NCT02034552|581987918|FG002|Overall Study|Never treated|0|||
161166574|NCT02034552|581987916|FG000|Overall Study|Radiological progression|3|||
161166575|NCT02034552|581987917|FG001|Overall Study|Radiological progression|5|||
161166576|NCT02034552|581987918|FG002|Overall Study|Radiological progression|4|||
161166577|NCT02034552|581987916|FG000|Overall Study|AE not assoc. with disease progression|1|||
161166578|NCT02034552|581987917|FG001|Overall Study|AE not assoc. with disease progression|4|||
161166579|NCT02034552|581987918|FG002|Overall Study|AE not assoc. with disease progression|2|||
161166580|NCT02034552|581987916|FG000|Overall Study|AE associated with disease progression|0|||
161166581|NCT02034552|581987917|FG001|Overall Study|AE associated with disease progression|1|||
161166582|NCT02034552|581987918|FG002|Overall Study|AE associated with disease progression|0|||
161166583|NCT02034552|581987916|FG000|Overall Study|Withdrawal by Subject|2|||
161166584|NCT02034552|581987917|FG001|Overall Study|Withdrawal by Subject|1|||
161166585|NCT02034552|581987918|FG002|Overall Study|Withdrawal by Subject|1|||
161166586|NCT02034552|581987916|FG000|Overall Study|Non-compliance with study drug|0|||
161166587|NCT02034552|581987917|FG001|Overall Study|Non-compliance with study drug|0|||
161166588|NCT02034552|581987918|FG002|Overall Study|Non-compliance with study drug|1|||
161166589|NCT02034552|581987916|FG000|Overall Study|Clinical progression|5|||
161166590|NCT02034552|581987917|FG001|Overall Study|Clinical progression|7|||
161166591|NCT02034552|581987918|FG002|Overall Study|Clinical progression|9|||
161166592|NCT03819218|581987921|FG000|Overall Study|Protocol Violation|1|||
161166593|NCT02501902|581987922|FG000|Overall Study|Subject Refused Further Follow-up|0|||
161166594|NCT02501902|581987923|FG001|Overall Study|Subject Refused Further Follow-up|0|||
161166595|NCT02501902|581987924|FG002|Overall Study|Subject Refused Further Follow-up|0|||
161166596|NCT02501902|581987925|FG003|Overall Study|Subject Refused Further Follow-up|0|||
161166597|NCT02501902|581987926|FG004|Overall Study|Subject Refused Further Follow-up|0|||
161166598|NCT02501902|581987927|FG005|Overall Study|Subject Refused Further Follow-up|0|||
161166599|NCT02501902|581987928|FG006|Overall Study|Subject Refused Further Follow-up|0|||
161166600|NCT02501902|581987929|FG007|Overall Study|Subject Refused Further Follow-up|1|||
161166601|NCT02501902|581987922|FG000|Overall Study|Study Terminated by Sponsor|0|||
161166602|NCT02501902|581987923|FG001|Overall Study|Study Terminated by Sponsor|3|||
161166603|NCT02501902|581987924|FG002|Overall Study|Study Terminated by Sponsor|0|||
161166604|NCT02501902|581987925|FG003|Overall Study|Study Terminated by Sponsor|1|||
161166605|NCT02501902|581987926|FG004|Overall Study|Study Terminated by Sponsor|1|||
161166606|NCT02501902|581987927|FG005|Overall Study|Study Terminated by Sponsor|0|||
161166607|NCT02501902|581987928|FG006|Overall Study|Study Terminated by Sponsor|2|||
161166608|NCT02501902|581987929|FG007|Overall Study|Study Terminated by Sponsor|4|||
161166609|NCT02501902|581987922|FG000|Overall Study|Death|3|||
161166610|NCT02501902|581987923|FG001|Overall Study|Death|4|||
161166611|NCT02501902|581987924|FG002|Overall Study|Death|4|||
161166612|NCT02501902|581987925|FG003|Overall Study|Death|10|||
161166613|NCT02501902|581987926|FG004|Overall Study|Death|10|||
161166614|NCT02501902|581987927|FG005|Overall Study|Death|11|||
161166615|NCT02501902|581987928|FG006|Overall Study|Death|7|||
161166616|NCT02501902|581987929|FG007|Overall Study|Death|15|||
161166617|NCT02267278|581987930|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
161166618|NCT02267278|581987930|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
161166619|NCT02267278|581987930|FG000|Overall Study|Developed new cancer diagnoses|2|||
161166620|NCT02267278|581987930|FG000|Overall Study|prescribed prohibited medication|1|||
161166621|NCT02513771|581987931|FG000|Overall Study|Lost to Follow-up|1|||
161166622|NCT02513771|581987932|FG001|Overall Study|Lost to Follow-up|1|||
161166623|NCT02513771|581987931|FG000|Overall Study|Not being able to get to clinic|1|||
161166624|NCT02513771|581987932|FG001|Overall Study|Not being able to get to clinic|0|||
161166625|NCT04295356|581987933|FG000|Overall Study|Physician Decision|1|||
161166626|NCT04295356|581987934|FG001|Overall Study|Physician Decision|0|||
161166627|NCT04295356|581987933|FG000|Overall Study|Lost to Follow-up|0|||
161166628|NCT04295356|581987934|FG001|Overall Study|Lost to Follow-up|3|||
161166629|NCT04295356|581987933|FG000|Overall Study|Protocol Violation|0|||
161166630|NCT04295356|581987934|FG001|Overall Study|Protocol Violation|1|||
161166631|NCT01280266|581987935|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
161166632|NCT01280266|581987936|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
161166633|NCT01280266|581987935|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
161166634|NCT01280266|581987936|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
161166635|NCT04116073|581987939|FG000|Overall Study|Withdrawal by Subject|2|||
161166636|NCT04116073|581987939|FG000|Overall Study|failed to maintained eligibility|1|||
161166637|NCT01453998|581987943|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
161166638|NCT01453998|581987944|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
161166639|NCT01453998|581987945|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
161166640|NCT01840228|581987952|FG000|Overall Study|Lost to Follow-up|1|||
161166641|NCT01840228|581987953|FG001|Overall Study|Lost to Follow-up|1|||
161166642|NCT03495453|581987954|FG000|Overall Study|Withdrawal by Subject|0|||
161166643|NCT03495453|581987955|FG001|Overall Study|Withdrawal by Subject|1|||
161166644|NCT00712933|581987956|FG000|Overall Study|Adverse Event|69|||
161166645|NCT00712933|581987956|FG000|Overall Study|Lack of Efficacy|6|||
161166646|NCT00712933|581987956|FG000|Overall Study|Lost to Follow-up|22|||
161166647|NCT00712933|581987956|FG000|Overall Study|Non-compliance with study drug|13|||
161166648|NCT00712933|581987956|FG000|Overall Study|Other Pregnancy|37|||
161166649|NCT00712933|581987956|FG000|Overall Study|Sponsor decision|14|||
161166650|NCT00712933|581987956|FG000|Overall Study|Withdrew consent|4|||
161166651|NCT00712933|581987956|FG000|Overall Study|Hip replacement surgery|1|||
161166652|NCT00712933|581987956|FG000|Overall Study|Involved in Clinical research|3|||
161166653|NCT00712933|581987956|FG000|Overall Study|Participant hospitalized|1|||
161166654|NCT00712933|581987956|FG000|Overall Study|Participant travelled overseas|2|||
161166655|NCT00712933|581987956|FG000|Overall Study|Death of patient|1|||
161166656|NCT00712933|581987956|FG000|Overall Study|Other Physician decision|1|||
161166657|NCT00712933|581987956|FG000|Overall Study|Not committed to contraception|1|||
161166658|NCT00712933|581987956|FG000|Overall Study|Participant received medication|1|||
161166659|NCT00712933|581987956|FG000|Overall Study|Physician Decision|36|||
161166660|NCT00712933|581987956|FG000|Overall Study|Protocol Violation|4|||
161166661|NCT00712933|581987956|FG000|Overall Study|Withdrawal by Subject|151|||
161166662|NCT02022033|581987962|FG000|Overall Study|Physician Decision|1|||
161166663|NCT01429077|581987963|FG000|Overall Study|Lost to Follow-up|0|||
161166664|NCT01429077|581987964|FG001|Overall Study|Lost to Follow-up|3|||
161166665|NCT01413542|581987966|FG000|Overall Study|Physician Decision|1|||
161166666|NCT01413542|581987967|FG001|Overall Study|Physician Decision|0|||
161166667|NCT01413542|581987968|FG002|Overall Study|Physician Decision|3|||
161166668|NCT01413542|581987969|FG003|Overall Study|Physician Decision|0|||
161166669|NCT01413542|581987966|FG000|Overall Study|Adverse Event|0|||
161166670|NCT01413542|581987967|FG001|Overall Study|Adverse Event|0|||
161166671|NCT01413542|581987968|FG002|Overall Study|Adverse Event|0|||
161166672|NCT01413542|581987969|FG003|Overall Study|Adverse Event|1|||
161166673|NCT01879319|581987974|FG000|Overall Study|Withdrawal by Subject|1|||
161166674|NCT01879319|581987975|FG001|Overall Study|Withdrawal by Subject|0|||
161166675|NCT01879319|581987974|FG000|Overall Study|Lost to Follow-up|1|||
161166676|NCT01879319|581987975|FG001|Overall Study|Lost to Follow-up|5|||
161166677|NCT01360762|581987976|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
161166678|NCT01360762|581987976|FG000|Main Study Period (12-month Treatment)|Death|5|||
161166679|NCT01360762|581987976|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
161166680|NCT01360762|581987976|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
161166681|NCT01360762|581987976|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
161166682|NCT01360762|581987976|FG000|Whole Study Period|Lost to Follow-up|10|||
161166683|NCT01360762|581987976|FG000|Whole Study Period|Death|7|||
161166684|NCT01360762|581987976|FG000|Whole Study Period|Patient relapsed|18|||
161166685|NCT01360762|581987976|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
161166686|NCT01103778|581987977|FG000|Overall Study|Lost to Follow-up|1|||
161166687|NCT01103778|581987977|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
161166688|NCT01103778|581987977|FG000|Overall Study|Screen failure|1|||
161166689|NCT03067129|581987978|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161166690|NCT03067129|581987979|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161166691|NCT03067129|581987980|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
161166692|NCT03067129|581987981|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
161166693|NCT03067129|581987978|FG000|Overall Study|Withdrawal by Subject|0|||
161166694|NCT03067129|581987979|FG001|Overall Study|Withdrawal by Subject|0|||
161166695|NCT03067129|581987980|FG002|Overall Study|Withdrawal by Subject|1|||
161166696|NCT03067129|581987981|FG003|Overall Study|Withdrawal by Subject|2|||
161166697|NCT03067129|581987978|FG000|Overall Study|Lost to Follow-up|5|||
161166698|NCT03067129|581987979|FG001|Overall Study|Lost to Follow-up|5|||
161166699|NCT03067129|581987980|FG002|Overall Study|Lost to Follow-up|4|||
161166700|NCT03067129|581987981|FG003|Overall Study|Lost to Follow-up|3|||
161166701|NCT03084718|581987982|FG000|Overall Study|Withdrawal by Subject|4|||
161166702|NCT03084718|581987983|FG001|Overall Study|Withdrawal by Subject|3|||
161166703|NCT03084718|581987984|FG002|Overall Study|Withdrawal by Subject|4|||
161166704|NCT03084718|581987985|FG003|Overall Study|Withdrawal by Subject|0|||
161166705|NCT03084718|581987986|FG004|Overall Study|Withdrawal by Subject|0|||
161166706|NCT03084718|581987982|FG000|Overall Study|Physician Decision|1|||
161166707|NCT03084718|581987983|FG001|Overall Study|Physician Decision|0|||
161166708|NCT03084718|581987984|FG002|Overall Study|Physician Decision|0|||
161166709|NCT03084718|581987985|FG003|Overall Study|Physician Decision|0|||
161166710|NCT03084718|581987986|FG004|Overall Study|Physician Decision|0|||
161166711|NCT03084718|581987982|FG000|Overall Study|Adverse Event|3|||
161166712|NCT03084718|581987983|FG001|Overall Study|Adverse Event|5|||
161166713|NCT03084718|581987984|FG002|Overall Study|Adverse Event|5|||
161166714|NCT03084718|581987985|FG003|Overall Study|Adverse Event|8|||
161166715|NCT03084718|581987986|FG004|Overall Study|Adverse Event|2|||
161166716|NCT03084718|581987982|FG000|Overall Study|Lack of Efficacy|2|||
161166717|NCT03084718|581987983|FG001|Overall Study|Lack of Efficacy|0|||
161166718|NCT03084718|581987984|FG002|Overall Study|Lack of Efficacy|1|||
161166719|NCT03084718|581987985|FG003|Overall Study|Lack of Efficacy|4|||
161166720|NCT03084718|581987986|FG004|Overall Study|Lack of Efficacy|0|||
161166721|NCT03084718|581987982|FG000|Overall Study|Lost to Follow-up|0|||
161166722|NCT03084718|581987983|FG001|Overall Study|Lost to Follow-up|1|||
161166723|NCT03084718|581987984|FG002|Overall Study|Lost to Follow-up|0|||
161166724|NCT03084718|581987985|FG003|Overall Study|Lost to Follow-up|0|||
161166725|NCT03084718|581987986|FG004|Overall Study|Lost to Follow-up|2|||
161166726|NCT03084718|581987982|FG000|Overall Study|Protocol Violation|0|||
161166727|NCT03084718|581987983|FG001|Overall Study|Protocol Violation|0|||
161166728|NCT03084718|581987984|FG002|Overall Study|Protocol Violation|1|||
161166729|NCT03084718|581987985|FG003|Overall Study|Protocol Violation|0|||
161166730|NCT03084718|581987986|FG004|Overall Study|Protocol Violation|0|||
161166731|NCT03084718|581987982|FG000|Overall Study|Death|0|||
161166732|NCT03084718|581987983|FG001|Overall Study|Death|1|||
161166733|NCT03084718|581987984|FG002|Overall Study|Death|0|||
161166734|NCT03084718|581987985|FG003|Overall Study|Death|0|||
161166735|NCT03084718|581987986|FG004|Overall Study|Death|0|||
161166736|NCT03084718|581987982|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
161166737|NCT03084718|581987983|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
161166738|NCT03084718|581987984|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
161166739|NCT03084718|581987985|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
161166740|NCT03084718|581987986|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
161166741|NCT02806947|581987987|FG000|Overall Study|Withdrawal by Subject|5|||
161166742|NCT02806947|581987988|FG001|Overall Study|Withdrawal by Subject|1|||
161166743|NCT04929613|581987989|FG000|Overall Study|Withdrawal by Subject|12|||
161166744|NCT00065442|581987994|FG000|Overall Study|Lost to Follow-up|1|||
161166745|NCT00065442|581987995|FG001|Overall Study|Lost to Follow-up|1|||
161166746|NCT00065442|581987994|FG000|Overall Study|Death|121|||
161166747|NCT00065442|581987995|FG001|Overall Study|Death|210|||
161166748|NCT00065442|581987994|FG000|Overall Study|Withdrawal by Subject|3|||
161166749|NCT00065442|581987995|FG001|Overall Study|Withdrawal by Subject|9|||
161166750|NCT00712322|581987999|FG000|Overall Study|Protocol deviation|0|||
161166751|NCT00712322|581988000|FG001|Overall Study|Protocol deviation|1|||
161166752|NCT00712322|581988001|FG002|Overall Study|Protocol deviation|0|||
161166753|NCT00400712|581988003|FG000|Overall Study|Death|1|||
161290050|NCT01894919|582442636|FG007|Overall Study|Adverse Event|0|||
161290051|NCT01894919|582442637|FG008|Overall Study|Adverse Event|0|||
161290052|NCT01894919|582442638|FG009|Overall Study|Adverse Event|0|||
161290053|NCT01894919|582442639|FG010|Overall Study|Adverse Event|1|||
161166754|NCT00400712|581988004|FG001|Overall Study|Death|0|||
161166755|NCT00400712|581988003|FG000|Overall Study|Withdrawal by Subject|11|||
161166756|NCT00400712|581988004|FG001|Overall Study|Withdrawal by Subject|12|||
161166757|NCT00400712|581988003|FG000|Overall Study|Physician Decision|5|||
161166758|NCT00400712|581988004|FG001|Overall Study|Physician Decision|4|||
161166759|NCT04404010|581988005|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
161290054|NCT01894919|582442640|FG011|Overall Study|Adverse Event|0|||
161290055|NCT01894919|582442641|FG012|Overall Study|Adverse Event|0|||
161290056|NCT01894919|582442629|FG000|Overall Study|Other-Unspecified|1|||
161166760|NCT04404010|581988006|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
161166761|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
161166762|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
161166763|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
161166764|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
161166765|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
161166766|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
161166767|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Death|1|||
161166768|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Death|3|||
161166769|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
161166770|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
161166771|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
161166772|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
161166773|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
161166774|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
161166775|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
161166776|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
161166777|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
161166778|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
161166779|NCT02553317|581988007|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
161166780|NCT02553317|581988008|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
161166781|NCT02120157|581988009|FG000|Overall Study|Death|8|||
161166782|NCT00622869|581988013|FG000|Overall Study|Subject Withdrew Consent|13|||
161166783|NCT00622869|581988014|FG001|Overall Study|Subject Withdrew Consent|17|||
161166784|NCT00622869|581988015|FG002|Overall Study|Subject Withdrew Consent|11|||
161166785|NCT00622869|581988013|FG000|Overall Study|Administrative Problems|11|||
161166786|NCT00622869|581988014|FG001|Overall Study|Administrative Problems|17|||
161166787|NCT00622869|581988015|FG002|Overall Study|Administrative Problems|13|||
161166788|NCT00622869|581988013|FG000|Overall Study|Death|12|||
161166789|NCT00622869|581988014|FG001|Overall Study|Death|15|||
161166790|NCT00622869|581988015|FG002|Overall Study|Death|10|||
161166791|NCT00622869|581988013|FG000|Overall Study|Lost to Follow-up|2|||
161166792|NCT00622869|581988014|FG001|Overall Study|Lost to Follow-up|4|||
161166793|NCT00622869|581988015|FG002|Overall Study|Lost to Follow-up|2|||
161166794|NCT00622869|581988013|FG000|Overall Study|Graft Loss|5|||
161166795|NCT00622869|581988014|FG001|Overall Study|Graft Loss|3|||
161166796|NCT00622869|581988015|FG002|Overall Study|Graft Loss|2|||
161166797|NCT00622869|581988013|FG000|Overall Study|Missing|0|||
161166798|NCT00622869|581988014|FG001|Overall Study|Missing|1|||
161166799|NCT00622869|581988015|FG002|Overall Study|Missing|1|||
161166800|NCT02648724|581988017|FG000|Overall Study|Withdrawal by Subject|0|||
161166801|NCT02648724|581988018|FG001|Overall Study|Withdrawal by Subject|1|||
161166802|NCT02648724|581988019|FG002|Overall Study|Withdrawal by Subject|1|||
161166803|NCT02648724|581988020|FG003|Overall Study|Withdrawal by Subject|0|||
161166804|NCT02648724|581988021|FG004|Overall Study|Withdrawal by Subject|1|||
161166805|NCT02648724|581988022|FG005|Overall Study|Withdrawal by Subject|0|||
161166806|NCT02648724|581988023|FG006|Overall Study|Withdrawal by Subject|0|||
161166807|NCT02648724|581988017|FG000|Overall Study|Progressive disease|2|||
161166808|NCT02648724|581988018|FG001|Overall Study|Progressive disease|2|||
161166809|NCT02648724|581988019|FG002|Overall Study|Progressive disease|2|||
161166810|NCT02648724|581988020|FG003|Overall Study|Progressive disease|3|||
161166811|NCT02648724|581988021|FG004|Overall Study|Progressive disease|22|||
161166812|NCT02648724|581988022|FG005|Overall Study|Progressive disease|7|||
161166813|NCT02648724|581988023|FG006|Overall Study|Progressive disease|8|||
161166814|NCT02648724|581988017|FG000|Overall Study|Other reason (unknown)|1|||
161166815|NCT02648724|581988018|FG001|Overall Study|Other reason (unknown)|0|||
161166816|NCT02648724|581988019|FG002|Overall Study|Other reason (unknown)|0|||
161166817|NCT02648724|581988020|FG003|Overall Study|Other reason (unknown)|0|||
161166818|NCT02648724|581988021|FG004|Overall Study|Other reason (unknown)|0|||
161166819|NCT02648724|581988022|FG005|Overall Study|Other reason (unknown)|0|||
161166820|NCT02648724|581988023|FG006|Overall Study|Other reason (unknown)|0|||
161166821|NCT02648724|581988017|FG000|Overall Study|Protocol Violation|0|||
161166822|NCT02648724|581988018|FG001|Overall Study|Protocol Violation|0|||
161166823|NCT02648724|581988019|FG002|Overall Study|Protocol Violation|0|||
161166824|NCT02648724|581988020|FG003|Overall Study|Protocol Violation|0|||
161166825|NCT02648724|581988021|FG004|Overall Study|Protocol Violation|1|||
161166826|NCT02648724|581988022|FG005|Overall Study|Protocol Violation|0|||
161166827|NCT02648724|581988023|FG006|Overall Study|Protocol Violation|0|||
161166828|NCT02648724|581988017|FG000|Overall Study|Death|0|||
161166829|NCT02648724|581988018|FG001|Overall Study|Death|0|||
161290057|NCT01894919|582442630|FG001|Overall Study|Other-Unspecified|0|||
161290058|NCT01894919|582442631|FG002|Overall Study|Other-Unspecified|0|||
161166830|NCT02648724|581988019|FG002|Overall Study|Death|0|||
161166831|NCT02648724|581988020|FG003|Overall Study|Death|0|||
161166832|NCT02648724|581988021|FG004|Overall Study|Death|0|||
161166833|NCT02648724|581988022|FG005|Overall Study|Death|0|||
161166834|NCT02648724|581988023|FG006|Overall Study|Death|3|||
161166835|NCT02648724|581988017|FG000|Overall Study|Physician Decision|0|||
161166836|NCT02648724|581988018|FG001|Overall Study|Physician Decision|0|||
161166837|NCT02648724|581988019|FG002|Overall Study|Physician Decision|0|||
161166838|NCT02648724|581988020|FG003|Overall Study|Physician Decision|0|||
161166839|NCT02648724|581988021|FG004|Overall Study|Physician Decision|1|||
161166840|NCT02648724|581988022|FG005|Overall Study|Physician Decision|0|||
161166841|NCT02648724|581988023|FG006|Overall Study|Physician Decision|1|||
161166842|NCT02648724|581988017|FG000|Overall Study|Transferred to named patient program|0|||
161166843|NCT02648724|581988018|FG001|Overall Study|Transferred to named patient program|0|||
161166844|NCT02648724|581988019|FG002|Overall Study|Transferred to named patient program|0|||
161166845|NCT02648724|581988020|FG003|Overall Study|Transferred to named patient program|0|||
161166846|NCT02648724|581988021|FG004|Overall Study|Transferred to named patient program|0|||
161166847|NCT02648724|581988022|FG005|Overall Study|Transferred to named patient program|1|||
161166848|NCT02648724|581988023|FG006|Overall Study|Transferred to named patient program|0|||
161166849|NCT00302718|581988024|FG000|Overall Study|Participant left the hospital|1|||
161166850|NCT00302718|581988025|FG001|Overall Study|Participant left the hospital|0|||
161166851|NCT00302718|581988026|FG002|Overall Study|Participant left the hospital|0|||
161166852|NCT00302718|581988027|FG003|Overall Study|Participant left the hospital|1|||
161166853|NCT00302718|581988024|FG000|Overall Study|Withdrawal by Subject|0|||
161166854|NCT00302718|581988025|FG001|Overall Study|Withdrawal by Subject|1|||
161166855|NCT00302718|581988026|FG002|Overall Study|Withdrawal by Subject|0|||
161166856|NCT00302718|581988027|FG003|Overall Study|Withdrawal by Subject|0|||
161166857|NCT00302718|581988024|FG000|Overall Study|Participant left primary care setting|0|||
161166858|NCT00302718|581988025|FG001|Overall Study|Participant left primary care setting|0|||
161166859|NCT00302718|581988026|FG002|Overall Study|Participant left primary care setting|2|||
161166860|NCT00302718|581988027|FG003|Overall Study|Participant left primary care setting|1|||
161166861|NCT00738374|581988028|FG000|Induction Treatment Phase|Adverse Event|14|||
161166862|NCT00738374|581988029|FG001|Induction Treatment Phase|Adverse Event|0|||
161166863|NCT00738374|581988030|FG002|Induction Treatment Phase|Adverse Event|0|||
161166864|NCT00738374|581988031|FG003|Induction Treatment Phase|Adverse Event|0|||
161166865|NCT00738374|581988028|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
161166866|NCT00738374|581988029|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161166867|NCT00738374|581988030|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161166868|NCT00738374|581988031|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
161166869|NCT00738374|581988028|FG000|Induction Treatment Phase|Physician Decision|2|||
161166870|NCT00738374|581988029|FG001|Induction Treatment Phase|Physician Decision|0|||
161166871|NCT00738374|581988030|FG002|Induction Treatment Phase|Physician Decision|0|||
161166872|NCT00738374|581988031|FG003|Induction Treatment Phase|Physician Decision|0|||
161166873|NCT00738374|581988028|FG000|Induction Treatment Phase|Protocol Violation|2|||
161166874|NCT00738374|581988029|FG001|Induction Treatment Phase|Protocol Violation|0|||
161166875|NCT00738374|581988030|FG002|Induction Treatment Phase|Protocol Violation|0|||
161166876|NCT00738374|581988031|FG003|Induction Treatment Phase|Protocol Violation|0|||
161166877|NCT00738374|581988028|FG000|Induction Treatment Phase|Non-compliance|1|||
161166878|NCT00738374|581988029|FG001|Induction Treatment Phase|Non-compliance|0|||
161166879|NCT00738374|581988030|FG002|Induction Treatment Phase|Non-compliance|0|||
161166880|NCT00738374|581988031|FG003|Induction Treatment Phase|Non-compliance|0|||
161166881|NCT00738374|581988028|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
161166882|NCT00738374|581988029|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
161166883|NCT00738374|581988030|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
161166884|NCT00738374|581988031|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
161166885|NCT00738374|581988028|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
161166886|NCT00738374|581988029|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
161166887|NCT00738374|581988030|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
161166888|NCT00738374|581988031|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
161166889|NCT00738374|581988028|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
161166890|NCT00738374|581988029|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
161166891|NCT00738374|581988030|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
161166892|NCT00738374|581988031|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
161166893|NCT00738374|581988028|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161166894|NCT00738374|581988029|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161166895|NCT00738374|581988030|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
161166896|NCT00738374|581988031|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
161166897|NCT00738374|581988028|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161166898|NCT00738374|581988029|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
161290059|NCT01894919|582442632|FG003|Overall Study|Other-Unspecified|0|||
161290060|NCT01894919|582442633|FG004|Overall Study|Other-Unspecified|0|||
161166899|NCT00738374|581988030|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161166900|NCT00738374|581988031|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
161166901|NCT00738374|581988028|FG000|Maintenance Treatment/Observation Phase|Other|0|||
161166902|NCT00738374|581988029|FG001|Maintenance Treatment/Observation Phase|Other|1|||
161166903|NCT00738374|581988030|FG002|Maintenance Treatment/Observation Phase|Other|0|||
161166904|NCT00738374|581988031|FG003|Maintenance Treatment/Observation Phase|Other|0|||
161166905|NCT00632541|581988032|FG000|Overall Study|Adverse Event|7|||
161166906|NCT02927873|581988033|FG000|Overall Study|Lost to Follow-up|0|||
161166907|NCT02927873|581988034|FG001|Overall Study|Lost to Follow-up|1|||
161166908|NCT02927873|581988035|FG002|Overall Study|Lost to Follow-up|0|||
161166909|NCT02927873|581988036|FG003|Overall Study|Lost to Follow-up|0|||
161166910|NCT02927873|581988037|FG004|Overall Study|Lost to Follow-up|0|||
161166911|NCT02927873|581988038|FG005|Overall Study|Lost to Follow-up|0|||
161166912|NCT02927873|581988033|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161166913|NCT02927873|581988034|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161166914|NCT02927873|581988035|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161166915|NCT02927873|581988036|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161166916|NCT02927873|581988037|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161166917|NCT02927873|581988038|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
161166918|NCT02927873|581988033|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161166919|NCT02927873|581988034|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161166920|NCT02927873|581988035|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161166921|NCT02927873|581988036|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161166922|NCT02927873|581988037|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
161166923|NCT02927873|581988038|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
161166924|NCT02927873|581988033|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161166925|NCT02927873|581988034|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
161166926|NCT02927873|581988035|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161166927|NCT02927873|581988036|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161166928|NCT02927873|581988037|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161166929|NCT02927873|581988038|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
161166930|NCT02927873|581988033|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
161166931|NCT02927873|581988034|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161166932|NCT02927873|581988035|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161166933|NCT02927873|581988036|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161166934|NCT02927873|581988037|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161166935|NCT02927873|581988038|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
161166936|NCT02927873|581988033|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
161166937|NCT02927873|581988034|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161166938|NCT02927873|581988035|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161166939|NCT02927873|581988036|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161166940|NCT02927873|581988037|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161166941|NCT02927873|581988038|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
161166942|NCT02017899|581989748|FG000|Overall Study|Withdrawal by Subject|0|||
161166943|NCT02017899|581989749|FG001|Overall Study|Withdrawal by Subject|0|||
161166944|NCT02017899|581989750|FG002|Overall Study|Withdrawal by Subject|0|||
161166945|NCT02017899|581989751|FG003|Overall Study|Withdrawal by Subject|1|||
161166946|NCT02017899|581989752|FG004|Overall Study|Withdrawal by Subject|1|||
161166947|NCT02017899|581989753|FG005|Overall Study|Withdrawal by Subject|0|||
161166948|NCT02843178|581989755|FG000|Overall Study|Lost to Follow-up|8|||
161166949|NCT02843178|581989756|FG001|Overall Study|Lost to Follow-up|8|||
161166950|NCT02843178|581989757|FG002|Overall Study|Lost to Follow-up|6|||
161166951|NCT02843178|581989758|FG003|Overall Study|Lost to Follow-up|3|||
161166952|NCT02843178|581989755|FG000|Overall Study|Withdrawal by Subject|0|||
161166953|NCT02843178|581989756|FG001|Overall Study|Withdrawal by Subject|0|||
161166954|NCT02843178|581989757|FG002|Overall Study|Withdrawal by Subject|1|||
161166955|NCT02843178|581989758|FG003|Overall Study|Withdrawal by Subject|1|||
161166956|NCT02420795|581989765|FG000|Overall Study|Withdrawal by Subject|1|||
161166957|NCT02420795|581989766|FG001|Overall Study|Withdrawal by Subject|0|||
161166958|NCT02420795|581989767|FG002|Overall Study|Withdrawal by Subject|0|||
161290061|NCT01894919|582442634|FG005|Overall Study|Other-Unspecified|0|||
161290062|NCT01894919|582442635|FG006|Overall Study|Other-Unspecified|0|||
161290063|NCT01894919|582442636|FG007|Overall Study|Other-Unspecified|0|||
161290064|NCT01894919|582442637|FG008|Overall Study|Other-Unspecified|0|||
161290065|NCT01894919|582442638|FG009|Overall Study|Other-Unspecified|0|||
161290066|NCT01894919|582442639|FG010|Overall Study|Other-Unspecified|0|||
161166959|NCT02420795|581989765|FG000|Overall Study|Adverse Event|1|||
161166960|NCT02420795|581989766|FG001|Overall Study|Adverse Event|0|||
161166961|NCT02420795|581989767|FG002|Overall Study|Adverse Event|0|||
161166962|NCT02420795|581989765|FG000|Overall Study|Progressive disease|2|||
161166963|NCT02420795|581989766|FG001|Overall Study|Progressive disease|2|||
161166964|NCT02420795|581989767|FG002|Overall Study|Progressive disease|4|||
161166965|NCT02420795|581989765|FG000|Overall Study|Death|0|||
161166966|NCT02420795|581989766|FG001|Overall Study|Death|0|||
161166967|NCT02420795|581989767|FG002|Overall Study|Death|1|||
161166968|NCT03927911|581989768|FG000|Overall Study|problems with eDiary|0|||
161166969|NCT03927911|581989769|FG001|Overall Study|problems with eDiary|1|||
161166970|NCT03927911|581989770|FG002|Overall Study|problems with eDiary|0|||
161166971|NCT03927911|581989771|FG003|Overall Study|problems with eDiary|1|||
161166972|NCT03927911|581989772|FG004|Overall Study|problems with eDiary|0|||
161166973|NCT03927911|581989773|FG005|Overall Study|problems with eDiary|4|||
161166974|NCT03927911|581989768|FG000|Overall Study|Adverse Event|0|||
161166975|NCT03927911|581989769|FG001|Overall Study|Adverse Event|0|||
161166976|NCT03927911|581989770|FG002|Overall Study|Adverse Event|0|||
161166977|NCT03927911|581989771|FG003|Overall Study|Adverse Event|0|||
161166978|NCT03927911|581989772|FG004|Overall Study|Adverse Event|0|||
161166979|NCT03927911|581989773|FG005|Overall Study|Adverse Event|1|||
161166980|NCT03927911|581989768|FG000|Overall Study|not treated -study terminated by sponsor|0|||
161166981|NCT03927911|581989769|FG001|Overall Study|not treated -study terminated by sponsor|1|||
161166982|NCT03927911|581989770|FG002|Overall Study|not treated -study terminated by sponsor|0|||
161166983|NCT03927911|581989771|FG003|Overall Study|not treated -study terminated by sponsor|0|||
161166984|NCT03927911|581989772|FG004|Overall Study|not treated -study terminated by sponsor|0|||
161166985|NCT03927911|581989773|FG005|Overall Study|not treated -study terminated by sponsor|0|||
161166986|NCT03927911|581989768|FG000|Overall Study|Surgery cancelled|0|||
161166987|NCT03927911|581989769|FG001|Overall Study|Surgery cancelled|0|||
161166988|NCT03927911|581989770|FG002|Overall Study|Surgery cancelled|0|||
161166989|NCT03927911|581989771|FG003|Overall Study|Surgery cancelled|1|||
161166990|NCT03927911|581989772|FG004|Overall Study|Surgery cancelled|0|||
161166991|NCT03927911|581989773|FG005|Overall Study|Surgery cancelled|1|||
161166992|NCT03927911|581989768|FG000|Overall Study|Protocol Violation|0|||
161166993|NCT03927911|581989769|FG001|Overall Study|Protocol Violation|0|||
161166994|NCT03927911|581989770|FG002|Overall Study|Protocol Violation|0|||
161166995|NCT03927911|581989771|FG003|Overall Study|Protocol Violation|0|||
161166996|NCT03927911|581989772|FG004|Overall Study|Protocol Violation|0|||
161166997|NCT03927911|581989773|FG005|Overall Study|Protocol Violation|1|||
161166998|NCT02658968|581989774|FG000|Received Rituximab|Adverse Event|0|||
161166999|NCT02658968|581989775|FG001|Received Rituximab|Adverse Event|0|||
161167000|NCT02658968|581989776|FG002|Received Rituximab|Adverse Event|0|||
161167001|NCT02658968|581989777|FG003|Received Rituximab|Adverse Event|0|||
161167002|NCT02658968|581989778|FG004|Received Rituximab|Adverse Event|1|||
161167003|NCT02658968|581989774|FG000|Received Rituximab|Progressive disease|0|||
161167004|NCT02658968|581989775|FG001|Received Rituximab|Progressive disease|0|||
161167005|NCT02658968|581989776|FG002|Received Rituximab|Progressive disease|0|||
161167006|NCT02658968|581989777|FG003|Received Rituximab|Progressive disease|0|||
161167007|NCT02658968|581989778|FG004|Received Rituximab|Progressive disease|1|||
161167008|NCT02658968|581989774|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
161167009|NCT02658968|581989775|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
161167010|NCT02658968|581989776|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
161167011|NCT02658968|581989777|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
161167012|NCT02658968|581989778|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
161167013|NCT02658968|581989774|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
161167014|NCT02658968|581989775|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
161167015|NCT02658968|581989776|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
161167016|NCT02658968|581989777|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
161167017|NCT02658968|581989778|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
161167018|NCT02658968|581989774|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161167019|NCT02658968|581989775|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
161167020|NCT02658968|581989776|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161167021|NCT02658968|581989777|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
161167022|NCT02658968|581989778|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
161290067|NCT01894919|582442640|FG011|Overall Study|Other-Unspecified|0|||
161167023|NCT02658968|581989774|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161290068|NCT01894919|582442641|FG012|Overall Study|Other-Unspecified|0|||
161290069|NCT01894919|582442629|FG000|Overall Study|Lost to Follow-up|0|||
161290070|NCT01894919|582442630|FG001|Overall Study|Lost to Follow-up|0|||
161290071|NCT01894919|582442631|FG002|Overall Study|Lost to Follow-up|0|||
161167024|NCT02658968|581989775|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
161167025|NCT02658968|581989776|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161167026|NCT02658968|581989777|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161167027|NCT02658968|581989778|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
161290072|NCT01894919|582442632|FG003|Overall Study|Lost to Follow-up|0|||
161290073|NCT01894919|582442633|FG004|Overall Study|Lost to Follow-up|2|||
161167028|NCT02658968|581989774|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
161167029|NCT02658968|581989775|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
161167030|NCT02658968|581989776|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
161167031|NCT02658968|581989777|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
161167032|NCT02658968|581989778|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
161167033|NCT02528253|581989781|FG000|Overall Study|Adverse Event|3|||
161167034|NCT02528253|581989782|FG001|Overall Study|Adverse Event|4|||
161167035|NCT02528253|581989783|FG002|Overall Study|Adverse Event|4|||
161167036|NCT02528253|581989784|FG003|Overall Study|Adverse Event|8|||
161167037|NCT02528253|581989785|FG004|Overall Study|Adverse Event|18|||
161167038|NCT02528253|581989781|FG000|Overall Study|Death|2|||
161167039|NCT02528253|581989782|FG001|Overall Study|Death|2|||
161167040|NCT02528253|581989783|FG002|Overall Study|Death|1|||
161167041|NCT02528253|581989784|FG003|Overall Study|Death|0|||
161167042|NCT02528253|581989785|FG004|Overall Study|Death|1|||
161167043|NCT02528253|581989781|FG000|Overall Study|Insufficient clinical response|7|||
161167044|NCT02528253|581989782|FG001|Overall Study|Insufficient clinical response|10|||
161167045|NCT02528253|581989783|FG002|Overall Study|Insufficient clinical response|13|||
161167046|NCT02528253|581989784|FG003|Overall Study|Insufficient clinical response|12|||
161167047|NCT02528253|581989785|FG004|Overall Study|Insufficient clinical response|16|||
161167048|NCT02528253|581989781|FG000|Overall Study|Lost to Follow-up|16|||
161167049|NCT02528253|581989782|FG001|Overall Study|Lost to Follow-up|9|||
161167050|NCT02528253|581989783|FG002|Overall Study|Lost to Follow-up|31|||
161167051|NCT02528253|581989784|FG003|Overall Study|Lost to Follow-up|16|||
161167052|NCT02528253|581989785|FG004|Overall Study|Lost to Follow-up|34|||
161167053|NCT02528253|581989781|FG000|Overall Study|Other|21|||
161167054|NCT02528253|581989782|FG001|Overall Study|Other|22|||
161167055|NCT02528253|581989783|FG002|Overall Study|Other|58|||
161167056|NCT02528253|581989784|FG003|Overall Study|Other|52|||
161167057|NCT02528253|581989785|FG004|Overall Study|Other|76|||
161167058|NCT02528253|581989781|FG000|Overall Study|Withdrawal by Subject|25|||
161167059|NCT02528253|581989782|FG001|Overall Study|Withdrawal by Subject|20|||
161167060|NCT02528253|581989783|FG002|Overall Study|Withdrawal by Subject|29|||
161167061|NCT02528253|581989784|FG003|Overall Study|Withdrawal by Subject|48|||
161167062|NCT02528253|581989785|FG004|Overall Study|Withdrawal by Subject|73|||
161167063|NCT02528253|581989781|FG000|Overall Study|Protocol Violation|1|||
161167064|NCT02528253|581989782|FG001|Overall Study|Protocol Violation|2|||
161167065|NCT02528253|581989783|FG002|Overall Study|Protocol Violation|4|||
161167066|NCT02528253|581989784|FG003|Overall Study|Protocol Violation|0|||
161167067|NCT02528253|581989785|FG004|Overall Study|Protocol Violation|4|||
161167068|NCT02528253|581989781|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
161167069|NCT02528253|581989782|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
161167070|NCT02528253|581989783|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
161167071|NCT02528253|581989784|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
161167072|NCT02528253|581989785|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
161167073|NCT00505752|581989786|FG000|Overall Study|Adverse Event|1|||
161167074|NCT00505752|581989787|FG001|Overall Study|Adverse Event|0|||
161167075|NCT00505752|581989788|FG002|Overall Study|Adverse Event|1|||
161167076|NCT00505752|581989789|FG003|Overall Study|Adverse Event|0|||
161167077|NCT00505752|581989786|FG000|Overall Study|Lost to Follow-up|1|||
161167078|NCT00505752|581989787|FG001|Overall Study|Lost to Follow-up|0|||
161167079|NCT00505752|581989788|FG002|Overall Study|Lost to Follow-up|0|||
161167080|NCT00505752|581989789|FG003|Overall Study|Lost to Follow-up|0|||
161167081|NCT00505752|581989786|FG000|Overall Study|Lack of ovarian response|1|||
161167082|NCT00505752|581989787|FG001|Overall Study|Lack of ovarian response|3|||
161167083|NCT00505752|581989788|FG002|Overall Study|Lack of ovarian response|0|||
161167084|NCT00505752|581989789|FG003|Overall Study|Lack of ovarian response|0|||
161167085|NCT00505752|581989786|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161167086|NCT00505752|581989787|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161167087|NCT00505752|581989788|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161167088|NCT00505752|581989789|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
161290074|NCT01894919|582442634|FG005|Overall Study|Lost to Follow-up|0|||
161290075|NCT01894919|582442635|FG006|Overall Study|Lost to Follow-up|0|||
161167089|NCT00505752|581989786|FG000|Overall Study|No oocytes retrieved|0|||
161167090|NCT00505752|581989787|FG001|Overall Study|No oocytes retrieved|2|||
161167091|NCT00505752|581989788|FG002|Overall Study|No oocytes retrieved|0|||
161167092|NCT00505752|581989789|FG003|Overall Study|No oocytes retrieved|1|||
161167093|NCT00505752|581989786|FG000|Overall Study|No Fertilization|1|||
161167094|NCT00505752|581989787|FG001|Overall Study|No Fertilization|1|||
161167095|NCT00505752|581989788|FG002|Overall Study|No Fertilization|2|||
161167096|NCT00505752|581989789|FG003|Overall Study|No Fertilization|1|||
161167097|NCT00505752|581989786|FG000|Overall Study|All embryos/blastocysts discarded|0|||
161167098|NCT00505752|581989787|FG001|Overall Study|All embryos/blastocysts discarded|0|||
161167099|NCT00505752|581989788|FG002|Overall Study|All embryos/blastocysts discarded|1|||
161167100|NCT00505752|581989789|FG003|Overall Study|All embryos/blastocysts discarded|1|||
161167101|NCT00505752|581989786|FG000|Overall Study|Other|1|||
161290076|NCT01894919|582442636|FG007|Overall Study|Lost to Follow-up|0|||
161167102|NCT00505752|581989787|FG001|Overall Study|Other|2|||
161167103|NCT00505752|581989788|FG002|Overall Study|Other|1|||
161167104|NCT00505752|581989789|FG003|Overall Study|Other|2|||
161167105|NCT01624506|581989790|FG000|Overall Study|Lost to Follow-up|29|||
161167106|NCT01624506|581989791|FG001|Overall Study|Lost to Follow-up|15|||
161167107|NCT01624506|581989790|FG000|Overall Study|Withdrawal by Subject|9|||
161167108|NCT01624506|581989791|FG001|Overall Study|Withdrawal by Subject|2|||
161167109|NCT01624506|581989790|FG000|Overall Study|Death|1|||
161167110|NCT01624506|581989791|FG001|Overall Study|Death|0|||
161167111|NCT01624506|581989790|FG000|Overall Study|LINX explants|23|||
161167112|NCT01624506|581989791|FG001|Overall Study|LINX explants|0|||
161167113|NCT01624506|581989790|FG000|Overall Study|Adverse Event|3|||
161167114|NCT01624506|581989791|FG001|Overall Study|Adverse Event|0|||
161167115|NCT00225147|581989792|FG000|Open-label Phase|Lost to Follow-up|0|||
161167116|NCT00225147|581989793|FG001|Open-label Phase|Lost to Follow-up|0|||
161167117|NCT00225147|581989794|FG002|Open-label Phase|Lost to Follow-up|0|||
161167118|NCT00225147|581989795|FG003|Open-label Phase|Lost to Follow-up|4|||
161167119|NCT00225147|581989792|FG000|Open-label Phase|Withdrawal by Subject|0|||
161167120|NCT00225147|581989793|FG001|Open-label Phase|Withdrawal by Subject|0|||
161167121|NCT00225147|581989794|FG002|Open-label Phase|Withdrawal by Subject|0|||
161167122|NCT00225147|581989795|FG003|Open-label Phase|Withdrawal by Subject|6|||
161167123|NCT04268004|581989805|FG000|Overall Study|Excluded from analyses|0|||
161167124|NCT04268004|581989806|FG001|Overall Study|Excluded from analyses|1|||
161167125|NCT04724733|581989809|FG000|Overall Study|Lost to Follow-up|1|||
161167126|NCT04724733|581989810|FG001|Overall Study|Lost to Follow-up|1|||
161167127|NCT04724733|581989811|FG002|Overall Study|Lost to Follow-up|1|||
161167128|NCT03372603|581989812|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
161167129|NCT03372603|581989813|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
161167130|NCT03372603|581989812|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
161167131|NCT03372603|581989813|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
161167132|NCT03341923|581989814|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
161167133|NCT03341923|581989815|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
161167134|NCT03986190|581989816|FG000|Overall Study|Withdrawal by Subject|12|||
161167135|NCT03986190|581989817|FG001|Overall Study|Withdrawal by Subject|0|||
161167136|NCT04511819|581989818|FG000|Overall Study|Non-compliance with study drug|5|||
161167137|NCT04511819|581989819|FG001|Overall Study|Non-compliance with study drug|1|||
161167138|NCT04511819|581989818|FG000|Overall Study|Withdrawal by Subject|0|||
161167139|NCT04511819|581989819|FG001|Overall Study|Withdrawal by Subject|3|||
161167140|NCT04511819|581989818|FG000|Overall Study|Adverse Event|0|||
161167141|NCT04511819|581989819|FG001|Overall Study|Adverse Event|1|||
161167142|NCT04511819|581989818|FG000|Overall Study|Protocol deviation|1|||
161167143|NCT04511819|581989819|FG001|Overall Study|Protocol deviation|0|||
161167144|NCT00844649|581989825|FG000|Overall Study|Progressive Disease|196|||
161167145|NCT00844649|581989826|FG001|Overall Study|Progressive Disease|245|||
161167146|NCT00844649|581989825|FG000|Overall Study|Adverse Event|128|||
161167147|NCT00844649|581989826|FG001|Overall Study|Adverse Event|73|||
161167148|NCT00844649|581989825|FG000|Overall Study|Physician Decision|25|||
161167149|NCT00844649|581989826|FG001|Overall Study|Physician Decision|18|||
161167150|NCT00844649|581989825|FG000|Overall Study|Protocol Violation|10|||
161290077|NCT01894919|582442637|FG008|Overall Study|Lost to Follow-up|0|||
161290078|NCT01894919|582442638|FG009|Overall Study|Lost to Follow-up|0|||
161167151|NCT00844649|581989826|FG001|Overall Study|Protocol Violation|6|||
161167152|NCT00844649|581989825|FG000|Overall Study|Withdrawal by Subject|28|||
161290079|NCT01894919|582442639|FG010|Overall Study|Lost to Follow-up|0|||
161290080|NCT01894919|582442640|FG011|Overall Study|Lost to Follow-up|0|||
161290081|NCT01894919|582442641|FG012|Overall Study|Lost to Follow-up|0|||
161290082|NCT03711188|582442642|FG000|Overall Study|Disease progression|11|||
161290083|NCT03711188|582442642|FG000|Overall Study|Adverse Event|1|||
161290084|NCT00063934|582442645|FG000|Overall Study|Ineligible|1|||
161290085|NCT04341363|582442646|FG000|Overall Study|Adverse Event|1|||
161290086|NCT04341363|582442646|FG000|Overall Study|Withdrawal by Subject|1|||
161290087|NCT03534687|582442647|FG000|Overall Study|Lost to Follow-up|7|||
161290088|NCT03534687|582442648|FG001|Overall Study|Lost to Follow-up|2|||
161290089|NCT02570308|582442651|FG000|Overall Study|Death|1|||
161290090|NCT02570308|582442652|FG001|Overall Study|Death|5|||
161167153|NCT00844649|581989826|FG001|Overall Study|Withdrawal by Subject|39|||
161167154|NCT00844649|581989825|FG000|Overall Study|Other|7|||
161167155|NCT00844649|581989826|FG001|Overall Study|Other|10|||
161167156|NCT00844649|581989825|FG000|Overall Study|Withdrew prior to starting treatment|11|||
161290091|NCT02570308|582442653|FG002|Overall Study|Death|4|||
161290092|NCT02570308|582442654|FG003|Overall Study|Death|4|||
161290093|NCT02570308|582442655|FG004|Overall Study|Death|69|||
161167157|NCT00844649|581989826|FG001|Overall Study|Withdrew prior to starting treatment|27|||
161167158|NCT01594333|581989828|FG000|Overall Study|Death|96|||
161167159|NCT01594333|581989829|FG001|Overall Study|Death|83|||
161167160|NCT01594333|581989828|FG000|Overall Study|Lost to Follow-up|5|||
161167161|NCT01594333|581989829|FG001|Overall Study|Lost to Follow-up|5|||
161167162|NCT01594333|581989828|FG000|Overall Study|Withdrawal by Subject|60|||
161290094|NCT02570308|582442651|FG000|Overall Study|Lost to Follow-up|0|||
161290095|NCT02570308|582442652|FG001|Overall Study|Lost to Follow-up|0|||
161290096|NCT02570308|582442653|FG002|Overall Study|Lost to Follow-up|0|||
161290097|NCT02570308|582442654|FG003|Overall Study|Lost to Follow-up|0|||
161167163|NCT01594333|581989829|FG001|Overall Study|Withdrawal by Subject|63|||
161167164|NCT00589979|581989830|FG000|Run-In Period|Adverse Event|5|||
161167165|NCT00589979|581989831|FG001|Run-In Period|Adverse Event|0|||
161167166|NCT00589979|581989832|FG002|Run-In Period|Adverse Event|0|||
161167167|NCT00589979|581989830|FG000|Run-In Period|Protocol Violation|3|||
161167168|NCT00589979|581989831|FG001|Run-In Period|Protocol Violation|0|||
161167169|NCT00589979|581989832|FG002|Run-In Period|Protocol Violation|0|||
161167170|NCT00589979|581989830|FG000|Run-In Period|Did not qualify for randomization|54|||
161167171|NCT00589979|581989831|FG001|Run-In Period|Did not qualify for randomization|0|||
161167172|NCT00589979|581989832|FG002|Run-In Period|Did not qualify for randomization|0|||
161167173|NCT00589979|581989830|FG000|Run-In Period|Withdrawal by Subject|10|||
161167174|NCT00589979|581989831|FG001|Run-In Period|Withdrawal by Subject|0|||
161167175|NCT00589979|581989832|FG002|Run-In Period|Withdrawal by Subject|0|||
161167176|NCT00589979|581989830|FG000|Run-In Period|Informed Consent Withdrawn|4|||
161167177|NCT00589979|581989831|FG001|Run-In Period|Informed Consent Withdrawn|0|||
161167178|NCT00589979|581989832|FG002|Run-In Period|Informed Consent Withdrawn|0|||
161167179|NCT00589979|581989830|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
161167180|NCT00589979|581989831|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
161167181|NCT00589979|581989832|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
161167182|NCT00589979|581989830|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
161167183|NCT00589979|581989831|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
161167184|NCT00589979|581989832|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
161167185|NCT00589979|581989830|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161167186|NCT00589979|581989831|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
161167187|NCT00589979|581989832|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
161167188|NCT00589979|581989830|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
161167189|NCT00589979|581989831|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
161167190|NCT00589979|581989832|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
161167191|NCT00589979|581989830|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161167192|NCT00589979|581989831|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161167193|NCT00589979|581989832|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
161167194|NCT00589979|581989830|FG000|Double-Blind Treatment Period 2|Other|0|||
161167195|NCT00589979|581989831|FG001|Double-Blind Treatment Period 2|Other|0|||
161167196|NCT00589979|581989832|FG002|Double-Blind Treatment Period 2|Other|1|||
161167197|NCT00589979|581989830|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
161167198|NCT00589979|581989831|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
161167199|NCT00589979|581989832|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
161167200|NCT00589979|581989830|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
161167201|NCT00589979|581989831|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
161167202|NCT00589979|581989832|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
161167203|NCT01354431|581989837|FG000|Pre-Treatment Period|Not reported|1|||
161167204|NCT01354431|581989838|FG001|Pre-Treatment Period|Not reported|0|||
161167205|NCT01354431|581989839|FG002|Pre-Treatment Period|Not reported|0|||
161167206|NCT01354431|581989837|FG000|Treatment Period|Disease Progression|50|||
161167207|NCT01354431|581989838|FG001|Treatment Period|Disease Progression|40|||
161167208|NCT01354431|581989839|FG002|Treatment Period|Disease Progression|44|||
161167209|NCT01354431|581989837|FG000|Treatment Period|Study Drug Toxicity|5|||
161167210|NCT01354431|581989838|FG001|Treatment Period|Study Drug Toxicity|8|||
161167211|NCT01354431|581989839|FG002|Treatment Period|Study Drug Toxicity|4|||
161167212|NCT01354431|581989837|FG000|Treatment Period|Death|0|||
161167213|NCT01354431|581989838|FG001|Treatment Period|Death|1|||
161167214|NCT01354431|581989839|FG002|Treatment Period|Death|0|||
161167215|NCT01354431|581989837|FG000|Treatment Period|AE unrelated to study drug|1|||
161167216|NCT01354431|581989838|FG001|Treatment Period|AE unrelated to study drug|2|||
161167217|NCT01354431|581989839|FG002|Treatment Period|AE unrelated to study drug|5|||
161167218|NCT01354431|581989837|FG000|Treatment Period|Participant request to discontinue|2|||
161167219|NCT01354431|581989838|FG001|Treatment Period|Participant request to discontinue|2|||
161167220|NCT01354431|581989839|FG002|Treatment Period|Participant request to discontinue|1|||
161290098|NCT02570308|582442655|FG004|Overall Study|Lost to Follow-up|2|||
161290099|NCT02570308|582442651|FG000|Overall Study|Withdrawal by Subject|0|||
161167221|NCT01354431|581989837|FG000|Treatment Period|Participant withdrew consent|0|||
161290100|NCT02570308|582442652|FG001|Overall Study|Withdrawal by Subject|0|||
161290101|NCT02570308|582442653|FG002|Overall Study|Withdrawal by Subject|0|||
161290102|NCT02570308|582442654|FG003|Overall Study|Withdrawal by Subject|0|||
161167222|NCT01354431|581989838|FG001|Treatment Period|Participant withdrew consent|1|||
161167223|NCT01354431|581989839|FG002|Treatment Period|Participant withdrew consent|0|||
161167224|NCT01354431|581989837|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
161167225|NCT01354431|581989838|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
161167226|NCT01354431|581989839|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
161290103|NCT02570308|582442655|FG004|Overall Study|Withdrawal by Subject|1|||
161290104|NCT02570308|582442651|FG000|Overall Study|Other|0|||
161290105|NCT02570308|582442652|FG001|Overall Study|Other|0|||
161290106|NCT02570308|582442653|FG002|Overall Study|Other|0|||
161290107|NCT02570308|582442654|FG003|Overall Study|Other|0|||
161290108|NCT02570308|582442655|FG004|Overall Study|Other|2|||
161290109|NCT00314340|582442657|FG000|Overall Study|lost interest|1|||
161290110|NCT02069015|582442658|FG000|Overall Study|Lost to Follow-up|39|||
161290111|NCT02069015|582442659|FG001|Overall Study|Lost to Follow-up|32|||
161290112|NCT02069015|582442658|FG000|Overall Study|Withdrawal by Subject|1|||
161083343|NCT00744757|581693694|FG000|Overall Study|Adverse Event|2|||
161083344|NCT00548262|581693695|FG000|Overall Study|Death|21|||
161083345|NCT00548262|581693695|FG000|Overall Study|Adverse Event|2|||
161083346|NCT00548262|581693695|FG000|Overall Study|Lack of Efficacy|4|||
161083347|NCT00548262|581693695|FG000|Overall Study|Lost to Follow-up|1|||
161083348|NCT00548262|581693695|FG000|Overall Study|Other|3|||
161083349|NCT00548262|581693695|FG000|Overall Study|Withdrawal by Subject|1|||
161083350|NCT02285153|581693696|FG000|Overall Study|Adverse Event|1|||
161083351|NCT02285153|581693697|FG001|Overall Study|Adverse Event|0|||
161083352|NCT01712659|581693698|FG000|Dose Escalation|Physician Decision|0|||
161083353|NCT01712659|581693699|FG001|Dose Escalation|Physician Decision|1|||
161083354|NCT01712659|581693700|FG002|Dose Escalation|Physician Decision|0|||
161083355|NCT01712659|581693701|FG003|Dose Escalation|Physician Decision|0|||
161083356|NCT01712659|581693702|FG004|Dose Escalation|Physician Decision|0|||
161083357|NCT01712659|581693698|FG000|Dose Escalation|Unable to take study drug|0|||
161083358|NCT01712659|581693699|FG001|Dose Escalation|Unable to take study drug|1|||
161083359|NCT01712659|581693700|FG002|Dose Escalation|Unable to take study drug|0|||
161083360|NCT01712659|581693701|FG003|Dose Escalation|Unable to take study drug|0|||
161083361|NCT01712659|581693702|FG004|Dose Escalation|Unable to take study drug|0|||
161083362|NCT01712659|581693698|FG000|Dose Expansion|Early disease progression|1|||
161083363|NCT01712659|581693699|FG001|Dose Expansion|Early disease progression|0|||
161083364|NCT01712659|581693700|FG002|Dose Expansion|Early disease progression|0|||
161083365|NCT01712659|581693701|FG003|Dose Expansion|Early disease progression|0|||
161083366|NCT01712659|581693702|FG004|Dose Expansion|Early disease progression|0|||
161083367|NCT01712659|581693698|FG000|Dose Expansion|Physician Decision|1|||
161083368|NCT01712659|581693699|FG001|Dose Expansion|Physician Decision|0|||
161083369|NCT01712659|581693700|FG002|Dose Expansion|Physician Decision|0|||
161083370|NCT01712659|581693701|FG003|Dose Expansion|Physician Decision|0|||
161083371|NCT01712659|581693702|FG004|Dose Expansion|Physician Decision|0|||
161083372|NCT00948766|581693703|FG000|Core Study|Adverse Event|73|||
161083373|NCT00948766|581693704|FG001|Core Study|Adverse Event|51|||
161083374|NCT00948766|581693703|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
161083375|NCT00948766|581693704|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
161083376|NCT00948766|581693703|FG000|Core Study|Patient Withdrew Consent|27|||
161083377|NCT00948766|581693704|FG001|Core Study|Patient Withdrew Consent|46|||
161083378|NCT00948766|581693703|FG000|Core Study|Lost to Follow-up|3|||
161083379|NCT00948766|581693704|FG001|Core Study|Lost to Follow-up|2|||
161083380|NCT00948766|581693703|FG000|Core Study|Administrative Problems|2|||
161083381|NCT00948766|581693704|FG001|Core Study|Administrative Problems|2|||
161083382|NCT00948766|581693703|FG000|Core Study|Death|1|||
161083383|NCT00948766|581693704|FG001|Core Study|Death|1|||
161083384|NCT00948766|581693703|FG000|Core Study|Protocol Deviation|8|||
161083385|NCT00948766|581693704|FG001|Core Study|Protocol Deviation|10|||
161083386|NCT00948766|581693703|FG000|Extension Study|Adverse Event|43|||
161083387|NCT00948766|581693704|FG001|Extension Study|Adverse Event|0|||
161083388|NCT00948766|581693703|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
161083389|NCT00948766|581693704|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
161083390|NCT00948766|581693703|FG000|Extension Study|Study Drug No Longer Required|1|||
161083391|NCT00948766|581693704|FG001|Extension Study|Study Drug No Longer Required|0|||
161083392|NCT00948766|581693703|FG000|Extension Study|Patient Withdrew Consent|32|||
161083393|NCT00948766|581693704|FG001|Extension Study|Patient Withdrew Consent|0|||
161083394|NCT00948766|581693703|FG000|Extension Study|Lost to Follow-up|8|||
161083395|NCT00948766|581693704|FG001|Extension Study|Lost to Follow-up|0|||
161083396|NCT00948766|581693703|FG000|Extension Study|Administrative Problems|1|||
161083397|NCT00948766|581693704|FG001|Extension Study|Administrative Problems|0|||
161083398|NCT00948766|581693703|FG000|Extension Study|Death|4|||
161083399|NCT00948766|581693704|FG001|Extension Study|Death|0|||
161083400|NCT02270515|581693705|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
161083401|NCT02270515|581693705|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
161083402|NCT02270515|581693705|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
161083403|NCT02270515|581693705|FG000|Intervention Period 1: 0-6 Months|Death|7|||
161083404|NCT02270515|581693705|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
161083405|NCT02270515|581693705|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
161083406|NCT02270515|581693705|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
161083407|NCT02270515|581693705|FG000|Intervention Period 2: 6-12 Months|Death|5|||
161167227|NCT03176277|581989840|FG000|Part A Dose Escalation Study|Adverse Event|1|||
161167228|NCT03176277|581989841|FG001|Part A Dose Escalation Study|Adverse Event|0|||
161167229|NCT03176277|581989842|FG002|Part A Dose Escalation Study|Adverse Event|1|||
161167230|NCT03176277|581989843|FG003|Part A Dose Escalation Study|Adverse Event|0|||
161167231|NCT03176277|581989840|FG000|Part A Dose Escalation Study|Physician Decision|1|||
161167232|NCT03176277|581989841|FG001|Part A Dose Escalation Study|Physician Decision|1|||
161167233|NCT03176277|581989842|FG002|Part A Dose Escalation Study|Physician Decision|2|||
161167234|NCT03176277|581989843|FG003|Part A Dose Escalation Study|Physician Decision|0|||
161167235|NCT03176277|581989840|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
161167236|NCT03176277|581989841|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
161167237|NCT03176277|581989842|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
161167238|NCT03176277|581989843|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
161167239|NCT03176277|581989840|FG000|Part A Dose Escalation Study|Progressive disease|3|||
161167240|NCT03176277|581989841|FG001|Part A Dose Escalation Study|Progressive disease|1|||
161167241|NCT03176277|581989842|FG002|Part A Dose Escalation Study|Progressive disease|3|||
161167242|NCT03176277|581989843|FG003|Part A Dose Escalation Study|Progressive disease|0|||
161167243|NCT02802878|581989844|FG000|Overall Study|Withdrawal by Subject|3|||
161167244|NCT02802878|581989845|FG001|Overall Study|Withdrawal by Subject|3|||
161167245|NCT02802878|581989844|FG000|Overall Study|Protocol Violation|1|||
161167246|NCT02802878|581989845|FG001|Overall Study|Protocol Violation|0|||
161167247|NCT00702052|581989846|FG000|Overall Study|Adverse Event|23|||
161167248|NCT00702052|581989846|FG000|Overall Study|Disease Progression|30|||
161167249|NCT00702052|581989846|FG000|Overall Study|Withdrawal by Subject|5|||
161167250|NCT00101192|581989847|FG000|Overall Study|Ineligible|6|||
161167251|NCT00101192|581989847|FG000|Overall Study|Inevaluable|1|||
161167252|NCT03691610|581989848|FG000|Overall Study|Adverse Event|0|||
161167253|NCT03691610|581989849|FG001|Overall Study|Adverse Event|1|||
161167254|NCT03691610|581989850|FG002|Overall Study|Adverse Event|0|||
161167255|NCT03691610|581989851|FG003|Overall Study|Adverse Event|0|||
161167256|NCT03691610|581989848|FG000|Overall Study|Protocol Deviation|15|||
161167257|NCT03691610|581989849|FG001|Overall Study|Protocol Deviation|8|||
161167258|NCT03691610|581989850|FG002|Overall Study|Protocol Deviation|1|||
161167259|NCT03691610|581989851|FG003|Overall Study|Protocol Deviation|2|||
161167260|NCT03691610|581989848|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
161167261|NCT03691610|581989849|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
161167262|NCT03691610|581989850|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
161167263|NCT03691610|581989851|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
161167264|NCT03691610|581989848|FG000|Overall Study|Lost to Follow-up|20|||
161167265|NCT03691610|581989849|FG001|Overall Study|Lost to Follow-up|11|||
161167266|NCT03691610|581989850|FG002|Overall Study|Lost to Follow-up|5|||
161167267|NCT03691610|581989851|FG003|Overall Study|Lost to Follow-up|2|||
161167268|NCT00536978|581989852|FG000|Overall Study|Not eligible for Adback Infusion|22|||
161167269|NCT00242580|581989853|FG000|Overall Study|Adverse Event|3|||
161167270|NCT00242580|581989854|FG001|Overall Study|Adverse Event|0|||
161167271|NCT00242580|581989855|FG002|Overall Study|Adverse Event|2|||
161167272|NCT00242580|581989853|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161167273|NCT00242580|581989854|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161167274|NCT00242580|581989855|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
161167275|NCT00242580|581989853|FG000|Overall Study|Protocol Violation|0|||
161167276|NCT00242580|581989854|FG001|Overall Study|Protocol Violation|0|||
161167277|NCT00242580|581989855|FG002|Overall Study|Protocol Violation|1|||
161167278|NCT00242580|581989853|FG000|Overall Study|Subject withdrew consent|2|||
161290113|NCT02069015|582442659|FG001|Overall Study|Withdrawal by Subject|1|||
161290114|NCT01283464|582442660|FG000|Overall Study|Lost to Follow-up|0|||
161290115|NCT01283464|582442661|FG001|Overall Study|Lost to Follow-up|1|||
161290116|NCT01283464|582442660|FG000|Overall Study|Withdrawal by Subject|1|||
161290117|NCT01283464|582442661|FG001|Overall Study|Withdrawal by Subject|0|||
161290118|NCT01283464|582442660|FG000|Overall Study|Physician Decision|1|||
161167279|NCT00242580|581989854|FG001|Overall Study|Subject withdrew consent|2|||
161167280|NCT00242580|581989855|FG002|Overall Study|Subject withdrew consent|5|||
161167281|NCT00242580|581989853|FG000|Overall Study|Lost to Follow-up|0|||
161167282|NCT00242580|581989854|FG001|Overall Study|Lost to Follow-up|3|||
161167283|NCT00242580|581989855|FG002|Overall Study|Lost to Follow-up|0|||
161167284|NCT00242580|581989853|FG000|Overall Study|Death|1|||
161167285|NCT00242580|581989854|FG001|Overall Study|Death|2|||
161167286|NCT00242580|581989855|FG002|Overall Study|Death|1|||
161167287|NCT01232894|581989856|FG000|Overall Study|Lost to Follow-up|0|||
161167288|NCT01232894|581989857|FG001|Overall Study|Lost to Follow-up|1|||
161167289|NCT01232894|581989856|FG000|Overall Study|Death|1|||
161167290|NCT01232894|581989857|FG001|Overall Study|Death|0|||
161167291|NCT01232894|581989856|FG000|Overall Study|Protocol Violation|1|||
161167292|NCT01232894|581989857|FG001|Overall Study|Protocol Violation|1|||
161167293|NCT01232894|581989856|FG000|Overall Study|Withdrawal by Subject|8|||
161167294|NCT01232894|581989857|FG001|Overall Study|Withdrawal by Subject|5|||
161167295|NCT01232894|581989856|FG000|Overall Study|Physician Decision|2|||
161290119|NCT01283464|582442661|FG001|Overall Study|Physician Decision|0|||
161290120|NCT03051100|582442662|FG000|Overall Study|Withdrawal by Subject|1|||
161347025|NCT02335944|582654753|FG000|Treatment Phase|Physician Decision|0|||
161347026|NCT02335944|582654754|FG001|Treatment Phase|Physician Decision|0|||
161347027|NCT02335944|582654755|FG002|Treatment Phase|Physician Decision|0|||
161347028|NCT02335944|582654756|FG003|Treatment Phase|Physician Decision|1|||
161347029|NCT02335944|582654757|FG004|Treatment Phase|Physician Decision|0|||
161347030|NCT02335944|582654758|FG005|Treatment Phase|Physician Decision|6|||
161347031|NCT02335944|582654759|FG006|Treatment Phase|Physician Decision|1|||
161347032|NCT02335944|582654760|FG007|Treatment Phase|Physician Decision|2|||
161347033|NCT02335944|582654761|FG008|Treatment Phase|Physician Decision|1|||
161347034|NCT02335944|582654762|FG009|Treatment Phase|Physician Decision|0|||
161167296|NCT01232894|581989857|FG001|Overall Study|Physician Decision|1|||
161167297|NCT03970395|581989860|FG000|Overall Study|Withdrawal by Subject|3|||
161167298|NCT03970395|581989861|FG001|Overall Study|Withdrawal by Subject|4|||
161167299|NCT03970395|581989860|FG000|Overall Study|Lost to Follow-up|4|||
161167300|NCT03970395|581989861|FG001|Overall Study|Lost to Follow-up|8|||
161167301|NCT02921919|581989862|FG000|Overall Study|Other|5|||
161167302|NCT02921919|581989863|FG001|Overall Study|Other|6|||
161167303|NCT02921919|581989862|FG000|Overall Study|Lost to Follow-up|0|||
161167304|NCT02921919|581989863|FG001|Overall Study|Lost to Follow-up|1|||
161167305|NCT02921919|581989862|FG000|Overall Study|Withdrawal by Subject|5|||
161167306|NCT02921919|581989863|FG001|Overall Study|Withdrawal by Subject|1|||
161290121|NCT03051100|582442663|FG001|Overall Study|Withdrawal by Subject|0|||
161290122|NCT01286467|582442670|FG000|Overall Study|Death|1|||
161290123|NCT01286467|582442671|FG001|Overall Study|Death|1|||
161290124|NCT01286467|582442672|FG002|Overall Study|Death|1|||
161290125|NCT01286467|582442673|FG003|Overall Study|Death|0|||
161290126|NCT01286467|582442670|FG000|Overall Study|Lost to Follow-up|0|||
161290127|NCT01286467|582442671|FG001|Overall Study|Lost to Follow-up|0|||
161290128|NCT01286467|582442672|FG002|Overall Study|Lost to Follow-up|0|||
161290129|NCT01286467|582442673|FG003|Overall Study|Lost to Follow-up|1|||
161290130|NCT01286467|582442670|FG000|Overall Study|Withdrawal by Subject|0|||
161290131|NCT01286467|582442671|FG001|Overall Study|Withdrawal by Subject|0|||
161290132|NCT01286467|582442672|FG002|Overall Study|Withdrawal by Subject|1|||
161290133|NCT01286467|582442673|FG003|Overall Study|Withdrawal by Subject|0|||
161290134|NCT01286467|582442670|FG000|Overall Study|Physician Decision|0|||
161290135|NCT01286467|582442671|FG001|Overall Study|Physician Decision|0|||
161290136|NCT01286467|582442672|FG002|Overall Study|Physician Decision|0|||
161290137|NCT01286467|582442673|FG003|Overall Study|Physician Decision|1|||
161290138|NCT01286467|582442670|FG000|Overall Study|Disease progression|3|||
161290139|NCT01286467|582442671|FG001|Overall Study|Disease progression|2|||
161290140|NCT01286467|582442672|FG002|Overall Study|Disease progression|2|||
161290141|NCT01286467|582442673|FG003|Overall Study|Disease progression|3|||
161290142|NCT01286467|582442670|FG000|Overall Study|Adverse Event|0|||
161290143|NCT01286467|582442671|FG001|Overall Study|Adverse Event|1|||
161290144|NCT01286467|582442672|FG002|Overall Study|Adverse Event|2|||
161290145|NCT01286467|582442673|FG003|Overall Study|Adverse Event|3|||
161290146|NCT01286467|582442670|FG000|Overall Study|Study drug stop longer than 14 days|0|||
161290147|NCT01286467|582442671|FG001|Overall Study|Study drug stop longer than 14 days|0|||
161290148|NCT01286467|582442672|FG002|Overall Study|Study drug stop longer than 14 days|1|||
161290149|NCT01286467|582442673|FG003|Overall Study|Study drug stop longer than 14 days|0|||
161290150|NCT03335475|582442674|FG000|Overall Study|Did not wear accelerometer|4|||
161290151|NCT03335475|582442675|FG001|Overall Study|Did not wear accelerometer|0|||
161290152|NCT03335475|582442674|FG000|Overall Study|Withdrawal by Subject|0|||
161290153|NCT03335475|582442675|FG001|Overall Study|Withdrawal by Subject|1|||
161290154|NCT04886596|582442676|FG000|Overall Study|Adverse Event|442|||
161290155|NCT04886596|582442677|FG001|Overall Study|Adverse Event|441|||
161290156|NCT04886596|582442676|FG000|Overall Study|Lost to Follow-up|448|||
161290157|NCT04886596|582442677|FG001|Overall Study|Lost to Follow-up|465|||
161290158|NCT04886596|582442676|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
161290159|NCT04886596|582442677|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
161290160|NCT04886596|582442676|FG000|Overall Study|Migrated/moved from the study area|201|||
161347035|NCT02335944|582654753|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
161290161|NCT04886596|582442677|FG001|Overall Study|Migrated/moved from the study area|184|||
161290162|NCT04886596|582442676|FG000|Overall Study|Other|298|||
161290163|NCT04886596|582442677|FG001|Overall Study|Other|326|||
161347036|NCT02335944|582654754|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
161167307|NCT02921919|581989862|FG000|Overall Study|Disease Progression|47|||
161167308|NCT02921919|581989863|FG001|Overall Study|Disease Progression|38|||
161167309|NCT02921919|581989862|FG000|Overall Study|Physician Decision|3|||
161167310|NCT02921919|581989863|FG001|Overall Study|Physician Decision|2|||
161167311|NCT02921919|581989862|FG000|Overall Study|Adverse Event|6|||
161167312|NCT02921919|581989863|FG001|Overall Study|Adverse Event|4|||
161290164|NCT03751098|582442680|FG000|Overall Study|Withdrawal by Subject|0|||
161290165|NCT03751098|582442681|FG001|Overall Study|Withdrawal by Subject|1|||
161290166|NCT05921903|582442682|FG000|Overall Study|Unsolicited non-SAE|0|||
161290167|NCT05921903|582442683|FG001|Overall Study|Unsolicited non-SAE|1|||
161290168|NCT05921903|582442684|FG002|Overall Study|Unsolicited non-SAE|0|||
161290169|NCT05921903|582442682|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
161290170|NCT05921903|582442683|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
161290171|NCT05921903|582442684|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
161290172|NCT05921903|582442682|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
161290173|NCT05921903|582442683|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
161290174|NCT05921903|582442684|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
161290175|NCT03305848|582442685|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
161290176|NCT03305848|582442685|FG000|Overall Study|Physician Decision|2|||
161290177|NCT01060072|582442689|FG000|Overall Study|Adverse Event|1|||
161290178|NCT01060072|582442690|FG001|Overall Study|Adverse Event|1|||
161290179|NCT01060072|582442689|FG000|Overall Study|Physician Decision|0|||
161290180|NCT01060072|582442690|FG001|Overall Study|Physician Decision|2|||
161290181|NCT01060072|582442689|FG000|Overall Study|Protocol Violation|0|||
161290182|NCT01060072|582442690|FG001|Overall Study|Protocol Violation|1|||
161290183|NCT01060072|582442689|FG000|Overall Study|Acute cholecystitis|1|||
161290184|NCT01060072|582442690|FG001|Overall Study|Acute cholecystitis|0|||
161083408|NCT02270515|581693705|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
161083409|NCT02270515|581693705|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
161083410|NCT02270515|581693705|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
161083411|NCT02270515|581693705|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
161083412|NCT02270515|581693705|FG000|Intervention Period 3: 12-18 Months|Death|3|||
161083413|NCT02270515|581693705|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
161083414|NCT02091206|581693707|FG000|Treatment Period|Adverse Event|0|||
161083415|NCT02091206|581693708|FG001|Treatment Period|Adverse Event|1|||
161083416|NCT02091206|581693709|FG002|Treatment Period|Adverse Event|0|||
161083417|NCT02091206|581693710|FG003|Treatment Period|Adverse Event|0|||
161083418|NCT02091206|581693707|FG000|Treatment Period|Met withdrawal criteria|0|||
161083419|NCT02091206|581693708|FG001|Treatment Period|Met withdrawal criteria|0|||
161083420|NCT02091206|581693709|FG002|Treatment Period|Met withdrawal criteria|1|||
161083421|NCT02091206|581693710|FG003|Treatment Period|Met withdrawal criteria|0|||
161083422|NCT02091206|581693707|FG000|Taper Period|Participant refused study drug|1|||
161083423|NCT02091206|581693708|FG001|Taper Period|Participant refused study drug|0|||
161083424|NCT02091206|581693709|FG002|Taper Period|Participant refused study drug|0|||
161083425|NCT02091206|581693710|FG003|Taper Period|Participant refused study drug|1|||
161083426|NCT02091206|581693707|FG000|Taper Period|Lost to Follow-up|0|||
161083427|NCT02091206|581693708|FG001|Taper Period|Lost to Follow-up|0|||
161083428|NCT02091206|581693709|FG002|Taper Period|Lost to Follow-up|0|||
161083429|NCT02091206|581693710|FG003|Taper Period|Lost to Follow-up|1|||
161083430|NCT01214642|581693711|FG000|Overall Study|Progressive Disease|3|||
161083431|NCT01214642|581693712|FG001|Overall Study|Progressive Disease|2|||
161083432|NCT01214642|581693713|FG002|Overall Study|Progressive Disease|3|||
161083433|NCT01214642|581693714|FG003|Overall Study|Progressive Disease|5|||
161083434|NCT01214642|581693715|FG004|Overall Study|Progressive Disease|5|||
161083435|NCT01214642|581693716|FG005|Overall Study|Progressive Disease|3|||
161083436|NCT01214642|581693717|FG006|Overall Study|Progressive Disease|5|||
161083437|NCT01214642|581693718|FG007|Overall Study|Progressive Disease|3|||
161083438|NCT01214642|581693719|FG008|Overall Study|Progressive Disease|10|||
161083439|NCT01214642|581693720|FG009|Overall Study|Progressive Disease|2|||
161083440|NCT01214642|581693721|FG010|Overall Study|Progressive Disease|1|||
161083441|NCT01214642|581693722|FG011|Overall Study|Progressive Disease|4|||
161083442|NCT01214642|581693711|FG000|Overall Study|Adverse Event|0|||
161083443|NCT01214642|581693712|FG001|Overall Study|Adverse Event|1|||
161083444|NCT01214642|581693713|FG002|Overall Study|Adverse Event|0|||
161083445|NCT01214642|581693714|FG003|Overall Study|Adverse Event|0|||
161083446|NCT01214642|581693715|FG004|Overall Study|Adverse Event|0|||
161083447|NCT01214642|581693716|FG005|Overall Study|Adverse Event|0|||
161083448|NCT01214642|581693717|FG006|Overall Study|Adverse Event|1|||
161083449|NCT01214642|581693718|FG007|Overall Study|Adverse Event|0|||
161083450|NCT01214642|581693719|FG008|Overall Study|Adverse Event|0|||
161083451|NCT01214642|581693720|FG009|Overall Study|Adverse Event|1|||
161083452|NCT01214642|581693721|FG010|Overall Study|Adverse Event|1|||
161083453|NCT01214642|581693722|FG011|Overall Study|Adverse Event|0|||
161083454|NCT01214642|581693711|FG000|Overall Study|Death|0|||
161083455|NCT01214642|581693712|FG001|Overall Study|Death|0|||
161083456|NCT01214642|581693713|FG002|Overall Study|Death|1|||
161083457|NCT01214642|581693714|FG003|Overall Study|Death|0|||
161083458|NCT01214642|581693715|FG004|Overall Study|Death|0|||
161083459|NCT01214642|581693716|FG005|Overall Study|Death|0|||
161083460|NCT01214642|581693717|FG006|Overall Study|Death|0|||
161083461|NCT01214642|581693718|FG007|Overall Study|Death|0|||
161083462|NCT01214642|581693719|FG008|Overall Study|Death|0|||
161083463|NCT01214642|581693720|FG009|Overall Study|Death|0|||
161083464|NCT01214642|581693721|FG010|Overall Study|Death|1|||
161083465|NCT01214642|581693722|FG011|Overall Study|Death|0|||
161083466|NCT01214642|581693711|FG000|Overall Study|Withdrawal by Subject|0|||
161083467|NCT01214642|581693712|FG001|Overall Study|Withdrawal by Subject|0|||
161083468|NCT01214642|581693713|FG002|Overall Study|Withdrawal by Subject|1|||
161083469|NCT01214642|581693714|FG003|Overall Study|Withdrawal by Subject|0|||
161167313|NCT03666858|581989864|FG000|Cohort 1|Adverse Event|1|||
161167314|NCT03666858|581989865|FG001|Cohort 1|Adverse Event|0|||
161167315|NCT03666858|581989864|FG000|Cohort 2|Adverse Event|0|||
161167316|NCT03666858|581989865|FG001|Cohort 2|Adverse Event|1|||
161167317|NCT03282357|581989866|FG000|Overall Study|Lost to Follow-up|3|||
161167318|NCT03282357|581989866|FG000|Overall Study|Withdrawal by Subject|4|||
161167319|NCT03282357|581989866|FG000|Overall Study|Adverse Event|1|||
161167320|NCT03282357|581989866|FG000|Overall Study|Other|9|||
161167321|NCT00393913|581989868|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
161167322|NCT00393913|581989868|FG000|Initial Assessment|Withdrawal by Subject|16|||
161167323|NCT00393913|581989868|FG000|CPAP|Withdrawal by Subject|3|||
161167324|NCT00393913|581989868|FG000|CPAP|Physician Decision|1|||
161167325|NCT00393913|581989868|FG000|CPAP|TEchnical problem with CPAP|3|||
161167326|NCT01518244|581989869|FG000|Overall Study|Adverse Event|3|||
161167327|NCT00870818|581989870|FG000|Overall Study|Lost to Follow-up|3|||
161167328|NCT00870818|581989871|FG001|Overall Study|Lost to Follow-up|2|||
161167329|NCT00870818|581989872|FG002|Overall Study|Lost to Follow-up|1|||
161167330|NCT00870818|581989873|FG003|Overall Study|Lost to Follow-up|0|||
161167331|NCT00870818|581989874|FG004|Overall Study|Lost to Follow-up|0|||
161167332|NCT00870818|581989870|FG000|Overall Study|Withdrawal by Subject|0|||
161167333|NCT00870818|581989871|FG001|Overall Study|Withdrawal by Subject|0|||
161167334|NCT00870818|581989872|FG002|Overall Study|Withdrawal by Subject|1|||
161167335|NCT00870818|581989873|FG003|Overall Study|Withdrawal by Subject|2|||
161167336|NCT00870818|581989874|FG004|Overall Study|Withdrawal by Subject|0|||
161167337|NCT00870818|581989870|FG000|Overall Study|Terminated by sponsor|29|||
161167338|NCT00870818|581989871|FG001|Overall Study|Terminated by sponsor|70|||
161167339|NCT00870818|581989872|FG002|Overall Study|Terminated by sponsor|36|||
161167340|NCT00870818|581989873|FG003|Overall Study|Terminated by sponsor|36|||
161167341|NCT00870818|581989874|FG004|Overall Study|Terminated by sponsor|38|||
161167342|NCT00870818|581989870|FG000|Overall Study|Other|0|||
161167343|NCT00870818|581989871|FG001|Overall Study|Other|1|||
161167344|NCT00870818|581989872|FG002|Overall Study|Other|0|||
161167345|NCT00870818|581989873|FG003|Overall Study|Other|0|||
161167346|NCT00870818|581989874|FG004|Overall Study|Other|0|||
161167347|NCT04900038|581989875|FG000|Overall Study|Adverse Event|1|||
161167348|NCT04900038|581989876|FG001|Overall Study|Adverse Event|0|||
161167349|NCT04900038|581989877|FG002|Overall Study|Adverse Event|1|||
161167350|NCT04900038|581989878|FG003|Overall Study|Adverse Event|1|||
161167351|NCT04900038|581989875|FG000|Overall Study|Withdrawal by Subject|0|||
161167352|NCT04900038|581989876|FG001|Overall Study|Withdrawal by Subject|1|||
161167353|NCT04900038|581989877|FG002|Overall Study|Withdrawal by Subject|0|||
161167354|NCT04900038|581989878|FG003|Overall Study|Withdrawal by Subject|0|||
161167355|NCT04900038|581989875|FG000|Overall Study|Study terminated by sponsor|18|||
161167356|NCT04900038|581989876|FG001|Overall Study|Study terminated by sponsor|15|||
161167357|NCT04900038|581989877|FG002|Overall Study|Study terminated by sponsor|17|||
161167358|NCT04900038|581989878|FG003|Overall Study|Study terminated by sponsor|14|||
161167359|NCT04900038|581989875|FG000|Overall Study|Protocol Deviation|1|||
161167360|NCT04900038|581989876|FG001|Overall Study|Protocol Deviation|1|||
161167361|NCT04900038|581989877|FG002|Overall Study|Protocol Deviation|0|||
161167362|NCT04900038|581989878|FG003|Overall Study|Protocol Deviation|0|||
161167363|NCT04900038|581989875|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
161167364|NCT04900038|581989876|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
161167365|NCT04900038|581989877|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
161167366|NCT04900038|581989878|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
161167367|NCT04900038|581989875|FG000|Overall Study|Lost to Follow-up|0|||
161167368|NCT04900038|581989876|FG001|Overall Study|Lost to Follow-up|0|||
161167369|NCT04900038|581989877|FG002|Overall Study|Lost to Follow-up|0|||
161167370|NCT04900038|581989878|FG003|Overall Study|Lost to Follow-up|1|||
161167371|NCT00594204|581989882|FG000|Overall Study|Adverse Event|15|||
161167372|NCT00594204|581989883|FG001|Overall Study|Adverse Event|3|||
161167373|NCT00594204|581989882|FG000|Overall Study|Lost to Follow-up|9|||
161167374|NCT00594204|581989883|FG001|Overall Study|Lost to Follow-up|5|||
161167375|NCT00594204|581989882|FG000|Overall Study|Withdrawal by Subject|23|||
161167376|NCT00594204|581989883|FG001|Overall Study|Withdrawal by Subject|29|||
161167377|NCT00594204|581989882|FG000|Overall Study|Other|4|||
161167378|NCT00594204|581989883|FG001|Overall Study|Other|3|||
161167379|NCT00594204|581989882|FG000|Overall Study|Lack of Efficacy|3|||
161167380|NCT00594204|581989883|FG001|Overall Study|Lack of Efficacy|4|||
161167381|NCT00594204|581989882|FG000|Overall Study|Randomized but not treated|4|||
161167382|NCT00594204|581989883|FG001|Overall Study|Randomized but not treated|1|||
161167383|NCT02721251|581989884|FG000|Overall Study|Withdrawal by Subject|8|||
161167384|NCT02721251|581989885|FG001|Overall Study|Withdrawal by Subject|7|||
161167385|NCT02721251|581989886|FG002|Overall Study|Withdrawal by Subject|9|||
161167386|NCT02721251|581989884|FG000|Overall Study|poor adherence|2|||
161167387|NCT02721251|581989885|FG001|Overall Study|poor adherence|2|||
161167388|NCT02721251|581989886|FG002|Overall Study|poor adherence|2|||
161167389|NCT01740388|581989889|FG000|Overall Study|Withdrawal by Subject|1|||
161167390|NCT01740388|581989890|FG001|Overall Study|Withdrawal by Subject|2|||
161290185|NCT01060072|582442689|FG000|Overall Study|Excluded Medications|0|||
161290186|NCT01060072|582442690|FG001|Overall Study|Excluded Medications|1|||
161290187|NCT02301169|582442691|FG000|Overall Study|Adverse Event|1|||
161290188|NCT02301169|582442692|FG001|Overall Study|Adverse Event|0|||
161290189|NCT03762265|582442693|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
161290190|NCT03762265|582442694|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
161290191|NCT03762265|582442693|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
161290192|NCT03762265|582442694|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
161290193|NCT03762265|582442693|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
161290194|NCT03762265|582442694|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
161083470|NCT01214642|581693715|FG004|Overall Study|Withdrawal by Subject|0|||
161083471|NCT01214642|581693716|FG005|Overall Study|Withdrawal by Subject|0|||
161083472|NCT01214642|581693717|FG006|Overall Study|Withdrawal by Subject|0|||
161083473|NCT01214642|581693718|FG007|Overall Study|Withdrawal by Subject|0|||
161083474|NCT01214642|581693719|FG008|Overall Study|Withdrawal by Subject|3|||
161083475|NCT01214642|581693720|FG009|Overall Study|Withdrawal by Subject|1|||
161083476|NCT01214642|581693721|FG010|Overall Study|Withdrawal by Subject|1|||
161083477|NCT01214642|581693722|FG011|Overall Study|Withdrawal by Subject|0|||
161083478|NCT01214642|581693711|FG000|Overall Study|Physician Decision|0|||
161083479|NCT01214642|581693712|FG001|Overall Study|Physician Decision|0|||
161083480|NCT01214642|581693713|FG002|Overall Study|Physician Decision|1|||
161083481|NCT01214642|581693714|FG003|Overall Study|Physician Decision|1|||
161083482|NCT01214642|581693715|FG004|Overall Study|Physician Decision|1|||
161083483|NCT01214642|581693716|FG005|Overall Study|Physician Decision|0|||
161083484|NCT01214642|581693717|FG006|Overall Study|Physician Decision|0|||
161083485|NCT01214642|581693718|FG007|Overall Study|Physician Decision|0|||
161083486|NCT01214642|581693719|FG008|Overall Study|Physician Decision|0|||
161083487|NCT01214642|581693720|FG009|Overall Study|Physician Decision|0|||
161083488|NCT01214642|581693721|FG010|Overall Study|Physician Decision|0|||
161083489|NCT01214642|581693722|FG011|Overall Study|Physician Decision|2|||
161083490|NCT00969709|581695327|FG000|Overall Study|Adverse Event|3|||
161083491|NCT00969709|581695328|FG001|Overall Study|Adverse Event|13|||
161083492|NCT00969709|581695329|FG002|Overall Study|Adverse Event|26|||
161083493|NCT00969709|581695330|FG003|Overall Study|Adverse Event|12|||
161083494|NCT00969709|581695327|FG000|Overall Study|Lack of Efficacy|7|||
161083495|NCT00969709|581695328|FG001|Overall Study|Lack of Efficacy|4|||
161083496|NCT00969709|581695329|FG002|Overall Study|Lack of Efficacy|1|||
161083497|NCT00969709|581695330|FG003|Overall Study|Lack of Efficacy|3|||
161083498|NCT00969709|581695327|FG000|Overall Study|Protocol Violation|9|||
161083499|NCT00969709|581695328|FG001|Overall Study|Protocol Violation|5|||
161083500|NCT00969709|581695329|FG002|Overall Study|Protocol Violation|9|||
161083501|NCT00969709|581695330|FG003|Overall Study|Protocol Violation|10|||
161083502|NCT00969709|581695327|FG000|Overall Study|Withdrawal by Subject|9|||
161083503|NCT00969709|581695328|FG001|Overall Study|Withdrawal by Subject|12|||
161083504|NCT00969709|581695329|FG002|Overall Study|Withdrawal by Subject|11|||
161083505|NCT00969709|581695330|FG003|Overall Study|Withdrawal by Subject|23|||
161083506|NCT00969709|581695327|FG000|Overall Study|Lost to Follow-up|10|||
161083507|NCT00969709|581695328|FG001|Overall Study|Lost to Follow-up|14|||
161083508|NCT00969709|581695329|FG002|Overall Study|Lost to Follow-up|8|||
161083509|NCT00969709|581695330|FG003|Overall Study|Lost to Follow-up|15|||
161083510|NCT00969709|581695327|FG000|Overall Study|Other reasons|0|||
161083511|NCT00969709|581695328|FG001|Overall Study|Other reasons|0|||
161083512|NCT00969709|581695329|FG002|Overall Study|Other reasons|3|||
161083513|NCT00969709|581695330|FG003|Overall Study|Other reasons|0|||
161083514|NCT02516332|581695331|FG000|Overall Study|Withdrawal by Subject|2|||
161083515|NCT02516332|581695332|FG001|Overall Study|Withdrawal by Subject|1|||
161083516|NCT02516332|581695333|FG002|Overall Study|Withdrawal by Subject|2|||
161083517|NCT03695237|581695334|FG000|Overall Study|Withdrawal by Subject|1|||
161083518|NCT03695237|581695335|FG001|Overall Study|Withdrawal by Subject|3|||
161083519|NCT03695237|581695334|FG000|Overall Study|Lost to Follow-up|1|||
161083520|NCT03695237|581695335|FG001|Overall Study|Lost to Follow-up|2|||
161083521|NCT03695237|581695334|FG000|Overall Study|Other, Not Specified|8|||
161083522|NCT03695237|581695335|FG001|Overall Study|Other, Not Specified|2|||
161083523|NCT00055601|581695336|FG000|Overall Study|Protocol Violation|1|||
161083524|NCT00055601|581695337|FG001|Overall Study|Protocol Violation|1|||
161083525|NCT00055601|581695336|FG000|Overall Study|No protocol treatment received|1|||
161083526|NCT00055601|581695337|FG001|Overall Study|No protocol treatment received|1|||
161083527|NCT02217332|581695338|FG000|Overall Study|Adverse Event|3|||
161083528|NCT02217332|581695338|FG000|Overall Study|Dose interruption >1 month|1|||
161083529|NCT02217332|581695338|FG000|Overall Study|Protocol Violation (eligibility)|1|||
161290195|NCT03762265|582442693|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
161083530|NCT02217332|581695338|FG000|Overall Study|Withdrawal by Subject|1|||
161083531|NCT02217332|581695338|FG000|Overall Study|Lost to Follow-up|1|||
161083532|NCT01639495|581695343|FG000|Overall Study|Lost to Follow-up|6|||
161290196|NCT03762265|582442694|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
161083533|NCT01639495|581695343|FG000|Overall Study|Consented but didn't have study catheter|4|||
161083534|NCT01639495|581695343|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
161290197|NCT03762265|582442693|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
161290198|NCT03762265|582442694|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
161290199|NCT03762265|582442693|FG000|BT Period: Weeks 1 to 37|Other|0|||
161290200|NCT03762265|582442694|FG001|BT Period: Weeks 1 to 37|Other|1|||
161290201|NCT03762265|582442693|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
161290202|NCT03762265|582442694|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
161290203|NCT03762265|582442693|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
161290204|NCT03762265|582442694|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
161290205|NCT03762265|582442693|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
161290206|NCT03762265|582442694|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
161290207|NCT03762265|582442693|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
161290208|NCT03762265|582442694|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
161290209|NCT03762265|582442693|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
161290210|NCT03762265|582442694|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
161290211|NCT03762265|582442693|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
161290212|NCT03762265|582442694|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
161290213|NCT03762265|582442693|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
161167391|NCT01740388|581989889|FG000|Overall Study|Lost to Follow-up|2|||
161167392|NCT01740388|581989890|FG001|Overall Study|Lost to Follow-up|0|||
161167393|NCT01740388|581989889|FG000|Overall Study|Physician Decision|2|||
161167394|NCT01740388|581989890|FG001|Overall Study|Physician Decision|6|||
161167395|NCT01740388|581989889|FG000|Overall Study|Subjects missing data, completed|41|||
161167396|NCT01740388|581989890|FG001|Overall Study|Subjects missing data, completed|36|||
161167397|NCT01582971|581989893|FG000|Overall Study|Death|2|||
161167398|NCT01582971|581989894|FG001|Overall Study|Death|1|||
161167399|NCT01582971|581989893|FG000|Overall Study|Lost to Follow-up|18|||
161167400|NCT01582971|581989894|FG001|Overall Study|Lost to Follow-up|21|||
161167401|NCT01582971|581989893|FG000|Overall Study|Withdrawal by Subject|4|||
161167402|NCT01582971|581989894|FG001|Overall Study|Withdrawal by Subject|2|||
161167403|NCT01582971|581989893|FG000|Overall Study|Other|15|||
161167404|NCT01582971|581989894|FG001|Overall Study|Other|13|||
161167405|NCT01641991|581989895|FG000|Overall Study|Physician Decision|0|||
161167406|NCT01641991|581989896|FG001|Overall Study|Physician Decision|1|||
161167407|NCT01641991|581989897|FG002|Overall Study|Physician Decision|7|||
161167408|NCT01641991|581989898|FG003|Overall Study|Physician Decision|5|||
161167409|NCT01641991|581989895|FG000|Overall Study|Withdrawal by Subject|4|||
161167410|NCT01641991|581989896|FG001|Overall Study|Withdrawal by Subject|2|||
161167411|NCT01641991|581989897|FG002|Overall Study|Withdrawal by Subject|1|||
161167412|NCT01641991|581989898|FG003|Overall Study|Withdrawal by Subject|5|||
161167413|NCT01641991|581989895|FG000|Overall Study|Adverse Event|2|||
161167414|NCT01641991|581989896|FG001|Overall Study|Adverse Event|1|||
161167415|NCT01641991|581989897|FG002|Overall Study|Adverse Event|2|||
161167416|NCT01641991|581989898|FG003|Overall Study|Adverse Event|1|||
161290214|NCT03762265|582442694|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
161290215|NCT03762265|582442693|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
161290216|NCT03762265|582442694|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
161290217|NCT03762265|582442693|FG000|LTE Period: Weeks 61 to 109|Other|1|||
161290218|NCT03762265|582442694|FG001|LTE Period: Weeks 61 to 109|Other|0|||
161290219|NCT00765102|582442695|FG000|Overall Study|Progressive disease|18|||
161290220|NCT00765102|582442695|FG000|Overall Study|Adverse Event|6|||
161290221|NCT00765102|582442695|FG000|Overall Study|Physician Decision|4|||
161290222|NCT00765102|582442695|FG000|Overall Study|Withdrawal by Subject|2|||
161290223|NCT00765102|582442695|FG000|Overall Study|Protocol Violation|1|||
161290224|NCT02289729|582442699|FG000|Overall Study|Lack of Efficacy|3|||
161290225|NCT02289729|582442699|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
161290226|NCT02289729|582442699|FG000|Overall Study|Withdrawal by Subject|1|||
161290227|NCT02289729|582442699|FG000|Overall Study|Death|1|||
161290228|NCT00470470|582442700|FG000|Overall Study|Adverse Event|2|||
161290229|NCT00470470|582442700|FG000|Overall Study|Death|2|||
161290230|NCT00470470|582442700|FG000|Overall Study|Not treated|1|||
161290231|NCT01149863|582442710|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
161290232|NCT03326193|582442712|FG000|Overall Study|Sponsor decision|35|||
161290233|NCT00822692|582442715|FG000|Overall Study|Lost to Follow-up|17|||
161290234|NCT00822692|582442716|FG001|Overall Study|Lost to Follow-up|25|||
161290235|NCT02452476|582442717|FG000|Overall Study|Death|4|||
161290236|NCT02452476|582442718|FG001|Overall Study|Death|7|||
161347037|NCT02335944|582654755|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
161167417|NCT01641991|581989895|FG000|Overall Study|Lost to Follow-up|0|||
161167418|NCT01641991|581989896|FG001|Overall Study|Lost to Follow-up|2|||
161167419|NCT01641991|581989897|FG002|Overall Study|Lost to Follow-up|3|||
161167420|NCT01641991|581989898|FG003|Overall Study|Lost to Follow-up|1|||
161167421|NCT01641991|581989895|FG000|Overall Study|Protocol Violation|1|||
161167422|NCT01641991|581989896|FG001|Overall Study|Protocol Violation|1|||
161167423|NCT01641991|581989897|FG002|Overall Study|Protocol Violation|3|||
161290237|NCT02452476|582442717|FG000|Overall Study|Lost to Follow-up|1|||
161167424|NCT01641991|581989898|FG003|Overall Study|Protocol Violation|0|||
161167425|NCT01641991|581989895|FG000|Overall Study|Pregnancy|0|||
161290238|NCT02452476|582442718|FG001|Overall Study|Lost to Follow-up|1|||
161290239|NCT02452476|582442717|FG000|Overall Study|Physician Decision|1|||
161290240|NCT02452476|582442718|FG001|Overall Study|Physician Decision|1|||
161083535|NCT01639495|581695343|FG000|Overall Study|No radiofrequency energy applied|2|||
161083536|NCT01119105|581695344|FG000|Overall Study|Withdrawal by Subject|1|||
161083537|NCT01119105|581695345|FG001|Overall Study|Withdrawal by Subject|1|||
161083538|NCT01119105|581695346|FG002|Overall Study|Withdrawal by Subject|1|||
161083539|NCT01119105|581695344|FG000|Overall Study|Lost to Follow-up|0|||
161083540|NCT01119105|581695345|FG001|Overall Study|Lost to Follow-up|2|||
161083541|NCT01119105|581695346|FG002|Overall Study|Lost to Follow-up|5|||
161083542|NCT01119105|581695344|FG000|Overall Study|Adverse Event|1|||
161083543|NCT01119105|581695345|FG001|Overall Study|Adverse Event|0|||
161083544|NCT01119105|581695346|FG002|Overall Study|Adverse Event|1|||
161083545|NCT01119105|581695344|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
161083546|NCT01119105|581695345|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
161083547|NCT01119105|581695346|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
161083548|NCT01119105|581695344|FG000|Overall Study|Other|1|||
161083549|NCT01119105|581695345|FG001|Overall Study|Other|1|||
161083550|NCT01119105|581695346|FG002|Overall Study|Other|0|||
161083551|NCT02366468|581695347|FG000|Overall Study|Adverse Event|2|||
161083552|NCT02366468|581695348|FG001|Overall Study|Adverse Event|0|||
161083553|NCT02366468|581695347|FG000|Overall Study|Withdrawal by Subject|1|||
161083554|NCT02366468|581695348|FG001|Overall Study|Withdrawal by Subject|5|||
161083555|NCT02366468|581695347|FG000|Overall Study|Lost to Follow-up|2|||
161083556|NCT02366468|581695348|FG001|Overall Study|Lost to Follow-up|0|||
161083557|NCT02366468|581695347|FG000|Overall Study|Death|1|||
161083558|NCT02366468|581695348|FG001|Overall Study|Death|2|||
161083559|NCT02366468|581695347|FG000|Overall Study|Other|0|||
161083560|NCT02366468|581695348|FG001|Overall Study|Other|2|||
161083561|NCT00446043|581695349|FG000|Overall Study|Adverse Event|9|||
161083562|NCT00446043|581695349|FG000|Overall Study|Withdrawal by Subject|70|||
161083563|NCT00446043|581695349|FG000|Overall Study|Protocol Violation|2|||
161083564|NCT00446043|581695349|FG000|Overall Study|Lost to Follow-up|42|||
161083565|NCT00446043|581695349|FG000|Overall Study|Pregnancy|2|||
161083566|NCT05540717|581695352|FG000|Overall Study|Lost to Follow-up|2|||
161083567|NCT05540717|581695353|FG001|Overall Study|Lost to Follow-up|5|||
161083568|NCT05540717|581695352|FG000|Overall Study|Withdrawal by Subject|6|||
161083569|NCT05540717|581695353|FG001|Overall Study|Withdrawal by Subject|6|||
161083570|NCT05540717|581695352|FG000|Overall Study|Sponsor request|1|||
161083571|NCT05540717|581695353|FG001|Overall Study|Sponsor request|0|||
161083572|NCT05540717|581695352|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
161083573|NCT05540717|581695353|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
161083574|NCT05540717|581695352|FG000|Overall Study|Other|0|||
161083575|NCT05540717|581695353|FG001|Overall Study|Other|1|||
161083576|NCT01144052|581695354|FG000|Overall Study|Withdrawal by Subject|1|||
161083577|NCT01144052|581695355|FG001|Overall Study|Withdrawal by Subject|1|||
161083578|NCT03836716|581695359|FG000|Overall Study|Adverse Event|3|||
161083579|NCT03836716|581695359|FG000|Overall Study|Death|22|||
161083580|NCT03836716|581695359|FG000|Overall Study|Withdrawal by Subject|8|||
161083581|NCT03836716|581695359|FG000|Overall Study|Study terminated by sponsor|87|||
161083582|NCT01983254|581695360|FG000|Overall Study|Death|6|||
161083583|NCT01983254|581695361|FG001|Overall Study|Death|6|||
161083584|NCT01983254|581695360|FG000|Overall Study|Lost to Follow-up|17|||
161083585|NCT01983254|581695361|FG001|Overall Study|Lost to Follow-up|16|||
161083586|NCT01983254|581695360|FG000|Overall Study|too ill|11|||
161083587|NCT01983254|581695361|FG001|Overall Study|too ill|8|||
161083588|NCT01631227|581695362|FG000|Overall Study|withdrawn consent|27|||
161083589|NCT01631227|581695363|FG001|Overall Study|withdrawn consent|21|||
161083590|NCT01631227|581695362|FG000|Overall Study|Adverse Event|1|||
161083591|NCT01631227|581695363|FG001|Overall Study|Adverse Event|0|||
161083592|NCT01631227|581695362|FG000|Overall Study|administrative|2|||
161083593|NCT01631227|581695363|FG001|Overall Study|administrative|1|||
161083594|NCT01153321|581695364|FG000|Overall Study|Development of study withdrawal criteria|0|||
161083595|NCT01153321|581695365|FG001|Overall Study|Development of study withdrawal criteria|1|||
161083596|NCT01153321|581695364|FG000|Overall Study|Withdrawal by Subject|0|||
161083597|NCT01153321|581695365|FG001|Overall Study|Withdrawal by Subject|1|||
161083598|NCT01153321|581695364|FG000|Overall Study|Adverse Event|1|||
161083599|NCT01153321|581695365|FG001|Overall Study|Adverse Event|1|||
161083600|NCT01177800|581695367|FG000|Overall Study|Adverse Event|9|||
161083601|NCT01177800|581695368|FG001|Overall Study|Adverse Event|3|||
161083602|NCT01177800|581695367|FG000|Overall Study|Protocol Violation|0|||
161083603|NCT01177800|581695368|FG001|Overall Study|Protocol Violation|1|||
161290241|NCT02452476|582442717|FG000|Overall Study|Not treated|5|||
161083604|NCT01177800|581695367|FG000|Overall Study|Physician Decision|1|||
161083605|NCT01177800|581695368|FG001|Overall Study|Physician Decision|0|||
161083606|NCT01177800|581695367|FG000|Overall Study|Withdrawal of informed consent|0|||
161083607|NCT01177800|581695368|FG001|Overall Study|Withdrawal of informed consent|1|||
161083608|NCT02071290|581695371|FG000|Overall Study|Death|1|||
161290242|NCT02452476|582442718|FG001|Overall Study|Not treated|1|||
161167426|NCT01641991|581989896|FG001|Overall Study|Pregnancy|0|||
161167427|NCT01641991|581989897|FG002|Overall Study|Pregnancy|1|||
161167428|NCT01641991|581989898|FG003|Overall Study|Pregnancy|0|||
161167429|NCT01641991|581989895|FG000|Overall Study|no longer eligible|2|||
161167430|NCT01641991|581989896|FG001|Overall Study|no longer eligible|1|||
161167431|NCT01641991|581989897|FG002|Overall Study|no longer eligible|0|||
161167432|NCT01641991|581989898|FG003|Overall Study|no longer eligible|4|||
161167433|NCT03245723|581989907|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
161347038|NCT02335944|582654756|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
161167434|NCT03245723|581989908|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
161167435|NCT03245723|581989907|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
161167436|NCT03245723|581989908|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
161167437|NCT03245723|581989907|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
161167438|NCT03245723|581989908|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
161167439|NCT03245723|581989907|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
161167440|NCT03245723|581989908|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
161167441|NCT00077376|581989911|FG000|Overall Study|Adverse Event|8|||
161167442|NCT00077376|581989911|FG000|Overall Study|Withdrawal by Subject|2|||
161167443|NCT00077376|581989911|FG000|Overall Study|Death|1|||
161167444|NCT00077376|581989911|FG000|Overall Study|Physician Decision|1|||
161167445|NCT00077376|581989911|FG000|Overall Study|Alternative therapy|5|||
161167446|NCT00077376|581989911|FG000|Overall Study|Complicating disease|1|||
161167447|NCT00077376|581989911|FG000|Overall Study|Still on treatment|1|||
161167448|NCT00077376|581989911|FG000|Overall Study|Symptomatic deterioration|1|||
161167449|NCT00077376|581989911|FG000|Overall Study|Surgery|1|||
161167450|NCT00077376|581989911|FG000|Overall Study|Insurance ran out|1|||
161167451|NCT03784027|581989912|FG000|Period 1|Withdrawal by Subject|0|||
161167452|NCT03784027|581989913|FG001|Period 1|Withdrawal by Subject|1|||
161167453|NCT06025396|581991337|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
161167454|NCT06025396|581991338|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
161167455|NCT06025396|581991339|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
161167456|NCT06025396|581991340|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
161167457|NCT06025396|581991341|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
161167458|NCT06025396|581991337|FG000|Overall Study|Withdrawal by Subject|0|||
161167459|NCT06025396|581991338|FG001|Overall Study|Withdrawal by Subject|1|||
161167460|NCT06025396|581991339|FG002|Overall Study|Withdrawal by Subject|1|||
161167461|NCT06025396|581991340|FG003|Overall Study|Withdrawal by Subject|0|||
161167462|NCT06025396|581991341|FG004|Overall Study|Withdrawal by Subject|0|||
161167463|NCT01512108|581991342|FG000|Overall Study|Adverse Event|9|||
161167464|NCT01512108|581991343|FG001|Overall Study|Adverse Event|4|||
161167465|NCT01512108|581991342|FG000|Overall Study|Protocol Violation|1|||
161167466|NCT01512108|581991343|FG001|Overall Study|Protocol Violation|2|||
161167467|NCT01512108|581991342|FG000|Overall Study|Withdrawal Criteria|1|||
161167468|NCT01512108|581991343|FG001|Overall Study|Withdrawal Criteria|0|||
161167469|NCT01512108|581991342|FG000|Overall Study|Unclassified|11|||
161167470|NCT01512108|581991343|FG001|Overall Study|Unclassified|3|||
161167471|NCT06422377|581991344|FG000|Overall Study|Study Terminated by Sponsor|1|||
161167472|NCT03287869|581991345|FG000|Overall Study|Adverse Event|14|||
161167473|NCT03287869|581991346|FG001|Overall Study|Adverse Event|12|||
161167474|NCT03287869|581991345|FG000|Overall Study|Lack of Efficacy|1|||
161167475|NCT03287869|581991346|FG001|Overall Study|Lack of Efficacy|0|||
161167476|NCT03287869|581991345|FG000|Overall Study|Lost to Follow-up|13|||
161167477|NCT03287869|581991346|FG001|Overall Study|Lost to Follow-up|19|||
161167478|NCT03287869|581991345|FG000|Overall Study|Non-Compliance With Study Drug|5|||
161167479|NCT03287869|581991346|FG001|Overall Study|Non-Compliance With Study Drug|9|||
161167480|NCT03287869|581991345|FG000|Overall Study|Progressive Disease|1|||
161167481|NCT03287869|581991346|FG001|Overall Study|Progressive Disease|0|||
161167482|NCT03287869|581991345|FG000|Overall Study|Protocol Deviation|2|||
161167483|NCT03287869|581991346|FG001|Overall Study|Protocol Deviation|1|||
161167484|NCT03287869|581991345|FG000|Overall Study|Withdrawal by Subject|36|||
161167485|NCT03287869|581991346|FG001|Overall Study|Withdrawal by Subject|43|||
161167486|NCT03287869|581991345|FG000|Overall Study|Early Closure of the Site|0|||
161167487|NCT03287869|581991346|FG001|Overall Study|Early Closure of the Site|1|||
161347039|NCT02335944|582654757|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
161167488|NCT03287869|581991345|FG000|Overall Study|Physician Decision|5|||
161167489|NCT03287869|581991346|FG001|Overall Study|Physician Decision|5|||
161167490|NCT03287869|581991345|FG000|Overall Study|Reason not Specified|6|||
161167491|NCT03287869|581991346|FG001|Overall Study|Reason not Specified|3|||
161167492|NCT01149343|581991347|FG000|Overall Study|Withdrawal by Subject|1|||
161167493|NCT01149343|581991348|FG001|Overall Study|Withdrawal by Subject|1|||
161167494|NCT01149343|581991349|FG002|Overall Study|Withdrawal by Subject|1|||
161167495|NCT01149343|581991350|FG003|Overall Study|Withdrawal by Subject|5|||
161167496|NCT01149343|581991347|FG000|Overall Study|Death|10|||
161167497|NCT01149343|581991348|FG001|Overall Study|Death|13|||
161167498|NCT01149343|581991349|FG002|Overall Study|Death|18|||
161167499|NCT01149343|581991350|FG003|Overall Study|Death|18|||
161167500|NCT01149343|581991347|FG000|Overall Study|Lost to Follow-up|1|||
161290243|NCT01964976|582442719|FG000|Overall Study|Protocol Violation|31|||
161290244|NCT02348112|582442720|FG000|Overall Study|Withdrawal by Subject|32|||
161290245|NCT02348112|582442721|FG001|Overall Study|Withdrawal by Subject|29|||
161290246|NCT02348112|582442720|FG000|Overall Study|Lost to Follow-up|24|||
161290247|NCT02348112|582442721|FG001|Overall Study|Lost to Follow-up|20|||
161290248|NCT02348112|582442720|FG000|Overall Study|Physician Decision|17|||
161290249|NCT02348112|582442721|FG001|Overall Study|Physician Decision|15|||
161290250|NCT02348112|582442720|FG000|Overall Study|Site closed due to PI leaving|0|||
161290251|NCT02348112|582442721|FG001|Overall Study|Site closed due to PI leaving|30|||
161290252|NCT02348112|582442720|FG000|Overall Study|Sponsor withdrawal|0|||
161290253|NCT02348112|582442721|FG001|Overall Study|Sponsor withdrawal|7|||
161290254|NCT02348112|582442720|FG000|Overall Study|Death|0|||
161290255|NCT02348112|582442721|FG001|Overall Study|Death|1|||
161290256|NCT00946920|582442723|FG000|Overall Study|Withdrawal by Subject|28|||
161167501|NCT01149343|581991348|FG001|Overall Study|Lost to Follow-up|0|||
161167502|NCT01149343|581991349|FG002|Overall Study|Lost to Follow-up|0|||
161167503|NCT01149343|581991350|FG003|Overall Study|Lost to Follow-up|1|||
161167504|NCT01149343|581991347|FG000|Overall Study|Other|8|||
161167505|NCT01149343|581991348|FG001|Overall Study|Other|10|||
161167506|NCT01149343|581991349|FG002|Overall Study|Other|2|||
161167507|NCT01149343|581991350|FG003|Overall Study|Other|14|||
161167508|NCT01149343|581991347|FG000|Overall Study|Sponsor study termination|0|||
161167509|NCT01149343|581991348|FG001|Overall Study|Sponsor study termination|0|||
161167510|NCT01149343|581991349|FG002|Overall Study|Sponsor study termination|0|||
161167511|NCT01149343|581991350|FG003|Overall Study|Sponsor study termination|2|||
161167512|NCT01149343|581991347|FG000|Overall Study|Recurrence / Progressive disease|0|||
161167513|NCT01149343|581991348|FG001|Overall Study|Recurrence / Progressive disease|0|||
161167514|NCT01149343|581991349|FG002|Overall Study|Recurrence / Progressive disease|1|||
161167515|NCT01149343|581991350|FG003|Overall Study|Recurrence / Progressive disease|0|||
161167516|NCT03472040|581991367|FG000|Overall Study|Physician Decision|0|||
161167517|NCT03472040|581991368|FG001|Overall Study|Physician Decision|3|||
161167518|NCT03472040|581991367|FG000|Overall Study|Withdrawal by Subject|10|||
161167519|NCT03472040|581991368|FG001|Overall Study|Withdrawal by Subject|23|||
161167520|NCT03472040|581991367|FG000|Overall Study|Perceived Lack of Efficacy|29|||
161167521|NCT03472040|581991368|FG001|Overall Study|Perceived Lack of Efficacy|30|||
161167522|NCT03472040|581991367|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
161167523|NCT03472040|581991368|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
161167524|NCT03472040|581991367|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
161167525|NCT03472040|581991368|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
161167526|NCT03472040|581991367|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
161167527|NCT03472040|581991368|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
161167528|NCT03472040|581991367|FG000|Overall Study|Subject Non-compliance|2|||
161167529|NCT03472040|581991368|FG001|Overall Study|Subject Non-compliance|5|||
161167530|NCT03472040|581991367|FG000|Overall Study|Discontinuation due to Rash|0|||
161167531|NCT03472040|581991368|FG001|Overall Study|Discontinuation due to Rash|1|||
161167532|NCT03472040|581991367|FG000|Overall Study|Subsequent Ineligibility|0|||
161167533|NCT03472040|581991368|FG001|Overall Study|Subsequent Ineligibility|2|||
161167534|NCT03472040|581991367|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
161167535|NCT03472040|581991368|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
161167536|NCT02769832|581991369|FG000|Overall Study|Death|30|||
161167537|NCT02197897|581991370|FG000|Overall Study|not eligible|1|||
161167538|NCT00650091|581991372|FG000|Amended Study Design|Withdrawal by Subject|12|||
161167539|NCT00650091|581991373|FG001|Amended Study Design|Withdrawal by Subject|11|||
161167540|NCT00650091|581991374|FG002|Amended Study Design|Withdrawal by Subject|0|||
161167541|NCT00650091|581991372|FG000|Amended Study Design|Physician Decision|5|||
161167542|NCT00650091|581991373|FG001|Amended Study Design|Physician Decision|0|||
161290257|NCT00946920|582442724|FG001|Overall Study|Withdrawal by Subject|15|||
161290258|NCT00946920|582442723|FG000|Overall Study|Lost to Follow-up|2|||
161290259|NCT00946920|582442724|FG001|Overall Study|Lost to Follow-up|2|||
161167543|NCT00650091|581991374|FG002|Amended Study Design|Physician Decision|0|||
161290260|NCT00946920|582442723|FG000|Overall Study|Physician Decision|5|||
161290261|NCT00946920|582442724|FG001|Overall Study|Physician Decision|2|||
161290262|NCT00946920|582442723|FG000|Overall Study|Adverse Event|41|||
161290263|NCT00946920|582442724|FG001|Overall Study|Adverse Event|14|||
161290264|NCT00946920|582442723|FG000|Overall Study|Protocol Violation|16|||
161167544|NCT00650091|581991372|FG000|Amended Study Design|Adverse Event|1|||
161167545|NCT00650091|581991373|FG001|Amended Study Design|Adverse Event|4|||
161167546|NCT00650091|581991374|FG002|Amended Study Design|Adverse Event|0|||
161167547|NCT00650091|581991372|FG000|Amended Study Design|Lung transplantation|4|||
161167548|NCT00650091|581991373|FG001|Amended Study Design|Lung transplantation|2|||
161290265|NCT00946920|582442724|FG001|Overall Study|Protocol Violation|8|||
161290266|NCT00946920|582442723|FG000|Overall Study|Miscellaneous reasons|18|||
161290267|NCT00946920|582442724|FG001|Overall Study|Miscellaneous reasons|3|||
161290268|NCT00397514|582442725|FG000|Overall Study|Withdrawal by Subject|1|||
161290269|NCT00397514|582442725|FG000|Overall Study|Pacing wire malfunction|1|||
161167549|NCT00650091|581991374|FG002|Amended Study Design|Lung transplantation|0|||
161167550|NCT00650091|581991372|FG000|Amended Study Design|Other|1|||
161167551|NCT00650091|581991373|FG001|Amended Study Design|Other|3|||
161167552|NCT00650091|581991374|FG002|Amended Study Design|Other|0|||
161167553|NCT00168064|581991383|FG000|Overall Study|Adverse Event|26|||
161167554|NCT00168064|581991384|FG001|Overall Study|Adverse Event|22|||
161167555|NCT00168064|581991383|FG000|Overall Study|Withdrawal by Subject|3|||
161167556|NCT00168064|581991384|FG001|Overall Study|Withdrawal by Subject|4|||
161167557|NCT00168064|581991383|FG000|Overall Study|Lack of Efficacy|4|||
161167558|NCT00168064|581991384|FG001|Overall Study|Lack of Efficacy|4|||
161167559|NCT00168064|581991383|FG000|Overall Study|Lost to Follow-up|4|||
161167560|NCT00168064|581991384|FG001|Overall Study|Lost to Follow-up|3|||
161167561|NCT00168064|581991383|FG000|Overall Study|Non-compliance|2|||
161167562|NCT00168064|581991384|FG001|Overall Study|Non-compliance|3|||
161167563|NCT00168064|581991383|FG000|Overall Study|Concurrent Illness|4|||
161167564|NCT00168064|581991384|FG001|Overall Study|Concurrent Illness|3|||
161167565|NCT00168064|581991383|FG000|Overall Study|Subject's Best interest|2|||
161167566|NCT00168064|581991384|FG001|Overall Study|Subject's Best interest|2|||
161167567|NCT00168064|581991383|FG000|Overall Study|Various|4|||
161167568|NCT00168064|581991384|FG001|Overall Study|Various|3|||
161167569|NCT01153841|581991385|FG000|Overall Study|Adverse Event|1|||
161167570|NCT01153841|581991386|FG001|Overall Study|Adverse Event|0|||
161167571|NCT01153841|581991385|FG000|Overall Study|Withdrawal by Subject|1|||
161167572|NCT01153841|581991386|FG001|Overall Study|Withdrawal by Subject|0|||
161167573|NCT01153841|581991385|FG000|Overall Study|Protocol Violation|2|||
161167574|NCT01153841|581991386|FG001|Overall Study|Protocol Violation|0|||
161167575|NCT01153841|581991385|FG000|Overall Study|Lost to Follow-up|2|||
161167576|NCT01153841|581991386|FG001|Overall Study|Lost to Follow-up|0|||
161167577|NCT03428997|581991392|FG000|Overall Study|Sponsor decision.|1|||
161167578|NCT03428997|581991392|FG000|Overall Study|Withdrawal by Subject|3|||
161167579|NCT03428997|581991392|FG000|Overall Study|Lost to Follow-up|4|||
161167580|NCT00510068|581991396|FG000|Double-blind Period|Disease progression|98|||
161167581|NCT00510068|581991397|FG001|Double-blind Period|Disease progression|169|||
161167582|NCT00510068|581991396|FG000|Double-blind Period|Final primary analysis|52|||
161167583|NCT00510068|581991397|FG001|Double-blind Period|Final primary analysis|18|||
161167584|NCT00510068|581991396|FG000|Double-blind Period|Adverse Event|37|||
161167585|NCT00510068|581991397|FG001|Double-blind Period|Adverse Event|7|||
161167586|NCT00510068|581991396|FG000|Double-blind Period|Withdrawal by Subject|8|||
161167587|NCT00510068|581991397|FG001|Double-blind Period|Withdrawal by Subject|6|||
161167588|NCT00510068|581991396|FG000|Double-blind Period|Death|4|||
161167589|NCT00510068|581991397|FG001|Double-blind Period|Death|3|||
161167590|NCT00510068|581991396|FG000|Double-blind Period|Abnormal test result (s)|1|||
161167591|NCT00510068|581991397|FG001|Double-blind Period|Abnormal test result (s)|0|||
161167592|NCT00510068|581991396|FG000|Double-blind Period|Lost to Follow-up|1|||
161167593|NCT00510068|581991397|FG001|Double-blind Period|Lost to Follow-up|0|||
161167594|NCT00510068|581991396|FG000|Double-blind Period|Protocol Violation|6|||
161167595|NCT00510068|581991397|FG001|Double-blind Period|Protocol Violation|0|||
161167596|NCT00510068|581991396|FG000|Open-label Period|Disease Progression|124|||
161167597|NCT00510068|581991397|FG001|Open-label Period|Disease Progression|0|||
161167598|NCT00510068|581991396|FG000|Open-label Period|Adverse Event|46|||
161167599|NCT00510068|581991397|FG001|Open-label Period|Adverse Event|0|||
161167600|NCT00510068|581991396|FG000|Open-label Period|Withdrawal by Subject|21|||
161167601|NCT00510068|581991397|FG001|Open-label Period|Withdrawal by Subject|0|||
161167602|NCT00510068|581991396|FG000|Open-label Period|Administrative problems|17|||
161167603|NCT00510068|581991397|FG001|Open-label Period|Administrative problems|0|||
161167604|NCT00510068|581991396|FG000|Open-label Period|Death|7|||
161167605|NCT00510068|581991397|FG001|Open-label Period|Death|0|||
161167606|NCT00510068|581991396|FG000|Open-label Period|New cancer therapy|7|||
161167607|NCT00510068|581991397|FG001|Open-label Period|New cancer therapy|0|||
161290270|NCT00397514|582442725|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
161290271|NCT00397514|582442725|FG000|Overall Study|early extubation|2|||
161290272|NCT00397514|582442725|FG000|Overall Study|poor echocardiographic windows|1|||
161290273|NCT02654054|582442729|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
161167608|NCT00510068|581991396|FG000|Open-label Period|Protocol Violation|2|||
161167609|NCT00510068|581991397|FG001|Open-label Period|Protocol Violation|0|||
161167610|NCT00510068|581991396|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
161167611|NCT00510068|581991397|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
161167612|NCT01397448|581991398|FG000|Overall Study|Adverse Event|4|||
161167613|NCT01397448|581991399|FG001|Overall Study|Adverse Event|4|||
161167614|NCT01397448|581991400|FG002|Overall Study|Adverse Event|6|||
161167615|NCT01397448|581991398|FG000|Overall Study|Withdrawal by Subject|4|||
161167616|NCT01397448|581991399|FG001|Overall Study|Withdrawal by Subject|4|||
161167617|NCT01397448|581991400|FG002|Overall Study|Withdrawal by Subject|3|||
161167618|NCT01397448|581991398|FG000|Overall Study|Lack of Efficacy|2|||
161167619|NCT01397448|581991399|FG001|Overall Study|Lack of Efficacy|0|||
161167620|NCT01397448|581991400|FG002|Overall Study|Lack of Efficacy|5|||
161167621|NCT01397448|581991398|FG000|Overall Study|Other|8|||
161167622|NCT01397448|581991399|FG001|Overall Study|Other|7|||
161290274|NCT02654054|582442730|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
161290275|NCT02654054|582442731|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
161290276|NCT02654054|582442729|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
161290277|NCT02654054|582442730|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161290278|NCT02654054|582442731|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
161290279|NCT02654054|582442729|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161290280|NCT02654054|582442730|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161083609|NCT02071290|581695372|FG001|Overall Study|Death|0|||
161083610|NCT02071290|581695371|FG000|Overall Study|Withdrawal by Subject|0|||
161083611|NCT02071290|581695372|FG001|Overall Study|Withdrawal by Subject|1|||
161083612|NCT02071290|581695371|FG000|Overall Study|Protocol Violation|3|||
161083613|NCT02071290|581695372|FG001|Overall Study|Protocol Violation|5|||
161083614|NCT02071290|581695371|FG000|Overall Study|Physician Decision|0|||
161290281|NCT02654054|582442731|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
161290282|NCT02654054|582442729|FG000|Post-Treatment Follow-Up Period|Other|1|||
161083615|NCT02071290|581695372|FG001|Overall Study|Physician Decision|1|||
161083616|NCT01941719|581695378|FG000|Overall Study|Lost to Follow-up|20|||
161083617|NCT01941719|581695379|FG001|Overall Study|Lost to Follow-up|19|||
161083618|NCT03819634|581695381|FG000|Overall Study|Physician Decision|2|||
161083619|NCT01125514|581695383|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
161083620|NCT01125514|581695383|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
161083621|NCT01125514|581695383|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
161083622|NCT01125514|581695383|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
161083623|NCT01125514|581695383|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
161083624|NCT01125514|581695383|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
161083625|NCT00858364|581695384|FG000|Overall Study|Administrative Decision|3|||
161083626|NCT00858364|581695385|FG001|Overall Study|Administrative Decision|2|||
161083627|NCT00858364|581695384|FG000|Overall Study|Adverse Event|5|||
161083628|NCT00858364|581695385|FG001|Overall Study|Adverse Event|2|||
161083629|NCT00858364|581695384|FG000|Overall Study|Withdrawal by Subject|44|||
161083630|NCT00858364|581695385|FG001|Overall Study|Withdrawal by Subject|118|||
161083631|NCT00858364|581695384|FG000|Overall Study|Ineligibility Determined|1|||
161083632|NCT00858364|581695385|FG001|Overall Study|Ineligibility Determined|10|||
161083633|NCT00858364|581695384|FG000|Overall Study|Lost to Follow-up|24|||
161083634|NCT00858364|581695385|FG001|Overall Study|Lost to Follow-up|54|||
161083635|NCT00858364|581695384|FG000|Overall Study|Noncompliance|3|||
161083636|NCT00858364|581695385|FG001|Overall Study|Noncompliance|4|||
161083637|NCT00858364|581695384|FG000|Overall Study|Protocol Deviation|0|||
161083638|NCT00858364|581695385|FG001|Overall Study|Protocol Deviation|2|||
161083639|NCT00858364|581695384|FG000|Overall Study|Other|9|||
161083640|NCT00858364|581695385|FG001|Overall Study|Other|17|||
161083641|NCT00858364|581695384|FG000|Overall Study|Missing|1|||
161083642|NCT00858364|581695385|FG001|Overall Study|Missing|1|||
161083643|NCT00858364|581695384|FG000|Overall Study|Still on-study|114|||
161083644|NCT00858364|581695385|FG001|Overall Study|Still on-study|247|||
161083645|NCT01655693|581695389|FG000|Overall Study|Progression of Disease|92|||
161083646|NCT01655693|581695390|FG001|Overall Study|Progression of Disease|76|||
161083647|NCT01655693|581695391|FG002|Overall Study|Progression of Disease|58|||
161083648|NCT01655693|581695389|FG000|Overall Study|Death|8|||
161083649|NCT01655693|581695390|FG001|Overall Study|Death|9|||
161083650|NCT01655693|581695391|FG002|Overall Study|Death|12|||
161083651|NCT01655693|581695389|FG000|Overall Study|Serious Adverse Event|3|||
161083652|NCT01655693|581695390|FG001|Overall Study|Serious Adverse Event|15|||
161083653|NCT01655693|581695391|FG002|Overall Study|Serious Adverse Event|11|||
161083654|NCT01655693|581695389|FG000|Overall Study|Withdrawal by Subject|3|||
161083655|NCT01655693|581695390|FG001|Overall Study|Withdrawal by Subject|2|||
161083656|NCT01655693|581695391|FG002|Overall Study|Withdrawal by Subject|20|||
161083657|NCT01655693|581695389|FG000|Overall Study|Adverse Event|3|||
161083658|NCT01655693|581695390|FG001|Overall Study|Adverse Event|11|||
161083659|NCT01655693|581695391|FG002|Overall Study|Adverse Event|3|||
161083660|NCT01655693|581695389|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
161083661|NCT01655693|581695390|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
161083662|NCT01655693|581695391|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
161083663|NCT01655693|581695389|FG000|Overall Study|Non-Compliance|0|||
161083664|NCT01655693|581695390|FG001|Overall Study|Non-Compliance|0|||
161083665|NCT01655693|581695391|FG002|Overall Study|Non-Compliance|7|||
161083666|NCT01655693|581695389|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
161083667|NCT01655693|581695390|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
161083668|NCT01655693|581695391|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
161083669|NCT01655693|581695389|FG000|Overall Study|Protocol Violation|1|||
161083670|NCT01655693|581695390|FG001|Overall Study|Protocol Violation|0|||
161083671|NCT01655693|581695391|FG002|Overall Study|Protocol Violation|3|||
161083672|NCT01655693|581695389|FG000|Overall Study|Lost to Follow-up|1|||
161167623|NCT01397448|581991400|FG002|Overall Study|Other|4|||
161167624|NCT00776555|581991407|FG000|Overall Study|Study terminated|3|||
161167625|NCT00776555|581991408|FG001|Overall Study|Study terminated|0|||
161167626|NCT03483116|581991410|FG000|Overall Study|Adverse Event|0|||
161167627|NCT03483116|581991411|FG001|Overall Study|Adverse Event|1|||
161167628|NCT03483116|581991412|FG002|Overall Study|Adverse Event|0|||
161167629|NCT03483116|581991413|FG003|Overall Study|Adverse Event|1|||
161167630|NCT03483116|581991410|FG000|Overall Study|Protocol Violation|1|||
161167631|NCT03483116|581991411|FG001|Overall Study|Protocol Violation|0|||
161167632|NCT03483116|581991412|FG002|Overall Study|Protocol Violation|0|||
161167633|NCT03483116|581991413|FG003|Overall Study|Protocol Violation|7|||
161167634|NCT03483116|581991410|FG000|Overall Study|Lost to Follow-up|9|||
161167635|NCT03483116|581991411|FG001|Overall Study|Lost to Follow-up|4|||
161167636|NCT03483116|581991412|FG002|Overall Study|Lost to Follow-up|9|||
161167637|NCT03483116|581991413|FG003|Overall Study|Lost to Follow-up|5|||
161167638|NCT03483116|581991410|FG000|Overall Study|Death|1|||
161167639|NCT03483116|581991411|FG001|Overall Study|Death|0|||
161167640|NCT03483116|581991412|FG002|Overall Study|Death|2|||
161167641|NCT03483116|581991413|FG003|Overall Study|Death|1|||
161167642|NCT03483116|581991410|FG000|Overall Study|Withdrawal by Subject|14|||
161167643|NCT03483116|581991411|FG001|Overall Study|Withdrawal by Subject|16|||
161167644|NCT03483116|581991412|FG002|Overall Study|Withdrawal by Subject|14|||
161167645|NCT03483116|581991413|FG003|Overall Study|Withdrawal by Subject|16|||
161167646|NCT03483116|581991410|FG000|Overall Study|Unknown other reason|3|||
161167647|NCT03483116|581991411|FG001|Overall Study|Unknown other reason|2|||
161167648|NCT03483116|581991412|FG002|Overall Study|Unknown other reason|1|||
161167649|NCT03483116|581991413|FG003|Overall Study|Unknown other reason|1|||
161167650|NCT01838590|581991418|FG000|Overall Study|Lack of Efficacy|12|||
161167651|NCT01838590|581991419|FG001|Overall Study|Lack of Efficacy|4|||
161167652|NCT01838590|581991418|FG000|Overall Study|Lost to Follow-up|0|||
161167653|NCT01838590|581991419|FG001|Overall Study|Lost to Follow-up|1|||
161167654|NCT04685499|581991420|FG000|Overall Study|Study Terminated Early|1|||
161167655|NCT01996904|581991423|FG000|Overall Study|Lost to Follow-up|38|||
161167656|NCT01996904|581991424|FG001|Overall Study|Lost to Follow-up|27|||
161167657|NCT00929734|581991426|FG000|Overall Study|Lost to Follow-up|2|||
161167658|NCT00929734|581991427|FG001|Overall Study|Lost to Follow-up|1|||
161167659|NCT00929734|581991426|FG000|Overall Study|Withdrawal by Subject|0|||
161167660|NCT00929734|581991427|FG001|Overall Study|Withdrawal by Subject|2|||
161167661|NCT00980980|581991428|FG000|Overall Study|Withdrawal by Hospital|0|||
161167662|NCT00980980|581991429|FG001|Overall Study|Withdrawal by Hospital|1|||
161167663|NCT00980980|581991430|FG002|Overall Study|Withdrawal by Hospital|0|||
161167664|NCT00121992|581991431|FG000|Overall Study|Treatment not received|2|||
161167665|NCT00121992|581991432|FG001|Overall Study|Treatment not received|11|||
161167666|NCT04664855|581991433|FG000|Overall Study|Withdrawal by Subject|0|||
161167667|NCT04664855|581991434|FG001|Overall Study|Withdrawal by Subject|2|||
161167668|NCT03076190|581991435|FG000|Overall Study|Lost to Follow-up|9|||
161167669|NCT03076190|581991436|FG001|Overall Study|Lost to Follow-up|34|||
161167670|NCT03076190|581991435|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
161167671|NCT03076190|581991436|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
161167672|NCT01441115|581991437|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
161167673|NCT02475395|581991445|FG000|Overall Study|Protocol Violation|30|||
161167674|NCT02475395|581991446|FG001|Overall Study|Protocol Violation|3|||
161167675|NCT01086150|581991447|FG000|Overall Study|Withdrawal by Subject|0|||
161167676|NCT01086150|581991448|FG001|Overall Study|Withdrawal by Subject|4|||
161167677|NCT01086150|581991449|FG002|Overall Study|Withdrawal by Subject|1|||
161167678|NCT01086150|581991447|FG000|Overall Study|Lost to Follow-up|0|||
161167679|NCT01086150|581991448|FG001|Overall Study|Lost to Follow-up|1|||
161167680|NCT01086150|581991449|FG002|Overall Study|Lost to Follow-up|0|||
161167681|NCT01086150|581991447|FG000|Overall Study|Screen Failure|0|||
161167682|NCT01086150|581991448|FG001|Overall Study|Screen Failure|1|||
161167683|NCT01086150|581991449|FG002|Overall Study|Screen Failure|0|||
161167684|NCT01681576|581991450|FG000|Period 1|Adverse Event|1|||
161167685|NCT01681576|581991451|FG001|Period 1|Adverse Event|0|||
161167686|NCT01681576|581991450|FG000|Period 1|Protocol Deviation|1|||
161167687|NCT01681576|581991451|FG001|Period 1|Protocol Deviation|0|||
161167688|NCT01681576|581991450|FG000|Period 2|subject/guardian decision|3|||
161167689|NCT01681576|581991451|FG001|Period 2|subject/guardian decision|1|||
161167690|NCT01681576|581991450|FG000|Period 2|Non-compliance with study treatment|1|||
161167691|NCT01681576|581991451|FG001|Period 2|Non-compliance with study treatment|0|||
161167692|NCT00178464|581991453|FG000|Overall Study|Withdrawal by Subject|1|||
161167693|NCT00178464|581991453|FG000|Overall Study|Physician Decision|1|||
161167694|NCT02260648|581991454|FG000|Overall Study|Adverse Event|3|||
161167695|NCT02260648|581991455|FG001|Overall Study|Adverse Event|0|||
161167696|NCT02260648|581991456|FG002|Overall Study|Adverse Event|1|||
161167697|NCT02260648|581991454|FG000|Overall Study|Withdrawal by Subject|1|||
161167698|NCT02260648|581991455|FG001|Overall Study|Withdrawal by Subject|1|||
161167699|NCT02260648|581991456|FG002|Overall Study|Withdrawal by Subject|0|||
161167700|NCT02260648|581991454|FG000|Overall Study|Protocol Violation|1|||
161167701|NCT02260648|581991455|FG001|Overall Study|Protocol Violation|0|||
161167702|NCT02260648|581991456|FG002|Overall Study|Protocol Violation|0|||
161167703|NCT02260648|581991454|FG000|Overall Study|Discontinue Due to Study Termination|13|||
161167704|NCT02260648|581991455|FG001|Overall Study|Discontinue Due to Study Termination|12|||
161167705|NCT02260648|581991456|FG002|Overall Study|Discontinue Due to Study Termination|7|||
161167706|NCT04093258|581991457|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
161167707|NCT04093258|581991458|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
161167708|NCT01890512|581991459|FG000|Overall Study|Physician Decision|1|||
161167709|NCT01890512|581991459|FG000|Overall Study|Withdrawal by Subject|1|||
161167710|NCT01890512|581991459|FG000|Overall Study|Protocol Violation|1|||
161167711|NCT01529385|581991460|FG000|Overall Study|Lost to Follow-up|2|||
161167712|NCT01529385|581991461|FG001|Overall Study|Lost to Follow-up|1|||
161167713|NCT00805545|581991462|FG000|Overall Study|Protocol Violation|3|||
161167714|NCT00805545|581991463|FG001|Overall Study|Protocol Violation|2|||
161167715|NCT00805545|581991462|FG000|Overall Study|Protocol Violation|3|||
161167716|NCT00805545|581991463|FG001|Overall Study|Protocol Violation|1|||
161167717|NCT03543358|581991464|FG000|Overall Study|Death|1|||
161167718|NCT03543358|581991465|FG001|Overall Study|Death|0|||
161167719|NCT03543358|581991464|FG000|Overall Study|Disease Progression|1|||
161167720|NCT03543358|581991465|FG001|Overall Study|Disease Progression|0|||
161167721|NCT03543358|581991464|FG000|Overall Study|Parent Study Closure|1|||
161167722|NCT03543358|581991465|FG001|Overall Study|Parent Study Closure|0|||
161167723|NCT00986427|581991466|FG000|Overall Study|Lost to Follow-up|2|||
161167724|NCT00986427|581991467|FG001|Overall Study|Lost to Follow-up|0|||
161167725|NCT00986427|581991466|FG000|Overall Study|Lack of Efficacy|1|||
161167726|NCT00986427|581991467|FG001|Overall Study|Lack of Efficacy|0|||
161167727|NCT00986427|581991466|FG000|Overall Study|Withdrawal by Subject|1|||
161167728|NCT00986427|581991467|FG001|Overall Study|Withdrawal by Subject|0|||
161167729|NCT01401465|581991468|FG000|Treatment Period 1|Adverse Event|4|||
161167730|NCT01401465|581991469|FG001|Treatment Period 1|Adverse Event|1|||
161167731|NCT01401465|581991468|FG000|Treatment Period 1|Pregnancy|0|||
161167732|NCT01401465|581991469|FG001|Treatment Period 1|Pregnancy|1|||
161167733|NCT01401465|581991468|FG000|Treatment Period 1|Protocol Violation|5|||
161167734|NCT01401465|581991469|FG001|Treatment Period 1|Protocol Violation|0|||
161167735|NCT01401465|581991468|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161167736|NCT01401465|581991469|FG001|Treatment Period 1|Withdrawal by Subject|4|||
161167737|NCT01401465|581991468|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
161167738|NCT01401465|581991469|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
161167739|NCT01401465|581991468|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
161167740|NCT01401465|581991469|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
161167741|NCT01401465|581991468|FG000|Treatment Period 1|Scheduling Difficulties|1|||
161167742|NCT01401465|581991469|FG001|Treatment Period 1|Scheduling Difficulties|1|||
161167743|NCT01401465|581991468|FG000|Treatment Period 2|Lost to Follow-up|0|||
161167744|NCT01401465|581991469|FG001|Treatment Period 2|Lost to Follow-up|1|||
161167745|NCT01401465|581991468|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161167746|NCT01401465|581991469|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161167747|NCT01115738|581991470|FG000|Overall Study|Death|1|||
161167748|NCT01115738|581991471|FG001|Overall Study|Death|0|||
161167749|NCT01115738|581991472|FG002|Overall Study|Death|0|||
161167750|NCT01115738|581991470|FG000|Overall Study|Lost to Follow-up|0|||
161167751|NCT01115738|581991471|FG001|Overall Study|Lost to Follow-up|0|||
161167752|NCT01115738|581991472|FG002|Overall Study|Lost to Follow-up|1|||
161167753|NCT01115738|581991470|FG000|Overall Study|Physician Decision|18|||
161167754|NCT01115738|581991471|FG001|Overall Study|Physician Decision|15|||
161167755|NCT01115738|581991472|FG002|Overall Study|Physician Decision|17|||
161167756|NCT01115738|581991470|FG000|Overall Study|Withdrawal by Subject|6|||
161167757|NCT01115738|581991471|FG001|Overall Study|Withdrawal by Subject|6|||
161167758|NCT01115738|581991472|FG002|Overall Study|Withdrawal by Subject|9|||
161167759|NCT02379390|581991477|FG000|Overall Study|Adverse Event|1|||
161167760|NCT02379390|581991478|FG001|Overall Study|Adverse Event|1|||
161167761|NCT02379390|581991477|FG000|Overall Study|Investigator's decision|1|||
161167762|NCT02379390|581991478|FG001|Overall Study|Investigator's decision|0|||
161167763|NCT02379390|581991477|FG000|Overall Study|Study Termination|0|||
161167764|NCT02379390|581991478|FG001|Overall Study|Study Termination|1|||
161167765|NCT00764478|581991479|FG000|Overall Study|Adverse Event|1|||
161290283|NCT02654054|582442730|FG001|Post-Treatment Follow-Up Period|Other|0|||
161290284|NCT02654054|582442731|FG002|Post-Treatment Follow-Up Period|Other|4|||
161290285|NCT02654054|582442729|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161290286|NCT02654054|582442730|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
161167766|NCT00764478|581991480|FG001|Overall Study|Adverse Event|1|||
161167767|NCT00764478|581991481|FG002|Overall Study|Adverse Event|1|||
161167768|NCT00764478|581991479|FG000|Overall Study|Withdrawal by Subject|7|||
161167769|NCT00764478|581991480|FG001|Overall Study|Withdrawal by Subject|12|||
161167770|NCT00764478|581991481|FG002|Overall Study|Withdrawal by Subject|1|||
161167771|NCT00764478|581991479|FG000|Overall Study|Lost to Follow-up|7|||
161167772|NCT00764478|581991480|FG001|Overall Study|Lost to Follow-up|8|||
161290287|NCT02654054|582442731|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
161167773|NCT00764478|581991481|FG002|Overall Study|Lost to Follow-up|5|||
161167774|NCT00764478|581991479|FG000|Overall Study|Protocol Violation|0|||
161167775|NCT00764478|581991480|FG001|Overall Study|Protocol Violation|1|||
161167776|NCT00764478|581991481|FG002|Overall Study|Protocol Violation|1|||
161167777|NCT00575094|581991482|FG000|Overall Study|Adverse Event|2|||
161167778|NCT00575094|581991482|FG000|Overall Study|Withdrawal by Subject|1|||
161167779|NCT00643604|581991486|FG000|Overall Study|Death|1|||
161167780|NCT02702011|581991487|FG000|Overall Study|Withdrawal by Subject|0|||
161167781|NCT02702011|581991488|FG001|Overall Study|Withdrawal by Subject|1|||
161167782|NCT02702011|581991489|FG002|Overall Study|Withdrawal by Subject|0|||
161167783|NCT02702011|581991490|FG003|Overall Study|Withdrawal by Subject|0|||
161167784|NCT02921763|581991492|FG000|Overall Study|Adverse Event|4|||
161167785|NCT02921763|581991492|FG000|Overall Study|Lost to Follow-up|4|||
161167786|NCT02921763|581991492|FG000|Overall Study|Lack of Efficacy|3|||
161167787|NCT02921763|581991492|FG000|Overall Study|Protocol Violation|2|||
161167788|NCT02921763|581991492|FG000|Overall Study|Withdrawal by Subject|2|||
161167789|NCT02921763|581991492|FG000|Overall Study|Physician Decision|1|||
161167790|NCT02921763|581991492|FG000|Overall Study|No data obtained|2|||
161167791|NCT05691829|581992865|FG000|Overall Study|Physician Decision|2|||
161167792|NCT05691829|581992865|FG000|Overall Study|Eligibility criteria not met|3|||
161167793|NCT00453180|581992870|FG000|Overall Study|Lost to Follow-up|2|||
161167794|NCT00453180|581992871|FG001|Overall Study|Lost to Follow-up|1|||
161167795|NCT00453180|581992870|FG000|Overall Study|Adverse Event|1|||
161167796|NCT00453180|581992871|FG001|Overall Study|Adverse Event|2|||
161167797|NCT00804843|581992872|FG000|Overall Study|Protocol Violation|1|||
161167798|NCT00804843|581992873|FG001|Overall Study|Protocol Violation|0|||
161167799|NCT00804843|581992872|FG000|Overall Study|Adverse Event|8|||
161167800|NCT00804843|581992873|FG001|Overall Study|Adverse Event|5|||
161167801|NCT00804843|581992872|FG000|Overall Study|Withdrawal by Subject|1|||
161167802|NCT00804843|581992873|FG001|Overall Study|Withdrawal by Subject|2|||
161167803|NCT03326869|581992879|FG000|Overall Study|Study data has been lost to natural disa|1|||
161167804|NCT03326869|581992880|FG001|Overall Study|Study data has been lost to natural disa|1|||
161167805|NCT01002742|581992883|FG000|Overall Study|Determined to be ineligible|0|||
161167806|NCT01002742|581992884|FG001|Overall Study|Determined to be ineligible|1|||
161167807|NCT00562640|581992885|FG000|Overall Study|Death|0|||
161167808|NCT00562640|581992886|FG001|Overall Study|Death|1|||
161167809|NCT00562640|581992887|FG002|Overall Study|Death|1|||
161167810|NCT00562640|581992888|FG003|Overall Study|Death|0|||
161167811|NCT05263921|581992889|FG000|Overall Study|Other: family emergency.|0|||
161167812|NCT05263921|581992890|FG001|Overall Study|Other: family emergency.|0|||
161167813|NCT05263921|581992891|FG002|Overall Study|Other: family emergency.|1|||
161167814|NCT05263921|581992892|FG003|Overall Study|Other: family emergency.|0|||
161167815|NCT01297309|581992897|FG000|Overall Study|Eligibility failure|2|||
161167816|NCT01297309|581992897|FG000|Overall Study|Screen failure|2|||
161167817|NCT01297309|581992897|FG000|Overall Study|Withdrawal by Subject|5|||
161167818|NCT01297309|581992897|FG000|Overall Study|Adverse Event|1|||
161167819|NCT01297309|581992897|FG000|Overall Study|Investigator Decision|2|||
161167820|NCT01297309|581992897|FG000|Overall Study|Death|1|||
161167821|NCT01297309|581992897|FG000|Overall Study|Participant not entering extensionperiod|1|||
161167822|NCT02670928|581992898|FG000|Overall Study|Adverse Event|3|||
161167823|NCT02670928|581992899|FG001|Overall Study|Adverse Event|1|||
161167824|NCT02670928|581992898|FG000|Overall Study|Withdrawal by Subject|4|||
161167825|NCT02670928|581992899|FG001|Overall Study|Withdrawal by Subject|0|||
161167826|NCT02670928|581992898|FG000|Overall Study|Lost to Follow-up|1|||
161167827|NCT02670928|581992899|FG001|Overall Study|Lost to Follow-up|0|||
161167828|NCT02670928|581992898|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
161167829|NCT02670928|581992899|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
161167830|NCT02678312|581992900|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
161167831|NCT02678312|581992901|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161167832|NCT02678312|581992902|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161167833|NCT02678312|581992903|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161167834|NCT02678312|581992904|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
161167835|NCT02678312|581992900|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
161167836|NCT02678312|581992901|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161167837|NCT02678312|581992902|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161167838|NCT02678312|581992903|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161167839|NCT02678312|581992904|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
161167840|NCT02678312|581992900|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
161167841|NCT02678312|581992901|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161167842|NCT02678312|581992902|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161167843|NCT02678312|581992903|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161167844|NCT02678312|581992904|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
161167845|NCT02678312|581992900|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
161167846|NCT02678312|581992901|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
161167847|NCT02678312|581992902|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
161290288|NCT06389487|582442734|FG000|Overall Study|Lost to Follow-up|9|||
161290289|NCT06389487|582442735|FG001|Overall Study|Lost to Follow-up|5|||
161083673|NCT01655693|581695390|FG001|Overall Study|Lost to Follow-up|0|||
161083674|NCT01655693|581695391|FG002|Overall Study|Lost to Follow-up|1|||
161083675|NCT01655693|581695389|FG000|Overall Study|Screening Failure|1|||
161083676|NCT01655693|581695390|FG001|Overall Study|Screening Failure|0|||
161083677|NCT01655693|581695391|FG002|Overall Study|Screening Failure|0|||
161083678|NCT01655693|581695389|FG000|Overall Study|Other|8|||
161083679|NCT01655693|581695390|FG001|Overall Study|Other|6|||
161083680|NCT01655693|581695391|FG002|Overall Study|Other|15|||
161083681|NCT00929110|581695394|FG000|Overall Study|Adverse Event|40|||
161083682|NCT00929110|581695395|FG001|Overall Study|Adverse Event|29|||
161083683|NCT00929110|581695396|FG002|Overall Study|Adverse Event|18|||
161083684|NCT00929110|581695394|FG000|Overall Study|Subject withdrew consent|40|||
161083685|NCT00929110|581695395|FG001|Overall Study|Subject withdrew consent|23|||
161083686|NCT00929110|581695396|FG002|Overall Study|Subject withdrew consent|26|||
161083687|NCT00929110|581695394|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
161083688|NCT00929110|581695395|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
161083689|NCT00929110|581695396|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
161083690|NCT00929110|581695394|FG000|Overall Study|Lost to Follow-up|7|||
161083691|NCT00929110|581695395|FG001|Overall Study|Lost to Follow-up|7|||
161083692|NCT00929110|581695396|FG002|Overall Study|Lost to Follow-up|3|||
161083693|NCT00929110|581695394|FG000|Overall Study|Protocol deviation|5|||
161083694|NCT00929110|581695395|FG001|Overall Study|Protocol deviation|2|||
161083695|NCT00929110|581695396|FG002|Overall Study|Protocol deviation|4|||
161083696|NCT00929110|581695394|FG000|Overall Study|Administrative problems|4|||
161083697|NCT00929110|581695395|FG001|Overall Study|Administrative problems|1|||
161083698|NCT00929110|581695396|FG002|Overall Study|Administrative problems|2|||
161083699|NCT00929110|581695394|FG000|Overall Study|Death|2|||
161083700|NCT00929110|581695395|FG001|Overall Study|Death|2|||
161083701|NCT00929110|581695396|FG002|Overall Study|Death|2|||
161083702|NCT00929110|581695394|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161083703|NCT00929110|581695395|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161083704|NCT00929110|581695396|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161083705|NCT00929110|581695394|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161083706|NCT00929110|581695395|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161083707|NCT00929110|581695396|FG002|Overall Study|Abnormal test procedure result(s)|1|||
161083708|NCT00929110|581695394|FG000|Overall Study|Patient inability to use the device|0|||
161083709|NCT00929110|581695395|FG001|Overall Study|Patient inability to use the device|1|||
161083710|NCT00929110|581695396|FG002|Overall Study|Patient inability to use the device|0|||
161083711|NCT01163292|581695400|FG000|Overall Study|Lack of Efficacy|9|||
161083712|NCT01163292|581695401|FG001|Overall Study|Lack of Efficacy|0|||
161083713|NCT01163292|581695400|FG000|Overall Study|Adverse Event|6|||
161083714|NCT01163292|581695401|FG001|Overall Study|Adverse Event|0|||
161083715|NCT01163292|581695400|FG000|Overall Study|Initiation of biological therapy|0|||
161083716|NCT01163292|581695401|FG001|Overall Study|Initiation of biological therapy|15|||
161083717|NCT01163292|581695400|FG000|Overall Study|Sufficient response to adalimumab|8|||
161083718|NCT01163292|581695401|FG001|Overall Study|Sufficient response to adalimumab|0|||
161083719|NCT01163292|581695400|FG000|Overall Study|Refusal to receive adalimumab|7|||
161083720|NCT01163292|581695401|FG001|Overall Study|Refusal to receive adalimumab|0|||
161083721|NCT01163292|581695400|FG000|Overall Study|Economic reasons|6|||
161083722|NCT01163292|581695401|FG001|Overall Study|Economic reasons|0|||
161083723|NCT01163292|581695400|FG000|Overall Study|No further visits|5|||
161083724|NCT01163292|581695401|FG001|Overall Study|No further visits|7|||
161083725|NCT02643472|581695405|FG000|Overall Study|Death|2|||
161083726|NCT02643472|581695406|FG001|Overall Study|Death|5|||
161083727|NCT02643472|581695405|FG000|Overall Study|Withdrawal by Subject|3|||
161083728|NCT02643472|581695406|FG001|Overall Study|Withdrawal by Subject|2|||
161083729|NCT02643472|581695405|FG000|Overall Study|Protocol Violation|0|||
161083730|NCT02643472|581695406|FG001|Overall Study|Protocol Violation|1|||
161083731|NCT02643472|581695405|FG000|Overall Study|Lost to Follow-up|22|||
161083732|NCT02643472|581695406|FG001|Overall Study|Lost to Follow-up|26|||
161083733|NCT01258595|581695407|FG000|Overall Study|Lost to Follow-up|1|||
161083734|NCT01258595|581695408|FG001|Overall Study|Lost to Follow-up|0|||
161290290|NCT06389487|582442736|FG002|Overall Study|Lost to Follow-up|13|||
161290291|NCT06389487|582442734|FG000|Overall Study|Protocol Violation|0|||
161290292|NCT06389487|582442735|FG001|Overall Study|Protocol Violation|0|||
161290293|NCT06389487|582442736|FG002|Overall Study|Protocol Violation|2|||
161083735|NCT01258595|581695407|FG000|Overall Study|Withdrawal by Subject|0|||
161083736|NCT01258595|581695408|FG001|Overall Study|Withdrawal by Subject|1|||
161083737|NCT01215188|581695409|FG000|Overall Study|Lost to Follow-up|22|||
161083738|NCT01215188|581695410|FG001|Overall Study|Lost to Follow-up|22|||
161083739|NCT01215188|581695411|FG002|Overall Study|Lost to Follow-up|16|||
161083740|NCT01215188|581695409|FG000|Overall Study|Adverse Event|1|||
161083741|NCT01215188|581695410|FG001|Overall Study|Adverse Event|1|||
161083742|NCT01215188|581695411|FG002|Overall Study|Adverse Event|3|||
161083743|NCT01215188|581695409|FG000|Overall Study|Physician Decision|2|||
161290294|NCT06389487|582442734|FG000|Overall Study|Withdrawal by Subject|2|||
161167848|NCT02678312|581992903|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
161167849|NCT02678312|581992904|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
161167850|NCT02678312|581992900|FG000|Part 2 Double Blind Epoch|Death|0|||
161167851|NCT02678312|581992901|FG001|Part 2 Double Blind Epoch|Death|0|||
161167852|NCT02678312|581992902|FG002|Part 2 Double Blind Epoch|Death|0|||
161167853|NCT02678312|581992903|FG003|Part 2 Double Blind Epoch|Death|8|||
161167854|NCT02678312|581992904|FG004|Part 2 Double Blind Epoch|Death|12|||
161167855|NCT02678312|581992900|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
161167856|NCT02678312|581992901|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
161167857|NCT02678312|581992902|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
161167858|NCT02678312|581992903|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
161167859|NCT02678312|581992904|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
161167860|NCT02678312|581992900|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161167861|NCT02678312|581992901|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161167862|NCT02678312|581992902|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161167863|NCT02678312|581992903|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
161167864|NCT02678312|581992904|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
161167865|NCT02678312|581992900|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161167866|NCT02678312|581992901|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161167867|NCT02678312|581992902|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
161167868|NCT02678312|581992903|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
161167869|NCT02678312|581992904|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
161167870|NCT02591238|581992905|FG000|Overall Study|Pregnancy|1|||
161167871|NCT02591238|581992906|FG001|Overall Study|Pregnancy|0|||
161167872|NCT02591238|581992907|FG002|Overall Study|Pregnancy|0|||
161167873|NCT02591238|581992908|FG003|Overall Study|Pregnancy|0|||
161167874|NCT02591238|581992905|FG000|Overall Study|Withdrawal by Subject|0|||
161167875|NCT02591238|581992906|FG001|Overall Study|Withdrawal by Subject|0|||
161167876|NCT02591238|581992907|FG002|Overall Study|Withdrawal by Subject|0|||
161167877|NCT02591238|581992908|FG003|Overall Study|Withdrawal by Subject|1|||
161083744|NCT01215188|581695410|FG001|Overall Study|Physician Decision|1|||
161083745|NCT01215188|581695411|FG002|Overall Study|Physician Decision|0|||
161083746|NCT01215188|581695409|FG000|Overall Study|Lack of Efficacy|0|||
161083747|NCT01215188|581695410|FG001|Overall Study|Lack of Efficacy|0|||
161083748|NCT01215188|581695411|FG002|Overall Study|Lack of Efficacy|1|||
161083749|NCT01215188|581695409|FG000|Overall Study|Protocol Violation|1|||
161083750|NCT01215188|581695410|FG001|Overall Study|Protocol Violation|1|||
161083751|NCT01215188|581695411|FG002|Overall Study|Protocol Violation|1|||
161083752|NCT01215188|581695409|FG000|Overall Study|Withdrawal by Subject|32|||
161083753|NCT01215188|581695410|FG001|Overall Study|Withdrawal by Subject|34|||
161083754|NCT01215188|581695411|FG002|Overall Study|Withdrawal by Subject|31|||
161083755|NCT02310100|581695412|FG000|Overall Study|Physician Decision|3|||
161290295|NCT06389487|582442735|FG001|Overall Study|Withdrawal by Subject|2|||
161083756|NCT02310100|581695412|FG000|Overall Study|Withdrawal by Subject|10|||
161083757|NCT02310100|581695412|FG000|Overall Study|Enrollment closure|1|||
161083758|NCT02310100|581695412|FG000|Overall Study|Unapproved ablation operator|1|||
161083759|NCT02310100|581695412|FG000|Overall Study|Visit compliance|1|||
161083760|NCT02310100|581695412|FG000|Overall Study|Lost to Follow-up|2|||
161083761|NCT01820585|581695419|FG000|Overall Study|Adverse Event|9|||
161083762|NCT01820585|581695420|FG001|Overall Study|Adverse Event|13|||
161083763|NCT01820585|581695421|FG002|Overall Study|Adverse Event|23|||
161083764|NCT01820585|581695422|FG003|Overall Study|Adverse Event|34|||
161167878|NCT02591238|581992905|FG000|Overall Study|influenza|0|||
161167879|NCT02591238|581992906|FG001|Overall Study|influenza|0|||
161167880|NCT02591238|581992907|FG002|Overall Study|influenza|0|||
161167881|NCT02591238|581992908|FG003|Overall Study|influenza|1|||
161167882|NCT02591238|581992905|FG000|Overall Study|personal circumstances|0|||
161167883|NCT02591238|581992906|FG001|Overall Study|personal circumstances|0|||
161167884|NCT02591238|581992907|FG002|Overall Study|personal circumstances|0|||
161167885|NCT02591238|581992908|FG003|Overall Study|personal circumstances|1|||
161167886|NCT02591238|581992905|FG000|Overall Study|personal circumstances|0|||
161167887|NCT02591238|581992906|FG001|Overall Study|personal circumstances|1|||
161167888|NCT02591238|581992907|FG002|Overall Study|personal circumstances|0|||
161167889|NCT02591238|581992908|FG003|Overall Study|personal circumstances|0|||
161167890|NCT00656084|581992909|FG000|Overall Study|Adverse Event|4|||
161167891|NCT00656084|581992909|FG000|Overall Study|Withdrawal by Subject|1|||
161167892|NCT00656084|581992909|FG000|Overall Study|Patient Request|1|||
161167893|NCT00656084|581992909|FG000|Overall Study|Investigator Request|1|||
161290296|NCT06389487|582442736|FG002|Overall Study|Withdrawal by Subject|1|||
161290297|NCT06389487|582442734|FG000|Overall Study|Other|1|||
161167894|NCT00640146|581992913|FG000|Overall Study|Adverse Event|2|||
161167895|NCT00640146|581992914|FG001|Overall Study|Adverse Event|0|||
161167896|NCT00640146|581992913|FG000|Overall Study|Lost to Follow-up|0|||
161167897|NCT00640146|581992914|FG001|Overall Study|Lost to Follow-up|1|||
161083765|NCT01820585|581695419|FG000|Overall Study|Lack of Efficacy|9|||
161083766|NCT01820585|581695420|FG001|Overall Study|Lack of Efficacy|7|||
161083767|NCT01820585|581695421|FG002|Overall Study|Lack of Efficacy|5|||
161167898|NCT00640146|581992913|FG000|Overall Study|Lack of Efficacy|0|||
161167899|NCT00640146|581992914|FG001|Overall Study|Lack of Efficacy|1|||
161167900|NCT00640146|581992913|FG000|Overall Study|Withdrawal by Subject|1|||
161167901|NCT00640146|581992914|FG001|Overall Study|Withdrawal by Subject|1|||
161167902|NCT00640146|581992913|FG000|Overall Study|Randomized but not treated|1|||
161167903|NCT00640146|581992914|FG001|Overall Study|Randomized but not treated|3|||
161167904|NCT02455388|581992918|FG000|Overall Study|Protocol Violation|1|||
161167905|NCT02455388|581992919|FG001|Overall Study|Protocol Violation|0|||
161167906|NCT02455388|581992920|FG002|Overall Study|Protocol Violation|4|||
161167907|NCT02455388|581992918|FG000|Overall Study|Withdrawal by Subject|0|||
161167908|NCT02455388|581992919|FG001|Overall Study|Withdrawal by Subject|0|||
161167909|NCT02455388|581992920|FG002|Overall Study|Withdrawal by Subject|7|||
161167910|NCT00525785|581992921|FG000|Overall Study|Withdrawal by Subject|1|||
161167911|NCT00525785|581992921|FG000|Overall Study|Lack of Efficacy|1|||
161167912|NCT00525785|581992921|FG000|Overall Study|Physician Decision|1|||
161167913|NCT04847141|581992922|FG000|Overall Study|Adverse Event|1|||
161167914|NCT04847141|581992923|FG001|Overall Study|Adverse Event|0|||
161167915|NCT04847141|581992924|FG002|Overall Study|Adverse Event|1|||
161167916|NCT04847141|581992922|FG000|Overall Study|Withdrawal by Subject|2|||
161167917|NCT04847141|581992923|FG001|Overall Study|Withdrawal by Subject|4|||
161167918|NCT04847141|581992924|FG002|Overall Study|Withdrawal by Subject|3|||
161167919|NCT04847141|581992922|FG000|Overall Study|Lost to Follow-up|7|||
161167920|NCT04847141|581992923|FG001|Overall Study|Lost to Follow-up|5|||
161167921|NCT04847141|581992924|FG002|Overall Study|Lost to Follow-up|7|||
161167922|NCT04847141|581992922|FG000|Overall Study|Reason not Specified|0|||
161167923|NCT04847141|581992923|FG001|Overall Study|Reason not Specified|1|||
161167924|NCT04847141|581992924|FG002|Overall Study|Reason not Specified|0|||
161167925|NCT00324740|581992925|FG000|Overall Study|Withdrawal by Subject|1|||
161167926|NCT00324740|581992926|FG001|Overall Study|Withdrawal by Subject|0|||
161167927|NCT00324740|581992927|FG002|Overall Study|Withdrawal by Subject|1|||
161167928|NCT01357980|581992932|FG000|Overall Study|Lack of Efficacy|0|||
161167929|NCT01357980|581992933|FG001|Overall Study|Lack of Efficacy|1|||
161167930|NCT01357980|581992934|FG002|Overall Study|Lack of Efficacy|0|||
161167931|NCT01357980|581992935|FG003|Overall Study|Lack of Efficacy|0|||
161167932|NCT01357980|581992932|FG000|Overall Study|Consent withdrawn|0|||
161167933|NCT01357980|581992933|FG001|Overall Study|Consent withdrawn|0|||
161167934|NCT01357980|581992934|FG002|Overall Study|Consent withdrawn|1|||
161167935|NCT01357980|581992935|FG003|Overall Study|Consent withdrawn|0|||
161167936|NCT00094835|581992939|FG000|Overall Study|Physician Decision|1|||
161167937|NCT00094835|581992940|FG001|Overall Study|Physician Decision|0|||
161167938|NCT00094835|581992941|FG002|Overall Study|Physician Decision|0|||
161167939|NCT00094835|581992942|FG003|Overall Study|Physician Decision|0|||
161167940|NCT00094835|581992943|FG004|Overall Study|Physician Decision|0|||
161167941|NCT00094835|581992944|FG005|Overall Study|Physician Decision|1|||
161167942|NCT00094835|581992945|FG006|Overall Study|Physician Decision|0|||
161167943|NCT00094835|581992939|FG000|Overall Study|Withdrawal by Subject|0|||
161167944|NCT00094835|581992940|FG001|Overall Study|Withdrawal by Subject|0|||
161167945|NCT00094835|581992941|FG002|Overall Study|Withdrawal by Subject|0|||
161167946|NCT00094835|581992942|FG003|Overall Study|Withdrawal by Subject|0|||
161167947|NCT00094835|581992943|FG004|Overall Study|Withdrawal by Subject|0|||
161167948|NCT00094835|581992944|FG005|Overall Study|Withdrawal by Subject|0|||
161167949|NCT00094835|581992945|FG006|Overall Study|Withdrawal by Subject|1|||
161167950|NCT00094835|581992939|FG000|Overall Study|Lost to Follow-up|0|||
161167951|NCT00094835|581992940|FG001|Overall Study|Lost to Follow-up|0|||
161167952|NCT00094835|581992941|FG002|Overall Study|Lost to Follow-up|0|||
161167953|NCT00094835|581992942|FG003|Overall Study|Lost to Follow-up|0|||
161167954|NCT00094835|581992943|FG004|Overall Study|Lost to Follow-up|1|||
161167955|NCT00094835|581992944|FG005|Overall Study|Lost to Follow-up|0|||
161167956|NCT00094835|581992945|FG006|Overall Study|Lost to Follow-up|0|||
161167957|NCT00094835|581992939|FG000|Overall Study|Death|1|||
161167958|NCT00094835|581992940|FG001|Overall Study|Death|0|||
161167959|NCT00094835|581992941|FG002|Overall Study|Death|0|||
161167960|NCT00094835|581992942|FG003|Overall Study|Death|0|||
161167961|NCT00094835|581992943|FG004|Overall Study|Death|1|||
161167962|NCT00094835|581992944|FG005|Overall Study|Death|0|||
161167963|NCT00094835|581992945|FG006|Overall Study|Death|0|||
161167964|NCT00094835|581992939|FG000|Overall Study|Non-compliance|1|||
161167965|NCT00094835|581992940|FG001|Overall Study|Non-compliance|2|||
161167966|NCT00094835|581992941|FG002|Overall Study|Non-compliance|2|||
161167967|NCT00094835|581992942|FG003|Overall Study|Non-compliance|0|||
161167968|NCT00094835|581992943|FG004|Overall Study|Non-compliance|2|||
161290298|NCT06389487|582442735|FG001|Overall Study|Other|0|||
161167969|NCT00094835|581992944|FG005|Overall Study|Non-compliance|2|||
161167970|NCT00094835|581992945|FG006|Overall Study|Non-compliance|1|||
161167971|NCT00094835|581992939|FG000|Overall Study|Other|1|||
161167972|NCT00094835|581992940|FG001|Overall Study|Other|1|||
161167973|NCT00094835|581992941|FG002|Overall Study|Other|1|||
161167974|NCT00094835|581992942|FG003|Overall Study|Other|1|||
161167975|NCT00094835|581992943|FG004|Overall Study|Other|0|||
161167976|NCT00094835|581992944|FG005|Overall Study|Other|0|||
161167977|NCT00094835|581992945|FG006|Overall Study|Other|0|||
161167978|NCT00387348|581992946|FG000|Overall Study|Death|1|||
161167979|NCT00387348|581992947|FG001|Overall Study|Death|1|||
161167980|NCT00387348|581992948|FG002|Overall Study|Death|0|||
161167981|NCT00387348|581992946|FG000|Overall Study|Physician Decision|1|||
161167982|NCT00387348|581992947|FG001|Overall Study|Physician Decision|0|||
161167983|NCT00387348|581992948|FG002|Overall Study|Physician Decision|1|||
161167984|NCT00387348|581992946|FG000|Overall Study|Withdrawal by Subject|0|||
161167985|NCT00387348|581992947|FG001|Overall Study|Withdrawal by Subject|2|||
161167986|NCT00387348|581992948|FG002|Overall Study|Withdrawal by Subject|2|||
161167987|NCT00387348|581992946|FG000|Overall Study|Adverse Event|1|||
161167988|NCT00387348|581992947|FG001|Overall Study|Adverse Event|0|||
161167989|NCT00387348|581992948|FG002|Overall Study|Adverse Event|1|||
161167990|NCT03628599|581992949|FG000|Overall Study|Adverse Event|0|||
161167991|NCT03628599|581992950|FG001|Overall Study|Adverse Event|1|||
161167992|NCT00868166|581992954|FG000|Overall Study|Death|58|||
161167993|NCT00868166|581992955|FG001|Overall Study|Death|65|||
161167994|NCT00868166|581992954|FG000|Overall Study|Withdrawal by Subject|33|||
161167995|NCT00868166|581992955|FG001|Overall Study|Withdrawal by Subject|25|||
161167996|NCT00868166|581992954|FG000|Overall Study|Protocol Violation|1|||
161167997|NCT00868166|581992955|FG001|Overall Study|Protocol Violation|0|||
161167998|NCT00868166|581992954|FG000|Overall Study|Lost to Follow-up|1|||
161167999|NCT00868166|581992955|FG001|Overall Study|Lost to Follow-up|3|||
161168000|NCT00868166|581992954|FG000|Overall Study|Adverse Event|9|||
161168001|NCT00868166|581992955|FG001|Overall Study|Adverse Event|10|||
161168002|NCT00868166|581992954|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
161168003|NCT00868166|581992955|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
161168004|NCT00868166|581992954|FG000|Overall Study|Non-compliance with IMP|1|||
161168005|NCT00868166|581992955|FG001|Overall Study|Non-compliance with IMP|1|||
161168006|NCT01204697|581992963|FG000|Overall Study|Death|26|||
161168007|NCT01204697|581992964|FG001|Overall Study|Death|27|||
161168008|NCT01204697|581992963|FG000|Overall Study|Lost to Follow-up|3|||
161168009|NCT01204697|581992964|FG001|Overall Study|Lost to Follow-up|4|||
161168010|NCT01204697|581992963|FG000|Overall Study|Withdrawal by Subject|2|||
161168011|NCT01204697|581992964|FG001|Overall Study|Withdrawal by Subject|4|||
161168012|NCT01204697|581992963|FG000|Overall Study|Randomized, but not treated|0|||
161168013|NCT01204697|581992964|FG001|Overall Study|Randomized, but not treated|1|||
161168014|NCT03939637|581992965|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
161168015|NCT03939637|581992966|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
161168016|NCT03939637|581992965|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
161168017|NCT03939637|581992966|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
161168018|NCT00830804|581992967|FG000|Overall Study|Lost to Follow-up|4|||
161168019|NCT00830804|581992967|FG000|Overall Study|Death|1|||
161168020|NCT00830804|581992967|FG000|Overall Study|Unable to get to clinic|7|||
161168021|NCT00830804|581992967|FG000|Overall Study|Consent withdrawn|2|||
161168022|NCT00830804|581992967|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
161168023|NCT02180217|581992969|FG000|Overall Study|Adverse Event|3|||
161168024|NCT02180217|581992970|FG001|Overall Study|Adverse Event|2|||
161168025|NCT02180217|581992971|FG002|Overall Study|Adverse Event|22|||
161168026|NCT02180217|581992969|FG000|Overall Study|Death|1|||
161168027|NCT02180217|581992970|FG001|Overall Study|Death|1|||
161168028|NCT02180217|581992971|FG002|Overall Study|Death|0|||
161168029|NCT02180217|581992969|FG000|Overall Study|Withdrawal by Subject|1|||
161168030|NCT02180217|581992970|FG001|Overall Study|Withdrawal by Subject|1|||
161168031|NCT02180217|581992971|FG002|Overall Study|Withdrawal by Subject|4|||
161168032|NCT02180217|581992969|FG000|Overall Study|Subject/Guardian decision|5|||
161168033|NCT02180217|581992970|FG001|Overall Study|Subject/Guardian decision|3|||
161168034|NCT02180217|581992971|FG002|Overall Study|Subject/Guardian decision|6|||
161168035|NCT02180217|581992969|FG000|Overall Study|Physician Decision|1|||
161168036|NCT02180217|581992970|FG001|Overall Study|Physician Decision|1|||
161168037|NCT02180217|581992971|FG002|Overall Study|Physician Decision|6|||
161168038|NCT02180217|581992969|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161168039|NCT02180217|581992970|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161290299|NCT06389487|582442736|FG002|Overall Study|Other|1|||
161168040|NCT02180217|581992971|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
161168041|NCT01181102|581992974|FG000|Overall Study|Adverse Event|28|||
161168042|NCT01181102|581992975|FG001|Overall Study|Adverse Event|26|||
161168043|NCT01181102|581992974|FG000|Overall Study|Lack of Efficacy|3|||
161168044|NCT01181102|581992975|FG001|Overall Study|Lack of Efficacy|1|||
161290300|NCT00955409|582444210|FG000|Overall Study|Lack of Efficacy|1|||
161290301|NCT00955409|582444211|FG001|Overall Study|Lack of Efficacy|0|||
161168045|NCT01181102|581992974|FG000|Overall Study|Lost to Follow-up|2|||
161168046|NCT01181102|581992975|FG001|Overall Study|Lost to Follow-up|0|||
161168047|NCT01181102|581992974|FG000|Overall Study|Physician Decision|3|||
161168048|NCT01181102|581992975|FG001|Overall Study|Physician Decision|1|||
161168049|NCT01181102|581992974|FG000|Overall Study|Protocol Violation|5|||
161168050|NCT01181102|581992975|FG001|Overall Study|Protocol Violation|6|||
161290302|NCT00955409|582444212|FG002|Overall Study|Lack of Efficacy|0|||
161168051|NCT01181102|581992974|FG000|Overall Study|Withdrawal by Subject|10|||
161168052|NCT01181102|581992975|FG001|Overall Study|Withdrawal by Subject|12|||
161168053|NCT01309841|581992978|FG000|Overall Study|Other|0|||
161168054|NCT01309841|581992979|FG001|Overall Study|Other|1|||
161168055|NCT01309841|581992980|FG002|Overall Study|Other|1|||
161168056|NCT01309841|581992978|FG000|Overall Study|Lost to Follow-up|7|||
161168057|NCT01309841|581992979|FG001|Overall Study|Lost to Follow-up|6|||
161168058|NCT01309841|581992980|FG002|Overall Study|Lost to Follow-up|4|||
161168059|NCT01309841|581992978|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
161168060|NCT01309841|581992979|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161168061|NCT01309841|581992980|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
161168062|NCT01309841|581992978|FG000|Overall Study|Lack of Efficacy|0|||
161168063|NCT01309841|581992979|FG001|Overall Study|Lack of Efficacy|0|||
161168064|NCT01309841|581992980|FG002|Overall Study|Lack of Efficacy|2|||
161168065|NCT01309841|581992978|FG000|Overall Study|Adverse Event|9|||
161168066|NCT01309841|581992979|FG001|Overall Study|Adverse Event|22|||
161168067|NCT01309841|581992980|FG002|Overall Study|Adverse Event|11|||
161168068|NCT01309841|581992978|FG000|Overall Study|Death|1|||
161168069|NCT01309841|581992979|FG001|Overall Study|Death|0|||
161168070|NCT01309841|581992980|FG002|Overall Study|Death|0|||
161168071|NCT01309841|581992978|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161168072|NCT01309841|581992979|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161168073|NCT01309841|581992980|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
161168074|NCT01309841|581992978|FG000|Overall Study|Withdrawal by Subject|17|||
161168075|NCT01309841|581992979|FG001|Overall Study|Withdrawal by Subject|6|||
161168076|NCT01309841|581992980|FG002|Overall Study|Withdrawal by Subject|13|||
161168077|NCT01309841|581992978|FG000|Overall Study|Did Not Receive Treatment|2|||
161168078|NCT01309841|581992979|FG001|Overall Study|Did Not Receive Treatment|0|||
161168079|NCT01309841|581992980|FG002|Overall Study|Did Not Receive Treatment|1|||
161168080|NCT01309841|581992978|FG000|Overall Study|Severe non-compliance with protocol|0|||
161168081|NCT01309841|581992979|FG001|Overall Study|Severe non-compliance with protocol|5|||
161168082|NCT01309841|581992980|FG002|Overall Study|Severe non-compliance with protocol|2|||
161168083|NCT00239837|581992981|FG000|Overall Study|Lost to Follow-up|3|||
161168084|NCT00239837|581992982|FG001|Overall Study|Lost to Follow-up|7|||
161168085|NCT03448224|581992983|FG000|Overall Study|Provided same answer to every question|1|||
161168086|NCT03448224|581992984|FG001|Overall Study|Provided same answer to every question|0|||
161168087|NCT03103906|581992988|FG000|Overall Study|Adverse Event|2|||
161168088|NCT03103906|581992989|FG001|Overall Study|Adverse Event|3|||
161168089|NCT03103906|581992988|FG000|Overall Study|Other|2|||
161168090|NCT03103906|581992989|FG001|Overall Study|Other|0|||
161168091|NCT03498287|581992993|FG000|Overall Study|Withdrawal by Subject|3|||
161168092|NCT03498287|581992994|FG001|Overall Study|Withdrawal by Subject|0|||
161168093|NCT03498287|581992993|FG000|Overall Study|Protocol Violation|0|||
161168094|NCT03498287|581992994|FG001|Overall Study|Protocol Violation|4|||
161168095|NCT03498287|581992993|FG000|Overall Study|Adverse Event|0|||
161168096|NCT03498287|581992994|FG001|Overall Study|Adverse Event|1|||
161168097|NCT04142216|581992995|FG000|Overall Study|Hospitalization|0|||
161168098|NCT04142216|581992996|FG001|Overall Study|Hospitalization|2|||
161168099|NCT04142216|581992995|FG000|Overall Study|Death|3|||
161168100|NCT04142216|581992996|FG001|Overall Study|Death|1|||
161168101|NCT04142216|581992995|FG000|Overall Study|Referral to another hemodialysis unit|3|||
161168102|NCT04142216|581992996|FG001|Overall Study|Referral to another hemodialysis unit|2|||
161168103|NCT04142216|581992995|FG000|Overall Study|Use of clove|0|||
161168104|NCT04142216|581992996|FG001|Overall Study|Use of clove|1|||
161168105|NCT00862121|581992997|FG000|Overall Study|Adverse Event|1|||
161168106|NCT00862121|581992998|FG001|Overall Study|Adverse Event|2|||
161168107|NCT00862121|581992997|FG000|Overall Study|Lack of Efficacy|0|||
161168108|NCT00862121|581992998|FG001|Overall Study|Lack of Efficacy|3|||
161168109|NCT00862121|581992997|FG000|Overall Study|Protocol Violation|0|||
161168110|NCT00862121|581992998|FG001|Overall Study|Protocol Violation|1|||
161168111|NCT00862121|581992997|FG000|Overall Study|Exclusion criterion violation|0|||
161168112|NCT00862121|581992998|FG001|Overall Study|Exclusion criterion violation|1|||
161168113|NCT00862121|581992997|FG000|Overall Study|Incorrect randomisation|0|||
161168114|NCT00862121|581992998|FG001|Overall Study|Incorrect randomisation|1|||
161168115|NCT02007954|581993001|FG000|Overall Study|Received liver transplant|3|||
161168116|NCT02007954|581993001|FG000|Overall Study|Switch in treatment modality|2|||
161168117|NCT02007954|581993001|FG000|Overall Study|Disease progression and unrelated AE|1|||
161168118|NCT02007954|581993001|FG000|Overall Study|Death|1|||
161168119|NCT01054976|581993004|FG000|Overall Study|Adverse Event|16|||
161168120|NCT01054976|581993004|FG000|Overall Study|Uncooperative participations to study|7|||
161168121|NCT01054976|581993004|FG000|Overall Study|Withdrawal by Subject|4|||
161168122|NCT01054976|581993004|FG000|Overall Study|Other|8|||
161168123|NCT01195363|581993006|FG000|Overall Study|Lost to Follow-up|7|||
161168124|NCT01195363|581993007|FG001|Overall Study|Lost to Follow-up|4|||
161168125|NCT01195363|581993006|FG000|Overall Study|Adverse Event|3|||
161168126|NCT01195363|581993007|FG001|Overall Study|Adverse Event|1|||
161168127|NCT01195363|581993006|FG000|Overall Study|Lack of Efficacy|0|||
161168128|NCT01195363|581993007|FG001|Overall Study|Lack of Efficacy|4|||
161083768|NCT01820585|581695422|FG003|Overall Study|Lack of Efficacy|1|||
161083769|NCT01820585|581695419|FG000|Overall Study|Withdrawal by Subject|3|||
161083770|NCT01820585|581695420|FG001|Overall Study|Withdrawal by Subject|7|||
161083771|NCT01820585|581695421|FG002|Overall Study|Withdrawal by Subject|3|||
161083772|NCT01820585|581695422|FG003|Overall Study|Withdrawal by Subject|8|||
161083773|NCT01820585|581695419|FG000|Overall Study|Lost to Follow-up|3|||
161083774|NCT01820585|581695420|FG001|Overall Study|Lost to Follow-up|3|||
161083775|NCT01820585|581695421|FG002|Overall Study|Lost to Follow-up|0|||
161083776|NCT01820585|581695422|FG003|Overall Study|Lost to Follow-up|3|||
161083777|NCT01820585|581695419|FG000|Overall Study|Protocol Violation|3|||
161083778|NCT01820585|581695420|FG001|Overall Study|Protocol Violation|1|||
161083779|NCT01820585|581695421|FG002|Overall Study|Protocol Violation|1|||
161083780|NCT01820585|581695422|FG003|Overall Study|Protocol Violation|1|||
161083781|NCT01820585|581695419|FG000|Overall Study|Subject non-compliance|0|||
161083782|NCT01820585|581695420|FG001|Overall Study|Subject non-compliance|0|||
161083783|NCT01820585|581695421|FG002|Overall Study|Subject non-compliance|1|||
161083784|NCT01820585|581695422|FG003|Overall Study|Subject non-compliance|2|||
161083785|NCT01820585|581695419|FG000|Overall Study|at sponsor request|0|||
161083786|NCT01820585|581695420|FG001|Overall Study|at sponsor request|0|||
161083787|NCT01820585|581695421|FG002|Overall Study|at sponsor request|1|||
161083788|NCT01820585|581695422|FG003|Overall Study|at sponsor request|0|||
161083789|NCT01820585|581695419|FG000|Overall Study|Pregnancy|0|||
161083790|NCT01820585|581695420|FG001|Overall Study|Pregnancy|1|||
161083791|NCT01820585|581695421|FG002|Overall Study|Pregnancy|0|||
161083792|NCT01820585|581695422|FG003|Overall Study|Pregnancy|0|||
161083793|NCT03592745|581695425|FG000|Overall Study|Adverse Event|0|||
161083794|NCT03592745|581695426|FG001|Overall Study|Adverse Event|2|||
161083795|NCT03592745|581695425|FG000|Overall Study|Lost to Follow-up|2|||
161083796|NCT03592745|581695426|FG001|Overall Study|Lost to Follow-up|0|||
161083797|NCT03592745|581695425|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
161083798|NCT03592745|581695426|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
161083799|NCT00293059|581695427|FG000|Overall Study|Adverse Event|12|||
161083800|NCT00293059|581695428|FG001|Overall Study|Adverse Event|4|||
161083801|NCT00293059|581695427|FG000|Overall Study|Lack of Efficacy|2|||
161083802|NCT00293059|581695428|FG001|Overall Study|Lack of Efficacy|0|||
161083803|NCT00293059|581695427|FG000|Overall Study|Lost to Follow-up|2|||
161083804|NCT00293059|581695428|FG001|Overall Study|Lost to Follow-up|3|||
161083805|NCT00293059|581695427|FG000|Overall Study|Pregnancy|1|||
161083806|NCT00293059|581695428|FG001|Overall Study|Pregnancy|1|||
161083807|NCT00293059|581695427|FG000|Overall Study|Protocol Violation|2|||
161083808|NCT00293059|581695428|FG001|Overall Study|Protocol Violation|0|||
161083809|NCT00293059|581695427|FG000|Overall Study|Withdrawal by Subject|11|||
161083810|NCT00293059|581695428|FG001|Overall Study|Withdrawal by Subject|5|||
161083811|NCT00293059|581695427|FG000|Overall Study|Participant moved out of state|1|||
161083812|NCT00293059|581695428|FG001|Overall Study|Participant moved out of state|0|||
161083813|NCT00293059|581695427|FG000|Overall Study|Participant stopped study drug|1|||
161083814|NCT00293059|581695428|FG001|Overall Study|Participant stopped study drug|0|||
161083815|NCT00293059|581695427|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
161083816|NCT00293059|581695428|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
161083817|NCT00293059|581695427|FG000|Overall Study|missing|3|||
161083818|NCT00293059|581695428|FG001|Overall Study|missing|5|||
161083819|NCT04362189|581695432|FG000|Overall Study|Lost to Follow-up|0|||
161083820|NCT04362189|581695433|FG001|Overall Study|Lost to Follow-up|1|||
161083821|NCT04362189|581695432|FG000|Overall Study|Withdrawal by Subject|1|||
161083822|NCT04362189|581695433|FG001|Overall Study|Withdrawal by Subject|0|||
161083823|NCT04362189|581695432|FG000|Overall Study|FDA Clinical Hold|7|||
161083824|NCT04362189|581695433|FG001|Overall Study|FDA Clinical Hold|2|||
161083825|NCT04362189|581695432|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
161083826|NCT04362189|581695433|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
161083827|NCT04362189|581695432|FG000|Overall Study|Adverse Event|0|||
161083828|NCT04362189|581695433|FG001|Overall Study|Adverse Event|2|||
161083829|NCT04362189|581695432|FG000|Overall Study|Death|4|||
161083830|NCT04362189|581695433|FG001|Overall Study|Death|1|||
161083831|NCT02111681|581695434|FG000|Overall Study|Death|5|||
161083832|NCT02111681|581695434|FG000|Overall Study|Lack of Efficacy|2|||
161083833|NCT02111681|581695434|FG000|Overall Study|Progression of disease|4|||
161083834|NCT03981861|581695435|FG000|Overall Study|Withdrawal by Subject|3|||
161083835|NCT01227577|581697427|FG000|Overall Study|Protocol deviation|3|||
161083836|NCT01227577|581697427|FG000|Overall Study|Death|3|||
161083837|NCT01227577|581697427|FG000|Overall Study|Administrative problems|2|||
161083838|NCT01227577|581697427|FG000|Overall Study|Lost to Follow-up|1|||
161083839|NCT01227577|581697427|FG000|Overall Study|Withdrawal by Subject|4|||
161083840|NCT01227577|581697427|FG000|Overall Study|Lack of Efficacy|5|||
161083841|NCT01227577|581697427|FG000|Overall Study|Adverse Event|17|||
161083842|NCT03809429|581697428|FG000|Overall Study|Withdrawal by Subject|7|||
161091282|NCT01272804|581723869|FG001|Overall Study|Adverse Event|0|||
161083843|NCT03809429|581697429|FG001|Overall Study|Withdrawal by Subject|3|||
161083844|NCT03809429|581697428|FG000|Overall Study|Adverse Event|6|||
161083845|NCT03809429|581697429|FG001|Overall Study|Adverse Event|9|||
161083846|NCT03809429|581697428|FG000|Overall Study|COVID-19|3|||
161083847|NCT03809429|581697429|FG001|Overall Study|COVID-19|1|||
161083848|NCT03809429|581697428|FG000|Overall Study|Participant was discontinued by investigator|12|||
161083849|NCT03809429|581697429|FG001|Overall Study|Participant was discontinued by investigator|7|||
161083850|NCT03828747|581697430|FG000|Double-Blind Treatment Period|Adverse Event|6|||
161083851|NCT03828747|581697431|FG001|Double-Blind Treatment Period|Adverse Event|6|||
161083852|NCT03828747|581697430|FG000|Double-Blind Treatment Period|Death|1|||
161083853|NCT03828747|581697431|FG001|Double-Blind Treatment Period|Death|1|||
161083854|NCT03828747|581697430|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161083855|NCT03828747|581697431|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161083856|NCT03828747|581697430|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
161083857|NCT03828747|581697431|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
161083858|NCT03828747|581697430|FG000|Double-Blind Treatment Period|Physician Decision|1|||
161083859|NCT03828747|581697431|FG001|Double-Blind Treatment Period|Physician Decision|4|||
161083860|NCT03828747|581697430|FG000|Double-Blind Treatment Period|Various reasons|5|||
161083861|NCT03828747|581697431|FG001|Double-Blind Treatment Period|Various reasons|3|||
161083862|NCT03828747|581697430|FG000|Open-Label Extension|Adverse Event|9|||
161083863|NCT03828747|581697431|FG001|Open-Label Extension|Adverse Event|7|||
161083864|NCT03828747|581697430|FG000|Open-Label Extension|Death|0|||
161083865|NCT03828747|581697431|FG001|Open-Label Extension|Death|2|||
161083866|NCT03828747|581697430|FG000|Open-Label Extension|Lost to Follow-up|4|||
161083867|NCT03828747|581697431|FG001|Open-Label Extension|Lost to Follow-up|0|||
161083868|NCT03828747|581697430|FG000|Open-Label Extension|Withdrawal by Subject|31|||
161083869|NCT03828747|581697431|FG001|Open-Label Extension|Withdrawal by Subject|30|||
161083870|NCT03828747|581697430|FG000|Open-Label Extension|Various reasons|4|||
161083871|NCT03828747|581697431|FG001|Open-Label Extension|Various reasons|4|||
161083872|NCT03828747|581697430|FG000|Open-Label Extension|Physician Decision|6|||
161083873|NCT03828747|581697431|FG001|Open-Label Extension|Physician Decision|2|||
161083874|NCT01658150|581697432|FG000|Overall Study|Withdrawal by Subject|1|||
161083875|NCT04187989|581697433|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
161083876|NCT04187989|581697434|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
161083877|NCT04187989|581697433|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
161083878|NCT04187989|581697434|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
161083879|NCT03646656|581697435|FG000|Overall Study|Lost to Follow-up|1|||
161083880|NCT03646656|581697436|FG001|Overall Study|Lost to Follow-up|0|||
161083881|NCT03646656|581697435|FG000|Overall Study|Withdrawal by Subject|2|||
161083882|NCT03646656|581697436|FG001|Overall Study|Withdrawal by Subject|0|||
161083883|NCT02245737|581697437|FG000|Overall Study|Adverse Event|23|||
161083884|NCT02245737|581697438|FG001|Overall Study|Adverse Event|26|||
161083885|NCT02245737|581697439|FG002|Overall Study|Adverse Event|33|||
161083886|NCT02245737|581697437|FG000|Overall Study|Condition Worsened|9|||
161083887|NCT02245737|581697438|FG001|Overall Study|Condition Worsened|10|||
161083888|NCT02245737|581697439|FG002|Overall Study|Condition Worsened|9|||
161083889|NCT02245737|581697437|FG000|Overall Study|Death|2|||
161083890|NCT02245737|581697438|FG001|Overall Study|Death|4|||
161083891|NCT02245737|581697439|FG002|Overall Study|Death|4|||
161083892|NCT02245737|581697437|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
161083893|NCT02245737|581697438|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
161083894|NCT02245737|581697439|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
161083895|NCT02245737|581697437|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
161083896|NCT02245737|581697438|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
161083897|NCT02245737|581697439|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
161083898|NCT02245737|581697437|FG000|Overall Study|Lost to Follow-up|2|||
161083899|NCT02245737|581697438|FG001|Overall Study|Lost to Follow-up|5|||
161083900|NCT02245737|581697439|FG002|Overall Study|Lost to Follow-up|4|||
161083901|NCT02245737|581697437|FG000|Overall Study|Other-determined by Investigator|9|||
161083902|NCT02245737|581697438|FG001|Overall Study|Other-determined by Investigator|10|||
161083903|NCT02245737|581697439|FG002|Overall Study|Other-determined by Investigator|10|||
161083904|NCT02245737|581697437|FG000|Overall Study|Physician Decision|6|||
161083905|NCT02245737|581697438|FG001|Overall Study|Physician Decision|3|||
161083906|NCT02245737|581697439|FG002|Overall Study|Physician Decision|6|||
161083907|NCT02245737|581697437|FG000|Overall Study|Protocol Violation|3|||
161083908|NCT02245737|581697438|FG001|Overall Study|Protocol Violation|2|||
161083909|NCT02245737|581697439|FG002|Overall Study|Protocol Violation|3|||
161083910|NCT02245737|581697437|FG000|Overall Study|Withdrawal by Subject|40|||
161083911|NCT02245737|581697438|FG001|Overall Study|Withdrawal by Subject|41|||
161083912|NCT02245737|581697439|FG002|Overall Study|Withdrawal by Subject|44|||
161083913|NCT02245737|581697437|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
161083914|NCT02245737|581697438|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
161083915|NCT02245737|581697439|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
161083916|NCT02245737|581697437|FG000|Overall Study|Sponsor Decision|445|||
161168129|NCT01195363|581993006|FG000|Overall Study|incarceration|1|||
161168130|NCT01195363|581993007|FG001|Overall Study|incarceration|0|||
161168131|NCT01164865|581993010|FG000|Overall Study|Lost to Follow-up|2|||
161168132|NCT01164865|581993011|FG001|Overall Study|Lost to Follow-up|1|||
161168133|NCT00475540|581993012|FG000|36 Months|Lost to Follow-up|4|||
161168134|NCT00475540|581993013|FG001|36 Months|Lost to Follow-up|4|||
161168135|NCT00475540|581993012|FG000|36 Months|Death|1|||
161168136|NCT00475540|581993013|FG001|36 Months|Death|2|||
161168137|NCT00475540|581993012|FG000|36 Months|Censored due to reoperation|3|||
161168138|NCT00475540|581993013|FG001|36 Months|Censored due to reoperation|0|||
161168139|NCT00377429|581993014|FG000|Overall Study|Withdrawal by Subject|5|||
161168140|NCT00377429|581993014|FG000|Overall Study|Adverse Event|8|||
161168141|NCT00377429|581993014|FG000|Overall Study|Physician Decision|1|||
161168142|NCT00377429|581993014|FG000|Overall Study|Patient non-compliance|1|||
161168143|NCT02394795|581993017|FG000|Overall Study|Adverse Event|92|||
161168144|NCT02394795|581993018|FG001|Overall Study|Adverse Event|70|||
161168145|NCT02394795|581993017|FG000|Overall Study|Lost to Follow-up|0|||
161168146|NCT02394795|581993018|FG001|Overall Study|Lost to Follow-up|1|||
161168147|NCT02394795|581993017|FG000|Overall Study|Withdrawal by Subject|17|||
161168148|NCT02394795|581993018|FG001|Overall Study|Withdrawal by Subject|26|||
161168149|NCT02394795|581993017|FG000|Overall Study|Lack of Efficacy|181|||
161168150|NCT02394795|581993018|FG001|Overall Study|Lack of Efficacy|211|||
161168151|NCT02394795|581993017|FG000|Overall Study|Death|4|||
161168152|NCT02394795|581993018|FG001|Overall Study|Death|5|||
161168153|NCT02394795|581993017|FG000|Overall Study|Physician Decision|109|||
161168154|NCT02394795|581993018|FG001|Overall Study|Physician Decision|93|||
161168155|NCT02939599|581993020|FG000|Overall Study|Adverse Event|1|||
161168156|NCT02939599|581993021|FG001|Overall Study|Adverse Event|0|||
161168157|NCT02939599|581993020|FG000|Overall Study|Study Terminated By Sponsor|2|||
161168158|NCT02939599|581993021|FG001|Overall Study|Study Terminated By Sponsor|2|||
161168159|NCT01669811|581993022|FG000|Overall Study|Investigator decision|0|||
161168160|NCT01669811|581993023|FG001|Overall Study|Investigator decision|1|||
161168161|NCT01669811|581993022|FG000|Overall Study|Withdrawal by Subject|1|||
161168162|NCT01669811|581993023|FG001|Overall Study|Withdrawal by Subject|2|||
161168163|NCT01669811|581993022|FG000|Overall Study|Adverse Event|2|||
161168164|NCT01669811|581993023|FG001|Overall Study|Adverse Event|6|||
161168165|NCT01669811|581993022|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
161168166|NCT01669811|581993023|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
161168167|NCT03288493|581993028|FG000|Overall Study|Withdrawal by Subject|4|||
161168168|NCT03288493|581993029|FG001|Overall Study|Withdrawal by Subject|0|||
161168169|NCT03288493|581993030|FG002|Overall Study|Withdrawal by Subject|0|||
161168170|NCT03288493|581993031|FG003|Overall Study|Withdrawal by Subject|0|||
161168171|NCT03288493|581993032|FG004|Overall Study|Withdrawal by Subject|0|||
161168172|NCT03288493|581993033|FG005|Overall Study|Withdrawal by Subject|2|||
161168173|NCT03288493|581993034|FG006|Overall Study|Withdrawal by Subject|0|||
161168174|NCT03288493|581993028|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
161168175|NCT03288493|581993029|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
161168176|NCT03288493|581993030|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
161168177|NCT03288493|581993031|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
161168178|NCT03288493|581993032|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
161168179|NCT03288493|581993033|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
161168180|NCT03288493|581993034|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
161168181|NCT03288493|581993028|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
161168182|NCT03288493|581993029|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161168183|NCT03288493|581993030|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161168184|NCT03288493|581993031|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
161168185|NCT03288493|581993032|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161168186|NCT03288493|581993033|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
161168187|NCT03288493|581993034|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
161168188|NCT03288493|581993028|FG000|Overall Study|Death|2|||
161168189|NCT03288493|581993029|FG001|Overall Study|Death|0|||
161168190|NCT03288493|581993030|FG002|Overall Study|Death|0|||
161168191|NCT03288493|581993031|FG003|Overall Study|Death|0|||
161168192|NCT03288493|581993032|FG004|Overall Study|Death|0|||
161290303|NCT00955409|582444213|FG003|Overall Study|Lack of Efficacy|0|||
161290304|NCT00955409|582444214|FG004|Overall Study|Lack of Efficacy|0|||
161168193|NCT03288493|581993033|FG005|Overall Study|Death|0|||
161290305|NCT00955409|582444215|FG005|Overall Study|Lack of Efficacy|0|||
161290306|NCT00955409|582444216|FG006|Overall Study|Lack of Efficacy|0|||
161168194|NCT03288493|581993034|FG006|Overall Study|Death|0|||
161168195|NCT03288493|581993028|FG000|Overall Study|other reason not listed above|2|||
161168196|NCT03288493|581993029|FG001|Overall Study|other reason not listed above|0|||
161168197|NCT03288493|581993030|FG002|Overall Study|other reason not listed above|0|||
161168198|NCT03288493|581993031|FG003|Overall Study|other reason not listed above|0|||
161168199|NCT03288493|581993032|FG004|Overall Study|other reason not listed above|0|||
161168200|NCT03288493|581993033|FG005|Overall Study|other reason not listed above|0|||
161168201|NCT03288493|581993034|FG006|Overall Study|other reason not listed above|0|||
161168202|NCT04507776|581995091|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
161168203|NCT01136746|581995094|FG000|Overall Study|Lost to Follow-up|0|||
161168204|NCT01136746|581995095|FG001|Overall Study|Lost to Follow-up|2|||
161168205|NCT01136746|581995094|FG000|Overall Study|Protocol Violation|2|||
161168206|NCT01136746|581995095|FG001|Overall Study|Protocol Violation|1|||
161168207|NCT01136746|581995094|FG000|Overall Study|Death|1|||
161168208|NCT01136746|581995095|FG001|Overall Study|Death|0|||
161168209|NCT00092677|581995101|FG000|Overall Study|Lost to Follow-up|0|||
161168210|NCT00092677|581995102|FG001|Overall Study|Lost to Follow-up|2|||
161168211|NCT00092677|581995101|FG000|Overall Study|Adminstrative|5|||
161168212|NCT00092677|581995102|FG001|Overall Study|Adminstrative|9|||
161168213|NCT04624672|581995103|FG000|Overall Study|Early Study Closure|2|||
161168214|NCT04624672|581995104|FG001|Overall Study|Early Study Closure|1|||
161168215|NCT05905601|581995111|FG000|Overall Study|Lost to Follow-up|1|||
161168216|NCT05905601|581995112|FG001|Overall Study|Lost to Follow-up|3|||
161168217|NCT03024255|581995113|FG000|Overall Study|Adverse Event|1|||
161168218|NCT03024255|581995114|FG001|Overall Study|Adverse Event|4|||
161168219|NCT03024255|581995115|FG002|Overall Study|Adverse Event|8|||
161168220|NCT03024255|581995116|FG003|Overall Study|Adverse Event|0|||
161168221|NCT03024255|581995113|FG000|Overall Study|Withdrawal by Subject|3|||
161168222|NCT03024255|581995114|FG001|Overall Study|Withdrawal by Subject|1|||
161168223|NCT03024255|581995115|FG002|Overall Study|Withdrawal by Subject|0|||
161168224|NCT03024255|581995116|FG003|Overall Study|Withdrawal by Subject|3|||
161168225|NCT03024255|581995113|FG000|Overall Study|Protocol Violation|0|||
161168226|NCT03024255|581995114|FG001|Overall Study|Protocol Violation|0|||
161168227|NCT03024255|581995115|FG002|Overall Study|Protocol Violation|2|||
161168228|NCT03024255|581995116|FG003|Overall Study|Protocol Violation|0|||
161168229|NCT03024255|581995113|FG000|Overall Study|Lost to Follow-up|1|||
161168230|NCT03024255|581995114|FG001|Overall Study|Lost to Follow-up|2|||
161168231|NCT03024255|581995115|FG002|Overall Study|Lost to Follow-up|1|||
161168232|NCT03024255|581995116|FG003|Overall Study|Lost to Follow-up|1|||
161168233|NCT03024255|581995113|FG000|Overall Study|Lack of Efficacy|1|||
161168234|NCT03024255|581995114|FG001|Overall Study|Lack of Efficacy|0|||
161168235|NCT03024255|581995115|FG002|Overall Study|Lack of Efficacy|0|||
161168236|NCT03024255|581995116|FG003|Overall Study|Lack of Efficacy|0|||
161168237|NCT03024255|581995113|FG000|Overall Study|Protocol Noncompliance|1|||
161168238|NCT03024255|581995114|FG001|Overall Study|Protocol Noncompliance|1|||
161168239|NCT03024255|581995115|FG002|Overall Study|Protocol Noncompliance|0|||
161168240|NCT03024255|581995116|FG003|Overall Study|Protocol Noncompliance|1|||
161168241|NCT01415908|581995117|FG000|Overall Study|Withdrawal by Subject|1|||
161168242|NCT01415908|581995118|FG001|Overall Study|Withdrawal by Subject|0|||
161168243|NCT02685995|581995121|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
161168244|NCT02685995|581995122|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
161168245|NCT01188096|581995125|FG000|Overall Study|progression of disease|4|||
161168246|NCT01188096|581995125|FG000|Overall Study|Withdrawal by Subject|2|||
161168247|NCT02384395|581995126|FG000|Overall Study|Physician Decision|4|||
161168248|NCT02384395|581995126|FG000|Overall Study|Withdrawal by Subject|3|||
161168249|NCT02384395|581995126|FG000|Overall Study|Lost to Follow-up|3|||
161168250|NCT01779648|581995127|FG000|Overall Study|Protocol Violation|1|||
161168251|NCT01779648|581995128|FG001|Overall Study|Protocol Violation|0|||
161168252|NCT01797445|581995129|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
161168253|NCT01797445|581995130|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
161168254|NCT01797445|581995129|FG000|Double-Blind Phase|Adverse Event|3|||
161168255|NCT01797445|581995130|FG001|Double-Blind Phase|Adverse Event|0|||
161168256|NCT01797445|581995129|FG000|Double-Blind Phase|Death|5|||
161168257|NCT01797445|581995130|FG001|Double-Blind Phase|Death|4|||
161168258|NCT01797445|581995129|FG000|Double-Blind Phase|Pregnancy|0|||
161168259|NCT01797445|581995130|FG001|Double-Blind Phase|Pregnancy|1|||
161168260|NCT01797445|581995129|FG000|Double-Blind Phase|Lack of Efficacy|1|||
161168261|NCT01797445|581995130|FG001|Double-Blind Phase|Lack of Efficacy|2|||
161168262|NCT01797445|581995129|FG000|Double-Blind Phase|Investigator's Discretion|15|||
161168263|NCT01797445|581995130|FG001|Double-Blind Phase|Investigator's Discretion|17|||
161168264|NCT01797445|581995129|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
161168265|NCT01797445|581995130|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
161168266|NCT01797445|581995129|FG000|Double-Blind Phase|Protocol Violation|0|||
161168267|NCT01797445|581995130|FG001|Double-Blind Phase|Protocol Violation|1|||
161168268|NCT01797445|581995129|FG000|Double-Blind Phase|Withdrew Consent|20|||
161168269|NCT01797445|581995130|FG001|Double-Blind Phase|Withdrew Consent|35|||
161168270|NCT01797445|581995129|FG000|Double-Blind Phase|Lost to Follow-up|34|||
161290307|NCT00955409|582444217|FG007|Overall Study|Lack of Efficacy|0|||
161290308|NCT00955409|582444218|FG008|Overall Study|Lack of Efficacy|0|||
161290309|NCT00955409|582444219|FG009|Overall Study|Lack of Efficacy|0|||
161290310|NCT00955409|582444210|FG000|Overall Study|Withdrawal by Subject|1|||
161290311|NCT00955409|582444211|FG001|Overall Study|Withdrawal by Subject|0|||
161290312|NCT00955409|582444212|FG002|Overall Study|Withdrawal by Subject|5|||
161290313|NCT00955409|582444213|FG003|Overall Study|Withdrawal by Subject|2|||
161290314|NCT00955409|582444214|FG004|Overall Study|Withdrawal by Subject|0|||
161290315|NCT00955409|582444215|FG005|Overall Study|Withdrawal by Subject|0|||
161290316|NCT00955409|582444216|FG006|Overall Study|Withdrawal by Subject|2|||
161290317|NCT00955409|582444217|FG007|Overall Study|Withdrawal by Subject|0|||
161290318|NCT00955409|582444218|FG008|Overall Study|Withdrawal by Subject|1|||
161290319|NCT00955409|582444219|FG009|Overall Study|Withdrawal by Subject|0|||
161290320|NCT00955409|582444210|FG000|Overall Study|Caregiver Request|2|||
161290321|NCT00955409|582444211|FG001|Overall Study|Caregiver Request|0|||
161290322|NCT00955409|582444212|FG002|Overall Study|Caregiver Request|6|||
161290323|NCT00955409|582444213|FG003|Overall Study|Caregiver Request|5|||
161290324|NCT00955409|582444214|FG004|Overall Study|Caregiver Request|0|||
161290325|NCT00955409|582444215|FG005|Overall Study|Caregiver Request|2|||
161290326|NCT00955409|582444216|FG006|Overall Study|Caregiver Request|3|||
161290327|NCT00955409|582444217|FG007|Overall Study|Caregiver Request|1|||
161290328|NCT00955409|582444218|FG008|Overall Study|Caregiver Request|3|||
161290329|NCT00955409|582444219|FG009|Overall Study|Caregiver Request|0|||
161290330|NCT00955409|582444210|FG000|Overall Study|Investigator Request|0|||
161290331|NCT00955409|582444211|FG001|Overall Study|Investigator Request|0|||
161290332|NCT00955409|582444212|FG002|Overall Study|Investigator Request|1|||
161290333|NCT00955409|582444213|FG003|Overall Study|Investigator Request|0|||
161290334|NCT00955409|582444214|FG004|Overall Study|Investigator Request|0|||
161290335|NCT00955409|582444215|FG005|Overall Study|Investigator Request|0|||
161290336|NCT00955409|582444216|FG006|Overall Study|Investigator Request|0|||
161290337|NCT00955409|582444217|FG007|Overall Study|Investigator Request|0|||
161290338|NCT00955409|582444218|FG008|Overall Study|Investigator Request|0|||
161290339|NCT00955409|582444219|FG009|Overall Study|Investigator Request|0|||
161290340|NCT00955409|582444210|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
161290341|NCT00955409|582444211|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161290342|NCT00955409|582444212|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
161083917|NCT02245737|581697438|FG001|Overall Study|Sponsor Decision|430|||
161083918|NCT02245737|581697439|FG002|Overall Study|Sponsor Decision|432|||
161083919|NCT01699503|581697443|FG000|Overall Study|Death|31|||
161083920|NCT01699503|581697444|FG001|Overall Study|Death|40|||
161083921|NCT01699503|581697443|FG000|Overall Study|Withdrawal by Subject|65|||
161083922|NCT01699503|581697444|FG001|Overall Study|Withdrawal by Subject|57|||
161083923|NCT01699503|581697443|FG000|Overall Study|Lost to Follow-up|121|||
161083924|NCT01699503|581697444|FG001|Overall Study|Lost to Follow-up|117|||
161083925|NCT01699503|581697443|FG000|Overall Study|Excluded due to quality|783|||
161083926|NCT01699503|581697444|FG001|Overall Study|Excluded due to quality|791|||
161083927|NCT01639560|581697445|FG000|Overall Study|Withdrawal by Subject|9|||
161083928|NCT01639560|581697446|FG001|Overall Study|Withdrawal by Subject|14|||
161083929|NCT01639560|581697445|FG000|Overall Study|Lack of Efficacy|1|||
161083930|NCT01639560|581697446|FG001|Overall Study|Lack of Efficacy|2|||
161083931|NCT01639560|581697445|FG000|Overall Study|Lost to Follow-up|9|||
161083932|NCT01639560|581697446|FG001|Overall Study|Lost to Follow-up|11|||
161083933|NCT01639560|581697445|FG000|Overall Study|Adverse Event|0|||
161083934|NCT01639560|581697446|FG001|Overall Study|Adverse Event|2|||
161083935|NCT00774930|581697448|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
161083936|NCT00774930|581697449|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
161083937|NCT00774930|581697448|FG000|DB Phase|Adverse Event|1|||
161083938|NCT00774930|581697449|FG001|DB Phase|Adverse Event|2|||
161083939|NCT00774930|581697448|FG000|DB Phase|Subject Decision|1|||
161083940|NCT00774930|581697449|FG001|DB Phase|Subject Decision|5|||
161083941|NCT00774930|581697448|FG000|DB Phase|Sponsor Decision|0|||
161083942|NCT00774930|581697449|FG001|DB Phase|Sponsor Decision|1|||
161083943|NCT00774930|581697448|FG000|DB Phase|Disease Progression|1|||
161083944|NCT00774930|581697449|FG001|DB Phase|Disease Progression|1|||
161083945|NCT00774930|581697448|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
161083946|NCT00774930|581697449|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
161083947|NCT00774930|581697448|FG000|IOL Phase|Adverse Event|1|||
161083948|NCT00774930|581697449|FG001|IOL Phase|Adverse Event|1|||
161083949|NCT00774930|581697448|FG000|IOL Phase|Subject Decision|4|||
161083950|NCT00774930|581697449|FG001|IOL Phase|Subject Decision|3|||
161083951|NCT00774930|581697448|FG000|IOL Phase|Physician Decision|3|||
161083952|NCT00774930|581697449|FG001|IOL Phase|Physician Decision|2|||
161083953|NCT00774930|581697448|FG000|IOL Phase|Sponsor Decision|1|||
161083954|NCT00774930|581697449|FG001|IOL Phase|Sponsor Decision|0|||
161083955|NCT00774930|581697448|FG000|IOL Phase|Disease Progression|2|||
161083956|NCT00774930|581697449|FG001|IOL Phase|Disease Progression|1|||
161091283|NCT01272804|581723870|FG002|Overall Study|Adverse Event|0|||
161290343|NCT00955409|582444213|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
161290344|NCT00955409|582444214|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
161290345|NCT00955409|582444215|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
161290346|NCT00955409|582444216|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
161290347|NCT00955409|582444217|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
161168271|NCT01797445|581995130|FG001|Double-Blind Phase|Lost to Follow-up|26|||
161168272|NCT01797445|581995129|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
161168273|NCT01797445|581995130|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
161168274|NCT00688545|581995131|FG000|Overall Study|Lost to Follow-up|1|||
161168275|NCT00688545|581995132|FG001|Overall Study|Lost to Follow-up|4|||
161168276|NCT00688545|581995131|FG000|Overall Study|Insurance/cost of drug|0|||
161168277|NCT00688545|581995132|FG001|Overall Study|Insurance/cost of drug|1|||
161168278|NCT00688545|581995131|FG000|Overall Study|Withdrawal by Subject|2|||
161168279|NCT00688545|581995132|FG001|Overall Study|Withdrawal by Subject|3|||
161168280|NCT00688545|581995131|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
161168281|NCT00688545|581995132|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
161168282|NCT01878097|581995133|FG000|Baseline|Surveys not fully completed|2497|||
161168283|NCT01878097|581995134|FG001|Baseline|Surveys not fully completed|1800|||
161168284|NCT01878097|581995133|FG000|Implementation Year 1|Surveys not fully completed|3202|||
161290348|NCT00955409|582444218|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
161168285|NCT01878097|581995134|FG001|Implementation Year 1|Surveys not fully completed|2549|||
161168286|NCT01878097|581995133|FG000|Implementation Year 2|Surveys not fully completed|3281|||
161168287|NCT01878097|581995134|FG001|Implementation Year 2|Surveys not fully completed|2841|||
161168288|NCT01878097|581995133|FG000|Implementation Year 3|Surveys not fully completed|3494|||
161168289|NCT01878097|581995134|FG001|Implementation Year 3|Surveys not fully completed|2980|||
161168290|NCT01878097|581995133|FG000|Implementation Year 4|Surveys not fully completed|3604|||
161168291|NCT01878097|581995134|FG001|Implementation Year 4|Surveys not fully completed|3007|||
161168292|NCT01595438|581995137|FG000|Overall Study|Lost to Follow-up|20|||
161168293|NCT01595438|581995138|FG001|Overall Study|Lost to Follow-up|20|||
161168294|NCT01595438|581995137|FG000|Overall Study|Withdrawal by Subject|12|||
161168295|NCT01595438|581995138|FG001|Overall Study|Withdrawal by Subject|12|||
161168296|NCT01595438|581995137|FG000|Overall Study|Other Eligibility criteria|11|||
161168297|NCT01595438|581995138|FG001|Overall Study|Other Eligibility criteria|9|||
161168298|NCT00985738|581995142|FG000|Overall Study|Study closed prematurely|8|||
161168299|NCT00985738|581995143|FG001|Overall Study|Study closed prematurely|8|||
161168300|NCT02119026|581995146|FG000|1st-line Treatment|Adverse Event|9|||
161168301|NCT02119026|581995147|FG001|1st-line Treatment|Adverse Event|14|||
161168302|NCT02119026|581995146|FG000|1st-line Treatment|Physician Decision|3|||
161168303|NCT02119026|581995147|FG001|1st-line Treatment|Physician Decision|8|||
161168304|NCT02119026|581995146|FG000|1st-line Treatment|Withdrawal by Subject|4|||
161168305|NCT02119026|581995147|FG001|1st-line Treatment|Withdrawal by Subject|10|||
161168306|NCT02119026|581995146|FG000|1st-line Treatment|Patient condition or compliance|6|||
161168307|NCT02119026|581995147|FG001|1st-line Treatment|Patient condition or compliance|4|||
161168308|NCT02119026|581995146|FG000|1st-line Treatment|Surgery of metastases|2|||
161168309|NCT02119026|581995147|FG001|1st-line Treatment|Surgery of metastases|1|||
161168310|NCT02119026|581995146|FG000|1st-line Treatment|Death|2|||
161168311|NCT02119026|581995147|FG001|1st-line Treatment|Death|1|||
161168312|NCT02119026|581995146|FG000|2nd-line Treatment|Lost to Follow-up|2|||
161168313|NCT02119026|581995147|FG001|2nd-line Treatment|Lost to Follow-up|0|||
161168314|NCT02119026|581995146|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
161168315|NCT02119026|581995147|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
161168316|NCT02119026|581995146|FG000|2nd-line Treatment|Adverse Event|4|||
161168317|NCT02119026|581995147|FG001|2nd-line Treatment|Adverse Event|1|||
161168318|NCT00340834|581995150|FG000|Core Phase of Study|Adverse Event|26|||
161168319|NCT00340834|581995151|FG001|Core Phase of Study|Adverse Event|9|||
161168320|NCT00340834|581995152|FG002|Core Phase of Study|Adverse Event|9|||
161168321|NCT00340834|581995153|FG003|Core Phase of Study|Adverse Event|0|||
161168322|NCT00340834|581995154|FG004|Core Phase of Study|Adverse Event|0|||
161168323|NCT00340834|581995150|FG000|Core Phase of Study|Withdrawal by Subject|11|||
161168324|NCT00340834|581995151|FG001|Core Phase of Study|Withdrawal by Subject|9|||
161290349|NCT00955409|582444219|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
161290350|NCT00955409|582444210|FG000|Overall Study|Lost to Follow-up|0|||
161290351|NCT00955409|582444211|FG001|Overall Study|Lost to Follow-up|0|||
161290352|NCT00955409|582444212|FG002|Overall Study|Lost to Follow-up|1|||
161290353|NCT00955409|582444213|FG003|Overall Study|Lost to Follow-up|0|||
161290354|NCT00955409|582444214|FG004|Overall Study|Lost to Follow-up|0|||
161290355|NCT00955409|582444215|FG005|Overall Study|Lost to Follow-up|0|||
161290356|NCT00955409|582444216|FG006|Overall Study|Lost to Follow-up|1|||
161290357|NCT00955409|582444217|FG007|Overall Study|Lost to Follow-up|0|||
161168325|NCT00340834|581995152|FG002|Core Phase of Study|Withdrawal by Subject|16|||
161168326|NCT00340834|581995153|FG003|Core Phase of Study|Withdrawal by Subject|0|||
161168327|NCT00340834|581995154|FG004|Core Phase of Study|Withdrawal by Subject|0|||
161168328|NCT00340834|581995150|FG000|Core Phase of Study|Administrative Problems|6|||
161168329|NCT00340834|581995151|FG001|Core Phase of Study|Administrative Problems|2|||
161168330|NCT00340834|581995152|FG002|Core Phase of Study|Administrative Problems|7|||
161168331|NCT00340834|581995153|FG003|Core Phase of Study|Administrative Problems|0|||
161168332|NCT00340834|581995154|FG004|Core Phase of Study|Administrative Problems|0|||
161168333|NCT00340834|581995150|FG000|Core Phase of Study|Lack of Efficacy|3|||
161168334|NCT00340834|581995151|FG001|Core Phase of Study|Lack of Efficacy|3|||
161168335|NCT00340834|581995152|FG002|Core Phase of Study|Lack of Efficacy|7|||
161168336|NCT00340834|581995153|FG003|Core Phase of Study|Lack of Efficacy|0|||
161168337|NCT00340834|581995154|FG004|Core Phase of Study|Lack of Efficacy|0|||
161168338|NCT00340834|581995150|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
161168339|NCT00340834|581995151|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
161168340|NCT00340834|581995152|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
161168341|NCT00340834|581995153|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
161168342|NCT00340834|581995154|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
161168343|NCT00340834|581995150|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
161290358|NCT00955409|582444218|FG008|Overall Study|Lost to Follow-up|0|||
161290359|NCT00955409|582444219|FG009|Overall Study|Lost to Follow-up|0|||
161290360|NCT00955409|582444210|FG000|Overall Study|Failed to Return|2|||
161290361|NCT00955409|582444211|FG001|Overall Study|Failed to Return|0|||
161290362|NCT00955409|582444212|FG002|Overall Study|Failed to Return|0|||
161290363|NCT00955409|582444213|FG003|Overall Study|Failed to Return|0|||
161290364|NCT00955409|582444214|FG004|Overall Study|Failed to Return|0|||
161290365|NCT00955409|582444215|FG005|Overall Study|Failed to Return|0|||
161347040|NCT02335944|582654758|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
161347041|NCT02335944|582654759|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
161347042|NCT02335944|582654760|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
161168344|NCT00340834|581995151|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
161168345|NCT00340834|581995152|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
161168346|NCT00340834|581995153|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
161168347|NCT00340834|581995154|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
161168348|NCT00340834|581995150|FG000|Core Phase of Study|Lost to Follow-up|1|||
161168349|NCT00340834|581995151|FG001|Core Phase of Study|Lost to Follow-up|1|||
161168350|NCT00340834|581995152|FG002|Core Phase of Study|Lost to Follow-up|4|||
161168351|NCT00340834|581995153|FG003|Core Phase of Study|Lost to Follow-up|0|||
161168352|NCT00340834|581995154|FG004|Core Phase of Study|Lost to Follow-up|0|||
161168353|NCT00340834|581995150|FG000|Core Phase of Study|Death|2|||
161168354|NCT00340834|581995151|FG001|Core Phase of Study|Death|0|||
161168355|NCT00340834|581995152|FG002|Core Phase of Study|Death|0|||
161168356|NCT00340834|581995153|FG003|Core Phase of Study|Death|0|||
161168357|NCT00340834|581995154|FG004|Core Phase of Study|Death|0|||
161168358|NCT00340834|581995150|FG000|Core Phase of Study|Protocol Violation|0|||
161168359|NCT00340834|581995151|FG001|Core Phase of Study|Protocol Violation|0|||
161168360|NCT00340834|581995152|FG002|Core Phase of Study|Protocol Violation|2|||
161168361|NCT00340834|581995153|FG003|Core Phase of Study|Protocol Violation|0|||
161168362|NCT00340834|581995154|FG004|Core Phase of Study|Protocol Violation|0|||
161168363|NCT00340834|581995150|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
161168364|NCT00340834|581995151|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
161168365|NCT00340834|581995152|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
161168366|NCT00340834|581995153|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
161168367|NCT00340834|581995154|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
161168368|NCT00340834|581995150|FG000|Extension Phase of Study|Subject withdrew consent|26|||
161168369|NCT00340834|581995151|FG001|Extension Phase of Study|Subject withdrew consent|31|||
161168370|NCT00340834|581995152|FG002|Extension Phase of Study|Subject withdrew consent|0|||
161168371|NCT00340834|581995153|FG003|Extension Phase of Study|Subject withdrew consent|12|||
161168372|NCT00340834|581995154|FG004|Extension Phase of Study|Subject withdrew consent|15|||
161168373|NCT00340834|581995150|FG000|Extension Phase of Study|Adverse Event|21|||
161168374|NCT00340834|581995151|FG001|Extension Phase of Study|Adverse Event|22|||
161290366|NCT00955409|582444216|FG006|Overall Study|Failed to Return|0|||
161290367|NCT00955409|582444217|FG007|Overall Study|Failed to Return|2|||
161290368|NCT00955409|582444218|FG008|Overall Study|Failed to Return|0|||
161290369|NCT00955409|582444219|FG009|Overall Study|Failed to Return|0|||
161290370|NCT00955409|582444210|FG000|Overall Study|Adverse Event (AE)|2|||
161290371|NCT00955409|582444211|FG001|Overall Study|Adverse Event (AE)|0|||
161290372|NCT00955409|582444212|FG002|Overall Study|Adverse Event (AE)|0|||
161290373|NCT00955409|582444213|FG003|Overall Study|Adverse Event (AE)|0|||
161347043|NCT02335944|582654761|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
161168375|NCT00340834|581995152|FG002|Extension Phase of Study|Adverse Event|0|||
161168376|NCT00340834|581995153|FG003|Extension Phase of Study|Adverse Event|19|||
161168377|NCT00340834|581995154|FG004|Extension Phase of Study|Adverse Event|7|||
161290374|NCT00955409|582444214|FG004|Overall Study|Adverse Event (AE)|0|||
161290375|NCT00955409|582444215|FG005|Overall Study|Adverse Event (AE)|1|||
161290376|NCT00955409|582444216|FG006|Overall Study|Adverse Event (AE)|2|||
161347044|NCT02335944|582654762|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
161168378|NCT00340834|581995150|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
161168379|NCT00340834|581995151|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
161168380|NCT00340834|581995152|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
161290377|NCT00955409|582444217|FG007|Overall Study|Adverse Event (AE)|0|||
161290378|NCT00955409|582444218|FG008|Overall Study|Adverse Event (AE)|2|||
161290379|NCT00955409|582444219|FG009|Overall Study|Adverse Event (AE)|0|||
161290380|NCT00955409|582444210|FG000|Overall Study|Reason not Specified|2|||
161083957|NCT00774930|581697448|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
161083958|NCT00774930|581697449|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
161083959|NCT00774930|581697448|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
161083960|NCT00774930|581697449|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
161083961|NCT00774930|581697448|FG000|IOL Phase|Other|1|||
161083962|NCT00774930|581697449|FG001|IOL Phase|Other|0|||
161083963|NCT00774930|581697448|FG000|IOL Phase|Brain radiation|0|||
161083964|NCT00774930|581697449|FG001|IOL Phase|Brain radiation|1|||
161083965|NCT00774930|581697448|FG000|LTOLE Phase|Adverse Event|7|||
161083966|NCT00774930|581697449|FG001|LTOLE Phase|Adverse Event|3|||
161083967|NCT00774930|581697448|FG000|LTOLE Phase|Subject decision|0|||
161083968|NCT00774930|581697449|FG001|LTOLE Phase|Subject decision|5|||
161083969|NCT00774930|581697448|FG000|LTOLE Phase|Physician Decision|4|||
161083970|NCT00774930|581697449|FG001|LTOLE Phase|Physician Decision|1|||
161083971|NCT00774930|581697448|FG000|LTOLE Phase|Sponsor decision|2|||
161083972|NCT00774930|581697449|FG001|LTOLE Phase|Sponsor decision|1|||
161083973|NCT00774930|581697448|FG000|LTOLE Phase|Disease Progression|2|||
161083974|NCT00774930|581697449|FG001|LTOLE Phase|Disease Progression|5|||
161083975|NCT00774930|581697448|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
161083976|NCT00774930|581697449|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
161083977|NCT00774930|581697448|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
161083978|NCT00774930|581697449|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
161083979|NCT00766363|581697450|FG000|Overall Study|Withdrawal by Subject|1|||
161083980|NCT00766363|581697451|FG001|Overall Study|Withdrawal by Subject|0|||
161083981|NCT00766363|581697452|FG002|Overall Study|Withdrawal by Subject|0|||
161083982|NCT00766363|581697453|FG003|Overall Study|Withdrawal by Subject|0|||
161083983|NCT00766363|581697450|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
161083984|NCT00766363|581697451|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
161083985|NCT00766363|581697452|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
161083986|NCT00766363|581697453|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
161083987|NCT03020576|581697458|FG000|Overall Study|Withdrawal by Subject|1|||
161083988|NCT03020576|581697459|FG001|Overall Study|Withdrawal by Subject|2|||
161083989|NCT03292432|581697460|FG000|Overall Study|Lost to Follow-up|11|||
161083990|NCT03292432|581697461|FG001|Overall Study|Lost to Follow-up|8|||
161083991|NCT03292432|581697460|FG000|Overall Study|Death|2|||
161083992|NCT03292432|581697461|FG001|Overall Study|Death|1|||
161083993|NCT03292432|581697460|FG000|Overall Study|Withdrawal by Subject|1|||
161083994|NCT03292432|581697461|FG001|Overall Study|Withdrawal by Subject|2|||
161083995|NCT03292432|581697460|FG000|Overall Study|Site closed before any data collected|1|||
161083996|NCT03292432|581697461|FG001|Overall Study|Site closed before any data collected|0|||
161083997|NCT00911937|581697462|FG000|Overall Study|Death|1|||
161083998|NCT00911937|581697463|FG001|Overall Study|Death|0|||
161083999|NCT00911937|581697462|FG000|Overall Study|Lost to Follow-up|8|||
161084000|NCT00911937|581697463|FG001|Overall Study|Lost to Follow-up|5|||
161084001|NCT00911937|581697462|FG000|Overall Study|Withdrawal by Subject|10|||
161084002|NCT00911937|581697463|FG001|Overall Study|Withdrawal by Subject|7|||
161084003|NCT00911937|581697462|FG000|Overall Study|Withdrawn due to pregnancy|1|||
161084004|NCT00911937|581697463|FG001|Overall Study|Withdrawn due to pregnancy|0|||
161084005|NCT00911937|581697462|FG000|Overall Study|Adverse Event|11|||
161084006|NCT00911937|581697463|FG001|Overall Study|Adverse Event|25|||
161084007|NCT00911937|581697462|FG000|Overall Study|Lack of Efficacy|11|||
161084008|NCT00911937|581697463|FG001|Overall Study|Lack of Efficacy|6|||
161084009|NCT00911937|581697462|FG000|Overall Study|Did not meet inclusion criteria|9|||
161084010|NCT00911937|581697463|FG001|Overall Study|Did not meet inclusion criteria|11|||
161084011|NCT00911937|581697462|FG000|Overall Study|Protocol Violation|14|||
161084012|NCT00911937|581697463|FG001|Overall Study|Protocol Violation|23|||
161084013|NCT00911937|581697462|FG000|Overall Study|Randomized but not treated|13|||
161084014|NCT00911937|581697463|FG001|Overall Study|Randomized but not treated|13|||
161084015|NCT00911937|581697462|FG000|Overall Study|Other|9|||
161084016|NCT00911937|581697463|FG001|Overall Study|Other|5|||
161084017|NCT01498679|581697464|FG000|Overall Study|Adverse Event|1|||
161084018|NCT01498679|581697465|FG001|Overall Study|Adverse Event|4|||
161084019|NCT01498679|581697464|FG000|Overall Study|Lack of Efficacy|72|||
161084020|NCT01498679|581697465|FG001|Overall Study|Lack of Efficacy|12|||
161290381|NCT00955409|582444211|FG001|Overall Study|Reason not Specified|1|||
161084021|NCT01498679|581697464|FG000|Overall Study|Protocol Violation|4|||
161084022|NCT01498679|581697465|FG001|Overall Study|Protocol Violation|0|||
161084023|NCT01498679|581697464|FG000|Overall Study|Physician Decision|0|||
161084024|NCT01498679|581697465|FG001|Overall Study|Physician Decision|2|||
161084025|NCT01498679|581697464|FG000|Overall Study|Withdrawal by Subject|12|||
161084026|NCT01498679|581697465|FG001|Overall Study|Withdrawal by Subject|4|||
161084027|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
161290382|NCT00955409|582444212|FG002|Overall Study|Reason not Specified|13|||
161084028|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161084029|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161084030|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161084031|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
161084032|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
161084033|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161084034|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161084035|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161084036|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
161084037|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
161084038|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161084039|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161084040|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161084041|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
161084042|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
161084043|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161084044|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161084045|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161084046|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
161084047|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
161084048|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161084049|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161084050|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161084051|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
161084052|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
161084053|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161084054|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161084055|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161084056|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
161084057|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
161084058|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161084059|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161084060|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161084061|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
161084062|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
161084063|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161084064|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161084065|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161084066|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
161084067|NCT00700427|581697466|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
161084068|NCT00700427|581697467|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161084069|NCT00700427|581697468|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161084070|NCT00700427|581697469|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161084071|NCT00700427|581697470|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
161084072|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161084073|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
161084074|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161084075|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161084076|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
161084077|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161084078|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
161084079|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161084080|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161084081|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
161084082|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161084083|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
161084084|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161084085|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161084086|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
161084087|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161084088|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
161084089|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161084090|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161168381|NCT00340834|581995153|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
161168382|NCT00340834|581995154|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
161168383|NCT00340834|581995150|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
161168384|NCT00340834|581995151|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
161168385|NCT00340834|581995152|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
161168386|NCT00340834|581995153|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
161168387|NCT00340834|581995154|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
161168388|NCT00340834|581995150|FG000|Extension Phase of Study|Lost to Follow-up|1|||
161168389|NCT00340834|581995151|FG001|Extension Phase of Study|Lost to Follow-up|1|||
161168390|NCT00340834|581995152|FG002|Extension Phase of Study|Lost to Follow-up|0|||
161168391|NCT00340834|581995153|FG003|Extension Phase of Study|Lost to Follow-up|2|||
161168392|NCT00340834|581995154|FG004|Extension Phase of Study|Lost to Follow-up|3|||
161168393|NCT00340834|581995150|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
161168394|NCT00340834|581995151|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
161168395|NCT00340834|581995152|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
161168396|NCT00340834|581995153|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
161168397|NCT00340834|581995154|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
161168398|NCT00340834|581995150|FG000|Extension Phase of Study|Administrative problems|3|||
161168399|NCT00340834|581995151|FG001|Extension Phase of Study|Administrative problems|0|||
161168400|NCT00340834|581995152|FG002|Extension Phase of Study|Administrative problems|0|||
161168401|NCT00340834|581995153|FG003|Extension Phase of Study|Administrative problems|1|||
161168402|NCT00340834|581995154|FG004|Extension Phase of Study|Administrative problems|1|||
161168403|NCT00340834|581995150|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161168404|NCT00340834|581995151|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
161168405|NCT00340834|581995152|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161168406|NCT00340834|581995153|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
161168407|NCT00340834|581995154|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
161168408|NCT00340834|581995150|FG000|Extension Phase of Study|Protocol Violation|3|||
161168409|NCT00340834|581995151|FG001|Extension Phase of Study|Protocol Violation|0|||
161168410|NCT00340834|581995152|FG002|Extension Phase of Study|Protocol Violation|0|||
161168411|NCT00340834|581995153|FG003|Extension Phase of Study|Protocol Violation|0|||
161168412|NCT00340834|581995154|FG004|Extension Phase of Study|Protocol Violation|0|||
161168413|NCT00340834|581995150|FG000|Extension Phase of Study|Death|0|||
161168414|NCT00340834|581995151|FG001|Extension Phase of Study|Death|0|||
161168415|NCT00340834|581995152|FG002|Extension Phase of Study|Death|0|||
161168416|NCT00340834|581995153|FG003|Extension Phase of Study|Death|0|||
161168417|NCT00340834|581995154|FG004|Extension Phase of Study|Death|1|||
161168418|NCT00291499|581995155|FG000|Overall Study|Adverse Event|3|||
161168419|NCT00291499|581995156|FG001|Overall Study|Adverse Event|8|||
161168420|NCT00291499|581995155|FG000|Overall Study|Change to other therapy|2|||
161168421|NCT00291499|581995156|FG001|Overall Study|Change to other therapy|1|||
161168422|NCT00291499|581995155|FG000|Overall Study|Intercurrent illness|1|||
161168423|NCT00291499|581995156|FG001|Overall Study|Intercurrent illness|0|||
161290383|NCT00955409|582444213|FG003|Overall Study|Reason not Specified|1|||
161290384|NCT00955409|582444214|FG004|Overall Study|Reason not Specified|2|||
161290385|NCT00955409|582444215|FG005|Overall Study|Reason not Specified|0|||
161290386|NCT00955409|582444216|FG006|Overall Study|Reason not Specified|16|||
161290387|NCT00955409|582444217|FG007|Overall Study|Reason not Specified|0|||
161290388|NCT00955409|582444218|FG008|Overall Study|Reason not Specified|8|||
161290389|NCT00955409|582444219|FG009|Overall Study|Reason not Specified|1|||
161290390|NCT00485732|582444220|FG000|Overall Study|Protocol Violation|1|||
161290391|NCT00485732|582444221|FG001|Overall Study|Protocol Violation|3|||
161290392|NCT00485732|582444220|FG000|Overall Study|Withdrawal by Subject|5|||
161290393|NCT00485732|582444221|FG001|Overall Study|Withdrawal by Subject|4|||
161290394|NCT00485732|582444220|FG000|Overall Study|Lost to Follow-up|2|||
161290395|NCT00485732|582444221|FG001|Overall Study|Lost to Follow-up|2|||
161290396|NCT05423093|582444223|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
161290397|NCT05423093|582444223|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
161290398|NCT05423093|582444223|FG000|Attended Intervention Session|Lost to Follow-up|3|||
161290399|NCT05423093|582444223|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
161290400|NCT05423093|582444223|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
161290401|NCT03593525|582444224|FG000|Overall Study|Withdrawal by Subject|1|||
161290402|NCT03593525|582444225|FG001|Overall Study|Withdrawal by Subject|0|||
161290403|NCT03593525|582444224|FG000|Overall Study|Lost to Follow-up|7|||
161290404|NCT03593525|582444225|FG001|Overall Study|Lost to Follow-up|5|||
161290405|NCT00210210|582444233|FG000|Overall Study|Withdrawal by Subject|3|||
161290406|NCT00210210|582444234|FG001|Overall Study|Withdrawal by Subject|2|||
161290407|NCT00210210|582444233|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
161319388|NCT01134263|582555301|FG001|Overall Study|Serious adverse event|1|||
161168424|NCT00291499|581995155|FG000|Overall Study|Protocol Violation|2|||
161168425|NCT00291499|581995156|FG001|Overall Study|Protocol Violation|2|||
161168426|NCT00291499|581995155|FG000|Overall Study|Other reasons|1|||
161168427|NCT00291499|581995156|FG001|Overall Study|Other reasons|4|||
161168428|NCT02786836|581995157|FG000|Overall Study|Death|1|||
161168429|NCT02786836|581995157|FG000|Overall Study|Lack of Efficacy|2|||
161290408|NCT00210210|582444234|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
161290409|NCT02445248|582444235|FG000|Overall Study|Death|45|||
161290410|NCT02445248|582444236|FG001|Overall Study|Death|12|||
161290411|NCT02445248|582444235|FG000|Overall Study|Progressive disease|13|||
161290412|NCT02445248|582444236|FG001|Overall Study|Progressive disease|1|||
161290413|NCT02445248|582444235|FG000|Overall Study|Subject decision|8|||
161290414|NCT02445248|582444236|FG001|Overall Study|Subject decision|0|||
161290415|NCT02445248|582444235|FG000|Overall Study|Physician Decision|5|||
161290416|NCT02445248|582444236|FG001|Overall Study|Physician Decision|0|||
161290417|NCT02445248|582444235|FG000|Overall Study|Adverse Event|1|||
161290418|NCT02445248|582444236|FG001|Overall Study|Adverse Event|0|||
161290419|NCT02445248|582444235|FG000|Overall Study|Lost to Follow-up|1|||
161290420|NCT02445248|582444236|FG001|Overall Study|Lost to Follow-up|0|||
161290421|NCT02596971|582444239|FG000|Overall Study|Death|5|||
161290422|NCT02596971|582444240|FG001|Overall Study|Death|1|||
161084091|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
161084092|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161084093|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
161084094|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161084095|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161084096|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
161084097|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161084098|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
161084099|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161084100|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161084101|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
161084102|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161084103|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
161168430|NCT02786836|581995157|FG000|Overall Study|Protocol Violation|3|||
161168431|NCT02786836|581995157|FG000|Overall Study|Withdrawal by Subject|3|||
161290423|NCT02596971|582444241|FG002|Overall Study|Death|5|||
161290424|NCT02596971|582444239|FG000|Overall Study|Withdrawal by Subject|5|||
161290425|NCT02596971|582444240|FG001|Overall Study|Withdrawal by Subject|1|||
161290426|NCT02596971|582444241|FG002|Overall Study|Withdrawal by Subject|4|||
161290427|NCT02764762|582444242|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
161290428|NCT02764762|582444242|FG000|Overall Study|Lost to Follow-up|4|||
161290429|NCT02764762|582444242|FG000|Overall Study|Voluntary Withdrawal|8|||
161290430|NCT02764762|582444242|FG000|Overall Study|Site Termination|1|||
161290431|NCT02764762|582444242|FG000|Overall Study|Lack of Efficacy|16|||
161290432|NCT02764762|582444242|FG000|Overall Study|Reason not Specified|1|||
161290433|NCT02954601|582444243|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
161290434|NCT02954601|582444244|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
161290435|NCT02954601|582444245|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
161290436|NCT02954601|582444246|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
161290437|NCT00917852|582444250|FG000|Overall Study|Death|6|||
161290438|NCT00471081|582444251|FG000|Active Phase|Protocol Violation|1|||
161290439|NCT00471081|582444252|FG001|Active Phase|Protocol Violation|1|||
161290440|NCT00471081|582444251|FG000|Active Phase|Withdrawal by Subject|0|||
161290441|NCT00471081|582444252|FG001|Active Phase|Withdrawal by Subject|3|||
161290442|NCT00471081|582444251|FG000|Active Phase|Lost to Follow-up|0|||
161290443|NCT00471081|582444252|FG001|Active Phase|Lost to Follow-up|1|||
161290444|NCT00471081|582444251|FG000|Active Phase|Lost health plan/insurance|1|||
161290445|NCT00471081|582444252|FG001|Active Phase|Lost health plan/insurance|8|||
161290446|NCT00471081|582444251|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
161290447|NCT00471081|582444252|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
161290448|NCT00471081|582444251|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
161290449|NCT00471081|582444252|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
161290450|NCT00471081|582444251|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
161290451|NCT00471081|582444252|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
161290452|NCT02393950|582444257|FG000|Overall Study|Adverse Event|1|||
161168432|NCT02786836|581995157|FG000|Overall Study|Liver Transplantation|2|||
161290453|NCT02393950|582444258|FG001|Overall Study|Adverse Event|0|||
161290454|NCT02393950|582444257|FG000|Overall Study|Withdrawal by Subject|0|||
161290455|NCT02393950|582444258|FG001|Overall Study|Withdrawal by Subject|1|||
161290456|NCT05486091|582444259|FG000|Overall Study|Withdrawal by Subject|1|||
161290457|NCT05486091|582444259|FG000|Overall Study|Lost to Follow-up|2|||
161290458|NCT00370552|582444260|FG000|Overall Study|Adverse Event|2|||
161290459|NCT00370552|582444261|FG001|Overall Study|Adverse Event|2|||
161290460|NCT00370552|582444262|FG002|Overall Study|Adverse Event|2|||
161290461|NCT00370552|582444260|FG000|Overall Study|Disease progression|23|||
161168433|NCT02786836|581995157|FG000|Overall Study|Device or Pharmacy Issues|3|||
161168434|NCT01143714|581995159|FG000|Overall Study|Adverse Event|4|||
161168435|NCT01143714|581995160|FG001|Overall Study|Adverse Event|2|||
161168436|NCT01143714|581995159|FG000|Overall Study|Withdrawal by Subject|1|||
161168437|NCT01143714|581995160|FG001|Overall Study|Withdrawal by Subject|0|||
161168438|NCT01143714|581995159|FG000|Overall Study|Subject non-compliance|0|||
161168439|NCT01143714|581995160|FG001|Overall Study|Subject non-compliance|1|||
161168440|NCT01143714|581995159|FG000|Overall Study|wound closed = deemed healed|1|||
161168441|NCT01143714|581995160|FG001|Overall Study|wound closed = deemed healed|0|||
161168442|NCT01143714|581995159|FG000|Overall Study|wound size increased|1|||
161168443|NCT01143714|581995160|FG001|Overall Study|wound size increased|0|||
161168444|NCT03783442|581995167|FG000|Overall Study|Death|252|||
161168445|NCT03783442|581995168|FG001|Overall Study|Death|268|||
161168446|NCT03783442|581995167|FG000|Overall Study|Withdrawal by Subject|19|||
161168447|NCT03783442|581995168|FG001|Overall Study|Withdrawal by Subject|21|||
161168448|NCT03783442|581995167|FG000|Overall Study|Lost to Follow-up|7|||
161168449|NCT03783442|581995168|FG001|Overall Study|Lost to Follow-up|6|||
161168450|NCT03783442|581995167|FG000|Overall Study|Sponsor Ended Study|48|||
161168451|NCT03783442|581995168|FG001|Overall Study|Sponsor Ended Study|28|||
161168452|NCT04190186|581995169|FG000|Overall Study|ILR is no longer functioning|0|||
161168453|NCT04190186|581995170|FG001|Overall Study|ILR is no longer functioning|1|||
161168454|NCT04190186|581995169|FG000|Overall Study|Lost to Follow-up|0|||
161168455|NCT04190186|581995170|FG001|Overall Study|Lost to Follow-up|1|||
161168456|NCT04190186|581995169|FG000|Overall Study|Withdrawal by Subject|2|||
161168457|NCT04190186|581995170|FG001|Overall Study|Withdrawal by Subject|0|||
161168458|NCT04190186|581995169|FG000|Overall Study|Subject choice to explant|1|||
161168459|NCT04190186|581995170|FG001|Overall Study|Subject choice to explant|0|||
161168460|NCT04190186|581995169|FG000|Overall Study|Physician Decision|0|||
161168461|NCT04190186|581995170|FG001|Overall Study|Physician Decision|1|||
161168462|NCT04190186|581995169|FG000|Overall Study|Study was stopped|4|||
161168463|NCT04190186|581995170|FG001|Overall Study|Study was stopped|5|||
161168464|NCT02016898|581995171|FG000|Overall Study|Death|1|||
161168465|NCT02016898|581995172|FG001|Overall Study|Death|1|||
161168466|NCT02016898|581995171|FG000|Overall Study|Lost to Follow-up|4|||
161168467|NCT02016898|581995172|FG001|Overall Study|Lost to Follow-up|4|||
161168468|NCT01381718|581995173|FG000|Overall Study|Withdrawal by Subject|2|||
161168469|NCT01381718|581995174|FG001|Overall Study|Withdrawal by Subject|5|||
161168470|NCT01381718|581995173|FG000|Overall Study|Lost to Follow-up|3|||
161168471|NCT01381718|581995174|FG001|Overall Study|Lost to Follow-up|5|||
161168472|NCT01381718|581995173|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
161168473|NCT01381718|581995174|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
161168474|NCT03017846|581995175|FG000|Overall Study|Lost to Follow-up|3|||
161168475|NCT03017846|581995175|FG000|Overall Study|Adverse Event|2|||
161168476|NCT00992186|581995178|FG000|Overall Study|Withdrawal by Subject|2|||
161168477|NCT00992186|581995178|FG000|Overall Study|Protocol Violation|1|||
161168478|NCT00992186|581995178|FG000|Overall Study|Physician Decision|1|||
161168479|NCT00992186|581995178|FG000|Overall Study|Adverse Event|9|||
161168480|NCT00992186|581995178|FG000|Overall Study|Progressive Disease|30|||
161168481|NCT00992186|581995178|FG000|Overall Study|Refusal To Receive Study Agent|3|||
161168482|NCT00171314|581995182|FG000|Overall Study|Adverse Event|44|||
161168483|NCT00171314|581995183|FG001|Overall Study|Adverse Event|41|||
161168484|NCT00171314|581995182|FG000|Overall Study|Lack of Efficacy|19|||
161168485|NCT00171314|581995183|FG001|Overall Study|Lack of Efficacy|14|||
161168486|NCT00171314|581995182|FG000|Overall Study|Withdrawal by Subject|9|||
161168487|NCT00171314|581995183|FG001|Overall Study|Withdrawal by Subject|6|||
161168488|NCT00171314|581995182|FG000|Overall Study|Abnormal Test Procedure Results|9|||
161168489|NCT00171314|581995183|FG001|Overall Study|Abnormal Test Procedure Results|3|||
161168490|NCT00171314|581995182|FG000|Overall Study|Protocol Violation|3|||
161168491|NCT00171314|581995183|FG001|Overall Study|Protocol Violation|7|||
161168492|NCT00171314|581995182|FG000|Overall Study|Administrative Problems|4|||
161168493|NCT00171314|581995183|FG001|Overall Study|Administrative Problems|3|||
161168494|NCT00171314|581995182|FG000|Overall Study|Lost to Follow-up|1|||
161168495|NCT00171314|581995183|FG001|Overall Study|Lost to Follow-up|3|||
161168496|NCT00171314|581995182|FG000|Overall Study|Death|2|||
161168497|NCT00171314|581995183|FG001|Overall Study|Death|1|||
161168498|NCT00318565|581995184|FG000|Overall Study|Excluded per protocol|24|||
161168499|NCT00493467|581995185|FG000|Overall Study|Death|1|||
161168500|NCT01409993|581995186|FG000|Overall Study|Adverse Event|4|||
161168501|NCT01409993|581995187|FG001|Overall Study|Adverse Event|4|||
161168502|NCT01409993|581995188|FG002|Overall Study|Adverse Event|3|||
161168503|NCT01409993|581995189|FG003|Overall Study|Adverse Event|1|||
161168504|NCT01409993|581995186|FG000|Overall Study|Withdrawal by Subject|0|||
161168505|NCT01409993|581995187|FG001|Overall Study|Withdrawal by Subject|0|||
161168506|NCT01409993|581995188|FG002|Overall Study|Withdrawal by Subject|0|||
161168507|NCT01409993|581995189|FG003|Overall Study|Withdrawal by Subject|4|||
161168508|NCT01409993|581995186|FG000|Overall Study|Lost to Follow-up|0|||
161168509|NCT01409993|581995187|FG001|Overall Study|Lost to Follow-up|1|||
161168510|NCT01409993|581995188|FG002|Overall Study|Lost to Follow-up|0|||
161168511|NCT01409993|581995189|FG003|Overall Study|Lost to Follow-up|0|||
161168512|NCT00830960|581995192|FG000|Overall Study|Death|5|||
161168513|NCT00830960|581995193|FG001|Overall Study|Death|4|||
161168514|NCT00830960|581995194|FG002|Overall Study|Death|3|||
161168515|NCT00830960|581995195|FG003|Overall Study|Death|2|||
161168516|NCT00830960|581995196|FG004|Overall Study|Death|6|||
161168517|NCT00830960|581995197|FG005|Overall Study|Death|1|||
161168518|NCT00830960|581995192|FG000|Overall Study|Lost to Follow-up|1|||
161168519|NCT00830960|581995193|FG001|Overall Study|Lost to Follow-up|1|||
161168520|NCT00830960|581995194|FG002|Overall Study|Lost to Follow-up|1|||
161168521|NCT00830960|581995195|FG003|Overall Study|Lost to Follow-up|0|||
161168522|NCT00830960|581995196|FG004|Overall Study|Lost to Follow-up|0|||
161168523|NCT00830960|581995197|FG005|Overall Study|Lost to Follow-up|1|||
161168524|NCT00830960|581995192|FG000|Overall Study|Withdrawal by Subject|19|||
161168525|NCT00830960|581995193|FG001|Overall Study|Withdrawal by Subject|19|||
161168526|NCT00830960|581995194|FG002|Overall Study|Withdrawal by Subject|18|||
161168527|NCT00830960|581995195|FG003|Overall Study|Withdrawal by Subject|23|||
161168528|NCT00830960|581995196|FG004|Overall Study|Withdrawal by Subject|16|||
161168529|NCT00830960|581995197|FG005|Overall Study|Withdrawal by Subject|21|||
161168530|NCT00830960|581995192|FG000|Overall Study|Sponsor Decision|1|||
161168531|NCT00830960|581995193|FG001|Overall Study|Sponsor Decision|2|||
161168532|NCT00830960|581995194|FG002|Overall Study|Sponsor Decision|3|||
161168533|NCT00830960|581995195|FG003|Overall Study|Sponsor Decision|4|||
161168534|NCT00830960|581995196|FG004|Overall Study|Sponsor Decision|5|||
161168535|NCT00830960|581995197|FG005|Overall Study|Sponsor Decision|7|||
161168536|NCT00830960|581995192|FG000|Overall Study|No study drug received|7|||
161168537|NCT00830960|581995193|FG001|Overall Study|No study drug received|2|||
161168538|NCT00830960|581995194|FG002|Overall Study|No study drug received|4|||
161168539|NCT00830960|581995195|FG003|Overall Study|No study drug received|3|||
161168540|NCT00830960|581995196|FG004|Overall Study|No study drug received|5|||
161168541|NCT00830960|581995197|FG005|Overall Study|No study drug received|7|||
161168542|NCT03074149|581995198|FG000|Overall Study|Reason unknown|22|||
161168543|NCT03074149|581995199|FG001|Overall Study|Reason unknown|35|||
161168544|NCT03074149|581995198|FG000|Overall Study|Death|10|||
161168545|NCT03074149|581995199|FG001|Overall Study|Death|45|||
161168546|NCT01335698|581995203|FG000|Treatment Stage 1|Lack of Efficacy|3|||
161168547|NCT01335698|581995204|FG001|Treatment Stage 1|Lack of Efficacy|1|||
161168548|NCT01335698|581995205|FG002|Treatment Stage 1|Lack of Efficacy|3|||
161168549|NCT01335698|581995206|FG003|Treatment Stage 1|Lack of Efficacy|3|||
161168550|NCT01335698|581995207|FG004|Treatment Stage 1|Lack of Efficacy|1|||
161168551|NCT01335698|581995203|FG000|Treatment Stage 1|Adverse Event|1|||
161168552|NCT01335698|581995204|FG001|Treatment Stage 1|Adverse Event|2|||
161168553|NCT01335698|581995205|FG002|Treatment Stage 1|Adverse Event|2|||
161168554|NCT01335698|581995206|FG003|Treatment Stage 1|Adverse Event|1|||
161168555|NCT01335698|581995207|FG004|Treatment Stage 1|Adverse Event|1|||
161168556|NCT01335698|581995203|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
161168557|NCT01335698|581995204|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
161168558|NCT01335698|581995205|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
161290462|NCT00370552|582444261|FG001|Overall Study|Disease progression|23|||
161290463|NCT00370552|582444262|FG002|Overall Study|Disease progression|15|||
161290464|NCT00370552|582444260|FG000|Overall Study|Maximum clinical benefit|3|||
161290465|NCT00370552|582444261|FG001|Overall Study|Maximum clinical benefit|5|||
161290466|NCT00370552|582444262|FG002|Overall Study|Maximum clinical benefit|5|||
161290467|NCT00370552|582444260|FG000|Overall Study|Poor or noncompliance|0|||
161290468|NCT00370552|582444261|FG001|Overall Study|Poor or noncompliance|0|||
161290469|NCT00370552|582444262|FG002|Overall Study|Poor or noncompliance|1|||
161290470|NCT00370552|582444260|FG000|Overall Study|Study drug toxicity|11|||
161290471|NCT00370552|582444261|FG001|Overall Study|Study drug toxicity|8|||
161290472|NCT00370552|582444262|FG002|Overall Study|Study drug toxicity|6|||
161290473|NCT00370552|582444260|FG000|Overall Study|Withdrawal by Subject|2|||
161290474|NCT00370552|582444261|FG001|Overall Study|Withdrawal by Subject|0|||
161290475|NCT00370552|582444262|FG002|Overall Study|Withdrawal by Subject|1|||
161290476|NCT00370552|582444260|FG000|Overall Study|Still on treatment|1|||
161168559|NCT01335698|581995206|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
161168560|NCT01335698|581995207|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
161168561|NCT01335698|581995203|FG000|Treatment Stage 1|Lost to Follow-up|1|||
161168562|NCT01335698|581995204|FG001|Treatment Stage 1|Lost to Follow-up|1|||
161168563|NCT01335698|581995205|FG002|Treatment Stage 1|Lost to Follow-up|0|||
161168564|NCT01335698|581995206|FG003|Treatment Stage 1|Lost to Follow-up|0|||
161168565|NCT01335698|581995207|FG004|Treatment Stage 1|Lost to Follow-up|0|||
161168566|NCT01335698|581995203|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
161168567|NCT01335698|581995204|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
161168568|NCT01335698|581995205|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
161290477|NCT00370552|582444261|FG001|Overall Study|Still on treatment|3|||
161168569|NCT01335698|581995206|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
161168570|NCT01335698|581995207|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
161168571|NCT01335698|581995203|FG000|Treatment Stage 1|No longer meets study criteria|1|||
161290478|NCT00370552|582444262|FG002|Overall Study|Still on treatment|2|||
161168572|NCT01335698|581995204|FG001|Treatment Stage 1|No longer meets study criteria|1|||
161168573|NCT01335698|581995205|FG002|Treatment Stage 1|No longer meets study criteria|0|||
161168574|NCT01335698|581995206|FG003|Treatment Stage 1|No longer meets study criteria|1|||
161168575|NCT01335698|581995207|FG004|Treatment Stage 1|No longer meets study criteria|0|||
161168576|NCT01335698|581995203|FG000|Treatment Stage 1|Other|1|||
161168577|NCT01335698|581995204|FG001|Treatment Stage 1|Other|0|||
161168578|NCT01335698|581995205|FG002|Treatment Stage 1|Other|0|||
161168579|NCT01335698|581995206|FG003|Treatment Stage 1|Other|1|||
161168580|NCT01335698|581995207|FG004|Treatment Stage 1|Other|0|||
161168581|NCT01335698|581995203|FG000|Treatment Stage 2|Lack of Efficacy|2|||
161168582|NCT01335698|581995204|FG001|Treatment Stage 2|Lack of Efficacy|1|||
161168583|NCT01335698|581995205|FG002|Treatment Stage 2|Lack of Efficacy|3|||
161168584|NCT01335698|581995206|FG003|Treatment Stage 2|Lack of Efficacy|1|||
161168585|NCT01335698|581995207|FG004|Treatment Stage 2|Lack of Efficacy|0|||
161168586|NCT01335698|581995203|FG000|Treatment Stage 2|Adverse Event|2|||
161168587|NCT01335698|581995204|FG001|Treatment Stage 2|Adverse Event|0|||
161168588|NCT01335698|581995205|FG002|Treatment Stage 2|Adverse Event|0|||
161168589|NCT01335698|581995206|FG003|Treatment Stage 2|Adverse Event|3|||
161168590|NCT01335698|581995207|FG004|Treatment Stage 2|Adverse Event|0|||
161168591|NCT01335698|581995203|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
161168592|NCT01335698|581995204|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
161168593|NCT01335698|581995205|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
161168594|NCT01335698|581995206|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
161168595|NCT01335698|581995207|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
161168596|NCT01335698|581995203|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
161168597|NCT01335698|581995204|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
161168598|NCT01335698|581995205|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
161168599|NCT01335698|581995206|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
161168600|NCT01335698|581995207|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
161168601|NCT01335698|581995203|FG000|Treatment Stage 2|Lost to Follow-up|1|||
161168602|NCT01335698|581995204|FG001|Treatment Stage 2|Lost to Follow-up|0|||
161168603|NCT01335698|581995205|FG002|Treatment Stage 2|Lost to Follow-up|0|||
161168604|NCT01335698|581995206|FG003|Treatment Stage 2|Lost to Follow-up|0|||
161168605|NCT01335698|581995207|FG004|Treatment Stage 2|Lost to Follow-up|0|||
161168606|NCT01335698|581995203|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
161168607|NCT01335698|581995204|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
161168608|NCT01335698|581995205|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
161168609|NCT01335698|581995206|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
161168610|NCT01335698|581995207|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
161168611|NCT01335698|581995203|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
161168612|NCT01335698|581995204|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
161168613|NCT01335698|581995205|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
161168614|NCT01335698|581995206|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
161168615|NCT01335698|581995207|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
161168616|NCT01335698|581995203|FG000|Treatment Stage 2|Switched to another formulation|1|||
161168617|NCT01335698|581995204|FG001|Treatment Stage 2|Switched to another formulation|1|||
161168618|NCT01335698|581995205|FG002|Treatment Stage 2|Switched to another formulation|0|||
161168619|NCT01335698|581995206|FG003|Treatment Stage 2|Switched to another formulation|0|||
161168620|NCT01335698|581995207|FG004|Treatment Stage 2|Switched to another formulation|0|||
161168621|NCT01162304|581995208|FG000|Overall Study|Beck scale to high|11|||
161168622|NCT00585923|581995209|FG000|Overall Study|Physician decided not to continue|31|||
161168623|NCT00585923|581995210|FG001|Overall Study|Physician decided not to continue|33|||
161168624|NCT02815293|581995211|FG000|Overall Study|Study termination by sponsor|10|||
161168625|NCT02815293|581995212|FG001|Overall Study|Study termination by sponsor|7|||
161168626|NCT02815293|581995213|FG002|Overall Study|Study termination by sponsor|0|||
161168627|NCT02815293|581995211|FG000|Overall Study|Participants not randomized|0|||
161168628|NCT02815293|581995212|FG001|Overall Study|Participants not randomized|0|||
161168629|NCT02815293|581995213|FG002|Overall Study|Participants not randomized|18|||
161168630|NCT02815293|581995211|FG000|Overall Study|Adverse Event|0|||
161168631|NCT02815293|581995212|FG001|Overall Study|Adverse Event|1|||
161168632|NCT02815293|581995213|FG002|Overall Study|Adverse Event|0|||
161168633|NCT01167582|581995214|FG000|Overall Study|Lost to Follow-up|0|||
161168634|NCT01167582|581995215|FG001|Overall Study|Lost to Follow-up|1|||
161168635|NCT03956225|581995216|FG000|Overall Study|Lack of Efficacy|1|||
161168636|NCT03956225|581995217|FG001|Overall Study|Lack of Efficacy|1|||
161168637|NCT03956225|581995216|FG000|Overall Study|Lost to Follow-up|0|||
161168638|NCT03956225|581995217|FG001|Overall Study|Lost to Follow-up|1|||
161168639|NCT03956225|581995216|FG000|Overall Study|Withdrawal by Subject|2|||
161168640|NCT03956225|581995217|FG001|Overall Study|Withdrawal by Subject|1|||
161290479|NCT00370552|582444260|FG000|Overall Study|Never treated|1|||
161290480|NCT00370552|582444261|FG001|Overall Study|Never treated|0|||
161168641|NCT03956225|581995216|FG000|Overall Study|Other Reasons|2|||
161168642|NCT03956225|581995217|FG001|Overall Study|Other Reasons|1|||
161290481|NCT00370552|582444262|FG002|Overall Study|Never treated|0|||
161290482|NCT00370552|582444260|FG000|Overall Study|Physician Decision|1|||
161168643|NCT00567541|581995218|FG000|Overall Study|Adverse Event|0|||
161168644|NCT00567541|581995219|FG001|Overall Study|Adverse Event|1|||
161168645|NCT02157506|581995220|FG000|Overall Study|Adverse Event|0|||
161168646|NCT02157506|581995221|FG001|Overall Study|Adverse Event|1|||
161168647|NCT02157506|581995222|FG002|Overall Study|Adverse Event|0|||
161168648|NCT02157506|581995223|FG003|Overall Study|Adverse Event|0|||
161168649|NCT02157506|581995224|FG004|Overall Study|Adverse Event|0|||
161168650|NCT02157506|581995220|FG000|Overall Study|Lost to Follow-up|0|||
161168651|NCT02157506|581995221|FG001|Overall Study|Lost to Follow-up|0|||
161168652|NCT02157506|581995222|FG002|Overall Study|Lost to Follow-up|1|||
161168653|NCT02157506|581995223|FG003|Overall Study|Lost to Follow-up|0|||
161168654|NCT02157506|581995224|FG004|Overall Study|Lost to Follow-up|0|||
161168655|NCT01763866|581995225|FG000|Overall Study|Withdrawal by Subject|2|||
161168656|NCT01763866|581995226|FG001|Overall Study|Withdrawal by Subject|1|||
161168657|NCT01763866|581995227|FG002|Overall Study|Withdrawal by Subject|4|||
161168658|NCT01763866|581995228|FG003|Overall Study|Withdrawal by Subject|0|||
161168659|NCT01763866|581995229|FG004|Overall Study|Withdrawal by Subject|0|||
161168660|NCT01763866|581995230|FG005|Overall Study|Withdrawal by Subject|3|||
161168661|NCT01763866|581995231|FG006|Overall Study|Withdrawal by Subject|4|||
161168662|NCT01763866|581995232|FG007|Overall Study|Withdrawal by Subject|0|||
161168663|NCT01763866|581995233|FG008|Overall Study|Withdrawal by Subject|1|||
161168664|NCT01763866|581995234|FG009|Overall Study|Withdrawal by Subject|1|||
161168665|NCT01763866|581995235|FG010|Overall Study|Withdrawal by Subject|2|||
161168666|NCT01763866|581995236|FG011|Overall Study|Withdrawal by Subject|2|||
161168667|NCT01763866|581995237|FG012|Overall Study|Withdrawal by Subject|2|||
161168668|NCT01763866|581995238|FG013|Overall Study|Withdrawal by Subject|0|||
161168669|NCT01763866|581995239|FG014|Overall Study|Withdrawal by Subject|6|||
161168670|NCT01763866|581995240|FG015|Overall Study|Withdrawal by Subject|3|||
161168671|NCT01763866|581995241|FG016|Overall Study|Withdrawal by Subject|0|||
161168672|NCT01763866|581995242|FG017|Overall Study|Withdrawal by Subject|1|||
161168673|NCT01763866|581995243|FG018|Overall Study|Withdrawal by Subject|1|||
161168674|NCT01763866|581995244|FG019|Overall Study|Withdrawal by Subject|1|||
161168675|NCT01763866|581995245|FG020|Overall Study|Withdrawal by Subject|2|||
161168676|NCT01763866|581995246|FG021|Overall Study|Withdrawal by Subject|1|||
161168677|NCT01763866|581995247|FG022|Overall Study|Withdrawal by Subject|2|||
161168678|NCT01763866|581995248|FG023|Overall Study|Withdrawal by Subject|1|||
161168679|NCT01763866|581995225|FG000|Overall Study|Decision by sponsor|0|||
161168680|NCT01763866|581995226|FG001|Overall Study|Decision by sponsor|0|||
161168681|NCT01763866|581995227|FG002|Overall Study|Decision by sponsor|1|||
161168682|NCT01763866|581995228|FG003|Overall Study|Decision by sponsor|0|||
161168683|NCT01763866|581995229|FG004|Overall Study|Decision by sponsor|2|||
161168684|NCT01763866|581995230|FG005|Overall Study|Decision by sponsor|0|||
161168685|NCT01763866|581995231|FG006|Overall Study|Decision by sponsor|2|||
161168686|NCT01763866|581995232|FG007|Overall Study|Decision by sponsor|0|||
161168687|NCT01763866|581995233|FG008|Overall Study|Decision by sponsor|2|||
161168688|NCT01763866|581995234|FG009|Overall Study|Decision by sponsor|0|||
161168689|NCT01763866|581995235|FG010|Overall Study|Decision by sponsor|6|||
161168690|NCT01763866|581995236|FG011|Overall Study|Decision by sponsor|0|||
161168691|NCT01763866|581995237|FG012|Overall Study|Decision by sponsor|1|||
161168692|NCT01763866|581995238|FG013|Overall Study|Decision by sponsor|0|||
161168693|NCT01763866|581995239|FG014|Overall Study|Decision by sponsor|5|||
161168694|NCT01763866|581995240|FG015|Overall Study|Decision by sponsor|0|||
161168695|NCT01763866|581995241|FG016|Overall Study|Decision by sponsor|0|||
161168696|NCT01763866|581995242|FG017|Overall Study|Decision by sponsor|0|||
161168697|NCT01763866|581995243|FG018|Overall Study|Decision by sponsor|4|||
161168698|NCT01763866|581995244|FG019|Overall Study|Decision by sponsor|0|||
161168699|NCT01763866|581995245|FG020|Overall Study|Decision by sponsor|2|||
161168700|NCT01763866|581995246|FG021|Overall Study|Decision by sponsor|0|||
161168701|NCT01763866|581995247|FG022|Overall Study|Decision by sponsor|1|||
161168702|NCT01763866|581995248|FG023|Overall Study|Decision by sponsor|0|||
161168703|NCT01763866|581995225|FG000|Overall Study|Lost to Follow-up|0|||
161168704|NCT01763866|581995226|FG001|Overall Study|Lost to Follow-up|0|||
161168705|NCT01763866|581995227|FG002|Overall Study|Lost to Follow-up|0|||
161168706|NCT01763866|581995228|FG003|Overall Study|Lost to Follow-up|0|||
161168707|NCT01763866|581995229|FG004|Overall Study|Lost to Follow-up|0|||
161168708|NCT01763866|581995230|FG005|Overall Study|Lost to Follow-up|0|||
161168709|NCT01763866|581995231|FG006|Overall Study|Lost to Follow-up|1|||
161168710|NCT01763866|581995232|FG007|Overall Study|Lost to Follow-up|0|||
161168711|NCT01763866|581995233|FG008|Overall Study|Lost to Follow-up|0|||
161168712|NCT01763866|581995234|FG009|Overall Study|Lost to Follow-up|0|||
161168713|NCT01763866|581995235|FG010|Overall Study|Lost to Follow-up|0|||
161168714|NCT01763866|581995236|FG011|Overall Study|Lost to Follow-up|0|||
161290483|NCT00370552|582444261|FG001|Overall Study|Physician Decision|1|||
161168715|NCT01763866|581995237|FG012|Overall Study|Lost to Follow-up|1|||
161168716|NCT01763866|581995238|FG013|Overall Study|Lost to Follow-up|0|||
161168717|NCT01763866|581995239|FG014|Overall Study|Lost to Follow-up|1|||
161168718|NCT01763866|581995240|FG015|Overall Study|Lost to Follow-up|0|||
161168719|NCT01763866|581995241|FG016|Overall Study|Lost to Follow-up|0|||
161168720|NCT01763866|581995242|FG017|Overall Study|Lost to Follow-up|0|||
161347045|NCT02335944|582654753|FG000|Treatment Phase|Subject/Guardian Decision|0|||
161347046|NCT02335944|582654754|FG001|Treatment Phase|Subject/Guardian Decision|0|||
161347047|NCT02335944|582654755|FG002|Treatment Phase|Subject/Guardian Decision|1|||
161168721|NCT01763866|581995243|FG018|Overall Study|Lost to Follow-up|1|||
161168722|NCT01763866|581995244|FG019|Overall Study|Lost to Follow-up|1|||
161168723|NCT01763866|581995245|FG020|Overall Study|Lost to Follow-up|0|||
161168724|NCT01763866|581995246|FG021|Overall Study|Lost to Follow-up|0|||
161168725|NCT01763866|581995247|FG022|Overall Study|Lost to Follow-up|0|||
161168726|NCT01763866|581995248|FG023|Overall Study|Lost to Follow-up|1|||
161168727|NCT01763866|581995225|FG000|Overall Study|Death|0|||
161168728|NCT01763866|581995226|FG001|Overall Study|Death|0|||
161168729|NCT01763866|581995227|FG002|Overall Study|Death|0|||
161168730|NCT01763866|581995228|FG003|Overall Study|Death|0|||
161168731|NCT01763866|581995229|FG004|Overall Study|Death|0|||
161168732|NCT01763866|581995230|FG005|Overall Study|Death|0|||
161168733|NCT01763866|581995231|FG006|Overall Study|Death|0|||
161168734|NCT01763866|581995232|FG007|Overall Study|Death|0|||
161168735|NCT01763866|581995233|FG008|Overall Study|Death|0|||
161168736|NCT01763866|581995234|FG009|Overall Study|Death|0|||
161168737|NCT01763866|581995235|FG010|Overall Study|Death|0|||
161168738|NCT01763866|581995236|FG011|Overall Study|Death|0|||
161168739|NCT01763866|581995237|FG012|Overall Study|Death|0|||
161168740|NCT01763866|581995238|FG013|Overall Study|Death|0|||
161168741|NCT01763866|581995239|FG014|Overall Study|Death|0|||
161168742|NCT01763866|581995240|FG015|Overall Study|Death|0|||
161168743|NCT01763866|581995241|FG016|Overall Study|Death|1|||
161168744|NCT01763866|581995242|FG017|Overall Study|Death|0|||
161168745|NCT01763866|581995243|FG018|Overall Study|Death|0|||
161168746|NCT01763866|581995244|FG019|Overall Study|Death|0|||
161168747|NCT01763866|581995245|FG020|Overall Study|Death|0|||
161168748|NCT01763866|581995246|FG021|Overall Study|Death|0|||
161168749|NCT01763866|581995247|FG022|Overall Study|Death|0|||
161168750|NCT01763866|581995248|FG023|Overall Study|Death|0|||
161168751|NCT00010803|581997142|FG000|Overall Study|Withdrawal by Subject|97|||
161168752|NCT00010803|581997143|FG001|Overall Study|Withdrawal by Subject|98|||
161168753|NCT03485222|581997144|FG000|Overall Study|Death|0|||
161168754|NCT03485222|581997145|FG001|Overall Study|Death|1|||
161168755|NCT03485222|581997144|FG000|Overall Study|Lost to Follow-up|2|||
161168756|NCT03485222|581997145|FG001|Overall Study|Lost to Follow-up|1|||
161168757|NCT01373918|581997148|FG000|Overall Study|Physician Decision|0|||
161168758|NCT01373918|581997149|FG001|Overall Study|Physician Decision|1|||
161168759|NCT01457924|581997154|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
161168760|NCT01457924|581997155|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
161168761|NCT01457924|581997156|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
161168762|NCT01457924|581997157|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
161168763|NCT01457924|581997158|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
161168764|NCT01457924|581997154|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161168765|NCT01457924|581997155|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161168766|NCT01457924|581997156|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161168767|NCT01457924|581997157|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
161168768|NCT01457924|581997158|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
161168769|NCT01457924|581997154|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
161168770|NCT01457924|581997155|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161168771|NCT01457924|581997156|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161168772|NCT01457924|581997157|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161168773|NCT01457924|581997158|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
161168774|NCT01457924|581997154|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
161168775|NCT01457924|581997155|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161168776|NCT01457924|581997156|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
161168777|NCT01457924|581997157|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161168778|NCT01457924|581997158|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
161168779|NCT01457924|581997154|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161168780|NCT01457924|581997155|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161168781|NCT01457924|581997156|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
161168782|NCT01457924|581997157|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
161168783|NCT01457924|581997158|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
161168784|NCT01457924|581997154|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
161168785|NCT01457924|581997155|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
161168786|NCT01457924|581997156|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
161168787|NCT01457924|581997157|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
161168788|NCT01457924|581997158|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
161168789|NCT01457924|581997154|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
161168790|NCT01457924|581997155|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
161168791|NCT01457924|581997156|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
161168792|NCT01457924|581997157|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
161168793|NCT01457924|581997158|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
161290484|NCT00370552|582444262|FG002|Overall Study|Physician Decision|0|||
161290485|NCT00370552|582444260|FG000|Overall Study|Investigator decision|2|||
161290486|NCT00370552|582444261|FG001|Overall Study|Investigator decision|1|||
161290487|NCT00370552|582444262|FG002|Overall Study|Investigator decision|0|||
161290488|NCT00370552|582444260|FG000|Overall Study|High risk of allergic reaction|0|||
161290489|NCT00370552|582444261|FG001|Overall Study|High risk of allergic reaction|1|||
161290490|NCT00370552|582444262|FG002|Overall Study|High risk of allergic reaction|0|||
161290491|NCT00370552|582444260|FG000|Overall Study|Planned radiation for palliation|0|||
161290492|NCT00370552|582444261|FG001|Overall Study|Planned radiation for palliation|1|||
161347048|NCT02335944|582654756|FG003|Treatment Phase|Subject/Guardian Decision|0|||
161084104|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161084105|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161084106|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
161084107|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161084108|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
161084109|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161084110|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161084111|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
161084112|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161084113|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
161084114|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161084115|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161084116|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
161084117|NCT00700427|581697466|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161084118|NCT00700427|581697467|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
161084119|NCT00700427|581697468|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161084120|NCT00700427|581697469|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161084121|NCT00700427|581697470|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
161084122|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
161084123|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
161084124|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
161084125|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
161084126|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
161084127|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
161084128|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
161084129|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
161084130|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
161084131|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
161084132|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
161084133|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
161084134|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
161084135|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
161084136|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
161084137|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
161084138|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
161084139|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
161084140|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
161084141|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
161084142|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
161084143|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
161084144|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
161084145|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
161084146|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
161084147|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161084148|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161084149|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161084150|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
161084151|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
161084152|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161084153|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161084154|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161084155|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
161084156|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
161084157|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
161091284|NCT01272804|581723871|FG003|Overall Study|Adverse Event|0|||
161168794|NCT01457924|581997154|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
161168795|NCT01457924|581997155|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
161168796|NCT01457924|581997156|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
161168797|NCT01457924|581997157|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
161168798|NCT01457924|581997158|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
161168799|NCT01457924|581997154|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161168800|NCT01457924|581997155|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161168801|NCT01457924|581997156|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161168802|NCT01457924|581997157|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
161168803|NCT01457924|581997158|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
161168804|NCT01457924|581997154|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
161168805|NCT01457924|581997155|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
161168806|NCT01457924|581997156|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
161168807|NCT01457924|581997157|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
161168808|NCT01457924|581997158|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
161168809|NCT01457924|581997154|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
161168810|NCT01457924|581997155|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161168811|NCT01457924|581997156|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
161168812|NCT01457924|581997157|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161168813|NCT01457924|581997158|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
161168814|NCT01457924|581997154|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
161168815|NCT01457924|581997155|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
161168816|NCT01457924|581997156|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
161168817|NCT01457924|581997157|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
161168818|NCT01457924|581997158|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
161168819|NCT01457924|581997154|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161168820|NCT01457924|581997155|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
161168821|NCT01457924|581997156|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161168822|NCT01457924|581997157|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
161168823|NCT01457924|581997158|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
161168824|NCT02505542|581997161|FG000|Part A: Open-Label Period|Adverse Event|31|||
161168825|NCT02505542|581997162|FG001|Part A: Open-Label Period|Adverse Event|0|||
161168826|NCT02505542|581997163|FG002|Part A: Open-Label Period|Adverse Event|0|||
161168827|NCT02505542|581997164|FG003|Part A: Open-Label Period|Adverse Event|0|||
161168828|NCT02505542|581997161|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
161168829|NCT02505542|581997162|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
161168830|NCT02505542|581997163|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
161168831|NCT02505542|581997164|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
161168832|NCT02505542|581997161|FG000|Part A: Open-Label Period|Protocol Violation|1|||
161168833|NCT02505542|581997162|FG001|Part A: Open-Label Period|Protocol Violation|0|||
161168834|NCT02505542|581997163|FG002|Part A: Open-Label Period|Protocol Violation|0|||
161168835|NCT02505542|581997164|FG003|Part A: Open-Label Period|Protocol Violation|0|||
161168836|NCT02505542|581997161|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
161168837|NCT02505542|581997162|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
161168838|NCT02505542|581997163|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
161168839|NCT02505542|581997164|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
161168840|NCT02505542|581997161|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
161168841|NCT02505542|581997162|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
161168842|NCT02505542|581997163|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
161168843|NCT02505542|581997164|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
161168844|NCT02505542|581997161|FG000|Part A: Open-Label Period|New medical history available|1|||
161168845|NCT02505542|581997162|FG001|Part A: Open-Label Period|New medical history available|0|||
161168846|NCT02505542|581997163|FG002|Part A: Open-Label Period|New medical history available|0|||
161168847|NCT02505542|581997164|FG003|Part A: Open-Label Period|New medical history available|0|||
161168848|NCT02505542|581997161|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
161168849|NCT02505542|581997162|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161168850|NCT02505542|581997163|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161168851|NCT02505542|581997164|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
161168852|NCT02505542|581997161|FG000|Part A: Open-Label Period|Pregnancy|2|||
161168853|NCT02505542|581997162|FG001|Part A: Open-Label Period|Pregnancy|0|||
161168854|NCT02505542|581997163|FG002|Part A: Open-Label Period|Pregnancy|0|||
161168855|NCT02505542|581997164|FG003|Part A: Open-Label Period|Pregnancy|0|||
161168856|NCT02505542|581997161|FG000|Part A: Open-Label Period|Sponsor directive|1|||
161168857|NCT02505542|581997162|FG001|Part A: Open-Label Period|Sponsor directive|0|||
161168858|NCT02505542|581997163|FG002|Part A: Open-Label Period|Sponsor directive|0|||
161168859|NCT02505542|581997164|FG003|Part A: Open-Label Period|Sponsor directive|0|||
161168860|NCT02505542|581997161|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
161168861|NCT02505542|581997162|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
161290493|NCT00370552|582444262|FG002|Overall Study|Planned radiation for palliation|0|||
161168862|NCT02505542|581997163|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
161168863|NCT02505542|581997164|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
161168864|NCT02505542|581997161|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
161168865|NCT02505542|581997162|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161168866|NCT02505542|581997163|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161168867|NCT02505542|581997164|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
161168868|NCT02505542|581997161|FG000|Part A: Open-Label Period|Non-compliance|1|||
161168869|NCT02505542|581997162|FG001|Part A: Open-Label Period|Non-compliance|0|||
161168870|NCT02505542|581997163|FG002|Part A: Open-Label Period|Non-compliance|0|||
161168871|NCT02505542|581997164|FG003|Part A: Open-Label Period|Non-compliance|0|||
161168872|NCT02505542|581997161|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
161168873|NCT02505542|581997162|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161168874|NCT02505542|581997163|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161168875|NCT02505542|581997164|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
161168876|NCT02505542|581997161|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
161168877|NCT02505542|581997162|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161168878|NCT02505542|581997163|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161168879|NCT02505542|581997164|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
161168880|NCT02505542|581997161|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
161168881|NCT02505542|581997162|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161168882|NCT02505542|581997163|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161168883|NCT02505542|581997164|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
161168884|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Adverse Event|0|||
161168885|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Adverse Event|0|||
161168886|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Adverse Event|1|||
161168887|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Adverse Event|3|||
161168888|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
161168889|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
161168890|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
161168891|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
161168892|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
161168893|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
161168894|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
161168895|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
161168896|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
161168897|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
161168898|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
161168899|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
161168900|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
161168901|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
161168902|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
161168903|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
161168904|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
161168905|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
161168906|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
161168907|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
161168908|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
161168909|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
161168910|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
161168911|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
161168912|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Miscalculation|0|||
161168913|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Miscalculation|1|||
161168914|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Miscalculation|0|||
161168915|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Miscalculation|0|||
161168916|NCT02505542|581997161|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161168917|NCT02505542|581997162|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
161168918|NCT02505542|581997163|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161168919|NCT02505542|581997164|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
161168920|NCT01438307|581997167|FG000|Overall Study|Death|1|||
161168921|NCT01438307|581997168|FG001|Overall Study|Death|1|||
161168922|NCT02378883|581997169|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
161168923|NCT02378883|581997169|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
161168924|NCT02378883|581997169|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
161168925|NCT02378883|581997169|FG000|30 Day Follow-Up|Physician Decision|2|||
161168926|NCT02378883|581997169|FG000|30 Day Follow-Up|Missed Visit|2|||
161168927|NCT02378883|581997169|FG000|30 Day Follow-Up|Death|1|||
161168928|NCT02378883|581997169|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
161168929|NCT02378883|581997169|FG000|12 Months Follow-Up|Death|2|||
161290494|NCT02392481|582444263|FG000|Overall Study|Adverse Event|0|||
161168930|NCT01588353|581997170|FG000|Step2|Withdrawal by Subject|0|||
161168931|NCT01588353|581997171|FG001|Step2|Withdrawal by Subject|1|||
161168932|NCT01588353|581997172|FG002|Step2|Withdrawal by Subject|0|||
161168933|NCT01588353|581997170|FG000|Step3|Adverse Event|0|||
161168934|NCT01588353|581997171|FG001|Step3|Adverse Event|0|||
161168935|NCT01588353|581997172|FG002|Step3|Adverse Event|2|||
161168936|NCT02855450|581997175|FG000|Overall Study|Adverse Event|1|||
161168937|NCT02855450|581997176|FG001|Overall Study|Adverse Event|0|||
161168938|NCT02855450|581997175|FG000|Overall Study|Lost to Follow-up|4|||
161168939|NCT02855450|581997176|FG001|Overall Study|Lost to Follow-up|0|||
161168940|NCT01504971|581997178|FG000|Overall Study|Physician Decision|13|||
161168941|NCT00936117|581997181|FG000|Overall Study|Adverse Event|7|||
161168942|NCT00936117|581997181|FG000|Overall Study|Unable to continue oral medication|3|||
161168943|NCT04581863|581997182|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
161168944|NCT04581863|581997183|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
161168945|NCT01803711|581997192|FG000|Overall Study|Adverse Event|1|||
161168946|NCT01803711|581997193|FG001|Overall Study|Adverse Event|1|||
161168947|NCT00225212|581997194|FG000|Overall Study|Disease progression|2|||
161168948|NCT00225212|581997194|FG000|Overall Study|Death|1|||
161168949|NCT00225212|581997194|FG000|Overall Study|Adverse Event|2|||
161168950|NCT00225212|581997194|FG000|Overall Study|Intercurrent illness|1|||
161168951|NCT05159362|581997197|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
161168952|NCT05159362|581997198|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
161168953|NCT05159362|581997199|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
161168954|NCT01376245|581997200|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
161168955|NCT01376245|581997201|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161168956|NCT01376245|581997202|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161168957|NCT01376245|581997203|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161168958|NCT01376245|581997204|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
161168959|NCT01376245|581997200|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
161168960|NCT01376245|581997201|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161168961|NCT01376245|581997202|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161168962|NCT01376245|581997203|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161168963|NCT01376245|581997204|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
161168964|NCT01376245|581997200|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
161168965|NCT01376245|581997201|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161168966|NCT01376245|581997202|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161168967|NCT01376245|581997203|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161168968|NCT01376245|581997204|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
161168969|NCT01376245|581997200|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
161168970|NCT01376245|581997201|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161168971|NCT01376245|581997202|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161168972|NCT01376245|581997203|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161168973|NCT01376245|581997204|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
161168974|NCT01376245|581997200|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
161168975|NCT01376245|581997201|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161168976|NCT01376245|581997202|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161168977|NCT01376245|581997203|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161168978|NCT01376245|581997204|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
161168979|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
161168980|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
161168981|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
161168982|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
161168983|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
161168984|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
161168985|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
161168986|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
161168987|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
161168988|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
161168989|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161290495|NCT02392481|582444264|FG001|Overall Study|Adverse Event|0|||
161168990|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161168991|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
161168992|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
161168993|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
161168994|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161290496|NCT02392481|582444265|FG002|Overall Study|Adverse Event|1|||
161290497|NCT02392481|582444266|FG003|Overall Study|Adverse Event|2|||
161168995|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
161168996|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
161168997|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
161168998|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
161168999|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161169000|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
161169001|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
161169002|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161169003|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
161169004|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
161169005|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
161169006|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
161169007|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
161169008|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
161169009|NCT01376245|581997200|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
161169010|NCT01376245|581997201|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
161169011|NCT01376245|581997202|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
161169012|NCT01376245|581997203|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
161169013|NCT01376245|581997204|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
161169014|NCT01357889|581997205|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
161169015|NCT01357889|581997206|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
161169016|NCT01357889|581997205|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
161169017|NCT01357889|581997206|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
161169018|NCT01357889|581997205|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
161169019|NCT01357889|581997206|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
161169020|NCT01357889|581997205|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
161169021|NCT01357889|581997206|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
161169022|NCT01357889|581997205|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
161169023|NCT01357889|581997206|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
161169024|NCT01357889|581997205|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
161169025|NCT01357889|581997206|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
161169026|NCT01357889|581997205|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
161169027|NCT01357889|581997206|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
161169028|NCT01357889|581997205|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
161169029|NCT01357889|581997206|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
161169030|NCT01357889|581997205|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
161169031|NCT01357889|581997206|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
161169032|NCT01357889|581997205|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
161169033|NCT01357889|581997206|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
161169034|NCT01357889|581997205|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
161169035|NCT01357889|581997206|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
161169036|NCT01357889|581997205|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
161169037|NCT01357889|581997206|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
161169038|NCT01357889|581997205|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
161169039|NCT01357889|581997206|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
161169040|NCT01170221|581997207|FG000|Overall Study|Lost to Follow-up|22|||
161169041|NCT01170221|581997208|FG001|Overall Study|Lost to Follow-up|21|||
161169042|NCT01170221|581997207|FG000|Overall Study|Withdrawal by Subject|9|||
161169043|NCT01170221|581997208|FG001|Overall Study|Withdrawal by Subject|7|||
161169044|NCT01170221|581997207|FG000|Overall Study|Subject completed only screening and LFU|1|||
161169045|NCT01170221|581997208|FG001|Overall Study|Subject completed only screening and LFU|0|||
161169046|NCT01170221|581997207|FG000|Overall Study|Randomized but not treated|1|||
161169047|NCT01170221|581997208|FG001|Overall Study|Randomized but not treated|0|||
161169048|NCT02693691|581997209|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
161169049|NCT02693691|581997209|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
161169050|NCT02693691|581997209|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
161169051|NCT02693691|581997209|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
161169052|NCT02693691|581997209|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
161169053|NCT02693691|581997209|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
161169054|NCT02693691|581997209|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
161169055|NCT00416312|581997210|FG000|Overall Study|tumors not visible on imaging|2|||
161169056|NCT00050960|581997211|FG000|Overall Study|Progressive Disease|137|||
161169057|NCT00050960|581997212|FG001|Overall Study|Progressive Disease|93|||
161169058|NCT00050960|581997211|FG000|Overall Study|Stable Disease|19|||
161169059|NCT00050960|581997212|FG001|Overall Study|Stable Disease|48|||
161169060|NCT00050960|581997211|FG000|Overall Study|Partial Response|14|||
161169061|NCT00050960|581997212|FG001|Overall Study|Partial Response|19|||
161169062|NCT00050960|581997211|FG000|Overall Study|Complete Response|0|||
161169063|NCT00050960|581997212|FG001|Overall Study|Complete Response|2|||
161169064|NCT00050960|581997211|FG000|Overall Study|Adverse Event|62|||
161169065|NCT00050960|581997212|FG001|Overall Study|Adverse Event|61|||
161169066|NCT00050960|581997211|FG000|Overall Study|Lost to Follow-up|0|||
161169067|NCT00050960|581997212|FG001|Overall Study|Lost to Follow-up|1|||
161169068|NCT00050960|581997211|FG000|Overall Study|Withdrawal by Subject|23|||
161169069|NCT00050960|581997212|FG001|Overall Study|Withdrawal by Subject|18|||
161169070|NCT00050960|581997211|FG000|Overall Study|Administrative|31|||
161169071|NCT00050960|581997212|FG001|Overall Study|Administrative|46|||
161169072|NCT00050960|581997211|FG000|Overall Study|Non-compliance|3|||
161169073|NCT00050960|581997212|FG001|Overall Study|Non-compliance|1|||
161169074|NCT00050960|581997211|FG000|Overall Study|Death|13|||
161169075|NCT00050960|581997212|FG001|Overall Study|Death|15|||
161169076|NCT02727660|581997213|FG000|Overall Study|Lack of Efficacy|40|||
161169077|NCT02727660|581997214|FG001|Overall Study|Lack of Efficacy|40|||
161169078|NCT02727660|581997215|FG002|Overall Study|Lack of Efficacy|70|||
161169079|NCT02727660|581997213|FG000|Overall Study|Adverse Event|28|||
161169080|NCT02727660|581997214|FG001|Overall Study|Adverse Event|21|||
161169081|NCT02727660|581997215|FG002|Overall Study|Adverse Event|32|||
161169082|NCT02727660|581997213|FG000|Overall Study|Withdrawal by Subject|26|||
161169083|NCT02727660|581997214|FG001|Overall Study|Withdrawal by Subject|25|||
161169084|NCT02727660|581997215|FG002|Overall Study|Withdrawal by Subject|30|||
161169085|NCT02727660|581997213|FG000|Overall Study|Physician Decision|3|||
161169086|NCT02727660|581997214|FG001|Overall Study|Physician Decision|8|||
161169087|NCT02727660|581997215|FG002|Overall Study|Physician Decision|14|||
161169088|NCT02727660|581997213|FG000|Overall Study|Lost to Follow-up|5|||
161290498|NCT02392481|582444263|FG000|Overall Study|Withdrawal by Subject|0|||
161290499|NCT02392481|582444264|FG001|Overall Study|Withdrawal by Subject|0|||
161290500|NCT02392481|582444265|FG002|Overall Study|Withdrawal by Subject|1|||
161290501|NCT02392481|582444266|FG003|Overall Study|Withdrawal by Subject|0|||
161290502|NCT04067050|582444274|FG000|One Month|Lost to Follow-up|4|||
161290503|NCT04067050|582444275|FG001|One Month|Lost to Follow-up|0|||
161290504|NCT04067050|582444274|FG000|Two Month|Lost to Follow-up|1|||
161290505|NCT04067050|582444275|FG001|Two Month|Lost to Follow-up|0|||
161290506|NCT04067050|582444274|FG000|Two Month|Adverse Event|1|||
161290507|NCT04067050|582444275|FG001|Two Month|Adverse Event|0|||
161290508|NCT00923013|582444285|FG000|Overall Study|Refused further treatment|0|||
161290509|NCT00923013|582444286|FG001|Overall Study|Refused further treatment|1|||
161290510|NCT00923013|582444287|FG002|Overall Study|Refused further treatment|2|||
161290511|NCT00923013|582444288|FG003|Overall Study|Refused further treatment|0|||
161290512|NCT00923013|582444289|FG004|Overall Study|Refused further treatment|0|||
161290513|NCT00923013|582444290|FG005|Overall Study|Refused further treatment|0|||
161290514|NCT00923013|582444285|FG000|Overall Study|Switched to alternative treatment|0|||
161290515|NCT00923013|582444286|FG001|Overall Study|Switched to alternative treatment|1|||
161290516|NCT00923013|582444287|FG002|Overall Study|Switched to alternative treatment|0|||
161290517|NCT00923013|582444288|FG003|Overall Study|Switched to alternative treatment|0|||
161290518|NCT00923013|582444289|FG004|Overall Study|Switched to alternative treatment|0|||
161290519|NCT00923013|582444290|FG005|Overall Study|Switched to alternative treatment|0|||
161290520|NCT00923013|582444285|FG000|Overall Study|Death on study|2|||
161290521|NCT00923013|582444286|FG001|Overall Study|Death on study|2|||
161290522|NCT00923013|582444287|FG002|Overall Study|Death on study|0|||
161290523|NCT00923013|582444288|FG003|Overall Study|Death on study|1|||
161290524|NCT00923013|582444289|FG004|Overall Study|Death on study|0|||
161290525|NCT00923013|582444290|FG005|Overall Study|Death on study|0|||
161290526|NCT01408043|582444293|FG000|Overall Study|unable to collect cells|1|||
161290527|NCT01168427|582444294|FG000|Overall Study|Patient exited prior to implant|1|||
161290528|NCT00640315|582444295|FG000|Overall Study|Withdrawal by Subject|0|||
161290529|NCT00640315|582444296|FG001|Overall Study|Withdrawal by Subject|1|||
161290530|NCT01256879|582444297|FG000|Overall Study|Withdrawal by Subject|1|||
161290531|NCT02964247|582444298|FG000|Overall Study|Lost to Follow-up|2|||
161290532|NCT02964247|582444299|FG001|Overall Study|Lost to Follow-up|0|||
161169089|NCT02727660|581997214|FG001|Overall Study|Lost to Follow-up|9|||
161169090|NCT02727660|581997215|FG002|Overall Study|Lost to Follow-up|8|||
161169091|NCT02727660|581997213|FG000|Overall Study|Protocol Violation|7|||
161169092|NCT02727660|581997214|FG001|Overall Study|Protocol Violation|5|||
161169093|NCT02727660|581997215|FG002|Overall Study|Protocol Violation|5|||
161169094|NCT02727660|581997213|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
161169095|NCT02727660|581997214|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
161169096|NCT02727660|581997215|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
161290533|NCT02964247|582444298|FG000|Overall Study|Withdrawal by Subject|1|||
161290534|NCT02964247|582444299|FG001|Overall Study|Withdrawal by Subject|2|||
161290535|NCT00725920|582444300|FG000|Overall Study|Lack of Efficacy|3|||
161290536|NCT00725920|582444301|FG001|Overall Study|Lack of Efficacy|6|||
161169097|NCT02727660|581997213|FG000|Overall Study|Administrative Reasons|2|||
161169098|NCT02727660|581997214|FG001|Overall Study|Administrative Reasons|3|||
161169099|NCT02727660|581997215|FG002|Overall Study|Administrative Reasons|4|||
161169100|NCT00764946|581997220|FG000|Overall Study|Lack of Efficacy|1|||
161169101|NCT00764946|581997221|FG001|Overall Study|Lack of Efficacy|0|||
161169102|NCT00764946|581997222|FG002|Overall Study|Lack of Efficacy|0|||
161169103|NCT00764946|581997220|FG000|Overall Study|Lost to Follow-up|3|||
161169104|NCT00764946|581997221|FG001|Overall Study|Lost to Follow-up|4|||
161169105|NCT00764946|581997222|FG002|Overall Study|Lost to Follow-up|0|||
161169106|NCT00764946|581997220|FG000|Overall Study|Physician Decision|2|||
161169107|NCT00764946|581997221|FG001|Overall Study|Physician Decision|4|||
161169108|NCT00764946|581997222|FG002|Overall Study|Physician Decision|0|||
161169109|NCT00764946|581997220|FG000|Overall Study|Adverse Event|3|||
161169110|NCT00764946|581997221|FG001|Overall Study|Adverse Event|2|||
161169111|NCT00764946|581997222|FG002|Overall Study|Adverse Event|1|||
161169112|NCT00764946|581997220|FG000|Overall Study|Withdrawal by Subject|3|||
161169113|NCT00764946|581997221|FG001|Overall Study|Withdrawal by Subject|6|||
161169114|NCT00764946|581997222|FG002|Overall Study|Withdrawal by Subject|2|||
161169115|NCT00764946|581997220|FG000|Overall Study|Never Treated|1|||
161169116|NCT00764946|581997221|FG001|Overall Study|Never Treated|1|||
161169117|NCT00764946|581997222|FG002|Overall Study|Never Treated|1|||
161169118|NCT01315847|581997223|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
161169119|NCT01315847|581997224|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
161169120|NCT01315847|581997223|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
161169121|NCT01315847|581997224|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
161169122|NCT02940626|581997225|FG000|Overall Study|Death|40|||
161169123|NCT02940626|581997226|FG001|Overall Study|Death|32|||
161169124|NCT02940626|581997225|FG000|Overall Study|Lost to Follow-up|5|||
161169125|NCT02940626|581997226|FG001|Overall Study|Lost to Follow-up|2|||
161169126|NCT02940626|581997225|FG000|Overall Study|Withdrawal by Subject|1|||
161169127|NCT02940626|581997226|FG001|Overall Study|Withdrawal by Subject|0|||
161169128|NCT02940626|581997225|FG000|Overall Study|Transfer to Hospice Care|1|||
161169129|NCT02940626|581997226|FG001|Overall Study|Transfer to Hospice Care|0|||
161169130|NCT02940626|581997225|FG000|Overall Study|Prohibited Concomitant Medication|0|||
161169131|NCT02940626|581997226|FG001|Overall Study|Prohibited Concomitant Medication|1|||
161169132|NCT01324622|581997228|FG000|Overall Study|Lost to Follow-up|7|||
161169133|NCT01324622|581997229|FG001|Overall Study|Lost to Follow-up|7|||
161169134|NCT01324622|581997228|FG000|Overall Study|Death|1|||
161169135|NCT01324622|581997229|FG001|Overall Study|Death|0|||
161169136|NCT01324622|581997228|FG000|Overall Study|Lack of Efficacy|1|||
161169137|NCT01324622|581997229|FG001|Overall Study|Lack of Efficacy|0|||
161169138|NCT00878215|581997230|FG000|Overall Study|Determined to be ineligible|0|||
161169139|NCT00878215|581997231|FG001|Overall Study|Determined to be ineligible|10|||
161169140|NCT00878215|581997232|FG002|Overall Study|Determined to be ineligible|0|||
161169141|NCT00878215|581997233|FG003|Overall Study|Determined to be ineligible|0|||
161169142|NCT00138424|581997234|FG000|Overall Study|Physician Decision|0|||
161169143|NCT00138424|581997235|FG001|Overall Study|Physician Decision|1|||
161169144|NCT00138424|581997236|FG002|Overall Study|Physician Decision|0|||
161169145|NCT00138424|581997237|FG003|Overall Study|Physician Decision|0|||
161169146|NCT00413062|581997244|FG000|Overall Study|Adverse event/serious adverse event|289|||
161169147|NCT00413062|581997245|FG001|Overall Study|Adverse event/serious adverse event|56|||
161169148|NCT00413062|581997244|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
161169149|NCT00413062|581997245|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
161169150|NCT00413062|581997244|FG000|Overall Study|Withdrawal of informed consent|111|||
161169151|NCT00413062|581997245|FG001|Overall Study|Withdrawal of informed consent|36|||
161169152|NCT00413062|581997244|FG000|Overall Study|Pregnancy|15|||
161169153|NCT00413062|581997245|FG001|Overall Study|Pregnancy|5|||
161169154|NCT00413062|581997244|FG000|Overall Study|Pregnancy wish|17|||
161169155|NCT00413062|581997245|FG001|Overall Study|Pregnancy wish|6|||
161169156|NCT00413062|581997244|FG000|Overall Study|Lost to Follow-up|175|||
161169157|NCT00413062|581997245|FG001|Overall Study|Lost to Follow-up|73|||
161169158|NCT00413062|581997244|FG000|Overall Study|Other reason|70|||
161169159|NCT00413062|581997245|FG001|Overall Study|Other reason|34|||
161169160|NCT02176291|581997246|FG000|Overall Study|Death|1|||
161169161|NCT02176291|581997247|FG001|Overall Study|Death|0|||
161169162|NCT02176291|581997246|FG000|Overall Study|non compliance with protocol|2|||
161169163|NCT02176291|581997247|FG001|Overall Study|non compliance with protocol|0|||
161169164|NCT02176291|581997246|FG000|Overall Study|Withdrawal by Subject|2|||
161169165|NCT02176291|581997247|FG001|Overall Study|Withdrawal by Subject|0|||
161169166|NCT00006604|581997248|FG000|Overall Study|Met study objective - no further FU|1|||
161169167|NCT00006604|581997249|FG001|Overall Study|Met study objective - no further FU|0|||
161169168|NCT00006604|581997250|FG002|Overall Study|Met study objective - no further FU|0|||
161169169|NCT00006604|581997251|FG003|Overall Study|Met study objective - no further FU|0|||
161169170|NCT00006604|581997252|FG004|Overall Study|Met study objective - no further FU|0|||
161169171|NCT00006604|581997253|FG005|Overall Study|Met study objective - no further FU|0|||
161169172|NCT00006604|581997254|FG006|Overall Study|Met study objective - no further FU|0|||
161169173|NCT00006604|581997255|FG007|Overall Study|Met study objective - no further FU|0|||
161169174|NCT00006604|581997256|FG008|Overall Study|Met study objective - no further FU|0|||
161169175|NCT00006604|581997257|FG009|Overall Study|Met study objective - no further FU|0|||
161169176|NCT00006604|581997258|FG010|Overall Study|Met study objective - no further FU|0|||
161169177|NCT00006604|581997259|FG011|Overall Study|Met study objective - no further FU|0|||
161169178|NCT00006604|581997260|FG012|Overall Study|Met study objective - no further FU|0|||
161169179|NCT00006604|581997261|FG013|Overall Study|Met study objective - no further FU|0|||
161169180|NCT00006604|581997262|FG014|Overall Study|Met study objective - no further FU|1|||
161169181|NCT00006604|581997263|FG015|Overall Study|Met study objective - no further FU|1|||
161169182|NCT00006604|581997264|FG016|Overall Study|Met study objective - no further FU|0|||
161169183|NCT00006604|581997248|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
161169184|NCT00006604|581997249|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
161169185|NCT00006604|581997250|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
161169186|NCT00006604|581997251|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
161169187|NCT00006604|581997252|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
161169188|NCT00006604|581997253|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
161169189|NCT00006604|581997254|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
161169190|NCT00006604|581997255|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
161169191|NCT00006604|581997256|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
161169192|NCT00006604|581997257|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
161169193|NCT00006604|581997258|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
161169194|NCT00006604|581997259|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
161169195|NCT00006604|581997260|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
161290537|NCT01530464|582444302|FG000|Washout (24h)|Withdrawal by Subject|1|||
161290538|NCT01530464|582444303|FG001|Washout (24h)|Withdrawal by Subject|0|||
161290539|NCT01530464|582444302|FG000|Washout (24h)|Withdrawal by Subject|0|||
161347049|NCT02335944|582654757|FG004|Treatment Phase|Subject/Guardian Decision|0|||
161347050|NCT02335944|582654758|FG005|Treatment Phase|Subject/Guardian Decision|1|||
161347051|NCT02335944|582654759|FG006|Treatment Phase|Subject/Guardian Decision|0|||
161347052|NCT02335944|582654760|FG007|Treatment Phase|Subject/Guardian Decision|4|||
161347053|NCT02335944|582654761|FG008|Treatment Phase|Subject/Guardian Decision|0|||
161347054|NCT02335944|582654762|FG009|Treatment Phase|Subject/Guardian Decision|0|||
161347055|NCT02335944|582654753|FG000|Post-treatment Follow-up|Progressive Disease|0|||
161347056|NCT02335944|582654754|FG001|Post-treatment Follow-up|Progressive Disease|0|||
161347057|NCT02335944|582654755|FG002|Post-treatment Follow-up|Progressive Disease|0|||
161347058|NCT02335944|582654756|FG003|Post-treatment Follow-up|Progressive Disease|1|||
161347059|NCT02335944|582654757|FG004|Post-treatment Follow-up|Progressive Disease|0|||
161347060|NCT02335944|582654758|FG005|Post-treatment Follow-up|Progressive Disease|9|||
161290540|NCT01530464|582444303|FG001|Washout (24h)|Withdrawal by Subject|1|||
161347061|NCT02335944|582654759|FG006|Post-treatment Follow-up|Progressive Disease|0|||
161347062|NCT02335944|582654760|FG007|Post-treatment Follow-up|Progressive Disease|2|||
161347063|NCT02335944|582654761|FG008|Post-treatment Follow-up|Progressive Disease|3|||
161347064|NCT02335944|582654762|FG009|Post-treatment Follow-up|Progressive Disease|0|||
161290541|NCT01709500|582444304|FG000|Overall Study|Randomized but not treated|0|||
161290542|NCT01709500|582444305|FG001|Overall Study|Randomized but not treated|1|||
161290543|NCT01709500|582444304|FG000|Overall Study|Adverse Event|5|||
161290544|NCT01709500|582444305|FG001|Overall Study|Adverse Event|1|||
161290545|NCT01709500|582444304|FG000|Overall Study|Poor compliance to protocol|2|||
161290546|NCT01709500|582444305|FG001|Overall Study|Poor compliance to protocol|1|||
161290547|NCT01709500|582444304|FG000|Overall Study|Other|3|||
161290548|NCT01709500|582444305|FG001|Overall Study|Other|1|||
161290549|NCT01709500|582444304|FG000|Overall Study|Related to IMP administration|1|||
161290550|NCT01709500|582444305|FG001|Overall Study|Related to IMP administration|0|||
161290551|NCT01709500|582444304|FG000|Overall Study|Treatment ongoing|156|||
161290552|NCT01709500|582444305|FG001|Overall Study|Treatment ongoing|78|||
161290553|NCT02107131|582444307|FG000|Overall Study|Lost to Follow-up|4|||
161290554|NCT02107131|582444308|FG001|Overall Study|Lost to Follow-up|4|||
161290555|NCT02107131|582444307|FG000|Overall Study|Physician Decision|1|||
161290556|NCT02107131|582444308|FG001|Overall Study|Physician Decision|0|||
161290557|NCT02107131|582444307|FG000|Overall Study|Withdrawal by Subject|2|||
161290558|NCT02107131|582444308|FG001|Overall Study|Withdrawal by Subject|0|||
161290559|NCT02107131|582444307|FG000|Overall Study|mental instability|1|||
161290560|NCT02107131|582444308|FG001|Overall Study|mental instability|0|||
161347065|NCT02335944|582654753|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161347066|NCT02335944|582654754|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161169196|NCT00006604|581997261|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
161290561|NCT02107131|582444307|FG000|Overall Study|Death|0|||
161290562|NCT02107131|582444308|FG001|Overall Study|Death|1|||
161347067|NCT02335944|582654755|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161347068|NCT02335944|582654756|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161290563|NCT02107131|582444307|FG000|Overall Study|Protocol Violation|0|||
161290564|NCT02107131|582444308|FG001|Overall Study|Protocol Violation|4|||
161347069|NCT02335944|582654757|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161290565|NCT02286713|582444309|FG000|One Week Follow-Up|Death|1|||
161290566|NCT02286713|582444310|FG001|One Week Follow-Up|Death|0|||
161169197|NCT00006604|581997262|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
161169198|NCT00006604|581997263|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
161169199|NCT00006604|581997264|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
161169200|NCT00006604|581997248|FG000|Overall Study|Death|0|||
161169201|NCT00006604|581997249|FG001|Overall Study|Death|0|||
161169202|NCT00006604|581997250|FG002|Overall Study|Death|0|||
161169203|NCT00006604|581997251|FG003|Overall Study|Death|0|||
161169204|NCT00006604|581997252|FG004|Overall Study|Death|0|||
161169205|NCT00006604|581997253|FG005|Overall Study|Death|0|||
161169206|NCT00006604|581997254|FG006|Overall Study|Death|0|||
161169207|NCT00006604|581997255|FG007|Overall Study|Death|0|||
161169208|NCT00006604|581997256|FG008|Overall Study|Death|0|||
161169209|NCT00006604|581997257|FG009|Overall Study|Death|1|||
161169210|NCT00006604|581997258|FG010|Overall Study|Death|1|||
161169211|NCT00006604|581997259|FG011|Overall Study|Death|1|||
161169212|NCT00006604|581997260|FG012|Overall Study|Death|0|||
161169213|NCT00006604|581997261|FG013|Overall Study|Death|0|||
161169214|NCT00006604|581997262|FG014|Overall Study|Death|0|||
161169215|NCT00006604|581997263|FG015|Overall Study|Death|0|||
161169216|NCT00006604|581997264|FG016|Overall Study|Death|0|||
161169217|NCT00006604|581997248|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161169218|NCT00006604|581997249|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161169219|NCT00006604|581997250|FG002|Overall Study|Severe debilitation, unable to continue|0|||
161169220|NCT00006604|581997251|FG003|Overall Study|Severe debilitation, unable to continue|0|||
161169221|NCT00006604|581997252|FG004|Overall Study|Severe debilitation, unable to continue|0|||
161169222|NCT00006604|581997253|FG005|Overall Study|Severe debilitation, unable to continue|0|||
161169223|NCT00006604|581997254|FG006|Overall Study|Severe debilitation, unable to continue|3|||
161169224|NCT00006604|581997255|FG007|Overall Study|Severe debilitation, unable to continue|0|||
161169225|NCT00006604|581997256|FG008|Overall Study|Severe debilitation, unable to continue|0|||
161169226|NCT00006604|581997257|FG009|Overall Study|Severe debilitation, unable to continue|5|||
161169227|NCT00006604|581997258|FG010|Overall Study|Severe debilitation, unable to continue|0|||
161169228|NCT00006604|581997259|FG011|Overall Study|Severe debilitation, unable to continue|2|||
161169229|NCT00006604|581997260|FG012|Overall Study|Severe debilitation, unable to continue|1|||
161169230|NCT00006604|581997261|FG013|Overall Study|Severe debilitation, unable to continue|0|||
161169231|NCT00006604|581997262|FG014|Overall Study|Severe debilitation, unable to continue|2|||
161169232|NCT00006604|581997263|FG015|Overall Study|Severe debilitation, unable to continue|0|||
161169233|NCT00006604|581997264|FG016|Overall Study|Severe debilitation, unable to continue|0|||
161169234|NCT00006604|581997248|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
161169235|NCT00006604|581997249|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
161169236|NCT00006604|581997250|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
161169237|NCT00006604|581997251|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
161169238|NCT00006604|581997252|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
161169239|NCT00006604|581997253|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
161169240|NCT00006604|581997254|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
161169241|NCT00006604|581997255|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
161169242|NCT00006604|581997256|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
161169243|NCT00006604|581997257|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
161169244|NCT00006604|581997258|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
161169245|NCT00006604|581997259|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
161169246|NCT00006604|581997260|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
161169247|NCT00006604|581997261|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
161169248|NCT00006604|581997262|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
161169249|NCT00006604|581997263|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
161169250|NCT00006604|581997264|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
161169251|NCT00006604|581997248|FG000|Overall Study|Site closing|0|||
161169252|NCT00006604|581997249|FG001|Overall Study|Site closing|0|||
161169253|NCT00006604|581997250|FG002|Overall Study|Site closing|1|||
161169254|NCT00006604|581997251|FG003|Overall Study|Site closing|1|||
161169255|NCT00006604|581997252|FG004|Overall Study|Site closing|0|||
161169256|NCT00006604|581997253|FG005|Overall Study|Site closing|0|||
161169257|NCT00006604|581997254|FG006|Overall Study|Site closing|0|||
161169258|NCT00006604|581997255|FG007|Overall Study|Site closing|1|||
161290567|NCT02286713|582444309|FG000|One Week Follow-Up|Lost to Follow-up|17|||
161290568|NCT02286713|582444310|FG001|One Week Follow-Up|Lost to Follow-up|21|||
161169259|NCT00006604|581997256|FG008|Overall Study|Site closing|0|||
161169260|NCT00006604|581997257|FG009|Overall Study|Site closing|0|||
161169261|NCT00006604|581997258|FG010|Overall Study|Site closing|0|||
161169262|NCT00006604|581997259|FG011|Overall Study|Site closing|1|||
161169263|NCT00006604|581997260|FG012|Overall Study|Site closing|1|||
161169264|NCT00006604|581997261|FG013|Overall Study|Site closing|1|||
161169265|NCT00006604|581997262|FG014|Overall Study|Site closing|0|||
161169266|NCT00006604|581997263|FG015|Overall Study|Site closing|0|||
161169267|NCT00006604|581997264|FG016|Overall Study|Site closing|1|||
161169268|NCT00006604|581997248|FG000|Overall Study|Withdrawal by Subject|1|||
161169269|NCT00006604|581997249|FG001|Overall Study|Withdrawal by Subject|0|||
161169270|NCT00006604|581997250|FG002|Overall Study|Withdrawal by Subject|2|||
161169271|NCT00006604|581997251|FG003|Overall Study|Withdrawal by Subject|0|||
161169272|NCT00006604|581997252|FG004|Overall Study|Withdrawal by Subject|1|||
161169273|NCT00006604|581997253|FG005|Overall Study|Withdrawal by Subject|2|||
161169274|NCT00006604|581997254|FG006|Overall Study|Withdrawal by Subject|2|||
161169275|NCT00006604|581997255|FG007|Overall Study|Withdrawal by Subject|0|||
161169276|NCT00006604|581997256|FG008|Overall Study|Withdrawal by Subject|1|||
161169277|NCT00006604|581997257|FG009|Overall Study|Withdrawal by Subject|3|||
161169278|NCT00006604|581997258|FG010|Overall Study|Withdrawal by Subject|2|||
161169279|NCT00006604|581997259|FG011|Overall Study|Withdrawal by Subject|0|||
161169280|NCT00006604|581997260|FG012|Overall Study|Withdrawal by Subject|1|||
161169281|NCT00006604|581997261|FG013|Overall Study|Withdrawal by Subject|2|||
161169282|NCT00006604|581997262|FG014|Overall Study|Withdrawal by Subject|1|||
161169283|NCT00006604|581997263|FG015|Overall Study|Withdrawal by Subject|0|||
161169284|NCT00006604|581997264|FG016|Overall Study|Withdrawal by Subject|1|||
161169285|NCT00006604|581997248|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
161169286|NCT00006604|581997249|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
161169287|NCT00006604|581997250|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
161169288|NCT00006604|581997251|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
161169289|NCT00006604|581997252|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
161169290|NCT00006604|581997253|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
161169291|NCT00006604|581997254|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
161169292|NCT00006604|581997255|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
161169293|NCT00006604|581997256|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
161169294|NCT00006604|581997257|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
161169295|NCT00006604|581997258|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
161169296|NCT00006604|581997259|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
161169297|NCT00006604|581997260|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
161169298|NCT00006604|581997261|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
161169299|NCT00006604|581997262|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
161169300|NCT00006604|581997263|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
161169301|NCT00006604|581997264|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
161169302|NCT00006604|581997248|FG000|Overall Study|Lost to Follow-up|0|||
161169303|NCT00006604|581997249|FG001|Overall Study|Lost to Follow-up|0|||
161169304|NCT00006604|581997250|FG002|Overall Study|Lost to Follow-up|0|||
161169305|NCT00006604|581997251|FG003|Overall Study|Lost to Follow-up|0|||
161169306|NCT00006604|581997252|FG004|Overall Study|Lost to Follow-up|0|||
161169307|NCT00006604|581997253|FG005|Overall Study|Lost to Follow-up|0|||
161169308|NCT00006604|581997254|FG006|Overall Study|Lost to Follow-up|0|||
161169309|NCT00006604|581997255|FG007|Overall Study|Lost to Follow-up|1|||
161169310|NCT00006604|581997256|FG008|Overall Study|Lost to Follow-up|0|||
161169311|NCT00006604|581997257|FG009|Overall Study|Lost to Follow-up|2|||
161169312|NCT00006604|581997258|FG010|Overall Study|Lost to Follow-up|0|||
161169313|NCT00006604|581997259|FG011|Overall Study|Lost to Follow-up|0|||
161169314|NCT00006604|581997260|FG012|Overall Study|Lost to Follow-up|0|||
161169315|NCT00006604|581997261|FG013|Overall Study|Lost to Follow-up|0|||
161169316|NCT00006604|581997262|FG014|Overall Study|Lost to Follow-up|0|||
161169317|NCT00006604|581997263|FG015|Overall Study|Lost to Follow-up|1|||
161169318|NCT00006604|581997264|FG016|Overall Study|Lost to Follow-up|3|||
161169319|NCT00006604|581997248|FG000|Overall Study|Other Reason|0|||
161169320|NCT00006604|581997249|FG001|Overall Study|Other Reason|0|||
161169321|NCT00006604|581997250|FG002|Overall Study|Other Reason|0|||
161169322|NCT00006604|581997251|FG003|Overall Study|Other Reason|0|||
161169323|NCT00006604|581997252|FG004|Overall Study|Other Reason|0|||
161169324|NCT00006604|581997253|FG005|Overall Study|Other Reason|1|||
161169325|NCT00006604|581997254|FG006|Overall Study|Other Reason|0|||
161347070|NCT02335944|582654758|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
161347071|NCT02335944|582654759|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161084158|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
161084159|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
161084160|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
161084161|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
161084162|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161084163|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161084164|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
161084165|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161084166|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
161084167|NCT00700427|581697466|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
161084168|NCT00700427|581697467|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
161169326|NCT00006604|581997255|FG007|Overall Study|Other Reason|0|||
161169327|NCT00006604|581997256|FG008|Overall Study|Other Reason|0|||
161169328|NCT00006604|581997257|FG009|Overall Study|Other Reason|1|||
161169329|NCT00006604|581997258|FG010|Overall Study|Other Reason|0|||
161347072|NCT02335944|582654760|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161347073|NCT02335944|582654761|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161347074|NCT02335944|582654762|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
161347075|NCT02335944|582654753|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
161347076|NCT02335944|582654754|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
161347077|NCT02335944|582654755|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
161347078|NCT02335944|582654756|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
161347079|NCT02335944|582654757|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
161169330|NCT00006604|581997259|FG011|Overall Study|Other Reason|0|||
161169331|NCT00006604|581997260|FG012|Overall Study|Other Reason|0|||
161169332|NCT00006604|581997261|FG013|Overall Study|Other Reason|0|||
161169333|NCT00006604|581997262|FG014|Overall Study|Other Reason|0|||
161169334|NCT00006604|581997263|FG015|Overall Study|Other Reason|0|||
161169335|NCT00006604|581997264|FG016|Overall Study|Other Reason|0|||
161169336|NCT02431468|581997265|FG000|Overall Study|Adverse Event|2|||
161169337|NCT02431468|581997266|FG001|Overall Study|Adverse Event|4|||
161169338|NCT02431468|581997267|FG002|Overall Study|Adverse Event|5|||
161169339|NCT02431468|581997265|FG000|Overall Study|Withdrawal by Subject|4|||
161169340|NCT02431468|581997266|FG001|Overall Study|Withdrawal by Subject|12|||
161169341|NCT02431468|581997267|FG002|Overall Study|Withdrawal by Subject|2|||
161169342|NCT02431468|581997265|FG000|Overall Study|noncompliance, investigator termination,|2|||
161169343|NCT02431468|581997266|FG001|Overall Study|noncompliance, investigator termination,|2|||
161169344|NCT02431468|581997267|FG002|Overall Study|noncompliance, investigator termination,|2|||
161169345|NCT01361919|581997268|FG000|Overall Study|technical issues|10|||
161169346|NCT01361919|581997269|FG001|Overall Study|technical issues|12|||
161169347|NCT01361919|581997270|FG002|Overall Study|technical issues|10|||
161169348|NCT01056341|581997271|FG000|Overall Study|Treatment Intolerance|0|||
161169349|NCT01056341|581997272|FG001|Overall Study|Treatment Intolerance|2|||
161169350|NCT01056341|581997273|FG002|Overall Study|Treatment Intolerance|0|||
161169351|NCT01056341|581997274|FG003|Overall Study|Treatment Intolerance|2|||
161169352|NCT01056341|581997275|FG004|Overall Study|Treatment Intolerance|0|||
161169353|NCT01056341|581997271|FG000|Overall Study|Lack of Efficacy|32|||
161169354|NCT01056341|581997272|FG001|Overall Study|Lack of Efficacy|30|||
161169355|NCT01056341|581997273|FG002|Overall Study|Lack of Efficacy|7|||
161169356|NCT01056341|581997274|FG003|Overall Study|Lack of Efficacy|25|||
161169357|NCT01056341|581997275|FG004|Overall Study|Lack of Efficacy|9|||
161169358|NCT01056341|581997271|FG000|Overall Study|Other reasons|4|||
161169359|NCT01056341|581997272|FG001|Overall Study|Other reasons|4|||
161169360|NCT01056341|581997273|FG002|Overall Study|Other reasons|8|||
161169361|NCT01056341|581997274|FG003|Overall Study|Other reasons|9|||
161169362|NCT01056341|581997275|FG004|Overall Study|Other reasons|5|||
161169363|NCT03454412|581997276|FG000|Baseline Assesment|Physician Decision|12|||
161169364|NCT02227108|581997281|FG000|Overall Study|Did not receive treatment|2|||
161169365|NCT02227108|581997281|FG000|Overall Study|Other|3|||
161169366|NCT02227108|581997281|FG000|Overall Study|Progressive disease|17|||
161169367|NCT02227108|581997281|FG000|Overall Study|Initiation of alternative therapy|2|||
161169368|NCT02227108|581997281|FG000|Overall Study|Investigator discretion|1|||
161169369|NCT02227108|581997281|FG000|Overall Study|Adverse Event|6|||
161169370|NCT02486952|581997282|FG000|Overall Study|Not Started Induction Therapy|3|||
161169371|NCT02486952|581997282|FG000|Overall Study|Adverse Event|1|||
161169372|NCT02486952|581997282|FG000|Overall Study|Death|15|||
161169373|NCT02486952|581997282|FG000|Overall Study|Lack of Efficacy|3|||
161169374|NCT02486952|581997282|FG000|Overall Study|Lost to Follow-up|26|||
161347080|NCT02335944|582654758|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
161169375|NCT02486952|581997282|FG000|Overall Study|Other|2|||
161169376|NCT03589885|581997283|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
161169377|NCT03589885|581997284|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
161169378|NCT03589885|581997285|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
161169379|NCT03589885|581997286|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
161169380|NCT03589885|581997287|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
161169381|NCT03589885|581997283|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161169382|NCT03589885|581997284|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161169383|NCT03589885|581997285|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
161169384|NCT03589885|581997286|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161169385|NCT03589885|581997287|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
161347081|NCT02335944|582654759|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
161347082|NCT02335944|582654760|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
161347083|NCT02335944|582654761|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
161169386|NCT03589885|581997283|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161169387|NCT03589885|581997284|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
161169388|NCT03589885|581997285|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161084169|NCT00700427|581697468|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
161084170|NCT00700427|581697469|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
161084171|NCT00700427|581697470|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
161084172|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161084173|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161084174|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161084175|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
161084176|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
161084177|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
161084178|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
161084179|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
161084180|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
161084181|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
161084182|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161084183|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161084184|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161084185|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
161084186|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
161084187|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161084188|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161084189|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161084190|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
161084191|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
161084192|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161084193|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161084194|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161084195|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
161084196|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
161084197|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161084198|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161084199|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161084200|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
161084201|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
161084202|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161084203|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161084204|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161084205|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
161084206|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
161084207|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161084208|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161084209|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161084210|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
161084211|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
161084212|NCT00700427|581697466|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161084213|NCT00700427|581697467|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161084214|NCT00700427|581697468|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161084215|NCT00700427|581697469|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
161084216|NCT00700427|581697470|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
161084217|NCT00424385|581697474|FG000|Cohort 0|Withdrawal by Subject|5|||
161084218|NCT00424385|581697474|FG000|Cohort 0|Physician Decision|1|||
161084219|NCT00424385|581697474|FG000|Cohort 1|Withdrawal by Subject|1|||
161084220|NCT02057523|581697475|FG000|Overall Study|Withdrawal by Subject|1|||
161084221|NCT02057523|581697475|FG000|Overall Study|Lack of Efficacy|1|||
161084222|NCT00964886|581697476|FG000|Overall Study|Lost to Follow-up|2|||
161084223|NCT00964886|581697477|FG001|Overall Study|Lost to Follow-up|2|||
161084224|NCT00964886|581697478|FG002|Overall Study|Lost to Follow-up|6|||
161084225|NCT00964886|581697479|FG003|Overall Study|Lost to Follow-up|4|||
161084226|NCT00964886|581697476|FG000|Overall Study|Withdrawal by Subject|6|||
161084227|NCT00964886|581697477|FG001|Overall Study|Withdrawal by Subject|2|||
161084228|NCT00964886|581697478|FG002|Overall Study|Withdrawal by Subject|5|||
161084229|NCT00964886|581697479|FG003|Overall Study|Withdrawal by Subject|3|||
161084230|NCT00964886|581697476|FG000|Overall Study|Adverse Event|3|||
161084231|NCT00964886|581697477|FG001|Overall Study|Adverse Event|1|||
161084232|NCT00964886|581697478|FG002|Overall Study|Adverse Event|5|||
161084233|NCT00964886|581697479|FG003|Overall Study|Adverse Event|2|||
161084234|NCT00964886|581697476|FG000|Overall Study|Protocol Violation|0|||
161084235|NCT00964886|581697477|FG001|Overall Study|Protocol Violation|2|||
161084236|NCT00964886|581697478|FG002|Overall Study|Protocol Violation|0|||
161084237|NCT00964886|581697479|FG003|Overall Study|Protocol Violation|0|||
161091285|NCT01272804|581723872|FG004|Overall Study|Adverse Event|2|||
161290569|NCT02286713|582444309|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
161290570|NCT02286713|582444310|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
161290571|NCT02286713|582444309|FG000|Three Month Follow-Up|Death|1|||
161290572|NCT02286713|582444310|FG001|Three Month Follow-Up|Death|1|||
161290573|NCT02286713|582444309|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
161290574|NCT02286713|582444310|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
161084238|NCT00381615|581697480|FG000|Overall Study|Withdrawal by Subject|1|||
161084239|NCT00381615|581697481|FG001|Overall Study|Withdrawal by Subject|3|||
161084240|NCT00381615|581697482|FG002|Overall Study|Withdrawal by Subject|0|||
161084241|NCT00381615|581697483|FG003|Overall Study|Withdrawal by Subject|1|||
161084242|NCT00381615|581697480|FG000|Overall Study|Lost to Follow-up|3|||
161084243|NCT00381615|581697481|FG001|Overall Study|Lost to Follow-up|2|||
161084244|NCT00381615|581697482|FG002|Overall Study|Lost to Follow-up|0|||
161084245|NCT00381615|581697483|FG003|Overall Study|Lost to Follow-up|1|||
161084246|NCT00381615|581697480|FG000|Overall Study|Protocol Violation|0|||
161084247|NCT00381615|581697481|FG001|Overall Study|Protocol Violation|0|||
161084248|NCT00381615|581697482|FG002|Overall Study|Protocol Violation|1|||
161084249|NCT00381615|581697483|FG003|Overall Study|Protocol Violation|0|||
161084250|NCT01012414|581697485|FG000|Overall Study|Withdrawal by Subject|2|||
161084251|NCT01012414|581697485|FG000|Overall Study|Lost to Follow-up|1|||
161084252|NCT01012414|581697485|FG000|Overall Study|Trial was stopped before completed|7|||
161084253|NCT02601300|581697486|FG000|Induction Phase|Lack of Efficacy|2|||
161084254|NCT02601300|581697486|FG000|Induction Phase|Protocol Violation|1|||
161084255|NCT02601300|581697486|FG000|Extension Phase|Withdrawal by Subject|3|||
161084256|NCT02601300|581697486|FG000|Extension Phase|Adverse Event|4|||
161084257|NCT02601300|581697486|FG000|Extension Phase|Lack of Efficacy|10|||
161084258|NCT00291642|581697491|FG000|Overall Study|Adverse Event|1|||
161084259|NCT00291642|581697492|FG001|Overall Study|Adverse Event|0|||
161084260|NCT00291642|581697493|FG002|Overall Study|Adverse Event|1|||
161084261|NCT00291642|581697494|FG003|Overall Study|Adverse Event|0|||
161084262|NCT00291642|581697495|FG004|Overall Study|Adverse Event|1|||
161084263|NCT00291642|581697491|FG000|Overall Study|Patient missed visit|0|||
161084264|NCT00291642|581697492|FG001|Overall Study|Patient missed visit|0|||
161084265|NCT00291642|581697493|FG002|Overall Study|Patient missed visit|1|||
161084266|NCT00291642|581697494|FG003|Overall Study|Patient missed visit|0|||
161084267|NCT00291642|581697495|FG004|Overall Study|Patient missed visit|0|||
161084268|NCT00291642|581697491|FG000|Overall Study|Intake of prohibited medication|1|||
161084269|NCT00291642|581697492|FG001|Overall Study|Intake of prohibited medication|0|||
161084270|NCT00291642|581697493|FG002|Overall Study|Intake of prohibited medication|0|||
161084271|NCT00291642|581697494|FG003|Overall Study|Intake of prohibited medication|0|||
161084272|NCT00291642|581697495|FG004|Overall Study|Intake of prohibited medication|0|||
161084273|NCT02544451|581697499|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
161084274|NCT02544451|581697500|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
161084275|NCT02544451|581697501|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
161084276|NCT02544451|581697502|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
161084277|NCT02544451|581697499|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
161084278|NCT02544451|581697500|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
161084279|NCT02544451|581697501|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
161084280|NCT02544451|581697502|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
161084281|NCT02544451|581697499|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
161084282|NCT02544451|581697500|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
161084283|NCT02544451|581697501|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
161084284|NCT02544451|581697502|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
161084285|NCT02544451|581697499|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
161084286|NCT02544451|581697500|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
161084287|NCT02544451|581697501|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
161084288|NCT02544451|581697502|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
161084289|NCT02544451|581697499|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
161084290|NCT02544451|581697500|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
161084291|NCT02544451|581697501|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
161084292|NCT02544451|581697502|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
161084293|NCT02544451|581697499|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
161084294|NCT02544451|581697500|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
161084295|NCT02544451|581697501|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
161084296|NCT02544451|581697502|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
161084297|NCT04602221|581697506|FG000|Overall Study|Discontinuation of trial treatment|0|||
161084298|NCT04602221|581697507|FG001|Overall Study|Discontinuation of trial treatment|0|||
161290575|NCT02286713|582444309|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
161084299|NCT04602221|581697508|FG002|Overall Study|Discontinuation of trial treatment|1|||
161084300|NCT04602221|581697509|FG003|Overall Study|Discontinuation of trial treatment|0|||
161084301|NCT04602221|581697510|FG004|Overall Study|Discontinuation of trial treatment|0|||
161084302|NCT04602221|581697511|FG005|Overall Study|Discontinuation of trial treatment|0|||
161169389|NCT03589885|581997286|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161169390|NCT03589885|581997287|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
161169391|NCT03589885|581997283|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161169392|NCT03589885|581997284|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161169393|NCT03589885|581997285|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
161169394|NCT03589885|581997286|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161169395|NCT03589885|581997287|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
161169396|NCT03589885|581997283|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
161169397|NCT03589885|581997284|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
161169398|NCT03589885|581997285|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
161169399|NCT03589885|581997286|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
161169400|NCT03589885|581997287|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
161169401|NCT03589885|581997283|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
161169402|NCT03589885|581997284|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
161169403|NCT03589885|581997285|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
161169404|NCT03589885|581997286|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
161169405|NCT03589885|581997287|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
161169406|NCT03589885|581997283|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
161169407|NCT03589885|581997284|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
161169408|NCT03589885|581997285|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
161169409|NCT03589885|581997286|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
161169410|NCT03589885|581997287|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
161169411|NCT03589885|581997283|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161169412|NCT03589885|581997284|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
161169413|NCT03589885|581997285|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161169414|NCT03589885|581997286|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161169415|NCT03589885|581997287|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
161169416|NCT04111107|581997288|FG000|Overall Study|Withdrawal by Subject|6|||
161169417|NCT04111107|581997288|FG000|Overall Study|Declining Health|5|||
161169418|NCT01928485|581997289|FG000|Overall Study|Physician Decision|0|||
161169419|NCT01928485|581997290|FG001|Overall Study|Physician Decision|1|||
161169420|NCT00039741|581997293|FG000|Overall Study|Death|0|||
161169421|NCT00039741|581997294|FG001|Overall Study|Death|1|||
161169422|NCT00039741|581997295|FG002|Overall Study|Death|0|||
161169423|NCT00039741|581997296|FG003|Overall Study|Death|0|||
161169424|NCT00039741|581997293|FG000|Overall Study|Lost to Follow-up|3|||
161169425|NCT00039741|581997294|FG001|Overall Study|Lost to Follow-up|1|||
161169426|NCT00039741|581997295|FG002|Overall Study|Lost to Follow-up|5|||
161169427|NCT00039741|581997296|FG003|Overall Study|Lost to Follow-up|2|||
161169428|NCT00039741|581997293|FG000|Overall Study|Confounding medical condition|1|||
161169429|NCT00039741|581997294|FG001|Overall Study|Confounding medical condition|0|||
161169430|NCT00039741|581997295|FG002|Overall Study|Confounding medical condition|0|||
161169431|NCT00039741|581997296|FG003|Overall Study|Confounding medical condition|0|||
161169432|NCT00039741|581997293|FG000|Overall Study|Not able to get to clinic|5|||
161169433|NCT00039741|581997294|FG001|Overall Study|Not able to get to clinic|2|||
161169434|NCT00039741|581997295|FG002|Overall Study|Not able to get to clinic|0|||
161169435|NCT00039741|581997296|FG003|Overall Study|Not able to get to clinic|3|||
161169436|NCT00039741|581997293|FG000|Overall Study|Moved|3|||
161169437|NCT00039741|581997294|FG001|Overall Study|Moved|2|||
161169438|NCT00039741|581997295|FG002|Overall Study|Moved|3|||
161169439|NCT00039741|581997296|FG003|Overall Study|Moved|6|||
161169440|NCT00039741|581997293|FG000|Overall Study|Non-compliance with protocol|1|||
161169441|NCT00039741|581997294|FG001|Overall Study|Non-compliance with protocol|0|||
161169442|NCT00039741|581997295|FG002|Overall Study|Non-compliance with protocol|1|||
161169443|NCT00039741|581997296|FG003|Overall Study|Non-compliance with protocol|0|||
161169444|NCT00039741|581997293|FG000|Overall Study|Withdrew consent|0|||
161169445|NCT00039741|581997294|FG001|Overall Study|Withdrew consent|5|||
161347084|NCT02335944|582654762|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
161169446|NCT00039741|581997295|FG002|Overall Study|Withdrew consent|0|||
161169447|NCT00039741|581997296|FG003|Overall Study|Withdrew consent|1|||
161169448|NCT00039741|581997293|FG000|Overall Study|Missed final visit|2|||
161169449|NCT00039741|581997294|FG001|Overall Study|Missed final visit|1|||
161169450|NCT00039741|581997295|FG002|Overall Study|Missed final visit|2|||
161169451|NCT00039741|581997296|FG003|Overall Study|Missed final visit|2|||
161169452|NCT00946881|581997297|FG000|First Treatment|Withdrawal by Subject|1|||
161169453|NCT00946881|581997297|FG000|First Treatment|Patient relocated to another state|1|||
161169454|NCT00946881|581997297|FG000|Retreatment|Withdrawal by Subject|1|||
161169455|NCT00293423|581997298|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
161169456|NCT00293423|581997299|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
161169457|NCT00293423|581997298|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
161169458|NCT00293423|581997299|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
161169459|NCT00293423|581997298|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
161290576|NCT02286713|582444310|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
161290577|NCT02286713|582444309|FG000|Six Month Follow-Up|Death|2|||
161290578|NCT02286713|582444310|FG001|Six Month Follow-Up|Death|0|||
161290579|NCT02286713|582444309|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
161290580|NCT02286713|582444310|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
161290581|NCT04314037|582444311|FG000|Treatment Period 2|Adverse Event|1|||
161347085|NCT02335944|582654753|FG000|Post-treatment Follow-up|Adverse Event|0|||
161084303|NCT04602221|581697512|FG006|Overall Study|Discontinuation of trial treatment|0|||
161084304|NCT04602221|581697513|FG007|Overall Study|Discontinuation of trial treatment|0|||
161084305|NCT04602221|581697514|FG008|Overall Study|Discontinuation of trial treatment|0|||
161084306|NCT04602221|581697515|FG009|Overall Study|Discontinuation of trial treatment|0|||
161084307|NCT04602221|581697516|FG010|Overall Study|Discontinuation of trial treatment|0|||
161084308|NCT04602221|581697517|FG011|Overall Study|Discontinuation of trial treatment|0|||
161084309|NCT04602221|581697518|FG012|Overall Study|Discontinuation of trial treatment|0|||
161084310|NCT04602221|581697519|FG013|Overall Study|Discontinuation of trial treatment|0|||
161084311|NCT04602221|581697520|FG014|Overall Study|Discontinuation of trial treatment|0|||
161084312|NCT04602221|581697521|FG015|Overall Study|Discontinuation of trial treatment|0|||
161084313|NCT04602221|581697522|FG016|Overall Study|Discontinuation of trial treatment|0|||
161084314|NCT04602221|581697523|FG017|Overall Study|Discontinuation of trial treatment|0|||
161084315|NCT04602221|581697506|FG000|Overall Study|Other than listed|0|||
161084316|NCT04602221|581697507|FG001|Overall Study|Other than listed|0|||
161084317|NCT04602221|581697508|FG002|Overall Study|Other than listed|0|||
161084318|NCT04602221|581697509|FG003|Overall Study|Other than listed|0|||
161084319|NCT04602221|581697510|FG004|Overall Study|Other than listed|0|||
161084320|NCT04602221|581697511|FG005|Overall Study|Other than listed|0|||
161084321|NCT04602221|581697512|FG006|Overall Study|Other than listed|0|||
161084322|NCT04602221|581697513|FG007|Overall Study|Other than listed|0|||
161084323|NCT04602221|581697514|FG008|Overall Study|Other than listed|0|||
161084324|NCT04602221|581697515|FG009|Overall Study|Other than listed|0|||
161084325|NCT04602221|581697516|FG010|Overall Study|Other than listed|0|||
161084326|NCT04602221|581697517|FG011|Overall Study|Other than listed|0|||
161084327|NCT04602221|581697518|FG012|Overall Study|Other than listed|0|||
161084328|NCT04602221|581697519|FG013|Overall Study|Other than listed|0|||
161084329|NCT04602221|581697520|FG014|Overall Study|Other than listed|0|||
161084330|NCT04602221|581697521|FG015|Overall Study|Other than listed|1|||
161084331|NCT04602221|581697522|FG016|Overall Study|Other than listed|0|||
161084332|NCT04602221|581697523|FG017|Overall Study|Other than listed|1|||
161084333|NCT04602221|581697506|FG000|Overall Study|Withdrawal by Subject|0|||
161084334|NCT04602221|581697507|FG001|Overall Study|Withdrawal by Subject|0|||
161084335|NCT04602221|581697508|FG002|Overall Study|Withdrawal by Subject|0|||
161084336|NCT04602221|581697509|FG003|Overall Study|Withdrawal by Subject|0|||
161084337|NCT04602221|581697510|FG004|Overall Study|Withdrawal by Subject|0|||
161084338|NCT04602221|581697511|FG005|Overall Study|Withdrawal by Subject|0|||
161084339|NCT04602221|581697512|FG006|Overall Study|Withdrawal by Subject|0|||
161084340|NCT04602221|581697513|FG007|Overall Study|Withdrawal by Subject|0|||
161084341|NCT04602221|581697514|FG008|Overall Study|Withdrawal by Subject|0|||
161084342|NCT04602221|581697515|FG009|Overall Study|Withdrawal by Subject|0|||
161084343|NCT04602221|581697516|FG010|Overall Study|Withdrawal by Subject|0|||
161084344|NCT04602221|581697517|FG011|Overall Study|Withdrawal by Subject|0|||
161084345|NCT04602221|581697518|FG012|Overall Study|Withdrawal by Subject|1|||
161084346|NCT04602221|581697519|FG013|Overall Study|Withdrawal by Subject|0|||
161084347|NCT04602221|581697520|FG014|Overall Study|Withdrawal by Subject|0|||
161084348|NCT04602221|581697521|FG015|Overall Study|Withdrawal by Subject|0|||
161084349|NCT04602221|581697522|FG016|Overall Study|Withdrawal by Subject|0|||
161084350|NCT04602221|581697523|FG017|Overall Study|Withdrawal by Subject|0|||
161084351|NCT04602221|581697506|FG000|Overall Study|Lost to Follow-up|0|||
161084352|NCT04602221|581697507|FG001|Overall Study|Lost to Follow-up|0|||
161084353|NCT04602221|581697508|FG002|Overall Study|Lost to Follow-up|0|||
161084354|NCT04602221|581697509|FG003|Overall Study|Lost to Follow-up|0|||
161084355|NCT04602221|581697510|FG004|Overall Study|Lost to Follow-up|0|||
161084356|NCT04602221|581697511|FG005|Overall Study|Lost to Follow-up|1|||
161084357|NCT04602221|581697512|FG006|Overall Study|Lost to Follow-up|0|||
161084358|NCT04602221|581697513|FG007|Overall Study|Lost to Follow-up|0|||
161084359|NCT04602221|581697514|FG008|Overall Study|Lost to Follow-up|0|||
161084360|NCT04602221|581697515|FG009|Overall Study|Lost to Follow-up|0|||
161084361|NCT04602221|581697516|FG010|Overall Study|Lost to Follow-up|0|||
161084362|NCT04602221|581697517|FG011|Overall Study|Lost to Follow-up|0|||
161084363|NCT04602221|581697518|FG012|Overall Study|Lost to Follow-up|0|||
161084364|NCT04602221|581697519|FG013|Overall Study|Lost to Follow-up|0|||
161084365|NCT04602221|581697520|FG014|Overall Study|Lost to Follow-up|0|||
161084366|NCT04602221|581697521|FG015|Overall Study|Lost to Follow-up|0|||
161084367|NCT04602221|581697522|FG016|Overall Study|Lost to Follow-up|0|||
161084368|NCT04602221|581697523|FG017|Overall Study|Lost to Follow-up|0|||
161084369|NCT03001076|581697524|FG000|Overall Study|Withdrawal by patient|2|||
161290582|NCT04314037|582444312|FG001|Treatment Period 2|Adverse Event|0|||
161290583|NCT04314037|582444311|FG000|Treatment Period 3|Protocol Violation|1|||
161084370|NCT03001076|581697525|FG001|Overall Study|Withdrawal by patient|0|||
161169460|NCT00293423|581997299|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
161169461|NCT00293423|581997298|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
161169462|NCT00293423|581997299|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
161169463|NCT00293423|581997298|FG000|Surgical Resection|processing error during surgical resection|1|||
161169464|NCT00293423|581997299|FG001|Surgical Resection|processing error during surgical resection|0|||
161169465|NCT00293423|581997298|FG000|Surgical Resection|Withdrawal by Subject|4|||
161169466|NCT00293423|581997299|FG001|Surgical Resection|Withdrawal by Subject|0|||
161169467|NCT00293423|581997298|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
161169468|NCT00293423|581997299|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
161169469|NCT01182337|581997304|FG000|Overall Study|Withdrawal by Subject|3|||
161169470|NCT01182337|581997305|FG001|Overall Study|Withdrawal by Subject|1|||
161169471|NCT01182337|581997304|FG000|Overall Study|Lost to Follow-up|0|||
161169472|NCT01182337|581997305|FG001|Overall Study|Lost to Follow-up|1|||
161169473|NCT03571256|581997306|FG000|Overall Study|Adverse Event|3|||
161169474|NCT03571256|581997307|FG001|Overall Study|Adverse Event|0|||
161169475|NCT03571256|581997308|FG002|Overall Study|Adverse Event|1|||
161169476|NCT03571256|581997306|FG000|Overall Study|Withdrawal by Subject|3|||
161169477|NCT03571256|581997307|FG001|Overall Study|Withdrawal by Subject|1|||
161169478|NCT03571256|581997308|FG002|Overall Study|Withdrawal by Subject|1|||
161169479|NCT03571256|581997306|FG000|Overall Study|Other than specified|0|||
161169480|NCT03571256|581997307|FG001|Overall Study|Other than specified|1|||
161169481|NCT03571256|581997308|FG002|Overall Study|Other than specified|1|||
161169482|NCT03571256|581997306|FG000|Overall Study|Protocol Violation|0|||
161169483|NCT03571256|581997307|FG001|Overall Study|Protocol Violation|1|||
161169484|NCT03571256|581997308|FG002|Overall Study|Protocol Violation|1|||
161169485|NCT01714817|581997309|FG000|Year 1 Period|Lack of Efficacy|11|||
161169486|NCT01714817|581997310|FG001|Year 1 Period|Lack of Efficacy|9|||
161169487|NCT01714817|581997309|FG000|Year 1 Period|Adverse Event|20|||
161169488|NCT01714817|581997310|FG001|Year 1 Period|Adverse Event|17|||
161169489|NCT01714817|581997309|FG000|Year 1 Period|Withdrawal by Subject|6|||
161169490|NCT01714817|581997310|FG001|Year 1 Period|Withdrawal by Subject|7|||
161169491|NCT01714817|581997309|FG000|Year 1 Period|Death|1|||
161169492|NCT01714817|581997310|FG001|Year 1 Period|Death|1|||
161169493|NCT01714817|581997309|FG000|Year 1 Period|Lost to Follow-up|0|||
161169494|NCT01714817|581997310|FG001|Year 1 Period|Lost to Follow-up|2|||
161169495|NCT01714817|581997309|FG000|Year 1 Period|Poor / non-compliance|0|||
161169496|NCT01714817|581997310|FG001|Year 1 Period|Poor / non-compliance|1|||
161169497|NCT01714817|581997309|FG000|Year 1 Period|Pregnancy|2|||
161169498|NCT01714817|581997310|FG001|Year 1 Period|Pregnancy|0|||
161169499|NCT01714817|581997309|FG000|Year 1 Period|Participant no longer meets criteria|6|||
161169500|NCT01714817|581997310|FG001|Year 1 Period|Participant no longer meets criteria|2|||
161169501|NCT01714817|581997309|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
161169502|NCT01714817|581997310|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
161169503|NCT01714817|581997309|FG000|Year 1 Period|Change in Concomitant Medication|0|||
161169504|NCT01714817|581997310|FG001|Year 1 Period|Change in Concomitant Medication|1|||
161169505|NCT01714817|581997309|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
161169506|NCT01714817|581997310|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
161169507|NCT01714817|581997309|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
161169508|NCT01714817|581997310|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
161169509|NCT01714817|581997309|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
161169510|NCT01714817|581997310|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
161169511|NCT01714817|581997309|FG000|Year 2 Period|Lack of Efficacy|4|||
161169512|NCT01714817|581997310|FG001|Year 2 Period|Lack of Efficacy|12|||
161169513|NCT01714817|581997309|FG000|Year 2 Period|Adverse Event|7|||
161169514|NCT01714817|581997310|FG001|Year 2 Period|Adverse Event|6|||
161169515|NCT01714817|581997309|FG000|Year 2 Period|Participant request to stop treatment|4|||
161169516|NCT01714817|581997310|FG001|Year 2 Period|Participant request to stop treatment|4|||
161169517|NCT01714817|581997309|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
161169518|NCT01714817|581997310|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
161169519|NCT01714817|581997309|FG000|Year 2 Period|Participant withdrew consent|1|||
161169520|NCT01714817|581997310|FG001|Year 2 Period|Participant withdrew consent|5|||
161347086|NCT02335944|582654754|FG001|Post-treatment Follow-up|Adverse Event|0|||
161169521|NCT01714817|581997309|FG000|Year 2 Period|Participant no longer meets criteria|1|||
161169522|NCT01714817|581997310|FG001|Year 2 Period|Participant no longer meets criteria|4|||
161169523|NCT01714817|581997309|FG000|Year 2 Period|Lost to Follow-up|2|||
161347087|NCT02335944|582654755|FG002|Post-treatment Follow-up|Adverse Event|0|||
161169524|NCT01714817|581997310|FG001|Year 2 Period|Lost to Follow-up|0|||
161169525|NCT01714817|581997309|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
161169526|NCT01714817|581997310|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
161169527|NCT01714817|581997309|FG000|Year 2 Period|Pregnancy|1|||
161169528|NCT01714817|581997310|FG001|Year 2 Period|Pregnancy|1|||
161169529|NCT01714817|581997309|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
161347088|NCT02335944|582654756|FG003|Post-treatment Follow-up|Adverse Event|0|||
161347089|NCT02335944|582654757|FG004|Post-treatment Follow-up|Adverse Event|0|||
161347090|NCT02335944|582654758|FG005|Post-treatment Follow-up|Adverse Event|1|||
161347091|NCT02335944|582654759|FG006|Post-treatment Follow-up|Adverse Event|0|||
161347092|NCT02335944|582654760|FG007|Post-treatment Follow-up|Adverse Event|0|||
161347093|NCT02335944|582654761|FG008|Post-treatment Follow-up|Adverse Event|0|||
161347094|NCT02335944|582654762|FG009|Post-treatment Follow-up|Adverse Event|0|||
161347095|NCT02335944|582654753|FG000|Post-treatment Follow-up|Death|0|||
161347096|NCT02335944|582654754|FG001|Post-treatment Follow-up|Death|0|||
161347097|NCT02335944|582654755|FG002|Post-treatment Follow-up|Death|0|||
161347098|NCT02335944|582654756|FG003|Post-treatment Follow-up|Death|1|||
161347099|NCT02335944|582654757|FG004|Post-treatment Follow-up|Death|0|||
161347100|NCT02335944|582654758|FG005|Post-treatment Follow-up|Death|1|||
161347101|NCT02335944|582654759|FG006|Post-treatment Follow-up|Death|0|||
161347102|NCT02335944|582654760|FG007|Post-treatment Follow-up|Death|0|||
161084371|NCT03001076|581697524|FG000|Overall Study|Other|1|||
161084372|NCT03001076|581697525|FG001|Overall Study|Other|0|||
161084373|NCT03001076|581697524|FG000|Overall Study|Adverse Event|3|||
161084374|NCT03001076|581697525|FG001|Overall Study|Adverse Event|3|||
161084375|NCT03001076|581697524|FG000|Overall Study|Sponsor decision|1|||
161084376|NCT03001076|581697525|FG001|Overall Study|Sponsor decision|0|||
161084377|NCT03001076|581697524|FG000|Overall Study|Lost to Follow-up|0|||
161084378|NCT03001076|581697525|FG001|Overall Study|Lost to Follow-up|2|||
161084379|NCT02576587|581697527|FG000|Baseline|Equipment failure|0|||
161084380|NCT02576587|581697528|FG001|Baseline|Equipment failure|1|||
161084381|NCT02576587|581697527|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
161084382|NCT02576587|581697528|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
161084383|NCT02576587|581697527|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
161084384|NCT02576587|581697528|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
161084385|NCT02576587|581697527|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
161084386|NCT02576587|581697528|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
161084387|NCT00844532|581697529|FG000|Overall Study|Death|16|||
161084388|NCT00844532|581697529|FG000|Overall Study|Withdrawal by Subject|16|||
161084389|NCT00844532|581697529|FG000|Overall Study|Lost to Follow-up|7|||
161084390|NCT01080716|581697530|FG000|Part 1|Physician Decision|1|||
161084391|NCT01080716|581697531|FG001|Part 1|Physician Decision|0|||
161084392|NCT01080716|581697532|FG002|Part 1|Physician Decision|0|||
161084393|NCT01080716|581697533|FG003|Part 1|Physician Decision|0|||
161084394|NCT01056718|581697534|FG000|Overall Study|Withdrawal by Subject|2|||
161084395|NCT01056718|581697534|FG000|Overall Study|Ischemia on baseline stress test|1|||
161084396|NCT03590366|581697535|FG000|Overall Study|Adverse Event|0|||
161084397|NCT03590366|581697536|FG001|Overall Study|Adverse Event|3|||
161084398|NCT03590366|581697535|FG000|Overall Study|Lost to Follow-up|3|||
161084399|NCT03590366|581697536|FG001|Overall Study|Lost to Follow-up|3|||
161084400|NCT03590366|581697535|FG000|Overall Study|Withdrawal by Subject|0|||
161084401|NCT03590366|581697536|FG001|Overall Study|Withdrawal by Subject|2|||
161084402|NCT00738894|581697537|FG000|Overall Study|Lost to Follow-up|23|||
161084403|NCT00738894|581697538|FG001|Overall Study|Lost to Follow-up|13|||
161084404|NCT00738894|581697537|FG000|Overall Study|Withdrawal by Subject|10|||
161084405|NCT00738894|581697538|FG001|Overall Study|Withdrawal by Subject|15|||
161084406|NCT00738894|581697537|FG000|Overall Study|Physician Decision|4|||
161084407|NCT00738894|581697538|FG001|Overall Study|Physician Decision|5|||
161084408|NCT00738894|581697537|FG000|Overall Study|Death|2|||
161084409|NCT00738894|581697538|FG001|Overall Study|Death|0|||
161084410|NCT05017103|581697539|FG000|Overall Study|Death|2|||
161084411|NCT02656329|581697540|FG000|Overall Study|Lost to Follow-up|2|||
161084412|NCT02656329|581697541|FG001|Overall Study|Lost to Follow-up|3|||
161084413|NCT02656329|581697540|FG000|Overall Study|Withdrawal by Subject|7|||
161084414|NCT02656329|581697541|FG001|Overall Study|Withdrawal by Subject|6|||
161084415|NCT02656329|581697540|FG000|Overall Study|Study termination by Sponsor|150|||
161084416|NCT02656329|581697541|FG001|Overall Study|Study termination by Sponsor|142|||
161084417|NCT02656329|581697540|FG000|Overall Study|Other than specified above|5|||
161084418|NCT02656329|581697541|FG001|Overall Study|Other than specified above|6|||
161084419|NCT01081665|581697543|FG000|Overall Study|Death|41|||
161084420|NCT01081665|581697543|FG000|Overall Study|Lost to Follow-up|18|||
161084421|NCT01081665|581697543|FG000|Overall Study|Withdrawal by Subject|17|||
161084422|NCT01081665|581697543|FG000|Overall Study|Change of dialysis unit|10|||
161084423|NCT01081665|581697543|FG000|Overall Study|Regulation of iPTH|5|||
161084424|NCT01081665|581697543|FG000|Overall Study|Change in renal replacement therapy|2|||
161084425|NCT01081665|581697543|FG000|Overall Study|Adverse Event|1|||
161084426|NCT01081665|581697543|FG000|Overall Study|Lack of Efficacy|1|||
161084427|NCT01413503|581697556|FG000|Overall Study|Lost to Follow-up|1|||
161084428|NCT02546921|581697557|FG000|Overall Study|Adverse Event|0|||
161084429|NCT02546921|581697558|FG001|Overall Study|Adverse Event|5|||
161084430|NCT02546921|581697559|FG002|Overall Study|Adverse Event|2|||
161084431|NCT02546921|581697560|FG003|Overall Study|Adverse Event|0|||
161347103|NCT02335944|582654761|FG008|Post-treatment Follow-up|Death|0|||
161347104|NCT02335944|582654762|FG009|Post-treatment Follow-up|Death|0|||
161347105|NCT02335944|582654753|FG000|Post-treatment Follow-up|Physician Decision|1|||
161169530|NCT01714817|581997310|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
161169531|NCT01714817|581997309|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
161169532|NCT01714817|581997310|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
161169533|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
161169534|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
161169535|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
161169536|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
161169537|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
161169538|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
161169539|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
161169540|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
161169541|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
161169542|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
161169543|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
161169544|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
161169545|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
161169546|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
161169547|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
161169548|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
161169549|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
161169550|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
161169551|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
161169552|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
161169553|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
161169554|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
161169555|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
161169556|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
161169557|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
161169558|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
161169559|NCT01714817|581997309|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
161169560|NCT01714817|581997310|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
161169561|NCT01374217|581997311|FG000|Overall Study|Lack of Efficacy|13|||
161169562|NCT02807363|581997314|FG000|Dosing Period|Adverse Event|0|||
161169563|NCT02807363|581997315|FG001|Dosing Period|Adverse Event|1|||
161169564|NCT02807363|581997316|FG002|Dosing Period|Adverse Event|0|||
161169565|NCT02807363|581997317|FG003|Dosing Period|Adverse Event|0|||
161169566|NCT01617187|581997318|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161169567|NCT01617187|581997319|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161169568|NCT01617187|581997320|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
161169569|NCT01617187|581997321|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
161169570|NCT01617187|581997318|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161169571|NCT01617187|581997319|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161169572|NCT01617187|581997320|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
161169573|NCT01617187|581997321|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
161169574|NCT01617187|581997318|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
161169575|NCT01617187|581997319|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161169576|NCT01617187|581997320|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161169577|NCT01617187|581997321|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
161169578|NCT01617187|581997318|FG000|Treatment Through Study Completion|Adverse Event|1|||
161169579|NCT01617187|581997319|FG001|Treatment Through Study Completion|Adverse Event|1|||
161169580|NCT01617187|581997320|FG002|Treatment Through Study Completion|Adverse Event|0|||
161169581|NCT01617187|581997321|FG003|Treatment Through Study Completion|Adverse Event|1|||
161169582|NCT01617187|581997318|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
161169583|NCT01617187|581997319|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
161169584|NCT01617187|581997320|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
161169585|NCT01617187|581997321|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
161169586|NCT01617187|581997318|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
161290584|NCT04314037|582444312|FG001|Treatment Period 3|Protocol Violation|0|||
161290585|NCT04314037|582444311|FG000|Treatment Period 3|Adverse Event|0|||
161290586|NCT04314037|582444312|FG001|Treatment Period 3|Adverse Event|1|||
161290587|NCT00856492|582444315|FG000|Overall Study|Ineligible or withdrew consent|1|||
161169587|NCT01617187|581997319|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
161290588|NCT00856492|582444316|FG001|Overall Study|Ineligible or withdrew consent|1|||
161290589|NCT00856492|582444317|FG002|Overall Study|Ineligible or withdrew consent|2|||
161290590|NCT06018129|582444318|FG000|Overall Study|Death|1|||
161290591|NCT06018129|582444319|FG001|Overall Study|Death|1|||
161290592|NCT06018129|582444320|FG002|Overall Study|Death|2|||
161290593|NCT06018129|582444318|FG000|Overall Study|Sponsor Decision|2|||
161290594|NCT06018129|582444319|FG001|Overall Study|Sponsor Decision|2|||
161290595|NCT06018129|582444320|FG002|Overall Study|Sponsor Decision|1|||
161290596|NCT03832686|582444321|FG000|Overall Study|Lost to Follow-up|6|||
161290597|NCT03832686|582444322|FG001|Overall Study|Lost to Follow-up|9|||
161290598|NCT03832686|582444321|FG000|Overall Study|Discontinued Intervention|5|||
161290599|NCT03832686|582444322|FG001|Overall Study|Discontinued Intervention|4|||
161290600|NCT03323398|582444323|FG000|Overall Study|Other than Specified|0|||
161290601|NCT03323398|582444324|FG001|Overall Study|Other than Specified|1|||
161290602|NCT03323398|582444325|FG002|Overall Study|Other than Specified|2|||
161290603|NCT03323398|582444326|FG003|Overall Study|Other than Specified|0|||
161290604|NCT03323398|582444327|FG004|Overall Study|Other than Specified|0|||
161290605|NCT03323398|582444328|FG005|Overall Study|Other than Specified|0|||
161084432|NCT02546921|581697561|FG004|Overall Study|Adverse Event|0|||
161084433|NCT02546921|581697562|FG005|Overall Study|Adverse Event|0|||
161084434|NCT02546921|581697563|FG006|Overall Study|Adverse Event|0|||
161084435|NCT02546921|581697557|FG000|Overall Study|Evidence of Disease Progression|1|||
161084436|NCT02546921|581697558|FG001|Overall Study|Evidence of Disease Progression|0|||
161084437|NCT02546921|581697559|FG002|Overall Study|Evidence of Disease Progression|0|||
161084438|NCT02546921|581697560|FG003|Overall Study|Evidence of Disease Progression|0|||
161084439|NCT02546921|581697561|FG004|Overall Study|Evidence of Disease Progression|1|||
161084440|NCT02546921|581697562|FG005|Overall Study|Evidence of Disease Progression|0|||
161084441|NCT02546921|581697563|FG006|Overall Study|Evidence of Disease Progression|0|||
161084442|NCT02546921|581697557|FG000|Overall Study|Patient Choice|0|||
161084443|NCT02546921|581697558|FG001|Overall Study|Patient Choice|1|||
161084444|NCT02546921|581697559|FG002|Overall Study|Patient Choice|0|||
161084445|NCT02546921|581697560|FG003|Overall Study|Patient Choice|0|||
161084446|NCT02546921|581697561|FG004|Overall Study|Patient Choice|0|||
161084447|NCT02546921|581697562|FG005|Overall Study|Patient Choice|1|||
161084448|NCT02546921|581697563|FG006|Overall Study|Patient Choice|0|||
161084449|NCT01373151|581697564|FG000|Period 1|Lack of Efficacy|3|||
161084450|NCT01373151|581697565|FG001|Period 1|Lack of Efficacy|0|||
161084451|NCT01373151|581697566|FG002|Period 1|Lack of Efficacy|0|||
161084452|NCT01373151|581697567|FG003|Period 1|Lack of Efficacy|0|||
161084453|NCT01373151|581697568|FG004|Period 1|Lack of Efficacy|1|||
161084454|NCT01373151|581697569|FG005|Period 1|Lack of Efficacy|0|||
161084455|NCT01373151|581697570|FG006|Period 1|Lack of Efficacy|0|||
161084456|NCT01373151|581697564|FG000|Period 1|Adverse Event|0|||
161084457|NCT01373151|581697565|FG001|Period 1|Adverse Event|0|||
161084458|NCT01373151|581697566|FG002|Period 1|Adverse Event|1|||
161084459|NCT01373151|581697567|FG003|Period 1|Adverse Event|0|||
161084460|NCT01373151|581697568|FG004|Period 1|Adverse Event|4|||
161084461|NCT01373151|581697569|FG005|Period 1|Adverse Event|3|||
161084462|NCT01373151|581697570|FG006|Period 1|Adverse Event|0|||
161084463|NCT01373151|581697564|FG000|Period 1|Withdrawal by Subject|2|||
161084464|NCT01373151|581697565|FG001|Period 1|Withdrawal by Subject|0|||
161084465|NCT01373151|581697566|FG002|Period 1|Withdrawal by Subject|3|||
161084466|NCT01373151|581697567|FG003|Period 1|Withdrawal by Subject|1|||
161084467|NCT01373151|581697568|FG004|Period 1|Withdrawal by Subject|0|||
161084468|NCT01373151|581697569|FG005|Period 1|Withdrawal by Subject|1|||
161084469|NCT01373151|581697570|FG006|Period 1|Withdrawal by Subject|0|||
161084470|NCT01373151|581697564|FG000|Period 2|Lack of Efficacy|9|||
161084471|NCT01373151|581697565|FG001|Period 2|Lack of Efficacy|0|||
161084472|NCT01373151|581697566|FG002|Period 2|Lack of Efficacy|0|||
161084473|NCT01373151|581697567|FG003|Period 2|Lack of Efficacy|1|||
161084474|NCT01373151|581697568|FG004|Period 2|Lack of Efficacy|2|||
161084475|NCT01373151|581697569|FG005|Period 2|Lack of Efficacy|0|||
161084476|NCT01373151|581697570|FG006|Period 2|Lack of Efficacy|3|||
161084477|NCT01373151|581697564|FG000|Period 2|Adverse Event|0|||
161084478|NCT01373151|581697565|FG001|Period 2|Adverse Event|0|||
161084479|NCT01373151|581697566|FG002|Period 2|Adverse Event|3|||
161084480|NCT01373151|581697567|FG003|Period 2|Adverse Event|3|||
161084481|NCT01373151|581697568|FG004|Period 2|Adverse Event|0|||
161084482|NCT01373151|581697569|FG005|Period 2|Adverse Event|0|||
161084483|NCT01373151|581697570|FG006|Period 2|Adverse Event|1|||
161084484|NCT01373151|581697564|FG000|Period 2|subject request to discontinue|0|||
161084485|NCT01373151|581697565|FG001|Period 2|subject request to discontinue|1|||
161084486|NCT01373151|581697566|FG002|Period 2|subject request to discontinue|0|||
161084487|NCT01373151|581697567|FG003|Period 2|subject request to discontinue|0|||
161084488|NCT01373151|581697568|FG004|Period 2|subject request to discontinue|0|||
161084489|NCT01373151|581697569|FG005|Period 2|subject request to discontinue|0|||
161084490|NCT01373151|581697570|FG006|Period 2|subject request to discontinue|0|||
161290606|NCT03323398|582444329|FG006|Overall Study|Other than Specified|1|||
161290607|NCT03323398|582444330|FG007|Overall Study|Other than Specified|0|||
161290608|NCT03323398|582444331|FG008|Overall Study|Other than Specified|2|||
161084491|NCT01373151|581697564|FG000|Period 2|Withdrawal by Subject|0|||
161084492|NCT01373151|581697565|FG001|Period 2|Withdrawal by Subject|0|||
161084493|NCT01373151|581697566|FG002|Period 2|Withdrawal by Subject|0|||
161290609|NCT03323398|582444323|FG000|Overall Study|Lost to Follow-up|1|||
161347106|NCT02335944|582654754|FG001|Post-treatment Follow-up|Physician Decision|0|||
161347107|NCT02335944|582654755|FG002|Post-treatment Follow-up|Physician Decision|0|||
161347108|NCT02335944|582654756|FG003|Post-treatment Follow-up|Physician Decision|0|||
161347109|NCT02335944|582654757|FG004|Post-treatment Follow-up|Physician Decision|0|||
161347110|NCT02335944|582654758|FG005|Post-treatment Follow-up|Physician Decision|0|||
161347111|NCT02335944|582654759|FG006|Post-treatment Follow-up|Physician Decision|0|||
161347112|NCT02335944|582654760|FG007|Post-treatment Follow-up|Physician Decision|1|||
161347113|NCT02335944|582654761|FG008|Post-treatment Follow-up|Physician Decision|0|||
161347114|NCT02335944|582654762|FG009|Post-treatment Follow-up|Physician Decision|0|||
161347115|NCT00832975|582654763|FG000|Overall Study|Lost to Follow-up|7|||
161347116|NCT00832975|582654763|FG000|Overall Study|Protocol Violation|6|||
161347117|NCT00832975|582654763|FG000|Overall Study|Death|5|||
161347118|NCT00832975|582654763|FG000|Overall Study|Physician Decision|4|||
161347119|NCT00832975|582654763|FG000|Overall Study|Withdrawal by Subject|3|||
161347120|NCT00832975|582654763|FG000|Overall Study|Other reasons|14|||
161347121|NCT06081829|582654766|FG000|Overall Study|Participants still on-study|8|||
161347122|NCT06081829|582654766|FG000|Overall Study|Death|4|||
161347123|NCT01525589|582654767|FG000|Overall Study|Non-treatment-related AE|1|||
161347124|NCT01525589|582654768|FG001|Overall Study|Non-treatment-related AE|0|||
161347125|NCT01525589|582654769|FG002|Overall Study|Non-treatment-related AE|0|||
161347126|NCT01525589|582654767|FG000|Overall Study|Progressive disease|48|||
161347127|NCT01525589|582654768|FG001|Overall Study|Progressive disease|15|||
161347128|NCT01525589|582654769|FG002|Overall Study|Progressive disease|29|||
161347129|NCT01525589|582654767|FG000|Overall Study|Never treated|2|||
161347130|NCT01525589|582654768|FG001|Overall Study|Never treated|0|||
161347131|NCT01525589|582654769|FG002|Overall Study|Never treated|0|||
161347132|NCT01525589|582654767|FG000|Overall Study|Physician Decision|4|||
161347133|NCT01525589|582654768|FG001|Overall Study|Physician Decision|2|||
161347134|NCT01525589|582654769|FG002|Overall Study|Physician Decision|2|||
161347135|NCT01525589|582654767|FG000|Overall Study|Death|0|||
161347136|NCT01525589|582654768|FG001|Overall Study|Death|0|||
161347137|NCT01525589|582654769|FG002|Overall Study|Death|2|||
161347138|NCT01525589|582654767|FG000|Overall Study|Treatment-related AE|1|||
161347139|NCT01525589|582654768|FG001|Overall Study|Treatment-related AE|1|||
161347140|NCT01525589|582654769|FG002|Overall Study|Treatment-related AE|2|||
161347141|NCT01525589|582654767|FG000|Overall Study|Other reasons|0|||
161347142|NCT01525589|582654768|FG001|Overall Study|Other reasons|1|||
161347143|NCT01525589|582654769|FG002|Overall Study|Other reasons|0|||
161347144|NCT01525589|582654767|FG000|Overall Study|Withdrawal by Subject|0|||
161347145|NCT01525589|582654768|FG001|Overall Study|Withdrawal by Subject|1|||
161347146|NCT01525589|582654769|FG002|Overall Study|Withdrawal by Subject|0|||
161347147|NCT04835441|582654771|FG000|Overall Study|Physician Decision|4|||
161347148|NCT04835441|582654772|FG001|Overall Study|Physician Decision|4|||
161347149|NCT04835441|582654771|FG000|Overall Study|Other|1|||
161347150|NCT04835441|582654772|FG001|Overall Study|Other|1|||
161347151|NCT04835441|582654771|FG000|Overall Study|Lost to Follow-up|0|||
161347152|NCT04835441|582654772|FG001|Overall Study|Lost to Follow-up|1|||
161347153|NCT05253807|582654773|FG000|Overall Study|Death|1|||
161347154|NCT05253807|582654774|FG001|Overall Study|Death|4|||
161347155|NCT05253807|582654773|FG000|Overall Study|Withdrawal by Subject|1|||
161347156|NCT05253807|582654774|FG001|Overall Study|Withdrawal by Subject|0|||
161347157|NCT05253807|582654773|FG000|Overall Study|Study Terminated by Sponsor|1|||
161347158|NCT05253807|582654774|FG001|Overall Study|Study Terminated by Sponsor|1|||
161347159|NCT02145390|582654777|FG000|Overall Study|Withdrawal by Subject|1|||
161347160|NCT02293499|582656208|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
161347161|NCT02293499|582656209|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
161347162|NCT02293499|582656210|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
161347163|NCT02293499|582656208|FG000|Intervention - Camp|Withdrawal by Subject|3|||
161347164|NCT02293499|582656209|FG001|Intervention - Camp|Withdrawal by Subject|6|||
161347165|NCT02293499|582656210|FG002|Intervention - Camp|Withdrawal by Subject|2|||
161347166|NCT02293499|582656208|FG000|Intervention - Camp|these are those not showing up at camp|24|||
161347167|NCT02293499|582656209|FG001|Intervention - Camp|these are those not showing up at camp|28|||
161347168|NCT02293499|582656210|FG002|Intervention - Camp|these are those not showing up at camp|4|||
161347169|NCT02293499|582656208|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
161347170|NCT02293499|582656209|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
161347171|NCT02293499|582656210|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
161347172|NCT02293499|582656208|FG000|3 Month Follow Up|Lost to Follow-up|14|||
161347173|NCT02293499|582656209|FG001|3 Month Follow Up|Lost to Follow-up|15|||
161347174|NCT02293499|582656210|FG002|3 Month Follow Up|Lost to Follow-up|6|||
161347175|NCT02293499|582656208|FG000|6 Month Follow Up|Lost to Follow-up|17|||
161347176|NCT02293499|582656209|FG001|6 Month Follow Up|Lost to Follow-up|27|||
161347177|NCT02293499|582656210|FG002|6 Month Follow Up|Lost to Follow-up|6|||
161347178|NCT02293499|582656208|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
161347179|NCT02293499|582656209|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
161169588|NCT01617187|581997320|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
161169589|NCT01617187|581997321|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
161169590|NCT01617187|581997318|FG000|Treatment Through Study Completion|Protocol Violation|1|||
161169591|NCT01617187|581997319|FG001|Treatment Through Study Completion|Protocol Violation|0|||
161169592|NCT01617187|581997320|FG002|Treatment Through Study Completion|Protocol Violation|0|||
161169593|NCT01617187|581997321|FG003|Treatment Through Study Completion|Protocol Violation|1|||
161169594|NCT01265420|581997322|FG000|Overall Study|Lost to Follow-up|1|||
161169595|NCT03337139|581997326|FG000|Phase I|Withdrawal by Subject|10|||
161169596|NCT03337139|581997327|FG001|Phase I|Withdrawal by Subject|0|||
161169597|NCT01561560|581997332|FG000|First Two Weeks of Wear|Time/job conflict|0|||
161169598|NCT01561560|581997333|FG001|First Two Weeks of Wear|Time/job conflict|1|||
161169599|NCT01561560|581997332|FG000|First Two Weeks of Wear|Adverse Event|0|||
161169600|NCT01561560|581997333|FG001|First Two Weeks of Wear|Adverse Event|1|||
161169601|NCT01561560|581997332|FG000|Second Two Weeks of Wear|Adverse Event|0|||
161169602|NCT01561560|581997333|FG001|Second Two Weeks of Wear|Adverse Event|1|||
161169603|NCT03862131|581997334|FG000|Overall Study|Lost to Follow-up|1|||
161169604|NCT03862131|581997335|FG001|Overall Study|Lost to Follow-up|0|||
161169605|NCT03862131|581997336|FG002|Overall Study|Lost to Follow-up|1|||
161169606|NCT03862131|581997334|FG000|Overall Study|Determined to be ineligible|0|||
161169607|NCT03862131|581997335|FG001|Overall Study|Determined to be ineligible|0|||
161169608|NCT03862131|581997336|FG002|Overall Study|Determined to be ineligible|5|||
161169609|NCT03862131|581997334|FG000|Overall Study|Death|4|||
161169610|NCT03862131|581997335|FG001|Overall Study|Death|4|||
161169611|NCT03862131|581997336|FG002|Overall Study|Death|0|||
161169612|NCT03862131|581997334|FG000|Overall Study|Withdrawal by Subject|5|||
161290610|NCT03323398|582444324|FG001|Overall Study|Lost to Follow-up|2|||
161290611|NCT03323398|582444325|FG002|Overall Study|Lost to Follow-up|1|||
161290612|NCT03323398|582444326|FG003|Overall Study|Lost to Follow-up|0|||
161290613|NCT03323398|582444327|FG004|Overall Study|Lost to Follow-up|0|||
161290614|NCT03323398|582444328|FG005|Overall Study|Lost to Follow-up|0|||
161290615|NCT03323398|582444329|FG006|Overall Study|Lost to Follow-up|0|||
161290616|NCT03323398|582444330|FG007|Overall Study|Lost to Follow-up|0|||
161290617|NCT03323398|582444331|FG008|Overall Study|Lost to Follow-up|0|||
161290618|NCT03323398|582444323|FG000|Overall Study|Death|4|||
161290619|NCT03323398|582444324|FG001|Overall Study|Death|6|||
161290620|NCT03323398|582444325|FG002|Overall Study|Death|2|||
161290621|NCT03323398|582444326|FG003|Overall Study|Death|2|||
161290622|NCT03323398|582444327|FG004|Overall Study|Death|1|||
161290623|NCT03323398|582444328|FG005|Overall Study|Death|2|||
161290624|NCT03323398|582444329|FG006|Overall Study|Death|0|||
161290625|NCT03323398|582444330|FG007|Overall Study|Death|0|||
161290626|NCT03323398|582444331|FG008|Overall Study|Death|6|||
161290627|NCT03323398|582444323|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
161290628|NCT03323398|582444324|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
161290629|NCT03323398|582444325|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
161290630|NCT03323398|582444326|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
161290631|NCT03323398|582444327|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
161290632|NCT03323398|582444328|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
161290633|NCT03323398|582444329|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
161290634|NCT03323398|582444330|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
161290635|NCT03323398|582444331|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
161290636|NCT03323398|582444323|FG000|Overall Study|Withdrawal by Subject|2|||
161290637|NCT03323398|582444324|FG001|Overall Study|Withdrawal by Subject|1|||
161290638|NCT03323398|582444325|FG002|Overall Study|Withdrawal by Subject|3|||
161290639|NCT03323398|582444326|FG003|Overall Study|Withdrawal by Subject|0|||
161290640|NCT03323398|582444327|FG004|Overall Study|Withdrawal by Subject|0|||
161290641|NCT03323398|582444328|FG005|Overall Study|Withdrawal by Subject|1|||
161290642|NCT03323398|582444329|FG006|Overall Study|Withdrawal by Subject|0|||
161290643|NCT03323398|582444330|FG007|Overall Study|Withdrawal by Subject|0|||
161169613|NCT03862131|581997335|FG001|Overall Study|Withdrawal by Subject|3|||
161347180|NCT02293499|582656210|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
161169614|NCT03862131|581997336|FG002|Overall Study|Withdrawal by Subject|0|||
161169615|NCT03862131|581997334|FG000|Overall Study|Physician Decision|0|||
161169616|NCT03862131|581997335|FG001|Overall Study|Physician Decision|1|||
161169617|NCT03862131|581997336|FG002|Overall Study|Physician Decision|0|||
161169618|NCT01871896|581997339|FG000|Overall Study|Lost to Follow-up|1|||
161169619|NCT01824693|581998757|FG000|Overall Study|Death|0|||
161169620|NCT01824693|581998758|FG001|Overall Study|Death|1|||
161169621|NCT01824693|581998759|FG002|Overall Study|Death|0|||
161290644|NCT03323398|582444331|FG008|Overall Study|Withdrawal by Subject|0|||
161290645|NCT03323398|582444323|FG000|Overall Study|Participant was Put on Hospice|0|||
161290646|NCT03323398|582444324|FG001|Overall Study|Participant was Put on Hospice|0|||
161290647|NCT03323398|582444325|FG002|Overall Study|Participant was Put on Hospice|0|||
161290648|NCT03323398|582444326|FG003|Overall Study|Participant was Put on Hospice|0|||
161290649|NCT03323398|582444327|FG004|Overall Study|Participant was Put on Hospice|0|||
161290650|NCT03323398|582444328|FG005|Overall Study|Participant was Put on Hospice|0|||
161169622|NCT01824693|581998757|FG000|Overall Study|Physician Decision|1|||
161169623|NCT01824693|581998758|FG001|Overall Study|Physician Decision|1|||
161169624|NCT01824693|581998759|FG002|Overall Study|Physician Decision|1|||
161169625|NCT01824693|581998757|FG000|Overall Study|Withdrawal by Subject|0|||
161169626|NCT01824693|581998758|FG001|Overall Study|Withdrawal by Subject|0|||
161169627|NCT01824693|581998759|FG002|Overall Study|Withdrawal by Subject|1|||
161169628|NCT01824693|581998757|FG000|Overall Study|Progressive Disease|0|||
161169629|NCT01824693|581998758|FG001|Overall Study|Progressive Disease|5|||
161169630|NCT01824693|581998759|FG002|Overall Study|Progressive Disease|0|||
161169631|NCT01824693|581998757|FG000|Overall Study|Ineligible|0|||
161169632|NCT01824693|581998758|FG001|Overall Study|Ineligible|0|||
161169633|NCT01824693|581998759|FG002|Overall Study|Ineligible|3|||
161169634|NCT01824693|581998757|FG000|Overall Study|No Transplant Planned|0|||
161169635|NCT01824693|581998758|FG001|Overall Study|No Transplant Planned|0|||
161169636|NCT01824693|581998759|FG002|Overall Study|No Transplant Planned|10|||
161169637|NCT02150213|581998760|FG000|Overall Study|Lost to Follow-up|1|||
161169638|NCT02150213|581998760|FG000|Overall Study|Withdrawal by Subject|1|||
161169639|NCT03488238|581998761|FG000|Overall Study|Equipment malfunction|1|||
161169640|NCT03488238|581998761|FG000|Overall Study|Adverse Event|1|||
161169641|NCT01432457|581998762|FG000|Overall Study|Adverse Event|7|||
161169642|NCT01432457|581998763|FG001|Overall Study|Adverse Event|10|||
161169643|NCT01432457|581998764|FG002|Overall Study|Adverse Event|16|||
161169644|NCT01432457|581998762|FG000|Overall Study|Lack of Efficacy|2|||
161169645|NCT01432457|581998763|FG001|Overall Study|Lack of Efficacy|1|||
161169646|NCT01432457|581998764|FG002|Overall Study|Lack of Efficacy|1|||
161169647|NCT01432457|581998762|FG000|Overall Study|Lost to Follow-up|11|||
161169648|NCT01432457|581998763|FG001|Overall Study|Lost to Follow-up|15|||
161169649|NCT01432457|581998764|FG002|Overall Study|Lost to Follow-up|20|||
161169650|NCT01432457|581998762|FG000|Overall Study|Protocol Violation|3|||
161169651|NCT01432457|581998763|FG001|Overall Study|Protocol Violation|2|||
161169652|NCT01432457|581998764|FG002|Overall Study|Protocol Violation|6|||
161169653|NCT01432457|581998762|FG000|Overall Study|Withdrawal by Subject|6|||
161169654|NCT01432457|581998763|FG001|Overall Study|Withdrawal by Subject|11|||
161169655|NCT01432457|581998764|FG002|Overall Study|Withdrawal by Subject|9|||
161169656|NCT01432457|581998762|FG000|Overall Study|Reasons not defined|2|||
161169657|NCT01432457|581998763|FG001|Overall Study|Reasons not defined|3|||
161169658|NCT01432457|581998764|FG002|Overall Study|Reasons not defined|4|||
161169659|NCT01432457|581998762|FG000|Overall Study|Did not take study drug|6|||
161169660|NCT01432457|581998763|FG001|Overall Study|Did not take study drug|6|||
161169661|NCT01432457|581998764|FG002|Overall Study|Did not take study drug|3|||
161169662|NCT03382262|581998765|FG000|Overall Study|Physician Decision|0|||
161169663|NCT03382262|581998766|FG001|Overall Study|Physician Decision|0|||
161169664|NCT03382262|581998767|FG002|Overall Study|Physician Decision|1|||
161169665|NCT03382262|581998768|FG003|Overall Study|Physician Decision|0|||
161169666|NCT03382262|581998765|FG000|Overall Study|Withdrawal by Subject|0|||
161169667|NCT03382262|581998766|FG001|Overall Study|Withdrawal by Subject|0|||
161169668|NCT03382262|581998767|FG002|Overall Study|Withdrawal by Subject|0|||
161169669|NCT03382262|581998768|FG003|Overall Study|Withdrawal by Subject|1|||
161169670|NCT02966353|581998769|FG000|Overall Study|Withdrawal by Subject|7|||
161169671|NCT02966353|581998769|FG000|Overall Study|Adverse Event|4|||
161169672|NCT02966353|581998769|FG000|Overall Study|Death|4|||
161169673|NCT02966353|581998769|FG000|Overall Study|Physician Decision|3|||
161169674|NCT02966353|581998769|FG000|Overall Study|Progressive disease|2|||
161169675|NCT02966353|581998769|FG000|Overall Study|Protocol deviation|2|||
161169676|NCT01090102|581998770|FG000|First 12 Weeks|Withdrawal by Subject|1|||
161169677|NCT01090102|581998771|FG001|First 12 Weeks|Withdrawal by Subject|1|||
161169678|NCT01090102|581998770|FG000|First 12 Weeks|Adverse Event|2|||
161169679|NCT01090102|581998771|FG001|First 12 Weeks|Adverse Event|0|||
161169680|NCT01090102|581998770|FG000|First 12 Weeks|Death|1|||
161169681|NCT01090102|581998771|FG001|First 12 Weeks|Death|1|||
161169682|NCT01090102|581998770|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
161169683|NCT01090102|581998771|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
161169684|NCT03518034|581998774|FG000|Overall Study|Not Treated|5|||
161169685|NCT03518034|581998775|FG001|Overall Study|Not Treated|1|||
161169686|NCT03518034|581998774|FG000|Overall Study|Withdrawal by Subject|309|||
161169687|NCT03518034|581998775|FG001|Overall Study|Withdrawal by Subject|351|||
161169688|NCT03518034|581998774|FG000|Overall Study|Lost to Follow-up|446|||
161169689|NCT03518034|581998775|FG001|Overall Study|Lost to Follow-up|458|||
161169690|NCT03518034|581998774|FG000|Overall Study|Adverse Event|138|||
161169691|NCT03518034|581998775|FG001|Overall Study|Adverse Event|130|||
161169692|NCT03518034|581998774|FG000|Overall Study|Lack of Efficacy|11|||
161169693|NCT03518034|581998775|FG001|Overall Study|Lack of Efficacy|23|||
161169694|NCT03518034|581998774|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
161169695|NCT03518034|581998775|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
161169696|NCT03518034|581998774|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
161169697|NCT03518034|581998775|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
161169698|NCT03518034|581998774|FG000|Overall Study|Other, Not Specified|84|||
161169699|NCT03518034|581998775|FG001|Overall Study|Other, Not Specified|53|||
161169700|NCT03518034|581998774|FG000|Overall Study|Reason Missing|2|||
161084494|NCT01373151|581697567|FG003|Period 2|Withdrawal by Subject|1|||
161084495|NCT01373151|581697568|FG004|Period 2|Withdrawal by Subject|0|||
161084496|NCT01373151|581697569|FG005|Period 2|Withdrawal by Subject|0|||
161084497|NCT01373151|581697570|FG006|Period 2|Withdrawal by Subject|0|||
161084498|NCT01373151|581697564|FG000|Period 2|Other|0|||
161084499|NCT01373151|581697565|FG001|Period 2|Other|0|||
161084500|NCT01373151|581697566|FG002|Period 2|Other|1|||
161084501|NCT01373151|581697567|FG003|Period 2|Other|0|||
161084502|NCT01373151|581697568|FG004|Period 2|Other|0|||
161084503|NCT01373151|581697569|FG005|Period 2|Other|0|||
161084504|NCT01373151|581697570|FG006|Period 2|Other|1|||
161084505|NCT03026075|581697574|FG000|Overall Study|Physician Decision|1|||
161084506|NCT03381339|581697575|FG000|Overall Study|Protocol Violation|4|||
161084507|NCT03381339|581697576|FG001|Overall Study|Protocol Violation|3|||
161084508|NCT03381339|581697575|FG000|Overall Study|Lost to Follow-up|0|||
161084509|NCT03381339|581697576|FG001|Overall Study|Lost to Follow-up|1|||
161084510|NCT02001064|581697578|FG000|Overall Study|Withdrawal by Subject|2|||
161084511|NCT02001064|581697579|FG001|Overall Study|Withdrawal by Subject|1|||
161084512|NCT00545753|581697580|FG000|Overall Study|Withdrawal by Subject|0|||
161084513|NCT00545753|581697581|FG001|Overall Study|Withdrawal by Subject|1|||
161084514|NCT00545753|581697582|FG002|Overall Study|Withdrawal by Subject|10|||
161084515|NCT00545753|581697580|FG000|Overall Study|Lost to Follow-up|13|||
161084516|NCT00545753|581697581|FG001|Overall Study|Lost to Follow-up|3|||
161084517|NCT00545753|581697582|FG002|Overall Study|Lost to Follow-up|12|||
161084518|NCT00545753|581697580|FG000|Overall Study|Protocol Violation|3|||
161084519|NCT00545753|581697581|FG001|Overall Study|Protocol Violation|1|||
161084520|NCT00545753|581697582|FG002|Overall Study|Protocol Violation|4|||
161084521|NCT01011153|581697583|FG000|Overall Study|Less than 78 cases completed|8|||
161084522|NCT01011153|581697584|FG001|Overall Study|Less than 78 cases completed|11|||
161084523|NCT01011153|581697585|FG002|Overall Study|Less than 78 cases completed|9|||
161084524|NCT03014479|581697590|FG000|Overall Study|Adverse Event|0|||
161084525|NCT03014479|581697591|FG001|Overall Study|Adverse Event|1|||
161084526|NCT03014479|581697590|FG000|Overall Study|Voluntary Withdrawal|0|||
161084527|NCT03014479|581697591|FG001|Overall Study|Voluntary Withdrawal|2|||
161084528|NCT03014479|581697590|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
161084529|NCT03014479|581697591|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
161084530|NCT01081132|581697597|FG000|Overall Study|Lack of Efficacy|25|||
161084531|NCT01081132|581697598|FG001|Overall Study|Lack of Efficacy|9|||
161084532|NCT01081132|581697597|FG000|Overall Study|Withdrawal by Subject|13|||
161084533|NCT01081132|581697598|FG001|Overall Study|Withdrawal by Subject|16|||
161084534|NCT01081132|581697597|FG000|Overall Study|Lost to Follow-up|4|||
161084535|NCT01081132|581697598|FG001|Overall Study|Lost to Follow-up|11|||
161084536|NCT01081132|581697597|FG000|Overall Study|Adverse Event|3|||
161084537|NCT01081132|581697598|FG001|Overall Study|Adverse Event|9|||
161084538|NCT01081132|581697597|FG000|Overall Study|Non Compliance|4|||
161084539|NCT01081132|581697598|FG001|Overall Study|Non Compliance|2|||
161084540|NCT01081132|581697597|FG000|Overall Study|Lack Of Compliance|0|||
161084541|NCT01081132|581697598|FG001|Overall Study|Lack Of Compliance|1|||
161084542|NCT01081132|581697597|FG000|Overall Study|Missed Visits|1|||
161084543|NCT01081132|581697598|FG001|Overall Study|Missed Visits|1|||
161084544|NCT01081132|581697597|FG000|Overall Study|Stopped Taking Meds|2|||
161084545|NCT01081132|581697598|FG001|Overall Study|Stopped Taking Meds|0|||
161084546|NCT01081132|581697597|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
161084547|NCT01081132|581697598|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
161084548|NCT01081132|581697597|FG000|Overall Study|Declined Taper Phase|0|||
161084549|NCT01081132|581697598|FG001|Overall Study|Declined Taper Phase|1|||
161084550|NCT01081132|581697597|FG000|Overall Study|Protocol Violation|3|||
161084551|NCT01081132|581697598|FG001|Overall Study|Protocol Violation|1|||
161084552|NCT02101385|581697599|FG000|Study Treatment|Disease Progression|9|||
161084553|NCT02101385|581697600|FG001|Study Treatment|Disease Progression|3|||
161084554|NCT02101385|581697599|FG000|Study Treatment|Alternative therapy|0|||
161084555|NCT02101385|581697600|FG001|Study Treatment|Alternative therapy|1|||
161084556|NCT02101385|581697599|FG000|Study Treatment|No treatment, per protocol criteria|0|||
161084557|NCT02101385|581697600|FG001|Study Treatment|No treatment, per protocol criteria|4|||
161084558|NCT02101385|581697599|FG000|Study Treatment|Patient Non compliance|0|||
161084559|NCT02101385|581697600|FG001|Study Treatment|Patient Non compliance|2|||
161084560|NCT02101385|581697599|FG000|Study Treatment|Withdrawal by Subject|5|||
161084561|NCT02101385|581697600|FG001|Study Treatment|Withdrawal by Subject|2|||
161084562|NCT02101385|581697599|FG000|Study Treatment|screen failure|1|||
161084563|NCT02101385|581697600|FG001|Study Treatment|screen failure|0|||
161084564|NCT02101385|581697599|FG000|Study Treatment|AE/Side Effects/Complications|8|||
161084565|NCT02101385|581697600|FG001|Study Treatment|AE/Side Effects/Complications|0|||
161084566|NCT02101385|581697599|FG000|Study Treatment|Lost to Follow-up|1|||
161084567|NCT02101385|581697600|FG001|Study Treatment|Lost to Follow-up|0|||
161290651|NCT03323398|582444329|FG006|Overall Study|Participant was Put on Hospice|1|||
161084568|NCT02101385|581697599|FG000|Study Treatment|Disease Progression before treatment|1|||
161290652|NCT03323398|582444330|FG007|Overall Study|Participant was Put on Hospice|0|||
161290653|NCT03323398|582444331|FG008|Overall Study|Participant was Put on Hospice|0|||
161169701|NCT03518034|581998775|FG001|Overall Study|Reason Missing|3|||
161169702|NCT00093470|581998784|FG000|Overall Study|Disease progression|39|||
161169703|NCT00093470|581998785|FG001|Overall Study|Disease progression|0|||
161169704|NCT00093470|581998784|FG000|Overall Study|Adverse Event|15|||
161169705|NCT00093470|581998785|FG001|Overall Study|Adverse Event|0|||
161169706|NCT00093470|581998784|FG000|Overall Study|Death|2|||
161169707|NCT00093470|581998785|FG001|Overall Study|Death|0|||
161290654|NCT03323398|582444323|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
161290655|NCT03323398|582444324|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
161290656|NCT03323398|582444325|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
161290657|NCT03323398|582444326|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
161290658|NCT03323398|582444327|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
161290659|NCT03323398|582444328|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
161290660|NCT03323398|582444329|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
161290661|NCT03323398|582444330|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
161290662|NCT03323398|582444331|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
161290663|NCT02235454|582444332|FG000|Overall Study|Withdrawal by Subject|2|||
161290664|NCT03641469|582444333|FG000|Overall Study|Ineligible|2|||
161290665|NCT03641469|582444333|FG000|Overall Study|Withdrawal by Subject|5|||
161290666|NCT03641469|582444333|FG000|Overall Study|Physician Decision|1|||
161169708|NCT00093470|581998784|FG000|Overall Study|Withdrawal by Subject|8|||
161169709|NCT00093470|581998785|FG001|Overall Study|Withdrawal by Subject|0|||
161169710|NCT00093470|581998784|FG000|Overall Study|Alternative therapy|2|||
161169711|NCT00093470|581998785|FG001|Overall Study|Alternative therapy|0|||
161169712|NCT00093470|581998784|FG000|Overall Study|Other complicating disease|3|||
161169713|NCT00093470|581998785|FG001|Overall Study|Other complicating disease|0|||
161169714|NCT00093470|581998784|FG000|Overall Study|Physician Decision|2|||
161169715|NCT00093470|581998785|FG001|Overall Study|Physician Decision|0|||
161169716|NCT00093470|581998784|FG000|Overall Study|Never started treatment|1|||
161169717|NCT00093470|581998785|FG001|Overall Study|Never started treatment|0|||
161169718|NCT00093470|581998784|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
161169719|NCT00093470|581998785|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
161169720|NCT01019252|581998786|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
161169721|NCT01019252|581998787|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
161169722|NCT01019252|581998786|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
161169723|NCT01019252|581998787|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
161169724|NCT01019252|581998786|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
161169725|NCT01019252|581998787|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
161169726|NCT01019252|581998786|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
161169727|NCT01019252|581998787|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
161169728|NCT02514772|581998788|FG000|Overall Study|Adverse Event|1|||
161169729|NCT02514772|581998789|FG001|Overall Study|Adverse Event|0|||
161169730|NCT02514772|581998788|FG000|Overall Study|Death|0|||
161169731|NCT02514772|581998789|FG001|Overall Study|Death|1|||
161169732|NCT02514772|581998788|FG000|Overall Study|Withdrawal by Subject|2|||
161169733|NCT02514772|581998789|FG001|Overall Study|Withdrawal by Subject|1|||
161169734|NCT00877006|581998790|FG000|Treatment Period|Death|2|||
161169735|NCT00877006|581998791|FG001|Treatment Period|Death|1|||
161169736|NCT00877006|581998790|FG000|Treatment Period|Adverse Event|10|||
161169737|NCT00877006|581998791|FG001|Treatment Period|Adverse Event|3|||
161169738|NCT00877006|581998790|FG000|Treatment Period|Withdrawal by Subject|2|||
161169739|NCT00877006|581998791|FG001|Treatment Period|Withdrawal by Subject|3|||
161169740|NCT00877006|581998790|FG000|Treatment Period|Protocol Violation|1|||
161169741|NCT00877006|581998791|FG001|Treatment Period|Protocol Violation|0|||
161169742|NCT00877006|581998790|FG000|Treatment Period|Lost to Follow-up|0|||
161290667|NCT03641469|582444333|FG000|Overall Study|Protocol Violation|1|||
161169743|NCT00877006|581998791|FG001|Treatment Period|Lost to Follow-up|1|||
161290668|NCT03641469|582444333|FG000|Overall Study|Lost to Follow-up|2|||
161290669|NCT01415518|582445936|FG000|Overall Study|Withdrawal by Subject|2|||
161290670|NCT01415518|582445937|FG001|Overall Study|Withdrawal by Subject|12|||
161290671|NCT01415518|582445936|FG000|Overall Study|Protocol Violation|6|||
161290672|NCT01415518|582445937|FG001|Overall Study|Protocol Violation|8|||
161169744|NCT00877006|581998790|FG000|Treatment Period|Disease Progression|1|||
161169745|NCT00877006|581998791|FG001|Treatment Period|Disease Progression|2|||
161169746|NCT00877006|581998790|FG000|Treatment Period|Started New Treatment Regimen|2|||
161169747|NCT00877006|581998791|FG001|Treatment Period|Started New Treatment Regimen|5|||
161169748|NCT00877006|581998790|FG000|Treatment Period|Other|4|||
161169749|NCT00877006|581998791|FG001|Treatment Period|Other|4|||
161169750|NCT00877006|581998790|FG000|Treatment Period|Randomized but Not Treated|3|||
161169751|NCT00877006|581998791|FG001|Treatment Period|Randomized but Not Treated|8|||
161290673|NCT01415518|582445936|FG000|Overall Study|Lost to Follow-up|3|||
161290674|NCT01415518|582445937|FG001|Overall Study|Lost to Follow-up|5|||
161290675|NCT01415518|582445936|FG000|Overall Study|Adverse Event|3|||
161169752|NCT00877006|581998790|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
161169753|NCT00877006|581998791|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
161169754|NCT00877006|581998790|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
161169755|NCT00877006|581998791|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
161169756|NCT00877006|581998790|FG000|Long-Term Follow-up Period|Death|26|||
161169757|NCT00877006|581998791|FG001|Long-Term Follow-up Period|Death|18|||
161169758|NCT00877006|581998790|FG000|Long-Term Follow-up Period|Other|7|||
161169759|NCT00877006|581998791|FG001|Long-Term Follow-up Period|Other|9|||
161169760|NCT04671342|581998792|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
161169761|NCT04671342|581998792|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
161169762|NCT04671342|581998792|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
161169763|NCT04671342|581998792|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
161169764|NCT04671342|581998792|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
161169765|NCT04671342|581998792|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
161169766|NCT03583606|581998793|FG000|Overall Study|Lost to Follow-up|0|||
161169767|NCT03583606|581998794|FG001|Overall Study|Lost to Follow-up|1|||
161169768|NCT03583606|581998795|FG002|Overall Study|Lost to Follow-up|0|||
161169769|NCT03583606|581998793|FG000|Overall Study|Ineligible at baseline|1|||
161169770|NCT03583606|581998794|FG001|Overall Study|Ineligible at baseline|0|||
161169771|NCT03583606|581998795|FG002|Overall Study|Ineligible at baseline|0|||
161169772|NCT00817206|581998796|FG000|Overall Study|Adverse Event|10|||
161169773|NCT00817206|581998797|FG001|Overall Study|Adverse Event|3|||
161169774|NCT00817206|581998796|FG000|Overall Study|Protocol Violation|0|||
161169775|NCT00817206|581998797|FG001|Overall Study|Protocol Violation|2|||
161169776|NCT00817206|581998796|FG000|Overall Study|Lost to Follow-up|0|||
161169777|NCT00817206|581998797|FG001|Overall Study|Lost to Follow-up|1|||
161169778|NCT00817206|581998796|FG000|Overall Study|Death|2|||
161169779|NCT00817206|581998797|FG001|Overall Study|Death|0|||
161169780|NCT00817206|581998796|FG000|Overall Study|Withdrawal by Subject|7|||
161169781|NCT00817206|581998797|FG001|Overall Study|Withdrawal by Subject|3|||
161169782|NCT00817206|581998796|FG000|Overall Study|Physician Decision|2|||
161169783|NCT00817206|581998797|FG001|Overall Study|Physician Decision|0|||
161169784|NCT00126581|581998798|FG000|Overall Study|Adverse Event|3|||
161169785|NCT00126581|581998799|FG001|Overall Study|Adverse Event|7|||
161169786|NCT00126581|581998798|FG000|Overall Study|Death|3|||
161169787|NCT00126581|581998799|FG001|Overall Study|Death|2|||
161169788|NCT00126581|581998798|FG000|Overall Study|Withdrawal by Subject|1|||
161169789|NCT00126581|581998799|FG001|Overall Study|Withdrawal by Subject|4|||
161169790|NCT00126581|581998798|FG000|Overall Study|Alternative therapy|3|||
161169791|NCT00126581|581998799|FG001|Overall Study|Alternative therapy|3|||
161169792|NCT00126581|581998798|FG000|Overall Study|Other illness/MD discretion|3|||
161169793|NCT00126581|581998799|FG001|Overall Study|Other illness/MD discretion|4|||
161169794|NCT00793182|581998800|FG000|Overall Study|Adverse Event|0|||
161169795|NCT00793182|581998801|FG001|Overall Study|Adverse Event|1|||
161169796|NCT03728140|581998802|FG000|Overall Study|Abnormal embryo transfer operation|10|||
161169797|NCT03728140|581998803|FG001|Overall Study|Abnormal embryo transfer operation|7|||
161169798|NCT02273037|581998805|FG000|Overall Study|Lost to Follow-up|1|||
161169799|NCT02273037|581998806|FG001|Overall Study|Lost to Follow-up|0|||
161169800|NCT02273037|581998805|FG000|Overall Study|Delivered before monitoring initiated|1|||
161169801|NCT02273037|581998806|FG001|Overall Study|Delivered before monitoring initiated|3|||
161169802|NCT02273037|581998805|FG000|Overall Study|Breech delivery|2|||
161169803|NCT02273037|581998806|FG001|Overall Study|Breech delivery|3|||
161169804|NCT02273037|581998805|FG000|Overall Study|Multiple delivery|2|||
161169805|NCT02273037|581998806|FG001|Overall Study|Multiple delivery|2|||
161169806|NCT02273037|581998805|FG000|Overall Study|Other complication|2|||
161169807|NCT02273037|581998806|FG001|Overall Study|Other complication|0|||
161169808|NCT00851253|581998807|FG000|Overall Study|Disease Progression|1|||
161169809|NCT00851253|581998808|FG001|Overall Study|Disease Progression|0|||
161290676|NCT01415518|582445937|FG001|Overall Study|Adverse Event|4|||
161290677|NCT01415518|582445936|FG000|Overall Study|Death|1|||
161290678|NCT01415518|582445937|FG001|Overall Study|Death|1|||
161290679|NCT01415518|582445936|FG000|Overall Study|Condition under Investigation Worsened|1|||
161169810|NCT03657810|581998813|FG000|Overall Study|Adverse Event|0|||
161169811|NCT03657810|581998814|FG001|Overall Study|Adverse Event|1|||
161169812|NCT03657810|581998815|FG002|Overall Study|Adverse Event|0|||
161169813|NCT03657810|581998813|FG000|Overall Study|Lack of Efficacy|4|||
161169814|NCT03657810|581998814|FG001|Overall Study|Lack of Efficacy|1|||
161169815|NCT03657810|581998815|FG002|Overall Study|Lack of Efficacy|3|||
161169816|NCT03657810|581998813|FG000|Overall Study|Protocol Violation|1|||
161169817|NCT03657810|581998814|FG001|Overall Study|Protocol Violation|0|||
161169818|NCT03657810|581998815|FG002|Overall Study|Protocol Violation|0|||
161169819|NCT03657810|581998813|FG000|Overall Study|Lost to Follow-up|0|||
161169820|NCT03657810|581998814|FG001|Overall Study|Lost to Follow-up|1|||
161169821|NCT03657810|581998815|FG002|Overall Study|Lost to Follow-up|0|||
161169822|NCT03657810|581998813|FG000|Overall Study|Not provided|0|||
161169823|NCT03657810|581998814|FG001|Overall Study|Not provided|1|||
161169824|NCT03657810|581998815|FG002|Overall Study|Not provided|0|||
161169825|NCT01527110|581998817|FG000|Overall Study|Adverse Event|1|||
161169826|NCT02007252|581998818|FG000|Overall Study|Administrative problems|3|||
161169827|NCT02007252|581998819|FG001|Overall Study|Administrative problems|7|||
161169828|NCT02007252|581998818|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161169829|NCT02007252|581998819|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161169830|NCT02007252|581998818|FG000|Overall Study|Adverse Event|7|||
161169831|NCT02007252|581998819|FG001|Overall Study|Adverse Event|4|||
161169832|NCT00367341|581998820|FG000|Overall Study|Physician Decision|1|||
161169833|NCT00367341|581998821|FG001|Overall Study|Physician Decision|0|||
161169834|NCT00367341|581998820|FG000|Overall Study|Protocol Violation|1|||
161169835|NCT00367341|581998821|FG001|Overall Study|Protocol Violation|0|||
161169836|NCT03325556|581998822|FG000|Open-label Period|Lack of Response in OL period|70|||
161169837|NCT03325556|581998823|FG001|Open-label Period|Lack of Response in OL period|0|||
161169838|NCT03325556|581998824|FG002|Open-label Period|Lack of Response in OL period|0|||
161169839|NCT03325556|581998822|FG000|Open-label Period|Adverse Event|27|||
161169840|NCT03325556|581998823|FG001|Open-label Period|Adverse Event|0|||
161169841|NCT03325556|581998824|FG002|Open-label Period|Adverse Event|0|||
161169842|NCT03325556|581998822|FG000|Open-label Period|Death|1|||
161169843|NCT03325556|581998823|FG001|Open-label Period|Death|0|||
161169844|NCT03325556|581998824|FG002|Open-label Period|Death|0|||
161169845|NCT03325556|581998822|FG000|Open-label Period|Lost to Follow-up|1|||
161169846|NCT03325556|581998823|FG001|Open-label Period|Lost to Follow-up|0|||
161169847|NCT03325556|581998824|FG002|Open-label Period|Lost to Follow-up|0|||
161169848|NCT03325556|581998822|FG000|Open-label Period|Non-compliance with study drug|5|||
161169849|NCT03325556|581998823|FG001|Open-label Period|Non-compliance with study drug|0|||
161169850|NCT03325556|581998824|FG002|Open-label Period|Non-compliance with study drug|0|||
161169851|NCT03325556|581998822|FG000|Open-label Period|Use of prohibited medication|1|||
161169852|NCT03325556|581998823|FG001|Open-label Period|Use of prohibited medication|0|||
161169853|NCT03325556|581998824|FG002|Open-label Period|Use of prohibited medication|0|||
161169854|NCT03325556|581998822|FG000|Open-label Period|Protocol Violation|4|||
161169855|NCT03325556|581998823|FG001|Open-label Period|Protocol Violation|0|||
161169856|NCT03325556|581998824|FG002|Open-label Period|Protocol Violation|0|||
161169857|NCT03325556|581998822|FG000|Open-label Period|Withdrawal by Subject|17|||
161169858|NCT03325556|581998823|FG001|Open-label Period|Withdrawal by Subject|0|||
161169859|NCT03325556|581998824|FG002|Open-label Period|Withdrawal by Subject|0|||
161169860|NCT03325556|581998822|FG000|Open-label Period|Not otherwise specified|8|||
161169861|NCT03325556|581998823|FG001|Open-label Period|Not otherwise specified|0|||
161169862|NCT03325556|581998824|FG002|Open-label Period|Not otherwise specified|0|||
161169863|NCT03325556|581998822|FG000|Open-label Period|Administrative discont. at study termination|41|||
161169864|NCT03325556|581998823|FG001|Open-label Period|Administrative discont. at study termination|0|||
161169865|NCT03325556|581998824|FG002|Open-label Period|Administrative discont. at study termination|0|||
161169866|NCT03325556|581998822|FG000|Double-blind Period|Relapse|0|||
161169867|NCT03325556|581998823|FG001|Double-blind Period|Relapse|15|||
161169868|NCT03325556|581998824|FG002|Double-blind Period|Relapse|34|||
161169869|NCT03325556|581998822|FG000|Double-blind Period|Adverse Event|0|||
161169870|NCT03325556|581998823|FG001|Double-blind Period|Adverse Event|3|||
161169871|NCT03325556|581998824|FG002|Double-blind Period|Adverse Event|1|||
161169872|NCT03325556|581998822|FG000|Double-blind Period|Noncompliance with study drug|0|||
161169873|NCT03325556|581998823|FG001|Double-blind Period|Noncompliance with study drug|0|||
161169874|NCT03325556|581998824|FG002|Double-blind Period|Noncompliance with study drug|1|||
161169875|NCT03325556|581998822|FG000|Double-blind Period|Use of prohibited medication|0|||
161169876|NCT03325556|581998823|FG001|Double-blind Period|Use of prohibited medication|1|||
161169877|NCT03325556|581998824|FG002|Double-blind Period|Use of prohibited medication|0|||
161169878|NCT03325556|581998822|FG000|Double-blind Period|Physician Decision|0|||
161169879|NCT03325556|581998823|FG001|Double-blind Period|Physician Decision|0|||
161169880|NCT03325556|581998824|FG002|Double-blind Period|Physician Decision|1|||
161169881|NCT03325556|581998822|FG000|Double-blind Period|Withdrawal by Subject|0|||
161169882|NCT03325556|581998823|FG001|Double-blind Period|Withdrawal by Subject|6|||
161169883|NCT03325556|581998824|FG002|Double-blind Period|Withdrawal by Subject|4|||
161169884|NCT03325556|581998822|FG000|Double-blind Period|Not otherwise specified|0|||
161169885|NCT03325556|581998823|FG001|Double-blind Period|Not otherwise specified|1|||
161169886|NCT03325556|581998824|FG002|Double-blind Period|Not otherwise specified|5|||
161169887|NCT03325556|581998822|FG000|Double-blind Period|Administrative discont. at study termination|0|||
161169888|NCT03325556|581998823|FG001|Double-blind Period|Administrative discont. at study termination|35|||
161169889|NCT03325556|581998824|FG002|Double-blind Period|Administrative discont. at study termination|31|||
161169890|NCT01705587|581998825|FG000|Overall Study|Withdrawal by Subject|0|||
161169891|NCT01705587|581998826|FG001|Overall Study|Withdrawal by Subject|1|||
161169892|NCT00762268|581998827|FG000|Overall Study|Withdrawal by Subject|3|||
161169893|NCT00762268|581998828|FG001|Overall Study|Withdrawal by Subject|3|||
161169894|NCT04603391|581998829|FG000|First Intervention (4 Days)|Adverse Event|1|||
161169895|NCT04603391|581998830|FG001|First Intervention (4 Days)|Adverse Event|0|||
161169896|NCT04603391|581998829|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
161169897|NCT04603391|581998830|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
161169898|NCT02759861|581998833|FG000|Overall Study|Death|1|||
161347181|NCT02293499|582656208|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
161169899|NCT02151682|581998834|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161169900|NCT02151682|581998835|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
161169901|NCT02151682|581998836|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161169902|NCT02151682|581998837|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161169903|NCT02151682|581998838|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161169904|NCT02151682|581998839|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
161169905|NCT02151682|581998834|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161169906|NCT02151682|581998835|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
161169907|NCT02151682|581998836|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161169908|NCT02151682|581998837|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161169909|NCT02151682|581998838|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161169910|NCT02151682|581998839|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
161169911|NCT02151682|581998834|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161169912|NCT02151682|581998835|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
161169913|NCT02151682|581998836|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161169914|NCT02151682|581998837|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161169915|NCT02151682|581998838|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161169916|NCT02151682|581998839|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
161169917|NCT02151682|581998834|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
161169918|NCT02151682|581998835|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
161169919|NCT02151682|581998836|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161169920|NCT02151682|581998837|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161169921|NCT02151682|581998838|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161169922|NCT02151682|581998839|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
161169923|NCT02151682|581998834|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
161169924|NCT02151682|581998835|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161169925|NCT02151682|581998836|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161084569|NCT02101385|581697600|FG001|Study Treatment|Disease Progression before treatment|0|||
161084570|NCT02101385|581697599|FG000|Study Treatment|Death|1|||
161084571|NCT02101385|581697600|FG001|Study Treatment|Death|0|||
161084572|NCT02101385|581697599|FG000|Follow up|Lost to Follow-up|4|||
161084573|NCT02101385|581697600|FG001|Follow up|Lost to Follow-up|9|||
161084574|NCT02101385|581697599|FG000|Follow up|Refused to follow up|5|||
161084575|NCT02101385|581697600|FG001|Follow up|Refused to follow up|4|||
161084576|NCT02101385|581697599|FG000|Follow up|Death|21|||
161084577|NCT02101385|581697600|FG001|Follow up|Death|39|||
161084578|NCT02101385|581697599|FG000|Follow up|study completed|33|||
161084579|NCT02101385|581697600|FG001|Follow up|study completed|52|||
161084580|NCT02101385|581697599|FG000|Follow up|screen failure|2|||
161084581|NCT02101385|581697600|FG001|Follow up|screen failure|0|||
161084582|NCT02101385|581697599|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
161084583|NCT02101385|581697600|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
161084584|NCT02101385|581697599|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
161084585|NCT02101385|581697600|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
161084586|NCT02101385|581697599|FG000|Follow up|Withdrawal by Subject|2|||
161084587|NCT02101385|581697600|FG001|Follow up|Withdrawal by Subject|2|||
161084588|NCT02101385|581697599|FG000|Follow up|PI requested closure of site|0|||
161084589|NCT02101385|581697600|FG001|Follow up|PI requested closure of site|5|||
161084590|NCT03973931|581697607|FG000|Overall Study|Lost to Follow-up|47|||
161084591|NCT03973931|581697608|FG001|Overall Study|Lost to Follow-up|63|||
161084592|NCT03973931|581697609|FG002|Overall Study|Lost to Follow-up|51|||
161084593|NCT03973931|581697610|FG003|Overall Study|Lost to Follow-up|54|||
161084594|NCT03973931|581697607|FG000|Overall Study|opted out|6|||
161084595|NCT03973931|581697608|FG001|Overall Study|opted out|5|||
161084596|NCT03973931|581697609|FG002|Overall Study|opted out|5|||
161084597|NCT03973931|581697610|FG003|Overall Study|opted out|1|||
161084598|NCT03541174|581698799|FG000|Part 1 Double-Blind|Adverse Event|6|||
161084599|NCT03541174|581698800|FG001|Part 1 Double-Blind|Adverse Event|5|||
161084600|NCT03541174|581698801|FG002|Part 1 Double-Blind|Adverse Event|2|||
161084601|NCT03541174|581698802|FG003|Part 1 Double-Blind|Adverse Event|0|||
161084602|NCT03541174|581698803|FG004|Part 1 Double-Blind|Adverse Event|0|||
161084603|NCT03541174|581698804|FG005|Part 1 Double-Blind|Adverse Event|0|||
161084604|NCT03541174|581698799|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
161084605|NCT03541174|581698800|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
161084606|NCT03541174|581698801|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
161084607|NCT03541174|581698802|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
161169926|NCT02151682|581998837|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161169927|NCT02151682|581998838|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161169928|NCT02151682|581998839|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
161169929|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161169930|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161169931|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
161169932|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161169933|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161169934|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
161169935|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
161169936|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
161169937|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
161169938|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
161169939|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
161169940|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
161169941|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161169942|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161169943|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
161169944|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
161169945|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161169946|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
161169947|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161169948|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161169949|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
161169950|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161169951|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161169952|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
161169953|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161169954|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161169955|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
161169956|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161169957|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161169958|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
161169959|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161169960|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161169961|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
161169962|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161169963|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161169964|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
161169965|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
161169966|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
161169967|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
161169968|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
161169969|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
161169970|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
161169971|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
161169972|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
161169973|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
161169974|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
161169975|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
161169976|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
161169977|NCT02151682|581998834|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161169978|NCT02151682|581998835|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161169979|NCT02151682|581998836|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
161169980|NCT02151682|581998837|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161169981|NCT02151682|581998838|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161169982|NCT02151682|581998839|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
161169983|NCT02151682|581998834|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161169984|NCT02151682|581998835|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161169985|NCT02151682|581998836|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161169986|NCT02151682|581998837|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161290680|NCT01415518|582445937|FG001|Overall Study|Condition under Investigation Worsened|1|||
161169987|NCT02151682|581998838|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
161169988|NCT02151682|581998839|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
161169989|NCT02151682|581998834|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161169990|NCT02151682|581998835|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161169991|NCT02151682|581998836|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161169992|NCT02151682|581998837|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161169993|NCT02151682|581998838|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
161084608|NCT03541174|581698803|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
161084609|NCT03541174|581698804|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
161084610|NCT03541174|581698799|FG000|Part 1 Double-Blind|Other reasons|3|||
161084611|NCT03541174|581698800|FG001|Part 1 Double-Blind|Other reasons|2|||
161084612|NCT03541174|581698801|FG002|Part 1 Double-Blind|Other reasons|3|||
161084613|NCT03541174|581698802|FG003|Part 1 Double-Blind|Other reasons|0|||
161084614|NCT03541174|581698803|FG004|Part 1 Double-Blind|Other reasons|0|||
161084615|NCT03541174|581698804|FG005|Part 1 Double-Blind|Other reasons|0|||
161084616|NCT03541174|581698799|FG000|Part 2 Single-Blind|Adverse Event|0|||
161084617|NCT03541174|581698800|FG001|Part 2 Single-Blind|Adverse Event|0|||
161084618|NCT03541174|581698801|FG002|Part 2 Single-Blind|Adverse Event|0|||
161084619|NCT03541174|581698802|FG003|Part 2 Single-Blind|Adverse Event|25|||
161084620|NCT03541174|581698803|FG004|Part 2 Single-Blind|Adverse Event|0|||
161084621|NCT03541174|581698804|FG005|Part 2 Single-Blind|Adverse Event|0|||
161084622|NCT03541174|581698799|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
161084623|NCT03541174|581698800|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
161084624|NCT03541174|581698801|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
161084625|NCT03541174|581698802|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
161084626|NCT03541174|581698803|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
161084627|NCT03541174|581698804|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
161084628|NCT03541174|581698799|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
161084629|NCT03541174|581698800|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
161084630|NCT03541174|581698801|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
161084631|NCT03541174|581698802|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
161084632|NCT03541174|581698803|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
161084633|NCT03541174|581698804|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
161084634|NCT03541174|581698799|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
161084635|NCT03541174|581698800|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
161084636|NCT03541174|581698801|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
161084637|NCT03541174|581698802|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
161084638|NCT03541174|581698803|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
161084639|NCT03541174|581698804|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
161084640|NCT03541174|581698799|FG000|Part 2 Single-Blind|Death|0|||
161084641|NCT03541174|581698800|FG001|Part 2 Single-Blind|Death|0|||
161084642|NCT03541174|581698801|FG002|Part 2 Single-Blind|Death|0|||
161084643|NCT03541174|581698802|FG003|Part 2 Single-Blind|Death|5|||
161084644|NCT03541174|581698803|FG004|Part 2 Single-Blind|Death|0|||
161084645|NCT03541174|581698804|FG005|Part 2 Single-Blind|Death|0|||
161084646|NCT03541174|581698799|FG000|Part 2 Single-Blind|Pregnancy|0|||
161084647|NCT03541174|581698800|FG001|Part 2 Single-Blind|Pregnancy|0|||
161084648|NCT03541174|581698801|FG002|Part 2 Single-Blind|Pregnancy|0|||
161084649|NCT03541174|581698802|FG003|Part 2 Single-Blind|Pregnancy|1|||
161084650|NCT03541174|581698803|FG004|Part 2 Single-Blind|Pregnancy|0|||
161084651|NCT03541174|581698804|FG005|Part 2 Single-Blind|Pregnancy|0|||
161084652|NCT03541174|581698799|FG000|Part 2 Single-Blind|Other reasons|0|||
161084653|NCT03541174|581698800|FG001|Part 2 Single-Blind|Other reasons|0|||
161084654|NCT03541174|581698801|FG002|Part 2 Single-Blind|Other reasons|0|||
161084655|NCT03541174|581698802|FG003|Part 2 Single-Blind|Other reasons|32|||
161084656|NCT03541174|581698803|FG004|Part 2 Single-Blind|Other reasons|0|||
161084657|NCT03541174|581698804|FG005|Part 2 Single-Blind|Other reasons|0|||
161084658|NCT03541174|581698799|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161084659|NCT03541174|581698800|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161084660|NCT03541174|581698801|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161084661|NCT03541174|581698802|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
161084662|NCT03541174|581698803|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
161084663|NCT03541174|581698804|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
161084664|NCT03541174|581698799|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161084665|NCT03541174|581698800|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161084666|NCT03541174|581698801|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161084667|NCT03541174|581698802|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
161084668|NCT03541174|581698803|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
161084669|NCT03541174|581698804|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
161084670|NCT03541174|581698799|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161084671|NCT03541174|581698800|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161084672|NCT03541174|581698801|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161084673|NCT03541174|581698802|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161084674|NCT03541174|581698803|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
161084675|NCT03541174|581698804|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
161084676|NCT03541174|581698799|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161084677|NCT03541174|581698800|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161084678|NCT03541174|581698801|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161084679|NCT03541174|581698802|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
161084680|NCT03541174|581698803|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
161084681|NCT03541174|581698804|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
161084682|NCT03541174|581698799|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161169994|NCT02151682|581998839|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
161169995|NCT02151682|581998834|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161169996|NCT02151682|581998835|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161169997|NCT02151682|581998836|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161169998|NCT02151682|581998837|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161169999|NCT02151682|581998838|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
161170000|NCT02151682|581998839|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
161170001|NCT02151682|581998834|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161170002|NCT02151682|581998835|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161170003|NCT02151682|581998836|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161170004|NCT02151682|581998837|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161170005|NCT02151682|581998838|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
161170006|NCT02151682|581998839|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
161170007|NCT01192204|581998842|FG000|Overall Study|could not keep recall appointments|1|||
161170008|NCT01192204|581998843|FG001|Overall Study|could not keep recall appointments|0|||
161170009|NCT05127421|581998844|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
161170010|NCT05127421|581998845|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
161170011|NCT05127421|581998846|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
161170012|NCT05127421|581998847|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
161170013|NCT05127421|581998844|FG000|4-Week Double-Blind Period|Physician Decision|1|||
161170014|NCT05127421|581998845|FG001|4-Week Double-Blind Period|Physician Decision|0|||
161170015|NCT05127421|581998846|FG002|4-Week Double-Blind Period|Physician Decision|0|||
161170016|NCT05127421|581998847|FG003|4-Week Double-Blind Period|Physician Decision|0|||
161170017|NCT05127421|581998844|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
161170018|NCT05127421|581998845|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
161170019|NCT05127421|581998846|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
161170020|NCT05127421|581998847|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
161170021|NCT05127421|581998844|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161170022|NCT05127421|581998845|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
161170023|NCT05127421|581998846|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161170024|NCT05127421|581998847|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
161170025|NCT05127421|581998844|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161170026|NCT05127421|581998845|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
161170027|NCT05127421|581998846|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161170028|NCT05127421|581998847|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
161170029|NCT05127421|581998844|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
161170030|NCT05127421|581998845|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
161170031|NCT05127421|581998846|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
161170032|NCT05127421|581998847|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
161170033|NCT05127421|581998844|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
161170034|NCT05127421|581998845|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
161170035|NCT05127421|581998846|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
161170036|NCT05127421|581998847|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
161170037|NCT05127421|581998844|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161290681|NCT05364931|582445941|FG000|Overall Study|Adverse Event|0|||
161290682|NCT05364931|582445942|FG001|Overall Study|Adverse Event|2|||
161290683|NCT05364931|582445943|FG002|Overall Study|Adverse Event|1|||
161290684|NCT05364931|582445944|FG003|Overall Study|Adverse Event|0|||
161290685|NCT05364931|582445941|FG000|Overall Study|Lost to Follow-up|1|||
161290686|NCT05364931|582445942|FG001|Overall Study|Lost to Follow-up|0|||
161290687|NCT05364931|582445943|FG002|Overall Study|Lost to Follow-up|0|||
161290688|NCT05364931|582445944|FG003|Overall Study|Lost to Follow-up|0|||
161290689|NCT05364931|582445941|FG000|Overall Study|Withdrawal by Subject|1|||
161290690|NCT05364931|582445942|FG001|Overall Study|Withdrawal by Subject|1|||
161290691|NCT05364931|582445943|FG002|Overall Study|Withdrawal by Subject|3|||
161290692|NCT05364931|582445944|FG003|Overall Study|Withdrawal by Subject|2|||
161290693|NCT05364931|582445941|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161290694|NCT05364931|582445942|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
161290695|NCT05364931|582445943|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161290696|NCT05364931|582445944|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
161290697|NCT05364931|582445941|FG000|Overall Study|Discontinued|1|||
161290698|NCT05364931|582445942|FG001|Overall Study|Discontinued|0|||
161290699|NCT05364931|582445943|FG002|Overall Study|Discontinued|0|||
161290700|NCT05364931|582445944|FG003|Overall Study|Discontinued|0|||
161319389|NCT01134263|582555302|FG002|Overall Study|Serious adverse event|1|||
161170038|NCT05127421|581998845|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161170039|NCT05127421|581998846|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
161170040|NCT05127421|581998847|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
161319390|NCT01134263|582555303|FG003|Overall Study|Serious adverse event|1|||
161170041|NCT00618449|581998848|FG000|Overall Study|Lost to Follow-up|98|||
161170042|NCT00618449|581998849|FG001|Overall Study|Lost to Follow-up|110|||
161170043|NCT02219087|581998850|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
161170044|NCT02219087|581998851|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
161170045|NCT04311177|581998852|FG000|Overall Study|Adverse Event|3|||
161170046|NCT04311177|581998853|FG001|Overall Study|Adverse Event|1|||
161170047|NCT04311177|581998852|FG000|Overall Study|Physician Decision|4|||
161170048|NCT04311177|581998853|FG001|Overall Study|Physician Decision|3|||
161170049|NCT04311177|581998852|FG000|Overall Study|Withdrawal by Subject|1|||
161170050|NCT04311177|581998853|FG001|Overall Study|Withdrawal by Subject|0|||
161170051|NCT00574496|581998856|FG000|Overall Study|Withdrawal by Subject|1|||
161170052|NCT01969799|581998857|FG000|Overall Study|Adverse Event|0|||
161170053|NCT01969799|581998858|FG001|Overall Study|Adverse Event|1|||
161170054|NCT01969799|581998857|FG000|Overall Study|Death|16|||
161170055|NCT01969799|581998858|FG001|Overall Study|Death|11|||
161170056|NCT01969799|581998857|FG000|Overall Study|Lost to Follow-up|0|||
161170057|NCT01969799|581998858|FG001|Overall Study|Lost to Follow-up|2|||
161170058|NCT01969799|581998857|FG000|Overall Study|Physician Decision|1|||
161170059|NCT01969799|581998858|FG001|Overall Study|Physician Decision|0|||
161170060|NCT02270684|581998863|FG000|Overall Study|Lost to Follow-up|0|||
161170061|NCT02270684|581998864|FG001|Overall Study|Lost to Follow-up|3|||
161170062|NCT02270684|581998863|FG000|Overall Study|Study terminated|1|||
161170063|NCT02270684|581998864|FG001|Overall Study|Study terminated|0|||
161170064|NCT02247401|581998865|FG000|Overall Study|Adverse Event|1|||
161170065|NCT02247401|581998866|FG001|Overall Study|Adverse Event|0|||
161170066|NCT02247401|581998867|FG002|Overall Study|Adverse Event|0|||
161170067|NCT02247401|581998865|FG000|Overall Study|Withdrawal by Subject|4|||
161170068|NCT02247401|581998866|FG001|Overall Study|Withdrawal by Subject|1|||
161170069|NCT02247401|581998867|FG002|Overall Study|Withdrawal by Subject|1|||
161170070|NCT02247401|581998865|FG000|Overall Study|Lost to Follow-up|1|||
161170071|NCT02247401|581998866|FG001|Overall Study|Lost to Follow-up|1|||
161170072|NCT02247401|581998867|FG002|Overall Study|Lost to Follow-up|1|||
161170073|NCT04169061|581998868|FG000|Overall Study|Adverse Event|2|||
161170074|NCT04169061|581998868|FG000|Overall Study|Death|1|||
161170075|NCT04169061|581998868|FG000|Overall Study|Withdrawal by Subject|1|||
161170076|NCT04169061|581998868|FG000|Overall Study|Protocol Violation|1|||
161170077|NCT02555657|581998869|FG000|Overall Study|Death|274|||
161170078|NCT02555657|581998870|FG001|Overall Study|Death|262|||
161170079|NCT02555657|581998869|FG000|Overall Study|Physician Decision|0|||
161170080|NCT02555657|581998870|FG001|Overall Study|Physician Decision|1|||
161170081|NCT02555657|581998869|FG000|Overall Study|Sponsor Decision|27|||
161170082|NCT02555657|581998870|FG001|Overall Study|Sponsor Decision|15|||
161170083|NCT02555657|581998869|FG000|Overall Study|Withdrawal by Subject|11|||
161170084|NCT02555657|581998870|FG001|Overall Study|Withdrawal by Subject|32|||
161170085|NCT02188719|581998872|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161170086|NCT02188719|581998873|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
161170087|NCT02188719|581998874|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161170088|NCT02188719|581998875|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
161170089|NCT00192036|581998878|FG000|Overall Study|Protocol Violation|3|||
161170090|NCT00192036|581998878|FG000|Overall Study|Adverse Event|6|||
161170091|NCT00192036|581998878|FG000|Overall Study|Patient/Physician Perception|1|||
161170092|NCT00192036|581998878|FG000|Overall Study|Objective Tumor Progression|4|||
161170093|NCT00192036|581998878|FG000|Overall Study|Clinical Disease Progression|1|||
161170094|NCT00192036|581998878|FG000|Overall Study|Death|1|||
161170095|NCT00192036|581998878|FG000|Overall Study|Unknown or Not Specified|5|||
161170096|NCT03371732|581998879|FG000|Overall Study|Withdrawal by Subject|9|||
161170097|NCT03371732|581998880|FG001|Overall Study|Withdrawal by Subject|3|||
161170098|NCT03371732|581998879|FG000|Overall Study|Refusal to continue|3|||
161170099|NCT03371732|581998880|FG001|Overall Study|Refusal to continue|4|||
161170100|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
161170101|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
161170102|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
161170103|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
161170104|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
161170105|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
161170106|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
161170107|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
161170108|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
161170109|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
161170110|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
161170111|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
161170112|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161170113|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
161170114|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161290701|NCT03976362|582445945|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
161290702|NCT03976362|582445946|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161290703|NCT03976362|582445947|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161290704|NCT03976362|582445945|FG000|Induction Phase|Death|62|||
161290705|NCT03976362|582445946|FG001|Induction Phase|Death|0|||
161290706|NCT03976362|582445947|FG002|Induction Phase|Death|0|||
161290707|NCT03976362|582445945|FG000|Maintenance Phase|Participants Ongoing|0|||
161290708|NCT03976362|582445946|FG001|Maintenance Phase|Participants Ongoing|106|||
161290709|NCT03976362|582445947|FG002|Maintenance Phase|Participants Ongoing|103|||
161290710|NCT03976362|582445945|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161290711|NCT03976362|582445946|FG001|Maintenance Phase|Withdrawal by Subject|4|||
161290712|NCT03976362|582445947|FG002|Maintenance Phase|Withdrawal by Subject|4|||
161290713|NCT03976362|582445945|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
161290714|NCT03976362|582445946|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
161290715|NCT03976362|582445947|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
161290716|NCT03976362|582445945|FG000|Maintenance Phase|Death|0|||
161290717|NCT03976362|582445946|FG001|Maintenance Phase|Death|186|||
161290718|NCT03976362|582445947|FG002|Maintenance Phase|Death|187|||
161290719|NCT04846569|582445948|FG000|Overall Study|Withdrawal by Subject|3|||
161290720|NCT04846569|582445949|FG001|Overall Study|Withdrawal by Subject|1|||
161170115|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
161170116|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
161170117|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
161170118|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
161170119|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
161170120|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
161170121|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
161170122|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
161170123|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
161170124|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
161170125|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
161170126|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
161170127|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
161170128|NCT00476996|581998881|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
161170129|NCT00476996|581998882|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
161170130|NCT00476996|581998883|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
161170131|NCT00476996|581998884|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
161170132|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161170133|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161170134|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
161170135|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
161170136|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
161170137|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
161170138|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
161170139|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
161170140|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Death|0|||
161170141|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Death|0|||
161170142|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Death|0|||
161170143|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Death|7|||
161170144|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161170145|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161170146|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
161170147|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
161170148|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161170149|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161170150|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
161170151|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
161170152|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161290721|NCT01120184|582445954|FG000|Overall Study|Adverse Event|0|||
161290722|NCT01120184|582445955|FG001|Overall Study|Adverse Event|1|||
161290723|NCT01120184|582445956|FG002|Overall Study|Adverse Event|0|||
161290724|NCT01120184|582445954|FG000|Overall Study|Lost to Follow-up|13|||
161290725|NCT01120184|582445955|FG001|Overall Study|Lost to Follow-up|13|||
161290726|NCT01120184|582445956|FG002|Overall Study|Lost to Follow-up|11|||
161290727|NCT01120184|582445954|FG000|Overall Study|Physician Decision|9|||
161290728|NCT01120184|582445955|FG001|Overall Study|Physician Decision|1|||
161290729|NCT01120184|582445956|FG002|Overall Study|Physician Decision|3|||
161347182|NCT02293499|582656209|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
161290730|NCT01120184|582445954|FG000|Overall Study|Reason not Specified|8|||
161290731|NCT01120184|582445955|FG001|Overall Study|Reason not Specified|3|||
161347183|NCT02293499|582656210|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
161170153|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161170154|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
161170155|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
161170156|NCT00476996|581998881|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
161170157|NCT00476996|581998882|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
161170158|NCT00476996|581998883|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
161170159|NCT00476996|581998884|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
161170160|NCT02133742|581998898|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
161170161|NCT02133742|581998898|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
161170162|NCT02133742|581998898|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
161170163|NCT02133742|581998898|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
161170164|NCT02133742|581998898|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
161170165|NCT03479216|581998899|FG000|Overall Study|Withdrawal by Subject|3|||
161170166|NCT03479216|581998900|FG001|Overall Study|Withdrawal by Subject|2|||
161170167|NCT03479216|581998899|FG000|Overall Study|Physician Decision|2|||
161170168|NCT03479216|581998900|FG001|Overall Study|Physician Decision|3|||
161170169|NCT02031432|581998905|FG000|Overall Study|Protocol Violation|1|||
161170170|NCT02031432|581998905|FG000|Overall Study|Lack of Efficacy|5|||
161170171|NCT02031432|581998905|FG000|Overall Study|Cancer Progression|2|||
161170172|NCT02031432|581998905|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
161170173|NCT02031432|581998905|FG000|Overall Study|Adverse Event|8|||
161170174|NCT02031432|581998905|FG000|Overall Study|Withdrawal by Subject|5|||
161170175|NCT02031432|581998905|FG000|Overall Study|Lost to Follow-up|1|||
161170176|NCT02031432|581998905|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
161170177|NCT02031432|581998905|FG000|Overall Study|Death|10|||
161170178|NCT02148211|581998906|FG000|Overall Study|Lost to Follow-up|352|||
161170179|NCT05406440|582000944|FG000|Overall Study|Lost to Follow-up|0|||
161170180|NCT05406440|582000945|FG001|Overall Study|Lost to Follow-up|0|||
161170181|NCT05406440|582000946|FG002|Overall Study|Lost to Follow-up|0|||
161170182|NCT05406440|582000947|FG003|Overall Study|Lost to Follow-up|0|||
161170183|NCT05406440|582000948|FG004|Overall Study|Lost to Follow-up|2|||
161170184|NCT05406440|582000949|FG005|Overall Study|Lost to Follow-up|0|||
161170185|NCT05406440|582000950|FG006|Overall Study|Lost to Follow-up|0|||
161170186|NCT05406440|582000944|FG000|Overall Study|Physician Decision|0|||
161170187|NCT05406440|582000945|FG001|Overall Study|Physician Decision|0|||
161170188|NCT05406440|582000946|FG002|Overall Study|Physician Decision|0|||
161170189|NCT05406440|582000947|FG003|Overall Study|Physician Decision|0|||
161170190|NCT05406440|582000948|FG004|Overall Study|Physician Decision|1|||
161170191|NCT05406440|582000949|FG005|Overall Study|Physician Decision|0|||
161170192|NCT05406440|582000950|FG006|Overall Study|Physician Decision|0|||
161170193|NCT05406440|582000944|FG000|Overall Study|Withdrawal by Subject|0|||
161170194|NCT05406440|582000945|FG001|Overall Study|Withdrawal by Subject|0|||
161170195|NCT05406440|582000946|FG002|Overall Study|Withdrawal by Subject|0|||
161170196|NCT05406440|582000947|FG003|Overall Study|Withdrawal by Subject|0|||
161170197|NCT05406440|582000948|FG004|Overall Study|Withdrawal by Subject|0|||
161170198|NCT05406440|582000949|FG005|Overall Study|Withdrawal by Subject|2|||
161170199|NCT05406440|582000950|FG006|Overall Study|Withdrawal by Subject|0|||
161170200|NCT01412151|582000951|FG000|Week 0 - 306 - Treatment Period|Death|1|||
161170201|NCT01412151|582000951|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
161170202|NCT01412151|582000951|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
161170203|NCT01412151|582000951|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
161170204|NCT03127852|582000952|FG000|Overall Study|Withdrawal by Subject|4|||
161170205|NCT03127852|582000953|FG001|Overall Study|Withdrawal by Subject|1|||
161170206|NCT03127852|582000952|FG000|Overall Study|Death|1|||
161170207|NCT03127852|582000953|FG001|Overall Study|Death|1|||
161170208|NCT03621189|582000954|FG000|Overall Study|Withdrawal by Subject|0|||
161170209|NCT03621189|582000955|FG001|Overall Study|Withdrawal by Subject|3|||
161170210|NCT03621189|582000954|FG000|Overall Study|Physician Decision|0|||
161170211|NCT03621189|582000955|FG001|Overall Study|Physician Decision|2|||
161170212|NCT03892707|582000962|FG000|Overall Study|Screen failure|6|||
161170213|NCT03892707|582000963|FG001|Overall Study|Screen failure|0|||
161170214|NCT03892707|582000962|FG000|Overall Study|Pain resolution|0|||
161170215|NCT03892707|582000963|FG001|Overall Study|Pain resolution|4|||
161170216|NCT03892707|582000962|FG000|Overall Study|Withdrawal by Subject|0|||
161170217|NCT03892707|582000963|FG001|Overall Study|Withdrawal by Subject|1|||
161170218|NCT03892707|582000962|FG000|Overall Study|Other (long business trip)|0|||
161170219|NCT03892707|582000963|FG001|Overall Study|Other (long business trip)|1|||
161170220|NCT05224076|582000966|FG000|Overall Study|Lost to Follow-up|24|||
161170221|NCT01807949|582000968|FG000|Overall Study|Adverse Event|1|||
161290732|NCT01120184|582445956|FG002|Overall Study|Reason not Specified|12|||
161290733|NCT01120184|582445954|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
161290734|NCT01120184|582445955|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
161290735|NCT01120184|582445956|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
161290736|NCT01120184|582445954|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
161170222|NCT01807949|582000969|FG001|Overall Study|Adverse Event|2|||
161084683|NCT03541174|581698800|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161084684|NCT03541174|581698801|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161084685|NCT03541174|581698802|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161084686|NCT03541174|581698803|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
161084687|NCT03541174|581698804|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
161084688|NCT00605215|581698805|FG000|Overall Study|Death|0|||
161084689|NCT00605215|581698806|FG001|Overall Study|Death|0|||
161084690|NCT00605215|581698807|FG002|Overall Study|Death|1|||
161084691|NCT00605215|581698805|FG000|Overall Study|Adverse Event|19|||
161084692|NCT00605215|581698806|FG001|Overall Study|Adverse Event|21|||
161084693|NCT00605215|581698807|FG002|Overall Study|Adverse Event|26|||
161084694|NCT00605215|581698805|FG000|Overall Study|Refusal to sign the re-consent form|8|||
161084695|NCT00605215|581698806|FG001|Overall Study|Refusal to sign the re-consent form|3|||
161084696|NCT00605215|581698807|FG002|Overall Study|Refusal to sign the re-consent form|3|||
161084697|NCT00605215|581698805|FG000|Overall Study|Withdrawal by Subject|39|||
161084698|NCT00605215|581698806|FG001|Overall Study|Withdrawal by Subject|37|||
161084699|NCT00605215|581698807|FG002|Overall Study|Withdrawal by Subject|27|||
161084700|NCT00605215|581698805|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
161084701|NCT00605215|581698806|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
161084702|NCT00605215|581698807|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
161084703|NCT00605215|581698805|FG000|Overall Study|Protocol Violation|3|||
161084704|NCT00605215|581698806|FG001|Overall Study|Protocol Violation|4|||
161084705|NCT00605215|581698807|FG002|Overall Study|Protocol Violation|1|||
161084706|NCT00605215|581698805|FG000|Overall Study|Pregnancy|8|||
161084707|NCT00605215|581698806|FG001|Overall Study|Pregnancy|5|||
161084708|NCT00605215|581698807|FG002|Overall Study|Pregnancy|4|||
161084709|NCT00605215|581698805|FG000|Overall Study|Lost to Follow-up|8|||
161084710|NCT00605215|581698806|FG001|Overall Study|Lost to Follow-up|5|||
161084711|NCT00605215|581698807|FG002|Overall Study|Lost to Follow-up|2|||
161084712|NCT00605215|581698805|FG000|Overall Study|Other than specified|0|||
161084713|NCT00605215|581698806|FG001|Overall Study|Other than specified|2|||
161084714|NCT00605215|581698807|FG002|Overall Study|Other than specified|1|||
161084715|NCT00275262|581698814|FG000|Overall Study|Adverse Event|2|||
161084716|NCT00275262|581698815|FG001|Overall Study|Adverse Event|0|||
161084717|NCT00275262|581698814|FG000|Overall Study|Disease progression|2|||
161084718|NCT00275262|581698815|FG001|Overall Study|Disease progression|5|||
161084719|NCT00275262|581698814|FG000|Overall Study|Lost to Follow-up|0|||
161084720|NCT00275262|581698815|FG001|Overall Study|Lost to Follow-up|2|||
161084721|NCT00275262|581698814|FG000|Overall Study|Protocol Violation|0|||
161084722|NCT00275262|581698815|FG001|Overall Study|Protocol Violation|2|||
161084723|NCT00275262|581698814|FG000|Overall Study|Death|1|||
161084724|NCT00275262|581698815|FG001|Overall Study|Death|0|||
161084725|NCT00275262|581698814|FG000|Overall Study|Started Chemotherapy|1|||
161084726|NCT00275262|581698815|FG001|Overall Study|Started Chemotherapy|0|||
161084727|NCT04058366|581698818|FG000|Overall Study|Adverse Event|14|||
161084728|NCT04058366|581698818|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
161084729|NCT04058366|581698818|FG000|Overall Study|Commercial drug is available for participants|6|||
161084730|NCT04058366|581698818|FG000|Overall Study|Death|1|||
161084731|NCT04058366|581698818|FG000|Overall Study|Other non-compliance|2|||
161084732|NCT04058366|581698818|FG000|Overall Study|Other|6|||
161084733|NCT02738203|581698819|FG000|Overall Study|Failed IUD Insertion|2|||
161084734|NCT02738203|581698820|FG001|Overall Study|Failed IUD Insertion|2|||
161084735|NCT02738203|581698819|FG000|Overall Study|Protocol Violation|0|||
161084736|NCT02738203|581698820|FG001|Overall Study|Protocol Violation|1|||
161084737|NCT05087979|581698821|FG000|Overall Study|Converted to general anesthesia|1|||
161084738|NCT05087979|581698822|FG001|Overall Study|Converted to general anesthesia|0|||
161084739|NCT00194987|581698823|FG000|Overall Study|Withdrawal by Subject|0|||
161084740|NCT00194987|581698824|FG001|Overall Study|Withdrawal by Subject|3|||
161084741|NCT01664598|581698825|FG000|Overall Study|Sponsor Decision|1|||
161084742|NCT01664598|581698825|FG000|Overall Study|Withdrawal of Informed Consent|4|||
161084743|NCT01664598|581698825|FG000|Overall Study|Adverse Event|1|||
161084744|NCT00836745|581698826|FG000|Overall Study|Death|2|||
161084745|NCT00836745|581698826|FG000|Overall Study|Lost to Follow-up|10|||
161084746|NCT00836745|581698826|FG000|Overall Study|Adverse Event|3|||
161084747|NCT00836745|581698826|FG000|Overall Study|Objective progression or relapse|4|||
161084748|NCT00836745|581698826|FG000|Overall Study|Other|2|||
161084749|NCT01239043|581698829|FG000|Overall Study|Protocol Violation|2|||
161084750|NCT01239043|581698830|FG001|Overall Study|Protocol Violation|1|||
161084751|NCT02929329|581698833|FG000|Overall Study|Withdrawal by Subject|24|||
161084752|NCT02929329|581698834|FG001|Overall Study|Withdrawal by Subject|21|||
161084753|NCT02929329|581698833|FG000|Overall Study|Lost to Follow-up|26|||
161084754|NCT02929329|581698834|FG001|Overall Study|Lost to Follow-up|20|||
161170223|NCT01807949|582000970|FG002|Overall Study|Adverse Event|2|||
161084755|NCT02929329|581698833|FG000|Overall Study|Death|1054|||
161084756|NCT02929329|581698834|FG001|Overall Study|Death|1051|||
161084757|NCT02121301|581698835|FG000|Overall Study|Protocol Violation|1|||
161170224|NCT01807949|582000968|FG000|Overall Study|Withdrawal by Subject|1|||
161170225|NCT01807949|582000969|FG001|Overall Study|Withdrawal by Subject|2|||
161170226|NCT01807949|582000970|FG002|Overall Study|Withdrawal by Subject|2|||
161170227|NCT01807949|582000968|FG000|Overall Study|Non-Compliance|0|||
161170228|NCT01807949|582000969|FG001|Overall Study|Non-Compliance|0|||
161170229|NCT01807949|582000970|FG002|Overall Study|Non-Compliance|1|||
161290737|NCT01120184|582445955|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
161290738|NCT01120184|582445956|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
161290739|NCT01120184|582445954|FG000|Overall Study|Death|170|||
161290740|NCT01120184|582445955|FG001|Overall Study|Death|176|||
161290741|NCT01120184|582445956|FG002|Overall Study|Death|169|||
161290742|NCT02525783|582445958|FG000|Overall Study|Lost to Follow-up|10|||
161290743|NCT00824772|582445959|FG000|Overall Study|Withdrawal by Subject|8|||
161290744|NCT04570670|582445962|FG000|Overall Study|Withdrawal by Subject|1|||
161290745|NCT04570670|582445963|FG001|Overall Study|Withdrawal by Subject|0|||
161290746|NCT00683618|582445964|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
161290747|NCT00683618|582445965|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
161290748|NCT00683618|582445966|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
161290749|NCT00683618|582445964|FG000|Randomised Treatment Period|Protocol Violation|0|||
161290750|NCT00683618|582445965|FG001|Randomised Treatment Period|Protocol Violation|1|||
161290751|NCT00683618|582445966|FG002|Randomised Treatment Period|Protocol Violation|0|||
161290752|NCT00683618|582445964|FG000|Randomised Treatment Period|Adverse Event|2|||
161290753|NCT00683618|582445965|FG001|Randomised Treatment Period|Adverse Event|0|||
161290754|NCT00683618|582445966|FG002|Randomised Treatment Period|Adverse Event|2|||
161290755|NCT00683618|582445964|FG000|Randomised Treatment Period|Reason not provided|0|||
161290756|NCT00683618|582445965|FG001|Randomised Treatment Period|Reason not provided|0|||
161290757|NCT00683618|582445966|FG002|Randomised Treatment Period|Reason not provided|2|||
161290758|NCT00683618|582445964|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
161290759|NCT00683618|582445965|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161290760|NCT00683618|582445966|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
161290761|NCT00683618|582445964|FG000|Extension Treatment Period|Adverse Event|1|||
161290762|NCT00683618|582445965|FG001|Extension Treatment Period|Adverse Event|0|||
161290763|NCT00683618|582445966|FG002|Extension Treatment Period|Adverse Event|0|||
161290764|NCT00683618|582445964|FG000|Extension Treatment Period|Protocol Violation|1|||
161290765|NCT00683618|582445965|FG001|Extension Treatment Period|Protocol Violation|0|||
161290766|NCT00683618|582445966|FG002|Extension Treatment Period|Protocol Violation|0|||
161290767|NCT01002989|582445970|FG000|Overall Study|exclusion criteria, no consent|5|||
161347184|NCT02293499|582656208|FG000|9 Month Follow Up|Lost to Follow-up|24|||
161347185|NCT02293499|582656209|FG001|9 Month Follow Up|Lost to Follow-up|28|||
161347186|NCT02293499|582656210|FG002|9 Month Follow Up|Lost to Follow-up|4|||
161170230|NCT01807949|582000968|FG000|Overall Study|Undefined|0|||
161170231|NCT01807949|582000969|FG001|Overall Study|Undefined|1|||
161170232|NCT01807949|582000970|FG002|Overall Study|Undefined|2|||
161170233|NCT01807949|582000968|FG000|Overall Study|Randomized But Not Treated|0|||
161170234|NCT01807949|582000969|FG001|Overall Study|Randomized But Not Treated|2|||
161170235|NCT01807949|582000970|FG002|Overall Study|Randomized But Not Treated|2|||
161170236|NCT04325906|582000973|FG000|Overall Study|Withdrawal by Subject|2|||
161170237|NCT04325906|582000974|FG001|Overall Study|Withdrawal by Subject|0|||
161170238|NCT00881361|582000975|FG000|Overall Study|Terminated prior to surgery|27|||
161170239|NCT00881361|582000976|FG001|Overall Study|Terminated prior to surgery|7|||
161170240|NCT00881361|582000977|FG002|Overall Study|Terminated prior to surgery|0|||
161170241|NCT00881361|582000975|FG000|Overall Study|Ineligible|17|||
161170242|NCT00881361|582000976|FG001|Overall Study|Ineligible|2|||
161170243|NCT00881361|582000977|FG002|Overall Study|Ineligible|2|||
161170244|NCT02141217|582000978|FG000|Overall Study|Adverse Event|1|||
161170245|NCT02141217|582000979|FG001|Overall Study|Adverse Event|2|||
161170246|NCT02141217|582000978|FG000|Overall Study|Protocol Violation|1|||
161170247|NCT02141217|582000979|FG001|Overall Study|Protocol Violation|4|||
161170248|NCT02141217|582000978|FG000|Overall Study|Withdrawal by Subject|6|||
161170249|NCT02141217|582000979|FG001|Overall Study|Withdrawal by Subject|0|||
161170250|NCT02141217|582000978|FG000|Overall Study|Lost to Follow-up|1|||
161170251|NCT02141217|582000979|FG001|Overall Study|Lost to Follow-up|1|||
161290768|NCT00318474|582445971|FG000|Overall Study|Adverse Event|1|||
161290769|NCT00318474|582445972|FG001|Overall Study|Adverse Event|1|||
161290770|NCT00318474|582445971|FG000|Overall Study|Lost to Follow-up|0|||
161347187|NCT02293499|582656208|FG000|12 Month Follow Up|Lost to Follow-up|26|||
161170252|NCT02141217|582000978|FG000|Overall Study|Physician Decision|1|||
161170253|NCT02141217|582000979|FG001|Overall Study|Physician Decision|0|||
161170254|NCT02141217|582000978|FG000|Overall Study|Surgical Intervention|1|||
161290771|NCT00318474|582445972|FG001|Overall Study|Lost to Follow-up|1|||
161290772|NCT00318474|582445971|FG000|Overall Study|Pregnancy|0|||
161290773|NCT00318474|582445972|FG001|Overall Study|Pregnancy|2|||
161290774|NCT00318474|582445971|FG000|Overall Study|Protocol Violation|1|||
161290775|NCT00318474|582445972|FG001|Overall Study|Protocol Violation|0|||
161170255|NCT02141217|582000979|FG001|Overall Study|Surgical Intervention|1|||
161290776|NCT00318474|582445971|FG000|Overall Study|Withdrawal by Subject|3|||
161347188|NCT02293499|582656209|FG001|12 Month Follow Up|Lost to Follow-up|25|||
161290777|NCT00318474|582445972|FG001|Overall Study|Withdrawal by Subject|2|||
161290778|NCT00318474|582445971|FG000|Overall Study|Fall in GFR|3|||
161290779|NCT00318474|582445972|FG001|Overall Study|Fall in GFR|3|||
161290780|NCT00318474|582445971|FG000|Overall Study|Post-therapy hyperflycemia|0|||
161290781|NCT00318474|582445972|FG001|Overall Study|Post-therapy hyperflycemia|1|||
161290782|NCT00318474|582445971|FG000|Overall Study|Trial terminated|10|||
161290783|NCT00318474|582445972|FG001|Overall Study|Trial terminated|7|||
161290784|NCT00957801|582445973|FG000|Overall Study|Withdrawal by Subject|0|||
161084758|NCT02121301|581698836|FG001|Overall Study|Protocol Violation|4|||
161084759|NCT02121301|581698837|FG002|Overall Study|Protocol Violation|1|||
161084760|NCT00434213|581698843|FG000|Overall Study|Adverse Event|12|||
161084761|NCT00434213|581698843|FG000|Overall Study|Lack of Efficacy|9|||
161084762|NCT00434213|581698843|FG000|Overall Study|Lost to Follow-up|14|||
161084763|NCT00434213|581698843|FG000|Overall Study|Withdrawal by Subject|7|||
161084764|NCT00434213|581698843|FG000|Overall Study|Protocol Violation|3|||
161084765|NCT00434213|581698843|FG000|Overall Study|Unable to comply with study visit window|2|||
161084766|NCT00434213|581698843|FG000|Overall Study|Application site reaction|1|||
161084767|NCT00434213|581698843|FG000|Overall Study|Non-compliant to study schedule|1|||
161084768|NCT01871805|581698853|FG000|Phase I|Death|7|||
161084769|NCT01871805|581698854|FG001|Phase I|Death|4|||
161084770|NCT01871805|581698855|FG002|Phase I|Death|6|||
161084771|NCT01871805|581698856|FG003|Phase I|Death|2|||
161084772|NCT01871805|581698857|FG004|Phase I|Death|9|||
161084773|NCT01871805|581698858|FG005|Phase I|Death|0|||
161084774|NCT01871805|581698853|FG000|Phase I|Alive in Survival Follow-up|0|||
161084775|NCT01871805|581698854|FG001|Phase I|Alive in Survival Follow-up|2|||
161084776|NCT01871805|581698855|FG002|Phase I|Alive in Survival Follow-up|4|||
161084777|NCT01871805|581698856|FG003|Phase I|Alive in Survival Follow-up|5|||
161084778|NCT01871805|581698857|FG004|Phase I|Alive in Survival Follow-up|4|||
161084779|NCT01871805|581698858|FG005|Phase I|Alive in Survival Follow-up|0|||
161084780|NCT01871805|581698853|FG000|Phase I|Lost to Follow-up|0|||
161084781|NCT01871805|581698854|FG001|Phase I|Lost to Follow-up|1|||
161084782|NCT01871805|581698855|FG002|Phase I|Lost to Follow-up|3|||
161084783|NCT01871805|581698856|FG003|Phase I|Lost to Follow-up|0|||
161084784|NCT01871805|581698857|FG004|Phase I|Lost to Follow-up|0|||
161084785|NCT01871805|581698858|FG005|Phase I|Lost to Follow-up|0|||
161084786|NCT01871805|581698853|FG000|Phase II|Death|0|||
161084787|NCT01871805|581698854|FG001|Phase II|Death|0|||
161084788|NCT01871805|581698855|FG002|Phase II|Death|0|||
161084789|NCT01871805|581698856|FG003|Phase II|Death|0|||
161084790|NCT01871805|581698857|FG004|Phase II|Death|0|||
161084791|NCT01871805|581698858|FG005|Phase II|Death|45|||
161084792|NCT01871805|581698853|FG000|Phase II|Alive in Survival Follow-up|0|||
161084793|NCT01871805|581698854|FG001|Phase II|Alive in Survival Follow-up|0|||
161084794|NCT01871805|581698855|FG002|Phase II|Alive in Survival Follow-up|0|||
161084795|NCT01871805|581698856|FG003|Phase II|Alive in Survival Follow-up|0|||
161084796|NCT01871805|581698857|FG004|Phase II|Alive in Survival Follow-up|0|||
161084797|NCT01871805|581698858|FG005|Phase II|Alive in Survival Follow-up|29|||
161084798|NCT01871805|581698853|FG000|Phase II|Lost to Follow-up|0|||
161084799|NCT01871805|581698854|FG001|Phase II|Lost to Follow-up|0|||
161084800|NCT01871805|581698855|FG002|Phase II|Lost to Follow-up|0|||
161084801|NCT01871805|581698856|FG003|Phase II|Lost to Follow-up|0|||
161084802|NCT01871805|581698857|FG004|Phase II|Lost to Follow-up|0|||
161084803|NCT01871805|581698858|FG005|Phase II|Lost to Follow-up|13|||
161084804|NCT00941070|581698863|FG000|Overall Study|Patient non-compliant|1|||
161084805|NCT03174431|581698864|FG000|Overall Study|Withdrawal by Subject|14|||
161084806|NCT03174431|581698865|FG001|Overall Study|Withdrawal by Subject|11|||
161084807|NCT03174431|581698864|FG000|Overall Study|alternative treatment|2|||
161084808|NCT03174431|581698865|FG001|Overall Study|alternative treatment|0|||
161084809|NCT03174431|581698864|FG000|Overall Study|Lost to Follow-up|1|||
161084810|NCT03174431|581698865|FG001|Overall Study|Lost to Follow-up|5|||
161084811|NCT03484273|581698870|FG000|Overall Study|Equipment Malfunction|1|||
161084812|NCT03484273|581698870|FG000|Overall Study|Data excluded from analysis|1|||
161084813|NCT00468104|581698876|FG000|First Intervention|Protocol Violation|2|||
161084814|NCT00468104|581698877|FG001|First Intervention|Protocol Violation|1|||
161084815|NCT00468104|581698876|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
161084816|NCT00468104|581698877|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
161084817|NCT00468104|581698876|FG000|First Intervention|died within 3 weeks|1|||
161084818|NCT00468104|581698877|FG001|First Intervention|died within 3 weeks|0|||
161084819|NCT00468104|581698876|FG000|First Intervention|malposition/blocked chest tube tube|2|||
161084820|NCT00468104|581698877|FG001|First Intervention|malposition/blocked chest tube tube|0|||
161084821|NCT00468104|581698876|FG000|First Intervention|large lung mass with minimal effusion|1|||
161084822|NCT00468104|581698877|FG001|First Intervention|large lung mass with minimal effusion|0|||
161084823|NCT00468104|581698876|FG000|First Intervention|associated prolonged pneumothorax|1|||
161084824|NCT00468104|581698877|FG001|First Intervention|associated prolonged pneumothorax|0|||
161084825|NCT00468104|581698876|FG000|First Intervention|trapped lung|1|||
161170256|NCT01329341|582000984|FG000|Overall Study|Withdrawal by Subject|44|||
161170257|NCT00448760|582000985|FG000|Overall Study|Death|3|||
161170258|NCT00561340|582000986|FG000|Overall Study|refused to drink pediasure|6|||
161170259|NCT00561340|582000987|FG001|Overall Study|refused to drink pediasure|0|||
161170260|NCT00618995|582000993|FG000|Period 1|Adverse Event|0|||
161170261|NCT00618995|582000994|FG001|Period 1|Adverse Event|0|||
161170262|NCT00618995|582000995|FG002|Period 1|Adverse Event|1|||
161170263|NCT00618995|582000996|FG003|Period 1|Adverse Event|0|||
161170264|NCT00618995|582000993|FG000|Period 1|Protocol Violation|0|||
161170265|NCT00618995|582000994|FG001|Period 1|Protocol Violation|1|||
161170266|NCT00618995|582000995|FG002|Period 1|Protocol Violation|1|||
161170267|NCT00618995|582000996|FG003|Period 1|Protocol Violation|0|||
161170268|NCT00618995|582000993|FG000|Period 2|Protocol Violation|0|||
161170269|NCT00618995|582000994|FG001|Period 2|Protocol Violation|0|||
161170270|NCT00618995|582000995|FG002|Period 2|Protocol Violation|1|||
161170271|NCT00618995|582000996|FG003|Period 2|Protocol Violation|0|||
161170272|NCT00618995|582000993|FG000|Period 4|Adverse Event|1|||
161170273|NCT00618995|582000994|FG001|Period 4|Adverse Event|0|||
161170274|NCT00618995|582000995|FG002|Period 4|Adverse Event|0|||
161170275|NCT00618995|582000996|FG003|Period 4|Adverse Event|0|||
161170276|NCT02988219|582000997|FG000|Overall Study|Lack of Efficacy|1|||
161170277|NCT02988219|582000998|FG001|Overall Study|Lack of Efficacy|1|||
161170278|NCT02988219|582000997|FG000|Overall Study|Withdrawal by Subject|0|||
161170279|NCT02988219|582000998|FG001|Overall Study|Withdrawal by Subject|2|||
161170280|NCT01306032|582000999|FG000|First Intervention|Adverse Event|1|||
161170281|NCT01306032|582001000|FG001|First Intervention|Adverse Event|0|||
161170282|NCT01306032|582001001|FG002|First Intervention|Adverse Event|1|||
161170283|NCT01306032|582001002|FG003|First Intervention|Adverse Event|0|||
161170284|NCT01306032|582001003|FG004|First Intervention|Adverse Event|0|||
161170285|NCT01306032|582001004|FG005|First Intervention|Adverse Event|1|||
161170286|NCT01306032|582000999|FG000|First Intervention|Withdrawal by Subject|0|||
161170287|NCT01306032|582001000|FG001|First Intervention|Withdrawal by Subject|2|||
161170288|NCT01306032|582001001|FG002|First Intervention|Withdrawal by Subject|0|||
161170289|NCT01306032|582001002|FG003|First Intervention|Withdrawal by Subject|1|||
161170290|NCT01306032|582001003|FG004|First Intervention|Withdrawal by Subject|0|||
161170291|NCT01306032|582001004|FG005|First Intervention|Withdrawal by Subject|0|||
161170292|NCT01306032|582000999|FG000|First Intervention|Death|0|||
161170293|NCT01306032|582001000|FG001|First Intervention|Death|0|||
161170294|NCT01306032|582001001|FG002|First Intervention|Death|1|||
161170295|NCT01306032|582001002|FG003|First Intervention|Death|0|||
161170296|NCT01306032|582001003|FG004|First Intervention|Death|0|||
161170297|NCT01306032|582001004|FG005|First Intervention|Death|0|||
161170298|NCT01306032|582000999|FG000|First Intervention|Ineligible|0|||
161170299|NCT01306032|582001000|FG001|First Intervention|Ineligible|0|||
161170300|NCT01306032|582001001|FG002|First Intervention|Ineligible|0|||
161170301|NCT01306032|582001002|FG003|First Intervention|Ineligible|0|||
161170302|NCT01306032|582001003|FG004|First Intervention|Ineligible|0|||
161170303|NCT01306032|582001004|FG005|First Intervention|Ineligible|1|||
161170304|NCT01306032|582000999|FG000|First Intervention|Progressive disease|0|||
161170305|NCT01306032|582001000|FG001|First Intervention|Progressive disease|0|||
161170306|NCT01306032|582001001|FG002|First Intervention|Progressive disease|0|||
161170307|NCT01306032|582001002|FG003|First Intervention|Progressive disease|0|||
161170308|NCT01306032|582001003|FG004|First Intervention|Progressive disease|2|||
161170309|NCT01306032|582001004|FG005|First Intervention|Progressive disease|0|||
161170310|NCT01306032|582000999|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
161170311|NCT01306032|582001000|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
161170312|NCT01306032|582001001|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
161170313|NCT01306032|582001002|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
161170314|NCT01306032|582001003|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
161170315|NCT01306032|582001004|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
161170316|NCT01306032|582000999|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
161290785|NCT00957801|582445974|FG001|Overall Study|Withdrawal by Subject|0|||
161170317|NCT01306032|582001000|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
161170318|NCT01306032|582001001|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
161170319|NCT01306032|582001002|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
161170320|NCT01306032|582001003|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
161170321|NCT01306032|582001004|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
161170322|NCT01213264|582001005|FG000|Overall Study|Adverse Event|1|||
161170323|NCT01213264|582001006|FG001|Overall Study|Adverse Event|0|||
161170324|NCT01213264|582001007|FG002|Overall Study|Adverse Event|0|||
161170325|NCT01213264|582001005|FG000|Overall Study|Lost to Follow-up|1|||
161170326|NCT01213264|582001006|FG001|Overall Study|Lost to Follow-up|2|||
161170327|NCT01213264|582001007|FG002|Overall Study|Lost to Follow-up|6|||
161170328|NCT01522443|582001011|FG000|Overall Study|No longer receiving clinical benefit|36|||
161170329|NCT01522443|582001012|FG001|Overall Study|No longer receiving clinical benefit|28|||
161170330|NCT01522443|582001011|FG000|Overall Study|Adverse Event|10|||
161290786|NCT00957801|582445975|FG002|Overall Study|Withdrawal by Subject|0|||
161170331|NCT01522443|582001012|FG001|Overall Study|Adverse Event|15|||
161170332|NCT01522443|582001011|FG000|Overall Study|Withdrawal by Subject|5|||
161170333|NCT01522443|582001012|FG001|Overall Study|Withdrawal by Subject|8|||
161170334|NCT01522443|582001011|FG000|Overall Study|No study treatment given|1|||
161170335|NCT01522443|582001012|FG001|Overall Study|No study treatment given|1|||
161170336|NCT01522443|582001011|FG000|Overall Study|Other|1|||
161170337|NCT01522443|582001012|FG001|Overall Study|Other|3|||
161170338|NCT03260894|582001013|FG000|Overall Study|Death|6|||
161170339|NCT03260894|582001014|FG001|Overall Study|Death|8|||
161170340|NCT03260894|582001013|FG000|Overall Study|Withdrawal by Subject|4|||
161170341|NCT03260894|582001014|FG001|Overall Study|Withdrawal by Subject|11|||
161170342|NCT03260894|582001013|FG000|Overall Study|On-going at clinical cut off date|36|||
161170343|NCT03260894|582001014|FG001|Overall Study|On-going at clinical cut off date|31|||
161170344|NCT00973622|582001015|FG000|Overall Study|did not attend MRI|14|||
161170345|NCT00973622|582001016|FG001|Overall Study|did not attend MRI|3|||
161170346|NCT00973622|582001015|FG000|Overall Study|did not pass MRI screen|6|||
161170347|NCT00973622|582001016|FG001|Overall Study|did not pass MRI screen|0|||
161170348|NCT00973622|582001015|FG000|Overall Study|did not complete rTMS sessions|11|||
161170349|NCT00973622|582001016|FG001|Overall Study|did not complete rTMS sessions|2|||
161170350|NCT00555568|582001017|FG000|Overall Study|Lost to Follow-up|26|||
161170351|NCT00555568|582001018|FG001|Overall Study|Lost to Follow-up|16|||
161170352|NCT00555568|582001019|FG002|Overall Study|Lost to Follow-up|16|||
161170353|NCT06000501|582001020|FG000|Overall Study|Screen failure|3|||
161170354|NCT06000501|582001020|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
161170355|NCT06000501|582001020|FG000|Overall Study|Physician Decision|4|||
161170356|NCT06000501|582001020|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
161170357|NCT06000501|582001020|FG000|Overall Study|Scheduling issues|2|||
161170358|NCT02677220|582001021|FG000|Overall Study|Adverse Event|1|||
161170359|NCT00067470|582001022|FG000|Overall Study|Withdrawal by Subject|0|||
161170360|NCT00067470|582001023|FG001|Overall Study|Withdrawal by Subject|1|||
161170361|NCT01074658|582001024|FG000|Overall Study|No implant attempted|19|||
161170362|NCT00050622|582001025|FG000|Overall Study|Adverse Event|1|||
161170363|NCT01342952|582001026|FG000|Overall Study|Adverse Event|0|||
161170364|NCT01342952|582001027|FG001|Overall Study|Adverse Event|5|||
161170365|NCT01342952|582001028|FG002|Overall Study|Adverse Event|1|||
161170366|NCT01342952|582001029|FG003|Overall Study|Adverse Event|0|||
161170367|NCT01342952|582001026|FG000|Overall Study|Lost to Follow-up|0|||
161170368|NCT01342952|582001027|FG001|Overall Study|Lost to Follow-up|2|||
161170369|NCT01342952|582001028|FG002|Overall Study|Lost to Follow-up|0|||
161170370|NCT01342952|582001029|FG003|Overall Study|Lost to Follow-up|0|||
161170371|NCT01342952|582001026|FG000|Overall Study|Withdrawal by Subject|1|||
161170372|NCT01342952|582001027|FG001|Overall Study|Withdrawal by Subject|1|||
161170373|NCT01342952|582001028|FG002|Overall Study|Withdrawal by Subject|0|||
161170374|NCT01342952|582001029|FG003|Overall Study|Withdrawal by Subject|0|||
161170375|NCT01342952|582001026|FG000|Overall Study|Physician Decision|3|||
161170376|NCT01342952|582001027|FG001|Overall Study|Physician Decision|3|||
161170377|NCT01342952|582001028|FG002|Overall Study|Physician Decision|1|||
161170378|NCT01342952|582001029|FG003|Overall Study|Physician Decision|0|||
161170379|NCT00426556|582001030|FG000|Phase I - Core Phase|Disease Progression|0|||
161170380|NCT00426556|582001031|FG001|Phase I - Core Phase|Disease Progression|6|||
161170381|NCT00426556|582001032|FG002|Phase I - Core Phase|Disease Progression|2|||
161170382|NCT00426556|582001033|FG003|Phase I - Core Phase|Disease Progression|0|||
161170383|NCT00426556|582001030|FG000|Phase I - Core Phase|Adverse Event|1|||
161170384|NCT00426556|582001031|FG001|Phase I - Core Phase|Adverse Event|3|||
161170385|NCT00426556|582001032|FG002|Phase I - Core Phase|Adverse Event|1|||
161170386|NCT00426556|582001033|FG003|Phase I - Core Phase|Adverse Event|0|||
161170387|NCT00426556|582001030|FG000|Phase I - Core Phase|Death|0|||
161170388|NCT00426556|582001031|FG001|Phase I - Core Phase|Death|1|||
161170389|NCT00426556|582001032|FG002|Phase I - Core Phase|Death|0|||
161290787|NCT00957801|582445976|FG003|Overall Study|Withdrawal by Subject|1|||
161170390|NCT00426556|582001033|FG003|Phase I - Core Phase|Death|0|||
161170391|NCT00426556|582001030|FG000|Phase I - Extension Phase|Adverse Event|0|||
161170392|NCT00426556|582001031|FG001|Phase I - Extension Phase|Adverse Event|1|||
161170393|NCT00426556|582001032|FG002|Phase I - Extension Phase|Adverse Event|1|||
161170394|NCT00426556|582001033|FG003|Phase I - Extension Phase|Adverse Event|0|||
161170395|NCT00426556|582001030|FG000|Phase I - Extension Phase|Disease Progression|5|||
161170396|NCT00426556|582001031|FG001|Phase I - Extension Phase|Disease Progression|5|||
161170397|NCT00426556|582001032|FG002|Phase I - Extension Phase|Disease Progression|6|||
161170398|NCT00426556|582001033|FG003|Phase I - Extension Phase|Disease Progression|0|||
161170399|NCT00426556|582001030|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
161170400|NCT00426556|582001031|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
161170401|NCT00426556|582001032|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
161170402|NCT00426556|582001033|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
161170403|NCT00426556|582001030|FG000|Phase II - Core Phase|Disease Progression|0|||
161170404|NCT00426556|582001031|FG001|Phase II - Core Phase|Disease Progression|0|||
161170405|NCT00426556|582001032|FG002|Phase II - Core Phase|Disease Progression|0|||
161290788|NCT02626026|582445978|FG000|Overall Study|Randomized but Never Treated|0|||
161170406|NCT00426556|582001033|FG003|Phase II - Core Phase|Disease Progression|16|||
161170407|NCT00426556|582001030|FG000|Phase II - Core Phase|Adverse Event|0|||
161170408|NCT00426556|582001031|FG001|Phase II - Core Phase|Adverse Event|0|||
161170409|NCT00426556|582001032|FG002|Phase II - Core Phase|Adverse Event|0|||
161170410|NCT00426556|582001033|FG003|Phase II - Core Phase|Adverse Event|8|||
161170411|NCT00426556|582001030|FG000|Phase II - Extension Phase|Disease Progression|0|||
161170412|NCT00426556|582001031|FG001|Phase II - Extension Phase|Disease Progression|0|||
161170413|NCT00426556|582001032|FG002|Phase II - Extension Phase|Disease Progression|0|||
161170414|NCT00426556|582001033|FG003|Phase II - Extension Phase|Disease Progression|21|||
161170415|NCT00426556|582001030|FG000|Phase II - Extension Phase|Adverse Event|0|||
161170416|NCT00426556|582001031|FG001|Phase II - Extension Phase|Adverse Event|0|||
161170417|NCT00426556|582001032|FG002|Phase II - Extension Phase|Adverse Event|0|||
161170418|NCT00426556|582001033|FG003|Phase II - Extension Phase|Adverse Event|2|||
161170419|NCT02146248|582001037|FG000|Overall Study|Withdrawal by Subject|2|||
161170420|NCT00425100|582001038|FG000|Overall Study|Adverse Event|36|||
161170421|NCT00425100|582001038|FG000|Overall Study|Lack of Efficacy|4|||
161170422|NCT00425100|582001038|FG000|Overall Study|Lost to Follow-up|2|||
161170423|NCT00425100|582001038|FG000|Overall Study|Protocol Violation|4|||
161170424|NCT00425100|582001038|FG000|Overall Study|Withdrawal by Subject|7|||
161170425|NCT03699631|582001042|FG000|Overall Study|Adverse Event|3|||
161170426|NCT00964158|582001043|FG000|Overall Study|Lost to Follow-up|0|||
161170427|NCT00964158|582001044|FG001|Overall Study|Lost to Follow-up|1|||
161170428|NCT00964158|582001045|FG002|Overall Study|Lost to Follow-up|2|||
161170429|NCT00964158|582001043|FG000|Overall Study|Withdrawal by Subject|0|||
161170430|NCT00964158|582001044|FG001|Overall Study|Withdrawal by Subject|0|||
161170431|NCT00964158|582001045|FG002|Overall Study|Withdrawal by Subject|6|||
161170432|NCT00507416|582001046|FG000|Overall Study|Adverse Event|58|||
161170433|NCT00507416|582001047|FG001|Overall Study|Adverse Event|67|||
161170434|NCT00507416|582001048|FG002|Overall Study|Adverse Event|65|||
161170435|NCT00507416|582001046|FG000|Overall Study|Protocol Violation|1|||
161170436|NCT00507416|582001047|FG001|Overall Study|Protocol Violation|2|||
161170437|NCT00507416|582001048|FG002|Overall Study|Protocol Violation|0|||
161170438|NCT00507416|582001046|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
161170439|NCT00507416|582001047|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
161170440|NCT00507416|582001048|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
161170441|NCT00507416|582001046|FG000|Overall Study|Progressive Disease|20|||
161170442|NCT00507416|582001047|FG001|Overall Study|Progressive Disease|10|||
161170443|NCT00507416|582001048|FG002|Overall Study|Progressive Disease|13|||
161170444|NCT00507416|582001046|FG000|Overall Study|Patient declined further treatment|18|||
161170445|NCT00507416|582001047|FG001|Overall Study|Patient declined further treatment|14|||
161170446|NCT00507416|582001048|FG002|Overall Study|Patient declined further treatment|11|||
161170447|NCT00507416|582001046|FG000|Overall Study|Other|11|||
161170448|NCT00507416|582001047|FG001|Overall Study|Other|16|||
161170449|NCT00507416|582001048|FG002|Overall Study|Other|13|||
161170450|NCT00507416|582001046|FG000|Overall Study|Did not Receive Study Treatment|3|||
161170451|NCT00507416|582001047|FG001|Overall Study|Did not Receive Study Treatment|9|||
161170452|NCT00507416|582001048|FG002|Overall Study|Did not Receive Study Treatment|4|||
161170453|NCT03101514|582001049|FG000|Overall Study|Withdrawal by Subject|4|||
161170454|NCT03101514|582001049|FG000|Overall Study|Protocol Violation|2|||
161170455|NCT03101514|582001049|FG000|Overall Study|patient's information was incomplete|1|||
161170456|NCT03695393|582001058|FG000|Overall Study|Death|3|||
161170457|NCT03695393|582001059|FG001|Overall Study|Death|1|||
161290789|NCT02626026|582445979|FG001|Overall Study|Randomized but Never Treated|0|||
161290790|NCT02626026|582445980|FG002|Overall Study|Randomized but Never Treated|0|||
161290791|NCT02626026|582445981|FG003|Overall Study|Randomized but Never Treated|0|||
161290792|NCT02626026|582445982|FG004|Overall Study|Randomized but Never Treated|1|||
161290793|NCT02626026|582445983|FG005|Overall Study|Randomized but Never Treated|0|||
161290794|NCT01778855|582445984|FG000|Overall Study|Death|0|||
161290795|NCT01778855|582445985|FG001|Overall Study|Death|1|||
161170458|NCT03695393|582001058|FG000|Overall Study|Lost to Follow-up|0|||
161170459|NCT03695393|582001059|FG001|Overall Study|Lost to Follow-up|1|||
161170460|NCT04585451|582001060|FG000|Overall Study|Withdrawal by Subject|26|||
161170461|NCT04585451|582001061|FG001|Overall Study|Withdrawal by Subject|0|||
161170462|NCT00966693|582001062|FG000|Overall Study|Adverse Event|0|||
161170463|NCT00966693|582001063|FG001|Overall Study|Adverse Event|0|||
161170464|NCT00966693|582001064|FG002|Overall Study|Adverse Event|1|||
161290796|NCT03776357|582445988|FG000|Overall Study|Lost to Follow-up|3|||
161290797|NCT00837148|582445989|FG000|Overall Study|Adverse Event|1|||
161290798|NCT00837148|582445989|FG000|Overall Study|Death|1|||
161170465|NCT00966693|582001065|FG003|Overall Study|Adverse Event|2|||
161170466|NCT00966693|582001062|FG000|Overall Study|Death|0|||
161170467|NCT00966693|582001063|FG001|Overall Study|Death|0|||
161170468|NCT00966693|582001064|FG002|Overall Study|Death|1|||
161170469|NCT00966693|582001065|FG003|Overall Study|Death|0|||
161170470|NCT00966693|582001062|FG000|Overall Study|Withdrawal by Subject|1|||
161170471|NCT00966693|582001063|FG001|Overall Study|Withdrawal by Subject|0|||
161290799|NCT00931411|582445992|FG000|First Intervention - 42 Days|Adverse Event|2|||
161290800|NCT00931411|582445993|FG001|First Intervention - 42 Days|Adverse Event|3|||
161290801|NCT00931411|582445992|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
161290802|NCT00931411|582445993|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
161290803|NCT00931411|582445992|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
161290804|NCT00931411|582445993|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
161290805|NCT01827111|582445994|FG000|Overall Study|Disease Progression|1|||
161290806|NCT03181633|582445997|FG000|Overall Study|Withdrawal by Subject|1|||
161290807|NCT03181633|582445997|FG000|Overall Study|Missing follow-up visit|1|||
161290808|NCT04383327|582446004|FG000|Overall Study|Lost to Follow-up|112|||
161290809|NCT04383327|582446005|FG001|Overall Study|Lost to Follow-up|14|||
161290810|NCT04383327|582446006|FG002|Overall Study|Lost to Follow-up|78|||
161290811|NCT04383327|582446007|FG003|Overall Study|Lost to Follow-up|13|||
161290812|NCT04383327|582446008|FG004|Overall Study|Lost to Follow-up|110|||
161290813|NCT04383327|582446009|FG005|Overall Study|Lost to Follow-up|13|||
161290814|NCT04383327|582446010|FG006|Overall Study|Lost to Follow-up|74|||
161290815|NCT04383327|582446011|FG007|Overall Study|Lost to Follow-up|13|||
161290816|NCT04383327|582446012|FG008|Overall Study|Lost to Follow-up|78|||
161290817|NCT04383327|582446013|FG009|Overall Study|Lost to Follow-up|10|||
161290818|NCT04383327|582446014|FG010|Overall Study|Lost to Follow-up|160|||
161290819|NCT04383327|582446015|FG011|Overall Study|Lost to Follow-up|13|||
161290820|NCT04837196|582446016|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161290821|NCT04837196|582446017|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
161290822|NCT04837196|582446018|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161290823|NCT04837196|582446019|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
161290824|NCT04837196|582446020|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
161290825|NCT04837196|582446016|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161290826|NCT04837196|582446017|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
161290827|NCT04837196|582446018|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
161290828|NCT04837196|582446019|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161290829|NCT04837196|582446020|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
161290830|NCT04837196|582446016|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161290831|NCT04837196|582446017|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
161290832|NCT04837196|582446018|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161290833|NCT04837196|582446019|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161290834|NCT04837196|582446020|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
161290835|NCT04837196|582446016|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161290836|NCT04837196|582446017|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161290837|NCT04837196|582446018|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
161290838|NCT04837196|582446019|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161290839|NCT04837196|582446020|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
161347189|NCT02293499|582656210|FG002|12 Month Follow Up|Lost to Follow-up|6|||
161170472|NCT00966693|582001064|FG002|Overall Study|Withdrawal by Subject|0|||
161170473|NCT00966693|582001065|FG003|Overall Study|Withdrawal by Subject|5|||
161170474|NCT00966693|582001062|FG000|Overall Study|Disease Progression|0|||
161170475|NCT00966693|582001063|FG001|Overall Study|Disease Progression|0|||
161170476|NCT00966693|582001064|FG002|Overall Study|Disease Progression|1|||
161170477|NCT00966693|582001065|FG003|Overall Study|Disease Progression|16|||
161170478|NCT01578785|582001066|FG000|Overall Study|Withdrawal by Subject|0|||
161170479|NCT01578785|582001067|FG001|Overall Study|Withdrawal by Subject|1|||
161170480|NCT01578785|582001066|FG000|Overall Study|Study terminated by sponsor|59|||
161170481|NCT01578785|582001067|FG001|Overall Study|Study terminated by sponsor|118|||
161170482|NCT00599027|582001070|FG000|Overall Study|Withdrawal by Subject|1|||
161170483|NCT00599027|582001071|FG001|Overall Study|Withdrawal by Subject|1|||
161170484|NCT00599027|582001070|FG000|Overall Study|Adverse Event|0|||
161170485|NCT00599027|582001071|FG001|Overall Study|Adverse Event|1|||
161170486|NCT00599027|582001070|FG000|Overall Study|Treatment Failure|0|||
161170487|NCT00599027|582001071|FG001|Overall Study|Treatment Failure|1|||
161170488|NCT02581982|582001072|FG000|Overall Study|Lack of Efficacy|12|||
161170489|NCT02581982|582001072|FG000|Overall Study|Adverse Event|3|||
161170490|NCT02581982|582001072|FG000|Overall Study|Physician Decision|1|||
161290840|NCT04837196|582446016|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161170491|NCT00405821|582001073|FG000|Overall Study|Death|5|||
161170492|NCT00405821|582001074|FG001|Overall Study|Death|7|||
161170493|NCT00405821|582001073|FG000|Overall Study|Lost to Follow-up|7|||
161290841|NCT04837196|582446017|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161290842|NCT04837196|582446018|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
161290843|NCT04837196|582446019|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161290844|NCT04837196|582446020|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
161290845|NCT00991887|582446021|FG000|Overall Study|Lost to Follow-up|2|||
161290846|NCT00991887|582446022|FG001|Overall Study|Lost to Follow-up|1|||
161290847|NCT01306305|582446023|FG000|Overall Study|Lost to Follow-up|1|||
161170494|NCT00405821|582001074|FG001|Overall Study|Lost to Follow-up|7|||
161170495|NCT00405821|582001073|FG000|Overall Study|Protocol Violation|1|||
161170496|NCT00405821|582001074|FG001|Overall Study|Protocol Violation|0|||
161170497|NCT00405821|582001073|FG000|Overall Study|initiated ART|9|||
161170498|NCT00405821|582001074|FG001|Overall Study|initiated ART|8|||
161170499|NCT01769469|582001085|FG000|Overall Study|Consent Withdrawn|5|||
161170500|NCT01769469|582001085|FG000|Overall Study|Moved Out Of Area|3|||
161170501|NCT01769469|582001085|FG000|Overall Study|Lost to Follow-up|17|||
161170502|NCT01769469|582001085|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
161170503|NCT01769469|582001085|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
161170504|NCT02713789|582001095|FG000|Overall Study|Lost to Follow-up|0|||
161170505|NCT02713789|582001096|FG001|Overall Study|Lost to Follow-up|1|||
161170506|NCT02713789|582001097|FG002|Overall Study|Lost to Follow-up|1|||
161170507|NCT04186663|582001105|FG000|Overall Study|Lost to Follow-up|1|||
161170508|NCT04186663|582001105|FG000|Overall Study|Unable to complete blood draw|3|||
161170509|NCT02554253|582001108|FG000|Overall Study|ineligible after enrollment|1|||
161170510|NCT02554253|582001109|FG001|Overall Study|ineligible after enrollment|0|||
161170511|NCT02554253|582001108|FG000|Overall Study|converted to transcatheter procedure|0|||
161170512|NCT02554253|582001109|FG001|Overall Study|converted to transcatheter procedure|1|||
161170513|NCT02554253|582001108|FG000|Overall Study|received both drugs|0|||
161170514|NCT02554253|582001109|FG001|Overall Study|received both drugs|1|||
161170515|NCT02559206|582001111|FG000|Overall Study|Adverse Event|0|||
161170516|NCT02559206|582001112|FG001|Overall Study|Adverse Event|4|||
161170517|NCT02559206|582001113|FG002|Overall Study|Adverse Event|1|||
161170518|NCT02559206|582001114|FG003|Overall Study|Adverse Event|5|||
161170519|NCT02559206|582001115|FG004|Overall Study|Adverse Event|3|||
161170520|NCT02559206|582001116|FG005|Overall Study|Adverse Event|0|||
161170521|NCT02559206|582001117|FG006|Overall Study|Adverse Event|1|||
161170522|NCT02559206|582001118|FG007|Overall Study|Adverse Event|0|||
161170523|NCT02559206|582001111|FG000|Overall Study|Protocol Violation|1|||
161170524|NCT02559206|582001112|FG001|Overall Study|Protocol Violation|0|||
161170525|NCT02559206|582001113|FG002|Overall Study|Protocol Violation|1|||
161170526|NCT02559206|582001114|FG003|Overall Study|Protocol Violation|0|||
161170527|NCT02559206|582001115|FG004|Overall Study|Protocol Violation|0|||
161170528|NCT02559206|582001116|FG005|Overall Study|Protocol Violation|2|||
161170529|NCT02559206|582001117|FG006|Overall Study|Protocol Violation|0|||
161170530|NCT02559206|582001118|FG007|Overall Study|Protocol Violation|0|||
161170531|NCT02559206|582001111|FG000|Overall Study|Withdrawal by Subject|3|||
161170532|NCT02559206|582001112|FG001|Overall Study|Withdrawal by Subject|3|||
161170533|NCT02559206|582001113|FG002|Overall Study|Withdrawal by Subject|1|||
161170534|NCT02559206|582001114|FG003|Overall Study|Withdrawal by Subject|3|||
161170535|NCT02559206|582001115|FG004|Overall Study|Withdrawal by Subject|5|||
161170536|NCT02559206|582001116|FG005|Overall Study|Withdrawal by Subject|4|||
161170537|NCT02559206|582001117|FG006|Overall Study|Withdrawal by Subject|1|||
161170538|NCT02559206|582001118|FG007|Overall Study|Withdrawal by Subject|2|||
161170539|NCT02559206|582001111|FG000|Overall Study|Lost to Follow-up|3|||
161170540|NCT02559206|582001112|FG001|Overall Study|Lost to Follow-up|5|||
161170541|NCT02559206|582001113|FG002|Overall Study|Lost to Follow-up|3|||
161170542|NCT02559206|582001114|FG003|Overall Study|Lost to Follow-up|3|||
161170543|NCT02559206|582001115|FG004|Overall Study|Lost to Follow-up|2|||
161170544|NCT02559206|582001116|FG005|Overall Study|Lost to Follow-up|5|||
161170545|NCT02559206|582001117|FG006|Overall Study|Lost to Follow-up|1|||
161170546|NCT02559206|582001118|FG007|Overall Study|Lost to Follow-up|4|||
161170547|NCT02559206|582001111|FG000|Overall Study|Lack of Efficacy|1|||
161170548|NCT02559206|582001112|FG001|Overall Study|Lack of Efficacy|0|||
161170549|NCT02559206|582001113|FG002|Overall Study|Lack of Efficacy|3|||
161170550|NCT02559206|582001114|FG003|Overall Study|Lack of Efficacy|2|||
161170551|NCT02559206|582001115|FG004|Overall Study|Lack of Efficacy|2|||
161170552|NCT02559206|582001116|FG005|Overall Study|Lack of Efficacy|3|||
161290848|NCT01306305|582446024|FG001|Overall Study|Lost to Follow-up|0|||
161290849|NCT01306305|582446023|FG000|Overall Study|Withdrew consent|1|||
161290850|NCT01306305|582446024|FG001|Overall Study|Withdrew consent|0|||
161290851|NCT04030299|582446025|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
161290852|NCT04030299|582446025|FG000|Overall Study|Withdrawal by Subject|3|||
161290853|NCT00699998|582446026|FG000|Overall Study|Withdrawal by Subject|194|||
161290854|NCT00699998|582446027|FG001|Overall Study|Withdrawal by Subject|83|||
161290855|NCT00699998|582446028|FG002|Overall Study|Withdrawal by Subject|202|||
161084826|NCT00468104|581698877|FG001|First Intervention|trapped lung|0|||
161084827|NCT00468104|581698876|FG000|Second Intervention|Withdrawal by Subject|5|||
161084828|NCT00468104|581698877|FG001|Second Intervention|Withdrawal by Subject|2|||
161084829|NCT00468104|581698876|FG000|Second Intervention|discarded for malposition of chest tube|0|||
161084830|NCT00468104|581698877|FG001|Second Intervention|discarded for malposition of chest tube|2|||
161084831|NCT01263665|581698878|FG000|Overall Study|Withdrew Consent|1|||
161084832|NCT01263665|581698878|FG000|Overall Study|Lost to Follow-up|3|||
161084833|NCT01263665|581698878|FG000|Overall Study|Death|2|||
161084834|NCT01263665|581698878|FG000|Overall Study|Amputation above the ankle|1|||
161084835|NCT01263665|581698878|FG000|Overall Study|Surgical Bypass|2|||
161084836|NCT02706899|581698883|FG000|Overall Study|Withdrawal by Subject|1|||
161290856|NCT00699998|582446029|FG003|Overall Study|Withdrawal by Subject|80|||
161290857|NCT00699998|582446026|FG000|Overall Study|Physician Decision|3|||
161290858|NCT00699998|582446027|FG001|Overall Study|Physician Decision|2|||
161290859|NCT00699998|582446028|FG002|Overall Study|Physician Decision|1|||
161290860|NCT00699998|582446029|FG003|Overall Study|Physician Decision|1|||
161290861|NCT00699998|582446026|FG000|Overall Study|Lost to Follow-up|2|||
161290862|NCT00699998|582446027|FG001|Overall Study|Lost to Follow-up|1|||
161290863|NCT00699998|582446028|FG002|Overall Study|Lost to Follow-up|3|||
161290864|NCT00699998|582446029|FG003|Overall Study|Lost to Follow-up|1|||
161290865|NCT04616612|582446036|FG000|Overall Study|Lost to Follow-up|6|||
161290866|NCT04616612|582446037|FG001|Overall Study|Lost to Follow-up|3|||
161290867|NCT04740918|582446039|FG000|Overall Study|Study Terminated by Sponsor|41|||
161290868|NCT04740918|582446040|FG001|Overall Study|Study Terminated by Sponsor|32|||
161290869|NCT04740918|582446039|FG000|Overall Study|Death|3|||
161290870|NCT04740918|582446040|FG001|Overall Study|Death|6|||
161290871|NCT04740918|582446039|FG000|Overall Study|Withdrawal by Subject|5|||
161290872|NCT04740918|582446040|FG001|Overall Study|Withdrawal by Subject|4|||
161290873|NCT04740918|582446039|FG000|Overall Study|Lost to Follow-up|1|||
161290874|NCT04740918|582446040|FG001|Overall Study|Lost to Follow-up|3|||
161290875|NCT04740918|582446039|FG000|Overall Study|Progressive disease|0|||
161290876|NCT04740918|582446040|FG001|Overall Study|Progressive disease|1|||
161290877|NCT00359424|582446044|FG000|Overall Study|Death|99|||
161290878|NCT00359424|582446045|FG001|Overall Study|Death|58|||
161290879|NCT00359424|582446044|FG000|Overall Study|Lost to Follow-up|19|||
161290880|NCT00359424|582446045|FG001|Overall Study|Lost to Follow-up|7|||
161290881|NCT00359424|582446044|FG000|Overall Study|Withdrawal by Subject|10|||
161290882|NCT00359424|582446045|FG001|Overall Study|Withdrawal by Subject|2|||
161290883|NCT00359424|582446044|FG000|Overall Study|follow up not conducted|2|||
161084837|NCT02706899|581698884|FG001|Overall Study|Withdrawal by Subject|0|||
161084838|NCT02706899|581698883|FG000|Overall Study|Death|8|||
161084839|NCT02706899|581698884|FG001|Overall Study|Death|0|||
161084840|NCT02706899|581698883|FG000|Overall Study|Study Termination by Sponsor|4|||
161084841|NCT02706899|581698884|FG001|Overall Study|Study Termination by Sponsor|6|||
161084842|NCT00324675|581698885|FG000|Overall Study|Adverse Event|1|||
161084843|NCT00324675|581698886|FG001|Overall Study|Adverse Event|0|||
161084844|NCT04811131|581698891|FG000|Overall Study|Adverse Event|0|||
161084845|NCT04811131|581698892|FG001|Overall Study|Adverse Event|0|||
161084846|NCT04811131|581698893|FG002|Overall Study|Adverse Event|1|||
161084847|NCT04811131|581698894|FG003|Overall Study|Adverse Event|0|||
161084848|NCT04811131|581698891|FG000|Overall Study|Lack of Efficacy|0|||
161084849|NCT04811131|581698892|FG001|Overall Study|Lack of Efficacy|0|||
161084850|NCT04811131|581698893|FG002|Overall Study|Lack of Efficacy|0|||
161084851|NCT04811131|581698894|FG003|Overall Study|Lack of Efficacy|1|||
161084852|NCT04811131|581698891|FG000|Overall Study|Lost to Follow-up|0|||
161084853|NCT04811131|581698892|FG001|Overall Study|Lost to Follow-up|1|||
161084854|NCT04811131|581698893|FG002|Overall Study|Lost to Follow-up|0|||
161084855|NCT04811131|581698894|FG003|Overall Study|Lost to Follow-up|0|||
161084856|NCT04811131|581698891|FG000|Overall Study|Sponsor request|31|||
161084857|NCT04811131|581698892|FG001|Overall Study|Sponsor request|35|||
161084858|NCT04811131|581698893|FG002|Overall Study|Sponsor request|27|||
161084859|NCT04811131|581698894|FG003|Overall Study|Sponsor request|10|||
161084860|NCT04811131|581698891|FG000|Overall Study|Withdrawal by Subject|3|||
161084861|NCT04811131|581698892|FG001|Overall Study|Withdrawal by Subject|1|||
161084862|NCT04811131|581698893|FG002|Overall Study|Withdrawal by Subject|3|||
161084863|NCT04811131|581698894|FG003|Overall Study|Withdrawal by Subject|1|||
161084864|NCT01127763|581698897|FG000|Overall Study|Adverse Event|2|||
161084865|NCT01127763|581698897|FG000|Overall Study|Withdrawal by Subject|1|||
161084866|NCT01127763|581698897|FG000|Overall Study|Physician Decision|2|||
161084867|NCT03181789|581698899|FG000|Overall Study|Withdrawal by Subject|0|||
161084868|NCT03181789|581698900|FG001|Overall Study|Withdrawal by Subject|1|||
161084869|NCT03181789|581698901|FG002|Overall Study|Withdrawal by Subject|1|||
161084870|NCT03181789|581698902|FG003|Overall Study|Withdrawal by Subject|0|||
161084871|NCT03181789|581698899|FG000|Overall Study|Lost to Follow-up|7|||
161084872|NCT03181789|581698900|FG001|Overall Study|Lost to Follow-up|1|||
161084873|NCT03181789|581698901|FG002|Overall Study|Lost to Follow-up|0|||
161170553|NCT02559206|582001117|FG006|Overall Study|Lack of Efficacy|3|||
161084874|NCT03181789|581698902|FG003|Overall Study|Lost to Follow-up|0|||
161084875|NCT03181789|581698899|FG000|Overall Study|Participant unable to adhere to visit|0|||
161084876|NCT03181789|581698900|FG001|Overall Study|Participant unable to adhere to visit|1|||
161084877|NCT03181789|581698901|FG002|Overall Study|Participant unable to adhere to visit|0|||
161084878|NCT03181789|581698902|FG003|Overall Study|Participant unable to adhere to visit|0|||
161170554|NCT02559206|582001118|FG007|Overall Study|Lack of Efficacy|3|||
161084879|NCT01131182|581698903|FG000|Overall Study|Withdrawal by Subject|1|||
161290884|NCT00359424|582446045|FG001|Overall Study|follow up not conducted|0|||
161290885|NCT02208362|582446046|FG000|Overall Study|Participant did not complete treatment|0|||
161290886|NCT02208362|582446047|FG001|Overall Study|Participant did not complete treatment|1|||
161290887|NCT02208362|582446048|FG002|Overall Study|Participant did not complete treatment|0|||
161290888|NCT02208362|582446049|FG003|Overall Study|Participant did not complete treatment|0|||
161170555|NCT02559206|582001111|FG000|Overall Study|Other Not Specified|0|||
161170556|NCT02559206|582001112|FG001|Overall Study|Other Not Specified|0|||
161170557|NCT02559206|582001113|FG002|Overall Study|Other Not Specified|0|||
161170558|NCT02559206|582001114|FG003|Overall Study|Other Not Specified|1|||
161170559|NCT02559206|582001115|FG004|Overall Study|Other Not Specified|0|||
161170560|NCT02559206|582001116|FG005|Overall Study|Other Not Specified|0|||
161170561|NCT02559206|582001117|FG006|Overall Study|Other Not Specified|0|||
161170562|NCT02559206|582001118|FG007|Overall Study|Other Not Specified|0|||
161170563|NCT01375647|582003174|FG000|Overall Study|Lost to Follow-up|3|||
161170564|NCT01375647|582003175|FG001|Overall Study|Lost to Follow-up|3|||
161170565|NCT01375647|582003176|FG002|Overall Study|Lost to Follow-up|7|||
161170566|NCT01375647|582003177|FG003|Overall Study|Lost to Follow-up|10|||
161170567|NCT01375647|582003174|FG000|Overall Study|Death|1|||
161170568|NCT01375647|582003175|FG001|Overall Study|Death|2|||
161170569|NCT01375647|582003176|FG002|Overall Study|Death|1|||
161170570|NCT01375647|582003177|FG003|Overall Study|Death|0|||
161170571|NCT01375647|582003174|FG000|Overall Study|Withdrawal by Subject|17|||
161170572|NCT01375647|582003175|FG001|Overall Study|Withdrawal by Subject|20|||
161170573|NCT01375647|582003176|FG002|Overall Study|Withdrawal by Subject|26|||
161170574|NCT01375647|582003177|FG003|Overall Study|Withdrawal by Subject|14|||
161170575|NCT01375647|582003174|FG000|Overall Study|Physician Decision|1|||
161170576|NCT01375647|582003175|FG001|Overall Study|Physician Decision|0|||
161170577|NCT01375647|582003176|FG002|Overall Study|Physician Decision|0|||
161170578|NCT01375647|582003177|FG003|Overall Study|Physician Decision|0|||
161170579|NCT01770145|582003178|FG000|Baseline|Adverse Event|20|||
161170580|NCT01770145|582003178|FG000|Baseline|Withdrawal by Subject|1|||
161170581|NCT01770145|582003178|FG000|Baseline|Lost to Follow-up|1|||
161170582|NCT01770145|582003178|FG000|Baseline|Unable to define optimal dose|4|||
161170583|NCT01770145|582003178|FG000|Treatment|Adverse Event|3|||
161170584|NCT01770145|582003178|FG000|Treatment|Withdrawal by Subject|1|||
161170585|NCT01102140|582003179|FG000|Overall Study|Lost to Follow-up|1|||
161170586|NCT01102140|582003180|FG001|Overall Study|Lost to Follow-up|0|||
161170587|NCT01102140|582003179|FG000|Overall Study|Investigator terminated study|2|||
161170588|NCT01102140|582003180|FG001|Overall Study|Investigator terminated study|2|||
161170589|NCT03788967|582003183|FG000|Overall Study|Lost to Follow-up|14|||
161170590|NCT03788967|582003184|FG001|Overall Study|Lost to Follow-up|10|||
161170591|NCT03788967|582003183|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
161170592|NCT03788967|582003184|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
161170593|NCT03788967|582003183|FG000|Overall Study|Participant Withdrawal of Consent|13|||
161170594|NCT03788967|582003184|FG001|Overall Study|Participant Withdrawal of Consent|5|||
161170595|NCT03788967|582003183|FG000|Overall Study|Adverse Event|1|||
161170596|NCT03788967|582003184|FG001|Overall Study|Adverse Event|1|||
161170597|NCT03788967|582003183|FG000|Overall Study|COVID-19|1|||
161170598|NCT03788967|582003184|FG001|Overall Study|COVID-19|2|||
161170599|NCT04268303|582003185|FG000|Overall Study|Lost to Follow-up|1|||
161170600|NCT04268303|582003186|FG001|Overall Study|Lost to Follow-up|1|||
161170601|NCT04268303|582003187|FG002|Overall Study|Lost to Follow-up|2|||
161170602|NCT04268303|582003185|FG000|Overall Study|Withdrawal by Subject|0|||
161170603|NCT04268303|582003186|FG001|Overall Study|Withdrawal by Subject|1|||
161170604|NCT04268303|582003187|FG002|Overall Study|Withdrawal by Subject|1|||
161170605|NCT04268303|582003185|FG000|Overall Study|Adverse Event|2|||
161170606|NCT04268303|582003186|FG001|Overall Study|Adverse Event|0|||
161170607|NCT04268303|582003187|FG002|Overall Study|Adverse Event|0|||
161170608|NCT00355134|582003188|FG000|Core Phase|Withdrawal by Subject|35|||
161170609|NCT00355134|582003189|FG001|Core Phase|Withdrawal by Subject|24|||
161170610|NCT00355134|582003190|FG002|Core Phase|Withdrawal by Subject|35|||
161170611|NCT00355134|582003191|FG003|Core Phase|Withdrawal by Subject|0|||
161170612|NCT00355134|582003192|FG004|Core Phase|Withdrawal by Subject|0|||
161170613|NCT00355134|582003188|FG000|Core Phase|Adverse Event|28|||
161170614|NCT00355134|582003189|FG001|Core Phase|Adverse Event|22|||
161170615|NCT00355134|582003190|FG002|Core Phase|Adverse Event|16|||
161170616|NCT00355134|582003191|FG003|Core Phase|Adverse Event|0|||
161290889|NCT02208362|582446050|FG004|Overall Study|Participant did not complete treatment|0|||
161290890|NCT02208362|582446051|FG005|Overall Study|Participant did not complete treatment|0|||
161290891|NCT02208362|582446052|FG006|Overall Study|Participant did not complete treatment|1|||
161290892|NCT02208362|582446053|FG007|Overall Study|Participant did not complete treatment|1|||
161290893|NCT02208362|582446054|FG008|Overall Study|Participant did not complete treatment|2|||
161170617|NCT00355134|582003192|FG004|Core Phase|Adverse Event|0|||
161170618|NCT00355134|582003188|FG000|Core Phase|Lost to Follow-up|17|||
161170619|NCT00355134|582003189|FG001|Core Phase|Lost to Follow-up|13|||
161170620|NCT00355134|582003190|FG002|Core Phase|Lost to Follow-up|21|||
161170621|NCT00355134|582003191|FG003|Core Phase|Lost to Follow-up|0|||
161170622|NCT00355134|582003192|FG004|Core Phase|Lost to Follow-up|0|||
161170623|NCT00355134|582003188|FG000|Core Phase|Abnormal laboratory value(s)|19|||
161170624|NCT00355134|582003189|FG001|Core Phase|Abnormal laboratory value(s)|14|||
161170625|NCT00355134|582003190|FG002|Core Phase|Abnormal laboratory value(s)|2|||
161170626|NCT00355134|582003191|FG003|Core Phase|Abnormal laboratory value(s)|0|||
161170627|NCT00355134|582003192|FG004|Core Phase|Abnormal laboratory value(s)|0|||
161170628|NCT00355134|582003188|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
161170629|NCT00355134|582003189|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
161170630|NCT00355134|582003190|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
161170631|NCT00355134|582003191|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
161347190|NCT02293499|582656208|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
161347191|NCT02293499|582656209|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
161170632|NCT00355134|582003192|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
161170633|NCT00355134|582003188|FG000|Core Phase|Administrative problems|5|||
161170634|NCT00355134|582003189|FG001|Core Phase|Administrative problems|3|||
161170635|NCT00355134|582003190|FG002|Core Phase|Administrative problems|5|||
161170636|NCT00355134|582003191|FG003|Core Phase|Administrative problems|0|||
161170637|NCT00355134|582003192|FG004|Core Phase|Administrative problems|0|||
161170638|NCT00355134|582003188|FG000|Core Phase|Protocol Violation|3|||
161170639|NCT00355134|582003189|FG001|Core Phase|Protocol Violation|2|||
161170640|NCT00355134|582003190|FG002|Core Phase|Protocol Violation|2|||
161170641|NCT00355134|582003191|FG003|Core Phase|Protocol Violation|0|||
161347192|NCT02293499|582656210|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
161347193|NCT02293499|582656208|FG000|15 Month Follow Up|Lost to Follow-up|22|||
161347194|NCT02293499|582656209|FG001|15 Month Follow Up|Lost to Follow-up|22|||
161084880|NCT01131182|581698904|FG001|Overall Study|Withdrawal by Subject|1|||
161084881|NCT01131182|581698903|FG000|Overall Study|Lost to Follow-up|14|||
161084882|NCT01131182|581698904|FG001|Overall Study|Lost to Follow-up|15|||
161084883|NCT01131182|581698903|FG000|Overall Study|Other Reason|1|||
161084884|NCT01131182|581698904|FG001|Overall Study|Other Reason|0|||
161084885|NCT00735475|581698905|FG000|Overall Study|Adverse Event|0|||
161084886|NCT00735475|581698906|FG001|Overall Study|Adverse Event|1|||
161084887|NCT00735475|581698905|FG000|Overall Study|Death|1|||
161084888|NCT00735475|581698906|FG001|Overall Study|Death|1|||
161084889|NCT00735475|581698905|FG000|Overall Study|Lost to Follow-up|3|||
161084890|NCT00735475|581698906|FG001|Overall Study|Lost to Follow-up|3|||
161084891|NCT00735475|581698905|FG000|Overall Study|Physician Decision|0|||
161084892|NCT00735475|581698906|FG001|Overall Study|Physician Decision|1|||
161084893|NCT00735475|581698905|FG000|Overall Study|Withdrawal by Subject|4|||
161084894|NCT00735475|581698906|FG001|Overall Study|Withdrawal by Subject|5|||
161084895|NCT05086276|581698907|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
161084896|NCT05086276|581698908|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
161084897|NCT00777088|581698909|FG000|Overall Study|PED Treatment not attempted|1|||
161084898|NCT00633880|581698910|FG000|Open Label Titration|Lack of Efficacy|1|||
161084899|NCT00633880|581698911|FG001|Open Label Titration|Lack of Efficacy|0|||
161084900|NCT00633880|581698912|FG002|Open Label Titration|Lack of Efficacy|0|||
161084901|NCT00633880|581698910|FG000|Open Label Titration|Adverse Event|13|||
161084902|NCT00633880|581698911|FG001|Open Label Titration|Adverse Event|0|||
161084903|NCT00633880|581698912|FG002|Open Label Titration|Adverse Event|0|||
161084904|NCT00633880|581698910|FG000|Open Label Titration|Treatment Failure|55|||
161084905|NCT00633880|581698911|FG001|Open Label Titration|Treatment Failure|0|||
161084906|NCT00633880|581698912|FG002|Open Label Titration|Treatment Failure|0|||
161084907|NCT00633880|581698910|FG000|Open Label Titration|Protocol Violation|6|||
161084908|NCT00633880|581698911|FG001|Open Label Titration|Protocol Violation|0|||
161084909|NCT00633880|581698912|FG002|Open Label Titration|Protocol Violation|0|||
161084910|NCT00633880|581698910|FG000|Open Label Titration|Physician Decision|1|||
161084911|NCT00633880|581698911|FG001|Open Label Titration|Physician Decision|0|||
161084912|NCT00633880|581698912|FG002|Open Label Titration|Physician Decision|0|||
161084913|NCT00633880|581698910|FG000|Open Label Titration|Withdrawal by Subject|4|||
161084914|NCT00633880|581698911|FG001|Open Label Titration|Withdrawal by Subject|0|||
161084915|NCT00633880|581698912|FG002|Open Label Titration|Withdrawal by Subject|0|||
161084916|NCT01468181|581698916|FG000|Overall Study|Adverse Event|8|||
161084917|NCT01468181|581698917|FG001|Overall Study|Adverse Event|1|||
161084918|NCT01468181|581698918|FG002|Overall Study|Adverse Event|6|||
161084919|NCT01468181|581698919|FG003|Overall Study|Adverse Event|2|||
161084920|NCT01468181|581698920|FG004|Overall Study|Adverse Event|2|||
161084921|NCT01468181|581698916|FG000|Overall Study|Protocol Violation|2|||
161084922|NCT01468181|581698917|FG001|Overall Study|Protocol Violation|0|||
161084923|NCT01468181|581698918|FG002|Overall Study|Protocol Violation|1|||
161084924|NCT01468181|581698919|FG003|Overall Study|Protocol Violation|0|||
161084925|NCT01468181|581698920|FG004|Overall Study|Protocol Violation|1|||
161084926|NCT01468181|581698916|FG000|Overall Study|Physician Decision|0|||
161084927|NCT01468181|581698917|FG001|Overall Study|Physician Decision|0|||
161084928|NCT01468181|581698918|FG002|Overall Study|Physician Decision|0|||
161084929|NCT01468181|581698919|FG003|Overall Study|Physician Decision|1|||
161084930|NCT01468181|581698920|FG004|Overall Study|Physician Decision|1|||
161170642|NCT00355134|582003192|FG004|Core Phase|Protocol Violation|0|||
161084931|NCT01468181|581698916|FG000|Overall Study|Lost to Follow-up|0|||
161084932|NCT01468181|581698917|FG001|Overall Study|Lost to Follow-up|0|||
161084933|NCT01468181|581698918|FG002|Overall Study|Lost to Follow-up|1|||
161084934|NCT01468181|581698919|FG003|Overall Study|Lost to Follow-up|0|||
161170643|NCT00355134|582003188|FG000|Core Phase|Abnormal test procedure result(s)|1|||
161170644|NCT00355134|582003189|FG001|Core Phase|Abnormal test procedure result(s)|2|||
161170645|NCT00355134|582003190|FG002|Core Phase|Abnormal test procedure result(s)|1|||
161290894|NCT02208362|582446055|FG009|Overall Study|Participant did not complete treatment|0|||
161290895|NCT02208362|582446056|FG010|Overall Study|Participant did not complete treatment|1|||
161084935|NCT01468181|581698920|FG004|Overall Study|Lost to Follow-up|1|||
161084936|NCT01468181|581698916|FG000|Overall Study|Withdrawal by Subject|0|||
161084937|NCT01468181|581698917|FG001|Overall Study|Withdrawal by Subject|1|||
161084938|NCT01468181|581698918|FG002|Overall Study|Withdrawal by Subject|0|||
161084939|NCT01468181|581698919|FG003|Overall Study|Withdrawal by Subject|0|||
161084940|NCT01468181|581698920|FG004|Overall Study|Withdrawal by Subject|0|||
161084941|NCT00513305|581698924|FG000|Overall Study|Adverse Event|6|||
161084942|NCT00513305|581698925|FG001|Overall Study|Adverse Event|2|||
161084943|NCT00513305|581698924|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
161084944|NCT00513305|581698925|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
161084945|NCT00513305|581698924|FG000|Overall Study|Lack of Efficacy|8|||
161084946|NCT00513305|581698925|FG001|Overall Study|Lack of Efficacy|13|||
161084947|NCT00513305|581698924|FG000|Overall Study|Withdrawal by Subject|1|||
161084948|NCT00513305|581698925|FG001|Overall Study|Withdrawal by Subject|2|||
161084949|NCT00513305|581698924|FG000|Overall Study|Disease progression|8|||
161084950|NCT00513305|581698925|FG001|Overall Study|Disease progression|5|||
161084951|NCT00513305|581698924|FG000|Overall Study|Eligible for stem cell transplant|1|||
161084952|NCT00513305|581698925|FG001|Overall Study|Eligible for stem cell transplant|0|||
161084953|NCT00513305|581698924|FG000|Overall Study|Hematologic counts did not recover|1|||
161084954|NCT00513305|581698925|FG001|Overall Study|Hematologic counts did not recover|0|||
161084955|NCT00513305|581698924|FG000|Overall Study|Physician Decision|1|||
161084956|NCT00513305|581698925|FG001|Overall Study|Physician Decision|0|||
161084957|NCT00513305|581698924|FG000|Overall Study|Persistent hypocellularity|0|||
161084958|NCT00513305|581698925|FG001|Overall Study|Persistent hypocellularity|1|||
161084959|NCT00513305|581698924|FG000|Overall Study|Sponsor Decision|0|||
161084960|NCT00513305|581698925|FG001|Overall Study|Sponsor Decision|2|||
161084961|NCT01262027|581698927|FG000|Overall Study|Adverse Event|1|||
161084962|NCT01262027|581698927|FG000|Overall Study|Withdrawal by Subject|3|||
161084963|NCT01262027|581698927|FG000|Overall Study|Protocol Violation|1|||
161084964|NCT01982448|581698934|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
161084965|NCT01982448|581698935|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
161084966|NCT01982448|581698934|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
161084967|NCT01982448|581698935|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
161084968|NCT01982448|581698934|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
161084969|NCT01982448|581698935|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
161084970|NCT01982448|581698934|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
161084971|NCT01982448|581698935|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
161084972|NCT00978627|581700143|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
161084973|NCT00978627|581700144|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
161084974|NCT00978627|581700143|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
161084975|NCT00978627|581700144|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
161084976|NCT00978627|581700143|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
161084977|NCT00978627|581700144|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
161084978|NCT00978627|581700143|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
161084979|NCT00978627|581700144|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
161084980|NCT00978627|581700143|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
161084981|NCT00978627|581700144|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
161084982|NCT00978627|581700143|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
161084983|NCT00978627|581700144|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
161084984|NCT00978627|581700143|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
161084985|NCT00978627|581700144|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
161084986|NCT00978627|581700143|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
161084987|NCT00978627|581700144|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
161084988|NCT00978627|581700143|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
161084989|NCT00978627|581700144|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
161084990|NCT01290315|581700145|FG000|Overall Study|Adverse Event|0|||
161084991|NCT01290315|581700146|FG001|Overall Study|Adverse Event|0|||
161084992|NCT01290315|581700147|FG002|Overall Study|Adverse Event|0|||
161084993|NCT01290315|581700148|FG003|Overall Study|Adverse Event|3|||
161084994|NCT01290315|581700145|FG000|Overall Study|Selection criteria/compliance|2|||
161084995|NCT01290315|581700146|FG001|Overall Study|Selection criteria/compliance|1|||
161084996|NCT01290315|581700147|FG002|Overall Study|Selection criteria/compliance|0|||
161084997|NCT01290315|581700148|FG003|Overall Study|Selection criteria/compliance|2|||
161084998|NCT01290315|581700145|FG000|Overall Study|Lost to Follow-up|0|||
161084999|NCT01290315|581700146|FG001|Overall Study|Lost to Follow-up|1|||
161085000|NCT01290315|581700147|FG002|Overall Study|Lost to Follow-up|0|||
161085001|NCT01290315|581700148|FG003|Overall Study|Lost to Follow-up|0|||
161085002|NCT01290315|581700145|FG000|Overall Study|Withdrawal by Subject|1|||
161085003|NCT01290315|581700146|FG001|Overall Study|Withdrawal by Subject|1|||
161290896|NCT02208362|582446057|FG011|Overall Study|Participant did not complete treatment|0|||
161290897|NCT02208362|582446046|FG000|Overall Study|Participant received disallowed treatment|0|||
161290898|NCT02208362|582446047|FG001|Overall Study|Participant received disallowed treatment|0|||
161290899|NCT02208362|582446048|FG002|Overall Study|Participant received disallowed treatment|0|||
161290900|NCT02208362|582446049|FG003|Overall Study|Participant received disallowed treatment|0|||
161290901|NCT02208362|582446050|FG004|Overall Study|Participant received disallowed treatment|0|||
161290902|NCT02208362|582446051|FG005|Overall Study|Participant received disallowed treatment|0|||
161290903|NCT02208362|582446052|FG006|Overall Study|Participant received disallowed treatment|0|||
161290904|NCT02208362|582446053|FG007|Overall Study|Participant received disallowed treatment|0|||
161290905|NCT02208362|582446054|FG008|Overall Study|Participant received disallowed treatment|1|||
161290906|NCT02208362|582446055|FG009|Overall Study|Participant received disallowed treatment|0|||
161290907|NCT02208362|582446056|FG010|Overall Study|Participant received disallowed treatment|0|||
161290908|NCT02208362|582446057|FG011|Overall Study|Participant received disallowed treatment|0|||
161290909|NCT05479435|582446060|FG000|Overall Study|Withdrawal by Subject|1|||
161290910|NCT05479435|582446061|FG001|Overall Study|Withdrawal by Subject|0|||
161290911|NCT05479435|582446062|FG002|Overall Study|Withdrawal by Subject|0|||
161290912|NCT05479435|582446060|FG000|Overall Study|Covid 19|0|||
161290913|NCT05479435|582446061|FG001|Overall Study|Covid 19|0|||
161290914|NCT05479435|582446062|FG002|Overall Study|Covid 19|2|||
161290915|NCT00955617|582446067|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
161290916|NCT00955617|582446068|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
161290917|NCT00955617|582446067|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
161290918|NCT00955617|582446068|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
161290919|NCT00955617|582446067|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
161290920|NCT00955617|582446068|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
161290921|NCT00955617|582446067|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
161290922|NCT00955617|582446068|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
161290923|NCT01609790|582446069|FG000|Overall Study|Protocol Violation|1|||
161290924|NCT01609790|582446070|FG001|Overall Study|Protocol Violation|7|||
161085004|NCT01290315|581700147|FG002|Overall Study|Withdrawal by Subject|0|||
161085005|NCT01290315|581700148|FG003|Overall Study|Withdrawal by Subject|0|||
161085006|NCT03725085|581700149|FG000|Overall Study|Lost to Follow-up|2|||
161085007|NCT00705679|581700150|FG000|Overall Study|Adverse Event|1|||
161085008|NCT00705679|581700151|FG001|Overall Study|Adverse Event|1|||
161085009|NCT00705679|581700152|FG002|Overall Study|Adverse Event|0|||
161085010|NCT00705679|581700153|FG003|Overall Study|Adverse Event|0|||
161085011|NCT00705679|581700154|FG004|Overall Study|Adverse Event|0|||
161085012|NCT00705679|581700150|FG000|Overall Study|Death|0|||
161085013|NCT00705679|581700151|FG001|Overall Study|Death|0|||
161085014|NCT00705679|581700152|FG002|Overall Study|Death|3|||
161085015|NCT00705679|581700153|FG003|Overall Study|Death|2|||
161085016|NCT00705679|581700154|FG004|Overall Study|Death|1|||
161085017|NCT00705679|581700150|FG000|Overall Study|Lost to Follow-up|32|||
161085018|NCT00705679|581700151|FG001|Overall Study|Lost to Follow-up|60|||
161085019|NCT00705679|581700152|FG002|Overall Study|Lost to Follow-up|44|||
161085020|NCT00705679|581700153|FG003|Overall Study|Lost to Follow-up|30|||
161085021|NCT00705679|581700154|FG004|Overall Study|Lost to Follow-up|35|||
161085022|NCT00705679|581700150|FG000|Overall Study|Physician Decision|0|||
161085023|NCT00705679|581700151|FG001|Overall Study|Physician Decision|1|||
161085024|NCT00705679|581700152|FG002|Overall Study|Physician Decision|0|||
161085025|NCT00705679|581700153|FG003|Overall Study|Physician Decision|1|||
161085026|NCT00705679|581700154|FG004|Overall Study|Physician Decision|0|||
161085027|NCT00705679|581700150|FG000|Overall Study|Withdrawal by Subject|32|||
161085028|NCT00705679|581700151|FG001|Overall Study|Withdrawal by Subject|77|||
161085029|NCT00705679|581700152|FG002|Overall Study|Withdrawal by Subject|68|||
161085030|NCT00705679|581700153|FG003|Overall Study|Withdrawal by Subject|47|||
161085031|NCT00705679|581700154|FG004|Overall Study|Withdrawal by Subject|33|||
161085032|NCT03527173|581700155|FG000|Overall Study|Lost to Follow-up|4|||
161085033|NCT03527173|581700156|FG001|Overall Study|Lost to Follow-up|2|||
161085034|NCT03527173|581700155|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
161085035|NCT03527173|581700156|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
161085036|NCT03527173|581700155|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
161085037|NCT03527173|581700156|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
161085038|NCT03527173|581700155|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
161085039|NCT03527173|581700156|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
161085040|NCT02704754|581700157|FG000|Overall Study|Lost to Follow-up|1|||
161085041|NCT02704754|581700158|FG001|Overall Study|Lost to Follow-up|1|||
161085042|NCT02704754|581700157|FG000|Overall Study|Lack of Efficacy|1|||
161085043|NCT02704754|581700158|FG001|Overall Study|Lack of Efficacy|0|||
161085044|NCT02704754|581700157|FG000|Overall Study|Withdrawal by Subject|1|||
161085045|NCT02704754|581700158|FG001|Overall Study|Withdrawal by Subject|0|||
161085046|NCT00423943|581700161|FG000|Overall Study|Withdrawal by Subject|3|||
161085047|NCT00423943|581700162|FG001|Overall Study|Withdrawal by Subject|1|||
161091286|NCT01272804|581723873|FG005|Overall Study|Adverse Event|1|||
161170646|NCT00355134|582003191|FG003|Core Phase|Abnormal test procedure result(s)|0|||
161170647|NCT00355134|582003192|FG004|Core Phase|Abnormal test procedure result(s)|0|||
161170648|NCT00355134|582003188|FG000|Core Phase|Condition no longer requires study drug|1|||
161170649|NCT00355134|582003189|FG001|Core Phase|Condition no longer requires study drug|0|||
161170650|NCT00355134|582003190|FG002|Core Phase|Condition no longer requires study drug|1|||
161170651|NCT00355134|582003191|FG003|Core Phase|Condition no longer requires study drug|0|||
161170652|NCT00355134|582003192|FG004|Core Phase|Condition no longer requires study drug|0|||
161170653|NCT00355134|582003188|FG000|Extension Phase|Withdrawal by Subject|7|||
161170654|NCT00355134|582003189|FG001|Extension Phase|Withdrawal by Subject|11|||
161170655|NCT00355134|582003190|FG002|Extension Phase|Withdrawal by Subject|0|||
161170656|NCT00355134|582003191|FG003|Extension Phase|Withdrawal by Subject|7|||
161170657|NCT00355134|582003192|FG004|Extension Phase|Withdrawal by Subject|5|||
161170658|NCT00355134|582003188|FG000|Extension Phase|Adverse Event|13|||
161170659|NCT00355134|582003189|FG001|Extension Phase|Adverse Event|9|||
161170660|NCT00355134|582003190|FG002|Extension Phase|Adverse Event|0|||
161170661|NCT00355134|582003191|FG003|Extension Phase|Adverse Event|3|||
161170662|NCT00355134|582003192|FG004|Extension Phase|Adverse Event|5|||
161170663|NCT00355134|582003188|FG000|Extension Phase|Lost to Follow-up|2|||
161170664|NCT00355134|582003189|FG001|Extension Phase|Lost to Follow-up|6|||
161170665|NCT00355134|582003190|FG002|Extension Phase|Lost to Follow-up|0|||
161170666|NCT00355134|582003191|FG003|Extension Phase|Lost to Follow-up|2|||
161170667|NCT00355134|582003192|FG004|Extension Phase|Lost to Follow-up|4|||
161170668|NCT00355134|582003188|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
161170669|NCT00355134|582003189|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
161170670|NCT00355134|582003190|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
161170671|NCT00355134|582003191|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
161170672|NCT00355134|582003192|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
161170673|NCT00355134|582003188|FG000|Extension Phase|Administrative problems|2|||
161170674|NCT00355134|582003189|FG001|Extension Phase|Administrative problems|4|||
161170675|NCT00355134|582003190|FG002|Extension Phase|Administrative problems|0|||
161170676|NCT00355134|582003191|FG003|Extension Phase|Administrative problems|1|||
161170677|NCT00355134|582003192|FG004|Extension Phase|Administrative problems|1|||
161170678|NCT00355134|582003188|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
161290925|NCT01609790|582446071|FG002|Overall Study|Protocol Violation|8|||
161290926|NCT00858273|582446072|FG000|Overall Study|Protocol Violation|3|||
161290927|NCT00858273|582446073|FG001|Overall Study|Protocol Violation|5|||
161290928|NCT00982657|582446074|FG000|Overall Study|Death|1|||
161290929|NCT00982657|582446075|FG001|Overall Study|Death|0|||
161290930|NCT00982657|582446076|FG002|Overall Study|Death|1|||
161290931|NCT00982657|582446077|FG003|Overall Study|Death|1|||
161290932|NCT00982657|582446074|FG000|Overall Study|Withdrawal by Subject|0|||
161290933|NCT00982657|582446075|FG001|Overall Study|Withdrawal by Subject|0|||
161290934|NCT00982657|582446076|FG002|Overall Study|Withdrawal by Subject|1|||
161290935|NCT00982657|582446077|FG003|Overall Study|Withdrawal by Subject|3|||
161290936|NCT00982657|582446074|FG000|Overall Study|Other|0|||
161290937|NCT00982657|582446075|FG001|Overall Study|Other|0|||
161290938|NCT00982657|582446076|FG002|Overall Study|Other|0|||
161290939|NCT00982657|582446077|FG003|Overall Study|Other|4|||
161290940|NCT00982657|582446074|FG000|Overall Study|On going at date of cut-off|0|||
161290941|NCT00982657|582446075|FG001|Overall Study|On going at date of cut-off|0|||
161290942|NCT00982657|582446076|FG002|Overall Study|On going at date of cut-off|0|||
161290943|NCT00982657|582446077|FG003|Overall Study|On going at date of cut-off|1|||
161290944|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Adverse Event|7|||
161290945|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
161290946|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Non-compliance|3|||
161290947|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Other|17|||
161290948|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Physician Decision|2|||
161290949|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Pregnancy|1|||
161290950|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
161290951|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
161290952|NCT05207865|582447941|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
161290953|NCT05207865|582447941|FG000|Follow-up Phase|Lost to Follow-up|1|||
161290954|NCT05207865|582447941|FG000|Follow-up Phase|Non-compliance|1|||
161170679|NCT00355134|582003189|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
161170680|NCT00355134|582003190|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
161170681|NCT00355134|582003191|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
161170682|NCT00355134|582003192|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
161170683|NCT00355134|582003188|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
161170684|NCT00355134|582003189|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
161290955|NCT05207865|582447941|FG000|Follow-up Phase|Not reported|2|||
161290956|NCT05207865|582447941|FG000|Follow-up Phase|Not collected|11|||
161290957|NCT00739882|582447946|FG000|Double-blind Period|Adverse Event|1|||
161290958|NCT00739882|582447947|FG001|Double-blind Period|Adverse Event|2|||
161290959|NCT00739882|582447946|FG000|Double-blind Period|Protocol Violation|1|||
161290960|NCT00739882|582447947|FG001|Double-blind Period|Protocol Violation|0|||
161347195|NCT02293499|582656210|FG002|15 Month Follow Up|Lost to Follow-up|7|||
161347196|NCT05977868|582656211|FG000|Overall Study|Withdrawal by Subject|1|||
161347197|NCT05977868|582656212|FG001|Overall Study|Withdrawal by Subject|2|||
161347198|NCT05977868|582656211|FG000|Overall Study|Transitioned to comfort care|1|||
161347199|NCT05977868|582656212|FG001|Overall Study|Transitioned to comfort care|0|||
161347200|NCT00876395|582656213|FG000|Overall Study|Untreated|8|||
161347201|NCT00876395|582656214|FG001|Overall Study|Untreated|1|||
161347202|NCT00876395|582656213|FG000|Overall Study|Adverse Event|63|||
161347203|NCT00876395|582656214|FG001|Overall Study|Adverse Event|11|||
161347204|NCT00876395|582656213|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161347205|NCT00876395|582656214|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161347206|NCT00876395|582656213|FG000|Overall Study|Disease progression|259|||
161347207|NCT00876395|582656214|FG001|Overall Study|Disease progression|162|||
161347208|NCT00876395|582656213|FG000|Overall Study|New cancer therapy|25|||
161347209|NCT00876395|582656214|FG001|Overall Study|New cancer therapy|7|||
161347210|NCT00876395|582656213|FG000|Overall Study|Protocol Violation|5|||
161347211|NCT00876395|582656214|FG001|Overall Study|Protocol Violation|2|||
161347212|NCT00876395|582656213|FG000|Overall Study|Withdrawal by Subject|66|||
161347213|NCT00876395|582656214|FG001|Overall Study|Withdrawal by Subject|33|||
161347214|NCT00876395|582656213|FG000|Overall Study|Lost to Follow-up|2|||
161347215|NCT00876395|582656214|FG001|Overall Study|Lost to Follow-up|0|||
161347216|NCT00876395|582656213|FG000|Overall Study|Administrative problems|39|||
161347217|NCT00876395|582656214|FG001|Overall Study|Administrative problems|23|||
161347218|NCT00876395|582656213|FG000|Overall Study|Death|12|||
161347219|NCT00876395|582656214|FG001|Overall Study|Death|0|||
161170685|NCT00355134|582003190|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
161170686|NCT00355134|582003191|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
161170687|NCT00355134|582003192|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
161170688|NCT00355134|582003188|FG000|Extension Phase|Protocol Violation|0|||
161170689|NCT00355134|582003189|FG001|Extension Phase|Protocol Violation|0|||
161170690|NCT00355134|582003190|FG002|Extension Phase|Protocol Violation|0|||
161170691|NCT00355134|582003191|FG003|Extension Phase|Protocol Violation|1|||
161170692|NCT00355134|582003192|FG004|Extension Phase|Protocol Violation|0|||
161170693|NCT01316939|582003200|FG000|Overall Study|Study closed/terminated|26|||
161347220|NCT01787838|582656223|FG000|Overall Study|refused|1413|||
161347221|NCT01991314|582656242|FG000|Overall Study|Adverse Event|5|||
161347222|NCT01991314|582656243|FG001|Overall Study|Adverse Event|1|||
161347223|NCT01991314|582656242|FG000|Overall Study|Lost to Follow-up|6|||
161347224|NCT01991314|582656243|FG001|Overall Study|Lost to Follow-up|10|||
161347225|NCT03915067|582656245|FG000|Overall Study|Adverse Event|0|||
161091287|NCT03801915|581723874|FG000|Overall Study|Screen failure|0|||
161091288|NCT03801915|581723875|FG001|Overall Study|Screen failure|0|||
161091289|NCT03801915|581723876|FG002|Overall Study|Screen failure|1|||
161091290|NCT03801915|581723874|FG000|Overall Study|Ineligible|1|||
161091291|NCT03801915|581723875|FG001|Overall Study|Ineligible|0|||
161091292|NCT03801915|581723876|FG002|Overall Study|Ineligible|0|||
161091293|NCT03801915|581723874|FG000|Overall Study|Physician Decision|2|||
161091294|NCT03801915|581723875|FG001|Overall Study|Physician Decision|1|||
161091295|NCT03801915|581723876|FG002|Overall Study|Physician Decision|0|||
161091296|NCT02308020|581723877|FG000|Overall Study|Lost to Follow-up|1|||
161091297|NCT02308020|581723878|FG001|Overall Study|Lost to Follow-up|7|||
161091298|NCT02308020|581723879|FG002|Overall Study|Lost to Follow-up|0|||
161091299|NCT02308020|581723880|FG003|Overall Study|Lost to Follow-up|0|||
161091300|NCT02308020|581723881|FG004|Overall Study|Lost to Follow-up|1|||
161091301|NCT02308020|581723882|FG005|Overall Study|Lost to Follow-up|2|||
161091302|NCT02308020|581723877|FG000|Overall Study|Sponsor Decision|0|||
161091303|NCT02308020|581723878|FG001|Overall Study|Sponsor Decision|8|||
161091304|NCT02308020|581723879|FG002|Overall Study|Sponsor Decision|0|||
161091305|NCT02308020|581723880|FG003|Overall Study|Sponsor Decision|2|||
161091306|NCT02308020|581723881|FG004|Overall Study|Sponsor Decision|2|||
161091307|NCT02308020|581723882|FG005|Overall Study|Sponsor Decision|1|||
161091308|NCT02308020|581723877|FG000|Overall Study|Withdrawal by Subject|3|||
161091309|NCT02308020|581723878|FG001|Overall Study|Withdrawal by Subject|5|||
161091310|NCT02308020|581723879|FG002|Overall Study|Withdrawal by Subject|3|||
161091311|NCT02308020|581723880|FG003|Overall Study|Withdrawal by Subject|2|||
161091312|NCT02308020|581723881|FG004|Overall Study|Withdrawal by Subject|1|||
161091313|NCT02308020|581723882|FG005|Overall Study|Withdrawal by Subject|2|||
161091314|NCT01211288|581723883|FG000|Overall Study|Lost to Follow-up|1|||
161091315|NCT01211288|581723884|FG001|Overall Study|Lost to Follow-up|1|||
161091316|NCT01270971|581723885|FG000|Overall Study|Withdrawal by Subject|24|||
161091317|NCT01270971|581723886|FG001|Overall Study|Withdrawal by Subject|11|||
161091318|NCT01270971|581723885|FG000|Overall Study|Lost to Follow-up|18|||
161091319|NCT01270971|581723886|FG001|Overall Study|Lost to Follow-up|5|||
161091320|NCT01270971|581723885|FG000|Overall Study|Adverse Event|1|||
161091321|NCT01270971|581723886|FG001|Overall Study|Adverse Event|2|||
161091322|NCT01270971|581723885|FG000|Overall Study|Non compliance|2|||
161091323|NCT01270971|581723886|FG001|Overall Study|Non compliance|2|||
161091324|NCT01270971|581723885|FG000|Overall Study|Non-specific|7|||
161170694|NCT01316939|582003201|FG001|Overall Study|Study closed/terminated|25|||
161170695|NCT01316939|582003202|FG002|Overall Study|Study closed/terminated|23|||
161170696|NCT01316939|582003200|FG000|Overall Study|Lack of Efficacy|24|||
161170697|NCT01316939|582003201|FG001|Overall Study|Lack of Efficacy|25|||
161170698|NCT01316939|582003202|FG002|Overall Study|Lack of Efficacy|25|||
161170699|NCT01316939|582003200|FG000|Overall Study|Adverse Event|9|||
161170700|NCT01316939|582003201|FG001|Overall Study|Adverse Event|12|||
161170701|NCT01316939|582003202|FG002|Overall Study|Adverse Event|11|||
161170702|NCT01316939|582003200|FG000|Overall Study|Withdrawal by Subject|1|||
161170703|NCT01316939|582003201|FG001|Overall Study|Withdrawal by Subject|3|||
161170704|NCT01316939|582003202|FG002|Overall Study|Withdrawal by Subject|6|||
161170705|NCT01316939|582003200|FG000|Overall Study|Physician Decision|2|||
161170706|NCT01316939|582003201|FG001|Overall Study|Physician Decision|2|||
161170707|NCT01316939|582003202|FG002|Overall Study|Physician Decision|1|||
161170708|NCT01316939|582003200|FG000|Overall Study|Lost to Follow-up|0|||
161170709|NCT01316939|582003201|FG001|Overall Study|Lost to Follow-up|0|||
161170710|NCT01316939|582003202|FG002|Overall Study|Lost to Follow-up|2|||
161170711|NCT01316939|582003200|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
161170712|NCT01316939|582003201|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
161170713|NCT01316939|582003202|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
161170714|NCT01316939|582003200|FG000|Overall Study|Protocol Violation|0|||
161170715|NCT01316939|582003201|FG001|Overall Study|Protocol Violation|1|||
161170716|NCT01316939|582003202|FG002|Overall Study|Protocol Violation|0|||
161170717|NCT04134728|582003203|FG000|Overall Study|Adverse Event|3|||
161170718|NCT04134728|582003204|FG001|Overall Study|Adverse Event|2|||
161170719|NCT04134728|582003205|FG002|Overall Study|Adverse Event|9|||
161170720|NCT04134728|582003206|FG003|Overall Study|Adverse Event|0|||
161170721|NCT04134728|582003207|FG004|Overall Study|Adverse Event|0|||
161170722|NCT04134728|582003208|FG005|Overall Study|Adverse Event|0|||
161170723|NCT04134728|582003203|FG000|Overall Study|Lack of Efficacy|3|||
161170724|NCT04134728|582003204|FG001|Overall Study|Lack of Efficacy|3|||
161170725|NCT04134728|582003205|FG002|Overall Study|Lack of Efficacy|1|||
161170726|NCT04134728|582003206|FG003|Overall Study|Lack of Efficacy|2|||
161170727|NCT04134728|582003207|FG004|Overall Study|Lack of Efficacy|0|||
161170728|NCT04134728|582003208|FG005|Overall Study|Lack of Efficacy|0|||
161170729|NCT04134728|582003203|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
161170730|NCT04134728|582003204|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161170731|NCT04134728|582003205|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
161170732|NCT04134728|582003206|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161170733|NCT04134728|582003207|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161170734|NCT04134728|582003208|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
161170735|NCT04134728|582003203|FG000|Overall Study|Protocol Deviation|0|||
161170736|NCT04134728|582003204|FG001|Overall Study|Protocol Deviation|0|||
161170737|NCT04134728|582003205|FG002|Overall Study|Protocol Deviation|1|||
161170738|NCT04134728|582003206|FG003|Overall Study|Protocol Deviation|0|||
161170739|NCT04134728|582003207|FG004|Overall Study|Protocol Deviation|0|||
161170740|NCT04134728|582003208|FG005|Overall Study|Protocol Deviation|0|||
161170741|NCT04134728|582003203|FG000|Overall Study|Informed Consent Withdrawn|3|||
161170742|NCT04134728|582003204|FG001|Overall Study|Informed Consent Withdrawn|6|||
161170743|NCT04134728|582003205|FG002|Overall Study|Informed Consent Withdrawn|8|||
161170744|NCT04134728|582003206|FG003|Overall Study|Informed Consent Withdrawn|1|||
161170745|NCT04134728|582003207|FG004|Overall Study|Informed Consent Withdrawn|1|||
161170746|NCT04134728|582003208|FG005|Overall Study|Informed Consent Withdrawn|0|||
161170747|NCT04134728|582003203|FG000|Overall Study|Physician Decision|2|||
161170748|NCT04134728|582003204|FG001|Overall Study|Physician Decision|0|||
161170749|NCT04134728|582003205|FG002|Overall Study|Physician Decision|0|||
161170750|NCT04134728|582003206|FG003|Overall Study|Physician Decision|0|||
161170751|NCT04134728|582003207|FG004|Overall Study|Physician Decision|0|||
161170752|NCT04134728|582003208|FG005|Overall Study|Physician Decision|0|||
161170753|NCT04134728|582003203|FG000|Overall Study|Lost to Follow-up|1|||
161170754|NCT04134728|582003204|FG001|Overall Study|Lost to Follow-up|2|||
161170755|NCT04134728|582003205|FG002|Overall Study|Lost to Follow-up|1|||
161170756|NCT04134728|582003206|FG003|Overall Study|Lost to Follow-up|0|||
161290961|NCT00739882|582447946|FG000|Double-blind Period|Lack of Efficacy|1|||
161290962|NCT00739882|582447947|FG001|Double-blind Period|Lack of Efficacy|1|||
161290963|NCT00739882|582447946|FG000|Double-blind Period|Other|16|||
161170757|NCT04134728|582003207|FG004|Overall Study|Lost to Follow-up|0|||
161170758|NCT04134728|582003208|FG005|Overall Study|Lost to Follow-up|1|||
161170759|NCT04134728|582003203|FG000|Overall Study|Investigator Site Closed|0|||
161290964|NCT00739882|582447947|FG001|Double-blind Period|Other|8|||
161170760|NCT04134728|582003204|FG001|Overall Study|Investigator Site Closed|1|||
161170761|NCT04134728|582003205|FG002|Overall Study|Investigator Site Closed|1|||
161170762|NCT04134728|582003206|FG003|Overall Study|Investigator Site Closed|0|||
161170763|NCT04134728|582003207|FG004|Overall Study|Investigator Site Closed|0|||
161170764|NCT04134728|582003208|FG005|Overall Study|Investigator Site Closed|0|||
161170765|NCT02715804|582003209|FG000|Overall Study|Death|222|||
161170766|NCT02715804|582003210|FG001|Overall Study|Death|106|||
161290965|NCT00739882|582447946|FG000|Open-label Period|Adverse Event|1|||
161085048|NCT03730480|581700163|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
161085049|NCT01248780|581700164|FG000|Overall Study|Lack of Efficacy|2|||
161085050|NCT01248780|581700165|FG001|Overall Study|Lack of Efficacy|0|||
161085051|NCT01248780|581700164|FG000|Overall Study|Lost to Follow-up|0|||
161085052|NCT01248780|581700165|FG001|Overall Study|Lost to Follow-up|1|||
161085053|NCT01248780|581700164|FG000|Overall Study|Death|0|||
161085054|NCT01248780|581700165|FG001|Overall Study|Death|1|||
161085055|NCT01248780|581700164|FG000|Overall Study|Adverse Event|2|||
161085056|NCT01248780|581700165|FG001|Overall Study|Adverse Event|7|||
161085057|NCT01248780|581700164|FG000|Overall Study|Protocol Violation|1|||
161085058|NCT01248780|581700165|FG001|Overall Study|Protocol Violation|1|||
161085059|NCT01248780|581700164|FG000|Overall Study|Withdrawal by Subject|4|||
161085060|NCT01248780|581700165|FG001|Overall Study|Withdrawal by Subject|4|||
161085061|NCT01248780|581700164|FG000|Overall Study|Not treated|0|||
161085062|NCT01248780|581700165|FG001|Overall Study|Not treated|1|||
161085063|NCT00107120|581700169|FG000|Overall Study|Adverse Event|4|||
161085064|NCT00107120|581700170|FG001|Overall Study|Adverse Event|1|||
161085065|NCT00107120|581700169|FG000|Overall Study|Lack of Efficacy|5|||
161085066|NCT00107120|581700170|FG001|Overall Study|Lack of Efficacy|5|||
161085067|NCT00107120|581700169|FG000|Overall Study|Protocol Violation|3|||
161085068|NCT00107120|581700170|FG001|Overall Study|Protocol Violation|0|||
161085069|NCT00107120|581700169|FG000|Overall Study|Withdrawal by Subject|8|||
161085070|NCT00107120|581700170|FG001|Overall Study|Withdrawal by Subject|9|||
161085071|NCT00107120|581700169|FG000|Overall Study|Lost to Follow-up|8|||
161085072|NCT00107120|581700170|FG001|Overall Study|Lost to Follow-up|6|||
161085073|NCT00107120|581700169|FG000|Overall Study|Pregnancy|0|||
161085074|NCT00107120|581700170|FG001|Overall Study|Pregnancy|1|||
161085075|NCT00107120|581700169|FG000|Overall Study|moving away from site|1|||
161085076|NCT00107120|581700170|FG001|Overall Study|moving away from site|1|||
161085077|NCT00107120|581700169|FG000|Overall Study|death of parent|0|||
161085078|NCT00107120|581700170|FG001|Overall Study|death of parent|1|||
161085079|NCT04214600|581700173|FG000|Overall Study|Lost to Follow-up|9|||
161085080|NCT04214600|581700174|FG001|Overall Study|Lost to Follow-up|14|||
161085081|NCT00896051|581700175|FG000|Overall Study|Adverse Event|2|||
161085082|NCT00896051|581700176|FG001|Overall Study|Adverse Event|1|||
161085083|NCT00896051|581700175|FG000|Overall Study|Lost to Follow-up|3|||
161085084|NCT00896051|581700176|FG001|Overall Study|Lost to Follow-up|2|||
161085085|NCT00896051|581700175|FG000|Overall Study|Withdrawal by Subject|3|||
161085086|NCT00896051|581700176|FG001|Overall Study|Withdrawal by Subject|2|||
161085087|NCT00896051|581700175|FG000|Overall Study|Subject noncompliant|1|||
161085088|NCT00896051|581700176|FG001|Overall Study|Subject noncompliant|3|||
161085089|NCT00896051|581700175|FG000|Overall Study|Other|1|||
161085090|NCT00896051|581700176|FG001|Overall Study|Other|1|||
161085091|NCT02935452|581700177|FG000|Overall Study|work and life commintment|3|||
161085092|NCT02935452|581700178|FG001|Overall Study|work and life commintment|1|||
161085093|NCT01635920|581700179|FG000|Overall Study|Adverse Event|1|||
161085094|NCT01635920|581700180|FG001|Overall Study|Adverse Event|0|||
161085095|NCT01635920|581700179|FG000|Overall Study|Lost to Follow-up|0|||
161085096|NCT01635920|581700180|FG001|Overall Study|Lost to Follow-up|1|||
161085097|NCT01635920|581700179|FG000|Overall Study|Subject decision|2|||
161085098|NCT01635920|581700180|FG001|Overall Study|Subject decision|0|||
161085099|NCT01813929|581700182|FG000|Overall Study|Withdrawal by Subject|0|||
161085100|NCT01813929|581700183|FG001|Overall Study|Withdrawal by Subject|1|||
161085101|NCT00007345|581700184|FG000|Overall Study|Refused further treatment|0|||
161085102|NCT00007345|581700185|FG001|Overall Study|Refused further treatment|7|||
161085103|NCT00007345|581700184|FG000|Overall Study|Switched to alternative treatment|0|||
161085104|NCT00007345|581700185|FG001|Overall Study|Switched to alternative treatment|3|||
161085105|NCT00007345|581700184|FG000|Overall Study|Intercurrent illness|1|||
161085106|NCT00007345|581700185|FG001|Overall Study|Intercurrent illness|0|||
161085107|NCT00007345|581700184|FG000|Overall Study|Death on study|1|||
161085108|NCT00007345|581700185|FG001|Overall Study|Death on study|1|||
161085109|NCT04433585|581700186|FG000|Overall Study|Withdrawal by Subject|15|||
161085110|NCT04433585|581700187|FG001|Overall Study|Withdrawal by Subject|3|||
161085111|NCT04433585|581700188|FG002|Overall Study|Withdrawal by Subject|15|||
161085112|NCT04433585|581700189|FG003|Overall Study|Withdrawal by Subject|6|||
161085113|NCT04433585|581700186|FG000|Overall Study|Adverse Event|10|||
161085114|NCT04433585|581700187|FG001|Overall Study|Adverse Event|4|||
161085115|NCT04433585|581700188|FG002|Overall Study|Adverse Event|1|||
161085116|NCT04433585|581700189|FG003|Overall Study|Adverse Event|0|||
161085117|NCT04433585|581700186|FG000|Overall Study|Due to the conflict in Ukraine|2|||
161085118|NCT04433585|581700187|FG001|Overall Study|Due to the conflict in Ukraine|1|||
161085119|NCT04433585|581700188|FG002|Overall Study|Due to the conflict in Ukraine|1|||
161085120|NCT04433585|581700189|FG003|Overall Study|Due to the conflict in Ukraine|2|||
161085121|NCT04433585|581700186|FG000|Overall Study|Physician Decision|1|||
161085122|NCT04433585|581700187|FG001|Overall Study|Physician Decision|2|||
161085123|NCT04433585|581700188|FG002|Overall Study|Physician Decision|0|||
161085124|NCT04433585|581700189|FG003|Overall Study|Physician Decision|0|||
161085125|NCT04433585|581700186|FG000|Overall Study|Lost to Follow-up|1|||
161085126|NCT04433585|581700187|FG001|Overall Study|Lost to Follow-up|1|||
161170767|NCT02715804|582003209|FG000|Overall Study|Withdrawal by Subject|5|||
161170768|NCT02715804|582003210|FG001|Overall Study|Withdrawal by Subject|4|||
161170769|NCT02715804|582003209|FG000|Overall Study|Other than specified|2|||
161170770|NCT02715804|582003210|FG001|Overall Study|Other than specified|3|||
161290966|NCT00739882|582447947|FG001|Open-label Period|Adverse Event|0|||
161290967|NCT00739882|582447946|FG000|Open-label Period|Other|9|||
161290968|NCT00739882|582447947|FG001|Open-label Period|Other|5|||
161290969|NCT01735916|582447952|FG000|Overall Study|Subject not eligible to be randomized|11|||
161290970|NCT01735916|582447953|FG001|Overall Study|Subject not eligible to be randomized|0|||
161290971|NCT01735916|582447954|FG002|Overall Study|Subject not eligible to be randomized|0|||
161290972|NCT01735916|582447952|FG000|Overall Study|Early termination of study by sponsor|4|||
161290973|NCT01735916|582447953|FG001|Overall Study|Early termination of study by sponsor|19|||
161290974|NCT01735916|582447954|FG002|Overall Study|Early termination of study by sponsor|7|||
161290975|NCT01735916|582447952|FG000|Overall Study|Withdrawal by Subject|3|||
161290976|NCT01735916|582447953|FG001|Overall Study|Withdrawal by Subject|0|||
161290977|NCT01735916|582447954|FG002|Overall Study|Withdrawal by Subject|0|||
161290978|NCT05177484|582447960|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
161290979|NCT05177484|582447961|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
161290980|NCT05177484|582447960|FG000|Overall Study|Inadvertently withdrawn|3|||
161290981|NCT05177484|582447961|FG001|Overall Study|Inadvertently withdrawn|1|||
161290982|NCT05177484|582447960|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
161290983|NCT05177484|582447961|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
161290984|NCT01379768|582447962|FG000|Overall Study|Adverse Event|1|||
161290985|NCT01379768|582447963|FG001|Overall Study|Adverse Event|1|||
161290986|NCT01379768|582447964|FG002|Overall Study|Adverse Event|0|||
161290987|NCT01379768|582447962|FG000|Overall Study|Lost to Follow-up|2|||
161170771|NCT01625611|582003213|FG000|Overall Study|No adlib drinks Lab 1|3|||
161170772|NCT01625611|582003214|FG001|Overall Study|No adlib drinks Lab 1|0|||
161170773|NCT01625611|582003213|FG000|Overall Study|Technical issues with PET|1|||
161170774|NCT01625611|582003214|FG001|Overall Study|Technical issues with PET|0|||
161170775|NCT01625611|582003213|FG000|Overall Study|Unable to complete study procedures|1|||
161170776|NCT01625611|582003214|FG001|Overall Study|Unable to complete study procedures|0|||
161170777|NCT01625611|582003213|FG000|Overall Study|Withdrawal by Subject|3|||
161170778|NCT01625611|582003214|FG001|Overall Study|Withdrawal by Subject|0|||
161170779|NCT00948194|582003215|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
161170780|NCT00948194|582003216|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
161170781|NCT00233324|582003217|FG000|Main Study|Death|68|||
161170782|NCT00233324|582003218|FG001|Main Study|Death|60|||
161170783|NCT00233324|582003219|FG002|Main Study|Death|62|||
161170784|NCT00233324|582003220|FG003|Main Study|Death|47|||
161170785|NCT00233324|582003217|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
161170786|NCT00233324|582003218|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
161170787|NCT00233324|582003219|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
161170788|NCT00233324|582003220|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
161170789|NCT00233324|582003217|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
161170790|NCT00233324|582003218|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
161170791|NCT00233324|582003219|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
161170792|NCT00233324|582003220|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
161170793|NCT00801892|582003227|FG000|Main Study Period|Withdrawal by Subject|0|||
161170794|NCT00801892|582003228|FG001|Main Study Period|Withdrawal by Subject|1|||
161170795|NCT00801892|582003227|FG000|Sham Crossover Period|Lost to Follow-up|0|||
161170796|NCT00801892|582003228|FG001|Sham Crossover Period|Lost to Follow-up|2|||
161170797|NCT01281189|582003233|FG000|Overall Study|Adverse Event|7|||
161170798|NCT01281189|582003234|FG001|Overall Study|Adverse Event|9|||
161170799|NCT01281189|582003233|FG000|Overall Study|Lost to Follow-up|6|||
161170800|NCT01281189|582003234|FG001|Overall Study|Lost to Follow-up|4|||
161170801|NCT01281189|582003233|FG000|Overall Study|Withdrawal by Subject|21|||
161170802|NCT01281189|582003234|FG001|Overall Study|Withdrawal by Subject|24|||
161290988|NCT01379768|582447963|FG001|Overall Study|Lost to Follow-up|0|||
161290989|NCT01379768|582447964|FG002|Overall Study|Lost to Follow-up|0|||
161290990|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
161290991|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
161290992|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
161290993|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
161290994|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
161319391|NCT01134263|582555304|FG004|Overall Study|Serious adverse event|1|||
161170803|NCT01281189|582003233|FG000|Overall Study|Physician Decision|2|||
161170804|NCT01281189|582003234|FG001|Overall Study|Physician Decision|3|||
161170805|NCT01281189|582003233|FG000|Overall Study|Death|103|||
161170806|NCT01281189|582003234|FG001|Overall Study|Death|91|||
161170807|NCT01281189|582003233|FG000|Overall Study|Other|8|||
161170808|NCT01281189|582003234|FG001|Overall Study|Other|12|||
161170809|NCT01175590|582003236|FG000|Overall Study|Lost to Follow-up|1|||
161170810|NCT01175590|582003237|FG001|Overall Study|Lost to Follow-up|0|||
161170811|NCT01175590|582003236|FG000|Overall Study|Withdrawal by Subject|0|||
161170812|NCT01175590|582003237|FG001|Overall Study|Withdrawal by Subject|2|||
161170813|NCT01175590|582003236|FG000|Overall Study|Adverse Event|4|||
161170814|NCT01175590|582003237|FG001|Overall Study|Adverse Event|0|||
161170815|NCT01175590|582003236|FG000|Overall Study|Physician Decision|1|||
161170816|NCT01175590|582003237|FG001|Overall Study|Physician Decision|4|||
161170817|NCT01175590|582003236|FG000|Overall Study|Lack of Efficacy|1|||
161170818|NCT01175590|582003237|FG001|Overall Study|Lack of Efficacy|1|||
161170819|NCT01175590|582003236|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
161170820|NCT01175590|582003237|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
161170821|NCT01175590|582003236|FG000|Overall Study|Treated not as randomized|3|||
161170822|NCT01175590|582003237|FG001|Overall Study|Treated not as randomized|2|||
161170823|NCT01175590|582003236|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
161170824|NCT01175590|582003237|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
161170825|NCT01175590|582003236|FG000|Overall Study|Protocol Violation|0|||
161170826|NCT01175590|582003237|FG001|Overall Study|Protocol Violation|1|||
161170827|NCT02062398|582003240|FG000|Overall Study|Implant removal|1|||
161170828|NCT03351478|582003243|FG000|Overall Study|At the subject's own request|11|||
161170829|NCT03351478|582003244|FG001|Overall Study|At the subject's own request|12|||
161170830|NCT03351478|582003245|FG002|Overall Study|At the subject's own request|5|||
161170831|NCT03351478|582003243|FG000|Overall Study|Adverse Event|1|||
161170832|NCT03351478|582003244|FG001|Overall Study|Adverse Event|2|||
161170833|NCT03351478|582003245|FG002|Overall Study|Adverse Event|1|||
161170834|NCT03351478|582003243|FG000|Overall Study|Poor compliance to protocol|1|||
161170835|NCT03351478|582003244|FG001|Overall Study|Poor compliance to protocol|0|||
161170836|NCT03351478|582003245|FG002|Overall Study|Poor compliance to protocol|0|||
161170837|NCT03351478|582003243|FG000|Overall Study|Reason not Specified|1|||
161170838|NCT03351478|582003244|FG001|Overall Study|Reason not Specified|3|||
161170839|NCT03351478|582003245|FG002|Overall Study|Reason not Specified|0|||
161170840|NCT03351478|582003243|FG000|Overall Study|Lost to Follow-up|0|||
161170841|NCT03351478|582003244|FG001|Overall Study|Lost to Follow-up|0|||
161170842|NCT03351478|582003245|FG002|Overall Study|Lost to Follow-up|1|||
161290995|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161290996|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161290997|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161290998|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161290999|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161291000|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161291001|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161291002|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161291003|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161291004|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
161291005|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
161291006|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
161291007|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
161291008|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
161291009|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
161170843|NCT03911869|582003248|FG000|Safety Lead-in Phase|Death|7|||
161170844|NCT03911869|582003249|FG001|Safety Lead-in Phase|Death|0|||
161170845|NCT03911869|582003250|FG002|Safety Lead-in Phase|Death|0|||
161170846|NCT03911869|582003248|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
161170847|NCT03911869|582003249|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
161170848|NCT03911869|582003250|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
161170849|NCT03911869|582003248|FG000|Safety Lead-in Phase|Other|1|||
161170850|NCT03911869|582003249|FG001|Safety Lead-in Phase|Other|0|||
161170851|NCT03911869|582003250|FG002|Safety Lead-in Phase|Other|0|||
161170852|NCT03911869|582003248|FG000|Phase 2|Death|0|||
161170853|NCT03911869|582003249|FG001|Phase 2|Death|3|||
161170854|NCT03911869|582003250|FG002|Phase 2|Death|0|||
161170855|NCT00608881|582003251|FG000|Overall Study|Death|22|||
161170856|NCT00608881|582003252|FG001|Overall Study|Death|13|||
161170857|NCT00608881|582003251|FG000|Overall Study|Adverse Event|5|||
161170858|NCT00608881|582003252|FG001|Overall Study|Adverse Event|3|||
161170859|NCT00608881|582003251|FG000|Overall Study|Lost to Follow-up|28|||
161170860|NCT00608881|582003252|FG001|Overall Study|Lost to Follow-up|14|||
161170861|NCT00608881|582003251|FG000|Overall Study|Withdrawal by Subject|18|||
161170862|NCT00608881|582003252|FG001|Overall Study|Withdrawal by Subject|29|||
161170863|NCT00608881|582003251|FG000|Overall Study|Physician Decision|5|||
161170864|NCT00608881|582003252|FG001|Overall Study|Physician Decision|5|||
161170865|NCT00608881|582003251|FG000|Overall Study|Institutionalized|1|||
161170866|NCT00608881|582003252|FG001|Overall Study|Institutionalized|2|||
161170867|NCT00510484|582003254|FG000|Wash-out Period|Adverse Event|0|||
161170868|NCT00510484|582003255|FG001|Wash-out Period|Adverse Event|1|||
161170869|NCT01590212|582003256|FG000|Overall Study|Withdrawal by Subject|2|||
161170870|NCT01590212|582003257|FG001|Overall Study|Withdrawal by Subject|2|||
161170871|NCT01590212|582003258|FG002|Overall Study|Withdrawal by Subject|2|||
161170872|NCT01590212|582003256|FG000|Overall Study|Lost to Follow-up|1|||
161170873|NCT01590212|582003257|FG001|Overall Study|Lost to Follow-up|2|||
161170874|NCT01590212|582003258|FG002|Overall Study|Lost to Follow-up|3|||
161170875|NCT03004976|582003259|FG000|Overall Study|Lost to Follow-up|7|||
161170876|NCT03004976|582003260|FG001|Overall Study|Lost to Follow-up|5|||
161170877|NCT03004976|582003259|FG000|Overall Study|Physician Decision|1|||
161170878|NCT03004976|582003260|FG001|Overall Study|Physician Decision|0|||
161170879|NCT03004976|582003259|FG000|Overall Study|Withdrawal by Subject|1|||
161170880|NCT03004976|582003260|FG001|Overall Study|Withdrawal by Subject|0|||
161170881|NCT03004976|582003259|FG000|Overall Study|Death|4|||
161170882|NCT03004976|582003260|FG001|Overall Study|Death|1|||
161170883|NCT02533401|582003261|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
161170884|NCT02533401|582003261|FG000|Overall Study|Death|5|||
161170885|NCT02533401|582003261|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
161170886|NCT02533401|582003261|FG000|Overall Study|Lost to Follow-up|1|||
161170887|NCT02533401|582003261|FG000|Overall Study|Violation of Selection Criteria|1|||
161170888|NCT01106391|582003264|FG000|Overall Study|Death|12|||
161170889|NCT01106391|582003264|FG000|Overall Study|Withdrawal by Subject|7|||
161170890|NCT01387074|582003265|FG000|Overall Study|Lost to Follow-up|7|||
161170891|NCT01387074|582003265|FG000|Overall Study|Lack of Efficacy|1|||
161170892|NCT00150345|582003266|FG000|Overall Study|Death|5|||
161170893|NCT00150345|582003267|FG001|Overall Study|Death|2|||
161170894|NCT00150345|582003266|FG000|Overall Study|Adverse Event|8|||
161170895|NCT00150345|582003267|FG001|Overall Study|Adverse Event|6|||
161170896|NCT00150345|582003266|FG000|Overall Study|Lack of Efficacy|5|||
161170897|NCT00150345|582003267|FG001|Overall Study|Lack of Efficacy|4|||
161170898|NCT00150345|582003266|FG000|Overall Study|Withdrawal by Subject|3|||
161170899|NCT00150345|582003267|FG001|Overall Study|Withdrawal by Subject|4|||
161170900|NCT00150345|582003266|FG000|Overall Study|Laboratory abnormality|1|||
161170901|NCT00150345|582003267|FG001|Overall Study|Laboratory abnormality|2|||
161170902|NCT00150345|582003266|FG000|Overall Study|Other|12|||
161170903|NCT00150345|582003267|FG001|Overall Study|Other|14|||
161170904|NCT01392742|582003268|FG000|Overall Study|Premature study termination|42|||
161170905|NCT01392742|582003268|FG000|Overall Study|Failure to return|35|||
161170906|NCT01392742|582003268|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
161170907|NCT01392742|582003268|FG000|Overall Study|Lost to Follow-up|34|||
161170908|NCT01392742|582003268|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
161170909|NCT01392742|582003268|FG000|Overall Study|ITR and Protocol deviation|1|||
161170910|NCT01392742|582003268|FG000|Overall Study|Adverse event/intercurrent illness|17|||
161291010|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161170911|NCT01392742|582003268|FG000|Overall Study|Protocol Violation|14|||
161170912|NCT01392742|582003268|FG000|Overall Study|Other|3|||
161170913|NCT01392742|582003268|FG000|Overall Study|Missing information|13|||
161170914|NCT01998958|582003269|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170915|NCT01998958|582003270|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
161170916|NCT01998958|582003271|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170917|NCT01998958|582003272|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170918|NCT01998958|582003273|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161291011|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161170919|NCT01998958|582003274|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170920|NCT01998958|582003275|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170921|NCT01998958|582003276|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170922|NCT01998958|582003277|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170923|NCT01998958|582003278|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170924|NCT01998958|582003279|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170925|NCT01998958|582003280|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170926|NCT01998958|582003281|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170927|NCT01998958|582003282|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170928|NCT01998958|582003283|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170929|NCT01998958|582003284|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170930|NCT01998958|582003285|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170931|NCT01998958|582003286|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170932|NCT01998958|582003287|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170933|NCT01998958|582003288|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170934|NCT01998958|582003289|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170935|NCT01998958|582003290|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170936|NCT01998958|582003291|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170937|NCT01998958|582003292|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170938|NCT01998958|582003293|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170939|NCT01998958|582003294|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170940|NCT01998958|582003295|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170941|NCT01998958|582003296|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170942|NCT01998958|582003297|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170943|NCT01998958|582003298|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170944|NCT01998958|582003299|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170945|NCT01998958|582003300|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
161170946|NCT01998958|582003269|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170947|NCT01998958|582003270|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
161170948|NCT01998958|582003271|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170949|NCT01998958|582003272|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170950|NCT01998958|582003273|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170951|NCT01998958|582003274|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170952|NCT01998958|582003275|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170953|NCT01998958|582003276|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170954|NCT01998958|582003277|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170955|NCT01998958|582003278|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170956|NCT01998958|582003279|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170957|NCT01998958|582003280|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170958|NCT01998958|582003281|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170959|NCT01998958|582003282|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170960|NCT01998958|582003283|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170961|NCT01998958|582003284|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170962|NCT01998958|582003285|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170963|NCT01998958|582003286|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170964|NCT01998958|582003287|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170965|NCT01998958|582003288|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170966|NCT01998958|582003289|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170967|NCT01998958|582003290|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170968|NCT01998958|582003291|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170969|NCT01998958|582003292|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170970|NCT01998958|582003293|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170971|NCT01998958|582003294|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170972|NCT01998958|582003295|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170973|NCT01998958|582003296|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170974|NCT01998958|582003297|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170975|NCT01998958|582003298|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170976|NCT01998958|582003299|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170977|NCT01998958|582003300|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
161170978|NCT01998958|582003269|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
161170979|NCT01998958|582003270|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
161170980|NCT01998958|582003271|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
161170981|NCT01998958|582003272|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
161170982|NCT01998958|582003273|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
161170983|NCT01998958|582003274|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
161170984|NCT01998958|582003275|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
161170985|NCT01998958|582003276|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
161170986|NCT01998958|582003277|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
161170987|NCT01998958|582003278|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
161170988|NCT01998958|582003279|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
161170989|NCT01998958|582003280|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
161170990|NCT01998958|582003281|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
161170991|NCT01998958|582003282|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
161170992|NCT01998958|582003283|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
161170993|NCT01998958|582003284|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
161170994|NCT01998958|582003285|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
161170995|NCT01998958|582003286|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
161170996|NCT01998958|582003287|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
161170997|NCT01998958|582003288|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
161170998|NCT01998958|582003289|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
161291012|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291013|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291014|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291015|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161319392|NCT01134263|582555300|FG000|Overall Study|Other adverse event|1|||
161170999|NCT01998958|582003290|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
161171000|NCT01998958|582003291|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
161171001|NCT01998958|582003292|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
161085127|NCT04433585|581700188|FG002|Overall Study|Lost to Follow-up|1|||
161085128|NCT04433585|581700189|FG003|Overall Study|Lost to Follow-up|0|||
161085129|NCT04433585|581700186|FG000|Overall Study|Lack of Efficacy|0|||
161085130|NCT04433585|581700187|FG001|Overall Study|Lack of Efficacy|1|||
161085131|NCT04433585|581700188|FG002|Overall Study|Lack of Efficacy|1|||
161085132|NCT04433585|581700189|FG003|Overall Study|Lack of Efficacy|1|||
161085133|NCT04433585|581700186|FG000|Overall Study|Death|0|||
161085134|NCT04433585|581700187|FG001|Overall Study|Death|1|||
161085135|NCT04433585|581700188|FG002|Overall Study|Death|0|||
161085136|NCT04433585|581700189|FG003|Overall Study|Death|0|||
161085137|NCT04988867|581700208|FG000|Overall Study|Study terminated by Sponsor|12|||
161085138|NCT04988867|581700208|FG000|Overall Study|Adverse Event|2|||
161085139|NCT04988867|581700208|FG000|Overall Study|Study drug noncompliance|1|||
161085140|NCT01097707|581700211|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161085141|NCT01097707|581700212|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
161085142|NCT01097707|581700213|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161085143|NCT01097707|581700214|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161085144|NCT01097707|581700215|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
161085145|NCT01097707|581700211|FG000|Overall Study|Adverse Event|4|||
161085146|NCT01097707|581700212|FG001|Overall Study|Adverse Event|2|||
161085147|NCT01097707|581700213|FG002|Overall Study|Adverse Event|3|||
161085148|NCT01097707|581700214|FG003|Overall Study|Adverse Event|1|||
161085149|NCT01097707|581700215|FG004|Overall Study|Adverse Event|3|||
161085150|NCT01097707|581700211|FG000|Overall Study|Entry Criteria Not Met|2|||
161085151|NCT01097707|581700212|FG001|Overall Study|Entry Criteria Not Met|1|||
161085152|NCT01097707|581700213|FG002|Overall Study|Entry Criteria Not Met|1|||
161085153|NCT01097707|581700214|FG003|Overall Study|Entry Criteria Not Met|0|||
161085154|NCT01097707|581700215|FG004|Overall Study|Entry Criteria Not Met|1|||
161085155|NCT01097707|581700211|FG000|Overall Study|Lack of Efficacy|1|||
161085156|NCT01097707|581700212|FG001|Overall Study|Lack of Efficacy|0|||
161085157|NCT01097707|581700213|FG002|Overall Study|Lack of Efficacy|0|||
161085158|NCT01097707|581700214|FG003|Overall Study|Lack of Efficacy|1|||
161085159|NCT01097707|581700215|FG004|Overall Study|Lack of Efficacy|0|||
161085160|NCT01097707|581700211|FG000|Overall Study|Lost to Follow-up|1|||
161085161|NCT01097707|581700212|FG001|Overall Study|Lost to Follow-up|1|||
161085162|NCT01097707|581700213|FG002|Overall Study|Lost to Follow-up|2|||
161085163|NCT01097707|581700214|FG003|Overall Study|Lost to Follow-up|0|||
161085164|NCT01097707|581700215|FG004|Overall Study|Lost to Follow-up|3|||
161085165|NCT01097707|581700211|FG000|Overall Study|Protocol Violation|2|||
161085166|NCT01097707|581700212|FG001|Overall Study|Protocol Violation|2|||
161085167|NCT01097707|581700213|FG002|Overall Study|Protocol Violation|3|||
161085168|NCT01097707|581700214|FG003|Overall Study|Protocol Violation|2|||
161085169|NCT01097707|581700215|FG004|Overall Study|Protocol Violation|2|||
161085170|NCT01097707|581700211|FG000|Overall Study|Sponsor Decision|31|||
161085171|NCT01097707|581700212|FG001|Overall Study|Sponsor Decision|31|||
161085172|NCT01097707|581700213|FG002|Overall Study|Sponsor Decision|34|||
161085173|NCT01097707|581700214|FG003|Overall Study|Sponsor Decision|35|||
161085174|NCT01097707|581700215|FG004|Overall Study|Sponsor Decision|36|||
161085175|NCT01097707|581700211|FG000|Overall Study|Withdrawal by Subject|3|||
161085176|NCT01097707|581700212|FG001|Overall Study|Withdrawal by Subject|6|||
161085177|NCT01097707|581700213|FG002|Overall Study|Withdrawal by Subject|1|||
161085178|NCT01097707|581700214|FG003|Overall Study|Withdrawal by Subject|4|||
161085179|NCT01097707|581700215|FG004|Overall Study|Withdrawal by Subject|3|||
161085180|NCT01097707|581700211|FG000|Overall Study|Reason unknown|0|||
161085181|NCT01097707|581700212|FG001|Overall Study|Reason unknown|0|||
161085182|NCT01097707|581700213|FG002|Overall Study|Reason unknown|0|||
161085183|NCT01097707|581700214|FG003|Overall Study|Reason unknown|0|||
161085184|NCT01097707|581700215|FG004|Overall Study|Reason unknown|1|||
161085185|NCT03212989|581700216|FG000|Overall Study|Physician Decision|8|||
161085186|NCT03117998|581700219|FG000|Overall Study|Adverse Event|1|||
161085187|NCT03117998|581700220|FG001|Overall Study|Adverse Event|0|||
161085188|NCT03117998|581700221|FG002|Overall Study|Adverse Event|0|||
161085189|NCT03117998|581700222|FG003|Overall Study|Adverse Event|0|||
161085190|NCT03117998|581700223|FG004|Overall Study|Adverse Event|0|||
161085191|NCT03117998|581700224|FG005|Overall Study|Adverse Event|0|||
161085192|NCT03117998|581700219|FG000|Overall Study|Withdrawal by Subject|0|||
161085193|NCT03117998|581700220|FG001|Overall Study|Withdrawal by Subject|0|||
161085194|NCT03117998|581700221|FG002|Overall Study|Withdrawal by Subject|2|||
161085195|NCT03117998|581700222|FG003|Overall Study|Withdrawal by Subject|3|||
161085196|NCT03117998|581700223|FG004|Overall Study|Withdrawal by Subject|3|||
161085197|NCT03117998|581700224|FG005|Overall Study|Withdrawal by Subject|0|||
161085198|NCT03117998|581700219|FG000|Overall Study|Physician Decision|0|||
161085199|NCT03117998|581700220|FG001|Overall Study|Physician Decision|1|||
161085200|NCT03117998|581700221|FG002|Overall Study|Physician Decision|1|||
161085201|NCT03117998|581700222|FG003|Overall Study|Physician Decision|0|||
161085202|NCT03117998|581700223|FG004|Overall Study|Physician Decision|0|||
161171002|NCT01998958|582003293|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
161171003|NCT01998958|582003294|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
161171004|NCT01998958|582003295|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
161171005|NCT01998958|582003296|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
161171006|NCT01998958|582003297|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
161171007|NCT01998958|582003298|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
161171008|NCT01998958|582003299|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
161171009|NCT01998958|582003300|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
161171010|NCT01998958|582003269|FG000|Period 1 (Panel A and B)|Other|1|||
161171011|NCT01998958|582003270|FG001|Period 1 (Panel A and B)|Other|0|||
161171012|NCT01998958|582003271|FG002|Period 1 (Panel A and B)|Other|0|||
161171013|NCT01998958|582003272|FG003|Period 1 (Panel A and B)|Other|0|||
161171014|NCT01998958|582003273|FG004|Period 1 (Panel A and B)|Other|0|||
161171015|NCT01998958|582003274|FG005|Period 1 (Panel A and B)|Other|0|||
161171016|NCT01998958|582003275|FG006|Period 1 (Panel A and B)|Other|0|||
161171017|NCT01998958|582003276|FG007|Period 1 (Panel A and B)|Other|0|||
161171018|NCT01998958|582003277|FG008|Period 1 (Panel A and B)|Other|0|||
161171019|NCT01998958|582003278|FG009|Period 1 (Panel A and B)|Other|0|||
161171020|NCT01998958|582003279|FG010|Period 1 (Panel A and B)|Other|0|||
161171021|NCT01998958|582003280|FG011|Period 1 (Panel A and B)|Other|0|||
161171022|NCT01998958|582003281|FG012|Period 1 (Panel A and B)|Other|0|||
161171023|NCT01998958|582003282|FG013|Period 1 (Panel A and B)|Other|0|||
161171024|NCT01998958|582003283|FG014|Period 1 (Panel A and B)|Other|0|||
161171025|NCT01998958|582003284|FG015|Period 1 (Panel A and B)|Other|0|||
161171026|NCT01998958|582003285|FG016|Period 1 (Panel A and B)|Other|0|||
161171027|NCT01998958|582003286|FG017|Period 1 (Panel A and B)|Other|0|||
161171028|NCT01998958|582003287|FG018|Period 1 (Panel A and B)|Other|0|||
161171029|NCT01998958|582003288|FG019|Period 1 (Panel A and B)|Other|0|||
161171030|NCT01998958|582003289|FG020|Period 1 (Panel A and B)|Other|0|||
161171031|NCT01998958|582003290|FG021|Period 1 (Panel A and B)|Other|0|||
161171032|NCT01998958|582003291|FG022|Period 1 (Panel A and B)|Other|0|||
161171033|NCT01998958|582003292|FG023|Period 1 (Panel A and B)|Other|0|||
161171034|NCT01998958|582003293|FG024|Period 1 (Panel A and B)|Other|0|||
161171035|NCT01998958|582003294|FG025|Period 1 (Panel A and B)|Other|0|||
161171036|NCT01998958|582003295|FG026|Period 1 (Panel A and B)|Other|0|||
161171037|NCT01998958|582003296|FG027|Period 1 (Panel A and B)|Other|0|||
161171038|NCT01998958|582003297|FG028|Period 1 (Panel A and B)|Other|0|||
161171039|NCT01998958|582003298|FG029|Period 1 (Panel A and B)|Other|0|||
161171040|NCT01998958|582003299|FG030|Period 1 (Panel A and B)|Other|0|||
161171041|NCT01998958|582003300|FG031|Period 1 (Panel A and B)|Other|0|||
161171042|NCT01998958|582003269|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
161171043|NCT01998958|582003270|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
161171044|NCT01998958|582003271|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
161171045|NCT01998958|582003272|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
161171046|NCT01998958|582003273|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
161171047|NCT01998958|582003274|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
161171048|NCT01998958|582003275|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
161171049|NCT01998958|582003276|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
161171050|NCT01998958|582003277|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
161171051|NCT01998958|582003278|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
161171052|NCT01998958|582003279|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
161171053|NCT01998958|582003280|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
161291016|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291017|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291018|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291019|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
161291020|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
161291021|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
161291022|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
161171054|NCT01998958|582003281|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
161171055|NCT01998958|582003282|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
161171056|NCT01998958|582003283|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
161291023|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
161291024|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
161291025|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161171057|NCT01998958|582003284|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
161171058|NCT01998958|582003285|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
161291026|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291027|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291028|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291029|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161347226|NCT03915067|582656246|FG001|Overall Study|Adverse Event|0|||
161291030|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161171059|NCT01998958|582003286|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
161171060|NCT01998958|582003287|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
161171061|NCT01998958|582003288|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
161171062|NCT01998958|582003289|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
161171063|NCT01998958|582003290|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
161171064|NCT01998958|582003291|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
161171065|NCT01998958|582003292|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
161171066|NCT01998958|582003293|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
161171067|NCT01998958|582003294|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
161171068|NCT01998958|582003295|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
161171069|NCT01998958|582003296|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
161171070|NCT01998958|582003297|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
161171071|NCT01998958|582003298|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
161171072|NCT01998958|582003299|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
161171073|NCT01998958|582003300|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
161171074|NCT01998958|582003269|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171075|NCT01998958|582003270|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171076|NCT01998958|582003271|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171077|NCT01998958|582003272|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171078|NCT01998958|582003273|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171079|NCT01998958|582003274|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171080|NCT01998958|582003275|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171081|NCT01998958|582003276|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171082|NCT01998958|582003277|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171083|NCT01998958|582003278|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171084|NCT01998958|582003279|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171085|NCT01998958|582003280|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171086|NCT01998958|582003281|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171087|NCT01998958|582003282|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171088|NCT01998958|582003283|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
161171089|NCT01998958|582003284|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171090|NCT01998958|582003285|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171091|NCT01998958|582003286|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171092|NCT01998958|582003287|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
161171093|NCT01998958|582003288|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171094|NCT01998958|582003289|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171095|NCT01998958|582003290|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171096|NCT01998958|582003291|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171097|NCT01998958|582003292|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171098|NCT01998958|582003293|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171099|NCT01998958|582003294|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171100|NCT01998958|582003295|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171101|NCT01998958|582003296|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171102|NCT01998958|582003297|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171103|NCT01998958|582003298|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171104|NCT01998958|582003299|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171105|NCT01998958|582003300|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
161171106|NCT01998958|582003269|FG000|Open Label Phase (Optional)|Adverse Event|0|||
161171107|NCT01998958|582003270|FG001|Open Label Phase (Optional)|Adverse Event|0|||
161171108|NCT01998958|582003271|FG002|Open Label Phase (Optional)|Adverse Event|0|||
161171109|NCT01998958|582003272|FG003|Open Label Phase (Optional)|Adverse Event|0|||
161171110|NCT01998958|582003273|FG004|Open Label Phase (Optional)|Adverse Event|0|||
161171111|NCT01998958|582003274|FG005|Open Label Phase (Optional)|Adverse Event|0|||
161171112|NCT01998958|582003275|FG006|Open Label Phase (Optional)|Adverse Event|0|||
161171113|NCT01998958|582003276|FG007|Open Label Phase (Optional)|Adverse Event|0|||
161171114|NCT01998958|582003277|FG008|Open Label Phase (Optional)|Adverse Event|0|||
161171115|NCT01998958|582003278|FG009|Open Label Phase (Optional)|Adverse Event|0|||
161171116|NCT01998958|582003279|FG010|Open Label Phase (Optional)|Adverse Event|0|||
161171117|NCT01998958|582003280|FG011|Open Label Phase (Optional)|Adverse Event|0|||
161171118|NCT01998958|582003281|FG012|Open Label Phase (Optional)|Adverse Event|0|||
161171119|NCT01998958|582003282|FG013|Open Label Phase (Optional)|Adverse Event|0|||
161171120|NCT01998958|582003283|FG014|Open Label Phase (Optional)|Adverse Event|0|||
161171121|NCT01998958|582003284|FG015|Open Label Phase (Optional)|Adverse Event|0|||
161171122|NCT01998958|582003285|FG016|Open Label Phase (Optional)|Adverse Event|0|||
161171123|NCT01998958|582003286|FG017|Open Label Phase (Optional)|Adverse Event|0|||
161171124|NCT01998958|582003287|FG018|Open Label Phase (Optional)|Adverse Event|0|||
161171125|NCT01998958|582003288|FG019|Open Label Phase (Optional)|Adverse Event|0|||
161171126|NCT01998958|582003289|FG020|Open Label Phase (Optional)|Adverse Event|0|||
161171127|NCT01998958|582003290|FG021|Open Label Phase (Optional)|Adverse Event|0|||
161171128|NCT01998958|582003291|FG022|Open Label Phase (Optional)|Adverse Event|0|||
161171129|NCT01998958|582003292|FG023|Open Label Phase (Optional)|Adverse Event|1|||
161171130|NCT01998958|582003293|FG024|Open Label Phase (Optional)|Adverse Event|0|||
161171131|NCT01998958|582003294|FG025|Open Label Phase (Optional)|Adverse Event|0|||
161171132|NCT01998958|582003295|FG026|Open Label Phase (Optional)|Adverse Event|0|||
161171133|NCT01998958|582003296|FG027|Open Label Phase (Optional)|Adverse Event|0|||
161171134|NCT01998958|582003297|FG028|Open Label Phase (Optional)|Adverse Event|0|||
161171135|NCT01998958|582003298|FG029|Open Label Phase (Optional)|Adverse Event|0|||
161171136|NCT01998958|582003299|FG030|Open Label Phase (Optional)|Adverse Event|0|||
161171137|NCT01998958|582003300|FG031|Open Label Phase (Optional)|Adverse Event|0|||
161171138|NCT01998958|582003269|FG000|Open Label Phase (Optional)|Other|0|||
161171139|NCT01998958|582003270|FG001|Open Label Phase (Optional)|Other|0|||
161171140|NCT01998958|582003271|FG002|Open Label Phase (Optional)|Other|0|||
161171141|NCT01998958|582003272|FG003|Open Label Phase (Optional)|Other|0|||
161171142|NCT01998958|582003273|FG004|Open Label Phase (Optional)|Other|0|||
161171143|NCT01998958|582003274|FG005|Open Label Phase (Optional)|Other|0|||
161171144|NCT01998958|582003275|FG006|Open Label Phase (Optional)|Other|0|||
161171145|NCT01998958|582003276|FG007|Open Label Phase (Optional)|Other|0|||
161171146|NCT01998958|582003277|FG008|Open Label Phase (Optional)|Other|0|||
161171147|NCT01998958|582003278|FG009|Open Label Phase (Optional)|Other|0|||
161171148|NCT01998958|582003279|FG010|Open Label Phase (Optional)|Other|0|||
161171149|NCT01998958|582003280|FG011|Open Label Phase (Optional)|Other|0|||
161171150|NCT01998958|582003281|FG012|Open Label Phase (Optional)|Other|0|||
161171151|NCT01998958|582003282|FG013|Open Label Phase (Optional)|Other|0|||
161171152|NCT01998958|582003283|FG014|Open Label Phase (Optional)|Other|0|||
161171153|NCT01998958|582003284|FG015|Open Label Phase (Optional)|Other|0|||
161171154|NCT01998958|582003285|FG016|Open Label Phase (Optional)|Other|0|||
161171155|NCT01998958|582003286|FG017|Open Label Phase (Optional)|Other|0|||
161171156|NCT01998958|582003287|FG018|Open Label Phase (Optional)|Other|0|||
161171157|NCT01998958|582003288|FG019|Open Label Phase (Optional)|Other|0|||
161171158|NCT01998958|582003289|FG020|Open Label Phase (Optional)|Other|0|||
161171159|NCT01998958|582003290|FG021|Open Label Phase (Optional)|Other|0|||
161171160|NCT01998958|582003291|FG022|Open Label Phase (Optional)|Other|5|||
161171161|NCT01998958|582003292|FG023|Open Label Phase (Optional)|Other|1|||
161171162|NCT01998958|582003293|FG024|Open Label Phase (Optional)|Other|0|||
161171163|NCT01998958|582003294|FG025|Open Label Phase (Optional)|Other|0|||
161171164|NCT01998958|582003295|FG026|Open Label Phase (Optional)|Other|0|||
161171165|NCT01998958|582003296|FG027|Open Label Phase (Optional)|Other|0|||
161171166|NCT01998958|582003297|FG028|Open Label Phase (Optional)|Other|0|||
161171167|NCT01998958|582003298|FG029|Open Label Phase (Optional)|Other|0|||
161171168|NCT01998958|582003299|FG030|Open Label Phase (Optional)|Other|0|||
161171169|NCT01998958|582003300|FG031|Open Label Phase (Optional)|Other|0|||
161171170|NCT01998958|582003269|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171171|NCT01998958|582003270|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171172|NCT01998958|582003271|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171173|NCT01998958|582003272|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171174|NCT01998958|582003273|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171175|NCT01998958|582003274|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171176|NCT01998958|582003275|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171177|NCT01998958|582003276|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171178|NCT01998958|582003277|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171179|NCT01998958|582003278|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171180|NCT01998958|582003279|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171181|NCT01998958|582003280|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171182|NCT01998958|582003281|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171183|NCT01998958|582003282|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171184|NCT01998958|582003283|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171185|NCT01998958|582003284|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171186|NCT01998958|582003285|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
161291031|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291032|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291033|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291034|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
161291035|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
161291036|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
161291037|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
161291038|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
161171187|NCT01998958|582003286|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171188|NCT01998958|582003287|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171189|NCT01998958|582003288|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171190|NCT01998958|582003289|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171191|NCT01998958|582003290|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171192|NCT01998958|582003291|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
161171193|NCT01998958|582003292|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171194|NCT01998958|582003293|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171195|NCT01998958|582003294|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171196|NCT01998958|582003295|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171197|NCT01998958|582003296|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171198|NCT01998958|582003297|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171199|NCT01998958|582003298|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
161291039|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
161291040|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291041|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291042|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291043|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291044|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291045|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291046|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291047|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291048|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291049|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
161291050|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
161291051|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291052|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
161291053|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
161291054|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
161291055|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291056|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291057|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291058|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291059|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291060|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291061|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291062|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291063|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291064|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
161291065|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291066|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291067|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291068|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
161291069|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291070|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291071|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291072|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291073|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291074|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291075|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291076|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291077|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291078|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291079|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
161291080|NCT03334435|582447969|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291081|NCT03334435|582447970|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
161291082|NCT03334435|582447971|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
161291083|NCT03334435|582447972|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
161291084|NCT03334435|582447973|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
161291085|NCT03334435|582447974|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291086|NCT03334435|582447975|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291087|NCT03334435|582447976|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291088|NCT03334435|582447977|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291089|NCT03334435|582447978|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291090|NCT03334435|582447979|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291091|NCT03334435|582447980|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291092|NCT03334435|582447981|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291093|NCT03334435|582447982|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291094|NCT03334435|582447983|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
161291095|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161291096|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161291097|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161291098|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161291099|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
161291100|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161291101|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
161347227|NCT03915067|582656247|FG002|Overall Study|Adverse Event|1|||
161347228|NCT03915067|582656245|FG000|Overall Study|Withdrawal by Subject|4|||
161085203|NCT03117998|581700224|FG005|Overall Study|Physician Decision|0|||
161291102|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161291103|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
161291104|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
161291105|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
161291106|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
161291107|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
161291108|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
161291109|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
161291110|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161291111|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161291112|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161291113|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161291114|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
161291115|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
161291116|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
161291117|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
161291118|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
161291119|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
161291120|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
161291121|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
161291122|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
161291123|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
161291124|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
161291125|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161291126|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161291127|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161291128|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161291129|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161291130|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
161291131|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
161291132|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
161291133|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
161291134|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
161291135|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
161291136|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
161291137|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
161291138|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
161291139|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
161291140|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161291141|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161291142|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161291143|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161291144|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
161291145|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
161291146|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
161291147|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161291148|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161291149|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
161291150|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
161347229|NCT03915067|582656246|FG001|Overall Study|Withdrawal by Subject|3|||
161347230|NCT03915067|582656247|FG002|Overall Study|Withdrawal by Subject|0|||
161347231|NCT03915067|582656245|FG000|Overall Study|Lost to Follow-up|3|||
161347232|NCT03915067|582656246|FG001|Overall Study|Lost to Follow-up|2|||
161347233|NCT03915067|582656247|FG002|Overall Study|Lost to Follow-up|0|||
161347234|NCT03915067|582656245|FG000|Overall Study|Protocol Deviation|0|||
161347235|NCT03915067|582656246|FG001|Overall Study|Protocol Deviation|0|||
161347236|NCT03915067|582656247|FG002|Overall Study|Protocol Deviation|1|||
161347237|NCT03915067|582656245|FG000|Overall Study|Covid-19 Related Issues|2|||
161347238|NCT03915067|582656246|FG001|Overall Study|Covid-19 Related Issues|4|||
161347239|NCT03915067|582656247|FG002|Overall Study|Covid-19 Related Issues|4|||
161347240|NCT03915067|582656245|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
161347241|NCT03915067|582656246|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
161347242|NCT03915067|582656247|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
161171200|NCT01998958|582003299|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
161347243|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
161347244|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
161291151|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
161291152|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
161291153|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
161291154|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
161291155|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291156|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291157|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291158|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291159|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291160|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291161|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
161291162|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
161291163|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
161291164|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161291165|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161291166|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
161291167|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
161291168|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
161291169|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
161291170|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291171|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291172|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291173|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291174|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291175|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291176|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291177|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291178|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291179|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291180|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291181|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
161291182|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291183|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
161291184|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
161291185|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291186|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291187|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291188|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291189|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291190|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
161291191|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291192|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291193|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291194|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291195|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291196|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291197|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
161291198|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
161171201|NCT01998958|582003300|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
161171202|NCT01998958|582003269|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171203|NCT01998958|582003270|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171204|NCT01998958|582003271|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171205|NCT01998958|582003272|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171206|NCT01998958|582003273|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171207|NCT01998958|582003274|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171208|NCT01998958|582003275|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171209|NCT01998958|582003276|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
161291199|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
161291200|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291201|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161171210|NCT01998958|582003277|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171211|NCT01998958|582003278|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171212|NCT01998958|582003279|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171213|NCT01998958|582003280|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
161291202|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291203|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291204|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291205|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161291206|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161291207|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161291208|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161291209|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
161291210|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161291211|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
161291212|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291213|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291214|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
161291215|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291216|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291217|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291218|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291219|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291220|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161291221|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161291222|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291223|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291224|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291225|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
161291226|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161291227|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
161291228|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
161291229|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
161291230|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291231|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291232|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291233|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291234|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291235|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161291236|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291237|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291238|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291239|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291240|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161291241|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291242|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291243|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
161291244|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
161291245|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291246|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291247|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291248|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291249|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291250|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291251|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291252|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161291253|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161291254|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291255|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161291256|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
161291257|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
161291258|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291259|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
161291260|NCT03334435|582447969|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291261|NCT03334435|582447970|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291262|NCT03334435|582447971|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161171214|NCT01998958|582003281|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171215|NCT01998958|582003282|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171216|NCT01998958|582003283|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171217|NCT01998958|582003284|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171218|NCT01998958|582003285|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171219|NCT01998958|582003286|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171220|NCT01998958|582003287|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171221|NCT01998958|582003288|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171222|NCT01998958|582003289|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171223|NCT01998958|582003290|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
161171224|NCT01998958|582003291|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
161171225|NCT01998958|582003292|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171226|NCT01998958|582003293|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171227|NCT01998958|582003294|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171228|NCT01998958|582003295|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171229|NCT01998958|582003296|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171230|NCT01998958|582003297|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171231|NCT01998958|582003298|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171232|NCT01998958|582003299|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171233|NCT01998958|582003300|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
161171234|NCT01998958|582003269|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171235|NCT01998958|582003270|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171236|NCT01998958|582003271|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171237|NCT01998958|582003272|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171238|NCT01998958|582003273|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171239|NCT01998958|582003274|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171240|NCT01998958|582003275|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171241|NCT01998958|582003276|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171242|NCT01998958|582003277|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171243|NCT01998958|582003278|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171244|NCT01998958|582003279|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171245|NCT01998958|582003280|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171246|NCT01998958|582003281|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171247|NCT01998958|582003282|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171248|NCT01998958|582003283|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171249|NCT01998958|582003284|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171250|NCT01998958|582003285|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171251|NCT01998958|582003286|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171252|NCT01998958|582003287|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171253|NCT01998958|582003288|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171254|NCT01998958|582003289|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171255|NCT01998958|582003290|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
161171256|NCT01998958|582003291|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
161171257|NCT01998958|582003292|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
161171258|NCT01998958|582003293|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171259|NCT01998958|582003294|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171260|NCT01998958|582003295|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171261|NCT01998958|582003296|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171262|NCT01998958|582003297|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171263|NCT01998958|582003298|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171264|NCT01998958|582003299|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171265|NCT01998958|582003300|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
161171266|NCT02432703|582003301|FG000|Overall Study|Adverse Event|1|||
161171267|NCT02432703|582003302|FG001|Overall Study|Adverse Event|4|||
161171268|NCT02432703|582003301|FG000|Overall Study|Lack of Efficacy|1|||
161171269|NCT02432703|582003302|FG001|Overall Study|Lack of Efficacy|0|||
161171270|NCT02432703|582003301|FG000|Overall Study|Lost to Follow-up|5|||
161171271|NCT02432703|582003302|FG001|Overall Study|Lost to Follow-up|3|||
161171272|NCT02432703|582003301|FG000|Overall Study|Withdrawal by Subject|9|||
161171273|NCT02432703|582003302|FG001|Overall Study|Withdrawal by Subject|6|||
161171274|NCT02432703|582003301|FG000|Overall Study|Other|6|||
161171275|NCT02432703|582003302|FG001|Overall Study|Other|5|||
161171276|NCT02137837|582003308|FG000|Overall Study|Adverse Event|0|||
161171277|NCT02137837|582003309|FG001|Overall Study|Adverse Event|2|||
161171278|NCT02137837|582003310|FG002|Overall Study|Adverse Event|1|||
161171279|NCT02137837|582003308|FG000|Overall Study|Refusal unrelated to adverse event|2|||
161171280|NCT02137837|582003309|FG001|Overall Study|Refusal unrelated to adverse event|2|||
161171281|NCT02137837|582003310|FG002|Overall Study|Refusal unrelated to adverse event|1|||
161171282|NCT02137837|582003308|FG000|Overall Study|Progression/relapse|9|||
161171283|NCT02137837|582003309|FG001|Overall Study|Progression/relapse|7|||
161171284|NCT02137837|582003310|FG002|Overall Study|Progression/relapse|7|||
161171285|NCT02137837|582003308|FG000|Overall Study|Not protocol specified|2|||
161171286|NCT02137837|582003309|FG001|Overall Study|Not protocol specified|1|||
161291263|NCT03334435|582447972|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291264|NCT03334435|582447973|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291265|NCT03334435|582447974|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291266|NCT03334435|582447975|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291267|NCT03334435|582447976|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291268|NCT03334435|582447977|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291269|NCT03334435|582447978|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291270|NCT03334435|582447979|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291271|NCT03334435|582447980|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161291272|NCT03334435|582447981|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
161291273|NCT03334435|582447982|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161291274|NCT03334435|582447983|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
161291275|NCT03922321|582447984|FG000|Overall Study|Participant Moved|1|||
161291276|NCT03922321|582447984|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
161291277|NCT02342678|582447988|FG000|Overall Study|Lost to Follow-up|0|||
161291278|NCT02342678|582447989|FG001|Overall Study|Lost to Follow-up|1|||
161291279|NCT02342678|582447988|FG000|Overall Study|Too busy to complete study|0|||
161291280|NCT02342678|582447989|FG001|Overall Study|Too busy to complete study|2|||
161291281|NCT02342678|582447988|FG000|Overall Study|Family illness/emergency|0|||
161291282|NCT02342678|582447989|FG001|Overall Study|Family illness/emergency|1|||
161291283|NCT02342678|582447988|FG000|Overall Study|Illness/medical reason|1|||
161291284|NCT02342678|582447989|FG001|Overall Study|Illness/medical reason|1|||
161291285|NCT00460603|582447990|FG000|Phase 1|Death|1|||
161291286|NCT00460603|582447991|FG001|Phase 1|Death|0|||
161291287|NCT00460603|582447992|FG002|Phase 1|Death|0|||
161291288|NCT00460603|582447993|FG003|Phase 1|Death|2|||
161291289|NCT00460603|582447994|FG004|Phase 1|Death|0|||
161291290|NCT00460603|582447995|FG005|Phase 1|Death|0|||
161291291|NCT00460603|582447996|FG006|Phase 1|Death|0|||
161291292|NCT00460603|582447997|FG007|Phase 1|Death|0|||
161291293|NCT00460603|582447998|FG008|Phase 1|Death|1|||
161291294|NCT00460603|582447999|FG009|Phase 1|Death|0|||
161291295|NCT00460603|582448000|FG010|Phase 1|Death|0|||
161291296|NCT00460603|582448001|FG011|Phase 1|Death|0|||
161291297|NCT00460603|582447990|FG000|Phase 1|Adverse Event|3|||
161291298|NCT00460603|582447991|FG001|Phase 1|Adverse Event|1|||
161291299|NCT00460603|582447992|FG002|Phase 1|Adverse Event|1|||
161291300|NCT00460603|582447993|FG003|Phase 1|Adverse Event|2|||
161291301|NCT00460603|582447994|FG004|Phase 1|Adverse Event|0|||
161291302|NCT00460603|582447995|FG005|Phase 1|Adverse Event|0|||
161291303|NCT00460603|582447996|FG006|Phase 1|Adverse Event|3|||
161291304|NCT00460603|582447997|FG007|Phase 1|Adverse Event|0|||
161291305|NCT00460603|582447998|FG008|Phase 1|Adverse Event|4|||
161291306|NCT00460603|582447999|FG009|Phase 1|Adverse Event|0|||
161291307|NCT00460603|582448000|FG010|Phase 1|Adverse Event|0|||
161347245|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
161085204|NCT03117998|581700219|FG000|Overall Study|Lost to Follow-up|0|||
161291308|NCT00460603|582448001|FG011|Phase 1|Adverse Event|0|||
161291309|NCT00460603|582447990|FG000|Phase 1|Lack of Efficacy|1|||
161291310|NCT00460603|582447991|FG001|Phase 1|Lack of Efficacy|0|||
161291311|NCT00460603|582447992|FG002|Phase 1|Lack of Efficacy|1|||
161291312|NCT00460603|582447993|FG003|Phase 1|Lack of Efficacy|2|||
161291313|NCT00460603|582447994|FG004|Phase 1|Lack of Efficacy|2|||
161291314|NCT00460603|582447995|FG005|Phase 1|Lack of Efficacy|2|||
161291315|NCT00460603|582447996|FG006|Phase 1|Lack of Efficacy|2|||
161291316|NCT00460603|582447997|FG007|Phase 1|Lack of Efficacy|2|||
161291317|NCT00460603|582447998|FG008|Phase 1|Lack of Efficacy|11|||
161291318|NCT00460603|582447999|FG009|Phase 1|Lack of Efficacy|0|||
161291319|NCT00460603|582448000|FG010|Phase 1|Lack of Efficacy|0|||
161291320|NCT00460603|582448001|FG011|Phase 1|Lack of Efficacy|0|||
161291321|NCT00460603|582447990|FG000|Phase 1|Withdrawal by Subject|1|||
161291322|NCT00460603|582447991|FG001|Phase 1|Withdrawal by Subject|2|||
161291323|NCT00460603|582447992|FG002|Phase 1|Withdrawal by Subject|1|||
161291324|NCT00460603|582447993|FG003|Phase 1|Withdrawal by Subject|1|||
161085205|NCT03117998|581700220|FG001|Overall Study|Lost to Follow-up|0|||
161085206|NCT03117998|581700221|FG002|Overall Study|Lost to Follow-up|0|||
161085207|NCT03117998|581700222|FG003|Overall Study|Lost to Follow-up|1|||
161085208|NCT03117998|581700223|FG004|Overall Study|Lost to Follow-up|4|||
161085209|NCT03117998|581700224|FG005|Overall Study|Lost to Follow-up|0|||
161085210|NCT03117998|581700219|FG000|Overall Study|Subject noncompliance|0|||
161085211|NCT03117998|581700220|FG001|Overall Study|Subject noncompliance|0|||
161085212|NCT03117998|581700221|FG002|Overall Study|Subject noncompliance|1|||
161085213|NCT03117998|581700222|FG003|Overall Study|Subject noncompliance|0|||
161085214|NCT03117998|581700223|FG004|Overall Study|Subject noncompliance|0|||
161291325|NCT00460603|582447994|FG004|Phase 1|Withdrawal by Subject|3|||
161291326|NCT00460603|582447995|FG005|Phase 1|Withdrawal by Subject|0|||
161291327|NCT00460603|582447996|FG006|Phase 1|Withdrawal by Subject|1|||
161291328|NCT00460603|582447997|FG007|Phase 1|Withdrawal by Subject|0|||
161291329|NCT00460603|582447998|FG008|Phase 1|Withdrawal by Subject|2|||
161291330|NCT00460603|582447999|FG009|Phase 1|Withdrawal by Subject|0|||
161291331|NCT00460603|582448000|FG010|Phase 1|Withdrawal by Subject|0|||
161291332|NCT00460603|582448001|FG011|Phase 1|Withdrawal by Subject|0|||
161171287|NCT02137837|582003310|FG002|Overall Study|Not protocol specified|3|||
161171288|NCT01181141|582003311|FG000|Overall Study|Adverse Event|2|||
161171289|NCT01181141|582003312|FG001|Overall Study|Adverse Event|1|||
161171290|NCT01181141|582003311|FG000|Overall Study|Lack of Efficacy|1|||
161171291|NCT01181141|582003312|FG001|Overall Study|Lack of Efficacy|0|||
161171292|NCT01181141|582003311|FG000|Overall Study|Lost to Follow-up|1|||
161171293|NCT01181141|582003312|FG001|Overall Study|Lost to Follow-up|1|||
161171294|NCT01181141|582003311|FG000|Overall Study|Physician Decision|2|||
161171295|NCT01181141|582003312|FG001|Overall Study|Physician Decision|0|||
161171296|NCT01181141|582003311|FG000|Overall Study|Protocol Violation|3|||
161171297|NCT01181141|582003312|FG001|Overall Study|Protocol Violation|1|||
161171298|NCT01181141|582003311|FG000|Overall Study|Withdrawal by Subject|3|||
161171299|NCT01181141|582003312|FG001|Overall Study|Withdrawal by Subject|1|||
161171300|NCT01628393|582003313|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
161171301|NCT01628393|582003314|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161171302|NCT01628393|582003315|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161171303|NCT01628393|582003316|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161171304|NCT01628393|582003317|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
161171305|NCT01628393|582003313|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
161171306|NCT01628393|582003314|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
161171307|NCT01628393|582003315|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
161171308|NCT01628393|582003316|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
161171309|NCT01628393|582003317|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
161171310|NCT01628393|582003313|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
161171311|NCT01628393|582003314|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
161171312|NCT01628393|582003315|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
161171313|NCT01628393|582003316|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161171314|NCT01628393|582003317|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
161171315|NCT01628393|582003313|FG000|Blinded Active Extension Period|Adverse Event|0|||
161171316|NCT01628393|582003314|FG001|Blinded Active Extension Period|Adverse Event|1|||
161171317|NCT01628393|582003315|FG002|Blinded Active Extension Period|Adverse Event|0|||
161171318|NCT01628393|582003316|FG003|Blinded Active Extension Period|Adverse Event|2|||
161171319|NCT01628393|582003317|FG004|Blinded Active Extension Period|Adverse Event|2|||
161171320|NCT01628393|582003313|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
161171321|NCT01628393|582003314|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
161171322|NCT01628393|582003315|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
161171323|NCT01628393|582003316|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
161171324|NCT01628393|582003317|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
161171325|NCT01628393|582003313|FG000|Blinded Active Extension Period|Physician Decision|0|||
161171326|NCT01628393|582003314|FG001|Blinded Active Extension Period|Physician Decision|3|||
161171327|NCT01628393|582003315|FG002|Blinded Active Extension Period|Physician Decision|0|||
161171328|NCT01628393|582003316|FG003|Blinded Active Extension Period|Physician Decision|1|||
161171329|NCT01628393|582003317|FG004|Blinded Active Extension Period|Physician Decision|0|||
161171330|NCT01628393|582003313|FG000|Blinded Active Extension Period|Protocol Violation|0|||
161171331|NCT01628393|582003314|FG001|Blinded Active Extension Period|Protocol Violation|0|||
161171332|NCT01628393|582003315|FG002|Blinded Active Extension Period|Protocol Violation|2|||
161171333|NCT01628393|582003316|FG003|Blinded Active Extension Period|Protocol Violation|1|||
161171334|NCT01628393|582003317|FG004|Blinded Active Extension Period|Protocol Violation|0|||
161171335|NCT01628393|582003313|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
161171336|NCT01628393|582003314|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
161171337|NCT01628393|582003315|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
161171338|NCT01628393|582003316|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
161171339|NCT01628393|582003317|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
161171340|NCT01665768|582003318|FG000|Overall Study|Adverse Event|3|||
161171341|NCT01665768|582003318|FG000|Overall Study|Lack of Efficacy|19|||
161171342|NCT01665768|582003318|FG000|Overall Study|Withdrawal by Subject|1|||
161171343|NCT00290589|582003319|FG000|Overall Study|Lost to Follow-up|2|||
161171344|NCT00290589|582003320|FG001|Overall Study|Lost to Follow-up|2|||
161171345|NCT00118911|582003321|FG000|Overall Study|Withdrawal by Subject|2|||
161291333|NCT00460603|582447990|FG000|Phase 1|Other|0|||
161291334|NCT00460603|582447991|FG001|Phase 1|Other|3|||
161291335|NCT00460603|582447992|FG002|Phase 1|Other|1|||
161291336|NCT00460603|582447993|FG003|Phase 1|Other|1|||
161291337|NCT00460603|582447994|FG004|Phase 1|Other|1|||
161171346|NCT00118911|582003322|FG001|Overall Study|Withdrawal by Subject|5|||
161171347|NCT03496662|582003323|FG000|Overall Study|Adverse Event|0|||
161171348|NCT03496662|582003324|FG001|Overall Study|Adverse Event|0|||
161171349|NCT03496662|582003325|FG002|Overall Study|Adverse Event|4|||
161291338|NCT00460603|582447995|FG005|Phase 1|Other|2|||
161291339|NCT00460603|582447996|FG006|Phase 1|Other|0|||
161291340|NCT00460603|582447997|FG007|Phase 1|Other|1|||
161291341|NCT00460603|582447998|FG008|Phase 1|Other|0|||
161291342|NCT00460603|582447999|FG009|Phase 1|Other|0|||
161291343|NCT00460603|582448000|FG010|Phase 1|Other|0|||
161291344|NCT00460603|582448001|FG011|Phase 1|Other|0|||
161291345|NCT00460603|582447990|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291346|NCT00460603|582447991|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291347|NCT00460603|582447992|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291348|NCT00460603|582447993|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291349|NCT00460603|582447994|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291350|NCT00460603|582447995|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291351|NCT00460603|582447996|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291352|NCT00460603|582447997|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291353|NCT00460603|582447998|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291354|NCT00460603|582447999|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
161291355|NCT00460603|582448000|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291356|NCT00460603|582448001|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
161291357|NCT00460603|582447990|FG000|Phase 2|Adverse Event|0|||
161291358|NCT00460603|582447991|FG001|Phase 2|Adverse Event|0|||
161291359|NCT00460603|582447992|FG002|Phase 2|Adverse Event|0|||
161291360|NCT00460603|582447993|FG003|Phase 2|Adverse Event|0|||
161291361|NCT00460603|582447994|FG004|Phase 2|Adverse Event|0|||
161291362|NCT00460603|582447995|FG005|Phase 2|Adverse Event|0|||
161291363|NCT00460603|582447996|FG006|Phase 2|Adverse Event|0|||
161291364|NCT00460603|582447997|FG007|Phase 2|Adverse Event|0|||
161291365|NCT00460603|582447998|FG008|Phase 2|Adverse Event|0|||
161291366|NCT00460603|582447999|FG009|Phase 2|Adverse Event|12|||
161291367|NCT00460603|582448000|FG010|Phase 2|Adverse Event|9|||
161291368|NCT00460603|582448001|FG011|Phase 2|Adverse Event|10|||
161291369|NCT00460603|582447990|FG000|Phase 2|Death|0|||
161291370|NCT00460603|582447991|FG001|Phase 2|Death|0|||
161291371|NCT00460603|582447992|FG002|Phase 2|Death|0|||
161291372|NCT00460603|582447993|FG003|Phase 2|Death|0|||
161291373|NCT00460603|582447994|FG004|Phase 2|Death|0|||
161291374|NCT00460603|582447995|FG005|Phase 2|Death|0|||
161291375|NCT00460603|582447996|FG006|Phase 2|Death|0|||
161291376|NCT00460603|582447997|FG007|Phase 2|Death|0|||
161291377|NCT00460603|582447998|FG008|Phase 2|Death|0|||
161291378|NCT00460603|582447999|FG009|Phase 2|Death|4|||
161291379|NCT00460603|582448000|FG010|Phase 2|Death|2|||
161291380|NCT00460603|582448001|FG011|Phase 2|Death|2|||
161291381|NCT00460603|582447990|FG000|Phase 2|Protocol Violation|0|||
161291382|NCT00460603|582447991|FG001|Phase 2|Protocol Violation|0|||
161291383|NCT00460603|582447992|FG002|Phase 2|Protocol Violation|0|||
161291384|NCT00460603|582447993|FG003|Phase 2|Protocol Violation|0|||
161291385|NCT00460603|582447994|FG004|Phase 2|Protocol Violation|0|||
161291386|NCT00460603|582447995|FG005|Phase 2|Protocol Violation|0|||
161291387|NCT00460603|582447996|FG006|Phase 2|Protocol Violation|0|||
161291388|NCT00460603|582447997|FG007|Phase 2|Protocol Violation|0|||
161291389|NCT00460603|582447998|FG008|Phase 2|Protocol Violation|0|||
161291390|NCT00460603|582447999|FG009|Phase 2|Protocol Violation|1|||
161291391|NCT00460603|582448000|FG010|Phase 2|Protocol Violation|1|||
161291392|NCT00460603|582448001|FG011|Phase 2|Protocol Violation|0|||
161171350|NCT03496662|582003323|FG000|Overall Study|Withdrawal by Subject|1|||
161171351|NCT03496662|582003324|FG001|Overall Study|Withdrawal by Subject|0|||
161171352|NCT03496662|582003325|FG002|Overall Study|Withdrawal by Subject|2|||
161291393|NCT00460603|582447990|FG000|Phase 2|Lost to Follow-up|0|||
161291394|NCT00460603|582447991|FG001|Phase 2|Lost to Follow-up|0|||
161291395|NCT00460603|582447992|FG002|Phase 2|Lost to Follow-up|0|||
161291396|NCT00460603|582447993|FG003|Phase 2|Lost to Follow-up|0|||
161291397|NCT00460603|582447994|FG004|Phase 2|Lost to Follow-up|0|||
161291398|NCT00460603|582447995|FG005|Phase 2|Lost to Follow-up|0|||
161291399|NCT00460603|582447996|FG006|Phase 2|Lost to Follow-up|0|||
161291400|NCT00460603|582447997|FG007|Phase 2|Lost to Follow-up|0|||
161291401|NCT00460603|582447998|FG008|Phase 2|Lost to Follow-up|0|||
161291402|NCT00460603|582447999|FG009|Phase 2|Lost to Follow-up|1|||
161291403|NCT00460603|582448000|FG010|Phase 2|Lost to Follow-up|0|||
161291404|NCT00460603|582448001|FG011|Phase 2|Lost to Follow-up|0|||
161291405|NCT00460603|582447990|FG000|Phase 2|Other|0|||
161291406|NCT00460603|582447991|FG001|Phase 2|Other|0|||
161291407|NCT00460603|582447992|FG002|Phase 2|Other|0|||
161291408|NCT00460603|582447993|FG003|Phase 2|Other|0|||
161291409|NCT00460603|582447994|FG004|Phase 2|Other|0|||
161291410|NCT00460603|582447995|FG005|Phase 2|Other|0|||
161347246|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
161291411|NCT00460603|582447996|FG006|Phase 2|Other|0|||
161291412|NCT00460603|582447997|FG007|Phase 2|Other|0|||
161291413|NCT00460603|582447998|FG008|Phase 2|Other|0|||
161291414|NCT00460603|582447999|FG009|Phase 2|Other|6|||
161291415|NCT00460603|582448000|FG010|Phase 2|Other|16|||
161291416|NCT00460603|582448001|FG011|Phase 2|Other|7|||
161291417|NCT00460603|582447990|FG000|Phase 2|Objective Progression or Relapse|0|||
161291418|NCT00460603|582447991|FG001|Phase 2|Objective Progression or Relapse|0|||
161291419|NCT00460603|582447992|FG002|Phase 2|Objective Progression or Relapse|0|||
161291420|NCT00460603|582447993|FG003|Phase 2|Objective Progression or Relapse|0|||
161291421|NCT00460603|582447994|FG004|Phase 2|Objective Progression or Relapse|0|||
161291422|NCT00460603|582447995|FG005|Phase 2|Objective Progression or Relapse|0|||
161291423|NCT00460603|582447996|FG006|Phase 2|Objective Progression or Relapse|0|||
161291424|NCT00460603|582447997|FG007|Phase 2|Objective Progression or Relapse|0|||
161291425|NCT00460603|582447998|FG008|Phase 2|Objective Progression or Relapse|0|||
161291426|NCT00460603|582447999|FG009|Phase 2|Objective Progression or Relapse|9|||
161291427|NCT00460603|582448000|FG010|Phase 2|Objective Progression or Relapse|10|||
161291428|NCT00460603|582448001|FG011|Phase 2|Objective Progression or Relapse|17|||
161291429|NCT00460603|582447990|FG000|Phase 2|Global Deterioration of Health Status|0|||
161291430|NCT00460603|582447991|FG001|Phase 2|Global Deterioration of Health Status|0|||
161291431|NCT00460603|582447992|FG002|Phase 2|Global Deterioration of Health Status|0|||
161291432|NCT00460603|582447993|FG003|Phase 2|Global Deterioration of Health Status|0|||
161291433|NCT00460603|582447994|FG004|Phase 2|Global Deterioration of Health Status|0|||
161291434|NCT00460603|582447995|FG005|Phase 2|Global Deterioration of Health Status|0|||
161291435|NCT00460603|582447996|FG006|Phase 2|Global Deterioration of Health Status|0|||
161291436|NCT00460603|582447997|FG007|Phase 2|Global Deterioration of Health Status|0|||
161291437|NCT00460603|582447998|FG008|Phase 2|Global Deterioration of Health Status|0|||
161291438|NCT00460603|582447999|FG009|Phase 2|Global Deterioration of Health Status|0|||
161291439|NCT00460603|582448000|FG010|Phase 2|Global Deterioration of Health Status|1|||
161291440|NCT00460603|582448001|FG011|Phase 2|Global Deterioration of Health Status|0|||
161291441|NCT00460603|582447990|FG000|Phase 2|Withdrawal by Subject|0|||
161291442|NCT00460603|582447991|FG001|Phase 2|Withdrawal by Subject|0|||
161291443|NCT00460603|582447992|FG002|Phase 2|Withdrawal by Subject|0|||
161291444|NCT00460603|582447993|FG003|Phase 2|Withdrawal by Subject|0|||
161291445|NCT00460603|582447994|FG004|Phase 2|Withdrawal by Subject|0|||
161291446|NCT00460603|582447995|FG005|Phase 2|Withdrawal by Subject|0|||
161291447|NCT00460603|582447996|FG006|Phase 2|Withdrawal by Subject|0|||
161291448|NCT00460603|582447997|FG007|Phase 2|Withdrawal by Subject|0|||
161291449|NCT00460603|582447998|FG008|Phase 2|Withdrawal by Subject|0|||
161291450|NCT00460603|582447999|FG009|Phase 2|Withdrawal by Subject|5|||
161291451|NCT00460603|582448000|FG010|Phase 2|Withdrawal by Subject|4|||
161291452|NCT00460603|582448001|FG011|Phase 2|Withdrawal by Subject|5|||
161291453|NCT00460603|582447990|FG000|Phase 2|Randomized, but not treated|0|||
161291454|NCT00460603|582447991|FG001|Phase 2|Randomized, but not treated|0|||
161291455|NCT00460603|582447992|FG002|Phase 2|Randomized, but not treated|0|||
161291456|NCT00460603|582447993|FG003|Phase 2|Randomized, but not treated|0|||
161291457|NCT00460603|582447994|FG004|Phase 2|Randomized, but not treated|0|||
161291458|NCT00460603|582447995|FG005|Phase 2|Randomized, but not treated|0|||
161291459|NCT00460603|582447996|FG006|Phase 2|Randomized, but not treated|0|||
161291460|NCT00460603|582447997|FG007|Phase 2|Randomized, but not treated|0|||
161291461|NCT00460603|582447998|FG008|Phase 2|Randomized, but not treated|0|||
161291462|NCT00460603|582447999|FG009|Phase 2|Randomized, but not treated|3|||
161291463|NCT00460603|582448000|FG010|Phase 2|Randomized, but not treated|0|||
161291464|NCT00460603|582448001|FG011|Phase 2|Randomized, but not treated|0|||
161291465|NCT01651117|582448005|FG000|Overall Study|Death|2|||
161291466|NCT01651117|582448006|FG001|Overall Study|Death|3|||
161291467|NCT01651117|582448007|FG002|Overall Study|Death|2|||
161291468|NCT01651117|582448008|FG003|Overall Study|Death|2|||
161291469|NCT02075203|582448010|FG000|Overall Study|Withdrawal by Subject|1|||
161291470|NCT02075203|582448011|FG001|Overall Study|Withdrawal by Subject|0|||
161291471|NCT02075203|582448012|FG002|Overall Study|Withdrawal by Subject|1|||
161291472|NCT02075203|582448010|FG000|Overall Study|Adverse Event|1|||
161291473|NCT02075203|582448011|FG001|Overall Study|Adverse Event|0|||
161291474|NCT02075203|582448012|FG002|Overall Study|Adverse Event|0|||
161291475|NCT02075203|582448010|FG000|Overall Study|participant refused to use contraception|1|||
161291476|NCT02075203|582448011|FG001|Overall Study|participant refused to use contraception|0|||
161291477|NCT02075203|582448012|FG002|Overall Study|participant refused to use contraception|0|||
161291478|NCT00350207|582448013|FG000|Overall Study|Adverse Event|5|||
161291479|NCT00350207|582448014|FG001|Overall Study|Adverse Event|2|||
161291480|NCT00350207|582448015|FG002|Overall Study|Adverse Event|2|||
161291481|NCT00350207|582448013|FG000|Overall Study|Lack of Efficacy|1|||
161291482|NCT00350207|582448014|FG001|Overall Study|Lack of Efficacy|0|||
161291483|NCT00350207|582448015|FG002|Overall Study|Lack of Efficacy|2|||
161291484|NCT00350207|582448013|FG000|Overall Study|Lost to Follow-up|1|||
161347247|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
161291485|NCT00350207|582448014|FG001|Overall Study|Lost to Follow-up|0|||
161291486|NCT00350207|582448015|FG002|Overall Study|Lost to Follow-up|1|||
161291487|NCT00350207|582448013|FG000|Overall Study|Withdrawal by Subject|0|||
161291488|NCT00350207|582448014|FG001|Overall Study|Withdrawal by Subject|1|||
161291489|NCT00350207|582448015|FG002|Overall Study|Withdrawal by Subject|1|||
161291490|NCT00350207|582448013|FG000|Overall Study|Other|1|||
161291491|NCT00350207|582448014|FG001|Overall Study|Other|3|||
161291492|NCT00350207|582448015|FG002|Overall Study|Other|1|||
161291493|NCT01293695|582448020|FG000|Overall Study|Withdrawal by Subject|7|||
161291494|NCT01293695|582448021|FG001|Overall Study|Withdrawal by Subject|1|||
161291495|NCT01293695|582448020|FG000|Overall Study|Lost to Follow-up|8|||
161291496|NCT01293695|582448021|FG001|Overall Study|Lost to Follow-up|6|||
161291497|NCT01082328|582448025|FG000|Overall Study|Adverse Event|1|||
161291498|NCT00791778|582448026|FG000|Double-blind Treatment|Adverse Event|49|||
161291499|NCT00791778|582448027|FG001|Double-blind Treatment|Adverse Event|9|||
161291500|NCT00791778|582448026|FG000|Double-blind Treatment|Physician Decision|6|||
161291501|NCT00791778|582448027|FG001|Double-blind Treatment|Physician Decision|26|||
161291502|NCT00791778|582448026|FG000|Double-blind Treatment|Protocol Violation|0|||
161291503|NCT00791778|582448027|FG001|Double-blind Treatment|Protocol Violation|4|||
161291504|NCT00791778|582448026|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
161291505|NCT00791778|582448027|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
161291506|NCT00791778|582448026|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
161291507|NCT00791778|582448027|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
161291508|NCT00791778|582448026|FG000|Follow-up|Withdrawal by Subject|3|||
161291509|NCT00791778|582448027|FG001|Follow-up|Withdrawal by Subject|0|||
161291510|NCT00791778|582448026|FG000|Follow-up|Lost to Follow-up|2|||
161291511|NCT00791778|582448027|FG001|Follow-up|Lost to Follow-up|1|||
161291512|NCT00031590|582448028|FG000|Overall Study|Adverse Event|1|||
161291513|NCT00031590|582448028|FG000|Overall Study|Withdrawal by parents|2|||
161291514|NCT05506046|582448029|FG000|Overall Study|Lost to Follow-up|89|||
161291515|NCT05506046|582448030|FG001|Overall Study|Lost to Follow-up|101|||
161291516|NCT05506046|582448031|FG002|Overall Study|Lost to Follow-up|102|||
161291517|NCT05506046|582448032|FG003|Overall Study|Lost to Follow-up|99|||
161291518|NCT03313180|582448037|FG000|Overall Study|Adverse Event|120|||
161291519|NCT03313180|582448037|FG000|Overall Study|Lost to Follow-up|3|||
161291520|NCT03313180|582448037|FG000|Overall Study|Withdrawal by Subject|39|||
161291521|NCT03313180|582448037|FG000|Overall Study|Other than listed above|15|||
161291522|NCT03313180|582448037|FG000|Overall Study|Covid-19 related|2|||
161291523|NCT01058642|582448040|FG000|Treatment Period 1|Adverse Event|0|||
161291524|NCT01058642|582448041|FG001|Treatment Period 1|Adverse Event|1|||
161291525|NCT01058642|582448042|FG002|Treatment Period 1|Adverse Event|1|||
161291526|NCT01058642|582448043|FG003|Treatment Period 1|Adverse Event|0|||
161291527|NCT01058642|582448040|FG000|Treatment Period 1|Physician Decision|0|||
161291528|NCT01058642|582448041|FG001|Treatment Period 1|Physician Decision|0|||
161291529|NCT01058642|582448042|FG002|Treatment Period 1|Physician Decision|1|||
161291530|NCT01058642|582448043|FG003|Treatment Period 1|Physician Decision|0|||
161291531|NCT01058642|582448040|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161291532|NCT01058642|582448041|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161291533|NCT01058642|582448042|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161291534|NCT01058642|582448043|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161291535|NCT01058642|582448040|FG000|Treatment Period 1|Lack of Efficacy|0|||
161347248|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161347249|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
161347250|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161347251|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161347252|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
161347253|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Death|0|||
161347254|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Death|0|||
161347255|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Death|1|||
161347256|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Death|0|||
161347257|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Death|0|||
161347258|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
161347259|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
161347260|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
161347261|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
161347262|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
161347263|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Other|2|||
161347264|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Other|1|||
161347265|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Other|0|||
161347266|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Other|0|||
161347267|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Other|0|||
161347268|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161347269|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161347270|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
161347271|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161347272|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
161347273|NCT03317496|582656248|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161347274|NCT03317496|582656249|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
161347275|NCT03317496|582656250|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161347276|NCT03317496|582656251|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
161347277|NCT03317496|582656252|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
161347278|NCT03317496|582656248|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
161347279|NCT03317496|582656249|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
161347280|NCT03317496|582656250|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
161347281|NCT03317496|582656251|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
161347282|NCT03317496|582656252|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
161347283|NCT03317496|582656248|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
161291536|NCT01058642|582448041|FG001|Treatment Period 1|Lack of Efficacy|0|||
161347284|NCT03317496|582656249|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161291537|NCT01058642|582448042|FG002|Treatment Period 1|Lack of Efficacy|0|||
161291538|NCT01058642|582448043|FG003|Treatment Period 1|Lack of Efficacy|1|||
161291539|NCT01058642|582448040|FG000|Treatment Period 1|Protocol Violation|0|||
161291540|NCT01058642|582448041|FG001|Treatment Period 1|Protocol Violation|0|||
161291541|NCT01058642|582448042|FG002|Treatment Period 1|Protocol Violation|0|||
161291542|NCT01058642|582448043|FG003|Treatment Period 1|Protocol Violation|1|||
161291543|NCT01058642|582448040|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
161291544|NCT01058642|582448041|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161291545|NCT01058642|582448042|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161291546|NCT01058642|582448043|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
161291547|NCT00777296|582448045|FG000|Overall Study|Adverse Event|0|||
161291548|NCT00777296|582448046|FG001|Overall Study|Adverse Event|1|||
161291549|NCT00777296|582448047|FG002|Overall Study|Adverse Event|0|||
161291550|NCT00777296|582448048|FG003|Overall Study|Adverse Event|1|||
161291551|NCT00777296|582448045|FG000|Overall Study|Withdrawal by Subject|1|||
161291552|NCT00777296|582448046|FG001|Overall Study|Withdrawal by Subject|0|||
161291553|NCT00777296|582448047|FG002|Overall Study|Withdrawal by Subject|0|||
161291554|NCT00777296|582448048|FG003|Overall Study|Withdrawal by Subject|0|||
161291555|NCT00777296|582448045|FG000|Overall Study|CRF form not completed|0|||
161291556|NCT00777296|582448046|FG001|Overall Study|CRF form not completed|0|||
161291557|NCT00777296|582448047|FG002|Overall Study|CRF form not completed|2|||
161291558|NCT00777296|582448048|FG003|Overall Study|CRF form not completed|0|||
161291559|NCT02211209|582448049|FG000|Overall Study|Investigator judgment|0|||
161291560|NCT02211209|582448050|FG001|Overall Study|Investigator judgment|1|||
161291561|NCT02211209|582448049|FG000|Overall Study|Voluntary withdrawal|1|||
161291562|NCT02211209|582448050|FG001|Overall Study|Voluntary withdrawal|4|||
161291563|NCT02211209|582448049|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
161291564|NCT02211209|582448050|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
161291565|NCT02211209|582448049|FG000|Overall Study|Reason Not Specified|1|||
161291566|NCT02211209|582448050|FG001|Overall Study|Reason Not Specified|0|||
161291567|NCT00658723|582448054|FG000|Overall Study|Lost to Follow-up|0|||
161291568|NCT00658723|582448055|FG001|Overall Study|Lost to Follow-up|2|||
161291569|NCT00658723|582448056|FG002|Overall Study|Lost to Follow-up|2|||
161291570|NCT00658723|582448054|FG000|Overall Study|Death|2|||
161291571|NCT00658723|582448055|FG001|Overall Study|Death|1|||
161291572|NCT00658723|582448056|FG002|Overall Study|Death|4|||
161291573|NCT00658723|582448054|FG000|Overall Study|Scheduling Issue|1|||
161291574|NCT00658723|582448055|FG001|Overall Study|Scheduling Issue|1|||
161291575|NCT00658723|582448056|FG002|Overall Study|Scheduling Issue|0|||
161291576|NCT00658723|582448054|FG000|Overall Study|Withdrawal by Subject|1|||
161291577|NCT00658723|582448055|FG001|Overall Study|Withdrawal by Subject|0|||
161291578|NCT00658723|582448056|FG002|Overall Study|Withdrawal by Subject|1|||
161291579|NCT03876743|582448057|FG000|Overall Study|Lost to Follow-up|6|||
161291580|NCT03876743|582448058|FG001|Overall Study|Lost to Follow-up|4|||
161291581|NCT03876743|582448059|FG002|Overall Study|Lost to Follow-up|4|||
161291582|NCT03876743|582448060|FG003|Overall Study|Lost to Follow-up|7|||
161291583|NCT03889418|582448061|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
161291584|NCT03889418|582448062|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291585|NCT03889418|582448063|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291586|NCT03889418|582448064|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291587|NCT03889418|582448065|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291588|NCT03889418|582448066|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291589|NCT03889418|582448067|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291590|NCT03889418|582448068|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291591|NCT03889418|582448069|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291592|NCT03889418|582448070|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
161291593|NCT03889418|582448061|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291594|NCT03889418|582448062|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
161291595|NCT03889418|582448063|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
161291596|NCT03889418|582448064|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291597|NCT03889418|582448065|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291598|NCT03889418|582448066|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291599|NCT03889418|582448067|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291600|NCT03889418|582448068|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291601|NCT03889418|582448069|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291602|NCT03889418|582448070|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
161291603|NCT03889418|582448061|FG000|October-December 2019 (Month 7-9)|Death|0|||
161291604|NCT03889418|582448062|FG001|October-December 2019 (Month 7-9)|Death|0|||
161291605|NCT03889418|582448063|FG002|October-December 2019 (Month 7-9)|Death|0|||
161291606|NCT03889418|582448064|FG003|October-December 2019 (Month 7-9)|Death|0|||
161291607|NCT03889418|582448065|FG004|October-December 2019 (Month 7-9)|Death|0|||
161291608|NCT03889418|582448066|FG005|October-December 2019 (Month 7-9)|Death|0|||
161291609|NCT03889418|582448067|FG006|October-December 2019 (Month 7-9)|Death|0|||
161291610|NCT03889418|582448068|FG007|October-December 2019 (Month 7-9)|Death|0|||
161291611|NCT03889418|582448069|FG008|October-December 2019 (Month 7-9)|Death|1|||
161291612|NCT03889418|582448070|FG009|October-December 2019 (Month 7-9)|Death|0|||
161291613|NCT03889418|582448061|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291614|NCT03889418|582448062|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291615|NCT03889418|582448063|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291616|NCT03889418|582448064|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
161291617|NCT03889418|582448065|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291618|NCT03889418|582448066|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291619|NCT03889418|582448067|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291620|NCT03889418|582448068|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
161291621|NCT03889418|582448069|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291622|NCT03889418|582448070|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
161291623|NCT03889418|582448061|FG000|April - June 2020 (Month 13-15)|Death|0|||
161291624|NCT03889418|582448062|FG001|April - June 2020 (Month 13-15)|Death|1|||
161291625|NCT03889418|582448063|FG002|April - June 2020 (Month 13-15)|Death|0|||
161291626|NCT03889418|582448064|FG003|April - June 2020 (Month 13-15)|Death|0|||
161291627|NCT03889418|582448065|FG004|April - June 2020 (Month 13-15)|Death|0|||
161291628|NCT03889418|582448066|FG005|April - June 2020 (Month 13-15)|Death|0|||
161291629|NCT03889418|582448067|FG006|April - June 2020 (Month 13-15)|Death|0|||
161291630|NCT03889418|582448068|FG007|April - June 2020 (Month 13-15)|Death|0|||
161291631|NCT03889418|582448069|FG008|April - June 2020 (Month 13-15)|Death|0|||
161291632|NCT03889418|582448070|FG009|April - June 2020 (Month 13-15)|Death|0|||
161291633|NCT03889418|582448061|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291634|NCT03889418|582448062|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291635|NCT03889418|582448063|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291636|NCT03889418|582448064|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
161291637|NCT03889418|582448065|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291638|NCT03889418|582448066|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291639|NCT03889418|582448067|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291640|NCT03889418|582448068|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291641|NCT03889418|582448069|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291642|NCT03889418|582448070|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
161291643|NCT03889418|582448061|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
161291644|NCT03889418|582448062|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
161291645|NCT03889418|582448063|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
161291646|NCT03889418|582448064|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
161291647|NCT03889418|582448065|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
161291648|NCT03889418|582448066|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
161291649|NCT03889418|582448067|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
161291650|NCT03889418|582448068|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
161291651|NCT03889418|582448069|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
161291652|NCT03889418|582448070|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
161291653|NCT03889418|582448061|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161291654|NCT03889418|582448062|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
161291655|NCT03889418|582448063|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
161291656|NCT03889418|582448064|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
161291657|NCT03889418|582448065|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161291658|NCT03889418|582448066|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161291659|NCT03889418|582448067|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161291660|NCT03889418|582448068|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
161291661|NCT03889418|582448069|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
161291662|NCT03889418|582448070|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
161291663|NCT00092118|582448072|FG000|Overall Study|Adverse Event|35|||
161291664|NCT00092118|582448073|FG001|Overall Study|Adverse Event|32|||
161291665|NCT00092118|582448072|FG000|Overall Study|Lack of Efficacy|12|||
161291666|NCT00092118|582448073|FG001|Overall Study|Lack of Efficacy|14|||
161291667|NCT00092118|582448072|FG000|Overall Study|Lost to Follow-up|4|||
161291668|NCT00092118|582448073|FG001|Overall Study|Lost to Follow-up|3|||
161291669|NCT00092118|582448072|FG000|Overall Study|Protocol Violation|23|||
161171353|NCT03496662|582003323|FG000|Overall Study|Death|0|||
161171354|NCT03496662|582003324|FG001|Overall Study|Death|0|||
161171355|NCT03496662|582003325|FG002|Overall Study|Death|2|||
161171356|NCT03496662|582003323|FG000|Overall Study|Noncompliance|0|||
161291670|NCT00092118|582448073|FG001|Overall Study|Protocol Violation|25|||
161291671|NCT00092118|582448072|FG000|Overall Study|Withdrawal by Subject|4|||
161291672|NCT00092118|582448073|FG001|Overall Study|Withdrawal by Subject|10|||
161291673|NCT00092118|582448072|FG000|Overall Study|Other|6|||
161291674|NCT00092118|582448073|FG001|Overall Study|Other|5|||
161291675|NCT01139125|582448077|FG000|Overall Study|Withdrawal by Subject|1|||
161291676|NCT03267212|582448078|FG000|First Intervention|Lost to Follow-up|0|||
161171357|NCT03496662|582003324|FG001|Overall Study|Noncompliance|0|||
161171358|NCT03496662|582003325|FG002|Overall Study|Noncompliance|1|||
161171359|NCT01467661|582003326|FG000|Overall Study|Adverse Event|16|||
161171360|NCT01467661|582003326|FG000|Overall Study|Withdrawal by Subject|1|||
161171361|NCT01467661|582003326|FG000|Overall Study|Lack of Efficacy|3|||
161171362|NCT01467661|582003326|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
161171363|NCT00691093|582003327|FG000|Overall Study|Adverse Event|1|||
161171364|NCT00691093|582003327|FG000|Overall Study|Lost to Follow-up|1|||
161171365|NCT00691093|582003327|FG000|Overall Study|Lack of Efficacy|1|||
161171366|NCT00691093|582003327|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
161171367|NCT03814005|582003329|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
161171368|NCT03814005|582003330|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
161171369|NCT03814005|582003331|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
161171370|NCT03814005|582003329|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
161171371|NCT03814005|582003330|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
161171372|NCT03814005|582003331|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
161171373|NCT03814005|582003329|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
161171374|NCT03814005|582003330|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
161171375|NCT03814005|582003331|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
161171376|NCT03814005|582003329|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
161171377|NCT03814005|582003330|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
161171378|NCT03814005|582003331|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
161171379|NCT03814005|582003329|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
161171380|NCT03814005|582003330|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
161171381|NCT03814005|582003331|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
161171382|NCT03814005|582003329|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
161171383|NCT03814005|582003330|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
161171384|NCT03814005|582003331|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
161171385|NCT03395223|582003332|FG000|Overall Study|Lost to Follow-up|3|||
161171386|NCT03395223|582003332|FG000|Overall Study|Other|1|||
161171387|NCT00810810|582003333|FG000|Overall Study|Withdrawal by Subject|0|||
161171388|NCT00810810|582003334|FG001|Overall Study|Withdrawal by Subject|8|||
161171389|NCT00810810|582003335|FG002|Overall Study|Withdrawal by Subject|10|||
161171390|NCT00810810|582003336|FG003|Overall Study|Withdrawal by Subject|8|||
161171391|NCT00810810|582003333|FG000|Overall Study|Physician Decision|0|||
161171392|NCT00810810|582003334|FG001|Overall Study|Physician Decision|3|||
161171393|NCT00810810|582003335|FG002|Overall Study|Physician Decision|1|||
161171394|NCT00810810|582003336|FG003|Overall Study|Physician Decision|5|||
161171395|NCT01700985|582003337|FG000|Overall Study|Incarcerated|0|||
161171396|NCT01700985|582003338|FG001|Overall Study|Incarcerated|1|||
161171397|NCT00965146|582003339|FG000|Overall Study|Death|7|||
161171398|NCT00965146|582003339|FG000|Overall Study|Lost to Follow-up|22|||
161171399|NCT00965146|582003339|FG000|Overall Study|Withdrawal by Subject|17|||
161171400|NCT00965146|582003339|FG000|Overall Study|Unable to return|1|||
161171401|NCT00965146|582003339|FG000|Overall Study|Unwilling to return|11|||
161171402|NCT00965146|582003339|FG000|Overall Study|Intercurrent illness|1|||
161171403|NCT00965146|582003339|FG000|Overall Study|Revision / Removal of Study Implant|6|||
161171404|NCT00965146|582003339|FG000|Overall Study|Overall Study Termination|145|||
161171405|NCT05067452|582003340|FG000|Overall Study|Lost to Follow-up|0|||
161171406|NCT05067452|582003341|FG001|Overall Study|Lost to Follow-up|4|||
161171407|NCT01135017|582003342|FG000|Overall Study|Adverse Event|3|||
161171408|NCT01135017|582003343|FG001|Overall Study|Adverse Event|8|||
161291677|NCT03267212|582448079|FG001|First Intervention|Lost to Follow-up|2|||
161291678|NCT03267212|582448078|FG000|First Intervention|Withdrawal by Subject|1|||
161291679|NCT03267212|582448079|FG001|First Intervention|Withdrawal by Subject|1|||
161291680|NCT03267212|582448078|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
161085215|NCT03117998|581700224|FG005|Overall Study|Subject noncompliance|2|||
161085216|NCT03117998|581700219|FG000|Overall Study|Protocol Violation|0|||
161085217|NCT03117998|581700220|FG001|Overall Study|Protocol Violation|0|||
161085218|NCT03117998|581700221|FG002|Overall Study|Protocol Violation|0|||
161085219|NCT03117998|581700222|FG003|Overall Study|Protocol Violation|0|||
161085220|NCT03117998|581700223|FG004|Overall Study|Protocol Violation|0|||
161085221|NCT03117998|581700224|FG005|Overall Study|Protocol Violation|1|||
161085222|NCT04927247|581700225|FG000|Overall Study|Other|2|||
161085223|NCT04927247|581700226|FG001|Overall Study|Other|1|||
161085224|NCT04927247|581700225|FG000|Overall Study|Physician Decision|0|||
161085225|NCT04927247|581700226|FG001|Overall Study|Physician Decision|1|||
161085226|NCT04927247|581700225|FG000|Overall Study|Adverse Event|1|||
161085227|NCT04927247|581700226|FG001|Overall Study|Adverse Event|0|||
161171409|NCT01135017|582003342|FG000|Overall Study|Other than above|3|||
161171410|NCT01135017|582003343|FG001|Overall Study|Other than above|4|||
161171411|NCT01148693|582003344|FG000|Overall Study|Attempts for cannulation were failed|13|||
161171412|NCT01148693|582003345|FG001|Overall Study|Attempts for cannulation were failed|10|||
161085228|NCT00320528|581700227|FG000|Study Period II|Adverse Event|3|||
161085229|NCT00320528|581700228|FG001|Study Period II|Adverse Event|4|||
161085230|NCT00320528|581700229|FG002|Study Period II|Adverse Event|8|||
161171413|NCT00432562|582003346|FG000|Overall Study|Death|3|||
161291681|NCT03267212|582448079|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
161291682|NCT03759392|582448080|FG000|Overall Study|Adverse Event|12|||
161291683|NCT03759392|582448081|FG001|Overall Study|Adverse Event|4|||
161085231|NCT00320528|581700227|FG000|Study Period II|Parent/Caregiver Decision|8|||
161085232|NCT00320528|581700228|FG001|Study Period II|Parent/Caregiver Decision|3|||
161085233|NCT00320528|581700229|FG002|Study Period II|Parent/Caregiver Decision|11|||
161085234|NCT00320528|581700227|FG000|Study Period II|Withdrawal by Subject|0|||
161085235|NCT00320528|581700228|FG001|Study Period II|Withdrawal by Subject|1|||
161085236|NCT00320528|581700229|FG002|Study Period II|Withdrawal by Subject|1|||
161085237|NCT00320528|581700227|FG000|Study Period II|Entry Criteria Exclusion|0|||
161085238|NCT00320528|581700228|FG001|Study Period II|Entry Criteria Exclusion|2|||
161291684|NCT03759392|582448080|FG000|Overall Study|Death|2|||
161291685|NCT03759392|582448081|FG001|Overall Study|Death|1|||
161291686|NCT03759392|582448080|FG000|Overall Study|Withdrawal by Subject|2|||
161291687|NCT03759392|582448081|FG001|Overall Study|Withdrawal by Subject|0|||
161291688|NCT03759392|582448080|FG000|Overall Study|Protocol Violation|2|||
161291689|NCT03759392|582448081|FG001|Overall Study|Protocol Violation|0|||
161291690|NCT03759392|582448080|FG000|Overall Study|Physician Decision|0|||
161291691|NCT03759392|582448081|FG001|Overall Study|Physician Decision|1|||
161291692|NCT03759392|582448080|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
161291693|NCT03759392|582448081|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
161291694|NCT03759392|582448080|FG000|Overall Study|No longer able to take medicines|1|||
161085239|NCT00320528|581700229|FG002|Study Period II|Entry Criteria Exclusion|2|||
161085240|NCT00320528|581700227|FG000|Study Period III|Adverse Event|1|||
161085241|NCT00320528|581700228|FG001|Study Period III|Adverse Event|0|||
161085242|NCT00320528|581700229|FG002|Study Period III|Adverse Event|0|||
161085243|NCT00320528|581700227|FG000|Study Period III|Lost to Follow-up|1|||
161085244|NCT00320528|581700228|FG001|Study Period III|Lost to Follow-up|0|||
161085245|NCT00320528|581700229|FG002|Study Period III|Lost to Follow-up|0|||
161085246|NCT00320528|581700227|FG000|Study Period III|Withdrawal by Subject|1|||
161085247|NCT00320528|581700228|FG001|Study Period III|Withdrawal by Subject|1|||
161085248|NCT00320528|581700229|FG002|Study Period III|Withdrawal by Subject|2|||
161085249|NCT00320528|581700227|FG000|Study Period III|Lack of Efficacy|2|||
161085250|NCT00320528|581700228|FG001|Study Period III|Lack of Efficacy|0|||
161085251|NCT00320528|581700229|FG002|Study Period III|Lack of Efficacy|0|||
161085252|NCT00320528|581700227|FG000|Study Period III|Parent/Caregiver Decision|14|||
161085253|NCT00320528|581700228|FG001|Study Period III|Parent/Caregiver Decision|3|||
161085254|NCT00320528|581700229|FG002|Study Period III|Parent/Caregiver Decision|11|||
161085255|NCT00320528|581700227|FG000|Study Period III|Protocol Violation|0|||
161085256|NCT00320528|581700228|FG001|Study Period III|Protocol Violation|1|||
161085257|NCT00320528|581700229|FG002|Study Period III|Protocol Violation|0|||
161085258|NCT00320528|581700227|FG000|Study Period III|Physician Decision|0|||
161085259|NCT00320528|581700228|FG001|Study Period III|Physician Decision|1|||
161085260|NCT00320528|581700229|FG002|Study Period III|Physician Decision|2|||
161085261|NCT00320528|581700227|FG000|Study Period III|Sponsor Decision|0|||
161085262|NCT00320528|581700228|FG001|Study Period III|Sponsor Decision|0|||
161085263|NCT00320528|581700229|FG002|Study Period III|Sponsor Decision|1|||
161085264|NCT00320528|581700227|FG000|Study Period III|Atomoxetine Commercially Available|68|||
161085265|NCT00320528|581700228|FG001|Study Period III|Atomoxetine Commercially Available|25|||
161085266|NCT00320528|581700229|FG002|Study Period III|Atomoxetine Commercially Available|90|||
161085267|NCT04828837|581700230|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
161085268|NCT04828837|581700231|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
161085269|NCT04828837|581700230|FG000|Overall Study|Lost to Follow-up|2|||
161085270|NCT04828837|581700231|FG001|Overall Study|Lost to Follow-up|6|||
161085271|NCT04828837|581700230|FG000|Overall Study|Lack of Efficacy|1|||
161085272|NCT04828837|581700231|FG001|Overall Study|Lack of Efficacy|0|||
161085273|NCT04828837|581700230|FG000|Overall Study|Admitted due to pneumothorax.|1|||
161085274|NCT04828837|581700231|FG001|Overall Study|Admitted due to pneumothorax.|0|||
161085275|NCT04828837|581700230|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
161291695|NCT03759392|582448081|FG001|Overall Study|No longer able to take medicines|0|||
161291696|NCT03759392|582448080|FG000|Overall Study|Stopped taking study drug|1|||
161291697|NCT03759392|582448081|FG001|Overall Study|Stopped taking study drug|0|||
161291698|NCT01288079|582448082|FG000|Overall Study|Withdrawal by Subject|2|||
161291699|NCT01288079|582448083|FG001|Overall Study|Withdrawal by Subject|4|||
161085276|NCT04828837|581700231|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
161085277|NCT01397422|581700232|FG000|Overall Study|Adverse Event|0|||
161085278|NCT01397422|581700233|FG001|Overall Study|Adverse Event|3|||
161085279|NCT01397422|581700234|FG002|Overall Study|Adverse Event|3|||
161085280|NCT01397422|581700235|FG003|Overall Study|Adverse Event|8|||
161085281|NCT01397422|581700232|FG000|Overall Study|Withdrawal by Subject|1|||
161085282|NCT01397422|581700233|FG001|Overall Study|Withdrawal by Subject|0|||
161291700|NCT01288079|582448084|FG002|Overall Study|Withdrawal by Subject|1|||
161291701|NCT01288079|582448085|FG003|Overall Study|Withdrawal by Subject|0|||
161085283|NCT01397422|581700234|FG002|Overall Study|Withdrawal by Subject|0|||
161291702|NCT01288079|582448082|FG000|Overall Study|Adverse Event|2|||
161291703|NCT01288079|582448083|FG001|Overall Study|Adverse Event|1|||
161291704|NCT01288079|582448084|FG002|Overall Study|Adverse Event|2|||
161291705|NCT01288079|582448085|FG003|Overall Study|Adverse Event|3|||
161291706|NCT01288079|582448082|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
161291707|NCT01288079|582448083|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
161291708|NCT01288079|582448084|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
161291709|NCT01288079|582448085|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
161291710|NCT01288079|582448082|FG000|Overall Study|Condition under Investigation Worsened|0|||
161291711|NCT01288079|582448083|FG001|Overall Study|Condition under Investigation Worsened|0|||
161291712|NCT01288079|582448084|FG002|Overall Study|Condition under Investigation Worsened|0|||
161291713|NCT01288079|582448085|FG003|Overall Study|Condition under Investigation Worsened|1|||
161291714|NCT01288079|582448082|FG000|Overall Study|Lack of Efficacy|2|||
161291715|NCT01288079|582448083|FG001|Overall Study|Lack of Efficacy|2|||
161291716|NCT01288079|582448084|FG002|Overall Study|Lack of Efficacy|0|||
161291717|NCT01288079|582448085|FG003|Overall Study|Lack of Efficacy|2|||
161291718|NCT01288079|582448082|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
161291719|NCT01288079|582448083|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
161291720|NCT01288079|582448084|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
161291721|NCT01288079|582448085|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
161291722|NCT01288079|582448082|FG000|Overall Study|Lost to Follow-up|1|||
161291723|NCT01288079|582448083|FG001|Overall Study|Lost to Follow-up|1|||
161291724|NCT01288079|582448084|FG002|Overall Study|Lost to Follow-up|1|||
161291725|NCT01288079|582448085|FG003|Overall Study|Lost to Follow-up|0|||
161291726|NCT01288079|582448082|FG000|Overall Study|Other or Study Termination|11|||
161291727|NCT01288079|582448083|FG001|Overall Study|Other or Study Termination|15|||
161291728|NCT01288079|582448084|FG002|Overall Study|Other or Study Termination|14|||
161291729|NCT01288079|582448085|FG003|Overall Study|Other or Study Termination|8|||
161291730|NCT03170544|582448086|FG000|Part 1|Lost to Follow-up|1|||
161291731|NCT03170544|582448087|FG001|Part 1|Lost to Follow-up|0|||
161291732|NCT03170544|582448088|FG002|Part 1|Lost to Follow-up|0|||
161291733|NCT03170544|582448089|FG003|Part 1|Lost to Follow-up|0|||
161291734|NCT03170544|582448090|FG004|Part 1|Lost to Follow-up|0|||
161291735|NCT03170544|582448091|FG005|Part 1|Lost to Follow-up|0|||
161291736|NCT03170544|582448092|FG006|Part 1|Lost to Follow-up|0|||
161291737|NCT03170544|582448093|FG007|Part 1|Lost to Follow-up|0|||
161291738|NCT03170544|582448094|FG008|Part 1|Lost to Follow-up|0|||
161291739|NCT03170544|582448095|FG009|Part 1|Lost to Follow-up|0|||
161291740|NCT03170544|582448096|FG010|Part 1|Lost to Follow-up|0|||
161291741|NCT03170544|582448097|FG011|Part 1|Lost to Follow-up|0|||
161291742|NCT03170544|582448086|FG000|Part 1|Not treated|0|||
161291743|NCT03170544|582448087|FG001|Part 1|Not treated|0|||
161291744|NCT03170544|582448088|FG002|Part 1|Not treated|0|||
161291745|NCT03170544|582448089|FG003|Part 1|Not treated|1|||
161291746|NCT03170544|582448090|FG004|Part 1|Not treated|0|||
161291747|NCT03170544|582448091|FG005|Part 1|Not treated|0|||
161291748|NCT03170544|582448092|FG006|Part 1|Not treated|0|||
161291749|NCT03170544|582448093|FG007|Part 1|Not treated|0|||
161291750|NCT03170544|582448094|FG008|Part 1|Not treated|0|||
161291751|NCT03170544|582448095|FG009|Part 1|Not treated|0|||
161291752|NCT03170544|582448096|FG010|Part 1|Not treated|0|||
161291753|NCT03170544|582448097|FG011|Part 1|Not treated|0|||
161291754|NCT02387840|582448098|FG000|Overall Study|Death|0|||
161291755|NCT02387840|582448099|FG001|Overall Study|Death|0|||
161291756|NCT02387840|582448100|FG002|Overall Study|Death|0|||
161291757|NCT02387840|582448101|FG003|Overall Study|Death|0|||
161291758|NCT02387840|582448102|FG004|Overall Study|Death|0|||
161291759|NCT02387840|582448103|FG005|Overall Study|Death|1|||
161291760|NCT01213966|582448104|FG000|Overall Study|Protocol Violation|1|||
161291761|NCT01213966|582448105|FG001|Overall Study|Protocol Violation|0|||
161291762|NCT01213966|582448106|FG002|Overall Study|Protocol Violation|3|||
161291763|NCT01213966|582448107|FG003|Overall Study|Protocol Violation|1|||
161291764|NCT03760744|582449898|FG000|Overall Study|Lost to Follow-up|3|||
161291765|NCT03760744|582449899|FG001|Overall Study|Lost to Follow-up|0|||
161291766|NCT03055338|582449902|FG000|Overall Study|Lost to Follow-up|9|||
161291767|NCT03055338|582449903|FG001|Overall Study|Lost to Follow-up|2|||
161291768|NCT03055338|582449904|FG002|Overall Study|Lost to Follow-up|3|||
161291769|NCT03055338|582449902|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
161291770|NCT03055338|582449903|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
161291771|NCT03055338|582449904|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
161291772|NCT03055338|582449902|FG000|Overall Study|Physician Decision|0|||
161291773|NCT03055338|582449903|FG001|Overall Study|Physician Decision|0|||
161291774|NCT03055338|582449904|FG002|Overall Study|Physician Decision|2|||
161291775|NCT03055338|582449902|FG000|Overall Study|Withdrawal by Subject|9|||
161291776|NCT03055338|582449903|FG001|Overall Study|Withdrawal by Subject|8|||
161291777|NCT03055338|582449904|FG002|Overall Study|Withdrawal by Subject|7|||
161291778|NCT00975611|582449905|FG000|Overall Study|Screen Fail|16|||
161291779|NCT00975611|582449905|FG000|Overall Study|Physician Decision|1|||
161291780|NCT03058705|582449906|FG000|Overall Study|Withdrawal by Subject|2|||
161291781|NCT03058705|582449906|FG000|Overall Study|Physician Decision|2|||
161291782|NCT01880554|582449907|FG000|Overall Study|Protocol Violation|14|||
161291783|NCT01880554|582449907|FG000|Overall Study|Simon's design requirements|2|||
161291784|NCT05161481|582449908|FG000|Overall Study|Withdrawal of consent|0|||
161291785|NCT05161481|582449909|FG001|Overall Study|Withdrawal of consent|1|||
161291786|NCT05161481|582449910|FG002|Overall Study|Withdrawal of consent|1|||
161291787|NCT05161481|582449908|FG000|Overall Study|Study terminated by sponsor|3|||
161291788|NCT05161481|582449909|FG001|Overall Study|Study terminated by sponsor|3|||
161291789|NCT05161481|582449910|FG002|Overall Study|Study terminated by sponsor|2|||
161291790|NCT05161481|582449908|FG000|Overall Study|Adverse Event|3|||
161291791|NCT05161481|582449909|FG001|Overall Study|Adverse Event|0|||
161291792|NCT05161481|582449910|FG002|Overall Study|Adverse Event|6|||
161291793|NCT05161481|582449908|FG000|Overall Study|Randomised in error and was not treated|1|||
161291794|NCT05161481|582449909|FG001|Overall Study|Randomised in error and was not treated|0|||
161291795|NCT05161481|582449910|FG002|Overall Study|Randomised in error and was not treated|0|||
161291796|NCT05161481|582449908|FG000|Overall Study|Subject decision|0|||
161291797|NCT05161481|582449909|FG001|Overall Study|Subject decision|0|||
161291798|NCT05161481|582449910|FG002|Overall Study|Subject decision|1|||
161291799|NCT01102257|582449915|FG000|Overall Study|Adverse Event|1|||
161291800|NCT01102257|582449916|FG001|Overall Study|Adverse Event|0|||
161291801|NCT01102257|582449915|FG000|Overall Study|Adverse Event|1|||
161291802|NCT01102257|582449916|FG001|Overall Study|Adverse Event|0|||
161291803|NCT03752970|582449917|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
161291804|NCT03752970|582449918|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
161291805|NCT03752970|582449919|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
161291806|NCT03752970|582449917|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
161291807|NCT03752970|582449918|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
161291808|NCT03752970|582449919|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
161291809|NCT03752970|582449917|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
161291810|NCT03752970|582449918|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
161291811|NCT03752970|582449919|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
161291812|NCT03752970|582449917|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
161291813|NCT03752970|582449918|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
161291814|NCT03752970|582449919|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
161291815|NCT03752970|582449917|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
161291816|NCT03752970|582449918|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
161291817|NCT03752970|582449919|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
161291818|NCT04767282|582449920|FG000|Overall Study|Refused or did not begin surveys|6|||
161291819|NCT04767282|582449921|FG001|Overall Study|Refused or did not begin surveys|2|||
161291820|NCT04767282|582449922|FG002|Overall Study|Refused or did not begin surveys|2|||
161291821|NCT04767282|582449920|FG000|Overall Study|Duplicate household previously enrolled|2|||
161291822|NCT04767282|582449921|FG001|Overall Study|Duplicate household previously enrolled|0|||
161291823|NCT04767282|582449922|FG002|Overall Study|Duplicate household previously enrolled|8|||
161291824|NCT04767282|582449920|FG000|Overall Study|Unable to confirm legal guardian|0|||
161291825|NCT04767282|582449921|FG001|Overall Study|Unable to confirm legal guardian|2|||
161291826|NCT04767282|582449922|FG002|Overall Study|Unable to confirm legal guardian|8|||
161291827|NCT04767282|582449920|FG000|Overall Study|Withdrawal by Subject|0|||
161291828|NCT04767282|582449921|FG001|Overall Study|Withdrawal by Subject|0|||
161291829|NCT04767282|582449922|FG002|Overall Study|Withdrawal by Subject|6|||
161291830|NCT04767282|582449920|FG000|Overall Study|Survey comprehension challenges|4|||
161291831|NCT04767282|582449921|FG001|Overall Study|Survey comprehension challenges|0|||
161291832|NCT04767282|582449922|FG002|Overall Study|Survey comprehension challenges|0|||
161291833|NCT01467713|582449924|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
161291834|NCT01467713|582449925|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
161291835|NCT01467713|582449926|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
161291836|NCT01467713|582449927|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
161291837|NCT01467713|582449924|FG000|Overall Study|Major Protocol Deviation|2|||
161291838|NCT01467713|582449925|FG001|Overall Study|Major Protocol Deviation|4|||
161291839|NCT01467713|582449926|FG002|Overall Study|Major Protocol Deviation|4|||
161291840|NCT01467713|582449927|FG003|Overall Study|Major Protocol Deviation|1|||
161291841|NCT01467713|582449924|FG000|Overall Study|Lost to Follow-up|9|||
161291842|NCT01467713|582449925|FG001|Overall Study|Lost to Follow-up|12|||
161291843|NCT01467713|582449926|FG002|Overall Study|Lost to Follow-up|6|||
161291844|NCT01467713|582449927|FG003|Overall Study|Lost to Follow-up|9|||
161291845|NCT01467713|582449924|FG000|Overall Study|Voluntary Withdrawal|18|||
161291846|NCT01467713|582449925|FG001|Overall Study|Voluntary Withdrawal|14|||
161291847|NCT01467713|582449926|FG002|Overall Study|Voluntary Withdrawal|21|||
161291848|NCT01467713|582449927|FG003|Overall Study|Voluntary Withdrawal|20|||
161291849|NCT01467713|582449924|FG000|Overall Study|Study Termination|23|||
161291850|NCT01467713|582449925|FG001|Overall Study|Study Termination|33|||
161291851|NCT01467713|582449926|FG002|Overall Study|Study Termination|28|||
161291852|NCT01467713|582449927|FG003|Overall Study|Study Termination|29|||
161291853|NCT01467713|582449924|FG000|Overall Study|Pregnancy|0|||
161085284|NCT01397422|581700235|FG003|Overall Study|Withdrawal by Subject|0|||
161085285|NCT01397422|581700232|FG000|Overall Study|Increased bradykinesia related to PD|1|||
161085286|NCT01397422|581700233|FG001|Overall Study|Increased bradykinesia related to PD|0|||
161085287|NCT01397422|581700234|FG002|Overall Study|Increased bradykinesia related to PD|0|||
161085288|NCT01397422|581700235|FG003|Overall Study|Increased bradykinesia related to PD|0|||
161085289|NCT03762200|581700246|FG000|Overall Study|Death|2|||
161085290|NCT02489968|581700247|FG000|Open-label Treatment Period|Adverse Event|14|||
161085291|NCT02489968|581700248|FG001|Open-label Treatment Period|Adverse Event|7|||
161085292|NCT02489968|581700249|FG002|Open-label Treatment Period|Adverse Event|0|||
161085293|NCT02489968|581700250|FG003|Open-label Treatment Period|Adverse Event|0|||
161085294|NCT02489968|581700251|FG004|Open-label Treatment Period|Adverse Event|0|||
161085295|NCT02489968|581700252|FG005|Open-label Treatment Period|Adverse Event|0|||
161085296|NCT02489968|581700247|FG000|Open-label Treatment Period|Protocol Violation|2|||
161085297|NCT02489968|581700248|FG001|Open-label Treatment Period|Protocol Violation|2|||
161085298|NCT02489968|581700249|FG002|Open-label Treatment Period|Protocol Violation|0|||
161085299|NCT02489968|581700250|FG003|Open-label Treatment Period|Protocol Violation|0|||
161085300|NCT02489968|581700251|FG004|Open-label Treatment Period|Protocol Violation|0|||
161085301|NCT02489968|581700252|FG005|Open-label Treatment Period|Protocol Violation|0|||
161085302|NCT02489968|581700247|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161085303|NCT02489968|581700248|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
161085304|NCT02489968|581700249|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161085305|NCT02489968|581700250|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161085306|NCT02489968|581700251|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
161085307|NCT02489968|581700252|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
161085308|NCT02489968|581700247|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
161085309|NCT02489968|581700248|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
161085310|NCT02489968|581700249|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161085311|NCT02489968|581700250|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
161085312|NCT02489968|581700251|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
161085313|NCT02489968|581700252|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
161085314|NCT02489968|581700247|FG000|Open-label Treatment Period|Other than specified above|204|||
161085315|NCT02489968|581700248|FG001|Open-label Treatment Period|Other than specified above|189|||
161085316|NCT02489968|581700249|FG002|Open-label Treatment Period|Other than specified above|0|||
161085317|NCT02489968|581700250|FG003|Open-label Treatment Period|Other than specified above|0|||
161085318|NCT02489968|581700251|FG004|Open-label Treatment Period|Other than specified above|0|||
161085319|NCT02489968|581700252|FG005|Open-label Treatment Period|Other than specified above|0|||
161085320|NCT02489968|581700247|FG000|Double-blind Treatment Period|Adverse Event|0|||
161085321|NCT02489968|581700248|FG001|Double-blind Treatment Period|Adverse Event|0|||
161085322|NCT02489968|581700249|FG002|Double-blind Treatment Period|Adverse Event|2|||
161085323|NCT02489968|581700250|FG003|Double-blind Treatment Period|Adverse Event|6|||
161085324|NCT02489968|581700251|FG004|Double-blind Treatment Period|Adverse Event|4|||
161085325|NCT02489968|581700252|FG005|Double-blind Treatment Period|Adverse Event|5|||
161085326|NCT02489968|581700247|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161085327|NCT02489968|581700248|FG001|Double-blind Treatment Period|Protocol Violation|0|||
161085328|NCT02489968|581700249|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161085329|NCT02489968|581700250|FG003|Double-blind Treatment Period|Protocol Violation|0|||
161085330|NCT02489968|581700251|FG004|Double-blind Treatment Period|Protocol Violation|1|||
161085331|NCT02489968|581700252|FG005|Double-blind Treatment Period|Protocol Violation|1|||
161085332|NCT02489968|581700247|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161085333|NCT02489968|581700248|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161085334|NCT02489968|581700249|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161085335|NCT02489968|581700250|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
161085336|NCT02489968|581700251|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
161085337|NCT02489968|581700252|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
161085338|NCT02489968|581700247|FG000|Double-blind Treatment Period|Other than specified above|0|||
161085339|NCT02489968|581700248|FG001|Double-blind Treatment Period|Other than specified above|0|||
161291854|NCT01467713|582449925|FG001|Overall Study|Pregnancy|1|||
161291855|NCT01467713|582449926|FG002|Overall Study|Pregnancy|1|||
161291856|NCT01467713|582449927|FG003|Overall Study|Pregnancy|3|||
161291857|NCT01467713|582449924|FG000|Overall Study|Relapse|35|||
161291858|NCT01467713|582449925|FG001|Overall Study|Relapse|25|||
161291859|NCT01467713|582449926|FG002|Overall Study|Relapse|28|||
161291860|NCT01467713|582449927|FG003|Overall Study|Relapse|35|||
161085340|NCT02489968|581700249|FG002|Double-blind Treatment Period|Other than specified above|0|||
161291861|NCT01467713|582449924|FG000|Overall Study|Reason not Specified|6|||
161291862|NCT01467713|582449925|FG001|Overall Study|Reason not Specified|11|||
161085341|NCT02489968|581700250|FG003|Double-blind Treatment Period|Other than specified above|0|||
161291863|NCT01467713|582449926|FG002|Overall Study|Reason not Specified|8|||
161085342|NCT02489968|581700251|FG004|Double-blind Treatment Period|Other than specified above|1|||
161091325|NCT01270971|581723886|FG001|Overall Study|Non-specific|3|||
161091326|NCT01551212|581723887|FG000|Overall Study|Graft loss/Retransplantation|0|||
161291864|NCT01467713|582449927|FG003|Overall Study|Reason not Specified|7|||
161291865|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
161291866|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
161291867|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
161291868|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
161291869|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
161291870|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
161291871|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
161291872|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
161291873|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
161291874|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
161291875|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
161291876|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
161291877|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161291878|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161291879|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
161291880|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
161291881|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
161291882|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
161291883|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
161291884|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
161291885|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
161291886|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
161291887|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
161291888|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
161291889|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
161291890|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
161291891|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
161291892|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
161291893|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
161291894|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
161291895|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
161291896|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
161291897|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161291898|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
161291899|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161291900|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
161291901|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161291902|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161291903|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
161291904|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
161291905|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
161291906|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161291907|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161291908|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
161291909|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
161291910|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
161291911|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
161291912|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
161291913|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161291914|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161291915|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
161291916|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
161291917|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Site closed|0|||
161291918|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Site closed|0|||
161291919|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Site closed|1|||
161291920|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Site closed|0|||
161291921|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
161291922|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161291923|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161291924|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
161291925|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
161291926|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
161291927|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
161291928|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
161291929|NCT00838903|582449930|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
161291930|NCT00838903|582449931|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161291931|NCT00838903|582449932|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161291932|NCT00838903|582449933|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
161291933|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
161291934|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
161291935|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
161291936|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
161291937|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
161291938|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
161291939|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
161291940|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
161291941|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
161291942|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
161291943|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
161291944|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
161291945|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
161291946|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
161291947|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
161291948|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
161291949|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
161291950|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
161291951|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
161291952|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
161291953|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
161291954|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
161291955|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
161291956|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
161291957|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
161291958|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161291959|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
161291960|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
161291961|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161291962|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
161291963|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161291964|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
161291965|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161291966|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
161291967|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161291968|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
161291969|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161291970|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161291971|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
161291972|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
161291973|NCT00838903|582449930|FG000|Follow-up Period (8 Weeks)|Missing|1|||
161291974|NCT00838903|582449931|FG001|Follow-up Period (8 Weeks)|Missing|2|||
161291975|NCT00838903|582449932|FG002|Follow-up Period (8 Weeks)|Missing|1|||
161291976|NCT00838903|582449933|FG003|Follow-up Period (8 Weeks)|Missing|1|||
161291977|NCT02512302|582449934|FG000|Period 1|Adverse Event|0|||
161291978|NCT02512302|582449935|FG001|Period 1|Adverse Event|1|||
161291979|NCT02512302|582449936|FG002|Period 1|Adverse Event|0|||
161291980|NCT02512302|582449937|FG003|Period 1|Adverse Event|0|||
161291981|NCT02512302|582449938|FG004|Period 1|Adverse Event|0|||
161291982|NCT02512302|582449939|FG005|Period 1|Adverse Event|0|||
161291983|NCT02512302|582449940|FG006|Period 1|Adverse Event|0|||
161291984|NCT02512302|582449941|FG007|Period 1|Adverse Event|0|||
161291985|NCT02512302|582449942|FG008|Period 1|Adverse Event|0|||
161291986|NCT02512302|582449943|FG009|Period 1|Adverse Event|0|||
161291987|NCT02512302|582449934|FG000|Period 2|Adverse Event|0|||
161291988|NCT02512302|582449935|FG001|Period 2|Adverse Event|0|||
161291989|NCT02512302|582449936|FG002|Period 2|Adverse Event|0|||
161291990|NCT02512302|582449937|FG003|Period 2|Adverse Event|0|||
161291991|NCT02512302|582449938|FG004|Period 2|Adverse Event|0|||
161291992|NCT02512302|582449939|FG005|Period 2|Adverse Event|0|||
161291993|NCT02512302|582449940|FG006|Period 2|Adverse Event|0|||
161291994|NCT02512302|582449941|FG007|Period 2|Adverse Event|0|||
161291995|NCT02512302|582449942|FG008|Period 2|Adverse Event|0|||
161291996|NCT02512302|582449943|FG009|Period 2|Adverse Event|1|||
161291997|NCT02512302|582449934|FG000|Period 3|Lost to Follow-up|0|||
161291998|NCT02512302|582449935|FG001|Period 3|Lost to Follow-up|0|||
161291999|NCT02512302|582449936|FG002|Period 3|Lost to Follow-up|1|||
161292000|NCT02512302|582449937|FG003|Period 3|Lost to Follow-up|0|||
161292001|NCT02512302|582449938|FG004|Period 3|Lost to Follow-up|0|||
161292002|NCT02512302|582449939|FG005|Period 3|Lost to Follow-up|0|||
161292003|NCT02512302|582449940|FG006|Period 3|Lost to Follow-up|0|||
161292004|NCT02512302|582449941|FG007|Period 3|Lost to Follow-up|0|||
161292005|NCT02512302|582449942|FG008|Period 3|Lost to Follow-up|0|||
161292006|NCT02512302|582449943|FG009|Period 3|Lost to Follow-up|0|||
161292007|NCT02512302|582449934|FG000|Period 4|Adverse Event|0|||
161292008|NCT02512302|582449935|FG001|Period 4|Adverse Event|0|||
161292009|NCT02512302|582449936|FG002|Period 4|Adverse Event|0|||
161292010|NCT02512302|582449937|FG003|Period 4|Adverse Event|0|||
161292011|NCT02512302|582449938|FG004|Period 4|Adverse Event|0|||
161292012|NCT02512302|582449939|FG005|Period 4|Adverse Event|0|||
161292013|NCT02512302|582449940|FG006|Period 4|Adverse Event|1|||
161292014|NCT02512302|582449941|FG007|Period 4|Adverse Event|0|||
161292015|NCT02512302|582449942|FG008|Period 4|Adverse Event|0|||
161292016|NCT02512302|582449943|FG009|Period 4|Adverse Event|0|||
161292017|NCT01894841|582449944|FG000|Overall Study|Withdrawal by Subject|9|||
161292018|NCT01894841|582449945|FG001|Overall Study|Withdrawal by Subject|4|||
161292019|NCT01894841|582449944|FG000|Overall Study|Withdrawn by investigator|2|||
161292020|NCT01894841|582449945|FG001|Overall Study|Withdrawn by investigator|2|||
161292021|NCT01894841|582449944|FG000|Overall Study|Lost to Follow-up|7|||
161292022|NCT01894841|582449945|FG001|Overall Study|Lost to Follow-up|3|||
161292023|NCT01100086|582449946|FG000|Period 1|Withdrawal by Subject|1|||
161292024|NCT01100086|582449947|FG001|Period 1|Withdrawal by Subject|0|||
161292025|NCT00495391|582449954|FG000|Overall Study|Lack of Efficacy|34|||
161292026|NCT00495391|582449955|FG001|Overall Study|Lack of Efficacy|18|||
161292027|NCT00495391|582449954|FG000|Overall Study|Withdrawal by Subject|2|||
161292028|NCT00495391|582449955|FG001|Overall Study|Withdrawal by Subject|3|||
161292029|NCT03214224|582449956|FG000|Overall Study|Protocol Violation|1|||
161292030|NCT03214224|582449956|FG000|Overall Study|Withdrawal by Subject|2|||
161292031|NCT03214224|582449956|FG000|Overall Study|Practice controls or therapists|6|||
161292032|NCT02712320|582449965|FG000|Overall Study|Lost to Follow-up|1|||
161292033|NCT02712320|582449965|FG000|Overall Study|Withdrawal by Subject|1|||
161292034|NCT02712320|582449965|FG000|Overall Study|Transferred to another facility|1|||
161292035|NCT02712320|582449965|FG000|Overall Study|Treating with the prohibited medications|2|||
161292036|NCT03802825|582449966|FG000|Overall Study|Lost to follow-up for intervention|12|||
161292037|NCT03802825|582449967|FG001|Overall Study|Lost to follow-up for intervention|3|||
161292038|NCT03802825|582449966|FG000|Overall Study|Received only 1 component of intervention|0|||
161292039|NCT03802825|582449967|FG001|Overall Study|Received only 1 component of intervention|13|||
161292040|NCT00568451|582449968|FG000|Overall Study|Disease Progression|0|||
161292041|NCT00568451|582449969|FG001|Overall Study|Disease Progression|0|||
161292042|NCT00568451|582449970|FG002|Overall Study|Disease Progression|2|||
161292043|NCT00568451|582449971|FG003|Overall Study|Disease Progression|7|||
161292044|NCT05266053|582449972|FG000|Overall Study|Withdrawal by Subject|8|||
161292045|NCT05266053|582449973|FG001|Overall Study|Withdrawal by Subject|4|||
161292046|NCT05344560|582449974|FG000|Period 1|Subject out of visit window|1|||
161292047|NCT05344560|582449975|FG001|Period 1|Subject out of visit window|1|||
161292048|NCT05344560|582449974|FG000|Period 2|Covid-19 Related|1|||
161292049|NCT05344560|582449975|FG001|Period 2|Covid-19 Related|0|||
161292050|NCT05344560|582449974|FG000|Period 2|Adverse Event|1|||
161292051|NCT05344560|582449975|FG001|Period 2|Adverse Event|0|||
161292052|NCT05344560|582449974|FG000|Period 2|Subject out of visit window|1|||
161292053|NCT05344560|582449975|FG001|Period 2|Subject out of visit window|1|||
161292054|NCT05344560|582449974|FG000|Period 3|Subject out of visit window|1|||
161292055|NCT05344560|582449975|FG001|Period 3|Subject out of visit window|0|||
161292056|NCT01051960|582449979|FG000|Overall Study|Adverse Event|1|||
161292057|NCT02996968|582449980|FG000|Overall Study|Withdrawal by Subject|1|||
161292058|NCT02996968|582449981|FG001|Overall Study|Withdrawal by Subject|0|||
161292059|NCT04177095|582449995|FG000|Overall Study|Withdrawal by Subject|3|||
161292060|NCT04177095|582449995|FG000|Overall Study|Screen Failure|3|||
161292061|NCT04177095|582449995|FG000|Overall Study|Problems with the Trugraf assay|1|||
161292062|NCT02275819|582449996|FG000|Overall Study|Adverse Event|0|||
161292063|NCT02275819|582449997|FG001|Overall Study|Adverse Event|1|||
161292064|NCT01346059|582449998|FG000|Overall Study|Withdrawal by Subject|1|||
161292065|NCT01346059|582449999|FG001|Overall Study|Withdrawal by Subject|0|||
161292066|NCT02556775|582450000|FG000|Overall Study|Withdrawal by Subject|1|||
161292067|NCT02556775|582450001|FG001|Overall Study|Withdrawal by Subject|0|||
161292068|NCT02556775|582450002|FG002|Overall Study|Withdrawal by Subject|1|||
161292069|NCT02556775|582450003|FG003|Overall Study|Withdrawal by Subject|0|||
161292070|NCT02556775|582450000|FG000|Overall Study|Lost to Follow-up|1|||
161292071|NCT02556775|582450001|FG001|Overall Study|Lost to Follow-up|0|||
161292072|NCT02556775|582450002|FG002|Overall Study|Lost to Follow-up|0|||
161292073|NCT02556775|582450003|FG003|Overall Study|Lost to Follow-up|0|||
161292074|NCT02025725|582450004|FG000|Overall Study|Adverse Event|5|||
161292075|NCT02025725|582450005|FG001|Overall Study|Adverse Event|0|||
161292076|NCT02025725|582450004|FG000|Overall Study|Lost to Follow-up|2|||
161292077|NCT02025725|582450005|FG001|Overall Study|Lost to Follow-up|0|||
161292078|NCT02025725|582450004|FG000|Overall Study|Protocol Violation|1|||
161292079|NCT02025725|582450005|FG001|Overall Study|Protocol Violation|1|||
161292080|NCT02025725|582450004|FG000|Overall Study|Withdrawal by Subject|3|||
161292081|NCT02025725|582450005|FG001|Overall Study|Withdrawal by Subject|2|||
161292082|NCT02025725|582450004|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
161292083|NCT02025725|582450005|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
161292084|NCT01592786|582450006|FG000|Overall Study|Adverse Event|60|||
161292085|NCT01592786|582450006|FG000|Overall Study|Lack of Efficacy|19|||
161292086|NCT01592786|582450006|FG000|Overall Study|Protocol Violation|14|||
161292087|NCT01592786|582450006|FG000|Overall Study|Withdrawal by Subject|23|||
161292088|NCT01592786|582450006|FG000|Overall Study|Lost to Follow-up|19|||
161292089|NCT01592786|582450006|FG000|Overall Study|Other|3|||
161292090|NCT02172664|582450014|FG000|Overall Study|Lost to Follow-up|4|||
161292091|NCT02172664|582450015|FG001|Overall Study|Lost to Follow-up|4|||
161292092|NCT02172664|582450014|FG000|Overall Study|Death|1|||
161292093|NCT02172664|582450015|FG001|Overall Study|Death|1|||
161292094|NCT02172664|582450014|FG000|Overall Study|Moved out of area|1|||
161292095|NCT02172664|582450015|FG001|Overall Study|Moved out of area|1|||
161292096|NCT01909934|582450016|FG000|Overall Study|Withdrawal by Subject|3|||
161292097|NCT01909934|582450016|FG000|Overall Study|Lost to Follow-up|1|||
161292098|NCT01909934|582450016|FG000|Overall Study|Death|25|||
161292099|NCT01909934|582450016|FG000|Overall Study|Withdrawal of Informed Consent|1|||
161292100|NCT01909934|582450016|FG000|Overall Study|Reason Not Specified|1|||
161292101|NCT03810092|582450017|FG000|Overall Study|no ground support|17|||
161292102|NCT03810092|582450017|FG000|Overall Study|ADL not done at J0|16|||
161292103|NCT03810092|582450017|FG000|Overall Study|No hemoglobin measure at J5|27|||
161347285|NCT03317496|582656250|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161347286|NCT03317496|582656251|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161347287|NCT03317496|582656252|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
161347288|NCT03317496|582656248|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161347289|NCT03317496|582656249|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161347290|NCT03317496|582656250|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
161347291|NCT03317496|582656251|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161347292|NCT03317496|582656252|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
161347293|NCT03317496|582656248|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
161347294|NCT03317496|582656249|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
161347295|NCT03317496|582656250|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
161347296|NCT03317496|582656251|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
161347297|NCT03317496|582656252|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
161347298|NCT03317496|582656248|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
161347299|NCT03317496|582656249|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
161347300|NCT03317496|582656250|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
161347301|NCT03317496|582656251|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
161347302|NCT03317496|582656252|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
161347303|NCT03317496|582656248|FG000|Phase 2: Treatment|Adverse Event|0|||
161347304|NCT03317496|582656249|FG001|Phase 2: Treatment|Adverse Event|0|||
161347305|NCT03317496|582656250|FG002|Phase 2: Treatment|Adverse Event|0|||
161347306|NCT03317496|582656251|FG003|Phase 2: Treatment|Adverse Event|0|||
161347307|NCT03317496|582656252|FG004|Phase 2: Treatment|Adverse Event|6|||
161347308|NCT03317496|582656248|FG000|Phase 2: Treatment|Progressive disease|0|||
161347309|NCT03317496|582656249|FG001|Phase 2: Treatment|Progressive disease|0|||
161347310|NCT03317496|582656250|FG002|Phase 2: Treatment|Progressive disease|0|||
161347311|NCT03317496|582656251|FG003|Phase 2: Treatment|Progressive disease|0|||
161347312|NCT03317496|582656252|FG004|Phase 2: Treatment|Progressive disease|22|||
161347313|NCT03317496|582656248|FG000|Phase 2: Treatment|Other|0|||
161347314|NCT03317496|582656249|FG001|Phase 2: Treatment|Other|0|||
161347315|NCT03317496|582656250|FG002|Phase 2: Treatment|Other|0|||
161347316|NCT03317496|582656251|FG003|Phase 2: Treatment|Other|0|||
161347317|NCT03317496|582656252|FG004|Phase 2: Treatment|Other|4|||
161347318|NCT03317496|582656248|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
161347319|NCT03317496|582656249|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
161347320|NCT03317496|582656250|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
161347321|NCT03317496|582656251|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
161347322|NCT03317496|582656252|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
161347323|NCT03317496|582656248|FG000|Phase 2: Treatment|Physician Decision|0|||
161347324|NCT03317496|582656249|FG001|Phase 2: Treatment|Physician Decision|0|||
161347325|NCT03317496|582656250|FG002|Phase 2: Treatment|Physician Decision|0|||
161347326|NCT03317496|582656251|FG003|Phase 2: Treatment|Physician Decision|0|||
161347327|NCT03317496|582656252|FG004|Phase 2: Treatment|Physician Decision|1|||
161347328|NCT03317496|582656248|FG000|Phase 2: Treatment|Death|0|||
161347329|NCT03317496|582656249|FG001|Phase 2: Treatment|Death|0|||
161347330|NCT03317496|582656250|FG002|Phase 2: Treatment|Death|0|||
161347331|NCT03317496|582656251|FG003|Phase 2: Treatment|Death|0|||
161292104|NCT04578535|582450019|FG000|Overall Study|Lost to Follow-up|1|||
161292105|NCT04578535|582450020|FG001|Overall Study|Lost to Follow-up|0|||
161292106|NCT04578535|582450021|FG002|Overall Study|Lost to Follow-up|0|||
161292107|NCT04578535|582450022|FG003|Overall Study|Lost to Follow-up|1|||
161292108|NCT04578535|582450023|FG004|Overall Study|Lost to Follow-up|0|||
161292109|NCT04578535|582450024|FG005|Overall Study|Lost to Follow-up|2|||
161292110|NCT04578535|582450019|FG000|Overall Study|Pregnancy|1|||
161292111|NCT04578535|582450020|FG001|Overall Study|Pregnancy|0|||
161292112|NCT04578535|582450021|FG002|Overall Study|Pregnancy|0|||
161292113|NCT04578535|582450022|FG003|Overall Study|Pregnancy|0|||
161292114|NCT04578535|582450023|FG004|Overall Study|Pregnancy|0|||
161292115|NCT04578535|582450024|FG005|Overall Study|Pregnancy|0|||
161292116|NCT04578535|582450019|FG000|Overall Study|Withdrawal by Subject|0|||
161292117|NCT04578535|582450020|FG001|Overall Study|Withdrawal by Subject|0|||
161292118|NCT04578535|582450021|FG002|Overall Study|Withdrawal by Subject|0|||
161347332|NCT03317496|582656252|FG004|Phase 2: Treatment|Death|1|||
161347333|NCT03317496|582656248|FG000|Phase 2: Follow-up|Death|0|||
161347334|NCT03317496|582656249|FG001|Phase 2: Follow-up|Death|0|||
161347335|NCT03317496|582656250|FG002|Phase 2: Follow-up|Death|0|||
161347336|NCT03317496|582656251|FG003|Phase 2: Follow-up|Death|0|||
161347337|NCT03317496|582656252|FG004|Phase 2: Follow-up|Death|24|||
161347338|NCT03317496|582656248|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
161347339|NCT03317496|582656249|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
161347340|NCT03317496|582656250|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
161347341|NCT03317496|582656251|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
161347342|NCT03317496|582656252|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
161347343|NCT03317496|582656248|FG000|Phase 2: Follow-up|Other|0|||
161347344|NCT03317496|582656249|FG001|Phase 2: Follow-up|Other|0|||
161347345|NCT03317496|582656250|FG002|Phase 2: Follow-up|Other|0|||
161347346|NCT03317496|582656251|FG003|Phase 2: Follow-up|Other|0|||
161347347|NCT03317496|582656252|FG004|Phase 2: Follow-up|Other|1|||
161347348|NCT03317496|582656248|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
161347349|NCT03317496|582656249|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
161347350|NCT03317496|582656250|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
161347351|NCT03317496|582656251|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
161347352|NCT03317496|582656252|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
161347353|NCT02693418|582656253|FG000|Overall Study|Lost to Follow-up|1|||
161347354|NCT02693418|582656254|FG001|Overall Study|Lost to Follow-up|2|||
161347355|NCT02693418|582656255|FG002|Overall Study|Lost to Follow-up|0|||
161347356|NCT02693418|582656256|FG003|Overall Study|Lost to Follow-up|0|||
161347357|NCT02693418|582656257|FG004|Overall Study|Lost to Follow-up|0|||
161347358|NCT02693418|582656253|FG000|Overall Study|Menses during study period|0|||
161347359|NCT02693418|582656254|FG001|Overall Study|Menses during study period|0|||
161347360|NCT02693418|582656255|FG002|Overall Study|Menses during study period|2|||
161347361|NCT02693418|582656256|FG003|Overall Study|Menses during study period|0|||
161347362|NCT02693418|582656257|FG004|Overall Study|Menses during study period|0|||
161347363|NCT01750346|582656258|FG000|Overall Study|Adverse Event|1|||
161292119|NCT04578535|582450022|FG003|Overall Study|Withdrawal by Subject|1|||
161292120|NCT04578535|582450023|FG004|Overall Study|Withdrawal by Subject|1|||
161292121|NCT04578535|582450024|FG005|Overall Study|Withdrawal by Subject|5|||
161292122|NCT04578535|582450019|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
161292123|NCT04578535|582450020|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
161292124|NCT04578535|582450021|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
161292125|NCT04578535|582450022|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
161292126|NCT04578535|582450023|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
161292127|NCT04578535|582450024|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
161292128|NCT00235755|582450025|FG000|4-Week Titration Phase|Adverse Event|6|||
161292129|NCT00235755|582450026|FG001|4-Week Titration Phase|Adverse Event|14|||
161292130|NCT00235755|582450027|FG002|4-Week Titration Phase|Adverse Event|20|||
161292131|NCT00235755|582450025|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
161292132|NCT00235755|582450026|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
161292133|NCT00235755|582450027|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
161292134|NCT00235755|582450025|FG000|4-Week Titration Phase|Protocol Violation|2|||
161292135|NCT00235755|582450026|FG001|4-Week Titration Phase|Protocol Violation|2|||
161292136|NCT00235755|582450027|FG002|4-Week Titration Phase|Protocol Violation|1|||
161292137|NCT00235755|582450025|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
161292138|NCT00235755|582450026|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
161292139|NCT00235755|582450027|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
161292140|NCT00235755|582450025|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161292141|NCT00235755|582450026|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161292142|NCT00235755|582450027|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
161292143|NCT00235755|582450025|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
161292144|NCT00235755|582450026|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
161292145|NCT00235755|582450027|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
161292146|NCT00235755|582450025|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
161292147|NCT00235755|582450026|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
161292148|NCT00235755|582450027|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
161292149|NCT00235755|582450025|FG000|12-Week Maintenance Phase|Adverse Event|8|||
161292150|NCT00235755|582450026|FG001|12-Week Maintenance Phase|Adverse Event|12|||
161292151|NCT00235755|582450027|FG002|12-Week Maintenance Phase|Adverse Event|26|||
161292152|NCT00235755|582450025|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
161292153|NCT00235755|582450026|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
161347364|NCT01750346|582656259|FG001|Overall Study|Adverse Event|0|||
161347365|NCT01750346|582656260|FG002|Overall Study|Adverse Event|0|||
161347366|NCT01001104|582656263|FG000|Overall Study|Adverse Event|2|||
161292154|NCT00235755|582450027|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
161292155|NCT00235755|582450025|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
161085343|NCT02489968|581700252|FG005|Double-blind Treatment Period|Other than specified above|0|||
161085344|NCT03738423|581700253|FG000|Overall Study|Withdrawal by Subject|9|||
161292156|NCT00235755|582450026|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
161292157|NCT00235755|582450027|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
161085345|NCT03738423|581700254|FG001|Overall Study|Withdrawal by Subject|12|||
161085346|NCT03738423|581700255|FG002|Overall Study|Withdrawal by Subject|9|||
161085347|NCT03738423|581700256|FG003|Overall Study|Withdrawal by Subject|12|||
161085348|NCT03738423|581700257|FG004|Overall Study|Withdrawal by Subject|10|||
161085349|NCT03738423|581700253|FG000|Overall Study|Lack of Efficacy|3|||
161085350|NCT03738423|581700254|FG001|Overall Study|Lack of Efficacy|1|||
161085351|NCT03738423|581700255|FG002|Overall Study|Lack of Efficacy|1|||
161085352|NCT03738423|581700256|FG003|Overall Study|Lack of Efficacy|1|||
161085353|NCT03738423|581700257|FG004|Overall Study|Lack of Efficacy|2|||
161085354|NCT03738423|581700253|FG000|Overall Study|Lost to Follow-up|1|||
161085355|NCT03738423|581700254|FG001|Overall Study|Lost to Follow-up|0|||
161085356|NCT03738423|581700255|FG002|Overall Study|Lost to Follow-up|1|||
161085357|NCT03738423|581700256|FG003|Overall Study|Lost to Follow-up|1|||
161085358|NCT03738423|581700257|FG004|Overall Study|Lost to Follow-up|0|||
161085359|NCT03738423|581700253|FG000|Overall Study|Protocol Violation|1|||
161085360|NCT03738423|581700254|FG001|Overall Study|Protocol Violation|0|||
161085361|NCT03738423|581700255|FG002|Overall Study|Protocol Violation|0|||
161085362|NCT03738423|581700256|FG003|Overall Study|Protocol Violation|0|||
161085363|NCT03738423|581700257|FG004|Overall Study|Protocol Violation|1|||
161085364|NCT03738423|581700253|FG000|Overall Study|Physician Decision|0|||
161085365|NCT03738423|581700254|FG001|Overall Study|Physician Decision|0|||
161085366|NCT03738423|581700255|FG002|Overall Study|Physician Decision|1|||
161085367|NCT03738423|581700256|FG003|Overall Study|Physician Decision|0|||
161085368|NCT03738423|581700257|FG004|Overall Study|Physician Decision|1|||
161085369|NCT03738423|581700253|FG000|Overall Study|Death|0|||
161085370|NCT03738423|581700254|FG001|Overall Study|Death|0|||
161085371|NCT03738423|581700255|FG002|Overall Study|Death|0|||
161085372|NCT03738423|581700256|FG003|Overall Study|Death|0|||
161085373|NCT03738423|581700257|FG004|Overall Study|Death|1|||
161085374|NCT03738423|581700253|FG000|Overall Study|Randomized but never treated|0|||
161085375|NCT03738423|581700254|FG001|Overall Study|Randomized but never treated|0|||
161085376|NCT03738423|581700255|FG002|Overall Study|Randomized but never treated|1|||
161085377|NCT03738423|581700256|FG003|Overall Study|Randomized but never treated|1|||
161085378|NCT03738423|581700257|FG004|Overall Study|Randomized but never treated|0|||
161085379|NCT02592876|581700263|FG000|Overall Study|Withdrawal by Subject|3|||
161085380|NCT02592876|581700264|FG001|Overall Study|Withdrawal by Subject|3|||
161085381|NCT02592876|581700263|FG000|Overall Study|Study Termination by Sponsor|32|||
161085382|NCT02592876|581700264|FG001|Overall Study|Study Termination by Sponsor|27|||
161085383|NCT02592876|581700263|FG000|Overall Study|Lost to Follow-up|0|||
161085384|NCT02592876|581700264|FG001|Overall Study|Lost to Follow-up|1|||
161085385|NCT02592876|581700263|FG000|Overall Study|Death|6|||
161085386|NCT02592876|581700264|FG001|Overall Study|Death|9|||
161085387|NCT01865747|581700265|FG000|Overall Study (ITT)|Adverse Event|32|||
161085388|NCT01865747|581700266|FG001|Overall Study (ITT)|Adverse Event|31|||
161085389|NCT01865747|581700265|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
161085390|NCT01865747|581700266|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
161085391|NCT01865747|581700265|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
161085392|NCT01865747|581700266|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
161085393|NCT01865747|581700265|FG000|Overall Study (ITT)|Protocol Violation|1|||
161085394|NCT01865747|581700266|FG001|Overall Study (ITT)|Protocol Violation|1|||
161085395|NCT01865747|581700265|FG000|Overall Study (ITT)|Physician Decision|5|||
161085396|NCT01865747|581700266|FG001|Overall Study (ITT)|Physician Decision|2|||
161085397|NCT01865747|581700265|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
161085398|NCT01865747|581700266|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
161085399|NCT01865747|581700265|FG000|Overall Study (ITT)|Sponsor Decision|0|||
161085400|NCT01865747|581700266|FG001|Overall Study (ITT)|Sponsor Decision|1|||
161085401|NCT01865747|581700265|FG000|Overall Study (ITT)|Progressive Disease|122|||
161085402|NCT01865747|581700266|FG001|Overall Study (ITT)|Progressive Disease|158|||
161085403|NCT01865747|581700265|FG000|Overall Study (ITT)|Reason Not Provided|0|||
161085404|NCT01865747|581700266|FG001|Overall Study (ITT)|Reason Not Provided|1|||
161085405|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
161085406|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
161171414|NCT00432562|582003347|FG001|Overall Study|Death|0|||
161171415|NCT03970824|582003348|FG000|Overall Study|Withdrawal by Subject|1|||
161085407|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
161085408|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
161085409|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
161085410|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
161085411|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
161171416|NCT03970824|582003349|FG001|Overall Study|Withdrawal by Subject|1|||
161292158|NCT00235755|582450025|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
161292159|NCT00235755|582450026|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
161292160|NCT00235755|582450027|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
161292161|NCT00235755|582450025|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
161292162|NCT00235755|582450026|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
161292163|NCT00235755|582450027|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
161292164|NCT00235755|582450025|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
161292165|NCT00235755|582450026|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
161292166|NCT00235755|582450027|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
161292167|NCT00806403|582450032|FG000|Overall Study|Death|4|||
161292168|NCT00806403|582450033|FG001|Overall Study|Death|3|||
161292169|NCT01787292|582450034|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
161292170|NCT01787292|582450035|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
161292171|NCT01787292|582450034|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
161292172|NCT01787292|582450035|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
161292173|NCT01597778|582450036|FG000|Overall Study|Death|7|||
161292174|NCT01597778|582450037|FG001|Overall Study|Death|10|||
161292175|NCT01597778|582450036|FG000|Overall Study|Withdrawal by Subject|3|||
161292176|NCT01597778|582450037|FG001|Overall Study|Withdrawal by Subject|4|||
161292177|NCT01597778|582450036|FG000|Overall Study|Adverse Event|1|||
161292178|NCT01597778|582450037|FG001|Overall Study|Adverse Event|1|||
161292179|NCT01597778|582450036|FG000|Overall Study|Protocol Violation|1|||
161292180|NCT01597778|582450037|FG001|Overall Study|Protocol Violation|11|||
161292181|NCT01597778|582450036|FG000|Overall Study|Transplanted off protocol|2|||
161292182|NCT01597778|582450037|FG001|Overall Study|Transplanted off protocol|3|||
161292183|NCT05691712|582450038|FG000|Overall Study|Adverse Event|0|||
161292184|NCT05691712|582450039|FG001|Overall Study|Adverse Event|1|||
161292185|NCT05691712|582450040|FG002|Overall Study|Adverse Event|2|||
161292186|NCT05691712|582450041|FG003|Overall Study|Adverse Event|1|||
161292187|NCT05691712|582450038|FG000|Overall Study|Withdrawal by Subject|2|||
161292188|NCT05691712|582450039|FG001|Overall Study|Withdrawal by Subject|3|||
161292189|NCT05691712|582450040|FG002|Overall Study|Withdrawal by Subject|3|||
161292190|NCT05691712|582450041|FG003|Overall Study|Withdrawal by Subject|1|||
161292191|NCT05691712|582450038|FG000|Overall Study|Death|1|||
161292192|NCT05691712|582450039|FG001|Overall Study|Death|0|||
161292193|NCT05691712|582450040|FG002|Overall Study|Death|0|||
161292194|NCT05691712|582450041|FG003|Overall Study|Death|0|||
161292195|NCT05691712|582450038|FG000|Overall Study|Pregnancy|0|||
161292196|NCT05691712|582450039|FG001|Overall Study|Pregnancy|1|||
161292197|NCT05691712|582450040|FG002|Overall Study|Pregnancy|0|||
161292198|NCT05691712|582450041|FG003|Overall Study|Pregnancy|0|||
161292199|NCT05691712|582450038|FG000|Overall Study|Assigned Treatment by Mistake|1|||
161292200|NCT05691712|582450039|FG001|Overall Study|Assigned Treatment by Mistake|0|||
161292201|NCT05691712|582450040|FG002|Overall Study|Assigned Treatment by Mistake|0|||
161292202|NCT05691712|582450041|FG003|Overall Study|Assigned Treatment by Mistake|1|||
161292203|NCT05303194|582450042|FG000|Overall Study|Lost to Follow-up|1|||
161292204|NCT05303194|582450043|FG001|Overall Study|Lost to Follow-up|1|||
161292205|NCT05303194|582450042|FG000|Overall Study|Withdrawal by Subject|0|||
161292206|NCT05303194|582450043|FG001|Overall Study|Withdrawal by Subject|1|||
161292207|NCT01289678|582450053|FG000|Overall Study|Physician Decision|6|||
161292208|NCT00226499|582450054|FG000|Overall Study|Adverse Event|10|||
161292209|NCT00226499|582450055|FG001|Overall Study|Adverse Event|6|||
161292210|NCT00226499|582450056|FG002|Overall Study|Adverse Event|3|||
161292211|NCT00226499|582450054|FG000|Overall Study|Others|1064|||
161292212|NCT00226499|582450055|FG001|Overall Study|Others|1066|||
161292213|NCT00226499|582450056|FG002|Overall Study|Others|356|||
161292214|NCT00468819|582450057|FG000|Overall Study|Withdrawal by Subject|4|||
161292215|NCT00468819|582450058|FG001|Overall Study|Withdrawal by Subject|0|||
161292216|NCT00468819|582450059|FG002|Overall Study|Withdrawal by Subject|1|||
161292217|NCT00468819|582450057|FG000|Overall Study|Lost to Follow-up|0|||
161292218|NCT00468819|582450058|FG001|Overall Study|Lost to Follow-up|0|||
161292219|NCT00468819|582450059|FG002|Overall Study|Lost to Follow-up|1|||
161292220|NCT00468819|582450057|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
161292221|NCT00468819|582450058|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
161347367|NCT01001104|582656264|FG001|Overall Study|Adverse Event|1|||
161347368|NCT01001104|582656265|FG002|Overall Study|Adverse Event|0|||
161292222|NCT00468819|582450059|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
161292223|NCT02723344|582450062|FG000|Overall Study|Lost to Follow-up|0|||
161292224|NCT02723344|582450063|FG001|Overall Study|Lost to Follow-up|4|||
161292225|NCT02524847|582450065|FG000|Overall Study|Adverse Event|4|||
161292226|NCT02524847|582450065|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
161292227|NCT02524847|582450065|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
161292228|NCT02524847|582450065|FG000|Overall Study|Death|1|||
161292229|NCT02524847|582450065|FG000|Overall Study|Reason not Specified|1|||
161292230|NCT04352101|582450066|FG000|Overall Study|Physician Decision|2|||
161292231|NCT04352101|582450067|FG001|Overall Study|Physician Decision|1|||
161292232|NCT03539302|582450076|FG000|Overall Study|Spontaneous cardio version|0|||
161292233|NCT03539302|582450077|FG001|Overall Study|Spontaneous cardio version|0|||
161292234|NCT03539302|582450078|FG002|Overall Study|Spontaneous cardio version|0|||
161292235|NCT03539302|582450079|FG003|Overall Study|Spontaneous cardio version|0|||
161292236|NCT03539302|582450080|FG004|Overall Study|Spontaneous cardio version|0|||
161292237|NCT03539302|582450081|FG005|Overall Study|Spontaneous cardio version|1|||
161292238|NCT03539302|582450082|FG006|Overall Study|Spontaneous cardio version|1|||
161292239|NCT04564092|582450084|FG000|Overall Study|Withdrawal by Subject|1|||
161292240|NCT00420420|582450087|FG000|Overall Study|Adverse Event|5|||
161292241|NCT00420420|582450088|FG001|Overall Study|Adverse Event|3|||
161292242|NCT00420420|582450087|FG000|Overall Study|Protocol Violation|1|||
161292243|NCT00420420|582450088|FG001|Overall Study|Protocol Violation|1|||
161292244|NCT00420420|582450087|FG000|Overall Study|Withdrawal by Subject|1|||
161292245|NCT00420420|582450088|FG001|Overall Study|Withdrawal by Subject|0|||
161292246|NCT00420420|582450087|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
161292247|NCT00420420|582450088|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
161292248|NCT00273182|582450089|FG000|Overall Study|Death|450|||
161292249|NCT00273182|582450089|FG000|Overall Study|Lost to Follow-up|88|||
161292250|NCT00273182|582450089|FG000|Overall Study|Withdrawal by Subject|257|||
161292251|NCT00273182|582450089|FG000|Overall Study|Device/System Explant|154|||
161292252|NCT00273182|582450089|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
161292253|NCT04762160|582450090|FG000|Overall Study|Study terminated early due to business reasons|5|||
161292254|NCT00868530|582450094|FG000|Overall Study|Adverse Event|3|||
161292255|NCT00868530|582450094|FG000|Overall Study|Lost to Follow-up|1|||
161292256|NCT05795153|582452079|FG000|Overall Study|Adverse Event|2|||
161292257|NCT05795153|582452079|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161292258|NCT05795153|582452079|FG000|Overall Study|Lost to Follow-up|1|||
161292259|NCT05795153|582452079|FG000|Overall Study|Subject decision|2|||
161292260|NCT03668119|582452080|FG000|Pre-treatment|Disease Progression|1|||
161292261|NCT03668119|582452081|FG001|Pre-treatment|Disease Progression|0|||
161292262|NCT03668119|582452080|FG000|Treatment|Disease Progression|76|||
161292263|NCT03668119|582452081|FG001|Treatment|Disease Progression|57|||
161292264|NCT03668119|582452080|FG000|Treatment|Study drug toxicity|19|||
161292265|NCT03668119|582452081|FG001|Treatment|Study drug toxicity|1|||
161292266|NCT03668119|582452080|FG000|Treatment|Death|3|||
161292267|NCT03668119|582452081|FG001|Treatment|Death|0|||
161292268|NCT03668119|582452080|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
161292269|NCT03668119|582452081|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
161292270|NCT03668119|582452080|FG000|Treatment|Withdrawal by Subject|1|||
161292271|NCT03668119|582452081|FG001|Treatment|Withdrawal by Subject|1|||
161292272|NCT03668119|582452080|FG000|Treatment|Participant request to discontinue study treatment|3|||
161292273|NCT03668119|582452081|FG001|Treatment|Participant request to discontinue study treatment|1|||
161292274|NCT03668119|582452080|FG000|Treatment|Maximum Clinical Benefit|0|||
161292275|NCT03668119|582452081|FG001|Treatment|Maximum Clinical Benefit|1|||
161292276|NCT03668119|582452080|FG000|Treatment|Participants completed treatment|27|||
161292277|NCT03668119|582452081|FG001|Treatment|Participants completed treatment|11|||
161292278|NCT03668119|582452080|FG000|Treatment|Other reasons|2|||
161292279|NCT03668119|582452081|FG001|Treatment|Other reasons|1|||
161292280|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161292281|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161292282|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161292283|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161292284|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
161292285|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161292286|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161292287|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
161292288|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161292289|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161292290|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
161292291|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161292292|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161292293|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
161347369|NCT01001104|582656266|FG003|Overall Study|Adverse Event|0|||
161347370|NCT01001104|582656263|FG000|Overall Study|Lost to Follow-up|0|||
161292294|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161292295|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
161292296|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161292297|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161292298|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161292299|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161292300|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161085412|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
161085413|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
161085414|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
161085415|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
161085416|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
161085417|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
161085418|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
161085419|NCT01865747|581700265|FG000|Primary Intent to Treat (PITT)|Other|0|||
161085420|NCT01865747|581700266|FG001|Primary Intent to Treat (PITT)|Other|1|||
161085421|NCT00867308|581700267|FG000|Overall Study|Death|1|||
161085422|NCT00867308|581700268|FG001|Overall Study|Death|0|||
161085423|NCT00867308|581700267|FG000|Overall Study|Adverse Event|1|||
161085424|NCT00867308|581700268|FG001|Overall Study|Adverse Event|4|||
161085425|NCT00867308|581700267|FG000|Overall Study|Lack of Efficacy|6|||
161085426|NCT00867308|581700268|FG001|Overall Study|Lack of Efficacy|12|||
161085427|NCT00867308|581700267|FG000|Overall Study|Withdrawal by Subject|1|||
161085428|NCT00867308|581700268|FG001|Overall Study|Withdrawal by Subject|2|||
161085429|NCT00611975|581700271|FG000|Overall Study|Withdrawal by Subject|3|||
161085430|NCT00611975|581700272|FG001|Overall Study|Withdrawal by Subject|7|||
161085431|NCT00611975|581700271|FG000|Overall Study|Pregnancy|2|||
161085432|NCT00611975|581700272|FG001|Overall Study|Pregnancy|1|||
161085433|NCT04625413|581700273|FG000|Overall Study|Hospice|2|||
161085434|NCT04625413|581700273|FG000|Overall Study|Distress|1|||
161085435|NCT04625413|581700273|FG000|Overall Study|Not feeling well|1|||
161085436|NCT05618912|581700274|FG000|Overall Study|Lost to Follow-up|14|||
161085437|NCT05618912|581700275|FG001|Overall Study|Lost to Follow-up|19|||
161085438|NCT00432666|581702147|FG000|Main Period|Adverse Event|1|||
161292301|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161085439|NCT00432666|581702148|FG001|Main Period|Adverse Event|1|||
161085440|NCT00432666|581702147|FG000|Main Period|Consent Withdrawn|1|||
161085441|NCT00432666|581702148|FG001|Main Period|Consent Withdrawn|0|||
161085442|NCT00432666|581702147|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
161085443|NCT00432666|581702148|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
161085444|NCT00432666|581702147|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
161085445|NCT00432666|581702148|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
161085446|NCT00432666|581702147|FG000|Open-Label Extension Period|Adverse Event|5|||
161085447|NCT00432666|581702148|FG001|Open-Label Extension Period|Adverse Event|0|||
161085448|NCT00432666|581702147|FG000|Open-Label Extension Period|Consent withdrawn|10|||
161085449|NCT00432666|581702148|FG001|Open-Label Extension Period|Consent withdrawn|0|||
161085450|NCT00432666|581702147|FG000|Open-Label Extension Period|Physician Decision|3|||
161085451|NCT00432666|581702148|FG001|Open-Label Extension Period|Physician Decision|0|||
161085452|NCT01506453|581702149|FG000|Overall Study|Withdrawal prior to treatment|0|||
161085453|NCT01506453|581702150|FG001|Overall Study|Withdrawal prior to treatment|2|||
161085454|NCT01342341|581702161|FG000|Overall Study|Lost to Follow-up|4|||
161085455|NCT01342341|581702162|FG001|Overall Study|Lost to Follow-up|4|||
161085456|NCT00603304|581702163|FG000|Overall Study|Lost to Follow-up|5|||
161085457|NCT00603304|581702164|FG001|Overall Study|Lost to Follow-up|7|||
161085458|NCT00603304|581702163|FG000|Overall Study|Withdrawal by Subject|8|||
161085459|NCT00603304|581702164|FG001|Overall Study|Withdrawal by Subject|5|||
161085460|NCT00603304|581702163|FG000|Overall Study|Protocol Violation|1|||
161085461|NCT00603304|581702164|FG001|Overall Study|Protocol Violation|0|||
161085462|NCT00603304|581702163|FG000|Overall Study|Adverse Event|4|||
161085463|NCT00603304|581702164|FG001|Overall Study|Adverse Event|2|||
161085464|NCT00603304|581702163|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
161085465|NCT00603304|581702164|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
161085466|NCT00603304|581702163|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
161085467|NCT00603304|581702164|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
161085468|NCT00603304|581702163|FG000|Overall Study|Exclusionary Medication|2|||
161085469|NCT00603304|581702164|FG001|Overall Study|Exclusionary Medication|3|||
161085470|NCT00603304|581702163|FG000|Overall Study|Non-Compliant|0|||
161085471|NCT00603304|581702164|FG001|Overall Study|Non-Compliant|1|||
161292302|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
161292303|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
161085472|NCT00603304|581702163|FG000|Overall Study|Moved Away|0|||
161085473|NCT00603304|581702164|FG001|Overall Study|Moved Away|2|||
161085474|NCT00603304|581702163|FG000|Overall Study|Other|2|||
161085475|NCT00603304|581702164|FG001|Overall Study|Other|0|||
161085476|NCT00603304|581702163|FG000|Overall Study|Patient Decision|2|||
161085477|NCT00603304|581702164|FG001|Overall Study|Patient Decision|0|||
161085478|NCT01076192|581702165|FG000|Overall Study|Other|197|||
161085479|NCT01034176|581702166|FG000|Overall Study|Physician Decision|2|||
161085480|NCT01034176|581702167|FG001|Overall Study|Physician Decision|0|||
161085481|NCT01034176|581702166|FG000|Overall Study|Withdrawal by Subject|0|||
161085482|NCT01034176|581702167|FG001|Overall Study|Withdrawal by Subject|1|||
161085483|NCT01034176|581702166|FG000|Overall Study|Lost to Follow-up|0|||
161292304|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161085484|NCT01034176|581702167|FG001|Overall Study|Lost to Follow-up|1|||
161085485|NCT00266227|581702170|FG000|Initial Treatment|Adverse Event|0|||
161085486|NCT00266227|581702171|FG001|Initial Treatment|Adverse Event|0|||
161085487|NCT00266227|581702172|FG002|Initial Treatment|Adverse Event|13|||
161085488|NCT00266227|581702170|FG000|Initial Treatment|Lost to Follow-up|0|||
161085489|NCT00266227|581702171|FG001|Initial Treatment|Lost to Follow-up|0|||
161085490|NCT00266227|581702172|FG002|Initial Treatment|Lost to Follow-up|6|||
161085491|NCT00266227|581702170|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
161085492|NCT00266227|581702171|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
161085493|NCT00266227|581702172|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
161085494|NCT00266227|581702170|FG000|Initial Treatment|Physician decision to withdraw|0|||
161085495|NCT00266227|581702171|FG001|Initial Treatment|Physician decision to withdraw|0|||
161085496|NCT00266227|581702172|FG002|Initial Treatment|Physician decision to withdraw|12|||
161085497|NCT00266227|581702170|FG000|Initial Treatment|Pregnancy|0|||
161085498|NCT00266227|581702171|FG001|Initial Treatment|Pregnancy|0|||
161085499|NCT00266227|581702172|FG002|Initial Treatment|Pregnancy|1|||
161085500|NCT00266227|581702170|FG000|Retreatment: Up to Week 48|Death|1|||
161085501|NCT00266227|581702171|FG001|Retreatment: Up to Week 48|Death|0|||
161085502|NCT00266227|581702172|FG002|Retreatment: Up to Week 48|Death|0|||
161085503|NCT00266227|581702170|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
161085504|NCT00266227|581702171|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
161085505|NCT00266227|581702172|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
161085506|NCT00266227|581702170|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
161085507|NCT00266227|581702171|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
161085508|NCT00266227|581702172|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
161085509|NCT00266227|581702170|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
161085510|NCT00266227|581702171|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
161085511|NCT00266227|581702172|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
161085512|NCT00266227|581702170|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
161085513|NCT00266227|581702171|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
161085514|NCT00266227|581702172|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
161085515|NCT00266227|581702170|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
161085516|NCT00266227|581702171|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
161085517|NCT00266227|581702172|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
161085518|NCT00266227|581702170|FG000|Retreatment: Week 48 to Week 72|Death|1|||
161085519|NCT00266227|581702171|FG001|Retreatment: Week 48 to Week 72|Death|1|||
161085520|NCT00266227|581702172|FG002|Retreatment: Week 48 to Week 72|Death|0|||
161085521|NCT00266227|581702170|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
161085522|NCT00266227|581702171|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
161085523|NCT00266227|581702172|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
161085524|NCT00266227|581702170|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
161085525|NCT00266227|581702171|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
161085526|NCT00266227|581702172|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
161085527|NCT00266227|581702170|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
161085528|NCT00266227|581702171|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
161085529|NCT00266227|581702172|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
161085530|NCT00266227|581702170|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
161085531|NCT00266227|581702171|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
161085532|NCT00266227|581702172|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
161085533|NCT02680002|581702174|FG000|Overall Study|Lost to Follow-up|5|||
161085534|NCT02680002|581702175|FG001|Overall Study|Lost to Follow-up|1|||
161085535|NCT02680002|581702176|FG002|Overall Study|Lost to Follow-up|4|||
161085536|NCT02680002|581702177|FG003|Overall Study|Lost to Follow-up|2|||
161085537|NCT02680002|581702178|FG004|Overall Study|Lost to Follow-up|0|||
161085538|NCT02680002|581702179|FG005|Overall Study|Lost to Follow-up|2|||
161085539|NCT02680002|581702174|FG000|Overall Study|Physician Decision|5|||
161085540|NCT02680002|581702175|FG001|Overall Study|Physician Decision|1|||
161085541|NCT02680002|581702176|FG002|Overall Study|Physician Decision|1|||
161085542|NCT02680002|581702177|FG003|Overall Study|Physician Decision|1|||
161085543|NCT02680002|581702178|FG004|Overall Study|Physician Decision|1|||
161085544|NCT02680002|581702179|FG005|Overall Study|Physician Decision|1|||
161085545|NCT02680002|581702174|FG000|Overall Study|Protocol Violation|1|||
161085546|NCT02680002|581702175|FG001|Overall Study|Protocol Violation|0|||
161085547|NCT02680002|581702176|FG002|Overall Study|Protocol Violation|1|||
161085548|NCT02680002|581702177|FG003|Overall Study|Protocol Violation|0|||
161085549|NCT02680002|581702178|FG004|Overall Study|Protocol Violation|1|||
161085550|NCT02680002|581702179|FG005|Overall Study|Protocol Violation|2|||
161085551|NCT02680002|581702174|FG000|Overall Study|Withdrawal by Subject|0|||
161085552|NCT02680002|581702175|FG001|Overall Study|Withdrawal by Subject|0|||
161085553|NCT02680002|581702176|FG002|Overall Study|Withdrawal by Subject|1|||
161085554|NCT02680002|581702177|FG003|Overall Study|Withdrawal by Subject|0|||
161085555|NCT02680002|581702178|FG004|Overall Study|Withdrawal by Subject|2|||
161085556|NCT02680002|581702179|FG005|Overall Study|Withdrawal by Subject|2|||
161292305|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161292306|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161292307|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161292308|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161292309|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
161292310|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161292311|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
161292312|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292313|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292314|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
161292315|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292316|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292317|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292318|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
161292319|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292320|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161292321|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161292322|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
161292323|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161292324|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161292325|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
161292326|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
161292327|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
161292328|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
161292329|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
161292330|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161292331|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161292332|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161292333|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161292334|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161292335|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
161292336|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292337|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
161292338|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292339|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292340|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292341|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292342|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292343|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
161292344|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292345|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292346|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292347|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292348|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
161292349|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292350|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292351|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
161292352|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292353|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161319393|NCT01134263|582555301|FG001|Overall Study|Other adverse event|2|||
161319394|NCT01134263|582555302|FG002|Overall Study|Other adverse event|5|||
161319395|NCT01134263|582555303|FG003|Overall Study|Other adverse event|3|||
161319396|NCT01134263|582555304|FG004|Overall Study|Other adverse event|0|||
161085557|NCT02680002|581702174|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
161085558|NCT02680002|581702175|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
161085559|NCT02680002|581702176|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
161085560|NCT02680002|581702177|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
161085561|NCT02680002|581702178|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
161085562|NCT02680002|581702179|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
161319397|NCT01134263|582555300|FG000|Overall Study|Protocol Violation|8|||
161085563|NCT02680002|581702174|FG000|Overall Study|Other|0|||
161085564|NCT02680002|581702175|FG001|Overall Study|Other|1|||
161085565|NCT02680002|581702176|FG002|Overall Study|Other|0|||
161085566|NCT02680002|581702177|FG003|Overall Study|Other|0|||
161085567|NCT02680002|581702178|FG004|Overall Study|Other|1|||
161085568|NCT02680002|581702179|FG005|Overall Study|Other|0|||
161085569|NCT02680002|581702174|FG000|Overall Study|Adverse Event|0|||
161085570|NCT02680002|581702175|FG001|Overall Study|Adverse Event|0|||
161085571|NCT02680002|581702176|FG002|Overall Study|Adverse Event|0|||
161085572|NCT02680002|581702177|FG003|Overall Study|Adverse Event|0|||
161085573|NCT02680002|581702178|FG004|Overall Study|Adverse Event|1|||
161085574|NCT02680002|581702179|FG005|Overall Study|Adverse Event|2|||
161085575|NCT04097301|581702182|FG000|Overall Study|Death|1|||
161085576|NCT04097301|581702182|FG000|Overall Study|Withdrawal by Subject|1|||
161085577|NCT04097301|581702182|FG000|Overall Study|Screening Failure|5|||
161085578|NCT01403610|581702186|FG000|Overall Study|Withdrawal by Subject|2|||
161085579|NCT01403610|581702187|FG001|Overall Study|Withdrawal by Subject|0|||
161085580|NCT01403610|581702188|FG002|Overall Study|Withdrawal by Subject|0|||
161085581|NCT01403610|581702189|FG003|Overall Study|Withdrawal by Subject|0|||
161085582|NCT01403610|581702186|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
161085583|NCT01403610|581702187|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
161085584|NCT01403610|581702188|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
161085585|NCT01403610|581702189|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
161085586|NCT00901186|581702190|FG000|Overall Study|Lack of Efficacy|0|||
161085587|NCT00901186|581702191|FG001|Overall Study|Lack of Efficacy|1|||
161085588|NCT00901186|581702190|FG000|Overall Study|Abnormal laboratory values|0|||
161085589|NCT00901186|581702191|FG001|Overall Study|Abnormal laboratory values|1|||
161085590|NCT00901186|581702190|FG000|Overall Study|Lost to Follow-up|2|||
161085591|NCT00901186|581702191|FG001|Overall Study|Lost to Follow-up|0|||
161085592|NCT00901186|581702190|FG000|Overall Study|Adverse Event|2|||
161085593|NCT00901186|581702191|FG001|Overall Study|Adverse Event|4|||
161085594|NCT00901186|581702190|FG000|Overall Study|Administration problems|0|||
161085595|NCT00901186|581702191|FG001|Overall Study|Administration problems|1|||
161085596|NCT00901186|581702190|FG000|Overall Study|Protocol deviations|5|||
161085597|NCT00901186|581702191|FG001|Overall Study|Protocol deviations|4|||
161085598|NCT02383056|581702192|FG000|Overall Study|Adverse Event|1|||
161085599|NCT02383056|581702193|FG001|Overall Study|Adverse Event|0|||
161085600|NCT02383056|581702192|FG000|Overall Study|Lost to Follow-up|0|||
161085601|NCT02383056|581702193|FG001|Overall Study|Lost to Follow-up|2|||
161085602|NCT01775475|581702194|FG000|Overall Study|Death|3|||
161085603|NCT01775475|581702195|FG001|Overall Study|Death|3|||
161085604|NCT02074553|581702199|FG000|Intervention Period 1|Family Emergency|0|||
161085605|NCT02074553|581702200|FG001|Intervention Period 1|Family Emergency|0|||
161085606|NCT02074553|581702201|FG002|Intervention Period 1|Family Emergency|0|||
161085607|NCT02074553|581702202|FG003|Intervention Period 1|Family Emergency|1|||
161085608|NCT02074553|581702203|FG004|Intervention Period 1|Family Emergency|0|||
161085609|NCT02074553|581702204|FG005|Intervention Period 1|Family Emergency|0|||
161085610|NCT02074553|581702205|FG006|Intervention Period 1|Family Emergency|0|||
161085611|NCT02074553|581702206|FG007|Intervention Period 1|Family Emergency|0|||
161085612|NCT02074553|581702199|FG000|Washout Period 1|Adverse Event|1|||
161085613|NCT02074553|581702200|FG001|Washout Period 1|Adverse Event|0|||
161085614|NCT02074553|581702201|FG002|Washout Period 1|Adverse Event|0|||
161085615|NCT02074553|581702202|FG003|Washout Period 1|Adverse Event|0|||
161085616|NCT02074553|581702203|FG004|Washout Period 1|Adverse Event|0|||
161085617|NCT02074553|581702204|FG005|Washout Period 1|Adverse Event|0|||
161347371|NCT01001104|582656264|FG001|Overall Study|Lost to Follow-up|0|||
161347372|NCT01001104|582656265|FG002|Overall Study|Lost to Follow-up|1|||
161085618|NCT02074553|581702205|FG006|Washout Period 1|Adverse Event|0|||
161085619|NCT02074553|581702206|FG007|Washout Period 1|Adverse Event|0|||
161085620|NCT02074553|581702199|FG000|Washout Period 1|Physician Decision|0|||
161085621|NCT02074553|581702200|FG001|Washout Period 1|Physician Decision|0|||
161085622|NCT02074553|581702201|FG002|Washout Period 1|Physician Decision|0|||
161085623|NCT02074553|581702202|FG003|Washout Period 1|Physician Decision|1|||
161085624|NCT02074553|581702203|FG004|Washout Period 1|Physician Decision|0|||
161085625|NCT02074553|581702204|FG005|Washout Period 1|Physician Decision|0|||
161085626|NCT02074553|581702205|FG006|Washout Period 1|Physician Decision|0|||
161085627|NCT02074553|581702206|FG007|Washout Period 1|Physician Decision|0|||
161085628|NCT02074553|581702199|FG000|Washout Period 1|Other|0|||
161085629|NCT02074553|581702200|FG001|Washout Period 1|Other|0|||
161085630|NCT02074553|581702201|FG002|Washout Period 1|Other|0|||
161085631|NCT02074553|581702202|FG003|Washout Period 1|Other|0|||
161085632|NCT02074553|581702203|FG004|Washout Period 1|Other|0|||
161085633|NCT02074553|581702204|FG005|Washout Period 1|Other|1|||
161085634|NCT02074553|581702205|FG006|Washout Period 1|Other|0|||
161085635|NCT02074553|581702206|FG007|Washout Period 1|Other|0|||
161085636|NCT02074553|581702199|FG000|Washout Period 2|Adverse Event|0|||
161085637|NCT02074553|581702200|FG001|Washout Period 2|Adverse Event|0|||
161085638|NCT02074553|581702201|FG002|Washout Period 2|Adverse Event|0|||
161085639|NCT02074553|581702202|FG003|Washout Period 2|Adverse Event|0|||
161085640|NCT02074553|581702203|FG004|Washout Period 2|Adverse Event|0|||
161085641|NCT02074553|581702204|FG005|Washout Period 2|Adverse Event|0|||
161085642|NCT02074553|581702205|FG006|Washout Period 2|Adverse Event|1|||
161085643|NCT02074553|581702206|FG007|Washout Period 2|Adverse Event|0|||
161085644|NCT02074553|581702199|FG000|Washout Period 2|Physician Decision|0|||
161085645|NCT02074553|581702200|FG001|Washout Period 2|Physician Decision|0|||
161085646|NCT02074553|581702201|FG002|Washout Period 2|Physician Decision|0|||
161085647|NCT02074553|581702202|FG003|Washout Period 2|Physician Decision|0|||
161292354|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292355|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292356|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292357|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
161292358|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292359|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
161292360|NCT03896503|582452082|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161292361|NCT03896503|582452083|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161292362|NCT03896503|582452084|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161292363|NCT03896503|582452085|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161292364|NCT03896503|582452086|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161292365|NCT03896503|582452087|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
161292366|NCT03896503|582452088|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
161292367|NCT03896503|582452089|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
161292368|NCT05400655|582452090|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
161292369|NCT05400655|582452091|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
161292370|NCT05400655|582452092|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
161292371|NCT05400655|582452093|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
161292372|NCT05400655|582452094|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
161292373|NCT05400655|582452095|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
161292374|NCT05400655|582452096|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
161292375|NCT05400655|582452097|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
161292376|NCT05400655|582452098|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
161292377|NCT05400655|582452099|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
161292378|NCT05400655|582452100|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
161292379|NCT05400655|582452101|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
161292380|NCT05400655|582452102|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
161292381|NCT05400655|582452103|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
161292382|NCT05400655|582452104|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
161292383|NCT05400655|582452105|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
161292384|NCT05400655|582452106|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
161292385|NCT05400655|582452107|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
161292386|NCT05400655|582452108|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
161292387|NCT05400655|582452109|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
161292388|NCT05400655|582452110|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
161292389|NCT05400655|582452111|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
161292390|NCT05400655|582452090|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292391|NCT05400655|582452091|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292392|NCT05400655|582452092|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292393|NCT05400655|582452093|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292394|NCT05400655|582452094|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292395|NCT05400655|582452095|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292396|NCT05400655|582452096|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292397|NCT05400655|582452097|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292398|NCT05400655|582452098|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292399|NCT05400655|582452099|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292400|NCT05400655|582452100|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292401|NCT05400655|582452101|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292402|NCT05400655|582452102|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161292403|NCT05400655|582452103|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292404|NCT05400655|582452104|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292405|NCT05400655|582452105|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292406|NCT05400655|582452106|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161292407|NCT05400655|582452107|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292408|NCT05400655|582452108|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
161292409|NCT05400655|582452109|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
161292410|NCT05400655|582452110|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292411|NCT05400655|582452111|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
161292412|NCT05400655|582452090|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292413|NCT05400655|582452091|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161319398|NCT01134263|582555301|FG001|Overall Study|Protocol Violation|7|||
161319399|NCT01134263|582555302|FG002|Overall Study|Protocol Violation|2|||
161085648|NCT02074553|581702203|FG004|Washout Period 2|Physician Decision|0|||
161085649|NCT02074553|581702204|FG005|Washout Period 2|Physician Decision|1|||
161085650|NCT02074553|581702205|FG006|Washout Period 2|Physician Decision|0|||
161085651|NCT02074553|581702206|FG007|Washout Period 2|Physician Decision|0|||
161085652|NCT02074553|581702199|FG000|Washout Period 2|Lost to Follow-up|0|||
161085653|NCT02074553|581702200|FG001|Washout Period 2|Lost to Follow-up|0|||
161085654|NCT02074553|581702201|FG002|Washout Period 2|Lost to Follow-up|1|||
161085655|NCT02074553|581702202|FG003|Washout Period 2|Lost to Follow-up|0|||
161085656|NCT02074553|581702203|FG004|Washout Period 2|Lost to Follow-up|0|||
161085657|NCT02074553|581702204|FG005|Washout Period 2|Lost to Follow-up|0|||
161085658|NCT02074553|581702205|FG006|Washout Period 2|Lost to Follow-up|0|||
161085659|NCT02074553|581702206|FG007|Washout Period 2|Lost to Follow-up|0|||
161085660|NCT02074553|581702199|FG000|Washout Period 3|Physician Decision|0|||
161085661|NCT02074553|581702200|FG001|Washout Period 3|Physician Decision|0|||
161085662|NCT02074553|581702201|FG002|Washout Period 3|Physician Decision|0|||
161085663|NCT02074553|581702202|FG003|Washout Period 3|Physician Decision|0|||
161085664|NCT02074553|581702203|FG004|Washout Period 3|Physician Decision|0|||
161085665|NCT02074553|581702204|FG005|Washout Period 3|Physician Decision|0|||
161085666|NCT02074553|581702205|FG006|Washout Period 3|Physician Decision|0|||
161085667|NCT02074553|581702206|FG007|Washout Period 3|Physician Decision|1|||
161085668|NCT02342743|581702207|FG000|Baseline Period|Withdrawal by Subject|3|||
161085669|NCT02342743|581702207|FG000|Baseline Period|Lost to Follow-up|2|||
161085670|NCT02342743|581702207|FG000|Baseline Period|Change in prophylactic medication|3|||
161085671|NCT02342743|581702207|FG000|Baseline Period|Screening failure regarding baseline|7|||
161085672|NCT02342743|581702207|FG000|Treatment Period|Withdrawal by Subject|2|||
161085673|NCT02342743|581702207|FG000|Treatment Period|Lost to Follow-up|8|||
161085674|NCT02342743|581702207|FG000|Treatment Period|Change in prophylactic medication|1|||
161085675|NCT00686725|581702208|FG000|Overall Study|Adverse Event|1|||
161085676|NCT00686725|581702209|FG001|Overall Study|Adverse Event|1|||
161085677|NCT00686725|581702208|FG000|Overall Study|Progressive Disease|17|||
161085678|NCT00686725|581702209|FG001|Overall Study|Progressive Disease|23|||
161085679|NCT00686725|581702208|FG000|Overall Study|Lost to Follow-up|7|||
161085680|NCT00686725|581702209|FG001|Overall Study|Lost to Follow-up|5|||
161085681|NCT00686725|581702208|FG000|Overall Study|Death|6|||
161085682|NCT00686725|581702209|FG001|Overall Study|Death|3|||
161085683|NCT00686725|581702208|FG000|Overall Study|Withdrawal by Subject|13|||
161085684|NCT00686725|581702209|FG001|Overall Study|Withdrawal by Subject|4|||
161085685|NCT00686725|581702208|FG000|Overall Study|Protocol Violation|1|||
161085686|NCT00686725|581702209|FG001|Overall Study|Protocol Violation|3|||
161085687|NCT00686725|581702208|FG000|Overall Study|Other|1|||
161085688|NCT00686725|581702209|FG001|Overall Study|Other|3|||
161085689|NCT03602066|581702210|FG000|Overall Study|Withdrawal by Subject|2|||
161085690|NCT03602066|581702211|FG001|Overall Study|Withdrawal by Subject|0|||
161085691|NCT03602066|581702210|FG000|Overall Study|Physician Decision|1|||
161085692|NCT03602066|581702211|FG001|Overall Study|Physician Decision|0|||
161085693|NCT00092495|581702212|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
161085694|NCT00092495|581702213|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
161085695|NCT00092495|581702214|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161085696|NCT00092495|581702215|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
161085697|NCT00092495|581702216|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
161085698|NCT00092495|581702212|FG000|Base Study Vaccination Period|Extended|0|||
161085699|NCT00092495|581702213|FG001|Base Study Vaccination Period|Extended|0|||
161085700|NCT00092495|581702214|FG002|Base Study Vaccination Period|Extended|0|||
161085701|NCT00092495|581702215|FG003|Base Study Vaccination Period|Extended|1|||
161085702|NCT00092495|581702216|FG004|Base Study Vaccination Period|Extended|0|||
161085703|NCT00092495|581702212|FG000|Base Study Vaccination Period|*Clinical AE|1|||
161085704|NCT00092495|581702213|FG001|Base Study Vaccination Period|*Clinical AE|0|||
161085705|NCT00092495|581702214|FG002|Base Study Vaccination Period|*Clinical AE|1|||
161085706|NCT00092495|581702215|FG003|Base Study Vaccination Period|*Clinical AE|2|||
161085707|NCT00092495|581702216|FG004|Base Study Vaccination Period|*Clinical AE|0|||
161085708|NCT00092495|581702212|FG000|Base Study Vaccination Period|*Other reasons|1|||
161292414|NCT05400655|582452092|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292415|NCT05400655|582452093|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292416|NCT05400655|582452094|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292417|NCT05400655|582452095|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292418|NCT05400655|582452096|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161085709|NCT00092495|581702213|FG001|Base Study Vaccination Period|*Other reasons|0|||
161085710|NCT00092495|581702214|FG002|Base Study Vaccination Period|*Other reasons|0|||
161085711|NCT00092495|581702215|FG003|Base Study Vaccination Period|*Other reasons|1|||
161085712|NCT00092495|581702216|FG004|Base Study Vaccination Period|*Other reasons|0|||
161085713|NCT00092495|581702212|FG000|Base Study Vaccination Period|*Pregnancy|0|||
161085714|NCT00092495|581702213|FG001|Base Study Vaccination Period|*Pregnancy|2|||
161085715|NCT00092495|581702214|FG002|Base Study Vaccination Period|*Pregnancy|5|||
161085716|NCT00092495|581702215|FG003|Base Study Vaccination Period|*Pregnancy|7|||
161085717|NCT00092495|581702216|FG004|Base Study Vaccination Period|*Pregnancy|0|||
161085718|NCT00092495|581702212|FG000|Base Study Vaccination Period|Adverse Event|1|||
161085719|NCT00092495|581702213|FG001|Base Study Vaccination Period|Adverse Event|0|||
161085720|NCT00092495|581702214|FG002|Base Study Vaccination Period|Adverse Event|0|||
161085721|NCT00092495|581702215|FG003|Base Study Vaccination Period|Adverse Event|3|||
161085722|NCT00092495|581702216|FG004|Base Study Vaccination Period|Adverse Event|0|||
161085723|NCT00092495|581702212|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
161085724|NCT00092495|581702213|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
161085725|NCT00092495|581702214|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
161085726|NCT00092495|581702215|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
161085727|NCT00092495|581702216|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161085728|NCT00092495|581702212|FG000|Base Study Vaccination Period|Moved|3|||
161085729|NCT00092495|581702213|FG001|Base Study Vaccination Period|Moved|1|||
161085730|NCT00092495|581702214|FG002|Base Study Vaccination Period|Moved|2|||
161085731|NCT00092495|581702215|FG003|Base Study Vaccination Period|Moved|2|||
161085732|NCT00092495|581702216|FG004|Base Study Vaccination Period|Moved|0|||
161085733|NCT00092495|581702212|FG000|Base Study Vaccination Period|Other|1|||
161085734|NCT00092495|581702213|FG001|Base Study Vaccination Period|Other|1|||
161085735|NCT00092495|581702214|FG002|Base Study Vaccination Period|Other|0|||
161085736|NCT00092495|581702215|FG003|Base Study Vaccination Period|Other|2|||
161085737|NCT00092495|581702216|FG004|Base Study Vaccination Period|Other|0|||
161085738|NCT00092495|581702212|FG000|Base Study Vaccination Period|Pregnancy|2|||
161085739|NCT00092495|581702213|FG001|Base Study Vaccination Period|Pregnancy|0|||
161085740|NCT00092495|581702214|FG002|Base Study Vaccination Period|Pregnancy|0|||
161085741|NCT00092495|581702215|FG003|Base Study Vaccination Period|Pregnancy|0|||
161085742|NCT00092495|581702216|FG004|Base Study Vaccination Period|Pregnancy|0|||
161085743|NCT00092495|581702212|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
161085744|NCT00092495|581702213|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
161085745|NCT00092495|581702214|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
161085746|NCT00092495|581702215|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
161085747|NCT00092495|581702216|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
161085748|NCT00092495|581702212|FG000|Base Study Vaccination Period|Protocol Violation|1|||
161085749|NCT00092495|581702213|FG001|Base Study Vaccination Period|Protocol Violation|0|||
161085750|NCT00092495|581702214|FG002|Base Study Vaccination Period|Protocol Violation|0|||
161085751|NCT00092495|581702215|FG003|Base Study Vaccination Period|Protocol Violation|0|||
161085752|NCT00092495|581702216|FG004|Base Study Vaccination Period|Protocol Violation|0|||
161085753|NCT00092495|581702212|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
161085754|NCT00092495|581702213|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
161085755|NCT00092495|581702214|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
161085756|NCT00092495|581702215|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
161085757|NCT00092495|581702216|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161085758|NCT00092495|581702212|FG000|Base Study Follow-up Period|Extended|0|||
161085759|NCT00092495|581702213|FG001|Base Study Follow-up Period|Extended|0|||
161085760|NCT00092495|581702214|FG002|Base Study Follow-up Period|Extended|1|||
161085761|NCT00092495|581702215|FG003|Base Study Follow-up Period|Extended|2|||
161085762|NCT00092495|581702216|FG004|Base Study Follow-up Period|Extended|0|||
161085763|NCT00092495|581702212|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
161085764|NCT00092495|581702213|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
161085765|NCT00092495|581702214|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
161085766|NCT00092495|581702215|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
161085767|NCT00092495|581702216|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161085768|NCT00092495|581702212|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
161085769|NCT00092495|581702213|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
161085770|NCT00092495|581702214|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161085771|NCT00092495|581702215|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161085772|NCT00092495|581702216|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161085773|NCT00938470|581702217|FG000|Overall Study|Disease Progression|3|||
161085774|NCT00938470|581702218|FG001|Overall Study|Disease Progression|0|||
161085775|NCT00938470|581702217|FG000|Overall Study|Alternate Treatment|1|||
161085776|NCT00938470|581702218|FG001|Overall Study|Alternate Treatment|0|||
161085777|NCT00938470|581702217|FG000|Overall Study|Death|3|||
161085778|NCT00938470|581702218|FG001|Overall Study|Death|2|||
161085779|NCT00938470|581702217|FG000|Overall Study|Other Reason|0|||
161085780|NCT00938470|581702218|FG001|Overall Study|Other Reason|1|||
161085781|NCT01552603|581702219|FG000|Overall Study|Physician Decision|1|||
161085782|NCT00618618|581702220|FG000|Overall Study|Patient Request|0|||
161085783|NCT00618618|581702221|FG001|Overall Study|Patient Request|0|||
161085784|NCT00618618|581702222|FG002|Overall Study|Patient Request|2|||
161085785|NCT00618618|581702223|FG003|Overall Study|Patient Request|0|||
161085786|NCT00618618|581702220|FG000|Overall Study|Inability to Complete Study Procedures|0|||
161085787|NCT00618618|581702221|FG001|Overall Study|Inability to Complete Study Procedures|1|||
161171417|NCT03970824|582003350|FG002|Overall Study|Withdrawal by Subject|3|||
161171418|NCT03970824|582003348|FG000|Overall Study|Lost to Follow-up|0|||
161171419|NCT03970824|582003349|FG001|Overall Study|Lost to Follow-up|2|||
161347373|NCT01001104|582656266|FG003|Overall Study|Lost to Follow-up|0|||
161085788|NCT00618618|581702222|FG002|Overall Study|Inability to Complete Study Procedures|0|||
161085789|NCT00618618|581702223|FG003|Overall Study|Inability to Complete Study Procedures|0|||
161085790|NCT00618618|581702220|FG000|Overall Study|Lost to Follow-up|3|||
161085791|NCT00618618|581702221|FG001|Overall Study|Lost to Follow-up|0|||
161085792|NCT00618618|581702222|FG002|Overall Study|Lost to Follow-up|0|||
161085793|NCT00618618|581702223|FG003|Overall Study|Lost to Follow-up|1|||
161085794|NCT00618618|581702220|FG000|Overall Study|Non-compliance|1|||
161085795|NCT00618618|581702221|FG001|Overall Study|Non-compliance|1|||
161085796|NCT00618618|581702222|FG002|Overall Study|Non-compliance|0|||
161085797|NCT00618618|581702223|FG003|Overall Study|Non-compliance|0|||
161085798|NCT00618618|581702220|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
161085799|NCT00618618|581702221|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
161085800|NCT00618618|581702222|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
161085801|NCT00618618|581702223|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
161085802|NCT00618618|581702220|FG000|Overall Study|Death|0|||
161085803|NCT00618618|581702221|FG001|Overall Study|Death|1|||
161085804|NCT00618618|581702222|FG002|Overall Study|Death|0|||
161085805|NCT00618618|581702223|FG003|Overall Study|Death|0|||
161085806|NCT01236365|581702227|FG000|Overall Study|Lost to Follow-up|0|||
161085807|NCT01236365|581702228|FG001|Overall Study|Lost to Follow-up|2|||
161085808|NCT01236365|581702227|FG000|Overall Study|Moved Out of State|1|||
161085809|NCT01236365|581702228|FG001|Overall Study|Moved Out of State|0|||
161085810|NCT01236365|581702227|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
161085811|NCT01236365|581702228|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
161085812|NCT00006011|581702234|FG000|Overall Study|Disease progression|13|||
161085813|NCT00006011|581702235|FG001|Overall Study|Disease progression|6|||
161085814|NCT00006011|581702236|FG002|Overall Study|Disease progression|26|||
161085815|NCT00006011|581702234|FG000|Overall Study|Refused further treatment|15|||
161085816|NCT00006011|581702235|FG001|Overall Study|Refused further treatment|13|||
161085817|NCT00006011|581702236|FG002|Overall Study|Refused further treatment|26|||
161085818|NCT00006011|581702234|FG000|Overall Study|Adverse Event|15|||
161085819|NCT00006011|581702235|FG001|Overall Study|Adverse Event|39|||
161085820|NCT00006011|581702236|FG002|Overall Study|Adverse Event|5|||
161085821|NCT00006011|581702234|FG000|Overall Study|Death|0|||
161085822|NCT00006011|581702235|FG001|Overall Study|Death|1|||
161085823|NCT00006011|581702236|FG002|Overall Study|Death|2|||
161085824|NCT00006011|581702234|FG000|Overall Study|Other|4|||
161085825|NCT00006011|581702235|FG001|Overall Study|Other|2|||
161085826|NCT00006011|581702236|FG002|Overall Study|Other|5|||
161085827|NCT00006011|581702234|FG000|Overall Study|Ineligible|18|||
161085828|NCT00006011|581702235|FG001|Overall Study|Ineligible|16|||
161085829|NCT00006011|581702236|FG002|Overall Study|Ineligible|9|||
161085830|NCT01236534|581702242|FG000|Overall Study|Adverse Event|3|||
161085831|NCT01236534|581702243|FG001|Overall Study|Adverse Event|0|||
161085832|NCT01844687|581702246|FG000|Visit 1|Protocol Violation|3|||
161085833|NCT01844687|581702246|FG000|Visit 1|Lost to Follow-up|5|||
161085834|NCT01844687|581702246|FG000|Visit 2|Withdrawal by Subject|1|||
161085835|NCT01844687|581702246|FG000|Visit 2|Protocol Violation|1|||
161085836|NCT01844687|581702246|FG000|Visit 3|Lost to Follow-up|1|||
161085837|NCT01844687|581702246|FG000|Visit 3|Withdrawal by Subject|3|||
161085838|NCT01844687|581702246|FG000|Visit 3|child care problems|1|||
161085839|NCT01844687|581702246|FG000|Visit 4|Pregnancy|1|||
161085840|NCT01844687|581702246|FG000|Visit 4|Lost to Follow-up|1|||
161085841|NCT01844687|581702246|FG000|Visit 4|Withdrawal by Subject|2|||
161085842|NCT00158860|581702261|FG000|Overall Study|Adverse Event|3|||
161085843|NCT00158860|581702262|FG001|Overall Study|Adverse Event|6|||
161085844|NCT00158860|581702261|FG000|Overall Study|Lost to Follow-up|11|||
161085845|NCT00158860|581702262|FG001|Overall Study|Lost to Follow-up|17|||
161085846|NCT00158860|581702261|FG000|Overall Study|Protocol Violation|8|||
161085847|NCT00158860|581702262|FG001|Overall Study|Protocol Violation|23|||
161085848|NCT00158860|581702261|FG000|Overall Study|Withdrawal by Subject|7|||
161171420|NCT03970824|582003350|FG002|Overall Study|Lost to Follow-up|1|||
161171421|NCT03970824|582003348|FG000|Overall Study|Adverse Event|1|||
161171422|NCT03970824|582003349|FG001|Overall Study|Adverse Event|0|||
161347374|NCT01001104|582656263|FG000|Overall Study|Entry Criteria Not Met|0|||
161347375|NCT01001104|582656264|FG001|Overall Study|Entry Criteria Not Met|0|||
161085849|NCT00158860|581702262|FG001|Overall Study|Withdrawal by Subject|17|||
161085850|NCT00158860|581702261|FG000|Overall Study|MOVING OUT OF STATE|1|||
161085851|NCT00158860|581702262|FG001|Overall Study|MOVING OUT OF STATE|0|||
161085852|NCT00158860|581702261|FG000|Overall Study|Pregnancy|3|||
161085853|NCT00158860|581702262|FG001|Overall Study|Pregnancy|3|||
161085854|NCT00158860|581702261|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
161085855|NCT00158860|581702262|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
161085856|NCT00158860|581702261|FG000|Overall Study|SPONSOR REQUEST|0|||
161085857|NCT00158860|581702262|FG001|Overall Study|SPONSOR REQUEST|1|||
161085858|NCT00158860|581702261|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
161085859|NCT00158860|581702262|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
161085860|NCT00158860|581702261|FG000|Overall Study|Closed per sponsor|0|||
161085861|NCT00158860|581702262|FG001|Overall Study|Closed per sponsor|1|||
161085862|NCT04638920|581702263|FG000|Overall Study|Withdrawal by Subject|5|||
161292419|NCT05400655|582452097|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292420|NCT05400655|582452098|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292421|NCT05400655|582452099|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292422|NCT05400655|582452100|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292423|NCT05400655|582452101|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292424|NCT05400655|582452102|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292425|NCT05400655|582452103|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
161292426|NCT05400655|582452104|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292427|NCT05400655|582452105|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292428|NCT05400655|582452106|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
161292429|NCT05400655|582452107|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292430|NCT05400655|582452108|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
161292431|NCT05400655|582452109|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292432|NCT05400655|582452110|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292433|NCT05400655|582452111|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
161292434|NCT05400655|582452090|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292435|NCT05400655|582452091|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292436|NCT05400655|582452092|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292437|NCT05400655|582452093|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292438|NCT05400655|582452094|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292439|NCT05400655|582452095|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292440|NCT05400655|582452096|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292441|NCT05400655|582452097|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292442|NCT05400655|582452098|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292443|NCT05400655|582452099|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292444|NCT05400655|582452100|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292445|NCT05400655|582452101|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292446|NCT05400655|582452102|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292447|NCT05400655|582452103|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292448|NCT05400655|582452104|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292449|NCT05400655|582452105|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161292450|NCT05400655|582452106|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161085863|NCT03775434|581702264|FG000|Overall Study|Adverse Event|2|||
161085864|NCT03775434|581702264|FG000|Overall Study|Withdrawal by Subject|1|||
161085865|NCT03047395|581702265|FG000|Overall Study|Adverse Event|142|||
161085866|NCT03047395|581702265|FG000|Overall Study|Withdrawal by Subject|155|||
161085867|NCT03047395|581702265|FG000|Overall Study|Lost to Follow-up|144|||
161085868|NCT03047395|581702265|FG000|Overall Study|COVID-19 Infection|2|||
161085869|NCT03047395|581702265|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
161085870|NCT03047395|581702265|FG000|Overall Study|Other, Not Specified|117|||
161085871|NCT00620282|581702273|FG000|Overall Study|Adverse Event|0|||
161085872|NCT00620282|581702274|FG001|Overall Study|Adverse Event|1|||
161085873|NCT00620282|581702275|FG002|Overall Study|Adverse Event|0|||
161085874|NCT00620282|581702273|FG000|Overall Study|Arterial line unable to be placed|0|||
161085875|NCT00620282|581702274|FG001|Overall Study|Arterial line unable to be placed|0|||
161085876|NCT00620282|581702275|FG002|Overall Study|Arterial line unable to be placed|1|||
161085877|NCT00620282|581702273|FG000|Overall Study|Withdrawal by Subject|0|||
161085878|NCT00620282|581702274|FG001|Overall Study|Withdrawal by Subject|1|||
161085879|NCT00620282|581702275|FG002|Overall Study|Withdrawal by Subject|0|||
161085880|NCT02217475|581702276|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
161085881|NCT02217475|581702277|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
161085882|NCT02217475|581702278|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
161085883|NCT02217475|581702276|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
161085884|NCT02217475|581702277|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
161085885|NCT02217475|581702278|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
161085886|NCT02217475|581702276|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
161085887|NCT02217475|581702277|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
161085888|NCT02217475|581702278|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
161085889|NCT02217475|581702276|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
161085890|NCT02217475|581702277|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
161085891|NCT02217475|581702278|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
161085892|NCT02217475|581702276|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
161085893|NCT02217475|581702277|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
161292451|NCT05400655|582452107|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161292452|NCT05400655|582452108|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
161292453|NCT05400655|582452109|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
161085894|NCT02217475|581702278|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
161085895|NCT02217475|581702276|FG000|Discontinued After Period 1|Adverse Event|1|||
161085896|NCT02217475|581702277|FG001|Discontinued After Period 1|Adverse Event|2|||
161085897|NCT02217475|581702278|FG002|Discontinued After Period 1|Adverse Event|0|||
161292454|NCT05400655|582452110|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
161292455|NCT05400655|582452111|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
161085898|NCT02217475|581702276|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
161085899|NCT02217475|581702277|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
161085900|NCT02217475|581702278|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
161085901|NCT02217475|581702276|FG000|Discontinued After Period 1|Physician Decision|0|||
161085902|NCT02217475|581702277|FG001|Discontinued After Period 1|Physician Decision|0|||
161085903|NCT02217475|581702278|FG002|Discontinued After Period 1|Physician Decision|1|||
161085904|NCT02217475|581702276|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
161085905|NCT02217475|581702277|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
161085906|NCT02217475|581702278|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
161085907|NCT02217475|581702276|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
161085908|NCT02217475|581702277|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
161085909|NCT02217475|581702278|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
161085910|NCT02217475|581702276|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
161085911|NCT02217475|581702277|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
161085912|NCT02217475|581702278|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
161085913|NCT02217475|581702276|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
161085914|NCT02217475|581702277|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
161085915|NCT02217475|581702278|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
161085916|NCT02217475|581702276|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
161085917|NCT02217475|581702277|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
161085918|NCT02217475|581702278|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
161085919|NCT04738292|581702283|FG000|Overall Study|Death|1|||
161085920|NCT02442336|581702284|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
161085921|NCT02442336|581702284|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
161085922|NCT02442336|581702284|FG000|Overall Study|Lost to Follow-up|11|||
161085923|NCT01237587|581702285|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
161292456|NCT05400655|582452090|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292457|NCT05400655|582452091|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292458|NCT05400655|582452092|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292459|NCT05400655|582452093|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292460|NCT05400655|582452094|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292461|NCT05400655|582452095|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292462|NCT05400655|582452096|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292463|NCT05400655|582452097|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292464|NCT05400655|582452098|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292465|NCT05400655|582452099|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292466|NCT05400655|582452100|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292467|NCT05400655|582452101|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292468|NCT05400655|582452102|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292469|NCT05400655|582452103|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292470|NCT05400655|582452104|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292471|NCT05400655|582452105|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292472|NCT05400655|582452106|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292473|NCT05400655|582452107|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
161292474|NCT05400655|582452108|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
161292475|NCT05400655|582452109|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292476|NCT05400655|582452110|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292477|NCT05400655|582452111|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
161292478|NCT05400655|582452090|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292479|NCT05400655|582452091|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292480|NCT05400655|582452092|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292481|NCT05400655|582452093|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292482|NCT05400655|582452094|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292483|NCT05400655|582452095|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292484|NCT05400655|582452096|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292485|NCT05400655|582452097|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292486|NCT05400655|582452098|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292487|NCT05400655|582452099|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292488|NCT05400655|582452100|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292489|NCT05400655|582452101|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292490|NCT05400655|582452102|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292491|NCT05400655|582452103|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292492|NCT05400655|582452104|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292493|NCT05400655|582452105|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292494|NCT05400655|582452106|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161292495|NCT05400655|582452107|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
161292496|NCT05400655|582452108|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161347376|NCT01001104|582656265|FG002|Overall Study|Entry Criteria Not Met|0|||
161085924|NCT01237587|581702286|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
161085925|NCT01237587|581702285|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
161085926|NCT01237587|581702286|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
161085927|NCT01237587|581702285|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
161085928|NCT01237587|581702286|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
161085929|NCT01237587|581702285|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
161085930|NCT01237587|581702286|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
161085931|NCT01237587|581702285|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
161085932|NCT01237587|581702286|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
161085933|NCT01237587|581702285|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
161085934|NCT01237587|581702286|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
161085935|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
161085936|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
161085937|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
161085938|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
161085939|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
161085940|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
161085941|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
161085942|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
161085943|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
161085944|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
161085945|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
161085946|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
161085947|NCT01237587|581702285|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
161085948|NCT01237587|581702286|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
161085949|NCT01237587|581702285|FG000|Taper Phase|Adverse Event|0|||
161085950|NCT01237587|581702286|FG001|Taper Phase|Adverse Event|2|||
161085951|NCT01237587|581702285|FG000|Taper Phase|Protocol Violation|2|||
161085952|NCT01237587|581702286|FG001|Taper Phase|Protocol Violation|0|||
161085953|NCT01237587|581702285|FG000|Taper Phase|Lack of Efficacy|2|||
161085954|NCT01237587|581702286|FG001|Taper Phase|Lack of Efficacy|5|||
161085955|NCT01237587|581702285|FG000|Taper Phase|Parent/Guardian Decision|0|||
161085956|NCT01237587|581702286|FG001|Taper Phase|Parent/Guardian Decision|2|||
161085957|NCT01237587|581702285|FG000|Taper Phase|Sponsor Decision|1|||
161085958|NCT01237587|581702286|FG001|Taper Phase|Sponsor Decision|0|||
161085959|NCT01237587|581702285|FG000|Taper Phase|Withdrawal by Subject|0|||
161085960|NCT01237587|581702286|FG001|Taper Phase|Withdrawal by Subject|1|||
161085961|NCT01011387|581702287|FG000|Overall Study|Withdrawal by Subject|3|||
161085962|NCT01011387|581702287|FG000|Overall Study|Adverse Event|2|||
161085963|NCT01011387|581702287|FG000|Overall Study|Protocol Violation|1|||
161085964|NCT01139580|581702288|FG000|Overall Study|Adverse Event|5|||
161085965|NCT01139580|581702289|FG001|Overall Study|Adverse Event|4|||
161085966|NCT01139580|581702288|FG000|Overall Study|Lost to Follow-up|9|||
161085967|NCT01139580|581702289|FG001|Overall Study|Lost to Follow-up|1|||
161085968|NCT01139580|581702288|FG000|Overall Study|Lack of Efficacy|0|||
161085969|NCT01139580|581702289|FG001|Overall Study|Lack of Efficacy|2|||
161085970|NCT01139580|581702288|FG000|Overall Study|Withdrawal by Subject|6|||
161085971|NCT01139580|581702289|FG001|Overall Study|Withdrawal by Subject|9|||
161085972|NCT01139580|581702288|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
161085973|NCT01139580|581702289|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
161085974|NCT01139580|581702288|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
161085975|NCT01139580|581702289|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
161085976|NCT01139580|581702288|FG000|Overall Study|Misrandomized|1|||
161085977|NCT01139580|581702289|FG001|Overall Study|Misrandomized|0|||
161085978|NCT01139580|581702288|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
161085979|NCT01139580|581702289|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
161085980|NCT01139580|581702288|FG000|Overall Study|Participant Randomization in Error|0|||
161085981|NCT01139580|581702289|FG001|Overall Study|Participant Randomization in Error|1|||
161085982|NCT01285609|581702290|FG000|Randomized|Progressive Disease|41|||
161085983|NCT01285609|581702291|FG001|Randomized|Progressive Disease|61|||
161085984|NCT01285609|581702290|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
161085985|NCT01285609|581702291|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
161085986|NCT01285609|581702290|FG000|Randomized|Study Drug Toxicity|13|||
161085987|NCT01285609|581702291|FG001|Randomized|Study Drug Toxicity|14|||
161085988|NCT01285609|581702290|FG000|Randomized|Death|5|||
161085989|NCT01285609|581702291|FG001|Randomized|Death|7|||
161085990|NCT01285609|581702290|FG000|Randomized|Withdrawal by Subject|8|||
161085991|NCT01285609|581702291|FG001|Randomized|Withdrawal by Subject|11|||
161085992|NCT01285609|581702290|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
161171423|NCT03970824|582003350|FG002|Overall Study|Adverse Event|0|||
161171424|NCT01736254|582003356|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
161171425|NCT01736254|582003356|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
161319400|NCT01134263|582555303|FG003|Overall Study|Protocol Violation|4|||
161085993|NCT01285609|581702291|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
161085994|NCT01285609|581702290|FG000|Randomized|Undisclosed Reasons|1|||
161085995|NCT01285609|581702291|FG001|Randomized|Undisclosed Reasons|0|||
161085996|NCT01285609|581702290|FG000|Randomized|Randomized but not Treated|4|||
161085997|NCT01285609|581702291|FG001|Randomized|Randomized but not Treated|4|||
161085998|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
161085999|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
161086000|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
161086001|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
161086002|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
161086003|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
161086004|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
161086005|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
161086006|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Death|11|||
161086007|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Death|3|||
161086008|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
161086009|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
161086010|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Not Reported|0|||
161086011|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Not Reported|2|||
161086012|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
161086013|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
161086014|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
161086015|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
161086016|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
161086017|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
161086018|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
161086019|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
161086020|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
161086021|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
161086022|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
161086023|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
161086024|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
161086025|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
161086026|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
161086027|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
161086028|NCT01285609|581702290|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
161086029|NCT01285609|581702291|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
161086030|NCT01285609|581702290|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
161086031|NCT01285609|581702291|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
161086032|NCT01142115|581702292|FG000|First Intervention|Lack of Efficacy|1|||
161086033|NCT01142115|581702293|FG001|First Intervention|Lack of Efficacy|1|||
161086034|NCT01142115|581702292|FG000|First Intervention|Adverse Event|1|||
161086035|NCT01142115|581702293|FG001|First Intervention|Adverse Event|0|||
161086036|NCT00760474|581702297|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
161086037|NCT00760474|581702298|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
161086038|NCT00760474|581702297|FG000|Placebo Washout Period|Other|0|||
161086039|NCT00760474|581702298|FG001|Placebo Washout Period|Other|1|||
161086040|NCT00760474|581702297|FG000|Period 2 (P2)|Lost to Follow-up|1|||
161086041|NCT00760474|581702298|FG001|Period 2 (P2)|Lost to Follow-up|0|||
161086042|NCT00760474|581702297|FG000|Period 2 (P2)|Adverse Event|0|||
161086043|NCT00760474|581702298|FG001|Period 2 (P2)|Adverse Event|1|||
161086044|NCT04664400|581702299|FG000|Overall Study|Withdrawal by Subject|2|||
161086045|NCT01394978|581702308|FG000|Overall Study|Withdrawal by Subject|2|||
161086046|NCT01394978|581702309|FG001|Overall Study|Withdrawal by Subject|4|||
161086047|NCT01394978|581702308|FG000|Overall Study|Lost to Follow-up|13|||
161086048|NCT01394978|581702309|FG001|Overall Study|Lost to Follow-up|20|||
161086049|NCT01394978|581702308|FG000|Overall Study|Death|6|||
161086050|NCT01394978|581702309|FG001|Overall Study|Death|7|||
161086051|NCT01758900|581702318|FG000|Overall Study|difficulty for further intubation|7|||
161086052|NCT01758900|581702319|FG001|Overall Study|difficulty for further intubation|8|||
161086053|NCT04577001|581702320|FG000|Overall Study|Subject became ineligible|0|||
161086054|NCT04577001|581702321|FG001|Overall Study|Subject became ineligible|1|||
161086055|NCT02594163|581704346|FG000|Treatment Period|Progressive disease|2|||
161086056|NCT02594163|581704347|FG001|Treatment Period|Progressive disease|3|||
161086057|NCT02594163|581704346|FG000|Treatment Period|Adverse Event|1|||
161086058|NCT02594163|581704347|FG001|Treatment Period|Adverse Event|5|||
161086059|NCT02594163|581704346|FG000|Treatment Period|Physician Decision|1|||
161086060|NCT02594163|581704347|FG001|Treatment Period|Physician Decision|3|||
161086061|NCT02594163|581704346|FG000|Treatment Period|Study termination by sponsor|2|||
161347377|NCT01001104|582656266|FG003|Overall Study|Entry Criteria Not Met|1|||
161347378|NCT01001104|582656263|FG000|Overall Study|Withdrawal by Subject|0|||
161347379|NCT01001104|582656264|FG001|Overall Study|Withdrawal by Subject|0|||
161347380|NCT01001104|582656265|FG002|Overall Study|Withdrawal by Subject|0|||
161347381|NCT01001104|582656266|FG003|Overall Study|Withdrawal by Subject|2|||
161347382|NCT02034591|582656267|FG000|Overall Study|Withdrawal by Subject|0|||
161347383|NCT02034591|582656268|FG001|Overall Study|Withdrawal by Subject|0|||
161347384|NCT02034591|582656269|FG002|Overall Study|Withdrawal by Subject|0|||
161347385|NCT02034591|582656270|FG003|Overall Study|Withdrawal by Subject|0|||
161086062|NCT02594163|581704347|FG001|Treatment Period|Study termination by sponsor|1|||
161086063|NCT02594163|581704346|FG000|Treatment Period|Other, Non-AE|1|||
161086064|NCT02594163|581704347|FG001|Treatment Period|Other, Non-AE|0|||
161086065|NCT02594163|581704346|FG000|Follow-up Period|Withdrawal by Subject|0|||
161086066|NCT02594163|581704347|FG001|Follow-up Period|Withdrawal by Subject|1|||
161086067|NCT02594163|581704346|FG000|Follow-up Period|Study Termination by Sponsor|6|||
161086068|NCT02594163|581704347|FG001|Follow-up Period|Study Termination by Sponsor|4|||
161086069|NCT02594163|581704346|FG000|Follow-up Period|Lost to Follow-up|1|||
161086070|NCT02594163|581704347|FG001|Follow-up Period|Lost to Follow-up|0|||
161086071|NCT02594163|581704346|FG000|Follow-up Period|Death|2|||
161086072|NCT02594163|581704347|FG001|Follow-up Period|Death|5|||
161086073|NCT02594163|581704346|FG000|Follow-up Period|Adverse Event|0|||
161086074|NCT02594163|581704347|FG001|Follow-up Period|Adverse Event|1|||
161086075|NCT02594163|581704346|FG000|Follow-up Period|Progressive Disease|2|||
161086076|NCT02594163|581704347|FG001|Follow-up Period|Progressive Disease|0|||
161086077|NCT02594163|581704346|FG000|Follow-up Period|Physician Decision|0|||
161086078|NCT02594163|581704347|FG001|Follow-up Period|Physician Decision|1|||
161086079|NCT01022268|581704350|FG000|Overall Study|Withdrawal by Subject|1|||
161086080|NCT01022268|581704351|FG001|Overall Study|Withdrawal by Subject|0|||
161086081|NCT01022268|581704350|FG000|Overall Study|Withdrawal by Subject|1|||
161086082|NCT01022268|581704351|FG001|Overall Study|Withdrawal by Subject|0|||
161086083|NCT00734097|581704352|FG000|Screening|Protocol Violation|12|||
161086084|NCT00734097|581704352|FG000|Screening|Withdrawal by Subject|5|||
161086085|NCT00734097|581704352|FG000|Screening|Lost to Follow-up|2|||
161086086|NCT00734097|581704352|FG000|Screening|Unconfirmed pregnancy|1|||
161086087|NCT00734097|581704352|FG000|Open Label|Lost to Follow-up|7|||
161086088|NCT00734097|581704352|FG000|Open Label|Withdrawal by Subject|5|||
161086089|NCT00734097|581704352|FG000|Open Label|Protocol Violation|4|||
161086090|NCT02233543|581704355|FG000|Period 1|Withdrawal by Subject|1|||
161086091|NCT02233543|581704356|FG001|Period 1|Withdrawal by Subject|0|||
161086092|NCT02233543|581704355|FG000|Period 1|Participants required other treatment.|2|||
161086093|NCT02233543|581704356|FG001|Period 1|Participants required other treatment.|3|||
161086094|NCT02233543|581704355|FG000|Period 2|Adverse Event|1|||
161086095|NCT02233543|581704356|FG001|Period 2|Adverse Event|0|||
161086096|NCT02233543|581704355|FG000|Period 2|Participant required other treatment.|0|||
161086097|NCT02233543|581704356|FG001|Period 2|Participant required other treatment.|1|||
161086098|NCT02233543|581704355|FG000|Period 2|COPD exacerbation|1|||
161086099|NCT02233543|581704356|FG001|Period 2|COPD exacerbation|0|||
161086100|NCT01302067|581704357|FG000|Overall Study|Death|0|||
161086101|NCT01302067|581704358|FG001|Overall Study|Death|0|||
161086102|NCT01302067|581704359|FG002|Overall Study|Death|1|||
161086103|NCT01302067|581704357|FG000|Overall Study|Physician Decision|9|||
161086104|NCT01302067|581704358|FG001|Overall Study|Physician Decision|5|||
161086105|NCT01302067|581704359|FG002|Overall Study|Physician Decision|14|||
161086106|NCT01302067|581704357|FG000|Overall Study|Lack of Efficacy|8|||
161086107|NCT01302067|581704358|FG001|Overall Study|Lack of Efficacy|4|||
161086108|NCT01302067|581704359|FG002|Overall Study|Lack of Efficacy|2|||
161086109|NCT01302067|581704357|FG000|Overall Study|Lost to Follow-up|9|||
161086110|NCT01302067|581704358|FG001|Overall Study|Lost to Follow-up|4|||
161086111|NCT01302067|581704359|FG002|Overall Study|Lost to Follow-up|15|||
161086112|NCT01302067|581704357|FG000|Overall Study|Withdrawal by Subject|13|||
161086113|NCT01302067|581704358|FG001|Overall Study|Withdrawal by Subject|6|||
161086114|NCT01302067|581704359|FG002|Overall Study|Withdrawal by Subject|10|||
161086115|NCT01302067|581704357|FG000|Overall Study|Other|1|||
161086116|NCT01302067|581704358|FG001|Overall Study|Other|1|||
161347386|NCT02034591|582656271|FG004|Overall Study|Withdrawal by Subject|1|||
161086117|NCT01302067|581704359|FG002|Overall Study|Other|3|||
161086118|NCT01302067|581704357|FG000|Overall Study|Protocol Violation|11|||
161086119|NCT01302067|581704358|FG001|Overall Study|Protocol Violation|0|||
161086120|NCT01302067|581704359|FG002|Overall Study|Protocol Violation|8|||
161347387|NCT02034591|582656272|FG005|Overall Study|Withdrawal by Subject|0|||
161347388|NCT00599313|582656275|FG000|Overall Study|Adverse Event|19|||
161086121|NCT01302067|581704357|FG000|Overall Study|Adverse Event|27|||
161086122|NCT01302067|581704358|FG001|Overall Study|Adverse Event|14|||
161086123|NCT01302067|581704359|FG002|Overall Study|Adverse Event|45|||
161086124|NCT02924428|581704360|FG000|Overall Study|Adverse Event|1|||
161086125|NCT02924428|581704361|FG001|Overall Study|Adverse Event|0|||
161086126|NCT02924428|581704360|FG000|Overall Study|Physician Decision|1|||
161086127|NCT02924428|581704361|FG001|Overall Study|Physician Decision|0|||
161086128|NCT02924428|581704360|FG000|Overall Study|Lost to Follow-up|2|||
161086129|NCT02924428|581704361|FG001|Overall Study|Lost to Follow-up|4|||
161347389|NCT00599313|582656275|FG000|Overall Study|Disease Progression|12|||
161086130|NCT02924428|581704360|FG000|Overall Study|Pregnancy|0|||
161086131|NCT02924428|581704361|FG001|Overall Study|Pregnancy|1|||
161086132|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
161086133|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
161086134|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
161086135|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
161086136|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
161086137|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
161086138|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
161086139|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
161086140|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
161086141|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
161086142|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
161086143|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
161086144|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
161086145|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
161086146|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
161086147|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
161086148|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
161086149|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
161086150|NCT02480153|581704362|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
161086151|NCT02480153|581704363|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
161086152|NCT02480153|581704364|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
161086153|NCT02480153|581704362|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
161086154|NCT02480153|581704363|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
161086155|NCT02480153|581704364|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
161086156|NCT02480153|581704362|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
161086157|NCT02480153|581704363|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
161086158|NCT02480153|581704364|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
161086159|NCT02480153|581704362|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
161086160|NCT02480153|581704363|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
161086161|NCT02480153|581704364|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
161086162|NCT02480153|581704362|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
161086163|NCT02480153|581704363|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
161086164|NCT02480153|581704364|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
161086165|NCT02480153|581704362|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
161086166|NCT02480153|581704363|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
161086167|NCT02480153|581704364|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
161086168|NCT02480153|581704362|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
161086169|NCT02480153|581704363|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
161086170|NCT02480153|581704364|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
161086171|NCT02480153|581704362|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
161086172|NCT02480153|581704363|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
161086173|NCT02480153|581704364|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
161086174|NCT02480153|581704362|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
161086175|NCT02480153|581704363|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
161086176|NCT02480153|581704364|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
161086177|NCT02480153|581704362|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
161086178|NCT02480153|581704363|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
161086179|NCT02480153|581704364|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
161086180|NCT02480153|581704362|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
161086181|NCT02480153|581704363|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
161086182|NCT02480153|581704364|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
161086183|NCT02480153|581704362|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
161086184|NCT02480153|581704363|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
161086185|NCT02480153|581704364|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
161086186|NCT03241225|581704368|FG000|Overall Study|Lost to Follow-up|2|||
161086187|NCT03241225|581704369|FG001|Overall Study|Lost to Follow-up|1|||
161086188|NCT03241225|581704368|FG000|Overall Study|Protocol Violation|4|||
161171426|NCT00107172|582005011|FG000|Overall Study|Withdrawal by Subject|1|||
161171427|NCT00107172|582005012|FG001|Overall Study|Withdrawal by Subject|0|||
161171428|NCT00107172|582005011|FG000|Overall Study|Death|0|||
161086189|NCT03241225|581704369|FG001|Overall Study|Protocol Violation|1|||
161086190|NCT03241225|581704368|FG000|Overall Study|Withdrawal by Subject|1|||
161086191|NCT03241225|581704369|FG001|Overall Study|Withdrawal by Subject|0|||
161086192|NCT00852540|581704370|FG000|Overall Study|Adverse Event|10|||
161171429|NCT00107172|582005012|FG001|Overall Study|Death|2|||
161086193|NCT00852540|581704371|FG001|Overall Study|Adverse Event|3|||
161086194|NCT00852540|581704370|FG000|Overall Study|Lack of Efficacy|15|||
161086195|NCT00852540|581704371|FG001|Overall Study|Lack of Efficacy|3|||
161086196|NCT00852540|581704370|FG000|Overall Study|Protocol Violation|1|||
161086197|NCT00852540|581704371|FG001|Overall Study|Protocol Violation|2|||
161086198|NCT00852540|581704370|FG000|Overall Study|Lost to Follow-up|2|||
161086199|NCT00852540|581704371|FG001|Overall Study|Lost to Follow-up|3|||
161086200|NCT00852540|581704370|FG000|Overall Study|Investigator Discretion|2|||
161086201|NCT00852540|581704371|FG001|Overall Study|Investigator Discretion|3|||
161086202|NCT00852540|581704370|FG000|Overall Study|Withdrawal by Subject|3|||
161086203|NCT00852540|581704371|FG001|Overall Study|Withdrawal by Subject|1|||
161086204|NCT00852540|581704370|FG000|Overall Study|Did Not Receive Study Drug|3|||
161086205|NCT00852540|581704371|FG001|Overall Study|Did Not Receive Study Drug|3|||
161086206|NCT04875676|581704381|FG000|Overall Study|Lost to Follow-up|1|||
161086207|NCT04875676|581704382|FG001|Overall Study|Lost to Follow-up|0|||
161086208|NCT04875676|581704383|FG002|Overall Study|Lost to Follow-up|0|||
161086209|NCT03064035|581704384|FG000|Overall Study|Did not receive allocated intervention|4|||
161086210|NCT03064035|581704385|FG001|Overall Study|Did not receive allocated intervention|2|||
161086211|NCT03064035|581704384|FG000|Overall Study|Lost to Follow-up|1|||
161171430|NCT00107172|582005011|FG000|Overall Study|Other Reason|4|||
161171431|NCT00107172|582005012|FG001|Overall Study|Other Reason|3|||
161171432|NCT04432376|582005013|FG000|Double-blind Treatment Period|Adverse Event|2|||
161171433|NCT04432376|582005014|FG001|Double-blind Treatment Period|Adverse Event|6|||
161171434|NCT04432376|582005015|FG002|Double-blind Treatment Period|Adverse Event|0|||
161171435|NCT04432376|582005013|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
161171436|NCT04432376|582005014|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161171437|NCT04432376|582005015|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161171438|NCT04432376|582005013|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161171439|NCT04432376|582005014|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161171440|NCT04432376|582005015|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161171441|NCT04432376|582005013|FG000|Double-blind Treatment Period|Protocol Violation|0|||
161171442|NCT04432376|582005014|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161171443|NCT04432376|582005015|FG002|Double-blind Treatment Period|Protocol Violation|0|||
161171444|NCT04432376|582005013|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
161171445|NCT04432376|582005014|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
161171446|NCT04432376|582005015|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
161171447|NCT01673490|582005016|FG000|Overall Study|Lost to Follow-up|1|||
161171448|NCT01673490|582005016|FG000|Overall Study|Adverse Event|3|||
161171449|NCT01673490|582005016|FG000|Overall Study|Withdrawal by Subject|3|||
161171450|NCT01711541|582005019|FG000|Overall Study|Cancel prior to treatment|0|||
161171451|NCT01711541|582005020|FG001|Overall Study|Cancel prior to treatment|0|||
161171452|NCT01711541|582005021|FG002|Overall Study|Cancel prior to treatment|0|||
161171453|NCT01711541|582005022|FG003|Overall Study|Cancel prior to treatment|1|||
161171454|NCT01711541|582005023|FG004|Overall Study|Cancel prior to treatment|0|||
161171455|NCT01711541|582005019|FG000|Overall Study|Ineligible|0|||
161171456|NCT01711541|582005020|FG001|Overall Study|Ineligible|1|||
161171457|NCT01711541|582005021|FG002|Overall Study|Ineligible|0|||
161171458|NCT01711541|582005022|FG003|Overall Study|Ineligible|0|||
161171459|NCT01711541|582005023|FG004|Overall Study|Ineligible|0|||
161171460|NCT00728936|582005024|FG000|Overall Study|Withdrawal by Subject|0|||
161171461|NCT00728936|582005025|FG001|Overall Study|Withdrawal by Subject|0|||
161171462|NCT00728936|582005026|FG002|Overall Study|Withdrawal by Subject|0|||
161171463|NCT00728936|582005027|FG003|Overall Study|Withdrawal by Subject|0|||
161171464|NCT00728936|582005028|FG004|Overall Study|Withdrawal by Subject|0|||
161171465|NCT00728936|582005029|FG005|Overall Study|Withdrawal by Subject|1|||
161171466|NCT00728936|582005030|FG006|Overall Study|Withdrawal by Subject|0|||
161171467|NCT00438464|582005031|FG000|Overall Study|Terminated Early|14|||
161171468|NCT00438464|582005032|FG001|Overall Study|Terminated Early|5|||
161171469|NCT00438464|582005031|FG000|Overall Study|Incomplete data submission|0|||
161171470|NCT00438464|582005032|FG001|Overall Study|Incomplete data submission|2|||
161171471|NCT03943446|582005033|FG000|Overall Study|Lost to Follow-up|0|||
161171472|NCT03943446|582005034|FG001|Overall Study|Lost to Follow-up|0|||
161347390|NCT00599313|582656275|FG000|Overall Study|Patient Request|4|||
161347391|NCT00599313|582656275|FG000|Overall Study|Ineligible|1|||
161086212|NCT03064035|581704385|FG001|Overall Study|Lost to Follow-up|1|||
161171473|NCT03943446|582005035|FG002|Overall Study|Lost to Follow-up|1|||
161171474|NCT03943446|582005033|FG000|Overall Study|Withdrawal by Subject|1|||
161171475|NCT03943446|582005034|FG001|Overall Study|Withdrawal by Subject|1|||
161171476|NCT03943446|582005035|FG002|Overall Study|Withdrawal by Subject|2|||
161171477|NCT03943446|582005033|FG000|Overall Study|Study Terminated by Sponsor|1|||
161347392|NCT01121926|582656276|FG000|First Intervention Period|Adverse Event|1|||
161347393|NCT01121926|582656277|FG001|First Intervention Period|Adverse Event|0|||
161086213|NCT03103763|581704388|FG000|Overall Study|Death|15|||
161086214|NCT03103763|581704389|FG001|Overall Study|Death|5|||
161086215|NCT03103763|581704390|FG002|Overall Study|Death|5|||
161086216|NCT03103763|581704388|FG000|Overall Study|Withdrawal by Subject|0|||
161171478|NCT03943446|582005034|FG001|Overall Study|Study Terminated by Sponsor|2|||
161171479|NCT03943446|582005035|FG002|Overall Study|Study Terminated by Sponsor|1|||
161171480|NCT03943446|582005033|FG000|Overall Study|Reason not Specified|5|||
161171481|NCT03943446|582005034|FG001|Overall Study|Reason not Specified|1|||
161171482|NCT03943446|582005035|FG002|Overall Study|Reason not Specified|3|||
161171483|NCT02905825|582005043|FG000|Overall Study|Protocol Violation|11|||
161171484|NCT02905825|582005043|FG000|Overall Study|Device Malfunction|1|||
161171485|NCT05355818|582005044|FG000|Overall Study|Adverse Event|1|||
161171486|NCT05355818|582005045|FG001|Overall Study|Adverse Event|1|||
161171487|NCT05355818|582005044|FG000|Overall Study|Lack of Efficacy|2|||
161171488|NCT05355818|582005045|FG001|Overall Study|Lack of Efficacy|1|||
161171489|NCT05355818|582005044|FG000|Overall Study|Lost to Follow-up|0|||
161171490|NCT05355818|582005045|FG001|Overall Study|Lost to Follow-up|1|||
161171491|NCT01601704|582005046|FG000|Overall Study|Randomized but not dispensed study med|1|||
161171492|NCT01601704|582005047|FG001|Overall Study|Randomized but not dispensed study med|4|||
161171493|NCT00527072|582005049|FG000|Overall Study|Adverse Event|13|||
161171494|NCT00527072|582005049|FG000|Overall Study|Lack of Efficacy|11|||
161171495|NCT00527072|582005049|FG000|Overall Study|Lost to Follow-up|3|||
161171496|NCT00527072|582005049|FG000|Overall Study|Protocol Violation|2|||
161171497|NCT00527072|582005049|FG000|Overall Study|Withdrawal by Subject|7|||
161171498|NCT02657434|582005050|FG000|Overall Study|Study Terminated By Sponsor|64|||
161171499|NCT02657434|582005051|FG001|Overall Study|Study Terminated By Sponsor|82|||
161171500|NCT02657434|582005050|FG000|Overall Study|Death|189|||
161171501|NCT02657434|582005051|FG001|Overall Study|Death|190|||
161171502|NCT02657434|582005050|FG000|Overall Study|Lost to Follow-up|2|||
161171503|NCT02657434|582005051|FG001|Overall Study|Lost to Follow-up|2|||
161171504|NCT02657434|582005050|FG000|Overall Study|Randomization by Error|2|||
161171505|NCT02657434|582005051|FG001|Overall Study|Randomization by Error|0|||
161171506|NCT02657434|582005050|FG000|Overall Study|Withdrawal by Subject|28|||
161171507|NCT02657434|582005051|FG001|Overall Study|Withdrawal by Subject|17|||
161171508|NCT02657434|582005050|FG000|Overall Study|Protocol Violation|1|||
161171509|NCT02657434|582005051|FG001|Overall Study|Protocol Violation|0|||
161171510|NCT02657434|582005050|FG000|Overall Study|Physician Decision|0|||
161171511|NCT02657434|582005051|FG001|Overall Study|Physician Decision|1|||
161171512|NCT04897594|582005054|FG000|Overall Study|Lost to Follow-up|0|||
161171513|NCT04897594|582005055|FG001|Overall Study|Lost to Follow-up|1|||
161171514|NCT04897594|582005056|FG002|Overall Study|Lost to Follow-up|1|||
161171515|NCT04897594|582005054|FG000|Overall Study|Sponsor Decision|0|||
161171516|NCT04897594|582005055|FG001|Overall Study|Sponsor Decision|0|||
161171517|NCT04897594|582005056|FG002|Overall Study|Sponsor Decision|1|||
161171518|NCT04897594|582005054|FG000|Overall Study|Withdrawal by Subject|1|||
161171519|NCT04897594|582005055|FG001|Overall Study|Withdrawal by Subject|0|||
161171520|NCT04897594|582005056|FG002|Overall Study|Withdrawal by Subject|1|||
161171521|NCT02147691|582005059|FG000|Overall Study|Withdrawal by Subject|2|||
161171522|NCT02147691|582005060|FG001|Overall Study|Withdrawal by Subject|0|||
161171523|NCT02147691|582005059|FG000|Overall Study|Adverse Event|2|||
161171524|NCT02147691|582005060|FG001|Overall Study|Adverse Event|0|||
161171525|NCT02147691|582005059|FG000|Overall Study|Lost to Follow-up|0|||
161171526|NCT02147691|582005060|FG001|Overall Study|Lost to Follow-up|1|||
161171527|NCT05014542|582005064|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
161171528|NCT05014542|582005065|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
161171529|NCT05014542|582005064|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
161171530|NCT05014542|582005065|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
161171531|NCT05014542|582005064|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
161171532|NCT05014542|582005065|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
161171533|NCT05014542|582005064|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
161171534|NCT05014542|582005065|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
161171535|NCT01896856|582005068|FG000|Overall Study|Transportation issues / Non-compliance|0|||
161171536|NCT01896856|582005069|FG001|Overall Study|Transportation issues / Non-compliance|0|||
161171537|NCT01896856|582005070|FG002|Overall Study|Transportation issues / Non-compliance|1|||
161171538|NCT01896856|582005071|FG003|Overall Study|Transportation issues / Non-compliance|0|||
161171539|NCT01896856|582005072|FG004|Overall Study|Transportation issues / Non-compliance|0|||
161292497|NCT05400655|582452109|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
161292498|NCT05400655|582452110|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
161171540|NCT01896856|582005073|FG005|Overall Study|Transportation issues / Non-compliance|0|||
161171541|NCT01156532|582005074|FG000|Overall Study|Family Reasons|1|||
161171542|NCT01156532|582005074|FG000|Overall Study|Lost to Follow-up|1|||
161171543|NCT02563925|582005077|FG000|Overall Study|Withdrawal by Subject|2|||
161171544|NCT00282867|582005081|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
161171545|NCT00282867|582005082|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
161171546|NCT00282867|582005083|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
161171547|NCT00673894|582005096|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
161171548|NCT00673894|582005097|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
161171549|NCT00673894|582005096|FG000|First Intervention 4 Weeks|Adverse Event|1|||
161171550|NCT00673894|582005097|FG001|First Intervention 4 Weeks|Adverse Event|0|||
161171551|NCT01688635|582005105|FG000|Washout 1|Withdrawal by Subject|1|||
161171552|NCT01688635|582005106|FG001|Washout 1|Withdrawal by Subject|0|||
161171553|NCT01688635|582005105|FG000|Washout 1|Adverse Event|0|||
161171554|NCT01688635|582005106|FG001|Washout 1|Adverse Event|1|||
161171555|NCT01688635|582005105|FG000|Washout 1|Physician Decision|0|||
161171556|NCT01688635|582005106|FG001|Washout 1|Physician Decision|1|||
161171557|NCT01688635|582005105|FG000|Washout 2|Physician Decision|1|||
161171558|NCT01688635|582005106|FG001|Washout 2|Physician Decision|0|||
161171559|NCT01688635|582005105|FG000|Washout 2|Withdrawal by Subject|1|||
161171560|NCT01688635|582005106|FG001|Washout 2|Withdrawal by Subject|0|||
161171561|NCT01688635|582005105|FG000|Washout 2|Sponsor Decision|1|||
161171562|NCT01688635|582005106|FG001|Washout 2|Sponsor Decision|2|||
161171563|NCT01688635|582005105|FG000|Washout 3|Withdrawal by Subject|1|||
161171564|NCT01688635|582005106|FG001|Washout 3|Withdrawal by Subject|0|||
161171565|NCT02674685|582005107|FG000|Overall Study|Withdrawal by Subject|4|||
161171566|NCT01181778|582005108|FG000|Overall Study|Physician Decision|48|||
161171567|NCT02726113|582005114|FG000|Total Enrollment|Physician Decision|0|||
161171568|NCT02726113|582005115|FG001|Total Enrollment|Physician Decision|1|||
161171569|NCT02726113|582005114|FG000|Total Enrollment|Protocol Violation|1|||
161171570|NCT02726113|582005115|FG001|Total Enrollment|Protocol Violation|0|||
161171571|NCT02726113|582005114|FG000|Total Enrollment|Withdrawal by Subject|2|||
161171572|NCT02726113|582005115|FG001|Total Enrollment|Withdrawal by Subject|1|||
161171573|NCT02726113|582005114|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
161171574|NCT02726113|582005115|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
161171575|NCT02726113|582005114|FG000|Genomic Analysis|Protocol Violation|1|||
161171576|NCT02726113|582005115|FG001|Genomic Analysis|Protocol Violation|0|||
161171577|NCT02726113|582005114|FG000|Genomic Analysis|Withdrawal by Subject|2|||
161171578|NCT02726113|582005115|FG001|Genomic Analysis|Withdrawal by Subject|1|||
161171579|NCT02726113|582005114|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
161171580|NCT02726113|582005115|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
161171581|NCT03549117|582005116|FG000|Overall Study|Withdrawal by Subject|1|||
161171582|NCT03549117|582005117|FG001|Overall Study|Withdrawal by Subject|0|||
161171583|NCT02661464|582005118|FG000|Overall Study|Lost to Follow-up|28|||
161171584|NCT02661464|582005119|FG001|Overall Study|Lost to Follow-up|0|||
161171585|NCT02661464|582005120|FG002|Overall Study|Lost to Follow-up|0|||
161171586|NCT02661464|582005121|FG003|Overall Study|Lost to Follow-up|0|||
161171587|NCT02661464|582005118|FG000|Overall Study|Withdrawal by Subject|3|||
161171588|NCT02661464|582005119|FG001|Overall Study|Withdrawal by Subject|1|||
161171589|NCT02661464|582005120|FG002|Overall Study|Withdrawal by Subject|0|||
161171590|NCT02661464|582005121|FG003|Overall Study|Withdrawal by Subject|0|||
161171591|NCT02661464|582005118|FG000|Overall Study|Participants terminated prematurely|288|||
161171592|NCT02661464|582005119|FG001|Overall Study|Participants terminated prematurely|52|||
161171593|NCT02661464|582005120|FG002|Overall Study|Participants terminated prematurely|1|||
161171594|NCT02661464|582005121|FG003|Overall Study|Participants terminated prematurely|1|||
161171595|NCT02661464|582005118|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
161171596|NCT02661464|582005119|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
161171597|NCT02661464|582005120|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
161171598|NCT02661464|582005121|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
161171599|NCT03148756|582005123|FG000|Overall Study|Study Terminated|0|||
161171600|NCT03148756|582005124|FG001|Overall Study|Study Terminated|1|||
161171601|NCT05567393|582005125|FG000|Overall Study|Voluntary Withdrawal|0|||
161171602|NCT05567393|582005126|FG001|Overall Study|Voluntary Withdrawal|0|||
161171603|NCT05567393|582005127|FG002|Overall Study|Voluntary Withdrawal|0|||
161171604|NCT05567393|582005128|FG003|Overall Study|Voluntary Withdrawal|0|||
161171605|NCT05567393|582005129|FG004|Overall Study|Voluntary Withdrawal|0|||
161171606|NCT05567393|582005130|FG005|Overall Study|Voluntary Withdrawal|0|||
161171607|NCT05567393|582005131|FG006|Overall Study|Voluntary Withdrawal|0|||
161171608|NCT05567393|582005132|FG007|Overall Study|Voluntary Withdrawal|0|||
161171609|NCT05567393|582005133|FG008|Overall Study|Voluntary Withdrawal|0|||
161171610|NCT05567393|582005134|FG009|Overall Study|Voluntary Withdrawal|0|||
161171611|NCT05567393|582005135|FG010|Overall Study|Voluntary Withdrawal|0|||
161292499|NCT05400655|582452111|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
161292500|NCT01611935|582452120|FG000|Overall Study|Family Declined Participation|1|||
161171612|NCT05567393|582005136|FG011|Overall Study|Voluntary Withdrawal|0|||
161171613|NCT05567393|582005137|FG012|Overall Study|Voluntary Withdrawal|0|||
161171614|NCT05567393|582005138|FG013|Overall Study|Voluntary Withdrawal|1|||
161171615|NCT05567393|582005139|FG014|Overall Study|Voluntary Withdrawal|0|||
161171616|NCT05567393|582005140|FG015|Overall Study|Voluntary Withdrawal|0|||
161171617|NCT05567393|582005141|FG016|Overall Study|Voluntary Withdrawal|0|||
161171618|NCT05567393|582005142|FG017|Overall Study|Voluntary Withdrawal|0|||
161171619|NCT01924299|582005146|FG000|Period 2|Withdrawal by Subject|1|||
161171620|NCT01924299|582005147|FG001|Period 2|Withdrawal by Subject|0|||
161171621|NCT01924299|582005146|FG000|Period 2|Adverse Event|0|||
161171622|NCT01924299|582005147|FG001|Period 2|Adverse Event|1|||
161171623|NCT02177175|582005148|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
161171624|NCT02177175|582005149|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
161171625|NCT04199793|582005150|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
161171626|NCT04199793|582005151|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
161171627|NCT04199793|582005150|FG000|Overall Study|Withdrawal by Subject|1|||
161171628|NCT04199793|582005151|FG001|Overall Study|Withdrawal by Subject|1|||
161171629|NCT03820726|582005152|FG000|Overall Study|Other than listed|23|||
161171630|NCT03820726|582005152|FG000|Overall Study|Withdrawal by Subject|37|||
161171631|NCT03820726|582005152|FG000|Overall Study|Lost to Follow-up|3|||
161171632|NCT03820726|582005152|FG000|Overall Study|Protocol deviation|1|||
161171633|NCT03820726|582005152|FG000|Overall Study|Adverse Event|146|||
161171634|NCT03820726|582005152|FG000|Overall Study|Not treated|1|||
161171635|NCT00141037|582005156|FG000|Overall Study|Physician Decision|1|||
161171636|NCT00141037|582005157|FG001|Overall Study|Physician Decision|2|||
161171637|NCT00141037|582005156|FG000|Overall Study|Lost to Follow-up|3|||
161171638|NCT00141037|582005157|FG001|Overall Study|Lost to Follow-up|1|||
161171639|NCT00141037|582005156|FG000|Overall Study|Protocol Violation|0|||
161171640|NCT00141037|582005157|FG001|Overall Study|Protocol Violation|2|||
161171641|NCT00141037|582005156|FG000|Overall Study|Withdrawal by Subject|2|||
161171642|NCT00141037|582005157|FG001|Overall Study|Withdrawal by Subject|1|||
161171643|NCT00141037|582005156|FG000|Overall Study|Other|0|||
161171644|NCT00141037|582005157|FG001|Overall Study|Other|1|||
161171645|NCT00141037|582005156|FG000|Overall Study|Moved from area|1|||
161171646|NCT00141037|582005157|FG001|Overall Study|Moved from area|7|||
161171647|NCT00141037|582005156|FG000|Overall Study|Graft Failure|3|||
161171648|NCT00141037|582005157|FG001|Overall Study|Graft Failure|4|||
161171649|NCT00888615|582005158|FG000|Overall Study|No treatment|2|||
161171650|NCT00861380|582005159|FG000|Overall Study|Withdrawal Information not recorded|8427|||
161171651|NCT00861380|582005160|FG001|Overall Study|Withdrawal Information not recorded|9112|||
161086217|NCT03103763|581704389|FG001|Overall Study|Withdrawal by Subject|3|||
161086218|NCT03103763|581704390|FG002|Overall Study|Withdrawal by Subject|2|||
161086219|NCT02336178|581704391|FG000|Overall Study|Lost to Follow-up|1|||
161086220|NCT02336178|581704391|FG000|Overall Study|Protocol Violation|1|||
161086221|NCT02336178|581704391|FG000|Overall Study|Withdrawal by Subject|1|||
161086222|NCT02336178|581704391|FG000|Overall Study|Other|1|||
161086223|NCT03245151|581704392|FG000|Overall Study|Withdrawal by Subject|2|||
161086224|NCT03245151|581704393|FG001|Overall Study|Withdrawal by Subject|0|||
161086225|NCT03245151|581704394|FG002|Overall Study|Withdrawal by Subject|0|||
161086226|NCT03245151|581704395|FG003|Overall Study|Withdrawal by Subject|2|||
161086227|NCT03245151|581704396|FG004|Overall Study|Withdrawal by Subject|1|||
161086228|NCT03245151|581704392|FG000|Overall Study|Death|3|||
161086229|NCT03245151|581704393|FG001|Overall Study|Death|14|||
161086230|NCT03245151|581704394|FG002|Overall Study|Death|9|||
161086231|NCT03245151|581704395|FG003|Overall Study|Death|16|||
161086232|NCT03245151|581704396|FG004|Overall Study|Death|7|||
161086233|NCT03245151|581704392|FG000|Overall Study|Sponsor's decision|0|||
161086234|NCT03245151|581704393|FG001|Overall Study|Sponsor's decision|1|||
161086235|NCT03245151|581704394|FG002|Overall Study|Sponsor's decision|0|||
161086236|NCT03245151|581704395|FG003|Overall Study|Sponsor's decision|0|||
161086237|NCT03245151|581704396|FG004|Overall Study|Sponsor's decision|0|||
161086238|NCT01970345|581704397|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
161086239|NCT01970345|581704398|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
161086240|NCT01970345|581704397|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
161086241|NCT01970345|581704398|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
161086242|NCT01346475|581704399|FG000|First Intervention|Lost to Follow-up|4|||
161086243|NCT01346475|581704400|FG001|First Intervention|Lost to Follow-up|3|||
161086244|NCT00558259|581704401|FG000|Overall Study|Adverse Event|50|||
161086245|NCT00558259|581704402|FG001|Overall Study|Adverse Event|81|||
161086246|NCT00558259|581704401|FG000|Overall Study|Protocol Violation|9|||
161086247|NCT00558259|581704402|FG001|Overall Study|Protocol Violation|5|||
161086248|NCT00558259|581704401|FG000|Overall Study|Withdrawal by Subject|12|||
161086249|NCT00558259|581704402|FG001|Overall Study|Withdrawal by Subject|13|||
161086250|NCT00700258|581704409|FG000|Overall Study|Premature discontinuation of documentation|136|||
161086251|NCT00700258|581704409|FG000|Overall Study|Type of study end not documented|1|||
161171652|NCT00861380|582005161|FG002|Overall Study|Withdrawal Information not recorded|8872|||
161171653|NCT00861380|582005162|FG003|Overall Study|Withdrawal Information not recorded|3689|||
161171654|NCT00861380|582005163|FG004|Overall Study|Withdrawal Information not recorded|1812|||
161171655|NCT00861380|582005164|FG005|Overall Study|Withdrawal Information not recorded|6249|||
161292501|NCT01611935|582452121|FG001|Overall Study|Family Declined Participation|0|||
161086252|NCT00700258|581704409|FG000|Overall Study|Lost to Follow-up|81|||
161086253|NCT00700258|581704409|FG000|Overall Study|Premature discontinuation of therapy|1013|||
161086254|NCT00473265|581704410|FG000|Overall Study|Unrelated adverse event|5|||
161086255|NCT00473265|581704410|FG000|Overall Study|Off treatment early|15|||
161086256|NCT02663518|581704413|FG000|Part 1: Phase 1a Escalation|Death|0|||
161086257|NCT02663518|581704414|FG001|Part 1: Phase 1a Escalation|Death|0|||
161086258|NCT02663518|581704415|FG002|Part 1: Phase 1a Escalation|Death|1|||
161171656|NCT00861380|582005165|FG006|Overall Study|Withdrawal Information not recorded|3020|||
161171657|NCT00628758|582005166|FG000|Overall Study|Adverse Event|2|||
161171658|NCT00628758|582005167|FG001|Overall Study|Adverse Event|3|||
161171659|NCT00628758|582005166|FG000|Overall Study|Withdrawal by Subject|6|||
161171660|NCT00628758|582005167|FG001|Overall Study|Withdrawal by Subject|3|||
161171661|NCT00628758|582005166|FG000|Overall Study|Death|1|||
161171662|NCT00628758|582005167|FG001|Overall Study|Death|0|||
161171663|NCT00628758|582005166|FG000|Overall Study|Protocol Violation|5|||
161171664|NCT00628758|582005167|FG001|Overall Study|Protocol Violation|1|||
161171665|NCT00628758|582005166|FG000|Overall Study|Lost to Follow-up|25|||
161171666|NCT00628758|582005167|FG001|Overall Study|Lost to Follow-up|31|||
161171667|NCT00628758|582005166|FG000|Overall Study|Pregnancy|2|||
161171668|NCT00628758|582005167|FG001|Overall Study|Pregnancy|2|||
161171669|NCT00628758|582005166|FG000|Overall Study|Investigator Moved|3|||
161171670|NCT00628758|582005167|FG001|Overall Study|Investigator Moved|0|||
161171671|NCT00628758|582005166|FG000|Overall Study|Treatment Failure|0|||
161171672|NCT00628758|582005167|FG001|Overall Study|Treatment Failure|2|||
161171673|NCT00637377|582005168|FG000|Overall Study|Adverse Event|2|||
161171674|NCT00637377|582005169|FG001|Overall Study|Adverse Event|6|||
161171675|NCT00637377|582005170|FG002|Overall Study|Adverse Event|8|||
161171676|NCT00637377|582005171|FG003|Overall Study|Adverse Event|9|||
161171677|NCT00637377|582005168|FG000|Overall Study|Death|1|||
161171678|NCT00637377|582005169|FG001|Overall Study|Death|3|||
161171679|NCT00637377|582005170|FG002|Overall Study|Death|2|||
161171680|NCT00637377|582005171|FG003|Overall Study|Death|1|||
161171681|NCT00637377|582005168|FG000|Overall Study|Lack of Efficacy|0|||
161171682|NCT00637377|582005169|FG001|Overall Study|Lack of Efficacy|0|||
161171683|NCT00637377|582005170|FG002|Overall Study|Lack of Efficacy|1|||
161171684|NCT00637377|582005171|FG003|Overall Study|Lack of Efficacy|1|||
161171685|NCT00637377|582005168|FG000|Overall Study|Lost to Follow-up|4|||
161171686|NCT00637377|582005169|FG001|Overall Study|Lost to Follow-up|1|||
161171687|NCT00637377|582005170|FG002|Overall Study|Lost to Follow-up|2|||
161171688|NCT00637377|582005171|FG003|Overall Study|Lost to Follow-up|2|||
161171689|NCT00637377|582005168|FG000|Overall Study|Protocol Violation|2|||
161171690|NCT00637377|582005169|FG001|Overall Study|Protocol Violation|1|||
161171691|NCT00637377|582005170|FG002|Overall Study|Protocol Violation|1|||
161171692|NCT00637377|582005171|FG003|Overall Study|Protocol Violation|0|||
161171693|NCT00637377|582005168|FG000|Overall Study|Withdrawal by Subject|11|||
161171694|NCT00637377|582005169|FG001|Overall Study|Withdrawal by Subject|15|||
161171695|NCT00637377|582005170|FG002|Overall Study|Withdrawal by Subject|13|||
161171696|NCT00637377|582005171|FG003|Overall Study|Withdrawal by Subject|11|||
161171697|NCT00637377|582005168|FG000|Overall Study|Other (no further information available)|7|||
161171698|NCT00637377|582005169|FG001|Overall Study|Other (no further information available)|6|||
161171699|NCT00637377|582005170|FG002|Overall Study|Other (no further information available)|10|||
161171700|NCT00637377|582005171|FG003|Overall Study|Other (no further information available)|5|||
161171701|NCT01293084|582005172|FG000|Overall Study|Physician Decision|3|||
161171702|NCT01293084|582005172|FG000|Overall Study|Withdrawal by Subject|2|||
161171703|NCT01184846|582005177|FG000|Overall Study|Adverse Event|2|||
161171704|NCT01184846|582005177|FG000|Overall Study|Insufficient response|1|||
161171705|NCT04021706|582007313|FG000|Overall Study|Adverse Event|2|||
161171706|NCT04021706|582007314|FG001|Overall Study|Adverse Event|0|||
161171707|NCT04021706|582007313|FG000|Overall Study|Withdrawal by Subject|1|||
161171708|NCT04021706|582007314|FG001|Overall Study|Withdrawal by Subject|2|||
161171709|NCT04021706|582007313|FG000|Overall Study|Physician Decision|1|||
161171710|NCT04021706|582007314|FG001|Overall Study|Physician Decision|0|||
161171711|NCT02332798|582007315|FG000|Overall Study|Unwilling to Participate in Study|0|||
161171712|NCT02332798|582007316|FG001|Overall Study|Unwilling to Participate in Study|1|||
161171713|NCT02332798|582007317|FG002|Overall Study|Unwilling to Participate in Study|1|||
161171714|NCT02332798|582007315|FG000|Overall Study|Positive Urine Drug Test|0|||
161171715|NCT02332798|582007316|FG001|Overall Study|Positive Urine Drug Test|1|||
161171716|NCT02332798|582007317|FG002|Overall Study|Positive Urine Drug Test|0|||
161171717|NCT02332798|582007315|FG000|Overall Study|Abnormal Laboratory Findings|1|||
161171718|NCT02332798|582007316|FG001|Overall Study|Abnormal Laboratory Findings|0|||
161171719|NCT02332798|582007317|FG002|Overall Study|Abnormal Laboratory Findings|0|||
161171720|NCT00595868|582007318|FG000|Overall Study|Lost to Follow-up|45|||
161171721|NCT00595868|582007319|FG001|Overall Study|Lost to Follow-up|50|||
161171722|NCT02688153|582007320|FG000|Overall Study|Death|7|||
161171723|NCT02688153|582007321|FG001|Overall Study|Death|5|||
161171724|NCT02688153|582007320|FG000|Overall Study|Withdrawal by Subject|4|||
161171725|NCT02688153|582007321|FG001|Overall Study|Withdrawal by Subject|2|||
161171726|NCT02688153|582007320|FG000|Overall Study|Valve Explant|1|||
161171727|NCT02688153|582007321|FG001|Overall Study|Valve Explant|0|||
161171728|NCT02688153|582007320|FG000|Overall Study|Conversion to Commercial Valve|3|||
161171729|NCT02688153|582007321|FG001|Overall Study|Conversion to Commercial Valve|0|||
161171730|NCT00859573|582007322|FG000|Overall Study|Withdrawal by Subject|4|||
161171731|NCT00859573|582007323|FG001|Overall Study|Withdrawal by Subject|1|||
161171732|NCT00859573|582007322|FG000|Overall Study|Physician Decision|1|||
161171733|NCT00859573|582007323|FG001|Overall Study|Physician Decision|1|||
161292502|NCT04227197|582452122|FG000|Randomization|Protocol Violation|1|||
161292503|NCT04227197|582452123|FG001|Randomization|Protocol Violation|0|||
161086259|NCT02663518|581704416|FG003|Part 1: Phase 1a Escalation|Death|0|||
161086260|NCT02663518|581704417|FG004|Part 1: Phase 1a Escalation|Death|0|||
161086261|NCT02663518|581704418|FG005|Part 1: Phase 1a Escalation|Death|0|||
161086262|NCT02663518|581704419|FG006|Part 1: Phase 1a Escalation|Death|0|||
161086263|NCT02663518|581704420|FG007|Part 1: Phase 1a Escalation|Death|0|||
161086264|NCT02663518|581704421|FG008|Part 1: Phase 1a Escalation|Death|0|||
161086265|NCT02663518|581704422|FG009|Part 1: Phase 1a Escalation|Death|0|||
161086266|NCT02663518|581704423|FG010|Part 1: Phase 1a Escalation|Death|0|||
161086267|NCT02663518|581704424|FG011|Part 1: Phase 1a Escalation|Death|0|||
161086268|NCT02663518|581704425|FG012|Part 1: Phase 1a Escalation|Death|0|||
161086269|NCT02663518|581704426|FG013|Part 1: Phase 1a Escalation|Death|0|||
161086270|NCT02663518|581704413|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086271|NCT02663518|581704414|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086272|NCT02663518|581704415|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
161086273|NCT02663518|581704416|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086274|NCT02663518|581704417|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086275|NCT02663518|581704418|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086276|NCT02663518|581704419|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086277|NCT02663518|581704420|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086278|NCT02663518|581704421|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086279|NCT02663518|581704422|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086280|NCT02663518|581704423|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086281|NCT02663518|581704424|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086282|NCT02663518|581704425|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086283|NCT02663518|581704426|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
161086284|NCT02663518|581704413|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
161086285|NCT02663518|581704414|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
161086286|NCT02663518|581704415|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
161086287|NCT02663518|581704416|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
161086288|NCT02663518|581704417|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086289|NCT02663518|581704418|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086290|NCT02663518|581704419|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086291|NCT02663518|581704420|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086292|NCT02663518|581704421|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086293|NCT02663518|581704422|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086294|NCT02663518|581704423|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086295|NCT02663518|581704424|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086296|NCT02663518|581704425|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086297|NCT02663518|581704426|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
161086298|NCT02663518|581704413|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
161086299|NCT02663518|581704414|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086300|NCT02663518|581704415|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
161086301|NCT02663518|581704416|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
161086302|NCT02663518|581704417|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086303|NCT02663518|581704418|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086304|NCT02663518|581704419|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086305|NCT02663518|581704420|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086306|NCT02663518|581704421|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086307|NCT02663518|581704422|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086308|NCT02663518|581704423|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086309|NCT02663518|581704424|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086310|NCT02663518|581704425|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086311|NCT02663518|581704426|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
161086312|NCT02663518|581704413|FG000|Part 1: Phase 1a Escalation|Other|0|||
161086313|NCT02663518|581704414|FG001|Part 1: Phase 1a Escalation|Other|0|||
161086314|NCT02663518|581704415|FG002|Part 1: Phase 1a Escalation|Other|2|||
161086315|NCT02663518|581704416|FG003|Part 1: Phase 1a Escalation|Other|0|||
161086316|NCT02663518|581704417|FG004|Part 1: Phase 1a Escalation|Other|0|||
161086317|NCT02663518|581704418|FG005|Part 1: Phase 1a Escalation|Other|0|||
161086318|NCT02663518|581704419|FG006|Part 1: Phase 1a Escalation|Other|0|||
161086319|NCT02663518|581704420|FG007|Part 1: Phase 1a Escalation|Other|0|||
161086320|NCT02663518|581704421|FG008|Part 1: Phase 1a Escalation|Other|0|||
161086321|NCT02663518|581704422|FG009|Part 1: Phase 1a Escalation|Other|0|||
161086322|NCT02663518|581704423|FG010|Part 1: Phase 1a Escalation|Other|0|||
161086323|NCT02663518|581704424|FG011|Part 1: Phase 1a Escalation|Other|0|||
161086324|NCT02663518|581704425|FG012|Part 1: Phase 1a Escalation|Other|0|||
161086325|NCT02663518|581704426|FG013|Part 1: Phase 1a Escalation|Other|0|||
161086326|NCT02663518|581704413|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086327|NCT02663518|581704414|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086328|NCT02663518|581704415|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
161292504|NCT04227197|582452122|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
161171734|NCT01135394|582007335|FG000|Screening|Lost to Follow-up|2|||
161171735|NCT01135394|582007335|FG000|Screening|Withdrawal by Subject|10|||
161171736|NCT01135394|582007335|FG000|Screening|Screening failure|16|||
161171737|NCT01135394|582007335|FG000|Screening|Physician Decision|5|||
161171738|NCT01135394|582007335|FG000|Baseline Assessment|Withdrawal by Subject|9|||
161171739|NCT01135394|582007335|FG000|Baseline Assessment|Physician Decision|3|||
161171740|NCT01135394|582007335|FG000|Baseline Assessment|Lost to Follow-up|2|||
161171741|NCT01135394|582007335|FG000|Baseline Assessment|Adverse Event|1|||
161171742|NCT01135394|582007335|FG000|Study Treatment|Withdrawal by Subject|1|||
161171743|NCT01135394|582007335|FG000|Study Treatment|Physician Decision|1|||
161171744|NCT01135394|582007335|FG000|Study Treatment|Adverse Event|2|||
161171745|NCT00462488|582007336|FG000|Overall Study|Protocol Violation|1|||
161171746|NCT00462488|582007337|FG001|Overall Study|Protocol Violation|0|||
161171747|NCT00462488|582007336|FG000|Overall Study|Lack of Efficacy|19|||
161171748|NCT00462488|582007337|FG001|Overall Study|Lack of Efficacy|17|||
161171749|NCT01742091|582007342|FG000|Overall Study|Adverse Event|0|||
161171750|NCT01742091|582007343|FG001|Overall Study|Adverse Event|0|||
161171751|NCT01742091|582007344|FG002|Overall Study|Adverse Event|0|||
161171752|NCT01742091|582007345|FG003|Overall Study|Adverse Event|0|||
161171753|NCT01742091|582007346|FG004|Overall Study|Adverse Event|1|||
161171754|NCT01742091|582007347|FG005|Overall Study|Adverse Event|0|||
161171755|NCT01742091|582007342|FG000|Overall Study|Physician Decision|0|||
161171756|NCT01742091|582007343|FG001|Overall Study|Physician Decision|0|||
161171757|NCT01742091|582007344|FG002|Overall Study|Physician Decision|0|||
161171758|NCT01742091|582007345|FG003|Overall Study|Physician Decision|0|||
161171759|NCT01742091|582007346|FG004|Overall Study|Physician Decision|0|||
161171760|NCT01742091|582007347|FG005|Overall Study|Physician Decision|1|||
161171761|NCT01742091|582007342|FG000|Overall Study|Withdrawal by Subject|0|||
161171762|NCT01742091|582007343|FG001|Overall Study|Withdrawal by Subject|0|||
161171763|NCT01742091|582007344|FG002|Overall Study|Withdrawal by Subject|0|||
161171764|NCT01742091|582007345|FG003|Overall Study|Withdrawal by Subject|1|||
161171765|NCT01742091|582007346|FG004|Overall Study|Withdrawal by Subject|0|||
161171766|NCT01742091|582007347|FG005|Overall Study|Withdrawal by Subject|0|||
161086329|NCT02663518|581704416|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086330|NCT02663518|581704417|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
161086331|NCT02663518|581704418|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086332|NCT02663518|581704419|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
161086333|NCT02663518|581704420|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
161086334|NCT02663518|581704421|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086335|NCT02663518|581704422|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086336|NCT02663518|581704423|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086337|NCT02663518|581704424|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086338|NCT02663518|581704425|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086339|NCT02663518|581704426|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
161086340|NCT02663518|581704413|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086341|NCT02663518|581704414|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086342|NCT02663518|581704415|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086343|NCT02663518|581704416|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086344|NCT02663518|581704417|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
161086345|NCT02663518|581704418|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086346|NCT02663518|581704419|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
161086347|NCT02663518|581704420|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
161086348|NCT02663518|581704421|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086349|NCT02663518|581704422|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086350|NCT02663518|581704423|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086351|NCT02663518|581704424|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086352|NCT02663518|581704425|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086353|NCT02663518|581704426|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
161086354|NCT02663518|581704413|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086355|NCT02663518|581704414|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086356|NCT02663518|581704415|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086357|NCT02663518|581704416|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086358|NCT02663518|581704417|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
161086359|NCT02663518|581704418|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086360|NCT02663518|581704419|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086361|NCT02663518|581704420|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086362|NCT02663518|581704421|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086363|NCT02663518|581704422|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086364|NCT02663518|581704423|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086365|NCT02663518|581704424|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086366|NCT02663518|581704425|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161086367|NCT02663518|581704426|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
161171767|NCT01742091|582007342|FG000|Overall Study|Lost to Follow-up|0|||
161171768|NCT01742091|582007343|FG001|Overall Study|Lost to Follow-up|0|||
161171769|NCT01742091|582007344|FG002|Overall Study|Lost to Follow-up|0|||
161171770|NCT01742091|582007345|FG003|Overall Study|Lost to Follow-up|0|||
161171771|NCT01742091|582007346|FG004|Overall Study|Lost to Follow-up|0|||
161171772|NCT01742091|582007347|FG005|Overall Study|Lost to Follow-up|1|||
161171773|NCT05742841|582007348|FG000|Overall Study|Withdrawal by Subject|1|||
161171774|NCT05742841|582007348|FG000|Overall Study|Lost to Follow-up|1|||
161171775|NCT02088541|582007349|FG000|Overall Study|Adverse Event|3|||
161171776|NCT02088541|582007350|FG001|Overall Study|Adverse Event|0|||
161171777|NCT02088541|582007351|FG002|Overall Study|Adverse Event|3|||
161171778|NCT02088541|582007352|FG003|Overall Study|Adverse Event|3|||
161171779|NCT02088541|582007353|FG004|Overall Study|Adverse Event|0|||
161171780|NCT02088541|582007349|FG000|Overall Study|Death|51|||
161171781|NCT02088541|582007350|FG001|Overall Study|Death|21|||
161171782|NCT02088541|582007351|FG002|Overall Study|Death|85|||
161171783|NCT02088541|582007352|FG003|Overall Study|Death|28|||
161171784|NCT02088541|582007353|FG004|Overall Study|Death|38|||
161171785|NCT02088541|582007349|FG000|Overall Study|Lost to Follow-up|2|||
161171786|NCT02088541|582007350|FG001|Overall Study|Lost to Follow-up|0|||
161171787|NCT02088541|582007351|FG002|Overall Study|Lost to Follow-up|1|||
161171788|NCT02088541|582007352|FG003|Overall Study|Lost to Follow-up|0|||
161171789|NCT02088541|582007353|FG004|Overall Study|Lost to Follow-up|0|||
161171790|NCT02088541|582007349|FG000|Overall Study|Physician Decision|2|||
161171791|NCT02088541|582007350|FG001|Overall Study|Physician Decision|1|||
161171792|NCT02088541|582007351|FG002|Overall Study|Physician Decision|2|||
161171793|NCT02088541|582007352|FG003|Overall Study|Physician Decision|0|||
161171794|NCT02088541|582007353|FG004|Overall Study|Physician Decision|2|||
161171795|NCT02088541|582007349|FG000|Overall Study|Disease progression|7|||
161171796|NCT02088541|582007350|FG001|Overall Study|Disease progression|1|||
161171797|NCT02088541|582007351|FG002|Overall Study|Disease progression|2|||
161171798|NCT02088541|582007352|FG003|Overall Study|Disease progression|3|||
161171799|NCT02088541|582007353|FG004|Overall Study|Disease progression|1|||
161171800|NCT02088541|582007349|FG000|Overall Study|Study terminated by sponsor|1|||
161171801|NCT02088541|582007350|FG001|Overall Study|Study terminated by sponsor|1|||
161171802|NCT02088541|582007351|FG002|Overall Study|Study terminated by sponsor|12|||
161171803|NCT02088541|582007352|FG003|Overall Study|Study terminated by sponsor|2|||
161171804|NCT02088541|582007353|FG004|Overall Study|Study terminated by sponsor|6|||
161171805|NCT02088541|582007349|FG000|Overall Study|Withdrawal by Subject|3|||
161171806|NCT02088541|582007350|FG001|Overall Study|Withdrawal by Subject|2|||
161171807|NCT02088541|582007351|FG002|Overall Study|Withdrawal by Subject|9|||
161171808|NCT02088541|582007352|FG003|Overall Study|Withdrawal by Subject|7|||
161171809|NCT02088541|582007353|FG004|Overall Study|Withdrawal by Subject|10|||
161171810|NCT02088541|582007349|FG000|Overall Study|Other|2|||
161171811|NCT02088541|582007350|FG001|Overall Study|Other|1|||
161171812|NCT02088541|582007351|FG002|Overall Study|Other|3|||
161171813|NCT02088541|582007352|FG003|Overall Study|Other|1|||
161171814|NCT02088541|582007353|FG004|Overall Study|Other|1|||
161171815|NCT03750240|582007355|FG000|Overall Study|Technical Difficulties|2|||
161171816|NCT03706040|582007356|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
161171817|NCT03706040|582007357|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
161171818|NCT03706040|582007358|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
161171819|NCT03706040|582007359|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
161171820|NCT03706040|582007360|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
161171821|NCT03706040|582007361|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
161171822|NCT03706040|582007362|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
161347394|NCT01121926|582656276|FG000|Washout Period|Adverse Event|0|||
161347395|NCT01121926|582656277|FG001|Washout Period|Adverse Event|1|||
161171823|NCT03706040|582007356|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
161171824|NCT03706040|582007357|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
161171825|NCT03706040|582007358|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
161171826|NCT03706040|582007359|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161171827|NCT03706040|582007360|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161171828|NCT03706040|582007361|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161171829|NCT03706040|582007362|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
161171830|NCT03706040|582007356|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
161171831|NCT03706040|582007357|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
161171832|NCT03706040|582007358|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
161171833|NCT03706040|582007359|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161171834|NCT03706040|582007360|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161171835|NCT03706040|582007361|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161171836|NCT03706040|582007362|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
161347396|NCT01121926|582656276|FG000|Washout Period|Positive pregnancy test|0|||
161347397|NCT01121926|582656277|FG001|Washout Period|Positive pregnancy test|1|||
161347398|NCT02782468|582656278|FG000|Overall Study|Progressive Disease|2|||
161171837|NCT03706040|582007356|FG000|Period A (Week 0 to Week 16)|Other|2|||
161171838|NCT03706040|582007357|FG001|Period A (Week 0 to Week 16)|Other|0|||
161171839|NCT03706040|582007358|FG002|Period A (Week 0 to Week 16)|Other|2|||
161171840|NCT03706040|582007359|FG003|Period A (Week 0 to Week 16)|Other|0|||
161171841|NCT03706040|582007360|FG004|Period A (Week 0 to Week 16)|Other|0|||
161171842|NCT03706040|582007361|FG005|Period A (Week 0 to Week 16)|Other|0|||
161171843|NCT03706040|582007362|FG006|Period A (Week 0 to Week 16)|Other|0|||
161171844|NCT03706040|582007356|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
161171845|NCT03706040|582007357|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
161171846|NCT03706040|582007358|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
161171847|NCT03706040|582007359|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
161171848|NCT03706040|582007360|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
161171849|NCT03706040|582007361|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
161171850|NCT03706040|582007362|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
161171851|NCT03706040|582007356|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161171852|NCT03706040|582007357|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161171853|NCT03706040|582007358|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
161171854|NCT03706040|582007359|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
161171855|NCT03706040|582007360|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
161171856|NCT03706040|582007361|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
161171857|NCT03706040|582007362|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
161171858|NCT03706040|582007356|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161171859|NCT03706040|582007357|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161171860|NCT03706040|582007358|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161171861|NCT03706040|582007359|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161171862|NCT03706040|582007360|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161171863|NCT03706040|582007361|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
161171864|NCT03706040|582007362|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
161171865|NCT03706040|582007356|FG000|Period B (Week 16 to Week 52)|Other|0|||
161171866|NCT03706040|582007357|FG001|Period B (Week 16 to Week 52)|Other|0|||
161171867|NCT03706040|582007358|FG002|Period B (Week 16 to Week 52)|Other|0|||
161171868|NCT03706040|582007359|FG003|Period B (Week 16 to Week 52)|Other|4|||
161171869|NCT03706040|582007360|FG004|Period B (Week 16 to Week 52)|Other|5|||
161171870|NCT03706040|582007361|FG005|Period B (Week 16 to Week 52)|Other|23|||
161171871|NCT03706040|582007362|FG006|Period B (Week 16 to Week 52)|Other|17|||
161171872|NCT00927758|582007363|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161171873|NCT00927758|582007364|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161171874|NCT00927758|582007365|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161171875|NCT00927758|582007366|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
161171876|NCT00927758|582007367|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
161171877|NCT00927758|582007368|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
161171878|NCT00927758|582007363|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161171879|NCT00927758|582007364|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161171880|NCT00927758|582007365|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161171881|NCT00927758|582007366|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161171882|NCT00927758|582007367|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
161171883|NCT00927758|582007368|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
161171884|NCT00439725|582007369|FG000|Treatment Period|Withdrawal by Subject|22|||
161171885|NCT00439725|582007370|FG001|Treatment Period|Withdrawal by Subject|19|||
161171886|NCT00439725|582007369|FG000|Treatment Period|Study terminated by sponsor|156|||
161171887|NCT00439725|582007370|FG001|Treatment Period|Study terminated by sponsor|148|||
161171888|NCT00439725|582007369|FG000|Treatment Period|Site closed by investigator|1|||
161171889|NCT00439725|582007370|FG001|Treatment Period|Site closed by investigator|2|||
161171890|NCT00439725|582007369|FG000|Treatment Period|Adverse Event|39|||
161171891|NCT00439725|582007370|FG001|Treatment Period|Adverse Event|18|||
161171892|NCT00439725|582007369|FG000|Treatment Period|Physician Decision|1|||
161171893|NCT00439725|582007370|FG001|Treatment Period|Physician Decision|1|||
161171894|NCT00439725|582007369|FG000|Treatment Period|Protocol Violation|2|||
161171895|NCT00439725|582007370|FG001|Treatment Period|Protocol Violation|1|||
161171896|NCT00439725|582007369|FG000|Treatment Period|Clinical endpoint reached|6|||
161171897|NCT00439725|582007370|FG001|Treatment Period|Clinical endpoint reached|50|||
161171898|NCT00439725|582007369|FG000|Treatment Period|Technical problems|1|||
161171899|NCT00439725|582007370|FG001|Treatment Period|Technical problems|0|||
161171900|NCT00439725|582007369|FG000|Treatment Period|Lost to Follow-up|1|||
161171901|NCT00439725|582007370|FG001|Treatment Period|Lost to Follow-up|1|||
161171902|NCT00439725|582007369|FG000|Treatment Period|Participant convenience|1|||
161171903|NCT00439725|582007370|FG001|Treatment Period|Participant convenience|0|||
161171904|NCT00439725|582007369|FG000|Treatment Period|Protocol driven decision point|1|||
161171905|NCT00439725|582007370|FG001|Treatment Period|Protocol driven decision point|1|||
161171906|NCT00439725|582007369|FG000|Treatment Period|Death|1|||
161171907|NCT00439725|582007370|FG001|Treatment Period|Death|1|||
161292505|NCT04227197|582452123|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
161171908|NCT00439725|582007369|FG000|Treatment Period|Participant did not receive treatment|4|||
161319401|NCT01134263|582555304|FG004|Overall Study|Protocol Violation|2|||
161171909|NCT00439725|582007370|FG001|Treatment Period|Participant did not receive treatment|4|||
161171910|NCT00439725|582007369|FG000|Observational Period|Withdrawal by Subject|2|||
161171911|NCT00439725|582007370|FG001|Observational Period|Withdrawal by Subject|2|||
161171912|NCT00439725|582007369|FG000|Observational Period|Lost to Follow-up|0|||
161171913|NCT00439725|582007370|FG001|Observational Period|Lost to Follow-up|1|||
161171914|NCT00439725|582007369|FG000|Observational Period|Death|0|||
161171915|NCT00439725|582007370|FG001|Observational Period|Death|2|||
161171916|NCT00439725|582007369|FG000|Observational Period|Study termination by sponsor|1|||
161171917|NCT00439725|582007370|FG001|Observational Period|Study termination by sponsor|1|||
161171918|NCT00439725|582007369|FG000|Observational Period|Clinical endpoint reached|3|||
161171919|NCT00439725|582007370|FG001|Observational Period|Clinical endpoint reached|1|||
161171920|NCT00439725|582007369|FG000|Observational Period|Technical problems|1|||
161171921|NCT00439725|582007370|FG001|Observational Period|Technical problems|0|||
161171922|NCT00439725|582007369|FG000|Observational Period|Participant convenience|1|||
161171923|NCT00439725|582007370|FG001|Observational Period|Participant convenience|0|||
161171924|NCT02848313|582007371|FG000|Overall Study|Adverse Event|1|||
161171925|NCT02848313|582007372|FG001|Overall Study|Adverse Event|2|||
161171926|NCT02848313|582007371|FG000|Overall Study|Lack of Efficacy|0|||
161171927|NCT02848313|582007372|FG001|Overall Study|Lack of Efficacy|1|||
161171928|NCT02848313|582007371|FG000|Overall Study|Withdrawal by Subject|1|||
161171929|NCT02848313|582007372|FG001|Overall Study|Withdrawal by Subject|1|||
161171930|NCT02848313|582007371|FG000|Overall Study|Lost to follow up|1|||
161171931|NCT02848313|582007372|FG001|Overall Study|Lost to follow up|0|||
161171932|NCT03984812|582007373|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171933|NCT03984812|582007374|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171934|NCT03984812|582007375|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
161171935|NCT03984812|582007376|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171936|NCT03984812|582007377|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171937|NCT03984812|582007378|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171938|NCT03984812|582007379|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171939|NCT03984812|582007380|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171940|NCT03984812|582007381|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171941|NCT03984812|582007382|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171942|NCT03984812|582007383|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
161171943|NCT03510910|582007384|FG000|Overall Study|Incomplete Survey|2|||
161171944|NCT03510910|582007385|FG001|Overall Study|Incomplete Survey|3|||
161171945|NCT00379236|582007386|FG000|Double-blind|Adverse Event|11|||
161171946|NCT00379236|582007387|FG001|Double-blind|Adverse Event|6|||
161171947|NCT00379236|582007388|FG002|Double-blind|Adverse Event|0|||
161171948|NCT00379236|582007386|FG000|Double-blind|Protocol Violation|3|||
161171949|NCT00379236|582007387|FG001|Double-blind|Protocol Violation|3|||
161171950|NCT00379236|582007388|FG002|Double-blind|Protocol Violation|0|||
161171951|NCT00379236|582007386|FG000|Double-blind|Withdrawal by Subject|12|||
161171952|NCT00379236|582007387|FG001|Double-blind|Withdrawal by Subject|13|||
161171953|NCT00379236|582007388|FG002|Double-blind|Withdrawal by Subject|0|||
161171954|NCT00379236|582007386|FG000|Double-blind|Lost to Follow-up|4|||
161171955|NCT00379236|582007387|FG001|Double-blind|Lost to Follow-up|3|||
161171956|NCT00379236|582007388|FG002|Double-blind|Lost to Follow-up|0|||
161171957|NCT00379236|582007386|FG000|Double-blind|Use of exclusionary medication|1|||
161171958|NCT00379236|582007387|FG001|Double-blind|Use of exclusionary medication|2|||
161171959|NCT00379236|582007388|FG002|Double-blind|Use of exclusionary medication|0|||
161171960|NCT00379236|582007386|FG000|Double-blind|Other|3|||
161171961|NCT00379236|582007387|FG001|Double-blind|Other|7|||
161171962|NCT00379236|582007388|FG002|Double-blind|Other|0|||
161171963|NCT00379236|582007386|FG000|Double-blind|Data could not be retrieved|2|||
161171964|NCT00379236|582007387|FG001|Double-blind|Data could not be retrieved|2|||
161171965|NCT00379236|582007388|FG002|Double-blind|Data could not be retrieved|0|||
161171966|NCT00379236|582007386|FG000|Open-label Extension|Adverse Event|0|||
161171967|NCT00379236|582007387|FG001|Open-label Extension|Adverse Event|0|||
161171968|NCT00379236|582007388|FG002|Open-label Extension|Adverse Event|13|||
161171969|NCT00379236|582007386|FG000|Open-label Extension|Protocol Violation|0|||
161171970|NCT00379236|582007387|FG001|Open-label Extension|Protocol Violation|0|||
161171971|NCT00379236|582007388|FG002|Open-label Extension|Protocol Violation|7|||
161347399|NCT02782468|582656279|FG001|Overall Study|Progressive Disease|5|||
161347400|NCT02782468|582656280|FG002|Overall Study|Progressive Disease|0|||
161347401|NCT02782468|582656281|FG003|Overall Study|Progressive Disease|4|||
161347402|NCT02782468|582656278|FG000|Overall Study|Adverse Event|0|||
161171972|NCT00379236|582007386|FG000|Open-label Extension|Withdrawal by Subject|0|||
161171973|NCT00379236|582007387|FG001|Open-label Extension|Withdrawal by Subject|0|||
161171974|NCT00379236|582007388|FG002|Open-label Extension|Withdrawal by Subject|13|||
161171975|NCT00379236|582007386|FG000|Open-label Extension|Lost to Follow-up|0|||
161171976|NCT00379236|582007387|FG001|Open-label Extension|Lost to Follow-up|0|||
161171977|NCT00379236|582007388|FG002|Open-label Extension|Lost to Follow-up|12|||
161171978|NCT00379236|582007386|FG000|Open-label Extension|Use of exclusionary medication|0|||
161171979|NCT00379236|582007387|FG001|Open-label Extension|Use of exclusionary medication|0|||
161086368|NCT02663518|581704413|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086369|NCT02663518|581704414|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086370|NCT02663518|581704415|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086371|NCT02663518|581704416|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086372|NCT02663518|581704417|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
161086373|NCT02663518|581704418|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
161086374|NCT02663518|581704419|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
161086375|NCT02663518|581704420|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
161086376|NCT02663518|581704421|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086377|NCT02663518|581704422|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086378|NCT02663518|581704423|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086379|NCT02663518|581704424|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086380|NCT02663518|581704425|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086381|NCT02663518|581704426|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
161086382|NCT02663518|581704413|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086383|NCT02663518|581704414|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086384|NCT02663518|581704415|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086385|NCT02663518|581704416|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086386|NCT02663518|581704417|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
161086387|NCT02663518|581704418|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086388|NCT02663518|581704419|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
161086389|NCT02663518|581704420|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086390|NCT02663518|581704421|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086391|NCT02663518|581704422|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086392|NCT02663518|581704423|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086393|NCT02663518|581704424|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086394|NCT02663518|581704425|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086395|NCT02663518|581704426|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
161086396|NCT02663518|581704413|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086397|NCT02663518|581704414|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086398|NCT02663518|581704415|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086399|NCT02663518|581704416|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086400|NCT02663518|581704417|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086401|NCT02663518|581704418|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086402|NCT02663518|581704419|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
161086403|NCT02663518|581704420|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086404|NCT02663518|581704421|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086405|NCT02663518|581704422|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086406|NCT02663518|581704423|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086407|NCT02663518|581704424|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086408|NCT02663518|581704425|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086409|NCT02663518|581704426|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
161086410|NCT02663518|581704413|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
161086411|NCT02663518|581704414|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
161086412|NCT02663518|581704415|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
161086413|NCT02663518|581704416|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
161086414|NCT02663518|581704417|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
161086415|NCT02663518|581704418|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
161086416|NCT02663518|581704419|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
161086417|NCT02663518|581704420|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
161086418|NCT02663518|581704421|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
161086419|NCT02663518|581704422|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
161086420|NCT02663518|581704423|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
161086421|NCT02663518|581704424|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
161086422|NCT02663518|581704425|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
161086423|NCT02663518|581704426|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
161086424|NCT02663518|581704413|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086425|NCT02663518|581704414|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086426|NCT02663518|581704415|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086427|NCT02663518|581704416|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086428|NCT02663518|581704417|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086429|NCT02663518|581704418|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086430|NCT02663518|581704419|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086431|NCT02663518|581704420|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086432|NCT02663518|581704421|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086433|NCT02663518|581704422|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086434|NCT02663518|581704423|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161171980|NCT00379236|582007388|FG002|Open-label Extension|Use of exclusionary medication|3|||
161171981|NCT00379236|582007386|FG000|Open-label Extension|Other|0|||
161171982|NCT00379236|582007387|FG001|Open-label Extension|Other|0|||
161171983|NCT00379236|582007388|FG002|Open-label Extension|Other|7|||
161171984|NCT02940860|582007396|FG000|Overall Study|Non-serious AE|1|||
161171985|NCT02940860|582007397|FG001|Overall Study|Non-serious AE|2|||
161171986|NCT02940860|582007396|FG000|Overall Study|Serious AE|7|||
161171987|NCT02940860|582007397|FG001|Overall Study|Serious AE|3|||
161171988|NCT02940860|582007396|FG000|Overall Study|Withdrawal by Subject|19|||
161171989|NCT02940860|582007397|FG001|Overall Study|Withdrawal by Subject|9|||
161171990|NCT02940860|582007396|FG000|Overall Study|Lost to Follow-up|13|||
161171991|NCT02940860|582007397|FG001|Overall Study|Lost to Follow-up|7|||
161171992|NCT02940860|582007396|FG000|Overall Study|Physician Decision|5|||
161171993|NCT02940860|582007397|FG001|Overall Study|Physician Decision|3|||
161171994|NCT02940860|582007396|FG000|Overall Study|Sponsor Decision|0|||
161171995|NCT02940860|582007397|FG001|Overall Study|Sponsor Decision|1|||
161171996|NCT02940860|582007396|FG000|Overall Study|Protocol Violation|0|||
161171997|NCT02940860|582007397|FG001|Overall Study|Protocol Violation|2|||
161171998|NCT02940860|582007396|FG000|Overall Study|Death|3|||
161171999|NCT02940860|582007397|FG001|Overall Study|Death|2|||
161172000|NCT02940860|582007396|FG000|Overall Study|Moved, poor venous access, transport|6|||
161172001|NCT02940860|582007397|FG001|Overall Study|Moved, poor venous access, transport|4|||
161172002|NCT02940860|582007396|FG000|Overall Study|Not treated|2|||
161172003|NCT02940860|582007397|FG001|Overall Study|Not treated|2|||
161172004|NCT04914819|582007398|FG000|Overall Study|Pregnancy|3|||
161172005|NCT04914819|582007399|FG001|Overall Study|Pregnancy|1|||
161172006|NCT04914819|582007398|FG000|Overall Study|Discontinued study|4|||
161292506|NCT04227197|582452122|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
161292507|NCT04227197|582452123|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
161086435|NCT02663518|581704424|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086436|NCT02663518|581704425|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
161086437|NCT02663518|581704426|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
161086438|NCT02663518|581704413|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086439|NCT02663518|581704414|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086440|NCT02663518|581704415|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086441|NCT02663518|581704416|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086442|NCT02663518|581704417|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086443|NCT02663518|581704418|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086444|NCT02663518|581704419|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086445|NCT02663518|581704420|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086446|NCT02663518|581704421|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086447|NCT02663518|581704422|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086448|NCT02663518|581704423|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086449|NCT02663518|581704424|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
161086450|NCT02663518|581704425|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086451|NCT02663518|581704426|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
161086452|NCT02663518|581704413|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086453|NCT02663518|581704414|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086454|NCT02663518|581704415|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086455|NCT02663518|581704416|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086456|NCT02663518|581704417|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086457|NCT02663518|581704418|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086458|NCT02663518|581704419|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086459|NCT02663518|581704420|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086460|NCT02663518|581704421|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086461|NCT02663518|581704422|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
161086462|NCT02663518|581704423|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
161086463|NCT02663518|581704424|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
161172007|NCT04914819|582007399|FG001|Overall Study|Discontinued study|1|||
161172008|NCT04914819|582007398|FG000|Overall Study|Lost to Follow-up|7|||
161172009|NCT04914819|582007399|FG001|Overall Study|Lost to Follow-up|0|||
161172010|NCT02431793|582007401|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
161172011|NCT02431793|582007402|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
161172012|NCT02431793|582007403|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
161172013|NCT02431793|582007401|FG000|Overall Study|Withdrawal by Subject|7|||
161172014|NCT02431793|582007402|FG001|Overall Study|Withdrawal by Subject|5|||
161172015|NCT02431793|582007403|FG002|Overall Study|Withdrawal by Subject|5|||
161172016|NCT02431793|582007401|FG000|Overall Study|Lost to Follow-up|101|||
161172017|NCT02431793|582007402|FG001|Overall Study|Lost to Follow-up|122|||
161172018|NCT02431793|582007403|FG002|Overall Study|Lost to Follow-up|104|||
161172019|NCT01563107|582007408|FG000|Overall Study|Physician Decision|0|||
161172020|NCT01563107|582007409|FG001|Overall Study|Physician Decision|1|||
161086464|NCT02663518|581704425|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
161086465|NCT02663518|581704426|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
161086466|NCT02663518|581704413|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
161086467|NCT02663518|581704414|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
161086468|NCT02663518|581704415|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
161086469|NCT02663518|581704416|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
161086470|NCT02663518|581704417|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
161086471|NCT02663518|581704418|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
161086472|NCT02663518|581704419|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
161086473|NCT02663518|581704420|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
161086474|NCT02663518|581704421|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
161086475|NCT02663518|581704422|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
161086476|NCT02663518|581704423|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
161086477|NCT02663518|581704424|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
161086478|NCT02663518|581704425|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
161086479|NCT02663518|581704426|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
161086480|NCT02663518|581704413|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086481|NCT02663518|581704414|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086482|NCT02663518|581704415|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086483|NCT02663518|581704416|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086484|NCT02663518|581704417|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086485|NCT02663518|581704418|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086486|NCT02663518|581704419|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086487|NCT02663518|581704420|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086488|NCT02663518|581704421|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086489|NCT02663518|581704422|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086490|NCT02663518|581704423|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086491|NCT02663518|581704424|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086492|NCT02663518|581704425|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
161086493|NCT02663518|581704426|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
161086494|NCT03215810|581704427|FG000|Overall Study|Still responding to nivolumab|1|||
161086495|NCT03215810|581704427|FG000|Overall Study|Insufficient TIL growth|1|||
161086496|NCT03215810|581704427|FG000|Overall Study|Decline in performance status|1|||
161086497|NCT03215810|581704427|FG000|Overall Study|Withdrawal by Subject|1|||
161086498|NCT01157676|581704431|FG000|Randomization|Death|1|||
161086499|NCT01157676|581704432|FG001|Randomization|Death|1|||
161086500|NCT01157676|581704431|FG000|Randomization|unresectable|2|||
161086501|NCT01157676|581704432|FG001|Randomization|unresectable|3|||
161086502|NCT01157676|581704431|FG000|Randomization|Withdrawal by Subject|17|||
161086503|NCT01157676|581704432|FG001|Randomization|Withdrawal by Subject|13|||
161086504|NCT01157676|581704431|FG000|Randomization|Physician Decision|1|||
161086505|NCT01157676|581704432|FG001|Randomization|Physician Decision|0|||
161086506|NCT01157676|581704431|FG000|Surgery|underwent open cystectomy|0|||
161086507|NCT01157676|581704432|FG001|Surgery|underwent open cystectomy|4|||
161086508|NCT01157676|581704431|FG000|Surgery|converted to open procedure|0|||
161086509|NCT01157676|581704432|FG001|Surgery|converted to open procedure|5|||
161086510|NCT01157676|581704431|FG000|Surgery|underwent robotic cystectomy|1|||
161086511|NCT01157676|581704432|FG001|Surgery|underwent robotic cystectomy|0|||
161086512|NCT00682890|581704433|FG000|Overall Study|Lost to Follow-up|1|||
161086513|NCT00682890|581704434|FG001|Overall Study|Lost to Follow-up|1|||
161086514|NCT00682890|581704433|FG000|Overall Study|subject moved away|0|||
161086515|NCT00682890|581704434|FG001|Overall Study|subject moved away|1|||
161086516|NCT00682890|581704433|FG000|Overall Study|heavy menstrual bleeding|1|||
161086517|NCT00682890|581704434|FG001|Overall Study|heavy menstrual bleeding|0|||
161086518|NCT00141219|581704437|FG000|Overall Study|Protocol violations|5|||
161086519|NCT00141219|581704438|FG001|Overall Study|Protocol violations|4|||
161086520|NCT00141219|581704437|FG000|Overall Study|Adverse Event|8|||
161086521|NCT00141219|581704438|FG001|Overall Study|Adverse Event|6|||
161086522|NCT00141219|581704437|FG000|Overall Study|Lack of Efficacy|5|||
161086523|NCT00141219|581704438|FG001|Overall Study|Lack of Efficacy|4|||
161086524|NCT00141219|581704437|FG000|Overall Study|Withdrawal by Subject|6|||
161086525|NCT00141219|581704438|FG001|Overall Study|Withdrawal by Subject|2|||
161086526|NCT01577745|581704439|FG000|Overall Study|Withdrawal by Subject|0|||
161086527|NCT01577745|581704440|FG001|Overall Study|Withdrawal by Subject|1|||
161086528|NCT01577745|581704441|FG002|Overall Study|Withdrawal by Subject|0|||
161086529|NCT01577745|581704442|FG003|Overall Study|Withdrawal by Subject|3|||
161086530|NCT01577745|581704443|FG004|Overall Study|Withdrawal by Subject|2|||
161086531|NCT01577745|581704444|FG005|Overall Study|Withdrawal by Subject|0|||
161086532|NCT01577745|581704439|FG000|Overall Study|Death|3|||
161086533|NCT01577745|581704440|FG001|Overall Study|Death|2|||
161086534|NCT01577745|581704441|FG002|Overall Study|Death|2|||
161086535|NCT01577745|581704442|FG003|Overall Study|Death|1|||
161086536|NCT01577745|581704443|FG004|Overall Study|Death|1|||
161086537|NCT01577745|581704444|FG005|Overall Study|Death|3|||
161172021|NCT01563107|582007410|FG002|Overall Study|Physician Decision|1|||
161172022|NCT01563107|582007411|FG003|Overall Study|Physician Decision|3|||
161172023|NCT01563107|582007408|FG000|Overall Study|Withdrawal by Subject|1|||
161172024|NCT01563107|582007409|FG001|Overall Study|Withdrawal by Subject|2|||
161172025|NCT01563107|582007410|FG002|Overall Study|Withdrawal by Subject|1|||
161172026|NCT01563107|582007411|FG003|Overall Study|Withdrawal by Subject|2|||
161172027|NCT02707601|582007412|FG000|Overall Study|Death|0|||
161172028|NCT02707601|582007413|FG001|Overall Study|Death|1|||
161172029|NCT02707601|582007412|FG000|Overall Study|Lack of Efficacy|0|||
161172030|NCT02707601|582007413|FG001|Overall Study|Lack of Efficacy|1|||
161172031|NCT02707601|582007412|FG000|Overall Study|Investigator's Discretion|1|||
161172032|NCT02707601|582007413|FG001|Overall Study|Investigator's Discretion|0|||
161172033|NCT02707601|582007412|FG000|Overall Study|Withdrew Consent|0|||
161172034|NCT02707601|582007413|FG001|Overall Study|Withdrew Consent|1|||
161172035|NCT02707601|582007412|FG000|Overall Study|Lost to Follow-up|1|||
161172036|NCT02707601|582007413|FG001|Overall Study|Lost to Follow-up|1|||
161172037|NCT02707601|582007412|FG000|Overall Study|Participants Randomized but Not Treated|2|||
161172038|NCT02707601|582007413|FG001|Overall Study|Participants Randomized but Not Treated|0|||
161172039|NCT00063986|582007415|FG000|Overall Study|Withdrawal by Subject|1|||
161172040|NCT00063986|582007415|FG000|Overall Study|Ineligible|1|||
161172041|NCT00063986|582007415|FG000|Overall Study|Intra-operatively ineligible|4|||
161172042|NCT00247273|582007416|FG000|Overall Study|Adverse Event|85|||
161172043|NCT00247273|582007417|FG001|Overall Study|Adverse Event|80|||
161172044|NCT00247273|582007416|FG000|Overall Study|Physician Decision|6|||
161172045|NCT00247273|582007417|FG001|Overall Study|Physician Decision|3|||
161172046|NCT00247273|582007416|FG000|Overall Study|Lost to Follow-up|7|||
161172047|NCT00247273|582007417|FG001|Overall Study|Lost to Follow-up|7|||
161172048|NCT00247273|582007416|FG000|Overall Study|Withdrawal by Subject|46|||
161172049|NCT00247273|582007417|FG001|Overall Study|Withdrawal by Subject|47|||
161172050|NCT00247273|582007416|FG000|Overall Study|Did not take any study drug|2|||
161172051|NCT00247273|582007417|FG001|Overall Study|Did not take any study drug|0|||
161172052|NCT01709708|582007418|FG000|Overall Study|Protocol Violation|1|||
161172053|NCT01709708|582007419|FG001|Overall Study|Protocol Violation|2|||
161172054|NCT00511108|582007422|FG000|Overall Study|Adverse Event|2|||
161172055|NCT00511108|582007423|FG001|Overall Study|Adverse Event|0|||
161172056|NCT00511108|582007424|FG002|Overall Study|Adverse Event|1|||
161292508|NCT04227197|582452122|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
161292509|NCT04227197|582452123|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
161292510|NCT04227197|582452122|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
161292511|NCT04227197|582452123|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
161292512|NCT04227197|582452122|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
161292513|NCT04227197|582452123|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
161292514|NCT04227197|582452122|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
161292515|NCT04227197|582452123|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
161292516|NCT02549859|582452128|FG000|Long-term 60 Hz DBS|Study Closed|1|||
161292517|NCT01209949|582452136|FG000|Overall Study|Lost to Follow-up|3|||
161292518|NCT00729612|582452137|FG000|Overall Study|Non evaluable for response|10|||
161292519|NCT00708552|582452138|FG000|Overall Study|Adverse Event|10|||
161292520|NCT00708552|582452139|FG001|Overall Study|Adverse Event|3|||
161292521|NCT00708552|582452140|FG002|Overall Study|Adverse Event|4|||
161292522|NCT00708552|582452141|FG003|Overall Study|Adverse Event|6|||
161292523|NCT00708552|582452138|FG000|Overall Study|Lack of Efficacy|0|||
161292524|NCT00708552|582452139|FG001|Overall Study|Lack of Efficacy|4|||
161292525|NCT00708552|582452140|FG002|Overall Study|Lack of Efficacy|1|||
161292526|NCT00708552|582452141|FG003|Overall Study|Lack of Efficacy|0|||
161292527|NCT00708552|582452138|FG000|Overall Study|Protocol Violation|0|||
161292528|NCT00708552|582452139|FG001|Overall Study|Protocol Violation|0|||
161292529|NCT00708552|582452140|FG002|Overall Study|Protocol Violation|2|||
161292530|NCT00708552|582452141|FG003|Overall Study|Protocol Violation|4|||
161292531|NCT00708552|582452138|FG000|Overall Study|Lost to Follow-up|4|||
161292532|NCT00708552|582452139|FG001|Overall Study|Lost to Follow-up|2|||
161172057|NCT00511108|582007425|FG003|Overall Study|Adverse Event|2|||
161172058|NCT00511108|582007422|FG000|Overall Study|Lost to Follow-up|0|||
161172059|NCT00511108|582007423|FG001|Overall Study|Lost to Follow-up|2|||
161172060|NCT00511108|582007424|FG002|Overall Study|Lost to Follow-up|1|||
161172061|NCT00511108|582007425|FG003|Overall Study|Lost to Follow-up|0|||
161172062|NCT00511108|582007422|FG000|Overall Study|Physician Decision|0|||
161172063|NCT00511108|582007423|FG001|Overall Study|Physician Decision|0|||
161172064|NCT00511108|582007424|FG002|Overall Study|Physician Decision|0|||
161172065|NCT00511108|582007425|FG003|Overall Study|Physician Decision|1|||
161172066|NCT00511108|582007422|FG000|Overall Study|Withdrawal by Subject|4|||
161172067|NCT00511108|582007423|FG001|Overall Study|Withdrawal by Subject|0|||
161172068|NCT00511108|582007424|FG002|Overall Study|Withdrawal by Subject|3|||
161172069|NCT00511108|582007425|FG003|Overall Study|Withdrawal by Subject|2|||
161172070|NCT02001688|582007426|FG000|Overall Study|Withdrawal by Subject|0|||
161172071|NCT02001688|582007427|FG001|Overall Study|Withdrawal by Subject|0|||
161172072|NCT02001688|582007428|FG002|Overall Study|Withdrawal by Subject|1|||
161172073|NCT02001688|582007426|FG000|Overall Study|Adverse Event|0|||
161172074|NCT02001688|582007427|FG001|Overall Study|Adverse Event|1|||
161172075|NCT02001688|582007428|FG002|Overall Study|Adverse Event|0|||
161172076|NCT01675141|582007430|FG000|Overall Study|Lenalidomide outside NIH|3|||
161172077|NCT01675141|582007430|FG000|Overall Study|Withdrawal by Subject|3|||
161172078|NCT01675141|582007430|FG000|Overall Study|Physician Decision|4|||
161172079|NCT01675141|582007430|FG000|Overall Study|No treatment, per protocol|1|||
161172080|NCT00305604|582007434|FG000|Overall Study|Adverse Event|6|||
161172081|NCT00305604|582007435|FG001|Overall Study|Adverse Event|3|||
161172082|NCT00305604|582007434|FG000|Overall Study|Lack of Efficacy|11|||
161172083|NCT00305604|582007435|FG001|Overall Study|Lack of Efficacy|18|||
161172084|NCT00305604|582007434|FG000|Overall Study|Lost to Follow-up|0|||
161172085|NCT00305604|582007435|FG001|Overall Study|Lost to Follow-up|4|||
161172086|NCT00305604|582007434|FG000|Overall Study|Protocol Violation|2|||
161172087|NCT00305604|582007435|FG001|Overall Study|Protocol Violation|1|||
161172088|NCT00305604|582007434|FG000|Overall Study|Withdrawal by Subject|12|||
161172089|NCT00305604|582007435|FG001|Overall Study|Withdrawal by Subject|21|||
161172090|NCT00305604|582007434|FG000|Overall Study|Patient moved|1|||
161172091|NCT00305604|582007435|FG001|Overall Study|Patient moved|0|||
161172092|NCT01248364|582007436|FG000|Overall Study|Adverse Event|0|||
161172093|NCT01248364|582007437|FG001|Overall Study|Adverse Event|1|||
161172094|NCT01248364|582007438|FG002|Overall Study|Adverse Event|0|||
161172095|NCT01248364|582007439|FG003|Overall Study|Adverse Event|0|||
161172096|NCT01021813|582007442|FG000|DB Treatment Phase|Adverse Event|60|||
161172097|NCT01021813|582007443|FG001|DB Treatment Phase|Adverse Event|22|||
161172098|NCT01021813|582007444|FG002|DB Treatment Phase|Adverse Event|0|||
161172099|NCT01021813|582007445|FG003|DB Treatment Phase|Adverse Event|0|||
161172100|NCT01021813|582007446|FG004|DB Treatment Phase|Adverse Event|0|||
161172101|NCT01021813|582007442|FG000|DB Treatment Phase|Lack of Efficacy|44|||
161172102|NCT01021813|582007443|FG001|DB Treatment Phase|Lack of Efficacy|28|||
161172103|NCT01021813|582007444|FG002|DB Treatment Phase|Lack of Efficacy|0|||
161172104|NCT01021813|582007445|FG003|DB Treatment Phase|Lack of Efficacy|0|||
161172105|NCT01021813|582007446|FG004|DB Treatment Phase|Lack of Efficacy|0|||
161172106|NCT01021813|582007442|FG000|DB Treatment Phase|Lost to Follow-up|14|||
161172107|NCT01021813|582007443|FG001|DB Treatment Phase|Lost to Follow-up|12|||
161172108|NCT01021813|582007444|FG002|DB Treatment Phase|Lost to Follow-up|0|||
161172109|NCT01021813|582007445|FG003|DB Treatment Phase|Lost to Follow-up|0|||
161172110|NCT01021813|582007446|FG004|DB Treatment Phase|Lost to Follow-up|0|||
161172111|NCT01021813|582007442|FG000|DB Treatment Phase|Physician Decision|17|||
161172112|NCT01021813|582007443|FG001|DB Treatment Phase|Physician Decision|8|||
161172113|NCT01021813|582007444|FG002|DB Treatment Phase|Physician Decision|0|||
161172114|NCT01021813|582007445|FG003|DB Treatment Phase|Physician Decision|0|||
161172115|NCT01021813|582007446|FG004|DB Treatment Phase|Physician Decision|0|||
161172116|NCT01021813|582007442|FG000|DB Treatment Phase|Pregnancy|1|||
161172117|NCT01021813|582007443|FG001|DB Treatment Phase|Pregnancy|0|||
161172118|NCT01021813|582007444|FG002|DB Treatment Phase|Pregnancy|0|||
161172119|NCT01021813|582007445|FG003|DB Treatment Phase|Pregnancy|0|||
161172120|NCT01021813|582007446|FG004|DB Treatment Phase|Pregnancy|0|||
161172121|NCT01021813|582007442|FG000|DB Treatment Phase|Protocol Violation|4|||
161172122|NCT01021813|582007443|FG001|DB Treatment Phase|Protocol Violation|3|||
161172123|NCT01021813|582007444|FG002|DB Treatment Phase|Protocol Violation|0|||
161172124|NCT01021813|582007445|FG003|DB Treatment Phase|Protocol Violation|0|||
161292533|NCT00708552|582452140|FG002|Overall Study|Lost to Follow-up|0|||
161292534|NCT00708552|582452141|FG003|Overall Study|Lost to Follow-up|1|||
161292535|NCT00708552|582452138|FG000|Overall Study|Physician Decision|1|||
161292536|NCT00708552|582452139|FG001|Overall Study|Physician Decision|2|||
161292537|NCT00708552|582452140|FG002|Overall Study|Physician Decision|0|||
161292538|NCT00708552|582452141|FG003|Overall Study|Physician Decision|0|||
161172125|NCT01021813|582007446|FG004|DB Treatment Phase|Protocol Violation|0|||
161172126|NCT01021813|582007442|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
161172127|NCT01021813|582007443|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
161172128|NCT01021813|582007444|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
161172129|NCT01021813|582007445|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
161172130|NCT01021813|582007446|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
161172131|NCT01021813|582007442|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
161172132|NCT01021813|582007443|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
161172133|NCT01021813|582007444|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
161172134|NCT01021813|582007445|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
161172135|NCT01021813|582007446|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
161172136|NCT01021813|582007442|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161172137|NCT01021813|582007443|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161172138|NCT01021813|582007444|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161172139|NCT01021813|582007445|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
161172140|NCT01021813|582007446|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
161172141|NCT01021813|582007442|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161292539|NCT00708552|582452138|FG000|Overall Study|Withdrawal by Subject|12|||
161172142|NCT01021813|582007443|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161172143|NCT01021813|582007444|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161172144|NCT01021813|582007445|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
161172145|NCT01021813|582007446|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
161172146|NCT01021813|582007442|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161172147|NCT01021813|582007443|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161172148|NCT01021813|582007444|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
161172149|NCT01021813|582007445|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161172150|NCT01021813|582007446|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
161172151|NCT01021813|582007442|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
161172152|NCT01021813|582007443|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
161172153|NCT01021813|582007444|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
161172154|NCT01021813|582007445|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
161172155|NCT01021813|582007446|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
161172156|NCT00493974|582007448|FG000|Overall Study|Death|1|||
161172157|NCT00493974|582007449|FG001|Overall Study|Death|2|||
161172158|NCT00493974|582007448|FG000|Overall Study|Withdrawal by Subject|8|||
161172159|NCT00493974|582007449|FG001|Overall Study|Withdrawal by Subject|6|||
161172160|NCT00493974|582007448|FG000|Overall Study|Lost to Follow-up|4|||
161172161|NCT00493974|582007449|FG001|Overall Study|Lost to Follow-up|6|||
161172162|NCT00326417|582007450|FG000|Overall Study|Withdrawal by Subject|0|||
161172163|NCT00326417|582007451|FG001|Overall Study|Withdrawal by Subject|0|||
161172164|NCT00326417|582007452|FG002|Overall Study|Withdrawal by Subject|1|||
161172165|NCT00326417|582007453|FG003|Overall Study|Withdrawal by Subject|0|||
161172166|NCT00326417|582007450|FG000|Overall Study|Arm Closed|7|||
161172167|NCT00326417|582007451|FG001|Overall Study|Arm Closed|0|||
161172168|NCT00326417|582007452|FG002|Overall Study|Arm Closed|0|||
161172169|NCT00326417|582007453|FG003|Overall Study|Arm Closed|3|||
161172170|NCT00326417|582007450|FG000|Overall Study|Death|7|||
161172171|NCT00326417|582007451|FG001|Overall Study|Death|0|||
161172172|NCT00326417|582007452|FG002|Overall Study|Death|0|||
161172173|NCT00326417|582007453|FG003|Overall Study|Death|0|||
161172174|NCT00844285|582007454|FG000|Overall Study|Other|0|||
161172175|NCT00844285|582007455|FG001|Overall Study|Other|1|||
161172176|NCT00844285|582007456|FG002|Overall Study|Other|0|||
161172177|NCT00844285|582007454|FG000|Overall Study|Other than specified|95|||
161172178|NCT00844285|582007455|FG001|Overall Study|Other than specified|129|||
161172179|NCT00844285|582007456|FG002|Overall Study|Other than specified|12|||
161172180|NCT00844285|582007454|FG000|Overall Study|Site closure|256|||
161172181|NCT00844285|582007455|FG001|Overall Study|Site closure|450|||
161172182|NCT00844285|582007456|FG002|Overall Study|Site closure|50|||
161172183|NCT00844285|582007454|FG000|Overall Study|Follow-up < 8 years|16|||
161172184|NCT00844285|582007455|FG001|Overall Study|Follow-up < 8 years|23|||
161172185|NCT00844285|582007456|FG002|Overall Study|Follow-up < 8 years|4|||
161172186|NCT00844285|582007454|FG000|Overall Study|Protocol Violation|26|||
161172187|NCT00844285|582007455|FG001|Overall Study|Protocol Violation|28|||
161172188|NCT00844285|582007456|FG002|Overall Study|Protocol Violation|54|||
161172189|NCT00844285|582007454|FG000|Overall Study|Death|22|||
161172190|NCT00844285|582007455|FG001|Overall Study|Death|21|||
161172191|NCT00844285|582007456|FG002|Overall Study|Death|8|||
161172192|NCT00844285|582007454|FG000|Overall Study|Withdrew Consent|344|||
161172193|NCT00844285|582007455|FG001|Overall Study|Withdrew Consent|466|||
161172194|NCT00844285|582007456|FG002|Overall Study|Withdrew Consent|70|||
161172195|NCT00844285|582007454|FG000|Overall Study|Lost to Follow-up|330|||
161172196|NCT00844285|582007455|FG001|Overall Study|Lost to Follow-up|486|||
161172197|NCT00844285|582007456|FG002|Overall Study|Lost to Follow-up|74|||
161172198|NCT04682353|582007457|FG000|Overall Study|Lost to Follow-up|0|||
161172199|NCT04682353|582007458|FG001|Overall Study|Lost to Follow-up|1|||
161172200|NCT04682353|582007459|FG002|Overall Study|Lost to Follow-up|0|||
161172201|NCT04682353|582007460|FG003|Overall Study|Lost to Follow-up|1|||
161172202|NCT04682353|582007457|FG000|Overall Study|Personal reasons|0|||
161172203|NCT04682353|582007458|FG001|Overall Study|Personal reasons|1|||
161172204|NCT04682353|582007459|FG002|Overall Study|Personal reasons|0|||
161172205|NCT04682353|582007460|FG003|Overall Study|Personal reasons|0|||
161172206|NCT00862654|582007461|FG000|Overall Study|Lack of Efficacy|1|||
161172207|NCT00862654|582007462|FG001|Overall Study|Lack of Efficacy|0|||
161292540|NCT00708552|582452139|FG001|Overall Study|Withdrawal by Subject|7|||
161172208|NCT00862654|582007463|FG002|Overall Study|Lack of Efficacy|1|||
161172209|NCT00862654|582007464|FG003|Overall Study|Lack of Efficacy|0|||
161172210|NCT00862654|582007461|FG000|Overall Study|Lost to Follow-up|1|||
161172211|NCT00862654|582007462|FG001|Overall Study|Lost to Follow-up|2|||
161172212|NCT00862654|582007463|FG002|Overall Study|Lost to Follow-up|1|||
161172213|NCT00862654|582007464|FG003|Overall Study|Lost to Follow-up|3|||
161172214|NCT00862654|582007461|FG000|Overall Study|Adverse Event|0|||
161172215|NCT00862654|582007462|FG001|Overall Study|Adverse Event|1|||
161172216|NCT00862654|582007463|FG002|Overall Study|Adverse Event|1|||
161172217|NCT00862654|582007464|FG003|Overall Study|Adverse Event|0|||
161172218|NCT00862654|582007461|FG000|Overall Study|Pregnancy|1|||
161172219|NCT00862654|582007462|FG001|Overall Study|Pregnancy|1|||
161172220|NCT00862654|582007463|FG002|Overall Study|Pregnancy|0|||
161172221|NCT00862654|582007464|FG003|Overall Study|Pregnancy|0|||
161172222|NCT00862654|582007461|FG000|Overall Study|Withdrawal by Subject|2|||
161172223|NCT00862654|582007462|FG001|Overall Study|Withdrawal by Subject|2|||
161172224|NCT00862654|582007463|FG002|Overall Study|Withdrawal by Subject|2|||
161172225|NCT00862654|582007464|FG003|Overall Study|Withdrawal by Subject|3|||
161172226|NCT00862654|582007461|FG000|Overall Study|Subject mistake|0|||
161172227|NCT00862654|582007462|FG001|Overall Study|Subject mistake|1|||
161172228|NCT00862654|582007463|FG002|Overall Study|Subject mistake|0|||
161172229|NCT00862654|582007464|FG003|Overall Study|Subject mistake|0|||
161172230|NCT00862654|582007461|FG000|Overall Study|Familly constraint|0|||
161172231|NCT00862654|582007462|FG001|Overall Study|Familly constraint|1|||
161172232|NCT00862654|582007463|FG002|Overall Study|Familly constraint|0|||
161172233|NCT00862654|582007464|FG003|Overall Study|Familly constraint|0|||
161172234|NCT00862654|582007461|FG000|Overall Study|Never used study drugs|1|||
161172235|NCT00862654|582007462|FG001|Overall Study|Never used study drugs|0|||
161172236|NCT00862654|582007463|FG002|Overall Study|Never used study drugs|0|||
161172237|NCT00862654|582007464|FG003|Overall Study|Never used study drugs|0|||
161172238|NCT00862654|582007461|FG000|Overall Study|Included after end of inclusions|0|||
161172239|NCT00862654|582007462|FG001|Overall Study|Included after end of inclusions|0|||
161172240|NCT00862654|582007463|FG002|Overall Study|Included after end of inclusions|1|||
161172241|NCT00862654|582007464|FG003|Overall Study|Included after end of inclusions|0|||
161172242|NCT03219567|582007465|FG000|Overall Study|Withdrawal by Subject|0|||
161172243|NCT03219567|582007466|FG001|Overall Study|Withdrawal by Subject|1|||
161172244|NCT01313208|582007467|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
161172245|NCT01313208|582007468|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
161172246|NCT01313208|582007467|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
161172247|NCT01313208|582007468|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
161172248|NCT01313208|582007467|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
161172249|NCT01313208|582007468|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
161172250|NCT01313208|582007467|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
161172251|NCT01313208|582007468|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
161172252|NCT01313208|582007467|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
161172253|NCT01313208|582007468|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
161172254|NCT01313208|582007467|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
161172255|NCT01313208|582007468|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
161172256|NCT01313208|582007467|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
161172257|NCT01313208|582007468|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
161172258|NCT01313208|582007467|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
161172259|NCT01313208|582007468|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
161172260|NCT01313208|582007467|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
161172261|NCT01313208|582007468|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
161172262|NCT01151540|582007470|FG000|Overall Study|Other|2|||
161172263|NCT01151540|582007470|FG000|Overall Study|Adverse event, non-fatal|4|||
161172264|NCT01151540|582007470|FG000|Overall Study|Withdrawal by Subject|7|||
161172265|NCT01412060|582007474|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
161172266|NCT01412060|582007475|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
161172267|NCT01412060|582007476|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
161172268|NCT01412060|582007474|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
161172269|NCT01412060|582007475|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
161172270|NCT01412060|582007476|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
161172271|NCT01412060|582007474|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
161172272|NCT01412060|582007475|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
161172273|NCT01412060|582007476|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
161172274|NCT01412060|582007474|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
161172275|NCT01412060|582007475|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
161172276|NCT01412060|582007476|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
161172277|NCT01412060|582007474|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
161172278|NCT01412060|582007475|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
161172279|NCT01412060|582007476|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
161172280|NCT01412060|582007474|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
161172281|NCT01412060|582007475|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
161172282|NCT01412060|582007476|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
161319402|NCT01134263|582555300|FG000|Overall Study|Lost to Follow-up|4|||
161319403|NCT01134263|582555301|FG001|Overall Study|Lost to Follow-up|3|||
161319404|NCT01134263|582555302|FG002|Overall Study|Lost to Follow-up|5|||
161319405|NCT01134263|582555303|FG003|Overall Study|Lost to Follow-up|3|||
161319406|NCT01134263|582555304|FG004|Overall Study|Lost to Follow-up|1|||
161319407|NCT01134263|582555300|FG000|Overall Study|Withdrawal by Subject|8|||
161319408|NCT01134263|582555301|FG001|Overall Study|Withdrawal by Subject|6|||
161319409|NCT01134263|582555302|FG002|Overall Study|Withdrawal by Subject|16|||
161172283|NCT01412060|582007474|FG000|Period Between RIP and SP|Adverse Event|4|||
161172284|NCT01412060|582007475|FG001|Period Between RIP and SP|Adverse Event|0|||
161172285|NCT01412060|582007476|FG002|Period Between RIP and SP|Adverse Event|0|||
161172286|NCT01412060|582007474|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
161172287|NCT01412060|582007475|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
161172288|NCT01412060|582007476|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
161172289|NCT01412060|582007474|FG000|Period Between RIP and SP|Protocol Violation|2|||
161172290|NCT01412060|582007475|FG001|Period Between RIP and SP|Protocol Violation|0|||
161172291|NCT01412060|582007476|FG002|Period Between RIP and SP|Protocol Violation|0|||
161172292|NCT01412060|582007474|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
161172293|NCT01412060|582007475|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
161172294|NCT01412060|582007476|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
161172295|NCT01412060|582007474|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
161172296|NCT01412060|582007475|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
161172297|NCT01412060|582007476|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
161172298|NCT01412060|582007474|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
161172299|NCT01412060|582007475|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
161172300|NCT01412060|582007476|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
161172301|NCT01412060|582007474|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
161172302|NCT01412060|582007475|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
161172303|NCT01412060|582007476|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
161172304|NCT01412060|582007474|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
161172305|NCT01412060|582007475|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
161172306|NCT01412060|582007476|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
161172307|NCT01412060|582007474|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
161172308|NCT01412060|582007475|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
161172309|NCT01412060|582007476|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
161172310|NCT01412060|582007474|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
161172311|NCT01412060|582007475|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
161172312|NCT01412060|582007476|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
161172313|NCT01412060|582007474|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
161172314|NCT01412060|582007475|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
161172315|NCT01412060|582007476|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
161172316|NCT01412060|582007474|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
161172317|NCT01412060|582007475|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
161172318|NCT01412060|582007476|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
161172319|NCT01412060|582007474|FG000|Period Between SP and DBP|Protocol Violation|2|||
161172320|NCT01412060|582007475|FG001|Period Between SP and DBP|Protocol Violation|0|||
161172321|NCT01412060|582007476|FG002|Period Between SP and DBP|Protocol Violation|0|||
161172322|NCT01412060|582007474|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
161172323|NCT01412060|582007475|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
161172324|NCT01412060|582007476|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
161172325|NCT01412060|582007474|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
161172326|NCT01412060|582007475|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
161172327|NCT01412060|582007476|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
161172328|NCT01412060|582007474|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
161172329|NCT01412060|582007475|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
161172330|NCT01412060|582007476|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
161172331|NCT01412060|582007474|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
161172332|NCT01412060|582007475|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
161172333|NCT01412060|582007476|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
161172334|NCT01412060|582007474|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
161172335|NCT01412060|582007475|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
161172336|NCT01412060|582007476|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
161172337|NCT01412060|582007474|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
161172338|NCT01412060|582007475|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
161172339|NCT01412060|582007476|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
161172340|NCT01412060|582007474|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
161172341|NCT01412060|582007475|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
161172342|NCT01412060|582007476|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
161172343|NCT01412060|582007474|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
161172344|NCT01412060|582007475|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
161172345|NCT01412060|582007476|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
161172346|NCT01412060|582007474|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
161172347|NCT01412060|582007475|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
161172348|NCT01412060|582007476|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
161172349|NCT01412060|582007474|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
161172350|NCT01412060|582007475|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
161172351|NCT01412060|582007476|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
161172352|NCT00004732|582007477|FG000|Overall Study|Withdrawal by Subject|36|||
161172353|NCT00004732|582007478|FG001|Overall Study|Withdrawal by Subject|64|||
161172354|NCT00004732|582007477|FG000|Overall Study|Lost to Follow-up|33|||
161172355|NCT00004732|582007478|FG001|Overall Study|Lost to Follow-up|47|||
161172356|NCT02983799|582007483|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
161172357|NCT02983799|582007484|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
161172358|NCT02983799|582007485|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
161172359|NCT02983799|582007486|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
161172360|NCT02983799|582007487|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
161172361|NCT02983799|582007483|FG000|Overall Study|Death|20|||
161172362|NCT02983799|582007484|FG001|Overall Study|Death|5|||
161172363|NCT02983799|582007485|FG002|Overall Study|Death|23|||
161172364|NCT02983799|582007486|FG003|Overall Study|Death|47|||
161172365|NCT02983799|582007487|FG004|Overall Study|Death|7|||
161172366|NCT02983799|582007483|FG000|Overall Study|Withdrawal by Subject|1|||
161172367|NCT02983799|582007484|FG001|Overall Study|Withdrawal by Subject|0|||
161172368|NCT02983799|582007485|FG002|Overall Study|Withdrawal by Subject|3|||
161172369|NCT02983799|582007486|FG003|Overall Study|Withdrawal by Subject|4|||
161172370|NCT02983799|582007487|FG004|Overall Study|Withdrawal by Subject|1|||
161172371|NCT02983799|582007483|FG000|Overall Study|Protocol Violation|0|||
161172372|NCT02983799|582007484|FG001|Overall Study|Protocol Violation|1|||
161172373|NCT02983799|582007485|FG002|Overall Study|Protocol Violation|0|||
161172374|NCT02983799|582007486|FG003|Overall Study|Protocol Violation|0|||
161172375|NCT02983799|582007487|FG004|Overall Study|Protocol Violation|1|||
161172376|NCT02983799|582007483|FG000|Overall Study|Lost to Follow-up|1|||
161172377|NCT02983799|582007484|FG001|Overall Study|Lost to Follow-up|0|||
161172378|NCT02983799|582007485|FG002|Overall Study|Lost to Follow-up|1|||
161172379|NCT02983799|582007486|FG003|Overall Study|Lost to Follow-up|0|||
161172380|NCT02983799|582007487|FG004|Overall Study|Lost to Follow-up|0|||
161172381|NCT00719862|582007493|FG000|Overall Study|Adverse Event|1|||
161172382|NCT00719862|582007494|FG001|Overall Study|Adverse Event|2|||
161172383|NCT00719862|582007493|FG000|Overall Study|Lack of Efficacy|3|||
161172384|NCT00719862|582007494|FG001|Overall Study|Lack of Efficacy|0|||
161172385|NCT00719862|582007493|FG000|Overall Study|Non-Compliance|1|||
161172386|NCT00719862|582007494|FG001|Overall Study|Non-Compliance|0|||
161172387|NCT00719862|582007493|FG000|Overall Study|Withdrawal by Subject|1|||
161172388|NCT00719862|582007494|FG001|Overall Study|Withdrawal by Subject|0|||
161172389|NCT00719862|582007493|FG000|Overall Study|Lost to Follow-up|0|||
161172390|NCT00719862|582007494|FG001|Overall Study|Lost to Follow-up|1|||
161172391|NCT00719862|582007493|FG000|Overall Study|Other|2|||
161172392|NCT00719862|582007494|FG001|Overall Study|Other|3|||
161172393|NCT01626989|582007495|FG000|Screening Period|Screen Failure|15|||
161172394|NCT01626989|582007496|FG001|Screening Period|Screen Failure|0|||
161172395|NCT01626989|582007497|FG002|Screening Period|Screen Failure|0|||
161172396|NCT01626989|582007495|FG000|Screening Period|Withdrawal by Subject|2|||
161172397|NCT01626989|582007496|FG001|Screening Period|Withdrawal by Subject|0|||
161172398|NCT01626989|582007497|FG002|Screening Period|Withdrawal by Subject|0|||
161172399|NCT02293902|582007506|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
161172400|NCT02293902|582007507|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
161172401|NCT02293902|582007508|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
161172402|NCT02293902|582007509|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
161172403|NCT02293902|582007510|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
161172404|NCT02293902|582007506|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
161172405|NCT02293902|582007507|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
161172406|NCT02293902|582007508|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
161172407|NCT02293902|582007509|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
161172408|NCT02293902|582007510|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
161172409|NCT02293902|582007506|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
161172410|NCT02293902|582007507|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161172411|NCT02293902|582007508|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161172412|NCT02293902|582007509|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161172413|NCT02293902|582007510|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
161172414|NCT02293902|582007506|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
161172415|NCT02293902|582007507|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
161172416|NCT02293902|582007508|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
161172417|NCT02293902|582007509|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
161172418|NCT02293902|582007510|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
161172419|NCT02293902|582007506|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161172420|NCT02293902|582007507|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
161172421|NCT02293902|582007508|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
161347403|NCT02782468|582656279|FG001|Overall Study|Adverse Event|2|||
161172422|NCT02293902|582007509|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161172423|NCT02293902|582007510|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
161172424|NCT03276572|582009674|FG000|Overall Study|In follow-up|0|||
161172425|NCT03276572|582009675|FG001|Overall Study|In follow-up|0|||
161172426|NCT03276572|582009676|FG002|Overall Study|In follow-up|0|||
161172427|NCT03276572|582009677|FG003|Overall Study|In follow-up|0|||
161172428|NCT03276572|582009678|FG004|Overall Study|In follow-up|0|||
161172429|NCT03276572|582009679|FG005|Overall Study|In follow-up|1|||
161172430|NCT03276572|582009680|FG006|Overall Study|In follow-up|1|||
161172431|NCT03276572|582009674|FG000|Overall Study|Lost to Follow-up|0|||
161172432|NCT03276572|582009675|FG001|Overall Study|Lost to Follow-up|0|||
161172433|NCT03276572|582009676|FG002|Overall Study|Lost to Follow-up|0|||
161172434|NCT03276572|582009677|FG003|Overall Study|Lost to Follow-up|0|||
161172435|NCT03276572|582009678|FG004|Overall Study|Lost to Follow-up|0|||
161172436|NCT03276572|582009679|FG005|Overall Study|Lost to Follow-up|0|||
161172437|NCT03276572|582009680|FG006|Overall Study|Lost to Follow-up|1|||
161172438|NCT02580240|582009681|FG000|Overall Study|Physician Decision|2|||
161172439|NCT02580240|582009682|FG001|Overall Study|Physician Decision|0|||
161172440|NCT02954952|582009695|FG000|Overall Study|Withdrawal by Subject|1|||
161172441|NCT02954952|582009696|FG001|Overall Study|Withdrawal by Subject|0|||
161172442|NCT02954952|582009697|FG002|Overall Study|Withdrawal by Subject|0|||
161172443|NCT02954952|582009695|FG000|Overall Study|No data collected|0|||
161172444|NCT02954952|582009696|FG001|Overall Study|No data collected|1|||
161172445|NCT02954952|582009697|FG002|Overall Study|No data collected|0|||
161172446|NCT02911519|582009698|FG000|Overall Study|Lost to Follow-up|2|||
161172447|NCT02911519|582009699|FG001|Overall Study|Lost to Follow-up|2|||
161172448|NCT02911519|582009698|FG000|Overall Study|Death|0|||
161172449|NCT02911519|582009699|FG001|Overall Study|Death|2|||
161172450|NCT00810043|582009700|FG000|Overall Study|Withdrawal by Subject|1|||
161172451|NCT00810043|582009701|FG001|Overall Study|Withdrawal by Subject|0|||
161172452|NCT00810043|582009702|FG002|Overall Study|Withdrawal by Subject|2|||
161172453|NCT00810043|582009700|FG000|Overall Study|Lost to Follow-up|1|||
161172454|NCT00810043|582009701|FG001|Overall Study|Lost to Follow-up|0|||
161172455|NCT00810043|582009702|FG002|Overall Study|Lost to Follow-up|0|||
161172456|NCT00810043|582009700|FG000|Overall Study|Physician Decision|0|||
161172457|NCT00810043|582009701|FG001|Overall Study|Physician Decision|0|||
161172458|NCT00810043|582009702|FG002|Overall Study|Physician Decision|2|||
161172459|NCT00810043|582009700|FG000|Overall Study|Death|2|||
161172460|NCT00810043|582009701|FG001|Overall Study|Death|0|||
161172461|NCT00810043|582009702|FG002|Overall Study|Death|0|||
161172462|NCT00810043|582009700|FG000|Overall Study|Unrelated medical problem|0|||
161172463|NCT00810043|582009701|FG001|Overall Study|Unrelated medical problem|1|||
161172464|NCT00810043|582009702|FG002|Overall Study|Unrelated medical problem|0|||
161172465|NCT00810043|582009700|FG000|Overall Study|Non-medical problem|0|||
161172466|NCT00810043|582009701|FG001|Overall Study|Non-medical problem|0|||
161172467|NCT00810043|582009702|FG002|Overall Study|Non-medical problem|1|||
161172468|NCT00810043|582009700|FG000|Overall Study|No longer met enrollment criteria|0|||
161172469|NCT00810043|582009701|FG001|Overall Study|No longer met enrollment criteria|0|||
161172470|NCT00810043|582009702|FG002|Overall Study|No longer met enrollment criteria|3|||
161172471|NCT00105183|582009708|FG000|Overall Study|Death|19|||
161172472|NCT00105183|582009709|FG001|Overall Study|Death|13|||
161172473|NCT00105183|582009710|FG002|Overall Study|Death|15|||
161172474|NCT00105183|582009708|FG000|Overall Study|Withdrawal by Subject|1|||
161172475|NCT00105183|582009709|FG001|Overall Study|Withdrawal by Subject|1|||
161172476|NCT00105183|582009710|FG002|Overall Study|Withdrawal by Subject|4|||
161172477|NCT00105183|582009708|FG000|Overall Study|Physician Decision|1|||
161172478|NCT00105183|582009709|FG001|Overall Study|Physician Decision|2|||
161172479|NCT00105183|582009710|FG002|Overall Study|Physician Decision|3|||
161172480|NCT00105183|582009708|FG000|Overall Study|Lost to Follow-up|0|||
161172481|NCT00105183|582009709|FG001|Overall Study|Lost to Follow-up|1|||
161172482|NCT00105183|582009710|FG002|Overall Study|Lost to Follow-up|1|||
161172483|NCT00105183|582009708|FG000|Overall Study|Other reason|1|||
161172484|NCT00105183|582009709|FG001|Overall Study|Other reason|2|||
161172485|NCT00105183|582009710|FG002|Overall Study|Other reason|0|||
161172486|NCT00270998|582009714|FG000|3 Month Follow-up|Adverse Event|1|||
161172487|NCT00270998|582009715|FG001|3 Month Follow-up|Adverse Event|0|||
161172488|NCT00270998|582009716|FG002|3 Month Follow-up|Adverse Event|0|||
161172489|NCT00270998|582009714|FG000|3 Month Follow-up|Lack of Efficacy|1|||
161172490|NCT00270998|582009715|FG001|3 Month Follow-up|Lack of Efficacy|2|||
161172491|NCT00270998|582009716|FG002|3 Month Follow-up|Lack of Efficacy|1|||
161172492|NCT00270998|582009714|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
161172493|NCT00270998|582009715|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
161172494|NCT00270998|582009716|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
161172495|NCT00270998|582009714|FG000|3 Month Follow-up|Pessary did not fit|12|||
161292541|NCT00708552|582452140|FG002|Overall Study|Withdrawal by Subject|8|||
161172496|NCT00270998|582009715|FG001|3 Month Follow-up|Pessary did not fit|0|||
161172497|NCT00270998|582009716|FG002|3 Month Follow-up|Pessary did not fit|0|||
161172498|NCT00270998|582009714|FG000|3 Month Follow-up|Personal/family health|1|||
161172499|NCT00270998|582009715|FG001|3 Month Follow-up|Personal/family health|1|||
161347404|NCT02782468|582656280|FG002|Overall Study|Adverse Event|2|||
161347405|NCT02782468|582656281|FG003|Overall Study|Adverse Event|3|||
161086538|NCT01577745|581704439|FG000|Overall Study|Physician Decision|0|||
161086539|NCT01577745|581704440|FG001|Overall Study|Physician Decision|0|||
161086540|NCT01577745|581704441|FG002|Overall Study|Physician Decision|0|||
161086541|NCT01577745|581704442|FG003|Overall Study|Physician Decision|1|||
161086542|NCT01577745|581704443|FG004|Overall Study|Physician Decision|1|||
161086543|NCT01577745|581704444|FG005|Overall Study|Physician Decision|0|||
161086544|NCT01577745|581704439|FG000|Overall Study|Lost to Follow-up|0|||
161086545|NCT01577745|581704440|FG001|Overall Study|Lost to Follow-up|0|||
161086546|NCT01577745|581704441|FG002|Overall Study|Lost to Follow-up|0|||
161086547|NCT01577745|581704442|FG003|Overall Study|Lost to Follow-up|0|||
161086548|NCT01577745|581704443|FG004|Overall Study|Lost to Follow-up|0|||
161086549|NCT01577745|581704444|FG005|Overall Study|Lost to Follow-up|1|||
161086550|NCT01577745|581704439|FG000|Overall Study|Alternative Therapy|0|||
161086551|NCT01577745|581704440|FG001|Overall Study|Alternative Therapy|0|||
161086552|NCT01577745|581704441|FG002|Overall Study|Alternative Therapy|0|||
161086553|NCT01577745|581704442|FG003|Overall Study|Alternative Therapy|1|||
161086554|NCT01577745|581704443|FG004|Overall Study|Alternative Therapy|1|||
161086555|NCT01577745|581704444|FG005|Overall Study|Alternative Therapy|0|||
161086556|NCT01801735|581704445|FG000|Overall Study|Adverse Event|79|||
161086557|NCT01801735|581704445|FG000|Overall Study|Lack of Efficacy|28|||
161086558|NCT01801735|581704445|FG000|Overall Study|Withdrawal by Subject|27|||
161086559|NCT01801735|581704445|FG000|Overall Study|Protocol Violation|25|||
161086560|NCT01801735|581704445|FG000|Overall Study|Lost to Follow-up|15|||
161086561|NCT01801735|581704445|FG000|Overall Study|Non-compliance with Trial Drug|13|||
161086562|NCT01801735|581704445|FG000|Overall Study|Physician Decision|3|||
161086563|NCT01801735|581704445|FG000|Overall Study|Death|1|||
161086564|NCT01801735|581704445|FG000|Overall Study|Other, including site closure|19|||
161086565|NCT01435616|581704446|FG000|Overall Study|Adverse Event|39|||
161086566|NCT01435616|581704447|FG001|Overall Study|Adverse Event|21|||
161086567|NCT01435616|581704446|FG000|Overall Study|Death|7|||
161086568|NCT01435616|581704447|FG001|Overall Study|Death|2|||
161086569|NCT01435616|581704446|FG000|Overall Study|Lost to Follow-up|22|||
161086570|NCT01435616|581704447|FG001|Overall Study|Lost to Follow-up|13|||
161086571|NCT01435616|581704446|FG000|Overall Study|Protocol Violation|16|||
161086572|NCT01435616|581704447|FG001|Overall Study|Protocol Violation|13|||
161086573|NCT01435616|581704446|FG000|Overall Study|Withdrawal by Subject|66|||
161086574|NCT01435616|581704447|FG001|Overall Study|Withdrawal by Subject|24|||
161086575|NCT01435616|581704446|FG000|Overall Study|Physician Decision|20|||
161086576|NCT01435616|581704447|FG001|Overall Study|Physician Decision|7|||
161086577|NCT01435616|581704446|FG000|Overall Study|Sponsor Decision|1|||
161086578|NCT01435616|581704447|FG001|Overall Study|Sponsor Decision|0|||
161086579|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|Death|1|||
161086580|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|Death|1|||
161086581|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
161086582|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
161086583|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
161086584|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
161086585|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
161086586|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
161086587|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
161086588|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
161086589|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
161086590|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
161086591|NCT00371683|581704450|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
161086592|NCT00371683|581704451|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
161086593|NCT00371683|581704450|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
161086594|NCT00371683|581704451|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
161086595|NCT00371683|581704450|FG000|Follow-Up Period - Randomized Patients|Death|0|||
161086596|NCT00371683|581704451|FG001|Follow-Up Period - Randomized Patients|Death|2|||
161086597|NCT00371683|581704450|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
161086598|NCT00371683|581704451|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
161086599|NCT00371683|581704450|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
161086600|NCT00371683|581704451|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
161086601|NCT01146782|581704452|FG000|Screening Cohort|Screen Failure|187|||
161086602|NCT01146782|581704452|FG000|Screening Cohort|Lost to Follow-up|4|||
161086603|NCT01146782|581704452|FG000|Screening Cohort|Physician Decision|1|||
161086604|NCT01146782|581704452|FG000|Screening Cohort|Withdrawal by Subject|29|||
161086605|NCT01146782|581704452|FG000|Safety Cohort|Screen Failure|61|||
161086606|NCT01146782|581704452|FG000|Safety Cohort|Withdrawal by Subject|4|||
161086607|NCT01146782|581704452|FG000|Safety Cohort|Control AHI <5|4|||
161347406|NCT02782468|582656278|FG000|Overall Study|Other|0|||
161086608|NCT01146782|581704452|FG000|Safety Cohort|TST <4 hrs|14|||
161347407|NCT02782468|582656279|FG001|Overall Study|Other|0|||
161172500|NCT00270998|582009716|FG002|3 Month Follow-up|Personal/family health|0|||
161172501|NCT00270998|582009714|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
161172502|NCT00270998|582009715|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
161086609|NCT01146782|581704452|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
161086610|NCT01146782|581704452|FG000|Primary Endpoint Cohort|Physician Decision|1|||
161086611|NCT03208036|581704456|FG000|Baseline Assessment|Withdrawal by Subject|1|||
161086612|NCT03208036|581704457|FG001|Baseline Assessment|Withdrawal by Subject|1|||
161086613|NCT03208036|581704456|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
161086614|NCT03208036|581704457|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
161086615|NCT03208036|581704456|FG000|Intervention|Withdrawal by Subject|3|||
161086616|NCT03208036|581704457|FG001|Intervention|Withdrawal by Subject|2|||
161086617|NCT03208036|581704456|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
161086618|NCT03208036|581704457|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
161086619|NCT00700778|581704458|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
161086620|NCT00350103|581704459|FG000|Overall Study|Adverse Event|12|||
161086621|NCT00350103|581704460|FG001|Overall Study|Adverse Event|29|||
161086622|NCT00350103|581704461|FG002|Overall Study|Adverse Event|17|||
161086623|NCT00350103|581704459|FG000|Overall Study|Lack of Efficacy|5|||
161086624|NCT00350103|581704460|FG001|Overall Study|Lack of Efficacy|1|||
161086625|NCT00350103|581704461|FG002|Overall Study|Lack of Efficacy|3|||
161086626|NCT00350103|581704459|FG000|Overall Study|Withdrawal by Subject|6|||
161086627|NCT00350103|581704460|FG001|Overall Study|Withdrawal by Subject|6|||
161086628|NCT00350103|581704461|FG002|Overall Study|Withdrawal by Subject|8|||
161086629|NCT00350103|581704459|FG000|Overall Study|Protocol Violation|0|||
161086630|NCT00350103|581704460|FG001|Overall Study|Protocol Violation|0|||
161086631|NCT00350103|581704461|FG002|Overall Study|Protocol Violation|1|||
161086632|NCT00350103|581704459|FG000|Overall Study|Unsatisfactory Compliance|2|||
161086633|NCT00350103|581704460|FG001|Overall Study|Unsatisfactory Compliance|2|||
161086634|NCT00350103|581704461|FG002|Overall Study|Unsatisfactory Compliance|1|||
161086635|NCT00350103|581704459|FG000|Overall Study|Investigator´s decision|1|||
161086636|NCT00350103|581704460|FG001|Overall Study|Investigator´s decision|1|||
161086637|NCT00350103|581704461|FG002|Overall Study|Investigator´s decision|0|||
161086638|NCT00350103|581704459|FG000|Overall Study|Exclusion criteria met|0|||
161086639|NCT00350103|581704460|FG001|Overall Study|Exclusion criteria met|0|||
161086640|NCT00350103|581704461|FG002|Overall Study|Exclusion criteria met|1|||
161086641|NCT00350103|581704459|FG000|Overall Study|Patient relocated|0|||
161086642|NCT00350103|581704460|FG001|Overall Study|Patient relocated|0|||
161086643|NCT00350103|581704461|FG002|Overall Study|Patient relocated|1|||
161086644|NCT00350103|581704459|FG000|Overall Study|Need for prohibited medication|1|||
161086645|NCT00350103|581704460|FG001|Overall Study|Need for prohibited medication|0|||
161086646|NCT00350103|581704461|FG002|Overall Study|Need for prohibited medication|0|||
161086647|NCT00350103|581704459|FG000|Overall Study|Personal reasons|0|||
161086648|NCT00350103|581704460|FG001|Overall Study|Personal reasons|0|||
161086649|NCT00350103|581704461|FG002|Overall Study|Personal reasons|1|||
161086650|NCT00350103|581704459|FG000|Overall Study|Patient stopped feeling pain|1|||
161086651|NCT00350103|581704460|FG001|Overall Study|Patient stopped feeling pain|0|||
161086652|NCT00350103|581704461|FG002|Overall Study|Patient stopped feeling pain|0|||
161086653|NCT00350103|581704459|FG000|Overall Study|PR greater than 250ms|0|||
161086654|NCT00350103|581704460|FG001|Overall Study|PR greater than 250ms|0|||
161086655|NCT00350103|581704461|FG002|Overall Study|PR greater than 250ms|1|||
161086656|NCT00350103|581704459|FG000|Overall Study|Wrong calculation of QT interval|0|||
161086657|NCT00350103|581704460|FG001|Overall Study|Wrong calculation of QT interval|0|||
161086658|NCT00350103|581704461|FG002|Overall Study|Wrong calculation of QT interval|1|||
161086659|NCT00350103|581704459|FG000|Overall Study|Sponsor mistake|1|||
161086660|NCT00350103|581704460|FG001|Overall Study|Sponsor mistake|0|||
161086661|NCT00350103|581704461|FG002|Overall Study|Sponsor mistake|0|||
161086662|NCT00350103|581704459|FG000|Overall Study|Randomization mistake|0|||
161086663|NCT00350103|581704460|FG001|Overall Study|Randomization mistake|1|||
161086664|NCT00350103|581704461|FG002|Overall Study|Randomization mistake|1|||
161086665|NCT00350103|581704459|FG000|Overall Study|Sponsor´s decision|0|||
161086666|NCT00350103|581704460|FG001|Overall Study|Sponsor´s decision|1|||
161086667|NCT00350103|581704461|FG002|Overall Study|Sponsor´s decision|0|||
161086668|NCT00350103|581704459|FG000|Overall Study|Lost, Reason unknown|1|||
161086669|NCT00350103|581704460|FG001|Overall Study|Lost, Reason unknown|1|||
161086670|NCT00350103|581704461|FG002|Overall Study|Lost, Reason unknown|0|||
161086671|NCT01879553|581704462|FG000|Overall Study|Withdrawal by Subject|1|||
161086672|NCT01879553|581704463|FG001|Overall Study|Withdrawal by Subject|0|||
161086673|NCT00438672|581704464|FG000|Overall Study|Lost to Follow-up|7|||
161086674|NCT00438672|581704465|FG001|Overall Study|Lost to Follow-up|9|||
161086675|NCT02559895|581704466|FG000|Overall Study|Adverse Event|3|||
161086676|NCT02559895|581704467|FG001|Overall Study|Adverse Event|3|||
161086677|NCT02559895|581704468|FG002|Overall Study|Adverse Event|2|||
161086678|NCT02559895|581704469|FG003|Overall Study|Adverse Event|1|||
161086679|NCT02559895|581704466|FG000|Overall Study|Lack of Efficacy|2|||
161347408|NCT02782468|582656280|FG002|Overall Study|Other|1|||
161172503|NCT00270998|582009716|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
161172504|NCT00270998|582009714|FG000|12 Month Follow-up|Lack of Efficacy|5|||
161172505|NCT00270998|582009715|FG001|12 Month Follow-up|Lack of Efficacy|4|||
161172506|NCT00270998|582009716|FG002|12 Month Follow-up|Lack of Efficacy|3|||
161172507|NCT00270998|582009714|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
161172508|NCT00270998|582009715|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
161172509|NCT00270998|582009716|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
161172510|NCT00270998|582009714|FG000|12 Month Follow-up|Pessary did not fit|1|||
161172511|NCT00270998|582009715|FG001|12 Month Follow-up|Pessary did not fit|0|||
161172512|NCT00270998|582009716|FG002|12 Month Follow-up|Pessary did not fit|0|||
161172513|NCT00270998|582009714|FG000|12 Month Follow-up|Personal/family health|0|||
161172514|NCT00270998|582009715|FG001|12 Month Follow-up|Personal/family health|5|||
161172515|NCT00270998|582009716|FG002|12 Month Follow-up|Personal/family health|1|||
161172516|NCT00270998|582009714|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
161172517|NCT00270998|582009715|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
161172518|NCT00270998|582009716|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
161172519|NCT04075396|582009717|FG000|Overall Study|Death|11|||
161172520|NCT04075396|582009718|FG001|Overall Study|Death|9|||
161172521|NCT04075396|582009717|FG000|Overall Study|Withdrawal by Subject|1|||
161172522|NCT04075396|582009718|FG001|Overall Study|Withdrawal by Subject|2|||
161172523|NCT04075396|582009717|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
161172524|NCT04075396|582009718|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
161172525|NCT04075396|582009717|FG000|Overall Study|Enrolled but not-treated|0|||
161172526|NCT04075396|582009718|FG001|Overall Study|Enrolled but not-treated|1|||
161172527|NCT02443805|582009723|FG000|Overall Study|Adverse Event|100|||
161172528|NCT02443805|582009724|FG001|Overall Study|Adverse Event|18|||
161172529|NCT02443805|582009723|FG000|Overall Study|Withdrawal by Subject|73|||
161172530|NCT02443805|582009724|FG001|Overall Study|Withdrawal by Subject|74|||
161172531|NCT02443805|582009723|FG000|Overall Study|Lost to Follow-up|19|||
161172532|NCT02443805|582009724|FG001|Overall Study|Lost to Follow-up|14|||
161172533|NCT02443805|582009723|FG000|Overall Study|Pregnancy|6|||
161172534|NCT02443805|582009724|FG001|Overall Study|Pregnancy|5|||
161172535|NCT02443805|582009723|FG000|Overall Study|Protocol Violation|2|||
161172536|NCT02443805|582009724|FG001|Overall Study|Protocol Violation|4|||
161172537|NCT02443805|582009723|FG000|Overall Study|Lack of Efficacy|1|||
161172538|NCT02443805|582009724|FG001|Overall Study|Lack of Efficacy|1|||
161172539|NCT02443805|582009723|FG000|Overall Study|Non-compliance with study drug|6|||
161172540|NCT02443805|582009724|FG001|Overall Study|Non-compliance with study drug|4|||
161172541|NCT02443805|582009723|FG000|Overall Study|Withdrawal by parent/guardian|3|||
161172542|NCT02443805|582009724|FG001|Overall Study|Withdrawal by parent/guardian|5|||
161172543|NCT02443805|582009723|FG000|Overall Study|Any other reason not above-mentioned|3|||
161172544|NCT02443805|582009724|FG001|Overall Study|Any other reason not above-mentioned|2|||
161172545|NCT00961116|582009725|FG000|Washout Period of 7 Days|Adverse Event|1|||
161172546|NCT00961116|582009726|FG001|Washout Period of 7 Days|Adverse Event|1|||
161172547|NCT00961116|582009725|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161172548|NCT00961116|582009726|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161172549|NCT00961116|582009725|FG000|Washout Period of 7 Days|Protocol Violation|0|||
161172550|NCT00961116|582009726|FG001|Washout Period of 7 Days|Protocol Violation|1|||
161172551|NCT00968708|582009727|FG000|Overall Study|Adverse Event|169|||
161172552|NCT00968708|582009728|FG001|Overall Study|Adverse Event|150|||
161172553|NCT00968708|582009727|FG000|Overall Study|Major Protocol Deviation|0|||
161172554|NCT00968708|582009728|FG001|Overall Study|Major Protocol Deviation|1|||
161172555|NCT00968708|582009727|FG000|Overall Study|Lost to Follow-up|19|||
161172556|NCT00968708|582009728|FG001|Overall Study|Lost to Follow-up|11|||
161172557|NCT00968708|582009727|FG000|Overall Study|Voluntary Withdrawal|104|||
161172558|NCT00968708|582009728|FG001|Overall Study|Voluntary Withdrawal|101|||
161172559|NCT00968708|582009727|FG000|Overall Study|Investigator Discretion|0|||
161172560|NCT00968708|582009728|FG001|Overall Study|Investigator Discretion|1|||
161292542|NCT00708552|582452141|FG003|Overall Study|Withdrawal by Subject|10|||
161292543|NCT04878432|582452142|FG000|Overall Study|Adverse Event|1|||
161292544|NCT04878432|582452142|FG000|Overall Study|Death|2|||
161292545|NCT04878432|582452142|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161292546|NCT04878432|582452142|FG000|Overall Study|Withdrawal by Subject|6|||
161172561|NCT00968708|582009727|FG000|Overall Study|Other|26|||
161172562|NCT00968708|582009728|FG001|Overall Study|Other|34|||
161292547|NCT04878432|582452142|FG000|Overall Study|Progressive Disease|7|||
161172563|NCT02708966|582009729|FG000|Overall Study|Lost to Follow-up|2|||
161172564|NCT02708966|582009730|FG001|Overall Study|Lost to Follow-up|2|||
161172565|NCT00389441|582009731|FG000|Overall Study|Adverse Event|7|||
161172566|NCT00389441|582009731|FG000|Overall Study|Death|4|||
161172567|NCT00389441|582009731|FG000|Overall Study|Lost to Follow-up|2|||
161172568|NCT00389441|582009731|FG000|Overall Study|Withdrawal by Subject|4|||
161172569|NCT00389441|582009731|FG000|Overall Study|Physician Decision|1|||
161172570|NCT00389441|582009731|FG000|Overall Study|Protocol Violation|1|||
161292548|NCT04878432|582452142|FG000|Overall Study|New Therapy for Study Indication|7|||
161172571|NCT00389441|582009731|FG000|Overall Study|Global deterioration of health status|4|||
161172572|NCT00389441|582009731|FG000|Overall Study|Objective progression or relapse|26|||
161172573|NCT00389441|582009731|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
161172574|NCT00389441|582009731|FG000|Overall Study|Clinical progression|1|||
161172575|NCT01981109|582009732|FG000|Overall Study|Death|36|||
161172576|NCT01981109|582009732|FG000|Overall Study|Withdrawal by Subject|40|||
161172577|NCT01981109|582009732|FG000|Overall Study|Lost to Follow-up|9|||
161172578|NCT01981109|582009732|FG000|Overall Study|No Discontinuation Documentation|37|||
161172579|NCT01981109|582009732|FG000|Overall Study|Study Termination|100|||
161086680|NCT02559895|581704467|FG001|Overall Study|Lack of Efficacy|3|||
161086681|NCT02559895|581704468|FG002|Overall Study|Lack of Efficacy|2|||
161086682|NCT02559895|581704469|FG003|Overall Study|Lack of Efficacy|8|||
161086683|NCT02559895|581704466|FG000|Overall Study|Lost to Follow-up|22|||
161086684|NCT02559895|581704467|FG001|Overall Study|Lost to Follow-up|16|||
161086685|NCT02559895|581704468|FG002|Overall Study|Lost to Follow-up|12|||
161086686|NCT02559895|581704469|FG003|Overall Study|Lost to Follow-up|17|||
161086687|NCT02559895|581704466|FG000|Overall Study|Physician Decision|1|||
161086688|NCT02559895|581704467|FG001|Overall Study|Physician Decision|1|||
161086689|NCT02559895|581704468|FG002|Overall Study|Physician Decision|3|||
161086690|NCT02559895|581704469|FG003|Overall Study|Physician Decision|0|||
161086691|NCT02559895|581704466|FG000|Overall Study|Withdrawal by Subject|16|||
161086692|NCT02559895|581704467|FG001|Overall Study|Withdrawal by Subject|9|||
161086693|NCT02559895|581704468|FG002|Overall Study|Withdrawal by Subject|20|||
161086694|NCT02559895|581704469|FG003|Overall Study|Withdrawal by Subject|9|||
161086695|NCT02559895|581704466|FG000|Overall Study|Study Burden|10|||
161086696|NCT02559895|581704467|FG001|Overall Study|Study Burden|16|||
161086697|NCT02559895|581704468|FG002|Overall Study|Study Burden|12|||
161172580|NCT01981109|582009732|FG000|Overall Study|No data available|2|||
161172581|NCT03407170|582009733|FG000|Overall Study|Adverse Event|1|||
161172582|NCT00636441|582009736|FG000|Overall Study|Adverse Event|0|||
161172583|NCT00636441|582009737|FG001|Overall Study|Adverse Event|1|||
161172584|NCT00636441|582009738|FG002|Overall Study|Adverse Event|1|||
161172585|NCT00636441|582009739|FG003|Overall Study|Adverse Event|0|||
161172586|NCT00636441|582009740|FG004|Overall Study|Adverse Event|0|||
161172587|NCT00636441|582009741|FG005|Overall Study|Adverse Event|1|||
161172588|NCT00636441|582009742|FG006|Overall Study|Adverse Event|0|||
161172589|NCT00636441|582009736|FG000|Overall Study|Late, ineligible|0|||
161172590|NCT00636441|582009737|FG001|Overall Study|Late, ineligible|0|||
161172591|NCT00636441|582009738|FG002|Overall Study|Late, ineligible|0|||
161172592|NCT00636441|582009739|FG003|Overall Study|Late, ineligible|0|||
161172593|NCT00636441|582009740|FG004|Overall Study|Late, ineligible|0|||
161172594|NCT00636441|582009741|FG005|Overall Study|Late, ineligible|0|||
161172595|NCT00636441|582009742|FG006|Overall Study|Late, ineligible|1|||
161172596|NCT00636441|582009736|FG000|Overall Study|Screen Failure|0|||
161172597|NCT00636441|582009737|FG001|Overall Study|Screen Failure|0|||
161172598|NCT00636441|582009738|FG002|Overall Study|Screen Failure|0|||
161172599|NCT00636441|582009739|FG003|Overall Study|Screen Failure|0|||
161172600|NCT00636441|582009740|FG004|Overall Study|Screen Failure|0|||
161172601|NCT00636441|582009741|FG005|Overall Study|Screen Failure|0|||
161172602|NCT00636441|582009742|FG006|Overall Study|Screen Failure|17|||
161172603|NCT00105560|582009743|FG000|Overall Study|Lost to Follow-up|1|||
161172604|NCT02559713|582009745|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
161172605|NCT01767519|582009747|FG000|Overall Study|Other Reasons|4|||
161172606|NCT01767519|582009748|FG001|Overall Study|Other Reasons|4|||
161172607|NCT01767519|582009749|FG002|Overall Study|Other Reasons|2|||
161172608|NCT01767519|582009747|FG000|Overall Study|Protocol Violation|0|||
161172609|NCT01767519|582009748|FG001|Overall Study|Protocol Violation|3|||
161172610|NCT01767519|582009749|FG002|Overall Study|Protocol Violation|0|||
161347409|NCT02782468|582656281|FG003|Overall Study|Other|1|||
161347410|NCT02782468|582656278|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161347411|NCT02782468|582656279|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161172611|NCT01767519|582009747|FG000|Overall Study|Personal Reasons|1|||
161172612|NCT01767519|582009748|FG001|Overall Study|Personal Reasons|0|||
161172613|NCT01767519|582009749|FG002|Overall Study|Personal Reasons|0|||
161172614|NCT01767519|582009747|FG000|Overall Study|Lost to Follow-up|3|||
161086698|NCT02559895|581704469|FG003|Overall Study|Study Burden|22|||
161086699|NCT02559895|581704466|FG000|Overall Study|Other|1|||
161086700|NCT02559895|581704467|FG001|Overall Study|Other|5|||
161172615|NCT01767519|582009748|FG001|Overall Study|Lost to Follow-up|1|||
161172616|NCT01767519|582009749|FG002|Overall Study|Lost to Follow-up|2|||
161172617|NCT01767519|582009747|FG000|Overall Study|Lack of Efficacy|1|||
161172618|NCT01767519|582009748|FG001|Overall Study|Lack of Efficacy|0|||
161086701|NCT02559895|581704468|FG002|Overall Study|Other|3|||
161086702|NCT02559895|581704469|FG003|Overall Study|Other|3|||
161086703|NCT04540887|581704470|FG000|Overall Study|Withdrawal by Subject|2|||
161086704|NCT02217501|581704471|FG000|Overall Study|Death|3|||
161172619|NCT01767519|582009749|FG002|Overall Study|Lack of Efficacy|0|||
161172620|NCT01767519|582009747|FG000|Overall Study|Adverse Event|5|||
161172621|NCT01767519|582009748|FG001|Overall Study|Adverse Event|5|||
161172622|NCT01767519|582009749|FG002|Overall Study|Adverse Event|1|||
161172623|NCT01117012|582009751|FG000|Overall Study|Adverse Event|0|||
161172624|NCT01117012|582009752|FG001|Overall Study|Adverse Event|1|||
161172625|NCT01117012|582009751|FG000|Overall Study|Death|1|||
161172626|NCT01117012|582009752|FG001|Overall Study|Death|1|||
161172627|NCT01117012|582009751|FG000|Overall Study|Withdrawal by Subject|3|||
161172628|NCT01117012|582009752|FG001|Overall Study|Withdrawal by Subject|0|||
161172629|NCT01117012|582009751|FG000|Overall Study|Undefined|4|||
161172630|NCT01117012|582009752|FG001|Overall Study|Undefined|3|||
161172631|NCT00555906|582009760|FG000|Phase 1|Objective Progression or Relapse|3|||
161172632|NCT00555906|582009761|FG001|Phase 1|Objective Progression or Relapse|5|||
161172633|NCT00555906|582009762|FG002|Phase 1|Objective Progression or Relapse|3|||
161172634|NCT00555906|582009763|FG003|Phase 1|Objective Progression or Relapse|1|||
161172635|NCT00555906|582009764|FG004|Phase 1|Objective Progression or Relapse|0|||
161172636|NCT00555906|582009760|FG000|Phase 1|Global Deterioration of Health Status|0|||
161172637|NCT00555906|582009761|FG001|Phase 1|Global Deterioration of Health Status|1|||
161172638|NCT00555906|582009762|FG002|Phase 1|Global Deterioration of Health Status|1|||
161172639|NCT00555906|582009763|FG003|Phase 1|Global Deterioration of Health Status|1|||
161172640|NCT00555906|582009764|FG004|Phase 1|Global Deterioration of Health Status|0|||
161172641|NCT00555906|582009760|FG000|Phase 1|Adverse Event|0|||
161172642|NCT00555906|582009761|FG001|Phase 1|Adverse Event|0|||
161172643|NCT00555906|582009762|FG002|Phase 1|Adverse Event|3|||
161172644|NCT00555906|582009763|FG003|Phase 1|Adverse Event|2|||
161172645|NCT00555906|582009764|FG004|Phase 1|Adverse Event|0|||
161172646|NCT00555906|582009760|FG000|Phase 1|Withdrawal by Subject|0|||
161172647|NCT00555906|582009761|FG001|Phase 1|Withdrawal by Subject|0|||
161172648|NCT00555906|582009762|FG002|Phase 1|Withdrawal by Subject|0|||
161172649|NCT00555906|582009763|FG003|Phase 1|Withdrawal by Subject|1|||
161172650|NCT00555906|582009764|FG004|Phase 1|Withdrawal by Subject|0|||
161172651|NCT00555906|582009760|FG000|Phase 2|Adverse Event|0|||
161172652|NCT00555906|582009761|FG001|Phase 2|Adverse Event|0|||
161172653|NCT00555906|582009762|FG002|Phase 2|Adverse Event|0|||
161172654|NCT00555906|582009763|FG003|Phase 2|Adverse Event|0|||
161172655|NCT00555906|582009764|FG004|Phase 2|Adverse Event|4|||
161172656|NCT00555906|582009760|FG000|Phase 2|Global Deterioration of Health Status|0|||
161172657|NCT00555906|582009761|FG001|Phase 2|Global Deterioration of Health Status|0|||
161172658|NCT00555906|582009762|FG002|Phase 2|Global Deterioration of Health Status|0|||
161172659|NCT00555906|582009763|FG003|Phase 2|Global Deterioration of Health Status|0|||
161172660|NCT00555906|582009764|FG004|Phase 2|Global Deterioration of Health Status|2|||
161172661|NCT00555906|582009760|FG000|Phase 2|Objective Progression or Relapse|0|||
161172662|NCT00555906|582009761|FG001|Phase 2|Objective Progression or Relapse|0|||
161172663|NCT00555906|582009762|FG002|Phase 2|Objective Progression or Relapse|0|||
161172664|NCT00555906|582009763|FG003|Phase 2|Objective Progression or Relapse|0|||
161172665|NCT00555906|582009764|FG004|Phase 2|Objective Progression or Relapse|16|||
161172666|NCT00555906|582009760|FG000|Phase 2|Withdrawal by Subject|0|||
161172667|NCT00555906|582009761|FG001|Phase 2|Withdrawal by Subject|0|||
161172668|NCT00555906|582009762|FG002|Phase 2|Withdrawal by Subject|0|||
161172669|NCT00555906|582009763|FG003|Phase 2|Withdrawal by Subject|0|||
161172670|NCT00555906|582009764|FG004|Phase 2|Withdrawal by Subject|2|||
161172671|NCT00555906|582009760|FG000|Phase 2|Other|0|||
161172672|NCT00555906|582009761|FG001|Phase 2|Other|0|||
161172673|NCT00555906|582009762|FG002|Phase 2|Other|0|||
161172674|NCT00555906|582009763|FG003|Phase 2|Other|0|||
161172675|NCT00555906|582009764|FG004|Phase 2|Other|6|||
161172676|NCT00555906|582009760|FG000|Phase 2|Randomized but not Treated|0|||
161172677|NCT00555906|582009761|FG001|Phase 2|Randomized but not Treated|0|||
161172678|NCT00555906|582009762|FG002|Phase 2|Randomized but not Treated|0|||
161172679|NCT00555906|582009763|FG003|Phase 2|Randomized but not Treated|0|||
161172680|NCT00555906|582009764|FG004|Phase 2|Randomized but not Treated|2|||
161172681|NCT01586806|582009765|FG000|Overall Study|Protocol Violation|0|||
161172682|NCT01586806|582009766|FG001|Overall Study|Protocol Violation|1|||
161172683|NCT01586806|582009767|FG002|Overall Study|Protocol Violation|0|||
161172684|NCT01586806|582009765|FG000|Overall Study|Withdrawal by Subject|1|||
161172685|NCT01586806|582009766|FG001|Overall Study|Withdrawal by Subject|0|||
161172686|NCT01586806|582009767|FG002|Overall Study|Withdrawal by Subject|0|||
161172687|NCT01586806|582009765|FG000|Overall Study|Lost to Follow-up|2|||
161172688|NCT01586806|582009766|FG001|Overall Study|Lost to Follow-up|3|||
161172689|NCT01586806|582009767|FG002|Overall Study|Lost to Follow-up|2|||
161172690|NCT02193828|582009768|FG000|Overall Study|Withdrawal by Subject|0|||
161172691|NCT02193828|582009769|FG001|Overall Study|Withdrawal by Subject|0|||
161172692|NCT02193828|582009770|FG002|Overall Study|Withdrawal by Subject|1|||
161172693|NCT02193828|582009771|FG003|Overall Study|Withdrawal by Subject|1|||
161172694|NCT02849626|582009772|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
161172695|NCT02849626|582009773|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
161172696|NCT02849626|582009774|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
161172697|NCT02849626|582009775|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
161172698|NCT02849626|582009772|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
161172699|NCT02849626|582009773|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
161172700|NCT02849626|582009774|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
161172701|NCT02849626|582009775|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
161172702|NCT02849626|582009772|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
161172703|NCT02849626|582009773|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
161172704|NCT02849626|582009774|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
161172705|NCT02849626|582009775|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
161172706|NCT02849626|582009772|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
161172707|NCT02849626|582009773|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
161172708|NCT02849626|582009774|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
161172709|NCT02849626|582009775|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
161172710|NCT02849626|582009772|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
161172711|NCT02849626|582009773|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
161172712|NCT02849626|582009774|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
161172713|NCT02849626|582009775|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
161172714|NCT02849626|582009772|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
161172715|NCT02849626|582009773|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161172716|NCT02849626|582009774|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161172717|NCT02849626|582009775|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
161172718|NCT02849626|582009772|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
161172719|NCT02849626|582009773|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
161172720|NCT02849626|582009774|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
161172721|NCT02849626|582009775|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
161172722|NCT02849626|582009772|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
161172723|NCT02849626|582009773|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161172724|NCT02849626|582009774|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161172725|NCT02849626|582009775|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
161172726|NCT02849626|582009772|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161172727|NCT02849626|582009773|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161172728|NCT02849626|582009774|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
161172729|NCT02849626|582009775|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
161172730|NCT02849626|582009772|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161172731|NCT02849626|582009773|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161172732|NCT02849626|582009774|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
161172733|NCT02849626|582009775|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
161172734|NCT02849626|582009772|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
161172735|NCT02849626|582009773|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
161172736|NCT02849626|582009774|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
161172737|NCT02849626|582009775|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
161172738|NCT01185704|582009776|FG000|Overall Study|Randomized but not treated|3|||
161172739|NCT01185704|582009777|FG001|Overall Study|Randomized but not treated|3|||
161172740|NCT01185704|582009776|FG000|Overall Study|Lack of ovarian response|5|||
161172741|NCT01185704|582009777|FG001|Overall Study|Lack of ovarian response|1|||
161172742|NCT01185704|582009776|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
161172743|NCT01185704|582009777|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
161172744|NCT01185704|582009776|FG000|Overall Study|Ectopic pregnancy|0|||
161172745|NCT01185704|582009777|FG001|Overall Study|Ectopic pregnancy|1|||
161172746|NCT00871572|582009778|FG000|Overall Study|Adverse Event|0|||
161172747|NCT00871572|582009779|FG001|Overall Study|Adverse Event|2|||
161172748|NCT00871572|582009780|FG002|Overall Study|Adverse Event|0|||
161172749|NCT00871572|582009781|FG003|Overall Study|Adverse Event|3|||
161172750|NCT00871572|582009778|FG000|Overall Study|Investigator Decision|0|||
161172751|NCT00871572|582009779|FG001|Overall Study|Investigator Decision|1|||
161172752|NCT00871572|582009780|FG002|Overall Study|Investigator Decision|0|||
161172753|NCT00871572|582009781|FG003|Overall Study|Investigator Decision|1|||
161172754|NCT00871572|582009778|FG000|Overall Study|Lost to Follow-up|0|||
161172755|NCT00871572|582009779|FG001|Overall Study|Lost to Follow-up|1|||
161172756|NCT00871572|582009780|FG002|Overall Study|Lost to Follow-up|0|||
161172757|NCT00871572|582009781|FG003|Overall Study|Lost to Follow-up|1|||
161172758|NCT00871572|582009778|FG000|Overall Study|Protocol Violation|0|||
161172759|NCT00871572|582009779|FG001|Overall Study|Protocol Violation|0|||
161172760|NCT00871572|582009780|FG002|Overall Study|Protocol Violation|1|||
161172761|NCT00871572|582009781|FG003|Overall Study|Protocol Violation|1|||
161172762|NCT00871572|582009778|FG000|Overall Study|Sponsor Decision|1|||
161172763|NCT00871572|582009779|FG001|Overall Study|Sponsor Decision|0|||
161172764|NCT00871572|582009780|FG002|Overall Study|Sponsor Decision|0|||
161172765|NCT00871572|582009781|FG003|Overall Study|Sponsor Decision|0|||
161172766|NCT00871572|582009778|FG000|Overall Study|Withdrawal by Subject|1|||
161172767|NCT00871572|582009779|FG001|Overall Study|Withdrawal by Subject|2|||
161172768|NCT00871572|582009780|FG002|Overall Study|Withdrawal by Subject|3|||
161172769|NCT00871572|582009781|FG003|Overall Study|Withdrawal by Subject|1|||
161172770|NCT04176445|582009784|FG000|Overall Study|Adverse Event|0|||
161172771|NCT04176445|582009785|FG001|Overall Study|Adverse Event|1|||
161172772|NCT04176445|582009784|FG000|Overall Study|change plans weaning after first intervention|0|||
161172773|NCT04176445|582009785|FG001|Overall Study|change plans weaning after first intervention|1|||
161172774|NCT00187889|582009786|FG000|Overall Study|Withdrawal by Subject|6|||
161172775|NCT00187889|582009787|FG001|Overall Study|Withdrawal by Subject|4|||
161172776|NCT04046341|582009788|FG000|Overall Study|Lost to Follow-up|2|||
161172777|NCT04046341|582009788|FG000|Overall Study|Withdrawal by Subject|1|||
161172778|NCT04377672|582009789|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
161172779|NCT03954444|582009790|FG000|Overall Study|Withdrawal by Subject|5|||
161172780|NCT03954444|582009791|FG001|Overall Study|Withdrawal by Subject|5|||
161172781|NCT03954444|582009792|FG002|Overall Study|Withdrawal by Subject|5|||
161172782|NCT03954444|582009790|FG000|Overall Study|Adverse Event|1|||
161172783|NCT03954444|582009791|FG001|Overall Study|Adverse Event|3|||
161172784|NCT03954444|582009792|FG002|Overall Study|Adverse Event|2|||
161172785|NCT03954444|582009790|FG000|Overall Study|Protocol Violation|0|||
161172786|NCT03954444|582009791|FG001|Overall Study|Protocol Violation|3|||
161172787|NCT03954444|582009792|FG002|Overall Study|Protocol Violation|5|||
161172788|NCT03954444|582009790|FG000|Overall Study|Use of prohibited therapy|1|||
161172789|NCT03954444|582009791|FG001|Overall Study|Use of prohibited therapy|1|||
161172790|NCT03954444|582009792|FG002|Overall Study|Use of prohibited therapy|2|||
161172791|NCT03954444|582009790|FG000|Overall Study|Lost to Follow-up|1|||
161172792|NCT03954444|582009791|FG001|Overall Study|Lost to Follow-up|0|||
161172793|NCT03954444|582009792|FG002|Overall Study|Lost to Follow-up|1|||
161172794|NCT03954444|582009790|FG000|Overall Study|Non-compliant with study drug application|2|||
161172795|NCT03954444|582009791|FG001|Overall Study|Non-compliant with study drug application|2|||
161172796|NCT03954444|582009792|FG002|Overall Study|Non-compliant with study drug application|0|||
161172797|NCT03954444|582009790|FG000|Overall Study|Administrative reasons|0|||
161172798|NCT03954444|582009791|FG001|Overall Study|Administrative reasons|0|||
161172799|NCT03954444|582009792|FG002|Overall Study|Administrative reasons|1|||
161172800|NCT03954444|582009790|FG000|Overall Study|Miscellaneous|3|||
161172801|NCT03954444|582009791|FG001|Overall Study|Miscellaneous|2|||
161172802|NCT03954444|582009792|FG002|Overall Study|Miscellaneous|1|||
161172803|NCT02447458|582009793|FG000|Overall Study|Other|0|||
161172804|NCT02447458|582009794|FG001|Overall Study|Other|0|||
161172805|NCT02447458|582009795|FG002|Overall Study|Other|1|||
161172806|NCT02447458|582009796|FG003|Overall Study|Other|0|||
161172807|NCT02447458|582009797|FG004|Overall Study|Other|0|||
161172808|NCT02447458|582009798|FG005|Overall Study|Other|0|||
161172809|NCT03505749|582009800|FG000|Overall Study|Lost to Follow-up|7|||
161172810|NCT03505749|582009801|FG001|Overall Study|Lost to Follow-up|11|||
161172811|NCT03505749|582009800|FG000|Overall Study|Withdrawal by Subject|6|||
161172812|NCT03505749|582009801|FG001|Overall Study|Withdrawal by Subject|0|||
161172813|NCT03505749|582009800|FG000|Overall Study|Discharged from treatment|3|||
161172814|NCT03505749|582009801|FG001|Overall Study|Discharged from treatment|6|||
161172815|NCT00435994|582009803|FG000|Overall Study|Lost to Follow-up|7|||
161172816|NCT00435994|582009804|FG001|Overall Study|Lost to Follow-up|0|||
161172817|NCT00435994|582009805|FG002|Overall Study|Lost to Follow-up|0|||
161172818|NCT03846219|582009807|FG000|Overall Study|Withdrawal by Subject|3|||
161172819|NCT03846219|582009808|FG001|Overall Study|Withdrawal by Subject|2|||
161172820|NCT03846219|582009809|FG002|Overall Study|Withdrawal by Subject|2|||
161172821|NCT03846219|582009807|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
161172822|NCT03846219|582009808|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
161172823|NCT03846219|582009809|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
161172824|NCT03846219|582009807|FG000|Overall Study|Physician Decision|0|||
161172825|NCT03846219|582009808|FG001|Overall Study|Physician Decision|0|||
161292549|NCT04878432|582452142|FG000|Overall Study|Physician Decision|11|||
161292550|NCT03971071|582452143|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161292551|NCT03971071|582452144|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
161292552|NCT03971071|582452145|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161292553|NCT03971071|582452146|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161292554|NCT03971071|582452147|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
161292555|NCT03971071|582452143|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
161292556|NCT03971071|582452144|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
161292557|NCT03971071|582452145|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
161292558|NCT03971071|582452146|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161172826|NCT03846219|582009809|FG002|Overall Study|Physician Decision|2|||
161172827|NCT05109702|582009810|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
161172828|NCT05109702|582009811|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
161172829|NCT05109702|582009812|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
161172830|NCT05109702|582009810|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
161172831|NCT05109702|582009811|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
161172832|NCT05109702|582009812|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
161172833|NCT05109702|582009810|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
161172834|NCT05109702|582009811|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
161172835|NCT05109702|582009812|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
161172836|NCT05109702|582009810|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
161172837|NCT05109702|582009811|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
161172838|NCT05109702|582009812|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
161172839|NCT05109702|582009810|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
161172840|NCT05109702|582009811|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
161172841|NCT05109702|582009812|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
161172842|NCT03094832|582009817|FG000|Overall Study|Lost to Follow-up|0|||
161172843|NCT03094832|582009818|FG001|Overall Study|Lost to Follow-up|0|||
161172844|NCT03094832|582009819|FG002|Overall Study|Lost to Follow-up|0|||
161172845|NCT03094832|582009820|FG003|Overall Study|Lost to Follow-up|1|||
161172846|NCT03094832|582009821|FG004|Overall Study|Lost to Follow-up|1|||
161172847|NCT03094832|582009817|FG000|Overall Study|Death|1|||
161172848|NCT03094832|582009818|FG001|Overall Study|Death|0|||
161172849|NCT03094832|582009819|FG002|Overall Study|Death|0|||
161172850|NCT03094832|582009820|FG003|Overall Study|Death|0|||
161172851|NCT03094832|582009821|FG004|Overall Study|Death|0|||
161172852|NCT03094832|582009817|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161172853|NCT03094832|582009818|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161172854|NCT03094832|582009819|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161172855|NCT03094832|582009820|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161172856|NCT03094832|582009821|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161172857|NCT03094832|582009817|FG000|Overall Study|Other|13|||
161172858|NCT03094832|582009818|FG001|Overall Study|Other|20|||
161172859|NCT03094832|582009819|FG002|Overall Study|Other|1|||
161172860|NCT03094832|582009820|FG003|Overall Study|Other|7|||
161172861|NCT03094832|582009821|FG004|Overall Study|Other|1|||
161172862|NCT01392378|582009822|FG000|Infant Series|Adverse Event|0|||
161172863|NCT01392378|582009823|FG001|Infant Series|Adverse Event|0|||
161172864|NCT01392378|582009824|FG002|Infant Series|Adverse Event|0|||
161172865|NCT01392378|582009825|FG003|Infant Series|Adverse Event|1|||
161172866|NCT01392378|582009826|FG004|Infant Series|Adverse Event|0|||
161172867|NCT01392378|582009822|FG000|Infant Series|Lost to Follow-up|0|||
161172868|NCT01392378|582009823|FG001|Infant Series|Lost to Follow-up|0|||
161172869|NCT01392378|582009824|FG002|Infant Series|Lost to Follow-up|0|||
161172870|NCT01392378|582009825|FG003|Infant Series|Lost to Follow-up|1|||
161172871|NCT01392378|582009826|FG004|Infant Series|Lost to Follow-up|0|||
161172872|NCT01392378|582009822|FG000|Infant Series|Protocol Violation|0|||
161172873|NCT01392378|582009823|FG001|Infant Series|Protocol Violation|1|||
161172874|NCT01392378|582009824|FG002|Infant Series|Protocol Violation|0|||
161172875|NCT01392378|582009825|FG003|Infant Series|Protocol Violation|0|||
161172876|NCT01392378|582009826|FG004|Infant Series|Protocol Violation|0|||
161172877|NCT01392378|582009822|FG000|Infant Series|Withdrawal by Parent|4|||
161172878|NCT01392378|582009823|FG001|Infant Series|Withdrawal by Parent|1|||
161172879|NCT01392378|582009824|FG002|Infant Series|Withdrawal by Parent|0|||
161172880|NCT01392378|582009825|FG003|Infant Series|Withdrawal by Parent|0|||
161172881|NCT01392378|582009826|FG004|Infant Series|Withdrawal by Parent|0|||
161172882|NCT01392378|582009822|FG000|After Infant Series|Lost to Follow-up|0|||
161172883|NCT01392378|582009823|FG001|After Infant Series|Lost to Follow-up|0|||
161172884|NCT01392378|582009824|FG002|After Infant Series|Lost to Follow-up|1|||
161172885|NCT01392378|582009825|FG003|After Infant Series|Lost to Follow-up|0|||
161172886|NCT01392378|582009826|FG004|After Infant Series|Lost to Follow-up|0|||
161172887|NCT01392378|582009822|FG000|After Infant Series|Withdrawal by Parent|0|||
161172888|NCT01392378|582009823|FG001|After Infant Series|Withdrawal by Parent|1|||
161172889|NCT01392378|582009824|FG002|After Infant Series|Withdrawal by Parent|1|||
161172890|NCT01392378|582009825|FG003|After Infant Series|Withdrawal by Parent|0|||
161172891|NCT01392378|582009826|FG004|After Infant Series|Withdrawal by Parent|1|||
161172892|NCT01392378|582009822|FG000|Toddler Dose|Lost to Follow-up|0|||
161172893|NCT01392378|582009823|FG001|Toddler Dose|Lost to Follow-up|0|||
161172894|NCT01392378|582009824|FG002|Toddler Dose|Lost to Follow-up|0|||
161172895|NCT01392378|582009825|FG003|Toddler Dose|Lost to Follow-up|1|||
161172896|NCT01392378|582009826|FG004|Toddler Dose|Lost to Follow-up|0|||
161172897|NCT01392378|582009822|FG000|Toddler Dose|Withdrawal by Parent|0|||
161172898|NCT01392378|582009823|FG001|Toddler Dose|Withdrawal by Parent|1|||
161172899|NCT01392378|582009824|FG002|Toddler Dose|Withdrawal by Parent|0|||
161172900|NCT01392378|582009825|FG003|Toddler Dose|Withdrawal by Parent|1|||
161292559|NCT03971071|582452147|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161292560|NCT03971071|582452143|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
161172901|NCT01392378|582009826|FG004|Toddler Dose|Withdrawal by Parent|1|||
161172902|NCT02322411|582009829|FG000|Overall Study|Lost to Follow-up|4|||
161172903|NCT02322411|582009830|FG001|Overall Study|Lost to Follow-up|7|||
161172904|NCT02322411|582009829|FG000|Overall Study|Withdrawal by Subject|1|||
161172905|NCT02322411|582009830|FG001|Overall Study|Withdrawal by Subject|0|||
161172906|NCT00788697|582009834|FG000|Overall Study|No study drug administered|12|||
161172907|NCT00788697|582009834|FG000|Overall Study|Training Patients|74|||
161172908|NCT00788697|582009834|FG000|Overall Study|no truth standard procedure available|5|||
161172909|NCT00788697|582009834|FG000|Overall Study|Technically inadequate truth standard|1|||
161172910|NCT00788697|582009834|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
161172911|NCT01998880|582009835|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
161172912|NCT01998880|582009836|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
161172913|NCT01998880|582009835|FG000|Overall Study|Disease Progression|1|||
161172914|NCT01998880|582009836|FG001|Overall Study|Disease Progression|8|||
161172915|NCT01998880|582009835|FG000|Overall Study|Withdrew Consent|2|||
161172916|NCT01998880|582009836|FG001|Overall Study|Withdrew Consent|1|||
161172917|NCT01998880|582009835|FG000|Overall Study|Death|3|||
161172918|NCT01998880|582009836|FG001|Overall Study|Death|6|||
161172919|NCT01998880|582009835|FG000|Overall Study|Insufficient Therapeutic Response|1|||
161172920|NCT01998880|582009836|FG001|Overall Study|Insufficient Therapeutic Response|5|||
161172921|NCT01998880|582009835|FG000|Overall Study|Administrative/Other|1|||
161172922|NCT01998880|582009836|FG001|Overall Study|Administrative/Other|1|||
161172923|NCT01998880|582009835|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
161172924|NCT01998880|582009836|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
161172925|NCT01998880|582009835|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
161172926|NCT01998880|582009836|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
161172927|NCT01998880|582009835|FG000|Overall Study|Did Not Receive Treatment|3|||
161172928|NCT01998880|582009836|FG001|Overall Study|Did Not Receive Treatment|2|||
161172929|NCT02248857|582009837|FG000|3 Month|Withdrawal by Subject|9|||
161172930|NCT02248857|582009838|FG001|3 Month|Withdrawal by Subject|3|||
161172931|NCT02248857|582009839|FG002|3 Month|Withdrawal by Subject|4|||
161172932|NCT02248857|582009837|FG000|3 Month|Unable to reach for 3 month|35|||
161172933|NCT02248857|582009838|FG001|3 Month|Unable to reach for 3 month|29|||
161172934|NCT02248857|582009839|FG002|3 Month|Unable to reach for 3 month|26|||
161172935|NCT02248857|582009837|FG000|3 Month|Partially completed, unable to finish|2|||
161172936|NCT02248857|582009838|FG001|3 Month|Partially completed, unable to finish|2|||
161172937|NCT02248857|582009839|FG002|3 Month|Partially completed, unable to finish|1|||
161172938|NCT02248857|582009837|FG000|6 Month|Lost to Follow-up|27|||
161172939|NCT02248857|582009838|FG001|6 Month|Lost to Follow-up|26|||
161172940|NCT02248857|582009839|FG002|6 Month|Lost to Follow-up|15|||
161172941|NCT02248857|582009837|FG000|6 Month|Partially completed, unable to finish|0|||
161172942|NCT02248857|582009838|FG001|6 Month|Partially completed, unable to finish|1|||
161172943|NCT02248857|582009839|FG002|6 Month|Partially completed, unable to finish|0|||
161172944|NCT02248857|582009837|FG000|6 Month|Withdrawal by Subject|0|||
161172945|NCT02248857|582009838|FG001|6 Month|Withdrawal by Subject|2|||
161172946|NCT02248857|582009839|FG002|6 Month|Withdrawal by Subject|2|||
161172947|NCT02248857|582009837|FG000|6 Month|Death|1|||
161172948|NCT02248857|582009838|FG001|6 Month|Death|0|||
161172949|NCT02248857|582009839|FG002|6 Month|Death|0|||
161172950|NCT02671461|582009840|FG000|Treatment|Adverse Event|0|||
161172951|NCT02671461|582009841|FG001|Treatment|Adverse Event|0|||
161172952|NCT02671461|582009842|FG002|Treatment|Adverse Event|1|||
161172953|NCT02671461|582009840|FG000|Treatment|Administrative Reason by Sponsor|1|||
161172954|NCT02671461|582009841|FG001|Treatment|Administrative Reason by Sponsor|3|||
161172955|NCT02671461|582009842|FG002|Treatment|Administrative Reason by Sponsor|4|||
161172956|NCT02671461|582009840|FG000|Treatment|Randomized, not treated|1|||
161172957|NCT02671461|582009841|FG001|Treatment|Randomized, not treated|0|||
161172958|NCT02671461|582009842|FG002|Treatment|Randomized, not treated|0|||
161172959|NCT02671461|582009840|FG000|Follow-up|Withdrawal by Subject|1|||
161172960|NCT02671461|582009841|FG001|Follow-up|Withdrawal by Subject|0|||
161172961|NCT02671461|582009842|FG002|Follow-up|Withdrawal by Subject|0|||
161172962|NCT02671461|582009840|FG000|Follow-up|Lost to Follow-up|0|||
161172963|NCT02671461|582009841|FG001|Follow-up|Lost to Follow-up|0|||
161172964|NCT02671461|582009842|FG002|Follow-up|Lost to Follow-up|1|||
161172965|NCT02671461|582009840|FG000|Follow-up|Administrative Reason by Sponsor|0|||
161172966|NCT02671461|582009841|FG001|Follow-up|Administrative Reason by Sponsor|1|||
161172967|NCT02671461|582009842|FG002|Follow-up|Administrative Reason by Sponsor|0|||
161172968|NCT02261883|582009843|FG000|Overall Study|Death|3|||
161172969|NCT02261883|582009844|FG001|Overall Study|Death|2|||
161347412|NCT02782468|582656280|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
161172970|NCT02261883|582009843|FG000|Overall Study|Physician Decision|1|||
161172971|NCT02261883|582009844|FG001|Overall Study|Physician Decision|0|||
161172972|NCT02261883|582009843|FG000|Overall Study|Protocol Violation|1|||
161172973|NCT02261883|582009844|FG001|Overall Study|Protocol Violation|0|||
161172974|NCT02261883|582009843|FG000|Overall Study|Withdrawal by Subject|0|||
161172975|NCT02261883|582009844|FG001|Overall Study|Withdrawal by Subject|1|||
161172976|NCT02261883|582009843|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
161172977|NCT02261883|582009844|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
161172978|NCT00903370|582009846|FG000|Overall Study|Death|13|||
161172979|NCT00903370|582009847|FG001|Overall Study|Death|10|||
161172980|NCT00903370|582009846|FG000|Overall Study|Withdrawal by Subject|9|||
161172981|NCT00903370|582009847|FG001|Overall Study|Withdrawal by Subject|6|||
161347413|NCT02782468|582656281|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
161172982|NCT00903370|582009846|FG000|Overall Study|Lost to Follow-up|6|||
161172983|NCT00903370|582009847|FG001|Overall Study|Lost to Follow-up|8|||
161172984|NCT00367432|582009848|FG000|First Period (16 Weeks)|Adverse Event|6|||
161172985|NCT00367432|582009849|FG001|First Period (16 Weeks)|Adverse Event|0|||
161172986|NCT00367432|582009848|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
161172987|NCT00367432|582009849|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
161172988|NCT00367432|582009848|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
161172989|NCT00367432|582009849|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
161172990|NCT00367432|582009848|FG000|First Period (16 Weeks)|Other Reason|2|||
161172991|NCT00367432|582009849|FG001|First Period (16 Weeks)|Other Reason|0|||
161172992|NCT00367432|582009848|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
161172993|NCT00367432|582009849|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
161172994|NCT00367432|582009848|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
161172995|NCT00367432|582009849|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
161172996|NCT00367432|582009848|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
161172997|NCT00367432|582009849|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
161172998|NCT00367432|582009848|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
161172999|NCT00367432|582009849|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
161173000|NCT00367432|582009848|FG000|Second Period (up to 54 Months)|Other Reason|6|||
161173001|NCT00367432|582009849|FG001|Second Period (up to 54 Months)|Other Reason|2|||
161173002|NCT00014911|582009850|FG000|Overall Study|Adverse Event|1|||
161173003|NCT00014911|582009850|FG000|Overall Study|Lost to Follow-up|1|||
161173004|NCT00014911|582009850|FG000|Overall Study|Withdrawal by Subject|6|||
161173005|NCT00014911|582009850|FG000|Overall Study|Unknown Reasons|2|||
161173006|NCT00014911|582009850|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
161173007|NCT03366844|582011655|FG000|Overall Study|Physician Decision|1|||
161173008|NCT03366844|582011655|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
161173009|NCT02687711|582011658|FG000|Overall Study|Adverse Event|89|||
161173010|NCT02687711|582011658|FG000|Overall Study|Lack of Efficacy|70|||
161173011|NCT02687711|582011658|FG000|Overall Study|Lost to Follow-up|20|||
161173012|NCT02687711|582011658|FG000|Overall Study|Consent withdrawn|15|||
161173013|NCT02687711|582011658|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
161173014|NCT02687711|582011658|FG000|Overall Study|Too expensive|4|||
161173015|NCT02687711|582011658|FG000|Overall Study|Participant moved abroad|1|||
161173016|NCT02687711|582011658|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
161173017|NCT02687711|582011658|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
161173018|NCT02687711|582011658|FG000|Overall Study|Disliked taste|1|||
161173019|NCT02687711|582011658|FG000|Overall Study|Low mood|1|||
161173020|NCT02687711|582011658|FG000|Overall Study|Side effects|1|||
161173021|NCT02687711|582011658|FG000|Overall Study|Change of Hospital|1|||
161173022|NCT02687711|582011658|FG000|Overall Study|Liver Encephalopathy|1|||
161173023|NCT02687711|582011658|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
161173024|NCT02687711|582011658|FG000|Overall Study|Withdrawn due to intake interruption|1|||
161173025|NCT02687711|582011658|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
161173026|NCT02687711|582011658|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
161173027|NCT02687711|582011658|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
161173028|NCT02971007|582011660|FG000|Overall Study|Adverse Event|1|||
161173029|NCT02971007|582011661|FG001|Overall Study|Adverse Event|0|||
161173030|NCT02971007|582011662|FG002|Overall Study|Adverse Event|0|||
161173031|NCT02971007|582011660|FG000|Overall Study|Lost to Follow-up|0|||
161173032|NCT02971007|582011661|FG001|Overall Study|Lost to Follow-up|1|||
161173033|NCT02971007|582011662|FG002|Overall Study|Lost to Follow-up|1|||
161173034|NCT02971007|582011660|FG000|Overall Study|Withdrawal by Subject|0|||
161173035|NCT02971007|582011661|FG001|Overall Study|Withdrawal by Subject|1|||
161173036|NCT02971007|582011662|FG002|Overall Study|Withdrawal by Subject|0|||
161173037|NCT02971007|582011660|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
161173038|NCT02971007|582011661|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
161173039|NCT02971007|582011662|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
161173040|NCT02971007|582011660|FG000|Overall Study|Patient discontinued study drug|0|||
161173041|NCT02971007|582011661|FG001|Overall Study|Patient discontinued study drug|1|||
161173042|NCT02971007|582011662|FG002|Overall Study|Patient discontinued study drug|0|||
161173043|NCT00607919|582011663|FG000|Acute Phase|Adverse Event|9|||
161173044|NCT00607919|582011664|FG001|Acute Phase|Adverse Event|2|||
161173045|NCT00607919|582011663|FG000|Acute Phase|Entry Criteria Not Met|1|||
161173046|NCT00607919|582011664|FG001|Acute Phase|Entry Criteria Not Met|1|||
161173047|NCT00607919|582011663|FG000|Acute Phase|Lack of Efficacy|1|||
161173048|NCT00607919|582011664|FG001|Acute Phase|Lack of Efficacy|2|||
161173049|NCT00607919|582011663|FG000|Acute Phase|Lost to Follow-up|9|||
161173050|NCT00607919|582011664|FG001|Acute Phase|Lost to Follow-up|3|||
161292561|NCT03971071|582452144|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
161292562|NCT03971071|582452145|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
161173051|NCT00607919|582011663|FG000|Acute Phase|Parent/Caregiver Decision|6|||
161292563|NCT03971071|582452146|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
161173052|NCT00607919|582011664|FG001|Acute Phase|Parent/Caregiver Decision|4|||
161173053|NCT00607919|582011663|FG000|Acute Phase|Protocol Violation|5|||
161292564|NCT03971071|582452147|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
161347414|NCT02782468|582656278|FG000|Overall Study|Symptomatic Deterioration|0|||
161086705|NCT02217501|581704472|FG001|Overall Study|Death|4|||
161086706|NCT02019667|581704473|FG000|First Intervention (6 Months)|Adverse Event|0|||
161086707|NCT02019667|581704474|FG001|First Intervention (6 Months)|Adverse Event|1|||
161086708|NCT02019667|581704473|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
161086709|NCT02019667|581704474|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
161086710|NCT02019667|581704473|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
161086711|NCT02019667|581704474|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
161086712|NCT02432196|581704477|FG000|Overall Study|Exit - did not receive study device|1|||
161086713|NCT02432196|581704477|FG000|Overall Study|Death|2|||
161086714|NCT02432196|581704477|FG000|Overall Study|Reoperation|3|||
161086715|NCT05038163|581704481|FG000|Stage 1|Did not complete survey|374|||
161086716|NCT05038163|581704482|FG001|Stage 1|Did not complete survey|0|||
161086717|NCT05038163|581704483|FG002|Stage 1|Did not complete survey|0|||
161086718|NCT05038163|581704484|FG003|Stage 1|Did not complete survey|0|||
161086719|NCT05038163|581704485|FG004|Stage 1|Did not complete survey|0|||
161086720|NCT05038163|581704486|FG005|Stage 1|Did not complete survey|0|||
161086721|NCT05038163|581704481|FG000|Stage 2|Did not complete Stage 2 survey|0|||
161086722|NCT05038163|581704482|FG001|Stage 2|Did not complete Stage 2 survey|29|||
161086723|NCT05038163|581704483|FG002|Stage 2|Did not complete Stage 2 survey|30|||
161086724|NCT05038163|581704484|FG003|Stage 2|Did not complete Stage 2 survey|24|||
161086725|NCT05038163|581704485|FG004|Stage 2|Did not complete Stage 2 survey|21|||
161086726|NCT05038163|581704486|FG005|Stage 2|Did not complete Stage 2 survey|100|||
161086727|NCT01905150|581704487|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
161086728|NCT01905150|581704488|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
161086729|NCT05453201|581704489|FG000|Overall Study|Withdrawal by Subject|1|||
161086730|NCT03562975|581704490|FG000|Overall Study|Death|1|||
161086731|NCT03562975|581704490|FG000|Overall Study|Lost to Follow-up|1|||
161086732|NCT03562975|581704490|FG000|Overall Study|Withdrawal by Subject|1|||
161086733|NCT01934790|581704491|FG000|Treatment|Adverse Event|3|||
161086734|NCT01934790|581704491|FG000|Treatment|Clinical progression|6|||
161086735|NCT01934790|581704491|FG000|Treatment|Radiological progression|4|||
161086736|NCT01934790|581704491|FG000|Treatment|Withdrawal by Subject|2|||
161086737|NCT01934790|581704491|FG000|Treatment|Study drug never administered|1|||
161086738|NCT01934790|581704491|FG000|Active Follow up|Death|20|||
161086739|NCT01934790|581704491|FG000|Active Follow up|Physician Decision|2|||
161086740|NCT01934790|581704491|FG000|Active Follow up|Progressive disease|1|||
161086741|NCT01934790|581704491|FG000|Active Follow up|Other reason|1|||
161086742|NCT00552929|581704494|FG000|Overall Study|Lost to Follow-up|0|||
161086743|NCT00552929|581704495|FG001|Overall Study|Lost to Follow-up|0|||
161086744|NCT00552929|581704496|FG002|Overall Study|Lost to Follow-up|0|||
161086745|NCT00552929|581704497|FG003|Overall Study|Lost to Follow-up|0|||
161086746|NCT00552929|581704498|FG004|Overall Study|Lost to Follow-up|0|||
161086747|NCT00552929|581704499|FG005|Overall Study|Lost to Follow-up|0|||
161086748|NCT00552929|581704500|FG006|Overall Study|Lost to Follow-up|0|||
161086749|NCT00552929|581704501|FG007|Overall Study|Lost to Follow-up|0|||
161086750|NCT00552929|581704502|FG008|Overall Study|Lost to Follow-up|1|||
161086751|NCT00552929|581704503|FG009|Overall Study|Lost to Follow-up|0|||
161086752|NCT00552929|581704494|FG000|Overall Study|Not Eligible|0|||
161086753|NCT00552929|581704495|FG001|Overall Study|Not Eligible|0|||
161086754|NCT00552929|581704496|FG002|Overall Study|Not Eligible|0|||
161086755|NCT00552929|581704497|FG003|Overall Study|Not Eligible|0|||
161086756|NCT00552929|581704498|FG004|Overall Study|Not Eligible|0|||
161086757|NCT00552929|581704499|FG005|Overall Study|Not Eligible|1|||
161086758|NCT00552929|581704500|FG006|Overall Study|Not Eligible|0|||
161086759|NCT00552929|581704501|FG007|Overall Study|Not Eligible|0|||
161086760|NCT00552929|581704502|FG008|Overall Study|Not Eligible|0|||
161086761|NCT00552929|581704503|FG009|Overall Study|Not Eligible|0|||
161086762|NCT01147536|581704504|FG000|Overall Study|Administrative study close|2|||
161086763|NCT01147536|581704504|FG000|Overall Study|Death|1|||
161086764|NCT03465904|581704505|FG000|Overall Study|Withdrawal by Subject|9|||
161086765|NCT03465904|581704506|FG001|Overall Study|Withdrawal by Subject|5|||
161086766|NCT03465904|581704505|FG000|Overall Study|Lost to Follow-up|11|||
161086767|NCT03465904|581704506|FG001|Overall Study|Lost to Follow-up|9|||
161086768|NCT03465904|581704505|FG000|Overall Study|Protocol Violation|20|||
161086769|NCT03465904|581704506|FG001|Overall Study|Protocol Violation|15|||
161086770|NCT03694275|581706667|FG000|Overall Study|Adverse Event|0|||
161086771|NCT03694275|581706668|FG001|Overall Study|Adverse Event|1|||
161086772|NCT03694275|581706667|FG000|Overall Study|Reason not Specified|0|||
161086773|NCT03694275|581706668|FG001|Overall Study|Reason not Specified|1|||
161086774|NCT00910689|581706669|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
161086775|NCT00910689|581706670|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
161086776|NCT00910689|581706671|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
161086777|NCT00910689|581706672|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
161086778|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
161086779|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
161173054|NCT00607919|582011664|FG001|Acute Phase|Protocol Violation|1|||
161173055|NCT00607919|582011663|FG000|Acute Phase|Withdrawal by Subject|3|||
161173056|NCT00607919|582011664|FG001|Acute Phase|Withdrawal by Subject|3|||
161173057|NCT00607919|582011663|FG000|Open-Label Phase|Adverse Event|1|||
161173058|NCT00607919|582011664|FG001|Open-Label Phase|Adverse Event|5|||
161173059|NCT00607919|582011663|FG000|Open-Label Phase|Lost to Follow-up|4|||
161173060|NCT00607919|582011664|FG001|Open-Label Phase|Lost to Follow-up|1|||
161173061|NCT00607919|582011663|FG000|Open-Label Phase|Protocol Violation|2|||
161173062|NCT00607919|582011664|FG001|Open-Label Phase|Protocol Violation|2|||
161173063|NCT00607919|582011663|FG000|Open-Label Phase|Withdrawal by Subject|2|||
161292565|NCT03971071|582452143|FG000|Open-label Treatment Period|Sponsor decision|0|||
161086780|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
161086781|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
161086782|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
161086783|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
161086784|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
161086785|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
161086786|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
161086787|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
161086788|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
161086789|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
161086790|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
161086791|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
161086792|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
161086793|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
161086794|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
161086795|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
161086796|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
161086797|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
161086798|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
161086799|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
161086800|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
161086801|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
161086802|NCT00910689|581706669|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
161086803|NCT00910689|581706670|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
161086804|NCT00910689|581706671|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
161086805|NCT00910689|581706672|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
161086806|NCT00910689|581706669|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
161086807|NCT00910689|581706670|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
161086808|NCT00910689|581706671|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
161086809|NCT00910689|581706672|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
161086810|NCT00910689|581706669|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
161086811|NCT00910689|581706670|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
161086812|NCT00910689|581706671|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
161086813|NCT00910689|581706672|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
161086814|NCT00910689|581706669|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
161086815|NCT00910689|581706670|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
161086816|NCT00910689|581706671|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
161086817|NCT00910689|581706672|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
161086818|NCT00910689|581706669|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
161086819|NCT00910689|581706670|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
161086820|NCT00910689|581706671|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
161086821|NCT00910689|581706672|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
161086822|NCT00910689|581706669|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
161086823|NCT00910689|581706670|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
161086824|NCT00910689|581706671|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
161086825|NCT00910689|581706672|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
161086826|NCT00910689|581706669|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
161086827|NCT00910689|581706670|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
161086828|NCT00910689|581706671|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
161086829|NCT00910689|581706672|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
161086830|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
161086831|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
161086832|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
161086833|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
161086834|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
161086835|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
161086836|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
161086837|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
161086838|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
161173064|NCT00607919|582011664|FG001|Open-Label Phase|Withdrawal by Subject|2|||
161173065|NCT00607919|582011663|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
161173066|NCT00607919|582011664|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
161173067|NCT00724815|582011669|FG000|Overall Study|Randomized, not treated|31|||
161173068|NCT00724815|582011670|FG001|Overall Study|Randomized, not treated|30|||
161173069|NCT00724815|582011669|FG000|Overall Study|Adverse Event|5|||
161173070|NCT00724815|582011670|FG001|Overall Study|Adverse Event|3|||
161173071|NCT00724815|582011669|FG000|Overall Study|Lost to Follow-up|4|||
161173072|NCT00724815|582011670|FG001|Overall Study|Lost to Follow-up|1|||
161173073|NCT00724815|582011669|FG000|Overall Study|Other Various|3|||
161173074|NCT00724815|582011670|FG001|Overall Study|Other Various|5|||
161173075|NCT03051217|582011674|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
161173076|NCT03051217|582011675|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161173077|NCT03051217|582011676|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161173078|NCT03051217|582011677|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161173079|NCT03051217|582011678|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161173080|NCT03051217|582011679|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161173081|NCT03051217|582011680|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161173082|NCT03051217|582011674|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161173083|NCT03051217|582011675|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
161173084|NCT03051217|582011676|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161173085|NCT03051217|582011677|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161173086|NCT03051217|582011678|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161173087|NCT03051217|582011679|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161173088|NCT03051217|582011680|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
161173089|NCT03051217|582011674|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161173090|NCT03051217|582011675|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161173091|NCT03051217|582011676|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
161173092|NCT03051217|582011677|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161173093|NCT03051217|582011678|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161173094|NCT03051217|582011679|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161173095|NCT03051217|582011680|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161173096|NCT03051217|582011674|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161173097|NCT03051217|582011675|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161173098|NCT03051217|582011676|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
161173099|NCT03051217|582011677|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161173100|NCT03051217|582011678|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
161173101|NCT03051217|582011679|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161173102|NCT03051217|582011680|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
161173103|NCT03051217|582011674|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161173104|NCT03051217|582011675|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161173105|NCT03051217|582011676|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161173106|NCT03051217|582011677|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
161173107|NCT03051217|582011678|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161173108|NCT03051217|582011679|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161173109|NCT03051217|582011680|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
161173110|NCT03051217|582011674|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161173111|NCT03051217|582011675|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161173112|NCT03051217|582011676|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161173113|NCT03051217|582011677|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
161173114|NCT03051217|582011678|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161173115|NCT03051217|582011679|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161173116|NCT03051217|582011680|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
161173117|NCT03051217|582011674|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161173118|NCT03051217|582011675|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161173119|NCT03051217|582011676|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161173120|NCT03051217|582011677|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161173121|NCT03051217|582011678|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
161173122|NCT03051217|582011679|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161173123|NCT03051217|582011680|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
161173124|NCT03051217|582011674|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161173125|NCT03051217|582011675|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161173126|NCT03051217|582011676|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161173127|NCT03051217|582011677|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161173128|NCT03051217|582011678|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161173129|NCT03051217|582011679|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
161173130|NCT03051217|582011680|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
161173131|NCT00792701|582011681|FG000|Overall Study|Adverse Event|0|||
161173132|NCT00792701|582011682|FG001|Overall Study|Adverse Event|22|||
161173133|NCT00792701|582011681|FG000|Overall Study|Ineligible|1|||
161173134|NCT00792701|582011682|FG001|Overall Study|Ineligible|3|||
161173135|NCT00792701|582011681|FG000|Overall Study|Withdrawal by Subject|1|||
161173136|NCT00792701|582011682|FG001|Overall Study|Withdrawal by Subject|19|||
161173137|NCT00792701|582011681|FG000|Overall Study|Not protocol specified|17|||
161173138|NCT00792701|582011682|FG001|Overall Study|Not protocol specified|0|||
161173139|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
161173140|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
161173141|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
161173142|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
161173143|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
161173144|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161173145|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
161173146|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161173147|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
161173148|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
161173149|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161173150|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161173151|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161173152|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
161173153|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
161173154|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
161173155|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
161173156|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
161173157|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
161173158|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
161173159|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
161173160|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161173161|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
161173162|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161173163|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
161173164|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Other|1|||
161173165|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Other|0|||
161173166|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Other|0|||
161173167|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Other|0|||
161173168|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Other|1|||
161173169|NCT02980692|582011683|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
161173170|NCT02980692|582011684|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
161173171|NCT02980692|582011685|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
161173172|NCT02980692|582011686|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
161173173|NCT02980692|582011687|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
161173174|NCT02980692|582011683|FG000|Double-blind Follow-up Period|Adverse Event|0|||
161173175|NCT02980692|582011684|FG001|Double-blind Follow-up Period|Adverse Event|0|||
161173176|NCT02980692|582011685|FG002|Double-blind Follow-up Period|Adverse Event|0|||
161173177|NCT02980692|582011686|FG003|Double-blind Follow-up Period|Adverse Event|1|||
161173178|NCT02980692|582011687|FG004|Double-blind Follow-up Period|Adverse Event|1|||
161173179|NCT02980692|582011683|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161173180|NCT02980692|582011684|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
161173181|NCT02980692|582011685|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
161173182|NCT02980692|582011686|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161173183|NCT02980692|582011687|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
161173184|NCT02980692|582011683|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
161173185|NCT02980692|582011684|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
161173186|NCT02980692|582011685|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
161173187|NCT02980692|582011686|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
161292566|NCT03971071|582452144|FG001|Open-label Treatment Period|Sponsor decision|0|||
161292567|NCT03971071|582452145|FG002|Open-label Treatment Period|Sponsor decision|0|||
161292568|NCT03971071|582452146|FG003|Open-label Treatment Period|Sponsor decision|0|||
161292569|NCT03971071|582452147|FG004|Open-label Treatment Period|Sponsor decision|1|||
161292570|NCT03971071|582452143|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
161292571|NCT03971071|582452144|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
161173188|NCT02980692|582011687|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
161173189|NCT02980692|582011683|FG000|Double-blind Follow-up Period|Pregnancy|0|||
161173190|NCT02980692|582011684|FG001|Double-blind Follow-up Period|Pregnancy|0|||
161173191|NCT02980692|582011685|FG002|Double-blind Follow-up Period|Pregnancy|1|||
161173192|NCT02980692|582011686|FG003|Double-blind Follow-up Period|Pregnancy|1|||
161173193|NCT02980692|582011687|FG004|Double-blind Follow-up Period|Pregnancy|0|||
161173194|NCT02980692|582011683|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
161173195|NCT02980692|582011684|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161173196|NCT02980692|582011685|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
161173197|NCT02980692|582011686|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161173198|NCT02980692|582011687|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
161173199|NCT02980692|582011683|FG000|Double-blind Follow-up Period|Other|0|||
161173200|NCT02980692|582011684|FG001|Double-blind Follow-up Period|Other|0|||
161173201|NCT02980692|582011685|FG002|Double-blind Follow-up Period|Other|1|||
161173202|NCT02980692|582011686|FG003|Double-blind Follow-up Period|Other|1|||
161173203|NCT02980692|582011687|FG004|Double-blind Follow-up Period|Other|3|||
161173204|NCT05507580|582011690|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
161173205|NCT05507580|582011691|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
161173206|NCT05507580|582011692|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
161173207|NCT05507580|582011693|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
161173208|NCT05507580|582011694|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
161173209|NCT05507580|582011695|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
161173210|NCT05507580|582011690|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
161173211|NCT05507580|582011691|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
161173212|NCT05507580|582011692|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161173213|NCT05507580|582011693|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161173214|NCT05507580|582011694|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161173215|NCT05507580|582011695|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
161173216|NCT05507580|582011690|FG000|Double-Blind Treatment Period|Other, not specified|5|||
161173217|NCT05507580|582011691|FG001|Double-Blind Treatment Period|Other, not specified|4|||
161173218|NCT05507580|582011692|FG002|Double-Blind Treatment Period|Other, not specified|0|||
161173219|NCT05507580|582011693|FG003|Double-Blind Treatment Period|Other, not specified|0|||
161173220|NCT05507580|582011694|FG004|Double-Blind Treatment Period|Other, not specified|0|||
161173221|NCT05507580|582011695|FG005|Double-Blind Treatment Period|Other, not specified|0|||
161173222|NCT05507580|582011690|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
161173223|NCT05507580|582011691|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
161173224|NCT05507580|582011692|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
161173225|NCT05507580|582011693|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
161173226|NCT05507580|582011694|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
161173227|NCT05507580|582011695|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
161173228|NCT05507580|582011690|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161173229|NCT05507580|582011691|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161173230|NCT05507580|582011692|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
161173231|NCT05507580|582011693|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
161173232|NCT05507580|582011694|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
161173233|NCT05507580|582011695|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
161292572|NCT03971071|582452145|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
161292573|NCT03971071|582452146|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
161292574|NCT03971071|582452147|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
161292575|NCT03971071|582452143|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
161292576|NCT03971071|582452144|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
161086839|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
161086840|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
161086841|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
161086842|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
161086843|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
161086844|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
161086845|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
161086846|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
161086847|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
161086848|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
161086849|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
161086850|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
161086851|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
161086852|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
161086853|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
161173234|NCT05507580|582011690|FG000|Single-Blind Treatment Period|Other, not specified|0|||
161292577|NCT03971071|582452145|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
161173235|NCT05507580|582011691|FG001|Single-Blind Treatment Period|Other, not specified|0|||
161173236|NCT05507580|582011692|FG002|Single-Blind Treatment Period|Other, not specified|2|||
161173237|NCT05507580|582011693|FG003|Single-Blind Treatment Period|Other, not specified|7|||
161173238|NCT05507580|582011694|FG004|Single-Blind Treatment Period|Other, not specified|3|||
161173239|NCT05507580|582011695|FG005|Single-Blind Treatment Period|Other, not specified|5|||
161173240|NCT03862495|582011700|FG000|Overall Study|Lost to Follow-up|37|||
161173241|NCT03862495|582011701|FG001|Overall Study|Lost to Follow-up|35|||
161173242|NCT00064077|582011702|FG000|Overall Study|Improper prior treatment|1|||
161173243|NCT00064077|582011703|FG001|Overall Study|Improper prior treatment|0|||
161173244|NCT00064077|582011704|FG002|Overall Study|Improper prior treatment|0|||
161173245|NCT00064077|582011705|FG003|Overall Study|Improper prior treatment|0|||
161173246|NCT00064077|582011702|FG000|Overall Study|Poor risk|2|||
161173247|NCT00064077|582011703|FG001|Overall Study|Poor risk|0|||
161173248|NCT00064077|582011704|FG002|Overall Study|Poor risk|1|||
161173249|NCT00064077|582011705|FG003|Overall Study|Poor risk|1|||
161173250|NCT00064077|582011702|FG000|Overall Study|Pathology|10|||
161173251|NCT00064077|582011703|FG001|Overall Study|Pathology|7|||
161173252|NCT00064077|582011704|FG002|Overall Study|Pathology|3|||
161173253|NCT00064077|582011705|FG003|Overall Study|Pathology|4|||
161173254|NCT00064077|582011702|FG000|Overall Study|No surgery|0|||
161173255|NCT00064077|582011703|FG001|Overall Study|No surgery|0|||
161173256|NCT00064077|582011704|FG002|Overall Study|No surgery|1|||
161173257|NCT00064077|582011705|FG003|Overall Study|No surgery|0|||
161173258|NCT00064077|582011702|FG000|Overall Study|No tumor|0|||
161173259|NCT00064077|582011703|FG001|Overall Study|No tumor|0|||
161173260|NCT00064077|582011704|FG002|Overall Study|No tumor|1|||
161173261|NCT00064077|582011705|FG003|Overall Study|No tumor|0|||
161173262|NCT00064077|582011702|FG000|Overall Study|Other reasons|2|||
161173263|NCT00064077|582011703|FG001|Overall Study|Other reasons|2|||
161173264|NCT00064077|582011704|FG002|Overall Study|Other reasons|1|||
161173265|NCT00064077|582011705|FG003|Overall Study|Other reasons|2|||
161173266|NCT00615914|582011706|FG000|Overall Study|Adverse Event|274|||
161173267|NCT00615914|582011706|FG000|Overall Study|Death|20|||
161173268|NCT00615914|582011706|FG000|Overall Study|Lack of Efficacy|59|||
161173269|NCT00615914|582011706|FG000|Overall Study|Lost to Follow-up|187|||
161173270|NCT00615914|582011706|FG000|Overall Study|Withdrawal by Subject|16|||
161173271|NCT00615914|582011706|FG000|Overall Study|Physician Decision|4|||
161173272|NCT00615914|582011706|FG000|Overall Study|No data was collected.|65|||
161173273|NCT00615914|582011706|FG000|Overall Study|No treatment|2|||
161173274|NCT00615914|582011706|FG000|Overall Study|Irregularly enrolled patients|10|||
161173275|NCT03673956|582011707|FG000|Overall Study|Lost to Follow-up|1|||
161173276|NCT03673956|582011708|FG001|Overall Study|Lost to Follow-up|0|||
161173277|NCT03673956|582011709|FG002|Overall Study|Lost to Follow-up|0|||
161173278|NCT03673956|582011710|FG003|Overall Study|Lost to Follow-up|0|||
161173279|NCT03673956|582011707|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
161173280|NCT03673956|582011708|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161173281|NCT03673956|582011709|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161173282|NCT03673956|582011710|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
161173283|NCT03037307|582011713|FG000|Period 1|Did Not Meet Study Criteria|0|||
161173284|NCT03037307|582011714|FG001|Period 1|Did Not Meet Study Criteria|0|||
161173285|NCT03037307|582011715|FG002|Period 1|Did Not Meet Study Criteria|0|||
161173286|NCT03037307|582011716|FG003|Period 1|Did Not Meet Study Criteria|1|||
161292578|NCT03971071|582452146|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
161292579|NCT03971071|582452147|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
161292580|NCT00360282|582452148|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
161292581|NCT00360282|582452149|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
161292582|NCT00360282|582452150|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
161292583|NCT00360282|582452151|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
161292584|NCT00360282|582452148|FG000|Second Intervention|Adverse Event|0|||
161292585|NCT00360282|582452149|FG001|Second Intervention|Adverse Event|1|||
161292586|NCT00360282|582452150|FG002|Second Intervention|Adverse Event|0|||
161292587|NCT00360282|582452151|FG003|Second Intervention|Adverse Event|0|||
161292588|NCT04537078|582452154|FG000|Overall Study|Protocol Violation|3|||
161173287|NCT03037307|582011717|FG004|Period 1|Did Not Meet Study Criteria|0|||
161173288|NCT03037307|582011718|FG005|Period 1|Did Not Meet Study Criteria|0|||
161173289|NCT04397796|582011719|FG000|Overall Study|Death|3|||
161173290|NCT04397796|582011720|FG001|Overall Study|Death|1|||
161173291|NCT00802867|582011723|FG000|Overall Study|Lost to Follow-up|6|||
161173292|NCT00802867|582011723|FG000|Overall Study|Protocol Violation|6|||
161173293|NCT00802867|582011723|FG000|Overall Study|Withdrawal by Subject|1|||
161173294|NCT00618813|582011724|FG000|Overall Study|Lack of Efficacy|1|||
161173295|NCT00618813|582011724|FG000|Overall Study|Physician Decision|2|||
161173296|NCT00618813|582011724|FG000|Overall Study|Withdrawal by Subject|1|||
161173297|NCT01809197|582011725|FG000|Overall Study|Lost to Follow-up|4|||
161173298|NCT01809197|582011726|FG001|Overall Study|Lost to Follow-up|2|||
161173299|NCT01809197|582011725|FG000|Overall Study|Adverse Event|2|||
161292589|NCT04537078|582452155|FG001|Overall Study|Protocol Violation|2|||
161292590|NCT04537078|582452154|FG000|Overall Study|Lost to Follow-up|1|||
161173300|NCT01809197|582011726|FG001|Overall Study|Adverse Event|3|||
161173301|NCT01809197|582011725|FG000|Overall Study|Failed slit lamp exam|1|||
161173302|NCT01809197|582011726|FG001|Overall Study|Failed slit lamp exam|0|||
161173303|NCT01809197|582011725|FG000|Overall Study|Non-Compliance|1|||
161173304|NCT01809197|582011726|FG001|Overall Study|Non-Compliance|1|||
161173305|NCT01809197|582011725|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
161173306|NCT01809197|582011726|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
161173307|NCT01809197|582011725|FG000|Overall Study|Withdrawal by Subject|1|||
161173308|NCT01809197|582011726|FG001|Overall Study|Withdrawal by Subject|1|||
161173309|NCT01809197|582011725|FG000|Overall Study|Product not available|0|||
161173310|NCT01809197|582011726|FG001|Overall Study|Product not available|1|||
161173311|NCT01855945|582011727|FG000|Overall Study|Adverse Event|0|||
161173312|NCT01855945|582011728|FG001|Overall Study|Adverse Event|0|||
161173313|NCT01855945|582011729|FG002|Overall Study|Adverse Event|0|||
161173314|NCT01855945|582011730|FG003|Overall Study|Adverse Event|0|||
161173315|NCT01855945|582011731|FG004|Overall Study|Adverse Event|0|||
161173316|NCT01855945|582011732|FG005|Overall Study|Adverse Event|0|||
161173317|NCT01855945|582011733|FG006|Overall Study|Adverse Event|1|||
161173318|NCT01855945|582011734|FG007|Overall Study|Adverse Event|0|||
161173319|NCT01855945|582011735|FG008|Overall Study|Adverse Event|0|||
161173320|NCT01855945|582011736|FG009|Overall Study|Adverse Event|0|||
161173321|NCT01855945|582011737|FG010|Overall Study|Adverse Event|0|||
161173322|NCT01855945|582011738|FG011|Overall Study|Adverse Event|0|||
161173323|NCT01855945|582011727|FG000|Overall Study|Death|0|||
161173324|NCT01855945|582011728|FG001|Overall Study|Death|0|||
161173325|NCT01855945|582011729|FG002|Overall Study|Death|0|||
161173326|NCT01855945|582011730|FG003|Overall Study|Death|0|||
161173327|NCT01855945|582011731|FG004|Overall Study|Death|0|||
161173328|NCT01855945|582011732|FG005|Overall Study|Death|0|||
161173329|NCT01855945|582011733|FG006|Overall Study|Death|2|||
161173330|NCT01855945|582011734|FG007|Overall Study|Death|0|||
161173331|NCT01855945|582011735|FG008|Overall Study|Death|0|||
161173332|NCT01855945|582011736|FG009|Overall Study|Death|0|||
161173333|NCT01855945|582011737|FG010|Overall Study|Death|0|||
161173334|NCT01855945|582011738|FG011|Overall Study|Death|0|||
161173335|NCT01855945|582011727|FG000|Overall Study|Lost to Follow-up|11|||
161173336|NCT01855945|582011728|FG001|Overall Study|Lost to Follow-up|10|||
161173337|NCT01855945|582011729|FG002|Overall Study|Lost to Follow-up|7|||
161173338|NCT01855945|582011730|FG003|Overall Study|Lost to Follow-up|3|||
161173339|NCT01855945|582011731|FG004|Overall Study|Lost to Follow-up|0|||
161173340|NCT01855945|582011732|FG005|Overall Study|Lost to Follow-up|3|||
161173341|NCT01855945|582011733|FG006|Overall Study|Lost to Follow-up|4|||
161173342|NCT01855945|582011734|FG007|Overall Study|Lost to Follow-up|7|||
161173343|NCT01855945|582011735|FG008|Overall Study|Lost to Follow-up|2|||
161173344|NCT01855945|582011736|FG009|Overall Study|Lost to Follow-up|0|||
161173345|NCT01855945|582011737|FG010|Overall Study|Lost to Follow-up|0|||
161173346|NCT01855945|582011738|FG011|Overall Study|Lost to Follow-up|2|||
161173347|NCT01855945|582011727|FG000|Overall Study|Other - Unclassified|1|||
161173348|NCT01855945|582011728|FG001|Overall Study|Other - Unclassified|1|||
161173349|NCT01855945|582011729|FG002|Overall Study|Other - Unclassified|1|||
161173350|NCT01855945|582011730|FG003|Overall Study|Other - Unclassified|0|||
161173351|NCT01855945|582011731|FG004|Overall Study|Other - Unclassified|0|||
161173352|NCT01855945|582011732|FG005|Overall Study|Other - Unclassified|0|||
161173353|NCT01855945|582011733|FG006|Overall Study|Other - Unclassified|2|||
161173354|NCT01855945|582011734|FG007|Overall Study|Other - Unclassified|1|||
161173355|NCT01855945|582011735|FG008|Overall Study|Other - Unclassified|0|||
161173356|NCT01855945|582011736|FG009|Overall Study|Other - Unclassified|0|||
161173357|NCT01855945|582011737|FG010|Overall Study|Other - Unclassified|1|||
161173358|NCT01855945|582011738|FG011|Overall Study|Other - Unclassified|0|||
161173359|NCT01855945|582011727|FG000|Overall Study|Withdrawal by Subject|4|||
161173360|NCT01855945|582011728|FG001|Overall Study|Withdrawal by Subject|0|||
161292591|NCT04537078|582452155|FG001|Overall Study|Lost to Follow-up|0|||
161292592|NCT04537078|582452154|FG000|Overall Study|Withdrawal by Subject|0|||
161292593|NCT04537078|582452155|FG001|Overall Study|Withdrawal by Subject|1|||
161292594|NCT03207815|582452156|FG000|Overall Study|Protocol Violation|3|||
161292595|NCT03207815|582452157|FG001|Overall Study|Protocol Violation|1|||
161292596|NCT03207815|582452156|FG000|Overall Study|Adverse Event|1|||
161173361|NCT01855945|582011729|FG002|Overall Study|Withdrawal by Subject|4|||
161173362|NCT01855945|582011730|FG003|Overall Study|Withdrawal by Subject|1|||
161173363|NCT01855945|582011731|FG004|Overall Study|Withdrawal by Subject|1|||
161173364|NCT01855945|582011732|FG005|Overall Study|Withdrawal by Subject|0|||
161173365|NCT01855945|582011733|FG006|Overall Study|Withdrawal by Subject|1|||
161173366|NCT01855945|582011734|FG007|Overall Study|Withdrawal by Subject|0|||
161173367|NCT01855945|582011735|FG008|Overall Study|Withdrawal by Subject|0|||
161173368|NCT01855945|582011736|FG009|Overall Study|Withdrawal by Subject|2|||
161173369|NCT01855945|582011737|FG010|Overall Study|Withdrawal by Subject|4|||
161173370|NCT01855945|582011738|FG011|Overall Study|Withdrawal by Subject|1|||
161292597|NCT03207815|582452157|FG001|Overall Study|Adverse Event|2|||
161292598|NCT03207815|582452156|FG000|Overall Study|Lost to Follow-up|1|||
161173371|NCT02156804|582011743|FG000|Overall Study|Withdrawal by Subject|1|||
161173372|NCT03228394|582011744|FG000|Overall Study|Lost to Follow-up|0|||
161173373|NCT03228394|582011745|FG001|Overall Study|Lost to Follow-up|0|||
161173374|NCT03228394|582011746|FG002|Overall Study|Lost to Follow-up|1|||
161173375|NCT03228394|582011747|FG003|Overall Study|Lost to Follow-up|1|||
161173376|NCT03228394|582011748|FG004|Overall Study|Lost to Follow-up|0|||
161173377|NCT03228394|582011749|FG005|Overall Study|Lost to Follow-up|0|||
161173378|NCT03228394|582011750|FG006|Overall Study|Lost to Follow-up|2|||
161173379|NCT03228394|582011751|FG007|Overall Study|Lost to Follow-up|0|||
161173380|NCT03228394|582011744|FG000|Overall Study|Withdrawal by Subject|0|||
161173381|NCT03228394|582011745|FG001|Overall Study|Withdrawal by Subject|0|||
161173382|NCT03228394|582011746|FG002|Overall Study|Withdrawal by Subject|1|||
161173383|NCT03228394|582011747|FG003|Overall Study|Withdrawal by Subject|0|||
161173384|NCT03228394|582011748|FG004|Overall Study|Withdrawal by Subject|0|||
161173385|NCT03228394|582011749|FG005|Overall Study|Withdrawal by Subject|0|||
161173386|NCT03228394|582011750|FG006|Overall Study|Withdrawal by Subject|1|||
161173387|NCT03228394|582011751|FG007|Overall Study|Withdrawal by Subject|3|||
161173388|NCT03228394|582011744|FG000|Overall Study|Protocol Violation|0|||
161173389|NCT03228394|582011745|FG001|Overall Study|Protocol Violation|0|||
161173390|NCT03228394|582011746|FG002|Overall Study|Protocol Violation|0|||
161173391|NCT03228394|582011747|FG003|Overall Study|Protocol Violation|1|||
161173392|NCT03228394|582011748|FG004|Overall Study|Protocol Violation|0|||
161173393|NCT03228394|582011749|FG005|Overall Study|Protocol Violation|0|||
161173394|NCT03228394|582011750|FG006|Overall Study|Protocol Violation|0|||
161173395|NCT03228394|582011751|FG007|Overall Study|Protocol Violation|0|||
161173396|NCT03228394|582011744|FG000|Overall Study|Physician Decision|0|||
161173397|NCT03228394|582011745|FG001|Overall Study|Physician Decision|0|||
161173398|NCT03228394|582011746|FG002|Overall Study|Physician Decision|0|||
161173399|NCT03228394|582011747|FG003|Overall Study|Physician Decision|0|||
161173400|NCT03228394|582011748|FG004|Overall Study|Physician Decision|0|||
161173401|NCT03228394|582011749|FG005|Overall Study|Physician Decision|0|||
161173402|NCT03228394|582011750|FG006|Overall Study|Physician Decision|1|||
161173403|NCT03228394|582011751|FG007|Overall Study|Physician Decision|0|||
161173404|NCT03228394|582011744|FG000|Overall Study|Noncompliance|0|||
161173405|NCT03228394|582011745|FG001|Overall Study|Noncompliance|0|||
161173406|NCT03228394|582011746|FG002|Overall Study|Noncompliance|0|||
161173407|NCT03228394|582011747|FG003|Overall Study|Noncompliance|0|||
161173408|NCT03228394|582011748|FG004|Overall Study|Noncompliance|0|||
161173409|NCT03228394|582011749|FG005|Overall Study|Noncompliance|0|||
161173410|NCT03228394|582011750|FG006|Overall Study|Noncompliance|1|||
161173411|NCT03228394|582011751|FG007|Overall Study|Noncompliance|0|||
161173412|NCT03000686|582011752|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161173413|NCT03000686|582011753|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
161173414|NCT03000686|582011754|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161173415|NCT03000686|582011755|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
161173416|NCT00770224|582011758|FG000|Step 1: Induction|Adverse Event|3|||
161173417|NCT00770224|582011759|FG001|Step 1: Induction|Adverse Event|0|||
161173418|NCT00770224|582011758|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
161173419|NCT00770224|582011759|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
161173420|NCT00770224|582011758|FG000|Step 1: Induction|Other reason not protocol specified|2|||
161173421|NCT00770224|582011759|FG001|Step 1: Induction|Other reason not protocol specified|0|||
161173422|NCT00770224|582011758|FG000|Step 1: Induction|Ineligible|2|||
161173423|NCT00770224|582011759|FG001|Step 1: Induction|Ineligible|0|||
161173424|NCT00770224|582011758|FG000|Step 1: Induction|No protocol treatment given|1|||
161173425|NCT00770224|582011759|FG001|Step 1: Induction|No protocol treatment given|0|||
161173426|NCT00770224|582011758|FG000|Step 2: Maintenance|Adverse Event|0|||
161173427|NCT00770224|582011759|FG001|Step 2: Maintenance|Adverse Event|10|||
161173428|NCT00770224|582011758|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
161173429|NCT00770224|582011759|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
161173430|NCT00770224|582011758|FG000|Step 2: Maintenance|Progression/relapse|0|||
161173431|NCT00770224|582011759|FG001|Step 2: Maintenance|Progression/relapse|1|||
161173432|NCT00770224|582011758|FG000|Step 2: Maintenance|Death|0|||
161292599|NCT03207815|582452157|FG001|Overall Study|Lost to Follow-up|2|||
161292600|NCT03207815|582452156|FG000|Overall Study|Investigator's Discretion|1|||
161173433|NCT00770224|582011759|FG001|Step 2: Maintenance|Death|2|||
161173434|NCT00770224|582011758|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
161173435|NCT00770224|582011759|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
161173436|NCT00770224|582011758|FG000|Step 2: Maintenance|Ineligible|0|||
161173437|NCT00770224|582011759|FG001|Step 2: Maintenance|Ineligible|2|||
161173438|NCT04737759|582011760|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
161173439|NCT04737759|582011761|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
161173440|NCT04737759|582011760|FG000|Overall Study|Death|2|||
161173441|NCT04737759|582011761|FG001|Overall Study|Death|0|||
161173442|NCT04737759|582011760|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
161173443|NCT04737759|582011761|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
161173444|NCT04737759|582011760|FG000|Overall Study|Lost to Follow-up|4|||
161173445|NCT04737759|582011761|FG001|Overall Study|Lost to Follow-up|12|||
161173446|NCT01484561|582011762|FG000|Overall Study|Lack of Efficacy|3|||
161173447|NCT01484561|582011763|FG001|Overall Study|Lack of Efficacy|1|||
161173448|NCT01484561|582011762|FG000|Overall Study|Lost to Follow-up|1|||
161173449|NCT01484561|582011763|FG001|Overall Study|Lost to Follow-up|0|||
161173450|NCT01484561|582011762|FG000|Overall Study|Withdrawal by Subject|3|||
161173451|NCT01484561|582011763|FG001|Overall Study|Withdrawal by Subject|0|||
161173452|NCT01484561|582011762|FG000|Overall Study|Other|1|||
161173453|NCT01484561|582011763|FG001|Overall Study|Other|1|||
161173454|NCT01484561|582011762|FG000|Overall Study|Adverse Event|1|||
161173455|NCT01484561|582011763|FG001|Overall Study|Adverse Event|4|||
161173456|NCT01112982|582011764|FG000|Overall Study|Withdrawal by Subject|1|||
161173457|NCT01112982|582011764|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
161173458|NCT03371251|582011765|FG000|Overall Study|Withdrawal by Subject|1|||
161173459|NCT03371251|582011766|FG001|Overall Study|Withdrawal by Subject|0|||
161173460|NCT03371251|582011767|FG002|Overall Study|Withdrawal by Subject|1|||
161173461|NCT03371251|582011768|FG003|Overall Study|Withdrawal by Subject|0|||
161173462|NCT03371251|582011769|FG004|Overall Study|Withdrawal by Subject|2|||
161173463|NCT03371251|582011770|FG005|Overall Study|Withdrawal by Subject|2|||
161173464|NCT03371251|582011765|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
161173465|NCT03371251|582011766|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161173466|NCT03371251|582011767|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161173467|NCT03371251|582011768|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
161173468|NCT03371251|582011769|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
161173469|NCT03371251|582011770|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
161173470|NCT03371251|582011765|FG000|Overall Study|Adverse Event|0|||
161173471|NCT03371251|582011766|FG001|Overall Study|Adverse Event|0|||
161173472|NCT03371251|582011767|FG002|Overall Study|Adverse Event|0|||
161347415|NCT02782468|582656279|FG001|Overall Study|Symptomatic Deterioration|0|||
161347416|NCT02782468|582656280|FG002|Overall Study|Symptomatic Deterioration|0|||
161347417|NCT02782468|582656281|FG003|Overall Study|Symptomatic Deterioration|1|||
161347418|NCT02782468|582656278|FG000|Overall Study|Withdrawal by Subject|1|||
161347419|NCT02782468|582656279|FG001|Overall Study|Withdrawal by Subject|0|||
161347420|NCT02782468|582656280|FG002|Overall Study|Withdrawal by Subject|0|||
161347421|NCT02782468|582656281|FG003|Overall Study|Withdrawal by Subject|0|||
161347422|NCT01496456|582656283|FG000|Overall Study|Protocol Violation|1|||
161347423|NCT01496456|582656283|FG000|Overall Study|Lost to Follow-up|7|||
161086854|NCT00910689|581706669|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
161086855|NCT00910689|581706670|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
161086856|NCT00910689|581706671|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
161086857|NCT00910689|581706672|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
161086858|NCT01290029|581706675|FG000|Overall Study|Other|2|||
161086859|NCT01877837|581706678|FG000|Overall Study|Lost to Follow-up|1|||
161086860|NCT01877837|581706678|FG000|Overall Study|Ineligible|4|||
161086861|NCT00645801|581706679|FG000|Overall Study|unclear if patient took all the medication.|1|||
161086862|NCT00645801|581706680|FG001|Overall Study|unclear if patient took all the medication.|0|||
161086863|NCT00645801|581706679|FG000|Overall Study|Lost to Follow-up|19|||
161086864|NCT00645801|581706680|FG001|Overall Study|Lost to Follow-up|15|||
161086865|NCT00759915|581706681|FG000|Overall Study|Withdrawal by Subject|1|||
161086866|NCT00759915|581706682|FG001|Overall Study|Withdrawal by Subject|0|||
161086867|NCT00759915|581706681|FG000|Overall Study|Adverse Event|0|||
161086868|NCT00759915|581706682|FG001|Overall Study|Adverse Event|1|||
161086869|NCT00932113|581706685|FG000|Overall Study|Lost to Follow-up|1|||
161086870|NCT00932113|581706686|FG001|Overall Study|Lost to Follow-up|0|||
161086871|NCT01773291|581706687|FG000|Overall Study|Protocol Violation|1|||
161086872|NCT01773291|581706688|FG001|Overall Study|Protocol Violation|0|||
161086873|NCT01773291|581706689|FG002|Overall Study|Protocol Violation|0|||
161086874|NCT01773291|581706687|FG000|Overall Study|Withdrawal by Subject|0|||
161086875|NCT01773291|581706688|FG001|Overall Study|Withdrawal by Subject|0|||
161086876|NCT01773291|581706689|FG002|Overall Study|Withdrawal by Subject|1|||
161086877|NCT00203476|581706690|FG000|Overall Study|Lost to Follow-up|1|||
161086878|NCT00203476|581706691|FG001|Overall Study|Lost to Follow-up|0|||
161086879|NCT00203476|581706692|FG002|Overall Study|Lost to Follow-up|0|||
161086880|NCT00203476|581706690|FG000|Overall Study|Withdrawal by Subject|0|||
161086881|NCT00203476|581706691|FG001|Overall Study|Withdrawal by Subject|1|||
161086882|NCT00203476|581706692|FG002|Overall Study|Withdrawal by Subject|0|||
161086883|NCT03310268|581706693|FG000|Overall Study|(Not specified)|1|||
161086884|NCT03310268|581706694|FG001|Overall Study|(Not specified)|5|||
161086885|NCT03310268|581706695|FG002|Overall Study|(Not specified)|0|||
161086886|NCT00621777|581706696|FG000|Open Phase|Adverse Event|20|||
161086887|NCT00621777|581706697|FG001|Open Phase|Adverse Event|0|||
161086888|NCT00621777|581706696|FG000|Open Phase|Did not abstain during open phase|56|||
161086889|NCT00621777|581706697|FG001|Open Phase|Did not abstain during open phase|0|||
161347424|NCT04919161|582656284|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
161173473|NCT03371251|582011768|FG003|Overall Study|Adverse Event|0|||
161173474|NCT03371251|582011769|FG004|Overall Study|Adverse Event|1|||
161173475|NCT03371251|582011770|FG005|Overall Study|Adverse Event|0|||
161173476|NCT03371251|582011765|FG000|Overall Study|Decision by Sponsor|0|||
161173477|NCT03371251|582011766|FG001|Overall Study|Decision by Sponsor|0|||
161173478|NCT03371251|582011767|FG002|Overall Study|Decision by Sponsor|0|||
161173479|NCT03371251|582011768|FG003|Overall Study|Decision by Sponsor|0|||
161173480|NCT03371251|582011769|FG004|Overall Study|Decision by Sponsor|2|||
161173481|NCT03371251|582011770|FG005|Overall Study|Decision by Sponsor|0|||
161173482|NCT00294684|582011773|FG000|Overall Study|Lost to Follow-up|5|||
161173483|NCT00294684|582011774|FG001|Overall Study|Lost to Follow-up|8|||
161173484|NCT02260388|582011777|FG000|Overall Study|Lost to Follow-up|2|||
161173485|NCT02260388|582011778|FG001|Overall Study|Lost to Follow-up|8|||
161173486|NCT02260388|582011779|FG002|Overall Study|Lost to Follow-up|3|||
161173487|NCT02260388|582011780|FG003|Overall Study|Lost to Follow-up|4|||
161173488|NCT05425719|582011781|FG000|Overall Study|Lost to Follow-up|4|||
161173489|NCT05425719|582011782|FG001|Overall Study|Lost to Follow-up|0|||
161173490|NCT05425719|582011781|FG000|Overall Study|Withdrew consent|1|||
161173491|NCT05425719|582011782|FG001|Overall Study|Withdrew consent|1|||
161173492|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
161173493|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
161173494|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
161173495|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161173496|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
161173497|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
161173498|NCT00996593|582011783|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
161173499|NCT00996593|582011783|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
161173500|NCT00996593|582011783|FG000|Long-Term Follow-Up|Site Closed|1|||
161173501|NCT01033487|582011784|FG000|Fourth Intervention Period|Adverse Event|0|||
161173502|NCT01033487|582011785|FG001|Fourth Intervention Period|Adverse Event|0|||
161173503|NCT01033487|582011786|FG002|Fourth Intervention Period|Adverse Event|0|||
161173504|NCT01033487|582011787|FG003|Fourth Intervention Period|Adverse Event|0|||
161173505|NCT01033487|582011788|FG004|Fourth Intervention Period|Adverse Event|0|||
161173506|NCT01033487|582011789|FG005|Fourth Intervention Period|Adverse Event|0|||
161173507|NCT01033487|582011790|FG006|Fourth Intervention Period|Adverse Event|0|||
161173508|NCT01033487|582011791|FG007|Fourth Intervention Period|Adverse Event|0|||
161173509|NCT01033487|582011792|FG008|Fourth Intervention Period|Adverse Event|1|||
161173510|NCT01033487|582011793|FG009|Fourth Intervention Period|Adverse Event|0|||
161173511|NCT00889681|582011794|FG000|Overall Study|Not meeting qualification Criteria|2|||
161173512|NCT00889681|582011794|FG000|Overall Study|Insurance disapproval|1|||
161173513|NCT00405652|582011797|FG000|Overall Study|Adverse Event|4|||
161173514|NCT00345540|582011798|FG000|Overall Study|Withdrawal by Subject|1|||
161173515|NCT04179786|582011799|FG000|Overall Study|Withdrawal by Subject|8|||
161173516|NCT01938001|582011800|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
161173517|NCT01938001|582011801|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
161173518|NCT01938001|582011800|FG000|Pre-Treatment|Death|1|||
161173519|NCT01938001|582011801|FG001|Pre-Treatment|Death|0|||
161173520|NCT01938001|582011800|FG000|Treatment|Death|2|||
161173521|NCT01938001|582011801|FG001|Treatment|Death|0|||
161173522|NCT01938001|582011800|FG000|Treatment|Adverse Event|14|||
161173523|NCT01938001|582011801|FG001|Treatment|Adverse Event|8|||
161173524|NCT01938001|582011800|FG000|Treatment|Progressive Disease|21|||
161173525|NCT01938001|582011801|FG001|Treatment|Progressive Disease|54|||
161173526|NCT01938001|582011800|FG000|Treatment|Withdrawal by Subject|13|||
161173527|NCT01938001|582011801|FG001|Treatment|Withdrawal by Subject|7|||
161173528|NCT01938001|582011800|FG000|Treatment|Other reasons|2|||
161173529|NCT01938001|582011801|FG001|Treatment|Other reasons|1|||
161173530|NCT03310580|582011802|FG000|Overall Study|Adverse Event|0|||
161173531|NCT03310580|582011803|FG001|Overall Study|Adverse Event|1|||
161173532|NCT03310580|582011804|FG002|Overall Study|Adverse Event|0|||
161173533|NCT03205982|582011805|FG000|Overall Study|Lost to Follow-up|20|||
161173534|NCT03205982|582011806|FG001|Overall Study|Lost to Follow-up|19|||
161173535|NCT03205982|582011805|FG000|Overall Study|Withdrawal by Subject|4|||
161173536|NCT03205982|582011806|FG001|Overall Study|Withdrawal by Subject|3|||
161173537|NCT03205982|582011805|FG000|Overall Study|Withdrawal by PI|0|||
161173538|NCT03205982|582011806|FG001|Overall Study|Withdrawal by PI|1|||
161173539|NCT00418717|582011807|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
161173540|NCT00418717|582011807|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
161173541|NCT02762708|582011812|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161173542|NCT02762708|582011813|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
161173543|NCT02762708|582011814|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161173544|NCT02762708|582011815|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
161173545|NCT01468701|582011816|FG000|Overall Study|Not eligible|91|||
161173546|NCT01468701|582011817|FG001|Overall Study|Not eligible|140|||
161173547|NCT01468701|582011818|FG002|Overall Study|Not eligible|29|||
161173548|NCT01468701|582011819|FG003|Overall Study|Not eligible|12|||
161173549|NCT01468701|582011820|FG004|Overall Study|Not eligible|22|||
161173550|NCT01468701|582011821|FG005|Overall Study|Not eligible|2|||
161173551|NCT01468701|582011822|FG006|Overall Study|Not eligible|39|||
161173552|NCT01468701|582011823|FG007|Overall Study|Not eligible|1|||
161173553|NCT01468701|582011824|FG008|Overall Study|Not eligible|40|||
161173554|NCT01468701|582011825|FG009|Overall Study|Not eligible|126|||
161173555|NCT01468701|582011826|FG010|Overall Study|Not eligible|39|||
161173556|NCT01468701|582011827|FG011|Overall Study|Not eligible|33|||
161173557|NCT01468701|582011828|FG012|Overall Study|Not eligible|1|||
161173558|NCT01468701|582011829|FG013|Overall Study|Not eligible|19|||
161173559|NCT01468701|582011830|FG014|Overall Study|Not eligible|1|||
161173560|NCT01468701|582011831|FG015|Overall Study|Not eligible|32|||
161173561|NCT01468701|582011832|FG016|Overall Study|Not eligible|0|||
161173562|NCT01468701|582011816|FG000|Overall Study|Lost to Follow-up|306|||
161173563|NCT01468701|582011817|FG001|Overall Study|Lost to Follow-up|0|||
161173564|NCT01468701|582011818|FG002|Overall Study|Lost to Follow-up|0|||
161173565|NCT01468701|582011819|FG003|Overall Study|Lost to Follow-up|0|||
161173566|NCT01468701|582011820|FG004|Overall Study|Lost to Follow-up|0|||
161173567|NCT01468701|582011821|FG005|Overall Study|Lost to Follow-up|0|||
161173568|NCT01468701|582011822|FG006|Overall Study|Lost to Follow-up|0|||
161173569|NCT01468701|582011823|FG007|Overall Study|Lost to Follow-up|0|||
161173570|NCT01468701|582011824|FG008|Overall Study|Lost to Follow-up|215|||
161173571|NCT01468701|582011825|FG009|Overall Study|Lost to Follow-up|309|||
161173572|NCT01468701|582011826|FG010|Overall Study|Lost to Follow-up|224|||
161173573|NCT01468701|582011827|FG011|Overall Study|Lost to Follow-up|212|||
161173574|NCT01468701|582011828|FG012|Overall Study|Lost to Follow-up|11|||
161173575|NCT01468701|582011829|FG013|Overall Study|Lost to Follow-up|164|||
161173576|NCT01468701|582011830|FG014|Overall Study|Lost to Follow-up|17|||
161173577|NCT01468701|582011831|FG015|Overall Study|Lost to Follow-up|127|||
161173578|NCT01468701|582011832|FG016|Overall Study|Lost to Follow-up|1|||
161173579|NCT01468701|582011816|FG000|Overall Study|Withdrawal by Subject|165|||
161173580|NCT01468701|582011817|FG001|Overall Study|Withdrawal by Subject|0|||
161173581|NCT01468701|582011818|FG002|Overall Study|Withdrawal by Subject|0|||
161173582|NCT01468701|582011819|FG003|Overall Study|Withdrawal by Subject|0|||
161173583|NCT01468701|582011820|FG004|Overall Study|Withdrawal by Subject|0|||
161173584|NCT01468701|582011821|FG005|Overall Study|Withdrawal by Subject|0|||
161173585|NCT01468701|582011822|FG006|Overall Study|Withdrawal by Subject|0|||
161173586|NCT01468701|582011823|FG007|Overall Study|Withdrawal by Subject|0|||
161173587|NCT01468701|582011824|FG008|Overall Study|Withdrawal by Subject|83|||
161173588|NCT01468701|582011825|FG009|Overall Study|Withdrawal by Subject|88|||
161173589|NCT01468701|582011826|FG010|Overall Study|Withdrawal by Subject|100|||
161173590|NCT01468701|582011827|FG011|Overall Study|Withdrawal by Subject|114|||
161173591|NCT01468701|582011828|FG012|Overall Study|Withdrawal by Subject|9|||
161173592|NCT01468701|582011829|FG013|Overall Study|Withdrawal by Subject|47|||
161173593|NCT01468701|582011830|FG014|Overall Study|Withdrawal by Subject|6|||
161173594|NCT01468701|582011831|FG015|Overall Study|Withdrawal by Subject|31|||
161173595|NCT01468701|582011832|FG016|Overall Study|Withdrawal by Subject|0|||
161173596|NCT01468701|582011816|FG000|Overall Study|Other reasons than listed|437|||
161173597|NCT01468701|582011817|FG001|Overall Study|Other reasons than listed|0|||
161173598|NCT01468701|582011818|FG002|Overall Study|Other reasons than listed|0|||
161173599|NCT01468701|582011819|FG003|Overall Study|Other reasons than listed|0|||
161173600|NCT01468701|582011820|FG004|Overall Study|Other reasons than listed|0|||
161173601|NCT01468701|582011821|FG005|Overall Study|Other reasons than listed|0|||
161173602|NCT01468701|582011822|FG006|Overall Study|Other reasons than listed|0|||
161173603|NCT01468701|582011823|FG007|Overall Study|Other reasons than listed|0|||
161173604|NCT01468701|582011824|FG008|Overall Study|Other reasons than listed|318|||
161173605|NCT01468701|582011825|FG009|Overall Study|Other reasons than listed|658|||
161173606|NCT01468701|582011826|FG010|Overall Study|Other reasons than listed|433|||
161173607|NCT01468701|582011827|FG011|Overall Study|Other reasons than listed|504|||
161173608|NCT01468701|582011828|FG012|Overall Study|Other reasons than listed|28|||
161173609|NCT01468701|582011829|FG013|Overall Study|Other reasons than listed|239|||
161173610|NCT01468701|582011830|FG014|Overall Study|Other reasons than listed|39|||
161173611|NCT01468701|582011831|FG015|Overall Study|Other reasons than listed|172|||
161173612|NCT01468701|582011832|FG016|Overall Study|Other reasons than listed|0|||
161292601|NCT03207815|582452157|FG001|Overall Study|Investigator's Discretion|1|||
161292602|NCT03207815|582452156|FG000|Overall Study|Lack of Efficacy|0|||
161292603|NCT03207815|582452157|FG001|Overall Study|Lack of Efficacy|1|||
161292604|NCT03207815|582452156|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
161292605|NCT03207815|582452157|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
161292606|NCT03207815|582452156|FG000|Overall Study|Withdrew Consent|1|||
161292607|NCT03207815|582452157|FG001|Overall Study|Withdrew Consent|0|||
161292608|NCT03817853|582452158|FG000|Induction Phase|Adverse Event|5|||
161173613|NCT01468701|582011816|FG000|Overall Study|No end of study case report form|0|||
161173614|NCT01468701|582011817|FG001|Overall Study|No end of study case report form|0|||
161173615|NCT01468701|582011818|FG002|Overall Study|No end of study case report form|0|||
161173616|NCT01468701|582011819|FG003|Overall Study|No end of study case report form|0|||
161173617|NCT01468701|582011820|FG004|Overall Study|No end of study case report form|0|||
161292609|NCT03817853|582452159|FG001|Induction Phase|Adverse Event|0|||
161086890|NCT00621777|581706696|FG000|Open Phase|Withdrawal by Subject|17|||
161086891|NCT00621777|581706697|FG001|Open Phase|Withdrawal by Subject|0|||
161086892|NCT00621777|581706696|FG000|Open Phase|administrative|13|||
161086893|NCT00621777|581706697|FG001|Open Phase|administrative|0|||
161086894|NCT00621777|581706696|FG000|Open Phase|Lost to Follow-up|10|||
161086895|NCT00621777|581706697|FG001|Open Phase|Lost to Follow-up|0|||
161086896|NCT00621777|581706696|FG000|Randomized Phase|Adverse Event|3|||
161086897|NCT00621777|581706697|FG001|Randomized Phase|Adverse Event|3|||
161086898|NCT00621777|581706696|FG000|Randomized Phase|Lost to Follow-up|3|||
161086899|NCT00621777|581706697|FG001|Randomized Phase|Lost to Follow-up|3|||
161086900|NCT00621777|581706696|FG000|Randomized Phase|Withdrawal by Subject|1|||
161086901|NCT00621777|581706697|FG001|Randomized Phase|Withdrawal by Subject|9|||
161086902|NCT00621777|581706696|FG000|Randomized Phase|administrative|0|||
161086903|NCT00621777|581706697|FG001|Randomized Phase|administrative|3|||
161086904|NCT00621777|581706696|FG000|Randomized Phase|Death|0|||
161086905|NCT00621777|581706697|FG001|Randomized Phase|Death|1|||
161086906|NCT04797650|581706698|FG000|Overall Study|Reason Not Specified|5|||
161086907|NCT04797650|581706699|FG001|Overall Study|Reason Not Specified|12|||
161086908|NCT04797650|581706700|FG002|Overall Study|Reason Not Specified|5|||
161086909|NCT04797650|581706698|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
161086910|NCT04797650|581706699|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
161086911|NCT04797650|581706700|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
161086912|NCT04797650|581706698|FG000|Overall Study|Lack of Efficacy|1|||
161086913|NCT04797650|581706699|FG001|Overall Study|Lack of Efficacy|0|||
161086914|NCT04797650|581706700|FG002|Overall Study|Lack of Efficacy|1|||
161086915|NCT04797650|581706698|FG000|Overall Study|Non-compliance with Study Drug|0|||
161086916|NCT04797650|581706699|FG001|Overall Study|Non-compliance with Study Drug|0|||
161086917|NCT04797650|581706700|FG002|Overall Study|Non-compliance with Study Drug|2|||
161086918|NCT04797650|581706698|FG000|Overall Study|Lost to Follow-up|4|||
161086919|NCT04797650|581706699|FG001|Overall Study|Lost to Follow-up|6|||
161086920|NCT04797650|581706700|FG002|Overall Study|Lost to Follow-up|1|||
161086921|NCT01888900|581706708|FG000|Overall Study|failed treatment|0|||
161086922|NCT01888900|581706709|FG001|Overall Study|failed treatment|2|||
161086923|NCT01004848|581706710|FG000|Overall Study|Lost to Follow-up|55|||
161086924|NCT01004848|581706711|FG001|Overall Study|Lost to Follow-up|45|||
161086925|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
161086926|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161086927|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161086928|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161086929|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161086930|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
161086931|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
161086932|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161086933|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161086934|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161086935|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161086936|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
161086937|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
161086938|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161086939|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161086940|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161086941|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161086942|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
161086943|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
161086944|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161086945|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161086946|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161086947|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161086948|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
161086949|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
161086950|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161086951|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161086952|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161086953|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161086954|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
161086955|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
161086956|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161086957|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161086958|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161173618|NCT01468701|582011821|FG005|Overall Study|No end of study case report form|0|||
161173619|NCT01468701|582011822|FG006|Overall Study|No end of study case report form|0|||
161173620|NCT01468701|582011823|FG007|Overall Study|No end of study case report form|0|||
161173621|NCT01468701|582011824|FG008|Overall Study|No end of study case report form|4|||
161173622|NCT01468701|582011825|FG009|Overall Study|No end of study case report form|1|||
161173623|NCT01468701|582011826|FG010|Overall Study|No end of study case report form|2|||
161173624|NCT01468701|582011827|FG011|Overall Study|No end of study case report form|3|||
161173625|NCT01468701|582011828|FG012|Overall Study|No end of study case report form|0|||
161173626|NCT01468701|582011829|FG013|Overall Study|No end of study case report form|1|||
161173627|NCT01468701|582011830|FG014|Overall Study|No end of study case report form|0|||
161173628|NCT01468701|582011831|FG015|Overall Study|No end of study case report form|0|||
161173629|NCT01468701|582011832|FG016|Overall Study|No end of study case report form|0|||
161173630|NCT01468701|582011816|FG000|Overall Study|Not being followed up|0|||
161173631|NCT01468701|582011817|FG001|Overall Study|Not being followed up|4963|||
161173632|NCT01468701|582011818|FG002|Overall Study|Not being followed up|1755|||
161173633|NCT01468701|582011819|FG003|Overall Study|Not being followed up|703|||
161173634|NCT01468701|582011820|FG004|Overall Study|Not being followed up|1714|||
161173635|NCT01468701|582011821|FG005|Overall Study|Not being followed up|126|||
161173636|NCT01468701|582011822|FG006|Overall Study|Not being followed up|1170|||
161173637|NCT01468701|582011823|FG007|Overall Study|Not being followed up|4|||
161173638|NCT01468701|582011824|FG008|Overall Study|Not being followed up|0|||
161173639|NCT01468701|582011825|FG009|Overall Study|Not being followed up|0|||
161173640|NCT01468701|582011826|FG010|Overall Study|Not being followed up|0|||
161173641|NCT01468701|582011827|FG011|Overall Study|Not being followed up|0|||
161173642|NCT01468701|582011828|FG012|Overall Study|Not being followed up|0|||
161173643|NCT01468701|582011829|FG013|Overall Study|Not being followed up|0|||
161173644|NCT01468701|582011830|FG014|Overall Study|Not being followed up|0|||
161173645|NCT01468701|582011831|FG015|Overall Study|Not being followed up|0|||
161173646|NCT01468701|582011832|FG016|Overall Study|Not being followed up|0|||
161173647|NCT00970268|582011837|FG000|Overall Study|Withdrawal by Subject|12|||
161173648|NCT00970268|582011838|FG001|Overall Study|Withdrawal by Subject|19|||
161173649|NCT00970268|582011837|FG000|Overall Study|Adverse Event|15|||
161173650|NCT00970268|582011838|FG001|Overall Study|Adverse Event|12|||
161173651|NCT00970268|582011837|FG000|Overall Study|Lack of Efficacy|3|||
161173652|NCT00970268|582011838|FG001|Overall Study|Lack of Efficacy|6|||
161173653|NCT00970268|582011837|FG000|Overall Study|Protocol Violation|4|||
161173654|NCT00970268|582011838|FG001|Overall Study|Protocol Violation|7|||
161173655|NCT00970268|582011837|FG000|Overall Study|Other Reason|3|||
161173656|NCT00970268|582011838|FG001|Overall Study|Other Reason|1|||
161173657|NCT00970268|582011837|FG000|Overall Study|COPD Exacerbation|4|||
161173658|NCT00970268|582011838|FG001|Overall Study|COPD Exacerbation|2|||
161173659|NCT00970268|582011837|FG000|Overall Study|Lost to Follow-up|1|||
161173660|NCT00970268|582011838|FG001|Overall Study|Lost to Follow-up|2|||
161173661|NCT00970268|582011837|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
161173662|NCT00970268|582011838|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
161173663|NCT01079195|582011839|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
161173664|NCT01079195|582011839|FG000|Overall Study|No Documentation Available|437|||
161173665|NCT01079195|582011839|FG000|Overall Study|Adverse Event|157|||
161173666|NCT01079195|582011839|FG000|Overall Study|Reason Unknown|39|||
161173667|NCT01079195|582011839|FG000|Overall Study|Withdrawal by Subject|18|||
161173668|NCT01079195|582011839|FG000|Overall Study|Financial Reasons|15|||
161173669|NCT01079195|582011839|FG000|Overall Study|Lack of Effectiveness|12|||
161173670|NCT01079195|582011839|FG000|Overall Study|Physician Decision|4|||
161173671|NCT01079195|582011839|FG000|Overall Study|Improved Status of Participant|4|||
161173672|NCT01079195|582011839|FG000|Overall Study|No Follow-up Documentation Available|4|||
161173673|NCT01079195|582011839|FG000|Overall Study|Non-compliance|2|||
161173674|NCT01999946|582011843|FG000|Overall Study|Participant not released from jail|2|||
161173675|NCT01999946|582011844|FG001|Overall Study|Participant not released from jail|2|||
161173676|NCT01999946|582011845|FG002|Overall Study|Participant not released from jail|0|||
161173677|NCT01999946|582011843|FG000|Overall Study|Not included in primary outcome analysis|0|||
161173678|NCT01999946|582011844|FG001|Overall Study|Not included in primary outcome analysis|0|||
161173679|NCT01999946|582011845|FG002|Overall Study|Not included in primary outcome analysis|79|||
161173680|NCT01105936|582013463|FG000|Period 1|Adverse Event|0|||
161173681|NCT01105936|582013464|FG001|Period 1|Adverse Event|0|||
161173682|NCT01105936|582013465|FG002|Period 1|Adverse Event|0|||
161173683|NCT01105936|582013466|FG003|Period 1|Adverse Event|1|||
161173684|NCT01105936|582013463|FG000|Period 2|Adverse Event|1|||
161173685|NCT01105936|582013464|FG001|Period 2|Adverse Event|0|||
161173686|NCT01105936|582013465|FG002|Period 2|Adverse Event|0|||
161173687|NCT01105936|582013466|FG003|Period 2|Adverse Event|0|||
161173688|NCT01105936|582013463|FG000|Period 3|Protocol Violation|0|||
161173689|NCT01105936|582013464|FG001|Period 3|Protocol Violation|2|||
161173690|NCT01105936|582013465|FG002|Period 3|Protocol Violation|0|||
161173691|NCT01105936|582013466|FG003|Period 3|Protocol Violation|0|||
161173692|NCT03170258|582013469|FG000|Overall Study|Physician Decision|4|||
161173693|NCT03170258|582013470|FG001|Overall Study|Physician Decision|0|||
161173694|NCT03170258|582013469|FG000|Overall Study|Equipment issues|1|||
161173695|NCT03170258|582013470|FG001|Overall Study|Equipment issues|0|||
161347425|NCT04919161|582656285|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
161086959|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161086960|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
161086961|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
161086962|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161086963|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161086964|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161086965|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161086966|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
161086967|NCT01160289|581706712|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
161086968|NCT01160289|581706713|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161086969|NCT01160289|581706714|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161086970|NCT01160289|581706715|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161086971|NCT01160289|581706716|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161086972|NCT01160289|581706717|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
161086973|NCT01160289|581706712|FG000|Post-Randomization Period|Adverse Event|0|||
161086974|NCT01160289|581706713|FG001|Post-Randomization Period|Adverse Event|4|||
161086975|NCT01160289|581706714|FG002|Post-Randomization Period|Adverse Event|4|||
161086976|NCT01160289|581706715|FG003|Post-Randomization Period|Adverse Event|2|||
161086977|NCT01160289|581706716|FG004|Post-Randomization Period|Adverse Event|0|||
161086978|NCT01160289|581706717|FG005|Post-Randomization Period|Adverse Event|0|||
161086979|NCT01160289|581706712|FG000|Post-Randomization Period|Death|0|||
161086980|NCT01160289|581706713|FG001|Post-Randomization Period|Death|0|||
161086981|NCT01160289|581706714|FG002|Post-Randomization Period|Death|0|||
161086982|NCT01160289|581706715|FG003|Post-Randomization Period|Death|1|||
161086983|NCT01160289|581706716|FG004|Post-Randomization Period|Death|0|||
161086984|NCT01160289|581706717|FG005|Post-Randomization Period|Death|0|||
161086985|NCT01160289|581706712|FG000|Post-Randomization Period|Lack of Efficacy|0|||
161086986|NCT01160289|581706713|FG001|Post-Randomization Period|Lack of Efficacy|1|||
161086987|NCT01160289|581706714|FG002|Post-Randomization Period|Lack of Efficacy|0|||
161086988|NCT01160289|581706715|FG003|Post-Randomization Period|Lack of Efficacy|3|||
161086989|NCT01160289|581706716|FG004|Post-Randomization Period|Lack of Efficacy|0|||
161086990|NCT01160289|581706717|FG005|Post-Randomization Period|Lack of Efficacy|0|||
161086991|NCT01160289|581706712|FG000|Post-Randomization Period|Lost to Follow-up|0|||
161086992|NCT01160289|581706713|FG001|Post-Randomization Period|Lost to Follow-up|3|||
161086993|NCT01160289|581706714|FG002|Post-Randomization Period|Lost to Follow-up|2|||
161086994|NCT01160289|581706715|FG003|Post-Randomization Period|Lost to Follow-up|5|||
161086995|NCT01160289|581706716|FG004|Post-Randomization Period|Lost to Follow-up|3|||
161086996|NCT01160289|581706717|FG005|Post-Randomization Period|Lost to Follow-up|4|||
161086997|NCT01160289|581706712|FG000|Post-Randomization Period|Physician Decision|0|||
161086998|NCT01160289|581706713|FG001|Post-Randomization Period|Physician Decision|0|||
161086999|NCT01160289|581706714|FG002|Post-Randomization Period|Physician Decision|1|||
161087000|NCT01160289|581706715|FG003|Post-Randomization Period|Physician Decision|0|||
161087001|NCT01160289|581706716|FG004|Post-Randomization Period|Physician Decision|0|||
161087002|NCT01160289|581706717|FG005|Post-Randomization Period|Physician Decision|0|||
161087003|NCT01160289|581706712|FG000|Post-Randomization Period|Protocol Violation|0|||
161087004|NCT01160289|581706713|FG001|Post-Randomization Period|Protocol Violation|4|||
161087005|NCT01160289|581706714|FG002|Post-Randomization Period|Protocol Violation|2|||
161087006|NCT01160289|581706715|FG003|Post-Randomization Period|Protocol Violation|0|||
161087007|NCT01160289|581706716|FG004|Post-Randomization Period|Protocol Violation|1|||
161087008|NCT01160289|581706717|FG005|Post-Randomization Period|Protocol Violation|3|||
161087009|NCT01160289|581706712|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
161087010|NCT01160289|581706713|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
161087011|NCT01160289|581706714|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
161087012|NCT01160289|581706715|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
161087013|NCT01160289|581706716|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
161087014|NCT01160289|581706717|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
161087015|NCT01160289|581706712|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
161087016|NCT01160289|581706713|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
161087017|NCT01160289|581706714|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
161087018|NCT01160289|581706715|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
161087019|NCT01160289|581706716|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
161087020|NCT01160289|581706717|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
161087021|NCT01160289|581706712|FG000|Post-Randomization Period|Sponsor Decision|0|||
161087022|NCT01160289|581706713|FG001|Post-Randomization Period|Sponsor Decision|1|||
161087023|NCT01160289|581706714|FG002|Post-Randomization Period|Sponsor Decision|0|||
161087024|NCT01160289|581706715|FG003|Post-Randomization Period|Sponsor Decision|0|||
161087025|NCT01160289|581706716|FG004|Post-Randomization Period|Sponsor Decision|0|||
161173696|NCT03170258|582013469|FG000|Overall Study|Medication|1|||
161173697|NCT03170258|582013470|FG001|Overall Study|Medication|0|||
161173698|NCT03170258|582013469|FG000|Overall Study|Sleep issues|1|||
161173699|NCT03170258|582013470|FG001|Overall Study|Sleep issues|0|||
161173700|NCT02471586|582013471|FG000|Overall Study|Lost to Follow-up|3|||
161173701|NCT02471586|582013472|FG001|Overall Study|Lost to Follow-up|8|||
161173702|NCT02471586|582013473|FG002|Overall Study|Lost to Follow-up|4|||
161173703|NCT02471586|582013471|FG000|Overall Study|Death|2|||
161173704|NCT02471586|582013472|FG001|Overall Study|Death|2|||
161173705|NCT02471586|582013473|FG002|Overall Study|Death|0|||
161173706|NCT04209530|582013476|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
161173707|NCT04209530|582013477|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
161173708|NCT04209530|582013476|FG000|Overall Study|Withdrawal by Subject|0|||
161173709|NCT04209530|582013477|FG001|Overall Study|Withdrawal by Subject|1|||
161173710|NCT04839393|582013478|FG000|Overall Study|Adverse Event|0|||
161173711|NCT04839393|582013479|FG001|Overall Study|Adverse Event|0|||
161173712|NCT04839393|582013480|FG002|Overall Study|Adverse Event|2|||
161173713|NCT04839393|582013478|FG000|Overall Study|Withdrawal by participant|0|||
161173714|NCT04839393|582013479|FG001|Overall Study|Withdrawal by participant|0|||
161173715|NCT04839393|582013480|FG002|Overall Study|Withdrawal by participant|1|||
161173716|NCT01510028|582013481|FG000|Overall Study|Lack of Efficacy|1|||
161173717|NCT01510028|582013482|FG001|Overall Study|Lack of Efficacy|0|||
161173718|NCT01510028|582013483|FG002|Overall Study|Lack of Efficacy|0|||
161173719|NCT01510028|582013484|FG003|Overall Study|Lack of Efficacy|0|||
161173720|NCT00633893|582013485|FG000|Overall Study|Death|1|||
161173721|NCT00633893|582013486|FG001|Overall Study|Death|3|||
161173722|NCT00633893|582013487|FG002|Overall Study|Death|9|||
161173723|NCT00633893|582013485|FG000|Overall Study|Adverse Event|65|||
161173724|NCT00633893|582013486|FG001|Overall Study|Adverse Event|58|||
161173725|NCT00633893|582013487|FG002|Overall Study|Adverse Event|126|||
161173726|NCT00633893|582013485|FG000|Overall Study|Withdrawal by Subject|7|||
161173727|NCT00633893|582013486|FG001|Overall Study|Withdrawal by Subject|12|||
161173728|NCT00633893|582013487|FG002|Overall Study|Withdrawal by Subject|6|||
161173729|NCT00633893|582013485|FG000|Overall Study|Lost to Follow-up|2|||
161173730|NCT00633893|582013486|FG001|Overall Study|Lost to Follow-up|4|||
161173731|NCT00633893|582013487|FG002|Overall Study|Lost to Follow-up|8|||
161173732|NCT00633893|582013485|FG000|Overall Study|Poor/non-compliance|5|||
161173733|NCT00633893|582013486|FG001|Overall Study|Poor/non-compliance|12|||
161173734|NCT00633893|582013487|FG002|Overall Study|Poor/non-compliance|3|||
161173735|NCT00633893|582013485|FG000|Overall Study|Pregnancy|2|||
161173736|NCT00633893|582013486|FG001|Overall Study|Pregnancy|1|||
161173737|NCT00633893|582013487|FG002|Overall Study|Pregnancy|1|||
161173738|NCT00633893|582013485|FG000|Overall Study|Not meet/no longer meets criteria|4|||
161173739|NCT00633893|582013486|FG001|Overall Study|Not meet/no longer meets criteria|6|||
161173740|NCT00633893|582013487|FG002|Overall Study|Not meet/no longer meets criteria|4|||
161173741|NCT00633893|582013485|FG000|Overall Study|Other|28|||
161173742|NCT00633893|582013486|FG001|Overall Study|Other|33|||
161173743|NCT00633893|582013487|FG002|Overall Study|Other|31|||
161173744|NCT02741310|582013488|FG000|Overall Study|Sponsor Decision|2|||
161173745|NCT02741310|582013489|FG001|Overall Study|Sponsor Decision|2|||
161173746|NCT05091918|582013490|FG000|Overall Study|Adverse Event|1|||
161173747|NCT05091918|582013490|FG000|Overall Study|Withdrawal by Subject|81|||
161173748|NCT01100658|582013495|FG000|Overall Study|Withdrawal by Subject|1|||
161173749|NCT00239356|582013496|FG000|Overall Study|Lack of Efficacy|1|||
161173750|NCT00239356|582013497|FG001|Overall Study|Lack of Efficacy|0|||
161173751|NCT00239356|582013496|FG000|Overall Study|Adverse Event|6|||
161173752|NCT00239356|582013497|FG001|Overall Study|Adverse Event|0|||
161173753|NCT00239356|582013496|FG000|Overall Study|Withdrawal by Subject|15|||
161173754|NCT00239356|582013497|FG001|Overall Study|Withdrawal by Subject|6|||
161173755|NCT00239356|582013496|FG000|Overall Study|Lost to Follow-up|3|||
161173756|NCT00239356|582013497|FG001|Overall Study|Lost to Follow-up|0|||
161173757|NCT00239356|582013496|FG000|Overall Study|poor/non-compliance|2|||
161173758|NCT00239356|582013497|FG001|Overall Study|poor/non-compliance|0|||
161173759|NCT00239356|582013496|FG000|Overall Study|Pregnancy|1|||
161173760|NCT00239356|582013497|FG001|Overall Study|Pregnancy|0|||
161173761|NCT00239356|582013496|FG000|Overall Study|Administrative reason|0|||
161173762|NCT00239356|582013497|FG001|Overall Study|Administrative reason|1|||
161173763|NCT00239356|582013496|FG000|Overall Study|Drug available on market|11|||
161173764|NCT00239356|582013497|FG001|Overall Study|Drug available on market|2|||
161173765|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
161173766|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
161173767|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
161173768|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
161173769|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
161173770|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
161173771|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
161173772|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
161173773|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
161173774|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
161173775|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
161173776|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
161173777|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
161173778|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
161173779|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
161173780|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
161173781|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
161173782|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
161173783|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
161173784|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
161173785|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
161173786|NCT01001572|582013498|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
161173787|NCT01001572|582013499|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
161173788|NCT01001572|582013500|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
161173789|NCT01001572|582013498|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161173790|NCT01001572|582013499|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
161173791|NCT01001572|582013500|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
161173792|NCT01001572|582013498|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161173793|NCT01001572|582013499|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
161173794|NCT01001572|582013500|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
161173795|NCT01001572|582013498|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
161173796|NCT01001572|582013499|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
161173797|NCT01001572|582013500|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
161173798|NCT01001572|582013498|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161173799|NCT01001572|582013499|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
161173800|NCT01001572|582013500|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
161173801|NCT01001572|582013498|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
161173802|NCT01001572|582013499|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
161173803|NCT01001572|582013500|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
161173804|NCT01001572|582013498|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161173805|NCT01001572|582013499|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161173806|NCT01001572|582013500|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161173807|NCT01094808|582013501|FG000|Overall Study|Withdrawal by Subject|1|||
161173808|NCT01094808|582013502|FG001|Overall Study|Withdrawal by Subject|1|||
161173809|NCT01094808|582013503|FG002|Overall Study|Withdrawal by Subject|0|||
161173810|NCT02044822|582013504|FG000|Overall Study|Study Terminated by Sponsor|77|||
161173811|NCT02044822|582013504|FG000|Overall Study|Investigator's Discretion|10|||
161173812|NCT02044822|582013504|FG000|Overall Study|Withdrew Consent|3|||
161173813|NCT02044822|582013504|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
161173814|NCT02044822|582013504|FG000|Overall Study|Lost to Follow-up|1|||
161173815|NCT02025530|582013507|FG000|Overall Study|No longer met elligibility criteria|5|||
161173816|NCT02025530|582013508|FG001|Overall Study|No longer met elligibility criteria|1|||
161173817|NCT03551626|582013509|FG000|Overall Study|Adverse Event|88|||
161173818|NCT03551626|582013509|FG000|Overall Study|Disease relapse|18|||
161173819|NCT03551626|582013509|FG000|Overall Study|Withdrawal of informed consent|6|||
161173820|NCT03551626|582013509|FG000|Overall Study|Patient decision|5|||
161173821|NCT03551626|582013509|FG000|Overall Study|Physician Decision|4|||
161173822|NCT03551626|582013509|FG000|Overall Study|Lost to Follow-up|3|||
161173823|NCT03551626|582013509|FG000|Overall Study|Pregnancy|1|||
161173824|NCT03551626|582013509|FG000|Overall Study|Protocol deviation|1|||
161173825|NCT03551626|582013509|FG000|Overall Study|Technical problems|1|||
161173826|NCT00653328|582013510|FG000|Overall Study|Withdrawal by Subject|1|||
161173827|NCT00653328|582013510|FG000|Overall Study|Adverse Event|2|||
161173828|NCT00653328|582013510|FG000|Overall Study|Disease progression|10|||
161173829|NCT00653328|582013510|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
161173830|NCT01237223|582013517|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
161173831|NCT01237223|582013518|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161173832|NCT01237223|582013519|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161173833|NCT01237223|582013520|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161173834|NCT01237223|582013521|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161173835|NCT01237223|582013522|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
161173836|NCT01237223|582013517|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
161292610|NCT03817853|582452160|FG002|Induction Phase|Adverse Event|0|||
161292611|NCT03817853|582452158|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
161173837|NCT01237223|582013518|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161292612|NCT03817853|582452159|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
161087026|NCT01160289|581706717|FG005|Post-Randomization Period|Sponsor Decision|0|||
161087027|NCT01156792|581706722|FG000|Overall Study|Adverse Event|1|||
161087028|NCT01156792|581706722|FG000|Overall Study|Lack of Efficacy|36|||
161087029|NCT01156792|581706722|FG000|Overall Study|Protocol Violation|6|||
161087030|NCT01156792|581706722|FG000|Overall Study|Lost to Follow-up|3|||
161087031|NCT01156792|581706722|FG000|Overall Study|Physician Decision|3|||
161087032|NCT01156792|581706722|FG000|Overall Study|Withdrawal by Subject|9|||
161087033|NCT01156792|581706722|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
161087034|NCT00768079|581706723|FG000|Overall Study|Lost to Follow-up|2|||
161087035|NCT00768079|581706724|FG001|Overall Study|Lost to Follow-up|0|||
161087036|NCT00768079|581706725|FG002|Overall Study|Lost to Follow-up|4|||
161087037|NCT00768079|581706723|FG000|Overall Study|Participant incarcerated|0|||
161087038|NCT00768079|581706724|FG001|Overall Study|Participant incarcerated|1|||
161087039|NCT00768079|581706725|FG002|Overall Study|Participant incarcerated|0|||
161087040|NCT03271021|581706726|FG000|Overall Study|Adverse Event|3|||
161087041|NCT03271021|581706727|FG001|Overall Study|Adverse Event|2|||
161087042|NCT03271021|581706726|FG000|Overall Study|Withdrawal by Subject|36|||
161087043|NCT03271021|581706727|FG001|Overall Study|Withdrawal by Subject|53|||
161087044|NCT03271021|581706726|FG000|Overall Study|Lost to Follow-up|34|||
161087045|NCT03271021|581706727|FG001|Overall Study|Lost to Follow-up|39|||
161087046|NCT03271021|581706726|FG000|Overall Study|Protocol Violation|6|||
161087047|NCT03271021|581706727|FG001|Overall Study|Protocol Violation|4|||
161087048|NCT03271021|581706726|FG000|Overall Study|Abnormal Lab Results|1|||
161087049|NCT03271021|581706727|FG001|Overall Study|Abnormal Lab Results|0|||
161087050|NCT03271021|581706726|FG000|Overall Study|Miscellaneous|9|||
161087051|NCT03271021|581706727|FG001|Overall Study|Miscellaneous|8|||
161087052|NCT00993668|581706730|FG000|Single-Blind Period|Adverse Event|1|||
161087053|NCT00993668|581706731|FG001|Single-Blind Period|Adverse Event|1|||
161087054|NCT00993668|581706730|FG000|Single-Blind Period|Lack of Efficacy|0|||
161087055|NCT00993668|581706731|FG001|Single-Blind Period|Lack of Efficacy|1|||
161087056|NCT00993668|581706730|FG000|Single-Blind Period|Lost to Follow-up|3|||
161087057|NCT00993668|581706731|FG001|Single-Blind Period|Lost to Follow-up|1|||
161087058|NCT00993668|581706730|FG000|Open-Label Period|Adverse Event|9|||
161087059|NCT00993668|581706731|FG001|Open-Label Period|Adverse Event|8|||
161087060|NCT00993668|581706730|FG000|Open-Label Period|Lack of Efficacy|4|||
161087061|NCT00993668|581706731|FG001|Open-Label Period|Lack of Efficacy|3|||
161087062|NCT00993668|581706730|FG000|Open-Label Period|Withdrawal by Subject|4|||
161087063|NCT00993668|581706731|FG001|Open-Label Period|Withdrawal by Subject|3|||
161087064|NCT00993668|581706730|FG000|Open-Label Period|Lost to Follow-up|6|||
161087065|NCT00993668|581706731|FG001|Open-Label Period|Lost to Follow-up|1|||
161087066|NCT02313233|581706737|FG000|Overall Study|Withdrawal by Subject|1|||
161087067|NCT02313233|581706738|FG001|Overall Study|Withdrawal by Subject|2|||
161087068|NCT02313233|581706737|FG000|Overall Study|Administrative reason|1|||
161087069|NCT02313233|581706738|FG001|Overall Study|Administrative reason|1|||
161087070|NCT02095951|581706739|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
161087071|NCT02095951|581706740|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
161087072|NCT03618823|581706741|FG000|Overall Study|Lost to Follow-up|63|||
161087073|NCT03618823|581706742|FG001|Overall Study|Lost to Follow-up|61|||
161087074|NCT05383508|581706743|FG000|Overall Study|Withdrawal by Subject|1|||
161087075|NCT05383508|581706744|FG001|Overall Study|Withdrawal by Subject|0|||
161087076|NCT05383508|581706745|FG002|Overall Study|Withdrawal by Subject|1|||
161087077|NCT05383508|581706746|FG003|Overall Study|Withdrawal by Subject|1|||
161087078|NCT05383508|581706747|FG004|Overall Study|Withdrawal by Subject|2|||
161087079|NCT05383508|581706748|FG005|Overall Study|Withdrawal by Subject|0|||
161087080|NCT01621568|581706750|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
161087081|NCT01621568|581706751|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
161087082|NCT01621568|581706750|FG000|Week 5-6 No Treatment|Death|1|||
161087083|NCT01621568|581706751|FG001|Week 5-6 No Treatment|Death|0|||
161087084|NCT01859988|581706752|FG000|Overall Study|Withdrawal by Subject|6|||
161087085|NCT01859988|581706753|FG001|Overall Study|Withdrawal by Subject|3|||
161087086|NCT01859988|581706754|FG002|Overall Study|Withdrawal by Subject|4|||
161087087|NCT01859988|581706755|FG003|Overall Study|Withdrawal by Subject|3|||
161087088|NCT01859988|581706756|FG004|Overall Study|Withdrawal by Subject|2|||
161087089|NCT01859988|581706757|FG005|Overall Study|Withdrawal by Subject|2|||
161087090|NCT01859988|581706752|FG000|Overall Study|Lack of Efficacy|1|||
161087091|NCT01859988|581706753|FG001|Overall Study|Lack of Efficacy|1|||
161087092|NCT01859988|581706754|FG002|Overall Study|Lack of Efficacy|5|||
161087093|NCT01859988|581706755|FG003|Overall Study|Lack of Efficacy|0|||
161087094|NCT01859988|581706756|FG004|Overall Study|Lack of Efficacy|7|||
161087095|NCT01859988|581706757|FG005|Overall Study|Lack of Efficacy|9|||
161087096|NCT01859988|581706752|FG000|Overall Study|Physician Decision|1|||
161087097|NCT01859988|581706753|FG001|Overall Study|Physician Decision|3|||
161087098|NCT01859988|581706754|FG002|Overall Study|Physician Decision|1|||
161087099|NCT01859988|581706755|FG003|Overall Study|Physician Decision|3|||
161087100|NCT01859988|581706756|FG004|Overall Study|Physician Decision|4|||
161087101|NCT01859988|581706757|FG005|Overall Study|Physician Decision|1|||
161173838|NCT01237223|582013519|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161173839|NCT01237223|582013520|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161173840|NCT01237223|582013521|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161173841|NCT01237223|582013522|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
161173842|NCT01237223|582013517|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
161173843|NCT01237223|582013518|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161173844|NCT01237223|582013519|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161173845|NCT01237223|582013520|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161173846|NCT01237223|582013521|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161173847|NCT01237223|582013522|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
161173848|NCT01237223|582013517|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
161173849|NCT01237223|582013518|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161173850|NCT01237223|582013519|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161173851|NCT01237223|582013520|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161173852|NCT01237223|582013521|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161173853|NCT01237223|582013522|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
161173854|NCT01237223|582013517|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
161173855|NCT01237223|582013518|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161173856|NCT01237223|582013519|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161292613|NCT03817853|582452160|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
161292614|NCT03817853|582452158|FG000|Induction Phase|Physician Decision|2|||
161292615|NCT03817853|582452159|FG001|Induction Phase|Physician Decision|0|||
161292616|NCT03817853|582452160|FG002|Induction Phase|Physician Decision|0|||
161292617|NCT03817853|582452158|FG000|Induction Phase|Progressive Disease|6|||
161292618|NCT03817853|582452159|FG001|Induction Phase|Progressive Disease|0|||
161292619|NCT03817853|582452160|FG002|Induction Phase|Progressive Disease|0|||
161292620|NCT03817853|582452158|FG000|Induction Phase|Withdrawal by Subject|4|||
161292621|NCT03817853|582452159|FG001|Induction Phase|Withdrawal by Subject|0|||
161292622|NCT03817853|582452160|FG002|Induction Phase|Withdrawal by Subject|0|||
161292623|NCT03817853|582452158|FG000|Maintenance Phase|Adverse Event|0|||
161292624|NCT03817853|582452159|FG001|Maintenance Phase|Adverse Event|8|||
161087102|NCT01859988|581706752|FG000|Overall Study|Adverse Event|2|||
161087103|NCT01859988|581706753|FG001|Overall Study|Adverse Event|1|||
161087104|NCT01859988|581706754|FG002|Overall Study|Adverse Event|3|||
161087105|NCT01859988|581706755|FG003|Overall Study|Adverse Event|1|||
161087106|NCT01859988|581706756|FG004|Overall Study|Adverse Event|2|||
161087107|NCT01859988|581706757|FG005|Overall Study|Adverse Event|2|||
161087108|NCT01859988|581706752|FG000|Overall Study|Lost to Follow-up|1|||
161087109|NCT01859988|581706753|FG001|Overall Study|Lost to Follow-up|2|||
161087110|NCT01859988|581706754|FG002|Overall Study|Lost to Follow-up|3|||
161087111|NCT01859988|581706755|FG003|Overall Study|Lost to Follow-up|0|||
161087112|NCT01859988|581706756|FG004|Overall Study|Lost to Follow-up|3|||
161087113|NCT01859988|581706757|FG005|Overall Study|Lost to Follow-up|2|||
161087114|NCT01859988|581706752|FG000|Overall Study|Protocol Violation|0|||
161087115|NCT01859988|581706753|FG001|Overall Study|Protocol Violation|0|||
161087116|NCT01859988|581706754|FG002|Overall Study|Protocol Violation|1|||
161087117|NCT01859988|581706755|FG003|Overall Study|Protocol Violation|0|||
161087118|NCT01859988|581706756|FG004|Overall Study|Protocol Violation|0|||
161087119|NCT01859988|581706757|FG005|Overall Study|Protocol Violation|0|||
161087120|NCT01859988|581706752|FG000|Overall Study|Other than specified above|0|||
161087121|NCT01859988|581706753|FG001|Overall Study|Other than specified above|2|||
161087122|NCT01859988|581706754|FG002|Overall Study|Other than specified above|11|||
161087123|NCT01859988|581706755|FG003|Overall Study|Other than specified above|3|||
161087124|NCT01859988|581706756|FG004|Overall Study|Other than specified above|5|||
161087125|NCT01859988|581706757|FG005|Overall Study|Other than specified above|3|||
161087126|NCT02930226|581706758|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
161087127|NCT02930226|581706759|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
161087128|NCT02930226|581706760|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
161087129|NCT02930226|581706761|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
161087130|NCT02930226|581706762|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
161087131|NCT02930226|581706763|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
161087132|NCT00564889|581706764|FG000|Overall Study|Death|7|||
161087133|NCT00564889|581706764|FG000|Overall Study|Adverse Event|12|||
161087134|NCT00564889|581706764|FG000|Overall Study|Alternative treatment|3|||
161087135|NCT00564889|581706764|FG000|Overall Study|Disease progression|3|||
161087136|NCT00564889|581706764|FG000|Overall Study|Other, not specified|4|||
161087137|NCT00635427|581706765|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161087138|NCT00635427|581706766|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161087139|NCT00635427|581706767|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
161292625|NCT03817853|582452160|FG002|Maintenance Phase|Adverse Event|0|||
161347426|NCT04919161|582656284|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
161347427|NCT04919161|582656285|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
161347428|NCT04919161|582656284|FG000|Overall Study|Acute ankle sprain after session 1|0|||
161347429|NCT04919161|582656285|FG001|Overall Study|Acute ankle sprain after session 1|1|||
161347430|NCT02175758|582656286|FG000|Treatment Phase|Lost to Follow-up|0|||
161347431|NCT02175758|582656287|FG001|Treatment Phase|Lost to Follow-up|1|||
161347432|NCT02175758|582656288|FG002|Treatment Phase|Lost to Follow-up|0|||
161347433|NCT02175758|582656289|FG003|Treatment Phase|Lost to Follow-up|0|||
161347434|NCT02175758|582656290|FG004|Treatment Phase|Lost to Follow-up|0|||
161347435|NCT02175758|582656291|FG005|Treatment Phase|Lost to Follow-up|0|||
161347436|NCT02175758|582656286|FG000|Treatment Phase|Adverse Event|0|||
161347437|NCT02175758|582656287|FG001|Treatment Phase|Adverse Event|0|||
161347438|NCT02175758|582656288|FG002|Treatment Phase|Adverse Event|0|||
161347439|NCT02175758|582656289|FG003|Treatment Phase|Adverse Event|0|||
161347440|NCT02175758|582656290|FG004|Treatment Phase|Adverse Event|1|||
161347441|NCT02175758|582656291|FG005|Treatment Phase|Adverse Event|0|||
161292626|NCT03817853|582452158|FG000|Maintenance Phase|Death|0|||
161292627|NCT03817853|582452159|FG001|Maintenance Phase|Death|5|||
161292628|NCT03817853|582452160|FG002|Maintenance Phase|Death|0|||
161292629|NCT03817853|582452158|FG000|Maintenance Phase|Progressive Disease|0|||
161292630|NCT03817853|582452159|FG001|Maintenance Phase|Progressive Disease|7|||
161292631|NCT03817853|582452160|FG002|Maintenance Phase|Progressive Disease|0|||
161292632|NCT03817853|582452158|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161292633|NCT03817853|582452159|FG001|Maintenance Phase|Withdrawal by Subject|2|||
161292634|NCT03817853|582452160|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161292635|NCT03817853|582452158|FG000|Maintenance Phase|Physician Decision|0|||
161292636|NCT03817853|582452159|FG001|Maintenance Phase|Physician Decision|1|||
161292637|NCT03817853|582452160|FG002|Maintenance Phase|Physician Decision|0|||
161292638|NCT03817853|582452158|FG000|Maintenance Phase|Various reasons|0|||
161292639|NCT03817853|582452159|FG001|Maintenance Phase|Various reasons|4|||
161292640|NCT03817853|582452160|FG002|Maintenance Phase|Various reasons|0|||
161292641|NCT03817853|582452158|FG000|Maintenance Phase|Protocol Deviation|0|||
161292642|NCT03817853|582452159|FG001|Maintenance Phase|Protocol Deviation|1|||
161292643|NCT03817853|582452160|FG002|Maintenance Phase|Protocol Deviation|0|||
161292644|NCT03817853|582452158|FG000|Follow-up Phase|Adverse Event|0|||
161292645|NCT03817853|582452159|FG001|Follow-up Phase|Adverse Event|0|||
161292646|NCT03817853|582452160|FG002|Follow-up Phase|Adverse Event|2|||
161292647|NCT03817853|582452158|FG000|Follow-up Phase|Death|0|||
161292648|NCT03817853|582452159|FG001|Follow-up Phase|Death|0|||
161292649|NCT03817853|582452160|FG002|Follow-up Phase|Death|1|||
161292650|NCT03817853|582452158|FG000|Follow-up Phase|Progressive Disease|0|||
161292651|NCT03817853|582452159|FG001|Follow-up Phase|Progressive Disease|0|||
161292652|NCT03817853|582452160|FG002|Follow-up Phase|Progressive Disease|3|||
161292653|NCT03817853|582452158|FG000|Follow-up Phase|Withdrawal by Subject|0|||
161292654|NCT03817853|582452159|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161292655|NCT03817853|582452160|FG002|Follow-up Phase|Withdrawal by Subject|1|||
161292656|NCT00391768|582452161|FG000|Overall Study|Withdrawal by Subject|0|||
161292657|NCT00391768|582452162|FG001|Overall Study|Withdrawal by Subject|0|||
161292658|NCT00391768|582452163|FG002|Overall Study|Withdrawal by Subject|1|||
161292659|NCT00391768|582452164|FG003|Overall Study|Withdrawal by Subject|0|||
161292660|NCT00391768|582452165|FG004|Overall Study|Withdrawal by Subject|0|||
161292661|NCT00391768|582452166|FG005|Overall Study|Withdrawal by Subject|1|||
161292662|NCT00391768|582452167|FG006|Overall Study|Withdrawal by Subject|1|||
161292663|NCT00391768|582452161|FG000|Overall Study|Lost to Follow-up|0|||
161292664|NCT00391768|582452162|FG001|Overall Study|Lost to Follow-up|0|||
161292665|NCT00391768|582452163|FG002|Overall Study|Lost to Follow-up|0|||
161292666|NCT00391768|582452164|FG003|Overall Study|Lost to Follow-up|1|||
161292667|NCT00391768|582452165|FG004|Overall Study|Lost to Follow-up|2|||
161292668|NCT00391768|582452166|FG005|Overall Study|Lost to Follow-up|2|||
161292669|NCT00391768|582452167|FG006|Overall Study|Lost to Follow-up|3|||
161292670|NCT01620138|582452168|FG000|Overall Study|Withdrawal by Subject|3|||
161292671|NCT01620138|582452169|FG001|Overall Study|Withdrawal by Subject|0|||
161292672|NCT01620138|582452168|FG000|Overall Study|Lack of Efficacy|1|||
161292673|NCT01620138|582452169|FG001|Overall Study|Lack of Efficacy|0|||
161292674|NCT01620138|582452168|FG000|Overall Study|Adverse Event|2|||
161292675|NCT01620138|582452169|FG001|Overall Study|Adverse Event|0|||
161347442|NCT02489773|582656292|FG000|Overall Study|Lost to Follow-up|4|||
161292676|NCT00444535|582452172|FG000|Overall Study|Withdrawal by Subject|5|||
161292677|NCT00444535|582452172|FG000|Overall Study|Physician Decision|5|||
161292678|NCT00444535|582452172|FG000|Overall Study|progressive disease|1|||
161292679|NCT00444535|582452172|FG000|Overall Study|Adverse Event|2|||
161292680|NCT01568892|582452173|FG000|Open-label Phase|Adverse Event|2|||
161347443|NCT02489773|582656293|FG001|Overall Study|Lost to Follow-up|1|||
161347444|NCT02489773|582656292|FG000|Overall Study|Physician Decision|1|||
161347445|NCT02489773|582656293|FG001|Overall Study|Physician Decision|0|||
161292681|NCT01568892|582452174|FG001|Open-label Phase|Adverse Event|0|||
161292682|NCT01568892|582452173|FG000|Open-label Phase|Lack of Efficacy|4|||
161292683|NCT01568892|582452174|FG001|Open-label Phase|Lack of Efficacy|2|||
161292684|NCT01568892|582452173|FG000|Open-label Phase|Lost to Follow-up|0|||
161292685|NCT01568892|582452174|FG001|Open-label Phase|Lost to Follow-up|1|||
161292686|NCT01697748|582452182|FG000|Overall Study|ineligible skin incision|1|||
161292687|NCT01697748|582452183|FG001|Overall Study|ineligible skin incision|2|||
161292688|NCT01697748|582452182|FG000|Overall Study|ineligible uterine incision|4|||
161292689|NCT01697748|582452183|FG001|Overall Study|ineligible uterine incision|1|||
161292690|NCT01697748|582452182|FG000|Overall Study|Lost to Follow-up|53|||
161292691|NCT01697748|582452183|FG001|Overall Study|Lost to Follow-up|65|||
161292692|NCT01704495|582452186|FG000|Subjects Randomized|Other Reason|3|||
161292693|NCT01704495|582452187|FG001|Subjects Randomized|Other Reason|2|||
161292694|NCT01704495|582452188|FG002|Subjects Randomized|Other Reason|3|||
161292695|NCT01704495|582452189|FG003|Subjects Randomized|Other Reason|2|||
161292696|NCT01704495|582452186|FG000|Subjects Randomized|Discontinuation criteria met|4|||
161292697|NCT01704495|582452187|FG001|Subjects Randomized|Discontinuation criteria met|2|||
161292698|NCT01704495|582452188|FG002|Subjects Randomized|Discontinuation criteria met|2|||
161292699|NCT01704495|582452189|FG003|Subjects Randomized|Discontinuation criteria met|0|||
161292700|NCT01704495|582452186|FG000|Subjects Randomized|Adverse Event|8|||
161292701|NCT01704495|582452187|FG001|Subjects Randomized|Adverse Event|2|||
161292702|NCT01704495|582452188|FG002|Subjects Randomized|Adverse Event|0|||
161292703|NCT01704495|582452189|FG003|Subjects Randomized|Adverse Event|7|||
161292704|NCT01704495|582452186|FG000|Subjects Randomized|Withdrawal by Subject|5|||
161292705|NCT01704495|582452187|FG001|Subjects Randomized|Withdrawal by Subject|5|||
161292706|NCT01704495|582452188|FG002|Subjects Randomized|Withdrawal by Subject|5|||
161292707|NCT01704495|582452189|FG003|Subjects Randomized|Withdrawal by Subject|5|||
161292708|NCT01704495|582452186|FG000|Subjects Randomized|Protocol Violation|1|||
161292709|NCT01704495|582452187|FG001|Subjects Randomized|Protocol Violation|1|||
161292710|NCT01704495|582452188|FG002|Subjects Randomized|Protocol Violation|2|||
161292711|NCT01704495|582452189|FG003|Subjects Randomized|Protocol Violation|0|||
161292712|NCT01704495|582452186|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
161292713|NCT01704495|582452187|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
161292714|NCT01704495|582452188|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
161292715|NCT01704495|582452189|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
161292716|NCT01704495|582452186|FG000|Optional Safety Extension|Adverse Event|0|||
161292717|NCT01704495|582452187|FG001|Optional Safety Extension|Adverse Event|4|||
161292718|NCT01704495|582452188|FG002|Optional Safety Extension|Adverse Event|0|||
161292719|NCT01704495|582452189|FG003|Optional Safety Extension|Adverse Event|1|||
161292720|NCT01704495|582452186|FG000|Optional Safety Extension|Other reason|27|||
161292721|NCT01704495|582452187|FG001|Optional Safety Extension|Other reason|29|||
161292722|NCT01704495|582452188|FG002|Optional Safety Extension|Other reason|30|||
161292723|NCT01704495|582452189|FG003|Optional Safety Extension|Other reason|28|||
161292724|NCT01704495|582452186|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
161292725|NCT01704495|582452187|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
161292726|NCT01704495|582452188|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
161292727|NCT01704495|582452189|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
161292728|NCT01256450|582452190|FG000|Open-label Titration|Adverse Event|39|||
161292729|NCT01256450|582452191|FG001|Open-label Titration|Adverse Event|0|||
161292730|NCT01256450|582452192|FG002|Open-label Titration|Adverse Event|0|||
161292731|NCT01256450|582452190|FG000|Open-label Titration|Lost to Follow-up|7|||
161292732|NCT01256450|582452191|FG001|Open-label Titration|Lost to Follow-up|0|||
161292733|NCT01256450|582452192|FG002|Open-label Titration|Lost to Follow-up|0|||
161292734|NCT01256450|582452190|FG000|Open-label Titration|Lack of analgesic effect|30|||
161292735|NCT01256450|582452191|FG001|Open-label Titration|Lack of analgesic effect|0|||
161292736|NCT01256450|582452192|FG002|Open-label Titration|Lack of analgesic effect|0|||
161292737|NCT01256450|582452190|FG000|Open-label Titration|Non-compliance|9|||
161292738|NCT01256450|582452191|FG001|Open-label Titration|Non-compliance|0|||
161292739|NCT01256450|582452192|FG002|Open-label Titration|Non-compliance|0|||
161292740|NCT01256450|582452190|FG000|Open-label Titration|Screen failure|1|||
161292741|NCT01256450|582452191|FG001|Open-label Titration|Screen failure|0|||
161292742|NCT01256450|582452192|FG002|Open-label Titration|Screen failure|0|||
161087140|NCT00635427|581706768|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161087141|NCT00635427|581706769|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
161087142|NCT00635427|581706765|FG000|Overall Study|Death|0|||
161292743|NCT01256450|582452190|FG000|Open-label Titration|Other|13|||
161292744|NCT01256450|582452191|FG001|Open-label Titration|Other|0|||
161292745|NCT01256450|582452192|FG002|Open-label Titration|Other|0|||
161292746|NCT01256450|582452190|FG000|Double-blind Treatment|Adverse Event|0|||
161292747|NCT01256450|582452191|FG001|Double-blind Treatment|Adverse Event|8|||
161292748|NCT01256450|582452192|FG002|Double-blind Treatment|Adverse Event|6|||
161292749|NCT01256450|582452190|FG000|Double-blind Treatment|Lost to Follow-up|0|||
161292750|NCT01256450|582452191|FG001|Double-blind Treatment|Lost to Follow-up|1|||
161292751|NCT01256450|582452192|FG002|Double-blind Treatment|Lost to Follow-up|7|||
161292752|NCT01256450|582452190|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
161292753|NCT01256450|582452191|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
161292754|NCT01256450|582452192|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
161173857|NCT01237223|582013520|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161173858|NCT01237223|582013521|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161173859|NCT01237223|582013522|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
161173860|NCT01237223|582013517|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
161173861|NCT01237223|582013518|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
161173862|NCT01237223|582013519|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
161173863|NCT01237223|582013520|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
161173864|NCT01237223|582013521|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
161173865|NCT01237223|582013522|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
161173866|NCT01237223|582013517|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
161173867|NCT01237223|582013518|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
161173868|NCT01237223|582013519|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
161173869|NCT01237223|582013520|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
161173870|NCT01237223|582013521|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
161173871|NCT01237223|582013522|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
161173872|NCT01237223|582013517|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161173873|NCT01237223|582013518|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
161173874|NCT01237223|582013519|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
161173875|NCT01237223|582013520|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
161173876|NCT01237223|582013521|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161173877|NCT01237223|582013522|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
161173878|NCT01237223|582013517|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161173879|NCT01237223|582013518|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161173880|NCT01237223|582013519|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161292755|NCT01256450|582452190|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
161292756|NCT01256450|582452191|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
161292757|NCT01256450|582452192|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
161292758|NCT01256450|582452190|FG000|Double-blind Treatment|Non-compliance|0|||
161292759|NCT01256450|582452191|FG001|Double-blind Treatment|Non-compliance|5|||
161292760|NCT01256450|582452192|FG002|Double-blind Treatment|Non-compliance|4|||
161292761|NCT01256450|582452190|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
161292762|NCT01256450|582452191|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
161292763|NCT01256450|582452192|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
161292764|NCT01256450|582452190|FG000|Double-blind Treatment|Other|0|||
161292765|NCT01256450|582452191|FG001|Double-blind Treatment|Other|9|||
161292766|NCT01256450|582452192|FG002|Double-blind Treatment|Other|12|||
161292767|NCT02375971|582452194|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
161292768|NCT02375971|582452195|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
161292769|NCT02375971|582452196|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
161292770|NCT02375971|582452194|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161292771|NCT02375971|582452195|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161292772|NCT02375971|582452196|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
161292773|NCT02375971|582452194|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
161292774|NCT02375971|582452195|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
161292775|NCT02375971|582452196|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
161292776|NCT02375971|582452194|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
161292777|NCT02375971|582452195|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
161292778|NCT02375971|582452196|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
161292779|NCT02375971|582452194|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
161292780|NCT02375971|582452195|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
161292781|NCT02375971|582452196|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
161292782|NCT02375971|582452194|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
161292783|NCT02375971|582452195|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
161292784|NCT02375971|582452196|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
161292785|NCT02375971|582452194|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
161292786|NCT02375971|582452195|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
161292787|NCT02375971|582452196|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
161292788|NCT02375971|582452194|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
161292789|NCT02375971|582452195|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
161292790|NCT02375971|582452196|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
161292791|NCT00891020|582452197|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
161292792|NCT00891020|582452198|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
161292793|NCT00891020|582452199|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
161292794|NCT00891020|582452197|FG000|24 Week Treatment Period|Death|0|||
161292795|NCT00891020|582452198|FG001|24 Week Treatment Period|Death|2|||
161292796|NCT00891020|582452199|FG002|24 Week Treatment Period|Death|0|||
161292797|NCT00891020|582452197|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
161292798|NCT00891020|582452198|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
161292799|NCT00891020|582452199|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
161292800|NCT00891020|582452197|FG000|24 Week Treatment Period|Failure to return|4|||
161292801|NCT00891020|582452198|FG001|24 Week Treatment Period|Failure to return|5|||
161292802|NCT00891020|582452199|FG002|24 Week Treatment Period|Failure to return|5|||
161292803|NCT00891020|582452197|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
161292804|NCT00891020|582452198|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
161292805|NCT00891020|582452199|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
161292806|NCT00891020|582452197|FG000|24 Week Treatment Period|Other protocol violation|1|||
161292807|NCT00891020|582452198|FG001|24 Week Treatment Period|Other protocol violation|1|||
161292808|NCT00891020|582452199|FG002|24 Week Treatment Period|Other protocol violation|2|||
161292809|NCT00891020|582452197|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
161292810|NCT00891020|582452198|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
161292811|NCT00891020|582452199|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
161292812|NCT00891020|582452197|FG000|24 Week Treatment Period|Withdrew consent|6|||
161292813|NCT00891020|582452198|FG001|24 Week Treatment Period|Withdrew consent|3|||
161292814|NCT00891020|582452199|FG002|24 Week Treatment Period|Withdrew consent|15|||
161292815|NCT00891020|582452197|FG000|24 Week Treatment Period|Administrative/Other|5|||
161292816|NCT00891020|582452198|FG001|24 Week Treatment Period|Administrative/Other|6|||
161292817|NCT00891020|582452199|FG002|24 Week Treatment Period|Administrative/Other|1|||
161347446|NCT02489773|582656292|FG000|Overall Study|Withdrawal by Subject|1|||
161347447|NCT02489773|582656293|FG001|Overall Study|Withdrawal by Subject|0|||
161347448|NCT02489773|582656292|FG000|Overall Study|Leave the country or the state|1|||
161347449|NCT02489773|582656293|FG001|Overall Study|Leave the country or the state|1|||
161347450|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
161347451|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
161347452|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
161347453|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
161347454|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
161087143|NCT00635427|581706766|FG001|Overall Study|Death|0|||
161087144|NCT00635427|581706767|FG002|Overall Study|Death|0|||
161087145|NCT00635427|581706768|FG003|Overall Study|Death|1|||
161087146|NCT00635427|581706769|FG004|Overall Study|Death|0|||
161087147|NCT00635427|581706765|FG000|Overall Study|Termination Of Study By Sponsor|12|||
161087148|NCT00635427|581706766|FG001|Overall Study|Termination Of Study By Sponsor|6|||
161087149|NCT00635427|581706767|FG002|Overall Study|Termination Of Study By Sponsor|10|||
161087150|NCT00635427|581706768|FG003|Overall Study|Termination Of Study By Sponsor|6|||
161087151|NCT00635427|581706769|FG004|Overall Study|Termination Of Study By Sponsor|6|||
161087152|NCT00635427|581706765|FG000|Overall Study|Withdrawal Of Consent|0|||
161087153|NCT00635427|581706766|FG001|Overall Study|Withdrawal Of Consent|0|||
161087154|NCT00635427|581706767|FG002|Overall Study|Withdrawal Of Consent|0|||
161087155|NCT00635427|581706768|FG003|Overall Study|Withdrawal Of Consent|2|||
161087156|NCT00635427|581706769|FG004|Overall Study|Withdrawal Of Consent|2|||
161087157|NCT01506609|581706774|FG000|Overall Study|Adverse Event Related to Progression|0|||
161087158|NCT01506609|581706775|FG001|Overall Study|Adverse Event Related to Progression|0|||
161087159|NCT01506609|581706776|FG002|Overall Study|Adverse Event Related to Progression|0|||
161087160|NCT01506609|581706777|FG003|Overall Study|Adverse Event Related to Progression|3|||
161087161|NCT01506609|581706778|FG004|Overall Study|Adverse Event Related to Progression|7|||
161087162|NCT01506609|581706779|FG005|Overall Study|Adverse Event Related to Progression|3|||
161087163|NCT01506609|581706774|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
161087164|NCT01506609|581706775|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
161087165|NCT01506609|581706776|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
161087166|NCT01506609|581706777|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
161087167|NCT01506609|581706778|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
161087168|NCT01506609|581706779|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
161087169|NCT01506609|581706774|FG000|Overall Study|Withdrawal by Subject|0|||
161087170|NCT01506609|581706775|FG001|Overall Study|Withdrawal by Subject|0|||
161087171|NCT01506609|581706776|FG002|Overall Study|Withdrawal by Subject|0|||
161087172|NCT01506609|581706777|FG003|Overall Study|Withdrawal by Subject|9|||
161087173|NCT01506609|581706778|FG004|Overall Study|Withdrawal by Subject|7|||
161087174|NCT01506609|581706779|FG005|Overall Study|Withdrawal by Subject|7|||
161173881|NCT01237223|582013520|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161173882|NCT01237223|582013521|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
161173883|NCT01237223|582013522|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
161173884|NCT01237223|582013517|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
161173885|NCT01237223|582013518|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161292818|NCT00891020|582452197|FG000|Long-term Extension Period|Adverse Event|1|||
161292819|NCT00891020|582452198|FG001|Long-term Extension Period|Adverse Event|11|||
161292820|NCT00891020|582452199|FG002|Long-term Extension Period|Adverse Event|10|||
161173886|NCT01237223|582013519|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161173887|NCT01237223|582013520|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
161173888|NCT01237223|582013521|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161173889|NCT01237223|582013522|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
161173890|NCT00443846|582013526|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
161173891|NCT00443846|582013527|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
161173892|NCT00443846|582013526|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
161173893|NCT00443846|582013527|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
161173894|NCT00443846|582013526|FG000|Overall Study|Adverse Event|0|||
161173895|NCT00443846|582013527|FG001|Overall Study|Adverse Event|1|||
161173896|NCT00443846|582013526|FG000|Overall Study|Personal reason|8|||
161173897|NCT00443846|582013527|FG001|Overall Study|Personal reason|3|||
161173898|NCT00443846|582013526|FG000|Overall Study|Lost to Follow-up|1|||
161173899|NCT00443846|582013527|FG001|Overall Study|Lost to Follow-up|2|||
161173900|NCT00445341|582013531|FG000|Overall Study|refused further treatment|1|||
161173901|NCT00445341|582013531|FG000|Overall Study|taken off treatment too early|1|||
161173902|NCT00641706|582013532|FG000|Overall Study|Adverse Event|2|||
161173903|NCT00641706|582013533|FG001|Overall Study|Adverse Event|1|||
161173904|NCT00641706|582013532|FG000|Overall Study|Withdrawal by Subject|6|||
161173905|NCT00641706|582013533|FG001|Overall Study|Withdrawal by Subject|1|||
161173906|NCT00641706|582013532|FG000|Overall Study|Clinical Decline|1|||
161173907|NCT00641706|582013533|FG001|Overall Study|Clinical Decline|0|||
161173908|NCT00641706|582013532|FG000|Overall Study|Lead Investigator Decision|0|||
161173909|NCT00641706|582013533|FG001|Overall Study|Lead Investigator Decision|1|||
161173910|NCT00109772|582013536|FG000|Double-blind Treatment|Adverse Event|14|||
161173911|NCT00109772|582013537|FG001|Double-blind Treatment|Adverse Event|5|||
161173912|NCT00109772|582013536|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161173913|NCT00109772|582013537|FG001|Double-blind Treatment|Lack of Efficacy|0|||
161173914|NCT00109772|582013536|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
161173915|NCT00109772|582013537|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
161173916|NCT00109772|582013536|FG000|Double-blind Treatment|Lost to Follow-up|2|||
161173917|NCT00109772|582013537|FG001|Double-blind Treatment|Lost to Follow-up|3|||
161173918|NCT00109772|582013536|FG000|Double-blind Treatment|Protocol Violation|0|||
161173919|NCT00109772|582013537|FG001|Double-blind Treatment|Protocol Violation|1|||
161173920|NCT00109772|582013536|FG000|Double-blind Treatment|Other|0|||
161173921|NCT00109772|582013537|FG001|Double-blind Treatment|Other|4|||
161173922|NCT00109772|582013536|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
161173923|NCT00109772|582013537|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
161173924|NCT00109772|582013536|FG000|Open-label Extension|Adverse Event|10|||
161173925|NCT00109772|582013537|FG001|Open-label Extension|Adverse Event|19|||
161173926|NCT00109772|582013536|FG000|Open-label Extension|Lack of Efficacy|19|||
161173927|NCT00109772|582013537|FG001|Open-label Extension|Lack of Efficacy|11|||
161173928|NCT00109772|582013536|FG000|Open-label Extension|Withdrawal by Subject|9|||
161173929|NCT00109772|582013537|FG001|Open-label Extension|Withdrawal by Subject|6|||
161173930|NCT00109772|582013536|FG000|Open-label Extension|Lost to Follow-up|1|||
161173931|NCT00109772|582013537|FG001|Open-label Extension|Lost to Follow-up|0|||
161173932|NCT00109772|582013536|FG000|Open-label Extension|Death|0|||
161173933|NCT00109772|582013537|FG001|Open-label Extension|Death|1|||
161173934|NCT00109772|582013536|FG000|Open-label Extension|Protocol Violation|2|||
161173935|NCT00109772|582013537|FG001|Open-label Extension|Protocol Violation|2|||
161173936|NCT00109772|582013536|FG000|Open-label Extension|Other|4|||
161173937|NCT00109772|582013537|FG001|Open-label Extension|Other|10|||
161173938|NCT01989754|582013538|FG000|Overall Study|Withdrawal by Subject|10|||
161173939|NCT01989754|582013539|FG001|Overall Study|Withdrawal by Subject|14|||
161173940|NCT01989754|582013538|FG000|Overall Study|Lost to Follow-up|28|||
161173941|NCT01989754|582013539|FG001|Overall Study|Lost to Follow-up|20|||
161173942|NCT01989754|582013538|FG000|Overall Study|Closed Site|1|||
161173943|NCT01989754|582013539|FG001|Overall Study|Closed Site|1|||
161173944|NCT00391807|582013545|FG000|Overall Study|Did not receive study medication|23|||
161173945|NCT00391807|582013545|FG000|Overall Study|Adverse Event|177|||
161173946|NCT00391807|582013545|FG000|Overall Study|Pregnancy|25|||
161173947|NCT00391807|582013545|FG000|Overall Study|Lost to Follow-up|227|||
161173948|NCT00391807|582013545|FG000|Overall Study|Withdrawal by Subject|147|||
161173949|NCT00391807|582013545|FG000|Overall Study|Protocol Violation|20|||
161173950|NCT00391807|582013545|FG000|Overall Study|Various|96|||
161173951|NCT05441540|582013546|FG000|Overall Study|Withdrawal by Subject|2|||
161173952|NCT00813917|582013547|FG000|Overall Study|Adverse Event|0|||
161173953|NCT00813917|582013548|FG001|Overall Study|Adverse Event|1|||
161173954|NCT00813917|582013547|FG000|Overall Study|Withdrawal by Subject|3|||
161173955|NCT00813917|582013548|FG001|Overall Study|Withdrawal by Subject|4|||
161173956|NCT00813917|582013547|FG000|Overall Study|Lost to Follow-up|3|||
161347455|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
161173957|NCT00813917|582013548|FG001|Overall Study|Lost to Follow-up|1|||
161173958|NCT01359046|582013549|FG000|Overall Study|Did not receive allocated intervention|6|||
161173959|NCT01359046|582013550|FG001|Overall Study|Did not receive allocated intervention|6|||
161173960|NCT01359046|582013549|FG000|Overall Study|Physician Decision|1|||
161173961|NCT01359046|582013550|FG001|Overall Study|Physician Decision|11|||
161173962|NCT01369225|582013555|FG000|Overall Study|Withdrawal by Subject|1|||
161173963|NCT01369225|582013556|FG001|Overall Study|Withdrawal by Subject|0|||
161173964|NCT01369225|582013557|FG002|Overall Study|Withdrawal by Subject|2|||
161173965|NCT01369225|582013558|FG003|Overall Study|Withdrawal by Subject|1|||
161173966|NCT01369225|582013559|FG004|Overall Study|Withdrawal by Subject|0|||
161173967|NCT01369225|582013560|FG005|Overall Study|Withdrawal by Subject|0|||
161173968|NCT01369225|582013555|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
161173969|NCT01369225|582013556|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
161173970|NCT01369225|582013557|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
161173971|NCT01369225|582013558|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
161173972|NCT01369225|582013559|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
161173973|NCT01369225|582013560|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
161173974|NCT01369225|582013555|FG000|Overall Study|Other|1|||
161173975|NCT01369225|582013556|FG001|Overall Study|Other|0|||
161173976|NCT01369225|582013557|FG002|Overall Study|Other|0|||
161173977|NCT01369225|582013558|FG003|Overall Study|Other|0|||
161173978|NCT01369225|582013559|FG004|Overall Study|Other|1|||
161173979|NCT01369225|582013560|FG005|Overall Study|Other|0|||
161173980|NCT01369225|582013555|FG000|Overall Study|Adverse Event|0|||
161173981|NCT01369225|582013556|FG001|Overall Study|Adverse Event|0|||
161173982|NCT01369225|582013557|FG002|Overall Study|Adverse Event|0|||
161173983|NCT01369225|582013558|FG003|Overall Study|Adverse Event|1|||
161173984|NCT01369225|582013559|FG004|Overall Study|Adverse Event|1|||
161173985|NCT01369225|582013560|FG005|Overall Study|Adverse Event|0|||
161173986|NCT04539262|582013562|FG000|Overall Study|Adverse Event|0|||
161173987|NCT04539262|582013563|FG001|Overall Study|Adverse Event|0|||
161173988|NCT04539262|582013564|FG002|Overall Study|Adverse Event|1|||
161173989|NCT04539262|582013565|FG003|Overall Study|Adverse Event|0|||
161173990|NCT04539262|582013566|FG004|Overall Study|Adverse Event|0|||
161173991|NCT04539262|582013567|FG005|Overall Study|Adverse Event|0|||
161173992|NCT04539262|582013568|FG006|Overall Study|Adverse Event|0|||
161173993|NCT04539262|582013569|FG007|Overall Study|Adverse Event|0|||
161173994|NCT04539262|582013562|FG000|Overall Study|Withdrew Consent|0|||
161173995|NCT04539262|582013563|FG001|Overall Study|Withdrew Consent|0|||
161173996|NCT04539262|582013564|FG002|Overall Study|Withdrew Consent|0|||
161173997|NCT04539262|582013565|FG003|Overall Study|Withdrew Consent|1|||
161173998|NCT04539262|582013566|FG004|Overall Study|Withdrew Consent|0|||
161173999|NCT04539262|582013567|FG005|Overall Study|Withdrew Consent|0|||
161174000|NCT04539262|582013568|FG006|Overall Study|Withdrew Consent|0|||
161174001|NCT04539262|582013569|FG007|Overall Study|Withdrew Consent|0|||
161174002|NCT04539262|582013562|FG000|Overall Study|Randomized, Not treated|0|||
161174003|NCT04539262|582013563|FG001|Overall Study|Randomized, Not treated|1|||
161174004|NCT04539262|582013564|FG002|Overall Study|Randomized, Not treated|0|||
161174005|NCT04539262|582013565|FG003|Overall Study|Randomized, Not treated|0|||
161174006|NCT04539262|582013566|FG004|Overall Study|Randomized, Not treated|0|||
161174007|NCT04539262|582013567|FG005|Overall Study|Randomized, Not treated|0|||
161174008|NCT04539262|582013568|FG006|Overall Study|Randomized, Not treated|1|||
161174009|NCT04539262|582013569|FG007|Overall Study|Randomized, Not treated|0|||
161174010|NCT04702984|582013572|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
161174011|NCT01851863|582013580|FG000|Overall Study|Did not receive study medication|2|||
161174012|NCT01851863|582013581|FG001|Overall Study|Did not receive study medication|5|||
161174013|NCT01851863|582013582|FG002|Overall Study|Did not receive study medication|3|||
161174014|NCT01851863|582013583|FG003|Overall Study|Did not receive study medication|0|||
161174015|NCT01851863|582013580|FG000|Overall Study|Lost to Follow-up|3|||
161174016|NCT01851863|582013581|FG001|Overall Study|Lost to Follow-up|4|||
161174017|NCT01851863|582013582|FG002|Overall Study|Lost to Follow-up|2|||
161174018|NCT01851863|582013583|FG003|Overall Study|Lost to Follow-up|3|||
161174019|NCT00753623|582013584|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
161174020|NCT00753623|582013585|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
161174021|NCT00753623|582013584|FG000|Phase I (14 Days)|Physician Decision|1|||
161174022|NCT00753623|582013585|FG001|Phase I (14 Days)|Physician Decision|2|||
161174023|NCT00753623|582013584|FG000|Phase I (14 Days)|Adverse Event|0|||
161174024|NCT00753623|582013585|FG001|Phase I (14 Days)|Adverse Event|1|||
161174025|NCT00753623|582013584|FG000|Washout (7 Days)|Physician Decision|1|||
161174026|NCT00753623|582013585|FG001|Washout (7 Days)|Physician Decision|0|||
161174027|NCT00753623|582013584|FG000|Phase II (14 Days)|Physician Decision|0|||
161174028|NCT00753623|582013585|FG001|Phase II (14 Days)|Physician Decision|1|||
161174029|NCT03332303|582013586|FG000|Overall Study|Participant did not dose|1|||
161174030|NCT03332303|582013587|FG001|Overall Study|Participant did not dose|2|||
161174031|NCT03332303|582013588|FG002|Overall Study|Participant did not dose|0|||
161347456|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161174032|NCT03332303|582013586|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
161174033|NCT03332303|582013587|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
161174034|NCT03332303|582013588|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
161174035|NCT03332303|582013586|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
161174036|NCT03332303|582013587|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
161174037|NCT03332303|582013588|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
161174038|NCT03332303|582013586|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
161174039|NCT03332303|582013587|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
161174040|NCT03332303|582013588|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
161174041|NCT03332303|582013586|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
161174042|NCT03332303|582013587|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
161174043|NCT03332303|582013588|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
161174044|NCT03332303|582013586|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
161174045|NCT03332303|582013587|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
161174046|NCT03332303|582013588|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
161174047|NCT03332303|582013586|FG000|Overall Study|Participant had a significant protocol deviation|0|||
161174048|NCT03332303|582013587|FG001|Overall Study|Participant had a significant protocol deviation|1|||
161174049|NCT03332303|582013588|FG002|Overall Study|Participant had a significant protocol deviation|0|||
161174050|NCT01957787|582013589|FG000|Overall Study|Death|18|||
161174051|NCT01957787|582013589|FG000|Overall Study|Lost to Follow-up|3|||
161174052|NCT01957787|582013589|FG000|Overall Study|Withdrawal by Subject|3|||
161174053|NCT01957787|582013589|FG000|Overall Study|Entered Hospice or Similar Program|2|||
161174054|NCT01957787|582013589|FG000|Overall Study|Index Tumor(s) Resected|2|||
161174055|NCT01957787|582013589|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
161174056|NCT01957787|582013589|FG000|Overall Study|Local therapy, not cryoablation|6|||
161174057|NCT02224638|582013593|FG000|Overall Study|Adverse Event|1|||
161174058|NCT02224638|582013594|FG001|Overall Study|Adverse Event|1|||
161174059|NCT01400139|582013600|FG000|HYD Core Study|Adverse Event|210|||
161174060|NCT01400139|582013600|FG000|HYD Core Study|Lack of Efficacy|59|||
161174061|NCT01400139|582013600|FG000|HYD Core Study|Withdrawal by Subject|114|||
161174062|NCT01400139|582013600|FG000|HYD Core Study|Lost to Follow-up|39|||
161174063|NCT01400139|582013600|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
161174064|NCT01400139|582013600|FG000|HYD Core Study|Administrative|56|||
161174065|NCT01400139|582013600|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
161174066|NCT01400139|582013600|FG000|HYD Extension Period|Adverse Event|8|||
161174067|NCT01400139|582013600|FG000|HYD Extension Period|Withdrawal by Subject|5|||
161174068|NCT01400139|582013600|FG000|HYD Extension Period|Administrative|10|||
161174069|NCT00631540|582013601|FG000|Overall Study|Withdrawal by Subject|5|||
161174070|NCT00631540|582013601|FG000|Overall Study|Death|4|||
161174071|NCT00631540|582013601|FG000|Overall Study|Lost to Follow-up|2|||
161174072|NCT00631540|582013601|FG000|Overall Study|Core Lab Data Unavailable|3|||
161174073|NCT00795509|582013602|FG000|Overall Study|Protocol Violation|31|||
161174074|NCT00719953|582013603|FG000|Overall Study|Adverse Event|4|||
161174075|NCT03726333|582013609|FG000|Overall Study|Progressive Disease|0|||
161174076|NCT03726333|582013610|FG001|Overall Study|Progressive Disease|0|||
161174077|NCT03726333|582013611|FG002|Overall Study|Progressive Disease|1|||
161174078|NCT03726333|582013612|FG003|Overall Study|Progressive Disease|0|||
161347457|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161347458|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
161347459|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
161347460|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
161087175|NCT01506609|581706774|FG000|Overall Study|Lost to Follow-up|0|||
161087176|NCT01506609|581706775|FG001|Overall Study|Lost to Follow-up|0|||
161087177|NCT01506609|581706776|FG002|Overall Study|Lost to Follow-up|0|||
161087178|NCT01506609|581706777|FG003|Overall Study|Lost to Follow-up|1|||
161087179|NCT01506609|581706778|FG004|Overall Study|Lost to Follow-up|2|||
161087180|NCT01506609|581706779|FG005|Overall Study|Lost to Follow-up|0|||
161087181|NCT01506609|581706774|FG000|Overall Study|Sponsor Discontinued Study|0|||
161087182|NCT01506609|581706775|FG001|Overall Study|Sponsor Discontinued Study|0|||
161087183|NCT01506609|581706776|FG002|Overall Study|Sponsor Discontinued Study|0|||
161087184|NCT01506609|581706777|FG003|Overall Study|Sponsor Discontinued Study|2|||
161087185|NCT01506609|581706778|FG004|Overall Study|Sponsor Discontinued Study|2|||
161087186|NCT01506609|581706779|FG005|Overall Study|Sponsor Discontinued Study|0|||
161087187|NCT01506609|581706774|FG000|Overall Study|Progressive Disease per Protocol|1|||
161087188|NCT01506609|581706775|FG001|Overall Study|Progressive Disease per Protocol|0|||
161087189|NCT01506609|581706776|FG002|Overall Study|Progressive Disease per Protocol|0|||
161087190|NCT01506609|581706777|FG003|Overall Study|Progressive Disease per Protocol|64|||
161087191|NCT01506609|581706778|FG004|Overall Study|Progressive Disease per Protocol|57|||
161087192|NCT01506609|581706779|FG005|Overall Study|Progressive Disease per Protocol|74|||
161087193|NCT01506609|581706774|FG000|Overall Study|Other, Not Specified|0|||
161087194|NCT01506609|581706775|FG001|Overall Study|Other, Not Specified|0|||
161087195|NCT01506609|581706776|FG002|Overall Study|Other, Not Specified|0|||
161087196|NCT01506609|581706777|FG003|Overall Study|Other, Not Specified|10|||
161087197|NCT01506609|581706778|FG004|Overall Study|Other, Not Specified|7|||
161174079|NCT03726333|582013613|FG004|Overall Study|Progressive Disease|0|||
161174080|NCT02947022|582013614|FG000|Overall Study|Study Stopped|1|||
161174081|NCT01230749|582013615|FG000|Overall Study|Adverse Event|0|||
161174082|NCT01230749|582013616|FG001|Overall Study|Adverse Event|0|||
161174083|NCT01230749|582013617|FG002|Overall Study|Adverse Event|0|||
161174084|NCT01230749|582013618|FG003|Overall Study|Adverse Event|1|||
161174085|NCT01230749|582013615|FG000|Overall Study|Physician Decision|0|||
161174086|NCT01230749|582013616|FG001|Overall Study|Physician Decision|0|||
161174087|NCT01230749|582013617|FG002|Overall Study|Physician Decision|1|||
161174088|NCT01230749|582013618|FG003|Overall Study|Physician Decision|0|||
161174089|NCT01230749|582013615|FG000|Overall Study|Withdrawal by Subject|0|||
161174090|NCT01230749|582013616|FG001|Overall Study|Withdrawal by Subject|1|||
161174091|NCT01230749|582013617|FG002|Overall Study|Withdrawal by Subject|0|||
161174092|NCT01230749|582013618|FG003|Overall Study|Withdrawal by Subject|0|||
161174093|NCT01230749|582013615|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
161174094|NCT01230749|582013616|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161174095|NCT01230749|582013617|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161174096|NCT01230749|582013618|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
161174097|NCT03906136|582015464|FG000|Overall Study|Adverse Event|1|||
161174098|NCT03906136|582015465|FG001|Overall Study|Adverse Event|0|||
161174099|NCT03906136|582015464|FG000|Overall Study|Lost to Follow-up|7|||
161174100|NCT03906136|582015465|FG001|Overall Study|Lost to Follow-up|4|||
161347461|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
161347462|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
161347463|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
161347464|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
161347465|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
161347466|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161347467|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
161347468|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161347469|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
161347470|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161347471|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
161347472|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161347473|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
161347474|NCT00620542|582656297|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
161347475|NCT00620542|582656298|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
161347476|NCT00620542|582656299|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
161174101|NCT03906136|582015464|FG000|Overall Study|Physician Decision|1|||
161292821|NCT00891020|582452197|FG000|Long-term Extension Period|Death|0|||
161292822|NCT00891020|582452198|FG001|Long-term Extension Period|Death|0|||
161292823|NCT00891020|582452199|FG002|Long-term Extension Period|Death|1|||
161292824|NCT00891020|582452197|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
161292825|NCT00891020|582452198|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
161292826|NCT00891020|582452199|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
161292827|NCT00891020|582452197|FG000|Long-term Extension Period|Protocol Violation|0|||
161292828|NCT00891020|582452198|FG001|Long-term Extension Period|Protocol Violation|1|||
161292829|NCT00891020|582452199|FG002|Long-term Extension Period|Protocol Violation|1|||
161292830|NCT00891020|582452197|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
161292831|NCT00891020|582452198|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
161292832|NCT00891020|582452199|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
161292833|NCT00891020|582452197|FG000|Long-term Extension Period|Failure to return|0|||
161292834|NCT00891020|582452198|FG001|Long-term Extension Period|Failure to return|2|||
161292835|NCT00891020|582452199|FG002|Long-term Extension Period|Failure to return|3|||
161292836|NCT00891020|582452197|FG000|Long-term Extension Period|Administrative|1|||
161347477|NCT00620542|582656300|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
161347478|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
161347479|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
161347480|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
161347481|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
161347482|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
161347483|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
161347484|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
161347485|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
161174102|NCT03906136|582015465|FG001|Overall Study|Physician Decision|0|||
161347486|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
161347487|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
161347488|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
161347489|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
161174103|NCT03906136|582015464|FG000|Overall Study|Withdrawal by Subject|3|||
161174104|NCT03906136|582015465|FG001|Overall Study|Withdrawal by Subject|7|||
161174105|NCT01696396|582015470|FG000|Overall Study|Withdrawal by Subject|19|||
161174106|NCT01696396|582015471|FG001|Overall Study|Withdrawal by Subject|5|||
161292837|NCT00891020|582452198|FG001|Long-term Extension Period|Administrative|2|||
161292838|NCT00891020|582452199|FG002|Long-term Extension Period|Administrative|2|||
161292839|NCT00320710|582452201|FG000|Overall Study|Disease progression|24|||
161292840|NCT00320710|582452202|FG001|Overall Study|Disease progression|19|||
161292841|NCT00320710|582452203|FG002|Overall Study|Disease progression|2|||
161292842|NCT00320710|582452201|FG000|Overall Study|Death|10|||
161292843|NCT00320710|582452202|FG001|Overall Study|Death|7|||
161292844|NCT00320710|582452203|FG002|Overall Study|Death|1|||
161292845|NCT00320710|582452201|FG000|Overall Study|Administrative problems|1|||
161292846|NCT00320710|582452202|FG001|Overall Study|Administrative problems|2|||
161292847|NCT00320710|582452203|FG002|Overall Study|Administrative problems|0|||
161292848|NCT00320710|582452201|FG000|Overall Study|Withdrawal by Subject|20|||
161292849|NCT00320710|582452202|FG001|Overall Study|Withdrawal by Subject|26|||
161292850|NCT00320710|582452203|FG002|Overall Study|Withdrawal by Subject|1|||
161292851|NCT00320710|582452201|FG000|Overall Study|Protocol Violation|6|||
161292852|NCT00320710|582452202|FG001|Overall Study|Protocol Violation|5|||
161292853|NCT00320710|582452203|FG002|Overall Study|Protocol Violation|0|||
161292854|NCT00320710|582452201|FG000|Overall Study|Abnormal test procedure result(s)|2|||
161292855|NCT00320710|582452202|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161292856|NCT00320710|582452203|FG002|Overall Study|Abnormal test procedure result(s)|0|||
161292857|NCT00320710|582452201|FG000|Overall Study|Abnormal laboratory value(s)|12|||
161292858|NCT00320710|582452202|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161292859|NCT00320710|582452203|FG002|Overall Study|Abnormal laboratory value(s)|0|||
161292860|NCT00320710|582452201|FG000|Overall Study|Adverse Event|18|||
161347490|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
161347491|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
161347492|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
161347493|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
161347494|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
161347495|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
161347496|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
161347497|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
161347498|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
161347499|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
161347500|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
161347501|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
161347502|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
161347503|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
161347504|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
161347505|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
161347506|NCT00620542|582656297|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
161347507|NCT00620542|582656298|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
161347508|NCT00620542|582656299|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
161347509|NCT00620542|582656300|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
161347510|NCT02225587|582656305|FG000|Overall Study|Adverse Event|5|||
161347511|NCT02225587|582656306|FG001|Overall Study|Adverse Event|5|||
161347512|NCT02225587|582656305|FG000|Overall Study|Lost to Follow-up|5|||
161347513|NCT02225587|582656306|FG001|Overall Study|Lost to Follow-up|5|||
161347514|NCT02225587|582656305|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161347515|NCT02225587|582656306|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161347516|NCT02225587|582656305|FG000|Overall Study|Physician Decision|2|||
161347517|NCT02225587|582656306|FG001|Overall Study|Physician Decision|0|||
161347518|NCT02225587|582656305|FG000|Overall Study|Protocol Violation|1|||
161347519|NCT02225587|582656306|FG001|Overall Study|Protocol Violation|0|||
161347520|NCT02225587|582656305|FG000|Overall Study|Participant Moved|1|||
161347521|NCT02225587|582656306|FG001|Overall Study|Participant Moved|0|||
161347522|NCT02225587|582656305|FG000|Overall Study|Withdrawal by Subject|13|||
161347523|NCT02225587|582656306|FG001|Overall Study|Withdrawal by Subject|28|||
161347524|NCT03483584|582656309|FG000|Overall Study|Lost to Follow-up|40|||
161347525|NCT03483584|582656310|FG001|Overall Study|Lost to Follow-up|7|||
161347526|NCT03483584|582656309|FG000|Overall Study|Withdrawal by Subject|4|||
161347527|NCT03483584|582656310|FG001|Overall Study|Withdrawal by Subject|1|||
161347528|NCT02879695|582656311|FG000|Overall Study|Did not start study treatment|2|||
161347529|NCT02879695|582656312|FG001|Overall Study|Did not start study treatment|0|||
161292861|NCT00320710|582452202|FG001|Overall Study|Adverse Event|14|||
161292862|NCT00320710|582452203|FG002|Overall Study|Adverse Event|1|||
161292863|NCT00320710|582452201|FG000|Overall Study|Lost to Follow-up|1|||
161087198|NCT01506609|581706779|FG005|Overall Study|Other, Not Specified|3|||
161292864|NCT00320710|582452202|FG001|Overall Study|Lost to Follow-up|0|||
161292865|NCT00320710|582452203|FG002|Overall Study|Lost to Follow-up|0|||
161292866|NCT03866512|582452204|FG000|Overall Study|Lost to Follow-up|1|||
161292867|NCT03866512|582452205|FG001|Overall Study|Lost to Follow-up|2|||
161292868|NCT03866512|582452206|FG002|Overall Study|Lost to Follow-up|1|||
161292869|NCT03866512|582452204|FG000|Overall Study|Cannulation issues|0|||
161292870|NCT03866512|582452205|FG001|Overall Study|Cannulation issues|1|||
161292871|NCT03866512|582452206|FG002|Overall Study|Cannulation issues|2|||
161292872|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
161292873|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161292874|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161292875|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161292876|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
161292877|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161292878|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161292879|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
161292880|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
161292881|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161292882|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161292883|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
161292884|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
161292885|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161292886|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161292887|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161292888|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
161292889|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161292890|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161292891|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161292892|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
161292893|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161292894|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161292895|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161292896|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
161292897|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161292898|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161292899|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
161292900|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
161292901|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161292902|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161292903|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
161292904|NCT00506415|582452212|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
161292905|NCT00506415|582452213|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161292906|NCT00506415|582452214|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161292907|NCT00506415|582452215|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161292908|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
161292909|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
161292910|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
161292911|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
161292912|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
161292913|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
161292914|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
161292915|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
161292916|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
161292917|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
161292918|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
161292919|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
161292920|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
161292921|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
161292922|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
161292923|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
161292924|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
161292925|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
161292926|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
161292927|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
161292928|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
161292929|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
161292930|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
161292931|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
161292932|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
161292933|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
161292934|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
161292935|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
161292936|NCT00506415|582452212|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161292937|NCT00506415|582452213|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161292938|NCT00506415|582452214|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
161292939|NCT00506415|582452215|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
161292940|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161292941|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161292942|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
161292943|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
161292944|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161087199|NCT01506609|581706774|FG000|Overall Study|Missing / Unknown Reason|1|||
161087200|NCT01506609|581706775|FG001|Overall Study|Missing / Unknown Reason|0|||
161087201|NCT01506609|581706776|FG002|Overall Study|Missing / Unknown Reason|1|||
161292945|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161292946|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
161292947|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
161292948|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161292949|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161292950|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
161292951|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
161292952|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161292953|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161292954|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
161292955|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
161292956|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161292957|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161292958|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
161292959|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
161292960|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161292961|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161292962|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
161292963|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
161292964|NCT00506415|582452212|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161292965|NCT00506415|582452213|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161292966|NCT00506415|582452214|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
161292967|NCT00506415|582452215|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
161292968|NCT00832455|582452216|FG000|Overall Study|Adverse Event|13|||
161292969|NCT00832455|582452216|FG000|Overall Study|Lost to Follow-up|26|||
161292970|NCT00832455|582452216|FG000|Overall Study|Protocol Violation|4|||
161292971|NCT00832455|582452216|FG000|Overall Study|Withdrawal by Subject|17|||
161292972|NCT00832455|582452216|FG000|Overall Study|Screening Failure|2|||
161292973|NCT00832455|582452216|FG000|Overall Study|Stopped Medication|4|||
161292974|NCT00832455|582452216|FG000|Overall Study|Parent misunderstood study|1|||
161292975|NCT00832455|582452216|FG000|Overall Study|Parent dissatisfied|1|||
161292976|NCT00832455|582452216|FG000|Overall Study|No improvement|3|||
161292977|NCT00832455|582452216|FG000|Overall Study|Patient moved|1|||
161292978|NCT04578457|582452217|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
161292979|NCT04578457|582452217|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
161292980|NCT04578457|582452217|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
161292981|NCT04578457|582452217|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
161292982|NCT00997373|582452218|FG000|Overall Study|Withdrawal by Subject|5|||
161292983|NCT00997373|582452219|FG001|Overall Study|Withdrawal by Subject|0|||
161292984|NCT00997373|582452218|FG000|Overall Study|wrong tumor type|4|||
161292985|NCT00997373|582452219|FG001|Overall Study|wrong tumor type|0|||
161292986|NCT00997373|582452218|FG000|Overall Study|could not have hysterectomy|6|||
161292987|NCT00997373|582452219|FG001|Overall Study|could not have hysterectomy|0|||
161292988|NCT00739661|582452221|FG000|Overall Study|Adverse Event|2|||
161292989|NCT00739661|582452222|FG001|Overall Study|Adverse Event|0|||
161292990|NCT00739661|582452221|FG000|Overall Study|Physician decision to withdraw patient|1|||
161292991|NCT00739661|582452222|FG001|Overall Study|Physician decision to withdraw patient|0|||
161292992|NCT00739661|582452221|FG000|Overall Study|Patient decision to withdraw|9|||
161292993|NCT00739661|582452222|FG001|Overall Study|Patient decision to withdraw|4|||
161292994|NCT00739661|582452221|FG000|Overall Study|Disease progression, radiographic|33|||
161292995|NCT00739661|582452222|FG001|Overall Study|Disease progression, radiographic|37|||
161292996|NCT00739661|582452221|FG000|Overall Study|Reason for discontinuation not available|1|||
161292997|NCT00739661|582452222|FG001|Overall Study|Reason for discontinuation not available|1|||
161292998|NCT02883062|582452225|FG000|Overall Study|Withdrawal by Subject|6|||
161292999|NCT02883062|582452226|FG001|Overall Study|Withdrawal by Subject|0|||
161174107|NCT01696396|582015472|FG002|Overall Study|Withdrawal by Subject|19|||
161174108|NCT01696396|582015473|FG003|Overall Study|Withdrawal by Subject|11|||
161174109|NCT01696396|582015470|FG000|Overall Study|Decision by Sponsor|3|||
161174110|NCT01696396|582015471|FG001|Overall Study|Decision by Sponsor|1|||
161174111|NCT01696396|582015472|FG002|Overall Study|Decision by Sponsor|2|||
161174112|NCT01696396|582015473|FG003|Overall Study|Decision by Sponsor|2|||
161174113|NCT01696396|582015470|FG000|Overall Study|Lost to Follow-up|9|||
161174114|NCT01696396|582015471|FG001|Overall Study|Lost to Follow-up|1|||
161174115|NCT01696396|582015472|FG002|Overall Study|Lost to Follow-up|4|||
161174116|NCT01696396|582015473|FG003|Overall Study|Lost to Follow-up|1|||
161174117|NCT01696396|582015470|FG000|Overall Study|Death|0|||
161174118|NCT01696396|582015471|FG001|Overall Study|Death|0|||
161174119|NCT01696396|582015472|FG002|Overall Study|Death|1|||
161174120|NCT01696396|582015473|FG003|Overall Study|Death|0|||
161174121|NCT02371980|582015479|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
161174122|NCT02371980|582015480|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
161174123|NCT02371980|582015481|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
161174124|NCT02371980|582015482|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
161174125|NCT02371980|582015483|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
161174126|NCT02371980|582015479|FG000|Open-label Period|Significant Protocol Deviation|19|||
161174127|NCT02371980|582015480|FG001|Open-label Period|Significant Protocol Deviation|0|||
161174128|NCT02371980|582015481|FG002|Open-label Period|Significant Protocol Deviation|0|||
161174129|NCT02371980|582015482|FG003|Open-label Period|Significant Protocol Deviation|0|||
161174130|NCT02371980|582015483|FG004|Open-label Period|Significant Protocol Deviation|0|||
161174131|NCT02371980|582015479|FG000|Open-label Period|Noncompliance with Study Drug|10|||
161174132|NCT02371980|582015480|FG001|Open-label Period|Noncompliance with Study Drug|0|||
161174133|NCT02371980|582015481|FG002|Open-label Period|Noncompliance with Study Drug|0|||
161174134|NCT02371980|582015482|FG003|Open-label Period|Noncompliance with Study Drug|0|||
161174135|NCT02371980|582015483|FG004|Open-label Period|Noncompliance with Study Drug|0|||
161174136|NCT02371980|582015479|FG000|Open-label Period|Lost to Follow-up|55|||
161174137|NCT02371980|582015480|FG001|Open-label Period|Lost to Follow-up|0|||
161174138|NCT02371980|582015481|FG002|Open-label Period|Lost to Follow-up|0|||
161174139|NCT02371980|582015482|FG003|Open-label Period|Lost to Follow-up|0|||
161174140|NCT02371980|582015483|FG004|Open-label Period|Lost to Follow-up|0|||
161174141|NCT02371980|582015479|FG000|Open-label Period|Voluntary Withdrawal|91|||
161174142|NCT02371980|582015480|FG001|Open-label Period|Voluntary Withdrawal|0|||
161174143|NCT02371980|582015481|FG002|Open-label Period|Voluntary Withdrawal|0|||
161174144|NCT02371980|582015482|FG003|Open-label Period|Voluntary Withdrawal|0|||
161174145|NCT02371980|582015483|FG004|Open-label Period|Voluntary Withdrawal|0|||
161174146|NCT02371980|582015479|FG000|Open-label Period|Pregnancy|1|||
161174147|NCT02371980|582015480|FG001|Open-label Period|Pregnancy|0|||
161174148|NCT02371980|582015481|FG002|Open-label Period|Pregnancy|0|||
161174149|NCT02371980|582015482|FG003|Open-label Period|Pregnancy|0|||
161174150|NCT02371980|582015483|FG004|Open-label Period|Pregnancy|0|||
161174151|NCT02371980|582015479|FG000|Open-label Period|Lack of Efficacy|116|||
161174152|NCT02371980|582015480|FG001|Open-label Period|Lack of Efficacy|0|||
161174153|NCT02371980|582015481|FG002|Open-label Period|Lack of Efficacy|0|||
161174154|NCT02371980|582015482|FG003|Open-label Period|Lack of Efficacy|0|||
161174155|NCT02371980|582015483|FG004|Open-label Period|Lack of Efficacy|0|||
161174156|NCT02371980|582015479|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
161174157|NCT02371980|582015480|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
161174158|NCT02371980|582015481|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
161174159|NCT02371980|582015482|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
161174160|NCT02371980|582015483|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
161174161|NCT02371980|582015479|FG000|Open-label Period|Reason not Specified|9|||
161174162|NCT02371980|582015480|FG001|Open-label Period|Reason not Specified|0|||
161174163|NCT02371980|582015481|FG002|Open-label Period|Reason not Specified|0|||
161174164|NCT02371980|582015482|FG003|Open-label Period|Reason not Specified|0|||
161174165|NCT02371980|582015483|FG004|Open-label Period|Reason not Specified|0|||
161174166|NCT02371980|582015479|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
161293000|NCT00380874|582452227|FG000|Overall Study|Adverse Event|7|||
161293001|NCT00380874|582452228|FG001|Overall Study|Adverse Event|7|||
161293002|NCT00380874|582452227|FG000|Overall Study|Death|1|||
161293003|NCT00380874|582452228|FG001|Overall Study|Death|0|||
161174167|NCT02371980|582015480|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
161174168|NCT02371980|582015481|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
161174169|NCT02371980|582015482|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
161174170|NCT02371980|582015483|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
161174171|NCT02371980|582015479|FG000|Double-blind Period|Significant Protocol Deviation|0|||
161174172|NCT02371980|582015480|FG001|Double-blind Period|Significant Protocol Deviation|2|||
161293004|NCT00380874|582452227|FG000|Overall Study|Withdrawal by Subject|2|||
161293005|NCT00380874|582452228|FG001|Overall Study|Withdrawal by Subject|1|||
161293006|NCT00380874|582452227|FG000|Overall Study|Not related to study drug|3|||
161174173|NCT02371980|582015481|FG002|Double-blind Period|Significant Protocol Deviation|7|||
161293007|NCT00380874|582452228|FG001|Overall Study|Not related to study drug|2|||
161293008|NCT03839628|582452229|FG000|Overall Study|Withdrawal by Subject|1|||
161293009|NCT03380429|582452230|FG000|Overall Study|Physician Decision|0|||
161293010|NCT03380429|582452231|FG001|Overall Study|Physician Decision|1|||
161293011|NCT03380429|582452232|FG002|Overall Study|Physician Decision|0|||
161293012|NCT03380429|582452233|FG003|Overall Study|Physician Decision|1|||
161293013|NCT03380429|582452234|FG004|Overall Study|Physician Decision|1|||
161293014|NCT03380429|582452230|FG000|Overall Study|Withdrawal by Subject|3|||
161293015|NCT03380429|582452231|FG001|Overall Study|Withdrawal by Subject|3|||
161293016|NCT03380429|582452232|FG002|Overall Study|Withdrawal by Subject|5|||
161293017|NCT03380429|582452233|FG003|Overall Study|Withdrawal by Subject|2|||
161293018|NCT03380429|582452234|FG004|Overall Study|Withdrawal by Subject|1|||
161293019|NCT03380429|582452230|FG000|Overall Study|Lost to Follow-up|0|||
161293020|NCT03380429|582452231|FG001|Overall Study|Lost to Follow-up|2|||
161293021|NCT03380429|582452232|FG002|Overall Study|Lost to Follow-up|4|||
161293022|NCT03380429|582452233|FG003|Overall Study|Lost to Follow-up|3|||
161293023|NCT03380429|582452234|FG004|Overall Study|Lost to Follow-up|1|||
161293024|NCT03380429|582452230|FG000|Overall Study|Protocol Violation|1|||
161293025|NCT03380429|582452231|FG001|Overall Study|Protocol Violation|0|||
161293026|NCT03380429|582452232|FG002|Overall Study|Protocol Violation|1|||
161293027|NCT03380429|582452233|FG003|Overall Study|Protocol Violation|0|||
161293028|NCT03380429|582452234|FG004|Overall Study|Protocol Violation|1|||
161293029|NCT03380429|582452230|FG000|Overall Study|Lack of Efficacy|0|||
161293030|NCT03380429|582452231|FG001|Overall Study|Lack of Efficacy|0|||
161293031|NCT03380429|582452232|FG002|Overall Study|Lack of Efficacy|0|||
161293032|NCT03380429|582452233|FG003|Overall Study|Lack of Efficacy|2|||
161293033|NCT03380429|582452234|FG004|Overall Study|Lack of Efficacy|1|||
161293034|NCT03380429|582452230|FG000|Overall Study|Adverse Event|1|||
161293035|NCT03380429|582452231|FG001|Overall Study|Adverse Event|1|||
161293036|NCT03380429|582452232|FG002|Overall Study|Adverse Event|1|||
161293037|NCT03380429|582452233|FG003|Overall Study|Adverse Event|2|||
161293038|NCT03380429|582452234|FG004|Overall Study|Adverse Event|0|||
161293039|NCT01707290|582452239|FG000|Overall Study|Adverse event (AE)|1|||
161293040|NCT01707290|582452240|FG001|Overall Study|Adverse event (AE)|0|||
161293041|NCT01707290|582452239|FG000|Overall Study|Physician Decision|1|||
161293042|NCT01707290|582452240|FG001|Overall Study|Physician Decision|0|||
161293043|NCT01707290|582452239|FG000|Overall Study|Lost to Follow-up|3|||
161293044|NCT01707290|582452240|FG001|Overall Study|Lost to Follow-up|0|||
161293045|NCT01707290|582452239|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
161293046|NCT01707290|582452240|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
161293047|NCT01707290|582452239|FG000|Overall Study|Commercial drug available|60|||
161293048|NCT01707290|582452240|FG001|Overall Study|Commercial drug available|1|||
161293049|NCT01707290|582452239|FG000|Overall Study|Other unspecified|17|||
161293050|NCT01707290|582452240|FG001|Overall Study|Other unspecified|0|||
161293051|NCT02314026|582452241|FG000|Overall Study|Protocol Violation|28|||
161293052|NCT01139775|582452242|FG000|Overall Study|Adverse Event|0|||
161293053|NCT01139775|582452243|FG001|Overall Study|Adverse Event|6|||
161293054|NCT01139775|582452244|FG002|Overall Study|Adverse Event|2|||
161293055|NCT01139775|582452242|FG000|Overall Study|Protocol Violation|0|||
161293056|NCT01139775|582452243|FG001|Overall Study|Protocol Violation|5|||
161293057|NCT01139775|582452244|FG002|Overall Study|Protocol Violation|0|||
161293058|NCT01139775|582452242|FG000|Overall Study|Withdrawal by Subject|1|||
161293059|NCT01139775|582452243|FG001|Overall Study|Withdrawal by Subject|0|||
161293060|NCT01139775|582452244|FG002|Overall Study|Withdrawal by Subject|2|||
161293061|NCT01139775|582452242|FG000|Overall Study|Physician Decision|0|||
161293062|NCT01139775|582452243|FG001|Overall Study|Physician Decision|2|||
161293063|NCT01139775|582452244|FG002|Overall Study|Physician Decision|2|||
161293064|NCT01882985|582452247|FG000|Overall Study|Lost to Follow-up|1|||
161293065|NCT01882985|582452247|FG000|Overall Study|Withdrawal by Subject|1|||
161293066|NCT03193853|582452254|FG000|Overall Study|Death|6|||
161293067|NCT04129125|582452255|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
161293068|NCT04129125|582452255|FG000|Overall Study|Study device was not used|3|||
161293069|NCT01320293|582452263|FG000|Overall Study|Lack of Efficacy|1|||
161293070|NCT01320293|582452263|FG000|Overall Study|Adverse Event|1|||
161293071|NCT01532934|582452266|FG000|Overall Study|Lost to Follow-up|11|||
161293072|NCT01532934|582452267|FG001|Overall Study|Lost to Follow-up|11|||
161293073|NCT01532934|582452266|FG000|Overall Study|In controlled environment|3|||
161293074|NCT01532934|582452267|FG001|Overall Study|In controlled environment|2|||
161293075|NCT01147068|582452268|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
161293076|NCT01147068|582452269|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161293077|NCT01147068|582452270|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161293078|NCT01147068|582452271|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161293079|NCT01147068|582452272|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161293080|NCT01147068|582452273|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
161293081|NCT01147068|582452274|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
161293082|NCT01147068|582452268|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
161293083|NCT01147068|582452269|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
161174174|NCT02371980|582015482|FG003|Double-blind Period|Significant Protocol Deviation|3|||
161174175|NCT02371980|582015483|FG004|Double-blind Period|Significant Protocol Deviation|3|||
161174176|NCT02371980|582015479|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
161174177|NCT02371980|582015480|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
161174178|NCT02371980|582015481|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
161174179|NCT02371980|582015482|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
161174180|NCT02371980|582015483|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
161174181|NCT02371980|582015479|FG000|Double-blind Period|Lost to Follow-up|0|||
161174182|NCT02371980|582015480|FG001|Double-blind Period|Lost to Follow-up|8|||
161174183|NCT02371980|582015481|FG002|Double-blind Period|Lost to Follow-up|8|||
161174184|NCT02371980|582015482|FG003|Double-blind Period|Lost to Follow-up|6|||
161174185|NCT02371980|582015483|FG004|Double-blind Period|Lost to Follow-up|5|||
161174186|NCT02371980|582015479|FG000|Double-blind Period|Voluntary Withdrawal|0|||
161174187|NCT02371980|582015480|FG001|Double-blind Period|Voluntary Withdrawal|12|||
161174188|NCT02371980|582015481|FG002|Double-blind Period|Voluntary Withdrawal|8|||
161174189|NCT02371980|582015482|FG003|Double-blind Period|Voluntary Withdrawal|9|||
161174190|NCT02371980|582015483|FG004|Double-blind Period|Voluntary Withdrawal|11|||
161174191|NCT02371980|582015479|FG000|Double-blind Period|Relapse|0|||
161174192|NCT02371980|582015480|FG001|Double-blind Period|Relapse|50|||
161174193|NCT02371980|582015481|FG002|Double-blind Period|Relapse|25|||
161174194|NCT02371980|582015482|FG003|Double-blind Period|Relapse|25|||
161174195|NCT02371980|582015483|FG004|Double-blind Period|Relapse|26|||
161174196|NCT02371980|582015479|FG000|Double-blind Period|Reason not Specified|0|||
161174197|NCT02371980|582015480|FG001|Double-blind Period|Reason not Specified|3|||
161174198|NCT02371980|582015481|FG002|Double-blind Period|Reason not Specified|3|||
161174199|NCT02371980|582015482|FG003|Double-blind Period|Reason not Specified|2|||
161174200|NCT02371980|582015483|FG004|Double-blind Period|Reason not Specified|1|||
161174201|NCT02371980|582015479|FG000|Double-blind Period|Missing|0|||
161174202|NCT02371980|582015480|FG001|Double-blind Period|Missing|1|||
161174203|NCT02371980|582015481|FG002|Double-blind Period|Missing|0|||
161174204|NCT02371980|582015482|FG003|Double-blind Period|Missing|0|||
161174205|NCT02371980|582015483|FG004|Double-blind Period|Missing|0|||
161174206|NCT01280812|582015485|FG000|Overall Study|Withdrawal by Subject|2|||
161174207|NCT01280812|582015486|FG001|Overall Study|Withdrawal by Subject|1|||
161174208|NCT01280812|582015487|FG002|Overall Study|Withdrawal by Subject|0|||
161174209|NCT01280812|582015485|FG000|Overall Study|Lost to Follow-up|1|||
161174210|NCT01280812|582015486|FG001|Overall Study|Lost to Follow-up|1|||
161174211|NCT01280812|582015487|FG002|Overall Study|Lost to Follow-up|1|||
161174212|NCT00959894|582015493|FG000|Overall Study|Lost to Follow-up|10|||
161174213|NCT00959894|582015493|FG000|Overall Study|Adverse Event|3|||
161174214|NCT00959894|582015493|FG000|Overall Study|Withdrawal by Subject|1|||
161174215|NCT00959894|582015493|FG000|Overall Study|Need for contraindicated medication|1|||
161174216|NCT00959894|582015493|FG000|Overall Study|Subject moved out of town|1|||
161174217|NCT00922974|582015494|FG000|Phase II Component|Protocol Violation|2|||
161174218|NCT00922974|582015495|FG001|Phase II Component|Protocol Violation|0|||
161174219|NCT00922974|582015494|FG000|Phase II Component|Not evaluable for treatment review|5|||
161174220|NCT00922974|582015495|FG001|Phase II Component|Not evaluable for treatment review|0|||
161174221|NCT00922974|582015494|FG000|Phase III Component|Protocol Violation|8|||
161174222|NCT00922974|582015495|FG001|Phase III Component|Protocol Violation|6|||
161174223|NCT03682055|582015496|FG000|Overall Study|Lack of Efficacy|1|||
161174224|NCT03682055|582015497|FG001|Overall Study|Lack of Efficacy|2|||
161174225|NCT03682055|582015498|FG002|Overall Study|Lack of Efficacy|1|||
161174226|NCT03682055|582015499|FG003|Overall Study|Lack of Efficacy|2|||
161174227|NCT03682055|582015500|FG004|Overall Study|Lack of Efficacy|1|||
161174228|NCT03682055|582015501|FG005|Overall Study|Lack of Efficacy|3|||
161174229|NCT03682055|582015496|FG000|Overall Study|Withdrawal by Subject|0|||
161174230|NCT03682055|582015497|FG001|Overall Study|Withdrawal by Subject|0|||
161174231|NCT03682055|582015498|FG002|Overall Study|Withdrawal by Subject|0|||
161174232|NCT03682055|582015499|FG003|Overall Study|Withdrawal by Subject|0|||
161174233|NCT03682055|582015500|FG004|Overall Study|Withdrawal by Subject|0|||
161174234|NCT03682055|582015501|FG005|Overall Study|Withdrawal by Subject|1|||
161174235|NCT03682055|582015496|FG000|Overall Study|Termination of Study by Sponsor|0|||
161293084|NCT01147068|582452270|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
161293085|NCT01147068|582452271|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
161293086|NCT01147068|582452272|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
161293087|NCT01147068|582452273|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
161293088|NCT01147068|582452274|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
161174236|NCT03682055|582015497|FG001|Overall Study|Termination of Study by Sponsor|0|||
161174237|NCT03682055|582015498|FG002|Overall Study|Termination of Study by Sponsor|0|||
161174238|NCT03682055|582015499|FG003|Overall Study|Termination of Study by Sponsor|0|||
161174239|NCT03682055|582015500|FG004|Overall Study|Termination of Study by Sponsor|0|||
161174240|NCT03682055|582015501|FG005|Overall Study|Termination of Study by Sponsor|3|||
161174241|NCT00191386|582015502|FG000|Overall Study|Adverse Event|16|||
161174242|NCT00191386|582015502|FG000|Overall Study|Lost to Follow-up|1|||
161293089|NCT01147068|582452268|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
161347530|NCT02879695|582656313|FG002|Overall Study|Did not start study treatment|3|||
161347531|NCT02879695|582656314|FG003|Overall Study|Did not start study treatment|0|||
161347532|NCT04063163|582656315|FG000|Overall Study|Death|281|||
161347533|NCT04063163|582656316|FG001|Overall Study|Death|166|||
161347534|NCT04063163|582656315|FG000|Overall Study|Lost to Follow-up|12|||
161347535|NCT04063163|582656316|FG001|Overall Study|Lost to Follow-up|8|||
161347536|NCT04063163|582656315|FG000|Overall Study|Withdrawal by Subject|19|||
161347537|NCT04063163|582656316|FG001|Overall Study|Withdrawal by Subject|10|||
161347538|NCT02572167|582656317|FG000|Overall Study|Withdrawal by Subject|0|||
161347539|NCT02572167|582656318|FG001|Overall Study|Withdrawal by Subject|3|||
161347540|NCT02572167|582656319|FG002|Overall Study|Withdrawal by Subject|0|||
161347541|NCT02572167|582656317|FG000|Overall Study|Lost to Follow-up|2|||
161347542|NCT02572167|582656318|FG001|Overall Study|Lost to Follow-up|5|||
161347543|NCT02572167|582656319|FG002|Overall Study|Lost to Follow-up|3|||
161347544|NCT02572167|582656317|FG000|Overall Study|Death|0|||
161347545|NCT02572167|582656318|FG001|Overall Study|Death|8|||
161347546|NCT02572167|582656319|FG002|Overall Study|Death|3|||
161347547|NCT02572167|582656317|FG000|Overall Study|Did not meet inclusion criteria|0|||
161347548|NCT02572167|582656318|FG001|Overall Study|Did not meet inclusion criteria|0|||
161347549|NCT02572167|582656319|FG002|Overall Study|Did not meet inclusion criteria|1|||
161347550|NCT02572167|582656317|FG000|Overall Study|Study closure by Sponsor|4|||
161087202|NCT01506609|581706777|FG003|Overall Study|Missing / Unknown Reason|4|||
161293090|NCT01147068|582452269|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
161293091|NCT01147068|582452270|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
161293092|NCT01147068|582452271|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
161293093|NCT01147068|582452272|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
161293094|NCT01147068|582452273|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
161293095|NCT01147068|582452274|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
161293096|NCT01147068|582452268|FG000|Subjects That Received 2nd Dose|Other|0|||
161293097|NCT01147068|582452269|FG001|Subjects That Received 2nd Dose|Other|3|||
161293098|NCT01147068|582452270|FG002|Subjects That Received 2nd Dose|Other|3|||
161293099|NCT01147068|582452271|FG003|Subjects That Received 2nd Dose|Other|0|||
161293100|NCT01147068|582452272|FG004|Subjects That Received 2nd Dose|Other|1|||
161293101|NCT01147068|582452273|FG005|Subjects That Received 2nd Dose|Other|0|||
161293102|NCT01147068|582452274|FG006|Subjects That Received 2nd Dose|Other|0|||
161347551|NCT02572167|582656318|FG001|Overall Study|Study closure by Sponsor|40|||
161347552|NCT02572167|582656319|FG002|Overall Study|Study closure by Sponsor|24|||
161087203|NCT01506609|581706778|FG004|Overall Study|Missing / Unknown Reason|4|||
161087204|NCT01506609|581706779|FG005|Overall Study|Missing / Unknown Reason|2|||
161087205|NCT00577473|581706784|FG000|Overall Study|Protocol Violation|1|||
161087206|NCT00577473|581706785|FG001|Overall Study|Protocol Violation|4|||
161087207|NCT00577473|581706784|FG000|Overall Study|Adverse Event|8|||
161087208|NCT00577473|581706785|FG001|Overall Study|Adverse Event|5|||
161087209|NCT00577473|581706784|FG000|Overall Study|Withdrawal by Subject|2|||
161087210|NCT00577473|581706785|FG001|Overall Study|Withdrawal by Subject|6|||
161087211|NCT00577473|581706784|FG000|Overall Study|Physician Decision|2|||
161087212|NCT00577473|581706785|FG001|Overall Study|Physician Decision|2|||
161087213|NCT00577473|581706784|FG000|Overall Study|Lack of Efficacy|8|||
161087214|NCT00577473|581706785|FG001|Overall Study|Lack of Efficacy|7|||
161087215|NCT02595073|581706788|FG000|Overall Study|Progressive Disease|0|||
161087216|NCT02595073|581706789|FG001|Overall Study|Progressive Disease|1|||
161087217|NCT02595073|581706788|FG000|Overall Study|Protocol Violation|2|||
161087218|NCT02595073|581706789|FG001|Overall Study|Protocol Violation|0|||
161087219|NCT01990560|581706792|FG000|Overall Study|Withdrawal by Subject|1|||
161087220|NCT02884908|581706798|FG000|Overall Study|Lost to Follow-up|13|||
161087221|NCT02884908|581706799|FG001|Overall Study|Lost to Follow-up|18|||
161087222|NCT01324440|581706800|FG000|Overall Study|Subject moved|0|||
161087223|NCT01324440|581706801|FG001|Overall Study|Subject moved|1|||
161087224|NCT01293487|581706805|FG000|Overall Study|Lost to Follow-up|0|||
161087225|NCT01293487|581706806|FG001|Overall Study|Lost to Follow-up|0|||
161087226|NCT01293487|581706807|FG002|Overall Study|Lost to Follow-up|0|||
161087227|NCT01293487|581706808|FG003|Overall Study|Lost to Follow-up|1|||
161087228|NCT01293487|581706809|FG004|Overall Study|Lost to Follow-up|0|||
161087229|NCT01293487|581706810|FG005|Overall Study|Lost to Follow-up|0|||
161087230|NCT01293487|581706811|FG006|Overall Study|Lost to Follow-up|0|||
161087231|NCT01293487|581706812|FG007|Overall Study|Lost to Follow-up|0|||
161087232|NCT01293487|581706805|FG000|Overall Study|Withdrawal by Subject|0|||
161087233|NCT01293487|581706806|FG001|Overall Study|Withdrawal by Subject|0|||
161347553|NCT00005047|582656320|FG000|Overall Study|Withdrawal by Subject|12|||
161347554|NCT00005047|582656321|FG001|Overall Study|Withdrawal by Subject|0|||
161347555|NCT00005047|582656322|FG002|Overall Study|Withdrawal by Subject|0|||
161347556|NCT00005047|582656323|FG003|Overall Study|Withdrawal by Subject|0|||
161347557|NCT00005047|582656320|FG000|Overall Study|Adverse Event|5|||
161087234|NCT01293487|581706807|FG002|Overall Study|Withdrawal by Subject|0|||
161087235|NCT01293487|581706808|FG003|Overall Study|Withdrawal by Subject|0|||
161087236|NCT01293487|581706809|FG004|Overall Study|Withdrawal by Subject|0|||
161293103|NCT01147068|582452268|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161293104|NCT01147068|582452269|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161293105|NCT01147068|582452270|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161293106|NCT01147068|582452271|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161293107|NCT01147068|582452272|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
161293108|NCT01147068|582452273|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161293109|NCT01147068|582452274|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
161293110|NCT01147068|582452268|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161293111|NCT01147068|582452269|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161293112|NCT01147068|582452270|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161293113|NCT01147068|582452271|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
161293114|NCT01147068|582452272|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161293115|NCT01147068|582452273|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161293116|NCT01147068|582452274|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
161293117|NCT01147068|582452268|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
161293118|NCT01147068|582452269|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
161293119|NCT01147068|582452270|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
161293120|NCT01147068|582452271|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
161293121|NCT01147068|582452272|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
161293122|NCT01147068|582452273|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
161293123|NCT01147068|582452274|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
161293124|NCT02962648|582452276|FG000|Overall Study|Withdrawal by Subject|3|||
161293125|NCT02962648|582452276|FG000|Overall Study|Lost to Follow-up|3|||
161293126|NCT02962648|582452276|FG000|Overall Study|Physician Decision|1|||
161293127|NCT02962648|582452276|FG000|Overall Study|Subject had problems with transportation|2|||
161293128|NCT02362360|582452283|FG000|Period 1|Lack of Efficacy|1|||
161293129|NCT02362360|582452284|FG001|Period 1|Lack of Efficacy|0|||
161293130|NCT02362360|582452283|FG000|Period 1|Withdrawal by Subject|2|||
161293131|NCT02362360|582452284|FG001|Period 1|Withdrawal by Subject|1|||
161293132|NCT03817190|582452285|FG000|Overall Study|Early Termination|13|||
161293133|NCT03817190|582452286|FG001|Overall Study|Early Termination|20|||
161293134|NCT03817190|582452285|FG000|Overall Study|Adverse Event|10|||
161293135|NCT03817190|582452286|FG001|Overall Study|Adverse Event|17|||
161293136|NCT03817190|582452285|FG000|Overall Study|Withdrawal by Subject|12|||
161293137|NCT03817190|582452286|FG001|Overall Study|Withdrawal by Subject|8|||
161293138|NCT03817190|582452285|FG000|Overall Study|Lost to Follow-up|11|||
161293139|NCT03817190|582452286|FG001|Overall Study|Lost to Follow-up|7|||
161293140|NCT03817190|582452285|FG000|Overall Study|Lack of Efficacy|7|||
161293141|NCT03817190|582452286|FG001|Overall Study|Lack of Efficacy|5|||
161293142|NCT03817190|582452285|FG000|Overall Study|Investigator Decision|5|||
161293143|NCT03817190|582452286|FG001|Overall Study|Investigator Decision|1|||
161293144|NCT03817190|582452285|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
161293145|NCT03817190|582452286|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
161293146|NCT03817190|582452285|FG000|Overall Study|Lack of Contact|1|||
161293147|NCT03817190|582452286|FG001|Overall Study|Lack of Contact|0|||
161293148|NCT03817190|582452285|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
161293149|NCT03817190|582452286|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
161293150|NCT04146012|582452287|FG000|Overall Study|Study Terminated|30|||
161293151|NCT04146012|582452288|FG001|Overall Study|Study Terminated|15|||
161293152|NCT01546025|582452289|FG000|Overall Study|Lost to Follow-up|0|||
161293153|NCT01546025|582452290|FG001|Overall Study|Lost to Follow-up|1|||
161293154|NCT04955691|582453895|FG000|Period 2|Discontinued intervention|1|||
161293155|NCT04955691|582453896|FG001|Period 2|Discontinued intervention|2|||
161293156|NCT03769168|582453897|FG000|Overall Study|Adverse Event|0|||
161293157|NCT03769168|582453898|FG001|Overall Study|Adverse Event|1|||
161293158|NCT03769168|582453897|FG000|Overall Study|Lack of Efficacy|2|||
161293159|NCT03769168|582453898|FG001|Overall Study|Lack of Efficacy|4|||
161174243|NCT00191386|582015502|FG000|Overall Study|Entry Criteria Exclusion|3|||
161174244|NCT00191386|582015502|FG000|Overall Study|Protocol Violation|18|||
161293160|NCT03769168|582453897|FG000|Overall Study|Post study access to treatment|3|||
161293161|NCT03769168|582453898|FG001|Overall Study|Post study access to treatment|11|||
161293162|NCT03769168|582453897|FG000|Overall Study|Physician Decision|1|||
161293163|NCT03769168|582453898|FG001|Overall Study|Physician Decision|4|||
161293164|NCT03769168|582453897|FG000|Overall Study|Subject Decision|2|||
161293165|NCT03769168|582453898|FG001|Overall Study|Subject Decision|4|||
161293166|NCT03769168|582453897|FG000|Overall Study|Guardian decision|1|||
161293167|NCT03769168|582453898|FG001|Overall Study|Guardian decision|0|||
161293168|NCT05142722|582453899|FG000|Overall Study|Lost to Follow-up|16|||
161293169|NCT05142722|582453900|FG001|Overall Study|Lost to Follow-up|38|||
161293170|NCT05142722|582453899|FG000|Overall Study|Withdrawal by Subject|20|||
161293171|NCT05142722|582453900|FG001|Overall Study|Withdrawal by Subject|27|||
161293172|NCT05142722|582453899|FG000|Overall Study|Death|11|||
161293173|NCT05142722|582453900|FG001|Overall Study|Death|17|||
161293174|NCT05142722|582453899|FG000|Overall Study|Physician Decision|0|||
161293175|NCT05142722|582453900|FG001|Overall Study|Physician Decision|1|||
161293176|NCT05142722|582453899|FG000|Overall Study|Participant Moved Away|0|||
161293177|NCT05142722|582453900|FG001|Overall Study|Participant Moved Away|2|||
161293178|NCT05142722|582453899|FG000|Overall Study|Adverse Event|2|||
161293179|NCT05142722|582453900|FG001|Overall Study|Adverse Event|1|||
161293180|NCT05086744|582453901|FG000|Part A|Adverse Event|0|||
161293181|NCT05086744|582453902|FG001|Part A|Adverse Event|1|||
161293182|NCT05086744|582453901|FG000|Part A|Lack of Efficacy|3|||
161293183|NCT05086744|582453902|FG001|Part A|Lack of Efficacy|0|||
161293184|NCT05086744|582453901|FG000|Part A|Protocol deviation|1|||
161293185|NCT05086744|582453902|FG001|Part A|Protocol deviation|0|||
161293186|NCT05086744|582453901|FG000|Part A|Subject decision|1|||
161293187|NCT05086744|582453902|FG001|Part A|Subject decision|0|||
161293188|NCT05086744|582453901|FG000|Part B|Adverse Event|0|||
161293189|NCT05086744|582453902|FG001|Part B|Adverse Event|1|||
161293190|NCT05086744|582453901|FG000|Part B|Lack of Efficacy|0|||
161293191|NCT05086744|582453902|FG001|Part B|Lack of Efficacy|1|||
161293192|NCT05086744|582453901|FG000|Part B|Study terminated by sponsor|1|||
161293193|NCT05086744|582453902|FG001|Part B|Study terminated by sponsor|6|||
161293194|NCT04053868|582453905|FG000|Overall Study|Withdrawal by Subject|1|||
161293195|NCT04053868|582453906|FG001|Overall Study|Withdrawal by Subject|0|||
161293196|NCT05731700|582453907|FG000|Overall Study|Death|1|||
161293197|NCT01068678|582453910|FG000|Overall Study|Lack of Efficacy|3|||
161293198|NCT01068678|582453911|FG001|Overall Study|Lack of Efficacy|2|||
161293199|NCT01068678|582453910|FG000|Overall Study|Protocol Violation|5|||
161293200|NCT01068678|582453911|FG001|Overall Study|Protocol Violation|1|||
161293201|NCT01068678|582453910|FG000|Overall Study|Withdrawal criteria|12|||
161293202|NCT01068678|582453911|FG001|Overall Study|Withdrawal criteria|6|||
161293203|NCT01068678|582453910|FG000|Overall Study|Unclassified|18|||
161293204|NCT01068678|582453911|FG001|Overall Study|Unclassified|15|||
161293205|NCT00536939|582453912|FG000|Overall Study|Withdrawal by Subject|1|||
161293206|NCT00536939|582453913|FG001|Overall Study|Withdrawal by Subject|0|||
161293207|NCT00536939|582453912|FG000|Overall Study|Other Complicating Disease|1|||
161293208|NCT00536939|582453913|FG001|Overall Study|Other Complicating Disease|0|||
161293209|NCT04225715|582453914|FG000|Overall Study|Reason not Specified|1|||
161293210|NCT04225715|582453915|FG001|Overall Study|Reason not Specified|0|||
161293211|NCT04225715|582453916|FG002|Overall Study|Reason not Specified|0|||
161293212|NCT04225715|582453917|FG003|Overall Study|Reason not Specified|0|||
161293213|NCT04225715|582453918|FG004|Overall Study|Reason not Specified|0|||
161293214|NCT04225715|582453919|FG005|Overall Study|Reason not Specified|0|||
161293215|NCT04225715|582453920|FG006|Overall Study|Reason not Specified|0|||
161293216|NCT04225715|582453921|FG007|Overall Study|Reason not Specified|0|||
161293217|NCT04225715|582453922|FG008|Overall Study|Reason not Specified|0|||
161293218|NCT04225715|582453914|FG000|Overall Study|Protocol Violation|1|||
161293219|NCT04225715|582453915|FG001|Overall Study|Protocol Violation|0|||
161293220|NCT04225715|582453916|FG002|Overall Study|Protocol Violation|0|||
161293221|NCT04225715|582453917|FG003|Overall Study|Protocol Violation|0|||
161293222|NCT04225715|582453918|FG004|Overall Study|Protocol Violation|0|||
161293223|NCT04225715|582453919|FG005|Overall Study|Protocol Violation|9|||
161293224|NCT04225715|582453920|FG006|Overall Study|Protocol Violation|0|||
161293225|NCT04225715|582453921|FG007|Overall Study|Protocol Violation|0|||
161293226|NCT04225715|582453922|FG008|Overall Study|Protocol Violation|0|||
161293227|NCT04225715|582453914|FG000|Overall Study|Withdrawal by Subject|4|||
161293228|NCT04225715|582453915|FG001|Overall Study|Withdrawal by Subject|1|||
161293229|NCT04225715|582453916|FG002|Overall Study|Withdrawal by Subject|1|||
161293230|NCT04225715|582453917|FG003|Overall Study|Withdrawal by Subject|0|||
161293231|NCT04225715|582453918|FG004|Overall Study|Withdrawal by Subject|3|||
161293232|NCT04225715|582453919|FG005|Overall Study|Withdrawal by Subject|1|||
161293233|NCT04225715|582453920|FG006|Overall Study|Withdrawal by Subject|1|||
161293234|NCT04225715|582453921|FG007|Overall Study|Withdrawal by Subject|1|||
161347558|NCT00005047|582656321|FG001|Overall Study|Adverse Event|0|||
161347559|NCT00005047|582656322|FG002|Overall Study|Adverse Event|0|||
161087237|NCT01293487|581706810|FG005|Overall Study|Withdrawal by Subject|0|||
161293235|NCT04225715|582453922|FG008|Overall Study|Withdrawal by Subject|0|||
161293236|NCT04225715|582453914|FG000|Overall Study|Adverse Event|0|||
161293237|NCT04225715|582453915|FG001|Overall Study|Adverse Event|0|||
161293238|NCT04225715|582453916|FG002|Overall Study|Adverse Event|0|||
161293239|NCT04225715|582453917|FG003|Overall Study|Adverse Event|0|||
161293240|NCT04225715|582453918|FG004|Overall Study|Adverse Event|0|||
161293241|NCT04225715|582453919|FG005|Overall Study|Adverse Event|0|||
161293242|NCT04225715|582453920|FG006|Overall Study|Adverse Event|0|||
161293243|NCT04225715|582453921|FG007|Overall Study|Adverse Event|0|||
161293244|NCT04225715|582453922|FG008|Overall Study|Adverse Event|1|||
161293245|NCT04225715|582453914|FG000|Overall Study|Arm Terminated By Sponsor|0|||
161087238|NCT01293487|581706811|FG006|Overall Study|Withdrawal by Subject|0|||
161293246|NCT04225715|582453915|FG001|Overall Study|Arm Terminated By Sponsor|0|||
161293247|NCT04225715|582453916|FG002|Overall Study|Arm Terminated By Sponsor|0|||
161347560|NCT00005047|582656323|FG003|Overall Study|Adverse Event|0|||
161293248|NCT04225715|582453917|FG003|Overall Study|Arm Terminated By Sponsor|0|||
161293249|NCT04225715|582453918|FG004|Overall Study|Arm Terminated By Sponsor|0|||
161293250|NCT04225715|582453919|FG005|Overall Study|Arm Terminated By Sponsor|0|||
161293251|NCT04225715|582453920|FG006|Overall Study|Arm Terminated By Sponsor|0|||
161293252|NCT04225715|582453921|FG007|Overall Study|Arm Terminated By Sponsor|17|||
161293253|NCT04225715|582453922|FG008|Overall Study|Arm Terminated By Sponsor|18|||
161293254|NCT02275546|582453925|FG000|Treatment Period 2|Withdrawal by Subject|2|||
161293255|NCT02275546|582453926|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161293256|NCT02275546|582453925|FG000|Treatment Period 2|Protocol Violation|0|||
161293257|NCT02275546|582453926|FG001|Treatment Period 2|Protocol Violation|1|||
161293258|NCT00570141|582453936|FG000|Overall Study|Adverse Event|1|||
161293259|NCT00570141|582453936|FG000|Overall Study|Missed visits|1|||
161293260|NCT00570141|582453936|FG000|Overall Study|Lost to Follow-up|1|||
161293261|NCT02309411|582453937|FG000|Overall Study|Physician Decision|1|||
161293262|NCT02309411|582453938|FG001|Overall Study|Physician Decision|0|||
161293263|NCT02309411|582453939|FG002|Overall Study|Physician Decision|0|||
161293264|NCT02309411|582453937|FG000|Overall Study|Withdrawal by Subject|1|||
161293265|NCT02309411|582453938|FG001|Overall Study|Withdrawal by Subject|1|||
161293266|NCT02309411|582453939|FG002|Overall Study|Withdrawal by Subject|0|||
161293267|NCT00925704|582453941|FG000|First Intervention|Withdrew consent|0|||
161293268|NCT00925704|582453942|FG001|First Intervention|Withdrew consent|0|||
161293269|NCT00925704|582453943|FG002|First Intervention|Withdrew consent|0|||
161293270|NCT00925704|582453944|FG003|First Intervention|Withdrew consent|1|||
161293271|NCT00925704|582453945|FG004|First Intervention|Withdrew consent|1|||
161293272|NCT00925704|582453946|FG005|First Intervention|Withdrew consent|0|||
161293273|NCT00925704|582453941|FG000|Second Intervention|Withdrawal by Subject|1|||
161293274|NCT00925704|582453942|FG001|Second Intervention|Withdrawal by Subject|0|||
161293275|NCT00925704|582453943|FG002|Second Intervention|Withdrawal by Subject|0|||
161293276|NCT00925704|582453944|FG003|Second Intervention|Withdrawal by Subject|0|||
161293277|NCT00925704|582453945|FG004|Second Intervention|Withdrawal by Subject|1|||
161293278|NCT00925704|582453946|FG005|Second Intervention|Withdrawal by Subject|0|||
161293279|NCT00925704|582453941|FG000|Third Intervention|Withdrew consent|0|||
161293280|NCT00925704|582453942|FG001|Third Intervention|Withdrew consent|0|||
161174245|NCT00191386|582015502|FG000|Overall Study|Withdrawal by Subject|96|||
161174246|NCT00191386|582015502|FG000|Overall Study|Physician Decision|11|||
161174247|NCT00191386|582015502|FG000|Overall Study|Lack of Efficacy|15|||
161174248|NCT03077243|582015504|FG000|Overall Study|Death|1|||
161174249|NCT03077243|582015505|FG001|Overall Study|Death|2|||
161174250|NCT03077243|582015506|FG002|Overall Study|Death|0|||
161174251|NCT03077243|582015507|FG003|Overall Study|Death|0|||
161174252|NCT03077243|582015504|FG000|Overall Study|Withdrawal by Subject|1|||
161174253|NCT03077243|582015505|FG001|Overall Study|Withdrawal by Subject|3|||
161174254|NCT03077243|582015506|FG002|Overall Study|Withdrawal by Subject|0|||
161174255|NCT03077243|582015507|FG003|Overall Study|Withdrawal by Subject|0|||
161174256|NCT03077243|582015504|FG000|Overall Study|Physician Decision|1|||
161174257|NCT03077243|582015505|FG001|Overall Study|Physician Decision|0|||
161174258|NCT03077243|582015506|FG002|Overall Study|Physician Decision|0|||
161174259|NCT03077243|582015507|FG003|Overall Study|Physician Decision|0|||
161174260|NCT03077243|582015504|FG000|Overall Study|Research at two study sites terminated early|0|||
161174261|NCT03077243|582015505|FG001|Overall Study|Research at two study sites terminated early|0|||
161174262|NCT03077243|582015506|FG002|Overall Study|Research at two study sites terminated early|0|||
161174263|NCT03077243|582015507|FG003|Overall Study|Research at two study sites terminated early|69|||
161174264|NCT01544478|582015508|FG000|Overall Study|Adverse Event|1|||
161174265|NCT01544478|582015508|FG000|Overall Study|Death|1|||
161174266|NCT01544478|582015508|FG000|Overall Study|Lost to Follow-up|48|||
161174267|NCT01544478|582015508|FG000|Overall Study|Physician Decision|15|||
161293281|NCT00925704|582453943|FG002|Third Intervention|Withdrew consent|0|||
161293282|NCT00925704|582453944|FG003|Third Intervention|Withdrew consent|0|||
161293283|NCT00925704|582453945|FG004|Third Intervention|Withdrew consent|0|||
161293284|NCT00925704|582453946|FG005|Third Intervention|Withdrew consent|1|||
161293285|NCT03922308|582453947|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
161293286|NCT03922308|582453948|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
161174268|NCT01544478|582015508|FG000|Overall Study|Pregnancy|1|||
161174269|NCT01544478|582015508|FG000|Overall Study|Withdrawal by Subject|52|||
161174270|NCT00212758|582015509|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
161293287|NCT03922308|582453949|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
161293288|NCT03922308|582453947|FG000|Overall Study|Lost to Follow-up|1|||
161293289|NCT03922308|582453948|FG001|Overall Study|Lost to Follow-up|0|||
161293290|NCT03922308|582453949|FG002|Overall Study|Lost to Follow-up|0|||
161174271|NCT00212758|582015510|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
161293291|NCT03922308|582453947|FG000|Overall Study|Reason not Specified|0|||
161293292|NCT03922308|582453948|FG001|Overall Study|Reason not Specified|2|||
161293293|NCT03922308|582453949|FG002|Overall Study|Reason not Specified|1|||
161174272|NCT00212758|582015509|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
161293294|NCT05005507|582453950|FG000|Overall Study|Premature termination of study|1|||
161293295|NCT02841995|582453951|FG000|Overall Study|Disease progression|5|||
161174273|NCT00212758|582015510|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
161174274|NCT02574481|582015511|FG000|Overall Study|Withdrawal by Subject|29|||
161174275|NCT02574481|582015512|FG001|Overall Study|Withdrawal by Subject|15|||
161174276|NCT02574481|582015513|FG002|Overall Study|Withdrawal by Subject|4|||
161174277|NCT02574481|582015514|FG003|Overall Study|Withdrawal by Subject|1|||
161174278|NCT02574481|582015511|FG000|Overall Study|Adverse Event|5|||
161174279|NCT02574481|582015512|FG001|Overall Study|Adverse Event|1|||
161174280|NCT02574481|582015513|FG002|Overall Study|Adverse Event|1|||
161174281|NCT02574481|582015514|FG003|Overall Study|Adverse Event|0|||
161174282|NCT02574481|582015511|FG000|Overall Study|Visit Missed|15|||
161174283|NCT02574481|582015512|FG001|Overall Study|Visit Missed|7|||
161174284|NCT02574481|582015513|FG002|Overall Study|Visit Missed|5|||
161174285|NCT02574481|582015514|FG003|Overall Study|Visit Missed|0|||
161174286|NCT02574481|582015511|FG000|Overall Study|Other|7|||
161174287|NCT02574481|582015512|FG001|Overall Study|Other|2|||
161174288|NCT02574481|582015513|FG002|Overall Study|Other|0|||
161174289|NCT02574481|582015514|FG003|Overall Study|Other|0|||
161174290|NCT02574481|582015511|FG000|Overall Study|Death|48|||
161174291|NCT02574481|582015512|FG001|Overall Study|Death|26|||
161174292|NCT02574481|582015513|FG002|Overall Study|Death|12|||
161174293|NCT02574481|582015514|FG003|Overall Study|Death|4|||
161174294|NCT02574481|582015511|FG000|Overall Study|Physician Decision|5|||
161174295|NCT02574481|582015512|FG001|Overall Study|Physician Decision|2|||
161174296|NCT02574481|582015513|FG002|Overall Study|Physician Decision|0|||
161174297|NCT02574481|582015514|FG003|Overall Study|Physician Decision|0|||
161174298|NCT02574481|582015511|FG000|Overall Study|Lost to Follow-up|5|||
161174299|NCT02574481|582015512|FG001|Overall Study|Lost to Follow-up|1|||
161174300|NCT02574481|582015513|FG002|Overall Study|Lost to Follow-up|3|||
161174301|NCT02574481|582015514|FG003|Overall Study|Lost to Follow-up|0|||
161174302|NCT02038790|582015520|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
161174303|NCT02038790|582015521|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
161174304|NCT00784459|582015523|FG000|Overall Study|Adverse Event|0|||
161174305|NCT00784459|582015524|FG001|Overall Study|Adverse Event|2|||
161174306|NCT02431702|582015525|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
161174307|NCT02431702|582015526|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161174308|NCT02431702|582015527|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161174309|NCT02431702|582015528|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161174310|NCT02431702|582015529|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161174311|NCT02431702|582015530|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161174312|NCT02431702|582015531|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
161174313|NCT02431702|582015525|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
161174314|NCT02431702|582015526|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161174315|NCT02431702|582015527|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161174316|NCT02431702|582015528|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161174317|NCT02431702|582015529|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161174318|NCT02431702|582015530|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
161174319|NCT02431702|582015531|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
161174320|NCT02431702|582015525|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
161174321|NCT02431702|582015526|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161174322|NCT02431702|582015527|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161174323|NCT02431702|582015528|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161174324|NCT02431702|582015529|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161174325|NCT02431702|582015530|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
161174326|NCT02431702|582015531|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
161174327|NCT02431702|582015525|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
161174328|NCT02431702|582015526|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161174329|NCT02431702|582015527|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161174330|NCT02431702|582015528|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161174331|NCT02431702|582015529|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161174332|NCT02431702|582015530|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
161174333|NCT02431702|582015531|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
161174334|NCT02431702|582015525|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
161174335|NCT02431702|582015526|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161174336|NCT02431702|582015527|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161174337|NCT02431702|582015528|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161174338|NCT02431702|582015529|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161174339|NCT02431702|582015530|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161174340|NCT02431702|582015531|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
161293296|NCT02841995|582453952|FG001|Overall Study|Disease progression|11|||
161174341|NCT02431702|582015525|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161174342|NCT02431702|582015526|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
161293297|NCT02841995|582453953|FG002|Overall Study|Disease progression|8|||
161293298|NCT02841995|582453951|FG000|Overall Study|Withdrawal by Subject|2|||
161174343|NCT02431702|582015527|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
161174344|NCT02431702|582015528|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161174345|NCT02431702|582015529|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161174346|NCT02431702|582015530|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161174347|NCT02431702|582015531|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
161174348|NCT02431702|582015525|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161174349|NCT02431702|582015526|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
161174350|NCT02431702|582015527|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
161174351|NCT02431702|582015528|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161174352|NCT02431702|582015529|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161174353|NCT02431702|582015530|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161174354|NCT02431702|582015531|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
161174355|NCT02431702|582015525|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161174356|NCT02431702|582015526|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
161174357|NCT02431702|582015527|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
161174358|NCT02431702|582015528|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161174359|NCT02431702|582015529|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161174360|NCT02431702|582015530|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161174361|NCT02431702|582015531|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
161174362|NCT02431702|582015525|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161174363|NCT02431702|582015526|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
161174364|NCT02431702|582015527|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161293299|NCT02841995|582453952|FG001|Overall Study|Withdrawal by Subject|4|||
161293300|NCT02841995|582453953|FG002|Overall Study|Withdrawal by Subject|4|||
161293301|NCT02841995|582453951|FG000|Overall Study|Adverse Event|2|||
161293302|NCT02841995|582453952|FG001|Overall Study|Adverse Event|0|||
161293303|NCT02841995|582453953|FG002|Overall Study|Adverse Event|1|||
161293304|NCT02841995|582453951|FG000|Overall Study|Investigator decision|2|||
161293305|NCT02841995|582453952|FG001|Overall Study|Investigator decision|0|||
161293306|NCT02841995|582453953|FG002|Overall Study|Investigator decision|1|||
161293307|NCT02841995|582453951|FG000|Overall Study|Death|0|||
161293308|NCT02841995|582453952|FG001|Overall Study|Death|0|||
161293309|NCT02841995|582453953|FG002|Overall Study|Death|2|||
161087239|NCT01293487|581706812|FG007|Overall Study|Withdrawal by Subject|2|||
161087240|NCT04860297|581706813|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
161087241|NCT04860297|581706814|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
161087242|NCT04860297|581706815|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
161087243|NCT04860297|581706816|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
161087244|NCT04860297|581706817|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
161087245|NCT04860297|581706818|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
161087246|NCT04860297|581706819|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
161087247|NCT04860297|581706820|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
161087248|NCT04860297|581706813|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
161087249|NCT04860297|581706814|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
161087250|NCT04860297|581706815|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
161087251|NCT04860297|581706816|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
161087252|NCT04860297|581706817|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
161087253|NCT04860297|581706818|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
161087254|NCT04860297|581706819|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
161087255|NCT04860297|581706820|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
161087256|NCT04860297|581706813|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
161087257|NCT04860297|581706814|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
161087258|NCT04860297|581706815|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
161087259|NCT04860297|581706816|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
161087260|NCT04860297|581706817|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
161087261|NCT04860297|581706818|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
161087262|NCT04860297|581706819|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
161087263|NCT04860297|581706820|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
161087264|NCT04860297|581706813|FG000|Part B (Booster Dose)|Other Than Specified|0|||
161087265|NCT04860297|581706814|FG001|Part B (Booster Dose)|Other Than Specified|0|||
161087266|NCT04860297|581706815|FG002|Part B (Booster Dose)|Other Than Specified|0|||
161087267|NCT04860297|581706816|FG003|Part B (Booster Dose)|Other Than Specified|0|||
161087268|NCT04860297|581706817|FG004|Part B (Booster Dose)|Other Than Specified|0|||
161087269|NCT04860297|581706818|FG005|Part B (Booster Dose)|Other Than Specified|1|||
161087270|NCT04860297|581706819|FG006|Part B (Booster Dose)|Other Than Specified|1|||
161087271|NCT04860297|581706820|FG007|Part B (Booster Dose)|Other Than Specified|0|||
161087272|NCT04860297|581706813|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
161087273|NCT04860297|581706814|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
161293310|NCT02841995|582453951|FG000|Overall Study|Noncompliance to protocol|1|||
161087274|NCT04860297|581706815|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
161087275|NCT04860297|581706816|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
161087276|NCT04860297|581706817|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
161087277|NCT04860297|581706818|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
161087278|NCT04860297|581706819|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
161087279|NCT04860297|581706820|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
161087280|NCT04860297|581706813|FG000|Part B (Booster Dose)|Death|0|||
161087281|NCT04860297|581706814|FG001|Part B (Booster Dose)|Death|0|||
161087282|NCT04860297|581706815|FG002|Part B (Booster Dose)|Death|0|||
161087283|NCT04860297|581706816|FG003|Part B (Booster Dose)|Death|0|||
161087284|NCT04860297|581706817|FG004|Part B (Booster Dose)|Death|1|||
161087285|NCT04860297|581706818|FG005|Part B (Booster Dose)|Death|2|||
161087286|NCT04860297|581706819|FG006|Part B (Booster Dose)|Death|1|||
161087287|NCT04860297|581706820|FG007|Part B (Booster Dose)|Death|0|||
161087288|NCT04860297|581706813|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
161087289|NCT04860297|581706814|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
161087290|NCT04860297|581706815|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
161087291|NCT04860297|581706816|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
161087292|NCT04860297|581706817|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
161087293|NCT04860297|581706818|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
161087294|NCT04860297|581706819|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
161087295|NCT04860297|581706820|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
161087296|NCT00468559|581706824|FG000|Open-label Treatment Phase|Adverse Event|5|||
161087297|NCT00468559|581706825|FG001|Open-label Treatment Phase|Adverse Event|0|||
161087298|NCT00468559|581706826|FG002|Open-label Treatment Phase|Adverse Event|0|||
161087299|NCT00468559|581706824|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
161087300|NCT00468559|581706825|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
161087301|NCT00468559|581706826|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
161087302|NCT00468559|581706824|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
161087303|NCT00468559|581706825|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161087304|NCT00468559|581706826|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
161087305|NCT00468559|581706824|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
161087306|NCT00468559|581706825|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
161087307|NCT00468559|581706826|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
161087308|NCT00468559|581706824|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
161087309|NCT00468559|581706825|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
161087310|NCT00468559|581706826|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
161087311|NCT00862719|581706827|FG000|Overall Study|Disease Progression|5|||
161087312|NCT00862719|581706828|FG001|Overall Study|Disease Progression|0|||
161087313|NCT00862719|581706829|FG002|Overall Study|Disease Progression|1|||
161087314|NCT00862719|581706830|FG003|Overall Study|Disease Progression|0|||
161087315|NCT00862719|581706827|FG000|Overall Study|Death|5|||
161087316|NCT00862719|581706828|FG001|Overall Study|Death|6|||
161087317|NCT00862719|581706829|FG002|Overall Study|Death|1|||
161087318|NCT00862719|581706830|FG003|Overall Study|Death|1|||
161087319|NCT00862719|581706827|FG000|Overall Study|Engraftment failure|0|||
161087320|NCT00862719|581706828|FG001|Overall Study|Engraftment failure|0|||
161087321|NCT00862719|581706829|FG002|Overall Study|Engraftment failure|1|||
161087322|NCT00862719|581706830|FG003|Overall Study|Engraftment failure|0|||
161087323|NCT00862719|581706827|FG000|Overall Study|Veno-Occlusive Disease|0|||
161087324|NCT00862719|581706828|FG001|Overall Study|Veno-Occlusive Disease|0|||
161087325|NCT00862719|581706829|FG002|Overall Study|Veno-Occlusive Disease|1|||
161087326|NCT00862719|581706830|FG003|Overall Study|Veno-Occlusive Disease|0|||
161087327|NCT01153958|581706831|FG000|Overall Study|Study Terminated|36|||
161087328|NCT01153958|581706832|FG001|Overall Study|Study Terminated|32|||
161087329|NCT02971761|581706833|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
161087330|NCT02624791|581706834|FG000|Overall Study|Withdrawal by Subject|2|||
161087331|NCT02624791|581706835|FG001|Overall Study|Withdrawal by Subject|0|||
161087332|NCT02624791|581706836|FG002|Overall Study|Withdrawal by Subject|0|||
161087333|NCT02624791|581706837|FG003|Overall Study|Withdrawal by Subject|0|||
161087334|NCT02624791|581706838|FG004|Overall Study|Withdrawal by Subject|0|||
161087335|NCT02624791|581706839|FG005|Overall Study|Withdrawal by Subject|0|||
161087336|NCT01605916|581706843|FG000|Overall Study|Adverse Event|1|||
161087337|NCT01605916|581706844|FG001|Overall Study|Adverse Event|0|||
161087338|NCT01605916|581706845|FG002|Overall Study|Adverse Event|0|||
161087339|NCT01605916|581706846|FG003|Overall Study|Adverse Event|1|||
161087340|NCT01605916|581706847|FG004|Overall Study|Adverse Event|0|||
161087341|NCT01605916|581706843|FG000|Overall Study|Lack of Efficacy|2|||
161087342|NCT01605916|581706844|FG001|Overall Study|Lack of Efficacy|3|||
161087343|NCT01605916|581706845|FG002|Overall Study|Lack of Efficacy|3|||
161087344|NCT01605916|581706846|FG003|Overall Study|Lack of Efficacy|5|||
161087345|NCT01605916|581706847|FG004|Overall Study|Lack of Efficacy|4|||
161087346|NCT01605916|581706843|FG000|Overall Study|Withdrawal by Subject|1|||
161087347|NCT01605916|581706844|FG001|Overall Study|Withdrawal by Subject|1|||
161087348|NCT01605916|581706845|FG002|Overall Study|Withdrawal by Subject|0|||
161087349|NCT01605916|581706846|FG003|Overall Study|Withdrawal by Subject|0|||
161087350|NCT01605916|581706847|FG004|Overall Study|Withdrawal by Subject|2|||
161174365|NCT02431702|582015528|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161174366|NCT02431702|582015529|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161174367|NCT02431702|582015530|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161174368|NCT02431702|582015531|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
161174369|NCT02431702|582015525|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
161174370|NCT02431702|582015526|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
161174371|NCT02431702|582015527|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
161293311|NCT02841995|582453952|FG001|Overall Study|Noncompliance to protocol|0|||
161293312|NCT02841995|582453953|FG002|Overall Study|Noncompliance to protocol|0|||
161293313|NCT02841995|582453951|FG000|Overall Study|Sponsor decision|1|||
161293314|NCT02841995|582453952|FG001|Overall Study|Sponsor decision|0|||
161293315|NCT02841995|582453953|FG002|Overall Study|Sponsor decision|0|||
161293316|NCT02841995|582453951|FG000|Overall Study|Other|4|||
161293317|NCT02841995|582453952|FG001|Overall Study|Other|1|||
161293318|NCT02841995|582453953|FG002|Overall Study|Other|5|||
161293319|NCT02755103|582453961|FG000|Overall Study|Lost to Follow-up|17|||
161293320|NCT02755103|582453962|FG001|Overall Study|Lost to Follow-up|15|||
161293321|NCT02755103|582453961|FG000|Overall Study|Death|0|||
161293322|NCT02755103|582453962|FG001|Overall Study|Death|1|||
161293323|NCT02755103|582453961|FG000|Overall Study|Physician Decision|0|||
161293324|NCT02755103|582453962|FG001|Overall Study|Physician Decision|1|||
161293325|NCT02755103|582453961|FG000|Overall Study|Pregnancy|0|||
161293326|NCT02755103|582453962|FG001|Overall Study|Pregnancy|1|||
161293327|NCT02755103|582453961|FG000|Overall Study|Withdrawal by Subject|3|||
161293328|NCT02755103|582453962|FG001|Overall Study|Withdrawal by Subject|0|||
161293329|NCT02198664|582453968|FG000|Overall Study|Adverse Event|2|||
161293330|NCT02198664|582453969|FG001|Overall Study|Adverse Event|0|||
161293331|NCT02198664|582453968|FG000|Overall Study|Withdrawal by Subject|11|||
161293332|NCT02198664|582453969|FG001|Overall Study|Withdrawal by Subject|8|||
161293333|NCT02198664|582453968|FG000|Overall Study|Failure to tolerate|2|||
161293334|NCT02198664|582453969|FG001|Overall Study|Failure to tolerate|0|||
161293335|NCT02198664|582453968|FG000|Overall Study|Not stated|1|||
161293336|NCT02198664|582453969|FG001|Overall Study|Not stated|0|||
161293337|NCT02632409|582453970|FG000|Randomized|AE unrelated to study Drug|0|||
161293338|NCT02632409|582453971|FG001|Randomized|AE unrelated to study Drug|1|||
161293339|NCT02632409|582453970|FG000|Randomized|Participant withdrew consent|2|||
161293340|NCT02632409|582453971|FG001|Randomized|Participant withdrew consent|1|||
161293341|NCT02632409|582453970|FG000|Randomized|No Longer meets study criteria|5|||
161293342|NCT02632409|582453971|FG001|Randomized|No Longer meets study criteria|0|||
161293343|NCT02632409|582453970|FG000|Randomized|other reasons|1|||
161293344|NCT02632409|582453971|FG001|Randomized|other reasons|0|||
161293345|NCT02632409|582453970|FG000|Treatment Period|Ongoing Treatment|20|||
161293346|NCT02632409|582453971|FG001|Treatment Period|Ongoing Treatment|21|||
161293347|NCT02632409|582453970|FG000|Treatment Period|Disease Recurrence|147|||
161293348|NCT02632409|582453971|FG001|Treatment Period|Disease Recurrence|90|||
161293349|NCT02632409|582453970|FG000|Treatment Period|Study Drug Toxicity|8|||
161293350|NCT02632409|582453971|FG001|Treatment Period|Study Drug Toxicity|49|||
161293351|NCT02632409|582453970|FG000|Treatment Period|Death|1|||
161293352|NCT02632409|582453971|FG001|Treatment Period|Death|0|||
161293353|NCT02632409|582453970|FG000|Treatment Period|AE unrelated to study drug|15|||
161293354|NCT02632409|582453971|FG001|Treatment Period|AE unrelated to study drug|16|||
161293355|NCT02632409|582453970|FG000|Treatment Period|Request to discontinue treatment|4|||
161293356|NCT02632409|582453971|FG001|Treatment Period|Request to discontinue treatment|19|||
161293357|NCT02632409|582453970|FG000|Treatment Period|Participant withdrew consent|7|||
161293358|NCT02632409|582453971|FG001|Treatment Period|Participant withdrew consent|5|||
161293359|NCT02632409|582453970|FG000|Treatment Period|Lost to Follow-up|0|||
161174372|NCT02431702|582015528|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
161174373|NCT02431702|582015529|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
161174374|NCT02431702|582015530|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
161174375|NCT02431702|582015531|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
161174376|NCT02431702|582015525|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161174377|NCT02431702|582015526|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161174378|NCT02431702|582015527|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
161293360|NCT02632409|582453971|FG001|Treatment Period|Lost to Follow-up|1|||
161293361|NCT02632409|582453970|FG000|Treatment Period|Maximum clinical benefit|1|||
161293362|NCT02632409|582453971|FG001|Treatment Period|Maximum clinical benefit|0|||
161293363|NCT02632409|582453970|FG000|Treatment Period|No longer meets study criteria|3|||
161293364|NCT02632409|582453971|FG001|Treatment Period|No longer meets study criteria|0|||
161293365|NCT02632409|582453970|FG000|Treatment Period|Administrative Reason by sponsor|0|||
161293366|NCT02632409|582453971|FG001|Treatment Period|Administrative Reason by sponsor|1|||
161293367|NCT02632409|582453970|FG000|Treatment Period|Other Reasons|10|||
161293368|NCT02632409|582453971|FG001|Treatment Period|Other Reasons|6|||
161293369|NCT01198470|582453972|FG000|Overall Study|Adverse Event|2|||
161293370|NCT01924689|582453973|FG000|Overall Study|Death|0|||
161293371|NCT01924689|582453974|FG001|Overall Study|Death|1|||
161174379|NCT02431702|582015528|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161174380|NCT02431702|582015529|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161174381|NCT02431702|582015530|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161174382|NCT02431702|582015531|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
161174383|NCT02431702|582015525|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161174384|NCT02431702|582015526|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161174385|NCT02431702|582015527|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161174386|NCT02431702|582015528|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
161174387|NCT02431702|582015529|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
161174388|NCT02431702|582015530|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161174389|NCT02431702|582015531|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
161174390|NCT02431702|582015525|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161174391|NCT02431702|582015526|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161174392|NCT02431702|582015527|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161174393|NCT02431702|582015528|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
161174394|NCT02431702|582015529|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161174395|NCT02431702|582015530|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
161174396|NCT02431702|582015531|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
161174397|NCT02431702|582015525|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161174398|NCT02431702|582015526|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161174399|NCT02431702|582015527|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161174400|NCT02431702|582015528|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
161174401|NCT02431702|582015529|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
161174402|NCT02431702|582015530|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
161174403|NCT02431702|582015531|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
161174404|NCT02431702|582015525|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
161174405|NCT02431702|582015526|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
161174406|NCT02431702|582015527|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
161174407|NCT02431702|582015528|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
161174408|NCT02431702|582015529|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
161174409|NCT02431702|582015530|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
161174410|NCT02431702|582015531|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
161174411|NCT02009930|582015544|FG000|Overall Study|withdrawn|5|||
161174412|NCT03907969|582015545|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
161174413|NCT03907969|582015546|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
161174414|NCT03907969|582015547|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
161174415|NCT03907969|582015548|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
161174416|NCT03907969|582015549|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
161174417|NCT03907969|582015550|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
161174418|NCT03907969|582015551|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
161174419|NCT03907969|582015552|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
161174420|NCT03907969|582015553|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
161174421|NCT03907969|582015554|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
161174422|NCT03907969|582015555|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
161174423|NCT03907969|582015545|FG000|Monotherapy Part A|Progressive Disease|0|||
161174424|NCT03907969|582015546|FG001|Monotherapy Part A|Progressive Disease|1|||
161174425|NCT03907969|582015547|FG002|Monotherapy Part A|Progressive Disease|0|||
161174426|NCT03907969|582015548|FG003|Monotherapy Part A|Progressive Disease|0|||
161174427|NCT03907969|582015549|FG004|Monotherapy Part A|Progressive Disease|0|||
161174428|NCT03907969|582015550|FG005|Monotherapy Part A|Progressive Disease|1|||
161174429|NCT03907969|582015551|FG006|Monotherapy Part A|Progressive Disease|2|||
161174430|NCT03907969|582015552|FG007|Monotherapy Part A|Progressive Disease|0|||
161174431|NCT03907969|582015553|FG008|Monotherapy Part A|Progressive Disease|0|||
161174432|NCT03907969|582015554|FG009|Monotherapy Part A|Progressive Disease|0|||
161174433|NCT03907969|582015555|FG010|Monotherapy Part A|Progressive Disease|0|||
161174434|NCT03907969|582015545|FG000|Monotherapy Part A|Death|0|||
161174435|NCT03907969|582015546|FG001|Monotherapy Part A|Death|0|||
161174436|NCT03907969|582015547|FG002|Monotherapy Part A|Death|1|||
161174437|NCT03907969|582015548|FG003|Monotherapy Part A|Death|1|||
161174438|NCT03907969|582015549|FG004|Monotherapy Part A|Death|0|||
161174439|NCT03907969|582015550|FG005|Monotherapy Part A|Death|1|||
161174440|NCT03907969|582015551|FG006|Monotherapy Part A|Death|0|||
161174441|NCT03907969|582015552|FG007|Monotherapy Part A|Death|0|||
161174442|NCT03907969|582015553|FG008|Monotherapy Part A|Death|0|||
161174443|NCT03907969|582015554|FG009|Monotherapy Part A|Death|0|||
161174444|NCT03907969|582015555|FG010|Monotherapy Part A|Death|0|||
161174445|NCT03907969|582015545|FG000|Combination Therapy Part A|Adverse Event|0|||
161174446|NCT03907969|582015546|FG001|Combination Therapy Part A|Adverse Event|0|||
161174447|NCT03907969|582015547|FG002|Combination Therapy Part A|Adverse Event|0|||
161174448|NCT03907969|582015548|FG003|Combination Therapy Part A|Adverse Event|0|||
161174449|NCT03907969|582015549|FG004|Combination Therapy Part A|Adverse Event|0|||
161174450|NCT03907969|582015550|FG005|Combination Therapy Part A|Adverse Event|0|||
161293372|NCT01924689|582453975|FG002|Overall Study|Death|0|||
161293373|NCT01924689|582453976|FG003|Overall Study|Death|1|||
161293374|NCT01924689|582453977|FG004|Overall Study|Death|0|||
161293375|NCT01924689|582453978|FG005|Overall Study|Death|0|||
161293376|NCT01924689|582453973|FG000|Overall Study|Disease progression|0|||
161293377|NCT01924689|582453974|FG001|Overall Study|Disease progression|0|||
161293378|NCT01924689|582453975|FG002|Overall Study|Disease progression|2|||
161293379|NCT01924689|582453976|FG003|Overall Study|Disease progression|0|||
161293380|NCT01924689|582453977|FG004|Overall Study|Disease progression|3|||
161293381|NCT01924689|582453978|FG005|Overall Study|Disease progression|2|||
161293382|NCT01924689|582453973|FG000|Overall Study|New therapy or study|3|||
161293383|NCT01924689|582453974|FG001|Overall Study|New therapy or study|2|||
161293384|NCT01924689|582453975|FG002|Overall Study|New therapy or study|1|||
161293385|NCT01924689|582453976|FG003|Overall Study|New therapy or study|4|||
161293386|NCT01924689|582453977|FG004|Overall Study|New therapy or study|2|||
161293387|NCT01924689|582453978|FG005|Overall Study|New therapy or study|0|||
161293388|NCT01924689|582453973|FG000|Overall Study|Withdrawal of consent|0|||
161293389|NCT01924689|582453974|FG001|Overall Study|Withdrawal of consent|0|||
161293390|NCT01924689|582453975|FG002|Overall Study|Withdrawal of consent|1|||
161293391|NCT01924689|582453976|FG003|Overall Study|Withdrawal of consent|1|||
161293392|NCT01924689|582453977|FG004|Overall Study|Withdrawal of consent|0|||
161293393|NCT01924689|582453978|FG005|Overall Study|Withdrawal of consent|0|||
161293394|NCT01924689|582453973|FG000|Overall Study|Other|0|||
161293395|NCT01924689|582453974|FG001|Overall Study|Other|0|||
161293396|NCT01924689|582453975|FG002|Overall Study|Other|0|||
161293397|NCT01924689|582453976|FG003|Overall Study|Other|0|||
161293398|NCT01924689|582453977|FG004|Overall Study|Other|1|||
161293399|NCT01924689|582453978|FG005|Overall Study|Other|0|||
161347561|NCT00005047|582656320|FG000|Overall Study|Lost to Follow-up|1|||
161347562|NCT00005047|582656321|FG001|Overall Study|Lost to Follow-up|0|||
161347563|NCT00005047|582656322|FG002|Overall Study|Lost to Follow-up|0|||
161347564|NCT00005047|582656323|FG003|Overall Study|Lost to Follow-up|0|||
161347565|NCT00005047|582656320|FG000|Overall Study|Lack of Efficacy|1|||
161347566|NCT00005047|582656321|FG001|Overall Study|Lack of Efficacy|0|||
161347567|NCT00005047|582656322|FG002|Overall Study|Lack of Efficacy|0|||
161347568|NCT00005047|582656323|FG003|Overall Study|Lack of Efficacy|0|||
161347569|NCT03036254|582656326|FG000|Overall Study|Adverse Event|6|||
161347570|NCT03036254|582656327|FG001|Overall Study|Adverse Event|4|||
161347571|NCT03036254|582656326|FG000|Overall Study|Death|3|||
161347572|NCT03036254|582656327|FG001|Overall Study|Death|1|||
161347573|NCT03036254|582656326|FG000|Overall Study|Lack of Efficacy|5|||
161347574|NCT03036254|582656327|FG001|Overall Study|Lack of Efficacy|1|||
161347575|NCT03036254|582656326|FG000|Overall Study|Withdrawal by Subject|3|||
161347576|NCT03036254|582656327|FG001|Overall Study|Withdrawal by Subject|5|||
161347577|NCT04556097|582656328|FG000|Overall Study|Death|0|||
161347578|NCT04556097|582656329|FG001|Overall Study|Death|5|||
161347579|NCT04556097|582656330|FG002|Overall Study|Death|0|||
161347580|NCT04556097|582656331|FG003|Overall Study|Death|0|||
161347581|NCT04556097|582656328|FG000|Overall Study|No caregiver|43|||
161347582|NCT04556097|582656329|FG001|Overall Study|No caregiver|53|||
161347583|NCT04556097|582656330|FG002|Overall Study|No caregiver|0|||
161347584|NCT04556097|582656331|FG003|Overall Study|No caregiver|0|||
161347585|NCT04556097|582656328|FG000|Overall Study|Ineligible, SNF|2|||
161347586|NCT04556097|582656329|FG001|Overall Study|Ineligible, SNF|2|||
161347587|NCT04556097|582656330|FG002|Overall Study|Ineligible, SNF|0|||
161347588|NCT04556097|582656331|FG003|Overall Study|Ineligible, SNF|0|||
161347589|NCT04556097|582656328|FG000|Overall Study|Ineligible, health|3|||
161347590|NCT04556097|582656329|FG001|Overall Study|Ineligible, health|4|||
161347591|NCT04556097|582656330|FG002|Overall Study|Ineligible, health|0|||
161347592|NCT04556097|582656331|FG003|Overall Study|Ineligible, health|0|||
161087351|NCT02842151|581706848|FG000|Overall Study|Adverse Event|1|||
161087352|NCT02842151|581706848|FG000|Overall Study|Subject moved too far away|1|||
161293400|NCT05271175|582453980|FG000|One Week Follow up|Lost to Follow-up|10|||
161293401|NCT05271175|582453981|FG001|One Week Follow up|Lost to Follow-up|7|||
161347593|NCT04556097|582656328|FG000|Overall Study|Ineligible, language|0|||
161347594|NCT04556097|582656329|FG001|Overall Study|Ineligible, language|1|||
161347595|NCT04556097|582656330|FG002|Overall Study|Ineligible, language|0|||
161347596|NCT04556097|582656331|FG003|Overall Study|Ineligible, language|0|||
161347597|NCT04556097|582656328|FG000|Overall Study|Ineligible, no longer in care management|0|||
161347598|NCT04556097|582656329|FG001|Overall Study|Ineligible, no longer in care management|2|||
161347599|NCT04556097|582656330|FG002|Overall Study|Ineligible, no longer in care management|1|||
161087353|NCT03965351|581706851|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161293402|NCT05271175|582453982|FG002|One Week Follow up|Lost to Follow-up|5|||
161293403|NCT05271175|582453980|FG000|One Month Follow up|Lost to Follow-up|12|||
161293404|NCT05271175|582453981|FG001|One Month Follow up|Lost to Follow-up|7|||
161293405|NCT05271175|582453982|FG002|One Month Follow up|Lost to Follow-up|9|||
161347600|NCT04556097|582656331|FG003|Overall Study|Ineligible, no longer in care management|0|||
161347601|NCT04556097|582656328|FG000|Overall Study|No dementia|13|||
161347602|NCT04556097|582656329|FG001|Overall Study|No dementia|3|||
161347603|NCT04556097|582656330|FG002|Overall Study|No dementia|0|||
161293406|NCT05271175|582453980|FG000|Six Months Follow up|Lost to Follow-up|8|||
161293407|NCT05271175|582453981|FG001|Six Months Follow up|Lost to Follow-up|2|||
161293408|NCT05271175|582453982|FG002|Six Months Follow up|Lost to Follow-up|2|||
161293409|NCT02492867|582453983|FG000|Overall Study|Alternate therapy|1|||
161293410|NCT02492867|582453983|FG000|Overall Study|Withdrawal by Subject|2|||
161293411|NCT02492867|582453983|FG000|Overall Study|Disease progression after treatment started|1|||
161293412|NCT02492867|582453983|FG000|Overall Study|Death|1|||
161293413|NCT03296527|582453984|FG000|Overall Study|Adverse Event|15|||
161293414|NCT03296527|582453985|FG001|Overall Study|Adverse Event|33|||
161293415|NCT03296527|582453984|FG000|Overall Study|Protocol Deviation|4|||
161293416|NCT03296527|582453985|FG001|Overall Study|Protocol Deviation|0|||
161293417|NCT03296527|582453984|FG000|Overall Study|Participant withdrew consent|3|||
161293418|NCT03296527|582453985|FG001|Overall Study|Participant withdrew consent|1|||
161293419|NCT03296527|582453984|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
161293420|NCT03296527|582453985|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
161293421|NCT03296527|582453984|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
161293422|NCT03296527|582453985|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
161293423|NCT03296527|582453984|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
161293424|NCT03296527|582453985|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
161293425|NCT03296527|582453984|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
161293426|NCT03296527|582453985|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
161293427|NCT03296527|582453984|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
161293428|NCT03296527|582453985|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
161293429|NCT01597973|582453986|FG000|Overall Study|Found ineligible before study medication started|4|||
161293430|NCT01597973|582453987|FG001|Overall Study|Found ineligible before study medication started|2|||
161293431|NCT01597973|582453986|FG000|Overall Study|Eligible pathogen not confirmed|14|||
161293432|NCT01597973|582453987|FG001|Overall Study|Eligible pathogen not confirmed|15|||
161293433|NCT01597973|582453986|FG000|Overall Study|LAR not authorized to consent|0|||
161293434|NCT01597973|582453987|FG001|Overall Study|LAR not authorized to consent|1|||
161293435|NCT01597973|582453986|FG000|Overall Study|Ineligible due to early seizures|1|||
161293436|NCT01597973|582453987|FG001|Overall Study|Ineligible due to early seizures|0|||
161293437|NCT01597973|582453986|FG000|Overall Study|Ineligible due to non-target infection|1|||
161293438|NCT01597973|582453987|FG001|Overall Study|Ineligible due to non-target infection|1|||
161293439|NCT01326845|582453988|FG000|Overall Study|Administrative Problems|5|||
161293440|NCT01326845|582453989|FG001|Overall Study|Administrative Problems|2|||
161293441|NCT01326845|582453988|FG000|Overall Study|Adverse Event|1|||
161293442|NCT01326845|582453989|FG001|Overall Study|Adverse Event|0|||
161293443|NCT01326845|582453988|FG000|Overall Study|Misisng|1|||
161293444|NCT01326845|582453989|FG001|Overall Study|Misisng|3|||
161293445|NCT00740636|582453992|FG000|Overall Study|Adverse Event|0|||
161293446|NCT00740636|582453993|FG001|Overall Study|Adverse Event|2|||
161293447|NCT00740636|582453992|FG000|Overall Study|Patient Ineligible|0|||
161293448|NCT00740636|582453993|FG001|Overall Study|Patient Ineligible|1|||
161174451|NCT03907969|582015551|FG006|Combination Therapy Part A|Adverse Event|0|||
161174452|NCT03907969|582015552|FG007|Combination Therapy Part A|Adverse Event|0|||
161174453|NCT03907969|582015553|FG008|Combination Therapy Part A|Adverse Event|0|||
161174454|NCT03907969|582015554|FG009|Combination Therapy Part A|Adverse Event|1|||
161174455|NCT03907969|582015555|FG010|Combination Therapy Part A|Adverse Event|1|||
161174456|NCT03907969|582015545|FG000|Combination Therapy Part A|Progressive disease|0|||
161174457|NCT03907969|582015546|FG001|Combination Therapy Part A|Progressive disease|0|||
161174458|NCT03907969|582015547|FG002|Combination Therapy Part A|Progressive disease|0|||
161174459|NCT03907969|582015548|FG003|Combination Therapy Part A|Progressive disease|0|||
161174460|NCT03907969|582015549|FG004|Combination Therapy Part A|Progressive disease|0|||
161174461|NCT03907969|582015550|FG005|Combination Therapy Part A|Progressive disease|0|||
161174462|NCT03907969|582015551|FG006|Combination Therapy Part A|Progressive disease|0|||
161174463|NCT03907969|582015552|FG007|Combination Therapy Part A|Progressive disease|1|||
161174464|NCT03907969|582015553|FG008|Combination Therapy Part A|Progressive disease|0|||
161174465|NCT03907969|582015554|FG009|Combination Therapy Part A|Progressive disease|2|||
161174466|NCT03907969|582015555|FG010|Combination Therapy Part A|Progressive disease|3|||
161174467|NCT03907969|582015545|FG000|Combination Therapy Part A|Death|0|||
161174468|NCT03907969|582015546|FG001|Combination Therapy Part A|Death|0|||
161293449|NCT00740636|582453992|FG000|Overall Study|Patient Not Treated|0|||
161293450|NCT00740636|582453993|FG001|Overall Study|Patient Not Treated|1|||
161293451|NCT00740636|582453992|FG000|Overall Study|Progressive Disease|1|||
161293452|NCT00740636|582453993|FG001|Overall Study|Progressive Disease|0|||
161293453|NCT00740636|582453992|FG000|Overall Study|Death|1|||
161293454|NCT00740636|582453993|FG001|Overall Study|Death|0|||
161293455|NCT02174627|582453998|FG000|Overall Study|Missing|0|||
161293456|NCT02174627|582453999|FG001|Overall Study|Missing|1|||
161293457|NCT02174627|582453998|FG000|Overall Study|Incorrect enrolment before randomization|0|||
161174469|NCT03907969|582015547|FG002|Combination Therapy Part A|Death|0|||
161174470|NCT03907969|582015548|FG003|Combination Therapy Part A|Death|0|||
161293458|NCT02174627|582453999|FG001|Overall Study|Incorrect enrolment before randomization|1|||
161293459|NCT02174627|582453998|FG000|Overall Study|Participant decision|84|||
161293460|NCT02174627|582453999|FG001|Overall Study|Participant decision|128|||
161293461|NCT02166333|582454000|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
161293462|NCT02166333|582454001|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161293463|NCT02166333|582454002|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161293464|NCT02166333|582454003|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
161293465|NCT02166333|582454004|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
161293466|NCT02166333|582454005|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
161293467|NCT02166333|582454000|FG000|Stage 1|Death|4|||
161293468|NCT02166333|582454001|FG001|Stage 1|Death|0|||
161293469|NCT02166333|582454002|FG002|Stage 1|Death|2|||
161293470|NCT02166333|582454003|FG003|Stage 1|Death|0|||
161293471|NCT02166333|582454004|FG004|Stage 1|Death|3|||
161293472|NCT02166333|582454005|FG005|Stage 1|Death|2|||
161293473|NCT02166333|582454000|FG000|Stage 1|Lost to Follow-up|12|||
161293474|NCT02166333|582454001|FG001|Stage 1|Lost to Follow-up|0|||
161293475|NCT02166333|582454002|FG002|Stage 1|Lost to Follow-up|6|||
161293476|NCT02166333|582454003|FG003|Stage 1|Lost to Follow-up|0|||
161293477|NCT02166333|582454004|FG004|Stage 1|Lost to Follow-up|3|||
161293478|NCT02166333|582454005|FG005|Stage 1|Lost to Follow-up|3|||
161293479|NCT02166333|582454000|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
161293480|NCT02166333|582454001|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
161293481|NCT02166333|582454002|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
161293482|NCT02166333|582454003|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
161293483|NCT02166333|582454004|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
161293484|NCT02166333|582454005|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
161293485|NCT02166333|582454000|FG000|Stage 2|Death|4|||
161293486|NCT02166333|582454001|FG001|Stage 2|Death|2|||
161293487|NCT02166333|582454002|FG002|Stage 2|Death|1|||
161293488|NCT02166333|582454003|FG003|Stage 2|Death|0|||
161293489|NCT02166333|582454004|FG004|Stage 2|Death|0|||
161293490|NCT02166333|582454005|FG005|Stage 2|Death|1|||
161293491|NCT02166333|582454000|FG000|Stage 2|Lost to Follow-up|23|||
161293492|NCT02166333|582454001|FG001|Stage 2|Lost to Follow-up|4|||
161293493|NCT02166333|582454002|FG002|Stage 2|Lost to Follow-up|11|||
161293494|NCT02166333|582454003|FG003|Stage 2|Lost to Follow-up|9|||
161293495|NCT02166333|582454004|FG004|Stage 2|Lost to Follow-up|3|||
161293496|NCT02166333|582454005|FG005|Stage 2|Lost to Follow-up|6|||
161293497|NCT02269098|582454006|FG000|Overall Study|Lost to Follow-up|14|||
161293498|NCT02269098|582454007|FG001|Overall Study|Lost to Follow-up|9|||
161293499|NCT00503698|582454008|FG000|Overall Study|Protocol Violation|5|||
161293500|NCT00503698|582454009|FG001|Overall Study|Protocol Violation|6|||
161293501|NCT00503698|582454008|FG000|Overall Study|Adverse Event|52|||
161293502|NCT00503698|582454009|FG001|Overall Study|Adverse Event|41|||
161293503|NCT00503698|582454008|FG000|Overall Study|Death|1|||
161293504|NCT00503698|582454009|FG001|Overall Study|Death|0|||
161293505|NCT00503698|582454008|FG000|Overall Study|Lack of Efficacy|3|||
161293506|NCT00503698|582454009|FG001|Overall Study|Lack of Efficacy|4|||
161293507|NCT00503698|582454008|FG000|Overall Study|Trial terminated|216|||
161293508|NCT00503698|582454009|FG001|Overall Study|Trial terminated|253|||
161293509|NCT00503698|582454008|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
161293510|NCT00503698|582454009|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
161293511|NCT00503698|582454008|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
161293512|NCT00503698|582454009|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
161293513|NCT00503698|582454008|FG000|Overall Study|Any condition in exclusion criteria|4|||
161293514|NCT00503698|582454009|FG001|Overall Study|Any condition in exclusion criteria|6|||
161293515|NCT00503698|582454008|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
161293516|NCT00503698|582454009|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
161293517|NCT00503698|582454008|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
161087354|NCT03965351|581706852|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161087355|NCT03965351|581706851|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
161293518|NCT00503698|582454009|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
161293519|NCT00503698|582454008|FG000|Overall Study|Critically ill|2|||
161293520|NCT00503698|582454009|FG001|Overall Study|Critically ill|0|||
161293521|NCT00503698|582454008|FG000|Overall Study|Unclassified|48|||
161293522|NCT00503698|582454009|FG001|Overall Study|Unclassified|32|||
161293523|NCT00503698|582454008|FG000|Overall Study|Not exposed to trial drug|11|||
161293524|NCT00503698|582454009|FG001|Overall Study|Not exposed to trial drug|6|||
161293525|NCT00682786|582454015|FG000|Overall Study|Withdrawal by Subject|2|||
161293526|NCT00682786|582454016|FG001|Overall Study|Withdrawal by Subject|2|||
161293527|NCT00682786|582454015|FG000|Overall Study|Did not receive irinotecan|0|||
161293528|NCT00682786|582454016|FG001|Overall Study|Did not receive irinotecan|1|||
161293529|NCT03644342|582454017|FG000|Overall Study|Adverse Event|2|||
161293530|NCT03644342|582454018|FG001|Overall Study|Adverse Event|0|||
161293531|NCT03644342|582454017|FG000|Overall Study|Protocol Violation|0|||
161293532|NCT03644342|582454018|FG001|Overall Study|Protocol Violation|1|||
161319410|NCT01134263|582555303|FG003|Overall Study|Withdrawal by Subject|7|||
161319411|NCT01134263|582555304|FG004|Overall Study|Withdrawal by Subject|5|||
161319412|NCT01134263|582555300|FG000|Overall Study|Enrolled, but not treated|1|||
161319413|NCT01134263|582555301|FG001|Overall Study|Enrolled, but not treated|1|||
161319414|NCT01134263|582555302|FG002|Overall Study|Enrolled, but not treated|0|||
161319415|NCT01134263|582555303|FG003|Overall Study|Enrolled, but not treated|1|||
161319416|NCT01134263|582555304|FG004|Overall Study|Enrolled, but not treated|0|||
161319417|NCT01557517|582555305|FG000|Overall Study|Death|1|||
161319418|NCT01557517|582555306|FG001|Overall Study|Death|0|||
161319419|NCT01557517|582555305|FG000|Overall Study|Refused further treatment|0|||
161319420|NCT01557517|582555306|FG001|Overall Study|Refused further treatment|2|||
161319421|NCT01557517|582555305|FG000|Overall Study|Adverse Event|0|||
161319422|NCT01557517|582555306|FG001|Overall Study|Adverse Event|2|||
161319423|NCT01557517|582555305|FG000|Overall Study|Pt declined before treatment started|1|||
161319424|NCT01557517|582555306|FG001|Overall Study|Pt declined before treatment started|0|||
161319425|NCT00162097|582555307|FG000|Overall Study|Participant no longer met study criteria|0|||
161319426|NCT00162097|582555308|FG001|Overall Study|Participant no longer met study criteria|0|||
161319427|NCT00162097|582555309|FG002|Overall Study|Participant no longer met study criteria|0|||
161319428|NCT00162097|582555310|FG003|Overall Study|Participant no longer met study criteria|1|||
161319429|NCT00770913|582555311|FG000|Overall Study|Adverse Event|1|||
161319430|NCT00770913|582555312|FG001|Overall Study|Adverse Event|3|||
161319431|NCT00770913|582555313|FG002|Overall Study|Adverse Event|6|||
161319432|NCT00770913|582555311|FG000|Overall Study|Refusal to continue participation|6|||
161319433|NCT00770913|582555312|FG001|Overall Study|Refusal to continue participation|4|||
161319434|NCT00770913|582555313|FG002|Overall Study|Refusal to continue participation|5|||
161319435|NCT00770913|582555311|FG000|Overall Study|Physician Decision|0|||
161319436|NCT00770913|582555312|FG001|Overall Study|Physician Decision|1|||
161319437|NCT00770913|582555313|FG002|Overall Study|Physician Decision|1|||
161319438|NCT00770913|582555311|FG000|Overall Study|Protocol Violation|3|||
161319439|NCT00770913|582555312|FG001|Overall Study|Protocol Violation|0|||
161319440|NCT00770913|582555313|FG002|Overall Study|Protocol Violation|1|||
161319441|NCT00770913|582555311|FG000|Overall Study|Incorrect drug was allocated|1|||
161319442|NCT00770913|582555312|FG001|Overall Study|Incorrect drug was allocated|0|||
161319443|NCT00770913|582555313|FG002|Overall Study|Incorrect drug was allocated|0|||
161319444|NCT01134393|582555314|FG000|Overall Study|Adverse Event|18|||
161319445|NCT01134393|582555314|FG000|Overall Study|Lack of Efficacy|2|||
161319446|NCT01134393|582555314|FG000|Overall Study|Protocol Violation|12|||
161319447|NCT01134393|582555314|FG000|Overall Study|Lost to Follow-up|3|||
161319448|NCT01134393|582555314|FG000|Overall Study|Withdrawal by Subject|11|||
161319449|NCT01134393|582555314|FG000|Overall Study|Other|6|||
161319450|NCT00575510|582555321|FG000|Overall Study|Lost to Follow-up|4|||
161319451|NCT00575510|582555322|FG001|Overall Study|Lost to Follow-up|6|||
161319452|NCT00575510|582555323|FG002|Overall Study|Lost to Follow-up|9|||
161319453|NCT00575510|582555321|FG000|Overall Study|Withdrawal by Subject|1|||
161319454|NCT00575510|582555322|FG001|Overall Study|Withdrawal by Subject|0|||
161319455|NCT00575510|582555323|FG002|Overall Study|Withdrawal by Subject|0|||
161319456|NCT00575510|582555321|FG000|Overall Study|Clinic Called Patient|7|||
161319457|NCT00575510|582555322|FG001|Overall Study|Clinic Called Patient|7|||
161174471|NCT03907969|582015549|FG004|Combination Therapy Part A|Death|0|||
161174472|NCT03907969|582015550|FG005|Combination Therapy Part A|Death|0|||
161319458|NCT00575510|582555323|FG002|Overall Study|Clinic Called Patient|7|||
161319459|NCT00575510|582555321|FG000|Overall Study|Pregnancy|0|||
161319460|NCT00575510|582555322|FG001|Overall Study|Pregnancy|0|||
161319461|NCT00575510|582555323|FG002|Overall Study|Pregnancy|1|||
161319462|NCT02697734|582555324|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
161319463|NCT02697734|582555325|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
161319464|NCT02697734|582555324|FG000|Core Phase - up to Week 48|Adverse Event|1|||
161319465|NCT02697734|582555325|FG001|Core Phase - up to Week 48|Adverse Event|2|||
161319466|NCT02697734|582555324|FG000|Core Phase - up to Week 48|Physician Decision|1|||
161319467|NCT02697734|582555325|FG001|Core Phase - up to Week 48|Physician Decision|0|||
161319468|NCT02697734|582555324|FG000|Optional Extension Phase|Adverse Event|5|||
161319469|NCT02697734|582555325|FG001|Optional Extension Phase|Adverse Event|1|||
161319470|NCT02697734|582555324|FG000|Optional Extension Phase|Physician Decision|0|||
161319471|NCT02697734|582555325|FG001|Optional Extension Phase|Physician Decision|1|||
161347604|NCT04556097|582656331|FG003|Overall Study|No dementia|0|||
161319472|NCT03970200|582555326|FG000|Overall Study|Death|2|||
161319473|NCT03970200|582555327|FG001|Overall Study|Death|2|||
161319474|NCT03970200|582555328|FG002|Overall Study|Death|1|||
161319475|NCT03970200|582555326|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
161319476|NCT03970200|582555327|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
161319477|NCT03970200|582555328|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
161319478|NCT03469999|582555333|FG000|Overall Study|Lost to Follow-up|2|||
161319479|NCT01863732|582555334|FG000|Overall Study|Adverse Event|2|||
161347605|NCT04556097|582656328|FG000|Overall Study|Missing identifier|2|||
161293533|NCT05336227|582455946|FG000|Overall Study|Adverse Event|1|||
161293534|NCT05336227|582455947|FG001|Overall Study|Adverse Event|0|||
161293535|NCT05336227|582455946|FG000|Overall Study|Lost to Follow-up|2|||
161293536|NCT05336227|582455947|FG001|Overall Study|Lost to Follow-up|0|||
161293537|NCT05336227|582455946|FG000|Overall Study|Withdrawal by Subject|1|||
161293538|NCT05336227|582455947|FG001|Overall Study|Withdrawal by Subject|0|||
161293539|NCT04050462|582455948|FG000|Overall Study|Withdrawal by Subject|1|||
161293540|NCT04050462|582455949|FG001|Overall Study|Withdrawal by Subject|0|||
161293541|NCT04050462|582455950|FG002|Overall Study|Withdrawal by Subject|0|||
161293542|NCT05151744|582455951|FG000|Overall Study|Adverse Event|6|||
161293543|NCT05151744|582455952|FG001|Overall Study|Adverse Event|2|||
161293544|NCT05151744|582455951|FG000|Overall Study|Death|1|||
161293545|NCT05151744|582455952|FG001|Overall Study|Death|2|||
161293546|NCT05151744|582455951|FG000|Overall Study|Lack of Efficacy|1|||
161293547|NCT05151744|582455952|FG001|Overall Study|Lack of Efficacy|1|||
161293548|NCT05151744|582455951|FG000|Overall Study|Lost to Follow-up|2|||
161293549|NCT05151744|582455952|FG001|Overall Study|Lost to Follow-up|2|||
161293550|NCT05151744|582455951|FG000|Overall Study|Need for Rescue Treatment|0|||
161293551|NCT05151744|582455952|FG001|Overall Study|Need for Rescue Treatment|1|||
161293552|NCT05151744|582455951|FG000|Overall Study|Non-compliance with Study Drug|0|||
161293553|NCT05151744|582455952|FG001|Overall Study|Non-compliance with Study Drug|1|||
161293554|NCT05151744|582455951|FG000|Overall Study|Reason not Specified|10|||
161293555|NCT05151744|582455952|FG001|Overall Study|Reason not Specified|0|||
161293556|NCT05151744|582455951|FG000|Overall Study|Physician Decision|2|||
161293557|NCT05151744|582455952|FG001|Overall Study|Physician Decision|1|||
161293558|NCT05151744|582455951|FG000|Overall Study|Protocol Violation|1|||
161293559|NCT05151744|582455952|FG001|Overall Study|Protocol Violation|0|||
161293560|NCT05151744|582455951|FG000|Overall Study|Withdrawal by Subject|6|||
161293561|NCT05151744|582455952|FG001|Overall Study|Withdrawal by Subject|3|||
161293562|NCT01682226|582455955|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
161293563|NCT01682226|582455955|FG000|Overall Study|Participants did not receive treatment|2|||
161293564|NCT01682226|582455955|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
161293565|NCT03771898|582455964|FG000|Overall Study|Adverse Event|1|||
161293566|NCT03771898|582455965|FG001|Overall Study|Adverse Event|0|||
161293567|NCT03771898|582455966|FG002|Overall Study|Adverse Event|0|||
161293568|NCT03771898|582455967|FG003|Overall Study|Adverse Event|0|||
161293569|NCT03771898|582455968|FG004|Overall Study|Adverse Event|0|||
161293570|NCT03771898|582455964|FG000|Overall Study|Lost to Follow-up|1|||
161293571|NCT03771898|582455965|FG001|Overall Study|Lost to Follow-up|1|||
161293572|NCT03771898|582455966|FG002|Overall Study|Lost to Follow-up|1|||
161293573|NCT03771898|582455967|FG003|Overall Study|Lost to Follow-up|0|||
161293574|NCT03771898|582455968|FG004|Overall Study|Lost to Follow-up|0|||
161293575|NCT03771898|582455964|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161293576|NCT03771898|582455965|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161293577|NCT03771898|582455966|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161293578|NCT03771898|582455967|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161293579|NCT03771898|582455968|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161293580|NCT03771898|582455964|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161293581|NCT03771898|582455965|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161293582|NCT03771898|582455966|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161293583|NCT03771898|582455967|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
161293584|NCT03771898|582455968|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
161293585|NCT03123120|582455969|FG000|Overall Study|Lost to Follow-up|0|||
161293586|NCT03123120|582455970|FG001|Overall Study|Lost to Follow-up|1|||
161293587|NCT03123120|582455969|FG000|Overall Study|Withdrawal by Subject|0|||
161293588|NCT03123120|582455970|FG001|Overall Study|Withdrawal by Subject|1|||
161293589|NCT03135548|582455974|FG000|Overall Study|Lost to Follow-up|3|||
161293590|NCT03135548|582455975|FG001|Overall Study|Lost to Follow-up|0|||
161293591|NCT03135548|582455976|FG002|Overall Study|Lost to Follow-up|0|||
161293592|NCT03135548|582455974|FG000|Overall Study|Withdrawal by Subject|2|||
161293593|NCT03135548|582455975|FG001|Overall Study|Withdrawal by Subject|2|||
161293594|NCT03135548|582455976|FG002|Overall Study|Withdrawal by Subject|1|||
161293595|NCT03135548|582455974|FG000|Overall Study|Other than listed|0|||
161293596|NCT03135548|582455975|FG001|Overall Study|Other than listed|2|||
161293597|NCT03135548|582455976|FG002|Overall Study|Other than listed|2|||
161293598|NCT02632175|582455977|FG000|Overall Study|Withdrawal by Subject|6|||
161293599|NCT02632175|582455977|FG000|Overall Study|Lost to Follow-up|1|||
161293600|NCT02632175|582455977|FG000|Overall Study|Lack of Efficacy|18|||
161293601|NCT02632175|582455977|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
161293602|NCT02632175|582455977|FG000|Overall Study|Subject noncompliance|3|||
161293603|NCT02632175|582455977|FG000|Overall Study|other|2|||
161293604|NCT02088554|582455978|FG000|Overall Study|Exited before procedure|130|||
161293605|NCT02088554|582455978|FG000|Overall Study|Attempted but not implanted|31|||
161293606|NCT02088554|582455978|FG000|Overall Study|Implant not attempted|19|||
161293607|NCT02088554|582455978|FG000|Overall Study|Pending next visit|532|||
161293608|NCT02088554|582455978|FG000|Overall Study|Death|170|||
161293609|NCT02088554|582455978|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
161293610|NCT02088554|582455978|FG000|Overall Study|Lost to Follow-up|23|||
161293611|NCT02088554|582455978|FG000|Overall Study|Explanted|32|||
161293612|NCT02088554|582455978|FG000|Overall Study|Any other reason not covered by previous categories|11|||
161293613|NCT04623216|582455979|FG000|Overall Study|Death|5|||
161293614|NCT04623216|582455980|FG001|Overall Study|Death|2|||
161293615|NCT04623216|582455981|FG002|Overall Study|Death|0|||
161293616|NCT04623216|582455982|FG003|Overall Study|Death|0|||
161293617|NCT04623216|582455979|FG000|Overall Study|Terminated by Sponsor|3|||
161293618|NCT04623216|582455980|FG001|Overall Study|Terminated by Sponsor|2|||
161293619|NCT04623216|582455981|FG002|Overall Study|Terminated by Sponsor|2|||
161293620|NCT04623216|582455982|FG003|Overall Study|Terminated by Sponsor|0|||
161293621|NCT04623216|582455979|FG000|Overall Study|Physician Decision|1|||
161293622|NCT04623216|582455980|FG001|Overall Study|Physician Decision|0|||
161293623|NCT04623216|582455981|FG002|Overall Study|Physician Decision|0|||
161293624|NCT04623216|582455982|FG003|Overall Study|Physician Decision|0|||
161293625|NCT03521154|582455985|FG000|Overall Study|Ongoing study at data cut-off|111|||
161293626|NCT03521154|582455986|FG001|Overall Study|Ongoing study at data cut-off|52|||
161293627|NCT05468164|582455987|FG000|Treatment Period 4|Adverse Event|0|||
161293628|NCT05468164|582455988|FG001|Treatment Period 4|Adverse Event|0|||
161293629|NCT05468164|582455989|FG002|Treatment Period 4|Adverse Event|0|||
161293630|NCT05468164|582455990|FG003|Treatment Period 4|Adverse Event|1|||
161293631|NCT04632927|582455991|FG000|Overall Study|Adverse Event|0|||
161293632|NCT04632927|582455992|FG001|Overall Study|Adverse Event|1|||
161293633|NCT04632927|582455991|FG000|Overall Study|Lack of Efficacy|0|||
161293634|NCT04632927|582455992|FG001|Overall Study|Lack of Efficacy|4|||
161293635|NCT04632927|582455991|FG000|Overall Study|Loss of efficacy|0|||
161293636|NCT04632927|582455992|FG001|Overall Study|Loss of efficacy|1|||
161293637|NCT04632927|582455991|FG000|Overall Study|Non-compliance with study drug|0|||
161293638|NCT04632927|582455992|FG001|Overall Study|Non-compliance with study drug|1|||
161293639|NCT04632927|582455991|FG000|Overall Study|Physician Decision|0|||
161293640|NCT04632927|582455992|FG001|Overall Study|Physician Decision|1|||
161293641|NCT04632927|582455991|FG000|Overall Study|Subject decision|0|||
161293642|NCT04632927|582455992|FG001|Overall Study|Subject decision|1|||
161293643|NCT04632927|582455991|FG000|Overall Study|Withdrawal by Subject|0|||
161293644|NCT04632927|582455992|FG001|Overall Study|Withdrawal by Subject|1|||
161293645|NCT03827291|582455993|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
161293646|NCT03827291|582455994|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
161293647|NCT04795466|582455995|FG000|Overall Study|Adverse Event|3|||
161293648|NCT04795466|582455996|FG001|Overall Study|Adverse Event|1|||
161293649|NCT04795466|582455995|FG000|Overall Study|Physician Decision|1|||
161293650|NCT04795466|582455996|FG001|Overall Study|Physician Decision|0|||
161293651|NCT04795466|582455995|FG000|Overall Study|Withdrawal by Subject|2|||
161293652|NCT04795466|582455996|FG001|Overall Study|Withdrawal by Subject|1|||
161293653|NCT04066244|582456008|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
161293654|NCT04066244|582456009|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
161293655|NCT04066244|582456010|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
161293656|NCT04066244|582456011|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
161293657|NCT04066244|582456012|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
161293658|NCT04066244|582456013|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
161293659|NCT04066244|582456008|FG000|Part 2 (Cohort 5)|Death|0|||
161293660|NCT04066244|582456009|FG001|Part 2 (Cohort 5)|Death|0|||
161293661|NCT04066244|582456010|FG002|Part 2 (Cohort 5)|Death|0|||
161293662|NCT04066244|582456011|FG003|Part 2 (Cohort 5)|Death|0|||
161293663|NCT04066244|582456012|FG004|Part 2 (Cohort 5)|Death|0|||
161293664|NCT04066244|582456013|FG005|Part 2 (Cohort 5)|Death|2|||
161293665|NCT04066244|582456008|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161293666|NCT04066244|582456009|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161293667|NCT04066244|582456010|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161293668|NCT04066244|582456011|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161293669|NCT04066244|582456012|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
161293670|NCT04066244|582456013|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
161347606|NCT04556097|582656329|FG001|Overall Study|Missing identifier|4|||
161347607|NCT04556097|582656330|FG002|Overall Study|Missing identifier|0|||
161293671|NCT04066244|582456008|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161293672|NCT04066244|582456009|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161293673|NCT04066244|582456010|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161293674|NCT04066244|582456011|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161174473|NCT03907969|582015551|FG006|Combination Therapy Part A|Death|0|||
161293675|NCT04066244|582456012|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
161293676|NCT04066244|582456013|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
161293677|NCT00866281|582456014|FG000|Overall Study|Adverse Event|1|||
161293678|NCT00866281|582456015|FG001|Overall Study|Adverse Event|0|||
161293679|NCT00866281|582456014|FG000|Overall Study|Withdrawal by participants|3|||
161293680|NCT00866281|582456015|FG001|Overall Study|Withdrawal by participants|0|||
161293681|NCT00866281|582456014|FG000|Overall Study|Disease progression|3|||
161174474|NCT03907969|582015552|FG007|Combination Therapy Part A|Death|0|||
161174475|NCT03907969|582015553|FG008|Combination Therapy Part A|Death|1|||
161174476|NCT03907969|582015554|FG009|Combination Therapy Part A|Death|0|||
161174477|NCT03907969|582015555|FG010|Combination Therapy Part A|Death|1|||
161174478|NCT03907969|582015545|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
161174479|NCT03907969|582015546|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
161174480|NCT03907969|582015547|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
161174481|NCT03907969|582015548|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
161174482|NCT03907969|582015549|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
161174483|NCT03907969|582015550|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
161174484|NCT03907969|582015551|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
161174485|NCT03907969|582015552|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
161174486|NCT03907969|582015553|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
161174487|NCT03907969|582015554|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
161174488|NCT03907969|582015555|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
161174489|NCT03907969|582015545|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
161174490|NCT03907969|582015546|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
161174491|NCT03907969|582015547|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
161174492|NCT03907969|582015548|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
161174493|NCT03907969|582015549|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
161174494|NCT03907969|582015550|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
161174495|NCT03907969|582015551|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
161174496|NCT03907969|582015552|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
161174497|NCT03907969|582015553|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
161174498|NCT03907969|582015554|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
161174499|NCT03907969|582015555|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
161174500|NCT03907969|582015545|FG000|Combination Therapy Part A|Physician Decision|0|||
161174501|NCT03907969|582015546|FG001|Combination Therapy Part A|Physician Decision|0|||
161174502|NCT03907969|582015547|FG002|Combination Therapy Part A|Physician Decision|0|||
161174503|NCT03907969|582015548|FG003|Combination Therapy Part A|Physician Decision|0|||
161174504|NCT03907969|582015549|FG004|Combination Therapy Part A|Physician Decision|0|||
161174505|NCT03907969|582015550|FG005|Combination Therapy Part A|Physician Decision|0|||
161174506|NCT03907969|582015551|FG006|Combination Therapy Part A|Physician Decision|0|||
161174507|NCT03907969|582015552|FG007|Combination Therapy Part A|Physician Decision|1|||
161174508|NCT03907969|582015553|FG008|Combination Therapy Part A|Physician Decision|0|||
161174509|NCT03907969|582015554|FG009|Combination Therapy Part A|Physician Decision|0|||
161174510|NCT03907969|582015555|FG010|Combination Therapy Part A|Physician Decision|1|||
161174511|NCT00666536|582015556|FG000|Overall Study|Adverse Event|9|||
161174512|NCT00666536|582015557|FG001|Overall Study|Adverse Event|19|||
161174513|NCT00666536|582015556|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
161174514|NCT00666536|582015557|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
161174515|NCT00666536|582015556|FG000|Overall Study|Protocol deviation(s)|8|||
161174516|NCT00666536|582015557|FG001|Overall Study|Protocol deviation(s)|6|||
161174517|NCT00666536|582015556|FG000|Overall Study|Withdrawal by Subject|10|||
161174518|NCT00666536|582015557|FG001|Overall Study|Withdrawal by Subject|9|||
161174519|NCT00666536|582015556|FG000|Overall Study|Lost to Follow-up|4|||
161174520|NCT00666536|582015557|FG001|Overall Study|Lost to Follow-up|3|||
161174521|NCT02853123|582015561|FG000|Treatment Period 1|Adverse Event|0|||
161174522|NCT02853123|582015562|FG001|Treatment Period 1|Adverse Event|3|||
161174523|NCT02853123|582015561|FG000|Washout Period|Worsening of COPD|0|||
161174524|NCT02853123|582015562|FG001|Washout Period|Worsening of COPD|3|||
161174525|NCT02853123|582015561|FG000|Washout Period|Adverse Event|1|||
161174526|NCT02853123|582015562|FG001|Washout Period|Adverse Event|0|||
161174527|NCT01419015|582015573|FG000|Overall Study|Death|2|||
161174528|NCT01784211|582015576|FG000|Part A (Days 1-15)|Adverse Event|1|||
161174529|NCT01784211|582015577|FG001|Part A (Days 1-15)|Adverse Event|1|||
161174530|NCT01784211|582015578|FG002|Part A (Days 1-15)|Adverse Event|0|||
161174531|NCT01784211|582015579|FG003|Part A (Days 1-15)|Adverse Event|0|||
161174532|NCT01784211|582015580|FG004|Part A (Days 1-15)|Adverse Event|0|||
161174533|NCT01784211|582015581|FG005|Part A (Days 1-15)|Adverse Event|0|||
161174534|NCT01784211|582015576|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
161174535|NCT01784211|582015577|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
161174536|NCT01784211|582015578|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
161174537|NCT01784211|582015579|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
161174538|NCT01784211|582015580|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
161174539|NCT01784211|582015581|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
161174540|NCT00369278|582015584|FG000|Overall Study|Adverse Event|14|||
161174541|NCT00369278|582015585|FG001|Overall Study|Adverse Event|11|||
161174542|NCT00369278|582015584|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
161174543|NCT00369278|582015585|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161174544|NCT00369278|582015584|FG000|Overall Study|Protocol Violation|2|||
161174545|NCT00369278|582015585|FG001|Overall Study|Protocol Violation|1|||
161174546|NCT00369278|582015584|FG000|Overall Study|Withdrawal by Subject|2|||
161293682|NCT00866281|582456015|FG001|Overall Study|Disease progression|11|||
161293683|NCT00866281|582456014|FG000|Overall Study|New cancer therapy|0|||
161293684|NCT00866281|582456015|FG001|Overall Study|New cancer therapy|4|||
161293685|NCT00529087|582456018|FG000|Overall Study|Adverse Event|10|||
161293686|NCT00529087|582456019|FG001|Overall Study|Adverse Event|13|||
161293687|NCT00529087|582456020|FG002|Overall Study|Adverse Event|4|||
161293688|NCT00529087|582456018|FG000|Overall Study|Lost to Follow-up|6|||
161293689|NCT00529087|582456019|FG001|Overall Study|Lost to Follow-up|4|||
161293690|NCT00529087|582456020|FG002|Overall Study|Lost to Follow-up|1|||
161293691|NCT00529087|582456018|FG000|Overall Study|Protocol Violation|8|||
161293692|NCT00529087|582456019|FG001|Overall Study|Protocol Violation|7|||
161293693|NCT00529087|582456020|FG002|Overall Study|Protocol Violation|6|||
161293694|NCT00529087|582456018|FG000|Overall Study|Withdrawal by Subject|3|||
161293695|NCT00529087|582456019|FG001|Overall Study|Withdrawal by Subject|3|||
161293696|NCT00529087|582456020|FG002|Overall Study|Withdrawal by Subject|3|||
161293697|NCT00529087|582456018|FG000|Overall Study|Protocol deviation|1|||
161293698|NCT00529087|582456019|FG001|Overall Study|Protocol deviation|1|||
161293699|NCT00529087|582456020|FG002|Overall Study|Protocol deviation|2|||
161293700|NCT04168112|582456021|FG000|Overall Study|Lost to Follow-up|1|||
161293701|NCT04168112|582456022|FG001|Overall Study|Lost to Follow-up|0|||
161293702|NCT04168112|582456021|FG000|Overall Study|Withdrawal by Subject|1|||
161293703|NCT04168112|582456022|FG001|Overall Study|Withdrawal by Subject|0|||
161293704|NCT04426006|582456028|FG000|Inclusion|Protocol Violation|1|||
161293705|NCT04426006|582456028|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
161293706|NCT04426006|582456028|FG000|Inclusion|Blood sample at inclusion not done|1|||
161293707|NCT04426006|582456028|FG000|3 Months|Lost to Follow-up|17|||
161293708|NCT04426006|582456028|FG000|12 Months|Lost to Follow-up|38|||
161293709|NCT01262872|582456031|FG000|Step 2|Death|0|||
161293710|NCT01262872|582456032|FG001|Step 2|Death|0|||
161293711|NCT01262872|582456033|FG002|Step 2|Death|0|||
161293712|NCT01262872|582456034|FG003|Step 2|Death|1|||
161293713|NCT01262872|582456035|FG004|Step 2|Death|0|||
161293714|NCT01262872|582456036|FG005|Step 2|Death|2|||
161293715|NCT01262872|582456037|FG006|Step 2|Death|2|||
161293716|NCT01262872|582456038|FG007|Step 2|Death|1|||
161293717|NCT01262872|582456031|FG000|Step 2|Protocol Violation|0|||
161293718|NCT01262872|582456032|FG001|Step 2|Protocol Violation|0|||
161293719|NCT01262872|582456033|FG002|Step 2|Protocol Violation|1|||
161293720|NCT01262872|582456034|FG003|Step 2|Protocol Violation|0|||
161293721|NCT01262872|582456035|FG004|Step 2|Protocol Violation|0|||
161293722|NCT01262872|582456036|FG005|Step 2|Protocol Violation|0|||
161293723|NCT01262872|582456037|FG006|Step 2|Protocol Violation|3|||
161293724|NCT01262872|582456038|FG007|Step 2|Protocol Violation|1|||
161293725|NCT01262872|582456031|FG000|Step 2|Withdrawal by Subject|0|||
161293726|NCT01262872|582456032|FG001|Step 2|Withdrawal by Subject|0|||
161293727|NCT01262872|582456033|FG002|Step 2|Withdrawal by Subject|4|||
161293728|NCT01262872|582456034|FG003|Step 2|Withdrawal by Subject|6|||
161293729|NCT01262872|582456035|FG004|Step 2|Withdrawal by Subject|3|||
161293730|NCT01262872|582456036|FG005|Step 2|Withdrawal by Subject|1|||
161293731|NCT01262872|582456037|FG006|Step 2|Withdrawal by Subject|2|||
161293732|NCT01262872|582456038|FG007|Step 2|Withdrawal by Subject|1|||
161293733|NCT01262872|582456031|FG000|Step 2|Migrated/moved from study area|0|||
161293734|NCT01262872|582456032|FG001|Step 2|Migrated/moved from study area|0|||
161293735|NCT01262872|582456033|FG002|Step 2|Migrated/moved from study area|4|||
161293736|NCT01262872|582456034|FG003|Step 2|Migrated/moved from study area|3|||
161293737|NCT01262872|582456035|FG004|Step 2|Migrated/moved from study area|2|||
161293738|NCT01262872|582456036|FG005|Step 2|Migrated/moved from study area|6|||
161293739|NCT01262872|582456037|FG006|Step 2|Migrated/moved from study area|2|||
161293740|NCT01262872|582456038|FG007|Step 2|Migrated/moved from study area|3|||
161293741|NCT01000155|582456041|FG000|Overall Study|Withdrawal by Subject|1|||
161293742|NCT01000155|582456041|FG000|Overall Study|Adverse Event|1|||
161087356|NCT03965351|581706852|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
161087357|NCT01942785|581706856|FG000|Overall Study|Adverse Event|2|||
161087358|NCT01942785|581706856|FG000|Overall Study|Withdrawal by Subject|1|||
161087359|NCT01942785|581706856|FG000|Overall Study|Protocol Violation|1|||
161087360|NCT00935818|581706860|FG000|Overall Study|Withdrawal by Subject|45|||
161087361|NCT00935818|581706861|FG001|Overall Study|Withdrawal by Subject|50|||
161293743|NCT00720213|582456044|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
161293744|NCT00720213|582456045|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
161293745|NCT00720213|582456046|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
161293746|NCT01808066|582456050|FG000|Overall Study|Withdrawal by Subject|15|||
161293747|NCT02949973|582456055|FG000|Overall Study|Physician Decision|1|||
161293748|NCT01420068|582456056|FG000|Overall Study|Administrative problems|1|||
161293749|NCT01420068|582456057|FG001|Overall Study|Administrative problems|3|||
161293750|NCT01420068|582456056|FG000|Overall Study|Withdrawal by Subject|1|||
161293751|NCT01420068|582456057|FG001|Overall Study|Withdrawal by Subject|2|||
161293752|NCT01252095|582456058|FG000|Overall Study|Disease progression|1|||
161293753|NCT01252095|582456059|FG001|Overall Study|Disease progression|0|||
161293754|NCT00365794|582456060|FG000|Overall Study|Withdrawal by Subject|2|||
161293755|NCT00586703|582456061|FG000|Overall Study|Death|12|||
161293756|NCT04760626|582456062|FG000|Overall Study|Withdrawal by Subject|24|||
161293757|NCT04760626|582456063|FG001|Overall Study|Withdrawal by Subject|20|||
161293758|NCT04760626|582456062|FG000|Overall Study|Lost to Follow-up|14|||
161087362|NCT00935818|581706860|FG000|Overall Study|Lost to Follow-up|40|||
161087363|NCT00935818|581706861|FG001|Overall Study|Lost to Follow-up|42|||
161087364|NCT00935818|581706860|FG000|Overall Study|Adverse Event|6|||
161087365|NCT00935818|581706861|FG001|Overall Study|Adverse Event|7|||
161087366|NCT00935818|581706860|FG000|Overall Study|Physician Decision|0|||
161087367|NCT00935818|581706861|FG001|Overall Study|Physician Decision|1|||
161087368|NCT02631577|581706864|FG000|Overall Study|Death|1|||
161087369|NCT02631577|581706865|FG001|Overall Study|Death|7|||
161087370|NCT02631577|581706864|FG000|Overall Study|Withdrawal by Subject|0|||
161087371|NCT02631577|581706865|FG001|Overall Study|Withdrawal by Subject|3|||
161087372|NCT00604825|581706866|FG000|Overall Study|Adverse Event|2|||
161087373|NCT00604825|581706867|FG001|Overall Study|Adverse Event|6|||
161087374|NCT00604825|581706868|FG002|Overall Study|Adverse Event|7|||
161087375|NCT00604825|581706869|FG003|Overall Study|Adverse Event|4|||
161087376|NCT00604825|581706866|FG000|Overall Study|Lost to Follow-up|0|||
161087377|NCT00604825|581706867|FG001|Overall Study|Lost to Follow-up|3|||
161087378|NCT00604825|581706868|FG002|Overall Study|Lost to Follow-up|1|||
161087379|NCT00604825|581706869|FG003|Overall Study|Lost to Follow-up|0|||
161087380|NCT00604825|581706866|FG000|Overall Study|Protocol Violation|0|||
161087381|NCT00604825|581706867|FG001|Overall Study|Protocol Violation|1|||
161087382|NCT00604825|581706868|FG002|Overall Study|Protocol Violation|0|||
161087383|NCT00604825|581706869|FG003|Overall Study|Protocol Violation|0|||
161087384|NCT00604825|581706866|FG000|Overall Study|Withdrawal by Subject|4|||
161087385|NCT00604825|581706867|FG001|Overall Study|Withdrawal by Subject|3|||
161087386|NCT00604825|581706868|FG002|Overall Study|Withdrawal by Subject|5|||
161087387|NCT00604825|581706869|FG003|Overall Study|Withdrawal by Subject|5|||
161087388|NCT00604825|581706866|FG000|Overall Study|Lack of Efficacy|3|||
161087389|NCT00604825|581706867|FG001|Overall Study|Lack of Efficacy|2|||
161087390|NCT00604825|581706868|FG002|Overall Study|Lack of Efficacy|1|||
161087391|NCT00604825|581706869|FG003|Overall Study|Lack of Efficacy|0|||
161087392|NCT00604825|581706866|FG000|Overall Study|Did not meet eligibility criteria|0|||
161087393|NCT00604825|581706867|FG001|Overall Study|Did not meet eligibility criteria|0|||
161087394|NCT00604825|581706868|FG002|Overall Study|Did not meet eligibility criteria|2|||
161087395|NCT00604825|581706869|FG003|Overall Study|Did not meet eligibility criteria|0|||
161087396|NCT00604825|581706866|FG000|Overall Study|Physician Decision|0|||
161087397|NCT00604825|581706867|FG001|Overall Study|Physician Decision|0|||
161087398|NCT00604825|581706868|FG002|Overall Study|Physician Decision|0|||
161087399|NCT00604825|581706869|FG003|Overall Study|Physician Decision|1|||
161087400|NCT00604825|581706866|FG000|Overall Study|Exclusion criterion met|0|||
161087401|NCT00604825|581706867|FG001|Overall Study|Exclusion criterion met|0|||
161087402|NCT00604825|581706868|FG002|Overall Study|Exclusion criterion met|0|||
161087403|NCT00604825|581706869|FG003|Overall Study|Exclusion criterion met|1|||
161087404|NCT05593445|581706870|FG000|12-Week DBVC Period|Adverse Event|1|||
161087405|NCT05593445|581706871|FG001|12-Week DBVC Period|Adverse Event|0|||
161087406|NCT05593445|581706872|FG002|12-Week DBVC Period|Adverse Event|0|||
161087407|NCT05593445|581706873|FG003|12-Week DBVC Period|Adverse Event|0|||
161087408|NCT05593445|581706870|FG000|12-Week DBVC Period|Physician Decision|0|||
161087409|NCT05593445|581706871|FG001|12-Week DBVC Period|Physician Decision|1|||
161087410|NCT05593445|581706872|FG002|12-Week DBVC Period|Physician Decision|0|||
161087411|NCT05593445|581706873|FG003|12-Week DBVC Period|Physician Decision|0|||
161087412|NCT05593445|581706870|FG000|12-Week DBVC Period|Protocol Violation|0|||
161087413|NCT05593445|581706871|FG001|12-Week DBVC Period|Protocol Violation|1|||
161087414|NCT05593445|581706872|FG002|12-Week DBVC Period|Protocol Violation|0|||
161087415|NCT05593445|581706873|FG003|12-Week DBVC Period|Protocol Violation|0|||
161087416|NCT05593445|581706870|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
161087417|NCT05593445|581706871|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
161087418|NCT05593445|581706872|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
161087419|NCT05593445|581706873|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
161087420|NCT05593445|581706870|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
161087421|NCT05593445|581706871|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
161087422|NCT05593445|581706872|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
161087423|NCT05593445|581706873|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
161087424|NCT05593445|581706870|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
161087425|NCT05593445|581706871|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
161087426|NCT05593445|581706872|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
161087427|NCT05593445|581706873|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
161087428|NCT05593445|581706870|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
161087429|NCT05593445|581706871|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
161087430|NCT05593445|581706872|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
161087431|NCT05593445|581706873|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
161087432|NCT05593445|581706870|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161087433|NCT05593445|581706871|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161293759|NCT04760626|582456063|FG001|Overall Study|Lost to Follow-up|19|||
161293760|NCT04760626|582456062|FG000|Overall Study|Physician Decision|3|||
161087434|NCT05593445|581706872|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
161087435|NCT05593445|581706873|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
161087436|NCT00812331|581708354|FG000|Overall Study|Adverse Event|1|||
161087437|NCT00812331|581708355|FG001|Overall Study|Adverse Event|0|||
161087438|NCT00812331|581708356|FG002|Overall Study|Adverse Event|0|||
161087439|NCT00812331|581708357|FG003|Overall Study|Adverse Event|0|||
161087440|NCT00812331|581708358|FG004|Overall Study|Adverse Event|0|||
161087441|NCT02502799|581708359|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
161087442|NCT02502799|581708360|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
161087443|NCT02502799|581708361|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
161087444|NCT02502799|581708362|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
161087445|NCT02502799|581708359|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
161087446|NCT02502799|581708360|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
161087447|NCT02502799|581708361|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
161087448|NCT02502799|581708362|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
161087449|NCT02502799|581708359|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
161087450|NCT02502799|581708360|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
161087451|NCT02502799|581708361|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
161087452|NCT02502799|581708362|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
161087453|NCT02502799|581708359|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
161087454|NCT02502799|581708360|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
161087455|NCT02502799|581708361|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
161087456|NCT02502799|581708362|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
161087457|NCT02502799|581708359|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
161087458|NCT02502799|581708360|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
161087459|NCT02502799|581708361|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
161087460|NCT02502799|581708362|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
161087461|NCT00153062|581708368|FG000|Overall Study|Death|360|||
161087462|NCT00153062|581708369|FG001|Overall Study|Death|352|||
161087463|NCT00153062|581708370|FG002|Overall Study|Death|369|||
161087464|NCT00153062|581708371|FG003|Overall Study|Death|365|||
161087465|NCT00153062|581708368|FG000|Overall Study|Withdrawal by Subject|14|||
161087466|NCT00153062|581708369|FG001|Overall Study|Withdrawal by Subject|30|||
161087467|NCT00153062|581708370|FG002|Overall Study|Withdrawal by Subject|27|||
161087468|NCT00153062|581708371|FG003|Overall Study|Withdrawal by Subject|28|||
161087469|NCT00153062|581708368|FG000|Overall Study|Lost to Follow-up|12|||
161087470|NCT00153062|581708369|FG001|Overall Study|Lost to Follow-up|20|||
161087471|NCT00153062|581708370|FG002|Overall Study|Lost to Follow-up|15|||
161087472|NCT00153062|581708371|FG003|Overall Study|Lost to Follow-up|16|||
161087473|NCT00153062|581708368|FG000|Overall Study|Adverse Event|0|||
161087474|NCT00153062|581708369|FG001|Overall Study|Adverse Event|1|||
161087475|NCT00153062|581708370|FG002|Overall Study|Adverse Event|1|||
161087476|NCT00153062|581708371|FG003|Overall Study|Adverse Event|0|||
161087477|NCT00153062|581708368|FG000|Overall Study|Protocol Violation|0|||
161087478|NCT00153062|581708369|FG001|Overall Study|Protocol Violation|2|||
161087479|NCT00153062|581708370|FG002|Overall Study|Protocol Violation|1|||
161087480|NCT00153062|581708371|FG003|Overall Study|Protocol Violation|1|||
161087481|NCT00153062|581708368|FG000|Overall Study|No disposition data available|1|||
161087482|NCT00153062|581708369|FG001|Overall Study|No disposition data available|1|||
161087483|NCT00153062|581708370|FG002|Overall Study|No disposition data available|1|||
161087484|NCT00153062|581708371|FG003|Overall Study|No disposition data available|1|||
161087485|NCT00153062|581708368|FG000|Overall Study|Other|0|||
161087486|NCT00153062|581708369|FG001|Overall Study|Other|0|||
161087487|NCT00153062|581708370|FG002|Overall Study|Other|1|||
161087488|NCT00153062|581708371|FG003|Overall Study|Other|0|||
161087489|NCT02359877|581708372|FG000|Overall Study|Withdrawal by Subject|1|||
161087490|NCT02359877|581708373|FG001|Overall Study|Withdrawal by Subject|0|||
161087491|NCT02359877|581708374|FG002|Overall Study|Withdrawal by Subject|0|||
161087492|NCT02359877|581708375|FG003|Overall Study|Withdrawal by Subject|2|||
161087493|NCT02359877|581708372|FG000|Overall Study|Adverse Event|0|||
161087494|NCT02359877|581708373|FG001|Overall Study|Adverse Event|0|||
161293761|NCT04760626|582456063|FG001|Overall Study|Physician Decision|5|||
161087495|NCT02359877|581708374|FG002|Overall Study|Adverse Event|0|||
161087496|NCT02359877|581708375|FG003|Overall Study|Adverse Event|1|||
161087497|NCT01589237|581708388|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
161087498|NCT01589237|581708389|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
161087499|NCT01589237|581708390|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
161087500|NCT01589237|581708391|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
161087501|NCT01589237|581708388|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
161087502|NCT01589237|581708389|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
161087503|NCT01589237|581708390|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
161087504|NCT01589237|581708391|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
161293762|NCT04760626|582456062|FG000|Overall Study|Death|3|||
161293763|NCT04760626|582456063|FG001|Overall Study|Death|6|||
161293764|NCT04760626|582456062|FG000|Overall Study|Site closure|1|||
161293765|NCT04760626|582456063|FG001|Overall Study|Site closure|0|||
161293766|NCT02554682|582456066|FG000|Overall Study|Lost to Follow-up|11|||
161293767|NCT02554682|582456067|FG001|Overall Study|Lost to Follow-up|9|||
161293768|NCT02554682|582456068|FG002|Overall Study|Lost to Follow-up|4|||
161293769|NCT02554682|582456069|FG003|Overall Study|Lost to Follow-up|3|||
161293770|NCT02554682|582456070|FG004|Overall Study|Lost to Follow-up|2|||
161293771|NCT02554682|582456071|FG005|Overall Study|Lost to Follow-up|1|||
161293772|NCT02554682|582456072|FG006|Overall Study|Lost to Follow-up|6|||
161293773|NCT02554682|582456073|FG007|Overall Study|Lost to Follow-up|6|||
161293774|NCT02554682|582456074|FG008|Overall Study|Lost to Follow-up|2|||
161293775|NCT02554682|582456075|FG009|Overall Study|Lost to Follow-up|2|||
161293776|NCT02554682|582456066|FG000|Overall Study|Withdrawal by Subject|2|||
161293777|NCT02554682|582456067|FG001|Overall Study|Withdrawal by Subject|1|||
161293778|NCT02554682|582456068|FG002|Overall Study|Withdrawal by Subject|0|||
161293779|NCT02554682|582456069|FG003|Overall Study|Withdrawal by Subject|0|||
161293780|NCT02554682|582456070|FG004|Overall Study|Withdrawal by Subject|0|||
161293781|NCT02554682|582456071|FG005|Overall Study|Withdrawal by Subject|0|||
161293782|NCT02554682|582456072|FG006|Overall Study|Withdrawal by Subject|0|||
161293783|NCT02554682|582456073|FG007|Overall Study|Withdrawal by Subject|0|||
161293784|NCT02554682|582456074|FG008|Overall Study|Withdrawal by Subject|0|||
161293785|NCT02554682|582456075|FG009|Overall Study|Withdrawal by Subject|0|||
161293786|NCT02554682|582456066|FG000|Overall Study|Physician Decision|2|||
161293787|NCT02554682|582456067|FG001|Overall Study|Physician Decision|2|||
161293788|NCT02554682|582456068|FG002|Overall Study|Physician Decision|0|||
161293789|NCT02554682|582456069|FG003|Overall Study|Physician Decision|0|||
161293790|NCT02554682|582456070|FG004|Overall Study|Physician Decision|0|||
161293791|NCT02554682|582456071|FG005|Overall Study|Physician Decision|0|||
161293792|NCT02554682|582456072|FG006|Overall Study|Physician Decision|0|||
161293793|NCT02554682|582456073|FG007|Overall Study|Physician Decision|0|||
161293794|NCT02554682|582456074|FG008|Overall Study|Physician Decision|0|||
161293795|NCT02554682|582456075|FG009|Overall Study|Physician Decision|0|||
161293796|NCT00884117|582456078|FG000|Overall Study|Adverse Event|2|||
161293797|NCT00884117|582456078|FG000|Overall Study|Withdrawal by Subject|89|||
161293798|NCT00884117|582456078|FG000|Overall Study|Death|3|||
161293799|NCT00884117|582456078|FG000|Overall Study|Lost to Follow-up|143|||
161293800|NCT00884117|582456078|FG000|Overall Study|Other|12|||
161293801|NCT02946463|582456079|FG000|Primary Evaluation Period|Physician Decision|0|||
161293802|NCT02946463|582456080|FG001|Primary Evaluation Period|Physician Decision|1|||
161293803|NCT02946463|582456081|FG002|Primary Evaluation Period|Physician Decision|0|||
161293804|NCT02946463|582456082|FG003|Primary Evaluation Period|Physician Decision|0|||
161293805|NCT02946463|582456079|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
161293806|NCT02946463|582456080|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
161293807|NCT02946463|582456081|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
161293808|NCT02946463|582456082|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
161293809|NCT02946463|582456079|FG000|Extension Period|Death|4|||
161293810|NCT02946463|582456080|FG001|Extension Period|Death|4|||
161293811|NCT02946463|582456081|FG002|Extension Period|Death|0|||
161293812|NCT02946463|582456082|FG003|Extension Period|Death|0|||
161087505|NCT01589237|581708388|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
161087506|NCT01589237|581708389|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
161087507|NCT01589237|581708390|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
161087508|NCT01589237|581708391|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
161087509|NCT01589237|581708388|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
161087510|NCT01589237|581708389|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
161087511|NCT01589237|581708390|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
161087512|NCT01589237|581708391|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
161087513|NCT00117845|581708392|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
161087514|NCT02349425|581708394|FG000|Period 1|Adverse Event|1|||
161087515|NCT02349425|581708395|FG001|Period 1|Adverse Event|1|||
161087516|NCT02349425|581708396|FG002|Period 1|Adverse Event|0|||
161087517|NCT02349425|581708397|FG003|Period 1|Adverse Event|0|||
161087518|NCT02349425|581708394|FG000|Period 2|Adverse Event|0|||
161087519|NCT02349425|581708395|FG001|Period 2|Adverse Event|1|||
161174547|NCT00369278|582015585|FG001|Overall Study|Withdrawal by Subject|2|||
161293813|NCT02946463|582456079|FG000|Extension Period|Withdrawal by Subject|4|||
161293814|NCT02946463|582456080|FG001|Extension Period|Withdrawal by Subject|3|||
161293815|NCT02946463|582456081|FG002|Extension Period|Withdrawal by Subject|0|||
161293816|NCT02946463|582456082|FG003|Extension Period|Withdrawal by Subject|0|||
161293817|NCT02946463|582456079|FG000|Extension Period|Other than specified|2|||
161174548|NCT00369278|582015584|FG000|Overall Study|Lost to Follow-up|1|||
161293818|NCT02946463|582456080|FG001|Extension Period|Other than specified|3|||
161293819|NCT02946463|582456081|FG002|Extension Period|Other than specified|2|||
161293820|NCT02946463|582456082|FG003|Extension Period|Other than specified|0|||
161293821|NCT02946463|582456079|FG000|Extension Period|Physician Decision|1|||
161293822|NCT02946463|582456080|FG001|Extension Period|Physician Decision|4|||
161293823|NCT02946463|582456081|FG002|Extension Period|Physician Decision|0|||
161293824|NCT02946463|582456082|FG003|Extension Period|Physician Decision|0|||
161293825|NCT02946463|582456079|FG000|Extension Period|Pregnancy|3|||
161293826|NCT02946463|582456080|FG001|Extension Period|Pregnancy|1|||
161293827|NCT02946463|582456081|FG002|Extension Period|Pregnancy|0|||
161293828|NCT02946463|582456082|FG003|Extension Period|Pregnancy|0|||
161293829|NCT02946463|582456079|FG000|Extension Period|Adverse Event|1|||
161293830|NCT02946463|582456080|FG001|Extension Period|Adverse Event|2|||
161293831|NCT02946463|582456081|FG002|Extension Period|Adverse Event|0|||
161293832|NCT02946463|582456082|FG003|Extension Period|Adverse Event|0|||
161293833|NCT02946463|582456079|FG000|Extension Period|Lost to Follow-up|1|||
161293834|NCT02946463|582456080|FG001|Extension Period|Lost to Follow-up|0|||
161293835|NCT02946463|582456081|FG002|Extension Period|Lost to Follow-up|0|||
161293836|NCT02946463|582456082|FG003|Extension Period|Lost to Follow-up|0|||
161293837|NCT02022202|582456083|FG000|Overall Study|Withdrawal by Subject|2|||
161293838|NCT02022202|582456083|FG000|Overall Study|Disease Progression|3|||
161293839|NCT02022202|582456083|FG000|Overall Study|Desire go to immediately to surgery|3|||
161293840|NCT01565889|582456085|FG000|Part A|Withdrawal by Subject|1|||
161293841|NCT01565889|582456086|FG001|Part A|Withdrawal by Subject|0|||
161293842|NCT01565889|582456087|FG002|Part A|Withdrawal by Subject|0|||
161293843|NCT01565889|582456088|FG003|Part A|Withdrawal by Subject|0|||
161293844|NCT01565889|582456089|FG004|Part A|Withdrawal by Subject|0|||
161293845|NCT01565889|582456090|FG005|Part A|Withdrawal by Subject|0|||
161293846|NCT01565889|582456085|FG000|Part B|Withdrawal by Subject|0|||
161293847|NCT01565889|582456086|FG001|Part B|Withdrawal by Subject|0|||
161293848|NCT01565889|582456087|FG002|Part B|Withdrawal by Subject|0|||
161293849|NCT01565889|582456088|FG003|Part B|Withdrawal by Subject|0|||
161293850|NCT01565889|582456089|FG004|Part B|Withdrawal by Subject|0|||
161293851|NCT01565889|582456090|FG005|Part B|Withdrawal by Subject|1|||
161293852|NCT01565889|582456085|FG000|Part B|Lack of Efficacy|0|||
161293853|NCT01565889|582456086|FG001|Part B|Lack of Efficacy|0|||
161293854|NCT01565889|582456087|FG002|Part B|Lack of Efficacy|0|||
161293855|NCT01565889|582456088|FG003|Part B|Lack of Efficacy|0|||
161293856|NCT01565889|582456089|FG004|Part B|Lack of Efficacy|0|||
161293857|NCT01565889|582456090|FG005|Part B|Lack of Efficacy|2|||
161293858|NCT01565889|582456085|FG000|Part B|Lost to Follow-up|0|||
161293859|NCT01565889|582456086|FG001|Part B|Lost to Follow-up|0|||
161293860|NCT01565889|582456087|FG002|Part B|Lost to Follow-up|0|||
161293861|NCT01565889|582456088|FG003|Part B|Lost to Follow-up|0|||
161293862|NCT01565889|582456089|FG004|Part B|Lost to Follow-up|0|||
161293863|NCT01565889|582456090|FG005|Part B|Lost to Follow-up|1|||
161293864|NCT00122382|582456091|FG000|Double-Blind Study|Adverse Event|9|||
161293865|NCT00122382|582456092|FG001|Double-Blind Study|Adverse Event|11|||
161293866|NCT00122382|582456093|FG002|Double-Blind Study|Adverse Event|0|||
161293867|NCT00122382|582456091|FG000|Double-Blind Study|Death|2|||
161293868|NCT00122382|582456092|FG001|Double-Blind Study|Death|2|||
161293869|NCT00122382|582456093|FG002|Double-Blind Study|Death|0|||
161293870|NCT00122382|582456091|FG000|Double-Blind Study|Lack of Efficacy|0|||
161347608|NCT04556097|582656331|FG003|Overall Study|Missing identifier|0|||
161087520|NCT02349425|581708396|FG002|Period 2|Adverse Event|1|||
161087521|NCT02349425|581708397|FG003|Period 2|Adverse Event|0|||
161087522|NCT00616902|581708398|FG000|Overall Study|Termination of study|6|||
161087523|NCT00616902|581708399|FG001|Overall Study|Termination of study|6|||
161087524|NCT03207009|581708400|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
161087525|NCT01491672|581708401|FG000|Overall Study|Lost to Follow-up|0|||
161087526|NCT01491672|581708402|FG001|Overall Study|Lost to Follow-up|4|||
161087527|NCT01491672|581708403|FG002|Overall Study|Lost to Follow-up|1|||
161087528|NCT01491672|581708401|FG000|Overall Study|Withdrawal by Subject|6|||
161087529|NCT01491672|581708402|FG001|Overall Study|Withdrawal by Subject|7|||
161087530|NCT01491672|581708403|FG002|Overall Study|Withdrawal by Subject|0|||
161087531|NCT01491672|581708401|FG000|Overall Study|Adverse Event|8|||
161087532|NCT01491672|581708402|FG001|Overall Study|Adverse Event|10|||
161087533|NCT01491672|581708403|FG002|Overall Study|Adverse Event|4|||
161087534|NCT01491672|581708401|FG000|Overall Study|Disease progression|42|||
161087535|NCT01491672|581708402|FG001|Overall Study|Disease progression|34|||
161087536|NCT01491672|581708403|FG002|Overall Study|Disease progression|6|||
161087537|NCT01491672|581708401|FG000|Overall Study|Protocol deviation|0|||
161087538|NCT01491672|581708402|FG001|Overall Study|Protocol deviation|1|||
161087539|NCT01491672|581708403|FG002|Overall Study|Protocol deviation|0|||
161087540|NCT01491672|581708401|FG000|Overall Study|Death|0|||
161087541|NCT01491672|581708402|FG001|Overall Study|Death|4|||
161087542|NCT01491672|581708403|FG002|Overall Study|Death|0|||
161087543|NCT01143038|581708404|FG000|Overall Study|Withdrawal by Subject|4|||
161087544|NCT01143038|581708404|FG000|Overall Study|Requirement for alternative therapy|5|||
161087545|NCT01143038|581708404|FG000|Overall Study|Adverse Event|3|||
161087546|NCT01143038|581708404|FG000|Overall Study|Lost to Follow-up|2|||
161087547|NCT01143038|581708404|FG000|Overall Study|Protocol Deviation|1|||
161087548|NCT01143038|581708404|FG000|Overall Study|Death|1|||
161293871|NCT00122382|582456092|FG001|Double-Blind Study|Lack of Efficacy|8|||
161293872|NCT00122382|582456093|FG002|Double-Blind Study|Lack of Efficacy|0|||
161293873|NCT00122382|582456091|FG000|Double-Blind Study|Lost to Follow-up|2|||
161293874|NCT00122382|582456092|FG001|Double-Blind Study|Lost to Follow-up|1|||
161293875|NCT00122382|582456093|FG002|Double-Blind Study|Lost to Follow-up|0|||
161293876|NCT00122382|582456091|FG000|Double-Blind Study|Pregnancy|2|||
161293877|NCT00122382|582456092|FG001|Double-Blind Study|Pregnancy|0|||
161293878|NCT00122382|582456093|FG002|Double-Blind Study|Pregnancy|0|||
161293879|NCT00122382|582456091|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
161293880|NCT00122382|582456092|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
161293881|NCT00122382|582456093|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
161293882|NCT00122382|582456091|FG000|Double-Blind Study|Withdrawal of Consent|7|||
161293883|NCT00122382|582456092|FG001|Double-Blind Study|Withdrawal of Consent|3|||
161293884|NCT00122382|582456093|FG002|Double-Blind Study|Withdrawal of Consent|0|||
161293885|NCT00122382|582456091|FG000|Double-Blind Study|Protocol Violation|1|||
161293886|NCT00122382|582456092|FG001|Double-Blind Study|Protocol Violation|0|||
161293887|NCT00122382|582456093|FG002|Double-Blind Study|Protocol Violation|0|||
161347609|NCT04556097|582656328|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
161174549|NCT00369278|582015585|FG001|Overall Study|Lost to Follow-up|0|||
161174550|NCT00369278|582015584|FG000|Overall Study|Graft loss|1|||
161174551|NCT00369278|582015585|FG001|Overall Study|Graft loss|2|||
161174552|NCT01017549|582015590|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
161174553|NCT01017549|582015590|FG000|One-year Follow-up|Lost to Follow-up|2|||
161174554|NCT01017549|582015590|FG000|One-year Follow-up|Withdrawal by Subject|5|||
161174555|NCT01017549|582015590|FG000|5 Year Follow-up|Lost to Follow-up|9|||
161174556|NCT01017549|582015590|FG000|5 Year Follow-up|Mastectomy|3|||
161174557|NCT03725293|582015597|FG000|Overall Study|Physician Decision|9|||
161174558|NCT03725293|582015598|FG001|Overall Study|Physician Decision|6|||
161174559|NCT03725293|582015597|FG000|Overall Study|alternative vascular access needs|1|||
161174560|NCT03725293|582015598|FG001|Overall Study|alternative vascular access needs|2|||
161174561|NCT03725293|582015597|FG000|Overall Study|venous anatomy screen failures|2|||
161174562|NCT03725293|582015598|FG001|Overall Study|venous anatomy screen failures|1|||
161174563|NCT02143141|582015599|FG000|Overall Study|pain scores at 24 hours not collected|1|||
161174564|NCT02143141|582015600|FG001|Overall Study|pain scores at 24 hours not collected|0|||
161174565|NCT01057862|582015601|FG000|Overall Study|Withdrawal by Subject|1|||
161174566|NCT01057862|582015602|FG001|Overall Study|Withdrawal by Subject|2|||
161174567|NCT03363165|582015603|FG000|3-month Follow-up|Death|0|||
161174568|NCT03363165|582015604|FG001|3-month Follow-up|Death|1|||
161174569|NCT03363165|582015603|FG000|6-month Follow-up|Death|0|||
161174570|NCT03363165|582015604|FG001|6-month Follow-up|Death|1|||
161174571|NCT03363165|582015603|FG000|6-month Follow-up|Withdrawal by Subject|1|||
161174572|NCT03363165|582015604|FG001|6-month Follow-up|Withdrawal by Subject|1|||
161174573|NCT03363165|582015603|FG000|12-month Follow-up|Death|1|||
161174574|NCT03363165|582015604|FG001|12-month Follow-up|Death|1|||
161174575|NCT03363165|582015603|FG000|12-month Follow-up|Withdrawal by Subject|1|||
161174576|NCT03363165|582015604|FG001|12-month Follow-up|Withdrawal by Subject|1|||
161174577|NCT02255760|582015605|FG000|Overall Study|Lost to Follow-up|0|||
161174578|NCT02255760|582015606|FG001|Overall Study|Lost to Follow-up|1|||
161174579|NCT02255760|582015607|FG002|Overall Study|Lost to Follow-up|0|||
161174580|NCT02255760|582015608|FG003|Overall Study|Lost to Follow-up|0|||
161174581|NCT02255760|582015609|FG004|Overall Study|Lost to Follow-up|0|||
161174582|NCT00003838|582015610|FG000|Overall Study|Death|0|||
161174583|NCT00003838|582015611|FG001|Overall Study|Death|12|||
161174584|NCT00003838|582015612|FG002|Overall Study|Death|7|||
161174585|NCT00003838|582015610|FG000|Overall Study|Lost to Follow-up|0|||
161174586|NCT00003838|582015611|FG001|Overall Study|Lost to Follow-up|1|||
161174587|NCT00003838|582015612|FG002|Overall Study|Lost to Follow-up|1|||
161174588|NCT00003838|582015610|FG000|Overall Study|Disease Progression|0|||
161087549|NCT00657020|581708409|FG000|PERIOD 1|Adverse Event|0|||
161087550|NCT00657020|581708410|FG001|PERIOD 1|Adverse Event|1|||
161087551|NCT01183234|581708411|FG000|First Intervention|Adverse Event|1|||
161087552|NCT01183234|581708412|FG001|First Intervention|Adverse Event|0|||
161087553|NCT00822172|581708415|FG000|Overall Study|Adverse Event|10|||
161087554|NCT00822172|581708416|FG001|Overall Study|Adverse Event|12|||
161087555|NCT00822172|581708415|FG000|Overall Study|Death|1|||
161087556|NCT00822172|581708416|FG001|Overall Study|Death|0|||
161087557|NCT00822172|581708415|FG000|Overall Study|Lost to Follow-up|3|||
161087558|NCT00822172|581708416|FG001|Overall Study|Lost to Follow-up|1|||
161087559|NCT00822172|581708415|FG000|Overall Study|Withdrawal by Subject|1|||
161087560|NCT00822172|581708416|FG001|Overall Study|Withdrawal by Subject|4|||
161087561|NCT00822172|581708415|FG000|Overall Study|site closed|0|||
161087562|NCT00822172|581708416|FG001|Overall Study|site closed|1|||
161087563|NCT00822172|581708415|FG000|Overall Study|Other|0|||
161174589|NCT00003838|582015611|FG001|Overall Study|Disease Progression|12|||
161174590|NCT00003838|582015612|FG002|Overall Study|Disease Progression|0|||
161174591|NCT00425113|582015613|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
161293888|NCT00122382|582456091|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
161293889|NCT00122382|582456092|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
161293890|NCT00122382|582456093|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
161293891|NCT00122382|582456091|FG000|Double-Blind Study|Randomized but not treated|0|||
161293892|NCT00122382|582456092|FG001|Double-Blind Study|Randomized but not treated|2|||
161293893|NCT00122382|582456093|FG002|Double-Blind Study|Randomized but not treated|0|||
161293894|NCT00122382|582456091|FG000|Open-Label Study|Adverse Event|0|||
161293895|NCT00122382|582456092|FG001|Open-Label Study|Adverse Event|0|||
161293896|NCT00122382|582456093|FG002|Open-Label Study|Adverse Event|11|||
161293897|NCT00122382|582456091|FG000|Open-Label Study|Death|0|||
161293898|NCT00122382|582456092|FG001|Open-Label Study|Death|0|||
161293899|NCT00122382|582456093|FG002|Open-Label Study|Death|2|||
161293900|NCT00122382|582456091|FG000|Open-Label Study|Lack of Efficacy|0|||
161293901|NCT00122382|582456092|FG001|Open-Label Study|Lack of Efficacy|0|||
161293902|NCT00122382|582456093|FG002|Open-Label Study|Lack of Efficacy|3|||
161293903|NCT00122382|582456091|FG000|Open-Label Study|Lost to Follow-up|0|||
161293904|NCT00122382|582456092|FG001|Open-Label Study|Lost to Follow-up|0|||
161293905|NCT00122382|582456093|FG002|Open-Label Study|Lost to Follow-up|3|||
161293906|NCT00122382|582456091|FG000|Open-Label Study|Pregnancy|0|||
161293907|NCT00122382|582456092|FG001|Open-Label Study|Pregnancy|0|||
161293908|NCT00122382|582456093|FG002|Open-Label Study|Pregnancy|2|||
161293909|NCT00122382|582456091|FG000|Open-Label Study|Poor/Non-Compliance|0|||
161293910|NCT00122382|582456092|FG001|Open-Label Study|Poor/Non-Compliance|0|||
161293911|NCT00122382|582456093|FG002|Open-Label Study|Poor/Non-Compliance|1|||
161293912|NCT00122382|582456091|FG000|Open-Label Study|Withdrawal of Consent|0|||
161293913|NCT00122382|582456092|FG001|Open-Label Study|Withdrawal of Consent|0|||
161293914|NCT00122382|582456093|FG002|Open-Label Study|Withdrawal of Consent|4|||
161293915|NCT02040805|582456095|FG000|Overall Study|Lost to Follow-up|14|||
161293916|NCT02040805|582456096|FG001|Overall Study|Lost to Follow-up|9|||
161293917|NCT02040805|582456095|FG000|Overall Study|Withdrawal by Subject|28|||
161293918|NCT02040805|582456096|FG001|Overall Study|Withdrawal by Subject|41|||
161293919|NCT00908544|582456097|FG000|Overall Study|Withdrawal by Subject|2|||
161293920|NCT00908544|582456098|FG001|Overall Study|Withdrawal by Subject|4|||
161293921|NCT00908544|582456097|FG000|Overall Study|Lack of Efficacy|0|||
161293922|NCT00908544|582456098|FG001|Overall Study|Lack of Efficacy|1|||
161293923|NCT00908544|582456097|FG000|Overall Study|Pregnancy|1|||
161293924|NCT00908544|582456098|FG001|Overall Study|Pregnancy|0|||
161293925|NCT00908544|582456097|FG000|Overall Study|Relocation abroad|1|||
161293926|NCT00908544|582456098|FG001|Overall Study|Relocation abroad|1|||
161293927|NCT00908544|582456097|FG000|Overall Study|Unable to visit sutdy center|1|||
161293928|NCT00908544|582456098|FG001|Overall Study|Unable to visit sutdy center|0|||
161293929|NCT02259010|582456099|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
161293930|NCT02462603|582456100|FG000|Overall Study|Investigator Decision|1|||
161293931|NCT02462603|582456100|FG000|Overall Study|Non-Compliance|1|||
161293932|NCT02462603|582456100|FG000|Overall Study|Withdrawal by Subject|2|||
161293933|NCT01662492|582456101|FG000|Overall Study|Other miscellaneous reasons.|1|||
161293934|NCT01662492|582456102|FG001|Overall Study|Other miscellaneous reasons.|0|||
161293935|NCT01662492|582456103|FG002|Overall Study|Other miscellaneous reasons.|1|||
161293936|NCT01662492|582456101|FG000|Overall Study|Withdrawal by Subject|0|||
161293937|NCT01662492|582456102|FG001|Overall Study|Withdrawal by Subject|0|||
161293938|NCT01662492|582456103|FG002|Overall Study|Withdrawal by Subject|1|||
161293939|NCT01662492|582456101|FG000|Overall Study|Protocol Violation|1|||
161293940|NCT01662492|582456102|FG001|Overall Study|Protocol Violation|0|||
161293941|NCT01662492|582456103|FG002|Overall Study|Protocol Violation|0|||
161293942|NCT01662492|582456101|FG000|Overall Study|Lost to Follow-up|0|||
161293943|NCT01662492|582456102|FG001|Overall Study|Lost to Follow-up|0|||
161293944|NCT01662492|582456103|FG002|Overall Study|Lost to Follow-up|2|||
161293945|NCT01662492|582456101|FG000|Overall Study|Lack of Efficacy|1|||
161293946|NCT01662492|582456102|FG001|Overall Study|Lack of Efficacy|1|||
161293947|NCT01662492|582456103|FG002|Overall Study|Lack of Efficacy|2|||
161293948|NCT01591096|582456104|FG000|Overall Study|Adverse Event|1|||
161293949|NCT01831635|582456105|FG000|Overall Study|Withdrawal by Subject|0|||
161293950|NCT01831635|582456106|FG001|Overall Study|Withdrawal by Subject|2|||
161293951|NCT01831635|582456107|FG002|Overall Study|Withdrawal by Subject|0|||
161293952|NCT03655405|582456110|FG000|Overall Study|Death after initial data collection|4|||
161293953|NCT03655405|582456111|FG001|Overall Study|Death after initial data collection|2|||
161293954|NCT03655405|582456110|FG000|Overall Study|Died before initial data collection|1|||
161293955|NCT03655405|582456111|FG001|Overall Study|Died before initial data collection|2|||
161293956|NCT03655405|582456110|FG000|Overall Study|Protocol Violation|0|||
161293957|NCT03655405|582456111|FG001|Overall Study|Protocol Violation|1|||
161293958|NCT01991743|582456112|FG000|Overall Study|external cephalic version not performed|0|||
161293959|NCT01991743|582456113|FG001|Overall Study|external cephalic version not performed|0|||
161293960|NCT01991743|582456114|FG002|Overall Study|external cephalic version not performed|1|||
161293961|NCT01991743|582456115|FG003|Overall Study|external cephalic version not performed|0|||
161293962|NCT02859337|582456117|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
161293963|NCT02859337|582456118|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
161293964|NCT02859337|582456119|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
161293965|NCT02859337|582456117|FG000|Overall Study|Withdrawal by Subject|3|||
161293966|NCT02859337|582456118|FG001|Overall Study|Withdrawal by Subject|1|||
161293967|NCT02859337|582456119|FG002|Overall Study|Withdrawal by Subject|0|||
161293968|NCT02859337|582456117|FG000|Overall Study|Lost to Follow-up|1|||
161293969|NCT02859337|582456118|FG001|Overall Study|Lost to Follow-up|0|||
161293970|NCT02859337|582456119|FG002|Overall Study|Lost to Follow-up|0|||
161293971|NCT00848718|582456120|FG000|Overall Study|Adverse Event|2|||
161293972|NCT00848718|582456121|FG001|Overall Study|Adverse Event|2|||
161293973|NCT00848718|582456122|FG002|Overall Study|Adverse Event|1|||
161293974|NCT00848718|582456123|FG003|Overall Study|Adverse Event|1|||
161293975|NCT00848718|582456124|FG004|Overall Study|Adverse Event|1|||
161293976|NCT00848718|582456125|FG005|Overall Study|Adverse Event|0|||
161293977|NCT00848718|582456126|FG006|Overall Study|Adverse Event|0|||
161293978|NCT00848718|582456127|FG007|Overall Study|Adverse Event|1|||
161293979|NCT00848718|582456128|FG008|Overall Study|Adverse Event|1|||
161293980|NCT00848718|582456129|FG009|Overall Study|Adverse Event|0|||
161293981|NCT00848718|582456130|FG010|Overall Study|Adverse Event|0|||
161293982|NCT00848718|582456131|FG011|Overall Study|Adverse Event|0|||
161293983|NCT00848718|582456132|FG012|Overall Study|Adverse Event|2|||
161293984|NCT00848718|582456120|FG000|Overall Study|Lack of Efficacy|0|||
161293985|NCT00848718|582456121|FG001|Overall Study|Lack of Efficacy|0|||
161293986|NCT00848718|582456122|FG002|Overall Study|Lack of Efficacy|1|||
161293987|NCT00848718|582456123|FG003|Overall Study|Lack of Efficacy|0|||
161293988|NCT00848718|582456124|FG004|Overall Study|Lack of Efficacy|0|||
161293989|NCT00848718|582456125|FG005|Overall Study|Lack of Efficacy|0|||
161293990|NCT00848718|582456126|FG006|Overall Study|Lack of Efficacy|1|||
161293991|NCT00848718|582456127|FG007|Overall Study|Lack of Efficacy|0|||
161293992|NCT00848718|582456128|FG008|Overall Study|Lack of Efficacy|0|||
161293993|NCT00848718|582456129|FG009|Overall Study|Lack of Efficacy|0|||
161293994|NCT00848718|582456130|FG010|Overall Study|Lack of Efficacy|0|||
161293995|NCT00848718|582456131|FG011|Overall Study|Lack of Efficacy|0|||
161293996|NCT00848718|582456132|FG012|Overall Study|Lack of Efficacy|0|||
161293997|NCT00848718|582456120|FG000|Overall Study|Physician Decision|0|||
161293998|NCT00848718|582456121|FG001|Overall Study|Physician Decision|1|||
161293999|NCT00848718|582456122|FG002|Overall Study|Physician Decision|0|||
161294000|NCT00848718|582456123|FG003|Overall Study|Physician Decision|0|||
161294001|NCT00848718|582456124|FG004|Overall Study|Physician Decision|1|||
161294002|NCT00848718|582456125|FG005|Overall Study|Physician Decision|1|||
161294003|NCT00848718|582456126|FG006|Overall Study|Physician Decision|0|||
161294004|NCT00848718|582456127|FG007|Overall Study|Physician Decision|0|||
161294005|NCT00848718|582456128|FG008|Overall Study|Physician Decision|1|||
161294006|NCT00848718|582456129|FG009|Overall Study|Physician Decision|2|||
161294007|NCT00848718|582456130|FG010|Overall Study|Physician Decision|0|||
161294008|NCT00848718|582456131|FG011|Overall Study|Physician Decision|0|||
161294009|NCT00848718|582456132|FG012|Overall Study|Physician Decision|1|||
161294010|NCT00848718|582456120|FG000|Overall Study|Progressive disease before treatment|1|||
161294011|NCT00848718|582456121|FG001|Overall Study|Progressive disease before treatment|5|||
161294012|NCT00848718|582456122|FG002|Overall Study|Progressive disease before treatment|1|||
161294013|NCT00848718|582456123|FG003|Overall Study|Progressive disease before treatment|3|||
161294014|NCT00848718|582456124|FG004|Overall Study|Progressive disease before treatment|4|||
161294015|NCT00848718|582456125|FG005|Overall Study|Progressive disease before treatment|4|||
161294016|NCT00848718|582456126|FG006|Overall Study|Progressive disease before treatment|2|||
161294017|NCT00848718|582456127|FG007|Overall Study|Progressive disease before treatment|1|||
161294018|NCT00848718|582456128|FG008|Overall Study|Progressive disease before treatment|2|||
161294019|NCT00848718|582456129|FG009|Overall Study|Progressive disease before treatment|7|||
161294020|NCT00848718|582456130|FG010|Overall Study|Progressive disease before treatment|3|||
161294021|NCT00848718|582456131|FG011|Overall Study|Progressive disease before treatment|6|||
161294022|NCT00848718|582456132|FG012|Overall Study|Progressive disease before treatment|2|||
161294023|NCT00848718|582456120|FG000|Overall Study|Protocol Violation|0|||
161294024|NCT00848718|582456121|FG001|Overall Study|Protocol Violation|1|||
161294025|NCT00848718|582456122|FG002|Overall Study|Protocol Violation|0|||
161087564|NCT00822172|581708416|FG001|Overall Study|Other|1|||
161087565|NCT04772898|581708417|FG000|Overall Study|Withdrawal by Subject|0|||
161087566|NCT04772898|581708418|FG001|Overall Study|Withdrawal by Subject|1|||
161294026|NCT00848718|582456123|FG003|Overall Study|Protocol Violation|0|||
161294027|NCT00848718|582456124|FG004|Overall Study|Protocol Violation|0|||
161294028|NCT00848718|582456125|FG005|Overall Study|Protocol Violation|0|||
161294029|NCT00848718|582456126|FG006|Overall Study|Protocol Violation|0|||
161294030|NCT00848718|582456127|FG007|Overall Study|Protocol Violation|1|||
161294031|NCT00848718|582456128|FG008|Overall Study|Protocol Violation|0|||
161294032|NCT00848718|582456129|FG009|Overall Study|Protocol Violation|0|||
161294033|NCT00848718|582456130|FG010|Overall Study|Protocol Violation|0|||
161294034|NCT00848718|582456131|FG011|Overall Study|Protocol Violation|0|||
161294035|NCT00848718|582456132|FG012|Overall Study|Protocol Violation|1|||
161294036|NCT00848718|582456120|FG000|Overall Study|Withdrawal by Subject|1|||
161294037|NCT00848718|582456121|FG001|Overall Study|Withdrawal by Subject|0|||
161294038|NCT00848718|582456122|FG002|Overall Study|Withdrawal by Subject|0|||
161294039|NCT00848718|582456123|FG003|Overall Study|Withdrawal by Subject|1|||
161319480|NCT01863732|582555335|FG001|Overall Study|Adverse Event|0|||
161294040|NCT00848718|582456124|FG004|Overall Study|Withdrawal by Subject|0|||
161294041|NCT00848718|582456125|FG005|Overall Study|Withdrawal by Subject|0|||
161294042|NCT00848718|582456126|FG006|Overall Study|Withdrawal by Subject|0|||
161294043|NCT00848718|582456127|FG007|Overall Study|Withdrawal by Subject|0|||
161294044|NCT00848718|582456128|FG008|Overall Study|Withdrawal by Subject|0|||
161294045|NCT00848718|582456129|FG009|Overall Study|Withdrawal by Subject|0|||
161294046|NCT00848718|582456130|FG010|Overall Study|Withdrawal by Subject|1|||
161294047|NCT00848718|582456131|FG011|Overall Study|Withdrawal by Subject|0|||
161294048|NCT00848718|582456132|FG012|Overall Study|Withdrawal by Subject|0|||
161087567|NCT00309959|581708420|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
161087568|NCT02937454|581708421|FG000|Overall Study|Adverse Event|0|||
161087569|NCT02937454|581708422|FG001|Overall Study|Adverse Event|1|||
161087570|NCT02937454|581708421|FG000|Overall Study|Death|98|||
161087571|NCT02937454|581708422|FG001|Overall Study|Death|95|||
161087572|NCT02937454|581708421|FG000|Overall Study|Lost to Follow-up|1|||
161087573|NCT02937454|581708422|FG001|Overall Study|Lost to Follow-up|1|||
161087574|NCT02937454|581708421|FG000|Overall Study|Physician Decision|0|||
161087575|NCT02937454|581708422|FG001|Overall Study|Physician Decision|1|||
161087576|NCT02937454|581708421|FG000|Overall Study|Protocol Violation|6|||
161087577|NCT02937454|581708422|FG001|Overall Study|Protocol Violation|10|||
161087578|NCT02937454|581708421|FG000|Overall Study|Withdrawal by Subject|27|||
161087579|NCT02937454|581708422|FG001|Overall Study|Withdrawal by Subject|15|||
161087580|NCT02937454|581708421|FG000|Overall Study|Other|8|||
161087581|NCT02937454|581708422|FG001|Overall Study|Other|5|||
161087582|NCT02947087|581708423|FG000|Overall Study|Withdrawal by Subject|3|||
161087583|NCT02947087|581708424|FG001|Overall Study|Withdrawal by Subject|2|||
161087584|NCT01253304|581708426|FG000|Overall Study|Adverse Event|0|||
161087585|NCT01253304|581708427|FG001|Overall Study|Adverse Event|0|||
161087586|NCT01253304|581708428|FG002|Overall Study|Adverse Event|0|||
161087587|NCT01253304|581708429|FG003|Overall Study|Adverse Event|1|||
161087588|NCT01474434|581708430|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
161087589|NCT01474434|581708431|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
161087590|NCT01474434|581708432|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
161087591|NCT01474434|581708433|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
161087592|NCT01474434|581708430|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
161087593|NCT01474434|581708431|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
161087594|NCT01474434|581708432|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
161087595|NCT01474434|581708433|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
161087596|NCT01474434|581708430|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
161087597|NCT01474434|581708431|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
161087598|NCT01474434|581708432|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
161087599|NCT01474434|581708433|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
161087600|NCT02207569|581708434|FG000|1-Month|Death|6|||
161087601|NCT02207569|581708434|FG000|1-Month|Withdrawal by Subject|2|||
161087602|NCT02207569|581708434|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
161087603|NCT02207569|581708434|FG000|6-Month|Death|8|||
161087604|NCT02207569|581708434|FG000|6-Month|Withdrawal by Subject|2|||
161087605|NCT02207569|581708434|FG000|12-Month|Death|14|||
161087606|NCT02207569|581708434|FG000|12-Month|Withdrawal by Subject|2|||
161087607|NCT02207569|581708434|FG000|24-Month|Death|23|||
161087608|NCT02207569|581708434|FG000|24-Month|Withdrawal by Subject|3|||
161087609|NCT02207569|581708434|FG000|36-Month|Death|23|||
161087610|NCT02207569|581708434|FG000|36-Month|Withdrawal by Subject|4|||
161087611|NCT02207569|581708434|FG000|48-Month|Death|25|||
161087612|NCT02207569|581708434|FG000|48-Month|Withdrawal by Subject|2|||
161087613|NCT02207569|581708434|FG000|48-Month|Lost to Follow-up|4|||
161087614|NCT02207569|581708434|FG000|60-Month|Death|1|||
161087615|NCT02207569|581708434|FG000|60-Month|Lost to Follow-up|1|||
161087616|NCT02207569|581708434|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
161087617|NCT02207569|581708434|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
161087618|NCT02585232|581708435|FG000|Overall Study|Lost to Follow-up|8|||
161087619|NCT02585232|581708436|FG001|Overall Study|Lost to Follow-up|8|||
161087620|NCT02585232|581708435|FG000|Overall Study|Withdrawal by Subject|4|||
161087621|NCT02585232|581708436|FG001|Overall Study|Withdrawal by Subject|8|||
161087622|NCT00652327|581708437|FG000|Overall Study|Adverse Event|0|||
161087623|NCT00652327|581708438|FG001|Overall Study|Adverse Event|2|||
161087624|NCT00652327|581708437|FG000|Overall Study|Lost to Follow-up|0|||
161087625|NCT00652327|581708438|FG001|Overall Study|Lost to Follow-up|3|||
161087626|NCT00470366|581708444|FG000|Overall Study|Adverse Event|3|||
161087627|NCT00470366|581708444|FG000|Overall Study|Poor compliance|1|||
161087628|NCT02414932|581708445|FG000|Overall Study|Withdrawal by Subject|2|||
161087629|NCT02414932|581708446|FG001|Overall Study|Withdrawal by Subject|3|||
161087630|NCT02414932|581708445|FG000|Overall Study|Adverse Event|1|||
161087631|NCT02414932|581708446|FG001|Overall Study|Adverse Event|0|||
161087632|NCT00540046|581708447|FG000|Overall Study|Lost to Follow-up|33|||
161294049|NCT00848718|582456120|FG000|Overall Study|Progressive disease during treatment|3|||
161294050|NCT00848718|582456121|FG001|Overall Study|Progressive disease during treatment|0|||
161294051|NCT00848718|582456122|FG002|Overall Study|Progressive disease during treatment|3|||
161294052|NCT00848718|582456123|FG003|Overall Study|Progressive disease during treatment|0|||
161294053|NCT00848718|582456124|FG004|Overall Study|Progressive disease during treatment|0|||
161294054|NCT00848718|582456125|FG005|Overall Study|Progressive disease during treatment|0|||
161294055|NCT00848718|582456126|FG006|Overall Study|Progressive disease during treatment|0|||
161294056|NCT00848718|582456127|FG007|Overall Study|Progressive disease during treatment|2|||
161294057|NCT00848718|582456128|FG008|Overall Study|Progressive disease during treatment|0|||
161294058|NCT00848718|582456129|FG009|Overall Study|Progressive disease during treatment|0|||
161294059|NCT00848718|582456130|FG010|Overall Study|Progressive disease during treatment|0|||
161294060|NCT00848718|582456131|FG011|Overall Study|Progressive disease during treatment|0|||
161294061|NCT00848718|582456132|FG012|Overall Study|Progressive disease during treatment|2|||
161294062|NCT02389829|582456138|FG000|Overall Study|Lost to Follow-up|0|||
161294063|NCT02389829|582456139|FG001|Overall Study|Lost to Follow-up|1|||
161294064|NCT02955355|582457824|FG000|Overall Study|Adverse Event|4|||
161294065|NCT02955355|582457824|FG000|Overall Study|Death|1|||
161294066|NCT02955355|582457824|FG000|Overall Study|Physician Decision|21|||
161294067|NCT02955355|582457824|FG000|Overall Study|Site Terminated by Sponsor|35|||
161294068|NCT02955355|582457824|FG000|Overall Study|Withdrawal by Subject|19|||
161294069|NCT02955355|582457824|FG000|Overall Study|Reason Not Specified|5|||
161294070|NCT02612623|582457825|FG000|Overall Study|Withdrawal by Subject|0|||
161294071|NCT02612623|582457826|FG001|Overall Study|Withdrawal by Subject|1|||
161294072|NCT02612623|582457827|FG002|Overall Study|Withdrawal by Subject|0|||
161294073|NCT02612623|582457828|FG003|Overall Study|Withdrawal by Subject|0|||
161294074|NCT02612623|582457825|FG000|Overall Study|Adverse Event|1|||
161294075|NCT02612623|582457826|FG001|Overall Study|Adverse Event|0|||
161294076|NCT02612623|582457827|FG002|Overall Study|Adverse Event|1|||
161294077|NCT02612623|582457828|FG003|Overall Study|Adverse Event|0|||
161294078|NCT01436370|582457829|FG000|Overall Study|Lost to Follow-up|0|||
161294079|NCT01436370|582457830|FG001|Overall Study|Lost to Follow-up|0|||
161294080|NCT01436370|582457831|FG002|Overall Study|Lost to Follow-up|0|||
161294081|NCT01436370|582457832|FG003|Overall Study|Lost to Follow-up|0|||
161294082|NCT01436370|582457833|FG004|Overall Study|Lost to Follow-up|1|||
161294083|NCT01436370|582457834|FG005|Overall Study|Lost to Follow-up|0|||
161294084|NCT01436370|582457835|FG006|Overall Study|Lost to Follow-up|0|||
161294085|NCT01436370|582457836|FG007|Overall Study|Lost to Follow-up|0|||
161294086|NCT03168711|582457839|FG000|Overall Study|Adverse Event|2|||
161294087|NCT03168711|582457840|FG001|Overall Study|Adverse Event|0|||
161294088|NCT03168711|582457839|FG000|Overall Study|Withdrawal by Subject|0|||
161294089|NCT03168711|582457840|FG001|Overall Study|Withdrawal by Subject|1|||
161294090|NCT03168711|582457839|FG000|Overall Study|Death|0|||
161294091|NCT03168711|582457840|FG001|Overall Study|Death|1|||
161294092|NCT02770170|582457848|FG000|Overall Study|Withdrawal by Subject|0|||
161294093|NCT02770170|582457849|FG001|Overall Study|Withdrawal by Subject|0|||
161294094|NCT02770170|582457850|FG002|Overall Study|Withdrawal by Subject|0|||
161294095|NCT02770170|582457851|FG003|Overall Study|Withdrawal by Subject|2|||
161294096|NCT02770170|582457848|FG000|Overall Study|due to pregnancy|1|||
161294097|NCT02770170|582457849|FG001|Overall Study|due to pregnancy|0|||
161294098|NCT02770170|582457850|FG002|Overall Study|due to pregnancy|0|||
161294099|NCT02770170|582457851|FG003|Overall Study|due to pregnancy|0|||
161294100|NCT02770170|582457848|FG000|Overall Study|Lack of Efficacy|2|||
161294101|NCT02770170|582457849|FG001|Overall Study|Lack of Efficacy|0|||
161294102|NCT02770170|582457850|FG002|Overall Study|Lack of Efficacy|0|||
161294103|NCT02770170|582457851|FG003|Overall Study|Lack of Efficacy|1|||
161294104|NCT02770170|582457848|FG000|Overall Study|Adverse Event|4|||
161294105|NCT02770170|582457849|FG001|Overall Study|Adverse Event|3|||
161294106|NCT02770170|582457850|FG002|Overall Study|Adverse Event|5|||
161294107|NCT02770170|582457851|FG003|Overall Study|Adverse Event|3|||
161294108|NCT02770170|582457848|FG000|Overall Study|due to disease worsening|0|||
161294109|NCT02770170|582457849|FG001|Overall Study|due to disease worsening|0|||
161347610|NCT04556097|582656329|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
161347611|NCT04556097|582656330|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
161294110|NCT02770170|582457850|FG002|Overall Study|due to disease worsening|0|||
161294111|NCT02770170|582457851|FG003|Overall Study|due to disease worsening|1|||
161294112|NCT03270657|582457852|FG000|Overall Study|Withdrawal by Subject|1|||
161347612|NCT04556097|582656331|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
161347613|NCT05436613|582656332|FG000|Overall Study|Lost to Follow-up|9|||
161347614|NCT05436613|582656332|FG000|Overall Study|Withdrawal by Subject|3|||
161294113|NCT00162981|582457853|FG000|Overall Study|Adverse Event|2|||
161294114|NCT00162981|582457854|FG001|Overall Study|Adverse Event|5|||
161294115|NCT00162981|582457853|FG000|Overall Study|Withdrawal by Subject|1|||
161294116|NCT00162981|582457854|FG001|Overall Study|Withdrawal by Subject|1|||
161294117|NCT00162981|582457853|FG000|Overall Study|Physician Decision|1|||
161294118|NCT00162981|582457854|FG001|Overall Study|Physician Decision|0|||
161294119|NCT01671007|582457862|FG000|Overall Study|Other reasons than listed|166|||
161347615|NCT05350202|582656335|FG000|Visit 1 - Baseline|Not-treated|18|||
161294120|NCT01671007|582457863|FG001|Overall Study|Other reasons than listed|373|||
161294121|NCT01671007|582457864|FG002|Overall Study|Other reasons than listed|197|||
161294122|NCT01671007|582457865|FG003|Overall Study|Other reasons than listed|228|||
161294123|NCT01671007|582457866|FG004|Overall Study|Other reasons than listed|14|||
161294124|NCT01671007|582457867|FG005|Overall Study|Other reasons than listed|71|||
161294125|NCT01671007|582457868|FG006|Overall Study|Other reasons than listed|17|||
161294126|NCT01671007|582457869|FG007|Overall Study|Other reasons than listed|66|||
161294127|NCT01671007|582457870|FG008|Overall Study|Other reasons than listed|0|||
161294128|NCT01671007|582457862|FG000|Overall Study|Withdrawal by Subject|36|||
161294129|NCT01671007|582457863|FG001|Overall Study|Withdrawal by Subject|59|||
161294130|NCT01671007|582457864|FG002|Overall Study|Withdrawal by Subject|53|||
161294131|NCT01671007|582457865|FG003|Overall Study|Withdrawal by Subject|58|||
161294132|NCT01671007|582457866|FG004|Overall Study|Withdrawal by Subject|4|||
161294133|NCT01671007|582457867|FG005|Overall Study|Withdrawal by Subject|15|||
161294134|NCT01671007|582457868|FG006|Overall Study|Withdrawal by Subject|1|||
161294135|NCT01671007|582457869|FG007|Overall Study|Withdrawal by Subject|19|||
161294136|NCT01671007|582457870|FG008|Overall Study|Withdrawal by Subject|0|||
161294137|NCT01671007|582457862|FG000|Overall Study|Lost to Follow-up|93|||
161294138|NCT01671007|582457863|FG001|Overall Study|Lost to Follow-up|142|||
161294139|NCT01671007|582457864|FG002|Overall Study|Lost to Follow-up|91|||
161294140|NCT01671007|582457865|FG003|Overall Study|Lost to Follow-up|63|||
161294141|NCT01671007|582457866|FG004|Overall Study|Lost to Follow-up|7|||
161294142|NCT01671007|582457867|FG005|Overall Study|Lost to Follow-up|20|||
161294143|NCT01671007|582457868|FG006|Overall Study|Lost to Follow-up|2|||
161294144|NCT01671007|582457869|FG007|Overall Study|Lost to Follow-up|28|||
161294145|NCT01671007|582457870|FG008|Overall Study|Lost to Follow-up|0|||
161294146|NCT01671007|582457862|FG000|Overall Study|No end of study case report form|3|||
161294147|NCT01671007|582457863|FG001|Overall Study|No end of study case report form|1|||
161294148|NCT01671007|582457864|FG002|Overall Study|No end of study case report form|0|||
161294149|NCT01671007|582457865|FG003|Overall Study|No end of study case report form|2|||
161294150|NCT01671007|582457866|FG004|Overall Study|No end of study case report form|0|||
161294151|NCT01671007|582457867|FG005|Overall Study|No end of study case report form|0|||
161294152|NCT01671007|582457868|FG006|Overall Study|No end of study case report form|0|||
161294153|NCT01671007|582457869|FG007|Overall Study|No end of study case report form|0|||
161294154|NCT01671007|582457870|FG008|Overall Study|No end of study case report form|0|||
161294155|NCT01671007|582457862|FG000|Overall Study|Not eligible|23|||
161294156|NCT01671007|582457863|FG001|Overall Study|Not eligible|76|||
161294157|NCT01671007|582457864|FG002|Overall Study|Not eligible|25|||
161294158|NCT01671007|582457865|FG003|Overall Study|Not eligible|17|||
161294159|NCT01671007|582457866|FG004|Overall Study|Not eligible|0|||
161294160|NCT01671007|582457867|FG005|Overall Study|Not eligible|6|||
161294161|NCT01671007|582457868|FG006|Overall Study|Not eligible|1|||
161294162|NCT01671007|582457869|FG007|Overall Study|Not eligible|19|||
161294163|NCT01671007|582457870|FG008|Overall Study|Not eligible|0|||
161294164|NCT03877068|582457871|FG000|Overall Study|Physician Decision|9|||
161294165|NCT03877068|582457872|FG001|Overall Study|Physician Decision|3|||
161294166|NCT00449865|582457873|FG000|Overall Study|Withdrawal by Subject|110|||
161294167|NCT00449865|582457874|FG001|Overall Study|Withdrawal by Subject|110|||
161294168|NCT00449865|582457873|FG000|Overall Study|Lost to Follow-up|36|||
161294169|NCT00449865|582457874|FG001|Overall Study|Lost to Follow-up|37|||
161294170|NCT00449865|582457873|FG000|Overall Study|Physician Decision|13|||
161294171|NCT00449865|582457874|FG001|Overall Study|Physician Decision|12|||
161294172|NCT00449865|582457873|FG000|Overall Study|Death|31|||
161294173|NCT00449865|582457874|FG001|Overall Study|Death|40|||
161294174|NCT00449865|582457873|FG000|Overall Study|Protocol Violation|8|||
161294175|NCT00449865|582457874|FG001|Overall Study|Protocol Violation|7|||
161294176|NCT00449865|582457873|FG000|Overall Study|Study was stopped|324|||
161294177|NCT00449865|582457874|FG001|Overall Study|Study was stopped|328|||
161294178|NCT00406367|582457875|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
161294179|NCT00406367|582457876|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
161294180|NCT00406367|582457875|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
161294181|NCT00406367|582457876|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
161294182|NCT00406367|582457875|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
161294183|NCT00406367|582457876|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
161294184|NCT00406367|582457875|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
161294185|NCT00406367|582457876|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
161294186|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
161294187|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
161294188|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
161294189|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
161294190|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
161294191|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
161294192|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
161294193|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
161174592|NCT00425113|582015614|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
161174593|NCT00425113|582015613|FG000|Overall Study|diagnosis of abdominal TB|0|||
161174594|NCT00425113|582015614|FG001|Overall Study|diagnosis of abdominal TB|1|||
161174595|NCT00425113|582015613|FG000|Overall Study|missing study drug more than 14 days|0|||
161174596|NCT00425113|582015614|FG001|Overall Study|missing study drug more than 14 days|1|||
161174597|NCT00425113|582015613|FG000|Overall Study|Withdrawal by Subject|1|||
161174598|NCT00425113|582015614|FG001|Overall Study|Withdrawal by Subject|0|||
161174599|NCT02920450|582015615|FG000|Overall Study|Death|1|||
161174600|NCT02920450|582015616|FG001|Overall Study|Death|0|||
161174601|NCT02920450|582015617|FG002|Overall Study|Death|0|||
161174602|NCT02920450|582015618|FG003|Overall Study|Death|0|||
161174603|NCT02920450|582015615|FG000|Overall Study|Withdrawal by Subject|1|||
161174604|NCT02920450|582015616|FG001|Overall Study|Withdrawal by Subject|0|||
161174605|NCT02920450|582015617|FG002|Overall Study|Withdrawal by Subject|0|||
161174606|NCT02920450|582015618|FG003|Overall Study|Withdrawal by Subject|0|||
161174607|NCT00126672|582015620|FG000|Overall Study|Adverse Event|4|||
161174608|NCT00126672|582015620|FG000|Overall Study|Lost to Follow-up|4|||
161174609|NCT01001234|582015622|FG000|Overall Study|Withdrawal by Subject|2|||
161174610|NCT01001234|582015623|FG001|Overall Study|Withdrawal by Subject|0|||
161174611|NCT01001234|582015624|FG002|Overall Study|Withdrawal by Subject|3|||
161174612|NCT01001234|582015625|FG003|Overall Study|Withdrawal by Subject|0|||
161174613|NCT01001234|582015626|FG004|Overall Study|Withdrawal by Subject|0|||
161174614|NCT01001234|582015622|FG000|Overall Study|Protocol Violation|34|||
161174615|NCT01001234|582015623|FG001|Overall Study|Protocol Violation|3|||
161174616|NCT01001234|582015624|FG002|Overall Study|Protocol Violation|19|||
161174617|NCT01001234|582015625|FG003|Overall Study|Protocol Violation|18|||
161174618|NCT01001234|582015626|FG004|Overall Study|Protocol Violation|0|||
161174619|NCT01001234|582015622|FG000|Overall Study|Lost to Follow-up|0|||
161174620|NCT01001234|582015623|FG001|Overall Study|Lost to Follow-up|0|||
161174621|NCT01001234|582015624|FG002|Overall Study|Lost to Follow-up|1|||
161174622|NCT01001234|582015625|FG003|Overall Study|Lost to Follow-up|2|||
161174623|NCT01001234|582015626|FG004|Overall Study|Lost to Follow-up|0|||
161174624|NCT01001234|582015622|FG000|Overall Study|Physician Decision|1|||
161174625|NCT01001234|582015623|FG001|Overall Study|Physician Decision|0|||
161174626|NCT01001234|582015624|FG002|Overall Study|Physician Decision|0|||
161174627|NCT01001234|582015625|FG003|Overall Study|Physician Decision|0|||
161174628|NCT01001234|582015626|FG004|Overall Study|Physician Decision|0|||
161174629|NCT01001234|582015622|FG000|Overall Study|Not Treated: Adverse Event|1|||
161174630|NCT01001234|582015623|FG001|Overall Study|Not Treated: Adverse Event|0|||
161174631|NCT01001234|582015624|FG002|Overall Study|Not Treated: Adverse Event|0|||
161174632|NCT01001234|582015625|FG003|Overall Study|Not Treated: Adverse Event|0|||
161174633|NCT01001234|582015626|FG004|Overall Study|Not Treated: Adverse Event|0|||
161174634|NCT01001234|582015622|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
161174635|NCT01001234|582015623|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
161174636|NCT01001234|582015624|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
161174637|NCT01001234|582015625|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
161174638|NCT01001234|582015626|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
161174639|NCT01001234|582015622|FG000|Overall Study|Not Treated: Protocol Violation|3|||
161174640|NCT01001234|582015623|FG001|Overall Study|Not Treated: Protocol Violation|0|||
161174641|NCT01001234|582015624|FG002|Overall Study|Not Treated: Protocol Violation|0|||
161174642|NCT01001234|582015625|FG003|Overall Study|Not Treated: Protocol Violation|0|||
161174643|NCT01001234|582015626|FG004|Overall Study|Not Treated: Protocol Violation|0|||
161174644|NCT01001234|582015622|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
161174645|NCT01001234|582015623|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
161174646|NCT01001234|582015624|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
161174647|NCT01001234|582015625|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
161174648|NCT01001234|582015626|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
161174649|NCT01001234|582015622|FG000|Overall Study|Not Treated: Pregnancy|3|||
161174650|NCT01001234|582015623|FG001|Overall Study|Not Treated: Pregnancy|0|||
161174651|NCT01001234|582015624|FG002|Overall Study|Not Treated: Pregnancy|0|||
161174652|NCT01001234|582015625|FG003|Overall Study|Not Treated: Pregnancy|0|||
161174653|NCT01001234|582015626|FG004|Overall Study|Not Treated: Pregnancy|0|||
161174654|NCT01001234|582015622|FG000|Overall Study|Not Treated: Physician Decision|37|||
161174655|NCT01001234|582015623|FG001|Overall Study|Not Treated: Physician Decision|4|||
161174656|NCT01001234|582015624|FG002|Overall Study|Not Treated: Physician Decision|0|||
161174657|NCT01001234|582015625|FG003|Overall Study|Not Treated: Physician Decision|0|||
161174658|NCT01001234|582015626|FG004|Overall Study|Not Treated: Physician Decision|0|||
161174659|NCT01001234|582015622|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
161174660|NCT01001234|582015623|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
161174661|NCT01001234|582015624|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161174662|NCT01001234|582015625|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161174663|NCT01001234|582015626|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
161174664|NCT01611298|582015632|FG000|Overall Study|Relapsed|2|||
161174665|NCT03238352|582015633|FG000|Overall Study|Lost to Follow-up|0|||
161174666|NCT03238352|582015634|FG001|Overall Study|Lost to Follow-up|2|||
161174667|NCT03238352|582015635|FG002|Overall Study|Lost to Follow-up|1|||
161174668|NCT03238352|582015633|FG000|Overall Study|Withdrawal by Subject|0|||
161294194|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
161294195|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
161294196|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
161294197|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
161294198|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
161294199|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
161294200|NCT00406367|582457875|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
161294201|NCT00406367|582457876|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
161294202|NCT00171210|582457877|FG000|Overall Study|Adverse Event|16|||
161294203|NCT00171210|582457878|FG001|Overall Study|Adverse Event|27|||
161294204|NCT00171210|582457877|FG000|Overall Study|Abnormal laboratory value(s)|6|||
161294205|NCT00171210|582457878|FG001|Overall Study|Abnormal laboratory value(s)|3|||
161294206|NCT00171210|582457877|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161294207|NCT00171210|582457878|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161294208|NCT00171210|582457877|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
161294209|NCT00171210|582457878|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
161294210|NCT00171210|582457877|FG000|Overall Study|Protocol Violation|0|||
161294211|NCT00171210|582457878|FG001|Overall Study|Protocol Violation|2|||
161294212|NCT00171210|582457877|FG000|Overall Study|Withdrawal by Subject|32|||
161294213|NCT00171210|582457878|FG001|Overall Study|Withdrawal by Subject|30|||
161294214|NCT00171210|582457877|FG000|Overall Study|Lost to Follow-up|1|||
161294215|NCT00171210|582457878|FG001|Overall Study|Lost to Follow-up|0|||
161294216|NCT00171210|582457877|FG000|Overall Study|Administrative problems|1|||
161294217|NCT00171210|582457878|FG001|Overall Study|Administrative problems|1|||
161294218|NCT00171210|582457877|FG000|Overall Study|Death|2|||
161294219|NCT00171210|582457878|FG001|Overall Study|Death|3|||
161294220|NCT00171210|582457877|FG000|Overall Study|Stopped at end of core|0|||
161294221|NCT00171210|582457878|FG001|Overall Study|Stopped at end of core|32|||
161294222|NCT00171210|582457877|FG000|Overall Study|Stopped at end of extension 1|0|||
161294223|NCT00171210|582457878|FG001|Overall Study|Stopped at end of extension 1|1|||
161294224|NCT03187301|582457881|FG000|Titration Period|Adverse Event|0|||
161294225|NCT03187301|582457882|FG001|Titration Period|Adverse Event|0|||
161174669|NCT03238352|582015634|FG001|Overall Study|Withdrawal by Subject|1|||
161174670|NCT03238352|582015635|FG002|Overall Study|Withdrawal by Subject|0|||
161294226|NCT03187301|582457883|FG002|Titration Period|Adverse Event|0|||
161294227|NCT03187301|582457884|FG003|Titration Period|Adverse Event|0|||
161294228|NCT03187301|582457885|FG004|Titration Period|Adverse Event|0|||
161294229|NCT03187301|582457886|FG005|Titration Period|Adverse Event|0|||
161294230|NCT03187301|582457887|FG006|Titration Period|Adverse Event|5|||
161294231|NCT03187301|582457881|FG000|Titration Period|Withdrawal by Subject|0|||
161294232|NCT03187301|582457882|FG001|Titration Period|Withdrawal by Subject|0|||
161294233|NCT03187301|582457883|FG002|Titration Period|Withdrawal by Subject|0|||
161294234|NCT03187301|582457884|FG003|Titration Period|Withdrawal by Subject|0|||
161294235|NCT03187301|582457885|FG004|Titration Period|Withdrawal by Subject|0|||
161294236|NCT03187301|582457886|FG005|Titration Period|Withdrawal by Subject|0|||
161294237|NCT03187301|582457887|FG006|Titration Period|Withdrawal by Subject|1|||
161294238|NCT03187301|582457881|FG000|Titration Period|Exclusion Criteria Met|0|||
161294239|NCT03187301|582457882|FG001|Titration Period|Exclusion Criteria Met|0|||
161294240|NCT03187301|582457883|FG002|Titration Period|Exclusion Criteria Met|0|||
161294241|NCT03187301|582457884|FG003|Titration Period|Exclusion Criteria Met|0|||
161294242|NCT03187301|582457885|FG004|Titration Period|Exclusion Criteria Met|0|||
161294243|NCT03187301|582457886|FG005|Titration Period|Exclusion Criteria Met|0|||
161294244|NCT03187301|582457887|FG006|Titration Period|Exclusion Criteria Met|1|||
161294245|NCT03187301|582457881|FG000|Pre-Intervention|Withdrawal by Subject|1|||
161294246|NCT03187301|582457882|FG001|Pre-Intervention|Withdrawal by Subject|0|||
161174671|NCT00928512|582015636|FG000|Overall Study|Adverse Event|4|||
161174672|NCT00928512|582015637|FG001|Overall Study|Adverse Event|3|||
161294247|NCT03187301|582457883|FG002|Pre-Intervention|Withdrawal by Subject|0|||
161294248|NCT03187301|582457884|FG003|Pre-Intervention|Withdrawal by Subject|0|||
161294249|NCT03187301|582457885|FG004|Pre-Intervention|Withdrawal by Subject|0|||
161294250|NCT03187301|582457886|FG005|Pre-Intervention|Withdrawal by Subject|0|||
161294251|NCT03187301|582457887|FG006|Pre-Intervention|Withdrawal by Subject|0|||
161294252|NCT03252535|582457889|FG000|Overall Study|Withdrawal by Subject|1|||
161294253|NCT03252535|582457890|FG001|Overall Study|Withdrawal by Subject|0|||
161294254|NCT03252535|582457891|FG002|Overall Study|Withdrawal by Subject|0|||
161294255|NCT03252535|582457889|FG000|Overall Study|Physician Decision|0|||
161294256|NCT03252535|582457890|FG001|Overall Study|Physician Decision|1|||
161294257|NCT03252535|582457891|FG002|Overall Study|Physician Decision|0|||
161294258|NCT03252535|582457889|FG000|Overall Study|Met discontinuation criteria|0|||
161319481|NCT01863732|582555336|FG002|Overall Study|Adverse Event|3|||
161319482|NCT01863732|582555337|FG003|Overall Study|Adverse Event|3|||
161319483|NCT01863732|582555334|FG000|Overall Study|Lack of Efficacy|1|||
161294259|NCT03252535|582457890|FG001|Overall Study|Met discontinuation criteria|1|||
161294260|NCT03252535|582457891|FG002|Overall Study|Met discontinuation criteria|0|||
161294261|NCT01966120|582457896|FG000|Overall Study|Withdrawal by Subject|0|||
161294262|NCT01966120|582457897|FG001|Overall Study|Withdrawal by Subject|5|||
161294263|NCT01966120|582457896|FG000|Overall Study|Lost to Follow-up|1|||
161294264|NCT01966120|582457897|FG001|Overall Study|Lost to Follow-up|1|||
161294265|NCT00461630|582457898|FG000|Overall Study|Death|798|||
161294266|NCT00461630|582457899|FG001|Overall Study|Death|732|||
161294267|NCT00461630|582457898|FG000|Overall Study|Lost to Follow-up|108|||
161294268|NCT00461630|582457899|FG001|Overall Study|Lost to Follow-up|95|||
161294269|NCT02588612|582457903|FG000|Overall Study|Physician Decision|1|||
161294270|NCT02588612|582457903|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
161294271|NCT02588612|582457903|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
161294272|NCT02588612|582457903|FG000|Overall Study|Death prior to T-cell infusion|1|||
161294273|NCT03809663|582457904|FG000|Overall Study|Decision by sponsor|24|||
161294274|NCT03809663|582457905|FG001|Overall Study|Decision by sponsor|18|||
161294275|NCT03809663|582457906|FG002|Overall Study|Decision by sponsor|20|||
161294276|NCT03809663|582457907|FG003|Overall Study|Decision by sponsor|20|||
161294277|NCT03809663|582457908|FG004|Overall Study|Decision by sponsor|0|||
161294278|NCT03809663|582457909|FG005|Overall Study|Decision by sponsor|0|||
161294279|NCT03809663|582457904|FG000|Overall Study|Withdrawal by Subject|26|||
161294280|NCT03809663|582457905|FG001|Overall Study|Withdrawal by Subject|22|||
161294281|NCT03809663|582457906|FG002|Overall Study|Withdrawal by Subject|27|||
161294282|NCT03809663|582457907|FG003|Overall Study|Withdrawal by Subject|26|||
161294283|NCT03809663|582457908|FG004|Overall Study|Withdrawal by Subject|0|||
161294284|NCT03809663|582457909|FG005|Overall Study|Withdrawal by Subject|0|||
161294285|NCT03809663|582457904|FG000|Overall Study|Lost to Follow-up|1|||
161294286|NCT03809663|582457905|FG001|Overall Study|Lost to Follow-up|4|||
161294287|NCT03809663|582457906|FG002|Overall Study|Lost to Follow-up|1|||
161294288|NCT03809663|582457907|FG003|Overall Study|Lost to Follow-up|1|||
161294289|NCT03809663|582457908|FG004|Overall Study|Lost to Follow-up|0|||
161294290|NCT03809663|582457909|FG005|Overall Study|Lost to Follow-up|0|||
161294291|NCT03376789|582457910|FG000|Overall Study|Withdrawal by Subject|3|||
161294292|NCT03376789|582457911|FG001|Overall Study|Withdrawal by Subject|5|||
161294293|NCT03376789|582457910|FG000|Overall Study|Protocol Violation|0|||
161294294|NCT03376789|582457911|FG001|Overall Study|Protocol Violation|1|||
161294295|NCT03376789|582457910|FG000|Overall Study|Adverse Event|0|||
161294296|NCT03376789|582457911|FG001|Overall Study|Adverse Event|1|||
161294297|NCT03376789|582457910|FG000|Overall Study|Lost to Follow-up|1|||
161294298|NCT03376789|582457911|FG001|Overall Study|Lost to Follow-up|1|||
161294299|NCT03376789|582457910|FG000|Overall Study|Per sponsor due to noncompliance|1|||
161294300|NCT03376789|582457911|FG001|Overall Study|Per sponsor due to noncompliance|0|||
161294301|NCT03376789|582457910|FG000|Overall Study|Subject off study medication|0|||
161294302|NCT03376789|582457911|FG001|Overall Study|Subject off study medication|1|||
161294303|NCT01703260|582457912|FG000|Overall Study|Adverse Event|1|||
161294304|NCT01703260|582457913|FG001|Overall Study|Adverse Event|2|||
161294305|NCT01703260|582457914|FG002|Overall Study|Adverse Event|2|||
161294306|NCT01703260|582457912|FG000|Overall Study|Lost to Follow-up|1|||
161294307|NCT01703260|582457913|FG001|Overall Study|Lost to Follow-up|0|||
161294308|NCT01703260|582457914|FG002|Overall Study|Lost to Follow-up|0|||
161294309|NCT01703260|582457912|FG000|Overall Study|Withdrawal by Subject|0|||
161294310|NCT01703260|582457913|FG001|Overall Study|Withdrawal by Subject|0|||
161294311|NCT01703260|582457914|FG002|Overall Study|Withdrawal by Subject|1|||
161294312|NCT01703260|582457912|FG000|Overall Study|Study Termination|1|||
161294313|NCT01703260|582457913|FG001|Overall Study|Study Termination|2|||
161294314|NCT01703260|582457914|FG002|Overall Study|Study Termination|0|||
161294315|NCT03123393|582457918|FG000|Overall Study|Study Terminated by Sponsor|6|||
161294316|NCT03123393|582457919|FG001|Overall Study|Study Terminated by Sponsor|9|||
161294317|NCT03123393|582457918|FG000|Overall Study|Withdrawal by Subject|2|||
161294318|NCT03123393|582457919|FG001|Overall Study|Withdrawal by Subject|1|||
161294319|NCT03123393|582457918|FG000|Overall Study|Reason not Specified|13|||
161294320|NCT03123393|582457919|FG001|Overall Study|Reason not Specified|13|||
161294321|NCT02230904|582457921|FG000|Overall Study|Safety follow up could not take place|0|||
161294322|NCT02230904|582457922|FG001|Overall Study|Safety follow up could not take place|1|||
161294323|NCT01464424|582457925|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
161294324|NCT01464424|582457926|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
161294325|NCT05047211|582457928|FG000|Overall Study|Lost to Follow-up|8|||
161294326|NCT05047211|582457929|FG001|Overall Study|Lost to Follow-up|5|||
161294327|NCT00561392|582457930|FG000|Overall Study|Adverse Event|38|||
161294328|NCT00561392|582457930|FG000|Overall Study|Lack of Efficacy|2|||
161294329|NCT00561392|582457930|FG000|Overall Study|Protocol Violation|1|||
161294330|NCT00561392|582457930|FG000|Overall Study|Withdrawal by Subject|8|||
161294331|NCT00561392|582457930|FG000|Overall Study|Administrative problems|4|||
161294332|NCT03822468|582457931|FG000|Treatment Period|Progressive disease|98|||
161294333|NCT03822468|582457932|FG001|Treatment Period|Progressive disease|94|||
161294334|NCT03822468|582457931|FG000|Treatment Period|Adverse Event|21|||
161294335|NCT03822468|582457932|FG001|Treatment Period|Adverse Event|24|||
161294336|NCT03822468|582457931|FG000|Treatment Period|Withdrawal by Subject|9|||
161294337|NCT03822468|582457932|FG001|Treatment Period|Withdrawal by Subject|5|||
161294338|NCT03822468|582457931|FG000|Treatment Period|Physician Decision|9|||
161294339|NCT03822468|582457932|FG001|Treatment Period|Physician Decision|7|||
161294340|NCT03822468|582457931|FG000|Treatment Period|Protocol Violation|2|||
161294341|NCT03822468|582457932|FG001|Treatment Period|Protocol Violation|1|||
161294342|NCT03822468|582457931|FG000|Treatment Period|Death|2|||
161294343|NCT03822468|582457932|FG001|Treatment Period|Death|3|||
161294344|NCT03822468|582457931|FG000|Treatment Period|Lost to Follow-up|1|||
161294345|NCT03822468|582457932|FG001|Treatment Period|Lost to Follow-up|1|||
161294346|NCT03822468|582457931|FG000|Treatment Period|Sponsor decision|46|||
161294347|NCT03822468|582457932|FG001|Treatment Period|Sponsor decision|53|||
161294348|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
161294349|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
161294350|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
161294351|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
161294352|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Death|1|||
161294353|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Death|0|||
161294354|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161294355|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
161294356|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
161294357|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
161294358|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
161294359|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
161294360|NCT03822468|582457931|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
161294361|NCT03822468|582457932|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
161294362|NCT03331796|582457933|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
161294363|NCT03331796|582457934|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
161294364|NCT03331796|582457935|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
161294365|NCT03331796|582457933|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
161294366|NCT03331796|582457934|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
161294367|NCT03331796|582457935|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
161294368|NCT03331796|582457933|FG000|Extended Follow-up|Adverse Event|1|||
161294369|NCT03331796|582457934|FG001|Extended Follow-up|Adverse Event|0|||
161294370|NCT03331796|582457935|FG002|Extended Follow-up|Adverse Event|1|||
161294371|NCT03331796|582457933|FG000|Extended Follow-up|Lost to Follow-up|0|||
161294372|NCT03331796|582457934|FG001|Extended Follow-up|Lost to Follow-up|0|||
161294373|NCT03331796|582457935|FG002|Extended Follow-up|Lost to Follow-up|1|||
161294374|NCT03331796|582457933|FG000|Extended Follow-up|Withdrawal by Subject|1|||
161294375|NCT03331796|582457934|FG001|Extended Follow-up|Withdrawal by Subject|0|||
161294376|NCT03331796|582457935|FG002|Extended Follow-up|Withdrawal by Subject|0|||
161294377|NCT03331796|582457933|FG000|Extended Follow-up|Termination of Funding|0|||
161294378|NCT03331796|582457934|FG001|Extended Follow-up|Termination of Funding|1|||
161294379|NCT03331796|582457935|FG002|Extended Follow-up|Termination of Funding|0|||
161294380|NCT01786993|582457937|FG000|Overall Study|Death|6|||
161294381|NCT01786993|582457938|FG001|Overall Study|Death|7|||
161294382|NCT01786993|582457937|FG000|Overall Study|Withdrawal by Subject|3|||
161294383|NCT01786993|582457938|FG001|Overall Study|Withdrawal by Subject|2|||
161294384|NCT01786993|582457937|FG000|Overall Study|Lost to Follow-up|0|||
161294385|NCT01786993|582457938|FG001|Overall Study|Lost to Follow-up|1|||
161294386|NCT01786993|582457937|FG000|Overall Study|Subject Non-Compliance|1|||
161294387|NCT01786993|582457938|FG001|Overall Study|Subject Non-Compliance|0|||
161294388|NCT01786993|582457937|FG000|Overall Study|System Explant|1|||
161294389|NCT01786993|582457938|FG001|Overall Study|System Explant|0|||
161294390|NCT01786993|582457937|FG000|Overall Study|Hospice Admission|1|||
161294391|NCT01786993|582457938|FG001|Overall Study|Hospice Admission|0|||
161294392|NCT00450437|582457939|FG000|Overall Study|Withdrawal by Subject|10|||
161294393|NCT00450437|582457940|FG001|Overall Study|Withdrawal by Subject|2|||
161294394|NCT00450437|582457941|FG002|Overall Study|Withdrawal by Subject|0|||
161294395|NCT00450437|582457942|FG003|Overall Study|Withdrawal by Subject|1|||
161294396|NCT00450437|582457939|FG000|Overall Study|Lost to Follow-up|31|||
161294397|NCT00450437|582457940|FG001|Overall Study|Lost to Follow-up|12|||
161294398|NCT00450437|582457941|FG002|Overall Study|Lost to Follow-up|19|||
161294399|NCT00450437|582457942|FG003|Overall Study|Lost to Follow-up|9|||
161294400|NCT00450437|582457939|FG000|Overall Study|Protocol Violation|0|||
161294401|NCT00450437|582457940|FG001|Overall Study|Protocol Violation|1|||
161294402|NCT00450437|582457941|FG002|Overall Study|Protocol Violation|0|||
161294403|NCT00450437|582457942|FG003|Overall Study|Protocol Violation|1|||
161294404|NCT00450437|582457939|FG000|Overall Study|Inappropriate enrollment|4|||
161294405|NCT00450437|582457940|FG001|Overall Study|Inappropriate enrollment|1|||
161294406|NCT00450437|582457941|FG002|Overall Study|Inappropriate enrollment|3|||
161294407|NCT00450437|582457942|FG003|Overall Study|Inappropriate enrollment|0|||
161294408|NCT00450437|582457939|FG000|Overall Study|Administrative reason|0|||
161294409|NCT00450437|582457940|FG001|Overall Study|Administrative reason|0|||
161294410|NCT00450437|582457941|FG002|Overall Study|Administrative reason|1|||
161294411|NCT00450437|582457942|FG003|Overall Study|Administrative reason|0|||
161294412|NCT00450437|582457939|FG000|Overall Study|Unable to Classify|1|||
161294413|NCT00450437|582457940|FG001|Overall Study|Unable to Classify|0|||
161294414|NCT00450437|582457941|FG002|Overall Study|Unable to Classify|1|||
161294415|NCT00450437|582457942|FG003|Overall Study|Unable to Classify|0|||
161294416|NCT01890122|582457943|FG000|Overall Study|Adverse Event|1|||
161294417|NCT01890122|582457944|FG001|Overall Study|Adverse Event|1|||
161294418|NCT01890122|582457945|FG002|Overall Study|Adverse Event|1|||
161294419|NCT01890122|582457946|FG003|Overall Study|Adverse Event|2|||
161294420|NCT01890122|582457943|FG000|Overall Study|Major Protocol Deviation|3|||
161294421|NCT01890122|582457944|FG001|Overall Study|Major Protocol Deviation|1|||
161294422|NCT01890122|582457945|FG002|Overall Study|Major Protocol Deviation|0|||
161294423|NCT01890122|582457946|FG003|Overall Study|Major Protocol Deviation|1|||
161294424|NCT01890122|582457943|FG000|Overall Study|Lost to Follow-up|0|||
161294425|NCT01890122|582457944|FG001|Overall Study|Lost to Follow-up|1|||
161294426|NCT01890122|582457945|FG002|Overall Study|Lost to Follow-up|2|||
161294427|NCT01890122|582457946|FG003|Overall Study|Lost to Follow-up|2|||
161294428|NCT01890122|582457943|FG000|Overall Study|Voluntary Withdrawal|8|||
161294429|NCT01890122|582457944|FG001|Overall Study|Voluntary Withdrawal|8|||
161294430|NCT01890122|582457945|FG002|Overall Study|Voluntary Withdrawal|2|||
161294431|NCT01890122|582457946|FG003|Overall Study|Voluntary Withdrawal|11|||
161294432|NCT01890122|582457943|FG000|Overall Study|Lack of Efficacy|14|||
161294433|NCT01890122|582457944|FG001|Overall Study|Lack of Efficacy|24|||
161294434|NCT01890122|582457945|FG002|Overall Study|Lack of Efficacy|7|||
161294435|NCT01890122|582457946|FG003|Overall Study|Lack of Efficacy|41|||
161294436|NCT01890122|582457943|FG000|Overall Study|Reason not Specified|0|||
161294437|NCT01890122|582457944|FG001|Overall Study|Reason not Specified|1|||
161294438|NCT01890122|582457945|FG002|Overall Study|Reason not Specified|1|||
161294439|NCT01890122|582457946|FG003|Overall Study|Reason not Specified|2|||
161294440|NCT01890122|582457943|FG000|Overall Study|Randomized but not Treated|1|||
161294441|NCT01890122|582457944|FG001|Overall Study|Randomized but not Treated|1|||
161294442|NCT01890122|582457945|FG002|Overall Study|Randomized but not Treated|0|||
161294443|NCT01890122|582457946|FG003|Overall Study|Randomized but not Treated|0|||
161294444|NCT04025879|582457947|FG000|Randomization|Participant withdrew consent|0|||
161294445|NCT04025879|582457948|FG001|Randomization|Participant withdrew consent|1|||
161294446|NCT04025879|582457947|FG000|Randomization|Participant no longer met study criteria|1|||
161294447|NCT04025879|582457948|FG001|Randomization|Participant no longer met study criteria|1|||
161294448|NCT04025879|582457947|FG000|Treatment|Ongoing treatment|10|||
161294449|NCT04025879|582457948|FG001|Treatment|Ongoing treatment|8|||
161294450|NCT04025879|582457947|FG000|Treatment|Disease progression/recurrence|36|||
161294451|NCT04025879|582457948|FG001|Treatment|Disease progression/recurrence|72|||
161294452|NCT04025879|582457947|FG000|Treatment|Study drug toxicity|36|||
161294453|NCT04025879|582457948|FG001|Treatment|Study drug toxicity|13|||
161294454|NCT04025879|582457947|FG000|Treatment|Death|2|||
161294455|NCT04025879|582457948|FG001|Treatment|Death|0|||
161294456|NCT04025879|582457947|FG000|Treatment|Adverse event unrelated to study drug|21|||
161294457|NCT04025879|582457948|FG001|Treatment|Adverse event unrelated to study drug|14|||
161294458|NCT04025879|582457947|FG000|Treatment|Participant request to discontinue study treatment|16|||
161294459|NCT04025879|582457948|FG001|Treatment|Participant request to discontinue study treatment|8|||
161294460|NCT04025879|582457947|FG000|Treatment|Participant withdrew consent|1|||
161294461|NCT04025879|582457948|FG001|Treatment|Participant withdrew consent|3|||
161294462|NCT04025879|582457947|FG000|Treatment|Participant no longer meets study criteria|3|||
161294463|NCT04025879|582457948|FG001|Treatment|Participant no longer meets study criteria|2|||
161294464|NCT04025879|582457947|FG000|Treatment|Lost to Follow-up|1|||
161294465|NCT04025879|582457948|FG001|Treatment|Lost to Follow-up|0|||
161294466|NCT04025879|582457947|FG000|Treatment|Other reasons|15|||
161294467|NCT04025879|582457948|FG001|Treatment|Other reasons|17|||
161294468|NCT04025879|582457947|FG000|Treatment|Administrative reason by sponsor|0|||
161294469|NCT04025879|582457948|FG001|Treatment|Administrative reason by sponsor|1|||
161294470|NCT04025879|582457947|FG000|Treatment|Not reported|2|||
161294471|NCT04025879|582457948|FG001|Treatment|Not reported|0|||
161294472|NCT00071110|582457953|FG000|Overall Study|Protocol Violation|0|||
161294473|NCT00071110|582457954|FG001|Overall Study|Protocol Violation|4|||
161294474|NCT02640664|582457963|FG000|Epoch 1|Withdrawal of informed consent|1|||
161294475|NCT02640664|582457964|FG001|Epoch 1|Withdrawal of informed consent|0|||
161294476|NCT02640664|582457965|FG002|Epoch 1|Withdrawal of informed consent|0|||
161294477|NCT02640664|582457963|FG000|Epoch 1|Death|0|||
161294478|NCT02640664|582457964|FG001|Epoch 1|Death|0|||
161294479|NCT02640664|582457965|FG002|Epoch 1|Death|1|||
161294480|NCT02640664|582457963|FG000|Epoch 2|Withdrawal of informed consent|3|||
161294481|NCT02640664|582457964|FG001|Epoch 2|Withdrawal of informed consent|4|||
161294482|NCT02640664|582457965|FG002|Epoch 2|Withdrawal of informed consent|2|||
161294483|NCT02640664|582457963|FG000|Epoch 2|Subject/guardian decision|0|||
161294484|NCT02640664|582457964|FG001|Epoch 2|Subject/guardian decision|2|||
161294485|NCT02640664|582457965|FG002|Epoch 2|Subject/guardian decision|2|||
161294486|NCT02640664|582457963|FG000|Epoch 2|Lost to Follow-up|3|||
161294487|NCT02640664|582457964|FG001|Epoch 2|Lost to Follow-up|4|||
161294488|NCT02640664|582457965|FG002|Epoch 2|Lost to Follow-up|1|||
161294489|NCT02640664|582457963|FG000|Epoch 2|Death|0|||
161294490|NCT02640664|582457964|FG001|Epoch 2|Death|0|||
161294491|NCT02640664|582457965|FG002|Epoch 2|Death|1|||
161294492|NCT05514873|582457968|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
161294493|NCT05514873|582457968|FG000|Main Treatment Period|Adverse Event|2|||
161294494|NCT05514873|582457968|FG000|Extension Treatment Period|Lost to Follow-up|3|||
161294495|NCT02729025|582457969|FG000|Overall Study|Sponsor Decision|0|||
161294496|NCT02729025|582457970|FG001|Overall Study|Sponsor Decision|1|||
161294497|NCT03525678|582457971|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
161294498|NCT03525678|582457972|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
161294499|NCT03525678|582457973|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
161294500|NCT03525678|582457974|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
161294501|NCT03525678|582457975|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
161294502|NCT03525678|582457971|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
161294503|NCT03525678|582457972|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
161294504|NCT03525678|582457973|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161294505|NCT03525678|582457974|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161294506|NCT03525678|582457975|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
161294507|NCT03525678|582457971|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
161294508|NCT03525678|582457972|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
161294509|NCT03525678|582457973|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
161294510|NCT03525678|582457974|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
161294511|NCT03525678|582457975|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
161294512|NCT03525678|582457971|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
161294513|NCT03525678|582457972|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
161294514|NCT03525678|582457973|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
161294515|NCT03525678|582457974|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
161294516|NCT03525678|582457975|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
161294517|NCT03525678|582457971|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
161294518|NCT03525678|582457972|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
161294519|NCT03525678|582457973|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
161294520|NCT03525678|582457974|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
161294521|NCT03525678|582457975|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
161294522|NCT03525678|582457971|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
161294523|NCT03525678|582457972|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
161294524|NCT03525678|582457973|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161294525|NCT03525678|582457974|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161294526|NCT03525678|582457975|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
161294527|NCT05271370|582459330|FG000|Overall Study|Study early termination|8|||
161294528|NCT05271370|582459331|FG001|Overall Study|Study early termination|16|||
161294529|NCT05271370|582459332|FG002|Overall Study|Study early termination|29|||
161294530|NCT02283268|582459339|FG000|Overall Study|Withdrawal by Subject|1|||
161294531|NCT00333983|582459340|FG000|Overall Study|Lost to Follow-up|2|||
161294532|NCT00333983|582459341|FG001|Overall Study|Lost to Follow-up|1|||
161294533|NCT00333983|582459342|FG002|Overall Study|Lost to Follow-up|0|||
161294534|NCT00333983|582459340|FG000|Overall Study|Adverse Event|1|||
161294535|NCT00333983|582459341|FG001|Overall Study|Adverse Event|1|||
161294536|NCT00333983|582459342|FG002|Overall Study|Adverse Event|1|||
161294537|NCT00333983|582459340|FG000|Overall Study|Withdrawal by Subject|0|||
161294538|NCT00333983|582459341|FG001|Overall Study|Withdrawal by Subject|3|||
161294539|NCT00333983|582459342|FG002|Overall Study|Withdrawal by Subject|1|||
161294540|NCT00833105|582459343|FG000|Overall Study|Withdrawal by Subject|1|||
161294541|NCT00833105|582459343|FG000|Overall Study|Adverse Event|2|||
161294542|NCT02898597|582459344|FG000|Overall Study|Protocol Violation|4|||
161294543|NCT02898597|582459345|FG001|Overall Study|Protocol Violation|2|||
161294544|NCT02898597|582459344|FG000|Overall Study|Lost to Follow-up|0|||
161294545|NCT02898597|582459345|FG001|Overall Study|Lost to Follow-up|9|||
161294546|NCT02898597|582459344|FG000|Overall Study|Death|0|||
161294547|NCT02898597|582459345|FG001|Overall Study|Death|1|||
161294548|NCT03656068|582459346|FG000|Overall Study|Withdrawal by Subject|4|||
161294549|NCT03656068|582459346|FG000|Overall Study|Adverse Event|1|||
161294550|NCT02042014|582459348|FG000|Overall Study|Adverse Event|1|||
161294551|NCT02042014|582459348|FG000|Overall Study|Physician Decision|7|||
161294552|NCT02792062|582459349|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
161174673|NCT00928512|582015638|FG002|Overall Study|Adverse Event|2|||
161174674|NCT00928512|582015639|FG003|Overall Study|Adverse Event|8|||
161294553|NCT02792062|582459350|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161294554|NCT02792062|582459351|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161294555|NCT02792062|582459352|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161294556|NCT02792062|582459353|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161294557|NCT02792062|582459354|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
161294558|NCT03309943|582459357|FG000|Overall Study|Withdrawal by Subject|0|||
161294559|NCT03309943|582459358|FG001|Overall Study|Withdrawal by Subject|1|||
161174675|NCT00928512|582015640|FG004|Overall Study|Adverse Event|6|||
161174676|NCT00928512|582015636|FG000|Overall Study|Lack of Efficacy|2|||
161174677|NCT00928512|582015637|FG001|Overall Study|Lack of Efficacy|0|||
161174678|NCT00928512|582015638|FG002|Overall Study|Lack of Efficacy|4|||
161174679|NCT00928512|582015639|FG003|Overall Study|Lack of Efficacy|7|||
161174680|NCT00928512|582015640|FG004|Overall Study|Lack of Efficacy|3|||
161174681|NCT00928512|582015636|FG000|Overall Study|Protocol Violation|0|||
161174682|NCT00928512|582015637|FG001|Overall Study|Protocol Violation|1|||
161174683|NCT00928512|582015638|FG002|Overall Study|Protocol Violation|0|||
161174684|NCT00928512|582015639|FG003|Overall Study|Protocol Violation|1|||
161174685|NCT00928512|582015640|FG004|Overall Study|Protocol Violation|3|||
161174686|NCT00928512|582015636|FG000|Overall Study|Withdrawal by Subject|3|||
161174687|NCT00928512|582015637|FG001|Overall Study|Withdrawal by Subject|0|||
161174688|NCT00928512|582015638|FG002|Overall Study|Withdrawal by Subject|3|||
161174689|NCT00928512|582015639|FG003|Overall Study|Withdrawal by Subject|4|||
161174690|NCT00928512|582015640|FG004|Overall Study|Withdrawal by Subject|0|||
161174691|NCT00928512|582015636|FG000|Overall Study|Lost to Follow-up|1|||
161174692|NCT00928512|582015637|FG001|Overall Study|Lost to Follow-up|1|||
161174693|NCT00928512|582015638|FG002|Overall Study|Lost to Follow-up|2|||
161174694|NCT00928512|582015639|FG003|Overall Study|Lost to Follow-up|1|||
161174695|NCT00928512|582015640|FG004|Overall Study|Lost to Follow-up|3|||
161174696|NCT00928512|582015636|FG000|Overall Study|Administrative Problems|0|||
161174697|NCT00928512|582015637|FG001|Overall Study|Administrative Problems|1|||
161174698|NCT00928512|582015638|FG002|Overall Study|Administrative Problems|0|||
161174699|NCT00928512|582015639|FG003|Overall Study|Administrative Problems|0|||
161174700|NCT00928512|582015640|FG004|Overall Study|Administrative Problems|0|||
161174701|NCT01963780|582015641|FG000|Overall Study|Death|7|||
161174702|NCT03383614|582015642|FG000|Overall Study|Withdrawal by Subject|0|||
161174703|NCT03383614|582015643|FG001|Overall Study|Withdrawal by Subject|1|||
161174704|NCT03383614|582015644|FG002|Overall Study|Withdrawal by Subject|0|||
161174705|NCT03383614|582015645|FG003|Overall Study|Withdrawal by Subject|0|||
161174706|NCT01296698|582015648|FG000|Overall Study|Adverse Event|1|||
161174707|NCT01296698|582015649|FG001|Overall Study|Adverse Event|0|||
161174708|NCT01296698|582015648|FG000|Overall Study|Death|1|||
161174709|NCT01296698|582015649|FG001|Overall Study|Death|0|||
161174710|NCT01296698|582015648|FG000|Overall Study|Lost to Follow-up|19|||
161174711|NCT01296698|582015649|FG001|Overall Study|Lost to Follow-up|1|||
161174712|NCT01296698|582015648|FG000|Overall Study|Withdrawal by Subject|12|||
161174713|NCT01296698|582015649|FG001|Overall Study|Withdrawal by Subject|0|||
161174714|NCT01296698|582015648|FG000|Overall Study|Difficulty Contacting Subject|2|||
161174715|NCT01296698|582015649|FG001|Overall Study|Difficulty Contacting Subject|0|||
161174716|NCT01296698|582015648|FG000|Overall Study|Study Terminated by Sponsor|209|||
161174717|NCT01296698|582015649|FG001|Overall Study|Study Terminated by Sponsor|12|||
161174718|NCT03495817|582015653|FG000|26 Week Open Label|Adverse Event|3|||
161174719|NCT03495817|582015653|FG000|26 Week Open Label|Withdrawal by Subject|4|||
161174720|NCT03495817|582015653|FG000|26 Week Open Label|Lost to Follow-up|1|||
161174721|NCT03495817|582015653|FG000|26 Week Extension|Lost to Follow-up|2|||
161174722|NCT01686958|582015654|FG000|Overall Study|Withdrawal by Subject|1|||
161174723|NCT04294095|582015661|FG000|Overall Study|Adverse Event|1|||
161174724|NCT04294095|582015662|FG001|Overall Study|Adverse Event|0|||
161174725|NCT00446641|582017654|FG000|Overall Study|Withdrawal by Subject|8|||
161174726|NCT00446641|582017655|FG001|Overall Study|Withdrawal by Subject|3|||
161294560|NCT03309943|582459357|FG000|Overall Study|Inappropriate behavior towards staff|0|||
161294561|NCT03309943|582459358|FG001|Overall Study|Inappropriate behavior towards staff|1|||
161294562|NCT00427648|582459362|FG000|Overall Study|Protocol Violation|1|||
161294563|NCT00427648|582459363|FG001|Overall Study|Protocol Violation|2|||
161294564|NCT00427648|582459362|FG000|Overall Study|Adverse Event|0|||
161294565|NCT00427648|582459363|FG001|Overall Study|Adverse Event|1|||
161294566|NCT01609296|582459364|FG000|Overall Study|Death|253|||
161294567|NCT01609296|582459364|FG000|Overall Study|Withdrawal by Subject|151|||
161294568|NCT01609296|582459364|FG000|Overall Study|Lost to Follow-up|21|||
161294569|NCT01609296|582459364|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
161294570|NCT01609296|582459364|FG000|Overall Study|missed visit but known to be alive|28|||
161294571|NCT01681212|582459367|FG000|Overall Study|No longer met study criteria|5|||
161294572|NCT01681212|582459367|FG000|Overall Study|Administrative reason by sponsor|1|||
161294573|NCT01464333|582459368|FG000|Overall Study|Adverse Event|34|||
161294574|NCT01464333|582459368|FG000|Overall Study|Lack of Efficacy|72|||
161294575|NCT01464333|582459368|FG000|Overall Study|Withdrawal by Subject|11|||
161294576|NCT01464333|582459368|FG000|Overall Study|Other|4|||
161294577|NCT01464333|582459368|FG000|Overall Study|No Hospital Visit|42|||
161294578|NCT03321968|582459372|FG000|Overall Study|Withdrawal by Subject|1|||
161294579|NCT03321968|582459373|FG001|Overall Study|Withdrawal by Subject|2|||
161294580|NCT03321968|582459374|FG002|Overall Study|Withdrawal by Subject|1|||
161174727|NCT00446641|582017654|FG000|Overall Study|poor compliance|8|||
161174728|NCT00446641|582017655|FG001|Overall Study|poor compliance|6|||
161174729|NCT00446641|582017654|FG000|Overall Study|Lost to Follow-up|1|||
161174730|NCT00446641|582017655|FG001|Overall Study|Lost to Follow-up|1|||
161294581|NCT03321968|582459372|FG000|Overall Study|Lost to Follow-up|2|||
161294582|NCT03321968|582459373|FG001|Overall Study|Lost to Follow-up|0|||
161294583|NCT03321968|582459374|FG002|Overall Study|Lost to Follow-up|1|||
161294584|NCT03321968|582459372|FG000|Overall Study|Other than specified|0|||
161294585|NCT03321968|582459373|FG001|Overall Study|Other than specified|0|||
161294586|NCT03321968|582459374|FG002|Overall Study|Other than specified|1|||
161294587|NCT02282813|582459377|FG000|Overall Study|Withdrawal by Subject|4|||
161294588|NCT02282813|582459378|FG001|Overall Study|Withdrawal by Subject|5|||
161294589|NCT02282813|582459379|FG002|Overall Study|Withdrawal by Subject|0|||
161294590|NCT02282813|582459377|FG000|Overall Study|Adverse Event|3|||
161294591|NCT02282813|582459378|FG001|Overall Study|Adverse Event|10|||
161294592|NCT02282813|582459379|FG002|Overall Study|Adverse Event|1|||
161294593|NCT02282813|582459377|FG000|Overall Study|Subject non-compliance|1|||
161294594|NCT02282813|582459378|FG001|Overall Study|Subject non-compliance|4|||
161294595|NCT02282813|582459379|FG002|Overall Study|Subject non-compliance|0|||
161294596|NCT02282813|582459377|FG000|Overall Study|Physician Decision|0|||
161294597|NCT02282813|582459378|FG001|Overall Study|Physician Decision|3|||
161294598|NCT02282813|582459379|FG002|Overall Study|Physician Decision|1|||
161294599|NCT02282813|582459377|FG000|Overall Study|Lost to Follow-up|2|||
161294600|NCT02282813|582459378|FG001|Overall Study|Lost to Follow-up|0|||
161294601|NCT02282813|582459379|FG002|Overall Study|Lost to Follow-up|1|||
161294602|NCT02282813|582459377|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
161294603|NCT02282813|582459378|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
161294604|NCT02282813|582459379|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
161294605|NCT02282813|582459377|FG000|Overall Study|Lack of Efficacy|1|||
161294606|NCT02282813|582459378|FG001|Overall Study|Lack of Efficacy|0|||
161294607|NCT02282813|582459379|FG002|Overall Study|Lack of Efficacy|0|||
161294608|NCT02282813|582459377|FG000|Overall Study|Administrative reasons|0|||
161294609|NCT02282813|582459378|FG001|Overall Study|Administrative reasons|1|||
161294610|NCT02282813|582459379|FG002|Overall Study|Administrative reasons|0|||
161294611|NCT00529308|582459380|FG000|Overall Study|Withdrawal by Subject|1|||
161294612|NCT00529308|582459381|FG001|Overall Study|Withdrawal by Subject|1|||
161294613|NCT06509438|582459382|FG000|Overall Study|Adverse Event|1|||
161294614|NCT06509438|582459382|FG000|Overall Study|Lost to Follow-up|3|||
161294615|NCT00745901|582459384|FG000|Overall Study|Adverse Event|3|||
161294616|NCT00745901|582459385|FG001|Overall Study|Adverse Event|4|||
161294617|NCT00745901|582459384|FG000|Overall Study|Protocol Violation|0|||
161294618|NCT00745901|582459385|FG001|Overall Study|Protocol Violation|1|||
161294619|NCT00745901|582459384|FG000|Overall Study|Withdrawal by Subject|1|||
161294620|NCT00745901|582459385|FG001|Overall Study|Withdrawal by Subject|0|||
161294621|NCT00745901|582459384|FG000|Overall Study|Lost to Follow-up|7|||
161294622|NCT00745901|582459385|FG001|Overall Study|Lost to Follow-up|4|||
161294623|NCT00745901|582459384|FG000|Overall Study|Pregnancy|2|||
161294624|NCT00745901|582459385|FG001|Overall Study|Pregnancy|4|||
161294625|NCT00745901|582459384|FG000|Overall Study|Lack of compliance|2|||
161294626|NCT00745901|582459385|FG001|Overall Study|Lack of compliance|2|||
161294627|NCT00745901|582459384|FG000|Overall Study|Patient's next menses did not start with|1|||
161294628|NCT00745901|582459385|FG001|Overall Study|Patient's next menses did not start with|0|||
161294629|NCT00745901|582459384|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
161294630|NCT00745901|582459385|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
161294631|NCT00745901|582459384|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
161294632|NCT00745901|582459385|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
161294633|NCT00745901|582459384|FG000|Overall Study|Patient didn't take any study medication|7|||
161087633|NCT00540046|581708448|FG001|Overall Study|Lost to Follow-up|23|||
161087634|NCT01021215|581708456|FG000|Overall Study|Lost to Follow-up|3|||
161087635|NCT01021215|581708457|FG001|Overall Study|Lost to Follow-up|0|||
161087636|NCT00185965|581708460|FG000|Overall Study|Adverse Event|0|||
161087637|NCT00185965|581708461|FG001|Overall Study|Adverse Event|1|||
161087638|NCT02533531|581708462|FG000|Overall Study|Device did not turn on|1|||
161087639|NCT01103362|581708463|FG000|Overall Study|study terminated|596|||
161294634|NCT00745901|582459385|FG001|Overall Study|Patient didn't take any study medication|3|||
161294635|NCT01753310|582459387|FG000|Overall Study|Entered into open label extension study|25|||
161294636|NCT01753310|582459388|FG001|Overall Study|Entered into open label extension study|22|||
161347616|NCT05350202|582656336|FG001|Visit 1 - Baseline|Not-treated|0|||
161294637|NCT01753310|582459387|FG000|Overall Study|Adverse Event|1|||
161294638|NCT01753310|582459388|FG001|Overall Study|Adverse Event|0|||
161294639|NCT01753310|582459387|FG000|Overall Study|Lost to Follow-up|2|||
161294640|NCT01753310|582459388|FG001|Overall Study|Lost to Follow-up|0|||
161294641|NCT01753310|582459387|FG000|Overall Study|Subject decision|2|||
161294642|NCT01753310|582459388|FG001|Overall Study|Subject decision|2|||
161294643|NCT01753310|582459387|FG000|Overall Study|Sponsor decision|1|||
161294644|NCT01753310|582459388|FG001|Overall Study|Sponsor decision|0|||
161294645|NCT01753310|582459387|FG000|Overall Study|Withdrawal by Subject|1|||
161294646|NCT01753310|582459388|FG001|Overall Study|Withdrawal by Subject|0|||
161294647|NCT05581641|582459389|FG000|Overall Study|Withdrawal by Subject|0|||
161347617|NCT05350202|582656335|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
161087640|NCT03814187|581708464|FG000|Overall Study|Sponsor's Administrative Decision|0|||
161174731|NCT01826448|582017657|FG000|Overall Study|Adverse Event|1|||
161174732|NCT01826448|582017658|FG001|Overall Study|Adverse Event|3|||
161174733|NCT01826448|582017657|FG000|Overall Study|Disease progression|2|||
161174734|NCT01826448|582017658|FG001|Overall Study|Disease progression|4|||
161174735|NCT01826448|582017657|FG000|Overall Study|Withdrawal by Subject|1|||
161174736|NCT01826448|582017658|FG001|Overall Study|Withdrawal by Subject|0|||
161174737|NCT01826448|582017657|FG000|Overall Study|Physician Decision|0|||
161174738|NCT01826448|582017658|FG001|Overall Study|Physician Decision|1|||
161174739|NCT01826448|582017657|FG000|Overall Study|2 active cancers|0|||
161174740|NCT01826448|582017658|FG001|Overall Study|2 active cancers|1|||
161174741|NCT01376388|582017663|FG000|Overall Study|Adverse Event|13|||
161174742|NCT01376388|582017663|FG000|Overall Study|Lack of Efficacy|2|||
161174743|NCT01376388|582017663|FG000|Overall Study|Withdrawal by Subject|3|||
161174744|NCT00879437|582017675|FG000|Overall Study|Protocol Violation|0|||
161174745|NCT00879437|582017676|FG001|Overall Study|Protocol Violation|1|||
161174746|NCT00879437|582017675|FG000|Overall Study|Death|1|||
161174747|NCT00879437|582017676|FG001|Overall Study|Death|0|||
161174748|NCT00291187|582017677|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
161174749|NCT00291187|582017678|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
161174750|NCT00291187|582017679|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
161174751|NCT00291187|582017680|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
161174752|NCT02023268|582017681|FG000|Overall Study|Lack of Efficacy|0|||
161174753|NCT02023268|582017682|FG001|Overall Study|Lack of Efficacy|1|||
161174754|NCT02023268|582017681|FG000|Overall Study|Adverse Event|0|||
161174755|NCT02023268|582017682|FG001|Overall Study|Adverse Event|2|||
161174756|NCT02023268|582017681|FG000|Overall Study|Withdrawal by Subject|0|||
161174757|NCT02023268|582017682|FG001|Overall Study|Withdrawal by Subject|1|||
161174758|NCT03379376|582017683|FG000|Overall Study|Lost to Follow-up|2|||
161174759|NCT03379376|582017683|FG000|Overall Study|Did not wish to complete follow up|1|||
161174760|NCT03379376|582017683|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
161174761|NCT03379376|582017683|FG000|Overall Study|Death|1|||
161174762|NCT02475629|582017684|FG000|Overall Study|Adverse Event|1|||
161174763|NCT02475629|582017684|FG000|Overall Study|Death|4|||
161174764|NCT02475629|582017684|FG000|Overall Study|Physician Decision|1|||
161174765|NCT02475629|582017684|FG000|Overall Study|Withdrawal by Subject|1|||
161174766|NCT02475629|582017684|FG000|Overall Study|Lost to Follow-up|1|||
161174767|NCT02475629|582017684|FG000|Overall Study|Subject non-compliance|1|||
161174768|NCT04153929|582017685|FG000|Overall Study|Other than listed|2|||
161174769|NCT04153929|582017686|FG001|Overall Study|Other than listed|2|||
161174770|NCT04153929|582017687|FG002|Overall Study|Other than listed|0|||
161174771|NCT04153929|582017688|FG003|Overall Study|Other than listed|1|||
161174772|NCT04153929|582017689|FG004|Overall Study|Other than listed|0|||
161174773|NCT04153929|582017690|FG005|Overall Study|Other than listed|2|||
161174774|NCT04153929|582017691|FG006|Overall Study|Other than listed|2|||
161174775|NCT04153929|582017692|FG007|Overall Study|Other than listed|1|||
161174776|NCT04153929|582017685|FG000|Overall Study|Lost to Follow-up|2|||
161174777|NCT04153929|582017686|FG001|Overall Study|Lost to Follow-up|1|||
161174778|NCT04153929|582017687|FG002|Overall Study|Lost to Follow-up|0|||
161174779|NCT04153929|582017688|FG003|Overall Study|Lost to Follow-up|1|||
161174780|NCT04153929|582017689|FG004|Overall Study|Lost to Follow-up|1|||
161174781|NCT04153929|582017690|FG005|Overall Study|Lost to Follow-up|0|||
161174782|NCT04153929|582017691|FG006|Overall Study|Lost to Follow-up|0|||
161174783|NCT04153929|582017692|FG007|Overall Study|Lost to Follow-up|0|||
161174784|NCT04153929|582017685|FG000|Overall Study|Withdrawal by Subject|3|||
161174785|NCT04153929|582017686|FG001|Overall Study|Withdrawal by Subject|1|||
161174786|NCT04153929|582017687|FG002|Overall Study|Withdrawal by Subject|0|||
161294648|NCT05581641|582459390|FG001|Overall Study|Withdrawal by Subject|1|||
161294649|NCT05581641|582459391|FG002|Overall Study|Withdrawal by Subject|3|||
161294650|NCT05581641|582459392|FG003|Overall Study|Withdrawal by Subject|1|||
161294651|NCT05581641|582459389|FG000|Overall Study|Lost to Follow-up|0|||
161294652|NCT05581641|582459390|FG001|Overall Study|Lost to Follow-up|1|||
161294653|NCT05581641|582459391|FG002|Overall Study|Lost to Follow-up|0|||
161294654|NCT05581641|582459392|FG003|Overall Study|Lost to Follow-up|1|||
161294655|NCT05581641|582459389|FG000|Overall Study|Protocol Violation|1|||
161294656|NCT05581641|582459390|FG001|Overall Study|Protocol Violation|0|||
161294657|NCT05581641|582459391|FG002|Overall Study|Protocol Violation|0|||
161294658|NCT05581641|582459392|FG003|Overall Study|Protocol Violation|0|||
161294659|NCT05581641|582459389|FG000|Overall Study|Other|1|||
161294660|NCT05581641|582459390|FG001|Overall Study|Other|0|||
161294661|NCT05581641|582459391|FG002|Overall Study|Other|2|||
161174787|NCT04153929|582017688|FG003|Overall Study|Withdrawal by Subject|3|||
161174788|NCT04153929|582017689|FG004|Overall Study|Withdrawal by Subject|1|||
161174789|NCT04153929|582017690|FG005|Overall Study|Withdrawal by Subject|0|||
161174790|NCT04153929|582017691|FG006|Overall Study|Withdrawal by Subject|1|||
161174791|NCT04153929|582017692|FG007|Overall Study|Withdrawal by Subject|0|||
161174792|NCT04153929|582017685|FG000|Overall Study|Protocol Violation|0|||
161174793|NCT04153929|582017686|FG001|Overall Study|Protocol Violation|0|||
161174794|NCT04153929|582017687|FG002|Overall Study|Protocol Violation|0|||
161294662|NCT05581641|582459392|FG003|Overall Study|Other|1|||
161087641|NCT03814187|581708465|FG001|Overall Study|Sponsor's Administrative Decision|0|||
161087642|NCT03814187|581708466|FG002|Overall Study|Sponsor's Administrative Decision|272|||
161294663|NCT04390763|582459393|FG000|Safety run-in Part|Adverse Event|4|||
161294664|NCT04390763|582459394|FG001|Safety run-in Part|Adverse Event|0|||
161294665|NCT04390763|582459395|FG002|Safety run-in Part|Adverse Event|0|||
161294666|NCT04390763|582459396|FG003|Safety run-in Part|Adverse Event|0|||
161294667|NCT04390763|582459393|FG000|Safety run-in Part|Physician Decision|1|||
161294668|NCT04390763|582459394|FG001|Safety run-in Part|Physician Decision|0|||
161294669|NCT04390763|582459395|FG002|Safety run-in Part|Physician Decision|0|||
161294670|NCT04390763|582459396|FG003|Safety run-in Part|Physician Decision|0|||
161294671|NCT04390763|582459393|FG000|Safety run-in Part|Progressive Disease|6|||
161294672|NCT04390763|582459394|FG001|Safety run-in Part|Progressive Disease|0|||
161294673|NCT04390763|582459395|FG002|Safety run-in Part|Progressive Disease|0|||
161294674|NCT04390763|582459396|FG003|Safety run-in Part|Progressive Disease|0|||
161294675|NCT04390763|582459393|FG000|Randomized Part|Adverse Event|0|||
161294676|NCT04390763|582459394|FG001|Randomized Part|Adverse Event|11|||
161294677|NCT04390763|582459395|FG002|Randomized Part|Adverse Event|5|||
161294678|NCT04390763|582459396|FG003|Randomized Part|Adverse Event|5|||
161294679|NCT04390763|582459393|FG000|Randomized Part|Death|0|||
161294680|NCT04390763|582459394|FG001|Randomized Part|Death|3|||
161294681|NCT04390763|582459395|FG002|Randomized Part|Death|4|||
161294682|NCT04390763|582459396|FG003|Randomized Part|Death|2|||
161294683|NCT04390763|582459393|FG000|Randomized Part|Physician Decision|0|||
161294684|NCT04390763|582459394|FG001|Randomized Part|Physician Decision|2|||
161294685|NCT04390763|582459395|FG002|Randomized Part|Physician Decision|2|||
161294686|NCT04390763|582459396|FG003|Randomized Part|Physician Decision|9|||
161294687|NCT04390763|582459393|FG000|Randomized Part|Progressive Disease|0|||
161294688|NCT04390763|582459394|FG001|Randomized Part|Progressive Disease|24|||
161294689|NCT04390763|582459395|FG002|Randomized Part|Progressive Disease|31|||
161294690|NCT04390763|582459396|FG003|Randomized Part|Progressive Disease|23|||
161294691|NCT04390763|582459393|FG000|Randomized Part|Study terminated by sponsor|0|||
161294692|NCT04390763|582459394|FG001|Randomized Part|Study terminated by sponsor|1|||
161294693|NCT04390763|582459395|FG002|Randomized Part|Study terminated by sponsor|0|||
161294694|NCT04390763|582459396|FG003|Randomized Part|Study terminated by sponsor|0|||
161294695|NCT04390763|582459393|FG000|Randomized Part|Participant Decision|0|||
161294696|NCT04390763|582459394|FG001|Randomized Part|Participant Decision|5|||
161294697|NCT04390763|582459395|FG002|Randomized Part|Participant Decision|7|||
161294698|NCT04390763|582459396|FG003|Randomized Part|Participant Decision|6|||
161087643|NCT03814187|581708464|FG000|Overall Study|Death|80|||
161087644|NCT03814187|581708465|FG001|Overall Study|Death|81|||
161087645|NCT03814187|581708466|FG002|Overall Study|Death|4|||
161087646|NCT03814187|581708464|FG000|Overall Study|Withdrew Consent|77|||
161087647|NCT03814187|581708465|FG001|Overall Study|Withdrew Consent|78|||
161087648|NCT03814187|581708466|FG002|Overall Study|Withdrew Consent|2|||
161087649|NCT03814187|581708464|FG000|Overall Study|Lost to Follow-up|47|||
161087650|NCT03814187|581708465|FG001|Overall Study|Lost to Follow-up|52|||
161087651|NCT03814187|581708466|FG002|Overall Study|Lost to Follow-up|1|||
161087652|NCT03814187|581708464|FG000|Overall Study|Adverse Event|22|||
161087653|NCT03814187|581708465|FG001|Overall Study|Adverse Event|23|||
161087654|NCT03814187|581708466|FG002|Overall Study|Adverse Event|0|||
161087655|NCT03814187|581708464|FG000|Overall Study|Physician Decision|7|||
161087656|NCT03814187|581708465|FG001|Overall Study|Physician Decision|4|||
161087657|NCT03814187|581708466|FG002|Overall Study|Physician Decision|2|||
161087658|NCT03814187|581708464|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
161087659|NCT03814187|581708465|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
161087660|NCT03814187|581708466|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
161087661|NCT03814187|581708464|FG000|Overall Study|Other reasons|34|||
161087662|NCT03814187|581708465|FG001|Overall Study|Other reasons|40|||
161294699|NCT04390763|582459393|FG000|Randomized Part|Not treated|0|||
161294700|NCT04390763|582459394|FG001|Randomized Part|Not treated|4|||
161294701|NCT04390763|582459395|FG002|Randomized Part|Not treated|2|||
161294702|NCT04390763|582459396|FG003|Randomized Part|Not treated|7|||
161294703|NCT01956773|582459403|FG000|Overall Study|Lost to Follow-up|628|||
161294704|NCT01956773|582459404|FG001|Overall Study|Lost to Follow-up|1|||
161294705|NCT01383174|582459405|FG000|3 Month Assessment|Death|0|||
161294706|NCT01383174|582459406|FG001|3 Month Assessment|Death|1|||
161294707|NCT01383174|582459405|FG000|3 Month Assessment|Lost to Follow-up|2|||
161294708|NCT01383174|582459406|FG001|3 Month Assessment|Lost to Follow-up|0|||
161087663|NCT03814187|581708466|FG002|Overall Study|Other reasons|2|||
161087664|NCT01014533|581708467|FG000|Overall Study|Protocol Violation|3|||
161087665|NCT01014533|581708468|FG001|Overall Study|Protocol Violation|2|||
161294709|NCT01383174|582459405|FG000|3 Month Assessment|Refused to complete|4|||
161294710|NCT01383174|582459406|FG001|3 Month Assessment|Refused to complete|0|||
161294711|NCT01383174|582459405|FG000|6 Month Assessment|Lost to Follow-up|1|||
161294712|NCT01383174|582459406|FG001|6 Month Assessment|Lost to Follow-up|1|||
161294713|NCT01383174|582459405|FG000|6 Month Assessment|Refused to complete|4|||
161319484|NCT01863732|582555335|FG001|Overall Study|Lack of Efficacy|0|||
161319485|NCT01863732|582555336|FG002|Overall Study|Lack of Efficacy|2|||
161347618|NCT05350202|582656336|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
161347619|NCT05350202|582656335|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
161347620|NCT05350202|582656336|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
161347621|NCT05350202|582656335|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
161347622|NCT05350202|582656336|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
161347623|NCT05350202|582656335|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
161347624|NCT05350202|582656336|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
161087666|NCT01014533|581708467|FG000|Overall Study|Withdrawal by Subject|2|||
161087667|NCT01014533|581708468|FG001|Overall Study|Withdrawal by Subject|0|||
161087668|NCT01014533|581708467|FG000|Overall Study|unable to come to appointment|0|||
161087669|NCT01014533|581708468|FG001|Overall Study|unable to come to appointment|3|||
161087670|NCT00513604|581708469|FG000|Overall Study|Not treated|2|||
161087671|NCT00513604|581708470|FG001|Overall Study|Not treated|0|||
161087672|NCT00513604|581708471|FG002|Overall Study|Not treated|1|||
161087673|NCT00513604|581708472|FG003|Overall Study|Not treated|0|||
161087674|NCT00513604|581708473|FG004|Overall Study|Not treated|0|||
161087675|NCT00513604|581708469|FG000|Overall Study|Death during treatment|0|||
161087676|NCT00513604|581708470|FG001|Overall Study|Death during treatment|3|||
161087677|NCT00513604|581708471|FG002|Overall Study|Death during treatment|2|||
161087678|NCT00513604|581708472|FG003|Overall Study|Death during treatment|0|||
161087679|NCT00513604|581708473|FG004|Overall Study|Death during treatment|0|||
161087680|NCT00412061|581708475|FG000|Double Blind Phase|Disease Progression|101|||
161087681|NCT00412061|581708476|FG001|Double Blind Phase|Disease Progression|154|||
161087682|NCT00412061|581708475|FG000|Double Blind Phase|Adverse Event|61|||
161087683|NCT00412061|581708476|FG001|Double Blind Phase|Adverse Event|16|||
161087684|NCT00412061|581708475|FG000|Double Blind Phase|Final Primary Analysis|26|||
161087685|NCT00412061|581708476|FG001|Double Blind Phase|Final Primary Analysis|14|||
161087686|NCT00412061|581708475|FG000|Double Blind Phase|Withdrawal by Subject|18|||
161087687|NCT00412061|581708476|FG001|Double Blind Phase|Withdrawal by Subject|20|||
161087688|NCT00412061|581708475|FG000|Double Blind Phase|Death|6|||
161087689|NCT00412061|581708476|FG001|Double Blind Phase|Death|3|||
161087690|NCT00412061|581708475|FG000|Double Blind Phase|Protocol Violation|3|||
161087691|NCT00412061|581708476|FG001|Double Blind Phase|Protocol Violation|4|||
161087692|NCT00412061|581708475|FG000|Double Blind Phase|New Cander Therapy|1|||
161087693|NCT00412061|581708476|FG001|Double Blind Phase|New Cander Therapy|1|||
161087694|NCT00412061|581708475|FG000|Double Blind Phase|Lost to Follow-up|0|||
161087695|NCT00412061|581708476|FG001|Double Blind Phase|Lost to Follow-up|1|||
161087696|NCT00412061|581708475|FG000|Open Label Phase|Disease Progression|0|||
161087697|NCT00412061|581708476|FG001|Open Label Phase|Disease Progression|86|||
161087698|NCT00412061|581708475|FG000|Open Label Phase|Adverse Event|0|||
161087699|NCT00412061|581708476|FG001|Open Label Phase|Adverse Event|46|||
161087700|NCT00412061|581708475|FG000|Open Label Phase|Withdrawal by Subject|0|||
161087701|NCT00412061|581708476|FG001|Open Label Phase|Withdrawal by Subject|15|||
161087702|NCT00412061|581708475|FG000|Open Label Phase|Administrative Problems|0|||
161087703|NCT00412061|581708476|FG001|Open Label Phase|Administrative Problems|13|||
161087704|NCT00412061|581708475|FG000|Open Label Phase|Death|0|||
161087705|NCT00412061|581708476|FG001|Open Label Phase|Death|7|||
161087706|NCT00412061|581708475|FG000|Open Label Phase|Lost to Follow-up|0|||
161087707|NCT00412061|581708476|FG001|Open Label Phase|Lost to Follow-up|2|||
161087708|NCT00412061|581708475|FG000|Open Label Phase|New Cancer Therapy|0|||
161087709|NCT00412061|581708476|FG001|Open Label Phase|New Cancer Therapy|1|||
161087710|NCT02689518|581708477|FG000|Overall Study|Withdrawal by Subject|3|||
161087711|NCT02859324|581708480|FG000|Overall Study|Death|4|||
161087712|NCT02859324|581708481|FG001|Overall Study|Death|6|||
161087713|NCT02859324|581708482|FG002|Overall Study|Death|5|||
161087714|NCT02859324|581708480|FG000|Overall Study|Other reasons|3|||
161087715|NCT02859324|581708481|FG001|Overall Study|Other reasons|3|||
161087716|NCT02859324|581708482|FG002|Overall Study|Other reasons|0|||
161087717|NCT00998335|581708484|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
161087718|NCT00998335|581708485|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
161087719|NCT01305200|581708486|FG000|Overall Study|Physician Decision|4|||
161087720|NCT01305200|581708487|FG001|Overall Study|Physician Decision|6|||
161087721|NCT01305200|581708488|FG002|Overall Study|Physician Decision|1|||
161087722|NCT01305200|581708486|FG000|Overall Study|Withdrawal by Subject|24|||
161087723|NCT01305200|581708487|FG001|Overall Study|Withdrawal by Subject|21|||
161087724|NCT01305200|581708488|FG002|Overall Study|Withdrawal by Subject|1|||
161087725|NCT01305200|581708486|FG000|Overall Study|Ineligible|1|||
161087726|NCT01305200|581708487|FG001|Overall Study|Ineligible|2|||
161087727|NCT01305200|581708488|FG002|Overall Study|Ineligible|1|||
161087728|NCT01305200|581708486|FG000|Overall Study|Death|0|||
161087729|NCT01305200|581708487|FG001|Overall Study|Death|2|||
161087730|NCT01305200|581708488|FG002|Overall Study|Death|0|||
161087731|NCT05559476|581708489|FG000|Overall Study|Adverse Event|2|||
161087732|NCT05559476|581708490|FG001|Overall Study|Adverse Event|0|||
161087733|NCT05559476|581708489|FG000|Overall Study|Lost to Follow-up|13|||
161087734|NCT05559476|581708490|FG001|Overall Study|Lost to Follow-up|12|||
161174795|NCT04153929|582017688|FG003|Overall Study|Protocol Violation|0|||
161294714|NCT01383174|582459406|FG001|6 Month Assessment|Refused to complete|0|||
161294715|NCT01153815|582459409|FG000|Overall Study|Adverse Event|3|||
161294716|NCT01153815|582459410|FG001|Overall Study|Adverse Event|1|||
161294717|NCT01153815|582459409|FG000|Overall Study|Withdrawal by Subject|6|||
161294718|NCT01153815|582459410|FG001|Overall Study|Withdrawal by Subject|4|||
161294719|NCT02169271|582459411|FG000|Overall Study|Protocol Violation|1|||
161294720|NCT02169271|582459412|FG001|Overall Study|Protocol Violation|2|||
161294721|NCT03591874|582459413|FG000|Overall Study|Adverse Event|4|||
161294722|NCT03591874|582459414|FG001|Overall Study|Adverse Event|0|||
161294723|NCT03591874|582459413|FG000|Overall Study|Withdrawal by Subject|2|||
161294724|NCT03591874|582459414|FG001|Overall Study|Withdrawal by Subject|1|||
161294725|NCT03591874|582459413|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
161294726|NCT03591874|582459414|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
161294727|NCT03591874|582459413|FG000|Overall Study|On Study at Time of Study Termination|12|||
161294728|NCT03591874|582459414|FG001|Overall Study|On Study at Time of Study Termination|6|||
161294729|NCT03194542|582459417|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
161294730|NCT03194542|582459418|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161294731|NCT03194542|582459419|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161294732|NCT03194542|582459420|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
161294733|NCT03194542|582459417|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
161294734|NCT03194542|582459418|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
161294735|NCT03194542|582459419|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
161294736|NCT03194542|582459420|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
161294737|NCT03194542|582459417|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
161294738|NCT03194542|582459418|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
161294739|NCT03194542|582459419|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
161294740|NCT03194542|582459420|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
161294741|NCT03194542|582459417|FG000|Overall Study|Loss of Response|4|||
161294742|NCT03194542|582459418|FG001|Overall Study|Loss of Response|2|||
161294743|NCT03194542|582459419|FG002|Overall Study|Loss of Response|3|||
161294744|NCT03194542|582459420|FG003|Overall Study|Loss of Response|4|||
161294745|NCT03194542|582459417|FG000|Overall Study|Physician Decision|0|||
161294746|NCT03194542|582459418|FG001|Overall Study|Physician Decision|1|||
161294747|NCT03194542|582459419|FG002|Overall Study|Physician Decision|0|||
161294748|NCT03194542|582459420|FG003|Overall Study|Physician Decision|0|||
161294749|NCT03194542|582459417|FG000|Overall Study|Lack of Efficacy|2|||
161294750|NCT03194542|582459418|FG001|Overall Study|Lack of Efficacy|2|||
161294751|NCT03194542|582459419|FG002|Overall Study|Lack of Efficacy|2|||
161294752|NCT03194542|582459420|FG003|Overall Study|Lack of Efficacy|6|||
161294753|NCT03194542|582459417|FG000|Overall Study|Withdrawal by Subject|2|||
161294754|NCT03194542|582459418|FG001|Overall Study|Withdrawal by Subject|1|||
161294755|NCT03194542|582459419|FG002|Overall Study|Withdrawal by Subject|5|||
161294756|NCT03194542|582459420|FG003|Overall Study|Withdrawal by Subject|4|||
161294757|NCT03194542|582459417|FG000|Overall Study|Progressive Disease|1|||
161294758|NCT03194542|582459418|FG001|Overall Study|Progressive Disease|0|||
161294759|NCT03194542|582459419|FG002|Overall Study|Progressive Disease|1|||
161294760|NCT03194542|582459420|FG003|Overall Study|Progressive Disease|1|||
161294761|NCT03194542|582459417|FG000|Overall Study|Adverse Event|1|||
161294762|NCT03194542|582459418|FG001|Overall Study|Adverse Event|2|||
161294763|NCT03194542|582459419|FG002|Overall Study|Adverse Event|0|||
161294764|NCT03194542|582459420|FG003|Overall Study|Adverse Event|5|||
161294765|NCT03194542|582459417|FG000|Overall Study|Death|1|||
161294766|NCT03194542|582459418|FG001|Overall Study|Death|2|||
161294767|NCT03194542|582459419|FG002|Overall Study|Death|0|||
161294768|NCT03194542|582459420|FG003|Overall Study|Death|5|||
161294769|NCT03194542|582459417|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
161294770|NCT03194542|582459418|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
161294771|NCT03194542|582459419|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
161294772|NCT03194542|582459420|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
161294773|NCT03859427|582459424|FG000|Overall Study|Withdrawal by Subject|4|||
161294774|NCT03859427|582459425|FG001|Overall Study|Withdrawal by Subject|7|||
161294775|NCT03859427|582459424|FG000|Overall Study|Decision by sponsor|0|||
161294776|NCT03859427|582459425|FG001|Overall Study|Decision by sponsor|3|||
161294777|NCT03859427|582459424|FG000|Overall Study|Lost to Follow-up|3|||
161294778|NCT03859427|582459425|FG001|Overall Study|Lost to Follow-up|2|||
161294779|NCT03859427|582459424|FG000|Overall Study|Death|22|||
161294780|NCT03859427|582459425|FG001|Overall Study|Death|25|||
161294781|NCT00722137|582459426|FG000|Overall Study|Overt Disease Progression|5|||
161294782|NCT00722137|582459427|FG001|Overall Study|Overt Disease Progression|4|||
161294783|NCT00722137|582459426|FG000|Overall Study|Adverse Event|17|||
161294784|NCT00722137|582459427|FG001|Overall Study|Adverse Event|21|||
161294785|NCT00722137|582459426|FG000|Overall Study|Death|12|||
161294786|NCT00722137|582459427|FG001|Overall Study|Death|7|||
161294787|NCT00722137|582459426|FG000|Overall Study|Withdrawal by Subject|6|||
161174796|NCT04153929|582017689|FG004|Overall Study|Protocol Violation|0|||
161174797|NCT04153929|582017690|FG005|Overall Study|Protocol Violation|0|||
161174798|NCT04153929|582017691|FG006|Overall Study|Protocol Violation|1|||
161174799|NCT04153929|582017692|FG007|Overall Study|Protocol Violation|2|||
161174800|NCT04153929|582017685|FG000|Overall Study|Adverse Event|3|||
161174801|NCT04153929|582017686|FG001|Overall Study|Adverse Event|5|||
161174802|NCT04153929|582017687|FG002|Overall Study|Adverse Event|5|||
161174803|NCT04153929|582017688|FG003|Overall Study|Adverse Event|11|||
161174804|NCT04153929|582017689|FG004|Overall Study|Adverse Event|15|||
161174805|NCT04153929|582017690|FG005|Overall Study|Adverse Event|4|||
161174806|NCT04153929|582017691|FG006|Overall Study|Adverse Event|8|||
161174807|NCT04153929|582017692|FG007|Overall Study|Adverse Event|2|||
161174808|NCT04153929|582017685|FG000|Overall Study|Not treated|1|||
161174809|NCT04153929|582017686|FG001|Overall Study|Not treated|0|||
161174810|NCT04153929|582017687|FG002|Overall Study|Not treated|0|||
161174811|NCT04153929|582017688|FG003|Overall Study|Not treated|0|||
161174812|NCT04153929|582017689|FG004|Overall Study|Not treated|0|||
161174813|NCT04153929|582017690|FG005|Overall Study|Not treated|0|||
161174814|NCT04153929|582017691|FG006|Overall Study|Not treated|1|||
161174815|NCT04153929|582017692|FG007|Overall Study|Not treated|0|||
161174816|NCT04083794|582017693|FG000|Overall Study|Lost to Follow-up|9|||
161174817|NCT01749800|582017694|FG000|Overall Study|not meeting inclusion criteria|3|||
161174818|NCT01749800|582017695|FG001|Overall Study|not meeting inclusion criteria|0|||
161174819|NCT01749800|582017696|FG002|Overall Study|not meeting inclusion criteria|0|||
161174820|NCT01749800|582017694|FG000|Overall Study|Withdrawal by Subject|0|||
161174821|NCT01749800|582017695|FG001|Overall Study|Withdrawal by Subject|1|||
161174822|NCT01749800|582017696|FG002|Overall Study|Withdrawal by Subject|0|||
161174823|NCT02810951|582017701|FG000|Overall Study|Adverse Event|1|||
161174824|NCT03199638|582017704|FG000|Overall Study|inability to drink glutamine during regularly|0|||
161174825|NCT03199638|582017705|FG001|Overall Study|inability to drink glutamine during regularly|2|||
161174826|NCT01575899|582017706|FG000|Overall Study|Lost to Follow-up|3|||
161174827|NCT01575899|582017707|FG001|Overall Study|Lost to Follow-up|4|||
161174828|NCT01575899|582017708|FG002|Overall Study|Lost to Follow-up|2|||
161174829|NCT01575899|582017706|FG000|Overall Study|Protocol Violation|2|||
161174830|NCT01575899|582017707|FG001|Overall Study|Protocol Violation|1|||
161174831|NCT01575899|582017708|FG002|Overall Study|Protocol Violation|0|||
161174832|NCT02807844|582017709|FG000|Overall Study|Physician Decision|0|||
161174833|NCT02807844|582017710|FG001|Overall Study|Physician Decision|0|||
161174834|NCT02807844|582017711|FG002|Overall Study|Physician Decision|0|||
161174835|NCT02807844|582017712|FG003|Overall Study|Physician Decision|0|||
161174836|NCT02807844|582017713|FG004|Overall Study|Physician Decision|0|||
161174837|NCT02807844|582017714|FG005|Overall Study|Physician Decision|0|||
161174838|NCT02807844|582017715|FG006|Overall Study|Physician Decision|3|||
161174839|NCT02807844|582017716|FG007|Overall Study|Physician Decision|0|||
161174840|NCT02807844|582017717|FG008|Overall Study|Physician Decision|1|||
161174841|NCT02807844|582017718|FG009|Overall Study|Physician Decision|2|||
161174842|NCT02807844|582017709|FG000|Overall Study|Death|0|||
161174843|NCT02807844|582017710|FG001|Overall Study|Death|0|||
161174844|NCT02807844|582017711|FG002|Overall Study|Death|2|||
161174845|NCT02807844|582017712|FG003|Overall Study|Death|4|||
161174846|NCT02807844|582017713|FG004|Overall Study|Death|1|||
161174847|NCT02807844|582017714|FG005|Overall Study|Death|2|||
161174848|NCT02807844|582017715|FG006|Overall Study|Death|1|||
161174849|NCT02807844|582017716|FG007|Overall Study|Death|2|||
161174850|NCT02807844|582017717|FG008|Overall Study|Death|0|||
161174851|NCT02807844|582017718|FG009|Overall Study|Death|1|||
161174852|NCT02807844|582017709|FG000|Overall Study|Withdrawal by Subject|0|||
161174853|NCT02807844|582017710|FG001|Overall Study|Withdrawal by Subject|0|||
161174854|NCT02807844|582017711|FG002|Overall Study|Withdrawal by Subject|2|||
161174855|NCT02807844|582017712|FG003|Overall Study|Withdrawal by Subject|1|||
161174856|NCT02807844|582017713|FG004|Overall Study|Withdrawal by Subject|1|||
161174857|NCT02807844|582017714|FG005|Overall Study|Withdrawal by Subject|0|||
161174858|NCT02807844|582017715|FG006|Overall Study|Withdrawal by Subject|1|||
161174859|NCT02807844|582017716|FG007|Overall Study|Withdrawal by Subject|0|||
161174860|NCT02807844|582017717|FG008|Overall Study|Withdrawal by Subject|0|||
161174861|NCT02807844|582017718|FG009|Overall Study|Withdrawal by Subject|0|||
161174862|NCT02807844|582017709|FG000|Overall Study|Progressive disease|5|||
161174863|NCT02807844|582017710|FG001|Overall Study|Progressive disease|12|||
161174864|NCT02807844|582017711|FG002|Overall Study|Progressive disease|8|||
161174865|NCT02807844|582017712|FG003|Overall Study|Progressive disease|8|||
161174866|NCT02807844|582017713|FG004|Overall Study|Progressive disease|3|||
161174867|NCT02807844|582017714|FG005|Overall Study|Progressive disease|8|||
161174868|NCT02807844|582017715|FG006|Overall Study|Progressive disease|14|||
161174869|NCT02807844|582017716|FG007|Overall Study|Progressive disease|17|||
161174870|NCT02807844|582017717|FG008|Overall Study|Progressive disease|19|||
161174871|NCT02807844|582017718|FG009|Overall Study|Progressive disease|15|||
161174872|NCT02807844|582017709|FG000|Overall Study|Adverse Event|1|||
161174873|NCT02807844|582017710|FG001|Overall Study|Adverse Event|0|||
161174874|NCT02807844|582017711|FG002|Overall Study|Adverse Event|0|||
161174875|NCT02807844|582017712|FG003|Overall Study|Adverse Event|0|||
161294788|NCT00722137|582459427|FG001|Overall Study|Withdrawal by Subject|9|||
161294789|NCT00722137|582459426|FG000|Overall Study|Other Reason Unknown|3|||
161294790|NCT00722137|582459427|FG001|Overall Study|Other Reason Unknown|4|||
161294791|NCT00722137|582459426|FG000|Overall Study|Randomized But Not Treated|2|||
161294792|NCT00722137|582459427|FG001|Overall Study|Randomized But Not Treated|3|||
161294793|NCT05343000|582460943|FG000|Overall Study|Physician Decision|2|||
161294794|NCT04432831|582460944|FG000|Overall Study|Withdrawal by Subject|24|||
161294795|NCT04432831|582460945|FG001|Overall Study|Withdrawal by Subject|28|||
161294796|NCT04432831|582460946|FG002|Overall Study|Withdrawal by Subject|21|||
161294797|NCT04432831|582460944|FG000|Overall Study|Death|23|||
161294798|NCT04432831|582460945|FG001|Overall Study|Death|23|||
161294799|NCT04432831|582460946|FG002|Overall Study|Death|17|||
161294800|NCT04432831|582460944|FG000|Overall Study|Lost to Follow-up|15|||
161294801|NCT04432831|582460945|FG001|Overall Study|Lost to Follow-up|15|||
161294802|NCT04432831|582460946|FG002|Overall Study|Lost to Follow-up|12|||
161294803|NCT04432831|582460944|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
161294804|NCT04432831|582460945|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
161294805|NCT04432831|582460946|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
161294806|NCT04432831|582460944|FG000|Overall Study|Reason Not Specified|7|||
161294807|NCT04432831|582460945|FG001|Overall Study|Reason Not Specified|11|||
161294808|NCT04432831|582460946|FG002|Overall Study|Reason Not Specified|9|||
161294809|NCT04432831|582460944|FG000|Overall Study|Adverse Event|7|||
161294810|NCT04432831|582460945|FG001|Overall Study|Adverse Event|7|||
161294811|NCT04432831|582460946|FG002|Overall Study|Adverse Event|7|||
161294812|NCT04432831|582460944|FG000|Overall Study|Physician Decision|1|||
161294813|NCT04432831|582460945|FG001|Overall Study|Physician Decision|3|||
161294814|NCT04432831|582460946|FG002|Overall Study|Physician Decision|6|||
161294815|NCT04432831|582460944|FG000|Overall Study|Protocol Violation|1|||
161294816|NCT04432831|582460945|FG001|Overall Study|Protocol Violation|0|||
161294817|NCT04432831|582460946|FG002|Overall Study|Protocol Violation|2|||
161294818|NCT04432831|582460944|FG000|Overall Study|Pregnancy|0|||
161294819|NCT04432831|582460945|FG001|Overall Study|Pregnancy|1|||
161294820|NCT04432831|582460946|FG002|Overall Study|Pregnancy|0|||
161294821|NCT04432831|582460944|FG000|Overall Study|Lack of Efficacy|0|||
161294822|NCT04432831|582460945|FG001|Overall Study|Lack of Efficacy|0|||
161294823|NCT04432831|582460946|FG002|Overall Study|Lack of Efficacy|2|||
161294824|NCT03782792|582460947|FG000|Overall Study|Patient left the country|0|||
161294825|NCT03782792|582460948|FG001|Overall Study|Patient left the country|1|||
161294826|NCT03782792|582460947|FG000|Overall Study|Withdrawal by Subject|1|||
161294827|NCT03782792|582460948|FG001|Overall Study|Withdrawal by Subject|2|||
161294828|NCT00617890|582460949|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
161294829|NCT00617890|582460950|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
161294830|NCT00617890|582460951|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
161294831|NCT00617890|582460952|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
161294832|NCT00617890|582460949|FG000|Overall Study|Lack of Efficacy|23|||
161294833|NCT00617890|582460950|FG001|Overall Study|Lack of Efficacy|26|||
161294834|NCT00617890|582460951|FG002|Overall Study|Lack of Efficacy|30|||
161294835|NCT00617890|582460952|FG003|Overall Study|Lack of Efficacy|97|||
161294836|NCT00617890|582460949|FG000|Overall Study|Lost to Follow-up|0|||
161294837|NCT00617890|582460950|FG001|Overall Study|Lost to Follow-up|0|||
161294838|NCT00617890|582460951|FG002|Overall Study|Lost to Follow-up|1|||
161294839|NCT00617890|582460952|FG003|Overall Study|Lost to Follow-up|2|||
161294840|NCT00617890|582460949|FG000|Overall Study|Withdrawal by Subject|4|||
161294841|NCT00617890|582460950|FG001|Overall Study|Withdrawal by Subject|1|||
161294842|NCT00617890|582460951|FG002|Overall Study|Withdrawal by Subject|0|||
161294843|NCT00617890|582460952|FG003|Overall Study|Withdrawal by Subject|2|||
161294844|NCT00617890|582460949|FG000|Overall Study|Protocol Violation|2|||
161294845|NCT00617890|582460950|FG001|Overall Study|Protocol Violation|1|||
161294846|NCT00617890|582460951|FG002|Overall Study|Protocol Violation|0|||
161294847|NCT00617890|582460952|FG003|Overall Study|Protocol Violation|0|||
161294848|NCT00617890|582460949|FG000|Overall Study|Adverse Event|1|||
161294849|NCT00617890|582460950|FG001|Overall Study|Adverse Event|0|||
161294850|NCT00617890|582460951|FG002|Overall Study|Adverse Event|3|||
161294851|NCT00617890|582460952|FG003|Overall Study|Adverse Event|8|||
161294852|NCT00617890|582460949|FG000|Overall Study|Not treated|1|||
161294853|NCT00617890|582460950|FG001|Overall Study|Not treated|0|||
161294854|NCT00617890|582460951|FG002|Overall Study|Not treated|1|||
161294855|NCT00617890|582460952|FG003|Overall Study|Not treated|1|||
161174876|NCT02807844|582017713|FG004|Overall Study|Adverse Event|1|||
161294856|NCT00154284|582460956|FG000|Overall Study|Adverse Event|6|||
161174877|NCT02807844|582017714|FG005|Overall Study|Adverse Event|1|||
161294857|NCT00154284|582460957|FG001|Overall Study|Adverse Event|9|||
161174878|NCT02807844|582017715|FG006|Overall Study|Adverse Event|1|||
161174879|NCT02807844|582017716|FG007|Overall Study|Adverse Event|1|||
161294858|NCT00154284|582460956|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161294859|NCT00154284|582460957|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161294860|NCT00154284|582460956|FG000|Overall Study|Lack of Efficacy|1|||
161294861|NCT00154284|582460957|FG001|Overall Study|Lack of Efficacy|2|||
161294862|NCT00154284|582460956|FG000|Overall Study|Protocol Violation|0|||
161174880|NCT02807844|582017717|FG008|Overall Study|Adverse Event|1|||
161174881|NCT02807844|582017718|FG009|Overall Study|Adverse Event|2|||
161174882|NCT03097029|582017719|FG000|Overall Study|Withdrawal by Subject|1|||
161174883|NCT00709124|582017720|FG000|Overall Study|Death|3|||
161174884|NCT00709124|582017721|FG001|Overall Study|Death|1|||
161174885|NCT00709124|582017720|FG000|Overall Study|encephalopathy; can't do assessment|1|||
161174886|NCT00709124|582017721|FG001|Overall Study|encephalopathy; can't do assessment|0|||
161174887|NCT00373490|582017722|FG000|Overall Study|Adverse Event|0|||
161174888|NCT00373490|582017723|FG001|Overall Study|Adverse Event|1|||
161174889|NCT00373490|582017722|FG000|Overall Study|Lack of Efficacy|9|||
161174890|NCT00373490|582017723|FG001|Overall Study|Lack of Efficacy|4|||
161174891|NCT00373490|582017722|FG000|Overall Study|Withdrawal by Subject|0|||
161174892|NCT00373490|582017723|FG001|Overall Study|Withdrawal by Subject|1|||
161174893|NCT00753688|582017730|FG000|Overall Study|Death|102|||
161174894|NCT00753688|582017731|FG001|Overall Study|Death|203|||
161174895|NCT00753688|582017730|FG000|Overall Study|Missing|4|||
161174896|NCT00753688|582017731|FG001|Overall Study|Missing|9|||
161174897|NCT00753688|582017730|FG000|Overall Study|Participant Withdrew Consent|2|||
161174898|NCT00753688|582017731|FG001|Overall Study|Participant Withdrew Consent|2|||
161174899|NCT00753688|582017730|FG000|Overall Study|Ongoing - in Follow-up|15|||
161174900|NCT00753688|582017731|FG001|Overall Study|Ongoing - in Follow-up|31|||
161174901|NCT00753688|582017730|FG000|Overall Study|Adverse Event|0|||
161174902|NCT00753688|582017731|FG001|Overall Study|Adverse Event|1|||
161174903|NCT00108953|582017732|FG000|Follow-up|Death|18|||
161174904|NCT00108953|582017733|FG001|Follow-up|Death|26|||
161174905|NCT00108953|582017732|FG000|Follow-up|Lost to Follow-up|1|||
161174906|NCT00108953|582017733|FG001|Follow-up|Lost to Follow-up|1|||
161174907|NCT00108953|582017732|FG000|Follow-up|Study terminated by sponsor|10|||
161174908|NCT00108953|582017733|FG001|Follow-up|Study terminated by sponsor|6|||
161174909|NCT01250756|582017734|FG000|Infant Series|Withdrawal by Subject|4|||
161174910|NCT01250756|582017735|FG001|Infant Series|Withdrawal by Subject|5|||
161174911|NCT01250756|582017734|FG000|Infant Series|Randomized, Not Vaccinated|2|||
161174912|NCT01250756|582017735|FG001|Infant Series|Randomized, Not Vaccinated|2|||
161174913|NCT01250756|582017734|FG000|Infant Series|Other|22|||
161174914|NCT01250756|582017735|FG001|Infant Series|Other|0|||
161174915|NCT01250756|582017734|FG000|After Infant Series|Adverse Event|5|||
161174916|NCT01250756|582017735|FG001|After Infant Series|Adverse Event|2|||
161174917|NCT01250756|582017734|FG000|After Infant Series|Withdrawal by Subject|4|||
161174918|NCT01250756|582017735|FG001|After Infant Series|Withdrawal by Subject|1|||
161174919|NCT01250756|582017734|FG000|After Infant Series|Other|2|||
161174920|NCT01250756|582017735|FG001|After Infant Series|Other|1|||
161174921|NCT01250756|582017734|FG000|Toddler Dose|Adverse Event|0|||
161174922|NCT01250756|582017735|FG001|Toddler Dose|Adverse Event|1|||
161174923|NCT01250756|582017734|FG000|After Toddler Dose|Adverse Event|0|||
161174924|NCT01250756|582017735|FG001|After Toddler Dose|Adverse Event|1|||
161174925|NCT02999100|582017738|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
161174926|NCT02999100|582017739|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
161174927|NCT02999100|582017740|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
161174928|NCT02999100|582017741|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
161174929|NCT02999100|582017742|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
161174930|NCT02999100|582017743|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
161174931|NCT02999100|582017738|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161174932|NCT02999100|582017739|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161174933|NCT02999100|582017740|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161174934|NCT02999100|582017741|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161174935|NCT02999100|582017742|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
161174936|NCT02999100|582017743|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
161174937|NCT02999100|582017738|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161174938|NCT02999100|582017739|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161174939|NCT02999100|582017740|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
161294863|NCT00154284|582460957|FG001|Overall Study|Protocol Violation|1|||
161294864|NCT01295671|582460966|FG000|Overall Study|Lost to Follow-up|4|||
161294865|NCT01295671|582460967|FG001|Overall Study|Lost to Follow-up|6|||
161294866|NCT01295671|582460968|FG002|Overall Study|Lost to Follow-up|3|||
161294867|NCT01295671|582460966|FG000|Overall Study|Withdrawal by Subject|3|||
161294868|NCT01295671|582460967|FG001|Overall Study|Withdrawal by Subject|1|||
161294869|NCT01295671|582460968|FG002|Overall Study|Withdrawal by Subject|0|||
161174940|NCT02999100|582017741|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161174941|NCT02999100|582017742|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161174942|NCT02999100|582017743|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
161174943|NCT03803202|582017744|FG000|Overall Study|Other|0|||
161174944|NCT03803202|582017745|FG001|Overall Study|Other|1|||
161174945|NCT03803202|582017746|FG002|Overall Study|Other|0|||
161174946|NCT03803202|582017747|FG003|Overall Study|Other|0|||
161174947|NCT03803202|582017748|FG004|Overall Study|Other|0|||
161174948|NCT03803202|582017749|FG005|Overall Study|Other|0|||
161174949|NCT03803202|582017750|FG006|Overall Study|Other|0|||
161174950|NCT03803202|582017751|FG007|Overall Study|Other|0|||
161294870|NCT02058537|582460969|FG000|Overall Study|Withdrawal by Subject|1|||
161294871|NCT02126579|582460970|FG000|Overall Study|disease progression|0|||
161294872|NCT02126579|582460971|FG001|Overall Study|disease progression|0|||
161294873|NCT02126579|582460972|FG002|Overall Study|disease progression|0|||
161294874|NCT02126579|582460973|FG003|Overall Study|disease progression|1|||
161294875|NCT02126579|582460974|FG004|Overall Study|disease progression|0|||
161294876|NCT02126579|582460975|FG005|Overall Study|disease progression|0|||
161294877|NCT02126579|582460976|FG006|Overall Study|disease progression|1|||
161294878|NCT01780038|582460979|FG000|Overall Study|Lost to Follow-up|4|||
161294879|NCT01780038|582460980|FG001|Overall Study|Lost to Follow-up|1|||
161294880|NCT00455403|582460981|FG000|Overall Study|Lost to Follow-up|2|||
161294881|NCT00455403|582460982|FG001|Overall Study|Lost to Follow-up|1|||
161294882|NCT00455403|582460981|FG000|Overall Study|Withdrawal by Subject|1|||
161294883|NCT00455403|582460982|FG001|Overall Study|Withdrawal by Subject|3|||
161294884|NCT00455403|582460981|FG000|Overall Study|Protocol Violation|0|||
161294885|NCT00455403|582460982|FG001|Overall Study|Protocol Violation|2|||
161294886|NCT01812109|582460983|FG000|Overall Study|research personnel delay|16|||
161294887|NCT01812109|582460983|FG000|Overall Study|NIRS Unattainable|17|||
161294888|NCT04630002|582460984|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
161294889|NCT04630002|582460985|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161294890|NCT04630002|582460986|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161294891|NCT04630002|582460984|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
161294892|NCT04630002|582460985|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161294893|NCT04630002|582460986|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161294894|NCT04630002|582460984|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
161294895|NCT04630002|582460985|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161294896|NCT04630002|582460986|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161294897|NCT04630002|582460984|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161294898|NCT04630002|582460985|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
161294899|NCT04630002|582460986|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
161294900|NCT04630002|582460984|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161294901|NCT04630002|582460985|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
161294902|NCT04630002|582460986|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
161294903|NCT04630002|582460984|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161294904|NCT04630002|582460985|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
161294905|NCT04630002|582460986|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
161294906|NCT04630002|582460984|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
161294907|NCT04630002|582460985|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
161294908|NCT04630002|582460986|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
161294909|NCT04630002|582460984|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
161294910|NCT04630002|582460985|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
161294911|NCT04630002|582460986|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
161294912|NCT00442897|582460988|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
161294913|NCT00442897|582460989|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
161294914|NCT00442897|582460988|FG000|Base Study (12 Week Follow-up)|Death|0|||
161294915|NCT00442897|582460989|FG001|Base Study (12 Week Follow-up)|Death|1|||
161294916|NCT00442897|582460988|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
161294917|NCT00442897|582460989|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
161294918|NCT00442897|582460988|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
161294919|NCT00442897|582460989|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
161294920|NCT00442897|582460988|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
161294921|NCT00442897|582460989|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
161294922|NCT00442897|582460988|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
161294923|NCT00442897|582460989|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
161294924|NCT00442897|582460988|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
161294925|NCT00442897|582460989|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
161294926|NCT00442897|582460988|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
161294927|NCT00442897|582460989|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
161294928|NCT04498182|582460990|FG000|Overall Study|Adverse Event|2|||
161294929|NCT04498182|582460991|FG001|Overall Study|Adverse Event|3|||
161294930|NCT04498182|582460992|FG002|Overall Study|Adverse Event|2|||
161294931|NCT04498182|582460990|FG000|Overall Study|Withdrawal of Consent|3|||
161347625|NCT05350202|582656335|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
161294932|NCT04498182|582460991|FG001|Overall Study|Withdrawal of Consent|4|||
161294933|NCT04498182|582460992|FG002|Overall Study|Withdrawal of Consent|3|||
161294934|NCT04498182|582460990|FG000|Overall Study|Non-Compliant|1|||
161294935|NCT04498182|582460991|FG001|Overall Study|Non-Compliant|0|||
161294936|NCT04498182|582460992|FG002|Overall Study|Non-Compliant|1|||
161294937|NCT04498182|582460990|FG000|Overall Study|Lost to Follow-up|0|||
161294938|NCT04498182|582460991|FG001|Overall Study|Lost to Follow-up|0|||
161294939|NCT04498182|582460992|FG002|Overall Study|Lost to Follow-up|1|||
161174951|NCT03803202|582017752|FG008|Overall Study|Other|0|||
161174952|NCT03803202|582017744|FG000|Overall Study|Death|0|||
161174953|NCT03803202|582017745|FG001|Overall Study|Death|0|||
161174954|NCT03803202|582017746|FG002|Overall Study|Death|0|||
161174955|NCT03803202|582017747|FG003|Overall Study|Death|0|||
161174956|NCT03803202|582017748|FG004|Overall Study|Death|0|||
161174957|NCT03803202|582017749|FG005|Overall Study|Death|1|||
161174958|NCT03803202|582017750|FG006|Overall Study|Death|0|||
161174959|NCT03803202|582017751|FG007|Overall Study|Death|0|||
161174960|NCT03803202|582017752|FG008|Overall Study|Death|0|||
161174961|NCT03803202|582017744|FG000|Overall Study|Withdrawal by Subject|0|||
161174962|NCT03803202|582017745|FG001|Overall Study|Withdrawal by Subject|0|||
161174963|NCT03803202|582017746|FG002|Overall Study|Withdrawal by Subject|1|||
161174964|NCT03803202|582017747|FG003|Overall Study|Withdrawal by Subject|0|||
161174965|NCT03803202|582017748|FG004|Overall Study|Withdrawal by Subject|0|||
161174966|NCT03803202|582017749|FG005|Overall Study|Withdrawal by Subject|0|||
161174967|NCT03803202|582017750|FG006|Overall Study|Withdrawal by Subject|0|||
161174968|NCT03803202|582017751|FG007|Overall Study|Withdrawal by Subject|1|||
161174969|NCT03803202|582017752|FG008|Overall Study|Withdrawal by Subject|0|||
161174970|NCT03803202|582017744|FG000|Overall Study|Lost to Follow-up|0|||
161174971|NCT03803202|582017745|FG001|Overall Study|Lost to Follow-up|0|||
161174972|NCT03803202|582017746|FG002|Overall Study|Lost to Follow-up|0|||
161174973|NCT03803202|582017747|FG003|Overall Study|Lost to Follow-up|1|||
161174974|NCT03803202|582017748|FG004|Overall Study|Lost to Follow-up|1|||
161174975|NCT03803202|582017749|FG005|Overall Study|Lost to Follow-up|0|||
161174976|NCT03803202|582017750|FG006|Overall Study|Lost to Follow-up|1|||
161174977|NCT03803202|582017751|FG007|Overall Study|Lost to Follow-up|0|||
161174978|NCT03803202|582017752|FG008|Overall Study|Lost to Follow-up|0|||
161174979|NCT00293241|582017753|FG000|Overall Study|Lost to Follow-up|9|||
161174980|NCT00293241|582017754|FG001|Overall Study|Lost to Follow-up|16|||
161174981|NCT00293241|582017753|FG000|Overall Study|Physician Decision|23|||
161174982|NCT00293241|582017754|FG001|Overall Study|Physician Decision|17|||
161174983|NCT00293241|582017753|FG000|Overall Study|Withdrawal by Subject|4|||
161174984|NCT00293241|582017754|FG001|Overall Study|Withdrawal by Subject|8|||
161174985|NCT03595384|582017755|FG000|Overall Study|Other time commitments|8|||
161174986|NCT03595384|582017755|FG000|Overall Study|Changes to session time|7|||
161174987|NCT03595384|582017755|FG000|Overall Study|Relocation out of country|1|||
161174988|NCT01125293|582017756|FG000|Overall Study|Disease Progression|1|||
161174989|NCT01125293|582017757|FG001|Overall Study|Disease Progression|3|||
161174990|NCT01125293|582017758|FG002|Overall Study|Disease Progression|4|||
161174991|NCT01125293|582017759|FG003|Overall Study|Disease Progression|3|||
161174992|NCT01125293|582017760|FG004|Overall Study|Disease Progression|5|||
161174993|NCT01125293|582017761|FG005|Overall Study|Disease Progression|12|||
161174994|NCT01125293|582017756|FG000|Overall Study|Adverse Event|1|||
161174995|NCT01125293|582017757|FG001|Overall Study|Adverse Event|0|||
161174996|NCT01125293|582017758|FG002|Overall Study|Adverse Event|0|||
161174997|NCT01125293|582017759|FG003|Overall Study|Adverse Event|0|||
161174998|NCT01125293|582017760|FG004|Overall Study|Adverse Event|2|||
161174999|NCT01125293|582017761|FG005|Overall Study|Adverse Event|8|||
161175000|NCT01125293|582017756|FG000|Overall Study|Symptomatic Deterioration|1|||
161175001|NCT01125293|582017757|FG001|Overall Study|Symptomatic Deterioration|0|||
161175002|NCT01125293|582017758|FG002|Overall Study|Symptomatic Deterioration|0|||
161175003|NCT01125293|582017759|FG003|Overall Study|Symptomatic Deterioration|0|||
161175004|NCT01125293|582017760|FG004|Overall Study|Symptomatic Deterioration|0|||
161175005|NCT01125293|582017761|FG005|Overall Study|Symptomatic Deterioration|0|||
161175006|NCT01125293|582017756|FG000|Overall Study|Death|0|||
161175007|NCT01125293|582017757|FG001|Overall Study|Death|0|||
161175008|NCT01125293|582017758|FG002|Overall Study|Death|0|||
161175009|NCT01125293|582017759|FG003|Overall Study|Death|0|||
161175010|NCT01125293|582017760|FG004|Overall Study|Death|1|||
161175011|NCT01125293|582017761|FG005|Overall Study|Death|0|||
161294940|NCT04498182|582460990|FG000|Overall Study|Investigator Decision|0|||
161294941|NCT04498182|582460991|FG001|Overall Study|Investigator Decision|0|||
161294942|NCT04498182|582460992|FG002|Overall Study|Investigator Decision|1|||
161294943|NCT04498182|582460990|FG000|Overall Study|Protocol Violation|1|||
161294944|NCT04498182|582460991|FG001|Overall Study|Protocol Violation|0|||
161175012|NCT01125293|582017756|FG000|Overall Study|Withdrawal by Subject|0|||
161175013|NCT01125293|582017757|FG001|Overall Study|Withdrawal by Subject|0|||
161294945|NCT04498182|582460992|FG002|Overall Study|Protocol Violation|2|||
161294946|NCT01372618|582461002|FG000|Overall Study|PI Died. Study Terminated|9|||
161294947|NCT03448419|582461003|FG000|Overall Study|Adverse Event|10|||
161175014|NCT01125293|582017758|FG002|Overall Study|Withdrawal by Subject|0|||
161175015|NCT01125293|582017759|FG003|Overall Study|Withdrawal by Subject|0|||
161175016|NCT01125293|582017760|FG004|Overall Study|Withdrawal by Subject|2|||
161175017|NCT01125293|582017761|FG005|Overall Study|Withdrawal by Subject|1|||
161175018|NCT01125293|582017756|FG000|Overall Study|Physician Decision|0|||
161175019|NCT01125293|582017757|FG001|Overall Study|Physician Decision|0|||
161175020|NCT01125293|582017758|FG002|Overall Study|Physician Decision|0|||
161175021|NCT01125293|582017759|FG003|Overall Study|Physician Decision|0|||
161294948|NCT03448419|582461004|FG001|Overall Study|Adverse Event|9|||
161294949|NCT03448419|582461003|FG000|Overall Study|Lost to Follow-up|0|||
161294950|NCT03448419|582461004|FG001|Overall Study|Lost to Follow-up|2|||
161294951|NCT03448419|582461003|FG000|Overall Study|Withdrawal by Subject|3|||
161294952|NCT03448419|582461004|FG001|Overall Study|Withdrawal by Subject|1|||
161294953|NCT03448419|582461003|FG000|Overall Study|Not treated|0|||
161294954|NCT03448419|582461004|FG001|Overall Study|Not treated|1|||
161294955|NCT03448419|582461003|FG000|Overall Study|Patient did not attend all visits|0|||
161294956|NCT03448419|582461004|FG001|Overall Study|Patient did not attend all visits|2|||
161294957|NCT03448419|582461003|FG000|Overall Study|Withdrawn by Sponsor|0|||
161294958|NCT03448419|582461004|FG001|Overall Study|Withdrawn by Sponsor|1|||
161294959|NCT04548193|582461015|FG000|Overall Study|Lost to Follow-up|0|||
161294960|NCT04548193|582461016|FG001|Overall Study|Lost to Follow-up|1|||
161294961|NCT04548193|582461015|FG000|Overall Study|Death|0|||
161294962|NCT04548193|582461016|FG001|Overall Study|Death|1|||
161294963|NCT04548193|582461015|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
161294964|NCT04548193|582461016|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
161294965|NCT04548193|582461015|FG000|Overall Study|Withdrawal by Subject|2|||
161294966|NCT04548193|582461016|FG001|Overall Study|Withdrawal by Subject|2|||
161294967|NCT00630825|582461017|FG000|Overall Study|Adverse Event|4|||
161294968|NCT00630825|582461018|FG001|Overall Study|Adverse Event|4|||
161294969|NCT00630825|582461019|FG002|Overall Study|Adverse Event|3|||
161294970|NCT00630825|582461020|FG003|Overall Study|Adverse Event|1|||
161294971|NCT00630825|582461017|FG000|Overall Study|Entry Criteria Not Met|1|||
161294972|NCT00630825|582461018|FG001|Overall Study|Entry Criteria Not Met|0|||
161294973|NCT00630825|582461019|FG002|Overall Study|Entry Criteria Not Met|2|||
161294974|NCT00630825|582461020|FG003|Overall Study|Entry Criteria Not Met|1|||
161294975|NCT00630825|582461017|FG000|Overall Study|Lost to Follow-up|1|||
161294976|NCT00630825|582461018|FG001|Overall Study|Lost to Follow-up|1|||
161294977|NCT00630825|582461019|FG002|Overall Study|Lost to Follow-up|1|||
161294978|NCT00630825|582461020|FG003|Overall Study|Lost to Follow-up|1|||
161294979|NCT00630825|582461017|FG000|Overall Study|Physician Decision|1|||
161294980|NCT00630825|582461018|FG001|Overall Study|Physician Decision|0|||
161294981|NCT00630825|582461019|FG002|Overall Study|Physician Decision|0|||
161294982|NCT00630825|582461020|FG003|Overall Study|Physician Decision|0|||
161294983|NCT00630825|582461017|FG000|Overall Study|Withdrawal by Subject|2|||
161294984|NCT00630825|582461018|FG001|Overall Study|Withdrawal by Subject|2|||
161294985|NCT00630825|582461019|FG002|Overall Study|Withdrawal by Subject|2|||
161294986|NCT00630825|582461020|FG003|Overall Study|Withdrawal by Subject|3|||
161294987|NCT01081769|582461023|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
161294988|NCT01081769|582461024|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
161294989|NCT01081769|582461023|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
161294990|NCT01081769|582461024|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
161294991|NCT01081769|582461023|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
161294992|NCT01081769|582461024|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
161294993|NCT01081769|582461023|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
161294994|NCT01081769|582461024|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
161294995|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Adverse Event|14|||
161294996|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Adverse Event|11|||
161294997|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Death|1|||
161294998|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Death|1|||
161294999|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
161295000|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
161295001|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
161295002|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
161295003|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Pregnancy|1|||
161295004|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Pregnancy|0|||
161295005|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
161295006|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
161295007|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
161295008|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
161295009|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Other|0|||
161295010|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Other|1|||
161295011|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Ineligibility|3|||
161295012|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Ineligibility|4|||
161295013|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
161295014|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
161295015|NCT01081769|582461023|FG000|CORE Intent-To-Treat|Patient Moved|2|||
161295016|NCT01081769|582461024|FG001|CORE Intent-To-Treat|Patient Moved|2|||
161295017|NCT00558701|582461025|FG000|Overall Study|Protocol Deviations|1|||
161295018|NCT00558701|582461026|FG001|Overall Study|Protocol Deviations|4|||
161295019|NCT02187198|582461027|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
161295020|NCT02187198|582461028|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
161295021|NCT02187198|582461027|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
161175022|NCT01125293|582017760|FG004|Overall Study|Physician Decision|0|||
161175023|NCT01125293|582017761|FG005|Overall Study|Physician Decision|2|||
161175024|NCT01270958|582017762|FG000|Overall Study|Lost to Follow-up|2|||
161295022|NCT02187198|582461028|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
161295023|NCT00546377|582461029|FG000|Overall Study|Deemed ineligible|1|||
161295024|NCT00546377|582461029|FG000|Overall Study|Adverse Event|6|||
161295025|NCT01532518|582461030|FG000|Overall Study|Withdrawal by Subject|0|||
161295026|NCT01532518|582461031|FG001|Overall Study|Withdrawal by Subject|0|||
161295027|NCT01532518|582461032|FG002|Overall Study|Withdrawal by Subject|1|||
161295028|NCT01575834|582461033|FG000|Overall Study|Withdrawal by Subject|352|||
161295029|NCT01575834|582461034|FG001|Overall Study|Withdrawal by Subject|390|||
161295030|NCT01575834|582461033|FG000|Overall Study|Death|81|||
161295031|NCT01575834|582461034|FG001|Overall Study|Death|74|||
161295032|NCT01575834|582461033|FG000|Overall Study|Other|70|||
161295033|NCT01575834|582461034|FG001|Overall Study|Other|70|||
161295034|NCT01575834|582461033|FG000|Overall Study|Adverse Event|63|||
161295035|NCT01575834|582461034|FG001|Overall Study|Adverse Event|61|||
161295036|NCT01575834|582461033|FG000|Overall Study|Lost to Follow-up|55|||
161295037|NCT01575834|582461034|FG001|Overall Study|Lost to Follow-up|68|||
161295038|NCT01575834|582461033|FG000|Overall Study|Noncompliance|52|||
161295039|NCT01575834|582461034|FG001|Overall Study|Noncompliance|27|||
161295040|NCT01575834|582461033|FG000|Overall Study|Administrative decision|15|||
161295041|NCT01575834|582461034|FG001|Overall Study|Administrative decision|33|||
161295042|NCT01575834|582461033|FG000|Overall Study|Ineligibility Determined|5|||
161295043|NCT01575834|582461034|FG001|Overall Study|Ineligibility Determined|8|||
161295044|NCT01575834|582461033|FG000|Overall Study|Protocol Deviation|4|||
161295045|NCT01575834|582461034|FG001|Overall Study|Protocol Deviation|3|||
161295046|NCT01575834|582461033|FG000|Overall Study|Requirement for Alternative Therapy|2|||
161295047|NCT01575834|582461034|FG001|Overall Study|Requirement for Alternative Therapy|4|||
161295048|NCT00488644|582461036|FG000|Overall Study|Not Eligible|1|||
161295049|NCT00488644|582461036|FG000|Overall Study|Not Evaluable|1|||
161295050|NCT02503540|582461041|FG000|Overall Study|Death|2|||
161295051|NCT02503540|582461041|FG000|Overall Study|Withdrawal by Subject|1|||
161295052|NCT00564850|582461042|FG000|Overall Study|Protocol Violation|2|||
161295053|NCT00979654|582461043|FG000|Overall Study|Lost to Follow-up|1|||
161295054|NCT00979654|582461043|FG000|Overall Study|Withdrawal by Subject|22|||
161295055|NCT00979654|582461043|FG000|Overall Study|Death|1|||
161295056|NCT00979654|582461043|FG000|Overall Study|Lack of Efficacy|6|||
161295057|NCT00979654|582461043|FG000|Overall Study|Adverse Event|1|||
161295058|NCT00979654|582461043|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
161295059|NCT00979654|582461043|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
161295060|NCT00979654|582461043|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
161295061|NCT00979654|582461043|FG000|Overall Study|Serious Adverse Event|1|||
161295062|NCT00979654|582461043|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
161295063|NCT01804946|582461046|FG000|Overall Study|Protocol Violation|1|||
161295064|NCT01804946|582461047|FG001|Overall Study|Protocol Violation|0|||
161175025|NCT01270958|582017762|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
161175026|NCT01406652|582017765|FG000|Overall Study|Lost-to-follow-up|3|||
161175027|NCT01406652|582017766|FG001|Overall Study|Lost-to-follow-up|4|||
161175028|NCT01406652|582017765|FG000|Overall Study|Withdrawal by Subject|2|||
161175029|NCT01406652|582017766|FG001|Overall Study|Withdrawal by Subject|2|||
161175030|NCT01406652|582017765|FG000|Overall Study|Insufficient follow-up|5|||
161175031|NCT01406652|582017766|FG001|Overall Study|Insufficient follow-up|4|||
161175032|NCT01406652|582017765|FG000|Overall Study|Infection not sure|10|||
161175033|NCT01406652|582017766|FG001|Overall Study|Infection not sure|10|||
161175034|NCT00260429|582017769|FG000|Overall Study|failure to follow appointments|1|||
161175035|NCT00260429|582017770|FG001|Overall Study|failure to follow appointments|0|||
161175036|NCT00260429|582017769|FG000|Overall Study|scheduled hand surgery|1|||
161175037|NCT00260429|582017770|FG001|Overall Study|scheduled hand surgery|0|||
161175038|NCT00659126|582017771|FG000|Overall Study|Adverse Event|2|||
161175039|NCT00659126|582017772|FG001|Overall Study|Adverse Event|2|||
161175040|NCT00659126|582017771|FG000|Overall Study|Screen failure|1|||
161175041|NCT00659126|582017772|FG001|Overall Study|Screen failure|1|||
161175042|NCT00659126|582017771|FG000|Overall Study|Technical problems with MRI|0|||
161175043|NCT00659126|582017772|FG001|Overall Study|Technical problems with MRI|1|||
161175044|NCT02228564|582017776|FG000|Overall Study|Withdrawal by Subject|10|||
161295065|NCT01804946|582461046|FG000|Overall Study|Adverse Event|0|||
161295066|NCT01804946|582461047|FG001|Overall Study|Adverse Event|1|||
161295067|NCT01804946|582461046|FG000|Overall Study|Insufficient data available|0|||
161295068|NCT01804946|582461047|FG001|Overall Study|Insufficient data available|1|||
161295069|NCT01804946|582461046|FG000|Overall Study|Do not meet inclusion criteria|1|||
161295070|NCT01804946|582461047|FG001|Overall Study|Do not meet inclusion criteria|2|||
161295071|NCT03830333|582461050|FG000|Overall Study|Death|0|||
161295072|NCT03830333|582461051|FG001|Overall Study|Death|1|||
161175045|NCT02228564|582017776|FG000|Overall Study|Death|11|||
161175046|NCT02228564|582017776|FG000|Overall Study|Physician Decision|5|||
161175047|NCT02228564|582017776|FG000|Overall Study|Lost to Follow-up|17|||
161319486|NCT01863732|582555337|FG003|Overall Study|Lack of Efficacy|1|||
161175048|NCT02228564|582017776|FG000|Overall Study|Other|6|||
161175049|NCT02633046|582017777|FG000|Overall Study|Adverse Event|8|||
161175050|NCT02633046|582017777|FG000|Overall Study|Physician Decision|7|||
161175051|NCT02633046|582017777|FG000|Overall Study|Withdrawal by Subject|8|||
161175052|NCT02633046|582017777|FG000|Overall Study|Increased proteinuria|2|||
161175053|NCT02633046|582017777|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
161175054|NCT02633046|582017777|FG000|Overall Study|Mutual decision patient and physician|1|||
161175055|NCT01455415|582017779|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
161175056|NCT01455415|582017780|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
161175057|NCT01455415|582017779|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
161175058|NCT01455415|582017780|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
161175059|NCT01455415|582017779|FG000|Period 1|Drug Error not Associated to AE|0|||
161175060|NCT01455415|582017780|FG001|Period 1|Drug Error not Associated to AE|1|||
161175061|NCT01455415|582017779|FG000|Period 1|AE Not Related to Study Drug|2|||
161175062|NCT01455415|582017780|FG001|Period 1|AE Not Related to Study Drug|6|||
161175063|NCT01455415|582017779|FG000|Period 1|Withdrawal by Subject|4|||
161175064|NCT01455415|582017780|FG001|Period 1|Withdrawal by Subject|5|||
161175065|NCT01455415|582017779|FG000|Period 1|Unspecified Reason|1|||
161175066|NCT01455415|582017780|FG001|Period 1|Unspecified Reason|1|||
161175067|NCT01455415|582017779|FG000|Period 1|Protocol Violation|0|||
161175068|NCT01455415|582017780|FG001|Period 1|Protocol Violation|2|||
161175069|NCT01455415|582017779|FG000|Washout|AE Related to Study Drug|2|||
161175070|NCT01455415|582017780|FG001|Washout|AE Related to Study Drug|0|||
161175071|NCT01455415|582017779|FG000|Washout|Lost to Follow-up|1|||
161175072|NCT01455415|582017780|FG001|Washout|Lost to Follow-up|0|||
161175073|NCT01455415|582017779|FG000|Washout|Drug Error not Associated to AE|2|||
161175074|NCT01455415|582017780|FG001|Washout|Drug Error not Associated to AE|1|||
161175075|NCT01455415|582017779|FG000|Washout|AE Not Related to Study Drug|2|||
161175076|NCT01455415|582017780|FG001|Washout|AE Not Related to Study Drug|3|||
161175077|NCT01455415|582017779|FG000|Washout|Unspecified Reason|1|||
161175078|NCT01455415|582017780|FG001|Washout|Unspecified Reason|2|||
161175079|NCT01455415|582017779|FG000|Washout|Protocol Violation|0|||
161175080|NCT01455415|582017780|FG001|Washout|Protocol Violation|1|||
161175081|NCT01455415|582017779|FG000|Period 2|AE Related to Study Drug|1|||
161175082|NCT01455415|582017780|FG001|Period 2|AE Related to Study Drug|2|||
161175083|NCT01455415|582017779|FG000|Period 2|Lost to Follow-up|2|||
161175084|NCT01455415|582017780|FG001|Period 2|Lost to Follow-up|1|||
161175085|NCT01455415|582017779|FG000|Period 2|AE Not Related to Study Drug|2|||
161175086|NCT01455415|582017780|FG001|Period 2|AE Not Related to Study Drug|1|||
161175087|NCT01455415|582017779|FG000|Period 2|Lack of Efficacy|2|||
161175088|NCT01455415|582017780|FG001|Period 2|Lack of Efficacy|0|||
161175089|NCT01455415|582017779|FG000|Period 2|Withdrawal by Subject|2|||
161175090|NCT01455415|582017780|FG001|Period 2|Withdrawal by Subject|3|||
161175091|NCT01455415|582017779|FG000|Period 2|Unspecified Reason|2|||
161175092|NCT01455415|582017780|FG001|Period 2|Unspecified Reason|3|||
161175093|NCT01455415|582017779|FG000|Period 2|Protocol Violation|2|||
161175094|NCT01455415|582017780|FG001|Period 2|Protocol Violation|0|||
161175095|NCT01455415|582017779|FG000|Follow-up|AE Related to Study Drug|0|||
161175096|NCT01455415|582017780|FG001|Follow-up|AE Related to Study Drug|1|||
161175097|NCT01455415|582017779|FG000|Follow-up|Lack of Efficacy|0|||
161175098|NCT01455415|582017780|FG001|Follow-up|Lack of Efficacy|1|||
161175099|NCT01455415|582017779|FG000|Follow-up|Withdrawal by Subject|2|||
161295073|NCT03830333|582461050|FG000|Overall Study|Withdrawal by Subject|5|||
161295074|NCT03830333|582461051|FG001|Overall Study|Withdrawal by Subject|1|||
161295075|NCT03830333|582461050|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
161295076|NCT03830333|582461051|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
161295077|NCT01129557|582461052|FG000|Overall Study|Adverse Event|1|||
161295078|NCT01129557|582461053|FG001|Overall Study|Adverse Event|2|||
161295079|NCT01129557|582461054|FG002|Overall Study|Adverse Event|2|||
161295080|NCT01129557|582461052|FG000|Overall Study|Novartis terminated study early|3|||
161295081|NCT01129557|582461053|FG001|Overall Study|Novartis terminated study early|3|||
161295082|NCT01129557|582461054|FG002|Overall Study|Novartis terminated study early|2|||
161347626|NCT05350202|582656336|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
161175100|NCT01455415|582017780|FG001|Follow-up|Withdrawal by Subject|0|||
161175101|NCT01455415|582017779|FG000|Follow-up|Unspecified Reason|1|||
161175102|NCT01455415|582017780|FG001|Follow-up|Unspecified Reason|0|||
161175103|NCT00587301|582017781|FG000|Overall Study|Screen Failure|9|||
161175104|NCT00587301|582017781|FG000|Overall Study|Lost to Follow-up|22|||
161175105|NCT00587301|582017781|FG000|Overall Study|Withdrawal by Subject|7|||
161175106|NCT00587301|582017781|FG000|Overall Study|Protocol Violation|7|||
161175107|NCT02460978|582017783|FG000|Overall Study|Adverse Event|17|||
161175108|NCT02460978|582017784|FG001|Overall Study|Adverse Event|11|||
161175109|NCT02460978|582017785|FG002|Overall Study|Adverse Event|11|||
161175110|NCT02460978|582017783|FG000|Overall Study|Withdrawal by Subject|5|||
161175111|NCT02460978|582017784|FG001|Overall Study|Withdrawal by Subject|5|||
161175112|NCT02460978|582017785|FG002|Overall Study|Withdrawal by Subject|14|||
161175113|NCT02460978|582017783|FG000|Overall Study|Lost to Follow-up|2|||
161295083|NCT01486446|582461055|FG000|Overall Study|Adverse Event|1|||
161295084|NCT01486446|582461056|FG001|Overall Study|Adverse Event|0|||
161295085|NCT04390113|582461057|FG000|Overall Study|Not Treated|0|||
161295086|NCT04390113|582461058|FG001|Overall Study|Not Treated|1|||
161295087|NCT04390113|582461057|FG000|Overall Study|Adverse Event|1|||
161295088|NCT04390113|582461058|FG001|Overall Study|Adverse Event|0|||
161295089|NCT04390113|582461057|FG000|Overall Study|Death|2|||
161087735|NCT05559476|581708489|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
161087736|NCT05559476|581708490|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
161087737|NCT05559476|581708489|FG000|Overall Study|Other|0|||
161087738|NCT05559476|581708490|FG001|Overall Study|Other|2|||
161087739|NCT05110690|581708491|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
161087740|NCT05110690|581708491|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
161087741|NCT05110690|581708491|FG000|Completion of Intervention|Lost to Follow-up|1|||
161087742|NCT05110690|581708491|FG000|Completion of Intervention|Death|1|||
161087743|NCT05110690|581708491|FG000|Completion of Intervention|Withdrawal by Subject|2|||
161087744|NCT00925353|581708492|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
161087745|NCT03647488|581710968|FG000|Overall Study|Progressive disease|10|||
161087746|NCT03647488|581710969|FG001|Overall Study|Progressive disease|0|||
161087747|NCT03647488|581710970|FG002|Overall Study|Progressive disease|0|||
161087748|NCT03647488|581710968|FG000|Overall Study|Adverse Event|5|||
161087749|NCT03647488|581710969|FG001|Overall Study|Adverse Event|0|||
161087750|NCT03647488|581710970|FG002|Overall Study|Adverse Event|0|||
161087751|NCT03647488|581710968|FG000|Overall Study|Clinical progression|2|||
161087752|NCT03647488|581710969|FG001|Overall Study|Clinical progression|0|||
161087753|NCT03647488|581710970|FG002|Overall Study|Clinical progression|0|||
161087754|NCT03647488|581710968|FG000|Overall Study|Participant refused to take investigational product|1|||
161087755|NCT03647488|581710969|FG001|Overall Study|Participant refused to take investigational product|0|||
161087756|NCT03647488|581710970|FG002|Overall Study|Participant refused to take investigational product|0|||
161087757|NCT00189488|581710975|FG000|Overall Study|Ineligibility determined|1|||
161087758|NCT00189488|581710976|FG001|Overall Study|Ineligibility determined|0|||
161087759|NCT00189488|581710975|FG000|Overall Study|Protocol deviation|2|||
161087760|NCT00189488|581710976|FG001|Overall Study|Protocol deviation|1|||
161087761|NCT00189488|581710975|FG000|Overall Study|Adverse Event|2|||
161087762|NCT00189488|581710976|FG001|Overall Study|Adverse Event|1|||
161087763|NCT00189488|581710975|FG000|Overall Study|Withdrawal by Subject|2|||
161087764|NCT00189488|581710976|FG001|Overall Study|Withdrawal by Subject|6|||
161087765|NCT00189488|581710975|FG000|Overall Study|Disease progression|2|||
161087766|NCT00189488|581710976|FG001|Overall Study|Disease progression|4|||
161087767|NCT00189488|581710975|FG000|Overall Study|Administrative Decision|0|||
161087768|NCT00189488|581710976|FG001|Overall Study|Administrative Decision|2|||
161087769|NCT00189488|581710975|FG000|Overall Study|Death|5|||
161087770|NCT00189488|581710976|FG001|Overall Study|Death|8|||
161087771|NCT00189488|581710975|FG000|Overall Study|Other|1|||
161087772|NCT00189488|581710976|FG001|Overall Study|Other|0|||
161087773|NCT01190514|581710977|FG000|First Intervention (Period 1)|Adverse Event|1|||
161087774|NCT01190514|581710978|FG001|First Intervention (Period 1)|Adverse Event|0|||
161087775|NCT01190514|581710979|FG002|First Intervention (Period 1)|Adverse Event|0|||
161087776|NCT01190514|581710980|FG003|First Intervention (Period 1)|Adverse Event|0|||
161087777|NCT01190514|581710977|FG000|Third Intervention (Period 3)|Adverse Event|1|||
161087778|NCT01190514|581710978|FG001|Third Intervention (Period 3)|Adverse Event|0|||
161087779|NCT01190514|581710979|FG002|Third Intervention (Period 3)|Adverse Event|0|||
161087780|NCT01190514|581710980|FG003|Third Intervention (Period 3)|Adverse Event|0|||
161087781|NCT00512317|581710981|FG000|Overall Study|Insufficient clinical response|36|||
161087782|NCT00512317|581710981|FG000|Overall Study|Withdrawal by Subject|23|||
161087783|NCT00512317|581710981|FG000|Overall Study|Sponsor closure of study|21|||
161087784|NCT00512317|581710981|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
161087785|NCT00512317|581710981|FG000|Overall Study|Adverse Event|13|||
161087786|NCT00512317|581710981|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
161087787|NCT00512317|581710981|FG000|Overall Study|Lost to Follow-up|2|||
161087788|NCT00512317|581710981|FG000|Overall Study|Other|2|||
161087789|NCT00706433|581710985|FG000|Overall Study|Lost to Follow-up|3|||
161087790|NCT00706433|581710986|FG001|Overall Study|Lost to Follow-up|1|||
161087791|NCT00706433|581710987|FG002|Overall Study|Lost to Follow-up|6|||
161175114|NCT02460978|582017784|FG001|Overall Study|Lost to Follow-up|3|||
161175115|NCT02460978|582017785|FG002|Overall Study|Lost to Follow-up|1|||
161295090|NCT04390113|582461058|FG001|Overall Study|Death|1|||
161087792|NCT00706433|581710988|FG003|Overall Study|Lost to Follow-up|0|||
161087793|NCT00706433|581710985|FG000|Overall Study|Withdrawal by Subject|1|||
161087794|NCT00706433|581710986|FG001|Overall Study|Withdrawal by Subject|2|||
161087795|NCT00706433|581710987|FG002|Overall Study|Withdrawal by Subject|3|||
161175116|NCT02460978|582017783|FG000|Overall Study|Protocol Violation|1|||
161295091|NCT04390113|582461057|FG000|Overall Study|Physician Decision|1|||
161295092|NCT04390113|582461058|FG001|Overall Study|Physician Decision|3|||
161295093|NCT04390113|582461057|FG000|Overall Study|Study Terminated by Sponsor|5|||
161295094|NCT04390113|582461058|FG001|Overall Study|Study Terminated by Sponsor|3|||
161295095|NCT04390113|582461057|FG000|Overall Study|Withdrawal by Subject|10|||
161295096|NCT04390113|582461058|FG001|Overall Study|Withdrawal by Subject|5|||
161295097|NCT04390113|582461057|FG000|Overall Study|Other|1|||
161295098|NCT04390113|582461058|FG001|Overall Study|Other|0|||
161295099|NCT04390113|582461057|FG000|Overall Study|Missing|0|||
161295100|NCT04390113|582461058|FG001|Overall Study|Missing|1|||
161295101|NCT04031846|582461062|FG000|Overall Study|Lost to Follow-up|4|||
161295102|NCT04031846|582461063|FG001|Overall Study|Lost to Follow-up|4|||
161295103|NCT04031846|582461062|FG000|Overall Study|Physician Decision|0|||
161295104|NCT04031846|582461063|FG001|Overall Study|Physician Decision|1|||
161295105|NCT04031846|582461062|FG000|Overall Study|Protocol Violation|1|||
161295106|NCT04031846|582461063|FG001|Overall Study|Protocol Violation|1|||
161295107|NCT04031846|582461062|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
161295108|NCT04031846|582461063|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
161295109|NCT02431676|582461064|FG000|Overall Study|no lab obtained|0|||
161295110|NCT02431676|582461065|FG001|Overall Study|no lab obtained|1|||
161295111|NCT02431676|582461066|FG002|Overall Study|no lab obtained|2|||
161295112|NCT00571727|582461067|FG000|Overall Study|Did not enter in this study|1|||
161295113|NCT00571727|582461067|FG000|Overall Study|Non-compliance|4|||
161295114|NCT00571727|582461067|FG000|Overall Study|Lost to Follow-up|30|||
161295115|NCT00571727|582461067|FG000|Overall Study|Poor growth|1|||
161295116|NCT00571727|582461067|FG000|Overall Study|Parent/patient decision|2|||
161295117|NCT00571727|582461067|FG000|Overall Study|Participant transferred to commercial drug|14|||
161295118|NCT00571727|582461067|FG000|Overall Study|Unable to provide study drug|6|||
161295119|NCT00571727|582461067|FG000|Overall Study|On-treatment at end of study|8|||
161295120|NCT01622673|582461068|FG000|Treatment Period 1|Withdrawal by Subject|0|||
161295121|NCT01622673|582461069|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161295122|NCT01622673|582461070|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161295123|NCT01622673|582461071|FG003|Treatment Period 1|Withdrawal by Subject|1|||
161295124|NCT01622673|582461072|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161295125|NCT01622673|582461073|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161295126|NCT01622673|582461068|FG000|Treatment Period 1|Protocol Violation|0|||
161295127|NCT01622673|582461069|FG001|Treatment Period 1|Protocol Violation|1|||
161295128|NCT01622673|582461070|FG002|Treatment Period 1|Protocol Violation|0|||
161295129|NCT01622673|582461071|FG003|Treatment Period 1|Protocol Violation|0|||
161295130|NCT01622673|582461072|FG004|Treatment Period 1|Protocol Violation|0|||
161295131|NCT01622673|582461073|FG005|Treatment Period 1|Protocol Violation|0|||
161295132|NCT01622673|582461068|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161295133|NCT01622673|582461069|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161295134|NCT01622673|582461070|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161295135|NCT01622673|582461071|FG003|Treatment Period 2|Withdrawal by Subject|1|||
161295136|NCT01622673|582461072|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161295137|NCT01622673|582461073|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161295138|NCT01622673|582461068|FG000|Treatment Period 3|Protocol Violation|0|||
161295139|NCT01622673|582461069|FG001|Treatment Period 3|Protocol Violation|1|||
161295140|NCT01622673|582461070|FG002|Treatment Period 3|Protocol Violation|0|||
161295141|NCT01622673|582461071|FG003|Treatment Period 3|Protocol Violation|0|||
161295142|NCT01622673|582461072|FG004|Treatment Period 3|Protocol Violation|0|||
161295143|NCT01622673|582461073|FG005|Treatment Period 3|Protocol Violation|0|||
161295144|NCT02395848|582463230|FG000|Overall Study|Lost to Follow-up|2|||
161295145|NCT02276560|582463231|FG000|Overall Study|Adverse Event|1|||
161295146|NCT02276560|582463232|FG001|Overall Study|Adverse Event|0|||
161295147|NCT02276560|582463233|FG002|Overall Study|Adverse Event|0|||
161295148|NCT01609010|582463236|FG000|Overall Study|Stable disease (SD)|22|||
161295149|NCT01609010|582463237|FG001|Overall Study|Stable disease (SD)|16|||
161295150|NCT01609010|582463236|FG000|Overall Study|Progressive disease (PD)|8|||
161295151|NCT01609010|582463237|FG001|Overall Study|Progressive disease (PD)|10|||
161295152|NCT01609010|582463236|FG000|Overall Study|Adverse Event|3|||
161295153|NCT01609010|582463237|FG001|Overall Study|Adverse Event|6|||
161295154|NCT01609010|582463236|FG000|Overall Study|Withdrawal by Subject|2|||
161295155|NCT01609010|582463237|FG001|Overall Study|Withdrawal by Subject|2|||
161295156|NCT01609010|582463236|FG000|Overall Study|Other|2|||
161295157|NCT01609010|582463237|FG001|Overall Study|Other|0|||
161295158|NCT01609010|582463236|FG000|Overall Study|Other malignancy|1|||
161295159|NCT01609010|582463237|FG001|Overall Study|Other malignancy|0|||
161295160|NCT01609010|582463236|FG000|Overall Study|Pathology review|2|||
161295161|NCT01609010|582463237|FG001|Overall Study|Pathology review|1|||
161295162|NCT01609010|582463236|FG000|Overall Study|Protocol Violation|1|||
161295163|NCT01609010|582463237|FG001|Overall Study|Protocol Violation|1|||
161295164|NCT01609010|582463236|FG000|Overall Study|New cancer|1|||
161295165|NCT01609010|582463237|FG001|Overall Study|New cancer|0|||
161295166|NCT01609010|582463236|FG000|Overall Study|Lost to Follow-up|1|||
161295167|NCT01609010|582463237|FG001|Overall Study|Lost to Follow-up|1|||
161295168|NCT01134107|582463238|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
161295169|NCT01134107|582463239|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
161295170|NCT01134107|582463238|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
161319487|NCT01863732|582555334|FG000|Overall Study|Lost to Follow-up|2|||
161295171|NCT01134107|582463239|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
161295172|NCT01134107|582463238|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
161295173|NCT01134107|582463239|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
161295174|NCT01134107|582463238|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
161295175|NCT01134107|582463239|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
161295176|NCT01134107|582463238|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
161295177|NCT01134107|582463239|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
161295178|NCT01134107|582463238|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
161295179|NCT01134107|582463239|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
161295180|NCT01134107|582463238|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
161295181|NCT01134107|582463239|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
161295182|NCT04541589|582463245|FG000|Treatment Period|Adverse Event|8|||
161295183|NCT04541589|582463246|FG001|Treatment Period|Adverse Event|2|||
161295184|NCT04541589|582463245|FG000|Treatment Period|Physician Decision|3|||
161087796|NCT00706433|581710988|FG003|Overall Study|Withdrawal by Subject|1|||
161087797|NCT00706433|581710985|FG000|Overall Study|Adverse Event|0|||
161087798|NCT00706433|581710986|FG001|Overall Study|Adverse Event|0|||
161087799|NCT00706433|581710987|FG002|Overall Study|Adverse Event|1|||
161087800|NCT00706433|581710988|FG003|Overall Study|Adverse Event|0|||
161087801|NCT00706433|581710985|FG000|Overall Study|Protocol Violation|1|||
161087802|NCT00706433|581710986|FG001|Overall Study|Protocol Violation|0|||
161087803|NCT00706433|581710987|FG002|Overall Study|Protocol Violation|0|||
161087804|NCT00706433|581710988|FG003|Overall Study|Protocol Violation|0|||
161087805|NCT00706433|581710985|FG000|Overall Study|new job|0|||
161087806|NCT00706433|581710986|FG001|Overall Study|new job|0|||
161087807|NCT00706433|581710987|FG002|Overall Study|new job|0|||
161087808|NCT00706433|581710988|FG003|Overall Study|new job|1|||
161087809|NCT04101318|581710990|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
161087810|NCT04101318|581710991|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
161087811|NCT04101318|581710990|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
161087812|NCT04101318|581710991|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
161087813|NCT04101318|581710990|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
161087814|NCT04101318|581710991|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
161087815|NCT00717067|581710992|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161087816|NCT00717067|581710993|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161087817|NCT00717067|581710994|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
161087818|NCT00717067|581710995|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161087819|NCT00717067|581710996|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
161087820|NCT02090959|581710997|FG000|Overall Study|Withdrawal by Subject|10|||
161087821|NCT02090959|581710997|FG000|Overall Study|Adverse Event|1|||
161087822|NCT02090959|581710997|FG000|Overall Study|Investigator decision|2|||
161087823|NCT02090959|581710997|FG000|Overall Study|Study termination|6|||
161087824|NCT02090959|581710997|FG000|Overall Study|Enrolled but not treated|1|||
161087825|NCT02090959|581710997|FG000|Overall Study|Transfer for compassionate use medicine|4|||
161087826|NCT02090959|581710997|FG000|Overall Study|Move to medical need program|3|||
161087827|NCT02090959|581710997|FG000|Overall Study|Entered in to other study|34|||
161087828|NCT02090959|581710997|FG000|Overall Study|Switched to commercial supply|88|||
161087829|NCT02090959|581710997|FG000|Overall Study|Other than specified|2|||
161087830|NCT00522873|581710998|FG000|Overall Study|Adverse Event|41|||
161087831|NCT00522873|581710999|FG001|Overall Study|Adverse Event|26|||
161087832|NCT00522873|581710998|FG000|Overall Study|Withdrawal by Subject|20|||
161087833|NCT00522873|581710999|FG001|Overall Study|Withdrawal by Subject|9|||
161087834|NCT00522873|581710998|FG000|Overall Study|Protocol Violation|14|||
161087835|NCT00522873|581710999|FG001|Overall Study|Protocol Violation|4|||
161087836|NCT00522873|581710998|FG000|Overall Study|Lost to Follow-up|11|||
161087837|NCT00522873|581710999|FG001|Overall Study|Lost to Follow-up|3|||
161087838|NCT00522873|581710998|FG000|Overall Study|Personal Reasons|8|||
161087839|NCT00522873|581710999|FG001|Overall Study|Personal Reasons|1|||
161087840|NCT00522873|581710998|FG000|Overall Study|Medication Errors|1|||
161087841|NCT00522873|581710999|FG001|Overall Study|Medication Errors|1|||
161087842|NCT00522873|581710998|FG000|Overall Study|Never Received Medication|1|||
161087843|NCT00522873|581710999|FG001|Overall Study|Never Received Medication|0|||
161087844|NCT02029846|581711000|FG000|Overall Study|n=1 each arm|1|||
161087845|NCT02029846|581711001|FG001|Overall Study|n=1 each arm|1|||
161087846|NCT02966301|581711005|FG000|Overall Study|Death|2|||
161175117|NCT02460978|582017784|FG001|Overall Study|Protocol Violation|1|||
161087847|NCT02966301|581711005|FG000|Overall Study|Withdrawal by Subject|1|||
161087848|NCT00370331|581711007|FG000|Overall Study|Adverse Event|4|||
161087849|NCT00370331|581711008|FG001|Overall Study|Adverse Event|13|||
161087850|NCT00370331|581711007|FG000|Overall Study|Withdrawal by Subject|2|||
161087851|NCT00370331|581711008|FG001|Overall Study|Withdrawal by Subject|4|||
161087852|NCT00370331|581711007|FG000|Overall Study|Lost to Follow-up|0|||
161087853|NCT00370331|581711008|FG001|Overall Study|Lost to Follow-up|3|||
161087854|NCT00370331|581711007|FG000|Overall Study|Lack of Efficacy|0|||
161087855|NCT00370331|581711008|FG001|Overall Study|Lack of Efficacy|1|||
161087856|NCT00370331|581711007|FG000|Overall Study|Non-compliance|0|||
161087857|NCT00370331|581711008|FG001|Overall Study|Non-compliance|1|||
161087858|NCT00370331|581711007|FG000|Overall Study|Protocol Violation|1|||
161087859|NCT00370331|581711008|FG001|Overall Study|Protocol Violation|1|||
161087860|NCT00545051|581711010|FG000|Overall Study|Adverse Event|7|||
161087861|NCT00545051|581711011|FG001|Overall Study|Adverse Event|3|||
161087862|NCT00545051|581711010|FG000|Overall Study|Death|1|||
161087863|NCT00545051|581711011|FG001|Overall Study|Death|0|||
161087864|NCT00545051|581711010|FG000|Overall Study|Violation of inclusion/exclusion|0|||
161087865|NCT00545051|581711011|FG001|Overall Study|Violation of inclusion/exclusion|2|||
161087866|NCT00545051|581711010|FG000|Overall Study|Protocol Violation|1|||
161087867|NCT00545051|581711011|FG001|Overall Study|Protocol Violation|0|||
161087868|NCT00545051|581711010|FG000|Overall Study|Withdrawal by Subject|0|||
161087869|NCT00545051|581711011|FG001|Overall Study|Withdrawal by Subject|1|||
161087870|NCT00545051|581711010|FG000|Overall Study|Administrative reasons|0|||
161087871|NCT00545051|581711011|FG001|Overall Study|Administrative reasons|1|||
161087872|NCT01375114|581711012|FG000|Overall Study|Lost to Follow-up|1|||
161087873|NCT01375114|581711013|FG001|Overall Study|Lost to Follow-up|0|||
161087874|NCT01375114|581711014|FG002|Overall Study|Lost to Follow-up|1|||
161087875|NCT01375114|581711012|FG000|Overall Study|Disease Progression|3|||
161087876|NCT01375114|581711013|FG001|Overall Study|Disease Progression|2|||
161087877|NCT01375114|581711014|FG002|Overall Study|Disease Progression|2|||
161087878|NCT01375114|581711012|FG000|Overall Study|Patient Changed Mind|0|||
161087879|NCT01375114|581711013|FG001|Overall Study|Patient Changed Mind|0|||
161087880|NCT01375114|581711014|FG002|Overall Study|Patient Changed Mind|2|||
161087881|NCT01375114|581711012|FG000|Overall Study|Pruritus|0|||
161087882|NCT01375114|581711013|FG001|Overall Study|Pruritus|0|||
161087883|NCT01375114|581711014|FG002|Overall Study|Pruritus|1|||
161087884|NCT01375114|581711012|FG000|Overall Study|Restlessness|0|||
161087885|NCT01375114|581711013|FG001|Overall Study|Restlessness|0|||
161087886|NCT01375114|581711014|FG002|Overall Study|Restlessness|1|||
161087887|NCT01375114|581711012|FG000|Overall Study|Diarrhea|0|||
161087888|NCT01375114|581711013|FG001|Overall Study|Diarrhea|0|||
161087889|NCT01375114|581711014|FG002|Overall Study|Diarrhea|1|||
161087890|NCT01375114|581711012|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
161087891|NCT01375114|581711013|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
161087892|NCT01375114|581711014|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
161087893|NCT01375114|581711012|FG000|Overall Study|Nausea|0|||
161087894|NCT01375114|581711013|FG001|Overall Study|Nausea|1|||
161087895|NCT01375114|581711014|FG002|Overall Study|Nausea|0|||
161087896|NCT01375114|581711012|FG000|Overall Study|Increased AST/ALT|0|||
161087897|NCT01375114|581711013|FG001|Overall Study|Increased AST/ALT|1|||
161087898|NCT01375114|581711014|FG002|Overall Study|Increased AST/ALT|0|||
161087899|NCT01375114|581711012|FG000|Overall Study|Vaginal Hemorrhage|0|||
161087900|NCT01375114|581711013|FG001|Overall Study|Vaginal Hemorrhage|1|||
161087901|NCT01375114|581711014|FG002|Overall Study|Vaginal Hemorrhage|0|||
161087902|NCT01375114|581711012|FG000|Overall Study|Family problem|0|||
161087903|NCT01375114|581711013|FG001|Overall Study|Family problem|1|||
161087904|NCT01375114|581711014|FG002|Overall Study|Family problem|0|||
161087905|NCT01375114|581711012|FG000|Overall Study|Protocol Violation|2|||
161087906|NCT01375114|581711013|FG001|Overall Study|Protocol Violation|0|||
161087907|NCT01375114|581711014|FG002|Overall Study|Protocol Violation|0|||
161087908|NCT04745026|581711018|FG000|Overall Study|Physician Decision|1|||
161087909|NCT04745026|581711019|FG001|Overall Study|Physician Decision|0|||
161087910|NCT04745026|581711018|FG000|Overall Study|Adverse Event|2|||
161087911|NCT04745026|581711019|FG001|Overall Study|Adverse Event|2|||
161087912|NCT04745026|581711018|FG000|Overall Study|Protocol Violation|1|||
161087913|NCT04745026|581711019|FG001|Overall Study|Protocol Violation|3|||
161087914|NCT04745026|581711018|FG000|Overall Study|Lost to Follow-up|4|||
161087915|NCT04745026|581711019|FG001|Overall Study|Lost to Follow-up|3|||
161087916|NCT04745026|581711018|FG000|Overall Study|Withdrawal by Subject|5|||
161087917|NCT04745026|581711019|FG001|Overall Study|Withdrawal by Subject|5|||
161087918|NCT01656733|581711020|FG000|Overall Study|No permission to collect birth outcomes|0|||
161087919|NCT01656733|581711021|FG001|Overall Study|No permission to collect birth outcomes|1|||
161087920|NCT01656733|581711020|FG000|Overall Study|Delivery at another hospital|0|||
161087921|NCT01656733|581711021|FG001|Overall Study|Delivery at another hospital|2|||
161087922|NCT01656733|581711020|FG000|Overall Study|Spontaneous abortion|0|||
161087923|NCT01656733|581711021|FG001|Overall Study|Spontaneous abortion|1|||
161087924|NCT02224690|581711022|FG000|Overall Study|Adverse Event|8|||
161087925|NCT02224690|581711023|FG001|Overall Study|Adverse Event|1|||
161087926|NCT02224690|581711022|FG000|Overall Study|Met Withdrawal Criteria|4|||
161087927|NCT02224690|581711023|FG001|Overall Study|Met Withdrawal Criteria|0|||
161087928|NCT02224690|581711022|FG000|Overall Study|Use of G-tube|1|||
161087929|NCT02224690|581711023|FG001|Overall Study|Use of G-tube|0|||
161087930|NCT02224690|581711022|FG000|Overall Study|Did not meet eligibility criteria|1|||
161087931|NCT02224690|581711023|FG001|Overall Study|Did not meet eligibility criteria|0|||
161087932|NCT01415531|581711024|FG000|Overall Study|Adverse Event|7|||
161087933|NCT01415531|581711025|FG001|Overall Study|Adverse Event|10|||
161295185|NCT04541589|582463246|FG001|Treatment Period|Physician Decision|1|||
161295186|NCT04541589|582463245|FG000|Treatment Period|Subject decision|7|||
161295187|NCT04541589|582463246|FG001|Treatment Period|Subject decision|4|||
161295188|NCT04541589|582463245|FG000|Treatment Period|Withdrawal by Subject|1|||
161295189|NCT04541589|582463246|FG001|Treatment Period|Withdrawal by Subject|0|||
161295190|NCT04541589|582463245|FG000|Safety Follow-up Period|Adverse Event|2|||
161295191|NCT04541589|582463246|FG001|Safety Follow-up Period|Adverse Event|1|||
161295192|NCT04541589|582463245|FG000|Safety Follow-up Period|Physician Decision|1|||
161295193|NCT04541589|582463246|FG001|Safety Follow-up Period|Physician Decision|0|||
161295194|NCT04541589|582463245|FG000|Safety Follow-up Period|Subject decision|5|||
161295195|NCT04541589|582463246|FG001|Safety Follow-up Period|Subject decision|3|||
161295196|NCT04541589|582463245|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
161295197|NCT04541589|582463246|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
161295198|NCT03581123|582463249|FG000|2-month Follow-up|Withdrawal by Subject|5|||
161295199|NCT03581123|582463250|FG001|2-month Follow-up|Withdrawal by Subject|4|||
161295200|NCT03581123|582463251|FG002|2-month Follow-up|Withdrawal by Subject|6|||
161295201|NCT03581123|582463252|FG003|2-month Follow-up|Withdrawal by Subject|4|||
161295202|NCT03581123|582463249|FG000|2-month Follow-up|Lost to Follow-up|8|||
161295203|NCT03581123|582463250|FG001|2-month Follow-up|Lost to Follow-up|1|||
161295204|NCT03581123|582463251|FG002|2-month Follow-up|Lost to Follow-up|2|||
161295205|NCT03581123|582463252|FG003|2-month Follow-up|Lost to Follow-up|2|||
161295206|NCT03581123|582463249|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
161295207|NCT03581123|582463250|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
161295208|NCT03581123|582463251|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
161295209|NCT03581123|582463252|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
161295210|NCT03581123|582463249|FG000|6-Month Follow-up|Lost to Follow-up|3|||
161295211|NCT03581123|582463250|FG001|6-Month Follow-up|Lost to Follow-up|3|||
161295212|NCT03581123|582463251|FG002|6-Month Follow-up|Lost to Follow-up|1|||
161295213|NCT03581123|582463252|FG003|6-Month Follow-up|Lost to Follow-up|1|||
161295214|NCT03581123|582463249|FG000|12-Month Follow-up|Lost to Follow-up|4|||
161295215|NCT03581123|582463250|FG001|12-Month Follow-up|Lost to Follow-up|3|||
161347627|NCT05350202|582656335|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
161347628|NCT05350202|582656336|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
161347629|NCT03682848|582656341|FG000|Overall Study|Withdrawal by Subject|3|||
161347630|NCT03682848|582656341|FG000|Overall Study|Site closed|5|||
161347631|NCT03682848|582656341|FG000|Overall Study|Protocol Deviation|1|||
161347632|NCT03682848|582656341|FG000|Overall Study|Adverse Event|2|||
161087934|NCT01415531|581711024|FG000|Overall Study|Lack of Efficacy|3|||
161087935|NCT01415531|581711025|FG001|Overall Study|Lack of Efficacy|2|||
161087936|NCT01415531|581711024|FG000|Overall Study|Protocol Violation|0|||
161087937|NCT01415531|581711025|FG001|Overall Study|Protocol Violation|1|||
161087938|NCT01415531|581711024|FG000|Overall Study|Withdrawal by Subject|5|||
161087939|NCT01415531|581711025|FG001|Overall Study|Withdrawal by Subject|4|||
161087940|NCT01415531|581711024|FG000|Overall Study|Lost to Follow-up|6|||
161087941|NCT01415531|581711025|FG001|Overall Study|Lost to Follow-up|14|||
161087942|NCT01415531|581711024|FG000|Overall Study|Lack of Compliance|1|||
161087943|NCT01415531|581711025|FG001|Overall Study|Lack of Compliance|4|||
161087944|NCT01415531|581711024|FG000|Overall Study|Other Reasons|3|||
161087945|NCT01415531|581711025|FG001|Overall Study|Other Reasons|2|||
161087946|NCT05753670|581711026|FG000|Overall Study|Withdrawal by Subject|6|||
161087947|NCT05753670|581711027|FG001|Overall Study|Withdrawal by Subject|8|||
161087948|NCT05753670|581711026|FG000|Overall Study|Protocol Violation|3|||
161087949|NCT05753670|581711027|FG001|Overall Study|Protocol Violation|1|||
161087950|NCT00122460|581711028|FG000|Overall Study|investigational study phase ongoing|7|||
161087951|NCT00122460|581711029|FG001|Overall Study|investigational study phase ongoing|1|||
161087952|NCT01236339|581711030|FG000|Overall Study|Termination of study by sponsor|11|||
161087953|NCT01236339|581711031|FG001|Overall Study|Termination of study by sponsor|13|||
161087954|NCT02325557|581711032|FG000|Overall Study|Progressive disease|1|||
161087955|NCT02325557|581711033|FG001|Overall Study|Progressive disease|0|||
161087956|NCT02325557|581711034|FG002|Overall Study|Progressive disease|0|||
161087957|NCT02325557|581711035|FG003|Overall Study|Progressive disease|0|||
161087958|NCT02325557|581711032|FG000|Overall Study|Withdrawal by Subject|4|||
161087959|NCT02325557|581711033|FG001|Overall Study|Withdrawal by Subject|0|||
161087960|NCT02325557|581711034|FG002|Overall Study|Withdrawal by Subject|0|||
161087961|NCT02325557|581711035|FG003|Overall Study|Withdrawal by Subject|15|||
161087962|NCT02325557|581711032|FG000|Overall Study|Death|5|||
161087963|NCT02325557|581711033|FG001|Overall Study|Death|1|||
161087964|NCT02325557|581711034|FG002|Overall Study|Death|1|||
161087965|NCT02325557|581711035|FG003|Overall Study|Death|16|||
161087966|NCT02325557|581711032|FG000|Overall Study|Lost to Follow-up|0|||
161087967|NCT02325557|581711033|FG001|Overall Study|Lost to Follow-up|0|||
161087968|NCT02325557|581711034|FG002|Overall Study|Lost to Follow-up|1|||
161087969|NCT02325557|581711035|FG003|Overall Study|Lost to Follow-up|1|||
161087970|NCT02325557|581711032|FG000|Overall Study|Other|0|||
161087971|NCT02325557|581711033|FG001|Overall Study|Other|0|||
161087972|NCT02325557|581711034|FG002|Overall Study|Other|0|||
161295216|NCT03581123|582463251|FG002|12-Month Follow-up|Lost to Follow-up|4|||
161295217|NCT03581123|582463252|FG003|12-Month Follow-up|Lost to Follow-up|5|||
161295218|NCT04195685|582463253|FG000|Overall Study|Withdrawal by Subject|6|||
161295219|NCT04195685|582463254|FG001|Overall Study|Withdrawal by Subject|2|||
161295220|NCT04195685|582463253|FG000|Overall Study|Lost to Follow-up|1|||
161295221|NCT04195685|582463254|FG001|Overall Study|Lost to Follow-up|4|||
161295222|NCT04509076|582463256|FG000|Overall Study|Withdrawal by Subject|1|||
161295223|NCT04509076|582463257|FG001|Overall Study|Withdrawal by Subject|2|||
161295224|NCT04509076|582463256|FG000|Overall Study|Lost to Follow-up|1|||
161295225|NCT04509076|582463257|FG001|Overall Study|Lost to Follow-up|2|||
161295226|NCT03351608|582463258|FG000|Overall Study|Lost to Follow-up|0|||
161295227|NCT03351608|582463259|FG001|Overall Study|Lost to Follow-up|1|||
161295228|NCT03351608|582463260|FG002|Overall Study|Lost to Follow-up|1|||
161295229|NCT03351608|582463261|FG003|Overall Study|Lost to Follow-up|1|||
161295230|NCT03351608|582463262|FG004|Overall Study|Lost to Follow-up|1|||
161295231|NCT03351608|582463258|FG000|Overall Study|Physician Decision|1|||
161295232|NCT03351608|582463259|FG001|Overall Study|Physician Decision|0|||
161295233|NCT03351608|582463260|FG002|Overall Study|Physician Decision|0|||
161295234|NCT03351608|582463261|FG003|Overall Study|Physician Decision|2|||
161295235|NCT03351608|582463262|FG004|Overall Study|Physician Decision|1|||
161295236|NCT03351608|582463258|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
161295237|NCT03351608|582463259|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
161295238|NCT03351608|582463260|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
161295239|NCT03351608|582463261|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
161295240|NCT03351608|582463262|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
161295241|NCT03351608|582463258|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161295242|NCT03351608|582463259|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161295243|NCT03351608|582463260|FG002|Overall Study|Withdrawal by parent/guardian|1|||
161295244|NCT03351608|582463261|FG003|Overall Study|Withdrawal by parent/guardian|1|||
161295245|NCT03351608|582463262|FG004|Overall Study|Withdrawal by parent/guardian|0|||
161295246|NCT03351608|582463258|FG000|Overall Study|Other|0|||
161295247|NCT03351608|582463259|FG001|Overall Study|Other|1|||
161295248|NCT03351608|582463260|FG002|Overall Study|Other|1|||
161295249|NCT03351608|582463261|FG003|Overall Study|Other|3|||
161295250|NCT03351608|582463262|FG004|Overall Study|Other|0|||
161295251|NCT02877004|582463263|FG000|Overall Study|Pregnancy|0|||
161295252|NCT02877004|582463264|FG001|Overall Study|Pregnancy|0|||
161295253|NCT02877004|582463265|FG002|Overall Study|Pregnancy|1|||
161295254|NCT02727478|582463266|FG000|Overall Study|Withdrawal by Subject|8|||
161295255|NCT02727478|582463267|FG001|Overall Study|Withdrawal by Subject|10|||
161295256|NCT02633293|582463268|FG000|Overall Study|Death|56|||
161295257|NCT02633293|582463268|FG000|Overall Study|Progressive Disease|12|||
161295258|NCT02633293|582463268|FG000|Overall Study|Adverse Event|29|||
161295259|NCT02633293|582463268|FG000|Overall Study|Withdrawal by Subject|41|||
161295260|NCT02633293|582463268|FG000|Overall Study|Protocol Violation|1|||
161295261|NCT02633293|582463268|FG000|Overall Study|Lost to Follow-up|1|||
161295262|NCT02633293|582463268|FG000|Overall Study|Study Terminated by Sponsor|24|||
161295263|NCT02633293|582463268|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
161295264|NCT02633293|582463268|FG000|Overall Study|Lung Transplant|5|||
161295265|NCT02633293|582463268|FG000|Overall Study|Lack of Efficacy|2|||
161295266|NCT02633293|582463268|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
161295267|NCT01343043|582463269|FG000|Overall Study|Disease progression before treatment|1|||
161295268|NCT01343043|582463270|FG001|Overall Study|Disease progression before treatment|0|||
161295269|NCT01343043|582463271|FG002|Overall Study|Disease progression before treatment|0|||
161295270|NCT01343043|582463272|FG003|Overall Study|Disease progression before treatment|0|||
161295271|NCT01343043|582463269|FG000|Overall Study|Withdrawal by Subject|1|||
161295272|NCT01343043|582463270|FG001|Overall Study|Withdrawal by Subject|0|||
161295273|NCT01343043|582463271|FG002|Overall Study|Withdrawal by Subject|0|||
161295274|NCT01343043|582463272|FG003|Overall Study|Withdrawal by Subject|0|||
161347633|NCT03682848|582656341|FG000|Overall Study|Lack of Efficacy|1|||
161347634|NCT02337686|582656343|FG000|Overall Study|Adverse Event|1|||
161347635|NCT00970944|582657326|FG000|Overall Study|Death|1|||
161347636|NCT00970944|582657327|FG001|Overall Study|Death|0|||
161347637|NCT00970944|582657326|FG000|Overall Study|Physician Decision|0|||
161175118|NCT02460978|582017785|FG002|Overall Study|Protocol Violation|1|||
161295275|NCT01343043|582463269|FG000|Overall Study|Death|1|||
161295276|NCT01343043|582463270|FG001|Overall Study|Death|1|||
161295277|NCT01343043|582463271|FG002|Overall Study|Death|0|||
161295278|NCT01343043|582463272|FG003|Overall Study|Death|1|||
161295279|NCT00502242|582463275|FG000|Overall Study|Lack of Efficacy|1|||
161295280|NCT00502242|582463276|FG001|Overall Study|Lack of Efficacy|11|||
161295281|NCT00502242|582463275|FG000|Overall Study|Adverse Event|31|||
161295282|NCT00502242|582463276|FG001|Overall Study|Adverse Event|20|||
161295283|NCT00502242|582463275|FG000|Overall Study|Physician Decision|2|||
161295284|NCT00502242|582463276|FG001|Overall Study|Physician Decision|3|||
161295285|NCT00502242|582463275|FG000|Overall Study|Other - Unspecified|8|||
161347638|NCT00970944|582657327|FG001|Overall Study|Physician Decision|2|||
161347639|NCT02008370|582657328|FG000|Overall Study|Lost to Follow-up|7|||
161295286|NCT00502242|582463276|FG001|Overall Study|Other - Unspecified|14|||
161295287|NCT00502242|582463275|FG000|Overall Study|Protocol Violation|3|||
161295288|NCT00502242|582463276|FG001|Overall Study|Protocol Violation|1|||
161295289|NCT00502242|582463275|FG000|Overall Study|Withdrawal by Subject|6|||
161295290|NCT00502242|582463276|FG001|Overall Study|Withdrawal by Subject|7|||
161295291|NCT02356588|582463277|FG000|Overall Study|Lack of Efficacy|4|||
161295292|NCT02356588|582463278|FG001|Overall Study|Lack of Efficacy|10|||
161295293|NCT02356588|582463277|FG000|Overall Study|Adverse Event|0|||
161295294|NCT02356588|582463278|FG001|Overall Study|Adverse Event|2|||
161295295|NCT02356588|582463277|FG000|Overall Study|Withdrawal by Subject|1|||
161295296|NCT02356588|582463278|FG001|Overall Study|Withdrawal by Subject|0|||
161295297|NCT02356588|582463277|FG000|Overall Study|Protocol Violation|0|||
161295298|NCT02356588|582463278|FG001|Overall Study|Protocol Violation|1|||
161295299|NCT01418378|582463279|FG000|Overall Study|Death|1|||
161295300|NCT01418378|582463280|FG001|Overall Study|Death|2|||
161295301|NCT01418378|582463279|FG000|Overall Study|Physician Decision|0|||
161295302|NCT01418378|582463280|FG001|Overall Study|Physician Decision|1|||
161295303|NCT01418378|582463279|FG000|Overall Study|ligament imbalance|0|||
161295304|NCT01418378|582463280|FG001|Overall Study|ligament imbalance|1|||
161295305|NCT01418378|582463279|FG000|Overall Study|developed chronic myopathy|0|||
161295306|NCT01418378|582463280|FG001|Overall Study|developed chronic myopathy|1|||
161295307|NCT01346696|582463285|FG000|Overall Study|Death|1|||
161295308|NCT02182843|582463286|FG000|Overall Study|Withdrawal by Subject|7|||
161295309|NCT02182843|582463286|FG000|Overall Study|Lost to Follow-up|2|||
161295310|NCT02182843|582463286|FG000|Overall Study|Adverse Event|1|||
161295311|NCT01051791|582463290|FG000|Overall Study|Failed screening|3|||
161295312|NCT01051791|582463290|FG000|Overall Study|Withdrawal by Subject|1|||
161295313|NCT00288626|582463297|FG000|Overall Study|Death|3|||
161295314|NCT00288626|582463297|FG000|Overall Study|Withdrawal by Subject|4|||
161295315|NCT04610346|582463298|FG000|Overall Study|Withdrawal by Subject|1|||
161295316|NCT04610346|582463299|FG001|Overall Study|Withdrawal by Subject|1|||
161295317|NCT04610346|582463298|FG000|Overall Study|did not complete shelter onboarding|2|||
161295318|NCT04610346|582463299|FG001|Overall Study|did not complete shelter onboarding|1|||
161295319|NCT00558467|582463300|FG000|Overall Study|Adverse Event|1|||
161295320|NCT00558467|582463301|FG001|Overall Study|Adverse Event|2|||
161295321|NCT00558467|582463300|FG000|Overall Study|Lack of Efficacy|0|||
161295322|NCT00558467|582463301|FG001|Overall Study|Lack of Efficacy|1|||
161295323|NCT00558467|582463300|FG000|Overall Study|Patient moving out of state|0|||
161295324|NCT00558467|582463301|FG001|Overall Study|Patient moving out of state|1|||
161295325|NCT00931255|582463302|FG000|Overall Study|Follow up biopsy not done|2|||
161295326|NCT00931255|582463303|FG001|Overall Study|Follow up biopsy not done|3|||
161295327|NCT02019264|582463306|FG000|Overall Study|Not treated|6|||
161295328|NCT02019264|582463307|FG001|Overall Study|Not treated|4|||
161295329|NCT02019264|582463306|FG000|Overall Study|Lost to Follow-up|50|||
161295330|NCT02019264|582463307|FG001|Overall Study|Lost to Follow-up|47|||
161295331|NCT02019264|582463306|FG000|Overall Study|Withdrawal by Subject|142|||
161295332|NCT02019264|582463307|FG001|Overall Study|Withdrawal by Subject|117|||
161295333|NCT02019264|582463306|FG000|Overall Study|Administrative reason|36|||
161295334|NCT02019264|582463307|FG001|Overall Study|Administrative reason|28|||
161295335|NCT02019264|582463306|FG000|Overall Study|Missing|14|||
161295336|NCT02019264|582463307|FG001|Overall Study|Missing|11|||
161295337|NCT00869999|582463317|FG000|Overall Study|Withdrawal by Subject|1|||
161295338|NCT00869999|582463317|FG000|Overall Study|removed prior to starting therapy|1|||
161295339|NCT03674112|582463321|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
161295340|NCT03674112|582463322|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
161295341|NCT03674112|582463321|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
161295342|NCT03674112|582463322|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
161295343|NCT03674112|582463321|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
161295344|NCT03674112|582463322|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
161295345|NCT03674112|582463321|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
161295346|NCT03674112|582463322|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
161295347|NCT03674112|582463321|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
161295348|NCT03674112|582463322|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
161295349|NCT03674112|582463321|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
161295350|NCT03674112|582463322|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
161295351|NCT03674112|582463321|FG000|Follow-Up Period (≥3 Years)|Death|2|||
161295352|NCT03674112|582463322|FG001|Follow-Up Period (≥3 Years)|Death|0|||
161295353|NCT03674112|582463321|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
161295354|NCT03674112|582463322|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
161295355|NCT04157348|582463323|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
161295356|NCT04157348|582463324|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
161295357|NCT04157348|582463323|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161319488|NCT01863732|582555335|FG001|Overall Study|Lost to Follow-up|2|||
161319489|NCT01863732|582555336|FG002|Overall Study|Lost to Follow-up|1|||
161319490|NCT01863732|582555337|FG003|Overall Study|Lost to Follow-up|1|||
161295358|NCT04157348|582463324|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
161295359|NCT04157348|582463323|FG000|Double-blind Treatment Period|Adverse Event|0|||
161295360|NCT04157348|582463324|FG001|Double-blind Treatment Period|Adverse Event|1|||
161295361|NCT04157348|582463323|FG000|Open-label Extension Period|Adverse Event|1|||
161295362|NCT04157348|582463324|FG001|Open-label Extension Period|Adverse Event|1|||
161295363|NCT04157348|582463323|FG000|Open-label Extension Period|Death|0|||
161295364|NCT04157348|582463324|FG001|Open-label Extension Period|Death|1|||
161295365|NCT04157348|582463323|FG000|Open-label Extension Period|Lack of Efficacy|2|||
161295366|NCT04157348|582463324|FG001|Open-label Extension Period|Lack of Efficacy|2|||
161295367|NCT04157348|582463323|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
161295368|NCT04157348|582463324|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161295369|NCT04157348|582463323|FG000|Open-label Extension Period|Ongoing|60|||
161295370|NCT04157348|582463324|FG001|Open-label Extension Period|Ongoing|57|||
161295371|NCT04157348|582463323|FG000|Open-label Extension Period|other reasons|1|||
161295372|NCT04157348|582463324|FG001|Open-label Extension Period|other reasons|1|||
161295373|NCT02220764|582463327|FG000|Overall Study|Lost to Follow-up|3|||
161295374|NCT02220764|582463328|FG001|Overall Study|Lost to Follow-up|1|||
161295375|NCT02220764|582463327|FG000|Overall Study|Death|1|||
161295376|NCT02220764|582463328|FG001|Overall Study|Death|0|||
161295377|NCT04526288|582463332|FG000|Overall Study|Disease Progression|1|||
161295378|NCT04526288|582463333|FG001|Overall Study|Disease Progression|0|||
161295379|NCT00952068|582463334|FG000|Overall Study|Adverse Event|3|||
161295380|NCT00952068|582463334|FG000|Overall Study|Withdrawal by Subject|4|||
161295381|NCT04926831|582463335|FG000|Overall Study|Withdrawal by Subject|2|||
161295382|NCT04926831|582463335|FG000|Overall Study|Adverse Event|2|||
161295383|NCT02712554|582463336|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
161295384|NCT02712554|582463337|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
161295385|NCT02712554|582463336|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
161295386|NCT02712554|582463337|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
161295387|NCT02712554|582463336|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
161295388|NCT02712554|582463337|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
161295389|NCT02712554|582463336|FG000|Part B: Qualification Phase|Adverse Event|0|||
161295390|NCT02712554|582463337|FG001|Part B: Qualification Phase|Adverse Event|1|||
161295391|NCT02712554|582463336|FG000|Part B: Treatment Phase|Adverse Event|0|||
161295392|NCT02712554|582463337|FG001|Part B: Treatment Phase|Adverse Event|1|||
161295393|NCT02712554|582463336|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
161295394|NCT02712554|582463337|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
161295395|NCT02712554|582463336|FG000|Part B: Treatment Phase|Other|0|||
161295396|NCT02712554|582463337|FG001|Part B: Treatment Phase|Other|1|||
161295397|NCT01445730|582463338|FG000|Overall Study|Adverse Event|1|||
161295398|NCT01445730|582463338|FG000|Overall Study|For the advice of a dentist|1|||
161295399|NCT01445730|582463338|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
161295400|NCT01367886|582463339|FG000|Overall Study|Lost to Follow-up|4|||
161295401|NCT01367886|582463339|FG000|Overall Study|Lack of Efficacy|2|||
161087973|NCT02325557|581711035|FG003|Overall Study|Other|5|||
161087974|NCT02084056|581711036|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
161087975|NCT02084056|581711037|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161087976|NCT02084056|581711038|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161087977|NCT02084056|581711039|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
161087978|NCT02084056|581711036|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
161087979|NCT02084056|581711037|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161087980|NCT02084056|581711038|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161087981|NCT02084056|581711039|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
161087982|NCT00938860|581711040|FG000|Overall Study|Adverse Event|2|||
161087983|NCT00938860|581711041|FG001|Overall Study|Adverse Event|1|||
161087984|NCT00938860|581711040|FG000|Overall Study|Abnormal laboratory values|2|||
161087985|NCT00938860|581711041|FG001|Overall Study|Abnormal laboratory values|2|||
161087986|NCT00938860|581711040|FG000|Overall Study|Withdrawal by Subject|11|||
161087987|NCT00938860|581711041|FG001|Overall Study|Withdrawal by Subject|8|||
161087988|NCT00938860|581711040|FG000|Overall Study|Lost to Follow-up|4|||
161087989|NCT00938860|581711041|FG001|Overall Study|Lost to Follow-up|4|||
161087990|NCT00938860|581711040|FG000|Overall Study|Administration problems|2|||
161087991|NCT00938860|581711041|FG001|Overall Study|Administration problems|0|||
161087992|NCT00938860|581711040|FG000|Overall Study|Death|1|||
161087993|NCT00938860|581711041|FG001|Overall Study|Death|1|||
161087994|NCT00938860|581711040|FG000|Overall Study|Protocol Violation|3|||
161087995|NCT00938860|581711041|FG001|Overall Study|Protocol Violation|1|||
161087996|NCT01605019|581711042|FG000|Overall Study|pt did not meet transplant endpoint|3|||
161087997|NCT01605019|581711043|FG001|Overall Study|pt did not meet transplant endpoint|0|||
161087998|NCT00324116|581711047|FG000|Overall Study|Adverse Event|5|||
161087999|NCT00324116|581711047|FG000|Overall Study|Lack of Efficacy|17|||
161088000|NCT00324116|581711047|FG000|Overall Study|Withdrawal by Subject|5|||
161088001|NCT00324116|581711047|FG000|Overall Study|Other|5|||
161088002|NCT02703259|581711048|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
161175119|NCT02460978|582017783|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
161295402|NCT01367886|582463339|FG000|Overall Study|Death|1|||
161295403|NCT01167140|582463344|FG000|Overall Study|Withdrawal by Subject|1|||
161295404|NCT00985504|582463345|FG000|Acute Treatment Period|Adverse Event|3|||
161295405|NCT00985504|582463346|FG001|Acute Treatment Period|Adverse Event|4|||
161295406|NCT00985504|582463345|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
161295407|NCT00985504|582463346|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
161295408|NCT00985504|582463345|FG000|Acute Treatment Period|Protocol Violation|2|||
161295409|NCT00985504|582463346|FG001|Acute Treatment Period|Protocol Violation|0|||
161295410|NCT00985504|582463345|FG000|Acute Treatment Period|Sponsor Decision|0|||
161295411|NCT00985504|582463346|FG001|Acute Treatment Period|Sponsor Decision|1|||
161295412|NCT00985504|582463345|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
161295413|NCT00985504|582463346|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
161295414|NCT00985504|582463345|FG000|Optimization Period|Adverse Event|7|||
161295415|NCT00985504|582463346|FG001|Optimization Period|Adverse Event|9|||
161295416|NCT00985504|582463345|FG000|Optimization Period|Death|0|||
161295417|NCT00985504|582463346|FG001|Optimization Period|Death|1|||
161295418|NCT00985504|582463345|FG000|Optimization Period|Lack of Efficacy|5|||
161295419|NCT00985504|582463346|FG001|Optimization Period|Lack of Efficacy|3|||
161295420|NCT00985504|582463345|FG000|Optimization Period|Lost to Follow-up|0|||
161295421|NCT00985504|582463346|FG001|Optimization Period|Lost to Follow-up|1|||
161295422|NCT00985504|582463345|FG000|Optimization Period|Physician Decision|1|||
161295423|NCT00985504|582463346|FG001|Optimization Period|Physician Decision|0|||
161295424|NCT00985504|582463345|FG000|Optimization Period|Protocol Violation|3|||
161295425|NCT00985504|582463346|FG001|Optimization Period|Protocol Violation|1|||
161295426|NCT00985504|582463345|FG000|Optimization Period|Withdrawal by Subject|10|||
161295427|NCT00985504|582463346|FG001|Optimization Period|Withdrawal by Subject|8|||
161295428|NCT03711786|582463351|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
161295429|NCT03711786|582463352|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
161295430|NCT03711786|582463351|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
161295431|NCT03711786|582463352|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
161295432|NCT03711786|582463351|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
161295433|NCT03711786|582463352|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
161295434|NCT03711786|582463351|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
161295435|NCT03711786|582463352|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
161295436|NCT03711786|582463351|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
161295437|NCT03711786|582463352|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
161295438|NCT03711786|582463351|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
161295439|NCT03711786|582463352|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
161295440|NCT03805412|582463353|FG000|Overall Study|Lost to Follow-up|0|||
161295441|NCT03805412|582463354|FG001|Overall Study|Lost to Follow-up|1|||
161295442|NCT00669669|582463361|FG000|Overall Study|To late to start treatment|1|||
161295443|NCT01611883|582463362|FG000|Overall Study|Adverse Event|1|||
161295444|NCT01611883|582463363|FG001|Overall Study|Adverse Event|1|||
161295445|NCT03379727|582463365|FG000|Overall Study|Lack of Efficacy|73|||
161295446|NCT03379727|582463365|FG000|Overall Study|Adverse Event|32|||
161295447|NCT03379727|582463365|FG000|Overall Study|Death|18|||
161295448|NCT03379727|582463365|FG000|Overall Study|Patient/guardian decision|17|||
161295449|NCT03379727|582463365|FG000|Overall Study|Physician Decision|104|||
161295450|NCT03379727|582463365|FG000|Overall Study|Protocol Violation|4|||
161295451|NCT03379727|582463365|FG000|Overall Study|Lost to Follow-up|1|||
161295452|NCT00030901|582463368|FG000|Initial Registration|Ineligible|167|||
161295453|NCT00030901|582463369|FG001|Initial Registration|Ineligible|0|||
161295454|NCT00030901|582463370|FG002|Initial Registration|Ineligible|0|||
161295455|NCT00030901|582463368|FG000|Randomization|Adverse Event|0|||
161295456|NCT00030901|582463369|FG001|Randomization|Adverse Event|11|||
161295457|NCT00030901|582463370|FG002|Randomization|Adverse Event|7|||
161295458|NCT00030901|582463368|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
161295459|NCT00030901|582463369|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
161295460|NCT00030901|582463370|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
161295461|NCT00030901|582463368|FG000|Randomization|Progression/Relapse|0|||
161295462|NCT00030901|582463369|FG001|Randomization|Progression/Relapse|22|||
161295463|NCT00030901|582463370|FG002|Randomization|Progression/Relapse|21|||
161175120|NCT02460978|582017784|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
161175121|NCT02460978|582017785|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
161175122|NCT02460978|582017783|FG000|Overall Study|Pregnancy|0|||
161175123|NCT02460978|582017784|FG001|Overall Study|Pregnancy|0|||
161295464|NCT00030901|582463368|FG000|Randomization|Death|0|||
161295465|NCT00030901|582463369|FG001|Randomization|Death|1|||
161295466|NCT00030901|582463370|FG002|Randomization|Death|3|||
161295467|NCT00030901|582463368|FG000|Randomization|Other|0|||
161295468|NCT00030901|582463369|FG001|Randomization|Other|36|||
161295469|NCT00030901|582463370|FG002|Randomization|Other|33|||
161295470|NCT00030901|582463368|FG000|Randomization|Ineligible|0|||
161295471|NCT00030901|582463369|FG001|Randomization|Ineligible|15|||
161175124|NCT02460978|582017785|FG002|Overall Study|Pregnancy|2|||
161175125|NCT00719537|582017786|FG000|Overall Study|Withdrawal by Subject|1|||
161175126|NCT00719537|582017787|FG001|Overall Study|Withdrawal by Subject|0|||
161175127|NCT00719537|582017786|FG000|Overall Study|Lost to Follow-up|0|||
161175128|NCT00719537|582017787|FG001|Overall Study|Lost to Follow-up|1|||
161175129|NCT01142193|582017788|FG000|Overall Study|Adverse Event|12|||
161175130|NCT01142193|582017789|FG001|Overall Study|Adverse Event|4|||
161175131|NCT01142193|582017788|FG000|Overall Study|Lack of Efficacy|2|||
161175132|NCT01142193|582017789|FG001|Overall Study|Lack of Efficacy|1|||
161295472|NCT00030901|582463370|FG002|Randomization|Ineligible|14|||
161295473|NCT02576847|582463371|FG000|Overall Study|Adverse Event|27|||
161295474|NCT02576847|582463371|FG000|Overall Study|Lost to Follow-up|22|||
161295475|NCT02576847|582463371|FG000|Overall Study|Physician Decision|1|||
161295476|NCT02576847|582463371|FG000|Overall Study|Pregnancy|1|||
161295477|NCT02576847|582463371|FG000|Overall Study|Protocol Violation|3|||
161295478|NCT02576847|582463371|FG000|Overall Study|Withdrawal by Subject|78|||
161295479|NCT02576847|582463371|FG000|Overall Study|Other|5|||
161295480|NCT01806051|582463372|FG000|Overall Study|Withdrawal by Subject|6|||
161295481|NCT01205776|582463375|FG000|Overall Study|Lost to Follow-up|53|||
161295482|NCT01205776|582463376|FG001|Overall Study|Lost to Follow-up|61|||
161295483|NCT01205776|582463375|FG000|Overall Study|Withdrawal by Subject|11|||
161295484|NCT01205776|582463376|FG001|Overall Study|Withdrawal by Subject|34|||
161295485|NCT02418182|582463377|FG000|Overall Study|Unable to re-consent|18|||
161295486|NCT02418182|582463378|FG001|Overall Study|Unable to re-consent|15|||
161295487|NCT02418182|582463377|FG000|Overall Study|Lost to Follow-up|0|||
161295488|NCT02418182|582463378|FG001|Overall Study|Lost to Follow-up|2|||
161295489|NCT00734994|582463381|FG000|Overall Study|Withdrawal by Subject|1|||
161295490|NCT02747108|582463385|FG000|Overall Study|Death|2|||
161295491|NCT02747108|582463386|FG001|Overall Study|Death|2|||
161295492|NCT02747108|582463385|FG000|Overall Study|Withdrawal by Subject|1|||
161295493|NCT02747108|582463386|FG001|Overall Study|Withdrawal by Subject|0|||
161295494|NCT02747108|582463385|FG000|Overall Study|Protocol Violation|2|||
161295495|NCT02747108|582463386|FG001|Overall Study|Protocol Violation|0|||
161295496|NCT03103152|582463387|FG000|Overall Study|Physician Decision|5|||
161295497|NCT03103152|582463388|FG001|Overall Study|Physician Decision|2|||
161295498|NCT03103152|582463389|FG002|Overall Study|Physician Decision|6|||
161295499|NCT03103152|582463390|FG003|Overall Study|Physician Decision|3|||
161295500|NCT03103152|582463391|FG004|Overall Study|Physician Decision|3|||
161295501|NCT03103152|582463392|FG005|Overall Study|Physician Decision|1|||
161295502|NCT03103152|582463387|FG000|Overall Study|Protocol Violation|2|||
161295503|NCT03103152|582463388|FG001|Overall Study|Protocol Violation|2|||
161295504|NCT03103152|582463389|FG002|Overall Study|Protocol Violation|1|||
161295505|NCT03103152|582463390|FG003|Overall Study|Protocol Violation|2|||
161295506|NCT03103152|582463391|FG004|Overall Study|Protocol Violation|1|||
161295507|NCT03103152|582463392|FG005|Overall Study|Protocol Violation|1|||
161295508|NCT03103152|582463387|FG000|Overall Study|Inter-current illness|0|||
161295509|NCT03103152|582463388|FG001|Overall Study|Inter-current illness|0|||
161295510|NCT03103152|582463389|FG002|Overall Study|Inter-current illness|1|||
161295511|NCT03103152|582463390|FG003|Overall Study|Inter-current illness|0|||
161295512|NCT03103152|582463391|FG004|Overall Study|Inter-current illness|0|||
161295513|NCT03103152|582463392|FG005|Overall Study|Inter-current illness|0|||
161295514|NCT03103152|582463387|FG000|Overall Study|Death|0|||
161295515|NCT03103152|582463388|FG001|Overall Study|Death|1|||
161295516|NCT03103152|582463389|FG002|Overall Study|Death|0|||
161295517|NCT03103152|582463390|FG003|Overall Study|Death|0|||
161295518|NCT03103152|582463391|FG004|Overall Study|Death|0|||
161295519|NCT03103152|582463392|FG005|Overall Study|Death|0|||
161295520|NCT03103152|582463387|FG000|Overall Study|Adverse Event|0|||
161295521|NCT03103152|582463388|FG001|Overall Study|Adverse Event|0|||
161295522|NCT03103152|582463389|FG002|Overall Study|Adverse Event|1|||
161295523|NCT03103152|582463390|FG003|Overall Study|Adverse Event|0|||
161295524|NCT03103152|582463391|FG004|Overall Study|Adverse Event|0|||
161295525|NCT03103152|582463392|FG005|Overall Study|Adverse Event|1|||
161295526|NCT03103152|582463387|FG000|Overall Study|Withdrawal by Subject|1|||
161295527|NCT03103152|582463388|FG001|Overall Study|Withdrawal by Subject|0|||
161295528|NCT03103152|582463389|FG002|Overall Study|Withdrawal by Subject|1|||
161295529|NCT03103152|582463390|FG003|Overall Study|Withdrawal by Subject|1|||
161295530|NCT03103152|582463391|FG004|Overall Study|Withdrawal by Subject|1|||
161295531|NCT03103152|582463392|FG005|Overall Study|Withdrawal by Subject|1|||
161295532|NCT03103152|582463387|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
161295533|NCT03103152|582463388|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
161295534|NCT03103152|582463389|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
161295535|NCT03103152|582463390|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
161295536|NCT03103152|582463391|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
161295537|NCT03103152|582463392|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
161295538|NCT03103152|582463387|FG000|Overall Study|Unacceptable side effects|0|||
161295539|NCT03103152|582463388|FG001|Overall Study|Unacceptable side effects|0|||
161295540|NCT03103152|582463389|FG002|Overall Study|Unacceptable side effects|0|||
161295541|NCT03103152|582463390|FG003|Overall Study|Unacceptable side effects|0|||
161295542|NCT03103152|582463391|FG004|Overall Study|Unacceptable side effects|0|||
161295543|NCT03103152|582463392|FG005|Overall Study|Unacceptable side effects|1|||
161295544|NCT03103152|582463387|FG000|Overall Study|Lost to Follow-up|0|||
161295545|NCT03103152|582463388|FG001|Overall Study|Lost to Follow-up|1|||
161295546|NCT03103152|582463389|FG002|Overall Study|Lost to Follow-up|0|||
161295547|NCT03103152|582463390|FG003|Overall Study|Lost to Follow-up|1|||
161295548|NCT03103152|582463391|FG004|Overall Study|Lost to Follow-up|0|||
161295549|NCT03103152|582463392|FG005|Overall Study|Lost to Follow-up|1|||
161295550|NCT03103152|582463387|FG000|Overall Study|Testicular pain|0|||
161295551|NCT03103152|582463388|FG001|Overall Study|Testicular pain|0|||
161295552|NCT03103152|582463389|FG002|Overall Study|Testicular pain|0|||
161295553|NCT03103152|582463390|FG003|Overall Study|Testicular pain|1|||
161295554|NCT03103152|582463391|FG004|Overall Study|Testicular pain|0|||
161295555|NCT03103152|582463392|FG005|Overall Study|Testicular pain|0|||
161295556|NCT05966584|582463393|FG000|Overall Study|Lost to Follow-up|1|||
161295557|NCT06360588|582465352|FG000|Overall Study|Adverse Event|3|||
161295558|NCT06360588|582465352|FG000|Overall Study|Death|2|||
161295559|NCT06360588|582465352|FG000|Overall Study|Disease Progression|14|||
161295560|NCT06360588|582465352|FG000|Overall Study|Withdrawal by Subject|1|||
161295561|NCT06360588|582465352|FG000|Overall Study|Lack of Efficacy|1|||
161295562|NCT06360588|582465352|FG000|Overall Study|Ineligible|1|||
161295563|NCT04010240|582465353|FG000|Overall Study|IHC not performed|2299|||
161295564|NCT01481766|582465354|FG000|4 months|Lost to Follow-up|3|||
161295565|NCT01481766|582465355|FG001|4 months|Lost to Follow-up|2|||
161295566|NCT01481766|582465356|FG002|4 months|Lost to Follow-up|1|||
161295567|NCT01481766|582465357|FG003|4 months|Lost to Follow-up|5|||
161295568|NCT01481766|582465354|FG000|12 months|Lost to Follow-up|7|||
161295569|NCT01481766|582465355|FG001|12 months|Lost to Follow-up|8|||
161295570|NCT01481766|582465356|FG002|12 months|Lost to Follow-up|5|||
161295571|NCT01481766|582465357|FG003|12 months|Lost to Follow-up|3|||
161295572|NCT00347958|582465358|FG000|Overall Study|Adverse Event|1|||
161295573|NCT00347958|582465358|FG000|Overall Study|Protocol Violation|2|||
161295574|NCT00347958|582465358|FG000|Overall Study|Withdrawal by Subject|1|||
161295575|NCT00754234|582465359|FG000|Overall Study|Withdrawal by Subject|3|||
161295576|NCT00570687|582465360|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295577|NCT00570687|582465361|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295578|NCT00570687|582465362|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295579|NCT00570687|582465363|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295580|NCT00570687|582465364|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161295581|NCT00570687|582465365|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161295582|NCT00570687|582465366|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
161295583|NCT00570687|582465367|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161295584|NCT00570687|582465368|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
161295585|NCT00570687|582465369|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
161295586|NCT00570687|582465360|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295587|NCT00570687|582465361|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295588|NCT00570687|582465362|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295589|NCT00570687|582465363|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295590|NCT00570687|582465364|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295591|NCT00570687|582465365|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295592|NCT00570687|582465366|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295593|NCT00570687|582465367|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295594|NCT00570687|582465368|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
161295595|NCT00570687|582465369|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295596|NCT00570687|582465360|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295597|NCT00570687|582465361|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295598|NCT00570687|582465362|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295599|NCT00570687|582465363|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295600|NCT00570687|582465364|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295601|NCT00570687|582465365|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295602|NCT00570687|582465366|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
161295603|NCT00570687|582465367|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295604|NCT00570687|582465368|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295605|NCT00570687|582465369|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
161295606|NCT03263936|582465370|FG000|Overall Study|Adverse Event|0|||
161295607|NCT03263936|582465371|FG001|Overall Study|Adverse Event|1|||
161295608|NCT03263936|582465372|FG002|Overall Study|Adverse Event|0|||
161295609|NCT03263936|582465370|FG000|Overall Study|Death|0|||
161295610|NCT03263936|582465371|FG001|Overall Study|Death|1|||
161295611|NCT03263936|582465372|FG002|Overall Study|Death|0|||
161295612|NCT01540487|582465373|FG000|Overall Study|Protocol Violation|1|||
161295613|NCT01540487|582465374|FG001|Overall Study|Protocol Violation|0|||
161295614|NCT03503370|582465375|FG000|Overall Study|Death|3|||
161295615|NCT03503370|582465376|FG001|Overall Study|Death|1|||
161295616|NCT03483961|582465377|FG000|Overall Study|Lost to Follow-up|7|||
161295617|NCT03483961|582465378|FG001|Overall Study|Lost to Follow-up|6|||
161295618|NCT03483961|582465379|FG002|Overall Study|Lost to Follow-up|6|||
161295619|NCT03483961|582465380|FG003|Overall Study|Lost to Follow-up|6|||
161295620|NCT03483961|582465381|FG004|Overall Study|Lost to Follow-up|6|||
161295621|NCT03483961|582465382|FG005|Overall Study|Lost to Follow-up|4|||
161175133|NCT01142193|582017788|FG000|Overall Study|Physician Decision|1|||
161175134|NCT01142193|582017789|FG001|Overall Study|Physician Decision|1|||
161295622|NCT03483961|582465383|FG006|Overall Study|Lost to Follow-up|4|||
161295623|NCT03483961|582465384|FG007|Overall Study|Lost to Follow-up|11|||
161295624|NCT03483961|582465385|FG008|Overall Study|Lost to Follow-up|1|||
161295625|NCT03483961|582465386|FG009|Overall Study|Lost to Follow-up|0|||
161295626|NCT03483961|582465377|FG000|Overall Study|Withdrawal by Subject|3|||
161295627|NCT03483961|582465378|FG001|Overall Study|Withdrawal by Subject|4|||
161295628|NCT03483961|582465379|FG002|Overall Study|Withdrawal by Subject|5|||
161295629|NCT03483961|582465380|FG003|Overall Study|Withdrawal by Subject|3|||
161295630|NCT03483961|582465381|FG004|Overall Study|Withdrawal by Subject|4|||
161295631|NCT03483961|582465382|FG005|Overall Study|Withdrawal by Subject|2|||
161295632|NCT03483961|582465383|FG006|Overall Study|Withdrawal by Subject|1|||
161295633|NCT03483961|582465384|FG007|Overall Study|Withdrawal by Subject|2|||
161295634|NCT03483961|582465385|FG008|Overall Study|Withdrawal by Subject|1|||
161295635|NCT03483961|582465386|FG009|Overall Study|Withdrawal by Subject|0|||
161295636|NCT03483961|582465377|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
161295637|NCT03483961|582465378|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295638|NCT03483961|582465379|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295639|NCT03483961|582465380|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295640|NCT03483961|582465381|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295641|NCT03483961|582465382|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295642|NCT03483961|582465383|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295643|NCT03483961|582465384|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295644|NCT03483961|582465385|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295645|NCT03483961|582465386|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
161295646|NCT03483961|582465377|FG000|Overall Study|Adverse Event|0|||
161295647|NCT03483961|582465378|FG001|Overall Study|Adverse Event|0|||
161295648|NCT03483961|582465379|FG002|Overall Study|Adverse Event|1|||
161295649|NCT03483961|582465380|FG003|Overall Study|Adverse Event|0|||
161295650|NCT03483961|582465381|FG004|Overall Study|Adverse Event|0|||
161295651|NCT03483961|582465382|FG005|Overall Study|Adverse Event|0|||
161295652|NCT03483961|582465383|FG006|Overall Study|Adverse Event|0|||
161295653|NCT03483961|582465384|FG007|Overall Study|Adverse Event|0|||
161295654|NCT03483961|582465385|FG008|Overall Study|Adverse Event|0|||
161295655|NCT03483961|582465386|FG009|Overall Study|Adverse Event|0|||
161295656|NCT00298272|582465388|FG000|Double-blind Phase|Adverse Event|2|||
161295657|NCT00298272|582465389|FG001|Double-blind Phase|Adverse Event|0|||
161295658|NCT00298272|582465388|FG000|Double-blind Phase|Failure to Return|2|||
161295659|NCT00298272|582465389|FG001|Double-blind Phase|Failure to Return|0|||
161295660|NCT00298272|582465388|FG000|Double-blind Phase|Protocol Violation|2|||
161295661|NCT00298272|582465389|FG001|Double-blind Phase|Protocol Violation|0|||
161295662|NCT00298272|582465388|FG000|Double-blind Phase|Withdrawal by Subject|2|||
161295663|NCT00298272|582465389|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161347640|NCT00662259|582657329|FG000|Overall Study|Adverse Event|2|||
161175135|NCT01142193|582017788|FG000|Overall Study|Withdrawal by Subject|4|||
161175136|NCT01142193|582017789|FG001|Overall Study|Withdrawal by Subject|3|||
161175137|NCT01142193|582017788|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
161175138|NCT01142193|582017789|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
161175139|NCT01142193|582017788|FG000|Overall Study|Other|1|||
161175140|NCT01142193|582017789|FG001|Overall Study|Other|2|||
161175141|NCT00994162|582017790|FG000|Overall Study|Withdrawal by Subject|1|||
161175142|NCT00994162|582017790|FG000|Overall Study|Lost to Follow-up|2|||
161175143|NCT00994162|582017790|FG000|Overall Study|Product Complaint|1|||
161175144|NCT00994162|582017790|FG000|Overall Study|Poor Compliance|5|||
161347641|NCT00662259|582657330|FG001|Overall Study|Adverse Event|0|||
161175145|NCT00994162|582017790|FG000|Overall Study|Lack of Response|3|||
161175146|NCT00994162|582017790|FG000|Overall Study|Discharged from Hospital|4|||
161175147|NCT00994162|582017790|FG000|Overall Study|Death|2|||
161175148|NCT00994162|582017790|FG000|Overall Study|Care Transferred to Another Physician|2|||
161295664|NCT00298272|582465388|FG000|Open Label Retreatment Phase|Adverse Event|1|||
161295665|NCT00298272|582465389|FG001|Open Label Retreatment Phase|Adverse Event|2|||
161295666|NCT00298272|582465388|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
161175149|NCT00994162|582017790|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
161295667|NCT00298272|582465389|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
161295668|NCT00298272|582465388|FG000|Open Label Retreatment Phase|Failure to Return|1|||
161295669|NCT00298272|582465389|FG001|Open Label Retreatment Phase|Failure to Return|0|||
161295670|NCT00298272|582465388|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
161295671|NCT00298272|582465389|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
161295672|NCT00298272|582465388|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
161295673|NCT00298272|582465389|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
161295674|NCT00298272|582465388|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
161295675|NCT00298272|582465389|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
161295676|NCT00298272|582465388|FG000|Safety Follow-up Phase|Failure to Return|1|||
161295677|NCT00298272|582465389|FG001|Safety Follow-up Phase|Failure to Return|1|||
161295678|NCT00298272|582465388|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
161295679|NCT00298272|582465389|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
161295680|NCT00298272|582465388|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
161295681|NCT00298272|582465389|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
161295682|NCT00326716|582465390|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
161295683|NCT00326716|582465391|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
161295684|NCT00326716|582465392|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
161295685|NCT00326716|582465393|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
161295686|NCT00684411|582465394|FG000|Overall Study|New Primary Cancer|1|||
161295687|NCT00684411|582465394|FG000|Overall Study|Disease Progression|10|||
161295688|NCT00684411|582465394|FG000|Overall Study|Adverse Event|1|||
161295689|NCT00734162|582465395|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
161295690|NCT00734162|582465396|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
161295691|NCT00734162|582465397|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
161295692|NCT00734162|582465398|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
161295693|NCT00734162|582465395|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161295694|NCT00734162|582465396|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161295695|NCT00734162|582465397|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
161295696|NCT00734162|582465398|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
161295697|NCT00734162|582465395|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
161295698|NCT00734162|582465396|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161295699|NCT00734162|582465397|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161295700|NCT00734162|582465398|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
161295701|NCT00734162|582465395|FG000|Open-Label Phase|Withdrew Consent|1|||
161295702|NCT00734162|582465396|FG001|Open-Label Phase|Withdrew Consent|0|||
161295703|NCT00734162|582465397|FG002|Open-Label Phase|Withdrew Consent|1|||
161295704|NCT00734162|582465398|FG003|Open-Label Phase|Withdrew Consent|1|||
161295705|NCT00734162|582465395|FG000|Open-Label Phase|Lost to Follow-up|1|||
161295706|NCT00734162|582465396|FG001|Open-Label Phase|Lost to Follow-up|2|||
161295707|NCT00734162|582465397|FG002|Open-Label Phase|Lost to Follow-up|0|||
161295708|NCT00734162|582465398|FG003|Open-Label Phase|Lost to Follow-up|1|||
161295709|NCT00734162|582465395|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161295710|NCT00734162|582465396|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161295711|NCT00734162|582465397|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
161295712|NCT00734162|582465398|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
161295713|NCT05253573|582465399|FG000|Overall Study|Death|1|||
161295714|NCT05253573|582465400|FG001|Overall Study|Death|0|||
161295715|NCT01344824|582465401|FG000|Overall Study|Adverse Event|15|||
161295716|NCT01344824|582465401|FG000|Overall Study|Withdrawal by Subject|6|||
161295717|NCT01344824|582465401|FG000|Overall Study|Other complicating disease|1|||
161295718|NCT01344824|582465401|FG000|Overall Study|Progression|15|||
161295719|NCT00566020|582465402|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
161295720|NCT00566020|582465403|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
161295721|NCT00566020|582465402|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
161295722|NCT00566020|582465403|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
161295723|NCT00566020|582465402|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
161295724|NCT00566020|582465403|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
161295725|NCT00566020|582465402|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
161295726|NCT00566020|582465403|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
161295727|NCT00566020|582465402|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
161295728|NCT00566020|582465403|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
161295729|NCT00566020|582465402|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
161295730|NCT00566020|582465403|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
161295731|NCT01754129|582465404|FG000|Overall Study|Death|13|||
161295732|NCT01754129|582465404|FG000|Overall Study|Duodopa discontinuation|9|||
161295733|NCT01754129|582465404|FG000|Overall Study|Lost to Follow-up|7|||
161088003|NCT02703259|581711049|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
161088004|NCT02703259|581711048|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
161295734|NCT01754129|582465404|FG000|Overall Study|Withdrew consent|1|||
161295735|NCT01754129|582465404|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
161295736|NCT01085630|582465405|FG000|Overall Study|Insufficient data|1|||
161295737|NCT01085630|582465406|FG001|Overall Study|Insufficient data|0|||
161295738|NCT01085630|582465405|FG000|Overall Study|Ineligible|3|||
161295739|NCT01085630|582465406|FG001|Overall Study|Ineligible|0|||
161295740|NCT02366637|582465412|FG000|First Intervention Period|Adverse Event|0|||
161295741|NCT02366637|582465413|FG001|First Intervention Period|Adverse Event|1|||
161295742|NCT02366637|582465412|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
161295743|NCT02366637|582465413|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
161295744|NCT02366637|582465412|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
161295745|NCT02366637|582465413|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
161295746|NCT02609607|582465419|FG000|Overall Study|Lost to Follow-up|0|||
161295747|NCT02609607|582465420|FG001|Overall Study|Lost to Follow-up|1|||
161295748|NCT03691207|582465421|FG000|Overall Study|Death|41|||
161295749|NCT03691207|582465422|FG001|Overall Study|Death|26|||
161295750|NCT03691207|582465421|FG000|Overall Study|Lost to Follow-up|1|||
161295751|NCT03691207|582465422|FG001|Overall Study|Lost to Follow-up|1|||
161295752|NCT03691207|582465421|FG000|Overall Study|Withdrawal by Subject|2|||
161295753|NCT03691207|582465422|FG001|Overall Study|Withdrawal by Subject|8|||
161295754|NCT03691207|582465421|FG000|Overall Study|Sponsor decision|1|||
161295755|NCT03691207|582465422|FG001|Overall Study|Sponsor decision|7|||
161295756|NCT00651261|582465423|FG000|Overall Study|Adverse Event|32|||
161295757|NCT00651261|582465424|FG001|Overall Study|Adverse Event|22|||
161295758|NCT00651261|582465423|FG000|Overall Study|Death|18|||
161295759|NCT00651261|582465424|FG001|Overall Study|Death|18|||
161295760|NCT00651261|582465423|FG000|Overall Study|Withdrawal by Subject|22|||
161295761|NCT00651261|582465424|FG001|Overall Study|Withdrawal by Subject|40|||
161295762|NCT00651261|582465423|FG000|Overall Study|Induction failure|24|||
161295763|NCT00651261|582465424|FG001|Overall Study|Induction failure|35|||
161295764|NCT00651261|582465423|FG000|Overall Study|Disease progression|58|||
161295765|NCT00651261|582465424|FG001|Overall Study|Disease progression|58|||
161295766|NCT00651261|582465423|FG000|Overall Study|Alternative therapy|109|||
161295767|NCT00651261|582465424|FG001|Overall Study|Alternative therapy|107|||
161295768|NCT00651261|582465423|FG000|Overall Study|Other disease or participant decisions|23|||
161295769|NCT00651261|582465424|FG001|Overall Study|Other disease or participant decisions|23|||
161295770|NCT00651261|582465423|FG000|Overall Study|Never treated|5|||
161295771|NCT00651261|582465424|FG001|Overall Study|Never treated|3|||
161295772|NCT02027545|582465425|FG000|Overall Study|Failed to sign HIPAA|0|||
161295773|NCT02027545|582465426|FG001|Overall Study|Failed to sign HIPAA|2|||
161295774|NCT02027545|582465425|FG000|Overall Study|Failed to attend study visit|2|||
161295775|NCT02027545|582465426|FG001|Overall Study|Failed to attend study visit|0|||
161295776|NCT02027545|582465425|FG000|Overall Study|Protocol Violation|1|||
161295777|NCT02027545|582465426|FG001|Overall Study|Protocol Violation|0|||
161295778|NCT01017874|582465432|FG000|Overall Study|Withdrawal by Subject|23|||
161295779|NCT01017874|582465433|FG001|Overall Study|Withdrawal by Subject|20|||
161295780|NCT01017874|582465432|FG000|Overall Study|Sponsor decision|3|||
161295781|NCT01017874|582465433|FG001|Overall Study|Sponsor decision|1|||
161295782|NCT01017874|582465432|FG000|Overall Study|Lost to Follow-up|3|||
161295783|NCT01017874|582465433|FG001|Overall Study|Lost to Follow-up|2|||
161295784|NCT01017874|582465432|FG000|Overall Study|Physician Decision|1|||
161295785|NCT01017874|582465433|FG001|Overall Study|Physician Decision|3|||
161295786|NCT00778817|582465438|FG000|Overall Study|Adverse Event|2|||
161295787|NCT00778817|582465438|FG000|Overall Study|Withdrawal by Subject|2|||
161295788|NCT02509507|582465439|FG000|Overall Study|Death|21|||
161295789|NCT02509507|582465440|FG001|Overall Study|Death|3|||
161295790|NCT02509507|582465441|FG002|Overall Study|Death|22|||
161295791|NCT02509507|582465442|FG003|Overall Study|Death|14|||
161295792|NCT02509507|582465443|FG004|Overall Study|Death|8|||
161295793|NCT02509507|582465444|FG005|Overall Study|Death|12|||
161295794|NCT02509507|582465445|FG006|Overall Study|Death|5|||
161295795|NCT02509507|582465446|FG007|Overall Study|Death|4|||
161295796|NCT02509507|582465447|FG008|Overall Study|Death|8|||
161295797|NCT02509507|582465439|FG000|Overall Study|Lost to Follow-up|0|||
161295798|NCT02509507|582465440|FG001|Overall Study|Lost to Follow-up|1|||
161295799|NCT02509507|582465441|FG002|Overall Study|Lost to Follow-up|0|||
161295800|NCT02509507|582465442|FG003|Overall Study|Lost to Follow-up|0|||
161295801|NCT02509507|582465443|FG004|Overall Study|Lost to Follow-up|0|||
161295802|NCT02509507|582465444|FG005|Overall Study|Lost to Follow-up|2|||
161088005|NCT02703259|581711049|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
161088006|NCT02703259|581711048|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
161088007|NCT02703259|581711049|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
161088008|NCT00528645|581711051|FG000|Overall Study|Adverse Event|3|||
161088009|NCT01642251|581711052|FG000|Overall Study|Progressive disease|0|||
161088010|NCT01642251|581711053|FG001|Overall Study|Progressive disease|0|||
161295803|NCT02509507|582465445|FG006|Overall Study|Lost to Follow-up|0|||
161295804|NCT02509507|582465446|FG007|Overall Study|Lost to Follow-up|0|||
161295805|NCT02509507|582465447|FG008|Overall Study|Lost to Follow-up|0|||
161295806|NCT02509507|582465439|FG000|Overall Study|Withdrawal by Subject|2|||
161295807|NCT02509507|582465440|FG001|Overall Study|Withdrawal by Subject|0|||
161295808|NCT02509507|582465441|FG002|Overall Study|Withdrawal by Subject|1|||
161295809|NCT02509507|582465442|FG003|Overall Study|Withdrawal by Subject|4|||
161295810|NCT02509507|582465443|FG004|Overall Study|Withdrawal by Subject|1|||
161295811|NCT02509507|582465444|FG005|Overall Study|Withdrawal by Subject|3|||
161295812|NCT02509507|582465445|FG006|Overall Study|Withdrawal by Subject|4|||
161295813|NCT02509507|582465446|FG007|Overall Study|Withdrawal by Subject|0|||
161295814|NCT02509507|582465447|FG008|Overall Study|Withdrawal by Subject|1|||
161295815|NCT01790984|582465448|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
161295816|NCT01790984|582465449|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
161295817|NCT01790984|582465450|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
161295818|NCT01790984|582465451|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
161295819|NCT01163851|582465459|FG000|Overall Study|Site Closure|0|||
161295820|NCT01163851|582465460|FG001|Overall Study|Site Closure|1|||
161295821|NCT01163851|582465459|FG000|Overall Study|Enrolled but not treated|1|||
161295822|NCT01163851|582465460|FG001|Overall Study|Enrolled but not treated|0|||
161295823|NCT00789373|582465464|FG000|Induction|Adverse Event|64|||
161295824|NCT00789373|582465465|FG001|Induction|Adverse Event|0|||
161295825|NCT00789373|582465466|FG002|Induction|Adverse Event|0|||
161295826|NCT00789373|582465464|FG000|Induction|Death Due to study disease|24|||
161295827|NCT00789373|582465465|FG001|Induction|Death Due to study disease|0|||
161295828|NCT00789373|582465466|FG002|Induction|Death Due to study disease|0|||
161295829|NCT00789373|582465464|FG000|Induction|Death due to adverse event|19|||
161295830|NCT00789373|582465465|FG001|Induction|Death due to adverse event|0|||
161295831|NCT00789373|582465466|FG002|Induction|Death due to adverse event|0|||
161295832|NCT00789373|582465464|FG000|Induction|Death due to toxicity|11|||
161295833|NCT00789373|582465465|FG001|Induction|Death due to toxicity|0|||
161295834|NCT00789373|582465466|FG002|Induction|Death due to toxicity|0|||
161295835|NCT00789373|582465464|FG000|Induction|Death due to procedure|1|||
161295836|NCT00789373|582465465|FG001|Induction|Death due to procedure|0|||
161295837|NCT00789373|582465466|FG002|Induction|Death due to procedure|0|||
161295838|NCT00789373|582465464|FG000|Induction|Investigator decision|7|||
161295839|NCT00789373|582465465|FG001|Induction|Investigator decision|0|||
161295840|NCT00789373|582465466|FG002|Induction|Investigator decision|0|||
161295841|NCT00789373|582465464|FG000|Induction|Protocol entry criteria not met|9|||
161295842|NCT00789373|582465465|FG001|Induction|Protocol entry criteria not met|0|||
161295843|NCT00789373|582465466|FG002|Induction|Protocol entry criteria not met|0|||
161295844|NCT00789373|582465464|FG000|Induction|Lost to Follow-up|6|||
161295845|NCT00789373|582465465|FG001|Induction|Lost to Follow-up|0|||
161295846|NCT00789373|582465466|FG002|Induction|Lost to Follow-up|0|||
161295847|NCT00789373|582465464|FG000|Induction|Protocol Violation|1|||
161295848|NCT00789373|582465465|FG001|Induction|Protocol Violation|0|||
161295849|NCT00789373|582465466|FG002|Induction|Protocol Violation|0|||
161295850|NCT00789373|582465464|FG000|Induction|Progressive Disease|220|||
161295851|NCT00789373|582465465|FG001|Induction|Progressive Disease|0|||
161295852|NCT00789373|582465466|FG002|Induction|Progressive Disease|0|||
161295853|NCT00789373|582465464|FG000|Induction|Withdrawal by Subject|37|||
161295854|NCT00789373|582465465|FG001|Induction|Withdrawal by Subject|0|||
161295855|NCT00789373|582465466|FG002|Induction|Withdrawal by Subject|0|||
161295856|NCT00789373|582465464|FG000|Maintenance|Adverse Event|0|||
161295857|NCT00789373|582465465|FG001|Maintenance|Adverse Event|65|||
161295858|NCT00789373|582465466|FG002|Maintenance|Adverse Event|12|||
161295859|NCT00789373|582465464|FG000|Maintenance|Death due to study disease|0|||
161295860|NCT00789373|582465465|FG001|Maintenance|Death due to study disease|3|||
161295861|NCT00789373|582465466|FG002|Maintenance|Death due to study disease|1|||
161295862|NCT00789373|582465464|FG000|Maintenance|Death due to adverse event|0|||
161295863|NCT00789373|582465465|FG001|Maintenance|Death due to adverse event|4|||
161295864|NCT00789373|582465466|FG002|Maintenance|Death due to adverse event|1|||
161295865|NCT00789373|582465464|FG000|Maintenance|Death due to toxicity|0|||
161295866|NCT00789373|582465465|FG001|Maintenance|Death due to toxicity|1|||
161295867|NCT00789373|582465466|FG002|Maintenance|Death due to toxicity|2|||
161295868|NCT00789373|582465464|FG000|Maintenance|Investigator Decision|0|||
161295869|NCT00789373|582465465|FG001|Maintenance|Investigator Decision|4|||
161295870|NCT00789373|582465466|FG002|Maintenance|Investigator Decision|2|||
161295871|NCT00789373|582465464|FG000|Maintenance|Protocol entry criteria not met|0|||
161295872|NCT00789373|582465465|FG001|Maintenance|Protocol entry criteria not met|2|||
161295873|NCT00789373|582465466|FG002|Maintenance|Protocol entry criteria not met|0|||
161295874|NCT00789373|582465464|FG000|Maintenance|Lost to Follow-up|0|||
161295875|NCT00789373|582465465|FG001|Maintenance|Lost to Follow-up|2|||
161295876|NCT00789373|582465466|FG002|Maintenance|Lost to Follow-up|0|||
161295877|NCT00789373|582465464|FG000|Maintenance|Progressive Disease|0|||
161295878|NCT00789373|582465465|FG001|Maintenance|Progressive Disease|253|||
161295879|NCT00789373|582465466|FG002|Maintenance|Progressive Disease|152|||
161088011|NCT01642251|581711054|FG002|Overall Study|Progressive disease|3|||
161295880|NCT00789373|582465464|FG000|Maintenance|Withdrawal by Subject|0|||
161295881|NCT00789373|582465465|FG001|Maintenance|Withdrawal by Subject|21|||
161295882|NCT00789373|582465466|FG002|Maintenance|Withdrawal by Subject|8|||
161295883|NCT00789373|582465464|FG000|Maintenance|Sponsor Decision|0|||
161295884|NCT00789373|582465465|FG001|Maintenance|Sponsor Decision|0|||
161295885|NCT00789373|582465466|FG002|Maintenance|Sponsor Decision|2|||
161295886|NCT00789373|582465464|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
161295887|NCT00789373|582465465|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
161295888|NCT00789373|582465466|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
161295889|NCT01684423|582465474|FG000|Overall Study|Withdrawal by Subject|0|||
161295890|NCT01684423|582465475|FG001|Overall Study|Withdrawal by Subject|0|||
161295891|NCT01684423|582465476|FG002|Overall Study|Withdrawal by Subject|1|||
161295892|NCT01684423|582465477|FG003|Overall Study|Withdrawal by Subject|0|||
161295893|NCT01684423|582465478|FG004|Overall Study|Withdrawal by Subject|0|||
161295894|NCT02155283|582465482|FG000|Overall Study|Lost to Follow-up|3|||
161295895|NCT02155283|582465482|FG000|Overall Study|Withdrawal by Subject|1|||
161295896|NCT02155283|582465482|FG000|Overall Study|Protocol Violation|3|||
161295897|NCT01741688|582465485|FG000|Overall Study|Lack of insurance coverage|2|||
161295898|NCT01741688|582465485|FG000|Overall Study|Withdrawal by Subject|1|||
161295899|NCT03850496|582465490|FG000|Overall Study|Withdrawal by Subject|1|||
161295900|NCT03850496|582465491|FG001|Overall Study|Withdrawal by Subject|0|||
161295901|NCT03850496|582465492|FG002|Overall Study|Withdrawal by Subject|0|||
161295902|NCT03850496|582465490|FG000|Overall Study|Lost to Follow-up|0|||
161295903|NCT03850496|582465491|FG001|Overall Study|Lost to Follow-up|1|||
161295904|NCT03850496|582465492|FG002|Overall Study|Lost to Follow-up|4|||
161295905|NCT05000164|582465493|FG000|Overall Study|Adverse Event|1|||
161295906|NCT05000164|582465493|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161347642|NCT00972738|582657331|FG000|Overall Study|Adverse Event|7|||
161175150|NCT00994162|582017790|FG000|Overall Study|Physician Decision|2|||
161175151|NCT00994162|582017790|FG000|Overall Study|Surrounding Wound Erythematous|1|||
161175152|NCT00994162|582017790|FG000|Overall Study|Machine Losing Vaccum|1|||
161175153|NCT00994162|582017790|FG000|Overall Study|Patient Lived Too Far Away|1|||
161175154|NCT00994162|582017790|FG000|Overall Study|Above Knee Amputation|1|||
161175155|NCT00994162|582017790|FG000|Overall Study|Reason Not Reported By Site|1|||
161175156|NCT01225172|582017794|FG000|Overall Study|Subject decision to stop|1|||
161175157|NCT01225172|582017795|FG001|Overall Study|Subject decision to stop|0|||
161175158|NCT01225172|582017794|FG000|Overall Study|Subject request to discontinue treatment|3|||
161175159|NCT01225172|582017795|FG001|Overall Study|Subject request to discontinue treatment|1|||
161175160|NCT01225172|582017794|FG000|Overall Study|Subject no longer meets study criteria|1|||
161175161|NCT01225172|582017795|FG001|Overall Study|Subject no longer meets study criteria|0|||
161175162|NCT01225172|582017794|FG000|Overall Study|Withdrawal by Subject|1|||
161175163|NCT01225172|582017795|FG001|Overall Study|Withdrawal by Subject|0|||
161175164|NCT03136367|582017810|FG000|T1 Consultation|discontinued mistakenly included|2|||
161175165|NCT03136367|582017811|FG001|T1 Consultation|discontinued mistakenly included|6|||
161175166|NCT03136367|582017812|FG002|T1 Consultation|discontinued mistakenly included|1|||
161175167|NCT03136367|582017810|FG000|T1 Consultation|Discontinued other|0|||
161175168|NCT03136367|582017811|FG001|T1 Consultation|Discontinued other|1|||
161175169|NCT03136367|582017812|FG002|T1 Consultation|Discontinued other|0|||
161175170|NCT03136367|582017810|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
161175171|NCT03136367|582017811|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
161175172|NCT03136367|582017812|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
161175173|NCT03136367|582017810|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
161175174|NCT03136367|582017811|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
161175175|NCT03136367|582017812|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
161175176|NCT03136367|582017810|FG000|T2 Post-consultation|Discontinued other|0|||
161175177|NCT03136367|582017811|FG001|T2 Post-consultation|Discontinued other|2|||
161175178|NCT03136367|582017812|FG002|T2 Post-consultation|Discontinued other|6|||
161175179|NCT03136367|582017810|FG000|T2 Post-consultation|Discontinued transferred care|0|||
161175180|NCT03136367|582017811|FG001|T2 Post-consultation|Discontinued transferred care|0|||
161175181|NCT03136367|582017812|FG002|T2 Post-consultation|Discontinued transferred care|3|||
161175182|NCT03136367|582017810|FG000|T2 Post-consultation|Discontinued lost contact|0|||
161175183|NCT03136367|582017811|FG001|T2 Post-consultation|Discontinued lost contact|1|||
161175184|NCT03136367|582017812|FG002|T2 Post-consultation|Discontinued lost contact|0|||
161175185|NCT03136367|582017810|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
161175186|NCT03136367|582017811|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
161175187|NCT03136367|582017812|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
161295907|NCT05000164|582465493|FG000|Overall Study|Lens Discomfort|3|||
161175188|NCT03136367|582017810|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
161175189|NCT03136367|582017811|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
161175190|NCT03136367|582017812|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
161175191|NCT03136367|582017810|FG000|T3 1 Week After Surgery|other discontinued|2|||
161295908|NCT05000164|582465493|FG000|Overall Study|Withdrew Consent during Study|2|||
161295909|NCT05000164|582465493|FG000|Overall Study|Subject Withdrawn by PI|2|||
161295910|NCT05000164|582465493|FG000|Overall Study|Other Fractured Test Article|1|||
161295911|NCT03020992|582465494|FG000|Overall Study|Adverse Event|5|||
161295912|NCT03020992|582465494|FG000|Overall Study|Withdrawal by Subject|1|||
161295913|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
161295914|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
161295915|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
161295916|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
161295917|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Pregnancy|0|||
161295918|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Pregnancy|1|||
161295919|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
161295920|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
161295921|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
161295922|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
161295923|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
161295924|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
161295925|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Other|3|||
161295926|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Other|0|||
161295927|NCT01006122|582465495|FG000|First Double-blind Intervention Period|Adverse Event|0|||
161295928|NCT01006122|582465496|FG001|First Double-blind Intervention Period|Adverse Event|4|||
161295929|NCT01006122|582465495|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
161295930|NCT01006122|582465496|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
161295931|NCT01006122|582465495|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
161295932|NCT01006122|582465496|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
161295933|NCT01006122|582465495|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
161295934|NCT01006122|582465496|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
161295935|NCT01006122|582465495|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
161295936|NCT01006122|582465496|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
161295937|NCT01006122|582465495|FG000|Second Double-blind Intervention Period|Death|0|||
161295938|NCT01006122|582465496|FG001|Second Double-blind Intervention Period|Death|1|||
161295939|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
161295940|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
161295941|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
161295942|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
161295943|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
161295944|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
161295945|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
161295946|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
161295947|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
161295948|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
161295949|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
161295950|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
161295951|NCT03493854|582465497|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
161295952|NCT03493854|582465498|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
161295953|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
161295954|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
161295955|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
161295956|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
161295957|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
161295958|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
161295959|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
161295960|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
161295961|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
161295962|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
161295963|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
161295964|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
161295965|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
161295966|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
161295967|NCT03493854|582465497|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
161295968|NCT03493854|582465498|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
161295969|NCT03493854|582465497|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
161295970|NCT03493854|582465498|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
161295971|NCT03493854|582465497|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
161295972|NCT03493854|582465498|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
161295973|NCT03493854|582465497|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
161295974|NCT03493854|582465498|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
161347643|NCT00972738|582657332|FG001|Overall Study|Adverse Event|1|||
161347644|NCT00972738|582657333|FG002|Overall Study|Adverse Event|8|||
161347645|NCT00972738|582657331|FG000|Overall Study|Protocol Violation|2|||
161088012|NCT01642251|581711055|FG003|Overall Study|Progressive disease|3|||
161295975|NCT00410813|582465501|FG000|Overall Study|Adverse Event|6|||
161295976|NCT00410813|582465502|FG001|Overall Study|Adverse Event|11|||
161295977|NCT00410813|582465501|FG000|Overall Study|Progression|32|||
161295978|NCT00410813|582465502|FG001|Overall Study|Progression|21|||
161295979|NCT00410813|582465501|FG000|Overall Study|Not protocol specified|3|||
161295980|NCT00410813|582465502|FG001|Overall Study|Not protocol specified|4|||
161295981|NCT00410813|582465501|FG000|Overall Study|Ineligible|2|||
161295982|NCT00410813|582465502|FG001|Overall Study|Ineligible|4|||
161295983|NCT00410813|582465501|FG000|Overall Study|Death|0|||
161295984|NCT00410813|582465502|FG001|Overall Study|Death|2|||
161295985|NCT02268916|582465514|FG000|Overall Study|Lost to Follow-up|1|||
161295986|NCT02268916|582465515|FG001|Overall Study|Lost to Follow-up|1|||
161295987|NCT02268916|582465514|FG000|Overall Study|Withdrawal by Subject|6|||
161295988|NCT02268916|582465515|FG001|Overall Study|Withdrawal by Subject|5|||
161295989|NCT02268916|582465514|FG000|Overall Study|Participant did not have diabetes|1|||
161295990|NCT02268916|582465515|FG001|Overall Study|Participant did not have diabetes|0|||
161295991|NCT02268916|582465514|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
161295992|NCT02268916|582465515|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
161295993|NCT00594165|582465518|FG000|Overall Study|Major protocol violation|1|||
161295994|NCT00594165|582465518|FG000|Overall Study|Lack of Efficacy|12|||
161295995|NCT00594165|582465518|FG000|Overall Study|Adverse Event|52|||
161295996|NCT00594165|582465518|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
161295997|NCT00594165|582465518|FG000|Overall Study|Subject withdrew consent|27|||
161295998|NCT00594165|582465518|FG000|Overall Study|Study ended per sponsor|102|||
161295999|NCT00594165|582465518|FG000|Overall Study|Lost to Follow-up|4|||
161296000|NCT00594165|582465518|FG000|Overall Study|Other: PI discretion|5|||
161296001|NCT00594165|582465518|FG000|Overall Study|Other: Subject moving|3|||
161296002|NCT00594165|582465518|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
161296003|NCT00594165|582465518|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
161296004|NCT00594165|582465518|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
161296005|NCT00594165|582465518|FG000|Overall Study|Other: Site terminated participation|2|||
161296006|NCT04830969|582465519|FG000|Overall Study|Withdrawal by Subject|6|||
161296007|NCT04830969|582465520|FG001|Overall Study|Withdrawal by Subject|2|||
161296008|NCT04830969|582465519|FG000|Overall Study|Protocol Violation|3|||
161296009|NCT04830969|582465520|FG001|Overall Study|Protocol Violation|9|||
161296010|NCT04830969|582465519|FG000|Overall Study|Lost to Follow-up|4|||
161296011|NCT04830969|582465520|FG001|Overall Study|Lost to Follow-up|4|||
161296012|NCT00996125|582465521|FG000|Overall Study|Adverse Event|0|||
161296013|NCT00996125|582465522|FG001|Overall Study|Adverse Event|2|||
161296014|NCT00996125|582465521|FG000|Overall Study|Lost to Follow-up|1|||
161296015|NCT00996125|582465522|FG001|Overall Study|Lost to Follow-up|6|||
161296016|NCT00996125|582465521|FG000|Overall Study|Withdrawal by Subject|4|||
161296017|NCT00996125|582465522|FG001|Overall Study|Withdrawal by Subject|3|||
161296018|NCT05236764|582465523|FG000|Overall Study|In follow up (ongoing)|1|||
161296019|NCT05236764|582465523|FG000|Overall Study|Taken off study - secondary graft failure|1|||
161296020|NCT05236764|582465523|FG000|Overall Study|Death|1|||
161296021|NCT02062450|582465531|FG000|Overall Study|No follow-up visit|124|||
161296022|NCT03100903|582467064|FG000|Overall Study|Withdrawal by Subject|0|||
161296023|NCT03100903|582467065|FG001|Overall Study|Withdrawal by Subject|0|||
161296024|NCT03100903|582467066|FG002|Overall Study|Withdrawal by Subject|1|||
161296025|NCT04659993|582467067|FG000|Overall Study|Withdrawal by Subject|2|||
161296026|NCT04659993|582467067|FG000|Overall Study|Lost to Follow-up|2|||
161296027|NCT03868930|582467071|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
161296028|NCT03868930|582467072|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
161296029|NCT03868930|582467071|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
161296030|NCT03868930|582467072|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
161296031|NCT03868930|582467071|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
161296032|NCT03868930|582467072|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
161296033|NCT03868930|582467071|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
161296034|NCT03868930|582467072|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
161296035|NCT03868930|582467071|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
161296036|NCT03868930|582467072|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
161296037|NCT02151851|582467075|FG000|Overall Study|Lack of Efficacy|67|||
161296038|NCT02151851|582467076|FG001|Overall Study|Lack of Efficacy|94|||
161296039|NCT02151851|582467075|FG000|Overall Study|Protocol Violation|0|||
161296040|NCT02151851|582467076|FG001|Overall Study|Protocol Violation|1|||
161296041|NCT02151851|582467075|FG000|Overall Study|Withdrawal by Subject|2|||
161296042|NCT02151851|582467076|FG001|Overall Study|Withdrawal by Subject|5|||
161296043|NCT02151851|582467075|FG000|Overall Study|Medical impairment|1|||
161296044|NCT02151851|582467076|FG001|Overall Study|Medical impairment|0|||
161296045|NCT02151851|582467075|FG000|Overall Study|Low compliance to study visits|0|||
161296046|NCT02151851|582467076|FG001|Overall Study|Low compliance to study visits|1|||
161296047|NCT02151851|582467075|FG000|Overall Study|Subject entered into study in error|0|||
161296048|NCT02151851|582467076|FG001|Overall Study|Subject entered into study in error|1|||
161175192|NCT03136367|582017811|FG001|T3 1 Week After Surgery|other discontinued|4|||
161175193|NCT03136367|582017812|FG002|T3 1 Week After Surgery|other discontinued|3|||
161175194|NCT03136367|582017810|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
161175195|NCT03136367|582017811|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
161175196|NCT03136367|582017812|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
161175197|NCT03136367|582017810|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
161175198|NCT03136367|582017811|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
161175199|NCT03136367|582017812|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
161175200|NCT03136367|582017810|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
161175201|NCT03136367|582017811|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
161175202|NCT03136367|582017812|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
161175203|NCT03136367|582017810|FG000|T4 12 Weeks After Surgery|Death|0|||
161175204|NCT03136367|582017811|FG001|T4 12 Weeks After Surgery|Death|1|||
161175205|NCT03136367|582017812|FG002|T4 12 Weeks After Surgery|Death|3|||
161175206|NCT03136367|582017810|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
161175207|NCT03136367|582017811|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
161175208|NCT03136367|582017812|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
161175209|NCT03136367|582017810|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
161175210|NCT03136367|582017811|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
161175211|NCT03136367|582017812|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
161175212|NCT03136367|582017810|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
161175213|NCT03136367|582017811|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
161175214|NCT03136367|582017812|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
161175215|NCT03136367|582017810|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161175216|NCT03136367|582017811|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161175217|NCT03136367|582017812|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
161175218|NCT03136367|582017810|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
161175219|NCT03136367|582017811|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
161175220|NCT03136367|582017812|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
161175221|NCT03136367|582017810|FG000|T5 1 Year After Surgery|Death|0|||
161175222|NCT03136367|582017811|FG001|T5 1 Year After Surgery|Death|0|||
161175223|NCT03136367|582017812|FG002|T5 1 Year After Surgery|Death|1|||
161175224|NCT03136367|582017810|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
161175225|NCT03136367|582017811|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
161175226|NCT03136367|582017812|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
161175227|NCT03136367|582017810|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
161175228|NCT03136367|582017811|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
161175229|NCT03136367|582017812|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
161175230|NCT03136367|582017810|FG000|T5 1 Year After Surgery|study ended before due|31|||
161175231|NCT03136367|582017811|FG001|T5 1 Year After Surgery|study ended before due|103|||
161175232|NCT03136367|582017812|FG002|T5 1 Year After Surgery|study ended before due|110|||
161175233|NCT03136367|582017810|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
161175234|NCT03136367|582017811|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
161175235|NCT03136367|582017812|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
161175236|NCT03175562|582017816|FG000|Overall Study|Adverse Event|1|||
161175237|NCT03175562|582017816|FG000|Overall Study|Lost to Follow-up|3|||
161175238|NCT03175562|582017816|FG000|Overall Study|Withdrawal by Subject|7|||
161175239|NCT03175562|582017816|FG000|Overall Study|Other (Not Specified)|5|||
161175240|NCT02146833|582017817|FG000|Overall Study|Death|10|||
161175241|NCT02146833|582017817|FG000|Overall Study|No longer consented to study treatment|1|||
161175242|NCT01946412|582017818|FG000|Overall Study|Adverse Event|1|||
161175243|NCT01946412|582017818|FG000|Overall Study|Non-Compliance|1|||
161175244|NCT01946412|582017818|FG000|Overall Study|Continued with commercial Kalydeco|2|||
161175245|NCT01946412|582017818|FG000|Overall Study|Difficulty in swallowing|1|||
161175246|NCT01594749|582019558|FG000|Overall Study|Adverse Event|2|||
161175247|NCT01594749|582019559|FG001|Overall Study|Adverse Event|1|||
161175248|NCT01594749|582019558|FG000|Overall Study|Withdrawal by Subject|2|||
161175249|NCT01594749|582019559|FG001|Overall Study|Withdrawal by Subject|2|||
161296049|NCT02151851|582467075|FG000|Overall Study|Adverse Event|6|||
161296050|NCT02151851|582467076|FG001|Overall Study|Adverse Event|28|||
161296051|NCT02159053|582467077|FG000|Overall Study|Death|2|||
161296052|NCT02159053|582467078|FG001|Overall Study|Death|0|||
161175250|NCT01594749|582019558|FG000|Overall Study|Protocol Violation|2|||
161175251|NCT01594749|582019559|FG001|Overall Study|Protocol Violation|0|||
161175252|NCT01594749|582019558|FG000|Overall Study|Physician Decision|1|||
161175253|NCT01594749|582019559|FG001|Overall Study|Physician Decision|1|||
161175254|NCT01594749|582019558|FG000|Overall Study|Non-compliance with Protocol|0|||
161175255|NCT01594749|582019559|FG001|Overall Study|Non-compliance with Protocol|1|||
161296053|NCT02159053|582467079|FG002|Overall Study|Death|1|||
161296054|NCT02159053|582467077|FG000|Overall Study|Physician Decision|0|||
161296055|NCT02159053|582467078|FG001|Overall Study|Physician Decision|1|||
161296056|NCT02159053|582467079|FG002|Overall Study|Physician Decision|1|||
161296057|NCT02159053|582467077|FG000|Overall Study|Lack of Efficacy|3|||
161296058|NCT02159053|582467078|FG001|Overall Study|Lack of Efficacy|4|||
161296059|NCT02159053|582467079|FG002|Overall Study|Lack of Efficacy|7|||
161296060|NCT02159053|582467077|FG000|Overall Study|Adverse Event|7|||
161296061|NCT02159053|582467078|FG001|Overall Study|Adverse Event|6|||
161296062|NCT02159053|582467079|FG002|Overall Study|Adverse Event|5|||
161296063|NCT02159053|582467077|FG000|Overall Study|Participants/guardian decision|8|||
161296064|NCT02159053|582467078|FG001|Overall Study|Participants/guardian decision|10|||
161296065|NCT02159053|582467079|FG002|Overall Study|Participants/guardian decision|6|||
161296066|NCT02640950|582467080|FG000|Overall Study|Adverse Event|1|||
161296067|NCT02640950|582467080|FG000|Overall Study|Withdrawal by Subject|1|||
161296068|NCT04545489|582467081|FG000|Overall Study|Withdrawal by Subject|12|||
161296069|NCT04545489|582467082|FG001|Overall Study|Withdrawal by Subject|4|||
161296070|NCT04545489|582467081|FG000|Overall Study|Lost to Follow-up|17|||
161296071|NCT04545489|582467082|FG001|Overall Study|Lost to Follow-up|18|||
161296072|NCT04545489|582467081|FG000|Overall Study|12month BP not collected|4|||
161296073|NCT04545489|582467082|FG001|Overall Study|12month BP not collected|4|||
161296074|NCT00652626|582467083|FG000|Initial Treatment Phase|Adverse Event|0|||
161296075|NCT00652626|582467084|FG001|Initial Treatment Phase|Adverse Event|0|||
161296076|NCT00652626|582467085|FG002|Initial Treatment Phase|Adverse Event|0|||
161296077|NCT00652626|582467086|FG003|Initial Treatment Phase|Adverse Event|0|||
161296078|NCT00652626|582467087|FG004|Initial Treatment Phase|Adverse Event|1|||
161296079|NCT00652626|582467088|FG005|Initial Treatment Phase|Adverse Event|0|||
161296080|NCT00652626|582467089|FG006|Initial Treatment Phase|Adverse Event|0|||
161296081|NCT00652626|582467083|FG000|Initial Treatment Phase|Protocol Violation|0|||
161296082|NCT00652626|582467084|FG001|Initial Treatment Phase|Protocol Violation|0|||
161296083|NCT00652626|582467085|FG002|Initial Treatment Phase|Protocol Violation|0|||
161296084|NCT00652626|582467086|FG003|Initial Treatment Phase|Protocol Violation|1|||
161296085|NCT00652626|582467087|FG004|Initial Treatment Phase|Protocol Violation|0|||
161296086|NCT00652626|582467088|FG005|Initial Treatment Phase|Protocol Violation|0|||
161296087|NCT00652626|582467089|FG006|Initial Treatment Phase|Protocol Violation|0|||
161296088|NCT00652626|582467083|FG000|Initial Treatment Phase|Physician Decision|0|||
161296089|NCT00652626|582467084|FG001|Initial Treatment Phase|Physician Decision|0|||
161296090|NCT00652626|582467085|FG002|Initial Treatment Phase|Physician Decision|0|||
161296091|NCT00652626|582467086|FG003|Initial Treatment Phase|Physician Decision|0|||
161296092|NCT00652626|582467087|FG004|Initial Treatment Phase|Physician Decision|1|||
161296093|NCT00652626|582467088|FG005|Initial Treatment Phase|Physician Decision|0|||
161296094|NCT00652626|582467089|FG006|Initial Treatment Phase|Physician Decision|0|||
161296095|NCT00652626|582467083|FG000|Initial Treatment Phase|Sponsor Request|0|||
161296096|NCT00652626|582467084|FG001|Initial Treatment Phase|Sponsor Request|0|||
161296097|NCT00652626|582467085|FG002|Initial Treatment Phase|Sponsor Request|1|||
161296098|NCT00652626|582467086|FG003|Initial Treatment Phase|Sponsor Request|0|||
161296099|NCT00652626|582467087|FG004|Initial Treatment Phase|Sponsor Request|0|||
161296100|NCT00652626|582467088|FG005|Initial Treatment Phase|Sponsor Request|0|||
161296101|NCT00652626|582467089|FG006|Initial Treatment Phase|Sponsor Request|0|||
161296102|NCT00652626|582467083|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
161296103|NCT00652626|582467084|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
161296104|NCT00652626|582467085|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
161296105|NCT00652626|582467086|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
161296106|NCT00652626|582467087|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
161296107|NCT00652626|582467088|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
161296108|NCT00652626|582467089|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
161296109|NCT00652626|582467083|FG000|Extension Phase|Withdrawal by Subject|0|||
161296110|NCT00652626|582467084|FG001|Extension Phase|Withdrawal by Subject|0|||
161296111|NCT00652626|582467085|FG002|Extension Phase|Withdrawal by Subject|0|||
161296112|NCT00652626|582467086|FG003|Extension Phase|Withdrawal by Subject|0|||
161296113|NCT00652626|582467087|FG004|Extension Phase|Withdrawal by Subject|0|||
161296114|NCT00652626|582467088|FG005|Extension Phase|Withdrawal by Subject|2|||
161296115|NCT00652626|582467089|FG006|Extension Phase|Withdrawal by Subject|0|||
161296116|NCT00652626|582467083|FG000|Extension Phase|Adverse Event|0|||
161296117|NCT00652626|582467084|FG001|Extension Phase|Adverse Event|0|||
161347646|NCT00972738|582657332|FG001|Overall Study|Protocol Violation|1|||
161347647|NCT00972738|582657333|FG002|Overall Study|Protocol Violation|3|||
161296118|NCT00652626|582467085|FG002|Extension Phase|Adverse Event|0|||
161296119|NCT00652626|582467086|FG003|Extension Phase|Adverse Event|0|||
161296120|NCT00652626|582467087|FG004|Extension Phase|Adverse Event|0|||
161296121|NCT00652626|582467088|FG005|Extension Phase|Adverse Event|2|||
161296122|NCT00652626|582467089|FG006|Extension Phase|Adverse Event|1|||
161296123|NCT00652626|582467083|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161347648|NCT00972738|582657331|FG000|Overall Study|Lost to Follow-up|1|||
161347649|NCT00972738|582657332|FG001|Overall Study|Lost to Follow-up|0|||
161088013|NCT01642251|581711052|FG000|Overall Study|Adverse Event|0|||
161296124|NCT00652626|582467084|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161296125|NCT00652626|582467085|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161296126|NCT00652626|582467086|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161347650|NCT00972738|582657333|FG002|Overall Study|Lost to Follow-up|1|||
161175256|NCT01594749|582019558|FG000|Overall Study|Lost to Follow-up|1|||
161175257|NCT01594749|582019559|FG001|Overall Study|Lost to Follow-up|0|||
161175258|NCT01594749|582019558|FG000|Overall Study|Death|9|||
161175259|NCT01594749|582019559|FG001|Overall Study|Death|3|||
161175260|NCT01594749|582019558|FG000|Overall Study|Not Treated|4|||
161175261|NCT01594749|582019559|FG001|Overall Study|Not Treated|10|||
161175262|NCT01594749|582019558|FG000|Overall Study|Lost Source Documentation|1|||
161175263|NCT01594749|582019559|FG001|Overall Study|Lost Source Documentation|0|||
161175264|NCT02578992|582019561|FG000|Overall Study|equipment not available or malfunction|3|||
161175265|NCT02578992|582019562|FG001|Overall Study|equipment not available or malfunction|3|||
161175266|NCT00086385|582019563|FG000|Overall Study|Death|2|||
161175267|NCT00086385|582019564|FG001|Overall Study|Death|2|||
161175268|NCT00086385|582019565|FG002|Overall Study|Death|1|||
161175269|NCT00086385|582019566|FG003|Overall Study|Death|1|||
161175270|NCT00880100|582019567|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
161175271|NCT00880100|582019567|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
161175272|NCT00880100|582019567|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
161175273|NCT04038385|582019569|FG000|Overall Study|Completed baseline assessment only|7|||
161175274|NCT04038385|582019570|FG001|Overall Study|Completed baseline assessment only|4|||
161175275|NCT04038385|582019569|FG000|Overall Study|Moved out of area|4|||
161175276|NCT04038385|582019570|FG001|Overall Study|Moved out of area|2|||
161175277|NCT04038385|582019569|FG000|Overall Study|Discontinued study involvement|6|||
161175278|NCT04038385|582019570|FG001|Overall Study|Discontinued study involvement|1|||
161175279|NCT03424044|582019571|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175280|NCT03424044|582019572|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175281|NCT03424044|582019573|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
161175282|NCT03424044|582019574|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175283|NCT03424044|582019575|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175284|NCT03424044|582019576|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175285|NCT03424044|582019577|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175286|NCT03424044|582019578|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175287|NCT03424044|582019579|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
161175288|NCT03424044|582019571|FG000|First Intervention (76 Hours)|Adverse Event|0|||
161175289|NCT03424044|582019572|FG001|First Intervention (76 Hours)|Adverse Event|0|||
161175290|NCT03424044|582019573|FG002|First Intervention (76 Hours)|Adverse Event|0|||
161175291|NCT03424044|582019574|FG003|First Intervention (76 Hours)|Adverse Event|0|||
161175292|NCT03424044|582019575|FG004|First Intervention (76 Hours)|Adverse Event|1|||
161175293|NCT03424044|582019576|FG005|First Intervention (76 Hours)|Adverse Event|0|||
161175294|NCT03424044|582019577|FG006|First Intervention (76 Hours)|Adverse Event|0|||
161175295|NCT03424044|582019578|FG007|First Intervention (76 Hours)|Adverse Event|0|||
161175296|NCT03424044|582019579|FG008|First Intervention (76 Hours)|Adverse Event|0|||
161175297|NCT03424044|582019571|FG000|First Intervention (76 Hours)|device issues|0|||
161175298|NCT03424044|582019572|FG001|First Intervention (76 Hours)|device issues|0|||
161175299|NCT03424044|582019573|FG002|First Intervention (76 Hours)|device issues|0|||
161175300|NCT03424044|582019574|FG003|First Intervention (76 Hours)|device issues|0|||
161175301|NCT03424044|582019575|FG004|First Intervention (76 Hours)|device issues|0|||
161175302|NCT03424044|582019576|FG005|First Intervention (76 Hours)|device issues|0|||
161175303|NCT03424044|582019577|FG006|First Intervention (76 Hours)|device issues|1|||
161175304|NCT03424044|582019578|FG007|First Intervention (76 Hours)|device issues|1|||
161175305|NCT03424044|582019579|FG008|First Intervention (76 Hours)|device issues|1|||
161175306|NCT03424044|582019571|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
161175307|NCT03424044|582019572|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
161175308|NCT03424044|582019573|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
161175309|NCT03424044|582019574|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
161175310|NCT03424044|582019575|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
161175311|NCT03424044|582019576|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
161296127|NCT00652626|582467087|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161296128|NCT00652626|582467088|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
161175312|NCT03424044|582019577|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
161175313|NCT03424044|582019578|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
161175314|NCT03424044|582019579|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
161175315|NCT03424044|582019571|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175316|NCT03424044|582019572|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175317|NCT03424044|582019573|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175318|NCT03424044|582019574|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
161175319|NCT03424044|582019575|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175320|NCT03424044|582019576|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161296129|NCT00652626|582467089|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
161296130|NCT00652626|582467083|FG000|Extension Phase|Physician Decision|0|||
161296131|NCT00652626|582467084|FG001|Extension Phase|Physician Decision|0|||
161296132|NCT00652626|582467085|FG002|Extension Phase|Physician Decision|0|||
161296133|NCT00652626|582467086|FG003|Extension Phase|Physician Decision|0|||
161296134|NCT00652626|582467087|FG004|Extension Phase|Physician Decision|0|||
161296135|NCT00652626|582467088|FG005|Extension Phase|Physician Decision|1|||
161296136|NCT00652626|582467089|FG006|Extension Phase|Physician Decision|1|||
161296137|NCT00652626|582467083|FG000|Extension Phase|Death|0|||
161296138|NCT00652626|582467084|FG001|Extension Phase|Death|0|||
161296139|NCT00652626|582467085|FG002|Extension Phase|Death|0|||
161296140|NCT00652626|582467086|FG003|Extension Phase|Death|0|||
161296141|NCT00652626|582467087|FG004|Extension Phase|Death|0|||
161296142|NCT00652626|582467088|FG005|Extension Phase|Death|1|||
161296143|NCT00652626|582467089|FG006|Extension Phase|Death|1|||
161296144|NCT04003636|582467090|FG000|Overall Study|Death|409|||
161296145|NCT04003636|582467091|FG001|Overall Study|Death|443|||
161296146|NCT04003636|582467090|FG000|Overall Study|Lost to Follow-up|0|||
161296147|NCT04003636|582467091|FG001|Overall Study|Lost to Follow-up|1|||
161296148|NCT04003636|582467090|FG000|Overall Study|Withdrawal by Subject|5|||
161296149|NCT04003636|582467091|FG001|Overall Study|Withdrawal by Subject|2|||
161296150|NCT04003636|582467090|FG000|Overall Study|Participant On-going|119|||
161296151|NCT04003636|582467091|FG001|Overall Study|Participant On-going|90|||
161296152|NCT03048747|582467092|FG000|Overall Study|Adverse Event|2|||
161296153|NCT03048747|582467092|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
161296154|NCT03048747|582467092|FG000|Overall Study|Physician Decision|1|||
161296155|NCT00915018|582467095|FG000|Overall Study|Death|75|||
161296156|NCT00915018|582467096|FG001|Overall Study|Death|70|||
161296157|NCT00915018|582467095|FG000|Overall Study|Lost to Follow-up|10|||
161296158|NCT00915018|582467096|FG001|Overall Study|Lost to Follow-up|5|||
161296159|NCT00915018|582467095|FG000|Overall Study|Withdrawal by Subject|38|||
161296160|NCT00915018|582467096|FG001|Overall Study|Withdrawal by Subject|27|||
161296161|NCT00915018|582467095|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
161296162|NCT00915018|582467096|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
161296163|NCT00457002|582467097|FG000|Overall Study|Death|40|||
161296164|NCT00457002|582467098|FG001|Overall Study|Death|47|||
161296165|NCT00457002|582467097|FG000|Overall Study|Adverse Event|284|||
161296166|NCT00457002|582467098|FG001|Overall Study|Adverse Event|260|||
161296167|NCT00457002|582467097|FG000|Overall Study|Withdrawal by Subject|299|||
161296168|NCT00457002|582467098|FG001|Overall Study|Withdrawal by Subject|271|||
161296169|NCT00457002|582467097|FG000|Overall Study|Lost to Follow-up|72|||
161296170|NCT00457002|582467098|FG001|Overall Study|Lost to Follow-up|71|||
161296171|NCT00457002|582467097|FG000|Overall Study|Poor/Non-compliance|46|||
161296172|NCT00457002|582467098|FG001|Overall Study|Poor/Non-compliance|33|||
161296173|NCT00457002|582467097|FG000|Overall Study|No longer met criteria|41|||
161296174|NCT00457002|582467098|FG001|Overall Study|No longer met criteria|37|||
161296175|NCT00457002|582467097|FG000|Overall Study|Administrative reason by Sponsor|1|||
161296176|NCT00457002|582467098|FG001|Overall Study|Administrative reason by Sponsor|0|||
161296177|NCT00457002|582467097|FG000|Overall Study|non-specified|29|||
161296178|NCT00457002|582467098|FG001|Overall Study|non-specified|38|||
161296179|NCT00457002|582467097|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
161296180|NCT00457002|582467098|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
161296181|NCT01623310|582467099|FG000|Overall Study|Adverse Event|21|||
161296182|NCT01623310|582467099|FG000|Overall Study|Lost to Follow-up|18|||
161296183|NCT01623310|582467099|FG000|Overall Study|Lack of Efficacy|6|||
161296184|NCT01623310|582467099|FG000|Overall Study|Protocol Violation|6|||
161296185|NCT01623310|582467099|FG000|Overall Study|Withdrawal by Subject|25|||
161296186|NCT01623310|582467099|FG000|Overall Study|Became potentially child-bearing|1|||
161296187|NCT01623310|582467099|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
161296188|NCT01623310|582467099|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
161296189|NCT00454246|582467100|FG000|Overall Study|Adverse Event|2|||
161296190|NCT00454246|582467101|FG001|Overall Study|Adverse Event|2|||
161296191|NCT00454246|582467102|FG002|Overall Study|Adverse Event|0|||
161296192|NCT00454246|582467100|FG000|Overall Study|Violation of selection criteria at entry|6|||
161296193|NCT00454246|582467101|FG001|Overall Study|Violation of selection criteria at entry|0|||
161296194|NCT00454246|582467102|FG002|Overall Study|Violation of selection criteria at entry|0|||
161296195|NCT00454246|582467100|FG000|Overall Study|Protocol Violation|1|||
161296196|NCT00454246|582467101|FG001|Overall Study|Protocol Violation|0|||
161296197|NCT00454246|582467102|FG002|Overall Study|Protocol Violation|0|||
161296198|NCT00454246|582467100|FG000|Overall Study|Refused Treatment|1|||
161296199|NCT00454246|582467101|FG001|Overall Study|Refused Treatment|1|||
161296200|NCT00454246|582467102|FG002|Overall Study|Refused Treatment|0|||
161296201|NCT00454246|582467100|FG000|Overall Study|Failure to return|1|||
161296202|NCT00454246|582467101|FG001|Overall Study|Failure to return|0|||
161296203|NCT00454246|582467102|FG002|Overall Study|Failure to return|0|||
161296204|NCT00454246|582467100|FG000|Overall Study|Early termination of study|62|||
161296205|NCT00454246|582467101|FG001|Overall Study|Early termination of study|26|||
161296206|NCT00454246|582467102|FG002|Overall Study|Early termination of study|9|||
161296207|NCT00356603|582467103|FG000|Overall Study|Other|6|||
161296208|NCT00356603|582467104|FG001|Overall Study|Other|3|||
161296209|NCT05326529|582467105|FG000|Overall Study|Lack of Efficacy|0|||
161296210|NCT05326529|582467106|FG001|Overall Study|Lack of Efficacy|1|||
161296211|NCT05326529|582467107|FG002|Overall Study|Lack of Efficacy|0|||
161296212|NCT05326529|582467105|FG000|Overall Study|Physician Decision|0|||
161296213|NCT05326529|582467106|FG001|Overall Study|Physician Decision|0|||
161296214|NCT05326529|582467107|FG002|Overall Study|Physician Decision|2|||
161296215|NCT01262287|582467109|FG000|Overall Study|Lost to Follow-up|2|||
161296216|NCT01262287|582467110|FG001|Overall Study|Lost to Follow-up|1|||
161296217|NCT00932373|582467111|FG000|Overall Study|Progressive disease|3|||
161296218|NCT00932373|582467112|FG001|Overall Study|Progressive disease|1|||
161296219|NCT00932373|582467113|FG002|Overall Study|Progressive disease|0|||
161296220|NCT00932373|582467114|FG003|Overall Study|Progressive disease|0|||
161296221|NCT00932373|582467115|FG004|Overall Study|Progressive disease|10|||
161296222|NCT00932373|582467116|FG005|Overall Study|Progressive disease|1|||
161296223|NCT00932373|582467117|FG006|Overall Study|Progressive disease|0|||
161296224|NCT00932373|582467118|FG007|Overall Study|Progressive disease|2|||
161296225|NCT00932373|582467119|FG008|Overall Study|Progressive disease|1|||
161175321|NCT03424044|582019577|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175322|NCT03424044|582019578|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175323|NCT03424044|582019579|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
161175324|NCT00402285|582019586|FG000|Overall Study|insufficient RNA quality|7|||
161175325|NCT00402285|582019587|FG001|Overall Study|insufficient RNA quality|6|||
161175326|NCT00402285|582019588|FG002|Overall Study|insufficient RNA quality|2|||
161175327|NCT00405275|582019591|FG000|Overall Study|Death|1|||
161175328|NCT00405275|582019592|FG001|Overall Study|Death|0|||
161175329|NCT00405275|582019591|FG000|Overall Study|Lost to Follow-up|5|||
161175330|NCT00405275|582019592|FG001|Overall Study|Lost to Follow-up|1|||
161175331|NCT00405275|582019591|FG000|Overall Study|Withdrawal by Subject|7|||
161175332|NCT00405275|582019592|FG001|Overall Study|Withdrawal by Subject|9|||
161175333|NCT00405275|582019591|FG000|Overall Study|Unwilling to continue|10|||
161175334|NCT00405275|582019592|FG001|Overall Study|Unwilling to continue|9|||
161175335|NCT00088595|582019593|FG000|Overall Study|Adverse Event|11|||
161175336|NCT00088595|582019593|FG000|Overall Study|Withdrawal by Subject|8|||
161175337|NCT00088595|582019593|FG000|Overall Study|Ongoing (After Core)|7|||
161175338|NCT00088595|582019593|FG000|Overall Study|New Cancer Therapy|2|||
161175339|NCT01308853|582019596|FG000|Overall Study|Adverse Event|1|||
161175340|NCT01308853|582019596|FG000|Overall Study|Lost to Follow-up|2|||
161175341|NCT01308853|582019596|FG000|Overall Study|Insertion of permanent implants|1|||
161175342|NCT02959970|582019606|FG000|Overall Study|Adverse Event|1|||
161175343|NCT02959970|582019607|FG001|Overall Study|Adverse Event|0|||
161175344|NCT02959970|582019606|FG000|Overall Study|Withdrawal by Subject|0|||
161175345|NCT02959970|582019607|FG001|Overall Study|Withdrawal by Subject|2|||
161175346|NCT02959970|582019606|FG000|Overall Study|Lost to Follow-up|1|||
161175347|NCT02959970|582019607|FG001|Overall Study|Lost to Follow-up|5|||
161175348|NCT01473355|582019610|FG000|Overall Study|Protocol Violation|2|||
161175349|NCT01473355|582019610|FG000|Overall Study|Adverse Event|2|||
161175350|NCT01473355|582019610|FG000|Overall Study|Lost to Follow-up|2|||
161175351|NCT00106249|582019611|FG000|Overall Study|Lost to Follow-up|3|||
161175352|NCT00106249|582019612|FG001|Overall Study|Lost to Follow-up|2|||
161175353|NCT03417505|582019615|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
161175354|NCT03417505|582019616|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
161175355|NCT03235726|582019617|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175356|NCT03235726|582019618|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175357|NCT03235726|582019619|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175358|NCT03235726|582019620|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175359|NCT03235726|582019621|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
161175360|NCT03235726|582019622|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175361|NCT03235726|582019623|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161296226|NCT00932373|582467120|FG009|Overall Study|Progressive disease|9|||
161296227|NCT00932373|582467121|FG010|Overall Study|Progressive disease|2|||
161296228|NCT00932373|582467111|FG000|Overall Study|Adverse Event|0|||
161296229|NCT00932373|582467112|FG001|Overall Study|Adverse Event|0|||
161175362|NCT03235726|582019624|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175363|NCT03235726|582019625|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175364|NCT03235726|582019626|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
161175365|NCT03235726|582019617|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175366|NCT03235726|582019618|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161296230|NCT00932373|582467113|FG002|Overall Study|Adverse Event|0|||
161296231|NCT00932373|582467114|FG003|Overall Study|Adverse Event|0|||
161175367|NCT03235726|582019619|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175368|NCT03235726|582019620|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175369|NCT03235726|582019621|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
161296232|NCT00932373|582467115|FG004|Overall Study|Adverse Event|2|||
161296233|NCT00932373|582467116|FG005|Overall Study|Adverse Event|1|||
161296234|NCT00932373|582467117|FG006|Overall Study|Adverse Event|0|||
161296235|NCT00932373|582467118|FG007|Overall Study|Adverse Event|1|||
161296236|NCT00932373|582467119|FG008|Overall Study|Adverse Event|0|||
161296237|NCT00932373|582467120|FG009|Overall Study|Adverse Event|2|||
161296238|NCT00932373|582467121|FG010|Overall Study|Adverse Event|1|||
161296239|NCT00932373|582467111|FG000|Overall Study|Physician Decision|0|||
161296240|NCT00932373|582467112|FG001|Overall Study|Physician Decision|0|||
161296241|NCT00932373|582467113|FG002|Overall Study|Physician Decision|1|||
161296242|NCT00932373|582467114|FG003|Overall Study|Physician Decision|0|||
161296243|NCT00932373|582467115|FG004|Overall Study|Physician Decision|2|||
161296244|NCT00932373|582467116|FG005|Overall Study|Physician Decision|0|||
161296245|NCT00932373|582467117|FG006|Overall Study|Physician Decision|0|||
161296246|NCT00932373|582467118|FG007|Overall Study|Physician Decision|0|||
161296247|NCT00932373|582467119|FG008|Overall Study|Physician Decision|0|||
161296248|NCT00932373|582467120|FG009|Overall Study|Physician Decision|1|||
161296249|NCT00932373|582467121|FG010|Overall Study|Physician Decision|0|||
161296250|NCT00932373|582467111|FG000|Overall Study|Dose limiting toxicity|0|||
161296251|NCT00932373|582467112|FG001|Overall Study|Dose limiting toxicity|0|||
161296252|NCT00932373|582467113|FG002|Overall Study|Dose limiting toxicity|0|||
161296253|NCT00932373|582467114|FG003|Overall Study|Dose limiting toxicity|0|||
161296254|NCT00932373|582467115|FG004|Overall Study|Dose limiting toxicity|0|||
161296255|NCT00932373|582467116|FG005|Overall Study|Dose limiting toxicity|1|||
161296256|NCT00932373|582467117|FG006|Overall Study|Dose limiting toxicity|0|||
161296257|NCT00932373|582467118|FG007|Overall Study|Dose limiting toxicity|0|||
161296258|NCT00932373|582467119|FG008|Overall Study|Dose limiting toxicity|0|||
161296259|NCT00932373|582467120|FG009|Overall Study|Dose limiting toxicity|0|||
161296260|NCT00932373|582467121|FG010|Overall Study|Dose limiting toxicity|0|||
161296261|NCT00932373|582467111|FG000|Overall Study|Withdrawal by Subject|0|||
161296262|NCT00932373|582467112|FG001|Overall Study|Withdrawal by Subject|0|||
161296263|NCT00932373|582467113|FG002|Overall Study|Withdrawal by Subject|0|||
161296264|NCT00932373|582467114|FG003|Overall Study|Withdrawal by Subject|0|||
161296265|NCT00932373|582467115|FG004|Overall Study|Withdrawal by Subject|0|||
161296266|NCT00932373|582467116|FG005|Overall Study|Withdrawal by Subject|0|||
161296267|NCT00932373|582467117|FG006|Overall Study|Withdrawal by Subject|0|||
161296268|NCT00932373|582467118|FG007|Overall Study|Withdrawal by Subject|0|||
161296269|NCT00932373|582467119|FG008|Overall Study|Withdrawal by Subject|1|||
161296270|NCT00932373|582467120|FG009|Overall Study|Withdrawal by Subject|0|||
161296271|NCT00932373|582467121|FG010|Overall Study|Withdrawal by Subject|0|||
161296272|NCT00932373|582467111|FG000|Overall Study|Clinical progression|0|||
161296273|NCT00932373|582467112|FG001|Overall Study|Clinical progression|0|||
161296274|NCT00932373|582467113|FG002|Overall Study|Clinical progression|0|||
161296275|NCT00932373|582467114|FG003|Overall Study|Clinical progression|0|||
161296276|NCT00932373|582467115|FG004|Overall Study|Clinical progression|0|||
161296277|NCT00932373|582467116|FG005|Overall Study|Clinical progression|0|||
161296278|NCT00932373|582467117|FG006|Overall Study|Clinical progression|1|||
161296279|NCT00932373|582467118|FG007|Overall Study|Clinical progression|0|||
161296280|NCT00932373|582467119|FG008|Overall Study|Clinical progression|0|||
161296281|NCT00932373|582467120|FG009|Overall Study|Clinical progression|0|||
161296282|NCT00932373|582467121|FG010|Overall Study|Clinical progression|0|||
161296283|NCT00932373|582467111|FG000|Overall Study|Lack of Efficacy|0|||
161296284|NCT00932373|582467112|FG001|Overall Study|Lack of Efficacy|0|||
161296285|NCT00932373|582467113|FG002|Overall Study|Lack of Efficacy|0|||
161296286|NCT00932373|582467114|FG003|Overall Study|Lack of Efficacy|0|||
161296287|NCT00932373|582467115|FG004|Overall Study|Lack of Efficacy|0|||
161296288|NCT00932373|582467116|FG005|Overall Study|Lack of Efficacy|0|||
161296289|NCT00932373|582467117|FG006|Overall Study|Lack of Efficacy|0|||
161296290|NCT00932373|582467118|FG007|Overall Study|Lack of Efficacy|0|||
161296291|NCT00932373|582467119|FG008|Overall Study|Lack of Efficacy|0|||
161296292|NCT00932373|582467120|FG009|Overall Study|Lack of Efficacy|1|||
161296293|NCT00932373|582467121|FG010|Overall Study|Lack of Efficacy|0|||
161296294|NCT04134767|582467124|FG000|Overall Study|Death|0|||
161296295|NCT04134767|582467125|FG001|Overall Study|Death|1|||
161296296|NCT04134767|582467124|FG000|Overall Study|Removed for harassing staff|0|||
161296297|NCT04134767|582467125|FG001|Overall Study|Removed for harassing staff|1|||
161296298|NCT04134767|582467124|FG000|Overall Study|Lost to Follow-up|44|||
161296299|NCT04134767|582467125|FG001|Overall Study|Lost to Follow-up|40|||
161296300|NCT02582242|582467126|FG000|Overall Study|Adverse Event|4|||
161296301|NCT02582242|582467127|FG001|Overall Study|Adverse Event|3|||
161296302|NCT02582242|582467126|FG000|Overall Study|Protocol Violation|3|||
161296303|NCT02582242|582467127|FG001|Overall Study|Protocol Violation|1|||
161296304|NCT02582242|582467126|FG000|Overall Study|Lost to Follow-up|0|||
161296305|NCT02582242|582467127|FG001|Overall Study|Lost to Follow-up|1|||
161296306|NCT02582242|582467126|FG000|Overall Study|Withdrawal by Subject|11|||
161296307|NCT02582242|582467127|FG001|Overall Study|Withdrawal by Subject|11|||
161296308|NCT02582242|582467126|FG000|Overall Study|Unclassified|2|||
161296309|NCT02582242|582467127|FG001|Overall Study|Unclassified|1|||
161296310|NCT02101736|582467128|FG000|Overall Study|Protocol Violation|3|||
161296311|NCT02101736|582467129|FG001|Overall Study|Protocol Violation|0|||
161296312|NCT02101736|582467128|FG000|Overall Study|Withdrawal by Subject|1|||
161296313|NCT02101736|582467129|FG001|Overall Study|Withdrawal by Subject|1|||
161296314|NCT03150719|582467134|FG000|Overall Study|Adverse Event|0|||
161296315|NCT03150719|582467135|FG001|Overall Study|Adverse Event|1|||
161296316|NCT03150719|582467134|FG000|Overall Study|Death|0|||
161296317|NCT03150719|582467135|FG001|Overall Study|Death|1|||
161296318|NCT03150719|582467134|FG000|Overall Study|Other|1|||
161296319|NCT03150719|582467135|FG001|Overall Study|Other|0|||
161296320|NCT04278417|582467143|FG000|Overall Study|Withdrawal by Subject|20|||
161296321|NCT04278417|582467144|FG001|Overall Study|Withdrawal by Subject|20|||
161296322|NCT04278417|582467143|FG000|Overall Study|Progressive disease|0|||
161296323|NCT04278417|582467144|FG001|Overall Study|Progressive disease|2|||
161296324|NCT04278417|582467143|FG000|Overall Study|Physician Decision|4|||
161296325|NCT04278417|582467144|FG001|Overall Study|Physician Decision|6|||
161296326|NCT04278417|582467143|FG000|Overall Study|Lost to Follow-up|11|||
161296327|NCT04278417|582467144|FG001|Overall Study|Lost to Follow-up|13|||
161296328|NCT04278417|582467143|FG000|Overall Study|Death|8|||
161296329|NCT04278417|582467144|FG001|Overall Study|Death|9|||
161296330|NCT04278417|582467143|FG000|Overall Study|Adverse Event|3|||
161296331|NCT04278417|582467144|FG001|Overall Study|Adverse Event|5|||
161296332|NCT00347009|582467148|FG000|Overall Study|Death|1|||
161296333|NCT00347009|582467148|FG000|Overall Study|Adverse Event|6|||
161296334|NCT00347009|582467148|FG000|Overall Study|Withdrawal by Subject|3|||
161296335|NCT00347009|582467148|FG000|Overall Study|Physician Decision|5|||
161296336|NCT00347009|582467148|FG000|Overall Study|Lost to Follow-up|4|||
161296337|NCT00347009|582467148|FG000|Overall Study|Protocol Violation|2|||
161296338|NCT00347009|582467148|FG000|Overall Study|Adverse Laboratory Experience|1|||
161296339|NCT00347009|582467148|FG000|Overall Study|Insufficient Viral Suppression|3|||
161296340|NCT00347009|582467148|FG000|Overall Study|Increased ALT/HBV DNA|1|||
161296341|NCT00347009|582467148|FG000|Overall Study|Serious Adverse Event|1|||
161296342|NCT02907177|582467149|FG000|Overall Study|Death|0|||
161296343|NCT02907177|582467150|FG001|Overall Study|Death|1|||
161296344|NCT02907177|582467149|FG000|Overall Study|Physician Decision|3|||
161296345|NCT02907177|582467150|FG001|Overall Study|Physician Decision|3|||
161296346|NCT02907177|582467149|FG000|Overall Study|Withdrawal by Subject|15|||
161296347|NCT02907177|582467150|FG001|Overall Study|Withdrawal by Subject|7|||
161296348|NCT02907177|582467149|FG000|Overall Study|Sponsor's Decision|50|||
161296349|NCT02907177|582467150|FG001|Overall Study|Sponsor's Decision|57|||
161296350|NCT01796392|582467151|FG000|Overall Study|Withdrawal by Subject|2|||
161296351|NCT01796392|582467152|FG001|Overall Study|Withdrawal by Subject|0|||
161296352|NCT01796392|582467151|FG000|Overall Study|Death|5|||
161296353|NCT01796392|582467152|FG001|Overall Study|Death|1|||
161296354|NCT01796392|582467151|FG000|Overall Study|Excluded for medical reasons|1|||
161296355|NCT01796392|582467152|FG001|Overall Study|Excluded for medical reasons|2|||
161296356|NCT01796392|582467151|FG000|Overall Study|Lost to Follow-up|1|||
161296357|NCT01796392|582467152|FG001|Overall Study|Lost to Follow-up|0|||
161296358|NCT03482635|582467153|FG000|Overall Study|Lack of Efficacy|0|||
161296359|NCT03482635|582467154|FG001|Overall Study|Lack of Efficacy|0|||
161296360|NCT03482635|582467155|FG002|Overall Study|Lack of Efficacy|1|||
161296361|NCT03482635|582467156|FG003|Overall Study|Lack of Efficacy|3|||
161296362|NCT03482635|582467153|FG000|Overall Study|Adverse Event|2|||
161296363|NCT03482635|582467154|FG001|Overall Study|Adverse Event|2|||
161296364|NCT03482635|582467155|FG002|Overall Study|Adverse Event|0|||
161296365|NCT03482635|582467156|FG003|Overall Study|Adverse Event|3|||
161296366|NCT03482635|582467153|FG000|Overall Study|Withdrawal by Subject|2|||
161296367|NCT03482635|582467154|FG001|Overall Study|Withdrawal by Subject|1|||
161296368|NCT03482635|582467155|FG002|Overall Study|Withdrawal by Subject|0|||
161296369|NCT03482635|582467156|FG003|Overall Study|Withdrawal by Subject|1|||
161296370|NCT03482635|582467153|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
161296371|NCT03482635|582467154|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
161296372|NCT03482635|582467155|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
161296373|NCT03482635|582467156|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
161296374|NCT03482635|582467153|FG000|Overall Study|Not treated|0|||
161296375|NCT03482635|582467154|FG001|Overall Study|Not treated|0|||
161296376|NCT03482635|582467155|FG002|Overall Study|Not treated|0|||
161296377|NCT03482635|582467156|FG003|Overall Study|Not treated|1|||
161296378|NCT04639219|582467157|FG000|Overall Study|Withdrawal by Subject|8|||
161296379|NCT04639219|582467157|FG000|Overall Study|Lost to Follow-up|6|||
161296380|NCT04639219|582467157|FG000|Overall Study|Death|55|||
161296381|NCT04681066|582467158|FG000|Overall Study|Lost to Follow-up|3|||
161296382|NCT04681066|582467159|FG001|Overall Study|Lost to Follow-up|1|||
161296383|NCT04681066|582467160|FG002|Overall Study|Lost to Follow-up|2|||
161296384|NCT04681066|582467161|FG003|Overall Study|Lost to Follow-up|1|||
161296385|NCT04681066|582467158|FG000|Overall Study|Withdrawal by Subject|2|||
161296386|NCT04681066|582467159|FG001|Overall Study|Withdrawal by Subject|1|||
161296387|NCT04681066|582467160|FG002|Overall Study|Withdrawal by Subject|0|||
161296388|NCT04681066|582467161|FG003|Overall Study|Withdrawal by Subject|3|||
161296389|NCT04681066|582467158|FG000|Overall Study|Death|0|||
161296390|NCT04681066|582467159|FG001|Overall Study|Death|1|||
161296391|NCT04681066|582467160|FG002|Overall Study|Death|0|||
161296392|NCT04681066|582467161|FG003|Overall Study|Death|0|||
161296393|NCT04495829|582467162|FG000|Overall Study|Lost to Follow-up|2|||
161296394|NCT04495829|582467162|FG000|Overall Study|Inclusion criterion not met|3|||
161296395|NCT01205269|582467171|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161296396|NCT01205269|582467172|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161296397|NCT01205269|582467173|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161296398|NCT01205269|582467174|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
161296399|NCT01205269|582467175|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161296400|NCT01205269|582467176|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
161296401|NCT00987337|582467177|FG000|Overall Study|Adverse Event|10|||
161296402|NCT00987337|582467178|FG001|Overall Study|Adverse Event|9|||
161296403|NCT00987337|582467179|FG002|Overall Study|Adverse Event|8|||
161296404|NCT00987337|582467177|FG000|Overall Study|Insufficient Virologic Response|10|||
161296405|NCT00987337|582467178|FG001|Overall Study|Insufficient Virologic Response|7|||
161296406|NCT00987337|582467179|FG002|Overall Study|Insufficient Virologic Response|12|||
161296407|NCT00987337|582467177|FG000|Overall Study|Virologic Breakthrough|2|||
161296408|NCT00987337|582467178|FG001|Overall Study|Virologic Breakthrough|2|||
161296409|NCT00987337|582467179|FG002|Overall Study|Virologic Breakthrough|8|||
161296410|NCT00987337|582467177|FG000|Overall Study|Lost to Follow-up|10|||
161296411|NCT00987337|582467178|FG001|Overall Study|Lost to Follow-up|6|||
161296412|NCT00987337|582467179|FG002|Overall Study|Lost to Follow-up|2|||
161296413|NCT00987337|582467177|FG000|Overall Study|Withdrawal by Subject|6|||
161296414|NCT00987337|582467178|FG001|Overall Study|Withdrawal by Subject|9|||
161296415|NCT00987337|582467179|FG002|Overall Study|Withdrawal by Subject|9|||
161296416|NCT00987337|582467177|FG000|Overall Study|Other|0|||
161296417|NCT00987337|582467178|FG001|Overall Study|Other|2|||
161296418|NCT00987337|582467179|FG002|Overall Study|Other|5|||
161296419|NCT00987337|582467177|FG000|Overall Study|Protocol Violation|1|||
161296420|NCT00987337|582467178|FG001|Overall Study|Protocol Violation|0|||
161296421|NCT00987337|582467179|FG002|Overall Study|Protocol Violation|2|||
161296422|NCT00987337|582467177|FG000|Overall Study|Participant Relapsed|18|||
161296423|NCT00987337|582467178|FG001|Overall Study|Participant Relapsed|20|||
161296424|NCT00987337|582467179|FG002|Overall Study|Participant Relapsed|5|||
161296425|NCT03474965|582467181|FG000|Overall Study|Pregnancy|1|||
161296426|NCT03474965|582467182|FG001|Overall Study|Pregnancy|0|||
161296427|NCT03474965|582467183|FG002|Overall Study|Pregnancy|0|||
161296428|NCT03474965|582467184|FG003|Overall Study|Pregnancy|0|||
161296429|NCT03474965|582467181|FG000|Overall Study|Lost to Follow-up|0|||
161296430|NCT03474965|582467182|FG001|Overall Study|Lost to Follow-up|0|||
161296431|NCT03474965|582467183|FG002|Overall Study|Lost to Follow-up|1|||
161296432|NCT03474965|582467184|FG003|Overall Study|Lost to Follow-up|0|||
161296433|NCT03474965|582467181|FG000|Overall Study|Death|1|||
161296434|NCT03474965|582467182|FG001|Overall Study|Death|0|||
161296435|NCT03474965|582467183|FG002|Overall Study|Death|0|||
161296436|NCT03474965|582467184|FG003|Overall Study|Death|0|||
161296437|NCT03474965|582467181|FG000|Overall Study|Adverse Event|1|||
161296438|NCT03474965|582467182|FG001|Overall Study|Adverse Event|0|||
161296439|NCT03474965|582467183|FG002|Overall Study|Adverse Event|0|||
161296440|NCT03474965|582467184|FG003|Overall Study|Adverse Event|1|||
161296441|NCT03474965|582467181|FG000|Overall Study|Physician Decision|3|||
161296442|NCT03474965|582467182|FG001|Overall Study|Physician Decision|1|||
161296443|NCT03474965|582467183|FG002|Overall Study|Physician Decision|2|||
161296444|NCT03474965|582467184|FG003|Overall Study|Physician Decision|0|||
161296445|NCT03474965|582467181|FG000|Overall Study|Participant Decision|7|||
161296446|NCT03474965|582467182|FG001|Overall Study|Participant Decision|0|||
161296447|NCT03474965|582467183|FG002|Overall Study|Participant Decision|1|||
161296448|NCT03474965|582467184|FG003|Overall Study|Participant Decision|0|||
161296449|NCT03474965|582467181|FG000|Overall Study|Guardian Decision|4|||
161296450|NCT03474965|582467182|FG001|Overall Study|Guardian Decision|2|||
161296451|NCT03474965|582467183|FG002|Overall Study|Guardian Decision|7|||
161296452|NCT03474965|582467184|FG003|Overall Study|Guardian Decision|2|||
161296453|NCT00300885|582468711|FG000|Treatment|Adverse Event|134|||
161296454|NCT00300885|582468712|FG001|Treatment|Adverse Event|82|||
161296455|NCT00300885|582468711|FG000|Treatment|Death|20|||
161296456|NCT00300885|582468712|FG001|Treatment|Death|7|||
161296457|NCT00300885|582468711|FG000|Treatment|Lack of Efficacy|1|||
161175370|NCT03235726|582019622|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161296458|NCT00300885|582468712|FG001|Treatment|Lack of Efficacy|1|||
161296459|NCT00300885|582468711|FG000|Treatment|Lost to Follow-up|3|||
161296460|NCT00300885|582468712|FG001|Treatment|Lost to Follow-up|2|||
161296461|NCT00300885|582468711|FG000|Treatment|Physician Decision|4|||
161296462|NCT00300885|582468712|FG001|Treatment|Physician Decision|5|||
161296463|NCT00300885|582468711|FG000|Treatment|Protocol Violation|11|||
161296464|NCT00300885|582468712|FG001|Treatment|Protocol Violation|11|||
161296465|NCT00300885|582468711|FG000|Treatment|Withdrawal by Subject|26|||
161296466|NCT00300885|582468712|FG001|Treatment|Withdrawal by Subject|23|||
161296467|NCT00300885|582468711|FG000|Treatment|Disease progression|171|||
161296468|NCT00300885|582468712|FG001|Treatment|Disease progression|238|||
161296469|NCT00300885|582468711|FG000|Treatment|Random code broken (subject died)|0|||
161319491|NCT01863732|582555334|FG000|Overall Study|Physician Decision|1|||
161175371|NCT03235726|582019623|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175372|NCT03235726|582019624|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175373|NCT03235726|582019625|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175374|NCT03235726|582019626|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
161175375|NCT01831804|582019627|FG000|Overall Study|Adverse Event|0|||
161175376|NCT01831804|582019628|FG001|Overall Study|Adverse Event|0|||
161175377|NCT01831804|582019629|FG002|Overall Study|Adverse Event|0|||
161175378|NCT01831804|582019630|FG003|Overall Study|Adverse Event|0|||
161175379|NCT01831804|582019631|FG004|Overall Study|Adverse Event|0|||
161175380|NCT01831804|582019632|FG005|Overall Study|Adverse Event|0|||
161175381|NCT01831804|582019633|FG006|Overall Study|Adverse Event|1|||
161175382|NCT01831804|582019634|FG007|Overall Study|Adverse Event|0|||
161175383|NCT01831804|582019635|FG008|Overall Study|Adverse Event|1|||
161175384|NCT01831804|582019627|FG000|Overall Study|Protocol Violation|0|||
161175385|NCT01831804|582019628|FG001|Overall Study|Protocol Violation|0|||
161175386|NCT01831804|582019629|FG002|Overall Study|Protocol Violation|2|||
161175387|NCT01831804|582019630|FG003|Overall Study|Protocol Violation|0|||
161175388|NCT01831804|582019631|FG004|Overall Study|Protocol Violation|0|||
161175389|NCT01831804|582019632|FG005|Overall Study|Protocol Violation|0|||
161175390|NCT01831804|582019633|FG006|Overall Study|Protocol Violation|0|||
161175391|NCT01831804|582019634|FG007|Overall Study|Protocol Violation|0|||
161175392|NCT01831804|582019635|FG008|Overall Study|Protocol Violation|0|||
161175393|NCT01831804|582019627|FG000|Overall Study|Protocol defined stopping criteria|1|||
161175394|NCT01831804|582019628|FG001|Overall Study|Protocol defined stopping criteria|1|||
161175395|NCT01831804|582019629|FG002|Overall Study|Protocol defined stopping criteria|3|||
161175396|NCT01831804|582019630|FG003|Overall Study|Protocol defined stopping criteria|0|||
161175397|NCT01831804|582019631|FG004|Overall Study|Protocol defined stopping criteria|1|||
161175398|NCT01831804|582019632|FG005|Overall Study|Protocol defined stopping criteria|0|||
161175399|NCT01831804|582019633|FG006|Overall Study|Protocol defined stopping criteria|0|||
161175400|NCT01831804|582019634|FG007|Overall Study|Protocol defined stopping criteria|0|||
161175401|NCT01831804|582019635|FG008|Overall Study|Protocol defined stopping criteria|0|||
161175402|NCT01831804|582019627|FG000|Overall Study|Lost to Follow-up|0|||
161175403|NCT01831804|582019628|FG001|Overall Study|Lost to Follow-up|0|||
161175404|NCT01831804|582019629|FG002|Overall Study|Lost to Follow-up|1|||
161175405|NCT01831804|582019630|FG003|Overall Study|Lost to Follow-up|0|||
161175406|NCT01831804|582019631|FG004|Overall Study|Lost to Follow-up|0|||
161175407|NCT01831804|582019632|FG005|Overall Study|Lost to Follow-up|0|||
161175408|NCT01831804|582019633|FG006|Overall Study|Lost to Follow-up|0|||
161175409|NCT01831804|582019634|FG007|Overall Study|Lost to Follow-up|0|||
161175410|NCT01831804|582019635|FG008|Overall Study|Lost to Follow-up|1|||
161175411|NCT01831804|582019627|FG000|Overall Study|Investigator discretion|0|||
161175412|NCT01831804|582019628|FG001|Overall Study|Investigator discretion|0|||
161175413|NCT01831804|582019629|FG002|Overall Study|Investigator discretion|0|||
161175414|NCT01831804|582019630|FG003|Overall Study|Investigator discretion|0|||
161175415|NCT01831804|582019631|FG004|Overall Study|Investigator discretion|1|||
161175416|NCT01831804|582019632|FG005|Overall Study|Investigator discretion|0|||
161175417|NCT01831804|582019633|FG006|Overall Study|Investigator discretion|0|||
161175418|NCT01831804|582019634|FG007|Overall Study|Investigator discretion|1|||
161175419|NCT01831804|582019635|FG008|Overall Study|Investigator discretion|0|||
161175420|NCT01831804|582019627|FG000|Overall Study|Withdrew Consent|0|||
161175421|NCT01831804|582019628|FG001|Overall Study|Withdrew Consent|1|||
161175422|NCT01831804|582019629|FG002|Overall Study|Withdrew Consent|0|||
161175423|NCT01831804|582019630|FG003|Overall Study|Withdrew Consent|0|||
161175424|NCT01831804|582019631|FG004|Overall Study|Withdrew Consent|0|||
161175425|NCT01831804|582019632|FG005|Overall Study|Withdrew Consent|0|||
161175426|NCT01831804|582019633|FG006|Overall Study|Withdrew Consent|0|||
161175427|NCT01831804|582019634|FG007|Overall Study|Withdrew Consent|2|||
161175428|NCT01831804|582019635|FG008|Overall Study|Withdrew Consent|0|||
161175429|NCT01819506|582019636|FG000|Overall Study|Physician Decision|5|||
161175430|NCT01819506|582019637|FG001|Overall Study|Physician Decision|2|||
161175431|NCT01819506|582019636|FG000|Overall Study|Withdrawal by Subject|3|||
161175432|NCT01819506|582019637|FG001|Overall Study|Withdrawal by Subject|3|||
161175433|NCT00268463|582019640|FG000|Overall Study|study terminated due to low accrual|10|||
161175434|NCT00268463|582019641|FG001|Overall Study|study terminated due to low accrual|12|||
161175435|NCT04685538|582019642|FG000|Overall Study|Adverse Event|0|||
161175436|NCT04685538|582019643|FG001|Overall Study|Adverse Event|1|||
161175437|NCT04685538|582019642|FG000|Overall Study|Lost to Follow-up|0|||
161175438|NCT04685538|582019643|FG001|Overall Study|Lost to Follow-up|2|||
161175439|NCT01040845|582019644|FG000|Overall Study|Withdrawal by Subject|1|||
161175440|NCT01040845|582019645|FG001|Overall Study|Withdrawal by Subject|1|||
161175441|NCT01040845|582019644|FG000|Overall Study|Physician Decision|1|||
161175442|NCT01040845|582019645|FG001|Overall Study|Physician Decision|0|||
161175443|NCT04362813|582019646|FG000|Overall Study|Death|12|||
161175444|NCT04362813|582019647|FG001|Overall Study|Death|16|||
161175445|NCT04362813|582019646|FG000|Overall Study|Withdrawal by Subject|3|||
161175446|NCT04362813|582019647|FG001|Overall Study|Withdrawal by Subject|1|||
161175447|NCT04362813|582019646|FG000|Overall Study|Protocol Violation|0|||
161175448|NCT04362813|582019647|FG001|Overall Study|Protocol Violation|3|||
161088014|NCT01642251|581711053|FG001|Overall Study|Adverse Event|0|||
161088015|NCT01642251|581711054|FG002|Overall Study|Adverse Event|5|||
161088016|NCT01642251|581711055|FG003|Overall Study|Adverse Event|4|||
161088017|NCT01642251|581711052|FG000|Overall Study|Death|0|||
161088018|NCT01642251|581711053|FG001|Overall Study|Death|0|||
161088019|NCT01642251|581711054|FG002|Overall Study|Death|1|||
161088020|NCT01642251|581711055|FG003|Overall Study|Death|3|||
161088021|NCT01642251|581711052|FG000|Overall Study|Withdrawal by Subject|0|||
161088022|NCT01642251|581711053|FG001|Overall Study|Withdrawal by Subject|0|||
161088023|NCT01642251|581711054|FG002|Overall Study|Withdrawal by Subject|1|||
161088024|NCT01642251|581711055|FG003|Overall Study|Withdrawal by Subject|3|||
161088025|NCT01642251|581711052|FG000|Overall Study|Alternative therapy|0|||
161088026|NCT01642251|581711053|FG001|Overall Study|Alternative therapy|0|||
161088027|NCT01642251|581711054|FG002|Overall Study|Alternative therapy|0|||
161088028|NCT01642251|581711055|FG003|Overall Study|Alternative therapy|2|||
161088029|NCT01642251|581711052|FG000|Overall Study|Other complicating disease|0|||
161088030|NCT01642251|581711053|FG001|Overall Study|Other complicating disease|0|||
161088031|NCT01642251|581711054|FG002|Overall Study|Other complicating disease|1|||
161088032|NCT01642251|581711055|FG003|Overall Study|Other complicating disease|0|||
161088033|NCT01642251|581711052|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
161088034|NCT01642251|581711053|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
161088035|NCT01642251|581711054|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
161088036|NCT01642251|581711055|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
161088037|NCT00998790|581711056|FG000|Overall Study|Withdrawal by Subject|21|||
161088038|NCT00895154|581711057|FG000|Overall Study|Lost to Follow-up|1|||
161088039|NCT00895154|581711058|FG001|Overall Study|Lost to Follow-up|1|||
161088040|NCT00895154|581711057|FG000|Overall Study|Withdrawal by Subject|0|||
161088041|NCT00895154|581711058|FG001|Overall Study|Withdrawal by Subject|1|||
161088042|NCT01993927|581711059|FG000|Overall Study|Case Report Forms Uncollected|18|||
161088043|NCT01993927|581711059|FG000|Overall Study|Protocol Violation|11|||
161088044|NCT00287690|581711062|FG000|Overall Study|Protocol Violation|20|||
161088045|NCT00287690|581711063|FG001|Overall Study|Protocol Violation|26|||
161088046|NCT02047903|581711064|FG000|Overall Study|Adverse Event|14|||
161088047|NCT02047903|581711064|FG000|Overall Study|Serious adverse event|10|||
161088048|NCT02047903|581711064|FG000|Overall Study|Withdrawal by Subject|16|||
161088049|NCT02047903|581711064|FG000|Overall Study|Lost to Follow-up|4|||
161088050|NCT02047903|581711064|FG000|Overall Study|Reason not listed|6|||
161088051|NCT02047903|581711064|FG000|Overall Study|Not Treated|9|||
161088052|NCT01942590|581711065|FG000|Overall Study|Withdrawal by Subject|0|||
161088053|NCT01942590|581711066|FG001|Overall Study|Withdrawal by Subject|1|||
161088054|NCT01942590|581711065|FG000|Overall Study|Adverse Event|1|||
161088055|NCT01942590|581711066|FG001|Overall Study|Adverse Event|0|||
161088056|NCT02433340|581711069|FG000|Overall Study|Adverse Event|0|||
161088057|NCT02433340|581711070|FG001|Overall Study|Adverse Event|0|||
161088058|NCT02433340|581711071|FG002|Overall Study|Adverse Event|1|||
161088059|NCT02433340|581711072|FG003|Overall Study|Adverse Event|0|||
161088060|NCT02433340|581711069|FG000|Overall Study|Withdrawal by Subject|1|||
161088061|NCT02433340|581711070|FG001|Overall Study|Withdrawal by Subject|0|||
161088062|NCT02433340|581711071|FG002|Overall Study|Withdrawal by Subject|1|||
161088063|NCT02433340|581711072|FG003|Overall Study|Withdrawal by Subject|2|||
161088064|NCT02433340|581711069|FG000|Overall Study|Lost to Follow-up|0|||
161088065|NCT02433340|581711070|FG001|Overall Study|Lost to Follow-up|1|||
161088066|NCT02433340|581711071|FG002|Overall Study|Lost to Follow-up|0|||
161088067|NCT02433340|581711072|FG003|Overall Study|Lost to Follow-up|0|||
161088068|NCT02433340|581711069|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
161088069|NCT02433340|581711070|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
161088070|NCT02433340|581711071|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
161088071|NCT02433340|581711072|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
161088072|NCT02433340|581711069|FG000|Overall Study|Other|0|||
161088073|NCT02433340|581711070|FG001|Overall Study|Other|1|||
161088074|NCT02433340|581711071|FG002|Overall Study|Other|0|||
161088075|NCT02433340|581711072|FG003|Overall Study|Other|0|||
161088076|NCT01226095|581711073|FG000|Overall Study|Poor compliance|1|||
161088077|NCT01688830|581711076|FG000|Overall Study|Lost to Follow-up|0|||
161088078|NCT01688830|581711077|FG001|Overall Study|Lost to Follow-up|0|||
161088079|NCT01688830|581711078|FG002|Overall Study|Lost to Follow-up|0|||
161088080|NCT01688830|581711079|FG003|Overall Study|Lost to Follow-up|0|||
161088081|NCT01688830|581711080|FG004|Overall Study|Lost to Follow-up|0|||
161088082|NCT01688830|581711081|FG005|Overall Study|Lost to Follow-up|0|||
161088083|NCT01688830|581711082|FG006|Overall Study|Lost to Follow-up|0|||
161088084|NCT01688830|581711083|FG007|Overall Study|Lost to Follow-up|0|||
161088085|NCT01688830|581711084|FG008|Overall Study|Lost to Follow-up|0|||
161088086|NCT01688830|581711085|FG009|Overall Study|Lost to Follow-up|0|||
161088087|NCT01688830|581711086|FG010|Overall Study|Lost to Follow-up|1|||
161088088|NCT01688830|581711087|FG011|Overall Study|Lost to Follow-up|0|||
161088089|NCT01688830|581711088|FG012|Overall Study|Lost to Follow-up|0|||
161088090|NCT01688830|581711089|FG013|Overall Study|Lost to Follow-up|0|||
161088091|NCT01688830|581711090|FG014|Overall Study|Lost to Follow-up|0|||
161296470|NCT00300885|582468712|FG001|Treatment|Random code broken (subject died)|1|||
161296471|NCT00300885|582468711|FG000|Treatment|Non-compliant with study medication|3|||
161296472|NCT00300885|582468712|FG001|Treatment|Non-compliant with study medication|4|||
161296473|NCT00300885|582468711|FG000|Follow-up|Death|141|||
161296474|NCT00300885|582468712|FG001|Follow-up|Death|163|||
161296475|NCT00300885|582468711|FG000|Follow-up|Lost to Follow-up|11|||
161296476|NCT00300885|582468712|FG001|Follow-up|Lost to Follow-up|7|||
161296477|NCT00300885|582468711|FG000|Follow-up|Withdrawal by Subject|26|||
161296478|NCT00300885|582468712|FG001|Follow-up|Withdrawal by Subject|25|||
161296479|NCT01637922|582468713|FG000|Overall Study|Adverse Event|0|||
161296480|NCT01637922|582468714|FG001|Overall Study|Adverse Event|1|||
161296481|NCT01637922|582468713|FG000|Overall Study|Protocol Violation|0|||
161296482|NCT01637922|582468714|FG001|Overall Study|Protocol Violation|1|||
161296483|NCT01637922|582468713|FG000|Overall Study|Withdrawal by Subject|0|||
161296484|NCT01637922|582468714|FG001|Overall Study|Withdrawal by Subject|3|||
161296485|NCT01637922|582468713|FG000|Overall Study|Lost to Follow-up|2|||
161296486|NCT01637922|582468714|FG001|Overall Study|Lost to Follow-up|0|||
161296487|NCT00638404|582468715|FG000|Overall Study|Physician Decision|8|||
161296488|NCT00638404|582468716|FG001|Overall Study|Physician Decision|0|||
161296489|NCT02492984|582468717|FG000|Overall Study|Adverse Event|1|||
161296490|NCT02492984|582468718|FG001|Overall Study|Adverse Event|0|||
161296491|NCT02492984|582468717|FG000|Overall Study|Protocol Violation|1|||
161296492|NCT02492984|582468718|FG001|Overall Study|Protocol Violation|0|||
161296493|NCT02492984|582468717|FG000|Overall Study|Withdrawal by Subject|1|||
161296494|NCT02492984|582468718|FG001|Overall Study|Withdrawal by Subject|0|||
161296495|NCT02282631|582468722|FG000|Overall Study|Lost to Follow-up|2|||
161296496|NCT02282631|582468723|FG001|Overall Study|Lost to Follow-up|0|||
161296497|NCT00459290|582468724|FG000|Overall Study|Adverse Event|3|||
161296498|NCT00459290|582468724|FG000|Overall Study|Ineligible|2|||
161296499|NCT00687271|582468725|FG000|Overall Study|Adverse Event|1|||
161296500|NCT00687271|582468726|FG001|Overall Study|Adverse Event|3|||
161296501|NCT00687271|582468727|FG002|Overall Study|Adverse Event|1|||
161296502|NCT00687271|582468728|FG003|Overall Study|Adverse Event|0|||
161296503|NCT00687271|582468725|FG000|Overall Study|Lost to Follow-up|0|||
161296504|NCT00687271|582468726|FG001|Overall Study|Lost to Follow-up|1|||
161296505|NCT00687271|582468727|FG002|Overall Study|Lost to Follow-up|0|||
161296506|NCT00687271|582468728|FG003|Overall Study|Lost to Follow-up|0|||
161296507|NCT00687271|582468725|FG000|Overall Study|Protocol Violation|2|||
161296508|NCT00687271|582468726|FG001|Overall Study|Protocol Violation|1|||
161296509|NCT00687271|582468727|FG002|Overall Study|Protocol Violation|1|||
161296510|NCT00687271|582468728|FG003|Overall Study|Protocol Violation|0|||
161296511|NCT00687271|582468725|FG000|Overall Study|Withdrawal by Subject|0|||
161296512|NCT00687271|582468726|FG001|Overall Study|Withdrawal by Subject|1|||
161296513|NCT00687271|582468727|FG002|Overall Study|Withdrawal by Subject|3|||
161296514|NCT00687271|582468728|FG003|Overall Study|Withdrawal by Subject|0|||
161296515|NCT02453334|582468729|FG000|Overall Study|Death|15|||
161296516|NCT02453334|582468730|FG001|Overall Study|Death|13|||
161296517|NCT02453334|582468729|FG000|Overall Study|Adverse Event|2|||
161296518|NCT02453334|582468730|FG001|Overall Study|Adverse Event|1|||
161296519|NCT02453334|582468729|FG000|Overall Study|Lost to Follow-up|5|||
161296520|NCT02453334|582468730|FG001|Overall Study|Lost to Follow-up|9|||
161296521|NCT02453334|582468729|FG000|Overall Study|Physician Decision|1|||
161296522|NCT02453334|582468730|FG001|Overall Study|Physician Decision|0|||
161296523|NCT02453334|582468729|FG000|Overall Study|Withdrawal by Subject|17|||
161296524|NCT02453334|582468730|FG001|Overall Study|Withdrawal by Subject|13|||
161296525|NCT02453334|582468729|FG000|Overall Study|Other reason|1|||
161296526|NCT02453334|582468730|FG001|Overall Study|Other reason|4|||
161296527|NCT01841762|582468731|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
161296528|NCT01841762|582468731|FG000|Treatment Period|Adverse Event|16|||
161296529|NCT01841762|582468731|FG000|Treatment Period|Death|1|||
161296530|NCT01841762|582468731|FG000|Treatment Period|Withdrawal by Subject|7|||
161296531|NCT01841762|582468731|FG000|Treatment Period|Lost to Follow-up|1|||
161296532|NCT01841762|582468731|FG000|Treatment Period|Physician Decision|2|||
161296533|NCT01841762|582468731|FG000|Treatment Period|Other, including non-compliance|5|||
161296534|NCT01841762|582468731|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
161296535|NCT01841762|582468731|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
161296536|NCT01841762|582468731|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
161296537|NCT01841762|582468731|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
161296538|NCT06152224|582468735|FG000|Overall Study|Withdrawal by Subject|1|||
161296539|NCT06152224|582468736|FG001|Overall Study|Withdrawal by Subject|0|||
161296540|NCT06152224|582468735|FG000|Overall Study|Lost to Follow-up|0|||
161296541|NCT06152224|582468736|FG001|Overall Study|Lost to Follow-up|1|||
161296542|NCT06152224|582468735|FG000|Overall Study|On Follow Up|18|||
161088092|NCT01688830|581711091|FG015|Overall Study|Lost to Follow-up|0|||
161296543|NCT06152224|582468736|FG001|Overall Study|On Follow Up|18|||
161296544|NCT05780983|582468737|FG000|Overall Study|Withdrawal by Subject|1|||
161296545|NCT06028438|582468738|FG000|Overall Study|Adverse Event|3|||
161296546|NCT06028438|582468739|FG001|Overall Study|Adverse Event|9|||
161296547|NCT06028438|582468738|FG000|Overall Study|Lack of Efficacy|1|||
161296548|NCT06028438|582468739|FG001|Overall Study|Lack of Efficacy|1|||
161296549|NCT06028438|582468738|FG000|Overall Study|Lost to Follow-up|1|||
161296550|NCT06028438|582468739|FG001|Overall Study|Lost to Follow-up|0|||
161296551|NCT06028438|582468738|FG000|Overall Study|Withdrawal by Subject|1|||
161296552|NCT06028438|582468739|FG001|Overall Study|Withdrawal by Subject|0|||
161296553|NCT06028438|582468738|FG000|Overall Study|Other|3|||
161296554|NCT06028438|582468739|FG001|Overall Study|Other|3|||
161296555|NCT00808210|582468740|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
161296556|NCT00808210|582468741|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
161296557|NCT00808210|582468740|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
161296558|NCT00808210|582468741|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
161296559|NCT00808210|582468740|FG000|Double-Blind TX Period|Adverse Event|0|||
161296560|NCT00808210|582468741|FG001|Double-Blind TX Period|Adverse Event|1|||
161296561|NCT00808210|582468740|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
161296562|NCT00808210|582468741|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
161296563|NCT00808210|582468740|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
161296564|NCT00808210|582468741|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
161296565|NCT00808210|582468740|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
161296566|NCT00808210|582468741|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
161296567|NCT02044302|582468742|FG000|Overall Study|study terminated|2|||
161296568|NCT02044302|582468743|FG001|Overall Study|study terminated|0|||
161296569|NCT03337113|582468750|FG000|Overall Study|Adverse Event|1|||
161296570|NCT03337113|582468751|FG001|Overall Study|Adverse Event|1|||
161347651|NCT00972738|582657331|FG000|Overall Study|Lack of Efficacy|5|||
161347652|NCT00972738|582657332|FG001|Overall Study|Lack of Efficacy|1|||
161347653|NCT00972738|582657333|FG002|Overall Study|Lack of Efficacy|11|||
161347654|NCT00972738|582657331|FG000|Overall Study|Withdrawal by Subject|5|||
161347655|NCT00972738|582657332|FG001|Overall Study|Withdrawal by Subject|1|||
161296571|NCT03337113|582468752|FG002|Overall Study|Adverse Event|0|||
161296572|NCT03337113|582468753|FG003|Overall Study|Adverse Event|1|||
161296573|NCT03337113|582468750|FG000|Overall Study|Physician Decision|0|||
161296574|NCT03337113|582468751|FG001|Overall Study|Physician Decision|2|||
161296575|NCT03337113|582468752|FG002|Overall Study|Physician Decision|0|||
161296576|NCT03337113|582468753|FG003|Overall Study|Physician Decision|1|||
161296577|NCT03337113|582468750|FG000|Overall Study|Withdrawal by Subject|0|||
161296578|NCT03337113|582468751|FG001|Overall Study|Withdrawal by Subject|0|||
161296579|NCT03337113|582468752|FG002|Overall Study|Withdrawal by Subject|1|||
161296580|NCT03337113|582468753|FG003|Overall Study|Withdrawal by Subject|0|||
161296581|NCT01372995|582468762|FG000|Overall Study|Spouse withdrew participant from study|0|||
161296582|NCT01372995|582468763|FG001|Overall Study|Spouse withdrew participant from study|1|||
161296583|NCT01372995|582468764|FG002|Overall Study|Spouse withdrew participant from study|0|||
161296584|NCT01372995|582468762|FG000|Overall Study|Physician Decision|0|||
161296585|NCT01372995|582468763|FG001|Overall Study|Physician Decision|0|||
161347656|NCT00972738|582657333|FG002|Overall Study|Withdrawal by Subject|4|||
161088093|NCT01688830|581711092|FG016|Overall Study|Lost to Follow-up|0|||
161088094|NCT01688830|581711093|FG017|Overall Study|Lost to Follow-up|0|||
161088095|NCT01688830|581711094|FG018|Overall Study|Lost to Follow-up|0|||
161088096|NCT01688830|581711095|FG019|Overall Study|Lost to Follow-up|0|||
161088097|NCT01688830|581711096|FG020|Overall Study|Lost to Follow-up|0|||
161088098|NCT04822597|581711097|FG000|Overall Study|Withdrawal by Subject|0|||
161088099|NCT04822597|581711098|FG001|Overall Study|Withdrawal by Subject|1|||
161088100|NCT04822597|581711099|FG002|Overall Study|Withdrawal by Subject|1|||
161088101|NCT04822597|581711100|FG003|Overall Study|Withdrawal by Subject|0|||
161088102|NCT04822597|581711097|FG000|Overall Study|Physician Decision|0|||
161088103|NCT04822597|581711098|FG001|Overall Study|Physician Decision|0|||
161088104|NCT04822597|581711099|FG002|Overall Study|Physician Decision|1|||
161088105|NCT04822597|581711100|FG003|Overall Study|Physician Decision|1|||
161088106|NCT04822597|581711097|FG000|Overall Study|Subject withdrawn after enrollment|0|||
161088107|NCT04822597|581711098|FG001|Overall Study|Subject withdrawn after enrollment|1|||
161088108|NCT04822597|581711099|FG002|Overall Study|Subject withdrawn after enrollment|0|||
161088109|NCT04822597|581711100|FG003|Overall Study|Subject withdrawn after enrollment|1|||
161088110|NCT04822597|581711097|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
161088111|NCT04822597|581711098|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
161088112|NCT04822597|581711099|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
161088113|NCT04822597|581711100|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
161088114|NCT00911768|581711101|FG000|Overall Study|Protocol Violation|5|||
161088115|NCT00911768|581711102|FG001|Overall Study|Protocol Violation|4|||
161088116|NCT00911768|581711101|FG000|Overall Study|Withdrawal by Subject|1|||
161088117|NCT00911768|581711102|FG001|Overall Study|Withdrawal by Subject|0|||
161175449|NCT04362813|582019646|FG000|Overall Study|Lost to Follow-up|1|||
161296586|NCT01372995|582468764|FG002|Overall Study|Physician Decision|1|||
161347657|NCT00972738|582657331|FG000|Overall Study|Moved|0|||
161088118|NCT03406078|581711104|FG000|Overall Study|Death|1|||
161088119|NCT03406078|581711105|FG001|Overall Study|Death|0|||
161296587|NCT01297517|582468769|FG000|Overall Study|Adverse Event|21|||
161296588|NCT01297517|582468770|FG001|Overall Study|Adverse Event|7|||
161296589|NCT01297517|582468771|FG002|Overall Study|Adverse Event|16|||
161296590|NCT01297517|582468769|FG000|Overall Study|Lost to Follow-up|1|||
161296591|NCT01297517|582468770|FG001|Overall Study|Lost to Follow-up|0|||
161296592|NCT01297517|582468771|FG002|Overall Study|Lost to Follow-up|1|||
161296593|NCT01297517|582468769|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
161296594|NCT01297517|582468770|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
161296595|NCT01297517|582468771|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
161175450|NCT04362813|582019647|FG001|Overall Study|Lost to Follow-up|1|||
161175451|NCT04362813|582019646|FG000|Overall Study|Enrolled but did not receive treatment|2|||
161296596|NCT01297517|582468769|FG000|Overall Study|Noncompliance|1|||
161296597|NCT01297517|582468770|FG001|Overall Study|Noncompliance|0|||
161296598|NCT01297517|582468771|FG002|Overall Study|Noncompliance|0|||
161296599|NCT01297517|582468769|FG000|Overall Study|Protocol Violation|1|||
161296600|NCT01297517|582468770|FG001|Overall Study|Protocol Violation|1|||
161296601|NCT01297517|582468771|FG002|Overall Study|Protocol Violation|1|||
161296602|NCT01297517|582468769|FG000|Overall Study|Inadequate Control of IOP|1|||
161296603|NCT01297517|582468770|FG001|Overall Study|Inadequate Control of IOP|1|||
161296604|NCT01297517|582468771|FG002|Overall Study|Inadequate Control of IOP|2|||
161296605|NCT02914613|582468772|FG000|Overall Study|Withdrawal by Subject|1|||
161175452|NCT04362813|582019647|FG001|Overall Study|Enrolled but did not receive treatment|4|||
161175453|NCT01732107|582019652|FG000|Overall Study|Adverse Event|2|||
161175454|NCT01732107|582019652|FG000|Overall Study|Disease Progression|8|||
161175455|NCT01732107|582019652|FG000|Overall Study|Physician Decision|1|||
161175456|NCT01732107|582019652|FG000|Overall Study|Withdrawal by Subject|2|||
161175457|NCT04445688|582019653|FG000|Washout (One Week)|Adverse Event|2|||
161175458|NCT04445688|582019653|FG000|Washout (One Week)|Withdrawal by Subject|1|||
161175459|NCT00615459|582019655|FG000|Period I|Adverse Event|2|||
161175460|NCT00615459|582019656|FG001|Period I|Adverse Event|0|||
161175461|NCT00615459|582019657|FG002|Period I|Adverse Event|1|||
161175462|NCT00615459|582019658|FG003|Period I|Adverse Event|0|||
161175463|NCT00615459|582019655|FG000|Period I|Subject withdrew consent|1|||
161175464|NCT00615459|582019656|FG001|Period I|Subject withdrew consent|0|||
161175465|NCT00615459|582019657|FG002|Period I|Subject withdrew consent|0|||
161175466|NCT00615459|582019658|FG003|Period I|Subject withdrew consent|1|||
161175467|NCT00615459|582019655|FG000|Period I|Abnormal test procedure results|1|||
161175468|NCT00615459|582019656|FG001|Period I|Abnormal test procedure results|1|||
161175469|NCT00615459|582019657|FG002|Period I|Abnormal test procedure results|1|||
161175470|NCT00615459|582019658|FG003|Period I|Abnormal test procedure results|0|||
161175471|NCT00615459|582019655|FG000|Period II|Adverse Event|1|||
161175472|NCT00615459|582019656|FG001|Period II|Adverse Event|0|||
161175473|NCT00615459|582019657|FG002|Period II|Adverse Event|0|||
161175474|NCT00615459|582019658|FG003|Period II|Adverse Event|0|||
161175475|NCT00615459|582019655|FG000|Period II|Lost to Follow-up|0|||
161175476|NCT00615459|582019656|FG001|Period II|Lost to Follow-up|0|||
161175477|NCT00615459|582019657|FG002|Period II|Lost to Follow-up|0|||
161175478|NCT00615459|582019658|FG003|Period II|Lost to Follow-up|1|||
161175479|NCT00615459|582019655|FG000|Period III|Adverse Event|0|||
161175480|NCT00615459|582019656|FG001|Period III|Adverse Event|1|||
161175481|NCT00615459|582019657|FG002|Period III|Adverse Event|0|||
161175482|NCT00615459|582019658|FG003|Period III|Adverse Event|0|||
161175483|NCT00615459|582019655|FG000|Period III|Administrative problems|0|||
161296606|NCT02914613|582468773|FG001|Overall Study|Withdrawal by Subject|2|||
161296607|NCT02914613|582468772|FG000|Overall Study|Adverse Event|1|||
161296608|NCT02914613|582468773|FG001|Overall Study|Adverse Event|0|||
161296609|NCT04938180|582468774|FG000|Overall Study|Adverse Event|1|||
161296610|NCT01964222|582468775|FG000|Overall Study|Lost to Follow-up|7|||
161296611|NCT01964222|582468776|FG001|Overall Study|Lost to Follow-up|5|||
161175484|NCT00615459|582019656|FG001|Period III|Administrative problems|1|||
161175485|NCT00615459|582019657|FG002|Period III|Administrative problems|1|||
161175486|NCT00615459|582019658|FG003|Period III|Administrative problems|0|||
161175487|NCT00615459|582019655|FG000|Period III|Unsatisfactory therapeutic effect|0|||
161175488|NCT00615459|582019656|FG001|Period III|Unsatisfactory therapeutic effect|1|||
161296612|NCT01964222|582468775|FG000|Overall Study|Withdrawal by Subject|6|||
161296613|NCT01964222|582468776|FG001|Overall Study|Withdrawal by Subject|6|||
161296614|NCT01964222|582468775|FG000|Overall Study|Screening Failure|2|||
161296615|NCT01964222|582468776|FG001|Overall Study|Screening Failure|0|||
161175489|NCT00615459|582019657|FG002|Period III|Unsatisfactory therapeutic effect|0|||
161175490|NCT00615459|582019658|FG003|Period III|Unsatisfactory therapeutic effect|0|||
161175491|NCT02017704|582019665|FG000|Overall Study|Withdrawal by Subject|2|||
161175492|NCT02017704|582019666|FG001|Overall Study|Withdrawal by Subject|0|||
161175493|NCT00918346|582019667|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
161296616|NCT01019694|582468781|FG000|Overall Study|Adverse Event|12|||
161175494|NCT00918346|582019668|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
161175495|NCT02076334|582019669|FG000|Overall Study|Protocol Violation|1|||
161175496|NCT02076334|582019670|FG001|Overall Study|Protocol Violation|0|||
161175497|NCT02076334|582019671|FG002|Overall Study|Protocol Violation|0|||
161296617|NCT01019694|582468782|FG001|Overall Study|Adverse Event|16|||
161296618|NCT01019694|582468783|FG002|Overall Study|Adverse Event|19|||
161296619|NCT01019694|582468781|FG000|Overall Study|Protocol Violation|2|||
161296620|NCT01019694|582468782|FG001|Overall Study|Protocol Violation|6|||
161296621|NCT01019694|582468783|FG002|Overall Study|Protocol Violation|4|||
161296622|NCT01019694|582468781|FG000|Overall Study|Lost to Follow-up|5|||
161296623|NCT01019694|582468782|FG001|Overall Study|Lost to Follow-up|3|||
161296624|NCT01019694|582468783|FG002|Overall Study|Lost to Follow-up|3|||
161296625|NCT01019694|582468781|FG000|Overall Study|Withdrawal by Subject|4|||
161296626|NCT01019694|582468782|FG001|Overall Study|Withdrawal by Subject|6|||
161296627|NCT01019694|582468783|FG002|Overall Study|Withdrawal by Subject|12|||
161296628|NCT01019694|582468781|FG000|Overall Study|Not treated|0|||
161296629|NCT01019694|582468782|FG001|Overall Study|Not treated|2|||
161296630|NCT01019694|582468783|FG002|Overall Study|Not treated|3|||
161296631|NCT01019694|582468781|FG000|Overall Study|Other reason (not specified)|1|||
161296632|NCT01019694|582468782|FG001|Overall Study|Other reason (not specified)|5|||
161296633|NCT01019694|582468783|FG002|Overall Study|Other reason (not specified)|6|||
161296634|NCT00441129|582468786|FG000|Overall Study|Withdrawal by Subject|6|||
161296635|NCT00441129|582468787|FG001|Overall Study|Withdrawal by Subject|14|||
161296636|NCT01737710|582468789|FG000|Overall Study|Lost to Follow-up|0|||
161296637|NCT01737710|582468790|FG001|Overall Study|Lost to Follow-up|2|||
161296638|NCT01737710|582468791|FG002|Overall Study|Lost to Follow-up|2|||
161296639|NCT01737710|582468792|FG003|Overall Study|Lost to Follow-up|0|||
161296640|NCT01737710|582468793|FG004|Overall Study|Lost to Follow-up|0|||
161296641|NCT01737710|582468789|FG000|Overall Study|Withdrawal by Subject|1|||
161296642|NCT01737710|582468790|FG001|Overall Study|Withdrawal by Subject|1|||
161296643|NCT01737710|582468791|FG002|Overall Study|Withdrawal by Subject|1|||
161296644|NCT01737710|582468792|FG003|Overall Study|Withdrawal by Subject|0|||
161296645|NCT01737710|582468793|FG004|Overall Study|Withdrawal by Subject|0|||
161296646|NCT01737710|582468789|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
161296647|NCT01737710|582468790|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
161296648|NCT01737710|582468791|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
161296649|NCT01737710|582468792|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
161296650|NCT01737710|582468793|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
161296651|NCT00758485|582468798|FG000|Overall Study|Lost to Follow-up|0|||
161296652|NCT00758485|582468799|FG001|Overall Study|Lost to Follow-up|1|||
161296653|NCT00758485|582468798|FG000|Overall Study|Not Treated|1|||
161296654|NCT00758485|582468799|FG001|Overall Study|Not Treated|2|||
161296655|NCT00921557|582468800|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
161296656|NCT00921557|582468801|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
161296657|NCT00921557|582468802|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
161296658|NCT00921557|582468800|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
161296659|NCT00921557|582468801|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
161296660|NCT00921557|582468802|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
161296661|NCT00921557|582468800|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
161296662|NCT00921557|582468801|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
161296663|NCT00921557|582468802|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
161296664|NCT00921557|582468800|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
161296665|NCT00921557|582468801|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
161296666|NCT00921557|582468802|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
161296667|NCT00921557|582468800|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
161296668|NCT00921557|582468801|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
161296669|NCT00921557|582468802|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
161296670|NCT03259425|582468803|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
161296671|NCT00463047|582468805|FG000|Titration Period 1|Adverse Event|10|||
161296672|NCT00463047|582468806|FG001|Titration Period 1|Adverse Event|8|||
161296673|NCT00463047|582468805|FG000|Titration Period 1|Lack of Efficacy|10|||
161296674|NCT00463047|582468806|FG001|Titration Period 1|Lack of Efficacy|4|||
161296675|NCT00463047|582468805|FG000|Titration Period 1|Lost to Follow-up|2|||
161296676|NCT00463047|582468806|FG001|Titration Period 1|Lost to Follow-up|0|||
161296677|NCT00463047|582468805|FG000|Titration Period 1|Non-compliance with study medication|3|||
161296678|NCT00463047|582468806|FG001|Titration Period 1|Non-compliance with study medication|5|||
161296679|NCT00463047|582468805|FG000|Titration Period 1|Protocol Violation|5|||
161088120|NCT03406078|581711104|FG000|Overall Study|Lost to Follow-up|0|||
161088121|NCT03406078|581711105|FG001|Overall Study|Lost to Follow-up|1|||
161296680|NCT00463047|582468806|FG001|Titration Period 1|Protocol Violation|5|||
161296681|NCT00463047|582468805|FG000|Titration Period 1|Withdrawal by Subject|3|||
161296682|NCT00463047|582468806|FG001|Titration Period 1|Withdrawal by Subject|5|||
161296683|NCT00463047|582468805|FG000|Titration Period 1|Non-compliance procedures|4|||
161296684|NCT00463047|582468806|FG001|Titration Period 1|Non-compliance procedures|10|||
161296685|NCT00463047|582468805|FG000|Titration Period 1|Other|0|||
161296686|NCT00463047|582468806|FG001|Titration Period 1|Other|2|||
161296687|NCT00463047|582468805|FG000|Titration Period 2|Adverse Event|9|||
161296688|NCT00463047|582468806|FG001|Titration Period 2|Adverse Event|9|||
161296689|NCT00463047|582468805|FG000|Titration Period 2|Lack of Efficacy|6|||
161296690|NCT00463047|582468806|FG001|Titration Period 2|Lack of Efficacy|4|||
161296691|NCT00463047|582468805|FG000|Titration Period 2|Withdrawal by Subject|1|||
161296692|NCT00463047|582468806|FG001|Titration Period 2|Withdrawal by Subject|0|||
161296693|NCT00463047|582468805|FG000|Titration Period 2|Protocol Violation|2|||
161296694|NCT00463047|582468806|FG001|Titration Period 2|Protocol Violation|3|||
161296695|NCT00463047|582468805|FG000|Titration Period 2|Lost to Follow-up|1|||
161296696|NCT00463047|582468806|FG001|Titration Period 2|Lost to Follow-up|2|||
161296697|NCT00463047|582468805|FG000|Titration Period 2|Non-compliance study medication|4|||
161296698|NCT00463047|582468806|FG001|Titration Period 2|Non-compliance study medication|2|||
161296699|NCT00463047|582468805|FG000|Titration Period 2|Non-compliance procedures|4|||
161296700|NCT00463047|582468806|FG001|Titration Period 2|Non-compliance procedures|1|||
161296701|NCT00463047|582468805|FG000|Titration Period 2|Other|3|||
161296702|NCT00463047|582468806|FG001|Titration Period 2|Other|2|||
161296703|NCT00463047|582468805|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
161296704|NCT00463047|582468806|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
161296705|NCT00463047|582468805|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
161296706|NCT00463047|582468806|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
161296707|NCT00463047|582468805|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
161296708|NCT00463047|582468806|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
161296709|NCT00463047|582468805|FG000|Double-Blind Treatment Period 1|Other|1|||
161296710|NCT00463047|582468806|FG001|Double-Blind Treatment Period 1|Other|0|||
161296711|NCT00463047|582468805|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
161175498|NCT02076334|582019672|FG003|Overall Study|Protocol Violation|0|||
161175499|NCT02076334|582019669|FG000|Overall Study|Lost to Follow-up|0|||
161175500|NCT02076334|582019670|FG001|Overall Study|Lost to Follow-up|1|||
161175501|NCT02076334|582019671|FG002|Overall Study|Lost to Follow-up|1|||
161175502|NCT02076334|582019672|FG003|Overall Study|Lost to Follow-up|0|||
161175503|NCT02076334|582019669|FG000|Overall Study|muscle soreness|0|||
161175504|NCT02076334|582019670|FG001|Overall Study|muscle soreness|0|||
161175505|NCT02076334|582019671|FG002|Overall Study|muscle soreness|0|||
161175506|NCT02076334|582019672|FG003|Overall Study|muscle soreness|1|||
161175507|NCT01975675|582019673|FG000|Overall Study|Death|0|||
161175508|NCT01975675|582019674|FG001|Overall Study|Death|1|||
161175509|NCT01975675|582019675|FG002|Overall Study|Death|0|||
161175510|NCT01975675|582019676|FG003|Overall Study|Death|0|||
161175511|NCT03639987|582019677|FG000|Overall Study|Study terminated by sponsor|26|||
161175512|NCT03639987|582019678|FG001|Overall Study|Study terminated by sponsor|25|||
161175513|NCT03639987|582019677|FG000|Overall Study|Lost to Follow-up|0|||
161175514|NCT03639987|582019678|FG001|Overall Study|Lost to Follow-up|1|||
161175515|NCT00224003|582019679|FG000|Overall Study|Adverse Event|1|||
161175516|NCT00224003|582019679|FG000|Overall Study|Protocol Violation|2|||
161175517|NCT00224003|582019679|FG000|Overall Study|Withdrawal by Subject|1|||
161175518|NCT00224003|582019679|FG000|Overall Study|unk|3|||
161175519|NCT03549429|582019680|FG000|Overall Study|Protocol Violation|5|||
161175520|NCT03549429|582019681|FG001|Overall Study|Protocol Violation|3|||
161175521|NCT00729326|582019689|FG000|Overall Study|Lost to Follow-up|2|||
161175522|NCT00729326|582019690|FG001|Overall Study|Lost to Follow-up|0|||
161175523|NCT00729326|582019689|FG000|Overall Study|Physician Decision|0|||
161175524|NCT00729326|582019690|FG001|Overall Study|Physician Decision|1|||
161175525|NCT00729326|582019689|FG000|Overall Study|Protocol Violation|3|||
161175526|NCT00729326|582019690|FG001|Overall Study|Protocol Violation|2|||
161175527|NCT00729326|582019689|FG000|Overall Study|Subject Decision|4|||
161175528|NCT00729326|582019690|FG001|Overall Study|Subject Decision|4|||
161175529|NCT00729326|582019689|FG000|Overall Study|Sponsor Decision|1|||
161175530|NCT00729326|582019690|FG001|Overall Study|Sponsor Decision|2|||
161175531|NCT01235728|582019693|FG000|Overall Study|Protocol Violation|0|||
161175532|NCT01235728|582019694|FG001|Overall Study|Protocol Violation|0|||
161175533|NCT01235728|582019695|FG002|Overall Study|Protocol Violation|0|||
161175534|NCT01235728|582019696|FG003|Overall Study|Protocol Violation|1|||
161175535|NCT01235728|582019697|FG004|Overall Study|Protocol Violation|0|||
161296712|NCT00463047|582468806|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
161175536|NCT01235728|582019698|FG005|Overall Study|Protocol Violation|0|||
161175537|NCT01235728|582019699|FG006|Overall Study|Protocol Violation|0|||
161296713|NCT00463047|582468805|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
161296714|NCT00463047|582468806|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
161175538|NCT01235728|582019700|FG007|Overall Study|Protocol Violation|0|||
161175539|NCT01000025|582019701|FG000|Overall Study|Adverse Event|43|||
161175540|NCT01000025|582019702|FG001|Overall Study|Adverse Event|2|||
161175541|NCT01000025|582019701|FG000|Overall Study|Withdrawal by Subject|13|||
161175542|NCT01000025|582019702|FG001|Overall Study|Withdrawal by Subject|8|||
161175543|NCT01000025|582019701|FG000|Overall Study|Death|23|||
161175544|NCT01000025|582019702|FG001|Overall Study|Death|13|||
161175545|NCT01000025|582019701|FG000|Overall Study|Lack of Efficacy|363|||
161175546|NCT01000025|582019702|FG001|Overall Study|Lack of Efficacy|208|||
161175547|NCT01000025|582019701|FG000|Overall Study|Intercurrent Illness|26|||
161296715|NCT00463047|582468805|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
161296716|NCT00463047|582468806|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
161296717|NCT02097745|582468816|FG000|Overall Study|Adverse Event|25|||
161296718|NCT02097745|582468816|FG000|Overall Study|Death|16|||
161296719|NCT02097745|582468816|FG000|Overall Study|Failure to Return|14|||
161296720|NCT02097745|582468816|FG000|Overall Study|Administrative/Other|27|||
161296721|NCT02097745|582468816|FG000|Overall Study|Reason Not Specified|96|||
161296722|NCT02748356|582468817|FG000|Overall Study|Withdrawal by Subject|1|||
161296723|NCT00425750|582468818|FG000|Overall Study|Death|1|||
161296724|NCT00425750|582468818|FG000|Overall Study|Withdrawal by Subject|3|||
161296725|NCT00425750|582468818|FG000|Overall Study|Adverse Event|3|||
161296726|NCT00425750|582468818|FG000|Overall Study|Progression of disease|18|||
161296727|NCT01732458|582468819|FG000|Overall Study|Lost to Follow-up|0|||
161296728|NCT01732458|582468820|FG001|Overall Study|Lost to Follow-up|2|||
161296729|NCT01732458|582468821|FG002|Overall Study|Lost to Follow-up|0|||
161296730|NCT01732458|582468822|FG003|Overall Study|Lost to Follow-up|0|||
161296731|NCT01732458|582468819|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161296732|NCT01732458|582468820|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161296733|NCT01732458|582468821|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161296734|NCT01732458|582468822|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161296735|NCT01732458|582468819|FG000|Overall Study|Physician Decision|1|||
161296736|NCT01732458|582468820|FG001|Overall Study|Physician Decision|2|||
161296737|NCT01732458|582468821|FG002|Overall Study|Physician Decision|2|||
161296738|NCT01732458|582468822|FG003|Overall Study|Physician Decision|0|||
161296739|NCT01732458|582468819|FG000|Overall Study|Protocol Violation|2|||
161296740|NCT01732458|582468820|FG001|Overall Study|Protocol Violation|0|||
161296741|NCT01732458|582468821|FG002|Overall Study|Protocol Violation|0|||
161296742|NCT01732458|582468822|FG003|Overall Study|Protocol Violation|2|||
161296743|NCT01732458|582468819|FG000|Overall Study|Screen Failure|0|||
161296744|NCT01732458|582468820|FG001|Overall Study|Screen Failure|1|||
161296745|NCT01732458|582468821|FG002|Overall Study|Screen Failure|0|||
161296746|NCT01732458|582468822|FG003|Overall Study|Screen Failure|0|||
161296747|NCT04331067|582468823|FG000|Overall Study|Adverse Event|1|||
161296748|NCT04331067|582468824|FG001|Overall Study|Adverse Event|3|||
161296749|NCT04331067|582468825|FG002|Overall Study|Adverse Event|1|||
161296750|NCT04331067|582468823|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
161296751|NCT04331067|582468824|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
161296752|NCT04331067|582468825|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
161296753|NCT05870371|582468826|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
161296754|NCT05870371|582468827|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
161296755|NCT02203721|582468828|FG000|Overall Study|Lost to Follow-up|1|||
161296756|NCT02203721|582468829|FG001|Overall Study|Lost to Follow-up|0|||
161296757|NCT02203721|582468828|FG000|Overall Study|Death|0|||
161296758|NCT02203721|582468829|FG001|Overall Study|Death|2|||
161296759|NCT02203721|582468828|FG000|Overall Study|Illness|0|||
161296760|NCT02203721|582468829|FG001|Overall Study|Illness|1|||
161296761|NCT00703157|582468830|FG000|Overall Study|Lost to Follow-up|0|||
161296762|NCT00703157|582468831|FG001|Overall Study|Lost to Follow-up|1|||
161296763|NCT00703157|582468830|FG000|Overall Study|source data permanently lost/ other|4|||
161296764|NCT00703157|582468831|FG001|Overall Study|source data permanently lost/ other|1|||
161296765|NCT02522884|582468832|FG000|Overall Study|Withdrawal by Subject|6|||
161296766|NCT02522884|582468832|FG000|Overall Study|Death|3|||
161296767|NCT02522884|582468832|FG000|Overall Study|Missed 12-month Follow-up|9|||
161296768|NCT04495751|582468835|FG000|Overall Study|Withdrawal by Subject|1|||
161296769|NCT04495751|582468836|FG001|Overall Study|Withdrawal by Subject|0|||
161296770|NCT04495751|582468835|FG000|Overall Study|Lost to Follow-up|1|||
161296771|NCT04495751|582468836|FG001|Overall Study|Lost to Follow-up|0|||
161296772|NCT03289754|582468837|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
161296773|NCT04873934|582468838|FG000|Overall Study|Adverse Event|0|||
161296774|NCT04873934|582468839|FG001|Overall Study|Adverse Event|1|||
161296775|NCT04873934|582468838|FG000|Overall Study|Death|0|||
161296776|NCT04873934|582468839|FG001|Overall Study|Death|2|||
161296777|NCT04873934|582468838|FG000|Overall Study|Lost to Follow-up|13|||
161296778|NCT04873934|582468839|FG001|Overall Study|Lost to Follow-up|9|||
161296779|NCT04873934|582468838|FG000|Overall Study|Physician Decision|1|||
161296780|NCT04873934|582468839|FG001|Overall Study|Physician Decision|1|||
161296781|NCT04873934|582468838|FG000|Overall Study|Protocol deviation|2|||
161296782|NCT04873934|582468839|FG001|Overall Study|Protocol deviation|1|||
161296783|NCT04873934|582468838|FG000|Overall Study|Subject decision|1|||
161296784|NCT04873934|582468839|FG001|Overall Study|Subject decision|8|||
161296785|NCT04873934|582468838|FG000|Overall Study|Withdrew consent|0|||
161296786|NCT04873934|582468839|FG001|Overall Study|Withdrew consent|4|||
161296787|NCT04873934|582468838|FG000|Overall Study|Missing|1|||
161296788|NCT04873934|582468839|FG001|Overall Study|Missing|0|||
161296789|NCT00708461|582468841|FG000|Overall Study|Lost to Follow-up|18|||
161296790|NCT00708461|582468842|FG001|Overall Study|Lost to Follow-up|11|||
161296791|NCT00708461|582468841|FG000|Overall Study|Withdrawal by Subject|8|||
161296792|NCT00708461|582468842|FG001|Overall Study|Withdrawal by Subject|9|||
161296793|NCT00708461|582468841|FG000|Overall Study|left workforce|115|||
161296794|NCT00708461|582468842|FG001|Overall Study|left workforce|180|||
161296795|NCT03584854|582468843|FG000|Overall Study|Primary outcome not measured|1|||
161296796|NCT03584854|582468844|FG001|Overall Study|Primary outcome not measured|2|||
161296797|NCT02968173|582468845|FG000|Overall Study|Withdrawal by Subject|1|||
161296798|NCT00314327|582468849|FG000|Overall Study|Withdrawal by Subject|1|||
161296799|NCT01207687|582468850|FG000|Overall Study|Adverse Event|1|||
161296800|NCT01207687|582468850|FG000|Overall Study|Withdrawal by Subject|1|||
161296801|NCT01801865|582468851|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
161296802|NCT01801865|582468851|FG000|Overall Study|Physician Decision|7|||
161296803|NCT01500382|582468852|FG000|Washout Period|Study site went out of business|0|||
161296804|NCT01500382|582468853|FG001|Washout Period|Study site went out of business|0|||
161296805|NCT01500382|582468854|FG002|Washout Period|Study site went out of business|1|||
161296806|NCT01500382|582468855|FG003|Washout Period|Study site went out of business|0|||
161296807|NCT02134015|582468856|FG000|Overall Study|Protocol Violation|0|||
161296808|NCT02134015|582468857|FG001|Overall Study|Protocol Violation|1|||
161296809|NCT02134015|582468856|FG000|Overall Study|Death|2|||
161296810|NCT02134015|582468857|FG001|Overall Study|Death|1|||
161296811|NCT02134015|582468856|FG000|Overall Study|Reason not provided|1|||
161296812|NCT02134015|582468857|FG001|Overall Study|Reason not provided|2|||
161296813|NCT02134015|582468856|FG000|Overall Study|Clinical progression|14|||
161296814|NCT02134015|582468857|FG001|Overall Study|Clinical progression|7|||
161296815|NCT02134015|582468856|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
161296816|NCT02134015|582468857|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
161296817|NCT02134015|582468856|FG000|Overall Study|Study terminated by sponsor|2|||
161296818|NCT02134015|582468857|FG001|Overall Study|Study terminated by sponsor|3|||
161296819|NCT02134015|582468856|FG000|Overall Study|Adverse Event|9|||
161296820|NCT02134015|582468857|FG001|Overall Study|Adverse Event|10|||
161296821|NCT02134015|582468856|FG000|Overall Study|Withdrawal by Subject|3|||
161296822|NCT02134015|582468857|FG001|Overall Study|Withdrawal by Subject|7|||
161296823|NCT05483686|582470432|FG000|Overall Study|Lost to Follow-up|5|||
161296824|NCT05483686|582470433|FG001|Overall Study|Lost to Follow-up|7|||
161296825|NCT02693106|582470434|FG000|Overall Study|No time|3|||
161296826|NCT03981900|582470435|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
161296827|NCT03981900|582470435|FG000|Overall Study|Adverse Event|5|||
161296828|NCT03981900|582470435|FG000|Overall Study|Protocol Violation|1|||
161296829|NCT03981900|582470435|FG000|Overall Study|Withdrawal by Subject|7|||
161296830|NCT03981900|582470435|FG000|Overall Study|Lost to Follow-up|46|||
161296831|NCT03981900|582470435|FG000|Overall Study|Decision of the researcher|3|||
161296832|NCT03981900|582470435|FG000|Overall Study|Death|3|||
161296833|NCT03981900|582470435|FG000|Overall Study|Other|5|||
161296834|NCT05625802|582470446|FG000|Overall Study|Lost to Follow-up|1|||
161296835|NCT05625802|582470447|FG001|Overall Study|Lost to Follow-up|0|||
161296836|NCT01954056|582470449|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
161296837|NCT01954056|582470450|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
161296838|NCT01164579|582470457|FG000|Overall Study|Lack of Efficacy|0|||
161296839|NCT01164579|582470458|FG001|Overall Study|Lack of Efficacy|0|||
161296840|NCT01164579|582470459|FG002|Overall Study|Lack of Efficacy|6|||
161296841|NCT01164579|582470457|FG000|Overall Study|Lost to Follow-up|1|||
161296842|NCT01164579|582470458|FG001|Overall Study|Lost to Follow-up|1|||
161296843|NCT01164579|582470459|FG002|Overall Study|Lost to Follow-up|0|||
161296844|NCT01164579|582470457|FG000|Overall Study|Withdrawal by Subject|2|||
161296845|NCT01164579|582470458|FG001|Overall Study|Withdrawal by Subject|5|||
161296846|NCT01164579|582470459|FG002|Overall Study|Withdrawal by Subject|3|||
161296847|NCT01164579|582470457|FG000|Overall Study|Protocol Violation|0|||
161296848|NCT01164579|582470458|FG001|Overall Study|Protocol Violation|1|||
161296849|NCT01164579|582470459|FG002|Overall Study|Protocol Violation|2|||
161296850|NCT01164579|582470457|FG000|Overall Study|Adverse Event|4|||
161296851|NCT01164579|582470458|FG001|Overall Study|Adverse Event|2|||
161296852|NCT01164579|582470459|FG002|Overall Study|Adverse Event|5|||
161296853|NCT01164579|582470457|FG000|Overall Study|Reason not specified|1|||
161296854|NCT01164579|582470458|FG001|Overall Study|Reason not specified|0|||
161296855|NCT01164579|582470459|FG002|Overall Study|Reason not specified|0|||
161296856|NCT06110494|582470460|FG000|Overall Study|Protocol Violation|2|||
161296857|NCT06110494|582470461|FG001|Overall Study|Protocol Violation|0|||
161296858|NCT06110494|582470462|FG002|Overall Study|Protocol Violation|1|||
161296859|NCT06110494|582470460|FG000|Overall Study|Dixon's test for outlier analysis|1|||
161296860|NCT06110494|582470461|FG001|Overall Study|Dixon's test for outlier analysis|1|||
161296861|NCT06110494|582470462|FG002|Overall Study|Dixon's test for outlier analysis|0|||
161296862|NCT00105079|582470463|FG000|Overall Study|Adverse Event|5|||
161296863|NCT00105079|582470464|FG001|Overall Study|Adverse Event|12|||
161296864|NCT00105079|582470463|FG000|Overall Study|Death|3|||
161296865|NCT00105079|582470464|FG001|Overall Study|Death|1|||
161296866|NCT00105079|582470463|FG000|Overall Study|Lost to Follow-up|12|||
161088122|NCT03406078|581711104|FG000|Overall Study|Withdrawal by Subject|5|||
161088123|NCT03406078|581711105|FG001|Overall Study|Withdrawal by Subject|2|||
161088124|NCT03616977|581711109|FG000|Period 1|Physician Decision|0|||
161088125|NCT03616977|581711110|FG001|Period 1|Physician Decision|1|||
161088126|NCT03616977|581711109|FG000|Period 3|Adverse Event|1|||
161175548|NCT01000025|582019702|FG001|Overall Study|Intercurrent Illness|7|||
161175549|NCT04423757|582019703|FG000|Overall Study|Adverse Event|2|||
161175550|NCT04423757|582019704|FG001|Overall Study|Adverse Event|0|||
161175551|NCT04423757|582019703|FG000|Overall Study|Not treated|1|||
161175552|NCT04423757|582019704|FG001|Overall Study|Not treated|1|||
161175553|NCT02738580|582019705|FG000|Overall Study|Adverse Event|1|||
161175554|NCT02738580|582019706|FG001|Overall Study|Adverse Event|0|||
161175555|NCT02738580|582019705|FG000|Overall Study|Lack of Efficacy|3|||
161175556|NCT02738580|582019706|FG001|Overall Study|Lack of Efficacy|2|||
161175557|NCT02738580|582019705|FG000|Overall Study|Withdrawal by Subject|0|||
161175558|NCT02738580|582019706|FG001|Overall Study|Withdrawal by Subject|1|||
161175559|NCT02738580|582019705|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
161175560|NCT02738580|582019706|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
161175561|NCT01202760|582019707|FG000|Overall Study|Entry Criteria Not Met|0|||
161175562|NCT01202760|582019708|FG001|Overall Study|Entry Criteria Not Met|3|||
161175563|NCT01202760|582019709|FG002|Overall Study|Entry Criteria Not Met|1|||
161175564|NCT01202760|582019707|FG000|Overall Study|Adverse Event|11|||
161175565|NCT01202760|582019708|FG001|Overall Study|Adverse Event|9|||
161175566|NCT01202760|582019709|FG002|Overall Study|Adverse Event|10|||
161175567|NCT01202760|582019707|FG000|Overall Study|Death|2|||
161175568|NCT01202760|582019708|FG001|Overall Study|Death|1|||
161175569|NCT01202760|582019709|FG002|Overall Study|Death|0|||
161175570|NCT01202760|582019707|FG000|Overall Study|Lack of Efficacy|6|||
161175571|NCT01202760|582019708|FG001|Overall Study|Lack of Efficacy|8|||
161175572|NCT01202760|582019709|FG002|Overall Study|Lack of Efficacy|7|||
161175573|NCT01202760|582019707|FG000|Overall Study|Lost to Follow-up|0|||
161175574|NCT01202760|582019708|FG001|Overall Study|Lost to Follow-up|2|||
161175575|NCT01202760|582019709|FG002|Overall Study|Lost to Follow-up|1|||
161175576|NCT01202760|582019707|FG000|Overall Study|Parent / Caregiver Decision|0|||
161175577|NCT01202760|582019708|FG001|Overall Study|Parent / Caregiver Decision|1|||
161175578|NCT01202760|582019709|FG002|Overall Study|Parent / Caregiver Decision|0|||
161175579|NCT01202760|582019707|FG000|Overall Study|Withdrawal by Subject|17|||
161175580|NCT01202760|582019708|FG001|Overall Study|Withdrawal by Subject|18|||
161175581|NCT01202760|582019709|FG002|Overall Study|Withdrawal by Subject|14|||
161175582|NCT01202760|582019707|FG000|Overall Study|Physician Decision|0|||
161175583|NCT01202760|582019708|FG001|Overall Study|Physician Decision|1|||
161175584|NCT01202760|582019709|FG002|Overall Study|Physician Decision|0|||
161175585|NCT01202760|582019707|FG000|Overall Study|Protocol Violation|7|||
161175586|NCT01202760|582019708|FG001|Overall Study|Protocol Violation|5|||
161175587|NCT01202760|582019709|FG002|Overall Study|Protocol Violation|2|||
161175588|NCT01202760|582019707|FG000|Overall Study|Sponsor Decision|4|||
161175589|NCT01202760|582019708|FG001|Overall Study|Sponsor Decision|4|||
161175590|NCT01202760|582019709|FG002|Overall Study|Sponsor Decision|0|||
161175591|NCT01654523|582019710|FG000|Overall Study|Withdrawal by Subject|1|||
161175592|NCT04354155|582019711|FG000|Overall Study|Withdrawal by Subject|1|||
161175593|NCT04354155|582019711|FG000|Overall Study|Did not meet criteria for study intervention|1|||
161175594|NCT01015820|582019714|FG000|Overall Study|Suboptimal measurements|1|||
161175595|NCT01015820|582019715|FG001|Overall Study|Suboptimal measurements|0|||
161175596|NCT02925312|582019722|FG000|Overall Study|Lost to Follow-up|25|||
161175597|NCT02925312|582019723|FG001|Overall Study|Lost to Follow-up|0|||
161175598|NCT02925312|582019722|FG000|Overall Study|Adverse Event|2|||
161175599|NCT02925312|582019723|FG001|Overall Study|Adverse Event|0|||
161175600|NCT02142504|582019724|FG000|Overall Study|Protocol Violation|2|||
161175601|NCT02142504|582019725|FG001|Overall Study|Protocol Violation|1|||
161175602|NCT02142504|582019726|FG002|Overall Study|Protocol Violation|2|||
161175603|NCT02142504|582019724|FG000|Overall Study|Adverse Event|2|||
161175604|NCT02142504|582019725|FG001|Overall Study|Adverse Event|3|||
161175605|NCT02142504|582019726|FG002|Overall Study|Adverse Event|4|||
161175606|NCT02142504|582019724|FG000|Overall Study|Lost to Follow-up|12|||
161175607|NCT02142504|582019725|FG001|Overall Study|Lost to Follow-up|19|||
161175608|NCT02142504|582019726|FG002|Overall Study|Lost to Follow-up|17|||
161175609|NCT02142504|582019724|FG000|Overall Study|Withdrawal by Subject|7|||
161175610|NCT02142504|582019725|FG001|Overall Study|Withdrawal by Subject|9|||
161175611|NCT02142504|582019726|FG002|Overall Study|Withdrawal by Subject|11|||
161347658|NCT00972738|582657332|FG001|Overall Study|Moved|0|||
161175612|NCT02142504|582019724|FG000|Overall Study|Pregnancy|4|||
161175613|NCT02142504|582019725|FG001|Overall Study|Pregnancy|4|||
161175614|NCT02142504|582019726|FG002|Overall Study|Pregnancy|2|||
161175615|NCT02142504|582019724|FG000|Overall Study|Physician Decision|0|||
161175616|NCT02142504|582019725|FG001|Overall Study|Physician Decision|1|||
161175617|NCT02142504|582019726|FG002|Overall Study|Physician Decision|3|||
161175618|NCT02142504|582019724|FG000|Overall Study|Reason Not Specified|4|||
161175619|NCT02142504|582019725|FG001|Overall Study|Reason Not Specified|5|||
161175620|NCT02142504|582019726|FG002|Overall Study|Reason Not Specified|4|||
161175621|NCT01998399|582019733|FG000|Overall Study|Lost to Follow-up|1|||
161175622|NCT01998399|582019734|FG001|Overall Study|Lost to Follow-up|3|||
161175623|NCT01998399|582019733|FG000|Overall Study|Death|4|||
161175624|NCT01998399|582019734|FG001|Overall Study|Death|2|||
161175625|NCT01998399|582019733|FG000|Overall Study|Study stopped before dosing completed|3|||
161347659|NCT00972738|582657333|FG002|Overall Study|Moved|1|||
161296867|NCT00105079|582470464|FG001|Overall Study|Lost to Follow-up|12|||
161296868|NCT00105079|582470463|FG000|Overall Study|Lack of Efficacy|9|||
161296869|NCT00105079|582470464|FG001|Overall Study|Lack of Efficacy|3|||
161296870|NCT00105079|582470463|FG000|Overall Study|Refused treatment|6|||
161296871|NCT00105079|582470464|FG001|Overall Study|Refused treatment|4|||
161296872|NCT00105079|582470463|FG000|Overall Study|Violation of selection criteria at entry|0|||
161296873|NCT00105079|582470464|FG001|Overall Study|Violation of selection criteria at entry|2|||
161296874|NCT00105079|582470463|FG000|Overall Study|Protocol Violation|1|||
161296875|NCT00105079|582470464|FG001|Overall Study|Protocol Violation|0|||
161296876|NCT00105079|582470463|FG000|Overall Study|Other|3|||
161296877|NCT00105079|582470464|FG001|Overall Study|Other|1|||
161296878|NCT02490371|582470465|FG000|Overall Study|Lost to Follow-up|1|||
161296879|NCT02490371|582470466|FG001|Overall Study|Lost to Follow-up|1|||
161296880|NCT00656292|582470469|FG000|Overall Study|Withdrawal by Subject|2|||
161296881|NCT00656292|582470470|FG001|Overall Study|Withdrawal by Subject|3|||
161296882|NCT00656292|582470469|FG000|Overall Study|Screen failure|1|||
161296883|NCT00656292|582470470|FG001|Overall Study|Screen failure|2|||
161296884|NCT03363776|582470471|FG000|Overall Study|Progressive disease|2|||
161296885|NCT03363776|582470472|FG001|Overall Study|Progressive disease|3|||
161296886|NCT03363776|582470473|FG002|Overall Study|Progressive disease|1|||
161296887|NCT03363776|582470471|FG000|Overall Study|Study drug toxicity|0|||
161296888|NCT03363776|582470472|FG001|Overall Study|Study drug toxicity|0|||
161296889|NCT03363776|582470473|FG002|Overall Study|Study drug toxicity|1|||
161296890|NCT03363776|582470471|FG000|Overall Study|Death|1|||
161296891|NCT03363776|582470472|FG001|Overall Study|Death|0|||
161296892|NCT03363776|582470473|FG002|Overall Study|Death|0|||
161296893|NCT02993250|582470481|FG000|Overall Study|Lost to Follow-up|0|||
161296894|NCT02993250|582470482|FG001|Overall Study|Lost to Follow-up|1|||
161296895|NCT02527434|582470484|FG000|Overall Study|Lost to Follow-up|2|||
161296896|NCT02527434|582470485|FG001|Overall Study|Lost to Follow-up|2|||
161088127|NCT03616977|581711110|FG001|Period 3|Adverse Event|1|||
161088128|NCT00591851|581711111|FG000|Overall Study|Withdrawal by Subject|3|||
161088129|NCT00591851|581711111|FG000|Overall Study|Adverse Event|2|||
161088130|NCT00591851|581711111|FG000|Overall Study|Progressive Disease|1|||
161088131|NCT00515853|581711112|FG000|Overall Study|Lost to Follow-up|9|||
161088132|NCT00515853|581711113|FG001|Overall Study|Lost to Follow-up|13|||
161088133|NCT00515853|581711112|FG000|Overall Study|Withdrawal by Subject|6|||
161088134|NCT00515853|581711113|FG001|Overall Study|Withdrawal by Subject|4|||
161088135|NCT00943111|581711118|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
161088136|NCT00943111|581711119|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
161088137|NCT00943111|581711120|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
161088138|NCT00943111|581711118|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
161296897|NCT02527434|582470486|FG002|Overall Study|Lost to Follow-up|0|||
161296898|NCT02527434|582470484|FG000|Overall Study|Death|19|||
161296899|NCT02527434|582470485|FG001|Overall Study|Death|6|||
161296900|NCT02527434|582470486|FG002|Overall Study|Death|17|||
161296901|NCT02527434|582470484|FG000|Overall Study|Withdrawal by Subject|5|||
161296902|NCT02527434|582470485|FG001|Overall Study|Withdrawal by Subject|3|||
161296903|NCT02527434|582470486|FG002|Overall Study|Withdrawal by Subject|3|||
161296904|NCT02527434|582470484|FG000|Overall Study|Reason Not Specified|1|||
161296905|NCT02527434|582470485|FG001|Overall Study|Reason Not Specified|0|||
161296906|NCT02527434|582470486|FG002|Overall Study|Reason Not Specified|0|||
161296907|NCT02527434|582470484|FG000|Overall Study|Site closure|1|||
161296908|NCT02527434|582470485|FG001|Overall Study|Site closure|0|||
161296909|NCT02527434|582470486|FG002|Overall Study|Site closure|0|||
161296910|NCT02861807|582470487|FG000|Overall Study|Lost to Follow-up|7|||
161296911|NCT02861807|582470488|FG001|Overall Study|Lost to Follow-up|6|||
161296912|NCT02861807|582470487|FG000|Overall Study|Withdrawal by Subject|5|||
161296913|NCT02861807|582470488|FG001|Overall Study|Withdrawal by Subject|8|||
161296914|NCT00568061|582470493|FG000|Overall Study|Inclusion / exclusion criteria|5|||
161296915|NCT00568061|582470494|FG001|Overall Study|Inclusion / exclusion criteria|1|||
161296916|NCT00568061|582470493|FG000|Overall Study|Adverse Event|0|||
161296917|NCT00568061|582470494|FG001|Overall Study|Adverse Event|1|||
161296918|NCT05027451|582470495|FG000|Overall Study|Lost to Follow-up|1|||
161296919|NCT05027451|582470496|FG001|Overall Study|Lost to Follow-up|1|||
161296920|NCT00356148|582470497|FG000|Overall Study|Reoperation within 30 days|2|||
161296921|NCT00356148|582470498|FG001|Overall Study|Reoperation within 30 days|1|||
161296922|NCT02693002|582470500|FG000|Overall Study|Withdrawal by Subject|1|||
161296923|NCT02693002|582470501|FG001|Overall Study|Withdrawal by Subject|0|||
161296924|NCT00812981|582470502|FG000|Overall Study|Other|0|||
161296925|NCT00812981|582470503|FG001|Overall Study|Other|1|||
161296926|NCT04666259|582470505|FG000|Treatment Phase|Physician Decision|9|||
161296927|NCT04666259|582470506|FG001|Treatment Phase|Physician Decision|3|||
161296928|NCT04666259|582470507|FG002|Treatment Phase|Physician Decision|3|||
161296929|NCT04666259|582470505|FG000|Treatment Phase|Adverse Event|3|||
161296930|NCT04666259|582470506|FG001|Treatment Phase|Adverse Event|1|||
161296931|NCT04666259|582470507|FG002|Treatment Phase|Adverse Event|0|||
161296932|NCT04666259|582470505|FG000|Treatment Phase|Subject decision|1|||
161296933|NCT04666259|582470506|FG001|Treatment Phase|Subject decision|2|||
161175626|NCT01998399|582019734|FG001|Overall Study|Study stopped before dosing completed|3|||
161175627|NCT01998399|582019733|FG000|Overall Study|Withdrawal by Subject|0|||
161175628|NCT01998399|582019734|FG001|Overall Study|Withdrawal by Subject|1|||
161175629|NCT04114539|582019736|FG000|Overall Study|Adverse Event|14|||
161175630|NCT04114539|582019736|FG000|Overall Study|Lost to Follow-up|2|||
161175631|NCT04114539|582019736|FG000|Overall Study|Non-compliance with Protocol|2|||
161175632|NCT04114539|582019736|FG000|Overall Study|Non-compliance with Study Drug|1|||
161175633|NCT04114539|582019736|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
161175634|NCT04114539|582019736|FG000|Overall Study|Withdrew consent|10|||
161175635|NCT04114539|582019736|FG000|Overall Study|Others not specified|5|||
161175636|NCT04114539|582019736|FG000|Overall Study|Investigator Decision|2|||
161175637|NCT00617591|582019737|FG000|Overall Study|Withdrew consent during Induction|4|||
161175638|NCT00617591|582019737|FG000|Overall Study|Withdrew consent during Maintenance|6|||
161175639|NCT00376246|582019738|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
161175640|NCT00376246|582019739|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
161175641|NCT00376246|582019738|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161175642|NCT00376246|582019739|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161175643|NCT00376246|582019738|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
161175644|NCT00376246|582019739|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
161175645|NCT00351819|582019745|FG000|Overall Study|Lost to Follow-up|4|||
161175646|NCT00351819|582019746|FG001|Overall Study|Lost to Follow-up|4|||
161175647|NCT00351819|582019745|FG000|Overall Study|Withdrawal by Subject|0|||
161175648|NCT00351819|582019746|FG001|Overall Study|Withdrawal by Subject|4|||
161175649|NCT00351819|582019745|FG000|Overall Study|Elevated PSA|1|||
161175650|NCT00351819|582019746|FG001|Overall Study|Elevated PSA|1|||
161175651|NCT00351819|582019745|FG000|Overall Study|Traumatic ankle fracture|1|||
161175652|NCT00351819|582019746|FG001|Overall Study|Traumatic ankle fracture|0|||
161175653|NCT00351819|582019745|FG000|Overall Study|Unprofessional behavior|1|||
161175654|NCT00351819|582019746|FG001|Overall Study|Unprofessional behavior|0|||
161175655|NCT00351819|582019745|FG000|Overall Study|Non-compliance|0|||
161175656|NCT00351819|582019746|FG001|Overall Study|Non-compliance|1|||
161175657|NCT00351819|582019745|FG000|Overall Study|Incarcerated|0|||
161175658|NCT00351819|582019746|FG001|Overall Study|Incarcerated|1|||
161175659|NCT00351819|582019745|FG000|Overall Study|Enrolled in another trial|0|||
161175660|NCT00351819|582019746|FG001|Overall Study|Enrolled in another trial|1|||
161175661|NCT00323310|582021651|FG000|Overall Study|Withdrawal by Subject|1|||
161175662|NCT00323310|582021651|FG000|Overall Study|a parent refused blood draw|1|||
161175663|NCT00323310|582021651|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
161175664|NCT03565991|582021652|FG000|Overall Study|Other|11|||
161175665|NCT03565991|582021653|FG001|Overall Study|Other|0|||
161175666|NCT03565991|582021652|FG000|Overall Study|Global deterioration of health status|14|||
161175667|NCT03565991|582021653|FG001|Overall Study|Global deterioration of health status|4|||
161175668|NCT03565991|582021652|FG000|Overall Study|Withdrawal by Subject|2|||
161175669|NCT03565991|582021653|FG001|Overall Study|Withdrawal by Subject|6|||
161175670|NCT03565991|582021652|FG000|Overall Study|Progressive disease|121|||
161175671|NCT03565991|582021653|FG001|Overall Study|Progressive disease|29|||
161175672|NCT03565991|582021652|FG000|Overall Study|Death|3|||
161175673|NCT03565991|582021653|FG001|Overall Study|Death|0|||
161175674|NCT03565991|582021652|FG000|Overall Study|Adverse Event|7|||
161175675|NCT03565991|582021653|FG001|Overall Study|Adverse Event|2|||
161175676|NCT02944513|582021654|FG000|Overall Study|Withdrawal by Subject|4|||
161175677|NCT02944513|582021655|FG001|Overall Study|Withdrawal by Subject|1|||
161175678|NCT00937326|582021656|FG000|Overall Study|Adverse Event|0|||
161175679|NCT00937326|582021657|FG001|Overall Study|Adverse Event|3|||
161175680|NCT00937326|582021658|FG002|Overall Study|Adverse Event|1|||
161175681|NCT00937326|582021659|FG003|Overall Study|Adverse Event|1|||
161296934|NCT04666259|582470507|FG002|Treatment Phase|Subject decision|0|||
161296935|NCT04666259|582470505|FG000|Treatment Phase|Progressive disease|0|||
161296936|NCT04666259|582470506|FG001|Treatment Phase|Progressive disease|1|||
161296937|NCT04666259|582470507|FG002|Treatment Phase|Progressive disease|0|||
161296938|NCT04666259|582470505|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
161296939|NCT04666259|582470506|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
161296940|NCT04666259|582470507|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
161296941|NCT04666259|582470505|FG000|Safety Follow-up Phase|Physician Decision|2|||
161296942|NCT04666259|582470506|FG001|Safety Follow-up Phase|Physician Decision|0|||
161296943|NCT04666259|582470507|FG002|Safety Follow-up Phase|Physician Decision|0|||
161175682|NCT00937326|582021660|FG004|Overall Study|Adverse Event|2|||
161175683|NCT00937326|582021656|FG000|Overall Study|Death|0|||
161175684|NCT00937326|582021657|FG001|Overall Study|Death|0|||
161175685|NCT00937326|582021658|FG002|Overall Study|Death|1|||
161175686|NCT00937326|582021659|FG003|Overall Study|Death|0|||
161175687|NCT00937326|582021660|FG004|Overall Study|Death|0|||
161175688|NCT00937326|582021656|FG000|Overall Study|Withdrawal by Subject|3|||
161175689|NCT00937326|582021657|FG001|Overall Study|Withdrawal by Subject|4|||
161175690|NCT00937326|582021658|FG002|Overall Study|Withdrawal by Subject|1|||
161175691|NCT00937326|582021659|FG003|Overall Study|Withdrawal by Subject|4|||
161175692|NCT00937326|582021660|FG004|Overall Study|Withdrawal by Subject|3|||
161175693|NCT00937326|582021656|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161175694|NCT00937326|582021657|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161175695|NCT00937326|582021658|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
161175696|NCT00937326|582021659|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161175697|NCT00937326|582021660|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
161175698|NCT00790218|582021661|FG000|Overall Study|Death|1|||
161175699|NCT00790218|582021662|FG001|Overall Study|Death|0|||
161175700|NCT00790218|582021663|FG002|Overall Study|Death|0|||
161175701|NCT04402385|582021669|FG000|Overall Study|Withdrawal by Subject|4|||
161175702|NCT04402385|582021670|FG001|Overall Study|Withdrawal by Subject|4|||
161175703|NCT04402385|582021669|FG000|Overall Study|Lost to Follow-up|1|||
161175704|NCT04402385|582021670|FG001|Overall Study|Lost to Follow-up|1|||
161175705|NCT04402385|582021669|FG000|Overall Study|Physician Decision|0|||
161175706|NCT04402385|582021670|FG001|Overall Study|Physician Decision|1|||
161175707|NCT00731666|582021671|FG000|Overall Study|Adverse Event|2|||
161175708|NCT00731666|582021671|FG000|Overall Study|Lost to Follow-up|8|||
161175709|NCT00731666|582021671|FG000|Overall Study|Withdrawal by Subject|2|||
161175710|NCT03250624|582021673|FG000|Overall Study|Lack of Efficacy|1|||
161175711|NCT03250624|582021674|FG001|Overall Study|Lack of Efficacy|4|||
161175712|NCT03250624|582021673|FG000|Overall Study|Adverse Event|0|||
161175713|NCT03250624|582021674|FG001|Overall Study|Adverse Event|1|||
161175714|NCT03250624|582021673|FG000|Overall Study|Other|1|||
161175715|NCT03250624|582021674|FG001|Overall Study|Other|2|||
161175716|NCT00948428|582021675|FG000|Overall Study|Withdrawal by Subject|6|||
161175717|NCT00948428|582021676|FG001|Overall Study|Withdrawal by Subject|12|||
161175718|NCT00948428|582021677|FG002|Overall Study|Withdrawal by Subject|7|||
161175719|NCT00948428|582021675|FG000|Overall Study|Adverse Event|6|||
161175720|NCT00948428|582021676|FG001|Overall Study|Adverse Event|3|||
161175721|NCT00948428|582021677|FG002|Overall Study|Adverse Event|0|||
161175722|NCT00948428|582021675|FG000|Overall Study|Lost to Follow-up|2|||
161175723|NCT00948428|582021676|FG001|Overall Study|Lost to Follow-up|1|||
161175724|NCT00948428|582021677|FG002|Overall Study|Lost to Follow-up|1|||
161175725|NCT00948428|582021675|FG000|Overall Study|Death|2|||
161175726|NCT00948428|582021676|FG001|Overall Study|Death|0|||
161175727|NCT00948428|582021677|FG002|Overall Study|Death|0|||
161175728|NCT00948428|582021675|FG000|Overall Study|Intercurrent Illness|1|||
161175729|NCT00948428|582021676|FG001|Overall Study|Intercurrent Illness|0|||
161175730|NCT00948428|582021677|FG002|Overall Study|Intercurrent Illness|0|||
161175731|NCT00948428|582021675|FG000|Overall Study|Non-compliance|1|||
161175732|NCT00948428|582021676|FG001|Overall Study|Non-compliance|2|||
161175733|NCT00948428|582021677|FG002|Overall Study|Non-compliance|0|||
161175734|NCT01843205|582021688|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
161175735|NCT01843205|582021689|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
161175736|NCT00606177|582021690|FG000|Overall Study|Adverse Event|9|||
161175737|NCT00606177|582021691|FG001|Overall Study|Adverse Event|5|||
161175738|NCT00606177|582021690|FG000|Overall Study|Lack of Efficacy|3|||
161175739|NCT00606177|582021691|FG001|Overall Study|Lack of Efficacy|7|||
161175740|NCT00606177|582021690|FG000|Overall Study|Physician Decision|1|||
161175741|NCT00606177|582021691|FG001|Overall Study|Physician Decision|0|||
161175742|NCT00606177|582021690|FG000|Overall Study|Protocol Violation|1|||
161175743|NCT00606177|582021691|FG001|Overall Study|Protocol Violation|4|||
161175744|NCT00606177|582021690|FG000|Overall Study|Withdrawal by Subject|5|||
161175745|NCT00606177|582021691|FG001|Overall Study|Withdrawal by Subject|6|||
161175746|NCT00606177|582021690|FG000|Overall Study|Progression to depressive phase|6|||
161175747|NCT00606177|582021691|FG001|Overall Study|Progression to depressive phase|1|||
161175748|NCT00606177|582021690|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
161175749|NCT00606177|582021691|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
161175750|NCT00606177|582021690|FG000|Overall Study|Change of residence or other commitments|1|||
161175751|NCT00606177|582021691|FG001|Overall Study|Change of residence or other commitments|1|||
161175752|NCT00136357|582021692|FG000|Overall Study|Withdrawal by Subject|3|||
161175753|NCT00136357|582021693|FG001|Overall Study|Withdrawal by Subject|2|||
161175754|NCT01518309|582021698|FG000|Overall Study|Adverse Event|6|||
161175755|NCT01518309|582021698|FG000|Overall Study|Death|6|||
161175756|NCT01518309|582021698|FG000|Overall Study|Lack of Efficacy|7|||
161175757|NCT01518309|582021698|FG000|Overall Study|Withdrawal by Subject|6|||
161175758|NCT01518309|582021698|FG000|Overall Study|Physician Decision|3|||
161175759|NCT01518309|582021698|FG000|Overall Study|Sponsor Decision|2|||
161175760|NCT01518309|582021698|FG000|Overall Study|Not in Predefined Categories|9|||
161175761|NCT02603172|582021699|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161175762|NCT02603172|582021700|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161175763|NCT02603172|582021701|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
161175764|NCT02603172|582021702|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161175765|NCT02603172|582021703|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161175766|NCT02603172|582021704|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161175767|NCT02603172|582021705|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161319492|NCT01863732|582555335|FG001|Overall Study|Physician Decision|0|||
161296944|NCT04666259|582470505|FG000|Safety Follow-up Phase|Subject decision|1|||
161296945|NCT04666259|582470506|FG001|Safety Follow-up Phase|Subject decision|0|||
161296946|NCT04666259|582470507|FG002|Safety Follow-up Phase|Subject decision|0|||
161296947|NCT04666259|582470505|FG000|Safety Follow-up Phase|Death|0|||
161296948|NCT04666259|582470506|FG001|Safety Follow-up Phase|Death|1|||
161296949|NCT04666259|582470507|FG002|Safety Follow-up Phase|Death|0|||
161296950|NCT04178122|582470508|FG000|Overall Study|Withdrawal by Subject|1|||
161296951|NCT04178122|582470509|FG001|Overall Study|Withdrawal by Subject|1|||
161296952|NCT04178122|582470508|FG000|Overall Study|Death|2|||
161296953|NCT04178122|582470509|FG001|Overall Study|Death|0|||
161296954|NCT04178122|582470508|FG000|Overall Study|Did not complete testing|3|||
161296955|NCT04178122|582470509|FG001|Overall Study|Did not complete testing|13|||
161296956|NCT03124407|582470514|FG000|Overall Study|Lost to Follow-up|1|||
161296957|NCT03124407|582470515|FG001|Overall Study|Lost to Follow-up|0|||
161296958|NCT03124407|582470516|FG002|Overall Study|Lost to Follow-up|0|||
161296959|NCT03124407|582470517|FG003|Overall Study|Lost to Follow-up|0|||
161296960|NCT03124407|582470514|FG000|Overall Study|Adverse Event|0|||
161296961|NCT03124407|582470515|FG001|Overall Study|Adverse Event|0|||
161296962|NCT03124407|582470516|FG002|Overall Study|Adverse Event|1|||
161296963|NCT03124407|582470517|FG003|Overall Study|Adverse Event|0|||
161296964|NCT05343364|582470518|FG000|Overall Study|Miscellaneous|0|||
161296965|NCT05343364|582470519|FG001|Overall Study|Miscellaneous|1|||
161296966|NCT01791894|582470520|FG000|Overall Study|Adverse Event|1|||
161296967|NCT00984542|582470523|FG000|Overall Study|disease progression|19|||
161296968|NCT00984542|582470523|FG000|Overall Study|toxicity|7|||
161296969|NCT00984542|582470523|FG000|Overall Study|Death|7|||
161296970|NCT00984542|582470523|FG000|Overall Study|complicating disease|3|||
161296971|NCT00984542|582470523|FG000|Overall Study|Withdrawal by Subject|3|||
161296972|NCT00984542|582470523|FG000|Overall Study|clinical deterioration|2|||
161296973|NCT01422889|582470524|FG000|Overall Study|No Data Entered for Study Stent|9|||
161296974|NCT02589639|582470535|FG000|Overall Study|Lost to Follow-up|1|||
161296975|NCT02589639|582470536|FG001|Overall Study|Lost to Follow-up|0|||
161296976|NCT02589639|582470537|FG002|Overall Study|Lost to Follow-up|0|||
161296977|NCT02589639|582470535|FG000|Overall Study|Protocol Violation|1|||
161296978|NCT02589639|582470536|FG001|Overall Study|Protocol Violation|0|||
161296979|NCT02589639|582470537|FG002|Overall Study|Protocol Violation|0|||
161296980|NCT02589639|582470535|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
161296981|NCT02589639|582470536|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
161296982|NCT02589639|582470537|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
161296983|NCT02589639|582470535|FG000|Overall Study|Adverse Event|4|||
161296984|NCT02589639|582470536|FG001|Overall Study|Adverse Event|5|||
161296985|NCT02589639|582470537|FG002|Overall Study|Adverse Event|3|||
161296986|NCT02589639|582470535|FG000|Overall Study|Other reason than specified above|1|||
161296987|NCT02589639|582470536|FG001|Overall Study|Other reason than specified above|2|||
161296988|NCT02589639|582470537|FG002|Overall Study|Other reason than specified above|1|||
161296989|NCT02589639|582470535|FG000|Overall Study|Not Treated|0|||
161296990|NCT02589639|582470536|FG001|Overall Study|Not Treated|3|||
161296991|NCT02589639|582470537|FG002|Overall Study|Not Treated|0|||
161296992|NCT01276756|582470538|FG000|Overall Study|Lost to Follow-up|2|||
161296993|NCT01276756|582470539|FG001|Overall Study|Lost to Follow-up|0|||
161296994|NCT01276756|582470538|FG000|Overall Study|Adverse Event|3|||
161296995|NCT01276756|582470539|FG001|Overall Study|Adverse Event|2|||
161296996|NCT02630251|582470540|FG000|Overall Study|Physician Decision|0|||
161296997|NCT02630251|582470541|FG001|Overall Study|Physician Decision|0|||
161296998|NCT02630251|582470542|FG002|Overall Study|Physician Decision|1|||
161296999|NCT02630251|582470543|FG003|Overall Study|Physician Decision|0|||
161297000|NCT00153179|582470549|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
161297001|NCT00153179|582470550|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
161297002|NCT00153179|582470551|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
161297003|NCT00153179|582470552|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
161297004|NCT03517540|582470553|FG000|Overall Study|Protocol Violation|2|||
161175768|NCT02603172|582021706|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
161175769|NCT00863317|582021707|FG000|Overall Study|Lost to Follow-up|8|||
161297005|NCT03517540|582470554|FG001|Overall Study|Protocol Violation|0|||
161297006|NCT03517540|582470555|FG002|Overall Study|Protocol Violation|0|||
161297007|NCT03517540|582470556|FG003|Overall Study|Protocol Violation|1|||
161297008|NCT03517540|582470553|FG000|Overall Study|Adverse Event|9|||
161297009|NCT03517540|582470554|FG001|Overall Study|Adverse Event|3|||
161297010|NCT03517540|582470555|FG002|Overall Study|Adverse Event|8|||
161297011|NCT03517540|582470556|FG003|Overall Study|Adverse Event|1|||
161175770|NCT00863317|582021708|FG001|Overall Study|Lost to Follow-up|9|||
161297012|NCT03517540|582470553|FG000|Overall Study|Withdrawal by Subject|3|||
161297013|NCT03517540|582470554|FG001|Overall Study|Withdrawal by Subject|4|||
161297014|NCT03517540|582470555|FG002|Overall Study|Withdrawal by Subject|1|||
161297015|NCT03517540|582470556|FG003|Overall Study|Withdrawal by Subject|3|||
161297016|NCT05763875|582470565|FG000|Overall Study|Subject decision|5|||
161297017|NCT05763875|582470566|FG001|Overall Study|Subject decision|2|||
161297018|NCT05763875|582470567|FG002|Overall Study|Subject decision|1|||
161297019|NCT05763875|582470565|FG000|Overall Study|Lost to Follow-up|4|||
161175771|NCT00038142|582021711|FG000|Overall Study|Ineligible|1|||
161175772|NCT00038142|582021712|FG001|Overall Study|Ineligible|0|||
161175773|NCT00038142|582021711|FG000|Overall Study|Progressive Disease|11|||
161175774|NCT00038142|582021712|FG001|Overall Study|Progressive Disease|7|||
161175775|NCT00038142|582021711|FG000|Overall Study|Death|1|||
161175776|NCT00038142|582021712|FG001|Overall Study|Death|0|||
161175777|NCT00038142|582021711|FG000|Overall Study|Adverse Event|1|||
161175778|NCT00038142|582021712|FG001|Overall Study|Adverse Event|0|||
161175779|NCT00038142|582021711|FG000|Overall Study|Unknown Reason|8|||
161175780|NCT00038142|582021712|FG001|Overall Study|Unknown Reason|0|||
161175781|NCT00441727|582021713|FG000|Overall Study|Protocol Violation|19|||
161175782|NCT00441727|582021714|FG001|Overall Study|Protocol Violation|28|||
161175783|NCT00441727|582021715|FG002|Overall Study|Protocol Violation|32|||
161175784|NCT00441727|582021713|FG000|Overall Study|Adverse Event|26|||
161175785|NCT00441727|582021714|FG001|Overall Study|Adverse Event|33|||
161175786|NCT00441727|582021715|FG002|Overall Study|Adverse Event|28|||
161175787|NCT00441727|582021713|FG000|Overall Study|Lack of Efficacy|7|||
161175788|NCT00441727|582021714|FG001|Overall Study|Lack of Efficacy|8|||
161175789|NCT00441727|582021715|FG002|Overall Study|Lack of Efficacy|48|||
161175790|NCT00441727|582021713|FG000|Overall Study|Withdrawal by Subject|40|||
161175791|NCT00441727|582021714|FG001|Overall Study|Withdrawal by Subject|34|||
161175792|NCT00441727|582021715|FG002|Overall Study|Withdrawal by Subject|47|||
161175793|NCT00441727|582021713|FG000|Overall Study|Lost to Follow-up|5|||
161175794|NCT00441727|582021714|FG001|Overall Study|Lost to Follow-up|6|||
161175795|NCT00441727|582021715|FG002|Overall Study|Lost to Follow-up|5|||
161175796|NCT00441727|582021713|FG000|Overall Study|Safety Reasons|3|||
161175797|NCT00441727|582021714|FG001|Overall Study|Safety Reasons|1|||
161175798|NCT00441727|582021715|FG002|Overall Study|Safety Reasons|3|||
161175799|NCT00441727|582021713|FG000|Overall Study|Various reason specified|6|||
161175800|NCT00441727|582021714|FG001|Overall Study|Various reason specified|8|||
161175801|NCT00441727|582021715|FG002|Overall Study|Various reason specified|5|||
161175802|NCT02133001|582021720|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
161175803|NCT02133001|582021721|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
161175804|NCT02133001|582021720|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
161175805|NCT02133001|582021721|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
161175806|NCT02133001|582021720|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
161175807|NCT02133001|582021721|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
161175808|NCT02133001|582021720|FG000|Double Blind (Day 1-25)|Other|2|||
161175809|NCT02133001|582021721|FG001|Double Blind (Day 1-25)|Other|2|||
161175810|NCT02133001|582021720|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
161175811|NCT02133001|582021721|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
161175812|NCT02133001|582021720|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
161175813|NCT02133001|582021721|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
161175814|NCT02133001|582021720|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
161175815|NCT02133001|582021721|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
161175816|NCT02133001|582021720|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
161175817|NCT02133001|582021721|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
161175818|NCT04211961|582021722|FG000|Overall Study|Death|0|||
161175819|NCT04211961|582021723|FG001|Overall Study|Death|1|||
161175820|NCT04211961|582021722|FG000|Overall Study|Lost to Follow-up|0|||
161175821|NCT04211961|582021723|FG001|Overall Study|Lost to Follow-up|1|||
161175822|NCT04211961|582021722|FG000|Overall Study|Withdrawal by Subject|0|||
161175823|NCT04211961|582021723|FG001|Overall Study|Withdrawal by Subject|1|||
161175824|NCT00420342|582021726|FG000|Overall Study|Lost to Follow-up|1|||
161175825|NCT00420342|582021727|FG001|Overall Study|Lost to Follow-up|0|||
161175826|NCT00420342|582021728|FG002|Overall Study|Lost to Follow-up|1|||
161175827|NCT00420342|582021726|FG000|Overall Study|Withdrawal by Subject|0|||
161175828|NCT00420342|582021727|FG001|Overall Study|Withdrawal by Subject|2|||
161175829|NCT00420342|582021728|FG002|Overall Study|Withdrawal by Subject|0|||
161175830|NCT04072575|582021735|FG000|Overall Study|Physician Decision|1|||
161175831|NCT04072575|582021735|FG000|Overall Study|Adverse Event|7|||
161175832|NCT04072575|582021735|FG000|Overall Study|Withdrawal by Subject|14|||
161175833|NCT04072575|582021735|FG000|Overall Study|Other|2|||
161175834|NCT00114218|582021738|FG000|Overall Study|Wrong Cell Type|2|||
161175835|NCT00114218|582021738|FG000|Overall Study|Wrong Primary|1|||
161175836|NCT00114218|582021738|FG000|Overall Study|Never Treated|1|||
161175837|NCT01505114|582021739|FG000|Overall Study|Withdrawal by Subject|5|||
161175838|NCT01505114|582021740|FG001|Overall Study|Withdrawal by Subject|4|||
161175839|NCT01505114|582021741|FG002|Overall Study|Withdrawal by Subject|4|||
161175840|NCT01505114|582021742|FG003|Overall Study|Withdrawal by Subject|7|||
161175841|NCT01505114|582021739|FG000|Overall Study|Death|1|||
161175842|NCT01505114|582021740|FG001|Overall Study|Death|0|||
161175843|NCT01505114|582021741|FG002|Overall Study|Death|0|||
161175844|NCT01505114|582021742|FG003|Overall Study|Death|1|||
161175845|NCT01505114|582021739|FG000|Overall Study|unable to adhere to visit schedule|3|||
161175846|NCT01505114|582021740|FG001|Overall Study|unable to adhere to visit schedule|2|||
161175847|NCT01505114|582021741|FG002|Overall Study|unable to adhere to visit schedule|3|||
161175848|NCT01505114|582021742|FG003|Overall Study|unable to adhere to visit schedule|3|||
161175849|NCT01505114|582021739|FG000|Overall Study|Lost to Follow-up|11|||
161175850|NCT01505114|582021740|FG001|Overall Study|Lost to Follow-up|5|||
161175851|NCT01505114|582021741|FG002|Overall Study|Lost to Follow-up|8|||
161175852|NCT01505114|582021742|FG003|Overall Study|Lost to Follow-up|7|||
161175853|NCT01505114|582021739|FG000|Overall Study|relocated|4|||
161175854|NCT01505114|582021740|FG001|Overall Study|relocated|2|||
161175855|NCT01505114|582021741|FG002|Overall Study|relocated|2|||
161175856|NCT01505114|582021742|FG003|Overall Study|relocated|3|||
161175857|NCT01505114|582021739|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
161175858|NCT01505114|582021740|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
161175859|NCT01505114|582021741|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
161175860|NCT01505114|582021742|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
161175861|NCT01505114|582021739|FG000|Overall Study|staff safety concerns|0|||
161175862|NCT01505114|582021740|FG001|Overall Study|staff safety concerns|0|||
161175863|NCT01505114|582021741|FG002|Overall Study|staff safety concerns|0|||
161175864|NCT01505114|582021742|FG003|Overall Study|staff safety concerns|1|||
161175865|NCT01505114|582021739|FG000|Overall Study|investigator decision|1|||
161175866|NCT01505114|582021740|FG001|Overall Study|investigator decision|0|||
161175867|NCT01505114|582021741|FG002|Overall Study|investigator decision|1|||
161175868|NCT01505114|582021742|FG003|Overall Study|investigator decision|0|||
161175869|NCT01235507|582021744|FG000|Overall Study|Adverse Event|1|||
161175870|NCT01235507|582021744|FG000|Overall Study|Withdrawal by Subject|1|||
161175871|NCT00588523|582021747|FG000|Overall Study|Not treated|3|||
161175872|NCT01459068|582021750|FG000|Overall Study|Withdrawal by Subject|8|||
161175873|NCT01459068|582021751|FG001|Overall Study|Withdrawal by Subject|18|||
161175874|NCT01459068|582021750|FG000|Overall Study|Lost to Follow-up|31|||
161175875|NCT01459068|582021751|FG001|Overall Study|Lost to Follow-up|15|||
161175876|NCT01459068|582021750|FG000|Overall Study|Death|0|||
161175877|NCT01459068|582021751|FG001|Overall Study|Death|1|||
161175878|NCT02023112|582021752|FG000|Overall Study|Withdrawal by Subject|2|||
161175879|NCT02023112|582021753|FG001|Overall Study|Withdrawal by Subject|1|||
161175880|NCT02910219|582021754|FG000|Overall Study|Withdrawal by Subject|1|||
161175881|NCT02910219|582021755|FG001|Overall Study|Withdrawal by Subject|1|||
161175882|NCT01425749|582021756|FG000|Overall Study|progression of melanoma|0|||
161175883|NCT01425749|582021757|FG001|Overall Study|progression of melanoma|1|||
161175884|NCT02096042|582021760|FG000|Overall Study|Disease Progression|1|||
161175885|NCT02096042|582021761|FG001|Overall Study|Disease Progression|0|||
161175886|NCT02096042|582021762|FG002|Overall Study|Disease Progression|0|||
161175887|NCT00701441|582021766|FG000|Overall Study|failure in cpap compliance|0|||
161175888|NCT00701441|582021767|FG001|Overall Study|failure in cpap compliance|4|||
161175889|NCT03034057|582021768|FG000|Overall Study|Withdrawal by Subject|10|||
161175890|NCT03034057|582021768|FG000|Overall Study|Protocol Violation|1|||
161175891|NCT03034057|582021768|FG000|Overall Study|Not defined|2|||
161175892|NCT03034057|582021768|FG000|Overall Study|Lost to Follow-up|19|||
161175893|NCT03034057|582021768|FG000|Overall Study|Adverse Event|22|||
161175894|NCT03034057|582021768|FG000|Overall Study|Medication error without associated AE|1|||
161175895|NCT03339401|582021770|FG000|Overall Study|Death|2|||
161175896|NCT03339401|582021771|FG001|Overall Study|Death|1|||
161175897|NCT03339401|582021770|FG000|Overall Study|Withdrawal by Subject|2|||
161175898|NCT03339401|582021771|FG001|Overall Study|Withdrawal by Subject|0|||
161175899|NCT03339401|582021770|FG000|Overall Study|Study terminated|4|||
161175900|NCT03339401|582021771|FG001|Overall Study|Study terminated|3|||
161175901|NCT03339401|582021770|FG000|Overall Study|Investigator Decision|1|||
161175902|NCT03339401|582021771|FG001|Overall Study|Investigator Decision|0|||
161175903|NCT00718523|582021772|FG000|Overall Study|Withdrawal by Subject|5|||
161175904|NCT00718523|582021773|FG001|Overall Study|Withdrawal by Subject|7|||
161175905|NCT00718523|582021772|FG000|Overall Study|Death|13|||
161175906|NCT00718523|582021773|FG001|Overall Study|Death|17|||
161175907|NCT01313078|582021774|FG000|Overall Study|Death|1|||
161175908|NCT01313078|582021774|FG000|Overall Study|Discontinued study drug|1|||
161175909|NCT01313078|582021774|FG000|Overall Study|Withdrawal by Subject|1|||
161175910|NCT00910728|582021775|FG000|Overall Study|Lack of Efficacy|2|||
161175911|NCT00910728|582021776|FG001|Overall Study|Lack of Efficacy|3|||
161175912|NCT00910728|582021777|FG002|Overall Study|Lack of Efficacy|1|||
161175913|NCT00910728|582021778|FG003|Overall Study|Lack of Efficacy|2|||
161175914|NCT00910728|582021779|FG004|Overall Study|Lack of Efficacy|1|||
161175915|NCT00910728|582021780|FG005|Overall Study|Lack of Efficacy|0|||
161175916|NCT00910728|582021781|FG006|Overall Study|Lack of Efficacy|2|||
161175917|NCT00910728|582021782|FG007|Overall Study|Lack of Efficacy|2|||
161175918|NCT00910728|582021783|FG008|Overall Study|Lack of Efficacy|2|||
161175919|NCT00910728|582021775|FG000|Overall Study|Withdrawal by Subject|0|||
161175920|NCT00910728|582021776|FG001|Overall Study|Withdrawal by Subject|0|||
161175921|NCT00910728|582021777|FG002|Overall Study|Withdrawal by Subject|0|||
161175922|NCT00910728|582021778|FG003|Overall Study|Withdrawal by Subject|0|||
161175923|NCT00910728|582021779|FG004|Overall Study|Withdrawal by Subject|3|||
161175924|NCT00910728|582021780|FG005|Overall Study|Withdrawal by Subject|1|||
161175925|NCT00910728|582021781|FG006|Overall Study|Withdrawal by Subject|2|||
161175926|NCT00910728|582021782|FG007|Overall Study|Withdrawal by Subject|0|||
161175927|NCT00910728|582021783|FG008|Overall Study|Withdrawal by Subject|0|||
161297020|NCT05763875|582470566|FG001|Overall Study|Lost to Follow-up|1|||
161297021|NCT05763875|582470567|FG002|Overall Study|Lost to Follow-up|2|||
161297022|NCT05763875|582470565|FG000|Overall Study|Adverse Event|1|||
161297023|NCT05763875|582470566|FG001|Overall Study|Adverse Event|0|||
161297024|NCT05763875|582470567|FG002|Overall Study|Adverse Event|0|||
161297025|NCT01777282|582470568|FG000|Overall Study|Persistent Hyperglycemia|0|||
161297026|NCT01777282|582470569|FG001|Overall Study|Persistent Hyperglycemia|0|||
161297027|NCT01777282|582470570|FG002|Overall Study|Persistent Hyperglycemia|1|||
161297028|NCT01777282|582470571|FG003|Overall Study|Persistent Hyperglycemia|0|||
161297029|NCT01777282|582470572|FG004|Overall Study|Persistent Hyperglycemia|0|||
161297030|NCT01777282|582470568|FG000|Overall Study|New Antidiabetic Medication|0|||
161297031|NCT01777282|582470569|FG001|Overall Study|New Antidiabetic Medication|0|||
161297032|NCT01777282|582470570|FG002|Overall Study|New Antidiabetic Medication|1|||
161297033|NCT01777282|582470571|FG003|Overall Study|New Antidiabetic Medication|0|||
161297034|NCT01777282|582470572|FG004|Overall Study|New Antidiabetic Medication|0|||
161297035|NCT01777282|582470568|FG000|Overall Study|Adverse Event|4|||
161297036|NCT01777282|582470569|FG001|Overall Study|Adverse Event|4|||
161297037|NCT01777282|582470570|FG002|Overall Study|Adverse Event|2|||
161297038|NCT01777282|582470571|FG003|Overall Study|Adverse Event|1|||
161297039|NCT01777282|582470572|FG004|Overall Study|Adverse Event|3|||
161297040|NCT01777282|582470568|FG000|Overall Study|Withdrawal by Subject|4|||
161297041|NCT01777282|582470569|FG001|Overall Study|Withdrawal by Subject|0|||
161297042|NCT01777282|582470570|FG002|Overall Study|Withdrawal by Subject|0|||
161297043|NCT01777282|582470571|FG003|Overall Study|Withdrawal by Subject|1|||
161297044|NCT01777282|582470572|FG004|Overall Study|Withdrawal by Subject|2|||
161297045|NCT01777282|582470568|FG000|Overall Study|Protocol Violation|2|||
161297046|NCT01777282|582470569|FG001|Overall Study|Protocol Violation|0|||
161297047|NCT01777282|582470570|FG002|Overall Study|Protocol Violation|1|||
161297048|NCT01777282|582470571|FG003|Overall Study|Protocol Violation|0|||
161297049|NCT01777282|582470572|FG004|Overall Study|Protocol Violation|2|||
161297050|NCT01777282|582470568|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
161297051|NCT01777282|582470569|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161297052|NCT01777282|582470570|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
161297053|NCT01777282|582470571|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161297054|NCT01777282|582470572|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
161297055|NCT04015518|582470573|FG000|Overall Study|Adverse Event|6|||
161297056|NCT04015518|582470574|FG001|Overall Study|Adverse Event|1|||
161297057|NCT04015518|582470575|FG002|Overall Study|Adverse Event|1|||
161297058|NCT04015518|582470576|FG003|Overall Study|Adverse Event|3|||
161297059|NCT04015518|582470577|FG004|Overall Study|Adverse Event|3|||
161175928|NCT00910728|582021775|FG000|Overall Study|(not specified)|2|||
161175929|NCT00910728|582021776|FG001|Overall Study|(not specified)|0|||
161175930|NCT00910728|582021777|FG002|Overall Study|(not specified)|1|||
161175931|NCT00910728|582021778|FG003|Overall Study|(not specified)|0|||
161175932|NCT00910728|582021779|FG004|Overall Study|(not specified)|1|||
161175933|NCT00910728|582021780|FG005|Overall Study|(not specified)|0|||
161175934|NCT00910728|582021781|FG006|Overall Study|(not specified)|0|||
161175935|NCT00910728|582021782|FG007|Overall Study|(not specified)|0|||
161175936|NCT00910728|582021783|FG008|Overall Study|(not specified)|0|||
161175937|NCT00910728|582021775|FG000|Overall Study|Adverse Event|2|||
161175938|NCT00910728|582021776|FG001|Overall Study|Adverse Event|0|||
161175939|NCT00910728|582021777|FG002|Overall Study|Adverse Event|1|||
161175940|NCT00910728|582021778|FG003|Overall Study|Adverse Event|1|||
161175941|NCT00910728|582021779|FG004|Overall Study|Adverse Event|0|||
161175942|NCT00910728|582021780|FG005|Overall Study|Adverse Event|0|||
161175943|NCT00910728|582021781|FG006|Overall Study|Adverse Event|2|||
161175944|NCT00910728|582021782|FG007|Overall Study|Adverse Event|1|||
161175945|NCT00910728|582021783|FG008|Overall Study|Adverse Event|1|||
161175946|NCT01068717|582021787|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
161175947|NCT01068717|582021788|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161175948|NCT01068717|582021789|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161175949|NCT01068717|582021790|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
161175950|NCT01822223|582021791|FG000|Overall Study|Death|0|||
161175951|NCT01822223|582021792|FG001|Overall Study|Death|1|||
161297060|NCT04015518|582470573|FG000|Overall Study|Lack of Efficacy|1|||
161297061|NCT04015518|582470574|FG001|Overall Study|Lack of Efficacy|0|||
161297062|NCT04015518|582470575|FG002|Overall Study|Lack of Efficacy|1|||
161297063|NCT04015518|582470576|FG003|Overall Study|Lack of Efficacy|0|||
161297064|NCT04015518|582470577|FG004|Overall Study|Lack of Efficacy|4|||
161297065|NCT04015518|582470573|FG000|Overall Study|Lost to Follow-up|0|||
161175952|NCT01449955|582021795|FG000|Overall Study|Withdrawal by Subject|1|||
161297066|NCT04015518|582470574|FG001|Overall Study|Lost to Follow-up|0|||
161175953|NCT01449955|582021796|FG001|Overall Study|Withdrawal by Subject|2|||
161175954|NCT03404518|582021801|FG000|Overall Study|Lost to Follow-up|28|||
161175955|NCT03404518|582021802|FG001|Overall Study|Lost to Follow-up|30|||
161175956|NCT03404518|582021801|FG000|Overall Study|Protocol Violation|13|||
161175957|NCT03404518|582021802|FG001|Overall Study|Protocol Violation|6|||
161175958|NCT05041062|582021803|FG000|Overall Study|Adverse Event|2|||
161175959|NCT03693404|582021807|FG000|Overall Study|Withdrawal by Subject|1|||
161175960|NCT03693404|582021808|FG001|Overall Study|Withdrawal by Subject|0|||
161175961|NCT03693404|582021807|FG000|Overall Study|Lost to Follow-up|0|||
161175962|NCT03693404|582021808|FG001|Overall Study|Lost to Follow-up|5|||
161175963|NCT03693404|582021807|FG000|Overall Study|Excluded from Analysis|0|||
161175964|NCT03693404|582021808|FG001|Overall Study|Excluded from Analysis|1|||
161175965|NCT01176240|582021809|FG000|Study 306A|Lack of Efficacy|2|||
161175966|NCT01176240|582021810|FG001|Study 306A|Lack of Efficacy|1|||
161175967|NCT01176240|582021809|FG000|Study 306A|Protocol Violation|0|||
161175968|NCT01176240|582021810|FG001|Study 306A|Protocol Violation|1|||
161175969|NCT01176240|582021809|FG000|Study 306A|Withdrawal by Subject|0|||
161175970|NCT01176240|582021810|FG001|Study 306A|Withdrawal by Subject|1|||
161175971|NCT01176240|582021809|FG000|Study 306A|Stop due to diverse problems|1|||
161175972|NCT01176240|582021810|FG001|Study 306A|Stop due to diverse problems|0|||
161175973|NCT01176240|582021809|FG000|Study 306B|Lack of Efficacy|5|||
161175974|NCT01176240|582021810|FG001|Study 306B|Lack of Efficacy|3|||
161175975|NCT01176240|582021809|FG000|Study 306B|Adverse Event|10|||
161175976|NCT01176240|582021810|FG001|Study 306B|Adverse Event|5|||
161175977|NCT01176240|582021809|FG000|Study 306B|Protocol Violation|2|||
161175978|NCT01176240|582021810|FG001|Study 306B|Protocol Violation|3|||
161175979|NCT01176240|582021809|FG000|Study 306B|Withdrawal by Subject|4|||
161175980|NCT01176240|582021810|FG001|Study 306B|Withdrawal by Subject|1|||
161175981|NCT01176240|582021809|FG000|Study 306B|Physician Decision|2|||
161175982|NCT01176240|582021810|FG001|Study 306B|Physician Decision|1|||
161175983|NCT01176240|582021809|FG000|Study 306B|Supine Hypertension|1|||
161175984|NCT01176240|582021810|FG001|Study 306B|Supine Hypertension|2|||
161175985|NCT01176240|582021809|FG000|Study 306B|Lost to Follow-up|0|||
161175986|NCT01176240|582021810|FG001|Study 306B|Lost to Follow-up|1|||
161175987|NCT01176240|582021809|FG000|Study 306B|withdrew prior to dosing|2|||
161175988|NCT01176240|582021810|FG001|Study 306B|withdrew prior to dosing|1|||
161175989|NCT05200455|582021811|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
161175990|NCT00807014|582021814|FG000|Overall Study|Participant Considered Disease Cured|13|||
161175991|NCT00807014|582021815|FG001|Overall Study|Participant Considered Disease Cured|2|||
161175992|NCT00807014|582021814|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
161175993|NCT00807014|582021815|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
161175994|NCT00807014|582021814|FG000|Overall Study|Protocol Violation|2|||
161175995|NCT00807014|582021815|FG001|Overall Study|Protocol Violation|8|||
161175996|NCT00807014|582021814|FG000|Overall Study|Adverse Event|0|||
161175997|NCT00807014|582021815|FG001|Overall Study|Adverse Event|2|||
161175998|NCT00807014|582021814|FG000|Overall Study|Lost to Follow-up|9|||
161175999|NCT00807014|582021815|FG001|Overall Study|Lost to Follow-up|7|||
161176000|NCT00807014|582021814|FG000|Overall Study|Recovery|1|||
161176001|NCT00807014|582021815|FG001|Overall Study|Recovery|0|||
161176002|NCT00807014|582021814|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
161176003|NCT00807014|582021815|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
161176004|NCT00651313|582021816|FG000|Overall Study|Adverse Event|0|||
161176005|NCT00651313|582021817|FG001|Overall Study|Adverse Event|1|||
161176006|NCT00651313|582021816|FG000|Overall Study|Withdrawal by Subject|3|||
161176007|NCT00651313|582021817|FG001|Overall Study|Withdrawal by Subject|1|||
161176008|NCT00651313|582021816|FG000|Overall Study|Lost to Follow-up|1|||
161176009|NCT00651313|582021817|FG001|Overall Study|Lost to Follow-up|1|||
161176010|NCT00651313|582021816|FG000|Overall Study|Adminstrative Discontinuation|2|||
161176011|NCT00651313|582021817|FG001|Overall Study|Adminstrative Discontinuation|3|||
161176012|NCT03700736|582021818|FG000|Overall Study|Pregnancy|1|||
161176013|NCT03700736|582021819|FG001|Overall Study|Pregnancy|1|||
161176014|NCT03700736|582021818|FG000|Overall Study|Withdrawal by Subject|2|||
161176015|NCT03700736|582021819|FG001|Overall Study|Withdrawal by Subject|6|||
161176016|NCT04126031|582021821|FG000|Part A|Withdrawal by Subject|0|||
161176017|NCT04126031|582021822|FG001|Part A|Withdrawal by Subject|0|||
161176018|NCT04126031|582021823|FG002|Part A|Withdrawal by Subject|1|||
161176019|NCT04126031|582021824|FG003|Part A|Withdrawal by Subject|0|||
161176020|NCT04126031|582021825|FG004|Part A|Withdrawal by Subject|0|||
161176021|NCT04126031|582021826|FG005|Part A|Withdrawal by Subject|0|||
161176022|NCT04126031|582021821|FG000|Part A|Other|1|||
161176023|NCT04126031|582021822|FG001|Part A|Other|0|||
161176024|NCT04126031|582021823|FG002|Part A|Other|0|||
161176025|NCT04126031|582021824|FG003|Part A|Other|0|||
161176026|NCT04126031|582021825|FG004|Part A|Other|0|||
161176027|NCT04126031|582021826|FG005|Part A|Other|0|||
161347660|NCT00972738|582657331|FG000|Overall Study|Other|1|||
161347661|NCT00972738|582657332|FG001|Overall Study|Other|2|||
161176028|NCT04126031|582021821|FG000|Part B|Adverse Event|0|||
161176029|NCT04126031|582021822|FG001|Part B|Adverse Event|0|||
161176030|NCT04126031|582021823|FG002|Part B|Adverse Event|0|||
161176031|NCT04126031|582021824|FG003|Part B|Adverse Event|0|||
161176032|NCT04126031|582021825|FG004|Part B|Adverse Event|0|||
161176033|NCT04126031|582021826|FG005|Part B|Adverse Event|2|||
161176034|NCT04126031|582021821|FG000|Part B|Pre-existing hypertransaminasemia|0|||
161347662|NCT00972738|582657333|FG002|Overall Study|Other|1|||
161297067|NCT04015518|582470575|FG002|Overall Study|Lost to Follow-up|0|||
161297068|NCT04015518|582470576|FG003|Overall Study|Lost to Follow-up|0|||
161297069|NCT04015518|582470577|FG004|Overall Study|Lost to Follow-up|1|||
161297070|NCT04015518|582470573|FG000|Overall Study|Withdrawal by Subject|0|||
161297071|NCT04015518|582470574|FG001|Overall Study|Withdrawal by Subject|1|||
161297072|NCT04015518|582470575|FG002|Overall Study|Withdrawal by Subject|0|||
161297073|NCT04015518|582470576|FG003|Overall Study|Withdrawal by Subject|1|||
161297074|NCT04015518|582470577|FG004|Overall Study|Withdrawal by Subject|1|||
161297075|NCT04015518|582470573|FG000|Overall Study|Patient did not come for consecutive visits|0|||
161297076|NCT04015518|582470574|FG001|Overall Study|Patient did not come for consecutive visits|1|||
161297077|NCT04015518|582470575|FG002|Overall Study|Patient did not come for consecutive visits|0|||
161297078|NCT04015518|582470576|FG003|Overall Study|Patient did not come for consecutive visits|0|||
161297079|NCT04015518|582470577|FG004|Overall Study|Patient did not come for consecutive visits|0|||
161297080|NCT04015518|582470573|FG000|Overall Study|not willing to travel due to Covid-19|0|||
161297081|NCT04015518|582470574|FG001|Overall Study|not willing to travel due to Covid-19|0|||
161297082|NCT04015518|582470575|FG002|Overall Study|not willing to travel due to Covid-19|1|||
161297083|NCT04015518|582470576|FG003|Overall Study|not willing to travel due to Covid-19|0|||
161297084|NCT04015518|582470577|FG004|Overall Study|not willing to travel due to Covid-19|0|||
161297085|NCT04015518|582470573|FG000|Overall Study|Patient wants to discontinue treatment|0|||
161297086|NCT04015518|582470574|FG001|Overall Study|Patient wants to discontinue treatment|0|||
161297087|NCT04015518|582470575|FG002|Overall Study|Patient wants to discontinue treatment|0|||
161297088|NCT04015518|582470576|FG003|Overall Study|Patient wants to discontinue treatment|1|||
161297089|NCT04015518|582470577|FG004|Overall Study|Patient wants to discontinue treatment|0|||
161297090|NCT04015518|582470573|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
161297091|NCT04015518|582470574|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
161297092|NCT04015518|582470575|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
161297093|NCT04015518|582470576|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
161297094|NCT04015518|582470577|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
161297095|NCT04015518|582470573|FG000|Overall Study|Pregnancy|0|||
161297096|NCT04015518|582470574|FG001|Overall Study|Pregnancy|0|||
161297097|NCT04015518|582470575|FG002|Overall Study|Pregnancy|0|||
161297098|NCT04015518|582470576|FG003|Overall Study|Pregnancy|0|||
161297099|NCT04015518|582470577|FG004|Overall Study|Pregnancy|1|||
161297100|NCT04015518|582470573|FG000|Overall Study|Personal reasons|1|||
161297101|NCT04015518|582470574|FG001|Overall Study|Personal reasons|0|||
161297102|NCT04015518|582470575|FG002|Overall Study|Personal reasons|0|||
161297103|NCT04015518|582470576|FG003|Overall Study|Personal reasons|0|||
161297104|NCT04015518|582470577|FG004|Overall Study|Personal reasons|1|||
161297105|NCT04015518|582470573|FG000|Overall Study|Withdrew consent|1|||
161297106|NCT04015518|582470574|FG001|Overall Study|Withdrew consent|0|||
161297107|NCT04015518|582470575|FG002|Overall Study|Withdrew consent|0|||
161297108|NCT04015518|582470576|FG003|Overall Study|Withdrew consent|0|||
161297109|NCT04015518|582470577|FG004|Overall Study|Withdrew consent|0|||
161297110|NCT04015518|582470573|FG000|Overall Study|Prostate carcinoma|1|||
161297111|NCT04015518|582470574|FG001|Overall Study|Prostate carcinoma|0|||
161297112|NCT04015518|582470575|FG002|Overall Study|Prostate carcinoma|0|||
161297113|NCT04015518|582470576|FG003|Overall Study|Prostate carcinoma|0|||
161297114|NCT04015518|582470577|FG004|Overall Study|Prostate carcinoma|0|||
161297115|NCT04015518|582470573|FG000|Overall Study|Could not keep appointments due to work|1|||
161297116|NCT04015518|582470574|FG001|Overall Study|Could not keep appointments due to work|0|||
161297117|NCT04015518|582470575|FG002|Overall Study|Could not keep appointments due to work|0|||
161297118|NCT04015518|582470576|FG003|Overall Study|Could not keep appointments due to work|0|||
161297119|NCT04015518|582470577|FG004|Overall Study|Could not keep appointments due to work|0|||
161297120|NCT00550745|582470578|FG000|Overall Study|Death|20|||
161297121|NCT00550745|582470579|FG001|Overall Study|Death|16|||
161297122|NCT00550745|582470578|FG000|Overall Study|Lost to Follow-up|45|||
161297123|NCT00550745|582470579|FG001|Overall Study|Lost to Follow-up|30|||
161297124|NCT00550745|582470578|FG000|Overall Study|Physician Decision|0|||
161297125|NCT00550745|582470579|FG001|Overall Study|Physician Decision|2|||
161297126|NCT00550745|582470578|FG000|Overall Study|Protocol Violation|4|||
161297127|NCT00550745|582470579|FG001|Overall Study|Protocol Violation|2|||
161297128|NCT00550745|582470578|FG000|Overall Study|Withdrawal by Subject|17|||
161297129|NCT00550745|582470579|FG001|Overall Study|Withdrawal by Subject|10|||
161297130|NCT00550745|582470578|FG000|Overall Study|Screen failure|1|||
161297131|NCT00550745|582470579|FG001|Overall Study|Screen failure|0|||
161297132|NCT01131455|582470580|FG000|Overall Study|Death of PI|6|||
161297133|NCT01131455|582470581|FG001|Overall Study|Death of PI|4|||
161297134|NCT01131455|582470582|FG002|Overall Study|Death of PI|0|||
161297135|NCT00764660|582470583|FG000|Overall Study|Adverse Event|6|||
161297136|NCT00764660|582470584|FG001|Overall Study|Adverse Event|3|||
161297137|NCT00764660|582470583|FG000|Overall Study|Lost to Follow-up|3|||
161297138|NCT00764660|582470584|FG001|Overall Study|Lost to Follow-up|4|||
161297139|NCT00764660|582470583|FG000|Overall Study|Withdrawal by Subject|7|||
161297140|NCT00764660|582470584|FG001|Overall Study|Withdrawal by Subject|3|||
161297141|NCT00764660|582470583|FG000|Overall Study|Noncompliance With Protocol|5|||
161297142|NCT00764660|582470584|FG001|Overall Study|Noncompliance With Protocol|1|||
161297143|NCT00764660|582470583|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
161297144|NCT00764660|582470584|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
161297145|NCT01515865|582472002|FG000|Part A (Open-label)|Other|3|||
161297146|NCT01515865|582472003|FG001|Part A (Open-label)|Other|0|||
161297147|NCT01515865|582472004|FG002|Part A (Open-label)|Other|0|||
161297148|NCT01515865|582472002|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
161297149|NCT01515865|582472003|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
161297150|NCT01515865|582472004|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
161297151|NCT01515865|582472002|FG000|Part B (Open-label)|Other|1|||
161297152|NCT01515865|582472003|FG001|Part B (Open-label)|Other|0|||
161176035|NCT04126031|582021822|FG001|Part B|Pre-existing hypertransaminasemia|0|||
161176036|NCT04126031|582021823|FG002|Part B|Pre-existing hypertransaminasemia|0|||
161176037|NCT04126031|582021824|FG003|Part B|Pre-existing hypertransaminasemia|0|||
161176038|NCT04126031|582021825|FG004|Part B|Pre-existing hypertransaminasemia|1|||
161176039|NCT04126031|582021826|FG005|Part B|Pre-existing hypertransaminasemia|0|||
161176040|NCT00131664|582021827|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
161176041|NCT00131664|582021828|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
161176042|NCT00131664|582021829|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
161176043|NCT00131664|582021830|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
161176044|NCT00131664|582021831|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
161176045|NCT00131664|582021832|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
161176046|NCT00131664|582021827|FG000|First Period (First 6 Months)|Death|0|||
161176047|NCT00131664|582021828|FG001|First Period (First 6 Months)|Death|1|||
161176048|NCT00131664|582021829|FG002|First Period (First 6 Months)|Death|0|||
161176049|NCT00131664|582021830|FG003|First Period (First 6 Months)|Death|0|||
161176050|NCT00131664|582021831|FG004|First Period (First 6 Months)|Death|0|||
161176051|NCT00131664|582021832|FG005|First Period (First 6 Months)|Death|0|||
161176052|NCT00131664|582021827|FG000|First Period (First 6 Months)|Protocol Violation|2|||
161176053|NCT00131664|582021828|FG001|First Period (First 6 Months)|Protocol Violation|2|||
161176054|NCT00131664|582021829|FG002|First Period (First 6 Months)|Protocol Violation|1|||
161176055|NCT00131664|582021830|FG003|First Period (First 6 Months)|Protocol Violation|0|||
161176056|NCT00131664|582021831|FG004|First Period (First 6 Months)|Protocol Violation|0|||
161176057|NCT00131664|582021832|FG005|First Period (First 6 Months)|Protocol Violation|0|||
161176058|NCT00131664|582021827|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
161176059|NCT00131664|582021828|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
161176060|NCT00131664|582021829|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
161176061|NCT00131664|582021830|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
161176062|NCT00131664|582021831|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
161176063|NCT00131664|582021832|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
161176064|NCT00131664|582021827|FG000|First Period (First 6 Months)|Adverse Event|9|||
161176065|NCT00131664|582021828|FG001|First Period (First 6 Months)|Adverse Event|4|||
161176066|NCT00131664|582021829|FG002|First Period (First 6 Months)|Adverse Event|5|||
161176067|NCT00131664|582021830|FG003|First Period (First 6 Months)|Adverse Event|0|||
161176068|NCT00131664|582021831|FG004|First Period (First 6 Months)|Adverse Event|0|||
161176069|NCT00131664|582021832|FG005|First Period (First 6 Months)|Adverse Event|0|||
161176070|NCT00131664|582021827|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
161176071|NCT00131664|582021828|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
161176072|NCT00131664|582021829|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161176073|NCT00131664|582021830|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161176074|NCT00131664|582021831|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161176075|NCT00131664|582021832|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
161176076|NCT00131664|582021827|FG000|First Period (First 6 Months)|Administrative reasons|2|||
161176077|NCT00131664|582021828|FG001|First Period (First 6 Months)|Administrative reasons|0|||
161176078|NCT00131664|582021829|FG002|First Period (First 6 Months)|Administrative reasons|5|||
161297153|NCT01515865|582472004|FG002|Part B (Open-label)|Other|0|||
161176079|NCT00131664|582021830|FG003|First Period (First 6 Months)|Administrative reasons|0|||
161176080|NCT00131664|582021831|FG004|First Period (First 6 Months)|Administrative reasons|0|||
161176081|NCT00131664|582021832|FG005|First Period (First 6 Months)|Administrative reasons|0|||
161176082|NCT00131664|582021827|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
161297154|NCT02510664|582472009|FG000|Overall Study|Transferred Care|9|||
161297155|NCT02510664|582472010|FG001|Overall Study|Transferred Care|9|||
161297156|NCT02510664|582472011|FG002|Overall Study|Transferred Care|0|||
161297157|NCT02510664|582472009|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
161297158|NCT02510664|582472010|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
161297159|NCT02510664|582472011|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
161297160|NCT02510664|582472009|FG000|Overall Study|Time Constraints|1|||
161297161|NCT02510664|582472010|FG001|Overall Study|Time Constraints|1|||
161297162|NCT02510664|582472011|FG002|Overall Study|Time Constraints|0|||
161297163|NCT04090060|582472013|FG000|Overall Study|Lost to Follow-up|76|||
161297164|NCT04090060|582472014|FG001|Overall Study|Lost to Follow-up|77|||
161176083|NCT00131664|582021828|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
161176084|NCT00131664|582021829|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
161176085|NCT00131664|582021830|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
161176086|NCT00131664|582021831|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
161176087|NCT00131664|582021832|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
161176088|NCT00131664|582021827|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
161176089|NCT00131664|582021828|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
161176090|NCT00131664|582021829|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
161176091|NCT00131664|582021830|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
161176092|NCT00131664|582021831|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
161176093|NCT00131664|582021832|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
161176094|NCT00131664|582021827|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
161176095|NCT00131664|582021828|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161176096|NCT00131664|582021829|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161176097|NCT00131664|582021830|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161176098|NCT00131664|582021831|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161176099|NCT00131664|582021832|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
161176100|NCT00131664|582021827|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
161176101|NCT00131664|582021828|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
161176102|NCT00131664|582021829|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
161176103|NCT00131664|582021830|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
161176104|NCT00131664|582021831|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
161176105|NCT00131664|582021832|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
161176106|NCT00131664|582021827|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161176107|NCT00131664|582021828|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161176108|NCT00131664|582021829|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161176109|NCT00131664|582021830|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
161176110|NCT00131664|582021831|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161176111|NCT00131664|582021832|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
161176112|NCT00131664|582021827|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
161176113|NCT00131664|582021828|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
161176114|NCT00131664|582021829|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
161176115|NCT00131664|582021830|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
161176116|NCT00131664|582021831|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
161176117|NCT00131664|582021832|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
161176118|NCT01731990|582024065|FG000|Overall Study|Adverse Event|1|||
161176119|NCT01731990|582024066|FG001|Overall Study|Adverse Event|5|||
161176120|NCT01731990|582024065|FG000|Overall Study|Withdrawal by Subject|1|||
161176121|NCT01731990|582024066|FG001|Overall Study|Withdrawal by Subject|1|||
161176122|NCT01731990|582024065|FG000|Overall Study|Protocol deviation|1|||
161176123|NCT01731990|582024066|FG001|Overall Study|Protocol deviation|2|||
161176124|NCT01731990|582024065|FG000|Overall Study|Death|1|||
161176125|NCT01731990|582024066|FG001|Overall Study|Death|0|||
161176126|NCT01183104|582024069|FG000|Overall Study|Adverse Event|8|||
161176127|NCT01183104|582024070|FG001|Overall Study|Adverse Event|6|||
161176128|NCT01183104|582024069|FG000|Overall Study|Death|0|||
161176129|NCT01183104|582024070|FG001|Overall Study|Death|1|||
161176130|NCT01183104|582024069|FG000|Overall Study|Lost to Follow-up|14|||
161176131|NCT01183104|582024070|FG001|Overall Study|Lost to Follow-up|7|||
161176132|NCT01183104|582024069|FG000|Overall Study|Physician Decision|5|||
161176133|NCT01183104|582024070|FG001|Overall Study|Physician Decision|8|||
161176134|NCT01183104|582024069|FG000|Overall Study|Withdrawal by Subject|6|||
161176135|NCT01183104|582024070|FG001|Overall Study|Withdrawal by Subject|11|||
161176136|NCT01183104|582024069|FG000|Overall Study|Nonparticipation in Extension Study|39|||
161176137|NCT01183104|582024070|FG001|Overall Study|Nonparticipation in Extension Study|50|||
161176138|NCT01183104|582024069|FG000|Overall Study|Did not receive study drug|5|||
161176139|NCT01183104|582024070|FG001|Overall Study|Did not receive study drug|9|||
161176140|NCT05516134|582024071|FG000|Overall Study|Lost to Follow-up|1|||
161176141|NCT05516134|582024072|FG001|Overall Study|Lost to Follow-up|0|||
161176142|NCT05516134|582024073|FG002|Overall Study|Lost to Follow-up|0|||
161176143|NCT01355497|582024082|FG000|Overall Study|Death|19|||
161176144|NCT01355497|582024083|FG001|Overall Study|Death|18|||
161176145|NCT01355497|582024082|FG000|Overall Study|Lost to Follow-up|3|||
161176146|NCT01355497|582024083|FG001|Overall Study|Lost to Follow-up|0|||
161176147|NCT01355497|582024082|FG000|Overall Study|Protocol Violation|0|||
161176148|NCT01355497|582024083|FG001|Overall Study|Protocol Violation|1|||
161176149|NCT01355497|582024082|FG000|Overall Study|other-not provided|9|||
161176150|NCT01355497|582024083|FG001|Overall Study|other-not provided|4|||
161176151|NCT01355497|582024082|FG000|Overall Study|Withdrawal by Subject|12|||
161176152|NCT01355497|582024083|FG001|Overall Study|Withdrawal by Subject|20|||
161297165|NCT00507455|582472018|FG000|Overall Study|Adverse Event|3|||
161297166|NCT00507455|582472019|FG001|Overall Study|Adverse Event|3|||
161297167|NCT00507455|582472020|FG002|Overall Study|Adverse Event|6|||
161297168|NCT00507455|582472018|FG000|Overall Study|Withdrawal by Subject|2|||
161297169|NCT00507455|582472019|FG001|Overall Study|Withdrawal by Subject|1|||
161297170|NCT00507455|582472020|FG002|Overall Study|Withdrawal by Subject|2|||
161297171|NCT00507455|582472018|FG000|Overall Study|Protocol Violation|4|||
161297172|NCT00507455|582472019|FG001|Overall Study|Protocol Violation|1|||
161297173|NCT00507455|582472020|FG002|Overall Study|Protocol Violation|1|||
161297174|NCT00507455|582472018|FG000|Overall Study|Lost to Follow-up|2|||
161297175|NCT00507455|582472019|FG001|Overall Study|Lost to Follow-up|0|||
161297176|NCT00507455|582472020|FG002|Overall Study|Lost to Follow-up|2|||
161297177|NCT00507455|582472018|FG000|Overall Study|Lack of Efficacy|0|||
161297178|NCT00507455|582472019|FG001|Overall Study|Lack of Efficacy|1|||
161297179|NCT00507455|582472020|FG002|Overall Study|Lack of Efficacy|0|||
161297180|NCT00507455|582472018|FG000|Overall Study|Other - miscellaneous reason|1|||
161297181|NCT00507455|582472019|FG001|Overall Study|Other - miscellaneous reason|0|||
161297182|NCT00507455|582472020|FG002|Overall Study|Other - miscellaneous reason|1|||
161297183|NCT02176655|582472021|FG000|Overall Study|Subjects did not treat|6|||
161297184|NCT01464593|582472027|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
161297185|NCT00386360|582472030|FG000|Overall Study|Adverse Event|4|||
161297186|NCT00386360|582472031|FG001|Overall Study|Adverse Event|2|||
161297187|NCT00386360|582472030|FG000|Overall Study|Physician Decision|2|||
161297188|NCT00386360|582472031|FG001|Overall Study|Physician Decision|2|||
161297189|NCT00386360|582472030|FG000|Overall Study|Lost to Follow-up|0|||
161297190|NCT00386360|582472031|FG001|Overall Study|Lost to Follow-up|2|||
161297191|NCT00386360|582472030|FG000|Overall Study|Protocol Violation|0|||
161297192|NCT00386360|582472031|FG001|Overall Study|Protocol Violation|3|||
161176153|NCT01355497|582024082|FG000|Overall Study|noncompliance|1|||
161176154|NCT01355497|582024083|FG001|Overall Study|noncompliance|2|||
161176155|NCT01355497|582024082|FG000|Overall Study|progressive disease|11|||
161176156|NCT01355497|582024083|FG001|Overall Study|progressive disease|8|||
161176157|NCT01355497|582024082|FG000|Overall Study|Adverse Event|11|||
161176158|NCT01355497|582024083|FG001|Overall Study|Adverse Event|10|||
161176159|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Death|3|||
161176160|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Death|0|||
161176161|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Death|0|||
161176162|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Death|0|||
161176163|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Death|0|||
161176164|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
161176165|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
161176166|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
161176167|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
161176168|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
161176169|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161176170|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
161176171|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
161176172|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161176173|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
161176174|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Other|0|||
161176175|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Other|0|||
161176176|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Other|1|||
161176177|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Other|0|||
161176178|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Other|0|||
161176179|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
161176180|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
161176181|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
161176182|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
161176183|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
161176184|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
161176185|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
161176186|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
161176187|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
161176188|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
161176189|NCT01224106|582024085|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161176190|NCT01224106|582024086|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161176191|NCT01224106|582024087|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161297193|NCT00386360|582472030|FG000|Overall Study|Withdrawal by Subject|3|||
161297194|NCT00386360|582472031|FG001|Overall Study|Withdrawal by Subject|6|||
161297195|NCT00386360|582472030|FG000|Overall Study|Did not take any study medication|0|||
161297196|NCT00386360|582472031|FG001|Overall Study|Did not take any study medication|2|||
161297197|NCT01073605|582472036|FG000|Overall Study|Ongoing at Cutoff Date|1|||
161297198|NCT01073605|582472037|FG001|Overall Study|Ongoing at Cutoff Date|1|||
161088139|NCT00943111|581711119|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
161088140|NCT00943111|581711120|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
161088141|NCT00943111|581711118|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
161088142|NCT00943111|581711119|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
161088143|NCT00943111|581711120|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
161088144|NCT00943111|581711118|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
161088145|NCT00943111|581711119|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
161088146|NCT00943111|581711120|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
161088147|NCT00943111|581711118|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
161088148|NCT00943111|581711119|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
161088149|NCT00943111|581711120|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
161088150|NCT00943111|581711118|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
161088151|NCT00943111|581711119|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
161088152|NCT00943111|581711120|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
161088153|NCT00943111|581711118|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
161088154|NCT00943111|581711119|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
161088155|NCT00943111|581711120|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
161088156|NCT00943111|581711118|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
161088157|NCT00943111|581711119|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
161088158|NCT00943111|581711120|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
161088159|NCT02665338|581711121|FG000|Overall Study|Withdrawal by Subject|0|||
161088160|NCT02665338|581711122|FG001|Overall Study|Withdrawal by Subject|1|||
161088161|NCT03798691|581711123|FG000|Overall Study|Lost to Follow-up|2|||
161088162|NCT03798691|581711124|FG001|Overall Study|Lost to Follow-up|2|||
161088163|NCT00953407|581712636|FG000|Overall Study|Failed inclusion criteria|1|||
161088164|NCT00953407|581712637|FG001|Overall Study|Failed inclusion criteria|1|||
161088165|NCT00953407|581712638|FG002|Overall Study|Failed inclusion criteria|1|||
161088166|NCT00953407|581712639|FG003|Overall Study|Failed inclusion criteria|1|||
161088167|NCT00953407|581712640|FG004|Overall Study|Failed inclusion criteria|1|||
161088168|NCT00953407|581712636|FG000|Overall Study|Lost to Follow-up|0|||
161088169|NCT00953407|581712637|FG001|Overall Study|Lost to Follow-up|0|||
161088170|NCT00953407|581712638|FG002|Overall Study|Lost to Follow-up|0|||
161088171|NCT00953407|581712639|FG003|Overall Study|Lost to Follow-up|1|||
161088172|NCT00953407|581712640|FG004|Overall Study|Lost to Follow-up|0|||
161088173|NCT02502097|581712641|FG000|Period 1|Adverse Event|0|||
161088174|NCT02502097|581712642|FG001|Period 1|Adverse Event|0|||
161088175|NCT02502097|581712643|FG002|Period 1|Adverse Event|1|||
161088176|NCT02502097|581712644|FG003|Period 1|Adverse Event|0|||
161088177|NCT02502097|581712641|FG000|Wash Out Period|Adverse Event|0|||
161088178|NCT02502097|581712642|FG001|Wash Out Period|Adverse Event|1|||
161088179|NCT02502097|581712643|FG002|Wash Out Period|Adverse Event|1|||
161088180|NCT02502097|581712644|FG003|Wash Out Period|Adverse Event|1|||
161088181|NCT02502097|581712641|FG000|Period 2|Adverse Event|0|||
161088182|NCT02502097|581712642|FG001|Period 2|Adverse Event|0|||
161088183|NCT02502097|581712643|FG002|Period 2|Adverse Event|1|||
161088184|NCT02502097|581712644|FG003|Period 2|Adverse Event|0|||
161088185|NCT02186223|581712645|FG000|Overall Study|Not eligible for device placement|6|||
161088186|NCT02186223|581712645|FG000|Overall Study|Unable to obtain femoral access|3|||
161088187|NCT02186223|581712645|FG000|Overall Study|Death|3|||
161088188|NCT02186223|581712645|FG000|Overall Study|Device in place less than 48 hours|9|||
161088189|NCT01111474|581712646|FG000|Overall Study|Lost to Follow-up|12|||
161088190|NCT00618982|581712647|FG000|Overall Study|Adverse Event|23|||
161088191|NCT00618982|581712647|FG000|Overall Study|Withdrawal by Subject|1|||
161088192|NCT00618982|581712647|FG000|Overall Study|Protocol Violation|1|||
161088193|NCT00618982|581712647|FG000|Overall Study|ongoing, still treated with study med.|25|||
161088194|NCT01383499|581712657|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
161088195|NCT01383499|581712658|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161088196|NCT01383499|581712659|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161088197|NCT01383499|581712660|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161088198|NCT02572882|581712662|FG000|Overall Study|Withdrawal by Subject|1|||
161088199|NCT02572882|581712662|FG000|Overall Study|Participant received kidney transplant|1|||
161088200|NCT01079663|581712665|FG000|Overall Study|Adverse Event|0|||
161088201|NCT01079663|581712666|FG001|Overall Study|Adverse Event|2|||
161088202|NCT01079663|581712665|FG000|Overall Study|Protocol Violation|0|||
161088203|NCT01079663|581712666|FG001|Overall Study|Protocol Violation|2|||
161088204|NCT03606668|581712667|FG000|Overall Study|Screen Failure|1|||
161088205|NCT03606668|581712667|FG000|Overall Study|Lost to Follow-up|1|||
161088206|NCT04447846|581712669|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
161088207|NCT00297232|581712670|FG000|Overall Study|Lack of Efficacy|7|||
161088208|NCT00297232|581712670|FG000|Overall Study|Lost to Follow-up|10|||
161088209|NCT00297232|581712670|FG000|Overall Study|Adverse Event|63|||
161088210|NCT00297232|581712670|FG000|Overall Study|Voluntary Withdrawal|120|||
161088211|NCT00297232|581712670|FG000|Overall Study|Subject was Noncompliant|9|||
161088212|NCT00297232|581712670|FG000|Overall Study|Death|9|||
161176192|NCT01224106|582024088|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161176193|NCT01224106|582024089|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161176194|NCT01224106|582024085|FG000|Open-Label Extension (OLE) Phase|Death|0|||
161176195|NCT01224106|582024086|FG001|Open-Label Extension (OLE) Phase|Death|0|||
161176196|NCT01224106|582024087|FG002|Open-Label Extension (OLE) Phase|Death|0|||
161176197|NCT01224106|582024088|FG003|Open-Label Extension (OLE) Phase|Death|1|||
161176198|NCT01224106|582024089|FG004|Open-Label Extension (OLE) Phase|Death|3|||
161176199|NCT01224106|582024085|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161176200|NCT01224106|582024086|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161176201|NCT01224106|582024087|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
161176202|NCT01224106|582024088|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
161176203|NCT01224106|582024089|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
161176204|NCT01224106|582024085|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161176205|NCT01224106|582024086|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161176206|NCT01224106|582024087|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
161176207|NCT01224106|582024088|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
161176208|NCT01224106|582024089|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
161176209|NCT01224106|582024085|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161176210|NCT01224106|582024086|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161176211|NCT01224106|582024087|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
161176212|NCT01224106|582024088|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
161176213|NCT01224106|582024089|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
161176214|NCT01224106|582024085|FG000|Open-Label Extension (OLE) Phase|Other|0|||
161176215|NCT01224106|582024086|FG001|Open-Label Extension (OLE) Phase|Other|0|||
161176216|NCT01224106|582024087|FG002|Open-Label Extension (OLE) Phase|Other|0|||
161176217|NCT01224106|582024088|FG003|Open-Label Extension (OLE) Phase|Other|5|||
161176218|NCT01224106|582024089|FG004|Open-Label Extension (OLE) Phase|Other|3|||
161176219|NCT00839436|582024090|FG000|Overall Study|Developed exclusionary condition|1|||
161176220|NCT00839436|582024091|FG001|Overall Study|Developed exclusionary condition|0|||
161176221|NCT00839436|582024092|FG002|Overall Study|Developed exclusionary condition|0|||
161176222|NCT00839436|582024090|FG000|Overall Study|Withdrawal by Subject|0|||
161176223|NCT00839436|582024091|FG001|Overall Study|Withdrawal by Subject|1|||
161176224|NCT00839436|582024092|FG002|Overall Study|Withdrawal by Subject|0|||
161176225|NCT00839436|582024090|FG000|Overall Study|Study drug no longer available|0|||
161176226|NCT00839436|582024091|FG001|Overall Study|Study drug no longer available|0|||
161176227|NCT00839436|582024092|FG002|Overall Study|Study drug no longer available|1|||
161176228|NCT01440972|582024093|FG000|Overall Study|Withdrawal by Subject|3|||
161176229|NCT01440972|582024094|FG001|Overall Study|Withdrawal by Subject|2|||
161176230|NCT03933215|582024095|FG000|Overall Study|Other|6|||
161176231|NCT03933215|582024095|FG000|Overall Study|Sponsor decision|5|||
161176232|NCT03933215|582024095|FG000|Overall Study|Protocol Violation|5|||
161176233|NCT03933215|582024095|FG000|Overall Study|Withdrawal by Subject|6|||
161176234|NCT03933215|582024095|FG000|Overall Study|Lost to Follow-up|6|||
161176235|NCT03933215|582024095|FG000|Overall Study|Enrolled but not treated|38|||
161176236|NCT05784129|582024096|FG000|Overall Study|Study terminated by sponsor|2|||
161176237|NCT05784129|582024097|FG001|Overall Study|Study terminated by sponsor|2|||
161176238|NCT00407550|582024098|FG000|Overall Study|Adverse Event|0|||
161176239|NCT00407550|582024099|FG001|Overall Study|Adverse Event|1|||
161176240|NCT00407550|582024098|FG000|Overall Study|Withdrawal by Subject|0|||
161176241|NCT00407550|582024099|FG001|Overall Study|Withdrawal by Subject|2|||
161176242|NCT00407550|582024098|FG000|Overall Study|Death|1|||
161176243|NCT00407550|582024099|FG001|Overall Study|Death|0|||
161176244|NCT00407550|582024098|FG000|Overall Study|Insurance or Other medical condition|2|||
161176245|NCT00407550|582024099|FG001|Overall Study|Insurance or Other medical condition|1|||
161176246|NCT01444898|582024100|FG000|Overall Study|Withdrawal by Subject|1|||
161176247|NCT02580591|582024102|FG000|Overall Study|Adverse Event|0|||
161176248|NCT02580591|582024103|FG001|Overall Study|Adverse Event|1|||
161176249|NCT02580591|582024104|FG002|Overall Study|Adverse Event|2|||
161176250|NCT02580591|582024105|FG003|Overall Study|Adverse Event|5|||
161176251|NCT02580591|582024102|FG000|Overall Study|Protocol Violation|3|||
161176252|NCT02580591|582024103|FG001|Overall Study|Protocol Violation|2|||
161176253|NCT02580591|582024104|FG002|Overall Study|Protocol Violation|1|||
161176254|NCT02580591|582024105|FG003|Overall Study|Protocol Violation|1|||
161176255|NCT02580591|582024102|FG000|Overall Study|Lost to Follow-up|5|||
161176256|NCT02580591|582024103|FG001|Overall Study|Lost to Follow-up|3|||
161176257|NCT02580591|582024104|FG002|Overall Study|Lost to Follow-up|3|||
161176258|NCT02580591|582024105|FG003|Overall Study|Lost to Follow-up|1|||
161176259|NCT02580591|582024102|FG000|Overall Study|Withdrawal by Subject|6|||
161176260|NCT02580591|582024103|FG001|Overall Study|Withdrawal by Subject|1|||
161176261|NCT02580591|582024104|FG002|Overall Study|Withdrawal by Subject|2|||
161176262|NCT02580591|582024105|FG003|Overall Study|Withdrawal by Subject|3|||
161176263|NCT02580591|582024102|FG000|Overall Study|Not treated|1|||
161176264|NCT02580591|582024103|FG001|Overall Study|Not treated|1|||
161176265|NCT02580591|582024104|FG002|Overall Study|Not treated|0|||
161176266|NCT02580591|582024105|FG003|Overall Study|Not treated|0|||
161176267|NCT02580591|582024102|FG000|Overall Study|Other than specified|3|||
161176268|NCT02580591|582024103|FG001|Overall Study|Other than specified|2|||
161176269|NCT02580591|582024104|FG002|Overall Study|Other than specified|5|||
161176270|NCT02580591|582024105|FG003|Overall Study|Other than specified|2|||
161176271|NCT01599806|582024107|FG000|Overall Study|Lost to Follow-up|20|||
161176272|NCT01599806|582024108|FG001|Overall Study|Lost to Follow-up|20|||
161176273|NCT01599806|582024107|FG000|Overall Study|Withdrawal by Subject|12|||
161176274|NCT01599806|582024108|FG001|Overall Study|Withdrawal by Subject|12|||
161176275|NCT01599806|582024107|FG000|Overall Study|Other Eligibility criteria|11|||
161176276|NCT01599806|582024108|FG001|Overall Study|Other Eligibility criteria|9|||
161176277|NCT03006926|582024109|FG000|Overall Study|Adverse Event|0|||
161176278|NCT03006926|582024110|FG001|Overall Study|Adverse Event|27|||
161176279|NCT03006926|582024109|FG000|Overall Study|Withdrawal by Subject|0|||
161176280|NCT03006926|582024110|FG001|Overall Study|Withdrawal by Subject|1|||
161176281|NCT03006926|582024109|FG000|Overall Study|Radiological Disease Progression|0|||
161176282|NCT03006926|582024110|FG001|Overall Study|Radiological Disease Progression|52|||
161176283|NCT03006926|582024109|FG000|Overall Study|Clinical Disease Progression|0|||
161176284|NCT03006926|582024110|FG001|Overall Study|Clinical Disease Progression|10|||
161176285|NCT03006926|582024109|FG000|Overall Study|Other|0|||
161176286|NCT03006926|582024110|FG001|Overall Study|Other|8|||
161176287|NCT01838213|582024111|FG000|Overall Study|Ineligible|166|||
161176288|NCT01838213|582024112|FG001|Overall Study|Ineligible|191|||
161176289|NCT04882072|582024117|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
161176290|NCT04882072|582024118|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
161176291|NCT04882072|582024117|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
161176292|NCT04882072|582024118|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
161176293|NCT04882072|582024117|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
161176294|NCT04882072|582024118|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
161176295|NCT02918318|582024119|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
161176296|NCT02918318|582024120|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
161176297|NCT02918318|582024121|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
161176298|NCT02918318|582024122|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
161176299|NCT02918318|582024123|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
161176300|NCT02918318|582024119|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161176301|NCT02918318|582024120|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161176302|NCT02918318|582024121|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161176303|NCT02918318|582024122|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
161176304|NCT02918318|582024123|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
161176305|NCT02918318|582024119|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161176306|NCT02918318|582024120|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161176307|NCT02918318|582024121|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161176308|NCT02918318|582024122|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
161176309|NCT02918318|582024123|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
161176310|NCT02918318|582024119|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
161176311|NCT02918318|582024120|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
161176312|NCT02918318|582024121|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161176313|NCT02918318|582024122|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161176314|NCT02918318|582024123|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
161176315|NCT02918318|582024119|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161176316|NCT02918318|582024120|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161176317|NCT02918318|582024121|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161176318|NCT02918318|582024122|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
161176319|NCT02918318|582024123|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
161176320|NCT02918318|582024119|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
161347663|NCT01793935|582657336|FG000|Overall Study|Pregnancy|1|||
161176321|NCT02918318|582024120|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
161176322|NCT02918318|582024121|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
161176323|NCT02918318|582024122|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
161176324|NCT02918318|582024123|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
161176325|NCT02918318|582024119|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161176326|NCT02918318|582024120|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161176327|NCT02918318|582024121|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161347664|NCT01793935|582657337|FG001|Overall Study|Pregnancy|0|||
161347665|NCT01793935|582657336|FG000|Overall Study|Protocol Violation|2|||
161347666|NCT01793935|582657337|FG001|Overall Study|Protocol Violation|1|||
161176328|NCT02918318|582024122|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
161176329|NCT02918318|582024123|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
161176330|NCT02918318|582024119|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161347667|NCT01793935|582657336|FG000|Overall Study|Adverse Event|2|||
161176331|NCT02918318|582024120|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
161176332|NCT02918318|582024121|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161176333|NCT02918318|582024122|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
161176334|NCT02918318|582024123|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
161176335|NCT02918318|582024119|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
161176336|NCT02918318|582024120|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161176337|NCT02918318|582024121|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161176338|NCT02918318|582024122|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
161176339|NCT02918318|582024123|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
161176340|NCT02918318|582024119|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
161176341|NCT02918318|582024120|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
161176342|NCT02918318|582024121|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
161176343|NCT02918318|582024122|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
161176344|NCT02918318|582024123|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
161176345|NCT02918318|582024119|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161176346|NCT02918318|582024120|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161176347|NCT02918318|582024121|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161176348|NCT02918318|582024122|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
161176349|NCT02918318|582024123|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
161176350|NCT02918318|582024119|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161176351|NCT02918318|582024120|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161176352|NCT02918318|582024121|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161176353|NCT02918318|582024122|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
161176354|NCT02918318|582024123|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
161176355|NCT00990249|582024124|FG000|Overall Study|Disease Progression|8|||
161176356|NCT00990249|582024124|FG000|Overall Study|Non-Compliance|1|||
161176357|NCT00990249|582024124|FG000|Overall Study|Death|2|||
161176358|NCT00990249|582024124|FG000|Overall Study|Not treated|2|||
161176359|NCT01548417|582024125|FG000|Overall Study|Withdrawal by Subject|0|||
161176360|NCT01548417|582024126|FG001|Overall Study|Withdrawal by Subject|2|||
161176361|NCT04583969|582024129|FG000|Overall Study|Death|31|||
161176362|NCT04583969|582024130|FG001|Overall Study|Death|38|||
161176363|NCT04583969|582024129|FG000|Overall Study|Lost to Follow-up|16|||
161176364|NCT04583969|582024130|FG001|Overall Study|Lost to Follow-up|13|||
161176365|NCT04583969|582024129|FG000|Overall Study|Protocol Violation|1|||
161176366|NCT04583969|582024130|FG001|Overall Study|Protocol Violation|0|||
161176367|NCT04583969|582024129|FG000|Overall Study|Withdrawal by Subject|3|||
161176368|NCT04583969|582024130|FG001|Overall Study|Withdrawal by Subject|3|||
161176369|NCT04583969|582024129|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
161176370|NCT04583969|582024130|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
161176371|NCT04583969|582024129|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
161176372|NCT04583969|582024130|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
161176373|NCT04583969|582024129|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
161176374|NCT04583969|582024130|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
161176375|NCT04583969|582024129|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
161176376|NCT04583969|582024130|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
161176377|NCT04583969|582024129|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
161176378|NCT04583969|582024130|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
161176379|NCT02873208|582024131|FG000|Overall Study|Withdrawal by Subject|36|||
161176380|NCT02873208|582024131|FG000|Overall Study|Lost to Follow-up|22|||
161176381|NCT02873208|582024131|FG000|Overall Study|Adverse Event|15|||
161176382|NCT02873208|582024131|FG000|Overall Study|Non-compliance with study drug|12|||
161176383|NCT02873208|582024131|FG000|Overall Study|Protocol Violation|8|||
161176384|NCT02873208|582024131|FG000|Overall Study|Pregnancy|2|||
161176385|NCT02873208|582024131|FG000|Overall Study|Incarceration|1|||
161176386|NCT02873208|582024131|FG000|Overall Study|Lack of Efficacy|1|||
161176387|NCT02873208|582024131|FG000|Overall Study|Physician Decision|1|||
161176388|NCT00415584|582024132|FG000|Overall Study|Withdrawal by Subject|1|||
161176389|NCT00563368|582024133|FG000|Overall Study|Lost to Follow-up|14|||
161176390|NCT00563368|582024134|FG001|Overall Study|Lost to Follow-up|14|||
161176391|NCT00563368|582024135|FG002|Overall Study|Lost to Follow-up|12|||
161176392|NCT00563368|582024136|FG003|Overall Study|Lost to Follow-up|6|||
161176393|NCT00563368|582024137|FG004|Overall Study|Lost to Follow-up|9|||
161176394|NCT00563368|582024138|FG005|Overall Study|Lost to Follow-up|8|||
161176395|NCT00563368|582024139|FG006|Overall Study|Lost to Follow-up|9|||
161176396|NCT00563368|582024133|FG000|Overall Study|Adverse Event|3|||
161176397|NCT00563368|582024134|FG001|Overall Study|Adverse Event|4|||
161176398|NCT00563368|582024135|FG002|Overall Study|Adverse Event|5|||
161297199|NCT01073605|582472038|FG002|Overall Study|Ongoing at Cutoff Date|0|||
161297200|NCT01073605|582472036|FG000|Overall Study|Adverse Event|2|||
161176399|NCT00563368|582024136|FG003|Overall Study|Adverse Event|9|||
161176400|NCT00563368|582024137|FG004|Overall Study|Adverse Event|6|||
161176401|NCT00563368|582024138|FG005|Overall Study|Adverse Event|10|||
161176402|NCT00563368|582024139|FG006|Overall Study|Adverse Event|17|||
161176403|NCT00563368|582024133|FG000|Overall Study|Withdrawal by Subject|11|||
161176404|NCT00563368|582024134|FG001|Overall Study|Withdrawal by Subject|6|||
161176405|NCT00563368|582024135|FG002|Overall Study|Withdrawal by Subject|5|||
161176406|NCT00563368|582024136|FG003|Overall Study|Withdrawal by Subject|7|||
161176407|NCT00563368|582024137|FG004|Overall Study|Withdrawal by Subject|8|||
161176408|NCT00563368|582024138|FG005|Overall Study|Withdrawal by Subject|5|||
161176409|NCT00563368|582024139|FG006|Overall Study|Withdrawal by Subject|4|||
161176410|NCT00563368|582024133|FG000|Overall Study|protocol non-compliance|1|||
161176411|NCT00563368|582024134|FG001|Overall Study|protocol non-compliance|1|||
161176412|NCT00563368|582024135|FG002|Overall Study|protocol non-compliance|2|||
161176413|NCT00563368|582024136|FG003|Overall Study|protocol non-compliance|1|||
161176414|NCT00563368|582024137|FG004|Overall Study|protocol non-compliance|0|||
161176415|NCT00563368|582024138|FG005|Overall Study|protocol non-compliance|1|||
161176416|NCT00563368|582024139|FG006|Overall Study|protocol non-compliance|3|||
161176417|NCT00563368|582024133|FG000|Overall Study|Pregnancy|1|||
161176418|NCT00563368|582024134|FG001|Overall Study|Pregnancy|0|||
161176419|NCT00563368|582024135|FG002|Overall Study|Pregnancy|1|||
161176420|NCT00563368|582024136|FG003|Overall Study|Pregnancy|2|||
161176421|NCT00563368|582024137|FG004|Overall Study|Pregnancy|1|||
161176422|NCT00563368|582024138|FG005|Overall Study|Pregnancy|2|||
161176423|NCT00563368|582024139|FG006|Overall Study|Pregnancy|0|||
161176424|NCT00563368|582024133|FG000|Overall Study|requirement for restricted medication|0|||
161176425|NCT00563368|582024134|FG001|Overall Study|requirement for restricted medication|0|||
161176426|NCT00563368|582024135|FG002|Overall Study|requirement for restricted medication|2|||
161176427|NCT00563368|582024136|FG003|Overall Study|requirement for restricted medication|0|||
161176428|NCT00563368|582024137|FG004|Overall Study|requirement for restricted medication|0|||
161176429|NCT00563368|582024138|FG005|Overall Study|requirement for restricted medication|0|||
161176430|NCT00563368|582024139|FG006|Overall Study|requirement for restricted medication|0|||
161176431|NCT00563368|582024133|FG000|Overall Study|Other|5|||
161176432|NCT00563368|582024134|FG001|Overall Study|Other|5|||
161176433|NCT00563368|582024135|FG002|Overall Study|Other|3|||
161176434|NCT00563368|582024136|FG003|Overall Study|Other|4|||
161176435|NCT00563368|582024137|FG004|Overall Study|Other|4|||
161176436|NCT00563368|582024138|FG005|Overall Study|Other|4|||
161176437|NCT00563368|582024139|FG006|Overall Study|Other|0|||
161176438|NCT01061567|582024140|FG000|Overall Study|Adverse Event|32|||
161176439|NCT01061567|582024140|FG000|Overall Study|Death|2|||
161176440|NCT01061567|582024140|FG000|Overall Study|Lack of Efficacy|3|||
161176441|NCT01061567|582024140|FG000|Overall Study|Lost to Follow-up|24|||
161176442|NCT01061567|582024140|FG000|Overall Study|Protocol Violation|1|||
161176443|NCT01061567|582024140|FG000|Overall Study|Withdrawal by Subject|11|||
161176444|NCT01061567|582024140|FG000|Overall Study|Other reason than stated above|3|||
161176445|NCT03168555|582024150|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
161176446|NCT03168555|582024150|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
161176447|NCT03168555|582024150|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
161176448|NCT03168555|582024150|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
161176449|NCT02959190|582024151|FG000|Open Label|Adverse Event|5|||
161176450|NCT02959190|582024152|FG001|Open Label|Adverse Event|7|||
161176451|NCT02959190|582024153|FG002|Open Label|Adverse Event|3|||
161176452|NCT02959190|582024154|FG003|Open Label|Adverse Event|4|||
161176453|NCT02959190|582024151|FG000|Open Label|Pregnancy|0|||
161176454|NCT02959190|582024152|FG001|Open Label|Pregnancy|1|||
161176455|NCT02959190|582024153|FG002|Open Label|Pregnancy|0|||
161176456|NCT02959190|582024154|FG003|Open Label|Pregnancy|0|||
161176457|NCT02959190|582024151|FG000|Open Label|Withdrawal by Subject|2|||
161176458|NCT02959190|582024152|FG001|Open Label|Withdrawal by Subject|8|||
161176459|NCT02959190|582024153|FG002|Open Label|Withdrawal by Subject|0|||
161176460|NCT02959190|582024154|FG003|Open Label|Withdrawal by Subject|0|||
161176461|NCT02959190|582024151|FG000|Open Label|Physician Decision|0|||
161176462|NCT02959190|582024152|FG001|Open Label|Physician Decision|0|||
161176463|NCT02959190|582024153|FG002|Open Label|Physician Decision|1|||
161347668|NCT01793935|582657337|FG001|Overall Study|Adverse Event|0|||
161347669|NCT01793935|582657336|FG000|Overall Study|Patient did not take study medication|1|||
161176464|NCT02959190|582024154|FG003|Open Label|Physician Decision|0|||
161176465|NCT02959190|582024151|FG000|Open Label|Protocol Violation|0|||
161176466|NCT02959190|582024152|FG001|Open Label|Protocol Violation|0|||
161176467|NCT02959190|582024153|FG002|Open Label|Protocol Violation|0|||
161176468|NCT02959190|582024154|FG003|Open Label|Protocol Violation|2|||
161176469|NCT02959190|582024151|FG000|Post Treatment Follow Up|Adverse Event|1|||
161176470|NCT02959190|582024152|FG001|Post Treatment Follow Up|Adverse Event|1|||
161176471|NCT02959190|582024153|FG002|Post Treatment Follow Up|Adverse Event|0|||
161176472|NCT02959190|582024154|FG003|Post Treatment Follow Up|Adverse Event|0|||
161176473|NCT02959190|582024151|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
161176474|NCT02959190|582024152|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
161176475|NCT02959190|582024153|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
161176476|NCT02959190|582024154|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
161176477|NCT01421069|582024158|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
161347670|NCT01793935|582657337|FG001|Overall Study|Patient did not take study medication|1|||
161176478|NCT01421069|582024158|FG000|Parent Study|Failed to return|3|||
161176479|NCT01421069|582024158|FG000|Parent Study|Withdrawal by Subject|1|||
161176480|NCT01421069|582024158|FG000|Parent Study|Lost to Follow-up|2|||
161176481|NCT01421069|582024158|FG000|Parent Study|Lack of Efficacy|1|||
161176482|NCT01421069|582024158|FG000|Overall Period for Extension Study|Other|2|||
161176483|NCT01421069|582024158|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
161176484|NCT01421069|582024158|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
161176485|NCT01421069|582024158|FG000|Overall Period for Extension Study|Pregnancy|1|||
161176486|NCT01421069|582024158|FG000|Overall Period for Extension Study|Adverse Event|1|||
161176487|NCT01421069|582024158|FG000|Overall Period for Extension Study|Protocol Violation|1|||
161176488|NCT01421069|582024158|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
161176489|NCT01421069|582024158|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
161176490|NCT01421069|582024158|FG000|Active Treatment Period|Other|1|||
161176491|NCT01421069|582024158|FG000|Active Treatment Period|No longer willing to participate in study|8|||
161176492|NCT01421069|582024158|FG000|Active Treatment Period|Insufficient clinical response|1|||
161176493|NCT01421069|582024158|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
161176494|NCT01421069|582024158|FG000|Active Treatment Period|Pregnancy|1|||
161176495|NCT01421069|582024158|FG000|Active Treatment Period|Adverse Event|1|||
161176496|NCT01421069|582024158|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
161176497|NCT01421069|582024158|FG000|Active Treatment Period|Enrolled in observational period|29|||
161176498|NCT01421069|582024158|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
161176499|NCT01421069|582024158|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
161176500|NCT01421069|582024158|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
161176501|NCT01421069|582024158|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
161176502|NCT01421069|582024158|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
161176503|NCT01421069|582024158|FG000|2b. Retreatment Period|Protocol Violation|1|||
161176504|NCT01421069|582024158|FG000|Observational Period|Other|1|||
161176505|NCT01421069|582024158|FG000|Observational Period|No longer willing to participate in study|4|||
161176506|NCT01421069|582024158|FG000|Observational Period|Lost to Follow-up|3|||
161176507|NCT01641081|582024159|FG000|Period 1|Sponsor request (potential unblinding)|0|||
161176508|NCT01641081|582024160|FG001|Period 1|Sponsor request (potential unblinding)|0|||
161176509|NCT01641081|582024161|FG002|Period 1|Sponsor request (potential unblinding)|0|||
161176510|NCT01641081|582024162|FG003|Period 1|Sponsor request (potential unblinding)|0|||
161176511|NCT01641081|582024163|FG004|Period 1|Sponsor request (potential unblinding)|0|||
161176512|NCT01641081|582024164|FG005|Period 1|Sponsor request (potential unblinding)|0|||
161176513|NCT01641081|582024165|FG006|Period 1|Sponsor request (potential unblinding)|1|||
161176514|NCT01641081|582024166|FG007|Period 1|Sponsor request (potential unblinding)|0|||
161176515|NCT01641081|582024167|FG008|Period 1|Sponsor request (potential unblinding)|0|||
161176516|NCT01641081|582024168|FG009|Period 1|Sponsor request (potential unblinding)|0|||
161176517|NCT01641081|582024159|FG000|Period 1|Protocol Violation|0|||
161176518|NCT01641081|582024160|FG001|Period 1|Protocol Violation|0|||
161176519|NCT01641081|582024161|FG002|Period 1|Protocol Violation|0|||
161176520|NCT01641081|582024162|FG003|Period 1|Protocol Violation|0|||
161176521|NCT01641081|582024163|FG004|Period 1|Protocol Violation|1|||
161176522|NCT01641081|582024164|FG005|Period 1|Protocol Violation|0|||
161176523|NCT01641081|582024165|FG006|Period 1|Protocol Violation|0|||
161176524|NCT01641081|582024166|FG007|Period 1|Protocol Violation|1|||
161176525|NCT01641081|582024167|FG008|Period 1|Protocol Violation|0|||
161176526|NCT01641081|582024168|FG009|Period 1|Protocol Violation|0|||
161176527|NCT01641081|582024159|FG000|Period 1|Adverse Event|1|||
161176528|NCT01641081|582024160|FG001|Period 1|Adverse Event|0|||
161176529|NCT01641081|582024161|FG002|Period 1|Adverse Event|0|||
161176530|NCT01641081|582024162|FG003|Period 1|Adverse Event|0|||
161176531|NCT01641081|582024163|FG004|Period 1|Adverse Event|0|||
161176532|NCT01641081|582024164|FG005|Period 1|Adverse Event|0|||
161176533|NCT01641081|582024165|FG006|Period 1|Adverse Event|0|||
161176534|NCT01641081|582024166|FG007|Period 1|Adverse Event|2|||
161176535|NCT01641081|582024167|FG008|Period 1|Adverse Event|0|||
161176536|NCT01641081|582024168|FG009|Period 1|Adverse Event|0|||
161176537|NCT01641081|582024159|FG000|Period 2|Adverse Event|0|||
161176538|NCT01641081|582024160|FG001|Period 2|Adverse Event|0|||
161176539|NCT01641081|582024161|FG002|Period 2|Adverse Event|0|||
161176540|NCT01641081|582024162|FG003|Period 2|Adverse Event|0|||
161176541|NCT01641081|582024163|FG004|Period 2|Adverse Event|0|||
161176542|NCT01641081|582024164|FG005|Period 2|Adverse Event|1|||
161176543|NCT01641081|582024165|FG006|Period 2|Adverse Event|0|||
161176544|NCT01641081|582024166|FG007|Period 2|Adverse Event|0|||
161176545|NCT01641081|582024167|FG008|Period 2|Adverse Event|0|||
161176546|NCT01641081|582024168|FG009|Period 2|Adverse Event|0|||
161176547|NCT01641081|582024159|FG000|Period 2|Withdrawal by Subject|0|||
161176548|NCT01641081|582024160|FG001|Period 2|Withdrawal by Subject|0|||
161176549|NCT01641081|582024161|FG002|Period 2|Withdrawal by Subject|0|||
161176550|NCT01641081|582024162|FG003|Period 2|Withdrawal by Subject|1|||
161176551|NCT01641081|582024163|FG004|Period 2|Withdrawal by Subject|0|||
161176552|NCT01641081|582024164|FG005|Period 2|Withdrawal by Subject|0|||
161176553|NCT01641081|582024165|FG006|Period 2|Withdrawal by Subject|2|||
161088213|NCT00297232|581712670|FG000|Overall Study|Anti-natalizumab Positive|8|||
161088214|NCT00297232|581712670|FG000|Overall Study|Switched to Commercial Tysabri|22|||
161088215|NCT00297232|581712670|FG000|Overall Study|Disease Progression|8|||
161088216|NCT00297232|581712670|FG000|Overall Study|Fear of PML|10|||
161088217|NCT00297232|581712670|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
161088218|NCT00297232|581712670|FG000|Overall Study|Miscellaneous|5|||
161088219|NCT00297232|581712670|FG000|Overall Study|Sponsor Decision|34|||
161088220|NCT00297232|581712670|FG000|Overall Study|Subject Relocated|7|||
161088221|NCT00297232|581712670|FG000|Overall Study|Subject Withdrew Consent|37|||
161088222|NCT00297232|581712670|FG000|Overall Study|Persistently Positive Antibodies|11|||
161088223|NCT00297232|581712670|FG000|Overall Study|Investigator Withdrew From Program|19|||
161088224|NCT00297232|581712670|FG000|Overall Study|Did Not Enroll to Week 264|34|||
161088225|NCT00297232|581712670|FG000|Overall Study|Did Not Enroll to Week 480|17|||
161088226|NCT00297232|581712670|FG000|Overall Study|No data available after Week 264|161|||
161088227|NCT00297232|581712670|FG000|Overall Study|Other|1|||
161088228|NCT03536143|581712671|FG000|Overall Study|Early termination, Sponsor decision|1|||
161088229|NCT00495586|581712672|FG000|Overall Study|Withdrawal by Subject|4|||
161088230|NCT00495586|581712673|FG001|Overall Study|Withdrawal by Subject|4|||
161088231|NCT01029652|581712674|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
161088232|NCT01029652|581712675|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
161088233|NCT01029652|581712674|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
161088234|NCT01029652|581712675|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
161088235|NCT01029652|581712674|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
161088236|NCT01029652|581712675|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
161088237|NCT01029652|581712674|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
161088238|NCT01029652|581712675|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
161088239|NCT01029652|581712674|FG000|Core Study (0-12 Weeks)|Death|0|||
161088240|NCT01029652|581712675|FG001|Core Study (0-12 Weeks)|Death|1|||
161088241|NCT01029652|581712674|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
161088242|NCT01029652|581712675|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
161088243|NCT01029652|581712674|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
161088244|NCT01029652|581712675|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
161088245|NCT01029652|581712674|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
161088246|NCT01029652|581712675|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
161088247|NCT01029652|581712674|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
161088248|NCT01029652|581712675|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
161088249|NCT01029652|581712674|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
161088250|NCT01029652|581712675|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
161088251|NCT01029652|581712674|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
161088252|NCT01029652|581712675|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
161088253|NCT01029652|581712674|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
161088254|NCT01029652|581712675|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
161088255|NCT06377488|581712676|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
161088256|NCT06377488|581712676|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
161088257|NCT06377488|581712676|FG000|Overall Study|Protocol Violation|1|||
161088258|NCT06377488|581712676|FG000|Overall Study|Lost to Follow-up|1|||
161088259|NCT06377488|581712676|FG000|Overall Study|Incorrect Lens Dispensed|2|||
161088260|NCT02399254|581712677|FG000|Overall Study|Physician Decision|2|||
161088261|NCT01076647|581712680|FG000|Overall Study|Adverse Event|4|||
161088262|NCT01076647|581712681|FG001|Overall Study|Adverse Event|1|||
161088263|NCT01076647|581712680|FG000|Overall Study|Lack of Efficacy|0|||
161088264|NCT01076647|581712681|FG001|Overall Study|Lack of Efficacy|1|||
161088265|NCT01076647|581712680|FG000|Overall Study|Protocol Violation|7|||
161088266|NCT01076647|581712681|FG001|Overall Study|Protocol Violation|9|||
161088267|NCT01076647|581712680|FG000|Overall Study|Withdrawal criteria|2|||
161088268|NCT01076647|581712681|FG001|Overall Study|Withdrawal criteria|2|||
161088269|NCT01076647|581712680|FG000|Overall Study|Unclassified|12|||
161088270|NCT01076647|581712681|FG001|Overall Study|Unclassified|12|||
161088271|NCT02292927|581712686|FG000|Overall Study|Protocol Violation|13|||
161088272|NCT02292927|581712687|FG001|Overall Study|Protocol Violation|7|||
161088273|NCT02962960|581712689|FG000|Overall Study|Withdrawal by Subject|1|||
161088274|NCT02962960|581712690|FG001|Overall Study|Withdrawal by Subject|1|||
161088275|NCT02962960|581712691|FG002|Overall Study|Withdrawal by Subject|0|||
161088276|NCT02962960|581712689|FG000|Overall Study|Adverse Event|1|||
161088277|NCT02962960|581712690|FG001|Overall Study|Adverse Event|1|||
161088278|NCT02962960|581712691|FG002|Overall Study|Adverse Event|0|||
161088279|NCT02962960|581712689|FG000|Overall Study|Protocol Violation|1|||
161088280|NCT02962960|581712690|FG001|Overall Study|Protocol Violation|0|||
161088281|NCT02962960|581712691|FG002|Overall Study|Protocol Violation|0|||
161088282|NCT02054741|581712692|FG000|Overall Study|Protocol Violation|13|||
161088283|NCT02054741|581712693|FG001|Overall Study|Protocol Violation|2|||
161088284|NCT02054741|581712692|FG000|Overall Study|Withdrawal by Subject|10|||
161088285|NCT02054741|581712693|FG001|Overall Study|Withdrawal by Subject|5|||
161088286|NCT02054741|581712692|FG000|Overall Study|Death|94|||
161088287|NCT02054741|581712693|FG001|Overall Study|Death|90|||
161176554|NCT01641081|582024166|FG007|Period 2|Withdrawal by Subject|0|||
161176555|NCT01641081|582024167|FG008|Period 2|Withdrawal by Subject|0|||
161176556|NCT01641081|582024168|FG009|Period 2|Withdrawal by Subject|0|||
161176557|NCT01641081|582024159|FG000|Period 2|Protocol Violation|1|||
161176558|NCT01641081|582024160|FG001|Period 2|Protocol Violation|0|||
161176559|NCT01641081|582024161|FG002|Period 2|Protocol Violation|0|||
161176560|NCT01641081|582024162|FG003|Period 2|Protocol Violation|0|||
161176561|NCT01641081|582024163|FG004|Period 2|Protocol Violation|0|||
161176562|NCT01641081|582024164|FG005|Period 2|Protocol Violation|0|||
161176563|NCT01641081|582024165|FG006|Period 2|Protocol Violation|0|||
161176564|NCT01641081|582024166|FG007|Period 2|Protocol Violation|0|||
161176565|NCT01641081|582024167|FG008|Period 2|Protocol Violation|0|||
161176566|NCT01641081|582024168|FG009|Period 2|Protocol Violation|0|||
161176567|NCT01641081|582024159|FG000|Period 3|Adverse Event|0|||
161176568|NCT01641081|582024160|FG001|Period 3|Adverse Event|0|||
161176569|NCT01641081|582024161|FG002|Period 3|Adverse Event|1|||
161176570|NCT01641081|582024162|FG003|Period 3|Adverse Event|0|||
161176571|NCT01641081|582024163|FG004|Period 3|Adverse Event|0|||
161176572|NCT01641081|582024164|FG005|Period 3|Adverse Event|0|||
161176573|NCT01641081|582024165|FG006|Period 3|Adverse Event|0|||
161176574|NCT01641081|582024166|FG007|Period 3|Adverse Event|0|||
161176575|NCT01641081|582024167|FG008|Period 3|Adverse Event|0|||
161176576|NCT01641081|582024168|FG009|Period 3|Adverse Event|0|||
161176577|NCT01641081|582024159|FG000|Period 3|Withdrawal by Subject|0|||
161176578|NCT01641081|582024160|FG001|Period 3|Withdrawal by Subject|0|||
161176579|NCT01641081|582024161|FG002|Period 3|Withdrawal by Subject|0|||
161176580|NCT01641081|582024162|FG003|Period 3|Withdrawal by Subject|0|||
161176581|NCT01641081|582024163|FG004|Period 3|Withdrawal by Subject|0|||
161176582|NCT01641081|582024164|FG005|Period 3|Withdrawal by Subject|0|||
161176583|NCT01641081|582024165|FG006|Period 3|Withdrawal by Subject|0|||
161176584|NCT01641081|582024166|FG007|Period 3|Withdrawal by Subject|0|||
161176585|NCT01641081|582024167|FG008|Period 3|Withdrawal by Subject|1|||
161176586|NCT01641081|582024168|FG009|Period 3|Withdrawal by Subject|0|||
161176587|NCT01641081|582024159|FG000|Period 4|Adverse Event|0|||
161176588|NCT01641081|582024160|FG001|Period 4|Adverse Event|1|||
161176589|NCT01641081|582024161|FG002|Period 4|Adverse Event|0|||
161176590|NCT01641081|582024162|FG003|Period 4|Adverse Event|1|||
161176591|NCT01641081|582024163|FG004|Period 4|Adverse Event|0|||
161176592|NCT01641081|582024164|FG005|Period 4|Adverse Event|0|||
161176593|NCT01641081|582024165|FG006|Period 4|Adverse Event|0|||
161176594|NCT01641081|582024166|FG007|Period 4|Adverse Event|0|||
161176595|NCT01641081|582024167|FG008|Period 4|Adverse Event|0|||
161176596|NCT01641081|582024168|FG009|Period 4|Adverse Event|0|||
161176597|NCT01641081|582024159|FG000|Period 5|Adverse Event|0|||
161176598|NCT01641081|582024160|FG001|Period 5|Adverse Event|0|||
161176599|NCT01641081|582024161|FG002|Period 5|Adverse Event|2|||
161176600|NCT01641081|582024162|FG003|Period 5|Adverse Event|0|||
161176601|NCT01641081|582024163|FG004|Period 5|Adverse Event|0|||
161176602|NCT01641081|582024164|FG005|Period 5|Adverse Event|0|||
161176603|NCT01641081|582024165|FG006|Period 5|Adverse Event|0|||
161176604|NCT01641081|582024166|FG007|Period 5|Adverse Event|0|||
161176605|NCT01641081|582024167|FG008|Period 5|Adverse Event|0|||
161176606|NCT01641081|582024168|FG009|Period 5|Adverse Event|0|||
161176607|NCT01095666|582024172|FG000|Overall Study|Lack of Efficacy|0|||
161176608|NCT01095666|582024173|FG001|Overall Study|Lack of Efficacy|0|||
161176609|NCT01095666|582024174|FG002|Overall Study|Lack of Efficacy|1|||
161176610|NCT01095666|582024172|FG000|Overall Study|Adverse Event|2|||
161176611|NCT01095666|582024173|FG001|Overall Study|Adverse Event|1|||
161176612|NCT01095666|582024174|FG002|Overall Study|Adverse Event|3|||
161347671|NCT01793935|582657336|FG000|Overall Study|Lost to Follow-up|0|||
161347672|NCT01793935|582657337|FG001|Overall Study|Lost to Follow-up|1|||
161176613|NCT01095666|582024172|FG000|Overall Study|Lost to Follow-up|2|||
161176614|NCT01095666|582024173|FG001|Overall Study|Lost to Follow-up|2|||
161176615|NCT01095666|582024174|FG002|Overall Study|Lost to Follow-up|0|||
161176616|NCT01095666|582024172|FG000|Overall Study|Withdrawal by Subject|6|||
161176617|NCT01095666|582024173|FG001|Overall Study|Withdrawal by Subject|6|||
161176618|NCT01095666|582024174|FG002|Overall Study|Withdrawal by Subject|1|||
161176619|NCT01095666|582024172|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
161176620|NCT01095666|582024173|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
161176621|NCT01095666|582024174|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
161176622|NCT00166517|582024178|FG000|Overall Study|Lost to Follow-up|1|||
161176623|NCT00166517|582024179|FG001|Overall Study|Lost to Follow-up|0|||
161176624|NCT00166517|582024178|FG000|Overall Study|Protocol Violation|4|||
161176625|NCT00166517|582024179|FG001|Overall Study|Protocol Violation|1|||
161176626|NCT00166517|582024178|FG000|Overall Study|Withdrawal by Subject|0|||
161176627|NCT00166517|582024179|FG001|Overall Study|Withdrawal by Subject|1|||
161176628|NCT03094611|582024183|FG000|Overall Study|Lack of Efficacy|1|||
161176629|NCT03094611|582024183|FG000|Overall Study|Stem Cell Transplant|1|||
161176630|NCT04285853|582024184|FG000|Overall Study|Withdrawal by Subject|1|||
161176631|NCT04285853|582024185|FG001|Overall Study|Withdrawal by Subject|0|||
161176632|NCT04285853|582024184|FG000|Overall Study|Lost to Follow-up|9|||
161347673|NCT00817063|582657338|FG000|Overall Study|Adverse Event|32|||
161176633|NCT04285853|582024185|FG001|Overall Study|Lost to Follow-up|5|||
161176634|NCT00196196|582024190|FG000|Overall Study|Withdrawal by Subject|2|||
161176635|NCT00196196|582024190|FG000|Overall Study|Did not have required condition (hydroce|5|||
161176636|NCT02679781|582024193|FG000|Overall Study|Lost to Follow-up|1|||
161176637|NCT02679781|582024194|FG001|Overall Study|Lost to Follow-up|2|||
161176638|NCT02679781|582024193|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
161176639|NCT02679781|582024194|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
161176640|NCT04209400|582024195|FG000|Overall Study|Withdrawal by Subject|0|||
161176641|NCT04209400|582024196|FG001|Overall Study|Withdrawal by Subject|1|||
161176642|NCT01496274|582024198|FG000|Overall Study|Protocol Violation|0|||
161176643|NCT01496274|582024199|FG001|Overall Study|Protocol Violation|1|||
161176644|NCT01496274|582024198|FG000|Overall Study|Adverse Event|1|||
161176645|NCT01496274|582024199|FG001|Overall Study|Adverse Event|1|||
161176646|NCT01496274|582024198|FG000|Overall Study|Withdrawal by Subject|2|||
161176647|NCT01496274|582024199|FG001|Overall Study|Withdrawal by Subject|0|||
161176648|NCT01496274|582024198|FG000|Overall Study|Lost to Follow-up|0|||
161176649|NCT01496274|582024199|FG001|Overall Study|Lost to Follow-up|3|||
161176650|NCT04968353|582024202|FG000|Overall Study|Non-compliance|1|||
161176651|NCT04968353|582024203|FG001|Overall Study|Non-compliance|0|||
161176652|NCT04968353|582024204|FG002|Overall Study|Non-compliance|2|||
161176653|NCT04968353|582024205|FG003|Overall Study|Non-compliance|0|||
161176654|NCT00318370|582024206|FG000|Period 1|Lack of Efficacy|5|||
161176655|NCT00318370|582024207|FG001|Period 1|Lack of Efficacy|0|||
161176656|NCT00318370|582024208|FG002|Period 1|Lack of Efficacy|0|||
161176657|NCT00318370|582024206|FG000|Period 1|Physician Decision|1|||
161176658|NCT00318370|582024207|FG001|Period 1|Physician Decision|0|||
161176659|NCT00318370|582024208|FG002|Period 1|Physician Decision|0|||
161176660|NCT00318370|582024206|FG000|Period 1|Withdrawal by Subject|1|||
161176661|NCT00318370|582024207|FG001|Period 1|Withdrawal by Subject|0|||
161176662|NCT00318370|582024208|FG002|Period 1|Withdrawal by Subject|0|||
161176663|NCT00318370|582024206|FG000|Period 2|Adverse Event|0|||
161176664|NCT00318370|582024207|FG001|Period 2|Adverse Event|3|||
161176665|NCT00318370|582024208|FG002|Period 2|Adverse Event|0|||
161176666|NCT00318370|582024206|FG000|Period 2|Lack of Efficacy|0|||
161176667|NCT00318370|582024207|FG001|Period 2|Lack of Efficacy|5|||
161176668|NCT00318370|582024208|FG002|Period 2|Lack of Efficacy|0|||
161176669|NCT00318370|582024206|FG000|Period 2|Physician Decision|0|||
161176670|NCT00318370|582024207|FG001|Period 2|Physician Decision|1|||
161176671|NCT00318370|582024208|FG002|Period 2|Physician Decision|0|||
161176672|NCT00318370|582024206|FG000|Period 2|Withdrawal by Subject|0|||
161176673|NCT00318370|582024207|FG001|Period 2|Withdrawal by Subject|1|||
161176674|NCT00318370|582024208|FG002|Period 2|Withdrawal by Subject|0|||
161176675|NCT00318370|582024206|FG000|Period 2|Other|0|||
161176676|NCT00318370|582024207|FG001|Period 2|Other|1|||
161176677|NCT00318370|582024208|FG002|Period 2|Other|0|||
161176678|NCT00318370|582024206|FG000|Period 3|Adverse Event|0|||
161176679|NCT00318370|582024207|FG001|Period 3|Adverse Event|0|||
161176680|NCT00318370|582024208|FG002|Period 3|Adverse Event|1|||
161176681|NCT00318370|582024206|FG000|Period 3|Lack of Efficacy|0|||
161176682|NCT00318370|582024207|FG001|Period 3|Lack of Efficacy|0|||
161176683|NCT00318370|582024208|FG002|Period 3|Lack of Efficacy|24|||
161176684|NCT00318370|582024206|FG000|Period 3|Death|0|||
161176685|NCT00318370|582024207|FG001|Period 3|Death|0|||
161176686|NCT00318370|582024208|FG002|Period 3|Death|1|||
161176687|NCT00318370|582024206|FG000|Period 3|Physician Decision|0|||
161176688|NCT00318370|582024207|FG001|Period 3|Physician Decision|0|||
161176689|NCT00318370|582024208|FG002|Period 3|Physician Decision|1|||
161176690|NCT00318370|582024206|FG000|Period 3|Withdrawal by Subject|0|||
161176691|NCT00318370|582024207|FG001|Period 3|Withdrawal by Subject|0|||
161176692|NCT00318370|582024208|FG002|Period 3|Withdrawal by Subject|3|||
161176693|NCT00318370|582024206|FG000|Period 3|Other|0|||
161176694|NCT00318370|582024207|FG001|Period 3|Other|0|||
161176695|NCT00318370|582024208|FG002|Period 3|Other|3|||
161176696|NCT00892957|582024214|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
161176697|NCT00892957|582024215|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
161176698|NCT00892957|582024214|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
161176699|NCT00892957|582024215|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
161176700|NCT03307629|582024221|FG000|Overall Study|Withdrawal by Subject|0|||
161347674|NCT00817063|582657339|FG001|Overall Study|Adverse Event|13|||
161176701|NCT03307629|582024222|FG001|Overall Study|Withdrawal by Subject|0|||
161176702|NCT03307629|582024223|FG002|Overall Study|Withdrawal by Subject|0|||
161176703|NCT03307629|582024224|FG003|Overall Study|Withdrawal by Subject|2|||
161176704|NCT03307629|582024221|FG000|Overall Study|Disease Progression|0|||
161176705|NCT03307629|582024222|FG001|Overall Study|Disease Progression|0|||
161176706|NCT03307629|582024223|FG002|Overall Study|Disease Progression|0|||
161176707|NCT03307629|582024224|FG003|Overall Study|Disease Progression|3|||
161176708|NCT03307629|582024221|FG000|Overall Study|Death|0|||
161176709|NCT03307629|582024222|FG001|Overall Study|Death|3|||
161176710|NCT03307629|582024223|FG002|Overall Study|Death|0|||
161176711|NCT03307629|582024224|FG003|Overall Study|Death|1|||
161176712|NCT02853032|582024229|FG000|Overall Study|Adverse Event|4|||
161347675|NCT00817063|582657338|FG000|Overall Study|Death|1|||
161176713|NCT02853032|582024230|FG001|Overall Study|Adverse Event|0|||
161176714|NCT02853032|582024229|FG000|Overall Study|Withdrawal by Subject|3|||
161176715|NCT02853032|582024230|FG001|Overall Study|Withdrawal by Subject|1|||
161176716|NCT02853032|582024229|FG000|Overall Study|Requested to withdraw from all treatment|2|||
161176717|NCT02853032|582024230|FG001|Overall Study|Requested to withdraw from all treatment|2|||
161176718|NCT04876599|582024231|FG000|Overall Study|Missed|2|||
161176719|NCT04876599|582024232|FG001|Overall Study|Missed|0|||
161176720|NCT04876599|582024231|FG000|Overall Study|Declined|2|||
161176721|NCT04876599|582024232|FG001|Overall Study|Declined|3|||
161176722|NCT00676208|582024239|FG000|Overall Study|Lost to Follow-up|0|||
161176723|NCT00676208|582024240|FG001|Overall Study|Lost to Follow-up|2|||
161176724|NCT00676208|582024239|FG000|Overall Study|Incomplete data|2|||
161176725|NCT00676208|582024240|FG001|Overall Study|Incomplete data|4|||
161176726|NCT00669032|582024241|FG000|Overall Study|Lost to Follow-up|6|||
161176727|NCT00669032|582024242|FG001|Overall Study|Lost to Follow-up|5|||
161176728|NCT00669032|582024241|FG000|Overall Study|Lack of Efficacy|8|||
161176729|NCT00669032|582024242|FG001|Overall Study|Lack of Efficacy|19|||
161176730|NCT00669032|582024241|FG000|Overall Study|Withdrawal by Subject|12|||
161176731|NCT00669032|582024242|FG001|Overall Study|Withdrawal by Subject|13|||
161176732|NCT00669032|582024241|FG000|Overall Study|Adverse Event|12|||
161176733|NCT00669032|582024242|FG001|Overall Study|Adverse Event|16|||
161176734|NCT00669032|582024241|FG000|Overall Study|Physician Decision|1|||
161176735|NCT00669032|582024242|FG001|Overall Study|Physician Decision|1|||
161176736|NCT00669032|582024241|FG000|Overall Study|No fulfilment of the selection criteria|5|||
161176737|NCT00669032|582024242|FG001|Overall Study|No fulfilment of the selection criteria|5|||
161176738|NCT00642018|582024245|FG000|Overall Study|Adverse Event|11|||
161176739|NCT00642018|582024246|FG001|Overall Study|Adverse Event|36|||
161176740|NCT00642018|582024245|FG000|Overall Study|Withdrawal by Subject|4|||
161176741|NCT00642018|582024246|FG001|Overall Study|Withdrawal by Subject|10|||
161176742|NCT00642018|582024245|FG000|Overall Study|Progressive Disease|13|||
161176743|NCT00642018|582024246|FG001|Overall Study|Progressive Disease|18|||
161176744|NCT00642018|582024245|FG000|Overall Study|Physician Decision|0|||
161176745|NCT00642018|582024246|FG001|Overall Study|Physician Decision|10|||
161176746|NCT00642018|582024245|FG000|Overall Study|Protocol Violation|0|||
161176747|NCT00642018|582024246|FG001|Overall Study|Protocol Violation|1|||
161176748|NCT00642018|582024245|FG000|Overall Study|Death|0|||
161176749|NCT00642018|582024246|FG001|Overall Study|Death|3|||
161176750|NCT00642018|582024245|FG000|Overall Study|Entry Criteria Not Met|0|||
161176751|NCT00642018|582024246|FG001|Overall Study|Entry Criteria Not Met|1|||
161176752|NCT01607073|582024247|FG000|Overall Study|Adverse Event|1|||
161176753|NCT01410799|582024248|FG000|Overall Study|PI decision|13|||
161176754|NCT00617656|582024249|FG000|Overall Study|Inclusion error|4|||
161176755|NCT00617656|582024250|FG001|Overall Study|Inclusion error|4|||
161176756|NCT00617656|582024251|FG002|Overall Study|Inclusion error|0|||
161176757|NCT00617656|582024252|FG003|Overall Study|Inclusion error|0|||
161176758|NCT00617656|582024249|FG000|Overall Study|Missing data|44|||
161176759|NCT00617656|582024250|FG001|Overall Study|Missing data|30|||
161176760|NCT00617656|582024251|FG002|Overall Study|Missing data|13|||
161176761|NCT00617656|582024252|FG003|Overall Study|Missing data|6|||
161176762|NCT00617656|582024249|FG000|Overall Study|Withdrawal by Subject|0|||
161176763|NCT00617656|582024250|FG001|Overall Study|Withdrawal by Subject|2|||
161176764|NCT00617656|582024251|FG002|Overall Study|Withdrawal by Subject|0|||
161176765|NCT00617656|582024252|FG003|Overall Study|Withdrawal by Subject|0|||
161176766|NCT00509028|582025705|FG000|Overall Study|Adverse Event|2|||
161176767|NCT00509028|582025706|FG001|Overall Study|Adverse Event|0|||
161176768|NCT00509028|582025705|FG000|Overall Study|Withdrawal by Subject|4|||
161176769|NCT00509028|582025706|FG001|Overall Study|Withdrawal by Subject|3|||
161176770|NCT00509028|582025705|FG000|Overall Study|Lost to Follow-up|0|||
161176771|NCT00509028|582025706|FG001|Overall Study|Lost to Follow-up|1|||
161176772|NCT00509028|582025705|FG000|Overall Study|Protocol Violation|4|||
161176773|NCT00509028|582025706|FG001|Overall Study|Protocol Violation|2|||
161176774|NCT00509028|582025705|FG000|Overall Study|Non-compliance|2|||
161176775|NCT00509028|582025706|FG001|Overall Study|Non-compliance|1|||
161176776|NCT01495689|582025708|FG000|Overall Study|Death|0|||
161176777|NCT01495689|582025709|FG001|Overall Study|Death|1|||
161176778|NCT01495689|582025708|FG000|Overall Study|Withdrawal by Subject|3|||
161176779|NCT01495689|582025709|FG001|Overall Study|Withdrawal by Subject|0|||
161176780|NCT01495689|582025708|FG000|Overall Study|Lost to Follow-up|7|||
161176781|NCT01495689|582025709|FG001|Overall Study|Lost to Follow-up|6|||
161176782|NCT00254163|582025710|FG000|Overall Study|Adverse Event|29|||
161176783|NCT00254163|582025711|FG001|Overall Study|Adverse Event|26|||
161176784|NCT00254163|582025710|FG000|Overall Study|Patient request/withdrew consent|6|||
161176785|NCT00254163|582025711|FG001|Overall Study|Patient request/withdrew consent|4|||
161176786|NCT00254163|582025710|FG000|Overall Study|Investigator request|1|||
161176787|NCT00254163|582025711|FG001|Overall Study|Investigator request|3|||
161176788|NCT00254163|582025710|FG000|Overall Study|Failed entry|1|||
161176789|NCT00254163|582025711|FG001|Overall Study|Failed entry|3|||
161176790|NCT00254163|582025710|FG000|Overall Study|Progressive disease|0|||
161176791|NCT00254163|582025711|FG001|Overall Study|Progressive disease|1|||
161176792|NCT00254163|582025710|FG000|Overall Study|Death|0|||
161176793|NCT00254163|582025711|FG001|Overall Study|Death|1|||
161176794|NCT00254163|582025710|FG000|Overall Study|Other|8|||
161176795|NCT00254163|582025711|FG001|Overall Study|Other|8|||
161176796|NCT01119963|582025712|FG000|Overall Study|Lost to Follow-up|1|||
161176797|NCT01119963|582025713|FG001|Overall Study|Lost to Follow-up|1|||
161176798|NCT02579863|582025714|FG000|Overall Study|Final Disposition Unknown|2|||
161176799|NCT02579863|582025715|FG001|Overall Study|Final Disposition Unknown|1|||
161176800|NCT02579863|582025714|FG000|Overall Study|Adverse Event|18|||
161176801|NCT02579863|582025715|FG001|Overall Study|Adverse Event|11|||
161176802|NCT02579863|582025714|FG000|Overall Study|Death|31|||
161176803|NCT02579863|582025715|FG001|Overall Study|Death|29|||
161176804|NCT02579863|582025714|FG000|Overall Study|Lost to Follow-up|2|||
161176805|NCT02579863|582025715|FG001|Overall Study|Lost to Follow-up|1|||
161176806|NCT02579863|582025714|FG000|Overall Study|Physician Decision|1|||
161176807|NCT02579863|582025715|FG001|Overall Study|Physician Decision|2|||
161176808|NCT02579863|582025714|FG000|Overall Study|Screen Failure|0|||
161176809|NCT02579863|582025715|FG001|Overall Study|Screen Failure|2|||
161176810|NCT02579863|582025714|FG000|Overall Study|Study Terminated at Selected Sites|82|||
161176811|NCT02579863|582025715|FG001|Overall Study|Study Terminated at Selected Sites|88|||
161176812|NCT02579863|582025714|FG000|Overall Study|Withdrawal by Subject|20|||
161176813|NCT02579863|582025715|FG001|Overall Study|Withdrawal by Subject|20|||
161176814|NCT00809614|582025720|FG000|Overall Study|Lack of Efficacy|2|||
161176815|NCT00809614|582025721|FG001|Overall Study|Lack of Efficacy|3|||
161176816|NCT00809614|582025720|FG000|Overall Study|Withdrawal by Subject|1|||
161176817|NCT00809614|582025721|FG001|Overall Study|Withdrawal by Subject|1|||
161176818|NCT00446797|582025722|FG000|Overall Study|Lack of Efficacy|0|||
161176819|NCT00446797|582025723|FG001|Overall Study|Lack of Efficacy|2|||
161176820|NCT00446797|582025722|FG000|Overall Study|Lost to Follow-up|5|||
161176821|NCT00446797|582025723|FG001|Overall Study|Lost to Follow-up|3|||
161176822|NCT00446797|582025722|FG000|Overall Study|Withdrawal by Subject|2|||
161176823|NCT00446797|582025723|FG001|Overall Study|Withdrawal by Subject|2|||
161176824|NCT00446797|582025722|FG000|Overall Study|Protocol Violation|1|||
161176825|NCT00446797|582025723|FG001|Overall Study|Protocol Violation|3|||
161176826|NCT00446797|582025722|FG000|Overall Study|subject entered at another site|0|||
161176827|NCT00446797|582025723|FG001|Overall Study|subject entered at another site|1|||
161176828|NCT00446797|582025722|FG000|Overall Study|did not meet entrance criteria|0|||
161176829|NCT00446797|582025723|FG001|Overall Study|did not meet entrance criteria|1|||
161176830|NCT00364832|582025724|FG000|Core Period|Early Withdrawals|2|||
161176831|NCT00364832|582025725|FG001|Core Period|Early Withdrawals|2|||
161176832|NCT00364832|582025726|FG002|Core Period|Early Withdrawals|1|||
161176833|NCT00364832|582025727|FG003|Core Period|Early Withdrawals|1|||
161176834|NCT00364832|582025728|FG004|Core Period|Early Withdrawals|0|||
161176835|NCT00364832|582025729|FG005|Core Period|Early Withdrawals|0|||
161176836|NCT00364832|582025730|FG006|Core Period|Early Withdrawals|4|||
161176837|NCT00364832|582025731|FG007|Core Period|Early Withdrawals|1|||
161176838|NCT00364832|582025732|FG008|Core Period|Early Withdrawals|0|||
161176839|NCT00364832|582025733|FG009|Core Period|Early Withdrawals|0|||
161176840|NCT00364832|582025734|FG010|Core Period|Early Withdrawals|0|||
161176841|NCT00364832|582025735|FG011|Core Period|Early Withdrawals|0|||
161176842|NCT00364832|582025724|FG000|Extension Year 1|Early Withdrawals|0|||
161176843|NCT00364832|582025725|FG001|Extension Year 1|Early Withdrawals|0|||
161176844|NCT00364832|582025726|FG002|Extension Year 1|Early Withdrawals|0|||
161176845|NCT00364832|582025727|FG003|Extension Year 1|Early Withdrawals|0|||
161176846|NCT00364832|582025728|FG004|Extension Year 1|Early Withdrawals|0|||
161176847|NCT00364832|582025729|FG005|Extension Year 1|Early Withdrawals|0|||
161176848|NCT00364832|582025730|FG006|Extension Year 1|Early Withdrawals|0|||
161176849|NCT00364832|582025731|FG007|Extension Year 1|Early Withdrawals|0|||
161176850|NCT00364832|582025732|FG008|Extension Year 1|Early Withdrawals|0|||
161176851|NCT00364832|582025733|FG009|Extension Year 1|Early Withdrawals|4|||
161176852|NCT00364832|582025734|FG010|Extension Year 1|Early Withdrawals|2|||
161176853|NCT00364832|582025735|FG011|Extension Year 1|Early Withdrawals|10|||
161176854|NCT00364832|582025724|FG000|Extension Year 2|Early Withdrawals|0|||
161176855|NCT00364832|582025725|FG001|Extension Year 2|Early Withdrawals|0|||
161176856|NCT00364832|582025726|FG002|Extension Year 2|Early Withdrawals|0|||
161176857|NCT00364832|582025727|FG003|Extension Year 2|Early Withdrawals|0|||
161176858|NCT00364832|582025728|FG004|Extension Year 2|Early Withdrawals|0|||
161176859|NCT00364832|582025729|FG005|Extension Year 2|Early Withdrawals|0|||
161176860|NCT00364832|582025730|FG006|Extension Year 2|Early Withdrawals|0|||
161176861|NCT00364832|582025731|FG007|Extension Year 2|Early Withdrawals|0|||
161176862|NCT00364832|582025732|FG008|Extension Year 2|Early Withdrawals|0|||
161176863|NCT00364832|582025733|FG009|Extension Year 2|Early Withdrawals|5|||
161176864|NCT00364832|582025734|FG010|Extension Year 2|Early Withdrawals|5|||
161176865|NCT00364832|582025735|FG011|Extension Year 2|Early Withdrawals|3|||
161176866|NCT03210220|582025736|FG000|Overall Study|Physician Decision|1|||
161176867|NCT03210220|582025737|FG001|Overall Study|Physician Decision|0|||
161176868|NCT01366534|582025753|FG000|Overall Study|Lost to Follow-up|1|||
161176869|NCT01366534|582025754|FG001|Overall Study|Lost to Follow-up|0|||
161176870|NCT01366534|582025755|FG002|Overall Study|Lost to Follow-up|0|||
161176871|NCT01366534|582025753|FG000|Overall Study|Migrated|1|||
161176872|NCT01366534|582025754|FG001|Overall Study|Migrated|1|||
161176873|NCT01366534|582025755|FG002|Overall Study|Migrated|0|||
161176874|NCT01366534|582025753|FG000|Overall Study|Declined challenged|0|||
161176875|NCT01366534|582025754|FG001|Overall Study|Declined challenged|1|||
161176876|NCT01366534|582025755|FG002|Overall Study|Declined challenged|0|||
161176877|NCT02640755|582025756|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
161176878|NCT02640755|582025757|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
161176879|NCT02640755|582025756|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
161176880|NCT02640755|582025757|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
161176881|NCT02640755|582025756|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
161176882|NCT02640755|582025757|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
161176883|NCT01192100|582025764|FG000|Overall Study|Withdrawal by Subject|0|||
161176884|NCT01192100|582025765|FG001|Overall Study|Withdrawal by Subject|0|||
161176885|NCT01192100|582025766|FG002|Overall Study|Withdrawal by Subject|0|||
161176886|NCT01192100|582025767|FG003|Overall Study|Withdrawal by Subject|0|||
161176887|NCT01192100|582025768|FG004|Overall Study|Withdrawal by Subject|1|||
161176888|NCT01192100|582025769|FG005|Overall Study|Withdrawal by Subject|0|||
161176889|NCT01192100|582025764|FG000|Overall Study|Protocol Violation|0|||
161176890|NCT01192100|582025765|FG001|Overall Study|Protocol Violation|0|||
161176891|NCT01192100|582025766|FG002|Overall Study|Protocol Violation|0|||
161176892|NCT01192100|582025767|FG003|Overall Study|Protocol Violation|1|||
161176893|NCT01192100|582025768|FG004|Overall Study|Protocol Violation|0|||
161176894|NCT01192100|582025769|FG005|Overall Study|Protocol Violation|0|||
161176895|NCT02057068|582025770|FG000|Overall Study|Withdrawal by Subject|2|||
161176896|NCT02057068|582025771|FG001|Overall Study|Withdrawal by Subject|2|||
161176897|NCT02057068|582025770|FG000|Overall Study|Caregiver (CG) Health|0|||
161176898|NCT02057068|582025771|FG001|Overall Study|Caregiver (CG) Health|2|||
161176899|NCT02057068|582025770|FG000|Overall Study|Carepartner (CP) Health|4|||
161176900|NCT02057068|582025771|FG001|Overall Study|Carepartner (CP) Health|2|||
161176901|NCT02057068|582025770|FG000|Overall Study|Lost to Follow-up|2|||
161176902|NCT02057068|582025771|FG001|Overall Study|Lost to Follow-up|2|||
161176903|NCT01098032|582025778|FG000|Overall Study|Withdrawal by Subject|1|||
161176904|NCT01098032|582025779|FG001|Overall Study|Withdrawal by Subject|1|||
161176905|NCT00841672|582025783|FG000|Overall Study|Adverse Event|7|||
161176906|NCT00841672|582025784|FG001|Overall Study|Adverse Event|16|||
161176907|NCT00841672|582025783|FG000|Overall Study|Abnormal test procedure result(s)|0|||
161176908|NCT00841672|582025784|FG001|Overall Study|Abnormal test procedure result(s)|1|||
161176909|NCT00841672|582025783|FG000|Overall Study|Subject withdrew consent|2|||
161176910|NCT00841672|582025784|FG001|Overall Study|Subject withdrew consent|4|||
161176911|NCT00841672|582025783|FG000|Overall Study|Lost to Follow-up|1|||
161176912|NCT00841672|582025784|FG001|Overall Study|Lost to Follow-up|1|||
161176913|NCT00841672|582025783|FG000|Overall Study|Administrative problems|9|||
161176914|NCT00841672|582025784|FG001|Overall Study|Administrative problems|9|||
161176915|NCT00841672|582025783|FG000|Overall Study|Misrandomized|1|||
161176916|NCT00841672|582025784|FG001|Overall Study|Misrandomized|0|||
161176917|NCT00841672|582025783|FG000|Overall Study|Protocol Deviation|0|||
161176918|NCT00841672|582025784|FG001|Overall Study|Protocol Deviation|1|||
161176919|NCT02758613|582025787|FG000|Treatment|Physician and Sponsor Decision|1|||
161176920|NCT02758613|582025788|FG001|Treatment|Physician and Sponsor Decision|0|||
161176921|NCT02758613|582025789|FG002|Treatment|Physician and Sponsor Decision|0|||
161176922|NCT02758613|582025790|FG003|Treatment|Physician and Sponsor Decision|0|||
161176923|NCT02758613|582025787|FG000|Treatment|Withdrawal by Subject|1|||
161176924|NCT02758613|582025788|FG001|Treatment|Withdrawal by Subject|0|||
161176925|NCT02758613|582025789|FG002|Treatment|Withdrawal by Subject|1|||
161176926|NCT02758613|582025790|FG003|Treatment|Withdrawal by Subject|0|||
161176927|NCT00249795|582025792|FG000|Overall Study|Not treated|16|||
161176928|NCT00249795|582025793|FG001|Overall Study|Not treated|14|||
161176929|NCT00249795|582025792|FG000|Overall Study|Symptomatic hypotension|127|||
161176930|NCT00249795|582025793|FG001|Overall Study|Symptomatic hypotension|64|||
161176931|NCT00249795|582025792|FG000|Overall Study|Other Serious Adverse Event|84|||
161297201|NCT01073605|582472037|FG001|Overall Study|Adverse Event|1|||
161297202|NCT01073605|582472038|FG002|Overall Study|Adverse Event|0|||
161297203|NCT01073605|582472036|FG000|Overall Study|Lost to Follow-up|3|||
161297204|NCT01073605|582472037|FG001|Overall Study|Lost to Follow-up|4|||
161176932|NCT00249795|582025793|FG001|Overall Study|Other Serious Adverse Event|93|||
161176933|NCT00249795|582025792|FG000|Overall Study|Qualifying condition not present|26|||
161176934|NCT00249795|582025793|FG001|Overall Study|Qualifying condition not present|29|||
161176935|NCT00249795|582025792|FG000|Overall Study|Withdrawal by Subject|678|||
161176936|NCT00249795|582025793|FG001|Overall Study|Withdrawal by Subject|742|||
161176937|NCT00249795|582025792|FG000|Overall Study|Thromboembolic / outcome event|39|||
161176938|NCT00249795|582025793|FG001|Overall Study|Thromboembolic / outcome event|45|||
161176939|NCT00249795|582025792|FG000|Overall Study|Oral anticoagulant required|2|||
161176940|NCT00249795|582025793|FG001|Overall Study|Oral anticoagulant required|0|||
161176941|NCT00249795|582025792|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
161176942|NCT00249795|582025793|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
161176943|NCT00249795|582025792|FG000|Overall Study|Non-compliance|71|||
161176944|NCT00249795|582025793|FG001|Overall Study|Non-compliance|69|||
161176945|NCT00249795|582025792|FG000|Overall Study|Study drug intolerance|3|||
161176946|NCT00249795|582025793|FG001|Overall Study|Study drug intolerance|3|||
161176947|NCT00249795|582025792|FG000|Overall Study|Other adverse events (non-serious)|188|||
161176948|NCT00249795|582025793|FG001|Overall Study|Other adverse events (non-serious)|159|||
161176949|NCT00249795|582025792|FG000|Overall Study|Physician withdrew consent|71|||
161176950|NCT00249795|582025793|FG001|Overall Study|Physician withdrew consent|63|||
161176951|NCT00249795|582025792|FG000|Overall Study|Surgery / procedure|4|||
161176952|NCT00249795|582025793|FG001|Overall Study|Surgery / procedure|5|||
161176953|NCT00249795|582025792|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
161176954|NCT00249795|582025793|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
161176955|NCT00249795|582025792|FG000|Overall Study|Lightheadedness / dizziness|15|||
161176956|NCT00249795|582025793|FG001|Overall Study|Lightheadedness / dizziness|11|||
161176957|NCT00249795|582025792|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
161176958|NCT00249795|582025793|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
161176959|NCT00249795|582025792|FG000|Overall Study|Other contraindicated medication|1|||
161176960|NCT00249795|582025793|FG001|Overall Study|Other contraindicated medication|1|||
161176961|NCT00249795|582025792|FG000|Overall Study|Event related to cardiac condition|17|||
161176962|NCT00249795|582025793|FG001|Overall Study|Event related to cardiac condition|16|||
161176963|NCT00249795|582025792|FG000|Overall Study|Patient not wish to continue after May08|4|||
161176964|NCT00249795|582025793|FG001|Overall Study|Patient not wish to continue after May08|6|||
161176965|NCT00249795|582025792|FG000|Overall Study|Site not agree to continue after May08|1|||
161176966|NCT00249795|582025793|FG001|Overall Study|Site not agree to continue after May08|1|||
161176967|NCT00249795|582025792|FG000|Overall Study|Lost to Follow-up|0|||
161176968|NCT00249795|582025793|FG001|Overall Study|Lost to Follow-up|2|||
161176969|NCT00249795|582025792|FG000|Overall Study|Missing|0|||
161176970|NCT00249795|582025793|FG001|Overall Study|Missing|1|||
161176971|NCT01203787|582025798|FG000|Overall Study|Death|12|||
161176972|NCT01203787|582025799|FG001|Overall Study|Death|10|||
161176973|NCT01203787|582025798|FG000|Overall Study|Withdrawal by Subject|6|||
161176974|NCT01203787|582025799|FG001|Overall Study|Withdrawal by Subject|2|||
161176975|NCT01203787|582025798|FG000|Overall Study|Lost to Follow-up|2|||
161176976|NCT01203787|582025799|FG001|Overall Study|Lost to Follow-up|0|||
161176977|NCT01203787|582025798|FG000|Overall Study|Adverse Event|11|||
161176978|NCT01203787|582025799|FG001|Overall Study|Adverse Event|15|||
161176979|NCT01601470|582025800|FG000|Period 2 - LCZ696|Physician Decision|1|||
161176980|NCT03032510|582025801|FG000|Overall Study|Adverse Event|5|||
161176981|NCT03032510|582025802|FG001|Overall Study|Adverse Event|2|||
161176982|NCT03032510|582025801|FG000|Overall Study|Lost to Follow-up|8|||
161176983|NCT03032510|582025802|FG001|Overall Study|Lost to Follow-up|7|||
161176984|NCT03032510|582025801|FG000|Overall Study|Withdrawal by Subject|8|||
161176985|NCT03032510|582025802|FG001|Overall Study|Withdrawal by Subject|7|||
161176986|NCT03032510|582025801|FG000|Overall Study|Subject noncompliance|4|||
161176987|NCT03032510|582025802|FG001|Overall Study|Subject noncompliance|2|||
161176988|NCT03032510|582025801|FG000|Overall Study|Physician Decision|2|||
161176989|NCT03032510|582025802|FG001|Overall Study|Physician Decision|0|||
161176990|NCT00431496|582025805|FG000|Overall Study|Adverse Event|3|||
161176991|NCT00431496|582025805|FG000|Overall Study|Lost to Follow-up|1|||
161176992|NCT00431496|582025805|FG000|Overall Study|Withdrawal by Subject|2|||
161176993|NCT00431496|582025805|FG000|Overall Study|Protocol-specified criteria|5|||
161176994|NCT02343952|582025806|FG000|Study Treatment|Disease Progression|23|||
161176995|NCT02343952|582025806|FG000|Study Treatment|Death|3|||
161176996|NCT02343952|582025806|FG000|Study Treatment|Adverse Event|19|||
161176997|NCT02343952|582025806|FG000|Study Treatment|Withdrawal by Subject|7|||
161176998|NCT02343952|582025806|FG000|Study Treatment|other complicating Diseases|1|||
161176999|NCT02343952|582025806|FG000|Follow up|Withdrawal by Subject|3|||
161177000|NCT02343952|582025806|FG000|Follow up|Death|33|||
161177001|NCT02343952|582025806|FG000|Follow up|Patient does not meet eligibility for study.|1|||
161177002|NCT02343952|582025806|FG000|Follow up|Research department closed by the practice.|5|||
161177003|NCT02343952|582025806|FG000|Follow up|Patient went home to Russia|1|||
161177004|NCT02343952|582025806|FG000|Follow up|Disease Progression|1|||
161177005|NCT02343952|582025806|FG000|Follow up|study terminated|1|||
161177006|NCT04018612|582025807|FG000|Overall Study|Withdrawal by Subject|1|||
161177007|NCT04018612|582025808|FG001|Overall Study|Withdrawal by Subject|0|||
161177008|NCT04018612|582025809|FG002|Overall Study|Withdrawal by Subject|1|||
161177009|NCT00361218|582025810|FG000|Overall Study|Lost to Follow-up|11|||
161177010|NCT00361218|582025810|FG000|Overall Study|Personal Reasons|7|||
161177011|NCT00361218|582025810|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
161177012|NCT02671760|582025811|FG000|Overall Study|Lost to Follow-up|0|||
161177013|NCT02671760|582025812|FG001|Overall Study|Lost to Follow-up|1|||
161177014|NCT02671760|582025813|FG002|Overall Study|Lost to Follow-up|0|||
161177015|NCT02079519|582025823|FG000|Overall Study|Disease Progression|9|||
161177016|NCT02079519|582025823|FG000|Overall Study|Adverse Event|1|||
161177017|NCT02566109|582025824|FG000|Overall Study|Withdrawal by Subject|1|||
161177018|NCT01802515|582025825|FG000|Overall Study|Withdrawal by Subject|3|||
161177019|NCT01802515|582025826|FG001|Overall Study|Withdrawal by Subject|0|||
161177020|NCT01802515|582025827|FG002|Overall Study|Withdrawal by Subject|0|||
161177021|NCT01041404|582025830|FG000|Overall Study|Adverse Event|45|||
161177022|NCT01041404|582025831|FG001|Overall Study|Adverse Event|35|||
161177023|NCT01041404|582025830|FG000|Overall Study|Lack of Efficacy|200|||
161177024|NCT01041404|582025831|FG001|Overall Study|Lack of Efficacy|210|||
161177025|NCT01041404|582025830|FG000|Overall Study|Violation of Selection Criteria|0|||
161177026|NCT01041404|582025831|FG001|Overall Study|Violation of Selection Criteria|1|||
161177027|NCT01041404|582025830|FG000|Overall Study|Protocol Violation|4|||
161177028|NCT01041404|582025831|FG001|Overall Study|Protocol Violation|0|||
161177029|NCT01041404|582025830|FG000|Overall Study|Withdrawal by Subject|29|||
161177030|NCT01041404|582025831|FG001|Overall Study|Withdrawal by Subject|23|||
161177031|NCT01041404|582025830|FG000|Overall Study|Failure to Return|1|||
161177032|NCT01041404|582025831|FG001|Overall Study|Failure to Return|2|||
161177033|NCT01041404|582025830|FG000|Overall Study|Other|11|||
161177034|NCT01041404|582025831|FG001|Overall Study|Other|23|||
161177035|NCT01750840|582025832|FG000|Overall Study|Lost to Follow-up|4|||
161177036|NCT01570309|582025833|FG000|Overall Study|Withdrawal by Subject|3|||
161177037|NCT01570309|582025834|FG001|Overall Study|Withdrawal by Subject|3|||
161177038|NCT02091921|582025835|FG000|Overall Study|Adverse Event|3|||
161177039|NCT02483078|582025836|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
161177040|NCT02483078|582025837|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
161177041|NCT02483078|582025836|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
161177042|NCT02483078|582025837|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
161177043|NCT02483078|582025836|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
161177044|NCT02483078|582025837|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
161177045|NCT02483078|582025836|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
161177046|NCT02483078|582025837|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
161177047|NCT02483078|582025836|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
161177048|NCT02483078|582025837|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
161177049|NCT02483078|582025836|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
161177050|NCT02483078|582025837|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
161177051|NCT03627494|582025838|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
161177052|NCT03627494|582025839|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177053|NCT03627494|582025840|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
161177054|NCT03627494|582025841|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177055|NCT03627494|582025842|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177056|NCT03627494|582025843|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177057|NCT03627494|582025844|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177058|NCT03627494|582025845|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177059|NCT03627494|582025846|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177060|NCT03627494|582025847|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177061|NCT03627494|582025848|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177062|NCT03627494|582025849|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
161177063|NCT03627494|582025838|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177064|NCT03627494|582025839|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177065|NCT03627494|582025840|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177066|NCT03627494|582025841|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177067|NCT03627494|582025842|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177068|NCT03627494|582025843|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177069|NCT03627494|582025844|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177070|NCT03627494|582025845|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177071|NCT03627494|582025846|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
161177072|NCT03627494|582025847|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177073|NCT03627494|582025848|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177074|NCT03627494|582025849|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
161177075|NCT03627494|582025838|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177076|NCT03627494|582025839|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177077|NCT03627494|582025840|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177078|NCT03627494|582025841|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177079|NCT03627494|582025842|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177080|NCT03627494|582025843|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177081|NCT03627494|582025844|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177082|NCT03627494|582025845|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177083|NCT03627494|582025846|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177084|NCT03627494|582025847|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
161177085|NCT03627494|582025848|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
161177086|NCT03627494|582025849|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
161177087|NCT01432756|582027799|FG000|Overall Study|Lost to Follow-up|1|||
161177088|NCT01432756|582027800|FG001|Overall Study|Lost to Follow-up|0|||
161177089|NCT01432756|582027801|FG002|Overall Study|Lost to Follow-up|2|||
161177090|NCT01432756|582027802|FG003|Overall Study|Lost to Follow-up|1|||
161177091|NCT02177786|582027803|FG000|Overall Study|Withdrew Consent|2|||
161177092|NCT02177786|582027804|FG001|Overall Study|Withdrew Consent|6|||
161177093|NCT02177786|582027805|FG002|Overall Study|Withdrew Consent|9|||
161088288|NCT02054741|581712692|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
161088289|NCT02054741|581712693|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
161088290|NCT00394082|581712694|FG000|Overall Study|Unacceptable toxicity|15|||
161088291|NCT00394082|581712694|FG000|Overall Study|Adverse Event|4|||
161088292|NCT00394082|581712694|FG000|Overall Study|Physician Decision|4|||
161088293|NCT00394082|581712694|FG000|Overall Study|Withdrawal by Subject|2|||
161088294|NCT00394082|581712694|FG000|Overall Study|Other|1|||
161088295|NCT02344004|581712696|FG000|Overall Study|Adverse Event|11|||
161088296|NCT02344004|581712697|FG001|Overall Study|Adverse Event|1|||
161088297|NCT02344004|581712696|FG000|Overall Study|Death|9|||
161088298|NCT02344004|581712697|FG001|Overall Study|Death|7|||
161088299|NCT02344004|581712696|FG000|Overall Study|Physician Decision|4|||
161088300|NCT02344004|581712697|FG001|Overall Study|Physician Decision|1|||
161088301|NCT02344004|581712696|FG000|Overall Study|Withdrawal by Subject|22|||
161088302|NCT02344004|581712697|FG001|Overall Study|Withdrawal by Subject|5|||
161088303|NCT02344004|581712696|FG000|Overall Study|Rescue Medication|2|||
161088304|NCT02344004|581712697|FG001|Overall Study|Rescue Medication|0|||
161088305|NCT02344004|581712696|FG000|Overall Study|Other Not Specified|12|||
161088306|NCT02344004|581712697|FG001|Overall Study|Other Not Specified|0|||
161088307|NCT02344004|581712696|FG000|Overall Study|Protocol Violation|1|||
161088308|NCT02344004|581712697|FG001|Overall Study|Protocol Violation|0|||
161088309|NCT01768117|581712698|FG000|Overall Study|Lost to Follow-up|1|||
161088310|NCT01768117|581712698|FG000|Overall Study|Withdrawal by Subject|2|||
161088311|NCT01768117|581712698|FG000|Overall Study|Protocol Violation|3|||
161088312|NCT01945060|581712699|FG000|Overall Study|Lost to follow up|1|||
161088313|NCT01945060|581712700|FG001|Overall Study|Lost to follow up|0|||
161088314|NCT01945060|581712699|FG000|Overall Study|Distress related to IV access|0|||
161088315|NCT01945060|581712700|FG001|Overall Study|Distress related to IV access|1|||
161088316|NCT00138671|581712701|FG000|Overall Study|Death|0|||
161088317|NCT00138671|581712702|FG001|Overall Study|Death|3|||
161088318|NCT00138671|581712701|FG000|Overall Study|Adverse Event|6|||
161088319|NCT00138671|581712702|FG001|Overall Study|Adverse Event|3|||
161088320|NCT00138671|581712701|FG000|Overall Study|Lost to Follow-up|1|||
161088321|NCT00138671|581712702|FG001|Overall Study|Lost to Follow-up|2|||
161088322|NCT00138671|581712701|FG000|Overall Study|Withdrawal by Subject|3|||
161088323|NCT00138671|581712702|FG001|Overall Study|Withdrawal by Subject|5|||
161088324|NCT00138671|581712701|FG000|Overall Study|Other|3|||
161088325|NCT00138671|581712702|FG001|Overall Study|Other|3|||
161088326|NCT01488487|581712703|FG000|Overall Study|Adverse Event|6|||
161088327|NCT01488487|581712703|FG000|Overall Study|Death|1|||
161088328|NCT01488487|581712703|FG000|Overall Study|Withdrawal by Subject|2|||
161088329|NCT00395460|581712706|FG000|Overall Study|Withdrawal by Subject|1|||
161088330|NCT00395460|581712707|FG001|Overall Study|Withdrawal by Subject|0|||
161088331|NCT04223830|581712715|FG000|Overall Study|Lost to Follow-up|9|||
161088332|NCT04223830|581712715|FG000|Overall Study|Adverse Event|1|||
161088333|NCT01806623|581712716|FG000|Overall Study|Withdrawal by Subject|1|||
161088334|NCT01806623|581712716|FG000|Overall Study|Adverse Event|1|||
161088335|NCT01806623|581712716|FG000|Overall Study|Did not meet the inclusion criteria|56|||
161088336|NCT01737827|581712717|FG000|Overall Study|Adverse Event|3|||
161088337|NCT01737827|581712718|FG001|Overall Study|Adverse Event|6|||
161088338|NCT01737827|581712719|FG002|Overall Study|Adverse Event|0|||
161088339|NCT01737827|581712717|FG000|Overall Study|Lost to Follow-up|0|||
161088340|NCT01737827|581712718|FG001|Overall Study|Lost to Follow-up|1|||
161088341|NCT01737827|581712719|FG002|Overall Study|Lost to Follow-up|0|||
161088342|NCT01737827|581712717|FG000|Overall Study|Physician Decision|0|||
161088343|NCT01737827|581712718|FG001|Overall Study|Physician Decision|2|||
161088344|NCT01737827|581712719|FG002|Overall Study|Physician Decision|0|||
161088345|NCT01737827|581712717|FG000|Overall Study|Progressive Disease|5|||
161088346|NCT01737827|581712718|FG001|Overall Study|Progressive Disease|16|||
161088347|NCT01737827|581712719|FG002|Overall Study|Progressive Disease|2|||
161088348|NCT01737827|581712717|FG000|Overall Study|Study Terminated by Sponsor|0|||
161088349|NCT01737827|581712718|FG001|Overall Study|Study Terminated by Sponsor|1|||
161088350|NCT01737827|581712719|FG002|Overall Study|Study Terminated by Sponsor|0|||
161088351|NCT01737827|581712717|FG000|Overall Study|Subject/Guardian Decision|0|||
161088352|NCT01737827|581712718|FG001|Overall Study|Subject/Guardian Decision|2|||
161088353|NCT01737827|581712719|FG002|Overall Study|Subject/Guardian Decision|0|||
161088354|NCT01451827|581712720|FG000|Overall Study|Adverse Event|2|||
161088355|NCT01451827|581712721|FG001|Overall Study|Adverse Event|0|||
161088356|NCT01451827|581712722|FG002|Overall Study|Adverse Event|1|||
161088357|NCT01451827|581712723|FG003|Overall Study|Adverse Event|1|||
161088358|NCT01451827|581712720|FG000|Overall Study|Protocol deviation|1|||
161088359|NCT01451827|581712721|FG001|Overall Study|Protocol deviation|0|||
161088360|NCT01451827|581712722|FG002|Overall Study|Protocol deviation|0|||
161088361|NCT01451827|581712723|FG003|Overall Study|Protocol deviation|0|||
161088362|NCT01451827|581712720|FG000|Overall Study|Lost to Follow-up|0|||
161088363|NCT01451827|581712721|FG001|Overall Study|Lost to Follow-up|3|||
161088364|NCT01451827|581712722|FG002|Overall Study|Lost to Follow-up|0|||
161177094|NCT02177786|582027806|FG003|Overall Study|Withdrew Consent|5|||
161177095|NCT02177786|582027803|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
161177096|NCT02177786|582027804|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
161177097|NCT02177786|582027805|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
161177098|NCT02177786|582027806|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
161177099|NCT02177786|582027803|FG000|Overall Study|Adverse Event|1|||
161177100|NCT02177786|582027804|FG001|Overall Study|Adverse Event|1|||
161177101|NCT02177786|582027805|FG002|Overall Study|Adverse Event|2|||
161177102|NCT02177786|582027806|FG003|Overall Study|Adverse Event|3|||
161177103|NCT02177786|582027803|FG000|Overall Study|Death|1|||
161177104|NCT02177786|582027804|FG001|Overall Study|Death|1|||
161177105|NCT02177786|582027805|FG002|Overall Study|Death|1|||
161177106|NCT02177786|582027806|FG003|Overall Study|Death|1|||
161177107|NCT02177786|582027803|FG000|Overall Study|Lost to Follow-up|0|||
161177108|NCT02177786|582027804|FG001|Overall Study|Lost to Follow-up|0|||
161177109|NCT02177786|582027805|FG002|Overall Study|Lost to Follow-up|2|||
161177110|NCT02177786|582027806|FG003|Overall Study|Lost to Follow-up|2|||
161177111|NCT02177786|582027803|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161177112|NCT02177786|582027804|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161177113|NCT02177786|582027805|FG002|Overall Study|Non-Compliance with Study Drug|0|||
161177114|NCT02177786|582027806|FG003|Overall Study|Non-Compliance with Study Drug|1|||
161177115|NCT02177786|582027803|FG000|Overall Study|Protocol Violation|0|||
161177116|NCT02177786|582027804|FG001|Overall Study|Protocol Violation|0|||
161177117|NCT02177786|582027805|FG002|Overall Study|Protocol Violation|2|||
161177118|NCT02177786|582027806|FG003|Overall Study|Protocol Violation|0|||
161177119|NCT02177786|582027803|FG000|Overall Study|Progressive Disease|0|||
161177120|NCT02177786|582027804|FG001|Overall Study|Progressive Disease|1|||
161177121|NCT02177786|582027805|FG002|Overall Study|Progressive Disease|0|||
161177122|NCT02177786|582027806|FG003|Overall Study|Progressive Disease|0|||
161177123|NCT02177786|582027803|FG000|Overall Study|Missing study completion status|0|||
161177124|NCT02177786|582027804|FG001|Overall Study|Missing study completion status|1|||
161177125|NCT02177786|582027805|FG002|Overall Study|Missing study completion status|0|||
161177126|NCT02177786|582027806|FG003|Overall Study|Missing study completion status|0|||
161177127|NCT01305941|582027807|FG000|Overall Study|Adverse Event|6|||
161177128|NCT01305941|582027807|FG000|Overall Study|Clinical decline|2|||
161177129|NCT01305941|582027807|FG000|Overall Study|Withdrawal by Subject|1|||
161177130|NCT01305941|582027807|FG000|Overall Study|Death|1|||
161177131|NCT01957215|582027808|FG000|Overall Study|Adverse Event|2|||
161177132|NCT01957215|582027809|FG001|Overall Study|Adverse Event|2|||
161177133|NCT01957215|582027808|FG000|Overall Study|Lost to Follow-up|3|||
161177134|NCT01957215|582027809|FG001|Overall Study|Lost to Follow-up|3|||
161177135|NCT01957215|582027808|FG000|Overall Study|Protocol Violation|1|||
161177136|NCT01957215|582027809|FG001|Overall Study|Protocol Violation|2|||
161177137|NCT01957215|582027808|FG000|Overall Study|Withdrawal by Subject|7|||
161177138|NCT01957215|582027809|FG001|Overall Study|Withdrawal by Subject|5|||
161177139|NCT03597503|582027813|FG000|Overall Study|Withdrawal by Subject|0|||
161177140|NCT03597503|582027814|FG001|Overall Study|Withdrawal by Subject|2|||
161177141|NCT03597503|582027813|FG000|Overall Study|Lost to Follow-up|1|||
161177142|NCT03597503|582027814|FG001|Overall Study|Lost to Follow-up|2|||
161177143|NCT03597503|582027813|FG000|Overall Study|Protocol Violation|1|||
161177144|NCT03597503|582027814|FG001|Overall Study|Protocol Violation|0|||
161177145|NCT02667236|582027815|FG000|Overall Study|Adverse Event|1|||
161177146|NCT02667236|582027816|FG001|Overall Study|Adverse Event|1|||
161177147|NCT02667236|582027815|FG000|Overall Study|Withdrawal by Subject|2|||
161177148|NCT02667236|582027816|FG001|Overall Study|Withdrawal by Subject|0|||
161177149|NCT02996110|582027821|FG000|Pre-Treatment|Other Reasons|0|||
161177150|NCT02996110|582027822|FG001|Pre-Treatment|Other Reasons|1|||
161177151|NCT02996110|582027823|FG002|Pre-Treatment|Other Reasons|0|||
161177152|NCT02996110|582027824|FG003|Pre-Treatment|Other Reasons|0|||
161177153|NCT02996110|582027825|FG004|Pre-Treatment|Other Reasons|1|||
161177154|NCT02996110|582027821|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
161177155|NCT02996110|582027822|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
161177156|NCT02996110|582027823|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
161177157|NCT02996110|582027824|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
161177158|NCT02996110|582027825|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
161177159|NCT02996110|582027821|FG000|Track 1|Disease Progression|15|||
161177160|NCT02996110|582027822|FG001|Track 1|Disease Progression|17|||
161177161|NCT02996110|582027823|FG002|Track 1|Disease Progression|0|||
161177162|NCT02996110|582027824|FG003|Track 1|Disease Progression|0|||
161177163|NCT02996110|582027825|FG004|Track 1|Disease Progression|0|||
161177164|NCT02996110|582027821|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
161177165|NCT02996110|582027822|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
161177166|NCT02996110|582027823|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
161177167|NCT02996110|582027824|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
161177168|NCT02996110|582027825|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
161177169|NCT02996110|582027821|FG000|Track 1|Study Drug Toxicity|5|||
161177170|NCT02996110|582027822|FG001|Track 1|Study Drug Toxicity|3|||
161177171|NCT02996110|582027823|FG002|Track 1|Study Drug Toxicity|0|||
161177172|NCT02996110|582027824|FG003|Track 1|Study Drug Toxicity|0|||
161177173|NCT02996110|582027825|FG004|Track 1|Study Drug Toxicity|0|||
161177174|NCT02996110|582027821|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
161177175|NCT02996110|582027822|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161177176|NCT02996110|582027823|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161177177|NCT02996110|582027824|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161177178|NCT02996110|582027825|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
161177179|NCT02996110|582027821|FG000|Track 1|Administrative Reason by Sponsor|0|||
161177180|NCT02996110|582027822|FG001|Track 1|Administrative Reason by Sponsor|1|||
161177181|NCT02996110|582027823|FG002|Track 1|Administrative Reason by Sponsor|0|||
161177182|NCT02996110|582027824|FG003|Track 1|Administrative Reason by Sponsor|0|||
161177183|NCT02996110|582027825|FG004|Track 1|Administrative Reason by Sponsor|0|||
161177184|NCT02996110|582027821|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
161177185|NCT02996110|582027822|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
161177186|NCT02996110|582027823|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
161177187|NCT02996110|582027824|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
161177188|NCT02996110|582027825|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
161177189|NCT02996110|582027821|FG000|Track 2|Disease Progression|33|||
161177190|NCT02996110|582027822|FG001|Track 2|Disease Progression|26|||
161177191|NCT02996110|582027823|FG002|Track 2|Disease Progression|19|||
161177192|NCT02996110|582027824|FG003|Track 2|Disease Progression|16|||
161177193|NCT02996110|582027825|FG004|Track 2|Disease Progression|15|||
161177194|NCT02996110|582027821|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
161177195|NCT02996110|582027822|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
161177196|NCT02996110|582027823|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
161177197|NCT02996110|582027824|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
161177198|NCT02996110|582027825|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
161177199|NCT02996110|582027821|FG000|Track 2|Death|0|||
161177200|NCT02996110|582027822|FG001|Track 2|Death|0|||
161177201|NCT02996110|582027823|FG002|Track 2|Death|1|||
161177202|NCT02996110|582027824|FG003|Track 2|Death|0|||
161177203|NCT02996110|582027825|FG004|Track 2|Death|1|||
161177204|NCT02996110|582027821|FG000|Track 2|Study Drug Toxicity|4|||
161177205|NCT02996110|582027822|FG001|Track 2|Study Drug Toxicity|1|||
161177206|NCT02996110|582027823|FG002|Track 2|Study Drug Toxicity|4|||
161177207|NCT02996110|582027824|FG003|Track 2|Study Drug Toxicity|1|||
161177208|NCT02996110|582027825|FG004|Track 2|Study Drug Toxicity|0|||
161177209|NCT02996110|582027821|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
161177210|NCT02996110|582027822|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
161177211|NCT02996110|582027823|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
161177212|NCT02996110|582027824|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
161177213|NCT02996110|582027825|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
161177214|NCT02996110|582027821|FG000|Track 2|Participant Withdrew Consent|1|||
161177215|NCT02996110|582027822|FG001|Track 2|Participant Withdrew Consent|2|||
161177216|NCT02996110|582027823|FG002|Track 2|Participant Withdrew Consent|3|||
161177217|NCT02996110|582027824|FG003|Track 2|Participant Withdrew Consent|1|||
161177218|NCT02996110|582027825|FG004|Track 2|Participant Withdrew Consent|1|||
161177219|NCT02996110|582027821|FG000|Track 2|Other Reasons|0|||
161177220|NCT02996110|582027822|FG001|Track 2|Other Reasons|0|||
161177221|NCT02996110|582027823|FG002|Track 2|Other Reasons|1|||
161177222|NCT02996110|582027824|FG003|Track 2|Other Reasons|0|||
161177223|NCT02996110|582027825|FG004|Track 2|Other Reasons|1|||
161177224|NCT02436915|582027826|FG000|Overall Study|Withdrawal by Subject|0|||
161177225|NCT02436915|582027827|FG001|Overall Study|Withdrawal by Subject|1|||
161177226|NCT03805971|582027828|FG000|Overall Study|Withdrawal by Subject|1|||
161177227|NCT03805971|582027828|FG000|Overall Study|Protocol Violation|2|||
161177228|NCT02939976|582027833|FG000|Overall Study|Lost to Follow-up|7|||
161177229|NCT02939976|582027834|FG001|Overall Study|Lost to Follow-up|1|||
161177230|NCT02939976|582027835|FG002|Overall Study|Lost to Follow-up|1|||
161177231|NCT02939976|582027836|FG003|Overall Study|Lost to Follow-up|2|||
161177232|NCT02939976|582027833|FG000|Overall Study|Withdrawal by Subject|4|||
161177233|NCT02939976|582027834|FG001|Overall Study|Withdrawal by Subject|0|||
161177234|NCT02939976|582027835|FG002|Overall Study|Withdrawal by Subject|2|||
161177235|NCT02939976|582027836|FG003|Overall Study|Withdrawal by Subject|4|||
161177236|NCT02939976|582027833|FG000|Overall Study|Due to early study closure|4|||
161177237|NCT02939976|582027834|FG001|Overall Study|Due to early study closure|3|||
161177238|NCT02939976|582027835|FG002|Overall Study|Due to early study closure|2|||
161177239|NCT02939976|582027836|FG003|Overall Study|Due to early study closure|3|||
161177240|NCT04080752|582027837|FG000|Overall Study|Adverse Event|2|||
161177241|NCT04080752|582027838|FG001|Overall Study|Adverse Event|3|||
161177242|NCT04080752|582027837|FG000|Overall Study|Lack of Efficacy|1|||
161177243|NCT04080752|582027838|FG001|Overall Study|Lack of Efficacy|0|||
161177244|NCT04080752|582027837|FG000|Overall Study|Lost to Follow-up|1|||
161177245|NCT04080752|582027838|FG001|Overall Study|Lost to Follow-up|0|||
161177246|NCT04080752|582027837|FG000|Overall Study|Pregnancy|0|||
161177247|NCT04080752|582027838|FG001|Overall Study|Pregnancy|1|||
161177248|NCT04080752|582027837|FG000|Overall Study|Withdrawal by Subject|7|||
161177249|NCT04080752|582027838|FG001|Overall Study|Withdrawal by Subject|0|||
161177250|NCT04080752|582027837|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161177251|NCT04080752|582027838|FG001|Overall Study|Non-Compliance with Study Drug|1|||
161177252|NCT04080752|582027837|FG000|Overall Study|Other|2|||
161177253|NCT04080752|582027838|FG001|Overall Study|Other|1|||
161177254|NCT01585168|582027839|FG000|Overall Study|Lost to Follow-up|3|||
161177255|NCT01585168|582027840|FG001|Overall Study|Lost to Follow-up|1|||
161177256|NCT01585168|582027841|FG002|Overall Study|Lost to Follow-up|1|||
161177257|NCT01585168|582027842|FG003|Overall Study|Lost to Follow-up|1|||
161177258|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
161177259|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
161177260|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
161177261|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
161347676|NCT00817063|582657339|FG001|Overall Study|Death|1|||
161347677|NCT00817063|582657338|FG000|Overall Study|Lack of Efficacy|33|||
161177262|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
161177263|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
161177264|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
161177265|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
161177266|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
161177267|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
161177268|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
161177269|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
161177270|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161177271|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
161177272|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161177273|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
161177274|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
161177275|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
161177276|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
161177277|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
161177278|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
161177279|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
161177280|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
161177281|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
161177282|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Other|0|||
161177283|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Other|1|||
161177284|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Other|0|||
161177285|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Other|0|||
161177286|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
161177287|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
161177288|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
161177289|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
161177290|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
161177291|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
161177292|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
161177293|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
161177294|NCT01194414|582027843|FG000|24 Weeks Double Blind Period|Death|0|||
161177295|NCT01194414|582027844|FG001|24 Weeks Double Blind Period|Death|1|||
161177296|NCT01194414|582027845|FG002|24 Weeks Double Blind Period|Death|0|||
161177297|NCT01194414|582027846|FG003|24 Weeks Double Blind Period|Death|0|||
161177298|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
161177299|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
161177300|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
161177301|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
161177302|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
161177303|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
161177304|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
161177305|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
161177306|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
161177307|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
161177308|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
161177309|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
161177310|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
161177311|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
161177312|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
161177313|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
161177314|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
161177315|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
161177316|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
161177317|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
161177318|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
161177319|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
161177320|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
161177321|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
161177322|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Other|2|||
161177323|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Other|1|||
161177324|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Other|0|||
161177325|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Other|0|||
161177326|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
161177327|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
161177328|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
161177329|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
161177330|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
161177331|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
161177332|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
161177333|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
161177334|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
161177335|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
161177336|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
161177337|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
161177338|NCT01194414|582027843|FG000|72 Weeks Open Label Extension|Death|1|||
161177339|NCT01194414|582027844|FG001|72 Weeks Open Label Extension|Death|2|||
161177340|NCT01194414|582027845|FG002|72 Weeks Open Label Extension|Death|0|||
161177341|NCT01194414|582027846|FG003|72 Weeks Open Label Extension|Death|2|||
161177342|NCT00865046|582027847|FG000|Overall Study|Lost to Follow-up|1|||
161177343|NCT00865046|582027848|FG001|Overall Study|Lost to Follow-up|4|||
161177344|NCT00865046|582027849|FG002|Overall Study|Lost to Follow-up|0|||
161177345|NCT00865046|582027847|FG000|Overall Study|Death|0|||
161177346|NCT00865046|582027848|FG001|Overall Study|Death|1|||
161177347|NCT00865046|582027849|FG002|Overall Study|Death|1|||
161177348|NCT00865046|582027847|FG000|Overall Study|Withdrawal by Subject|5|||
161177349|NCT00865046|582027848|FG001|Overall Study|Withdrawal by Subject|0|||
161177350|NCT00865046|582027849|FG002|Overall Study|Withdrawal by Subject|0|||
161177351|NCT00329784|582027850|FG000|Overall Study|Lost to Follow-up|0|||
161177352|NCT00329784|582027851|FG001|Overall Study|Lost to Follow-up|1|||
161177353|NCT00329784|582027852|FG002|Overall Study|Lost to Follow-up|0|||
161177354|NCT00329784|582027853|FG003|Overall Study|Lost to Follow-up|0|||
161177355|NCT00329784|582027850|FG000|Overall Study|Withdrawal by Subject|4|||
161177356|NCT00329784|582027851|FG001|Overall Study|Withdrawal by Subject|2|||
161177357|NCT00329784|582027852|FG002|Overall Study|Withdrawal by Subject|0|||
161177358|NCT00329784|582027853|FG003|Overall Study|Withdrawal by Subject|0|||
161177359|NCT00329784|582027850|FG000|Overall Study|Other|1|||
161177360|NCT00329784|582027851|FG001|Overall Study|Other|2|||
161177361|NCT00329784|582027852|FG002|Overall Study|Other|0|||
161177362|NCT00329784|582027853|FG003|Overall Study|Other|0|||
161177363|NCT01587274|582027854|FG000|Overall Study|Lost to Follow-up|4|||
161177364|NCT01587274|582027855|FG001|Overall Study|Lost to Follow-up|5|||
161177365|NCT01587274|582027856|FG002|Overall Study|Lost to Follow-up|3|||
161177366|NCT02709109|582027870|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
161177367|NCT02709109|582027871|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
161177368|NCT02709109|582027872|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
161177369|NCT02709109|582027873|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
161177370|NCT02709109|582027870|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161177371|NCT02709109|582027871|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
161177372|NCT02709109|582027872|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161177373|NCT02709109|582027873|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
161177374|NCT02709109|582027870|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
161177375|NCT02709109|582027871|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161177376|NCT02709109|582027872|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161177377|NCT02709109|582027873|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
161177378|NCT02709109|582027870|FG000|Washout Period (28 Days)|Other|2|||
161177379|NCT02709109|582027871|FG001|Washout Period (28 Days)|Other|2|||
161177380|NCT02709109|582027872|FG002|Washout Period (28 Days)|Other|3|||
161177381|NCT02709109|582027873|FG003|Washout Period (28 Days)|Other|0|||
161177382|NCT02709109|582027870|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
161177383|NCT02709109|582027871|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
161297205|NCT01073605|582472038|FG002|Overall Study|Lost to Follow-up|9|||
161177384|NCT02709109|582027872|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
161177385|NCT02709109|582027873|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
161177386|NCT02709109|582027870|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
161177387|NCT02709109|582027871|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
161177388|NCT02709109|582027872|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
161177389|NCT02709109|582027873|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
161177390|NCT02709109|582027870|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161177391|NCT02709109|582027871|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161177392|NCT02709109|582027872|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
161177393|NCT02709109|582027873|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
161177394|NCT02709109|582027870|FG000|Treatment Period 2 (28 Days)|Other|0|||
161177395|NCT02709109|582027871|FG001|Treatment Period 2 (28 Days)|Other|0|||
161177396|NCT02709109|582027872|FG002|Treatment Period 2 (28 Days)|Other|1|||
161177397|NCT02709109|582027873|FG003|Treatment Period 2 (28 Days)|Other|0|||
161177398|NCT02565615|582027874|FG000|Overall Study|Death|0|||
161177399|NCT02565615|582027875|FG001|Overall Study|Death|1|||
161177400|NCT02565615|582027876|FG002|Overall Study|Death|0|||
161177401|NCT02565615|582027877|FG003|Overall Study|Death|0|||
161177402|NCT02565615|582027878|FG004|Overall Study|Death|4|||
161177403|NCT02565615|582027874|FG000|Overall Study|Not willing to participate in study|2|||
161177404|NCT02565615|582027875|FG001|Overall Study|Not willing to participate in study|21|||
161177405|NCT02565615|582027876|FG002|Overall Study|Not willing to participate in study|0|||
161177406|NCT02565615|582027877|FG003|Overall Study|Not willing to participate in study|1|||
161177407|NCT02565615|582027878|FG004|Overall Study|Not willing to participate in study|169|||
161177408|NCT02565615|582027874|FG000|Overall Study|Lost to Follow-up|0|||
161177409|NCT02565615|582027875|FG001|Overall Study|Lost to Follow-up|4|||
161177410|NCT02565615|582027876|FG002|Overall Study|Lost to Follow-up|0|||
161177411|NCT02565615|582027877|FG003|Overall Study|Lost to Follow-up|1|||
161177412|NCT02565615|582027878|FG004|Overall Study|Lost to Follow-up|765|||
161177413|NCT02565615|582027874|FG000|Overall Study|Not meeting eligibility criteria|0|||
161177414|NCT02565615|582027875|FG001|Overall Study|Not meeting eligibility criteria|7|||
161177415|NCT02565615|582027876|FG002|Overall Study|Not meeting eligibility criteria|0|||
161177416|NCT02565615|582027877|FG003|Overall Study|Not meeting eligibility criteria|0|||
161177417|NCT02565615|582027878|FG004|Overall Study|Not meeting eligibility criteria|25|||
161177418|NCT02565615|582027874|FG000|Overall Study|Reason not defined|0|||
161177419|NCT02565615|582027875|FG001|Overall Study|Reason not defined|2|||
161177420|NCT02565615|582027876|FG002|Overall Study|Reason not defined|0|||
161177421|NCT02565615|582027877|FG003|Overall Study|Reason not defined|1|||
161177422|NCT02565615|582027878|FG004|Overall Study|Reason not defined|62|||
161177423|NCT02565615|582027874|FG000|Overall Study|Adverse Event|1|||
161177424|NCT02565615|582027875|FG001|Overall Study|Adverse Event|1|||
161177425|NCT02565615|582027876|FG002|Overall Study|Adverse Event|0|||
161177426|NCT02565615|582027877|FG003|Overall Study|Adverse Event|0|||
161177427|NCT02565615|582027878|FG004|Overall Study|Adverse Event|9|||
161177428|NCT02565615|582027874|FG000|Overall Study|Untreated|0|||
161177429|NCT02565615|582027875|FG001|Overall Study|Untreated|0|||
161177430|NCT02565615|582027876|FG002|Overall Study|Untreated|0|||
161177431|NCT02565615|582027877|FG003|Overall Study|Untreated|0|||
161177432|NCT02565615|582027878|FG004|Overall Study|Untreated|567|||
161177433|NCT01928082|582027883|FG000|Overall Study|Study terminated.|1|||
161177434|NCT05563714|582027885|FG000|Overall Study|Death|2|||
161177435|NCT05563714|582027886|FG001|Overall Study|Death|2|||
161177436|NCT05563714|582027887|FG002|Overall Study|Death|0|||
161177437|NCT05563714|582027888|FG003|Overall Study|Death|0|||
161177438|NCT05563714|582027885|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
161177439|NCT05563714|582027886|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
161177440|NCT05563714|582027887|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
161177441|NCT05563714|582027888|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
161177442|NCT05563714|582027885|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
161177443|NCT05563714|582027886|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
161347678|NCT00817063|582657339|FG001|Overall Study|Lack of Efficacy|86|||
161177444|NCT05563714|582027887|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
161177445|NCT05563714|582027888|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
161177446|NCT05563714|582027885|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161177447|NCT05563714|582027886|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
161177448|NCT05563714|582027887|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161177449|NCT05563714|582027888|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
161177450|NCT05563714|582027885|FG000|Overall Study|Lost to Follow-up|22|||
161347679|NCT00817063|582657338|FG000|Overall Study|Failure to Return|13|||
161347680|NCT00817063|582657339|FG001|Overall Study|Failure to Return|12|||
161177451|NCT05563714|582027886|FG001|Overall Study|Lost to Follow-up|19|||
161177452|NCT05563714|582027887|FG002|Overall Study|Lost to Follow-up|0|||
161177453|NCT05563714|582027888|FG003|Overall Study|Lost to Follow-up|0|||
161177454|NCT01815580|582027891|FG000|Overall Study|Lost to Follow-up|4|||
161177455|NCT01815580|582027892|FG001|Overall Study|Lost to Follow-up|7|||
161177456|NCT01815580|582027891|FG000|Overall Study|Withdrawal by Subject|3|||
161177457|NCT01815580|582027892|FG001|Overall Study|Withdrawal by Subject|4|||
161177458|NCT01815580|582027891|FG000|Overall Study|Excluded from analysis|5|||
161177459|NCT01815580|582027892|FG001|Overall Study|Excluded from analysis|4|||
161177460|NCT02427100|582027898|FG000|Overall Study|Lost to Follow-up|0|||
161177461|NCT02427100|582027899|FG001|Overall Study|Lost to Follow-up|2|||
161177462|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
161177463|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
161177464|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
161177465|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
161177466|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
161177467|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
161177468|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
161177469|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
161177470|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161177471|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161177472|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161177473|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161177474|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161177475|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
161177476|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
161177477|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
161177478|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
161177479|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
161177480|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
161177481|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
161177482|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
161177483|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
161177484|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161177485|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161177486|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161177487|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161177488|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161177489|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
161177490|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
161177491|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161177492|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161177493|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161177494|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161177495|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161177496|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
161177497|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
161177498|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161177499|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161177500|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161177501|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161177502|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161177503|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
161177504|NCT02120352|582027902|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
161177505|NCT02120352|582027903|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
161177506|NCT02120352|582027904|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
161177507|NCT02120352|582027905|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
161177508|NCT02120352|582027906|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
161177509|NCT02120352|582027907|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
161177510|NCT02120352|582027908|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
161177511|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161177512|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
161177513|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
161177514|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
161177515|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161177516|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161177517|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
161177518|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161177519|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
161177520|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161177521|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
161177522|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161177523|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161177524|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
161177525|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161177526|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
161177527|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
161177528|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161177529|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161177530|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161177531|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
161177532|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161177533|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161177534|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
161177535|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
161177536|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161177537|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161177538|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
161177539|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161177540|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161177541|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161177542|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
161177543|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161177544|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161177545|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
161177546|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161177547|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
161177548|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
161177549|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
161177550|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161177551|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161177552|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
161177553|NCT02120352|582027902|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161177554|NCT02120352|582027903|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
161177555|NCT02120352|582027904|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161177556|NCT02120352|582027905|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161177557|NCT02120352|582027906|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161177558|NCT02120352|582027907|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161177559|NCT02120352|582027908|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
161177560|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161177561|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
161177562|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
161177563|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161177564|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
161177565|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
161177566|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
161177567|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161177568|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161177569|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161177570|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161177571|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
161177572|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161177573|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
161177574|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161177575|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
161177576|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
161177577|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161177578|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
161177579|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161177580|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
161177581|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161177582|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
161177583|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
161177584|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161177585|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
161177586|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161177587|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
161177588|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161177589|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
161177590|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
161177591|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161177592|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
161177593|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161177594|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
161177595|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161177596|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
161177597|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
161177598|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161177599|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161177600|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161177601|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
161177602|NCT02120352|582027902|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
161177603|NCT02120352|582027903|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
161177604|NCT02120352|582027904|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
161177605|NCT02120352|582027905|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
161177606|NCT02120352|582027906|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
161177607|NCT02120352|582027907|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
161177608|NCT02120352|582027908|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
161177609|NCT02120352|582027902|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161177610|NCT02120352|582027903|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161177611|NCT02120352|582027904|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161177612|NCT02120352|582027905|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161177613|NCT02120352|582027906|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161177614|NCT02120352|582027907|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
161177615|NCT02120352|582027908|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
161177616|NCT00842361|582027910|FG000|Overall Study|Protocol Violation|1|||
161177617|NCT00842361|582027911|FG001|Overall Study|Protocol Violation|0|||
161177618|NCT00842361|582027910|FG000|Overall Study|Unclassified|0|||
161177619|NCT00842361|582027911|FG001|Overall Study|Unclassified|2|||
161177620|NCT02186561|582027912|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
161177621|NCT02186561|582027912|FG000|Enrollment|Enrollment Cap Reached|5|||
161177622|NCT02186561|582027912|FG000|Enrollment|Insurance Denial|2|||
161177623|NCT02186561|582027912|FG000|Enrollment|Withdrawal by Subject|2|||
161177624|NCT02186561|582027912|FG000|Enrollment|Investigator Withdrew Consent|1|||
161177625|NCT02186561|582027912|FG000|30-Day Post Index Procedure Visit|Death|1|||
161177626|NCT02186561|582027912|FG000|1- Year Post Index Procedure Visit|Death|1|||
161177627|NCT02186561|582027912|FG000|1- Year Post Index Procedure Visit|Missed|1|||
161177628|NCT01072448|582027915|FG000|Overall Study|Adverse Event|9|||
161177629|NCT01072448|582027916|FG001|Overall Study|Adverse Event|10|||
161177630|NCT01072448|582027915|FG000|Overall Study|Subject withdrew consent|4|||
161177631|NCT01072448|582027916|FG001|Overall Study|Subject withdrew consent|9|||
161177632|NCT01072448|582027915|FG000|Overall Study|Protocol deviation|3|||
161177633|NCT01072448|582027916|FG001|Overall Study|Protocol deviation|4|||
161177634|NCT01072448|582027915|FG000|Overall Study|Abnormal test procedure result(s)|1|||
161177635|NCT01072448|582027916|FG001|Overall Study|Abnormal test procedure result(s)|0|||
161177636|NCT01072448|582027915|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161177637|NCT01072448|582027916|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
161177638|NCT01072448|582027915|FG000|Overall Study|Lost to Follow-up|1|||
161177639|NCT01072448|582027916|FG001|Overall Study|Lost to Follow-up|1|||
161177640|NCT01072448|582027915|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161177641|NCT01072448|582027916|FG001|Overall Study|Abnormal laboratory value(s)|1|||
161177642|NCT01072448|582027915|FG000|Overall Study|Death|0|||
161177643|NCT01072448|582027916|FG001|Overall Study|Death|2|||
161177644|NCT01814826|582027919|FG000|Overall Study|Other|3|||
161177645|NCT01814826|582027920|FG001|Overall Study|Other|5|||
161177646|NCT01814826|582027921|FG002|Overall Study|Other|0|||
161177647|NCT01814826|582027919|FG000|Overall Study|Death|29|||
161177648|NCT01814826|582027920|FG001|Overall Study|Death|24|||
161177649|NCT01814826|582027921|FG002|Overall Study|Death|3|||
161177650|NCT02917629|582027922|FG000|Overall Study|Withdrawal by Subject|0|||
161177651|NCT02917629|582027923|FG001|Overall Study|Withdrawal by Subject|1|||
161177652|NCT03271307|582027924|FG000|Overall Study|Lost to Follow-up|0|||
161177653|NCT03271307|582027925|FG001|Overall Study|Lost to Follow-up|0|||
161177654|NCT03271307|582027926|FG002|Overall Study|Lost to Follow-up|0|||
161177655|NCT03271307|582027927|FG003|Overall Study|Lost to Follow-up|28|||
161177656|NCT03271307|582027928|FG004|Overall Study|Lost to Follow-up|91|||
161177657|NCT01042938|582027929|FG000|Overall Study|Withdrawal by Subject|1|||
161177658|NCT01042938|582027930|FG001|Overall Study|Withdrawal by Subject|1|||
161177659|NCT01042938|582027929|FG000|Overall Study|Protocol Violation|1|||
161177660|NCT01042938|582027930|FG001|Overall Study|Protocol Violation|1|||
161177661|NCT01042938|582027929|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
161177662|NCT01042938|582027930|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
161177663|NCT03136484|582027931|FG000|Overall Study|Withdrawal by Subject|19|||
161177664|NCT03136484|582027932|FG001|Overall Study|Withdrawal by Subject|14|||
161177665|NCT03136484|582027931|FG000|Overall Study|Lost to Follow-up|7|||
161177666|NCT03136484|582027932|FG001|Overall Study|Lost to Follow-up|8|||
161177667|NCT03136484|582027931|FG000|Overall Study|Death|1|||
161177668|NCT03136484|582027932|FG001|Overall Study|Death|0|||
161177669|NCT03997760|582027933|FG000|Overall Study|Protocol Deviation|0|||
161177670|NCT03997760|582027934|FG001|Overall Study|Protocol Deviation|1|||
161177671|NCT03997760|582027935|FG002|Overall Study|Protocol Deviation|0|||
161177672|NCT03997760|582027936|FG003|Overall Study|Protocol Deviation|0|||
161177673|NCT00856986|582027937|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
161177674|NCT00856986|582027938|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
161177675|NCT00856986|582027939|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
161177676|NCT00856986|582027940|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
161177677|NCT00856986|582027941|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
161177678|NCT00856986|582027937|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161177679|NCT00856986|582027938|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161177680|NCT00856986|582027939|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161177681|NCT00856986|582027940|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
161177682|NCT00856986|582027941|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
161177683|NCT00856986|582027937|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161177684|NCT00856986|582027938|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161177685|NCT00856986|582027939|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161177686|NCT00856986|582027940|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
161177687|NCT00856986|582027941|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
161177688|NCT00856986|582027937|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161347681|NCT00817063|582657338|FG000|Overall Study|Violation of Selection at Entry|7|||
161347682|NCT00817063|582657339|FG001|Overall Study|Violation of Selection at Entry|4|||
161347683|NCT00817063|582657338|FG000|Overall Study|Protocol Violation|3|||
161347684|NCT00817063|582657339|FG001|Overall Study|Protocol Violation|8|||
161347685|NCT00817063|582657338|FG000|Overall Study|Withdrawal by Subject|17|||
161347686|NCT00817063|582657339|FG001|Overall Study|Withdrawal by Subject|37|||
161347687|NCT00817063|582657338|FG000|Overall Study|Early Improvement|19|||
161347688|NCT00817063|582657339|FG001|Overall Study|Early Improvement|4|||
161347689|NCT00817063|582657338|FG000|Overall Study|Administrative|10|||
161347690|NCT00817063|582657339|FG001|Overall Study|Administrative|4|||
161347691|NCT00817063|582657338|FG000|Overall Study|Abnormality of Laboratory Test|2|||
161347692|NCT00817063|582657339|FG001|Overall Study|Abnormality of Laboratory Test|1|||
161347693|NCT02696616|582657340|FG000|Overall Study|Adverse Event|0|||
161347694|NCT02696616|582657341|FG001|Overall Study|Adverse Event|1|||
161347695|NCT02696616|582657342|FG002|Overall Study|Adverse Event|0|||
161347696|NCT02696616|582657343|FG003|Overall Study|Adverse Event|0|||
161347697|NCT02696616|582657344|FG004|Overall Study|Adverse Event|0|||
161347698|NCT02696616|582657345|FG005|Overall Study|Adverse Event|0|||
161347699|NCT02696616|582657346|FG006|Overall Study|Adverse Event|0|||
161347700|NCT01500083|582657347|FG000|Overall Study|Adverse Event|4|||
161347701|NCT01500083|582657348|FG001|Overall Study|Adverse Event|17|||
161347702|NCT01500083|582657347|FG000|Overall Study|Death|0|||
161347703|NCT01500083|582657348|FG001|Overall Study|Death|2|||
161347704|NCT01500083|582657347|FG000|Overall Study|Lost to Follow-up|1|||
161347705|NCT01500083|582657348|FG001|Overall Study|Lost to Follow-up|0|||
161347706|NCT01500083|582657347|FG000|Overall Study|Withdrawal of Consent|0|||
161347707|NCT01500083|582657348|FG001|Overall Study|Withdrawal of Consent|1|||
161347708|NCT01500083|582657347|FG000|Overall Study|Disease Progression|2|||
161347709|NCT01500083|582657348|FG001|Overall Study|Disease Progression|10|||
161347710|NCT01500083|582657347|FG000|Overall Study|Investigator Discretion|3|||
161347711|NCT01500083|582657348|FG001|Overall Study|Investigator Discretion|8|||
161347712|NCT01500083|582657347|FG000|Overall Study|Other Reasons|2|||
161177689|NCT00856986|582027938|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161177690|NCT00856986|582027939|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161177691|NCT00856986|582027940|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
161177692|NCT00856986|582027941|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
161177693|NCT00856986|582027937|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161177694|NCT00856986|582027938|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161177695|NCT00856986|582027939|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161177696|NCT00856986|582027940|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
161347713|NCT01500083|582657348|FG001|Overall Study|Other Reasons|5|||
161347714|NCT01970371|582657349|FG000|Overall Study|Death|8|||
161347715|NCT01970371|582657350|FG001|Overall Study|Death|13|||
161347716|NCT01970371|582657351|FG002|Overall Study|Death|12|||
161347717|NCT01970371|582657349|FG000|Overall Study|Lost to Follow-up|0|||
161297206|NCT01073605|582472036|FG000|Overall Study|Other|25|||
161297207|NCT01073605|582472037|FG001|Overall Study|Other|21|||
161297208|NCT01073605|582472038|FG002|Overall Study|Other|29|||
161297209|NCT01073605|582472036|FG000|Overall Study|Withdrawal by Subject|31|||
161297210|NCT01073605|582472037|FG001|Overall Study|Withdrawal by Subject|39|||
161297211|NCT01073605|582472038|FG002|Overall Study|Withdrawal by Subject|22|||
161297212|NCT01073605|582472036|FG000|Overall Study|Randomized But Not Treated|0|||
161297213|NCT01073605|582472037|FG001|Overall Study|Randomized But Not Treated|1|||
161297214|NCT01073605|582472038|FG002|Overall Study|Randomized But Not Treated|1|||
161297215|NCT03491462|582472039|FG000|Overall Study|Lost to Follow-up|2|||
161297216|NCT03491462|582472040|FG001|Overall Study|Lost to Follow-up|0|||
161297217|NCT03491462|582472039|FG000|Overall Study|Adverse Event|11|||
161297218|NCT03491462|582472040|FG001|Overall Study|Adverse Event|1|||
161297219|NCT03491462|582472039|FG000|Overall Study|Physician Decision|3|||
161297220|NCT03491462|582472040|FG001|Overall Study|Physician Decision|0|||
161297221|NCT03491462|582472039|FG000|Overall Study|Withdrawal by Subject|22|||
161297222|NCT03491462|582472040|FG001|Overall Study|Withdrawal by Subject|15|||
161297223|NCT03018080|582472041|FG000|Overall Study|Death|12|||
161297224|NCT03018080|582472042|FG001|Overall Study|Death|19|||
161297225|NCT00740792|582472043|FG000|Overall Study|Adverse Event|3|||
161297226|NCT00740792|582472044|FG001|Overall Study|Adverse Event|1|||
161297227|NCT00740792|582472045|FG002|Overall Study|Adverse Event|1|||
161297228|NCT00740792|582472046|FG003|Overall Study|Adverse Event|3|||
161297229|NCT00740792|582472043|FG000|Overall Study|Lack of Efficacy|1|||
161297230|NCT00740792|582472044|FG001|Overall Study|Lack of Efficacy|1|||
161297231|NCT00740792|582472045|FG002|Overall Study|Lack of Efficacy|0|||
161297232|NCT00740792|582472046|FG003|Overall Study|Lack of Efficacy|3|||
161297233|NCT00740792|582472043|FG000|Overall Study|Lost to Follow-up|2|||
161297234|NCT00740792|582472044|FG001|Overall Study|Lost to Follow-up|1|||
161297235|NCT00740792|582472045|FG002|Overall Study|Lost to Follow-up|0|||
161297236|NCT00740792|582472046|FG003|Overall Study|Lost to Follow-up|0|||
161177697|NCT00856986|582027941|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
161177698|NCT00856986|582027937|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
161177699|NCT00856986|582027938|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
161177700|NCT00856986|582027939|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
161177701|NCT00856986|582027940|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
161177702|NCT00856986|582027941|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
161177703|NCT00856986|582027937|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
161177704|NCT00856986|582027938|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
161177705|NCT00856986|582027939|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
161177706|NCT00856986|582027940|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
161177707|NCT00856986|582027941|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
161177708|NCT00856986|582027937|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
161177709|NCT00856986|582027938|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
161177710|NCT00856986|582027939|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
161177711|NCT00856986|582027940|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
161177712|NCT00856986|582027941|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
161177713|NCT00856986|582027937|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
161177714|NCT00856986|582027938|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161177715|NCT00856986|582027939|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
161177716|NCT00856986|582027940|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161177717|NCT00856986|582027941|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
161177718|NCT00856986|582027937|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
161177719|NCT00856986|582027938|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
161177720|NCT00856986|582027939|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
161177721|NCT00856986|582027940|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
161177722|NCT00856986|582027941|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
161177723|NCT00856986|582027937|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
161177724|NCT00856986|582027938|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
161177725|NCT00856986|582027939|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161297237|NCT00740792|582472043|FG000|Overall Study|Protocol Violation|0|||
161297238|NCT00740792|582472044|FG001|Overall Study|Protocol Violation|1|||
161297239|NCT00740792|582472045|FG002|Overall Study|Protocol Violation|0|||
161297240|NCT00740792|582472046|FG003|Overall Study|Protocol Violation|2|||
161297241|NCT00740792|582472043|FG000|Overall Study|Withdrawal by Subject|1|||
161297242|NCT00740792|582472044|FG001|Overall Study|Withdrawal by Subject|1|||
161297243|NCT00740792|582472045|FG002|Overall Study|Withdrawal by Subject|0|||
161297244|NCT00740792|582472046|FG003|Overall Study|Withdrawal by Subject|0|||
161177726|NCT00856986|582027940|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161177727|NCT00856986|582027941|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
161177728|NCT00856986|582027937|FG000|Main Period, Weeks 0-26|Unclassified|7|||
161177729|NCT00856986|582027938|FG001|Main Period, Weeks 0-26|Unclassified|6|||
161177730|NCT00856986|582027939|FG002|Main Period, Weeks 0-26|Unclassified|7|||
161177731|NCT00856986|582027940|FG003|Main Period, Weeks 0-26|Unclassified|0|||
161297245|NCT00740792|582472043|FG000|Overall Study|administrative|3|||
161297246|NCT00740792|582472044|FG001|Overall Study|administrative|3|||
161297247|NCT00740792|582472045|FG002|Overall Study|administrative|8|||
161177732|NCT00856986|582027941|FG004|Main Period, Weeks 0-26|Unclassified|0|||
161177733|NCT00856986|582027937|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
161177734|NCT00856986|582027938|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
161177735|NCT00856986|582027939|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
161177736|NCT00856986|582027940|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
161177737|NCT00856986|582027941|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
161177738|NCT00856986|582027937|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
161177739|NCT00856986|582027938|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
161177740|NCT00856986|582027939|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
161177741|NCT00856986|582027940|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
161177742|NCT00856986|582027941|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
161177743|NCT00856986|582027937|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
161177744|NCT00856986|582027938|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161177745|NCT00856986|582027939|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
161177746|NCT00856986|582027940|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161177747|NCT00856986|582027941|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
161177748|NCT00856986|582027937|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161177749|NCT00856986|582027938|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
161177750|NCT00856986|582027939|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
161177751|NCT00856986|582027940|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161177752|NCT00856986|582027941|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
161177753|NCT00856986|582027937|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
161177754|NCT00856986|582027938|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
161177755|NCT00856986|582027939|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
161177756|NCT00856986|582027940|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
161177757|NCT00856986|582027941|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
161177758|NCT00856986|582027937|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
161177759|NCT00856986|582027938|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
161177760|NCT00856986|582027939|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
161177761|NCT00856986|582027940|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
161177762|NCT00856986|582027941|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
161177763|NCT02999191|582027943|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
161177764|NCT02999191|582027944|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
161177765|NCT02999191|582027945|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
161177766|NCT01906476|582027946|FG000|Overall Study|Lost to Follow-up|17|||
161177767|NCT01906476|582027947|FG001|Overall Study|Lost to Follow-up|16|||
161177768|NCT01993667|582027951|FG000|Overall Study|Insufficient data to analyze|16|||
161177769|NCT01993667|582027952|FG001|Overall Study|Insufficient data to analyze|16|||
161177770|NCT01993667|582027951|FG000|Overall Study|Insufficient altitude reached|3|||
161177771|NCT01993667|582027952|FG001|Overall Study|Insufficient altitude reached|1|||
161177772|NCT01993667|582027951|FG000|Overall Study|Lost to Follow-up|2|||
161177773|NCT01993667|582027952|FG001|Overall Study|Lost to Follow-up|2|||
161177774|NCT01931150|582027953|FG000|Overall Study|Withdrawal by Subject|1|||
161177775|NCT01931150|582027954|FG001|Overall Study|Withdrawal by Subject|2|||
161177776|NCT00845845|582027957|FG000|Overall Study|Lost to Follow-up|0|||
161177777|NCT00845845|582027958|FG001|Overall Study|Lost to Follow-up|4|||
161177778|NCT01685203|582027959|FG000|Overall Study|Lost to Follow-up|3|||
161177779|NCT01685203|582027960|FG001|Overall Study|Lost to Follow-up|3|||
161177780|NCT01685203|582027961|FG002|Overall Study|Lost to Follow-up|0|||
161177781|NCT01685203|582027962|FG003|Overall Study|Lost to Follow-up|1|||
161177782|NCT01685203|582027963|FG004|Overall Study|Lost to Follow-up|0|||
161177783|NCT01685203|582027964|FG005|Overall Study|Lost to Follow-up|0|||
161177784|NCT01685203|582027965|FG006|Overall Study|Lost to Follow-up|0|||
161177785|NCT01685203|582027959|FG000|Overall Study|Adverse Event|0|||
161177786|NCT01685203|582027960|FG001|Overall Study|Adverse Event|0|||
161177787|NCT01685203|582027961|FG002|Overall Study|Adverse Event|0|||
161177788|NCT01685203|582027962|FG003|Overall Study|Adverse Event|0|||
161177789|NCT01685203|582027963|FG004|Overall Study|Adverse Event|0|||
161177790|NCT01685203|582027964|FG005|Overall Study|Adverse Event|2|||
161177791|NCT01685203|582027965|FG006|Overall Study|Adverse Event|0|||
161177792|NCT01685203|582027959|FG000|Overall Study|Adverse event and withdrew consent|1|||
161177793|NCT01685203|582027960|FG001|Overall Study|Adverse event and withdrew consent|0|||
161177794|NCT01685203|582027961|FG002|Overall Study|Adverse event and withdrew consent|0|||
161177795|NCT01685203|582027962|FG003|Overall Study|Adverse event and withdrew consent|0|||
161177796|NCT01685203|582027963|FG004|Overall Study|Adverse event and withdrew consent|0|||
161177797|NCT01685203|582027964|FG005|Overall Study|Adverse event and withdrew consent|0|||
161177798|NCT01685203|582027965|FG006|Overall Study|Adverse event and withdrew consent|0|||
161177799|NCT01685203|582027959|FG000|Overall Study|Patient's decision|0|||
161177800|NCT01685203|582027960|FG001|Overall Study|Patient's decision|0|||
161177801|NCT01685203|582027961|FG002|Overall Study|Patient's decision|0|||
161177802|NCT01685203|582027962|FG003|Overall Study|Patient's decision|0|||
161177803|NCT01685203|582027963|FG004|Overall Study|Patient's decision|0|||
161177804|NCT01685203|582027964|FG005|Overall Study|Patient's decision|1|||
161177805|NCT01685203|582027965|FG006|Overall Study|Patient's decision|0|||
161297248|NCT00740792|582472046|FG003|Overall Study|administrative|2|||
161297249|NCT00026494|582472049|FG000|Overall Study|Withdrawal by Subject|1|||
161297250|NCT00026494|582472050|FG001|Overall Study|Withdrawal by Subject|0|||
161297251|NCT00026494|582472051|FG002|Overall Study|Withdrawal by Subject|1|||
161297252|NCT00026494|582472052|FG003|Overall Study|Withdrawal by Subject|0|||
161297253|NCT00026494|582472049|FG000|Overall Study|Patient non-compliance|1|||
161297254|NCT00026494|582472050|FG001|Overall Study|Patient non-compliance|0|||
161297255|NCT00026494|582472051|FG002|Overall Study|Patient non-compliance|0|||
161297256|NCT00026494|582472052|FG003|Overall Study|Patient non-compliance|0|||
161297257|NCT00026494|582472049|FG000|Overall Study|Patient not treated|0|||
161297258|NCT00026494|582472050|FG001|Overall Study|Patient not treated|0|||
161297259|NCT00026494|582472051|FG002|Overall Study|Patient not treated|2|||
161297260|NCT00026494|582472052|FG003|Overall Study|Patient not treated|0|||
161297261|NCT00026494|582472049|FG000|Overall Study|Clinical progression|0|||
161297262|NCT00026494|582472050|FG001|Overall Study|Clinical progression|0|||
161297263|NCT00026494|582472051|FG002|Overall Study|Clinical progression|3|||
161297264|NCT00026494|582472052|FG003|Overall Study|Clinical progression|0|||
161297265|NCT01455597|582472053|FG000|Overall Study|Adverse Event|7|||
161297266|NCT01455597|582472054|FG001|Overall Study|Adverse Event|0|||
161297267|NCT01455597|582472055|FG002|Overall Study|Adverse Event|5|||
161297268|NCT01455597|582472056|FG003|Overall Study|Adverse Event|1|||
161297269|NCT01455597|582472053|FG000|Overall Study|Lack of Efficacy|0|||
161297270|NCT01455597|582472054|FG001|Overall Study|Lack of Efficacy|1|||
161297271|NCT01455597|582472055|FG002|Overall Study|Lack of Efficacy|2|||
161297272|NCT01455597|582472056|FG003|Overall Study|Lack of Efficacy|0|||
161297273|NCT01455597|582472053|FG000|Overall Study|Lost to Follow-up|3|||
161297274|NCT01455597|582472054|FG001|Overall Study|Lost to Follow-up|0|||
161297275|NCT01455597|582472055|FG002|Overall Study|Lost to Follow-up|2|||
161297276|NCT01455597|582472056|FG003|Overall Study|Lost to Follow-up|1|||
161297277|NCT01455597|582472053|FG000|Overall Study|Withdrew Consent|6|||
161297278|NCT01455597|582472054|FG001|Overall Study|Withdrew Consent|5|||
161297279|NCT01455597|582472055|FG002|Overall Study|Withdrew Consent|8|||
161297280|NCT01455597|582472056|FG003|Overall Study|Withdrew Consent|5|||
161297281|NCT01455597|582472053|FG000|Overall Study|Reason not Specified|1|||
161297282|NCT01455597|582472054|FG001|Overall Study|Reason not Specified|2|||
161297283|NCT01455597|582472055|FG002|Overall Study|Reason not Specified|3|||
161297284|NCT01455597|582472056|FG003|Overall Study|Reason not Specified|3|||
161297285|NCT03412734|582472060|FG000|Overall Study|Incorrect labeling of samples|2|||
161297286|NCT03412734|582472061|FG001|Overall Study|Incorrect labeling of samples|0|||
161297287|NCT03412734|582472060|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
161297288|NCT03412734|582472061|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
161297289|NCT00423332|582472062|FG000|Overall Study|Adverse Event|6|||
161297290|NCT00423332|582472063|FG001|Overall Study|Adverse Event|2|||
161297291|NCT00423332|582472062|FG000|Overall Study|Withdrawal by Subject|1|||
161297292|NCT00423332|582472063|FG001|Overall Study|Withdrawal by Subject|0|||
161297293|NCT00423332|582472062|FG000|Overall Study|Condition under investigation worsened|1|||
161297294|NCT00423332|582472063|FG001|Overall Study|Condition under investigation worsened|1|||
161297295|NCT00423332|582472062|FG000|Overall Study|Progressive at Week 6|0|||
161297296|NCT00423332|582472063|FG001|Overall Study|Progressive at Week 6|1|||
161297297|NCT00423332|582472062|FG000|Overall Study|Unblinded before 12 weeks|1|||
161297298|NCT00423332|582472063|FG001|Overall Study|Unblinded before 12 weeks|3|||
161297299|NCT00179660|582472072|FG000|Overall Study|Adverse Event|7|||
161297300|NCT00179660|582472072|FG000|Overall Study|Lack of therapeutic effect|28|||
161297301|NCT00179660|582472072|FG000|Overall Study|Withdrawal by Subject|2|||
161297302|NCT00179660|582472072|FG000|Overall Study|Lost to Follow-up|1|||
161297303|NCT00179660|582472072|FG000|Overall Study|Death|3|||
161297304|NCT00179660|582472072|FG000|Overall Study|Other - Unspecified|9|||
161297305|NCT02035202|582472073|FG000|Overall Study|Lost to Follow-up|8|||
161177806|NCT00479167|582027966|FG000|Overall Study|Withdrawal by Subject|1|||
161177807|NCT03619837|582027967|FG000|Screening|received organs from HCV-negative donors|47|||
161177808|NCT03619837|582027967|FG000|Screening|died on the wait-list|2|||
161177809|NCT03619837|582027967|FG000|Screening|remained on the wait list|40|||
161177810|NCT03619837|582027967|FG000|Screening|didn't meet eligibility criteria|3|||
161297306|NCT02035202|582472074|FG001|Overall Study|Lost to Follow-up|16|||
161297307|NCT02035202|582472075|FG002|Overall Study|Lost to Follow-up|2|||
161297308|NCT03777436|582472076|FG000|Placebo-controlled Phase|Adverse Event|8|||
161297309|NCT03777436|582472077|FG001|Placebo-controlled Phase|Adverse Event|10|||
161297310|NCT03777436|582472078|FG002|Placebo-controlled Phase|Adverse Event|0|||
161297311|NCT03777436|582472076|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
161297312|NCT03777436|582472077|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
161297313|NCT03777436|582472078|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
161297314|NCT03777436|582472076|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
161297315|NCT03777436|582472077|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
161297316|NCT03777436|582472078|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
161297317|NCT03777436|582472076|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
161297318|NCT03777436|582472077|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
161177811|NCT03619837|582027967|FG000|Screening|withdrew consent|2|||
161177812|NCT03619837|582027967|FG000|Screening|never listed for HCV-viremic donor|1|||
161177813|NCT03619837|582027967|FG000|Screening|developed exclusion criteria|2|||
161177814|NCT03619837|582027967|FG000|Screening|excluded by the investigator due to non-compliance|1|||
161177815|NCT04095793|582027968|FG000|Overall Study|Adverse Event|3|||
161177816|NCT04095793|582027968|FG000|Overall Study|Study Terminated by Sponsor|103|||
161177817|NCT04095793|582027968|FG000|Overall Study|Withdrawal by Subject|4|||
161177818|NCT01602549|582027969|FG000|Overall Study|Protocol Violation|0|||
161177819|NCT01602549|582027970|FG001|Overall Study|Protocol Violation|1|||
161177820|NCT01602549|582027969|FG000|Overall Study|Withdrawal by Subject|1|||
161177821|NCT01602549|582027970|FG001|Overall Study|Withdrawal by Subject|0|||
161177822|NCT02712008|582030126|FG000|Baseline (Day 1) up to Week 12|Death|3|||
161177823|NCT02712008|582030127|FG001|Baseline (Day 1) up to Week 12|Death|0|||
161177824|NCT02712008|582030128|FG002|Baseline (Day 1) up to Week 12|Death|0|||
161177825|NCT02712008|582030129|FG003|Baseline (Day 1) up to Week 12|Death|0|||
161177826|NCT02712008|582030130|FG004|Baseline (Day 1) up to Week 12|Death|0|||
161177827|NCT02712008|582030131|FG005|Baseline (Day 1) up to Week 12|Death|0|||
161177828|NCT02712008|582030132|FG006|Baseline (Day 1) up to Week 12|Death|0|||
161177829|NCT02712008|582030133|FG007|Baseline (Day 1) up to Week 12|Death|0|||
161177830|NCT02712008|582030126|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161177831|NCT02712008|582030127|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
161177832|NCT02712008|582030128|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
161177833|NCT02712008|582030129|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161177834|NCT02712008|582030130|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161177835|NCT02712008|582030131|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161177836|NCT02712008|582030132|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161177837|NCT02712008|582030133|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
161177838|NCT02712008|582030126|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
161177839|NCT02712008|582030127|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161177840|NCT02712008|582030128|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
161177841|NCT02712008|582030129|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161177842|NCT02712008|582030130|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161177843|NCT02712008|582030131|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161177844|NCT02712008|582030132|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161177845|NCT02712008|582030133|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
161177846|NCT02712008|582030126|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177847|NCT02712008|582030127|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177848|NCT02712008|582030128|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
161177849|NCT02712008|582030129|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177850|NCT02712008|582030130|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177851|NCT02712008|582030131|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177852|NCT02712008|582030132|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177853|NCT02712008|582030133|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
161177854|NCT02712008|582030126|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177855|NCT02712008|582030127|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
161177856|NCT02712008|582030128|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177857|NCT02712008|582030129|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177858|NCT02712008|582030130|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177859|NCT02712008|582030131|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177860|NCT02712008|582030132|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177861|NCT02712008|582030133|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
161177862|NCT02712008|582030126|FG000|From Week 12 up to Week 36|Adverse Event|0|||
161177863|NCT02712008|582030127|FG001|From Week 12 up to Week 36|Adverse Event|0|||
161177864|NCT02712008|582030128|FG002|From Week 12 up to Week 36|Adverse Event|0|||
161177865|NCT02712008|582030129|FG003|From Week 12 up to Week 36|Adverse Event|0|||
161177866|NCT02712008|582030130|FG004|From Week 12 up to Week 36|Adverse Event|1|||
161177867|NCT02712008|582030131|FG005|From Week 12 up to Week 36|Adverse Event|0|||
161177868|NCT02712008|582030132|FG006|From Week 12 up to Week 36|Adverse Event|0|||
161177869|NCT02712008|582030133|FG007|From Week 12 up to Week 36|Adverse Event|2|||
161177870|NCT02712008|582030126|FG000|From Week 12 up to Week 36|Death|1|||
161177871|NCT02712008|582030127|FG001|From Week 12 up to Week 36|Death|0|||
161177872|NCT02712008|582030128|FG002|From Week 12 up to Week 36|Death|0|||
161177873|NCT02712008|582030129|FG003|From Week 12 up to Week 36|Death|0|||
161177874|NCT02712008|582030130|FG004|From Week 12 up to Week 36|Death|0|||
161177875|NCT02712008|582030131|FG005|From Week 12 up to Week 36|Death|0|||
161177876|NCT02712008|582030132|FG006|From Week 12 up to Week 36|Death|1|||
161177877|NCT02712008|582030133|FG007|From Week 12 up to Week 36|Death|0|||
161177878|NCT02712008|582030126|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
161177879|NCT02712008|582030127|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
161177880|NCT02712008|582030128|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
161177881|NCT02712008|582030129|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
161177882|NCT02712008|582030130|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
161297319|NCT03777436|582472078|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
161297320|NCT03777436|582472076|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
161297321|NCT03777436|582472077|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
161297322|NCT03777436|582472078|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
161297323|NCT03777436|582472076|FG000|Placebo-controlled Phase|Physician Decision|0|||
161297324|NCT03777436|582472077|FG001|Placebo-controlled Phase|Physician Decision|1|||
161297325|NCT03777436|582472078|FG002|Placebo-controlled Phase|Physician Decision|0|||
161297326|NCT03777436|582472076|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
161297327|NCT03777436|582472077|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
161297328|NCT03777436|582472078|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
161297329|NCT03777436|582472076|FG000|Apremilast Extension Phase|Adverse Event|0|||
161297330|NCT03777436|582472077|FG001|Apremilast Extension Phase|Adverse Event|0|||
161297331|NCT03777436|582472078|FG002|Apremilast Extension Phase|Adverse Event|6|||
161297332|NCT03777436|582472076|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
161297333|NCT03777436|582472077|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
161297334|NCT03777436|582472078|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
161297335|NCT03777436|582472076|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
161297336|NCT03777436|582472077|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
161297337|NCT03777436|582472078|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
161297338|NCT03777436|582472076|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
161297339|NCT03777436|582472077|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
161297340|NCT03777436|582472078|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
161297341|NCT03777436|582472076|FG000|Apremilast Extension Phase|Miscellaneous|0|||
161297342|NCT03777436|582472077|FG001|Apremilast Extension Phase|Miscellaneous|0|||
161297343|NCT03777436|582472078|FG002|Apremilast Extension Phase|Miscellaneous|1|||
161297344|NCT00685399|582472080|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161297345|NCT00685399|582472081|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161297346|NCT00685399|582472082|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161297347|NCT00685399|582472083|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161297348|NCT00685399|582472084|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161297349|NCT00685399|582472085|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161297350|NCT00685399|582472086|FG006|Treatment Period 1|Withdrawal by Subject|0|||
161297351|NCT00685399|582472087|FG007|Treatment Period 1|Withdrawal by Subject|0|||
161297352|NCT00685399|582472080|FG000|Treatment Period 1|Protocol Violation|1|||
161088365|NCT01451827|581712723|FG003|Overall Study|Lost to Follow-up|2|||
161088366|NCT01451827|581712720|FG000|Overall Study|Participant met withdrawal criteria|0|||
161088367|NCT01451827|581712721|FG001|Overall Study|Participant met withdrawal criteria|2|||
161088368|NCT01451827|581712722|FG002|Overall Study|Participant met withdrawal criteria|0|||
161088369|NCT01451827|581712723|FG003|Overall Study|Participant met withdrawal criteria|0|||
161088370|NCT01451827|581712720|FG000|Overall Study|Withdrawal by Subject|0|||
161088371|NCT01451827|581712721|FG001|Overall Study|Withdrawal by Subject|0|||
161088372|NCT01451827|581712722|FG002|Overall Study|Withdrawal by Subject|1|||
161088373|NCT01451827|581712723|FG003|Overall Study|Withdrawal by Subject|1|||
161088374|NCT01964924|581712724|FG000|Trametinib Monotherapy|Progression|19|||
161088375|NCT01964924|581712725|FG001|Trametinib Monotherapy|Progression|0|||
161088376|NCT01528345|581712726|FG000|Overall Study|Adverse Event|10|||
161088377|NCT01528345|581712727|FG001|Overall Study|Adverse Event|1|||
161088378|NCT01528345|581712726|FG000|Overall Study|Death|1|||
161088379|NCT01528345|581712727|FG001|Overall Study|Death|1|||
161088380|NCT01528345|581712726|FG000|Overall Study|Non-compliance with study treatment|1|||
161088381|NCT01528345|581712727|FG001|Overall Study|Non-compliance with study treatment|0|||
161088382|NCT01528345|581712726|FG000|Overall Study|Progressive Disease|26|||
161088383|NCT01528345|581712727|FG001|Overall Study|Progressive Disease|40|||
161088384|NCT01528345|581712726|FG000|Overall Study|Study Terminated by Sponsor|4|||
161088385|NCT01528345|581712727|FG001|Overall Study|Study Terminated by Sponsor|8|||
161088386|NCT01528345|581712726|FG000|Overall Study|Subject/Guardian Decision|5|||
161088387|NCT01528345|581712727|FG001|Overall Study|Subject/Guardian Decision|0|||
161088388|NCT01034163|581712728|FG000|Overall Study|Treatment completed as per protocol|8|||
161088389|NCT01034163|581712729|FG001|Overall Study|Treatment completed as per protocol|7|||
161088390|NCT01034163|581712728|FG000|Overall Study|Withdrawal by Subject|8|||
161088391|NCT01034163|581712729|FG001|Overall Study|Withdrawal by Subject|2|||
161088392|NCT01034163|581712728|FG000|Overall Study|Protocol deviation|1|||
161088393|NCT01034163|581712729|FG001|Overall Study|Protocol deviation|0|||
161088394|NCT01034163|581712728|FG000|Overall Study|Disease progression|3|||
161088395|NCT01034163|581712729|FG001|Overall Study|Disease progression|4|||
161088396|NCT01034163|581712728|FG000|Overall Study|Adverse Event|6|||
161088397|NCT01034163|581712729|FG001|Overall Study|Adverse Event|0|||
161088398|NCT01034163|581712728|FG000|Overall Study|Administrative problems|0|||
161088399|NCT01034163|581712729|FG001|Overall Study|Administrative problems|1|||
161088400|NCT01034163|581712728|FG000|Overall Study|Abnormal laboratory value|1|||
161088401|NCT01034163|581712729|FG001|Overall Study|Abnormal laboratory value|0|||
161088402|NCT00296400|581712733|FG000|Overall Study|Adverse Event|7|||
161088403|NCT00296400|581712734|FG001|Overall Study|Adverse Event|7|||
161088404|NCT00296400|581712735|FG002|Overall Study|Adverse Event|7|||
161297353|NCT00685399|582472081|FG001|Treatment Period 1|Protocol Violation|0|||
161297354|NCT00685399|582472082|FG002|Treatment Period 1|Protocol Violation|0|||
161297355|NCT00685399|582472083|FG003|Treatment Period 1|Protocol Violation|0|||
161297356|NCT00685399|582472084|FG004|Treatment Period 1|Protocol Violation|0|||
161297357|NCT00685399|582472085|FG005|Treatment Period 1|Protocol Violation|0|||
161297358|NCT00685399|582472086|FG006|Treatment Period 1|Protocol Violation|0|||
161297359|NCT00685399|582472087|FG007|Treatment Period 1|Protocol Violation|0|||
161297360|NCT00685399|582472080|FG000|Treatment Period 1|Administrative|2|||
161297361|NCT00685399|582472081|FG001|Treatment Period 1|Administrative|0|||
161297362|NCT00685399|582472082|FG002|Treatment Period 1|Administrative|0|||
161297363|NCT00685399|582472083|FG003|Treatment Period 1|Administrative|0|||
161297364|NCT00685399|582472084|FG004|Treatment Period 1|Administrative|0|||
161297365|NCT00685399|582472085|FG005|Treatment Period 1|Administrative|0|||
161297366|NCT00685399|582472086|FG006|Treatment Period 1|Administrative|0|||
161297367|NCT00685399|582472087|FG007|Treatment Period 1|Administrative|0|||
161297368|NCT00685399|582472080|FG000|Treatment Period 1|Lack of Efficacy|1|||
161297369|NCT00685399|582472081|FG001|Treatment Period 1|Lack of Efficacy|0|||
161297370|NCT00685399|582472082|FG002|Treatment Period 1|Lack of Efficacy|0|||
161297371|NCT00685399|582472083|FG003|Treatment Period 1|Lack of Efficacy|0|||
161297372|NCT00685399|582472084|FG004|Treatment Period 1|Lack of Efficacy|0|||
161297373|NCT00685399|582472085|FG005|Treatment Period 1|Lack of Efficacy|0|||
161297374|NCT00685399|582472086|FG006|Treatment Period 1|Lack of Efficacy|0|||
161297375|NCT00685399|582472087|FG007|Treatment Period 1|Lack of Efficacy|0|||
161297376|NCT00685399|582472080|FG000|Treatment Period 2|Administrative Problems|0|||
161297377|NCT00685399|582472081|FG001|Treatment Period 2|Administrative Problems|2|||
161297378|NCT00685399|582472082|FG002|Treatment Period 2|Administrative Problems|1|||
161297379|NCT00685399|582472083|FG003|Treatment Period 2|Administrative Problems|0|||
161297380|NCT00685399|582472084|FG004|Treatment Period 2|Administrative Problems|0|||
161297381|NCT00685399|582472085|FG005|Treatment Period 2|Administrative Problems|0|||
161297382|NCT00685399|582472086|FG006|Treatment Period 2|Administrative Problems|0|||
161297383|NCT00685399|582472087|FG007|Treatment Period 2|Administrative Problems|0|||
161297384|NCT00685399|582472080|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161297385|NCT00685399|582472081|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161297386|NCT00685399|582472082|FG002|Treatment Period 2|Withdrawal by Subject|0|||
161297387|NCT00685399|582472083|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161297388|NCT00685399|582472084|FG004|Treatment Period 2|Withdrawal by Subject|0|||
161297389|NCT00685399|582472085|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161297390|NCT00685399|582472086|FG006|Treatment Period 2|Withdrawal by Subject|0|||
161297391|NCT00685399|582472087|FG007|Treatment Period 2|Withdrawal by Subject|2|||
161297392|NCT00685399|582472080|FG000|Treatment Period 2|Adverse Event|0|||
161297393|NCT00685399|582472081|FG001|Treatment Period 2|Adverse Event|0|||
161297394|NCT00685399|582472082|FG002|Treatment Period 2|Adverse Event|0|||
161297395|NCT00685399|582472083|FG003|Treatment Period 2|Adverse Event|0|||
161297396|NCT00685399|582472084|FG004|Treatment Period 2|Adverse Event|0|||
161297397|NCT00685399|582472085|FG005|Treatment Period 2|Adverse Event|1|||
161297398|NCT00685399|582472086|FG006|Treatment Period 2|Adverse Event|0|||
161297399|NCT00685399|582472087|FG007|Treatment Period 2|Adverse Event|0|||
161297400|NCT00685399|582472080|FG000|Treatment Period 2|Lack of Efficacy|0|||
161297401|NCT00685399|582472081|FG001|Treatment Period 2|Lack of Efficacy|10|||
161297402|NCT00685399|582472082|FG002|Treatment Period 2|Lack of Efficacy|2|||
161297403|NCT00685399|582472083|FG003|Treatment Period 2|Lack of Efficacy|0|||
161297404|NCT00685399|582472084|FG004|Treatment Period 2|Lack of Efficacy|0|||
161297405|NCT00685399|582472085|FG005|Treatment Period 2|Lack of Efficacy|1|||
161297406|NCT00685399|582472086|FG006|Treatment Period 2|Lack of Efficacy|0|||
161297407|NCT00685399|582472087|FG007|Treatment Period 2|Lack of Efficacy|0|||
161297408|NCT00685399|582472080|FG000|Extension|Administrative Issues|0|||
161297409|NCT00685399|582472081|FG001|Extension|Administrative Issues|0|||
161297410|NCT00685399|582472082|FG002|Extension|Administrative Issues|0|||
161297411|NCT00685399|582472083|FG003|Extension|Administrative Issues|1|||
161297412|NCT00685399|582472084|FG004|Extension|Administrative Issues|0|||
161347718|NCT01970371|582657350|FG001|Overall Study|Lost to Follow-up|0|||
161347719|NCT01970371|582657351|FG002|Overall Study|Lost to Follow-up|1|||
161347720|NCT01481779|582657352|FG000|Overall Study|Adverse Event|23|||
161297413|NCT00685399|582472085|FG005|Extension|Administrative Issues|0|||
161297414|NCT00685399|582472086|FG006|Extension|Administrative Issues|0|||
161297415|NCT00685399|582472087|FG007|Extension|Administrative Issues|0|||
161297416|NCT00685399|582472080|FG000|Extension|Withdrawal by Subject|0|||
161297417|NCT00685399|582472081|FG001|Extension|Withdrawal by Subject|0|||
161297418|NCT00685399|582472082|FG002|Extension|Withdrawal by Subject|0|||
161297419|NCT00685399|582472083|FG003|Extension|Withdrawal by Subject|1|||
161297420|NCT00685399|582472084|FG004|Extension|Withdrawal by Subject|0|||
161297421|NCT00685399|582472085|FG005|Extension|Withdrawal by Subject|0|||
161297422|NCT00685399|582472086|FG006|Extension|Withdrawal by Subject|0|||
161297423|NCT00685399|582472087|FG007|Extension|Withdrawal by Subject|0|||
161297424|NCT00685399|582472080|FG000|Extension|Protocol Violation|0|||
161347721|NCT01481779|582657353|FG001|Overall Study|Adverse Event|5|||
161297425|NCT00685399|582472081|FG001|Extension|Protocol Violation|0|||
161297426|NCT00685399|582472082|FG002|Extension|Protocol Violation|0|||
161297427|NCT00685399|582472083|FG003|Extension|Protocol Violation|1|||
161297428|NCT00685399|582472084|FG004|Extension|Protocol Violation|0|||
161297429|NCT00685399|582472085|FG005|Extension|Protocol Violation|0|||
161297430|NCT00685399|582472086|FG006|Extension|Protocol Violation|0|||
161297431|NCT00685399|582472087|FG007|Extension|Protocol Violation|0|||
161297432|NCT00685399|582472080|FG000|Extension|Lack of Efficacy|0|||
161297433|NCT00685399|582472081|FG001|Extension|Lack of Efficacy|0|||
161297434|NCT00685399|582472082|FG002|Extension|Lack of Efficacy|0|||
161297435|NCT00685399|582472083|FG003|Extension|Lack of Efficacy|2|||
161297436|NCT00685399|582472084|FG004|Extension|Lack of Efficacy|0|||
161297437|NCT00685399|582472085|FG005|Extension|Lack of Efficacy|0|||
161297438|NCT00685399|582472086|FG006|Extension|Lack of Efficacy|0|||
161297439|NCT00685399|582472087|FG007|Extension|Lack of Efficacy|0|||
161297440|NCT00685399|582472080|FG000|Extension|Adverse Event|0|||
161297441|NCT00685399|582472081|FG001|Extension|Adverse Event|0|||
161297442|NCT00685399|582472082|FG002|Extension|Adverse Event|0|||
161297443|NCT00685399|582472083|FG003|Extension|Adverse Event|2|||
161297444|NCT00685399|582472084|FG004|Extension|Adverse Event|0|||
161297445|NCT00685399|582472085|FG005|Extension|Adverse Event|0|||
161297446|NCT00685399|582472086|FG006|Extension|Adverse Event|0|||
161297447|NCT00685399|582472087|FG007|Extension|Adverse Event|0|||
161297448|NCT04478695|582472088|FG000|Overall Study|Death|1|||
161297449|NCT04478695|582472089|FG001|Overall Study|Death|0|||
161297450|NCT00644917|582472090|FG000|Overall Study|Withdrawal by Subject|2|||
161297451|NCT01136356|582472091|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
161297452|NCT01136356|582472092|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
161297453|NCT01136356|582472091|FG000|First 18-day Withdrawal|Physician Decision|1|||
161297454|NCT01136356|582472092|FG001|First 18-day Withdrawal|Physician Decision|0|||
161297455|NCT01136356|582472091|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
161297456|NCT01136356|582472092|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
161297457|NCT00402688|582472093|FG000|Overall Study|Adverse Event|12|||
161297458|NCT00402688|582472094|FG001|Overall Study|Adverse Event|9|||
161297459|NCT00402688|582472095|FG002|Overall Study|Adverse Event|3|||
161297460|NCT00402688|582472093|FG000|Overall Study|Withdrawal by Subject|3|||
161297461|NCT00402688|582472094|FG001|Overall Study|Withdrawal by Subject|1|||
161297462|NCT00402688|582472095|FG002|Overall Study|Withdrawal by Subject|1|||
161297463|NCT00402688|582472093|FG000|Overall Study|Physician Decision|0|||
161297464|NCT00402688|582472094|FG001|Overall Study|Physician Decision|0|||
161297465|NCT00402688|582472095|FG002|Overall Study|Physician Decision|1|||
161297466|NCT00402688|582472093|FG000|Overall Study|Lack of Efficacy|4|||
161297467|NCT00402688|582472094|FG001|Overall Study|Lack of Efficacy|4|||
161297468|NCT00402688|582472095|FG002|Overall Study|Lack of Efficacy|5|||
161297469|NCT00402688|582472093|FG000|Overall Study|Protocol Violation|1|||
161297470|NCT00402688|582472094|FG001|Overall Study|Protocol Violation|1|||
161297471|NCT00402688|582472095|FG002|Overall Study|Protocol Violation|1|||
161297472|NCT00402688|582472093|FG000|Overall Study|Lost to Follow-up|1|||
161297473|NCT00402688|582472094|FG001|Overall Study|Lost to Follow-up|0|||
161297474|NCT00402688|582472095|FG002|Overall Study|Lost to Follow-up|2|||
161297475|NCT00402688|582472093|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
161297476|NCT00402688|582472094|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
161297477|NCT00402688|582472095|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
161297478|NCT00402688|582472093|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
161297479|NCT00402688|582472094|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
161297480|NCT00402688|582472095|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
161297481|NCT00402688|582472093|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
161297482|NCT00402688|582472094|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
161297483|NCT00402688|582472095|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
161297484|NCT00178685|582472096|FG000|Overall Study|Death|3|||
161297485|NCT00178685|582472097|FG001|Overall Study|Death|3|||
161297486|NCT00178685|582472098|FG002|Overall Study|Death|6|||
161297487|NCT00178685|582472096|FG000|Overall Study|Lost to Follow-up|100|||
161347722|NCT01481779|582657352|FG000|Overall Study|Lost to Follow-up|3|||
161347723|NCT01481779|582657353|FG001|Overall Study|Lost to Follow-up|2|||
161347724|NCT01481779|582657352|FG000|Overall Study|Protocol Violation|2|||
161347725|NCT01481779|582657353|FG001|Overall Study|Protocol Violation|3|||
161297488|NCT00178685|582472097|FG001|Overall Study|Lost to Follow-up|187|||
161297489|NCT00178685|582472098|FG002|Overall Study|Lost to Follow-up|183|||
161297490|NCT00178685|582472096|FG000|Overall Study|Withdrawal by Subject|8|||
161297491|NCT00178685|582472097|FG001|Overall Study|Withdrawal by Subject|14|||
161347726|NCT01481779|582657352|FG000|Overall Study|Withdrawal by Subject|26|||
161347727|NCT01481779|582657353|FG001|Overall Study|Withdrawal by Subject|13|||
161297492|NCT00178685|582472098|FG002|Overall Study|Withdrawal by Subject|7|||
161297493|NCT00927862|582472099|FG000|Overall Study|Missing data needed for endpt analyses|27|||
161297494|NCT00927862|582472100|FG001|Overall Study|Missing data needed for endpt analyses|45|||
161297495|NCT00820248|582472101|FG000|Overall Study|No treated|4|||
161297496|NCT00820248|582472102|FG001|Overall Study|No treated|1|||
161297497|NCT04157296|582472112|FG000|Overall Study|Withdrawal by Subject|0|||
161297498|NCT04157296|582472113|FG001|Overall Study|Withdrawal by Subject|1|||
161297499|NCT04157296|582472112|FG000|Overall Study|Did not obtain second fMRI.|0|||
161297500|NCT04157296|582472113|FG001|Overall Study|Did not obtain second fMRI.|1|||
161297501|NCT04157296|582472112|FG000|Overall Study|MRI failed/no second fMRI|0|||
161297502|NCT04157296|582472113|FG001|Overall Study|MRI failed/no second fMRI|1|||
161297503|NCT02088905|582472120|FG000|Overall Study|Withdrawal by Subject|5|||
161297504|NCT02088905|582472121|FG001|Overall Study|Withdrawal by Subject|1|||
161297505|NCT01562782|582472127|FG000|Overall Study|Withdrawal by Subject|3|||
161297506|NCT01562782|582472128|FG001|Overall Study|Withdrawal by Subject|3|||
161297507|NCT01562782|582472127|FG000|Overall Study|screen failure|1|||
161297508|NCT01562782|582472128|FG001|Overall Study|screen failure|2|||
161297509|NCT02308540|582472129|FG000|Overall Study|Lost to Follow-up|0|||
161297510|NCT02308540|582472130|FG001|Overall Study|Lost to Follow-up|0|||
161297511|NCT02308540|582472131|FG002|Overall Study|Lost to Follow-up|0|||
161297512|NCT02308540|582472132|FG003|Overall Study|Lost to Follow-up|0|||
161297513|NCT02308540|582472133|FG004|Overall Study|Lost to Follow-up|0|||
161297514|NCT02308540|582472134|FG005|Overall Study|Lost to Follow-up|1|||
161297515|NCT04109391|582472135|FG000|Overall Study|Adverse Event|2|||
161297516|NCT04109391|582472136|FG001|Overall Study|Adverse Event|2|||
161297517|NCT04109391|582472137|FG002|Overall Study|Adverse Event|0|||
161297518|NCT04109391|582472135|FG000|Overall Study|Withdrawal by Subject|2|||
161297519|NCT04109391|582472136|FG001|Overall Study|Withdrawal by Subject|0|||
161297520|NCT04109391|582472137|FG002|Overall Study|Withdrawal by Subject|0|||
161297521|NCT04109391|582472135|FG000|Overall Study|Pregnancy|1|||
161297522|NCT04109391|582472136|FG001|Overall Study|Pregnancy|0|||
161297523|NCT04109391|582472137|FG002|Overall Study|Pregnancy|0|||
161297524|NCT04109391|582472135|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
161297525|NCT04109391|582472136|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
161297526|NCT04109391|582472137|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
161297527|NCT04109391|582472135|FG000|Overall Study|Lost to Follow-up|0|||
161297528|NCT04109391|582472136|FG001|Overall Study|Lost to Follow-up|0|||
161297529|NCT04109391|582472137|FG002|Overall Study|Lost to Follow-up|1|||
161297530|NCT04109391|582472135|FG000|Overall Study|Lack of Efficacy|2|||
161297531|NCT04109391|582472136|FG001|Overall Study|Lack of Efficacy|2|||
161297532|NCT04109391|582472137|FG002|Overall Study|Lack of Efficacy|3|||
161297533|NCT02649439|582472138|FG000|Overall Study|Switched to alternative treatment|6|||
161297534|NCT02649439|582472139|FG001|Overall Study|Switched to alternative treatment|4|||
161297535|NCT02649439|582472138|FG000|Overall Study|Patient decision|1|||
161297536|NCT02649439|582472139|FG001|Overall Study|Patient decision|0|||
161297537|NCT02649439|582472138|FG000|Overall Study|Patient going out of country|1|||
161297538|NCT02649439|582472139|FG001|Overall Study|Patient going out of country|0|||
161297539|NCT02649439|582472138|FG000|Overall Study|To start finasteride|1|||
161297540|NCT02649439|582472139|FG001|Overall Study|To start finasteride|0|||
161297541|NCT02649439|582472138|FG000|Overall Study|Physician Decision|1|||
161297542|NCT02649439|582472139|FG001|Overall Study|Physician Decision|0|||
161297543|NCT02649439|582472138|FG000|Overall Study|Disease progression on study|12|||
161297544|NCT02649439|582472139|FG001|Overall Study|Disease progression on study|13|||
161297545|NCT02649439|582472138|FG000|Overall Study|Refused further treatment|1|||
161297546|NCT02649439|582472139|FG001|Overall Study|Refused further treatment|0|||
161297547|NCT02649439|582472138|FG000|Overall Study|Refused further follow up|2|||
161297548|NCT02649439|582472139|FG001|Overall Study|Refused further follow up|7|||
161297549|NCT02649439|582472138|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
161297550|NCT02649439|582472139|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
161297551|NCT02649439|582472138|FG000|Overall Study|No treatment, per protocol|1|||
161297552|NCT02649439|582472139|FG001|Overall Study|No treatment, per protocol|0|||
161177883|NCT02712008|582030131|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
161177884|NCT02712008|582030132|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
161177885|NCT02712008|582030133|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
161177886|NCT02712008|582030126|FG000|From Week 12 up to Week 36|Physician Decision|0|||
161297553|NCT02649439|582472138|FG000|Overall Study|PSA DT makes ineligible|0|||
161297554|NCT02649439|582472139|FG001|Overall Study|PSA DT makes ineligible|1|||
161297555|NCT02649439|582472138|FG000|Overall Study|Rising PSA No Mets|0|||
161297556|NCT02649439|582472139|FG001|Overall Study|Rising PSA No Mets|1|||
161297557|NCT02649439|582472138|FG000|Overall Study|Rising PSA|0|||
161297558|NCT02649439|582472139|FG001|Overall Study|Rising PSA|1|||
161297559|NCT02649439|582472138|FG000|Overall Study|Signed follow up protocol|0|||
161297560|NCT02649439|582472139|FG001|Overall Study|Signed follow up protocol|1|||
161297561|NCT04468347|582472145|FG000|Overall Study|Withdrawal by Subject|0|||
161297562|NCT04468347|582472146|FG001|Overall Study|Withdrawal by Subject|1|||
161297563|NCT04468347|582472147|FG002|Overall Study|Withdrawal by Subject|3|||
161297564|NCT04468347|582472148|FG003|Overall Study|Withdrawal by Subject|3|||
161297565|NCT04468347|582472145|FG000|Overall Study|Lost to Follow-up|0|||
161297566|NCT04468347|582472146|FG001|Overall Study|Lost to Follow-up|0|||
161177887|NCT02712008|582030127|FG001|From Week 12 up to Week 36|Physician Decision|0|||
161297567|NCT04468347|582472147|FG002|Overall Study|Lost to Follow-up|1|||
161297568|NCT04468347|582472148|FG003|Overall Study|Lost to Follow-up|1|||
161297569|NCT04468347|582472145|FG000|Overall Study|Physician Decision|1|||
161297570|NCT04468347|582472146|FG001|Overall Study|Physician Decision|0|||
161297571|NCT04468347|582472147|FG002|Overall Study|Physician Decision|2|||
161297572|NCT04468347|582472148|FG003|Overall Study|Physician Decision|0|||
161297573|NCT04468347|582472145|FG000|Overall Study|Protocol Violation|1|||
161297574|NCT04468347|582472146|FG001|Overall Study|Protocol Violation|0|||
161297575|NCT04468347|582472147|FG002|Overall Study|Protocol Violation|0|||
161297576|NCT04468347|582472148|FG003|Overall Study|Protocol Violation|0|||
161297577|NCT00994461|582472150|FG000|Overall Study|Adverse Event|2|||
161297578|NCT00994461|582472151|FG001|Overall Study|Adverse Event|1|||
161297579|NCT00994461|582472152|FG002|Overall Study|Adverse Event|0|||
161297580|NCT04339062|582472153|FG000|Overall Study|Death|0|||
161297581|NCT04339062|582472154|FG001|Overall Study|Death|1|||
161297582|NCT05868577|582472155|FG000|Overall Study|Lost to Follow-up|5|||
161297583|NCT05868577|582472156|FG001|Overall Study|Lost to Follow-up|5|||
161297584|NCT02505217|582472157|FG000|Overall Study|Withdrawal by Subject|1|||
161297585|NCT02505217|582472158|FG001|Overall Study|Withdrawal by Subject|2|||
161297586|NCT00615550|582472163|FG000|Overall Study|Lost to Follow-up|6|||
161297587|NCT00615550|582472164|FG001|Overall Study|Lost to Follow-up|1|||
161297588|NCT01408303|582472165|FG000|Overall Study|Adverse Event|3|||
161297589|NCT01408303|582472166|FG001|Overall Study|Adverse Event|7|||
161297590|NCT01408303|582472167|FG002|Overall Study|Adverse Event|2|||
161297591|NCT01408303|582472165|FG000|Overall Study|Lost to Follow-up|0|||
161297592|NCT01408303|582472166|FG001|Overall Study|Lost to Follow-up|1|||
161297593|NCT01408303|582472167|FG002|Overall Study|Lost to Follow-up|2|||
161297594|NCT01408303|582472165|FG000|Overall Study|Withdrawal by Subject|2|||
161297595|NCT01408303|582472166|FG001|Overall Study|Withdrawal by Subject|3|||
161297596|NCT01408303|582472167|FG002|Overall Study|Withdrawal by Subject|1|||
161297597|NCT01408303|582472165|FG000|Overall Study|Protocol Violation|0|||
161297598|NCT01408303|582472166|FG001|Overall Study|Protocol Violation|1|||
161297599|NCT01408303|582472167|FG002|Overall Study|Protocol Violation|0|||
161297600|NCT01408303|582472165|FG000|Overall Study|Noncompliance|1|||
161297601|NCT01408303|582472166|FG001|Overall Study|Noncompliance|0|||
161297602|NCT01408303|582472167|FG002|Overall Study|Noncompliance|1|||
161297603|NCT02644668|582472168|FG000|Overall Study|Adverse Event|2|||
161297604|NCT02644668|582472169|FG001|Overall Study|Adverse Event|0|||
161297605|NCT02644668|582472170|FG002|Overall Study|Adverse Event|1|||
161297606|NCT02644668|582472168|FG000|Overall Study|Protocol Violation|0|||
161297607|NCT02644668|582472169|FG001|Overall Study|Protocol Violation|0|||
161297608|NCT02644668|582472170|FG002|Overall Study|Protocol Violation|1|||
161297609|NCT02644668|582472168|FG000|Overall Study|Withdrawal by Subject|0|||
161297610|NCT02644668|582472169|FG001|Overall Study|Withdrawal by Subject|0|||
161297611|NCT02644668|582472170|FG002|Overall Study|Withdrawal by Subject|1|||
161297612|NCT02186873|582473957|FG000|Overall Study|Adverse Event|1|||
161297613|NCT02186873|582473958|FG001|Overall Study|Adverse Event|3|||
161297614|NCT02186873|582473957|FG000|Overall Study|Lack of Efficacy|0|||
161297615|NCT02186873|582473958|FG001|Overall Study|Lack of Efficacy|1|||
161297616|NCT02186873|582473957|FG000|Overall Study|Lost to Follow-up|1|||
161297617|NCT02186873|582473958|FG001|Overall Study|Lost to Follow-up|2|||
161297618|NCT02186873|582473957|FG000|Overall Study|Withdrawal by Subject|7|||
161297619|NCT02186873|582473958|FG001|Overall Study|Withdrawal by Subject|2|||
161297620|NCT03694002|582473959|FG000|Overall Study|Progression|4|||
161297621|NCT03694002|582473960|FG001|Overall Study|Progression|2|||
161297622|NCT03694002|582473959|FG000|Overall Study|Adverse Event|2|||
161297623|NCT03694002|582473960|FG001|Overall Study|Adverse Event|0|||
161297624|NCT03694002|582473959|FG000|Overall Study|Other not protocol specified|1|||
161297625|NCT03694002|582473960|FG001|Overall Study|Other not protocol specified|0|||
161297626|NCT03694002|582473959|FG000|Overall Study|Ineligible|0|||
161297627|NCT03694002|582473960|FG001|Overall Study|Ineligible|1|||
161297628|NCT03694002|582473959|FG000|Overall Study|Withdrew consent before starting treatment|0|||
161297629|NCT03694002|582473960|FG001|Overall Study|Withdrew consent before starting treatment|3|||
161297630|NCT01760655|582473961|FG000|Overall Study|Death|18|||
161297631|NCT01760655|582473961|FG000|Overall Study|Physician Decision|1|||
161297632|NCT00068393|582473966|FG000|Overall Study|Adverse Event|2|||
161297633|NCT00068393|582473966|FG000|Overall Study|Death|3|||
161297634|NCT00068393|582473966|FG000|Overall Study|Withdrawal by Subject|3|||
161297635|NCT00068393|582473966|FG000|Overall Study|Alternative treatment|1|||
161297636|NCT00068393|582473966|FG000|Overall Study|Quality of life worsening|1|||
161297637|NCT01399047|582473967|FG000|Overall Study|Withdrawal by Subject|0|||
161297638|NCT01399047|582473968|FG001|Overall Study|Withdrawal by Subject|1|||
161297639|NCT03300505|582473983|FG000|Overall Study|Death|0|||
161297640|NCT03300505|582473984|FG001|Overall Study|Death|1|||
161297641|NCT03300505|582473985|FG002|Overall Study|Death|0|||
161297642|NCT03300505|582473983|FG000|Overall Study|Withdrawal by Subject|0|||
161297643|NCT03300505|582473984|FG001|Overall Study|Withdrawal by Subject|1|||
161297644|NCT03300505|582473985|FG002|Overall Study|Withdrawal by Subject|1|||
161297645|NCT03300505|582473983|FG000|Overall Study|Sponsor Termination|0|||
161297646|NCT03300505|582473984|FG001|Overall Study|Sponsor Termination|1|||
161297647|NCT03300505|582473985|FG002|Overall Study|Sponsor Termination|0|||
161177888|NCT02712008|582030128|FG002|From Week 12 up to Week 36|Physician Decision|0|||
161177889|NCT02712008|582030129|FG003|From Week 12 up to Week 36|Physician Decision|1|||
161177890|NCT02712008|582030130|FG004|From Week 12 up to Week 36|Physician Decision|1|||
161177891|NCT02712008|582030131|FG005|From Week 12 up to Week 36|Physician Decision|0|||
161177892|NCT02712008|582030132|FG006|From Week 12 up to Week 36|Physician Decision|0|||
161177893|NCT02712008|582030133|FG007|From Week 12 up to Week 36|Physician Decision|0|||
161177894|NCT02712008|582030126|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161177895|NCT02712008|582030127|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161177896|NCT02712008|582030128|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161177897|NCT02712008|582030129|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161177898|NCT02712008|582030130|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161177899|NCT02712008|582030131|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
161177900|NCT02712008|582030132|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
161177901|NCT02712008|582030133|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
161177902|NCT04483544|582030134|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
161177903|NCT04483544|582030134|FG000|Post-Treatment|Admitted to hospice|2|||
161177904|NCT04483544|582030134|FG000|Post-Treatment|Study terminated|3|||
161177905|NCT01131078|582030135|FG000|Overall Study|Adverse Event|22|||
161177906|NCT01131078|582030136|FG001|Overall Study|Adverse Event|12|||
161177907|NCT01131078|582030137|FG002|Overall Study|Adverse Event|17|||
161177908|NCT01131078|582030135|FG000|Overall Study|Progressive Disease|58|||
161177909|NCT01131078|582030136|FG001|Overall Study|Progressive Disease|77|||
161177910|NCT01131078|582030137|FG002|Overall Study|Progressive Disease|71|||
161177911|NCT01131078|582030135|FG000|Overall Study|Protocol Violation|1|||
161177912|NCT01131078|582030136|FG001|Overall Study|Protocol Violation|0|||
161177913|NCT01131078|582030137|FG002|Overall Study|Protocol Violation|0|||
161177914|NCT01131078|582030135|FG000|Overall Study|Lost to Follow-up|1|||
161177915|NCT01131078|582030136|FG001|Overall Study|Lost to Follow-up|1|||
161177916|NCT01131078|582030137|FG002|Overall Study|Lost to Follow-up|1|||
161177917|NCT01131078|582030135|FG000|Overall Study|Withdrawal by Subject|2|||
161177918|NCT01131078|582030136|FG001|Overall Study|Withdrawal by Subject|4|||
161177919|NCT01131078|582030137|FG002|Overall Study|Withdrawal by Subject|3|||
161177920|NCT01131078|582030135|FG000|Overall Study|Non-compliance|3|||
161177921|NCT01131078|582030136|FG001|Overall Study|Non-compliance|0|||
161177922|NCT01131078|582030137|FG002|Overall Study|Non-compliance|0|||
161177923|NCT01131078|582030135|FG000|Overall Study|Physician Decision|10|||
161177924|NCT01131078|582030136|FG001|Overall Study|Physician Decision|6|||
161177925|NCT01131078|582030137|FG002|Overall Study|Physician Decision|8|||
161177926|NCT01131078|582030135|FG000|Overall Study|Death|4|||
161177927|NCT01131078|582030136|FG001|Overall Study|Death|0|||
161177928|NCT01131078|582030137|FG002|Overall Study|Death|2|||
161177929|NCT01131078|582030135|FG000|Overall Study|Other|0|||
161177930|NCT01131078|582030136|FG001|Overall Study|Other|1|||
161177931|NCT01131078|582030137|FG002|Overall Study|Other|0|||
161177932|NCT00364351|582030138|FG000|Overall Study|Adverse Event|90|||
161177933|NCT00364351|582030139|FG001|Overall Study|Adverse Event|44|||
161177934|NCT00364351|582030138|FG000|Overall Study|Condition under investigation worsened|469|||
161177935|NCT00364351|582030139|FG001|Overall Study|Condition under investigation worsened|497|||
161177936|NCT00364351|582030138|FG000|Overall Study|Prohibited concomitant medication|0|||
161177937|NCT00364351|582030139|FG001|Overall Study|Prohibited concomitant medication|2|||
161177938|NCT00364351|582030138|FG000|Overall Study|Lost to Follow-up|1|||
161177939|NCT00364351|582030139|FG001|Overall Study|Lost to Follow-up|1|||
161177940|NCT00364351|582030138|FG000|Overall Study|Withdrawal by Subject|30|||
161177941|NCT00364351|582030139|FG001|Overall Study|Withdrawal by Subject|29|||
161177942|NCT00364351|582030138|FG000|Overall Study|Incorrect enrollment|1|||
161177943|NCT00364351|582030139|FG001|Overall Study|Incorrect enrollment|1|||
161177944|NCT00364351|582030138|FG000|Overall Study|Sponsor decision|1|||
161177945|NCT00364351|582030139|FG001|Overall Study|Sponsor decision|0|||
161177946|NCT00364351|582030138|FG000|Overall Study|Poor treatment compliance|0|||
161177947|NCT00364351|582030139|FG001|Overall Study|Poor treatment compliance|3|||
161177948|NCT00364351|582030138|FG000|Overall Study|Investigator error|0|||
161177949|NCT00364351|582030139|FG001|Overall Study|Investigator error|2|||
161297648|NCT03300505|582473983|FG000|Overall Study|Adverse Event|0|||
161177950|NCT00364351|582030138|FG000|Overall Study|Patient could not travel to site|0|||
161177951|NCT00364351|582030139|FG001|Overall Study|Patient could not travel to site|1|||
161177952|NCT00364351|582030138|FG000|Overall Study|Randomised treatment not started|0|||
161177953|NCT00364351|582030139|FG001|Overall Study|Randomised treatment not started|3|||
161177954|NCT01977040|582030147|FG000|Overall Study|Vasa previa not confirmed|2|||
161177955|NCT00688623|582030152|FG000|Overall Study|Adverse Event|22|||
161177956|NCT00688623|582030152|FG000|Overall Study|abnormal lab value|1|||
161177957|NCT00688623|582030152|FG000|Overall Study|Withdrawal by Subject|4|||
161177958|NCT00688623|582030152|FG000|Overall Study|Death|3|||
161177959|NCT00688623|582030152|FG000|Overall Study|disease progression|23|||
161177960|NCT00688623|582030152|FG000|Overall Study|Protocol Violation|2|||
161177961|NCT02443155|582030153|FG000|Overall Study|Adverse Event|3|||
161177962|NCT02443155|582030154|FG001|Overall Study|Adverse Event|4|||
161177963|NCT02443155|582030155|FG002|Overall Study|Adverse Event|1|||
161297649|NCT03300505|582473984|FG001|Overall Study|Adverse Event|0|||
161297650|NCT03300505|582473985|FG002|Overall Study|Adverse Event|2|||
161297651|NCT01806961|582473986|FG000|Overall Study|sponsor decision|16|||
161297652|NCT01108341|582473990|FG000|Overall Study|Death|2|||
161297653|NCT01108341|582473990|FG000|Overall Study|Withdrawal by Subject|1|||
161297654|NCT01108341|582473990|FG000|Overall Study|Lost to Follow-up|1|||
161297655|NCT01108341|582473990|FG000|Overall Study|Other|1|||
161297656|NCT03056638|582473995|FG000|Overall Study|Death|1|||
161297657|NCT03056638|582473996|FG001|Overall Study|Death|0|||
161297658|NCT02530125|582473997|FG000|Completed Treatment|Early termination of study|1|||
161297659|NCT02530125|582473997|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
161297660|NCT00468481|582473998|FG000|Overall Study|Adverse Event|13|||
161297661|NCT00468481|582473999|FG001|Overall Study|Adverse Event|3|||
161297662|NCT00468481|582473998|FG000|Overall Study|Lost to Follow-up|25|||
161297663|NCT00468481|582473999|FG001|Overall Study|Lost to Follow-up|8|||
161297664|NCT00468481|582473998|FG000|Overall Study|Pregnancy|2|||
161177964|NCT02443155|582030156|FG003|Overall Study|Adverse Event|2|||
161177965|NCT02443155|582030153|FG000|Overall Study|Unclassified|0|||
161177966|NCT02443155|582030154|FG001|Overall Study|Unclassified|0|||
161177967|NCT02443155|582030155|FG002|Overall Study|Unclassified|2|||
161177968|NCT02443155|582030156|FG003|Overall Study|Unclassified|1|||
161177969|NCT02443155|582030153|FG000|Overall Study|Withdrawal by Subject|4|||
161177970|NCT02443155|582030154|FG001|Overall Study|Withdrawal by Subject|7|||
161177971|NCT02443155|582030155|FG002|Overall Study|Withdrawal by Subject|3|||
161177972|NCT02443155|582030156|FG003|Overall Study|Withdrawal by Subject|9|||
161177973|NCT02443155|582030153|FG000|Overall Study|Pregnancy|3|||
161177974|NCT02443155|582030154|FG001|Overall Study|Pregnancy|1|||
161177975|NCT02443155|582030155|FG002|Overall Study|Pregnancy|1|||
161177976|NCT02443155|582030156|FG003|Overall Study|Pregnancy|2|||
161177977|NCT02443155|582030153|FG000|Overall Study|Lost to Follow-up|1|||
161177978|NCT02443155|582030154|FG001|Overall Study|Lost to Follow-up|2|||
161177979|NCT02443155|582030155|FG002|Overall Study|Lost to Follow-up|0|||
161177980|NCT02443155|582030156|FG003|Overall Study|Lost to Follow-up|1|||
161177981|NCT02443155|582030153|FG000|Overall Study|Protocol Violation|1|||
161177982|NCT02443155|582030154|FG001|Overall Study|Protocol Violation|0|||
161177983|NCT02443155|582030155|FG002|Overall Study|Protocol Violation|1|||
161177984|NCT02443155|582030156|FG003|Overall Study|Protocol Violation|1|||
161177985|NCT02443155|582030153|FG000|Overall Study|Death|0|||
161177986|NCT02443155|582030154|FG001|Overall Study|Death|0|||
161177987|NCT02443155|582030155|FG002|Overall Study|Death|1|||
161177988|NCT02443155|582030156|FG003|Overall Study|Death|0|||
161177989|NCT00634751|582030157|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
161177990|NCT00634751|582030158|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161177991|NCT00634751|582030159|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161177992|NCT00634751|582030160|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
161177993|NCT00634751|582030157|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161177994|NCT00634751|582030158|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
161177995|NCT00634751|582030159|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161177996|NCT00634751|582030160|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
161177997|NCT00634751|582030157|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
161177998|NCT00634751|582030158|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
161177999|NCT00634751|582030159|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
161178000|NCT00634751|582030160|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
161178001|NCT00608894|582030161|FG000|Overall Study|Withdrawal by Subject|0|||
161178002|NCT00608894|582030162|FG001|Overall Study|Withdrawal by Subject|2|||
161178003|NCT03654560|582030169|FG000|Overall Study|Death|3|||
161178004|NCT03654560|582030170|FG001|Overall Study|Death|1|||
161178005|NCT03654560|582030169|FG000|Overall Study|Lost to Follow-up|1|||
161297665|NCT00468481|582473999|FG001|Overall Study|Pregnancy|0|||
161297666|NCT00468481|582473998|FG000|Overall Study|Protocol Violation|18|||
161297667|NCT00468481|582473999|FG001|Overall Study|Protocol Violation|8|||
161347728|NCT01481779|582657352|FG000|Overall Study|Physician Decision|13|||
161178006|NCT03654560|582030170|FG001|Overall Study|Lost to Follow-up|0|||
161297668|NCT00468481|582473998|FG000|Overall Study|Withdrawal by Subject|12|||
161297669|NCT00468481|582473999|FG001|Overall Study|Withdrawal by Subject|3|||
161297670|NCT00468481|582473998|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
161297671|NCT00468481|582473999|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
161178007|NCT00209092|582030171|FG000|Overall Study|Progression of disease|7|||
161178008|NCT00209092|582030172|FG001|Overall Study|Progression of disease|1|||
161178009|NCT00209092|582030171|FG000|Overall Study|Adverse Event|0|||
161178010|NCT00209092|582030172|FG001|Overall Study|Adverse Event|1|||
161178011|NCT00209092|582030171|FG000|Overall Study|Withdrawal by Subject|1|||
161178012|NCT00209092|582030172|FG001|Overall Study|Withdrawal by Subject|0|||
161178013|NCT00693420|582030173|FG000|Overall Study|Adverse Event|4|||
161178014|NCT00693420|582030174|FG001|Overall Study|Adverse Event|4|||
161178015|NCT00693420|582030173|FG000|Overall Study|Lost to Follow-up|0|||
161297672|NCT00468481|582473998|FG000|Overall Study|Prohibited Medication|1|||
161297673|NCT00468481|582473999|FG001|Overall Study|Prohibited Medication|1|||
161297674|NCT00468481|582473998|FG000|Overall Study|Egg Donor|1|||
161297675|NCT00468481|582473999|FG001|Overall Study|Egg Donor|0|||
161297676|NCT00468481|582473998|FG000|Overall Study|Moved out of area|4|||
161297677|NCT00468481|582473999|FG001|Overall Study|Moved out of area|1|||
161297678|NCT00468481|582473998|FG000|Overall Study|Non-Compliance|5|||
161297679|NCT00468481|582473999|FG001|Overall Study|Non-Compliance|0|||
161297680|NCT00468481|582473998|FG000|Overall Study|Other|6|||
161297681|NCT00468481|582473999|FG001|Overall Study|Other|0|||
161297682|NCT00728468|582474000|FG000|Overall Study|Enrolled but not treated|1|||
161297683|NCT00728468|582474000|FG000|Overall Study|Death|1|||
161297684|NCT00728468|582474000|FG000|Overall Study|Protocol Violation|4|||
161297685|NCT00728468|582474000|FG000|Overall Study|Objective progression or relapse|9|||
161297686|NCT00728468|582474000|FG000|Overall Study|Study terminated by sponsor|1|||
161297687|NCT00596687|582474001|FG000|Overall Study|< 24 hours of insulin treatment|8|||
161297688|NCT00596687|582474002|FG001|Overall Study|< 24 hours of insulin treatment|6|||
161297689|NCT00596687|582474001|FG000|Overall Study|continuous insulin infusion during TPN|2|||
161297690|NCT00596687|582474002|FG001|Overall Study|continuous insulin infusion during TPN|1|||
161297691|NCT00596687|582474001|FG000|Overall Study|Withdrawal by Subject|3|||
161297692|NCT00596687|582474002|FG001|Overall Study|Withdrawal by Subject|1|||
161297693|NCT00596687|582474001|FG000|Overall Study|cancelled surgery|1|||
161297694|NCT00596687|582474002|FG001|Overall Study|cancelled surgery|1|||
161297695|NCT03831113|582474003|FG000|Overall Study|Withdrawal by Subject|0|||
161297696|NCT03831113|582474004|FG001|Overall Study|Withdrawal by Subject|2|||
161297697|NCT03831113|582474003|FG000|Overall Study|Protocol Violation|0|||
161297698|NCT03831113|582474004|FG001|Overall Study|Protocol Violation|9|||
161297699|NCT02498444|582474005|FG000|Overall Study|Withdrawal by Subject|3|||
161297700|NCT02498444|582474006|FG001|Overall Study|Withdrawal by Subject|0|||
161297701|NCT02498444|582474005|FG000|Overall Study|Physician Decision|1|||
161297702|NCT02498444|582474006|FG001|Overall Study|Physician Decision|0|||
161297703|NCT02097238|582474017|FG000|Overall Study|Death|1|||
161297704|NCT02097238|582474017|FG000|Overall Study|Physician Decision|1|||
161297705|NCT02097238|582474017|FG000|Overall Study|Progressive Disease|17|||
161297706|NCT01106911|582474018|FG000|Overall Study|Physician Decision|2|||
161297707|NCT01106911|582474018|FG000|Overall Study|deemed ineligible after screening|3|||
161297708|NCT01282372|582474027|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
161297709|NCT01282372|582474027|FG000|Overall Study|Lost to Follow-up|23|||
161297710|NCT01282372|582474027|FG000|Overall Study|Withdrawal by Subject|11|||
161297711|NCT01282372|582474027|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
161297712|NCT01282372|582474027|FG000|Overall Study|Death|1|||
161297713|NCT01282372|582474027|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
161297714|NCT01282372|582474027|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
161297715|NCT01282372|582474027|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
161297716|NCT01282372|582474027|FG000|Overall Study|Adverse Event|12|||
161297717|NCT01814696|582474028|FG000|Overall Study|Withdrawal by Subject|1|||
161297718|NCT01814696|582474029|FG001|Overall Study|Withdrawal by Subject|0|||
161297719|NCT01814696|582474028|FG000|Overall Study|Randomized to wrong group|1|||
161297720|NCT01814696|582474029|FG001|Overall Study|Randomized to wrong group|0|||
161297721|NCT02737930|582474034|FG000|Overall Study|Withdrawal by Subject|0|||
161297722|NCT02737930|582474035|FG001|Overall Study|Withdrawal by Subject|1|||
161297723|NCT05708976|582474044|FG000|Overall Study|Withdrawal by Subject|0|||
161297724|NCT05708976|582474045|FG001|Overall Study|Withdrawal by Subject|1|||
161297725|NCT05310071|582474046|FG000|Overall Study|Death|0|||
161297726|NCT05310071|582474047|FG001|Overall Study|Death|3|||
161297727|NCT05310071|582474046|FG000|Overall Study|Adverse Event|4|||
161297728|NCT05310071|582474047|FG001|Overall Study|Adverse Event|31|||
161297729|NCT05310071|582474046|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
161297730|NCT05310071|582474047|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
161297731|NCT05310071|582474046|FG000|Overall Study|Protocol Deviation|2|||
161297732|NCT05310071|582474047|FG001|Overall Study|Protocol Deviation|0|||
161297733|NCT05310071|582474046|FG000|Overall Study|Randomized by Mistake|0|||
161297734|NCT05310071|582474047|FG001|Overall Study|Randomized by Mistake|1|||
161297735|NCT05310071|582474046|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
161297736|NCT05310071|582474047|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
161297737|NCT05310071|582474046|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
161297738|NCT05310071|582474047|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
161297739|NCT05310071|582474046|FG000|Overall Study|Site Terminated by Sponsor|0|||
161297740|NCT05310071|582474047|FG001|Overall Study|Site Terminated by Sponsor|2|||
161297741|NCT05310071|582474046|FG000|Overall Study|Study Terminated by Sponsor|282|||
161297742|NCT05310071|582474047|FG001|Overall Study|Study Terminated by Sponsor|559|||
161297743|NCT05310071|582474046|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
161297744|NCT05310071|582474047|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
161297745|NCT05310071|582474046|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
161319493|NCT01863732|582555336|FG002|Overall Study|Physician Decision|1|||
161319494|NCT01863732|582555337|FG003|Overall Study|Physician Decision|0|||
161319495|NCT01863732|582555334|FG000|Overall Study|Pregnancy|0|||
161319496|NCT01863732|582555335|FG001|Overall Study|Pregnancy|0|||
161297746|NCT05310071|582474047|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
161297747|NCT05310071|582474046|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
161297748|NCT05310071|582474047|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
161297749|NCT05310071|582474046|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
161178016|NCT00693420|582030174|FG001|Overall Study|Lost to Follow-up|3|||
161178017|NCT00693420|582030173|FG000|Overall Study|Withdrawal by Subject|1|||
161178018|NCT00693420|582030174|FG001|Overall Study|Withdrawal by Subject|0|||
161178019|NCT00693420|582030173|FG000|Overall Study|Protocol Violation|0|||
161178020|NCT00693420|582030174|FG001|Overall Study|Protocol Violation|2|||
161178021|NCT00693420|582030173|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
161178022|NCT00693420|582030174|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
161178023|NCT00693420|582030173|FG000|Overall Study|Personal Reasons|1|||
161178024|NCT00693420|582030174|FG001|Overall Study|Personal Reasons|4|||
161178025|NCT01235338|582030176|FG000|Overall Study|Adverse Event|3|||
161178026|NCT01235338|582030177|FG001|Overall Study|Adverse Event|2|||
161178027|NCT01235338|582030176|FG000|Overall Study|Protocol Violation|1|||
161178028|NCT01235338|582030177|FG001|Overall Study|Protocol Violation|1|||
161178029|NCT01235338|582030176|FG000|Overall Study|Withdrawal by Subject|5|||
161178030|NCT01235338|582030177|FG001|Overall Study|Withdrawal by Subject|0|||
161178031|NCT01235338|582030176|FG000|Overall Study|Exclusion criteria violations|1|||
161178032|NCT01235338|582030177|FG001|Overall Study|Exclusion criteria violations|1|||
161178033|NCT01235338|582030176|FG000|Overall Study|Positive drug screen|0|||
161178034|NCT01235338|582030177|FG001|Overall Study|Positive drug screen|1|||
161178035|NCT01235338|582030176|FG000|Overall Study|Prohibited meds|1|||
161178036|NCT01235338|582030177|FG001|Overall Study|Prohibited meds|0|||
161178037|NCT05283499|582030179|FG000|Overall Study|Did not receive intervention|1|||
161178038|NCT05283499|582030180|FG001|Overall Study|Did not receive intervention|2|||
161178039|NCT02828644|582030181|FG000|Overall Study|Lost to Follow-up|23|||
161178040|NCT02828644|582030182|FG001|Overall Study|Lost to Follow-up|22|||
161178041|NCT02408484|582030183|FG000|Overall Study|Withdrawal by Subject|3|||
161178042|NCT02408484|582030183|FG000|Overall Study|Not treated during study period|1|||
161178043|NCT01117181|582030187|FG000|Overall Study|Lost to Follow-up|1|||
161178044|NCT01117181|582030188|FG001|Overall Study|Lost to Follow-up|0|||
161178045|NCT01117181|582030187|FG000|Overall Study|Withdrawal by Subject|0|||
161178046|NCT01117181|582030188|FG001|Overall Study|Withdrawal by Subject|2|||
161178047|NCT00524043|582030194|FG000|Overall Study|Lack of Efficacy|15|||
161178048|NCT00524043|582030195|FG001|Overall Study|Lack of Efficacy|13|||
161178049|NCT00524043|582030196|FG002|Overall Study|Lack of Efficacy|14|||
161178050|NCT00524043|582030194|FG000|Overall Study|Withdrawal by Subject|5|||
161178051|NCT00524043|582030195|FG001|Overall Study|Withdrawal by Subject|7|||
161178052|NCT00524043|582030196|FG002|Overall Study|Withdrawal by Subject|7|||
161178053|NCT00524043|582030194|FG000|Overall Study|Adverse Event|5|||
161178054|NCT00524043|582030195|FG001|Overall Study|Adverse Event|2|||
161178055|NCT00524043|582030196|FG002|Overall Study|Adverse Event|7|||
161178056|NCT00524043|582030194|FG000|Overall Study|Lost to Follow-up|3|||
161178057|NCT00524043|582030195|FG001|Overall Study|Lost to Follow-up|5|||
161178058|NCT00524043|582030196|FG002|Overall Study|Lost to Follow-up|3|||
161178059|NCT00524043|582030194|FG000|Overall Study|Various (eg, incarceration)|2|||
161178060|NCT00524043|582030195|FG001|Overall Study|Various (eg, incarceration)|1|||
161178061|NCT00524043|582030196|FG002|Overall Study|Various (eg, incarceration)|0|||
161178062|NCT00517413|582030198|FG000|Overall Study|Adverse Event|7|||
161178063|NCT00517413|582030198|FG000|Overall Study|Death|13|||
161178064|NCT00517413|582030198|FG000|Overall Study|Protocol Violation|15|||
161178065|NCT00517413|582030198|FG000|Overall Study|Withdrawal by Subject|2|||
161178066|NCT00517413|582030198|FG000|Overall Study|Failure to return|1|||
161178067|NCT00517413|582030198|FG000|Overall Study|Other-Reasons|23|||
161178068|NCT03938636|582030199|FG000|Overall Study|Protocol Violation|0|||
161297750|NCT05310071|582474047|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
161297751|NCT05310071|582474046|FG000|Overall Study|Withdrawal by Participant - Other|25|||
161297752|NCT05310071|582474047|FG001|Overall Study|Withdrawal by Participant - Other|30|||
161178069|NCT03938636|582030200|FG001|Overall Study|Protocol Violation|1|||
161178070|NCT03938636|582030201|FG002|Overall Study|Protocol Violation|1|||
161178071|NCT03938636|582030199|FG000|Overall Study|Subject withdrew due to death in family|0|||
161178072|NCT03938636|582030200|FG001|Overall Study|Subject withdrew due to death in family|1|||
161178073|NCT03938636|582030201|FG002|Overall Study|Subject withdrew due to death in family|0|||
161178074|NCT03938636|582030199|FG000|Overall Study|Missed visit|0|||
161178075|NCT03938636|582030200|FG001|Overall Study|Missed visit|1|||
161178076|NCT03938636|582030201|FG002|Overall Study|Missed visit|0|||
161178077|NCT03938636|582030199|FG000|Overall Study|Adverse Event|0|||
161178078|NCT03938636|582030200|FG001|Overall Study|Adverse Event|0|||
161178079|NCT03938636|582030201|FG002|Overall Study|Adverse Event|1|||
161178080|NCT03938636|582030199|FG000|Overall Study|Lost to Follow-up|0|||
161178081|NCT03938636|582030200|FG001|Overall Study|Lost to Follow-up|0|||
161178082|NCT03938636|582030201|FG002|Overall Study|Lost to Follow-up|1|||
161178083|NCT00216086|582030202|FG000|Overall Study|Protocol Violation|1|||
161178084|NCT00216086|582030202|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
161178085|NCT00216086|582030202|FG000|Overall Study|Social Reasons|2|||
161178086|NCT01080625|582030209|FG000|Overall Study|Physician Decision|0|||
161178087|NCT01080625|582030210|FG001|Overall Study|Physician Decision|2|||
161178088|NCT01080625|582030211|FG002|Overall Study|Physician Decision|1|||
161178089|NCT03135262|582030217|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
161178090|NCT03135262|582030218|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161178091|NCT03135262|582030219|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161178092|NCT03135262|582030220|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161178093|NCT03135262|582030221|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
161178094|NCT03135262|582030217|FG000|Overall Study|Progression of disease|0|||
161178095|NCT03135262|582030218|FG001|Overall Study|Progression of disease|0|||
161178096|NCT03135262|582030219|FG002|Overall Study|Progression of disease|0|||
161178097|NCT03135262|582030220|FG003|Overall Study|Progression of disease|1|||
161178098|NCT03135262|582030221|FG004|Overall Study|Progression of disease|0|||
161178099|NCT03135262|582030217|FG000|Overall Study|Death|6|||
161178100|NCT03135262|582030218|FG001|Overall Study|Death|2|||
161178101|NCT03135262|582030219|FG002|Overall Study|Death|2|||
161178102|NCT03135262|582030220|FG003|Overall Study|Death|2|||
161178103|NCT03135262|582030221|FG004|Overall Study|Death|0|||
161178104|NCT03135262|582030217|FG000|Overall Study|Withdrawal by Subject|0|||
161178105|NCT03135262|582030218|FG001|Overall Study|Withdrawal by Subject|0|||
161178106|NCT03135262|582030219|FG002|Overall Study|Withdrawal by Subject|1|||
161178107|NCT03135262|582030220|FG003|Overall Study|Withdrawal by Subject|0|||
161178108|NCT03135262|582030221|FG004|Overall Study|Withdrawal by Subject|1|||
161178109|NCT03135262|582030217|FG000|Overall Study|Study terminated by sponsor|2|||
161178110|NCT03135262|582030218|FG001|Overall Study|Study terminated by sponsor|4|||
161178111|NCT03135262|582030219|FG002|Overall Study|Study terminated by sponsor|4|||
161178112|NCT03135262|582030220|FG003|Overall Study|Study terminated by sponsor|3|||
161178113|NCT03135262|582030221|FG004|Overall Study|Study terminated by sponsor|0|||
161178114|NCT00282568|582030227|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
161178115|NCT00282568|582030227|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
161178116|NCT00282568|582030227|FG000|Extended Treatment Period|Adverse Event|17|||
161178117|NCT00282568|582030227|FG000|Extended Treatment Period|Non-compliance|4|||
161178118|NCT00282568|582030227|FG000|Extended Treatment Period|Physician Decision|1|||
161178119|NCT00282568|582030227|FG000|Extended Treatment Period|Lost to Follow-up|2|||
161178120|NCT01408732|582030228|FG000|Overall Study|Withdrawal by Subject|2|||
161178121|NCT01408732|582030229|FG001|Overall Study|Withdrawal by Subject|2|||
161178122|NCT03185819|582030230|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161178123|NCT03185819|582030231|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161178124|NCT03185819|582030232|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
161178125|NCT03185819|582030233|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
161178126|NCT03185819|582030230|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
161178127|NCT03185819|582030231|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
161178128|NCT03185819|582030232|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
161178129|NCT03185819|582030233|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
161178130|NCT03185819|582030230|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
161178131|NCT03185819|582030231|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161178132|NCT03185819|582030232|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161178133|NCT03185819|582030233|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
161178134|NCT03185819|582030230|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
161178135|NCT03185819|582030231|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
161178136|NCT03185819|582030232|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
161178137|NCT03185819|582030233|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
161178138|NCT03185819|582030230|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161178139|NCT03185819|582030231|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161178140|NCT03185819|582030232|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
161178141|NCT03185819|582030233|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
161178142|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
161178143|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
161297753|NCT05310071|582474046|FG000|Overall Study|Lost to Follow-up|2|||
161297754|NCT05310071|582474047|FG001|Overall Study|Lost to Follow-up|4|||
161297755|NCT05310071|582474046|FG000|Overall Study|Reason Not Specified|1|||
161178144|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
161178145|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
161178146|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
161178147|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
161178148|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
161297756|NCT05310071|582474047|FG001|Overall Study|Reason Not Specified|3|||
161088405|NCT00296400|581712733|FG000|Overall Study|Withdrawal by Subject|5|||
161088406|NCT00296400|581712734|FG001|Overall Study|Withdrawal by Subject|6|||
161088407|NCT00296400|581712735|FG002|Overall Study|Withdrawal by Subject|2|||
161088408|NCT00296400|581712733|FG000|Overall Study|Incorrect enrollment|2|||
161088409|NCT00296400|581712734|FG001|Overall Study|Incorrect enrollment|0|||
161088410|NCT00296400|581712735|FG002|Overall Study|Incorrect enrollment|0|||
161088411|NCT00296400|581712733|FG000|Overall Study|Protocol Violation|1|||
161088412|NCT00296400|581712734|FG001|Overall Study|Protocol Violation|1|||
161088413|NCT00296400|581712735|FG002|Overall Study|Protocol Violation|1|||
161088414|NCT00296400|581712733|FG000|Overall Study|Lost to Follow-up|1|||
161088415|NCT00296400|581712734|FG001|Overall Study|Lost to Follow-up|1|||
161088416|NCT00296400|581712735|FG002|Overall Study|Lost to Follow-up|2|||
161088417|NCT00296400|581712733|FG000|Overall Study|Study specific discontinuation criteria|0|||
161088418|NCT00296400|581712734|FG001|Overall Study|Study specific discontinuation criteria|0|||
161088419|NCT00296400|581712735|FG002|Overall Study|Study specific discontinuation criteria|1|||
161088420|NCT00296400|581712733|FG000|Overall Study|Visit 10 was performed earlier|0|||
161088421|NCT00296400|581712734|FG001|Overall Study|Visit 10 was performed earlier|1|||
161088422|NCT00296400|581712735|FG002|Overall Study|Visit 10 was performed earlier|0|||
161088423|NCT00296400|581712733|FG000|Overall Study|Pregnancy|1|||
161088424|NCT00296400|581712734|FG001|Overall Study|Pregnancy|2|||
161088425|NCT00296400|581712735|FG002|Overall Study|Pregnancy|0|||
161088426|NCT03538301|581712745|FG000|Overall Study|Adverse Event|1|||
161088427|NCT03538301|581712746|FG001|Overall Study|Adverse Event|4|||
161088428|NCT03538301|581712747|FG002|Overall Study|Adverse Event|4|||
161088429|NCT03538301|581712745|FG000|Overall Study|Death|1|||
161088430|NCT03538301|581712746|FG001|Overall Study|Death|1|||
161088431|NCT03538301|581712747|FG002|Overall Study|Death|0|||
161088432|NCT03538301|581712745|FG000|Overall Study|Physician Decision|0|||
161088433|NCT03538301|581712746|FG001|Overall Study|Physician Decision|1|||
161088434|NCT03538301|581712747|FG002|Overall Study|Physician Decision|0|||
161088435|NCT03538301|581712745|FG000|Overall Study|Protocol Violation|0|||
161088436|NCT03538301|581712746|FG001|Overall Study|Protocol Violation|0|||
161088437|NCT03538301|581712747|FG002|Overall Study|Protocol Violation|1|||
161088438|NCT03538301|581712745|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
161088439|NCT03538301|581712746|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
161088440|NCT03538301|581712747|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
161088441|NCT01586910|581715150|FG000|Overall Study|Death|4|||
161088442|NCT01586910|581715151|FG001|Overall Study|Death|4|||
161088443|NCT01586910|581715150|FG000|Overall Study|Withdrawal by Subject|6|||
161088444|NCT01586910|581715151|FG001|Overall Study|Withdrawal by Subject|43|||
161088445|NCT01586910|581715150|FG000|Overall Study|Physician withdrew Subject|5|||
161088446|NCT01586910|581715151|FG001|Overall Study|Physician withdrew Subject|24|||
161088447|NCT00252733|581715152|FG000|Overall Study|Withdrawal by Subject|73|||
161088448|NCT00252733|581715153|FG001|Overall Study|Withdrawal by Subject|67|||
161088449|NCT00252733|581715152|FG000|Overall Study|Death|7|||
161088450|NCT00252733|581715153|FG001|Overall Study|Death|5|||
161088451|NCT00252733|581715152|FG000|Overall Study|Lost to Follow-up|12|||
161088452|NCT00252733|581715153|FG001|Overall Study|Lost to Follow-up|6|||
161088453|NCT00252733|581715152|FG000|Overall Study|Multiple Reasons|14|||
161088454|NCT00252733|581715153|FG001|Overall Study|Multiple Reasons|14|||
161088455|NCT04289051|581715154|FG000|Overall Study|Lost to Follow-up|0|||
161088456|NCT04289051|581715155|FG001|Overall Study|Lost to Follow-up|0|||
161088457|NCT04289051|581715156|FG002|Overall Study|Lost to Follow-up|2|||
161088458|NCT00156819|581715159|FG000|Overall Study|Lost to Follow-up|1|||
161088459|NCT00156819|581715160|FG001|Overall Study|Lost to Follow-up|1|||
161088460|NCT00156819|581715161|FG002|Overall Study|Lost to Follow-up|3|||
161088461|NCT01689337|581715162|FG000|Overall Study|Study Discontinuation|1|||
161088462|NCT00642772|581715164|FG000|Overall Study|Lost to Follow-up|3|||
161088463|NCT00642772|581715164|FG000|Overall Study|Withdrawal by Subject|7|||
161088464|NCT05398237|581715171|FG000|Overall Study|Withdrawal by Subject|1|||
161088465|NCT01312857|581715172|FG000|Overall Study|Adverse Event|1|||
161088466|NCT01312857|581715173|FG001|Overall Study|Adverse Event|1|||
161088467|NCT01312857|581715172|FG000|Overall Study|Lost to Follow-up|2|||
161088468|NCT01312857|581715173|FG001|Overall Study|Lost to Follow-up|0|||
161088469|NCT01312857|581715172|FG000|Overall Study|Physician Decision|3|||
161088470|NCT01312857|581715173|FG001|Overall Study|Physician Decision|0|||
161088471|NCT01312857|581715172|FG000|Overall Study|Withdrawal by Subject|2|||
161088472|NCT01312857|581715173|FG001|Overall Study|Withdrawal by Subject|0|||
161088473|NCT01248065|581715174|FG000|Overall Study|Lost to Follow-up|3|||
161088474|NCT01248065|581715175|FG001|Overall Study|Lost to Follow-up|5|||
161088475|NCT01248065|581715174|FG000|Overall Study|Withdrawal by Subject|14|||
161088476|NCT01248065|581715175|FG001|Overall Study|Withdrawal by Subject|11|||
161088477|NCT01248065|581715174|FG000|Overall Study|Adverse Event|3|||
161088478|NCT01248065|581715175|FG001|Overall Study|Adverse Event|0|||
161088479|NCT01248065|581715174|FG000|Overall Study|Third treatment failure event|3|||
161088480|NCT01248065|581715175|FG001|Overall Study|Third treatment failure event|1|||
161088481|NCT01248065|581715174|FG000|Overall Study|Other|3|||
161088482|NCT01248065|581715175|FG001|Overall Study|Other|5|||
161178149|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
161178150|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161178151|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
161178152|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161178153|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
161178154|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
161178155|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161178156|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161178157|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
161178158|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
161178159|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
161178160|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
161178161|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
161178162|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
161178163|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
161178164|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
161178165|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
161178166|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
161178167|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
161178168|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
161178169|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
161178170|NCT03185819|582030230|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
161178171|NCT03185819|582030231|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161178172|NCT03185819|582030232|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161178173|NCT03185819|582030233|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
161178174|NCT03447821|582030235|FG000|Overall Study|Withdrawal by Subject|1|||
161178175|NCT03447821|582030236|FG001|Overall Study|Withdrawal by Subject|1|||
161178176|NCT03447821|582030237|FG002|Overall Study|Withdrawal by Subject|0|||
161178177|NCT03447821|582030235|FG000|Overall Study|Lost to Follow-up|0|||
161178178|NCT03447821|582030236|FG001|Overall Study|Lost to Follow-up|0|||
161178179|NCT03447821|582030237|FG002|Overall Study|Lost to Follow-up|1|||
161178180|NCT02977507|582030238|FG000|Overall Study|Protocol Deviation|1|||
161178181|NCT02977507|582030239|FG001|Overall Study|Protocol Deviation|0|||
161178182|NCT02977507|582030238|FG000|Overall Study|Lost to Follow-up|1|||
161178183|NCT02977507|582030239|FG001|Overall Study|Lost to Follow-up|0|||
161178184|NCT00654420|582030240|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
161178185|NCT00654420|582030241|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
161178186|NCT00654420|582030242|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
161178187|NCT00654420|582030243|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
161178188|NCT00654420|582030240|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
161178189|NCT00654420|582030241|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
161178190|NCT00654420|582030242|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
161178191|NCT00654420|582030243|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
161178192|NCT00654420|582030240|FG000|Phase II|Adverse Event|0|||
161178193|NCT00654420|582030241|FG001|Phase II|Adverse Event|0|||
161178194|NCT00654420|582030242|FG002|Phase II|Adverse Event|3|||
161178195|NCT00654420|582030243|FG003|Phase II|Adverse Event|3|||
161178196|NCT00654420|582030240|FG000|Phase II|Lost to Follow-up|0|||
161178197|NCT00654420|582030241|FG001|Phase II|Lost to Follow-up|0|||
161178198|NCT00654420|582030242|FG002|Phase II|Lost to Follow-up|0|||
161178199|NCT00654420|582030243|FG003|Phase II|Lost to Follow-up|1|||
161178200|NCT00654420|582030240|FG000|Phase II|Physician Decision|0|||
161178201|NCT00654420|582030241|FG001|Phase II|Physician Decision|0|||
161178202|NCT00654420|582030242|FG002|Phase II|Physician Decision|0|||
161178203|NCT00654420|582030243|FG003|Phase II|Physician Decision|4|||
161178204|NCT00654420|582030240|FG000|Phase II|Progressive Disease|0|||
161297757|NCT02105987|582474048|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
161297758|NCT02105987|582474049|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161297759|NCT02105987|582474050|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161297760|NCT02105987|582474051|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161297761|NCT02105987|582474052|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161297762|NCT02105987|582474053|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
161297763|NCT02105987|582474048|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
161178205|NCT00654420|582030241|FG001|Phase II|Progressive Disease|0|||
161178206|NCT00654420|582030242|FG002|Phase II|Progressive Disease|29|||
161178207|NCT00654420|582030243|FG003|Phase II|Progressive Disease|29|||
161178208|NCT00654420|582030240|FG000|Phase II|Withdrawal by Subject|0|||
161178209|NCT00654420|582030241|FG001|Phase II|Withdrawal by Subject|0|||
161297764|NCT02105987|582474049|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
161178210|NCT00654420|582030242|FG002|Phase II|Withdrawal by Subject|4|||
161178211|NCT00654420|582030243|FG003|Phase II|Withdrawal by Subject|1|||
161178212|NCT00654420|582030240|FG000|Phase II|Missing Disposition Record|0|||
161178213|NCT00654420|582030241|FG001|Phase II|Missing Disposition Record|0|||
161178214|NCT00654420|582030242|FG002|Phase II|Missing Disposition Record|1|||
161178215|NCT00654420|582030243|FG003|Phase II|Missing Disposition Record|0|||
161178216|NCT00610207|582030248|FG000|Overall Study|Lost to Follow-up|3|||
161178217|NCT03236506|582030249|FG000|Overall Study|Death|1|||
161178218|NCT03236506|582030250|FG001|Overall Study|Death|1|||
161178219|NCT03236506|582030251|FG002|Overall Study|Death|1|||
161178220|NCT03236506|582030249|FG000|Overall Study|Withdrawal by Subject|3|||
161178221|NCT03236506|582030250|FG001|Overall Study|Withdrawal by Subject|3|||
161178222|NCT03236506|582030251|FG002|Overall Study|Withdrawal by Subject|4|||
161178223|NCT03236506|582030249|FG000|Overall Study|Did not initiate treatment|2|||
161178224|NCT03236506|582030250|FG001|Overall Study|Did not initiate treatment|1|||
161178225|NCT03236506|582030251|FG002|Overall Study|Did not initiate treatment|2|||
161178226|NCT00422669|582030256|FG000|Overall Study|The study was terminated early.|98|||
161178227|NCT00422669|582030257|FG001|Overall Study|The study was terminated early.|100|||
161178228|NCT00422669|582030258|FG002|Overall Study|The study was terminated early.|7|||
161178229|NCT00741260|582030260|FG000|Overall Study|Disease Progression|3|||
161178230|NCT00741260|582030261|FG001|Overall Study|Disease Progression|5|||
161178231|NCT00741260|582030262|FG002|Overall Study|Disease Progression|3|||
161178232|NCT00741260|582030263|FG003|Overall Study|Disease Progression|3|||
161178233|NCT00741260|582030264|FG004|Overall Study|Disease Progression|5|||
161178234|NCT00741260|582030265|FG005|Overall Study|Disease Progression|37|||
161178235|NCT00741260|582030266|FG006|Overall Study|Disease Progression|4|||
161178236|NCT00741260|582030260|FG000|Overall Study|Death|0|||
161178237|NCT00741260|582030261|FG001|Overall Study|Death|1|||
161178238|NCT00741260|582030262|FG002|Overall Study|Death|0|||
161178239|NCT00741260|582030263|FG003|Overall Study|Death|1|||
161178240|NCT00741260|582030264|FG004|Overall Study|Death|2|||
161178241|NCT00741260|582030265|FG005|Overall Study|Death|2|||
161178242|NCT00741260|582030266|FG006|Overall Study|Death|1|||
161178243|NCT00741260|582030260|FG000|Overall Study|Withdrawal by Subject|0|||
161178244|NCT00741260|582030261|FG001|Overall Study|Withdrawal by Subject|0|||
161178245|NCT00741260|582030262|FG002|Overall Study|Withdrawal by Subject|0|||
161178246|NCT00741260|582030263|FG003|Overall Study|Withdrawal by Subject|0|||
161178247|NCT00741260|582030264|FG004|Overall Study|Withdrawal by Subject|1|||
161178248|NCT00741260|582030265|FG005|Overall Study|Withdrawal by Subject|3|||
161178249|NCT00741260|582030266|FG006|Overall Study|Withdrawal by Subject|1|||
161178250|NCT00741260|582030260|FG000|Overall Study|Physician Decision|1|||
161178251|NCT00741260|582030261|FG001|Overall Study|Physician Decision|1|||
161178252|NCT00741260|582030262|FG002|Overall Study|Physician Decision|0|||
161178253|NCT00741260|582030263|FG003|Overall Study|Physician Decision|0|||
161178254|NCT00741260|582030264|FG004|Overall Study|Physician Decision|0|||
161178255|NCT00741260|582030265|FG005|Overall Study|Physician Decision|0|||
161178256|NCT00741260|582030266|FG006|Overall Study|Physician Decision|0|||
161178257|NCT00741260|582030260|FG000|Overall Study|Other|2|||
161178258|NCT00741260|582030261|FG001|Overall Study|Other|1|||
161178259|NCT00741260|582030262|FG002|Overall Study|Other|1|||
161178260|NCT00741260|582030263|FG003|Overall Study|Other|2|||
161178261|NCT00741260|582030264|FG004|Overall Study|Other|1|||
161178262|NCT00741260|582030265|FG005|Overall Study|Other|3|||
161178263|NCT00741260|582030266|FG006|Overall Study|Other|1|||
161178264|NCT01610206|582030269|FG000|Overall Study|Adverse Event|10|||
161178265|NCT01610206|582030270|FG001|Overall Study|Adverse Event|30|||
161178266|NCT00924729|582030271|FG000|Overall Study|insufficient volume for analysis|1|||
161178267|NCT00924729|582030272|FG001|Overall Study|insufficient volume for analysis|0|||
161178268|NCT00924729|582030271|FG000|Overall Study|Protocol Violation|1|||
161178269|NCT00924729|582030272|FG001|Overall Study|Protocol Violation|0|||
161178270|NCT00023712|582030273|FG000|Overall Study|Not platinum sensitive|1|||
161178271|NCT00023712|582030274|FG001|Overall Study|Not platinum sensitive|0|||
161297765|NCT02105987|582474050|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161297766|NCT02105987|582474051|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161297767|NCT02105987|582474052|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161178272|NCT00023712|582030273|FG000|Overall Study|Never treated|1|||
161178273|NCT00023712|582030274|FG001|Overall Study|Never treated|1|||
161178274|NCT00437203|582030275|FG000|Overall Study|Death|0|||
161178275|NCT00437203|582030276|FG001|Overall Study|Death|0|||
161178276|NCT00437203|582030277|FG002|Overall Study|Death|1|||
161178277|NCT00437203|582030278|FG003|Overall Study|Death|0|||
161178278|NCT00437203|582030279|FG004|Overall Study|Death|0|||
161178279|NCT00437203|582030280|FG005|Overall Study|Death|0|||
161178280|NCT00437203|582030281|FG006|Overall Study|Death|0|||
161178281|NCT00437203|582030282|FG007|Overall Study|Death|1|||
161178282|NCT00437203|582030283|FG008|Overall Study|Death|0|||
161178283|NCT00437203|582030284|FG009|Overall Study|Death|1|||
161319497|NCT01863732|582555336|FG002|Overall Study|Pregnancy|0|||
161178284|NCT00437203|582030275|FG000|Overall Study|Adverse Event|1|||
161178285|NCT00437203|582030276|FG001|Overall Study|Adverse Event|1|||
161178286|NCT00437203|582030277|FG002|Overall Study|Adverse Event|0|||
161178287|NCT00437203|582030278|FG003|Overall Study|Adverse Event|0|||
161178288|NCT00437203|582030279|FG004|Overall Study|Adverse Event|0|||
161178289|NCT00437203|582030280|FG005|Overall Study|Adverse Event|0|||
161178290|NCT00437203|582030281|FG006|Overall Study|Adverse Event|0|||
161178291|NCT00437203|582030282|FG007|Overall Study|Adverse Event|1|||
161178292|NCT00437203|582030283|FG008|Overall Study|Adverse Event|0|||
161178293|NCT00437203|582030284|FG009|Overall Study|Adverse Event|1|||
161178294|NCT00437203|582030275|FG000|Overall Study|Study terminated by sponsor|0|||
161178295|NCT00437203|582030276|FG001|Overall Study|Study terminated by sponsor|0|||
161178296|NCT00437203|582030277|FG002|Overall Study|Study terminated by sponsor|0|||
161178297|NCT00437203|582030278|FG003|Overall Study|Study terminated by sponsor|0|||
161178298|NCT00437203|582030279|FG004|Overall Study|Study terminated by sponsor|0|||
161178299|NCT00437203|582030280|FG005|Overall Study|Study terminated by sponsor|0|||
161178300|NCT00437203|582030281|FG006|Overall Study|Study terminated by sponsor|0|||
161178301|NCT00437203|582030282|FG007|Overall Study|Study terminated by sponsor|0|||
161178302|NCT00437203|582030283|FG008|Overall Study|Study terminated by sponsor|1|||
161178303|NCT00437203|582030284|FG009|Overall Study|Study terminated by sponsor|0|||
161178304|NCT00437203|582030275|FG000|Overall Study|Objective progression or relapse|5|||
161178305|NCT00437203|582030276|FG001|Overall Study|Objective progression or relapse|6|||
161178306|NCT00437203|582030277|FG002|Overall Study|Objective progression or relapse|2|||
161178307|NCT00437203|582030278|FG003|Overall Study|Objective progression or relapse|3|||
161178308|NCT00437203|582030279|FG004|Overall Study|Objective progression or relapse|3|||
161178309|NCT00437203|582030280|FG005|Overall Study|Objective progression or relapse|3|||
161178310|NCT00437203|582030281|FG006|Overall Study|Objective progression or relapse|6|||
161178311|NCT00437203|582030282|FG007|Overall Study|Objective progression or relapse|1|||
161178312|NCT00437203|582030283|FG008|Overall Study|Objective progression or relapse|2|||
161178313|NCT00437203|582030284|FG009|Overall Study|Objective progression or relapse|2|||
161178314|NCT00437203|582030275|FG000|Overall Study|Other|0|||
161178315|NCT00437203|582030276|FG001|Overall Study|Other|1|||
161178316|NCT00437203|582030277|FG002|Overall Study|Other|0|||
161178317|NCT00437203|582030278|FG003|Overall Study|Other|0|||
161178318|NCT00437203|582030279|FG004|Overall Study|Other|0|||
161178319|NCT00437203|582030280|FG005|Overall Study|Other|0|||
161178320|NCT00437203|582030281|FG006|Overall Study|Other|1|||
161178321|NCT00437203|582030282|FG007|Overall Study|Other|0|||
161178322|NCT00437203|582030283|FG008|Overall Study|Other|0|||
161178323|NCT00437203|582030284|FG009|Overall Study|Other|0|||
161178324|NCT02384993|582030288|FG000|Overall Study|Adverse Event|0|||
161178325|NCT02384993|582030289|FG001|Overall Study|Adverse Event|1|||
161178326|NCT01576406|582030290|FG000|Overall Study|Lost to Follow-up|1|||
161178327|NCT01576406|582030291|FG001|Overall Study|Lost to Follow-up|2|||
161178328|NCT01576406|582030292|FG002|Overall Study|Lost to Follow-up|0|||
161178329|NCT01576406|582030293|FG003|Overall Study|Lost to Follow-up|0|||
161178330|NCT01576406|582030294|FG004|Overall Study|Lost to Follow-up|0|||
161178331|NCT01576406|582030295|FG005|Overall Study|Lost to Follow-up|0|||
161178332|NCT01576406|582030290|FG000|Overall Study|Death|3|||
161178333|NCT01576406|582030291|FG001|Overall Study|Death|4|||
161178334|NCT01576406|582030292|FG002|Overall Study|Death|8|||
161178335|NCT01576406|582030293|FG003|Overall Study|Death|5|||
161178336|NCT01576406|582030294|FG004|Overall Study|Death|7|||
161178337|NCT01576406|582030295|FG005|Overall Study|Death|9|||
161178338|NCT01576406|582030290|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161178339|NCT01576406|582030291|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161178340|NCT01576406|582030292|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
161178341|NCT01576406|582030293|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
161178342|NCT01576406|582030294|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161178343|NCT01576406|582030295|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
161178344|NCT01576406|582030290|FG000|Overall Study|Withdrawal the consent|2|||
161178345|NCT01576406|582030291|FG001|Overall Study|Withdrawal the consent|2|||
161178346|NCT01576406|582030292|FG002|Overall Study|Withdrawal the consent|5|||
161178347|NCT01576406|582030293|FG003|Overall Study|Withdrawal the consent|1|||
161178348|NCT01576406|582030294|FG004|Overall Study|Withdrawal the consent|1|||
161178349|NCT01576406|582030295|FG005|Overall Study|Withdrawal the consent|3|||
161178350|NCT01576406|582030290|FG000|Overall Study|Other|0|||
161297768|NCT02105987|582474053|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
161297769|NCT02105987|582474048|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
161178351|NCT01576406|582030291|FG001|Overall Study|Other|0|||
161178352|NCT01576406|582030292|FG002|Overall Study|Other|2|||
161178353|NCT01576406|582030293|FG003|Overall Study|Other|2|||
161178354|NCT01576406|582030294|FG004|Overall Study|Other|0|||
161178355|NCT01576406|582030295|FG005|Overall Study|Other|0|||
161178356|NCT01627782|582030296|FG000|Overall Study|Adverse Event|1|||
161178357|NCT01627782|582030297|FG001|Overall Study|Adverse Event|2|||
161178358|NCT01627782|582030298|FG002|Overall Study|Adverse Event|0|||
161178359|NCT01627782|582030299|FG003|Overall Study|Adverse Event|1|||
161178360|NCT01627782|582030296|FG000|Overall Study|Lack of Efficacy|11|||
161178361|NCT01627782|582030297|FG001|Overall Study|Lack of Efficacy|1|||
161178362|NCT01627782|582030298|FG002|Overall Study|Lack of Efficacy|15|||
161178363|NCT01627782|582030299|FG003|Overall Study|Lack of Efficacy|2|||
161178364|NCT01627782|582030296|FG000|Overall Study|Protocol Violation|1|||
161178365|NCT01627782|582030297|FG001|Overall Study|Protocol Violation|0|||
161178366|NCT01627782|582030298|FG002|Overall Study|Protocol Violation|0|||
161178367|NCT01627782|582030299|FG003|Overall Study|Protocol Violation|0|||
161178368|NCT01627782|582030296|FG000|Overall Study|Withdrawal by Subject|2|||
161178369|NCT01627782|582030297|FG001|Overall Study|Withdrawal by Subject|1|||
161178370|NCT01627782|582030298|FG002|Overall Study|Withdrawal by Subject|0|||
161178371|NCT01627782|582030299|FG003|Overall Study|Withdrawal by Subject|0|||
161178372|NCT01627782|582030296|FG000|Overall Study|Other|0|||
161178373|NCT01627782|582030297|FG001|Overall Study|Other|2|||
161178374|NCT01627782|582030298|FG002|Overall Study|Other|0|||
161178375|NCT01627782|582030299|FG003|Overall Study|Other|3|||
161178376|NCT01627782|582030296|FG000|Overall Study|Randomized But Not Treated|1|||
161178377|NCT01627782|582030297|FG001|Overall Study|Randomized But Not Treated|0|||
161178378|NCT01627782|582030298|FG002|Overall Study|Randomized But Not Treated|0|||
161178379|NCT01627782|582030299|FG003|Overall Study|Randomized But Not Treated|0|||
161178380|NCT03695471|582032241|FG000|Overall Study|Cancellation|1|||
161178381|NCT02859558|582032242|FG000|Step 1|Not Eligible|0|||
161178382|NCT02859558|582032243|FG001|Step 1|Not Eligible|0|||
161178383|NCT02859558|582032244|FG002|Step 1|Not Eligible|0|||
161178384|NCT02859558|582032245|FG003|Step 1|Not Eligible|0|||
161178385|NCT02859558|582032246|FG004|Step 1|Not Eligible|3|||
161178386|NCT02859558|582032242|FG000|Step 1|Lost to Follow-up|1|||
161178387|NCT02859558|582032243|FG001|Step 1|Lost to Follow-up|3|||
161178388|NCT02859558|582032244|FG002|Step 1|Lost to Follow-up|3|||
161178389|NCT02859558|582032245|FG003|Step 1|Lost to Follow-up|0|||
161178390|NCT02859558|582032246|FG004|Step 1|Lost to Follow-up|0|||
161178391|NCT02859558|582032242|FG000|Step 1|Did Not Return to Clinic|2|||
161178392|NCT02859558|582032243|FG001|Step 1|Did Not Return to Clinic|3|||
161178393|NCT02859558|582032244|FG002|Step 1|Did Not Return to Clinic|4|||
161178394|NCT02859558|582032245|FG003|Step 1|Did Not Return to Clinic|0|||
161297770|NCT02105987|582474049|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
161297771|NCT02105987|582474050|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297772|NCT02105987|582474051|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297773|NCT02105987|582474052|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297774|NCT02105987|582474053|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297775|NCT02105987|582474048|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161297776|NCT02105987|582474049|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161297777|NCT02105987|582474050|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297778|NCT02105987|582474051|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297779|NCT02105987|582474052|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297780|NCT02105987|582474053|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297781|NCT02105987|582474048|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
161297782|NCT02105987|582474049|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
161297783|NCT02105987|582474050|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161297784|NCT02105987|582474051|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161297785|NCT02105987|582474052|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161297786|NCT02105987|582474053|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
161297787|NCT02105987|582474048|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161297788|NCT02105987|582474049|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
161297789|NCT02105987|582474050|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161297790|NCT02105987|582474051|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161297791|NCT02105987|582474052|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161297792|NCT02105987|582474053|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
161347729|NCT01481779|582657353|FG001|Overall Study|Physician Decision|4|||
161347730|NCT01481779|582657352|FG000|Overall Study|Sponsor Decision|3|||
161178395|NCT02859558|582032246|FG004|Step 1|Did Not Return to Clinic|0|||
161178396|NCT02859558|582032242|FG000|Step 1|Moved|0|||
161178397|NCT02859558|582032243|FG001|Step 1|Moved|1|||
161178398|NCT02859558|582032244|FG002|Step 1|Moved|1|||
161178399|NCT02859558|582032245|FG003|Step 1|Moved|0|||
161297793|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161347731|NCT01481779|582657353|FG001|Overall Study|Sponsor Decision|1|||
161347732|NCT01922011|582657354|FG000|Overall Study|Protocol Violation|0|||
161347733|NCT01922011|582657355|FG001|Overall Study|Protocol Violation|1|||
161178400|NCT02859558|582032246|FG004|Step 1|Moved|0|||
161178401|NCT02859558|582032242|FG000|Step 1|Withdrawal By Participant|1|||
161297794|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161297795|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
161347734|NCT01922011|582657354|FG000|Overall Study|Physician Decision|0|||
161178402|NCT02859558|582032243|FG001|Step 1|Withdrawal By Participant|2|||
161178403|NCT02859558|582032244|FG002|Step 1|Withdrawal By Participant|1|||
161178404|NCT02859558|582032245|FG003|Step 1|Withdrawal By Participant|0|||
161178405|NCT02859558|582032246|FG004|Step 1|Withdrawal By Participant|0|||
161178406|NCT02859558|582032242|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
161178407|NCT02859558|582032243|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161178408|NCT02859558|582032244|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161178409|NCT02859558|582032245|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161178410|NCT02859558|582032246|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
161178411|NCT02859558|582032242|FG000|Step 1|Incarceration|0|||
161178412|NCT02859558|582032243|FG001|Step 1|Incarceration|1|||
161178413|NCT02859558|582032244|FG002|Step 1|Incarceration|0|||
161178414|NCT02859558|582032245|FG003|Step 1|Incarceration|0|||
161347735|NCT01922011|582657355|FG001|Overall Study|Physician Decision|1|||
161178415|NCT02859558|582032246|FG004|Step 1|Incarceration|0|||
161178416|NCT02859558|582032242|FG000|Step 1|Non-Adherence to Study Drug|2|||
161178417|NCT02859558|582032243|FG001|Step 1|Non-Adherence to Study Drug|0|||
161178418|NCT02859558|582032244|FG002|Step 1|Non-Adherence to Study Drug|1|||
161178419|NCT02859558|582032245|FG003|Step 1|Non-Adherence to Study Drug|0|||
161178420|NCT02859558|582032246|FG004|Step 1|Non-Adherence to Study Drug|0|||
161178421|NCT02859558|582032242|FG000|Step 1|Non-Adherence to Study Requirements|3|||
161178422|NCT02859558|582032243|FG001|Step 1|Non-Adherence to Study Requirements|1|||
161178423|NCT02859558|582032244|FG002|Step 1|Non-Adherence to Study Requirements|0|||
161178424|NCT02859558|582032245|FG003|Step 1|Non-Adherence to Study Requirements|0|||
161178425|NCT02859558|582032246|FG004|Step 1|Non-Adherence to Study Requirements|0|||
161178426|NCT02859558|582032242|FG000|Step 1|Virologic Failure|2|||
161178427|NCT02859558|582032243|FG001|Step 1|Virologic Failure|1|||
161178428|NCT02859558|582032244|FG002|Step 1|Virologic Failure|1|||
161178429|NCT02859558|582032245|FG003|Step 1|Virologic Failure|0|||
161178430|NCT02859558|582032246|FG004|Step 1|Virologic Failure|0|||
161178431|NCT02859558|582032242|FG000|Step 2|Lost to Follow-up|3|||
161178432|NCT02859558|582032243|FG001|Step 2|Lost to Follow-up|3|||
161178433|NCT02859558|582032244|FG002|Step 2|Lost to Follow-up|1|||
161178434|NCT02859558|582032245|FG003|Step 2|Lost to Follow-up|0|||
161178435|NCT02859558|582032246|FG004|Step 2|Lost to Follow-up|0|||
161178436|NCT02859558|582032242|FG000|Step 2|Withdrawal by Subject|0|||
161178437|NCT02859558|582032243|FG001|Step 2|Withdrawal by Subject|1|||
161178438|NCT02859558|582032244|FG002|Step 2|Withdrawal by Subject|1|||
161178439|NCT02859558|582032245|FG003|Step 2|Withdrawal by Subject|0|||
161178440|NCT02859558|582032246|FG004|Step 2|Withdrawal by Subject|0|||
161178441|NCT02859558|582032242|FG000|Step 2|Unexpected Closure of Site|0|||
161347736|NCT01922011|582657354|FG000|Overall Study|Parent/Guardian Decision|3|||
161347737|NCT01922011|582657355|FG001|Overall Study|Parent/Guardian Decision|0|||
161347738|NCT01922011|582657354|FG000|Overall Study|Lost to Follow-up|0|||
161347739|NCT01922011|582657355|FG001|Overall Study|Lost to Follow-up|1|||
161347740|NCT01922011|582657354|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
161178442|NCT02859558|582032243|FG001|Step 2|Unexpected Closure of Site|1|||
161178443|NCT02859558|582032244|FG002|Step 2|Unexpected Closure of Site|1|||
161178444|NCT02859558|582032245|FG003|Step 2|Unexpected Closure of Site|0|||
161178445|NCT02859558|582032246|FG004|Step 2|Unexpected Closure of Site|0|||
161178446|NCT02859558|582032242|FG000|Step 2|Death|1|||
161178447|NCT02859558|582032243|FG001|Step 2|Death|0|||
161178448|NCT02859558|582032244|FG002|Step 2|Death|0|||
161178449|NCT02859558|582032245|FG003|Step 2|Death|0|||
161178450|NCT02859558|582032246|FG004|Step 2|Death|0|||
161178451|NCT02859558|582032242|FG000|Step 2|Incarceration|0|||
161297796|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
161297797|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161297798|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
161297799|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161297800|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161297801|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
161297802|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
161178452|NCT02859558|582032243|FG001|Step 2|Incarceration|0|||
161178453|NCT02859558|582032244|FG002|Step 2|Incarceration|1|||
161178454|NCT02859558|582032245|FG003|Step 2|Incarceration|0|||
161178455|NCT02859558|582032246|FG004|Step 2|Incarceration|0|||
161297803|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161347741|NCT01922011|582657355|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
161347742|NCT01922011|582657354|FG000|Overall Study|Not Treated|1|||
161178456|NCT04507360|582032247|FG000|Week 1|Lost to Follow-up|0|||
161178457|NCT04507360|582032248|FG001|Week 1|Lost to Follow-up|0|||
161178458|NCT04507360|582032249|FG002|Week 1|Lost to Follow-up|0|||
161178459|NCT04507360|582032250|FG003|Week 1|Lost to Follow-up|0|||
161178460|NCT04507360|582032251|FG004|Week 1|Lost to Follow-up|0|||
161178461|NCT04507360|582032252|FG005|Week 1|Lost to Follow-up|0|||
161178462|NCT04507360|582032253|FG006|Week 1|Lost to Follow-up|0|||
161297804|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
161347743|NCT01922011|582657355|FG001|Overall Study|Not Treated|0|||
161178463|NCT04507360|582032254|FG007|Week 1|Lost to Follow-up|0|||
161178464|NCT04507360|582032255|FG008|Week 1|Lost to Follow-up|72|||
161178465|NCT04507360|582032256|FG009|Week 1|Lost to Follow-up|22|||
161178466|NCT04507360|582032257|FG010|Week 1|Lost to Follow-up|10|||
161178467|NCT04507360|582032247|FG000|Week 2|Lost to Follow-up|0|||
161178468|NCT04507360|582032248|FG001|Week 2|Lost to Follow-up|0|||
161178469|NCT04507360|582032249|FG002|Week 2|Lost to Follow-up|0|||
161178470|NCT04507360|582032250|FG003|Week 2|Lost to Follow-up|0|||
161178471|NCT04507360|582032251|FG004|Week 2|Lost to Follow-up|0|||
161178472|NCT04507360|582032252|FG005|Week 2|Lost to Follow-up|0|||
161178473|NCT04507360|582032253|FG006|Week 2|Lost to Follow-up|0|||
161178474|NCT04507360|582032254|FG007|Week 2|Lost to Follow-up|0|||
161178475|NCT04507360|582032255|FG008|Week 2|Lost to Follow-up|121|||
161178476|NCT04507360|582032256|FG009|Week 2|Lost to Follow-up|85|||
161178477|NCT04507360|582032257|FG010|Week 2|Lost to Follow-up|82|||
161178478|NCT04507360|582032247|FG000|Week 3|Lost to Follow-up|0|||
161178479|NCT04507360|582032248|FG001|Week 3|Lost to Follow-up|0|||
161178480|NCT04507360|582032249|FG002|Week 3|Lost to Follow-up|0|||
161178481|NCT04507360|582032250|FG003|Week 3|Lost to Follow-up|0|||
161178482|NCT04507360|582032251|FG004|Week 3|Lost to Follow-up|0|||
161178483|NCT04507360|582032252|FG005|Week 3|Lost to Follow-up|0|||
161178484|NCT04507360|582032253|FG006|Week 3|Lost to Follow-up|0|||
161178485|NCT04507360|582032254|FG007|Week 3|Lost to Follow-up|0|||
161178486|NCT04507360|582032255|FG008|Week 3|Lost to Follow-up|123|||
161178487|NCT04507360|582032256|FG009|Week 3|Lost to Follow-up|92|||
161178488|NCT04507360|582032257|FG010|Week 3|Lost to Follow-up|84|||
161178489|NCT04507360|582032247|FG000|Week 4|Lost to Follow-up|0|||
161178490|NCT04507360|582032248|FG001|Week 4|Lost to Follow-up|0|||
161178491|NCT04507360|582032249|FG002|Week 4|Lost to Follow-up|0|||
161178492|NCT04507360|582032250|FG003|Week 4|Lost to Follow-up|0|||
161178493|NCT04507360|582032251|FG004|Week 4|Lost to Follow-up|0|||
161178494|NCT04507360|582032252|FG005|Week 4|Lost to Follow-up|0|||
161178495|NCT04507360|582032253|FG006|Week 4|Lost to Follow-up|0|||
161178496|NCT04507360|582032254|FG007|Week 4|Lost to Follow-up|0|||
161178497|NCT04507360|582032255|FG008|Week 4|Lost to Follow-up|131|||
161178498|NCT04507360|582032256|FG009|Week 4|Lost to Follow-up|115|||
161178499|NCT04507360|582032257|FG010|Week 4|Lost to Follow-up|102|||
161178500|NCT04507360|582032247|FG000|Week 5|Lost to Follow-up|0|||
161178501|NCT04507360|582032248|FG001|Week 5|Lost to Follow-up|0|||
161178502|NCT04507360|582032249|FG002|Week 5|Lost to Follow-up|0|||
161178503|NCT04507360|582032250|FG003|Week 5|Lost to Follow-up|0|||
161178504|NCT04507360|582032251|FG004|Week 5|Lost to Follow-up|0|||
161178505|NCT04507360|582032252|FG005|Week 5|Lost to Follow-up|0|||
161178506|NCT04507360|582032253|FG006|Week 5|Lost to Follow-up|0|||
161178507|NCT04507360|582032254|FG007|Week 5|Lost to Follow-up|0|||
161178508|NCT04507360|582032255|FG008|Week 5|Lost to Follow-up|103|||
161178509|NCT04507360|582032256|FG009|Week 5|Lost to Follow-up|135|||
161178510|NCT04507360|582032257|FG010|Week 5|Lost to Follow-up|143|||
161178511|NCT04507360|582032247|FG000|Week 8|Lost to Follow-up|0|||
161178512|NCT04507360|582032248|FG001|Week 8|Lost to Follow-up|0|||
161178513|NCT04507360|582032249|FG002|Week 8|Lost to Follow-up|0|||
161178514|NCT04507360|582032250|FG003|Week 8|Lost to Follow-up|0|||
161178515|NCT04507360|582032251|FG004|Week 8|Lost to Follow-up|0|||
161178516|NCT04507360|582032252|FG005|Week 8|Lost to Follow-up|0|||
161178517|NCT04507360|582032253|FG006|Week 8|Lost to Follow-up|0|||
161178518|NCT04507360|582032254|FG007|Week 8|Lost to Follow-up|0|||
161178519|NCT04507360|582032255|FG008|Week 8|Lost to Follow-up|139|||
161178520|NCT04507360|582032256|FG009|Week 8|Lost to Follow-up|145|||
161178521|NCT04507360|582032257|FG010|Week 8|Lost to Follow-up|152|||
161178522|NCT00400946|582032258|FG000|Overall Study|Ineligible|0|||
161178523|NCT00400946|582032259|FG001|Overall Study|Ineligible|0|||
161178524|NCT00400946|582032260|FG002|Overall Study|Ineligible|0|||
161178525|NCT00400946|582032261|FG003|Overall Study|Ineligible|5|||
161178526|NCT00400946|582032262|FG004|Overall Study|Ineligible|1|||
161178527|NCT00400946|582032258|FG000|Overall Study|Induction Failure|0|||
161178528|NCT00400946|582032259|FG001|Overall Study|Induction Failure|0|||
161178529|NCT00400946|582032260|FG002|Overall Study|Induction Failure|0|||
161178530|NCT00400946|582032261|FG003|Overall Study|Induction Failure|11|||
161178531|NCT00400946|582032262|FG004|Overall Study|Induction Failure|8|||
161178532|NCT00400946|582032258|FG000|Overall Study|Induction Death|0|||
161178533|NCT00400946|582032259|FG001|Overall Study|Induction Death|0|||
161178534|NCT00400946|582032260|FG002|Overall Study|Induction Death|0|||
161178535|NCT00400946|582032261|FG003|Overall Study|Induction Death|13|||
161178536|NCT00400946|582032262|FG004|Overall Study|Induction Death|3|||
161178537|NCT00400946|582032258|FG000|Overall Study|Lost to Follow-up|1|||
161178538|NCT00400946|582032259|FG001|Overall Study|Lost to Follow-up|1|||
161178539|NCT00400946|582032260|FG002|Overall Study|Lost to Follow-up|0|||
161178540|NCT00400946|582032261|FG003|Overall Study|Lost to Follow-up|0|||
161178541|NCT00400946|582032262|FG004|Overall Study|Lost to Follow-up|1|||
161178542|NCT00400946|582032258|FG000|Overall Study|Remission Death|1|||
161178543|NCT00400946|582032259|FG001|Overall Study|Remission Death|1|||
161178544|NCT00400946|582032260|FG002|Overall Study|Remission Death|0|||
161178545|NCT00400946|582032261|FG003|Overall Study|Remission Death|0|||
161178546|NCT00400946|582032262|FG004|Overall Study|Remission Death|1|||
161178547|NCT00400946|582032258|FG000|Overall Study|Relapse|9|||
161178548|NCT00400946|582032259|FG001|Overall Study|Relapse|2|||
161178549|NCT00400946|582032260|FG002|Overall Study|Relapse|1|||
161178550|NCT00400946|582032261|FG003|Overall Study|Relapse|1|||
161178551|NCT00400946|582032262|FG004|Overall Study|Relapse|5|||
161178552|NCT00400946|582032258|FG000|Overall Study|Transplant in CR1|0|||
161178553|NCT00400946|582032259|FG001|Overall Study|Transplant in CR1|0|||
161178554|NCT00400946|582032260|FG002|Overall Study|Transplant in CR1|0|||
161178555|NCT00400946|582032261|FG003|Overall Study|Transplant in CR1|10|||
161178556|NCT00400946|582032262|FG004|Overall Study|Transplant in CR1|1|||
161178557|NCT00400946|582032258|FG000|Overall Study|Withdrawal by Subject|2|||
161178558|NCT00400946|582032259|FG001|Overall Study|Withdrawal by Subject|5|||
161178559|NCT00400946|582032260|FG002|Overall Study|Withdrawal by Subject|1|||
161178560|NCT00400946|582032261|FG003|Overall Study|Withdrawal by Subject|5|||
161178561|NCT00400946|582032262|FG004|Overall Study|Withdrawal by Subject|8|||
161178562|NCT00400946|582032258|FG000|Overall Study|Clinical|1|||
161178563|NCT00400946|582032259|FG001|Overall Study|Clinical|2|||
161178564|NCT00400946|582032260|FG002|Overall Study|Clinical|0|||
161178565|NCT00400946|582032261|FG003|Overall Study|Clinical|2|||
161178566|NCT00400946|582032262|FG004|Overall Study|Clinical|9|||
161178567|NCT00400946|582032258|FG000|Overall Study|Other|0|||
161178568|NCT00400946|582032259|FG001|Overall Study|Other|0|||
161178569|NCT00400946|582032260|FG002|Overall Study|Other|0|||
161178570|NCT00400946|582032261|FG003|Overall Study|Other|0|||
161178571|NCT00400946|582032262|FG004|Overall Study|Other|1|||
161178572|NCT01199198|582032268|FG000|Overall Study|Adverse Event|3|||
161178573|NCT01199198|582032269|FG001|Overall Study|Adverse Event|0|||
161178574|NCT01199198|582032268|FG000|Overall Study|Lost to Follow-up|1|||
161178575|NCT01199198|582032269|FG001|Overall Study|Lost to Follow-up|5|||
161178576|NCT01199198|582032268|FG000|Overall Study|Withdrawal by Subject|1|||
161178577|NCT01199198|582032269|FG001|Overall Study|Withdrawal by Subject|2|||
161178578|NCT01199198|582032268|FG000|Overall Study|ICU Transfer|1|||
161178579|NCT01199198|582032269|FG001|Overall Study|ICU Transfer|2|||
161178580|NCT01199198|582032268|FG000|Overall Study|Hospice-care transfer|1|||
161178581|NCT01199198|582032269|FG001|Overall Study|Hospice-care transfer|2|||
161178582|NCT04315298|582032270|FG000|Overall Study|Withdrawal by Subject|0|||
161178583|NCT04315298|582032271|FG001|Overall Study|Withdrawal by Subject|0|||
161178584|NCT04315298|582032272|FG002|Overall Study|Withdrawal by Subject|0|||
161178585|NCT04315298|582032273|FG003|Overall Study|Withdrawal by Subject|2|||
161178586|NCT04315298|582032274|FG004|Overall Study|Withdrawal by Subject|2|||
161178587|NCT04315298|582032275|FG005|Overall Study|Withdrawal by Subject|2|||
161178588|NCT04315298|582032276|FG006|Overall Study|Withdrawal by Subject|0|||
161178589|NCT04315298|582032277|FG007|Overall Study|Withdrawal by Subject|1|||
161178590|NCT04315298|582032278|FG008|Overall Study|Withdrawal by Subject|1|||
161178591|NCT04315298|582032279|FG009|Overall Study|Withdrawal by Subject|1|||
161178592|NCT04315298|582032280|FG010|Overall Study|Withdrawal by Subject|0|||
161178593|NCT04315298|582032281|FG011|Overall Study|Withdrawal by Subject|0|||
161178594|NCT04315298|582032282|FG012|Overall Study|Withdrawal by Subject|0|||
161178595|NCT04315298|582032283|FG013|Overall Study|Withdrawal by Subject|0|||
161178596|NCT04315298|582032284|FG014|Overall Study|Withdrawal by Subject|0|||
161178597|NCT04315298|582032285|FG015|Overall Study|Withdrawal by Subject|0|||
161178598|NCT04315298|582032286|FG016|Overall Study|Withdrawal by Subject|0|||
161178599|NCT04315298|582032287|FG017|Overall Study|Withdrawal by Subject|0|||
161178600|NCT04315298|582032288|FG018|Overall Study|Withdrawal by Subject|0|||
161178601|NCT04315298|582032270|FG000|Overall Study|Physician Decision|0|||
161178602|NCT04315298|582032271|FG001|Overall Study|Physician Decision|0|||
161178603|NCT04315298|582032272|FG002|Overall Study|Physician Decision|0|||
161178604|NCT04315298|582032273|FG003|Overall Study|Physician Decision|0|||
161178605|NCT04315298|582032274|FG004|Overall Study|Physician Decision|1|||
161178606|NCT04315298|582032275|FG005|Overall Study|Physician Decision|0|||
161178607|NCT04315298|582032276|FG006|Overall Study|Physician Decision|0|||
161178608|NCT04315298|582032277|FG007|Overall Study|Physician Decision|0|||
161178609|NCT04315298|582032278|FG008|Overall Study|Physician Decision|0|||
161178610|NCT04315298|582032279|FG009|Overall Study|Physician Decision|0|||
161178611|NCT04315298|582032280|FG010|Overall Study|Physician Decision|0|||
161178612|NCT04315298|582032281|FG011|Overall Study|Physician Decision|0|||
161178613|NCT04315298|582032282|FG012|Overall Study|Physician Decision|0|||
161178614|NCT04315298|582032283|FG013|Overall Study|Physician Decision|0|||
161178615|NCT04315298|582032284|FG014|Overall Study|Physician Decision|0|||
161178616|NCT04315298|582032285|FG015|Overall Study|Physician Decision|0|||
161178617|NCT04315298|582032286|FG016|Overall Study|Physician Decision|0|||
161178618|NCT04315298|582032287|FG017|Overall Study|Physician Decision|0|||
161178619|NCT04315298|582032288|FG018|Overall Study|Physician Decision|0|||
161178620|NCT04315298|582032270|FG000|Overall Study|Lost to Follow-up|5|||
161178621|NCT04315298|582032271|FG001|Overall Study|Lost to Follow-up|10|||
161178622|NCT04315298|582032272|FG002|Overall Study|Lost to Follow-up|6|||
161178623|NCT04315298|582032273|FG003|Overall Study|Lost to Follow-up|8|||
161178624|NCT04315298|582032274|FG004|Overall Study|Lost to Follow-up|12|||
161178625|NCT04315298|582032275|FG005|Overall Study|Lost to Follow-up|13|||
161178626|NCT04315298|582032276|FG006|Overall Study|Lost to Follow-up|9|||
161178627|NCT04315298|582032277|FG007|Overall Study|Lost to Follow-up|16|||
161178628|NCT04315298|582032278|FG008|Overall Study|Lost to Follow-up|14|||
161178629|NCT04315298|582032279|FG009|Overall Study|Lost to Follow-up|0|||
161178630|NCT04315298|582032280|FG010|Overall Study|Lost to Follow-up|2|||
161178631|NCT04315298|582032281|FG011|Overall Study|Lost to Follow-up|1|||
161178632|NCT04315298|582032282|FG012|Overall Study|Lost to Follow-up|0|||
161178633|NCT04315298|582032283|FG013|Overall Study|Lost to Follow-up|0|||
161178634|NCT04315298|582032284|FG014|Overall Study|Lost to Follow-up|0|||
161178635|NCT04315298|582032285|FG015|Overall Study|Lost to Follow-up|2|||
161178636|NCT04315298|582032286|FG016|Overall Study|Lost to Follow-up|0|||
161297805|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161088483|NCT02781844|581715178|FG000|Treatment Period 1|Adverse Event|0|||
161088484|NCT02781844|581715179|FG001|Treatment Period 1|Adverse Event|0|||
161088485|NCT02781844|581715180|FG002|Treatment Period 1|Adverse Event|0|||
161088486|NCT02781844|581715181|FG003|Treatment Period 1|Adverse Event|0|||
161088487|NCT02781844|581715182|FG004|Treatment Period 1|Adverse Event|0|||
161088488|NCT02781844|581715183|FG005|Treatment Period 1|Adverse Event|1|||
161088489|NCT02781844|581715184|FG006|Treatment Period 1|Adverse Event|0|||
161088490|NCT02781844|581715185|FG007|Treatment Period 1|Adverse Event|0|||
161088491|NCT04256629|581715188|FG000|Overall Study|Adverse Event|0|||
161088492|NCT04256629|581715189|FG001|Overall Study|Adverse Event|0|||
161088493|NCT04256629|581715190|FG002|Overall Study|Adverse Event|0|||
161088494|NCT04256629|581715191|FG003|Overall Study|Adverse Event|0|||
161088495|NCT04256629|581715192|FG004|Overall Study|Adverse Event|0|||
161088496|NCT04256629|581715193|FG005|Overall Study|Adverse Event|1|||
161088497|NCT04256629|581715188|FG000|Overall Study|Protocol Violation|0|||
161088498|NCT04256629|581715189|FG001|Overall Study|Protocol Violation|1|||
161088499|NCT04256629|581715190|FG002|Overall Study|Protocol Violation|0|||
161088500|NCT04256629|581715191|FG003|Overall Study|Protocol Violation|0|||
161088501|NCT04256629|581715192|FG004|Overall Study|Protocol Violation|0|||
161088502|NCT04256629|581715193|FG005|Overall Study|Protocol Violation|0|||
161088503|NCT00321373|581715194|FG000|Overall Study|Adverse Event|0|||
161088504|NCT00321373|581715195|FG001|Overall Study|Adverse Event|0|||
161088505|NCT00321373|581715196|FG002|Overall Study|Adverse Event|1|||
161088506|NCT00321373|581715194|FG000|Overall Study|Lost to Follow-up|1|||
161088507|NCT00321373|581715195|FG001|Overall Study|Lost to Follow-up|0|||
161088508|NCT00321373|581715196|FG002|Overall Study|Lost to Follow-up|1|||
161088509|NCT00321373|581715194|FG000|Overall Study|Withdrawal by Subject|1|||
161088510|NCT00321373|581715195|FG001|Overall Study|Withdrawal by Subject|0|||
161088511|NCT00321373|581715196|FG002|Overall Study|Withdrawal by Subject|0|||
161088512|NCT00321373|581715194|FG000|Overall Study|Other|0|||
161088513|NCT00321373|581715195|FG001|Overall Study|Other|0|||
161088514|NCT00321373|581715196|FG002|Overall Study|Other|1|||
161088515|NCT01774487|581715197|FG000|Overall Study|Did not tolerate taste|4|||
161088516|NCT01774487|581715198|FG001|Overall Study|Did not tolerate taste|4|||
161088517|NCT00477334|581715202|FG000|Overall Study|Discontinued prior to taking study drug|106|||
161088518|NCT00477334|581715203|FG001|Overall Study|Discontinued prior to taking study drug|53|||
161088519|NCT00477334|581715202|FG000|Overall Study|Adverse Event|1|||
161088520|NCT00477334|581715203|FG001|Overall Study|Adverse Event|2|||
161088521|NCT00477334|581715202|FG000|Overall Study|Withdrawal by Subject|2|||
161088522|NCT00477334|581715203|FG001|Overall Study|Withdrawal by Subject|1|||
161088523|NCT00477334|581715202|FG000|Overall Study|Lost to Follow-up|15|||
161088524|NCT00477334|581715203|FG001|Overall Study|Lost to Follow-up|4|||
161088525|NCT00477334|581715202|FG000|Overall Study|Administrative Problems|39|||
161088526|NCT00477334|581715203|FG001|Overall Study|Administrative Problems|15|||
161088527|NCT00477334|581715202|FG000|Overall Study|Protocol Violation|7|||
161088528|NCT00477334|581715203|FG001|Overall Study|Protocol Violation|1|||
161088529|NCT04275089|581715204|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
161088530|NCT01014143|581715208|FG000|Second Intervention|Lost to Follow-up|2|||
161088531|NCT01014143|581715209|FG001|Second Intervention|Lost to Follow-up|0|||
161088532|NCT01014143|581715210|FG002|Second Intervention|Lost to Follow-up|0|||
161088533|NCT02354508|581715211|FG000|Period 1: Core Phase|Adverse Event|1|||
161088534|NCT02354508|581715212|FG001|Period 1: Core Phase|Adverse Event|1|||
161088535|NCT02354508|581715213|FG002|Period 1: Core Phase|Adverse Event|2|||
161088536|NCT02354508|581715211|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
161088537|NCT02354508|581715212|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
161088538|NCT02354508|581715213|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
161088539|NCT02354508|581715211|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
161088540|NCT02354508|581715212|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
161088541|NCT02354508|581715213|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
161088542|NCT02354508|581715211|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
161088543|NCT02354508|581715212|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
161088544|NCT02354508|581715213|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
161088545|NCT02354508|581715211|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
161088546|NCT02354508|581715212|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
161088547|NCT02354508|581715213|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
161088548|NCT02354508|581715211|FG000|Period 2: Extension Phase|Physician Decision|5|||
161088549|NCT02354508|581715212|FG001|Period 2: Extension Phase|Physician Decision|0|||
161088550|NCT02354508|581715213|FG002|Period 2: Extension Phase|Physician Decision|1|||
161088551|NCT02354508|581715211|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
161088552|NCT02354508|581715212|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
161088553|NCT02354508|581715213|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
161088554|NCT02354508|581715211|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
161088555|NCT02354508|581715212|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
161178637|NCT04315298|582032287|FG017|Overall Study|Lost to Follow-up|0|||
161178638|NCT04315298|582032288|FG018|Overall Study|Lost to Follow-up|0|||
161178639|NCT04315298|582032270|FG000|Overall Study|Death|24|||
161178640|NCT04315298|582032271|FG001|Overall Study|Death|60|||
161178641|NCT04315298|582032272|FG002|Overall Study|Death|49|||
161178642|NCT04315298|582032273|FG003|Overall Study|Death|59|||
161178643|NCT04315298|582032274|FG004|Overall Study|Death|70|||
161178644|NCT04315298|582032275|FG005|Overall Study|Death|114|||
161297806|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297807|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
161297808|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
161297809|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297810|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
161297811|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297812|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297813|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
161297814|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
161297815|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297816|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
161297817|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161297818|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161297819|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
161297820|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161297821|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161297822|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
161297823|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161297824|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161178645|NCT04315298|582032276|FG006|Overall Study|Death|9|||
161178646|NCT04315298|582032277|FG007|Overall Study|Death|12|||
161178647|NCT04315298|582032278|FG008|Overall Study|Death|21|||
161178648|NCT04315298|582032279|FG009|Overall Study|Death|16|||
161178649|NCT04315298|582032280|FG010|Overall Study|Death|40|||
161178650|NCT04315298|582032281|FG011|Overall Study|Death|40|||
161178651|NCT04315298|582032282|FG012|Overall Study|Death|3|||
161178652|NCT04315298|582032283|FG013|Overall Study|Death|4|||
161178653|NCT04315298|582032284|FG014|Overall Study|Death|6|||
161178654|NCT04315298|582032285|FG015|Overall Study|Death|4|||
161178655|NCT04315298|582032286|FG016|Overall Study|Death|3|||
161178656|NCT04315298|582032287|FG017|Overall Study|Death|1|||
161178657|NCT04315298|582032288|FG018|Overall Study|Death|0|||
161178658|NCT00736385|582032289|FG000|Overall Study|Withdrawal by Subject|2|||
161178659|NCT00736385|582032290|FG001|Overall Study|Withdrawal by Subject|2|||
161178660|NCT00736385|582032289|FG000|Overall Study|Adverse Event|0|||
161178661|NCT00736385|582032290|FG001|Overall Study|Adverse Event|1|||
161178662|NCT00098865|582032291|FG000|Overall Study|Progressive Disease|6|||
161178663|NCT00098865|582032291|FG000|Overall Study|Adverse Event|2|||
161178664|NCT00098865|582032291|FG000|Overall Study|Alternative Therapy|1|||
161178665|NCT03267511|582032292|FG000|Overall Study|Lost to Follow-up|0|||
161178666|NCT03267511|582032293|FG001|Overall Study|Lost to Follow-up|0|||
161178667|NCT03267511|582032294|FG002|Overall Study|Lost to Follow-up|0|||
161178668|NCT03267511|582032295|FG003|Overall Study|Lost to Follow-up|1|||
161178669|NCT03050307|582032298|FG000|Overall Study|Adverse Event|4|||
161178670|NCT03050307|582032299|FG001|Overall Study|Adverse Event|2|||
161178671|NCT03050307|582032298|FG000|Overall Study|Significant Protocol Deviation|0|||
161178672|NCT03050307|582032299|FG001|Overall Study|Significant Protocol Deviation|1|||
161178673|NCT03050307|582032298|FG000|Overall Study|Lost to Follow-up|0|||
161178674|NCT03050307|582032299|FG001|Overall Study|Lost to Follow-up|1|||
161178675|NCT03050307|582032298|FG000|Overall Study|Voluntary Withdrawal|3|||
161297825|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161297826|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
161297827|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161297828|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
161297829|NCT02105987|582474048|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161297830|NCT02105987|582474049|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161178676|NCT03050307|582032299|FG001|Overall Study|Voluntary Withdrawal|4|||
161178677|NCT03050307|582032298|FG000|Overall Study|Reason not Specified|1|||
161178678|NCT03050307|582032299|FG001|Overall Study|Reason not Specified|1|||
161178679|NCT00653068|582032300|FG000|Overall Study|Death|9|||
161178680|NCT00653068|582032300|FG000|Overall Study|Lack of Efficacy|34|||
161178681|NCT00653068|582032300|FG000|Overall Study|Physician Decision|4|||
161178682|NCT00653068|582032300|FG000|Overall Study|Withdrawal by Subject|1|||
161178683|NCT00653068|582032300|FG000|Overall Study|Ineligible|2|||
161178684|NCT03950440|582032301|FG000|Overall Study|Death|8|||
161178685|NCT03950440|582032302|FG001|Overall Study|Death|2|||
161178686|NCT03950440|582032303|FG002|Overall Study|Death|1|||
161178687|NCT02892734|582032304|FG000|Treatment on Study|Progressive Disease|2|||
161088556|NCT02354508|581715213|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
161088557|NCT02354508|581715211|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
161088558|NCT02354508|581715212|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
161088559|NCT02354508|581715213|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
161088560|NCT00461032|581715216|FG000|Overall Study|Adverse Event|5|||
161088561|NCT00461032|581715217|FG001|Overall Study|Adverse Event|6|||
161088562|NCT00461032|581715216|FG000|Overall Study|Lack of Efficacy|5|||
161088563|NCT00461032|581715217|FG001|Overall Study|Lack of Efficacy|1|||
161088564|NCT00461032|581715216|FG000|Overall Study|Lost to Follow-up|7|||
161088565|NCT00461032|581715217|FG001|Overall Study|Lost to Follow-up|12|||
161088566|NCT00461032|581715216|FG000|Overall Study|Protocol Violation|4|||
161088567|NCT00461032|581715217|FG001|Overall Study|Protocol Violation|4|||
161088568|NCT00461032|581715216|FG000|Overall Study|Withdrawal by Subject|7|||
161088569|NCT00461032|581715217|FG001|Overall Study|Withdrawal by Subject|15|||
161088570|NCT00461032|581715216|FG000|Overall Study|Patient Moved or Relocated|2|||
161088571|NCT00461032|581715217|FG001|Overall Study|Patient Moved or Relocated|1|||
161088572|NCT00461032|581715216|FG000|Overall Study|Other|7|||
161088573|NCT00461032|581715217|FG001|Overall Study|Other|5|||
161088574|NCT01878214|581715221|FG000|Overall Study|Withdrawal by Subject|18|||
161088575|NCT01878214|581715222|FG001|Overall Study|Withdrawal by Subject|7|||
161088576|NCT01878214|581715221|FG000|Overall Study|Death|0|||
161088577|NCT01878214|581715222|FG001|Overall Study|Death|1|||
161088578|NCT01878214|581715221|FG000|Overall Study|Lost to Follow-up|35|||
161088579|NCT01878214|581715222|FG001|Overall Study|Lost to Follow-up|36|||
161088580|NCT03038438|581715223|FG000|Overall Study|Death|3|||
161088581|NCT03038438|581715223|FG000|Overall Study|Lost to Follow-up|8|||
161088582|NCT03038438|581715223|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
161088583|NCT03038438|581715223|FG000|Overall Study|Withdrawal by Subject|5|||
161088584|NCT03038438|581715223|FG000|Overall Study|No 36-Month Follow-Up|18|||
161088585|NCT01174160|581715224|FG000|Overall Study|Adverse Event|1|||
161088586|NCT01174160|581715225|FG001|Overall Study|Adverse Event|0|||
161088587|NCT01174160|581715224|FG000|Overall Study|Lost to Follow-up|1|||
161088588|NCT01174160|581715225|FG001|Overall Study|Lost to Follow-up|0|||
161088589|NCT01174160|581715224|FG000|Overall Study|Physician Decision|1|||
161088590|NCT01174160|581715225|FG001|Overall Study|Physician Decision|0|||
161088591|NCT01174160|581715224|FG000|Overall Study|Protocol Violation|4|||
161088592|NCT01174160|581715225|FG001|Overall Study|Protocol Violation|6|||
161088593|NCT01174160|581715224|FG000|Overall Study|Withdrawal by Subject|1|||
161088594|NCT01174160|581715225|FG001|Overall Study|Withdrawal by Subject|0|||
161088595|NCT02038543|581715228|FG000|Overall Study|Screen Failure|0|||
161088596|NCT02038543|581715229|FG001|Overall Study|Screen Failure|0|||
161088597|NCT02038543|581715230|FG002|Overall Study|Screen Failure|0|||
161088598|NCT02038543|581715231|FG003|Overall Study|Screen Failure|1|||
161088599|NCT02038543|581715228|FG000|Overall Study|Withdrawal by Subject|0|||
161088600|NCT02038543|581715229|FG001|Overall Study|Withdrawal by Subject|0|||
161088601|NCT02038543|581715230|FG002|Overall Study|Withdrawal by Subject|0|||
161088602|NCT02038543|581715231|FG003|Overall Study|Withdrawal by Subject|1|||
161088603|NCT00093808|581715232|FG000|Overall Study|Cancel participation before receiving tx|1|||
161088604|NCT00093808|581715232|FG000|Overall Study|Protocol Violation|1|||
161088605|NCT02647866|581715233|FG000|Overall Study|Adverse Event|0|||
161088606|NCT02647866|581715234|FG001|Overall Study|Adverse Event|0|||
161088607|NCT02647866|581715235|FG002|Overall Study|Adverse Event|2|||
161088608|NCT02647866|581715236|FG003|Overall Study|Adverse Event|2|||
161088609|NCT02647866|581715237|FG004|Overall Study|Adverse Event|1|||
161088610|NCT02647866|581715233|FG000|Overall Study|Disease Worsening|3|||
161088611|NCT02647866|581715234|FG001|Overall Study|Disease Worsening|1|||
161088612|NCT02647866|581715235|FG002|Overall Study|Disease Worsening|0|||
161088613|NCT02647866|581715236|FG003|Overall Study|Disease Worsening|0|||
161088614|NCT02647866|581715237|FG004|Overall Study|Disease Worsening|1|||
161088615|NCT02647866|581715233|FG000|Overall Study|Withdrawal by Subject|1|||
161088616|NCT02647866|581715234|FG001|Overall Study|Withdrawal by Subject|1|||
161088617|NCT02647866|581715235|FG002|Overall Study|Withdrawal by Subject|2|||
161088618|NCT02647866|581715236|FG003|Overall Study|Withdrawal by Subject|4|||
161088619|NCT02647866|581715237|FG004|Overall Study|Withdrawal by Subject|4|||
161088620|NCT02647866|581715233|FG000|Overall Study|Physician Decision|0|||
161088621|NCT02647866|581715234|FG001|Overall Study|Physician Decision|1|||
161178688|NCT02892734|582032304|FG000|Follow up for 2 Years|Death|2|||
161178689|NCT02892734|582032304|FG000|Follow up for 2 Years|Study closed early|1|||
161088622|NCT02647866|581715235|FG002|Overall Study|Physician Decision|1|||
161088623|NCT02647866|581715236|FG003|Overall Study|Physician Decision|0|||
161088624|NCT02647866|581715237|FG004|Overall Study|Physician Decision|2|||
161088625|NCT02647866|581715233|FG000|Overall Study|Death|0|||
161088626|NCT02647866|581715234|FG001|Overall Study|Death|1|||
161088627|NCT02647866|581715235|FG002|Overall Study|Death|0|||
161088628|NCT02647866|581715236|FG003|Overall Study|Death|0|||
161088629|NCT02647866|581715237|FG004|Overall Study|Death|0|||
161088630|NCT02647866|581715233|FG000|Overall Study|Subject moved to different country|1|||
161088631|NCT02647866|581715234|FG001|Overall Study|Subject moved to different country|0|||
161178690|NCT00439309|582032305|FG000|Follow-Up|Death|1|||
161178691|NCT00439309|582032306|FG001|Follow-Up|Death|0|||
161178692|NCT00439309|582032305|FG000|Follow-Up|Lost to Follow-up|2|||
161178693|NCT00439309|582032306|FG001|Follow-Up|Lost to Follow-up|0|||
161178694|NCT00439309|582032305|FG000|Follow-Up|Withdrawal by Subject|0|||
161178695|NCT00439309|582032306|FG001|Follow-Up|Withdrawal by Subject|1|||
161178696|NCT00439309|582032305|FG000|Follow-Up|Late response by subject|0|||
161178697|NCT00439309|582032306|FG001|Follow-Up|Late response by subject|1|||
161178698|NCT02043509|582032307|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
161178699|NCT02043509|582032308|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
161178700|NCT02043509|582032307|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
161178701|NCT02043509|582032308|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
161178702|NCT02043509|582032307|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
161178703|NCT02043509|582032308|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
161178704|NCT02043509|582032307|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
161178705|NCT02043509|582032308|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
161178706|NCT00608244|582032309|FG000|Overall Study|Adverse Event|1|||
161178707|NCT00608244|582032309|FG000|Overall Study|Low trough levels|1|||
161178708|NCT00430027|582032310|FG000|Overall Study|Study terminated|8|||
161178709|NCT01685060|582032313|FG000|Overall Study|Rollover patients|16|||
161178710|NCT01685060|582032313|FG000|Overall Study|Adverse Event|12|||
161178711|NCT01685060|582032313|FG000|Overall Study|Progressive disease|69|||
161178712|NCT01685060|582032313|FG000|Overall Study|Physician Decision|14|||
161178713|NCT01685060|582032313|FG000|Overall Study|Subject/guardian decision|20|||
161178714|NCT01685060|582032313|FG000|Overall Study|Lost to Follow-up|1|||
161178715|NCT01685060|582032313|FG000|Overall Study|Death|8|||
161178716|NCT02000219|582032314|FG000|14-Week Study Period|Physician Decision|1|||
161178717|NCT02000219|582032314|FG000|14-Week Study Period|Adverse Event|1|||
161178718|NCT02000219|582032314|FG000|14-Week Study Period|Underwent transplantation|1|||
161178719|NCT02000219|582032314|FG000|Continuation Period|Withdrawal by Subject|1|||
161178720|NCT02000219|582032314|FG000|Continuation Period|Had liver transplant|2|||
161178721|NCT02000219|582032314|FG000|Continuation Period|Non-compliance with study drug|2|||
161178722|NCT00464620|582032315|FG000|Overall Study|Physician Decision|1|||
161178723|NCT00464620|582032316|FG001|Overall Study|Physician Decision|0|||
161178724|NCT00464620|582032317|FG002|Overall Study|Physician Decision|0|||
161178725|NCT00464620|582032315|FG000|Overall Study|Withdrawal by Subject|1|||
161178726|NCT00464620|582032316|FG001|Overall Study|Withdrawal by Subject|0|||
161178727|NCT00464620|582032317|FG002|Overall Study|Withdrawal by Subject|3|||
161178728|NCT00464620|582032315|FG000|Overall Study|Ineligible sarcoma subtype|0|||
161178729|NCT00464620|582032316|FG001|Overall Study|Ineligible sarcoma subtype|2|||
161178730|NCT00464620|582032317|FG002|Overall Study|Ineligible sarcoma subtype|2|||
161178731|NCT00464620|582032315|FG000|Overall Study|Use of prohibited concomitant medication|0|||
161178732|NCT00464620|582032316|FG001|Overall Study|Use of prohibited concomitant medication|0|||
161178733|NCT00464620|582032317|FG002|Overall Study|Use of prohibited concomitant medication|2|||
161178734|NCT01998906|582032318|FG000|Overall Study|Participants ongoing in follow-up|77|||
161178735|NCT01998906|582032319|FG001|Overall Study|Participants ongoing in follow-up|60|||
161178736|NCT01998906|582032320|FG002|Overall Study|Participants ongoing in follow-up|58|||
161178737|NCT01998906|582032318|FG000|Overall Study|Death|21|||
161178738|NCT01998906|582032319|FG001|Overall Study|Death|30|||
161178739|NCT01998906|582032320|FG002|Overall Study|Death|17|||
161178740|NCT01998906|582032318|FG000|Overall Study|Lack of Efficacy|10|||
161178741|NCT01998906|582032319|FG001|Overall Study|Lack of Efficacy|9|||
161178742|NCT01998906|582032320|FG002|Overall Study|Lack of Efficacy|8|||
161178743|NCT01998906|582032318|FG000|Overall Study|Failure to return|0|||
161178744|NCT01998906|582032319|FG001|Overall Study|Failure to return|2|||
161178745|NCT01998906|582032320|FG002|Overall Study|Failure to return|4|||
161178746|NCT01998906|582032318|FG000|Overall Study|Violation of Selection Criteria|0|||
161178747|NCT01998906|582032319|FG001|Overall Study|Violation of Selection Criteria|0|||
161178748|NCT01998906|582032320|FG002|Overall Study|Violation of Selection Criteria|1|||
161178749|NCT01998906|582032318|FG000|Overall Study|Withdrawal by Subject|1|||
161178750|NCT01998906|582032319|FG001|Overall Study|Withdrawal by Subject|4|||
161178751|NCT01998906|582032320|FG002|Overall Study|Withdrawal by Subject|3|||
161178752|NCT01998906|582032318|FG000|Overall Study|Administrative/Other|2|||
161178753|NCT01998906|582032319|FG001|Overall Study|Administrative/Other|1|||
161178754|NCT01998906|582032320|FG002|Overall Study|Administrative/Other|3|||
161178755|NCT01998906|582032318|FG000|Overall Study|Other|3|||
161178756|NCT01998906|582032319|FG001|Overall Study|Other|8|||
161178757|NCT01998906|582032320|FG002|Overall Study|Other|4|||
161178758|NCT01572844|582032321|FG000|Overall Study|Physician Decision|1|||
161178759|NCT01572844|582032322|FG001|Overall Study|Physician Decision|1|||
161178760|NCT02809118|582032325|FG000|Overall Study|Withdrawal by Subject|0|||
161178761|NCT02809118|582032326|FG001|Overall Study|Withdrawal by Subject|1|||
161178762|NCT02809118|582032327|FG002|Overall Study|Withdrawal by Subject|1|||
161178763|NCT06048809|582032336|FG000|Overall Study|Adverse Event|2|||
161178764|NCT06048809|582032337|FG001|Overall Study|Adverse Event|0|||
161178765|NCT06048809|582032336|FG000|Overall Study|Withdrawal by Subject|1|||
161178766|NCT06048809|582032337|FG001|Overall Study|Withdrawal by Subject|1|||
161178767|NCT02158728|582032338|FG000|Overall Study|no procedure according to CIP done|3|||
161178768|NCT02158728|582032338|FG000|Overall Study|no qualified dataset|24|||
161178769|NCT02658149|582032351|FG000|Overall Study|Physician Decision|1|||
161178770|NCT02658149|582032352|FG001|Overall Study|Physician Decision|0|||
161178771|NCT01680991|582032355|FG000|Overall Study|Adverse Event|1|||
161178772|NCT01680991|582032356|FG001|Overall Study|Adverse Event|0|||
161178773|NCT01680991|582032357|FG002|Overall Study|Adverse Event|0|||
161178774|NCT01680991|582032355|FG000|Overall Study|Death|1|||
161178775|NCT01680991|582032356|FG001|Overall Study|Death|0|||
161178776|NCT01680991|582032357|FG002|Overall Study|Death|1|||
161178777|NCT01680991|582032355|FG000|Overall Study|Protocol Violation|0|||
161178778|NCT01680991|582032356|FG001|Overall Study|Protocol Violation|1|||
161178779|NCT01680991|582032357|FG002|Overall Study|Protocol Violation|0|||
161178780|NCT01680991|582032355|FG000|Overall Study|Withdrawal by Subject|5|||
161178781|NCT01680991|582032356|FG001|Overall Study|Withdrawal by Subject|1|||
161178782|NCT01680991|582032357|FG002|Overall Study|Withdrawal by Subject|0|||
161178783|NCT01680991|582032355|FG000|Overall Study|Progressive disease (PD)|0|||
161178784|NCT01680991|582032356|FG001|Overall Study|Progressive disease (PD)|10|||
161178785|NCT01680991|582032357|FG002|Overall Study|Progressive disease (PD)|0|||
161178786|NCT01680991|582032355|FG000|Overall Study|Physician Decision|0|||
161178787|NCT01680991|582032356|FG001|Overall Study|Physician Decision|7|||
161178788|NCT01680991|582032357|FG002|Overall Study|Physician Decision|2|||
161178789|NCT01680991|582032355|FG000|Overall Study|Bad physical condition|0|||
161178790|NCT01680991|582032356|FG001|Overall Study|Bad physical condition|0|||
161178791|NCT01680991|582032357|FG002|Overall Study|Bad physical condition|1|||
161178792|NCT01680991|582032355|FG000|Overall Study|PD confirmed in other hospital|1|||
161178793|NCT01680991|582032356|FG001|Overall Study|PD confirmed in other hospital|0|||
161178794|NCT01680991|582032357|FG002|Overall Study|PD confirmed in other hospital|0|||
161178795|NCT04097028|582032358|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
161178796|NCT04097028|582032358|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
161178797|NCT04097028|582032358|FG000|Overall Study|Disease Progression prior to Surgery|2|||
161178798|NCT04097028|582032358|FG000|Overall Study|Adverse Event prior to Surgery|1|||
161178799|NCT01156363|582032359|FG000|Overall Study|Adverse Event|6|||
161178800|NCT01156363|582032359|FG000|Overall Study|Insufficient Therapeutic Response|5|||
161178801|NCT01156363|582032359|FG000|Overall Study|Failure to Return|1|||
161178802|NCT01156363|582032359|FG000|Overall Study|Refused Treatment|4|||
161178803|NCT01156363|582032359|FG000|Overall Study|Other|6|||
161178804|NCT03745989|582032361|FG000|Overall Study|Death|3|||
161178805|NCT03745989|582032362|FG001|Overall Study|Death|7|||
161178806|NCT03745989|582032363|FG002|Overall Study|Death|4|||
161178807|NCT03745989|582032361|FG000|Overall Study|Lost to Follow-up|0|||
161178808|NCT03745989|582032362|FG001|Overall Study|Lost to Follow-up|2|||
161178809|NCT03745989|582032363|FG002|Overall Study|Lost to Follow-up|0|||
161178810|NCT03745989|582032361|FG000|Overall Study|Sponsor Decision|0|||
161178811|NCT03745989|582032362|FG001|Overall Study|Sponsor Decision|2|||
161178812|NCT03745989|582032363|FG002|Overall Study|Sponsor Decision|8|||
161178813|NCT03745989|582032361|FG000|Overall Study|Withdrawal by Subject|0|||
161178814|NCT03745989|582032362|FG001|Overall Study|Withdrawal by Subject|1|||
161178815|NCT03745989|582032363|FG002|Overall Study|Withdrawal by Subject|3|||
161178816|NCT02728206|582032365|FG000|Overall Study|Death|1|||
161178817|NCT00735072|582032370|FG000|Overall Study|interrupted study med during ARV change|1|||
161178818|NCT00735072|582032371|FG001|Overall Study|interrupted study med during ARV change|0|||
161178819|NCT00735072|582032370|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
161178820|NCT00735072|582032371|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
161178821|NCT00911144|582032372|FG000|Overall Study|Withdrawal by Subject|16|||
161178822|NCT00911144|582032373|FG001|Overall Study|Withdrawal by Subject|5|||
161178823|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
161178824|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
161178825|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
161178826|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
161178827|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
161178828|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
161178829|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
161178830|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
161178831|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
161178832|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
161178833|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
161178834|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
161178835|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
161178836|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
161178837|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
161178838|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
161178839|NCT01291511|582032374|FG000|Cross-Titration and Stabilization Phase|Death|1|||
161178840|NCT01291511|582032375|FG001|Cross-Titration and Stabilization Phase|Death|0|||
161178841|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
161178842|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
161178843|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
161178844|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
161178845|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
161178846|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
161178847|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
161178848|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
161178849|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
161178850|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
161178851|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
161178852|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
161178853|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
161178854|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
161178855|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
161178856|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
161178857|NCT01291511|582032374|FG000|Double-blind Relapse Prevention Phase|Death|1|||
161178858|NCT01291511|582032375|FG001|Double-blind Relapse Prevention Phase|Death|0|||
161178859|NCT00047008|582032377|FG000|Overall Study|Withdrawn consent|2|||
161178860|NCT00047008|582032378|FG001|Overall Study|Withdrawn consent|3|||
161178861|NCT00047008|582032377|FG000|Overall Study|Ineligible|9|||
161178862|NCT00047008|582032378|FG001|Overall Study|Ineligible|8|||
161178863|NCT00429572|582032379|FG000|Overall Study|Disease progression|1|||
161178864|NCT02773368|582032382|FG000|Overall Study|Lost to Follow-up|4|||
161178865|NCT02773368|582032383|FG001|Overall Study|Lost to Follow-up|1|||
161178866|NCT02773368|582032382|FG000|Overall Study|Withdrawal by Subject|5|||
161178867|NCT02773368|582032383|FG001|Overall Study|Withdrawal by Subject|1|||
161178868|NCT02773368|582032382|FG000|Overall Study|Unclassified|1|||
161178869|NCT02773368|582032383|FG001|Overall Study|Unclassified|1|||
161178870|NCT02773368|582032382|FG000|Overall Study|Missing|0|||
161178871|NCT02773368|582032383|FG001|Overall Study|Missing|1|||
161178872|NCT01929018|582032384|FG000|Overall Study|Lost to Follow-up|1|||
161178873|NCT01929018|582032385|FG001|Overall Study|Lost to Follow-up|0|||
161178874|NCT01929018|582032384|FG000|Overall Study|Hospitalization|0|||
161178875|NCT01929018|582032385|FG001|Overall Study|Hospitalization|1|||
161178876|NCT01047436|582032387|FG000|Overall Study|Protocol Violation|1|||
161178877|NCT01047436|582032388|FG001|Overall Study|Protocol Violation|0|||
161178878|NCT02635867|582032391|FG000|Overall Study|Lost to Follow-up|4|||
161178879|NCT02635867|582032392|FG001|Overall Study|Lost to Follow-up|3|||
161178880|NCT02635867|582032393|FG002|Overall Study|Lost to Follow-up|3|||
161178881|NCT02635867|582032394|FG003|Overall Study|Lost to Follow-up|4|||
161178882|NCT02635867|582032395|FG004|Overall Study|Lost to Follow-up|1|||
161178883|NCT02565576|582032398|FG000|Overall Study|abnormal lab value|2|||
161178884|NCT02565576|582032399|FG001|Overall Study|abnormal lab value|0|||
161178885|NCT02565576|582032398|FG000|Overall Study|subject / guardian decision|1|||
161178886|NCT02565576|582032399|FG001|Overall Study|subject / guardian decision|3|||
161178887|NCT02565576|582032398|FG000|Overall Study|Lost to Follow-up|1|||
161178888|NCT02565576|582032399|FG001|Overall Study|Lost to Follow-up|0|||
161178889|NCT02565576|582032398|FG000|Overall Study|Death|0|||
161178890|NCT02565576|582032399|FG001|Overall Study|Death|2|||
161178891|NCT02565576|582032398|FG000|Overall Study|Adverse Event|1|||
161178892|NCT02565576|582032399|FG001|Overall Study|Adverse Event|0|||
161178893|NCT01266070|582032400|FG000|Overall Study|Adverse Event|3|||
161178894|NCT01266070|582032400|FG000|Overall Study|Protocol Violation|1|||
161178895|NCT00939341|582032401|FG000|Overall Study|Adverse Event|15|||
161178896|NCT00939341|582032401|FG000|Overall Study|Pregnancy|1|||
161178897|NCT00939341|582032401|FG000|Overall Study|Lost to Follow-up|23|||
161178898|NCT00939341|582032401|FG000|Overall Study|Withdrawal by Subject|13|||
161178899|NCT00939341|582032401|FG000|Overall Study|Protocol Violation|6|||
161178900|NCT00939341|582032401|FG000|Overall Study|Incorrect enrolment|8|||
161178901|NCT00764322|582032403|FG000|Overall Study|Withdrawal by Subject|11|||
161178902|NCT00764322|582032403|FG000|Overall Study|No CYP2D6 genotyping|9|||
161178903|NCT00796003|582032404|FG000|Overall Study|Disease Progression|2|||
161178904|NCT00796003|582032405|FG001|Overall Study|Disease Progression|13|||
161178905|NCT00796003|582032404|FG000|Overall Study|Adverse Event|1|||
161178906|NCT00796003|582032405|FG001|Overall Study|Adverse Event|7|||
161178907|NCT00796003|582032404|FG000|Overall Study|Specified organ function not met|0|||
161178908|NCT00796003|582032405|FG001|Overall Study|Specified organ function not met|1|||
161178909|NCT00796003|582032404|FG000|Overall Study|Physician Decision|0|||
161178910|NCT00796003|582032405|FG001|Overall Study|Physician Decision|4|||
161178911|NCT00796003|582032404|FG000|Overall Study|Withdrawal by Subject|0|||
161178912|NCT00796003|582032405|FG001|Overall Study|Withdrawal by Subject|1|||
161178913|NCT00796003|582032404|FG000|Overall Study|Other|0|||
161178914|NCT00796003|582032405|FG001|Overall Study|Other|1|||
161178915|NCT00796003|582032404|FG000|Overall Study|Participants Not treated|0|||
161178916|NCT00796003|582032405|FG001|Overall Study|Participants Not treated|2|||
161178917|NCT01131130|582032407|FG000|Period 1 - Baseline|Pregnancy|1|||
161178918|NCT01131130|582032407|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
161178919|NCT02417064|582032408|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
161178920|NCT02417064|582032409|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
161178921|NCT02417064|582032410|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
161178922|NCT02417064|582032408|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161178923|NCT02417064|582032409|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161178924|NCT02417064|582032410|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
161178925|NCT02417064|582032408|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161178926|NCT02417064|582032409|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
161178927|NCT02417064|582032410|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161178928|NCT02417064|582032408|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
161178929|NCT02417064|582032409|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161178930|NCT02417064|582032410|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161178931|NCT02417064|582032408|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161178932|NCT02417064|582032409|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
161178933|NCT02417064|582032410|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161178934|NCT02417064|582032408|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
161178935|NCT02417064|582032409|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
161178936|NCT02417064|582032410|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
161178937|NCT02417064|582032408|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
161178938|NCT02417064|582032409|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
161178939|NCT02417064|582032410|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
161178940|NCT02417064|582032408|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
161178941|NCT02417064|582032409|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
161178942|NCT02417064|582032410|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
161178943|NCT02417064|582032408|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
161178944|NCT02417064|582032409|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
161178945|NCT02417064|582032410|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
161178946|NCT02417064|582032408|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
161178947|NCT02417064|582032409|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
161297831|NCT02105987|582474050|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
161297832|NCT02105987|582474051|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161297833|NCT02105987|582474052|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161297834|NCT02105987|582474053|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
161297835|NCT02105987|582474048|FG000|Continuation Phase|Protocol Violation|0|||
161297836|NCT02105987|582474049|FG001|Continuation Phase|Protocol Violation|0|||
161297837|NCT02105987|582474050|FG002|Continuation Phase|Protocol Violation|0|||
161297838|NCT02105987|582474051|FG003|Continuation Phase|Protocol Violation|0|||
161297839|NCT02105987|582474052|FG004|Continuation Phase|Protocol Violation|1|||
161297840|NCT02105987|582474053|FG005|Continuation Phase|Protocol Violation|0|||
161297841|NCT02418949|582474060|FG000|Overall Study|Withdrawal by Subject|1|||
161178948|NCT02417064|582032410|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
161178949|NCT02417064|582032408|FG000|Follow-up Phase (24 Weeks)|Other|2|||
161178950|NCT02417064|582032409|FG001|Follow-up Phase (24 Weeks)|Other|2|||
161178951|NCT02417064|582032410|FG002|Follow-up Phase (24 Weeks)|Other|3|||
161178952|NCT01782885|582032412|FG000|Overall Study|Lost to Follow-up|4|||
161178953|NCT01782885|582032413|FG001|Overall Study|Lost to Follow-up|6|||
161297842|NCT02418949|582474061|FG001|Overall Study|Withdrawal by Subject|0|||
161297843|NCT02418949|582474062|FG002|Overall Study|Withdrawal by Subject|1|||
161297844|NCT02418949|582474063|FG003|Overall Study|Withdrawal by Subject|1|||
161297845|NCT02418949|582474060|FG000|Overall Study|Lost to Follow-up|1|||
161297846|NCT02418949|582474061|FG001|Overall Study|Lost to Follow-up|0|||
161297847|NCT02418949|582474062|FG002|Overall Study|Lost to Follow-up|1|||
161297848|NCT02418949|582474063|FG003|Overall Study|Lost to Follow-up|0|||
161297849|NCT02418949|582474060|FG000|Overall Study|Physician Decision|1|||
161297850|NCT02418949|582474061|FG001|Overall Study|Physician Decision|1|||
161297851|NCT02418949|582474062|FG002|Overall Study|Physician Decision|1|||
161297852|NCT02418949|582474063|FG003|Overall Study|Physician Decision|0|||
161297853|NCT00396656|582474069|FG000|First Treatment Period|Withdrawal by Subject|0|||
161297854|NCT00396656|582474070|FG001|First Treatment Period|Withdrawal by Subject|2|||
161297855|NCT00396656|582474069|FG000|Second Treatment Period|Adverse Event|0|||
161297856|NCT00396656|582474070|FG001|Second Treatment Period|Adverse Event|1|||
161297857|NCT02343939|582474071|FG000|Overall Study|Death|0|||
161297858|NCT02343939|582474072|FG001|Overall Study|Death|15|||
161297859|NCT02343939|582474073|FG002|Overall Study|Death|4|||
161297860|NCT02343939|582474074|FG003|Overall Study|Death|2|||
161297861|NCT02343939|582474075|FG004|Overall Study|Death|5|||
161297862|NCT02343939|582474076|FG005|Overall Study|Death|11|||
161297863|NCT02343939|582474077|FG006|Overall Study|Death|8|||
161297864|NCT02343939|582474078|FG007|Overall Study|Death|22|||
161297865|NCT02343939|582474079|FG008|Overall Study|Death|1|||
161297866|NCT02343939|582474071|FG000|Overall Study|Study terminated by sponsor|0|||
161178954|NCT01929707|582032420|FG000|Intervention Period 1|Lost to Follow-up|0|||
161178955|NCT01929707|582032421|FG001|Intervention Period 1|Lost to Follow-up|0|||
161178956|NCT01929707|582032422|FG002|Intervention Period 1|Lost to Follow-up|0|||
161178957|NCT01929707|582032423|FG003|Intervention Period 1|Lost to Follow-up|1|||
161178958|NCT01929707|582032424|FG004|Intervention Period 1|Lost to Follow-up|0|||
161178959|NCT01929707|582032425|FG005|Intervention Period 1|Lost to Follow-up|0|||
161178960|NCT01929707|582032426|FG006|Intervention Period 1|Lost to Follow-up|0|||
161178961|NCT01929707|582032427|FG007|Intervention Period 1|Lost to Follow-up|0|||
161178962|NCT01929707|582032420|FG000|Intervention Period 1|Withdrawal by Subject|0|||
161178963|NCT01929707|582032421|FG001|Intervention Period 1|Withdrawal by Subject|0|||
161178964|NCT01929707|582032422|FG002|Intervention Period 1|Withdrawal by Subject|0|||
161178965|NCT01929707|582032423|FG003|Intervention Period 1|Withdrawal by Subject|2|||
161178966|NCT01929707|582032424|FG004|Intervention Period 1|Withdrawal by Subject|0|||
161178967|NCT01929707|582032425|FG005|Intervention Period 1|Withdrawal by Subject|0|||
161178968|NCT01929707|582032426|FG006|Intervention Period 1|Withdrawal by Subject|0|||
161178969|NCT01929707|582032427|FG007|Intervention Period 1|Withdrawal by Subject|0|||
161178970|NCT01929707|582032420|FG000|Intervention Period 2|Withdrawal by Subject|0|||
161178971|NCT01929707|582032421|FG001|Intervention Period 2|Withdrawal by Subject|0|||
161178972|NCT01929707|582032422|FG002|Intervention Period 2|Withdrawal by Subject|0|||
161178973|NCT01929707|582032423|FG003|Intervention Period 2|Withdrawal by Subject|0|||
161178974|NCT01929707|582032424|FG004|Intervention Period 2|Withdrawal by Subject|0|||
161178975|NCT01929707|582032425|FG005|Intervention Period 2|Withdrawal by Subject|2|||
161178976|NCT01929707|582032426|FG006|Intervention Period 2|Withdrawal by Subject|0|||
161178977|NCT01929707|582032427|FG007|Intervention Period 2|Withdrawal by Subject|0|||
161178978|NCT02896192|582032437|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
161178979|NCT02896192|582032437|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
161178980|NCT02896192|582032437|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
161178981|NCT01997281|582032438|FG000|Overall Study|Withdrawal by Subject|1|||
161178982|NCT01997281|582032439|FG001|Overall Study|Withdrawal by Subject|0|||
161178983|NCT00981682|582032440|FG000|Overall Study|Adverse Event|48|||
161178984|NCT00981682|582032440|FG000|Overall Study|Withdrawal by Subject|52|||
161178985|NCT00981682|582032440|FG000|Overall Study|Lost to Follow-up|14|||
161178986|NCT00981682|582032440|FG000|Overall Study|Lack of Efficacy|13|||
161178987|NCT00981682|582032440|FG000|Overall Study|Protocol Violation|6|||
161178988|NCT00981682|582032440|FG000|Overall Study|administrative|9|||
161297867|NCT02343939|582474072|FG001|Overall Study|Study terminated by sponsor|27|||
161297868|NCT02343939|582474073|FG002|Overall Study|Study terminated by sponsor|0|||
161297869|NCT02343939|582474074|FG003|Overall Study|Study terminated by sponsor|1|||
161297870|NCT02343939|582474075|FG004|Overall Study|Study terminated by sponsor|1|||
161297871|NCT02343939|582474076|FG005|Overall Study|Study terminated by sponsor|5|||
161297872|NCT02343939|582474077|FG006|Overall Study|Study terminated by sponsor|3|||
161297873|NCT02343939|582474078|FG007|Overall Study|Study terminated by sponsor|4|||
161297874|NCT02343939|582474079|FG008|Overall Study|Study terminated by sponsor|0|||
161297875|NCT02343939|582474071|FG000|Overall Study|Withdrew consent|3|||
161297876|NCT02343939|582474072|FG001|Overall Study|Withdrew consent|6|||
161297877|NCT02343939|582474073|FG002|Overall Study|Withdrew consent|1|||
161297878|NCT02343939|582474074|FG003|Overall Study|Withdrew consent|2|||
161297879|NCT02343939|582474075|FG004|Overall Study|Withdrew consent|2|||
161297880|NCT02343939|582474076|FG005|Overall Study|Withdrew consent|0|||
161297881|NCT02343939|582474077|FG006|Overall Study|Withdrew consent|0|||
161297882|NCT02343939|582474078|FG007|Overall Study|Withdrew consent|8|||
161297883|NCT02343939|582474079|FG008|Overall Study|Withdrew consent|6|||
161297884|NCT02343939|582474071|FG000|Overall Study|Treatment failure|0|||
161297885|NCT02343939|582474072|FG001|Overall Study|Treatment failure|0|||
161297886|NCT02343939|582474073|FG002|Overall Study|Treatment failure|0|||
161297887|NCT02343939|582474074|FG003|Overall Study|Treatment failure|0|||
161297888|NCT02343939|582474075|FG004|Overall Study|Treatment failure|0|||
161297889|NCT02343939|582474076|FG005|Overall Study|Treatment failure|0|||
161297890|NCT02343939|582474077|FG006|Overall Study|Treatment failure|2|||
161297891|NCT02343939|582474078|FG007|Overall Study|Treatment failure|1|||
161297892|NCT02343939|582474079|FG008|Overall Study|Treatment failure|0|||
161297893|NCT02343939|582474071|FG000|Overall Study|Investigator's discretion|0|||
161297894|NCT02343939|582474072|FG001|Overall Study|Investigator's discretion|0|||
161297895|NCT02343939|582474073|FG002|Overall Study|Investigator's discretion|0|||
161297896|NCT02343939|582474074|FG003|Overall Study|Investigator's discretion|1|||
161297897|NCT02343939|582474075|FG004|Overall Study|Investigator's discretion|0|||
161297898|NCT02343939|582474076|FG005|Overall Study|Investigator's discretion|0|||
161297899|NCT02343939|582474077|FG006|Overall Study|Investigator's discretion|1|||
161297900|NCT02343939|582474078|FG007|Overall Study|Investigator's discretion|0|||
161297901|NCT02343939|582474079|FG008|Overall Study|Investigator's discretion|0|||
161297902|NCT02343939|582474071|FG000|Overall Study|Adverse Event|0|||
161297903|NCT02343939|582474072|FG001|Overall Study|Adverse Event|0|||
161297904|NCT02343939|582474073|FG002|Overall Study|Adverse Event|0|||
161297905|NCT02343939|582474074|FG003|Overall Study|Adverse Event|0|||
161297906|NCT02343939|582474075|FG004|Overall Study|Adverse Event|0|||
161297907|NCT02343939|582474076|FG005|Overall Study|Adverse Event|1|||
161178989|NCT01004159|582034264|FG000|Overall Study|Adverse Event|2|||
161178990|NCT01004159|582034264|FG000|Overall Study|Disease Progression|18|||
161178991|NCT02204410|582034265|FG000|Overall Study|Lost to Follow-up|5|||
161178992|NCT02204410|582034265|FG000|Overall Study|Physician Decision|2|||
161178993|NCT02204410|582034265|FG000|Overall Study|Protocol Violation|1|||
161178994|NCT02204410|582034265|FG000|Overall Study|Withdrawal by Subject|3|||
161178995|NCT01536418|582034277|FG000|Overall Study|Protocol Violation|2|||
161178996|NCT01536418|582034278|FG001|Overall Study|Protocol Violation|3|||
161178997|NCT01536418|582034277|FG000|Overall Study|Physician Decision|1|||
161178998|NCT01536418|582034278|FG001|Overall Study|Physician Decision|3|||
161178999|NCT01536418|582034277|FG000|Overall Study|Study closed/terminated|41|||
161179000|NCT01536418|582034278|FG001|Overall Study|Study closed/terminated|37|||
161179001|NCT01536418|582034277|FG000|Overall Study|Lack of Efficacy|10|||
161179002|NCT01536418|582034278|FG001|Overall Study|Lack of Efficacy|16|||
161179003|NCT01536418|582034277|FG000|Overall Study|Adverse Event|9|||
161179004|NCT01536418|582034278|FG001|Overall Study|Adverse Event|4|||
161179005|NCT01536418|582034277|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
161179006|NCT01536418|582034278|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
161179007|NCT01536418|582034277|FG000|Overall Study|Withdrawal by Subject|5|||
161179008|NCT01536418|582034278|FG001|Overall Study|Withdrawal by Subject|3|||
161179009|NCT00711412|582034285|FG000|Induction Treatment|Death|2|||
161179010|NCT00711412|582034285|FG000|Induction Treatment|Adverse Event|1|||
161179011|NCT00711412|582034285|FG000|Induction Treatment|Other|1|||
161179012|NCT00711412|582034285|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
161179013|NCT00711412|582034285|FG000|Evaluated for Combination Treatment|Death|1|||
161179014|NCT00711412|582034285|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
161179015|NCT00711412|582034285|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
161297908|NCT02343939|582474077|FG006|Overall Study|Adverse Event|0|||
161297909|NCT02343939|582474078|FG007|Overall Study|Adverse Event|0|||
161297910|NCT02343939|582474079|FG008|Overall Study|Adverse Event|0|||
161297911|NCT02343939|582474071|FG000|Overall Study|Never Treated With ENTO|0|||
161297912|NCT02343939|582474072|FG001|Overall Study|Never Treated With ENTO|0|||
161297913|NCT02343939|582474073|FG002|Overall Study|Never Treated With ENTO|0|||
161297914|NCT02343939|582474074|FG003|Overall Study|Never Treated With ENTO|0|||
161297915|NCT02343939|582474075|FG004|Overall Study|Never Treated With ENTO|0|||
161297916|NCT02343939|582474076|FG005|Overall Study|Never Treated With ENTO|0|||
161297917|NCT02343939|582474077|FG006|Overall Study|Never Treated With ENTO|1|||
161297918|NCT02343939|582474078|FG007|Overall Study|Never Treated With ENTO|2|||
161297919|NCT02343939|582474079|FG008|Overall Study|Never Treated With ENTO|0|||
161297920|NCT01303172|582474080|FG000|Overall Study|Physician Decision|9|||
161297921|NCT01303172|582474081|FG001|Overall Study|Physician Decision|6|||
161297922|NCT01303172|582474080|FG000|Overall Study|Adverse Event|5|||
161297923|NCT01303172|582474081|FG001|Overall Study|Adverse Event|2|||
161297924|NCT01303172|582474080|FG000|Overall Study|Withdrawal by Subject|4|||
161297925|NCT01303172|582474081|FG001|Overall Study|Withdrawal by Subject|2|||
161297926|NCT01303172|582474080|FG000|Overall Study|Death|20|||
161297927|NCT01303172|582474081|FG001|Overall Study|Death|7|||
161297928|NCT01303172|582474080|FG000|Overall Study|Lack of Efficacy|25|||
161297929|NCT01303172|582474081|FG001|Overall Study|Lack of Efficacy|17|||
161297930|NCT02684097|582474082|FG000|Overall Study|Lack of Efficacy|13|||
161297931|NCT02684097|582474083|FG001|Overall Study|Lack of Efficacy|6|||
161297932|NCT00462709|582474084|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
161297933|NCT00462709|582474084|FG000|Overall Study|Lost to Follow-up|10|||
161297934|NCT00462709|582474084|FG000|Overall Study|Withdrawal by Subject|8|||
161297935|NCT00462709|582474084|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
161297936|NCT00462709|582474084|FG000|Overall Study|Death|2|||
161297937|NCT00462709|582474084|FG000|Overall Study|Logistical reasons|2|||
161297938|NCT00462709|582474084|FG000|Overall Study|Physician Decision|1|||
161297939|NCT00462709|582474084|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
161297940|NCT02099110|582474089|FG000|Overall Study|Protocol Violation|2|||
161297941|NCT02099110|582474090|FG001|Overall Study|Protocol Violation|1|||
161297942|NCT02099110|582474091|FG002|Overall Study|Protocol Violation|0|||
161297943|NCT02099110|582474092|FG003|Overall Study|Protocol Violation|3|||
161297944|NCT02099110|582474093|FG004|Overall Study|Protocol Violation|1|||
161297945|NCT02099110|582474089|FG000|Overall Study|Participant moved|1|||
161297946|NCT02099110|582474090|FG001|Overall Study|Participant moved|1|||
161297947|NCT02099110|582474091|FG002|Overall Study|Participant moved|1|||
161297948|NCT02099110|582474092|FG003|Overall Study|Participant moved|0|||
161297949|NCT02099110|582474093|FG004|Overall Study|Participant moved|2|||
161297950|NCT02099110|582474089|FG000|Overall Study|Withdrawal by Subject|7|||
161297951|NCT02099110|582474090|FG001|Overall Study|Withdrawal by Subject|11|||
161297952|NCT02099110|582474091|FG002|Overall Study|Withdrawal by Subject|13|||
161297953|NCT02099110|582474092|FG003|Overall Study|Withdrawal by Subject|9|||
161297954|NCT02099110|582474093|FG004|Overall Study|Withdrawal by Subject|13|||
161297955|NCT02099110|582474089|FG000|Overall Study|Adverse Event|3|||
161297956|NCT02099110|582474090|FG001|Overall Study|Adverse Event|5|||
161297957|NCT02099110|582474091|FG002|Overall Study|Adverse Event|2|||
161297958|NCT02099110|582474092|FG003|Overall Study|Adverse Event|3|||
161179016|NCT00711412|582034285|FG000|Combination Treatment|Progressive Disease|1|||
161179017|NCT00711412|582034285|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
161179018|NCT00711412|582034285|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
161179019|NCT00711412|582034285|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
161179020|NCT00711412|582034285|FG000|Evaluation for Response and Surgery|Death|1|||
161179021|NCT00711412|582034285|FG000|Survival Follow up Until Death|Other|12|||
161179022|NCT02234050|582034288|FG000|Overall Study|Lack of Efficacy|38|||
161179023|NCT02234050|582034289|FG001|Overall Study|Lack of Efficacy|22|||
161179024|NCT02234050|582034288|FG000|Overall Study|Adverse Event|13|||
161179025|NCT02234050|582034289|FG001|Overall Study|Adverse Event|1|||
161179026|NCT02234050|582034288|FG000|Overall Study|Withdrawal by Subject|4|||
161179027|NCT02234050|582034289|FG001|Overall Study|Withdrawal by Subject|2|||
161179028|NCT02234050|582034288|FG000|Overall Study|Sponsor's decision|6|||
161179029|NCT02234050|582034289|FG001|Overall Study|Sponsor's decision|0|||
161179030|NCT02473289|582034290|FG000|Overall Study|Adverse Event|2|||
161179031|NCT02473289|582034291|FG001|Overall Study|Adverse Event|3|||
161179032|NCT02473289|582034290|FG000|Overall Study|Lost to Follow-up|1|||
161179033|NCT02473289|582034291|FG001|Overall Study|Lost to Follow-up|1|||
161179034|NCT02473289|582034290|FG000|Overall Study|Protocol Violation|0|||
161179035|NCT02473289|582034291|FG001|Overall Study|Protocol Violation|1|||
161179036|NCT02473289|582034290|FG000|Overall Study|Withdrawal of consent|6|||
161179037|NCT02473289|582034291|FG001|Overall Study|Withdrawal of consent|7|||
161179038|NCT02473289|582034290|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
161179039|NCT02473289|582034291|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
161179040|NCT02473289|582034290|FG000|Overall Study|Other|2|||
161179041|NCT02473289|582034291|FG001|Overall Study|Other|0|||
161179042|NCT02244619|582034292|FG000|Overall Study|Did not receive study intervention|8|||
161179043|NCT02244619|582034293|FG001|Overall Study|Did not receive study intervention|21|||
161179044|NCT03285490|582034294|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
161179045|NCT03285490|582034295|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
161179046|NCT03285490|582034294|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
161179047|NCT03285490|582034295|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
161179048|NCT00068822|582034296|FG000|First Randomized Intervention|Lost to Follow-up|1|||
161179049|NCT00068822|582034297|FG001|First Randomized Intervention|Lost to Follow-up|2|||
161179050|NCT00424099|582034298|FG000|Overall Study|Adverse Event|0|||
161179051|NCT00424099|582034299|FG001|Overall Study|Adverse Event|1|||
161179052|NCT00424099|582034300|FG002|Overall Study|Adverse Event|1|||
161179053|NCT00424099|582034301|FG003|Overall Study|Adverse Event|0|||
161179054|NCT00424099|582034298|FG000|Overall Study|Death|0|||
161179055|NCT00424099|582034299|FG001|Overall Study|Death|1|||
161179056|NCT00424099|582034300|FG002|Overall Study|Death|0|||
161179057|NCT00424099|582034301|FG003|Overall Study|Death|0|||
161179058|NCT00424099|582034298|FG000|Overall Study|Illness|2|||
161179059|NCT00424099|582034299|FG001|Overall Study|Illness|0|||
161179060|NCT00424099|582034300|FG002|Overall Study|Illness|1|||
161179061|NCT00424099|582034301|FG003|Overall Study|Illness|4|||
161179062|NCT00424099|582034298|FG000|Overall Study|Lost to Follow-up|0|||
161179063|NCT00424099|582034299|FG001|Overall Study|Lost to Follow-up|0|||
161179064|NCT00424099|582034300|FG002|Overall Study|Lost to Follow-up|3|||
161179065|NCT00424099|582034301|FG003|Overall Study|Lost to Follow-up|0|||
161179066|NCT00424099|582034298|FG000|Overall Study|Hospitalized|1|||
161179067|NCT00424099|582034299|FG001|Overall Study|Hospitalized|2|||
161179068|NCT00424099|582034300|FG002|Overall Study|Hospitalized|1|||
161179069|NCT00424099|582034301|FG003|Overall Study|Hospitalized|3|||
161179070|NCT00424099|582034298|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
161179071|NCT00424099|582034299|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
161179072|NCT00424099|582034300|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
161179073|NCT00424099|582034301|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
161179074|NCT00424099|582034298|FG000|Overall Study|Withdrawal by Subject|1|||
161179075|NCT00424099|582034299|FG001|Overall Study|Withdrawal by Subject|9|||
161179076|NCT00424099|582034300|FG002|Overall Study|Withdrawal by Subject|4|||
161179077|NCT00424099|582034301|FG003|Overall Study|Withdrawal by Subject|6|||
161179078|NCT00424099|582034298|FG000|Overall Study|Physician Decision|0|||
161179079|NCT00424099|582034299|FG001|Overall Study|Physician Decision|0|||
161179080|NCT00424099|582034300|FG002|Overall Study|Physician Decision|1|||
161179081|NCT00424099|582034301|FG003|Overall Study|Physician Decision|0|||
161179082|NCT00424099|582034298|FG000|Overall Study|Missing|0|||
161179083|NCT00424099|582034299|FG001|Overall Study|Missing|0|||
161179084|NCT00424099|582034300|FG002|Overall Study|Missing|1|||
161179085|NCT00424099|582034301|FG003|Overall Study|Missing|0|||
161179086|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
161179087|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
161179088|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161179089|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161179090|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
161179091|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161179092|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
161179093|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161179094|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161179095|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
161179096|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161179097|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
161179098|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161179099|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161179100|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
161179101|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
161179102|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
161179103|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161179104|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161179105|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
161179106|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
161179107|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
161179108|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161179109|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161179110|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
161179111|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
161179112|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
161179113|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161179114|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161179115|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
161179116|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
161179117|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
161179118|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161179119|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161179120|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
161179121|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
161179122|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
161179123|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161179124|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161179125|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
161179126|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
161179127|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
161179128|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161179129|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161179130|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
161179131|NCT03689972|582034302|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
161179132|NCT03689972|582034303|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
161179133|NCT03689972|582034304|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161179134|NCT03689972|582034305|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161179135|NCT03689972|582034306|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
161179136|NCT03689972|582034302|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161179137|NCT03689972|582034303|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161179138|NCT03689972|582034304|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
161179139|NCT03689972|582034305|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161179140|NCT03689972|582034306|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
161179141|NCT03689972|582034302|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161179142|NCT03689972|582034303|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161179143|NCT03689972|582034304|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
161179144|NCT03689972|582034305|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161179145|NCT03689972|582034306|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
161179146|NCT03689972|582034302|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161297959|NCT02099110|582474093|FG004|Overall Study|Adverse Event|2|||
161179147|NCT03689972|582034303|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161179148|NCT03689972|582034304|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
161179149|NCT03689972|582034305|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161297960|NCT02099110|582474089|FG000|Overall Study|Lost to Follow-up|6|||
161297961|NCT02099110|582474090|FG001|Overall Study|Lost to Follow-up|12|||
161179150|NCT03689972|582034306|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
161179151|NCT03689972|582034302|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161179152|NCT03689972|582034303|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161297962|NCT02099110|582474091|FG002|Overall Study|Lost to Follow-up|11|||
161297963|NCT02099110|582474092|FG003|Overall Study|Lost to Follow-up|5|||
161179153|NCT03689972|582034304|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
161179154|NCT03689972|582034305|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
161179155|NCT03689972|582034306|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
161179156|NCT03689972|582034302|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161179157|NCT03689972|582034303|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161179158|NCT03689972|582034304|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
161179159|NCT03689972|582034305|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
161179160|NCT03689972|582034306|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
161179161|NCT03689972|582034302|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161179162|NCT03689972|582034303|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161179163|NCT03689972|582034304|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
161179164|NCT03689972|582034305|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
161179165|NCT03689972|582034306|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
161179166|NCT03689972|582034302|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161179167|NCT03689972|582034303|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161179168|NCT03689972|582034304|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161179169|NCT03689972|582034305|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
161179170|NCT03689972|582034306|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
161179171|NCT03689972|582034302|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161179172|NCT03689972|582034303|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161179173|NCT03689972|582034304|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
161179174|NCT03689972|582034305|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
161179175|NCT03689972|582034306|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
161179176|NCT03689972|582034302|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161179177|NCT03689972|582034303|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161179178|NCT03689972|582034304|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161179179|NCT03689972|582034305|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
161179180|NCT03689972|582034306|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
161179181|NCT02437162|582034307|FG000|Overall Study|Protocol Violation|0|||
161179182|NCT02437162|582034308|FG001|Overall Study|Protocol Violation|1|||
161179183|NCT02437162|582034309|FG002|Overall Study|Protocol Violation|0|||
161179184|NCT02437162|582034307|FG000|Overall Study|Randomized but not treated|0|||
161179185|NCT02437162|582034308|FG001|Overall Study|Randomized but not treated|0|||
161179186|NCT02437162|582034309|FG002|Overall Study|Randomized but not treated|1|||
161179187|NCT02437162|582034307|FG000|Overall Study|Study discontinued by Sponsor|93|||
161179188|NCT02437162|582034308|FG001|Overall Study|Study discontinued by Sponsor|98|||
161179189|NCT02437162|582034309|FG002|Overall Study|Study discontinued by Sponsor|97|||
161179190|NCT02437162|582034307|FG000|Overall Study|Withdrawal by Subject|13|||
161179191|NCT02437162|582034308|FG001|Overall Study|Withdrawal by Subject|7|||
161179192|NCT02437162|582034309|FG002|Overall Study|Withdrawal by Subject|9|||
161179193|NCT02437162|582034307|FG000|Overall Study|Adverse Event|0|||
161179194|NCT02437162|582034308|FG001|Overall Study|Adverse Event|1|||
161179195|NCT02437162|582034309|FG002|Overall Study|Adverse Event|0|||
161179196|NCT02437162|582034307|FG000|Overall Study|Lost to Follow-up|1|||
161179197|NCT02437162|582034308|FG001|Overall Study|Lost to Follow-up|0|||
161179198|NCT02437162|582034309|FG002|Overall Study|Lost to Follow-up|1|||
161179199|NCT02437162|582034307|FG000|Overall Study|Death|0|||
161179200|NCT02437162|582034308|FG001|Overall Study|Death|1|||
161179201|NCT02437162|582034309|FG002|Overall Study|Death|0|||
161179202|NCT02437162|582034307|FG000|Overall Study|Other|0|||
161179203|NCT02437162|582034308|FG001|Overall Study|Other|0|||
161179204|NCT02437162|582034309|FG002|Overall Study|Other|1|||
161179205|NCT03981744|582034314|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161179206|NCT03981744|582034315|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
161179207|NCT03981744|582034316|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161179208|NCT03981744|582034317|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
161179209|NCT03981744|582034314|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161179210|NCT03981744|582034315|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161179211|NCT03981744|582034316|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
161179212|NCT03981744|582034317|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
161179213|NCT03981744|582034314|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161179214|NCT03981744|582034315|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161179215|NCT03981744|582034316|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
161179216|NCT03981744|582034317|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
161179217|NCT04338321|582034318|FG000|Overall Study|Adverse Event|4|||
161179218|NCT04338321|582034319|FG001|Overall Study|Adverse Event|10|||
161297964|NCT02099110|582474093|FG004|Overall Study|Lost to Follow-up|6|||
161179219|NCT04338321|582034318|FG000|Overall Study|Death|1|||
161179220|NCT04338321|582034319|FG001|Overall Study|Death|1|||
161179221|NCT04338321|582034318|FG000|Overall Study|Lost to Follow-up|4|||
161179222|NCT04338321|582034319|FG001|Overall Study|Lost to Follow-up|9|||
161179223|NCT04338321|582034318|FG000|Overall Study|Withdrawal by Subject|45|||
161179224|NCT04338321|582034319|FG001|Overall Study|Withdrawal by Subject|69|||
161179225|NCT04338321|582034318|FG000|Overall Study|Physician Decision|5|||
161179226|NCT04338321|582034319|FG001|Overall Study|Physician Decision|9|||
161179227|NCT04338321|582034318|FG000|Overall Study|Other|3|||
161179228|NCT04338321|582034319|FG001|Overall Study|Other|10|||
161179229|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
161179230|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
161179231|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
161179232|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
161179233|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
161179234|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
161179235|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
161179236|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
161179237|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
161179238|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
161179239|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
161179240|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
161179241|NCT03321526|582034320|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
161179242|NCT03321526|582034321|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
161179243|NCT03321526|582034320|FG000|Follow-up Phase (2 Weeks)|Other|24|||
161179244|NCT03321526|582034321|FG001|Follow-up Phase (2 Weeks)|Other|24|||
161179245|NCT03097133|582034322|FG000|Overall Study|Lost to Follow-up|3|||
161179246|NCT03097133|582034323|FG001|Overall Study|Lost to Follow-up|2|||
161179247|NCT03097133|582034322|FG000|Overall Study|Withdrawal by Subject|2|||
161179248|NCT03097133|582034323|FG001|Overall Study|Withdrawal by Subject|5|||
161179249|NCT03097133|582034322|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
161179250|NCT03097133|582034323|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
161179251|NCT03097133|582034322|FG000|Overall Study|Other|3|||
161179252|NCT03097133|582034323|FG001|Overall Study|Other|2|||
161179253|NCT03097133|582034322|FG000|Overall Study|Adverse Event|1|||
161179254|NCT03097133|582034323|FG001|Overall Study|Adverse Event|0|||
161179255|NCT01989572|582034326|FG000|Overall Study|Lack of Efficacy|35|||
161179256|NCT01989572|582034327|FG001|Overall Study|Lack of Efficacy|48|||
161179257|NCT01989572|582034328|FG002|Overall Study|Lack of Efficacy|48|||
161179258|NCT01989572|582034329|FG003|Overall Study|Lack of Efficacy|43|||
161179259|NCT01989572|582034330|FG004|Overall Study|Lack of Efficacy|71|||
161179260|NCT01989572|582034331|FG005|Overall Study|Lack of Efficacy|79|||
161179261|NCT01989572|582034326|FG000|Overall Study|Adverse Event|2|||
161179262|NCT01989572|582034327|FG001|Overall Study|Adverse Event|1|||
161179263|NCT01989572|582034328|FG002|Overall Study|Adverse Event|3|||
161179264|NCT01989572|582034329|FG003|Overall Study|Adverse Event|0|||
161179265|NCT01989572|582034330|FG004|Overall Study|Adverse Event|3|||
161179266|NCT01989572|582034331|FG005|Overall Study|Adverse Event|0|||
161179267|NCT01989572|582034326|FG000|Overall Study|Death|0|||
161179268|NCT01989572|582034327|FG001|Overall Study|Death|0|||
161179269|NCT01989572|582034328|FG002|Overall Study|Death|0|||
161179270|NCT01989572|582034329|FG003|Overall Study|Death|0|||
161179271|NCT01989572|582034330|FG004|Overall Study|Death|1|||
161179272|NCT01989572|582034331|FG005|Overall Study|Death|0|||
161179273|NCT01989572|582034326|FG000|Overall Study|Withdrawal by Subject|4|||
161179274|NCT01989572|582034327|FG001|Overall Study|Withdrawal by Subject|1|||
161179275|NCT01989572|582034328|FG002|Overall Study|Withdrawal by Subject|5|||
161179276|NCT01989572|582034329|FG003|Overall Study|Withdrawal by Subject|1|||
161179277|NCT01989572|582034330|FG004|Overall Study|Withdrawal by Subject|12|||
161179278|NCT01989572|582034331|FG005|Overall Study|Withdrawal by Subject|4|||
161179279|NCT01989572|582034326|FG000|Overall Study|complicating disease|1|||
161179280|NCT01989572|582034327|FG001|Overall Study|complicating disease|1|||
161179281|NCT01989572|582034328|FG002|Overall Study|complicating disease|2|||
161179282|NCT01989572|582034329|FG003|Overall Study|complicating disease|0|||
161179283|NCT01989572|582034330|FG004|Overall Study|complicating disease|1|||
161347744|NCT01922011|582657354|FG000|Overall Study|Lack of willing home health agency|1|||
161347745|NCT01922011|582657355|FG001|Overall Study|Lack of willing home health agency|0|||
161179284|NCT01989572|582034331|FG005|Overall Study|complicating disease|0|||
161179285|NCT01989572|582034326|FG000|Overall Study|error|2|||
161179286|NCT01989572|582034327|FG001|Overall Study|error|1|||
161179287|NCT01989572|582034328|FG002|Overall Study|error|1|||
161179288|NCT01989572|582034329|FG003|Overall Study|error|1|||
161179289|NCT01989572|582034330|FG004|Overall Study|error|1|||
161179290|NCT01989572|582034331|FG005|Overall Study|error|1|||
161179291|NCT01989572|582034326|FG000|Overall Study|maximum dose reached|0|||
161347746|NCT01922011|582657354|FG000|Overall Study|Randomized in error|1|||
161179292|NCT01989572|582034327|FG001|Overall Study|maximum dose reached|1|||
161179293|NCT01989572|582034328|FG002|Overall Study|maximum dose reached|0|||
161179294|NCT01989572|582034329|FG003|Overall Study|maximum dose reached|0|||
161179295|NCT01989572|582034330|FG004|Overall Study|maximum dose reached|1|||
161179296|NCT01989572|582034331|FG005|Overall Study|maximum dose reached|0|||
161179297|NCT01989572|582034326|FG000|Overall Study|unknown/not specify|3|||
161179298|NCT01989572|582034327|FG001|Overall Study|unknown/not specify|4|||
161179299|NCT01989572|582034328|FG002|Overall Study|unknown/not specify|1|||
161179300|NCT01989572|582034329|FG003|Overall Study|unknown/not specify|3|||
161179301|NCT01989572|582034330|FG004|Overall Study|unknown/not specify|3|||
161179302|NCT01989572|582034331|FG005|Overall Study|unknown/not specify|5|||
161179303|NCT01989572|582034326|FG000|Overall Study|not start protocol therapy|5|||
161179304|NCT01989572|582034327|FG001|Overall Study|not start protocol therapy|1|||
161179305|NCT01989572|582034328|FG002|Overall Study|not start protocol therapy|2|||
161179306|NCT01989572|582034329|FG003|Overall Study|not start protocol therapy|3|||
161179307|NCT01989572|582034330|FG004|Overall Study|not start protocol therapy|4|||
161179308|NCT01989572|582034331|FG005|Overall Study|not start protocol therapy|18|||
161179309|NCT01989572|582034326|FG000|Overall Study|alternative therapy|3|||
161179310|NCT01989572|582034327|FG001|Overall Study|alternative therapy|0|||
161179311|NCT01989572|582034328|FG002|Overall Study|alternative therapy|0|||
161179312|NCT01989572|582034329|FG003|Overall Study|alternative therapy|0|||
161179313|NCT01989572|582034330|FG004|Overall Study|alternative therapy|1|||
161179314|NCT01989572|582034331|FG005|Overall Study|alternative therapy|3|||
161179315|NCT00732641|582034336|FG000|Overall Study|Relapse or Progressive Disease|65|||
161179316|NCT00732641|582034337|FG001|Overall Study|Relapse or Progressive Disease|101|||
161179317|NCT00732641|582034336|FG000|Overall Study|Serious Adverse Events|12|||
161179318|NCT00732641|582034337|FG001|Overall Study|Serious Adverse Events|3|||
161179319|NCT00732641|582034336|FG000|Overall Study|Physician Decision|6|||
161179320|NCT00732641|582034337|FG001|Overall Study|Physician Decision|0|||
161179321|NCT00732641|582034336|FG000|Overall Study|Withdrawal by Subject|4|||
161179322|NCT00732641|582034337|FG001|Overall Study|Withdrawal by Subject|2|||
161179323|NCT00732641|582034336|FG000|Overall Study|Unable to Complete|1|||
161179324|NCT00732641|582034337|FG001|Overall Study|Unable to Complete|1|||
161179325|NCT00732641|582034336|FG000|Overall Study|Other|18|||
161179326|NCT00732641|582034337|FG001|Overall Study|Other|5|||
161179327|NCT00732238|582034338|FG000|Overall Study|Bacteremia|4|||
161179328|NCT00732238|582034339|FG001|Overall Study|Bacteremia|1|||
161179329|NCT00732238|582034338|FG000|Overall Study|Asymptomatic bacteriuria|1|||
161179330|NCT00732238|582034339|FG001|Overall Study|Asymptomatic bacteriuria|0|||
161179331|NCT02910089|582034340|FG000|Overall Study|Lost insurance eligibility|22|||
161179332|NCT02910089|582034341|FG001|Overall Study|Lost insurance eligibility|16|||
161179333|NCT02280096|582034342|FG000|Overall Study|Pregnancy|1|||
161179334|NCT02280096|582034343|FG001|Overall Study|Pregnancy|0|||
161179335|NCT02280096|582034342|FG000|Overall Study|Functional neurological disorder|1|||
161179336|NCT02280096|582034343|FG001|Overall Study|Functional neurological disorder|0|||
161179337|NCT02280096|582034342|FG000|Overall Study|Lack of attachment|0|||
161179338|NCT02280096|582034343|FG001|Overall Study|Lack of attachment|1|||
161179339|NCT00246376|582034348|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
161179340|NCT00246376|582034349|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
161179341|NCT00246376|582034350|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
161179342|NCT00246376|582034351|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
161179343|NCT00246376|582034352|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
161179344|NCT00246376|582034348|FG000|Overall Study|Adverse Event|2|||
161179345|NCT00246376|582034349|FG001|Overall Study|Adverse Event|3|||
161179346|NCT00246376|582034350|FG002|Overall Study|Adverse Event|1|||
161179347|NCT00246376|582034351|FG003|Overall Study|Adverse Event|3|||
161179348|NCT00246376|582034352|FG004|Overall Study|Adverse Event|1|||
161179349|NCT00246376|582034348|FG000|Overall Study|Lost to Follow-up|2|||
161179350|NCT00246376|582034349|FG001|Overall Study|Lost to Follow-up|11|||
161179351|NCT00246376|582034350|FG002|Overall Study|Lost to Follow-up|11|||
161179352|NCT00246376|582034351|FG003|Overall Study|Lost to Follow-up|16|||
161179353|NCT00246376|582034352|FG004|Overall Study|Lost to Follow-up|13|||
161179354|NCT01872897|582034353|FG000|Overall Study|Withdrawal by Subject|1|||
161179355|NCT01872897|582034354|FG001|Overall Study|Withdrawal by Subject|0|||
161179356|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
161179357|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
161179358|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
161179359|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
161179360|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
161297965|NCT02099110|582474089|FG000|Overall Study|Death|0|||
161179361|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
161179362|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
161179363|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
161179364|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
161179365|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
161179366|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
161179367|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
161179368|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
161179369|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
161179370|NCT03434041|582034359|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
161179371|NCT03434041|582034360|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
161179372|NCT03434041|582034359|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
161179373|NCT03434041|582034360|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
161179374|NCT03434041|582034359|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
161179375|NCT03434041|582034360|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
161179376|NCT03434041|582034359|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
161179377|NCT03434041|582034360|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
161179378|NCT04159701|582034361|FG000|Period 1: Treatment Period|Pregnancy|1|||
161179379|NCT04159701|582034362|FG001|Period 1: Treatment Period|Pregnancy|0|||
161179380|NCT04159701|582034361|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
161179381|NCT04159701|582034362|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
161179382|NCT04159701|582034361|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
161179383|NCT04159701|582034362|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
161179384|NCT04159701|582034361|FG000|Washout Period|site terminated by sponsor|0|||
161179385|NCT04159701|582034362|FG001|Washout Period|site terminated by sponsor|1|||
161179386|NCT04159701|582034361|FG000|Washout Period|study terminated by sponsor|10|||
161179387|NCT04159701|582034362|FG001|Washout Period|study terminated by sponsor|3|||
161179388|NCT04159701|582034361|FG000|Washout Period|Withdrawal by Subject|1|||
161179389|NCT04159701|582034362|FG001|Washout Period|Withdrawal by Subject|0|||
161179390|NCT04159701|582034361|FG000|Washout Period|Inadvertent Enrollment|1|||
161179391|NCT04159701|582034362|FG001|Washout Period|Inadvertent Enrollment|0|||
161179392|NCT04159701|582034361|FG000|Washout Period|Miscellaneous|1|||
161179393|NCT04159701|582034362|FG001|Washout Period|Miscellaneous|0|||
161179394|NCT04159701|582034361|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
161179395|NCT04159701|582034362|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
161179396|NCT04159701|582034361|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
161179397|NCT04159701|582034362|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
161179398|NCT04159701|582034361|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
161179399|NCT04159701|582034362|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
161179400|NCT04159701|582034361|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
161179401|NCT04159701|582034362|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
161179402|NCT04159701|582034361|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
161179403|NCT04159701|582034362|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
161179404|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
161179405|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161179406|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161179407|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
161179408|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
161179409|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161179410|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161179411|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
161179412|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
161179413|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161179414|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161179415|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
161179416|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
161179417|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161179418|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161179419|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
161179420|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
161179421|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161179422|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161179423|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
161179424|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
161179425|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161297966|NCT02099110|582474090|FG001|Overall Study|Death|1|||
161297967|NCT02099110|582474091|FG002|Overall Study|Death|0|||
161297968|NCT02099110|582474092|FG003|Overall Study|Death|0|||
161297969|NCT02099110|582474093|FG004|Overall Study|Death|0|||
161297970|NCT02099110|582474089|FG000|Overall Study|Screen failure|0|||
161297971|NCT02099110|582474090|FG001|Overall Study|Screen failure|0|||
161179426|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161179427|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
161179428|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
161297972|NCT02099110|582474091|FG002|Overall Study|Screen failure|0|||
161297973|NCT02099110|582474092|FG003|Overall Study|Screen failure|0|||
161297974|NCT02099110|582474093|FG004|Overall Study|Screen failure|1|||
161297975|NCT02099110|582474089|FG000|Overall Study|Non-compliance with study drug|2|||
161297976|NCT02099110|582474090|FG001|Overall Study|Non-compliance with study drug|0|||
161297977|NCT02099110|582474091|FG002|Overall Study|Non-compliance with study drug|0|||
161297978|NCT02099110|582474092|FG003|Overall Study|Non-compliance with study drug|0|||
161297979|NCT02099110|582474093|FG004|Overall Study|Non-compliance with study drug|1|||
161297980|NCT02099110|582474089|FG000|Overall Study|Physician Decision|3|||
161297981|NCT02099110|582474090|FG001|Overall Study|Physician Decision|0|||
161297982|NCT02099110|582474091|FG002|Overall Study|Physician Decision|1|||
161297983|NCT02099110|582474092|FG003|Overall Study|Physician Decision|2|||
161297984|NCT02099110|582474093|FG004|Overall Study|Physician Decision|1|||
161297985|NCT02064816|582474094|FG000|Overall Study|Adverse Event|3|||
161297986|NCT02064816|582474095|FG001|Overall Study|Adverse Event|2|||
161297987|NCT02064816|582474094|FG000|Overall Study|Withdrawal by Subject|2|||
161297988|NCT02064816|582474095|FG001|Overall Study|Withdrawal by Subject|1|||
161297989|NCT02064816|582474094|FG000|Overall Study|Lost to Follow-up|2|||
161297990|NCT02064816|582474095|FG001|Overall Study|Lost to Follow-up|1|||
161297991|NCT02064816|582474094|FG000|Overall Study|Therapeutic failure|0|||
161297992|NCT02064816|582474095|FG001|Overall Study|Therapeutic failure|1|||
161297993|NCT02064816|582474094|FG000|Overall Study|Other|1|||
161297994|NCT02064816|582474095|FG001|Overall Study|Other|3|||
161297995|NCT01757184|582474102|FG000|Double-blind Period|Adverse Event|1|||
161297996|NCT01757184|582474103|FG001|Double-blind Period|Adverse Event|0|||
161297997|NCT01757184|582474104|FG002|Double-blind Period|Adverse Event|0|||
161297998|NCT01757184|582474105|FG003|Double-blind Period|Adverse Event|0|||
161297999|NCT01757184|582474102|FG000|Open-label Period|Lost to Follow-up|0|||
161298000|NCT01757184|582474103|FG001|Open-label Period|Lost to Follow-up|0|||
161298001|NCT01757184|582474104|FG002|Open-label Period|Lost to Follow-up|2|||
161298002|NCT01757184|582474105|FG003|Open-label Period|Lost to Follow-up|0|||
161298003|NCT01757184|582474102|FG000|Open-label Period|Withdrawal by Subject|0|||
161298004|NCT01757184|582474103|FG001|Open-label Period|Withdrawal by Subject|0|||
161298005|NCT01757184|582474104|FG002|Open-label Period|Withdrawal by Subject|1|||
161298006|NCT01757184|582474105|FG003|Open-label Period|Withdrawal by Subject|1|||
161298007|NCT01757184|582474102|FG000|Open-label Period|Discontinued by Sponsor|0|||
161298008|NCT01757184|582474103|FG001|Open-label Period|Discontinued by Sponsor|0|||
161298009|NCT01757184|582474104|FG002|Open-label Period|Discontinued by Sponsor|1|||
161298010|NCT01757184|582474105|FG003|Open-label Period|Discontinued by Sponsor|2|||
161298011|NCT00237458|582474106|FG000|Overall Study|Lack of Efficacy|1|||
161298012|NCT00237458|582474106|FG000|Overall Study|Adverse Event|1|||
161298013|NCT00237458|582474106|FG000|Overall Study|Withdrawal by Subject|1|||
161088632|NCT02647866|581715235|FG002|Overall Study|Subject moved to different country|0|||
161088633|NCT02647866|581715236|FG003|Overall Study|Subject moved to different country|0|||
161088634|NCT02647866|581715237|FG004|Overall Study|Subject moved to different country|0|||
161088635|NCT03406260|581715238|FG000|Period 1|Adverse Event|0|||
161088636|NCT03406260|581715239|FG001|Period 1|Adverse Event|0|||
161088637|NCT03406260|581715240|FG002|Period 1|Adverse Event|0|||
161088638|NCT03406260|581715241|FG003|Period 1|Adverse Event|0|||
161088639|NCT03406260|581715242|FG004|Period 1|Adverse Event|1|||
161088640|NCT03406260|581715243|FG005|Period 1|Adverse Event|0|||
161088641|NCT00871780|581715244|FG000|Overall Study|Enrolled But Not Treated|6|||
161088642|NCT00871780|581715244|FG000|Overall Study|Withdrawal by Subject|9|||
161088643|NCT00871780|581715244|FG000|Overall Study|Adverse Event|6|||
161088644|NCT00871780|581715244|FG000|Overall Study|Voluntary Discontinuation|4|||
161088645|NCT00871780|581715244|FG000|Overall Study|Death|1|||
161088646|NCT00871780|581715244|FG000|Overall Study|Physician Decision|1|||
161088647|NCT02527343|581715248|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
161088648|NCT02527343|581715249|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161088649|NCT02527343|581715250|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161088650|NCT02527343|581715251|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161088651|NCT02527343|581715252|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161088652|NCT02527343|581715253|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
161088653|NCT02527343|581715248|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
161088654|NCT02527343|581715249|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161088655|NCT02527343|581715250|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161088656|NCT02527343|581715251|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161088657|NCT02527343|581715252|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161088658|NCT02527343|581715253|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
161088659|NCT02527343|581715248|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161088660|NCT02527343|581715249|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
161091327|NCT01551212|581723888|FG001|Overall Study|Graft loss/Retransplantation|1|||
161298014|NCT05107492|582474107|FG000|Overall Study|Lost to Follow-up|1|||
161298015|NCT05107492|582474108|FG001|Overall Study|Lost to Follow-up|0|||
161298016|NCT03218826|582474109|FG000|Overall Study|Non-compliance with protocol|1|||
161298017|NCT03218826|582474110|FG001|Overall Study|Non-compliance with protocol|0|||
161298018|NCT03218826|582474111|FG002|Overall Study|Non-compliance with protocol|2|||
161298019|NCT03218826|582474112|FG003|Overall Study|Non-compliance with protocol|1|||
161179429|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161179430|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161179431|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
161179432|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
161179433|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161179434|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161179435|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
161179436|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
161179437|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161179438|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161179439|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
161179440|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
161179441|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161179442|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161179443|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
161179444|NCT03605836|582034363|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
161179445|NCT03605836|582034364|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161179446|NCT03605836|582034365|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161179447|NCT03605836|582034366|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
161179448|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
161179449|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
161179450|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
161179451|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
161179452|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
161179453|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
161179454|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
161179455|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
161179456|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
161179457|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
161179458|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
161179459|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
161179460|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
161179461|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
161179462|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
161179463|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
161179464|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
161179465|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
161179466|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
161179467|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
161179468|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161179469|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
161179470|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161179471|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
161179472|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
161179473|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
161179474|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
161179475|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
161179476|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
161179477|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
161179478|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
161179479|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
161179480|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
161179481|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
161179482|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
161179483|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
161179484|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
161179485|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
161179486|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
161179487|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
161298020|NCT03218826|582474113|FG004|Overall Study|Non-compliance with protocol|1|||
161298021|NCT04586244|582474120|FG000|Overall Study|Lost to Follow-up|1|||
161298022|NCT04586244|582474121|FG001|Overall Study|Lost to Follow-up|0|||
161298023|NCT04586244|582474122|FG002|Overall Study|Lost to Follow-up|0|||
161298024|NCT04586244|582474123|FG003|Overall Study|Lost to Follow-up|1|||
161298025|NCT04586244|582474124|FG004|Overall Study|Lost to Follow-up|0|||
161298026|NCT04586244|582474120|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161298027|NCT04586244|582474121|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
161298028|NCT04586244|582474122|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161298029|NCT04586244|582474123|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161298030|NCT04586244|582474124|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
161298031|NCT03564119|582474125|FG000|Overall Study|Adverse Event|4|||
161298032|NCT03564119|582474126|FG001|Overall Study|Adverse Event|0|||
161298033|NCT03564119|582474125|FG000|Overall Study|Lost to Follow-up|1|||
161298034|NCT03564119|582474126|FG001|Overall Study|Lost to Follow-up|4|||
161298035|NCT03564119|582474125|FG000|Overall Study|Protocol Violation|1|||
161298036|NCT03564119|582474126|FG001|Overall Study|Protocol Violation|0|||
161298037|NCT03564119|582474125|FG000|Overall Study|Withdrawal by Subject|9|||
161298038|NCT03564119|582474126|FG001|Overall Study|Withdrawal by Subject|4|||
161298039|NCT03564119|582474125|FG000|Overall Study|Other Than Specified|0|||
161298040|NCT03564119|582474126|FG001|Overall Study|Other Than Specified|1|||
161088661|NCT02527343|581715250|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161088662|NCT02527343|581715251|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161088663|NCT02527343|581715252|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161088664|NCT02527343|581715253|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
161088665|NCT02527343|581715248|FG000|RT Period: Weeks 1 to 52|Other|4|||
161088666|NCT02527343|581715249|FG001|RT Period: Weeks 1 to 52|Other|3|||
161088667|NCT02527343|581715250|FG002|RT Period: Weeks 1 to 52|Other|0|||
161088668|NCT02527343|581715251|FG003|RT Period: Weeks 1 to 52|Other|0|||
161088669|NCT02527343|581715252|FG004|RT Period: Weeks 1 to 52|Other|0|||
161088670|NCT02527343|581715253|FG005|RT Period: Weeks 1 to 52|Other|0|||
161088671|NCT02527343|581715248|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161088672|NCT02527343|581715249|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161088673|NCT02527343|581715250|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
161088674|NCT02527343|581715251|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161088675|NCT02527343|581715252|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161088676|NCT02527343|581715253|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
161088677|NCT02527343|581715248|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161088678|NCT02527343|581715249|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161088679|NCT02527343|581715250|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161088680|NCT02527343|581715251|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
161088681|NCT02527343|581715252|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161088682|NCT02527343|581715253|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
161088683|NCT02527343|581715248|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161088684|NCT02527343|581715249|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161088685|NCT02527343|581715250|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161088686|NCT02527343|581715251|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161088687|NCT02527343|581715252|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
161088688|NCT02527343|581715253|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
161088689|NCT02527343|581715248|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161088690|NCT02527343|581715249|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161088691|NCT02527343|581715250|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161088692|NCT02527343|581715251|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
161088693|NCT02527343|581715252|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
161088694|NCT02527343|581715253|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
161088695|NCT02527343|581715248|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161088696|NCT02527343|581715249|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161088697|NCT02527343|581715250|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161088698|NCT02527343|581715251|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
161088699|NCT02527343|581715252|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
161088700|NCT02527343|581715253|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
161088701|NCT02527343|581715248|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
161088702|NCT02527343|581715249|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
161088703|NCT02527343|581715250|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
161088704|NCT02527343|581715251|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
161088705|NCT02527343|581715252|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
161088706|NCT02527343|581715253|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
161088707|NCT02527343|581715248|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
161088708|NCT02527343|581715249|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
161088709|NCT02527343|581715250|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
161088710|NCT02527343|581715251|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
161088711|NCT02527343|581715252|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
161179488|NCT03605836|582034363|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
161179489|NCT03605836|582034364|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
161179490|NCT03605836|582034365|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
161179491|NCT03605836|582034366|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
161179492|NCT00633360|582034370|FG000|Overall Study|Lost to Follow-up|1|||
161179493|NCT00633360|582034371|FG001|Overall Study|Lost to Follow-up|1|||
161179494|NCT00633360|582034370|FG000|Overall Study|Adverse Event|3|||
161179495|NCT00633360|582034371|FG001|Overall Study|Adverse Event|1|||
161179496|NCT00633360|582034370|FG000|Overall Study|Protocol Violation|0|||
161179497|NCT00633360|582034371|FG001|Overall Study|Protocol Violation|1|||
161179498|NCT02348840|582034377|FG000|Overall Study|Withdrawal by Subject|2|||
161179499|NCT02348840|582034378|FG001|Overall Study|Withdrawal by Subject|1|||
161179500|NCT02348840|582034379|FG002|Overall Study|Withdrawal by Subject|0|||
161179501|NCT02348840|582034380|FG003|Overall Study|Withdrawal by Subject|0|||
161179502|NCT00621244|582034381|FG000|Overall Study|Withdrawal by Subject|7|||
161179503|NCT00621244|582034382|FG001|Overall Study|Withdrawal by Subject|3|||
161179504|NCT00621244|582034383|FG002|Overall Study|Withdrawal by Subject|3|||
161179505|NCT00621244|582034384|FG003|Overall Study|Withdrawal by Subject|3|||
161179506|NCT00621244|582034381|FG000|Overall Study|Disease progression|44|||
161179507|NCT00621244|582034382|FG001|Overall Study|Disease progression|20|||
161179508|NCT00621244|582034383|FG002|Overall Study|Disease progression|20|||
161179509|NCT00621244|582034384|FG003|Overall Study|Disease progression|15|||
161179510|NCT00621244|582034381|FG000|Overall Study|Death|3|||
161179511|NCT00621244|582034382|FG001|Overall Study|Death|3|||
161298041|NCT00634036|582474127|FG000|Overall Study|Lost to Follow-up|1|||
161298042|NCT00634036|582474128|FG001|Overall Study|Lost to Follow-up|1|||
161298043|NCT00634036|582474127|FG000|Overall Study|Withdrawal by Subject|1|||
161298044|NCT00634036|582474128|FG001|Overall Study|Withdrawal by Subject|1|||
161298045|NCT03896022|582474129|FG000|Overall Study|Withdrawal by Subject|1|||
161298046|NCT03896022|582474130|FG001|Overall Study|Withdrawal by Subject|0|||
161298047|NCT03896022|582474131|FG002|Overall Study|Withdrawal by Subject|0|||
161298048|NCT03896022|582474129|FG000|Overall Study|Did not have procedure|3|||
161298049|NCT03896022|582474130|FG001|Overall Study|Did not have procedure|0|||
161298050|NCT03896022|582474131|FG002|Overall Study|Did not have procedure|0|||
161298051|NCT02741076|582474132|FG000|Overall Study|Adverse Event|0|||
161298052|NCT02741076|582474133|FG001|Overall Study|Adverse Event|1|||
161298053|NCT02741076|582474134|FG002|Overall Study|Adverse Event|1|||
161298054|NCT02741076|582474135|FG003|Overall Study|Adverse Event|0|||
161298055|NCT02741076|582474132|FG000|Overall Study|Lack of Efficacy|1|||
161298056|NCT02741076|582474133|FG001|Overall Study|Lack of Efficacy|0|||
161298057|NCT02741076|582474134|FG002|Overall Study|Lack of Efficacy|0|||
161298058|NCT02741076|582474135|FG003|Overall Study|Lack of Efficacy|0|||
161298059|NCT02741076|582474132|FG000|Overall Study|Withdrawal by Subject|0|||
161298060|NCT02741076|582474133|FG001|Overall Study|Withdrawal by Subject|1|||
161298061|NCT02741076|582474134|FG002|Overall Study|Withdrawal by Subject|0|||
161298062|NCT02741076|582474135|FG003|Overall Study|Withdrawal by Subject|0|||
161298063|NCT02741076|582474132|FG000|Overall Study|Sponsor Request|2|||
161298064|NCT02741076|582474133|FG001|Overall Study|Sponsor Request|3|||
161298065|NCT02741076|582474134|FG002|Overall Study|Sponsor Request|0|||
161298066|NCT02741076|582474135|FG003|Overall Study|Sponsor Request|1|||
161298067|NCT02741076|582474132|FG000|Overall Study|No additional information available|0|||
161298068|NCT02741076|582474133|FG001|Overall Study|No additional information available|0|||
161298069|NCT02741076|582474134|FG002|Overall Study|No additional information available|1|||
161298070|NCT02741076|582474135|FG003|Overall Study|No additional information available|1|||
161298071|NCT01779440|582474136|FG000|Overall Study|Withdrawal by Subject|3|||
161298072|NCT01779440|582474137|FG001|Overall Study|Withdrawal by Subject|5|||
161298073|NCT05119595|582475594|FG000|Overall Study|Death|1|||
161298074|NCT05119595|582475594|FG000|Overall Study|Lost to Follow-up|7|||
161298075|NCT00784238|582475597|FG000|Overall Study|Adverse Event|14|||
161298076|NCT00784238|582475597|FG000|Overall Study|Death|2|||
161298077|NCT00784238|582475597|FG000|Overall Study|Lack of Efficacy|33|||
161298078|NCT00784238|582475597|FG000|Overall Study|Lost to Follow-up|29|||
161298079|NCT00784238|582475597|FG000|Overall Study|Pregnancy|1|||
161298080|NCT00784238|582475597|FG000|Overall Study|Withdrawal by Subject|26|||
161298081|NCT00784238|582475597|FG000|Overall Study|Other|14|||
161298082|NCT04390503|582475599|FG000|Overall Study|Physician Decision|2|||
161298083|NCT04390503|582475600|FG001|Overall Study|Physician Decision|1|||
161298084|NCT04390503|582475599|FG000|Overall Study|Adverse Event|1|||
161298085|NCT04390503|582475600|FG001|Overall Study|Adverse Event|0|||
161298086|NCT01568034|582475601|FG000|Overall Study|Withdrawal by Subject|1|||
161179512|NCT00621244|582034383|FG002|Overall Study|Death|1|||
161179513|NCT00621244|582034384|FG003|Overall Study|Death|1|||
161298087|NCT01568034|582475602|FG001|Overall Study|Withdrawal by Subject|0|||
161298088|NCT01568034|582475603|FG002|Overall Study|Withdrawal by Subject|0|||
161179514|NCT00621244|582034381|FG000|Overall Study|Adverse Event|27|||
161179515|NCT00621244|582034382|FG001|Overall Study|Adverse Event|7|||
161179516|NCT00621244|582034383|FG002|Overall Study|Adverse Event|9|||
161179517|NCT00621244|582034384|FG003|Overall Study|Adverse Event|2|||
161347747|NCT01922011|582657355|FG001|Overall Study|Randomized in error|0|||
161347748|NCT02903914|582657361|FG000|Overall Study|Adverse Event|0|||
161347749|NCT02903914|582657362|FG001|Overall Study|Adverse Event|0|||
161088712|NCT02527343|581715253|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
161298089|NCT01568034|582475604|FG003|Overall Study|Withdrawal by Subject|0|||
161298090|NCT06098339|582475605|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
161298091|NCT06098339|582475606|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
161298092|NCT06098339|582475605|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
161298093|NCT06098339|582475606|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
161298094|NCT01068730|582475607|FG000|Period 3|Personal reason|1|||
161298095|NCT01068730|582475608|FG001|Period 3|Personal reason|0|||
161298096|NCT01068730|582475609|FG002|Period 3|Personal reason|0|||
161298097|NCT01068730|582475610|FG003|Period 3|Personal reason|0|||
161298098|NCT01068730|582475607|FG000|Period 4|Family emergency|0|||
161298099|NCT01068730|582475608|FG001|Period 4|Family emergency|1|||
161298100|NCT01068730|582475609|FG002|Period 4|Family emergency|0|||
161298101|NCT01068730|582475610|FG003|Period 4|Family emergency|0|||
161298102|NCT03508726|582475611|FG000|Overall Study|Withdrawal by Subject|0|||
161298103|NCT03508726|582475612|FG001|Overall Study|Withdrawal by Subject|1|||
161298104|NCT03656692|582475618|FG000|Overall Study|Worsening of disease activity|2|||
161298105|NCT03656692|582475618|FG000|Overall Study|Physician Decision|1|||
161298106|NCT03233529|582475619|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
161298107|NCT03233529|582475619|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
161298108|NCT01177293|582475620|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
161298109|NCT01177293|582475621|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
161298110|NCT00594100|582475622|FG000|Procedure|Technical Failure|9|||
161298111|NCT00594100|582475622|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
161298112|NCT00594100|582475622|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
161298113|NCT00594100|582475622|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
161298114|NCT02448537|582475623|FG000|Overall Study|Withdrawal by Subject|1|||
161298115|NCT02448537|582475624|FG001|Overall Study|Withdrawal by Subject|1|||
161298116|NCT02448537|582475625|FG002|Overall Study|Withdrawal by Subject|1|||
161298117|NCT03528369|582475628|FG000|Overall Study|Withdrawal by Subject|2|||
161298118|NCT03528369|582475629|FG001|Overall Study|Withdrawal by Subject|0|||
161298119|NCT03528369|582475630|FG002|Overall Study|Withdrawal by Subject|0|||
161298120|NCT03528369|582475628|FG000|Overall Study|Lost to Follow-up|1|||
161298121|NCT03528369|582475629|FG001|Overall Study|Lost to Follow-up|0|||
161298122|NCT03528369|582475630|FG002|Overall Study|Lost to Follow-up|0|||
161298123|NCT03528369|582475628|FG000|Overall Study|Adverse Event|0|||
161298124|NCT03528369|582475629|FG001|Overall Study|Adverse Event|1|||
161298125|NCT03528369|582475630|FG002|Overall Study|Adverse Event|0|||
161298126|NCT04725812|582475631|FG000|Overall Study|Withdrawal by Subject|1|||
161298127|NCT05656534|582475633|FG000|Overall Study|Withdrawal by Subject|1|||
161298128|NCT05656534|582475634|FG001|Overall Study|Withdrawal by Subject|1|||
161298129|NCT05656534|582475635|FG002|Overall Study|Withdrawal by Subject|0|||
161298130|NCT05656534|582475636|FG003|Overall Study|Withdrawal by Subject|0|||
161298131|NCT05656534|582475633|FG000|Overall Study|Physician Decision|1|||
161298132|NCT05656534|582475634|FG001|Overall Study|Physician Decision|1|||
161298133|NCT05656534|582475635|FG002|Overall Study|Physician Decision|0|||
161298134|NCT05656534|582475636|FG003|Overall Study|Physician Decision|0|||
161298135|NCT00839800|582475641|FG000|Overall Study|Adverse Event|8|||
161298136|NCT00839800|582475642|FG001|Overall Study|Adverse Event|12|||
161347750|NCT02903914|582657363|FG002|Overall Study|Adverse Event|1|||
161088713|NCT02527343|581715248|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161088714|NCT02527343|581715249|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161088715|NCT02527343|581715250|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161088716|NCT02527343|581715251|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161088717|NCT02527343|581715252|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
161088718|NCT02527343|581715253|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
161088719|NCT02527343|581715248|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
161088720|NCT02527343|581715249|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
161088721|NCT02527343|581715250|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
161088722|NCT02527343|581715251|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
161088723|NCT02527343|581715252|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
161088724|NCT02527343|581715253|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
161088725|NCT05767021|581715254|FG000|Overall Study|Adverse Event|2|||
161088726|NCT05767021|581715254|FG000|Overall Study|Protocol Deviation|1|||
161088727|NCT05767021|581715254|FG000|Overall Study|Withdrawal by Subject|1|||
161088728|NCT05767021|581715254|FG000|Overall Study|Physician Decision|1|||
161088729|NCT05767021|581715254|FG000|Overall Study|Lack of Efficacy|11|||
161088730|NCT05767021|581715254|FG000|Overall Study|Assigned Treatment by Mistake|1|||
161088731|NCT00523640|581715259|FG000|Overall Study|Death|1|||
161088732|NCT02334423|581715262|FG000|Overall Study|Protocol Violation|10|||
161088733|NCT02334423|581715263|FG001|Overall Study|Protocol Violation|3|||
161298137|NCT00839800|582475641|FG000|Overall Study|Lost to Follow-up|31|||
161298138|NCT00839800|582475642|FG001|Overall Study|Lost to Follow-up|26|||
161298139|NCT00839800|582475641|FG000|Overall Study|Withdrawal by Subject|28|||
161298140|NCT00839800|582475642|FG001|Overall Study|Withdrawal by Subject|34|||
161298141|NCT00839800|582475641|FG000|Overall Study|Incorrect Enrolment|3|||
161298142|NCT00839800|582475642|FG001|Overall Study|Incorrect Enrolment|3|||
161298143|NCT00839800|582475641|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
161298144|NCT00839800|582475642|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
161298145|NCT00839800|582475641|FG000|Overall Study|Safety Reasons|2|||
161298146|NCT00839800|582475642|FG001|Overall Study|Safety Reasons|1|||
161298147|NCT00839800|582475641|FG000|Overall Study|Other|8|||
161347751|NCT02903914|582657364|FG003|Overall Study|Adverse Event|0|||
161347752|NCT02903914|582657365|FG004|Overall Study|Adverse Event|0|||
161347753|NCT02903914|582657366|FG005|Overall Study|Adverse Event|0|||
161088734|NCT04426851|581715264|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
161088735|NCT04426851|581715265|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
161088736|NCT04426851|581715264|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
161088737|NCT04426851|581715265|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
161088738|NCT03545503|581715267|FG000|Overall Study|Protocol Violation|14|||
161088739|NCT03545503|581715268|FG001|Overall Study|Protocol Violation|16|||
161088740|NCT04494256|581715269|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
161088741|NCT04494256|581715270|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
161088742|NCT04494256|581715271|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
161088743|NCT04494256|581715272|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
161088744|NCT04494256|581715273|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
161088745|NCT04494256|581715274|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
161088746|NCT04494256|581715275|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
161088747|NCT04494256|581715269|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161088748|NCT04494256|581715270|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161088749|NCT04494256|581715271|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161088750|NCT04494256|581715272|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161088751|NCT04494256|581715273|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
161088752|NCT04494256|581715274|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161088753|NCT04494256|581715275|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
161088754|NCT04494256|581715269|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
161088755|NCT04494256|581715270|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
161088756|NCT04494256|581715271|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
161088757|NCT04494256|581715272|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
161088758|NCT04494256|581715273|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
161088759|NCT04494256|581715274|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
161088760|NCT04494256|581715275|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
161088761|NCT04494256|581715269|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088762|NCT04494256|581715270|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088763|NCT04494256|581715271|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088764|NCT04494256|581715272|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
161088765|NCT04494256|581715273|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
161088766|NCT04494256|581715274|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088767|NCT04494256|581715275|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088768|NCT04494256|581715269|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161088769|NCT04494256|581715270|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
161088770|NCT04494256|581715271|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161088771|NCT04494256|581715272|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161088772|NCT04494256|581715273|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
161088773|NCT04494256|581715274|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
161088774|NCT04494256|581715275|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
161088775|NCT04494256|581715269|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
161088776|NCT04494256|581715270|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
161088777|NCT04494256|581715271|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
161088778|NCT04494256|581715272|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
161088779|NCT04494256|581715273|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
161088780|NCT04494256|581715274|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
161088781|NCT04494256|581715275|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
161088782|NCT04494256|581715269|FG000|Part 2: Open Label Period|Death|0|||
161088783|NCT04494256|581715270|FG001|Part 2: Open Label Period|Death|0|||
161088784|NCT04494256|581715271|FG002|Part 2: Open Label Period|Death|0|||
161088785|NCT04494256|581715272|FG003|Part 2: Open Label Period|Death|0|||
161298148|NCT00839800|582475642|FG001|Overall Study|Other|14|||
161179518|NCT00621244|582034381|FG000|Overall Study|Administrative problems|5|||
161179519|NCT00621244|582034382|FG001|Overall Study|Administrative problems|1|||
161179520|NCT00621244|582034383|FG002|Overall Study|Administrative problems|0|||
161179521|NCT00621244|582034384|FG003|Overall Study|Administrative problems|2|||
161347754|NCT02903914|582657367|FG006|Overall Study|Adverse Event|2|||
161347755|NCT02903914|582657368|FG007|Overall Study|Adverse Event|0|||
161347756|NCT02903914|582657361|FG000|Overall Study|Withdrawal by Subject|3|||
161347757|NCT02903914|582657362|FG001|Overall Study|Withdrawal by Subject|1|||
161347758|NCT02903914|582657363|FG002|Overall Study|Withdrawal by Subject|28|||
161347759|NCT02903914|582657364|FG003|Overall Study|Withdrawal by Subject|0|||
161347760|NCT02903914|582657365|FG004|Overall Study|Withdrawal by Subject|1|||
161347761|NCT02903914|582657366|FG005|Overall Study|Withdrawal by Subject|2|||
161347762|NCT02903914|582657367|FG006|Overall Study|Withdrawal by Subject|12|||
161179522|NCT01690988|582034385|FG000|Overall Study|Withdrawal by Subject|2|||
161179523|NCT01690988|582034386|FG001|Overall Study|Withdrawal by Subject|2|||
161179524|NCT01690988|582034387|FG002|Overall Study|Withdrawal by Subject|3|||
161179525|NCT01690988|582034385|FG000|Overall Study|Physician Decision|0|||
161179526|NCT01690988|582034386|FG001|Overall Study|Physician Decision|0|||
161179527|NCT01690988|582034387|FG002|Overall Study|Physician Decision|1|||
161179528|NCT01690988|582034385|FG000|Overall Study|Operation Cancelled|1|||
161179529|NCT01690988|582034386|FG001|Overall Study|Operation Cancelled|1|||
161179530|NCT01690988|582034387|FG002|Overall Study|Operation Cancelled|0|||
161179531|NCT01690988|582034385|FG000|Overall Study|Determined ineligible|1|||
161179532|NCT01690988|582034386|FG001|Overall Study|Determined ineligible|0|||
161179533|NCT01690988|582034387|FG002|Overall Study|Determined ineligible|0|||
161179534|NCT01690988|582034385|FG000|Overall Study|Death|1|||
161179535|NCT01690988|582034386|FG001|Overall Study|Death|1|||
161179536|NCT01690988|582034387|FG002|Overall Study|Death|1|||
161179537|NCT01690988|582034385|FG000|Overall Study|Sedated|1|||
161179538|NCT01690988|582034386|FG001|Overall Study|Sedated|1|||
161179539|NCT01690988|582034387|FG002|Overall Study|Sedated|2|||
161179540|NCT00312728|582034388|FG000|Overall Study|Progressive disease|53|||
161179541|NCT00312728|582034388|FG000|Overall Study|Adverse Event|32|||
161179542|NCT00312728|582034388|FG000|Overall Study|Withdrawal by Subject|10|||
161179543|NCT00312728|582034388|FG000|Overall Study|Required non-protocol cancer treatment|2|||
161179544|NCT00312728|582034388|FG000|Overall Study|Protocol Violation|2|||
161179545|NCT00312728|582034388|FG000|Overall Study|Other|10|||
161179546|NCT00312728|582034388|FG000|Overall Study|Other|1|||
161179547|NCT03696576|582034389|FG000|Overall Study|Soreness of throat after therapy|1|||
161179548|NCT03696576|582034390|FG001|Overall Study|Soreness of throat after therapy|1|||
161179549|NCT03696576|582034389|FG000|Overall Study|Lost to Follow-up|2|||
161179550|NCT03696576|582034390|FG001|Overall Study|Lost to Follow-up|4|||
161179551|NCT00744991|582034391|FG000|Overall Study|Progressive Disease|11|||
161179552|NCT00744991|582034391|FG000|Overall Study|Withdrawal by Subject|8|||
161179553|NCT00744991|582034391|FG000|Overall Study|Physician Decision|3|||
161179554|NCT00744991|582034391|FG000|Overall Study|Adverse Event|2|||
161298149|NCT00839800|582475641|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
161298150|NCT00839800|582475642|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
161298151|NCT02801617|582475643|FG000|Overall Study|Protocol Violation|2|||
161298152|NCT02801617|582475644|FG001|Overall Study|Protocol Violation|6|||
161298153|NCT00302328|582475645|FG000|Overall Study|Physician Decision|0|||
161298154|NCT00302328|582475646|FG001|Overall Study|Physician Decision|1|||
161298155|NCT00302328|582475647|FG002|Overall Study|Physician Decision|0|||
161298156|NCT01718535|582475650|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
161298157|NCT01718535|582475651|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
161298158|NCT01718535|582475652|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
161298159|NCT01718535|582475653|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
161298160|NCT01718535|582475654|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
161298161|NCT01718535|582475655|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
161298162|NCT01718535|582475656|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
161298163|NCT01718535|582475657|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
161298164|NCT01718535|582475658|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
161298165|NCT01718535|582475659|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
161298166|NCT02476578|582475660|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
161298167|NCT02476578|582475661|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
161179555|NCT00744991|582034391|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
161179556|NCT01662986|582034394|FG000|Overall Study|Adverse Event|5|||
161179557|NCT01662986|582034395|FG001|Overall Study|Adverse Event|4|||
161298168|NCT02476578|582475660|FG000|Overall Study|Lost to Follow-up|6|||
161347763|NCT02903914|582657368|FG007|Overall Study|Withdrawal by Subject|0|||
161347764|NCT02903914|582657361|FG000|Overall Study|Progressive Disease|1|||
161347765|NCT02903914|582657362|FG001|Overall Study|Progressive Disease|0|||
161179558|NCT01662986|582034394|FG000|Overall Study|Protocol Violation|2|||
161347766|NCT02903914|582657363|FG002|Overall Study|Progressive Disease|4|||
161179559|NCT01662986|582034395|FG001|Overall Study|Protocol Violation|3|||
161179560|NCT01662986|582034394|FG000|Overall Study|Lost to Follow-up|5|||
161179561|NCT01662986|582034395|FG001|Overall Study|Lost to Follow-up|4|||
161179562|NCT01662986|582034394|FG000|Overall Study|Withdrawal by Subject|2|||
161179563|NCT01662986|582034395|FG001|Overall Study|Withdrawal by Subject|2|||
161179564|NCT01662986|582034394|FG000|Overall Study|Not Treated|1|||
161179565|NCT01662986|582034395|FG001|Overall Study|Not Treated|0|||
161179566|NCT01662986|582034394|FG000|Overall Study|Other than stated above|3|||
161179567|NCT01662986|582034395|FG001|Overall Study|Other than stated above|0|||
161179568|NCT01594411|582034396|FG000|Overall Study|Lost to Follow-up|2|||
161179569|NCT01975376|582034397|FG000|Overall Study|Adverse Event|5|||
161179570|NCT01975376|582034398|FG001|Overall Study|Adverse Event|5|||
161179571|NCT01975376|582034397|FG000|Overall Study|Death|65|||
161179572|NCT01975376|582034398|FG001|Overall Study|Death|72|||
161179573|NCT01975376|582034397|FG000|Overall Study|Lost to Follow-up|70|||
161179574|NCT01975376|582034398|FG001|Overall Study|Lost to Follow-up|66|||
161179575|NCT01975376|582034397|FG000|Overall Study|Withdrew consent|68|||
161179576|NCT01975376|582034398|FG001|Overall Study|Withdrew consent|62|||
161179577|NCT01975376|582034397|FG000|Overall Study|Other|2|||
161179578|NCT01975376|582034398|FG001|Overall Study|Other|4|||
161179579|NCT01975376|582034397|FG000|Overall Study|Randomized, Not Treated|16|||
161179580|NCT01975376|582034398|FG001|Overall Study|Randomized, Not Treated|8|||
161179581|NCT01451398|582034399|FG000|Overall Study|Adverse Event|7|||
161298169|NCT02476578|582475661|FG001|Overall Study|Lost to Follow-up|13|||
161298170|NCT00912743|582475668|FG000|Overall Study|Adverse Event|3|||
161298171|NCT00912743|582475669|FG001|Overall Study|Adverse Event|1|||
161298172|NCT00912743|582475668|FG000|Overall Study|Lack of Efficacy|9|||
161298173|NCT00912743|582475669|FG001|Overall Study|Lack of Efficacy|18|||
161298174|NCT00912743|582475668|FG000|Overall Study|Toxicity|0|||
161298175|NCT00912743|582475669|FG001|Overall Study|Toxicity|1|||
161298176|NCT00912743|582475668|FG000|Overall Study|End of treatment form was not collected|1|||
161298177|NCT00912743|582475669|FG001|Overall Study|End of treatment form was not collected|0|||
161298178|NCT04747886|582475670|FG000|Overall Study|Withdrawal by Subject|1|||
161298179|NCT04747886|582475671|FG001|Overall Study|Withdrawal by Subject|4|||
161298180|NCT02237196|582475672|FG000|Overall Study|Adverse Event|0|||
161298181|NCT02237196|582475673|FG001|Overall Study|Adverse Event|1|||
161298182|NCT02237196|582475674|FG002|Overall Study|Adverse Event|1|||
161298183|NCT02237196|582475675|FG003|Overall Study|Adverse Event|0|||
161298184|NCT02237196|582475672|FG000|Overall Study|Lost to Follow-up|4|||
161298185|NCT02237196|582475673|FG001|Overall Study|Lost to Follow-up|2|||
161298186|NCT02237196|582475674|FG002|Overall Study|Lost to Follow-up|4|||
161298187|NCT02237196|582475675|FG003|Overall Study|Lost to Follow-up|6|||
161298188|NCT02237196|582475672|FG000|Overall Study|Physician Decision|2|||
161298189|NCT02237196|582475673|FG001|Overall Study|Physician Decision|0|||
161298190|NCT02237196|582475674|FG002|Overall Study|Physician Decision|0|||
161298191|NCT02237196|582475675|FG003|Overall Study|Physician Decision|1|||
161298192|NCT02237196|582475672|FG000|Overall Study|Pregnancy|0|||
161298193|NCT02237196|582475673|FG001|Overall Study|Pregnancy|0|||
161298194|NCT02237196|582475674|FG002|Overall Study|Pregnancy|1|||
161298195|NCT02237196|582475675|FG003|Overall Study|Pregnancy|1|||
161298196|NCT02237196|582475672|FG000|Overall Study|Withdrawal by Subject|1|||
161298197|NCT02237196|582475673|FG001|Overall Study|Withdrawal by Subject|1|||
161298198|NCT02237196|582475674|FG002|Overall Study|Withdrawal by Subject|4|||
161298199|NCT02237196|582475675|FG003|Overall Study|Withdrawal by Subject|1|||
161298200|NCT02237196|582475672|FG000|Overall Study|Site Error|1|||
161298201|NCT02237196|582475673|FG001|Overall Study|Site Error|2|||
161298202|NCT02237196|582475674|FG002|Overall Study|Site Error|0|||
161298203|NCT02237196|582475675|FG003|Overall Study|Site Error|2|||
161298204|NCT01057810|582475676|FG000|Overall Study|Disease progression|156|||
161298205|NCT01057810|582475677|FG001|Overall Study|Disease progression|197|||
161298206|NCT01057810|582475676|FG000|Overall Study|Study drug toxicity|5|||
161298207|NCT01057810|582475677|FG001|Overall Study|Study drug toxicity|114|||
161298208|NCT01057810|582475676|FG000|Overall Study|Adverse event unrelated to study drug|13|||
161298209|NCT01057810|582475677|FG001|Overall Study|Adverse event unrelated to study drug|29|||
161298210|NCT01057810|582475676|FG000|Overall Study|Withdrawal by Subject|10|||
161298211|NCT01057810|582475677|FG001|Overall Study|Withdrawal by Subject|25|||
161298212|NCT01057810|582475676|FG000|Overall Study|Death|2|||
161298213|NCT01057810|582475677|FG001|Overall Study|Death|12|||
161298214|NCT01057810|582475676|FG000|Overall Study|Maximum clinical benefit|5|||
161298215|NCT01057810|582475677|FG001|Overall Study|Maximum clinical benefit|5|||
161298216|NCT01057810|582475676|FG000|Overall Study|Poor/non-compliance|0|||
161298217|NCT01057810|582475677|FG001|Overall Study|Poor/non-compliance|1|||
161179582|NCT01451398|582034400|FG001|Overall Study|Adverse Event|9|||
161179583|NCT01451398|582034399|FG000|Overall Study|Protocol Violation|1|||
161179584|NCT01451398|582034400|FG001|Overall Study|Protocol Violation|2|||
161298218|NCT01057810|582475676|FG000|Overall Study|No longer met study criteria|0|||
161298219|NCT01057810|582475677|FG001|Overall Study|No longer met study criteria|1|||
161298220|NCT01057810|582475676|FG000|Overall Study|Other|7|||
161179585|NCT01451398|582034399|FG000|Overall Study|Physician Decision|1|||
161298221|NCT01057810|582475677|FG001|Overall Study|Other|14|||
161298222|NCT00267969|582475678|FG000|Controlled Period|Adverse Event|6|||
161298223|NCT00267969|582475679|FG001|Controlled Period|Adverse Event|0|||
161179586|NCT01451398|582034400|FG001|Overall Study|Physician Decision|1|||
161179587|NCT01451398|582034399|FG000|Overall Study|Withdrawal by Subject|10|||
161179588|NCT01451398|582034400|FG001|Overall Study|Withdrawal by Subject|14|||
161179589|NCT01451398|582034399|FG000|Overall Study|Lost to Follow-up|6|||
161179590|NCT01451398|582034400|FG001|Overall Study|Lost to Follow-up|4|||
161179591|NCT01451398|582034399|FG000|Overall Study|Non-compliance with study drug|1|||
161179592|NCT01451398|582034400|FG001|Overall Study|Non-compliance with study drug|3|||
161179593|NCT01451398|582034399|FG000|Overall Study|Non-compliance with protocol|1|||
161179594|NCT01451398|582034400|FG001|Overall Study|Non-compliance with protocol|1|||
161179595|NCT01451398|582034399|FG000|Overall Study|Moved out of country|0|||
161179596|NCT01451398|582034400|FG001|Overall Study|Moved out of country|1|||
161179597|NCT01451398|582034399|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
161179598|NCT01451398|582034400|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
161179599|NCT01451398|582034399|FG000|Overall Study|Lack of Efficacy|0|||
161179600|NCT01451398|582034400|FG001|Overall Study|Lack of Efficacy|1|||
161179601|NCT01614795|582034401|FG000|Overall Study|Adverse Event|0|||
161179602|NCT01614795|582034402|FG001|Overall Study|Adverse Event|0|||
161179603|NCT01614795|582034403|FG002|Overall Study|Adverse Event|1|||
161179604|NCT01614795|582034404|FG003|Overall Study|Adverse Event|1|||
161179605|NCT01614795|582034401|FG000|Overall Study|Lack of Efficacy|10|||
161179606|NCT01614795|582034402|FG001|Overall Study|Lack of Efficacy|10|||
161179607|NCT01614795|582034403|FG002|Overall Study|Lack of Efficacy|9|||
161179608|NCT01614795|582034404|FG003|Overall Study|Lack of Efficacy|8|||
161179609|NCT01614795|582034401|FG000|Overall Study|Physician Decision|1|||
161179610|NCT01614795|582034402|FG001|Overall Study|Physician Decision|0|||
161179611|NCT01614795|582034403|FG002|Overall Study|Physician Decision|1|||
161179612|NCT01614795|582034404|FG003|Overall Study|Physician Decision|1|||
161179613|NCT01614795|582034401|FG000|Overall Study|Withdrawal by Subject|0|||
161179614|NCT01614795|582034402|FG001|Overall Study|Withdrawal by Subject|1|||
161179615|NCT01614795|582034403|FG002|Overall Study|Withdrawal by Subject|0|||
161179616|NCT01614795|582034404|FG003|Overall Study|Withdrawal by Subject|2|||
161179617|NCT01614795|582034401|FG000|Overall Study|Ineligible|0|||
161179618|NCT01614795|582034402|FG001|Overall Study|Ineligible|1|||
161179619|NCT01614795|582034403|FG002|Overall Study|Ineligible|0|||
161179620|NCT01614795|582034404|FG003|Overall Study|Ineligible|0|||
161179621|NCT00701103|582034405|FG000|Overall Study|Adverse Event|0|||
161179622|NCT00701103|582034406|FG001|Overall Study|Adverse Event|0|||
161179623|NCT00701103|582034407|FG002|Overall Study|Adverse Event|1|||
161179624|NCT00701103|582034408|FG003|Overall Study|Adverse Event|1|||
161179625|NCT00701103|582034409|FG004|Overall Study|Adverse Event|0|||
161179626|NCT00701103|582034410|FG005|Overall Study|Adverse Event|1|||
161179627|NCT00701103|582034411|FG006|Overall Study|Adverse Event|1|||
161179628|NCT00701103|582034412|FG007|Overall Study|Adverse Event|0|||
161179629|NCT00701103|582034413|FG008|Overall Study|Adverse Event|0|||
161179630|NCT00701103|582034414|FG009|Overall Study|Adverse Event|2|||
161179631|NCT00701103|582034415|FG010|Overall Study|Adverse Event|0|||
161179632|NCT00701103|582034405|FG000|Overall Study|Progressive Disease|5|||
161179633|NCT00701103|582034406|FG001|Overall Study|Progressive Disease|2|||
161179634|NCT00701103|582034407|FG002|Overall Study|Progressive Disease|6|||
161179635|NCT00701103|582034408|FG003|Overall Study|Progressive Disease|5|||
161179636|NCT00701103|582034409|FG004|Overall Study|Progressive Disease|6|||
161088786|NCT04494256|581715273|FG004|Part 2: Open Label Period|Death|0|||
161088787|NCT04494256|581715274|FG005|Part 2: Open Label Period|Death|4|||
161088788|NCT04494256|581715275|FG006|Part 2: Open Label Period|Death|2|||
161088789|NCT04494256|581715269|FG000|Part 2: Open Label Period|Adverse Event|0|||
161088790|NCT04494256|581715270|FG001|Part 2: Open Label Period|Adverse Event|0|||
161088791|NCT04494256|581715271|FG002|Part 2: Open Label Period|Adverse Event|0|||
161088792|NCT04494256|581715272|FG003|Part 2: Open Label Period|Adverse Event|0|||
161088793|NCT04494256|581715273|FG004|Part 2: Open Label Period|Adverse Event|0|||
161088794|NCT04494256|581715274|FG005|Part 2: Open Label Period|Adverse Event|0|||
161088795|NCT04494256|581715275|FG006|Part 2: Open Label Period|Adverse Event|2|||
161088796|NCT04494256|581715269|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161088797|NCT04494256|581715270|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161088798|NCT04494256|581715271|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161088799|NCT04494256|581715272|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161088800|NCT04494256|581715273|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
161088801|NCT04494256|581715274|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
161088802|NCT04494256|581715275|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
161088803|NCT04494256|581715269|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161088804|NCT04494256|581715270|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161088805|NCT04494256|581715271|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161088806|NCT04494256|581715272|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161088807|NCT04494256|581715273|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161179637|NCT00701103|582034410|FG005|Overall Study|Progressive Disease|5|||
161179638|NCT00701103|582034411|FG006|Overall Study|Progressive Disease|7|||
161179639|NCT00701103|582034412|FG007|Overall Study|Progressive Disease|7|||
161179640|NCT00701103|582034413|FG008|Overall Study|Progressive Disease|8|||
161179641|NCT00701103|582034414|FG009|Overall Study|Progressive Disease|8|||
161179642|NCT00701103|582034415|FG010|Overall Study|Progressive Disease|11|||
161179643|NCT00701103|582034405|FG000|Overall Study|Withdrawal by Subject|0|||
161179644|NCT00701103|582034406|FG001|Overall Study|Withdrawal by Subject|1|||
161179645|NCT00701103|582034407|FG002|Overall Study|Withdrawal by Subject|1|||
161179646|NCT00701103|582034408|FG003|Overall Study|Withdrawal by Subject|0|||
161179647|NCT00701103|582034409|FG004|Overall Study|Withdrawal by Subject|0|||
161179648|NCT00701103|582034410|FG005|Overall Study|Withdrawal by Subject|0|||
161179649|NCT00701103|582034411|FG006|Overall Study|Withdrawal by Subject|0|||
161179650|NCT00701103|582034412|FG007|Overall Study|Withdrawal by Subject|0|||
161179651|NCT00701103|582034413|FG008|Overall Study|Withdrawal by Subject|0|||
161179652|NCT00701103|582034414|FG009|Overall Study|Withdrawal by Subject|0|||
161179653|NCT00701103|582034415|FG010|Overall Study|Withdrawal by Subject|0|||
161179654|NCT00701103|582034405|FG000|Overall Study|Other|0|||
161179655|NCT00701103|582034406|FG001|Overall Study|Other|0|||
161179656|NCT00701103|582034407|FG002|Overall Study|Other|0|||
161179657|NCT00701103|582034408|FG003|Overall Study|Other|0|||
161179658|NCT00701103|582034409|FG004|Overall Study|Other|0|||
161179659|NCT00701103|582034410|FG005|Overall Study|Other|0|||
161179660|NCT00701103|582034411|FG006|Overall Study|Other|0|||
161179661|NCT00701103|582034412|FG007|Overall Study|Other|0|||
161179662|NCT00701103|582034413|FG008|Overall Study|Other|1|||
161179663|NCT00701103|582034414|FG009|Overall Study|Other|1|||
161179664|NCT00701103|582034415|FG010|Overall Study|Other|0|||
161179665|NCT01915095|582034416|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
161179666|NCT01915095|582034417|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
161179667|NCT01915095|582034418|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
161179668|NCT01915095|582034419|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
161179669|NCT01915095|582034420|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
161179670|NCT02067533|582034421|FG000|Overall Study|Lost to Follow-up|4|||
161179671|NCT02067533|582034422|FG001|Overall Study|Lost to Follow-up|2|||
161179672|NCT00565812|582034423|FG000|Overall Study|Death|2|||
161179673|NCT00565812|582034424|FG001|Overall Study|Death|1|||
161179674|NCT00565812|582034425|FG002|Overall Study|Death|3|||
161179675|NCT00565812|582034423|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
161179676|NCT00565812|582034424|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
161179677|NCT00565812|582034425|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
161179678|NCT00565812|582034423|FG000|Overall Study|Lost to Follow-up|10|||
161179679|NCT00565812|582034424|FG001|Overall Study|Lost to Follow-up|8|||
161179680|NCT00565812|582034425|FG002|Overall Study|Lost to Follow-up|8|||
161179681|NCT00565812|582034423|FG000|Overall Study|Withdrawal by Subject|58|||
161179682|NCT00565812|582034424|FG001|Overall Study|Withdrawal by Subject|47|||
161179683|NCT00565812|582034425|FG002|Overall Study|Withdrawal by Subject|48|||
161179684|NCT00565812|582034423|FG000|Overall Study|Work Schedule|5|||
161179685|NCT00565812|582034424|FG001|Overall Study|Work Schedule|3|||
161179686|NCT00565812|582034425|FG002|Overall Study|Work Schedule|1|||
161179687|NCT00565812|582034423|FG000|Overall Study|Protocol Violation|2|||
161179688|NCT00565812|582034424|FG001|Overall Study|Protocol Violation|6|||
161179689|NCT00565812|582034425|FG002|Overall Study|Protocol Violation|4|||
161179690|NCT00565812|582034423|FG000|Overall Study|Adverse Event|41|||
161179691|NCT00565812|582034424|FG001|Overall Study|Adverse Event|54|||
161179692|NCT00565812|582034425|FG002|Overall Study|Adverse Event|40|||
161179693|NCT00565812|582034423|FG000|Overall Study|Jury Duty|1|||
161179694|NCT00565812|582034424|FG001|Overall Study|Jury Duty|0|||
161179695|NCT00565812|582034425|FG002|Overall Study|Jury Duty|0|||
161179696|NCT00565812|582034423|FG000|Overall Study|Relocated Out of Area|5|||
161179697|NCT00565812|582034424|FG001|Overall Study|Relocated Out of Area|8|||
161179698|NCT00565812|582034425|FG002|Overall Study|Relocated Out of Area|9|||
161179699|NCT00565812|582034423|FG000|Overall Study|Sponsor Decision|1|||
161179700|NCT00565812|582034424|FG001|Overall Study|Sponsor Decision|5|||
161179701|NCT00565812|582034425|FG002|Overall Study|Sponsor Decision|1|||
161179702|NCT00565812|582034423|FG000|Overall Study|Domestic Reasons|7|||
161179703|NCT00565812|582034424|FG001|Overall Study|Domestic Reasons|1|||
161179704|NCT00565812|582034425|FG002|Overall Study|Domestic Reasons|3|||
161179705|NCT00565812|582034423|FG000|Overall Study|Research Site Closure|6|||
161179706|NCT00565812|582034424|FG001|Overall Study|Research Site Closure|1|||
161179707|NCT00565812|582034425|FG002|Overall Study|Research Site Closure|8|||
161179708|NCT00565812|582034423|FG000|Overall Study|Surgical Intervention|0|||
161179709|NCT00565812|582034424|FG001|Overall Study|Surgical Intervention|1|||
161179710|NCT00565812|582034425|FG002|Overall Study|Surgical Intervention|2|||
161179711|NCT00565812|582034423|FG000|Overall Study|Low Compliance|1|||
161179712|NCT00565812|582034424|FG001|Overall Study|Low Compliance|0|||
161179713|NCT00565812|582034425|FG002|Overall Study|Low Compliance|1|||
161179714|NCT00565812|582034423|FG000|Overall Study|Follow-up Visit Not Completed|2|||
161179715|NCT00565812|582034424|FG001|Overall Study|Follow-up Visit Not Completed|0|||
161179716|NCT00565812|582034425|FG002|Overall Study|Follow-up Visit Not Completed|1|||
161179717|NCT00565812|582034423|FG000|Overall Study|Physician Decision|2|||
161179718|NCT00565812|582034424|FG001|Overall Study|Physician Decision|0|||
161179719|NCT00565812|582034425|FG002|Overall Study|Physician Decision|0|||
161179720|NCT00368472|582034430|FG000|Overall Study|Adverse Event|22|||
161179721|NCT00368472|582034430|FG000|Overall Study|Medication non-compliance|4|||
161179722|NCT00368472|582034430|FG000|Overall Study|Protocol Violation|2|||
161179723|NCT00368472|582034430|FG000|Overall Study|Request of Investigator or Sponsor|3|||
161179724|NCT00368472|582034430|FG000|Overall Study|Withdrawal by Subject|40|||
161179725|NCT00368472|582034430|FG000|Overall Study|Diary non-compliance|1|||
161179726|NCT00368472|582034430|FG000|Overall Study|Other|32|||
161179727|NCT00368472|582034430|FG000|Overall Study|Missing Final Disposition Date|1|||
161179728|NCT02650895|582034432|FG000|Overall Study|Withdrawal by Subject|0|||
161179729|NCT02650895|582034433|FG001|Overall Study|Withdrawal by Subject|1|||
161179730|NCT02650895|582034434|FG002|Overall Study|Withdrawal by Subject|0|||
161179731|NCT02650895|582034435|FG003|Overall Study|Withdrawal by Subject|0|||
161179732|NCT02650895|582034436|FG004|Overall Study|Withdrawal by Subject|0|||
161179733|NCT02650895|582034437|FG005|Overall Study|Withdrawal by Subject|0|||
161179734|NCT03209362|582034438|FG000|Overall Study|Adverse Event|0|||
161179735|NCT03209362|582034439|FG001|Overall Study|Adverse Event|1|||
161179736|NCT03209362|582034438|FG000|Overall Study|Lost to Follow-up|0|||
161179737|NCT03209362|582034439|FG001|Overall Study|Lost to Follow-up|1|||
161179738|NCT03209362|582034438|FG000|Overall Study|Withdrawal by Subject|2|||
161179739|NCT03209362|582034439|FG001|Overall Study|Withdrawal by Subject|0|||
161179740|NCT03209362|582034438|FG000|Overall Study|Other|0|||
161179741|NCT03209362|582034439|FG001|Overall Study|Other|1|||
161179742|NCT00643448|582034444|FG000|Overall Study|Lack of Efficacy|2|||
161179743|NCT00643448|582034445|FG001|Overall Study|Lack of Efficacy|0|||
161179744|NCT00643448|582034446|FG002|Overall Study|Lack of Efficacy|4|||
161179745|NCT00643448|582034444|FG000|Overall Study|Adverse Event|2|||
161179746|NCT00643448|582034445|FG001|Overall Study|Adverse Event|2|||
161179747|NCT00643448|582034446|FG002|Overall Study|Adverse Event|2|||
161179748|NCT00643448|582034444|FG000|Overall Study|QTcF>550 ms|0|||
161179749|NCT00643448|582034445|FG001|Overall Study|QTcF>550 ms|3|||
161179750|NCT00643448|582034446|FG002|Overall Study|QTcF>550 ms|0|||
161179751|NCT02358863|582036723|FG000|Overall Study|Physician Decision|3|||
161179752|NCT05426460|582036728|FG000|Overall Study|Protocol Violation|1|||
161179753|NCT05426460|582036729|FG001|Overall Study|Protocol Violation|1|||
161179754|NCT05426460|582036730|FG002|Overall Study|Protocol Violation|1|||
161179755|NCT05426460|582036731|FG003|Overall Study|Protocol Violation|0|||
161179756|NCT01405027|582036734|FG000|Overall Study|Withdrawn consent|3|||
161179757|NCT01405027|582036735|FG001|Overall Study|Withdrawn consent|0|||
161179758|NCT01405027|582036734|FG000|Overall Study|Lost to Follow-up|16|||
161179759|NCT01405027|582036735|FG001|Overall Study|Lost to Follow-up|24|||
161179760|NCT01405027|582036734|FG000|Overall Study|Investigator judgement|0|||
161179761|NCT01405027|582036735|FG001|Overall Study|Investigator judgement|2|||
161179762|NCT01405027|582036734|FG000|Overall Study|Death|1|||
161179763|NCT01405027|582036735|FG001|Overall Study|Death|0|||
161179764|NCT01405027|582036734|FG000|Overall Study|Other or Unknown|12|||
161179765|NCT01405027|582036735|FG001|Overall Study|Other or Unknown|25|||
161179766|NCT02498392|582036738|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
161179767|NCT02498392|582036739|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
161179768|NCT02498392|582036738|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
161179769|NCT02498392|582036739|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
161179770|NCT02498392|582036738|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
161179771|NCT02498392|582036739|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
161179772|NCT02498392|582036738|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
161298224|NCT00267969|582475680|FG002|Controlled Period|Adverse Event|2|||
161179773|NCT02498392|582036739|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
161179774|NCT02498392|582036738|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
161179775|NCT02498392|582036739|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
161179776|NCT02498392|582036738|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
161179777|NCT02498392|582036739|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
161179778|NCT06073054|582036740|FG000|Overall Study|Withdrawal by Subject|2|||
161179779|NCT00981292|582036743|FG000|Day 1|Protocol Violation|1|||
161179780|NCT00981292|582036744|FG001|Day 1|Protocol Violation|0|||
161179781|NCT00981292|582036745|FG002|Day 1|Protocol Violation|0|||
161179782|NCT00981292|582036746|FG003|Day 1|Protocol Violation|0|||
161179783|NCT00981292|582036747|FG004|Day 1|Protocol Violation|0|||
161179784|NCT00981292|582036748|FG005|Day 1|Protocol Violation|2|||
161179785|NCT00981292|582036743|FG000|Day 2|Protocol Violation|2|||
161179786|NCT00981292|582036744|FG001|Day 2|Protocol Violation|0|||
161179787|NCT00981292|582036745|FG002|Day 2|Protocol Violation|0|||
161179788|NCT00981292|582036746|FG003|Day 2|Protocol Violation|0|||
161179789|NCT00981292|582036747|FG004|Day 2|Protocol Violation|0|||
161179790|NCT00981292|582036748|FG005|Day 2|Protocol Violation|0|||
161179791|NCT00981292|582036743|FG000|Day 3|Protocol Violation|0|||
161179792|NCT00981292|582036744|FG001|Day 3|Protocol Violation|0|||
161179793|NCT00981292|582036745|FG002|Day 3|Protocol Violation|0|||
161179794|NCT00981292|582036746|FG003|Day 3|Protocol Violation|0|||
161179795|NCT00981292|582036747|FG004|Day 3|Protocol Violation|0|||
161179796|NCT00981292|582036748|FG005|Day 3|Protocol Violation|1|||
161179797|NCT02782104|582036751|FG000|Overall Study|Other|215|||
161179798|NCT02782104|582036751|FG000|Overall Study|Induction Day 28 Non Responder|9|||
161179799|NCT02782104|582036751|FG000|Overall Study|Non-Compliance with Study Drug|2|||
161179800|NCT02782104|582036751|FG000|Overall Study|Death|8|||
161298225|NCT00267969|582475681|FG003|Controlled Period|Adverse Event|0|||
161298226|NCT00267969|582475682|FG004|Controlled Period|Adverse Event|0|||
161298227|NCT00267969|582475683|FG005|Controlled Period|Adverse Event|0|||
161298228|NCT00267969|582475684|FG006|Controlled Period|Adverse Event|0|||
161298229|NCT00267969|582475678|FG000|Controlled Period|Lack of Efficacy|3|||
161298230|NCT00267969|582475679|FG001|Controlled Period|Lack of Efficacy|0|||
161298231|NCT00267969|582475680|FG002|Controlled Period|Lack of Efficacy|1|||
161298232|NCT00267969|582475681|FG003|Controlled Period|Lack of Efficacy|0|||
161298233|NCT00267969|582475682|FG004|Controlled Period|Lack of Efficacy|0|||
161298234|NCT00267969|582475683|FG005|Controlled Period|Lack of Efficacy|0|||
161298235|NCT00267969|582475684|FG006|Controlled Period|Lack of Efficacy|0|||
161298236|NCT00267969|582475678|FG000|Controlled Period|Lost to Follow-up|1|||
161298237|NCT00267969|582475679|FG001|Controlled Period|Lost to Follow-up|0|||
161298238|NCT00267969|582475680|FG002|Controlled Period|Lost to Follow-up|1|||
161298239|NCT00267969|582475681|FG003|Controlled Period|Lost to Follow-up|0|||
161298240|NCT00267969|582475682|FG004|Controlled Period|Lost to Follow-up|0|||
161298241|NCT00267969|582475683|FG005|Controlled Period|Lost to Follow-up|0|||
161298242|NCT00267969|582475684|FG006|Controlled Period|Lost to Follow-up|0|||
161298243|NCT00267969|582475678|FG000|Controlled Period|Randomized but not treated|0|||
161298244|NCT00267969|582475679|FG001|Controlled Period|Randomized but not treated|0|||
161298245|NCT00267969|582475680|FG002|Controlled Period|Randomized but not treated|1|||
161298246|NCT00267969|582475681|FG003|Controlled Period|Randomized but not treated|0|||
161298247|NCT00267969|582475682|FG004|Controlled Period|Randomized but not treated|0|||
161298248|NCT00267969|582475683|FG005|Controlled Period|Randomized but not treated|0|||
161298249|NCT00267969|582475684|FG006|Controlled Period|Randomized but not treated|0|||
161298250|NCT00267969|582475678|FG000|Controlled Period|Other|2|||
161298251|NCT00267969|582475679|FG001|Controlled Period|Other|1|||
161298252|NCT00267969|582475680|FG002|Controlled Period|Other|6|||
161298253|NCT00267969|582475681|FG003|Controlled Period|Other|0|||
161298254|NCT00267969|582475682|FG004|Controlled Period|Other|0|||
161298255|NCT00267969|582475683|FG005|Controlled Period|Other|0|||
161298256|NCT00267969|582475684|FG006|Controlled Period|Other|0|||
161298257|NCT00267969|582475678|FG000|After Controlled Period|Adverse Event|0|||
161298258|NCT00267969|582475679|FG001|After Controlled Period|Adverse Event|0|||
161298259|NCT00267969|582475680|FG002|After Controlled Period|Adverse Event|0|||
161298260|NCT00267969|582475681|FG003|After Controlled Period|Adverse Event|7|||
161298261|NCT00267969|582475682|FG004|After Controlled Period|Adverse Event|8|||
161298262|NCT00267969|582475683|FG005|After Controlled Period|Adverse Event|23|||
161298263|NCT00267969|582475684|FG006|After Controlled Period|Adverse Event|21|||
161298264|NCT00267969|582475678|FG000|After Controlled Period|Death|0|||
161298265|NCT00267969|582475679|FG001|After Controlled Period|Death|0|||
161298266|NCT00267969|582475680|FG002|After Controlled Period|Death|0|||
161298267|NCT00267969|582475681|FG003|After Controlled Period|Death|1|||
161298268|NCT00267969|582475682|FG004|After Controlled Period|Death|2|||
161298269|NCT00267969|582475683|FG005|After Controlled Period|Death|0|||
161298270|NCT00267969|582475684|FG006|After Controlled Period|Death|1|||
161298271|NCT00267969|582475678|FG000|After Controlled Period|Lack of Efficacy|0|||
161298272|NCT00267969|582475679|FG001|After Controlled Period|Lack of Efficacy|0|||
161298273|NCT00267969|582475680|FG002|After Controlled Period|Lack of Efficacy|0|||
161298274|NCT00267969|582475681|FG003|After Controlled Period|Lack of Efficacy|10|||
161298275|NCT00267969|582475682|FG004|After Controlled Period|Lack of Efficacy|6|||
161298276|NCT00267969|582475683|FG005|After Controlled Period|Lack of Efficacy|28|||
161298277|NCT00267969|582475684|FG006|After Controlled Period|Lack of Efficacy|15|||
161298278|NCT00267969|582475678|FG000|After Controlled Period|Lost to Follow-up|0|||
161298279|NCT00267969|582475679|FG001|After Controlled Period|Lost to Follow-up|0|||
161298280|NCT00267969|582475680|FG002|After Controlled Period|Lost to Follow-up|0|||
161347767|NCT02903914|582657364|FG003|Overall Study|Progressive Disease|0|||
161347768|NCT02903914|582657365|FG004|Overall Study|Progressive Disease|0|||
161347769|NCT02903914|582657366|FG005|Overall Study|Progressive Disease|0|||
161298281|NCT00267969|582475681|FG003|After Controlled Period|Lost to Follow-up|5|||
161347770|NCT02903914|582657367|FG006|Overall Study|Progressive Disease|2|||
161179801|NCT02782104|582036751|FG000|Overall Study|Pregnancy|6|||
161298282|NCT00267969|582475682|FG004|After Controlled Period|Lost to Follow-up|8|||
161298283|NCT00267969|582475683|FG005|After Controlled Period|Lost to Follow-up|9|||
161298284|NCT00267969|582475684|FG006|After Controlled Period|Lost to Follow-up|10|||
161298285|NCT00267969|582475678|FG000|After Controlled Period|Other|0|||
161298286|NCT00267969|582475679|FG001|After Controlled Period|Other|0|||
161298287|NCT00267969|582475680|FG002|After Controlled Period|Other|0|||
161298288|NCT00267969|582475681|FG003|After Controlled Period|Other|13|||
161179802|NCT02782104|582036751|FG000|Overall Study|Withdrawal by Subject|63|||
161179803|NCT02782104|582036751|FG000|Overall Study|Protocol Violation|7|||
161179804|NCT02782104|582036751|FG000|Overall Study|Lack of Efficacy|61|||
161179805|NCT02782104|582036751|FG000|Overall Study|Lost to Follow-up|23|||
161179806|NCT02782104|582036751|FG000|Overall Study|Adverse Event|74|||
161179807|NCT02438787|582036752|FG000|Overall Study|Adverse Event|1|||
161179808|NCT02438787|582036753|FG001|Overall Study|Adverse Event|0|||
161179809|NCT02438787|582036754|FG002|Overall Study|Adverse Event|2|||
161179810|NCT02438787|582036752|FG000|Overall Study|Lack of Efficacy|1|||
161179811|NCT02438787|582036753|FG001|Overall Study|Lack of Efficacy|2|||
161179812|NCT02438787|582036754|FG002|Overall Study|Lack of Efficacy|0|||
161179813|NCT02438787|582036752|FG000|Overall Study|Lost to Follow-up|0|||
161179814|NCT02438787|582036753|FG001|Overall Study|Lost to Follow-up|1|||
161179815|NCT02438787|582036754|FG002|Overall Study|Lost to Follow-up|0|||
161179816|NCT02438787|582036752|FG000|Overall Study|Protocol Violation|0|||
161179817|NCT02438787|582036753|FG001|Overall Study|Protocol Violation|0|||
161179818|NCT02438787|582036754|FG002|Overall Study|Protocol Violation|1|||
161179819|NCT02438787|582036752|FG000|Overall Study|Withdrawal by Subject|15|||
161179820|NCT02438787|582036753|FG001|Overall Study|Withdrawal by Subject|7|||
161179821|NCT02438787|582036754|FG002|Overall Study|Withdrawal by Subject|10|||
161179822|NCT02438787|582036752|FG000|Overall Study|Study discontinued by sponsor|64|||
161179823|NCT02438787|582036753|FG001|Overall Study|Study discontinued by sponsor|72|||
161179824|NCT02438787|582036754|FG002|Overall Study|Study discontinued by sponsor|69|||
161179825|NCT02438787|582036752|FG000|Overall Study|Other|0|||
161179826|NCT02438787|582036753|FG001|Overall Study|Other|1|||
161179827|NCT02438787|582036754|FG002|Overall Study|Other|0|||
161179828|NCT02438787|582036752|FG000|Overall Study|Site terminated by sponsor|0|||
161179829|NCT02438787|582036753|FG001|Overall Study|Site terminated by sponsor|0|||
161179830|NCT02438787|582036754|FG002|Overall Study|Site terminated by sponsor|1|||
161179831|NCT03412565|582036755|FG000|Overall Study|Lost to Follow-up|0|||
161179832|NCT03412565|582036756|FG001|Overall Study|Lost to Follow-up|0|||
161179833|NCT03412565|582036757|FG002|Overall Study|Lost to Follow-up|1|||
161179834|NCT03412565|582036758|FG003|Overall Study|Lost to Follow-up|0|||
161179835|NCT03412565|582036755|FG000|Overall Study|Physician Decision|0|||
161179836|NCT03412565|582036756|FG001|Overall Study|Physician Decision|0|||
161179837|NCT03412565|582036757|FG002|Overall Study|Physician Decision|0|||
161179838|NCT03412565|582036758|FG003|Overall Study|Physician Decision|1|||
161179839|NCT03412565|582036755|FG000|Overall Study|Withdrawal by Subject|0|||
161179840|NCT03412565|582036756|FG001|Overall Study|Withdrawal by Subject|4|||
161179841|NCT03412565|582036757|FG002|Overall Study|Withdrawal by Subject|5|||
161179842|NCT03412565|582036758|FG003|Overall Study|Withdrawal by Subject|5|||
161179843|NCT03412565|582036755|FG000|Overall Study|Death|1|||
161179844|NCT03412565|582036756|FG001|Overall Study|Death|3|||
161179845|NCT03412565|582036757|FG002|Overall Study|Death|4|||
161179846|NCT03412565|582036758|FG003|Overall Study|Death|5|||
161179847|NCT03412565|582036755|FG000|Overall Study|Data collection ended|0|||
161179848|NCT03412565|582036756|FG001|Overall Study|Data collection ended|41|||
161179849|NCT03412565|582036757|FG002|Overall Study|Data collection ended|41|||
161179850|NCT03412565|582036758|FG003|Overall Study|Data collection ended|40|||
161179851|NCT01849562|582036768|FG000|Overall Study|Lost to Follow-up|1|||
161179852|NCT01849562|582036769|FG001|Overall Study|Lost to Follow-up|0|||
161179853|NCT01849562|582036770|FG002|Overall Study|Lost to Follow-up|0|||
161179854|NCT01849562|582036768|FG000|Overall Study|Non-compliance with Study Drug|1|||
161179855|NCT01849562|582036769|FG001|Overall Study|Non-compliance with Study Drug|0|||
161179856|NCT01849562|582036770|FG002|Overall Study|Non-compliance with Study Drug|0|||
161179857|NCT00481988|582036773|FG000|Overall Study|Withdrawal by Subject|1|||
161179858|NCT00481988|582036774|FG001|Overall Study|Withdrawal by Subject|1|||
161179859|NCT02252588|582036777|FG000|Overall Study|Withdrawal by Subject|4|||
161179860|NCT02252588|582036778|FG001|Overall Study|Withdrawal by Subject|0|||
161179861|NCT00693693|582036779|FG000|Overall Study|Lost to Follow-up|1|||
161179862|NCT00693693|582036780|FG001|Overall Study|Lost to Follow-up|1|||
161179863|NCT00693693|582036781|FG002|Overall Study|Lost to Follow-up|2|||
161179864|NCT04599972|582036786|FG000|Overall Study|Withdrawal by Subject|6|||
161179865|NCT04599972|582036787|FG001|Overall Study|Withdrawal by Subject|1|||
161179866|NCT04599972|582036786|FG000|Overall Study|Adverse Event|1|||
161179867|NCT04599972|582036787|FG001|Overall Study|Adverse Event|1|||
161179868|NCT04599972|582036786|FG000|Overall Study|Lost to Follow-up|1|||
161179869|NCT04599972|582036787|FG001|Overall Study|Lost to Follow-up|6|||
161179870|NCT04599972|582036786|FG000|Overall Study|Protocol Violation|1|||
161179871|NCT04599972|582036787|FG001|Overall Study|Protocol Violation|0|||
161298289|NCT00267969|582475682|FG004|After Controlled Period|Other|11|||
161179872|NCT04599972|582036786|FG000|Overall Study|Other reason|1|||
161179873|NCT04599972|582036787|FG001|Overall Study|Other reason|0|||
161179874|NCT00638690|582036790|FG000|Overall Study|Death|655|||
161179875|NCT00638690|582036791|FG001|Overall Study|Death|335|||
161179876|NCT00638690|582036790|FG000|Overall Study|Withdrawal by Subject|22|||
161179877|NCT00638690|582036791|FG001|Overall Study|Withdrawal by Subject|5|||
161179878|NCT00638690|582036790|FG000|Overall Study|Lost to Follow-up|4|||
161179879|NCT00638690|582036791|FG001|Overall Study|Lost to Follow-up|2|||
161179880|NCT01025232|582036797|FG000|Overall Study|Study drug no longer available|3|||
161179881|NCT01025232|582036798|FG001|Overall Study|Study drug no longer available|6|||
161298290|NCT00267969|582475683|FG005|After Controlled Period|Other|22|||
161298291|NCT00267969|582475684|FG006|After Controlled Period|Other|25|||
161298292|NCT00862823|582475685|FG000|First Intervention|Withdrawal by Subject|1|||
161298293|NCT00862823|582475686|FG001|First Intervention|Withdrawal by Subject|1|||
161298294|NCT00887315|582475687|FG000|Overall Study|Study termination|7|||
161298295|NCT00887315|582475688|FG001|Overall Study|Study termination|4|||
161298296|NCT00619892|582475692|FG000|Overall Study|Adverse Event|3|||
161298297|NCT00619892|582475693|FG001|Overall Study|Adverse Event|0|||
161298298|NCT00619892|582475692|FG000|Overall Study|Lost to Follow-up|0|||
161298299|NCT00619892|582475693|FG001|Overall Study|Lost to Follow-up|1|||
161298300|NCT00619892|582475692|FG000|Overall Study|Intercurrent illness|0|||
161298301|NCT00619892|582475693|FG001|Overall Study|Intercurrent illness|1|||
161298302|NCT00857896|582475700|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
161298303|NCT01091662|582475702|FG000|Overall Study|Adverse Event|1|||
161298304|NCT01091662|582475703|FG001|Overall Study|Adverse Event|9|||
161298305|NCT01091662|582475702|FG000|Overall Study|Physician Decision|1|||
161298306|NCT01091662|582475703|FG001|Overall Study|Physician Decision|1|||
161298307|NCT01091662|582475702|FG000|Overall Study|Withdrawal by Subject|7|||
161298308|NCT01091662|582475703|FG001|Overall Study|Withdrawal by Subject|6|||
161298309|NCT01091662|582475702|FG000|Overall Study|met exit criteria|7|||
161298310|NCT01091662|582475703|FG001|Overall Study|met exit criteria|13|||
161298311|NCT01091662|582475702|FG000|Overall Study|met exclusion criteria|1|||
161298312|NCT01091662|582475703|FG001|Overall Study|met exclusion criteria|0|||
161298313|NCT01091662|582475702|FG000|Overall Study|Lost to Follow-up|0|||
161298314|NCT01091662|582475703|FG001|Overall Study|Lost to Follow-up|1|||
161298315|NCT01091662|582475702|FG000|Overall Study|Pregnancy|0|||
161298316|NCT01091662|582475703|FG001|Overall Study|Pregnancy|1|||
161298317|NCT01091662|582475702|FG000|Overall Study|Protocol Violation|0|||
161298318|NCT01091662|582475703|FG001|Overall Study|Protocol Violation|2|||
161298319|NCT01091662|582475702|FG000|Overall Study|unable to swallow capsule|0|||
161298320|NCT01091662|582475703|FG001|Overall Study|unable to swallow capsule|1|||
161298321|NCT00443079|582475706|FG000|Overall Study|Lost to Follow-up|0|||
161298322|NCT00443079|582475707|FG001|Overall Study|Lost to Follow-up|1|||
161298323|NCT01421225|582475708|FG000|Overall Study|Withdrawal by Subject|0|||
161298324|NCT01421225|582475709|FG001|Overall Study|Withdrawal by Subject|1|||
161298325|NCT02049814|582475710|FG000|Overall Study|Reason not Specified|4|||
161298326|NCT02049814|582475711|FG001|Overall Study|Reason not Specified|3|||
161298327|NCT02049814|582475710|FG000|Overall Study|Pregnancy|1|||
161298328|NCT02049814|582475711|FG001|Overall Study|Pregnancy|0|||
161298329|NCT02049814|582475710|FG000|Overall Study|Lost to Follow-up|2|||
161298330|NCT02049814|582475711|FG001|Overall Study|Lost to Follow-up|3|||
161298331|NCT02049814|582475710|FG000|Overall Study|Serious Protocol Violation|5|||
161298332|NCT02049814|582475711|FG001|Overall Study|Serious Protocol Violation|7|||
161298333|NCT02049814|582475710|FG000|Overall Study|Study Termination|0|||
161298334|NCT02049814|582475711|FG001|Overall Study|Study Termination|1|||
161298335|NCT02049814|582475710|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
161298336|NCT02049814|582475711|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
161298337|NCT02049814|582475710|FG000|Overall Study|Voluntary withdrawal|9|||
161298338|NCT02049814|582475711|FG001|Overall Study|Voluntary withdrawal|8|||
161298339|NCT02714595|582475712|FG000|Overall Study|Lost to Follow-up|1|||
161298340|NCT02714595|582475713|FG001|Overall Study|Lost to Follow-up|0|||
161298341|NCT02714595|582475712|FG000|Overall Study|Withdrawal by Subject|1|||
161298342|NCT02714595|582475713|FG001|Overall Study|Withdrawal by Subject|2|||
161298343|NCT02714595|582475712|FG000|Overall Study|Lack of Efficacy|0|||
161298344|NCT02714595|582475713|FG001|Overall Study|Lack of Efficacy|1|||
161298345|NCT02714595|582475712|FG000|Overall Study|Death|30|||
161298346|NCT02714595|582475713|FG001|Overall Study|Death|9|||
161298347|NCT02714595|582475712|FG000|Overall Study|Other-Miscellaneous|0|||
161298348|NCT02714595|582475713|FG001|Overall Study|Other-Miscellaneous|1|||
161298349|NCT00713258|582475714|FG000|Overall Study|Adverse Event|2|||
161298350|NCT00713258|582475715|FG001|Overall Study|Adverse Event|4|||
161298351|NCT00713258|582475714|FG000|Overall Study|Non-Compliance|2|||
161298352|NCT00713258|582475715|FG001|Overall Study|Non-Compliance|1|||
161298353|NCT00713258|582475714|FG000|Overall Study|Other|1|||
161298354|NCT00713258|582475715|FG001|Overall Study|Other|1|||
161298355|NCT03515811|582475728|FG000|Overall Study|Lost to Follow-up|2|||
161298356|NCT03515811|582475729|FG001|Overall Study|Lost to Follow-up|1|||
161298357|NCT03515811|582475728|FG000|Overall Study|Protocol Violation|1|||
161298358|NCT03515811|582475729|FG001|Overall Study|Protocol Violation|1|||
161347771|NCT02903914|582657368|FG007|Overall Study|Progressive Disease|0|||
161298359|NCT03515811|582475728|FG000|Overall Study|Death|1|||
161298360|NCT03515811|582475729|FG001|Overall Study|Death|1|||
161298361|NCT03515811|582475728|FG000|Overall Study|Withdrawal by Subject|0|||
161298362|NCT03515811|582475729|FG001|Overall Study|Withdrawal by Subject|2|||
161298363|NCT03515811|582475728|FG000|Overall Study|Technical Problems|1|||
161298364|NCT03515811|582475729|FG001|Overall Study|Technical Problems|0|||
161298365|NCT03515811|582475728|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
161347772|NCT02903914|582657361|FG000|Overall Study|Death|0|||
161347773|NCT02903914|582657362|FG001|Overall Study|Death|0|||
161298366|NCT03515811|582475729|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
161298367|NCT03515811|582475728|FG000|Overall Study|COVID-19|0|||
161298368|NCT03515811|582475729|FG001|Overall Study|COVID-19|1|||
161347774|NCT02903914|582657363|FG002|Overall Study|Death|9|||
161347775|NCT02903914|582657364|FG003|Overall Study|Death|0|||
161347776|NCT02903914|582657365|FG004|Overall Study|Death|1|||
161347777|NCT02903914|582657366|FG005|Overall Study|Death|3|||
161347778|NCT02903914|582657367|FG006|Overall Study|Death|24|||
161347779|NCT02903914|582657368|FG007|Overall Study|Death|2|||
161347780|NCT02903914|582657361|FG000|Overall Study|Lost to Follow-up|0|||
161298369|NCT01197534|582475730|FG000|Overall Study|Not reported|16|||
161298370|NCT01197534|582475731|FG001|Overall Study|Not reported|10|||
161298371|NCT01197534|582475732|FG002|Overall Study|Not reported|16|||
161298372|NCT01197534|582475730|FG000|Overall Study|Enrolment in long term extension|57|||
161298373|NCT01197534|582475731|FG001|Overall Study|Enrolment in long term extension|66|||
161298374|NCT01197534|582475732|FG002|Overall Study|Enrolment in long term extension|119|||
161298375|NCT01197534|582475730|FG000|Overall Study|Severe non-compliance to protocol|3|||
161298376|NCT01197534|582475731|FG001|Overall Study|Severe non-compliance to protocol|4|||
161347781|NCT02903914|582657362|FG001|Overall Study|Lost to Follow-up|1|||
161347782|NCT02903914|582657363|FG002|Overall Study|Lost to Follow-up|0|||
161347783|NCT02903914|582657364|FG003|Overall Study|Lost to Follow-up|0|||
161088808|NCT04494256|581715274|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
161088809|NCT04494256|581715275|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
161088810|NCT04494256|581715269|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161088811|NCT04494256|581715270|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161088812|NCT04494256|581715271|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161088813|NCT04494256|581715272|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161088814|NCT04494256|581715273|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
161088815|NCT04494256|581715274|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
161088816|NCT04494256|581715275|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
161088817|NCT04494256|581715269|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088818|NCT04494256|581715270|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088819|NCT04494256|581715271|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088820|NCT04494256|581715272|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088821|NCT04494256|581715273|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
161088822|NCT04494256|581715274|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
161088823|NCT04494256|581715275|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
161088824|NCT04494256|581715269|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161088825|NCT04494256|581715270|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161088826|NCT04494256|581715271|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161088827|NCT04494256|581715272|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161088828|NCT04494256|581715273|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
161088829|NCT04494256|581715274|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
161088830|NCT04494256|581715275|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
161088831|NCT00262951|581715276|FG000|Overall Study|Progressive disease/relapse|3|||
161088832|NCT00262951|581715276|FG000|Overall Study|Adverse Event|7|||
161088833|NCT00262951|581715276|FG000|Overall Study|Death|1|||
161088834|NCT00262951|581715276|FG000|Overall Study|Withdrawal by Subject|1|||
161088835|NCT00262951|581715276|FG000|Overall Study|Alternative treatment|3|||
161088836|NCT00262951|581715276|FG000|Overall Study|Off treatment for other disease|1|||
161088837|NCT02483585|581715277|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
161088838|NCT02483585|581715278|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
161088839|NCT02483585|581715277|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
161088840|NCT02483585|581715278|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
161088841|NCT02483585|581715277|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
161088842|NCT02483585|581715278|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
161088843|NCT02483585|581715277|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
161088844|NCT02483585|581715278|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
161179882|NCT03748420|582036799|FG000|Overall Study|No 12 month medication adherence data available|0|||
161298377|NCT01197534|582475732|FG002|Overall Study|Severe non-compliance to protocol|1|||
161298378|NCT01197534|582475730|FG000|Overall Study|Lack of therapeutic response|9|||
161298379|NCT01197534|582475731|FG001|Overall Study|Lack of therapeutic response|4|||
161298380|NCT01197534|582475732|FG002|Overall Study|Lack of therapeutic response|9|||
161347784|NCT02903914|582657365|FG004|Overall Study|Lost to Follow-up|2|||
161347785|NCT02903914|582657366|FG005|Overall Study|Lost to Follow-up|0|||
161347786|NCT02903914|582657367|FG006|Overall Study|Lost to Follow-up|1|||
161347787|NCT02903914|582657368|FG007|Overall Study|Lost to Follow-up|0|||
161347788|NCT02903914|582657361|FG000|Overall Study|Physician Decision|0|||
161347789|NCT02903914|582657362|FG001|Overall Study|Physician Decision|0|||
161179883|NCT03748420|582036800|FG001|Overall Study|No 12 month medication adherence data available|1|||
161179884|NCT03748420|582036799|FG000|Overall Study|Death|24|||
161179885|NCT03748420|582036800|FG001|Overall Study|Death|28|||
161179886|NCT03748420|582036799|FG000|Overall Study|Lost to Follow-up|231|||
161179887|NCT03748420|582036800|FG001|Overall Study|Lost to Follow-up|230|||
161179888|NCT00373880|582036801|FG000|Overall Study|Physician Decision|3|||
161179889|NCT00373880|582036801|FG000|Overall Study|Arrested|1|||
161179890|NCT00373880|582036801|FG000|Overall Study|Protocol Violation|14|||
161179891|NCT01347073|582036803|FG000|Overall Study|Adverse Event|1|||
161179892|NCT01347073|582036803|FG000|Overall Study|Liver Transplant|1|||
161179893|NCT03152110|582036814|FG000|Overall Study|Withdrawal by Subject|3|||
161179894|NCT01634100|582036826|FG000|Overall Study|Withdrawal by Subject|1|||
161179895|NCT01634100|582036827|FG001|Overall Study|Withdrawal by Subject|0|||
161179896|NCT01634100|582036828|FG002|Overall Study|Withdrawal by Subject|1|||
161179897|NCT01634100|582036829|FG003|Overall Study|Withdrawal by Subject|0|||
161179898|NCT01634100|582036830|FG004|Overall Study|Withdrawal by Subject|0|||
161179899|NCT01634100|582036831|FG005|Overall Study|Withdrawal by Subject|0|||
161179900|NCT00552344|582036832|FG000|Overall Study|Lack of Efficacy|55|||
161179901|NCT00552344|582036832|FG000|Overall Study|Loss of efficacy|75|||
161179902|NCT00552344|582036832|FG000|Overall Study|Lost to Follow-up|8|||
161179903|NCT00552344|582036832|FG000|Overall Study|Withdrawal by Subject|48|||
161179904|NCT00552344|582036832|FG000|Overall Study|SAE, non-fatal|6|||
161179905|NCT00552344|582036832|FG000|Overall Study|AE, non-serious non-fatal|38|||
161179906|NCT00552344|582036832|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
161179907|NCT00552344|582036832|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
161179908|NCT00552344|582036832|FG000|Overall Study|Other Reason|22|||
161179909|NCT00338806|582036833|FG000|Acute Phase|Withdrawal by Subject|0|||
161179910|NCT00338806|582036834|FG001|Acute Phase|Withdrawal by Subject|1|||
161179911|NCT00338806|582036833|FG000|Follow-up|Lost to Follow-up|1|||
161179912|NCT00338806|582036834|FG001|Follow-up|Lost to Follow-up|3|||
161179913|NCT01819194|582036840|FG000|Overall Study|Loss of study articles|2|||
161179914|NCT00045630|582036841|FG000|Overall Study|Adverse Event|1|||
161179915|NCT00045630|582036841|FG000|Overall Study|Refusal unrelated to adverse event|1|||
161179916|NCT00045630|582036841|FG000|Overall Study|Progression/relapse|1|||
161179917|NCT00045630|582036841|FG000|Overall Study|Death|1|||
161179918|NCT00045630|582036841|FG000|Overall Study|Ineligible|2|||
161179919|NCT04449276|582036842|FG000|Overall Study|Adverse Event|1|||
161179920|NCT04449276|582036843|FG001|Overall Study|Adverse Event|2|||
161179921|NCT04449276|582036844|FG002|Overall Study|Adverse Event|0|||
161179922|NCT04449276|582036845|FG003|Overall Study|Adverse Event|0|||
161179923|NCT04449276|582036846|FG004|Overall Study|Adverse Event|2|||
161179924|NCT04449276|582036847|FG005|Overall Study|Adverse Event|0|||
161179925|NCT04449276|582036848|FG006|Overall Study|Adverse Event|0|||
161179926|NCT04449276|582036849|FG007|Overall Study|Adverse Event|1|||
161179927|NCT04449276|582036842|FG000|Overall Study|Withdrawal by Subject|2|||
161179928|NCT04449276|582036843|FG001|Overall Study|Withdrawal by Subject|0|||
161179929|NCT04449276|582036844|FG002|Overall Study|Withdrawal by Subject|0|||
161179930|NCT04449276|582036845|FG003|Overall Study|Withdrawal by Subject|1|||
161179931|NCT04449276|582036846|FG004|Overall Study|Withdrawal by Subject|0|||
161179932|NCT04449276|582036847|FG005|Overall Study|Withdrawal by Subject|0|||
161179933|NCT04449276|582036848|FG006|Overall Study|Withdrawal by Subject|0|||
161179934|NCT04449276|582036849|FG007|Overall Study|Withdrawal by Subject|0|||
161179935|NCT04449276|582036842|FG000|Overall Study|Other|0|||
161179936|NCT04449276|582036843|FG001|Overall Study|Other|2|||
161179937|NCT04449276|582036844|FG002|Overall Study|Other|3|||
161179938|NCT04449276|582036845|FG003|Overall Study|Other|2|||
161179939|NCT04449276|582036846|FG004|Overall Study|Other|0|||
161179940|NCT04449276|582036847|FG005|Overall Study|Other|0|||
161179941|NCT04449276|582036848|FG006|Overall Study|Other|0|||
161179942|NCT04449276|582036849|FG007|Overall Study|Other|1|||
161179943|NCT00179517|582036851|FG000|Overall Study|Withdrawal by Subject|2|||
161179944|NCT00179517|582036852|FG001|Overall Study|Withdrawal by Subject|1|||
161179945|NCT01448707|582036856|FG000|Overall Study|Adverse Event|3|||
161179946|NCT01448707|582036857|FG001|Overall Study|Adverse Event|1|||
161179947|NCT01448707|582036856|FG000|Overall Study|Lost to Follow-up|2|||
161179948|NCT01448707|582036857|FG001|Overall Study|Lost to Follow-up|6|||
161179949|NCT01448707|582036856|FG000|Overall Study|Withdrawal by Subject|6|||
161179950|NCT01448707|582036857|FG001|Overall Study|Withdrawal by Subject|7|||
161179951|NCT01448707|582036856|FG000|Overall Study|Other|7|||
161179952|NCT01448707|582036857|FG001|Overall Study|Other|4|||
161179953|NCT00383708|582036863|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
161179954|NCT00383708|582036863|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
161179955|NCT00383708|582036863|FG000|Run-in Period|Protocol Violation|4|||
161179956|NCT00383708|582036863|FG000|Run-in Period|Adverse Event|2|||
161179957|NCT00383708|582036863|FG000|Run-in Period|Claustrophobia|1|||
161179958|NCT00383708|582036863|FG000|Co-administration Period|Adverse Event|5|||
161179959|NCT02033850|582036864|FG000|Overall Study|Death|1|||
161179960|NCT02033850|582036865|FG001|Overall Study|Death|0|||
161179961|NCT02033850|582036864|FG000|Overall Study|unrelated medical reason|1|||
161179962|NCT02033850|582036865|FG001|Overall Study|unrelated medical reason|1|||
161179963|NCT02820038|582036869|FG000|Overall Study|Lost to Follow-up|7|||
161179964|NCT02820038|582036870|FG001|Overall Study|Lost to Follow-up|11|||
161179965|NCT02820038|582036871|FG002|Overall Study|Lost to Follow-up|2|||
161179966|NCT02820038|582036872|FG003|Overall Study|Lost to Follow-up|9|||
161179967|NCT02820038|582036869|FG000|Overall Study|Withdrawal by Subject|3|||
161179968|NCT02820038|582036870|FG001|Overall Study|Withdrawal by Subject|14|||
161179969|NCT02820038|582036871|FG002|Overall Study|Withdrawal by Subject|3|||
161179970|NCT02820038|582036872|FG003|Overall Study|Withdrawal by Subject|13|||
161179971|NCT03215667|582036873|FG000|Overall Study|Physician Decision|4|||
161179972|NCT00560794|582036875|FG000|Overall Study|Adverse Event|2|||
161179973|NCT00560794|582036875|FG000|Overall Study|Patient was not Compliant|1|||
161179974|NCT00560794|582036875|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
161179975|NCT00560794|582036875|FG000|Overall Study|Hematological Relapse|1|||
161179976|NCT00560794|582036875|FG000|Overall Study|Received Bone Marrow Transplant|6|||
161179977|NCT04857892|582036876|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
161179978|NCT04857892|582036877|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161179979|NCT04857892|582036878|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161179980|NCT04857892|582036879|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161179981|NCT04857892|582036880|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
161179982|NCT04857892|582036876|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
161179983|NCT04857892|582036877|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
161179984|NCT04857892|582036878|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
161179985|NCT04857892|582036879|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
161179986|NCT04857892|582036880|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
161179987|NCT04857892|582036876|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161179988|NCT04857892|582036877|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161179989|NCT04857892|582036878|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161179990|NCT04857892|582036879|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
161179991|NCT04857892|582036880|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
161179992|NCT01922739|582036881|FG000|Titration/Adjustment Period|Adverse Event|3|||
161179993|NCT01922739|582036881|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
161179994|NCT01922739|582036881|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
161179995|NCT01922739|582036881|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
161179996|NCT01922739|582036881|FG000|Open-label Treatment Period|Adverse Event|6|||
161179997|NCT01922739|582036881|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
161179998|NCT01922739|582036881|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
161179999|NCT01922739|582036881|FG000|Open-label Treatment Period|Protocol Violation|5|||
161180000|NCT01922739|582036881|FG000|Open-label Treatment Period|Pregnancy|1|||
161180001|NCT01922739|582036881|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
161180002|NCT01922739|582036881|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
161180003|NCT01922739|582036881|FG000|Open-label Treatment Period|Physician Decision|1|||
161180004|NCT01922739|582036881|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
161180005|NCT05104749|582036882|FG000|Overall Study|Lost to Follow-up|2|||
161180006|NCT05104749|582036883|FG001|Overall Study|Lost to Follow-up|3|||
161180007|NCT02963766|582036884|FG000|Double-Blind Period|Adverse Event|1|||
161180008|NCT02963766|582036885|FG001|Double-Blind Period|Adverse Event|0|||
161180009|NCT02963766|582036886|FG002|Double-Blind Period|Adverse Event|1|||
161180010|NCT02963766|582036884|FG000|Double-Blind Period|Physician Decision|1|||
161180011|NCT02963766|582036885|FG001|Double-Blind Period|Physician Decision|0|||
161180012|NCT02963766|582036886|FG002|Double-Blind Period|Physician Decision|0|||
161180013|NCT02963766|582036884|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161180014|NCT02963766|582036885|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161180015|NCT02963766|582036886|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161180016|NCT02963766|582036884|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
161180017|NCT02963766|582036885|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
161180018|NCT02963766|582036886|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
161298381|NCT01197534|582475730|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
161180019|NCT02963766|582036884|FG000|Double-Blind Period|Protocol Violation|1|||
161180020|NCT02963766|582036885|FG001|Double-Blind Period|Protocol Violation|0|||
161180021|NCT02963766|582036886|FG002|Double-Blind Period|Protocol Violation|0|||
161180022|NCT02963766|582036884|FG000|Double-Blind Period|Lost to Follow-up|0|||
161180023|NCT02963766|582036885|FG001|Double-Blind Period|Lost to Follow-up|1|||
161180024|NCT02963766|582036886|FG002|Double-Blind Period|Lost to Follow-up|0|||
161180025|NCT02963766|582036884|FG000|Open Label Extension (OLE)|Physician Decision|1|||
161180026|NCT02963766|582036885|FG001|Open Label Extension (OLE)|Physician Decision|2|||
161180027|NCT02963766|582036886|FG002|Open Label Extension (OLE)|Physician Decision|2|||
161180028|NCT02963766|582036884|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
161298382|NCT01197534|582475731|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
161298383|NCT01197534|582475732|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
161180029|NCT02963766|582036885|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
161180030|NCT02963766|582036886|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
161180031|NCT00901394|582036887|FG000|Overall Study|Physician Decision|1|||
161180032|NCT00901394|582036888|FG001|Overall Study|Physician Decision|1|||
161180033|NCT00901394|582036889|FG002|Overall Study|Physician Decision|2|||
161180034|NCT04964557|582036893|FG000|Overall Study|Withdrawal by Subject|3|||
161180035|NCT04964557|582036894|FG001|Overall Study|Withdrawal by Subject|2|||
161180036|NCT04964557|582036893|FG000|Overall Study|Lost to Follow-up|1|||
161180037|NCT04964557|582036894|FG001|Overall Study|Lost to Follow-up|2|||
161180038|NCT04964557|582036893|FG000|Overall Study|Physician Decision|2|||
161180039|NCT04964557|582036894|FG001|Overall Study|Physician Decision|0|||
161180040|NCT04964557|582036893|FG000|Overall Study|Death|3|||
161180041|NCT04964557|582036894|FG001|Overall Study|Death|0|||
161180042|NCT04964557|582036893|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
161180043|NCT04964557|582036894|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
161180044|NCT00251589|582036896|FG000|Overall Study|Adverse Event|5|||
161180045|NCT00251589|582036897|FG001|Overall Study|Adverse Event|1|||
161180046|NCT00251589|582036898|FG002|Overall Study|Adverse Event|2|||
161180047|NCT00251589|582036899|FG003|Overall Study|Adverse Event|1|||
161180048|NCT00251589|582036896|FG000|Overall Study|Withdrawal by Subject|1|||
161180049|NCT00251589|582036897|FG001|Overall Study|Withdrawal by Subject|1|||
161180050|NCT00251589|582036898|FG002|Overall Study|Withdrawal by Subject|0|||
161180051|NCT00251589|582036899|FG003|Overall Study|Withdrawal by Subject|0|||
161180052|NCT00251589|582036896|FG000|Overall Study|Discontinued due to progressive disease|9|||
161180053|NCT00251589|582036897|FG001|Overall Study|Discontinued due to progressive disease|1|||
161180054|NCT00251589|582036898|FG002|Overall Study|Discontinued due to progressive disease|0|||
161180055|NCT00251589|582036899|FG003|Overall Study|Discontinued due to progressive disease|1|||
161180056|NCT04888507|582038389|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
161180057|NCT00636155|582038390|FG000|Overall Study|Adverse Event|8|||
161180058|NCT00636155|582038390|FG000|Overall Study|Lack of Efficacy|1|||
161180059|NCT00636155|582038390|FG000|Overall Study|Withdrawal by Subject|3|||
161180060|NCT00636155|582038390|FG000|Overall Study|Stem cell transplant|1|||
161180061|NCT00636155|582038390|FG000|Overall Study|Physician Decision|5|||
161180062|NCT00766142|582038391|FG000|Overall Study|Protocol Violation|4|||
161180063|NCT05643170|582038392|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
161180064|NCT05643170|582038392|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
161180065|NCT02632344|582038403|FG000|Overall Study|Adverse Event|3|||
161180066|NCT02632344|582038403|FG000|Overall Study|Lack of Efficacy|3|||
161180067|NCT02632344|582038403|FG000|Overall Study|Withdrawal by Subject|2|||
161180068|NCT00777257|582038404|FG000|Overall Study|Adverse Event|3|||
161180069|NCT00777257|582038405|FG001|Overall Study|Adverse Event|1|||
161180070|NCT00777257|582038406|FG002|Overall Study|Adverse Event|0|||
161180071|NCT00777257|582038404|FG000|Overall Study|Lost to Follow-up|3|||
161180072|NCT00777257|582038405|FG001|Overall Study|Lost to Follow-up|3|||
161180073|NCT00777257|582038406|FG002|Overall Study|Lost to Follow-up|2|||
161180074|NCT00777257|582038404|FG000|Overall Study|Protocol Violation|2|||
161180075|NCT00777257|582038405|FG001|Overall Study|Protocol Violation|2|||
161180076|NCT00777257|582038406|FG002|Overall Study|Protocol Violation|2|||
161180077|NCT00777257|582038404|FG000|Overall Study|Withdrawal by Subject|3|||
161180078|NCT00777257|582038405|FG001|Overall Study|Withdrawal by Subject|6|||
161180079|NCT00777257|582038406|FG002|Overall Study|Withdrawal by Subject|5|||
161180080|NCT01431521|582038407|FG000|Overall Study|Withdrawal by Subject|0|||
161180081|NCT01431521|582038408|FG001|Overall Study|Withdrawal by Subject|0|||
161180082|NCT01431521|582038409|FG002|Overall Study|Withdrawal by Subject|1|||
161180083|NCT01431521|582038410|FG003|Overall Study|Withdrawal by Subject|0|||
161180084|NCT04984876|582038411|FG000|Overall Study|Subject decision|2|||
161180085|NCT04984876|582038412|FG001|Overall Study|Subject decision|10|||
161180086|NCT04984876|582038413|FG002|Overall Study|Subject decision|3|||
161180087|NCT04984876|582038414|FG003|Overall Study|Subject decision|3|||
161180088|NCT04984876|582038415|FG004|Overall Study|Subject decision|3|||
161180089|NCT04984876|582038416|FG005|Overall Study|Subject decision|0|||
161180090|NCT04984876|582038411|FG000|Overall Study|Guardian decision|0|||
161180091|NCT04984876|582038412|FG001|Overall Study|Guardian decision|1|||
161180092|NCT04984876|582038413|FG002|Overall Study|Guardian decision|0|||
161180093|NCT04984876|582038414|FG003|Overall Study|Guardian decision|2|||
161180094|NCT04984876|582038415|FG004|Overall Study|Guardian decision|0|||
161180095|NCT04984876|582038416|FG005|Overall Study|Guardian decision|1|||
161180096|NCT04984876|582038411|FG000|Overall Study|Lost to Follow-up|0|||
161180097|NCT04984876|582038412|FG001|Overall Study|Lost to Follow-up|0|||
161180098|NCT04984876|582038413|FG002|Overall Study|Lost to Follow-up|1|||
161180099|NCT04984876|582038414|FG003|Overall Study|Lost to Follow-up|1|||
161180100|NCT04984876|582038415|FG004|Overall Study|Lost to Follow-up|0|||
161180101|NCT04984876|582038416|FG005|Overall Study|Lost to Follow-up|0|||
161180102|NCT04984876|582038411|FG000|Overall Study|Physician Decision|1|||
161180103|NCT04984876|582038412|FG001|Overall Study|Physician Decision|0|||
161180104|NCT04984876|582038413|FG002|Overall Study|Physician Decision|0|||
161180105|NCT04984876|582038414|FG003|Overall Study|Physician Decision|1|||
161298384|NCT01197534|582475730|FG000|Overall Study|Lost to Follow-up|1|||
161298385|NCT01197534|582475731|FG001|Overall Study|Lost to Follow-up|4|||
161298386|NCT01197534|582475732|FG002|Overall Study|Lost to Follow-up|2|||
161298387|NCT01197534|582475730|FG000|Overall Study|Adverse Event|35|||
161298388|NCT01197534|582475731|FG001|Overall Study|Adverse Event|36|||
161298389|NCT01197534|582475732|FG002|Overall Study|Adverse Event|24|||
161298390|NCT02593097|582475733|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
161298391|NCT02593097|582475734|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
161298392|NCT02593097|582475733|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
161298393|NCT02593097|582475734|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
161298394|NCT02593097|582475733|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
161298395|NCT02593097|582475734|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
161298396|NCT02593097|582475733|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
161298397|NCT02593097|582475734|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
161298398|NCT02593097|582475733|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
161298399|NCT02593097|582475734|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
161298400|NCT02858583|582475735|FG000|Overall Study|Declined consent|1|||
161298401|NCT02858583|582475736|FG001|Overall Study|Declined consent|1|||
161298402|NCT03627546|582475741|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
161298403|NCT03627546|582475742|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
161298404|NCT03627546|582475743|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
161298405|NCT03627546|582475741|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
161298406|NCT03627546|582475742|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
161298407|NCT03627546|582475743|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
161298408|NCT00961350|582475746|FG000|Overall Study|Adverse Event|18|||
161298409|NCT00961350|582475747|FG001|Overall Study|Adverse Event|33|||
161298410|NCT00961350|582475746|FG000|Overall Study|Withdrawal by Subject|10|||
161298411|NCT00961350|582475747|FG001|Overall Study|Withdrawal by Subject|10|||
161298412|NCT00961350|582475746|FG000|Overall Study|Lost to Follow-up|3|||
161298413|NCT00961350|582475747|FG001|Overall Study|Lost to Follow-up|3|||
161298414|NCT00961350|582475746|FG000|Overall Study|Misc|16|||
161298415|NCT00961350|582475747|FG001|Overall Study|Misc|21|||
161298416|NCT03291431|582475749|FG000|Overall Study|Protocol Violation|2|||
161298417|NCT03291431|582475750|FG001|Overall Study|Protocol Violation|1|||
161298418|NCT03291431|582475749|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
161298419|NCT03291431|582475750|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
161298420|NCT03291431|582475749|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
161298421|NCT03291431|582475750|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
161298422|NCT06868654|582475751|FG000|Overall Study|Death|4|||
161298423|NCT06868654|582475752|FG001|Overall Study|Death|14|||
161298424|NCT06868654|582475751|FG000|Overall Study|Lost to Follow-up|0|||
161298425|NCT06868654|582475752|FG001|Overall Study|Lost to Follow-up|1|||
161298426|NCT06868654|582475751|FG000|Overall Study|Withdrawal by Subject|5|||
161298427|NCT06868654|582475752|FG001|Overall Study|Withdrawal by Subject|3|||
161298428|NCT06868654|582475751|FG000|Overall Study|Physician Decision|0|||
161298429|NCT06868654|582475752|FG001|Overall Study|Physician Decision|1|||
161298430|NCT06868654|582475751|FG000|Overall Study|Ongoing|23|||
161298431|NCT06868654|582475752|FG001|Overall Study|Ongoing|21|||
161298432|NCT03867201|582475753|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
161298433|NCT03867201|582475754|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
161298434|NCT03867201|582475753|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
161298435|NCT03867201|582475754|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
161298436|NCT03867201|582475753|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
161298437|NCT03867201|582475754|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
161298438|NCT03867201|582475753|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
161298439|NCT03867201|582475754|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
161298440|NCT03867201|582475753|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
161298441|NCT03867201|582475754|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
161298442|NCT03867201|582475753|FG000|Open-Label Period From Week 12|Adverse Event|5|||
161298443|NCT03867201|582475754|FG001|Open-Label Period From Week 12|Adverse Event|11|||
161298444|NCT03867201|582475753|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
161298445|NCT03867201|582475754|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
161298446|NCT03867201|582475753|FG000|Open-Label Period From Week 12|Physician Decision|6|||
161298447|NCT03867201|582475754|FG001|Open-Label Period From Week 12|Physician Decision|3|||
161298448|NCT03867201|582475753|FG000|Open-Label Period From Week 12|Pregnancy|2|||
161298449|NCT03867201|582475754|FG001|Open-Label Period From Week 12|Pregnancy|2|||
161298450|NCT03867201|582475753|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
161298451|NCT03867201|582475754|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
161298452|NCT03867201|582475753|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
161298453|NCT03867201|582475754|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
161319498|NCT01863732|582555337|FG003|Overall Study|Pregnancy|1|||
161180106|NCT04984876|582038415|FG004|Overall Study|Physician Decision|0|||
161180107|NCT04984876|582038416|FG005|Overall Study|Physician Decision|0|||
161180108|NCT04984876|582038411|FG000|Overall Study|Adverse Event|0|||
161180109|NCT04984876|582038412|FG001|Overall Study|Adverse Event|0|||
161180110|NCT04984876|582038413|FG002|Overall Study|Adverse Event|1|||
161180111|NCT04984876|582038414|FG003|Overall Study|Adverse Event|0|||
161180112|NCT04984876|582038415|FG004|Overall Study|Adverse Event|0|||
161180113|NCT04984876|582038416|FG005|Overall Study|Adverse Event|0|||
161180114|NCT01077193|582038419|FG000|Overall Study|Lost to Follow-up|1|||
161180115|NCT01077193|582038419|FG000|Overall Study|Withdrawal by Subject|2|||
161180116|NCT01077193|582038419|FG000|Overall Study|Lack of Efficacy|1|||
161180117|NCT01077193|582038419|FG000|Overall Study|Study Terminated by Sponsor|40|||
161180118|NCT04960202|582038420|FG000|Overall Study|Other|5|||
161180119|NCT04960202|582038421|FG001|Overall Study|Other|0|||
161180120|NCT04960202|582038420|FG000|Overall Study|Withdrawal by Subject|37|||
161180121|NCT04960202|582038421|FG001|Overall Study|Withdrawal by Subject|43|||
161180122|NCT04960202|582038420|FG000|Overall Study|Lost to Follow-up|20|||
161180123|NCT04960202|582038421|FG001|Overall Study|Lost to Follow-up|16|||
161180124|NCT04960202|582038420|FG000|Overall Study|Death|0|||
161180125|NCT04960202|582038421|FG001|Overall Study|Death|15|||
161180126|NCT03687827|582038425|FG000|Treatment Period 1|Death|0|||
161180127|NCT03687827|582038426|FG001|Treatment Period 1|Death|1|||
161180128|NCT03687827|582038425|FG000|Treatment Period 1|Lost to Follow-up|2|||
161180129|NCT03687827|582038426|FG001|Treatment Period 1|Lost to Follow-up|2|||
161180130|NCT03687827|582038425|FG000|Treatment Period 1|Physician Decision|5|||
161180131|NCT03687827|582038426|FG001|Treatment Period 1|Physician Decision|2|||
161180132|NCT03687827|582038425|FG000|Treatment Period 1|Withdrawal by Subject|7|||
161180133|NCT03687827|582038426|FG001|Treatment Period 1|Withdrawal by Subject|3|||
161180134|NCT03687827|582038425|FG000|Treatment Period 2|Physician Decision|4|||
161180135|NCT03687827|582038426|FG001|Treatment Period 2|Physician Decision|1|||
161180136|NCT03687827|582038425|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161180137|NCT03687827|582038426|FG001|Treatment Period 2|Withdrawal by Subject|2|||
161180138|NCT03377452|582038429|FG000|Overall Study|Refused assessment|0|||
161180139|NCT03377452|582038430|FG001|Overall Study|Refused assessment|2|||
161180140|NCT03377452|582038429|FG000|Overall Study|Lost to Follow-up|5|||
161180141|NCT03377452|582038430|FG001|Overall Study|Lost to Follow-up|4|||
161180142|NCT03464136|582038431|FG000|Overall Study|Lost to Follow-up|5|||
161180143|NCT03464136|582038432|FG001|Overall Study|Lost to Follow-up|8|||
161180144|NCT03464136|582038431|FG000|Overall Study|Withdrawal by Subject|16|||
161180145|NCT03464136|582038432|FG001|Overall Study|Withdrawal by Subject|13|||
161180146|NCT03464136|582038431|FG000|Overall Study|Death|1|||
161180147|NCT03464136|582038432|FG001|Overall Study|Death|0|||
161180148|NCT03464136|582038431|FG000|Overall Study|Other|8|||
161180149|NCT03464136|582038432|FG001|Overall Study|Other|4|||
161180150|NCT03146403|582038433|FG000|Overall Study|Withdrawal by Subject|0|||
161180151|NCT03146403|582038434|FG001|Overall Study|Withdrawal by Subject|3|||
161180152|NCT03146403|582038433|FG000|Overall Study|Lost to Follow-up|2|||
161180153|NCT03146403|582038434|FG001|Overall Study|Lost to Follow-up|0|||
161180154|NCT02182999|582038435|FG000|Overall Study|Adverse Event|4|||
161180155|NCT02182999|582038436|FG001|Overall Study|Adverse Event|3|||
161180156|NCT02182999|582038435|FG000|Overall Study|Physician Decision|1|||
161180157|NCT02182999|582038436|FG001|Overall Study|Physician Decision|0|||
161180158|NCT02203916|582038439|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161180159|NCT02203916|582038440|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
161180160|NCT02203916|582038441|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
161180161|NCT02203916|582038439|FG000|Overall Study|Major Protocol Deviation|1|||
161180162|NCT02203916|582038440|FG001|Overall Study|Major Protocol Deviation|1|||
161180163|NCT02203916|582038441|FG002|Overall Study|Major Protocol Deviation|0|||
161180164|NCT02203916|582038439|FG000|Overall Study|Lost to Follow-up|0|||
161180165|NCT02203916|582038440|FG001|Overall Study|Lost to Follow-up|1|||
161180166|NCT02203916|582038441|FG002|Overall Study|Lost to Follow-up|0|||
161180167|NCT02203916|582038439|FG000|Overall Study|Voluntary Withdrawal|3|||
161180168|NCT02203916|582038440|FG001|Overall Study|Voluntary Withdrawal|3|||
161180169|NCT02203916|582038441|FG002|Overall Study|Voluntary Withdrawal|8|||
161180170|NCT02203916|582038439|FG000|Overall Study|Lack of Efficacy|3|||
161180171|NCT02203916|582038440|FG001|Overall Study|Lack of Efficacy|0|||
161180172|NCT02203916|582038441|FG002|Overall Study|Lack of Efficacy|0|||
161180173|NCT02203916|582038439|FG000|Overall Study|Reason Not Specified|0|||
161180174|NCT02203916|582038440|FG001|Overall Study|Reason Not Specified|2|||
161180175|NCT02203916|582038441|FG002|Overall Study|Reason Not Specified|1|||
161180176|NCT04247828|582038444|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
161180177|NCT03077711|582038445|FG000|Overall Study|Lost to Follow-up|2|||
161180178|NCT03077711|582038446|FG001|Overall Study|Lost to Follow-up|2|||
161180179|NCT03077711|582038445|FG000|Overall Study|noncompliant taking medication|2|||
161180180|NCT03077711|582038446|FG001|Overall Study|noncompliant taking medication|0|||
161180181|NCT00333970|582038449|FG000|Overall Study|Withdrawal by Subject|13|||
161180182|NCT00333970|582038450|FG001|Overall Study|Withdrawal by Subject|7|||
161180183|NCT00614991|582038451|FG000|Overall Study|Adverse Event|3|||
161180184|NCT00614991|582038452|FG001|Overall Study|Adverse Event|3|||
161298454|NCT03867201|582475753|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
161298455|NCT03867201|582475754|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
161298456|NCT03867201|582475753|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
161298457|NCT03867201|582475754|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
161298458|NCT01190410|582477532|FG000|Overall Study|Adverse Event|0|||
161298459|NCT01190410|582477533|FG001|Overall Study|Adverse Event|3|||
161298460|NCT01190410|582477532|FG000|Overall Study|Lack of Efficacy|0|||
161298461|NCT01190410|582477533|FG001|Overall Study|Lack of Efficacy|2|||
161298462|NCT01190410|582477532|FG000|Overall Study|Withdrawal by Subject|0|||
161298463|NCT01190410|582477533|FG001|Overall Study|Withdrawal by Subject|2|||
161298464|NCT01190410|582477532|FG000|Overall Study|Administrative decision|1|||
161298465|NCT01190410|582477533|FG001|Overall Study|Administrative decision|0|||
161298466|NCT01190410|582477532|FG000|Overall Study|PI discretion|0|||
161298467|NCT01190410|582477533|FG001|Overall Study|PI discretion|2|||
161298468|NCT01283334|582477535|FG000|Overall Study|Withdrawal by Subject|1|||
161298469|NCT01283334|582477535|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
161298470|NCT01283334|582477535|FG000|Overall Study|Adverse Event|4|||
161298471|NCT01283334|582477535|FG000|Overall Study|Physician Decision|1|||
161298472|NCT03467217|582477536|FG000|Overall Study|Trial stopped early|5|||
161298473|NCT03467217|582477537|FG001|Overall Study|Trial stopped early|2|||
161298474|NCT03467217|582477536|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
161298475|NCT03467217|582477537|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
161298476|NCT03467217|582477536|FG000|Overall Study|Lost to Follow-up|0|||
161298477|NCT03467217|582477537|FG001|Overall Study|Lost to Follow-up|2|||
161298478|NCT00769067|582477538|FG000|Overall Study|Death|89|||
161298479|NCT00769067|582477539|FG001|Overall Study|Death|86|||
161298480|NCT00769067|582477538|FG000|Overall Study|Lost to Follow-up|3|||
161298481|NCT00769067|582477539|FG001|Overall Study|Lost to Follow-up|1|||
161298482|NCT00769067|582477538|FG000|Overall Study|Study terminated by sponsor|1|||
161298483|NCT00769067|582477539|FG001|Overall Study|Study terminated by sponsor|3|||
161298484|NCT00769067|582477538|FG000|Overall Study|Other|1|||
161298485|NCT00769067|582477539|FG001|Overall Study|Other|3|||
161298486|NCT00769067|582477538|FG000|Overall Study|Withdrawal by Subject|0|||
161298487|NCT00769067|582477539|FG001|Overall Study|Withdrawal by Subject|1|||
161298488|NCT04981470|582477542|FG000|Overall Study|Device failure in all 4 patients|4|||
161298489|NCT04402138|582477543|FG000|Overall Study|Progressive Disease|2|||
161298490|NCT04402138|582477543|FG000|Overall Study|Adverse Event|1|||
161298491|NCT00078767|582477544|FG000|Overall Study|Withdrawal by Subject|1|||
161298492|NCT00078767|582477545|FG001|Overall Study|Withdrawal by Subject|1|||
161298493|NCT02285166|582477546|FG000|Overall Study|Case Report Forms Uncollected|564|||
161298494|NCT02285166|582477546|FG000|Overall Study|Protocol Deviation|402|||
161298495|NCT00384839|582477553|FG000|Overall Study|Adverse Event|4|||
161298496|NCT00384839|582477553|FG000|Overall Study|Investigator Request|1|||
161298497|NCT00384839|582477553|FG000|Overall Study|Patient Request|1|||
161298498|NCT00384839|582477553|FG000|Overall Study|Ineligible|2|||
161298499|NCT01431716|582477556|FG000|Overall Study|Withdrawal of consent|1|||
161298500|NCT02484456|582477559|FG000|Washout Period|Withdrawal by Subject|0|||
161298501|NCT02484456|582477560|FG001|Washout Period|Withdrawal by Subject|1|||
161298502|NCT02484456|582477559|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
161298503|NCT02484456|582477560|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
161298504|NCT02484456|582477559|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
161298505|NCT02484456|582477560|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
161298506|NCT02484456|582477559|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
161298507|NCT02484456|582477560|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
161298508|NCT00708214|582477561|FG000|Overall Study|Other Adverse Event|3|||
161298509|NCT00708214|582477562|FG001|Overall Study|Other Adverse Event|6|||
161088845|NCT02483585|581715277|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
161088846|NCT02483585|581715278|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
161088847|NCT02483585|581715277|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
161088848|NCT02483585|581715278|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
161088849|NCT02483585|581715277|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
161088850|NCT02483585|581715278|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
161088851|NCT00825916|581715280|FG000|Overall Study|Lost to Follow-up|4|||
161298510|NCT00708214|582477563|FG002|Overall Study|Other Adverse Event|2|||
161347790|NCT02903914|582657363|FG002|Overall Study|Physician Decision|1|||
161088852|NCT00825916|581715281|FG001|Overall Study|Lost to Follow-up|2|||
161088853|NCT00825916|581715282|FG002|Overall Study|Lost to Follow-up|1|||
161088854|NCT01098097|581715283|FG000|Overall Study|Adverse Event|17|||
161298511|NCT00708214|582477561|FG000|Overall Study|Other|0|||
161298512|NCT00708214|582477562|FG001|Overall Study|Other|1|||
161298513|NCT00708214|582477563|FG002|Overall Study|Other|1|||
161298514|NCT00708214|582477561|FG000|Overall Study|Progressive Disease|4|||
161298515|NCT00708214|582477562|FG001|Overall Study|Progressive Disease|6|||
161298516|NCT00708214|582477563|FG002|Overall Study|Progressive Disease|5|||
161298517|NCT02199795|582477564|FG000|Overall Study|no longer met inclusion criteria|1|||
161298518|NCT02199795|582477565|FG001|Overall Study|no longer met inclusion criteria|0|||
161298519|NCT02199795|582477564|FG000|Overall Study|withdrew due to shoulder pain|1|||
161298520|NCT02199795|582477565|FG001|Overall Study|withdrew due to shoulder pain|0|||
161298521|NCT01908829|582477569|FG000|Overall Study|Adverse Event|13|||
161298522|NCT01908829|582477570|FG001|Overall Study|Adverse Event|11|||
161298523|NCT01908829|582477571|FG002|Overall Study|Adverse Event|13|||
161298524|NCT01908829|582477569|FG000|Overall Study|Lost to Follow-up|4|||
161298525|NCT01908829|582477570|FG001|Overall Study|Lost to Follow-up|2|||
161298526|NCT01908829|582477571|FG002|Overall Study|Lost to Follow-up|1|||
161298527|NCT01908829|582477569|FG000|Overall Study|Randomized no double-blind drug received|1|||
161298528|NCT01908829|582477570|FG001|Overall Study|Randomized no double-blind drug received|0|||
161298529|NCT01908829|582477571|FG002|Overall Study|Randomized no double-blind drug received|1|||
161298530|NCT01908829|582477569|FG000|Overall Study|Discontinued (no EoT page)|2|||
161298531|NCT01908829|582477570|FG001|Overall Study|Discontinued (no EoT page)|0|||
161298532|NCT01908829|582477571|FG002|Overall Study|Discontinued (no EoT page)|0|||
161298533|NCT01908829|582477569|FG000|Overall Study|Miscellaneous|0|||
161298534|NCT01908829|582477570|FG001|Overall Study|Miscellaneous|2|||
161298535|NCT01908829|582477571|FG002|Overall Study|Miscellaneous|0|||
161298536|NCT01908829|582477569|FG000|Overall Study|Protocol Violation|2|||
161298537|NCT01908829|582477570|FG001|Overall Study|Protocol Violation|2|||
161298538|NCT01908829|582477571|FG002|Overall Study|Protocol Violation|0|||
161298539|NCT01908829|582477569|FG000|Overall Study|Lack of Efficacy|1|||
161298540|NCT01908829|582477570|FG001|Overall Study|Lack of Efficacy|3|||
161298541|NCT01908829|582477571|FG002|Overall Study|Lack of Efficacy|2|||
161298542|NCT01908829|582477569|FG000|Overall Study|Withdrawal by Subject|26|||
161298543|NCT01908829|582477570|FG001|Overall Study|Withdrawal by Subject|29|||
161298544|NCT01908829|582477571|FG002|Overall Study|Withdrawal by Subject|22|||
161298545|NCT02792192|582477572|FG000|Overall Study|Death|1|||
161298546|NCT02792192|582477573|FG001|Overall Study|Death|0|||
161298547|NCT02792192|582477574|FG002|Overall Study|Death|0|||
161298548|NCT02792192|582477575|FG003|Overall Study|Death|0|||
161298549|NCT02792192|582477572|FG000|Overall Study|Informed Consent Withdrawn|4|||
161298550|NCT02792192|582477573|FG001|Overall Study|Informed Consent Withdrawn|0|||
161298551|NCT02792192|582477574|FG002|Overall Study|Informed Consent Withdrawn|0|||
161298552|NCT02792192|582477575|FG003|Overall Study|Informed Consent Withdrawn|0|||
161298553|NCT02792192|582477572|FG000|Overall Study|Physician Decision|1|||
161298554|NCT02792192|582477573|FG001|Overall Study|Physician Decision|0|||
161298555|NCT02792192|582477574|FG002|Overall Study|Physician Decision|0|||
161298556|NCT02792192|582477575|FG003|Overall Study|Physician Decision|0|||
161298557|NCT02792192|582477572|FG000|Overall Study|Progressive Disease|0|||
161298558|NCT02792192|582477573|FG001|Overall Study|Progressive Disease|1|||
161298559|NCT02792192|582477574|FG002|Overall Study|Progressive Disease|0|||
161298560|NCT02792192|582477575|FG003|Overall Study|Progressive Disease|0|||
161298561|NCT02792192|582477572|FG000|Overall Study|Study Terminated By Sponsor|6|||
161298562|NCT02792192|582477573|FG001|Overall Study|Study Terminated By Sponsor|10|||
161088855|NCT01098097|581715283|FG000|Overall Study|Lost to Follow-up|18|||
161088856|NCT01098097|581715283|FG000|Overall Study|Status unknown|16|||
161088857|NCT01098097|581715283|FG000|Overall Study|No reason reported|31|||
161088858|NCT01502631|581715284|FG000|Overall Study|Adverse Event|5|||
161088859|NCT01502631|581715285|FG001|Overall Study|Adverse Event|8|||
161088860|NCT01502631|581715284|FG000|Overall Study|Lost to Follow-up|2|||
161088861|NCT01502631|581715285|FG001|Overall Study|Lost to Follow-up|2|||
161088862|NCT01502631|581715284|FG000|Overall Study|Participant withdrew consent|2|||
161088863|NCT01502631|581715285|FG001|Overall Study|Participant withdrew consent|4|||
161298563|NCT02792192|582477574|FG002|Overall Study|Study Terminated By Sponsor|0|||
161298564|NCT02792192|582477575|FG003|Overall Study|Study Terminated By Sponsor|0|||
161298565|NCT01339923|582477576|FG000|Overall Study|Adverse Event|1|||
161298566|NCT01339923|582477577|FG001|Overall Study|Adverse Event|1|||
161088864|NCT01502631|581715284|FG000|Overall Study|Participant non-compliant|1|||
161088865|NCT01502631|581715285|FG001|Overall Study|Participant non-compliant|0|||
161088866|NCT01502631|581715284|FG000|Overall Study|Investigator's decision|0|||
161088867|NCT01502631|581715285|FG001|Overall Study|Investigator's decision|1|||
161088868|NCT01502631|581715284|FG000|Overall Study|Other|10|||
161088869|NCT01502631|581715285|FG001|Overall Study|Other|5|||
161088870|NCT02729753|581715292|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
161088871|NCT02729753|581715293|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
161088872|NCT00190749|581715294|FG000|Overall Study|Lost to Follow-up|8|||
161088873|NCT00190749|581715295|FG001|Overall Study|Lost to Follow-up|11|||
161088874|NCT00190749|581715294|FG000|Overall Study|Withdrawal by Subject|10|||
161088875|NCT00190749|581715295|FG001|Overall Study|Withdrawal by Subject|6|||
161088876|NCT00190749|581715294|FG000|Overall Study|Protocol Violation|5|||
161088877|NCT00190749|581715295|FG001|Overall Study|Protocol Violation|4|||
161088878|NCT00190749|581715294|FG000|Overall Study|Adverse Event|0|||
161088879|NCT00190749|581715295|FG001|Overall Study|Adverse Event|5|||
161088880|NCT00190749|581715294|FG000|Overall Study|Lack of Efficacy|2|||
161088881|NCT00190749|581715295|FG001|Overall Study|Lack of Efficacy|3|||
161298567|NCT01339923|582477578|FG002|Overall Study|Adverse Event|1|||
161298568|NCT01339923|582477579|FG003|Overall Study|Adverse Event|0|||
161088882|NCT00190749|581715294|FG000|Overall Study|Reason Not Specified|0|||
161180185|NCT00614991|582038453|FG002|Overall Study|Adverse Event|0|||
161180186|NCT00614991|582038454|FG003|Overall Study|Adverse Event|0|||
161180187|NCT00614991|582038455|FG004|Overall Study|Adverse Event|1|||
161298569|NCT01339923|582477580|FG004|Overall Study|Adverse Event|0|||
161298570|NCT01339923|582477581|FG005|Overall Study|Adverse Event|0|||
161298571|NCT01339923|582477582|FG006|Overall Study|Adverse Event|1|||
161298572|NCT01339923|582477576|FG000|Overall Study|Inappropriate Enrollment|1|||
161180188|NCT00614991|582038456|FG005|Overall Study|Adverse Event|0|||
161180189|NCT00441480|582038457|FG000|Overall Study|Protocol Violation|1|||
161180190|NCT00441480|582038458|FG001|Overall Study|Protocol Violation|1|||
161180191|NCT00441480|582038457|FG000|Overall Study|Withdrawal by Subject|2|||
161180192|NCT00441480|582038458|FG001|Overall Study|Withdrawal by Subject|3|||
161180193|NCT00899678|582038459|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
161180194|NCT00899678|582038460|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
161180195|NCT00899678|582038461|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
161180196|NCT00899678|582038459|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
161180197|NCT00899678|582038460|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
161180198|NCT00899678|582038461|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
161180199|NCT00899678|582038459|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
161180200|NCT00899678|582038460|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
161180201|NCT00899678|582038461|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
161180202|NCT00899678|582038459|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
161180203|NCT00899678|582038460|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
161180204|NCT00899678|582038461|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
161180205|NCT00899678|582038459|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
161180206|NCT00899678|582038460|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
161180207|NCT00899678|582038461|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
161180208|NCT00899678|582038459|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
161180209|NCT00899678|582038460|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
161180210|NCT00899678|582038461|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
161180211|NCT00899678|582038459|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
161180212|NCT00899678|582038460|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
161180213|NCT00899678|582038461|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
161180214|NCT00899678|582038459|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
161180215|NCT00899678|582038460|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
161180216|NCT00899678|582038461|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
161180217|NCT00899678|582038459|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
161180218|NCT00899678|582038460|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
161180219|NCT00899678|582038461|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
161180220|NCT02092324|582038466|FG000|Overall Study|Adverse Event|1|||
161180221|NCT02092324|582038466|FG000|Overall Study|Lack of Efficacy|6|||
161180222|NCT02092324|582038466|FG000|Overall Study|Proceed to Transplant|3|||
161180223|NCT02092324|582038466|FG000|Overall Study|Physician Decision|7|||
161180224|NCT02092324|582038466|FG000|Overall Study|Misdiagnosis|2|||
161180225|NCT00044213|582038472|FG000|Overall Study|Withdrawal by Subject|50|||
161180226|NCT00044213|582038473|FG001|Overall Study|Withdrawal by Subject|65|||
161180227|NCT00044213|582038474|FG002|Overall Study|Withdrawal by Subject|91|||
161180228|NCT00044213|582038475|FG003|Overall Study|Withdrawal by Subject|83|||
161180229|NCT00044213|582038472|FG000|Overall Study|Death|42|||
161180230|NCT00044213|582038473|FG001|Overall Study|Death|42|||
161180231|NCT00044213|582038474|FG002|Overall Study|Death|42|||
161180232|NCT00044213|582038475|FG003|Overall Study|Death|49|||
161180233|NCT00044213|582038472|FG000|Overall Study|Lost to Follow-up|8|||
161180234|NCT00044213|582038473|FG001|Overall Study|Lost to Follow-up|5|||
161180235|NCT00044213|582038474|FG002|Overall Study|Lost to Follow-up|5|||
161180236|NCT00044213|582038475|FG003|Overall Study|Lost to Follow-up|4|||
161180237|NCT00422240|582038476|FG000|Overall Study|Lack of Efficacy|1|||
161180238|NCT00422240|582038477|FG001|Overall Study|Lack of Efficacy|2|||
161298573|NCT01339923|582477577|FG001|Overall Study|Inappropriate Enrollment|0|||
161298574|NCT01339923|582477578|FG002|Overall Study|Inappropriate Enrollment|0|||
161298575|NCT01339923|582477579|FG003|Overall Study|Inappropriate Enrollment|0|||
161180239|NCT00422240|582038478|FG002|Overall Study|Lack of Efficacy|0|||
161180240|NCT00422240|582038479|FG003|Overall Study|Lack of Efficacy|1|||
161180241|NCT00422240|582038476|FG000|Overall Study|Adverse Event|11|||
161298576|NCT01339923|582477580|FG004|Overall Study|Inappropriate Enrollment|0|||
161298577|NCT01339923|582477581|FG005|Overall Study|Inappropriate Enrollment|1|||
161298578|NCT01339923|582477582|FG006|Overall Study|Inappropriate Enrollment|0|||
161298579|NCT01339923|582477576|FG000|Overall Study|Lost to Follow-up|4|||
161298580|NCT01339923|582477577|FG001|Overall Study|Lost to Follow-up|4|||
161298581|NCT01339923|582477578|FG002|Overall Study|Lost to Follow-up|0|||
161180242|NCT00422240|582038477|FG001|Overall Study|Adverse Event|4|||
161180243|NCT00422240|582038478|FG002|Overall Study|Adverse Event|5|||
161180244|NCT00422240|582038479|FG003|Overall Study|Adverse Event|2|||
161180245|NCT00422240|582038476|FG000|Overall Study|Subject request|21|||
161180246|NCT00422240|582038477|FG001|Overall Study|Subject request|17|||
161180247|NCT00422240|582038478|FG002|Overall Study|Subject request|18|||
161180248|NCT00422240|582038479|FG003|Overall Study|Subject request|30|||
161180249|NCT00422240|582038476|FG000|Overall Study|Protocol Violation|0|||
161180250|NCT00422240|582038477|FG001|Overall Study|Protocol Violation|1|||
161180251|NCT00422240|582038478|FG002|Overall Study|Protocol Violation|0|||
161180252|NCT00422240|582038479|FG003|Overall Study|Protocol Violation|1|||
161180253|NCT00422240|582038476|FG000|Overall Study|Lost to Follow-up|31|||
161180254|NCT00422240|582038477|FG001|Overall Study|Lost to Follow-up|32|||
161180255|NCT00422240|582038478|FG002|Overall Study|Lost to Follow-up|19|||
161180256|NCT00422240|582038479|FG003|Overall Study|Lost to Follow-up|34|||
161180257|NCT00422240|582038476|FG000|Overall Study|Other|1|||
161180258|NCT00422240|582038477|FG001|Overall Study|Other|0|||
161180259|NCT00422240|582038478|FG002|Overall Study|Other|0|||
161180260|NCT00422240|582038479|FG003|Overall Study|Other|1|||
161180261|NCT00422240|582038476|FG000|Overall Study|Pregnancy|3|||
161180262|NCT00422240|582038477|FG001|Overall Study|Pregnancy|1|||
161180263|NCT00422240|582038478|FG002|Overall Study|Pregnancy|1|||
161180264|NCT00422240|582038479|FG003|Overall Study|Pregnancy|2|||
161180265|NCT01927068|582038483|FG000|Overall Study|Death|37|||
161180266|NCT01927068|582038484|FG001|Overall Study|Death|3|||
161180267|NCT01927068|582038483|FG000|Overall Study|Withdrawal by Subject|50|||
161180268|NCT01927068|582038484|FG001|Overall Study|Withdrawal by Subject|3|||
161180269|NCT01927068|582038483|FG000|Overall Study|Lost to Follow-up|10|||
161180270|NCT01927068|582038484|FG001|Overall Study|Lost to Follow-up|2|||
161180271|NCT01927068|582038483|FG000|Overall Study|Physician Decision|9|||
161180272|NCT01927068|582038484|FG001|Overall Study|Physician Decision|0|||
161180273|NCT01927068|582038483|FG000|Overall Study|Missed last follow-up visit|2|||
161180274|NCT01927068|582038484|FG001|Overall Study|Missed last follow-up visit|0|||
161180275|NCT00880607|582038485|FG000|Overall Study|Physician Decision|2|||
161180276|NCT00880607|582038486|FG001|Overall Study|Physician Decision|2|||
161180277|NCT00880607|582038485|FG000|Overall Study|Protocol Violation|2|||
161180278|NCT00880607|582038486|FG001|Overall Study|Protocol Violation|1|||
161180279|NCT00880607|582038485|FG000|Overall Study|surgery did not extend past L1 level|3|||
161180280|NCT00880607|582038486|FG001|Overall Study|surgery did not extend past L1 level|0|||
161180281|NCT01624467|582038487|FG000|Overall Study|Withdrawal by Subject|2|||
161180282|NCT01624467|582038487|FG000|Overall Study|Lost to Follow-up|1|||
161180283|NCT01624467|582038487|FG000|Overall Study|Adverse Event|7|||
161180284|NCT01624467|582038487|FG000|Overall Study|Progressive Disease|19|||
161180285|NCT01624467|582038487|FG000|Overall Study|Per Sponsor Requirement|1|||
161180286|NCT01624467|582038487|FG000|Overall Study|Subject Withdrew from Treatment|1|||
161180287|NCT03964493|582038488|FG000|Overall Study|Withdrawal by Subject|4|||
161180288|NCT03964493|582038489|FG001|Overall Study|Withdrawal by Subject|1|||
161180289|NCT03964493|582038488|FG000|Overall Study|Lost to Follow-up|13|||
161180290|NCT03964493|582038489|FG001|Overall Study|Lost to Follow-up|4|||
161180291|NCT02224274|582038493|FG000|Overall Study|Death|1|||
161180292|NCT02224274|582038494|FG001|Overall Study|Death|0|||
161180293|NCT00499460|582038495|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
161180294|NCT00499460|582038496|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
161180295|NCT00499460|582038495|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
161180296|NCT00499460|582038496|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
161180297|NCT00499460|582038495|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
161180298|NCT00499460|582038496|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
161180299|NCT00887068|582038497|FG000|Overall Study|Withdrawal by Subject|2|||
161180300|NCT00887068|582038498|FG001|Overall Study|Withdrawal by Subject|0|||
161180301|NCT00887068|582038497|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
161180302|NCT00887068|582038498|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
161180303|NCT03073200|582038507|FG000|Double Blind Treatment Period|Protocol Violation|1|||
161180304|NCT03073200|582038508|FG001|Double Blind Treatment Period|Protocol Violation|0|||
161180305|NCT03073200|582038509|FG002|Double Blind Treatment Period|Protocol Violation|0|||
161180306|NCT03073200|582038510|FG003|Double Blind Treatment Period|Protocol Violation|0|||
161180307|NCT03073200|582038511|FG004|Double Blind Treatment Period|Protocol Violation|0|||
161180308|NCT03073200|582038512|FG005|Double Blind Treatment Period|Protocol Violation|0|||
161180309|NCT03073200|582038513|FG006|Double Blind Treatment Period|Protocol Violation|0|||
161347791|NCT02903914|582657364|FG003|Overall Study|Physician Decision|0|||
161347792|NCT02903914|582657365|FG004|Overall Study|Physician Decision|0|||
161180310|NCT03073200|582038514|FG007|Double Blind Treatment Period|Protocol Violation|0|||
161180311|NCT03073200|582038515|FG008|Double Blind Treatment Period|Protocol Violation|0|||
161180312|NCT03073200|582038516|FG009|Double Blind Treatment Period|Protocol Violation|0|||
161180313|NCT03073200|582038517|FG010|Double Blind Treatment Period|Protocol Violation|0|||
161180314|NCT03073200|582038518|FG011|Double Blind Treatment Period|Protocol Violation|0|||
161180315|NCT03073200|582038519|FG012|Double Blind Treatment Period|Protocol Violation|0|||
161180316|NCT03073200|582038520|FG013|Double Blind Treatment Period|Protocol Violation|0|||
161180317|NCT03073200|582038521|FG014|Double Blind Treatment Period|Protocol Violation|0|||
161180318|NCT03073200|582038507|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180319|NCT03073200|582038508|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
161180320|NCT03073200|582038509|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180321|NCT03073200|582038510|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180322|NCT03073200|582038511|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180323|NCT03073200|582038512|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180324|NCT03073200|582038513|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180325|NCT03073200|582038514|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180326|NCT03073200|582038515|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180327|NCT03073200|582038516|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180328|NCT03073200|582038517|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180329|NCT03073200|582038518|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180330|NCT03073200|582038519|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180331|NCT03073200|582038520|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180332|NCT03073200|582038521|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
161180333|NCT03073200|582038507|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
161180334|NCT03073200|582038508|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180335|NCT03073200|582038509|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180336|NCT03073200|582038510|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180337|NCT03073200|582038511|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180338|NCT03073200|582038512|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180339|NCT03073200|582038513|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180340|NCT03073200|582038514|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180341|NCT03073200|582038515|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180342|NCT03073200|582038516|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180343|NCT03073200|582038517|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180344|NCT03073200|582038518|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180345|NCT03073200|582038519|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180346|NCT03073200|582038520|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180347|NCT03073200|582038521|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
161180348|NCT03073200|582038507|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180349|NCT03073200|582038508|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180350|NCT03073200|582038509|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180351|NCT03073200|582038510|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
161180352|NCT03073200|582038511|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
161180353|NCT03073200|582038512|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180354|NCT03073200|582038513|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180355|NCT03073200|582038514|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180356|NCT03073200|582038515|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180357|NCT03073200|582038516|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180358|NCT03073200|582038517|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180359|NCT03073200|582038518|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180360|NCT03073200|582038519|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180361|NCT03073200|582038520|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180362|NCT03073200|582038521|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
161180363|NCT03073200|582038507|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
161180364|NCT03073200|582038508|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
161180365|NCT03073200|582038509|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
161180366|NCT03073200|582038510|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
161180367|NCT03073200|582038511|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
161180368|NCT03073200|582038512|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
161180369|NCT03073200|582038513|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
161180370|NCT03073200|582038514|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
161180371|NCT03073200|582038515|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
161180372|NCT03073200|582038516|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
161180373|NCT03073200|582038517|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
161180374|NCT03073200|582038518|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
161180375|NCT03073200|582038519|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
161180376|NCT03073200|582038520|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
161180377|NCT03073200|582038521|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
161180378|NCT03073200|582038507|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180379|NCT03073200|582038508|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180380|NCT03073200|582038509|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180381|NCT03073200|582038510|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180382|NCT03073200|582038511|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
161298582|NCT01339923|582477579|FG003|Overall Study|Lost to Follow-up|3|||
161298583|NCT01339923|582477580|FG004|Overall Study|Lost to Follow-up|1|||
161298584|NCT01339923|582477581|FG005|Overall Study|Lost to Follow-up|1|||
161298585|NCT01339923|582477582|FG006|Overall Study|Lost to Follow-up|5|||
161298586|NCT01339923|582477576|FG000|Overall Study|Protocol Violation|0|||
161298587|NCT01339923|582477577|FG001|Overall Study|Protocol Violation|0|||
161298588|NCT01339923|582477578|FG002|Overall Study|Protocol Violation|0|||
161298589|NCT01339923|582477579|FG003|Overall Study|Protocol Violation|0|||
161298590|NCT01339923|582477580|FG004|Overall Study|Protocol Violation|0|||
161298591|NCT01339923|582477581|FG005|Overall Study|Protocol Violation|3|||
161298592|NCT01339923|582477582|FG006|Overall Study|Protocol Violation|1|||
161298593|NCT01339923|582477576|FG000|Overall Study|Unable to Classify|1|||
161298594|NCT01339923|582477577|FG001|Overall Study|Unable to Classify|0|||
161298595|NCT01339923|582477578|FG002|Overall Study|Unable to Classify|1|||
161298596|NCT01339923|582477579|FG003|Overall Study|Unable to Classify|0|||
161088883|NCT00190749|581715295|FG001|Overall Study|Reason Not Specified|2|||
161088884|NCT00190749|581715294|FG000|Overall Study|Sponsor Decision|1|||
161088885|NCT00190749|581715295|FG001|Overall Study|Sponsor Decision|0|||
161088886|NCT01090427|581715296|FG000|After Controlled Period|Death|0|||
161088887|NCT01090427|581715297|FG001|After Controlled Period|Death|0|||
161088888|NCT01090427|581715298|FG002|After Controlled Period|Death|0|||
161088889|NCT01090427|581715299|FG003|After Controlled Period|Death|0|||
161088890|NCT01090427|581715300|FG004|After Controlled Period|Death|0|||
161088891|NCT01090427|581715301|FG005|After Controlled Period|Death|1|||
161088892|NCT01090427|581715302|FG006|After Controlled Period|Death|0|||
161088893|NCT01090427|581715296|FG000|After Controlled Period|Lack of Efficacy|0|||
161088894|NCT01090427|581715297|FG001|After Controlled Period|Lack of Efficacy|0|||
161088895|NCT01090427|581715298|FG002|After Controlled Period|Lack of Efficacy|0|||
161088896|NCT01090427|581715299|FG003|After Controlled Period|Lack of Efficacy|0|||
161088897|NCT01090427|581715300|FG004|After Controlled Period|Lack of Efficacy|0|||
161088898|NCT01090427|581715301|FG005|After Controlled Period|Lack of Efficacy|3|||
161088899|NCT01090427|581715302|FG006|After Controlled Period|Lack of Efficacy|2|||
161088900|NCT01090427|581715296|FG000|After Controlled Period|Adverse Event|0|||
161088901|NCT01090427|581715297|FG001|After Controlled Period|Adverse Event|0|||
161088902|NCT01090427|581715298|FG002|After Controlled Period|Adverse Event|0|||
161088903|NCT01090427|581715299|FG003|After Controlled Period|Adverse Event|2|||
161088904|NCT01090427|581715300|FG004|After Controlled Period|Adverse Event|0|||
161088905|NCT01090427|581715301|FG005|After Controlled Period|Adverse Event|1|||
161088906|NCT01090427|581715302|FG006|After Controlled Period|Adverse Event|0|||
161088907|NCT01154010|581715303|FG000|Overall Study|Lost to Follow-up|0|||
161088908|NCT01154010|581715304|FG001|Overall Study|Lost to Follow-up|1|||
161088909|NCT00439231|581715305|FG000|Overall Study|Lack of Efficacy|28|||
161088910|NCT01465347|581715311|FG000|Overall Study|Withdrawal by Subject|1|||
161088911|NCT01465347|581715312|FG001|Overall Study|Withdrawal by Subject|1|||
161088912|NCT01465347|581715311|FG000|Overall Study|Physician Decision|0|||
161088913|NCT01465347|581715312|FG001|Overall Study|Physician Decision|1|||
161088914|NCT01465347|581715311|FG000|Overall Study|Admitted to hospice|0|||
161088915|NCT01465347|581715312|FG001|Overall Study|Admitted to hospice|1|||
161088916|NCT02413333|581715313|FG000|Period 1|Adverse Event|1|||
161088917|NCT02413333|581715314|FG001|Period 1|Adverse Event|0|||
161088918|NCT02413333|581715313|FG000|Period 1|Reason Not Specified|0|||
161088919|NCT02413333|581715314|FG001|Period 1|Reason Not Specified|1|||
161088920|NCT02413333|581715313|FG000|Period 2|Protocol Deviation|1|||
161088921|NCT02413333|581715314|FG001|Period 2|Protocol Deviation|0|||
161088922|NCT02996474|581715315|FG000|Overall Study|Physician Decision|5|||
161088923|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
161088924|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
161088925|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
161088926|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
161088927|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
161088928|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
161088929|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
161088930|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
161088931|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
161088932|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
161088933|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
161088934|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
161088935|NCT04493502|581715316|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
161088936|NCT04493502|581715317|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
161088937|NCT04493502|581715316|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
161088938|NCT04493502|581715317|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
161088939|NCT04493502|581715316|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
161088940|NCT04493502|581715317|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
161298597|NCT01339923|582477580|FG004|Overall Study|Unable to Classify|0|||
161298598|NCT01339923|582477581|FG005|Overall Study|Unable to Classify|1|||
161298599|NCT01339923|582477582|FG006|Overall Study|Unable to Classify|5|||
161088941|NCT04493502|581715316|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
161088942|NCT04493502|581715317|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
161298600|NCT01339923|582477576|FG000|Overall Study|Withdrawal by Subject|7|||
161180383|NCT03073200|582038512|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180384|NCT03073200|582038513|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180385|NCT03073200|582038514|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180386|NCT03073200|582038515|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180387|NCT03073200|582038516|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180388|NCT03073200|582038517|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180389|NCT03073200|582038518|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180390|NCT03073200|582038519|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180391|NCT03073200|582038520|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180392|NCT03073200|582038521|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
161180393|NCT03073200|582038507|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180394|NCT03073200|582038508|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180395|NCT03073200|582038509|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180396|NCT03073200|582038510|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
161180397|NCT03073200|582038511|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
161180398|NCT03073200|582038512|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180399|NCT03073200|582038513|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180400|NCT03073200|582038514|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180401|NCT03073200|582038515|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180402|NCT03073200|582038516|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180403|NCT03073200|582038517|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180404|NCT03073200|582038518|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180405|NCT03073200|582038519|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180406|NCT03073200|582038520|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180407|NCT03073200|582038521|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
161180408|NCT03073200|582038507|FG000|Extension Period|Lost to Follow-up|0|||
161180409|NCT03073200|582038508|FG001|Extension Period|Lost to Follow-up|0|||
161180410|NCT03073200|582038509|FG002|Extension Period|Lost to Follow-up|0|||
161180411|NCT03073200|582038510|FG003|Extension Period|Lost to Follow-up|0|||
161180412|NCT03073200|582038511|FG004|Extension Period|Lost to Follow-up|0|||
161180413|NCT03073200|582038512|FG005|Extension Period|Lost to Follow-up|0|||
161180414|NCT03073200|582038513|FG006|Extension Period|Lost to Follow-up|1|||
161180415|NCT03073200|582038514|FG007|Extension Period|Lost to Follow-up|1|||
161180416|NCT03073200|582038515|FG008|Extension Period|Lost to Follow-up|0|||
161180417|NCT03073200|582038516|FG009|Extension Period|Lost to Follow-up|0|||
161180418|NCT03073200|582038517|FG010|Extension Period|Lost to Follow-up|0|||
161180419|NCT03073200|582038518|FG011|Extension Period|Lost to Follow-up|0|||
161180420|NCT03073200|582038519|FG012|Extension Period|Lost to Follow-up|0|||
161180421|NCT03073200|582038520|FG013|Extension Period|Lost to Follow-up|0|||
161180422|NCT03073200|582038521|FG014|Extension Period|Lost to Follow-up|0|||
161180423|NCT03073200|582038507|FG000|Extension Period|Sponsor Decision|0|||
161180424|NCT03073200|582038508|FG001|Extension Period|Sponsor Decision|0|||
161180425|NCT03073200|582038509|FG002|Extension Period|Sponsor Decision|0|||
161180426|NCT03073200|582038510|FG003|Extension Period|Sponsor Decision|0|||
161180427|NCT03073200|582038511|FG004|Extension Period|Sponsor Decision|0|||
161180428|NCT03073200|582038512|FG005|Extension Period|Sponsor Decision|0|||
161180429|NCT03073200|582038513|FG006|Extension Period|Sponsor Decision|0|||
161180430|NCT03073200|582038514|FG007|Extension Period|Sponsor Decision|0|||
161180431|NCT03073200|582038515|FG008|Extension Period|Sponsor Decision|1|||
161180432|NCT03073200|582038516|FG009|Extension Period|Sponsor Decision|0|||
161180433|NCT03073200|582038517|FG010|Extension Period|Sponsor Decision|0|||
161180434|NCT03073200|582038518|FG011|Extension Period|Sponsor Decision|0|||
161180435|NCT03073200|582038519|FG012|Extension Period|Sponsor Decision|0|||
161180436|NCT03073200|582038520|FG013|Extension Period|Sponsor Decision|0|||
161180437|NCT03073200|582038521|FG014|Extension Period|Sponsor Decision|0|||
161180438|NCT03073200|582038507|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
161180439|NCT03073200|582038508|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
161180440|NCT03073200|582038509|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
161180441|NCT03073200|582038510|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
161180442|NCT03073200|582038511|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
161180443|NCT03073200|582038512|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
161180444|NCT03073200|582038513|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
161180445|NCT03073200|582038514|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
161298601|NCT01339923|582477577|FG001|Overall Study|Withdrawal by Subject|11|||
161298602|NCT01339923|582477578|FG002|Overall Study|Withdrawal by Subject|6|||
161298603|NCT01339923|582477579|FG003|Overall Study|Withdrawal by Subject|1|||
161180446|NCT03073200|582038515|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
161180447|NCT03073200|582038516|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
161180448|NCT03073200|582038517|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
161180449|NCT03073200|582038518|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
161180450|NCT03073200|582038519|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
161298604|NCT01339923|582477580|FG004|Overall Study|Withdrawal by Subject|4|||
161180451|NCT03073200|582038520|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
161180452|NCT03073200|582038521|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
161180453|NCT03073200|582038507|FG000|Extension Period|Withdrawal by Subject|0|||
161180454|NCT03073200|582038508|FG001|Extension Period|Withdrawal by Subject|0|||
161180455|NCT03073200|582038509|FG002|Extension Period|Withdrawal by Subject|0|||
161180456|NCT03073200|582038510|FG003|Extension Period|Withdrawal by Subject|0|||
161180457|NCT03073200|582038511|FG004|Extension Period|Withdrawal by Subject|0|||
161180458|NCT03073200|582038512|FG005|Extension Period|Withdrawal by Subject|0|||
161180459|NCT03073200|582038513|FG006|Extension Period|Withdrawal by Subject|1|||
161180460|NCT03073200|582038514|FG007|Extension Period|Withdrawal by Subject|2|||
161180461|NCT03073200|582038515|FG008|Extension Period|Withdrawal by Subject|0|||
161180462|NCT03073200|582038516|FG009|Extension Period|Withdrawal by Subject|0|||
161180463|NCT03073200|582038517|FG010|Extension Period|Withdrawal by Subject|0|||
161180464|NCT03073200|582038518|FG011|Extension Period|Withdrawal by Subject|0|||
161180465|NCT03073200|582038519|FG012|Extension Period|Withdrawal by Subject|0|||
161180466|NCT03073200|582038520|FG013|Extension Period|Withdrawal by Subject|0|||
161180467|NCT03073200|582038521|FG014|Extension Period|Withdrawal by Subject|0|||
161180468|NCT03073200|582038507|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180469|NCT03073200|582038508|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180470|NCT03073200|582038509|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180471|NCT03073200|582038510|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180472|NCT03073200|582038511|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180473|NCT03073200|582038512|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180474|NCT03073200|582038513|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180475|NCT03073200|582038514|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180476|NCT03073200|582038515|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180477|NCT03073200|582038516|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180478|NCT03073200|582038517|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180479|NCT03073200|582038518|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
161180480|NCT03073200|582038519|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180481|NCT03073200|582038520|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180482|NCT03073200|582038521|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
161180483|NCT03073200|582038507|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180484|NCT03073200|582038508|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180485|NCT03073200|582038509|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180486|NCT03073200|582038510|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180487|NCT03073200|582038511|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180488|NCT03073200|582038512|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180489|NCT03073200|582038513|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180490|NCT03073200|582038514|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180491|NCT03073200|582038515|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180492|NCT03073200|582038516|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180493|NCT03073200|582038517|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180494|NCT03073200|582038518|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
161180495|NCT03073200|582038519|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180496|NCT03073200|582038520|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180497|NCT03073200|582038521|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
161180498|NCT03073200|582038507|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180499|NCT03073200|582038508|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180500|NCT03073200|582038509|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180501|NCT03073200|582038510|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180502|NCT03073200|582038511|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180503|NCT03073200|582038512|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180504|NCT03073200|582038513|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180505|NCT03073200|582038514|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180506|NCT03073200|582038515|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180507|NCT03073200|582038516|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180508|NCT03073200|582038517|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161180509|NCT03073200|582038518|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
161180510|NCT03073200|582038519|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180511|NCT03073200|582038520|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180512|NCT03073200|582038521|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
161180513|NCT03073200|582038507|FG000|Randomized Withdrawal Period|Adverse Event|0|||
161180514|NCT03073200|582038508|FG001|Randomized Withdrawal Period|Adverse Event|0|||
161180515|NCT03073200|582038509|FG002|Randomized Withdrawal Period|Adverse Event|0|||
161180516|NCT03073200|582038510|FG003|Randomized Withdrawal Period|Adverse Event|0|||
161180517|NCT03073200|582038511|FG004|Randomized Withdrawal Period|Adverse Event|0|||
161180518|NCT03073200|582038512|FG005|Randomized Withdrawal Period|Adverse Event|0|||
161180519|NCT03073200|582038513|FG006|Randomized Withdrawal Period|Adverse Event|0|||
161180520|NCT03073200|582038514|FG007|Randomized Withdrawal Period|Adverse Event|0|||
161180521|NCT03073200|582038515|FG008|Randomized Withdrawal Period|Adverse Event|0|||
161180522|NCT03073200|582038516|FG009|Randomized Withdrawal Period|Adverse Event|0|||
161180523|NCT03073200|582038517|FG010|Randomized Withdrawal Period|Adverse Event|1|||
161180524|NCT03073200|582038518|FG011|Randomized Withdrawal Period|Adverse Event|0|||
161180525|NCT03073200|582038519|FG012|Randomized Withdrawal Period|Adverse Event|0|||
161180526|NCT03073200|582038520|FG013|Randomized Withdrawal Period|Adverse Event|0|||
161180527|NCT03073200|582038521|FG014|Randomized Withdrawal Period|Adverse Event|0|||
161180528|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180529|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180530|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180531|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180532|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180533|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180534|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180535|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180536|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180537|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180538|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180539|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180540|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180541|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
161180542|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
161180543|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180544|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180545|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180546|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180547|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180548|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180549|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180550|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180551|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180552|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180553|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180554|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180555|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180556|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
161180557|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
161180558|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180559|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180560|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180561|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180562|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180563|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180564|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180565|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180566|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180567|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180568|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180569|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180570|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180571|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
161180572|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
161180573|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180574|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180575|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161298605|NCT01339923|582477581|FG005|Overall Study|Withdrawal by Subject|3|||
161298606|NCT01339923|582477582|FG006|Overall Study|Withdrawal by Subject|2|||
161298607|NCT01430403|582477585|FG000|Overall Study|Lost to Follow-up|5|||
161298608|NCT01430403|582477586|FG001|Overall Study|Lost to Follow-up|5|||
161298609|NCT01430403|582477587|FG002|Overall Study|Lost to Follow-up|3|||
161298610|NCT01430403|582477585|FG000|Overall Study|Physician Decision|1|||
161298611|NCT01430403|582477586|FG001|Overall Study|Physician Decision|0|||
161180576|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180577|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180578|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161298612|NCT01430403|582477587|FG002|Overall Study|Physician Decision|0|||
161298613|NCT01430403|582477585|FG000|Overall Study|Protocol Violation|2|||
161180579|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180580|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180581|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180582|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180583|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180584|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180585|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180586|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
161180587|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
161180588|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180589|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180590|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180591|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180592|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180593|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180594|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180595|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180596|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180597|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180598|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180599|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180600|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180601|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
161180602|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
161180603|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180604|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180605|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180606|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180607|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180608|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180609|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180610|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180611|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180612|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180613|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180614|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180615|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180616|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
161180617|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
161180618|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180619|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180620|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180621|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180622|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180623|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180624|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180625|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180626|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180627|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180628|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180629|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180630|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180631|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
161347793|NCT02903914|582657366|FG005|Overall Study|Physician Decision|0|||
161347794|NCT02903914|582657367|FG006|Overall Study|Physician Decision|1|||
161347795|NCT02903914|582657368|FG007|Overall Study|Physician Decision|0|||
161347796|NCT02903914|582657361|FG000|Overall Study|Symptomatic Deterioration|0|||
161347797|NCT02903914|582657362|FG001|Overall Study|Symptomatic Deterioration|0|||
161180632|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
161180633|NCT03073200|582038507|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180634|NCT03073200|582038508|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180635|NCT03073200|582038509|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180636|NCT03073200|582038510|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161347798|NCT02903914|582657363|FG002|Overall Study|Symptomatic Deterioration|1|||
161298614|NCT01430403|582477586|FG001|Overall Study|Protocol Violation|3|||
161298615|NCT01430403|582477587|FG002|Overall Study|Protocol Violation|2|||
161298616|NCT01430403|582477585|FG000|Overall Study|Withdrawal by Subject|9|||
161298617|NCT01430403|582477586|FG001|Overall Study|Withdrawal by Subject|1|||
161298618|NCT01430403|582477587|FG002|Overall Study|Withdrawal by Subject|3|||
161298619|NCT02677922|582477588|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
161298620|NCT02677922|582477589|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
161298621|NCT02677922|582477590|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
161298622|NCT02677922|582477591|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
161298623|NCT02677922|582477592|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
161298624|NCT02677922|582477593|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
161088943|NCT04493502|581715316|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
161088944|NCT04493502|581715317|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
161088945|NCT04493502|581715316|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
161088946|NCT04493502|581715317|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
161088947|NCT04493502|581715316|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
161088948|NCT04493502|581715317|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
161088949|NCT02891837|581715318|FG000|Overall Study|Lost to Follow-up|2|||
161088950|NCT02891837|581715319|FG001|Overall Study|Lost to Follow-up|0|||
161088951|NCT02891837|581715318|FG000|Overall Study|Withdrawal by Subject|1|||
161088952|NCT02891837|581715319|FG001|Overall Study|Withdrawal by Subject|0|||
161088953|NCT00709852|581715320|FG000|Period 1|Adverse Event|2|||
161088954|NCT00709852|581715321|FG001|Period 1|Adverse Event|0|||
161088955|NCT00709852|581715320|FG000|Period 1|Withdrawal by Subject|4|||
161088956|NCT00709852|581715321|FG001|Period 1|Withdrawal by Subject|2|||
161088957|NCT00709852|581715320|FG000|Period 1|Protocol Violation|1|||
161088958|NCT00709852|581715321|FG001|Period 1|Protocol Violation|0|||
161088959|NCT00709852|581715320|FG000|Period 1|Defective scanner|0|||
161088960|NCT00709852|581715321|FG001|Period 1|Defective scanner|1|||
161088961|NCT00709852|581715320|FG000|Period 1|Lost to Follow-up|1|||
161088962|NCT00709852|581715321|FG001|Period 1|Lost to Follow-up|0|||
161088963|NCT00709852|581715320|FG000|Period 2|Protocol Violation|4|||
161088964|NCT00709852|581715321|FG001|Period 2|Protocol Violation|1|||
161088965|NCT00709852|581715320|FG000|Period 2|Adverse Event|1|||
161088966|NCT00709852|581715321|FG001|Period 2|Adverse Event|1|||
161088967|NCT00709852|581715320|FG000|Period 2|Lost to Follow-up|1|||
161088968|NCT00709852|581715321|FG001|Period 2|Lost to Follow-up|0|||
161088969|NCT00709852|581715320|FG000|Period 2|No 72-hour follow-up|3|||
161088970|NCT00709852|581715321|FG001|Period 2|No 72-hour follow-up|0|||
161088971|NCT01048671|581715322|FG000|Overall Study|Protocol Violation|0|||
161088972|NCT01048671|581715323|FG001|Overall Study|Protocol Violation|1|||
161088973|NCT01048671|581715324|FG002|Overall Study|Protocol Violation|1|||
161088974|NCT01178385|581715329|FG000|Overall Study|Withdrawal by Subject|2|||
161088975|NCT01178385|581715330|FG001|Overall Study|Withdrawal by Subject|0|||
161088976|NCT00985946|581715331|FG000|Overall Study|Lost to Follow-up|6|||
161088977|NCT00985946|581715331|FG000|Overall Study|Withdrawal by Subject|1|||
161088978|NCT00928018|581715336|FG000|Overall Study|Withdrawal by Subject|1|||
161088979|NCT00928018|581715337|FG001|Overall Study|Withdrawal by Subject|0|||
161088980|NCT02008877|581715338|FG000|Overall Study|Inevaluable|0|||
161088981|NCT02008877|581715339|FG001|Overall Study|Inevaluable|1|||
161088982|NCT02008877|581715340|FG002|Overall Study|Inevaluable|0|||
161088983|NCT00847808|581715341|FG000|Overall Study|Adverse Event|7|||
161088984|NCT00847808|581715341|FG000|Overall Study|Protocol Violation|1|||
161088985|NCT00847808|581715341|FG000|Overall Study|Lost to Follow-up|1|||
161088986|NCT00847808|581715341|FG000|Overall Study|Withdrawal by Subject|4|||
161298625|NCT02677922|582477588|FG000|Treatment Period|Adverse Event|0|||
161298626|NCT02677922|582477589|FG001|Treatment Period|Adverse Event|0|||
161298627|NCT02677922|582477590|FG002|Treatment Period|Adverse Event|1|||
161088987|NCT00847808|581715341|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
161088988|NCT00847808|581715341|FG000|Overall Study|Participant Took Excluded Medication|1|||
161088989|NCT05000931|581715351|FG000|Overall Study|Lost to Follow-up|1|||
161088990|NCT05326815|581715352|FG000|Overall Study|Withdrawal by Subject|3|||
161088991|NCT05326815|581715352|FG000|Overall Study|Did not complete required labs|6|||
161088992|NCT05326815|581715352|FG000|Overall Study|Screen fail- abnormal labs|5|||
161088993|NCT00979134|581715353|FG000|Overall Study|Disease progression|18|||
161088994|NCT00979134|581715354|FG001|Overall Study|Disease progression|2|||
161088995|NCT00979134|581715355|FG002|Overall Study|Disease progression|5|||
161088996|NCT00979134|581715353|FG000|Overall Study|Adverse Event|0|||
161088997|NCT00979134|581715354|FG001|Overall Study|Adverse Event|0|||
161088998|NCT00979134|581715355|FG002|Overall Study|Adverse Event|2|||
161088999|NCT00979134|581715353|FG000|Overall Study|Withdrawal by Subject|1|||
161089000|NCT00979134|581715354|FG001|Overall Study|Withdrawal by Subject|1|||
161089001|NCT00979134|581715355|FG002|Overall Study|Withdrawal by Subject|2|||
161089002|NCT00979134|581715353|FG000|Overall Study|Lost to Follow-up|2|||
161298628|NCT02677922|582477591|FG003|Treatment Period|Adverse Event|3|||
161347799|NCT02903914|582657364|FG003|Overall Study|Symptomatic Deterioration|0|||
161089003|NCT00979134|581715354|FG001|Overall Study|Lost to Follow-up|2|||
161089004|NCT00979134|581715355|FG002|Overall Study|Lost to Follow-up|0|||
161089005|NCT00979134|581715353|FG000|Overall Study|Death|4|||
161089006|NCT00979134|581715354|FG001|Overall Study|Death|0|||
161089007|NCT00979134|581715355|FG002|Overall Study|Death|26|||
161089008|NCT00979134|581715353|FG000|Overall Study|Other|8|||
161089009|NCT00979134|581715354|FG001|Overall Study|Other|1|||
161089010|NCT00979134|581715355|FG002|Overall Study|Other|5|||
161089011|NCT05172050|581715356|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
161089012|NCT05172050|581715357|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
161089013|NCT05172050|581715358|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
161089014|NCT05172050|581715356|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
161089015|NCT05172050|581715357|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
161089016|NCT05172050|581715358|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
161089017|NCT05172050|581715356|FG000|Overall Study|Other|2|||
161089018|NCT05172050|581715357|FG001|Overall Study|Other|2|||
161089019|NCT05172050|581715358|FG002|Overall Study|Other|1|||
161089020|NCT04617275|581715363|FG000|Treatment Period|Adverse Event|1|||
161089021|NCT04617275|581715364|FG001|Treatment Period|Adverse Event|6|||
161089022|NCT04617275|581715365|FG002|Treatment Period|Adverse Event|4|||
161089023|NCT04617275|581715366|FG003|Treatment Period|Adverse Event|6|||
161089024|NCT04617275|581715367|FG004|Treatment Period|Adverse Event|7|||
161089025|NCT04617275|581715368|FG005|Treatment Period|Adverse Event|8|||
161089026|NCT04617275|581715369|FG006|Treatment Period|Adverse Event|0|||
161089027|NCT04617275|581715370|FG007|Treatment Period|Adverse Event|12|||
161089028|NCT04617275|581715363|FG000|Treatment Period|Lost to Follow-up|0|||
161089029|NCT04617275|581715364|FG001|Treatment Period|Lost to Follow-up|0|||
161089030|NCT04617275|581715365|FG002|Treatment Period|Lost to Follow-up|2|||
161089031|NCT04617275|581715366|FG003|Treatment Period|Lost to Follow-up|0|||
161089032|NCT04617275|581715367|FG004|Treatment Period|Lost to Follow-up|0|||
161089033|NCT04617275|581715368|FG005|Treatment Period|Lost to Follow-up|3|||
161089034|NCT04617275|581715369|FG006|Treatment Period|Lost to Follow-up|0|||
161089035|NCT04617275|581715370|FG007|Treatment Period|Lost to Follow-up|2|||
161089036|NCT04617275|581715363|FG000|Treatment Period|No longer meets eligibility criteria|0|||
161089037|NCT04617275|581715364|FG001|Treatment Period|No longer meets eligibility criteria|0|||
161089038|NCT04617275|581715365|FG002|Treatment Period|No longer meets eligibility criteria|0|||
161089039|NCT04617275|581715366|FG003|Treatment Period|No longer meets eligibility criteria|1|||
161089040|NCT04617275|581715367|FG004|Treatment Period|No longer meets eligibility criteria|0|||
161089041|NCT04617275|581715368|FG005|Treatment Period|No longer meets eligibility criteria|0|||
161089042|NCT04617275|581715369|FG006|Treatment Period|No longer meets eligibility criteria|0|||
161089043|NCT04617275|581715370|FG007|Treatment Period|No longer meets eligibility criteria|0|||
161089044|NCT04617275|581715363|FG000|Treatment Period|Other|0|||
161089045|NCT04617275|581715364|FG001|Treatment Period|Other|1|||
161089046|NCT04617275|581715365|FG002|Treatment Period|Other|0|||
161089047|NCT04617275|581715366|FG003|Treatment Period|Other|0|||
161089048|NCT04617275|581715367|FG004|Treatment Period|Other|0|||
161089049|NCT04617275|581715368|FG005|Treatment Period|Other|0|||
161089050|NCT04617275|581715369|FG006|Treatment Period|Other|0|||
161089051|NCT04617275|581715370|FG007|Treatment Period|Other|0|||
161089052|NCT04617275|581715363|FG000|Treatment Period|Withdrawal by Subject|2|||
161089053|NCT04617275|581715364|FG001|Treatment Period|Withdrawal by Subject|0|||
161089054|NCT04617275|581715365|FG002|Treatment Period|Withdrawal by Subject|0|||
161089055|NCT04617275|581715366|FG003|Treatment Period|Withdrawal by Subject|2|||
161089056|NCT04617275|581715367|FG004|Treatment Period|Withdrawal by Subject|2|||
161089057|NCT04617275|581715368|FG005|Treatment Period|Withdrawal by Subject|0|||
161089058|NCT04617275|581715369|FG006|Treatment Period|Withdrawal by Subject|1|||
161089059|NCT04617275|581715370|FG007|Treatment Period|Withdrawal by Subject|2|||
161089060|NCT04617275|581715363|FG000|Follow-up Period|Adverse Event|1|||
161089061|NCT04617275|581715364|FG001|Follow-up Period|Adverse Event|1|||
161089062|NCT04617275|581715365|FG002|Follow-up Period|Adverse Event|2|||
161089063|NCT04617275|581715366|FG003|Follow-up Period|Adverse Event|3|||
161089064|NCT04617275|581715367|FG004|Follow-up Period|Adverse Event|4|||
161089065|NCT04617275|581715368|FG005|Follow-up Period|Adverse Event|3|||
161089066|NCT04617275|581715369|FG006|Follow-up Period|Adverse Event|0|||
161089067|NCT04617275|581715370|FG007|Follow-up Period|Adverse Event|3|||
161089068|NCT04617275|581715363|FG000|Follow-up Period|Lost to Follow-up|0|||
161089069|NCT04617275|581715364|FG001|Follow-up Period|Lost to Follow-up|1|||
161089070|NCT04617275|581715365|FG002|Follow-up Period|Lost to Follow-up|2|||
161089071|NCT04617275|581715366|FG003|Follow-up Period|Lost to Follow-up|0|||
161089072|NCT04617275|581715367|FG004|Follow-up Period|Lost to Follow-up|0|||
161089073|NCT04617275|581715368|FG005|Follow-up Period|Lost to Follow-up|4|||
161089074|NCT04617275|581715369|FG006|Follow-up Period|Lost to Follow-up|0|||
161089075|NCT04617275|581715370|FG007|Follow-up Period|Lost to Follow-up|3|||
161089076|NCT04617275|581715363|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
161089077|NCT04617275|581715364|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
161089078|NCT04617275|581715365|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
161089079|NCT04617275|581715366|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
161298629|NCT02677922|582477592|FG004|Treatment Period|Adverse Event|5|||
161180637|NCT03073200|582038511|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180638|NCT03073200|582038512|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180639|NCT03073200|582038513|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180640|NCT03073200|582038514|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180641|NCT03073200|582038515|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180642|NCT03073200|582038516|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180643|NCT03073200|582038517|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180644|NCT03073200|582038518|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180645|NCT03073200|582038519|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180646|NCT03073200|582038520|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
161180647|NCT03073200|582038521|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
161180648|NCT01474889|582038522|FG000|Overall Study|Physician Decision|1|||
161180649|NCT01474889|582038523|FG001|Overall Study|Physician Decision|0|||
161180650|NCT01474889|582038524|FG002|Overall Study|Physician Decision|0|||
161180651|NCT01474889|582038522|FG000|Overall Study|Did not meet inclusion|1|||
161180652|NCT01474889|582038523|FG001|Overall Study|Did not meet inclusion|0|||
161180653|NCT01474889|582038524|FG002|Overall Study|Did not meet inclusion|0|||
161180654|NCT01474889|582038522|FG000|Overall Study|Withdrawal by Subject|0|||
161180655|NCT01474889|582038523|FG001|Overall Study|Withdrawal by Subject|1|||
161180656|NCT01474889|582038524|FG002|Overall Study|Withdrawal by Subject|0|||
161180657|NCT02290340|582038526|FG000|Overall Study|Lost to Follow-up|0|||
161180658|NCT02290340|582038527|FG001|Overall Study|Lost to Follow-up|0|||
161180659|NCT02290340|582038528|FG002|Overall Study|Lost to Follow-up|0|||
161180660|NCT02290340|582038529|FG003|Overall Study|Lost to Follow-up|1|||
161180661|NCT02290340|582038526|FG000|Overall Study|Withdrawal by Subject|1|||
161180662|NCT02290340|582038527|FG001|Overall Study|Withdrawal by Subject|0|||
161180663|NCT02290340|582038528|FG002|Overall Study|Withdrawal by Subject|0|||
161180664|NCT02290340|582038529|FG003|Overall Study|Withdrawal by Subject|0|||
161180665|NCT02290340|582038526|FG000|Overall Study|Other|1|||
161180666|NCT02290340|582038527|FG001|Overall Study|Other|0|||
161180667|NCT02290340|582038528|FG002|Overall Study|Other|0|||
161180668|NCT02290340|582038529|FG003|Overall Study|Other|1|||
161180669|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Adverse Event|22|||
161180670|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Adverse Event|0|||
161180671|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
161180672|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
161180673|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
161180674|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
161180675|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
161180676|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
161180677|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
161180678|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
161180679|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
161180680|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
161180681|NCT02493868|582038530|FG000|Induction Phase: DE Participants|Other|8|||
161180682|NCT02493868|582038531|FG001|Induction Phase: DE Participants|Other|0|||
161180683|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
161180684|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
161180685|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
161180686|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
161180687|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
161180688|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
161180689|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
161180690|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
161180691|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
161180692|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
161180693|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
161180694|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
161180695|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
161180696|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
161180697|NCT02493868|582038530|FG000|Optimization Phase: DE+TE Participants|Other|10|||
161180698|NCT02493868|582038531|FG001|Optimization Phase: DE+TE Participants|Other|2|||
161347800|NCT02903914|582657365|FG004|Overall Study|Symptomatic Deterioration|0|||
161347801|NCT02903914|582657366|FG005|Overall Study|Symptomatic Deterioration|0|||
161347802|NCT02903914|582657367|FG006|Overall Study|Symptomatic Deterioration|0|||
161347803|NCT02903914|582657368|FG007|Overall Study|Symptomatic Deterioration|0|||
161180699|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
161347804|NCT02903914|582657361|FG000|Overall Study|New Cancer Therapy|2|||
161347805|NCT02903914|582657362|FG001|Overall Study|New Cancer Therapy|2|||
161180700|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
161180701|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
161180702|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
161180703|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
161180704|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
161180705|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
161180706|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
161180707|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
161180708|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
161180709|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
161180710|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
161180711|NCT02493868|582038530|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
161180712|NCT02493868|582038531|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
161180713|NCT02493868|582038530|FG000|Follow-up Phase|Lost to Follow-up|1|||
161180714|NCT02493868|582038531|FG001|Follow-up Phase|Lost to Follow-up|0|||
161180715|NCT02493868|582038530|FG000|Follow-up Phase|Withdrawal by Subject|3|||
161180716|NCT02493868|582038531|FG001|Follow-up Phase|Withdrawal by Subject|0|||
161180717|NCT02493868|582038530|FG000|Follow-up Phase|Investigator Decision|5|||
161180718|NCT02493868|582038531|FG001|Follow-up Phase|Investigator Decision|1|||
161180719|NCT02493868|582038530|FG000|Follow-up Phase|Other|2|||
161180720|NCT02493868|582038531|FG001|Follow-up Phase|Other|1|||
161180721|NCT02407236|582038532|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
161180722|NCT02407236|582038533|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
161180723|NCT02407236|582038534|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
161180724|NCT02407236|582038535|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
161180725|NCT02407236|582038536|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
161180726|NCT02407236|582038537|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
161180727|NCT02407236|582038538|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
161180728|NCT02407236|582038539|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
161180729|NCT02407236|582038540|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
161180730|NCT02407236|582038541|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
161180731|NCT02407236|582038542|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
161180732|NCT02407236|582038543|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
161180733|NCT02407236|582038544|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
161180734|NCT02407236|582038532|FG000|Induction Study (8 Weeks)|Death|0|||
161180735|NCT02407236|582038533|FG001|Induction Study (8 Weeks)|Death|0|||
161180736|NCT02407236|582038534|FG002|Induction Study (8 Weeks)|Death|1|||
161180737|NCT02407236|582038535|FG003|Induction Study (8 Weeks)|Death|0|||
161180738|NCT02407236|582038536|FG004|Induction Study (8 Weeks)|Death|0|||
161180739|NCT02407236|582038537|FG005|Induction Study (8 Weeks)|Death|0|||
161180740|NCT02407236|582038538|FG006|Induction Study (8 Weeks)|Death|0|||
161180741|NCT02407236|582038539|FG007|Induction Study (8 Weeks)|Death|0|||
161180742|NCT02407236|582038540|FG008|Induction Study (8 Weeks)|Death|0|||
161180743|NCT02407236|582038541|FG009|Induction Study (8 Weeks)|Death|0|||
161180744|NCT02407236|582038542|FG010|Induction Study (8 Weeks)|Death|0|||
161180745|NCT02407236|582038543|FG011|Induction Study (8 Weeks)|Death|0|||
161180746|NCT02407236|582038544|FG012|Induction Study (8 Weeks)|Death|0|||
161180747|NCT02407236|582038532|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
161180748|NCT02407236|582038533|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
161180749|NCT02407236|582038534|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
161180750|NCT02407236|582038535|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180751|NCT02407236|582038536|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161298630|NCT02677922|582477593|FG005|Treatment Period|Adverse Event|2|||
161298631|NCT02677922|582477588|FG000|Treatment Period|Progressive Disease|1|||
161298632|NCT02677922|582477589|FG001|Treatment Period|Progressive Disease|1|||
161298633|NCT02677922|582477590|FG002|Treatment Period|Progressive Disease|0|||
161298634|NCT02677922|582477591|FG003|Treatment Period|Progressive Disease|0|||
161298635|NCT02677922|582477592|FG004|Treatment Period|Progressive Disease|8|||
161180752|NCT02407236|582038537|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161298636|NCT02677922|582477593|FG005|Treatment Period|Progressive Disease|7|||
161298637|NCT02677922|582477588|FG000|Treatment Period|Lack of Efficacy|0|||
161298638|NCT02677922|582477589|FG001|Treatment Period|Lack of Efficacy|0|||
161298639|NCT02677922|582477590|FG002|Treatment Period|Lack of Efficacy|0|||
161298640|NCT02677922|582477591|FG003|Treatment Period|Lack of Efficacy|1|||
161180753|NCT02407236|582038538|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180754|NCT02407236|582038539|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180755|NCT02407236|582038540|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180756|NCT02407236|582038541|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180757|NCT02407236|582038542|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180758|NCT02407236|582038543|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180759|NCT02407236|582038544|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
161180760|NCT02407236|582038532|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180761|NCT02407236|582038533|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161298641|NCT02677922|582477592|FG004|Treatment Period|Lack of Efficacy|1|||
161180762|NCT02407236|582038534|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
161180763|NCT02407236|582038535|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180764|NCT02407236|582038536|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180765|NCT02407236|582038537|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180766|NCT02407236|582038538|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180767|NCT02407236|582038539|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180768|NCT02407236|582038540|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180769|NCT02407236|582038541|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180770|NCT02407236|582038542|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180771|NCT02407236|582038543|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180772|NCT02407236|582038544|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
161180773|NCT02407236|582038532|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
161180774|NCT02407236|582038533|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
161180775|NCT02407236|582038534|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
161180776|NCT02407236|582038535|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
161180777|NCT02407236|582038536|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
161180778|NCT02407236|582038537|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
161180779|NCT02407236|582038538|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
161180780|NCT02407236|582038539|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
161180781|NCT02407236|582038540|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
161180782|NCT02407236|582038541|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
161180783|NCT02407236|582038542|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
161180784|NCT02407236|582038543|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
161180785|NCT02407236|582038544|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
161180786|NCT02407236|582038532|FG000|Induction Study (8 Weeks)|Other|2|||
161180787|NCT02407236|582038533|FG001|Induction Study (8 Weeks)|Other|1|||
161180788|NCT02407236|582038534|FG002|Induction Study (8 Weeks)|Other|5|||
161180789|NCT02407236|582038535|FG003|Induction Study (8 Weeks)|Other|0|||
161180790|NCT02407236|582038536|FG004|Induction Study (8 Weeks)|Other|0|||
161180791|NCT02407236|582038537|FG005|Induction Study (8 Weeks)|Other|0|||
161180792|NCT02407236|582038538|FG006|Induction Study (8 Weeks)|Other|0|||
161180793|NCT02407236|582038539|FG007|Induction Study (8 Weeks)|Other|0|||
161180794|NCT02407236|582038540|FG008|Induction Study (8 Weeks)|Other|0|||
161180795|NCT02407236|582038541|FG009|Induction Study (8 Weeks)|Other|0|||
161180796|NCT02407236|582038542|FG010|Induction Study (8 Weeks)|Other|0|||
161180797|NCT02407236|582038543|FG011|Induction Study (8 Weeks)|Other|0|||
161180798|NCT02407236|582038544|FG012|Induction Study (8 Weeks)|Other|0|||
161180799|NCT02407236|582038532|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180800|NCT02407236|582038533|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180801|NCT02407236|582038534|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180802|NCT02407236|582038535|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
161180803|NCT02407236|582038536|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
161180804|NCT02407236|582038537|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
161180805|NCT02407236|582038538|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
161180806|NCT02407236|582038539|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
161180807|NCT02407236|582038540|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180808|NCT02407236|582038541|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180809|NCT02407236|582038542|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180810|NCT02407236|582038543|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
161180811|NCT02407236|582038544|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
161298642|NCT02677922|582477593|FG005|Treatment Period|Lack of Efficacy|6|||
161298643|NCT02677922|582477588|FG000|Treatment Period|Withdrawal by Subject|0|||
161298644|NCT02677922|582477589|FG001|Treatment Period|Withdrawal by Subject|0|||
161319499|NCT01863732|582555334|FG000|Overall Study|Technical problems|0|||
161180812|NCT02407236|582038532|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180813|NCT02407236|582038533|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180814|NCT02407236|582038534|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180815|NCT02407236|582038535|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
161180816|NCT02407236|582038536|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
161180817|NCT02407236|582038537|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
161180818|NCT02407236|582038538|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
161180819|NCT02407236|582038539|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
161180820|NCT02407236|582038540|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180821|NCT02407236|582038541|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180822|NCT02407236|582038542|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180823|NCT02407236|582038543|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180824|NCT02407236|582038544|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
161180825|NCT02407236|582038532|FG000|Maintenance Study (44 Weeks)|Other|0|||
161180826|NCT02407236|582038533|FG001|Maintenance Study (44 Weeks)|Other|0|||
161180827|NCT02407236|582038534|FG002|Maintenance Study (44 Weeks)|Other|0|||
161180828|NCT02407236|582038535|FG003|Maintenance Study (44 Weeks)|Other|5|||
161180829|NCT02407236|582038536|FG004|Maintenance Study (44 Weeks)|Other|7|||
161180830|NCT02407236|582038537|FG005|Maintenance Study (44 Weeks)|Other|8|||
161347806|NCT02903914|582657363|FG002|Overall Study|New Cancer Therapy|21|||
161347807|NCT02903914|582657364|FG003|Overall Study|New Cancer Therapy|4|||
161347808|NCT02903914|582657365|FG004|Overall Study|New Cancer Therapy|3|||
161347809|NCT02903914|582657366|FG005|Overall Study|New Cancer Therapy|6|||
161347810|NCT02903914|582657367|FG006|Overall Study|New Cancer Therapy|56|||
161347811|NCT02903914|582657368|FG007|Overall Study|New Cancer Therapy|3|||
161347812|NCT02903914|582657361|FG000|Overall Study|Didn't Return to Site|1|||
161347813|NCT02903914|582657362|FG001|Overall Study|Didn't Return to Site|0|||
161347814|NCT02903914|582657363|FG002|Overall Study|Didn't Return to Site|1|||
161347815|NCT02903914|582657364|FG003|Overall Study|Didn't Return to Site|1|||
161347816|NCT02903914|582657365|FG004|Overall Study|Didn't Return to Site|0|||
161347817|NCT02903914|582657366|FG005|Overall Study|Didn't Return to Site|0|||
161347818|NCT02903914|582657367|FG006|Overall Study|Didn't Return to Site|2|||
161347819|NCT02903914|582657368|FG007|Overall Study|Didn't Return to Site|0|||
161347820|NCT02903914|582657361|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
161347821|NCT02903914|582657362|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
161347822|NCT02903914|582657363|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
161347823|NCT02903914|582657364|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
161347824|NCT02903914|582657365|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
161347825|NCT02903914|582657366|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
161347826|NCT02903914|582657367|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
161347827|NCT02903914|582657368|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
161347828|NCT02903914|582657361|FG000|Overall Study|Follow-up Did Not Occur|0|||
161347829|NCT02903914|582657362|FG001|Overall Study|Follow-up Did Not Occur|1|||
161347830|NCT02903914|582657363|FG002|Overall Study|Follow-up Did Not Occur|1|||
161347831|NCT02903914|582657364|FG003|Overall Study|Follow-up Did Not Occur|0|||
161298645|NCT02677922|582477590|FG002|Treatment Period|Withdrawal by Subject|1|||
161298646|NCT02677922|582477591|FG003|Treatment Period|Withdrawal by Subject|3|||
161298647|NCT02677922|582477592|FG004|Treatment Period|Withdrawal by Subject|5|||
161298648|NCT02677922|582477593|FG005|Treatment Period|Withdrawal by Subject|5|||
161298649|NCT02677922|582477588|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
161298650|NCT02677922|582477589|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
161298651|NCT02677922|582477590|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
161298652|NCT02677922|582477591|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
161298653|NCT02677922|582477592|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
161298654|NCT02677922|582477593|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
161298655|NCT02677922|582477588|FG000|Treatment Period|Disease Relapse|0|||
161298656|NCT02677922|582477589|FG001|Treatment Period|Disease Relapse|0|||
161298657|NCT02677922|582477590|FG002|Treatment Period|Disease Relapse|0|||
161298658|NCT02677922|582477591|FG003|Treatment Period|Disease Relapse|3|||
161298659|NCT02677922|582477592|FG004|Treatment Period|Disease Relapse|6|||
161298660|NCT02677922|582477593|FG005|Treatment Period|Disease Relapse|1|||
161298661|NCT02677922|582477588|FG000|Treatment Period|Allogeneic HSCT|1|||
161298662|NCT02677922|582477589|FG001|Treatment Period|Allogeneic HSCT|0|||
161298663|NCT02677922|582477590|FG002|Treatment Period|Allogeneic HSCT|0|||
161298664|NCT02677922|582477591|FG003|Treatment Period|Allogeneic HSCT|1|||
161298665|NCT02677922|582477592|FG004|Treatment Period|Allogeneic HSCT|4|||
161298666|NCT02677922|582477593|FG005|Treatment Period|Allogeneic HSCT|1|||
161298667|NCT02677922|582477588|FG000|Treatment Period|Other Reasons|0|||
161298668|NCT02677922|582477589|FG001|Treatment Period|Other Reasons|0|||
161298669|NCT02677922|582477590|FG002|Treatment Period|Other Reasons|0|||
161298670|NCT02677922|582477591|FG003|Treatment Period|Other Reasons|1|||
161298671|NCT02677922|582477592|FG004|Treatment Period|Other Reasons|3|||
161298672|NCT02677922|582477593|FG005|Treatment Period|Other Reasons|5|||
161298673|NCT02677922|582477588|FG000|Treatment Period|Death|0|||
161298674|NCT02677922|582477589|FG001|Treatment Period|Death|0|||
161298675|NCT02677922|582477590|FG002|Treatment Period|Death|0|||
161298676|NCT02677922|582477591|FG003|Treatment Period|Death|0|||
161298677|NCT02677922|582477592|FG004|Treatment Period|Death|12|||
161298678|NCT02677922|582477593|FG005|Treatment Period|Death|1|||
161298679|NCT02677922|582477588|FG000|Treatment Period|Non-compliance with Study Drug|0|||
161298680|NCT02677922|582477589|FG001|Treatment Period|Non-compliance with Study Drug|0|||
161347832|NCT02903914|582657365|FG004|Overall Study|Follow-up Did Not Occur|2|||
161298681|NCT02677922|582477590|FG002|Treatment Period|Non-compliance with Study Drug|0|||
161347833|NCT02903914|582657366|FG005|Overall Study|Follow-up Did Not Occur|0|||
161347834|NCT02903914|582657367|FG006|Overall Study|Follow-up Did Not Occur|8|||
161347835|NCT02903914|582657368|FG007|Overall Study|Follow-up Did Not Occur|0|||
161298682|NCT02677922|582477591|FG003|Treatment Period|Non-compliance with Study Drug|0|||
161298683|NCT02677922|582477592|FG004|Treatment Period|Non-compliance with Study Drug|1|||
161298684|NCT02677922|582477593|FG005|Treatment Period|Non-compliance with Study Drug|0|||
161298685|NCT02677922|582477588|FG000|Treatment Period|Physician Decision|0|||
161298686|NCT02677922|582477589|FG001|Treatment Period|Physician Decision|0|||
161298687|NCT02677922|582477590|FG002|Treatment Period|Physician Decision|0|||
161347836|NCT02903914|582657361|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
161347837|NCT02903914|582657362|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
161347838|NCT02903914|582657363|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
161347839|NCT02903914|582657364|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
161347840|NCT02903914|582657365|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
161347841|NCT02903914|582657366|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
161180831|NCT02407236|582038538|FG006|Maintenance Study (44 Weeks)|Other|4|||
161180832|NCT02407236|582038539|FG007|Maintenance Study (44 Weeks)|Other|6|||
161180833|NCT02407236|582038540|FG008|Maintenance Study (44 Weeks)|Other|0|||
161180834|NCT02407236|582038541|FG009|Maintenance Study (44 Weeks)|Other|0|||
161180835|NCT02407236|582038542|FG010|Maintenance Study (44 Weeks)|Other|0|||
161180836|NCT02407236|582038543|FG011|Maintenance Study (44 Weeks)|Other|0|||
161180837|NCT02407236|582038544|FG012|Maintenance Study (44 Weeks)|Other|0|||
161180838|NCT02407236|582038532|FG000|Maintenance Study (44 Weeks)|Death|0|||
161180839|NCT02407236|582038533|FG001|Maintenance Study (44 Weeks)|Death|0|||
161180840|NCT02407236|582038534|FG002|Maintenance Study (44 Weeks)|Death|0|||
161180841|NCT02407236|582038535|FG003|Maintenance Study (44 Weeks)|Death|0|||
161180842|NCT02407236|582038536|FG004|Maintenance Study (44 Weeks)|Death|0|||
161180843|NCT02407236|582038537|FG005|Maintenance Study (44 Weeks)|Death|0|||
161180844|NCT02407236|582038538|FG006|Maintenance Study (44 Weeks)|Death|0|||
161180845|NCT02407236|582038539|FG007|Maintenance Study (44 Weeks)|Death|1|||
161180846|NCT02407236|582038540|FG008|Maintenance Study (44 Weeks)|Death|0|||
161180847|NCT02407236|582038541|FG009|Maintenance Study (44 Weeks)|Death|0|||
161180848|NCT02407236|582038542|FG010|Maintenance Study (44 Weeks)|Death|0|||
161180849|NCT02407236|582038543|FG011|Maintenance Study (44 Weeks)|Death|0|||
161180850|NCT02407236|582038544|FG012|Maintenance Study (44 Weeks)|Death|0|||
161180851|NCT02407236|582038532|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180852|NCT02407236|582038533|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180853|NCT02407236|582038534|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180854|NCT02407236|582038535|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180855|NCT02407236|582038536|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180856|NCT02407236|582038537|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180857|NCT02407236|582038538|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180858|NCT02407236|582038539|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
161180859|NCT02407236|582038540|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
161180860|NCT02407236|582038541|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
161180861|NCT02407236|582038542|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
161180862|NCT02407236|582038543|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
161180863|NCT02407236|582038544|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
161180864|NCT02407236|582038532|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180865|NCT02407236|582038533|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180866|NCT02407236|582038534|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180867|NCT02407236|582038535|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180868|NCT02407236|582038536|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180869|NCT02407236|582038537|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180870|NCT02407236|582038538|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180871|NCT02407236|582038539|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180872|NCT02407236|582038540|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180873|NCT02407236|582038541|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180874|NCT02407236|582038542|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
161180875|NCT02407236|582038543|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180876|NCT02407236|582038544|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
161180877|NCT02407236|582038532|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180878|NCT02407236|582038533|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180879|NCT02407236|582038534|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180880|NCT02407236|582038535|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180881|NCT02407236|582038536|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180882|NCT02407236|582038537|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180883|NCT02407236|582038538|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180884|NCT02407236|582038539|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
161180885|NCT02407236|582038540|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
161180886|NCT02407236|582038541|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
161180887|NCT02407236|582038542|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
161180888|NCT02407236|582038543|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
161347842|NCT02903914|582657367|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
161180889|NCT02407236|582038544|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
161180890|NCT02407236|582038532|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
161180891|NCT02407236|582038533|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
161180892|NCT02407236|582038534|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
161180893|NCT02407236|582038535|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
161298688|NCT02677922|582477591|FG003|Treatment Period|Physician Decision|0|||
161298689|NCT02677922|582477592|FG004|Treatment Period|Physician Decision|0|||
161298690|NCT02677922|582477593|FG005|Treatment Period|Physician Decision|1|||
161298691|NCT02677922|582477588|FG000|Treatment Period|Symptomatic Deterioration|0|||
161298692|NCT02677922|582477589|FG001|Treatment Period|Symptomatic Deterioration|0|||
161298693|NCT02677922|582477590|FG002|Treatment Period|Symptomatic Deterioration|0|||
161298694|NCT02677922|582477591|FG003|Treatment Period|Symptomatic Deterioration|0|||
161298695|NCT02677922|582477592|FG004|Treatment Period|Symptomatic Deterioration|1|||
161298696|NCT02677922|582477593|FG005|Treatment Period|Symptomatic Deterioration|0|||
161298697|NCT00637000|582477594|FG000|Overall Study|Withdrawal by Subject|4|||
161298698|NCT00637000|582477595|FG001|Overall Study|Withdrawal by Subject|3|||
161298699|NCT00183885|582477618|FG000|Overall Study|Adverse Event|11|||
161298700|NCT00183885|582477618|FG000|Overall Study|Death|1|||
161298701|NCT00183885|582477618|FG000|Overall Study|Lost to Follow-up|3|||
161298702|NCT00183885|582477618|FG000|Overall Study|Physician Decision|6|||
161298703|NCT00183885|582477618|FG000|Overall Study|Withdrawal by Subject|5|||
161180894|NCT02407236|582038536|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
161180895|NCT02407236|582038537|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
161180896|NCT02407236|582038538|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
161180897|NCT02407236|582038539|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
161180898|NCT02407236|582038540|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
161180899|NCT02407236|582038541|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
161180900|NCT02407236|582038542|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
161180901|NCT02407236|582038543|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
161180902|NCT02407236|582038544|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
161180903|NCT03039569|582038547|FG000|Overall Study|Lost to Follow-up|5|||
161180904|NCT03039569|582038548|FG001|Overall Study|Lost to Follow-up|4|||
161180905|NCT01167153|582038549|FG000|Overall Study|Non-effective therapy|1|||
161180906|NCT01167153|582038550|FG001|Overall Study|Non-effective therapy|4|||
161180907|NCT01167153|582038549|FG000|Overall Study|AE including clinical laboratory AE|2|||
161180908|NCT01167153|582038550|FG001|Overall Study|AE including clinical laboratory AE|8|||
161180909|NCT01167153|582038549|FG000|Overall Study|Hypotension|1|||
161180910|NCT01167153|582038550|FG001|Overall Study|Hypotension|0|||
161180911|NCT01167153|582038549|FG000|Overall Study|Lost to Follow-up|7|||
161180912|NCT01167153|582038550|FG001|Overall Study|Lost to Follow-up|9|||
161180913|NCT01167153|582038549|FG000|Overall Study|Non-compliance to concomitant medication|0|||
161180914|NCT01167153|582038550|FG001|Overall Study|Non-compliance to concomitant medication|2|||
161180915|NCT01167153|582038549|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
161180916|NCT01167153|582038550|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
161180917|NCT01167153|582038549|FG000|Overall Study|Withdrawal consent|1|||
161180918|NCT01167153|582038550|FG001|Overall Study|Withdrawal consent|1|||
161180919|NCT01167153|582038549|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
161180920|NCT01167153|582038550|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
161180921|NCT02710422|582040474|FG000|Overall Study|Termination of study|9|||
161180922|NCT02710422|582040475|FG001|Overall Study|Termination of study|9|||
161180923|NCT01370499|582040476|FG000|Overall Study|Adverse Event|38|||
161180924|NCT01370499|582040477|FG001|Overall Study|Adverse Event|12|||
161180925|NCT01370499|582040476|FG000|Overall Study|Lack of Efficacy|4|||
161180926|NCT01370499|582040477|FG001|Overall Study|Lack of Efficacy|2|||
161180927|NCT01370499|582040476|FG000|Overall Study|Lost to Follow-up|2|||
161180928|NCT01370499|582040477|FG001|Overall Study|Lost to Follow-up|1|||
161180929|NCT01370499|582040476|FG000|Overall Study|Physician Decision|3|||
161180930|NCT01370499|582040477|FG001|Overall Study|Physician Decision|3|||
161180931|NCT01370499|582040476|FG000|Overall Study|Protocol Violation|5|||
161180932|NCT01370499|582040477|FG001|Overall Study|Protocol Violation|4|||
161180933|NCT01370499|582040476|FG000|Overall Study|Withdrawal by Subject|18|||
161180934|NCT01370499|582040477|FG001|Overall Study|Withdrawal by Subject|7|||
161180935|NCT01370499|582040476|FG000|Overall Study|Sponsor Decision|41|||
161180936|NCT01370499|582040477|FG001|Overall Study|Sponsor Decision|15|||
161180937|NCT02000622|582040478|FG000|Overall Study|Withdrawal by Subject|5|||
161298704|NCT00183885|582477618|FG000|Overall Study|Switched to alternative treatment|8|||
161180938|NCT02000622|582040479|FG001|Overall Study|Withdrawal by Subject|7|||
161298705|NCT00183885|582477618|FG000|Overall Study|Treatment delayed too long|4|||
161180939|NCT02000622|582040478|FG000|Overall Study|Lost to Follow-up|4|||
161180940|NCT02000622|582040479|FG001|Overall Study|Lost to Follow-up|0|||
161298706|NCT00183885|582477618|FG000|Overall Study|Developed second malignancy|1|||
161298707|NCT00014495|582477621|FG000|Overall Study|Death|0|||
161298708|NCT00014495|582477622|FG001|Overall Study|Death|0|||
161298709|NCT00014495|582477623|FG002|Overall Study|Death|1|||
161180941|NCT02000622|582040478|FG000|Overall Study|Death|159|||
161180942|NCT02000622|582040479|FG001|Overall Study|Death|73|||
161180943|NCT02000622|582040478|FG000|Overall Study|Withdrawn due to site closure|1|||
161298710|NCT00014495|582477624|FG003|Overall Study|Death|0|||
161298711|NCT00014495|582477621|FG000|Overall Study|Clinical deterioration|0|||
161180944|NCT02000622|582040479|FG001|Overall Study|Withdrawn due to site closure|0|||
161180945|NCT01462045|582040480|FG000|Overall Study|Family matter|0|||
161180946|NCT01462045|582040481|FG001|Overall Study|Family matter|1|||
161180947|NCT01462045|582040482|FG002|Overall Study|Family matter|0|||
161180948|NCT01938391|582040483|FG000|6 Month Follow up|Withdrawal by Subject|1|||
161180949|NCT01938391|582040483|FG000|12 Month Follow up|Physician Decision|1|||
161180950|NCT01938391|582040483|FG000|12 Month Follow up|Withdrawal by Subject|1|||
161180951|NCT04924114|582040487|FG000|Overall Study|Withdrawal by Subject|0|||
161180952|NCT04924114|582040488|FG001|Overall Study|Withdrawal by Subject|2|||
161180953|NCT04924114|582040489|FG002|Overall Study|Withdrawal by Subject|2|||
161180954|NCT04924114|582040490|FG003|Overall Study|Withdrawal by Subject|0|||
161180955|NCT04924114|582040491|FG004|Overall Study|Withdrawal by Subject|2|||
161180956|NCT03558828|582040492|FG000|Overall Study|Lost to Follow-up|4|||
161180957|NCT03558828|582040493|FG001|Overall Study|Lost to Follow-up|3|||
161180958|NCT03558828|582040494|FG002|Overall Study|Lost to Follow-up|3|||
161180959|NCT03558828|582040495|FG003|Overall Study|Lost to Follow-up|5|||
161180960|NCT03558828|582040496|FG004|Overall Study|Lost to Follow-up|2|||
161180961|NCT03558828|582040497|FG005|Overall Study|Lost to Follow-up|3|||
161180962|NCT03558828|582040492|FG000|Overall Study|dropped before the intervention|1|||
161180963|NCT03558828|582040493|FG001|Overall Study|dropped before the intervention|1|||
161180964|NCT03558828|582040494|FG002|Overall Study|dropped before the intervention|0|||
161180965|NCT03558828|582040495|FG003|Overall Study|dropped before the intervention|0|||
161180966|NCT03558828|582040496|FG004|Overall Study|dropped before the intervention|0|||
161180967|NCT03558828|582040497|FG005|Overall Study|dropped before the intervention|0|||
161180968|NCT03671148|582040498|FG000|Overall Study|Adverse Event|3|||
161180969|NCT03671148|582040499|FG001|Overall Study|Adverse Event|2|||
161180970|NCT03671148|582040498|FG000|Overall Study|Withdrawal by Subject|8|||
161180971|NCT03671148|582040499|FG001|Overall Study|Withdrawal by Subject|2|||
161180972|NCT03671148|582040498|FG000|Overall Study|Lost to Follow-up|1|||
161180973|NCT03671148|582040499|FG001|Overall Study|Lost to Follow-up|2|||
161180974|NCT03671148|582040498|FG000|Overall Study|Lack of Efficacy|7|||
161180975|NCT03671148|582040499|FG001|Overall Study|Lack of Efficacy|2|||
161180976|NCT03671148|582040498|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
161180977|NCT03671148|582040499|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
161180978|NCT03671148|582040498|FG000|Overall Study|Other|1|||
161180979|NCT03671148|582040499|FG001|Overall Study|Other|0|||
161180980|NCT03671148|582040498|FG000|Overall Study|Incomplete Randomization Visit|1|||
161180981|NCT03671148|582040499|FG001|Overall Study|Incomplete Randomization Visit|0|||
161180982|NCT00673816|582040500|FG000|Overall Study|Adverse Event|1|||
161180983|NCT00673816|582040500|FG000|Overall Study|Withdrawal by Subject|1|||
161180984|NCT01804842|582040504|FG000|Overall Study|Adverse Event|1|||
161180985|NCT01804842|582040505|FG001|Overall Study|Adverse Event|1|||
161180986|NCT01804842|582040506|FG002|Overall Study|Adverse Event|0|||
161180987|NCT01804842|582040504|FG000|Overall Study|Lost to Follow-up|1|||
161180988|NCT01804842|582040505|FG001|Overall Study|Lost to Follow-up|0|||
161180989|NCT01804842|582040506|FG002|Overall Study|Lost to Follow-up|0|||
161180990|NCT01804842|582040504|FG000|Overall Study|Non-Compliance|1|||
161180991|NCT01804842|582040505|FG001|Overall Study|Non-Compliance|1|||
161180992|NCT01804842|582040506|FG002|Overall Study|Non-Compliance|0|||
161180993|NCT01804842|582040504|FG000|Overall Study|Personal Reason|0|||
161180994|NCT01804842|582040505|FG001|Overall Study|Personal Reason|0|||
161180995|NCT01804842|582040506|FG002|Overall Study|Personal Reason|1|||
161180996|NCT03774875|582040509|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
161180997|NCT03774875|582040510|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
161180998|NCT03774875|582040509|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
161180999|NCT03774875|582040510|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
161181000|NCT03774875|582040509|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
161181001|NCT03774875|582040510|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
161181002|NCT03774875|582040509|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
161181003|NCT03774875|582040510|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
161181004|NCT03774875|582040509|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
161181005|NCT03774875|582040510|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
161181006|NCT03774875|582040509|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
161181007|NCT03774875|582040510|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
161181008|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
161181009|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
161181010|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
161181011|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
161347843|NCT02903914|582657368|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
161181012|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
161181013|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
161181014|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
161181015|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
161181016|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
161181017|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
161298712|NCT00014495|582477622|FG001|Overall Study|Clinical deterioration|0|||
161298713|NCT00014495|582477623|FG002|Overall Study|Clinical deterioration|0|||
161298714|NCT00014495|582477624|FG003|Overall Study|Clinical deterioration|1|||
161298715|NCT00828568|582477625|FG000|Randomized|Withdrawal by Subject|1|||
161298716|NCT00828568|582477626|FG001|Randomized|Withdrawal by Subject|0|||
161298717|NCT00828568|582477627|FG002|Randomized|Withdrawal by Subject|2|||
161298718|NCT00828568|582477625|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
161298719|NCT00828568|582477626|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
161298720|NCT00828568|582477627|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
161298721|NCT00828568|582477625|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
161298722|NCT00828568|582477626|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
161298723|NCT00828568|582477627|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
161298724|NCT00828568|582477625|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
161298725|NCT00828568|582477626|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
161298726|NCT00828568|582477627|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
161298727|NCT00828568|582477625|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
161298728|NCT00828568|582477626|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
161298729|NCT00828568|582477627|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
161298730|NCT00460811|582477629|FG000|Overall Study|Adverse Event|4|||
161298731|NCT00460811|582477630|FG001|Overall Study|Adverse Event|6|||
161298732|NCT00460811|582477631|FG002|Overall Study|Adverse Event|3|||
161298733|NCT00460811|582477632|FG003|Overall Study|Adverse Event|10|||
161298734|NCT00460811|582477633|FG004|Overall Study|Adverse Event|2|||
161298735|NCT00460811|582477629|FG000|Overall Study|Noncompliance|1|||
161298736|NCT00460811|582477630|FG001|Overall Study|Noncompliance|0|||
161298737|NCT00460811|582477631|FG002|Overall Study|Noncompliance|0|||
161298738|NCT00460811|582477632|FG003|Overall Study|Noncompliance|2|||
161298739|NCT00460811|582477633|FG004|Overall Study|Noncompliance|1|||
161298740|NCT00460811|582477629|FG000|Overall Study|Withdrawal by Subject|7|||
161298741|NCT00460811|582477630|FG001|Overall Study|Withdrawal by Subject|7|||
161298742|NCT00460811|582477631|FG002|Overall Study|Withdrawal by Subject|6|||
161298743|NCT00460811|582477632|FG003|Overall Study|Withdrawal by Subject|3|||
161298744|NCT00460811|582477633|FG004|Overall Study|Withdrawal by Subject|11|||
161298745|NCT00460811|582477629|FG000|Overall Study|Physician Decision|1|||
161298746|NCT00460811|582477630|FG001|Overall Study|Physician Decision|0|||
161298747|NCT00460811|582477631|FG002|Overall Study|Physician Decision|0|||
161298748|NCT00460811|582477632|FG003|Overall Study|Physician Decision|0|||
161298749|NCT00460811|582477633|FG004|Overall Study|Physician Decision|0|||
161298750|NCT00460811|582477629|FG000|Overall Study|Lost to Follow-up|3|||
161298751|NCT00460811|582477630|FG001|Overall Study|Lost to Follow-up|2|||
161298752|NCT00460811|582477631|FG002|Overall Study|Lost to Follow-up|5|||
161298753|NCT00460811|582477632|FG003|Overall Study|Lost to Follow-up|3|||
161298754|NCT00460811|582477633|FG004|Overall Study|Lost to Follow-up|6|||
161298755|NCT02821754|582477634|FG000|Overall Study|Procedure not required prior to amendment change|13|||
161298756|NCT02821754|582477635|FG001|Overall Study|Procedure not required prior to amendment change|11|||
161298757|NCT02821754|582477636|FG002|Overall Study|Procedure not required prior to amendment change|0|||
161298758|NCT02821754|582477634|FG000|Overall Study|Participant's Clinical status|2|||
161298759|NCT02821754|582477635|FG001|Overall Study|Participant's Clinical status|0|||
161298760|NCT02821754|582477636|FG002|Overall Study|Participant's Clinical status|0|||
161298761|NCT02821754|582477634|FG000|Overall Study|Participant removed for noncompliance|1|||
161298762|NCT02821754|582477635|FG001|Overall Study|Participant removed for noncompliance|0|||
161298763|NCT02821754|582477636|FG002|Overall Study|Participant removed for noncompliance|0|||
161298764|NCT02821754|582477634|FG000|Overall Study|Drug not available.|0|||
161298765|NCT02821754|582477635|FG001|Overall Study|Drug not available.|0|||
161298766|NCT02821754|582477636|FG002|Overall Study|Drug not available.|1|||
161298767|NCT02821754|582477634|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
161298768|NCT02821754|582477635|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
161298769|NCT02821754|582477636|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
161298770|NCT01355575|582477637|FG000|Overall Study|Withdrawal by Subject|2|||
161298771|NCT01166438|582477638|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
161298772|NCT01166438|582477639|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
161298773|NCT01166438|582477638|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
161298774|NCT01166438|582477639|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
161298775|NCT01166438|582477638|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
161298776|NCT01166438|582477639|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
161298777|NCT01166438|582477638|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
161298778|NCT01166438|582477639|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
161298779|NCT01166438|582477638|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
161298780|NCT01166438|582477639|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
161298781|NCT01166438|582477638|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
161298782|NCT01166438|582477639|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
161181018|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
161181019|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
161181020|NCT03774875|582040509|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
161181021|NCT03774875|582040510|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
161181022|NCT02352090|582040511|FG000|Overall Study|general malaise|1|||
161181023|NCT02352090|582040512|FG001|Overall Study|general malaise|0|||
161181024|NCT02352090|582040513|FG002|Overall Study|general malaise|0|||
161181025|NCT02352090|582040511|FG000|Overall Study|non-specified mild side-effects|0|||
161181026|NCT02352090|582040512|FG001|Overall Study|non-specified mild side-effects|0|||
161181027|NCT02352090|582040513|FG002|Overall Study|non-specified mild side-effects|2|||
161181028|NCT00413777|582040515|FG000|Fixed-dose Period|Lost to Follow-up|1|||
161181029|NCT00413777|582040516|FG001|Fixed-dose Period|Lost to Follow-up|1|||
161181030|NCT00413777|582040515|FG000|Fixed-dose Period|Adverse Event|2|||
161181031|NCT00413777|582040516|FG001|Fixed-dose Period|Adverse Event|1|||
161181032|NCT00413777|582040515|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
161181033|NCT00413777|582040516|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
161181034|NCT00413777|582040515|FG000|Fixed-dose Period|Withdrew Consent|0|||
161181035|NCT00413777|582040516|FG001|Fixed-dose Period|Withdrew Consent|1|||
161181036|NCT01678313|582040517|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
161181037|NCT01678313|582040518|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
161181038|NCT01678313|582040517|FG000|Completed the 3-month Therapy|Physician Decision|3|||
161181039|NCT01678313|582040518|FG001|Completed the 3-month Therapy|Physician Decision|4|||
161181040|NCT01678313|582040517|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
161181041|NCT01678313|582040518|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
161181042|NCT01678313|582040517|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
161181043|NCT01678313|582040518|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
161181044|NCT05179057|582040519|FG000|Overall Study|Adverse Event|3|||
161181045|NCT05179057|582040520|FG001|Overall Study|Adverse Event|2|||
161181046|NCT05179057|582040519|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
161181047|NCT05179057|582040520|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
161181048|NCT05179057|582040519|FG000|Overall Study|Study terminated|13|||
161181049|NCT05179057|582040520|FG001|Overall Study|Study terminated|7|||
161181050|NCT05179057|582040519|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
161181051|NCT05179057|582040520|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
161181052|NCT05179057|582040519|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
161181053|NCT05179057|582040520|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
161181054|NCT03345342|582040521|FG000|Open-Label Phase|Adverse Event|30|||
161181055|NCT03345342|582040522|FG001|Open-Label Phase|Adverse Event|0|||
161181056|NCT03345342|582040523|FG002|Open-Label Phase|Adverse Event|0|||
161181057|NCT03345342|582040524|FG003|Open-Label Phase|Adverse Event|0|||
161181058|NCT03345342|582040525|FG004|Open-Label Phase|Adverse Event|0|||
161181059|NCT03345342|582040521|FG000|Open-Label Phase|Death|1|||
161181060|NCT03345342|582040522|FG001|Open-Label Phase|Death|0|||
161181061|NCT03345342|582040523|FG002|Open-Label Phase|Death|0|||
161181062|NCT03345342|582040524|FG003|Open-Label Phase|Death|0|||
161181063|NCT03345342|582040525|FG004|Open-Label Phase|Death|0|||
161181064|NCT03345342|582040521|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
161181065|NCT03345342|582040522|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
161181066|NCT03345342|582040523|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
161181067|NCT03345342|582040524|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
161181068|NCT03345342|582040525|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
161181069|NCT03345342|582040521|FG000|Open-Label Phase|Lack of Efficacy|6|||
161181070|NCT03345342|582040522|FG001|Open-Label Phase|Lack of Efficacy|0|||
161181071|NCT03345342|582040523|FG002|Open-Label Phase|Lack of Efficacy|0|||
161181072|NCT03345342|582040524|FG003|Open-Label Phase|Lack of Efficacy|0|||
161181073|NCT03345342|582040525|FG004|Open-Label Phase|Lack of Efficacy|0|||
161181074|NCT03345342|582040521|FG000|Open-Label Phase|Lost to Follow-up|9|||
161181075|NCT03345342|582040522|FG001|Open-Label Phase|Lost to Follow-up|0|||
161181076|NCT03345342|582040523|FG002|Open-Label Phase|Lost to Follow-up|0|||
161181077|NCT03345342|582040524|FG003|Open-Label Phase|Lost to Follow-up|0|||
161181078|NCT03345342|582040525|FG004|Open-Label Phase|Lost to Follow-up|0|||
161181079|NCT03345342|582040521|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
161181080|NCT03345342|582040522|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
161181081|NCT03345342|582040523|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
161181082|NCT03345342|582040524|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
161181083|NCT03345342|582040525|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
161181084|NCT03345342|582040521|FG000|Open-Label Phase|Physician Decision|4|||
161181085|NCT03345342|582040522|FG001|Open-Label Phase|Physician Decision|0|||
161181086|NCT03345342|582040523|FG002|Open-Label Phase|Physician Decision|0|||
161181087|NCT03345342|582040524|FG003|Open-Label Phase|Physician Decision|0|||
161181088|NCT03345342|582040525|FG004|Open-Label Phase|Physician Decision|0|||
161298783|NCT03759587|582477650|FG000|Overall Study|Adverse Event|5|||
161298784|NCT03759587|582477650|FG000|Overall Study|Progressive Disease|10|||
161181089|NCT03345342|582040521|FG000|Open-Label Phase|Protocol Violation|8|||
161181090|NCT03345342|582040522|FG001|Open-Label Phase|Protocol Violation|0|||
161181091|NCT03345342|582040523|FG002|Open-Label Phase|Protocol Violation|0|||
161181092|NCT03345342|582040524|FG003|Open-Label Phase|Protocol Violation|0|||
161181093|NCT03345342|582040525|FG004|Open-Label Phase|Protocol Violation|0|||
161181094|NCT03345342|582040521|FG000|Open-Label Phase|Withdrawal by Subject|57|||
161181095|NCT03345342|582040522|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161181096|NCT03345342|582040523|FG002|Open-Label Phase|Withdrawal by Subject|0|||
161181097|NCT03345342|582040524|FG003|Open-Label Phase|Withdrawal by Subject|0|||
161181098|NCT03345342|582040525|FG004|Open-Label Phase|Withdrawal by Subject|0|||
161181099|NCT03345342|582040521|FG000|Open-Label Phase|Other|15|||
161181100|NCT03345342|582040522|FG001|Open-Label Phase|Other|0|||
161181101|NCT03345342|582040523|FG002|Open-Label Phase|Other|0|||
161181102|NCT03345342|582040524|FG003|Open-Label Phase|Other|0|||
161181103|NCT03345342|582040525|FG004|Open-Label Phase|Other|0|||
161181104|NCT03345342|582040521|FG000|Double-Blind Phase|Adverse Event|0|||
161181105|NCT03345342|582040522|FG001|Double-Blind Phase|Adverse Event|1|||
161181106|NCT03345342|582040523|FG002|Double-Blind Phase|Adverse Event|6|||
161181107|NCT03345342|582040524|FG003|Double-Blind Phase|Adverse Event|0|||
161181108|NCT03345342|582040525|FG004|Double-Blind Phase|Adverse Event|0|||
161181109|NCT03345342|582040521|FG000|Double-Blind Phase|Death|0|||
161181110|NCT03345342|582040522|FG001|Double-Blind Phase|Death|2|||
161181111|NCT03345342|582040523|FG002|Double-Blind Phase|Death|1|||
161181112|NCT03345342|582040524|FG003|Double-Blind Phase|Death|0|||
161181113|NCT03345342|582040525|FG004|Double-Blind Phase|Death|0|||
161181114|NCT03345342|582040521|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
161181115|NCT03345342|582040522|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
161181116|NCT03345342|582040523|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
161181117|NCT03345342|582040524|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
161181118|NCT03345342|582040525|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
161181119|NCT03345342|582040521|FG000|Double-Blind Phase|Lost to Follow-up|0|||
161181120|NCT03345342|582040522|FG001|Double-Blind Phase|Lost to Follow-up|1|||
161181121|NCT03345342|582040523|FG002|Double-Blind Phase|Lost to Follow-up|7|||
161181122|NCT03345342|582040524|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161181123|NCT03345342|582040525|FG004|Double-Blind Phase|Lost to Follow-up|0|||
161181124|NCT03345342|582040521|FG000|Double-Blind Phase|Physician Decision|0|||
161181125|NCT03345342|582040522|FG001|Double-Blind Phase|Physician Decision|1|||
161181126|NCT03345342|582040523|FG002|Double-Blind Phase|Physician Decision|4|||
161181127|NCT03345342|582040524|FG003|Double-Blind Phase|Physician Decision|0|||
161181128|NCT03345342|582040525|FG004|Double-Blind Phase|Physician Decision|0|||
161181129|NCT03345342|582040521|FG000|Double-Blind Phase|Protocol Violation|0|||
161181130|NCT03345342|582040522|FG001|Double-Blind Phase|Protocol Violation|0|||
161181131|NCT03345342|582040523|FG002|Double-Blind Phase|Protocol Violation|1|||
161181132|NCT03345342|582040524|FG003|Double-Blind Phase|Protocol Violation|0|||
161181133|NCT03345342|582040525|FG004|Double-Blind Phase|Protocol Violation|0|||
161181134|NCT03345342|582040521|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
161181135|NCT03345342|582040522|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
161181136|NCT03345342|582040523|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
161181137|NCT03345342|582040524|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
161181138|NCT03345342|582040525|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
161181139|NCT03345342|582040521|FG000|Double-Blind Phase|Other|0|||
161181140|NCT03345342|582040522|FG001|Double-Blind Phase|Other|1|||
161181141|NCT03345342|582040523|FG002|Double-Blind Phase|Other|3|||
161181142|NCT03345342|582040524|FG003|Double-Blind Phase|Other|0|||
161181143|NCT03345342|582040525|FG004|Double-Blind Phase|Other|0|||
161181144|NCT03345342|582040521|FG000|Follow-Up Phase|Adverse Event|0|||
161181145|NCT03345342|582040522|FG001|Follow-Up Phase|Adverse Event|0|||
161181146|NCT03345342|582040523|FG002|Follow-Up Phase|Adverse Event|0|||
161181147|NCT03345342|582040524|FG003|Follow-Up Phase|Adverse Event|0|||
161181148|NCT03345342|582040525|FG004|Follow-Up Phase|Adverse Event|4|||
161181149|NCT03345342|582040521|FG000|Follow-Up Phase|Lost to Follow-up|0|||
161181150|NCT03345342|582040522|FG001|Follow-Up Phase|Lost to Follow-up|0|||
161181151|NCT03345342|582040523|FG002|Follow-Up Phase|Lost to Follow-up|0|||
161181152|NCT03345342|582040524|FG003|Follow-Up Phase|Lost to Follow-up|0|||
161181153|NCT03345342|582040525|FG004|Follow-Up Phase|Lost to Follow-up|6|||
161298785|NCT03759587|582477650|FG000|Overall Study|Site Terminated by Sponsor|3|||
161181154|NCT03345342|582040521|FG000|Follow-Up Phase|Physician Decision|0|||
161181155|NCT03345342|582040522|FG001|Follow-Up Phase|Physician Decision|0|||
161181156|NCT03345342|582040523|FG002|Follow-Up Phase|Physician Decision|0|||
161298786|NCT03759587|582477650|FG000|Overall Study|Withdrawal by Subject|1|||
161298787|NCT00591565|582477651|FG000|Overall Study|lost follow up, withdrawn|5|||
161181157|NCT03345342|582040524|FG003|Follow-Up Phase|Physician Decision|0|||
161181158|NCT03345342|582040525|FG004|Follow-Up Phase|Physician Decision|5|||
161181159|NCT03345342|582040521|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161181160|NCT03345342|582040522|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
161181161|NCT03345342|582040523|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
161181162|NCT03345342|582040524|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
161181163|NCT03345342|582040525|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
161181164|NCT03345342|582040521|FG000|Follow-Up Phase|Other|0|||
161181165|NCT03345342|582040522|FG001|Follow-Up Phase|Other|0|||
161181166|NCT03345342|582040523|FG002|Follow-Up Phase|Other|0|||
161181167|NCT03345342|582040524|FG003|Follow-Up Phase|Other|3|||
161181168|NCT03345342|582040525|FG004|Follow-Up Phase|Other|1|||
161181169|NCT03375203|582040526|FG000|Overall Study|Protocol Violation|0|||
161181170|NCT03375203|582040527|FG001|Overall Study|Protocol Violation|0|||
161181171|NCT03375203|582040528|FG002|Overall Study|Protocol Violation|1|||
161181172|NCT03375203|582040529|FG003|Overall Study|Protocol Violation|0|||
161181173|NCT03375203|582040530|FG004|Overall Study|Protocol Violation|0|||
161181174|NCT03375203|582040526|FG000|Overall Study|Adverse Event|2|||
161181175|NCT03375203|582040527|FG001|Overall Study|Adverse Event|3|||
161181176|NCT03375203|582040528|FG002|Overall Study|Adverse Event|0|||
161181177|NCT03375203|582040529|FG003|Overall Study|Adverse Event|2|||
161181178|NCT03375203|582040530|FG004|Overall Study|Adverse Event|2|||
161181179|NCT03375203|582040526|FG000|Overall Study|Withdrawal by Subject|3|||
161181180|NCT03375203|582040527|FG001|Overall Study|Withdrawal by Subject|0|||
161181181|NCT03375203|582040528|FG002|Overall Study|Withdrawal by Subject|1|||
161181182|NCT03375203|582040529|FG003|Overall Study|Withdrawal by Subject|0|||
161181183|NCT03375203|582040530|FG004|Overall Study|Withdrawal by Subject|2|||
161181184|NCT03375203|582040526|FG000|Overall Study|Non-compliance with study drug|1|||
161181185|NCT03375203|582040527|FG001|Overall Study|Non-compliance with study drug|0|||
161181186|NCT03375203|582040528|FG002|Overall Study|Non-compliance with study drug|0|||
161181187|NCT03375203|582040529|FG003|Overall Study|Non-compliance with study drug|0|||
161181188|NCT03375203|582040530|FG004|Overall Study|Non-compliance with study drug|0|||
161181189|NCT03375203|582040526|FG000|Overall Study|Randomized, not treated.|0|||
161181190|NCT03375203|582040527|FG001|Overall Study|Randomized, not treated.|1|||
161181191|NCT03375203|582040528|FG002|Overall Study|Randomized, not treated.|0|||
161181192|NCT03375203|582040529|FG003|Overall Study|Randomized, not treated.|0|||
161181193|NCT03375203|582040530|FG004|Overall Study|Randomized, not treated.|0|||
161181194|NCT03107793|582040531|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
161181195|NCT03107793|582040532|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
161181196|NCT03107793|582040533|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
161181197|NCT03107793|582040534|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
161181198|NCT03107793|582040535|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
161181199|NCT03107793|582040531|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
161181200|NCT03107793|582040532|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
161181201|NCT03107793|582040533|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
161181202|NCT03107793|582040534|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
161181203|NCT03107793|582040535|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
161181204|NCT03107793|582040531|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
161181205|NCT03107793|582040532|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
161181206|NCT03107793|582040533|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
161181207|NCT03107793|582040534|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
161181208|NCT03107793|582040535|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
161181209|NCT03107793|582040531|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
161181210|NCT03107793|582040532|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161181211|NCT03107793|582040533|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161181212|NCT03107793|582040534|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161181213|NCT03107793|582040535|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
161181214|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161181215|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
161181216|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
161181217|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161181218|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
161181219|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161181220|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
161181221|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
161181222|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161181223|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
161181224|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161181225|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161298788|NCT00454363|582477652|FG000|Overall Study|Adverse Event|1|||
161298789|NCT00454363|582477653|FG001|Overall Study|Adverse Event|2|||
161298790|NCT00454363|582477652|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
161298791|NCT00454363|582477653|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
161298792|NCT01554527|582477655|FG000|Overall Study|Withdrawal by Subject|1|||
161181226|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
161181227|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161181228|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
161181229|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161181230|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
161319500|NCT01863732|582555335|FG001|Overall Study|Technical problems|1|||
161298793|NCT01554527|582477656|FG001|Overall Study|Withdrawal by Subject|0|||
161298794|NCT01554527|582477657|FG002|Overall Study|Withdrawal by Subject|3|||
161298795|NCT01554527|582477655|FG000|Overall Study|Lost to Follow-up|0|||
161298796|NCT01554527|582477656|FG001|Overall Study|Lost to Follow-up|0|||
161298797|NCT01554527|582477657|FG002|Overall Study|Lost to Follow-up|4|||
161298798|NCT01554527|582477655|FG000|Overall Study|Physician Decision|0|||
161298799|NCT01554527|582477656|FG001|Overall Study|Physician Decision|0|||
161298800|NCT01554527|582477657|FG002|Overall Study|Physician Decision|1|||
161298801|NCT01863667|582477664|FG000|Overall Study|Adverse Event|1|||
161298802|NCT01863667|582477665|FG001|Overall Study|Adverse Event|0|||
161298803|NCT01863667|582477664|FG000|Overall Study|Study terminated by Sponsor|30|||
161298804|NCT01863667|582477665|FG001|Overall Study|Study terminated by Sponsor|30|||
161298805|NCT01863667|582477664|FG000|Overall Study|Withdrawal by Subject|2|||
161298806|NCT01863667|582477665|FG001|Overall Study|Withdrawal by Subject|2|||
161298807|NCT01537042|582477669|FG000|Overall Study|Adverse Event|0|||
161298808|NCT01537042|582477670|FG001|Overall Study|Adverse Event|2|||
161298809|NCT01537042|582477669|FG000|Overall Study|Lack of Efficacy|0|||
161298810|NCT01537042|582477670|FG001|Overall Study|Lack of Efficacy|1|||
161298811|NCT01537042|582477669|FG000|Overall Study|Protocol Violation|0|||
161298812|NCT01537042|582477670|FG001|Overall Study|Protocol Violation|1|||
161298813|NCT01537042|582477669|FG000|Overall Study|Other|0|||
161298814|NCT01537042|582477670|FG001|Overall Study|Other|1|||
161298815|NCT02837731|582477671|FG000|Allocation|Admitted to General Floor|3|||
161298816|NCT02837731|582477672|FG001|Allocation|Admitted to General Floor|4|||
161298817|NCT02837731|582477671|FG000|Allocation|Immediate surgery/withdrew|2|||
161298818|NCT02837731|582477672|FG001|Allocation|Immediate surgery/withdrew|0|||
161298819|NCT02837731|582477671|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
161298820|NCT02837731|582477672|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
161298821|NCT02837731|582477671|FG000|Allocation|Withdrawal by Subject|2|||
161298822|NCT02837731|582477672|FG001|Allocation|Withdrawal by Subject|0|||
161298823|NCT02837731|582477671|FG000|Allocation|Device not available|1|||
161298824|NCT02837731|582477672|FG001|Allocation|Device not available|0|||
161298825|NCT02837731|582477671|FG000|Allocation|Protocol not implemented|7|||
161298826|NCT02837731|582477672|FG001|Allocation|Protocol not implemented|0|||
161298827|NCT02837731|582477671|FG000|Allocation|Moribund/Do not resuscitate|2|||
161298828|NCT02837731|582477672|FG001|Allocation|Moribund/Do not resuscitate|0|||
161298829|NCT02837731|582477671|FG000|Allocation|Did not meet sepsis criteria|1|||
161298830|NCT02837731|582477672|FG001|Allocation|Did not meet sepsis criteria|2|||
161298831|NCT02837731|582477671|FG000|Allocation|Known aortic abnormalities|0|||
161298832|NCT02837731|582477672|FG001|Allocation|Known aortic abnormalities|1|||
161298833|NCT02965573|582477673|FG000|Overall Study|Lack of Efficacy|1|||
161298834|NCT02965573|582477674|FG001|Overall Study|Lack of Efficacy|0|||
161298835|NCT00315458|582477676|FG000|Overall Study|Administrative|0|||
161298836|NCT00315458|582477677|FG001|Overall Study|Administrative|3|||
161298837|NCT00315458|582477678|FG002|Overall Study|Administrative|8|||
161298838|NCT00315458|582477679|FG003|Overall Study|Administrative|21|||
161298839|NCT00315458|582477676|FG000|Overall Study|Adverse Event|2|||
161298840|NCT00315458|582477677|FG001|Overall Study|Adverse Event|4|||
161298841|NCT00315458|582477678|FG002|Overall Study|Adverse Event|23|||
161298842|NCT00315458|582477679|FG003|Overall Study|Adverse Event|3|||
161298843|NCT00315458|582477676|FG000|Overall Study|Lost to Follow-up|1|||
161298844|NCT00315458|582477677|FG001|Overall Study|Lost to Follow-up|2|||
161298845|NCT00315458|582477678|FG002|Overall Study|Lost to Follow-up|0|||
161298846|NCT00315458|582477679|FG003|Overall Study|Lost to Follow-up|2|||
161298847|NCT00315458|582477676|FG000|Overall Study|Withdrawal by Subject|0|||
161298848|NCT00315458|582477677|FG001|Overall Study|Withdrawal by Subject|3|||
161298849|NCT00315458|582477678|FG002|Overall Study|Withdrawal by Subject|0|||
161298850|NCT00315458|582477679|FG003|Overall Study|Withdrawal by Subject|2|||
161298851|NCT00315458|582477676|FG000|Overall Study|Lack of Efficacy|0|||
161298852|NCT00315458|582477677|FG001|Overall Study|Lack of Efficacy|0|||
161298853|NCT00315458|582477678|FG002|Overall Study|Lack of Efficacy|20|||
161298854|NCT00315458|582477679|FG003|Overall Study|Lack of Efficacy|1|||
161298855|NCT00315458|582477676|FG000|Overall Study|Did not qualify|0|||
161298856|NCT00315458|582477677|FG001|Overall Study|Did not qualify|0|||
161298857|NCT00315458|582477678|FG002|Overall Study|Did not qualify|1|||
161298858|NCT00315458|582477679|FG003|Overall Study|Did not qualify|0|||
161298859|NCT00523848|582477681|FG000|Overall Study|Adverse Event|11|||
161298860|NCT00523848|582477681|FG000|Overall Study|Withdrawal by Subject|2|||
161298861|NCT00523848|582477681|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
161298862|NCT00523848|582477681|FG000|Overall Study|Disease Progression|5|||
161298863|NCT00523848|582477681|FG000|Overall Study|Other, unspecified|4|||
161298864|NCT00086619|582477683|FG000|Overall Study|Withdrawal by Subject|6|||
161298865|NCT00086619|582477684|FG001|Overall Study|Withdrawal by Subject|6|||
161298866|NCT00086619|582477683|FG000|Overall Study|Adverse Event|8|||
161298867|NCT00086619|582477684|FG001|Overall Study|Adverse Event|10|||
161298868|NCT00086619|582477683|FG000|Overall Study|Protocol Violation|1|||
161298869|NCT00086619|582477684|FG001|Overall Study|Protocol Violation|1|||
161298870|NCT00489918|582477685|FG000|Overall Study|Withdrawal by Subject|2|||
161298871|NCT00489918|582477686|FG001|Overall Study|Withdrawal by Subject|1|||
161347844|NCT02903914|582657361|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
161347845|NCT02903914|582657362|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
161347846|NCT02903914|582657363|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
161347847|NCT02903914|582657364|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
161347848|NCT02903914|582657365|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
161347849|NCT02903914|582657366|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
161089080|NCT04617275|581715367|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
161089081|NCT04617275|581715368|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
161089082|NCT04617275|581715369|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
161089083|NCT04617275|581715370|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
161089084|NCT04617275|581715363|FG000|Follow-up Period|Other|0|||
161089085|NCT04617275|581715364|FG001|Follow-up Period|Other|1|||
161089086|NCT04617275|581715365|FG002|Follow-up Period|Other|0|||
161089087|NCT04617275|581715366|FG003|Follow-up Period|Other|0|||
161089088|NCT04617275|581715367|FG004|Follow-up Period|Other|0|||
161089089|NCT04617275|581715368|FG005|Follow-up Period|Other|0|||
161089090|NCT04617275|581715369|FG006|Follow-up Period|Other|0|||
161089091|NCT04617275|581715370|FG007|Follow-up Period|Other|0|||
161089092|NCT04617275|581715363|FG000|Follow-up Period|Withdrawal by Subject|2|||
161089093|NCT04617275|581715364|FG001|Follow-up Period|Withdrawal by Subject|0|||
161089094|NCT04617275|581715365|FG002|Follow-up Period|Withdrawal by Subject|0|||
161089095|NCT04617275|581715366|FG003|Follow-up Period|Withdrawal by Subject|2|||
161089096|NCT04617275|581715367|FG004|Follow-up Period|Withdrawal by Subject|2|||
161089097|NCT04617275|581715368|FG005|Follow-up Period|Withdrawal by Subject|0|||
161089098|NCT04617275|581715369|FG006|Follow-up Period|Withdrawal by Subject|1|||
161089099|NCT04617275|581715370|FG007|Follow-up Period|Withdrawal by Subject|2|||
161089100|NCT04227704|581715371|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
161089101|NCT04227704|581715372|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
161089102|NCT04227704|581715373|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
161089103|NCT04227704|581715371|FG000|Overall Study|due to C/S being cancelled|1|||
161089104|NCT04227704|581715372|FG001|Overall Study|due to C/S being cancelled|0|||
161089105|NCT04227704|581715373|FG002|Overall Study|due to C/S being cancelled|0|||
161089106|NCT00729378|581717272|FG000|Baseline|Did not complete study measurements|72|||
161089107|NCT00729378|581717273|FG001|Baseline|Did not complete study measurements|33|||
161089108|NCT00729378|581717272|FG000|Baseline|Withdrawal by Subject|66|||
161089109|NCT00729378|581717273|FG001|Baseline|Withdrawal by Subject|59|||
161089110|NCT00729378|581717272|FG000|12-months|Lost to Follow-up|100|||
161089111|NCT00729378|581717273|FG001|12-months|Lost to Follow-up|65|||
161089112|NCT00729378|581717272|FG000|24-months|Lost to Follow-up|72|||
161089113|NCT00729378|581717273|FG001|24-months|Lost to Follow-up|51|||
161089114|NCT00729378|581717272|FG000|36-months|Lost to Follow-up|15|||
161089115|NCT00729378|581717273|FG001|36-months|Lost to Follow-up|6|||
161089116|NCT00484289|581717281|FG000|Long Term Phase|Adverse Event|1|||
161089117|NCT00484289|581717282|FG001|Long Term Phase|Adverse Event|17|||
161089118|NCT00484289|581717283|FG002|Long Term Phase|Adverse Event|5|||
161089119|NCT00484289|581717281|FG000|Long Term Phase|Withdrawal by Subject|0|||
161089120|NCT00484289|581717282|FG001|Long Term Phase|Withdrawal by Subject|7|||
161089121|NCT00484289|581717283|FG002|Long Term Phase|Withdrawal by Subject|6|||
161089122|NCT00484289|581717281|FG000|Long Term Phase|Inadequate response|2|||
161089123|NCT00484289|581717282|FG001|Long Term Phase|Inadequate response|7|||
161089124|NCT00484289|581717283|FG002|Long Term Phase|Inadequate response|4|||
161089125|NCT00484289|581717281|FG000|Long Term Phase|Other Reason|0|||
161089126|NCT00484289|581717282|FG001|Long Term Phase|Other Reason|5|||
161089127|NCT00484289|581717283|FG002|Long Term Phase|Other Reason|1|||
161089128|NCT00484289|581717281|FG000|Post Marketing Phase|Adverse Event|0|||
161089129|NCT00484289|581717282|FG001|Post Marketing Phase|Adverse Event|1|||
161089130|NCT00484289|581717283|FG002|Post Marketing Phase|Adverse Event|0|||
161089131|NCT00690443|581717284|FG000|Overall Study|Adverse Event|1|||
161089132|NCT00690443|581717285|FG001|Overall Study|Adverse Event|2|||
161089133|NCT02874924|581717288|FG000|Overall Study|Adverse Event|2|||
161089134|NCT02874924|581717289|FG001|Overall Study|Adverse Event|0|||
161089135|NCT02874924|581717290|FG002|Overall Study|Adverse Event|0|||
161089136|NCT02874924|581717288|FG000|Overall Study|Withdrawal by Subject|1|||
161089137|NCT02874924|581717289|FG001|Overall Study|Withdrawal by Subject|0|||
161089138|NCT02874924|581717290|FG002|Overall Study|Withdrawal by Subject|0|||
161089139|NCT02808143|581717291|FG000|Maintenance Phase|Disease recurrence|1|||
161089140|NCT02808143|581717292|FG001|Maintenance Phase|Disease recurrence|3|||
161089141|NCT02808143|581717291|FG000|Maintenance Phase|Disease progression|1|||
161089142|NCT02808143|581717292|FG001|Maintenance Phase|Disease progression|2|||
161089143|NCT02808143|581717291|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
161089144|NCT02808143|581717292|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
161089145|NCT02808143|581717291|FG000|Survival Follow-Up|Disease recurrence|0|||
161089146|NCT02808143|581717292|FG001|Survival Follow-Up|Disease recurrence|2|||
161089147|NCT02808143|581717291|FG000|Survival Follow-Up|Adverse Event|0|||
161089148|NCT02808143|581717292|FG001|Survival Follow-Up|Adverse Event|1|||
161181231|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
161181232|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161181233|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
161181234|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
161181235|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
161181236|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
161181237|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
161181238|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
161181239|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161181240|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
161181241|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
161181242|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161181243|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
161181244|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161181245|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
161181246|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161181247|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161181248|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
161181249|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161181250|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
161181251|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
161181252|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161181253|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
161181254|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161181255|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161181256|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
161181257|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161181258|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
161181259|NCT03107793|582040531|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161181260|NCT03107793|582040532|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
161181261|NCT03107793|582040533|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
161181262|NCT03107793|582040534|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161181263|NCT03107793|582040535|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
161181264|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161181265|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161181266|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
161181267|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
161181268|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
161181269|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161181270|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161181271|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161181272|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
161181273|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
161181274|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161181275|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161181276|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
161181277|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
161181278|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
161181279|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Death|0|||
161181280|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Death|0|||
161181281|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Death|0|||
161181282|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Death|0|||
161181283|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Death|1|||
161181284|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161181285|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161181286|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161181287|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
161181288|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
161181289|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161181290|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161181291|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
161181292|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
161181293|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
161181294|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161181295|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161298872|NCT00489918|582477687|FG002|Overall Study|Withdrawal by Subject|1|||
161298873|NCT00489918|582477688|FG003|Overall Study|Withdrawal by Subject|0|||
161298874|NCT00489918|582477689|FG004|Overall Study|Withdrawal by Subject|1|||
161298875|NCT00489918|582477685|FG000|Overall Study|Adverse Event|0|||
161298876|NCT00489918|582477686|FG001|Overall Study|Adverse Event|1|||
161298877|NCT00489918|582477687|FG002|Overall Study|Adverse Event|1|||
161298878|NCT00489918|582477688|FG003|Overall Study|Adverse Event|0|||
161298879|NCT00489918|582477689|FG004|Overall Study|Adverse Event|0|||
161298880|NCT00489918|582477685|FG000|Overall Study|Lost to Follow-up|0|||
161298881|NCT00489918|582477686|FG001|Overall Study|Lost to Follow-up|0|||
161298882|NCT00489918|582477687|FG002|Overall Study|Lost to Follow-up|1|||
161298883|NCT00489918|582477688|FG003|Overall Study|Lost to Follow-up|1|||
161298884|NCT00489918|582477689|FG004|Overall Study|Lost to Follow-up|0|||
161298885|NCT00489918|582477685|FG000|Overall Study|Physician Decision|0|||
161298886|NCT00489918|582477686|FG001|Overall Study|Physician Decision|0|||
161298887|NCT00489918|582477687|FG002|Overall Study|Physician Decision|1|||
161298888|NCT00489918|582477688|FG003|Overall Study|Physician Decision|0|||
161298889|NCT00489918|582477689|FG004|Overall Study|Physician Decision|0|||
161298890|NCT02748213|582477690|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
161298891|NCT02748213|582477691|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
161298892|NCT02748213|582477690|FG000|Overall Study|Abnormal Laboratory Test|1|||
161298893|NCT02748213|582477691|FG001|Overall Study|Abnormal Laboratory Test|0|||
161298894|NCT02748213|582477690|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
161298895|NCT02748213|582477691|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
161298896|NCT02748213|582477690|FG000|Overall Study|Death|5|||
161298897|NCT02748213|582477691|FG001|Overall Study|Death|3|||
161298898|NCT02748213|582477690|FG000|Overall Study|Insufficient Therapeutic Response|56|||
161298899|NCT02748213|582477691|FG001|Overall Study|Insufficient Therapeutic Response|57|||
161298900|NCT02748213|582477690|FG000|Overall Study|Violation of Selection Criteria|2|||
161298901|NCT02748213|582477691|FG001|Overall Study|Violation of Selection Criteria|0|||
161298902|NCT02748213|582477690|FG000|Overall Study|Protocol Violation|6|||
161298903|NCT02748213|582477691|FG001|Overall Study|Protocol Violation|4|||
161298904|NCT02748213|582477690|FG000|Overall Study|Refused Treatment*|6|||
161298905|NCT02748213|582477691|FG001|Overall Study|Refused Treatment*|6|||
161298906|NCT02748213|582477690|FG000|Overall Study|Failure to Return|1|||
161298907|NCT02748213|582477691|FG001|Overall Study|Failure to Return|0|||
161298908|NCT02748213|582477690|FG000|Overall Study|Other|30|||
161298909|NCT02748213|582477691|FG001|Overall Study|Other|29|||
161298910|NCT01209520|582477695|FG000|Overall Study|Withdrawal by Subject|3|||
161298911|NCT03850483|582477696|FG000|Treatment for Stage 1|Adverse Event|1|||
161298912|NCT03850483|582477697|FG001|Treatment for Stage 1|Adverse Event|1|||
161298913|NCT03850483|582477698|FG002|Treatment for Stage 1|Adverse Event|3|||
161298914|NCT03850483|582477699|FG003|Treatment for Stage 1|Adverse Event|0|||
161298915|NCT03850483|582477700|FG004|Treatment for Stage 1|Adverse Event|2|||
161298916|NCT03850483|582477701|FG005|Treatment for Stage 1|Adverse Event|0|||
161298917|NCT03850483|582477702|FG006|Treatment for Stage 1|Adverse Event|2|||
161298918|NCT03850483|582477703|FG007|Treatment for Stage 1|Adverse Event|2|||
161298919|NCT03850483|582477704|FG008|Treatment for Stage 1|Adverse Event|0|||
161298920|NCT03850483|582477705|FG009|Treatment for Stage 1|Adverse Event|0|||
161298921|NCT03850483|582477696|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
161298922|NCT03850483|582477697|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
161298923|NCT03850483|582477698|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
161298924|NCT03850483|582477699|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
161298925|NCT03850483|582477700|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
161298926|NCT03850483|582477701|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
161298927|NCT03850483|582477702|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
161298928|NCT03850483|582477703|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
161298929|NCT03850483|582477704|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
161298930|NCT03850483|582477705|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
161181296|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
161181297|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
161298931|NCT03850483|582477696|FG000|Treatment for Stage 1|Protocol Violation|1|||
161298932|NCT03850483|582477697|FG001|Treatment for Stage 1|Protocol Violation|0|||
161298933|NCT03850483|582477698|FG002|Treatment for Stage 1|Protocol Violation|0|||
161181298|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
161298934|NCT03850483|582477699|FG003|Treatment for Stage 1|Protocol Violation|0|||
161298935|NCT03850483|582477700|FG004|Treatment for Stage 1|Protocol Violation|0|||
161298936|NCT03850483|582477701|FG005|Treatment for Stage 1|Protocol Violation|0|||
161181299|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161298937|NCT03850483|582477702|FG006|Treatment for Stage 1|Protocol Violation|1|||
161298938|NCT03850483|582477703|FG007|Treatment for Stage 1|Protocol Violation|0|||
161298939|NCT03850483|582477704|FG008|Treatment for Stage 1|Protocol Violation|0|||
161298940|NCT03850483|582477705|FG009|Treatment for Stage 1|Protocol Violation|0|||
161298941|NCT03850483|582477696|FG000|Treatment for Stage 1|Physician Decision|0|||
161298942|NCT03850483|582477697|FG001|Treatment for Stage 1|Physician Decision|0|||
161298943|NCT03850483|582477698|FG002|Treatment for Stage 1|Physician Decision|0|||
161298944|NCT03850483|582477699|FG003|Treatment for Stage 1|Physician Decision|0|||
161298945|NCT03850483|582477700|FG004|Treatment for Stage 1|Physician Decision|0|||
161298946|NCT03850483|582477701|FG005|Treatment for Stage 1|Physician Decision|1|||
161298947|NCT03850483|582477702|FG006|Treatment for Stage 1|Physician Decision|0|||
161298948|NCT03850483|582477703|FG007|Treatment for Stage 1|Physician Decision|0|||
161298949|NCT03850483|582477704|FG008|Treatment for Stage 1|Physician Decision|0|||
161298950|NCT03850483|582477705|FG009|Treatment for Stage 1|Physician Decision|0|||
161298951|NCT03850483|582477696|FG000|Treatment for Stage 1|Other|0|||
161298952|NCT03850483|582477697|FG001|Treatment for Stage 1|Other|0|||
161298953|NCT03850483|582477698|FG002|Treatment for Stage 1|Other|0|||
161298954|NCT03850483|582477699|FG003|Treatment for Stage 1|Other|0|||
161298955|NCT03850483|582477700|FG004|Treatment for Stage 1|Other|2|||
161298956|NCT03850483|582477701|FG005|Treatment for Stage 1|Other|1|||
161298957|NCT03850483|582477702|FG006|Treatment for Stage 1|Other|0|||
161298958|NCT03850483|582477703|FG007|Treatment for Stage 1|Other|0|||
161298959|NCT03850483|582477704|FG008|Treatment for Stage 1|Other|0|||
161298960|NCT03850483|582477705|FG009|Treatment for Stage 1|Other|0|||
161298961|NCT03850483|582477696|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298962|NCT03850483|582477697|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298963|NCT03850483|582477698|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
161298964|NCT03850483|582477699|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298965|NCT03850483|582477700|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298966|NCT03850483|582477701|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298967|NCT03850483|582477702|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298968|NCT03850483|582477703|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298969|NCT03850483|582477704|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298970|NCT03850483|582477705|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
161298971|NCT03850483|582477696|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298972|NCT03850483|582477697|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298973|NCT03850483|582477698|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298974|NCT03850483|582477699|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161089149|NCT02808143|581717291|FG000|Survival Follow-Up|Death|1|||
161089150|NCT02808143|581717292|FG001|Survival Follow-Up|Death|0|||
161089151|NCT01874431|581717293|FG000|Overall Study|Physician Decision|0|||
161089152|NCT01874431|581717294|FG001|Overall Study|Physician Decision|0|||
161089153|NCT01874431|581717295|FG002|Overall Study|Physician Decision|1|||
161089154|NCT01874431|581717296|FG003|Overall Study|Physician Decision|0|||
161089155|NCT01874431|581717297|FG004|Overall Study|Physician Decision|0|||
161089156|NCT01874431|581717298|FG005|Overall Study|Physician Decision|0|||
161089157|NCT01874431|581717299|FG006|Overall Study|Physician Decision|0|||
161089158|NCT01874431|581717300|FG007|Overall Study|Physician Decision|0|||
161089159|NCT01874431|581717293|FG000|Overall Study|Adverse Event|5|||
161089160|NCT01874431|581717294|FG001|Overall Study|Adverse Event|4|||
161089161|NCT01874431|581717295|FG002|Overall Study|Adverse Event|6|||
161089162|NCT01874431|581717296|FG003|Overall Study|Adverse Event|5|||
161089163|NCT01874431|581717297|FG004|Overall Study|Adverse Event|2|||
161089164|NCT01874431|581717298|FG005|Overall Study|Adverse Event|8|||
161089165|NCT01874431|581717299|FG006|Overall Study|Adverse Event|2|||
161089166|NCT01874431|581717300|FG007|Overall Study|Adverse Event|3|||
161089167|NCT01874431|581717293|FG000|Overall Study|Protocol Violation|1|||
161089168|NCT01874431|581717294|FG001|Overall Study|Protocol Violation|1|||
161089169|NCT01874431|581717295|FG002|Overall Study|Protocol Violation|1|||
161089170|NCT01874431|581717296|FG003|Overall Study|Protocol Violation|0|||
161089171|NCT01874431|581717297|FG004|Overall Study|Protocol Violation|3|||
161298975|NCT03850483|582477700|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161089172|NCT01874431|581717298|FG005|Overall Study|Protocol Violation|2|||
161089173|NCT01874431|581717299|FG006|Overall Study|Protocol Violation|1|||
161089174|NCT01874431|581717300|FG007|Overall Study|Protocol Violation|1|||
161089175|NCT01874431|581717293|FG000|Overall Study|Non-compliance|0|||
161089176|NCT01874431|581717294|FG001|Overall Study|Non-compliance|0|||
161089177|NCT01874431|581717295|FG002|Overall Study|Non-compliance|0|||
161089178|NCT01874431|581717296|FG003|Overall Study|Non-compliance|0|||
161089179|NCT01874431|581717297|FG004|Overall Study|Non-compliance|1|||
161089180|NCT01874431|581717298|FG005|Overall Study|Non-compliance|0|||
161089181|NCT01874431|581717299|FG006|Overall Study|Non-compliance|1|||
161089182|NCT01874431|581717300|FG007|Overall Study|Non-compliance|0|||
161089183|NCT01874431|581717293|FG000|Overall Study|Logistical difficulties|0|||
161089184|NCT01874431|581717294|FG001|Overall Study|Logistical difficulties|0|||
161089185|NCT01874431|581717295|FG002|Overall Study|Logistical difficulties|0|||
161089186|NCT01874431|581717296|FG003|Overall Study|Logistical difficulties|0|||
161089187|NCT01874431|581717297|FG004|Overall Study|Logistical difficulties|0|||
161089188|NCT01874431|581717298|FG005|Overall Study|Logistical difficulties|0|||
161089189|NCT01874431|581717299|FG006|Overall Study|Logistical difficulties|1|||
161089190|NCT01874431|581717300|FG007|Overall Study|Logistical difficulties|0|||
161089191|NCT01874431|581717293|FG000|Overall Study|Withdrawal by Subject|0|||
161089192|NCT01874431|581717294|FG001|Overall Study|Withdrawal by Subject|0|||
161298976|NCT03850483|582477701|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
161298977|NCT03850483|582477702|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298978|NCT03850483|582477703|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298979|NCT03850483|582477704|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298980|NCT03850483|582477705|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
161298981|NCT03850483|582477696|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
161298982|NCT03850483|582477697|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
161298983|NCT03850483|582477698|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
161298984|NCT03850483|582477699|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
161298985|NCT03850483|582477700|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
161298986|NCT03850483|582477701|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
161298987|NCT03850483|582477702|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
161298988|NCT03850483|582477703|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
161298989|NCT03850483|582477704|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
161298990|NCT03850483|582477705|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
161298991|NCT03850483|582477696|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
161298992|NCT03850483|582477697|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
161298993|NCT03850483|582477698|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
161298994|NCT03850483|582477699|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
161298995|NCT03850483|582477700|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
161298996|NCT03850483|582477701|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
161298997|NCT03850483|582477702|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
161298998|NCT03850483|582477703|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
161298999|NCT03850483|582477704|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
161299000|NCT03850483|582477705|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
161299001|NCT03850483|582477696|FG000|Treatment for Stage 1|Death|0|||
161299002|NCT03850483|582477697|FG001|Treatment for Stage 1|Death|0|||
161299003|NCT03850483|582477698|FG002|Treatment for Stage 1|Death|0|||
161299004|NCT03850483|582477699|FG003|Treatment for Stage 1|Death|0|||
161299005|NCT03850483|582477700|FG004|Treatment for Stage 1|Death|0|||
161299006|NCT03850483|582477701|FG005|Treatment for Stage 1|Death|1|||
161299007|NCT03850483|582477702|FG006|Treatment for Stage 1|Death|0|||
161299008|NCT03850483|582477703|FG007|Treatment for Stage 1|Death|0|||
161299009|NCT03850483|582477704|FG008|Treatment for Stage 1|Death|0|||
161299010|NCT03850483|582477705|FG009|Treatment for Stage 1|Death|0|||
161299011|NCT03850483|582477696|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
161299012|NCT03850483|582477697|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
161299013|NCT03850483|582477698|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
161299014|NCT03850483|582477699|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
161299015|NCT03850483|582477700|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
161299016|NCT03850483|582477701|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
161299017|NCT03850483|582477702|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
161299018|NCT03850483|582477703|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
161299019|NCT03850483|582477704|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
161299020|NCT03850483|582477705|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
161299021|NCT03850483|582477696|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
161299022|NCT03850483|582477697|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
161299023|NCT03850483|582477698|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
161299024|NCT03850483|582477699|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
161299025|NCT03850483|582477700|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
161299026|NCT03850483|582477701|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
161299027|NCT03850483|582477702|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
161299028|NCT03850483|582477703|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
161299029|NCT03850483|582477704|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
161299030|NCT03850483|582477705|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
161299031|NCT03850483|582477696|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299032|NCT03850483|582477697|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299033|NCT03850483|582477698|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299034|NCT03850483|582477699|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299035|NCT03850483|582477700|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299036|NCT03850483|582477701|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299037|NCT03850483|582477702|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
161299038|NCT03850483|582477703|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
161299039|NCT03850483|582477704|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299040|NCT03850483|582477705|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
161299041|NCT03850483|582477696|FG000|Follow-up for Stage 1|Physician Decision|0|||
161299042|NCT03850483|582477697|FG001|Follow-up for Stage 1|Physician Decision|0|||
161299043|NCT03850483|582477698|FG002|Follow-up for Stage 1|Physician Decision|0|||
161299044|NCT03850483|582477699|FG003|Follow-up for Stage 1|Physician Decision|0|||
161089193|NCT01874431|581717295|FG002|Overall Study|Withdrawal by Subject|1|||
161299045|NCT03850483|582477700|FG004|Follow-up for Stage 1|Physician Decision|1|||
161299046|NCT03850483|582477701|FG005|Follow-up for Stage 1|Physician Decision|0|||
161299047|NCT03850483|582477702|FG006|Follow-up for Stage 1|Physician Decision|1|||
161299048|NCT03850483|582477703|FG007|Follow-up for Stage 1|Physician Decision|0|||
161299049|NCT03850483|582477704|FG008|Follow-up for Stage 1|Physician Decision|0|||
161299050|NCT03850483|582477705|FG009|Follow-up for Stage 1|Physician Decision|0|||
161299051|NCT03850483|582477696|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
161299052|NCT03850483|582477697|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
161299053|NCT03850483|582477698|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
161299054|NCT03850483|582477699|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
161299055|NCT03850483|582477700|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
161299056|NCT03850483|582477701|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
161299057|NCT03850483|582477702|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
161299058|NCT03850483|582477703|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
161299059|NCT03850483|582477704|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
161299060|NCT03850483|582477705|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
161299061|NCT03850483|582477696|FG000|Follow-up for Stage 1|Adverse Event|0|||
161299062|NCT03850483|582477697|FG001|Follow-up for Stage 1|Adverse Event|0|||
161299063|NCT03850483|582477698|FG002|Follow-up for Stage 1|Adverse Event|1|||
161299064|NCT03850483|582477699|FG003|Follow-up for Stage 1|Adverse Event|0|||
161299065|NCT03850483|582477700|FG004|Follow-up for Stage 1|Adverse Event|0|||
161299066|NCT03850483|582477701|FG005|Follow-up for Stage 1|Adverse Event|1|||
161299067|NCT03850483|582477702|FG006|Follow-up for Stage 1|Adverse Event|0|||
161299068|NCT03850483|582477703|FG007|Follow-up for Stage 1|Adverse Event|0|||
161299069|NCT03850483|582477704|FG008|Follow-up for Stage 1|Adverse Event|0|||
161299070|NCT03850483|582477705|FG009|Follow-up for Stage 1|Adverse Event|0|||
161299071|NCT03850483|582477696|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299072|NCT03850483|582477697|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
161299073|NCT03850483|582477698|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299074|NCT03850483|582477699|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299075|NCT03850483|582477700|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
161299076|NCT03850483|582477701|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
161299077|NCT03850483|582477702|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299078|NCT03850483|582477703|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299079|NCT03850483|582477704|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299080|NCT03850483|582477705|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
161299081|NCT03850483|582477696|FG000|Follow-up for Stage 1|Other|0|||
161299082|NCT03850483|582477697|FG001|Follow-up for Stage 1|Other|2|||
161299083|NCT03850483|582477698|FG002|Follow-up for Stage 1|Other|0|||
161299084|NCT03850483|582477699|FG003|Follow-up for Stage 1|Other|2|||
161299085|NCT03850483|582477700|FG004|Follow-up for Stage 1|Other|0|||
161299086|NCT03850483|582477701|FG005|Follow-up for Stage 1|Other|1|||
161299087|NCT03850483|582477702|FG006|Follow-up for Stage 1|Other|0|||
161299088|NCT03850483|582477703|FG007|Follow-up for Stage 1|Other|0|||
161299089|NCT03850483|582477704|FG008|Follow-up for Stage 1|Other|0|||
161299090|NCT03850483|582477705|FG009|Follow-up for Stage 1|Other|0|||
161299091|NCT03850483|582477696|FG000|Treatment for Stage 2|Adverse Event|0|||
161299092|NCT03850483|582477697|FG001|Treatment for Stage 2|Adverse Event|0|||
161299093|NCT03850483|582477698|FG002|Treatment for Stage 2|Adverse Event|0|||
161299094|NCT03850483|582477699|FG003|Treatment for Stage 2|Adverse Event|0|||
161299095|NCT03850483|582477700|FG004|Treatment for Stage 2|Adverse Event|0|||
161299096|NCT03850483|582477701|FG005|Treatment for Stage 2|Adverse Event|0|||
161299097|NCT03850483|582477702|FG006|Treatment for Stage 2|Adverse Event|0|||
161299098|NCT03850483|582477703|FG007|Treatment for Stage 2|Adverse Event|0|||
161299099|NCT03850483|582477704|FG008|Treatment for Stage 2|Adverse Event|0|||
161299100|NCT03850483|582477705|FG009|Treatment for Stage 2|Adverse Event|1|||
161299101|NCT03850483|582477696|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
161299102|NCT03850483|582477697|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
161299103|NCT03850483|582477698|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
161299104|NCT03850483|582477699|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
161299105|NCT03850483|582477700|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
161299106|NCT03850483|582477701|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
161299107|NCT03850483|582477702|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
161299108|NCT03850483|582477703|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
161299109|NCT03850483|582477704|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
161299110|NCT03850483|582477705|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
161299111|NCT03850483|582477696|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
161299112|NCT03850483|582477697|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
161299113|NCT03850483|582477698|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
161299114|NCT03850483|582477699|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
161299115|NCT03850483|582477700|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
161299116|NCT03850483|582477701|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
161299117|NCT03850483|582477702|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
161299118|NCT03850483|582477703|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
161299119|NCT03850483|582477704|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
161299120|NCT03850483|582477705|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
161181300|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161181301|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161181302|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
161181303|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
161181304|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161181305|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161181306|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161181307|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
161181308|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
161181309|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Other|0|||
161181310|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Other|0|||
161181311|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Other|0|||
161181312|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Other|1|||
161181313|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Other|3|||
161181314|NCT03107793|582040531|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161181315|NCT03107793|582040532|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161181316|NCT03107793|582040533|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
161181317|NCT03107793|582040534|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
161181318|NCT03107793|582040535|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
161181319|NCT03277105|582040536|FG000|Overall Study|Death|129|||
161181320|NCT03277105|582040537|FG001|Overall Study|Death|124|||
161181321|NCT03277105|582040536|FG000|Overall Study|Lost to Follow-up|2|||
161181322|NCT03277105|582040537|FG001|Overall Study|Lost to Follow-up|4|||
161181323|NCT03277105|582040536|FG000|Overall Study|Withdrawal by Subject|10|||
161181324|NCT03277105|582040537|FG001|Overall Study|Withdrawal by Subject|10|||
161181325|NCT03277105|582040536|FG000|Overall Study|Other|118|||
161181326|NCT03277105|582040537|FG001|Overall Study|Other|125|||
161181327|NCT05180721|582040541|FG000|Overall Study|Lost to Follow-up|4|||
161181328|NCT02040857|582040545|FG000|Overall Study|Adverse Event|14|||
161181329|NCT02040857|582040545|FG000|Overall Study|Physician Decision|5|||
161181330|NCT02040857|582040545|FG000|Overall Study|Withdrawal by Subject|31|||
161181331|NCT02040857|582040545|FG000|Overall Study|patient non-compliance|3|||
161181332|NCT02040857|582040545|FG000|Overall Study|Lost to Follow-up|2|||
161181333|NCT02040857|582040545|FG000|Overall Study|recurrence|4|||
161181334|NCT02040857|582040545|FG000|Overall Study|ineligible|1|||
161181335|NCT00976963|582040546|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
161181336|NCT00976963|582040547|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
161181337|NCT00976963|582040546|FG000|Overall Study|administrative error|1|||
161181338|NCT00976963|582040547|FG001|Overall Study|administrative error|0|||
161181339|NCT00976963|582040546|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
161181340|NCT00976963|582040547|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
161181341|NCT00608842|582040548|FG000|Overall Study|Participant's Request|0|||
161181342|NCT00608842|582040549|FG001|Overall Study|Participant's Request|1|||
161181343|NCT00608842|582040550|FG002|Overall Study|Participant's Request|2|||
161181344|NCT00608842|582040551|FG003|Overall Study|Participant's Request|1|||
161181345|NCT00608842|582040548|FG000|Overall Study|Lost to Follow-up|1|||
161181346|NCT00608842|582040549|FG001|Overall Study|Lost to Follow-up|0|||
161181347|NCT00608842|582040550|FG002|Overall Study|Lost to Follow-up|0|||
161181348|NCT00608842|582040551|FG003|Overall Study|Lost to Follow-up|0|||
161181349|NCT01024920|582040552|FG000|Overall Study|Progressive disease|47|||
161181350|NCT01024920|582040553|FG001|Overall Study|Progressive disease|25|||
161181351|NCT01024920|582040552|FG000|Overall Study|Adverse Event|8|||
161181352|NCT01024920|582040553|FG001|Overall Study|Adverse Event|4|||
161181353|NCT01024920|582040552|FG000|Overall Study|Lost to Follow-up|0|||
161181354|NCT01024920|582040553|FG001|Overall Study|Lost to Follow-up|1|||
161181355|NCT01024920|582040552|FG000|Overall Study|Patient refusal to continue|4|||
161181356|NCT01024920|582040553|FG001|Overall Study|Patient refusal to continue|0|||
161181357|NCT01024920|582040552|FG000|Overall Study|Other than listed|5|||
161181358|NCT01024920|582040553|FG001|Overall Study|Other than listed|1|||
161181359|NCT01024920|582040552|FG000|Overall Study|Not treated|3|||
161181360|NCT01024920|582040553|FG001|Overall Study|Not treated|0|||
161181361|NCT01024920|582040552|FG000|Overall Study|Protocol Violation|0|||
161181362|NCT01024920|582040553|FG001|Overall Study|Protocol Violation|1|||
161181363|NCT03039790|582040555|FG000|Overall Study|Lost to Follow-up|2|||
161181364|NCT03039790|582040556|FG001|Overall Study|Lost to Follow-up|0|||
161181365|NCT03039790|582040557|FG002|Overall Study|Lost to Follow-up|1|||
161181366|NCT03039790|582040558|FG003|Overall Study|Lost to Follow-up|1|||
161181367|NCT03039790|582040559|FG004|Overall Study|Lost to Follow-up|0|||
161181368|NCT03039790|582040560|FG005|Overall Study|Lost to Follow-up|1|||
161181369|NCT03039790|582040561|FG006|Overall Study|Lost to Follow-up|1|||
161181370|NCT03039790|582040562|FG007|Overall Study|Lost to Follow-up|1|||
161181371|NCT03039790|582040563|FG008|Overall Study|Lost to Follow-up|0|||
161181372|NCT03039790|582040564|FG009|Overall Study|Lost to Follow-up|1|||
161181373|NCT03039790|582040565|FG010|Overall Study|Lost to Follow-up|1|||
161181374|NCT03039790|582040566|FG011|Overall Study|Lost to Follow-up|0|||
161181375|NCT03039790|582040567|FG012|Overall Study|Lost to Follow-up|1|||
161181376|NCT03039790|582040568|FG013|Overall Study|Lost to Follow-up|0|||
161181377|NCT03039790|582040569|FG014|Overall Study|Lost to Follow-up|3|||
161181378|NCT03039790|582040570|FG015|Overall Study|Lost to Follow-up|1|||
161181379|NCT03039790|582040571|FG016|Overall Study|Lost to Follow-up|2|||
161181380|NCT03039790|582040572|FG017|Overall Study|Lost to Follow-up|2|||
161181381|NCT03039790|582040573|FG018|Overall Study|Lost to Follow-up|1|||
161181382|NCT03039790|582040574|FG019|Overall Study|Lost to Follow-up|3|||
161181383|NCT03039790|582040555|FG000|Overall Study|Withdrawal of Consent|1|||
161181384|NCT03039790|582040556|FG001|Overall Study|Withdrawal of Consent|0|||
161181385|NCT03039790|582040557|FG002|Overall Study|Withdrawal of Consent|0|||
161181386|NCT03039790|582040558|FG003|Overall Study|Withdrawal of Consent|1|||
161181387|NCT03039790|582040559|FG004|Overall Study|Withdrawal of Consent|0|||
161181388|NCT03039790|582040560|FG005|Overall Study|Withdrawal of Consent|0|||
161181389|NCT03039790|582040561|FG006|Overall Study|Withdrawal of Consent|0|||
161181390|NCT03039790|582040562|FG007|Overall Study|Withdrawal of Consent|0|||
161181391|NCT03039790|582040563|FG008|Overall Study|Withdrawal of Consent|0|||
161181392|NCT03039790|582040564|FG009|Overall Study|Withdrawal of Consent|1|||
161181393|NCT03039790|582040565|FG010|Overall Study|Withdrawal of Consent|0|||
161181394|NCT03039790|582040566|FG011|Overall Study|Withdrawal of Consent|0|||
161181395|NCT03039790|582040567|FG012|Overall Study|Withdrawal of Consent|2|||
161181396|NCT03039790|582040568|FG013|Overall Study|Withdrawal of Consent|0|||
161181397|NCT03039790|582040569|FG014|Overall Study|Withdrawal of Consent|1|||
161181398|NCT03039790|582040570|FG015|Overall Study|Withdrawal of Consent|5|||
161181399|NCT03039790|582040571|FG016|Overall Study|Withdrawal of Consent|3|||
161181400|NCT03039790|582040572|FG017|Overall Study|Withdrawal of Consent|0|||
161181401|NCT03039790|582040573|FG018|Overall Study|Withdrawal of Consent|2|||
161181402|NCT03039790|582040574|FG019|Overall Study|Withdrawal of Consent|5|||
161181403|NCT03039790|582040555|FG000|Overall Study|Death|0|||
161181404|NCT03039790|582040556|FG001|Overall Study|Death|0|||
161181405|NCT03039790|582040557|FG002|Overall Study|Death|0|||
161181406|NCT03039790|582040558|FG003|Overall Study|Death|0|||
161181407|NCT03039790|582040559|FG004|Overall Study|Death|0|||
161181408|NCT03039790|582040560|FG005|Overall Study|Death|0|||
161181409|NCT03039790|582040561|FG006|Overall Study|Death|0|||
161181410|NCT03039790|582040562|FG007|Overall Study|Death|0|||
161181411|NCT03039790|582040563|FG008|Overall Study|Death|0|||
161181412|NCT03039790|582040564|FG009|Overall Study|Death|0|||
161181413|NCT03039790|582040565|FG010|Overall Study|Death|0|||
161181414|NCT03039790|582040566|FG011|Overall Study|Death|0|||
161181415|NCT03039790|582040567|FG012|Overall Study|Death|0|||
161181416|NCT03039790|582040568|FG013|Overall Study|Death|0|||
161181417|NCT03039790|582040569|FG014|Overall Study|Death|0|||
161181418|NCT03039790|582040570|FG015|Overall Study|Death|1|||
161181419|NCT03039790|582040571|FG016|Overall Study|Death|3|||
161181420|NCT03039790|582040572|FG017|Overall Study|Death|0|||
161181421|NCT03039790|582040573|FG018|Overall Study|Death|2|||
161181422|NCT03039790|582040574|FG019|Overall Study|Death|0|||
161181423|NCT03039790|582040555|FG000|Overall Study|Reason, not Specified|1|||
161181424|NCT03039790|582040556|FG001|Overall Study|Reason, not Specified|0|||
161181425|NCT03039790|582040557|FG002|Overall Study|Reason, not Specified|0|||
161181426|NCT03039790|582040558|FG003|Overall Study|Reason, not Specified|0|||
161181427|NCT03039790|582040559|FG004|Overall Study|Reason, not Specified|0|||
161181428|NCT03039790|582040560|FG005|Overall Study|Reason, not Specified|0|||
161181429|NCT03039790|582040561|FG006|Overall Study|Reason, not Specified|0|||
161181430|NCT03039790|582040562|FG007|Overall Study|Reason, not Specified|0|||
161181431|NCT03039790|582040563|FG008|Overall Study|Reason, not Specified|0|||
161181432|NCT03039790|582040564|FG009|Overall Study|Reason, not Specified|0|||
161181433|NCT03039790|582040565|FG010|Overall Study|Reason, not Specified|0|||
161181434|NCT03039790|582040566|FG011|Overall Study|Reason, not Specified|0|||
161181435|NCT03039790|582040567|FG012|Overall Study|Reason, not Specified|0|||
161181436|NCT03039790|582040568|FG013|Overall Study|Reason, not Specified|0|||
161181437|NCT03039790|582040569|FG014|Overall Study|Reason, not Specified|0|||
161181438|NCT03039790|582040570|FG015|Overall Study|Reason, not Specified|0|||
161181439|NCT03039790|582040571|FG016|Overall Study|Reason, not Specified|2|||
161181440|NCT03039790|582040572|FG017|Overall Study|Reason, not Specified|0|||
161181441|NCT03039790|582040573|FG018|Overall Study|Reason, not Specified|1|||
161181442|NCT03039790|582040574|FG019|Overall Study|Reason, not Specified|0|||
161181443|NCT02736929|582040579|FG000|Main Study|Lost to Follow-up|7|||
161181444|NCT02736929|582040580|FG001|Main Study|Lost to Follow-up|1|||
161181445|NCT02736929|582040581|FG002|Main Study|Lost to Follow-up|0|||
161181446|NCT02736929|582040579|FG000|Main Study|Withdrawal by Subject|1|||
161181447|NCT02736929|582040580|FG001|Main Study|Withdrawal by Subject|1|||
161181448|NCT02736929|582040581|FG002|Main Study|Withdrawal by Subject|0|||
161181449|NCT02736929|582040579|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
161319501|NCT01863732|582555336|FG002|Overall Study|Technical problems|1|||
161089194|NCT01874431|581717296|FG003|Overall Study|Withdrawal by Subject|2|||
161089195|NCT01874431|581717297|FG004|Overall Study|Withdrawal by Subject|1|||
161089196|NCT01874431|581717298|FG005|Overall Study|Withdrawal by Subject|1|||
161089197|NCT01874431|581717299|FG006|Overall Study|Withdrawal by Subject|3|||
161089198|NCT01874431|581717300|FG007|Overall Study|Withdrawal by Subject|0|||
161089199|NCT01874431|581717293|FG000|Overall Study|Sponsor decision|0|||
161089200|NCT01874431|581717294|FG001|Overall Study|Sponsor decision|0|||
161089201|NCT01874431|581717295|FG002|Overall Study|Sponsor decision|0|||
161089202|NCT01874431|581717296|FG003|Overall Study|Sponsor decision|0|||
161089203|NCT01874431|581717297|FG004|Overall Study|Sponsor decision|1|||
161089204|NCT01874431|581717298|FG005|Overall Study|Sponsor decision|0|||
161089205|NCT01874431|581717299|FG006|Overall Study|Sponsor decision|0|||
161089206|NCT01874431|581717300|FG007|Overall Study|Sponsor decision|0|||
161089207|NCT01874431|581717293|FG000|Overall Study|Lost to Follow-up|0|||
161089208|NCT01874431|581717294|FG001|Overall Study|Lost to Follow-up|0|||
161089209|NCT01874431|581717295|FG002|Overall Study|Lost to Follow-up|1|||
161089210|NCT01874431|581717296|FG003|Overall Study|Lost to Follow-up|0|||
161089211|NCT01874431|581717297|FG004|Overall Study|Lost to Follow-up|0|||
161089212|NCT01874431|581717298|FG005|Overall Study|Lost to Follow-up|0|||
161089213|NCT01874431|581717299|FG006|Overall Study|Lost to Follow-up|0|||
161089214|NCT01874431|581717300|FG007|Overall Study|Lost to Follow-up|0|||
161089215|NCT03718533|581717302|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
161089216|NCT03718533|581717302|FG000|Overall Study|Protocol deviation|1|||
161089217|NCT03718533|581717302|FG000|Overall Study|Disease progression|1|||
161089218|NCT03718533|581717302|FG000|Overall Study|Relapse|1|||
161089219|NCT03718533|581717302|FG000|Overall Study|Physician Decision|2|||
161089220|NCT03718533|581717302|FG000|Overall Study|Physician Decision and Adverse Event|1|||
161089221|NCT02257567|581717303|FG000|Overall Study|Adverse Event|0|||
161089222|NCT02257567|581717304|FG001|Overall Study|Adverse Event|0|||
161089223|NCT02257567|581717305|FG002|Overall Study|Adverse Event|0|||
161089224|NCT02257567|581717306|FG003|Overall Study|Adverse Event|1|||
161089225|NCT02257567|581717307|FG004|Overall Study|Adverse Event|1|||
161089226|NCT02257567|581717308|FG005|Overall Study|Adverse Event|0|||
161089227|NCT02257567|581717309|FG006|Overall Study|Adverse Event|0|||
161089228|NCT02257567|581717310|FG007|Overall Study|Adverse Event|0|||
161089229|NCT02257567|581717311|FG008|Overall Study|Adverse Event|1|||
161089230|NCT02257567|581717312|FG009|Overall Study|Adverse Event|0|||
161089231|NCT02257567|581717313|FG010|Overall Study|Adverse Event|0|||
161089232|NCT02257567|581717303|FG000|Overall Study|Death|2|||
161089233|NCT02257567|581717304|FG001|Overall Study|Death|2|||
161089234|NCT02257567|581717305|FG002|Overall Study|Death|2|||
161089235|NCT02257567|581717306|FG003|Overall Study|Death|4|||
161089236|NCT02257567|581717307|FG004|Overall Study|Death|15|||
161089237|NCT02257567|581717308|FG005|Overall Study|Death|11|||
161089238|NCT02257567|581717309|FG006|Overall Study|Death|26|||
161089239|NCT02257567|581717310|FG007|Overall Study|Death|30|||
161089240|NCT02257567|581717311|FG008|Overall Study|Death|2|||
161089241|NCT02257567|581717312|FG009|Overall Study|Death|18|||
161089242|NCT02257567|581717313|FG010|Overall Study|Death|65|||
161089243|NCT02257567|581717303|FG000|Overall Study|Lost to Follow-up|0|||
161089244|NCT02257567|581717304|FG001|Overall Study|Lost to Follow-up|0|||
161089245|NCT02257567|581717305|FG002|Overall Study|Lost to Follow-up|0|||
161089246|NCT02257567|581717306|FG003|Overall Study|Lost to Follow-up|0|||
161089247|NCT02257567|581717307|FG004|Overall Study|Lost to Follow-up|2|||
161089248|NCT02257567|581717308|FG005|Overall Study|Lost to Follow-up|2|||
161089249|NCT02257567|581717309|FG006|Overall Study|Lost to Follow-up|0|||
161089250|NCT02257567|581717310|FG007|Overall Study|Lost to Follow-up|0|||
161089251|NCT02257567|581717311|FG008|Overall Study|Lost to Follow-up|0|||
161089252|NCT02257567|581717312|FG009|Overall Study|Lost to Follow-up|1|||
161089253|NCT02257567|581717313|FG010|Overall Study|Lost to Follow-up|1|||
161089254|NCT02257567|581717303|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089255|NCT02257567|581717304|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089256|NCT02257567|581717305|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089257|NCT02257567|581717306|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089258|NCT02257567|581717307|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
161089259|NCT02257567|581717308|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089260|NCT02257567|581717309|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
161089261|NCT02257567|581717310|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089262|NCT02257567|581717311|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089263|NCT02257567|581717312|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089264|NCT02257567|581717313|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
161089265|NCT02257567|581717303|FG000|Overall Study|Physician Decision|0|||
161089266|NCT02257567|581717304|FG001|Overall Study|Physician Decision|0|||
161089267|NCT02257567|581717305|FG002|Overall Study|Physician Decision|0|||
161089268|NCT02257567|581717306|FG003|Overall Study|Physician Decision|0|||
161089269|NCT02257567|581717307|FG004|Overall Study|Physician Decision|0|||
161089270|NCT02257567|581717308|FG005|Overall Study|Physician Decision|0|||
161089271|NCT02257567|581717309|FG006|Overall Study|Physician Decision|0|||
161089272|NCT02257567|581717310|FG007|Overall Study|Physician Decision|2|||
161089273|NCT02257567|581717311|FG008|Overall Study|Physician Decision|0|||
161089274|NCT02257567|581717312|FG009|Overall Study|Physician Decision|1|||
161089275|NCT02257567|581717313|FG010|Overall Study|Physician Decision|0|||
161089276|NCT02257567|581717303|FG000|Overall Study|Withdrawal by Subject|0|||
161089277|NCT02257567|581717304|FG001|Overall Study|Withdrawal by Subject|0|||
161089278|NCT02257567|581717305|FG002|Overall Study|Withdrawal by Subject|2|||
161089279|NCT02257567|581717306|FG003|Overall Study|Withdrawal by Subject|0|||
161089280|NCT02257567|581717307|FG004|Overall Study|Withdrawal by Subject|0|||
161089281|NCT02257567|581717308|FG005|Overall Study|Withdrawal by Subject|6|||
161089282|NCT02257567|581717309|FG006|Overall Study|Withdrawal by Subject|6|||
161089283|NCT02257567|581717310|FG007|Overall Study|Withdrawal by Subject|6|||
161089284|NCT02257567|581717311|FG008|Overall Study|Withdrawal by Subject|1|||
161089285|NCT02257567|581717312|FG009|Overall Study|Withdrawal by Subject|1|||
161089286|NCT02257567|581717313|FG010|Overall Study|Withdrawal by Subject|10|||
161089287|NCT00946101|581717314|FG000|Overall Study|Lost to Follow-up|2|||
161089288|NCT00946101|581717315|FG001|Overall Study|Lost to Follow-up|1|||
161089289|NCT00946101|581717314|FG000|Overall Study|Withdrawal of consent|2|||
161089290|NCT00946101|581717315|FG001|Overall Study|Withdrawal of consent|0|||
161089291|NCT00946101|581717314|FG000|Overall Study|Physician Decision|0|||
161089292|NCT00946101|581717315|FG001|Overall Study|Physician Decision|1|||
161089293|NCT01590017|581717316|FG000|Overall Study|Adverse Event|1|||
161089294|NCT01590017|581717316|FG000|Overall Study|Withdrawal by Subject|1|||
161089295|NCT01590017|581717316|FG000|Overall Study|Lack of Efficacy|1|||
161089296|NCT01590017|581717316|FG000|Overall Study|Physician Decision|1|||
161089297|NCT03625895|581717317|FG000|Overall Study|Protocol Violation|585|||
161089298|NCT03256851|581717318|FG000|Overall Study|Withdrawal by Subject|1|||
161089299|NCT03256851|581717319|FG001|Overall Study|Withdrawal by Subject|0|||
161089300|NCT01065844|581717322|FG000|Overall Study|Adverse Event|5|||
161089301|NCT02081417|581717323|FG000|Overall Study|Lost to Follow-up|26|||
161089302|NCT02081417|581717324|FG001|Overall Study|Lost to Follow-up|23|||
161089303|NCT02081417|581717323|FG000|Overall Study|Moved Away|1|||
161089304|NCT02081417|581717324|FG001|Overall Study|Moved Away|2|||
161089305|NCT02081417|581717323|FG000|Overall Study|Incarcerated|2|||
161089306|NCT02081417|581717324|FG001|Overall Study|Incarcerated|2|||
161089307|NCT02081417|581717323|FG000|Overall Study|Death|4|||
161089308|NCT02081417|581717324|FG001|Overall Study|Death|3|||
161089309|NCT02081417|581717323|FG000|Overall Study|Withdrawal by Subject|4|||
161089310|NCT02081417|581717324|FG001|Overall Study|Withdrawal by Subject|0|||
161089311|NCT02081417|581717323|FG000|Overall Study|Admitted to Residential Treatment|2|||
161089312|NCT02081417|581717324|FG001|Overall Study|Admitted to Residential Treatment|0|||
161089313|NCT02081417|581717323|FG000|Overall Study|Did not start treatment|17|||
161089314|NCT02081417|581717324|FG001|Overall Study|Did not start treatment|21|||
161089315|NCT01778023|581717328|FG000|Overall Study|Withdrawal by Subject|0|||
161089316|NCT01778023|581717329|FG001|Overall Study|Withdrawal by Subject|3|||
161089317|NCT01000636|581717334|FG000|Overall Study|Withdrawal by Subject|1|||
161089318|NCT01000636|581717334|FG000|Overall Study|Adverse Event|1|||
161089319|NCT02319525|581717335|FG000|Overall Study|Withdrawal by Subject|2|||
161089320|NCT02319525|581717336|FG001|Overall Study|Withdrawal by Subject|1|||
161089321|NCT00577577|581717341|FG000|Overall Study|Adverse Event|3|||
161089322|NCT00577577|581717342|FG001|Overall Study|Adverse Event|2|||
161089323|NCT00577577|581717341|FG000|Overall Study|Lost to Follow-up|1|||
161089324|NCT00577577|581717342|FG001|Overall Study|Lost to Follow-up|0|||
161089325|NCT00577577|581717341|FG000|Overall Study|Protocol Violation|0|||
161089326|NCT00577577|581717342|FG001|Overall Study|Protocol Violation|3|||
161089327|NCT00577577|581717341|FG000|Overall Study|Transportation|1|||
161089328|NCT00577577|581717342|FG001|Overall Study|Transportation|0|||
161089329|NCT02424734|581717343|FG000|Overall Study|Treatment stopped to be discharged home|2|||
161089330|NCT02424734|581717344|FG001|Overall Study|Treatment stopped to be discharged home|2|||
161089331|NCT02424734|581717345|FG002|Overall Study|Treatment stopped to be discharged home|0|||
161089332|NCT01445301|581717346|FG000|Overall Study|Adverse Event|15|||
161089333|NCT01445301|581717347|FG001|Overall Study|Adverse Event|25|||
161089334|NCT01445301|581717348|FG002|Overall Study|Adverse Event|4|||
161089335|NCT01445301|581717346|FG000|Overall Study|Lack of Efficacy|0|||
161089336|NCT01445301|581717347|FG001|Overall Study|Lack of Efficacy|1|||
161089337|NCT01445301|581717348|FG002|Overall Study|Lack of Efficacy|0|||
161089338|NCT01445301|581717346|FG000|Overall Study|Protocol Violation|1|||
161089339|NCT01445301|581717347|FG001|Overall Study|Protocol Violation|0|||
161089340|NCT01445301|581717348|FG002|Overall Study|Protocol Violation|0|||
161089341|NCT01445301|581717346|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
161089342|NCT01445301|581717347|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
161089343|NCT01445301|581717348|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
161299121|NCT03850483|582477696|FG000|Treatment for Stage 2|Physician Decision|0|||
161299122|NCT03850483|582477697|FG001|Treatment for Stage 2|Physician Decision|0|||
161299123|NCT03850483|582477698|FG002|Treatment for Stage 2|Physician Decision|0|||
161299124|NCT03850483|582477699|FG003|Treatment for Stage 2|Physician Decision|0|||
161299125|NCT03850483|582477700|FG004|Treatment for Stage 2|Physician Decision|0|||
161299126|NCT03850483|582477701|FG005|Treatment for Stage 2|Physician Decision|0|||
161299127|NCT03850483|582477702|FG006|Treatment for Stage 2|Physician Decision|0|||
161299128|NCT03850483|582477703|FG007|Treatment for Stage 2|Physician Decision|0|||
161299129|NCT03850483|582477704|FG008|Treatment for Stage 2|Physician Decision|0|||
161299130|NCT03850483|582477705|FG009|Treatment for Stage 2|Physician Decision|1|||
161299131|NCT03850483|582477696|FG000|Treatment for Stage 2|Protocol Violation|0|||
161299132|NCT03850483|582477697|FG001|Treatment for Stage 2|Protocol Violation|0|||
161299133|NCT03850483|582477698|FG002|Treatment for Stage 2|Protocol Violation|0|||
161299134|NCT03850483|582477699|FG003|Treatment for Stage 2|Protocol Violation|0|||
161299135|NCT03850483|582477700|FG004|Treatment for Stage 2|Protocol Violation|0|||
161299136|NCT03850483|582477701|FG005|Treatment for Stage 2|Protocol Violation|0|||
161299137|NCT03850483|582477702|FG006|Treatment for Stage 2|Protocol Violation|0|||
161299138|NCT03850483|582477703|FG007|Treatment for Stage 2|Protocol Violation|0|||
161299139|NCT03850483|582477704|FG008|Treatment for Stage 2|Protocol Violation|1|||
161299140|NCT03850483|582477705|FG009|Treatment for Stage 2|Protocol Violation|0|||
161299141|NCT03850483|582477696|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
161299142|NCT03850483|582477697|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
161299143|NCT03850483|582477698|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
161299144|NCT03850483|582477699|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
161299145|NCT03850483|582477700|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
161299146|NCT03850483|582477701|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
161299147|NCT03850483|582477702|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
161299148|NCT03850483|582477703|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
161299149|NCT03850483|582477704|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
161299150|NCT03850483|582477705|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
161299151|NCT03850483|582477696|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299152|NCT03850483|582477697|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299153|NCT03850483|582477698|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299154|NCT03850483|582477699|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299155|NCT03850483|582477700|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299156|NCT03850483|582477701|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299157|NCT03850483|582477702|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299158|NCT03850483|582477703|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299159|NCT03850483|582477704|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
161299160|NCT03850483|582477705|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
161299161|NCT03850483|582477696|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
161299162|NCT03850483|582477697|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
161299163|NCT03850483|582477698|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
161299164|NCT03850483|582477699|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
161299165|NCT03850483|582477700|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
161299166|NCT03850483|582477701|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
161299167|NCT03850483|582477702|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
161299168|NCT03850483|582477703|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
161299169|NCT03850483|582477704|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
161299170|NCT03850483|582477705|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
161299171|NCT03850483|582477696|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
161299172|NCT03850483|582477697|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
161299173|NCT03850483|582477698|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
161299174|NCT03850483|582477699|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
161299175|NCT03850483|582477700|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
161299176|NCT03850483|582477701|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
161299177|NCT03850483|582477702|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
161299178|NCT03850483|582477703|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
161299179|NCT03850483|582477704|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
161299180|NCT03850483|582477705|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
161299181|NCT03850483|582477696|FG000|Follow-up For Stage 2|Other|0|||
161299182|NCT03850483|582477697|FG001|Follow-up For Stage 2|Other|0|||
161299183|NCT03850483|582477698|FG002|Follow-up For Stage 2|Other|0|||
161299184|NCT03850483|582477699|FG003|Follow-up For Stage 2|Other|0|||
161299185|NCT03850483|582477700|FG004|Follow-up For Stage 2|Other|0|||
161299186|NCT03850483|582477701|FG005|Follow-up For Stage 2|Other|0|||
161299187|NCT03850483|582477702|FG006|Follow-up For Stage 2|Other|0|||
161299188|NCT03850483|582477703|FG007|Follow-up For Stage 2|Other|0|||
161299189|NCT03850483|582477704|FG008|Follow-up For Stage 2|Other|0|||
161299190|NCT03850483|582477705|FG009|Follow-up For Stage 2|Other|1|||
161299191|NCT03260244|582478993|FG000|Overall Study|Death|19|||
161299192|NCT03260244|582478993|FG000|Overall Study|Lost to Follow-up|60|||
161299193|NCT03260244|582478993|FG000|Overall Study|Withdrawal by Subject|48|||
161299194|NCT03260244|582478993|FG000|Overall Study|Procedure Not Performed|21|||
161299195|NCT03260244|582478993|FG000|Overall Study|Enrollment Criteria Not Met|31|||
161299196|NCT03260244|582478993|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
161299197|NCT03260244|582478993|FG000|Overall Study|Subject Noncompliance|6|||
161299198|NCT03260244|582478993|FG000|Overall Study|No inducible Arrhythmia|2|||
161299199|NCT03260244|582478993|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
161299200|NCT03260244|582478993|FG000|Overall Study|Screen Failure|2|||
161299201|NCT03260244|582478993|FG000|Overall Study|Treated Off Label|69|||
161299202|NCT03260244|582478993|FG000|Overall Study|No Radiofrequency Ablation|14|||
161299203|NCT01288937|582478994|FG000|Overall Study|Adverse Event|1|||
161299204|NCT01288937|582478995|FG001|Overall Study|Adverse Event|0|||
161299205|NCT01750697|582479001|FG000|Overall Study|Transferred Back to Local Hospital|1|||
161299206|NCT01750697|582479001|FG000|Overall Study|Physician and Family Decision|1|||
161299207|NCT01750697|582479001|FG000|Overall Study|Transferred to Adult Services|5|||
161299208|NCT01750697|582479001|FG000|Overall Study|Physician Decision|1|||
161299209|NCT01750697|582479001|FG000|Overall Study|Withdrawal by Subject|1|||
161299210|NCT00892151|582479002|FG000|Overall Study|Protocol Violation|1|||
161299211|NCT04606394|582479007|FG000|Overall Study|Withdrawal by Subject|3|||
161299212|NCT04606394|582479007|FG000|Overall Study|Exclusion criteria screen failure|12|||
161299213|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
161299214|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
161299215|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
161299216|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
161299217|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
161299218|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
161299219|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
161299220|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
161299221|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
161299222|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
161299223|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
161299224|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
161299225|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
161299226|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
161299227|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161299228|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161299229|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161299230|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
161299231|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
161299232|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
161299233|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
161299234|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
161299235|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
161299236|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
161299237|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
161299238|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
161299239|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
161299240|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
161299241|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
161299242|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
161299243|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
161299244|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
161299245|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161299246|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161299247|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161299248|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
161299249|NCT02016105|582479008|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
161347850|NCT02903914|582657367|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
161347851|NCT02903914|582657368|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
161347852|NCT02903914|582657361|FG000|Overall Study|Clinical Disease Progression|0|||
161347853|NCT02903914|582657362|FG001|Overall Study|Clinical Disease Progression|0|||
161347854|NCT02903914|582657363|FG002|Overall Study|Clinical Disease Progression|2|||
161347855|NCT02903914|582657364|FG003|Overall Study|Clinical Disease Progression|0|||
161089344|NCT01445301|581717346|FG000|Overall Study|Physician Decision|0|||
161299250|NCT02016105|582479009|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
161299251|NCT02016105|582479010|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161299252|NCT02016105|582479011|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161299253|NCT02016105|582479012|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161299254|NCT02016105|582479013|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
161299255|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
161299256|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
161299257|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
161299258|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
161299259|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
161299260|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
161299261|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
161299262|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
161299263|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
161299264|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
161299265|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
161299266|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
161299267|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
161299268|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
161299269|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
161299270|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
161299271|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
161299272|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
161299273|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Death|0|||
161299274|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Death|0|||
161299275|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Death|0|||
161299276|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Death|0|||
161299277|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Death|0|||
161299278|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Death|1|||
161299279|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
161299280|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
161299281|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
161299282|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
161299283|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
161299284|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
161299285|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
161299286|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
161299287|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
161299288|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
161299289|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
161299290|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
161299291|NCT02016105|582479008|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161299292|NCT02016105|582479009|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161299293|NCT02016105|582479010|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
161299294|NCT02016105|582479011|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161299295|NCT02016105|582479012|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
161299296|NCT02016105|582479013|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
161299297|NCT02016105|582479008|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
161299298|NCT02016105|582479009|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
161299299|NCT02016105|582479010|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
161299300|NCT02016105|582479011|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
161299301|NCT02016105|582479012|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
161299302|NCT02016105|582479013|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
161299303|NCT02016105|582479008|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
161299304|NCT02016105|582479009|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
161299305|NCT02016105|582479010|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
161299306|NCT02016105|582479011|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
161299307|NCT02016105|582479012|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
161299308|NCT02016105|582479013|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
161299309|NCT02016105|582479008|FG000|EXTENSION PERIOD|Adverse Event|0|||
161299310|NCT02016105|582479009|FG001|EXTENSION PERIOD|Adverse Event|0|||
161299311|NCT02016105|582479010|FG002|EXTENSION PERIOD|Adverse Event|2|||
161299312|NCT02016105|582479011|FG003|EXTENSION PERIOD|Adverse Event|0|||
161299313|NCT02016105|582479012|FG004|EXTENSION PERIOD|Adverse Event|1|||
161299314|NCT02016105|582479013|FG005|EXTENSION PERIOD|Adverse Event|0|||
161299315|NCT02016105|582479008|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
161181450|NCT02736929|582040580|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
161181451|NCT02736929|582040581|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
161181452|NCT02972593|582040582|FG000|Overall Study|Lost to Follow-up|19|||
161181453|NCT02972593|582040583|FG001|Overall Study|Lost to Follow-up|15|||
161181454|NCT02972593|582040582|FG000|Overall Study|Protocol Violation|1|||
161181455|NCT02972593|582040583|FG001|Overall Study|Protocol Violation|0|||
161181456|NCT00285649|582040584|FG000|Overall Study|Lost to Follow-up|6|||
161181457|NCT00285649|582040585|FG001|Overall Study|Lost to Follow-up|4|||
161181458|NCT00285649|582040586|FG002|Overall Study|Lost to Follow-up|4|||
161299316|NCT02016105|582479009|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
161299317|NCT02016105|582479010|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
161299318|NCT02016105|582479011|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
161299319|NCT02016105|582479012|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
161299320|NCT02016105|582479013|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
161299321|NCT02016105|582479008|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
161299322|NCT02016105|582479009|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
161299323|NCT02016105|582479010|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
161299324|NCT02016105|582479011|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
161299325|NCT02016105|582479012|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
161299326|NCT02016105|582479013|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
161299327|NCT02016105|582479008|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
161299328|NCT02016105|582479009|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
161299329|NCT02016105|582479010|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
161299330|NCT02016105|582479011|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
161299331|NCT02016105|582479012|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
161299332|NCT02016105|582479013|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
161299333|NCT00090493|582479014|FG000|Overall Study|Physician Decision|2|||
161299334|NCT02865499|582479015|FG000|Baseline|Adverse Event|1|||
161299335|NCT02865499|582479015|FG000|Baseline|Withdrawal by Subject|1|||
161299336|NCT02320058|582479016|FG000|Overall Study|Death|25|||
161299337|NCT02320058|582479017|FG001|Overall Study|Death|10|||
161299338|NCT02320058|582479016|FG000|Overall Study|Lost to Follow-up|4|||
161299339|NCT02320058|582479017|FG001|Overall Study|Lost to Follow-up|0|||
161299340|NCT02320058|582479016|FG000|Overall Study|Other reasons|4|||
161299341|NCT02320058|582479017|FG001|Overall Study|Other reasons|1|||
161299342|NCT02320058|582479016|FG000|Overall Study|Withdrawal by Subject|8|||
161299343|NCT02320058|582479017|FG001|Overall Study|Withdrawal by Subject|2|||
161299344|NCT02320058|582479016|FG000|Overall Study|Not reported|1|||
161299345|NCT02320058|582479017|FG001|Overall Study|Not reported|0|||
161299346|NCT00661609|582479018|FG000|Overall Study|Adverse Event|4|||
161299347|NCT00661609|582479018|FG000|Overall Study|Death|20|||
161181459|NCT00285649|582040584|FG000|Overall Study|Withdrawal by Subject|3|||
161181460|NCT00285649|582040585|FG001|Overall Study|Withdrawal by Subject|2|||
161181461|NCT00285649|582040586|FG002|Overall Study|Withdrawal by Subject|2|||
161181462|NCT01855425|582040591|FG000|Overall Study|Physician Decision|20|||
161181463|NCT01600105|582040598|FG000|Total Participants|Withdrawal by Subject|1|||
161181464|NCT01600105|582040599|FG001|Total Participants|Withdrawal by Subject|0|||
161181465|NCT01600105|582040598|FG000|Total Participants|No images in PACS|10|||
161181466|NCT01600105|582040599|FG001|Total Participants|No images in PACS|0|||
161181467|NCT01600105|582040598|FG000|Total Participants|Insufficient image quality|30|||
161181468|NCT01600105|582040599|FG001|Total Participants|Insufficient image quality|10|||
161181469|NCT01600105|582040598|FG000|Sub Study I|Insufficient image quality|0|||
161181470|NCT01600105|582040599|FG001|Sub Study I|Insufficient image quality|10|||
161181471|NCT01600105|582040598|FG000|Sub Study II|Withdrawal by Subject|1|||
161181472|NCT01600105|582040599|FG001|Sub Study II|Withdrawal by Subject|0|||
161181473|NCT01600105|582040598|FG000|Sub Study II|No images in PACS|1|||
161181474|NCT01600105|582040599|FG001|Sub Study II|No images in PACS|0|||
161181475|NCT01600105|582040598|FG000|Sub Study II|Insufficient image quality|3|||
161181476|NCT01600105|582040599|FG001|Sub Study II|Insufficient image quality|0|||
161181477|NCT01600105|582040598|FG000|Sub Study III|Insufficient image quality|5|||
161181478|NCT01600105|582040599|FG001|Sub Study III|Insufficient image quality|0|||
161181479|NCT01600105|582040598|FG000|Sub Study V|Poor Image Quality|2|||
161181480|NCT01600105|582040599|FG001|Sub Study V|Poor Image Quality|0|||
161181481|NCT01263444|582040600|FG000|Overall Study|Adverse Event|8|||
161181482|NCT01263444|582040600|FG000|Overall Study|Withdrawal by Subject|1|||
161181483|NCT01263444|582040600|FG000|Overall Study|Protocol Violation|1|||
161181484|NCT01764022|582040601|FG000|Overall Study|Death|3|||
161181485|NCT01764022|582040602|FG001|Overall Study|Death|5|||
161181486|NCT01764022|582040601|FG000|Overall Study|Withdrawal by Subject|2|||
161181487|NCT01764022|582040602|FG001|Overall Study|Withdrawal by Subject|6|||
161181488|NCT01764022|582040601|FG000|Overall Study|Lack of Efficacy|0|||
161181489|NCT01764022|582040602|FG001|Overall Study|Lack of Efficacy|1|||
161181490|NCT01764022|582040601|FG000|Overall Study|Physician Decision|0|||
161181491|NCT01764022|582040602|FG001|Overall Study|Physician Decision|2|||
161181492|NCT01764022|582040601|FG000|Overall Study|Lost to Follow-up|2|||
161181493|NCT01764022|582040602|FG001|Overall Study|Lost to Follow-up|0|||
161181494|NCT01764022|582040601|FG000|Overall Study|Protocol Violation|1|||
161181495|NCT01764022|582040602|FG001|Overall Study|Protocol Violation|0|||
161181496|NCT01899768|582040603|FG000|Part A|Adverse Event|2|||
161181497|NCT01899768|582040603|FG000|Part A|Withdrawal by Subject|1|||
161181498|NCT01899768|582040603|FG000|Part B|Adverse Event|1|||
161299348|NCT00661609|582479018|FG000|Overall Study|Withdrawal by Subject|2|||
161299349|NCT00661609|582479018|FG000|Overall Study|PI Decision|1|||
161299350|NCT00661609|582479018|FG000|Overall Study|Survival follow up stage discontinued|11|||
161181499|NCT01899768|582040603|FG000|Part B|Withdrawal by Subject|1|||
161181500|NCT04043416|582040605|FG000|Washout|Change in health condition|0|||
161181501|NCT04043416|582040606|FG001|Washout|Change in health condition|1|||
161181502|NCT00414973|582040607|FG000|Overall Study|Withdrawal by Subject|14|||
161181503|NCT00414973|582040608|FG001|Overall Study|Withdrawal by Subject|4|||
161181504|NCT00414973|582040609|FG002|Overall Study|Withdrawal by Subject|1|||
161181505|NCT00414973|582040610|FG003|Overall Study|Withdrawal by Subject|0|||
161299351|NCT00661609|582479018|FG000|Overall Study|Disease progression|3|||
161299352|NCT01769508|582479019|FG000|Overall Study|Death|3|||
161181506|NCT00414973|582040607|FG000|Overall Study|Adverse Event|10|||
161181507|NCT00414973|582040608|FG001|Overall Study|Adverse Event|0|||
161181508|NCT00414973|582040609|FG002|Overall Study|Adverse Event|1|||
161299353|NCT01769508|582479019|FG000|Overall Study|Withdrawal by Subject|1|||
161181509|NCT00414973|582040610|FG003|Overall Study|Adverse Event|0|||
161299354|NCT01769508|582479019|FG000|Overall Study|Adverse Event|1|||
161299355|NCT01769508|582479019|FG000|Overall Study|Lost to Follow-up|1|||
161181510|NCT00414973|582040607|FG000|Overall Study|Protocol Violation|3|||
161181511|NCT00414973|582040608|FG001|Overall Study|Protocol Violation|4|||
161181512|NCT00414973|582040609|FG002|Overall Study|Protocol Violation|0|||
161181513|NCT00414973|582040610|FG003|Overall Study|Protocol Violation|0|||
161181514|NCT00414973|582040607|FG000|Overall Study|Lost to Follow-up|0|||
161181515|NCT00414973|582040608|FG001|Overall Study|Lost to Follow-up|2|||
161181516|NCT00414973|582040609|FG002|Overall Study|Lost to Follow-up|0|||
161181517|NCT00414973|582040610|FG003|Overall Study|Lost to Follow-up|0|||
161181518|NCT00414973|582040607|FG000|Overall Study|Sponsor Decision|1|||
161181519|NCT00414973|582040608|FG001|Overall Study|Sponsor Decision|0|||
161181520|NCT00414973|582040609|FG002|Overall Study|Sponsor Decision|0|||
161181521|NCT00414973|582040610|FG003|Overall Study|Sponsor Decision|0|||
161181522|NCT00414973|582040607|FG000|Overall Study|Death|0|||
161181523|NCT00414973|582040608|FG001|Overall Study|Death|0|||
161181524|NCT00414973|582040609|FG002|Overall Study|Death|1|||
161181525|NCT00414973|582040610|FG003|Overall Study|Death|0|||
161181526|NCT01466062|582040611|FG000|Overall Study|Adverse Event|1|||
161181527|NCT01466062|582040611|FG000|Overall Study|Withdrawal by Subject|1|||
161181528|NCT02865928|582040612|FG000|Overall Study|Withdrawal by Subject|1|||
161181529|NCT02865928|582040613|FG001|Overall Study|Withdrawal by Subject|0|||
161181530|NCT02865928|582040612|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
161181531|NCT02865928|582040613|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
161181532|NCT02865928|582040612|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
161181533|NCT02865928|582040613|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
161181534|NCT01925014|582040614|FG000|Overall Study|Inappropriate enrollment|4|||
161181535|NCT01925014|582040615|FG001|Overall Study|Inappropriate enrollment|6|||
161181536|NCT01925014|582040614|FG000|Overall Study|Withdrawal by Subject|5|||
161181537|NCT01925014|582040615|FG001|Overall Study|Withdrawal by Subject|13|||
161181538|NCT01196091|582040619|FG000|Overall Study|Adverse Event|22|||
161181539|NCT01196091|582040620|FG001|Overall Study|Adverse Event|27|||
161181540|NCT01196091|582040621|FG002|Overall Study|Adverse Event|26|||
161181541|NCT01196091|582040619|FG000|Overall Study|Death|3|||
161181542|NCT01196091|582040620|FG001|Overall Study|Death|2|||
161181543|NCT01196091|582040621|FG002|Overall Study|Death|2|||
161181544|NCT01196091|582040619|FG000|Overall Study|Entry Criteria Not Met|11|||
161181545|NCT01196091|582040620|FG001|Overall Study|Entry Criteria Not Met|11|||
161181546|NCT01196091|582040621|FG002|Overall Study|Entry Criteria Not Met|10|||
161181547|NCT01196091|582040619|FG000|Overall Study|Lack of Efficacy|15|||
161181548|NCT01196091|582040620|FG001|Overall Study|Lack of Efficacy|12|||
161181549|NCT01196091|582040621|FG002|Overall Study|Lack of Efficacy|17|||
161181550|NCT01196091|582040619|FG000|Overall Study|Lost to Follow-up|5|||
161181551|NCT01196091|582040620|FG001|Overall Study|Lost to Follow-up|5|||
161181552|NCT01196091|582040621|FG002|Overall Study|Lost to Follow-up|6|||
161181553|NCT01196091|582040619|FG000|Overall Study|Parent/Caregiver Decision|0|||
161181554|NCT01196091|582040620|FG001|Overall Study|Parent/Caregiver Decision|0|||
161181555|NCT01196091|582040621|FG002|Overall Study|Parent/Caregiver Decision|1|||
161181556|NCT01196091|582040619|FG000|Overall Study|Withdrawal by Subject|16|||
161181557|NCT01196091|582040620|FG001|Overall Study|Withdrawal by Subject|19|||
161181558|NCT01196091|582040621|FG002|Overall Study|Withdrawal by Subject|22|||
161181559|NCT01196091|582040619|FG000|Overall Study|Physician Decision|3|||
161181560|NCT01196091|582040620|FG001|Overall Study|Physician Decision|3|||
161181561|NCT01196091|582040621|FG002|Overall Study|Physician Decision|4|||
161181562|NCT01196091|582040619|FG000|Overall Study|Protocol Violation|1|||
161181563|NCT01196091|582040620|FG001|Overall Study|Protocol Violation|3|||
161181564|NCT01196091|582040621|FG002|Overall Study|Protocol Violation|3|||
161181565|NCT01196091|582040619|FG000|Overall Study|Sponsor Decision|6|||
161181566|NCT01196091|582040620|FG001|Overall Study|Sponsor Decision|5|||
161181567|NCT01196091|582040621|FG002|Overall Study|Sponsor Decision|4|||
161181568|NCT01196091|582040619|FG000|Overall Study|Excluded Site|5|||
161181569|NCT01196091|582040620|FG001|Overall Study|Excluded Site|11|||
161181570|NCT01196091|582040621|FG002|Overall Study|Excluded Site|8|||
161181571|NCT01196091|582040619|FG000|Overall Study|Randomized, No Study Drug Received|1|||
161181572|NCT01196091|582040620|FG001|Overall Study|Randomized, No Study Drug Received|0|||
161181573|NCT01196091|582040621|FG002|Overall Study|Randomized, No Study Drug Received|1|||
161181574|NCT00471276|582040622|FG000|Overall Study|Death|2|||
161181575|NCT00471276|582040622|FG000|Overall Study|Adverse Event|16|||
161181576|NCT00471276|582040622|FG000|Overall Study|Protocol Violation|1|||
161181577|NCT00471276|582040622|FG000|Overall Study|Objective progression or relapse|54|||
161181578|NCT00471276|582040622|FG000|Overall Study|Global deterioration of health status|1|||
161181579|NCT00471276|582040622|FG000|Overall Study|Other|3|||
161181580|NCT00471276|582040622|FG000|Overall Study|Refused treatment|6|||
161181581|NCT01487863|582040626|FG000|Overall Study|Death|19|||
161181582|NCT01487863|582040627|FG001|Overall Study|Death|19|||
161181583|NCT02324049|582040631|FG000|Part C|Study terminated|11|||
161181584|NCT02159365|582040632|FG000|Overall Study|Disease Progression|23|||
161181585|NCT02159365|582040632|FG000|Overall Study|Other reasons|11|||
161181586|NCT02159365|582040632|FG000|Overall Study|Administrative reason by Sponsor|9|||
161299356|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
161299357|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
161299358|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
161299359|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
161299360|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
161299361|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
161299362|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
161299363|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
161299364|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
161299365|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
161299366|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
161299367|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
161299368|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
161299369|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
161299370|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
161299371|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
161299372|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
161299373|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
161299374|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
161299375|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
161299376|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
161299377|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
161299378|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
161299379|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
161299380|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
161299381|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
161299382|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
161299383|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
161299384|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161299385|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
161299386|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
161299387|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
161299388|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
161299389|NCT00839527|582479020|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
161299390|NCT00839527|582479021|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
161299391|NCT00839527|582479022|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
161181587|NCT02159365|582040632|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
161181588|NCT02159365|582040632|FG000|Overall Study|Study drug toxicity|7|||
161181589|NCT02159365|582040632|FG000|Overall Study|Maximum clinical benefit|3|||
161181590|NCT02159365|582040632|FG000|Overall Study|Subject request to discontinue treatment|3|||
161181591|NCT02159365|582040632|FG000|Overall Study|Subject withdrew consent|3|||
161181592|NCT02159365|582040632|FG000|Overall Study|Death|1|||
161181593|NCT02159365|582040632|FG000|Overall Study|Lost to Follow-up|1|||
161181594|NCT01437267|582040633|FG000|Overall Study|Withdrawal by Subject|0|||
161181595|NCT01437267|582040634|FG001|Overall Study|Withdrawal by Subject|0|||
161181596|NCT01437267|582040635|FG002|Overall Study|Withdrawal by Subject|0|||
161181597|NCT01437267|582040636|FG003|Overall Study|Withdrawal by Subject|1|||
161181598|NCT01437267|582040637|FG004|Overall Study|Withdrawal by Subject|0|||
161181599|NCT01437267|582040638|FG005|Overall Study|Withdrawal by Subject|0|||
161181600|NCT01437267|582040633|FG000|Overall Study|Protocol Violation|0|||
161181601|NCT01437267|582040634|FG001|Overall Study|Protocol Violation|1|||
161181602|NCT01437267|582040635|FG002|Overall Study|Protocol Violation|0|||
161181603|NCT01437267|582040636|FG003|Overall Study|Protocol Violation|0|||
161181604|NCT01437267|582040637|FG004|Overall Study|Protocol Violation|0|||
161181605|NCT01437267|582040638|FG005|Overall Study|Protocol Violation|0|||
161181606|NCT03934203|582040639|FG000|Overall Study|Adverse Event|0|||
161181607|NCT03934203|582040640|FG001|Overall Study|Adverse Event|0|||
161181608|NCT03934203|582040641|FG002|Overall Study|Adverse Event|1|||
161181609|NCT03934203|582040642|FG003|Overall Study|Adverse Event|0|||
161181610|NCT03934203|582040643|FG004|Overall Study|Adverse Event|1|||
161181611|NCT03934203|582040644|FG005|Overall Study|Adverse Event|0|||
161181612|NCT03934203|582040645|FG006|Overall Study|Adverse Event|2|||
161181613|NCT03934203|582040646|FG007|Overall Study|Adverse Event|0|||
161181614|NCT03934203|582040647|FG008|Overall Study|Adverse Event|0|||
161181615|NCT03934203|582040648|FG009|Overall Study|Adverse Event|0|||
161181616|NCT03934203|582040649|FG010|Overall Study|Adverse Event|0|||
161181617|NCT03934203|582040650|FG011|Overall Study|Adverse Event|0|||
161181618|NCT03934203|582040651|FG012|Overall Study|Adverse Event|0|||
161181619|NCT03934203|582040652|FG013|Overall Study|Adverse Event|1|||
161181620|NCT03934203|582040653|FG014|Overall Study|Adverse Event|0|||
161181621|NCT02973997|582043360|FG000|Overall Study|Withdrawal by Subject|4|||
161181622|NCT02973997|582043361|FG001|Overall Study|Withdrawal by Subject|0|||
161181623|NCT02973997|582043360|FG000|Overall Study|Adverse Event|4|||
161181624|NCT02973997|582043361|FG001|Overall Study|Adverse Event|1|||
161181625|NCT02973997|582043360|FG000|Overall Study|Disease Progression|11|||
161181626|NCT02973997|582043361|FG001|Overall Study|Disease Progression|20|||
161181627|NCT02973997|582043360|FG000|Overall Study|Alternative Therapy|3|||
161181628|NCT02973997|582043361|FG001|Overall Study|Alternative Therapy|0|||
161181629|NCT02973997|582043360|FG000|Overall Study|Other complicating disease|0|||
161181630|NCT02973997|582043361|FG001|Overall Study|Other complicating disease|1|||
161181631|NCT02973997|582043360|FG000|Overall Study|Death|0|||
161181632|NCT02973997|582043361|FG001|Overall Study|Death|1|||
161181633|NCT00444951|582043362|FG000|Overall Study|Lost to Follow-up|1|||
161181634|NCT00444951|582043363|FG001|Overall Study|Lost to Follow-up|1|||
161181635|NCT00444951|582043364|FG002|Overall Study|Lost to Follow-up|0|||
161181636|NCT00444951|582043362|FG000|Overall Study|Withdrawal by Subject|4|||
161181637|NCT00444951|582043363|FG001|Overall Study|Withdrawal by Subject|5|||
161181638|NCT00444951|582043364|FG002|Overall Study|Withdrawal by Subject|3|||
161181639|NCT00887822|582043365|FG000|Overall Study|Insufficient therapeutic response|53|||
161181640|NCT00887822|582043366|FG001|Overall Study|Insufficient therapeutic response|55|||
161181641|NCT00887822|582043365|FG000|Overall Study|Adverse Event|14|||
161181642|NCT00887822|582043366|FG001|Overall Study|Adverse Event|17|||
161181643|NCT00887822|582043365|FG000|Overall Study|Failure to return|11|||
161181644|NCT00887822|582043366|FG001|Overall Study|Failure to return|11|||
161181645|NCT00887822|582043365|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
161181646|NCT00887822|582043366|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
161181647|NCT00887822|582043365|FG000|Overall Study|Administrative/Other than specified|5|||
161181648|NCT00887822|582043366|FG001|Overall Study|Administrative/Other than specified|4|||
161181649|NCT00887822|582043365|FG000|Overall Study|Death|2|||
161181650|NCT00887822|582043366|FG001|Overall Study|Death|3|||
161181651|NCT00887822|582043365|FG000|Overall Study|Protocol Violation|0|||
161181652|NCT00887822|582043366|FG001|Overall Study|Protocol Violation|1|||
161181653|NCT00887822|582043365|FG000|Overall Study|Randomized but not treated|0|||
161181654|NCT00887822|582043366|FG001|Overall Study|Randomized but not treated|1|||
161181655|NCT02045979|582043370|FG000|Overall Study|Informed Consent Withdrawn|2|||
161181656|NCT02045979|582043371|FG001|Overall Study|Informed Consent Withdrawn|0|||
161181657|NCT02045979|582043372|FG002|Overall Study|Informed Consent Withdrawn|1|||
161181658|NCT02045979|582043370|FG000|Overall Study|not specified above|0|||
161181659|NCT02045979|582043371|FG001|Overall Study|not specified above|1|||
161181660|NCT02045979|582043372|FG002|Overall Study|not specified above|0|||
161181661|NCT00378534|582043378|FG000|Overall Study|Participants did not receive transplant|3|||
161181662|NCT00378534|582043379|FG001|Overall Study|Participants did not receive transplant|0|||
161181663|NCT00425945|582043383|FG000|Overall Study|Concern about Supplement|2|||
161181664|NCT00425945|582043384|FG001|Overall Study|Concern about Supplement|0|||
161181665|NCT00425945|582043383|FG000|Overall Study|Inconvenience|0|||
161181666|NCT00425945|582043384|FG001|Overall Study|Inconvenience|2|||
161181667|NCT00425945|582043383|FG000|Overall Study|Lost to Follow-up|0|||
161181668|NCT00425945|582043384|FG001|Overall Study|Lost to Follow-up|2|||
161181669|NCT00425945|582043383|FG000|Overall Study|Began hypertension medication|1|||
161181670|NCT00425945|582043384|FG001|Overall Study|Began hypertension medication|0|||
161181671|NCT00425945|582043383|FG000|Overall Study|Began cancer treatments|1|||
161181672|NCT00425945|582043384|FG001|Overall Study|Began cancer treatments|0|||
161181673|NCT00425945|582043383|FG000|Overall Study|Moved from area|0|||
161181674|NCT00425945|582043384|FG001|Overall Study|Moved from area|1|||
161181675|NCT03878160|582043388|FG000|Overall Study|Lost to Follow-up|1|||
161181676|NCT03878160|582043389|FG001|Overall Study|Lost to Follow-up|1|||
161181677|NCT03878160|582043390|FG002|Overall Study|Lost to Follow-up|1|||
161181678|NCT03878160|582043388|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
161181679|NCT03878160|582043389|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
161181680|NCT03878160|582043390|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
161181681|NCT05618808|582043391|FG000|Overall Study|Withdrawal by Subject|3|||
161181682|NCT05618808|582043392|FG001|Overall Study|Withdrawal by Subject|1|||
161181683|NCT05618808|582043393|FG002|Overall Study|Withdrawal by Subject|3|||
161181684|NCT02365506|582043394|FG000|Overall Study|Investigator's Discretion|0|||
161299392|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161299393|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
161181685|NCT02365506|582043395|FG001|Overall Study|Investigator's Discretion|0|||
161181686|NCT02365506|582043396|FG002|Overall Study|Investigator's Discretion|1|||
161181687|NCT06048367|582043399|FG000|Overall Study|Withdrawal by Subject|0|||
161181688|NCT06048367|582043400|FG001|Overall Study|Withdrawal by Subject|1|||
161181689|NCT06048367|582043401|FG002|Overall Study|Withdrawal by Subject|0|||
161181690|NCT06048367|582043402|FG003|Overall Study|Withdrawal by Subject|0|||
161181691|NCT06048367|582043403|FG004|Overall Study|Withdrawal by Subject|0|||
161181692|NCT06048367|582043399|FG000|Overall Study|Withdrawal by Subject|0|||
161181693|NCT06048367|582043400|FG001|Overall Study|Withdrawal by Subject|0|||
161181694|NCT06048367|582043401|FG002|Overall Study|Withdrawal by Subject|1|||
161181695|NCT06048367|582043402|FG003|Overall Study|Withdrawal by Subject|0|||
161299394|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
161299395|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
161299396|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
161299397|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
161299398|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
161299399|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
161299400|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
161299401|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
161299402|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
161299403|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
161299404|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
161299405|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
161299406|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
161299407|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
161299408|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
161299409|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
161299410|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
161299411|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
161299412|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
161299413|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
161299414|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
161299415|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
161299416|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
161299417|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
161299418|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
161299419|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
161299420|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
161299421|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
161299422|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
161299423|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
161299424|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
161299425|NCT00839527|582479020|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
161299426|NCT00839527|582479021|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
161299427|NCT00839527|582479022|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
161299428|NCT02751450|582479023|FG000|Overall Study|Adverse Event|1|||
161299429|NCT02751450|582479024|FG001|Overall Study|Adverse Event|0|||
161299430|NCT02587598|582479025|FG000|Overall Study|Death|4|||
161299431|NCT02587598|582479026|FG001|Overall Study|Death|8|||
161299432|NCT02587598|582479027|FG002|Overall Study|Death|4|||
161299433|NCT02587598|582479028|FG003|Overall Study|Death|16|||
161299434|NCT02587598|582479029|FG004|Overall Study|Death|9|||
161299435|NCT02587598|582479030|FG005|Overall Study|Death|4|||
161299436|NCT02587598|582479031|FG006|Overall Study|Death|6|||
161299437|NCT02587598|582479032|FG007|Overall Study|Death|7|||
161299438|NCT02587598|582479033|FG008|Overall Study|Death|9|||
161299439|NCT02587598|582479034|FG009|Overall Study|Death|1|||
161299440|NCT02587598|582479035|FG010|Overall Study|Death|3|||
161299441|NCT02587598|582479025|FG000|Overall Study|Study Terminated by the Sponsor|0|||
161299442|NCT02587598|582479026|FG001|Overall Study|Study Terminated by the Sponsor|1|||
161299443|NCT02587598|582479027|FG002|Overall Study|Study Terminated by the Sponsor|0|||
161299444|NCT02587598|582479028|FG003|Overall Study|Study Terminated by the Sponsor|3|||
161299445|NCT02587598|582479029|FG004|Overall Study|Study Terminated by the Sponsor|0|||
161299446|NCT02587598|582479030|FG005|Overall Study|Study Terminated by the Sponsor|1|||
161299447|NCT02587598|582479031|FG006|Overall Study|Study Terminated by the Sponsor|0|||
161299448|NCT02587598|582479032|FG007|Overall Study|Study Terminated by the Sponsor|0|||
161299449|NCT02587598|582479033|FG008|Overall Study|Study Terminated by the Sponsor|0|||
161299450|NCT02587598|582479034|FG009|Overall Study|Study Terminated by the Sponsor|1|||
161299451|NCT02587598|582479035|FG010|Overall Study|Study Terminated by the Sponsor|6|||
161299452|NCT02587598|582479025|FG000|Overall Study|Reason for study withdrawal not specified|0|||
161299453|NCT02587598|582479026|FG001|Overall Study|Reason for study withdrawal not specified|1|||
161299454|NCT02587598|582479027|FG002|Overall Study|Reason for study withdrawal not specified|0|||
161299455|NCT02587598|582479028|FG003|Overall Study|Reason for study withdrawal not specified|0|||
161299456|NCT02587598|582479029|FG004|Overall Study|Reason for study withdrawal not specified|0|||
161299457|NCT02587598|582479030|FG005|Overall Study|Reason for study withdrawal not specified|0|||
161299458|NCT02587598|582479031|FG006|Overall Study|Reason for study withdrawal not specified|0|||
161299459|NCT02587598|582479032|FG007|Overall Study|Reason for study withdrawal not specified|0|||
161299460|NCT02587598|582479033|FG008|Overall Study|Reason for study withdrawal not specified|0|||
161299461|NCT02587598|582479034|FG009|Overall Study|Reason for study withdrawal not specified|0|||
161299462|NCT02587598|582479035|FG010|Overall Study|Reason for study withdrawal not specified|0|||
161181696|NCT06048367|582043403|FG004|Overall Study|Withdrawal by Subject|0|||
161181697|NCT06048367|582043399|FG000|Overall Study|Withdrawal by Subject|0|||
161181698|NCT06048367|582043400|FG001|Overall Study|Withdrawal by Subject|0|||
161181699|NCT06048367|582043401|FG002|Overall Study|Withdrawal by Subject|0|||
161181700|NCT06048367|582043402|FG003|Overall Study|Withdrawal by Subject|1|||
161181701|NCT06048367|582043403|FG004|Overall Study|Withdrawal by Subject|0|||
161181702|NCT06048367|582043399|FG000|Overall Study|Withdrawal by Subject|0|||
161181703|NCT06048367|582043400|FG001|Overall Study|Withdrawal by Subject|0|||
161181704|NCT06048367|582043401|FG002|Overall Study|Withdrawal by Subject|0|||
161181705|NCT06048367|582043402|FG003|Overall Study|Withdrawal by Subject|1|||
161181706|NCT06048367|582043403|FG004|Overall Study|Withdrawal by Subject|0|||
161181707|NCT03287830|582043408|FG000|Overall Study|Withdrawal by Subject|1|||
161181708|NCT03287830|582043409|FG001|Overall Study|Withdrawal by Subject|1|||
161181709|NCT03287830|582043408|FG000|Overall Study|not meeting inclusion criteria|5|||
161181710|NCT03287830|582043409|FG001|Overall Study|not meeting inclusion criteria|12|||
161181711|NCT03598140|582043412|FG000|Overall Study|enrolled but didn't start|1|||
161181712|NCT03598140|582043413|FG001|Overall Study|enrolled but didn't start|0|||
161181713|NCT02155712|582043417|FG000|Overall Study|Death|12|||
161181714|NCT02155712|582043418|FG001|Overall Study|Death|0|||
161181715|NCT02155712|582043417|FG000|Overall Study|Lost to Follow-up|37|||
161181716|NCT02155712|582043418|FG001|Overall Study|Lost to Follow-up|22|||
161181717|NCT02155712|582043417|FG000|Overall Study|Revision of device|4|||
161181718|NCT02155712|582043418|FG001|Overall Study|Revision of device|3|||
161181719|NCT02155712|582043417|FG000|Overall Study|Withdrawal by Subject|39|||
161181720|NCT02155712|582043418|FG001|Overall Study|Withdrawal by Subject|21|||
161181721|NCT02155712|582043417|FG000|Overall Study|Site termination|77|||
161181722|NCT02155712|582043418|FG001|Overall Study|Site termination|19|||
161181723|NCT02155712|582043417|FG000|Overall Study|Sponsor terminated study early|150|||
161181724|NCT02155712|582043418|FG001|Overall Study|Sponsor terminated study early|0|||
161181725|NCT02155712|582043417|FG000|Overall Study|Missed final 5-year protocol visit|0|||
161181726|NCT02155712|582043418|FG001|Overall Study|Missed final 5-year protocol visit|32|||
161181727|NCT02155712|582043417|FG000|Overall Study|Censored because surgery cancelled|6|||
161181728|NCT02155712|582043418|FG001|Overall Study|Censored because surgery cancelled|10|||
161181729|NCT02155712|582043417|FG000|Overall Study|Censored because study device was not implanted|61|||
161181730|NCT02155712|582043418|FG001|Overall Study|Censored because study device was not implanted|66|||
161181731|NCT02155712|582043417|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
161181732|NCT02155712|582043418|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
161181733|NCT02060903|582043419|FG000|Overall Study|Lost to Follow-up|4|||
161181734|NCT02060903|582043420|FG001|Overall Study|Lost to Follow-up|0|||
161181735|NCT02060903|582043419|FG000|Overall Study|Withdrawal by Subject|0|||
161181736|NCT02060903|582043420|FG001|Overall Study|Withdrawal by Subject|7|||
161181737|NCT02418585|582043421|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
161181738|NCT02418585|582043422|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
161181739|NCT02418585|582043421|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
161181740|NCT02418585|582043422|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
161181741|NCT02418585|582043421|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
161181742|NCT02418585|582043422|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
161181743|NCT02418585|582043421|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
161181744|NCT02418585|582043422|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
161181745|NCT02418585|582043421|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
161181746|NCT02418585|582043422|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
161181747|NCT02418585|582043421|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
161181748|NCT02418585|582043422|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
161181749|NCT02418585|582043421|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
161181750|NCT02418585|582043422|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
161181751|NCT02418585|582043421|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
161181752|NCT02418585|582043422|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
161181753|NCT02418585|582043421|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
161181754|NCT02418585|582043422|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
161181755|NCT02418585|582043421|FG000|Follow-up Phase (24 Weeks)|Other|3|||
161181756|NCT02418585|582043422|FG001|Follow-up Phase (24 Weeks)|Other|2|||
161181757|NCT01688999|582043425|FG000|Overall Study|Withdrawal by Subject|5|||
161181758|NCT01688999|582043426|FG001|Overall Study|Withdrawal by Subject|1|||
161181759|NCT01688999|582043427|FG002|Overall Study|Withdrawal by Subject|1|||
161181760|NCT01688999|582043425|FG000|Overall Study|Adverse Event|2|||
161181761|NCT01688999|582043426|FG001|Overall Study|Adverse Event|0|||
161181762|NCT01688999|582043427|FG002|Overall Study|Adverse Event|2|||
161181763|NCT01688999|582043425|FG000|Overall Study|Ineligible/Not treated|1|||
161181764|NCT01688999|582043426|FG001|Overall Study|Ineligible/Not treated|0|||
161181765|NCT01688999|582043427|FG002|Overall Study|Ineligible/Not treated|0|||
161181766|NCT02768103|582043428|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
161181767|NCT00498368|582043456|FG000|Overall Study|Withdrawal by Subject|3|||
161181768|NCT00498368|582043457|FG001|Overall Study|Withdrawal by Subject|2|||
161299463|NCT02587598|582479025|FG000|Overall Study|Withdrawal by Subject|0|||
161299464|NCT02587598|582479026|FG001|Overall Study|Withdrawal by Subject|1|||
161299465|NCT02587598|582479027|FG002|Overall Study|Withdrawal by Subject|0|||
161299466|NCT02587598|582479028|FG003|Overall Study|Withdrawal by Subject|2|||
161299467|NCT02587598|582479029|FG004|Overall Study|Withdrawal by Subject|3|||
161299468|NCT02587598|582479030|FG005|Overall Study|Withdrawal by Subject|1|||
161299469|NCT02587598|582479031|FG006|Overall Study|Withdrawal by Subject|0|||
161299470|NCT02587598|582479032|FG007|Overall Study|Withdrawal by Subject|0|||
161299471|NCT02587598|582479033|FG008|Overall Study|Withdrawal by Subject|0|||
161299472|NCT02587598|582479034|FG009|Overall Study|Withdrawal by Subject|1|||
161299473|NCT02587598|582479035|FG010|Overall Study|Withdrawal by Subject|2|||
161299474|NCT02587598|582479025|FG000|Overall Study|Physician Decision|0|||
161299475|NCT02587598|582479026|FG001|Overall Study|Physician Decision|0|||
161299476|NCT02587598|582479027|FG002|Overall Study|Physician Decision|0|||
161299477|NCT02587598|582479028|FG003|Overall Study|Physician Decision|0|||
161299478|NCT02587598|582479029|FG004|Overall Study|Physician Decision|0|||
161299479|NCT02587598|582479030|FG005|Overall Study|Physician Decision|0|||
161299480|NCT02587598|582479031|FG006|Overall Study|Physician Decision|0|||
161299481|NCT02587598|582479032|FG007|Overall Study|Physician Decision|0|||
161299482|NCT02587598|582479033|FG008|Overall Study|Physician Decision|0|||
161299483|NCT02587598|582479034|FG009|Overall Study|Physician Decision|0|||
161299484|NCT02587598|582479035|FG010|Overall Study|Physician Decision|3|||
161299485|NCT00679289|582479036|FG000|Overall Study|Progressive disease|4|||
161299486|NCT00679289|582479037|FG001|Overall Study|Progressive disease|5|||
161299487|NCT00679289|582479038|FG002|Overall Study|Progressive disease|18|||
161299488|NCT00679289|582479036|FG000|Overall Study|Withdrawal by Subject|0|||
161299489|NCT00679289|582479037|FG001|Overall Study|Withdrawal by Subject|1|||
161299490|NCT00679289|582479038|FG002|Overall Study|Withdrawal by Subject|1|||
161299491|NCT00679289|582479036|FG000|Overall Study|Adverse Event|0|||
161299492|NCT00679289|582479037|FG001|Overall Study|Adverse Event|0|||
161299493|NCT00679289|582479038|FG002|Overall Study|Adverse Event|3|||
161299494|NCT00679289|582479036|FG000|Overall Study|Physician Decision|1|||
161299495|NCT00679289|582479037|FG001|Overall Study|Physician Decision|0|||
161299496|NCT00679289|582479038|FG002|Overall Study|Physician Decision|1|||
161299497|NCT00937040|582479039|FG000|Overall Study|Adverse Event|5|||
161299498|NCT00937040|582479040|FG001|Overall Study|Adverse Event|8|||
161299499|NCT00937040|582479039|FG000|Overall Study|Lost to Follow-up|12|||
161299500|NCT00937040|582479040|FG001|Overall Study|Lost to Follow-up|12|||
161299501|NCT00937040|582479039|FG000|Overall Study|Protocol Violation|3|||
161299502|NCT00937040|582479040|FG001|Overall Study|Protocol Violation|0|||
161299503|NCT00937040|582479039|FG000|Overall Study|Withdrawal by Subject|13|||
161299504|NCT00937040|582479040|FG001|Overall Study|Withdrawal by Subject|7|||
161347856|NCT02903914|582657365|FG004|Overall Study|Clinical Disease Progression|0|||
161181769|NCT02266004|582043458|FG000|Overall Study|unrelated adverse event|1|||
161181770|NCT02266004|582043458|FG000|Overall Study|Physician Decision|1|||
161181771|NCT00537771|582043462|FG000|Overall Study|Withdrawal by Subject|6|||
161181772|NCT00537771|582043463|FG001|Overall Study|Withdrawal by Subject|23|||
161181773|NCT00537771|582043462|FG000|Overall Study|Adverse Event|8|||
161181774|NCT00537771|582043463|FG001|Overall Study|Adverse Event|15|||
161181775|NCT00537771|582043462|FG000|Overall Study|Lost to Follow-up|9|||
161181776|NCT00537771|582043463|FG001|Overall Study|Lost to Follow-up|15|||
161181777|NCT00537771|582043462|FG000|Overall Study|Protocol Violation|2|||
161181778|NCT00537771|582043463|FG001|Overall Study|Protocol Violation|6|||
161181779|NCT00537771|582043462|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
161181780|NCT00537771|582043463|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
161181781|NCT02465489|582043466|FG000|Overall Study|Adverse Event|5|||
161181782|NCT02148952|582043469|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
161181783|NCT02148952|582043470|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
161181784|NCT02148952|582043469|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
161181785|NCT02148952|582043470|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
161181786|NCT02148952|582043469|FG000|Follow-Up|Lost to Follow-up|219|||
161181787|NCT02148952|582043470|FG001|Follow-Up|Lost to Follow-up|231|||
161181788|NCT02148952|582043469|FG000|Follow-Up|Withdrawal by Subject|46|||
161299505|NCT00937040|582479039|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
161299506|NCT00937040|582479040|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
161299507|NCT00937040|582479039|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
161299508|NCT00937040|582479040|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
161299509|NCT02477826|582479041|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
161299510|NCT02477826|582479042|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
161181789|NCT02148952|582043470|FG001|Follow-Up|Withdrawal by Subject|48|||
161181790|NCT00118040|582043471|FG000|Overall Study|Adverse Event|0|||
161181791|NCT00118040|582043472|FG001|Overall Study|Adverse Event|1|||
161181792|NCT00118040|582043473|FG002|Overall Study|Adverse Event|0|||
161299511|NCT02477826|582479043|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
161299512|NCT02477826|582479044|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
161299513|NCT02477826|582479045|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
161299514|NCT02477826|582479046|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
161299515|NCT02477826|582479047|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
161299516|NCT02477826|582479048|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
161299517|NCT02477826|582479049|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
161299518|NCT02477826|582479050|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
161299519|NCT02477826|582479041|FG000|Pre-Treatment|Other reasons|4|||
161299520|NCT02477826|582479042|FG001|Pre-Treatment|Other reasons|1|||
161299521|NCT02477826|582479043|FG002|Pre-Treatment|Other reasons|4|||
161299522|NCT02477826|582479044|FG003|Pre-Treatment|Other reasons|1|||
161299523|NCT02477826|582479045|FG004|Pre-Treatment|Other reasons|4|||
161299524|NCT02477826|582479046|FG005|Pre-Treatment|Other reasons|2|||
161299525|NCT02477826|582479047|FG006|Pre-Treatment|Other reasons|0|||
161299526|NCT02477826|582479048|FG007|Pre-Treatment|Other reasons|0|||
161299527|NCT02477826|582479049|FG008|Pre-Treatment|Other reasons|0|||
161299528|NCT02477826|582479050|FG009|Pre-Treatment|Other reasons|0|||
161299529|NCT02477826|582479041|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
161299530|NCT02477826|582479042|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
161299531|NCT02477826|582479043|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
161299532|NCT02477826|582479044|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
161299533|NCT02477826|582479045|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
161299534|NCT02477826|582479046|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
161299535|NCT02477826|582479047|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
161299536|NCT02477826|582479048|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
161299537|NCT02477826|582479049|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
161299538|NCT02477826|582479050|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
161299539|NCT02477826|582479041|FG000|Pre-Treatment|Subject withdrew consent|0|||
161299540|NCT02477826|582479042|FG001|Pre-Treatment|Subject withdrew consent|0|||
161299541|NCT02477826|582479043|FG002|Pre-Treatment|Subject withdrew consent|3|||
161299542|NCT02477826|582479044|FG003|Pre-Treatment|Subject withdrew consent|0|||
161299543|NCT02477826|582479045|FG004|Pre-Treatment|Subject withdrew consent|0|||
161299544|NCT02477826|582479046|FG005|Pre-Treatment|Subject withdrew consent|1|||
161299545|NCT02477826|582479047|FG006|Pre-Treatment|Subject withdrew consent|0|||
161299546|NCT02477826|582479048|FG007|Pre-Treatment|Subject withdrew consent|1|||
161299547|NCT02477826|582479049|FG008|Pre-Treatment|Subject withdrew consent|0|||
161299548|NCT02477826|582479050|FG009|Pre-Treatment|Subject withdrew consent|3|||
161299549|NCT02477826|582479041|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299550|NCT02477826|582479042|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
161299551|NCT02477826|582479043|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299552|NCT02477826|582479044|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299553|NCT02477826|582479045|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299554|NCT02477826|582479046|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299555|NCT02477826|582479047|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299556|NCT02477826|582479048|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
161299557|NCT02477826|582479049|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
161181793|NCT00118040|582043471|FG000|Overall Study|Withdrawal by Subject|0|||
161181794|NCT00118040|582043472|FG001|Overall Study|Withdrawal by Subject|0|||
161181795|NCT00118040|582043473|FG002|Overall Study|Withdrawal by Subject|2|||
161181796|NCT00118040|582043471|FG000|Overall Study|Medical Contraindication|0|||
161181797|NCT00118040|582043472|FG001|Overall Study|Medical Contraindication|0|||
161181798|NCT00118040|582043473|FG002|Overall Study|Medical Contraindication|1|||
161181799|NCT00118040|582043471|FG000|Overall Study|Non-Compliant Participant|1|||
161181800|NCT00118040|582043472|FG001|Overall Study|Non-Compliant Participant|1|||
161181801|NCT00118040|582043473|FG002|Overall Study|Non-Compliant Participant|2|||
161299558|NCT02477826|582479050|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
161299559|NCT02477826|582479041|FG000|Pre-Treatment|Death|0|||
161299560|NCT02477826|582479042|FG001|Pre-Treatment|Death|0|||
161299561|NCT02477826|582479043|FG002|Pre-Treatment|Death|0|||
161299562|NCT02477826|582479044|FG003|Pre-Treatment|Death|0|||
161299563|NCT02477826|582479045|FG004|Pre-Treatment|Death|0|||
161299564|NCT02477826|582479046|FG005|Pre-Treatment|Death|0|||
161299565|NCT02477826|582479047|FG006|Pre-Treatment|Death|1|||
161299566|NCT02477826|582479048|FG007|Pre-Treatment|Death|0|||
161299567|NCT02477826|582479049|FG008|Pre-Treatment|Death|0|||
161299568|NCT02477826|582479050|FG009|Pre-Treatment|Death|0|||
161299569|NCT02477826|582479041|FG000|Treatment Period|Not reported|8|||
161299570|NCT02477826|582479042|FG001|Treatment Period|Not reported|6|||
161299571|NCT02477826|582479043|FG002|Treatment Period|Not reported|4|||
161299572|NCT02477826|582479044|FG003|Treatment Period|Not reported|4|||
161299573|NCT02477826|582479045|FG004|Treatment Period|Not reported|2|||
161299574|NCT02477826|582479046|FG005|Treatment Period|Not reported|1|||
161181802|NCT00118040|582043471|FG000|Overall Study|Other|0|||
161181803|NCT00118040|582043472|FG001|Overall Study|Other|0|||
161181804|NCT00118040|582043473|FG002|Overall Study|Other|1|||
161181805|NCT03733249|582043474|FG000|Overall Study|Death|7|||
161181806|NCT03733249|582043474|FG000|Overall Study|Disease relapse|16|||
161181807|NCT03733249|582043474|FG000|Overall Study|Lost to Follow-up|4|||
161181808|NCT03733249|582043474|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
161181809|NCT03733249|582043474|FG000|Overall Study|Withdrawal by Subject|1|||
161181810|NCT04476108|582043475|FG000|Overall Study|Adverse Event|4|||
161181811|NCT04476108|582043476|FG001|Overall Study|Adverse Event|1|||
161181812|NCT04476108|582043475|FG000|Overall Study|Lost to Follow-up|1|||
161181813|NCT04476108|582043476|FG001|Overall Study|Lost to Follow-up|0|||
161181814|NCT04476108|582043475|FG000|Overall Study|Inadvertent Enrollment|1|||
161181815|NCT04476108|582043476|FG001|Overall Study|Inadvertent Enrollment|0|||
161181816|NCT04476108|582043475|FG000|Overall Study|Protocol Violation|1|||
161181817|NCT04476108|582043476|FG001|Overall Study|Protocol Violation|1|||
161181818|NCT04476108|582043475|FG000|Overall Study|Withdrawal by Subject|1|||
161181819|NCT04476108|582043476|FG001|Overall Study|Withdrawal by Subject|1|||
161181820|NCT00850135|582043477|FG000|Overall Study|Physician Decision|1|||
161181821|NCT02253992|582043478|FG000|Overall Study|Study drug toxicity|1|||
161181822|NCT02253992|582043479|FG001|Overall Study|Study drug toxicity|0|||
161181823|NCT02253992|582043480|FG002|Overall Study|Study drug toxicity|10|||
161181824|NCT02253992|582043478|FG000|Overall Study|Disease progression|4|||
161181825|NCT02253992|582043479|FG001|Overall Study|Disease progression|3|||
161181826|NCT02253992|582043480|FG002|Overall Study|Disease progression|98|||
161181827|NCT02253992|582043478|FG000|Overall Study|Withdrawal by Subject|0|||
161181828|NCT02253992|582043479|FG001|Overall Study|Withdrawal by Subject|0|||
161181829|NCT02253992|582043480|FG002|Overall Study|Withdrawal by Subject|3|||
161181830|NCT02253992|582043478|FG000|Overall Study|Adverse Event|0|||
161181831|NCT02253992|582043479|FG001|Overall Study|Adverse Event|0|||
161181832|NCT02253992|582043480|FG002|Overall Study|Adverse Event|8|||
161181833|NCT02253992|582043478|FG000|Overall Study|Death|0|||
161181834|NCT02253992|582043479|FG001|Overall Study|Death|0|||
161181835|NCT02253992|582043480|FG002|Overall Study|Death|1|||
161181836|NCT02253992|582043478|FG000|Overall Study|Subject discontinued study drug|1|||
161181837|NCT02253992|582043479|FG001|Overall Study|Subject discontinued study drug|0|||
161181838|NCT02253992|582043480|FG002|Overall Study|Subject discontinued study drug|1|||
161181839|NCT02253992|582043478|FG000|Overall Study|Completed treatment as per protocol|0|||
161181840|NCT02253992|582043479|FG001|Overall Study|Completed treatment as per protocol|1|||
161181841|NCT02253992|582043480|FG002|Overall Study|Completed treatment as per protocol|22|||
161181842|NCT02253992|582043478|FG000|Overall Study|Other|0|||
161181843|NCT02253992|582043479|FG001|Overall Study|Other|0|||
161181844|NCT02253992|582043480|FG002|Overall Study|Other|1|||
161181845|NCT03198728|582043481|FG000|Overall Study|Adverse Event|10|||
161181846|NCT03198728|582043482|FG001|Overall Study|Adverse Event|5|||
161181847|NCT03198728|582043481|FG000|Overall Study|Lost to Follow-up|21|||
161181848|NCT03198728|582043482|FG001|Overall Study|Lost to Follow-up|7|||
161181849|NCT03198728|582043481|FG000|Overall Study|Physician Decision|7|||
161181850|NCT03198728|582043482|FG001|Overall Study|Physician Decision|2|||
161181851|NCT03198728|582043481|FG000|Overall Study|Withdrawal by Subject|14|||
161181852|NCT03198728|582043482|FG001|Overall Study|Withdrawal by Subject|10|||
161181853|NCT04051944|582043483|FG000|Overall Study|Study ending|1|||
161181854|NCT04051944|582043484|FG001|Overall Study|Study ending|1|||
161181855|NCT04051944|582043483|FG000|Overall Study|Early study termination by participant|1|||
161181856|NCT04051944|582043484|FG001|Overall Study|Early study termination by participant|0|||
161181857|NCT04051944|582043483|FG000|Overall Study|Withdrawal by Subject|2|||
161181858|NCT04051944|582043484|FG001|Overall Study|Withdrawal by Subject|2|||
161181859|NCT04051944|582043483|FG000|Overall Study|Lack of Efficacy|3|||
161181860|NCT04051944|582043484|FG001|Overall Study|Lack of Efficacy|0|||
161181861|NCT04051944|582043483|FG000|Overall Study|Adverse event, non- fatal|1|||
161181862|NCT04051944|582043484|FG001|Overall Study|Adverse event, non- fatal|1|||
161181863|NCT03083470|582043485|FG000|Overall Study|Lost to Follow-up|0|||
161181864|NCT03083470|582043486|FG001|Overall Study|Lost to Follow-up|0|||
161181865|NCT03083470|582043487|FG002|Overall Study|Lost to Follow-up|0|||
161181866|NCT03083470|582043488|FG003|Overall Study|Lost to Follow-up|0|||
161181867|NCT03083470|582043489|FG004|Overall Study|Lost to Follow-up|1|||
161181868|NCT03083470|582043485|FG000|Overall Study|Withdrawal by Subject|0|||
161181869|NCT03083470|582043486|FG001|Overall Study|Withdrawal by Subject|0|||
161181870|NCT03083470|582043487|FG002|Overall Study|Withdrawal by Subject|0|||
161181871|NCT03083470|582043488|FG003|Overall Study|Withdrawal by Subject|0|||
161181872|NCT03083470|582043489|FG004|Overall Study|Withdrawal by Subject|1|||
161181873|NCT01512693|582043490|FG000|Overall Study|Withdrawal by Subject|0|||
161181874|NCT01512693|582043491|FG001|Overall Study|Withdrawal by Subject|1|||
161181875|NCT02139280|582043492|FG000|Overall Study|No longer eligible|2|||
161181876|NCT02139280|582043493|FG001|Overall Study|No longer eligible|0|||
161181877|NCT00736450|582043500|FG000|Overall Study|Not ABC gene eligible|19|||
161181878|NCT00736450|582043500|FG000|Overall Study|Withdrawal by Subject|5|||
161181879|NCT00736450|582043500|FG000|Overall Study|Physician Decision|1|||
161181880|NCT04731922|582043504|FG000|Overall Study|Adverse Event|0|||
161181881|NCT04731922|582043505|FG001|Overall Study|Adverse Event|0|||
161181882|NCT04731922|582043506|FG002|Overall Study|Adverse Event|0|||
161181883|NCT04731922|582043507|FG003|Overall Study|Adverse Event|0|||
161299575|NCT02477826|582479047|FG006|Treatment Period|Not reported|14|||
161299576|NCT02477826|582479048|FG007|Treatment Period|Not reported|8|||
161299577|NCT02477826|582479049|FG008|Treatment Period|Not reported|5|||
161299578|NCT02477826|582479050|FG009|Treatment Period|Not reported|2|||
161299579|NCT02477826|582479041|FG000|Treatment Period|Other reasons|5|||
161299580|NCT02477826|582479042|FG001|Treatment Period|Other reasons|6|||
161299581|NCT02477826|582479043|FG002|Treatment Period|Other reasons|12|||
161299582|NCT02477826|582479044|FG003|Treatment Period|Other reasons|7|||
161299583|NCT02477826|582479045|FG004|Treatment Period|Other reasons|5|||
161299584|NCT02477826|582479046|FG005|Treatment Period|Other reasons|1|||
161299585|NCT02477826|582479047|FG006|Treatment Period|Other reasons|8|||
161299586|NCT02477826|582479048|FG007|Treatment Period|Other reasons|8|||
161299587|NCT02477826|582479049|FG008|Treatment Period|Other reasons|21|||
161299588|NCT02477826|582479050|FG009|Treatment Period|Other reasons|1|||
161299589|NCT02477826|582479041|FG000|Treatment Period|Administrative reason by sponsor|0|||
161299590|NCT02477826|582479042|FG001|Treatment Period|Administrative reason by sponsor|3|||
161299591|NCT02477826|582479043|FG002|Treatment Period|Administrative reason by sponsor|0|||
161299592|NCT02477826|582479044|FG003|Treatment Period|Administrative reason by sponsor|0|||
161299593|NCT02477826|582479045|FG004|Treatment Period|Administrative reason by sponsor|0|||
161299594|NCT02477826|582479046|FG005|Treatment Period|Administrative reason by sponsor|0|||
161299595|NCT02477826|582479047|FG006|Treatment Period|Administrative reason by sponsor|0|||
161299596|NCT02477826|582479048|FG007|Treatment Period|Administrative reason by sponsor|0|||
161299597|NCT02477826|582479049|FG008|Treatment Period|Administrative reason by sponsor|0|||
161299598|NCT02477826|582479050|FG009|Treatment Period|Administrative reason by sponsor|0|||
161299599|NCT02477826|582479041|FG000|Treatment Period|Participant meet no longer study criteria|1|||
161299600|NCT02477826|582479042|FG001|Treatment Period|Participant meet no longer study criteria|1|||
161299601|NCT02477826|582479043|FG002|Treatment Period|Participant meet no longer study criteria|0|||
161299602|NCT02477826|582479044|FG003|Treatment Period|Participant meet no longer study criteria|0|||
161299603|NCT02477826|582479045|FG004|Treatment Period|Participant meet no longer study criteria|1|||
161299604|NCT02477826|582479046|FG005|Treatment Period|Participant meet no longer study criteria|1|||
161299605|NCT02477826|582479047|FG006|Treatment Period|Participant meet no longer study criteria|0|||
161299606|NCT02477826|582479048|FG007|Treatment Period|Participant meet no longer study criteria|1|||
161299607|NCT02477826|582479049|FG008|Treatment Period|Participant meet no longer study criteria|0|||
161299608|NCT02477826|582479050|FG009|Treatment Period|Participant meet no longer study criteria|0|||
161299609|NCT02477826|582479041|FG000|Treatment Period|Poor/Non Compliance|1|||
161299610|NCT02477826|582479042|FG001|Treatment Period|Poor/Non Compliance|0|||
161299611|NCT02477826|582479043|FG002|Treatment Period|Poor/Non Compliance|2|||
161299612|NCT02477826|582479044|FG003|Treatment Period|Poor/Non Compliance|0|||
161299613|NCT02477826|582479045|FG004|Treatment Period|Poor/Non Compliance|0|||
161299614|NCT02477826|582479046|FG005|Treatment Period|Poor/Non Compliance|1|||
161299615|NCT02477826|582479047|FG006|Treatment Period|Poor/Non Compliance|1|||
161299616|NCT02477826|582479048|FG007|Treatment Period|Poor/Non Compliance|0|||
161299617|NCT02477826|582479049|FG008|Treatment Period|Poor/Non Compliance|0|||
161299618|NCT02477826|582479050|FG009|Treatment Period|Poor/Non Compliance|1|||
161299619|NCT02477826|582479041|FG000|Treatment Period|Maximum Clinical Benefit|3|||
161299620|NCT02477826|582479042|FG001|Treatment Period|Maximum Clinical Benefit|3|||
161299621|NCT02477826|582479043|FG002|Treatment Period|Maximum Clinical Benefit|1|||
161299622|NCT02477826|582479044|FG003|Treatment Period|Maximum Clinical Benefit|1|||
161299623|NCT02477826|582479045|FG004|Treatment Period|Maximum Clinical Benefit|3|||
161299624|NCT02477826|582479046|FG005|Treatment Period|Maximum Clinical Benefit|0|||
161299625|NCT02477826|582479047|FG006|Treatment Period|Maximum Clinical Benefit|3|||
161299626|NCT02477826|582479048|FG007|Treatment Period|Maximum Clinical Benefit|2|||
161299627|NCT02477826|582479049|FG008|Treatment Period|Maximum Clinical Benefit|2|||
161299628|NCT02477826|582479050|FG009|Treatment Period|Maximum Clinical Benefit|2|||
161299629|NCT02477826|582479041|FG000|Treatment Period|Lost to Follow-up|0|||
161299630|NCT02477826|582479042|FG001|Treatment Period|Lost to Follow-up|0|||
161299631|NCT02477826|582479043|FG002|Treatment Period|Lost to Follow-up|1|||
161299632|NCT02477826|582479044|FG003|Treatment Period|Lost to Follow-up|1|||
161299633|NCT02477826|582479045|FG004|Treatment Period|Lost to Follow-up|0|||
161299634|NCT02477826|582479046|FG005|Treatment Period|Lost to Follow-up|0|||
161089345|NCT01445301|581717347|FG001|Overall Study|Physician Decision|2|||
161299635|NCT02477826|582479047|FG006|Treatment Period|Lost to Follow-up|2|||
161299636|NCT02477826|582479048|FG007|Treatment Period|Lost to Follow-up|2|||
161299637|NCT02477826|582479049|FG008|Treatment Period|Lost to Follow-up|0|||
161299638|NCT02477826|582479050|FG009|Treatment Period|Lost to Follow-up|0|||
161299639|NCT02477826|582479041|FG000|Treatment Period|Participant withdrew Consent|5|||
161299640|NCT02477826|582479042|FG001|Treatment Period|Participant withdrew Consent|5|||
161299641|NCT02477826|582479043|FG002|Treatment Period|Participant withdrew Consent|3|||
161299642|NCT02477826|582479044|FG003|Treatment Period|Participant withdrew Consent|3|||
161299643|NCT02477826|582479045|FG004|Treatment Period|Participant withdrew Consent|1|||
161299644|NCT02477826|582479046|FG005|Treatment Period|Participant withdrew Consent|3|||
161299645|NCT02477826|582479047|FG006|Treatment Period|Participant withdrew Consent|3|||
161299646|NCT02477826|582479048|FG007|Treatment Period|Participant withdrew Consent|3|||
161299647|NCT02477826|582479049|FG008|Treatment Period|Participant withdrew Consent|2|||
161299648|NCT02477826|582479050|FG009|Treatment Period|Participant withdrew Consent|3|||
161299649|NCT02477826|582479041|FG000|Treatment Period|Participant request to discontinue treatment|5|||
161299650|NCT02477826|582479042|FG001|Treatment Period|Participant request to discontinue treatment|3|||
161299651|NCT02477826|582479043|FG002|Treatment Period|Participant request to discontinue treatment|15|||
161299652|NCT02477826|582479044|FG003|Treatment Period|Participant request to discontinue treatment|5|||
161299653|NCT02477826|582479045|FG004|Treatment Period|Participant request to discontinue treatment|3|||
161299654|NCT02477826|582479046|FG005|Treatment Period|Participant request to discontinue treatment|6|||
161299655|NCT02477826|582479047|FG006|Treatment Period|Participant request to discontinue treatment|13|||
161299656|NCT02477826|582479048|FG007|Treatment Period|Participant request to discontinue treatment|15|||
161299657|NCT02477826|582479049|FG008|Treatment Period|Participant request to discontinue treatment|4|||
161299658|NCT02477826|582479050|FG009|Treatment Period|Participant request to discontinue treatment|18|||
161299659|NCT02477826|582479041|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
161299660|NCT02477826|582479042|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
161299661|NCT02477826|582479043|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
161299662|NCT02477826|582479044|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
161299663|NCT02477826|582479045|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
161299664|NCT02477826|582479046|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
161299665|NCT02477826|582479047|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
161299666|NCT02477826|582479048|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
161299667|NCT02477826|582479049|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
161299668|NCT02477826|582479050|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
161299669|NCT02477826|582479041|FG000|Treatment Period|Death|4|||
161299670|NCT02477826|582479042|FG001|Treatment Period|Death|7|||
161299671|NCT02477826|582479043|FG002|Treatment Period|Death|0|||
161299672|NCT02477826|582479044|FG003|Treatment Period|Death|0|||
161299673|NCT02477826|582479045|FG004|Treatment Period|Death|1|||
161299674|NCT02477826|582479046|FG005|Treatment Period|Death|2|||
161299675|NCT02477826|582479047|FG006|Treatment Period|Death|6|||
161299676|NCT02477826|582479048|FG007|Treatment Period|Death|5|||
161299677|NCT02477826|582479049|FG008|Treatment Period|Death|9|||
161299678|NCT02477826|582479050|FG009|Treatment Period|Death|0|||
161299679|NCT02477826|582479041|FG000|Treatment Period|Study Drug Toxicity|79|||
161299680|NCT02477826|582479042|FG001|Treatment Period|Study Drug Toxicity|51|||
161299681|NCT02477826|582479043|FG002|Treatment Period|Study Drug Toxicity|31|||
161299682|NCT02477826|582479044|FG003|Treatment Period|Study Drug Toxicity|39|||
161299683|NCT02477826|582479045|FG004|Treatment Period|Study Drug Toxicity|12|||
161299684|NCT02477826|582479046|FG005|Treatment Period|Study Drug Toxicity|25|||
161299685|NCT02477826|582479047|FG006|Treatment Period|Study Drug Toxicity|52|||
161299686|NCT02477826|582479048|FG007|Treatment Period|Study Drug Toxicity|30|||
161299687|NCT02477826|582479049|FG008|Treatment Period|Study Drug Toxicity|20|||
161299688|NCT02477826|582479050|FG009|Treatment Period|Study Drug Toxicity|9|||
161299689|NCT02477826|582479041|FG000|Treatment Period|Disease progression|212|||
161299690|NCT02477826|582479042|FG001|Treatment Period|Disease progression|240|||
161299691|NCT02477826|582479043|FG002|Treatment Period|Disease progression|202|||
161299692|NCT02477826|582479044|FG003|Treatment Period|Disease progression|93|||
161299693|NCT02477826|582479045|FG004|Treatment Period|Disease progression|113|||
161299694|NCT02477826|582479046|FG005|Treatment Period|Disease progression|96|||
161299695|NCT02477826|582479047|FG006|Treatment Period|Disease progression|208|||
161299696|NCT02477826|582479048|FG007|Treatment Period|Disease progression|195|||
161299697|NCT02477826|582479049|FG008|Treatment Period|Disease progression|59|||
161299698|NCT02477826|582479050|FG009|Treatment Period|Disease progression|46|||
161299699|NCT02477826|582479041|FG000|Treatment Period|Pregnancy|0|||
161299700|NCT02477826|582479042|FG001|Treatment Period|Pregnancy|0|||
161299701|NCT02477826|582479043|FG002|Treatment Period|Pregnancy|0|||
161299702|NCT02477826|582479044|FG003|Treatment Period|Pregnancy|0|||
161299703|NCT02477826|582479045|FG004|Treatment Period|Pregnancy|0|||
161299704|NCT02477826|582479046|FG005|Treatment Period|Pregnancy|0|||
161299705|NCT02477826|582479047|FG006|Treatment Period|Pregnancy|0|||
161299706|NCT02477826|582479048|FG007|Treatment Period|Pregnancy|0|||
161299707|NCT02477826|582479049|FG008|Treatment Period|Pregnancy|0|||
161299708|NCT02477826|582479050|FG009|Treatment Period|Pregnancy|1|||
161299709|NCT02477826|582479041|FG000|Treatment Period|Other|0|||
161299710|NCT02477826|582479042|FG001|Treatment Period|Other|0|||
161299711|NCT02477826|582479043|FG002|Treatment Period|Other|0|||
161299712|NCT02477826|582479044|FG003|Treatment Period|Other|0|||
161299713|NCT02477826|582479045|FG004|Treatment Period|Other|0|||
161299714|NCT02477826|582479046|FG005|Treatment Period|Other|0|||
161299715|NCT02477826|582479047|FG006|Treatment Period|Other|0|||
161299716|NCT02477826|582479048|FG007|Treatment Period|Other|0|||
161299717|NCT02477826|582479049|FG008|Treatment Period|Other|0|||
161299718|NCT02477826|582479050|FG009|Treatment Period|Other|1|||
161299719|NCT00403481|582479085|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
161299720|NCT00403481|582479085|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
161299721|NCT00403481|582479085|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
161181884|NCT04731922|582043508|FG004|Overall Study|Adverse Event|0|||
161181885|NCT04731922|582043509|FG005|Overall Study|Adverse Event|0|||
161181886|NCT04731922|582043510|FG006|Overall Study|Adverse Event|0|||
161181887|NCT04731922|582043511|FG007|Overall Study|Adverse Event|0|||
161181888|NCT04731922|582043512|FG008|Overall Study|Adverse Event|0|||
161181889|NCT04731922|582043513|FG009|Overall Study|Adverse Event|0|||
161181890|NCT04731922|582043514|FG010|Overall Study|Adverse Event|1|||
161181891|NCT04731922|582043515|FG011|Overall Study|Adverse Event|0|||
161181892|NCT04731922|582043516|FG012|Overall Study|Adverse Event|0|||
161181893|NCT04731922|582043517|FG013|Overall Study|Adverse Event|0|||
161181894|NCT04731922|582043518|FG014|Overall Study|Adverse Event|0|||
161181895|NCT04731922|582043519|FG015|Overall Study|Adverse Event|0|||
161181896|NCT04731922|582043520|FG016|Overall Study|Adverse Event|0|||
161181897|NCT04731922|582043504|FG000|Overall Study|Lost to Follow-up|0|||
161181898|NCT04731922|582043505|FG001|Overall Study|Lost to Follow-up|0|||
161181899|NCT04731922|582043506|FG002|Overall Study|Lost to Follow-up|0|||
161181900|NCT04731922|582043507|FG003|Overall Study|Lost to Follow-up|1|||
161181901|NCT04731922|582043508|FG004|Overall Study|Lost to Follow-up|0|||
161181902|NCT04731922|582043509|FG005|Overall Study|Lost to Follow-up|1|||
161181903|NCT04731922|582043510|FG006|Overall Study|Lost to Follow-up|0|||
161181904|NCT04731922|582043511|FG007|Overall Study|Lost to Follow-up|0|||
161181905|NCT04731922|582043512|FG008|Overall Study|Lost to Follow-up|0|||
161181906|NCT04731922|582043513|FG009|Overall Study|Lost to Follow-up|0|||
161181907|NCT04731922|582043514|FG010|Overall Study|Lost to Follow-up|0|||
161181908|NCT04731922|582043515|FG011|Overall Study|Lost to Follow-up|0|||
161181909|NCT04731922|582043516|FG012|Overall Study|Lost to Follow-up|0|||
161181910|NCT04731922|582043517|FG013|Overall Study|Lost to Follow-up|0|||
161181911|NCT04731922|582043518|FG014|Overall Study|Lost to Follow-up|0|||
161181912|NCT04731922|582043519|FG015|Overall Study|Lost to Follow-up|0|||
161181913|NCT04731922|582043520|FG016|Overall Study|Lost to Follow-up|0|||
161181914|NCT04731922|582043504|FG000|Overall Study|Withdrawal by Subject|1|||
161181915|NCT04731922|582043505|FG001|Overall Study|Withdrawal by Subject|0|||
161181916|NCT04731922|582043506|FG002|Overall Study|Withdrawal by Subject|0|||
161181917|NCT04731922|582043507|FG003|Overall Study|Withdrawal by Subject|0|||
161181918|NCT04731922|582043508|FG004|Overall Study|Withdrawal by Subject|1|||
161181919|NCT04731922|582043509|FG005|Overall Study|Withdrawal by Subject|0|||
161181920|NCT04731922|582043510|FG006|Overall Study|Withdrawal by Subject|1|||
161181921|NCT04731922|582043511|FG007|Overall Study|Withdrawal by Subject|0|||
161181922|NCT04731922|582043512|FG008|Overall Study|Withdrawal by Subject|0|||
161181923|NCT04731922|582043513|FG009|Overall Study|Withdrawal by Subject|0|||
161181924|NCT04731922|582043514|FG010|Overall Study|Withdrawal by Subject|0|||
161181925|NCT04731922|582043515|FG011|Overall Study|Withdrawal by Subject|0|||
161181926|NCT04731922|582043516|FG012|Overall Study|Withdrawal by Subject|0|||
161181927|NCT04731922|582043517|FG013|Overall Study|Withdrawal by Subject|1|||
161181928|NCT04731922|582043518|FG014|Overall Study|Withdrawal by Subject|0|||
161181929|NCT04731922|582043519|FG015|Overall Study|Withdrawal by Subject|0|||
161181930|NCT04731922|582043520|FG016|Overall Study|Withdrawal by Subject|0|||
161181931|NCT04731922|582043504|FG000|Overall Study|Other|0|||
161181932|NCT04731922|582043505|FG001|Overall Study|Other|0|||
161181933|NCT04731922|582043506|FG002|Overall Study|Other|0|||
161181934|NCT04731922|582043507|FG003|Overall Study|Other|0|||
161181935|NCT04731922|582043508|FG004|Overall Study|Other|0|||
161181936|NCT04731922|582043509|FG005|Overall Study|Other|0|||
161181937|NCT04731922|582043510|FG006|Overall Study|Other|1|||
161181938|NCT04731922|582043511|FG007|Overall Study|Other|0|||
161181939|NCT04731922|582043512|FG008|Overall Study|Other|0|||
161181940|NCT04731922|582043513|FG009|Overall Study|Other|0|||
161181941|NCT04731922|582043514|FG010|Overall Study|Other|0|||
161299722|NCT00403481|582479085|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
161299723|NCT00403481|582479085|FG000|Olm 40 mg|Adverse Event|2|||
161299724|NCT00403481|582479085|FG000|Olm 40 mg|Protocol Violation|1|||
161299725|NCT00403481|582479085|FG000|Olm 40 mg|Withdrawal by Subject|1|||
161181942|NCT04731922|582043515|FG011|Overall Study|Other|0|||
161181943|NCT04731922|582043516|FG012|Overall Study|Other|0|||
161181944|NCT04731922|582043517|FG013|Overall Study|Other|0|||
161181945|NCT04731922|582043518|FG014|Overall Study|Other|0|||
161181946|NCT04731922|582043519|FG015|Overall Study|Other|0|||
161181947|NCT04731922|582043520|FG016|Overall Study|Other|0|||
161181948|NCT04157751|582043521|FG000|Overall Study|Withdrawal by Subject|12|||
161181949|NCT04157751|582043522|FG001|Overall Study|Withdrawal by Subject|17|||
161181950|NCT04157751|582043521|FG000|Overall Study|Lost to Follow-up|6|||
161299726|NCT00403481|582479085|FG000|Olm 40 mg|Other|1|||
161181951|NCT04157751|582043522|FG001|Overall Study|Lost to Follow-up|2|||
161181952|NCT04157751|582043521|FG000|Overall Study|Adverse Event|34|||
161181953|NCT04157751|582043522|FG001|Overall Study|Adverse Event|23|||
161181954|NCT04157751|582043521|FG000|Overall Study|Not treated|1|||
161181955|NCT04157751|582043522|FG001|Overall Study|Not treated|5|||
161181956|NCT04157751|582043521|FG000|Overall Study|Other reason not stated above|10|||
161181957|NCT04157751|582043522|FG001|Overall Study|Other reason not stated above|10|||
161181958|NCT00981747|582043529|FG000|Losartan|Withdrawal by Subject|1|||
161299727|NCT00403481|582479085|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
161299728|NCT00403481|582479085|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
161299729|NCT00403481|582479085|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
161299730|NCT00403481|582479085|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
161299731|NCT00403481|582479085|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
161299732|NCT00403481|582479085|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
161299733|NCT02091089|582479086|FG000|Overall Study|Lost to Follow-up|2|||
161299734|NCT02929589|582479087|FG000|Overall Study|Withdrawal by Subject|1|||
161299735|NCT02929589|582479088|FG001|Overall Study|Withdrawal by Subject|0|||
161299736|NCT02929589|582479089|FG002|Overall Study|Withdrawal by Subject|0|||
161299737|NCT02929589|582479090|FG003|Overall Study|Withdrawal by Subject|0|||
161299738|NCT02929589|582479087|FG000|Overall Study|Physician Decision|2|||
161299739|NCT02929589|582479088|FG001|Overall Study|Physician Decision|0|||
161299740|NCT02929589|582479089|FG002|Overall Study|Physician Decision|0|||
161299741|NCT02929589|582479090|FG003|Overall Study|Physician Decision|0|||
161299742|NCT00766636|582479101|FG000|Overall Study|Withdrawal by Subject|1|||
161299743|NCT00766636|582479102|FG001|Overall Study|Withdrawal by Subject|1|||
161299744|NCT00766636|582479101|FG000|Overall Study|Incomplete Treatment|0|||
161299745|NCT00766636|582479102|FG001|Overall Study|Incomplete Treatment|1|||
161299746|NCT00766636|582479101|FG000|Overall Study|Adverse Event|1|||
161299747|NCT00766636|582479102|FG001|Overall Study|Adverse Event|0|||
161299748|NCT00766636|582479101|FG000|Overall Study|Disease Progression|1|||
161299749|NCT00766636|582479102|FG001|Overall Study|Disease Progression|0|||
161299750|NCT02477332|582479105|FG000|Overall Study|Adverse Event|0|||
161299751|NCT02477332|582479106|FG001|Overall Study|Adverse Event|1|||
161299752|NCT02477332|582479107|FG002|Overall Study|Adverse Event|1|||
161299753|NCT02477332|582479108|FG003|Overall Study|Adverse Event|2|||
161299754|NCT02477332|582479109|FG004|Overall Study|Adverse Event|1|||
161299755|NCT02477332|582479110|FG005|Overall Study|Adverse Event|2|||
161299756|NCT02477332|582479105|FG000|Overall Study|Lack of Efficacy|1|||
161299757|NCT02477332|582479106|FG001|Overall Study|Lack of Efficacy|2|||
161299758|NCT02477332|582479107|FG002|Overall Study|Lack of Efficacy|1|||
161299759|NCT02477332|582479108|FG003|Overall Study|Lack of Efficacy|2|||
161299760|NCT02477332|582479109|FG004|Overall Study|Lack of Efficacy|1|||
161299761|NCT02477332|582479110|FG005|Overall Study|Lack of Efficacy|1|||
161299762|NCT02477332|582479105|FG000|Overall Study|Non-compliance with study treatment|0|||
161299763|NCT02477332|582479106|FG001|Overall Study|Non-compliance with study treatment|1|||
161299764|NCT02477332|582479107|FG002|Overall Study|Non-compliance with study treatment|2|||
161299765|NCT02477332|582479108|FG003|Overall Study|Non-compliance with study treatment|0|||
161299766|NCT02477332|582479109|FG004|Overall Study|Non-compliance with study treatment|0|||
161299767|NCT02477332|582479110|FG005|Overall Study|Non-compliance with study treatment|0|||
161299768|NCT02477332|582479105|FG000|Overall Study|Pregnancy|0|||
161299769|NCT02477332|582479106|FG001|Overall Study|Pregnancy|0|||
161299770|NCT02477332|582479107|FG002|Overall Study|Pregnancy|0|||
161299771|NCT02477332|582479108|FG003|Overall Study|Pregnancy|1|||
161299772|NCT02477332|582479109|FG004|Overall Study|Pregnancy|0|||
161299773|NCT02477332|582479110|FG005|Overall Study|Pregnancy|0|||
161299774|NCT02477332|582479105|FG000|Overall Study|Protocol Violation|2|||
161299775|NCT02477332|582479106|FG001|Overall Study|Protocol Violation|0|||
161299776|NCT02477332|582479107|FG002|Overall Study|Protocol Violation|3|||
161299777|NCT02477332|582479108|FG003|Overall Study|Protocol Violation|3|||
161299778|NCT02477332|582479109|FG004|Overall Study|Protocol Violation|1|||
161299779|NCT02477332|582479110|FG005|Overall Study|Protocol Violation|1|||
161299780|NCT02477332|582479105|FG000|Overall Study|Technical problems|0|||
161299781|NCT02477332|582479106|FG001|Overall Study|Technical problems|0|||
161299782|NCT02477332|582479107|FG002|Overall Study|Technical problems|1|||
161299783|NCT02477332|582479108|FG003|Overall Study|Technical problems|0|||
161299784|NCT02477332|582479109|FG004|Overall Study|Technical problems|0|||
161299785|NCT02477332|582479110|FG005|Overall Study|Technical problems|0|||
161299786|NCT02477332|582479105|FG000|Overall Study|Lost to Follow-up|0|||
161299787|NCT02477332|582479106|FG001|Overall Study|Lost to Follow-up|0|||
161299788|NCT02477332|582479107|FG002|Overall Study|Lost to Follow-up|2|||
161299789|NCT02477332|582479108|FG003|Overall Study|Lost to Follow-up|0|||
161299790|NCT02477332|582479109|FG004|Overall Study|Lost to Follow-up|0|||
161299791|NCT02477332|582479110|FG005|Overall Study|Lost to Follow-up|0|||
161299792|NCT02477332|582479105|FG000|Overall Study|Physician Decision|0|||
161299793|NCT02477332|582479106|FG001|Overall Study|Physician Decision|0|||
161299794|NCT02477332|582479107|FG002|Overall Study|Physician Decision|1|||
161299795|NCT02477332|582479108|FG003|Overall Study|Physician Decision|3|||
161299796|NCT02477332|582479109|FG004|Overall Study|Physician Decision|0|||
161299797|NCT02477332|582479110|FG005|Overall Study|Physician Decision|1|||
161299798|NCT02477332|582479105|FG000|Overall Study|Withdrawal by Subject|0|||
161299799|NCT02477332|582479106|FG001|Overall Study|Withdrawal by Subject|3|||
161299800|NCT02477332|582479107|FG002|Overall Study|Withdrawal by Subject|1|||
161299801|NCT02477332|582479108|FG003|Overall Study|Withdrawal by Subject|2|||
161299802|NCT02477332|582479109|FG004|Overall Study|Withdrawal by Subject|1|||
161299803|NCT02477332|582479110|FG005|Overall Study|Withdrawal by Subject|0|||
161299804|NCT04657198|582479111|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
161299805|NCT04657198|582479112|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161181959|NCT00981747|582043529|FG000|Losartan|Death|1|||
161181960|NCT00981747|582043529|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
161181961|NCT00033371|582043535|FG000|Overall Study|Adverse Event|1|||
161181962|NCT00033371|582043536|FG001|Overall Study|Adverse Event|5|||
161181963|NCT00033371|582043535|FG000|Overall Study|Lost to Follow-up|2|||
161181964|NCT00033371|582043536|FG001|Overall Study|Lost to Follow-up|1|||
161181965|NCT00033371|582043535|FG000|Overall Study|Withdrawal by Subject|3|||
161181966|NCT00033371|582043536|FG001|Overall Study|Withdrawal by Subject|3|||
161181967|NCT00033371|582043535|FG000|Overall Study|Disease Progression|0|||
161181968|NCT00033371|582043536|FG001|Overall Study|Disease Progression|1|||
161181969|NCT02699125|582043537|FG000|Placebo|Lost to Follow-up|2|||
161181970|NCT02699125|582043538|FG001|Placebo|Lost to Follow-up|0|||
161181971|NCT02699125|582043537|FG000|Placebo|Protocol Violation|1|||
161181972|NCT02699125|582043538|FG001|Placebo|Protocol Violation|0|||
161181973|NCT02699125|582043537|FG000|Placebo|Withdrawal by Subject|0|||
161181974|NCT02699125|582043538|FG001|Placebo|Withdrawal by Subject|4|||
161181975|NCT02699125|582043537|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
161181976|NCT02699125|582043538|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
161181977|NCT01390038|582043541|FG000|Overall Study|Death|1|||
161181978|NCT01390038|582043541|FG000|Overall Study|Lost to Follow-up|1|||
161181979|NCT01390038|582043541|FG000|Overall Study|Withdrawal by Subject|4|||
161181980|NCT01390038|582043541|FG000|Overall Study|Simpliciti System Removal|2|||
161181981|NCT03799627|582043542|FG000|Overall Study|Adverse Event|1|||
161181982|NCT03799627|582043543|FG001|Overall Study|Adverse Event|2|||
161181983|NCT03799627|582043544|FG002|Overall Study|Adverse Event|0|||
161181984|NCT03799627|582043545|FG003|Overall Study|Adverse Event|0|||
161181985|NCT03799627|582043546|FG004|Overall Study|Adverse Event|2|||
161181986|NCT03799627|582043547|FG005|Overall Study|Adverse Event|5|||
161181987|NCT03799627|582043548|FG006|Overall Study|Adverse Event|0|||
161181988|NCT03799627|582043549|FG007|Overall Study|Adverse Event|2|||
161181989|NCT03799627|582043550|FG008|Overall Study|Adverse Event|0|||
161181990|NCT03799627|582043542|FG000|Overall Study|Physician Decision|2|||
161181991|NCT03799627|582043543|FG001|Overall Study|Physician Decision|2|||
161181992|NCT03799627|582043544|FG002|Overall Study|Physician Decision|0|||
161181993|NCT03799627|582043545|FG003|Overall Study|Physician Decision|0|||
161181994|NCT03799627|582043546|FG004|Overall Study|Physician Decision|2|||
161181995|NCT03799627|582043547|FG005|Overall Study|Physician Decision|2|||
161181996|NCT03799627|582043548|FG006|Overall Study|Physician Decision|0|||
161181997|NCT03799627|582043549|FG007|Overall Study|Physician Decision|0|||
161181998|NCT03799627|582043550|FG008|Overall Study|Physician Decision|0|||
161181999|NCT03799627|582043542|FG000|Overall Study|Withdrawal by Subject|1|||
161182000|NCT03799627|582043543|FG001|Overall Study|Withdrawal by Subject|1|||
161182001|NCT03799627|582043544|FG002|Overall Study|Withdrawal by Subject|0|||
161182002|NCT03799627|582043545|FG003|Overall Study|Withdrawal by Subject|2|||
161182003|NCT03799627|582043546|FG004|Overall Study|Withdrawal by Subject|0|||
161182004|NCT03799627|582043547|FG005|Overall Study|Withdrawal by Subject|3|||
161182005|NCT03799627|582043548|FG006|Overall Study|Withdrawal by Subject|0|||
161182006|NCT03799627|582043549|FG007|Overall Study|Withdrawal by Subject|0|||
161299806|NCT04657198|582479113|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
161299807|NCT02977572|582479116|FG000|Overall Study|Exclusion criterion|2|||
161299808|NCT02977572|582479117|FG001|Overall Study|Exclusion criterion|2|||
161299809|NCT01075256|582479120|FG000|Overall Study|Withdrawal by Subject|1|||
161299810|NCT01075256|582479121|FG001|Overall Study|Withdrawal by Subject|0|||
161299811|NCT01075256|582479122|FG002|Overall Study|Withdrawal by Subject|0|||
161299812|NCT03502070|582479123|FG000|Overall Study|Withdrawal by Subject|1|||
161299813|NCT03502070|582479123|FG000|Overall Study|Screen Failure|1|||
161299814|NCT01218087|582479135|FG000|Overall Study|Death|2|||
161299815|NCT01218087|582479136|FG001|Overall Study|Death|1|||
161299816|NCT01218087|582479135|FG000|Overall Study|Withdrawal by Subject|5|||
161299817|NCT01218087|582479136|FG001|Overall Study|Withdrawal by Subject|0|||
161299818|NCT01218087|582479135|FG000|Overall Study|Transferred|8|||
161299819|NCT01218087|582479136|FG001|Overall Study|Transferred|5|||
161299820|NCT00552396|582479137|FG000|Overall Study|protocol withdrawal criteria|3|||
161299821|NCT00552396|582479138|FG001|Overall Study|protocol withdrawal criteria|3|||
161299822|NCT00552396|582479139|FG002|Overall Study|protocol withdrawal criteria|3|||
161299823|NCT00552396|582479140|FG003|Overall Study|protocol withdrawal criteria|6|||
161299824|NCT00552396|582479141|FG004|Overall Study|protocol withdrawal criteria|3|||
161299825|NCT00552396|582479142|FG005|Overall Study|protocol withdrawal criteria|3|||
161299826|NCT00552396|582479143|FG006|Overall Study|protocol withdrawal criteria|9|||
161299827|NCT03170362|582479144|FG000|Overall Study|Death|2|||
161299828|NCT03170362|582479145|FG001|Overall Study|Death|2|||
161319502|NCT01863732|582555337|FG003|Overall Study|Technical problems|0|||
161182007|NCT03799627|582043550|FG008|Overall Study|Withdrawal by Subject|0|||
161182008|NCT03799627|582043542|FG000|Overall Study|Lack of Efficacy|0|||
161182009|NCT03799627|582043543|FG001|Overall Study|Lack of Efficacy|0|||
161182010|NCT03799627|582043544|FG002|Overall Study|Lack of Efficacy|0|||
161182011|NCT03799627|582043545|FG003|Overall Study|Lack of Efficacy|1|||
161182012|NCT03799627|582043546|FG004|Overall Study|Lack of Efficacy|0|||
161182013|NCT03799627|582043547|FG005|Overall Study|Lack of Efficacy|0|||
161182014|NCT03799627|582043548|FG006|Overall Study|Lack of Efficacy|0|||
161182015|NCT03799627|582043549|FG007|Overall Study|Lack of Efficacy|0|||
161299829|NCT03170362|582479144|FG000|Overall Study|Withdrawal by Subject|23|||
161299830|NCT03170362|582479145|FG001|Overall Study|Withdrawal by Subject|22|||
161299831|NCT03170362|582479144|FG000|Overall Study|Lost to Follow-up|187|||
161299832|NCT03170362|582479145|FG001|Overall Study|Lost to Follow-up|167|||
161299833|NCT03340454|582479146|FG000|Overall Study|Lost to Follow-up|0|||
161299834|NCT03340454|582479147|FG001|Overall Study|Lost to Follow-up|4|||
161299835|NCT03307252|582479153|FG000|Part 2, Period 1|Treatment not received|0|||
161299836|NCT03307252|582479154|FG001|Part 2, Period 1|Treatment not received|0|||
161299837|NCT03307252|582479155|FG002|Part 2, Period 1|Treatment not received|0|||
161299838|NCT03307252|582479156|FG003|Part 2, Period 1|Treatment not received|0|||
161299839|NCT03307252|582479157|FG004|Part 2, Period 1|Treatment not received|0|||
161299840|NCT03307252|582479158|FG005|Part 2, Period 1|Treatment not received|1|||
161299841|NCT03307252|582479159|FG006|Part 2, Period 1|Treatment not received|0|||
161299842|NCT03307252|582479160|FG007|Part 2, Period 1|Treatment not received|0|||
161299843|NCT03307252|582479161|FG008|Part 2, Period 1|Treatment not received|0|||
161299844|NCT03307252|582479162|FG009|Part 2, Period 1|Treatment not received|0|||
161299845|NCT03307252|582479163|FG010|Part 2, Period 1|Treatment not received|0|||
161299846|NCT03307252|582479153|FG000|Part 2, Period 3|Other than listed|0|||
161299847|NCT03307252|582479154|FG001|Part 2, Period 3|Other than listed|0|||
161299848|NCT03307252|582479155|FG002|Part 2, Period 3|Other than listed|0|||
161299849|NCT03307252|582479156|FG003|Part 2, Period 3|Other than listed|0|||
161299850|NCT03307252|582479157|FG004|Part 2, Period 3|Other than listed|1|||
161299851|NCT03307252|582479158|FG005|Part 2, Period 3|Other than listed|0|||
161299852|NCT03307252|582479159|FG006|Part 2, Period 3|Other than listed|0|||
161299853|NCT03307252|582479160|FG007|Part 2, Period 3|Other than listed|0|||
161299854|NCT03307252|582479161|FG008|Part 2, Period 3|Other than listed|0|||
161299855|NCT03307252|582479162|FG009|Part 2, Period 3|Other than listed|0|||
161299856|NCT03307252|582479163|FG010|Part 2, Period 3|Other than listed|0|||
161299857|NCT03307252|582479153|FG000|Part 2, Period 4|Other than listed|0|||
161299858|NCT03307252|582479154|FG001|Part 2, Period 4|Other than listed|0|||
161299859|NCT03307252|582479155|FG002|Part 2, Period 4|Other than listed|0|||
161299860|NCT03307252|582479156|FG003|Part 2, Period 4|Other than listed|0|||
161299861|NCT03307252|582479157|FG004|Part 2, Period 4|Other than listed|0|||
161299862|NCT03307252|582479158|FG005|Part 2, Period 4|Other than listed|0|||
161299863|NCT03307252|582479159|FG006|Part 2, Period 4|Other than listed|1|||
161299864|NCT03307252|582479160|FG007|Part 2, Period 4|Other than listed|0|||
161299865|NCT03307252|582479161|FG008|Part 2, Period 4|Other than listed|0|||
161299866|NCT03307252|582479162|FG009|Part 2, Period 4|Other than listed|0|||
161299867|NCT03307252|582479163|FG010|Part 2, Period 4|Other than listed|0|||
161299868|NCT03307252|582479153|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299869|NCT03307252|582479154|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299870|NCT03307252|582479155|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299871|NCT03307252|582479156|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299872|NCT03307252|582479157|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299873|NCT03307252|582479158|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299874|NCT03307252|582479159|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299875|NCT03307252|582479160|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299876|NCT03307252|582479161|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299877|NCT03307252|582479162|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
161299878|NCT03307252|582479163|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
161299879|NCT01052480|582479164|FG000|Overall Study|Lost to Follow-up|3|||
161299880|NCT01052480|582479165|FG001|Overall Study|Lost to Follow-up|3|||
161299881|NCT01052480|582479164|FG000|Overall Study|Protocol Violation|1|||
161299882|NCT01052480|582479165|FG001|Overall Study|Protocol Violation|0|||
161299883|NCT01052480|582479164|FG000|Overall Study|Withdrawal by Subject|3|||
161299884|NCT01052480|582479165|FG001|Overall Study|Withdrawal by Subject|7|||
161299885|NCT01052480|582479164|FG000|Overall Study|Physician Decision|0|||
161299886|NCT01052480|582479165|FG001|Overall Study|Physician Decision|2|||
161299887|NCT01052480|582479164|FG000|Overall Study|Death|1|||
161299888|NCT01052480|582479165|FG001|Overall Study|Death|5|||
161299889|NCT04185220|582479170|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
161299890|NCT04185220|582479171|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
161319503|NCT01863732|582555334|FG000|Overall Study|Subject/guardian decision|6|||
161319504|NCT01863732|582555335|FG001|Overall Study|Subject/guardian decision|9|||
161319505|NCT01863732|582555336|FG002|Overall Study|Subject/guardian decision|3|||
161319506|NCT01863732|582555337|FG003|Overall Study|Subject/guardian decision|1|||
161319507|NCT01863732|582555334|FG000|Overall Study|Death|1|||
161319508|NCT01863732|582555335|FG001|Overall Study|Death|0|||
161319509|NCT01863732|582555336|FG002|Overall Study|Death|0|||
161182016|NCT03799627|582043550|FG008|Overall Study|Lack of Efficacy|0|||
161182017|NCT03799627|582043542|FG000|Overall Study|Lost to Follow-up|0|||
161182018|NCT03799627|582043543|FG001|Overall Study|Lost to Follow-up|0|||
161182019|NCT03799627|582043544|FG002|Overall Study|Lost to Follow-up|0|||
161182020|NCT03799627|582043545|FG003|Overall Study|Lost to Follow-up|0|||
161182021|NCT03799627|582043546|FG004|Overall Study|Lost to Follow-up|0|||
161182022|NCT03799627|582043547|FG005|Overall Study|Lost to Follow-up|0|||
161182023|NCT03799627|582043548|FG006|Overall Study|Lost to Follow-up|1|||
161182024|NCT03799627|582043549|FG007|Overall Study|Lost to Follow-up|0|||
161182025|NCT03799627|582043550|FG008|Overall Study|Lost to Follow-up|1|||
161182026|NCT03799627|582043542|FG000|Overall Study|Death|0|||
161182027|NCT03799627|582043543|FG001|Overall Study|Death|0|||
161182028|NCT03799627|582043544|FG002|Overall Study|Death|0|||
161182029|NCT03799627|582043545|FG003|Overall Study|Death|1|||
161182030|NCT03799627|582043546|FG004|Overall Study|Death|0|||
161182031|NCT03799627|582043547|FG005|Overall Study|Death|0|||
161182032|NCT03799627|582043548|FG006|Overall Study|Death|0|||
161182033|NCT03799627|582043549|FG007|Overall Study|Death|0|||
161182034|NCT03799627|582043550|FG008|Overall Study|Death|0|||
161182035|NCT03799627|582043542|FG000|Overall Study|Study Drug Put on Hold|1|||
161182036|NCT03799627|582043543|FG001|Overall Study|Study Drug Put on Hold|0|||
161182037|NCT03799627|582043544|FG002|Overall Study|Study Drug Put on Hold|0|||
161182038|NCT03799627|582043545|FG003|Overall Study|Study Drug Put on Hold|0|||
161182039|NCT03799627|582043546|FG004|Overall Study|Study Drug Put on Hold|0|||
161182040|NCT03799627|582043547|FG005|Overall Study|Study Drug Put on Hold|0|||
161182041|NCT03799627|582043548|FG006|Overall Study|Study Drug Put on Hold|0|||
161182042|NCT03799627|582043549|FG007|Overall Study|Study Drug Put on Hold|0|||
161182043|NCT03799627|582043550|FG008|Overall Study|Study Drug Put on Hold|0|||
161182044|NCT03799627|582043542|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
161182045|NCT03799627|582043543|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
161089346|NCT01445301|581717348|FG002|Overall Study|Physician Decision|0|||
161089347|NCT01445301|581717346|FG000|Overall Study|Withdrawal by Subject|5|||
161089348|NCT01445301|581717347|FG001|Overall Study|Withdrawal by Subject|6|||
161089349|NCT01445301|581717348|FG002|Overall Study|Withdrawal by Subject|4|||
161089350|NCT00752557|581717349|FG000|Overall Study|Withdrawal by Subject|4|||
161089351|NCT00752557|581717350|FG001|Overall Study|Withdrawal by Subject|3|||
161089352|NCT00752557|581717351|FG002|Overall Study|Withdrawal by Subject|3|||
161089353|NCT00752557|581717349|FG000|Overall Study|Unspecified resaons|0|||
161089354|NCT00752557|581717350|FG001|Overall Study|Unspecified resaons|2|||
161089355|NCT00752557|581717351|FG002|Overall Study|Unspecified resaons|2|||
161089356|NCT00752557|581717349|FG000|Overall Study|Lost to Follow-up|1|||
161089357|NCT00752557|581717350|FG001|Overall Study|Lost to Follow-up|0|||
161089358|NCT00752557|581717351|FG002|Overall Study|Lost to Follow-up|1|||
161089359|NCT02150343|581717352|FG000|Overall Study|Adverse Event|2|||
161089360|NCT02150343|581717353|FG001|Overall Study|Adverse Event|0|||
161089361|NCT02150343|581717354|FG002|Overall Study|Adverse Event|1|||
161089362|NCT02150343|581717355|FG003|Overall Study|Adverse Event|1|||
161089363|NCT02150343|581717352|FG000|Overall Study|Withdrawal by Subject|13|||
161089364|NCT02150343|581717353|FG001|Overall Study|Withdrawal by Subject|10|||
161089365|NCT02150343|581717354|FG002|Overall Study|Withdrawal by Subject|9|||
161089366|NCT02150343|581717355|FG003|Overall Study|Withdrawal by Subject|4|||
161089367|NCT02150343|581717352|FG000|Overall Study|Lost to Follow-up|4|||
161089368|NCT02150343|581717353|FG001|Overall Study|Lost to Follow-up|4|||
161089369|NCT02150343|581717354|FG002|Overall Study|Lost to Follow-up|2|||
161089370|NCT02150343|581717355|FG003|Overall Study|Lost to Follow-up|3|||
161089371|NCT02150343|581717352|FG000|Overall Study|Other|2|||
161089372|NCT02150343|581717353|FG001|Overall Study|Other|6|||
161089373|NCT02150343|581717354|FG002|Overall Study|Other|0|||
161089374|NCT02150343|581717355|FG003|Overall Study|Other|2|||
161089375|NCT00906945|581717356|FG000|Overall Study|Found to be not eligible|0|||
161089376|NCT00906945|581717357|FG001|Overall Study|Found to be not eligible|0|||
161089377|NCT00906945|581717358|FG002|Overall Study|Found to be not eligible|0|||
161089378|NCT00906945|581717359|FG003|Overall Study|Found to be not eligible|1|||
161089379|NCT00906945|581717360|FG004|Overall Study|Found to be not eligible|1|||
161089380|NCT00906945|581717361|FG005|Overall Study|Found to be not eligible|1|||
161089381|NCT00906945|581717356|FG000|Overall Study|Physician Decision|0|||
161089382|NCT00906945|581717357|FG001|Overall Study|Physician Decision|0|||
161089383|NCT00906945|581717358|FG002|Overall Study|Physician Decision|0|||
161089384|NCT00906945|581717359|FG003|Overall Study|Physician Decision|0|||
161089385|NCT00906945|581717360|FG004|Overall Study|Physician Decision|0|||
161182046|NCT03799627|582043544|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
161182047|NCT03799627|582043545|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
161182048|NCT03799627|582043546|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
161182049|NCT03799627|582043547|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
161182050|NCT03799627|582043548|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
161182051|NCT03799627|582043549|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
161089386|NCT00906945|581717361|FG005|Overall Study|Physician Decision|1|||
161089387|NCT01210664|581717363|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
161182052|NCT03799627|582043550|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
161299891|NCT04185220|582479170|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
161299892|NCT04185220|582479171|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
161299893|NCT03225105|582479178|FG000|Overall Study|Withdrawal by Subject|1|||
161299894|NCT03225105|582479179|FG001|Overall Study|Withdrawal by Subject|0|||
161299895|NCT03225105|582479180|FG002|Overall Study|Withdrawal by Subject|0|||
161299896|NCT03225105|582479181|FG003|Overall Study|Withdrawal by Subject|0|||
161299897|NCT03225105|582479178|FG000|Overall Study|Death|0|||
161299898|NCT03225105|582479179|FG001|Overall Study|Death|4|||
161299899|NCT03225105|582479180|FG002|Overall Study|Death|2|||
161299900|NCT03225105|582479181|FG003|Overall Study|Death|0|||
161299901|NCT03225105|582479178|FG000|Overall Study|Study termination per Sponsor Decision|2|||
161299902|NCT03225105|582479179|FG001|Overall Study|Study termination per Sponsor Decision|0|||
161299903|NCT03225105|582479180|FG002|Overall Study|Study termination per Sponsor Decision|3|||
161299904|NCT03225105|582479181|FG003|Overall Study|Study termination per Sponsor Decision|3|||
161299905|NCT03232931|582480714|FG000|Overall Study|Physician Decision|1|||
161299906|NCT03232931|582480715|FG001|Overall Study|Physician Decision|1|||
161299907|NCT03232931|582480714|FG000|Overall Study|Withdrawal by Subject|6|||
161299908|NCT03232931|582480715|FG001|Overall Study|Withdrawal by Subject|0|||
161299909|NCT03232931|582480714|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
161299910|NCT03232931|582480715|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
161299911|NCT03232931|582480714|FG000|Overall Study|Parent did not record voice|1|||
161299912|NCT03232931|582480715|FG001|Overall Study|Parent did not record voice|2|||
161299913|NCT03232931|582480714|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
161299914|NCT03232931|582480715|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
161299915|NCT04925557|582480716|FG000|Overall Study|Study closed|5|||
161299916|NCT04925557|582480717|FG001|Overall Study|Study closed|3|||
161299917|NCT05488470|582480718|FG000|Overall Study|Physician Decision|2|||
161299918|NCT05488470|582480718|FG000|Overall Study|Withdrawal by Subject|1|||
161299919|NCT05488470|582480718|FG000|Overall Study|Death|1|||
161299920|NCT01270464|582480722|FG000|Overall Study|Protocol Violation|4|||
161299921|NCT01270464|582480723|FG001|Overall Study|Protocol Violation|3|||
161299922|NCT01270464|582480724|FG002|Overall Study|Protocol Violation|2|||
161299923|NCT01270464|582480722|FG000|Overall Study|Lack of Efficacy|2|||
161299924|NCT01270464|582480723|FG001|Overall Study|Lack of Efficacy|3|||
161299925|NCT01270464|582480724|FG002|Overall Study|Lack of Efficacy|1|||
161299926|NCT01270464|582480722|FG000|Overall Study|Adverse Event|9|||
161299927|NCT01270464|582480723|FG001|Overall Study|Adverse Event|1|||
161299928|NCT01270464|582480724|FG002|Overall Study|Adverse Event|7|||
161299929|NCT01270464|582480722|FG000|Overall Study|Withdrawal by Subject|2|||
161299930|NCT01270464|582480723|FG001|Overall Study|Withdrawal by Subject|1|||
161299931|NCT01270464|582480724|FG002|Overall Study|Withdrawal by Subject|4|||
161299932|NCT01270464|582480722|FG000|Overall Study|Lost to Follow-up|2|||
161299933|NCT01270464|582480723|FG001|Overall Study|Lost to Follow-up|3|||
161299934|NCT01270464|582480724|FG002|Overall Study|Lost to Follow-up|1|||
161299935|NCT01270464|582480722|FG000|Overall Study|Other|1|||
161299936|NCT01270464|582480723|FG001|Overall Study|Other|1|||
161299937|NCT01270464|582480724|FG002|Overall Study|Other|3|||
161299938|NCT00076752|582480725|FG000|Overall Study|Death|2|||
161299939|NCT00076752|582480725|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
161299940|NCT02028767|582480726|FG000|Treatment Period 2|Non compliant with protocol|1|||
161299941|NCT02028767|582480727|FG001|Treatment Period 2|Non compliant with protocol|0|||
161299942|NCT02028767|582480726|FG000|Treatment Period 2|Reason other than those specified above|1|||
161299943|NCT02028767|582480727|FG001|Treatment Period 2|Reason other than those specified above|0|||
161299944|NCT02875613|582480730|FG000|Overall Study|Withdrawal by Subject|1|||
161299945|NCT02875613|582480730|FG000|Overall Study|Screen Failure|1|||
161299946|NCT02347774|582480731|FG000|Study Participation|Lost to Follow-up|3|||
161299947|NCT02347774|582480732|FG001|Study Participation|Lost to Follow-up|6|||
161299948|NCT02347774|582480733|FG002|Study Participation|Lost to Follow-up|2|||
161299949|NCT02347774|582480731|FG000|Study Participation|Withdrawal by Subject|8|||
161299950|NCT02347774|582480732|FG001|Study Participation|Withdrawal by Subject|9|||
161299951|NCT02347774|582480733|FG002|Study Participation|Withdrawal by Subject|15|||
161299952|NCT02347774|582480731|FG000|Study Participation|Adverse Event|1|||
161299953|NCT02347774|582480732|FG001|Study Participation|Adverse Event|4|||
161299954|NCT02347774|582480733|FG002|Study Participation|Adverse Event|6|||
161299955|NCT02347774|582480731|FG000|Study Participation|withdrew consent|1|||
161299956|NCT02347774|582480732|FG001|Study Participation|withdrew consent|1|||
161299957|NCT02347774|582480733|FG002|Study Participation|withdrew consent|1|||
161299958|NCT02347774|582480731|FG000|Study Participation|Met Prolonged QT criteria|1|||
161299959|NCT02347774|582480732|FG001|Study Participation|Met Prolonged QT criteria|0|||
161299960|NCT02347774|582480733|FG002|Study Participation|Met Prolonged QT criteria|0|||
161299961|NCT02347774|582480731|FG000|Study Participation|non-compliance with study drug|0|||
161299962|NCT02347774|582480732|FG001|Study Participation|non-compliance with study drug|1|||
161299963|NCT02347774|582480733|FG002|Study Participation|non-compliance with study drug|0|||
161299964|NCT02347774|582480731|FG000|Study Participation|incarceration|1|||
161299965|NCT02347774|582480732|FG001|Study Participation|incarceration|0|||
161299966|NCT02347774|582480733|FG002|Study Participation|incarceration|0|||
161299967|NCT02347774|582480731|FG000|Study Participation|randomized in error|0|||
161299968|NCT02347774|582480732|FG001|Study Participation|randomized in error|0|||
161299969|NCT02347774|582480733|FG002|Study Participation|randomized in error|1|||
161299970|NCT02347774|582480731|FG000|On Study Treatment|Adverse Event|9|||
161299971|NCT02347774|582480732|FG001|On Study Treatment|Adverse Event|15|||
161299972|NCT02347774|582480733|FG002|On Study Treatment|Adverse Event|19|||
161299973|NCT02347774|582480731|FG000|On Study Treatment|Lack of Efficacy|3|||
161299974|NCT02347774|582480732|FG001|On Study Treatment|Lack of Efficacy|0|||
161299975|NCT02347774|582480733|FG002|On Study Treatment|Lack of Efficacy|2|||
161299976|NCT02347774|582480731|FG000|On Study Treatment|non-complicance with study medication|0|||
161299977|NCT02347774|582480732|FG001|On Study Treatment|non-complicance with study medication|2|||
161299978|NCT02347774|582480733|FG002|On Study Treatment|non-complicance with study medication|0|||
161299979|NCT02347774|582480731|FG000|On Study Treatment|Protocol Violation|0|||
161299980|NCT02347774|582480732|FG001|On Study Treatment|Protocol Violation|0|||
161299981|NCT02347774|582480733|FG002|On Study Treatment|Protocol Violation|1|||
161299982|NCT02347774|582480731|FG000|On Study Treatment|withdrew consent|9|||
161299983|NCT02347774|582480732|FG001|On Study Treatment|withdrew consent|8|||
161299984|NCT02347774|582480733|FG002|On Study Treatment|withdrew consent|12|||
161299985|NCT02347774|582480731|FG000|On Study Treatment|Lost to Follow-up|2|||
161299986|NCT02347774|582480732|FG001|On Study Treatment|Lost to Follow-up|6|||
161299987|NCT02347774|582480733|FG002|On Study Treatment|Lost to Follow-up|1|||
161299988|NCT02347774|582480731|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
161299989|NCT02347774|582480732|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
161299990|NCT02347774|582480733|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
161299991|NCT02347774|582480731|FG000|On Study Treatment|ranomized in error|0|||
161299992|NCT02347774|582480732|FG001|On Study Treatment|ranomized in error|0|||
161299993|NCT02347774|582480733|FG002|On Study Treatment|ranomized in error|1|||
161299994|NCT01222520|582480734|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
161299995|NCT01222520|582480735|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
161299996|NCT01222520|582480734|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
161299997|NCT01222520|582480735|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
161299998|NCT01222520|582480734|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
161299999|NCT01222520|582480735|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
161300000|NCT01222520|582480734|FG000|Double-blind Period|Adverse Event|0|||
161300001|NCT01222520|582480735|FG001|Double-blind Period|Adverse Event|1|||
161300002|NCT01222520|582480734|FG000|Double-blind Period|Lack of Efficacy|0|||
161300003|NCT01222520|582480735|FG001|Double-blind Period|Lack of Efficacy|1|||
161300004|NCT01222520|582480734|FG000|Double-blind Period|Study medication stolen|1|||
161300005|NCT01222520|582480735|FG001|Double-blind Period|Study medication stolen|0|||
161300006|NCT01322490|582480738|FG000|Treatment Period|Adverse Event|12|||
161182053|NCT03799627|582043542|FG000|Overall Study|Kidney Transplantation|1|||
161182054|NCT03799627|582043543|FG001|Overall Study|Kidney Transplantation|0|||
161182055|NCT03799627|582043544|FG002|Overall Study|Kidney Transplantation|0|||
161182056|NCT03799627|582043545|FG003|Overall Study|Kidney Transplantation|1|||
161182057|NCT03799627|582043546|FG004|Overall Study|Kidney Transplantation|1|||
161182058|NCT03799627|582043547|FG005|Overall Study|Kidney Transplantation|0|||
161182059|NCT03799627|582043548|FG006|Overall Study|Kidney Transplantation|0|||
161182060|NCT03799627|582043549|FG007|Overall Study|Kidney Transplantation|0|||
161182061|NCT03799627|582043550|FG008|Overall Study|Kidney Transplantation|0|||
161182062|NCT03799627|582043542|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
161182063|NCT03799627|582043543|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
161182064|NCT03799627|582043544|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
161182065|NCT03799627|582043545|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
161182066|NCT03799627|582043546|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
161182067|NCT03799627|582043547|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
161182068|NCT03799627|582043548|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
161182069|NCT03799627|582043549|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
161182070|NCT03799627|582043550|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
161182071|NCT03799627|582043542|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182072|NCT03799627|582043543|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
161182073|NCT03799627|582043544|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182074|NCT03799627|582043545|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182075|NCT03799627|582043546|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182076|NCT03799627|582043547|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182077|NCT03799627|582043548|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182078|NCT03799627|582043549|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161182079|NCT03799627|582043550|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
161300007|NCT01322490|582480739|FG001|Treatment Period|Adverse Event|18|||
161300008|NCT01322490|582480740|FG002|Treatment Period|Adverse Event|15|||
161300009|NCT01322490|582480738|FG000|Treatment Period|Death|5|||
161300010|NCT01322490|582480739|FG001|Treatment Period|Death|7|||
161300011|NCT01322490|582480740|FG002|Treatment Period|Death|3|||
161300012|NCT01322490|582480738|FG000|Treatment Period|Lack of Efficacy|89|||
161300013|NCT01322490|582480739|FG001|Treatment Period|Lack of Efficacy|100|||
161300014|NCT01322490|582480740|FG002|Treatment Period|Lack of Efficacy|112|||
161300015|NCT01322490|582480738|FG000|Treatment Period|Physician Decision|0|||
161182080|NCT03799627|582043542|FG000|Overall Study|Met Exclusion Criteria|0|||
161182081|NCT03799627|582043543|FG001|Overall Study|Met Exclusion Criteria|0|||
161182082|NCT03799627|582043544|FG002|Overall Study|Met Exclusion Criteria|0|||
161182083|NCT03799627|582043545|FG003|Overall Study|Met Exclusion Criteria|1|||
161182084|NCT03799627|582043546|FG004|Overall Study|Met Exclusion Criteria|0|||
161182085|NCT03799627|582043547|FG005|Overall Study|Met Exclusion Criteria|0|||
161182086|NCT03799627|582043548|FG006|Overall Study|Met Exclusion Criteria|0|||
161182087|NCT03799627|582043549|FG007|Overall Study|Met Exclusion Criteria|0|||
161182088|NCT03799627|582043550|FG008|Overall Study|Met Exclusion Criteria|0|||
161182089|NCT03799627|582043542|FG000|Overall Study|Investigational Product Noncompliance|0|||
161182090|NCT03799627|582043543|FG001|Overall Study|Investigational Product Noncompliance|0|||
161182091|NCT03799627|582043544|FG002|Overall Study|Investigational Product Noncompliance|0|||
161182092|NCT03799627|582043545|FG003|Overall Study|Investigational Product Noncompliance|1|||
161182093|NCT03799627|582043546|FG004|Overall Study|Investigational Product Noncompliance|0|||
161182094|NCT03799627|582043547|FG005|Overall Study|Investigational Product Noncompliance|0|||
161182095|NCT03799627|582043548|FG006|Overall Study|Investigational Product Noncompliance|0|||
161182096|NCT03799627|582043549|FG007|Overall Study|Investigational Product Noncompliance|0|||
161182097|NCT03799627|582043550|FG008|Overall Study|Investigational Product Noncompliance|0|||
161182098|NCT03799627|582043542|FG000|Overall Study|Participant Relocation|0|||
161182099|NCT03799627|582043543|FG001|Overall Study|Participant Relocation|0|||
161182100|NCT03799627|582043544|FG002|Overall Study|Participant Relocation|0|||
161182101|NCT03799627|582043545|FG003|Overall Study|Participant Relocation|1|||
161182102|NCT03799627|582043546|FG004|Overall Study|Participant Relocation|0|||
161182103|NCT03799627|582043547|FG005|Overall Study|Participant Relocation|1|||
161182104|NCT03799627|582043548|FG006|Overall Study|Participant Relocation|0|||
161182105|NCT03799627|582043549|FG007|Overall Study|Participant Relocation|0|||
161182106|NCT03799627|582043550|FG008|Overall Study|Participant Relocation|0|||
161182107|NCT03799627|582043542|FG000|Overall Study|Eurofin Issue|0|||
161182108|NCT03799627|582043543|FG001|Overall Study|Eurofin Issue|0|||
161182109|NCT03799627|582043544|FG002|Overall Study|Eurofin Issue|0|||
161182110|NCT03799627|582043545|FG003|Overall Study|Eurofin Issue|0|||
161182111|NCT03799627|582043546|FG004|Overall Study|Eurofin Issue|1|||
161182112|NCT03799627|582043547|FG005|Overall Study|Eurofin Issue|0|||
161182113|NCT03799627|582043548|FG006|Overall Study|Eurofin Issue|0|||
161182114|NCT03799627|582043549|FG007|Overall Study|Eurofin Issue|0|||
161182115|NCT03799627|582043550|FG008|Overall Study|Eurofin Issue|0|||
161182116|NCT03799627|582043542|FG000|Overall Study|Noncompliance with Site Instructions|0|||
161182117|NCT03799627|582043543|FG001|Overall Study|Noncompliance with Site Instructions|0|||
161182118|NCT03799627|582043544|FG002|Overall Study|Noncompliance with Site Instructions|0|||
161182119|NCT03799627|582043545|FG003|Overall Study|Noncompliance with Site Instructions|0|||
161182120|NCT03799627|582043546|FG004|Overall Study|Noncompliance with Site Instructions|1|||
161182121|NCT03799627|582043547|FG005|Overall Study|Noncompliance with Site Instructions|0|||
161182122|NCT03799627|582043548|FG006|Overall Study|Noncompliance with Site Instructions|0|||
161182123|NCT03799627|582043549|FG007|Overall Study|Noncompliance with Site Instructions|0|||
161182124|NCT03799627|582043550|FG008|Overall Study|Noncompliance with Site Instructions|0|||
161182125|NCT03799627|582043542|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182126|NCT03799627|582043543|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182127|NCT03799627|582043544|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182128|NCT03799627|582043545|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182129|NCT03799627|582043546|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
161182130|NCT03799627|582043547|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182131|NCT03799627|582043548|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182132|NCT03799627|582043549|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182133|NCT03799627|582043550|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
161182134|NCT03799627|582043542|FG000|Overall Study|Changes In Hemoglobin Values|1|||
161182135|NCT03799627|582043543|FG001|Overall Study|Changes In Hemoglobin Values|2|||
161182136|NCT03799627|582043544|FG002|Overall Study|Changes In Hemoglobin Values|1|||
161182137|NCT03799627|582043545|FG003|Overall Study|Changes In Hemoglobin Values|0|||
161182138|NCT03799627|582043546|FG004|Overall Study|Changes In Hemoglobin Values|0|||
161182139|NCT03799627|582043547|FG005|Overall Study|Changes In Hemoglobin Values|2|||
161300016|NCT01322490|582480739|FG001|Treatment Period|Physician Decision|2|||
161182140|NCT03799627|582043548|FG006|Overall Study|Changes In Hemoglobin Values|1|||
161182141|NCT03799627|582043549|FG007|Overall Study|Changes In Hemoglobin Values|0|||
161182142|NCT03799627|582043550|FG008|Overall Study|Changes In Hemoglobin Values|1|||
161300017|NCT01322490|582480740|FG002|Treatment Period|Physician Decision|1|||
161300018|NCT01322490|582480738|FG000|Treatment Period|Protocol Violation|7|||
161300019|NCT01322490|582480739|FG001|Treatment Period|Protocol Violation|5|||
161300020|NCT01322490|582480740|FG002|Treatment Period|Protocol Violation|4|||
161300021|NCT01322490|582480738|FG000|Treatment Period|Withdrawal by Subject|14|||
161300022|NCT01322490|582480739|FG001|Treatment Period|Withdrawal by Subject|16|||
161300023|NCT01322490|582480740|FG002|Treatment Period|Withdrawal by Subject|11|||
161300024|NCT01322490|582480738|FG000|Treatment Period|Non-compliance with study drug|0|||
161300025|NCT01322490|582480739|FG001|Treatment Period|Non-compliance with study drug|0|||
161300026|NCT01322490|582480740|FG002|Treatment Period|Non-compliance with study drug|1|||
161300027|NCT01322490|582480738|FG000|Treatment Period|Other per report|2|||
161300028|NCT01322490|582480739|FG001|Treatment Period|Other per report|2|||
161300029|NCT01322490|582480740|FG002|Treatment Period|Other per report|1|||
161300030|NCT01322490|582480738|FG000|Treatment Period|Randomized but Not Treated|3|||
161300031|NCT01322490|582480739|FG001|Treatment Period|Randomized but Not Treated|3|||
161300032|NCT01322490|582480740|FG002|Treatment Period|Randomized but Not Treated|5|||
161300033|NCT01322490|582480738|FG000|Long Term Follow-up Period|Death|235|||
161300034|NCT01322490|582480739|FG001|Long Term Follow-up Period|Death|239|||
161300035|NCT01322490|582480740|FG002|Long Term Follow-up Period|Death|236|||
161300036|NCT01322490|582480738|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
161300037|NCT01322490|582480739|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
161300038|NCT01322490|582480740|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
161300039|NCT01322490|582480738|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
161300040|NCT01322490|582480739|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
161300041|NCT01322490|582480740|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
161300042|NCT01322490|582480738|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
161300043|NCT01322490|582480739|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
161300044|NCT01322490|582480740|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
161300045|NCT01322490|582480738|FG000|Long Term Follow-up Period|Other per report|3|||
161300046|NCT01322490|582480739|FG001|Long Term Follow-up Period|Other per report|2|||
161300047|NCT01322490|582480740|FG002|Long Term Follow-up Period|Other per report|2|||
161300048|NCT01322490|582480738|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
161300049|NCT01322490|582480739|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
161300050|NCT01322490|582480740|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
161300051|NCT02257489|582480741|FG000|Overall Study|Withdrawal by Subject|0|||
161300052|NCT02257489|582480742|FG001|Overall Study|Withdrawal by Subject|0|||
161300053|NCT02257489|582480743|FG002|Overall Study|Withdrawal by Subject|0|||
161300054|NCT02257489|582480744|FG003|Overall Study|Withdrawal by Subject|1|||
161300055|NCT02257489|582480745|FG004|Overall Study|Withdrawal by Subject|0|||
161300056|NCT02257489|582480746|FG005|Overall Study|Withdrawal by Subject|0|||
161300057|NCT02257489|582480747|FG006|Overall Study|Withdrawal by Subject|0|||
161300058|NCT02257489|582480748|FG007|Overall Study|Withdrawal by Subject|0|||
161300059|NCT02257489|582480749|FG008|Overall Study|Withdrawal by Subject|0|||
161300060|NCT01896128|582480752|FG000|Overall Study|Withdrawal by Subject|3|||
161300061|NCT01896128|582480753|FG001|Overall Study|Withdrawal by Subject|3|||
161300062|NCT00954941|582480754|FG000|Overall Study|Received treatment at home|1|||
161300063|NCT00954941|582480755|FG001|Overall Study|Received treatment at home|0|||
161300064|NCT00954941|582480754|FG000|Overall Study|Withdrawal by Subject|1|||
161300065|NCT00954941|582480755|FG001|Overall Study|Withdrawal by Subject|0|||
161300066|NCT00954941|582480754|FG000|Overall Study|Insurance Denial|2|||
161300067|NCT00954941|582480755|FG001|Overall Study|Insurance Denial|2|||
161300068|NCT00954941|582480754|FG000|Overall Study|Physician Decision|2|||
161300069|NCT00954941|582480755|FG001|Overall Study|Physician Decision|2|||
161300070|NCT00954941|582480754|FG000|Overall Study|Ineligible|2|||
161300071|NCT00954941|582480755|FG001|Overall Study|Ineligible|2|||
161300072|NCT00954941|582480754|FG000|Overall Study|Adverse Event|0|||
161300073|NCT00954941|582480755|FG001|Overall Study|Adverse Event|1|||
161300074|NCT00955955|582480756|FG000|Overall Study|Lost to Follow-up|2|||
161300075|NCT00955955|582480757|FG001|Overall Study|Lost to Follow-up|0|||
161300076|NCT00955955|582480758|FG002|Overall Study|Lost to Follow-up|0|||
161300077|NCT01996254|582480762|FG000|Overall Study|Change in Eligibility|0|||
161300078|NCT01996254|582480763|FG001|Overall Study|Change in Eligibility|2|||
161300079|NCT01996254|582480764|FG002|Overall Study|Change in Eligibility|0|||
161300080|NCT01996254|582480762|FG000|Overall Study|Withdrawal by Subject|0|||
161300081|NCT01996254|582480763|FG001|Overall Study|Withdrawal by Subject|3|||
161347857|NCT02903914|582657366|FG005|Overall Study|Clinical Disease Progression|0|||
161347858|NCT02903914|582657367|FG006|Overall Study|Clinical Disease Progression|0|||
161347859|NCT02903914|582657368|FG007|Overall Study|Clinical Disease Progression|0|||
161347860|NCT02903914|582657361|FG000|Overall Study|Completed Follow-up Period|0|||
161089388|NCT01210664|581717364|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
161089389|NCT01210664|581717365|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
161089390|NCT01210664|581717366|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
161300082|NCT01996254|582480764|FG002|Overall Study|Withdrawal by Subject|4|||
161300083|NCT01996254|582480762|FG000|Overall Study|Lost to Follow-up|1|||
161300084|NCT01996254|582480763|FG001|Overall Study|Lost to Follow-up|0|||
161182143|NCT00398138|582043559|FG000|Overall Study|Adverse Event|2|||
161182144|NCT03418376|582043565|FG000|Overall Study|Musculoskeletal injury|1|||
161182145|NCT03418376|582043566|FG001|Overall Study|Musculoskeletal injury|2|||
161182146|NCT03418376|582043567|FG002|Overall Study|Musculoskeletal injury|1|||
161182147|NCT03418376|582043568|FG003|Overall Study|Musculoskeletal injury|0|||
161182148|NCT03418376|582043565|FG000|Overall Study|Personal reasons|0|||
161182149|NCT03418376|582043566|FG001|Overall Study|Personal reasons|2|||
161182150|NCT03418376|582043567|FG002|Overall Study|Personal reasons|2|||
161182151|NCT03418376|582043568|FG003|Overall Study|Personal reasons|1|||
161182152|NCT03418376|582043565|FG000|Overall Study|Exacerbation|0|||
161182153|NCT03418376|582043566|FG001|Overall Study|Exacerbation|1|||
161182154|NCT03418376|582043567|FG002|Overall Study|Exacerbation|0|||
161182155|NCT03418376|582043568|FG003|Overall Study|Exacerbation|0|||
161182156|NCT00814307|582043569|FG000|Overall Study|Randomized but not treated|1|||
161182157|NCT00814307|582043570|FG001|Overall Study|Randomized but not treated|0|||
161182158|NCT00814307|582043571|FG002|Overall Study|Randomized but not treated|0|||
161182159|NCT00814307|582043572|FG003|Overall Study|Randomized but not treated|0|||
161182160|NCT00814307|582043569|FG000|Overall Study|Adverse Event|3|||
161182161|NCT00814307|582043570|FG001|Overall Study|Adverse Event|9|||
161182162|NCT00814307|582043571|FG002|Overall Study|Adverse Event|3|||
161182163|NCT00814307|582043572|FG003|Overall Study|Adverse Event|2|||
161182164|NCT00814307|582043569|FG000|Overall Study|Lack of Efficacy|1|||
161182165|NCT00814307|582043570|FG001|Overall Study|Lack of Efficacy|1|||
161182166|NCT00814307|582043571|FG002|Overall Study|Lack of Efficacy|3|||
161182167|NCT00814307|582043572|FG003|Overall Study|Lack of Efficacy|4|||
161182168|NCT00814307|582043569|FG000|Overall Study|Other|1|||
161182169|NCT00814307|582043570|FG001|Overall Study|Other|2|||
161182170|NCT00814307|582043571|FG002|Overall Study|Other|0|||
161182171|NCT00814307|582043572|FG003|Overall Study|Other|1|||
161182172|NCT00814307|582043569|FG000|Overall Study|Protocol Violation|2|||
161182173|NCT00814307|582043570|FG001|Overall Study|Protocol Violation|8|||
161182174|NCT00814307|582043571|FG002|Overall Study|Protocol Violation|1|||
161182175|NCT00814307|582043572|FG003|Overall Study|Protocol Violation|1|||
161182176|NCT00814307|582043569|FG000|Overall Study|Withdrawal by Subject|4|||
161182177|NCT00814307|582043570|FG001|Overall Study|Withdrawal by Subject|6|||
161182178|NCT00814307|582043571|FG002|Overall Study|Withdrawal by Subject|0|||
161182179|NCT00814307|582043572|FG003|Overall Study|Withdrawal by Subject|2|||
161182180|NCT00814307|582043569|FG000|Overall Study|Death|0|||
161182181|NCT00814307|582043570|FG001|Overall Study|Death|1|||
161182182|NCT00814307|582043571|FG002|Overall Study|Death|0|||
161182183|NCT00814307|582043572|FG003|Overall Study|Death|0|||
161182184|NCT00149890|582043576|FG000|Overall Study|Adverse Event|1|||
161182185|NCT00149890|582043577|FG001|Overall Study|Adverse Event|8|||
161182186|NCT00149890|582043576|FG000|Overall Study|Lack of Efficacy|8|||
161182187|NCT00149890|582043577|FG001|Overall Study|Lack of Efficacy|9|||
161182188|NCT00149890|582043576|FG000|Overall Study|Protocol Violation|1|||
161182189|NCT00149890|582043577|FG001|Overall Study|Protocol Violation|0|||
161182190|NCT00149890|582043576|FG000|Overall Study|Lost to Follow-up|1|||
161182191|NCT00149890|582043577|FG001|Overall Study|Lost to Follow-up|0|||
161182192|NCT00149890|582043576|FG000|Overall Study|Graft Loss|2|||
161182193|NCT00149890|582043577|FG001|Overall Study|Graft Loss|1|||
161182194|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
161182195|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
161182196|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161182197|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161182198|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
161182199|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
161182200|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
161182201|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161182202|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161182203|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
161300085|NCT01996254|582480764|FG002|Overall Study|Lost to Follow-up|4|||
161300086|NCT02920008|582480765|FG000|Overall Study|Death|117|||
161182204|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
161182205|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
161182206|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161182207|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161182208|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
161182209|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161182210|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
161182211|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161182212|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161182213|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
161182214|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
161182215|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161300087|NCT02920008|582480766|FG001|Overall Study|Death|127|||
161300088|NCT02920008|582480765|FG000|Overall Study|Withdrawal by Subject|3|||
161300089|NCT02920008|582480766|FG001|Overall Study|Withdrawal by Subject|6|||
161300090|NCT02920008|582480765|FG000|Overall Study|Lost to Follow-up|0|||
161300091|NCT02920008|582480766|FG001|Overall Study|Lost to Follow-up|1|||
161300092|NCT01053663|582480767|FG000|Overall Study|Death|2|||
161300093|NCT01053663|582480767|FG000|Overall Study|Lost to Follow-up|1|||
161300094|NCT01053663|582480767|FG000|Overall Study|Poor IV Access|1|||
161300095|NCT01053663|582480767|FG000|Overall Study|Transferred to Another Hospital|1|||
161300096|NCT01053663|582480767|FG000|Overall Study|Negative Influenza Diagnosis|1|||
161300097|NCT03533114|582480770|FG000|Overall|Adverse Event|16|||
161300098|NCT03533114|582480771|FG001|Overall|Adverse Event|11|||
161300099|NCT03533114|582480770|FG000|Overall|Consent Withdrawal by Participant|7|||
161300100|NCT03533114|582480771|FG001|Overall|Consent Withdrawal by Participant|6|||
161300101|NCT03533114|582480770|FG000|Overall|Lack of Efficacy|5|||
161300102|NCT03533114|582480771|FG001|Overall|Lack of Efficacy|3|||
161300103|NCT03533114|582480770|FG000|Overall|Lost to Follow-up|1|||
161300104|NCT03533114|582480771|FG001|Overall|Lost to Follow-up|1|||
161300105|NCT03533114|582480770|FG000|Overall|Physician Decision|0|||
161300106|NCT03533114|582480771|FG001|Overall|Physician Decision|2|||
161300107|NCT03533114|582480770|FG000|Overall|Protocol deviation|1|||
161300108|NCT03533114|582480771|FG001|Overall|Protocol deviation|1|||
161300109|NCT03533114|582480770|FG000|Overall|Failure to meet randomization criteria|1|||
161300110|NCT03533114|582480771|FG001|Overall|Failure to meet randomization criteria|2|||
161300111|NCT03533114|582480770|FG000|Overall|Non-Compliance with study drug|0|||
161300112|NCT03533114|582480771|FG001|Overall|Non-Compliance with study drug|1|||
161300113|NCT03533114|582480770|FG000|Overall|Other|0|||
161300114|NCT03533114|582480771|FG001|Overall|Other|1|||
161300115|NCT03533114|582480770|FG000|Open Label Titration and Optimization|Adverse Event|11|||
161300116|NCT03533114|582480771|FG001|Open Label Titration and Optimization|Adverse Event|8|||
161300117|NCT03533114|582480770|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
161300118|NCT03533114|582480771|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
161300119|NCT03533114|582480770|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
161300120|NCT03533114|582480771|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
161300121|NCT03533114|582480770|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
161300122|NCT03533114|582480771|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
161300123|NCT03533114|582480770|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
161300124|NCT03533114|582480771|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
161300125|NCT03533114|582480770|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
161300126|NCT03533114|582480771|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
161300127|NCT03533114|582480770|FG000|Stable Dose|Adverse Event|0|||
161300128|NCT03533114|582480771|FG001|Stable Dose|Adverse Event|2|||
161300129|NCT03533114|582480770|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
161300130|NCT03533114|582480771|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
161300131|NCT03533114|582480770|FG000|Stable Dose|Lack of Efficacy|1|||
161300132|NCT03533114|582480771|FG001|Stable Dose|Lack of Efficacy|0|||
161300133|NCT03533114|582480770|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
161300134|NCT03533114|582480771|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
161300135|NCT03533114|582480770|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
161300136|NCT03533114|582480771|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
161300137|NCT03533114|582480770|FG000|Open-Label Safety Extension|Adverse Event|3|||
161300138|NCT03533114|582480771|FG001|Open-Label Safety Extension|Adverse Event|0|||
161300139|NCT03533114|582480770|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
161300140|NCT03533114|582480771|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
161300141|NCT03533114|582480770|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
161300142|NCT03533114|582480771|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
161300143|NCT03533114|582480770|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
161300144|NCT03533114|582480771|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
161300145|NCT03533114|582480770|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
161300146|NCT03533114|582480771|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
161300147|NCT01862250|582480772|FG000|Overall Study|Adverse Event|4|||
161300148|NCT03852264|582480773|FG000|Third Research Visit|Lost to Follow-up|1|||
161300149|NCT03852264|582480774|FG001|Third Research Visit|Lost to Follow-up|0|||
161300150|NCT02411396|582480778|FG000|Overall Study|Lost to Follow-up|31|||
161300151|NCT02411396|582480778|FG000|Overall Study|Death|10|||
161300152|NCT03575793|582480787|FG000|Overall Study|Withdrawal by Subject|0|||
161300153|NCT03575793|582480788|FG001|Overall Study|Withdrawal by Subject|1|||
161300154|NCT03575793|582480787|FG000|Overall Study|Never Treated|0|||
161300155|NCT03575793|582480788|FG001|Overall Study|Never Treated|2|||
161182216|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161300156|NCT03521115|582480792|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
161182217|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161182218|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
161300157|NCT03521115|582480793|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
161300158|NCT03521115|582480792|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
161300159|NCT03521115|582480793|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
161300160|NCT02295020|582480802|FG000|Overall Study|Adverse Event|0|||
161300161|NCT02295020|582480803|FG001|Overall Study|Adverse Event|1|||
161300162|NCT02295020|582480802|FG000|Overall Study|Withdrawal by Subject|3|||
161300163|NCT02295020|582480803|FG001|Overall Study|Withdrawal by Subject|2|||
161300164|NCT00562302|582480804|FG000|Overall Study|Lost to Follow-up|3|||
161300165|NCT00562302|582480805|FG001|Overall Study|Lost to Follow-up|3|||
161300166|NCT00562302|582480804|FG000|Overall Study|Adverse Event|0|||
161300167|NCT00562302|582480805|FG001|Overall Study|Adverse Event|6|||
161300168|NCT00562302|582480804|FG000|Overall Study|Non-compliance|1|||
161300169|NCT00562302|582480805|FG001|Overall Study|Non-compliance|2|||
161300170|NCT00562302|582480804|FG000|Overall Study|Withdrawal by Subject|7|||
161300171|NCT00562302|582480805|FG001|Overall Study|Withdrawal by Subject|8|||
161300172|NCT00562302|582480804|FG000|Overall Study|Death|1|||
161300173|NCT00562302|582480805|FG001|Overall Study|Death|2|||
161300174|NCT00562302|582480804|FG000|Overall Study|Lung resection prior to study completion|7|||
161300175|NCT00562302|582480805|FG001|Overall Study|Lung resection prior to study completion|7|||
161300176|NCT00562302|582480804|FG000|Overall Study|Not stated|1|||
161300177|NCT00562302|582480805|FG001|Overall Study|Not stated|4|||
161300178|NCT01860040|582480806|FG000|Overall Study|Withdrawal by Subject|1|||
161300179|NCT01860040|582480807|FG001|Overall Study|Withdrawal by Subject|0|||
161300180|NCT01931995|582480808|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
161300181|NCT01931995|582480809|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
161300182|NCT01931995|582480808|FG000|First Intervention (1 Day)|Physician Decision|1|||
161300183|NCT01931995|582480809|FG001|First Intervention (1 Day)|Physician Decision|1|||
161300184|NCT01931995|582480808|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
161300185|NCT01931995|582480809|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
161300186|NCT00791661|582480810|FG000|7 Day Wash-out|Adverse Event|0|||
161300187|NCT00791661|582480811|FG001|7 Day Wash-out|Adverse Event|0|||
161300188|NCT00791661|582480812|FG002|7 Day Wash-out|Adverse Event|1|||
161300189|NCT00791661|582480810|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
161300190|NCT00791661|582480811|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
161300191|NCT00791661|582480812|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
161300192|NCT00364923|582480813|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
161300193|NCT00364923|582480813|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
161300194|NCT00427921|582480817|FG000|Overall Study|Adverse Event|26|||
161300195|NCT00427921|582480817|FG000|Overall Study|Withdrawal by Subject|4|||
161300196|NCT00427921|582480817|FG000|Overall Study|Lost to Follow-up|2|||
161300197|NCT00427921|582480817|FG000|Overall Study|Other reason not specified|10|||
161300198|NCT00427921|582480817|FG000|Overall Study|Adverse Event + Hospitalization|1|||
161300199|NCT00427921|582480817|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
161300200|NCT00427921|582480817|FG000|Overall Study|Adverse Event + No Response|1|||
161300201|NCT00427921|582480817|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
161300202|NCT00427921|582480817|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
161300203|NCT00427921|582480817|FG000|Overall Study|Adverse Event + Lost Response|1|||
161300204|NCT00427921|582480817|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
161300205|NCT00427921|582480817|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
161300206|NCT00520533|582480820|FG000|Overall Study|Death|1|||
161300207|NCT00520533|582480820|FG000|Overall Study|Suspension of the study for safety reasons|1|||
161300208|NCT00520533|582480820|FG000|Overall Study|Withdrawal by Subject|1|||
161300209|NCT00520533|582480820|FG000|Overall Study|Physician Decision|1|||
161300210|NCT01972438|582480826|FG000|Baseline-Month 3 Crossover Period|Death|1|||
161300211|NCT01972438|582480827|FG001|Baseline-Month 3 Crossover Period|Death|0|||
161300212|NCT01972438|582480826|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
161300213|NCT01972438|582480827|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
161300214|NCT01972438|582480826|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
161300215|NCT01972438|582480827|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
161300216|NCT01972438|582480826|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
161300217|NCT01972438|582480827|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
161300218|NCT01972438|582480826|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
161300219|NCT01972438|582480827|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
161300220|NCT01972438|582480826|FG000|Months 6-12 Study Period|Death|1|||
161300221|NCT01972438|582480827|FG001|Months 6-12 Study Period|Death|0|||
161300222|NCT01972438|582480826|FG000|Months 6-12 Study Period|Early Study Closure|2|||
161300223|NCT01972438|582480827|FG001|Months 6-12 Study Period|Early Study Closure|2|||
161300224|NCT01972438|582480826|FG000|Post Month 12 Study Period|Early Study Closure|3|||
161300225|NCT01972438|582480827|FG001|Post Month 12 Study Period|Early Study Closure|4|||
161300226|NCT00697463|582480828|FG000|Overall Study|Withdrawal by Subject|1|||
161300227|NCT02568189|582480829|FG000|Overall Study|Protocol Violation|0|||
161300228|NCT02568189|582480830|FG001|Overall Study|Protocol Violation|0|||
161300229|NCT02568189|582480831|FG002|Overall Study|Protocol Violation|19|||
161300230|NCT02568189|582480832|FG003|Overall Study|Protocol Violation|18|||
161300231|NCT00529373|582480833|FG000|Base Study|Adverse Event|525|||
161300232|NCT00529373|582480834|FG001|Base Study|Adverse Event|470|||
161300233|NCT00529373|582480833|FG000|Base Study|Lack of Efficacy|16|||
161300234|NCT00529373|582480834|FG001|Base Study|Lack of Efficacy|75|||
161300235|NCT00529373|582480833|FG000|Base Study|Lost to Follow-up|221|||
161300236|NCT00529373|582480834|FG001|Base Study|Lost to Follow-up|208|||
161300237|NCT00529373|582480833|FG000|Base Study|Other Protocol Specified Criteria|19|||
161300238|NCT00529373|582480834|FG001|Base Study|Other Protocol Specified Criteria|20|||
161300239|NCT00529373|582480833|FG000|Base Study|Physician Decision|60|||
161300240|NCT00529373|582480834|FG001|Base Study|Physician Decision|52|||
161300241|NCT00529373|582480833|FG000|Base Study|Protocol Violation|48|||
161300242|NCT00529373|582480834|FG001|Base Study|Protocol Violation|38|||
161300243|NCT00529373|582480833|FG000|Base Study|Withdrawal by Subject|1062|||
161300244|NCT00529373|582480834|FG001|Base Study|Withdrawal by Subject|967|||
161300245|NCT00529373|582480833|FG000|Base Study|Did not continue into Extension|1795|||
161300246|NCT00529373|582480834|FG001|Base Study|Did not continue into Extension|2238|||
161300247|NCT00529373|582480833|FG000|First Extension Study|Adverse Event|162|||
161300248|NCT00529373|582480834|FG001|First Extension Study|Adverse Event|142|||
161300249|NCT00529373|582480833|FG000|First Extension Study|Lack of Efficacy|65|||
161300250|NCT00529373|582480834|FG001|First Extension Study|Lack of Efficacy|427|||
161300251|NCT00529373|582480833|FG000|First Extension Study|Lost to Follow-up|41|||
161300252|NCT00529373|582480834|FG001|First Extension Study|Lost to Follow-up|37|||
161300253|NCT00529373|582480833|FG000|First Extension Study|Other|27|||
161300254|NCT00529373|582480834|FG001|First Extension Study|Other|47|||
161300255|NCT00529373|582480833|FG000|First Extension Study|Physician Decision|50|||
161300256|NCT00529373|582480834|FG001|First Extension Study|Physician Decision|45|||
161300257|NCT00529373|582480833|FG000|First Extension Study|Protocol Violation|16|||
161300258|NCT00529373|582480834|FG001|First Extension Study|Protocol Violation|13|||
161300259|NCT00529373|582480833|FG000|First Extension Study|Withdrawal by Subject|296|||
161300260|NCT00529373|582480834|FG001|First Extension Study|Withdrawal by Subject|287|||
161300261|NCT00529373|582480833|FG000|First Extension Study|Disposition record non-existing|0|||
161300262|NCT00529373|582480834|FG001|First Extension Study|Disposition record non-existing|1|||
161300263|NCT00529373|582480833|FG000|First Extension Study|Discontinued after 5 years completion|208|||
161300264|NCT00529373|582480834|FG001|First Extension Study|Discontinued after 5 years completion|346|||
161300265|NCT00529373|582480833|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
161300266|NCT00529373|582480834|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
161300267|NCT00529373|582480833|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
161300268|NCT00529373|582480834|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
161300269|NCT00529373|582480833|FG000|Second Extension Study|Adverse Event|101|||
161300270|NCT00529373|582480834|FG001|Second Extension Study|Adverse Event|51|||
161300271|NCT00529373|582480833|FG000|Second Extension Study|Lack of Efficacy|7|||
161300272|NCT00529373|582480834|FG001|Second Extension Study|Lack of Efficacy|15|||
161300273|NCT00529373|582480833|FG000|Second Extension Study|Lost to Follow-up|18|||
161300274|NCT00529373|582480834|FG001|Second Extension Study|Lost to Follow-up|12|||
161300275|NCT00529373|582480833|FG000|Second Extension Study|Other|7|||
161300276|NCT00529373|582480834|FG001|Second Extension Study|Other|12|||
161300277|NCT00529373|582480833|FG000|Second Extension Study|Physician Decision|63|||
161300278|NCT00529373|582480834|FG001|Second Extension Study|Physician Decision|26|||
161300279|NCT00529373|582480833|FG000|Second Extension Study|Protocol Violation|2|||
161300280|NCT00529373|582480834|FG001|Second Extension Study|Protocol Violation|1|||
161300281|NCT00529373|582480833|FG000|Second Extension Study|Withdrawal by Subject|97|||
161300282|NCT00529373|582480834|FG001|Second Extension Study|Withdrawal by Subject|75|||
161300283|NCT00529373|582480833|FG000|Second Extension Study|Status Missing|5|||
161300284|NCT00529373|582480834|FG001|Second Extension Study|Status Missing|5|||
161300285|NCT01074268|582480835|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
161300286|NCT01074268|582480836|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
161300287|NCT01074268|582480835|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
161300288|NCT01074268|582480836|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
161300289|NCT01074268|582480835|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
161347861|NCT02903914|582657362|FG001|Overall Study|Completed Follow-up Period|0|||
161300290|NCT01074268|582480836|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
161300291|NCT01074268|582480835|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
161300292|NCT01074268|582480836|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
161300293|NCT01074268|582480835|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
161300294|NCT01074268|582480836|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
161300295|NCT01074268|582480835|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
161300296|NCT01074268|582480836|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
161300297|NCT01074268|582480835|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
161300298|NCT01074268|582480836|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
161300299|NCT01074268|582480835|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
161347862|NCT02903914|582657363|FG002|Overall Study|Completed Follow-up Period|6|||
161300300|NCT01074268|582480836|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
161300301|NCT01074268|582480835|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
161300302|NCT01074268|582480836|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
161300303|NCT01119859|582480839|FG000|Overall Study|Adverse Event|9|||
161300304|NCT01119859|582480840|FG001|Overall Study|Adverse Event|10|||
161300305|NCT01119859|582480839|FG000|Overall Study|Death|2|||
161182219|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161182220|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
161182221|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161182222|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161182223|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
161182224|NCT04757376|582043578|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
161182225|NCT04757376|582043579|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
161182226|NCT04757376|582043580|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161182227|NCT04757376|582043581|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161182228|NCT04757376|582043582|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
161182229|NCT04757376|582043578|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161182230|NCT04757376|582043579|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161182231|NCT04757376|582043580|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
161182232|NCT04757376|582043581|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161182233|NCT04757376|582043582|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
161182234|NCT01307046|582043583|FG000|Overall Study|Adverse Event|3|||
161182235|NCT01307046|582043584|FG001|Overall Study|Adverse Event|3|||
161182236|NCT01307046|582043583|FG000|Overall Study|Lack of Efficacy|0|||
161182237|NCT01307046|582043584|FG001|Overall Study|Lack of Efficacy|2|||
161182238|NCT01307046|582043583|FG000|Overall Study|Physician Decision|2|||
161182239|NCT01307046|582043584|FG001|Overall Study|Physician Decision|0|||
161182240|NCT01307046|582043583|FG000|Overall Study|Withdrawal by Subject|1|||
161182241|NCT01307046|582043584|FG001|Overall Study|Withdrawal by Subject|1|||
161182242|NCT01307046|582043583|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
161182243|NCT01307046|582043584|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
161182244|NCT01307046|582043583|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
161182245|NCT01307046|582043584|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
161182246|NCT03898323|582043585|FG000|Overall Study|Physician Decision|1|||
161182247|NCT02569398|582043588|FG000|Overall Study|Adverse Event|0|||
161182248|NCT02569398|582043589|FG001|Overall Study|Adverse Event|1|||
161182249|NCT02569398|582043590|FG002|Overall Study|Adverse Event|6|||
161182250|NCT02569398|582043588|FG000|Overall Study|Withdrawal by Subject|43|||
161182251|NCT02569398|582043589|FG001|Overall Study|Withdrawal by Subject|43|||
161182252|NCT02569398|582043590|FG002|Overall Study|Withdrawal by Subject|30|||
161182253|NCT02569398|582043588|FG000|Overall Study|Study terminated by sponsor|130|||
161182254|NCT02569398|582043589|FG001|Overall Study|Study terminated by sponsor|131|||
161182255|NCT02569398|582043590|FG002|Overall Study|Study terminated by sponsor|134|||
161182256|NCT02569398|582043588|FG000|Overall Study|Other|12|||
161182257|NCT02569398|582043589|FG001|Overall Study|Other|14|||
161182258|NCT02569398|582043590|FG002|Overall Study|Other|13|||
161182259|NCT04195750|582043593|FG000|Overall Study|Death|245|||
161182260|NCT04195750|582043594|FG001|Overall Study|Death|253|||
161182261|NCT04195750|582043595|FG002|Overall Study|Death|5|||
161182262|NCT04195750|582043593|FG000|Overall Study|Physician Decision|0|||
161182263|NCT04195750|582043594|FG001|Overall Study|Physician Decision|1|||
161182264|NCT04195750|582043595|FG002|Overall Study|Physician Decision|0|||
161182265|NCT04195750|582043593|FG000|Overall Study|Withdrawal by Subject|9|||
161182266|NCT04195750|582043594|FG001|Overall Study|Withdrawal by Subject|8|||
161182267|NCT04195750|582043595|FG002|Overall Study|Withdrawal by Subject|0|||
161182268|NCT04195750|582043593|FG000|Overall Study|Ongoing|120|||
161182269|NCT04195750|582043594|FG001|Overall Study|Ongoing|110|||
161300306|NCT01119859|582480840|FG001|Overall Study|Death|0|||
161300307|NCT01119859|582480839|FG000|Overall Study|Insufficient therapeutic response|7|||
161300308|NCT01119859|582480840|FG001|Overall Study|Insufficient therapeutic response|14|||
161300309|NCT01119859|582480839|FG000|Overall Study|Refused treatment|3|||
161182270|NCT04195750|582043595|FG002|Overall Study|Ongoing|4|||
161182271|NCT02406027|582043596|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161182272|NCT02406027|582043597|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
161300310|NCT01119859|582480840|FG001|Overall Study|Refused treatment|6|||
161300311|NCT01119859|582480839|FG000|Overall Study|Failure to return|3|||
161300312|NCT01119859|582480840|FG001|Overall Study|Failure to return|0|||
161347863|NCT02903914|582657364|FG003|Overall Study|Completed Follow-up Period|2|||
161300313|NCT00603473|582480841|FG000|Overall Study|Adverse Event|4|||
161300314|NCT00603473|582480841|FG000|Overall Study|Lack of Efficacy|4|||
161300315|NCT00603473|582480841|FG000|Overall Study|Protocol Violation|1|||
161300316|NCT01134939|582480845|FG000|Overall Study|Adverse Event|9|||
161300317|NCT01134939|582480846|FG001|Overall Study|Adverse Event|3|||
161300318|NCT01134939|582480847|FG002|Overall Study|Adverse Event|4|||
161300319|NCT01134939|582480848|FG003|Overall Study|Adverse Event|5|||
161300320|NCT01134939|582480849|FG004|Overall Study|Adverse Event|5|||
161300321|NCT01134939|582480850|FG005|Overall Study|Adverse Event|5|||
161300322|NCT01134939|582480851|FG006|Overall Study|Adverse Event|1|||
161300323|NCT01134939|582480852|FG007|Overall Study|Adverse Event|0|||
161300324|NCT01134939|582480845|FG000|Overall Study|Lack of Efficacy|2|||
161300325|NCT01134939|582480846|FG001|Overall Study|Lack of Efficacy|5|||
161300326|NCT01134939|582480847|FG002|Overall Study|Lack of Efficacy|1|||
161300327|NCT01134939|582480848|FG003|Overall Study|Lack of Efficacy|0|||
161300328|NCT01134939|582480849|FG004|Overall Study|Lack of Efficacy|3|||
161300329|NCT01134939|582480850|FG005|Overall Study|Lack of Efficacy|0|||
161300330|NCT01134939|582480851|FG006|Overall Study|Lack of Efficacy|1|||
161300331|NCT01134939|582480852|FG007|Overall Study|Lack of Efficacy|0|||
161300332|NCT01134939|582480845|FG000|Overall Study|Lost to Follow-up|2|||
161300333|NCT01134939|582480846|FG001|Overall Study|Lost to Follow-up|3|||
161300334|NCT01134939|582480847|FG002|Overall Study|Lost to Follow-up|0|||
161300335|NCT01134939|582480848|FG003|Overall Study|Lost to Follow-up|1|||
161300336|NCT01134939|582480849|FG004|Overall Study|Lost to Follow-up|2|||
161300337|NCT01134939|582480850|FG005|Overall Study|Lost to Follow-up|1|||
161300338|NCT01134939|582480851|FG006|Overall Study|Lost to Follow-up|0|||
161300339|NCT01134939|582480852|FG007|Overall Study|Lost to Follow-up|0|||
161300340|NCT01134939|582480845|FG000|Overall Study|Death|0|||
161300341|NCT01134939|582480846|FG001|Overall Study|Death|1|||
161300342|NCT01134939|582480847|FG002|Overall Study|Death|0|||
161300343|NCT01134939|582480848|FG003|Overall Study|Death|0|||
161300344|NCT01134939|582480849|FG004|Overall Study|Death|0|||
161300345|NCT01134939|582480850|FG005|Overall Study|Death|0|||
161300346|NCT01134939|582480851|FG006|Overall Study|Death|0|||
161300347|NCT01134939|582480852|FG007|Overall Study|Death|0|||
161300348|NCT01134939|582480845|FG000|Overall Study|Termination page not available|4|||
161300349|NCT01134939|582480846|FG001|Overall Study|Termination page not available|6|||
161300350|NCT01134939|582480847|FG002|Overall Study|Termination page not available|5|||
161300351|NCT01134939|582480848|FG003|Overall Study|Termination page not available|8|||
161300352|NCT01134939|582480849|FG004|Overall Study|Termination page not available|0|||
161300353|NCT01134939|582480850|FG005|Overall Study|Termination page not available|3|||
161300354|NCT01134939|582480851|FG006|Overall Study|Termination page not available|7|||
161300355|NCT01134939|582480852|FG007|Overall Study|Termination page not available|0|||
161300356|NCT00733421|582480853|FG000|Overall Study|Withdrawal by Subject|1|||
161300357|NCT00733421|582480854|FG001|Overall Study|Withdrawal by Subject|1|||
161300358|NCT01736397|582482539|FG000|Overall Study|Lack of Efficacy|1|||
161300359|NCT01736397|582482540|FG001|Overall Study|Lack of Efficacy|11|||
161300360|NCT01736397|582482539|FG000|Overall Study|Withdrawal by Subject|6|||
161300361|NCT01736397|582482540|FG001|Overall Study|Withdrawal by Subject|5|||
161300362|NCT01736397|582482539|FG000|Overall Study|Lost to Follow-up|0|||
161300363|NCT01736397|582482540|FG001|Overall Study|Lost to Follow-up|1|||
161300364|NCT01736397|582482539|FG000|Overall Study|Adverse Event|6|||
161300365|NCT01736397|582482540|FG001|Overall Study|Adverse Event|3|||
161300366|NCT01736397|582482539|FG000|Overall Study|Not stated|1|||
161300367|NCT01736397|582482540|FG001|Overall Study|Not stated|4|||
161300368|NCT01868438|582482541|FG000|First Intervention|Withdrawal by Subject|5|||
161300369|NCT01868438|582482542|FG001|First Intervention|Withdrawal by Subject|1|||
161300370|NCT01868438|582482541|FG000|First Intervention|Lost to Follow-up|2|||
161300371|NCT01868438|582482542|FG001|First Intervention|Lost to Follow-up|3|||
161300372|NCT01868438|582482541|FG000|First Intervention|Meeting the non-redosing criteria|0|||
161347864|NCT02903914|582657365|FG004|Overall Study|Completed Follow-up Period|1|||
161182273|NCT02406027|582043598|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
161182274|NCT02406027|582043599|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161182275|NCT02406027|582043600|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161182276|NCT02406027|582043601|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161182277|NCT02406027|582043602|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
161300373|NCT01868438|582482542|FG001|First Intervention|Meeting the non-redosing criteria|1|||
161300374|NCT01868438|582482541|FG000|Second Intervention|Adverse Event|3|||
161300375|NCT01868438|582482542|FG001|Second Intervention|Adverse Event|3|||
161300376|NCT01284348|582482543|FG000|Overall Study|Death|1|||
161300377|NCT01284348|582482544|FG001|Overall Study|Death|1|||
161300378|NCT01284348|582482543|FG000|Overall Study|Withdrew consent|0|||
161300379|NCT01284348|582482544|FG001|Overall Study|Withdrew consent|1|||
161300380|NCT01284348|582482543|FG000|Overall Study|Status not recorded|9|||
161300381|NCT01284348|582482544|FG001|Overall Study|Status not recorded|10|||
161300382|NCT04112043|582482546|FG000|Overall Study|Withdrawal by Subject|1|||
161300383|NCT04112043|582482547|FG001|Overall Study|Withdrawal by Subject|1|||
161300384|NCT04112043|582482548|FG002|Overall Study|Withdrawal by Subject|1|||
161182278|NCT02406027|582043596|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
161182279|NCT02406027|582043597|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161182280|NCT02406027|582043598|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
161182281|NCT02406027|582043599|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161182282|NCT02406027|582043600|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161182283|NCT02406027|582043601|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161182284|NCT02406027|582043602|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
161182285|NCT02406027|582043596|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
161182286|NCT02406027|582043597|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
161182287|NCT02406027|582043598|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
161182288|NCT02406027|582043599|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161182289|NCT02406027|582043600|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161182290|NCT02406027|582043601|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161182291|NCT02406027|582043602|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
161182292|NCT02406027|582043596|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
161182293|NCT02406027|582043597|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161182294|NCT02406027|582043598|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
161182295|NCT02406027|582043599|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161182296|NCT02406027|582043600|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161182297|NCT02406027|582043601|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161182298|NCT02406027|582043602|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
161182299|NCT02406027|582043596|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
161182300|NCT02406027|582043597|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
161182301|NCT02406027|582043598|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
161182302|NCT02406027|582043599|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
161182303|NCT02406027|582043600|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
161182304|NCT02406027|582043601|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
161182305|NCT02406027|582043602|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
161182306|NCT02406027|582043596|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
161182307|NCT02406027|582043597|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
161182308|NCT02406027|582043598|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
161182309|NCT02406027|582043599|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
161182310|NCT02406027|582043600|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
161182311|NCT02406027|582043601|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
161182312|NCT02406027|582043602|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
161182313|NCT02406027|582043596|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161182314|NCT02406027|582043597|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161182315|NCT02406027|582043598|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161182316|NCT02406027|582043599|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
161182317|NCT02406027|582043600|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
161182318|NCT02406027|582043601|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
161182319|NCT02406027|582043602|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
161182320|NCT02406027|582043596|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161182321|NCT02406027|582043597|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161182322|NCT02406027|582043598|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
161182323|NCT02406027|582043599|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
161182324|NCT02406027|582043600|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
161182325|NCT02406027|582043601|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
161182326|NCT02406027|582043602|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
161182327|NCT02406027|582043596|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161182328|NCT02406027|582043597|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161182329|NCT02406027|582043598|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161182330|NCT02406027|582043599|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161182331|NCT02406027|582043600|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161182332|NCT02406027|582043601|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
161182333|NCT02406027|582043602|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
161182334|NCT02406027|582043596|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161182335|NCT02406027|582043597|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161182336|NCT02406027|582043598|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161182337|NCT02406027|582043599|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161182338|NCT02406027|582043600|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
161182339|NCT02406027|582043601|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161182340|NCT02406027|582043602|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
161182341|NCT03039192|582043603|FG000|Overall Study|Lost to Follow-up|4|||
161300385|NCT04112043|582482546|FG000|Overall Study|Taking NR supplement|1|||
161300386|NCT04112043|582482547|FG001|Overall Study|Taking NR supplement|0|||
161300387|NCT04112043|582482548|FG002|Overall Study|Taking NR supplement|0|||
161300388|NCT04112043|582482546|FG000|Overall Study|Adverse Event|0|||
161300389|NCT04112043|582482547|FG001|Overall Study|Adverse Event|1|||
161300390|NCT04112043|582482548|FG002|Overall Study|Adverse Event|0|||
161300391|NCT04075682|582482551|FG000|Overall Study|Lost to Follow-up|5|||
161300392|NCT04075682|582482552|FG001|Overall Study|Lost to Follow-up|5|||
161300393|NCT04075682|582482553|FG002|Overall Study|Lost to Follow-up|2|||
161300394|NCT04075682|582482554|FG003|Overall Study|Lost to Follow-up|2|||
161300395|NCT04075682|582482551|FG000|Overall Study|Withdrawal by Subject|1|||
161300396|NCT04075682|582482552|FG001|Overall Study|Withdrawal by Subject|0|||
161300397|NCT04075682|582482553|FG002|Overall Study|Withdrawal by Subject|1|||
161300398|NCT04075682|582482554|FG003|Overall Study|Withdrawal by Subject|0|||
161300399|NCT04075682|582482551|FG000|Overall Study|Protocol Violation|0|||
161300400|NCT04075682|582482552|FG001|Overall Study|Protocol Violation|1|||
161300401|NCT04075682|582482553|FG002|Overall Study|Protocol Violation|1|||
161300402|NCT04075682|582482554|FG003|Overall Study|Protocol Violation|0|||
161300403|NCT04075682|582482551|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
161300404|NCT04075682|582482552|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
161300405|NCT04075682|582482553|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
161300406|NCT04075682|582482554|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
161300407|NCT04075682|582482551|FG000|Overall Study|Lost study phone the first day of study participation|0|||
161300408|NCT04075682|582482552|FG001|Overall Study|Lost study phone the first day of study participation|1|||
161300409|NCT04075682|582482553|FG002|Overall Study|Lost study phone the first day of study participation|0|||
161300410|NCT04075682|582482554|FG003|Overall Study|Lost study phone the first day of study participation|0|||
161300411|NCT03423173|582482555|FG000|Overall Study|Randomized but not vaccinated|1|||
161300412|NCT03423173|582482556|FG001|Overall Study|Randomized but not vaccinated|0|||
161300413|NCT03423173|582482557|FG002|Overall Study|Randomized but not vaccinated|2|||
161300414|NCT03423173|582482558|FG003|Overall Study|Randomized but not vaccinated|1|||
161300415|NCT03423173|582482555|FG000|Overall Study|Adverse Event|1|||
161300416|NCT03423173|582482556|FG001|Overall Study|Adverse Event|1|||
161300417|NCT03423173|582482557|FG002|Overall Study|Adverse Event|1|||
161300418|NCT03423173|582482558|FG003|Overall Study|Adverse Event|1|||
161300419|NCT03423173|582482555|FG000|Overall Study|Lost to Follow-up|10|||
161300420|NCT03423173|582482556|FG001|Overall Study|Lost to Follow-up|19|||
161300421|NCT03423173|582482557|FG002|Overall Study|Lost to Follow-up|17|||
161300422|NCT03423173|582482558|FG003|Overall Study|Lost to Follow-up|22|||
161300423|NCT03423173|582482555|FG000|Overall Study|Withdrawal of consent|4|||
161300424|NCT03423173|582482556|FG001|Overall Study|Withdrawal of consent|10|||
161300425|NCT03423173|582482557|FG002|Overall Study|Withdrawal of consent|4|||
161300426|NCT03423173|582482558|FG003|Overall Study|Withdrawal of consent|5|||
161300427|NCT03423173|582482555|FG000|Overall Study|Death|1|||
161300428|NCT03423173|582482556|FG001|Overall Study|Death|0|||
161300429|NCT03423173|582482557|FG002|Overall Study|Death|0|||
161300430|NCT03423173|582482558|FG003|Overall Study|Death|0|||
161300431|NCT03423173|582482555|FG000|Overall Study|Reason not Specified|2|||
161300432|NCT03423173|582482556|FG001|Overall Study|Reason not Specified|5|||
161300433|NCT03423173|582482557|FG002|Overall Study|Reason not Specified|3|||
161300434|NCT03423173|582482558|FG003|Overall Study|Reason not Specified|1|||
161300435|NCT05338502|582482559|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
161300436|NCT05338502|582482560|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
161300437|NCT05338502|582482561|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
161300438|NCT05338502|582482559|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
161300439|NCT05338502|582482560|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
161300440|NCT05338502|582482561|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
161300441|NCT02071706|582482562|FG000|Overall Study|Adverse Event|1|||
161300442|NCT02071706|582482562|FG000|Overall Study|Withdrawal by Subject|2|||
161300443|NCT02247440|582482563|FG000|Overall Study|Withdrawal by Subject|1|||
161300444|NCT02247440|582482563|FG000|Overall Study|Lack of Efficacy|3|||
161300445|NCT00729157|582482564|FG000|Overall Study|Withdrawal by Subject|1|||
161300446|NCT01855243|582482565|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
161300447|NCT01855243|582482566|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
161089391|NCT01210664|581717363|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161089392|NCT01210664|581717364|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161089393|NCT01210664|581717365|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
161182342|NCT03039192|582043604|FG001|Overall Study|Lost to Follow-up|4|||
161300448|NCT01855243|582482567|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
161300449|NCT03615144|582482568|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
161300450|NCT03615144|582482569|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
161300451|NCT04791319|582482572|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
161300452|NCT04791319|582482573|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
161319510|NCT01863732|582555337|FG003|Overall Study|Death|1|||
161182343|NCT03039192|582043603|FG000|Overall Study|Adverse event, serious fatal|0|||
161182344|NCT03039192|582043604|FG001|Overall Study|Adverse event, serious fatal|1|||
161182345|NCT03039192|582043603|FG000|Overall Study|Adverse event, non-fatal|0|||
161182346|NCT03039192|582043604|FG001|Overall Study|Adverse event, non-fatal|2|||
161182347|NCT03039192|582043603|FG000|Overall Study|Withdrawal by Subject|6|||
161182348|NCT03039192|582043604|FG001|Overall Study|Withdrawal by Subject|9|||
161182349|NCT03039192|582043603|FG000|Overall Study|Discontinued from treatment phase|19|||
161182350|NCT03039192|582043604|FG001|Overall Study|Discontinued from treatment phase|12|||
161182351|NCT03039192|582043603|FG000|Overall Study|Other|3|||
161182352|NCT03039192|582043604|FG001|Overall Study|Other|2|||
161182353|NCT03277794|582043605|FG000|Overall Study|Lost to Follow-up|2|||
161182354|NCT03277794|582043606|FG001|Overall Study|Lost to Follow-up|4|||
161182355|NCT03277794|582043605|FG000|Overall Study|Withdrew due to high acuity|1|||
161182356|NCT03277794|582043606|FG001|Overall Study|Withdrew due to high acuity|0|||
161182357|NCT02177812|582043610|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161182358|NCT02177812|582043611|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161182359|NCT02177812|582043612|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161182360|NCT02177812|582043613|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161182361|NCT02177812|582043614|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161182362|NCT02177812|582043615|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
161182363|NCT02177812|582043616|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
161182364|NCT02177812|582043617|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
161182365|NCT02177812|582043618|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
161182366|NCT02177812|582043610|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182367|NCT02177812|582043611|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182368|NCT02177812|582043612|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182369|NCT02177812|582043613|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182370|NCT02177812|582043614|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182371|NCT02177812|582043615|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
161182372|NCT02177812|582043616|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
161182373|NCT02177812|582043617|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182374|NCT02177812|582043618|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
161182375|NCT02177812|582043610|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161182376|NCT02177812|582043611|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161182377|NCT02177812|582043612|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161182378|NCT02177812|582043613|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161182379|NCT02177812|582043614|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161182380|NCT02177812|582043615|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161182381|NCT02177812|582043616|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
161182382|NCT02177812|582043617|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
161182383|NCT02177812|582043618|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
161182384|NCT00089999|582043619|FG000|Overall Study|Adverse Event|4|||
161182385|NCT00089999|582043620|FG001|Overall Study|Adverse Event|7|||
161182386|NCT00089999|582043619|FG000|Overall Study|Withdrawal by Subject|0|||
161182387|NCT00089999|582043620|FG001|Overall Study|Withdrawal by Subject|4|||
161182388|NCT00089999|582043619|FG000|Overall Study|Lost to Follow-up|2|||
161182389|NCT00089999|582043620|FG001|Overall Study|Lost to Follow-up|1|||
161182390|NCT00089999|582043619|FG000|Overall Study|Radiological Progression of Cancer|52|||
161182391|NCT00089999|582043620|FG001|Overall Study|Radiological Progression of Cancer|44|||
161182392|NCT00089999|582043619|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
161182393|NCT00089999|582043620|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
161182394|NCT00089999|582043619|FG000|Overall Study|Death|3|||
161182395|NCT00089999|582043620|FG001|Overall Study|Death|3|||
161182396|NCT00089999|582043619|FG000|Overall Study|Poor General Condition|1|||
161182397|NCT00089999|582043620|FG001|Overall Study|Poor General Condition|0|||
161182398|NCT00089999|582043619|FG000|Overall Study|Clinical Progression|1|||
161182399|NCT00089999|582043620|FG001|Overall Study|Clinical Progression|2|||
161182400|NCT00089999|582043619|FG000|Overall Study|Physician Decision|2|||
161182401|NCT00089999|582043620|FG001|Overall Study|Physician Decision|2|||
161182402|NCT00089999|582043619|FG000|Overall Study|Patient Underwent Surgery|2|||
161182403|NCT00089999|582043620|FG001|Overall Study|Patient Underwent Surgery|0|||
161182404|NCT00089999|582043619|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
161182405|NCT00089999|582043620|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
161182406|NCT04418427|582045606|FG000|Overall Study|Death|0|||
161182407|NCT04418427|582045607|FG001|Overall Study|Death|1|||
161182408|NCT04418427|582045608|FG002|Overall Study|Death|0|||
161182409|NCT04418427|582045606|FG000|Overall Study|Lost to Follow-up|0|||
161182410|NCT04418427|582045607|FG001|Overall Study|Lost to Follow-up|2|||
161182411|NCT04418427|582045608|FG002|Overall Study|Lost to Follow-up|2|||
161182412|NCT04418427|582045606|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
161182413|NCT04418427|582045607|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
161182414|NCT04418427|582045608|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
161182415|NCT04418427|582045606|FG000|Overall Study|Pre-existing medical condition|0|||
161182416|NCT04418427|582045607|FG001|Overall Study|Pre-existing medical condition|1|||
161300453|NCT04791319|582482574|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
161300454|NCT04791319|582482575|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
161300455|NCT04791319|582482576|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300456|NCT04791319|582482577|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300457|NCT04791319|582482578|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300458|NCT04791319|582482579|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300459|NCT04791319|582482580|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300460|NCT04791319|582482581|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300461|NCT04791319|582482582|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
161300462|NCT04791319|582482572|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
161300463|NCT04791319|582482573|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300464|NCT04791319|582482574|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
161300465|NCT04791319|582482575|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
161300466|NCT04791319|582482576|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300467|NCT04791319|582482577|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300468|NCT04791319|582482578|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300469|NCT04791319|582482579|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300470|NCT04791319|582482580|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300471|NCT04791319|582482581|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300472|NCT04791319|582482582|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
161300473|NCT04791319|582482572|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
161300474|NCT04791319|582482573|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
161300475|NCT04791319|582482574|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
161300476|NCT04791319|582482575|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
161300477|NCT04791319|582482576|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300478|NCT04791319|582482577|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300479|NCT04791319|582482578|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300480|NCT04791319|582482579|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300481|NCT04791319|582482580|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300482|NCT04791319|582482581|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300483|NCT04791319|582482582|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
161300484|NCT04791319|582482572|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
161300485|NCT04791319|582482573|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
161300486|NCT04791319|582482574|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
161300487|NCT04791319|582482575|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
161300488|NCT04791319|582482576|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300489|NCT04791319|582482577|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300490|NCT04791319|582482578|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300491|NCT04791319|582482579|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300492|NCT04791319|582482580|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300493|NCT04791319|582482581|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300494|NCT04791319|582482582|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
161300495|NCT04791319|582482572|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300496|NCT04791319|582482573|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300497|NCT04791319|582482574|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300498|NCT04791319|582482575|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
161300499|NCT04791319|582482576|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300500|NCT04791319|582482577|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300501|NCT04791319|582482578|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300502|NCT04791319|582482579|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300503|NCT04791319|582482580|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300504|NCT04791319|582482581|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161182417|NCT04418427|582045608|FG002|Overall Study|Pre-existing medical condition|0|||
161182418|NCT01673373|582045611|FG000|Overall Study|Death|2|||
161182419|NCT02010567|582045613|FG000|Overall Study|Adverse Event|0|||
161182420|NCT02010567|582045614|FG001|Overall Study|Adverse Event|0|||
161182421|NCT02010567|582045615|FG002|Overall Study|Adverse Event|1|||
161182422|NCT02010567|582045616|FG003|Overall Study|Adverse Event|0|||
161182423|NCT02010567|582045617|FG004|Overall Study|Adverse Event|1|||
161182424|NCT00623766|582045620|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
161182425|NCT00623766|582045621|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
161182426|NCT00623766|582045620|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
161182427|NCT00623766|582045621|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
161182428|NCT00623766|582045620|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
161300505|NCT04791319|582482582|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
161300506|NCT04791319|582482572|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300507|NCT04791319|582482573|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300508|NCT04791319|582482574|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300509|NCT04791319|582482575|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300510|NCT04791319|582482576|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
161300511|NCT04791319|582482577|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
161300512|NCT04791319|582482578|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
161300513|NCT04791319|582482579|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300514|NCT04791319|582482580|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300515|NCT04791319|582482581|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
161300516|NCT04791319|582482582|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
161300517|NCT04791319|582482572|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300518|NCT04791319|582482573|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300519|NCT04791319|582482574|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300520|NCT04791319|582482575|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300521|NCT04791319|582482576|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300522|NCT04791319|582482577|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300523|NCT04791319|582482578|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300524|NCT04791319|582482579|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300525|NCT04791319|582482580|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300526|NCT04791319|582482581|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
161300527|NCT04791319|582482582|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
161300528|NCT04791319|582482572|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161300529|NCT04791319|582482573|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161300530|NCT04791319|582482574|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161300531|NCT04791319|582482575|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161300532|NCT04791319|582482576|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
161300533|NCT04791319|582482577|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
161300534|NCT04791319|582482578|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
161300535|NCT04791319|582482579|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
161300536|NCT04791319|582482580|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
161300537|NCT04791319|582482581|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
161300538|NCT04791319|582482582|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
161300539|NCT04791319|582482572|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161300540|NCT04791319|582482573|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161300541|NCT04791319|582482574|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161300542|NCT04791319|582482575|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
161300543|NCT04791319|582482576|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
161300544|NCT04791319|582482577|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
161300545|NCT04791319|582482578|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
161300546|NCT04791319|582482579|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
161300547|NCT04791319|582482580|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
161300548|NCT04791319|582482581|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
161300549|NCT04791319|582482582|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
161300550|NCT01704651|582482587|FG000|Overall Study|Pre-op withdrawal by subject|1|||
161300551|NCT01704651|582482588|FG001|Overall Study|Pre-op withdrawal by subject|1|||
161300552|NCT01704651|582482587|FG000|Overall Study|Pre-op change in treatment plan|1|||
161300553|NCT01704651|582482588|FG001|Overall Study|Pre-op change in treatment plan|4|||
161300554|NCT01704651|582482587|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
161300555|NCT01704651|582482588|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
161300556|NCT01704651|582482587|FG000|Overall Study|Post-op did not have laparotomy|2|||
161300557|NCT01704651|582482588|FG001|Overall Study|Post-op did not have laparotomy|1|||
161300558|NCT03474731|582482598|FG000|Overall Study|Withdrawal by Subject|36|||
161300559|NCT03474731|582482599|FG001|Overall Study|Withdrawal by Subject|29|||
161300560|NCT03474731|582482600|FG002|Overall Study|Withdrawal by Subject|11|||
161300561|NCT03474731|582482601|FG003|Overall Study|Withdrawal by Subject|27|||
161300562|NCT03474731|582482598|FG000|Overall Study|COVID|0|||
161300563|NCT03474731|582482599|FG001|Overall Study|COVID|23|||
161300564|NCT03474731|582482600|FG002|Overall Study|COVID|0|||
161300565|NCT03474731|582482601|FG003|Overall Study|COVID|0|||
161300566|NCT03474731|582482598|FG000|Overall Study|Participant moved from area|1|||
161300567|NCT03474731|582482599|FG001|Overall Study|Participant moved from area|0|||
161300568|NCT03474731|582482600|FG002|Overall Study|Participant moved from area|0|||
161300569|NCT03474731|582482601|FG003|Overall Study|Participant moved from area|0|||
161300570|NCT03474731|582482598|FG000|Overall Study|Lost to Follow-up|11|||
161300571|NCT03474731|582482599|FG001|Overall Study|Lost to Follow-up|3|||
161300572|NCT03474731|582482600|FG002|Overall Study|Lost to Follow-up|18|||
161300573|NCT03474731|582482601|FG003|Overall Study|Lost to Follow-up|17|||
161300574|NCT03474731|582482598|FG000|Overall Study|Death|0|||
161300575|NCT03474731|582482599|FG001|Overall Study|Death|1|||
161300576|NCT03474731|582482600|FG002|Overall Study|Death|0|||
161300577|NCT03474731|582482601|FG003|Overall Study|Death|0|||
161300578|NCT03474731|582482598|FG000|Overall Study|Participant Removed|0|||
161300579|NCT03474731|582482599|FG001|Overall Study|Participant Removed|0|||
161300580|NCT03474731|582482600|FG002|Overall Study|Participant Removed|0|||
161300581|NCT03474731|582482601|FG003|Overall Study|Participant Removed|1|||
161300582|NCT00554515|582482602|FG000|Overall Study|Withdrawal by Subject|3|||
161300583|NCT00554515|582482602|FG000|Overall Study|Disease progression|52|||
161300584|NCT00554515|582482602|FG000|Overall Study|Physician Decision|18|||
161300585|NCT00554515|582482602|FG000|Overall Study|Withdrawal by Subject|11|||
161300586|NCT00554515|582482602|FG000|Overall Study|Adverse Event|9|||
161300587|NCT00554515|582482602|FG000|Overall Study|Death|2|||
161300588|NCT00554515|582482602|FG000|Overall Study|Achieved Stable Disease|7|||
161300589|NCT00554515|582482602|FG000|Overall Study|Other|1|||
161300590|NCT00554515|582482602|FG000|Overall Study|Misc|15|||
161300591|NCT03793842|582482610|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
161300592|NCT03793842|582482611|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
161300593|NCT03793842|582482610|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
161300594|NCT03793842|582482611|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
161300595|NCT02549287|582482612|FG000|Overall Study|Lost to Follow-up|65|||
161300596|NCT02549287|582482613|FG001|Overall Study|Lost to Follow-up|26|||
161300597|NCT02549287|582482612|FG000|Overall Study|Withdrawal by Subject|15|||
161300598|NCT02549287|582482613|FG001|Overall Study|Withdrawal by Subject|6|||
161300599|NCT04087720|582482614|FG000|Overall Study|Withdrawal by Subject|2|||
161300600|NCT04087720|582482614|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
161300601|NCT00900159|582482617|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
161300602|NCT00900159|582482618|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
161300603|NCT00765336|582482619|FG000|Overall Study|Protocol Violation|4|||
161300604|NCT00765336|582482620|FG001|Overall Study|Protocol Violation|2|||
161300605|NCT00765336|582482619|FG000|Overall Study|Withdrawal by Subject|6|||
161300606|NCT00765336|582482620|FG001|Overall Study|Withdrawal by Subject|4|||
161300607|NCT00765336|582482619|FG000|Overall Study|Lost to Follow-up|7|||
161300608|NCT00765336|582482620|FG001|Overall Study|Lost to Follow-up|9|||
161300609|NCT00765336|582482619|FG000|Overall Study|Adverse Event|2|||
161300610|NCT00765336|582482620|FG001|Overall Study|Adverse Event|1|||
161089394|NCT01210664|581717366|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
161089395|NCT01210664|581717363|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161089396|NCT01210664|581717364|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161089397|NCT01210664|581717365|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
161089398|NCT01210664|581717366|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
161089399|NCT01853644|581717367|FG000|Registration and Treatment Start|Did not start treatment|1|||
161089400|NCT01853644|581717367|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
161089401|NCT01853644|581717367|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
161089402|NCT01853644|581717367|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
161089403|NCT01853644|581717367|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
161089404|NCT01853644|581717367|FG000|Continued Treatment After First Response|Adverse Event|2|||
161089405|NCT01853644|581717367|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
161089406|NCT02891408|581717368|FG000|Overall Study|Lost to Follow-up|0|||
161089407|NCT02891408|581717369|FG001|Overall Study|Lost to Follow-up|0|||
161089408|NCT02891408|581717370|FG002|Overall Study|Lost to Follow-up|1|||
161089409|NCT02891408|581717371|FG003|Overall Study|Lost to Follow-up|0|||
161089410|NCT02891408|581717372|FG004|Overall Study|Lost to Follow-up|0|||
161089411|NCT02891408|581717373|FG005|Overall Study|Lost to Follow-up|0|||
161089412|NCT02891408|581717374|FG006|Overall Study|Lost to Follow-up|0|||
161089413|NCT00950950|581717375|FG000|Overall Study|Adverse Event|1|||
161089414|NCT00950950|581717376|FG001|Overall Study|Adverse Event|0|||
161089415|NCT00950950|581717375|FG000|Overall Study|Withdrawal by Subject|0|||
161089416|NCT00950950|581717376|FG001|Overall Study|Withdrawal by Subject|1|||
161089417|NCT02679508|581717377|FG000|Healing Phase|Protocol Violation|1|||
161089418|NCT02679508|581717378|FG001|Healing Phase|Protocol Violation|1|||
161089419|NCT02679508|581717377|FG000|Healing Phase|Lost to Follow-up|1|||
161089420|NCT02679508|581717378|FG001|Healing Phase|Lost to Follow-up|0|||
161089421|NCT02679508|581717377|FG000|Maintenance Phase|Adverse Event|12|||
161089422|NCT02679508|581717378|FG001|Maintenance Phase|Adverse Event|2|||
161089423|NCT02679508|581717377|FG000|Maintenance Phase|Lost to Follow-up|0|||
161089424|NCT02679508|581717378|FG001|Maintenance Phase|Lost to Follow-up|1|||
161089425|NCT02679508|581717377|FG000|Maintenance Phase|Withdrawal by Subject|15|||
161089426|NCT02679508|581717378|FG001|Maintenance Phase|Withdrawal by Subject|8|||
161089427|NCT02679508|581717377|FG000|Maintenance Phase|Other|5|||
161089428|NCT02679508|581717378|FG001|Maintenance Phase|Other|4|||
161089429|NCT01588496|581717379|FG000|Overall Study|Withdrawal by Subject|0|||
161089430|NCT01588496|581717380|FG001|Overall Study|Withdrawal by Subject|1|||
161089431|NCT01588496|581717381|FG002|Overall Study|Withdrawal by Subject|0|||
161089432|NCT03143166|581717382|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
161089433|NCT05924945|581717383|FG000|Overall Study|Withdrawal by Subject|3|||
161300611|NCT01377922|582482621|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
161300612|NCT01377922|582482622|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
161300613|NCT04615403|582482623|FG000|Overall Study|Death|1|||
161300614|NCT00665431|582482624|FG000|Overall Study|Adverse Event|16|||
161300615|NCT00665431|582482625|FG001|Overall Study|Adverse Event|22|||
161300616|NCT00665431|582482626|FG002|Overall Study|Adverse Event|6|||
161300617|NCT00665431|582482624|FG000|Overall Study|Withdrawal by Subject|17|||
161300618|NCT00665431|582482625|FG001|Overall Study|Withdrawal by Subject|25|||
161300619|NCT00665431|582482626|FG002|Overall Study|Withdrawal by Subject|15|||
161300620|NCT00665431|582482624|FG000|Overall Study|Lost to Follow-up|3|||
161300621|NCT00665431|582482625|FG001|Overall Study|Lost to Follow-up|3|||
161300622|NCT00665431|582482626|FG002|Overall Study|Lost to Follow-up|1|||
161300623|NCT00665431|582482624|FG000|Overall Study|Other|4|||
161300624|NCT00665431|582482625|FG001|Overall Study|Other|7|||
161300625|NCT00665431|582482626|FG002|Overall Study|Other|2|||
161300626|NCT01464164|582482630|FG000|Overall Study|Screen failure|0|||
161300627|NCT01464164|582482631|FG001|Overall Study|Screen failure|1|||
161300628|NCT01464164|582482632|FG002|Overall Study|Screen failure|2|||
161300629|NCT01464164|582482633|FG003|Overall Study|Screen failure|0|||
161300630|NCT01464164|582482634|FG004|Overall Study|Screen failure|0|||
161300631|NCT01464164|582482635|FG005|Overall Study|Screen failure|0|||
161300632|NCT01464164|582482636|FG006|Overall Study|Screen failure|0|||
161300633|NCT01464164|582482630|FG000|Overall Study|Physician Decision|0|||
161300634|NCT01464164|582482631|FG001|Overall Study|Physician Decision|1|||
161300635|NCT01464164|582482632|FG002|Overall Study|Physician Decision|0|||
161300636|NCT01464164|582482633|FG003|Overall Study|Physician Decision|0|||
161300637|NCT01464164|582482634|FG004|Overall Study|Physician Decision|0|||
161300638|NCT01464164|582482635|FG005|Overall Study|Physician Decision|0|||
161300639|NCT01464164|582482636|FG006|Overall Study|Physician Decision|2|||
161300640|NCT01578239|582482637|FG000|Treatment Period|Progressive Disease|19|||
161300641|NCT01578239|582482638|FG001|Treatment Period|Progressive Disease|64|||
161300642|NCT01578239|582482637|FG000|Treatment Period|Physician Decision|17|||
161300643|NCT01578239|582482638|FG001|Treatment Period|Physician Decision|17|||
161300644|NCT01578239|582482637|FG000|Treatment Period|Adverse Event|13|||
161300645|NCT01578239|582482638|FG001|Treatment Period|Adverse Event|10|||
161300646|NCT01578239|582482637|FG000|Treatment Period|Non-compliance|2|||
161300647|NCT01578239|582482638|FG001|Treatment Period|Non-compliance|0|||
161300648|NCT01578239|582482637|FG000|Treatment Period|Withdrawal by Subject|10|||
161300649|NCT01578239|582482638|FG001|Treatment Period|Withdrawal by Subject|9|||
161300650|NCT01578239|582482637|FG000|Treatment Period|Other|6|||
161300651|NCT01578239|582482638|FG001|Treatment Period|Other|1|||
161300652|NCT01578239|582482637|FG000|Long-term Follow-Up Period|Death|69|||
161300653|NCT01578239|582482638|FG001|Long-term Follow-Up Period|Death|64|||
161300654|NCT01578239|582482637|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
161300655|NCT01578239|582482638|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
161300656|NCT01578239|582482637|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
161300657|NCT01578239|582482638|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
161300658|NCT01578239|582482637|FG000|Long-term Follow-Up Period|Other|2|||
161300659|NCT01578239|582482638|FG001|Long-term Follow-Up Period|Other|2|||
161300660|NCT02347813|582482641|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
161300661|NCT02347813|582482642|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
161300662|NCT02347813|582482641|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
161300663|NCT02347813|582482642|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
161300664|NCT02547220|582482646|FG000|Overall Study|Withdrawal by Subject|1|||
161300665|NCT02547220|582482647|FG001|Overall Study|Withdrawal by Subject|0|||
161300666|NCT02547220|582482646|FG000|Overall Study|Study terminated by sponsor|18|||
161300667|NCT02547220|582482647|FG001|Overall Study|Study terminated by sponsor|20|||
161300668|NCT03817229|582482648|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
161300669|NCT03817229|582482649|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
161300670|NCT03817229|582482650|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
161300671|NCT03817229|582482651|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
161300672|NCT03817229|582482648|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161300673|NCT03817229|582482649|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
161300674|NCT03817229|582482650|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161300675|NCT03817229|582482651|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
161300676|NCT03817229|582482648|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
161089434|NCT05924945|581717384|FG001|Overall Study|Withdrawal by Subject|4|||
161300677|NCT03817229|582482649|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
161300678|NCT03817229|582482650|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
161300679|NCT03817229|582482651|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
161300680|NCT03817229|582482648|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
161300681|NCT03817229|582482649|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
161300682|NCT03817229|582482650|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
161300683|NCT03817229|582482651|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
161300684|NCT03817229|582482648|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161300685|NCT03817229|582482649|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161300686|NCT03817229|582482650|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
161300687|NCT03817229|582482651|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
161300688|NCT03817229|582482648|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
161300689|NCT03817229|582482649|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
161300690|NCT03817229|582482650|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
161300691|NCT03817229|582482651|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
161300692|NCT03817229|582482648|FG000|Post-Intervention|Withdrawal by Subject|6|||
161300693|NCT03817229|582482649|FG001|Post-Intervention|Withdrawal by Subject|0|||
161300694|NCT03817229|582482650|FG002|Post-Intervention|Withdrawal by Subject|2|||
161300695|NCT03817229|582482651|FG003|Post-Intervention|Withdrawal by Subject|2|||
161300696|NCT03817229|582482648|FG000|Post-Intervention|Withdrawal by Study Team|3|||
161300697|NCT03817229|582482649|FG001|Post-Intervention|Withdrawal by Study Team|1|||
161300698|NCT03817229|582482650|FG002|Post-Intervention|Withdrawal by Study Team|1|||
161300699|NCT03817229|582482651|FG003|Post-Intervention|Withdrawal by Study Team|4|||
161300700|NCT03817229|582482648|FG000|Post-Intervention|Weaned from medication|3|||
161300701|NCT03817229|582482649|FG001|Post-Intervention|Weaned from medication|0|||
161300702|NCT03817229|582482650|FG002|Post-Intervention|Weaned from medication|2|||
161300703|NCT03817229|582482651|FG003|Post-Intervention|Weaned from medication|1|||
161300704|NCT03817229|582482648|FG000|Post-Intervention|Transferred care to another institution|1|||
161300705|NCT03817229|582482649|FG001|Post-Intervention|Transferred care to another institution|0|||
161300706|NCT03817229|582482650|FG002|Post-Intervention|Transferred care to another institution|0|||
161300707|NCT03817229|582482651|FG003|Post-Intervention|Transferred care to another institution|0|||
161300708|NCT03817229|582482648|FG000|Post-Intervention|Change in parental guardianship|0|||
161300709|NCT03817229|582482649|FG001|Post-Intervention|Change in parental guardianship|0|||
161300710|NCT03817229|582482650|FG002|Post-Intervention|Change in parental guardianship|1|||
161300711|NCT03817229|582482651|FG003|Post-Intervention|Change in parental guardianship|0|||
161182429|NCT00623766|582045621|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
161182430|NCT00623766|582045620|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
161182431|NCT00623766|582045621|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
161182432|NCT00623766|582045620|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
161182433|NCT00623766|582045621|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
161182434|NCT03523715|582045623|FG000|Overall Study|Lost to Follow-up|11|||
161182435|NCT03523715|582045624|FG001|Overall Study|Lost to Follow-up|14|||
161182436|NCT03523715|582045623|FG000|Overall Study|Did not meet inclusion criteria|1|||
161182437|NCT03523715|582045624|FG001|Overall Study|Did not meet inclusion criteria|0|||
161182438|NCT03523715|582045623|FG000|Overall Study|Internally inconsistent reporting|0|||
161182439|NCT03523715|582045624|FG001|Overall Study|Internally inconsistent reporting|2|||
161182440|NCT01526928|582045625|FG000|Overall Study|Progressive Disease|35|||
161182441|NCT01526928|582045626|FG001|Overall Study|Progressive Disease|17|||
161182442|NCT01526928|582045627|FG002|Overall Study|Progressive Disease|150|||
161182443|NCT01526928|582045628|FG003|Overall Study|Progressive Disease|182|||
161182444|NCT01526928|582045629|FG004|Overall Study|Progressive Disease|76|||
161182445|NCT01526928|582045630|FG005|Overall Study|Progressive Disease|4|||
161182446|NCT01526928|582045625|FG000|Overall Study|Adverse Event|2|||
161182447|NCT01526928|582045626|FG001|Overall Study|Adverse Event|1|||
161182448|NCT01526928|582045627|FG002|Overall Study|Adverse Event|29|||
161182449|NCT01526928|582045628|FG003|Overall Study|Adverse Event|40|||
161182450|NCT01526928|582045629|FG004|Overall Study|Adverse Event|13|||
161182451|NCT01526928|582045630|FG005|Overall Study|Adverse Event|2|||
161182452|NCT01526928|582045625|FG000|Overall Study|Death|0|||
161182453|NCT01526928|582045626|FG001|Overall Study|Death|0|||
161182454|NCT01526928|582045627|FG002|Overall Study|Death|3|||
161182455|NCT01526928|582045628|FG003|Overall Study|Death|0|||
161182456|NCT01526928|582045629|FG004|Overall Study|Death|0|||
161182457|NCT01526928|582045630|FG005|Overall Study|Death|0|||
161300712|NCT03817229|582482648|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
161300713|NCT03817229|582482649|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
161182458|NCT01526928|582045625|FG000|Overall Study|Withdrawal by Subject|1|||
161182459|NCT01526928|582045626|FG001|Overall Study|Withdrawal by Subject|0|||
161300714|NCT03817229|582482650|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
161300715|NCT03817229|582482651|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
161182460|NCT01526928|582045627|FG002|Overall Study|Withdrawal by Subject|13|||
161300716|NCT03817229|582482648|FG000|Follow-up 1|Withdrawal by Subject|1|||
161300717|NCT03817229|582482649|FG001|Follow-up 1|Withdrawal by Subject|2|||
161300718|NCT03817229|582482650|FG002|Follow-up 1|Withdrawal by Subject|0|||
161300719|NCT03817229|582482651|FG003|Follow-up 1|Withdrawal by Subject|0|||
161300720|NCT03817229|582482648|FG000|Follow-up 1|Withdrawal by Study Team|3|||
161300721|NCT03817229|582482649|FG001|Follow-up 1|Withdrawal by Study Team|1|||
161300722|NCT03817229|582482650|FG002|Follow-up 1|Withdrawal by Study Team|0|||
161300723|NCT03817229|582482651|FG003|Follow-up 1|Withdrawal by Study Team|0|||
161300724|NCT03817229|582482648|FG000|Follow-up 1|Wean from medication|3|||
161300725|NCT03817229|582482649|FG001|Follow-up 1|Wean from medication|4|||
161300726|NCT03817229|582482650|FG002|Follow-up 1|Wean from medication|0|||
161300727|NCT03817229|582482651|FG003|Follow-up 1|Wean from medication|1|||
161300728|NCT03817229|582482648|FG000|Follow-up 1|Transferred care to another hospital|1|||
161300729|NCT03817229|582482649|FG001|Follow-up 1|Transferred care to another hospital|0|||
161300730|NCT03817229|582482650|FG002|Follow-up 1|Transferred care to another hospital|0|||
161300731|NCT03817229|582482651|FG003|Follow-up 1|Transferred care to another hospital|0|||
161300732|NCT03817229|582482648|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
161300733|NCT03817229|582482649|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
161300734|NCT03817229|582482650|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
161300735|NCT03817229|582482651|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
161300736|NCT03817229|582482648|FG000|Follow-up 2|Withdrawal by Subject|2|||
161300737|NCT03817229|582482649|FG001|Follow-up 2|Withdrawal by Subject|0|||
161300738|NCT03817229|582482650|FG002|Follow-up 2|Withdrawal by Subject|1|||
161300739|NCT03817229|582482651|FG003|Follow-up 2|Withdrawal by Subject|1|||
161300740|NCT03817229|582482648|FG000|Follow-up 2|Withdrawal by Study Team|2|||
161300741|NCT03817229|582482649|FG001|Follow-up 2|Withdrawal by Study Team|0|||
161182461|NCT01526928|582045628|FG003|Overall Study|Withdrawal by Subject|11|||
161182462|NCT01526928|582045629|FG004|Overall Study|Withdrawal by Subject|3|||
161182463|NCT01526928|582045630|FG005|Overall Study|Withdrawal by Subject|0|||
161182464|NCT01526928|582045625|FG000|Overall Study|Physician Decision|0|||
161182465|NCT01526928|582045626|FG001|Overall Study|Physician Decision|0|||
161300742|NCT03817229|582482650|FG002|Follow-up 2|Withdrawal by Study Team|1|||
161300743|NCT03817229|582482651|FG003|Follow-up 2|Withdrawal by Study Team|0|||
161300744|NCT03817229|582482648|FG000|Follow-up 2|Wean from medication|1|||
161300745|NCT03817229|582482649|FG001|Follow-up 2|Wean from medication|0|||
161300746|NCT03817229|582482650|FG002|Follow-up 2|Wean from medication|0|||
161300747|NCT03817229|582482651|FG003|Follow-up 2|Wean from medication|0|||
161300748|NCT03817229|582482648|FG000|Follow-up 2|Transferred care|0|||
161300749|NCT03817229|582482649|FG001|Follow-up 2|Transferred care|0|||
161300750|NCT03817229|582482650|FG002|Follow-up 2|Transferred care|1|||
161300751|NCT03817229|582482651|FG003|Follow-up 2|Transferred care|0|||
161300752|NCT02887183|582482653|FG000|Overall Study|Adverse Event|44|||
161300753|NCT02887183|582482653|FG000|Overall Study|Death|30|||
161182466|NCT01526928|582045627|FG002|Overall Study|Physician Decision|2|||
161182467|NCT01526928|582045628|FG003|Overall Study|Physician Decision|5|||
161182468|NCT01526928|582045629|FG004|Overall Study|Physician Decision|0|||
161182469|NCT01526928|582045630|FG005|Overall Study|Physician Decision|0|||
161182470|NCT01526928|582045625|FG000|Overall Study|Other Reason|0|||
161182471|NCT01526928|582045626|FG001|Overall Study|Other Reason|1|||
161300754|NCT02887183|582482653|FG000|Overall Study|Pregnancy|1|||
161300755|NCT02887183|582482653|FG000|Overall Study|Protocol Violation|6|||
161300756|NCT02887183|582482653|FG000|Overall Study|Technical Problems|2|||
161300757|NCT02887183|582482653|FG000|Overall Study|Lost to Follow-up|13|||
161300758|NCT02887183|582482653|FG000|Overall Study|Physician Decision|10|||
161300759|NCT02887183|582482653|FG000|Overall Study|Withdrawal by Subject|35|||
161300760|NCT01029782|582482654|FG000|Overall Study|Lost to Follow-up|2|||
161300761|NCT01029782|582482655|FG001|Overall Study|Lost to Follow-up|2|||
161300762|NCT01029782|582482654|FG000|Overall Study|Diagnosis changed|1|||
161347865|NCT02903914|582657366|FG005|Overall Study|Completed Follow-up Period|0|||
161347866|NCT02903914|582657367|FG006|Overall Study|Completed Follow-up Period|9|||
161347867|NCT02903914|582657368|FG007|Overall Study|Completed Follow-up Period|1|||
161347868|NCT02903914|582657361|FG000|Overall Study|Taken off Treatment per Protocol|0|||
161182472|NCT01526928|582045627|FG002|Overall Study|Other Reason|11|||
161182473|NCT01526928|582045628|FG003|Overall Study|Other Reason|4|||
161182474|NCT01526928|582045629|FG004|Overall Study|Other Reason|1|||
161300763|NCT01029782|582482655|FG001|Overall Study|Diagnosis changed|1|||
161347869|NCT02903914|582657362|FG001|Overall Study|Taken off Treatment per Protocol|0|||
161347870|NCT02903914|582657363|FG002|Overall Study|Taken off Treatment per Protocol|0|||
161182475|NCT01526928|582045630|FG005|Overall Study|Other Reason|0|||
161182476|NCT01526928|582045625|FG000|Overall Study|Lost to Follow-up|0|||
161300764|NCT01029782|582482654|FG000|Overall Study|Adverse Event|0|||
161300765|NCT01029782|582482655|FG001|Overall Study|Adverse Event|1|||
161300766|NCT01029782|582482654|FG000|Overall Study|Physician Decision|0|||
161300767|NCT01029782|582482655|FG001|Overall Study|Physician Decision|1|||
161300768|NCT01029782|582482654|FG000|Overall Study|Protocol Violation|0|||
161300769|NCT01029782|582482655|FG001|Overall Study|Protocol Violation|2|||
161300770|NCT01029782|582482654|FG000|Overall Study|Withdrawal by Subject|0|||
161182477|NCT01526928|582045626|FG001|Overall Study|Lost to Follow-up|0|||
161182478|NCT01526928|582045627|FG002|Overall Study|Lost to Follow-up|0|||
161182479|NCT01526928|582045628|FG003|Overall Study|Lost to Follow-up|1|||
161182480|NCT01526928|582045629|FG004|Overall Study|Lost to Follow-up|0|||
161182481|NCT01526928|582045630|FG005|Overall Study|Lost to Follow-up|0|||
161182482|NCT01526928|582045625|FG000|Overall Study|Protocol Deviation|0|||
161182483|NCT01526928|582045626|FG001|Overall Study|Protocol Deviation|0|||
161182484|NCT01526928|582045627|FG002|Overall Study|Protocol Deviation|0|||
161182485|NCT01526928|582045628|FG003|Overall Study|Protocol Deviation|2|||
161182486|NCT01526928|582045629|FG004|Overall Study|Protocol Deviation|0|||
161182487|NCT01526928|582045630|FG005|Overall Study|Protocol Deviation|0|||
161182488|NCT01526928|582045625|FG000|Overall Study|Missing|0|||
161182489|NCT01526928|582045626|FG001|Overall Study|Missing|0|||
161182490|NCT01526928|582045627|FG002|Overall Study|Missing|1|||
161182491|NCT01526928|582045628|FG003|Overall Study|Missing|0|||
161182492|NCT01526928|582045629|FG004|Overall Study|Missing|2|||
161182493|NCT01526928|582045630|FG005|Overall Study|Missing|0|||
161182494|NCT05559203|582045638|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
161182495|NCT01810380|582045648|FG000|Overall Study|Randomised not treated|2|||
161182496|NCT01810380|582045649|FG001|Overall Study|Randomised not treated|1|||
161182497|NCT01810380|582045650|FG002|Overall Study|Randomised not treated|1|||
161182498|NCT01810380|582045648|FG000|Overall Study|Adverse Event|11|||
161182499|NCT01810380|582045649|FG001|Overall Study|Adverse Event|14|||
161182500|NCT01810380|582045650|FG002|Overall Study|Adverse Event|4|||
161182501|NCT01810380|582045648|FG000|Overall Study|Lack of Efficacy|24|||
161182502|NCT01810380|582045649|FG001|Overall Study|Lack of Efficacy|10|||
161182503|NCT01810380|582045650|FG002|Overall Study|Lack of Efficacy|11|||
161182504|NCT01810380|582045648|FG000|Overall Study|Protocol Violation|1|||
161182505|NCT01810380|582045649|FG001|Overall Study|Protocol Violation|0|||
161182506|NCT01810380|582045650|FG002|Overall Study|Protocol Violation|1|||
161182507|NCT01810380|582045648|FG000|Overall Study|Withdrawal by Subject|6|||
161182508|NCT01810380|582045649|FG001|Overall Study|Withdrawal by Subject|0|||
161182509|NCT01810380|582045650|FG002|Overall Study|Withdrawal by Subject|6|||
161182510|NCT01810380|582045648|FG000|Overall Study|Administrative or other reasons|11|||
161182511|NCT01810380|582045649|FG001|Overall Study|Administrative or other reasons|13|||
161182512|NCT01810380|582045650|FG002|Overall Study|Administrative or other reasons|9|||
161182513|NCT02829775|582045651|FG000|Overall Study|Death|1|||
161182514|NCT02829775|582045651|FG000|Overall Study|Withdrawal by Subject|3|||
161182515|NCT02829775|582045651|FG000|Overall Study|Disease remission|1|||
161182516|NCT03148795|582045664|FG000|Overall Study|Progressive Disease|1|||
161182517|NCT00441012|582045665|FG000|Overall Study|Adverse Event|0|||
161182518|NCT00441012|582045666|FG001|Overall Study|Adverse Event|1|||
161182519|NCT00441012|582045665|FG000|Overall Study|Lost to Follow-up|3|||
161182520|NCT00441012|582045666|FG001|Overall Study|Lost to Follow-up|3|||
161182521|NCT00441012|582045665|FG000|Overall Study|Protocol Violation|10|||
161182522|NCT00441012|582045666|FG001|Overall Study|Protocol Violation|9|||
161182523|NCT00441012|582045665|FG000|Overall Study|Withdrawal by Subject|4|||
161182524|NCT00441012|582045666|FG001|Overall Study|Withdrawal by Subject|0|||
161182525|NCT00441012|582045665|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
161182526|NCT00441012|582045666|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
161182527|NCT04489940|582045667|FG000|Overall Study|Other|2|||
161182528|NCT04489940|582045667|FG000|Overall Study|Withdrawal by Subject|2|||
161182529|NCT04489940|582045667|FG000|Overall Study|Death|5|||
161182530|NCT04489940|582045667|FG000|Overall Study|Lost to Follow-up|1|||
161182531|NCT04498468|582045668|FG000|Overall Study|Lost to Follow-up|3|||
161182532|NCT02725268|582045669|FG000|Overall Study|Death|58|||
161182533|NCT02725268|582045670|FG001|Overall Study|Death|59|||
161182534|NCT02725268|582045671|FG002|Overall Study|Death|30|||
161182535|NCT02725268|582045672|FG003|Overall Study|Death|16|||
161182536|NCT02725268|582045669|FG000|Overall Study|Lost to Follow-up|4|||
161182537|NCT02725268|582045670|FG001|Overall Study|Lost to Follow-up|3|||
161182538|NCT02725268|582045671|FG002|Overall Study|Lost to Follow-up|0|||
161182539|NCT02725268|582045672|FG003|Overall Study|Lost to Follow-up|1|||
161182540|NCT02725268|582045669|FG000|Overall Study|Site Terminated by Sponsor|0|||
161182541|NCT02725268|582045670|FG001|Overall Study|Site Terminated by Sponsor|1|||
161182542|NCT02725268|582045671|FG002|Overall Study|Site Terminated by Sponsor|0|||
161182543|NCT02725268|582045672|FG003|Overall Study|Site Terminated by Sponsor|0|||
161182544|NCT02725268|582045669|FG000|Overall Study|Withdrawal by Subject|8|||
161182545|NCT02725268|582045670|FG001|Overall Study|Withdrawal by Subject|6|||
161182546|NCT02725268|582045671|FG002|Overall Study|Withdrawal by Subject|8|||
161182547|NCT02725268|582045672|FG003|Overall Study|Withdrawal by Subject|1|||
161182548|NCT02725268|582045669|FG000|Overall Study|Reason not Specified|2|||
161182549|NCT02725268|582045670|FG001|Overall Study|Reason not Specified|1|||
161182550|NCT02725268|582045671|FG002|Overall Study|Reason not Specified|0|||
161182551|NCT02725268|582045672|FG003|Overall Study|Reason not Specified|0|||
161182552|NCT00262314|582045678|FG000|Overall Study|Changing physicians|38|||
161182553|NCT00262314|582045678|FG000|Overall Study|Death|12|||
161182554|NCT00262314|582045678|FG000|Overall Study|Patient's decision|92|||
161182555|NCT00262314|582045678|FG000|Overall Study|Other|95|||
161300771|NCT01029782|582482655|FG001|Overall Study|Withdrawal by Subject|1|||
161300772|NCT02195869|582482657|FG000|Overall Study|cGVHD Progression|5|||
161300773|NCT02195869|582482657|FG000|Overall Study|Malignancy Progression/relapse|2|||
161300774|NCT02195869|582482657|FG000|Overall Study|Adverse Event|15|||
161300775|NCT02195869|582482657|FG000|Overall Study|Withdrawal by Subject|7|||
161300776|NCT02195869|582482657|FG000|Overall Study|Physician Decision|4|||
161300777|NCT02195869|582482657|FG000|Overall Study|Study Terminated by Sponsor|7|||
161300778|NCT02195869|582482657|FG000|Overall Study|Noncompliance with study drug|2|||
161300779|NCT00757042|582482661|FG000|Overall Study|Lost to Follow-up|0|||
161300780|NCT00757042|582482662|FG001|Overall Study|Lost to Follow-up|0|||
161300781|NCT00757042|582482663|FG002|Overall Study|Lost to Follow-up|0|||
161300782|NCT00757042|582482664|FG003|Overall Study|Lost to Follow-up|0|||
161300783|NCT00757042|582482665|FG004|Overall Study|Lost to Follow-up|0|||
161300784|NCT00757042|582482666|FG005|Overall Study|Lost to Follow-up|0|||
161300785|NCT00757042|582482667|FG006|Overall Study|Lost to Follow-up|0|||
161300786|NCT00757042|582482668|FG007|Overall Study|Lost to Follow-up|0|||
161300787|NCT00757042|582482669|FG008|Overall Study|Lost to Follow-up|1|||
161300788|NCT00757042|582482670|FG009|Overall Study|Lost to Follow-up|0|||
161300789|NCT00757042|582482671|FG010|Overall Study|Lost to Follow-up|0|||
161300790|NCT00757042|582482661|FG000|Overall Study|Ineligibility Determined|0|||
161300791|NCT00757042|582482662|FG001|Overall Study|Ineligibility Determined|0|||
161300792|NCT00757042|582482663|FG002|Overall Study|Ineligibility Determined|0|||
161300793|NCT00757042|582482664|FG003|Overall Study|Ineligibility Determined|0|||
161300794|NCT00757042|582482665|FG004|Overall Study|Ineligibility Determined|0|||
161300795|NCT00757042|582482666|FG005|Overall Study|Ineligibility Determined|0|||
161300796|NCT00757042|582482667|FG006|Overall Study|Ineligibility Determined|0|||
161300797|NCT00757042|582482668|FG007|Overall Study|Ineligibility Determined|0|||
161300798|NCT00757042|582482669|FG008|Overall Study|Ineligibility Determined|0|||
161300799|NCT00757042|582482670|FG009|Overall Study|Ineligibility Determined|0|||
161300800|NCT00757042|582482671|FG010|Overall Study|Ineligibility Determined|1|||
161300801|NCT00757042|582482661|FG000|Overall Study|Withdrawal by Subject|0|||
161300802|NCT00757042|582482662|FG001|Overall Study|Withdrawal by Subject|0|||
161300803|NCT00757042|582482663|FG002|Overall Study|Withdrawal by Subject|0|||
161300804|NCT00757042|582482664|FG003|Overall Study|Withdrawal by Subject|0|||
161300805|NCT00757042|582482665|FG004|Overall Study|Withdrawal by Subject|0|||
161300806|NCT00757042|582482666|FG005|Overall Study|Withdrawal by Subject|0|||
161300807|NCT00757042|582482667|FG006|Overall Study|Withdrawal by Subject|0|||
161300808|NCT00757042|582482668|FG007|Overall Study|Withdrawal by Subject|0|||
161300809|NCT00757042|582482669|FG008|Overall Study|Withdrawal by Subject|0|||
161300810|NCT00757042|582482670|FG009|Overall Study|Withdrawal by Subject|1|||
161300811|NCT00757042|582482671|FG010|Overall Study|Withdrawal by Subject|0|||
161300812|NCT02654977|582482672|FG000|Overall Study|Death|1|||
161300813|NCT02654977|582482672|FG000|Overall Study|Lost to Follow-up|1|||
161300814|NCT02654977|582482672|FG000|Overall Study|Adverse Event|1|||
161300815|NCT02654977|582482672|FG000|Overall Study|Withdrawal by Subject|1|||
161300816|NCT02654977|582482672|FG000|Overall Study|Lack of Efficacy|3|||
161300817|NCT01266291|582482673|FG000|Overall Study|Adverse Event|1|||
161300818|NCT02702388|582482677|FG000|Overall Study|Disease Progression|18|||
161300819|NCT02702388|582482678|FG001|Overall Study|Disease Progression|25|||
161300820|NCT02702388|582482677|FG000|Overall Study|Withdrawal by Subject|9|||
161300821|NCT02702388|582482678|FG001|Overall Study|Withdrawal by Subject|7|||
161300822|NCT02702388|582482677|FG000|Overall Study|Adverse Event|11|||
161300823|NCT02702388|582482678|FG001|Overall Study|Adverse Event|15|||
161300824|NCT02702388|582482677|FG000|Overall Study|Other|2|||
161300825|NCT02702388|582482678|FG001|Overall Study|Other|4|||
161300826|NCT02729051|582482679|FG000|Overall Study|Adverse Event|21|||
161300827|NCT02729051|582482680|FG001|Overall Study|Adverse Event|11|||
161300828|NCT02729051|582482679|FG000|Overall Study|Lack of Efficacy|1|||
161300829|NCT02729051|582482680|FG001|Overall Study|Lack of Efficacy|1|||
161300830|NCT02729051|582482679|FG000|Overall Study|Lost to Follow-up|1|||
161300831|NCT02729051|582482680|FG001|Overall Study|Lost to Follow-up|2|||
161300832|NCT02729051|582482679|FG000|Overall Study|Physician Decision|1|||
161300833|NCT02729051|582482680|FG001|Overall Study|Physician Decision|1|||
161089435|NCT00126503|581717385|FG000|Overall Study|disease progression|23|||
161300834|NCT02729051|582482679|FG000|Overall Study|Withdrawal by Subject|6|||
161300835|NCT02729051|582482680|FG001|Overall Study|Withdrawal by Subject|17|||
161300836|NCT02981082|582482681|FG000|Overall Study|Withdrawal by Subject|2|||
161300837|NCT02981082|582482682|FG001|Overall Study|Withdrawal by Subject|0|||
161300838|NCT02981082|582482681|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
161300839|NCT02981082|582482682|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
161300840|NCT02981082|582482681|FG000|Overall Study|Adverse Event|0|||
161089436|NCT00126503|581717386|FG001|Overall Study|disease progression|14|||
161089437|NCT00126503|581717385|FG000|Overall Study|Withdrawal by Subject|0|||
161089438|NCT00126503|581717386|FG001|Overall Study|Withdrawal by Subject|1|||
161300841|NCT02981082|582482682|FG001|Overall Study|Adverse Event|1|||
161300842|NCT03652636|582484176|FG000|Overall Study|Withdrawal by Subject|7|||
161300843|NCT00679029|582484179|FG000|Overall Study|Adverse Event|3|||
161089439|NCT00126503|581717385|FG000|Overall Study|alternative therapy|1|||
161089440|NCT00126503|581717386|FG001|Overall Study|alternative therapy|1|||
161089441|NCT00126503|581717385|FG000|Overall Study|other complicating disease|4|||
161089442|NCT00126503|581717386|FG001|Overall Study|other complicating disease|1|||
161089443|NCT00126503|581717385|FG000|Overall Study|Death|3|||
161089444|NCT00126503|581717386|FG001|Overall Study|Death|0|||
161089445|NCT00126503|581717385|FG000|Overall Study|Adverse Event|13|||
161089446|NCT00126503|581717386|FG001|Overall Study|Adverse Event|3|||
161089447|NCT00126503|581717385|FG000|Overall Study|non-compliant|1|||
161089448|NCT00126503|581717386|FG001|Overall Study|non-compliant|0|||
161089449|NCT00126503|581717385|FG000|Overall Study|Physician Decision|2|||
161089450|NCT00126503|581717386|FG001|Overall Study|Physician Decision|1|||
161089451|NCT02495792|581717387|FG000|Overall Study|Lost to Follow-up|5|||
161089452|NCT02495792|581717388|FG001|Overall Study|Lost to Follow-up|9|||
161089453|NCT02495792|581717387|FG000|Overall Study|Protocol Violation|32|||
161089454|NCT02495792|581717388|FG001|Overall Study|Protocol Violation|31|||
161089455|NCT03519971|581717389|FG000|Overall Study|Death|142|||
161089456|NCT03519971|581717390|FG001|Overall Study|Death|69|||
161089457|NCT03519971|581717389|FG000|Overall Study|Lost to Follow-up|0|||
161089458|NCT03519971|581717390|FG001|Overall Study|Lost to Follow-up|1|||
161089459|NCT03519971|581717389|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
161089460|NCT03519971|581717390|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
161089461|NCT03519971|581717389|FG000|Overall Study|Withdrawal by Subject|3|||
161089462|NCT03519971|581717390|FG001|Overall Study|Withdrawal by Subject|2|||
161089463|NCT03519971|581717389|FG000|Overall Study|Other|1|||
161089464|NCT03519971|581717390|FG001|Overall Study|Other|0|||
161089465|NCT00925132|581717391|FG000|Overall Study|Withdrawal by Subject|2|||
161089466|NCT00925132|581717392|FG001|Overall Study|Withdrawal by Subject|0|||
161089467|NCT00925132|581717393|FG002|Overall Study|Withdrawal by Subject|0|||
161089468|NCT00925132|581717394|FG003|Overall Study|Withdrawal by Subject|0|||
161089469|NCT00925132|581717395|FG004|Overall Study|Withdrawal by Subject|1|||
161089470|NCT00925132|581717391|FG000|Overall Study|Removed due to disease progression|0|||
161089471|NCT00925132|581717392|FG001|Overall Study|Removed due to disease progression|0|||
161089472|NCT00925132|581717393|FG002|Overall Study|Removed due to disease progression|0|||
161089473|NCT00925132|581717394|FG003|Overall Study|Removed due to disease progression|0|||
161089474|NCT00925132|581717395|FG004|Overall Study|Removed due to disease progression|4|||
161089475|NCT02545933|581717396|FG000|Overall Study|Adverse Event|3|||
161089476|NCT02545933|581717397|FG001|Overall Study|Adverse Event|0|||
161089477|NCT02545933|581717398|FG002|Overall Study|Adverse Event|0|||
161089478|NCT02545933|581717396|FG000|Overall Study|Withdrawal by Subject|2|||
161089479|NCT02545933|581717397|FG001|Overall Study|Withdrawal by Subject|3|||
161089480|NCT02545933|581717398|FG002|Overall Study|Withdrawal by Subject|3|||
161089481|NCT02545933|581717396|FG000|Overall Study|Protocol Violation|1|||
161089482|NCT02545933|581717397|FG001|Overall Study|Protocol Violation|0|||
161089483|NCT02545933|581717398|FG002|Overall Study|Protocol Violation|1|||
161089484|NCT03149549|581717399|FG000|Study Discontinuation--Treatment Period|Death|0|||
161089485|NCT03149549|581717400|FG001|Study Discontinuation--Treatment Period|Death|0|||
161089486|NCT03149549|581717401|FG002|Study Discontinuation--Treatment Period|Death|0|||
161089487|NCT03149549|581717402|FG003|Study Discontinuation--Treatment Period|Death|1|||
161089488|NCT03149549|581717403|FG004|Study Discontinuation--Treatment Period|Death|2|||
161089489|NCT03149549|581717404|FG005|Study Discontinuation--Treatment Period|Death|1|||
161089490|NCT03149549|581717405|FG006|Study Discontinuation--Treatment Period|Death|1|||
161089491|NCT03149549|581717406|FG007|Study Discontinuation--Treatment Period|Death|2|||
161089492|NCT03149549|581717407|FG008|Study Discontinuation--Treatment Period|Death|4|||
161089493|NCT03149549|581717408|FG009|Study Discontinuation--Treatment Period|Death|1|||
161089494|NCT03149549|581717409|FG010|Study Discontinuation--Treatment Period|Death|0|||
161089495|NCT03149549|581717410|FG011|Study Discontinuation--Treatment Period|Death|0|||
161089496|NCT03149549|581717411|FG012|Study Discontinuation--Treatment Period|Death|1|||
161089497|NCT03149549|581717399|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089498|NCT03149549|581717400|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089499|NCT03149549|581717401|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089500|NCT03149549|581717402|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089501|NCT03149549|581717403|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089502|NCT03149549|581717404|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089503|NCT03149549|581717405|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089504|NCT03149549|581717406|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
161089505|NCT03149549|581717407|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089506|NCT03149549|581717408|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089507|NCT03149549|581717409|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089508|NCT03149549|581717410|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
161089509|NCT03149549|581717411|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
161089510|NCT03149549|581717399|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161182556|NCT00262314|582045678|FG000|Overall Study|Lost to Follow-up|70|||
161182557|NCT00262314|582045678|FG000|Overall Study|Administrative withdrawal|30|||
161182558|NCT00117572|582045683|FG000|Overall Study|Site withdrew before starting treatment|2|||
161182559|NCT00117572|582045684|FG001|Overall Study|Site withdrew before starting treatment|3|||
161182560|NCT00117572|582045683|FG000|Overall Study|Withdrawal by Subject|3|||
161182561|NCT00117572|582045684|FG001|Overall Study|Withdrawal by Subject|3|||
161182562|NCT00117572|582045683|FG000|Overall Study|Protocol Violation|1|||
161182563|NCT00117572|582045684|FG001|Overall Study|Protocol Violation|0|||
161182564|NCT04973085|582045685|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
161182565|NCT04973085|582045686|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
161182566|NCT00090766|582045689|FG000|Overall Study|Nephrectomy Planned|0|||
161182567|NCT00090766|582045690|FG001|Overall Study|Nephrectomy Planned|0|||
161182568|NCT00090766|582045691|FG002|Overall Study|Nephrectomy Planned|1|||
161182569|NCT00090766|582045689|FG000|Overall Study|Death|1|||
161182570|NCT00090766|582045690|FG001|Overall Study|Death|0|||
161182571|NCT00090766|582045691|FG002|Overall Study|Death|0|||
161182572|NCT00090766|582045689|FG000|Overall Study|Admin|0|||
161182573|NCT00090766|582045690|FG001|Overall Study|Admin|2|||
161182574|NCT00090766|582045691|FG002|Overall Study|Admin|0|||
161182575|NCT00090766|582045689|FG000|Overall Study|Lost to Follow-up|2|||
161182576|NCT00090766|582045690|FG001|Overall Study|Lost to Follow-up|0|||
161182577|NCT00090766|582045691|FG002|Overall Study|Lost to Follow-up|2|||
161182578|NCT00804986|582045692|FG000|Overall Study|Adverse Event|0|||
161182579|NCT00804986|582045693|FG001|Overall Study|Adverse Event|1|||
161182580|NCT00804986|582045694|FG002|Overall Study|Adverse Event|2|||
161182581|NCT00804986|582045695|FG003|Overall Study|Adverse Event|1|||
161182582|NCT00804986|582045696|FG004|Overall Study|Adverse Event|3|||
161182583|NCT00804986|582045697|FG005|Overall Study|Adverse Event|0|||
161182584|NCT00804986|582045692|FG000|Overall Study|Lack of Efficacy|0|||
161182585|NCT00804986|582045693|FG001|Overall Study|Lack of Efficacy|0|||
161182586|NCT00804986|582045694|FG002|Overall Study|Lack of Efficacy|0|||
161182587|NCT00804986|582045695|FG003|Overall Study|Lack of Efficacy|1|||
161182588|NCT00804986|582045696|FG004|Overall Study|Lack of Efficacy|0|||
161182589|NCT00804986|582045697|FG005|Overall Study|Lack of Efficacy|3|||
161182590|NCT00804986|582045692|FG000|Overall Study|Lost to Follow-up|0|||
161182591|NCT00804986|582045693|FG001|Overall Study|Lost to Follow-up|0|||
161182592|NCT00804986|582045694|FG002|Overall Study|Lost to Follow-up|0|||
161182593|NCT00804986|582045695|FG003|Overall Study|Lost to Follow-up|1|||
161182594|NCT00804986|582045696|FG004|Overall Study|Lost to Follow-up|1|||
161182595|NCT00804986|582045697|FG005|Overall Study|Lost to Follow-up|3|||
161182596|NCT00804986|582045692|FG000|Overall Study|Protocol Violation|0|||
161182597|NCT00804986|582045693|FG001|Overall Study|Protocol Violation|1|||
161182598|NCT00804986|582045694|FG002|Overall Study|Protocol Violation|0|||
161182599|NCT00804986|582045695|FG003|Overall Study|Protocol Violation|1|||
161182600|NCT00804986|582045696|FG004|Overall Study|Protocol Violation|0|||
161182601|NCT00804986|582045697|FG005|Overall Study|Protocol Violation|0|||
161182602|NCT00804986|582045692|FG000|Overall Study|Withdrawal by Subject|0|||
161182603|NCT00804986|582045693|FG001|Overall Study|Withdrawal by Subject|3|||
161182604|NCT00804986|582045694|FG002|Overall Study|Withdrawal by Subject|0|||
161182605|NCT00804986|582045695|FG003|Overall Study|Withdrawal by Subject|3|||
161182606|NCT00804986|582045696|FG004|Overall Study|Withdrawal by Subject|5|||
161182607|NCT00804986|582045697|FG005|Overall Study|Withdrawal by Subject|3|||
161182608|NCT00804986|582045692|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
161182609|NCT00804986|582045693|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
161182610|NCT00804986|582045694|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
161347871|NCT02903914|582657364|FG003|Overall Study|Taken off Treatment per Protocol|0|||
161347872|NCT02903914|582657365|FG004|Overall Study|Taken off Treatment per Protocol|0|||
161182611|NCT00804986|582045695|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
161182612|NCT00804986|582045696|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
161182613|NCT00804986|582045697|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
161182614|NCT00804986|582045692|FG000|Overall Study|Sponsor Decision|0|||
161182615|NCT00804986|582045693|FG001|Overall Study|Sponsor Decision|1|||
161182616|NCT00804986|582045694|FG002|Overall Study|Sponsor Decision|0|||
161182617|NCT00804986|582045695|FG003|Overall Study|Sponsor Decision|0|||
161182618|NCT00804986|582045696|FG004|Overall Study|Sponsor Decision|0|||
161347873|NCT02903914|582657366|FG005|Overall Study|Taken off Treatment per Protocol|1|||
161182619|NCT00804986|582045697|FG005|Overall Study|Sponsor Decision|0|||
161182620|NCT00804986|582045692|FG000|Overall Study|Physician Decision|1|||
161182621|NCT00804986|582045693|FG001|Overall Study|Physician Decision|0|||
161182622|NCT00804986|582045694|FG002|Overall Study|Physician Decision|0|||
161182623|NCT00804986|582045695|FG003|Overall Study|Physician Decision|0|||
161182624|NCT00804986|582045696|FG004|Overall Study|Physician Decision|0|||
161182625|NCT00804986|582045697|FG005|Overall Study|Physician Decision|0|||
161182626|NCT02774291|582045702|FG000|Overall Study|Lost to Follow-up|1|||
161182627|NCT01387594|582045703|FG000|Overall Study|Withdrawal by Subject|0|||
161182628|NCT01387594|582045704|FG001|Overall Study|Withdrawal by Subject|2|||
161182629|NCT01387594|582045703|FG000|Overall Study|Lost to Follow-up|0|||
161182630|NCT01387594|582045704|FG001|Overall Study|Lost to Follow-up|1|||
161300844|NCT00679029|582484179|FG000|Overall Study|Withdrawal by Subject|1|||
161300845|NCT00679029|582484179|FG000|Overall Study|Lost to Follow-up|1|||
161300846|NCT00972816|582484181|FG000|Overall Study|Adverse Event|0|||
161300847|NCT00972816|582484182|FG001|Overall Study|Adverse Event|0|||
161300848|NCT00972816|582484183|FG002|Overall Study|Adverse Event|1|||
161300849|NCT00972816|582484184|FG003|Overall Study|Adverse Event|0|||
161300850|NCT00972816|582484185|FG004|Overall Study|Adverse Event|0|||
161300851|NCT00972816|582484186|FG005|Overall Study|Adverse Event|0|||
161300852|NCT00972816|582484187|FG006|Overall Study|Adverse Event|0|||
161300853|NCT00972816|582484188|FG007|Overall Study|Adverse Event|0|||
161300854|NCT00972816|582484181|FG000|Overall Study|Withdrawal by Subject|4|||
161300855|NCT00972816|582484182|FG001|Overall Study|Withdrawal by Subject|2|||
161300856|NCT00972816|582484183|FG002|Overall Study|Withdrawal by Subject|1|||
161300857|NCT00972816|582484184|FG003|Overall Study|Withdrawal by Subject|3|||
161300858|NCT00972816|582484185|FG004|Overall Study|Withdrawal by Subject|0|||
161300859|NCT00972816|582484186|FG005|Overall Study|Withdrawal by Subject|1|||
161300860|NCT00972816|582484187|FG006|Overall Study|Withdrawal by Subject|1|||
161300861|NCT00972816|582484188|FG007|Overall Study|Withdrawal by Subject|2|||
161300862|NCT00972816|582484181|FG000|Overall Study|Lost to Follow-up|11|||
161300863|NCT00972816|582484182|FG001|Overall Study|Lost to Follow-up|9|||
161300864|NCT00972816|582484183|FG002|Overall Study|Lost to Follow-up|7|||
161300865|NCT00972816|582484184|FG003|Overall Study|Lost to Follow-up|5|||
161300866|NCT00972816|582484185|FG004|Overall Study|Lost to Follow-up|11|||
161300867|NCT00972816|582484186|FG005|Overall Study|Lost to Follow-up|10|||
161300868|NCT00972816|582484187|FG006|Overall Study|Lost to Follow-up|7|||
161300869|NCT00972816|582484188|FG007|Overall Study|Lost to Follow-up|7|||
161300870|NCT00972816|582484181|FG000|Overall Study|Inappropriate enrolment|0|||
161300871|NCT00972816|582484182|FG001|Overall Study|Inappropriate enrolment|0|||
161300872|NCT00972816|582484183|FG002|Overall Study|Inappropriate enrolment|0|||
161300873|NCT00972816|582484184|FG003|Overall Study|Inappropriate enrolment|0|||
161300874|NCT00972816|582484185|FG004|Overall Study|Inappropriate enrolment|0|||
161300875|NCT00972816|582484186|FG005|Overall Study|Inappropriate enrolment|0|||
161300876|NCT00972816|582484187|FG006|Overall Study|Inappropriate enrolment|2|||
161300877|NCT00972816|582484188|FG007|Overall Study|Inappropriate enrolment|0|||
161300878|NCT00972816|582484181|FG000|Overall Study|Unable to classify|2|||
161300879|NCT00972816|582484182|FG001|Overall Study|Unable to classify|0|||
161300880|NCT00972816|582484183|FG002|Overall Study|Unable to classify|0|||
161300881|NCT00972816|582484184|FG003|Overall Study|Unable to classify|0|||
161300882|NCT00972816|582484185|FG004|Overall Study|Unable to classify|1|||
161300883|NCT00972816|582484186|FG005|Overall Study|Unable to classify|0|||
161300884|NCT00972816|582484187|FG006|Overall Study|Unable to classify|0|||
161300885|NCT00972816|582484188|FG007|Overall Study|Unable to classify|0|||
161300886|NCT03806933|582484189|FG000|Main Period|Physician Decision|0|||
161300887|NCT03806933|582484190|FG001|Main Period|Physician Decision|0|||
161300888|NCT03806933|582484191|FG002|Main Period|Physician Decision|0|||
161300889|NCT03806933|582484192|FG003|Main Period|Physician Decision|1|||
161300890|NCT03806933|582484189|FG000|Main Period|Pregnancy|0|||
161300891|NCT03806933|582484190|FG001|Main Period|Pregnancy|0|||
161300892|NCT03806933|582484191|FG002|Main Period|Pregnancy|1|||
161300893|NCT03806933|582484192|FG003|Main Period|Pregnancy|0|||
161300894|NCT03806933|582484189|FG000|Main Period|Withdrawal by Subject|2|||
161300895|NCT03806933|582484190|FG001|Main Period|Withdrawal by Subject|1|||
161300896|NCT03806933|582484191|FG002|Main Period|Withdrawal by Subject|1|||
161300897|NCT03806933|582484192|FG003|Main Period|Withdrawal by Subject|2|||
161300898|NCT03806933|582484189|FG000|Main Period|Lost to Follow-up|2|||
161300899|NCT03806933|582484190|FG001|Main Period|Lost to Follow-up|2|||
161300900|NCT03806933|582484191|FG002|Main Period|Lost to Follow-up|0|||
161300901|NCT03806933|582484192|FG003|Main Period|Lost to Follow-up|0|||
161300902|NCT03806933|582484189|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161300903|NCT03806933|582484190|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161300904|NCT03806933|582484191|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
161300905|NCT03806933|582484192|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
161300906|NCT05088603|582484193|FG000|Overall Study|Protocol Violation|6|||
161300907|NCT05088603|582484194|FG001|Overall Study|Protocol Violation|1|||
161300908|NCT00956592|582484199|FG000|Overall Study|Protocol Violation|1|||
161300909|NCT00956592|582484200|FG001|Overall Study|Protocol Violation|3|||
161300910|NCT02162719|582484201|FG000|Overall Study|Death|41|||
161300911|NCT02162719|582484202|FG001|Overall Study|Death|46|||
161300912|NCT02162719|582484201|FG000|Overall Study|Lost to Follow-up|1|||
161300913|NCT02162719|582484202|FG001|Overall Study|Lost to Follow-up|3|||
161300914|NCT02162719|582484201|FG000|Overall Study|Disease Progression|2|||
161347874|NCT02903914|582657367|FG006|Overall Study|Taken off Treatment per Protocol|0|||
161347875|NCT02903914|582657368|FG007|Overall Study|Taken off Treatment per Protocol|0|||
161300915|NCT02162719|582484202|FG001|Overall Study|Disease Progression|1|||
161300916|NCT02162719|582484201|FG000|Overall Study|Withdrawal by Subject|8|||
161300917|NCT02162719|582484202|FG001|Overall Study|Withdrawal by Subject|2|||
161300918|NCT02162719|582484201|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
161300919|NCT02162719|582484202|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
161300920|NCT03555565|582484204|FG000|Overall Study|Case Report Forms Uncollected|2|||
161300921|NCT03555565|582484204|FG000|Overall Study|Protocol Deviation|13|||
161300922|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
161300923|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
161300924|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
161300925|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
161300926|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
161300927|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
161300928|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
161300929|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
161300930|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Death|0|||
161300931|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Death|1|||
161300932|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
161300933|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
161300934|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
161300935|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
161300936|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
161300937|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
161300938|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
161300939|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
161300940|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
161300941|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
161300942|NCT00394836|582484209|FG000|Teatment or Follow-up Phase|Non compliance|0|||
161300943|NCT00394836|582484210|FG001|Teatment or Follow-up Phase|Non compliance|1|||
161300944|NCT00394836|582484209|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
161300945|NCT00394836|582484210|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
161300946|NCT00394836|582484209|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
161300947|NCT00394836|582484210|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
161300948|NCT00394836|582484209|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
161300949|NCT00394836|582484210|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
161300950|NCT00394836|582484209|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
161300951|NCT00394836|582484210|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
161300952|NCT03692325|582484211|FG000|Overall Study|Adverse Event|2|||
161300953|NCT03692325|582484211|FG000|Overall Study|Progression/Recurrence|2|||
161300954|NCT02817516|582484212|FG000|Overall Study|Other|0|||
161300955|NCT02817516|582484213|FG001|Overall Study|Other|0|||
161300956|NCT02817516|582484214|FG002|Overall Study|Other|1|||
161300957|NCT02817516|582484215|FG003|Overall Study|Other|0|||
161300958|NCT00610155|582484219|FG000|Period 1|Withdrawal by Subject|0|||
161300959|NCT00610155|582484220|FG001|Period 1|Withdrawal by Subject|0|||
161300960|NCT00610155|582484221|FG002|Period 1|Withdrawal by Subject|1|||
161300961|NCT00610155|582484222|FG003|Period 1|Withdrawal by Subject|0|||
161300962|NCT00610155|582484223|FG004|Period 1|Withdrawal by Subject|0|||
161300963|NCT00610155|582484224|FG005|Period 1|Withdrawal by Subject|0|||
161300964|NCT00610155|582484219|FG000|Period 3|Adverse Event|1|||
161300965|NCT00610155|582484220|FG001|Period 3|Adverse Event|0|||
161300966|NCT00610155|582484221|FG002|Period 3|Adverse Event|0|||
161300967|NCT00610155|582484222|FG003|Period 3|Adverse Event|0|||
161300968|NCT00610155|582484223|FG004|Period 3|Adverse Event|0|||
161300969|NCT00610155|582484224|FG005|Period 3|Adverse Event|0|||
161300970|NCT01560234|582484225|FG000|Overall Study|Lost to Follow-up|3|||
161300971|NCT01560234|582484226|FG001|Overall Study|Lost to Follow-up|0|||
161300972|NCT01560234|582484227|FG002|Overall Study|Lost to Follow-up|1|||
161300973|NCT01560234|582484228|FG003|Overall Study|Lost to Follow-up|0|||
161300974|NCT01560234|582484229|FG004|Overall Study|Lost to Follow-up|0|||
161300975|NCT01560234|582484230|FG005|Overall Study|Lost to Follow-up|2|||
161300976|NCT01560234|582484231|FG006|Overall Study|Lost to Follow-up|0|||
161300977|NCT01560234|582484232|FG007|Overall Study|Lost to Follow-up|2|||
161347876|NCT02903914|582657361|FG000|Overall Study|Refused Further Treatment/Contact|0|||
161347877|NCT02903914|582657362|FG001|Overall Study|Refused Further Treatment/Contact|0|||
161347878|NCT02903914|582657363|FG002|Overall Study|Refused Further Treatment/Contact|0|||
161347879|NCT02903914|582657364|FG003|Overall Study|Refused Further Treatment/Contact|0|||
161347880|NCT02903914|582657365|FG004|Overall Study|Refused Further Treatment/Contact|0|||
161347881|NCT02903914|582657366|FG005|Overall Study|Refused Further Treatment/Contact|0|||
161300978|NCT00083759|582484236|FG000|Overall Study|Adverse Event|5|||
161300979|NCT00083759|582484237|FG001|Overall Study|Adverse Event|3|||
161300980|NCT00083759|582484236|FG000|Overall Study|Lost to Follow-up|1|||
161300981|NCT00083759|582484237|FG001|Overall Study|Lost to Follow-up|0|||
161182631|NCT03954704|582045716|FG000|Overall Study|Death|1|||
161300982|NCT00083759|582484236|FG000|Overall Study|Death|1|||
161300983|NCT00083759|582484237|FG001|Overall Study|Death|1|||
161347882|NCT02903914|582657367|FG006|Overall Study|Refused Further Treatment/Contact|1|||
161347883|NCT02903914|582657368|FG007|Overall Study|Refused Further Treatment/Contact|0|||
161182632|NCT03954704|582045717|FG001|Overall Study|Death|1|||
161300984|NCT00083759|582484236|FG000|Overall Study|Inadequate Therapeutic Response|32|||
161300985|NCT00083759|582484237|FG001|Overall Study|Inadequate Therapeutic Response|35|||
161300986|NCT00083759|582484236|FG000|Overall Study|Subject Withdrew Consent|2|||
161300987|NCT00083759|582484237|FG001|Overall Study|Subject Withdrew Consent|2|||
161300988|NCT00083759|582484236|FG000|Overall Study|Non-Compliance|1|||
161300989|NCT00083759|582484237|FG001|Overall Study|Non-Compliance|0|||
161300990|NCT00083759|582484236|FG000|Overall Study|Sponsor's Discretion|28|||
161300991|NCT00083759|582484237|FG001|Overall Study|Sponsor's Discretion|29|||
161300992|NCT00083759|582484236|FG000|Overall Study|Other|14|||
161300993|NCT00083759|582484237|FG001|Overall Study|Other|13|||
161300994|NCT04292912|582484242|FG000|Overall Study|Physician Decision|1|||
161300995|NCT04292912|582484242|FG000|Overall Study|Protocol Violation|6|||
161300996|NCT03348930|582484243|FG000|Washout (1 Week)|Lost to Follow-up|1|||
161300997|NCT03348930|582484244|FG001|Washout (1 Week)|Lost to Follow-up|1|||
161300998|NCT01062113|582484252|FG000|Overall Study|Adverse Event|1|||
161300999|NCT01062113|582484253|FG001|Overall Study|Adverse Event|0|||
161301000|NCT01062113|582484254|FG002|Overall Study|Adverse Event|0|||
161301001|NCT01062113|582484252|FG000|Overall Study|Lack of Efficacy|38|||
161301002|NCT01062113|582484253|FG001|Overall Study|Lack of Efficacy|22|||
161301003|NCT01062113|582484254|FG002|Overall Study|Lack of Efficacy|31|||
161301004|NCT01062113|582484252|FG000|Overall Study|Withdrawal by Subject|1|||
161301005|NCT01062113|582484253|FG001|Overall Study|Withdrawal by Subject|0|||
161301006|NCT01062113|582484254|FG002|Overall Study|Withdrawal by Subject|0|||
161301007|NCT03499899|582484255|FG000|Overall Study|Adverse Event|2|||
161301008|NCT03499899|582484256|FG001|Overall Study|Adverse Event|3|||
161301009|NCT03499899|582484257|FG002|Overall Study|Adverse Event|3|||
161301010|NCT03499899|582484255|FG000|Overall Study|Death|0|||
161301011|NCT03499899|582484256|FG001|Overall Study|Death|0|||
161301012|NCT03499899|582484257|FG002|Overall Study|Death|1|||
161301013|NCT03499899|582484255|FG000|Overall Study|Physician Decision|3|||
161301014|NCT03499899|582484256|FG001|Overall Study|Physician Decision|6|||
161301015|NCT03499899|582484257|FG002|Overall Study|Physician Decision|6|||
161301016|NCT03499899|582484255|FG000|Overall Study|Progressive disease|15|||
161301017|NCT03499899|582484256|FG001|Overall Study|Progressive disease|23|||
161301018|NCT03499899|582484257|FG002|Overall Study|Progressive disease|23|||
161301019|NCT03499899|582484255|FG000|Overall Study|Patient decision|0|||
161301020|NCT03499899|582484256|FG001|Overall Study|Patient decision|1|||
161301021|NCT03499899|582484257|FG002|Overall Study|Patient decision|1|||
161301022|NCT03499899|582484255|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
161301023|NCT03499899|582484256|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
161301024|NCT03499899|582484257|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
161301025|NCT03655470|582484258|FG000|Overall Study|Lost to Follow-up|6|||
161301026|NCT03655470|582484259|FG001|Overall Study|Lost to Follow-up|7|||
161301027|NCT03063086|582484260|FG000|Overall Study|technical problems|1|||
161301028|NCT03063086|582484261|FG001|Overall Study|technical problems|0|||
161301029|NCT03063086|582484262|FG002|Overall Study|technical problems|0|||
161301030|NCT03063086|582484263|FG003|Overall Study|technical problems|0|||
161301031|NCT03063086|582484264|FG004|Overall Study|technical problems|0|||
161301032|NCT03063086|582484265|FG005|Overall Study|technical problems|0|||
161347884|NCT02903914|582657361|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161347885|NCT02903914|582657362|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161301033|NCT03063086|582484260|FG000|Overall Study|Adverse Event|1|||
161301034|NCT03063086|582484261|FG001|Overall Study|Adverse Event|1|||
161301035|NCT03063086|582484262|FG002|Overall Study|Adverse Event|1|||
161089511|NCT03149549|581717400|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161089512|NCT03149549|581717401|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161089513|NCT03149549|581717402|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
161089514|NCT03149549|581717403|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
161089515|NCT03149549|581717404|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
161089516|NCT03149549|581717405|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
161089517|NCT03149549|581717406|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161089518|NCT03149549|581717407|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
161089519|NCT03149549|581717408|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161089520|NCT03149549|581717409|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161089521|NCT03149549|581717410|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161301036|NCT03063086|582484263|FG003|Overall Study|Adverse Event|1|||
161301037|NCT03063086|582484264|FG004|Overall Study|Adverse Event|0|||
161301038|NCT03063086|582484265|FG005|Overall Study|Adverse Event|0|||
161301039|NCT03063086|582484260|FG000|Overall Study|subject/guardian decision|1|||
161301040|NCT03063086|582484261|FG001|Overall Study|subject/guardian decision|0|||
161301041|NCT03063086|582484262|FG002|Overall Study|subject/guardian decision|0|||
161301042|NCT03063086|582484263|FG003|Overall Study|subject/guardian decision|0|||
161301043|NCT03063086|582484264|FG004|Overall Study|subject/guardian decision|0|||
161301044|NCT03063086|582484265|FG005|Overall Study|subject/guardian decision|0|||
161182633|NCT03954704|582045718|FG002|Overall Study|Death|1|||
161182634|NCT03954704|582045719|FG003|Overall Study|Death|3|||
161182635|NCT03954704|582045720|FG004|Overall Study|Death|2|||
161301045|NCT03063086|582484260|FG000|Overall Study|Non-compliance with study treatment|0|||
161301046|NCT03063086|582484261|FG001|Overall Study|Non-compliance with study treatment|0|||
161301047|NCT03063086|582484262|FG002|Overall Study|Non-compliance with study treatment|0|||
161301048|NCT03063086|582484263|FG003|Overall Study|Non-compliance with study treatment|1|||
161301049|NCT03063086|582484264|FG004|Overall Study|Non-compliance with study treatment|0|||
161301050|NCT03063086|582484265|FG005|Overall Study|Non-compliance with study treatment|1|||
161301051|NCT03063086|582484260|FG000|Overall Study|Physician Decision|0|||
161301052|NCT03063086|582484261|FG001|Overall Study|Physician Decision|0|||
161301053|NCT03063086|582484262|FG002|Overall Study|Physician Decision|0|||
161301054|NCT03063086|582484263|FG003|Overall Study|Physician Decision|1|||
161301055|NCT03063086|582484264|FG004|Overall Study|Physician Decision|0|||
161301056|NCT03063086|582484265|FG005|Overall Study|Physician Decision|0|||
161301057|NCT05481125|582484268|FG000|Overall Study|Adverse Event|1|||
161301058|NCT05481125|582484269|FG001|Overall Study|Adverse Event|0|||
161301059|NCT05481125|582484268|FG000|Overall Study|Lost to Follow-up|0|||
161301060|NCT05481125|582484269|FG001|Overall Study|Lost to Follow-up|1|||
161301061|NCT05481125|582484268|FG000|Overall Study|Withdrawal by Subject|0|||
161301062|NCT05481125|582484269|FG001|Overall Study|Withdrawal by Subject|1|||
161301063|NCT02244463|582484272|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
161301064|NCT02244463|582484273|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161301065|NCT02244463|582484274|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161301066|NCT02244463|582484275|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161301067|NCT02244463|582484276|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161301068|NCT02244463|582484277|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
161301069|NCT02244463|582484272|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
161301070|NCT02244463|582484273|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
161301071|NCT02244463|582484274|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
161301072|NCT02244463|582484275|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
161301073|NCT02244463|582484276|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
161301074|NCT02244463|582484277|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
161301075|NCT02244463|582484272|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161301076|NCT02244463|582484273|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
161301077|NCT02244463|582484274|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161301078|NCT02244463|582484275|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161301079|NCT02244463|582484276|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161301080|NCT02244463|582484277|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
161301081|NCT02244463|582484272|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161301082|NCT02244463|582484273|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161301083|NCT02244463|582484274|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
161301084|NCT02244463|582484275|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161301085|NCT02244463|582484276|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161301086|NCT02244463|582484277|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
161301087|NCT02244463|582484272|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161301088|NCT02244463|582484273|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161301089|NCT02244463|582484274|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161182636|NCT03954704|582045721|FG005|Overall Study|Death|2|||
161182637|NCT03954704|582045722|FG006|Overall Study|Death|0|||
161182638|NCT03954704|582045716|FG000|Overall Study|Withdrew Consent|0|||
161182639|NCT03954704|582045717|FG001|Overall Study|Withdrew Consent|0|||
161182640|NCT03954704|582045718|FG002|Overall Study|Withdrew Consent|1|||
161182641|NCT03954704|582045719|FG003|Overall Study|Withdrew Consent|0|||
161182642|NCT03954704|582045720|FG004|Overall Study|Withdrew Consent|0|||
161182643|NCT03954704|582045721|FG005|Overall Study|Withdrew Consent|1|||
161182644|NCT03954704|582045722|FG006|Overall Study|Withdrew Consent|0|||
161182645|NCT03954704|582045716|FG000|Overall Study|Lost to Follow-up|0|||
161182646|NCT03954704|582045717|FG001|Overall Study|Lost to Follow-up|0|||
161182647|NCT03954704|582045718|FG002|Overall Study|Lost to Follow-up|0|||
161182648|NCT03954704|582045719|FG003|Overall Study|Lost to Follow-up|0|||
161182649|NCT03954704|582045720|FG004|Overall Study|Lost to Follow-up|0|||
161182650|NCT03954704|582045721|FG005|Overall Study|Lost to Follow-up|0|||
161182651|NCT03954704|582045722|FG006|Overall Study|Lost to Follow-up|1|||
161301090|NCT02244463|582484275|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
161301091|NCT02244463|582484276|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161301092|NCT02244463|582484277|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
161301093|NCT02244463|582484272|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161182652|NCT03954704|582045716|FG000|Overall Study|Study Terminated by Sponsor|0|||
161182653|NCT03954704|582045717|FG001|Overall Study|Study Terminated by Sponsor|0|||
161182654|NCT03954704|582045718|FG002|Overall Study|Study Terminated by Sponsor|1|||
161182655|NCT03954704|582045719|FG003|Overall Study|Study Terminated by Sponsor|0|||
161182656|NCT03954704|582045720|FG004|Overall Study|Study Terminated by Sponsor|1|||
161182657|NCT03954704|582045721|FG005|Overall Study|Study Terminated by Sponsor|4|||
161301094|NCT02244463|582484273|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161301095|NCT02244463|582484274|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161301096|NCT02244463|582484275|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
161301097|NCT02244463|582484276|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161301098|NCT02244463|582484277|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
161301099|NCT02244463|582484272|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161301100|NCT02244463|582484273|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161301101|NCT02244463|582484274|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161301102|NCT02244463|582484275|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
161301103|NCT02244463|582484276|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161301104|NCT02244463|582484277|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
161301105|NCT02244463|582484272|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161301106|NCT02244463|582484273|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161301107|NCT02244463|582484274|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161301108|NCT02244463|582484275|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
161301109|NCT02244463|582484276|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161301110|NCT02244463|582484277|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
161301111|NCT02244463|582484272|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161182658|NCT03954704|582045722|FG006|Overall Study|Study Terminated by Sponsor|2|||
161182659|NCT03954704|582045716|FG000|Overall Study|Enrolled but not Treated|0|||
161182660|NCT03954704|582045717|FG001|Overall Study|Enrolled but not Treated|0|||
161182661|NCT03954704|582045718|FG002|Overall Study|Enrolled but not Treated|0|||
161182662|NCT03954704|582045719|FG003|Overall Study|Enrolled but not Treated|0|||
161182663|NCT03954704|582045720|FG004|Overall Study|Enrolled but not Treated|0|||
161182664|NCT03954704|582045721|FG005|Overall Study|Enrolled but not Treated|1|||
161182665|NCT03954704|582045722|FG006|Overall Study|Enrolled but not Treated|0|||
161182666|NCT00397891|582045723|FG000|Overall Study|Withdrawal by Subject|1|||
161182667|NCT00397891|582045724|FG001|Overall Study|Withdrawal by Subject|0|||
161182668|NCT00397891|582045725|FG002|Overall Study|Withdrawal by Subject|0|||
161182669|NCT00397891|582045726|FG003|Overall Study|Withdrawal by Subject|0|||
161182670|NCT00397891|582045727|FG004|Overall Study|Withdrawal by Subject|1|||
161182671|NCT02116361|582045736|FG000|Overall Study|Pregnancy|0|||
161182672|NCT02116361|582045737|FG001|Overall Study|Pregnancy|0|||
161182673|NCT02116361|582045738|FG002|Overall Study|Pregnancy|0|||
161182674|NCT02116361|582045739|FG003|Overall Study|Pregnancy|1|||
161182675|NCT02116361|582045736|FG000|Overall Study|Protocol Violation|1|||
161182676|NCT02116361|582045737|FG001|Overall Study|Protocol Violation|0|||
161182677|NCT02116361|582045738|FG002|Overall Study|Protocol Violation|0|||
161182678|NCT02116361|582045739|FG003|Overall Study|Protocol Violation|2|||
161182679|NCT02116361|582045736|FG000|Overall Study|Physician Decision|2|||
161182680|NCT02116361|582045737|FG001|Overall Study|Physician Decision|3|||
161182681|NCT02116361|582045738|FG002|Overall Study|Physician Decision|0|||
161182682|NCT02116361|582045739|FG003|Overall Study|Physician Decision|0|||
161182683|NCT02116361|582045736|FG000|Overall Study|Adverse Event|1|||
161182684|NCT02116361|582045737|FG001|Overall Study|Adverse Event|0|||
161182685|NCT02116361|582045738|FG002|Overall Study|Adverse Event|0|||
161301112|NCT02244463|582484273|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161301113|NCT02244463|582484274|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161182686|NCT02116361|582045739|FG003|Overall Study|Adverse Event|3|||
161182687|NCT02116361|582045736|FG000|Overall Study|Other Reasons|3|||
161182688|NCT02116361|582045737|FG001|Overall Study|Other Reasons|3|||
161182689|NCT02116361|582045738|FG002|Overall Study|Other Reasons|3|||
161182690|NCT02116361|582045739|FG003|Overall Study|Other Reasons|3|||
161182691|NCT02116361|582045736|FG000|Overall Study|Lack of Efficacy|5|||
161182692|NCT02116361|582045737|FG001|Overall Study|Lack of Efficacy|7|||
161182693|NCT02116361|582045738|FG002|Overall Study|Lack of Efficacy|4|||
161182694|NCT02116361|582045739|FG003|Overall Study|Lack of Efficacy|3|||
161182695|NCT02116361|582045736|FG000|Overall Study|Lost to Follow-up|4|||
161182696|NCT02116361|582045737|FG001|Overall Study|Lost to Follow-up|5|||
161182697|NCT02116361|582045738|FG002|Overall Study|Lost to Follow-up|7|||
161182698|NCT02116361|582045739|FG003|Overall Study|Lost to Follow-up|5|||
161182699|NCT02116361|582045736|FG000|Overall Study|Personal Reasons|6|||
161182700|NCT02116361|582045737|FG001|Overall Study|Personal Reasons|6|||
161182701|NCT02116361|582045738|FG002|Overall Study|Personal Reasons|4|||
161182702|NCT02116361|582045739|FG003|Overall Study|Personal Reasons|9|||
161182703|NCT02116361|582045736|FG000|Overall Study|Investigator Decision - Relapse|9|||
161182704|NCT02116361|582045737|FG001|Overall Study|Investigator Decision - Relapse|7|||
161182705|NCT02116361|582045738|FG002|Overall Study|Investigator Decision - Relapse|8|||
161301114|NCT02244463|582484275|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
161301115|NCT02244463|582484276|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161182706|NCT02116361|582045739|FG003|Overall Study|Investigator Decision - Relapse|5|||
161182707|NCT02571972|582045740|FG000|Overall Study|Protocol Violation|2|||
161182708|NCT02571972|582045740|FG000|Overall Study|Withdrawal by Subject|2|||
161182709|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
161182710|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161182711|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
161182712|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
161182713|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
161182714|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
161182715|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161182716|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
161182717|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
161182718|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
161182719|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
161182720|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
161182721|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
161182722|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161182723|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161182724|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
161182725|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161182726|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161182727|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
161182728|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
161182729|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
161182730|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
161182731|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
161182732|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
161182733|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
161182734|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161182735|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
161182736|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
161182737|NCT03227224|582045741|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
161182738|NCT03227224|582045742|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
161182739|NCT03227224|582045743|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
161182740|NCT03227224|582045744|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
161182741|NCT03227224|582045741|FG000|Follow-up Phase (2 Weeks)|Other|4|||
161182742|NCT03227224|582045742|FG001|Follow-up Phase (2 Weeks)|Other|4|||
161182743|NCT03227224|582045743|FG002|Follow-up Phase (2 Weeks)|Other|6|||
161182744|NCT03227224|582045744|FG003|Follow-up Phase (2 Weeks)|Other|3|||
161182745|NCT03782376|582045745|FG000|Overall Study|Lost to Follow-up|2|||
161182746|NCT03782376|582045746|FG001|Overall Study|Lost to Follow-up|2|||
161182747|NCT03782376|582045745|FG000|Overall Study|Withdrawal by Subject|7|||
161182748|NCT03782376|582045746|FG001|Overall Study|Withdrawal by Subject|11|||
161182749|NCT03782376|582045745|FG000|Overall Study|Death|1|||
161182750|NCT03782376|582045746|FG001|Overall Study|Death|0|||
161182751|NCT03782376|582045745|FG000|Overall Study|Other|16|||
161182752|NCT03782376|582045746|FG001|Overall Study|Other|17|||
161182753|NCT02659098|582045747|FG000|Overall Study|Withdrawal by Subject|7|||
161182754|NCT04363944|582045748|FG000|Overall Study|Withdrawal by Subject|2|||
161182755|NCT04363944|582045749|FG001|Overall Study|Withdrawal by Subject|0|||
161182756|NCT03559192|582045750|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
161182757|NCT03559192|582045751|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
161182758|NCT03559192|582045752|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
161182759|NCT03559192|582045750|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
161182760|NCT03559192|582045751|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
161182761|NCT03559192|582045752|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
161182762|NCT03559192|582045750|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
161301116|NCT02244463|582484277|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
161301117|NCT02244463|582484272|FG000|Period 5: Phase II|Disease Progression|0|||
161301118|NCT02244463|582484273|FG001|Period 5: Phase II|Disease Progression|0|||
161301119|NCT02244463|582484274|FG002|Period 5: Phase II|Disease Progression|0|||
161301120|NCT02244463|582484275|FG003|Period 5: Phase II|Disease Progression|0|||
161301121|NCT02244463|582484276|FG004|Period 5: Phase II|Disease Progression|10|||
161301122|NCT02244463|582484277|FG005|Period 5: Phase II|Disease Progression|11|||
161301123|NCT02244463|582484272|FG000|Period 5: Phase II|Physician Decision|0|||
161301124|NCT02244463|582484273|FG001|Period 5: Phase II|Physician Decision|0|||
161301125|NCT02244463|582484274|FG002|Period 5: Phase II|Physician Decision|0|||
161182763|NCT03559192|582045751|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
161182764|NCT03559192|582045752|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
161182765|NCT03559192|582045750|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
161182766|NCT03559192|582045751|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
161182767|NCT03559192|582045752|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
161301126|NCT02244463|582484275|FG003|Period 5: Phase II|Physician Decision|0|||
161182768|NCT03559192|582045750|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
161182769|NCT03559192|582045751|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
161301127|NCT02244463|582484276|FG004|Period 5: Phase II|Physician Decision|3|||
161301128|NCT02244463|582484277|FG005|Period 5: Phase II|Physician Decision|2|||
161301129|NCT02244463|582484272|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
161301130|NCT02244463|582484273|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
161301131|NCT02244463|582484274|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
161301132|NCT02244463|582484275|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
161301133|NCT02244463|582484276|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
161301134|NCT02244463|582484277|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
161301135|NCT02244463|582484272|FG000|Period 5: Phase II|Intercurrent Illness|0|||
161301136|NCT02244463|582484273|FG001|Period 5: Phase II|Intercurrent Illness|0|||
161301137|NCT02244463|582484274|FG002|Period 5: Phase II|Intercurrent Illness|0|||
161301138|NCT02244463|582484275|FG003|Period 5: Phase II|Intercurrent Illness|0|||
161301139|NCT02244463|582484276|FG004|Period 5: Phase II|Intercurrent Illness|2|||
161301140|NCT02244463|582484277|FG005|Period 5: Phase II|Intercurrent Illness|0|||
161301141|NCT02244463|582484272|FG000|Period 5: Phase II|Adverse Event|0|||
161301142|NCT02244463|582484273|FG001|Period 5: Phase II|Adverse Event|0|||
161301143|NCT02244463|582484274|FG002|Period 5: Phase II|Adverse Event|0|||
161301144|NCT02244463|582484275|FG003|Period 5: Phase II|Adverse Event|0|||
161301145|NCT02244463|582484276|FG004|Period 5: Phase II|Adverse Event|0|||
161301146|NCT02244463|582484277|FG005|Period 5: Phase II|Adverse Event|2|||
161301147|NCT02244463|582484272|FG000|Period 5: Phase II|Still On treatment|0|||
161301148|NCT02244463|582484273|FG001|Period 5: Phase II|Still On treatment|0|||
161301149|NCT02244463|582484274|FG002|Period 5: Phase II|Still On treatment|0|||
161301150|NCT02244463|582484275|FG003|Period 5: Phase II|Still On treatment|0|||
161301151|NCT02244463|582484276|FG004|Period 5: Phase II|Still On treatment|0|||
161301152|NCT02244463|582484277|FG005|Period 5: Phase II|Still On treatment|3|||
161301153|NCT03702010|582484280|FG000|Follow-up (30days)|Lack of Efficacy|2|||
161301154|NCT03702010|582484281|FG001|Follow-up (30days)|Lack of Efficacy|2|||
161301155|NCT01598090|582484284|FG000|Treatment Period|Poor/non-compliance|0|||
161301156|NCT01598090|582484285|FG001|Treatment Period|Poor/non-compliance|2|||
161301157|NCT01598090|582484286|FG002|Treatment Period|Poor/non-compliance|0|||
161301158|NCT01598090|582484284|FG000|Treatment Period|No longer meet study criteria|0|||
161301159|NCT01598090|582484285|FG001|Treatment Period|No longer meet study criteria|1|||
161301160|NCT01598090|582484286|FG002|Treatment Period|No longer meet study criteria|0|||
161301161|NCT01598090|582484284|FG000|Treatment Period|Lack of Efficacy|5|||
161301162|NCT01598090|582484285|FG001|Treatment Period|Lack of Efficacy|14|||
161301163|NCT01598090|582484286|FG002|Treatment Period|Lack of Efficacy|6|||
161301164|NCT01598090|582484284|FG000|Treatment Period|Adverse Event|2|||
161301165|NCT01598090|582484285|FG001|Treatment Period|Adverse Event|33|||
161301166|NCT01598090|582484286|FG002|Treatment Period|Adverse Event|17|||
161301167|NCT01598090|582484284|FG000|Treatment Period|Other reasons|0|||
161301168|NCT01598090|582484285|FG001|Treatment Period|Other reasons|4|||
161301169|NCT01598090|582484286|FG002|Treatment Period|Other reasons|1|||
161301170|NCT01598090|582484284|FG000|Treatment Period|Withdrawal by Subject|3|||
161301171|NCT01598090|582484285|FG001|Treatment Period|Withdrawal by Subject|13|||
161301172|NCT01598090|582484286|FG002|Treatment Period|Withdrawal by Subject|10|||
161301173|NCT01598090|582484284|FG000|Treatment Period|Lost to Follow-up|1|||
161301174|NCT01598090|582484285|FG001|Treatment Period|Lost to Follow-up|5|||
161301175|NCT01598090|582484286|FG002|Treatment Period|Lost to Follow-up|1|||
161301176|NCT01598090|582484284|FG000|Follow-up Period|Death|0|||
161301177|NCT01598090|582484285|FG001|Follow-up Period|Death|1|||
161301178|NCT01598090|582484286|FG002|Follow-up Period|Death|0|||
161301179|NCT01598090|582484284|FG000|Follow-up Period|No longer required per protocol|1|||
161301180|NCT01598090|582484285|FG001|Follow-up Period|No longer required per protocol|3|||
161301181|NCT01598090|582484286|FG002|Follow-up Period|No longer required per protocol|2|||
161301182|NCT01598090|582484284|FG000|Follow-up Period|Not reported|0|||
161301183|NCT01598090|582484285|FG001|Follow-up Period|Not reported|10|||
161301184|NCT01598090|582484286|FG002|Follow-up Period|Not reported|4|||
161301185|NCT01598090|582484284|FG000|Follow-up Period|Withdrawal by Subject|0|||
161182770|NCT03559192|582045752|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
161182771|NCT03559192|582045750|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
161301186|NCT01598090|582484285|FG001|Follow-up Period|Withdrawal by Subject|3|||
161301187|NCT01598090|582484286|FG002|Follow-up Period|Withdrawal by Subject|2|||
161301188|NCT01598090|582484284|FG000|Follow-up Period|Other reasons|2|||
161301189|NCT01598090|582484285|FG001|Follow-up Period|Other reasons|8|||
161301190|NCT01598090|582484286|FG002|Follow-up Period|Other reasons|8|||
161301191|NCT01598090|582484284|FG000|Follow-up Period|Lost to Follow-up|2|||
161301192|NCT01598090|582484285|FG001|Follow-up Period|Lost to Follow-up|10|||
161301193|NCT01598090|582484286|FG002|Follow-up Period|Lost to Follow-up|12|||
161301194|NCT03557931|582484287|FG000|Overall Study|Adverse Event|4|||
161301195|NCT03557931|582484288|FG001|Overall Study|Adverse Event|6|||
161301196|NCT03557931|582484289|FG002|Overall Study|Adverse Event|1|||
161301197|NCT03557931|582484287|FG000|Overall Study|Lost to Follow-up|4|||
161182772|NCT03559192|582045751|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
161347886|NCT02903914|582657363|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161182773|NCT03559192|582045752|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
161182774|NCT03559192|582045750|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
161182775|NCT03559192|582045751|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
161182776|NCT03559192|582045752|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
161182777|NCT03559192|582045750|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
161182778|NCT03559192|582045751|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
161182779|NCT03559192|582045752|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
161182780|NCT03559192|582045750|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
161182781|NCT03559192|582045751|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
161182782|NCT03559192|582045752|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
161182783|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
161182784|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
161182785|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Death|0|||
161182786|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Death|4|||
161182787|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
161182788|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
161182789|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
161182790|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
161182791|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
161182792|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
161182793|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
161182794|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
161182795|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
161182796|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
161182797|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Other|4|||
161182798|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Other|3|||
161182799|NCT03517722|582045753|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
161182800|NCT03517722|582045754|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
161182801|NCT03517722|582045753|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
161182802|NCT03517722|582045754|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
161182803|NCT03517722|582045753|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
161182804|NCT03517722|582045754|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
161182805|NCT03517722|582045753|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
161182806|NCT03517722|582045754|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
161182807|NCT03517722|582045753|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
161182808|NCT03517722|582045754|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
161182809|NCT02254304|582045760|FG000|Overall Study|Adverse Event|2|||
161182810|NCT02254304|582045761|FG001|Overall Study|Adverse Event|1|||
161182811|NCT02254304|582045760|FG000|Overall Study|Lost to Follow-up|2|||
161182812|NCT02254304|582045761|FG001|Overall Study|Lost to Follow-up|2|||
161182813|NCT02254304|582045760|FG000|Overall Study|Protocol Violation|1|||
161182814|NCT02254304|582045761|FG001|Overall Study|Protocol Violation|0|||
161182815|NCT02254304|582045760|FG000|Overall Study|Withdrawal by Subject|3|||
161182816|NCT02254304|582045761|FG001|Overall Study|Withdrawal by Subject|0|||
161182817|NCT02254304|582045760|FG000|Overall Study|Injection site pain and Injection fear|1|||
161182818|NCT02254304|582045761|FG001|Overall Study|Injection site pain and Injection fear|0|||
161182819|NCT02254304|582045760|FG000|Overall Study|Personal causes|4|||
161182820|NCT02254304|582045761|FG001|Overall Study|Personal causes|1|||
161182821|NCT02254304|582045760|FG000|Overall Study|Personal decision|1|||
161182822|NCT02254304|582045761|FG001|Overall Study|Personal decision|0|||
161182823|NCT03573804|582045762|FG000|Overall Study|claustrophobia or MRI table problems|10|||
161182824|NCT00952419|582045764|FG000|Overall Study|Adverse Event|2|||
161182825|NCT00952419|582045765|FG001|Overall Study|Adverse Event|0|||
161182826|NCT00952419|582045766|FG002|Overall Study|Adverse Event|0|||
161182827|NCT00952419|582045764|FG000|Overall Study|Protocol Violation|3|||
161182828|NCT00952419|582045765|FG001|Overall Study|Protocol Violation|7|||
161182829|NCT00952419|582045766|FG002|Overall Study|Protocol Violation|0|||
161182830|NCT00952419|582045764|FG000|Overall Study|Withdrawal by Subject|1|||
161182831|NCT00952419|582045765|FG001|Overall Study|Withdrawal by Subject|3|||
161182832|NCT00952419|582045766|FG002|Overall Study|Withdrawal by Subject|0|||
161182833|NCT05166603|582045769|FG000|Overall Study|Withdrawal by Subject|68|||
161182834|NCT05166603|582045770|FG001|Overall Study|Withdrawal by Subject|0|||
161182835|NCT00366444|582047456|FG000|Overall Study|Withdrawal by Subject|1|||
161182836|NCT00366444|582047457|FG001|Overall Study|Withdrawal by Subject|1|||
161182837|NCT00366444|582047456|FG000|Overall Study|Lack of Efficacy|0|||
161182838|NCT00366444|582047457|FG001|Overall Study|Lack of Efficacy|1|||
161182839|NCT01654224|582047462|FG000|Overall Study|Lost to Follow-up|2|||
161182840|NCT01654224|582047463|FG001|Overall Study|Lost to Follow-up|2|||
161182841|NCT01654224|582047462|FG000|Overall Study|Did not receive allocation|1|||
161301198|NCT03557931|582484288|FG001|Overall Study|Lost to Follow-up|4|||
161301199|NCT03557931|582484289|FG002|Overall Study|Lost to Follow-up|1|||
161301200|NCT03557931|582484287|FG000|Overall Study|Protocol Violation|1|||
161301201|NCT03557931|582484288|FG001|Overall Study|Protocol Violation|4|||
161301202|NCT03557931|582484289|FG002|Overall Study|Protocol Violation|1|||
161301203|NCT03557931|582484287|FG000|Overall Study|Withdrawal by Subject|14|||
161301204|NCT03557931|582484288|FG001|Overall Study|Withdrawal by Subject|0|||
161301205|NCT03557931|582484289|FG002|Overall Study|Withdrawal by Subject|7|||
161301206|NCT03557931|582484287|FG000|Overall Study|Miscellaneous|8|||
161301207|NCT03557931|582484288|FG001|Overall Study|Miscellaneous|5|||
161301208|NCT03557931|582484289|FG002|Overall Study|Miscellaneous|3|||
161301209|NCT02394340|582484290|FG000|Overall Study|Failed drug screen test|1|||
161301210|NCT02394340|582484290|FG000|Overall Study|Adverse Event|1|||
161301211|NCT03605862|582484293|FG000|Overall Study|Withdrawal by Subject|12|||
161301212|NCT03605862|582484294|FG001|Overall Study|Withdrawal by Subject|9|||
161301213|NCT03605862|582484293|FG000|Overall Study|Adverse Event|2|||
161301214|NCT03605862|582484294|FG001|Overall Study|Adverse Event|1|||
161301215|NCT03605862|582484293|FG000|Overall Study|Physician Decision|3|||
161301216|NCT03605862|582484294|FG001|Overall Study|Physician Decision|1|||
161301217|NCT03605862|582484293|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
161301218|NCT03605862|582484294|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
161301219|NCT01582178|582484299|FG000|Overall Study|Physician Decision|6|||
161301220|NCT01582178|582484300|FG001|Overall Study|Physician Decision|5|||
161301221|NCT01323387|582484301|FG000|Overall Study|Withdrawal by Subject|41|||
161301222|NCT01323387|582484301|FG000|Overall Study|Radiographic Data Unavailable|1|||
161301223|NCT01323387|582484301|FG000|Overall Study|Revision|14|||
161301224|NCT01323387|582484301|FG000|Overall Study|Protocol Violation|12|||
161301225|NCT01323387|582484301|FG000|Overall Study|Randomized but Never Treated|16|||
161301226|NCT02157376|582484304|FG000|Overall Study|Death|10|||
161301227|NCT02157376|582484305|FG001|Overall Study|Death|4|||
161301228|NCT02157376|582484304|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161301229|NCT02157376|582484305|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161301230|NCT02157376|582484304|FG000|Overall Study|Withdrawal by Subject|3|||
161301231|NCT02157376|582484305|FG001|Overall Study|Withdrawal by Subject|8|||
161301232|NCT02157376|582484304|FG000|Overall Study|Not treated|8|||
161301233|NCT02157376|582484305|FG001|Overall Study|Not treated|3|||
161301234|NCT02157376|582484304|FG000|Overall Study|Investigator's misjudgement|1|||
161301235|NCT02157376|582484305|FG001|Overall Study|Investigator's misjudgement|2|||
161301236|NCT04200651|582484306|FG000|Overall Study|Moved to another country during follow-up|2|||
161301237|NCT04200651|582484307|FG001|Overall Study|Moved to another country during follow-up|2|||
161301238|NCT04200651|582484306|FG000|Overall Study|Lost to Follow-up|1|||
161301239|NCT04200651|582484307|FG001|Overall Study|Lost to Follow-up|3|||
161301240|NCT01031680|582484308|FG000|Overall Study|Adverse Event|8|||
161301241|NCT01031680|582484309|FG001|Overall Study|Adverse Event|3|||
161301242|NCT01031680|582484308|FG000|Overall Study|Lost to Follow-up|2|||
161301243|NCT01031680|582484309|FG001|Overall Study|Lost to Follow-up|10|||
161301244|NCT01031680|582484308|FG000|Overall Study|Withdrawal by Subject|12|||
161301245|NCT01031680|582484309|FG001|Overall Study|Withdrawal by Subject|16|||
161301246|NCT01031680|582484308|FG000|Overall Study|Death|2|||
161301247|NCT01031680|582484309|FG001|Overall Study|Death|1|||
161301248|NCT01031680|582484308|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
161301249|NCT01031680|582484309|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
161301250|NCT01031680|582484308|FG000|Overall Study|Poor/Non-compliance|5|||
161301251|NCT01031680|582484309|FG001|Overall Study|Poor/Non-compliance|6|||
161301252|NCT01031680|582484308|FG000|Overall Study|Safety|1|||
161301253|NCT01031680|582484309|FG001|Overall Study|Safety|0|||
161301254|NCT01031680|582484308|FG000|Overall Study|Incorrect Enrolment|1|||
161301255|NCT01031680|582484309|FG001|Overall Study|Incorrect Enrolment|2|||
161301256|NCT01031680|582484308|FG000|Overall Study|Administrative Reason by Sponsor|0|||
161301257|NCT01031680|582484309|FG001|Overall Study|Administrative Reason by Sponsor|1|||
161301258|NCT01031680|582484308|FG000|Overall Study|Various|0|||
161301259|NCT01031680|582484309|FG001|Overall Study|Various|2|||
161301260|NCT01186692|582484316|FG000|Overall Study|Not Catheterized|11|||
161301261|NCT01186692|582484316|FG000|Overall Study|Futher testing contraindicated implant|19|||
161301262|NCT01186692|582484316|FG000|Overall Study|Adverse Event|2|||
161301263|NCT03319732|582484317|FG000|Overall Study|Adverse Event|40|||
161301264|NCT03319732|582484317|FG000|Overall Study|Withdrawal by Subject|50|||
161301265|NCT03319732|582484317|FG000|Overall Study|MS relapse|10|||
161301266|NCT03319732|582484317|FG000|Overall Study|reason not specified|5|||
161301267|NCT01921101|582484319|FG000|Overall Study|Death|16|||
161301268|NCT01921101|582484320|FG001|Overall Study|Death|6|||
161301269|NCT00596817|582484322|FG000|Open-label Period|Adverse Event|0|||
161301270|NCT00596817|582484323|FG001|Open-label Period|Adverse Event|49|||
161301271|NCT00596817|582484322|FG000|Open-label Period|Lack of Efficacy|0|||
161301272|NCT00596817|582484323|FG001|Open-label Period|Lack of Efficacy|33|||
161301273|NCT00596817|582484322|FG000|Open-label Period|Other Reasons|0|||
161301274|NCT00596817|582484323|FG001|Open-label Period|Other Reasons|65|||
161301275|NCT00596817|582484322|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
161301276|NCT00596817|582484323|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
161301277|NCT00596817|582484322|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
161301278|NCT00596817|582484323|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
161301279|NCT00596817|582484322|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
161301280|NCT00596817|582484323|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
161301281|NCT00596817|582484322|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
161301282|NCT00596817|582484323|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
161301283|NCT00596817|582484322|FG000|Double-blind Period|Adverse Event|5|||
161301284|NCT00596817|582484323|FG001|Double-blind Period|Adverse Event|16|||
161301285|NCT00596817|582484322|FG000|Double-blind Period|Lack of Efficacy|52|||
161301286|NCT00596817|582484323|FG001|Double-blind Period|Lack of Efficacy|28|||
161301287|NCT00596817|582484322|FG000|Double-blind Period|Non-compliance With Study Product|3|||
161301288|NCT00596817|582484323|FG001|Double-blind Period|Non-compliance With Study Product|4|||
161301289|NCT00596817|582484322|FG000|Double-blind Period|Protocol Violation|11|||
161301290|NCT00596817|582484323|FG001|Double-blind Period|Protocol Violation|8|||
161301291|NCT00596817|582484322|FG000|Double-blind Period|Withdrawal of Consent|7|||
161301292|NCT00596817|582484323|FG001|Double-blind Period|Withdrawal of Consent|3|||
161301293|NCT00596817|582484322|FG000|Double-blind Period|Lost to Follow-up|0|||
161301294|NCT00596817|582484323|FG001|Double-blind Period|Lost to Follow-up|2|||
161301295|NCT00596817|582484322|FG000|Double-blind Period|Other Reasons|10|||
161301296|NCT00596817|582484323|FG001|Double-blind Period|Other Reasons|18|||
161301297|NCT01314872|582484329|FG000|Treatment Period 1|Protocol Violation|2|||
161301298|NCT01314872|582484330|FG001|Treatment Period 1|Protocol Violation|1|||
161301299|NCT01314872|582484331|FG002|Treatment Period 1|Protocol Violation|1|||
161301300|NCT01314872|582484332|FG003|Treatment Period 1|Protocol Violation|0|||
161301301|NCT01314872|582484333|FG004|Treatment Period 1|Protocol Violation|1|||
161301302|NCT01314872|582484334|FG005|Treatment Period 1|Protocol Violation|0|||
161301303|NCT01314872|582484335|FG006|Treatment Period 1|Protocol Violation|0|||
161301304|NCT01314872|582484336|FG007|Treatment Period 1|Protocol Violation|0|||
161301305|NCT01314872|582484337|FG008|Treatment Period 1|Protocol Violation|0|||
161301306|NCT01314872|582484338|FG009|Treatment Period 1|Protocol Violation|1|||
161301307|NCT01314872|582484339|FG010|Treatment Period 1|Protocol Violation|1|||
161301308|NCT01314872|582484340|FG011|Treatment Period 1|Protocol Violation|0|||
161301309|NCT01314872|582484341|FG012|Treatment Period 1|Protocol Violation|0|||
161301310|NCT01314872|582484342|FG013|Treatment Period 1|Protocol Violation|0|||
161301311|NCT01314872|582484343|FG014|Treatment Period 1|Protocol Violation|0|||
161301312|NCT01314872|582484329|FG000|Treatment Period 1|Physician Decision|0|||
161301313|NCT01314872|582484330|FG001|Treatment Period 1|Physician Decision|1|||
161301314|NCT01314872|582484331|FG002|Treatment Period 1|Physician Decision|0|||
161301315|NCT01314872|582484332|FG003|Treatment Period 1|Physician Decision|1|||
161301316|NCT01314872|582484333|FG004|Treatment Period 1|Physician Decision|0|||
161301317|NCT01314872|582484334|FG005|Treatment Period 1|Physician Decision|0|||
161301318|NCT01314872|582484335|FG006|Treatment Period 1|Physician Decision|0|||
161301319|NCT01314872|582484336|FG007|Treatment Period 1|Physician Decision|0|||
161301320|NCT01314872|582484337|FG008|Treatment Period 1|Physician Decision|0|||
161301321|NCT01314872|582484338|FG009|Treatment Period 1|Physician Decision|1|||
161301322|NCT01314872|582484339|FG010|Treatment Period 1|Physician Decision|0|||
161301323|NCT01314872|582484340|FG011|Treatment Period 1|Physician Decision|0|||
161301324|NCT01314872|582484341|FG012|Treatment Period 1|Physician Decision|0|||
161301325|NCT01314872|582484342|FG013|Treatment Period 1|Physician Decision|0|||
161301326|NCT01314872|582484343|FG014|Treatment Period 1|Physician Decision|0|||
161301327|NCT01314872|582484329|FG000|Treatment Period 1|Lack of Efficacy|1|||
161347887|NCT02903914|582657364|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161089522|NCT03149549|581717411|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
161089523|NCT03149549|581717399|FG000|Study Discontinuation--Treatment Period|Other|0|||
161089524|NCT03149549|581717400|FG001|Study Discontinuation--Treatment Period|Other|0|||
161089525|NCT03149549|581717401|FG002|Study Discontinuation--Treatment Period|Other|0|||
161089526|NCT03149549|581717402|FG003|Study Discontinuation--Treatment Period|Other|0|||
161089527|NCT03149549|581717403|FG004|Study Discontinuation--Treatment Period|Other|0|||
161089528|NCT03149549|581717404|FG005|Study Discontinuation--Treatment Period|Other|0|||
161089529|NCT03149549|581717405|FG006|Study Discontinuation--Treatment Period|Other|0|||
161089530|NCT03149549|581717406|FG007|Study Discontinuation--Treatment Period|Other|1|||
161089531|NCT03149549|581717407|FG008|Study Discontinuation--Treatment Period|Other|0|||
161089532|NCT03149549|581717408|FG009|Study Discontinuation--Treatment Period|Other|1|||
161089533|NCT03149549|581717409|FG010|Study Discontinuation--Treatment Period|Other|0|||
161089534|NCT03149549|581717410|FG011|Study Discontinuation--Treatment Period|Other|0|||
161089535|NCT03149549|581717411|FG012|Study Discontinuation--Treatment Period|Other|0|||
161089536|NCT03149549|581717399|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089537|NCT03149549|581717400|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089538|NCT03149549|581717401|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161182842|NCT01654224|582047463|FG001|Overall Study|Did not receive allocation|8|||
161182843|NCT01654224|582047462|FG000|Overall Study|Insufficient blood sample|3|||
161182844|NCT01654224|582047463|FG001|Overall Study|Insufficient blood sample|2|||
161182845|NCT00166504|582047465|FG000|Overall Study|Adverse Event|3|||
161182846|NCT00166504|582047466|FG001|Overall Study|Adverse Event|3|||
161182847|NCT00166504|582047465|FG000|Overall Study|Lost to Follow-up|1|||
161182848|NCT00166504|582047466|FG001|Overall Study|Lost to Follow-up|1|||
161182849|NCT00166504|582047465|FG000|Overall Study|Withdrawal by Subject|1|||
161182850|NCT00166504|582047466|FG001|Overall Study|Withdrawal by Subject|0|||
161182851|NCT02200510|582047467|FG000|Overall Study|Death|1|||
161182852|NCT02200510|582047468|FG001|Overall Study|Death|1|||
161182853|NCT02200510|582047467|FG000|Overall Study|Protocol Violation|0|||
161182854|NCT02200510|582047468|FG001|Overall Study|Protocol Violation|1|||
161182855|NCT02200510|582047467|FG000|Overall Study|Lost to Follow-up|7|||
161182856|NCT02200510|582047468|FG001|Overall Study|Lost to Follow-up|1|||
161182857|NCT02200510|582047467|FG000|Overall Study|potential COI - joined study team|1|||
161182858|NCT02200510|582047468|FG001|Overall Study|potential COI - joined study team|0|||
161182859|NCT04969900|582047469|FG000|Overall Study|Physician Decision|1|||
161182860|NCT04969900|582047470|FG001|Overall Study|Physician Decision|1|||
161182861|NCT04969900|582047469|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
161182862|NCT04969900|582047470|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
161182863|NCT03261037|582047473|FG000|Overall Study|Withdrawal by Subject|2|||
161182864|NCT03261037|582047474|FG001|Overall Study|Withdrawal by Subject|13|||
161182865|NCT03261037|582047475|FG002|Overall Study|Withdrawal by Subject|0|||
161182866|NCT03261037|582047476|FG003|Overall Study|Withdrawal by Subject|18|||
161182867|NCT03261037|582047473|FG000|Overall Study|Non-compliance with study procedures|0|||
161182868|NCT03261037|582047474|FG001|Overall Study|Non-compliance with study procedures|2|||
161182869|NCT03261037|582047475|FG002|Overall Study|Non-compliance with study procedures|0|||
161182870|NCT03261037|582047476|FG003|Overall Study|Non-compliance with study procedures|6|||
161182871|NCT03261037|582047473|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
161182872|NCT03261037|582047474|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
161182873|NCT03261037|582047475|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
161182874|NCT03261037|582047476|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
161182875|NCT03261037|582047473|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
161182876|NCT03261037|582047474|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
161182877|NCT03261037|582047475|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
161182878|NCT03261037|582047476|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
161182879|NCT03261037|582047473|FG000|Overall Study|Diagnosed but protocol deviation|1|||
161182880|NCT03261037|582047474|FG001|Overall Study|Diagnosed but protocol deviation|0|||
161182881|NCT03261037|582047475|FG002|Overall Study|Diagnosed but protocol deviation|0|||
161182882|NCT03261037|582047476|FG003|Overall Study|Diagnosed but protocol deviation|0|||
161182883|NCT03261037|582047473|FG000|Overall Study|Participant did not want to continue the study|0|||
161182884|NCT03261037|582047474|FG001|Overall Study|Participant did not want to continue the study|1|||
161182885|NCT03261037|582047475|FG002|Overall Study|Participant did not want to continue the study|0|||
161182886|NCT03261037|582047476|FG003|Overall Study|Participant did not want to continue the study|0|||
161182887|NCT03261037|582047473|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161182888|NCT03261037|582047474|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161182889|NCT03261037|582047475|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
161182890|NCT03261037|582047476|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
161182891|NCT03261037|582047473|FG000|Overall Study|Participant presented clinical improvement|0|||
161182892|NCT03261037|582047474|FG001|Overall Study|Participant presented clinical improvement|2|||
161182893|NCT03261037|582047475|FG002|Overall Study|Participant presented clinical improvement|0|||
161182894|NCT03261037|582047476|FG003|Overall Study|Participant presented clinical improvement|0|||
161182895|NCT03261037|582047473|FG000|Overall Study|Technical difficulties|0|||
161182896|NCT03261037|582047474|FG001|Overall Study|Technical difficulties|0|||
161182897|NCT03261037|582047475|FG002|Overall Study|Technical difficulties|0|||
161182898|NCT03261037|582047476|FG003|Overall Study|Technical difficulties|1|||
161182899|NCT03261037|582047473|FG000|Overall Study|Equipment failed to work|0|||
161182900|NCT03261037|582047474|FG001|Overall Study|Equipment failed to work|0|||
161182901|NCT03261037|582047475|FG002|Overall Study|Equipment failed to work|0|||
161182902|NCT03261037|582047476|FG003|Overall Study|Equipment failed to work|1|||
161182903|NCT03261037|582047473|FG000|Overall Study|End of study for participant and no follow up|0|||
161182904|NCT03261037|582047474|FG001|Overall Study|End of study for participant and no follow up|0|||
161182905|NCT03261037|582047475|FG002|Overall Study|End of study for participant and no follow up|0|||
161182906|NCT03261037|582047476|FG003|Overall Study|End of study for participant and no follow up|1|||
161182907|NCT03261037|582047473|FG000|Overall Study|Participant was too weak to continue in study|1|||
161182908|NCT03261037|582047474|FG001|Overall Study|Participant was too weak to continue in study|0|||
161301328|NCT01314872|582484330|FG001|Treatment Period 1|Lack of Efficacy|0|||
161301329|NCT01314872|582484331|FG002|Treatment Period 1|Lack of Efficacy|0|||
161301330|NCT01314872|582484332|FG003|Treatment Period 1|Lack of Efficacy|0|||
161301331|NCT01314872|582484333|FG004|Treatment Period 1|Lack of Efficacy|0|||
161301332|NCT01314872|582484334|FG005|Treatment Period 1|Lack of Efficacy|1|||
161301333|NCT01314872|582484335|FG006|Treatment Period 1|Lack of Efficacy|0|||
161301334|NCT01314872|582484336|FG007|Treatment Period 1|Lack of Efficacy|2|||
161301335|NCT01314872|582484337|FG008|Treatment Period 1|Lack of Efficacy|0|||
161301336|NCT01314872|582484338|FG009|Treatment Period 1|Lack of Efficacy|0|||
161301337|NCT01314872|582484339|FG010|Treatment Period 1|Lack of Efficacy|0|||
161301338|NCT01314872|582484340|FG011|Treatment Period 1|Lack of Efficacy|0|||
161301339|NCT01314872|582484341|FG012|Treatment Period 1|Lack of Efficacy|0|||
161301340|NCT01314872|582484342|FG013|Treatment Period 1|Lack of Efficacy|0|||
161301341|NCT01314872|582484343|FG014|Treatment Period 1|Lack of Efficacy|0|||
161301342|NCT01314872|582484329|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
161301343|NCT01314872|582484330|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
161301344|NCT01314872|582484331|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
161301345|NCT01314872|582484332|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
161301346|NCT01314872|582484333|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
161301347|NCT01314872|582484334|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
161301348|NCT01314872|582484335|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
161301349|NCT01314872|582484336|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
161301350|NCT01314872|582484337|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
161301351|NCT01314872|582484338|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
161301352|NCT01314872|582484339|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
161301353|NCT01314872|582484340|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
161301354|NCT01314872|582484341|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
161301355|NCT01314872|582484342|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
161301356|NCT01314872|582484343|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
161301357|NCT01314872|582484329|FG000|Treatment Period 1|Withdrawal by Subject|3|||
161301358|NCT01314872|582484330|FG001|Treatment Period 1|Withdrawal by Subject|1|||
161301359|NCT01314872|582484331|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161301360|NCT01314872|582484332|FG003|Treatment Period 1|Withdrawal by Subject|2|||
161301361|NCT01314872|582484333|FG004|Treatment Period 1|Withdrawal by Subject|3|||
161301362|NCT01314872|582484334|FG005|Treatment Period 1|Withdrawal by Subject|1|||
161301363|NCT01314872|582484335|FG006|Treatment Period 1|Withdrawal by Subject|3|||
161301364|NCT01314872|582484336|FG007|Treatment Period 1|Withdrawal by Subject|2|||
161301365|NCT01314872|582484337|FG008|Treatment Period 1|Withdrawal by Subject|2|||
161301366|NCT01314872|582484338|FG009|Treatment Period 1|Withdrawal by Subject|2|||
161301367|NCT01314872|582484339|FG010|Treatment Period 1|Withdrawal by Subject|1|||
161301368|NCT01314872|582484340|FG011|Treatment Period 1|Withdrawal by Subject|0|||
161301369|NCT01314872|582484341|FG012|Treatment Period 1|Withdrawal by Subject|0|||
161301370|NCT01314872|582484342|FG013|Treatment Period 1|Withdrawal by Subject|0|||
161301371|NCT01314872|582484343|FG014|Treatment Period 1|Withdrawal by Subject|0|||
161301372|NCT01314872|582484329|FG000|Treatment Period 1|Lost to Follow-up|0|||
161301373|NCT01314872|582484330|FG001|Treatment Period 1|Lost to Follow-up|1|||
161301374|NCT01314872|582484331|FG002|Treatment Period 1|Lost to Follow-up|2|||
161301375|NCT01314872|582484332|FG003|Treatment Period 1|Lost to Follow-up|2|||
161301376|NCT01314872|582484333|FG004|Treatment Period 1|Lost to Follow-up|1|||
161301377|NCT01314872|582484334|FG005|Treatment Period 1|Lost to Follow-up|1|||
161301378|NCT01314872|582484335|FG006|Treatment Period 1|Lost to Follow-up|1|||
161301379|NCT01314872|582484336|FG007|Treatment Period 1|Lost to Follow-up|1|||
161301380|NCT01314872|582484337|FG008|Treatment Period 1|Lost to Follow-up|1|||
161301381|NCT01314872|582484338|FG009|Treatment Period 1|Lost to Follow-up|0|||
161301382|NCT01314872|582484339|FG010|Treatment Period 1|Lost to Follow-up|0|||
161301383|NCT01314872|582484340|FG011|Treatment Period 1|Lost to Follow-up|0|||
161301384|NCT01314872|582484341|FG012|Treatment Period 1|Lost to Follow-up|0|||
161301385|NCT01314872|582484342|FG013|Treatment Period 1|Lost to Follow-up|0|||
161301386|NCT01314872|582484343|FG014|Treatment Period 1|Lost to Follow-up|0|||
161301387|NCT01314872|582484329|FG000|Period 2|Protocol Violation|0|||
161301388|NCT01314872|582484330|FG001|Period 2|Protocol Violation|0|||
161301389|NCT01314872|582484331|FG002|Period 2|Protocol Violation|0|||
161301390|NCT01314872|582484332|FG003|Period 2|Protocol Violation|0|||
161301391|NCT01314872|582484333|FG004|Period 2|Protocol Violation|0|||
161301392|NCT01314872|582484334|FG005|Period 2|Protocol Violation|0|||
161301393|NCT01314872|582484335|FG006|Period 2|Protocol Violation|0|||
161301394|NCT01314872|582484336|FG007|Period 2|Protocol Violation|0|||
161301395|NCT01314872|582484337|FG008|Period 2|Protocol Violation|0|||
161301396|NCT01314872|582484338|FG009|Period 2|Protocol Violation|0|||
161301397|NCT01314872|582484339|FG010|Period 2|Protocol Violation|0|||
161301398|NCT01314872|582484340|FG011|Period 2|Protocol Violation|3|||
161301399|NCT01314872|582484341|FG012|Period 2|Protocol Violation|3|||
161301400|NCT01314872|582484342|FG013|Period 2|Protocol Violation|2|||
161301401|NCT01314872|582484343|FG014|Period 2|Protocol Violation|0|||
161301402|NCT01314872|582484329|FG000|Period 2|Non-compliance with study drug|0|||
161301403|NCT01314872|582484330|FG001|Period 2|Non-compliance with study drug|0|||
161301404|NCT01314872|582484331|FG002|Period 2|Non-compliance with study drug|0|||
161301405|NCT01314872|582484332|FG003|Period 2|Non-compliance with study drug|0|||
161301406|NCT01314872|582484333|FG004|Period 2|Non-compliance with study drug|0|||
161301407|NCT01314872|582484334|FG005|Period 2|Non-compliance with study drug|0|||
161301408|NCT01314872|582484335|FG006|Period 2|Non-compliance with study drug|0|||
161301409|NCT01314872|582484336|FG007|Period 2|Non-compliance with study drug|0|||
161301410|NCT01314872|582484337|FG008|Period 2|Non-compliance with study drug|0|||
161301411|NCT01314872|582484338|FG009|Period 2|Non-compliance with study drug|0|||
161301412|NCT01314872|582484339|FG010|Period 2|Non-compliance with study drug|0|||
161301413|NCT01314872|582484340|FG011|Period 2|Non-compliance with study drug|3|||
161301414|NCT01314872|582484341|FG012|Period 2|Non-compliance with study drug|3|||
161301415|NCT01314872|582484342|FG013|Period 2|Non-compliance with study drug|1|||
161301416|NCT01314872|582484343|FG014|Period 2|Non-compliance with study drug|2|||
161301417|NCT01314872|582484329|FG000|Period 2|Lack of Efficacy|0|||
161301418|NCT01314872|582484330|FG001|Period 2|Lack of Efficacy|0|||
161301419|NCT01314872|582484331|FG002|Period 2|Lack of Efficacy|0|||
161301420|NCT01314872|582484332|FG003|Period 2|Lack of Efficacy|0|||
161301421|NCT01314872|582484333|FG004|Period 2|Lack of Efficacy|0|||
161301422|NCT01314872|582484334|FG005|Period 2|Lack of Efficacy|0|||
161301423|NCT01314872|582484335|FG006|Period 2|Lack of Efficacy|0|||
161301424|NCT01314872|582484336|FG007|Period 2|Lack of Efficacy|0|||
161301425|NCT01314872|582484337|FG008|Period 2|Lack of Efficacy|0|||
161301426|NCT01314872|582484338|FG009|Period 2|Lack of Efficacy|0|||
161301427|NCT01314872|582484339|FG010|Period 2|Lack of Efficacy|0|||
161301428|NCT01314872|582484340|FG011|Period 2|Lack of Efficacy|7|||
161301429|NCT01314872|582484341|FG012|Period 2|Lack of Efficacy|12|||
161301430|NCT01314872|582484342|FG013|Period 2|Lack of Efficacy|9|||
161301431|NCT01314872|582484343|FG014|Period 2|Lack of Efficacy|2|||
161301432|NCT01314872|582484329|FG000|Period 2|Pregnancy|0|||
161301433|NCT01314872|582484330|FG001|Period 2|Pregnancy|0|||
161301434|NCT01314872|582484331|FG002|Period 2|Pregnancy|0|||
161301435|NCT01314872|582484332|FG003|Period 2|Pregnancy|0|||
161301436|NCT01314872|582484333|FG004|Period 2|Pregnancy|0|||
161301437|NCT01314872|582484334|FG005|Period 2|Pregnancy|0|||
161301438|NCT01314872|582484335|FG006|Period 2|Pregnancy|0|||
161301439|NCT01314872|582484336|FG007|Period 2|Pregnancy|0|||
161301440|NCT01314872|582484337|FG008|Period 2|Pregnancy|0|||
161301441|NCT01314872|582484338|FG009|Period 2|Pregnancy|0|||
161301442|NCT01314872|582484339|FG010|Period 2|Pregnancy|0|||
161301443|NCT01314872|582484340|FG011|Period 2|Pregnancy|0|||
161301444|NCT01314872|582484341|FG012|Period 2|Pregnancy|0|||
161301445|NCT01314872|582484342|FG013|Period 2|Pregnancy|0|||
161301446|NCT01314872|582484343|FG014|Period 2|Pregnancy|1|||
161301447|NCT01314872|582484329|FG000|Period 2|Study terminated by Sponsor|0|||
161301448|NCT01314872|582484330|FG001|Period 2|Study terminated by Sponsor|0|||
161301449|NCT01314872|582484331|FG002|Period 2|Study terminated by Sponsor|0|||
161301450|NCT01314872|582484332|FG003|Period 2|Study terminated by Sponsor|0|||
161301451|NCT01314872|582484333|FG004|Period 2|Study terminated by Sponsor|0|||
161301452|NCT01314872|582484334|FG005|Period 2|Study terminated by Sponsor|0|||
161301453|NCT01314872|582484335|FG006|Period 2|Study terminated by Sponsor|0|||
161301454|NCT01314872|582484336|FG007|Period 2|Study terminated by Sponsor|0|||
161301455|NCT01314872|582484337|FG008|Period 2|Study terminated by Sponsor|0|||
161301456|NCT01314872|582484338|FG009|Period 2|Study terminated by Sponsor|0|||
161301457|NCT01314872|582484339|FG010|Period 2|Study terminated by Sponsor|0|||
161301458|NCT01314872|582484340|FG011|Period 2|Study terminated by Sponsor|2|||
161301459|NCT01314872|582484341|FG012|Period 2|Study terminated by Sponsor|2|||
161301460|NCT01314872|582484342|FG013|Period 2|Study terminated by Sponsor|3|||
161301461|NCT01314872|582484343|FG014|Period 2|Study terminated by Sponsor|0|||
161301462|NCT01314872|582484329|FG000|Period 2|Adverse event, non-fatal|0|||
161301463|NCT01314872|582484330|FG001|Period 2|Adverse event, non-fatal|0|||
161301464|NCT01314872|582484331|FG002|Period 2|Adverse event, non-fatal|0|||
161301465|NCT01314872|582484332|FG003|Period 2|Adverse event, non-fatal|0|||
161301466|NCT01314872|582484333|FG004|Period 2|Adverse event, non-fatal|0|||
161301467|NCT01314872|582484334|FG005|Period 2|Adverse event, non-fatal|0|||
161347888|NCT02903914|582657365|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161347889|NCT02903914|582657366|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161347890|NCT02903914|582657367|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
161347891|NCT02903914|582657368|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
161301468|NCT01314872|582484335|FG006|Period 2|Adverse event, non-fatal|0|||
161301469|NCT01314872|582484336|FG007|Period 2|Adverse event, non-fatal|0|||
161301470|NCT01314872|582484337|FG008|Period 2|Adverse event, non-fatal|0|||
161301471|NCT01314872|582484338|FG009|Period 2|Adverse event, non-fatal|0|||
161301472|NCT01314872|582484339|FG010|Period 2|Adverse event, non-fatal|0|||
161301473|NCT01314872|582484340|FG011|Period 2|Adverse event, non-fatal|13|||
161301474|NCT01314872|582484341|FG012|Period 2|Adverse event, non-fatal|16|||
161301475|NCT01314872|582484342|FG013|Period 2|Adverse event, non-fatal|24|||
161182909|NCT03261037|582047475|FG002|Overall Study|Participant was too weak to continue in study|0|||
161301476|NCT01314872|582484343|FG014|Period 2|Adverse event, non-fatal|9|||
161301477|NCT01314872|582484329|FG000|Period 2|Withdrawal by Subject|0|||
161301478|NCT01314872|582484330|FG001|Period 2|Withdrawal by Subject|0|||
161301479|NCT01314872|582484331|FG002|Period 2|Withdrawal by Subject|0|||
161301480|NCT01314872|582484332|FG003|Period 2|Withdrawal by Subject|0|||
161301481|NCT01314872|582484333|FG004|Period 2|Withdrawal by Subject|0|||
161301482|NCT01314872|582484334|FG005|Period 2|Withdrawal by Subject|0|||
161301483|NCT01314872|582484335|FG006|Period 2|Withdrawal by Subject|0|||
161301484|NCT01314872|582484336|FG007|Period 2|Withdrawal by Subject|0|||
161301485|NCT01314872|582484337|FG008|Period 2|Withdrawal by Subject|0|||
161301486|NCT01314872|582484338|FG009|Period 2|Withdrawal by Subject|0|||
161301487|NCT01314872|582484339|FG010|Period 2|Withdrawal by Subject|0|||
161301488|NCT01314872|582484340|FG011|Period 2|Withdrawal by Subject|14|||
161301489|NCT01314872|582484341|FG012|Period 2|Withdrawal by Subject|17|||
161301490|NCT01314872|582484342|FG013|Period 2|Withdrawal by Subject|12|||
161301491|NCT01314872|582484343|FG014|Period 2|Withdrawal by Subject|4|||
161301492|NCT01314872|582484329|FG000|Period 2|Lost to Follow-up|0|||
161301493|NCT01314872|582484330|FG001|Period 2|Lost to Follow-up|0|||
161301494|NCT01314872|582484331|FG002|Period 2|Lost to Follow-up|0|||
161301495|NCT01314872|582484332|FG003|Period 2|Lost to Follow-up|0|||
161301496|NCT01314872|582484333|FG004|Period 2|Lost to Follow-up|0|||
161301497|NCT01314872|582484334|FG005|Period 2|Lost to Follow-up|0|||
161301498|NCT01314872|582484335|FG006|Period 2|Lost to Follow-up|0|||
161301499|NCT01314872|582484336|FG007|Period 2|Lost to Follow-up|0|||
161301500|NCT01314872|582484337|FG008|Period 2|Lost to Follow-up|0|||
161301501|NCT01314872|582484338|FG009|Period 2|Lost to Follow-up|0|||
161301502|NCT01314872|582484339|FG010|Period 2|Lost to Follow-up|0|||
161301503|NCT01314872|582484340|FG011|Period 2|Lost to Follow-up|6|||
161301504|NCT01314872|582484341|FG012|Period 2|Lost to Follow-up|7|||
161301505|NCT01314872|582484342|FG013|Period 2|Lost to Follow-up|2|||
161301506|NCT01314872|582484343|FG014|Period 2|Lost to Follow-up|6|||
161182910|NCT03261037|582047476|FG003|Overall Study|Participant was too weak to continue in study|0|||
161182911|NCT04423718|582047477|FG000|Main Study|Adverse Event|9|||
161182912|NCT04423718|582047478|FG001|Main Study|Adverse Event|5|||
161182913|NCT04423718|582047479|FG002|Main Study|Adverse Event|8|||
161182914|NCT04423718|582047477|FG000|Main Study|Physician Decision|3|||
161182915|NCT04423718|582047478|FG001|Main Study|Physician Decision|3|||
161182916|NCT04423718|582047479|FG002|Main Study|Physician Decision|2|||
161182917|NCT04423718|582047477|FG000|Main Study|Protocol Violation|0|||
161182918|NCT04423718|582047478|FG001|Main Study|Protocol Violation|0|||
161182919|NCT04423718|582047479|FG002|Main Study|Protocol Violation|1|||
161182920|NCT04423718|582047477|FG000|Main Study|Lost to Follow-up|3|||
161182921|NCT04423718|582047478|FG001|Main Study|Lost to Follow-up|3|||
161182922|NCT04423718|582047479|FG002|Main Study|Lost to Follow-up|4|||
161182923|NCT04423718|582047477|FG000|Main Study|Lack of Efficacy|2|||
161182924|NCT04423718|582047478|FG001|Main Study|Lack of Efficacy|1|||
161182925|NCT04423718|582047479|FG002|Main Study|Lack of Efficacy|0|||
161182926|NCT04423718|582047477|FG000|Main Study|Withdrawal by Subject|14|||
161182927|NCT04423718|582047478|FG001|Main Study|Withdrawal by Subject|20|||
161182928|NCT04423718|582047479|FG002|Main Study|Withdrawal by Subject|20|||
161182929|NCT04423718|582047477|FG000|Main Study|Death|10|||
161182930|NCT04423718|582047478|FG001|Main Study|Death|7|||
161182931|NCT04423718|582047479|FG002|Main Study|Death|7|||
161182932|NCT04423718|582047477|FG000|Main Study|COVID-19 pandemic|2|||
161182933|NCT04423718|582047478|FG001|Main Study|COVID-19 pandemic|2|||
161182934|NCT04423718|582047479|FG002|Main Study|COVID-19 pandemic|2|||
161182935|NCT04423718|582047477|FG000|Main Study|Other|7|||
161182936|NCT04423718|582047478|FG001|Main Study|Other|3|||
161182937|NCT04423718|582047479|FG002|Main Study|Other|2|||
161182938|NCT04423718|582047477|FG000|Extension Phase|Other|1|||
161182939|NCT04423718|582047478|FG001|Extension Phase|Other|0|||
161182940|NCT04423718|582047479|FG002|Extension Phase|Other|0|||
161182941|NCT04423718|582047477|FG000|Extension Phase|Logistical problems|0|||
161182942|NCT04423718|582047478|FG001|Extension Phase|Logistical problems|1|||
161301507|NCT00504725|582485789|FG000|Overall Study|Protocol Violation|1|||
161301508|NCT00504725|582485790|FG001|Overall Study|Protocol Violation|0|||
161301509|NCT01435018|582485791|FG000|Overall Study|Death|37|||
161301510|NCT01435018|582485792|FG001|Overall Study|Death|18|||
161301511|NCT01435018|582485793|FG002|Overall Study|Death|25|||
161301512|NCT01435018|582485791|FG000|Overall Study|Site is closing|4|||
161301513|NCT01435018|582485792|FG001|Overall Study|Site is closing|9|||
161301514|NCT01435018|582485793|FG002|Overall Study|Site is closing|7|||
161301515|NCT01435018|582485791|FG000|Overall Study|Withdrew consent|0|||
161301516|NCT01435018|582485792|FG001|Overall Study|Withdrew consent|3|||
161182943|NCT04423718|582047479|FG002|Extension Phase|Logistical problems|1|||
161182944|NCT04423718|582047477|FG000|Extension Phase|Physician Decision|1|||
161182945|NCT04423718|582047478|FG001|Extension Phase|Physician Decision|0|||
161182946|NCT04423718|582047479|FG002|Extension Phase|Physician Decision|1|||
161182947|NCT04423718|582047477|FG000|Extension Phase|Lack of Efficacy|2|||
161182948|NCT04423718|582047478|FG001|Extension Phase|Lack of Efficacy|0|||
161182949|NCT04423718|582047479|FG002|Extension Phase|Lack of Efficacy|1|||
161182950|NCT04423718|582047477|FG000|Extension Phase|Lost to Follow-up|0|||
161182951|NCT04423718|582047478|FG001|Extension Phase|Lost to Follow-up|2|||
161182952|NCT04423718|582047479|FG002|Extension Phase|Lost to Follow-up|3|||
161182953|NCT04423718|582047477|FG000|Extension Phase|Adverse Event|2|||
161182954|NCT04423718|582047478|FG001|Extension Phase|Adverse Event|3|||
161182955|NCT04423718|582047479|FG002|Extension Phase|Adverse Event|1|||
161182956|NCT04423718|582047477|FG000|Extension Phase|Death|4|||
161182957|NCT04423718|582047478|FG001|Extension Phase|Death|7|||
161182958|NCT04423718|582047479|FG002|Extension Phase|Death|2|||
161182959|NCT04423718|582047477|FG000|Extension Phase|Withdrawal by Subject|11|||
161182960|NCT04423718|582047478|FG001|Extension Phase|Withdrawal by Subject|11|||
161182961|NCT04423718|582047479|FG002|Extension Phase|Withdrawal by Subject|7|||
161182962|NCT02881151|582047482|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
161182963|NCT00589602|582047487|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
161182964|NCT04284787|582047489|FG000|Overall Study|Disease Progression|9|||
161182965|NCT04284787|582047490|FG001|Overall Study|Disease Progression|12|||
161182966|NCT04284787|582047489|FG000|Overall Study|Physician Decision|12|||
161182967|NCT04284787|582047490|FG001|Overall Study|Physician Decision|7|||
161182968|NCT04284787|582047489|FG000|Overall Study|Transplant|5|||
161182969|NCT04284787|582047490|FG001|Overall Study|Transplant|4|||
161182970|NCT04284787|582047489|FG000|Overall Study|Death|1|||
161182971|NCT04284787|582047490|FG001|Overall Study|Death|2|||
161182972|NCT04284787|582047489|FG000|Overall Study|Adverse Event|0|||
161182973|NCT04284787|582047490|FG001|Overall Study|Adverse Event|4|||
161182974|NCT04284787|582047489|FG000|Overall Study|Non-adherence|2|||
161182975|NCT04284787|582047490|FG001|Overall Study|Non-adherence|0|||
161182976|NCT04284787|582047489|FG000|Overall Study|Lack of Efficacy|2|||
161182977|NCT04284787|582047490|FG001|Overall Study|Lack of Efficacy|0|||
161182978|NCT01874353|582047491|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
161182979|NCT01874353|582047492|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161182980|NCT01874353|582047493|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161182981|NCT01874353|582047494|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
161182982|NCT01874353|582047491|FG000|Overall Study|Lost to Follow-up|2|||
161182983|NCT01874353|582047492|FG001|Overall Study|Lost to Follow-up|2|||
161182984|NCT01874353|582047493|FG002|Overall Study|Lost to Follow-up|2|||
161182985|NCT01874353|582047494|FG003|Overall Study|Lost to Follow-up|0|||
161182986|NCT01874353|582047491|FG000|Overall Study|Death|110|||
161182987|NCT01874353|582047492|FG001|Overall Study|Death|60|||
161182988|NCT01874353|582047493|FG002|Overall Study|Death|13|||
161182989|NCT01874353|582047494|FG003|Overall Study|Death|7|||
161182990|NCT01874353|582047491|FG000|Overall Study|Withdrawal by Subject|13|||
161182991|NCT01874353|582047492|FG001|Overall Study|Withdrawal by Subject|11|||
161182992|NCT01874353|582047493|FG002|Overall Study|Withdrawal by Subject|0|||
161182993|NCT01874353|582047494|FG003|Overall Study|Withdrawal by Subject|0|||
161182994|NCT05298774|582047497|FG000|Overall Study|Physician Decision|3|||
161182995|NCT05298774|582047497|FG000|Overall Study|Withdrawal by Subject|2|||
161182996|NCT05298774|582047497|FG000|Overall Study|Lost to Follow-up|3|||
161182997|NCT05298774|582047497|FG000|Overall Study|Screen failure|1|||
161182998|NCT04992507|582047498|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
161182999|NCT04992507|582047499|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
161183000|NCT04992507|582047498|FG000|Overall Study|Death|0|||
161183001|NCT04992507|582047499|FG001|Overall Study|Death|1|||
161183002|NCT03887052|582047500|FG000|Overall Study|Adverse Event|2|||
161183003|NCT03887052|582047500|FG000|Overall Study|Physician Decision|2|||
161183004|NCT03887052|582047500|FG000|Overall Study|Withdrawal by Subject|3|||
161183005|NCT03887052|582047500|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
161183006|NCT03887052|582047500|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
161183007|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
161183008|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
161183009|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Death|1|||
161183010|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Death|1|||
161183011|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
161183012|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
161183013|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
161183014|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
161183015|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
161183016|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
161183017|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
161183018|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
161183019|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
161183020|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
161183021|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
161183022|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
161183023|NCT03728881|582047501|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
161183024|NCT03728881|582047502|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
161183025|NCT03728881|582047501|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
161183026|NCT03728881|582047502|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
161183027|NCT03728881|582047501|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
161183028|NCT03728881|582047502|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
161183029|NCT04517253|582047505|FG000|Primary Treatment Period|Adverse Event|1|||
161183030|NCT04517253|582047506|FG001|Primary Treatment Period|Adverse Event|0|||
161183031|NCT04517253|582047507|FG002|Primary Treatment Period|Adverse Event|0|||
161183032|NCT04517253|582047505|FG000|Primary Treatment Period|Death|0|||
161183033|NCT04517253|582047506|FG001|Primary Treatment Period|Death|1|||
161183034|NCT04517253|582047507|FG002|Primary Treatment Period|Death|0|||
161183035|NCT04517253|582047505|FG000|Maintenance Period|Withdrawal by Subject|1|||
161183036|NCT04517253|582047506|FG001|Maintenance Period|Withdrawal by Subject|0|||
161183037|NCT04517253|582047507|FG002|Maintenance Period|Withdrawal by Subject|0|||
161183038|NCT04517253|582047505|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
161183039|NCT04517253|582047506|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
161183040|NCT04517253|582047507|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
161183041|NCT04651777|582047508|FG000|Overall Study|Adverse Event|1|||
161183042|NCT04651777|582047508|FG000|Overall Study|Withdrawal by Subject|2|||
161183046|NCT05505734|582047510|FG000|Overall Study|Withdrawal by Subject|51|||
161183047|NCT05505734|582047511|FG001|Overall Study|Withdrawal by Subject|64|||
161183048|NCT05505734|582047510|FG000|Overall Study|Adverse Event|6|||
161183049|NCT05505734|582047511|FG001|Overall Study|Adverse Event|20|||
161183050|NCT05505734|582047510|FG000|Overall Study|Protocol Violation|8|||
161183051|NCT05505734|582047511|FG001|Overall Study|Protocol Violation|15|||
161183052|NCT05505734|582047510|FG000|Overall Study|Lack of therapeutic response|0|||
161183053|NCT05505734|582047511|FG001|Overall Study|Lack of therapeutic response|1|||
161183054|NCT05505734|582047510|FG000|Overall Study|Lost to Follow-up|247|||
161183055|NCT05505734|582047511|FG001|Overall Study|Lost to Follow-up|237|||
161183056|NCT05505734|582047510|FG000|Overall Study|Physician Decision|22|||
161183057|NCT05505734|582047511|FG001|Overall Study|Physician Decision|13|||
161183058|NCT05505734|582047510|FG000|Overall Study|Death|2|||
161183059|NCT05505734|582047511|FG001|Overall Study|Death|1|||
161183060|NCT05505734|582047510|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161183061|NCT05505734|582047511|FG001|Overall Study|Withdrawal by parent/guardian|1|||
161183062|NCT05505734|582047510|FG000|Overall Study|Pregnancy|1|||
161183063|NCT05505734|582047511|FG001|Overall Study|Pregnancy|0|||
161183064|NCT05505734|582047510|FG000|Overall Study|Other|17|||
161183065|NCT05505734|582047511|FG001|Overall Study|Other|13|||
161183066|NCT01023516|582047512|FG000|Overall Study|Voluntary discontinuation|7|||
161183067|NCT01023516|582047513|FG001|Overall Study|Voluntary discontinuation|5|||
161183068|NCT01023516|582047512|FG000|Overall Study|Adverse Event|9|||
161183069|NCT01023516|582047513|FG001|Overall Study|Adverse Event|6|||
161183070|NCT01023516|582047512|FG000|Overall Study|Safety reason|0|||
161183071|NCT01023516|582047513|FG001|Overall Study|Safety reason|3|||
161183072|NCT01023516|582047512|FG000|Overall Study|Study-specific criteria|4|||
161183073|NCT01023516|582047513|FG001|Overall Study|Study-specific criteria|2|||
161183074|NCT01023516|582047512|FG000|Overall Study|Incorrect enrolment|4|||
161183075|NCT01023516|582047513|FG001|Overall Study|Incorrect enrolment|2|||
161183076|NCT01266876|582047514|FG000|Overall Study|Adverse Event|0|||
161183077|NCT01266876|582047515|FG001|Overall Study|Adverse Event|0|||
161183078|NCT01266876|582047516|FG002|Overall Study|Adverse Event|0|||
161183079|NCT01266876|582047517|FG003|Overall Study|Adverse Event|1|||
161183080|NCT01266876|582047518|FG004|Overall Study|Adverse Event|0|||
161183081|NCT01058395|582047519|FG000|Overall Study|Death|2|||
161183082|NCT01058395|582047520|FG001|Overall Study|Death|1|||
161183083|NCT01058395|582047519|FG000|Overall Study|Lost to Follow-up|1|||
161183084|NCT01058395|582047520|FG001|Overall Study|Lost to Follow-up|0|||
161301517|NCT01435018|582485793|FG002|Overall Study|Withdrew consent|1|||
161301518|NCT01435018|582485791|FG000|Overall Study|Not willing to adhere to requirements|0|||
161301519|NCT01435018|582485792|FG001|Overall Study|Not willing to adhere to requirements|2|||
161183085|NCT05016037|582047522|FG000|Overall Study|Lost to Follow-up|2|||
161183086|NCT00557323|582047523|FG000|Overall Study|Death|3|||
161183087|NCT00557323|582047523|FG000|Overall Study|Withdrawal by Subject|2|||
161183088|NCT00557323|582047523|FG000|Overall Study|Administrative change|2|||
161183089|NCT04007367|582047525|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
161183090|NCT04007367|582047526|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
161301520|NCT01435018|582485793|FG002|Overall Study|Not willing to adhere to requirements|3|||
161301521|NCT01435018|582485791|FG000|Overall Study|Not able to get to clinic|2|||
161183091|NCT04007367|582047527|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
161183092|NCT04007367|582047525|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
161183093|NCT04007367|582047526|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
161183094|NCT04007367|582047527|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
161183095|NCT04007367|582047525|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
161301522|NCT01435018|582485792|FG001|Overall Study|Not able to get to clinic|0|||
161301523|NCT01435018|582485793|FG002|Overall Study|Not able to get to clinic|2|||
161301524|NCT01435018|582485791|FG000|Overall Study|Severe debilitation, unable to continue|0|||
161301525|NCT01435018|582485792|FG001|Overall Study|Severe debilitation, unable to continue|0|||
161301526|NCT01435018|582485793|FG002|Overall Study|Severe debilitation, unable to continue|1|||
161301527|NCT01435018|582485791|FG000|Overall Study|Unable to contact participant/parent|1|||
161301528|NCT01435018|582485792|FG001|Overall Study|Unable to contact participant/parent|1|||
161301529|NCT01435018|582485793|FG002|Overall Study|Unable to contact participant/parent|1|||
161301530|NCT01435018|582485791|FG000|Overall Study|Enrollment Violation|0|||
161301531|NCT01435018|582485792|FG001|Overall Study|Enrollment Violation|1|||
161301532|NCT01435018|582485793|FG002|Overall Study|Enrollment Violation|0|||
161301533|NCT01435018|582485791|FG000|Overall Study|Never started chemotherapy|3|||
161301534|NCT01435018|582485792|FG001|Overall Study|Never started chemotherapy|0|||
161301535|NCT01435018|582485793|FG002|Overall Study|Never started chemotherapy|1|||
161301536|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
161301537|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
161301538|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
161301539|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
161301540|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Death|0|||
161301541|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Death|0|||
161301542|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Death|1|||
161301543|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Death|0|||
161301544|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
161301545|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161301546|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161301547|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
161301548|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
161301549|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
161301550|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
161301551|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
161301552|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
161301553|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
161301554|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
161301555|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
161301556|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
161301557|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
161301558|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
161301559|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
161301560|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
161301561|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
161301562|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
161301563|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
161301564|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
161301565|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
161301566|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
161301567|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
161301568|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
161301569|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
161301570|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161301571|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
161301572|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
161301573|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
161301574|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
161301575|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
161301576|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
161301577|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
161301578|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
161301579|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
161301580|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Other|8|||
161301581|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Other|14|||
161301582|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Other|8|||
161301583|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Other|23|||
161183096|NCT04007367|582047526|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
161301584|NCT01106677|582485794|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
161301585|NCT01106677|582485795|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
161301586|NCT01106677|582485796|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
161183097|NCT04007367|582047527|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
161301587|NCT01106677|582485797|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
161301588|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161301589|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
161301590|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
161301591|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
161301592|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Death|0|||
161301593|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Death|0|||
161301594|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Death|0|||
161301595|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Death|1|||
161301596|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
161301597|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
161301598|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
161301599|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
161301600|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
161301601|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161301602|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161301603|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
161301604|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161301605|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
161301606|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
161301607|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
161301608|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
161301609|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161301610|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161301611|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
161301612|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161301613|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
161301614|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
161301615|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
161301616|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161301617|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
161301618|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
161301619|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
161301620|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161301621|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161301622|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
161301623|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
161301624|NCT01106677|582485794|FG000|Extension Period: Week 26 to Week 52|Other|6|||
161301625|NCT01106677|582485795|FG001|Extension Period: Week 26 to Week 52|Other|5|||
161301626|NCT01106677|582485796|FG002|Extension Period: Week 26 to Week 52|Other|8|||
161301627|NCT01106677|582485797|FG003|Extension Period: Week 26 to Week 52|Other|5|||
161301628|NCT03937908|582485798|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
161301629|NCT03937908|582485799|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
161301630|NCT03875092|582485800|FG000|Overall Study|Adverse Event|2|||
161301631|NCT03875092|582485801|FG001|Overall Study|Adverse Event|5|||
161301632|NCT03875092|582485800|FG000|Overall Study|Death|44|||
161301633|NCT03875092|582485801|FG001|Overall Study|Death|51|||
161301634|NCT03875092|582485800|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
161301635|NCT03875092|582485801|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
161301636|NCT03205761|582485802|FG000|Overall Study|Withdrawal by Subject|1|||
161301637|NCT03205761|582485802|FG000|Overall Study|Progressive Disease|10|||
161301638|NCT00636194|582485803|FG000|Overall Study|Study related symptoms and complaints|1|||
161301639|NCT00636194|582485804|FG001|Overall Study|Study related symptoms and complaints|0|||
161301640|NCT00636194|582485803|FG000|Overall Study|Protocol Violation|2|||
161301641|NCT00636194|582485804|FG001|Overall Study|Protocol Violation|0|||
161301642|NCT02163226|582485806|FG000|Overall Study|Death|2|||
161301643|NCT02163226|582485807|FG001|Overall Study|Death|1|||
161301644|NCT02163226|582485806|FG000|Overall Study|Withdrawal by Subject|5|||
161301645|NCT02163226|582485807|FG001|Overall Study|Withdrawal by Subject|2|||
161301646|NCT02163226|582485806|FG000|Overall Study|Returned home, local radiotherapy|3|||
161301647|NCT02163226|582485807|FG001|Overall Study|Returned home, local radiotherapy|0|||
161301648|NCT02163226|582485806|FG000|Overall Study|Repeat imaging showed no disease|2|||
161301649|NCT02163226|582485807|FG001|Overall Study|Repeat imaging showed no disease|0|||
161301650|NCT02163226|582485806|FG000|Overall Study|Incomplete radiotherapy|3|||
161301651|NCT02163226|582485807|FG001|Overall Study|Incomplete radiotherapy|0|||
161301652|NCT02163226|582485806|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
161301653|NCT02163226|582485807|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
161183098|NCT04007367|582047525|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
161183099|NCT04007367|582047526|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
161183100|NCT04007367|582047527|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
161183101|NCT04007367|582047525|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
161183102|NCT04007367|582047526|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
161183103|NCT04007367|582047527|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
161183104|NCT00372489|582047530|FG000|Overall Study|Adverse Event|18|||
161183105|NCT00372489|582047530|FG000|Overall Study|Lack of Efficacy|1|||
161183106|NCT00372489|582047530|FG000|Overall Study|Lost to Follow-up|3|||
161183107|NCT00372489|582047530|FG000|Overall Study|Physician Decision|3|||
161183108|NCT00372489|582047530|FG000|Overall Study|Withdrawal by Subject|5|||
161183109|NCT00372489|582047530|FG000|Overall Study|Patient Relocation|2|||
161183110|NCT00372489|582047530|FG000|Overall Study|Renal transplant|6|||
161183111|NCT00372489|582047530|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
161183112|NCT03323086|582047532|FG000|Overall Study|Lost to Follow-up|3|||
161183113|NCT03323086|582047533|FG001|Overall Study|Lost to Follow-up|2|||
161183114|NCT00355615|582047539|FG000|Randomized Double Blind Period|Adverse Event|1|||
161183115|NCT00355615|582047540|FG001|Randomized Double Blind Period|Adverse Event|0|||
161183116|NCT00355615|582047541|FG002|Randomized Double Blind Period|Adverse Event|0|||
161183117|NCT00355615|582047542|FG003|Randomized Double Blind Period|Adverse Event|0|||
161183118|NCT00355615|582047543|FG004|Randomized Double Blind Period|Adverse Event|0|||
161183119|NCT00355615|582047539|FG000|Randomized Double Blind Period|Protocol Violation|0|||
161183120|NCT00355615|582047540|FG001|Randomized Double Blind Period|Protocol Violation|0|||
161183121|NCT00355615|582047541|FG002|Randomized Double Blind Period|Protocol Violation|1|||
161183122|NCT00355615|582047542|FG003|Randomized Double Blind Period|Protocol Violation|1|||
161183123|NCT00355615|582047543|FG004|Randomized Double Blind Period|Protocol Violation|0|||
161183124|NCT00355615|582047539|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161183125|NCT00355615|582047540|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161183126|NCT00355615|582047541|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161183127|NCT00355615|582047542|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
161183128|NCT00355615|582047543|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
161183129|NCT00355615|582047539|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161183130|NCT00355615|582047540|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161183131|NCT00355615|582047541|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161183132|NCT00355615|582047542|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
161183133|NCT00355615|582047543|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
161183134|NCT00355615|582047539|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161183135|NCT00355615|582047540|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161183136|NCT00355615|582047541|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161183137|NCT00355615|582047542|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
161183138|NCT00355615|582047543|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
161183139|NCT00355615|582047539|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161183140|NCT00355615|582047540|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161183141|NCT00355615|582047541|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161183142|NCT00355615|582047542|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
161183143|NCT00355615|582047543|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
161183144|NCT00085644|582047544|FG000|Double-Blind Period|Adverse Event|5|||
161183145|NCT00085644|582047545|FG001|Double-Blind Period|Adverse Event|2|||
161183146|NCT00085644|582047546|FG002|Double-Blind Period|Adverse Event|0|||
161183147|NCT00085644|582047544|FG000|Double-Blind Period|Withdrawal by Subject|3|||
161183148|NCT00085644|582047545|FG001|Double-Blind Period|Withdrawal by Subject|0|||
161183149|NCT00085644|582047546|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161183150|NCT00085644|582047544|FG000|Double-Blind Period|Lost to Follow-up|2|||
161183151|NCT00085644|582047545|FG001|Double-Blind Period|Lost to Follow-up|1|||
161183152|NCT00085644|582047546|FG002|Double-Blind Period|Lost to Follow-up|0|||
161183153|NCT00085644|582047544|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
161183154|NCT00085644|582047545|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
161183155|NCT00085644|582047546|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
161183156|NCT00085644|582047544|FG000|Double-Blind Period|Contemplating pregnancy|1|||
161183157|NCT00085644|582047545|FG001|Double-Blind Period|Contemplating pregnancy|0|||
161183158|NCT00085644|582047546|FG002|Double-Blind Period|Contemplating pregnancy|0|||
161183159|NCT00085644|582047544|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
161183160|NCT00085644|582047545|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
161183161|NCT00085644|582047546|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
161183162|NCT00085644|582047544|FG000|Open-Label Period|Adverse Event|0|||
161183163|NCT00085644|582047545|FG001|Open-Label Period|Adverse Event|0|||
161183164|NCT00085644|582047546|FG002|Open-Label Period|Adverse Event|38|||
161183165|NCT00085644|582047544|FG000|Open-Label Period|Withdrawal by Subject|0|||
161183166|NCT00085644|582047545|FG001|Open-Label Period|Withdrawal by Subject|0|||
161183167|NCT00085644|582047546|FG002|Open-Label Period|Withdrawal by Subject|29|||
161301654|NCT02163226|582485806|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
161301655|NCT02163226|582485807|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
161301656|NCT02163226|582485806|FG000|Overall Study|ineligible|0|||
161301657|NCT02163226|582485807|FG001|Overall Study|ineligible|3|||
161301658|NCT04114357|582485808|FG000|Baseline-Randomization|Adverse Event|2|||
161301659|NCT04114357|582485809|FG001|Baseline-Randomization|Adverse Event|1|||
161301660|NCT04114357|582485808|FG000|Baseline-Randomization|Lost to Follow-up|1|||
161301661|NCT04114357|582485809|FG001|Baseline-Randomization|Lost to Follow-up|1|||
161301662|NCT04114357|582485808|FG000|Cross-over|Adverse Event|0|||
161301663|NCT04114357|582485809|FG001|Cross-over|Adverse Event|1|||
161301664|NCT03625466|582485813|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
161301665|NCT03625466|582485814|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
161301666|NCT03625466|582485815|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
161301667|NCT03625466|582485813|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161301668|NCT03625466|582485814|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161301669|NCT03625466|582485815|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161301670|NCT03625466|582485813|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161301671|NCT03625466|582485814|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
161301672|NCT03625466|582485815|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
161301673|NCT00160706|582485816|FG000|Overall Study|Adverse Event|53|||
161301674|NCT00160706|582485816|FG000|Overall Study|Adverse Event and Other Reason|105|||
161301675|NCT00160706|582485816|FG000|Overall Study|Protocol Violation|3|||
161301676|NCT00160706|582485816|FG000|Overall Study|Withdrawal by Subject|41|||
161301677|NCT00160706|582485816|FG000|Overall Study|Withdrawal by Subject and Other|12|||
161301678|NCT00160706|582485816|FG000|Overall Study|Physician Decision|10|||
161301679|NCT00160706|582485816|FG000|Overall Study|Physician Decision and Other|3|||
161301680|NCT00160706|582485816|FG000|Overall Study|Lost to Follow-up|4|||
161301681|NCT00160706|582485816|FG000|Overall Study|Lost to Follow-up and Other|1|||
161301682|NCT00160706|582485816|FG000|Overall Study|Lack of Efficacy|42|||
161301683|NCT00160706|582485816|FG000|Overall Study|Lack of Efficacy and Other|1|||
161301684|NCT00160706|582485816|FG000|Overall Study|Other Reason|11|||
161301685|NCT03214380|582485817|FG000|Lead-in|Adverse Event|3|||
161301686|NCT03214380|582485818|FG001|Lead-in|Adverse Event|0|||
161301687|NCT03214380|582485819|FG002|Lead-in|Adverse Event|0|||
161301688|NCT03214380|582485820|FG003|Lead-in|Adverse Event|1|||
161301689|NCT03214380|582485821|FG004|Lead-in|Adverse Event|0|||
161301690|NCT03214380|582485822|FG005|Lead-in|Adverse Event|0|||
161301691|NCT03214380|582485817|FG000|Lead-in|Lost to Follow-up|4|||
161301692|NCT03214380|582485818|FG001|Lead-in|Lost to Follow-up|0|||
161301693|NCT03214380|582485819|FG002|Lead-in|Lost to Follow-up|0|||
161301694|NCT03214380|582485820|FG003|Lead-in|Lost to Follow-up|1|||
161301695|NCT03214380|582485821|FG004|Lead-in|Lost to Follow-up|0|||
161301696|NCT03214380|582485822|FG005|Lead-in|Lost to Follow-up|0|||
161301697|NCT03214380|582485817|FG000|Lead-in|Eligibility Criteria|3|||
161301698|NCT03214380|582485818|FG001|Lead-in|Eligibility Criteria|0|||
161301699|NCT03214380|582485819|FG002|Lead-in|Eligibility Criteria|0|||
161301700|NCT03214380|582485820|FG003|Lead-in|Eligibility Criteria|0|||
161301701|NCT03214380|582485821|FG004|Lead-in|Eligibility Criteria|0|||
161301702|NCT03214380|582485822|FG005|Lead-in|Eligibility Criteria|0|||
161301703|NCT03214380|582485817|FG000|Lead-in|Physician Decision|6|||
161301704|NCT03214380|582485818|FG001|Lead-in|Physician Decision|0|||
161301705|NCT03214380|582485819|FG002|Lead-in|Physician Decision|0|||
161301706|NCT03214380|582485820|FG003|Lead-in|Physician Decision|0|||
161301707|NCT03214380|582485821|FG004|Lead-in|Physician Decision|0|||
161301708|NCT03214380|582485822|FG005|Lead-in|Physician Decision|0|||
161301709|NCT03214380|582485817|FG000|Lead-in|Protocol Deviation|7|||
161301710|NCT03214380|582485818|FG001|Lead-in|Protocol Deviation|0|||
161301711|NCT03214380|582485819|FG002|Lead-in|Protocol Deviation|0|||
161301712|NCT03214380|582485820|FG003|Lead-in|Protocol Deviation|3|||
161301713|NCT03214380|582485821|FG004|Lead-in|Protocol Deviation|0|||
161301714|NCT03214380|582485822|FG005|Lead-in|Protocol Deviation|0|||
161301715|NCT03214380|582485817|FG000|Lead-in|Withdrawal by Subject|41|||
161301716|NCT03214380|582485818|FG001|Lead-in|Withdrawal by Subject|0|||
161301717|NCT03214380|582485819|FG002|Lead-in|Withdrawal by Subject|0|||
161301718|NCT03214380|582485820|FG003|Lead-in|Withdrawal by Subject|14|||
161301719|NCT03214380|582485821|FG004|Lead-in|Withdrawal by Subject|0|||
161347892|NCT03487445|582657372|FG000|Randomization|Not treated for administrative reasons|1|||
161301720|NCT03214380|582485822|FG005|Lead-in|Withdrawal by Subject|0|||
161301721|NCT03214380|582485817|FG000|Lead-in|Family Emergency|1|||
161301722|NCT03214380|582485818|FG001|Lead-in|Family Emergency|0|||
161301723|NCT03214380|582485819|FG002|Lead-in|Family Emergency|0|||
161301724|NCT03214380|582485820|FG003|Lead-in|Family Emergency|0|||
161301725|NCT03214380|582485821|FG004|Lead-in|Family Emergency|0|||
161301726|NCT03214380|582485822|FG005|Lead-in|Family Emergency|0|||
161183168|NCT00085644|582047544|FG000|Open-Label Period|Lost to Follow-up|0|||
161301727|NCT03214380|582485817|FG000|Lead-in|Natural Disaster|9|||
161301728|NCT03214380|582485818|FG001|Lead-in|Natural Disaster|0|||
161301729|NCT03214380|582485819|FG002|Lead-in|Natural Disaster|0|||
161301730|NCT03214380|582485820|FG003|Lead-in|Natural Disaster|0|||
161301731|NCT03214380|582485821|FG004|Lead-in|Natural Disaster|0|||
161301732|NCT03214380|582485822|FG005|Lead-in|Natural Disaster|0|||
161301733|NCT03214380|582485817|FG000|Lead-in|Non Compliance|1|||
161301734|NCT03214380|582485818|FG001|Lead-in|Non Compliance|0|||
161301735|NCT03214380|582485819|FG002|Lead-in|Non Compliance|0|||
161301736|NCT03214380|582485820|FG003|Lead-in|Non Compliance|0|||
161301737|NCT03214380|582485821|FG004|Lead-in|Non Compliance|0|||
161301738|NCT03214380|582485822|FG005|Lead-in|Non Compliance|0|||
161301739|NCT03214380|582485817|FG000|Lead-in|Participant Schedule|2|||
161301740|NCT03214380|582485818|FG001|Lead-in|Participant Schedule|0|||
161301741|NCT03214380|582485819|FG002|Lead-in|Participant Schedule|0|||
161301742|NCT03214380|582485820|FG003|Lead-in|Participant Schedule|0|||
161301743|NCT03214380|582485821|FG004|Lead-in|Participant Schedule|0|||
161301744|NCT03214380|582485822|FG005|Lead-in|Participant Schedule|0|||
161301745|NCT03214380|582485817|FG000|Treatment Period|Adverse Event|0|||
161301746|NCT03214380|582485818|FG001|Treatment Period|Adverse Event|1|||
161301747|NCT03214380|582485819|FG002|Treatment Period|Adverse Event|1|||
161301748|NCT03214380|582485820|FG003|Treatment Period|Adverse Event|0|||
161301749|NCT03214380|582485821|FG004|Treatment Period|Adverse Event|1|||
161301750|NCT03214380|582485822|FG005|Treatment Period|Adverse Event|0|||
161301751|NCT03214380|582485817|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
161301752|NCT03214380|582485818|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
161301753|NCT03214380|582485819|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
161301754|NCT03214380|582485820|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
161301755|NCT03214380|582485821|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
161301756|NCT03214380|582485822|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
161183169|NCT00085644|582047545|FG001|Open-Label Period|Lost to Follow-up|0|||
161183170|NCT00085644|582047546|FG002|Open-Label Period|Lost to Follow-up|13|||
161183171|NCT00085644|582047544|FG000|Open-Label Period|Lack of Efficacy|0|||
161301757|NCT03214380|582485817|FG000|Treatment Period|Withdrawal by Subject|0|||
161301758|NCT03214380|582485818|FG001|Treatment Period|Withdrawal by Subject|10|||
161301759|NCT03214380|582485819|FG002|Treatment Period|Withdrawal by Subject|8|||
161301760|NCT03214380|582485820|FG003|Treatment Period|Withdrawal by Subject|0|||
161301761|NCT03214380|582485821|FG004|Treatment Period|Withdrawal by Subject|7|||
161301762|NCT03214380|582485822|FG005|Treatment Period|Withdrawal by Subject|11|||
161301763|NCT03214380|582485817|FG000|Treatment Period|Death|0|||
161301764|NCT03214380|582485818|FG001|Treatment Period|Death|1|||
161301765|NCT03214380|582485819|FG002|Treatment Period|Death|2|||
161301766|NCT03214380|582485820|FG003|Treatment Period|Death|0|||
161301767|NCT03214380|582485821|FG004|Treatment Period|Death|0|||
161301768|NCT03214380|582485822|FG005|Treatment Period|Death|0|||
161301769|NCT03214380|582485817|FG000|Treatment Period|Lost to Follow-up|0|||
161301770|NCT03214380|582485818|FG001|Treatment Period|Lost to Follow-up|6|||
161301771|NCT03214380|582485819|FG002|Treatment Period|Lost to Follow-up|3|||
161301772|NCT03214380|582485820|FG003|Treatment Period|Lost to Follow-up|0|||
161301773|NCT03214380|582485821|FG004|Treatment Period|Lost to Follow-up|0|||
161301774|NCT03214380|582485822|FG005|Treatment Period|Lost to Follow-up|0|||
161301775|NCT03214380|582485817|FG000|Treatment Period|Participant schedule|0|||
161301776|NCT03214380|582485818|FG001|Treatment Period|Participant schedule|0|||
161301777|NCT03214380|582485819|FG002|Treatment Period|Participant schedule|1|||
161301778|NCT03214380|582485820|FG003|Treatment Period|Participant schedule|0|||
161301779|NCT03214380|582485821|FG004|Treatment Period|Participant schedule|0|||
161301780|NCT03214380|582485822|FG005|Treatment Period|Participant schedule|0|||
161301781|NCT03214380|582485817|FG000|Treatment Period|Treatment Interruption|0|||
161183172|NCT00085644|582047545|FG001|Open-Label Period|Lack of Efficacy|0|||
161183173|NCT00085644|582047546|FG002|Open-Label Period|Lack of Efficacy|15|||
161183174|NCT00085644|582047544|FG000|Open-Label Period|Pregnancy|0|||
161183175|NCT00085644|582047545|FG001|Open-Label Period|Pregnancy|0|||
161183176|NCT00085644|582047546|FG002|Open-Label Period|Pregnancy|3|||
161183177|NCT00085644|582047544|FG000|Open-Label Period|Contemplating pregnancy|0|||
161183178|NCT00085644|582047545|FG001|Open-Label Period|Contemplating pregnancy|0|||
161183179|NCT00085644|582047546|FG002|Open-Label Period|Contemplating pregnancy|3|||
161301782|NCT03214380|582485818|FG001|Treatment Period|Treatment Interruption|0|||
161301783|NCT03214380|582485819|FG002|Treatment Period|Treatment Interruption|1|||
161301784|NCT03214380|582485820|FG003|Treatment Period|Treatment Interruption|0|||
161301785|NCT03214380|582485821|FG004|Treatment Period|Treatment Interruption|0|||
161183180|NCT00085644|582047544|FG000|Open-Label Period|Protocol Violation|0|||
161183181|NCT00085644|582047545|FG001|Open-Label Period|Protocol Violation|0|||
161301786|NCT03214380|582485822|FG005|Treatment Period|Treatment Interruption|0|||
161301787|NCT00614523|582485826|FG000|Overall Study|Adverse Event|4|||
161301788|NCT00614523|582485827|FG001|Overall Study|Adverse Event|20|||
161301789|NCT00614523|582485826|FG000|Overall Study|Death|5|||
161301790|NCT00614523|582485827|FG001|Overall Study|Death|8|||
161301791|NCT00614523|582485826|FG000|Overall Study|Lack of Efficacy|9|||
161183182|NCT00085644|582047546|FG002|Open-Label Period|Protocol Violation|4|||
161301792|NCT00614523|582485827|FG001|Overall Study|Lack of Efficacy|11|||
161301793|NCT00614523|582485826|FG000|Overall Study|Lost to Follow-up|0|||
161301794|NCT00614523|582485827|FG001|Overall Study|Lost to Follow-up|1|||
161301795|NCT00614523|582485826|FG000|Overall Study|Protocol Violation|3|||
161301796|NCT00614523|582485827|FG001|Overall Study|Protocol Violation|2|||
161301797|NCT00614523|582485826|FG000|Overall Study|Withdrawal by Subject|12|||
161301798|NCT00614523|582485827|FG001|Overall Study|Withdrawal by Subject|22|||
161301799|NCT00614523|582485826|FG000|Overall Study|Other|6|||
161301800|NCT00614523|582485827|FG001|Overall Study|Other|11|||
161301801|NCT00614523|582485826|FG000|Overall Study|Ineligibility Determined|1|||
161301802|NCT00614523|582485827|FG001|Overall Study|Ineligibility Determined|2|||
161301803|NCT00614523|582485826|FG000|Overall Study|Disease Progression|0|||
161301804|NCT00614523|582485827|FG001|Overall Study|Disease Progression|8|||
161301805|NCT00614523|582485826|FG000|Overall Study|Administrative Decision|23|||
161301806|NCT00614523|582485827|FG001|Overall Study|Administrative Decision|46|||
161301807|NCT00723255|582485828|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
161301808|NCT00723255|582485828|FG000|Overall Study|Ineligible: Second primary|1|||
161301809|NCT00723255|582485828|FG000|Overall Study|Ineligible: Wrong Primary|2|||
161301810|NCT03854370|582485836|FG000|Overall Study|samples not collected|1|||
161301811|NCT03854370|582485837|FG001|Overall Study|samples not collected|1|||
161301812|NCT03854370|582485838|FG002|Overall Study|samples not collected|1|||
161301813|NCT03854370|582485839|FG003|Overall Study|samples not collected|1|||
161301814|NCT00452673|582485841|FG000|Dose Escalation Period|Disease Progression|6|||
161301815|NCT00452673|582485842|FG001|Dose Escalation Period|Disease Progression|6|||
161301816|NCT00452673|582485843|FG002|Dose Escalation Period|Disease Progression|2|||
161301817|NCT00452673|582485844|FG003|Dose Escalation Period|Disease Progression|6|||
161301818|NCT00452673|582485845|FG004|Dose Escalation Period|Disease Progression|0|||
161301819|NCT00452673|582485841|FG000|Dose Escalation Period|study drug toxicity|1|||
161301820|NCT00452673|582485842|FG001|Dose Escalation Period|study drug toxicity|3|||
161301821|NCT00452673|582485843|FG002|Dose Escalation Period|study drug toxicity|3|||
161301822|NCT00452673|582485844|FG003|Dose Escalation Period|study drug toxicity|1|||
161301823|NCT00452673|582485845|FG004|Dose Escalation Period|study drug toxicity|0|||
161301824|NCT00452673|582485841|FG000|Dose Escalation Period|Other|0|||
161301825|NCT00452673|582485842|FG001|Dose Escalation Period|Other|0|||
161301826|NCT00452673|582485843|FG002|Dose Escalation Period|Other|1|||
161301827|NCT00452673|582485844|FG003|Dose Escalation Period|Other|0|||
161301828|NCT00452673|582485845|FG004|Dose Escalation Period|Other|0|||
161301829|NCT00452673|582485841|FG000|Dose Escalation Period|Adverse Event|0|||
161301830|NCT00452673|582485842|FG001|Dose Escalation Period|Adverse Event|0|||
161301831|NCT00452673|582485843|FG002|Dose Escalation Period|Adverse Event|0|||
161301832|NCT00452673|582485844|FG003|Dose Escalation Period|Adverse Event|1|||
161301833|NCT00452673|582485845|FG004|Dose Escalation Period|Adverse Event|0|||
161301834|NCT00452673|582485841|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
161301835|NCT00452673|582485842|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
161301836|NCT00452673|582485843|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
161301837|NCT00452673|582485844|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
161301838|NCT00452673|582485845|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
161301839|NCT00452673|582485841|FG000|Dose Expansion Period|Disease Progression|0|||
161301840|NCT00452673|582485842|FG001|Dose Expansion Period|Disease Progression|0|||
161301841|NCT00452673|582485843|FG002|Dose Expansion Period|Disease Progression|0|||
161301842|NCT00452673|582485844|FG003|Dose Expansion Period|Disease Progression|0|||
161301843|NCT00452673|582485845|FG004|Dose Expansion Period|Disease Progression|19|||
161301844|NCT00452673|582485841|FG000|Dose Expansion Period|Other|0|||
161301845|NCT00452673|582485842|FG001|Dose Expansion Period|Other|0|||
161301846|NCT00452673|582485843|FG002|Dose Expansion Period|Other|0|||
161301847|NCT00452673|582485844|FG003|Dose Expansion Period|Other|0|||
161301848|NCT00452673|582485845|FG004|Dose Expansion Period|Other|2|||
161301849|NCT02656290|582485846|FG000|Overall Study|Lost to Follow-up|1|||
161301850|NCT02656290|582485846|FG000|Overall Study|Reintervention|3|||
161301851|NCT00748189|582485849|FG000|Overall Study|Death|99|||
161301852|NCT00748189|582485850|FG001|Overall Study|Death|84|||
161301853|NCT00748189|582485849|FG000|Overall Study|Withdrawal by Subject|23|||
161301854|NCT00748189|582485850|FG001|Overall Study|Withdrawal by Subject|29|||
161301855|NCT00748189|582485849|FG000|Overall Study|Physician Decision|16|||
161301856|NCT00748189|582485850|FG001|Overall Study|Physician Decision|5|||
161301857|NCT00748189|582485849|FG000|Overall Study|Lost to Follow-up|8|||
161301858|NCT00748189|582485850|FG001|Overall Study|Lost to Follow-up|15|||
161301859|NCT00748189|582485849|FG000|Overall Study|Study terminated by Sponsor|70|||
161301860|NCT00748189|582485850|FG001|Overall Study|Study terminated by Sponsor|79|||
161301861|NCT04481191|582485857|FG000|Overall Study|Withdrawn by parent/guardian|15|||
161301862|NCT04481191|582485858|FG001|Overall Study|Withdrawn by parent/guardian|10|||
161301863|NCT00546117|582485863|FG000|Overall Study|Withdrawal by Subject|3|||
161301864|NCT00546117|582485864|FG001|Overall Study|Withdrawal by Subject|0|||
161301865|NCT00546117|582485863|FG000|Overall Study|Inability to schedule follow-up visit|1|||
161301866|NCT00546117|582485864|FG001|Overall Study|Inability to schedule follow-up visit|0|||
161301867|NCT04984278|582485869|FG000|Period 1|Withdrawal by Subject|1|||
161301868|NCT04984278|582485870|FG001|Period 1|Withdrawal by Subject|0|||
161301869|NCT04984278|582485869|FG000|Period 1|Other|0|||
161183183|NCT00085644|582047544|FG000|Open-Label Period|Personal reason|0|||
161183184|NCT00085644|582047545|FG001|Open-Label Period|Personal reason|0|||
161183185|NCT00085644|582047546|FG002|Open-Label Period|Personal reason|4|||
161183186|NCT04259346|582047547|FG000|Overall Study|Lost to Follow-up|1|||
161183187|NCT04259346|582047548|FG001|Overall Study|Lost to Follow-up|3|||
161183188|NCT04259346|582047547|FG000|Overall Study|Protocol Violation|1|||
161183189|NCT04259346|582047548|FG001|Overall Study|Protocol Violation|0|||
161183190|NCT04259346|582047547|FG000|Overall Study|Withdrawal by Subject|1|||
161183191|NCT04259346|582047548|FG001|Overall Study|Withdrawal by Subject|0|||
161183192|NCT04259346|582047547|FG000|Overall Study|Adverse Event|1|||
161183193|NCT04259346|582047548|FG001|Overall Study|Adverse Event|1|||
161183194|NCT03330106|582047556|FG000|Part A|Withdrawal by Subject|1|||
161183195|NCT03330106|582047557|FG001|Part A|Withdrawal by Subject|1|||
161183196|NCT03330106|582047558|FG002|Part A|Withdrawal by Subject|0|||
161183197|NCT03330106|582047559|FG003|Part A|Withdrawal by Subject|0|||
161183198|NCT03330106|582047556|FG000|Part A|Death|2|||
161183199|NCT03330106|582047557|FG001|Part A|Death|1|||
161183200|NCT03330106|582047558|FG002|Part A|Death|0|||
161183201|NCT03330106|582047559|FG003|Part A|Death|0|||
161301870|NCT04984278|582485870|FG001|Period 1|Other|1|||
161183202|NCT03330106|582047556|FG000|Part A|Adverse Event|0|||
161183203|NCT03330106|582047557|FG001|Part A|Adverse Event|1|||
161301871|NCT04984278|582485869|FG000|Period 2|Adverse Event|1|||
161301872|NCT04984278|582485870|FG001|Period 2|Adverse Event|0|||
161301873|NCT04984278|582485869|FG000|Period 2|Other|0|||
161301874|NCT04984278|582485870|FG001|Period 2|Other|1|||
161301875|NCT04696055|582485871|FG000|Overall Study|Adverse Event|10|||
161301876|NCT04696055|582485872|FG001|Overall Study|Adverse Event|2|||
161301877|NCT04696055|582485871|FG000|Overall Study|Death|4|||
161301878|NCT04696055|582485872|FG001|Overall Study|Death|0|||
161089539|NCT03149549|581717402|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089540|NCT03149549|581717403|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089541|NCT03149549|581717404|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
161089542|NCT03149549|581717405|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
161089543|NCT03149549|581717406|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089544|NCT03149549|581717407|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
161089545|NCT03149549|581717408|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089546|NCT03149549|581717409|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089547|NCT03149549|581717410|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089548|NCT03149549|581717411|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
161089549|NCT03149549|581717399|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161089550|NCT03149549|581717400|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161089551|NCT03149549|581717401|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161089552|NCT03149549|581717402|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161089553|NCT03149549|581717403|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
161089554|NCT03149549|581717404|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161183204|NCT03330106|582047558|FG002|Part A|Adverse Event|0|||
161183205|NCT03330106|582047559|FG003|Part A|Adverse Event|0|||
161183206|NCT03330106|582047556|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161183207|NCT03330106|582047557|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
161183208|NCT03330106|582047558|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161183209|NCT03330106|582047559|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
161183210|NCT03330106|582047556|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
161183211|NCT03330106|582047557|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161089555|NCT03149549|581717405|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161183212|NCT03330106|582047558|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161183213|NCT03330106|582047559|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
161183214|NCT03330106|582047556|FG000|Part A|Progressive Disease|0|||
161183215|NCT03330106|582047557|FG001|Part A|Progressive Disease|1|||
161183216|NCT03330106|582047558|FG002|Part A|Progressive Disease|0|||
161183217|NCT03330106|582047559|FG003|Part A|Progressive Disease|0|||
161089556|NCT03149549|581717406|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
161089557|NCT03149549|581717407|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
161089558|NCT03149549|581717408|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161089559|NCT03149549|581717409|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
161089560|NCT03149549|581717410|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
161089561|NCT03149549|581717411|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
161301879|NCT04696055|582485871|FG000|Overall Study|Other|7|||
161301880|NCT04696055|582485872|FG001|Overall Study|Other|2|||
161089562|NCT03149549|581717399|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161183218|NCT03330106|582047556|FG000|Part B|Lost to Follow-up|0|||
161301881|NCT04696055|582485871|FG000|Overall Study|Physician Decision|3|||
161301882|NCT04696055|582485872|FG001|Overall Study|Physician Decision|0|||
161347893|NCT03487445|582657373|FG001|Randomization|Not treated for administrative reasons|0|||
161347894|NCT04225039|582657376|FG000|Overall Study|Withdrawal by Subject|1|||
161347895|NCT04225039|582657377|FG001|Overall Study|Withdrawal by Subject|0|||
161347896|NCT04225039|582657378|FG002|Overall Study|Withdrawal by Subject|0|||
161347897|NCT04225039|582657379|FG003|Overall Study|Withdrawal by Subject|1|||
161347898|NCT04225039|582657376|FG000|Overall Study|Currently active on study treatment|0|||
161347899|NCT04225039|582657377|FG001|Overall Study|Currently active on study treatment|1|||
161347900|NCT04225039|582657378|FG002|Overall Study|Currently active on study treatment|0|||
161347901|NCT04225039|582657379|FG003|Overall Study|Currently active on study treatment|0|||
161347902|NCT04225039|582657376|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
161347903|NCT04225039|582657377|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161347904|NCT04225039|582657378|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161347905|NCT04225039|582657379|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
161347906|NCT04225039|582657376|FG000|Overall Study|Ineligible for treatment|0|||
161347907|NCT04225039|582657377|FG001|Overall Study|Ineligible for treatment|0|||
161347908|NCT04225039|582657378|FG002|Overall Study|Ineligible for treatment|0|||
161347909|NCT04225039|582657379|FG003|Overall Study|Ineligible for treatment|4|||
161347910|NCT00975923|582657380|FG000|Overall Study|Withdrawal by Subject|0|||
161347911|NCT00975923|582657381|FG001|Overall Study|Withdrawal by Subject|1|||
161347912|NCT01964404|582657382|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
161347913|NCT01964404|582657383|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
161347914|NCT01964404|582657384|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
161347915|NCT01964404|582657385|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
161347916|NCT01964404|582657386|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
161347917|NCT01964404|582657387|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
161347918|NCT01964404|582657388|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
161347919|NCT01964404|582657389|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
161347920|NCT01964404|582657390|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
161347921|NCT01964404|582657391|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
161347922|NCT01964404|582657382|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
161347923|NCT01964404|582657383|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
161347924|NCT01964404|582657384|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161347925|NCT01964404|582657385|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161347926|NCT01964404|582657386|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347927|NCT01964404|582657387|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347928|NCT01964404|582657388|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347929|NCT01964404|582657389|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347930|NCT01964404|582657390|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347931|NCT01964404|582657391|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347932|NCT01964404|582657382|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
161347933|NCT01964404|582657383|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
161347934|NCT01964404|582657384|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347935|NCT01964404|582657385|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
161347936|NCT01964404|582657386|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347937|NCT01964404|582657387|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347938|NCT01964404|582657388|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347939|NCT01964404|582657389|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347940|NCT01964404|582657390|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347941|NCT01964404|582657391|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
161347942|NCT00325416|582657394|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
161347943|NCT00325416|582657395|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
161347944|NCT00325416|582657394|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
161347945|NCT00325416|582657395|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
161347946|NCT00325416|582657394|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
161347947|NCT00325416|582657395|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
161301883|NCT04696055|582485871|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
161301884|NCT04696055|582485872|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
161301885|NCT04696055|582485871|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
161301886|NCT04696055|582485872|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
161301887|NCT04696055|582485871|FG000|Overall Study|Subject Decision|1|||
161301888|NCT04696055|582485872|FG001|Overall Study|Subject Decision|2|||
161301889|NCT03969901|582485873|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161301890|NCT03969901|582485874|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161301891|NCT03969901|582485875|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161347948|NCT00325416|582657394|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
161347949|NCT00325416|582657395|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
161347950|NCT00325416|582657394|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
161347951|NCT00325416|582657395|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
161347952|NCT00325416|582657394|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
161347953|NCT00325416|582657395|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
161301892|NCT03969901|582485876|FG003|Overall Study|Withdrawal by parent/guardian|0|||
161301893|NCT03969901|582485877|FG004|Overall Study|Withdrawal by parent/guardian|1|||
161301894|NCT03969901|582485878|FG005|Overall Study|Withdrawal by parent/guardian|0|||
161301895|NCT03969901|582485879|FG006|Overall Study|Withdrawal by parent/guardian|0|||
161301896|NCT03969901|582485880|FG007|Overall Study|Withdrawal by parent/guardian|1|||
161301897|NCT03969901|582485881|FG008|Overall Study|Withdrawal by parent/guardian|1|||
161301898|NCT03969901|582485882|FG009|Overall Study|Withdrawal by parent/guardian|0|||
161301899|NCT00348595|582485883|FG000|Overall Study|Adverse Event|5|||
161301900|NCT00348595|582485884|FG001|Overall Study|Adverse Event|8|||
161301901|NCT01920958|582485885|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
161301902|NCT03192306|582485890|FG000|Overall Study|Did not treat cold sore during study|149|||
161301903|NCT03192306|582485891|FG001|Overall Study|Did not treat cold sore during study|143|||
161301904|NCT03192306|582485890|FG000|Overall Study|Withdrawal by Subject|1|||
161301905|NCT03192306|582485891|FG001|Overall Study|Withdrawal by Subject|1|||
161301906|NCT03192306|582485890|FG000|Overall Study|Lost to Follow-up|1|||
161301907|NCT03192306|582485891|FG001|Overall Study|Lost to Follow-up|0|||
161301908|NCT03192306|582485890|FG000|Overall Study|Protocol Violation|1|||
161301909|NCT03192306|582485891|FG001|Overall Study|Protocol Violation|1|||
161301910|NCT02589626|582485896|FG000|Overall Study|Other than the reason specified|1|||
161301911|NCT02589626|582485897|FG001|Overall Study|Other than the reason specified|0|||
161301912|NCT02589626|582485896|FG000|Overall Study|Withdrawal by Subject|1|||
161301913|NCT02589626|582485897|FG001|Overall Study|Withdrawal by Subject|1|||
161301914|NCT02589626|582485896|FG000|Overall Study|Adverse Event|1|||
161301915|NCT02589626|582485897|FG001|Overall Study|Adverse Event|1|||
161301916|NCT00379080|582485898|FG000|Overall Study|Withdrawal by Subject|0|||
161301917|NCT00379080|582485899|FG001|Overall Study|Withdrawal by Subject|4|||
161301918|NCT00379080|582485900|FG002|Overall Study|Withdrawal by Subject|0|||
161301919|NCT01089608|582485901|FG000|Overall Study|Adverse Event|0|||
161301920|NCT01089608|582485902|FG001|Overall Study|Adverse Event|4|||
161301921|NCT01089608|582485901|FG000|Overall Study|Lost to Follow-up|0|||
161301922|NCT01089608|582485902|FG001|Overall Study|Lost to Follow-up|2|||
161301923|NCT02429778|582485904|FG000|Overall Study|Lost to Follow-up|2|||
161301924|NCT02429778|582485905|FG001|Overall Study|Lost to Follow-up|0|||
161301925|NCT02429778|582485904|FG000|Overall Study|Withdrawal by Subject|5|||
161301926|NCT02429778|582485905|FG001|Overall Study|Withdrawal by Subject|0|||
161301927|NCT01893281|582485906|FG000|Overall Study|Adverse Event|1|||
161301928|NCT01893281|582485906|FG000|Overall Study|Protocol Violation|1|||
161301929|NCT01893281|582485906|FG000|Overall Study|Withdrawal by Subject|1|||
161301930|NCT01290679|582485910|FG000|Overall Study|Adverse Event|2|||
161301931|NCT01290679|582485911|FG001|Overall Study|Adverse Event|0|||
161301932|NCT01290679|582485910|FG000|Overall Study|Lost to Follow-up|8|||
161301933|NCT01290679|582485911|FG001|Overall Study|Lost to Follow-up|10|||
161301934|NCT01290679|582485910|FG000|Overall Study|Protocol Violation|0|||
161301935|NCT01290679|582485911|FG001|Overall Study|Protocol Violation|1|||
161301936|NCT01290679|582485910|FG000|Overall Study|Withdrawal by Subject|6|||
161301937|NCT01290679|582485911|FG001|Overall Study|Withdrawal by Subject|5|||
161301938|NCT01290679|582485910|FG000|Overall Study|Subject Entered Another Trial|0|||
161301939|NCT01290679|582485911|FG001|Overall Study|Subject Entered Another Trial|5|||
161301940|NCT00355147|582485916|FG000|Overall Study|Lost to Follow-up|10|||
161301941|NCT00355147|582485917|FG001|Overall Study|Lost to Follow-up|8|||
161301942|NCT00355147|582485916|FG000|Overall Study|Withdrawal by Subject|8|||
161301943|NCT00355147|582485917|FG001|Overall Study|Withdrawal by Subject|12|||
161301944|NCT00675428|582485924|FG000|Overall Study|Disease Progression|2|||
161301945|NCT00675428|582485925|FG001|Overall Study|Disease Progression|2|||
161301946|NCT00675428|582485924|FG000|Overall Study|No Disease Response After Cycle 6|0|||
161301947|NCT00675428|582485925|FG001|Overall Study|No Disease Response After Cycle 6|1|||
161301948|NCT00675428|582485924|FG000|Overall Study|Physician Decision|1|||
161301949|NCT00675428|582485925|FG001|Overall Study|Physician Decision|0|||
161301950|NCT00886743|582485927|FG000|Overall Study|Adverse Event|3|||
161301951|NCT00886743|582485927|FG000|Overall Study|Other|1|||
161301952|NCT00478777|582485928|FG000|Overall Study|Adverse Event|29|||
161301953|NCT00478777|582485928|FG000|Overall Study|Lack of Efficacy|23|||
161301954|NCT00478777|582485928|FG000|Overall Study|Withdrawal by Subject|4|||
161301955|NCT00478777|582485928|FG000|Overall Study|Death|3|||
161301956|NCT00478777|582485928|FG000|Overall Study|Protocol Violation|3|||
161301957|NCT00478777|582485928|FG000|Overall Study|Lost to Follow-up|3|||
161301958|NCT00478777|582485928|FG000|Overall Study|Physician Decision|1|||
161301959|NCT00478777|582485928|FG000|Overall Study|Intolerance of therapy|1|||
161301960|NCT00478777|582485928|FG000|Overall Study|Lack of compliance|1|||
161301961|NCT00478777|582485928|FG000|Overall Study|Lymphocytes infusion|1|||
161301962|NCT00478777|582485928|FG000|Overall Study|End of therapy|2|||
161301963|NCT00478777|582485928|FG000|Overall Study|Not treated with lenalidomide|6|||
161301964|NCT01726270|582485929|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
161089563|NCT03149549|581717400|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161301965|NCT01726270|582485929|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
161301966|NCT01726270|582485929|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
161301967|NCT01726270|582485929|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
161301968|NCT01726270|582485929|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
161301969|NCT01726270|582485929|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
161301970|NCT03634033|582487385|FG000|Overall Study|Did not have a post-assessment|384|||
161301971|NCT03634033|582487386|FG001|Overall Study|Did not have a post-assessment|291|||
161301972|NCT03634033|582487387|FG002|Overall Study|Did not have a post-assessment|114|||
161301973|NCT03634033|582487388|FG003|Overall Study|Did not have a post-assessment|161|||
161301974|NCT03634033|582487389|FG004|Overall Study|Did not have a post-assessment|5|||
161301975|NCT03634033|582487390|FG005|Overall Study|Did not have a post-assessment|0|||
161301976|NCT03634033|582487391|FG006|Overall Study|Did not have a post-assessment|0|||
161301977|NCT03634033|582487385|FG000|Overall Study|Death|0|||
161301978|NCT03634033|582487386|FG001|Overall Study|Death|0|||
161301979|NCT03634033|582487387|FG002|Overall Study|Death|0|||
161301980|NCT03634033|582487388|FG003|Overall Study|Death|0|||
161301981|NCT03634033|582487389|FG004|Overall Study|Death|0|||
161301982|NCT03634033|582487390|FG005|Overall Study|Death|7|||
161301983|NCT03634033|582487391|FG006|Overall Study|Death|7|||
161301984|NCT03634033|582487385|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161301985|NCT03634033|582487386|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161301986|NCT03634033|582487387|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161301987|NCT03634033|582487388|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161301988|NCT03634033|582487389|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
161301989|NCT03634033|582487390|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
161301990|NCT03634033|582487391|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
161301991|NCT03634033|582487385|FG000|Overall Study|Lost to Follow-up|0|||
161301992|NCT03634033|582487386|FG001|Overall Study|Lost to Follow-up|0|||
161301993|NCT03634033|582487387|FG002|Overall Study|Lost to Follow-up|0|||
161301994|NCT03634033|582487388|FG003|Overall Study|Lost to Follow-up|0|||
161301995|NCT03634033|582487389|FG004|Overall Study|Lost to Follow-up|0|||
161301996|NCT03634033|582487390|FG005|Overall Study|Lost to Follow-up|1|||
161301997|NCT03634033|582487391|FG006|Overall Study|Lost to Follow-up|2|||
161301998|NCT03634033|582487385|FG000|Overall Study|Withdrawal by Subject|0|||
161301999|NCT03634033|582487386|FG001|Overall Study|Withdrawal by Subject|0|||
161302000|NCT03634033|582487387|FG002|Overall Study|Withdrawal by Subject|0|||
161302001|NCT03634033|582487388|FG003|Overall Study|Withdrawal by Subject|0|||
161302002|NCT03634033|582487389|FG004|Overall Study|Withdrawal by Subject|0|||
161302003|NCT03634033|582487390|FG005|Overall Study|Withdrawal by Subject|0|||
161302004|NCT03634033|582487391|FG006|Overall Study|Withdrawal by Subject|1|||
161302005|NCT06366087|582487392|FG000|Overall Study|Withdrawal by Subject|0|||
161302006|NCT06366087|582487393|FG001|Overall Study|Withdrawal by Subject|1|||
161302007|NCT00199797|582487394|FG000|Overall Study|Progressive Disease|1|||
161302008|NCT00199797|582487394|FG000|Overall Study|Adverse Event|1|||
161302009|NCT00199797|582487394|FG000|Overall Study|Physician Decision|1|||
161302010|NCT01397786|582487396|FG000|Phase A|Lost to Follow-up|0|||
161302011|NCT01397786|582487397|FG001|Phase A|Lost to Follow-up|0|||
161302012|NCT01397786|582487398|FG002|Phase A|Lost to Follow-up|6|||
161302013|NCT01397786|582487396|FG000|Phase A|Adverse Event|0|||
161302014|NCT01397786|582487397|FG001|Phase A|Adverse Event|0|||
161302015|NCT01397786|582487398|FG002|Phase A|Adverse Event|8|||
161302016|NCT01397786|582487396|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
161302017|NCT01397786|582487397|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
161302018|NCT01397786|582487398|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
161302019|NCT01397786|582487396|FG000|Phase A|Physician Decision|0|||
161302020|NCT01397786|582487397|FG001|Phase A|Physician Decision|0|||
161302021|NCT01397786|582487398|FG002|Phase A|Physician Decision|1|||
161302022|NCT01397786|582487396|FG000|Phase A|Withdrawal by Subject|0|||
161302023|NCT01397786|582487397|FG001|Phase A|Withdrawal by Subject|0|||
161302024|NCT01397786|582487398|FG002|Phase A|Withdrawal by Subject|5|||
161302025|NCT01397786|582487396|FG000|Phase A|Lack of Efficacy|0|||
161302026|NCT01397786|582487397|FG001|Phase A|Lack of Efficacy|0|||
161302027|NCT01397786|582487398|FG002|Phase A|Lack of Efficacy|1|||
161302028|NCT01397786|582487396|FG000|Phase B|Lost to Follow-up|22|||
161183219|NCT03330106|582047557|FG001|Part B|Lost to Follow-up|0|||
161183220|NCT03330106|582047558|FG002|Part B|Lost to Follow-up|0|||
161183221|NCT03330106|582047559|FG003|Part B|Lost to Follow-up|1|||
161302029|NCT01397786|582487397|FG001|Phase B|Lost to Follow-up|12|||
161302030|NCT01397786|582487398|FG002|Phase B|Lost to Follow-up|22|||
161302031|NCT01397786|582487396|FG000|Phase B|Adverse Event|109|||
161302032|NCT01397786|582487397|FG001|Phase B|Adverse Event|23|||
161302033|NCT01397786|582487398|FG002|Phase B|Adverse Event|27|||
161302034|NCT01397786|582487396|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
161302035|NCT01397786|582487397|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
161302036|NCT01397786|582487398|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
161302037|NCT01397786|582487396|FG000|Phase B|Physician Decision|9|||
161302038|NCT01397786|582487397|FG001|Phase B|Physician Decision|1|||
161302039|NCT01397786|582487398|FG002|Phase B|Physician Decision|3|||
161183222|NCT03330106|582047556|FG000|Part B|Withdrawal by Subject|0|||
161302040|NCT01397786|582487396|FG000|Phase B|Withdrawal by Subject|102|||
161302041|NCT01397786|582487397|FG001|Phase B|Withdrawal by Subject|45|||
161302042|NCT01397786|582487398|FG002|Phase B|Withdrawal by Subject|30|||
161302043|NCT01397786|582487396|FG000|Phase B|Protocol Deviation|1|||
161302044|NCT01397786|582487397|FG001|Phase B|Protocol Deviation|2|||
161302045|NCT01397786|582487398|FG002|Phase B|Protocol Deviation|4|||
161302046|NCT01397786|582487396|FG000|Phase B|Lack of Efficacy|22|||
161302047|NCT01397786|582487397|FG001|Phase B|Lack of Efficacy|7|||
161302048|NCT01397786|582487398|FG002|Phase B|Lack of Efficacy|14|||
161302049|NCT04250350|582487402|FG000|Overall Study|Withdrawal by Subject|13|||
161302050|NCT04250350|582487402|FG000|Overall Study|Lost to Follow-up|8|||
161302051|NCT04250350|582487402|FG000|Overall Study|Adverse Event|5|||
161302052|NCT04250350|582487402|FG000|Overall Study|Lack of Efficacy|4|||
161302053|NCT04250350|582487402|FG000|Overall Study|Physician Decision|1|||
161302054|NCT04250350|582487402|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
161302055|NCT00860249|582487403|FG000|Overall Study|trial was terminated prior to completion|21|||
161302056|NCT00860249|582487404|FG001|Overall Study|trial was terminated prior to completion|18|||
161302057|NCT00860249|582487405|FG002|Overall Study|trial was terminated prior to completion|21|||
161302058|NCT00743288|582487406|FG000|Overall Study|Adverse Event|1|||
161302059|NCT00743288|582487407|FG001|Overall Study|Adverse Event|1|||
161302060|NCT00743288|582487408|FG002|Overall Study|Adverse Event|2|||
161302061|NCT00743288|582487409|FG003|Overall Study|Adverse Event|2|||
161302062|NCT00743288|582487410|FG004|Overall Study|Adverse Event|1|||
161302063|NCT00743288|582487411|FG005|Overall Study|Adverse Event|1|||
161302064|NCT00743288|582487412|FG006|Overall Study|Adverse Event|2|||
161302065|NCT00743288|582487406|FG000|Overall Study|Withdrawal by Subject|0|||
161302066|NCT00743288|582487407|FG001|Overall Study|Withdrawal by Subject|0|||
161302067|NCT00743288|582487408|FG002|Overall Study|Withdrawal by Subject|1|||
161302068|NCT00743288|582487409|FG003|Overall Study|Withdrawal by Subject|0|||
161302069|NCT00743288|582487410|FG004|Overall Study|Withdrawal by Subject|0|||
161302070|NCT00743288|582487411|FG005|Overall Study|Withdrawal by Subject|1|||
161302071|NCT00743288|582487412|FG006|Overall Study|Withdrawal by Subject|1|||
161302072|NCT00743288|582487406|FG000|Overall Study|Progressive disease (PD)|2|||
161302073|NCT00743288|582487407|FG001|Overall Study|Progressive disease (PD)|0|||
161302074|NCT00743288|582487408|FG002|Overall Study|Progressive disease (PD)|1|||
161302075|NCT00743288|582487409|FG003|Overall Study|Progressive disease (PD)|4|||
161302076|NCT00743288|582487410|FG004|Overall Study|Progressive disease (PD)|5|||
161302077|NCT00743288|582487411|FG005|Overall Study|Progressive disease (PD)|3|||
161302078|NCT00743288|582487412|FG006|Overall Study|Progressive disease (PD)|6|||
161302079|NCT00743288|582487406|FG000|Overall Study|Worsening of condition (Not PD)|0|||
161302080|NCT00743288|582487407|FG001|Overall Study|Worsening of condition (Not PD)|2|||
161302081|NCT00743288|582487408|FG002|Overall Study|Worsening of condition (Not PD)|1|||
161302082|NCT00743288|582487409|FG003|Overall Study|Worsening of condition (Not PD)|1|||
161302083|NCT00743288|582487410|FG004|Overall Study|Worsening of condition (Not PD)|0|||
161302084|NCT00743288|582487411|FG005|Overall Study|Worsening of condition (Not PD)|0|||
161302085|NCT00743288|582487412|FG006|Overall Study|Worsening of condition (Not PD)|0|||
161302086|NCT02836236|582487414|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
161302087|NCT02836236|582487415|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
161302088|NCT02836236|582487416|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
161302089|NCT02836236|582487417|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
161302090|NCT02836236|582487414|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
161302091|NCT02836236|582487415|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
161302092|NCT02836236|582487416|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161302093|NCT02836236|582487417|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
161302094|NCT02836236|582487414|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161302095|NCT02836236|582487415|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
161302096|NCT02836236|582487416|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161302097|NCT02836236|582487417|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161302098|NCT02836236|582487414|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
161302099|NCT02836236|582487415|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161302100|NCT02836236|582487416|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161302101|NCT02836236|582487417|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
161302102|NCT02836236|582487414|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161302103|NCT02836236|582487415|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
161302104|NCT02836236|582487416|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
161302105|NCT02836236|582487417|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
161302106|NCT02836236|582487414|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161302107|NCT02836236|582487415|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
161302108|NCT02836236|582487416|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
161302109|NCT02836236|582487417|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
161302110|NCT02836236|582487414|FG000|Open-Label TAF Treatment Phase|Death|0|||
161302111|NCT02836236|582487415|FG001|Open-Label TAF Treatment Phase|Death|0|||
161302112|NCT02836236|582487416|FG002|Open-Label TAF Treatment Phase|Death|1|||
161302113|NCT02836236|582487417|FG003|Open-Label TAF Treatment Phase|Death|1|||
161183223|NCT03330106|582047557|FG001|Part B|Withdrawal by Subject|0|||
161183224|NCT03330106|582047558|FG002|Part B|Withdrawal by Subject|4|||
161183225|NCT03330106|582047559|FG003|Part B|Withdrawal by Subject|0|||
161183226|NCT03330106|582047556|FG000|Part B|Death|0|||
161183227|NCT03330106|582047557|FG001|Part B|Death|0|||
161183228|NCT03330106|582047558|FG002|Part B|Death|2|||
161183229|NCT03330106|582047559|FG003|Part B|Death|0|||
161183230|NCT03330106|582047556|FG000|Part B|Clinical Progression|0|||
161183231|NCT03330106|582047557|FG001|Part B|Clinical Progression|0|||
161183232|NCT03330106|582047558|FG002|Part B|Clinical Progression|1|||
161183233|NCT03330106|582047559|FG003|Part B|Clinical Progression|1|||
161183234|NCT03330106|582047556|FG000|Part B|Symptomatic Deterioration|0|||
161183235|NCT03330106|582047557|FG001|Part B|Symptomatic Deterioration|0|||
161183236|NCT03330106|582047558|FG002|Part B|Symptomatic Deterioration|0|||
161183237|NCT03330106|582047559|FG003|Part B|Symptomatic Deterioration|1|||
161183238|NCT03330106|582047556|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161183239|NCT03330106|582047557|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161183240|NCT03330106|582047558|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
161183241|NCT03330106|582047559|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
161183242|NCT03330106|582047556|FG000|Part B|Progressive Disease|0|||
161183243|NCT03330106|582047557|FG001|Part B|Progressive Disease|0|||
161183244|NCT03330106|582047558|FG002|Part B|Progressive Disease|11|||
161183245|NCT03330106|582047559|FG003|Part B|Progressive Disease|4|||
161183246|NCT00486889|582047562|FG000|Overall Study|Death|3|||
161183247|NCT00486889|582047562|FG000|Overall Study|Non-compliant|2|||
161183248|NCT00486889|582047562|FG000|Overall Study|Withdrawal by Subject|6|||
161183249|NCT00893763|582047563|FG000|Overall Study|extubated|110|||
161183250|NCT00893763|582047564|FG001|Overall Study|extubated|110|||
161183251|NCT00796549|582047565|FG000|Overall Study|Adverse Event|11|||
161183252|NCT00796549|582047565|FG000|Overall Study|not entered|149|||
161183253|NCT00796549|582047565|FG000|Overall Study|Other|2|||
161183254|NCT00796549|582047565|FG000|Overall Study|Progressive disease|56|||
161183255|NCT00606229|582047568|FG000|Overall Study|Adverse Event|11|||
161183256|NCT00606229|582047568|FG000|Overall Study|Lack of Efficacy|1|||
161183257|NCT00606229|582047568|FG000|Overall Study|Withdrawal by Subject|4|||
161183258|NCT00606229|582047568|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
161183259|NCT00606229|582047568|FG000|Overall Study|change of residence or other commitments|2|||
161183260|NCT00942422|582047569|FG000|Overall Study|Withdrawal by Subject|1|||
161183261|NCT00942422|582047569|FG000|Overall Study|Death|1|||
161183262|NCT00942422|582047569|FG000|Overall Study|Progressive diease|1|||
161183263|NCT00422903|582047570|FG000|Overall Study|Disease Progression|3|||
161183264|NCT00422903|582047571|FG001|Overall Study|Disease Progression|1|||
161183265|NCT00422903|582047570|FG000|Overall Study|Adverse Event|0|||
161183266|NCT00422903|582047571|FG001|Overall Study|Adverse Event|2|||
161183267|NCT00422903|582047570|FG000|Overall Study|Informed Consent Withdrawn|1|||
161183268|NCT00422903|582047571|FG001|Overall Study|Informed Consent Withdrawn|2|||
161183269|NCT01947894|582047572|FG000|Overall Study|Other|3|||
161183270|NCT01947894|582047573|FG001|Overall Study|Other|4|||
161183271|NCT01947894|582047574|FG002|Overall Study|Other|3|||
161183272|NCT01947894|582047572|FG000|Overall Study|Withdrawal by Subject|12|||
161183273|NCT01947894|582047573|FG001|Overall Study|Withdrawal by Subject|4|||
161183274|NCT01947894|582047574|FG002|Overall Study|Withdrawal by Subject|1|||
161183275|NCT01947894|582047572|FG000|Overall Study|Death|12|||
161183276|NCT01947894|582047573|FG001|Overall Study|Death|1|||
161183277|NCT01947894|582047574|FG002|Overall Study|Death|0|||
161183278|NCT01947894|582047572|FG000|Overall Study|Physician Decision|2|||
161183279|NCT01947894|582047573|FG001|Overall Study|Physician Decision|0|||
161183280|NCT01947894|582047574|FG002|Overall Study|Physician Decision|0|||
161183281|NCT01947894|582047572|FG000|Overall Study|Adverse Event|5|||
161183282|NCT01947894|582047573|FG001|Overall Study|Adverse Event|1|||
161183283|NCT01947894|582047574|FG002|Overall Study|Adverse Event|0|||
161183284|NCT01947894|582047572|FG000|Overall Study|Switched to other growth hormone brand|53|||
161183285|NCT01947894|582047573|FG001|Overall Study|Switched to other growth hormone brand|8|||
161183286|NCT01947894|582047574|FG002|Overall Study|Switched to other growth hormone brand|23|||
161183287|NCT01302691|582047575|FG000|Overall Study|Adverse Event|2|||
161347954|NCT06239610|582657396|FG000|Overall Study|no usable migration data for minimum of one day|11|||
161183288|NCT01302691|582047576|FG001|Overall Study|Adverse Event|0|||
161183289|NCT01302691|582047575|FG000|Overall Study|Death|0|||
161183290|NCT01302691|582047576|FG001|Overall Study|Death|1|||
161183291|NCT01302691|582047575|FG000|Overall Study|Lost to Follow-up|1|||
161183292|NCT01302691|582047576|FG001|Overall Study|Lost to Follow-up|0|||
161183293|NCT01302691|582047575|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
161183294|NCT01302691|582047576|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
161183295|NCT01302691|582047575|FG000|Overall Study|Physician Decision|0|||
161183296|NCT01302691|582047576|FG001|Overall Study|Physician Decision|1|||
161183297|NCT01302691|582047575|FG000|Overall Study|Protocol Violation|1|||
161183298|NCT01302691|582047576|FG001|Overall Study|Protocol Violation|0|||
161183299|NCT03446612|582047577|FG000|Overall Study|Protocol defined stopping criteria|0|||
161183300|NCT03446612|582047578|FG001|Overall Study|Protocol defined stopping criteria|1|||
161183301|NCT01602744|582047585|FG000|Overall Study|Death|17|||
161183302|NCT01602744|582047586|FG001|Overall Study|Death|15|||
161183303|NCT01602744|582047585|FG000|Overall Study|Lost to Follow-up|13|||
161183304|NCT01602744|582047586|FG001|Overall Study|Lost to Follow-up|8|||
161302114|NCT02836236|582487414|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161302115|NCT02836236|582487415|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161302116|NCT02836236|582487416|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
161302117|NCT02836236|582487417|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
161302118|NCT00378508|582487421|FG000|Overall Study|Withdrawal by Subject|1|||
161302119|NCT00378508|582487422|FG001|Overall Study|Withdrawal by Subject|3|||
161302120|NCT00378508|582487421|FG000|Overall Study|Lost to Follow-up|1|||
161302121|NCT00378508|582487422|FG001|Overall Study|Lost to Follow-up|0|||
161302122|NCT00593684|582487423|FG000|Overall Study|Death|2|||
161302123|NCT00593684|582487424|FG001|Overall Study|Death|1|||
161302124|NCT00809471|582487427|FG000|Overall Study|Protocol non-compliance|15|||
161302125|NCT00809471|582487428|FG001|Overall Study|Protocol non-compliance|15|||
161302126|NCT00809471|582487429|FG002|Overall Study|Protocol non-compliance|6|||
161302127|NCT00809471|582487427|FG000|Overall Study|Lost to Follow-up|4|||
161302128|NCT00809471|582487428|FG001|Overall Study|Lost to Follow-up|2|||
161302129|NCT00809471|582487429|FG002|Overall Study|Lost to Follow-up|9|||
161302130|NCT00809471|582487427|FG000|Overall Study|Adverse Event|0|||
161302131|NCT00809471|582487428|FG001|Overall Study|Adverse Event|2|||
161302132|NCT00809471|582487429|FG002|Overall Study|Adverse Event|2|||
161302133|NCT00809471|582487427|FG000|Overall Study|Requirement for restricted medication|1|||
161302134|NCT00809471|582487428|FG001|Overall Study|Requirement for restricted medication|1|||
161302135|NCT00809471|582487429|FG002|Overall Study|Requirement for restricted medication|0|||
161302136|NCT00831311|582487430|FG000|Overall Study|Definitive Contraindication|3|||
161302137|NCT00831311|582487431|FG001|Overall Study|Definitive Contraindication|3|||
161302138|NCT00831311|582487430|FG000|Overall Study|Lost to Follow-up|3|||
161302139|NCT00831311|582487431|FG001|Overall Study|Lost to Follow-up|0|||
161302140|NCT00831311|582487430|FG000|Overall Study|Physician Decision|0|||
161302141|NCT00831311|582487431|FG001|Overall Study|Physician Decision|1|||
161302142|NCT00831311|582487430|FG000|Overall Study|Withdrawal by Subject|6|||
161302143|NCT00831311|582487431|FG001|Overall Study|Withdrawal by Subject|4|||
161302144|NCT05318092|582487435|FG000|Overall Study|Lost to Follow-up|3|||
161302145|NCT05318092|582487435|FG000|Overall Study|Withdrawal by Subject|1|||
161302146|NCT01669174|582487443|FG000|Overall Study|Subject withdrew consent|2|||
161302147|NCT01669174|582487444|FG001|Overall Study|Subject withdrew consent|2|||
161302148|NCT01669174|582487443|FG000|Overall Study|Lost to Follow-up|1|||
161302149|NCT01669174|582487444|FG001|Overall Study|Lost to Follow-up|0|||
161302150|NCT01669174|582487443|FG000|Overall Study|Adverse Event|2|||
161302151|NCT01669174|582487444|FG001|Overall Study|Adverse Event|2|||
161302152|NCT01669174|582487443|FG000|Overall Study|Administrative problems|1|||
161302153|NCT01669174|582487444|FG001|Overall Study|Administrative problems|2|||
161302154|NCT01953601|582487448|FG000|Part 1 (Base Study)|Adverse Event|24|||
161302155|NCT01953601|582487449|FG001|Part 1 (Base Study)|Adverse Event|37|||
161302156|NCT01953601|582487450|FG002|Part 1 (Base Study)|Adverse Event|15|||
161302157|NCT01953601|582487448|FG000|Part 1 (Base Study)|Death|2|||
161302158|NCT01953601|582487449|FG001|Part 1 (Base Study)|Death|0|||
161302159|NCT01953601|582487450|FG002|Part 1 (Base Study)|Death|3|||
161302160|NCT01953601|582487448|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
161302161|NCT01953601|582487449|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
161302162|NCT01953601|582487450|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
161302163|NCT01953601|582487448|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
161302164|NCT01953601|582487449|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
161302165|NCT01953601|582487450|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
161302166|NCT01953601|582487448|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
161302167|NCT01953601|582487449|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
161302168|NCT01953601|582487450|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
161183305|NCT03924427|582047587|FG000|Overall Study|Adverse Event|4|||
161183306|NCT03924427|582047587|FG000|Overall Study|Lack of Efficacy|1|||
161302169|NCT01953601|582487448|FG000|Part 1 (Base Study)|Physician Decision|3|||
161302170|NCT01953601|582487449|FG001|Part 1 (Base Study)|Physician Decision|7|||
161302171|NCT01953601|582487450|FG002|Part 1 (Base Study)|Physician Decision|4|||
161183307|NCT03924427|582047587|FG000|Overall Study|Withdrawal by Subject|1|||
161183308|NCT04035473|582047589|FG000|Screening/Baseline|Death|0|||
161183309|NCT04035473|582047590|FG001|Screening/Baseline|Death|1|||
161302172|NCT01953601|582487448|FG000|Part 1 (Base Study)|Screen failure|1|||
161302173|NCT01953601|582487449|FG001|Part 1 (Base Study)|Screen failure|0|||
161302174|NCT01953601|582487450|FG002|Part 1 (Base Study)|Screen failure|1|||
161183310|NCT04035473|582047589|FG000|Screening/Baseline|Adverse Event|0|||
161183311|NCT04035473|582047590|FG001|Screening/Baseline|Adverse Event|1|||
161183312|NCT04035473|582047589|FG000|Follow-up Period|Adverse Event|2|||
161183313|NCT04035473|582047590|FG001|Follow-up Period|Adverse Event|0|||
161302175|NCT01953601|582487448|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
161302176|NCT01953601|582487449|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
161302177|NCT01953601|582487450|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
161302178|NCT01953601|582487448|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
161302179|NCT01953601|582487449|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
161302180|NCT01953601|582487450|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
161302181|NCT01953601|582487448|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
161302182|NCT01953601|582487449|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
161302183|NCT01953601|582487450|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
161302184|NCT01953601|582487448|FG000|Part 1 (Base Study)|Subject moved|2|||
161302185|NCT01953601|582487449|FG001|Part 1 (Base Study)|Subject moved|2|||
161302186|NCT01953601|582487450|FG002|Part 1 (Base Study)|Subject moved|1|||
161302187|NCT01953601|582487448|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
161302188|NCT01953601|582487449|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
161302189|NCT01953601|582487450|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
161302190|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Adverse Event|1|||
161302191|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Adverse Event|1|||
161302192|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Adverse Event|10|||
161302193|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Death|0|||
161302194|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Death|3|||
161302195|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Death|0|||
161302196|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
161302197|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
161302198|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
161302199|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
161302200|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
161302201|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
161302202|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Physician Decision|2|||
161302203|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Physician Decision|0|||
161302204|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Physician Decision|2|||
161302205|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
161302206|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
161302207|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
161302208|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
161302209|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
161302210|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
161302211|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
161302212|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
161302213|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
161302214|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Subject moved|0|||
161302215|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Subject moved|0|||
161302216|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Subject moved|1|||
161302217|NCT01953601|582487448|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
161302218|NCT01953601|582487449|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
161302219|NCT01953601|582487450|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
161302220|NCT01905553|582487457|FG000|Period 2|Adverse Event|1|||
161302221|NCT01905553|582487458|FG001|Period 2|Adverse Event|0|||
161302222|NCT04310397|582487459|FG000|Overall Study|Lack of Efficacy|3|||
161302223|NCT04310397|582487459|FG000|Overall Study|Withdrawal by Subject|1|||
161302224|NCT03645395|582487464|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
161302225|NCT03645395|582487465|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
161302226|NCT03645395|582487466|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
161302227|NCT03645395|582487467|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
161302228|NCT03645395|582487464|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
161302229|NCT03645395|582487465|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
161302230|NCT03645395|582487466|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
161302231|NCT03645395|582487467|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
161302232|NCT03645395|582487464|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161302233|NCT03645395|582487465|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161302234|NCT03645395|582487466|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
161302235|NCT03645395|582487467|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
161302236|NCT03645395|582487464|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
161302237|NCT03645395|582487465|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
161302238|NCT03645395|582487466|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
161302239|NCT03645395|582487467|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
161347955|NCT02830087|582657399|FG000|Overall Study|No study staff to follow-up patients|4|||
161347956|NCT02830087|582657400|FG001|Overall Study|No study staff to follow-up patients|4|||
161302240|NCT01289639|582487469|FG000|Overall Study|Lost to Follow-up|1|||
161302241|NCT01289639|582487470|FG001|Overall Study|Lost to Follow-up|0|||
161302242|NCT01289639|582487471|FG002|Overall Study|Lost to Follow-up|0|||
161302243|NCT02780713|582487472|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161302244|NCT02780713|582487473|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161302245|NCT02780713|582487474|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
161302246|NCT02780713|582487475|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161302247|NCT02780713|582487476|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
161302248|NCT01931475|582487477|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
161302249|NCT01931475|582487478|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
161302250|NCT01931475|582487477|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
161302251|NCT01931475|582487478|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
161302252|NCT01931475|582487477|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
161302253|NCT01931475|582487478|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
161302254|NCT01931475|582487477|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
161302255|NCT01931475|582487478|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
161302256|NCT01931475|582487477|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
161302257|NCT01931475|582487478|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
161302258|NCT01931475|582487477|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
161302259|NCT01931475|582487478|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
161302260|NCT01931475|582487477|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
161302261|NCT01931475|582487478|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
161302262|NCT01931475|582487477|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
161302263|NCT01931475|582487478|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
161302264|NCT01931475|582487477|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
161302265|NCT01931475|582487478|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
161302266|NCT01931475|582487477|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
161302267|NCT01931475|582487478|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
161302268|NCT01931475|582487477|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
161302269|NCT01931475|582487478|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
161302270|NCT01028014|582487490|FG000|Overall Study|Lost to Follow-up|1|||
161302271|NCT01028014|582487491|FG001|Overall Study|Lost to Follow-up|2|||
161302272|NCT01028014|582487492|FG002|Overall Study|Lost to Follow-up|0|||
161302273|NCT01028014|582487493|FG003|Overall Study|Lost to Follow-up|1|||
161302274|NCT01028014|582487494|FG004|Overall Study|Lost to Follow-up|1|||
161302275|NCT01028014|582487495|FG005|Overall Study|Lost to Follow-up|2|||
161302276|NCT01127451|582487496|FG000|Overall Study|Other|2|||
161302277|NCT01127451|582487497|FG001|Overall Study|Other|1|||
161302278|NCT01127451|582487496|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
161302279|NCT01127451|582487497|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
161302280|NCT01127451|582487496|FG000|Overall Study|Death|22|||
161302281|NCT01127451|582487497|FG001|Overall Study|Death|17|||
161302282|NCT01127451|582487496|FG000|Overall Study|Lost to Follow-up|3|||
161302283|NCT01127451|582487497|FG001|Overall Study|Lost to Follow-up|0|||
161302284|NCT01127451|582487496|FG000|Overall Study|Administrative Reason by Sponsor|2|||
161302285|NCT01127451|582487497|FG001|Overall Study|Administrative Reason by Sponsor|2|||
161302286|NCT02111577|582487498|FG000|Overall Study|Protocol Violation|2|||
161302287|NCT02111577|582487499|FG001|Overall Study|Protocol Violation|0|||
161302288|NCT02111577|582487498|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
161302289|NCT02111577|582487499|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
161302290|NCT02111577|582487498|FG000|Overall Study|Failure to produce study treatment|6|||
161302291|NCT02111577|582487499|FG001|Overall Study|Failure to produce study treatment|0|||
161302292|NCT02111577|582487498|FG000|Overall Study|Death|518|||
161302293|NCT02111577|582487499|FG001|Overall Study|Death|254|||
161302294|NCT02111577|582487498|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
161302295|NCT02111577|582487499|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
161302296|NCT02111577|582487498|FG000|Overall Study|Adverse Event|1|||
161302297|NCT02111577|582487499|FG001|Overall Study|Adverse Event|1|||
161302298|NCT02111577|582487498|FG000|Overall Study|Withdrawal by Subject|51|||
161302299|NCT02111577|582487499|FG001|Overall Study|Withdrawal by Subject|23|||
161302300|NCT02111577|582487498|FG000|Overall Study|Disease progression|0|||
161302301|NCT02111577|582487499|FG001|Overall Study|Disease progression|1|||
161302302|NCT02111577|582487498|FG000|Overall Study|Lost to Follow-up|19|||
161302303|NCT02111577|582487499|FG001|Overall Study|Lost to Follow-up|10|||
161302304|NCT04590586|582487506|FG000|Overall Study|Death|7|||
161302305|NCT04590586|582487507|FG001|Overall Study|Death|1|||
161302306|NCT04590586|582487508|FG002|Overall Study|Death|37|||
161302307|NCT04590586|582487509|FG003|Overall Study|Death|34|||
161302308|NCT04590586|582487510|FG004|Overall Study|Death|19|||
161302309|NCT04590586|582487511|FG005|Overall Study|Death|3|||
161302310|NCT04590586|582487506|FG000|Overall Study|Lost to Follow-up|3|||
161302311|NCT04590586|582487507|FG001|Overall Study|Lost to Follow-up|0|||
161347957|NCT02830087|582657401|FG002|Overall Study|No study staff to follow-up patients|4|||
161302312|NCT04590586|582487508|FG002|Overall Study|Lost to Follow-up|11|||
161302313|NCT04590586|582487509|FG003|Overall Study|Lost to Follow-up|11|||
161302314|NCT04590586|582487510|FG004|Overall Study|Lost to Follow-up|6|||
161302315|NCT04590586|582487511|FG005|Overall Study|Lost to Follow-up|0|||
161302316|NCT04590586|582487506|FG000|Overall Study|Withdrawal by Subject|0|||
161302317|NCT04590586|582487507|FG001|Overall Study|Withdrawal by Subject|0|||
161302318|NCT04590586|582487508|FG002|Overall Study|Withdrawal by Subject|6|||
161183314|NCT00796224|582047591|FG000|Overall Study|Adverse Event|1|||
161183315|NCT00796224|582047592|FG001|Overall Study|Adverse Event|0|||
161183316|NCT00796224|582047591|FG000|Overall Study|Protocol Violation|0|||
161183317|NCT00796224|582047592|FG001|Overall Study|Protocol Violation|1|||
161183318|NCT01592773|582048988|FG000|Overall Study|Study Terminated by Sponsor|582|||
161183319|NCT01592773|582048988|FG000|Overall Study|Withdrawal by Subject|35|||
161183320|NCT01592773|582048988|FG000|Overall Study|Lost to Follow-up|19|||
161183321|NCT01592773|582048988|FG000|Overall Study|Adverse Event|17|||
161183322|NCT01592773|582048988|FG000|Overall Study|Lack of Efficacy|9|||
161183323|NCT01592773|582048988|FG000|Overall Study|Protocol Violation|2|||
161183324|NCT01592773|582048988|FG000|Overall Study|Inclusion/exclusion not meet|1|||
161183325|NCT01592773|582048988|FG000|Overall Study|Other Reason|1|||
161183326|NCT04124952|582048989|FG000|Overall Study|Lost to Follow-up|1|||
161183327|NCT03763942|582048990|FG000|Overall Study|Lost to Follow-up|114|||
161183328|NCT03763942|582048991|FG001|Overall Study|Lost to Follow-up|54|||
161183329|NCT03763942|582048990|FG000|Overall Study|Protocol Violation|1|||
161183330|NCT03763942|582048991|FG001|Overall Study|Protocol Violation|0|||
161183331|NCT03763942|582048990|FG000|Overall Study|Withdrawal by Subject|2|||
161183332|NCT03763942|582048991|FG001|Overall Study|Withdrawal by Subject|0|||
161183333|NCT03763942|582048990|FG000|Overall Study|Other|2|||
161183334|NCT03763942|582048991|FG001|Overall Study|Other|3|||
161183335|NCT03575351|582048994|FG000|Overall Study|Adverse Event|1|||
161183336|NCT03575351|582048995|FG001|Overall Study|Adverse Event|0|||
161183337|NCT03575351|582048994|FG000|Overall Study|Death|2|||
161183338|NCT03575351|582048995|FG001|Overall Study|Death|2|||
161183339|NCT03575351|582048994|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
161183340|NCT03575351|582048995|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
161183341|NCT03575351|582048994|FG000|Overall Study|Lack of Efficacy|28|||
161183342|NCT03575351|582048995|FG001|Overall Study|Lack of Efficacy|0|||
161183343|NCT03575351|582048994|FG000|Overall Study|Withdrawal by Subject|1|||
161183344|NCT03575351|582048995|FG001|Overall Study|Withdrawal by Subject|1|||
161183345|NCT03575351|582048994|FG000|Overall Study|Physician Decision|3|||
161183346|NCT03575351|582048995|FG001|Overall Study|Physician Decision|0|||
161183347|NCT03575351|582048994|FG000|Overall Study|Disease relapse|15|||
161183348|NCT03575351|582048995|FG001|Overall Study|Disease relapse|6|||
161183349|NCT03575351|582048994|FG000|Overall Study|Study drug manufacturing failure|0|||
161183350|NCT03575351|582048995|FG001|Overall Study|Study drug manufacturing failure|1|||
161183351|NCT03575351|582048994|FG000|Overall Study|other reasons|5|||
161183352|NCT03575351|582048995|FG001|Overall Study|other reasons|0|||
161183353|NCT04288089|582048996|FG000|Overall Study|Ongoing Treatment|2|||
161183354|NCT04288089|582048997|FG001|Overall Study|Ongoing Treatment|1|||
161183355|NCT04288089|582048998|FG002|Overall Study|Ongoing Treatment|1|||
161183356|NCT04288089|582048999|FG003|Overall Study|Ongoing Treatment|4|||
161183357|NCT03715205|582049000|FG000|Overall Study|Death|13|||
161183358|NCT03715205|582049000|FG000|Overall Study|Lost to Follow-up|2|||
161183359|NCT03715205|582049000|FG000|Overall Study|Physician Decision|93|||
161183360|NCT03715205|582049000|FG000|Overall Study|Withdrawal by Subject|26|||
161183361|NCT02623699|582049001|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183362|NCT02623699|582049002|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
161183363|NCT02623699|582049003|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183364|NCT02623699|582049004|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183365|NCT02623699|582049005|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183366|NCT02623699|582049006|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183367|NCT02623699|582049007|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183368|NCT02623699|582049008|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183369|NCT02623699|582049009|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183370|NCT02623699|582049010|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183371|NCT02623699|582049011|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183372|NCT02623699|582049012|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
161183373|NCT02623699|582049001|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183374|NCT02623699|582049002|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161302319|NCT04590586|582487509|FG003|Overall Study|Withdrawal by Subject|0|||
161302320|NCT04590586|582487510|FG004|Overall Study|Withdrawal by Subject|3|||
161302321|NCT04590586|582487511|FG005|Overall Study|Withdrawal by Subject|0|||
161183375|NCT02623699|582049003|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183376|NCT02623699|582049004|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183377|NCT02623699|582049005|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183378|NCT02623699|582049006|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183379|NCT02623699|582049007|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
161183380|NCT02623699|582049008|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183381|NCT02623699|582049009|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183382|NCT02623699|582049010|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183383|NCT02623699|582049011|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183384|NCT02623699|582049012|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
161183385|NCT02623699|582049001|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183386|NCT02623699|582049002|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183387|NCT02623699|582049003|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183388|NCT02623699|582049004|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161302322|NCT04590586|582487506|FG000|Overall Study|Other|3|||
161302323|NCT04590586|582487507|FG001|Overall Study|Other|0|||
161302324|NCT04590586|582487508|FG002|Overall Study|Other|1|||
161302325|NCT04590586|582487509|FG003|Overall Study|Other|1|||
161302326|NCT04590586|582487510|FG004|Overall Study|Other|2|||
161302327|NCT04590586|582487511|FG005|Overall Study|Other|1|||
161302328|NCT03990571|582487512|FG000|Overall Study|Withdrawal by Subject|1|||
161302329|NCT03990571|582487512|FG000|Overall Study|Insurance Issues|3|||
161302330|NCT03990571|582487512|FG000|Overall Study|Covid Restrictions|2|||
161302331|NCT00634803|582487513|FG000|Overall Study|Lost to Follow-up|6|||
161302332|NCT00634803|582487514|FG001|Overall Study|Lost to Follow-up|7|||
161302333|NCT00634803|582487515|FG002|Overall Study|Lost to Follow-up|7|||
161302334|NCT04105218|582487517|FG000|Overall Study|Withdrawal by Subject|3|||
161302335|NCT04105218|582487518|FG001|Overall Study|Withdrawal by Subject|2|||
161302336|NCT04105218|582487517|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
161302337|NCT04105218|582487518|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
161302338|NCT04105218|582487517|FG000|Overall Study|Failed screening tests|2|||
161302339|NCT04105218|582487518|FG001|Overall Study|Failed screening tests|1|||
161302340|NCT02553499|582487525|FG000|Overall Study|Adverse Event|0|||
161302341|NCT02553499|582487526|FG001|Overall Study|Adverse Event|0|||
161302342|NCT02553499|582487527|FG002|Overall Study|Adverse Event|0|||
161302343|NCT02553499|582487528|FG003|Overall Study|Adverse Event|0|||
161302344|NCT02553499|582487529|FG004|Overall Study|Adverse Event|0|||
161302345|NCT02553499|582487530|FG005|Overall Study|Adverse Event|0|||
161302346|NCT02553499|582487531|FG006|Overall Study|Adverse Event|1|||
161302347|NCT02553499|582487532|FG007|Overall Study|Adverse Event|1|||
161302348|NCT02553499|582487533|FG008|Overall Study|Adverse Event|0|||
161302349|NCT02553499|582487534|FG009|Overall Study|Adverse Event|0|||
161302350|NCT02553499|582487535|FG010|Overall Study|Adverse Event|0|||
161302351|NCT02553499|582487536|FG011|Overall Study|Adverse Event|0|||
161302352|NCT02553499|582487537|FG012|Overall Study|Adverse Event|0|||
161302353|NCT02553499|582487538|FG013|Overall Study|Adverse Event|1|||
161302354|NCT02553499|582487525|FG000|Overall Study|Death|0|||
161302355|NCT02553499|582487526|FG001|Overall Study|Death|1|||
161302356|NCT02553499|582487527|FG002|Overall Study|Death|1|||
161302357|NCT02553499|582487528|FG003|Overall Study|Death|0|||
161302358|NCT02553499|582487529|FG004|Overall Study|Death|1|||
161302359|NCT02553499|582487530|FG005|Overall Study|Death|2|||
161302360|NCT02553499|582487531|FG006|Overall Study|Death|0|||
161302361|NCT02553499|582487532|FG007|Overall Study|Death|0|||
161302362|NCT02553499|582487533|FG008|Overall Study|Death|0|||
161302363|NCT02553499|582487534|FG009|Overall Study|Death|0|||
161302364|NCT02553499|582487535|FG010|Overall Study|Death|1|||
161302365|NCT02553499|582487536|FG011|Overall Study|Death|0|||
161302366|NCT02553499|582487537|FG012|Overall Study|Death|0|||
161302367|NCT02553499|582487538|FG013|Overall Study|Death|0|||
161302368|NCT02553499|582487525|FG000|Overall Study|Lost to Follow-up|0|||
161302369|NCT02553499|582487526|FG001|Overall Study|Lost to Follow-up|0|||
161302370|NCT02553499|582487527|FG002|Overall Study|Lost to Follow-up|0|||
161302371|NCT02553499|582487528|FG003|Overall Study|Lost to Follow-up|0|||
161302372|NCT02553499|582487529|FG004|Overall Study|Lost to Follow-up|0|||
161302373|NCT02553499|582487530|FG005|Overall Study|Lost to Follow-up|0|||
161302374|NCT02553499|582487531|FG006|Overall Study|Lost to Follow-up|1|||
161302375|NCT02553499|582487532|FG007|Overall Study|Lost to Follow-up|0|||
161302376|NCT02553499|582487533|FG008|Overall Study|Lost to Follow-up|0|||
161302377|NCT02553499|582487534|FG009|Overall Study|Lost to Follow-up|0|||
161302378|NCT02553499|582487535|FG010|Overall Study|Lost to Follow-up|0|||
161302379|NCT02553499|582487536|FG011|Overall Study|Lost to Follow-up|0|||
161302380|NCT02553499|582487537|FG012|Overall Study|Lost to Follow-up|0|||
161302381|NCT02553499|582487538|FG013|Overall Study|Lost to Follow-up|0|||
161302382|NCT02553499|582487525|FG000|Overall Study|Physician Decision|0|||
161302383|NCT02553499|582487526|FG001|Overall Study|Physician Decision|1|||
161302384|NCT02553499|582487527|FG002|Overall Study|Physician Decision|1|||
161302385|NCT02553499|582487528|FG003|Overall Study|Physician Decision|0|||
161302386|NCT02553499|582487529|FG004|Overall Study|Physician Decision|1|||
161347958|NCT02830087|582657402|FG003|Overall Study|No study staff to follow-up patients|3|||
161347959|NCT02830087|582657403|FG004|Overall Study|No study staff to follow-up patients|3|||
161347960|NCT02830087|582657404|FG005|Overall Study|No study staff to follow-up patients|3|||
161302387|NCT02553499|582487530|FG005|Overall Study|Physician Decision|0|||
161302388|NCT02553499|582487531|FG006|Overall Study|Physician Decision|0|||
161302389|NCT02553499|582487532|FG007|Overall Study|Physician Decision|1|||
161302390|NCT02553499|582487533|FG008|Overall Study|Physician Decision|1|||
161302391|NCT02553499|582487534|FG009|Overall Study|Physician Decision|2|||
161302392|NCT02553499|582487535|FG010|Overall Study|Physician Decision|1|||
161302393|NCT02553499|582487536|FG011|Overall Study|Physician Decision|3|||
161302394|NCT02553499|582487537|FG012|Overall Study|Physician Decision|1|||
161302395|NCT02553499|582487538|FG013|Overall Study|Physician Decision|0|||
161302396|NCT02553499|582487525|FG000|Overall Study|Progressive Disease|0|||
161302397|NCT02553499|582487526|FG001|Overall Study|Progressive Disease|0|||
161302398|NCT02553499|582487527|FG002|Overall Study|Progressive Disease|0|||
161302399|NCT02553499|582487528|FG003|Overall Study|Progressive Disease|2|||
161183389|NCT02623699|582049005|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183390|NCT02623699|582049006|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
161183391|NCT02623699|582049007|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183392|NCT02623699|582049008|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183393|NCT02623699|582049009|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183394|NCT02623699|582049010|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183395|NCT02623699|582049011|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183396|NCT02623699|582049012|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
161183397|NCT02623699|582049001|FG000|Part B (Up to 289 Days)|Death|0|||
161183398|NCT02623699|582049002|FG001|Part B (Up to 289 Days)|Death|0|||
161183399|NCT02623699|582049003|FG002|Part B (Up to 289 Days)|Death|0|||
161183400|NCT02623699|582049004|FG003|Part B (Up to 289 Days)|Death|0|||
161183401|NCT02623699|582049005|FG004|Part B (Up to 289 Days)|Death|0|||
161183402|NCT02623699|582049006|FG005|Part B (Up to 289 Days)|Death|1|||
161183403|NCT02623699|582049007|FG006|Part B (Up to 289 Days)|Death|1|||
161347961|NCT02916771|582657405|FG000|Overall Study|Withdrawal by Subject|9|||
161347962|NCT02916771|582657405|FG000|Overall Study|Physician Decision|1|||
161347963|NCT02916771|582657405|FG000|Overall Study|Began treatment for another active malignancy|1|||
161347964|NCT02924376|582657406|FG000|Overall Study|Progressive Disease|4|||
161347965|NCT02924376|582657407|FG001|Overall Study|Progressive Disease|0|||
161347966|NCT02924376|582657408|FG002|Overall Study|Progressive Disease|1|||
161347967|NCT02924376|582657409|FG003|Overall Study|Progressive Disease|0|||
161347968|NCT02924376|582657406|FG000|Overall Study|Death|73|||
161347969|NCT02924376|582657407|FG001|Overall Study|Death|18|||
161347970|NCT02924376|582657408|FG002|Overall Study|Death|15|||
161347971|NCT02924376|582657409|FG003|Overall Study|Death|2|||
161347972|NCT02924376|582657406|FG000|Overall Study|Lost to Follow-up|3|||
161347973|NCT02924376|582657407|FG001|Overall Study|Lost to Follow-up|0|||
161347974|NCT02924376|582657408|FG002|Overall Study|Lost to Follow-up|0|||
161347975|NCT02924376|582657409|FG003|Overall Study|Lost to Follow-up|0|||
161183404|NCT02623699|582049008|FG007|Part B (Up to 289 Days)|Death|0|||
161183405|NCT02623699|582049009|FG008|Part B (Up to 289 Days)|Death|1|||
161183406|NCT02623699|582049010|FG009|Part B (Up to 289 Days)|Death|0|||
161302400|NCT02553499|582487529|FG004|Overall Study|Progressive Disease|1|||
161302401|NCT02553499|582487530|FG005|Overall Study|Progressive Disease|1|||
161302402|NCT02553499|582487531|FG006|Overall Study|Progressive Disease|1|||
161302403|NCT02553499|582487532|FG007|Overall Study|Progressive Disease|0|||
161302404|NCT02553499|582487533|FG008|Overall Study|Progressive Disease|0|||
161302405|NCT02553499|582487534|FG009|Overall Study|Progressive Disease|1|||
161302406|NCT02553499|582487535|FG010|Overall Study|Progressive Disease|0|||
161302407|NCT02553499|582487536|FG011|Overall Study|Progressive Disease|0|||
161302408|NCT02553499|582487537|FG012|Overall Study|Progressive Disease|2|||
161302409|NCT02553499|582487538|FG013|Overall Study|Progressive Disease|1|||
161302410|NCT02553499|582487525|FG000|Overall Study|Study Terminated by Sponsor|0|||
161302411|NCT02553499|582487526|FG001|Overall Study|Study Terminated by Sponsor|0|||
161302412|NCT02553499|582487527|FG002|Overall Study|Study Terminated by Sponsor|0|||
161302413|NCT02553499|582487528|FG003|Overall Study|Study Terminated by Sponsor|0|||
161302414|NCT02553499|582487529|FG004|Overall Study|Study Terminated by Sponsor|0|||
161302415|NCT02553499|582487530|FG005|Overall Study|Study Terminated by Sponsor|0|||
161302416|NCT02553499|582487531|FG006|Overall Study|Study Terminated by Sponsor|0|||
161302417|NCT02553499|582487532|FG007|Overall Study|Study Terminated by Sponsor|0|||
161302418|NCT02553499|582487533|FG008|Overall Study|Study Terminated by Sponsor|1|||
161302419|NCT02553499|582487534|FG009|Overall Study|Study Terminated by Sponsor|0|||
161302420|NCT02553499|582487535|FG010|Overall Study|Study Terminated by Sponsor|0|||
161302421|NCT02553499|582487536|FG011|Overall Study|Study Terminated by Sponsor|0|||
161302422|NCT02553499|582487537|FG012|Overall Study|Study Terminated by Sponsor|0|||
161302423|NCT02553499|582487538|FG013|Overall Study|Study Terminated by Sponsor|0|||
161302424|NCT02553499|582487525|FG000|Overall Study|Withdrawal by Subject|2|||
161302425|NCT02553499|582487526|FG001|Overall Study|Withdrawal by Subject|0|||
161302426|NCT02553499|582487527|FG002|Overall Study|Withdrawal by Subject|0|||
161302427|NCT02553499|582487528|FG003|Overall Study|Withdrawal by Subject|0|||
161302428|NCT02553499|582487529|FG004|Overall Study|Withdrawal by Subject|0|||
161302429|NCT02553499|582487530|FG005|Overall Study|Withdrawal by Subject|0|||
161302430|NCT02553499|582487531|FG006|Overall Study|Withdrawal by Subject|0|||
161183407|NCT02623699|582049011|FG010|Part B (Up to 289 Days)|Death|0|||
161183408|NCT02623699|582049012|FG011|Part B (Up to 289 Days)|Death|0|||
161302431|NCT02553499|582487532|FG007|Overall Study|Withdrawal by Subject|1|||
161302432|NCT02553499|582487533|FG008|Overall Study|Withdrawal by Subject|1|||
161302433|NCT02553499|582487534|FG009|Overall Study|Withdrawal by Subject|0|||
161302434|NCT02553499|582487535|FG010|Overall Study|Withdrawal by Subject|1|||
161302435|NCT02553499|582487536|FG011|Overall Study|Withdrawal by Subject|0|||
161183409|NCT02623699|582049001|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
161183410|NCT02623699|582049002|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
161183411|NCT02623699|582049003|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
161183412|NCT02623699|582049004|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
161183413|NCT02623699|582049005|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
161347976|NCT02924376|582657406|FG000|Overall Study|Study Terminated by Sponsor|19|||
161347977|NCT02924376|582657407|FG001|Overall Study|Study Terminated by Sponsor|0|||
161302436|NCT02553499|582487537|FG012|Overall Study|Withdrawal by Subject|0|||
161302437|NCT02553499|582487538|FG013|Overall Study|Withdrawal by Subject|0|||
161302438|NCT00570063|582487539|FG000|Overall Study|Adverse Event|4|||
161302439|NCT00570063|582487540|FG001|Overall Study|Adverse Event|1|||
161302440|NCT00570063|582487539|FG000|Overall Study|Lack of Efficacy|0|||
161302441|NCT00570063|582487540|FG001|Overall Study|Lack of Efficacy|1|||
161302442|NCT00570063|582487539|FG000|Overall Study|Withdrawal by Subject|4|||
161302443|NCT00570063|582487540|FG001|Overall Study|Withdrawal by Subject|3|||
161302444|NCT00570063|582487539|FG000|Overall Study|Sponsor's Decision|7|||
161302445|NCT00570063|582487540|FG001|Overall Study|Sponsor's Decision|3|||
161302446|NCT00550043|582487544|FG000|Overall Study|Adverse Event|0|||
161302447|NCT00550043|582487545|FG001|Overall Study|Adverse Event|0|||
161302448|NCT00550043|582487546|FG002|Overall Study|Adverse Event|0|||
161302449|NCT00550043|582487547|FG003|Overall Study|Adverse Event|1|||
161302450|NCT00550043|582487548|FG004|Overall Study|Adverse Event|1|||
161302451|NCT00550043|582487544|FG000|Overall Study|Subject Withdrew Consent|0|||
161302452|NCT00550043|582487545|FG001|Overall Study|Subject Withdrew Consent|2|||
161302453|NCT00550043|582487546|FG002|Overall Study|Subject Withdrew Consent|1|||
161302454|NCT00550043|582487547|FG003|Overall Study|Subject Withdrew Consent|0|||
161302455|NCT00550043|582487548|FG004|Overall Study|Subject Withdrew Consent|0|||
161302456|NCT00550043|582487544|FG000|Overall Study|Other Reasons- Unspecified|0|||
161302457|NCT00550043|582487545|FG001|Overall Study|Other Reasons- Unspecified|1|||
161302458|NCT00550043|582487546|FG002|Overall Study|Other Reasons- Unspecified|0|||
161302459|NCT00550043|582487547|FG003|Overall Study|Other Reasons- Unspecified|1|||
161302460|NCT00550043|582487548|FG004|Overall Study|Other Reasons- Unspecified|0|||
161302461|NCT00789698|582487552|FG000|Overall Study|Lack of Efficacy|10|||
161302462|NCT00789698|582487553|FG001|Overall Study|Lack of Efficacy|4|||
161302463|NCT00789698|582487554|FG002|Overall Study|Lack of Efficacy|5|||
161302464|NCT00789698|582487555|FG003|Overall Study|Lack of Efficacy|18|||
161302465|NCT00789698|582487552|FG000|Overall Study|Adverse Event|5|||
161302466|NCT00789698|582487553|FG001|Overall Study|Adverse Event|5|||
161302467|NCT00789698|582487554|FG002|Overall Study|Adverse Event|3|||
161302468|NCT00789698|582487555|FG003|Overall Study|Adverse Event|4|||
161302469|NCT00789698|582487552|FG000|Overall Study|Lost to Follow-up|5|||
161302470|NCT00789698|582487553|FG001|Overall Study|Lost to Follow-up|5|||
161302471|NCT00789698|582487554|FG002|Overall Study|Lost to Follow-up|2|||
161302472|NCT00789698|582487555|FG003|Overall Study|Lost to Follow-up|9|||
161302473|NCT00789698|582487552|FG000|Overall Study|Protocol Violation|6|||
161302474|NCT00789698|582487553|FG001|Overall Study|Protocol Violation|1|||
161302475|NCT00789698|582487554|FG002|Overall Study|Protocol Violation|2|||
161302476|NCT00789698|582487555|FG003|Overall Study|Protocol Violation|1|||
161302477|NCT00789698|582487552|FG000|Overall Study|Withdrawal by Subject|14|||
161302478|NCT00789698|582487553|FG001|Overall Study|Withdrawal by Subject|15|||
161302479|NCT00789698|582487554|FG002|Overall Study|Withdrawal by Subject|12|||
161302480|NCT00789698|582487555|FG003|Overall Study|Withdrawal by Subject|19|||
161302481|NCT00789698|582487552|FG000|Overall Study|Administrative|0|||
161302482|NCT00789698|582487553|FG001|Overall Study|Administrative|3|||
161302483|NCT00789698|582487554|FG002|Overall Study|Administrative|3|||
161302484|NCT00789698|582487555|FG003|Overall Study|Administrative|1|||
161302485|NCT03693612|582489976|FG000|Overall Study|Lost to Follow-up|0|||
161302486|NCT03693612|582489977|FG001|Overall Study|Lost to Follow-up|0|||
161302487|NCT03693612|582489978|FG002|Overall Study|Lost to Follow-up|0|||
161302488|NCT03693612|582489979|FG003|Overall Study|Lost to Follow-up|0|||
161302489|NCT03693612|582489980|FG004|Overall Study|Lost to Follow-up|1|||
161302490|NCT03693612|582489981|FG005|Overall Study|Lost to Follow-up|0|||
161302491|NCT03693612|582489982|FG006|Overall Study|Lost to Follow-up|0|||
161302492|NCT03693612|582489976|FG000|Overall Study|Withdrawal by Subject|0|||
161302493|NCT03693612|582489977|FG001|Overall Study|Withdrawal by Subject|0|||
161302494|NCT03693612|582489978|FG002|Overall Study|Withdrawal by Subject|1|||
161302495|NCT03693612|582489979|FG003|Overall Study|Withdrawal by Subject|0|||
161302496|NCT03693612|582489980|FG004|Overall Study|Withdrawal by Subject|2|||
161302497|NCT03693612|582489981|FG005|Overall Study|Withdrawal by Subject|0|||
161302498|NCT03693612|582489982|FG006|Overall Study|Withdrawal by Subject|0|||
161302499|NCT03693612|582489976|FG000|Overall Study|Study Terminated by Sponsor|0|||
161302500|NCT03693612|582489977|FG001|Overall Study|Study Terminated by Sponsor|1|||
161302501|NCT03693612|582489978|FG002|Overall Study|Study Terminated by Sponsor|0|||
161302502|NCT03693612|582489979|FG003|Overall Study|Study Terminated by Sponsor|0|||
161347978|NCT02924376|582657408|FG002|Overall Study|Study Terminated by Sponsor|0|||
161302503|NCT03693612|582489980|FG004|Overall Study|Study Terminated by Sponsor|3|||
161302504|NCT03693612|582489981|FG005|Overall Study|Study Terminated by Sponsor|0|||
161302505|NCT03693612|582489982|FG006|Overall Study|Study Terminated by Sponsor|0|||
161302506|NCT03962790|582489983|FG000|Period 1|Adverse Event|0|||
161302507|NCT03962790|582489984|FG001|Period 1|Adverse Event|1|||
161302508|NCT03962790|582489983|FG000|Period 1|Failed to meet all eligibility criteria|1|||
161302509|NCT03962790|582489984|FG001|Period 1|Failed to meet all eligibility criteria|1|||
161302510|NCT03962790|582489983|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
161302511|NCT03962790|582489984|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
161302512|NCT03962790|582489983|FG000|Period 1|Withdrawal by Subject|1|||
161302513|NCT03962790|582489984|FG001|Period 1|Withdrawal by Subject|0|||
161302514|NCT01608087|582489990|FG000|Overall Study|Lost to Follow-up|0|||
161302515|NCT01608087|582489991|FG001|Overall Study|Lost to Follow-up|1|||
161302516|NCT01608087|582489992|FG002|Overall Study|Lost to Follow-up|0|||
161302517|NCT01608087|582489990|FG000|Overall Study|Other Reason|0|||
161302518|NCT01608087|582489991|FG001|Overall Study|Other Reason|1|||
161302519|NCT01608087|582489992|FG002|Overall Study|Other Reason|0|||
161302520|NCT00664859|582490001|FG000|Overall Study|Adverse Event|2|||
161302521|NCT00664859|582490002|FG001|Overall Study|Adverse Event|1|||
161302522|NCT00664859|582490003|FG002|Overall Study|Adverse Event|3|||
161302523|NCT00664859|582490001|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
161302524|NCT00664859|582490002|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
161302525|NCT00664859|582490003|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
161302526|NCT00664859|582490001|FG000|Overall Study|Noncompliance with protocol|1|||
161302527|NCT00664859|582490002|FG001|Overall Study|Noncompliance with protocol|0|||
161302528|NCT00664859|582490003|FG002|Overall Study|Noncompliance with protocol|4|||
161302529|NCT00664859|582490001|FG000|Overall Study|Laboratory abnormality|2|||
161302530|NCT00664859|582490002|FG001|Overall Study|Laboratory abnormality|1|||
161302531|NCT00664859|582490003|FG002|Overall Study|Laboratory abnormality|4|||
161302532|NCT00664859|582490001|FG000|Overall Study|Withdrawal by Subject|4|||
161302533|NCT00664859|582490002|FG001|Overall Study|Withdrawal by Subject|1|||
161302534|NCT00664859|582490003|FG002|Overall Study|Withdrawal by Subject|3|||
161302535|NCT00664859|582490001|FG000|Overall Study|Lost to Follow-up|2|||
161302536|NCT00664859|582490002|FG001|Overall Study|Lost to Follow-up|2|||
161302537|NCT00664859|582490003|FG002|Overall Study|Lost to Follow-up|1|||
161302538|NCT00664859|582490001|FG000|Overall Study|Other|0|||
161302539|NCT00664859|582490002|FG001|Overall Study|Other|1|||
161302540|NCT00664859|582490003|FG002|Overall Study|Other|2|||
161302541|NCT01943851|582490004|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302542|NCT01943851|582490005|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302543|NCT01943851|582490006|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302544|NCT01943851|582490007|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161302545|NCT01943851|582490008|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302546|NCT01943851|582490009|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302547|NCT01943851|582490010|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161302548|NCT01943851|582490011|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161302549|NCT01943851|582490012|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
161302550|NCT01943851|582490013|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302551|NCT01943851|582490014|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302552|NCT01943851|582490015|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302553|NCT01943851|582490016|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302554|NCT01943851|582490017|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302555|NCT01943851|582490018|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302556|NCT01943851|582490019|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302557|NCT01943851|582490020|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302558|NCT01943851|582490021|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
161302559|NCT01943851|582490004|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302560|NCT01943851|582490005|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302561|NCT01943851|582490006|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302562|NCT01943851|582490007|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302563|NCT01943851|582490008|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
161302564|NCT01943851|582490009|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302565|NCT01943851|582490010|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302566|NCT01943851|582490011|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
161302567|NCT01943851|582490012|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302568|NCT01943851|582490013|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302569|NCT01943851|582490014|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302570|NCT01943851|582490015|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302571|NCT01943851|582490016|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302572|NCT01943851|582490017|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302573|NCT01943851|582490018|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302574|NCT01943851|582490019|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302575|NCT01943851|582490020|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302576|NCT01943851|582490021|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
161302577|NCT01943851|582490004|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302578|NCT01943851|582490005|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302579|NCT01943851|582490006|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302580|NCT01943851|582490007|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302581|NCT01943851|582490008|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302582|NCT01943851|582490009|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302583|NCT01943851|582490010|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302584|NCT01943851|582490011|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302585|NCT01943851|582490012|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161183414|NCT02623699|582049006|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
161183415|NCT02623699|582049007|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
161183416|NCT02623699|582049008|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
161183417|NCT02623699|582049009|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
161183418|NCT02623699|582049010|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
161183419|NCT02623699|582049011|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
161183420|NCT02623699|582049012|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
161183421|NCT02623699|582049001|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183422|NCT02623699|582049002|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183423|NCT02623699|582049003|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183424|NCT02623699|582049004|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183425|NCT02623699|582049005|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183426|NCT02623699|582049006|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183427|NCT02623699|582049007|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183428|NCT02623699|582049008|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183429|NCT02623699|582049009|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183430|NCT02623699|582049010|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
161183431|NCT02623699|582049011|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
161183432|NCT02623699|582049012|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
161183433|NCT02623699|582049001|FG000|Part C (Up to 236 Days)|Death|0|||
161183434|NCT02623699|582049002|FG001|Part C (Up to 236 Days)|Death|0|||
161183435|NCT02623699|582049003|FG002|Part C (Up to 236 Days)|Death|0|||
161183436|NCT02623699|582049004|FG003|Part C (Up to 236 Days)|Death|0|||
161183437|NCT02623699|582049005|FG004|Part C (Up to 236 Days)|Death|0|||
161183438|NCT02623699|582049006|FG005|Part C (Up to 236 Days)|Death|0|||
161183439|NCT02623699|582049007|FG006|Part C (Up to 236 Days)|Death|0|||
161183440|NCT02623699|582049008|FG007|Part C (Up to 236 Days)|Death|0|||
161183441|NCT02623699|582049009|FG008|Part C (Up to 236 Days)|Death|0|||
161183442|NCT02623699|582049010|FG009|Part C (Up to 236 Days)|Death|0|||
161183443|NCT02623699|582049011|FG010|Part C (Up to 236 Days)|Death|0|||
161183444|NCT02623699|582049012|FG011|Part C (Up to 236 Days)|Death|1|||
161183445|NCT02623699|582049001|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
161183446|NCT02623699|582049002|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
161183447|NCT02623699|582049003|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
161183448|NCT02623699|582049004|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
161183449|NCT02623699|582049005|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
161183450|NCT02623699|582049006|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
161183451|NCT02623699|582049007|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
161183452|NCT02623699|582049008|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
161183453|NCT02623699|582049009|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
161183454|NCT02623699|582049010|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
161183455|NCT02623699|582049011|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
161183456|NCT02623699|582049012|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
161183457|NCT00592072|582049013|FG000|Wash Out Period|Lost to Follow-up|1|||
161183458|NCT00592072|582049014|FG001|Wash Out Period|Lost to Follow-up|1|||
161183459|NCT05333289|582049015|FG000|Overall Study|Other|1|||
161183460|NCT05333289|582049016|FG001|Overall Study|Other|0|||
161183461|NCT05333289|582049017|FG002|Overall Study|Other|0|||
161183462|NCT05333289|582049018|FG003|Overall Study|Other|1|||
161183463|NCT05333289|582049019|FG004|Overall Study|Other|1|||
161183464|NCT05333289|582049020|FG005|Overall Study|Other|2|||
161183465|NCT05333289|582049021|FG006|Overall Study|Other|2|||
161183466|NCT05333289|582049022|FG007|Overall Study|Other|0|||
161183467|NCT05333289|582049015|FG000|Overall Study|Withdrawal by Subject|1|||
161183468|NCT05333289|582049016|FG001|Overall Study|Withdrawal by Subject|2|||
161183469|NCT05333289|582049017|FG002|Overall Study|Withdrawal by Subject|2|||
161183470|NCT05333289|582049018|FG003|Overall Study|Withdrawal by Subject|1|||
161183471|NCT05333289|582049019|FG004|Overall Study|Withdrawal by Subject|1|||
161183472|NCT05333289|582049020|FG005|Overall Study|Withdrawal by Subject|2|||
161183473|NCT05333289|582049021|FG006|Overall Study|Withdrawal by Subject|1|||
161183474|NCT05333289|582049022|FG007|Overall Study|Withdrawal by Subject|3|||
161183475|NCT05333289|582049015|FG000|Overall Study|Protocol Violation|1|||
161183476|NCT05333289|582049016|FG001|Overall Study|Protocol Violation|0|||
161183477|NCT05333289|582049017|FG002|Overall Study|Protocol Violation|0|||
161183478|NCT05333289|582049018|FG003|Overall Study|Protocol Violation|0|||
161183479|NCT05333289|582049019|FG004|Overall Study|Protocol Violation|0|||
161302586|NCT01943851|582490013|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302587|NCT01943851|582490014|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302588|NCT01943851|582490015|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161183480|NCT05333289|582049020|FG005|Overall Study|Protocol Violation|0|||
161183481|NCT05333289|582049021|FG006|Overall Study|Protocol Violation|0|||
161183482|NCT05333289|582049022|FG007|Overall Study|Protocol Violation|0|||
161183483|NCT05333289|582049015|FG000|Overall Study|Physician Decision|0|||
161183484|NCT05333289|582049016|FG001|Overall Study|Physician Decision|0|||
161183485|NCT05333289|582049017|FG002|Overall Study|Physician Decision|1|||
161183486|NCT05333289|582049018|FG003|Overall Study|Physician Decision|0|||
161183487|NCT05333289|582049019|FG004|Overall Study|Physician Decision|0|||
161183488|NCT05333289|582049020|FG005|Overall Study|Physician Decision|2|||
161183489|NCT05333289|582049021|FG006|Overall Study|Physician Decision|0|||
161183490|NCT05333289|582049022|FG007|Overall Study|Physician Decision|0|||
161183491|NCT05333289|582049015|FG000|Overall Study|Lost to Follow-up|6|||
161183492|NCT05333289|582049016|FG001|Overall Study|Lost to Follow-up|0|||
161183493|NCT05333289|582049017|FG002|Overall Study|Lost to Follow-up|1|||
161183494|NCT05333289|582049018|FG003|Overall Study|Lost to Follow-up|6|||
161183495|NCT05333289|582049019|FG004|Overall Study|Lost to Follow-up|3|||
161183496|NCT05333289|582049020|FG005|Overall Study|Lost to Follow-up|3|||
161183497|NCT05333289|582049021|FG006|Overall Study|Lost to Follow-up|2|||
161183498|NCT05333289|582049022|FG007|Overall Study|Lost to Follow-up|1|||
161183499|NCT05333289|582049015|FG000|Overall Study|Death|1|||
161183500|NCT05333289|582049016|FG001|Overall Study|Death|0|||
161183501|NCT05333289|582049017|FG002|Overall Study|Death|0|||
161183502|NCT05333289|582049018|FG003|Overall Study|Death|0|||
161183503|NCT05333289|582049019|FG004|Overall Study|Death|0|||
161183504|NCT05333289|582049020|FG005|Overall Study|Death|0|||
161183505|NCT05333289|582049021|FG006|Overall Study|Death|0|||
161183506|NCT05333289|582049022|FG007|Overall Study|Death|0|||
161183507|NCT00772889|582049023|FG000|Overall Study|Adverse Event|7|||
161183508|NCT00772889|582049024|FG001|Overall Study|Adverse Event|4|||
161183509|NCT00772889|582049025|FG002|Overall Study|Adverse Event|0|||
161183510|NCT00772889|582049023|FG000|Overall Study|Withdrawal by Subject|9|||
161183511|NCT00772889|582049024|FG001|Overall Study|Withdrawal by Subject|8|||
161183512|NCT00772889|582049025|FG002|Overall Study|Withdrawal by Subject|9|||
161183513|NCT00772889|582049023|FG000|Overall Study|Lost to Follow-up|6|||
161183514|NCT00772889|582049024|FG001|Overall Study|Lost to Follow-up|6|||
161183515|NCT00772889|582049025|FG002|Overall Study|Lost to Follow-up|7|||
161183516|NCT02750501|582049026|FG000|Overall Study|Adverse Event|4|||
161183517|NCT02750501|582049026|FG000|Overall Study|Physician Decision|1|||
161183518|NCT02750501|582049026|FG000|Overall Study|Protocol Violation|1|||
161183519|NCT02750501|582049026|FG000|Overall Study|G-tube came out|1|||
161183520|NCT02750501|582049026|FG000|Overall Study|Non-compliant use of PERT|1|||
161183521|NCT01738594|582049028|FG000|Registration and Treatment Start|Adverse Event|0|||
161183522|NCT01738594|582049029|FG001|Registration and Treatment Start|Adverse Event|1|||
161183523|NCT01738594|582049030|FG002|Registration and Treatment Start|Adverse Event|0|||
161183524|NCT01738594|582049031|FG003|Registration and Treatment Start|Adverse Event|0|||
161183525|NCT01738594|582049032|FG004|Registration and Treatment Start|Adverse Event|0|||
161183526|NCT01738594|582049033|FG005|Registration and Treatment Start|Adverse Event|0|||
161183527|NCT01738594|582049034|FG006|Registration and Treatment Start|Adverse Event|0|||
161183528|NCT01738594|582049035|FG007|Registration and Treatment Start|Adverse Event|0|||
161183529|NCT01738594|582049028|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183530|NCT01738594|582049029|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183531|NCT01738594|582049030|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183532|NCT01738594|582049031|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183533|NCT01738594|582049032|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183534|NCT01738594|582049033|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
161183535|NCT01738594|582049034|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183536|NCT01738594|582049035|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
161183537|NCT01738594|582049028|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183538|NCT01738594|582049029|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
161183539|NCT01738594|582049030|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183540|NCT01738594|582049031|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183541|NCT01738594|582049032|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183542|NCT01738594|582049033|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183543|NCT01738594|582049034|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183544|NCT01738594|582049035|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
161183545|NCT01738594|582049028|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161302589|NCT01943851|582490016|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302590|NCT01943851|582490017|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
161302591|NCT01943851|582490018|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302592|NCT01943851|582490019|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302593|NCT01943851|582490020|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161302594|NCT01943851|582490021|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
161183546|NCT01738594|582049029|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161183547|NCT01738594|582049030|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161183548|NCT01738594|582049031|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161183549|NCT01738594|582049032|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161302595|NCT01943851|582490004|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161183550|NCT01738594|582049033|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
161183551|NCT01738594|582049034|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161183552|NCT01738594|582049035|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
161302596|NCT01943851|582490005|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302597|NCT01943851|582490006|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302598|NCT01943851|582490007|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302599|NCT01943851|582490008|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302600|NCT01943851|582490009|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302601|NCT01943851|582490010|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302602|NCT01943851|582490011|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302603|NCT01943851|582490012|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302604|NCT01943851|582490013|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302605|NCT01943851|582490014|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302606|NCT01943851|582490015|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302607|NCT01943851|582490016|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302608|NCT01943851|582490017|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302609|NCT01943851|582490018|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302610|NCT01943851|582490019|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
161302611|NCT01943851|582490020|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302612|NCT01943851|582490021|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
161302613|NCT01943851|582490004|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302614|NCT01943851|582490005|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302615|NCT01943851|582490006|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302616|NCT01943851|582490007|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302617|NCT01943851|582490008|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302618|NCT01943851|582490009|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302619|NCT01943851|582490010|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302620|NCT01943851|582490011|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302621|NCT01943851|582490012|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302622|NCT01943851|582490013|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302623|NCT01943851|582490014|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302624|NCT01943851|582490015|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302625|NCT01943851|582490016|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302626|NCT01943851|582490017|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302627|NCT01943851|582490018|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
161302628|NCT01943851|582490019|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
161302629|NCT01943851|582490020|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
161302630|NCT01943851|582490021|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
161302631|NCT00401544|582490027|FG000|Overall Study|Adverse Event|5|||
161302632|NCT00401544|582490028|FG001|Overall Study|Adverse Event|1|||
161302633|NCT00401544|582490029|FG002|Overall Study|Adverse Event|1|||
161302634|NCT00401544|582490030|FG003|Overall Study|Adverse Event|1|||
161302635|NCT00401544|582490027|FG000|Overall Study|Death|3|||
161302636|NCT00401544|582490028|FG001|Overall Study|Death|6|||
161302637|NCT00401544|582490029|FG002|Overall Study|Death|2|||
161302638|NCT00401544|582490030|FG003|Overall Study|Death|5|||
161302639|NCT00401544|582490027|FG000|Overall Study|Lost to Follow-up|2|||
161302640|NCT00401544|582490028|FG001|Overall Study|Lost to Follow-up|0|||
161302641|NCT00401544|582490029|FG002|Overall Study|Lost to Follow-up|1|||
161302642|NCT00401544|582490030|FG003|Overall Study|Lost to Follow-up|1|||
161302643|NCT00401544|582490027|FG000|Overall Study|Withdrawal by Subject|7|||
161302644|NCT00401544|582490028|FG001|Overall Study|Withdrawal by Subject|6|||
161302645|NCT00401544|582490029|FG002|Overall Study|Withdrawal by Subject|6|||
161302646|NCT00401544|582490030|FG003|Overall Study|Withdrawal by Subject|5|||
161302647|NCT00401544|582490027|FG000|Overall Study|Physician Decision|1|||
161302648|NCT00401544|582490028|FG001|Overall Study|Physician Decision|3|||
161302649|NCT00401544|582490029|FG002|Overall Study|Physician Decision|0|||
161302650|NCT00401544|582490030|FG003|Overall Study|Physician Decision|0|||
161302651|NCT00401544|582490027|FG000|Overall Study|Ineligibility determined|0|||
161302652|NCT00401544|582490028|FG001|Overall Study|Ineligibility determined|1|||
161302653|NCT00401544|582490029|FG002|Overall Study|Ineligibility determined|0|||
161302654|NCT00401544|582490030|FG003|Overall Study|Ineligibility determined|2|||
161302655|NCT00401544|582490027|FG000|Overall Study|Disease progression|0|||
161302656|NCT00401544|582490028|FG001|Overall Study|Disease progression|1|||
161302657|NCT00401544|582490029|FG002|Overall Study|Disease progression|0|||
161302658|NCT00401544|582490030|FG003|Overall Study|Disease progression|0|||
161302659|NCT00401544|582490027|FG000|Overall Study|Other|0|||
161302660|NCT00401544|582490028|FG001|Overall Study|Other|0|||
161302661|NCT00401544|582490029|FG002|Overall Study|Other|2|||
161302662|NCT00401544|582490030|FG003|Overall Study|Other|2|||
161302663|NCT00280397|582490032|FG000|Overall Study|Adverse Event|1|||
161302664|NCT01250873|582490033|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
161302665|NCT01250873|582490033|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
161302666|NCT00930774|582490034|FG000|Overall Study|Withdrawal by Subject|1|||
161302667|NCT00930774|582490035|FG001|Overall Study|Withdrawal by Subject|9|||
161302668|NCT00930774|582490036|FG002|Overall Study|Withdrawal by Subject|2|||
161302669|NCT00930774|582490037|FG003|Overall Study|Withdrawal by Subject|0|||
161302670|NCT03200704|582490038|FG000|Overall Study|Withdrawal by Subject|1|||
161302671|NCT00425061|582490039|FG000|Overall Study|Adverse Event|1|||
161302672|NCT00425061|582490040|FG001|Overall Study|Adverse Event|0|||
161302673|NCT00425061|582490041|FG002|Overall Study|Adverse Event|0|||
161302674|NCT00425061|582490042|FG003|Overall Study|Adverse Event|2|||
161302675|NCT00425061|582490043|FG004|Overall Study|Adverse Event|2|||
161302676|NCT00425061|582490044|FG005|Overall Study|Adverse Event|0|||
161302677|NCT00425061|582490045|FG006|Overall Study|Adverse Event|0|||
161302678|NCT00425061|582490039|FG000|Overall Study|Lost to Follow-up|0|||
161302679|NCT00425061|582490040|FG001|Overall Study|Lost to Follow-up|1|||
161302680|NCT00425061|582490041|FG002|Overall Study|Lost to Follow-up|0|||
161302681|NCT00425061|582490042|FG003|Overall Study|Lost to Follow-up|0|||
161302682|NCT00425061|582490043|FG004|Overall Study|Lost to Follow-up|0|||
161302683|NCT00425061|582490044|FG005|Overall Study|Lost to Follow-up|0|||
161302684|NCT00425061|582490045|FG006|Overall Study|Lost to Follow-up|0|||
161302685|NCT00425061|582490039|FG000|Overall Study|Protocol Violation|1|||
161302686|NCT00425061|582490040|FG001|Overall Study|Protocol Violation|0|||
161302687|NCT00425061|582490041|FG002|Overall Study|Protocol Violation|0|||
161302688|NCT00425061|582490042|FG003|Overall Study|Protocol Violation|0|||
161302689|NCT00425061|582490043|FG004|Overall Study|Protocol Violation|0|||
161302690|NCT00425061|582490044|FG005|Overall Study|Protocol Violation|0|||
161302691|NCT00425061|582490045|FG006|Overall Study|Protocol Violation|0|||
161302692|NCT00425061|582490039|FG000|Overall Study|Withdrawal by Subject|0|||
161302693|NCT00425061|582490040|FG001|Overall Study|Withdrawal by Subject|1|||
161302694|NCT00425061|582490041|FG002|Overall Study|Withdrawal by Subject|0|||
161302695|NCT00425061|582490042|FG003|Overall Study|Withdrawal by Subject|0|||
161302696|NCT00425061|582490043|FG004|Overall Study|Withdrawal by Subject|1|||
161302697|NCT00425061|582490044|FG005|Overall Study|Withdrawal by Subject|0|||
161302698|NCT00425061|582490045|FG006|Overall Study|Withdrawal by Subject|3|||
161302699|NCT00425061|582490039|FG000|Overall Study|Sponsor's request|0|||
161302700|NCT00425061|582490040|FG001|Overall Study|Sponsor's request|0|||
161302701|NCT00425061|582490041|FG002|Overall Study|Sponsor's request|0|||
161302702|NCT00425061|582490042|FG003|Overall Study|Sponsor's request|0|||
161302703|NCT00425061|582490043|FG004|Overall Study|Sponsor's request|19|||
161302704|NCT00425061|582490044|FG005|Overall Study|Sponsor's request|4|||
161302705|NCT00425061|582490045|FG006|Overall Study|Sponsor's request|15|||
161302706|NCT00425061|582490039|FG000|Overall Study|Physician Decision|0|||
161302707|NCT00425061|582490040|FG001|Overall Study|Physician Decision|0|||
161302708|NCT00425061|582490041|FG002|Overall Study|Physician Decision|0|||
161302709|NCT00425061|582490042|FG003|Overall Study|Physician Decision|0|||
161302710|NCT00425061|582490043|FG004|Overall Study|Physician Decision|1|||
161302711|NCT00425061|582490044|FG005|Overall Study|Physician Decision|0|||
161302712|NCT00425061|582490045|FG006|Overall Study|Physician Decision|0|||
161302713|NCT00425061|582490039|FG000|Overall Study|Other|0|||
161302714|NCT00425061|582490040|FG001|Overall Study|Other|0|||
161302715|NCT00425061|582490041|FG002|Overall Study|Other|0|||
161302716|NCT00425061|582490042|FG003|Overall Study|Other|0|||
161302717|NCT00425061|582490043|FG004|Overall Study|Other|3|||
161302718|NCT00425061|582490044|FG005|Overall Study|Other|0|||
161302719|NCT00425061|582490045|FG006|Overall Study|Other|1|||
161302720|NCT04967885|582490046|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
161302721|NCT04967885|582490047|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
161347979|NCT02924376|582657409|FG003|Overall Study|Study Terminated by Sponsor|0|||
161347980|NCT02924376|582657406|FG000|Overall Study|Physician Decision|1|||
161347981|NCT02924376|582657407|FG001|Overall Study|Physician Decision|0|||
161347982|NCT02924376|582657408|FG002|Overall Study|Physician Decision|0|||
161183553|NCT01738594|582049028|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183554|NCT01738594|582049029|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183555|NCT01738594|582049030|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183556|NCT01738594|582049031|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183557|NCT01738594|582049032|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183558|NCT01738594|582049033|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
161302722|NCT04967885|582490046|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
161302723|NCT04967885|582490047|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
161302724|NCT04967885|582490046|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
161302725|NCT04967885|582490047|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
161302726|NCT04967885|582490046|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
161302727|NCT04967885|582490047|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
161302728|NCT04967885|582490046|FG000|EMI-II Intervention|Lost to Follow-up|14|||
161302729|NCT04967885|582490047|FG001|EMI-II Intervention|Lost to Follow-up|10|||
161302730|NCT01940887|582490053|FG000|Year 1|Protocol Violation|0|||
161302731|NCT01940887|582490054|FG001|Year 1|Protocol Violation|1|||
161302732|NCT01940887|582490053|FG000|Year 1|Physician Decision|7|||
161302733|NCT01940887|582490054|FG001|Year 1|Physician Decision|3|||
161302734|NCT01940887|582490053|FG000|Year 1|Death|5|||
161302735|NCT01940887|582490054|FG001|Year 1|Death|3|||
161302736|NCT01940887|582490053|FG000|Year 1|Adverse Event|7|||
161302737|NCT01940887|582490054|FG001|Year 1|Adverse Event|6|||
161302738|NCT01940887|582490053|FG000|Year 1|Withdrawal by Subject|18|||
161302739|NCT01940887|582490054|FG001|Year 1|Withdrawal by Subject|9|||
161302740|NCT01940887|582490053|FG000|Year 1|Lost to Follow-up|2|||
161183559|NCT01738594|582049034|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183560|NCT01738594|582049035|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
161183561|NCT01738594|582049028|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183562|NCT01738594|582049029|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183563|NCT01738594|582049030|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183564|NCT01738594|582049031|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183565|NCT01738594|582049032|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
161183566|NCT01738594|582049033|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183567|NCT01738594|582049034|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183568|NCT01738594|582049035|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
161183569|NCT01738594|582049028|FG000|Follow up for 1 Year|Death|0|||
161183570|NCT01738594|582049029|FG001|Follow up for 1 Year|Death|0|||
161183571|NCT01738594|582049030|FG002|Follow up for 1 Year|Death|0|||
161183572|NCT01738594|582049031|FG003|Follow up for 1 Year|Death|0|||
161183573|NCT01738594|582049032|FG004|Follow up for 1 Year|Death|0|||
161183574|NCT01738594|582049033|FG005|Follow up for 1 Year|Death|1|||
161183575|NCT01738594|582049034|FG006|Follow up for 1 Year|Death|0|||
161183576|NCT01738594|582049035|FG007|Follow up for 1 Year|Death|0|||
161183577|NCT01738594|582049028|FG000|Follow up for 1 Year|Other|0|||
161183578|NCT01738594|582049029|FG001|Follow up for 1 Year|Other|0|||
161183579|NCT01738594|582049030|FG002|Follow up for 1 Year|Other|0|||
161183580|NCT01738594|582049031|FG003|Follow up for 1 Year|Other|0|||
161183581|NCT01738594|582049032|FG004|Follow up for 1 Year|Other|0|||
161183582|NCT01738594|582049033|FG005|Follow up for 1 Year|Other|2|||
161183583|NCT01738594|582049034|FG006|Follow up for 1 Year|Other|0|||
161183584|NCT01738594|582049035|FG007|Follow up for 1 Year|Other|0|||
161183585|NCT04430036|582049036|FG000|Safety Run in Phase|Progression of disease|2|||
161183586|NCT04107935|582049037|FG000|Overall Study|Death|1|||
161183587|NCT04107935|582049038|FG001|Overall Study|Death|0|||
161183588|NCT01842334|582049039|FG000|Overall Study|Withdrawal by Subject|3|||
161183589|NCT01842334|582049040|FG001|Overall Study|Withdrawal by Subject|3|||
161183590|NCT01842334|582049039|FG000|Overall Study|Moved away mid-study|0|||
161183591|NCT01842334|582049040|FG001|Overall Study|Moved away mid-study|1|||
161183592|NCT00376675|582049041|FG000|Overall Study|Withdrawal by Subject|9|||
161183593|NCT00376675|582049042|FG001|Overall Study|Withdrawal by Subject|2|||
161183594|NCT00376675|582049041|FG000|Overall Study|Adverse Event|10|||
161183595|NCT00376675|582049042|FG001|Overall Study|Adverse Event|5|||
161183596|NCT00376675|582049041|FG000|Overall Study|Other Reason|1|||
161183597|NCT00376675|582049042|FG001|Overall Study|Other Reason|7|||
161183598|NCT01332851|582049045|FG000|Overall Study|Withdrawal by Subject|4|||
161183599|NCT01332851|582049046|FG001|Overall Study|Withdrawal by Subject|2|||
161183600|NCT01332851|582049045|FG000|Overall Study|Lost to Follow-up|7|||
161183601|NCT01332851|582049046|FG001|Overall Study|Lost to Follow-up|11|||
161183602|NCT03796195|582049047|FG000|Overall Study|Study closed early|1|||
161183603|NCT02392468|582049048|FG000|Overall Study|Adverse Event|0|||
161183604|NCT02392468|582049049|FG001|Overall Study|Adverse Event|1|||
161183605|NCT02392468|582049050|FG002|Overall Study|Adverse Event|0|||
161183606|NCT02392468|582049051|FG003|Overall Study|Adverse Event|0|||
161183607|NCT02392468|582049052|FG004|Overall Study|Adverse Event|0|||
161183608|NCT02392468|582049053|FG005|Overall Study|Adverse Event|1|||
161183609|NCT01039428|582049054|FG000|Overall Study|Protocol Violation|1|||
161183610|NCT01039428|582049055|FG001|Overall Study|Protocol Violation|0|||
161183611|NCT01039428|582049054|FG000|Overall Study|Withdrawal by Subject|1|||
161183612|NCT01039428|582049055|FG001|Overall Study|Withdrawal by Subject|0|||
161302741|NCT01940887|582490054|FG001|Year 1|Lost to Follow-up|1|||
161302742|NCT01940887|582490053|FG000|Year 2|Physician Decision|8|||
161302743|NCT01940887|582490054|FG001|Year 2|Physician Decision|1|||
161302744|NCT01940887|582490053|FG000|Year 2|Death|0|||
161302745|NCT01940887|582490054|FG001|Year 2|Death|2|||
161302746|NCT01940887|582490053|FG000|Year 2|Sponsor Decision, early termination|192|||
161183613|NCT01313039|582049056|FG000|Overall Study|Physician Decision|1|||
161183614|NCT01313039|582049056|FG000|Overall Study|Adverse Event|1|||
161183615|NCT03630016|582049057|FG000|Overall Study|Poor Sensor Placement|1|||
161183616|NCT01678560|582049058|FG000|Overall Study|Physician Decision|4|||
161183617|NCT01678560|582049059|FG001|Overall Study|Physician Decision|4|||
161183618|NCT01678560|582049058|FG000|Overall Study|Death|0|||
161183619|NCT01678560|582049059|FG001|Overall Study|Death|1|||
161183620|NCT01678560|582049058|FG000|Overall Study|Withdrawal by Subject|0|||
161183621|NCT01678560|582049059|FG001|Overall Study|Withdrawal by Subject|1|||
161183622|NCT02201472|582049060|FG000|Overall Study|Lack of Efficacy|2|||
161183623|NCT01300767|582049061|FG000|Overall Study|Discomfort|2|||
161183624|NCT01300767|582049061|FG000|Overall Study|Biomicroscopy|1|||
161302747|NCT01940887|582490054|FG001|Year 2|Sponsor Decision, early termination|203|||
161302748|NCT01940887|582490053|FG000|Year 2|Adverse Event|8|||
161302749|NCT01940887|582490054|FG001|Year 2|Adverse Event|2|||
161302750|NCT01940887|582490053|FG000|Year 2|Withdrawal by Subject|8|||
161302751|NCT01940887|582490054|FG001|Year 2|Withdrawal by Subject|8|||
161302752|NCT01940887|582490053|FG000|Year 2|Lost to Follow-up|1|||
161183625|NCT01300767|582049061|FG000|Overall Study|Unacceptable fit|1|||
161183626|NCT01188811|582049066|FG000|Overall Study|Withdrawal by Subject|0|||
161183627|NCT01188811|582049067|FG001|Overall Study|Withdrawal by Subject|2|||
161183628|NCT01188811|582049066|FG000|Overall Study|Adverse Event|6|||
161183629|NCT01188811|582049067|FG001|Overall Study|Adverse Event|0|||
161183630|NCT00654368|582049068|FG000|Overall Study|Ineligibility determined|6|||
161183631|NCT00654368|582049069|FG001|Overall Study|Ineligibility determined|0|||
161183632|NCT00654368|582049070|FG002|Overall Study|Ineligibility determined|0|||
161183633|NCT00654368|582049068|FG000|Overall Study|Protocol deviation|3|||
161183634|NCT00654368|582049069|FG001|Overall Study|Protocol deviation|2|||
161183635|NCT00654368|582049070|FG002|Overall Study|Protocol deviation|1|||
161183636|NCT00654368|582049068|FG000|Overall Study|Non-compliance|2|||
161183637|NCT00654368|582049069|FG001|Overall Study|Non-compliance|1|||
161183638|NCT00654368|582049070|FG002|Overall Study|Non-compliance|2|||
161183639|NCT00654368|582049068|FG000|Overall Study|Withdrawal by Subject|5|||
161183640|NCT00654368|582049069|FG001|Overall Study|Withdrawal by Subject|2|||
161183641|NCT00654368|582049070|FG002|Overall Study|Withdrawal by Subject|2|||
161183642|NCT00654368|582049068|FG000|Overall Study|Disease progression|21|||
161183643|NCT00654368|582049069|FG001|Overall Study|Disease progression|31|||
161183644|NCT00654368|582049070|FG002|Overall Study|Disease progression|13|||
161183645|NCT00654368|582049068|FG000|Overall Study|Requirement for alternative therapy|1|||
161183646|NCT00654368|582049069|FG001|Overall Study|Requirement for alternative therapy|1|||
161183647|NCT00654368|582049070|FG002|Overall Study|Requirement for alternative therapy|1|||
161183648|NCT00654368|582049068|FG000|Overall Study|Physician Decision|0|||
161183649|NCT00654368|582049069|FG001|Overall Study|Physician Decision|0|||
161183650|NCT00654368|582049070|FG002|Overall Study|Physician Decision|2|||
161183651|NCT00654368|582049068|FG000|Overall Study|Death|1|||
161183652|NCT00654368|582049069|FG001|Overall Study|Death|0|||
161183653|NCT00654368|582049070|FG002|Overall Study|Death|0|||
161183654|NCT00654368|582049068|FG000|Overall Study|Pregnancy|0|||
161183655|NCT00654368|582049069|FG001|Overall Study|Pregnancy|0|||
161183656|NCT00654368|582049070|FG002|Overall Study|Pregnancy|2|||
161183657|NCT00654368|582049068|FG000|Overall Study|Other|0|||
161183658|NCT00654368|582049069|FG001|Overall Study|Other|2|||
161183659|NCT00654368|582049070|FG002|Overall Study|Other|3|||
161183660|NCT00654368|582049068|FG000|Overall Study|Adverse Event|14|||
161183661|NCT00654368|582049069|FG001|Overall Study|Adverse Event|9|||
161183662|NCT00654368|582049070|FG002|Overall Study|Adverse Event|6|||
161183663|NCT00959699|582049071|FG000|Treatment Period|Adverse Event|3|||
161183664|NCT00959699|582049072|FG001|Treatment Period|Adverse Event|13|||
161183665|NCT00959699|582049071|FG000|Treatment Period|Lack of Efficacy|15|||
161183666|NCT00959699|582049072|FG001|Treatment Period|Lack of Efficacy|6|||
161183667|NCT00959699|582049071|FG000|Treatment Period|Lost to Follow-up|0|||
161183668|NCT00959699|582049072|FG001|Treatment Period|Lost to Follow-up|1|||
161183669|NCT00959699|582049071|FG000|Treatment Period|Withdrawal by Subject|1|||
161183670|NCT00959699|582049072|FG001|Treatment Period|Withdrawal by Subject|3|||
161183671|NCT00959699|582049071|FG000|Treatment Period|Non-Compliance with Protocol|0|||
161183672|NCT00959699|582049072|FG001|Treatment Period|Non-Compliance with Protocol|1|||
161183673|NCT00959699|582049071|FG000|Treatment Period|Did not receive treatment|0|||
161183674|NCT00959699|582049072|FG001|Treatment Period|Did not receive treatment|1|||
161183675|NCT00959699|582049071|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
161183676|NCT00959699|582049072|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
161183677|NCT00959699|582049071|FG000|Follow-up Period|Lost to Follow-up|3|||
161183678|NCT00959699|582049072|FG001|Follow-up Period|Lost to Follow-up|2|||
161183679|NCT00959699|582049071|FG000|Follow-up Period|Withdrawal by Subject|3|||
161183680|NCT00959699|582049072|FG001|Follow-up Period|Withdrawal by Subject|4|||
161183681|NCT04228445|582049073|FG000|Overall Study|Lost to Follow-up|1|||
161183682|NCT04228445|582049074|FG001|Overall Study|Lost to Follow-up|1|||
161183683|NCT04228445|582049073|FG000|Overall Study|Physician Decision|1|||
161302753|NCT01940887|582490054|FG001|Year 2|Lost to Follow-up|6|||
161302754|NCT02475265|582490055|FG000|Overall Study|Physician Decision|1|||
161183684|NCT04228445|582049074|FG001|Overall Study|Physician Decision|2|||
161183685|NCT04228445|582049073|FG000|Overall Study|Withdrawal by Subject|0|||
161183686|NCT04228445|582049074|FG001|Overall Study|Withdrawal by Subject|1|||
161183687|NCT04228445|582049073|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
161183688|NCT04228445|582049074|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
161183689|NCT00606294|582049075|FG000|Overall Study|Withdrawal by Subject|36|||
161183690|NCT00606294|582049076|FG001|Overall Study|Withdrawal by Subject|0|||
161302755|NCT02475265|582490055|FG000|Overall Study|Withdrawal by Subject|2|||
161183691|NCT00471315|582049083|FG000|Overall Study|Adverse Event|7|||
161183692|NCT00471315|582049083|FG000|Overall Study|Withdrawal by Subject|1|||
161183693|NCT00609167|582049087|FG000|Overall Study|Withdrawal by Subject|1|||
161183694|NCT00609167|582049088|FG001|Overall Study|Withdrawal by Subject|0|||
161183695|NCT00609167|582049087|FG000|Overall Study|Lack of Efficacy|1|||
161183696|NCT00609167|582049088|FG001|Overall Study|Lack of Efficacy|0|||
161183697|NCT00609167|582049087|FG000|Overall Study|Adverse Event|5|||
161183698|NCT00609167|582049088|FG001|Overall Study|Adverse Event|1|||
161183699|NCT00609167|582049087|FG000|Overall Study|Disease Progression|1|||
161183700|NCT00609167|582049088|FG001|Overall Study|Disease Progression|0|||
161089564|NCT03149549|581717401|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161089565|NCT03149549|581717402|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161089566|NCT03149549|581717403|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161089567|NCT03149549|581717404|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161089568|NCT03149549|581717405|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161089569|NCT03149549|581717406|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
161089570|NCT03149549|581717407|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161089571|NCT03149549|581717408|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161089572|NCT03149549|581717409|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
161089573|NCT03149549|581717410|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
161089574|NCT03149549|581717411|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
161089575|NCT03149549|581717399|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
161089576|NCT03149549|581717400|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
161089577|NCT03149549|581717401|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
161089578|NCT03149549|581717402|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
161089579|NCT03149549|581717403|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
161089580|NCT03149549|581717404|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
161089581|NCT03149549|581717405|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
161089582|NCT03149549|581717406|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
161089583|NCT03149549|581717407|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
161089584|NCT03149549|581717408|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
161089585|NCT03149549|581717409|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
161089586|NCT03149549|581717410|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
161089587|NCT03149549|581717411|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
161089588|NCT03149549|581717399|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
161089589|NCT03149549|581717400|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
161089590|NCT03149549|581717401|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
161089591|NCT03149549|581717402|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
161089592|NCT03149549|581717403|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
161089593|NCT03149549|581717404|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
161089594|NCT03149549|581717405|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
161089595|NCT03149549|581717406|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
161089596|NCT03149549|581717407|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
161089597|NCT03149549|581717408|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
161089598|NCT03149549|581717409|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
161089599|NCT03149549|581717410|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
161089600|NCT03149549|581717411|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
161089601|NCT05917470|581717412|FG000|Overall Study|Progressive Disease|1|||
161089602|NCT05917470|581717413|FG001|Overall Study|Progressive Disease|1|||
161089603|NCT05917470|581717414|FG002|Overall Study|Progressive Disease|2|||
161089604|NCT05917470|581717415|FG003|Overall Study|Progressive Disease|3|||
161089605|NCT05917470|581717416|FG004|Overall Study|Progressive Disease|1|||
161089606|NCT05917470|581717417|FG005|Overall Study|Progressive Disease|1|||
161089607|NCT05917470|581717418|FG006|Overall Study|Progressive Disease|0|||
161089608|NCT05917470|581717419|FG007|Overall Study|Progressive Disease|0|||
161089609|NCT05917470|581717412|FG000|Overall Study|Withdrawal by Subject|0|||
161089610|NCT05917470|581717413|FG001|Overall Study|Withdrawal by Subject|0|||
161089611|NCT05917470|581717414|FG002|Overall Study|Withdrawal by Subject|1|||
161089612|NCT05917470|581717415|FG003|Overall Study|Withdrawal by Subject|0|||
161089613|NCT05917470|581717416|FG004|Overall Study|Withdrawal by Subject|0|||
161089614|NCT05917470|581717417|FG005|Overall Study|Withdrawal by Subject|0|||
161089615|NCT05917470|581717418|FG006|Overall Study|Withdrawal by Subject|0|||
161089616|NCT05917470|581717419|FG007|Overall Study|Withdrawal by Subject|0|||
161089617|NCT05917470|581717412|FG000|Overall Study|Sponsor Decision|0|||
161089618|NCT05917470|581717413|FG001|Overall Study|Sponsor Decision|0|||
161089619|NCT05917470|581717414|FG002|Overall Study|Sponsor Decision|1|||
161089620|NCT05917470|581717415|FG003|Overall Study|Sponsor Decision|0|||
161089621|NCT05917470|581717416|FG004|Overall Study|Sponsor Decision|2|||
161089622|NCT05917470|581717417|FG005|Overall Study|Sponsor Decision|1|||
161089623|NCT05917470|581717418|FG006|Overall Study|Sponsor Decision|3|||
161089624|NCT05917470|581717419|FG007|Overall Study|Sponsor Decision|3|||
161089625|NCT05917470|581717412|FG000|Overall Study|Adverse Event|0|||
161089626|NCT05917470|581717413|FG001|Overall Study|Adverse Event|0|||
161089627|NCT05917470|581717414|FG002|Overall Study|Adverse Event|0|||
161089628|NCT05917470|581717415|FG003|Overall Study|Adverse Event|0|||
161089629|NCT05917470|581717416|FG004|Overall Study|Adverse Event|0|||
161089630|NCT05917470|581717417|FG005|Overall Study|Adverse Event|1|||
161089631|NCT05917470|581717418|FG006|Overall Study|Adverse Event|0|||
161089632|NCT05917470|581717419|FG007|Overall Study|Adverse Event|0|||
161089633|NCT02317432|581717420|FG000|Overall Study|Death|4|||
161089634|NCT02317432|581717421|FG001|Overall Study|Death|1|||
161302756|NCT01609543|582490059|FG000|Overall Study|Disease Progression|28|||
161302757|NCT01609543|582490059|FG000|Overall Study|Adverse Event|5|||
161302758|NCT01609543|582490059|FG000|Overall Study|Withdrawal by Subject|1|||
161302759|NCT01609543|582490059|FG000|Overall Study|Protocol Violation|1|||
161302760|NCT01609543|582490059|FG000|Overall Study|Death|7|||
161302761|NCT01254318|582490060|FG000|Overall Study|Lost to Follow-up|5|||
161302762|NCT01254318|582490060|FG000|Overall Study|Death|47|||
161302763|NCT01137110|582490067|FG000|Overall Study|Protocol Violation|1|||
161302764|NCT01137110|582490068|FG001|Overall Study|Protocol Violation|0|||
161302765|NCT02828124|582490071|FG000|Overall Study|Disease Progression|1|||
161302766|NCT02828124|582490072|FG001|Overall Study|Disease Progression|2|||
161302767|NCT02828124|582490073|FG002|Overall Study|Disease Progression|1|||
161302768|NCT02828124|582490074|FG003|Overall Study|Disease Progression|4|||
161302769|NCT02828124|582490071|FG000|Overall Study|AE Unrelated to Study Drug|0|||
161302770|NCT02828124|582490072|FG001|Overall Study|AE Unrelated to Study Drug|0|||
161302771|NCT02828124|582490073|FG002|Overall Study|AE Unrelated to Study Drug|0|||
161302772|NCT02828124|582490074|FG003|Overall Study|AE Unrelated to Study Drug|1|||
161302773|NCT02828124|582490071|FG000|Overall Study|Subject Withdrew Consent|0|||
161302774|NCT02828124|582490072|FG001|Overall Study|Subject Withdrew Consent|0|||
161302775|NCT02828124|582490073|FG002|Overall Study|Subject Withdrew Consent|0|||
161302776|NCT02828124|582490074|FG003|Overall Study|Subject Withdrew Consent|1|||
161302777|NCT06586788|582490075|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
161302778|NCT03514485|582490077|FG000|Overall Study|Lost to Follow-up|5|||
161302779|NCT03514485|582490078|FG001|Overall Study|Lost to Follow-up|3|||
161302780|NCT03514485|582490079|FG002|Overall Study|Lost to Follow-up|2|||
161302781|NCT03514485|582490080|FG003|Overall Study|Lost to Follow-up|0|||
161302782|NCT03514485|582490081|FG004|Overall Study|Lost to Follow-up|1|||
161302783|NCT03514485|582490082|FG005|Overall Study|Lost to Follow-up|4|||
161302784|NCT03514485|582490077|FG000|Overall Study|Withdrawal by Subject|0|||
161302785|NCT03514485|582490078|FG001|Overall Study|Withdrawal by Subject|1|||
161302786|NCT03514485|582490079|FG002|Overall Study|Withdrawal by Subject|3|||
161302787|NCT03514485|582490080|FG003|Overall Study|Withdrawal by Subject|1|||
161302788|NCT03514485|582490081|FG004|Overall Study|Withdrawal by Subject|2|||
161302789|NCT03514485|582490082|FG005|Overall Study|Withdrawal by Subject|1|||
161302790|NCT03075891|582490083|FG000|Overall Study|Withdrawal by Subject|3|||
161302791|NCT03075891|582490084|FG001|Overall Study|Withdrawal by Subject|6|||
161302792|NCT03075891|582490083|FG000|Overall Study|Lost to Follow-up|1|||
161089635|NCT02317432|581717420|FG000|Overall Study|Lost to Follow-up|0|||
161089636|NCT02317432|581717421|FG001|Overall Study|Lost to Follow-up|5|||
161089637|NCT02317432|581717420|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
161089638|NCT02317432|581717421|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
161089639|NCT01328717|581719786|FG000|Overall Study|Adverse Event|1|||
161089640|NCT00346268|581719787|FG000|Overall Study|Adverse Event|1|||
161089641|NCT00346268|581719788|FG001|Overall Study|Adverse Event|0|||
161089642|NCT00346268|581719787|FG000|Overall Study|Protocol Violation|1|||
161089643|NCT00346268|581719788|FG001|Overall Study|Protocol Violation|0|||
161089644|NCT00346268|581719787|FG000|Overall Study|Participant refused|0|||
161089645|NCT00346268|581719788|FG001|Overall Study|Participant refused|3|||
161089646|NCT03184870|581719791|FG000|Initial Treatment|Death|6|||
161089647|NCT03184870|581719792|FG001|Initial Treatment|Death|6|||
161089648|NCT03184870|581719793|FG002|Initial Treatment|Death|8|||
161089649|NCT03184870|581719794|FG003|Initial Treatment|Death|8|||
161089650|NCT03184870|581719795|FG004|Initial Treatment|Death|6|||
161089651|NCT03184870|581719796|FG005|Initial Treatment|Death|6|||
161089652|NCT03184870|581719797|FG006|Initial Treatment|Death|6|||
161089653|NCT03184870|581719798|FG007|Initial Treatment|Death|7|||
161089654|NCT03184870|581719799|FG008|Initial Treatment|Death|1|||
161089655|NCT03184870|581719800|FG009|Initial Treatment|Death|2|||
161089656|NCT03184870|581719801|FG010|Initial Treatment|Death|26|||
161089657|NCT03184870|581719802|FG011|Initial Treatment|Death|28|||
161089658|NCT03184870|581719803|FG012|Initial Treatment|Death|10|||
161089659|NCT03184870|581719804|FG013|Initial Treatment|Death|33|||
161089660|NCT03184870|581719805|FG014|Initial Treatment|Death|34|||
161089661|NCT03184870|581719806|FG015|Initial Treatment|Death|26|||
161089662|NCT03184870|581719807|FG016|Initial Treatment|Death|20|||
161089663|NCT03184870|581719808|FG017|Initial Treatment|Death|18|||
161089664|NCT03184870|581719791|FG000|Initial Treatment|Other Reasons|2|||
161089665|NCT03184870|581719792|FG001|Initial Treatment|Other Reasons|2|||
161089666|NCT03184870|581719793|FG002|Initial Treatment|Other Reasons|0|||
161089667|NCT03184870|581719794|FG003|Initial Treatment|Other Reasons|1|||
161089668|NCT03184870|581719795|FG004|Initial Treatment|Other Reasons|0|||
161089669|NCT03184870|581719796|FG005|Initial Treatment|Other Reasons|0|||
161089670|NCT03184870|581719797|FG006|Initial Treatment|Other Reasons|0|||
161089671|NCT03184870|581719798|FG007|Initial Treatment|Other Reasons|2|||
161089672|NCT03184870|581719799|FG008|Initial Treatment|Other Reasons|0|||
161089673|NCT03184870|581719800|FG009|Initial Treatment|Other Reasons|0|||
161089674|NCT03184870|581719801|FG010|Initial Treatment|Other Reasons|4|||
161089675|NCT03184870|581719802|FG011|Initial Treatment|Other Reasons|2|||
161302793|NCT03075891|582490084|FG001|Overall Study|Lost to Follow-up|0|||
161302794|NCT03075891|582490083|FG000|Overall Study|Pregnancy|3|||
161302795|NCT03075891|582490084|FG001|Overall Study|Pregnancy|1|||
161302796|NCT03075891|582490083|FG000|Overall Study|visits not performed (no time)|1|||
161302797|NCT03075891|582490084|FG001|Overall Study|visits not performed (no time)|0|||
161302798|NCT03075891|582490083|FG000|Overall Study|Drug abuse relapse issue|0|||
161302799|NCT03075891|582490084|FG001|Overall Study|Drug abuse relapse issue|1|||
161302800|NCT03075891|582490083|FG000|Overall Study|Participant requiring study withdrawal|0|||
161302801|NCT03075891|582490084|FG001|Overall Study|Participant requiring study withdrawal|1|||
161302802|NCT03075891|582490083|FG000|Overall Study|Adverse event, non-fatal|1|||
161302803|NCT03075891|582490084|FG001|Overall Study|Adverse event, non-fatal|4|||
161302804|NCT00582608|582490100|FG000|Overall Study|Not Treated|7|||
161302805|NCT00582608|582490100|FG000|Overall Study|Patient Ineligible|1|||
161302806|NCT00582608|582490100|FG000|Overall Study|Lack of accrual|4|||
161302807|NCT03482453|582490101|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302808|NCT03482453|582490102|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302809|NCT03482453|582490103|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302810|NCT03482453|582490104|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302811|NCT03482453|582490105|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302812|NCT03482453|582490106|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302813|NCT03482453|582490107|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302814|NCT03482453|582490108|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302815|NCT03482453|582490109|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302816|NCT03482453|582490110|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302817|NCT03482453|582490111|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
161302818|NCT03482453|582490112|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
161302819|NCT03478644|582490113|FG000|Phase 2|Withdrawal by Subject|2|||
161302820|NCT03478644|582490114|FG001|Phase 2|Withdrawal by Subject|1|||
161302821|NCT03478644|582490113|FG000|Phase 2|Lost to Follow-up|1|||
161302822|NCT03478644|582490114|FG001|Phase 2|Lost to Follow-up|0|||
161302823|NCT02073929|582490115|FG000|Overall Study|Lost to Follow-up|2|||
161302824|NCT02073929|582490116|FG001|Overall Study|Lost to Follow-up|1|||
161302825|NCT02073929|582490115|FG000|Overall Study|Adverse Event|2|||
161302826|NCT02073929|582490116|FG001|Overall Study|Adverse Event|1|||
161302827|NCT02073929|582490115|FG000|Overall Study|Withdrawal by Subject|0|||
161302828|NCT02073929|582490116|FG001|Overall Study|Withdrawal by Subject|1|||
161302829|NCT01870973|582490117|FG000|Overall Study|Lost to Follow-up|10|||
161302830|NCT01870973|582490118|FG001|Overall Study|Lost to Follow-up|3|||
161302831|NCT02504827|582490121|FG000|Overall Study|Could not produce sputum|1|||
161302832|NCT00686829|582490122|FG000|Overall Study|Adverse Event|5|||
161302833|NCT00686829|582490122|FG000|Overall Study|Lack of Efficacy|6|||
161302834|NCT00686829|582490122|FG000|Overall Study|Lost to Follow-up|4|||
161302835|NCT00686829|582490122|FG000|Overall Study|Withdrawal by Subject|14|||
161302836|NCT00686829|582490122|FG000|Overall Study|Protocol Violation|3|||
161302837|NCT00686829|582490122|FG000|Overall Study|Sponsor discontinued VCV|47|||
161302838|NCT00712543|582490123|FG000|Day 8-14|Lost to Follow-up|0|||
161302839|NCT00712543|582490124|FG001|Day 8-14|Lost to Follow-up|2|||
161302840|NCT04740827|582490125|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
161302841|NCT04740827|582490126|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
161302842|NCT04740827|582490125|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
161302843|NCT04740827|582490126|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
161302844|NCT04740827|582490125|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
161302845|NCT04740827|582490126|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
161302846|NCT04740827|582490125|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
161302847|NCT04740827|582490126|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
161302848|NCT04740827|582490125|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
161302849|NCT04740827|582490126|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
161302850|NCT04740827|582490125|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
161302851|NCT04740827|582490126|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
161302852|NCT00940823|582490127|FG000|Overall Study|Death|8|||
161302853|NCT00940823|582490128|FG001|Overall Study|Death|12|||
161302854|NCT00940823|582490127|FG000|Overall Study|Lost to Follow-up|27|||
161302855|NCT00940823|582490128|FG001|Overall Study|Lost to Follow-up|20|||
161302856|NCT00519428|582492776|FG000|Overall Study|Adverse Event|5|||
161302857|NCT00519428|582492777|FG001|Overall Study|Adverse Event|2|||
161302858|NCT00519428|582492778|FG002|Overall Study|Adverse Event|10|||
161183701|NCT00609167|582049087|FG000|Overall Study|Stem Cell Transplant|0|||
161183702|NCT00609167|582049088|FG001|Overall Study|Stem Cell Transplant|6|||
161302859|NCT00519428|582492776|FG000|Overall Study|Lost to Follow-up|7|||
161302860|NCT00519428|582492777|FG001|Overall Study|Lost to Follow-up|7|||
161302861|NCT00519428|582492778|FG002|Overall Study|Lost to Follow-up|6|||
161302862|NCT00519428|582492776|FG000|Overall Study|Withdrawal by Subject|8|||
161302863|NCT00519428|582492777|FG001|Overall Study|Withdrawal by Subject|3|||
161183703|NCT00712270|582049089|FG000|Overall Study|Withdrawal by Subject|11|||
161302864|NCT00519428|582492778|FG002|Overall Study|Withdrawal by Subject|7|||
161302865|NCT00519428|582492776|FG000|Overall Study|unstated|1|||
161302866|NCT00519428|582492777|FG001|Overall Study|unstated|3|||
161302867|NCT00519428|582492778|FG002|Overall Study|unstated|2|||
161302868|NCT00688701|582492779|FG000|Overall Study|Adverse Event|1|||
161302869|NCT00688701|582492780|FG001|Overall Study|Adverse Event|0|||
161302870|NCT00688701|582492781|FG002|Overall Study|Adverse Event|5|||
161302871|NCT00688701|582492782|FG003|Overall Study|Adverse Event|3|||
161302872|NCT00688701|582492779|FG000|Overall Study|Lack of Efficacy|0|||
161302873|NCT00688701|582492780|FG001|Overall Study|Lack of Efficacy|1|||
161302874|NCT00688701|582492781|FG002|Overall Study|Lack of Efficacy|0|||
161302875|NCT00688701|582492782|FG003|Overall Study|Lack of Efficacy|0|||
161302876|NCT00688701|582492779|FG000|Overall Study|Withdrawal by Subject|3|||
161302877|NCT00688701|582492780|FG001|Overall Study|Withdrawal by Subject|3|||
161302878|NCT00688701|582492781|FG002|Overall Study|Withdrawal by Subject|4|||
161302879|NCT00688701|582492782|FG003|Overall Study|Withdrawal by Subject|8|||
161302880|NCT00688701|582492779|FG000|Overall Study|Poor compliance to protocol|0|||
161302881|NCT00688701|582492780|FG001|Overall Study|Poor compliance to protocol|1|||
161302882|NCT00688701|582492781|FG002|Overall Study|Poor compliance to protocol|1|||
161302883|NCT00688701|582492782|FG003|Overall Study|Poor compliance to protocol|0|||
161302884|NCT01275755|582492786|FG000|Double-blind Treatment Period|Adverse Event|0|||
161302885|NCT01275755|582492787|FG001|Double-blind Treatment Period|Adverse Event|2|||
161302886|NCT01275755|582492786|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
161302887|NCT01275755|582492787|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161302888|NCT01275755|582492786|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161302889|NCT01275755|582492787|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161302890|NCT01275755|582492786|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
161302891|NCT01275755|582492787|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
161302892|NCT04420585|582492790|FG000|Overall Study|Adverse Event|1|||
161302893|NCT04420585|582492790|FG000|Overall Study|Never initiated medication|2|||
161302894|NCT00477750|582492791|FG000|Overall Study|Currently Receiving Treatment|11|||
161302895|NCT01300338|582492793|FG000|Overall Study|Lost to Follow-up|5|||
161302896|NCT01300338|582492794|FG001|Overall Study|Lost to Follow-up|0|||
161302897|NCT02461524|582492796|FG000|Overall Study|Death|16|||
161302898|NCT02461524|582492796|FG000|Overall Study|Withdrawal by Subject|4|||
161302899|NCT02461524|582492796|FG000|Overall Study|Device Explanted|5|||
161302900|NCT02461524|582492796|FG000|Overall Study|Missed Visit|6|||
161302901|NCT00381238|582492800|FG000|Overall Study|Adverse Event|3|||
161302902|NCT00381238|582492800|FG000|Overall Study|Protocol Violation|1|||
161302903|NCT00381238|582492800|FG000|Overall Study|Withdrawal by Subject|4|||
161302904|NCT00381238|582492800|FG000|Overall Study|Lack of Efficacy|2|||
161302905|NCT00381238|582492800|FG000|Overall Study|Withdrew by physician|1|||
161302906|NCT00381238|582492800|FG000|Overall Study|Disease progression|1|||
161302907|NCT00843037|582492803|FG000|Overall Study|Lost to Follow-up|1|||
161302908|NCT02564900|582492804|FG000|Dose Escalation|Progressive disease per RECIST|2|||
161302909|NCT02564900|582492805|FG001|Dose Escalation|Progressive disease per RECIST|3|||
161302910|NCT02564900|582492806|FG002|Dose Escalation|Progressive disease per RECIST|3|||
161302911|NCT02564900|582492807|FG003|Dose Escalation|Progressive disease per RECIST|3|||
161302912|NCT02564900|582492808|FG004|Dose Escalation|Progressive disease per RECIST|3|||
161302913|NCT02564900|582492809|FG005|Dose Escalation|Progressive disease per RECIST|1|||
161302914|NCT02564900|582492810|FG006|Dose Escalation|Progressive disease per RECIST|0|||
161302915|NCT02564900|582492811|FG007|Dose Escalation|Progressive disease per RECIST|0|||
161302916|NCT02564900|582492812|FG008|Dose Escalation|Progressive disease per RECIST|0|||
161302917|NCT02564900|582492813|FG009|Dose Escalation|Progressive disease per RECIST|0|||
161302918|NCT02564900|582492814|FG010|Dose Escalation|Progressive disease per RECIST|0|||
161302919|NCT02564900|582492815|FG011|Dose Escalation|Progressive disease per RECIST|0|||
161302920|NCT02564900|582492816|FG012|Dose Escalation|Progressive disease per RECIST|0|||
161302921|NCT02564900|582492817|FG013|Dose Escalation|Progressive disease per RECIST|0|||
161302922|NCT02564900|582492818|FG014|Dose Escalation|Progressive disease per RECIST|0|||
161302923|NCT02564900|582492804|FG000|Dose Escalation|Ongoing|1|||
161302924|NCT02564900|582492805|FG001|Dose Escalation|Ongoing|0|||
161302925|NCT02564900|582492806|FG002|Dose Escalation|Ongoing|0|||
161302926|NCT02564900|582492807|FG003|Dose Escalation|Ongoing|2|||
161302927|NCT02564900|582492808|FG004|Dose Escalation|Ongoing|2|||
161302928|NCT02564900|582492809|FG005|Dose Escalation|Ongoing|2|||
161302929|NCT02564900|582492810|FG006|Dose Escalation|Ongoing|0|||
161302930|NCT02564900|582492811|FG007|Dose Escalation|Ongoing|0|||
161302931|NCT02564900|582492812|FG008|Dose Escalation|Ongoing|0|||
161302932|NCT02564900|582492813|FG009|Dose Escalation|Ongoing|0|||
161302933|NCT02564900|582492814|FG010|Dose Escalation|Ongoing|0|||
161302934|NCT02564900|582492815|FG011|Dose Escalation|Ongoing|0|||
161302935|NCT02564900|582492816|FG012|Dose Escalation|Ongoing|0|||
161302936|NCT02564900|582492817|FG013|Dose Escalation|Ongoing|0|||
161089676|NCT03184870|581719803|FG012|Initial Treatment|Other Reasons|2|||
161302937|NCT02564900|582492818|FG014|Dose Escalation|Ongoing|0|||
161302938|NCT02564900|582492804|FG000|Dose Escalation|Adverse Event|0|||
161302939|NCT02564900|582492805|FG001|Dose Escalation|Adverse Event|0|||
161302940|NCT02564900|582492806|FG002|Dose Escalation|Adverse Event|0|||
161302941|NCT02564900|582492807|FG003|Dose Escalation|Adverse Event|1|||
161302942|NCT02564900|582492808|FG004|Dose Escalation|Adverse Event|1|||
161302943|NCT02564900|582492809|FG005|Dose Escalation|Adverse Event|3|||
161302944|NCT02564900|582492810|FG006|Dose Escalation|Adverse Event|0|||
161302945|NCT02564900|582492811|FG007|Dose Escalation|Adverse Event|0|||
161302946|NCT02564900|582492812|FG008|Dose Escalation|Adverse Event|0|||
161302947|NCT02564900|582492813|FG009|Dose Escalation|Adverse Event|0|||
161302948|NCT02564900|582492814|FG010|Dose Escalation|Adverse Event|0|||
161302949|NCT02564900|582492815|FG011|Dose Escalation|Adverse Event|0|||
161302950|NCT02564900|582492816|FG012|Dose Escalation|Adverse Event|0|||
161302951|NCT02564900|582492817|FG013|Dose Escalation|Adverse Event|0|||
161302952|NCT02564900|582492818|FG014|Dose Escalation|Adverse Event|0|||
161302953|NCT02564900|582492804|FG000|Dose Expansion|Progressive disease per RECIST|0|||
161302954|NCT02564900|582492805|FG001|Dose Expansion|Progressive disease per RECIST|0|||
161302955|NCT02564900|582492806|FG002|Dose Expansion|Progressive disease per RECIST|0|||
161302956|NCT02564900|582492807|FG003|Dose Expansion|Progressive disease per RECIST|0|||
161302957|NCT02564900|582492808|FG004|Dose Expansion|Progressive disease per RECIST|0|||
161302958|NCT02564900|582492809|FG005|Dose Expansion|Progressive disease per RECIST|0|||
161302959|NCT02564900|582492810|FG006|Dose Expansion|Progressive disease per RECIST|19|||
161302960|NCT02564900|582492811|FG007|Dose Expansion|Progressive disease per RECIST|17|||
161302961|NCT02564900|582492812|FG008|Dose Expansion|Progressive disease per RECIST|8|||
161302962|NCT02564900|582492813|FG009|Dose Expansion|Progressive disease per RECIST|16|||
161302963|NCT02564900|582492814|FG010|Dose Expansion|Progressive disease per RECIST|13|||
161302964|NCT02564900|582492815|FG011|Dose Expansion|Progressive disease per RECIST|19|||
161302965|NCT02564900|582492816|FG012|Dose Expansion|Progressive disease per RECIST|10|||
161302966|NCT02564900|582492817|FG013|Dose Expansion|Progressive disease per RECIST|13|||
161302967|NCT02564900|582492818|FG014|Dose Expansion|Progressive disease per RECIST|11|||
161302968|NCT02564900|582492804|FG000|Dose Expansion|Clinical progression|0|||
161302969|NCT02564900|582492805|FG001|Dose Expansion|Clinical progression|0|||
161302970|NCT02564900|582492806|FG002|Dose Expansion|Clinical progression|0|||
161302971|NCT02564900|582492807|FG003|Dose Expansion|Clinical progression|0|||
161302972|NCT02564900|582492808|FG004|Dose Expansion|Clinical progression|0|||
161302973|NCT02564900|582492809|FG005|Dose Expansion|Clinical progression|0|||
161302974|NCT02564900|582492810|FG006|Dose Expansion|Clinical progression|5|||
161302975|NCT02564900|582492811|FG007|Dose Expansion|Clinical progression|12|||
161302976|NCT02564900|582492812|FG008|Dose Expansion|Clinical progression|0|||
161302977|NCT02564900|582492813|FG009|Dose Expansion|Clinical progression|3|||
161302978|NCT02564900|582492814|FG010|Dose Expansion|Clinical progression|2|||
161302979|NCT02564900|582492815|FG011|Dose Expansion|Clinical progression|0|||
161302980|NCT02564900|582492816|FG012|Dose Expansion|Clinical progression|1|||
161302981|NCT02564900|582492817|FG013|Dose Expansion|Clinical progression|3|||
161302982|NCT02564900|582492818|FG014|Dose Expansion|Clinical progression|1|||
161302983|NCT02564900|582492804|FG000|Dose Expansion|Adverse Event|0|||
161302984|NCT02564900|582492805|FG001|Dose Expansion|Adverse Event|0|||
161302985|NCT02564900|582492806|FG002|Dose Expansion|Adverse Event|0|||
161302986|NCT02564900|582492807|FG003|Dose Expansion|Adverse Event|0|||
161302987|NCT02564900|582492808|FG004|Dose Expansion|Adverse Event|0|||
161302988|NCT02564900|582492809|FG005|Dose Expansion|Adverse Event|0|||
161302989|NCT02564900|582492810|FG006|Dose Expansion|Adverse Event|9|||
161302990|NCT02564900|582492811|FG007|Dose Expansion|Adverse Event|22|||
161302991|NCT02564900|582492812|FG008|Dose Expansion|Adverse Event|0|||
161302992|NCT02564900|582492813|FG009|Dose Expansion|Adverse Event|11|||
161302993|NCT02564900|582492814|FG010|Dose Expansion|Adverse Event|0|||
161302994|NCT02564900|582492815|FG011|Dose Expansion|Adverse Event|5|||
161302995|NCT02564900|582492816|FG012|Dose Expansion|Adverse Event|2|||
161302996|NCT02564900|582492817|FG013|Dose Expansion|Adverse Event|2|||
161302997|NCT02564900|582492818|FG014|Dose Expansion|Adverse Event|1|||
161302998|NCT02564900|582492804|FG000|Dose Expansion|Ongoing|0|||
161302999|NCT02564900|582492805|FG001|Dose Expansion|Ongoing|0|||
161303000|NCT02564900|582492806|FG002|Dose Expansion|Ongoing|0|||
161303001|NCT02564900|582492807|FG003|Dose Expansion|Ongoing|0|||
161303002|NCT02564900|582492808|FG004|Dose Expansion|Ongoing|0|||
161303003|NCT02564900|582492809|FG005|Dose Expansion|Ongoing|0|||
161303004|NCT02564900|582492810|FG006|Dose Expansion|Ongoing|9|||
161303005|NCT02564900|582492811|FG007|Dose Expansion|Ongoing|10|||
161303006|NCT02564900|582492812|FG008|Dose Expansion|Ongoing|11|||
161303007|NCT02564900|582492813|FG009|Dose Expansion|Ongoing|3|||
161303008|NCT02564900|582492814|FG010|Dose Expansion|Ongoing|0|||
161303009|NCT02564900|582492815|FG011|Dose Expansion|Ongoing|0|||
161303010|NCT02564900|582492816|FG012|Dose Expansion|Ongoing|4|||
161303011|NCT02564900|582492817|FG013|Dose Expansion|Ongoing|0|||
161303012|NCT02564900|582492818|FG014|Dose Expansion|Ongoing|6|||
161303013|NCT02564900|582492804|FG000|Dose Expansion|Death|0|||
161303014|NCT02564900|582492805|FG001|Dose Expansion|Death|0|||
161303015|NCT02564900|582492806|FG002|Dose Expansion|Death|0|||
161303016|NCT02564900|582492807|FG003|Dose Expansion|Death|0|||
161303017|NCT02564900|582492808|FG004|Dose Expansion|Death|0|||
161303018|NCT02564900|582492809|FG005|Dose Expansion|Death|0|||
161303019|NCT02564900|582492810|FG006|Dose Expansion|Death|1|||
161183704|NCT00712270|582049089|FG000|Overall Study|Screen Failure|3|||
161183705|NCT02574520|582049090|FG000|Overall Study|Not dosed|2|||
161183706|NCT02574520|582049091|FG001|Overall Study|Not dosed|0|||
161183707|NCT02574520|582049092|FG002|Overall Study|Not dosed|5|||
161183708|NCT02574520|582049093|FG003|Overall Study|Not dosed|4|||
161183709|NCT02574520|582049090|FG000|Overall Study|Adverse Event|0|||
161183710|NCT02574520|582049091|FG001|Overall Study|Adverse Event|0|||
161183711|NCT02574520|582049092|FG002|Overall Study|Adverse Event|0|||
161183712|NCT02574520|582049093|FG003|Overall Study|Adverse Event|1|||
161183713|NCT02574520|582049090|FG000|Overall Study|Withdrawal by Subject|0|||
161303020|NCT02564900|582492811|FG007|Dose Expansion|Death|0|||
161303021|NCT02564900|582492812|FG008|Dose Expansion|Death|0|||
161303022|NCT02564900|582492813|FG009|Dose Expansion|Death|0|||
161303023|NCT02564900|582492814|FG010|Dose Expansion|Death|1|||
161183714|NCT02574520|582049091|FG001|Overall Study|Withdrawal by Subject|0|||
161183715|NCT02574520|582049092|FG002|Overall Study|Withdrawal by Subject|0|||
161183716|NCT02574520|582049093|FG003|Overall Study|Withdrawal by Subject|1|||
161183717|NCT02574520|582049090|FG000|Overall Study|Other|0|||
161183718|NCT02574520|582049091|FG001|Overall Study|Other|0|||
161183719|NCT02574520|582049092|FG002|Overall Study|Other|0|||
161183720|NCT02574520|582049093|FG003|Overall Study|Other|2|||
161183721|NCT01365091|582049096|FG000|Period 1|Adverse Event|1|||
161183722|NCT01365091|582049097|FG001|Period 1|Adverse Event|0|||
161183723|NCT01365091|582049098|FG002|Period 1|Adverse Event|2|||
161183724|NCT01365091|582049099|FG003|Period 1|Adverse Event|3|||
161183725|NCT01365091|582049096|FG000|Period 1|Positive test result for drugs of abuse|1|||
161183726|NCT01365091|582049097|FG001|Period 1|Positive test result for drugs of abuse|0|||
161183727|NCT01365091|582049098|FG002|Period 1|Positive test result for drugs of abuse|0|||
161183728|NCT01365091|582049099|FG003|Period 1|Positive test result for drugs of abuse|0|||
161183729|NCT01365091|582049096|FG000|Period 1|No longer met study criteria|0|||
161183730|NCT01365091|582049097|FG001|Period 1|No longer met study criteria|1|||
161183731|NCT01365091|582049098|FG002|Period 1|No longer met study criteria|0|||
161183732|NCT01365091|582049099|FG003|Period 1|No longer met study criteria|0|||
161183733|NCT01365091|582049096|FG000|Period 1|Withdrawal by Subject|0|||
161183734|NCT01365091|582049097|FG001|Period 1|Withdrawal by Subject|1|||
161183735|NCT01365091|582049098|FG002|Period 1|Withdrawal by Subject|0|||
161183736|NCT01365091|582049099|FG003|Period 1|Withdrawal by Subject|0|||
161183737|NCT01365091|582049096|FG000|Period 1|Personal reasons|0|||
161183738|NCT01365091|582049097|FG001|Period 1|Personal reasons|0|||
161183739|NCT01365091|582049098|FG002|Period 1|Personal reasons|1|||
161183740|NCT01365091|582049099|FG003|Period 1|Personal reasons|0|||
161183741|NCT01365091|582049096|FG000|Period 2|Withdrawal by Subject|1|||
161183742|NCT01365091|582049097|FG001|Period 2|Withdrawal by Subject|0|||
161183743|NCT01365091|582049098|FG002|Period 2|Withdrawal by Subject|0|||
161183744|NCT01365091|582049099|FG003|Period 2|Withdrawal by Subject|0|||
161183745|NCT01365091|582049096|FG000|Period 2|Adverse Event|0|||
161183746|NCT01365091|582049097|FG001|Period 2|Adverse Event|0|||
161183747|NCT01365091|582049098|FG002|Period 2|Adverse Event|1|||
161183748|NCT01365091|582049099|FG003|Period 2|Adverse Event|0|||
161183749|NCT05307523|582049101|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
161183750|NCT05307523|582049102|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
161183751|NCT05307523|582049101|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
161183752|NCT05307523|582049102|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
161183753|NCT05116683|582049103|FG000|Overall Study|Physician Decision|4|||
161183754|NCT03935594|582049113|FG000|Overall Study|Physician Decision|3|||
161183755|NCT01435122|582049114|FG000|Overall Study|Early withdrawal due to toxicity|8|||
161183756|NCT04412668|582049115|FG000|Overall Study|Death - multiple comorbidities|2|||
161183757|NCT04412668|582049116|FG001|Overall Study|Death - multiple comorbidities|0|||
161183758|NCT04412668|582049117|FG002|Overall Study|Death - multiple comorbidities|0|||
161183759|NCT04412668|582049115|FG000|Overall Study|Withdrawal by Subject|3|||
161183760|NCT04412668|582049116|FG001|Overall Study|Withdrawal by Subject|0|||
161183761|NCT04412668|582049117|FG002|Overall Study|Withdrawal by Subject|0|||
161183762|NCT04412668|582049115|FG000|Overall Study|Other than Specified|2|||
161183763|NCT04412668|582049116|FG001|Overall Study|Other than Specified|0|||
161303024|NCT02564900|582492815|FG011|Dose Expansion|Death|0|||
161183764|NCT04412668|582049117|FG002|Overall Study|Other than Specified|0|||
161303025|NCT02564900|582492816|FG012|Dose Expansion|Death|1|||
161303026|NCT02564900|582492817|FG013|Dose Expansion|Death|1|||
161183765|NCT03864627|582049119|FG000|Overall Study|Adverse Event|0|||
161183766|NCT03864627|582049120|FG001|Overall Study|Adverse Event|1|||
161183767|NCT03864627|582049119|FG000|Overall Study|Lack of Efficacy|0|||
161183768|NCT03864627|582049120|FG001|Overall Study|Lack of Efficacy|1|||
161183769|NCT03864627|582049119|FG000|Overall Study|Lost to Follow-up|0|||
161183770|NCT03864627|582049120|FG001|Overall Study|Lost to Follow-up|1|||
161183771|NCT03864627|582049119|FG000|Overall Study|Withdrawal by Subject|4|||
161183772|NCT03864627|582049120|FG001|Overall Study|Withdrawal by Subject|8|||
161183773|NCT03864627|582049119|FG000|Overall Study|Study terminated by sponsor|0|||
161183774|NCT03864627|582049120|FG001|Overall Study|Study terminated by sponsor|1|||
161183775|NCT01388491|582049121|FG000|Overall Study|Adverse Event|10|||
161303027|NCT02564900|582492818|FG014|Dose Expansion|Death|0|||
161303028|NCT02564900|582492804|FG000|Dose Expansion|Withdrawal by Subject|0|||
161303029|NCT02564900|582492805|FG001|Dose Expansion|Withdrawal by Subject|0|||
161303030|NCT02564900|582492806|FG002|Dose Expansion|Withdrawal by Subject|0|||
161303031|NCT02564900|582492807|FG003|Dose Expansion|Withdrawal by Subject|0|||
161303032|NCT02564900|582492808|FG004|Dose Expansion|Withdrawal by Subject|0|||
161303033|NCT02564900|582492809|FG005|Dose Expansion|Withdrawal by Subject|0|||
161303034|NCT02564900|582492810|FG006|Dose Expansion|Withdrawal by Subject|4|||
161303035|NCT02564900|582492811|FG007|Dose Expansion|Withdrawal by Subject|0|||
161303036|NCT02564900|582492812|FG008|Dose Expansion|Withdrawal by Subject|0|||
161303037|NCT02564900|582492813|FG009|Dose Expansion|Withdrawal by Subject|0|||
161303038|NCT02564900|582492814|FG010|Dose Expansion|Withdrawal by Subject|1|||
161303039|NCT02564900|582492815|FG011|Dose Expansion|Withdrawal by Subject|0|||
161303040|NCT02564900|582492816|FG012|Dose Expansion|Withdrawal by Subject|0|||
161303041|NCT02564900|582492817|FG013|Dose Expansion|Withdrawal by Subject|1|||
161303042|NCT02564900|582492818|FG014|Dose Expansion|Withdrawal by Subject|1|||
161303043|NCT02564900|582492804|FG000|Dose Expansion|Other|0|||
161303044|NCT02564900|582492805|FG001|Dose Expansion|Other|0|||
161303045|NCT02564900|582492806|FG002|Dose Expansion|Other|0|||
161303046|NCT02564900|582492807|FG003|Dose Expansion|Other|0|||
161303047|NCT02564900|582492808|FG004|Dose Expansion|Other|0|||
161303048|NCT02564900|582492809|FG005|Dose Expansion|Other|0|||
161303049|NCT02564900|582492810|FG006|Dose Expansion|Other|1|||
161303050|NCT02564900|582492811|FG007|Dose Expansion|Other|0|||
161303051|NCT02564900|582492812|FG008|Dose Expansion|Other|1|||
161303052|NCT02564900|582492813|FG009|Dose Expansion|Other|0|||
161303053|NCT02564900|582492814|FG010|Dose Expansion|Other|0|||
161303054|NCT02564900|582492815|FG011|Dose Expansion|Other|0|||
161303055|NCT02564900|582492816|FG012|Dose Expansion|Other|0|||
161303056|NCT02564900|582492817|FG013|Dose Expansion|Other|0|||
161303057|NCT02564900|582492818|FG014|Dose Expansion|Other|1|||
161303058|NCT02564900|582492804|FG000|Dose Expansion|Did not receive treatment|0|||
161303059|NCT02564900|582492805|FG001|Dose Expansion|Did not receive treatment|0|||
161303060|NCT02564900|582492806|FG002|Dose Expansion|Did not receive treatment|0|||
161303061|NCT02564900|582492807|FG003|Dose Expansion|Did not receive treatment|0|||
161303062|NCT02564900|582492808|FG004|Dose Expansion|Did not receive treatment|0|||
161303063|NCT02564900|582492809|FG005|Dose Expansion|Did not receive treatment|0|||
161303064|NCT02564900|582492810|FG006|Dose Expansion|Did not receive treatment|1|||
161303065|NCT02564900|582492811|FG007|Dose Expansion|Did not receive treatment|1|||
161303066|NCT02564900|582492812|FG008|Dose Expansion|Did not receive treatment|0|||
161303067|NCT02564900|582492813|FG009|Dose Expansion|Did not receive treatment|0|||
161303068|NCT02564900|582492814|FG010|Dose Expansion|Did not receive treatment|0|||
161303069|NCT02564900|582492815|FG011|Dose Expansion|Did not receive treatment|0|||
161303070|NCT02564900|582492816|FG012|Dose Expansion|Did not receive treatment|0|||
161303071|NCT02564900|582492817|FG013|Dose Expansion|Did not receive treatment|0|||
161303072|NCT02564900|582492818|FG014|Dose Expansion|Did not receive treatment|1|||
161303073|NCT03991299|582492819|FG000|Overall Study|Study closed, sponsor decision|3|||
161303074|NCT03991299|582492819|FG000|Overall Study|Withdrawal by Subject|1|||
161303075|NCT02278939|582492820|FG000|Overall Study|lack of time|1|||
161303076|NCT02278939|582492821|FG001|Overall Study|lack of time|0|||
161303077|NCT02278939|582492820|FG000|Overall Study|Lost to Follow-up|1|||
161303078|NCT02278939|582492821|FG001|Overall Study|Lost to Follow-up|1|||
161303079|NCT02278939|582492820|FG000|Overall Study|death in family|1|||
161303080|NCT02278939|582492821|FG001|Overall Study|death in family|0|||
161303081|NCT02278939|582492820|FG000|Overall Study|family emergency unable to commit|2|||
161303082|NCT02278939|582492821|FG001|Overall Study|family emergency unable to commit|0|||
161303083|NCT02423343|582492824|FG000|Overall Study|Withdrawal by Subject|0|||
161303084|NCT02423343|582492825|FG001|Overall Study|Withdrawal by Subject|1|||
161303085|NCT02423343|582492826|FG002|Overall Study|Withdrawal by Subject|0|||
161303086|NCT02423343|582492827|FG003|Overall Study|Withdrawal by Subject|0|||
161303087|NCT02423343|582492828|FG004|Overall Study|Withdrawal by Subject|0|||
161303088|NCT02423343|582492829|FG005|Overall Study|Withdrawal by Subject|0|||
161303089|NCT02423343|582492824|FG000|Overall Study|Progressive Disease|0|||
161303090|NCT02423343|582492825|FG001|Overall Study|Progressive Disease|0|||
161303091|NCT02423343|582492826|FG002|Overall Study|Progressive Disease|0|||
161303092|NCT02423343|582492827|FG003|Overall Study|Progressive Disease|0|||
161303093|NCT02423343|582492828|FG004|Overall Study|Progressive Disease|2|||
161303094|NCT02423343|582492829|FG005|Overall Study|Progressive Disease|0|||
161303095|NCT02423343|582492824|FG000|Overall Study|Adverse Event|0|||
161303096|NCT02423343|582492825|FG001|Overall Study|Adverse Event|0|||
161303097|NCT02423343|582492826|FG002|Overall Study|Adverse Event|0|||
161303098|NCT02423343|582492827|FG003|Overall Study|Adverse Event|0|||
161303099|NCT02423343|582492828|FG004|Overall Study|Adverse Event|2|||
161303100|NCT02423343|582492829|FG005|Overall Study|Adverse Event|0|||
161303101|NCT02423343|582492824|FG000|Overall Study|Death|0|||
161303102|NCT02423343|582492825|FG001|Overall Study|Death|0|||
161303103|NCT02423343|582492826|FG002|Overall Study|Death|0|||
161303104|NCT02423343|582492827|FG003|Overall Study|Death|0|||
161303105|NCT02423343|582492828|FG004|Overall Study|Death|1|||
161303106|NCT02423343|582492829|FG005|Overall Study|Death|0|||
161303107|NCT04429555|582492837|FG000|Overall Study|Death|0|||
161303108|NCT04429555|582492838|FG001|Overall Study|Death|2|||
161303109|NCT04429555|582492837|FG000|Overall Study|Other|2|||
161303110|NCT04429555|582492838|FG001|Overall Study|Other|0|||
161303111|NCT00712881|582492839|FG000|Overall Study|Adverse Event|3|||
161303112|NCT00712881|582492840|FG001|Overall Study|Adverse Event|3|||
161303113|NCT00712881|582492839|FG000|Overall Study|Withdrawal by Subject|1|||
161303114|NCT00712881|582492840|FG001|Overall Study|Withdrawal by Subject|1|||
161303115|NCT00712881|582492839|FG000|Overall Study|Disease Progression|2|||
161303116|NCT00712881|582492840|FG001|Overall Study|Disease Progression|1|||
161303117|NCT00712881|582492839|FG000|Overall Study|Lost to Follow-up|1|||
161303118|NCT00712881|582492840|FG001|Overall Study|Lost to Follow-up|1|||
161303119|NCT00712881|582492839|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
161303120|NCT00712881|582492840|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
161303121|NCT00712881|582492839|FG000|Overall Study|Protocol Violation|1|||
161303122|NCT00712881|582492840|FG001|Overall Study|Protocol Violation|1|||
161303123|NCT00712881|582492839|FG000|Overall Study|Randomized but not treated|1|||
161303124|NCT00712881|582492840|FG001|Overall Study|Randomized but not treated|0|||
161303125|NCT00654875|582492841|FG000|Overall Study|Adverse Event|5|||
161303126|NCT00654875|582492842|FG001|Overall Study|Adverse Event|5|||
161303127|NCT00654875|582492841|FG000|Overall Study|Withdrawal by Subject|4|||
161303128|NCT00654875|582492842|FG001|Overall Study|Withdrawal by Subject|4|||
161303129|NCT00654875|582492841|FG000|Overall Study|Protocol Violation|3|||
161303130|NCT00654875|582492842|FG001|Overall Study|Protocol Violation|3|||
161303131|NCT00654875|582492841|FG000|Overall Study|Lack of Efficacy|2|||
161303132|NCT00654875|582492842|FG001|Overall Study|Lack of Efficacy|2|||
161303133|NCT00654875|582492841|FG000|Overall Study|Lost to Follow-up|1|||
161303134|NCT00654875|582492842|FG001|Overall Study|Lost to Follow-up|3|||
161303135|NCT00654875|582492841|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
161303136|NCT00654875|582492842|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161303137|NCT00654875|582492841|FG000|Overall Study|Administrative Problems|1|||
161303138|NCT00654875|582492842|FG001|Overall Study|Administrative Problems|0|||
161303139|NCT01011465|582492843|FG000|Overall Study|Withdrawal by Subject|2|||
161303140|NCT01011465|582492844|FG001|Overall Study|Withdrawal by Subject|1|||
161303141|NCT01011465|582492845|FG002|Overall Study|Withdrawal by Subject|0|||
161303142|NCT01011465|582492846|FG003|Overall Study|Withdrawal by Subject|0|||
161303143|NCT01011465|582492847|FG004|Overall Study|Withdrawal by Subject|1|||
161303144|NCT01011465|582492848|FG005|Overall Study|Withdrawal by Subject|0|||
161303145|NCT01011465|582492849|FG006|Overall Study|Withdrawal by Subject|1|||
161303146|NCT01011465|582492850|FG007|Overall Study|Withdrawal by Subject|0|||
161303147|NCT02042950|582492851|FG000|Overall Study|Progressive Disease|4|||
161303148|NCT00723008|582492852|FG000|Enrollment|Lost to Follow-up|1|||
161303149|NCT00723008|582492853|FG001|Enrollment|Lost to Follow-up|0|||
161303150|NCT00723008|582492852|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
161303151|NCT00723008|582492853|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
161303152|NCT00723008|582492852|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
161303153|NCT00723008|582492853|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
161303154|NCT00723008|582492852|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
161303155|NCT00723008|582492853|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
161303156|NCT00723008|582492852|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
161303157|NCT00723008|582492853|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
161303158|NCT00723008|582492852|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
161303159|NCT00723008|582492853|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
161303160|NCT01014988|582492854|FG000|Overall Study|Adverse Event|20|||
161303161|NCT01014988|582492855|FG001|Overall Study|Adverse Event|0|||
161303162|NCT01014988|582492856|FG002|Overall Study|Adverse Event|1|||
161303163|NCT01014988|582492857|FG003|Overall Study|Adverse Event|0|||
161303164|NCT01014988|582492858|FG004|Overall Study|Adverse Event|1|||
161303165|NCT01014988|582492859|FG005|Overall Study|Adverse Event|3|||
161303166|NCT01014988|582492854|FG000|Overall Study|Lost to Follow-up|1|||
161303167|NCT01014988|582492855|FG001|Overall Study|Lost to Follow-up|0|||
161303168|NCT01014988|582492856|FG002|Overall Study|Lost to Follow-up|1|||
161303169|NCT01014988|582492857|FG003|Overall Study|Lost to Follow-up|0|||
161303170|NCT01014988|582492858|FG004|Overall Study|Lost to Follow-up|0|||
161303171|NCT01014988|582492859|FG005|Overall Study|Lost to Follow-up|0|||
161303172|NCT01014988|582492854|FG000|Overall Study|Physician Decision|1|||
161303173|NCT01014988|582492855|FG001|Overall Study|Physician Decision|0|||
161303174|NCT01014988|582492856|FG002|Overall Study|Physician Decision|0|||
161303175|NCT01014988|582492857|FG003|Overall Study|Physician Decision|0|||
161303176|NCT01014988|582492858|FG004|Overall Study|Physician Decision|0|||
161303177|NCT01014988|582492859|FG005|Overall Study|Physician Decision|0|||
161303178|NCT01014988|582492854|FG000|Overall Study|Withdrawal by Subject|1|||
161303179|NCT01014988|582492855|FG001|Overall Study|Withdrawal by Subject|0|||
161303180|NCT01014988|582492856|FG002|Overall Study|Withdrawal by Subject|0|||
161347983|NCT02924376|582657409|FG003|Overall Study|Physician Decision|0|||
161303181|NCT01014988|582492857|FG003|Overall Study|Withdrawal by Subject|0|||
161303182|NCT01014988|582492858|FG004|Overall Study|Withdrawal by Subject|0|||
161303183|NCT01014988|582492859|FG005|Overall Study|Withdrawal by Subject|0|||
161303184|NCT05835011|582492861|FG000|Overall Study|Study Terminated by the Sponsor|1|||
161303185|NCT05835011|582492861|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
161303186|NCT01683266|582492862|FG000|Overall Study|Adverse Event|5|||
161303187|NCT01683266|582492863|FG001|Overall Study|Adverse Event|4|||
161303188|NCT01683266|582492862|FG000|Overall Study|Lack of Efficacy|5|||
161303189|NCT01683266|582492863|FG001|Overall Study|Lack of Efficacy|2|||
161303190|NCT01683266|582492862|FG000|Overall Study|Protocol Violation|13|||
161303191|NCT01683266|582492863|FG001|Overall Study|Protocol Violation|6|||
161303192|NCT01683266|582492862|FG000|Overall Study|Personal Reason|17|||
161303193|NCT01683266|582492863|FG001|Overall Study|Personal Reason|25|||
161303194|NCT01683266|582492862|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
161303195|NCT01683266|582492863|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
161303196|NCT01683266|582492862|FG000|Overall Study|Lost to Follow-up|5|||
161303197|NCT01683266|582492863|FG001|Overall Study|Lost to Follow-up|0|||
161303198|NCT01683266|582492862|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
161303199|NCT01683266|582492863|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
161303200|NCT01683266|582492862|FG000|Overall Study|Nonserious Hypoglycemia|0|||
161303201|NCT01683266|582492863|FG001|Overall Study|Nonserious Hypoglycemia|3|||
161303202|NCT01683266|582492862|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161303203|NCT01683266|582492863|FG001|Overall Study|Perceived Lack of Efficacy|1|||
161303204|NCT01683266|582492862|FG000|Overall Study|Possibly Hypoglycemia|1|||
161303205|NCT01683266|582492863|FG001|Overall Study|Possibly Hypoglycemia|0|||
161303206|NCT01683266|582492862|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
161303207|NCT01683266|582492863|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
161303208|NCT02217410|582492866|FG000|Overall Study|Graft Loss|0|||
161303209|NCT02217410|582492867|FG001|Overall Study|Graft Loss|0|||
161303210|NCT02217410|582492868|FG002|Overall Study|Graft Loss|2|||
161303211|NCT02217410|582492866|FG000|Overall Study|Withdrawal by Subject|0|||
161303212|NCT02217410|582492867|FG001|Overall Study|Withdrawal by Subject|0|||
161303213|NCT02217410|582492868|FG002|Overall Study|Withdrawal by Subject|2|||
161303214|NCT02217410|582492866|FG000|Overall Study|Lost to Follow-up|0|||
161303215|NCT02217410|582492867|FG001|Overall Study|Lost to Follow-up|0|||
161303216|NCT02217410|582492868|FG002|Overall Study|Lost to Follow-up|1|||
161303217|NCT02217410|582492866|FG000|Overall Study|Lack of Efficacy|0|||
161303218|NCT02217410|582492867|FG001|Overall Study|Lack of Efficacy|1|||
161303219|NCT02217410|582492868|FG002|Overall Study|Lack of Efficacy|0|||
161303220|NCT02217410|582492866|FG000|Overall Study|Physician Decision|1|||
161303221|NCT02217410|582492867|FG001|Overall Study|Physician Decision|3|||
161303222|NCT02217410|582492868|FG002|Overall Study|Physician Decision|0|||
161303223|NCT00626821|582492871|FG000|Overall Study|Adverse Event|44|||
161303224|NCT00626821|582492871|FG000|Overall Study|Protocol Violation|33|||
161303225|NCT00626821|582492871|FG000|Overall Study|Withdrawal by Subject|10|||
161303226|NCT00626821|582492871|FG000|Overall Study|Physician Decision|9|||
161303227|NCT00626821|582492871|FG000|Overall Study|Product dysfunction|21|||
161303228|NCT00626821|582492871|FG000|Overall Study|other/unknown reason|104|||
161303229|NCT00090220|582492872|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
161303230|NCT00090220|582492873|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
161303231|NCT00090220|582492874|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161303232|NCT00090220|582492875|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161303233|NCT00090220|582492876|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161303234|NCT00090220|582492877|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
161303235|NCT00090220|582492872|FG000|Base Study Vaccination Period|Adverse Event|6|||
161303236|NCT00090220|582492873|FG001|Base Study Vaccination Period|Adverse Event|1|||
161303237|NCT00090220|582492874|FG002|Base Study Vaccination Period|Adverse Event|0|||
161303238|NCT00090220|582492875|FG003|Base Study Vaccination Period|Adverse Event|0|||
161303239|NCT00090220|582492876|FG004|Base Study Vaccination Period|Adverse Event|0|||
161303240|NCT00090220|582492877|FG005|Base Study Vaccination Period|Adverse Event|0|||
161303241|NCT00090220|582492872|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
161303242|NCT00090220|582492873|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
161303243|NCT00090220|582492874|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
161303244|NCT00090220|582492875|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
161303245|NCT00090220|582492876|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
161303246|NCT00090220|582492877|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
161303247|NCT00090220|582492872|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
161303248|NCT00090220|582492873|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
161303249|NCT00090220|582492874|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
161303250|NCT00090220|582492875|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
161303251|NCT00090220|582492876|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
161303252|NCT00090220|582492877|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
161303253|NCT00090220|582492872|FG000|Base Study Vaccination Period|Patient Moved|6|||
161303254|NCT00090220|582492873|FG001|Base Study Vaccination Period|Patient Moved|2|||
161347984|NCT02924376|582657406|FG000|Overall Study|Withdrawal by Subject|7|||
161303255|NCT00090220|582492874|FG002|Base Study Vaccination Period|Patient Moved|0|||
161303256|NCT00090220|582492875|FG003|Base Study Vaccination Period|Patient Moved|0|||
161183776|NCT01388491|582049122|FG001|Overall Study|Adverse Event|9|||
161183777|NCT01388491|582049121|FG000|Overall Study|Sponsor Request|9|||
161183778|NCT01388491|582049122|FG001|Overall Study|Sponsor Request|7|||
161183779|NCT01388491|582049121|FG000|Overall Study|Withdrawal by Subject|6|||
161183780|NCT01388491|582049122|FG001|Overall Study|Withdrawal by Subject|10|||
161183781|NCT01388491|582049121|FG000|Overall Study|Lost to Follow-up|4|||
161183782|NCT01388491|582049122|FG001|Overall Study|Lost to Follow-up|3|||
161183783|NCT01388491|582049121|FG000|Overall Study|Protocol Violation|2|||
161183784|NCT01388491|582049122|FG001|Overall Study|Protocol Violation|0|||
161183785|NCT01388491|582049121|FG000|Overall Study|Noncompliance|2|||
161183786|NCT01388491|582049122|FG001|Overall Study|Noncompliance|0|||
161183787|NCT01388491|582049121|FG000|Overall Study|Pregnancy|1|||
161183788|NCT01388491|582049122|FG001|Overall Study|Pregnancy|0|||
161183789|NCT00112840|582049123|FG000|Overall Study|Physician Decision|1|||
161183790|NCT00112840|582049124|FG001|Overall Study|Physician Decision|0|||
161183791|NCT00112840|582049125|FG002|Overall Study|Physician Decision|0|||
161183792|NCT00112840|582049123|FG000|Overall Study|Withdrawal by Subject|1|||
161183793|NCT00112840|582049124|FG001|Overall Study|Withdrawal by Subject|0|||
161183794|NCT00112840|582049125|FG002|Overall Study|Withdrawal by Subject|1|||
161183795|NCT00112840|582049123|FG000|Overall Study|Protocol Violation|0|||
161183796|NCT00112840|582049124|FG001|Overall Study|Protocol Violation|0|||
161183797|NCT00112840|582049125|FG002|Overall Study|Protocol Violation|5|||
161183798|NCT02875366|582049126|FG000|Overall Study|Adverse Event|0|||
161183799|NCT02875366|582049127|FG001|Overall Study|Adverse Event|2|||
161183800|NCT02875366|582049126|FG000|Overall Study|Noncompliance|0|||
161183801|NCT02875366|582049127|FG001|Overall Study|Noncompliance|1|||
161183802|NCT00683774|582049128|FG000|Overall Study|Withdrawal by Subject|0|||
161183803|NCT00683774|582049129|FG001|Overall Study|Withdrawal by Subject|1|||
161183804|NCT00683774|582049128|FG000|Overall Study|Physician Decision|3|||
161183805|NCT00683774|582049129|FG001|Overall Study|Physician Decision|0|||
161183806|NCT00412113|582049130|FG000|Overall Study|Adverse Event|11|||
161183807|NCT00412113|582049131|FG001|Overall Study|Adverse Event|15|||
161183808|NCT00412113|582049130|FG000|Overall Study|did not receive treatment|1|||
161183809|NCT00412113|582049131|FG001|Overall Study|did not receive treatment|0|||
161183810|NCT01201967|582049132|FG000|Overall Study|Lost to Follow-up|6|||
161183811|NCT01201967|582049133|FG001|Overall Study|Lost to Follow-up|5|||
161183812|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
161183813|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
161183814|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
161183815|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
161183816|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Other|13|||
161183817|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
161183818|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
161183819|NCT02497287|582049134|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
161183820|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
161183821|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
161183822|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
161183823|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
161183824|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
161183825|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
161183826|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
161183827|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
161183828|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
161183829|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
161183830|NCT02497287|582049134|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
161183831|NCT02497287|582049134|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
161183832|NCT02497287|582049134|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
161183833|NCT02497287|582049134|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
161303257|NCT00090220|582492876|FG004|Base Study Vaccination Period|Patient Moved|0|||
161303258|NCT00090220|582492877|FG005|Base Study Vaccination Period|Patient Moved|0|||
161303259|NCT00090220|582492872|FG000|Base Study Vaccination Period|Other|4|||
161303260|NCT00090220|582492873|FG001|Base Study Vaccination Period|Other|4|||
161303261|NCT00090220|582492874|FG002|Base Study Vaccination Period|Other|0|||
161183834|NCT02497287|582049134|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
161183835|NCT02497287|582049134|FG000|Follow-up Phase (4 Week)|Other|1|||
161183836|NCT01226472|582049136|FG000|Overall Study|Progressive Disease|1|||
161183837|NCT03128307|582049139|FG000|Overall Study|Lost to Follow-up|29|||
161183838|NCT03128307|582049139|FG000|Overall Study|Withdrawal by Subject|5|||
161303262|NCT00090220|582492875|FG003|Base Study Vaccination Period|Other|0|||
161183839|NCT00121485|582051107|FG000|Overall Study|Not implanted|1|||
161183840|NCT00121485|582051108|FG001|Overall Study|Not implanted|5|||
161183841|NCT00121485|582051107|FG000|Overall Study|Crossover|0|||
161183842|NCT00121485|582051108|FG001|Overall Study|Crossover|2|||
161183843|NCT02425891|582051109|FG000|Overall Study|Death|333|||
161183844|NCT02425891|582051110|FG001|Overall Study|Death|314|||
161303263|NCT00090220|582492876|FG004|Base Study Vaccination Period|Other|0|||
161303264|NCT00090220|582492877|FG005|Base Study Vaccination Period|Other|0|||
161303265|NCT00090220|582492872|FG000|Base Study Follow-up Period|Adverse Event|6|||
161303266|NCT00090220|582492873|FG001|Base Study Follow-up Period|Adverse Event|1|||
161303267|NCT00090220|582492874|FG002|Base Study Follow-up Period|Adverse Event|0|||
161303268|NCT00090220|582492875|FG003|Base Study Follow-up Period|Adverse Event|0|||
161303269|NCT00090220|582492876|FG004|Base Study Follow-up Period|Adverse Event|0|||
161303270|NCT00090220|582492877|FG005|Base Study Follow-up Period|Adverse Event|0|||
161303271|NCT00090220|582492872|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
161303272|NCT00090220|582492873|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
161303273|NCT00090220|582492874|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
161303274|NCT00090220|582492875|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
161303275|NCT00090220|582492876|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
161303276|NCT00090220|582492877|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
161303277|NCT00090220|582492872|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
161303278|NCT00090220|582492873|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
161303279|NCT00090220|582492874|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
161303280|NCT00090220|582492875|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
161303281|NCT00090220|582492876|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
161303282|NCT00090220|582492877|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
161303283|NCT00090220|582492872|FG000|Base Study Follow-up Period|Patient Moved|20|||
161303284|NCT00090220|582492873|FG001|Base Study Follow-up Period|Patient Moved|28|||
161303285|NCT00090220|582492874|FG002|Base Study Follow-up Period|Patient Moved|0|||
161303286|NCT00090220|582492875|FG003|Base Study Follow-up Period|Patient Moved|0|||
161303287|NCT00090220|582492876|FG004|Base Study Follow-up Period|Patient Moved|0|||
161303288|NCT00090220|582492877|FG005|Base Study Follow-up Period|Patient Moved|0|||
161303289|NCT00090220|582492872|FG000|Base Study Follow-up Period|Other|19|||
161303290|NCT00090220|582492873|FG001|Base Study Follow-up Period|Other|21|||
161303291|NCT00090220|582492874|FG002|Base Study Follow-up Period|Other|0|||
161303292|NCT00090220|582492875|FG003|Base Study Follow-up Period|Other|0|||
161303293|NCT00090220|582492876|FG004|Base Study Follow-up Period|Other|0|||
161303294|NCT00090220|582492877|FG005|Base Study Follow-up Period|Other|0|||
161303295|NCT00090220|582492872|FG000|Extension 1 (EXT1)|Adverse Event|0|||
161303296|NCT00090220|582492873|FG001|Extension 1 (EXT1)|Adverse Event|0|||
161303297|NCT00090220|582492874|FG002|Extension 1 (EXT1)|Adverse Event|4|||
161303298|NCT00090220|582492875|FG003|Extension 1 (EXT1)|Adverse Event|0|||
161303299|NCT00090220|582492876|FG004|Extension 1 (EXT1)|Adverse Event|0|||
161303300|NCT00090220|582492877|FG005|Extension 1 (EXT1)|Adverse Event|0|||
161183845|NCT02425891|582051109|FG000|Overall Study|Lost to Follow-up|4|||
161183846|NCT02425891|582051110|FG001|Overall Study|Lost to Follow-up|6|||
161183847|NCT02425891|582051109|FG000|Overall Study|Non-Compliance|1|||
161183848|NCT02425891|582051110|FG001|Overall Study|Non-Compliance|1|||
161183849|NCT02425891|582051109|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
161183850|NCT02425891|582051110|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
161183851|NCT02425891|582051109|FG000|Overall Study|Physician Decision|0|||
161303301|NCT00090220|582492872|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
161303302|NCT00090220|582492873|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
161303303|NCT00090220|582492874|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
161303304|NCT00090220|582492875|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
161303305|NCT00090220|582492876|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
161303306|NCT00090220|582492877|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
161303307|NCT00090220|582492872|FG000|Extension 1 (EXT1)|Moved|0|||
161303308|NCT00090220|582492873|FG001|Extension 1 (EXT1)|Moved|0|||
161303309|NCT00090220|582492874|FG002|Extension 1 (EXT1)|Moved|2|||
161303310|NCT00090220|582492875|FG003|Extension 1 (EXT1)|Moved|1|||
161303311|NCT00090220|582492876|FG004|Extension 1 (EXT1)|Moved|0|||
161303312|NCT00090220|582492877|FG005|Extension 1 (EXT1)|Moved|0|||
161303313|NCT00090220|582492872|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161303314|NCT00090220|582492873|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161303315|NCT00090220|582492874|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
161303316|NCT00090220|582492875|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161303317|NCT00090220|582492876|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161303318|NCT00090220|582492877|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
161303319|NCT00090220|582492872|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
161303320|NCT00090220|582492873|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
161303321|NCT00090220|582492874|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
161303322|NCT00090220|582492875|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
161303323|NCT00090220|582492876|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
161303324|NCT00090220|582492877|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
161303325|NCT00090220|582492872|FG000|Extension 1 (EXT1)|Other reason|0|||
161303326|NCT00090220|582492873|FG001|Extension 1 (EXT1)|Other reason|0|||
161303327|NCT00090220|582492874|FG002|Extension 1 (EXT1)|Other reason|2|||
161303328|NCT00090220|582492875|FG003|Extension 1 (EXT1)|Other reason|0|||
161303329|NCT00090220|582492876|FG004|Extension 1 (EXT1)|Other reason|0|||
161303330|NCT00090220|582492877|FG005|Extension 1 (EXT1)|Other reason|0|||
161303331|NCT00090220|582492872|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161303332|NCT00090220|582492873|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161303333|NCT00090220|582492874|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161303334|NCT00090220|582492875|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
161303335|NCT00090220|582492876|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
161303336|NCT00090220|582492877|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
161303337|NCT00090220|582492872|FG000|Long-term Follow-up (EXT2)|Death|0|||
161303338|NCT00090220|582492873|FG001|Long-term Follow-up (EXT2)|Death|0|||
161303339|NCT00090220|582492874|FG002|Long-term Follow-up (EXT2)|Death|0|||
161303340|NCT00090220|582492875|FG003|Long-term Follow-up (EXT2)|Death|0|||
161303341|NCT00090220|582492876|FG004|Long-term Follow-up (EXT2)|Death|1|||
161303342|NCT00090220|582492877|FG005|Long-term Follow-up (EXT2)|Death|1|||
161303343|NCT00090220|582492872|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161303344|NCT00090220|582492873|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161303345|NCT00090220|582492874|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161303346|NCT00090220|582492875|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
161303347|NCT00090220|582492876|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
161303348|NCT00090220|582492877|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
161303349|NCT00090220|582492872|FG000|Long-term Follow-up (EXT2)|Other|0|||
161303350|NCT00090220|582492873|FG001|Long-term Follow-up (EXT2)|Other|0|||
161303351|NCT00090220|582492874|FG002|Long-term Follow-up (EXT2)|Other|0|||
161303352|NCT00090220|582492875|FG003|Long-term Follow-up (EXT2)|Other|0|||
161303353|NCT00090220|582492876|FG004|Long-term Follow-up (EXT2)|Other|1|||
161303354|NCT00090220|582492877|FG005|Long-term Follow-up (EXT2)|Other|0|||
161303355|NCT00941863|582492878|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
161303356|NCT00941863|582492879|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
161303357|NCT00941863|582492880|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
161303358|NCT00941863|582492881|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
161303359|NCT00941863|582492882|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
161303360|NCT00941863|582492878|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
161303361|NCT00941863|582492879|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
161303362|NCT00941863|582492880|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
161303363|NCT00941863|582492881|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
161303364|NCT00941863|582492882|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
161303365|NCT00941863|582492878|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161303366|NCT00941863|582492879|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161303367|NCT00941863|582492880|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
161303368|NCT00941863|582492881|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
161303369|NCT00941863|582492882|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
161303370|NCT00941863|582492878|FG000|Until Primary Completion Date (PCD)|Death|0|||
161303371|NCT00941863|582492879|FG001|Until Primary Completion Date (PCD)|Death|0|||
161303372|NCT00941863|582492880|FG002|Until Primary Completion Date (PCD)|Death|1|||
161303373|NCT00941863|582492881|FG003|Until Primary Completion Date (PCD)|Death|2|||
161303374|NCT00941863|582492882|FG004|Until Primary Completion Date (PCD)|Death|7|||
161303375|NCT00941863|582492878|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
161303376|NCT00941863|582492879|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
161303377|NCT00941863|582492880|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
161303378|NCT00941863|582492881|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
161303379|NCT00941863|582492882|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
161303380|NCT00941863|582492878|FG000|Continued After PCD|Withdrawal by Subject|0|||
161303381|NCT00941863|582492879|FG001|Continued After PCD|Withdrawal by Subject|0|||
161303382|NCT00941863|582492880|FG002|Continued After PCD|Withdrawal by Subject|0|||
161303383|NCT00941863|582492881|FG003|Continued After PCD|Withdrawal by Subject|0|||
161303384|NCT00941863|582492882|FG004|Continued After PCD|Withdrawal by Subject|1|||
161303385|NCT00941863|582492878|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
161303386|NCT00941863|582492879|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
161303387|NCT00941863|582492880|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
161303388|NCT00941863|582492881|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
161303389|NCT00941863|582492882|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
161303390|NCT01471340|582492883|FG000|Overall Study|Death|5|||
161303391|NCT01471340|582492884|FG001|Overall Study|Death|4|||
161303392|NCT01471340|582492883|FG000|Overall Study|Lost to Follow-up|0|||
161303393|NCT01471340|582492884|FG001|Overall Study|Lost to Follow-up|1|||
161303394|NCT01471340|582492883|FG000|Overall Study|Investigational site closure|0|||
161347985|NCT02924376|582657407|FG001|Overall Study|Withdrawal by Subject|2|||
161347986|NCT02924376|582657408|FG002|Overall Study|Withdrawal by Subject|1|||
161347987|NCT02924376|582657409|FG003|Overall Study|Withdrawal by Subject|0|||
161303395|NCT01471340|582492884|FG001|Overall Study|Investigational site closure|1|||
161303396|NCT01471340|582492883|FG000|Overall Study|Invalid informed consent|1|||
161303397|NCT01471340|582492884|FG001|Overall Study|Invalid informed consent|0|||
161303398|NCT03452488|582492888|FG000|Overall Study|Adverse Event|4|||
161303399|NCT03452488|582492889|FG001|Overall Study|Adverse Event|6|||
161303400|NCT03452488|582492890|FG002|Overall Study|Adverse Event|1|||
161303401|NCT03452488|582492888|FG000|Overall Study|Death|0|||
161303402|NCT03452488|582492889|FG001|Overall Study|Death|0|||
161303403|NCT03452488|582492890|FG002|Overall Study|Death|1|||
161303404|NCT03452488|582492888|FG000|Overall Study|Lost to Follow-up|1|||
161303405|NCT03452488|582492889|FG001|Overall Study|Lost to Follow-up|2|||
161303406|NCT03452488|582492890|FG002|Overall Study|Lost to Follow-up|0|||
161303407|NCT03452488|582492888|FG000|Overall Study|PI Decision|1|||
161303408|NCT03452488|582492889|FG001|Overall Study|PI Decision|0|||
161303409|NCT03452488|582492890|FG002|Overall Study|PI Decision|0|||
161347988|NCT02924376|582657406|FG000|Overall Study|Rolled Over to Another Study|1|||
161303410|NCT03452488|582492888|FG000|Overall Study|Withdrew consent|4|||
161303411|NCT03452488|582492889|FG001|Overall Study|Withdrew consent|2|||
161303412|NCT03452488|582492890|FG002|Overall Study|Withdrew consent|2|||
161303413|NCT03452488|582492888|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
161303414|NCT03452488|582492889|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
161303415|NCT03452488|582492890|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
161303416|NCT03452488|582492888|FG000|Overall Study|Other|0|||
161303417|NCT03452488|582492889|FG001|Overall Study|Other|2|||
161303418|NCT03452488|582492890|FG002|Overall Study|Other|2|||
161303419|NCT03315286|582492891|FG000|Overall Study|Lost to Follow-up|0|||
161303420|NCT03315286|582492892|FG001|Overall Study|Lost to Follow-up|3|||
161303421|NCT03315286|582492891|FG000|Overall Study|Withdrawal by Subject|1|||
161303422|NCT03315286|582492892|FG001|Overall Study|Withdrawal by Subject|0|||
161303423|NCT03315286|582492891|FG000|Overall Study|Protocol Violation|0|||
161303424|NCT03315286|582492892|FG001|Overall Study|Protocol Violation|1|||
161303425|NCT00747474|582492894|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303426|NCT00747474|582492895|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303427|NCT00747474|582492896|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303428|NCT00747474|582492897|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303429|NCT00747474|582492898|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303430|NCT00747474|582492899|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303431|NCT00747474|582492900|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303432|NCT00747474|582492901|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
161303433|NCT00747474|582492902|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303434|NCT00747474|582492903|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303435|NCT00747474|582492904|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303436|NCT00747474|582492905|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
161303437|NCT02829723|582492906|FG000|Overall Study|Adverse Event|0|||
161303438|NCT02829723|582492907|FG001|Overall Study|Adverse Event|0|||
161303439|NCT02829723|582492908|FG002|Overall Study|Adverse Event|1|||
161303440|NCT02829723|582492909|FG003|Overall Study|Adverse Event|1|||
161303441|NCT02829723|582492910|FG004|Overall Study|Adverse Event|0|||
161303442|NCT02829723|582492911|FG005|Overall Study|Adverse Event|0|||
161303443|NCT02829723|582492912|FG006|Overall Study|Adverse Event|0|||
161303444|NCT02829723|582492913|FG007|Overall Study|Adverse Event|1|||
161303445|NCT02829723|582492914|FG008|Overall Study|Adverse Event|0|||
161303446|NCT02829723|582492915|FG009|Overall Study|Adverse Event|0|||
161303447|NCT02829723|582492916|FG010|Overall Study|Adverse Event|0|||
161303448|NCT02829723|582492917|FG011|Overall Study|Adverse Event|0|||
161303449|NCT02829723|582492918|FG012|Overall Study|Adverse Event|0|||
161303450|NCT02829723|582492919|FG013|Overall Study|Adverse Event|0|||
161303451|NCT02829723|582492920|FG014|Overall Study|Adverse Event|1|||
161303452|NCT02829723|582492921|FG015|Overall Study|Adverse Event|1|||
161303453|NCT02829723|582492922|FG016|Overall Study|Adverse Event|1|||
161303454|NCT02829723|582492923|FG017|Overall Study|Adverse Event|2|||
161303455|NCT02829723|582492924|FG018|Overall Study|Adverse Event|1|||
161303456|NCT02829723|582492925|FG019|Overall Study|Adverse Event|1|||
161303457|NCT02829723|582492926|FG020|Overall Study|Adverse Event|3|||
161303458|NCT02829723|582492927|FG021|Overall Study|Adverse Event|0|||
161303459|NCT02829723|582492928|FG022|Overall Study|Adverse Event|0|||
161303460|NCT02829723|582492929|FG023|Overall Study|Adverse Event|1|||
161303461|NCT02829723|582492930|FG024|Overall Study|Adverse Event|1|||
161303462|NCT02829723|582492931|FG025|Overall Study|Adverse Event|3|||
161303463|NCT02829723|582492932|FG026|Overall Study|Adverse Event|5|||
161303464|NCT02829723|582492906|FG000|Overall Study|Death|1|||
161303465|NCT02829723|582492907|FG001|Overall Study|Death|0|||
161303466|NCT02829723|582492908|FG002|Overall Study|Death|1|||
161303467|NCT02829723|582492909|FG003|Overall Study|Death|1|||
161303468|NCT02829723|582492910|FG004|Overall Study|Death|0|||
161303469|NCT02829723|582492911|FG005|Overall Study|Death|0|||
161303470|NCT02829723|582492912|FG006|Overall Study|Death|2|||
161303471|NCT02829723|582492913|FG007|Overall Study|Death|0|||
161303472|NCT02829723|582492914|FG008|Overall Study|Death|1|||
161303473|NCT02829723|582492915|FG009|Overall Study|Death|0|||
161303474|NCT02829723|582492916|FG010|Overall Study|Death|0|||
161303475|NCT02829723|582492917|FG011|Overall Study|Death|0|||
161303476|NCT02829723|582492918|FG012|Overall Study|Death|2|||
161303477|NCT02829723|582492919|FG013|Overall Study|Death|1|||
161303478|NCT02829723|582492920|FG014|Overall Study|Death|0|||
161303479|NCT02829723|582492921|FG015|Overall Study|Death|0|||
161303480|NCT02829723|582492922|FG016|Overall Study|Death|0|||
161303481|NCT02829723|582492923|FG017|Overall Study|Death|0|||
161303482|NCT02829723|582492924|FG018|Overall Study|Death|0|||
161303483|NCT02829723|582492925|FG019|Overall Study|Death|0|||
161303484|NCT02829723|582492926|FG020|Overall Study|Death|0|||
161303485|NCT02829723|582492927|FG021|Overall Study|Death|2|||
161303486|NCT02829723|582492928|FG022|Overall Study|Death|0|||
161303487|NCT02829723|582492929|FG023|Overall Study|Death|0|||
161303488|NCT02829723|582492930|FG024|Overall Study|Death|0|||
161303489|NCT02829723|582492931|FG025|Overall Study|Death|1|||
161303490|NCT02829723|582492932|FG026|Overall Study|Death|2|||
161303491|NCT02829723|582492906|FG000|Overall Study|Physician Decision|0|||
161303492|NCT02829723|582492907|FG001|Overall Study|Physician Decision|0|||
161303493|NCT02829723|582492908|FG002|Overall Study|Physician Decision|0|||
161303494|NCT02829723|582492909|FG003|Overall Study|Physician Decision|0|||
161303495|NCT02829723|582492910|FG004|Overall Study|Physician Decision|0|||
161303496|NCT02829723|582492911|FG005|Overall Study|Physician Decision|0|||
161303497|NCT02829723|582492912|FG006|Overall Study|Physician Decision|0|||
161303498|NCT02829723|582492913|FG007|Overall Study|Physician Decision|0|||
161303499|NCT02829723|582492914|FG008|Overall Study|Physician Decision|0|||
161303500|NCT02829723|582492915|FG009|Overall Study|Physician Decision|1|||
161303501|NCT02829723|582492916|FG010|Overall Study|Physician Decision|1|||
161303502|NCT02829723|582492917|FG011|Overall Study|Physician Decision|0|||
161303503|NCT02829723|582492918|FG012|Overall Study|Physician Decision|0|||
161303504|NCT02829723|582492919|FG013|Overall Study|Physician Decision|1|||
161303505|NCT02829723|582492920|FG014|Overall Study|Physician Decision|0|||
161303506|NCT02829723|582492921|FG015|Overall Study|Physician Decision|0|||
161303507|NCT02829723|582492922|FG016|Overall Study|Physician Decision|2|||
161303508|NCT02829723|582492923|FG017|Overall Study|Physician Decision|0|||
161303509|NCT02829723|582492924|FG018|Overall Study|Physician Decision|0|||
161303510|NCT02829723|582492925|FG019|Overall Study|Physician Decision|0|||
161303511|NCT02829723|582492926|FG020|Overall Study|Physician Decision|0|||
161303512|NCT02829723|582492927|FG021|Overall Study|Physician Decision|0|||
161303513|NCT02829723|582492928|FG022|Overall Study|Physician Decision|1|||
161303514|NCT02829723|582492929|FG023|Overall Study|Physician Decision|1|||
161303515|NCT02829723|582492930|FG024|Overall Study|Physician Decision|1|||
161303516|NCT02829723|582492931|FG025|Overall Study|Physician Decision|1|||
161303517|NCT02829723|582492932|FG026|Overall Study|Physician Decision|3|||
161303518|NCT02829723|582492906|FG000|Overall Study|Progressive disease|4|||
161303519|NCT02829723|582492907|FG001|Overall Study|Progressive disease|6|||
161303520|NCT02829723|582492908|FG002|Overall Study|Progressive disease|3|||
161303521|NCT02829723|582492909|FG003|Overall Study|Progressive disease|3|||
161303522|NCT02829723|582492910|FG004|Overall Study|Progressive disease|3|||
161303523|NCT02829723|582492911|FG005|Overall Study|Progressive disease|5|||
161303524|NCT02829723|582492912|FG006|Overall Study|Progressive disease|4|||
161303525|NCT02829723|582492913|FG007|Overall Study|Progressive disease|6|||
161303526|NCT02829723|582492914|FG008|Overall Study|Progressive disease|8|||
161303527|NCT02829723|582492915|FG009|Overall Study|Progressive disease|4|||
161303528|NCT02829723|582492916|FG010|Overall Study|Progressive disease|9|||
161303529|NCT02829723|582492917|FG011|Overall Study|Progressive disease|0|||
161303530|NCT02829723|582492918|FG012|Overall Study|Progressive disease|3|||
161303531|NCT02829723|582492919|FG013|Overall Study|Progressive disease|4|||
161303532|NCT02829723|582492920|FG014|Overall Study|Progressive disease|2|||
161303533|NCT02829723|582492921|FG015|Overall Study|Progressive disease|4|||
161303534|NCT02829723|582492922|FG016|Overall Study|Progressive disease|5|||
161303535|NCT02829723|582492923|FG017|Overall Study|Progressive disease|3|||
161303536|NCT02829723|582492924|FG018|Overall Study|Progressive disease|4|||
161303537|NCT02829723|582492925|FG019|Overall Study|Progressive disease|4|||
161303538|NCT02829723|582492926|FG020|Overall Study|Progressive disease|7|||
161303539|NCT02829723|582492927|FG021|Overall Study|Progressive disease|6|||
161303540|NCT02829723|582492928|FG022|Overall Study|Progressive disease|3|||
161347989|NCT02924376|582657407|FG001|Overall Study|Rolled Over to Another Study|0|||
161347990|NCT02924376|582657408|FG002|Overall Study|Rolled Over to Another Study|0|||
161303541|NCT02829723|582492929|FG023|Overall Study|Progressive disease|3|||
161303542|NCT02829723|582492930|FG024|Overall Study|Progressive disease|3|||
161303543|NCT02829723|582492931|FG025|Overall Study|Progressive disease|16|||
161303544|NCT02829723|582492932|FG026|Overall Study|Progressive disease|10|||
161303545|NCT02829723|582492906|FG000|Overall Study|Subject/guardian decision|0|||
161303546|NCT02829723|582492907|FG001|Overall Study|Subject/guardian decision|1|||
161303547|NCT02829723|582492908|FG002|Overall Study|Subject/guardian decision|0|||
161303548|NCT02829723|582492909|FG003|Overall Study|Subject/guardian decision|1|||
161303549|NCT02829723|582492910|FG004|Overall Study|Subject/guardian decision|0|||
161303550|NCT02829723|582492911|FG005|Overall Study|Subject/guardian decision|0|||
161303551|NCT02829723|582492912|FG006|Overall Study|Subject/guardian decision|0|||
161303552|NCT02829723|582492913|FG007|Overall Study|Subject/guardian decision|1|||
161303553|NCT02829723|582492914|FG008|Overall Study|Subject/guardian decision|0|||
161303554|NCT02829723|582492915|FG009|Overall Study|Subject/guardian decision|0|||
161303555|NCT02829723|582492916|FG010|Overall Study|Subject/guardian decision|0|||
161303556|NCT02829723|582492917|FG011|Overall Study|Subject/guardian decision|0|||
161303557|NCT02829723|582492918|FG012|Overall Study|Subject/guardian decision|0|||
161089677|NCT03184870|581719804|FG013|Initial Treatment|Other Reasons|0|||
161089678|NCT03184870|581719805|FG014|Initial Treatment|Other Reasons|0|||
161089679|NCT03184870|581719806|FG015|Initial Treatment|Other Reasons|1|||
161089680|NCT03184870|581719807|FG016|Initial Treatment|Other Reasons|0|||
161089681|NCT03184870|581719808|FG017|Initial Treatment|Other Reasons|2|||
161089682|NCT03184870|581719791|FG000|Initial Treatment|Lost to Follow-up|2|||
161089683|NCT03184870|581719792|FG001|Initial Treatment|Lost to Follow-up|0|||
161089684|NCT03184870|581719793|FG002|Initial Treatment|Lost to Follow-up|0|||
161089685|NCT03184870|581719794|FG003|Initial Treatment|Lost to Follow-up|1|||
161089686|NCT03184870|581719795|FG004|Initial Treatment|Lost to Follow-up|1|||
161089687|NCT03184870|581719796|FG005|Initial Treatment|Lost to Follow-up|1|||
161089688|NCT03184870|581719797|FG006|Initial Treatment|Lost to Follow-up|0|||
161089689|NCT03184870|581719798|FG007|Initial Treatment|Lost to Follow-up|2|||
161089690|NCT03184870|581719799|FG008|Initial Treatment|Lost to Follow-up|0|||
161089691|NCT03184870|581719800|FG009|Initial Treatment|Lost to Follow-up|0|||
161089692|NCT03184870|581719801|FG010|Initial Treatment|Lost to Follow-up|2|||
161089693|NCT03184870|581719802|FG011|Initial Treatment|Lost to Follow-up|0|||
161089694|NCT03184870|581719803|FG012|Initial Treatment|Lost to Follow-up|2|||
161089695|NCT03184870|581719804|FG013|Initial Treatment|Lost to Follow-up|2|||
161089696|NCT03184870|581719805|FG014|Initial Treatment|Lost to Follow-up|0|||
161089697|NCT03184870|581719806|FG015|Initial Treatment|Lost to Follow-up|0|||
161089698|NCT03184870|581719807|FG016|Initial Treatment|Lost to Follow-up|2|||
161089699|NCT03184870|581719808|FG017|Initial Treatment|Lost to Follow-up|2|||
161089700|NCT03184870|581719791|FG000|Initial Treatment|Withdrawal by Subject|0|||
161089701|NCT03184870|581719792|FG001|Initial Treatment|Withdrawal by Subject|0|||
161089702|NCT03184870|581719793|FG002|Initial Treatment|Withdrawal by Subject|2|||
161089703|NCT03184870|581719794|FG003|Initial Treatment|Withdrawal by Subject|1|||
161089704|NCT03184870|581719795|FG004|Initial Treatment|Withdrawal by Subject|1|||
161089705|NCT03184870|581719796|FG005|Initial Treatment|Withdrawal by Subject|0|||
161089706|NCT03184870|581719797|FG006|Initial Treatment|Withdrawal by Subject|1|||
161089707|NCT03184870|581719798|FG007|Initial Treatment|Withdrawal by Subject|0|||
161089708|NCT03184870|581719799|FG008|Initial Treatment|Withdrawal by Subject|0|||
161089709|NCT03184870|581719800|FG009|Initial Treatment|Withdrawal by Subject|0|||
161089710|NCT03184870|581719801|FG010|Initial Treatment|Withdrawal by Subject|0|||
161089711|NCT03184870|581719802|FG011|Initial Treatment|Withdrawal by Subject|2|||
161089712|NCT03184870|581719803|FG012|Initial Treatment|Withdrawal by Subject|3|||
161089713|NCT03184870|581719804|FG013|Initial Treatment|Withdrawal by Subject|0|||
161089714|NCT03184870|581719805|FG014|Initial Treatment|Withdrawal by Subject|1|||
161089715|NCT03184870|581719806|FG015|Initial Treatment|Withdrawal by Subject|5|||
161089716|NCT03184870|581719807|FG016|Initial Treatment|Withdrawal by Subject|2|||
161089717|NCT03184870|581719808|FG017|Initial Treatment|Withdrawal by Subject|2|||
161089718|NCT03184870|581719791|FG000|Initial Treatment|Moved to crossover treatment|0|||
161089719|NCT03184870|581719792|FG001|Initial Treatment|Moved to crossover treatment|0|||
161089720|NCT03184870|581719793|FG002|Initial Treatment|Moved to crossover treatment|0|||
161089721|NCT03184870|581719794|FG003|Initial Treatment|Moved to crossover treatment|0|||
161089722|NCT03184870|581719795|FG004|Initial Treatment|Moved to crossover treatment|0|||
161089723|NCT03184870|581719796|FG005|Initial Treatment|Moved to crossover treatment|0|||
161089724|NCT03184870|581719797|FG006|Initial Treatment|Moved to crossover treatment|0|||
161089725|NCT03184870|581719798|FG007|Initial Treatment|Moved to crossover treatment|0|||
161089726|NCT03184870|581719799|FG008|Initial Treatment|Moved to crossover treatment|0|||
161089727|NCT03184870|581719800|FG009|Initial Treatment|Moved to crossover treatment|0|||
161089728|NCT03184870|581719801|FG010|Initial Treatment|Moved to crossover treatment|0|||
161089729|NCT03184870|581719802|FG011|Initial Treatment|Moved to crossover treatment|0|||
161089730|NCT03184870|581719803|FG012|Initial Treatment|Moved to crossover treatment|9|||
161089731|NCT03184870|581719804|FG013|Initial Treatment|Moved to crossover treatment|0|||
161089732|NCT03184870|581719805|FG014|Initial Treatment|Moved to crossover treatment|0|||
161089733|NCT03184870|581719806|FG015|Initial Treatment|Moved to crossover treatment|0|||
161089734|NCT03184870|581719807|FG016|Initial Treatment|Moved to crossover treatment|0|||
161089735|NCT03184870|581719808|FG017|Initial Treatment|Moved to crossover treatment|0|||
161089736|NCT03184870|581719791|FG000|Crossover Treatment|Other reasons|0|||
161089737|NCT03184870|581719792|FG001|Crossover Treatment|Other reasons|0|||
161089738|NCT03184870|581719793|FG002|Crossover Treatment|Other reasons|0|||
161089739|NCT03184870|581719794|FG003|Crossover Treatment|Other reasons|0|||
161089740|NCT03184870|581719795|FG004|Crossover Treatment|Other reasons|0|||
161089741|NCT03184870|581719796|FG005|Crossover Treatment|Other reasons|0|||
161089742|NCT03184870|581719797|FG006|Crossover Treatment|Other reasons|0|||
161089743|NCT03184870|581719798|FG007|Crossover Treatment|Other reasons|0|||
161089744|NCT03184870|581719799|FG008|Crossover Treatment|Other reasons|0|||
161089745|NCT03184870|581719800|FG009|Crossover Treatment|Other reasons|0|||
161089746|NCT03184870|581719801|FG010|Crossover Treatment|Other reasons|0|||
161089747|NCT03184870|581719802|FG011|Crossover Treatment|Other reasons|0|||
161089748|NCT03184870|581719803|FG012|Crossover Treatment|Other reasons|0|||
161089749|NCT03184870|581719804|FG013|Crossover Treatment|Other reasons|0|||
161089750|NCT03184870|581719805|FG014|Crossover Treatment|Other reasons|0|||
161089751|NCT03184870|581719806|FG015|Crossover Treatment|Other reasons|0|||
161183852|NCT02425891|582051110|FG001|Overall Study|Physician Decision|1|||
161183853|NCT02425891|582051109|FG000|Overall Study|Protocol Violation|1|||
161183854|NCT02425891|582051110|FG001|Overall Study|Protocol Violation|1|||
161183855|NCT02425891|582051109|FG000|Overall Study|Study Terminated By Sponsor|85|||
161183856|NCT02425891|582051110|FG001|Overall Study|Study Terminated By Sponsor|95|||
161183857|NCT02425891|582051109|FG000|Overall Study|Withdrawal by Subject|27|||
161183858|NCT02425891|582051110|FG001|Overall Study|Withdrawal by Subject|32|||
161183859|NCT00963469|582051111|FG000|Overall Study|Adverse Event|15|||
161183860|NCT00963469|582051112|FG001|Overall Study|Adverse Event|11|||
161183861|NCT00963469|582051113|FG002|Overall Study|Adverse Event|1|||
161183862|NCT00963469|582051111|FG000|Overall Study|Lack of Efficacy|10|||
161183863|NCT00963469|582051112|FG001|Overall Study|Lack of Efficacy|7|||
161183864|NCT00963469|582051113|FG002|Overall Study|Lack of Efficacy|2|||
161183865|NCT00963469|582051111|FG000|Overall Study|Lost to Follow-up|1|||
161183866|NCT00963469|582051112|FG001|Overall Study|Lost to Follow-up|1|||
161183867|NCT00963469|582051113|FG002|Overall Study|Lost to Follow-up|0|||
161183868|NCT00963469|582051111|FG000|Overall Study|Protocol Violation|5|||
161183869|NCT00963469|582051112|FG001|Overall Study|Protocol Violation|5|||
161183870|NCT00963469|582051113|FG002|Overall Study|Protocol Violation|3|||
161183871|NCT00963469|582051111|FG000|Overall Study|Withdrawal by Subject|4|||
161183872|NCT00963469|582051112|FG001|Overall Study|Withdrawal by Subject|1|||
161183873|NCT00963469|582051113|FG002|Overall Study|Withdrawal by Subject|1|||
161183874|NCT00963469|582051111|FG000|Overall Study|Pre-randomization Adverse Event|1|||
161183875|NCT00963469|582051112|FG001|Overall Study|Pre-randomization Adverse Event|2|||
161183876|NCT00963469|582051113|FG002|Overall Study|Pre-randomization Adverse Event|0|||
161183877|NCT00963469|582051111|FG000|Overall Study|Moved|1|||
161183878|NCT00963469|582051112|FG001|Overall Study|Moved|0|||
161183879|NCT00963469|582051113|FG002|Overall Study|Moved|0|||
161183880|NCT00963469|582051111|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
161183881|NCT00963469|582051112|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
161183882|NCT00963469|582051113|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
161183883|NCT02145429|582051116|FG000|Overall Study|Death|4|||
161183884|NCT02145429|582051117|FG001|Overall Study|Death|5|||
161183885|NCT02145429|582051116|FG000|Overall Study|Lost to Follow-up|4|||
161183886|NCT02145429|582051117|FG001|Overall Study|Lost to Follow-up|3|||
161183887|NCT02145429|582051116|FG000|Overall Study|Withdrawal by Subject|8|||
161183888|NCT02145429|582051117|FG001|Overall Study|Withdrawal by Subject|3|||
161183889|NCT02943577|582051118|FG000|Overall Study|Protocol Violation|0|||
161183890|NCT02943577|582051119|FG001|Overall Study|Protocol Violation|1|||
161183891|NCT02943577|582051118|FG000|Overall Study|Adverse Event|3|||
161183892|NCT02943577|582051119|FG001|Overall Study|Adverse Event|2|||
161183893|NCT02943577|582051118|FG000|Overall Study|Lost to Follow-up|0|||
161183894|NCT02943577|582051119|FG001|Overall Study|Lost to Follow-up|1|||
161183895|NCT02943577|582051118|FG000|Overall Study|Withdrawal by Subject|1|||
161183896|NCT02943577|582051119|FG001|Overall Study|Withdrawal by Subject|1|||
161183897|NCT02943577|582051118|FG000|Overall Study|Pregnancy|1|||
161183898|NCT02943577|582051119|FG001|Overall Study|Pregnancy|0|||
161183899|NCT03070119|582051130|FG000|Overall Study|Adverse Event|0|||
161183900|NCT03070119|582051131|FG001|Overall Study|Adverse Event|0|||
161183901|NCT03070119|582051132|FG002|Overall Study|Adverse Event|1|||
161183902|NCT03070119|582051130|FG000|Overall Study|Lost to Follow-up|0|||
161183903|NCT03070119|582051131|FG001|Overall Study|Lost to Follow-up|1|||
161183904|NCT03070119|582051132|FG002|Overall Study|Lost to Follow-up|0|||
161183905|NCT03070119|582051130|FG000|Overall Study|Consent Withdrawn|6|||
161183906|NCT03070119|582051131|FG001|Overall Study|Consent Withdrawn|5|||
161183907|NCT03070119|582051132|FG002|Overall Study|Consent Withdrawn|3|||
161183908|NCT03070119|582051130|FG000|Overall Study|Investigator Decision|0|||
161183909|NCT03070119|582051131|FG001|Overall Study|Investigator Decision|0|||
161183910|NCT03070119|582051132|FG002|Overall Study|Investigator Decision|1|||
161183911|NCT03070119|582051130|FG000|Overall Study|Death|7|||
161183912|NCT03070119|582051131|FG001|Overall Study|Death|14|||
161183913|NCT03070119|582051132|FG002|Overall Study|Death|5|||
161183914|NCT03070119|582051130|FG000|Overall Study|Disease Progression|5|||
161183915|NCT03070119|582051131|FG001|Overall Study|Disease Progression|7|||
161183916|NCT03070119|582051132|FG002|Overall Study|Disease Progression|7|||
161183917|NCT03070119|582051130|FG000|Overall Study|Reason not Specified|2|||
161183918|NCT03070119|582051131|FG001|Overall Study|Reason not Specified|2|||
161183919|NCT03070119|582051132|FG002|Overall Study|Reason not Specified|1|||
161183920|NCT02974621|582051133|FG000|Overall Study|Didn't receive study treatment|1|||
161183921|NCT02974621|582051134|FG001|Overall Study|Didn't receive study treatment|10|||
161183922|NCT00732472|582051135|FG000|Overall Study|Adverse Event|0|||
161347991|NCT02924376|582657409|FG003|Overall Study|Rolled Over to Another Study|0|||
161183923|NCT00732472|582051136|FG001|Overall Study|Adverse Event|1|||
161183924|NCT00732472|582051137|FG002|Overall Study|Adverse Event|1|||
161183925|NCT00732472|582051138|FG003|Overall Study|Adverse Event|1|||
161183926|NCT00732472|582051135|FG000|Overall Study|Protocol Violation|0|||
161183927|NCT00732472|582051136|FG001|Overall Study|Protocol Violation|0|||
161347992|NCT03608033|582657410|FG000|Treatment Period|Death|0|||
161183928|NCT00732472|582051137|FG002|Overall Study|Protocol Violation|0|||
161303558|NCT02829723|582492919|FG013|Overall Study|Subject/guardian decision|0|||
161303559|NCT02829723|582492920|FG014|Overall Study|Subject/guardian decision|1|||
161303560|NCT02829723|582492921|FG015|Overall Study|Subject/guardian decision|0|||
161303561|NCT02829723|582492922|FG016|Overall Study|Subject/guardian decision|1|||
161303562|NCT02829723|582492923|FG017|Overall Study|Subject/guardian decision|0|||
161303563|NCT02829723|582492924|FG018|Overall Study|Subject/guardian decision|1|||
161303564|NCT02829723|582492925|FG019|Overall Study|Subject/guardian decision|0|||
161303565|NCT02829723|582492926|FG020|Overall Study|Subject/guardian decision|1|||
161303566|NCT02829723|582492927|FG021|Overall Study|Subject/guardian decision|0|||
161303567|NCT02829723|582492928|FG022|Overall Study|Subject/guardian decision|0|||
161303568|NCT02829723|582492929|FG023|Overall Study|Subject/guardian decision|1|||
161303569|NCT02829723|582492930|FG024|Overall Study|Subject/guardian decision|0|||
161303570|NCT02829723|582492931|FG025|Overall Study|Subject/guardian decision|1|||
161303571|NCT02829723|582492932|FG026|Overall Study|Subject/guardian decision|1|||
161303572|NCT02829723|582492906|FG000|Overall Study|Study terminated by sponsor|0|||
161303573|NCT02829723|582492907|FG001|Overall Study|Study terminated by sponsor|0|||
161303574|NCT02829723|582492908|FG002|Overall Study|Study terminated by sponsor|0|||
161303575|NCT02829723|582492909|FG003|Overall Study|Study terminated by sponsor|0|||
161303576|NCT02829723|582492910|FG004|Overall Study|Study terminated by sponsor|0|||
161303577|NCT02829723|582492911|FG005|Overall Study|Study terminated by sponsor|0|||
161303578|NCT02829723|582492912|FG006|Overall Study|Study terminated by sponsor|0|||
161303579|NCT02829723|582492913|FG007|Overall Study|Study terminated by sponsor|0|||
161303580|NCT02829723|582492914|FG008|Overall Study|Study terminated by sponsor|0|||
161303581|NCT02829723|582492915|FG009|Overall Study|Study terminated by sponsor|0|||
161303582|NCT02829723|582492916|FG010|Overall Study|Study terminated by sponsor|0|||
161303583|NCT02829723|582492917|FG011|Overall Study|Study terminated by sponsor|0|||
161303584|NCT02829723|582492918|FG012|Overall Study|Study terminated by sponsor|0|||
161303585|NCT02829723|582492919|FG013|Overall Study|Study terminated by sponsor|0|||
161303586|NCT02829723|582492920|FG014|Overall Study|Study terminated by sponsor|0|||
161303587|NCT02829723|582492921|FG015|Overall Study|Study terminated by sponsor|0|||
161303588|NCT02829723|582492922|FG016|Overall Study|Study terminated by sponsor|0|||
161303589|NCT02829723|582492923|FG017|Overall Study|Study terminated by sponsor|0|||
161303590|NCT02829723|582492924|FG018|Overall Study|Study terminated by sponsor|0|||
161303591|NCT02829723|582492925|FG019|Overall Study|Study terminated by sponsor|0|||
161303592|NCT02829723|582492926|FG020|Overall Study|Study terminated by sponsor|0|||
161303593|NCT02829723|582492927|FG021|Overall Study|Study terminated by sponsor|1|||
161303594|NCT02829723|582492928|FG022|Overall Study|Study terminated by sponsor|0|||
161303595|NCT02829723|582492929|FG023|Overall Study|Study terminated by sponsor|0|||
161303596|NCT02829723|582492930|FG024|Overall Study|Study terminated by sponsor|0|||
161303597|NCT02829723|582492931|FG025|Overall Study|Study terminated by sponsor|0|||
161303598|NCT02829723|582492932|FG026|Overall Study|Study terminated by sponsor|0|||
161303599|NCT02989649|582492933|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
161303600|NCT02989649|582492933|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
161303601|NCT02989649|582492933|FG000|Overall Study|Lost For Observation During Study|3|||
161303602|NCT02989649|582492933|FG000|Overall Study|Reason Not Specified|13|||
161303603|NCT00330343|582492934|FG000|Overall Study|Lost to Follow-up|5|||
161303604|NCT00256854|582492935|FG000|Overall Study|Withdrawal by Subject|2|||
161303605|NCT00256854|582492936|FG001|Overall Study|Withdrawal by Subject|3|||
161303606|NCT00256854|582492937|FG002|Overall Study|Withdrawal by Subject|0|||
161303607|NCT00256854|582492938|FG003|Overall Study|Withdrawal by Subject|0|||
161303608|NCT00256854|582492939|FG004|Overall Study|Withdrawal by Subject|0|||
161303609|NCT00256854|582492940|FG005|Overall Study|Withdrawal by Subject|0|||
161303610|NCT00256854|582492935|FG000|Overall Study|Lack of Efficacy|1|||
161303611|NCT00256854|582492936|FG001|Overall Study|Lack of Efficacy|0|||
161303612|NCT00256854|582492937|FG002|Overall Study|Lack of Efficacy|0|||
161303613|NCT00256854|582492938|FG003|Overall Study|Lack of Efficacy|0|||
161303614|NCT00256854|582492939|FG004|Overall Study|Lack of Efficacy|0|||
161303615|NCT00256854|582492940|FG005|Overall Study|Lack of Efficacy|0|||
161303616|NCT00256854|582492935|FG000|Overall Study|Protocol Violation|0|||
161303617|NCT00256854|582492936|FG001|Overall Study|Protocol Violation|1|||
161303618|NCT00256854|582492937|FG002|Overall Study|Protocol Violation|1|||
161303619|NCT00256854|582492938|FG003|Overall Study|Protocol Violation|1|||
161089752|NCT03184870|581719807|FG016|Crossover Treatment|Other reasons|0|||
161303620|NCT00256854|582492939|FG004|Overall Study|Protocol Violation|0|||
161303621|NCT00256854|582492940|FG005|Overall Study|Protocol Violation|0|||
161303622|NCT00256854|582492935|FG000|Overall Study|Adverse Event|0|||
161303623|NCT00256854|582492936|FG001|Overall Study|Adverse Event|0|||
161303624|NCT00256854|582492937|FG002|Overall Study|Adverse Event|2|||
161303625|NCT00256854|582492938|FG003|Overall Study|Adverse Event|2|||
161303626|NCT00256854|582492939|FG004|Overall Study|Adverse Event|0|||
161303627|NCT00256854|582492940|FG005|Overall Study|Adverse Event|1|||
161303628|NCT00256854|582492935|FG000|Overall Study|Not compliant with the study drug|0|||
161303629|NCT00256854|582492936|FG001|Overall Study|Not compliant with the study drug|0|||
161303630|NCT00256854|582492937|FG002|Overall Study|Not compliant with the study drug|0|||
161089753|NCT03184870|581719808|FG017|Crossover Treatment|Other reasons|2|||
161089754|NCT03184870|581719791|FG000|Crossover Treatment|Death|0|||
161183929|NCT00732472|582051138|FG003|Overall Study|Protocol Violation|1|||
161183930|NCT00732472|582051135|FG000|Overall Study|Withdrawal by Subject|0|||
161183931|NCT00732472|582051136|FG001|Overall Study|Withdrawal by Subject|2|||
161183932|NCT00732472|582051137|FG002|Overall Study|Withdrawal by Subject|0|||
161183933|NCT00732472|582051138|FG003|Overall Study|Withdrawal by Subject|1|||
161183934|NCT02559115|582051141|FG000|Overall Study|Withdrawal by Subject|3|||
161303631|NCT00256854|582492938|FG003|Overall Study|Not compliant with the study drug|0|||
161303632|NCT00256854|582492939|FG004|Overall Study|Not compliant with the study drug|1|||
161303633|NCT00256854|582492940|FG005|Overall Study|Not compliant with the study drug|0|||
161303634|NCT00281632|582492941|FG000|Overall Study|Adverse Event|7|||
161303635|NCT00281632|582492941|FG000|Overall Study|Withdrawal by Subject|2|||
161303636|NCT00281632|582492941|FG000|Overall Study|Disease Progression|22|||
161303637|NCT00281632|582492941|FG000|Overall Study|Death|1|||
161303638|NCT00281632|582492941|FG000|Overall Study|Physician Decision|1|||
161303639|NCT00281632|582492941|FG000|Overall Study|Ongoing|3|||
161303640|NCT03047720|582492947|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
161303641|NCT03047720|582492948|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
161303642|NCT04603482|582492949|FG000|Overall Study|Lost to Follow-up|15|||
161303643|NCT04603482|582492950|FG001|Overall Study|Lost to Follow-up|15|||
161303644|NCT04603482|582492951|FG002|Overall Study|Lost to Follow-up|15|||
161303645|NCT00732758|582492952|FG000|Overall Study|Lost to Follow-up|8|||
161303646|NCT00732758|582492953|FG001|Overall Study|Lost to Follow-up|16|||
161303647|NCT00373958|582492954|FG000|Infant Series|Withdrawal by Subject|13|||
161303648|NCT00373958|582492955|FG001|Infant Series|Withdrawal by Subject|15|||
161303649|NCT00373958|582492954|FG000|Infant Series|Failed to return|8|||
161303650|NCT00373958|582492955|FG001|Infant Series|Failed to return|13|||
161303651|NCT00373958|582492954|FG000|Infant Series|Lost to Follow-up|6|||
161303652|NCT00373958|582492955|FG001|Infant Series|Lost to Follow-up|5|||
161303653|NCT00373958|582492954|FG000|Infant Series|Protocol Violation|3|||
161303654|NCT00373958|582492955|FG001|Infant Series|Protocol Violation|7|||
161303655|NCT00373958|582492954|FG000|Infant Series|Lost Kaiser coverage|4|||
161303656|NCT00373958|582492955|FG001|Infant Series|Lost Kaiser coverage|0|||
161303657|NCT00373958|582492954|FG000|Infant Series|Child relocated|1|||
161303658|NCT00373958|582492955|FG001|Infant Series|Child relocated|0|||
161303659|NCT00373958|582492954|FG000|Infant Series|Consent was not received|1|||
161303660|NCT00373958|582492955|FG001|Infant Series|Consent was not received|0|||
161303661|NCT00373958|582492954|FG000|Infant Series|Adverse Event|3|||
161303662|NCT00373958|582492955|FG001|Infant Series|Adverse Event|1|||
161303663|NCT00373958|582492954|FG000|Infant Series|Physician Decision|1|||
161303664|NCT00373958|582492955|FG001|Infant Series|Physician Decision|1|||
161303665|NCT00373958|582492954|FG000|Toddler Dose|Lost to Follow-up|5|||
161303666|NCT00373958|582492955|FG001|Toddler Dose|Lost to Follow-up|8|||
161303667|NCT00373958|582492954|FG000|Toddler Dose|Withdrawal by Subject|2|||
161303668|NCT00373958|582492955|FG001|Toddler Dose|Withdrawal by Subject|2|||
161303669|NCT00373958|582492954|FG000|Toddler Dose|Failed to return|1|||
161303670|NCT00373958|582492955|FG001|Toddler Dose|Failed to return|2|||
161303671|NCT00373958|582492954|FG000|Toddler Dose|Protocol Violation|0|||
161303672|NCT00373958|582492955|FG001|Toddler Dose|Protocol Violation|1|||
161303673|NCT00373958|582492954|FG000|Toddler Dose|Withdrawn after infant series|22|||
161303674|NCT00373958|582492955|FG001|Toddler Dose|Withdrawn after infant series|25|||
161303675|NCT00179673|582492958|FG000|Overall Study|Adverse Event|7|||
161303676|NCT00179673|582492958|FG000|Overall Study|Lack of Efficacy|15|||
161303677|NCT00179673|582492958|FG000|Overall Study|Withdrawal by Subject|3|||
161303678|NCT00179673|582492958|FG000|Overall Study|Death|4|||
161303679|NCT00179673|582492958|FG000|Overall Study|Other Observations and options|14|||
161303680|NCT00492648|582492959|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
161303681|NCT00492648|582492960|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
161303682|NCT00282113|582492961|FG000|Overall Study|Removed at parents request|1|||
161303683|NCT00282113|582492962|FG001|Overall Study|Removed at parents request|0|||
161303684|NCT00282113|582492963|FG002|Overall Study|Removed at parents request|0|||
161303685|NCT02294396|582492964|FG000|Overall Study|Adverse Event|26|||
161303686|NCT02294396|582492965|FG001|Overall Study|Adverse Event|25|||
161303687|NCT02294396|582492966|FG002|Overall Study|Adverse Event|21|||
161303688|NCT02294396|582492967|FG003|Overall Study|Adverse Event|24|||
161303689|NCT02294396|582492964|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
161303690|NCT02294396|582492965|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
161183935|NCT01996865|582051142|FG000|Induction Period|Protocol Violation|1|||
161303691|NCT02294396|582492966|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
161303692|NCT02294396|582492967|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
161303693|NCT02294396|582492964|FG000|Overall Study|Withdrawal by Subject|8|||
161303694|NCT02294396|582492965|FG001|Overall Study|Withdrawal by Subject|6|||
161303695|NCT02294396|582492966|FG002|Overall Study|Withdrawal by Subject|6|||
161303696|NCT02294396|582492967|FG003|Overall Study|Withdrawal by Subject|8|||
161303697|NCT02294396|582492964|FG000|Overall Study|Lost to Follow-up|0|||
161303698|NCT02294396|582492965|FG001|Overall Study|Lost to Follow-up|0|||
161303699|NCT02294396|582492966|FG002|Overall Study|Lost to Follow-up|1|||
161303700|NCT02294396|582492967|FG003|Overall Study|Lost to Follow-up|1|||
161183936|NCT01996865|582051143|FG001|Induction Period|Protocol Violation|0|||
161183937|NCT01996865|582051144|FG002|Induction Period|Protocol Violation|0|||
161183938|NCT01996865|582051142|FG000|Induction Period|Progressive Disease|4|||
161183939|NCT01996865|582051143|FG001|Induction Period|Progressive Disease|0|||
161183940|NCT01996865|582051144|FG002|Induction Period|Progressive Disease|0|||
161183941|NCT01996865|582051142|FG000|Induction Period|Lost to Follow-up|10|||
161183942|NCT01996865|582051143|FG001|Induction Period|Lost to Follow-up|0|||
161183943|NCT01996865|582051144|FG002|Induction Period|Lost to Follow-up|0|||
161183944|NCT01996865|582051142|FG000|Induction Period|Other Reasons|13|||
161183945|NCT01996865|582051143|FG001|Induction Period|Other Reasons|0|||
161183946|NCT01996865|582051144|FG002|Induction Period|Other Reasons|0|||
161183947|NCT01996865|582051142|FG000|Induction Period|Adverse Event|20|||
161183948|NCT01996865|582051143|FG001|Induction Period|Adverse Event|0|||
161183949|NCT01996865|582051144|FG002|Induction Period|Adverse Event|0|||
161183950|NCT01996865|582051142|FG000|Induction Period|Withdrawal by Subject|60|||
161183951|NCT01996865|582051143|FG001|Induction Period|Withdrawal by Subject|0|||
161183952|NCT01996865|582051144|FG002|Induction Period|Withdrawal by Subject|0|||
161183953|NCT01996865|582051142|FG000|Induction Period|Death|111|||
161183954|NCT01996865|582051143|FG001|Induction Period|Death|0|||
161183955|NCT01996865|582051144|FG002|Induction Period|Death|0|||
161183956|NCT01996865|582051142|FG000|Maintenance Period|Protocol Violation|0|||
161183957|NCT01996865|582051143|FG001|Maintenance Period|Protocol Violation|1|||
161183958|NCT01996865|582051144|FG002|Maintenance Period|Protocol Violation|1|||
161183959|NCT01996865|582051142|FG000|Maintenance Period|Other reasons|0|||
161183960|NCT01996865|582051143|FG001|Maintenance Period|Other reasons|8|||
161183961|NCT01996865|582051144|FG002|Maintenance Period|Other reasons|5|||
161183962|NCT01996865|582051142|FG000|Maintenance Period|Progressive Disease|0|||
161183963|NCT01996865|582051143|FG001|Maintenance Period|Progressive Disease|6|||
161183964|NCT01996865|582051144|FG002|Maintenance Period|Progressive Disease|23|||
161183965|NCT01996865|582051142|FG000|Maintenance Period|Withdrawal by Subject|0|||
161183966|NCT01996865|582051143|FG001|Maintenance Period|Withdrawal by Subject|18|||
161183967|NCT01996865|582051144|FG002|Maintenance Period|Withdrawal by Subject|4|||
161183968|NCT01996865|582051142|FG000|Maintenance Period|Adverse Event|0|||
161183969|NCT01996865|582051143|FG001|Maintenance Period|Adverse Event|7|||
161183970|NCT01996865|582051144|FG002|Maintenance Period|Adverse Event|7|||
161183971|NCT01996865|582051142|FG000|Maintenance Period|Death|0|||
161183972|NCT01996865|582051143|FG001|Maintenance Period|Death|15|||
161183973|NCT01996865|582051144|FG002|Maintenance Period|Death|3|||
161183974|NCT01996865|582051142|FG000|Maintenance Period|Lost to Follow-up|0|||
161183975|NCT01996865|582051143|FG001|Maintenance Period|Lost to Follow-up|2|||
161183976|NCT01996865|582051144|FG002|Maintenance Period|Lost to Follow-up|0|||
161183977|NCT05304611|582051147|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183978|NCT05304611|582051148|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183979|NCT05304611|582051149|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183980|NCT05304611|582051150|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183981|NCT05304611|582051151|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183982|NCT05304611|582051152|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183983|NCT05304611|582051153|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
161183984|NCT05304611|582051154|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183985|NCT05304611|582051155|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
161183986|NCT05304611|582051156|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183987|NCT05304611|582051157|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
161303701|NCT02294396|582492964|FG000|Overall Study|Protocol Deviation|3|||
161303702|NCT02294396|582492965|FG001|Overall Study|Protocol Deviation|2|||
161303703|NCT02294396|582492966|FG002|Overall Study|Protocol Deviation|2|||
161303704|NCT02294396|582492967|FG003|Overall Study|Protocol Deviation|1|||
161303705|NCT02294396|582492964|FG000|Overall Study|Miscellaneous|2|||
161303706|NCT02294396|582492965|FG001|Overall Study|Miscellaneous|0|||
161303707|NCT02294396|582492966|FG002|Overall Study|Miscellaneous|5|||
161303708|NCT02294396|582492967|FG003|Overall Study|Miscellaneous|2|||
161303709|NCT02120833|582492968|FG000|Overall Study|Adverse Event|1|||
161303710|NCT02120833|582492969|FG001|Overall Study|Adverse Event|0|||
161303711|NCT02120833|582492968|FG000|Overall Study|Withdrawal by Subject|2|||
161303712|NCT02120833|582492969|FG001|Overall Study|Withdrawal by Subject|0|||
161303713|NCT02120833|582492968|FG000|Overall Study|Lost to Follow-up|1|||
161303714|NCT02120833|582492969|FG001|Overall Study|Lost to Follow-up|1|||
161303715|NCT02438826|582492970|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
161183988|NCT05304611|582051158|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
161183989|NCT05304611|582051147|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
161183990|NCT05304611|582051148|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
161183991|NCT05304611|582051149|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
161183992|NCT05304611|582051150|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
161183993|NCT05304611|582051151|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
161183994|NCT05304611|582051152|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
161183995|NCT05304611|582051153|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
161303716|NCT02438826|582492971|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
161303717|NCT02438826|582492972|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
161303718|NCT02438826|582492973|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161303719|NCT02438826|582492970|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
161303720|NCT02438826|582492971|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161303721|NCT02438826|582492972|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161303722|NCT02438826|582492973|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161303723|NCT02438826|582492970|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161303724|NCT02438826|582492971|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
161303725|NCT02438826|582492972|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161303726|NCT02438826|582492973|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161303727|NCT02438826|582492970|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161303728|NCT02438826|582492971|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
161303729|NCT02438826|582492972|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161303730|NCT02438826|582492973|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161303731|NCT02438826|582492970|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
161303732|NCT02438826|582492971|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
161303733|NCT02438826|582492972|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
161303734|NCT02438826|582492973|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
161303735|NCT02438826|582492970|FG000|Open-Label Treatment Phase|Adverse Event|11|||
161303736|NCT02438826|582492971|FG001|Open-Label Treatment Phase|Adverse Event|6|||
161303737|NCT02438826|582492972|FG002|Open-Label Treatment Phase|Adverse Event|0|||
161303738|NCT02438826|582492973|FG003|Open-Label Treatment Phase|Adverse Event|0|||
161303739|NCT02438826|582492970|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
161303740|NCT02438826|582492971|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
161303741|NCT02438826|582492972|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
161303742|NCT02438826|582492973|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
161303743|NCT02438826|582492970|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
161303744|NCT02438826|582492971|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
161303745|NCT02438826|582492972|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
161303746|NCT02438826|582492973|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
161303747|NCT02438826|582492970|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
161303748|NCT02438826|582492971|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
161303749|NCT02438826|582492972|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
161303750|NCT02438826|582492973|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
161303751|NCT02438826|582492970|FG000|Post-Treatment Phase|Adverse Event|3|||
161303752|NCT02438826|582492971|FG001|Post-Treatment Phase|Adverse Event|0|||
161303753|NCT02438826|582492972|FG002|Post-Treatment Phase|Adverse Event|0|||
161303754|NCT02438826|582492973|FG003|Post-Treatment Phase|Adverse Event|0|||
161303755|NCT02438826|582492970|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
161303756|NCT02438826|582492971|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
161303757|NCT02438826|582492972|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
161303758|NCT02438826|582492973|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
161303759|NCT02438826|582492970|FG000|Post-Treatment Phase|Physician Decision|1|||
161303760|NCT02438826|582492971|FG001|Post-Treatment Phase|Physician Decision|0|||
161303761|NCT02438826|582492972|FG002|Post-Treatment Phase|Physician Decision|0|||
161303762|NCT02438826|582492973|FG003|Post-Treatment Phase|Physician Decision|0|||
161303763|NCT02438826|582492970|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
161303764|NCT02438826|582492971|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
161303765|NCT02438826|582492972|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
161303766|NCT02438826|582492973|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
161303767|NCT03429244|582492974|FG000|Overall Study|Withdrawal by Subject|2|||
161303768|NCT03429244|582492975|FG001|Overall Study|Withdrawal by Subject|1|||
161303769|NCT03429244|582492976|FG002|Overall Study|Withdrawal by Subject|1|||
161303770|NCT01500187|582492977|FG000|Overall Study|Lost to Follow-up|6|||
161303771|NCT01500187|582492978|FG001|Overall Study|Lost to Follow-up|0|||
161303772|NCT03558152|582494608|FG000|Overall Study|Adverse Event|0|||
161303773|NCT03558152|582494609|FG001|Overall Study|Adverse Event|0|||
161303774|NCT03558152|582494610|FG002|Overall Study|Adverse Event|1|||
161303775|NCT03558152|582494611|FG003|Overall Study|Adverse Event|1|||
161303776|NCT03558152|582494612|FG004|Overall Study|Adverse Event|2|||
161303777|NCT03558152|582494613|FG005|Overall Study|Adverse Event|1|||
161303778|NCT03558152|582494614|FG006|Overall Study|Adverse Event|1|||
161303779|NCT03558152|582494615|FG007|Overall Study|Adverse Event|0|||
161303780|NCT03558152|582494608|FG000|Overall Study|Death|0|||
161303781|NCT03558152|582494609|FG001|Overall Study|Death|0|||
161303782|NCT03558152|582494610|FG002|Overall Study|Death|0|||
161303783|NCT03558152|582494611|FG003|Overall Study|Death|0|||
161303784|NCT03558152|582494612|FG004|Overall Study|Death|1|||
161303785|NCT03558152|582494613|FG005|Overall Study|Death|0|||
161303786|NCT03558152|582494614|FG006|Overall Study|Death|0|||
161303787|NCT03558152|582494615|FG007|Overall Study|Death|0|||
161303788|NCT03558152|582494608|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
161303789|NCT03558152|582494609|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161303790|NCT03558152|582494610|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161347993|NCT03608033|582657411|FG001|Treatment Period|Death|1|||
161347994|NCT03608033|582657410|FG000|Treatment Period|Adverse Event|1|||
161347995|NCT03608033|582657411|FG001|Treatment Period|Adverse Event|5|||
161347996|NCT03608033|582657410|FG000|Treatment Period|Lack of Efficacy|4|||
161347997|NCT03608033|582657411|FG001|Treatment Period|Lack of Efficacy|3|||
161347998|NCT03608033|582657410|FG000|Treatment Period|Lost to Follow-up|2|||
161347999|NCT03608033|582657411|FG001|Treatment Period|Lost to Follow-up|6|||
161348000|NCT03608033|582657410|FG000|Treatment Period|Physician Decision|6|||
161348001|NCT03608033|582657411|FG001|Treatment Period|Physician Decision|10|||
161348002|NCT03608033|582657410|FG000|Treatment Period|Pregnancy|1|||
161348003|NCT03608033|582657411|FG001|Treatment Period|Pregnancy|0|||
161348004|NCT03608033|582657410|FG000|Treatment Period|Protocol Violation|1|||
161348005|NCT03608033|582657411|FG001|Treatment Period|Protocol Violation|2|||
161348006|NCT03608033|582657410|FG000|Treatment Period|Withdrawal by Subject|46|||
161348007|NCT03608033|582657411|FG001|Treatment Period|Withdrawal by Subject|45|||
161348008|NCT03608033|582657410|FG000|Treatment Period|Study terminated by sponsor|82|||
161348009|NCT03608033|582657411|FG001|Treatment Period|Study terminated by sponsor|68|||
161348010|NCT03608033|582657410|FG000|Treatment Period|Site Terminated by Sponsor|1|||
161183996|NCT05304611|582051154|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
161183997|NCT05304611|582051155|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
161183998|NCT05304611|582051156|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
161183999|NCT05304611|582051157|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
161184000|NCT05304611|582051158|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
161184001|NCT05304611|582051147|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
161184002|NCT05304611|582051148|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
161184003|NCT05304611|582051149|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
161184004|NCT05304611|582051150|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
161184005|NCT05304611|582051151|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
161184006|NCT05304611|582051152|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
161184007|NCT05304611|582051153|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
161184008|NCT05304611|582051154|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
161184009|NCT05304611|582051155|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
161184010|NCT05304611|582051156|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
161184011|NCT05304611|582051157|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
161184012|NCT05304611|582051158|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
161184013|NCT02354690|582051163|FG000|Overall Study|Physician Decision|1|||
161184014|NCT00963820|582051164|FG000|Dose Escalation Phase|Progressive Disease|3|||
161184015|NCT00963820|582051165|FG001|Dose Escalation Phase|Progressive Disease|3|||
161184016|NCT00963820|582051166|FG002|Dose Escalation Phase|Progressive Disease|3|||
161184017|NCT00963820|582051167|FG003|Dose Escalation Phase|Progressive Disease|3|||
161184018|NCT00963820|582051168|FG004|Dose Escalation Phase|Progressive Disease|4|||
161184019|NCT00963820|582051169|FG005|Dose Escalation Phase|Progressive Disease|3|||
161184020|NCT00963820|582051170|FG006|Dose Escalation Phase|Progressive Disease|3|||
161303791|NCT03558152|582494611|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161303792|NCT03558152|582494612|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161303793|NCT03558152|582494613|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161303794|NCT03558152|582494614|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161303795|NCT03558152|582494615|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
161303796|NCT03558152|582494608|FG000|Overall Study|Miscalculation in mmcs|0|||
161303797|NCT03558152|582494609|FG001|Overall Study|Miscalculation in mmcs|0|||
161303798|NCT03558152|582494610|FG002|Overall Study|Miscalculation in mmcs|0|||
161303799|NCT03558152|582494611|FG003|Overall Study|Miscalculation in mmcs|0|||
161303800|NCT03558152|582494612|FG004|Overall Study|Miscalculation in mmcs|0|||
161303801|NCT03558152|582494613|FG005|Overall Study|Miscalculation in mmcs|0|||
161303802|NCT03558152|582494614|FG006|Overall Study|Miscalculation in mmcs|1|||
161303803|NCT03558152|582494615|FG007|Overall Study|Miscalculation in mmcs|0|||
161303804|NCT03558152|582494608|FG000|Overall Study|Mistake in calculation|0|||
161303805|NCT03558152|582494609|FG001|Overall Study|Mistake in calculation|0|||
161303806|NCT03558152|582494610|FG002|Overall Study|Mistake in calculation|0|||
161303807|NCT03558152|582494611|FG003|Overall Study|Mistake in calculation|1|||
161303808|NCT03558152|582494612|FG004|Overall Study|Mistake in calculation|0|||
161303809|NCT03558152|582494613|FG005|Overall Study|Mistake in calculation|0|||
161303810|NCT03558152|582494614|FG006|Overall Study|Mistake in calculation|0|||
161303811|NCT03558152|582494615|FG007|Overall Study|Mistake in calculation|0|||
161303812|NCT03558152|582494608|FG000|Overall Study|Mistake in evaluation of disease status|0|||
161303813|NCT03558152|582494609|FG001|Overall Study|Mistake in evaluation of disease status|0|||
161303814|NCT03558152|582494610|FG002|Overall Study|Mistake in evaluation of disease status|0|||
161303815|NCT03558152|582494611|FG003|Overall Study|Mistake in evaluation of disease status|0|||
161303816|NCT03558152|582494612|FG004|Overall Study|Mistake in evaluation of disease status|0|||
161348011|NCT03608033|582657411|FG001|Treatment Period|Site Terminated by Sponsor|0|||
161348012|NCT03608033|582657410|FG000|Open-Label Period: OMS721|Adverse Event|1|||
161348013|NCT03608033|582657411|FG001|Open-Label Period: OMS721|Adverse Event|0|||
161184021|NCT00963820|582051171|FG007|Dose Escalation Phase|Progressive Disease|2|||
161348014|NCT03608033|582657410|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
161303817|NCT03558152|582494613|FG005|Overall Study|Mistake in evaluation of disease status|0|||
161303818|NCT03558152|582494614|FG006|Overall Study|Mistake in evaluation of disease status|0|||
161303819|NCT03558152|582494615|FG007|Overall Study|Mistake in evaluation of disease status|1|||
161303820|NCT03558152|582494608|FG000|Overall Study|Physician Decision|0|||
161303821|NCT03558152|582494609|FG001|Overall Study|Physician Decision|0|||
161303822|NCT03558152|582494610|FG002|Overall Study|Physician Decision|0|||
161303823|NCT03558152|582494611|FG003|Overall Study|Physician Decision|0|||
161303824|NCT03558152|582494612|FG004|Overall Study|Physician Decision|0|||
161303825|NCT03558152|582494613|FG005|Overall Study|Physician Decision|0|||
161303826|NCT03558152|582494614|FG006|Overall Study|Physician Decision|1|||
161303827|NCT03558152|582494615|FG007|Overall Study|Physician Decision|0|||
161303828|NCT03558152|582494608|FG000|Overall Study|Withdrawal by Subject|2|||
161303829|NCT03558152|582494609|FG001|Overall Study|Withdrawal by Subject|3|||
161303830|NCT03558152|582494610|FG002|Overall Study|Withdrawal by Subject|2|||
161303831|NCT03558152|582494611|FG003|Overall Study|Withdrawal by Subject|1|||
161303832|NCT03558152|582494612|FG004|Overall Study|Withdrawal by Subject|1|||
161303833|NCT03558152|582494613|FG005|Overall Study|Withdrawal by Subject|1|||
161303834|NCT03558152|582494614|FG006|Overall Study|Withdrawal by Subject|3|||
161303835|NCT03558152|582494615|FG007|Overall Study|Withdrawal by Subject|2|||
161303836|NCT03558152|582494608|FG000|Overall Study|Lack of Efficacy|11|||
161303837|NCT03558152|582494609|FG001|Overall Study|Lack of Efficacy|11|||
161303838|NCT03558152|582494610|FG002|Overall Study|Lack of Efficacy|10|||
161303839|NCT03558152|582494611|FG003|Overall Study|Lack of Efficacy|11|||
161303840|NCT03558152|582494612|FG004|Overall Study|Lack of Efficacy|14|||
161303841|NCT03558152|582494613|FG005|Overall Study|Lack of Efficacy|12|||
161303842|NCT03558152|582494614|FG006|Overall Study|Lack of Efficacy|14|||
161303843|NCT03558152|582494615|FG007|Overall Study|Lack of Efficacy|13|||
161303844|NCT03558152|582494608|FG000|Overall Study|Protocol Violation|1|||
161303845|NCT03558152|582494609|FG001|Overall Study|Protocol Violation|1|||
161303846|NCT03558152|582494610|FG002|Overall Study|Protocol Violation|0|||
161303847|NCT03558152|582494611|FG003|Overall Study|Protocol Violation|1|||
161303848|NCT03558152|582494612|FG004|Overall Study|Protocol Violation|1|||
161303849|NCT03558152|582494613|FG005|Overall Study|Protocol Violation|0|||
161303850|NCT03558152|582494614|FG006|Overall Study|Protocol Violation|2|||
161303851|NCT03558152|582494615|FG007|Overall Study|Protocol Violation|0|||
161303852|NCT03960021|582494616|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
161303853|NCT01936181|582494620|FG000|Randomised, Double-blind|Adverse Event|27|||
161303854|NCT01936181|582494621|FG001|Randomised, Double-blind|Adverse Event|21|||
161303855|NCT01936181|582494622|FG002|Randomised, Double-blind|Adverse Event|0|||
161303856|NCT01936181|582494623|FG003|Randomised, Double-blind|Adverse Event|0|||
161303857|NCT01936181|582494620|FG000|Randomised, Double-blind|Protocol Violation|1|||
161303858|NCT01936181|582494621|FG001|Randomised, Double-blind|Protocol Violation|5|||
161303859|NCT01936181|582494622|FG002|Randomised, Double-blind|Protocol Violation|0|||
161303860|NCT01936181|582494623|FG003|Randomised, Double-blind|Protocol Violation|0|||
161303861|NCT01936181|582494620|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
161303862|NCT01936181|582494621|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
161303863|NCT01936181|582494622|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
161303864|NCT01936181|582494623|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
161303865|NCT01936181|582494620|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
161303866|NCT01936181|582494621|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
161303867|NCT01936181|582494622|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
161303868|NCT01936181|582494623|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
161303869|NCT01936181|582494620|FG000|Randomised, Double-blind|Pregnancy|0|||
161303870|NCT01936181|582494621|FG001|Randomised, Double-blind|Pregnancy|1|||
161303871|NCT01936181|582494622|FG002|Randomised, Double-blind|Pregnancy|0|||
161303872|NCT01936181|582494623|FG003|Randomised, Double-blind|Pregnancy|0|||
161303873|NCT01936181|582494620|FG000|Randomised, Double-blind|Physician Decision|4|||
161303874|NCT01936181|582494621|FG001|Randomised, Double-blind|Physician Decision|4|||
161303875|NCT01936181|582494622|FG002|Randomised, Double-blind|Physician Decision|0|||
161303876|NCT01936181|582494623|FG003|Randomised, Double-blind|Physician Decision|0|||
161303877|NCT01936181|582494620|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
161303878|NCT01936181|582494621|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
161303879|NCT01936181|582494622|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
161303880|NCT01936181|582494623|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
161303881|NCT01936181|582494620|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
161303882|NCT01936181|582494621|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
161303883|NCT01936181|582494622|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
161303884|NCT01936181|582494623|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
161303885|NCT01936181|582494620|FG000|Transition-extension|Adverse Event|3|||
161303886|NCT01936181|582494621|FG001|Transition-extension|Adverse Event|0|||
161303887|NCT01936181|582494622|FG002|Transition-extension|Adverse Event|3|||
161303888|NCT01936181|582494623|FG003|Transition-extension|Adverse Event|1|||
161303889|NCT01936181|582494620|FG000|Transition-extension|Lost to Follow-up|3|||
161303890|NCT01936181|582494621|FG001|Transition-extension|Lost to Follow-up|0|||
161348015|NCT03608033|582657411|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
161348016|NCT03608033|582657410|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
161348017|NCT03608033|582657411|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
161348018|NCT03608033|582657410|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
161348019|NCT03608033|582657411|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
161348020|NCT03608033|582657410|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
161348021|NCT03608033|582657411|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
161348022|NCT02360579|582657413|FG000|Initial|Death|16|||
161348023|NCT02360579|582657414|FG001|Initial|Death|49|||
161348024|NCT02360579|582657415|FG002|Initial|Death|0|||
161348025|NCT02360579|582657416|FG003|Initial|Death|71|||
161348026|NCT02360579|582657413|FG000|Initial|Lost to Follow-up|0|||
161348027|NCT02360579|582657414|FG001|Initial|Lost to Follow-up|4|||
161348028|NCT02360579|582657415|FG002|Initial|Lost to Follow-up|0|||
161348029|NCT02360579|582657416|FG003|Initial|Lost to Follow-up|1|||
161348030|NCT02360579|582657413|FG000|Initial|Withdrawal by Subject|0|||
161348031|NCT02360579|582657414|FG001|Initial|Withdrawal by Subject|0|||
161348032|NCT02360579|582657415|FG002|Initial|Withdrawal by Subject|0|||
161348033|NCT02360579|582657416|FG003|Initial|Withdrawal by Subject|3|||
161348034|NCT02360579|582657413|FG000|Initial|Other|7|||
161348035|NCT02360579|582657414|FG001|Initial|Other|0|||
161348036|NCT02360579|582657415|FG002|Initial|Other|0|||
161348037|NCT02360579|582657416|FG003|Initial|Other|0|||
161348038|NCT02360579|582657413|FG000|Initial|Did not receive TIL|8|||
161348039|NCT02360579|582657414|FG001|Initial|Did not receive TIL|11|||
161348040|NCT02360579|582657415|FG002|Initial|Did not receive TIL|0|||
161348041|NCT02360579|582657416|FG003|Initial|Did not receive TIL|22|||
161348042|NCT02360579|582657413|FG000|Retreatment|Death|0|||
161348043|NCT02360579|582657414|FG001|Retreatment|Death|0|||
161348044|NCT02360579|582657415|FG002|Retreatment|Death|11|||
161348045|NCT02360579|582657416|FG003|Retreatment|Death|0|||
161348046|NCT06455111|582657419|FG000|Overall Study|Withdrawal by Subject|11|||
161348047|NCT06455111|582657420|FG001|Overall Study|Withdrawal by Subject|4|||
161348048|NCT00529035|582658414|FG000|Overall Study|Withdrawal by Subject|1|||
161348049|NCT03439514|582658415|FG000|Double-Blind Treatment Period|Other|4|||
161348050|NCT03439514|582658416|FG001|Double-Blind Treatment Period|Other|1|||
161348051|NCT03439514|582658415|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
161348052|NCT03439514|582658416|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
161184022|NCT00963820|582051172|FG008|Dose Escalation Phase|Progressive Disease|0|||
161303891|NCT01936181|582494622|FG002|Transition-extension|Lost to Follow-up|1|||
161303892|NCT01936181|582494623|FG003|Transition-extension|Lost to Follow-up|2|||
161303893|NCT01936181|582494620|FG000|Transition-extension|Physician Decision|2|||
161303894|NCT01936181|582494621|FG001|Transition-extension|Physician Decision|0|||
161303895|NCT01936181|582494622|FG002|Transition-extension|Physician Decision|0|||
161303896|NCT01936181|582494623|FG003|Transition-extension|Physician Decision|1|||
161303897|NCT01936181|582494620|FG000|Transition-extension|Withdrawal by Subject|7|||
161303898|NCT01936181|582494621|FG001|Transition-extension|Withdrawal by Subject|0|||
161303899|NCT01936181|582494622|FG002|Transition-extension|Withdrawal by Subject|2|||
161303900|NCT01936181|582494623|FG003|Transition-extension|Withdrawal by Subject|1|||
161303901|NCT01346189|582494624|FG000|Overall Study|Withdrawal by Subject|7|||
161303902|NCT01346189|582494625|FG001|Overall Study|Withdrawal by Subject|5|||
161303903|NCT01346189|582494626|FG002|Overall Study|Withdrawal by Subject|3|||
161303904|NCT01346189|582494627|FG003|Overall Study|Withdrawal by Subject|5|||
161303905|NCT01346189|582494624|FG000|Overall Study|Physician Decision|4|||
161303906|NCT01346189|582494625|FG001|Overall Study|Physician Decision|0|||
161303907|NCT01346189|582494626|FG002|Overall Study|Physician Decision|0|||
161303908|NCT01346189|582494627|FG003|Overall Study|Physician Decision|0|||
161303909|NCT01346189|582494624|FG000|Overall Study|Moved|3|||
161303910|NCT01346189|582494625|FG001|Overall Study|Moved|0|||
161303911|NCT01346189|582494626|FG002|Overall Study|Moved|4|||
161303912|NCT01346189|582494627|FG003|Overall Study|Moved|0|||
161303913|NCT01346189|582494624|FG000|Overall Study|Other|2|||
161303914|NCT01346189|582494625|FG001|Overall Study|Other|4|||
161303915|NCT01346189|582494626|FG002|Overall Study|Other|7|||
161303916|NCT01346189|582494627|FG003|Overall Study|Other|3|||
161303917|NCT01346189|582494624|FG000|Overall Study|Death|0|||
161303918|NCT01346189|582494625|FG001|Overall Study|Death|3|||
161303919|NCT01346189|582494626|FG002|Overall Study|Death|0|||
161348053|NCT03439514|582658415|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
161348054|NCT03439514|582658416|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
161348055|NCT03439514|582658415|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
161348056|NCT03439514|582658416|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
161348057|NCT03439514|582658415|FG000|Double-Blind Treatment Period|Death|1|||
161303920|NCT01346189|582494627|FG003|Overall Study|Death|0|||
161303921|NCT01346189|582494624|FG000|Overall Study|Non-health system primary care physician|0|||
161348058|NCT03439514|582658416|FG001|Double-Blind Treatment Period|Death|2|||
161348059|NCT02636283|582658417|FG000|Overall Study|Adverse Event|2|||
161348060|NCT02636283|582658418|FG001|Overall Study|Adverse Event|0|||
161348061|NCT02636283|582658417|FG000|Overall Study|Trial Terminated Prematurely|0|||
161303922|NCT01346189|582494625|FG001|Overall Study|Non-health system primary care physician|5|||
161303923|NCT01346189|582494626|FG002|Overall Study|Non-health system primary care physician|0|||
161303924|NCT01346189|582494627|FG003|Overall Study|Non-health system primary care physician|0|||
161303925|NCT01346189|582494624|FG000|Overall Study|Travel|0|||
161303926|NCT01346189|582494625|FG001|Overall Study|Travel|0|||
161303927|NCT01346189|582494626|FG002|Overall Study|Travel|0|||
161303928|NCT01346189|582494627|FG003|Overall Study|Travel|3|||
161303929|NCT00900757|582494628|FG000|Overall Study|screen failure|19|||
161303930|NCT03535194|582494631|FG000|Induction Period|Adverse Event|2|||
161303931|NCT03535194|582494632|FG001|Induction Period|Adverse Event|2|||
161303932|NCT03535194|582494633|FG002|Induction Period|Adverse Event|1|||
161303933|NCT03535194|582494634|FG003|Induction Period|Adverse Event|3|||
161303934|NCT03535194|582494635|FG004|Induction Period|Adverse Event|0|||
161303935|NCT03535194|582494631|FG000|Induction Period|Death|0|||
161303936|NCT03535194|582494632|FG001|Induction Period|Death|1|||
161303937|NCT03535194|582494633|FG002|Induction Period|Death|0|||
161303938|NCT03535194|582494634|FG003|Induction Period|Death|0|||
161303939|NCT03535194|582494635|FG004|Induction Period|Death|0|||
161303940|NCT03535194|582494631|FG000|Induction Period|Lack of Efficacy|1|||
161303941|NCT03535194|582494632|FG001|Induction Period|Lack of Efficacy|3|||
161303942|NCT03535194|582494633|FG002|Induction Period|Lack of Efficacy|2|||
161303943|NCT03535194|582494634|FG003|Induction Period|Lack of Efficacy|2|||
161303944|NCT03535194|582494635|FG004|Induction Period|Lack of Efficacy|0|||
161303945|NCT03535194|582494631|FG000|Induction Period|Lost to Follow-up|3|||
161303946|NCT03535194|582494632|FG001|Induction Period|Lost to Follow-up|5|||
161303947|NCT03535194|582494633|FG002|Induction Period|Lost to Follow-up|2|||
161303948|NCT03535194|582494634|FG003|Induction Period|Lost to Follow-up|3|||
161303949|NCT03535194|582494635|FG004|Induction Period|Lost to Follow-up|0|||
161303950|NCT03535194|582494631|FG000|Induction Period|Physician Decision|1|||
161303951|NCT03535194|582494632|FG001|Induction Period|Physician Decision|1|||
161303952|NCT03535194|582494633|FG002|Induction Period|Physician Decision|0|||
161303953|NCT03535194|582494634|FG003|Induction Period|Physician Decision|0|||
161303954|NCT03535194|582494635|FG004|Induction Period|Physician Decision|0|||
161303955|NCT03535194|582494631|FG000|Induction Period|Protocol Violation|1|||
161303956|NCT03535194|582494632|FG001|Induction Period|Protocol Violation|0|||
161303957|NCT03535194|582494633|FG002|Induction Period|Protocol Violation|0|||
161303958|NCT03535194|582494634|FG003|Induction Period|Protocol Violation|1|||
161303959|NCT03535194|582494635|FG004|Induction Period|Protocol Violation|0|||
161303960|NCT03535194|582494631|FG000|Induction Period|Screen Failure|0|||
161303961|NCT03535194|582494632|FG001|Induction Period|Screen Failure|1|||
161303962|NCT03535194|582494633|FG002|Induction Period|Screen Failure|0|||
161303963|NCT03535194|582494634|FG003|Induction Period|Screen Failure|0|||
161303964|NCT03535194|582494635|FG004|Induction Period|Screen Failure|0|||
161303965|NCT03535194|582494631|FG000|Induction Period|Withdrawal by Subject|3|||
161303966|NCT03535194|582494632|FG001|Induction Period|Withdrawal by Subject|4|||
161303967|NCT03535194|582494633|FG002|Induction Period|Withdrawal by Subject|3|||
161303968|NCT03535194|582494634|FG003|Induction Period|Withdrawal by Subject|2|||
161303969|NCT03535194|582494635|FG004|Induction Period|Withdrawal by Subject|0|||
161303970|NCT03535194|582494631|FG000|Maintenance Period|Adverse Event|6|||
161303971|NCT03535194|582494632|FG001|Maintenance Period|Adverse Event|5|||
161303972|NCT03535194|582494633|FG002|Maintenance Period|Adverse Event|1|||
161303973|NCT03535194|582494634|FG003|Maintenance Period|Adverse Event|11|||
161303974|NCT03535194|582494635|FG004|Maintenance Period|Adverse Event|4|||
161303975|NCT03535194|582494631|FG000|Maintenance Period|Lack of Efficacy|3|||
161303976|NCT03535194|582494632|FG001|Maintenance Period|Lack of Efficacy|2|||
161303977|NCT03535194|582494633|FG002|Maintenance Period|Lack of Efficacy|5|||
161303978|NCT03535194|582494634|FG003|Maintenance Period|Lack of Efficacy|9|||
161303979|NCT03535194|582494635|FG004|Maintenance Period|Lack of Efficacy|0|||
161303980|NCT03535194|582494631|FG000|Maintenance Period|Lost to Follow-up|4|||
161303981|NCT03535194|582494632|FG001|Maintenance Period|Lost to Follow-up|2|||
161303982|NCT03535194|582494633|FG002|Maintenance Period|Lost to Follow-up|1|||
161303983|NCT03535194|582494634|FG003|Maintenance Period|Lost to Follow-up|5|||
161303984|NCT03535194|582494635|FG004|Maintenance Period|Lost to Follow-up|2|||
161303985|NCT03535194|582494631|FG000|Maintenance Period|Other|1|||
161303986|NCT03535194|582494632|FG001|Maintenance Period|Other|2|||
161303987|NCT03535194|582494633|FG002|Maintenance Period|Other|0|||
161348062|NCT02636283|582658418|FG001|Overall Study|Trial Terminated Prematurely|3|||
161348063|NCT03418675|582658419|FG000|Overall Study|Lost to Follow-up|13|||
161303988|NCT03535194|582494634|FG003|Maintenance Period|Other|0|||
161303989|NCT03535194|582494635|FG004|Maintenance Period|Other|0|||
161303990|NCT03535194|582494631|FG000|Maintenance Period|Physician Decision|1|||
161303991|NCT03535194|582494632|FG001|Maintenance Period|Physician Decision|2|||
161303992|NCT03535194|582494633|FG002|Maintenance Period|Physician Decision|0|||
161303993|NCT03535194|582494634|FG003|Maintenance Period|Physician Decision|2|||
161303994|NCT03535194|582494635|FG004|Maintenance Period|Physician Decision|0|||
161303995|NCT03535194|582494631|FG000|Maintenance Period|Pregnancy|0|||
161303996|NCT03535194|582494632|FG001|Maintenance Period|Pregnancy|0|||
161303997|NCT03535194|582494633|FG002|Maintenance Period|Pregnancy|0|||
161348064|NCT03418675|582658420|FG001|Overall Study|Lost to Follow-up|10|||
161303998|NCT03535194|582494634|FG003|Maintenance Period|Pregnancy|2|||
161303999|NCT03535194|582494635|FG004|Maintenance Period|Pregnancy|0|||
161304000|NCT03535194|582494631|FG000|Maintenance Period|Protocol Violation|0|||
161304001|NCT03535194|582494632|FG001|Maintenance Period|Protocol Violation|1|||
161304002|NCT03535194|582494633|FG002|Maintenance Period|Protocol Violation|0|||
161304003|NCT03535194|582494634|FG003|Maintenance Period|Protocol Violation|0|||
161304004|NCT03535194|582494635|FG004|Maintenance Period|Protocol Violation|0|||
161304005|NCT03535194|582494631|FG000|Maintenance Period|Withdrawal by Subject|7|||
161304006|NCT03535194|582494632|FG001|Maintenance Period|Withdrawal by Subject|2|||
161304007|NCT03535194|582494633|FG002|Maintenance Period|Withdrawal by Subject|1|||
161304008|NCT03535194|582494634|FG003|Maintenance Period|Withdrawal by Subject|8|||
161304009|NCT03535194|582494635|FG004|Maintenance Period|Withdrawal by Subject|0|||
161304010|NCT03535194|582494631|FG000|Post-Treatment Followup Period|Adverse Event|4|||
161304011|NCT03535194|582494632|FG001|Post-Treatment Followup Period|Adverse Event|5|||
161304012|NCT03535194|582494633|FG002|Post-Treatment Followup Period|Adverse Event|1|||
161304013|NCT03535194|582494634|FG003|Post-Treatment Followup Period|Adverse Event|8|||
161304014|NCT03535194|582494635|FG004|Post-Treatment Followup Period|Adverse Event|0|||
161304015|NCT03535194|582494631|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
161304016|NCT03535194|582494632|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
161304017|NCT03535194|582494633|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
161304018|NCT03535194|582494634|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
161304019|NCT03535194|582494635|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
161304020|NCT03535194|582494631|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
161304021|NCT03535194|582494632|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
161304022|NCT03535194|582494633|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
161304023|NCT03535194|582494634|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
161304024|NCT03535194|582494635|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
161304025|NCT03535194|582494631|FG000|Post-Treatment Followup Period|Other|1|||
161304026|NCT03535194|582494632|FG001|Post-Treatment Followup Period|Other|0|||
161304027|NCT03535194|582494633|FG002|Post-Treatment Followup Period|Other|0|||
161304028|NCT03535194|582494634|FG003|Post-Treatment Followup Period|Other|5|||
161304029|NCT03535194|582494635|FG004|Post-Treatment Followup Period|Other|0|||
161304030|NCT03535194|582494631|FG000|Post-Treatment Followup Period|Physician Decision|0|||
161304031|NCT03535194|582494632|FG001|Post-Treatment Followup Period|Physician Decision|2|||
161304032|NCT03535194|582494633|FG002|Post-Treatment Followup Period|Physician Decision|1|||
161304033|NCT03535194|582494634|FG003|Post-Treatment Followup Period|Physician Decision|1|||
161304034|NCT03535194|582494635|FG004|Post-Treatment Followup Period|Physician Decision|0|||
161304035|NCT03535194|582494631|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
161304036|NCT03535194|582494632|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
161304037|NCT03535194|582494633|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
161304038|NCT03535194|582494634|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
161304039|NCT03535194|582494635|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
161304040|NCT04411810|582494636|FG000|Overall Study|Screen failure|1|||
161304041|NCT04411810|582494636|FG000|Overall Study|Withdrawal by Subject|1|||
161304042|NCT04304235|582494640|FG000|Overall Study|incomplete triage data|0|||
161304043|NCT04304235|582494641|FG001|Overall Study|incomplete triage data|69|||
161304044|NCT04304235|582494642|FG002|Overall Study|incomplete triage data|0|||
161304045|NCT04304235|582494643|FG003|Overall Study|incomplete triage data|0|||
161304046|NCT04304235|582494644|FG004|Overall Study|incomplete triage data|289|||
161304047|NCT04304235|582494645|FG005|Overall Study|incomplete triage data|123|||
161304048|NCT04304235|582494646|FG006|Overall Study|incomplete triage data|65|||
161304049|NCT02703272|582494651|FG000|Overall Study|Death|4|||
161304050|NCT02703272|582494652|FG001|Overall Study|Death|9|||
161304051|NCT02703272|582494653|FG002|Overall Study|Death|19|||
161304052|NCT02703272|582494654|FG003|Overall Study|Death|10|||
161304053|NCT02703272|582494651|FG000|Overall Study|Withdrawal by Subject|0|||
161304054|NCT02703272|582494652|FG001|Overall Study|Withdrawal by Subject|0|||
161304055|NCT02703272|582494653|FG002|Overall Study|Withdrawal by Subject|4|||
161304056|NCT02703272|582494654|FG003|Overall Study|Withdrawal by Subject|2|||
161304057|NCT02703272|582494651|FG000|Overall Study|Study Terminated by Sponsor|6|||
161304058|NCT02703272|582494652|FG001|Overall Study|Study Terminated by Sponsor|1|||
161304059|NCT02703272|582494653|FG002|Overall Study|Study Terminated by Sponsor|12|||
161348065|NCT03418675|582658419|FG000|Overall Study|Adverse Event|2|||
161348066|NCT03418675|582658420|FG001|Overall Study|Adverse Event|0|||
161304060|NCT02703272|582494654|FG003|Overall Study|Study Terminated by Sponsor|4|||
161304061|NCT02703272|582494651|FG000|Overall Study|Other|1|||
161304062|NCT02703272|582494652|FG001|Overall Study|Other|0|||
161304063|NCT02703272|582494653|FG002|Overall Study|Other|0|||
161304064|NCT02703272|582494654|FG003|Overall Study|Other|0|||
161348067|NCT01879852|582658421|FG000|Overall Study|Withdrawal by Subject|2|||
161348068|NCT01879852|582658422|FG001|Overall Study|Withdrawal by Subject|0|||
161304065|NCT04470544|582494655|FG000|Overall Study|Withdrawal by Subject|4|||
161304066|NCT04470544|582494656|FG001|Overall Study|Withdrawal by Subject|6|||
161304067|NCT01680861|582494657|FG000|Early Post-transplant Period|Protocol Violation|1|||
161348069|NCT03086343|582658424|FG000|Period 1|Adverse Event|7|||
161184023|NCT00963820|582051173|FG009|Dose Escalation Phase|Progressive Disease|0|||
161184024|NCT00963820|582051174|FG010|Dose Escalation Phase|Progressive Disease|0|||
161184025|NCT00963820|582051175|FG011|Dose Escalation Phase|Progressive Disease|0|||
161184026|NCT00963820|582051164|FG000|Dose Escalation Phase|Adverse Event|0|||
161184027|NCT00963820|582051165|FG001|Dose Escalation Phase|Adverse Event|0|||
161184028|NCT00963820|582051166|FG002|Dose Escalation Phase|Adverse Event|0|||
161184029|NCT00963820|582051167|FG003|Dose Escalation Phase|Adverse Event|0|||
161184030|NCT00963820|582051168|FG004|Dose Escalation Phase|Adverse Event|0|||
161184031|NCT00963820|582051169|FG005|Dose Escalation Phase|Adverse Event|0|||
161184032|NCT00963820|582051170|FG006|Dose Escalation Phase|Adverse Event|3|||
161184033|NCT00963820|582051171|FG007|Dose Escalation Phase|Adverse Event|1|||
161184034|NCT00963820|582051172|FG008|Dose Escalation Phase|Adverse Event|0|||
161184035|NCT00963820|582051173|FG009|Dose Escalation Phase|Adverse Event|0|||
161184036|NCT00963820|582051174|FG010|Dose Escalation Phase|Adverse Event|0|||
161184037|NCT00963820|582051175|FG011|Dose Escalation Phase|Adverse Event|0|||
161184038|NCT00963820|582051164|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
161184039|NCT00963820|582051165|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
161184040|NCT00963820|582051166|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
161184041|NCT00963820|582051167|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
161184042|NCT00963820|582051168|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
161184043|NCT00963820|582051169|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
161184044|NCT00963820|582051170|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
161184045|NCT00963820|582051171|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
161184046|NCT00963820|582051172|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
161184047|NCT00963820|582051173|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
161184048|NCT00963820|582051174|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
161184049|NCT00963820|582051175|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
161184050|NCT00963820|582051164|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184051|NCT00963820|582051165|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184052|NCT00963820|582051166|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184053|NCT00963820|582051167|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184054|NCT00963820|582051168|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184055|NCT00963820|582051169|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184056|NCT00963820|582051170|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
161184057|NCT00963820|582051171|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184058|NCT00963820|582051172|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184059|NCT00963820|582051173|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184060|NCT00963820|582051174|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184061|NCT00963820|582051175|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
161184062|NCT00963820|582051164|FG000|Expansion Phase|Progressive Disease|0|||
161184063|NCT00963820|582051165|FG001|Expansion Phase|Progressive Disease|0|||
161184064|NCT00963820|582051166|FG002|Expansion Phase|Progressive Disease|0|||
161184065|NCT00963820|582051167|FG003|Expansion Phase|Progressive Disease|0|||
161184066|NCT00963820|582051168|FG004|Expansion Phase|Progressive Disease|0|||
161184067|NCT00963820|582051169|FG005|Expansion Phase|Progressive Disease|0|||
161184068|NCT00963820|582051170|FG006|Expansion Phase|Progressive Disease|0|||
161184069|NCT00963820|582051171|FG007|Expansion Phase|Progressive Disease|0|||
161184070|NCT00963820|582051172|FG008|Expansion Phase|Progressive Disease|8|||
161184071|NCT00963820|582051173|FG009|Expansion Phase|Progressive Disease|6|||
161184072|NCT00963820|582051174|FG010|Expansion Phase|Progressive Disease|4|||
161184073|NCT00963820|582051175|FG011|Expansion Phase|Progressive Disease|2|||
161184074|NCT00963820|582051164|FG000|Expansion Phase|Adverse Event|0|||
161184075|NCT00963820|582051165|FG001|Expansion Phase|Adverse Event|0|||
161184076|NCT00963820|582051166|FG002|Expansion Phase|Adverse Event|0|||
161304068|NCT01680861|582494658|FG001|Early Post-transplant Period|Protocol Violation|1|||
161304069|NCT02222545|582494659|FG000|Overall Study|Adverse Event|1|||
161304070|NCT02222545|582494660|FG001|Overall Study|Adverse Event|0|||
161304071|NCT02222545|582494661|FG002|Overall Study|Adverse Event|2|||
161184077|NCT00963820|582051167|FG003|Expansion Phase|Adverse Event|0|||
161184078|NCT00963820|582051168|FG004|Expansion Phase|Adverse Event|0|||
161184079|NCT00963820|582051169|FG005|Expansion Phase|Adverse Event|0|||
161184080|NCT00963820|582051170|FG006|Expansion Phase|Adverse Event|0|||
161184081|NCT00963820|582051171|FG007|Expansion Phase|Adverse Event|0|||
161184082|NCT00963820|582051172|FG008|Expansion Phase|Adverse Event|1|||
161184083|NCT00963820|582051173|FG009|Expansion Phase|Adverse Event|3|||
161184084|NCT00963820|582051174|FG010|Expansion Phase|Adverse Event|0|||
161184085|NCT00963820|582051175|FG011|Expansion Phase|Adverse Event|0|||
161184086|NCT00963820|582051164|FG000|Expansion Phase|Withdrawal by Subject|0|||
161184087|NCT00963820|582051165|FG001|Expansion Phase|Withdrawal by Subject|0|||
161184088|NCT00963820|582051166|FG002|Expansion Phase|Withdrawal by Subject|0|||
161184089|NCT00963820|582051167|FG003|Expansion Phase|Withdrawal by Subject|0|||
161304072|NCT02222545|582494659|FG000|Overall Study|Death|0|||
161184090|NCT00963820|582051168|FG004|Expansion Phase|Withdrawal by Subject|0|||
161304073|NCT02222545|582494660|FG001|Overall Study|Death|0|||
161304074|NCT02222545|582494661|FG002|Overall Study|Death|9|||
161304075|NCT02222545|582494659|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
161304076|NCT02222545|582494660|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
161304077|NCT02222545|582494661|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
161304078|NCT02222545|582494659|FG000|Overall Study|Withdrawal by Subject|0|||
161304079|NCT02222545|582494660|FG001|Overall Study|Withdrawal by Subject|0|||
161304080|NCT02222545|582494661|FG002|Overall Study|Withdrawal by Subject|3|||
161304081|NCT02222545|582494659|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
161304082|NCT02222545|582494660|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
161304083|NCT02222545|582494661|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
161304084|NCT05113979|582494665|FG000|Overall Study|Death|2|||
161304085|NCT05113979|582494665|FG000|Overall Study|Lost to Follow-up|1|||
161304086|NCT00526669|582494666|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
161304087|NCT00526669|582494667|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
161304088|NCT00526669|582494666|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
161304089|NCT00526669|582494667|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
161304090|NCT00526669|582494666|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
161304091|NCT00526669|582494667|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
161304092|NCT00526669|582494666|FG000|Combined Treatment Phase|Death|0|||
161304093|NCT00526669|582494667|FG001|Combined Treatment Phase|Death|2|||
161304094|NCT02218736|582494671|FG000|Overall Study|Withdrawal by Subject|10|||
161304095|NCT02218736|582494672|FG001|Overall Study|Withdrawal by Subject|9|||
161304096|NCT02218736|582494671|FG000|Overall Study|Protocol Violation|2|||
161304097|NCT02218736|582494672|FG001|Overall Study|Protocol Violation|0|||
161304098|NCT04016779|582494675|FG000|Overall Study|Adverse Event|9|||
161304099|NCT04016779|582494676|FG001|Overall Study|Adverse Event|17|||
161304100|NCT04016779|582494675|FG000|Overall Study|Lack of Efficacy|4|||
161304101|NCT04016779|582494676|FG001|Overall Study|Lack of Efficacy|1|||
161304102|NCT04016779|582494675|FG000|Overall Study|Lost to Follow-up|5|||
161304103|NCT04016779|582494676|FG001|Overall Study|Lost to Follow-up|14|||
161304104|NCT04016779|582494675|FG000|Overall Study|Physician Decision|1|||
161304105|NCT04016779|582494676|FG001|Overall Study|Physician Decision|3|||
161304106|NCT04016779|582494675|FG000|Overall Study|Withdrawal by Subject|6|||
161304107|NCT04016779|582494676|FG001|Overall Study|Withdrawal by Subject|8|||
161304108|NCT04016779|582494675|FG000|Overall Study|Non-compliance with Study Drug|2|||
161304109|NCT04016779|582494676|FG001|Overall Study|Non-compliance with Study Drug|3|||
161304110|NCT04016779|582494675|FG000|Overall Study|Other, Multiple categories|17|||
161304111|NCT04016779|582494676|FG001|Overall Study|Other, Multiple categories|17|||
161304112|NCT00623935|582494677|FG000|Overall Study|Death|1|||
161304113|NCT00623935|582494677|FG000|Overall Study|Patient Declined Transplant|1|||
161304114|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
161304115|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
161304116|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
161304117|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
161304118|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
161304119|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
161304120|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
161304121|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
161304122|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
161304123|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
161304124|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Death|1|||
161304125|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Death|0|||
161304126|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
161304127|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
161304128|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
161304129|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
161304130|NCT01876784|582494678|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
161304131|NCT01876784|582494679|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
161304132|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
161304133|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
161304134|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Adverse Event|2|||
161304135|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Adverse Event|6|||
161304136|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
161304137|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
161304138|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Progressive disease|4|||
161304139|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Progressive disease|35|||
161304140|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
161304141|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
161304142|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
161348070|NCT03086343|582658425|FG001|Period 1|Adverse Event|7|||
161348071|NCT03086343|582658426|FG002|Period 1|Adverse Event|0|||
161348072|NCT03086343|582658427|FG003|Period 1|Adverse Event|1|||
161348073|NCT03086343|582658424|FG000|Period 1|Withdrawal by Subject|6|||
161348074|NCT03086343|582658425|FG001|Period 1|Withdrawal by Subject|10|||
161348075|NCT03086343|582658426|FG002|Period 1|Withdrawal by Subject|0|||
161348076|NCT03086343|582658427|FG003|Period 1|Withdrawal by Subject|0|||
161348077|NCT03086343|582658424|FG000|Period 1|Lost to Follow-up|1|||
161348078|NCT03086343|582658425|FG001|Period 1|Lost to Follow-up|3|||
161348079|NCT03086343|582658426|FG002|Period 1|Lost to Follow-up|1|||
161348080|NCT03086343|582658427|FG003|Period 1|Lost to Follow-up|0|||
161348081|NCT03086343|582658424|FG000|Period 1|Other, Not Specified|10|||
161348082|NCT03086343|582658425|FG001|Period 1|Other, Not Specified|12|||
161348083|NCT03086343|582658426|FG002|Period 1|Other, Not Specified|2|||
161348084|NCT03086343|582658427|FG003|Period 1|Other, Not Specified|1|||
161348085|NCT03086343|582658424|FG000|Period 1|Missing|1|||
161348086|NCT03086343|582658425|FG001|Period 1|Missing|0|||
161348087|NCT03086343|582658426|FG002|Period 1|Missing|0|||
161348088|NCT03086343|582658427|FG003|Period 1|Missing|0|||
161348089|NCT03086343|582658424|FG000|Period 2|Adverse Event|20|||
161348090|NCT03086343|582658425|FG001|Period 2|Adverse Event|11|||
161348091|NCT03086343|582658426|FG002|Period 2|Adverse Event|1|||
161348092|NCT03086343|582658427|FG003|Period 2|Adverse Event|2|||
161348093|NCT03086343|582658424|FG000|Period 2|Withdrawal by Subject|15|||
161348094|NCT03086343|582658425|FG001|Period 2|Withdrawal by Subject|25|||
161348095|NCT03086343|582658426|FG002|Period 2|Withdrawal by Subject|2|||
161348096|NCT03086343|582658427|FG003|Period 2|Withdrawal by Subject|2|||
161348097|NCT03086343|582658424|FG000|Period 2|Lost to Follow-up|6|||
161348098|NCT03086343|582658425|FG001|Period 2|Lost to Follow-up|11|||
161348099|NCT03086343|582658426|FG002|Period 2|Lost to Follow-up|1|||
161348100|NCT03086343|582658427|FG003|Period 2|Lost to Follow-up|0|||
161348101|NCT03086343|582658424|FG000|Period 2|COVID-19 Infection|5|||
161348102|NCT03086343|582658425|FG001|Period 2|COVID-19 Infection|0|||
161348103|NCT03086343|582658426|FG002|Period 2|COVID-19 Infection|0|||
161348104|NCT03086343|582658427|FG003|Period 2|COVID-19 Infection|0|||
161348105|NCT03086343|582658424|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
161348106|NCT03086343|582658425|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
161348107|NCT03086343|582658426|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
161348108|NCT03086343|582658427|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
161348109|NCT03086343|582658424|FG000|Period 2|Other, Not Specified|23|||
161348110|NCT03086343|582658425|FG001|Period 2|Other, Not Specified|22|||
161348111|NCT03086343|582658426|FG002|Period 2|Other, Not Specified|2|||
161348112|NCT03086343|582658427|FG003|Period 2|Other, Not Specified|4|||
161348113|NCT04900272|582658428|FG000|Overall Study|Lost to Follow-up|2|||
161348114|NCT04900272|582658428|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
161348115|NCT04900272|582658428|FG000|Overall Study|Withdrawal by Subject|1|||
161348116|NCT01625182|582658430|FG000|Overall Study|Administrative problems|1|||
161348117|NCT01625182|582658431|FG001|Overall Study|Administrative problems|0|||
161348118|NCT01625182|582658430|FG000|Overall Study|Protocol deviation|0|||
161348119|NCT01625182|582658431|FG001|Overall Study|Protocol deviation|2|||
161348120|NCT01625182|582658430|FG000|Overall Study|Adverse Event|2|||
161348121|NCT01625182|582658431|FG001|Overall Study|Adverse Event|0|||
161348122|NCT01625182|582658430|FG000|Overall Study|Withdrawal by Subject|5|||
161348123|NCT01625182|582658431|FG001|Overall Study|Withdrawal by Subject|1|||
161348124|NCT01625182|582658430|FG000|Overall Study|Lack of Efficacy|12|||
161348125|NCT01625182|582658431|FG001|Overall Study|Lack of Efficacy|8|||
161348126|NCT00741611|582658432|FG000|Overall Study|Death|0|||
161348127|NCT00741611|582658433|FG001|Overall Study|Death|0|||
161348128|NCT00741611|582658434|FG002|Overall Study|Death|1|||
161348129|NCT00741611|582658432|FG000|Overall Study|Withdrawal by Subject|0|||
161348130|NCT00741611|582658433|FG001|Overall Study|Withdrawal by Subject|2|||
161348131|NCT00741611|582658434|FG002|Overall Study|Withdrawal by Subject|2|||
161348132|NCT01555931|582658437|FG000|Overall Study|Lost to Follow-up|2|||
161348133|NCT01555931|582658438|FG001|Overall Study|Lost to Follow-up|5|||
161348134|NCT01510756|582658439|FG000|Overall Study|Death|1|||
161348135|NCT01510756|582658439|FG000|Overall Study|Lack of Efficacy|2|||
161348136|NCT01510756|582658439|FG000|Overall Study|Physician Decision|1|||
161348137|NCT04398134|582658443|FG000|Overall Study|Adverse Event|0|||
161348138|NCT04398134|582658444|FG001|Overall Study|Adverse Event|0|||
161348139|NCT04398134|582658445|FG002|Overall Study|Adverse Event|1|||
161348140|NCT04398134|582658446|FG003|Overall Study|Adverse Event|0|||
161089755|NCT03184870|581719792|FG001|Crossover Treatment|Death|0|||
161348141|NCT04398134|582658443|FG000|Overall Study|Withdrawal by Subject|2|||
161089756|NCT03184870|581719793|FG002|Crossover Treatment|Death|0|||
161089757|NCT03184870|581719794|FG003|Crossover Treatment|Death|0|||
161089758|NCT03184870|581719795|FG004|Crossover Treatment|Death|0|||
161089759|NCT03184870|581719796|FG005|Crossover Treatment|Death|0|||
161089760|NCT03184870|581719797|FG006|Crossover Treatment|Death|0|||
161089761|NCT03184870|581719798|FG007|Crossover Treatment|Death|0|||
161089762|NCT03184870|581719799|FG008|Crossover Treatment|Death|0|||
161089763|NCT03184870|581719800|FG009|Crossover Treatment|Death|0|||
161089764|NCT03184870|581719801|FG010|Crossover Treatment|Death|0|||
161304143|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
161304144|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Death|0|||
161304145|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Death|1|||
161304146|NCT01876784|582494678|FG000|Open-label Period (31 Months)|Other than specified above|9|||
161304147|NCT01876784|582494679|FG001|Open-label Period (31 Months)|Other than specified above|18|||
161304148|NCT01878084|582494680|FG000|Overall Study|Physician Decision|2|||
161304149|NCT00638443|582494681|FG000|First Intervention|Adverse Event|2|||
161304150|NCT00638443|582494682|FG001|First Intervention|Adverse Event|1|||
161304151|NCT01044290|582494683|FG000|Follow-up 1|Death|3|||
161304152|NCT01044290|582494684|FG001|Follow-up 1|Death|3|||
161304153|NCT01044290|582494685|FG002|Follow-up 1|Death|1|||
161304154|NCT01044290|582494683|FG000|Follow-up 1|Withdrawal by Subject|2|||
161304155|NCT01044290|582494684|FG001|Follow-up 1|Withdrawal by Subject|2|||
161304156|NCT01044290|582494685|FG002|Follow-up 1|Withdrawal by Subject|0|||
161304157|NCT01044290|582494683|FG000|Follow-Up 2|Death|0|||
161304158|NCT01044290|582494684|FG001|Follow-Up 2|Death|1|||
161304159|NCT01044290|582494685|FG002|Follow-Up 2|Death|1|||
161304160|NCT01044290|582494683|FG000|Follow-Up 2|Withdrawal by Subject|0|||
161304161|NCT01044290|582494684|FG001|Follow-Up 2|Withdrawal by Subject|1|||
161304162|NCT01044290|582494685|FG002|Follow-Up 2|Withdrawal by Subject|1|||
161304163|NCT01967706|582494688|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
161304164|NCT01967706|582494689|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
161304165|NCT01967706|582494690|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
161304166|NCT01967706|582494691|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
161304167|NCT01475851|582494702|FG000|Overall Study|Protocol defined stopping criteria|1|||
161304168|NCT01475851|582494703|FG001|Overall Study|Protocol defined stopping criteria|0|||
161304169|NCT01552915|582494704|FG000|Overall Study|Adverse Event|3|||
161304170|NCT01552915|582494705|FG001|Overall Study|Adverse Event|14|||
161304171|NCT01552915|582494706|FG002|Overall Study|Adverse Event|3|||
161304172|NCT01552915|582494704|FG000|Overall Study|Lost to Follow-up|4|||
161304173|NCT01552915|582494705|FG001|Overall Study|Lost to Follow-up|6|||
161304174|NCT01552915|582494706|FG002|Overall Study|Lost to Follow-up|5|||
161304175|NCT01552915|582494704|FG000|Overall Study|Withdrawal by Subject|6|||
161304176|NCT01552915|582494705|FG001|Overall Study|Withdrawal by Subject|4|||
161304177|NCT01552915|582494706|FG002|Overall Study|Withdrawal by Subject|5|||
161304178|NCT01552915|582494704|FG000|Overall Study|Protocol Violation|0|||
161304179|NCT01552915|582494705|FG001|Overall Study|Protocol Violation|4|||
161304180|NCT01552915|582494706|FG002|Overall Study|Protocol Violation|4|||
161304181|NCT01552915|582494704|FG000|Overall Study|Lack of Efficacy|8|||
161304182|NCT01552915|582494705|FG001|Overall Study|Lack of Efficacy|1|||
161304183|NCT01552915|582494706|FG002|Overall Study|Lack of Efficacy|4|||
161304184|NCT01552915|582494704|FG000|Overall Study|Other|2|||
161304185|NCT01552915|582494705|FG001|Overall Study|Other|0|||
161304186|NCT01552915|582494706|FG002|Overall Study|Other|6|||
161304187|NCT03382834|582494707|FG000|Step 1|Lost to Follow-up|0|||
161304188|NCT03382834|582494708|FG001|Step 1|Lost to Follow-up|1|||
161304189|NCT03382834|582494707|FG000|Step 2|Death|1|||
161304190|NCT03382834|582494708|FG001|Step 2|Death|0|||
161304191|NCT03382834|582494707|FG000|Step 2|Lost to Follow-up|2|||
161304192|NCT03382834|582494708|FG001|Step 2|Lost to Follow-up|2|||
161304193|NCT03382834|582494707|FG000|Step 2|Site Terminated by Sponsor|1|||
161304194|NCT03382834|582494708|FG001|Step 2|Site Terminated by Sponsor|0|||
161304195|NCT02387957|582494709|FG000|Overall Study|The study was discontinued|21|||
161304196|NCT02387957|582494710|FG001|Overall Study|The study was discontinued|21|||
161304197|NCT02387957|582494711|FG002|Overall Study|The study was discontinued|20|||
161304198|NCT02887248|582494712|FG000|Overall Study|Withdrawal by Subject|1|||
161304199|NCT02887248|582494712|FG000|Overall Study|Adverse Event|1|||
161304200|NCT02887248|582494712|FG000|Overall Study|Progressive Disease|1|||
161304201|NCT04152837|582494728|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
161304202|NCT04152837|582494728|FG000|Maintenance Period|Adverse Event|1|||
161304203|NCT04152837|582494728|FG000|Maintenance Period|Withdrawal by Subject|1|||
161304204|NCT04152837|582494728|FG000|Maintenance Period|Sponsor Termination of Study|2|||
161304205|NCT00586820|582494729|FG000|Overall Study|Unsuccessful PCI|1|||
161304206|NCT00586820|582494730|FG001|Overall Study|Unsuccessful PCI|0|||
161304207|NCT00430573|582494731|FG000|Overall Study|Withdrawal by Subject|5|||
161304208|NCT01483027|582494736|FG000|Overall Study|Administrative Reasons|2|||
161304209|NCT01483027|582494737|FG001|Overall Study|Administrative Reasons|1|||
161304210|NCT01483027|582494736|FG000|Overall Study|Withdrawal by Subject|21|||
161304211|NCT01483027|582494737|FG001|Overall Study|Withdrawal by Subject|32|||
161304212|NCT01483027|582494736|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
161304213|NCT01483027|582494737|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
161304214|NCT01483027|582494736|FG000|Overall Study|Lost to Follow-up|1|||
161304215|NCT01483027|582494737|FG001|Overall Study|Lost to Follow-up|1|||
161304216|NCT01483027|582494736|FG000|Overall Study|Adverse Event|0|||
161304217|NCT01483027|582494737|FG001|Overall Study|Adverse Event|1|||
161304218|NCT01483027|582494736|FG000|Overall Study|Withdrawal by Subject|0|||
161304219|NCT01483027|582494737|FG001|Overall Study|Withdrawal by Subject|1|||
161304220|NCT04463251|582494740|FG000|Overall Study|Death|1|||
161304221|NCT04463251|582494741|FG001|Overall Study|Death|0|||
161304222|NCT04463251|582494742|FG002|Overall Study|Death|1|||
161304223|NCT04463251|582494740|FG000|Overall Study|Adverse Event|0|||
161304224|NCT04463251|582494741|FG001|Overall Study|Adverse Event|1|||
161304225|NCT04463251|582494742|FG002|Overall Study|Adverse Event|0|||
161304226|NCT04463251|582494740|FG000|Overall Study|Lost to Follow-up|0|||
161304227|NCT04463251|582494741|FG001|Overall Study|Lost to Follow-up|1|||
161304228|NCT04463251|582494742|FG002|Overall Study|Lost to Follow-up|0|||
161304229|NCT04463251|582494740|FG000|Overall Study|Withdrawal by Subject|0|||
161304230|NCT04463251|582494741|FG001|Overall Study|Withdrawal by Subject|2|||
161304231|NCT04463251|582494742|FG002|Overall Study|Withdrawal by Subject|2|||
161304232|NCT05020665|582494743|FG000|Overall Study|Study terminated by Sponsor|5|||
161304233|NCT05020665|582494744|FG001|Overall Study|Study terminated by Sponsor|4|||
161304234|NCT05020665|582494743|FG000|Overall Study|Death|2|||
161304235|NCT05020665|582494744|FG001|Overall Study|Death|1|||
161304236|NCT05020665|582494743|FG000|Overall Study|Physician Decision|0|||
161304237|NCT05020665|582494744|FG001|Overall Study|Physician Decision|1|||
161304238|NCT05020665|582494743|FG000|Overall Study|Withdrawal by Subject|0|||
161304239|NCT05020665|582494744|FG001|Overall Study|Withdrawal by Subject|1|||
161304240|NCT05020665|582494743|FG000|Overall Study|Reason not specified|1|||
161304241|NCT05020665|582494744|FG001|Overall Study|Reason not specified|0|||
161304242|NCT01743560|582494749|FG000|Overall Study|Disease progression|26|||
161304243|NCT01743560|582494749|FG000|Overall Study|Adverse Event|8|||
161304244|NCT01743560|582494749|FG000|Overall Study|Death|3|||
161304245|NCT01743560|582494749|FG000|Overall Study|Withdrawal by Subject|2|||
161304246|NCT01743560|582494749|FG000|Overall Study|Protocol Violation|1|||
161304247|NCT01743560|582494749|FG000|Overall Study|>1 dose of study drug|3|||
161304248|NCT01732640|582494755|FG000|Overall Study|Adverse Event|0|||
161304249|NCT01732640|582494756|FG001|Overall Study|Adverse Event|1|||
161304250|NCT01732640|582494755|FG000|Overall Study|Death|0|||
161304251|NCT01732640|582494756|FG001|Overall Study|Death|1|||
161304252|NCT00877487|582494759|FG000|Open-label Treatment Phase|Adverse Event|1|||
161304253|NCT00877487|582494760|FG001|Open-label Treatment Phase|Adverse Event|0|||
161304254|NCT00877487|582494759|FG000|Open-label Treatment Phase|Protocol Violation|3|||
161304255|NCT00877487|582494760|FG001|Open-label Treatment Phase|Protocol Violation|0|||
161304256|NCT00877487|582494759|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
161304257|NCT00877487|582494760|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
161304258|NCT00877487|582494759|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
161304259|NCT00877487|582494760|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
161304260|NCT00877487|582494759|FG000|Open-label Treatment Phase|Out of country for business|1|||
161304261|NCT00877487|582494760|FG001|Open-label Treatment Phase|Out of country for business|0|||
161304262|NCT00877487|582494759|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
161304263|NCT00877487|582494760|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
161304264|NCT00877487|582494759|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
161304265|NCT00877487|582494760|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
161304266|NCT00877487|582494759|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
161304267|NCT00877487|582494760|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
161304268|NCT00877487|582494759|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
161304269|NCT00877487|582494760|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
161304270|NCT03070002|582494761|FG000|Follow up for 2 Years|Death|1|||
161304271|NCT03425396|582494773|FG000|Overall Study|Lost to Follow-up|2|||
161304272|NCT03425396|582494774|FG001|Overall Study|Lost to Follow-up|5|||
161304273|NCT03425396|582494775|FG002|Overall Study|Lost to Follow-up|2|||
161304274|NCT03425396|582494776|FG003|Overall Study|Lost to Follow-up|0|||
161304275|NCT03425396|582494777|FG004|Overall Study|Lost to Follow-up|0|||
161304276|NCT03425396|582494773|FG000|Overall Study|Withdrawal by Subject|0|||
161304277|NCT03425396|582494774|FG001|Overall Study|Withdrawal by Subject|1|||
161304278|NCT03425396|582494775|FG002|Overall Study|Withdrawal by Subject|0|||
161304279|NCT03425396|582494776|FG003|Overall Study|Withdrawal by Subject|1|||
161304280|NCT03425396|582494777|FG004|Overall Study|Withdrawal by Subject|0|||
161304281|NCT03425396|582494773|FG000|Overall Study|Other|0|||
161304282|NCT03425396|582494774|FG001|Overall Study|Other|1|||
161304283|NCT03425396|582494775|FG002|Overall Study|Other|1|||
161304284|NCT03425396|582494776|FG003|Overall Study|Other|0|||
161304285|NCT03425396|582494777|FG004|Overall Study|Other|1|||
161304286|NCT01082211|582494780|FG000|Overall Study|Protocol Violation|4|||
161304287|NCT01082211|582494780|FG000|Overall Study|No protocol treatment received|3|||
161304288|NCT04999163|582494781|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
161304289|NCT04999163|582494782|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
161304290|NCT04999163|582494781|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
161304291|NCT04999163|582494782|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
161089765|NCT03184870|581719802|FG011|Crossover Treatment|Death|0|||
161304292|NCT04999163|582494781|FG000|Overall Study|Withdrawal by Subject|1|||
161304293|NCT04999163|582494782|FG001|Overall Study|Withdrawal by Subject|0|||
161089766|NCT03184870|581719803|FG012|Crossover Treatment|Death|0|||
161089767|NCT03184870|581719804|FG013|Crossover Treatment|Death|0|||
161304294|NCT00784550|582496734|FG000|Overall Study|Adverse Event|12|||
161304295|NCT00784550|582496735|FG001|Overall Study|Adverse Event|10|||
161304296|NCT00784550|582496734|FG000|Overall Study|Lack of Efficacy|0|||
161304297|NCT00784550|582496735|FG001|Overall Study|Lack of Efficacy|1|||
161304298|NCT00784550|582496734|FG000|Overall Study|Protocol Violation|10|||
161304299|NCT00784550|582496735|FG001|Overall Study|Protocol Violation|10|||
161304300|NCT00784550|582496734|FG000|Overall Study|Lost to Follow-up|8|||
161304301|NCT00784550|582496735|FG001|Overall Study|Lost to Follow-up|5|||
161304302|NCT00784550|582496734|FG000|Overall Study|Physician Decision|2|||
161304303|NCT00784550|582496735|FG001|Overall Study|Physician Decision|3|||
161304304|NCT00784550|582496734|FG000|Overall Study|Withdrawal by Subject|4|||
161304305|NCT00784550|582496735|FG001|Overall Study|Withdrawal by Subject|13|||
161304306|NCT04166591|582496736|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161304307|NCT04166591|582496737|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161304308|NCT04166591|582496738|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161304309|NCT04166591|582496739|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161304310|NCT04166591|582496736|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
161304311|NCT04166591|582496737|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
161304312|NCT04166591|582496738|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161304313|NCT04166591|582496739|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
161304314|NCT00601172|582496740|FG000|Overall Study|Adverse Event|43|||
161304315|NCT00601172|582496741|FG001|Overall Study|Adverse Event|32|||
161304316|NCT00601172|582496740|FG000|Overall Study|Lack of Efficacy|11|||
161304317|NCT00601172|582496741|FG001|Overall Study|Lack of Efficacy|12|||
161304318|NCT00601172|582496740|FG000|Overall Study|Protocol Violation|2|||
161304319|NCT00601172|582496741|FG001|Overall Study|Protocol Violation|5|||
161304320|NCT00601172|582496740|FG000|Overall Study|Lost to Follow-up|4|||
161304321|NCT00601172|582496741|FG001|Overall Study|Lost to Follow-up|3|||
161304322|NCT00601172|582496740|FG000|Overall Study|Physician Decision|27|||
161304323|NCT00601172|582496741|FG001|Overall Study|Physician Decision|28|||
161304324|NCT00601172|582496740|FG000|Overall Study|Withdrawal by Subject|35|||
161304325|NCT00601172|582496741|FG001|Overall Study|Withdrawal by Subject|27|||
161304326|NCT00601172|582496740|FG000|Overall Study|Did not meet continuation criteria|19|||
161304327|NCT00601172|582496741|FG001|Overall Study|Did not meet continuation criteria|20|||
161304328|NCT04434469|582496745|FG000|Overall Study|Death|2|||
161304329|NCT04434469|582496746|FG001|Overall Study|Death|3|||
161304330|NCT04434469|582496747|FG002|Overall Study|Death|2|||
161304331|NCT04434469|582496748|FG003|Overall Study|Death|2|||
161304332|NCT04434469|582496749|FG004|Overall Study|Death|2|||
161304333|NCT04434469|582496750|FG005|Overall Study|Death|0|||
161304334|NCT04434469|582496745|FG000|Overall Study|Lost to Follow-up|0|||
161304335|NCT04434469|582496746|FG001|Overall Study|Lost to Follow-up|0|||
161304336|NCT04434469|582496747|FG002|Overall Study|Lost to Follow-up|0|||
161304337|NCT04434469|582496748|FG003|Overall Study|Lost to Follow-up|1|||
161304338|NCT04434469|582496749|FG004|Overall Study|Lost to Follow-up|1|||
161304339|NCT04434469|582496750|FG005|Overall Study|Lost to Follow-up|0|||
161304340|NCT04434469|582496745|FG000|Overall Study|Study terminated by sponsor|1|||
161304341|NCT04434469|582496746|FG001|Overall Study|Study terminated by sponsor|1|||
161304342|NCT04434469|582496747|FG002|Overall Study|Study terminated by sponsor|1|||
161304343|NCT04434469|582496748|FG003|Overall Study|Study terminated by sponsor|2|||
161304344|NCT04434469|582496749|FG004|Overall Study|Study terminated by sponsor|3|||
161304345|NCT04434469|582496750|FG005|Overall Study|Study terminated by sponsor|3|||
161304346|NCT04434469|582496745|FG000|Overall Study|Withdrawal by Subject|0|||
161304347|NCT04434469|582496746|FG001|Overall Study|Withdrawal by Subject|0|||
161304348|NCT04434469|582496747|FG002|Overall Study|Withdrawal by Subject|1|||
161304349|NCT04434469|582496748|FG003|Overall Study|Withdrawal by Subject|0|||
161304350|NCT04434469|582496749|FG004|Overall Study|Withdrawal by Subject|0|||
161304351|NCT04434469|582496750|FG005|Overall Study|Withdrawal by Subject|0|||
161304352|NCT02005692|582496753|FG000|Overall Study|Protocol Violation|1|||
161304353|NCT02005692|582496753|FG000|Overall Study|Withdrawal by Subject|1|||
161304354|NCT02005692|582496753|FG000|Overall Study|Discharged earlier than anticipated|5|||
161304355|NCT05896527|582496754|FG000|Overall Study|Withdrawal by Subject|11|||
161304356|NCT05896527|582496755|FG001|Overall Study|Withdrawal by Subject|10|||
161304357|NCT05896527|582496756|FG002|Overall Study|Withdrawal by Subject|4|||
161304358|NCT05896527|582496757|FG003|Overall Study|Withdrawal by Subject|3|||
161304359|NCT05896527|582496758|FG004|Overall Study|Withdrawal by Subject|2|||
161304360|NCT05896527|582496754|FG000|Overall Study|Lost to Follow-up|0|||
161304361|NCT05896527|582496755|FG001|Overall Study|Lost to Follow-up|2|||
161304362|NCT05896527|582496756|FG002|Overall Study|Lost to Follow-up|2|||
161304363|NCT05896527|582496757|FG003|Overall Study|Lost to Follow-up|2|||
161304364|NCT05896527|582496758|FG004|Overall Study|Lost to Follow-up|1|||
161304365|NCT05896527|582496754|FG000|Overall Study|Significant protocol noncompliance|0|||
161304366|NCT05896527|582496755|FG001|Overall Study|Significant protocol noncompliance|1|||
161304367|NCT05896527|582496756|FG002|Overall Study|Significant protocol noncompliance|0|||
161089768|NCT03184870|581719805|FG014|Crossover Treatment|Death|0|||
161089769|NCT03184870|581719806|FG015|Crossover Treatment|Death|0|||
161089770|NCT03184870|581719807|FG016|Crossover Treatment|Death|0|||
161184091|NCT00963820|582051169|FG005|Expansion Phase|Withdrawal by Subject|0|||
161304368|NCT05896527|582496757|FG003|Overall Study|Significant protocol noncompliance|0|||
161304369|NCT05896527|582496758|FG004|Overall Study|Significant protocol noncompliance|0|||
161304370|NCT05896527|582496754|FG000|Overall Study|Eligibility criteria not met|1|||
161304371|NCT05896527|582496755|FG001|Overall Study|Eligibility criteria not met|0|||
161304372|NCT05896527|582496756|FG002|Overall Study|Eligibility criteria not met|0|||
161304373|NCT05896527|582496757|FG003|Overall Study|Eligibility criteria not met|0|||
161304374|NCT05896527|582496758|FG004|Overall Study|Eligibility criteria not met|0|||
161304375|NCT05896527|582496754|FG000|Overall Study|Sponsor's decision|0|||
161304376|NCT05896527|582496755|FG001|Overall Study|Sponsor's decision|0|||
161304377|NCT05896527|582496756|FG002|Overall Study|Sponsor's decision|0|||
161304378|NCT05896527|582496757|FG003|Overall Study|Sponsor's decision|1|||
161304379|NCT05896527|582496758|FG004|Overall Study|Sponsor's decision|0|||
161304380|NCT05896527|582496754|FG000|Overall Study|Investigator's decision|0|||
161304381|NCT05896527|582496755|FG001|Overall Study|Investigator's decision|1|||
161304382|NCT05896527|582496756|FG002|Overall Study|Investigator's decision|0|||
161304383|NCT05896527|582496757|FG003|Overall Study|Investigator's decision|0|||
161304384|NCT05896527|582496758|FG004|Overall Study|Investigator's decision|0|||
161304385|NCT05896527|582496754|FG000|Overall Study|Pregnancy of his partner|0|||
161304386|NCT05896527|582496755|FG001|Overall Study|Pregnancy of his partner|0|||
161304387|NCT05896527|582496756|FG002|Overall Study|Pregnancy of his partner|0|||
161304388|NCT05896527|582496757|FG003|Overall Study|Pregnancy of his partner|1|||
161304389|NCT05896527|582496758|FG004|Overall Study|Pregnancy of his partner|0|||
161304390|NCT02651155|582496761|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
161304391|NCT02651155|582496762|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
161304392|NCT02651155|582496761|FG000|Overall Study|Voluntary Withdrawal|5|||
161304393|NCT02651155|582496762|FG001|Overall Study|Voluntary Withdrawal|0|||
161304394|NCT01867710|582496763|FG000|Overall Study|Death|25|||
161304395|NCT01867710|582496764|FG001|Overall Study|Death|15|||
161304396|NCT01867710|582496765|FG002|Overall Study|Death|27|||
161304397|NCT01867710|582496766|FG003|Overall Study|Death|20|||
161304398|NCT01867710|582496763|FG000|Overall Study|Lost to Follow-up|3|||
161304399|NCT01867710|582496764|FG001|Overall Study|Lost to Follow-up|4|||
161304400|NCT01867710|582496765|FG002|Overall Study|Lost to Follow-up|3|||
161304401|NCT01867710|582496766|FG003|Overall Study|Lost to Follow-up|2|||
161304402|NCT01867710|582496763|FG000|Overall Study|Withdrawal of consent|2|||
161304403|NCT01867710|582496764|FG001|Overall Study|Withdrawal of consent|5|||
161304404|NCT01867710|582496765|FG002|Overall Study|Withdrawal of consent|1|||
161304405|NCT01867710|582496766|FG003|Overall Study|Withdrawal of consent|2|||
161304406|NCT01867710|582496763|FG000|Overall Study|Study Terminated by Sponsor|9|||
161304407|NCT01867710|582496764|FG001|Overall Study|Study Terminated by Sponsor|13|||
161304408|NCT01867710|582496765|FG002|Overall Study|Study Terminated by Sponsor|8|||
161304409|NCT01867710|582496766|FG003|Overall Study|Study Terminated by Sponsor|16|||
161304410|NCT01867710|582496763|FG000|Overall Study|Biochemical progression|0|||
161304411|NCT01867710|582496764|FG001|Overall Study|Biochemical progression|1|||
161304412|NCT01867710|582496765|FG002|Overall Study|Biochemical progression|0|||
161304413|NCT01867710|582496766|FG003|Overall Study|Biochemical progression|0|||
161304414|NCT01867710|582496763|FG000|Overall Study|Clinical progression|0|||
161304415|NCT01867710|582496764|FG001|Overall Study|Clinical progression|0|||
161304416|NCT01867710|582496765|FG002|Overall Study|Clinical progression|1|||
161304417|NCT01867710|582496766|FG003|Overall Study|Clinical progression|0|||
161304418|NCT01867710|582496763|FG000|Overall Study|Disease progression|1|||
161304419|NCT01867710|582496764|FG001|Overall Study|Disease progression|0|||
161304420|NCT01867710|582496765|FG002|Overall Study|Disease progression|0|||
161304421|NCT01867710|582496766|FG003|Overall Study|Disease progression|0|||
161304422|NCT01867710|582496763|FG000|Overall Study|Patient decision|0|||
161304423|NCT01867710|582496764|FG001|Overall Study|Patient decision|0|||
161304424|NCT01867710|582496765|FG002|Overall Study|Patient decision|0|||
161304425|NCT01867710|582496766|FG003|Overall Study|Patient decision|1|||
161304426|NCT01867710|582496763|FG000|Overall Study|Patient to follow subsequent treatment|0|||
161184092|NCT00963820|582051170|FG006|Expansion Phase|Withdrawal by Subject|0|||
161184093|NCT00963820|582051171|FG007|Expansion Phase|Withdrawal by Subject|0|||
161304427|NCT01867710|582496764|FG001|Overall Study|Patient to follow subsequent treatment|1|||
161304428|NCT01867710|582496765|FG002|Overall Study|Patient to follow subsequent treatment|0|||
161304429|NCT01867710|582496766|FG003|Overall Study|Patient to follow subsequent treatment|0|||
161304430|NCT01867710|582496763|FG000|Overall Study|Progressive disease|1|||
161304431|NCT01867710|582496764|FG001|Overall Study|Progressive disease|0|||
161304432|NCT01867710|582496765|FG002|Overall Study|Progressive disease|0|||
161304433|NCT01867710|582496766|FG003|Overall Study|Progressive disease|0|||
161304434|NCT01867710|582496763|FG000|Overall Study|Protocol Violation|0|||
161304435|NCT01867710|582496764|FG001|Overall Study|Protocol Violation|0|||
161304436|NCT01867710|582496765|FG002|Overall Study|Protocol Violation|0|||
161304437|NCT01867710|582496766|FG003|Overall Study|Protocol Violation|1|||
161304438|NCT01867710|582496763|FG000|Overall Study|PSA-progression|0|||
161304439|NCT01867710|582496764|FG001|Overall Study|PSA-progression|1|||
161304440|NCT01867710|582496765|FG002|Overall Study|PSA-progression|0|||
161304441|NCT01867710|582496766|FG003|Overall Study|PSA-progression|0|||
161304442|NCT01867710|582496763|FG000|Overall Study|Study medication no longer effective|0|||
161304443|NCT01867710|582496764|FG001|Overall Study|Study medication no longer effective|1|||
161304444|NCT01867710|582496765|FG002|Overall Study|Study medication no longer effective|0|||
161304445|NCT01867710|582496766|FG003|Overall Study|Study medication no longer effective|0|||
161304446|NCT00976820|582496767|FG000|Overall Study|Lost to Follow-up|5|||
161304447|NCT00976820|582496768|FG001|Overall Study|Lost to Follow-up|16|||
161304448|NCT00976820|582496769|FG002|Overall Study|Lost to Follow-up|2|||
161304449|NCT00976820|582496770|FG003|Overall Study|Lost to Follow-up|3|||
161304450|NCT00976820|582496767|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
161304451|NCT00976820|582496768|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
161304452|NCT00976820|582496769|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
161304453|NCT00976820|582496770|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
161304454|NCT00976820|582496767|FG000|Overall Study|Withdrawal by Subject|2|||
161304455|NCT00976820|582496768|FG001|Overall Study|Withdrawal by Subject|4|||
161304456|NCT00976820|582496769|FG002|Overall Study|Withdrawal by Subject|1|||
161304457|NCT00976820|582496770|FG003|Overall Study|Withdrawal by Subject|4|||
161304458|NCT02048826|582496771|FG000|Overall Study|Withdrawal by Subject|1|||
161304459|NCT02048826|582496772|FG001|Overall Study|Withdrawal by Subject|0|||
161304460|NCT00968981|582496773|FG000|Overall Study|Adverse Event|2|||
161304461|NCT00968981|582496774|FG001|Overall Study|Adverse Event|0|||
161304462|NCT00968981|582496775|FG002|Overall Study|Adverse Event|0|||
161304463|NCT00968981|582496773|FG000|Overall Study|Disease Progression|14|||
161304464|NCT00968981|582496774|FG001|Overall Study|Disease Progression|16|||
161304465|NCT00968981|582496775|FG002|Overall Study|Disease Progression|13|||
161304466|NCT00968981|582496773|FG000|Overall Study|Lost to Follow-up|0|||
161304467|NCT00968981|582496774|FG001|Overall Study|Lost to Follow-up|0|||
161304468|NCT00968981|582496775|FG002|Overall Study|Lost to Follow-up|1|||
161304469|NCT00968981|582496773|FG000|Overall Study|Physician Decision|5|||
161304470|NCT00968981|582496774|FG001|Overall Study|Physician Decision|3|||
161304471|NCT00968981|582496775|FG002|Overall Study|Physician Decision|5|||
161304472|NCT00968981|582496773|FG000|Overall Study|Withdrawal by Subject|1|||
161304473|NCT00968981|582496774|FG001|Overall Study|Withdrawal by Subject|3|||
161304474|NCT00968981|582496775|FG002|Overall Study|Withdrawal by Subject|3|||
161304475|NCT01489254|582496786|FG000|Double-blind Part|Adverse Event|7|||
161304476|NCT01489254|582496787|FG001|Double-blind Part|Adverse Event|2|||
161304477|NCT01489254|582496788|FG002|Double-blind Part|Adverse Event|2|||
161304478|NCT01489254|582496789|FG003|Double-blind Part|Adverse Event|0|||
161304479|NCT01489254|582496786|FG000|Double-blind Part|Pregnancy|1|||
161304480|NCT01489254|582496787|FG001|Double-blind Part|Pregnancy|3|||
161304481|NCT01489254|582496788|FG002|Double-blind Part|Pregnancy|0|||
161304482|NCT01489254|582496789|FG003|Double-blind Part|Pregnancy|0|||
161304483|NCT01489254|582496786|FG000|Double-blind Part|Withdrawal by Subject|12|||
161304484|NCT01489254|582496787|FG001|Double-blind Part|Withdrawal by Subject|20|||
161304485|NCT01489254|582496788|FG002|Double-blind Part|Withdrawal by Subject|1|||
161304486|NCT01489254|582496789|FG003|Double-blind Part|Withdrawal by Subject|0|||
161304487|NCT01489254|582496786|FG000|Double-blind Part|Lost to Follow-up|1|||
161304488|NCT01489254|582496787|FG001|Double-blind Part|Lost to Follow-up|2|||
161304489|NCT01489254|582496788|FG002|Double-blind Part|Lost to Follow-up|0|||
161304490|NCT01489254|582496789|FG003|Double-blind Part|Lost to Follow-up|0|||
161304491|NCT01489254|582496786|FG000|Double-blind Part|Other reasons for not completing study|4|||
161304492|NCT01489254|582496787|FG001|Double-blind Part|Other reasons for not completing study|6|||
161304493|NCT01489254|582496788|FG002|Double-blind Part|Other reasons for not completing study|0|||
161304494|NCT01489254|582496789|FG003|Double-blind Part|Other reasons for not completing study|0|||
161304495|NCT01489254|582496786|FG000|Open-label Extension Part|Adverse Event|0|||
161304496|NCT01489254|582496787|FG001|Open-label Extension Part|Adverse Event|0|||
161304497|NCT01489254|582496788|FG002|Open-label Extension Part|Adverse Event|0|||
161304498|NCT01489254|582496789|FG003|Open-label Extension Part|Adverse Event|10|||
161304499|NCT01489254|582496786|FG000|Open-label Extension Part|Pregnancy|0|||
161304500|NCT01489254|582496787|FG001|Open-label Extension Part|Pregnancy|0|||
161304501|NCT01489254|582496788|FG002|Open-label Extension Part|Pregnancy|0|||
161304502|NCT01489254|582496789|FG003|Open-label Extension Part|Pregnancy|3|||
161304503|NCT01489254|582496786|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
161304504|NCT01489254|582496787|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
161304505|NCT01489254|582496788|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
161304506|NCT01489254|582496789|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
161304507|NCT01489254|582496786|FG000|Open-label Extension Part|Protocol Violation|0|||
161304508|NCT01489254|582496787|FG001|Open-label Extension Part|Protocol Violation|0|||
161304509|NCT01489254|582496788|FG002|Open-label Extension Part|Protocol Violation|0|||
161304510|NCT01489254|582496789|FG003|Open-label Extension Part|Protocol Violation|1|||
161304511|NCT01489254|582496786|FG000|Open-label Extension Part|Lost to Follow-up|0|||
161304512|NCT01489254|582496787|FG001|Open-label Extension Part|Lost to Follow-up|0|||
161304513|NCT01489254|582496788|FG002|Open-label Extension Part|Lost to Follow-up|0|||
161304514|NCT01489254|582496789|FG003|Open-label Extension Part|Lost to Follow-up|9|||
161304515|NCT01489254|582496786|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
161348142|NCT04398134|582658444|FG001|Overall Study|Withdrawal by Subject|0|||
161348143|NCT04398134|582658445|FG002|Overall Study|Withdrawal by Subject|0|||
161348144|NCT04398134|582658446|FG003|Overall Study|Withdrawal by Subject|1|||
161348145|NCT04398134|582658443|FG000|Overall Study|Study Terminated by Sponsor|30|||
161348146|NCT04398134|582658444|FG001|Overall Study|Study Terminated by Sponsor|11|||
161348147|NCT04398134|582658445|FG002|Overall Study|Study Terminated by Sponsor|32|||
161348148|NCT04398134|582658446|FG003|Overall Study|Study Terminated by Sponsor|11|||
161348149|NCT06420232|582658450|FG000|Overall Study|Withdrawal by Subject|3|||
161348150|NCT01697579|582658452|FG000|Base Study-Cycle 1|Adverse Event|1|||
161348151|NCT01697579|582658453|FG001|Base Study-Cycle 1|Adverse Event|0|||
161348152|NCT01697579|582658454|FG002|Base Study-Cycle 1|Adverse Event|0|||
161348153|NCT01697579|582658455|FG003|Base Study-Cycle 1|Adverse Event|0|||
161348154|NCT01697579|582658456|FG004|Base Study-Cycle 1|Adverse Event|0|||
161348155|NCT01697579|582658457|FG005|Base Study-Cycle 1|Adverse Event|0|||
161348156|NCT01697579|582658458|FG006|Base Study-Cycle 1|Adverse Event|0|||
161348157|NCT01697579|582658452|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
161348158|NCT01697579|582658453|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161348159|NCT01697579|582658454|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161348160|NCT01697579|582658455|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161348161|NCT01697579|582658456|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161348162|NCT01697579|582658457|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161348163|NCT01697579|582658458|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
161348164|NCT01697579|582658452|FG000|Base Study-Cycle 1|Protocol Violation|0|||
161348165|NCT01697579|582658453|FG001|Base Study-Cycle 1|Protocol Violation|0|||
161348166|NCT01697579|582658454|FG002|Base Study-Cycle 1|Protocol Violation|0|||
161304516|NCT01489254|582496787|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
161304517|NCT01489254|582496788|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
161304518|NCT01489254|582496789|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
161304519|NCT01981954|582496790|FG000|Titration Period|Protocol Deviation|1|||
161304520|NCT01981954|582496790|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
161304521|NCT00890084|582496804|FG000|Overall Study|Adverse Event|16|||
161304522|NCT00890084|582496804|FG000|Overall Study|Lost to Follow-up|126|||
161304523|NCT02738879|582496805|FG000|Overall Study|Adverse Event|1|||
161304524|NCT02738879|582496806|FG001|Overall Study|Adverse Event|1|||
161304525|NCT02738879|582496805|FG000|Overall Study|Death|0|||
161304526|NCT02738879|582496806|FG001|Overall Study|Death|2|||
161304527|NCT02738879|582496805|FG000|Overall Study|Lost to Follow-up|1|||
161304528|NCT02738879|582496806|FG001|Overall Study|Lost to Follow-up|5|||
161304529|NCT02738879|582496805|FG000|Overall Study|Protocol Violation|1|||
161304530|NCT02738879|582496806|FG001|Overall Study|Protocol Violation|3|||
161304531|NCT02738879|582496805|FG000|Overall Study|Physician Decision|3|||
161304532|NCT02738879|582496806|FG001|Overall Study|Physician Decision|4|||
161304533|NCT02738879|582496805|FG000|Overall Study|Pregnancy|0|||
161304534|NCT02738879|582496806|FG001|Overall Study|Pregnancy|1|||
161304535|NCT02738879|582496805|FG000|Overall Study|Screen Failure|1|||
161304536|NCT02738879|582496806|FG001|Overall Study|Screen Failure|2|||
161304537|NCT02738879|582496805|FG000|Overall Study|Site Discontinued Study Participation|1|||
161304538|NCT02738879|582496806|FG001|Overall Study|Site Discontinued Study Participation|0|||
161304539|NCT02738879|582496805|FG000|Overall Study|Withdrawal by Subject|5|||
161304540|NCT02738879|582496806|FG001|Overall Study|Withdrawal by Subject|7|||
161304541|NCT02980341|582496811|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161304542|NCT02980341|582496812|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161304543|NCT02980341|582496813|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
161304544|NCT02980341|582496814|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
161304545|NCT02980341|582496815|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
161348167|NCT01697579|582658455|FG003|Base Study-Cycle 1|Protocol Violation|0|||
161348168|NCT01697579|582658456|FG004|Base Study-Cycle 1|Protocol Violation|3|||
161348169|NCT01697579|582658457|FG005|Base Study-Cycle 1|Protocol Violation|0|||
161348170|NCT01697579|582658458|FG006|Base Study-Cycle 1|Protocol Violation|0|||
161304546|NCT02980341|582496816|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161304547|NCT02980341|582496817|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161304548|NCT02980341|582496818|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161304549|NCT02980341|582496819|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161304550|NCT02980341|582496820|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161348171|NCT01697579|582658452|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161348172|NCT01697579|582658453|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
161348173|NCT01697579|582658454|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161348174|NCT01697579|582658455|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161348175|NCT01697579|582658456|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161089771|NCT03184870|581719808|FG017|Crossover Treatment|Death|7|||
161304551|NCT02980341|582496821|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
161304552|NCT02980341|582496811|FG000|Dose Escalation|Clinical progression|0|||
161304553|NCT02980341|582496812|FG001|Dose Escalation|Clinical progression|0|||
161304554|NCT02980341|582496813|FG002|Dose Escalation|Clinical progression|2|||
161304555|NCT02980341|582496814|FG003|Dose Escalation|Clinical progression|1|||
161304556|NCT02980341|582496815|FG004|Dose Escalation|Clinical progression|0|||
161304557|NCT02980341|582496816|FG005|Dose Escalation|Clinical progression|0|||
161304558|NCT02980341|582496817|FG006|Dose Escalation|Clinical progression|0|||
161304559|NCT02980341|582496818|FG007|Dose Escalation|Clinical progression|0|||
161304560|NCT02980341|582496819|FG008|Dose Escalation|Clinical progression|0|||
161304561|NCT02980341|582496820|FG009|Dose Escalation|Clinical progression|0|||
161304562|NCT02980341|582496821|FG010|Dose Escalation|Clinical progression|0|||
161304563|NCT02980341|582496811|FG000|Dose Escalation|Adverse Event|0|||
161304564|NCT02980341|582496812|FG001|Dose Escalation|Adverse Event|0|||
161304565|NCT02980341|582496813|FG002|Dose Escalation|Adverse Event|1|||
161304566|NCT02980341|582496814|FG003|Dose Escalation|Adverse Event|2|||
161304567|NCT02980341|582496815|FG004|Dose Escalation|Adverse Event|2|||
161304568|NCT02980341|582496816|FG005|Dose Escalation|Adverse Event|0|||
161304569|NCT02980341|582496817|FG006|Dose Escalation|Adverse Event|0|||
161304570|NCT02980341|582496818|FG007|Dose Escalation|Adverse Event|0|||
161304571|NCT02980341|582496819|FG008|Dose Escalation|Adverse Event|0|||
161304572|NCT02980341|582496820|FG009|Dose Escalation|Adverse Event|0|||
161304573|NCT02980341|582496821|FG010|Dose Escalation|Adverse Event|0|||
161304574|NCT02980341|582496811|FG000|Dose Escalation|Withdrawal by Subject|0|||
161304575|NCT02980341|582496812|FG001|Dose Escalation|Withdrawal by Subject|0|||
161304576|NCT02980341|582496813|FG002|Dose Escalation|Withdrawal by Subject|1|||
161304577|NCT02980341|582496814|FG003|Dose Escalation|Withdrawal by Subject|0|||
161304578|NCT02980341|582496815|FG004|Dose Escalation|Withdrawal by Subject|0|||
161304579|NCT02980341|582496816|FG005|Dose Escalation|Withdrawal by Subject|0|||
161304580|NCT02980341|582496817|FG006|Dose Escalation|Withdrawal by Subject|0|||
161304581|NCT02980341|582496818|FG007|Dose Escalation|Withdrawal by Subject|0|||
161304582|NCT02980341|582496819|FG008|Dose Escalation|Withdrawal by Subject|0|||
161304583|NCT02980341|582496820|FG009|Dose Escalation|Withdrawal by Subject|0|||
161304584|NCT02980341|582496821|FG010|Dose Escalation|Withdrawal by Subject|0|||
161304585|NCT02980341|582496811|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304586|NCT02980341|582496812|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304587|NCT02980341|582496813|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304588|NCT02980341|582496814|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
161304589|NCT02980341|582496815|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304590|NCT02980341|582496816|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304591|NCT02980341|582496817|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304592|NCT02980341|582496818|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304593|NCT02980341|582496819|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304594|NCT02980341|582496820|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304595|NCT02980341|582496821|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
161304596|NCT02980341|582496811|FG000|Dose Escalation|Due to investigator's decision|0|||
161304597|NCT02980341|582496812|FG001|Dose Escalation|Due to investigator's decision|0|||
161304598|NCT02980341|582496813|FG002|Dose Escalation|Due to investigator's decision|0|||
161304599|NCT02980341|582496814|FG003|Dose Escalation|Due to investigator's decision|0|||
161304600|NCT02980341|582496815|FG004|Dose Escalation|Due to investigator's decision|1|||
161304601|NCT02980341|582496816|FG005|Dose Escalation|Due to investigator's decision|0|||
161304602|NCT02980341|582496817|FG006|Dose Escalation|Due to investigator's decision|0|||
161304603|NCT02980341|582496818|FG007|Dose Escalation|Due to investigator's decision|0|||
161304604|NCT02980341|582496819|FG008|Dose Escalation|Due to investigator's decision|0|||
161304605|NCT02980341|582496820|FG009|Dose Escalation|Due to investigator's decision|0|||
161304606|NCT02980341|582496821|FG010|Dose Escalation|Due to investigator's decision|0|||
161304607|NCT02980341|582496811|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304608|NCT02980341|582496812|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
161348176|NCT01697579|582658457|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161304609|NCT02980341|582496813|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304610|NCT02980341|582496814|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304611|NCT02980341|582496815|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304612|NCT02980341|582496816|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
161304613|NCT02980341|582496817|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
161304614|NCT02980341|582496818|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304615|NCT02980341|582496819|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304616|NCT02980341|582496820|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
161304617|NCT02980341|582496821|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
161348177|NCT01697579|582658458|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
161348178|NCT01697579|582658452|FG000|Base Study-Cycle 1|Technical Problems|0|||
161348179|NCT01697579|582658453|FG001|Base Study-Cycle 1|Technical Problems|0|||
161304618|NCT02980341|582496811|FG000|Dose Finding|Adverse Event|0|||
161304619|NCT02980341|582496812|FG001|Dose Finding|Adverse Event|0|||
161304620|NCT02980341|582496813|FG002|Dose Finding|Adverse Event|0|||
161304621|NCT02980341|582496814|FG003|Dose Finding|Adverse Event|0|||
161304622|NCT02980341|582496815|FG004|Dose Finding|Adverse Event|0|||
161304623|NCT02980341|582496816|FG005|Dose Finding|Adverse Event|3|||
161304624|NCT02980341|582496817|FG006|Dose Finding|Adverse Event|0|||
161304625|NCT02980341|582496818|FG007|Dose Finding|Adverse Event|0|||
161304626|NCT02980341|582496819|FG008|Dose Finding|Adverse Event|0|||
161304627|NCT02980341|582496820|FG009|Dose Finding|Adverse Event|0|||
161304628|NCT02980341|582496821|FG010|Dose Finding|Adverse Event|0|||
161304629|NCT02980341|582496811|FG000|Dose Finding|Withdrawal by Subject|0|||
161304630|NCT02980341|582496812|FG001|Dose Finding|Withdrawal by Subject|0|||
161304631|NCT02980341|582496813|FG002|Dose Finding|Withdrawal by Subject|0|||
161304632|NCT02980341|582496814|FG003|Dose Finding|Withdrawal by Subject|0|||
161304633|NCT02980341|582496815|FG004|Dose Finding|Withdrawal by Subject|0|||
161304634|NCT02980341|582496816|FG005|Dose Finding|Withdrawal by Subject|1|||
161304635|NCT02980341|582496817|FG006|Dose Finding|Withdrawal by Subject|1|||
161304636|NCT02980341|582496818|FG007|Dose Finding|Withdrawal by Subject|0|||
161304637|NCT02980341|582496819|FG008|Dose Finding|Withdrawal by Subject|0|||
161304638|NCT02980341|582496820|FG009|Dose Finding|Withdrawal by Subject|0|||
161304639|NCT02980341|582496821|FG010|Dose Finding|Withdrawal by Subject|0|||
161304640|NCT02980341|582496811|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304641|NCT02980341|582496812|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304642|NCT02980341|582496813|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304643|NCT02980341|582496814|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304644|NCT02980341|582496815|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304645|NCT02980341|582496816|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304646|NCT02980341|582496817|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
161304647|NCT02980341|582496818|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
161304648|NCT02980341|582496819|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
161304649|NCT02980341|582496820|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
161304650|NCT02980341|582496821|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
161304651|NCT02980341|582496811|FG000|Dose Expansion|Clinical progression|0|||
161304652|NCT02980341|582496812|FG001|Dose Expansion|Clinical progression|0|||
161304653|NCT02980341|582496813|FG002|Dose Expansion|Clinical progression|0|||
161304654|NCT02980341|582496814|FG003|Dose Expansion|Clinical progression|0|||
161304655|NCT02980341|582496815|FG004|Dose Expansion|Clinical progression|0|||
161304656|NCT02980341|582496816|FG005|Dose Expansion|Clinical progression|0|||
161304657|NCT02980341|582496817|FG006|Dose Expansion|Clinical progression|0|||
161304658|NCT02980341|582496818|FG007|Dose Expansion|Clinical progression|4|||
161304659|NCT02980341|582496819|FG008|Dose Expansion|Clinical progression|3|||
161304660|NCT02980341|582496820|FG009|Dose Expansion|Clinical progression|1|||
161304661|NCT02980341|582496821|FG010|Dose Expansion|Clinical progression|4|||
161304662|NCT02980341|582496811|FG000|Dose Expansion|Adverse Event|0|||
161304663|NCT02980341|582496812|FG001|Dose Expansion|Adverse Event|0|||
161304664|NCT02980341|582496813|FG002|Dose Expansion|Adverse Event|0|||
161304665|NCT02980341|582496814|FG003|Dose Expansion|Adverse Event|0|||
161304666|NCT02980341|582496815|FG004|Dose Expansion|Adverse Event|0|||
161304667|NCT02980341|582496816|FG005|Dose Expansion|Adverse Event|0|||
161304668|NCT02980341|582496817|FG006|Dose Expansion|Adverse Event|0|||
161304669|NCT02980341|582496818|FG007|Dose Expansion|Adverse Event|3|||
161304670|NCT02980341|582496819|FG008|Dose Expansion|Adverse Event|0|||
161304671|NCT02980341|582496820|FG009|Dose Expansion|Adverse Event|1|||
161304672|NCT02980341|582496821|FG010|Dose Expansion|Adverse Event|3|||
161304673|NCT02980341|582496811|FG000|Dose Expansion|Death|0|||
161304674|NCT02980341|582496812|FG001|Dose Expansion|Death|0|||
161304675|NCT02980341|582496813|FG002|Dose Expansion|Death|0|||
161304676|NCT02980341|582496814|FG003|Dose Expansion|Death|0|||
161304677|NCT02980341|582496815|FG004|Dose Expansion|Death|0|||
161304678|NCT02980341|582496816|FG005|Dose Expansion|Death|0|||
161304679|NCT02980341|582496817|FG006|Dose Expansion|Death|0|||
161304680|NCT02980341|582496818|FG007|Dose Expansion|Death|0|||
161304681|NCT02980341|582496819|FG008|Dose Expansion|Death|2|||
161304682|NCT02980341|582496820|FG009|Dose Expansion|Death|1|||
161304683|NCT02980341|582496821|FG010|Dose Expansion|Death|0|||
161304684|NCT02980341|582496811|FG000|Dose Expansion|Withdrawal by Subject|0|||
161304685|NCT02980341|582496812|FG001|Dose Expansion|Withdrawal by Subject|0|||
161304686|NCT02980341|582496813|FG002|Dose Expansion|Withdrawal by Subject|0|||
161089772|NCT03786783|581719809|FG000|Overall Study|Death|1|||
161089773|NCT03786783|581719809|FG000|Overall Study|Physician Decision|6|||
161089774|NCT03786783|581719809|FG000|Overall Study|Withdrawal by Subject|2|||
161089775|NCT03786783|581719809|FG000|Overall Study|Disease Progression|7|||
161089776|NCT03786783|581719809|FG000|Overall Study|Patient/Parent Refusal|4|||
161089777|NCT01776541|581719810|FG000|Overall Study|Administrative Reason|6|||
161089778|NCT01776541|581719811|FG001|Overall Study|Administrative Reason|2|||
161089779|NCT01776541|581719810|FG000|Overall Study|Death|4|||
161089780|NCT01776541|581719811|FG001|Overall Study|Death|0|||
161089781|NCT01776541|581719810|FG000|Overall Study|Lost to Follow-up|27|||
161089782|NCT01776541|581719811|FG001|Overall Study|Lost to Follow-up|48|||
161089783|NCT01776541|581719810|FG000|Overall Study|Unclassified|5|||
161304687|NCT02980341|582496814|FG003|Dose Expansion|Withdrawal by Subject|0|||
161304688|NCT02980341|582496815|FG004|Dose Expansion|Withdrawal by Subject|0|||
161304689|NCT02980341|582496816|FG005|Dose Expansion|Withdrawal by Subject|0|||
161304690|NCT02980341|582496817|FG006|Dose Expansion|Withdrawal by Subject|0|||
161304691|NCT02980341|582496818|FG007|Dose Expansion|Withdrawal by Subject|2|||
161304692|NCT02980341|582496819|FG008|Dose Expansion|Withdrawal by Subject|0|||
161304693|NCT02980341|582496820|FG009|Dose Expansion|Withdrawal by Subject|1|||
161304694|NCT02980341|582496821|FG010|Dose Expansion|Withdrawal by Subject|0|||
161304695|NCT02980341|582496811|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304696|NCT02980341|582496812|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304697|NCT02980341|582496813|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304698|NCT02980341|582496814|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304699|NCT02980341|582496815|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304700|NCT02980341|582496816|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304701|NCT02980341|582496817|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304702|NCT02980341|582496818|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
161304703|NCT02980341|582496819|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304704|NCT02980341|582496820|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304705|NCT02980341|582496821|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
161304706|NCT02980341|582496811|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304707|NCT02980341|582496812|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304708|NCT02980341|582496813|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304709|NCT02980341|582496814|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304710|NCT02980341|582496815|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304711|NCT02980341|582496816|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304712|NCT02980341|582496817|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304713|NCT02980341|582496818|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304714|NCT02980341|582496819|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
161304715|NCT02980341|582496820|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304716|NCT02980341|582496821|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
161304717|NCT02980341|582496811|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304718|NCT02980341|582496812|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304719|NCT02980341|582496813|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304720|NCT02980341|582496814|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304721|NCT02980341|582496815|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304722|NCT02980341|582496816|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304723|NCT02980341|582496817|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304724|NCT02980341|582496818|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304725|NCT02980341|582496819|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
161304726|NCT02980341|582496820|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304727|NCT02980341|582496821|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
161304728|NCT02980341|582496811|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304729|NCT02980341|582496812|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304730|NCT02980341|582496813|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304731|NCT02980341|582496814|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304732|NCT02980341|582496815|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304733|NCT02980341|582496816|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304734|NCT02980341|582496817|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304735|NCT02980341|582496818|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304736|NCT02980341|582496819|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304737|NCT02980341|582496820|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
161304738|NCT02980341|582496821|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
161304739|NCT01647516|582496822|FG000|Induction Period (IP)|Physician Decision|2|||
161304740|NCT01647516|582496823|FG001|Induction Period (IP)|Physician Decision|0|||
161304741|NCT01647516|582496824|FG002|Induction Period (IP)|Physician Decision|0|||
161304742|NCT01647516|582496825|FG003|Induction Period (IP)|Physician Decision|0|||
161304743|NCT01647516|582496826|FG004|Induction Period (IP)|Physician Decision|0|||
161304744|NCT01647516|582496827|FG005|Induction Period (IP)|Physician Decision|0|||
161304745|NCT01647516|582496822|FG000|Induction Period (IP)|Adverse Event|1|||
161304746|NCT01647516|582496823|FG001|Induction Period (IP)|Adverse Event|2|||
161304747|NCT01647516|582496824|FG002|Induction Period (IP)|Adverse Event|0|||
161304748|NCT01647516|582496825|FG003|Induction Period (IP)|Adverse Event|0|||
161304749|NCT01647516|582496826|FG004|Induction Period (IP)|Adverse Event|0|||
161304750|NCT01647516|582496827|FG005|Induction Period (IP)|Adverse Event|0|||
161304751|NCT01647516|582496822|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
161304752|NCT01647516|582496823|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
161304753|NCT01647516|582496824|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
161304754|NCT01647516|582496825|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
161304755|NCT01647516|582496826|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
161304756|NCT01647516|582496827|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
161304757|NCT01647516|582496822|FG000|Induction Period (IP)|Participant Choice|0|||
161304758|NCT01647516|582496823|FG001|Induction Period (IP)|Participant Choice|0|||
161304759|NCT01647516|582496824|FG002|Induction Period (IP)|Participant Choice|1|||
161304760|NCT01647516|582496825|FG003|Induction Period (IP)|Participant Choice|0|||
161304761|NCT01647516|582496826|FG004|Induction Period (IP)|Participant Choice|0|||
161304762|NCT01647516|582496827|FG005|Induction Period (IP)|Participant Choice|0|||
161304763|NCT01647516|582496822|FG000|Induction Period (IP)|Lack of Efficacy|1|||
161304764|NCT01647516|582496823|FG001|Induction Period (IP)|Lack of Efficacy|0|||
161304765|NCT01647516|582496824|FG002|Induction Period (IP)|Lack of Efficacy|0|||
161304766|NCT01647516|582496825|FG003|Induction Period (IP)|Lack of Efficacy|0|||
161304767|NCT01647516|582496826|FG004|Induction Period (IP)|Lack of Efficacy|0|||
161304768|NCT01647516|582496827|FG005|Induction Period (IP)|Lack of Efficacy|0|||
161304769|NCT01647516|582496822|FG000|Induction Period (IP)|No study drug received|1|||
161304770|NCT01647516|582496823|FG001|Induction Period (IP)|No study drug received|1|||
161304771|NCT01647516|582496824|FG002|Induction Period (IP)|No study drug received|0|||
161304772|NCT01647516|582496825|FG003|Induction Period (IP)|No study drug received|0|||
161304773|NCT01647516|582496826|FG004|Induction Period (IP)|No study drug received|0|||
161304774|NCT01647516|582496827|FG005|Induction Period (IP)|No study drug received|0|||
161304775|NCT01647516|582496822|FG000|Maintenance Period (MP)|Adverse Event|2|||
161304776|NCT01647516|582496823|FG001|Maintenance Period (MP)|Adverse Event|1|||
161304777|NCT01647516|582496824|FG002|Maintenance Period (MP)|Adverse Event|0|||
161304778|NCT01647516|582496825|FG003|Maintenance Period (MP)|Adverse Event|0|||
161304779|NCT01647516|582496826|FG004|Maintenance Period (MP)|Adverse Event|0|||
161304780|NCT01647516|582496827|FG005|Maintenance Period (MP)|Adverse Event|0|||
161304781|NCT01647516|582496822|FG000|Maintenance Period (MP)|Non-compliance|1|||
161304782|NCT01647516|582496823|FG001|Maintenance Period (MP)|Non-compliance|0|||
161304783|NCT01647516|582496824|FG002|Maintenance Period (MP)|Non-compliance|0|||
161304784|NCT01647516|582496825|FG003|Maintenance Period (MP)|Non-compliance|0|||
161304785|NCT01647516|582496826|FG004|Maintenance Period (MP)|Non-compliance|0|||
161304786|NCT01647516|582496827|FG005|Maintenance Period (MP)|Non-compliance|0|||
161304787|NCT01647516|582496822|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
161304788|NCT01647516|582496823|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
161304789|NCT01647516|582496824|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
161304790|NCT01647516|582496825|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
161304791|NCT01647516|582496826|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
161304792|NCT01647516|582496827|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
161304793|NCT01647516|582496822|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
161304794|NCT01647516|582496823|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
161304795|NCT01647516|582496824|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
161304796|NCT01647516|582496825|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
161304797|NCT01647516|582496826|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
161304798|NCT01647516|582496827|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
161304799|NCT01647516|582496822|FG000|Open-Label Period|Adverse Event|0|||
161304800|NCT01647516|582496823|FG001|Open-Label Period|Adverse Event|0|||
161304801|NCT01647516|582496824|FG002|Open-Label Period|Adverse Event|0|||
161304802|NCT01647516|582496825|FG003|Open-Label Period|Adverse Event|5|||
161304803|NCT01647516|582496826|FG004|Open-Label Period|Adverse Event|6|||
161304804|NCT01647516|582496827|FG005|Open-Label Period|Adverse Event|3|||
161304805|NCT01647516|582496822|FG000|Open-Label Period|Pregnancy|0|||
161304806|NCT01647516|582496823|FG001|Open-Label Period|Pregnancy|0|||
161304807|NCT01647516|582496824|FG002|Open-Label Period|Pregnancy|0|||
161304808|NCT01647516|582496825|FG003|Open-Label Period|Pregnancy|0|||
161304809|NCT01647516|582496826|FG004|Open-Label Period|Pregnancy|0|||
161304810|NCT01647516|582496827|FG005|Open-Label Period|Pregnancy|1|||
161304811|NCT01647516|582496822|FG000|Open-Label Period|Non-compliance|0|||
161304812|NCT01647516|582496823|FG001|Open-Label Period|Non-compliance|0|||
161304813|NCT01647516|582496824|FG002|Open-Label Period|Non-compliance|0|||
161304814|NCT01647516|582496825|FG003|Open-Label Period|Non-compliance|1|||
161304815|NCT01647516|582496826|FG004|Open-Label Period|Non-compliance|0|||
161304816|NCT01647516|582496827|FG005|Open-Label Period|Non-compliance|1|||
161304817|NCT01647516|582496822|FG000|Open-Label Period|Physician Decision|0|||
161304818|NCT01647516|582496823|FG001|Open-Label Period|Physician Decision|0|||
161304819|NCT01647516|582496824|FG002|Open-Label Period|Physician Decision|0|||
161184094|NCT00963820|582051172|FG008|Expansion Phase|Withdrawal by Subject|1|||
161184095|NCT00963820|582051173|FG009|Expansion Phase|Withdrawal by Subject|0|||
161184096|NCT00963820|582051174|FG010|Expansion Phase|Withdrawal by Subject|1|||
161184097|NCT00963820|582051175|FG011|Expansion Phase|Withdrawal by Subject|1|||
161184098|NCT00963820|582051164|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184099|NCT00963820|582051165|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184100|NCT00963820|582051166|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184101|NCT00963820|582051167|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184102|NCT00963820|582051168|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184103|NCT00963820|582051169|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184104|NCT00963820|582051170|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184105|NCT00963820|582051171|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184106|NCT00963820|582051172|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184107|NCT00963820|582051173|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184108|NCT00963820|582051174|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
161184109|NCT00963820|582051175|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
161184110|NCT04556175|582051183|FG000|Overall Study|Study terminated due to COVID-19|8|||
161184111|NCT04556175|582051184|FG001|Overall Study|Study terminated due to COVID-19|8|||
161184112|NCT05549505|582051186|FG000|Overall Study|Lost to Follow-up|2|||
161184113|NCT05549505|582051187|FG001|Overall Study|Lost to Follow-up|0|||
161184114|NCT05549505|582051186|FG000|Overall Study|Withdrawal by Subject|3|||
161184115|NCT05549505|582051187|FG001|Overall Study|Withdrawal by Subject|3|||
161184116|NCT05549505|582051186|FG000|Overall Study|Other: Miscellaneous|3|||
161184117|NCT05549505|582051187|FG001|Overall Study|Other: Miscellaneous|6|||
161184118|NCT01426009|582051190|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
161184119|NCT01426009|582051190|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
161184120|NCT01426009|582051190|FG000|Washout 1|Withdrawal by Subject|1|||
161184121|NCT01426009|582051190|FG000|Washout 1|Personal Reasons|1|||
161184122|NCT01426009|582051190|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
161184123|NCT01426009|582051190|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
161184124|NCT01426009|582051190|FG000|Washout 2|electrive surgery|1|||
161184125|NCT01426009|582051190|FG000|Washout 3|personal reasons|1|||
161184126|NCT01426009|582051190|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
161184127|NCT01426009|582051190|FG000|Washout 4|Lost to Follow-up|1|||
161184128|NCT02756845|582051193|FG000|Overall Study|Death|12|||
161184129|NCT02756845|582051194|FG001|Overall Study|Death|2|||
161184130|NCT02756845|582051193|FG000|Overall Study|Withdrawal by Subject|1|||
161184131|NCT02756845|582051194|FG001|Overall Study|Withdrawal by Subject|0|||
161184132|NCT00515099|582051198|FG000|Overall Study|Lost to Follow-up|0|||
161184133|NCT00515099|582051199|FG001|Overall Study|Lost to Follow-up|4|||
161184134|NCT00515099|582051198|FG000|Overall Study|Withdrawal by Subject|2|||
161184135|NCT00515099|582051199|FG001|Overall Study|Withdrawal by Subject|0|||
161184136|NCT00515099|582051198|FG000|Overall Study|IRB Recommendation|1|||
161184137|NCT00515099|582051199|FG001|Overall Study|IRB Recommendation|0|||
161184138|NCT03342404|582051200|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
161184139|NCT03342404|582051201|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
161184140|NCT03342404|582051200|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
161184141|NCT03342404|582051201|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
161184142|NCT03342404|582051200|FG000|Blinded Treatment Phase|Adverse Event|5|||
161184143|NCT03342404|582051201|FG001|Blinded Treatment Phase|Adverse Event|4|||
161184144|NCT03342404|582051200|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
161184145|NCT03342404|582051201|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
161184146|NCT03342404|582051200|FG000|Blinded Treatment Phase|Other reasons|1|||
161184147|NCT03342404|582051201|FG001|Blinded Treatment Phase|Other reasons|0|||
161184148|NCT03342404|582051200|FG000|Blinded Treatment Phase|Physician Decision|1|||
161184149|NCT03342404|582051201|FG001|Blinded Treatment Phase|Physician Decision|0|||
161184150|NCT03342404|582051200|FG000|Blinded Treatment Phase|Death|1|||
161184151|NCT03342404|582051201|FG001|Blinded Treatment Phase|Death|0|||
161184152|NCT03342404|582051200|FG000|Open-Label Phase|Lost to Follow-up|0|||
161184153|NCT03342404|582051201|FG001|Open-Label Phase|Lost to Follow-up|1|||
161184154|NCT03342404|582051200|FG000|Open-Label Phase|Other reasons|0|||
161184155|NCT03342404|582051201|FG001|Open-Label Phase|Other reasons|1|||
161184156|NCT03342404|582051200|FG000|Open-Label Phase|Adverse Event|0|||
161184157|NCT03342404|582051201|FG001|Open-Label Phase|Adverse Event|3|||
161184158|NCT03342404|582051200|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161184159|NCT03342404|582051201|FG001|Open-Label Phase|Withdrawal by Subject|6|||
161184160|NCT00397631|582051210|FG000|Overall Study|Adverse Event|5|||
161184161|NCT00397631|582051211|FG001|Overall Study|Adverse Event|6|||
161348180|NCT01697579|582658454|FG002|Base Study-Cycle 1|Technical Problems|1|||
161184162|NCT00397631|582051210|FG000|Overall Study|Lack of Efficacy|7|||
161184163|NCT00397631|582051211|FG001|Overall Study|Lack of Efficacy|10|||
161348181|NCT01697579|582658455|FG003|Base Study-Cycle 1|Technical Problems|1|||
161348182|NCT01697579|582658456|FG004|Base Study-Cycle 1|Technical Problems|0|||
161184164|NCT00397631|582051210|FG000|Overall Study|Lost to Follow-up|8|||
161304820|NCT01647516|582496825|FG003|Open-Label Period|Physician Decision|1|||
161304821|NCT01647516|582496826|FG004|Open-Label Period|Physician Decision|1|||
161304822|NCT01647516|582496827|FG005|Open-Label Period|Physician Decision|0|||
161304823|NCT01647516|582496822|FG000|Open-Label Period|Withdrawal by Subject|0|||
161304824|NCT01647516|582496823|FG001|Open-Label Period|Withdrawal by Subject|0|||
161304825|NCT01647516|582496824|FG002|Open-Label Period|Withdrawal by Subject|0|||
161304826|NCT01647516|582496825|FG003|Open-Label Period|Withdrawal by Subject|9|||
161304827|NCT01647516|582496826|FG004|Open-Label Period|Withdrawal by Subject|11|||
161304828|NCT01647516|582496827|FG005|Open-Label Period|Withdrawal by Subject|6|||
161304829|NCT01647516|582496822|FG000|Open-Label Period|Lost to Follow-up|0|||
161304830|NCT01647516|582496823|FG001|Open-Label Period|Lost to Follow-up|0|||
161304831|NCT01647516|582496824|FG002|Open-Label Period|Lost to Follow-up|0|||
161304832|NCT01647516|582496825|FG003|Open-Label Period|Lost to Follow-up|1|||
161304833|NCT01647516|582496826|FG004|Open-Label Period|Lost to Follow-up|0|||
161304834|NCT01647516|582496827|FG005|Open-Label Period|Lost to Follow-up|1|||
161304835|NCT01647516|582496822|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161304836|NCT01647516|582496823|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161304837|NCT01647516|582496824|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
161304838|NCT01647516|582496825|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
161304839|NCT01647516|582496826|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
161304840|NCT01647516|582496827|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
161304841|NCT01647516|582496822|FG000|Open-Label Period|Lack of Efficacy|0|||
161304842|NCT01647516|582496823|FG001|Open-Label Period|Lack of Efficacy|0|||
161304843|NCT01647516|582496824|FG002|Open-Label Period|Lack of Efficacy|0|||
161304844|NCT01647516|582496825|FG003|Open-Label Period|Lack of Efficacy|7|||
161304845|NCT01647516|582496826|FG004|Open-Label Period|Lack of Efficacy|9|||
161304846|NCT01647516|582496827|FG005|Open-Label Period|Lack of Efficacy|10|||
161304847|NCT01647516|582496822|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161304848|NCT01647516|582496823|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161304849|NCT01647516|582496824|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
161304850|NCT01647516|582496825|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
161304851|NCT01647516|582496826|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
161304852|NCT01647516|582496827|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
161304853|NCT01647516|582496822|FG000|Open-Label Period|No completion / discontinuation visit|0|||
161304854|NCT01647516|582496823|FG001|Open-Label Period|No completion / discontinuation visit|0|||
161304855|NCT01647516|582496824|FG002|Open-Label Period|No completion / discontinuation visit|0|||
161304856|NCT01647516|582496825|FG003|Open-Label Period|No completion / discontinuation visit|0|||
161304857|NCT01647516|582496826|FG004|Open-Label Period|No completion / discontinuation visit|2|||
161304858|NCT01647516|582496827|FG005|Open-Label Period|No completion / discontinuation visit|1|||
161304859|NCT04964544|582496832|FG000|Overall Study|Screen failure or other uncategorised|10|||
161304860|NCT04964544|582496832|FG000|Overall Study|Physician Decision|4|||
161304861|NCT04964544|582496832|FG000|Overall Study|Lost to Follow-up|9|||
161304862|NCT04964544|582496832|FG000|Overall Study|Withdrawal by Subject|18|||
161304863|NCT04964544|582496832|FG000|Overall Study|Death|1|||
161304864|NCT02949843|582496835|FG000|Overall Study|Withdrawal by Subject|0|||
161304865|NCT02949843|582496836|FG001|Overall Study|Withdrawal by Subject|1|||
161304866|NCT02949843|582496837|FG002|Overall Study|Withdrawal by Subject|1|||
161304867|NCT03613649|582496838|FG000|Second Treatment|Lost to Follow-up|0|||
161304868|NCT03613649|582496839|FG001|Second Treatment|Lost to Follow-up|0|||
161304869|NCT03613649|582496840|FG002|Second Treatment|Lost to Follow-up|1|||
161304870|NCT03613649|582496841|FG003|Second Treatment|Lost to Follow-up|0|||
161304871|NCT03613649|582496842|FG004|Second Treatment|Lost to Follow-up|0|||
161304872|NCT03613649|582496843|FG005|Second Treatment|Lost to Follow-up|0|||
161304873|NCT03613649|582496844|FG006|Second Treatment|Lost to Follow-up|0|||
161304874|NCT03613649|582496845|FG007|Second Treatment|Lost to Follow-up|0|||
161304875|NCT03613649|582496846|FG008|Second Treatment|Lost to Follow-up|0|||
161304876|NCT03613649|582496847|FG009|Second Treatment|Lost to Follow-up|0|||
161304877|NCT03613649|582496848|FG010|Second Treatment|Lost to Follow-up|0|||
161304878|NCT03613649|582496849|FG011|Second Treatment|Lost to Follow-up|0|||
161089784|NCT01776541|581719811|FG001|Overall Study|Unclassified|4|||
161089785|NCT01776541|581719810|FG000|Overall Study|Protocol Violation|2|||
161089786|NCT01776541|581719811|FG001|Overall Study|Protocol Violation|1|||
161089787|NCT01776541|581719810|FG000|Overall Study|Withdrawal by Subject|12|||
161089788|NCT01776541|581719811|FG001|Overall Study|Withdrawal by Subject|20|||
161089789|NCT02518490|581719820|FG000|Overall Study|Withdrawal by Subject|1|||
161089790|NCT02518490|581719821|FG001|Overall Study|Withdrawal by Subject|1|||
161089791|NCT00346632|581719822|FG000|Overall Study|Progressive Disease|2|||
161089792|NCT00346632|581719823|FG001|Overall Study|Progressive Disease|2|||
161089793|NCT00346632|581719824|FG002|Overall Study|Progressive Disease|4|||
161089794|NCT00346632|581719825|FG003|Overall Study|Progressive Disease|3|||
161089795|NCT00346632|581719826|FG004|Overall Study|Progressive Disease|3|||
161089796|NCT00346632|581719827|FG005|Overall Study|Progressive Disease|1|||
161304879|NCT03613649|582496838|FG000|Second Treatment|Withdrawal by Subject|0|||
161348183|NCT01697579|582658457|FG005|Base Study-Cycle 1|Technical Problems|0|||
161348184|NCT01697579|582658458|FG006|Base Study-Cycle 1|Technical Problems|0|||
161348185|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Death|0|||
161348186|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Death|0|||
161348187|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Death|0|||
161348188|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Death|0|||
161348189|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Death|0|||
161348190|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Death|0|||
161348191|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Death|2|||
161348192|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161348193|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161348194|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161184165|NCT00397631|582051211|FG001|Overall Study|Lost to Follow-up|9|||
161304880|NCT03613649|582496839|FG001|Second Treatment|Withdrawal by Subject|0|||
161304881|NCT03613649|582496840|FG002|Second Treatment|Withdrawal by Subject|0|||
161304882|NCT03613649|582496841|FG003|Second Treatment|Withdrawal by Subject|0|||
161304883|NCT03613649|582496842|FG004|Second Treatment|Withdrawal by Subject|1|||
161304884|NCT03613649|582496843|FG005|Second Treatment|Withdrawal by Subject|0|||
161304885|NCT03613649|582496844|FG006|Second Treatment|Withdrawal by Subject|0|||
161304886|NCT03613649|582496845|FG007|Second Treatment|Withdrawal by Subject|0|||
161304887|NCT03613649|582496846|FG008|Second Treatment|Withdrawal by Subject|0|||
161304888|NCT03613649|582496847|FG009|Second Treatment|Withdrawal by Subject|0|||
161304889|NCT03613649|582496848|FG010|Second Treatment|Withdrawal by Subject|0|||
161304890|NCT03613649|582496849|FG011|Second Treatment|Withdrawal by Subject|0|||
161304891|NCT03613649|582496838|FG000|Third Treatment|Lost to Follow-up|0|||
161304892|NCT03613649|582496839|FG001|Third Treatment|Lost to Follow-up|0|||
161304893|NCT03613649|582496840|FG002|Third Treatment|Lost to Follow-up|0|||
161304894|NCT03613649|582496841|FG003|Third Treatment|Lost to Follow-up|0|||
161304895|NCT03613649|582496842|FG004|Third Treatment|Lost to Follow-up|1|||
161304896|NCT03613649|582496843|FG005|Third Treatment|Lost to Follow-up|0|||
161304897|NCT03613649|582496844|FG006|Third Treatment|Lost to Follow-up|0|||
161304898|NCT03613649|582496845|FG007|Third Treatment|Lost to Follow-up|0|||
161304899|NCT03613649|582496846|FG008|Third Treatment|Lost to Follow-up|0|||
161304900|NCT03613649|582496847|FG009|Third Treatment|Lost to Follow-up|0|||
161304901|NCT03613649|582496848|FG010|Third Treatment|Lost to Follow-up|0|||
161304902|NCT03613649|582496849|FG011|Third Treatment|Lost to Follow-up|1|||
161304903|NCT03613649|582496838|FG000|Third Treatment|Protocol Violation|0|||
161304904|NCT03613649|582496839|FG001|Third Treatment|Protocol Violation|0|||
161304905|NCT03613649|582496840|FG002|Third Treatment|Protocol Violation|0|||
161304906|NCT03613649|582496841|FG003|Third Treatment|Protocol Violation|0|||
161304907|NCT03613649|582496842|FG004|Third Treatment|Protocol Violation|0|||
161304908|NCT03613649|582496843|FG005|Third Treatment|Protocol Violation|0|||
161304909|NCT03613649|582496844|FG006|Third Treatment|Protocol Violation|1|||
161304910|NCT03613649|582496845|FG007|Third Treatment|Protocol Violation|0|||
161304911|NCT03613649|582496846|FG008|Third Treatment|Protocol Violation|0|||
161304912|NCT03613649|582496847|FG009|Third Treatment|Protocol Violation|0|||
161304913|NCT03613649|582496848|FG010|Third Treatment|Protocol Violation|0|||
161304914|NCT03613649|582496849|FG011|Third Treatment|Protocol Violation|1|||
161304915|NCT03613649|582496838|FG000|Fourth Treatment|Protocol Violation|1|||
161304916|NCT03613649|582496839|FG001|Fourth Treatment|Protocol Violation|0|||
161304917|NCT03613649|582496840|FG002|Fourth Treatment|Protocol Violation|0|||
161304918|NCT03613649|582496841|FG003|Fourth Treatment|Protocol Violation|0|||
161304919|NCT03613649|582496842|FG004|Fourth Treatment|Protocol Violation|1|||
161304920|NCT03613649|582496843|FG005|Fourth Treatment|Protocol Violation|0|||
161304921|NCT03613649|582496844|FG006|Fourth Treatment|Protocol Violation|0|||
161304922|NCT03613649|582496845|FG007|Fourth Treatment|Protocol Violation|0|||
161304923|NCT03613649|582496846|FG008|Fourth Treatment|Protocol Violation|0|||
161304924|NCT03613649|582496847|FG009|Fourth Treatment|Protocol Violation|0|||
161304925|NCT03613649|582496848|FG010|Fourth Treatment|Protocol Violation|0|||
161304926|NCT03613649|582496849|FG011|Fourth Treatment|Protocol Violation|0|||
161304927|NCT03613649|582496838|FG000|Fourth Treatment|Physician Decision|0|||
161304928|NCT03613649|582496839|FG001|Fourth Treatment|Physician Decision|0|||
161304929|NCT03613649|582496840|FG002|Fourth Treatment|Physician Decision|0|||
161304930|NCT03613649|582496841|FG003|Fourth Treatment|Physician Decision|0|||
161304931|NCT03613649|582496842|FG004|Fourth Treatment|Physician Decision|0|||
161304932|NCT03613649|582496843|FG005|Fourth Treatment|Physician Decision|0|||
161304933|NCT03613649|582496844|FG006|Fourth Treatment|Physician Decision|1|||
161304934|NCT03613649|582496845|FG007|Fourth Treatment|Physician Decision|0|||
161304935|NCT03613649|582496846|FG008|Fourth Treatment|Physician Decision|0|||
161304936|NCT03613649|582496847|FG009|Fourth Treatment|Physician Decision|0|||
161304937|NCT03613649|582496848|FG010|Fourth Treatment|Physician Decision|0|||
161304938|NCT03613649|582496849|FG011|Fourth Treatment|Physician Decision|0|||
161304939|NCT02693171|582496850|FG000|Overall Study|Adverse Event|1|||
161348195|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161304940|NCT02693171|582496850|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
161348196|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
161348197|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
161348198|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
161348199|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
161348200|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
161348201|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
161348202|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
161348203|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
161348204|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
161348205|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
161348206|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161348207|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161348208|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161348209|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161348210|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161348211|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
161348212|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
161348213|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161348214|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161348215|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161348216|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161348217|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
161348218|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
161348219|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
161348220|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161348221|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161348222|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161348223|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161348224|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161348225|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
161348226|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
161348227|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161348228|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161348229|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161348230|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161348231|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
161348232|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
161348233|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
161348234|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161348235|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161348236|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161348237|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161348238|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
161348239|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
161348240|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
161348241|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161348242|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161348243|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161348244|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161348245|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161348246|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
161348247|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
161348248|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
161348249|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
161348250|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
161348251|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
161348252|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
161348253|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
161348254|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
161348255|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
161348256|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
161348257|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
161348258|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
161089797|NCT00346632|581719828|FG006|Overall Study|Progressive Disease|2|||
161304941|NCT00319592|582496852|FG000|Overall Study|Protocol Violation|1|||
161304942|NCT00319592|582496853|FG001|Overall Study|Protocol Violation|0|||
161304943|NCT00319592|582496852|FG000|Overall Study|Physician Decision|0|||
161304944|NCT00319592|582496853|FG001|Overall Study|Physician Decision|1|||
161304945|NCT00658775|582496861|FG000|Overall Study|Adverse Event|4|||
161304946|NCT00658775|582496862|FG001|Overall Study|Adverse Event|6|||
161304947|NCT00658775|582496861|FG000|Overall Study|Lost to Follow-up|17|||
161304948|NCT00658775|582496862|FG001|Overall Study|Lost to Follow-up|18|||
161304949|NCT00658775|582496861|FG000|Overall Study|Withdrawal by Subject|6|||
161304950|NCT00658775|582496862|FG001|Overall Study|Withdrawal by Subject|4|||
161304951|NCT00658775|582496861|FG000|Overall Study|Withdrawal of consent|8|||
161304952|NCT00658775|582496862|FG001|Overall Study|Withdrawal of consent|7|||
161304953|NCT00658775|582496861|FG000|Overall Study|Other|7|||
161304954|NCT00658775|582496862|FG001|Overall Study|Other|8|||
161304955|NCT03887442|582496867|FG000|Overall Study|Adverse Event|1|||
161304956|NCT03887442|582496868|FG001|Overall Study|Adverse Event|0|||
161304957|NCT00767455|582496869|FG000|Overall Study|Investigator error|19|||
161304958|NCT00746564|582496872|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
161304959|NCT01628198|582496873|FG000|Overall Study|Lost to Follow-up|7|||
161304960|NCT01628198|582496873|FG000|Overall Study|Withdrawal by Subject|10|||
161304961|NCT01628198|582496873|FG000|Overall Study|Screen failure|1|||
161304962|NCT03386994|582496874|FG000|Overall Study|Lung transplant|1|||
161304963|NCT03386994|582496874|FG000|Overall Study|Adverse Event|14|||
161304964|NCT03386994|582496874|FG000|Overall Study|Lost to Follow-up|4|||
161304965|NCT03386994|582496874|FG000|Overall Study|Withdrawal by Subject|3|||
161304966|NCT03386994|582496874|FG000|Overall Study|Death|16|||
161304967|NCT01827267|582496875|FG000|Overall Study|Did not receive study drug|1|||
161304968|NCT01827267|582496876|FG001|Overall Study|Did not receive study drug|1|||
161304969|NCT01827267|582496875|FG000|Overall Study|Physician Decision|1|||
161304970|NCT01827267|582496876|FG001|Overall Study|Physician Decision|0|||
161304971|NCT01827267|582496875|FG000|Overall Study|Disease Progression|1|||
161304972|NCT01827267|582496876|FG001|Overall Study|Disease Progression|1|||
161304973|NCT01827267|582496875|FG000|Overall Study|Sponsor Discontinued Study|2|||
161304974|NCT01827267|582496876|FG001|Overall Study|Sponsor Discontinued Study|8|||
161304975|NCT01827267|582496875|FG000|Overall Study|Still on study|0|||
161304976|NCT01827267|582496876|FG001|Overall Study|Still on study|2|||
161304977|NCT02147158|582496880|FG000|Treatment Course 1|Adverse Event|1|||
161304978|NCT02147158|582496881|FG001|Treatment Course 1|Adverse Event|4|||
161304979|NCT02147158|582496882|FG002|Treatment Course 1|Adverse Event|3|||
161304980|NCT02147158|582496883|FG003|Treatment Course 1|Adverse Event|4|||
161304981|NCT02147158|582496884|FG004|Treatment Course 1|Adverse Event|1|||
161304982|NCT02147158|582496885|FG005|Treatment Course 1|Adverse Event|2|||
161304983|NCT02147158|582496880|FG000|Treatment Course 1|Lost to Follow-up|2|||
161304984|NCT02147158|582496881|FG001|Treatment Course 1|Lost to Follow-up|4|||
161304985|NCT02147158|582496882|FG002|Treatment Course 1|Lost to Follow-up|3|||
161304986|NCT02147158|582496883|FG003|Treatment Course 1|Lost to Follow-up|3|||
161304987|NCT02147158|582496884|FG004|Treatment Course 1|Lost to Follow-up|2|||
161304988|NCT02147158|582496885|FG005|Treatment Course 1|Lost to Follow-up|4|||
161304989|NCT02147158|582496880|FG000|Treatment Course 1|Protocol Violation|0|||
161304990|NCT02147158|582496881|FG001|Treatment Course 1|Protocol Violation|0|||
161304991|NCT02147158|582496882|FG002|Treatment Course 1|Protocol Violation|1|||
161304992|NCT02147158|582496883|FG003|Treatment Course 1|Protocol Violation|1|||
161304993|NCT02147158|582496884|FG004|Treatment Course 1|Protocol Violation|0|||
161304994|NCT02147158|582496885|FG005|Treatment Course 1|Protocol Violation|0|||
161304995|NCT02147158|582496880|FG000|Treatment Course 1|Withdrawal of Consent|1|||
161304996|NCT02147158|582496881|FG001|Treatment Course 1|Withdrawal of Consent|1|||
161304997|NCT02147158|582496882|FG002|Treatment Course 1|Withdrawal of Consent|1|||
161304998|NCT02147158|582496883|FG003|Treatment Course 1|Withdrawal of Consent|5|||
161304999|NCT02147158|582496884|FG004|Treatment Course 1|Withdrawal of Consent|3|||
161305000|NCT02147158|582496885|FG005|Treatment Course 1|Withdrawal of Consent|2|||
161305001|NCT02147158|582496880|FG000|Off-Treatment Interval 1|Adverse Event|1|||
161305002|NCT02147158|582496881|FG001|Off-Treatment Interval 1|Adverse Event|0|||
161305003|NCT02147158|582496882|FG002|Off-Treatment Interval 1|Adverse Event|0|||
161305004|NCT02147158|582496883|FG003|Off-Treatment Interval 1|Adverse Event|1|||
161305005|NCT02147158|582496884|FG004|Off-Treatment Interval 1|Adverse Event|0|||
161305006|NCT02147158|582496885|FG005|Off-Treatment Interval 1|Adverse Event|0|||
161305007|NCT02147158|582496880|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
161305008|NCT02147158|582496881|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
161305009|NCT02147158|582496882|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
161305010|NCT02147158|582496883|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
161348259|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
161305011|NCT02147158|582496884|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
161305012|NCT02147158|582496885|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
161305013|NCT02147158|582496880|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
161305014|NCT02147158|582496881|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
161305015|NCT02147158|582496882|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
161305016|NCT02147158|582496883|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
161184166|NCT00397631|582051210|FG000|Overall Study|Physician Decision|2|||
161184167|NCT00397631|582051211|FG001|Overall Study|Physician Decision|0|||
161184168|NCT00397631|582051210|FG000|Overall Study|Protocol Violation|0|||
161184169|NCT00397631|582051211|FG001|Overall Study|Protocol Violation|1|||
161184170|NCT00397631|582051210|FG000|Overall Study|Withdrawal by Subject|7|||
161184171|NCT00397631|582051211|FG001|Overall Study|Withdrawal by Subject|14|||
161184172|NCT00397631|582051210|FG000|Overall Study|protocol discontinuation criteria|1|||
161184173|NCT00397631|582051211|FG001|Overall Study|protocol discontinuation criteria|4|||
161184174|NCT02202161|582051212|FG000|Overall Study|Adverse Event|1|||
161184175|NCT02202161|582051213|FG001|Overall Study|Adverse Event|1|||
161184176|NCT02202161|582051214|FG002|Overall Study|Adverse Event|0|||
161184177|NCT02202161|582051215|FG003|Overall Study|Adverse Event|0|||
161184178|NCT02202161|582051216|FG004|Overall Study|Adverse Event|0|||
161184179|NCT02202161|582051217|FG005|Overall Study|Adverse Event|1|||
161184180|NCT02202161|582051218|FG006|Overall Study|Adverse Event|0|||
161184181|NCT02202161|582051219|FG007|Overall Study|Adverse Event|0|||
161184182|NCT02202161|582051212|FG000|Overall Study|Did not meet continuation criteria|0|||
161184183|NCT02202161|582051213|FG001|Overall Study|Did not meet continuation criteria|0|||
161184184|NCT02202161|582051214|FG002|Overall Study|Did not meet continuation criteria|0|||
161184185|NCT02202161|582051215|FG003|Overall Study|Did not meet continuation criteria|0|||
161184186|NCT02202161|582051216|FG004|Overall Study|Did not meet continuation criteria|0|||
161184187|NCT02202161|582051217|FG005|Overall Study|Did not meet continuation criteria|0|||
161184188|NCT02202161|582051218|FG006|Overall Study|Did not meet continuation criteria|0|||
161184189|NCT02202161|582051219|FG007|Overall Study|Did not meet continuation criteria|3|||
161184190|NCT02202161|582051212|FG000|Overall Study|Physician Decision|0|||
161184191|NCT02202161|582051213|FG001|Overall Study|Physician Decision|0|||
161184192|NCT02202161|582051214|FG002|Overall Study|Physician Decision|0|||
161184193|NCT02202161|582051215|FG003|Overall Study|Physician Decision|0|||
161184194|NCT02202161|582051216|FG004|Overall Study|Physician Decision|0|||
161184195|NCT02202161|582051217|FG005|Overall Study|Physician Decision|0|||
161184196|NCT02202161|582051218|FG006|Overall Study|Physician Decision|0|||
161184197|NCT02202161|582051219|FG007|Overall Study|Physician Decision|3|||
161184198|NCT02202161|582051212|FG000|Overall Study|Withdrawal by Subject|0|||
161184199|NCT02202161|582051213|FG001|Overall Study|Withdrawal by Subject|0|||
161184200|NCT02202161|582051214|FG002|Overall Study|Withdrawal by Subject|0|||
161184201|NCT02202161|582051215|FG003|Overall Study|Withdrawal by Subject|0|||
161184202|NCT02202161|582051216|FG004|Overall Study|Withdrawal by Subject|1|||
161184203|NCT02202161|582051217|FG005|Overall Study|Withdrawal by Subject|0|||
161184204|NCT02202161|582051218|FG006|Overall Study|Withdrawal by Subject|0|||
161184205|NCT02202161|582051219|FG007|Overall Study|Withdrawal by Subject|0|||
161184206|NCT03685643|582051222|FG000|Overall Study|Lost to Follow-up|14|||
161184207|NCT03685643|582051223|FG001|Overall Study|Lost to Follow-up|22|||
161184208|NCT03797144|582051224|FG000|Enrollment|Protocol Violation|4|||
161184209|NCT03797144|582051225|FG001|Enrollment|Protocol Violation|1|||
161184210|NCT03797144|582051224|FG000|Surgery|Protocol Violation|1|||
161184211|NCT03797144|582051225|FG001|Surgery|Protocol Violation|0|||
161184212|NCT03797144|582051224|FG000|3 Month|Early termination cut-off date|2|||
161184213|NCT03797144|582051225|FG001|3 Month|Early termination cut-off date|0|||
161184214|NCT03797144|582051224|FG000|12 Month|Early termination cut-off date|8|||
161184215|NCT03797144|582051225|FG001|12 Month|Early termination cut-off date|9|||
161184216|NCT03797144|582051224|FG000|24 Month|Early termination cut-off date|1|||
161184217|NCT03797144|582051225|FG001|24 Month|Early termination cut-off date|1|||
161184218|NCT00403390|582051227|FG000|Overall Study|Withdrawal by Subject|1|||
161184219|NCT00403390|582051228|FG001|Overall Study|Withdrawal by Subject|0|||
161184220|NCT00403390|582051227|FG000|Overall Study|samples lost|1|||
161184221|NCT00403390|582051228|FG001|Overall Study|samples lost|0|||
161184222|NCT00403390|582051227|FG000|Overall Study|non-compliant|1|||
161184223|NCT00403390|582051228|FG001|Overall Study|non-compliant|0|||
161184224|NCT01878175|582051229|FG000|Overall Study|Developed contraindicated health problem|2|||
161184225|NCT01796106|582051230|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
161184226|NCT01796106|582051231|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
161184227|NCT01249157|582051234|FG000|Overall Study|Withdrawal by Subject|1|||
161184228|NCT04445051|582051235|FG000|Overall Study|Adverse Event|0|||
161184229|NCT04445051|582051236|FG001|Overall Study|Adverse Event|0|||
161184230|NCT04445051|582051237|FG002|Overall Study|Adverse Event|1|||
161184231|NCT04445051|582051238|FG003|Overall Study|Adverse Event|0|||
161184232|NCT04445051|582051239|FG004|Overall Study|Adverse Event|0|||
161184233|NCT04445051|582051240|FG005|Overall Study|Adverse Event|0|||
161184234|NCT05083949|582051243|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
161184235|NCT05083949|582051244|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
161184236|NCT05083949|582051243|FG000|Period 1|Adverse Event|1|||
161184237|NCT05083949|582051244|FG001|Period 1|Adverse Event|1|||
161184238|NCT05083949|582051243|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
161184239|NCT05083949|582051244|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
161184240|NCT05083949|582051243|FG000|Period 2|Adverse Event|0|||
161348260|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
161348261|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
161348262|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161348263|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161348264|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161348265|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161348266|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
161348267|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
161348268|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
161348269|NCT01697579|582658452|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161348270|NCT01697579|582658453|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161348271|NCT01697579|582658454|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161348272|NCT01697579|582658455|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161348273|NCT01697579|582658456|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161348274|NCT01697579|582658457|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
161348275|NCT01697579|582658458|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
161348276|NCT01044498|582658459|FG000|Overall Study|Withdrew consent|1|||
161348277|NCT01044498|582658460|FG001|Overall Study|Withdrew consent|1|||
161348278|NCT01044498|582658459|FG000|Overall Study|Adverse Event|1|||
161348279|NCT01044498|582658460|FG001|Overall Study|Adverse Event|1|||
161348280|NCT01044498|582658459|FG000|Overall Study|Other|1|||
161348281|NCT01044498|582658460|FG001|Overall Study|Other|0|||
161348282|NCT04132050|582658468|FG000|Period I (Double-blind Period)|Adverse Event|3|||
161348283|NCT04132050|582658469|FG001|Period I (Double-blind Period)|Adverse Event|0|||
161348284|NCT04132050|582658468|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
161348285|NCT04132050|582658469|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
161348286|NCT04132050|582658468|FG000|R788 Treatment Period|Adverse Event|5|||
161348287|NCT04132050|582658469|FG001|R788 Treatment Period|Adverse Event|0|||
161348288|NCT04132050|582658468|FG000|R788 Treatment Period|Lack of Efficacy|5|||
161348289|NCT04132050|582658469|FG001|R788 Treatment Period|Lack of Efficacy|0|||
161348290|NCT04132050|582658468|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
161348291|NCT04132050|582658469|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
161348298|NCT02406612|582658482|FG000|Overall Study|Screening Failure|3|||
161348299|NCT02406612|582658483|FG001|Overall Study|Screening Failure|0|||
161348300|NCT02406612|582658482|FG000|Overall Study|Intra-procedural Exclusion|1|||
161348301|NCT02406612|582658483|FG001|Overall Study|Intra-procedural Exclusion|3|||
161348302|NCT02406612|582658482|FG000|Overall Study|Guidewire Failure|0|||
161348303|NCT02406612|582658483|FG001|Overall Study|Guidewire Failure|1|||
161348304|NCT03483012|582658487|FG000|Overall Study|Lack of Efficacy|6|||
161348305|NCT02900976|582658488|FG000|Overall Study|Adverse Event|0|||
161348306|NCT02900976|582658489|FG001|Overall Study|Adverse Event|1|||
161348307|NCT02900976|582658488|FG000|Overall Study|Physician Decision|0|||
161348308|NCT02900976|582658489|FG001|Overall Study|Physician Decision|2|||
161348309|NCT02900976|582658488|FG000|Overall Study|Progressive disease|0|||
161348310|NCT02900976|582658489|FG001|Overall Study|Progressive disease|6|||
161348311|NCT03611946|582658496|FG000|Overall Study|Withdrawal by Subject|0|||
161348312|NCT03611946|582658497|FG001|Overall Study|Withdrawal by Subject|0|||
161348313|NCT03611946|582658498|FG002|Overall Study|Withdrawal by Subject|1|||
161348314|NCT03611946|582658499|FG003|Overall Study|Withdrawal by Subject|0|||
161348315|NCT03069989|582658504|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
161348316|NCT03069989|582658505|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
161348317|NCT00479232|582659966|FG000|Overall Study|Adverse Event|0|||
161348318|NCT00479232|582659967|FG001|Overall Study|Adverse Event|0|||
161348319|NCT00479232|582659968|FG002|Overall Study|Adverse Event|5|||
161348320|NCT00479232|582659969|FG003|Overall Study|Adverse Event|0|||
161348321|NCT00479232|582659970|FG004|Overall Study|Adverse Event|0|||
161348322|NCT00479232|582659971|FG005|Overall Study|Adverse Event|10|||
161348323|NCT00479232|582659966|FG000|Overall Study|Deviation from Protocol|0|||
161348324|NCT00479232|582659967|FG001|Overall Study|Deviation from Protocol|0|||
161348325|NCT00479232|582659968|FG002|Overall Study|Deviation from Protocol|1|||
161348326|NCT00479232|582659969|FG003|Overall Study|Deviation from Protocol|0|||
161348327|NCT00479232|582659970|FG004|Overall Study|Deviation from Protocol|0|||
161348328|NCT00479232|582659971|FG005|Overall Study|Deviation from Protocol|0|||
161348329|NCT00479232|582659966|FG000|Overall Study|Lack of Efficacy|0|||
161348330|NCT00479232|582659967|FG001|Overall Study|Lack of Efficacy|0|||
161348331|NCT00479232|582659968|FG002|Overall Study|Lack of Efficacy|2|||
161348332|NCT00479232|582659969|FG003|Overall Study|Lack of Efficacy|0|||
161348333|NCT00479232|582659970|FG004|Overall Study|Lack of Efficacy|0|||
161348334|NCT00479232|582659971|FG005|Overall Study|Lack of Efficacy|4|||
161184241|NCT05083949|582051244|FG001|Period 2|Adverse Event|2|||
161184242|NCT02470429|582051245|FG000|Overall Study|Adverse Event|1|||
161184243|NCT02470429|582051246|FG001|Overall Study|Adverse Event|0|||
161184244|NCT02470429|582051245|FG000|Overall Study|Withdrawal by Subject|1|||
161184245|NCT02470429|582051246|FG001|Overall Study|Withdrawal by Subject|0|||
161184246|NCT01976624|582051247|FG000|Overall Study|Participants contraindicated|2|||
161184247|NCT01976624|582051247|FG000|Overall Study|Participants age less than 19 years|12|||
161184248|NCT01316380|582051248|FG000|Overall Study|Adverse Event|0|||
161184249|NCT01316380|582051249|FG001|Overall Study|Adverse Event|2|||
161184250|NCT01316380|582051250|FG002|Overall Study|Adverse Event|1|||
161184251|NCT01316380|582051248|FG000|Overall Study|Protocol Violation|0|||
161184252|NCT01316380|582051249|FG001|Overall Study|Protocol Violation|0|||
161184253|NCT01316380|582051250|FG002|Overall Study|Protocol Violation|1|||
161184254|NCT01316380|582051248|FG000|Overall Study|Withdrawal by Subject|1|||
161184255|NCT01316380|582051249|FG001|Overall Study|Withdrawal by Subject|2|||
161184256|NCT01316380|582051250|FG002|Overall Study|Withdrawal by Subject|0|||
161184257|NCT01316380|582051248|FG000|Overall Study|Other|0|||
161184258|NCT01316380|582051249|FG001|Overall Study|Other|1|||
161184259|NCT01316380|582051250|FG002|Overall Study|Other|1|||
161184260|NCT01316380|582051248|FG000|Overall Study|Not treated|1|||
161184261|NCT01316380|582051249|FG001|Overall Study|Not treated|0|||
161184262|NCT01316380|582051250|FG002|Overall Study|Not treated|0|||
161184263|NCT03595176|582051253|FG000|Overall Study|Death|0|||
161184264|NCT03595176|582051254|FG001|Overall Study|Death|2|||
161184265|NCT03595176|582051253|FG000|Overall Study|Lost to Follow-up|0|||
161184266|NCT03595176|582051254|FG001|Overall Study|Lost to Follow-up|1|||
161184267|NCT02735044|582051256|FG000|Overall Study|Adverse Event|3|||
161184268|NCT02735044|582051257|FG001|Overall Study|Adverse Event|3|||
161184269|NCT02735044|582051256|FG000|Overall Study|Lack of Efficacy|1|||
161184270|NCT02735044|582051257|FG001|Overall Study|Lack of Efficacy|0|||
161184271|NCT02735044|582051256|FG000|Overall Study|Poor compliance to protocol|7|||
161184272|NCT02735044|582051257|FG001|Overall Study|Poor compliance to protocol|7|||
161184273|NCT02735044|582051256|FG000|Overall Study|Randomized and not treated|0|||
161184274|NCT02735044|582051257|FG001|Overall Study|Randomized and not treated|2|||
161184275|NCT02735044|582051256|FG000|Overall Study|Other, not specified above|5|||
161184276|NCT02735044|582051257|FG001|Overall Study|Other, not specified above|11|||
161184277|NCT01682759|582051258|FG000|Overall Study|Death|2|||
161184278|NCT01682759|582051259|FG001|Overall Study|Death|1|||
161184279|NCT01682759|582051258|FG000|Overall Study|Lost to Follow-up|10|||
161184280|NCT01682759|582051259|FG001|Overall Study|Lost to Follow-up|13|||
161184281|NCT01682759|582051258|FG000|Overall Study|Physician Decision|1|||
161184282|NCT01682759|582051259|FG001|Overall Study|Physician Decision|1|||
161184283|NCT01682759|582051258|FG000|Overall Study|Withdrawal by Subject|56|||
161184284|NCT01682759|582051259|FG001|Overall Study|Withdrawal by Subject|55|||
161184285|NCT00740116|582053023|FG000|Overall Study|Withdrawal by Subject|1|||
161184286|NCT00740116|582053024|FG001|Overall Study|Withdrawal by Subject|1|||
161184287|NCT00740116|582053023|FG000|Overall Study|Protocol Violation|1|||
161184288|NCT00740116|582053024|FG001|Overall Study|Protocol Violation|4|||
161184289|NCT00621764|582053025|FG000|Overall Study|Protocol Violation|0|||
161184290|NCT00621764|582053026|FG001|Overall Study|Protocol Violation|0|||
161184291|NCT00621764|582053027|FG002|Overall Study|Protocol Violation|0|||
161184292|NCT00621764|582053028|FG003|Overall Study|Protocol Violation|1|||
161184293|NCT02499172|582053029|FG000|Overall Study|Financial reason|0|||
161184294|NCT02499172|582053030|FG001|Overall Study|Financial reason|0|||
161184295|NCT02499172|582053031|FG002|Overall Study|Financial reason|523|||
161184296|NCT02499172|582053032|FG003|Overall Study|Financial reason|436|||
161348335|NCT00479232|582659966|FG000|Overall Study|Physician Decision|0|||
161348336|NCT00479232|582659967|FG001|Overall Study|Physician Decision|0|||
161348337|NCT00479232|582659968|FG002|Overall Study|Physician Decision|2|||
161348338|NCT00479232|582659969|FG003|Overall Study|Physician Decision|0|||
161184297|NCT02499172|582053029|FG000|Overall Study|Lost to Follow-up|65|||
161184298|NCT02499172|582053030|FG001|Overall Study|Lost to Follow-up|64|||
161184299|NCT02499172|582053031|FG002|Overall Study|Lost to Follow-up|0|||
161184300|NCT02499172|582053032|FG003|Overall Study|Lost to Follow-up|0|||
161184301|NCT01293123|582053033|FG000|Overall Study|Lost to Follow-up|0|||
161184302|NCT01293123|582053034|FG001|Overall Study|Lost to Follow-up|1|||
161184303|NCT01888965|582053044|FG000|Overall Study|Adverse Event|5|||
161184304|NCT01888965|582053044|FG000|Overall Study|Lack of Efficacy|4|||
161184305|NCT04076579|582053045|FG000|Overall Study|Adverse Event|2|||
161184306|NCT04076579|582053046|FG001|Overall Study|Adverse Event|0|||
161184307|NCT04076579|582053045|FG000|Overall Study|discontinued due to toxicity|1|||
161184308|NCT04076579|582053046|FG001|Overall Study|discontinued due to toxicity|0|||
161184309|NCT04076579|582053045|FG000|Overall Study|Physician Decision|1|||
161184310|NCT04076579|582053046|FG001|Overall Study|Physician Decision|0|||
161184311|NCT04076579|582053045|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
161184312|NCT04076579|582053046|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
161184313|NCT04076579|582053045|FG000|Overall Study|Noncompliance|0|||
161184314|NCT04076579|582053046|FG001|Overall Study|Noncompliance|1|||
161184315|NCT04076579|582053045|FG000|Overall Study|Withdrawal by Subject|0|||
161184316|NCT04076579|582053046|FG001|Overall Study|Withdrawal by Subject|2|||
161184317|NCT01997892|582053049|FG000|Overall Study|Physician Decision|2|||
161184318|NCT01997892|582053049|FG000|Overall Study|Lost to Follow-up|6|||
161184319|NCT01997892|582053049|FG000|Overall Study|Death|14|||
161184320|NCT01997892|582053049|FG000|Overall Study|Renal transplant|8|||
161184321|NCT01997892|582053049|FG000|Overall Study|Other|3|||
161184322|NCT01997892|582053049|FG000|Overall Study|Study completion data not recorded|35|||
161184323|NCT02531633|582053050|FG000|Part A (52 Weeks)|Sponsor request|24|||
161184324|NCT02531633|582053051|FG001|Part A (52 Weeks)|Sponsor request|24|||
161184325|NCT02531633|582053052|FG002|Part A (52 Weeks)|Sponsor request|18|||
161184326|NCT02531633|582053053|FG003|Part A (52 Weeks)|Sponsor request|18|||
161184327|NCT02531633|582053054|FG004|Part A (52 Weeks)|Sponsor request|19|||
161184328|NCT02531633|582053055|FG005|Part A (52 Weeks)|Sponsor request|0|||
161184329|NCT02531633|582053056|FG006|Part A (52 Weeks)|Sponsor request|0|||
161184330|NCT02531633|582053057|FG007|Part A (52 Weeks)|Sponsor request|0|||
161184331|NCT02531633|582053058|FG008|Part A (52 Weeks)|Sponsor request|0|||
161184332|NCT02531633|582053059|FG009|Part A (52 Weeks)|Sponsor request|0|||
161184333|NCT02531633|582053050|FG000|Part A (52 Weeks)|Protocol Violation|1|||
161184334|NCT02531633|582053051|FG001|Part A (52 Weeks)|Protocol Violation|0|||
161184335|NCT02531633|582053052|FG002|Part A (52 Weeks)|Protocol Violation|0|||
161184336|NCT02531633|582053053|FG003|Part A (52 Weeks)|Protocol Violation|0|||
161184337|NCT02531633|582053054|FG004|Part A (52 Weeks)|Protocol Violation|0|||
161184338|NCT02531633|582053055|FG005|Part A (52 Weeks)|Protocol Violation|0|||
161184339|NCT02531633|582053056|FG006|Part A (52 Weeks)|Protocol Violation|0|||
161184340|NCT02531633|582053057|FG007|Part A (52 Weeks)|Protocol Violation|0|||
161184341|NCT02531633|582053058|FG008|Part A (52 Weeks)|Protocol Violation|0|||
161184342|NCT02531633|582053059|FG009|Part A (52 Weeks)|Protocol Violation|0|||
161184343|NCT02531633|582053050|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
161184344|NCT02531633|582053051|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
161184345|NCT02531633|582053052|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
161184346|NCT02531633|582053053|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
161184347|NCT02531633|582053054|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
161184348|NCT02531633|582053055|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
161184349|NCT02531633|582053056|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
161184350|NCT02531633|582053057|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
161184351|NCT02531633|582053058|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
161184352|NCT02531633|582053059|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
161184353|NCT02531633|582053050|FG000|Part A (52 Weeks)|Physician Decision|1|||
161184354|NCT02531633|582053051|FG001|Part A (52 Weeks)|Physician Decision|4|||
161184355|NCT02531633|582053052|FG002|Part A (52 Weeks)|Physician Decision|3|||
161184356|NCT02531633|582053053|FG003|Part A (52 Weeks)|Physician Decision|1|||
161184357|NCT02531633|582053054|FG004|Part A (52 Weeks)|Physician Decision|0|||
161184358|NCT02531633|582053055|FG005|Part A (52 Weeks)|Physician Decision|0|||
161184359|NCT02531633|582053056|FG006|Part A (52 Weeks)|Physician Decision|0|||
161184360|NCT02531633|582053057|FG007|Part A (52 Weeks)|Physician Decision|0|||
161184361|NCT02531633|582053058|FG008|Part A (52 Weeks)|Physician Decision|0|||
161184362|NCT02531633|582053059|FG009|Part A (52 Weeks)|Physician Decision|0|||
161184363|NCT02531633|582053050|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
161184364|NCT02531633|582053051|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
161184365|NCT02531633|582053052|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
161184366|NCT02531633|582053053|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
161184367|NCT02531633|582053054|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
161184368|NCT02531633|582053055|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
161184369|NCT02531633|582053056|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
161184370|NCT02531633|582053057|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
161184371|NCT02531633|582053058|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
161184372|NCT02531633|582053059|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
161184373|NCT02531633|582053050|FG000|Part A (52 Weeks)|Other|2|||
161184374|NCT02531633|582053051|FG001|Part A (52 Weeks)|Other|0|||
161184375|NCT02531633|582053052|FG002|Part A (52 Weeks)|Other|0|||
161184376|NCT02531633|582053053|FG003|Part A (52 Weeks)|Other|0|||
161184377|NCT02531633|582053054|FG004|Part A (52 Weeks)|Other|0|||
161305017|NCT02147158|582496884|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
161184378|NCT02531633|582053055|FG005|Part A (52 Weeks)|Other|0|||
161184379|NCT02531633|582053056|FG006|Part A (52 Weeks)|Other|0|||
161184380|NCT02531633|582053057|FG007|Part A (52 Weeks)|Other|0|||
161184381|NCT02531633|582053058|FG008|Part A (52 Weeks)|Other|0|||
161184382|NCT02531633|582053059|FG009|Part A (52 Weeks)|Other|0|||
161184383|NCT02531633|582053050|FG000|Part B (104 Weeks)|Sponsor request|0|||
161184384|NCT02531633|582053051|FG001|Part B (104 Weeks)|Sponsor request|0|||
161305018|NCT02147158|582496885|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
161184385|NCT02531633|582053052|FG002|Part B (104 Weeks)|Sponsor request|0|||
161184386|NCT02531633|582053053|FG003|Part B (104 Weeks)|Sponsor request|0|||
161184387|NCT02531633|582053054|FG004|Part B (104 Weeks)|Sponsor request|0|||
161184388|NCT02531633|582053055|FG005|Part B (104 Weeks)|Sponsor request|8|||
161184389|NCT02531633|582053056|FG006|Part B (104 Weeks)|Sponsor request|5|||
161184390|NCT02531633|582053057|FG007|Part B (104 Weeks)|Sponsor request|3|||
161184391|NCT02531633|582053058|FG008|Part B (104 Weeks)|Sponsor request|5|||
161184392|NCT02531633|582053059|FG009|Part B (104 Weeks)|Sponsor request|4|||
161184393|NCT02531633|582053050|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
161184394|NCT02531633|582053051|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
161184395|NCT02531633|582053052|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
161184396|NCT02531633|582053053|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
161184397|NCT02531633|582053054|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
161184398|NCT02531633|582053055|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
161184399|NCT02531633|582053056|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
161184400|NCT02531633|582053057|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
161184401|NCT02531633|582053058|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
161184402|NCT02531633|582053059|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
161184403|NCT04097925|582053066|FG000|Overall Study|Withdrawal by Subject|1|||
161184404|NCT02608099|582053067|FG000|Overall Study|Ablation procedure not initiated|3|||
161184405|NCT02608099|582053068|FG001|Overall Study|Ablation procedure not initiated|2|||
161184406|NCT01952041|582053072|FG000|Overall Study|Lost to Follow-up|9|||
161184407|NCT01952041|582053073|FG001|Overall Study|Lost to Follow-up|16|||
161184408|NCT01952041|582053072|FG000|Overall Study|Withdrawal by Subject|7|||
161184409|NCT01952041|582053073|FG001|Overall Study|Withdrawal by Subject|5|||
161184410|NCT01952041|582053072|FG000|Overall Study|Death|1|||
161184411|NCT01952041|582053073|FG001|Overall Study|Death|0|||
161184412|NCT01736176|582053074|FG000|Overall Study|Adverse Event|3|||
161184413|NCT01736176|582053074|FG000|Overall Study|Withdrawal by Subject|4|||
161184414|NCT01736176|582053074|FG000|Overall Study|Lack of Efficacy|3|||
161184415|NCT01736176|582053074|FG000|Overall Study|Unable to Complete PEG Placement|1|||
161184416|NCT00186121|582053075|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
161184417|NCT00186121|582053075|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
161184418|NCT00186121|582053075|FG000|Overall Study|Not eligible (no treatment)|1|||
161184419|NCT03650387|582053076|FG000|Overall Study|Withdrawal by Subject|13|||
161184420|NCT03650387|582053076|FG000|Overall Study|Lost to Follow-up|12|||
161305019|NCT02147158|582496880|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
161305020|NCT02147158|582496881|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
161305021|NCT02147158|582496882|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
161305022|NCT02147158|582496883|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
161305023|NCT02147158|582496884|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
161305024|NCT02147158|582496885|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
161305025|NCT02147158|582496880|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
161305026|NCT02147158|582496881|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
161305027|NCT02147158|582496882|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
161305028|NCT02147158|582496883|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
161305029|NCT02147158|582496884|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
161305030|NCT02147158|582496885|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
161305031|NCT02147158|582496880|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
161305032|NCT02147158|582496881|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161305033|NCT02147158|582496882|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
161305034|NCT02147158|582496883|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
161305035|NCT02147158|582496884|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161305036|NCT02147158|582496885|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
161305037|NCT02147158|582496880|FG000|Treatment Course 2|Adverse Event|0|||
161305038|NCT02147158|582496881|FG001|Treatment Course 2|Adverse Event|4|||
161305039|NCT02147158|582496882|FG002|Treatment Course 2|Adverse Event|2|||
161305040|NCT02147158|582496883|FG003|Treatment Course 2|Adverse Event|1|||
161305041|NCT02147158|582496884|FG004|Treatment Course 2|Adverse Event|0|||
161305042|NCT02147158|582496885|FG005|Treatment Course 2|Adverse Event|1|||
161305043|NCT02147158|582496880|FG000|Treatment Course 2|Withdrawal of Consent|0|||
161305044|NCT02147158|582496881|FG001|Treatment Course 2|Withdrawal of Consent|1|||
161305045|NCT02147158|582496882|FG002|Treatment Course 2|Withdrawal of Consent|2|||
161305046|NCT02147158|582496883|FG003|Treatment Course 2|Withdrawal of Consent|3|||
161305047|NCT02147158|582496884|FG004|Treatment Course 2|Withdrawal of Consent|0|||
161305048|NCT02147158|582496885|FG005|Treatment Course 2|Withdrawal of Consent|0|||
161305049|NCT02147158|582496880|FG000|Treatment Course 2|Lost to Follow-up|1|||
161305050|NCT02147158|582496881|FG001|Treatment Course 2|Lost to Follow-up|0|||
161305051|NCT02147158|582496882|FG002|Treatment Course 2|Lost to Follow-up|1|||
161305052|NCT02147158|582496883|FG003|Treatment Course 2|Lost to Follow-up|1|||
161348339|NCT00479232|582659970|FG004|Overall Study|Physician Decision|0|||
161348340|NCT00479232|582659971|FG005|Overall Study|Physician Decision|1|||
161348341|NCT00479232|582659966|FG000|Overall Study|Progressive Disease|3|||
161305053|NCT02147158|582496884|FG004|Treatment Course 2|Lost to Follow-up|0|||
161348342|NCT00479232|582659967|FG001|Overall Study|Progressive Disease|1|||
161348343|NCT00479232|582659968|FG002|Overall Study|Progressive Disease|12|||
161305054|NCT02147158|582496885|FG005|Treatment Course 2|Lost to Follow-up|1|||
161305055|NCT02147158|582496880|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
161305056|NCT02147158|582496881|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
161184421|NCT03650387|582053076|FG000|Overall Study|Adverse Event (Not related)|1|||
161184422|NCT03650387|582053076|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
161348344|NCT00479232|582659969|FG003|Overall Study|Progressive Disease|3|||
161184423|NCT00417248|582053077|FG000|Overall Study|Study Terminated|6|||
161184424|NCT00417248|582053077|FG000|Overall Study|Death|1|||
161184425|NCT00417248|582053077|FG000|Overall Study|Lack of Efficacy|1|||
161184426|NCT01569568|582053078|FG000|Overall Study|Physician Decision|0|||
161184427|NCT01569568|582053079|FG001|Overall Study|Physician Decision|2|||
161184428|NCT05815758|582053080|FG000|Overall Study|Adverse Event|6|||
161184429|NCT05815758|582053081|FG001|Overall Study|Adverse Event|2|||
161184430|NCT05815758|582053080|FG000|Overall Study|Lost to Follow-up|14|||
161184431|NCT05815758|582053081|FG001|Overall Study|Lost to Follow-up|1|||
161184432|NCT05815758|582053080|FG000|Overall Study|Withdrawal by Subject|6|||
161184433|NCT05815758|582053081|FG001|Overall Study|Withdrawal by Subject|6|||
161184434|NCT05815758|582053080|FG000|Overall Study|Protocol Violation|1|||
161184435|NCT05815758|582053081|FG001|Overall Study|Protocol Violation|1|||
161184436|NCT05815758|582053080|FG000|Overall Study|Discontinued|4|||
161184437|NCT05815758|582053081|FG001|Overall Study|Discontinued|4|||
161184438|NCT03661983|582053082|FG000|Open Label Stabilization Phase|Adverse Event|5|||
161184439|NCT03661983|582053083|FG001|Open Label Stabilization Phase|Adverse Event|0|||
161184440|NCT03661983|582053084|FG002|Open Label Stabilization Phase|Adverse Event|0|||
161184441|NCT03661983|582053085|FG003|Open Label Stabilization Phase|Adverse Event|0|||
161184442|NCT03661983|582053082|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
161184443|NCT03661983|582053083|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
161184444|NCT03661983|582053084|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
161184445|NCT03661983|582053085|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
161184446|NCT03661983|582053082|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
161184447|NCT03661983|582053083|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161184448|NCT03661983|582053084|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161184449|NCT03661983|582053085|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
161184450|NCT03661983|582053082|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
161184451|NCT03661983|582053083|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161184452|NCT03661983|582053084|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161184453|NCT03661983|582053085|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
161184454|NCT03661983|582053082|FG000|Double-blind Randomized Phase|Adverse Event|0|||
161184455|NCT03661983|582053083|FG001|Double-blind Randomized Phase|Adverse Event|1|||
161184456|NCT03661983|582053084|FG002|Double-blind Randomized Phase|Adverse Event|0|||
161184457|NCT03661983|582053085|FG003|Double-blind Randomized Phase|Adverse Event|0|||
161184458|NCT03661983|582053082|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
161184459|NCT03661983|582053083|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
161184460|NCT03661983|582053084|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
161184461|NCT03661983|582053085|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
161184462|NCT03661983|582053082|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161184463|NCT03661983|582053083|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161184464|NCT03661983|582053084|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
161184465|NCT03661983|582053085|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
161184466|NCT03661983|582053082|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
161184467|NCT03661983|582053083|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161184468|NCT03661983|582053084|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161184469|NCT03661983|582053085|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
161184470|NCT02903966|582053086|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
161184471|NCT02903966|582053087|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
161184472|NCT02903966|582053086|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
161184473|NCT02903966|582053087|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
161184474|NCT02903966|582053086|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
161184475|NCT02903966|582053087|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
161184476|NCT00934791|582053088|FG000|Overall Study|Withdrawal by Subject|1|||
161184477|NCT00934791|582053089|FG001|Overall Study|Withdrawal by Subject|0|||
161184478|NCT01320033|582053091|FG000|Overall Study|Lack of Efficacy|0|||
161184479|NCT01320033|582053092|FG001|Overall Study|Lack of Efficacy|0|||
161184480|NCT01320033|582053093|FG002|Overall Study|Lack of Efficacy|1|||
161184481|NCT01320033|582053091|FG000|Overall Study|Adverse Event|9|||
161184482|NCT01320033|582053092|FG001|Overall Study|Adverse Event|7|||
161184483|NCT01320033|582053093|FG002|Overall Study|Adverse Event|8|||
161184484|NCT01320033|582053091|FG000|Overall Study|Withdrawal by Subject|22|||
161184485|NCT01320033|582053092|FG001|Overall Study|Withdrawal by Subject|23|||
161184486|NCT01320033|582053093|FG002|Overall Study|Withdrawal by Subject|23|||
161184487|NCT01320033|582053091|FG000|Overall Study|Protocol Violation|3|||
161184488|NCT01320033|582053092|FG001|Overall Study|Protocol Violation|5|||
161184489|NCT01320033|582053093|FG002|Overall Study|Protocol Violation|3|||
161184490|NCT01320033|582053091|FG000|Overall Study|Lost to Follow-up|22|||
161184491|NCT01320033|582053092|FG001|Overall Study|Lost to Follow-up|26|||
161184492|NCT01320033|582053093|FG002|Overall Study|Lost to Follow-up|17|||
161184493|NCT01320033|582053091|FG000|Overall Study|Other|2|||
161184494|NCT01320033|582053092|FG001|Overall Study|Other|3|||
161184495|NCT01320033|582053093|FG002|Overall Study|Other|1|||
161184496|NCT00081263|582053103|FG000|Overall Study|clerical error|1|||
161184497|NCT00081263|582053104|FG001|Overall Study|clerical error|0|||
161348345|NCT00479232|582659970|FG004|Overall Study|Progressive Disease|3|||
161348346|NCT00479232|582659971|FG005|Overall Study|Progressive Disease|12|||
161348347|NCT00479232|582659966|FG000|Overall Study|Withdrew Consent|0|||
161348348|NCT00479232|582659967|FG001|Overall Study|Withdrew Consent|2|||
161348349|NCT00479232|582659968|FG002|Overall Study|Withdrew Consent|6|||
161348350|NCT00479232|582659969|FG003|Overall Study|Withdrew Consent|0|||
161348351|NCT00479232|582659970|FG004|Overall Study|Withdrew Consent|1|||
161348352|NCT00479232|582659971|FG005|Overall Study|Withdrew Consent|3|||
161348353|NCT02260986|582659974|FG000|Overall Study|Adverse Event|24|||
161348354|NCT02260986|582659975|FG001|Overall Study|Adverse Event|0|||
161348355|NCT02260986|582659976|FG002|Overall Study|Adverse Event|11|||
161348356|NCT02260986|582659974|FG000|Overall Study|Lack of Efficacy|27|||
161348357|NCT02260986|582659975|FG001|Overall Study|Lack of Efficacy|3|||
161348358|NCT02260986|582659976|FG002|Overall Study|Lack of Efficacy|0|||
161348359|NCT02260986|582659974|FG000|Overall Study|Protocol Violation|14|||
161348360|NCT02260986|582659975|FG001|Overall Study|Protocol Violation|5|||
161348361|NCT02260986|582659976|FG002|Overall Study|Protocol Violation|16|||
161348362|NCT02260986|582659974|FG000|Overall Study|Car accident|0|||
161348363|NCT02260986|582659975|FG001|Overall Study|Car accident|0|||
161184498|NCT00081263|582053103|FG000|Overall Study|wrong cell type|7|||
161184499|NCT00081263|582053104|FG001|Overall Study|wrong cell type|5|||
161184500|NCT00081263|582053103|FG000|Overall Study|improper pre-protocol therapy|0|||
161184501|NCT00081263|582053104|FG001|Overall Study|improper pre-protocol therapy|1|||
161184502|NCT00081263|582053103|FG000|Overall Study|Inadequate pathology|0|||
161184503|NCT00081263|582053104|FG001|Overall Study|Inadequate pathology|1|||
161184504|NCT00081263|582053103|FG000|Overall Study|Never treated|4|||
161184505|NCT00081263|582053104|FG001|Overall Study|Never treated|5|||
161184506|NCT00081263|582053103|FG000|Overall Study|Inadequate data|5|||
161184507|NCT00081263|582053104|FG001|Overall Study|Inadequate data|10|||
161184508|NCT01852591|582053105|FG000|Overall Study|Withdrawal by Subject|2|||
161184509|NCT01852591|582053105|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
161184510|NCT01267955|582053112|FG000|Stage 1 (6 Months)|Death|3|||
161184511|NCT01267955|582053112|FG000|Stage 2 (6 Months)|Death|5|||
161348364|NCT02260986|582659976|FG002|Overall Study|Car accident|1|||
161348365|NCT02260986|582659974|FG000|Overall Study|Withdrawal by Subject|17|||
161348366|NCT02260986|582659975|FG001|Overall Study|Withdrawal by Subject|4|||
161348367|NCT02260986|582659976|FG002|Overall Study|Withdrawal by Subject|9|||
161348368|NCT02260986|582659974|FG000|Overall Study|Incorrect randomization|0|||
161348369|NCT02260986|582659975|FG001|Overall Study|Incorrect randomization|1|||
161348370|NCT02260986|582659976|FG002|Overall Study|Incorrect randomization|0|||
161348371|NCT02260986|582659974|FG000|Overall Study|Lack of investigation product supply|2|||
161348372|NCT02260986|582659975|FG001|Overall Study|Lack of investigation product supply|0|||
161348373|NCT02260986|582659976|FG002|Overall Study|Lack of investigation product supply|1|||
161348374|NCT02260986|582659974|FG000|Overall Study|Lost to Follow-up|4|||
161348375|NCT02260986|582659975|FG001|Overall Study|Lost to Follow-up|0|||
161348376|NCT02260986|582659976|FG002|Overall Study|Lost to Follow-up|3|||
161348377|NCT02260986|582659974|FG000|Overall Study|Pregnancy|2|||
161348378|NCT02260986|582659975|FG001|Overall Study|Pregnancy|0|||
161348379|NCT02260986|582659976|FG002|Overall Study|Pregnancy|0|||
161348380|NCT02536794|582659979|FG000|Reached 1st Response Assessment|Adverse Event|2|||
161348381|NCT02536794|582659979|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
161089798|NCT00346632|581719829|FG007|Overall Study|Progressive Disease|2|||
161089799|NCT00346632|581719830|FG008|Overall Study|Progressive Disease|2|||
161089800|NCT00346632|581719831|FG009|Overall Study|Progressive Disease|2|||
161089801|NCT00346632|581719822|FG000|Overall Study|Adverse Event|0|||
161089802|NCT00346632|581719823|FG001|Overall Study|Adverse Event|0|||
161089803|NCT00346632|581719824|FG002|Overall Study|Adverse Event|0|||
161089804|NCT00346632|581719825|FG003|Overall Study|Adverse Event|0|||
161089805|NCT00346632|581719826|FG004|Overall Study|Adverse Event|1|||
161089806|NCT00346632|581719827|FG005|Overall Study|Adverse Event|1|||
161089807|NCT00346632|581719828|FG006|Overall Study|Adverse Event|1|||
161089808|NCT00346632|581719829|FG007|Overall Study|Adverse Event|0|||
161089809|NCT00346632|581719830|FG008|Overall Study|Adverse Event|0|||
161089810|NCT00346632|581719831|FG009|Overall Study|Adverse Event|0|||
161089811|NCT00346632|581719822|FG000|Overall Study|Death|0|||
161089812|NCT00346632|581719823|FG001|Overall Study|Death|0|||
161089813|NCT00346632|581719824|FG002|Overall Study|Death|1|||
161089814|NCT00346632|581719825|FG003|Overall Study|Death|0|||
161089815|NCT00346632|581719826|FG004|Overall Study|Death|0|||
161089816|NCT00346632|581719827|FG005|Overall Study|Death|0|||
161089817|NCT00346632|581719828|FG006|Overall Study|Death|0|||
161089818|NCT00346632|581719829|FG007|Overall Study|Death|0|||
161089819|NCT00346632|581719830|FG008|Overall Study|Death|0|||
161089820|NCT00346632|581719831|FG009|Overall Study|Death|0|||
161089821|NCT00346632|581719822|FG000|Overall Study|Protocol Violation|0|||
161089822|NCT00346632|581719823|FG001|Overall Study|Protocol Violation|0|||
161089823|NCT00346632|581719824|FG002|Overall Study|Protocol Violation|0|||
161089824|NCT00346632|581719825|FG003|Overall Study|Protocol Violation|0|||
161305057|NCT02147158|582496882|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
161305058|NCT02147158|582496883|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
161089825|NCT00346632|581719826|FG004|Overall Study|Protocol Violation|0|||
161089826|NCT00346632|581719827|FG005|Overall Study|Protocol Violation|0|||
161089827|NCT00346632|581719828|FG006|Overall Study|Protocol Violation|1|||
161089828|NCT00346632|581719829|FG007|Overall Study|Protocol Violation|0|||
161089829|NCT00346632|581719830|FG008|Overall Study|Protocol Violation|0|||
161089830|NCT00346632|581719831|FG009|Overall Study|Protocol Violation|0|||
161089831|NCT00346632|581719822|FG000|Overall Study|Withdrawal by Subject|0|||
161089832|NCT00346632|581719823|FG001|Overall Study|Withdrawal by Subject|0|||
161089833|NCT00346632|581719824|FG002|Overall Study|Withdrawal by Subject|0|||
161089834|NCT00346632|581719825|FG003|Overall Study|Withdrawal by Subject|0|||
161089835|NCT00346632|581719826|FG004|Overall Study|Withdrawal by Subject|0|||
161089836|NCT00346632|581719827|FG005|Overall Study|Withdrawal by Subject|0|||
161089837|NCT00346632|581719828|FG006|Overall Study|Withdrawal by Subject|1|||
161089838|NCT00346632|581719829|FG007|Overall Study|Withdrawal by Subject|0|||
161089839|NCT00346632|581719830|FG008|Overall Study|Withdrawal by Subject|0|||
161089840|NCT00346632|581719831|FG009|Overall Study|Withdrawal by Subject|0|||
161089841|NCT00346632|581719822|FG000|Overall Study|Switched to alternative treatment|0|||
161089842|NCT00346632|581719823|FG001|Overall Study|Switched to alternative treatment|0|||
161089843|NCT00346632|581719824|FG002|Overall Study|Switched to alternative treatment|1|||
161089844|NCT00346632|581719825|FG003|Overall Study|Switched to alternative treatment|0|||
161089845|NCT00346632|581719826|FG004|Overall Study|Switched to alternative treatment|0|||
161089846|NCT00346632|581719827|FG005|Overall Study|Switched to alternative treatment|0|||
161089847|NCT00346632|581719828|FG006|Overall Study|Switched to alternative treatment|0|||
161089848|NCT00346632|581719829|FG007|Overall Study|Switched to alternative treatment|0|||
161089849|NCT00346632|581719830|FG008|Overall Study|Switched to alternative treatment|0|||
161089850|NCT00346632|581719831|FG009|Overall Study|Switched to alternative treatment|0|||
161089851|NCT00346632|581719822|FG000|Overall Study|Not Stated|1|||
161089852|NCT00346632|581719823|FG001|Overall Study|Not Stated|1|||
161089853|NCT00346632|581719824|FG002|Overall Study|Not Stated|0|||
161089854|NCT00346632|581719825|FG003|Overall Study|Not Stated|0|||
161089855|NCT00346632|581719826|FG004|Overall Study|Not Stated|0|||
161089856|NCT00346632|581719827|FG005|Overall Study|Not Stated|0|||
161089857|NCT00346632|581719828|FG006|Overall Study|Not Stated|0|||
161089858|NCT00346632|581719829|FG007|Overall Study|Not Stated|2|||
161089859|NCT00346632|581719830|FG008|Overall Study|Not Stated|2|||
161089860|NCT00346632|581719831|FG009|Overall Study|Not Stated|1|||
161089861|NCT03587974|581719832|FG000|Overall Study|caregiver demented, care recipient died|3|||
161089862|NCT03587974|581719833|FG001|Overall Study|caregiver demented, care recipient died|3|||
161089863|NCT03587974|581719832|FG000|Overall Study|Withdrawal by Subject|2|||
161089864|NCT03587974|581719833|FG001|Overall Study|Withdrawal by Subject|1|||
161089865|NCT03486457|581719834|FG000|Up to Month 3|Adverse Event|2|||
161089866|NCT03486457|581719835|FG001|Up to Month 3|Adverse Event|5|||
161089867|NCT03486457|581719834|FG000|Up to Month 3|Lack of Efficacy|1|||
161089868|NCT03486457|581719835|FG001|Up to Month 3|Lack of Efficacy|0|||
161089869|NCT03486457|581719834|FG000|Up to Month 3|Withdrawal by Subject|1|||
161089870|NCT03486457|581719835|FG001|Up to Month 3|Withdrawal by Subject|0|||
161089871|NCT03486457|581719834|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
161089872|NCT03486457|581719835|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
161089873|NCT03486457|581719834|FG000|Up to Month 3|Other|1|||
161089874|NCT03486457|581719835|FG001|Up to Month 3|Other|0|||
161089875|NCT03486457|581719834|FG000|Month 3 to Month 6|Adverse Event|2|||
161089876|NCT03486457|581719835|FG001|Month 3 to Month 6|Adverse Event|0|||
161089877|NCT03486457|581719834|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
161089878|NCT03486457|581719835|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
161089879|NCT03486457|581719834|FG000|Month 3 to Month 6|Pregnancy|0|||
161089880|NCT03486457|581719835|FG001|Month 3 to Month 6|Pregnancy|1|||
161089881|NCT03486457|581719834|FG000|Month 3 to Month 6|Other|1|||
161089882|NCT03486457|581719835|FG001|Month 3 to Month 6|Other|0|||
161089883|NCT01382706|581719836|FG000|Overall Study|Adverse Event|1|||
161089884|NCT01382706|581719836|FG000|Overall Study|Withdrawal by Subject|1|||
161089885|NCT04055090|581719837|FG000|Overall Study|screen failure|1|||
161089886|NCT04055090|581719838|FG001|Overall Study|screen failure|0|||
161089887|NCT04055090|581719837|FG000|Overall Study|Withdrawal by Subject|1|||
161089888|NCT04055090|581719838|FG001|Overall Study|Withdrawal by Subject|0|||
161089889|NCT00552240|581719844|FG000|Overall Study|Adverse Event|9|||
161089890|NCT00552240|581719845|FG001|Overall Study|Adverse Event|9|||
161089891|NCT00552240|581719844|FG000|Overall Study|Protocol Violation|1|||
161089892|NCT00552240|581719845|FG001|Overall Study|Protocol Violation|1|||
161089893|NCT00552240|581719844|FG000|Overall Study|Lost to Follow-up|5|||
161089894|NCT00552240|581719845|FG001|Overall Study|Lost to Follow-up|6|||
161089895|NCT00552240|581719844|FG000|Overall Study|Withdrawal by Subject|2|||
161089896|NCT00552240|581719845|FG001|Overall Study|Withdrawal by Subject|2|||
161089897|NCT00552240|581719844|FG000|Overall Study|Lack of Efficacy|6|||
161348382|NCT02536794|582659979|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
161348383|NCT02536794|582659979|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
161348384|NCT02536794|582659979|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
161348385|NCT02536794|582659979|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
161184512|NCT01267955|582053112|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
161184513|NCT01263470|582053113|FG000|Overall Study|Adverse Event|2|||
161184514|NCT01263470|582053114|FG001|Overall Study|Adverse Event|2|||
161184515|NCT01263470|582053115|FG002|Overall Study|Adverse Event|1|||
161184516|NCT01263470|582053116|FG003|Overall Study|Adverse Event|1|||
161184517|NCT01263470|582053117|FG004|Overall Study|Adverse Event|2|||
161184518|NCT01263470|582053118|FG005|Overall Study|Adverse Event|2|||
161184519|NCT01263470|582053113|FG000|Overall Study|Protocol Violation|0|||
161184520|NCT01263470|582053114|FG001|Overall Study|Protocol Violation|1|||
161184521|NCT01263470|582053115|FG002|Overall Study|Protocol Violation|0|||
161184522|NCT01263470|582053116|FG003|Overall Study|Protocol Violation|0|||
161184523|NCT01263470|582053117|FG004|Overall Study|Protocol Violation|0|||
161184524|NCT01263470|582053118|FG005|Overall Study|Protocol Violation|1|||
161184525|NCT01263470|582053113|FG000|Overall Study|Withdrawal by Subject|0|||
161184526|NCT01263470|582053114|FG001|Overall Study|Withdrawal by Subject|1|||
161184527|NCT01263470|582053115|FG002|Overall Study|Withdrawal by Subject|1|||
161184528|NCT01263470|582053116|FG003|Overall Study|Withdrawal by Subject|2|||
161184529|NCT01263470|582053117|FG004|Overall Study|Withdrawal by Subject|0|||
161184530|NCT01263470|582053118|FG005|Overall Study|Withdrawal by Subject|2|||
161184531|NCT01263470|582053113|FG000|Overall Study|Lack of Efficacy|0|||
161184532|NCT01263470|582053114|FG001|Overall Study|Lack of Efficacy|0|||
161184533|NCT01263470|582053115|FG002|Overall Study|Lack of Efficacy|2|||
161184534|NCT01263470|582053116|FG003|Overall Study|Lack of Efficacy|0|||
161184535|NCT01263470|582053117|FG004|Overall Study|Lack of Efficacy|0|||
161184536|NCT01263470|582053118|FG005|Overall Study|Lack of Efficacy|0|||
161184537|NCT01263470|582053113|FG000|Overall Study|Participant Unavailability|0|||
161184538|NCT01263470|582053114|FG001|Overall Study|Participant Unavailability|1|||
161184539|NCT01263470|582053115|FG002|Overall Study|Participant Unavailability|0|||
161184540|NCT01263470|582053116|FG003|Overall Study|Participant Unavailability|0|||
161184541|NCT01263470|582053117|FG004|Overall Study|Participant Unavailability|0|||
161184542|NCT01263470|582053118|FG005|Overall Study|Participant Unavailability|0|||
161184543|NCT01263470|582053113|FG000|Overall Study|Study Drug Non-compliance|0|||
161184544|NCT01263470|582053114|FG001|Overall Study|Study Drug Non-compliance|0|||
161184545|NCT01263470|582053115|FG002|Overall Study|Study Drug Non-compliance|0|||
161184546|NCT01263470|582053116|FG003|Overall Study|Study Drug Non-compliance|0|||
161184547|NCT01263470|582053117|FG004|Overall Study|Study Drug Non-compliance|1|||
161184548|NCT01263470|582053118|FG005|Overall Study|Study Drug Non-compliance|0|||
161184549|NCT00610714|582053119|FG000|Overall Study|Adverse Event|3|||
161184550|NCT00610714|582053120|FG001|Overall Study|Adverse Event|1|||
161184551|NCT00610714|582053119|FG000|Overall Study|Death|12|||
161184552|NCT00610714|582053120|FG001|Overall Study|Death|18|||
161184553|NCT00610714|582053119|FG000|Overall Study|Withdrawal by Subject|9|||
161184554|NCT00610714|582053120|FG001|Overall Study|Withdrawal by Subject|3|||
161184555|NCT00610714|582053119|FG000|Overall Study|Study completion at 120 PFS events|2|||
161184556|NCT00610714|582053120|FG001|Overall Study|Study completion at 120 PFS events|2|||
161184557|NCT01327573|582053121|FG000|Overall Study|Physician Decision|3|||
161184558|NCT01327573|582053122|FG001|Overall Study|Physician Decision|1|||
161184559|NCT01108263|582053123|FG000|Overall Study|Adverse Event|0|||
161184560|NCT01108263|582053124|FG001|Overall Study|Adverse Event|1|||
161184561|NCT00729560|582053125|FG000|Overall Study|Withdrawal by Subject|3|||
161184562|NCT03233308|582053126|FG000|Overall Study|Adverse Event|1|||
161184563|NCT03233308|582053126|FG000|Overall Study|Protocol Violation|1|||
161184564|NCT03662789|582053127|FG000|Overall Study|Lost to Follow-up|1|||
161184565|NCT03662789|582053128|FG001|Overall Study|Lost to Follow-up|2|||
161184566|NCT03662789|582053127|FG000|Overall Study|Could not perform treadmill test|4|||
161184567|NCT03662789|582053128|FG001|Overall Study|Could not perform treadmill test|4|||
161184568|NCT03662789|582053127|FG000|Overall Study|Death|0|||
161184569|NCT03662789|582053128|FG001|Overall Study|Death|1|||
161184570|NCT02136134|582053129|FG000|Overall Study|Death|170|||
161348386|NCT00313170|582659980|FG000|Overall Study|Death|2|||
161348387|NCT00313170|582659981|FG001|Overall Study|Death|4|||
161348388|NCT00313170|582659982|FG002|Overall Study|Death|2|||
161184571|NCT02136134|582053130|FG001|Overall Study|Death|148|||
161184572|NCT02136134|582053129|FG000|Overall Study|Withdrawal by Subject|19|||
161184573|NCT02136134|582053130|FG001|Overall Study|Withdrawal by Subject|10|||
161184574|NCT02136134|582053129|FG000|Overall Study|Lost to Follow-up|3|||
161184575|NCT02136134|582053130|FG001|Overall Study|Lost to Follow-up|3|||
161184576|NCT02136134|582053129|FG000|Overall Study|Uspecified|55|||
161184577|NCT02136134|582053130|FG001|Overall Study|Uspecified|90|||
161184578|NCT00638989|582053131|FG000|Overall Study|Lost to Follow-up|0|||
161184579|NCT00638989|582053132|FG001|Overall Study|Lost to Follow-up|0|||
161184580|NCT00638989|582053133|FG002|Overall Study|Lost to Follow-up|1|||
161184581|NCT05245071|582053134|FG000|Overall Study|Progressive disease|18|||
161184582|NCT05245071|582053134|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
161184583|NCT05245071|582053134|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
161184584|NCT01602822|582053135|FG000|Overall Study|Adverse Event|11|||
161184585|NCT02005211|582053139|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161184586|NCT02005211|582053140|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161184587|NCT02005211|582053141|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161184588|NCT02005211|582053142|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161184589|NCT02005211|582053143|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
161184590|NCT02005211|582053144|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161184591|NCT02005211|582053145|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
161184592|NCT03299166|582053148|FG000|Overall Study|Adverse Event|9|||
161184593|NCT03299166|582053149|FG001|Overall Study|Adverse Event|4|||
161184594|NCT03299166|582053148|FG000|Overall Study|Withdrawal by Subject|6|||
161184595|NCT03299166|582053149|FG001|Overall Study|Withdrawal by Subject|5|||
161184596|NCT03299166|582053148|FG000|Overall Study|Physician Decision|1|||
161184597|NCT03299166|582053149|FG001|Overall Study|Physician Decision|1|||
161184598|NCT03299166|582053148|FG000|Overall Study|Sponsor Decision|3|||
161184599|NCT03299166|582053149|FG001|Overall Study|Sponsor Decision|0|||
161184600|NCT03299166|582053148|FG000|Overall Study|Lost to Follow-up|2|||
161184601|NCT03299166|582053149|FG001|Overall Study|Lost to Follow-up|4|||
161184602|NCT03299166|582053148|FG000|Overall Study|Randomization Error|0|||
161184603|NCT03299166|582053149|FG001|Overall Study|Randomization Error|1|||
161184604|NCT03299166|582053148|FG000|Overall Study|Subject unable to return due to COVID|1|||
161184605|NCT03299166|582053149|FG001|Overall Study|Subject unable to return due to COVID|0|||
161184606|NCT03299166|582053148|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
161184607|NCT03299166|582053149|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
161184608|NCT00423592|582053151|FG000|Overall Study|Adverse Event (through Week 12)|2|||
161184609|NCT00423592|582053151|FG000|Overall Study|Adverse Event (post Week 12)|5|||
161184610|NCT00062647|582053152|FG000|Overall Study|Death|2|||
161184611|NCT00062647|582053153|FG001|Overall Study|Death|2|||
161184612|NCT00062647|582053152|FG000|Overall Study|Adverse Event|1|||
161184613|NCT00062647|582053153|FG001|Overall Study|Adverse Event|1|||
161184614|NCT00062647|582053152|FG000|Overall Study|Withdrawal by Subject|2|||
161184615|NCT00062647|582053153|FG001|Overall Study|Withdrawal by Subject|1|||
161184616|NCT00062647|582053152|FG000|Overall Study|Protocol Violation|1|||
161184617|NCT00062647|582053153|FG001|Overall Study|Protocol Violation|0|||
161184618|NCT00062647|582053152|FG000|Overall Study|Lost to Follow-up|1|||
161184619|NCT00062647|582053153|FG001|Overall Study|Lost to Follow-up|2|||
161184620|NCT00062647|582053152|FG000|Overall Study|Failed continuation criteria|4|||
161184621|NCT00062647|582053153|FG001|Overall Study|Failed continuation criteria|2|||
161184622|NCT00062647|582053152|FG000|Overall Study|Other|4|||
161184623|NCT00062647|582053153|FG001|Overall Study|Other|4|||
161184624|NCT00062647|582053152|FG000|Overall Study|Never received study treatment|1|||
161184625|NCT00062647|582053153|FG001|Overall Study|Never received study treatment|1|||
161184626|NCT00002981|582053156|FG000|Overall Study|Inevaluable|6|||
161184627|NCT00255008|582053157|FG000|Overall Study|Adverse Event|1|||
161184628|NCT00255008|582053158|FG001|Overall Study|Adverse Event|1|||
161184629|NCT00255008|582053159|FG002|Overall Study|Adverse Event|2|||
161184630|NCT00255008|582053160|FG003|Overall Study|Adverse Event|0|||
161184631|NCT00255008|582053157|FG000|Overall Study|Lost to Follow-up|1|||
161184632|NCT00255008|582053158|FG001|Overall Study|Lost to Follow-up|0|||
161184633|NCT00255008|582053159|FG002|Overall Study|Lost to Follow-up|1|||
161184634|NCT00255008|582053160|FG003|Overall Study|Lost to Follow-up|2|||
161184635|NCT00255008|582053157|FG000|Overall Study|Did not meet viral reduction criteria|4|||
161184636|NCT00255008|582053158|FG001|Overall Study|Did not meet viral reduction criteria|5|||
161184637|NCT00255008|582053159|FG002|Overall Study|Did not meet viral reduction criteria|0|||
161184638|NCT00255008|582053160|FG003|Overall Study|Did not meet viral reduction criteria|1|||
161184639|NCT00255008|582053157|FG000|Overall Study|Withdrew consent|0|||
161184640|NCT00255008|582053158|FG001|Overall Study|Withdrew consent|0|||
161184641|NCT00255008|582053159|FG002|Overall Study|Withdrew consent|2|||
161184642|NCT00255008|582053160|FG003|Overall Study|Withdrew consent|0|||
161305059|NCT02147158|582496884|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
161305060|NCT02147158|582496885|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
161305061|NCT02147158|582496880|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
161184643|NCT00255008|582053157|FG000|Overall Study|Sponsor request|18|||
161305062|NCT02147158|582496881|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
161305063|NCT02147158|582496882|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
161305064|NCT02147158|582496883|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
161305065|NCT02147158|582496884|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
161184644|NCT00255008|582053158|FG001|Overall Study|Sponsor request|3|||
161184645|NCT00255008|582053159|FG002|Overall Study|Sponsor request|8|||
161184646|NCT00255008|582053160|FG003|Overall Study|Sponsor request|17|||
161184647|NCT00255008|582053157|FG000|Overall Study|Adverse lab experience|1|||
161184648|NCT00255008|582053158|FG001|Overall Study|Adverse lab experience|0|||
161184649|NCT00255008|582053159|FG002|Overall Study|Adverse lab experience|0|||
161305066|NCT02147158|582496885|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
161184650|NCT00255008|582053160|FG003|Overall Study|Adverse lab experience|0|||
161184651|NCT00255008|582053157|FG000|Overall Study|Other|7|||
161184652|NCT00255008|582053158|FG001|Overall Study|Other|0|||
161184653|NCT00255008|582053159|FG002|Overall Study|Other|3|||
161184654|NCT00255008|582053160|FG003|Overall Study|Other|2|||
161184655|NCT00322387|582053165|FG000|Treatment Period|Adverse Event|0|||
161184656|NCT00322387|582053166|FG001|Treatment Period|Adverse Event|1|||
161184657|NCT00322387|582053165|FG000|Follow-up Period|Final assessment not done|1|||
161184658|NCT00322387|582053166|FG001|Follow-up Period|Final assessment not done|3|||
161184659|NCT00322387|582053165|FG000|Follow-up Period|Death|1|||
161184660|NCT00322387|582053166|FG001|Follow-up Period|Death|0|||
161184661|NCT00707486|582053171|FG000|Overall Study|Withdrawal by Subject|1|||
161184662|NCT01885104|582053181|FG000|Overall Study|Withdrawal of Consent|1|||
161184663|NCT01885104|582053182|FG001|Overall Study|Withdrawal of Consent|0|||
161184664|NCT01885104|582053181|FG000|Overall Study|Lost to Follow-up|0|||
161184665|NCT01885104|582053182|FG001|Overall Study|Lost to Follow-up|1|||
161184666|NCT01885104|582053181|FG000|Overall Study|Physician Decision|1|||
161184667|NCT01885104|582053182|FG001|Overall Study|Physician Decision|0|||
161184668|NCT00126425|582053183|FG000|Overall Study|Withdrawal by Subject|17|||
161184669|NCT00126425|582053184|FG001|Overall Study|Withdrawal by Subject|1|||
161184670|NCT00126425|582053183|FG000|Overall Study|Lost to Follow-up|8|||
161184671|NCT00126425|582053184|FG001|Overall Study|Lost to Follow-up|4|||
161184672|NCT00126425|582053183|FG000|Overall Study|Protocol Violation|9|||
161184673|NCT00126425|582053184|FG001|Overall Study|Protocol Violation|6|||
161184674|NCT00126425|582053183|FG000|Overall Study|Adverse Event|1|||
161184675|NCT00126425|582053184|FG001|Overall Study|Adverse Event|0|||
161184676|NCT00126425|582053183|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
161184677|NCT00126425|582053184|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
161184678|NCT00126425|582053183|FG000|Overall Study|Other|5|||
161184679|NCT00126425|582053184|FG001|Overall Study|Other|0|||
161184680|NCT01894776|582053185|FG000|Overall Study|Withdrawal by Subject|1|||
161184681|NCT02415595|582053186|FG000|Overall Study|Administrative reason by sponsor|39|||
161184682|NCT02415595|582053187|FG001|Overall Study|Administrative reason by sponsor|40|||
161184683|NCT02415595|582053188|FG002|Overall Study|Administrative reason by sponsor|41|||
161184684|NCT02415595|582053189|FG003|Overall Study|Administrative reason by sponsor|39|||
161184685|NCT02415595|582053186|FG000|Overall Study|Adverse Event|1|||
161184686|NCT02415595|582053187|FG001|Overall Study|Adverse Event|3|||
161184687|NCT02415595|582053188|FG002|Overall Study|Adverse Event|5|||
161184688|NCT02415595|582053189|FG003|Overall Study|Adverse Event|10|||
161184689|NCT02415595|582053186|FG000|Overall Study|Lack of Efficacy|4|||
161184690|NCT02415595|582053187|FG001|Overall Study|Lack of Efficacy|4|||
161184691|NCT02415595|582053188|FG002|Overall Study|Lack of Efficacy|0|||
161184692|NCT02415595|582053189|FG003|Overall Study|Lack of Efficacy|0|||
161184693|NCT02415595|582053186|FG000|Overall Study|Lost to Follow-up|1|||
161184694|NCT02415595|582053187|FG001|Overall Study|Lost to Follow-up|3|||
161184695|NCT02415595|582053188|FG002|Overall Study|Lost to Follow-up|1|||
161184696|NCT02415595|582053189|FG003|Overall Study|Lost to Follow-up|1|||
161184697|NCT02415595|582053186|FG000|Overall Study|Poor/Non-compliance|1|||
161184698|NCT02415595|582053187|FG001|Overall Study|Poor/Non-compliance|0|||
161184699|NCT02415595|582053188|FG002|Overall Study|Poor/Non-compliance|1|||
161184700|NCT02415595|582053189|FG003|Overall Study|Poor/Non-compliance|0|||
161184701|NCT02415595|582053186|FG000|Overall Study|Reached stopping criteria|0|||
161184702|NCT02415595|582053187|FG001|Overall Study|Reached stopping criteria|1|||
161184703|NCT02415595|582053188|FG002|Overall Study|Reached stopping criteria|1|||
161184704|NCT02415595|582053189|FG003|Overall Study|Reached stopping criteria|0|||
161184705|NCT02415595|582053186|FG000|Overall Study|Withdrawal by Subject|4|||
161184706|NCT02415595|582053187|FG001|Overall Study|Withdrawal by Subject|0|||
161184707|NCT02415595|582053188|FG002|Overall Study|Withdrawal by Subject|1|||
161184708|NCT02415595|582053189|FG003|Overall Study|Withdrawal by Subject|3|||
161305067|NCT02147158|582496880|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
161305068|NCT02147158|582496881|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
161305069|NCT02147158|582496882|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
161184709|NCT02415595|582053186|FG000|Overall Study|Other|0|||
161184710|NCT02415595|582053187|FG001|Overall Study|Other|1|||
161184711|NCT02415595|582053188|FG002|Overall Study|Other|1|||
161305070|NCT02147158|582496883|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
161184712|NCT02415595|582053189|FG003|Overall Study|Other|0|||
161184713|NCT01855919|582054855|FG000|Overall Study|Adverse Event|16|||
161184714|NCT01855919|582054856|FG001|Overall Study|Adverse Event|8|||
161184715|NCT01855919|582054855|FG000|Overall Study|Lack of Efficacy|1|||
161184716|NCT01855919|582054856|FG001|Overall Study|Lack of Efficacy|3|||
161184717|NCT01855919|582054855|FG000|Overall Study|Withdrawal by Subject|4|||
161184718|NCT01855919|582054856|FG001|Overall Study|Withdrawal by Subject|10|||
161184719|NCT01855919|582054855|FG000|Overall Study|Entry Criteria Not Met|1|||
161184720|NCT01855919|582054856|FG001|Overall Study|Entry Criteria Not Met|1|||
161184721|NCT01855919|582054855|FG000|Overall Study|Protocol Violation|1|||
161184722|NCT01855919|582054856|FG001|Overall Study|Protocol Violation|4|||
161184723|NCT01625897|582054859|FG000|Overall Study|Adverse Event|27|||
161184724|NCT01625897|582054860|FG001|Overall Study|Adverse Event|10|||
161348389|NCT00313170|582659980|FG000|Overall Study|Adverse Event|1|||
161348390|NCT00313170|582659981|FG001|Overall Study|Adverse Event|2|||
161348391|NCT00313170|582659982|FG002|Overall Study|Adverse Event|0|||
161348392|NCT00313170|582659980|FG000|Overall Study|Disease progression|31|||
161348393|NCT00313170|582659981|FG001|Overall Study|Disease progression|26|||
161348394|NCT00313170|582659982|FG002|Overall Study|Disease progression|27|||
161348395|NCT00313170|582659980|FG000|Overall Study|Withdrawal by Subject|1|||
161348396|NCT00313170|582659981|FG001|Overall Study|Withdrawal by Subject|0|||
161348397|NCT00313170|582659982|FG002|Overall Study|Withdrawal by Subject|1|||
161348398|NCT00313170|582659980|FG000|Overall Study|Incorrect enrollment|0|||
161348399|NCT00313170|582659981|FG001|Overall Study|Incorrect enrollment|2|||
161348400|NCT00313170|582659982|FG002|Overall Study|Incorrect enrollment|1|||
161348401|NCT00313170|582659980|FG000|Overall Study|Lost to Follow-up|0|||
161348402|NCT00313170|582659981|FG001|Overall Study|Lost to Follow-up|0|||
161348403|NCT00313170|582659982|FG002|Overall Study|Lost to Follow-up|1|||
161348404|NCT00313170|582659980|FG000|Overall Study|Progression (investigators opinion)|1|||
161348405|NCT00313170|582659981|FG001|Overall Study|Progression (investigators opinion)|0|||
161348406|NCT00313170|582659982|FG002|Overall Study|Progression (investigators opinion)|0|||
161348407|NCT00407511|582659988|FG000|Overall Study|Adverse Event|9|||
161348408|NCT00407511|582659988|FG000|Overall Study|Lost to Follow-up|4|||
161348409|NCT00407511|582659988|FG000|Overall Study|Other|5|||
161348410|NCT00407511|582659988|FG000|Overall Study|Withdrawal by Subject|4|||
161348411|NCT01521364|582659989|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
161348412|NCT01521364|582659989|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
161348413|NCT02447029|582659993|FG000|Overall Study|Withdrawal by Subject|3|||
161348414|NCT02447029|582659994|FG001|Overall Study|Withdrawal by Subject|2|||
161348415|NCT02299167|582659995|FG000|Overall Study|patients were excluded from the study|11|||
161348416|NCT05696847|582660001|FG000|Overall Study|Withdrawal by Subject|1|||
161348417|NCT05696847|582660002|FG001|Overall Study|Withdrawal by Subject|0|||
161348418|NCT05696847|582660003|FG002|Overall Study|Withdrawal by Subject|0|||
161348419|NCT05696847|582660004|FG003|Overall Study|Withdrawal by Subject|0|||
161348420|NCT05696847|582660005|FG004|Overall Study|Withdrawal by Subject|0|||
161348421|NCT05696847|582660006|FG005|Overall Study|Withdrawal by Subject|0|||
161348422|NCT05696847|582660001|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161348423|NCT05696847|582660002|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161348424|NCT05696847|582660003|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
161348425|NCT05696847|582660004|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161348426|NCT05696847|582660005|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
161348427|NCT05696847|582660006|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
161348428|NCT05696847|582660001|FG000|Overall Study|Adverse Event|0|||
161348429|NCT05696847|582660002|FG001|Overall Study|Adverse Event|0|||
161348430|NCT05696847|582660003|FG002|Overall Study|Adverse Event|0|||
161348431|NCT05696847|582660004|FG003|Overall Study|Adverse Event|0|||
161348432|NCT05696847|582660005|FG004|Overall Study|Adverse Event|0|||
161348433|NCT05696847|582660006|FG005|Overall Study|Adverse Event|1|||
161348434|NCT05696847|582660001|FG000|Overall Study|Sponsor Decision|0|||
161089898|NCT00552240|581719845|FG001|Overall Study|Lack of Efficacy|0|||
161089899|NCT00552240|581719844|FG000|Overall Study|Other|1|||
161089900|NCT00552240|581719845|FG001|Overall Study|Other|0|||
161089901|NCT02679573|581719846|FG000|Overall Study|Adverse Event|13|||
161089902|NCT02679573|581719847|FG001|Overall Study|Adverse Event|6|||
161089903|NCT02679573|581719846|FG000|Overall Study|Lack of Efficacy|12|||
161089904|NCT02679573|581719847|FG001|Overall Study|Lack of Efficacy|15|||
161089905|NCT02679573|581719846|FG000|Overall Study|Could not complete required study visits|6|||
161089906|NCT02679573|581719847|FG001|Overall Study|Could not complete required study visits|2|||
161089907|NCT02679573|581719846|FG000|Overall Study|Withdrawal by Subject|2|||
161089908|NCT02679573|581719847|FG001|Overall Study|Withdrawal by Subject|9|||
161089909|NCT02679573|581719846|FG000|Overall Study|Death|2|||
161089910|NCT02679573|581719847|FG001|Overall Study|Death|0|||
161089911|NCT02679573|581719846|FG000|Overall Study|Physician Decision|2|||
161089912|NCT02679573|581719847|FG001|Overall Study|Physician Decision|4|||
161089913|NCT02679573|581719846|FG000|Overall Study|Lost to Follow-up|0|||
161089914|NCT02679573|581719847|FG001|Overall Study|Lost to Follow-up|3|||
161089915|NCT02128542|581719848|FG000|Overall Study|Lost to Follow-up|3|||
161089916|NCT02128542|581719849|FG001|Overall Study|Lost to Follow-up|0|||
161089917|NCT02128542|581719848|FG000|Overall Study|Withdrew Consent|1|||
161089918|NCT02128542|581719849|FG001|Overall Study|Withdrew Consent|0|||
161089919|NCT00232544|581719855|FG000|Overall Study|Lost to Follow-up|20|||
161348435|NCT05696847|582660002|FG001|Overall Study|Sponsor Decision|0|||
161348436|NCT05696847|582660003|FG002|Overall Study|Sponsor Decision|0|||
161348437|NCT05696847|582660004|FG003|Overall Study|Sponsor Decision|1|||
161348438|NCT05696847|582660005|FG004|Overall Study|Sponsor Decision|0|||
161089920|NCT00232544|581719856|FG001|Overall Study|Lost to Follow-up|15|||
161089921|NCT00116753|581719857|FG000|Overall Study|Adverse Event|16|||
161348439|NCT05696847|582660006|FG005|Overall Study|Sponsor Decision|0|||
161348440|NCT01695746|582660010|FG000|Overall Study|Adverse Event|1|||
161348441|NCT01695746|582660010|FG000|Overall Study|Non-compliance by the participant|3|||
161184725|NCT01625897|582054859|FG000|Overall Study|Physician Decision|0|||
161184726|NCT01625897|582054860|FG001|Overall Study|Physician Decision|1|||
161184727|NCT01625897|582054859|FG000|Overall Study|Withdrawal by Subject|25|||
161184728|NCT01625897|582054860|FG001|Overall Study|Withdrawal by Subject|3|||
161184729|NCT03455530|582054861|FG000|Overall Study|Withdrawal by Subject|9|||
161184730|NCT03455530|582054862|FG001|Overall Study|Withdrawal by Subject|1|||
161184731|NCT03455530|582054863|FG002|Overall Study|Withdrawal by Subject|3|||
161184732|NCT03455530|582054864|FG003|Overall Study|Withdrawal by Subject|3|||
161184733|NCT02972658|582054869|FG000|Overall Study|Adverse Event|0|||
161184734|NCT02972658|582054870|FG001|Overall Study|Adverse Event|3|||
161184735|NCT02972658|582054871|FG002|Overall Study|Adverse Event|0|||
161184736|NCT02972658|582054872|FG003|Overall Study|Adverse Event|2|||
161184737|NCT02972658|582054869|FG000|Overall Study|Other-determined by Investigator|1|||
161184738|NCT02972658|582054870|FG001|Overall Study|Other-determined by Investigator|1|||
161184739|NCT02972658|582054871|FG002|Overall Study|Other-determined by Investigator|0|||
161184740|NCT02972658|582054872|FG003|Overall Study|Other-determined by Investigator|0|||
161184741|NCT02972658|582054869|FG000|Overall Study|Death|0|||
161184742|NCT02972658|582054870|FG001|Overall Study|Death|0|||
161184743|NCT02972658|582054871|FG002|Overall Study|Death|0|||
161184744|NCT02972658|582054872|FG003|Overall Study|Death|1|||
161184745|NCT02972658|582054869|FG000|Overall Study|Lost to Follow-up|0|||
161184746|NCT02972658|582054870|FG001|Overall Study|Lost to Follow-up|1|||
161184747|NCT02972658|582054871|FG002|Overall Study|Lost to Follow-up|1|||
161184748|NCT02972658|582054872|FG003|Overall Study|Lost to Follow-up|2|||
161184749|NCT02972658|582054869|FG000|Overall Study|Progressive Disease|0|||
161184750|NCT02972658|582054870|FG001|Overall Study|Progressive Disease|1|||
161184751|NCT02972658|582054871|FG002|Overall Study|Progressive Disease|0|||
161184752|NCT02972658|582054872|FG003|Overall Study|Progressive Disease|1|||
161184753|NCT02972658|582054869|FG000|Overall Study|Withdrawal by Subject|4|||
161184754|NCT02972658|582054870|FG001|Overall Study|Withdrawal by Subject|4|||
161184755|NCT02972658|582054871|FG002|Overall Study|Withdrawal by Subject|1|||
161184756|NCT02972658|582054872|FG003|Overall Study|Withdrawal by Subject|6|||
161184757|NCT02972658|582054869|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161184758|NCT02972658|582054870|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161184759|NCT02972658|582054871|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
161184760|NCT02972658|582054872|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
161184761|NCT02972658|582054869|FG000|Overall Study|Sponsor Decision|70|||
161184762|NCT02972658|582054870|FG001|Overall Study|Sponsor Decision|127|||
161184763|NCT02972658|582054871|FG002|Overall Study|Sponsor Decision|72|||
161184764|NCT02972658|582054872|FG003|Overall Study|Sponsor Decision|119|||
161184765|NCT03958149|582054877|FG000|Overall Study|Withdrawal by Subject|0|||
161184766|NCT03958149|582054878|FG001|Overall Study|Withdrawal by Subject|1|||
161184767|NCT02785588|582054881|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
161184768|NCT02785588|582054881|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
161184769|NCT03037489|582054882|FG000|Overall Study|Adverse Event|4|||
161184770|NCT03037489|582054883|FG001|Overall Study|Adverse Event|0|||
161184771|NCT03037489|582054882|FG000|Overall Study|Withdrawal by Subject|3|||
161184772|NCT03037489|582054883|FG001|Overall Study|Withdrawal by Subject|0|||
161184773|NCT00724243|582054885|FG000|Overall Study|Lack of Efficacy|10|||
161184774|NCT00724243|582054885|FG000|Overall Study|Adverse Event|5|||
161184775|NCT03031327|582054886|FG000|Overall Study|Withdrawal by Subject|0|||
161184776|NCT03031327|582054887|FG001|Overall Study|Withdrawal by Subject|1|||
161184777|NCT03031327|582054888|FG002|Overall Study|Withdrawal by Subject|1|||
161184778|NCT00669240|582054889|FG000|Overall Study|Lack of Efficacy|33|||
161184779|NCT00669240|582054889|FG000|Overall Study|Withdrawal by Subject|42|||
161184780|NCT00669240|582054889|FG000|Overall Study|Lost to Follow-up|34|||
161184781|NCT00669240|582054889|FG000|Overall Study|Adverse Event|21|||
161184782|NCT00669240|582054889|FG000|Overall Study|Other|19|||
161184783|NCT00669240|582054889|FG000|Overall Study|Enrolled but not treated|15|||
161184784|NCT00669240|582054889|FG000|Overall Study|Enrolled but no dosing record|1|||
161305071|NCT02147158|582496884|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
161305072|NCT02147158|582496885|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
161305073|NCT02147158|582496880|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
161184785|NCT00686699|582054890|FG000|Treatment Period 1|Adverse Event|0|||
161184786|NCT00686699|582054891|FG001|Treatment Period 1|Adverse Event|2|||
161184787|NCT00908895|582054892|FG000|Overall Study|Lost to Follow-up|1|||
161184788|NCT00908895|582054893|FG001|Overall Study|Lost to Follow-up|3|||
161184789|NCT00908895|582054892|FG000|Overall Study|algodystrophy|2|||
161184790|NCT00908895|582054893|FG001|Overall Study|algodystrophy|2|||
161184791|NCT00908895|582054892|FG000|Overall Study|Adverse Event|1|||
161184792|NCT00908895|582054893|FG001|Overall Study|Adverse Event|1|||
161184793|NCT03793010|582054894|FG000|Overall Study|Withdrawal by Subject|5|||
161184794|NCT03793010|582054895|FG001|Overall Study|Withdrawal by Subject|7|||
161184795|NCT03793010|582054894|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
161184796|NCT03793010|582054895|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
161184797|NCT03793010|582054894|FG000|Overall Study|Lost to Follow-up|1|||
161184798|NCT03793010|582054895|FG001|Overall Study|Lost to Follow-up|2|||
161184799|NCT03793010|582054894|FG000|Overall Study|Patient couldn't sit still for injection|1|||
161184800|NCT03793010|582054895|FG001|Overall Study|Patient couldn't sit still for injection|0|||
161184801|NCT03793010|582054894|FG000|Overall Study|Withdrew to pursue other treatment|1|||
161184802|NCT03793010|582054895|FG001|Overall Study|Withdrew to pursue other treatment|0|||
161184803|NCT03793010|582054894|FG000|Overall Study|Did not meet eligibility criteria|1|||
161184804|NCT03793010|582054895|FG001|Overall Study|Did not meet eligibility criteria|0|||
161184805|NCT00364611|582054898|FG000|Overall Study|Did not receive study medication|0|||
161184806|NCT00364611|582054899|FG001|Overall Study|Did not receive study medication|1|||
161184807|NCT00364611|582054898|FG000|Overall Study|Adverse Event|7|||
161184808|NCT00364611|582054899|FG001|Overall Study|Adverse Event|4|||
161184809|NCT00364611|582054898|FG000|Overall Study|Participant's Request|3|||
161184810|NCT00364611|582054899|FG001|Overall Study|Participant's Request|4|||
161184811|NCT00364611|582054898|FG000|Overall Study|Disease Progression|38|||
161184812|NCT00364611|582054899|FG001|Overall Study|Disease Progression|8|||
161184813|NCT00364611|582054898|FG000|Overall Study|Investigator decision|2|||
161184814|NCT00364611|582054899|FG001|Overall Study|Investigator decision|2|||
161184815|NCT00364611|582054898|FG000|Overall Study|Found Ineligible|1|||
161184816|NCT00364611|582054899|FG001|Overall Study|Found Ineligible|0|||
161184817|NCT00364611|582054898|FG000|Overall Study|Presumed CR on Study|0|||
161184818|NCT00364611|582054899|FG001|Overall Study|Presumed CR on Study|1|||
161184819|NCT00364611|582054898|FG000|Overall Study|Receiving Liver Ablation|0|||
161184820|NCT00364611|582054899|FG001|Overall Study|Receiving Liver Ablation|1|||
161184821|NCT02059174|582054925|FG000|Period 1|Withdrawal by Subject|0|||
161184822|NCT02059174|582054926|FG001|Period 1|Withdrawal by Subject|2|||
161184823|NCT02059174|582054925|FG000|Period 2|Withdrawal by Subject|0|||
161305074|NCT02147158|582496881|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
161305075|NCT02147158|582496882|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
161305076|NCT02147158|582496883|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
161305077|NCT02147158|582496884|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
161305078|NCT02147158|582496885|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
161305079|NCT02147158|582496880|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
161305080|NCT02147158|582496881|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
161305081|NCT02147158|582496882|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
161305082|NCT02147158|582496883|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
161305083|NCT02147158|582496884|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
161305084|NCT02147158|582496885|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
161305085|NCT04520997|582496886|FG000|Overall Study|Lost to Follow-up|1|||
161305086|NCT04520997|582496887|FG001|Overall Study|Lost to Follow-up|1|||
161305087|NCT04520997|582496886|FG000|Overall Study|Withdrawal by Subject|1|||
161305088|NCT04520997|582496887|FG001|Overall Study|Withdrawal by Subject|0|||
161305089|NCT04520997|582496886|FG000|Overall Study|Not Treated|0|||
161305090|NCT04520997|582496887|FG001|Overall Study|Not Treated|1|||
161305091|NCT03689374|582496888|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
161305092|NCT03689374|582496889|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
161305093|NCT03689374|582496890|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
161305094|NCT03689374|582496888|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
161305095|NCT03689374|582496889|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
161305096|NCT03689374|582496890|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
161305097|NCT03689374|582496888|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
161305098|NCT03689374|582496889|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
161305099|NCT03689374|582496890|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
161305100|NCT03689374|582496888|FG000|Treatment Period (Week 0 to 52)|Death|0|||
161305101|NCT03689374|582496889|FG001|Treatment Period (Week 0 to 52)|Death|11|||
161305102|NCT03689374|582496890|FG002|Treatment Period (Week 0 to 52)|Death|1|||
161305103|NCT05367973|582496891|FG000|Overall Study|Adverse Event|0|||
161305104|NCT05367973|582496892|FG001|Overall Study|Adverse Event|2|||
161305105|NCT00986921|582496893|FG000|Overall Study|Physician Decision|1|||
161305106|NCT00986921|582496894|FG001|Overall Study|Physician Decision|0|||
161305107|NCT01758731|582496895|FG000|Overall Study|Physician Decision|1|||
161305108|NCT04445714|582496896|FG000|Overall Study|Discontinuation of the study|14|||
161305109|NCT04445714|582496896|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
161184824|NCT02059174|582054926|FG001|Period 2|Withdrawal by Subject|2|||
161184825|NCT02059174|582054925|FG000|Period 2|Protocol Violation|1|||
161184826|NCT02059174|582054926|FG001|Period 2|Protocol Violation|0|||
161184827|NCT02059174|582054925|FG000|Period 3|Physician Decision|1|||
161184828|NCT02059174|582054926|FG001|Period 3|Physician Decision|0|||
161184829|NCT00087594|582054931|FG000|Overall Study|Adverse Event|2|||
161184830|NCT00087594|582054932|FG001|Overall Study|Adverse Event|3|||
161184831|NCT00087594|582054931|FG000|Overall Study|Lost to Follow-up|0|||
161305110|NCT04445714|582496896|FG000|Overall Study|Withdrawal of Informed Consent|8|||
161305111|NCT02396420|582496897|FG000|Overall Study|Death|1|||
161305112|NCT01273623|582496902|FG000|Overall Study|did not meet IVUS criteria|29|||
161305113|NCT02122887|582496910|FG000|Overall Study|Withdrawal by Subject|20|||
161184832|NCT00087594|582054932|FG001|Overall Study|Lost to Follow-up|2|||
161184833|NCT00087594|582054931|FG000|Overall Study|Withdrawal by Subject|4|||
161184834|NCT00087594|582054932|FG001|Overall Study|Withdrawal by Subject|2|||
161184835|NCT00087594|582054931|FG000|Overall Study|Lack of Efficacy|2|||
161184836|NCT00087594|582054932|FG001|Overall Study|Lack of Efficacy|5|||
161184837|NCT00290355|582054937|FG000|Overall Study|Serious adverse event|7|||
161184838|NCT00290355|582054938|FG001|Overall Study|Serious adverse event|4|||
161184839|NCT00290355|582054937|FG000|Overall Study|Study product reactogenicity|1|||
161184840|NCT00290355|582054938|FG001|Overall Study|Study product reactogenicity|0|||
161184841|NCT00290355|582054937|FG000|Overall Study|Protocol Violation|1|||
161184842|NCT00290355|582054938|FG001|Overall Study|Protocol Violation|0|||
161184843|NCT00290355|582054937|FG000|Overall Study|Withdrawal by Subject|2|||
161184844|NCT00290355|582054938|FG001|Overall Study|Withdrawal by Subject|0|||
161184845|NCT00290355|582054937|FG000|Overall Study|Migrated / moved from the study area|1|||
161184846|NCT00290355|582054938|FG001|Overall Study|Migrated / moved from the study area|0|||
161184847|NCT00290355|582054937|FG000|Overall Study|Lost to Follow-up|3|||
161184848|NCT00290355|582054938|FG001|Overall Study|Lost to Follow-up|1|||
161184849|NCT00290355|582054937|FG000|Overall Study|Other|2|||
161184850|NCT00290355|582054938|FG001|Overall Study|Other|0|||
161184851|NCT03345849|582054939|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
161184852|NCT03345849|582054940|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
161184853|NCT03345849|582054941|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
161184854|NCT03345849|582054942|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
161184855|NCT03345849|582054939|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
161184856|NCT03345849|582054940|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
161184857|NCT03345849|582054941|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
161184858|NCT03345849|582054942|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
161184859|NCT03345849|582054939|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161184860|NCT03345849|582054940|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
161184861|NCT03345849|582054941|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161184862|NCT03345849|582054942|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
161184863|NCT03345849|582054939|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
161184864|NCT03345849|582054940|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
161184865|NCT03345849|582054941|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
161184866|NCT03345849|582054942|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
161184867|NCT03345849|582054939|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161184868|NCT03345849|582054940|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
161184869|NCT03345849|582054941|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161184870|NCT03345849|582054942|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
161184871|NCT03345849|582054939|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
161184872|NCT03345849|582054940|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
161184873|NCT03345849|582054941|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
161184874|NCT03345849|582054942|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
161184875|NCT03345849|582054939|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
161184876|NCT03345849|582054940|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
161184877|NCT03345849|582054941|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
161184878|NCT03345849|582054942|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
161184879|NCT03345849|582054939|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
161184880|NCT03345849|582054940|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
161184881|NCT03345849|582054941|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
161184882|NCT03345849|582054942|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
161184883|NCT03345849|582054939|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161184884|NCT03345849|582054940|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161184885|NCT03345849|582054941|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
161184886|NCT03345849|582054942|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
161184887|NCT03345849|582054939|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161184888|NCT03345849|582054940|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161184889|NCT03345849|582054941|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
161184890|NCT03345849|582054942|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
161184891|NCT03345849|582054939|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
161184892|NCT03345849|582054940|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
161184893|NCT03345849|582054941|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
161184894|NCT03345849|582054942|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
161184895|NCT03991936|582054943|FG000|Overall Study|Lost to Follow-up|1|||
161184896|NCT03991936|582054944|FG001|Overall Study|Lost to Follow-up|1|||
161184897|NCT03991936|582054945|FG002|Overall Study|Lost to Follow-up|1|||
161184898|NCT03991936|582054946|FG003|Overall Study|Lost to Follow-up|1|||
161184899|NCT03991936|582054947|FG004|Overall Study|Lost to Follow-up|1|||
161305114|NCT02122887|582496911|FG001|Overall Study|Withdrawal by Subject|2|||
161305115|NCT00174967|582498935|FG000|Overall Study|Adverse Event|1|||
161305116|NCT00174967|582498936|FG001|Overall Study|Adverse Event|2|||
161305117|NCT00174967|582498937|FG002|Overall Study|Adverse Event|2|||
161305118|NCT00174967|582498938|FG003|Overall Study|Adverse Event|1|||
161305119|NCT00174967|582498935|FG000|Overall Study|Gout Flare|0|||
161305120|NCT00174967|582498936|FG001|Overall Study|Gout Flare|0|||
161305121|NCT00174967|582498937|FG002|Overall Study|Gout Flare|0|||
161305122|NCT00174967|582498938|FG003|Overall Study|Gout Flare|1|||
161305123|NCT00174967|582498935|FG000|Overall Study|Other|0|||
161305124|NCT00174967|582498936|FG001|Overall Study|Other|1|||
161305125|NCT00174967|582498937|FG002|Overall Study|Other|0|||
161305126|NCT00174967|582498938|FG003|Overall Study|Other|0|||
161305127|NCT03030989|582498939|FG000|Overall Study|Fever|2|||
161305128|NCT03030989|582498940|FG001|Overall Study|Fever|2|||
161305129|NCT03030989|582498939|FG000|Overall Study|Rash|2|||
161305130|NCT03030989|582498940|FG001|Overall Study|Rash|1|||
161305131|NCT03030989|582498939|FG000|Overall Study|Fatigue/Overwhelmed|1|||
161305132|NCT03030989|582498940|FG001|Overall Study|Fatigue/Overwhelmed|5|||
161305133|NCT03030989|582498939|FG000|Overall Study|Positive Blood Cultures|2|||
161305134|NCT03030989|582498940|FG001|Overall Study|Positive Blood Cultures|1|||
161305135|NCT03030989|582498939|FG000|Overall Study|Line Removed|0|||
161305136|NCT03030989|582498940|FG001|Overall Study|Line Removed|2|||
161305137|NCT03030989|582498939|FG000|Overall Study|No longer interested|5|||
161305138|NCT03030989|582498940|FG001|Overall Study|No longer interested|3|||
161305139|NCT02730377|582498941|FG000|Overall Study|Other|5|||
161305140|NCT02730377|582498942|FG001|Overall Study|Other|4|||
161305141|NCT02730377|582498941|FG000|Overall Study|Death|1|||
161305142|NCT02730377|582498942|FG001|Overall Study|Death|8|||
161305143|NCT02730377|582498941|FG000|Overall Study|Inadequate glycaemic control|368|||
161305144|NCT02730377|582498942|FG001|Overall Study|Inadequate glycaemic control|473|||
161305145|NCT02730377|582498941|FG000|Overall Study|Adverse Event|79|||
161305146|NCT02730377|582498942|FG001|Overall Study|Adverse Event|41|||
161305147|NCT02730377|582498941|FG000|Overall Study|Protocol Violation|23|||
161305148|NCT02730377|582498942|FG001|Overall Study|Protocol Violation|30|||
161305149|NCT02730377|582498941|FG000|Overall Study|Lack of Efficacy|4|||
161305150|NCT02730377|582498942|FG001|Overall Study|Lack of Efficacy|13|||
161305151|NCT02730377|582498941|FG000|Overall Study|Pregnancy|0|||
161305152|NCT02730377|582498942|FG001|Overall Study|Pregnancy|1|||
161305153|NCT02730377|582498941|FG000|Overall Study|Withdrawal by Subject|45|||
161305154|NCT02730377|582498942|FG001|Overall Study|Withdrawal by Subject|42|||
161305155|NCT02730377|582498941|FG000|Overall Study|Lost to Follow-up|25|||
161305156|NCT02730377|582498942|FG001|Overall Study|Lost to Follow-up|21|||
161305157|NCT02706886|582498943|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
161305158|NCT02706886|582498944|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
161305159|NCT02706886|582498945|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
161305160|NCT02706886|582498946|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
161305161|NCT02706886|582498947|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
161305162|NCT02706886|582498948|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
161305163|NCT02706886|582498949|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
161305164|NCT02706886|582498950|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
161305165|NCT02706886|582498951|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
161305166|NCT03917472|582498952|FG000|Overall Study|Physician Decision|4|||
161305167|NCT03917472|582498953|FG001|Overall Study|Physician Decision|0|||
161305168|NCT03917472|582498952|FG000|Overall Study|Adverse Event|3|||
161305169|NCT03917472|582498953|FG001|Overall Study|Adverse Event|1|||
161305170|NCT03917472|582498952|FG000|Overall Study|Death|7|||
161305171|NCT03917472|582498953|FG001|Overall Study|Death|5|||
161305172|NCT03917472|582498952|FG000|Overall Study|Withdrawal by Subject|11|||
161305173|NCT03917472|582498953|FG001|Overall Study|Withdrawal by Subject|4|||
161305174|NCT03917472|582498952|FG000|Overall Study|Lost to Follow-up|10|||
161089922|NCT00116753|581719858|FG001|Overall Study|Adverse Event|10|||
161089923|NCT00116753|581719859|FG002|Overall Study|Adverse Event|7|||
161089924|NCT00116753|581719857|FG000|Overall Study|Withdrawal by Subject|11|||
161089925|NCT00116753|581719858|FG001|Overall Study|Withdrawal by Subject|12|||
161089926|NCT00116753|581719859|FG002|Overall Study|Withdrawal by Subject|8|||
161089927|NCT00116753|581719857|FG000|Overall Study|Lost to Follow-up|0|||
161089928|NCT00116753|581719858|FG001|Overall Study|Lost to Follow-up|2|||
161089929|NCT00116753|581719859|FG002|Overall Study|Lost to Follow-up|1|||
161089930|NCT00116753|581719857|FG000|Overall Study|Protocol Violation|0|||
161089931|NCT00116753|581719858|FG001|Overall Study|Protocol Violation|0|||
161089932|NCT00116753|581719859|FG002|Overall Study|Protocol Violation|1|||
161089933|NCT00116753|581719857|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
161089934|NCT00116753|581719858|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
161089935|NCT00116753|581719859|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
161089936|NCT00116753|581719857|FG000|Overall Study|Disease Progression|3|||
161089937|NCT00116753|581719858|FG001|Overall Study|Disease Progression|4|||
161089938|NCT00116753|581719859|FG002|Overall Study|Disease Progression|3|||
161089939|NCT00116753|581719857|FG000|Overall Study|Abnormal Echocardiogram|0|||
161089940|NCT00116753|581719858|FG001|Overall Study|Abnormal Echocardiogram|0|||
161184900|NCT00939055|582054948|FG000|Overall Study|Discontinuation prior to procedure|4|||
161348442|NCT01695746|582660010|FG000|Overall Study|Protocol Violation|5|||
161348443|NCT01695746|582660010|FG000|Overall Study|Participant not willing to participate|3|||
161184901|NCT00939055|582054949|FG001|Overall Study|Discontinuation prior to procedure|0|||
161184902|NCT00584987|582054950|FG000|Overall Study|Protocol Violation|1|||
161184903|NCT00584987|582054951|FG001|Overall Study|Protocol Violation|1|||
161184904|NCT00584987|582054952|FG002|Overall Study|Protocol Violation|1|||
161184905|NCT00584987|582054953|FG003|Overall Study|Protocol Violation|0|||
161184906|NCT00584987|582054950|FG000|Overall Study|Adverse Event|0|||
161184907|NCT00584987|582054951|FG001|Overall Study|Adverse Event|0|||
161184908|NCT00584987|582054952|FG002|Overall Study|Adverse Event|0|||
161184909|NCT00584987|582054953|FG003|Overall Study|Adverse Event|1|||
161184910|NCT01944462|582054957|FG000|PPPP Educational Program|Lost to Follow-up|60|||
161184911|NCT00808028|582054958|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
161184912|NCT00808028|582054959|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
161184913|NCT00808028|582054960|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
161184914|NCT00808028|582054961|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
161184915|NCT00808028|582054958|FG000|Stage 1 (6 Months)|Other|1|||
161184916|NCT00808028|582054959|FG001|Stage 1 (6 Months)|Other|0|||
161184917|NCT00808028|582054960|FG002|Stage 1 (6 Months)|Other|2|||
161184918|NCT00808028|582054961|FG003|Stage 1 (6 Months)|Other|4|||
161184919|NCT00808028|582054958|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
161184920|NCT00808028|582054959|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
161184921|NCT00808028|582054960|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
161184922|NCT00808028|582054961|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
161184923|NCT00808028|582054958|FG000|Stage 1 (6 Months)|Adverse Event|0|||
161184924|NCT00808028|582054959|FG001|Stage 1 (6 Months)|Adverse Event|0|||
161184925|NCT00808028|582054960|FG002|Stage 1 (6 Months)|Adverse Event|1|||
161184926|NCT00808028|582054961|FG003|Stage 1 (6 Months)|Adverse Event|2|||
161184927|NCT00808028|582054958|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
161184928|NCT00808028|582054959|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
161184929|NCT00808028|582054960|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
161184930|NCT00808028|582054961|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
161184931|NCT00808028|582054958|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
161184932|NCT00808028|582054959|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
161184933|NCT00808028|582054960|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
161184934|NCT00808028|582054961|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
161184935|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
161184936|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
161184937|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
161184938|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
161184939|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161184940|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161184941|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
161184942|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
161348444|NCT03506477|582660013|FG000|Overall Study|Withdrawal by Subject|1|||
161348445|NCT03506477|582660014|FG001|Overall Study|Withdrawal by Subject|0|||
161348446|NCT03462680|582660015|FG000|Overall Study|Withdrawal by Subject|3|||
161348447|NCT03462680|582660016|FG001|Overall Study|Withdrawal by Subject|5|||
161348448|NCT02516241|582660017|FG000|Overall Study|Death|255|||
161348449|NCT02516241|582660018|FG001|Overall Study|Death|262|||
161348450|NCT02516241|582660019|FG002|Overall Study|Death|270|||
161348451|NCT02516241|582660017|FG000|Overall Study|Lost to Follow-up|1|||
161348452|NCT02516241|582660018|FG001|Overall Study|Lost to Follow-up|1|||
161348453|NCT02516241|582660019|FG002|Overall Study|Lost to Follow-up|3|||
161348454|NCT02516241|582660017|FG000|Overall Study|Withdrawal by Subject|2|||
161184943|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
161184944|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
161184945|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
161184946|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
161348455|NCT02516241|582660018|FG001|Overall Study|Withdrawal by Subject|7|||
161348456|NCT02516241|582660019|FG002|Overall Study|Withdrawal by Subject|12|||
161348457|NCT02516241|582660017|FG000|Overall Study|participants ongoing at data cut-off|84|||
161348458|NCT02516241|582660018|FG001|Overall Study|participants ongoing at data cut-off|76|||
161348459|NCT02516241|582660019|FG002|Overall Study|participants ongoing at data cut-off|59|||
161348460|NCT00462462|582660020|FG000|Overall Study|Physician Decision|0|||
161184947|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
161184948|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
161348461|NCT00462462|582660021|FG001|Overall Study|Physician Decision|1|||
161184949|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
161184950|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
161184951|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
161348462|NCT01163617|582660022|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161348463|NCT01163617|582660023|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
161184952|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
161184953|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
161184954|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
161184955|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
161184956|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
161184957|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
161184958|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
161184959|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161184960|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161184961|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
161184962|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
161184963|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
161184964|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
161184965|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
161184966|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
161184967|NCT00808028|582054958|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161184968|NCT00808028|582054959|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161184969|NCT00808028|582054960|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
161184970|NCT00808028|582054961|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
161184971|NCT01222767|582054965|FG000|Overall Study|Progressive disease|13|||
161184972|NCT01222767|582054965|FG000|Overall Study|Adverse Event|2|||
161184973|NCT01222767|582054965|FG000|Overall Study|Surgical resection|1|||
161184974|NCT01222767|582054965|FG000|Overall Study|Never treated|1|||
161184975|NCT02773849|582054966|FG000|Overall Study|Lost to Follow-up|11|||
161184976|NCT02773849|582054966|FG000|Overall Study|Death|26|||
161184977|NCT02773849|582054966|FG000|Overall Study|Withdrawal by Subject|5|||
161184978|NCT02773849|582054966|FG000|Overall Study|Withdrawal of Consent|9|||
161184979|NCT02773849|582054966|FG000|Overall Study|Other: not due to lack of tolerability|11|||
161184980|NCT00723489|582054967|FG000|Overall Study|Physician Decision|0|||
161184981|NCT00723489|582054968|FG001|Overall Study|Physician Decision|1|||
161184982|NCT00723489|582054969|FG002|Overall Study|Physician Decision|0|||
161184983|NCT00723489|582054970|FG003|Overall Study|Physician Decision|0|||
161184984|NCT00723489|582054967|FG000|Overall Study|Pregnancy|0|||
161184985|NCT00723489|582054968|FG001|Overall Study|Pregnancy|0|||
161184986|NCT00723489|582054969|FG002|Overall Study|Pregnancy|0|||
161184987|NCT00723489|582054970|FG003|Overall Study|Pregnancy|1|||
161184988|NCT00723489|582054967|FG000|Overall Study|Withdrawal by Subject|0|||
161184989|NCT00723489|582054968|FG001|Overall Study|Withdrawal by Subject|0|||
161184990|NCT00723489|582054969|FG002|Overall Study|Withdrawal by Subject|0|||
161184991|NCT00723489|582054970|FG003|Overall Study|Withdrawal by Subject|1|||
161184992|NCT00723489|582054967|FG000|Overall Study|Seropositive at baseline|1|||
161184993|NCT00723489|582054968|FG001|Overall Study|Seropositive at baseline|0|||
161184994|NCT00723489|582054969|FG002|Overall Study|Seropositive at baseline|0|||
161184995|NCT00723489|582054970|FG003|Overall Study|Seropositive at baseline|0|||
161184996|NCT00723489|582054967|FG000|Overall Study|Prohibited Medication|0|||
161184997|NCT00723489|582054968|FG001|Overall Study|Prohibited Medication|0|||
161184998|NCT00723489|582054969|FG002|Overall Study|Prohibited Medication|0|||
161184999|NCT00723489|582054970|FG003|Overall Study|Prohibited Medication|1|||
161185000|NCT00723489|582054967|FG000|Overall Study|Samples Collected Out of Window|0|||
161185001|NCT00723489|582054968|FG001|Overall Study|Samples Collected Out of Window|3|||
161185002|NCT00723489|582054969|FG002|Overall Study|Samples Collected Out of Window|0|||
161185003|NCT00723489|582054970|FG003|Overall Study|Samples Collected Out of Window|0|||
161185004|NCT02274311|582054977|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
161185005|NCT00508001|582054978|FG000|Overall Study|Adverse Event|2|||
161185006|NCT00508001|582054979|FG001|Overall Study|Adverse Event|0|||
161185007|NCT00508001|582054980|FG002|Overall Study|Adverse Event|4|||
161185008|NCT00508001|582054978|FG000|Overall Study|condition under investigation worsened|13|||
161185009|NCT00508001|582054979|FG001|Overall Study|condition under investigation worsened|7|||
161305175|NCT03917472|582498953|FG001|Overall Study|Lost to Follow-up|5|||
161305176|NCT01154296|582498954|FG000|Randomization and Intervention|Decided to decline|1|||
161305177|NCT01154296|582498955|FG001|Randomization and Intervention|Decided to decline|1|||
161305178|NCT01154296|582498954|FG000|Randomization and Intervention|Declined by staff|1|||
161305179|NCT01154296|582498955|FG001|Randomization and Intervention|Declined by staff|0|||
161305180|NCT01154296|582498954|FG000|Randomization and Intervention|Did not return|1|||
161305181|NCT01154296|582498955|FG001|Randomization and Intervention|Did not return|0|||
161185010|NCT00508001|582054980|FG002|Overall Study|condition under investigation worsened|1|||
161185011|NCT00508001|582054978|FG000|Overall Study|Death|0|||
161185012|NCT00508001|582054979|FG001|Overall Study|Death|1|||
161185013|NCT00508001|582054980|FG002|Overall Study|Death|1|||
161185014|NCT00508001|582054978|FG000|Overall Study|Withdrawal by Subject|4|||
161185015|NCT00508001|582054979|FG001|Overall Study|Withdrawal by Subject|4|||
161185016|NCT00508001|582054980|FG002|Overall Study|Withdrawal by Subject|1|||
161185017|NCT01599585|582054981|FG000|Overall Study|Withdrawal by Subject|16|||
161185018|NCT01599585|582054982|FG001|Overall Study|Withdrawal by Subject|9|||
161185019|NCT01599585|582054981|FG000|Overall Study|Lost to Follow-up|3|||
161185020|NCT01599585|582054982|FG001|Overall Study|Lost to Follow-up|5|||
161185021|NCT01599585|582054981|FG000|Overall Study|randomized did not start treatment|3|||
161185022|NCT01599585|582054982|FG001|Overall Study|randomized did not start treatment|3|||
161185023|NCT03657576|582054983|FG000|Overall Study|Death|0|||
161185024|NCT03657576|582054984|FG001|Overall Study|Death|1|||
161185025|NCT03657576|582054985|FG002|Overall Study|Death|1|||
161185026|NCT03657576|582054986|FG003|Overall Study|Death|0|||
161185027|NCT03657576|582054987|FG004|Overall Study|Death|0|||
161185028|NCT03657576|582054988|FG005|Overall Study|Death|0|||
161185029|NCT03657576|582054983|FG000|Overall Study|Withdrawal by Subject|0|||
161185030|NCT03657576|582054984|FG001|Overall Study|Withdrawal by Subject|0|||
161185031|NCT03657576|582054985|FG002|Overall Study|Withdrawal by Subject|0|||
161185032|NCT03657576|582054986|FG003|Overall Study|Withdrawal by Subject|1|||
161185033|NCT03657576|582054987|FG004|Overall Study|Withdrawal by Subject|0|||
161185034|NCT03657576|582054988|FG005|Overall Study|Withdrawal by Subject|0|||
161185035|NCT03657576|582054983|FG000|Overall Study|Screen Fail|0|||
161185036|NCT03657576|582054984|FG001|Overall Study|Screen Fail|0|||
161185037|NCT03657576|582054985|FG002|Overall Study|Screen Fail|0|||
161185038|NCT03657576|582054986|FG003|Overall Study|Screen Fail|0|||
161185039|NCT03657576|582054987|FG004|Overall Study|Screen Fail|0|||
161185040|NCT03657576|582054988|FG005|Overall Study|Screen Fail|5|||
161185041|NCT03657576|582054983|FG000|Overall Study|Disease Progression|1|||
161185042|NCT03657576|582054984|FG001|Overall Study|Disease Progression|1|||
161185043|NCT03657576|582054985|FG002|Overall Study|Disease Progression|0|||
161185044|NCT03657576|582054986|FG003|Overall Study|Disease Progression|5|||
161185045|NCT03657576|582054987|FG004|Overall Study|Disease Progression|0|||
161185046|NCT03657576|582054988|FG005|Overall Study|Disease Progression|0|||
161185047|NCT03657576|582054983|FG000|Overall Study|Insurance Coverage|0|||
161185048|NCT03657576|582054984|FG001|Overall Study|Insurance Coverage|0|||
161185049|NCT03657576|582054985|FG002|Overall Study|Insurance Coverage|0|||
161185050|NCT03657576|582054986|FG003|Overall Study|Insurance Coverage|1|||
161185051|NCT03657576|582054987|FG004|Overall Study|Insurance Coverage|0|||
161185052|NCT03657576|582054988|FG005|Overall Study|Insurance Coverage|0|||
161185053|NCT04437511|582054989|FG000|Overall Study|Adverse Event|50|||
161185054|NCT04437511|582054990|FG001|Overall Study|Adverse Event|21|||
161185055|NCT04437511|582054989|FG000|Overall Study|Death|15|||
161185056|NCT04437511|582054990|FG001|Overall Study|Death|10|||
161185057|NCT04437511|582054989|FG000|Overall Study|Lost to Follow-up|11|||
161185058|NCT04437511|582054990|FG001|Overall Study|Lost to Follow-up|11|||
161185059|NCT04437511|582054989|FG000|Overall Study|Physician Decision|19|||
161185060|NCT04437511|582054990|FG001|Overall Study|Physician Decision|10|||
161185061|NCT04437511|582054989|FG000|Overall Study|Progressive Disease|4|||
161185062|NCT04437511|582054990|FG001|Overall Study|Progressive Disease|7|||
161185063|NCT04437511|582054989|FG000|Overall Study|Withdrawal by Subject|111|||
161185064|NCT04437511|582054990|FG001|Overall Study|Withdrawal by Subject|94|||
161185065|NCT04437511|582054989|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
161185066|NCT04437511|582054990|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
161185067|NCT04437511|582054989|FG000|Overall Study|Continuing Study|7|||
161185068|NCT04437511|582054990|FG001|Overall Study|Continuing Study|5|||
161185069|NCT03093350|582054993|FG000|Overall Study|Death|1|||
161185070|NCT03093350|582054993|FG000|Overall Study|Signed consent, never began treartment|1|||
161185071|NCT00777036|582054994|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
161185072|NCT00777036|582054995|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
161185073|NCT00777036|582054996|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
161185074|NCT00777036|582054997|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
161185075|NCT00777036|582054994|FG000|On Treatment|Administrative Reason By Sponsor|1|||
161185076|NCT00777036|582054995|FG001|On Treatment|Administrative Reason By Sponsor|0|||
161185077|NCT00777036|582054996|FG002|On Treatment|Administrative Reason By Sponsor|9|||
161185078|NCT00777036|582054997|FG003|On Treatment|Administrative Reason By Sponsor|0|||
161185079|NCT00777036|582054994|FG000|On Treatment|Failure to Meet Study Criteria|0|||
161185080|NCT00777036|582054995|FG001|On Treatment|Failure to Meet Study Criteria|1|||
161185081|NCT00777036|582054996|FG002|On Treatment|Failure to Meet Study Criteria|4|||
161185082|NCT00777036|582054997|FG003|On Treatment|Failure to Meet Study Criteria|0|||
161185083|NCT00777036|582054994|FG000|On Treatment|Pregnancy|1|||
161185084|NCT00777036|582054995|FG001|On Treatment|Pregnancy|0|||
161185085|NCT00777036|582054996|FG002|On Treatment|Pregnancy|1|||
161185086|NCT00777036|582054997|FG003|On Treatment|Pregnancy|0|||
161185087|NCT00777036|582054994|FG000|On Treatment|Non-compliance with Study Drug|1|||
161185088|NCT00777036|582054995|FG001|On Treatment|Non-compliance with Study Drug|0|||
161185089|NCT00777036|582054996|FG002|On Treatment|Non-compliance with Study Drug|1|||
161185090|NCT00777036|582054997|FG003|On Treatment|Non-compliance with Study Drug|0|||
161185091|NCT00777036|582054994|FG000|On Treatment|Maximum Clinical Benefit|2|||
161185092|NCT00777036|582054995|FG001|On Treatment|Maximum Clinical Benefit|0|||
161185093|NCT00777036|582054996|FG002|On Treatment|Maximum Clinical Benefit|5|||
161185094|NCT00777036|582054997|FG003|On Treatment|Maximum Clinical Benefit|0|||
161185095|NCT00777036|582054994|FG000|On Treatment|Withdrawal by Subject|0|||
161185096|NCT00777036|582054995|FG001|On Treatment|Withdrawal by Subject|2|||
161185097|NCT00777036|582054996|FG002|On Treatment|Withdrawal by Subject|2|||
161185098|NCT00777036|582054997|FG003|On Treatment|Withdrawal by Subject|0|||
161185099|NCT00777036|582054994|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
161185100|NCT00777036|582054995|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
161185101|NCT00777036|582054996|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
161185102|NCT00777036|582054997|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
161185103|NCT00777036|582054994|FG000|On Treatment|Death|0|||
161185104|NCT00777036|582054995|FG001|On Treatment|Death|2|||
161185105|NCT00777036|582054996|FG002|On Treatment|Death|0|||
161185106|NCT00777036|582054997|FG003|On Treatment|Death|0|||
161185107|NCT00777036|582054994|FG000|On Treatment|Study Drug Toxicity|1|||
161185108|NCT00777036|582054995|FG001|On Treatment|Study Drug Toxicity|0|||
161185109|NCT00777036|582054996|FG002|On Treatment|Study Drug Toxicity|4|||
161185110|NCT00777036|582054997|FG003|On Treatment|Study Drug Toxicity|0|||
161185111|NCT00777036|582054994|FG000|On Treatment|Progressive Disease|6|||
161185112|NCT00777036|582054995|FG001|On Treatment|Progressive Disease|4|||
161185113|NCT00777036|582054996|FG002|On Treatment|Progressive Disease|7|||
161185114|NCT00777036|582054997|FG003|On Treatment|Progressive Disease|0|||
161185115|NCT00777036|582054994|FG000|On Treatment|Not Reported|0|||
161185116|NCT00777036|582054995|FG001|On Treatment|Not Reported|0|||
161185117|NCT00777036|582054996|FG002|On Treatment|Not Reported|2|||
161185118|NCT00777036|582054997|FG003|On Treatment|Not Reported|0|||
161185119|NCT00777036|582054994|FG000|On Treatment|Site Closed|0|||
161185120|NCT00777036|582054995|FG001|On Treatment|Site Closed|1|||
161185121|NCT00777036|582054996|FG002|On Treatment|Site Closed|1|||
161185122|NCT00777036|582054997|FG003|On Treatment|Site Closed|0|||
161185123|NCT00777036|582054994|FG000|Follow-Up|Withdrawal by Subject|0|||
161185124|NCT00777036|582054995|FG001|Follow-Up|Withdrawal by Subject|0|||
161185125|NCT00777036|582054996|FG002|Follow-Up|Withdrawal by Subject|5|||
161185126|NCT00777036|582054997|FG003|Follow-Up|Withdrawal by Subject|0|||
161185127|NCT00777036|582054994|FG000|Follow-Up|Death|1|||
161185128|NCT00777036|582054995|FG001|Follow-Up|Death|9|||
161185129|NCT00777036|582054996|FG002|Follow-Up|Death|0|||
161185130|NCT00777036|582054997|FG003|Follow-Up|Death|0|||
161185131|NCT00777036|582054994|FG000|Follow-Up|Lost to Follow-up|3|||
161185132|NCT00777036|582054995|FG001|Follow-Up|Lost to Follow-up|0|||
161185133|NCT00777036|582054996|FG002|Follow-Up|Lost to Follow-up|0|||
161185134|NCT00777036|582054997|FG003|Follow-Up|Lost to Follow-up|0|||
161185135|NCT00777036|582054994|FG000|Follow-Up|Reason Not Specified|4|||
161185136|NCT00777036|582054995|FG001|Follow-Up|Reason Not Specified|0|||
161185137|NCT00777036|582054996|FG002|Follow-Up|Reason Not Specified|13|||
161305182|NCT01154296|582498954|FG000|Randomization and Intervention|Left before test|0|||
161305183|NCT01154296|582498955|FG001|Randomization and Intervention|Left before test|1|||
161305184|NCT01154296|582498954|FG000|Randomization and Intervention|Left clinic early|2|||
161305185|NCT01154296|582498955|FG001|Randomization and Intervention|Left clinic early|0|||
161305186|NCT01154296|582498954|FG000|6-month Follow-up|Lost contact|269|||
161305187|NCT01154296|582498955|FG001|6-month Follow-up|Lost contact|275|||
161305188|NCT01154296|582498954|FG000|6-month Follow-up|Incarcerated|37|||
161305189|NCT01154296|582498955|FG001|6-month Follow-up|Incarcerated|32|||
161305190|NCT01154296|582498954|FG000|6-month Follow-up|Withdrew consent|14|||
161305191|NCT01154296|582498955|FG001|6-month Follow-up|Withdrew consent|15|||
161305192|NCT01154296|582498954|FG000|6-month Follow-up|Death|3|||
161305193|NCT01154296|582498955|FG001|6-month Follow-up|Death|2|||
161305194|NCT01154296|582498954|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
161305195|NCT01154296|582498955|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
161305196|NCT02203851|582498956|FG000|Overall Study|Lost to Follow-up|4|||
161305197|NCT02203851|582498956|FG000|Overall Study|Withdrawal by Subject|6|||
161305198|NCT02203851|582498956|FG000|Overall Study|Other|1|||
161305199|NCT02031640|582498959|FG000|Screening Period|Adverse Event|1|||
161305200|NCT02031640|582498960|FG001|Screening Period|Adverse Event|0|||
161305201|NCT02031640|582498961|FG002|Screening Period|Adverse Event|0|||
161305202|NCT02031640|582498962|FG003|Screening Period|Adverse Event|0|||
161305203|NCT02031640|582498963|FG004|Screening Period|Adverse Event|0|||
161305204|NCT02031640|582498964|FG005|Screening Period|Adverse Event|0|||
161305205|NCT02031640|582498959|FG000|Screening Period|Withdrawal by Subject|29|||
161305206|NCT02031640|582498960|FG001|Screening Period|Withdrawal by Subject|0|||
161305207|NCT02031640|582498961|FG002|Screening Period|Withdrawal by Subject|0|||
161305208|NCT02031640|582498962|FG003|Screening Period|Withdrawal by Subject|0|||
161305209|NCT02031640|582498963|FG004|Screening Period|Withdrawal by Subject|0|||
161185138|NCT00777036|582054997|FG003|Follow-Up|Reason Not Specified|0|||
161185139|NCT00777036|582054994|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
161185140|NCT00777036|582054995|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
161185141|NCT00777036|582054996|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
161185142|NCT00777036|582054997|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
161185143|NCT05564039|582055000|FG000|Overall Study|Adverse Event|1|||
161185144|NCT05564039|582055001|FG001|Overall Study|Adverse Event|0|||
161185145|NCT05564039|582055000|FG000|Overall Study|Death|1|||
161185146|NCT05564039|582055001|FG001|Overall Study|Death|1|||
161185147|NCT05564039|582055000|FG000|Overall Study|Lost to Follow-up|3|||
161185148|NCT05564039|582055001|FG001|Overall Study|Lost to Follow-up|2|||
161185149|NCT05564039|582055000|FG000|Overall Study|Withdrawal by Subject|2|||
161185150|NCT05564039|582055001|FG001|Overall Study|Withdrawal by Subject|0|||
161185151|NCT05564039|582055000|FG000|Overall Study|Inadvertent enrollment|3|||
161185152|NCT05564039|582055001|FG001|Overall Study|Inadvertent enrollment|6|||
161185153|NCT00853112|582055002|FG000|Overall Study|Randomized but not treated|0|||
161185154|NCT00853112|582055003|FG001|Overall Study|Randomized but not treated|1|||
161185155|NCT00853112|582055004|FG002|Overall Study|Randomized but not treated|0|||
161185156|NCT00853112|582055005|FG003|Overall Study|Randomized but not treated|2|||
161185157|NCT00853112|582055006|FG004|Overall Study|Randomized but not treated|0|||
161185158|NCT00853112|582055007|FG005|Overall Study|Randomized but not treated|0|||
161185159|NCT00853112|582055008|FG006|Overall Study|Randomized but not treated|1|||
161185160|NCT01553591|582055009|FG000|Overall Study|Voluntarily withdrew|94|||
161185161|NCT01553591|582055010|FG001|Overall Study|Voluntarily withdrew|79|||
161185162|NCT01553591|582055011|FG002|Overall Study|Voluntarily withdrew|96|||
161185163|NCT01553591|582055009|FG000|Overall Study|Adverse Event|36|||
161185164|NCT01553591|582055010|FG001|Overall Study|Adverse Event|45|||
161185165|NCT01553591|582055011|FG002|Overall Study|Adverse Event|16|||
161185166|NCT01553591|582055009|FG000|Overall Study|Lost to Follow-up|25|||
161185167|NCT01553591|582055010|FG001|Overall Study|Lost to Follow-up|23|||
161185168|NCT01553591|582055011|FG002|Overall Study|Lost to Follow-up|16|||
161185169|NCT01553591|582055009|FG000|Overall Study|Physician decision: other|11|||
161185170|NCT01553591|582055010|FG001|Overall Study|Physician decision: other|14|||
161185171|NCT01553591|582055011|FG002|Overall Study|Physician decision: other|16|||
161185172|NCT01553591|582055009|FG000|Overall Study|Physician decision: lack of efficacy|2|||
161185173|NCT01553591|582055010|FG001|Overall Study|Physician decision: lack of efficacy|3|||
161185174|NCT01553591|582055011|FG002|Overall Study|Physician decision: lack of efficacy|7|||
161185175|NCT01553591|582055009|FG000|Overall Study|Protocol Violation|3|||
161185176|NCT01553591|582055010|FG001|Overall Study|Protocol Violation|4|||
161185177|NCT01553591|582055011|FG002|Overall Study|Protocol Violation|4|||
161185178|NCT01553591|582055009|FG000|Overall Study|Sponsor decision|1|||
161185179|NCT01553591|582055010|FG001|Overall Study|Sponsor decision|0|||
161185180|NCT01553591|582055011|FG002|Overall Study|Sponsor decision|3|||
161185181|NCT01553591|582055009|FG000|Overall Study|Randomized and never dispensed drug|0|||
161185182|NCT01553591|582055010|FG001|Overall Study|Randomized and never dispensed drug|1|||
161185183|NCT01553591|582055011|FG002|Overall Study|Randomized and never dispensed drug|0|||
161185184|NCT02477800|582055012|FG000|Placebo-Controlled Period|Adverse Event|16|||
161185185|NCT02477800|582055013|FG001|Placebo-Controlled Period|Adverse Event|25|||
161185186|NCT02477800|582055014|FG002|Placebo-Controlled Period|Adverse Event|28|||
161185187|NCT02477800|582055015|FG003|Placebo-Controlled Period|Adverse Event|0|||
161185188|NCT02477800|582055016|FG004|Placebo-Controlled Period|Adverse Event|0|||
161185189|NCT02477800|582055017|FG005|Placebo-Controlled Period|Adverse Event|0|||
161185190|NCT02477800|582055018|FG006|Placebo-Controlled Period|Adverse Event|0|||
161185191|NCT02477800|582055012|FG000|Placebo-Controlled Period|Change of Treatment|1|||
161185192|NCT02477800|582055013|FG001|Placebo-Controlled Period|Change of Treatment|2|||
161185193|NCT02477800|582055014|FG002|Placebo-Controlled Period|Change of Treatment|1|||
161185194|NCT02477800|582055015|FG003|Placebo-Controlled Period|Change of Treatment|0|||
161185195|NCT02477800|582055016|FG004|Placebo-Controlled Period|Change of Treatment|0|||
161185196|NCT02477800|582055017|FG005|Placebo-Controlled Period|Change of Treatment|0|||
161185197|NCT02477800|582055018|FG006|Placebo-Controlled Period|Change of Treatment|0|||
161185198|NCT02477800|582055012|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
161185199|NCT02477800|582055013|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
161185200|NCT02477800|582055014|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
161185201|NCT02477800|582055015|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
161185202|NCT02477800|582055016|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
161185203|NCT02477800|582055017|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
161185204|NCT02477800|582055018|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
161185205|NCT02477800|582055012|FG000|Placebo-Controlled Period|Death|0|||
161185206|NCT02477800|582055013|FG001|Placebo-Controlled Period|Death|3|||
161185207|NCT02477800|582055014|FG002|Placebo-Controlled Period|Death|2|||
161185208|NCT02477800|582055015|FG003|Placebo-Controlled Period|Death|0|||
161185209|NCT02477800|582055016|FG004|Placebo-Controlled Period|Death|0|||
161185210|NCT02477800|582055017|FG005|Placebo-Controlled Period|Death|0|||
161185211|NCT02477800|582055018|FG006|Placebo-Controlled Period|Death|0|||
161185212|NCT02477800|582055012|FG000|Placebo-Controlled Period|Disease Progression|1|||
161185213|NCT02477800|582055013|FG001|Placebo-Controlled Period|Disease Progression|0|||
161185214|NCT02477800|582055014|FG002|Placebo-Controlled Period|Disease Progression|1|||
161185215|NCT02477800|582055015|FG003|Placebo-Controlled Period|Disease Progression|0|||
161185216|NCT02477800|582055016|FG004|Placebo-Controlled Period|Disease Progression|0|||
161185217|NCT02477800|582055017|FG005|Placebo-Controlled Period|Disease Progression|0|||
161185218|NCT02477800|582055018|FG006|Placebo-Controlled Period|Disease Progression|0|||
161185219|NCT02477800|582055012|FG000|Placebo-Controlled Period|Investigator Decision|3|||
161185220|NCT02477800|582055013|FG001|Placebo-Controlled Period|Investigator Decision|2|||
161185221|NCT02477800|582055014|FG002|Placebo-Controlled Period|Investigator Decision|1|||
161185222|NCT02477800|582055015|FG003|Placebo-Controlled Period|Investigator Decision|0|||
161185223|NCT02477800|582055016|FG004|Placebo-Controlled Period|Investigator Decision|0|||
161185224|NCT02477800|582055017|FG005|Placebo-Controlled Period|Investigator Decision|0|||
161185225|NCT02477800|582055018|FG006|Placebo-Controlled Period|Investigator Decision|0|||
161185226|NCT02477800|582055012|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
161185227|NCT02477800|582055013|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
161185228|NCT02477800|582055014|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
161185229|NCT02477800|582055015|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
161185230|NCT02477800|582055016|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
161185231|NCT02477800|582055017|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
161185232|NCT02477800|582055018|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
161185233|NCT02477800|582055012|FG000|Placebo-Controlled Period|Relocation|2|||
161185234|NCT02477800|582055013|FG001|Placebo-Controlled Period|Relocation|0|||
161185235|NCT02477800|582055014|FG002|Placebo-Controlled Period|Relocation|0|||
161185236|NCT02477800|582055015|FG003|Placebo-Controlled Period|Relocation|0|||
161185237|NCT02477800|582055016|FG004|Placebo-Controlled Period|Relocation|0|||
161185238|NCT02477800|582055017|FG005|Placebo-Controlled Period|Relocation|0|||
161185239|NCT02477800|582055018|FG006|Placebo-Controlled Period|Relocation|0|||
161185240|NCT02477800|582055012|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161185241|NCT02477800|582055013|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161185242|NCT02477800|582055014|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
161185243|NCT02477800|582055015|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161185244|NCT02477800|582055016|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161185245|NCT02477800|582055017|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161185246|NCT02477800|582055018|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
161185247|NCT02477800|582055012|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
161185248|NCT02477800|582055013|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
161185249|NCT02477800|582055014|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161185250|NCT02477800|582055015|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161185251|NCT02477800|582055016|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161185252|NCT02477800|582055017|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161185253|NCT02477800|582055018|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
161185254|NCT02477800|582055012|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
161185255|NCT02477800|582055013|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
161185256|NCT02477800|582055014|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
161185257|NCT02477800|582055015|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
161185258|NCT02477800|582055016|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
161185259|NCT02477800|582055017|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
161185260|NCT02477800|582055018|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
161185261|NCT02477800|582055012|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
161185262|NCT02477800|582055013|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
161185263|NCT02477800|582055014|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
161185264|NCT02477800|582055015|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161185265|NCT02477800|582055016|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161185266|NCT02477800|582055017|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161185267|NCT02477800|582055018|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
161185268|NCT02477800|582055012|FG000|Placebo-Controlled Period|Reason not Specified|161|||
161185269|NCT02477800|582055013|FG001|Placebo-Controlled Period|Reason not Specified|161|||
161185270|NCT02477800|582055014|FG002|Placebo-Controlled Period|Reason not Specified|189|||
161185271|NCT02477800|582055015|FG003|Placebo-Controlled Period|Reason not Specified|0|||
161185272|NCT02477800|582055016|FG004|Placebo-Controlled Period|Reason not Specified|0|||
161185273|NCT02477800|582055017|FG005|Placebo-Controlled Period|Reason not Specified|0|||
161185274|NCT02477800|582055018|FG006|Placebo-Controlled Period|Reason not Specified|0|||
161185275|NCT02477800|582055012|FG000|Long Term Extension Period|Adverse Event|0|||
161185276|NCT02477800|582055013|FG001|Long Term Extension Period|Adverse Event|0|||
161185277|NCT02477800|582055014|FG002|Long Term Extension Period|Adverse Event|0|||
161185278|NCT02477800|582055015|FG003|Long Term Extension Period|Adverse Event|6|||
161185279|NCT02477800|582055016|FG004|Long Term Extension Period|Adverse Event|2|||
161185280|NCT02477800|582055017|FG005|Long Term Extension Period|Adverse Event|4|||
161185281|NCT02477800|582055018|FG006|Long Term Extension Period|Adverse Event|3|||
161185282|NCT02477800|582055012|FG000|Long Term Extension Period|Death|0|||
161185283|NCT02477800|582055013|FG001|Long Term Extension Period|Death|0|||
161185284|NCT02477800|582055014|FG002|Long Term Extension Period|Death|0|||
161185285|NCT02477800|582055015|FG003|Long Term Extension Period|Death|1|||
161185286|NCT02477800|582055016|FG004|Long Term Extension Period|Death|1|||
161185287|NCT02477800|582055017|FG005|Long Term Extension Period|Death|1|||
161185288|NCT02477800|582055018|FG006|Long Term Extension Period|Death|2|||
161185289|NCT02477800|582055012|FG000|Long Term Extension Period|Consent Withdrawn|0|||
161305210|NCT02031640|582498964|FG005|Screening Period|Withdrawal by Subject|0|||
161185290|NCT02477800|582055013|FG001|Long Term Extension Period|Consent Withdrawn|0|||
161185291|NCT02477800|582055014|FG002|Long Term Extension Period|Consent Withdrawn|0|||
161185292|NCT02477800|582055015|FG003|Long Term Extension Period|Consent Withdrawn|10|||
161185293|NCT02477800|582055016|FG004|Long Term Extension Period|Consent Withdrawn|4|||
161185294|NCT02477800|582055017|FG005|Long Term Extension Period|Consent Withdrawn|13|||
161185295|NCT02477800|582055018|FG006|Long Term Extension Period|Consent Withdrawn|16|||
161185296|NCT02477800|582055012|FG000|Long Term Extension Period|Disease Progression|0|||
161185297|NCT02477800|582055013|FG001|Long Term Extension Period|Disease Progression|0|||
161185298|NCT02477800|582055014|FG002|Long Term Extension Period|Disease Progression|0|||
161185299|NCT02477800|582055015|FG003|Long Term Extension Period|Disease Progression|3|||
161185300|NCT02477800|582055016|FG004|Long Term Extension Period|Disease Progression|1|||
161185301|NCT02477800|582055017|FG005|Long Term Extension Period|Disease Progression|1|||
161185302|NCT02477800|582055018|FG006|Long Term Extension Period|Disease Progression|0|||
161185303|NCT02477800|582055012|FG000|Long Term Extension Period|Investigator Decision|0|||
161185304|NCT02477800|582055013|FG001|Long Term Extension Period|Investigator Decision|0|||
161185305|NCT02477800|582055014|FG002|Long Term Extension Period|Investigator Decision|0|||
161185306|NCT02477800|582055015|FG003|Long Term Extension Period|Investigator Decision|0|||
161185307|NCT02477800|582055016|FG004|Long Term Extension Period|Investigator Decision|0|||
161185308|NCT02477800|582055017|FG005|Long Term Extension Period|Investigator Decision|0|||
161185309|NCT02477800|582055018|FG006|Long Term Extension Period|Investigator Decision|2|||
161185310|NCT02477800|582055012|FG000|Long Term Extension Period|Lost to Follow-up|0|||
161185311|NCT02477800|582055013|FG001|Long Term Extension Period|Lost to Follow-up|0|||
161185312|NCT02477800|582055014|FG002|Long Term Extension Period|Lost to Follow-up|0|||
161185313|NCT02477800|582055015|FG003|Long Term Extension Period|Lost to Follow-up|0|||
161185314|NCT02477800|582055016|FG004|Long Term Extension Period|Lost to Follow-up|1|||
161185315|NCT02477800|582055017|FG005|Long Term Extension Period|Lost to Follow-up|3|||
161185316|NCT02477800|582055018|FG006|Long Term Extension Period|Lost to Follow-up|0|||
161185317|NCT02477800|582055012|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
161185318|NCT02477800|582055013|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
161185319|NCT02477800|582055014|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
161185320|NCT02477800|582055015|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
161185321|NCT02477800|582055016|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
161185322|NCT02477800|582055017|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
161185323|NCT02477800|582055018|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
161185324|NCT02477800|582055012|FG000|Long Term Extension Period|Study Visit Burden|0|||
161185325|NCT02477800|582055013|FG001|Long Term Extension Period|Study Visit Burden|0|||
161185326|NCT02477800|582055014|FG002|Long Term Extension Period|Study Visit Burden|0|||
161185327|NCT02477800|582055015|FG003|Long Term Extension Period|Study Visit Burden|3|||
161185328|NCT02477800|582055016|FG004|Long Term Extension Period|Study Visit Burden|0|||
161185329|NCT02477800|582055017|FG005|Long Term Extension Period|Study Visit Burden|2|||
161185330|NCT02477800|582055018|FG006|Long Term Extension Period|Study Visit Burden|2|||
161185331|NCT02477800|582055012|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161185332|NCT02477800|582055013|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161185333|NCT02477800|582055014|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
161185334|NCT02477800|582055015|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
161185335|NCT02477800|582055016|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
161185336|NCT02477800|582055017|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
161185337|NCT02477800|582055018|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
161185338|NCT02477800|582055012|FG000|Long Term Extension Period|Reason not Specified|0|||
161185339|NCT02477800|582055013|FG001|Long Term Extension Period|Reason not Specified|0|||
161185340|NCT02477800|582055014|FG002|Long Term Extension Period|Reason not Specified|0|||
161185341|NCT02477800|582055015|FG003|Long Term Extension Period|Reason not Specified|126|||
161185342|NCT02477800|582055016|FG004|Long Term Extension Period|Reason not Specified|140|||
161185343|NCT02477800|582055017|FG005|Long Term Extension Period|Reason not Specified|270|||
161185344|NCT02477800|582055018|FG006|Long Term Extension Period|Reason not Specified|224|||
161185345|NCT04350372|582055021|FG000|Overall Study|Death|1|||
161185346|NCT03512275|582055023|FG000|Overall Study|Withdrawal by Subject|1|||
161185347|NCT03512275|582055024|FG001|Overall Study|Withdrawal by Subject|3|||
161185348|NCT03512275|582055023|FG000|Overall Study|Physician Decision|0|||
161185349|NCT03512275|582055024|FG001|Overall Study|Physician Decision|1|||
161185350|NCT03512275|582055023|FG000|Overall Study|Lost to Follow-up|0|||
161185351|NCT03512275|582055024|FG001|Overall Study|Lost to Follow-up|3|||
161348464|NCT01163617|582660024|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161348465|NCT01163617|582660025|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161185352|NCT03512275|582055023|FG000|Overall Study|Other|1|||
161185353|NCT03512275|582055024|FG001|Overall Study|Other|0|||
161185354|NCT00113555|582055025|FG000|Overall Study|Baseline Failure|59|||
161185355|NCT00113555|582055025|FG000|Overall Study|Permanently Explanted|7|||
161185356|NCT00113555|582055025|FG000|Overall Study|Death|1|||
161185357|NCT00113555|582055025|FG000|Overall Study|Missed Followup|4|||
161348466|NCT01163617|582660026|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161185358|NCT00113555|582055025|FG000|Overall Study|Lost to Follow-up|8|||
161185359|NCT04474366|582055026|FG000|Overall Study|Lost to Follow-up|2|||
161185360|NCT04474366|582055027|FG001|Overall Study|Lost to Follow-up|5|||
161185361|NCT01700140|582055028|FG000|Overall Study|Use of rescue drugs|3|||
161185362|NCT01700140|582055029|FG001|Overall Study|Use of rescue drugs|3|||
161185363|NCT01700140|582055030|FG002|Overall Study|Use of rescue drugs|1|||
161185364|NCT01700140|582055028|FG000|Overall Study|Discontinuation of radiotherapy|1|||
161185365|NCT01700140|582055029|FG001|Overall Study|Discontinuation of radiotherapy|0|||
161185366|NCT01700140|582055030|FG002|Overall Study|Discontinuation of radiotherapy|0|||
161185367|NCT01700140|582055028|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
161185368|NCT01700140|582055029|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
161185369|NCT01700140|582055030|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
161185370|NCT01700140|582055028|FG000|Overall Study|Aggravation of symptoms|1|||
161185371|NCT01700140|582055029|FG001|Overall Study|Aggravation of symptoms|0|||
161185372|NCT01700140|582055030|FG002|Overall Study|Aggravation of symptoms|0|||
161185373|NCT01700140|582055028|FG000|Overall Study|Adverse Event|0|||
161185374|NCT01700140|582055029|FG001|Overall Study|Adverse Event|1|||
161185375|NCT01700140|582055030|FG002|Overall Study|Adverse Event|0|||
161185376|NCT01700140|582055028|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
161185377|NCT01700140|582055029|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
161185378|NCT01700140|582055030|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
161185379|NCT02299206|582055031|FG000|Overall Study|Lost to Follow-up|1|||
161185380|NCT02299206|582055031|FG000|Overall Study|Withdrawal by Subject|1|||
161185381|NCT00691054|582055032|FG000|Overall Study|Withdrawal by Subject|1|||
161185382|NCT03074318|582055038|FG000|Overall Study|Adverse Event|0|||
161185383|NCT03074318|582055039|FG001|Overall Study|Adverse Event|1|||
161185384|NCT03074318|582055040|FG002|Overall Study|Adverse Event|1|||
161185385|NCT03074318|582055041|FG003|Overall Study|Adverse Event|1|||
161185386|NCT03074318|582055038|FG000|Overall Study|Death|1|||
161185387|NCT03074318|582055039|FG001|Overall Study|Death|0|||
161185388|NCT03074318|582055040|FG002|Overall Study|Death|0|||
161185389|NCT03074318|582055041|FG003|Overall Study|Death|0|||
161185390|NCT03074318|582055038|FG000|Overall Study|Withdrawal by Subject|1|||
161185391|NCT03074318|582055039|FG001|Overall Study|Withdrawal by Subject|2|||
161185392|NCT03074318|582055040|FG002|Overall Study|Withdrawal by Subject|2|||
161185393|NCT03074318|582055041|FG003|Overall Study|Withdrawal by Subject|4|||
161185394|NCT03074318|582055038|FG000|Overall Study|Trial Closure|2|||
161185395|NCT03074318|582055039|FG001|Overall Study|Trial Closure|2|||
161185396|NCT03074318|582055040|FG002|Overall Study|Trial Closure|3|||
161185397|NCT03074318|582055041|FG003|Overall Study|Trial Closure|11|||
161185398|NCT02314637|582056249|FG000|Overall Study|Adverse Event|4|||
161185399|NCT02314637|582056250|FG001|Overall Study|Adverse Event|8|||
161185400|NCT02314637|582056249|FG000|Overall Study|Lack of Efficacy|1|||
161185401|NCT02314637|582056250|FG001|Overall Study|Lack of Efficacy|0|||
161185402|NCT02314637|582056249|FG000|Overall Study|Physician Decision|5|||
161185403|NCT02314637|582056250|FG001|Overall Study|Physician Decision|2|||
161185404|NCT02314637|582056249|FG000|Overall Study|Withdrawal by Subject|5|||
161185405|NCT02314637|582056250|FG001|Overall Study|Withdrawal by Subject|4|||
161185406|NCT02314637|582056249|FG000|Overall Study|Other Reason|1|||
161185407|NCT02314637|582056250|FG001|Overall Study|Other Reason|0|||
161185408|NCT00768040|582056254|FG000|Overall Study|Adverse Event|3|||
161185409|NCT00768040|582056255|FG001|Overall Study|Adverse Event|2|||
161185410|NCT00768040|582056254|FG000|Overall Study|Abnormal laboratory value|1|||
161185411|NCT00768040|582056255|FG001|Overall Study|Abnormal laboratory value|1|||
161305211|NCT02031640|582498959|FG000|Screening Period|Inclusion criteria not met|312|||
161305212|NCT02031640|582498960|FG001|Screening Period|Inclusion criteria not met|0|||
161305213|NCT02031640|582498961|FG002|Screening Period|Inclusion criteria not met|0|||
161305214|NCT02031640|582498962|FG003|Screening Period|Inclusion criteria not met|0|||
161305215|NCT02031640|582498963|FG004|Screening Period|Inclusion criteria not met|0|||
161305216|NCT02031640|582498964|FG005|Screening Period|Inclusion criteria not met|0|||
161305217|NCT02031640|582498959|FG000|Screening Period|Exclusion criteria met|30|||
161305218|NCT02031640|582498960|FG001|Screening Period|Exclusion criteria met|0|||
161305219|NCT02031640|582498961|FG002|Screening Period|Exclusion criteria met|0|||
161348467|NCT01163617|582660027|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161185412|NCT02511106|582056260|FG000|Overall Study|Lost to Follow-up|6|||
161185413|NCT02511106|582056261|FG001|Overall Study|Lost to Follow-up|4|||
161185414|NCT02511106|582056260|FG000|Overall Study|Withdrawal by Subject|24|||
161185415|NCT02511106|582056261|FG001|Overall Study|Withdrawal by Subject|21|||
161185416|NCT02511106|582056260|FG000|Overall Study|Death|42|||
161185417|NCT02511106|582056261|FG001|Overall Study|Death|82|||
161185418|NCT02511106|582056260|FG000|Overall Study|Ongoing study at data cut-off|3|||
161185419|NCT02511106|582056261|FG001|Overall Study|Ongoing study at data cut-off|2|||
161185420|NCT02511106|582056260|FG000|Overall Study|Without specified reason|3|||
161185421|NCT02511106|582056261|FG001|Overall Study|Without specified reason|0|||
161185422|NCT04221945|582056262|FG000|Overall Study|Death|103|||
161185423|NCT04221945|582056263|FG001|Overall Study|Death|140|||
161185424|NCT04221945|582056262|FG000|Overall Study|Lost to Follow-up|5|||
161185425|NCT04221945|582056263|FG001|Overall Study|Lost to Follow-up|8|||
161185426|NCT04221945|582056262|FG000|Overall Study|Withdrawal by Subject|21|||
161185427|NCT04221945|582056263|FG001|Overall Study|Withdrawal by Subject|11|||
161185428|NCT04221945|582056262|FG000|Overall Study|Participants Ongoing|400|||
161185429|NCT04221945|582056263|FG001|Overall Study|Participants Ongoing|372|||
161185430|NCT00974090|582056265|FG000|Period 1: Double Blind Period|Adverse Event|2|||
161185431|NCT00974090|582056266|FG001|Period 1: Double Blind Period|Adverse Event|1|||
161185432|NCT00974090|582056265|FG000|Period 1: Double Blind Period|Physician Decision|1|||
161185433|NCT00974090|582056266|FG001|Period 1: Double Blind Period|Physician Decision|0|||
161185434|NCT00974090|582056265|FG000|Period 2: Open-label Period|Adverse Event|4|||
161185435|NCT00974090|582056266|FG001|Period 2: Open-label Period|Adverse Event|6|||
161185436|NCT00974090|582056265|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
161185437|NCT00974090|582056266|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
161185438|NCT00974090|582056265|FG000|Period 2: Open-label Period|Physician Decision|0|||
161185439|NCT00974090|582056266|FG001|Period 2: Open-label Period|Physician Decision|3|||
161185440|NCT00974090|582056265|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
161185441|NCT00974090|582056266|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
161185442|NCT01626872|582056267|FG000|Overall Study|Physician Decision|13|||
161185443|NCT01626872|582056268|FG001|Overall Study|Physician Decision|9|||
161185444|NCT01626872|582056269|FG002|Overall Study|Physician Decision|6|||
161185445|NCT01626872|582056267|FG000|Overall Study|Withdrawal by Subject|19|||
161185446|NCT01626872|582056268|FG001|Overall Study|Withdrawal by Subject|27|||
161185447|NCT01626872|582056269|FG002|Overall Study|Withdrawal by Subject|8|||
161185448|NCT01626872|582056267|FG000|Overall Study|Adverse Event (including Death)|20|||
161185449|NCT01626872|582056268|FG001|Overall Study|Adverse Event (including Death)|28|||
161185450|NCT01626872|582056269|FG002|Overall Study|Adverse Event (including Death)|8|||
161185451|NCT01626872|582056267|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
161185452|NCT01626872|582056268|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
161185453|NCT01626872|582056269|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
161185454|NCT05626751|582056270|FG000|Overall Study|Lost to Follow-up|1|||
161185455|NCT05626751|582056271|FG001|Overall Study|Lost to Follow-up|2|||
161185456|NCT05626751|582056272|FG002|Overall Study|Lost to Follow-up|1|||
161185457|NCT05626751|582056270|FG000|Overall Study|Trial Terminated by Sponsor|39|||
161185458|NCT05626751|582056271|FG001|Overall Study|Trial Terminated by Sponsor|30|||
161185459|NCT05626751|582056272|FG002|Overall Study|Trial Terminated by Sponsor|37|||
161185460|NCT05626751|582056270|FG000|Overall Study|Withdrawal by Subject|7|||
161185461|NCT05626751|582056271|FG001|Overall Study|Withdrawal by Subject|5|||
161185462|NCT05626751|582056272|FG002|Overall Study|Withdrawal by Subject|5|||
161185463|NCT04295759|582056273|FG000|Overall Study|Lack of Efficacy|9|||
161185464|NCT04295759|582056273|FG000|Overall Study|Death|1|||
161185465|NCT04295759|582056273|FG000|Overall Study|Withdrawal by Subject|2|||
161185466|NCT04295759|582056273|FG000|Overall Study|Deemed ineligible|1|||
161185467|NCT01685372|582056274|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
161185468|NCT01685372|582056275|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
161185469|NCT01626859|582056276|FG000|Overall Study|Adverse Event|1|||
161185470|NCT01626859|582056277|FG001|Overall Study|Adverse Event|3|||
161185471|NCT01626859|582056278|FG002|Overall Study|Adverse Event|2|||
161185472|NCT01626859|582056276|FG000|Overall Study|Physician Decision|0|||
161185473|NCT01626859|582056277|FG001|Overall Study|Physician Decision|1|||
161185474|NCT01626859|582056278|FG002|Overall Study|Physician Decision|0|||
161185475|NCT01626859|582056276|FG000|Overall Study|Withdrawal by Subject|1|||
161185476|NCT01626859|582056277|FG001|Overall Study|Withdrawal by Subject|4|||
161185477|NCT01626859|582056278|FG002|Overall Study|Withdrawal by Subject|2|||
161185478|NCT05616221|582056289|FG000|Overall Study|Withdrawal by Subject|0|||
161185479|NCT05616221|582056290|FG001|Overall Study|Withdrawal by Subject|1|||
161185480|NCT05616221|582056291|FG002|Overall Study|Withdrawal by Subject|0|||
161185481|NCT05616221|582056292|FG003|Overall Study|Withdrawal by Subject|0|||
161185482|NCT05616221|582056293|FG004|Overall Study|Withdrawal by Subject|0|||
161185483|NCT05616221|582056294|FG005|Overall Study|Withdrawal by Subject|0|||
161185484|NCT05616221|582056289|FG000|Overall Study|Adverse Event|0|||
161185485|NCT05616221|582056290|FG001|Overall Study|Adverse Event|2|||
161185486|NCT05616221|582056291|FG002|Overall Study|Adverse Event|0|||
161185487|NCT05616221|582056292|FG003|Overall Study|Adverse Event|0|||
161185488|NCT05616221|582056293|FG004|Overall Study|Adverse Event|2|||
161185489|NCT05616221|582056294|FG005|Overall Study|Adverse Event|0|||
161185490|NCT04880733|582056295|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
161185491|NCT04880733|582056296|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
161185492|NCT04880733|582056297|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
161185493|NCT04880733|582056295|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
161185494|NCT04880733|582056296|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
161185495|NCT04880733|582056297|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
161185496|NCT04880733|582056295|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
161185497|NCT04880733|582056296|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
161185498|NCT04880733|582056297|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
161185499|NCT04880733|582056295|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
161185500|NCT04880733|582056296|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
161185501|NCT04880733|582056297|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
161185502|NCT04880733|582056295|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
161185503|NCT04880733|582056296|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
161185504|NCT04880733|582056297|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
161185505|NCT00862992|582056298|FG000|Overall Study|Adverse Event|2|||
161185506|NCT00862992|582056299|FG001|Overall Study|Adverse Event|1|||
161185507|NCT00862992|582056300|FG002|Overall Study|Adverse Event|1|||
161185508|NCT00862992|582056298|FG000|Overall Study|Physician Decision|1|||
161185509|NCT00862992|582056299|FG001|Overall Study|Physician Decision|0|||
161185510|NCT00862992|582056300|FG002|Overall Study|Physician Decision|0|||
161185511|NCT00862992|582056298|FG000|Overall Study|Withdrawal by Subject|0|||
161185512|NCT00862992|582056299|FG001|Overall Study|Withdrawal by Subject|0|||
161185513|NCT00862992|582056300|FG002|Overall Study|Withdrawal by Subject|2|||
161185514|NCT00528840|582056307|FG000|Overall Study|Lost to Follow-up|10|||
161185515|NCT00528840|582056307|FG000|Overall Study|Adverse Event|1|||
161185516|NCT00528840|582056307|FG000|Overall Study|Withdrawal by Subject|17|||
161185517|NCT00528840|582056307|FG000|Overall Study|Death|2|||
161185518|NCT00528840|582056307|FG000|Overall Study|Administrative Reasons|1|||
161185519|NCT00528840|582056307|FG000|Overall Study|Other|2|||
161185520|NCT01603628|582056308|FG000|Overall Study|Personal Reasons|1|||
161185521|NCT01603628|582056309|FG001|Overall Study|Personal Reasons|1|||
161185522|NCT01603628|582056310|FG002|Overall Study|Personal Reasons|2|||
161185523|NCT01603628|582056308|FG000|Overall Study|Protocol Violation|1|||
161185524|NCT01603628|582056309|FG001|Overall Study|Protocol Violation|1|||
161185525|NCT01603628|582056310|FG002|Overall Study|Protocol Violation|0|||
161185526|NCT01603628|582056308|FG000|Overall Study|Lost to Follow-up|0|||
161185527|NCT01603628|582056309|FG001|Overall Study|Lost to Follow-up|1|||
161185528|NCT01603628|582056310|FG002|Overall Study|Lost to Follow-up|0|||
161185529|NCT01603628|582056308|FG000|Overall Study|Other Miscellaneous Reason|1|||
161185530|NCT01603628|582056309|FG001|Overall Study|Other Miscellaneous Reason|0|||
161185531|NCT01603628|582056310|FG002|Overall Study|Other Miscellaneous Reason|0|||
161185532|NCT01969565|582056311|FG000|Overall Study|Withdrawal by Subject|1|||
161185533|NCT00832091|582056312|FG000|Overall Study|Adverse Event|1|||
161185534|NCT00832091|582056313|FG001|Overall Study|Adverse Event|1|||
161185535|NCT00832091|582056312|FG000|Overall Study|Protocol Violation|1|||
161185536|NCT00832091|582056313|FG001|Overall Study|Protocol Violation|0|||
161185537|NCT00832091|582056312|FG000|Overall Study|Withdrawal by Subject|2|||
161185538|NCT00832091|582056313|FG001|Overall Study|Withdrawal by Subject|1|||
161185539|NCT00832091|582056312|FG000|Overall Study|Prohibited Medication|1|||
161185540|NCT00832091|582056313|FG001|Overall Study|Prohibited Medication|0|||
161185541|NCT02943668|582056315|FG000|Overall Study|Disease Progression|1|||
161185542|NCT03457636|582056316|FG000|Overall Study|Lost to Follow-up|2|||
161305220|NCT02031640|582498962|FG003|Screening Period|Exclusion criteria met|0|||
161305221|NCT02031640|582498963|FG004|Screening Period|Exclusion criteria met|0|||
161305222|NCT02031640|582498964|FG005|Screening Period|Exclusion criteria met|0|||
161305223|NCT02031640|582498959|FG000|Screening Period|Lost to Follow-up|14|||
161305224|NCT02031640|582498960|FG001|Screening Period|Lost to Follow-up|0|||
161305225|NCT02031640|582498961|FG002|Screening Period|Lost to Follow-up|0|||
161305226|NCT02031640|582498962|FG003|Screening Period|Lost to Follow-up|0|||
161305227|NCT02031640|582498963|FG004|Screening Period|Lost to Follow-up|0|||
161305228|NCT02031640|582498964|FG005|Screening Period|Lost to Follow-up|0|||
161305229|NCT02031640|582498959|FG000|Screening Period|Enrollment closed|26|||
161305230|NCT02031640|582498960|FG001|Screening Period|Enrollment closed|0|||
161305231|NCT02031640|582498961|FG002|Screening Period|Enrollment closed|0|||
161305232|NCT02031640|582498962|FG003|Screening Period|Enrollment closed|0|||
161305233|NCT02031640|582498963|FG004|Screening Period|Enrollment closed|0|||
161305234|NCT02031640|582498964|FG005|Screening Period|Enrollment closed|0|||
161305235|NCT02031640|582498959|FG000|Run-In Period|Adverse Event|4|||
161305236|NCT02031640|582498960|FG001|Run-In Period|Adverse Event|0|||
161305237|NCT02031640|582498961|FG002|Run-In Period|Adverse Event|0|||
161305238|NCT02031640|582498962|FG003|Run-In Period|Adverse Event|0|||
161305239|NCT02031640|582498963|FG004|Run-In Period|Adverse Event|0|||
161305240|NCT02031640|582498964|FG005|Run-In Period|Adverse Event|0|||
161185543|NCT01828567|582056319|FG000|Overall Study|Lost to Follow-up|27|||
161305241|NCT02031640|582498959|FG000|Run-In Period|Withdrawal by Subject|17|||
161305242|NCT02031640|582498960|FG001|Run-In Period|Withdrawal by Subject|0|||
161305243|NCT02031640|582498961|FG002|Run-In Period|Withdrawal by Subject|0|||
161305244|NCT02031640|582498962|FG003|Run-In Period|Withdrawal by Subject|0|||
161185544|NCT01828567|582056320|FG001|Overall Study|Lost to Follow-up|9|||
161185545|NCT01828567|582056319|FG000|Overall Study|Excluded - did not meet criteria|4|||
161185546|NCT01828567|582056320|FG001|Overall Study|Excluded - did not meet criteria|1|||
161185547|NCT03325010|582056330|FG000|Overall Study|Adverse Event|3|||
161305245|NCT02031640|582498963|FG004|Run-In Period|Withdrawal by Subject|0|||
161185548|NCT03325010|582056331|FG001|Overall Study|Adverse Event|8|||
161185549|NCT03325010|582056330|FG000|Overall Study|Protocol Violation|1|||
161185550|NCT03325010|582056331|FG001|Overall Study|Protocol Violation|8|||
161185551|NCT03325010|582056330|FG000|Overall Study|Withdrawal by Subject|1|||
161185552|NCT03325010|582056331|FG001|Overall Study|Withdrawal by Subject|3|||
161185553|NCT03325010|582056330|FG000|Overall Study|Lost to Follow-up|1|||
161185554|NCT03325010|582056331|FG001|Overall Study|Lost to Follow-up|0|||
161185555|NCT03325010|582056330|FG000|Overall Study|Physician Decision|1|||
161185556|NCT03325010|582056331|FG001|Overall Study|Physician Decision|1|||
161185557|NCT03325010|582056330|FG000|Overall Study|Lack of Efficacy|2|||
161185558|NCT03325010|582056331|FG001|Overall Study|Lack of Efficacy|0|||
161185559|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
161185560|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
161185561|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
161185562|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
161185563|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
161185564|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161185565|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161185566|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
161185567|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
161185568|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
161185569|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
161185570|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
161185571|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
161185572|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
161185573|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
161185574|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
161185575|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
161185576|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
161185577|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
161185578|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
161185579|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
161185580|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161185581|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
161185582|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
161185583|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Screen failure|0|||
161185584|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Screen failure|1|||
161185585|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Screen failure|2|||
161185586|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Screen failure|0|||
161185587|NCT02614261|582056332|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
161185588|NCT02614261|582056333|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161185589|NCT02614261|582056334|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
161185590|NCT02614261|582056335|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
161185591|NCT02614261|582056332|FG000|Open-Label Extension Phase|Adverse Event|23|||
161185592|NCT02614261|582056333|FG001|Open-Label Extension Phase|Adverse Event|12|||
161185593|NCT02614261|582056334|FG002|Open-Label Extension Phase|Adverse Event|11|||
161185594|NCT02614261|582056335|FG003|Open-Label Extension Phase|Adverse Event|0|||
161185595|NCT02614261|582056332|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
161185596|NCT02614261|582056333|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
161185597|NCT02614261|582056334|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
161185598|NCT02614261|582056335|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
161185599|NCT02614261|582056332|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
161185600|NCT02614261|582056333|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
161185601|NCT02614261|582056334|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
161185602|NCT02614261|582056335|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
161185603|NCT02614261|582056332|FG000|Open-Label Extension Phase|Physician Decision|2|||
161185604|NCT02614261|582056333|FG001|Open-Label Extension Phase|Physician Decision|0|||
161185605|NCT02614261|582056334|FG002|Open-Label Extension Phase|Physician Decision|0|||
161185606|NCT02614261|582056335|FG003|Open-Label Extension Phase|Physician Decision|0|||
161185607|NCT02614261|582056332|FG000|Open-Label Extension Phase|Pregnancy|1|||
161185608|NCT02614261|582056333|FG001|Open-Label Extension Phase|Pregnancy|2|||
161185609|NCT02614261|582056334|FG002|Open-Label Extension Phase|Pregnancy|1|||
161185610|NCT02614261|582056335|FG003|Open-Label Extension Phase|Pregnancy|0|||
161185611|NCT02614261|582056332|FG000|Open-Label Extension Phase|Protocol Violation|3|||
161185612|NCT02614261|582056333|FG001|Open-Label Extension Phase|Protocol Violation|4|||
161185613|NCT02614261|582056334|FG002|Open-Label Extension Phase|Protocol Violation|1|||
161185614|NCT02614261|582056335|FG003|Open-Label Extension Phase|Protocol Violation|0|||
161185615|NCT02614261|582056332|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
161185616|NCT02614261|582056333|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
161185617|NCT02614261|582056334|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
161185618|NCT02614261|582056335|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
161185619|NCT02614261|582056332|FG000|Follow-up Phase|Adverse Event|2|||
161185620|NCT02614261|582056333|FG001|Follow-up Phase|Adverse Event|0|||
161185621|NCT02614261|582056334|FG002|Follow-up Phase|Adverse Event|1|||
161185622|NCT02614261|582056335|FG003|Follow-up Phase|Adverse Event|0|||
161185623|NCT02614261|582056332|FG000|Follow-up Phase|Lost to Follow-up|12|||
161185624|NCT02614261|582056333|FG001|Follow-up Phase|Lost to Follow-up|5|||
161185625|NCT02614261|582056334|FG002|Follow-up Phase|Lost to Follow-up|2|||
161185626|NCT02614261|582056335|FG003|Follow-up Phase|Lost to Follow-up|0|||
161185627|NCT02614261|582056332|FG000|Follow-up Phase|Physician Decision|5|||
161185628|NCT02614261|582056333|FG001|Follow-up Phase|Physician Decision|1|||
161185629|NCT02614261|582056334|FG002|Follow-up Phase|Physician Decision|0|||
161185630|NCT02614261|582056335|FG003|Follow-up Phase|Physician Decision|0|||
161185631|NCT02614261|582056332|FG000|Follow-up Phase|Pregnancy|0|||
161185632|NCT02614261|582056333|FG001|Follow-up Phase|Pregnancy|1|||
161185633|NCT02614261|582056334|FG002|Follow-up Phase|Pregnancy|0|||
161185634|NCT02614261|582056335|FG003|Follow-up Phase|Pregnancy|0|||
161185635|NCT02614261|582056332|FG000|Follow-up Phase|Protocol Violation|1|||
161185636|NCT02614261|582056333|FG001|Follow-up Phase|Protocol Violation|0|||
161185637|NCT02614261|582056334|FG002|Follow-up Phase|Protocol Violation|0|||
161185638|NCT02614261|582056335|FG003|Follow-up Phase|Protocol Violation|0|||
161185639|NCT02614261|582056332|FG000|Follow-up Phase|Withdrawal by Subject|12|||
161185640|NCT02614261|582056333|FG001|Follow-up Phase|Withdrawal by Subject|4|||
161185641|NCT02614261|582056334|FG002|Follow-up Phase|Withdrawal by Subject|11|||
161185642|NCT02614261|582056335|FG003|Follow-up Phase|Withdrawal by Subject|0|||
161185643|NCT02614261|582056332|FG000|Israel Addendum|Withdrawal by Subject|0|||
161185644|NCT02614261|582056333|FG001|Israel Addendum|Withdrawal by Subject|0|||
161185645|NCT02614261|582056334|FG002|Israel Addendum|Withdrawal by Subject|0|||
161185646|NCT02614261|582056335|FG003|Israel Addendum|Withdrawal by Subject|4|||
161185647|NCT01060124|582056337|FG000|Overall Study|Other|16|||
161185648|NCT01060124|582056337|FG000|Overall Study|Adverse Event|14|||
161185649|NCT01060124|582056337|FG000|Overall Study|Withdrawal by Subject|7|||
161185650|NCT03858686|582056340|FG000|Period 1|Adverse Event|1|||
161185651|NCT03858686|582056341|FG001|Period 1|Adverse Event|1|||
161185652|NCT03858686|582056340|FG000|Period 1|Lack of compliance|0|||
161185653|NCT03858686|582056341|FG001|Period 1|Lack of compliance|1|||
161185654|NCT03858686|582056340|FG000|Period 1|Adverse Event|0|||
161185655|NCT03858686|582056341|FG001|Period 1|Adverse Event|1|||
161185656|NCT03858686|582056340|FG000|Period 2|Adverse Event|0|||
161185657|NCT03858686|582056341|FG001|Period 2|Adverse Event|1|||
161185658|NCT00102804|582056342|FG000|Overall Study|Progressive Disease (PD)|307|||
161185659|NCT00102804|582056343|FG001|Overall Study|Progressive Disease (PD)|196|||
161185660|NCT00102804|582056342|FG000|Overall Study|Withdrawal by Subject|46|||
161185661|NCT00102804|582056343|FG001|Overall Study|Withdrawal by Subject|7|||
161185662|NCT00102804|582056342|FG000|Overall Study|Adverse Event|37|||
161185663|NCT00102804|582056343|FG001|Overall Study|Adverse Event|3|||
161185664|NCT00102804|582056342|FG000|Overall Study|Physician Decision|24|||
161185665|NCT00102804|582056343|FG001|Overall Study|Physician Decision|6|||
161185666|NCT00102804|582056342|FG000|Overall Study|Death|5|||
161185667|NCT00102804|582056343|FG001|Overall Study|Death|6|||
161185668|NCT00102804|582056342|FG000|Overall Study|Enrollment Criteria Not Met|6|||
161185669|NCT00102804|582056343|FG001|Overall Study|Enrollment Criteria Not Met|0|||
161185670|NCT00102804|582056342|FG000|Overall Study|Lost to Follow-up|4|||
161185671|NCT00102804|582056343|FG001|Overall Study|Lost to Follow-up|1|||
161185672|NCT00102804|582056342|FG000|Overall Study|Protocol Violation|2|||
161185673|NCT00102804|582056343|FG001|Overall Study|Protocol Violation|1|||
161185674|NCT00102804|582056342|FG000|Overall Study|Satisfactory Response|2|||
161185675|NCT00102804|582056343|FG001|Overall Study|Satisfactory Response|0|||
161185676|NCT00102804|582056342|FG000|Overall Study|Sponsor Decision|1|||
161185677|NCT00102804|582056343|FG001|Overall Study|Sponsor Decision|0|||
161305246|NCT02031640|582498964|FG005|Run-In Period|Withdrawal by Subject|0|||
161305247|NCT02031640|582498959|FG000|Run-In Period|Inclusion criteria not met|38|||
161305248|NCT02031640|582498960|FG001|Run-In Period|Inclusion criteria not met|0|||
161305249|NCT02031640|582498961|FG002|Run-In Period|Inclusion criteria not met|0|||
161305250|NCT02031640|582498962|FG003|Run-In Period|Inclusion criteria not met|0|||
161305251|NCT02031640|582498963|FG004|Run-In Period|Inclusion criteria not met|0|||
161185678|NCT00102804|582056342|FG000|Overall Study|Alive, Receiving Treatment|7|||
161185679|NCT00102804|582056343|FG001|Overall Study|Alive, Receiving Treatment|2|||
161305252|NCT02031640|582498964|FG005|Run-In Period|Inclusion criteria not met|0|||
161305253|NCT02031640|582498959|FG000|Run-In Period|Exclusion criteria met|8|||
161185680|NCT00518336|582056350|FG000|Year 7|Lost to Follow-up|2|||
161185681|NCT00518336|582056351|FG001|Year 7|Lost to Follow-up|0|||
161185682|NCT00518336|582056350|FG000|Year 7|Could not attend in time|0|||
161185683|NCT00518336|582056351|FG001|Year 7|Could not attend in time|3|||
161185684|NCT00518336|582056350|FG000|Year 8|Lost to Follow-up|1|||
161305254|NCT02031640|582498960|FG001|Run-In Period|Exclusion criteria met|0|||
161185685|NCT00518336|582056351|FG001|Year 8|Lost to Follow-up|1|||
161185686|NCT00518336|582056350|FG000|Year 8|Could not attend in time|0|||
161185687|NCT00518336|582056351|FG001|Year 8|Could not attend in time|1|||
161185688|NCT00518336|582056350|FG000|Year 9|Migrated/moved from study area|1|||
161185689|NCT00518336|582056351|FG001|Year 9|Migrated/moved from study area|1|||
161185690|NCT00518336|582056350|FG000|Year 9|Lost to Follow-up|3|||
161185691|NCT00518336|582056351|FG001|Year 9|Lost to Follow-up|0|||
161305255|NCT02031640|582498961|FG002|Run-In Period|Exclusion criteria met|0|||
161305256|NCT02031640|582498962|FG003|Run-In Period|Exclusion criteria met|0|||
161305257|NCT02031640|582498963|FG004|Run-In Period|Exclusion criteria met|0|||
161305258|NCT02031640|582498964|FG005|Run-In Period|Exclusion criteria met|0|||
161305259|NCT02031640|582498959|FG000|Run-In Period|Randomization criteria not met|85|||
161305260|NCT02031640|582498960|FG001|Run-In Period|Randomization criteria not met|0|||
161305261|NCT02031640|582498961|FG002|Run-In Period|Randomization criteria not met|0|||
161305262|NCT02031640|582498962|FG003|Run-In Period|Randomization criteria not met|0|||
161305263|NCT02031640|582498963|FG004|Run-In Period|Randomization criteria not met|0|||
161305264|NCT02031640|582498964|FG005|Run-In Period|Randomization criteria not met|0|||
161305265|NCT02031640|582498959|FG000|Run-In Period|Various administrative reasons|17|||
161305266|NCT02031640|582498960|FG001|Run-In Period|Various administrative reasons|0|||
161305267|NCT02031640|582498961|FG002|Run-In Period|Various administrative reasons|0|||
161305268|NCT02031640|582498962|FG003|Run-In Period|Various administrative reasons|0|||
161305269|NCT02031640|582498963|FG004|Run-In Period|Various administrative reasons|0|||
161305270|NCT02031640|582498964|FG005|Run-In Period|Various administrative reasons|0|||
161305271|NCT02031640|582498959|FG000|Double-blind Treatment Period|Protocol deviation|0|||
161305272|NCT02031640|582498960|FG001|Double-blind Treatment Period|Protocol deviation|2|||
161305273|NCT02031640|582498961|FG002|Double-blind Treatment Period|Protocol deviation|0|||
161305274|NCT02031640|582498962|FG003|Double-blind Treatment Period|Protocol deviation|1|||
161305275|NCT02031640|582498963|FG004|Double-blind Treatment Period|Protocol deviation|3|||
161089941|NCT00116753|581719859|FG002|Overall Study|Abnormal Echocardiogram|1|||
161089942|NCT00116753|581719857|FG000|Overall Study|Progressive Parkinson's Disease|1|||
161089943|NCT00116753|581719858|FG001|Overall Study|Progressive Parkinson's Disease|0|||
161089944|NCT00116753|581719859|FG002|Overall Study|Progressive Parkinson's Disease|0|||
161089945|NCT00116753|581719857|FG000|Overall Study|Dosing Error|0|||
161089946|NCT00116753|581719858|FG001|Overall Study|Dosing Error|1|||
161089947|NCT00116753|581719859|FG002|Overall Study|Dosing Error|0|||
161089948|NCT01200589|581719860|FG000|Overall Study|Withdrawal by Subject|13|||
161089949|NCT01200589|581719861|FG001|Overall Study|Withdrawal by Subject|11|||
161089950|NCT01200589|581719860|FG000|Overall Study|Physician Decision|2|||
161089951|NCT01200589|581719861|FG001|Overall Study|Physician Decision|2|||
161089952|NCT01200589|581719860|FG000|Overall Study|Lost to Follow-up|5|||
161089953|NCT01200589|581719861|FG001|Overall Study|Lost to Follow-up|4|||
161089954|NCT01200589|581719860|FG000|Overall Study|Study terminated|170|||
161089955|NCT01200589|581719861|FG001|Overall Study|Study terminated|172|||
161089956|NCT00986973|581719862|FG000|Overall Study|Withdrawn by study team|1|||
161089957|NCT00598273|581719863|FG000|Overall Study|Adverse Event|4|||
161089958|NCT00598273|581719864|FG001|Overall Study|Adverse Event|5|||
161089959|NCT00598273|581719865|FG002|Overall Study|Adverse Event|2|||
161089960|NCT00598273|581719863|FG000|Overall Study|Death|6|||
161089961|NCT00598273|581719864|FG001|Overall Study|Death|12|||
161089962|NCT00598273|581719865|FG002|Overall Study|Death|8|||
161089963|NCT00598273|581719863|FG000|Overall Study|Lost to Follow-up|8|||
161089964|NCT00598273|581719864|FG001|Overall Study|Lost to Follow-up|3|||
161089965|NCT00598273|581719865|FG002|Overall Study|Lost to Follow-up|5|||
161089966|NCT00598273|581719863|FG000|Overall Study|Physician Decision|0|||
161089967|NCT00598273|581719864|FG001|Overall Study|Physician Decision|0|||
161089968|NCT00598273|581719865|FG002|Overall Study|Physician Decision|1|||
161089969|NCT00598273|581719863|FG000|Overall Study|Withdrawal by Subject|12|||
161089970|NCT00598273|581719864|FG001|Overall Study|Withdrawal by Subject|10|||
161089971|NCT00598273|581719865|FG002|Overall Study|Withdrawal by Subject|10|||
161089972|NCT00598273|581719863|FG000|Overall Study|Noncompliance|3|||
161089973|NCT00598273|581719864|FG001|Overall Study|Noncompliance|2|||
161089974|NCT00598273|581719865|FG002|Overall Study|Noncompliance|3|||
161089975|NCT00598273|581719863|FG000|Overall Study|Relocation|0|||
161089976|NCT00598273|581719864|FG001|Overall Study|Relocation|2|||
161089977|NCT00598273|581719865|FG002|Overall Study|Relocation|4|||
161089978|NCT00598273|581719863|FG000|Overall Study|Renal transplant|1|||
161089979|NCT00598273|581719864|FG001|Overall Study|Renal transplant|0|||
161089980|NCT00598273|581719865|FG002|Overall Study|Renal transplant|1|||
161089981|NCT00598273|581719863|FG000|Overall Study|Site elected to close|1|||
161089982|NCT00598273|581719864|FG001|Overall Study|Site elected to close|0|||
161089983|NCT00598273|581719865|FG002|Overall Study|Site elected to close|0|||
161089984|NCT00598273|581719863|FG000|Overall Study|Started dialysis|6|||
161089985|NCT00598273|581719864|FG001|Overall Study|Started dialysis|4|||
161089986|NCT00598273|581719865|FG002|Overall Study|Started dialysis|5|||
161089987|NCT01590082|581719866|FG000|Overall Study|Withdrawal by Subject|1|||
161089988|NCT01590082|581719867|FG001|Overall Study|Withdrawal by Subject|0|||
161089989|NCT01590082|581719866|FG000|Overall Study|Ineligible|1|||
161089990|NCT01590082|581719867|FG001|Overall Study|Ineligible|0|||
161089991|NCT02549196|581719868|FG000|Overall Study|Protocol Violation|0|||
161089992|NCT02549196|581719869|FG001|Overall Study|Protocol Violation|0|||
161089993|NCT02549196|581719870|FG002|Overall Study|Protocol Violation|0|||
161089994|NCT02549196|581719871|FG003|Overall Study|Protocol Violation|1|||
161089995|NCT02549196|581719868|FG000|Overall Study|Withdrawal by Subject|1|||
161089996|NCT02549196|581719869|FG001|Overall Study|Withdrawal by Subject|0|||
161185692|NCT00518336|582056350|FG000|Year 9|Personal reasons|1|||
161185693|NCT00518336|582056351|FG001|Year 9|Personal reasons|0|||
161185694|NCT03399786|582056352|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
161185695|NCT03399786|582056353|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161185696|NCT03399786|582056354|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161185697|NCT03399786|582056355|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
161185698|NCT03399786|582056352|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161185699|NCT03399786|582056353|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161185700|NCT03399786|582056354|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
161185701|NCT03399786|582056355|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
161185702|NCT03399786|582056352|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161185703|NCT03399786|582056353|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161185704|NCT03399786|582056354|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
161185705|NCT03399786|582056355|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
161185706|NCT04167514|582057632|FG000|Overall Study|Adverse event, not serious|0|||
161185707|NCT04167514|582057633|FG001|Overall Study|Adverse event, not serious|1|||
161185708|NCT04167514|582057632|FG000|Overall Study|Lost to Follow-up|1|||
161185709|NCT04167514|582057633|FG001|Overall Study|Lost to Follow-up|0|||
161185710|NCT04167514|582057632|FG000|Overall Study|Participant Decision|2|||
161185711|NCT04167514|582057633|FG001|Overall Study|Participant Decision|4|||
161185712|NCT04167514|582057632|FG000|Overall Study|Physician Decision|3|||
161185713|NCT04167514|582057633|FG001|Overall Study|Physician Decision|2|||
161185714|NCT04167514|582057632|FG000|Overall Study|Death|14|||
161185715|NCT04167514|582057633|FG001|Overall Study|Death|18|||
161185716|NCT04167514|582057632|FG000|Overall Study|Enrolled but treatment not administered|2|||
161185717|NCT04167514|582057633|FG001|Overall Study|Enrolled but treatment not administered|0|||
161185718|NCT04167514|582057632|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
161185719|NCT04167514|582057633|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
161185720|NCT04167514|582057632|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
161185721|NCT04167514|582057633|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
161185722|NCT03225833|582057636|FG000|Overall Study|Adverse Event|0|||
161185723|NCT03225833|582057637|FG001|Overall Study|Adverse Event|1|||
161185724|NCT03225833|582057638|FG002|Overall Study|Adverse Event|2|||
161185725|NCT03225833|582057639|FG003|Overall Study|Adverse Event|0|||
161185726|NCT03225833|582057640|FG004|Overall Study|Adverse Event|0|||
161185727|NCT03225833|582057641|FG005|Overall Study|Adverse Event|2|||
161185728|NCT03225833|582057636|FG000|Overall Study|Withdrawal by Subject|1|||
161185729|NCT03225833|582057637|FG001|Overall Study|Withdrawal by Subject|0|||
161185730|NCT03225833|582057638|FG002|Overall Study|Withdrawal by Subject|0|||
161185731|NCT03225833|582057639|FG003|Overall Study|Withdrawal by Subject|0|||
161185732|NCT03225833|582057640|FG004|Overall Study|Withdrawal by Subject|1|||
161185733|NCT03225833|582057641|FG005|Overall Study|Withdrawal by Subject|0|||
161185734|NCT03225833|582057636|FG000|Overall Study|Termination of Study by Sponsor|4|||
161185735|NCT03225833|582057637|FG001|Overall Study|Termination of Study by Sponsor|0|||
161185736|NCT03225833|582057638|FG002|Overall Study|Termination of Study by Sponsor|0|||
161185737|NCT03225833|582057639|FG003|Overall Study|Termination of Study by Sponsor|0|||
161185738|NCT03225833|582057640|FG004|Overall Study|Termination of Study by Sponsor|0|||
161185739|NCT03225833|582057641|FG005|Overall Study|Termination of Study by Sponsor|7|||
161185740|NCT03225833|582057636|FG000|Overall Study|Sponsor Decision|0|||
161185741|NCT03225833|582057637|FG001|Overall Study|Sponsor Decision|0|||
161185742|NCT03225833|582057638|FG002|Overall Study|Sponsor Decision|0|||
161185743|NCT03225833|582057639|FG003|Overall Study|Sponsor Decision|0|||
161185744|NCT03225833|582057640|FG004|Overall Study|Sponsor Decision|0|||
161185745|NCT03225833|582057641|FG005|Overall Study|Sponsor Decision|1|||
161185746|NCT06029127|582057643|FG000|Overall Study|Withdrawal by Subject|2|||
161185747|NCT06029127|582057644|FG001|Overall Study|Withdrawal by Subject|0|||
161185748|NCT06029127|582057643|FG000|Overall Study|Lost to Follow-up|1|||
161185749|NCT06029127|582057644|FG001|Overall Study|Lost to Follow-up|0|||
161185750|NCT06029127|582057643|FG000|Overall Study|Study Closed by Sponsor|6|||
161185751|NCT06029127|582057644|FG001|Overall Study|Study Closed by Sponsor|6|||
161185752|NCT06029127|582057643|FG000|Overall Study|Death|12|||
161185753|NCT06029127|582057644|FG001|Overall Study|Death|7|||
161185754|NCT06029127|582057643|FG000|Overall Study|Declined Follow-Up Contact|0|||
161185755|NCT06029127|582057644|FG001|Overall Study|Declined Follow-Up Contact|1|||
161185756|NCT01625000|582057645|FG000|Overall Study|Physician Decision|15|||
161185757|NCT01625000|582057646|FG001|Overall Study|Physician Decision|7|||
161185758|NCT01625000|582057647|FG002|Overall Study|Physician Decision|7|||
161185759|NCT01625000|582057648|FG003|Overall Study|Physician Decision|2|||
161185760|NCT01625000|582057649|FG004|Overall Study|Physician Decision|15|||
161305276|NCT02031640|582498964|FG005|Double-blind Treatment Period|Protocol deviation|1|||
161305277|NCT02031640|582498959|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
161185761|NCT01625000|582057645|FG000|Overall Study|Protocol Violation|3|||
161185762|NCT01625000|582057646|FG001|Overall Study|Protocol Violation|10|||
161185763|NCT01625000|582057647|FG002|Overall Study|Protocol Violation|4|||
161185764|NCT01625000|582057648|FG003|Overall Study|Protocol Violation|1|||
161185765|NCT01625000|582057649|FG004|Overall Study|Protocol Violation|2|||
161185766|NCT01625000|582057645|FG000|Overall Study|Withdrawal by Subject|19|||
161185767|NCT01625000|582057646|FG001|Overall Study|Withdrawal by Subject|16|||
161185768|NCT01625000|582057647|FG002|Overall Study|Withdrawal by Subject|11|||
161185769|NCT01625000|582057648|FG003|Overall Study|Withdrawal by Subject|9|||
161185770|NCT01625000|582057649|FG004|Overall Study|Withdrawal by Subject|17|||
161185771|NCT01625000|582057645|FG000|Overall Study|Adverse Event (including Death)|15|||
161185772|NCT01625000|582057646|FG001|Overall Study|Adverse Event (including Death)|19|||
161185773|NCT01625000|582057647|FG002|Overall Study|Adverse Event (including Death)|11|||
161185774|NCT01625000|582057648|FG003|Overall Study|Adverse Event (including Death)|7|||
161185775|NCT01625000|582057649|FG004|Overall Study|Adverse Event (including Death)|21|||
161185776|NCT03912064|582057650|FG000|Overall Study|Withdrawal by Subject|2|||
161185777|NCT03912064|582057651|FG001|Overall Study|Withdrawal by Subject|0|||
161185778|NCT03912064|582057652|FG002|Overall Study|Withdrawal by Subject|0|||
161185779|NCT03912064|582057650|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
161185780|NCT03912064|582057651|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
161185781|NCT03912064|582057652|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
161185782|NCT03912064|582057650|FG000|Overall Study|Progression/Relapse|7|||
161185783|NCT03912064|582057651|FG001|Overall Study|Progression/Relapse|3|||
161185784|NCT03912064|582057652|FG002|Overall Study|Progression/Relapse|0|||
161185785|NCT03912064|582057650|FG000|Overall Study|Prolonged treatment delays|3|||
161185786|NCT03912064|582057651|FG001|Overall Study|Prolonged treatment delays|2|||
161185787|NCT03912064|582057652|FG002|Overall Study|Prolonged treatment delays|0|||
161185788|NCT03912064|582057650|FG000|Overall Study|Prohibited concomitant treatments|3|||
161185789|NCT03912064|582057651|FG001|Overall Study|Prohibited concomitant treatments|1|||
161185790|NCT03912064|582057652|FG002|Overall Study|Prohibited concomitant treatments|0|||
161185791|NCT01026194|582057653|FG000|Period 1：Double Blind Period|Adverse Event|2|||
161185792|NCT01026194|582057654|FG001|Period 1：Double Blind Period|Adverse Event|1|||
161185793|NCT01026194|582057653|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
161185794|NCT01026194|582057654|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
161185795|NCT01026194|582057653|FG000|Period 1：Double Blind Period|Physician Decision|0|||
161185796|NCT01026194|582057654|FG001|Period 1：Double Blind Period|Physician Decision|4|||
161185797|NCT01026194|582057653|FG000|Period 2：Open-label Period|Adverse Event|4|||
161185798|NCT01026194|582057654|FG001|Period 2：Open-label Period|Adverse Event|5|||
161185799|NCT01026194|582057653|FG000|Period 2：Open-label Period|Physician Decision|3|||
161185800|NCT01026194|582057654|FG001|Period 2：Open-label Period|Physician Decision|1|||
161185801|NCT01026194|582057653|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
161185802|NCT01026194|582057654|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
161185803|NCT05740566|582057655|FG000|Overall Study|Death|151|||
161185804|NCT05740566|582057656|FG001|Overall Study|Death|111|||
161185805|NCT05740566|582057655|FG000|Overall Study|Withdrawal by Subject|2|||
161185806|NCT05740566|582057656|FG001|Overall Study|Withdrawal by Subject|0|||
161185807|NCT05740566|582057655|FG000|Overall Study|Ongoing in study|102|||
161185808|NCT05740566|582057656|FG001|Overall Study|Ongoing in study|143|||
161185809|NCT00829010|582057659|FG000|Overall Study|Adverse Event|1|||
161185810|NCT00829010|582057660|FG001|Overall Study|Adverse Event|0|||
161185811|NCT00829010|582057661|FG002|Overall Study|Adverse Event|0|||
161185812|NCT00829010|582057662|FG003|Overall Study|Adverse Event|0|||
161185813|NCT00829010|582057663|FG004|Overall Study|Adverse Event|0|||
161185814|NCT00829010|582057659|FG000|Overall Study|Withdrawal by Subject|0|||
161185815|NCT00829010|582057660|FG001|Overall Study|Withdrawal by Subject|1|||
161185816|NCT00829010|582057661|FG002|Overall Study|Withdrawal by Subject|1|||
161185817|NCT00829010|582057662|FG003|Overall Study|Withdrawal by Subject|0|||
161185818|NCT00829010|582057663|FG004|Overall Study|Withdrawal by Subject|2|||
161185819|NCT00829010|582057659|FG000|Overall Study|Lost to Follow-up|1|||
161185820|NCT00829010|582057660|FG001|Overall Study|Lost to Follow-up|0|||
161185821|NCT00829010|582057661|FG002|Overall Study|Lost to Follow-up|2|||
161185822|NCT00829010|582057662|FG003|Overall Study|Lost to Follow-up|0|||
161185823|NCT00829010|582057663|FG004|Overall Study|Lost to Follow-up|0|||
161185824|NCT00829010|582057659|FG000|Overall Study|Fatality|5|||
161185825|NCT00829010|582057660|FG001|Overall Study|Fatality|4|||
161185826|NCT00829010|582057661|FG002|Overall Study|Fatality|0|||
161185827|NCT00829010|582057662|FG003|Overall Study|Fatality|3|||
161185828|NCT00829010|582057663|FG004|Overall Study|Fatality|0|||
161185829|NCT00829010|582057659|FG000|Overall Study|Migrated/Moved from study area|3|||
161185830|NCT00829010|582057660|FG001|Overall Study|Migrated/Moved from study area|4|||
161185831|NCT00829010|582057661|FG002|Overall Study|Migrated/Moved from study area|0|||
161185832|NCT00829010|582057662|FG003|Overall Study|Migrated/Moved from study area|5|||
161185833|NCT00829010|582057663|FG004|Overall Study|Migrated/Moved from study area|0|||
161185834|NCT06210035|582057664|FG000|Overall Study|Withdrawal by Subject|3|||
161185835|NCT06210035|582057665|FG001|Overall Study|Withdrawal by Subject|0|||
161185836|NCT06210035|582057666|FG002|Overall Study|Withdrawal by Subject|0|||
161305278|NCT02031640|582498960|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
161305279|NCT02031640|582498961|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
161305280|NCT02031640|582498962|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
161305281|NCT02031640|582498963|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
161305282|NCT02031640|582498964|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
161305283|NCT02031640|582498959|FG000|Double-blind Treatment Period|Non-compliance|0|||
161185837|NCT01029691|582057667|FG000|Continued APAP to Delivery|Death|0|||
161185838|NCT01029691|582057668|FG001|Continued APAP to Delivery|Death|0|||
161185839|NCT01029691|582057669|FG002|Continued APAP to Delivery|Death|1|||
161185840|NCT05492877|582057674|FG000|Overall Study|Adverse Event|11|||
161185841|NCT05492877|582057675|FG001|Overall Study|Adverse Event|7|||
161185842|NCT05492877|582057674|FG000|Overall Study|Death|1|||
161185843|NCT05492877|582057675|FG001|Overall Study|Death|0|||
161185844|NCT05492877|582057674|FG000|Overall Study|Lost to Follow-up|1|||
161185845|NCT05492877|582057675|FG001|Overall Study|Lost to Follow-up|1|||
161185846|NCT05492877|582057674|FG000|Overall Study|Physician Decision|1|||
161185847|NCT05492877|582057675|FG001|Overall Study|Physician Decision|2|||
161185848|NCT05492877|582057674|FG000|Overall Study|Protocol Violation|1|||
161185849|NCT05492877|582057675|FG001|Overall Study|Protocol Violation|1|||
161185850|NCT05492877|582057674|FG000|Overall Study|Withdrawal by Subject|3|||
161185851|NCT05492877|582057675|FG001|Overall Study|Withdrawal by Subject|7|||
161185852|NCT05492877|582057674|FG000|Overall Study|Reason not specified|6|||
161185853|NCT05492877|582057675|FG001|Overall Study|Reason not specified|4|||
161185854|NCT03737318|582057678|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
161185855|NCT03737318|582057679|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
161185856|NCT03737318|582057680|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
161185857|NCT04554394|582057681|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
161185858|NCT04554394|582057682|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
161185859|NCT04554394|582057681|FG000|Overall Study|Withdrawal by Subject|2|||
161185860|NCT04554394|582057682|FG001|Overall Study|Withdrawal by Subject|2|||
161185861|NCT04554394|582057681|FG000|Overall Study|Lost to Follow-up|2|||
161185862|NCT04554394|582057682|FG001|Overall Study|Lost to Follow-up|2|||
161185863|NCT04554394|582057681|FG000|Overall Study|Physician Decision|1|||
161185864|NCT04554394|582057682|FG001|Overall Study|Physician Decision|1|||
161185865|NCT00886587|582057683|FG000|Overall Study|Adverse Event|2|||
161185866|NCT00886587|582057684|FG001|Overall Study|Adverse Event|1|||
161185867|NCT00886587|582057683|FG000|Overall Study|Protocol Violation|2|||
161185868|NCT00886587|582057684|FG001|Overall Study|Protocol Violation|0|||
161185869|NCT00886587|582057683|FG000|Overall Study|Withdrawal by Subject|0|||
161185870|NCT00886587|582057684|FG001|Overall Study|Withdrawal by Subject|1|||
161185871|NCT00398086|582057688|FG000|Overall Study|Unacceptable Toxicity|2|||
161185872|NCT00398086|582057689|FG001|Overall Study|Unacceptable Toxicity|8|||
161185873|NCT00398086|582057690|FG002|Overall Study|Unacceptable Toxicity|2|||
161185874|NCT00398086|582057688|FG000|Overall Study|Adverse Event|1|||
161185875|NCT00398086|582057689|FG001|Overall Study|Adverse Event|4|||
161185876|NCT00398086|582057690|FG002|Overall Study|Adverse Event|0|||
161185877|NCT00398086|582057688|FG000|Overall Study|Physician Decision|1|||
161185878|NCT00398086|582057689|FG001|Overall Study|Physician Decision|4|||
161185879|NCT00398086|582057690|FG002|Overall Study|Physician Decision|0|||
161185880|NCT00398086|582057688|FG000|Overall Study|Withdrawal by Subject|5|||
161185881|NCT00398086|582057689|FG001|Overall Study|Withdrawal by Subject|7|||
161185882|NCT00398086|582057690|FG002|Overall Study|Withdrawal by Subject|0|||
161185883|NCT00696774|582057691|FG000|Period II|Adverse Event|0|||
161185884|NCT00696774|582057692|FG001|Period II|Adverse Event|0|||
161185885|NCT00696774|582057693|FG002|Period II|Adverse Event|15|||
161185886|NCT00696774|582057691|FG000|Period II|Lost to Follow-up|0|||
161185887|NCT00696774|582057692|FG001|Period II|Lost to Follow-up|0|||
161185888|NCT00696774|582057693|FG002|Period II|Lost to Follow-up|4|||
161185889|NCT00696774|582057691|FG000|Period II|Protocol Violation|0|||
161185890|NCT00696774|582057692|FG001|Period II|Protocol Violation|0|||
161185891|NCT00696774|582057693|FG002|Period II|Protocol Violation|11|||
161185892|NCT00696774|582057691|FG000|Period II|Withdrawal by Subject|0|||
161185893|NCT00696774|582057692|FG001|Period II|Withdrawal by Subject|0|||
161185894|NCT00696774|582057693|FG002|Period II|Withdrawal by Subject|4|||
161185895|NCT00696774|582057691|FG000|Period II|Sponsor Decision|0|||
161185896|NCT00696774|582057692|FG001|Period II|Sponsor Decision|0|||
161185897|NCT00696774|582057693|FG002|Period II|Sponsor Decision|0|||
161185898|NCT00696774|582057691|FG000|Period II|Lack of Efficacy|0|||
161185899|NCT00696774|582057692|FG001|Period II|Lack of Efficacy|0|||
161185900|NCT00696774|582057693|FG002|Period II|Lack of Efficacy|2|||
161185901|NCT00696774|582057691|FG000|Period III|Adverse Event|1|||
161185902|NCT00696774|582057692|FG001|Period III|Adverse Event|1|||
161185903|NCT00696774|582057693|FG002|Period III|Adverse Event|0|||
161185904|NCT00696774|582057691|FG000|Period III|Lost to Follow-up|2|||
161185905|NCT00696774|582057692|FG001|Period III|Lost to Follow-up|1|||
161185906|NCT00696774|582057693|FG002|Period III|Lost to Follow-up|0|||
161185907|NCT00696774|582057691|FG000|Period III|Protocol Violation|1|||
161185908|NCT00696774|582057692|FG001|Period III|Protocol Violation|1|||
161185909|NCT00696774|582057693|FG002|Period III|Protocol Violation|0|||
161185910|NCT00696774|582057691|FG000|Period III|Withdrawal by Subject|1|||
161185911|NCT00696774|582057692|FG001|Period III|Withdrawal by Subject|2|||
161185912|NCT00696774|582057693|FG002|Period III|Withdrawal by Subject|0|||
161185913|NCT00696774|582057691|FG000|Period III|Sponsor Decision|2|||
161185914|NCT00696774|582057692|FG001|Period III|Sponsor Decision|0|||
161185915|NCT00696774|582057693|FG002|Period III|Sponsor Decision|0|||
161185916|NCT00696774|582057691|FG000|Period III|Lack of Efficacy|0|||
161185917|NCT00696774|582057692|FG001|Period III|Lack of Efficacy|2|||
161185918|NCT00696774|582057693|FG002|Period III|Lack of Efficacy|0|||
161185919|NCT01021553|582057694|FG000|Overall Study|Adverse Event|1|||
161185920|NCT01021553|582057695|FG001|Overall Study|Adverse Event|0|||
161185921|NCT01021553|582057696|FG002|Overall Study|Adverse Event|0|||
161185922|NCT01021553|582057694|FG000|Overall Study|Lack of Efficacy|2|||
161185923|NCT01021553|582057695|FG001|Overall Study|Lack of Efficacy|2|||
161185924|NCT01021553|582057696|FG002|Overall Study|Lack of Efficacy|0|||
161185925|NCT01021553|582057694|FG000|Overall Study|Protocol Violation|0|||
161185926|NCT01021553|582057695|FG001|Overall Study|Protocol Violation|2|||
161185927|NCT01021553|582057696|FG002|Overall Study|Protocol Violation|2|||
161185928|NCT01021553|582057694|FG000|Overall Study|Lost to Follow-up|0|||
161185929|NCT01021553|582057695|FG001|Overall Study|Lost to Follow-up|0|||
161185930|NCT01021553|582057696|FG002|Overall Study|Lost to Follow-up|1|||
161185931|NCT01021553|582057694|FG000|Overall Study|Withdrawal by Subject|1|||
161185932|NCT01021553|582057695|FG001|Overall Study|Withdrawal by Subject|1|||
161185933|NCT01021553|582057696|FG002|Overall Study|Withdrawal by Subject|0|||
161185934|NCT01950364|582057697|FG000|Overall Study|Adverse Event|3|||
161185935|NCT01950364|582057698|FG001|Overall Study|Adverse Event|0|||
161185936|NCT01950364|582057697|FG000|Overall Study|Stem Cell Transplant|2|||
161185937|NCT01950364|582057698|FG001|Overall Study|Stem Cell Transplant|6|||
161185938|NCT01950364|582057697|FG000|Overall Study|Disease Progression|5|||
161185939|NCT01950364|582057698|FG001|Overall Study|Disease Progression|2|||
161185940|NCT01950364|582057697|FG000|Overall Study|Withdrawal by Subject|0|||
161185941|NCT01950364|582057698|FG001|Overall Study|Withdrawal by Subject|1|||
161185942|NCT01950364|582057697|FG000|Overall Study|Protocol Violation|0|||
161185943|NCT01950364|582057698|FG001|Overall Study|Protocol Violation|1|||
161185944|NCT00033293|582057705|FG000|Overall Study|Death|0|||
161185945|NCT00033293|582057706|FG001|Overall Study|Death|1|||
161185946|NCT00033293|582057705|FG000|Overall Study|Lack of Efficacy|5|||
161185947|NCT00033293|582057706|FG001|Overall Study|Lack of Efficacy|8|||
161185948|NCT00033293|582057705|FG000|Overall Study|Lost to Follow-up|0|||
161185949|NCT00033293|582057706|FG001|Overall Study|Lost to Follow-up|1|||
161185950|NCT00033293|582057705|FG000|Overall Study|Physician Decision|3|||
161185951|NCT00033293|582057706|FG001|Overall Study|Physician Decision|1|||
161185952|NCT00033293|582057705|FG000|Overall Study|Withdrawal by Subject|1|||
161185953|NCT00033293|582057706|FG001|Overall Study|Withdrawal by Subject|0|||
161185954|NCT00033293|582057705|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
161185955|NCT00033293|582057706|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
161185956|NCT00033293|582057705|FG000|Overall Study|Treatment refused|0|||
161185957|NCT00033293|582057706|FG001|Overall Study|Treatment refused|6|||
161185958|NCT00935701|582057707|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
161185959|NCT02087241|582057708|FG000|Overall Study|Death|2|||
161185960|NCT02087241|582057709|FG001|Overall Study|Death|1|||
161185961|NCT02087241|582057710|FG002|Overall Study|Death|1|||
161185962|NCT02087241|582057711|FG003|Overall Study|Death|1|||
161185963|NCT02087241|582057708|FG000|Overall Study|Withdrawal by Subject|1|||
161185964|NCT02087241|582057709|FG001|Overall Study|Withdrawal by Subject|0|||
161185965|NCT02087241|582057710|FG002|Overall Study|Withdrawal by Subject|0|||
161185966|NCT02087241|582057711|FG003|Overall Study|Withdrawal by Subject|1|||
161185967|NCT02087241|582057708|FG000|Overall Study|Progressive Disease|0|||
161185968|NCT02087241|582057709|FG001|Overall Study|Progressive Disease|0|||
161185969|NCT02087241|582057710|FG002|Overall Study|Progressive Disease|0|||
161185970|NCT02087241|582057711|FG003|Overall Study|Progressive Disease|1|||
161185971|NCT02087241|582057708|FG000|Overall Study|Study Terminated by Sponsor|0|||
161185972|NCT02087241|582057709|FG001|Overall Study|Study Terminated by Sponsor|2|||
161185973|NCT02087241|582057710|FG002|Overall Study|Study Terminated by Sponsor|0|||
161185974|NCT02087241|582057711|FG003|Overall Study|Study Terminated by Sponsor|4|||
161185975|NCT01955005|582057712|FG000|Overall Study|Withdrawal by Subject|3|||
161185976|NCT01955005|582057713|FG001|Overall Study|Withdrawal by Subject|5|||
161185977|NCT00836953|582057714|FG000|Overall Study|Withdrawal by Subject|1|||
161185978|NCT00836953|582057714|FG000|Overall Study|Lost to Follow-up|1|||
161185979|NCT01200758|582057715|FG000|Stage I|Death|0|||
161305284|NCT02031640|582498960|FG001|Double-blind Treatment Period|Non-compliance|1|||
161185980|NCT01200758|582057716|FG001|Stage I|Death|1|||
161185981|NCT01200758|582057717|FG002|Stage I|Death|0|||
161185982|NCT01200758|582057718|FG003|Stage I|Death|0|||
161185983|NCT01200758|582057715|FG000|Stage I|Physician Decision|1|||
161185984|NCT01200758|582057716|FG001|Stage I|Physician Decision|1|||
161185985|NCT01200758|582057717|FG002|Stage I|Physician Decision|0|||
161185986|NCT01200758|582057718|FG003|Stage I|Physician Decision|0|||
161185987|NCT01200758|582057715|FG000|Stage I|Lack of Efficacy|2|||
161185988|NCT01200758|582057716|FG001|Stage I|Lack of Efficacy|1|||
161185989|NCT01200758|582057717|FG002|Stage I|Lack of Efficacy|0|||
161185990|NCT01200758|582057718|FG003|Stage I|Lack of Efficacy|0|||
161185991|NCT01200758|582057715|FG000|Stage I|Adverse Event|5|||
161185992|NCT01200758|582057716|FG001|Stage I|Adverse Event|5|||
161185993|NCT01200758|582057717|FG002|Stage I|Adverse Event|0|||
161185994|NCT01200758|582057718|FG003|Stage I|Adverse Event|0|||
161185995|NCT01200758|582057715|FG000|Stage I|Withdrawal by Subject|1|||
161185996|NCT01200758|582057716|FG001|Stage I|Withdrawal by Subject|2|||
161185997|NCT01200758|582057717|FG002|Stage I|Withdrawal by Subject|0|||
161185998|NCT01200758|582057718|FG003|Stage I|Withdrawal by Subject|0|||
161185999|NCT01200758|582057715|FG000|Stage I|Disease Progression|9|||
161186000|NCT01200758|582057716|FG001|Stage I|Disease Progression|7|||
161186001|NCT01200758|582057717|FG002|Stage I|Disease Progression|0|||
161186002|NCT01200758|582057718|FG003|Stage I|Disease Progression|0|||
161186003|NCT01200758|582057715|FG000|Stage 2|Disease Progression|0|||
161186004|NCT01200758|582057716|FG001|Stage 2|Disease Progression|0|||
161186005|NCT01200758|582057717|FG002|Stage 2|Disease Progression|16|||
161186006|NCT01200758|582057718|FG003|Stage 2|Disease Progression|21|||
161186007|NCT01200758|582057715|FG000|Stage 2|Lack of Efficacy|0|||
161186008|NCT01200758|582057716|FG001|Stage 2|Lack of Efficacy|0|||
161186009|NCT01200758|582057717|FG002|Stage 2|Lack of Efficacy|4|||
161186010|NCT01200758|582057718|FG003|Stage 2|Lack of Efficacy|2|||
161186011|NCT01200758|582057715|FG000|Stage 2|Physician Decision|0|||
161186012|NCT01200758|582057716|FG001|Stage 2|Physician Decision|0|||
161186013|NCT01200758|582057717|FG002|Stage 2|Physician Decision|5|||
161186014|NCT01200758|582057718|FG003|Stage 2|Physician Decision|7|||
161186015|NCT01200758|582057715|FG000|Stage 2|Adverse Event|0|||
161186016|NCT01200758|582057716|FG001|Stage 2|Adverse Event|0|||
161186017|NCT01200758|582057717|FG002|Stage 2|Adverse Event|5|||
161186018|NCT01200758|582057718|FG003|Stage 2|Adverse Event|9|||
161186019|NCT01200758|582057715|FG000|Stage 2|Withdrawal by Subject|0|||
161186020|NCT01200758|582057716|FG001|Stage 2|Withdrawal by Subject|0|||
161186021|NCT01200758|582057717|FG002|Stage 2|Withdrawal by Subject|4|||
161186022|NCT01200758|582057718|FG003|Stage 2|Withdrawal by Subject|1|||
161186023|NCT01200758|582057715|FG000|Stage 2|Lost to Follow-up|0|||
161186024|NCT01200758|582057716|FG001|Stage 2|Lost to Follow-up|0|||
161186025|NCT01200758|582057717|FG002|Stage 2|Lost to Follow-up|3|||
161186026|NCT01200758|582057718|FG003|Stage 2|Lost to Follow-up|1|||
161186027|NCT01200758|582057715|FG000|Stage 2|Protocol Violation|0|||
161186028|NCT01200758|582057716|FG001|Stage 2|Protocol Violation|0|||
161186029|NCT01200758|582057717|FG002|Stage 2|Protocol Violation|1|||
161186030|NCT01200758|582057718|FG003|Stage 2|Protocol Violation|4|||
161186031|NCT01200758|582057715|FG000|Stage 2|Death|0|||
161186032|NCT01200758|582057716|FG001|Stage 2|Death|0|||
161186033|NCT01200758|582057717|FG002|Stage 2|Death|3|||
161186034|NCT01200758|582057718|FG003|Stage 2|Death|5|||
161186035|NCT02711553|582057721|FG000|Overall Study|Withdrawal by Subject|2|||
161186036|NCT02711553|582057722|FG001|Overall Study|Withdrawal by Subject|1|||
161186037|NCT02711553|582057723|FG002|Overall Study|Withdrawal by Subject|1|||
161186038|NCT02711553|582057724|FG003|Overall Study|Withdrawal by Subject|0|||
161186039|NCT02711553|582057721|FG000|Overall Study|Lost to Follow-up|3|||
161186040|NCT02711553|582057722|FG001|Overall Study|Lost to Follow-up|3|||
161186041|NCT02711553|582057723|FG002|Overall Study|Lost to Follow-up|6|||
161186042|NCT02711553|582057724|FG003|Overall Study|Lost to Follow-up|3|||
161186043|NCT02711553|582057721|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
161186044|NCT02711553|582057722|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
161186045|NCT02711553|582057723|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
161186046|NCT02711553|582057724|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
161186047|NCT04048876|582057731|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
161186048|NCT04048876|582057732|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
161186049|NCT04048876|582057733|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
161186050|NCT04048876|582057734|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
161186051|NCT04048876|582057731|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
161186052|NCT04048876|582057732|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
161186053|NCT04048876|582057733|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
161186054|NCT04048876|582057734|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
161186055|NCT04048876|582057731|FG000|Placebo Controlled Phase|Adverse Event|0|||
161186056|NCT04048876|582057732|FG001|Placebo Controlled Phase|Adverse Event|1|||
161186057|NCT04048876|582057733|FG002|Placebo Controlled Phase|Adverse Event|0|||
161186058|NCT04048876|582057734|FG003|Placebo Controlled Phase|Adverse Event|0|||
161186059|NCT04048876|582057731|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
161186060|NCT04048876|582057732|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
161305285|NCT02031640|582498961|FG002|Double-blind Treatment Period|Non-compliance|0|||
161186061|NCT04048876|582057733|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
161186062|NCT04048876|582057734|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
161186063|NCT04063865|582057740|FG000|Overall Study|Physician Decision|1|||
161186064|NCT04063865|582057741|FG001|Overall Study|Physician Decision|3|||
161186065|NCT04063865|582057740|FG000|Overall Study|Study Closed Prior to Completion|4|||
161186066|NCT04063865|582057741|FG001|Overall Study|Study Closed Prior to Completion|4|||
161186067|NCT04063865|582057740|FG000|Overall Study|Withdrawal by Subject|1|||
161186068|NCT04063865|582057741|FG001|Overall Study|Withdrawal by Subject|1|||
161186069|NCT00320190|582057742|FG000|First 12 Months|Completed but did not enter extension|5|||
161186070|NCT00320190|582057743|FG001|First 12 Months|Completed but did not enter extension|3|||
161186071|NCT00320190|582057742|FG000|First 12 Months|Sponsor terminated study|2|||
161186072|NCT00320190|582057743|FG001|First 12 Months|Sponsor terminated study|2|||
161186073|NCT00320190|582057742|FG000|First 12 Months|Lost to Follow-up|0|||
161186074|NCT00320190|582057743|FG001|First 12 Months|Lost to Follow-up|1|||
161186075|NCT00320190|582057742|FG000|First 12 Months|Enrollment failure|0|||
161186076|NCT00320190|582057743|FG001|First 12 Months|Enrollment failure|1|||
161186077|NCT00320190|582057742|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
161186078|NCT00320190|582057743|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
161186079|NCT00320190|582057742|FG000|First 12 Months|Investigator request|0|||
161186080|NCT00320190|582057743|FG001|First 12 Months|Investigator request|1|||
161186081|NCT00320190|582057742|FG000|First 12 Months|Study drug toxicity|0|||
161186082|NCT00320190|582057743|FG001|First 12 Months|Study drug toxicity|1|||
161186083|NCT00320190|582057742|FG000|First 12 Months|Withdrawal by Subject|0|||
161186084|NCT00320190|582057743|FG001|First 12 Months|Withdrawal by Subject|1|||
161186085|NCT00320190|582057742|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
161186086|NCT00320190|582057743|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
161186087|NCT00320190|582057742|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
161186088|NCT00320190|582057743|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
161186089|NCT00320190|582057742|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
161186090|NCT00320190|582057743|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
161186091|NCT03053180|582058906|FG000|Overall Study|Failure to Return|1|||
161186092|NCT01465958|582058911|FG000|Run-in Phase|Protocol Violation|1|||
161186093|NCT01465958|582058912|FG001|Run-in Phase|Protocol Violation|0|||
161186094|NCT01465958|582058911|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
161186095|NCT01465958|582058912|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
161186096|NCT00211536|582058915|FG000|Overall Study|Withdrawal by Subject|2|||
161186097|NCT00211536|582058916|FG001|Overall Study|Withdrawal by Subject|2|||
161186098|NCT00211536|582058915|FG000|Overall Study|Physician Decision|0|||
161186099|NCT00211536|582058916|FG001|Overall Study|Physician Decision|5|||
161186100|NCT00211536|582058915|FG000|Overall Study|Adverse Event|2|||
161186101|NCT00211536|582058916|FG001|Overall Study|Adverse Event|0|||
161186102|NCT02583399|582058917|FG000|Overall Study|Able to be discharged|3|||
161186103|NCT02583399|582058917|FG000|Overall Study|Wanted to use a restricted medication|3|||
161186104|NCT01004861|582058918|FG000|Overall Study|Disease progression|3|||
161186105|NCT01004861|582058919|FG001|Overall Study|Disease progression|4|||
161186106|NCT01004861|582058920|FG002|Overall Study|Disease progression|5|||
161186107|NCT01004861|582058921|FG003|Overall Study|Disease progression|4|||
161186108|NCT01004861|582058922|FG004|Overall Study|Disease progression|4|||
161186109|NCT01004861|582058923|FG005|Overall Study|Disease progression|4|||
161186110|NCT01004861|582058924|FG006|Overall Study|Disease progression|5|||
161186111|NCT01004861|582058925|FG007|Overall Study|Disease progression|1|||
161186112|NCT01004861|582058926|FG008|Overall Study|Disease progression|4|||
161186113|NCT01004861|582058927|FG009|Overall Study|Disease progression|7|||
161186114|NCT01004861|582058928|FG010|Overall Study|Disease progression|6|||
161186115|NCT01004861|582058929|FG011|Overall Study|Disease progression|3|||
161186116|NCT01004861|582058930|FG012|Overall Study|Disease progression|8|||
161186117|NCT01004861|582058918|FG000|Overall Study|Physician Decision|0|||
161186118|NCT01004861|582058919|FG001|Overall Study|Physician Decision|2|||
161186119|NCT01004861|582058920|FG002|Overall Study|Physician Decision|1|||
161186120|NCT01004861|582058921|FG003|Overall Study|Physician Decision|1|||
161186121|NCT01004861|582058922|FG004|Overall Study|Physician Decision|1|||
161186122|NCT01004861|582058923|FG005|Overall Study|Physician Decision|0|||
161186123|NCT01004861|582058924|FG006|Overall Study|Physician Decision|0|||
161186124|NCT01004861|582058925|FG007|Overall Study|Physician Decision|1|||
161186125|NCT01004861|582058926|FG008|Overall Study|Physician Decision|0|||
161186126|NCT01004861|582058927|FG009|Overall Study|Physician Decision|0|||
161305286|NCT02031640|582498962|FG003|Double-blind Treatment Period|Non-compliance|1|||
161305287|NCT02031640|582498963|FG004|Double-blind Treatment Period|Non-compliance|1|||
161305288|NCT02031640|582498964|FG005|Double-blind Treatment Period|Non-compliance|0|||
161186127|NCT01004861|582058928|FG010|Overall Study|Physician Decision|0|||
161186128|NCT01004861|582058929|FG011|Overall Study|Physician Decision|0|||
161186129|NCT01004861|582058930|FG012|Overall Study|Physician Decision|3|||
161186130|NCT01004861|582058918|FG000|Overall Study|Adverse Event|0|||
161186131|NCT01004861|582058919|FG001|Overall Study|Adverse Event|0|||
161186132|NCT01004861|582058920|FG002|Overall Study|Adverse Event|0|||
161186133|NCT01004861|582058921|FG003|Overall Study|Adverse Event|1|||
161186134|NCT01004861|582058922|FG004|Overall Study|Adverse Event|0|||
161186135|NCT01004861|582058923|FG005|Overall Study|Adverse Event|2|||
161186136|NCT01004861|582058924|FG006|Overall Study|Adverse Event|1|||
161186137|NCT01004861|582058925|FG007|Overall Study|Adverse Event|1|||
161186138|NCT01004861|582058926|FG008|Overall Study|Adverse Event|13|||
161348468|NCT01163617|582660028|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161348469|NCT01163617|582660029|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
161348470|NCT01163617|582660022|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348471|NCT01163617|582660023|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
161348472|NCT01163617|582660024|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348473|NCT01163617|582660025|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348474|NCT01163617|582660026|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348475|NCT01163617|582660027|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348476|NCT01163617|582660028|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348477|NCT01163617|582660029|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
161348478|NCT01163617|582660022|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348479|NCT01163617|582660023|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348480|NCT01163617|582660024|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
161348481|NCT01163617|582660025|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348482|NCT01163617|582660026|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348483|NCT01163617|582660027|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348484|NCT01163617|582660028|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348485|NCT01163617|582660029|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
161348486|NCT02875080|582660030|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
161348487|NCT02875080|582660031|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
161348488|NCT02875080|582660032|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
161348489|NCT02394756|582660033|FG000|Period 1|Lens Discomfort|0|||
161348490|NCT02394756|582660034|FG001|Period 1|Lens Discomfort|0|||
161348491|NCT02394756|582660035|FG002|Period 1|Lens Discomfort|0|||
161089997|NCT02549196|581719870|FG002|Overall Study|Withdrawal by Subject|1|||
161089998|NCT02549196|581719871|FG003|Overall Study|Withdrawal by Subject|0|||
161089999|NCT01442779|581719872|FG000|Overall Study|Withdrawal by Subject|3|||
161090000|NCT01442779|581719872|FG000|Overall Study|Death|3|||
161090001|NCT01442779|581719872|FG000|Overall Study|Non-compliance|1|||
161090002|NCT05249829|581719873|FG000|Overall Study|Participant Relocation|0|||
161090003|NCT05249829|581719874|FG001|Overall Study|Participant Relocation|1|||
161348492|NCT02394756|582660036|FG003|Period 1|Lens Discomfort|0|||
161348493|NCT02394756|582660037|FG004|Period 1|Lens Discomfort|0|||
161348494|NCT02394756|582660038|FG005|Period 1|Lens Discomfort|1|||
161348495|NCT02394756|582660033|FG000|Period 1|Withdrawal by Subject|0|||
161348496|NCT02394756|582660034|FG001|Period 1|Withdrawal by Subject|1|||
161348497|NCT02394756|582660035|FG002|Period 1|Withdrawal by Subject|1|||
161348498|NCT02394756|582660036|FG003|Period 1|Withdrawal by Subject|1|||
161348499|NCT02394756|582660037|FG004|Period 1|Withdrawal by Subject|0|||
161348500|NCT02394756|582660038|FG005|Period 1|Withdrawal by Subject|0|||
161348501|NCT02394756|582660033|FG000|Period 2|Unsatisfactory Visual Response|0|||
161348502|NCT02394756|582660034|FG001|Period 2|Unsatisfactory Visual Response|0|||
161348503|NCT02394756|582660035|FG002|Period 2|Unsatisfactory Visual Response|0|||
161348504|NCT02394756|582660036|FG003|Period 2|Unsatisfactory Visual Response|0|||
161348505|NCT02394756|582660037|FG004|Period 2|Unsatisfactory Visual Response|1|||
161348506|NCT02394756|582660038|FG005|Period 2|Unsatisfactory Visual Response|0|||
161348507|NCT03018938|582660039|FG000|Overall Study|Death|0|||
161348508|NCT03018938|582660040|FG001|Overall Study|Death|1|||
161348509|NCT03018938|582660039|FG000|Overall Study|Lost to Follow-up|21|||
161348510|NCT03018938|582660040|FG001|Overall Study|Lost to Follow-up|32|||
161348511|NCT03018938|582660039|FG000|Overall Study|Withdrawal by Subject|38|||
161348512|NCT03018938|582660040|FG001|Overall Study|Withdrawal by Subject|45|||
161348513|NCT03018938|582660039|FG000|Overall Study|Physician Decision|3|||
161348514|NCT03018938|582660040|FG001|Overall Study|Physician Decision|2|||
161348515|NCT03018938|582660039|FG000|Overall Study|Sponsor Decision|0|||
161348516|NCT03018938|582660040|FG001|Overall Study|Sponsor Decision|1|||
161348517|NCT03018938|582660039|FG000|Overall Study|Screen failure-After randomization|4|||
161348518|NCT03018938|582660040|FG001|Overall Study|Screen failure-After randomization|2|||
161348519|NCT03018938|582660039|FG000|Overall Study|Not recorded|0|||
161348520|NCT03018938|582660040|FG001|Overall Study|Not recorded|2|||
161348521|NCT00191100|582660041|FG000|Overall Study|Adverse Event|18|||
161348522|NCT00191100|582660042|FG001|Overall Study|Adverse Event|1|||
161348523|NCT00191100|582660041|FG000|Overall Study|Lost to Follow-up|2|||
161348524|NCT00191100|582660042|FG001|Overall Study|Lost to Follow-up|0|||
161348525|NCT00191100|582660041|FG000|Overall Study|Patient Moved|0|||
161348526|NCT00191100|582660042|FG001|Overall Study|Patient Moved|1|||
161348527|NCT00191100|582660041|FG000|Overall Study|Withdrawal by Subject|9|||
161348528|NCT00191100|582660042|FG001|Overall Study|Withdrawal by Subject|3|||
161348529|NCT00191100|582660041|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
161090004|NCT05249829|581719875|FG002|Overall Study|Participant Relocation|2|||
161090005|NCT05249829|581719876|FG003|Overall Study|Participant Relocation|2|||
161186139|NCT01004861|582058927|FG009|Overall Study|Adverse Event|1|||
161186140|NCT01004861|582058928|FG010|Overall Study|Adverse Event|1|||
161186141|NCT01004861|582058929|FG011|Overall Study|Adverse Event|0|||
161186142|NCT01004861|582058930|FG012|Overall Study|Adverse Event|2|||
161186143|NCT01004861|582058918|FG000|Overall Study|Protocol Violation|0|||
161186144|NCT01004861|582058919|FG001|Overall Study|Protocol Violation|0|||
161186145|NCT01004861|582058920|FG002|Overall Study|Protocol Violation|0|||
161186146|NCT01004861|582058921|FG003|Overall Study|Protocol Violation|0|||
161186147|NCT01004861|582058922|FG004|Overall Study|Protocol Violation|1|||
161186148|NCT01004861|582058923|FG005|Overall Study|Protocol Violation|0|||
161186149|NCT01004861|582058924|FG006|Overall Study|Protocol Violation|0|||
161186150|NCT01004861|582058925|FG007|Overall Study|Protocol Violation|0|||
161186151|NCT01004861|582058926|FG008|Overall Study|Protocol Violation|0|||
161186152|NCT01004861|582058927|FG009|Overall Study|Protocol Violation|0|||
161186153|NCT01004861|582058928|FG010|Overall Study|Protocol Violation|0|||
161186154|NCT01004861|582058929|FG011|Overall Study|Protocol Violation|0|||
161186155|NCT01004861|582058930|FG012|Overall Study|Protocol Violation|0|||
161186156|NCT01004861|582058918|FG000|Overall Study|Lost to Follow-up|0|||
161186157|NCT01004861|582058919|FG001|Overall Study|Lost to Follow-up|0|||
161186158|NCT01004861|582058920|FG002|Overall Study|Lost to Follow-up|0|||
161186159|NCT01004861|582058921|FG003|Overall Study|Lost to Follow-up|0|||
161186160|NCT01004861|582058922|FG004|Overall Study|Lost to Follow-up|0|||
161186161|NCT01004861|582058923|FG005|Overall Study|Lost to Follow-up|0|||
161186162|NCT01004861|582058924|FG006|Overall Study|Lost to Follow-up|0|||
161186163|NCT01004861|582058925|FG007|Overall Study|Lost to Follow-up|1|||
161186164|NCT01004861|582058926|FG008|Overall Study|Lost to Follow-up|3|||
161186165|NCT01004861|582058927|FG009|Overall Study|Lost to Follow-up|0|||
161186166|NCT01004861|582058928|FG010|Overall Study|Lost to Follow-up|0|||
161186167|NCT01004861|582058929|FG011|Overall Study|Lost to Follow-up|1|||
161186168|NCT01004861|582058930|FG012|Overall Study|Lost to Follow-up|0|||
161186169|NCT01004861|582058918|FG000|Overall Study|Non-compliance|0|||
161186170|NCT01004861|582058919|FG001|Overall Study|Non-compliance|0|||
161186171|NCT01004861|582058920|FG002|Overall Study|Non-compliance|0|||
161186172|NCT01004861|582058921|FG003|Overall Study|Non-compliance|0|||
161186173|NCT01004861|582058922|FG004|Overall Study|Non-compliance|0|||
161186174|NCT01004861|582058923|FG005|Overall Study|Non-compliance|0|||
161186175|NCT01004861|582058924|FG006|Overall Study|Non-compliance|0|||
161186176|NCT01004861|582058925|FG007|Overall Study|Non-compliance|0|||
161186177|NCT01004861|582058926|FG008|Overall Study|Non-compliance|5|||
161186178|NCT01004861|582058927|FG009|Overall Study|Non-compliance|0|||
161186179|NCT01004861|582058928|FG010|Overall Study|Non-compliance|0|||
161186180|NCT01004861|582058929|FG011|Overall Study|Non-compliance|0|||
161186181|NCT01004861|582058930|FG012|Overall Study|Non-compliance|1|||
161186182|NCT01004861|582058918|FG000|Overall Study|Other|0|||
161186183|NCT01004861|582058919|FG001|Overall Study|Other|0|||
161186184|NCT01004861|582058920|FG002|Overall Study|Other|0|||
161186185|NCT01004861|582058921|FG003|Overall Study|Other|0|||
161186186|NCT01004861|582058922|FG004|Overall Study|Other|0|||
161186187|NCT01004861|582058923|FG005|Overall Study|Other|0|||
161186188|NCT01004861|582058924|FG006|Overall Study|Other|0|||
161186189|NCT01004861|582058925|FG007|Overall Study|Other|0|||
161186190|NCT01004861|582058926|FG008|Overall Study|Other|0|||
161186191|NCT01004861|582058927|FG009|Overall Study|Other|2|||
161186192|NCT01004861|582058928|FG010|Overall Study|Other|1|||
161186193|NCT01004861|582058929|FG011|Overall Study|Other|2|||
161186194|NCT01004861|582058930|FG012|Overall Study|Other|3|||
161186195|NCT01004861|582058918|FG000|Overall Study|Patient decision|0|||
161186196|NCT01004861|582058919|FG001|Overall Study|Patient decision|0|||
161186197|NCT01004861|582058920|FG002|Overall Study|Patient decision|0|||
161186198|NCT01004861|582058921|FG003|Overall Study|Patient decision|0|||
161186199|NCT01004861|582058922|FG004|Overall Study|Patient decision|1|||
161186200|NCT01004861|582058923|FG005|Overall Study|Patient decision|0|||
161186201|NCT01004861|582058924|FG006|Overall Study|Patient decision|1|||
161186202|NCT01004861|582058925|FG007|Overall Study|Patient decision|0|||
161186203|NCT01004861|582058926|FG008|Overall Study|Patient decision|7|||
161305289|NCT02031640|582498959|FG000|Double-blind Treatment Period|Adverse Event|0|||
161305290|NCT02031640|582498960|FG001|Double-blind Treatment Period|Adverse Event|0|||
161305291|NCT02031640|582498961|FG002|Double-blind Treatment Period|Adverse Event|0|||
161305292|NCT02031640|582498962|FG003|Double-blind Treatment Period|Adverse Event|2|||
161186204|NCT01004861|582058927|FG009|Overall Study|Patient decision|1|||
161186205|NCT01004861|582058928|FG010|Overall Study|Patient decision|1|||
161186206|NCT01004861|582058929|FG011|Overall Study|Patient decision|2|||
161186207|NCT01004861|582058930|FG012|Overall Study|Patient decision|3|||
161186208|NCT01004861|582058918|FG000|Overall Study|Transitioned to Phase 4 study|0|||
161186209|NCT01004861|582058919|FG001|Overall Study|Transitioned to Phase 4 study|0|||
161186210|NCT01004861|582058920|FG002|Overall Study|Transitioned to Phase 4 study|0|||
161186211|NCT01004861|582058921|FG003|Overall Study|Transitioned to Phase 4 study|0|||
161186212|NCT01004861|582058922|FG004|Overall Study|Transitioned to Phase 4 study|0|||
161186213|NCT01004861|582058923|FG005|Overall Study|Transitioned to Phase 4 study|0|||
161186214|NCT01004861|582058924|FG006|Overall Study|Transitioned to Phase 4 study|0|||
161348530|NCT00191100|582660042|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
161348531|NCT00191100|582660041|FG000|Overall Study|Clinical Relapse|2|||
161348532|NCT00191100|582660042|FG001|Overall Study|Clinical Relapse|1|||
161348533|NCT00191100|582660041|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
161348534|NCT00191100|582660042|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
161348535|NCT00191100|582660041|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
161348536|NCT00191100|582660042|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
161348537|NCT00191100|582660041|FG000|Overall Study|Physician Decision|3|||
161348538|NCT00191100|582660042|FG001|Overall Study|Physician Decision|1|||
161348539|NCT00191100|582660041|FG000|Overall Study|Death from Study Drug Toxicity|2|||
161348540|NCT00191100|582660042|FG001|Overall Study|Death from Study Drug Toxicity|0|||
161348541|NCT00191100|582660041|FG000|Overall Study|Protocol Violation|1|||
161348542|NCT00191100|582660042|FG001|Overall Study|Protocol Violation|1|||
161348543|NCT00191100|582660041|FG000|Overall Study|Death from Other Cause|1|||
161348544|NCT00191100|582660042|FG001|Overall Study|Death from Other Cause|0|||
161348545|NCT00191100|582660041|FG000|Overall Study|Reason Not Specified|0|||
161348546|NCT00191100|582660042|FG001|Overall Study|Reason Not Specified|1|||
161348547|NCT02872714|582660058|FG000|Overall Study|Progressive Disease|1|||
161348548|NCT02872714|582660059|FG001|Overall Study|Progressive Disease|2|||
161348549|NCT02872714|582660060|FG002|Overall Study|Progressive Disease|0|||
161348550|NCT02872714|582660061|FG003|Overall Study|Progressive Disease|0|||
161348551|NCT02872714|582660062|FG004|Overall Study|Progressive Disease|0|||
161348552|NCT02872714|582660058|FG000|Overall Study|Death|87|||
161348553|NCT02872714|582660059|FG001|Overall Study|Death|36|||
161348554|NCT02872714|582660060|FG002|Overall Study|Death|8|||
161348555|NCT02872714|582660061|FG003|Overall Study|Death|81|||
161348556|NCT02872714|582660062|FG004|Overall Study|Death|2|||
161348557|NCT02872714|582660058|FG000|Overall Study|Lost to Follow-up|2|||
161348558|NCT02872714|582660059|FG001|Overall Study|Lost to Follow-up|1|||
161348559|NCT02872714|582660060|FG002|Overall Study|Lost to Follow-up|0|||
161348560|NCT02872714|582660061|FG003|Overall Study|Lost to Follow-up|3|||
161348561|NCT02872714|582660062|FG004|Overall Study|Lost to Follow-up|0|||
161348562|NCT02872714|582660058|FG000|Overall Study|Physician Decision|0|||
161348563|NCT02872714|582660059|FG001|Overall Study|Physician Decision|0|||
161348564|NCT02872714|582660060|FG002|Overall Study|Physician Decision|0|||
161348565|NCT02872714|582660061|FG003|Overall Study|Physician Decision|1|||
161348566|NCT02872714|582660062|FG004|Overall Study|Physician Decision|0|||
161186215|NCT01004861|582058925|FG007|Overall Study|Transitioned to Phase 4 study|0|||
161186216|NCT01004861|582058926|FG008|Overall Study|Transitioned to Phase 4 study|2|||
161186217|NCT01004861|582058927|FG009|Overall Study|Transitioned to Phase 4 study|0|||
161186218|NCT01004861|582058928|FG010|Overall Study|Transitioned to Phase 4 study|0|||
161186219|NCT01004861|582058929|FG011|Overall Study|Transitioned to Phase 4 study|0|||
161186220|NCT01004861|582058930|FG012|Overall Study|Transitioned to Phase 4 study|0|||
161186221|NCT01004861|582058918|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186222|NCT01004861|582058919|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186223|NCT01004861|582058920|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186224|NCT01004861|582058921|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186225|NCT01004861|582058922|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186226|NCT01004861|582058923|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186227|NCT01004861|582058924|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186228|NCT01004861|582058925|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186229|NCT01004861|582058926|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
161186230|NCT01004861|582058927|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186231|NCT01004861|582058928|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186232|NCT01004861|582058929|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186233|NCT01004861|582058930|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
161186234|NCT01004861|582058918|FG000|Overall Study|Patient withdrew|0|||
161186235|NCT01004861|582058919|FG001|Overall Study|Patient withdrew|0|||
161186236|NCT01004861|582058920|FG002|Overall Study|Patient withdrew|0|||
161186237|NCT01004861|582058921|FG003|Overall Study|Patient withdrew|0|||
161186238|NCT01004861|582058922|FG004|Overall Study|Patient withdrew|0|||
161186239|NCT01004861|582058923|FG005|Overall Study|Patient withdrew|0|||
161348567|NCT02872714|582660058|FG000|Overall Study|Withdrawal by Subject|1|||
161348568|NCT02872714|582660059|FG001|Overall Study|Withdrawal by Subject|3|||
161348569|NCT02872714|582660060|FG002|Overall Study|Withdrawal by Subject|0|||
161348570|NCT02872714|582660061|FG003|Overall Study|Withdrawal by Subject|2|||
161348571|NCT02872714|582660062|FG004|Overall Study|Withdrawal by Subject|0|||
161348572|NCT02872714|582660058|FG000|Overall Study|Captured as Other|2|||
161348573|NCT02872714|582660059|FG001|Overall Study|Captured as Other|0|||
161348574|NCT02872714|582660060|FG002|Overall Study|Captured as Other|0|||
161186240|NCT01004861|582058924|FG006|Overall Study|Patient withdrew|0|||
161186241|NCT01004861|582058925|FG007|Overall Study|Patient withdrew|0|||
161186242|NCT01004861|582058926|FG008|Overall Study|Patient withdrew|1|||
161186243|NCT01004861|582058927|FG009|Overall Study|Patient withdrew|0|||
161186244|NCT01004861|582058928|FG010|Overall Study|Patient withdrew|0|||
161186245|NCT01004861|582058929|FG011|Overall Study|Patient withdrew|0|||
161186246|NCT01004861|582058930|FG012|Overall Study|Patient withdrew|0|||
161186247|NCT01004861|582058918|FG000|Overall Study|Surgical resection|0|||
161186248|NCT01004861|582058919|FG001|Overall Study|Surgical resection|0|||
161186249|NCT01004861|582058920|FG002|Overall Study|Surgical resection|0|||
161186250|NCT01004861|582058921|FG003|Overall Study|Surgical resection|0|||
161186251|NCT01004861|582058922|FG004|Overall Study|Surgical resection|0|||
161186252|NCT01004861|582058923|FG005|Overall Study|Surgical resection|0|||
161186253|NCT01004861|582058924|FG006|Overall Study|Surgical resection|0|||
161186254|NCT01004861|582058925|FG007|Overall Study|Surgical resection|0|||
161186255|NCT01004861|582058926|FG008|Overall Study|Surgical resection|1|||
161186256|NCT01004861|582058927|FG009|Overall Study|Surgical resection|0|||
161186257|NCT01004861|582058928|FG010|Overall Study|Surgical resection|0|||
161186258|NCT01004861|582058929|FG011|Overall Study|Surgical resection|0|||
161186259|NCT01004861|582058930|FG012|Overall Study|Surgical resection|0|||
161186260|NCT01004861|582058918|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186261|NCT01004861|582058919|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186262|NCT01004861|582058920|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186263|NCT01004861|582058921|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186264|NCT01004861|582058922|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186265|NCT01004861|582058923|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186266|NCT01004861|582058924|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186267|NCT01004861|582058925|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186268|NCT01004861|582058926|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
161186269|NCT01004861|582058927|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186270|NCT01004861|582058928|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186271|NCT01004861|582058929|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186272|NCT01004861|582058930|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
161186273|NCT01004861|582058918|FG000|Overall Study|Study termination by Sponsor|0|||
161186274|NCT01004861|582058919|FG001|Overall Study|Study termination by Sponsor|0|||
161186275|NCT01004861|582058920|FG002|Overall Study|Study termination by Sponsor|0|||
161186276|NCT01004861|582058921|FG003|Overall Study|Study termination by Sponsor|0|||
161186277|NCT01004861|582058922|FG004|Overall Study|Study termination by Sponsor|0|||
161186278|NCT01004861|582058923|FG005|Overall Study|Study termination by Sponsor|0|||
161186279|NCT01004861|582058924|FG006|Overall Study|Study termination by Sponsor|0|||
161186280|NCT01004861|582058925|FG007|Overall Study|Study termination by Sponsor|0|||
161186281|NCT01004861|582058926|FG008|Overall Study|Study termination by Sponsor|1|||
161186282|NCT01004861|582058927|FG009|Overall Study|Study termination by Sponsor|0|||
161186283|NCT01004861|582058928|FG010|Overall Study|Study termination by Sponsor|0|||
161186284|NCT01004861|582058929|FG011|Overall Study|Study termination by Sponsor|0|||
161186285|NCT01004861|582058930|FG012|Overall Study|Study termination by Sponsor|0|||
161186286|NCT04610827|582058932|FG000|Overall Study|Withdrawal by Subject|1|||
161186287|NCT04610827|582058933|FG001|Overall Study|Withdrawal by Subject|1|||
161186288|NCT04610827|582058934|FG002|Overall Study|Withdrawal by Subject|0|||
161186289|NCT01823991|582058935|FG000|Overall Study|Withdrawal by Subject|8|||
161186290|NCT01823991|582058936|FG001|Overall Study|Withdrawal by Subject|5|||
161305293|NCT02031640|582498963|FG004|Double-blind Treatment Period|Adverse Event|0|||
161305294|NCT02031640|582498964|FG005|Double-blind Treatment Period|Adverse Event|0|||
161305295|NCT02031640|582498959|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
161186291|NCT00805194|582058937|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
161186292|NCT00805194|582058938|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
161186293|NCT00805194|582058937|FG000|Overall Study|Worsening or AE of underlying disease|64|||
161186294|NCT00805194|582058938|FG001|Overall Study|Worsening or AE of underlying disease|70|||
161186295|NCT00805194|582058937|FG000|Overall Study|Other AE|84|||
161186296|NCT00805194|582058938|FG001|Overall Study|Other AE|73|||
161186297|NCT00805194|582058937|FG000|Overall Study|Protocol Violation|9|||
161186298|NCT00805194|582058938|FG001|Overall Study|Protocol Violation|9|||
161186299|NCT00805194|582058937|FG000|Overall Study|Lost to Follow-up|5|||
161186300|NCT00805194|582058938|FG001|Overall Study|Lost to Follow-up|5|||
161186301|NCT00805194|582058937|FG000|Overall Study|Withdrawal by Subject|60|||
161186302|NCT00805194|582058938|FG001|Overall Study|Withdrawal by Subject|42|||
161186303|NCT00805194|582058937|FG000|Overall Study|Not treated|3|||
161186304|NCT00805194|582058938|FG001|Overall Study|Not treated|4|||
161186305|NCT00805194|582058937|FG000|Overall Study|Reasons other than stated above|20|||
161305296|NCT02031640|582498960|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161348575|NCT02872714|582660061|FG003|Overall Study|Captured as Other|1|||
161186306|NCT00805194|582058938|FG001|Overall Study|Reasons other than stated above|16|||
161186307|NCT02185040|582058942|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
161186308|NCT02185040|582058943|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
161186309|NCT02185040|582058944|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
161186310|NCT02185040|582058945|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
161186311|NCT02185040|582058946|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
161186312|NCT02185040|582058947|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
161186313|NCT02185040|582058948|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
161186314|NCT02185040|582058942|FG000|Part 1 Treatment Phase|Adverse Event|1|||
161186315|NCT02185040|582058943|FG001|Part 1 Treatment Phase|Adverse Event|0|||
161186316|NCT02185040|582058944|FG002|Part 1 Treatment Phase|Adverse Event|0|||
161186317|NCT02185040|582058945|FG003|Part 1 Treatment Phase|Adverse Event|2|||
161186318|NCT02185040|582058946|FG004|Part 1 Treatment Phase|Adverse Event|3|||
161186319|NCT02185040|582058947|FG005|Part 1 Treatment Phase|Adverse Event|0|||
161186320|NCT02185040|582058948|FG006|Part 1 Treatment Phase|Adverse Event|0|||
161186321|NCT02185040|582058942|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161186322|NCT02185040|582058943|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
161186323|NCT02185040|582058944|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161186324|NCT02185040|582058945|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161186325|NCT02185040|582058946|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161186326|NCT02185040|582058947|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161186327|NCT02185040|582058948|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
161186328|NCT02185040|582058942|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
161186329|NCT02185040|582058943|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
161186330|NCT02185040|582058944|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
161186331|NCT02185040|582058945|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
161186332|NCT02185040|582058946|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
161186333|NCT02185040|582058947|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
161186334|NCT02185040|582058948|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
161186335|NCT02185040|582058942|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
161186336|NCT02185040|582058943|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
161186337|NCT02185040|582058944|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
161186338|NCT02185040|582058945|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
161186339|NCT02185040|582058946|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
161186340|NCT02185040|582058947|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
161186341|NCT02185040|582058948|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
161186342|NCT02185040|582058942|FG000|Active Treatment Extension Phase|Adverse Event|0|||
161186343|NCT02185040|582058943|FG001|Active Treatment Extension Phase|Adverse Event|0|||
161186344|NCT02185040|582058944|FG002|Active Treatment Extension Phase|Adverse Event|0|||
161186345|NCT02185040|582058945|FG003|Active Treatment Extension Phase|Adverse Event|0|||
161186346|NCT02185040|582058946|FG004|Active Treatment Extension Phase|Adverse Event|0|||
161186347|NCT02185040|582058947|FG005|Active Treatment Extension Phase|Adverse Event|1|||
161186348|NCT02185040|582058948|FG006|Active Treatment Extension Phase|Adverse Event|4|||
161186349|NCT02185040|582058942|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161186350|NCT02185040|582058943|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161186351|NCT02185040|582058944|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161186352|NCT02185040|582058945|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161186353|NCT02185040|582058946|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
161186354|NCT02185040|582058947|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
161186355|NCT02185040|582058948|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
161186356|NCT02185040|582058942|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
161186357|NCT02185040|582058943|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
161186358|NCT02185040|582058944|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
161186359|NCT02185040|582058945|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
161186360|NCT02185040|582058946|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
161186361|NCT02185040|582058947|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
161186362|NCT02185040|582058948|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
161186363|NCT02094612|582058953|FG000|Overall Study|Lost to Follow-up|47|||
161186364|NCT02094612|582058954|FG001|Overall Study|Lost to Follow-up|47|||
161186365|NCT02094612|582058953|FG000|Overall Study|Never started ADHD medication|32|||
161186366|NCT02094612|582058954|FG001|Overall Study|Never started ADHD medication|23|||
161348576|NCT02872714|582660062|FG004|Overall Study|Captured as Other|0|||
161186367|NCT02646891|582058955|FG000|Overall Study|Adverse Event|0|||
161186368|NCT02646891|582058956|FG001|Overall Study|Adverse Event|1|||
161186369|NCT02646891|582058957|FG002|Overall Study|Adverse Event|0|||
161186370|NCT02646891|582058958|FG003|Overall Study|Adverse Event|0|||
161186371|NCT02646891|582058959|FG004|Overall Study|Adverse Event|0|||
161186372|NCT02646891|582058960|FG005|Overall Study|Adverse Event|0|||
161186373|NCT02646891|582058961|FG006|Overall Study|Adverse Event|0|||
161186374|NCT02646891|582058962|FG007|Overall Study|Adverse Event|0|||
161186375|NCT02646891|582058963|FG008|Overall Study|Adverse Event|0|||
161186376|NCT02646891|582058964|FG009|Overall Study|Adverse Event|0|||
161186377|NCT02646891|582058955|FG000|Overall Study|Lost to Follow-up|0|||
161186378|NCT02646891|582058956|FG001|Overall Study|Lost to Follow-up|0|||
161186379|NCT02646891|582058957|FG002|Overall Study|Lost to Follow-up|0|||
161186380|NCT02646891|582058958|FG003|Overall Study|Lost to Follow-up|0|||
161186381|NCT02646891|582058959|FG004|Overall Study|Lost to Follow-up|0|||
161186382|NCT02646891|582058960|FG005|Overall Study|Lost to Follow-up|0|||
161186383|NCT02646891|582058961|FG006|Overall Study|Lost to Follow-up|2|||
161186384|NCT02646891|582058962|FG007|Overall Study|Lost to Follow-up|2|||
161186385|NCT02646891|582058963|FG008|Overall Study|Lost to Follow-up|2|||
161186386|NCT02646891|582058964|FG009|Overall Study|Lost to Follow-up|2|||
161186387|NCT02646891|582058955|FG000|Overall Study|Protocol Violation|0|||
161186388|NCT02646891|582058956|FG001|Overall Study|Protocol Violation|0|||
161186389|NCT02646891|582058957|FG002|Overall Study|Protocol Violation|0|||
161186390|NCT02646891|582058958|FG003|Overall Study|Protocol Violation|0|||
161186391|NCT02646891|582058959|FG004|Overall Study|Protocol Violation|0|||
161186392|NCT02646891|582058960|FG005|Overall Study|Protocol Violation|0|||
161186393|NCT02646891|582058961|FG006|Overall Study|Protocol Violation|1|||
161186394|NCT02646891|582058962|FG007|Overall Study|Protocol Violation|1|||
161186395|NCT02646891|582058963|FG008|Overall Study|Protocol Violation|0|||
161186396|NCT02646891|582058964|FG009|Overall Study|Protocol Violation|0|||
161186397|NCT02646891|582058955|FG000|Overall Study|Withdrawal by Subject|2|||
161186398|NCT02646891|582058956|FG001|Overall Study|Withdrawal by Subject|0|||
161186399|NCT02646891|582058957|FG002|Overall Study|Withdrawal by Subject|1|||
161186400|NCT02646891|582058958|FG003|Overall Study|Withdrawal by Subject|0|||
161186401|NCT02646891|582058959|FG004|Overall Study|Withdrawal by Subject|0|||
161186402|NCT02646891|582058960|FG005|Overall Study|Withdrawal by Subject|0|||
161186403|NCT02646891|582058961|FG006|Overall Study|Withdrawal by Subject|5|||
161186404|NCT02646891|582058962|FG007|Overall Study|Withdrawal by Subject|9|||
161186405|NCT02646891|582058963|FG008|Overall Study|Withdrawal by Subject|7|||
161186406|NCT02646891|582058964|FG009|Overall Study|Withdrawal by Subject|3|||
161186407|NCT02646891|582058955|FG000|Overall Study|Death|0|||
161186408|NCT02646891|582058956|FG001|Overall Study|Death|0|||
161186409|NCT02646891|582058957|FG002|Overall Study|Death|0|||
161186410|NCT02646891|582058958|FG003|Overall Study|Death|0|||
161186411|NCT02646891|582058959|FG004|Overall Study|Death|0|||
161186412|NCT02646891|582058960|FG005|Overall Study|Death|0|||
161186413|NCT02646891|582058961|FG006|Overall Study|Death|1|||
161186414|NCT02646891|582058962|FG007|Overall Study|Death|1|||
161186415|NCT02646891|582058963|FG008|Overall Study|Death|1|||
161186416|NCT02646891|582058964|FG009|Overall Study|Death|0|||
161186417|NCT01542632|582058965|FG000|Overall Study|Withdrawal of Consent|0|||
161186418|NCT01542632|582058966|FG001|Overall Study|Withdrawal of Consent|0|||
161186419|NCT01542632|582058967|FG002|Overall Study|Withdrawal of Consent|0|||
161186420|NCT01542632|582058968|FG003|Overall Study|Withdrawal of Consent|2|||
161186421|NCT01542632|582058969|FG004|Overall Study|Withdrawal of Consent|3|||
161186422|NCT01542632|582058970|FG005|Overall Study|Withdrawal of Consent|0|||
161186423|NCT01542632|582058965|FG000|Overall Study|Adverse Event|0|||
161186424|NCT01542632|582058966|FG001|Overall Study|Adverse Event|0|||
161186425|NCT01542632|582058967|FG002|Overall Study|Adverse Event|1|||
161186426|NCT01542632|582058968|FG003|Overall Study|Adverse Event|0|||
161186427|NCT01542632|582058969|FG004|Overall Study|Adverse Event|0|||
161186428|NCT01542632|582058970|FG005|Overall Study|Adverse Event|0|||
161186429|NCT01542632|582058965|FG000|Overall Study|Lost to Follow-up|0|||
161186430|NCT01542632|582058966|FG001|Overall Study|Lost to Follow-up|1|||
161186431|NCT01542632|582058967|FG002|Overall Study|Lost to Follow-up|0|||
161186432|NCT01542632|582058968|FG003|Overall Study|Lost to Follow-up|0|||
161186433|NCT01542632|582058969|FG004|Overall Study|Lost to Follow-up|0|||
161186434|NCT01542632|582058970|FG005|Overall Study|Lost to Follow-up|0|||
161186435|NCT01542632|582058965|FG000|Overall Study|Sponsor/Investigator Decision|0|||
161186436|NCT01542632|582058966|FG001|Overall Study|Sponsor/Investigator Decision|0|||
161186437|NCT01542632|582058967|FG002|Overall Study|Sponsor/Investigator Decision|0|||
161186438|NCT01542632|582058968|FG003|Overall Study|Sponsor/Investigator Decision|0|||
161186439|NCT01542632|582058969|FG004|Overall Study|Sponsor/Investigator Decision|1|||
161186440|NCT01542632|582058970|FG005|Overall Study|Sponsor/Investigator Decision|0|||
161186441|NCT00033514|582058971|FG000|Overall Study|Lost to Follow-up|1|||
161186442|NCT00033514|582058972|FG001|Overall Study|Lost to Follow-up|1|||
161186443|NCT00033514|582058971|FG000|Overall Study|Withdrawal by Subject|0|||
161186444|NCT00033514|582058972|FG001|Overall Study|Withdrawal by Subject|3|||
161186445|NCT02871791|582058974|FG000|Phase 1b|Death|0|||
161186446|NCT02871791|582058975|FG001|Phase 1b|Death|1|||
161186447|NCT02871791|582058974|FG000|Phase 1b|progressive disease|6|||
161186448|NCT02871791|582058975|FG001|Phase 1b|progressive disease|2|||
161186449|NCT02871791|582058974|FG000|Phase 2|Death|1|||
161186450|NCT02871791|582058975|FG001|Phase 2|Death|0|||
161186451|NCT02871791|582058974|FG000|Phase 2|Lost to Follow-up|2|||
161186452|NCT02871791|582058975|FG001|Phase 2|Lost to Follow-up|0|||
161186453|NCT00129376|582058976|FG000|Overall Study|Adverse Event|1|||
161186454|NCT00129376|582058976|FG000|Overall Study|Lack of Efficacy|1|||
161186455|NCT01766401|582058984|FG000|Overall Study|Adverse Event|7|||
161186456|NCT01766401|582058985|FG001|Overall Study|Adverse Event|22|||
161186457|NCT01766401|582058984|FG000|Overall Study|Lack of Efficacy|1|||
161186458|NCT01766401|582058985|FG001|Overall Study|Lack of Efficacy|2|||
161186459|NCT01766401|582058984|FG000|Overall Study|Protocol Violation|3|||
161186460|NCT01766401|582058985|FG001|Overall Study|Protocol Violation|8|||
161186461|NCT01766401|582058984|FG000|Overall Study|Withdrawal by Subject|15|||
161186462|NCT01766401|582058985|FG001|Overall Study|Withdrawal by Subject|12|||
161186463|NCT01766401|582058984|FG000|Overall Study|Lost to Follow-up|10|||
161186464|NCT01766401|582058985|FG001|Overall Study|Lost to Follow-up|11|||
161186465|NCT01766401|582058984|FG000|Overall Study|Pregnancy|1|||
161186466|NCT01766401|582058985|FG001|Overall Study|Pregnancy|1|||
161186467|NCT01108068|582058986|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
161186468|NCT01108068|582058987|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
161186469|NCT02201251|582058988|FG000|Overall Study|Adverse Event|1|||
161186470|NCT02201251|582058989|FG001|Overall Study|Adverse Event|1|||
161186471|NCT02201251|582058988|FG000|Overall Study|Protocol Violation|1|||
161186472|NCT02201251|582058989|FG001|Overall Study|Protocol Violation|0|||
161186473|NCT02201251|582058988|FG000|Overall Study|Noncompliance with Study Drug|0|||
161186474|NCT02201251|582058989|FG001|Overall Study|Noncompliance with Study Drug|1|||
161186475|NCT02201251|582058988|FG000|Overall Study|Withdrawal by Subject|2|||
161186476|NCT02201251|582058989|FG001|Overall Study|Withdrawal by Subject|1|||
161186477|NCT01197794|582058990|FG000|Overall Study|Adverse Event|3|||
161186478|NCT01197794|582058991|FG001|Overall Study|Adverse Event|2|||
161186479|NCT01197794|582058992|FG002|Overall Study|Adverse Event|4|||
161186480|NCT01197794|582058993|FG003|Overall Study|Adverse Event|4|||
161186481|NCT01197794|582058994|FG004|Overall Study|Adverse Event|4|||
161186482|NCT01197794|582058995|FG005|Overall Study|Adverse Event|2|||
161186483|NCT01197794|582058996|FG006|Overall Study|Adverse Event|3|||
161186484|NCT01197794|582058990|FG000|Overall Study|Protocol Violation|0|||
161186485|NCT01197794|582058991|FG001|Overall Study|Protocol Violation|0|||
161186486|NCT01197794|582058992|FG002|Overall Study|Protocol Violation|0|||
161186487|NCT01197794|582058993|FG003|Overall Study|Protocol Violation|0|||
161186488|NCT01197794|582058994|FG004|Overall Study|Protocol Violation|2|||
161186489|NCT01197794|582058995|FG005|Overall Study|Protocol Violation|0|||
161186490|NCT01197794|582058996|FG006|Overall Study|Protocol Violation|1|||
161186491|NCT01197794|582058990|FG000|Overall Study|Development of study withdrawal criteria|3|||
161186492|NCT01197794|582058991|FG001|Overall Study|Development of study withdrawal criteria|0|||
161186493|NCT01197794|582058992|FG002|Overall Study|Development of study withdrawal criteria|0|||
161186494|NCT01197794|582058993|FG003|Overall Study|Development of study withdrawal criteria|1|||
161186495|NCT01197794|582058994|FG004|Overall Study|Development of study withdrawal criteria|0|||
161186496|NCT01197794|582058995|FG005|Overall Study|Development of study withdrawal criteria|0|||
161186497|NCT01197794|582058996|FG006|Overall Study|Development of study withdrawal criteria|1|||
161186498|NCT01197794|582058990|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
161186499|NCT01197794|582058991|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
161186500|NCT01197794|582058992|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
161186501|NCT01197794|582058993|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
161186502|NCT01197794|582058994|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
161186503|NCT01197794|582058995|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
161186504|NCT01197794|582058996|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
161186505|NCT01197794|582058990|FG000|Overall Study|Withdrawal by Subject|3|||
161186506|NCT01197794|582058991|FG001|Overall Study|Withdrawal by Subject|3|||
161186507|NCT01197794|582058992|FG002|Overall Study|Withdrawal by Subject|4|||
161186508|NCT01197794|582058993|FG003|Overall Study|Withdrawal by Subject|1|||
161186509|NCT01197794|582058994|FG004|Overall Study|Withdrawal by Subject|1|||
161186510|NCT01197794|582058995|FG005|Overall Study|Withdrawal by Subject|5|||
161186511|NCT01197794|582058996|FG006|Overall Study|Withdrawal by Subject|6|||
161186512|NCT01197794|582058990|FG000|Overall Study|Lost to Follow-up|1|||
161186513|NCT01197794|582058991|FG001|Overall Study|Lost to Follow-up|1|||
161186514|NCT01197794|582058992|FG002|Overall Study|Lost to Follow-up|0|||
161186515|NCT01197794|582058993|FG003|Overall Study|Lost to Follow-up|1|||
161186516|NCT01197794|582058994|FG004|Overall Study|Lost to Follow-up|0|||
161186517|NCT01197794|582058995|FG005|Overall Study|Lost to Follow-up|1|||
161186518|NCT01197794|582058996|FG006|Overall Study|Lost to Follow-up|0|||
161186519|NCT01197794|582058990|FG000|Overall Study|Other|1|||
161305297|NCT02031640|582498961|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
161305298|NCT02031640|582498962|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
161186520|NCT01197794|582058991|FG001|Overall Study|Other|1|||
161186521|NCT01197794|582058992|FG002|Overall Study|Other|3|||
161186522|NCT01197794|582058993|FG003|Overall Study|Other|0|||
161186523|NCT01197794|582058994|FG004|Overall Study|Other|2|||
161186524|NCT01197794|582058995|FG005|Overall Study|Other|2|||
161186525|NCT01197794|582058996|FG006|Overall Study|Other|4|||
161186526|NCT04055844|582058997|FG000|Overall Study|Adverse Event|12|||
161186527|NCT04055844|582058997|FG000|Overall Study|Poor Performance|1|||
161186528|NCT04055844|582058997|FG000|Overall Study|Death|1|||
161186529|NCT00572728|582058998|FG000|Overall Study|Withdrawal by Subject|10|||
161186530|NCT00572728|582058998|FG000|Overall Study|Ineligible|3|||
161186531|NCT00572728|582058998|FG000|Overall Study|Enrolled under Amendment 4|5|||
161186532|NCT00572728|582058998|FG000|Overall Study|Offstudy due to complicating disease|1|||
161186533|NCT00572728|582058998|FG000|Overall Study|FLT1 not completed|4|||
161186534|NCT00572728|582058998|FG000|Overall Study|First Chemotherapy not initiated|2|||
161186535|NCT00572728|582058998|FG000|Overall Study|FLT2 not completed|5|||
161186536|NCT00572728|582058998|FG000|Overall Study|Second chemotherapy not initiated|1|||
161186537|NCT00572728|582058998|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
161186538|NCT00572728|582058998|FG000|Overall Study|Pathology missing|1|||
161186539|NCT01833806|582059005|FG000|Overall Study|Alternative treatment|2|||
161186540|NCT01833806|582059005|FG000|Overall Study|Death|5|||
161186541|NCT01833806|582059005|FG000|Overall Study|Physician Decision|1|||
161186542|NCT01833806|582059005|FG000|Overall Study|Lost to Follow-up|1|||
161186543|NCT02724111|582059006|FG000|Overall Study|Protocol Violation|2|||
161186544|NCT02724111|582059007|FG001|Overall Study|Protocol Violation|5|||
161186545|NCT02332876|582059008|FG000|Overall Study|Lost to Follow-up|1|||
161186546|NCT02332876|582059009|FG001|Overall Study|Lost to Follow-up|1|||
161186547|NCT03231228|582059014|FG000|Overall Study|Lost to Follow-up|2|||
161186548|NCT03231228|582059015|FG001|Overall Study|Lost to Follow-up|0|||
161186549|NCT03231228|582059014|FG000|Overall Study|Physician Decision|1|||
161186550|NCT03231228|582059015|FG001|Overall Study|Physician Decision|0|||
161186551|NCT01868594|582059019|FG000|Overall Study|Do not meet inclusion criteria|4|||
161186552|NCT01868594|582059020|FG001|Overall Study|Do not meet inclusion criteria|3|||
161186553|NCT04490057|582059021|FG000|Stage 1|Death|1|||
161186554|NCT04490057|582059022|FG001|Stage 1|Death|2|||
161186555|NCT04490057|582059023|FG002|Stage 1|Death|0|||
161186556|NCT04490057|582059024|FG003|Stage 1|Death|0|||
161186557|NCT04490057|582059025|FG004|Stage 1|Death|0|||
161186558|NCT04490057|582059026|FG005|Stage 1|Death|0|||
161186559|NCT04490057|582059027|FG006|Stage 1|Death|0|||
161186560|NCT04490057|582059028|FG007|Stage 1|Death|0|||
161186561|NCT04490057|582059021|FG000|Stage 1|Withdrawal by Subject|2|||
161186562|NCT04490057|582059022|FG001|Stage 1|Withdrawal by Subject|0|||
161186563|NCT04490057|582059023|FG002|Stage 1|Withdrawal by Subject|0|||
161186564|NCT04490057|582059024|FG003|Stage 1|Withdrawal by Subject|0|||
161186565|NCT04490057|582059025|FG004|Stage 1|Withdrawal by Subject|0|||
161186566|NCT04490057|582059026|FG005|Stage 1|Withdrawal by Subject|0|||
161186567|NCT04490057|582059027|FG006|Stage 1|Withdrawal by Subject|0|||
161186568|NCT04490057|582059028|FG007|Stage 1|Withdrawal by Subject|0|||
161186569|NCT04490057|582059021|FG000|Stage 2|Death|0|||
161186570|NCT04490057|582059022|FG001|Stage 2|Death|0|||
161186571|NCT04490057|582059023|FG002|Stage 2|Death|0|||
161186572|NCT04490057|582059024|FG003|Stage 2|Death|0|||
161186573|NCT04490057|582059025|FG004|Stage 2|Death|1|||
161186574|NCT04490057|582059026|FG005|Stage 2|Death|0|||
161186575|NCT04490057|582059027|FG006|Stage 2|Death|0|||
161186576|NCT04490057|582059028|FG007|Stage 2|Death|0|||
161186577|NCT04490057|582059021|FG000|Stage 2|Lost to Follow-up|0|||
161186578|NCT04490057|582059022|FG001|Stage 2|Lost to Follow-up|0|||
161186579|NCT04490057|582059023|FG002|Stage 2|Lost to Follow-up|0|||
161186580|NCT04490057|582059024|FG003|Stage 2|Lost to Follow-up|11|||
161186581|NCT04490057|582059025|FG004|Stage 2|Lost to Follow-up|17|||
161186582|NCT04490057|582059026|FG005|Stage 2|Lost to Follow-up|4|||
161186583|NCT04490057|582059027|FG006|Stage 2|Lost to Follow-up|21|||
161186584|NCT04490057|582059028|FG007|Stage 2|Lost to Follow-up|14|||
161186585|NCT02598661|582059031|FG000|Overall Study|Death|27|||
161186586|NCT02598661|582059032|FG001|Overall Study|Death|34|||
161186587|NCT02598661|582059033|FG002|Overall Study|Death|14|||
161186588|NCT02598661|582059034|FG003|Overall Study|Death|1|||
161348577|NCT06717399|582660063|FG000|Overall Study|Death|1|||
161348578|NCT03043573|582660066|FG000|Overall Study|Lost to Follow-up|3|||
161348579|NCT03043573|582660067|FG001|Overall Study|Lost to Follow-up|3|||
161348580|NCT03043573|582660066|FG000|Overall Study|Physician Decision|0|||
161348581|NCT03043573|582660067|FG001|Overall Study|Physician Decision|5|||
161348582|NCT03043573|582660066|FG000|Overall Study|Withdrawal by Subject|0|||
161186589|NCT02598661|582059035|FG004|Overall Study|Death|0|||
161186590|NCT02598661|582059031|FG000|Overall Study|Lost to Follow-up|2|||
161348583|NCT03043573|582660067|FG001|Overall Study|Withdrawal by Subject|4|||
161348584|NCT03580928|582660072|FG000|Overall Study|Death|0|||
161186591|NCT02598661|582059032|FG001|Overall Study|Lost to Follow-up|3|||
161186592|NCT02598661|582059033|FG002|Overall Study|Lost to Follow-up|2|||
161186593|NCT02598661|582059034|FG003|Overall Study|Lost to Follow-up|0|||
161186594|NCT02598661|582059035|FG004|Overall Study|Lost to Follow-up|0|||
161186595|NCT02598661|582059031|FG000|Overall Study|Withdrawal by Subject|13|||
161186596|NCT02598661|582059032|FG001|Overall Study|Withdrawal by Subject|24|||
161186597|NCT02598661|582059033|FG002|Overall Study|Withdrawal by Subject|14|||
161186598|NCT02598661|582059034|FG003|Overall Study|Withdrawal by Subject|1|||
161186599|NCT02598661|582059035|FG004|Overall Study|Withdrawal by Subject|1|||
161186600|NCT02598661|582059031|FG000|Overall Study|Adverse Event|0|||
161186601|NCT02598661|582059032|FG001|Overall Study|Adverse Event|0|||
161186602|NCT02598661|582059033|FG002|Overall Study|Adverse Event|1|||
161186603|NCT02598661|582059034|FG003|Overall Study|Adverse Event|0|||
161186604|NCT02598661|582059035|FG004|Overall Study|Adverse Event|0|||
161186605|NCT02598661|582059031|FG000|Overall Study|Randomized, Never Treated|0|||
161186606|NCT02598661|582059032|FG001|Overall Study|Randomized, Never Treated|0|||
161186607|NCT02598661|582059033|FG002|Overall Study|Randomized, Never Treated|0|||
161186608|NCT02598661|582059034|FG003|Overall Study|Randomized, Never Treated|0|||
161186609|NCT02598661|582059035|FG004|Overall Study|Randomized, Never Treated|1|||
161186610|NCT00027027|582061316|FG000|Overall Study|Adverse Event|0|||
161186611|NCT00027027|582061317|FG001|Overall Study|Adverse Event|0|||
161186612|NCT00027027|582061318|FG002|Overall Study|Adverse Event|1|||
161186613|NCT00027027|582061319|FG003|Overall Study|Adverse Event|0|||
161186614|NCT00027027|582061320|FG004|Overall Study|Adverse Event|1|||
161186615|NCT00027027|582061316|FG000|Overall Study|Admitted for Signs of PD|0|||
161186616|NCT00027027|582061317|FG001|Overall Study|Admitted for Signs of PD|0|||
161186617|NCT00027027|582061318|FG002|Overall Study|Admitted for Signs of PD|0|||
161186618|NCT00027027|582061319|FG003|Overall Study|Admitted for Signs of PD|0|||
161186619|NCT00027027|582061320|FG004|Overall Study|Admitted for Signs of PD|1|||
161186620|NCT00027027|582061316|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
161186621|NCT00027027|582061317|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
161186622|NCT00027027|582061318|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
161186623|NCT00027027|582061319|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
161186624|NCT00027027|582061320|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
161186625|NCT00027027|582061316|FG000|Overall Study|PD Requiring Surgery|0|||
161186626|NCT00027027|582061317|FG001|Overall Study|PD Requiring Surgery|0|||
161186627|NCT00027027|582061318|FG002|Overall Study|PD Requiring Surgery|1|||
161186628|NCT00027027|582061319|FG003|Overall Study|PD Requiring Surgery|0|||
161186629|NCT00027027|582061320|FG004|Overall Study|PD Requiring Surgery|0|||
161186630|NCT00027027|582061316|FG000|Overall Study|Physician Decision Due To PD|2|||
161186631|NCT00027027|582061317|FG001|Overall Study|Physician Decision Due To PD|3|||
161186632|NCT00027027|582061318|FG002|Overall Study|Physician Decision Due To PD|2|||
161186633|NCT00027027|582061319|FG003|Overall Study|Physician Decision Due To PD|3|||
161186634|NCT00027027|582061320|FG004|Overall Study|Physician Decision Due To PD|5|||
161186635|NCT00027027|582061316|FG000|Overall Study|Withdrawal by Subject|0|||
161186636|NCT00027027|582061317|FG001|Overall Study|Withdrawal by Subject|0|||
161186637|NCT00027027|582061318|FG002|Overall Study|Withdrawal by Subject|0|||
161186638|NCT00027027|582061319|FG003|Overall Study|Withdrawal by Subject|0|||
161186639|NCT00027027|582061320|FG004|Overall Study|Withdrawal by Subject|1|||
161186640|NCT04397757|582061322|FG000|Overall Study|Death|3|||
161186641|NCT04397757|582061323|FG001|Overall Study|Death|11|||
161186642|NCT04397757|582061322|FG000|Overall Study|Withdrawal by Subject|2|||
161186643|NCT04397757|582061323|FG001|Overall Study|Withdrawal by Subject|0|||
161186644|NCT04397757|582061322|FG000|Overall Study|Lost to Follow-up|4|||
161186645|NCT04397757|582061323|FG001|Overall Study|Lost to Follow-up|3|||
161186646|NCT02306148|582061324|FG000|Overall Study|Adverse Event|12|||
161186647|NCT02306148|582061325|FG001|Overall Study|Adverse Event|6|||
161186648|NCT02306148|582061324|FG000|Overall Study|Lost to Follow-up|1|||
161186649|NCT02306148|582061325|FG001|Overall Study|Lost to Follow-up|4|||
161186650|NCT04657003|582061332|FG000|Overall Study|Adverse Event|5|||
161186651|NCT04657003|582061333|FG001|Overall Study|Adverse Event|1|||
161186652|NCT04657003|582061334|FG002|Overall Study|Adverse Event|5|||
161186653|NCT04657003|582061332|FG000|Overall Study|Death|0|||
161186654|NCT04657003|582061333|FG001|Overall Study|Death|2|||
161186655|NCT04657003|582061334|FG002|Overall Study|Death|0|||
161186656|NCT04657003|582061332|FG000|Overall Study|Lost to Follow-up|8|||
161186657|NCT04657003|582061333|FG001|Overall Study|Lost to Follow-up|4|||
161186658|NCT04657003|582061334|FG002|Overall Study|Lost to Follow-up|10|||
161305299|NCT02031640|582498963|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
161305300|NCT02031640|582498964|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
161305301|NCT02031640|582498959|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161305302|NCT02031640|582498960|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
161305303|NCT02031640|582498961|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161305304|NCT02031640|582498962|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161305305|NCT02031640|582498963|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
161305306|NCT02031640|582498964|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
161305307|NCT01194999|582498967|FG000|Overall Study|Lost to Follow-up|17|||
161305308|NCT01895270|582498968|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
161305309|NCT01895270|582498969|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
161348585|NCT03580928|582660073|FG001|Overall Study|Death|3|||
161186659|NCT04657003|582061332|FG000|Overall Study|Other - As Reported by Investigator|3|||
161186660|NCT04657003|582061333|FG001|Overall Study|Other - As Reported by Investigator|2|||
161186661|NCT04657003|582061334|FG002|Overall Study|Other - As Reported by Investigator|2|||
161186662|NCT04657003|582061332|FG000|Overall Study|Pregnancy|2|||
161186663|NCT04657003|582061333|FG001|Overall Study|Pregnancy|0|||
161186664|NCT04657003|582061334|FG002|Overall Study|Pregnancy|2|||
161186665|NCT04657003|582061332|FG000|Overall Study|Withdrawal by Subject|16|||
161186666|NCT04657003|582061333|FG001|Overall Study|Withdrawal by Subject|7|||
161186667|NCT04657003|582061334|FG002|Overall Study|Withdrawal by Subject|10|||
161186668|NCT05158244|582061337|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
161186669|NCT05158244|582061338|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161186670|NCT05158244|582061339|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161186671|NCT05158244|582061340|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161186672|NCT05158244|582061341|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
161186673|NCT05158244|582061337|FG000|Overall Study|Withdrawal by Subject|0|||
161186674|NCT05158244|582061338|FG001|Overall Study|Withdrawal by Subject|0|||
161186675|NCT05158244|582061339|FG002|Overall Study|Withdrawal by Subject|1|||
161186676|NCT05158244|582061340|FG003|Overall Study|Withdrawal by Subject|0|||
161186677|NCT05158244|582061341|FG004|Overall Study|Withdrawal by Subject|0|||
161186678|NCT02408016|582061343|FG000|Overall Study|Death|6|||
161186679|NCT02408016|582061344|FG001|Overall Study|Death|1|||
161186680|NCT02408016|582061345|FG002|Overall Study|Death|0|||
161186681|NCT02408016|582061343|FG000|Overall Study|Physician Decision|0|||
161186682|NCT02408016|582061344|FG001|Overall Study|Physician Decision|2|||
161186683|NCT02408016|582061345|FG002|Overall Study|Physician Decision|0|||
161186684|NCT00718887|582061346|FG000|Overall Study|Withdrawal by Subject|3|||
161186685|NCT00718887|582061347|FG001|Overall Study|Withdrawal by Subject|2|||
161186686|NCT00718887|582061346|FG000|Overall Study|Not identified|2|||
161186687|NCT00718887|582061347|FG001|Overall Study|Not identified|7|||
161186688|NCT00775138|582061350|FG000|Overall Study|Withdrawal by Subject|0|||
161186689|NCT00775138|582061351|FG001|Overall Study|Withdrawal by Subject|0|||
161186690|NCT00775138|582061352|FG002|Overall Study|Withdrawal by Subject|2|||
161186691|NCT00775138|582061353|FG003|Overall Study|Withdrawal by Subject|2|||
161186692|NCT00775138|582061350|FG000|Overall Study|Adverse Event|0|||
161186693|NCT00775138|582061351|FG001|Overall Study|Adverse Event|0|||
161186694|NCT00775138|582061352|FG002|Overall Study|Adverse Event|1|||
161186695|NCT00775138|582061353|FG003|Overall Study|Adverse Event|0|||
161186696|NCT03557801|582061354|FG000|Overall Study|Protocol Violation|1|||
161186697|NCT03557801|582061355|FG001|Overall Study|Protocol Violation|0|||
161186698|NCT03557801|582061356|FG002|Overall Study|Protocol Violation|0|||
161186699|NCT03557801|582061354|FG000|Overall Study|Withdrawal by Subject|1|||
161186700|NCT03557801|582061355|FG001|Overall Study|Withdrawal by Subject|0|||
161186701|NCT03557801|582061356|FG002|Overall Study|Withdrawal by Subject|3|||
161186702|NCT03557801|582061354|FG000|Overall Study|Lost to Follow-up|0|||
161186703|NCT03557801|582061355|FG001|Overall Study|Lost to Follow-up|1|||
161186704|NCT03557801|582061356|FG002|Overall Study|Lost to Follow-up|0|||
161186705|NCT00535236|582061357|FG000|Overall Study|Adverse Event|1|||
161186706|NCT00535236|582061358|FG001|Overall Study|Adverse Event|0|||
161186707|NCT00535236|582061359|FG002|Overall Study|Adverse Event|9|||
161186708|NCT00535236|582061360|FG003|Overall Study|Adverse Event|3|||
161186709|NCT00535236|582061361|FG004|Overall Study|Adverse Event|3|||
161186710|NCT00535236|582061362|FG005|Overall Study|Adverse Event|0|||
161186711|NCT00535236|582061363|FG006|Overall Study|Adverse Event|5|||
161186712|NCT00535236|582061364|FG007|Overall Study|Adverse Event|1|||
161186713|NCT00535236|582061365|FG008|Overall Study|Adverse Event|2|||
161186714|NCT00535236|582061366|FG009|Overall Study|Adverse Event|1|||
161186715|NCT00535236|582061357|FG000|Overall Study|Lost to Follow-up|1|||
161186716|NCT00535236|582061358|FG001|Overall Study|Lost to Follow-up|2|||
161186717|NCT00535236|582061359|FG002|Overall Study|Lost to Follow-up|0|||
161186718|NCT00535236|582061360|FG003|Overall Study|Lost to Follow-up|0|||
161186719|NCT00535236|582061361|FG004|Overall Study|Lost to Follow-up|2|||
161186720|NCT00535236|582061362|FG005|Overall Study|Lost to Follow-up|0|||
161186721|NCT00535236|582061363|FG006|Overall Study|Lost to Follow-up|0|||
161186722|NCT00535236|582061364|FG007|Overall Study|Lost to Follow-up|0|||
161186723|NCT00535236|582061365|FG008|Overall Study|Lost to Follow-up|6|||
161186724|NCT00535236|582061366|FG009|Overall Study|Lost to Follow-up|1|||
161186725|NCT00535236|582061357|FG000|Overall Study|Physician Decision|0|||
161186726|NCT00535236|582061358|FG001|Overall Study|Physician Decision|0|||
161186727|NCT00535236|582061359|FG002|Overall Study|Physician Decision|0|||
161186728|NCT00535236|582061360|FG003|Overall Study|Physician Decision|0|||
161186729|NCT00535236|582061361|FG004|Overall Study|Physician Decision|1|||
161186730|NCT00535236|582061362|FG005|Overall Study|Physician Decision|0|||
161305310|NCT01895270|582498968|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
161305311|NCT01895270|582498969|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
161305312|NCT01895270|582498968|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
161305313|NCT01895270|582498969|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
161186731|NCT00535236|582061363|FG006|Overall Study|Physician Decision|1|||
161186732|NCT00535236|582061364|FG007|Overall Study|Physician Decision|0|||
161186733|NCT00535236|582061365|FG008|Overall Study|Physician Decision|0|||
161186734|NCT00535236|582061366|FG009|Overall Study|Physician Decision|0|||
161186735|NCT00535236|582061357|FG000|Overall Study|Protocol Violation|2|||
161186736|NCT00535236|582061358|FG001|Overall Study|Protocol Violation|0|||
161186737|NCT00535236|582061359|FG002|Overall Study|Protocol Violation|1|||
161186738|NCT00535236|582061360|FG003|Overall Study|Protocol Violation|0|||
161186739|NCT00535236|582061361|FG004|Overall Study|Protocol Violation|0|||
161186740|NCT00535236|582061362|FG005|Overall Study|Protocol Violation|0|||
161186741|NCT00535236|582061363|FG006|Overall Study|Protocol Violation|0|||
161186742|NCT00535236|582061364|FG007|Overall Study|Protocol Violation|0|||
161186743|NCT00535236|582061365|FG008|Overall Study|Protocol Violation|1|||
161186744|NCT00535236|582061366|FG009|Overall Study|Protocol Violation|0|||
161186745|NCT00535236|582061357|FG000|Overall Study|Withdrawal by Subject|3|||
161186746|NCT00535236|582061358|FG001|Overall Study|Withdrawal by Subject|0|||
161186747|NCT00535236|582061359|FG002|Overall Study|Withdrawal by Subject|2|||
161186748|NCT00535236|582061360|FG003|Overall Study|Withdrawal by Subject|1|||
161186749|NCT00535236|582061361|FG004|Overall Study|Withdrawal by Subject|6|||
161186750|NCT00535236|582061362|FG005|Overall Study|Withdrawal by Subject|1|||
161186751|NCT00535236|582061363|FG006|Overall Study|Withdrawal by Subject|5|||
161186752|NCT00535236|582061364|FG007|Overall Study|Withdrawal by Subject|0|||
161186753|NCT00535236|582061365|FG008|Overall Study|Withdrawal by Subject|4|||
161186754|NCT00535236|582061366|FG009|Overall Study|Withdrawal by Subject|2|||
161186755|NCT03558503|582061367|FG000|Overall Study|Adverse Event|1|||
161186756|NCT03558503|582061367|FG000|Overall Study|Death|1|||
161186757|NCT03558503|582061367|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
161186758|NCT00561795|582061368|FG000|Overall Study|Adverse Event|3|||
161186759|NCT00561795|582061369|FG001|Overall Study|Adverse Event|3|||
161186760|NCT00561795|582061370|FG002|Overall Study|Adverse Event|0|||
161186761|NCT00561795|582061371|FG003|Overall Study|Adverse Event|0|||
161186762|NCT00561795|582061368|FG000|Overall Study|Study Closed/Terminated|0|||
161186763|NCT00561795|582061369|FG001|Overall Study|Study Closed/Terminated|3|||
161186764|NCT00561795|582061370|FG002|Overall Study|Study Closed/Terminated|0|||
161186765|NCT00561795|582061371|FG003|Overall Study|Study Closed/Terminated|0|||
161186766|NCT00561795|582061368|FG000|Overall Study|Physician Decision|1|||
161186767|NCT00561795|582061369|FG001|Overall Study|Physician Decision|0|||
161186768|NCT00561795|582061370|FG002|Overall Study|Physician Decision|0|||
161186769|NCT00561795|582061371|FG003|Overall Study|Physician Decision|0|||
161186770|NCT04564027|582061374|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
161186771|NCT04564027|582061375|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
161186772|NCT04564027|582061376|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
161186773|NCT04564027|582061377|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
161186774|NCT05827978|582061378|FG000|Overall Study|Adverse Event|1|||
161186775|NCT05827978|582061379|FG001|Overall Study|Adverse Event|0|||
161186776|NCT05827978|582061380|FG002|Overall Study|Adverse Event|0|||
161186777|NCT05827978|582061381|FG003|Overall Study|Adverse Event|1|||
161186778|NCT05827978|582061382|FG004|Overall Study|Adverse Event|0|||
161186779|NCT05827978|582061383|FG005|Overall Study|Adverse Event|0|||
161186780|NCT05827978|582061378|FG000|Overall Study|Death|1|||
161186781|NCT05827978|582061379|FG001|Overall Study|Death|5|||
161186782|NCT05827978|582061380|FG002|Overall Study|Death|2|||
161186783|NCT05827978|582061381|FG003|Overall Study|Death|3|||
161186784|NCT05827978|582061382|FG004|Overall Study|Death|1|||
161186785|NCT05827978|582061383|FG005|Overall Study|Death|3|||
161186786|NCT05827978|582061378|FG000|Overall Study|Lost to Follow-up|57|||
161186787|NCT05827978|582061379|FG001|Overall Study|Lost to Follow-up|88|||
161186788|NCT05827978|582061380|FG002|Overall Study|Lost to Follow-up|54|||
161186789|NCT05827978|582061381|FG003|Overall Study|Lost to Follow-up|47|||
161186790|NCT05827978|582061382|FG004|Overall Study|Lost to Follow-up|25|||
161186791|NCT05827978|582061383|FG005|Overall Study|Lost to Follow-up|10|||
161186792|NCT05827978|582061378|FG000|Overall Study|Noncompliance with Study Procedures|0|||
161186793|NCT05827978|582061379|FG001|Overall Study|Noncompliance with Study Procedures|1|||
161186794|NCT05827978|582061380|FG002|Overall Study|Noncompliance with Study Procedures|1|||
161186795|NCT05827978|582061381|FG003|Overall Study|Noncompliance with Study Procedures|1|||
161305314|NCT01895270|582498968|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
161305315|NCT01895270|582498969|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
161305316|NCT01895270|582498968|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
161305317|NCT01895270|582498969|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
161305318|NCT01895270|582498968|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
161305319|NCT01895270|582498969|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
161186796|NCT05827978|582061382|FG004|Overall Study|Noncompliance with Study Procedures|1|||
161186797|NCT05827978|582061383|FG005|Overall Study|Noncompliance with Study Procedures|0|||
161186798|NCT05827978|582061378|FG000|Overall Study|Physician Decision|2|||
161186799|NCT05827978|582061379|FG001|Overall Study|Physician Decision|0|||
161305320|NCT01895270|582498968|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
161305321|NCT01895270|582498969|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
161186800|NCT05827978|582061380|FG002|Overall Study|Physician Decision|1|||
161186801|NCT05827978|582061381|FG003|Overall Study|Physician Decision|2|||
161186802|NCT05827978|582061382|FG004|Overall Study|Physician Decision|1|||
161186803|NCT05827978|582061383|FG005|Overall Study|Physician Decision|1|||
161186804|NCT05827978|582061378|FG000|Overall Study|Protocol Violation|5|||
161186805|NCT05827978|582061379|FG001|Overall Study|Protocol Violation|2|||
161186806|NCT05827978|582061380|FG002|Overall Study|Protocol Violation|0|||
161186807|NCT05827978|582061381|FG003|Overall Study|Protocol Violation|0|||
161186808|NCT05827978|582061382|FG004|Overall Study|Protocol Violation|0|||
161186809|NCT05827978|582061383|FG005|Overall Study|Protocol Violation|0|||
161186810|NCT05827978|582061378|FG000|Overall Study|Withdrawal by Subject|17|||
161305322|NCT02091375|582498972|FG000|Overall Study|Adverse Event|8|||
161186811|NCT05827978|582061379|FG001|Overall Study|Withdrawal by Subject|16|||
161186812|NCT05827978|582061380|FG002|Overall Study|Withdrawal by Subject|10|||
161186813|NCT05827978|582061381|FG003|Overall Study|Withdrawal by Subject|12|||
161186814|NCT05827978|582061382|FG004|Overall Study|Withdrawal by Subject|10|||
161186815|NCT05827978|582061383|FG005|Overall Study|Withdrawal by Subject|9|||
161186816|NCT05827978|582061378|FG000|Overall Study|Other Than Specified|0|||
161186817|NCT05827978|582061379|FG001|Overall Study|Other Than Specified|0|||
161186818|NCT05827978|582061380|FG002|Overall Study|Other Than Specified|1|||
161186819|NCT05827978|582061381|FG003|Overall Study|Other Than Specified|0|||
161186820|NCT05827978|582061382|FG004|Overall Study|Other Than Specified|2|||
161186821|NCT05827978|582061383|FG005|Overall Study|Other Than Specified|0|||
161186822|NCT04566445|582061384|FG000|Overall Study|Death|4|||
161186823|NCT04566445|582061385|FG001|Overall Study|Death|1|||
161186824|NCT04566445|582061386|FG002|Overall Study|Death|1|||
161186825|NCT04566445|582061384|FG000|Overall Study|Lost to Follow-up|3|||
161186826|NCT04566445|582061385|FG001|Overall Study|Lost to Follow-up|1|||
161186827|NCT04566445|582061386|FG002|Overall Study|Lost to Follow-up|1|||
161186828|NCT04566445|582061384|FG000|Overall Study|Study terminated by sponsor|11|||
161186829|NCT04566445|582061385|FG001|Overall Study|Study terminated by sponsor|17|||
161186830|NCT04566445|582061386|FG002|Overall Study|Study terminated by sponsor|32|||
161186831|NCT04566445|582061384|FG000|Overall Study|Withdrawal by Subject|12|||
161186832|NCT04566445|582061385|FG001|Overall Study|Withdrawal by Subject|14|||
161186833|NCT04566445|582061386|FG002|Overall Study|Withdrawal by Subject|13|||
161186834|NCT04566445|582061384|FG000|Overall Study|Randomized but not treated due to AE|2|||
161186835|NCT04566445|582061385|FG001|Overall Study|Randomized but not treated due to AE|1|||
161186836|NCT04566445|582061386|FG002|Overall Study|Randomized but not treated due to AE|0|||
161186837|NCT04566445|582061384|FG000|Overall Study|Adverse Event|1|||
161186838|NCT04566445|582061385|FG001|Overall Study|Adverse Event|1|||
161186839|NCT04566445|582061386|FG002|Overall Study|Adverse Event|0|||
161186840|NCT04785144|582061387|FG000|Overall Study|Withdrawal by Subject|4|||
161186841|NCT04785144|582061388|FG001|Overall Study|Withdrawal by Subject|1|||
161186842|NCT04785144|582061389|FG002|Overall Study|Withdrawal by Subject|0|||
161186843|NCT04785144|582061390|FG003|Overall Study|Withdrawal by Subject|0|||
161186844|NCT04785144|582061391|FG004|Overall Study|Withdrawal by Subject|0|||
161186845|NCT04785144|582061392|FG005|Overall Study|Withdrawal by Subject|2|||
161186846|NCT04785144|582061393|FG006|Overall Study|Withdrawal by Subject|2|||
161186847|NCT04785144|582061394|FG007|Overall Study|Withdrawal by Subject|0|||
161186848|NCT04785144|582061395|FG008|Overall Study|Withdrawal by Subject|1|||
161186849|NCT04785144|582061396|FG009|Overall Study|Withdrawal by Subject|0|||
161186850|NCT04785144|582061387|FG000|Overall Study|Lost to Follow-up|1|||
161186851|NCT04785144|582061388|FG001|Overall Study|Lost to Follow-up|0|||
161186852|NCT04785144|582061389|FG002|Overall Study|Lost to Follow-up|0|||
161186853|NCT04785144|582061390|FG003|Overall Study|Lost to Follow-up|0|||
161186854|NCT04785144|582061391|FG004|Overall Study|Lost to Follow-up|1|||
161186855|NCT04785144|582061392|FG005|Overall Study|Lost to Follow-up|2|||
161186856|NCT04785144|582061393|FG006|Overall Study|Lost to Follow-up|1|||
161186857|NCT04785144|582061394|FG007|Overall Study|Lost to Follow-up|2|||
161186858|NCT04785144|582061395|FG008|Overall Study|Lost to Follow-up|4|||
161186859|NCT04785144|582061396|FG009|Overall Study|Lost to Follow-up|1|||
161186860|NCT04785144|582061387|FG000|Overall Study|Protocol Violation|0|||
161186861|NCT04785144|582061388|FG001|Overall Study|Protocol Violation|0|||
161186862|NCT04785144|582061389|FG002|Overall Study|Protocol Violation|0|||
161186863|NCT04785144|582061390|FG003|Overall Study|Protocol Violation|0|||
161186864|NCT04785144|582061391|FG004|Overall Study|Protocol Violation|0|||
161186865|NCT04785144|582061392|FG005|Overall Study|Protocol Violation|0|||
161186866|NCT04785144|582061393|FG006|Overall Study|Protocol Violation|1|||
161186867|NCT04785144|582061394|FG007|Overall Study|Protocol Violation|0|||
161186868|NCT04785144|582061395|FG008|Overall Study|Protocol Violation|0|||
161186869|NCT04785144|582061396|FG009|Overall Study|Protocol Violation|0|||
161186870|NCT04785144|582061387|FG000|Overall Study|Physician Decision|0|||
161348586|NCT03580928|582660072|FG000|Overall Study|Withdrawal by Subject|2|||
161186871|NCT04785144|582061388|FG001|Overall Study|Physician Decision|0|||
161186872|NCT04785144|582061389|FG002|Overall Study|Physician Decision|0|||
161186873|NCT04785144|582061390|FG003|Overall Study|Physician Decision|0|||
161186874|NCT04785144|582061391|FG004|Overall Study|Physician Decision|0|||
161186875|NCT04785144|582061392|FG005|Overall Study|Physician Decision|0|||
161186876|NCT04785144|582061393|FG006|Overall Study|Physician Decision|0|||
161186877|NCT04785144|582061394|FG007|Overall Study|Physician Decision|0|||
161186878|NCT04785144|582061395|FG008|Overall Study|Physician Decision|0|||
161186879|NCT04785144|582061396|FG009|Overall Study|Physician Decision|1|||
161186880|NCT04785144|582061387|FG000|Overall Study|Unable to continue due to work schedule|0|||
161186881|NCT04785144|582061388|FG001|Overall Study|Unable to continue due to work schedule|0|||
161186882|NCT04785144|582061389|FG002|Overall Study|Unable to continue due to work schedule|0|||
161186883|NCT04785144|582061390|FG003|Overall Study|Unable to continue due to work schedule|0|||
161186884|NCT04785144|582061391|FG004|Overall Study|Unable to continue due to work schedule|0|||
161186885|NCT04785144|582061392|FG005|Overall Study|Unable to continue due to work schedule|0|||
161186886|NCT04785144|582061393|FG006|Overall Study|Unable to continue due to work schedule|0|||
161186887|NCT04785144|582061394|FG007|Overall Study|Unable to continue due to work schedule|0|||
161186888|NCT04785144|582061395|FG008|Overall Study|Unable to continue due to work schedule|0|||
161186889|NCT04785144|582061396|FG009|Overall Study|Unable to continue due to work schedule|1|||
161186890|NCT00137267|582061399|FG000|Overall Study|Lost to Follow-up|15|||
161186891|NCT00137267|582061400|FG001|Overall Study|Lost to Follow-up|21|||
161186892|NCT02061540|582061404|FG000|Overall Study|Adverse Event|2|||
161186893|NCT02061540|582061404|FG000|Overall Study|Withdrawal by Subject|2|||
161186894|NCT04005755|582061406|FG000|Overall Study|Adverse Event|6|||
161186895|NCT04005755|582061406|FG000|Overall Study|Physician Decision|3|||
161186896|NCT04005755|582061406|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
161186897|NCT04005755|582061406|FG000|Overall Study|Withdrawal by Subject|3|||
161186898|NCT04005755|582061406|FG000|Overall Study|Lost to Follow-up|1|||
161186899|NCT02289833|582061407|FG000|Overall Study|Study discontinuation|0|||
161186900|NCT02289833|582061408|FG001|Overall Study|Study discontinuation|1|||
161186901|NCT02289833|582061407|FG000|Overall Study|Lost to Follow-up|4|||
161186902|NCT02289833|582061408|FG001|Overall Study|Lost to Follow-up|0|||
161186903|NCT02289833|582061407|FG000|Overall Study|Death|23|||
161186904|NCT02289833|582061408|FG001|Overall Study|Death|16|||
161186905|NCT02561273|582061415|FG000|Overall Study|Protocol Violation|1|||
161186906|NCT02561273|582061416|FG001|Overall Study|Protocol Violation|0|||
161186907|NCT02723019|582061417|FG000|Overall Study|Death|17|||
161186908|NCT02723019|582061418|FG001|Overall Study|Death|13|||
161186909|NCT02723019|582061417|FG000|Overall Study|Withdrawal by Subject|11|||
161186910|NCT02723019|582061418|FG001|Overall Study|Withdrawal by Subject|7|||
161186911|NCT02723019|582061417|FG000|Overall Study|Lost to Follow-up|57|||
161186912|NCT02723019|582061418|FG001|Overall Study|Lost to Follow-up|70|||
161186913|NCT00611767|582061420|FG000|Overall Study|Withdrawal by Subject|4|||
161186914|NCT00611767|582061421|FG001|Overall Study|Withdrawal by Subject|1|||
161186915|NCT00611767|582061420|FG000|Overall Study|Thiopental not available|3|||
161186916|NCT00611767|582061421|FG001|Overall Study|Thiopental not available|0|||
161186917|NCT00611767|582061420|FG000|Overall Study|didn't like the medication|1|||
161186918|NCT00611767|582061421|FG001|Overall Study|didn't like the medication|1|||
161186919|NCT00611767|582061420|FG000|Overall Study|Physician Decision|1|||
161186920|NCT00611767|582061421|FG001|Overall Study|Physician Decision|0|||
161186921|NCT01947127|582061426|FG000|Overall Study|Protocol Violation|18|||
161186922|NCT01947127|582061427|FG001|Overall Study|Protocol Violation|38|||
161186923|NCT01947127|582061426|FG000|Overall Study|Withdrawal by Subject|1|||
161186924|NCT01947127|582061427|FG001|Overall Study|Withdrawal by Subject|1|||
161186925|NCT01947127|582061426|FG000|Overall Study|Data loss|4|||
161186926|NCT01947127|582061427|FG001|Overall Study|Data loss|4|||
161186927|NCT01562327|582061428|FG000|Overall Study|Adverse Event|2|||
161186928|NCT01562327|582061428|FG000|Overall Study|Lack of Efficacy|1|||
161186929|NCT01562327|582061428|FG000|Overall Study|Participant drop-out|1|||
161186930|NCT01562327|582061428|FG000|Overall Study|Infusion not received at 6 month window|4|||
161186931|NCT00170846|582061429|FG000|Overall Study|Subject withdrew Informed Consent|5|||
161186932|NCT00170846|582061430|FG001|Overall Study|Subject withdrew Informed Consent|12|||
161186933|NCT00170846|582061431|FG002|Overall Study|Subject withdrew Informed Consent|8|||
161186934|NCT00170846|582061429|FG000|Overall Study|Lost to Follow-up|6|||
161186935|NCT00170846|582061430|FG001|Overall Study|Lost to Follow-up|3|||
161186936|NCT00170846|582061431|FG002|Overall Study|Lost to Follow-up|2|||
161186937|NCT00170846|582061429|FG000|Overall Study|Death|0|||
161186938|NCT00170846|582061430|FG001|Overall Study|Death|3|||
161186939|NCT00170846|582061431|FG002|Overall Study|Death|3|||
161186940|NCT00170846|582061429|FG000|Overall Study|Reason Missing|0|||
161186941|NCT00170846|582061430|FG001|Overall Study|Reason Missing|1|||
161186942|NCT00170846|582061431|FG002|Overall Study|Reason Missing|0|||
161186943|NCT00952588|582061440|FG000|Overall Study|Death|28|||
161186944|NCT00952588|582061441|FG001|Overall Study|Death|13|||
161186945|NCT00952588|582061440|FG000|Overall Study|Withdrawal by Subject|2|||
161186946|NCT00952588|582061441|FG001|Overall Study|Withdrawal by Subject|5|||
161186947|NCT00952588|582061440|FG000|Overall Study|Adverse Event|2|||
161186948|NCT00952588|582061441|FG001|Overall Study|Adverse Event|3|||
161186949|NCT00952588|582061440|FG000|Overall Study|Lost to Follow-up|2|||
161186950|NCT00952588|582061441|FG001|Overall Study|Lost to Follow-up|0|||
161186951|NCT00952588|582061440|FG000|Overall Study|Physician Decision|0|||
161305323|NCT02091375|582498973|FG001|Overall Study|Adverse Event|1|||
161305324|NCT02091375|582498972|FG000|Overall Study|Lost to Follow-up|0|||
161305325|NCT02091375|582498973|FG001|Overall Study|Lost to Follow-up|1|||
161305326|NCT02091375|582498972|FG000|Overall Study|Withdrawal by Subject|0|||
161305327|NCT02091375|582498973|FG001|Overall Study|Withdrawal by Subject|1|||
161305328|NCT02091375|582498972|FG000|Overall Study|Withdrawn by the investigator|1|||
161186952|NCT00952588|582061441|FG001|Overall Study|Physician Decision|1|||
161186953|NCT00952588|582061440|FG000|Overall Study|Lack of Efficacy|2|||
161186954|NCT00952588|582061441|FG001|Overall Study|Lack of Efficacy|2|||
161186955|NCT02795182|582061442|FG000|Overall Study|Death|5|||
161186956|NCT02795182|582061443|FG001|Overall Study|Death|4|||
161186957|NCT02795182|582061444|FG002|Overall Study|Death|4|||
161186958|NCT02795182|582061445|FG003|Overall Study|Death|18|||
161305329|NCT02091375|582498973|FG001|Overall Study|Withdrawn by the investigator|0|||
161186959|NCT02795182|582061442|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161186960|NCT02795182|582061443|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161186961|NCT02795182|582061444|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
161186962|NCT02795182|582061445|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
161186963|NCT02795182|582061442|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161186964|NCT02795182|582061443|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161186965|NCT02795182|582061444|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
161186966|NCT02795182|582061445|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
161186967|NCT02795182|582061442|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
161186968|NCT02795182|582061443|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
161186969|NCT02795182|582061444|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
161186970|NCT02795182|582061445|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
161186971|NCT02795182|582061442|FG000|Overall Study|Withdrawal by Subject|4|||
161186972|NCT02795182|582061443|FG001|Overall Study|Withdrawal by Subject|0|||
161186973|NCT02795182|582061444|FG002|Overall Study|Withdrawal by Subject|0|||
161186974|NCT02795182|582061445|FG003|Overall Study|Withdrawal by Subject|3|||
161186975|NCT02795182|582061442|FG000|Overall Study|Lost to Follow-up|0|||
161186976|NCT02795182|582061443|FG001|Overall Study|Lost to Follow-up|0|||
161186977|NCT02795182|582061444|FG002|Overall Study|Lost to Follow-up|1|||
161186978|NCT02795182|582061445|FG003|Overall Study|Lost to Follow-up|1|||
161186979|NCT02795182|582061442|FG000|Overall Study|Roll Over to Long Term Extension|3|||
161186980|NCT02795182|582061443|FG001|Overall Study|Roll Over to Long Term Extension|3|||
161186981|NCT02795182|582061444|FG002|Overall Study|Roll Over to Long Term Extension|2|||
161186982|NCT02795182|582061445|FG003|Overall Study|Roll Over to Long Term Extension|5|||
161186983|NCT02795182|582061442|FG000|Overall Study|Progressive Disease|0|||
161186984|NCT02795182|582061443|FG001|Overall Study|Progressive Disease|1|||
161186985|NCT02795182|582061444|FG002|Overall Study|Progressive Disease|0|||
161186986|NCT02795182|582061445|FG003|Overall Study|Progressive Disease|4|||
161186987|NCT02795182|582061442|FG000|Overall Study|Physician Decision|0|||
161186988|NCT02795182|582061443|FG001|Overall Study|Physician Decision|0|||
161186989|NCT02795182|582061444|FG002|Overall Study|Physician Decision|0|||
161186990|NCT02795182|582061445|FG003|Overall Study|Physician Decision|1|||
161186991|NCT00887913|582061446|FG000|Overall Study|Withdrawal by Subject|6|||
161186992|NCT01371721|582061447|FG000|Overall Study|Adverse Event|5|||
161186993|NCT01371721|582061448|FG001|Overall Study|Adverse Event|4|||
161186994|NCT01371721|582061449|FG002|Overall Study|Adverse Event|5|||
161186995|NCT01371721|582061447|FG000|Overall Study|Protocol Violation|6|||
161186996|NCT01371721|582061448|FG001|Overall Study|Protocol Violation|4|||
161186997|NCT01371721|582061449|FG002|Overall Study|Protocol Violation|5|||
161186998|NCT01371721|582061447|FG000|Overall Study|Lost to Follow-up|8|||
161186999|NCT01371721|582061448|FG001|Overall Study|Lost to Follow-up|2|||
161187000|NCT01371721|582061449|FG002|Overall Study|Lost to Follow-up|6|||
161187001|NCT01371721|582061447|FG000|Overall Study|Withdrawal by Subject|5|||
161187002|NCT01371721|582061448|FG001|Overall Study|Withdrawal by Subject|7|||
161187003|NCT01371721|582061449|FG002|Overall Study|Withdrawal by Subject|11|||
161187004|NCT01371721|582061447|FG000|Overall Study|Other|2|||
161187005|NCT01371721|582061448|FG001|Overall Study|Other|3|||
161187006|NCT01371721|582061449|FG002|Overall Study|Other|0|||
161187007|NCT01371721|582061447|FG000|Overall Study|Lack of Efficacy|2|||
161187008|NCT01371721|582061448|FG001|Overall Study|Lack of Efficacy|4|||
161187009|NCT01371721|582061449|FG002|Overall Study|Lack of Efficacy|3|||
161187010|NCT01371721|582061447|FG000|Overall Study|Randomized but not treated|1|||
161187011|NCT01371721|582061448|FG001|Overall Study|Randomized but not treated|0|||
161187012|NCT01371721|582061449|FG002|Overall Study|Randomized but not treated|0|||
161187013|NCT02996500|582061458|FG000|Overall Study|Adverse Event|1|||
161187014|NCT02996500|582061459|FG001|Overall Study|Adverse Event|1|||
161187015|NCT02996500|582061460|FG002|Overall Study|Adverse Event|4|||
161187016|NCT02996500|582061461|FG003|Overall Study|Adverse Event|3|||
161187017|NCT02996500|582061462|FG004|Overall Study|Adverse Event|1|||
161187018|NCT02996500|582061463|FG005|Overall Study|Adverse Event|2|||
161187019|NCT02996500|582061458|FG000|Overall Study|Lack of Efficacy|0|||
161187020|NCT02996500|582061459|FG001|Overall Study|Lack of Efficacy|0|||
161187021|NCT02996500|582061460|FG002|Overall Study|Lack of Efficacy|0|||
161187022|NCT02996500|582061461|FG003|Overall Study|Lack of Efficacy|0|||
161187023|NCT02996500|582061462|FG004|Overall Study|Lack of Efficacy|2|||
161305330|NCT01279070|582498976|FG000|Overall Study|Withdrawal by Subject|2|||
161305331|NCT01279070|582498977|FG001|Overall Study|Withdrawal by Subject|3|||
161305332|NCT01279070|582498976|FG000|Overall Study|Acute exacerbation|3|||
161187024|NCT02996500|582061463|FG005|Overall Study|Lack of Efficacy|0|||
161187025|NCT02996500|582061458|FG000|Overall Study|Lost to Follow-up|1|||
161187026|NCT02996500|582061459|FG001|Overall Study|Lost to Follow-up|0|||
161187027|NCT02996500|582061460|FG002|Overall Study|Lost to Follow-up|0|||
161187028|NCT02996500|582061461|FG003|Overall Study|Lost to Follow-up|0|||
161187029|NCT02996500|582061462|FG004|Overall Study|Lost to Follow-up|0|||
161187030|NCT02996500|582061463|FG005|Overall Study|Lost to Follow-up|1|||
161187031|NCT02996500|582061458|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
161187032|NCT02996500|582061459|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
161187033|NCT02996500|582061460|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
161187034|NCT02996500|582061461|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
161187035|NCT02996500|582061462|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
161187036|NCT02996500|582061463|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
161187037|NCT02996500|582061458|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161187038|NCT02996500|582061459|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161187039|NCT02996500|582061460|FG002|Overall Study|Non-Compliance With Study Drug|0|||
161187040|NCT02996500|582061461|FG003|Overall Study|Non-Compliance With Study Drug|0|||
161187041|NCT02996500|582061462|FG004|Overall Study|Non-Compliance With Study Drug|0|||
161187042|NCT02996500|582061463|FG005|Overall Study|Non-Compliance With Study Drug|1|||
161187043|NCT02996500|582061458|FG000|Overall Study|Progressive Disease|1|||
161187044|NCT02996500|582061459|FG001|Overall Study|Progressive Disease|0|||
161187045|NCT02996500|582061460|FG002|Overall Study|Progressive Disease|0|||
161187046|NCT02996500|582061461|FG003|Overall Study|Progressive Disease|0|||
161187047|NCT02996500|582061462|FG004|Overall Study|Progressive Disease|0|||
161187048|NCT02996500|582061463|FG005|Overall Study|Progressive Disease|0|||
161187049|NCT02996500|582061458|FG000|Overall Study|Other|2|||
161187050|NCT02996500|582061459|FG001|Overall Study|Other|0|||
161187051|NCT02996500|582061460|FG002|Overall Study|Other|2|||
161187052|NCT02996500|582061461|FG003|Overall Study|Other|0|||
161187053|NCT02996500|582061462|FG004|Overall Study|Other|0|||
161187054|NCT02996500|582061463|FG005|Overall Study|Other|0|||
161187055|NCT02996500|582061458|FG000|Overall Study|Protocol Violation|0|||
161187056|NCT02996500|582061459|FG001|Overall Study|Protocol Violation|0|||
161187057|NCT02996500|582061460|FG002|Overall Study|Protocol Violation|0|||
161187058|NCT02996500|582061461|FG003|Overall Study|Protocol Violation|1|||
161187059|NCT02996500|582061462|FG004|Overall Study|Protocol Violation|0|||
161187060|NCT02996500|582061463|FG005|Overall Study|Protocol Violation|0|||
161187061|NCT02996500|582061458|FG000|Overall Study|Withdrawal by Subject|3|||
161187062|NCT02996500|582061459|FG001|Overall Study|Withdrawal by Subject|0|||
161187063|NCT02996500|582061460|FG002|Overall Study|Withdrawal by Subject|3|||
161187064|NCT02996500|582061461|FG003|Overall Study|Withdrawal by Subject|0|||
161187065|NCT02996500|582061462|FG004|Overall Study|Withdrawal by Subject|2|||
161187066|NCT02996500|582061463|FG005|Overall Study|Withdrawal by Subject|0|||
161187067|NCT02187224|582061464|FG000|Overall Study|Did not show up for test day|1|||
161187068|NCT02187224|582061465|FG001|Overall Study|Did not show up for test day|0|||
161187069|NCT01010776|582061466|FG000|Main Phase|Withdrawal by Subject|14|||
161187070|NCT01010776|582061466|FG000|Main Phase|Lack of Efficacy|8|||
161187071|NCT01010776|582061466|FG000|Main Phase|Adverse Event|7|||
161187072|NCT01010776|582061466|FG000|Main Phase|Lost to Follow-up|6|||
161187073|NCT01010776|582061466|FG000|Main Phase|Non-compliance to study medication|5|||
161348587|NCT03580928|582660073|FG001|Overall Study|Withdrawal by Subject|1|||
161348588|NCT03580928|582660072|FG000|Overall Study|Lost to Follow-up|2|||
161348589|NCT03580928|582660073|FG001|Overall Study|Lost to Follow-up|0|||
161348590|NCT03580928|582660072|FG000|Overall Study|Progressive Disease|0|||
161348591|NCT03580928|582660073|FG001|Overall Study|Progressive Disease|1|||
161348592|NCT03759379|582663510|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
161348593|NCT03759379|582663511|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
161348594|NCT03759379|582663510|FG000|Treatment Period|Death|2|||
161348595|NCT03759379|582663511|FG001|Treatment Period|Death|3|||
161348596|NCT03759379|582663510|FG000|Treatment Period|Lost to Follow-up|1|||
161348597|NCT03759379|582663511|FG001|Treatment Period|Lost to Follow-up|0|||
161348598|NCT03759379|582663510|FG000|Treatment Period|Physician Decision|0|||
161348599|NCT03759379|582663511|FG001|Treatment Period|Physician Decision|1|||
161348600|NCT04924608|582663512|FG000|Overall Study|Adverse Event|10|||
161348601|NCT04924608|582663513|FG001|Overall Study|Adverse Event|6|||
161348602|NCT04924608|582663512|FG000|Overall Study|Lost to Follow-up|1|||
161348603|NCT04924608|582663513|FG001|Overall Study|Lost to Follow-up|1|||
161348604|NCT04924608|582663512|FG000|Overall Study|Ongoing at the data cut-off date|54|||
161187074|NCT01010776|582061466|FG000|Main Phase|Selection failure|2|||
161187075|NCT01010776|582061466|FG000|Main Phase|Inform consent withdrawal|1|||
161187076|NCT01010776|582061466|FG000|Main Phase|Other|1|||
161187077|NCT01010776|582061466|FG000|Main Phase|Did not received study medication|5|||
161187078|NCT01010776|582061466|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
161187079|NCT01010776|582061466|FG000|Extension Phase|Other|3|||
161187080|NCT00415623|582061471|FG000|Overall Study|Adverse Event|3|||
161187081|NCT00415623|582061472|FG001|Overall Study|Adverse Event|4|||
161187082|NCT00415623|582061471|FG000|Overall Study|Death|1|||
161187083|NCT00415623|582061472|FG001|Overall Study|Death|0|||
161187084|NCT00415623|582061471|FG000|Overall Study|Withdrawal by Subject|1|||
161348605|NCT04924608|582663513|FG001|Overall Study|Ongoing at the data cut-off date|60|||
161348606|NCT04924608|582663512|FG000|Overall Study|Progressive Disease|2|||
161348607|NCT04924608|582663513|FG001|Overall Study|Progressive Disease|0|||
161348608|NCT04924608|582663512|FG000|Overall Study|Withdrawal by Subject|3|||
161187085|NCT00415623|582061472|FG001|Overall Study|Withdrawal by Subject|1|||
161187086|NCT03267576|582061475|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
161187087|NCT03267576|582061476|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
161187088|NCT03267576|582061475|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
161187089|NCT03267576|582061476|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
161187090|NCT02573012|582061479|FG000|Overall Study|Adverse Event|5|||
161187091|NCT02573012|582061480|FG001|Overall Study|Adverse Event|5|||
161187092|NCT02573012|582061479|FG000|Overall Study|Lack of Efficacy|5|||
161187093|NCT02573012|582061480|FG001|Overall Study|Lack of Efficacy|4|||
161187094|NCT02573012|582061479|FG000|Overall Study|Non-compliance|1|||
161187095|NCT02573012|582061480|FG001|Overall Study|Non-compliance|2|||
161187096|NCT02573012|582061479|FG000|Overall Study|Withdrawal by Subject|2|||
161187097|NCT02573012|582061480|FG001|Overall Study|Withdrawal by Subject|2|||
161187098|NCT02573012|582061479|FG000|Overall Study|Study Ended per Protocol|1|||
161187099|NCT02573012|582061480|FG001|Overall Study|Study Ended per Protocol|0|||
161187100|NCT02573012|582061479|FG000|Overall Study|Physician Decision|1|||
161187101|NCT02573012|582061480|FG001|Overall Study|Physician Decision|2|||
161187102|NCT00882362|582061481|FG000|Overall Study|Adverse Event|13|||
161187103|NCT00882362|582061482|FG001|Overall Study|Adverse Event|10|||
161187104|NCT00882362|582061481|FG000|Overall Study|Withdrawal by Subject|13|||
161187105|NCT00882362|582061482|FG001|Overall Study|Withdrawal by Subject|10|||
161187106|NCT00882362|582061481|FG000|Overall Study|Lack of Efficacy|3|||
161187107|NCT00882362|582061482|FG001|Overall Study|Lack of Efficacy|0|||
161187108|NCT00882362|582061481|FG000|Overall Study|Protocol Violation|7|||
161187109|NCT00882362|582061482|FG001|Overall Study|Protocol Violation|2|||
161187110|NCT00882362|582061481|FG000|Overall Study|Pregnancy|1|||
161187111|NCT00882362|582061482|FG001|Overall Study|Pregnancy|0|||
161187112|NCT00882362|582061481|FG000|Overall Study|Physician Decision|5|||
161187113|NCT00882362|582061482|FG001|Overall Study|Physician Decision|1|||
161187114|NCT00882362|582061481|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
161187115|NCT00882362|582061482|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
161187116|NCT00882362|582061481|FG000|Overall Study|change of residence or other commitments|5|||
161187117|NCT00882362|582061482|FG001|Overall Study|change of residence or other commitments|0|||
161187118|NCT02382276|582061485|FG000|Overall Study|Withdrawal by Subject|4|||
161187119|NCT02382276|582061486|FG001|Overall Study|Withdrawal by Subject|8|||
161187120|NCT02382276|582061487|FG002|Overall Study|Withdrawal by Subject|5|||
161187121|NCT02382276|582061485|FG000|Overall Study|Adverse Event|7|||
161187122|NCT02382276|582061486|FG001|Overall Study|Adverse Event|2|||
161187123|NCT02382276|582061487|FG002|Overall Study|Adverse Event|32|||
161187124|NCT02382276|582061485|FG000|Overall Study|Physician Decision|0|||
161187125|NCT02382276|582061486|FG001|Overall Study|Physician Decision|0|||
161187126|NCT02382276|582061487|FG002|Overall Study|Physician Decision|2|||
161187127|NCT01222416|582061488|FG000|Overall Study|ineligible;metastasis|3|||
161187128|NCT01222416|582061489|FG001|Overall Study|ineligible;metastasis|0|||
161187129|NCT01222416|582061488|FG000|Overall Study|Adverse Event|4|||
161187130|NCT01222416|582061489|FG001|Overall Study|Adverse Event|0|||
161187131|NCT01222416|582061488|FG000|Overall Study|Withdrawal by Subject|5|||
161187132|NCT01222416|582061489|FG001|Overall Study|Withdrawal by Subject|0|||
161187133|NCT01222416|582061488|FG000|Overall Study|scheduling|6|||
161187134|NCT01222416|582061489|FG001|Overall Study|scheduling|0|||
161187135|NCT01222416|582061488|FG000|Overall Study|missed view/scan|1|||
161187136|NCT01222416|582061489|FG001|Overall Study|missed view/scan|0|||
161187137|NCT01222416|582061488|FG000|Overall Study|Death|1|||
161187138|NCT01222416|582061489|FG001|Overall Study|Death|0|||
161187139|NCT03049852|582061500|FG000|Overall Study|Lost to Follow-up|0|||
161187140|NCT03049852|582061501|FG001|Overall Study|Lost to Follow-up|1|||
161187141|NCT03049852|582061502|FG002|Overall Study|Lost to Follow-up|0|||
161187142|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
161187143|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161187144|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161187145|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161305333|NCT01279070|582498977|FG001|Overall Study|Acute exacerbation|1|||
161187146|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161187147|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
161187148|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
161187149|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161187150|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161187151|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161187152|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161187153|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
161187154|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
161187155|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161187156|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161187157|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161187158|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161187159|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
161187160|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Other|14|||
161187161|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Other|0|||
161187162|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Other|0|||
161187163|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Other|0|||
161187164|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Other|0|||
161187165|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Other|0|||
161187166|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
161187167|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
161187168|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
161187169|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
161187170|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
161187171|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
161187172|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
161187173|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161187174|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161187175|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161187176|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161187177|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
161187178|NCT02141854|582061503|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
161187179|NCT02141854|582061504|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161187180|NCT02141854|582061505|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161187181|NCT02141854|582061506|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161187182|NCT02141854|582061507|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161187183|NCT02141854|582061508|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
161187184|NCT02141854|582061503|FG000|Treatment Period|Protocol Violation|0|||
161187185|NCT02141854|582061504|FG001|Treatment Period|Protocol Violation|1|||
161187186|NCT02141854|582061505|FG002|Treatment Period|Protocol Violation|0|||
161187187|NCT02141854|582061506|FG003|Treatment Period|Protocol Violation|2|||
161187188|NCT02141854|582061507|FG004|Treatment Period|Protocol Violation|2|||
161187189|NCT02141854|582061508|FG005|Treatment Period|Protocol Violation|1|||
161187190|NCT02141854|582061503|FG000|Treatment Period|Noncompliance|0|||
161187191|NCT02141854|582061504|FG001|Treatment Period|Noncompliance|0|||
161187192|NCT02141854|582061505|FG002|Treatment Period|Noncompliance|0|||
161187193|NCT02141854|582061506|FG003|Treatment Period|Noncompliance|1|||
161187194|NCT02141854|582061507|FG004|Treatment Period|Noncompliance|0|||
161187195|NCT02141854|582061508|FG005|Treatment Period|Noncompliance|0|||
161187196|NCT02141854|582061503|FG000|Treatment Period|Lack of Efficacy|0|||
161187197|NCT02141854|582061504|FG001|Treatment Period|Lack of Efficacy|0|||
161187198|NCT02141854|582061505|FG002|Treatment Period|Lack of Efficacy|0|||
161187199|NCT02141854|582061506|FG003|Treatment Period|Lack of Efficacy|1|||
161187200|NCT02141854|582061507|FG004|Treatment Period|Lack of Efficacy|1|||
161187201|NCT02141854|582061508|FG005|Treatment Period|Lack of Efficacy|7|||
161187202|NCT02141854|582061503|FG000|Treatment Period|Pregnancy|0|||
161187203|NCT02141854|582061504|FG001|Treatment Period|Pregnancy|1|||
161187204|NCT02141854|582061505|FG002|Treatment Period|Pregnancy|0|||
161187205|NCT02141854|582061506|FG003|Treatment Period|Pregnancy|0|||
161187206|NCT02141854|582061507|FG004|Treatment Period|Pregnancy|0|||
161187207|NCT02141854|582061508|FG005|Treatment Period|Pregnancy|0|||
161187208|NCT02141854|582061503|FG000|Treatment Period|Other|0|||
161187209|NCT02141854|582061504|FG001|Treatment Period|Other|1|||
161187210|NCT02141854|582061505|FG002|Treatment Period|Other|2|||
161187211|NCT02141854|582061506|FG003|Treatment Period|Other|0|||
161187212|NCT02141854|582061507|FG004|Treatment Period|Other|1|||
161187213|NCT02141854|582061508|FG005|Treatment Period|Other|2|||
161187214|NCT02141854|582061503|FG000|Treatment Period|Adverse Event|0|||
161187215|NCT02141854|582061504|FG001|Treatment Period|Adverse Event|2|||
161187216|NCT02141854|582061505|FG002|Treatment Period|Adverse Event|2|||
161187217|NCT02141854|582061506|FG003|Treatment Period|Adverse Event|0|||
161187218|NCT02141854|582061507|FG004|Treatment Period|Adverse Event|2|||
161187219|NCT02141854|582061508|FG005|Treatment Period|Adverse Event|2|||
161305334|NCT03781583|582498980|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
161305335|NCT03781583|582498981|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
161187220|NCT02141854|582061503|FG000|Treatment Period|Withdrawal by Subject|0|||
161187221|NCT02141854|582061504|FG001|Treatment Period|Withdrawal by Subject|2|||
161187222|NCT02141854|582061505|FG002|Treatment Period|Withdrawal by Subject|3|||
161187223|NCT02141854|582061506|FG003|Treatment Period|Withdrawal by Subject|3|||
161187224|NCT02141854|582061507|FG004|Treatment Period|Withdrawal by Subject|4|||
161187225|NCT02141854|582061508|FG005|Treatment Period|Withdrawal by Subject|7|||
161187226|NCT02141854|582061503|FG000|Treatment Period|Disease progression|0|||
161305336|NCT03781583|582498982|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
161187227|NCT02141854|582061504|FG001|Treatment Period|Disease progression|2|||
161187228|NCT02141854|582061505|FG002|Treatment Period|Disease progression|1|||
161187229|NCT02141854|582061506|FG003|Treatment Period|Disease progression|3|||
161187230|NCT02141854|582061507|FG004|Treatment Period|Disease progression|0|||
161187231|NCT02141854|582061508|FG005|Treatment Period|Disease progression|18|||
161187232|NCT02141854|582061503|FG000|Treatment Period|Lost to Follow-up|0|||
161187233|NCT02141854|582061504|FG001|Treatment Period|Lost to Follow-up|1|||
161187234|NCT02141854|582061505|FG002|Treatment Period|Lost to Follow-up|1|||
161187235|NCT02141854|582061506|FG003|Treatment Period|Lost to Follow-up|1|||
161187236|NCT02141854|582061507|FG004|Treatment Period|Lost to Follow-up|0|||
161187237|NCT02141854|582061508|FG005|Treatment Period|Lost to Follow-up|1|||
161187238|NCT03258762|582061509|FG000|Overall Study|Lost to Follow-up|0|||
161187239|NCT03258762|582061510|FG001|Overall Study|Lost to Follow-up|1|||
161187240|NCT02545049|582061511|FG000|Overall Study|Withdrawal by Subject|1|||
161187241|NCT02545049|582061512|FG001|Overall Study|Withdrawal by Subject|7|||
161187242|NCT02545049|582061511|FG000|Overall Study|Lost to Follow-up|4|||
161187243|NCT02545049|582061512|FG001|Overall Study|Lost to Follow-up|6|||
161187244|NCT02545049|582061511|FG000|Overall Study|GCP violations|37|||
161187245|NCT02545049|582061512|FG001|Overall Study|GCP violations|48|||
161187246|NCT00656799|582061514|FG000|Overall Study|Death|2|||
161187247|NCT02422186|582061515|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
161187248|NCT02422186|582061516|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
161187249|NCT02422186|582061515|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
161187250|NCT02422186|582061516|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
161187251|NCT02422186|582061515|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
161187252|NCT02422186|582061516|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
161187253|NCT02422186|582061515|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
161187254|NCT02422186|582061516|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
161187255|NCT02422186|582061515|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
161187256|NCT02422186|582061516|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
161187257|NCT02422186|582061515|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
161187258|NCT02422186|582061516|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
161187259|NCT02422186|582061515|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
161187260|NCT02422186|582061516|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
161187261|NCT02422186|582061515|FG000|Follow-up Phase (2 Weeks)|Other|3|||
161187262|NCT02422186|582061516|FG001|Follow-up Phase (2 Weeks)|Other|0|||
161187263|NCT05281094|582061517|FG000|Overall Study|Adverse Event|1|||
161187264|NCT05281094|582061518|FG001|Overall Study|Adverse Event|0|||
161187265|NCT05281094|582061517|FG000|Overall Study|Lost to Follow-up|29|||
161187266|NCT05281094|582061518|FG001|Overall Study|Lost to Follow-up|22|||
161187267|NCT05281094|582061517|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
161187268|NCT05281094|582061518|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
161187269|NCT05281094|582061517|FG000|Overall Study|Death|1|||
161187270|NCT05281094|582061518|FG001|Overall Study|Death|2|||
161187271|NCT05281094|582061517|FG000|Overall Study|Not pre-specified reason|8|||
161187272|NCT05281094|582061518|FG001|Overall Study|Not pre-specified reason|5|||
161187273|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161187274|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161187275|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
161187276|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
161187277|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
161187278|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
161187279|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
161187280|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
161187281|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Death|0|||
161187282|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Death|0|||
161187283|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Death|0|||
161187284|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Death|1|||
161187285|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Death|1|||
161187286|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Death|0|||
161187287|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Death|2|||
161187288|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Death|0|||
161187289|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187290|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187291|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187292|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
161187293|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187294|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187295|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187296|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
161187297|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187298|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187299|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187300|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
161187301|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187302|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187303|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187304|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
161187305|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161187306|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161187307|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161187308|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
161187309|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161187310|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
161187311|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
161187312|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
161187313|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161187314|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161187315|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161187316|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
161187317|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161187318|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
161187319|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
161187320|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
161187321|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161187322|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161187323|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161187324|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161187325|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
161187326|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
161187327|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
161187328|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
161187329|NCT02442765|582063803|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161187330|NCT02442765|582063804|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161187331|NCT02442765|582063805|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161348609|NCT04924608|582663513|FG001|Overall Study|Withdrawal by Subject|6|||
161348610|NCT04924608|582663512|FG000|Overall Study|Other reason|1|||
161348611|NCT04924608|582663513|FG001|Overall Study|Other reason|1|||
161348612|NCT05199571|582663514|FG000|Treatment period|Participant decision|3|||
161348613|NCT05199571|582663514|FG000|Treatment period|Physician Decision|1|||
161348614|NCT05199571|582663514|FG000|Post-treatment follow up period|Participant decision|3|||
161348615|NCT02892344|582663515|FG000|Overall Study|Protocol deviation|3|||
161348616|NCT02892344|582663516|FG001|Overall Study|Protocol deviation|4|||
161348617|NCT02892344|582663515|FG000|Overall Study|Adverse Event|1|||
161348618|NCT02892344|582663516|FG001|Overall Study|Adverse Event|8|||
161348619|NCT02892344|582663515|FG000|Overall Study|Lost to Follow-up|0|||
161348620|NCT02892344|582663516|FG001|Overall Study|Lost to Follow-up|1|||
161348621|NCT02892344|582663515|FG000|Overall Study|Non-compliance with study treatment|0|||
161348622|NCT02892344|582663516|FG001|Overall Study|Non-compliance with study treatment|1|||
161348623|NCT02892344|582663515|FG000|Overall Study|Physician Decision|0|||
161348624|NCT02892344|582663516|FG001|Overall Study|Physician Decision|2|||
161348625|NCT02892344|582663515|FG000|Overall Study|Subject/guardian decision|0|||
161348626|NCT02892344|582663516|FG001|Overall Study|Subject/guardian decision|4|||
161348627|NCT02892344|582663515|FG000|Overall Study|Technical problems|0|||
161348628|NCT02892344|582663516|FG001|Overall Study|Technical problems|1|||
161348629|NCT04500769|582663517|FG000|Overall Study|Withdrawal by Subject|5|||
161348630|NCT01511562|582663518|FG000|Induction|Adverse Event|2|||
161348631|NCT01511562|582663519|FG001|Induction|Adverse Event|0|||
161348632|NCT01511562|582663518|FG000|Induction|Disease Progression|3|||
161348633|NCT01511562|582663519|FG001|Induction|Disease Progression|7|||
161348634|NCT01511562|582663518|FG000|Induction|Death|1|||
161348635|NCT01511562|582663519|FG001|Induction|Death|3|||
161348636|NCT01511562|582663518|FG000|Induction|Withdrawal by Subject|0|||
161348637|NCT01511562|582663519|FG001|Induction|Withdrawal by Subject|4|||
161348638|NCT01511562|582663518|FG000|Induction|Other|3|||
161348639|NCT01511562|582663519|FG001|Induction|Other|0|||
161348640|NCT01511562|582663518|FG000|Consolidation|Withdrawal by Subject|1|||
161348641|NCT01511562|582663519|FG001|Consolidation|Withdrawal by Subject|0|||
161348642|NCT01511562|582663518|FG000|Consolidation|Other|1|||
161348643|NCT01511562|582663519|FG001|Consolidation|Other|0|||
161348644|NCT03938454|582663520|FG000|Overall Study|Protocol Violation|1|||
161348645|NCT03938454|582663520|FG000|Overall Study|Withdrawal by Subject|2|||
161348646|NCT03938454|582663520|FG000|Overall Study|Lost to Follow-up|3|||
161348647|NCT04441905|582663521|FG000|Overall Study|Lost to Follow-up|1|||
161187332|NCT02442765|582063806|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161187333|NCT02442765|582063807|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
161187334|NCT02442765|582063808|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161348648|NCT04441905|582663522|FG001|Overall Study|Lost to Follow-up|0|||
161348649|NCT04441905|582663523|FG002|Overall Study|Lost to Follow-up|0|||
161348650|NCT04441905|582663524|FG003|Overall Study|Lost to Follow-up|0|||
161305337|NCT03781583|582498983|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
161305338|NCT03781583|582498980|FG000|Overall Study|Technology did not work for that person in that environment|1|||
161305339|NCT03781583|582498981|FG001|Overall Study|Technology did not work for that person in that environment|0|||
161187335|NCT02442765|582063809|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
161187336|NCT02442765|582063810|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
161187337|NCT01693562|582063811|FG000|Escalation Phase|Withdrawal by Subject|0|||
161187338|NCT01693562|582063812|FG001|Escalation Phase|Withdrawal by Subject|1|||
161187339|NCT01693562|582063813|FG002|Escalation Phase|Withdrawal by Subject|0|||
161187340|NCT01693562|582063814|FG003|Escalation Phase|Withdrawal by Subject|0|||
161187341|NCT01693562|582063815|FG004|Escalation Phase|Withdrawal by Subject|0|||
161187342|NCT01693562|582063816|FG005|Escalation Phase|Withdrawal by Subject|2|||
161187343|NCT01693562|582063817|FG006|Escalation Phase|Withdrawal by Subject|0|||
161187344|NCT01693562|582063818|FG007|Escalation Phase|Withdrawal by Subject|0|||
161187345|NCT01693562|582063819|FG008|Escalation Phase|Withdrawal by Subject|0|||
161187346|NCT01693562|582063820|FG009|Escalation Phase|Withdrawal by Subject|0|||
161187347|NCT01693562|582063821|FG010|Escalation Phase|Withdrawal by Subject|0|||
161187348|NCT01693562|582063822|FG011|Escalation Phase|Withdrawal by Subject|0|||
161187349|NCT01693562|582063823|FG012|Escalation Phase|Withdrawal by Subject|0|||
161187350|NCT01693562|582063824|FG013|Escalation Phase|Withdrawal by Subject|0|||
161187351|NCT01693562|582063825|FG014|Escalation Phase|Withdrawal by Subject|0|||
161187352|NCT01693562|582063826|FG015|Escalation Phase|Withdrawal by Subject|0|||
161187353|NCT01693562|582063827|FG016|Escalation Phase|Withdrawal by Subject|0|||
161187354|NCT01693562|582063828|FG017|Escalation Phase|Withdrawal by Subject|0|||
161187355|NCT01693562|582063829|FG018|Escalation Phase|Withdrawal by Subject|0|||
161187356|NCT01693562|582063830|FG019|Escalation Phase|Withdrawal by Subject|0|||
161187357|NCT01693562|582063831|FG020|Escalation Phase|Withdrawal by Subject|0|||
161187358|NCT01693562|582063832|FG021|Escalation Phase|Withdrawal by Subject|0|||
161187359|NCT01693562|582063833|FG022|Escalation Phase|Withdrawal by Subject|0|||
161187360|NCT01693562|582063811|FG000|Escalation Phase|Death|4|||
161187361|NCT01693562|582063812|FG001|Escalation Phase|Death|2|||
161187362|NCT01693562|582063813|FG002|Escalation Phase|Death|0|||
161187363|NCT01693562|582063814|FG003|Escalation Phase|Death|3|||
161187364|NCT01693562|582063815|FG004|Escalation Phase|Death|6|||
161187365|NCT01693562|582063816|FG005|Escalation Phase|Death|4|||
161187366|NCT01693562|582063817|FG006|Escalation Phase|Death|0|||
161187367|NCT01693562|582063818|FG007|Escalation Phase|Death|0|||
161187368|NCT01693562|582063819|FG008|Escalation Phase|Death|0|||
161187369|NCT01693562|582063820|FG009|Escalation Phase|Death|0|||
161187370|NCT01693562|582063821|FG010|Escalation Phase|Death|0|||
161187371|NCT01693562|582063822|FG011|Escalation Phase|Death|0|||
161187372|NCT01693562|582063823|FG012|Escalation Phase|Death|0|||
161187373|NCT01693562|582063824|FG013|Escalation Phase|Death|0|||
161187374|NCT01693562|582063825|FG014|Escalation Phase|Death|0|||
161187375|NCT01693562|582063826|FG015|Escalation Phase|Death|0|||
161187376|NCT01693562|582063827|FG016|Escalation Phase|Death|0|||
161187377|NCT01693562|582063828|FG017|Escalation Phase|Death|0|||
161187378|NCT01693562|582063829|FG018|Escalation Phase|Death|0|||
161187379|NCT01693562|582063830|FG019|Escalation Phase|Death|0|||
161187380|NCT01693562|582063831|FG020|Escalation Phase|Death|0|||
161187381|NCT01693562|582063832|FG021|Escalation Phase|Death|0|||
161187382|NCT01693562|582063833|FG022|Escalation Phase|Death|0|||
161187383|NCT01693562|582063811|FG000|Escalation Phase|Lost to Follow-up|0|||
161187384|NCT01693562|582063812|FG001|Escalation Phase|Lost to Follow-up|1|||
161187385|NCT01693562|582063813|FG002|Escalation Phase|Lost to Follow-up|1|||
161187386|NCT01693562|582063814|FG003|Escalation Phase|Lost to Follow-up|0|||
161187387|NCT01693562|582063815|FG004|Escalation Phase|Lost to Follow-up|0|||
161187388|NCT01693562|582063816|FG005|Escalation Phase|Lost to Follow-up|0|||
161187389|NCT01693562|582063817|FG006|Escalation Phase|Lost to Follow-up|0|||
161187390|NCT01693562|582063818|FG007|Escalation Phase|Lost to Follow-up|0|||
161187391|NCT01693562|582063819|FG008|Escalation Phase|Lost to Follow-up|0|||
161187392|NCT01693562|582063820|FG009|Escalation Phase|Lost to Follow-up|0|||
161187393|NCT01693562|582063821|FG010|Escalation Phase|Lost to Follow-up|0|||
161187394|NCT01693562|582063822|FG011|Escalation Phase|Lost to Follow-up|0|||
161187395|NCT01693562|582063823|FG012|Escalation Phase|Lost to Follow-up|0|||
161187396|NCT01693562|582063824|FG013|Escalation Phase|Lost to Follow-up|0|||
161187397|NCT01693562|582063825|FG014|Escalation Phase|Lost to Follow-up|0|||
161187398|NCT01693562|582063826|FG015|Escalation Phase|Lost to Follow-up|0|||
161187399|NCT01693562|582063827|FG016|Escalation Phase|Lost to Follow-up|0|||
161187400|NCT01693562|582063828|FG017|Escalation Phase|Lost to Follow-up|0|||
161187401|NCT01693562|582063829|FG018|Escalation Phase|Lost to Follow-up|0|||
161187402|NCT01693562|582063830|FG019|Escalation Phase|Lost to Follow-up|0|||
161187403|NCT01693562|582063831|FG020|Escalation Phase|Lost to Follow-up|0|||
161187404|NCT01693562|582063832|FG021|Escalation Phase|Lost to Follow-up|0|||
161187405|NCT01693562|582063833|FG022|Escalation Phase|Lost to Follow-up|0|||
161187406|NCT01693562|582063811|FG000|Escalation Phase|Other|0|||
161187407|NCT01693562|582063812|FG001|Escalation Phase|Other|0|||
161187408|NCT01693562|582063813|FG002|Escalation Phase|Other|2|||
161187409|NCT01693562|582063814|FG003|Escalation Phase|Other|0|||
161187410|NCT01693562|582063815|FG004|Escalation Phase|Other|0|||
161187411|NCT01693562|582063816|FG005|Escalation Phase|Other|1|||
161187412|NCT01693562|582063817|FG006|Escalation Phase|Other|0|||
161187413|NCT01693562|582063818|FG007|Escalation Phase|Other|0|||
161187414|NCT01693562|582063819|FG008|Escalation Phase|Other|0|||
161187415|NCT01693562|582063820|FG009|Escalation Phase|Other|0|||
161187416|NCT01693562|582063821|FG010|Escalation Phase|Other|0|||
161187417|NCT01693562|582063822|FG011|Escalation Phase|Other|0|||
161187418|NCT01693562|582063823|FG012|Escalation Phase|Other|0|||
161187419|NCT01693562|582063824|FG013|Escalation Phase|Other|0|||
161187420|NCT01693562|582063825|FG014|Escalation Phase|Other|0|||
161187421|NCT01693562|582063826|FG015|Escalation Phase|Other|0|||
161187422|NCT01693562|582063827|FG016|Escalation Phase|Other|0|||
161187423|NCT01693562|582063828|FG017|Escalation Phase|Other|0|||
161187424|NCT01693562|582063829|FG018|Escalation Phase|Other|0|||
161187425|NCT01693562|582063830|FG019|Escalation Phase|Other|0|||
161187426|NCT01693562|582063831|FG020|Escalation Phase|Other|0|||
161187427|NCT01693562|582063832|FG021|Escalation Phase|Other|0|||
161187428|NCT01693562|582063833|FG022|Escalation Phase|Other|0|||
161187429|NCT01693562|582063811|FG000|Exploration Phase|Withdrawal by Subject|0|||
161187430|NCT01693562|582063812|FG001|Exploration Phase|Withdrawal by Subject|0|||
161187431|NCT01693562|582063813|FG002|Exploration Phase|Withdrawal by Subject|0|||
161187432|NCT01693562|582063814|FG003|Exploration Phase|Withdrawal by Subject|0|||
161187433|NCT01693562|582063815|FG004|Exploration Phase|Withdrawal by Subject|0|||
161187434|NCT01693562|582063816|FG005|Exploration Phase|Withdrawal by Subject|0|||
161187435|NCT01693562|582063817|FG006|Exploration Phase|Withdrawal by Subject|2|||
161187436|NCT01693562|582063818|FG007|Exploration Phase|Withdrawal by Subject|0|||
161187437|NCT01693562|582063819|FG008|Exploration Phase|Withdrawal by Subject|0|||
161187438|NCT01693562|582063820|FG009|Exploration Phase|Withdrawal by Subject|0|||
161187439|NCT01693562|582063821|FG010|Exploration Phase|Withdrawal by Subject|0|||
161187440|NCT01693562|582063822|FG011|Exploration Phase|Withdrawal by Subject|0|||
161187441|NCT01693562|582063823|FG012|Exploration Phase|Withdrawal by Subject|0|||
161187442|NCT01693562|582063824|FG013|Exploration Phase|Withdrawal by Subject|0|||
161187443|NCT01693562|582063825|FG014|Exploration Phase|Withdrawal by Subject|0|||
161187444|NCT01693562|582063826|FG015|Exploration Phase|Withdrawal by Subject|0|||
161187445|NCT01693562|582063827|FG016|Exploration Phase|Withdrawal by Subject|0|||
161187446|NCT01693562|582063828|FG017|Exploration Phase|Withdrawal by Subject|0|||
161187447|NCT01693562|582063829|FG018|Exploration Phase|Withdrawal by Subject|0|||
161187448|NCT01693562|582063830|FG019|Exploration Phase|Withdrawal by Subject|0|||
161187449|NCT01693562|582063831|FG020|Exploration Phase|Withdrawal by Subject|0|||
161187450|NCT01693562|582063832|FG021|Exploration Phase|Withdrawal by Subject|0|||
161187451|NCT01693562|582063833|FG022|Exploration Phase|Withdrawal by Subject|0|||
161187452|NCT01693562|582063811|FG000|Exploration Phase|Death|0|||
161187453|NCT01693562|582063812|FG001|Exploration Phase|Death|0|||
161187454|NCT01693562|582063813|FG002|Exploration Phase|Death|0|||
161187455|NCT01693562|582063814|FG003|Exploration Phase|Death|0|||
161187456|NCT01693562|582063815|FG004|Exploration Phase|Death|0|||
161187457|NCT01693562|582063816|FG005|Exploration Phase|Death|0|||
161187458|NCT01693562|582063817|FG006|Exploration Phase|Death|17|||
161187459|NCT01693562|582063818|FG007|Exploration Phase|Death|0|||
161187460|NCT01693562|582063819|FG008|Exploration Phase|Death|0|||
161187461|NCT01693562|582063820|FG009|Exploration Phase|Death|0|||
161187462|NCT01693562|582063821|FG010|Exploration Phase|Death|0|||
161187463|NCT01693562|582063822|FG011|Exploration Phase|Death|0|||
161187464|NCT01693562|582063823|FG012|Exploration Phase|Death|0|||
161187465|NCT01693562|582063824|FG013|Exploration Phase|Death|0|||
161187466|NCT01693562|582063825|FG014|Exploration Phase|Death|0|||
161187467|NCT01693562|582063826|FG015|Exploration Phase|Death|0|||
161187468|NCT01693562|582063827|FG016|Exploration Phase|Death|0|||
161187469|NCT01693562|582063828|FG017|Exploration Phase|Death|0|||
161187470|NCT01693562|582063829|FG018|Exploration Phase|Death|0|||
161187471|NCT01693562|582063830|FG019|Exploration Phase|Death|0|||
161187472|NCT01693562|582063831|FG020|Exploration Phase|Death|0|||
161187473|NCT01693562|582063832|FG021|Exploration Phase|Death|0|||
161187474|NCT01693562|582063833|FG022|Exploration Phase|Death|0|||
161187475|NCT01693562|582063811|FG000|Exploration Phase|Other|0|||
161187476|NCT01693562|582063812|FG001|Exploration Phase|Other|0|||
161187477|NCT01693562|582063813|FG002|Exploration Phase|Other|0|||
161187478|NCT01693562|582063814|FG003|Exploration Phase|Other|0|||
161187479|NCT01693562|582063815|FG004|Exploration Phase|Other|0|||
161187480|NCT01693562|582063816|FG005|Exploration Phase|Other|0|||
161187481|NCT01693562|582063817|FG006|Exploration Phase|Other|2|||
161187482|NCT01693562|582063818|FG007|Exploration Phase|Other|0|||
161187483|NCT01693562|582063819|FG008|Exploration Phase|Other|0|||
161187484|NCT01693562|582063820|FG009|Exploration Phase|Other|0|||
161187485|NCT01693562|582063821|FG010|Exploration Phase|Other|0|||
161187486|NCT01693562|582063822|FG011|Exploration Phase|Other|0|||
161187487|NCT01693562|582063823|FG012|Exploration Phase|Other|0|||
161187488|NCT01693562|582063824|FG013|Exploration Phase|Other|0|||
161187489|NCT01693562|582063825|FG014|Exploration Phase|Other|0|||
161187490|NCT01693562|582063826|FG015|Exploration Phase|Other|0|||
161187491|NCT01693562|582063827|FG016|Exploration Phase|Other|0|||
161187492|NCT01693562|582063828|FG017|Exploration Phase|Other|0|||
161187493|NCT01693562|582063829|FG018|Exploration Phase|Other|0|||
161305340|NCT03781583|582498982|FG002|Overall Study|Technology did not work for that person in that environment|0|||
161305341|NCT03781583|582498983|FG003|Overall Study|Technology did not work for that person in that environment|0|||
161305342|NCT03781583|582498980|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
161305343|NCT03781583|582498981|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
161305344|NCT03781583|582498982|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
161305345|NCT03781583|582498983|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
161305346|NCT03781583|582498980|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161305347|NCT03781583|582498981|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
161305348|NCT03781583|582498982|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161305349|NCT03781583|582498983|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
161305350|NCT01938430|582498985|FG000|Overall Study|Randomized but Not Treated|0|||
161305351|NCT01938430|582498986|FG001|Overall Study|Randomized but Not Treated|0|||
161305352|NCT01938430|582498987|FG002|Overall Study|Randomized but Not Treated|0|||
161305353|NCT01938430|582498988|FG003|Overall Study|Randomized but Not Treated|0|||
161090006|NCT05249829|581719873|FG000|Overall Study|Withdrawal by Subject|9|||
161090007|NCT05249829|581719874|FG001|Overall Study|Withdrawal by Subject|17|||
161090008|NCT05249829|581719875|FG002|Overall Study|Withdrawal by Subject|40|||
161090009|NCT05249829|581719876|FG003|Overall Study|Withdrawal by Subject|35|||
161090010|NCT05249829|581719873|FG000|Overall Study|Physician Decision|1|||
161090011|NCT05249829|581719874|FG001|Overall Study|Physician Decision|0|||
161090012|NCT05249829|581719875|FG002|Overall Study|Physician Decision|0|||
161090013|NCT05249829|581719876|FG003|Overall Study|Physician Decision|0|||
161090014|NCT05249829|581719873|FG000|Overall Study|Lost to Follow-up|16|||
161090015|NCT05249829|581719874|FG001|Overall Study|Lost to Follow-up|16|||
161090016|NCT05249829|581719875|FG002|Overall Study|Lost to Follow-up|57|||
161090017|NCT05249829|581719876|FG003|Overall Study|Lost to Follow-up|60|||
161090018|NCT05249829|581719873|FG000|Overall Study|Adverse Event|2|||
161090019|NCT05249829|581719874|FG001|Overall Study|Adverse Event|2|||
161090020|NCT05249829|581719875|FG002|Overall Study|Adverse Event|2|||
161090021|NCT05249829|581719876|FG003|Overall Study|Adverse Event|2|||
161090022|NCT05249829|581719873|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
161090023|NCT05249829|581719874|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
161090024|NCT05249829|581719875|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
161090025|NCT05249829|581719876|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
161090026|NCT05249829|581719873|FG000|Overall Study|Protocol Violation|2|||
161090027|NCT05249829|581719874|FG001|Overall Study|Protocol Violation|0|||
161090028|NCT05249829|581719875|FG002|Overall Study|Protocol Violation|5|||
161090029|NCT05249829|581719876|FG003|Overall Study|Protocol Violation|3|||
161090030|NCT05249829|581719873|FG000|Overall Study|Death|0|||
161090031|NCT05249829|581719874|FG001|Overall Study|Death|1|||
161090032|NCT05249829|581719875|FG002|Overall Study|Death|2|||
161090033|NCT05249829|581719876|FG003|Overall Study|Death|4|||
161090034|NCT00196976|581719877|FG000|Primary Study|Migrated from study area|0|||
161090035|NCT00196976|581719878|FG001|Primary Study|Migrated from study area|0|||
161090036|NCT00196976|581719879|FG002|Primary Study|Migrated from study area|0|||
161090037|NCT00196976|581719880|FG003|Primary Study|Migrated from study area|0|||
161090038|NCT00196976|581719881|FG004|Primary Study|Migrated from study area|0|||
161090039|NCT00196976|581719882|FG005|Primary Study|Migrated from study area|0|||
161090040|NCT00196976|581719883|FG006|Primary Study|Migrated from study area|0|||
161090041|NCT00196976|581719884|FG007|Primary Study|Migrated from study area|1|||
161090042|NCT00196976|581719885|FG008|Primary Study|Migrated from study area|0|||
161090043|NCT00196976|581719886|FG009|Primary Study|Migrated from study area|0|||
161090044|NCT00196976|581719887|FG010|Primary Study|Migrated from study area|0|||
161090045|NCT00196976|581719888|FG011|Primary Study|Migrated from study area|0|||
161090046|NCT00196976|581719889|FG012|Primary Study|Migrated from study area|0|||
161090047|NCT00196976|581719890|FG013|Primary Study|Migrated from study area|0|||
161090048|NCT00196976|581719877|FG000|Primary Study|Protocol Violation|0|||
161090049|NCT00196976|581719878|FG001|Primary Study|Protocol Violation|1|||
161090050|NCT00196976|581719879|FG002|Primary Study|Protocol Violation|1|||
161090051|NCT00196976|581719880|FG003|Primary Study|Protocol Violation|0|||
161090052|NCT00196976|581719881|FG004|Primary Study|Protocol Violation|0|||
161090053|NCT00196976|581719882|FG005|Primary Study|Protocol Violation|0|||
161090054|NCT00196976|581719883|FG006|Primary Study|Protocol Violation|0|||
161090055|NCT00196976|581719884|FG007|Primary Study|Protocol Violation|0|||
161090056|NCT00196976|581719885|FG008|Primary Study|Protocol Violation|0|||
161090057|NCT00196976|581719886|FG009|Primary Study|Protocol Violation|0|||
161090058|NCT00196976|581719887|FG010|Primary Study|Protocol Violation|0|||
161090059|NCT00196976|581719888|FG011|Primary Study|Protocol Violation|0|||
161090060|NCT00196976|581719889|FG012|Primary Study|Protocol Violation|0|||
161187494|NCT01693562|582063830|FG019|Exploration Phase|Other|0|||
161090061|NCT00196976|581719890|FG013|Primary Study|Protocol Violation|0|||
161090062|NCT00196976|581719877|FG000|Primary Study|Withdrawal by Subject|1|||
161090063|NCT00196976|581719878|FG001|Primary Study|Withdrawal by Subject|0|||
161187495|NCT01693562|582063831|FG020|Exploration Phase|Other|0|||
161187496|NCT01693562|582063832|FG021|Exploration Phase|Other|0|||
161305354|NCT01938430|582498989|FG004|Overall Study|Randomized but Not Treated|0|||
161348651|NCT04441905|582663525|FG004|Overall Study|Lost to Follow-up|0|||
161348652|NCT04441905|582663526|FG005|Overall Study|Lost to Follow-up|0|||
161348653|NCT04441905|582663521|FG000|Overall Study|Enrolled but treatment not administered|0|||
161348654|NCT04441905|582663522|FG001|Overall Study|Enrolled but treatment not administered|1|||
161348655|NCT04441905|582663523|FG002|Overall Study|Enrolled but treatment not administered|0|||
161348656|NCT04441905|582663524|FG003|Overall Study|Enrolled but treatment not administered|0|||
161348657|NCT04441905|582663525|FG004|Overall Study|Enrolled but treatment not administered|0|||
161348658|NCT04441905|582663526|FG005|Overall Study|Enrolled but treatment not administered|0|||
161348659|NCT04441905|582663521|FG000|Overall Study|Became ineligible after enrollment|0|||
161348660|NCT04441905|582663522|FG001|Overall Study|Became ineligible after enrollment|0|||
161348661|NCT04441905|582663523|FG002|Overall Study|Became ineligible after enrollment|0|||
161348662|NCT04441905|582663524|FG003|Overall Study|Became ineligible after enrollment|0|||
161348663|NCT04441905|582663525|FG004|Overall Study|Became ineligible after enrollment|1|||
161348664|NCT04441905|582663526|FG005|Overall Study|Became ineligible after enrollment|0|||
161348665|NCT05415215|582663527|FG000|Neoadjuvant Phase|Adverse Event|0|||
161348666|NCT05415215|582663528|FG001|Neoadjuvant Phase|Adverse Event|8|||
161348667|NCT05415215|582663529|FG002|Neoadjuvant Phase|Adverse Event|0|||
161348668|NCT05415215|582663530|FG003|Neoadjuvant Phase|Adverse Event|0|||
161348669|NCT05415215|582663531|FG004|Neoadjuvant Phase|Adverse Event|0|||
161348670|NCT05415215|582663532|FG005|Neoadjuvant Phase|Adverse Event|0|||
161348671|NCT05415215|582663533|FG006|Neoadjuvant Phase|Adverse Event|0|||
161348672|NCT05415215|582663534|FG007|Neoadjuvant Phase|Adverse Event|0|||
161348673|NCT05415215|582663527|FG000|Neoadjuvant Phase|Death|0|||
161348674|NCT05415215|582663528|FG001|Neoadjuvant Phase|Death|4|||
161348675|NCT05415215|582663529|FG002|Neoadjuvant Phase|Death|0|||
161348676|NCT05415215|582663530|FG003|Neoadjuvant Phase|Death|0|||
161348677|NCT05415215|582663531|FG004|Neoadjuvant Phase|Death|0|||
161348678|NCT05415215|582663532|FG005|Neoadjuvant Phase|Death|0|||
161348679|NCT05415215|582663533|FG006|Neoadjuvant Phase|Death|0|||
161348680|NCT05415215|582663534|FG007|Neoadjuvant Phase|Death|0|||
161348681|NCT05415215|582663527|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
161348682|NCT05415215|582663528|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
161348683|NCT05415215|582663529|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
161348684|NCT05415215|582663530|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
161348685|NCT05415215|582663531|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
161348686|NCT05415215|582663532|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
161348687|NCT05415215|582663533|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
161348688|NCT05415215|582663534|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
161348689|NCT05415215|582663527|FG000|Neoadjuvant Phase|Progressive Disease|0|||
161348690|NCT05415215|582663528|FG001|Neoadjuvant Phase|Progressive Disease|2|||
161348691|NCT05415215|582663529|FG002|Neoadjuvant Phase|Progressive Disease|0|||
161348692|NCT05415215|582663530|FG003|Neoadjuvant Phase|Progressive Disease|0|||
161348693|NCT05415215|582663531|FG004|Neoadjuvant Phase|Progressive Disease|0|||
161348694|NCT05415215|582663532|FG005|Neoadjuvant Phase|Progressive Disease|0|||
161348695|NCT05415215|582663533|FG006|Neoadjuvant Phase|Progressive Disease|0|||
161348696|NCT05415215|582663534|FG007|Neoadjuvant Phase|Progressive Disease|0|||
161348697|NCT05415215|582663527|FG000|Neoadjuvant Phase|Reason not Specified|1|||
161305355|NCT01938430|582498990|FG005|Overall Study|Randomized but Not Treated|0|||
161305356|NCT01938430|582498991|FG006|Overall Study|Randomized but Not Treated|0|||
161305357|NCT01938430|582498992|FG007|Overall Study|Randomized but Not Treated|0|||
161305358|NCT01938430|582498993|FG008|Overall Study|Randomized but Not Treated|0|||
161305359|NCT01938430|582498994|FG009|Overall Study|Randomized but Not Treated|0|||
161305360|NCT01938430|582498995|FG010|Overall Study|Randomized but Not Treated|1|||
161305361|NCT01938430|582498996|FG011|Overall Study|Randomized but Not Treated|0|||
161305362|NCT01938430|582498997|FG012|Overall Study|Randomized but Not Treated|0|||
161305363|NCT01938430|582498998|FG013|Overall Study|Randomized but Not Treated|1|||
161305364|NCT01938430|582498985|FG000|Overall Study|Adverse Event|0|||
161305365|NCT01938430|582498986|FG001|Overall Study|Adverse Event|0|||
161305366|NCT01938430|582498987|FG002|Overall Study|Adverse Event|0|||
161305367|NCT01938430|582498988|FG003|Overall Study|Adverse Event|0|||
161305368|NCT01938430|582498989|FG004|Overall Study|Adverse Event|0|||
161305369|NCT01938430|582498990|FG005|Overall Study|Adverse Event|0|||
161305370|NCT01938430|582498991|FG006|Overall Study|Adverse Event|1|||
161305371|NCT01938430|582498992|FG007|Overall Study|Adverse Event|0|||
161305372|NCT01938430|582498993|FG008|Overall Study|Adverse Event|0|||
161305373|NCT01938430|582498994|FG009|Overall Study|Adverse Event|0|||
161305374|NCT01938430|582498995|FG010|Overall Study|Adverse Event|0|||
161305375|NCT01938430|582498996|FG011|Overall Study|Adverse Event|0|||
161305376|NCT01938430|582498997|FG012|Overall Study|Adverse Event|0|||
161305377|NCT01938430|582498998|FG013|Overall Study|Adverse Event|0|||
161305378|NCT01938430|582498985|FG000|Overall Study|Death|1|||
161305379|NCT01938430|582498986|FG001|Overall Study|Death|2|||
161348698|NCT05415215|582663528|FG001|Neoadjuvant Phase|Reason not Specified|4|||
161305380|NCT01938430|582498987|FG002|Overall Study|Death|2|||
161187497|NCT01693562|582063833|FG022|Exploration Phase|Other|0|||
161187498|NCT01693562|582063811|FG000|Expansion Phase|Withdrawal by Subject|0|||
161187499|NCT01693562|582063812|FG001|Expansion Phase|Withdrawal by Subject|0|||
161187500|NCT01693562|582063813|FG002|Expansion Phase|Withdrawal by Subject|0|||
161187501|NCT01693562|582063814|FG003|Expansion Phase|Withdrawal by Subject|0|||
161187502|NCT01693562|582063815|FG004|Expansion Phase|Withdrawal by Subject|0|||
161187503|NCT01693562|582063816|FG005|Expansion Phase|Withdrawal by Subject|0|||
161187504|NCT01693562|582063817|FG006|Expansion Phase|Withdrawal by Subject|0|||
161187505|NCT01693562|582063818|FG007|Expansion Phase|Withdrawal by Subject|16|||
161187506|NCT01693562|582063819|FG008|Expansion Phase|Withdrawal by Subject|2|||
161187507|NCT01693562|582063820|FG009|Expansion Phase|Withdrawal by Subject|54|||
161187508|NCT01693562|582063821|FG010|Expansion Phase|Withdrawal by Subject|2|||
161187509|NCT01693562|582063822|FG011|Expansion Phase|Withdrawal by Subject|2|||
161187510|NCT01693562|582063823|FG012|Expansion Phase|Withdrawal by Subject|3|||
161187511|NCT01693562|582063824|FG013|Expansion Phase|Withdrawal by Subject|5|||
161187512|NCT01693562|582063825|FG014|Expansion Phase|Withdrawal by Subject|16|||
161187513|NCT01693562|582063826|FG015|Expansion Phase|Withdrawal by Subject|7|||
161187514|NCT01693562|582063827|FG016|Expansion Phase|Withdrawal by Subject|40|||
161187515|NCT01693562|582063828|FG017|Expansion Phase|Withdrawal by Subject|4|||
161187516|NCT01693562|582063829|FG018|Expansion Phase|Withdrawal by Subject|8|||
161187517|NCT01693562|582063830|FG019|Expansion Phase|Withdrawal by Subject|3|||
161187518|NCT01693562|582063831|FG020|Expansion Phase|Withdrawal by Subject|1|||
161187519|NCT01693562|582063832|FG021|Expansion Phase|Withdrawal by Subject|8|||
161187520|NCT01693562|582063833|FG022|Expansion Phase|Withdrawal by Subject|1|||
161187521|NCT01693562|582063811|FG000|Expansion Phase|Death|0|||
161187522|NCT01693562|582063812|FG001|Expansion Phase|Death|0|||
161187523|NCT01693562|582063813|FG002|Expansion Phase|Death|0|||
161187524|NCT01693562|582063814|FG003|Expansion Phase|Death|0|||
161187525|NCT01693562|582063815|FG004|Expansion Phase|Death|0|||
161187526|NCT01693562|582063816|FG005|Expansion Phase|Death|0|||
161187527|NCT01693562|582063817|FG006|Expansion Phase|Death|0|||
161187528|NCT01693562|582063818|FG007|Expansion Phase|Death|42|||
161187529|NCT01693562|582063819|FG008|Expansion Phase|Death|17|||
161187530|NCT01693562|582063820|FG009|Expansion Phase|Death|208|||
161187531|NCT01693562|582063821|FG010|Expansion Phase|Death|30|||
161187532|NCT01693562|582063822|FG011|Expansion Phase|Death|8|||
161187533|NCT01693562|582063823|FG012|Expansion Phase|Death|19|||
161187534|NCT01693562|582063824|FG013|Expansion Phase|Death|42|||
161187535|NCT01693562|582063825|FG014|Expansion Phase|Death|23|||
161187536|NCT01693562|582063826|FG015|Expansion Phase|Death|23|||
161187537|NCT01693562|582063827|FG016|Expansion Phase|Death|128|||
161187538|NCT01693562|582063828|FG017|Expansion Phase|Death|16|||
161187539|NCT01693562|582063829|FG018|Expansion Phase|Death|36|||
161187540|NCT01693562|582063830|FG019|Expansion Phase|Death|16|||
161187541|NCT01693562|582063831|FG020|Expansion Phase|Death|17|||
161187542|NCT01693562|582063832|FG021|Expansion Phase|Death|35|||
161187543|NCT01693562|582063833|FG022|Expansion Phase|Death|7|||
161187544|NCT01693562|582063811|FG000|Expansion Phase|Lost to Follow-up|0|||
161187545|NCT01693562|582063812|FG001|Expansion Phase|Lost to Follow-up|0|||
161187546|NCT01693562|582063813|FG002|Expansion Phase|Lost to Follow-up|0|||
161187547|NCT01693562|582063814|FG003|Expansion Phase|Lost to Follow-up|0|||
161187548|NCT01693562|582063815|FG004|Expansion Phase|Lost to Follow-up|0|||
161187549|NCT01693562|582063816|FG005|Expansion Phase|Lost to Follow-up|0|||
161187550|NCT01693562|582063817|FG006|Expansion Phase|Lost to Follow-up|0|||
161187551|NCT01693562|582063818|FG007|Expansion Phase|Lost to Follow-up|1|||
161187552|NCT01693562|582063819|FG008|Expansion Phase|Lost to Follow-up|2|||
161187553|NCT01693562|582063820|FG009|Expansion Phase|Lost to Follow-up|10|||
161187554|NCT01693562|582063821|FG010|Expansion Phase|Lost to Follow-up|4|||
161187555|NCT01693562|582063822|FG011|Expansion Phase|Lost to Follow-up|4|||
161187556|NCT01693562|582063823|FG012|Expansion Phase|Lost to Follow-up|1|||
161187557|NCT01693562|582063824|FG013|Expansion Phase|Lost to Follow-up|3|||
161187558|NCT01693562|582063825|FG014|Expansion Phase|Lost to Follow-up|0|||
161187559|NCT01693562|582063826|FG015|Expansion Phase|Lost to Follow-up|1|||
161187560|NCT01693562|582063827|FG016|Expansion Phase|Lost to Follow-up|1|||
161187561|NCT01693562|582063828|FG017|Expansion Phase|Lost to Follow-up|0|||
161187562|NCT01693562|582063829|FG018|Expansion Phase|Lost to Follow-up|2|||
161187563|NCT01693562|582063830|FG019|Expansion Phase|Lost to Follow-up|1|||
161187564|NCT01693562|582063831|FG020|Expansion Phase|Lost to Follow-up|2|||
161187565|NCT01693562|582063832|FG021|Expansion Phase|Lost to Follow-up|2|||
161187566|NCT01693562|582063833|FG022|Expansion Phase|Lost to Follow-up|1|||
161187567|NCT01693562|582063811|FG000|Expansion Phase|Other|0|||
161187568|NCT01693562|582063812|FG001|Expansion Phase|Other|0|||
161305381|NCT01938430|582498988|FG003|Overall Study|Death|1|||
161187569|NCT01693562|582063813|FG002|Expansion Phase|Other|0|||
161187570|NCT01693562|582063814|FG003|Expansion Phase|Other|0|||
161187571|NCT01693562|582063815|FG004|Expansion Phase|Other|0|||
161187572|NCT01693562|582063816|FG005|Expansion Phase|Other|0|||
161187573|NCT01693562|582063817|FG006|Expansion Phase|Other|0|||
161187574|NCT01693562|582063818|FG007|Expansion Phase|Other|3|||
161187575|NCT01693562|582063819|FG008|Expansion Phase|Other|1|||
161187576|NCT01693562|582063820|FG009|Expansion Phase|Other|28|||
161187577|NCT01693562|582063821|FG010|Expansion Phase|Other|4|||
161348699|NCT05415215|582663529|FG002|Neoadjuvant Phase|Reason not Specified|0|||
161348700|NCT05415215|582663530|FG003|Neoadjuvant Phase|Reason not Specified|0|||
161348701|NCT05415215|582663531|FG004|Neoadjuvant Phase|Reason not Specified|0|||
161348702|NCT05415215|582663532|FG005|Neoadjuvant Phase|Reason not Specified|0|||
161348703|NCT05415215|582663533|FG006|Neoadjuvant Phase|Reason not Specified|0|||
161348704|NCT05415215|582663534|FG007|Neoadjuvant Phase|Reason not Specified|0|||
161348705|NCT05415215|582663527|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
161348706|NCT05415215|582663528|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
161187578|NCT01693562|582063822|FG011|Expansion Phase|Other|7|||
161187579|NCT01693562|582063823|FG012|Expansion Phase|Other|0|||
161187580|NCT01693562|582063824|FG013|Expansion Phase|Other|1|||
161187581|NCT01693562|582063825|FG014|Expansion Phase|Other|1|||
161187582|NCT01693562|582063826|FG015|Expansion Phase|Other|0|||
161187583|NCT01693562|582063827|FG016|Expansion Phase|Other|28|||
161187584|NCT01693562|582063828|FG017|Expansion Phase|Other|0|||
161187585|NCT01693562|582063829|FG018|Expansion Phase|Other|1|||
161187586|NCT01693562|582063830|FG019|Expansion Phase|Other|0|||
161187587|NCT01693562|582063831|FG020|Expansion Phase|Other|1|||
161187588|NCT01693562|582063832|FG021|Expansion Phase|Other|17|||
161187589|NCT01693562|582063833|FG022|Expansion Phase|Other|1|||
161187590|NCT05466240|582063834|FG000|Overall Study|Adverse Event|1|||
161187591|NCT05466240|582063835|FG001|Overall Study|Adverse Event|0|||
161187592|NCT05466240|582063834|FG000|Overall Study|Withdrawal by Subject|1|||
161187593|NCT05466240|582063835|FG001|Overall Study|Withdrawal by Subject|0|||
161187594|NCT02759939|582063836|FG000|Overall Study|Missing data on first outcome assessed|11|||
161187595|NCT02759939|582063837|FG001|Overall Study|Missing data on first outcome assessed|2|||
161187596|NCT02759939|582063838|FG002|Overall Study|Missing data on first outcome assessed|5|||
161187597|NCT02759939|582063839|FG003|Overall Study|Missing data on first outcome assessed|2|||
161187598|NCT02759939|582063836|FG000|Overall Study|Ineligible for T2 and T3|310|||
161187599|NCT02759939|582063837|FG001|Overall Study|Ineligible for T2 and T3|179|||
161187600|NCT02759939|582063838|FG002|Overall Study|Ineligible for T2 and T3|366|||
161187601|NCT02759939|582063839|FG003|Overall Study|Ineligible for T2 and T3|391|||
161187602|NCT02759939|582063836|FG000|Overall Study|Lost to Follow-up|735|||
161187603|NCT02759939|582063837|FG001|Overall Study|Lost to Follow-up|791|||
161187604|NCT02759939|582063838|FG002|Overall Study|Lost to Follow-up|783|||
161187605|NCT02759939|582063839|FG003|Overall Study|Lost to Follow-up|650|||
161187606|NCT04735432|582063840|FG000|Overall Study|Other - due to personal reason|1|||
161187607|NCT04735432|582063841|FG001|Overall Study|Other - due to personal reason|0|||
161187608|NCT04735432|582063840|FG000|Overall Study|Adverse Event|2|||
161187609|NCT04735432|582063841|FG001|Overall Study|Adverse Event|0|||
161187610|NCT00141297|582063843|FG000|Overall Study|Adverse Event|0|||
161187611|NCT00141297|582063844|FG001|Overall Study|Adverse Event|0|||
161187612|NCT00141297|582063845|FG002|Overall Study|Adverse Event|1|||
161187613|NCT00141297|582063846|FG003|Overall Study|Adverse Event|0|||
161187614|NCT00141297|582063847|FG004|Overall Study|Adverse Event|1|||
161187615|NCT00141297|582063848|FG005|Overall Study|Adverse Event|1|||
161187616|NCT00141297|582063849|FG006|Overall Study|Adverse Event|0|||
161187617|NCT00141297|582063850|FG007|Overall Study|Adverse Event|1|||
161187618|NCT00141297|582063851|FG008|Overall Study|Adverse Event|1|||
161187619|NCT00141297|582063852|FG009|Overall Study|Adverse Event|0|||
161187620|NCT00141297|582063843|FG000|Overall Study|Death|1|||
161187621|NCT00141297|582063844|FG001|Overall Study|Death|0|||
161187622|NCT00141297|582063845|FG002|Overall Study|Death|0|||
161187623|NCT00141297|582063846|FG003|Overall Study|Death|0|||
161187624|NCT00141297|582063847|FG004|Overall Study|Death|0|||
161187625|NCT00141297|582063848|FG005|Overall Study|Death|0|||
161187626|NCT00141297|582063849|FG006|Overall Study|Death|0|||
161187627|NCT00141297|582063850|FG007|Overall Study|Death|0|||
161187628|NCT00141297|582063851|FG008|Overall Study|Death|1|||
161187629|NCT00141297|582063852|FG009|Overall Study|Death|0|||
161187630|NCT00141297|582063843|FG000|Overall Study|Withdrawal by Subject|0|||
161187631|NCT00141297|582063844|FG001|Overall Study|Withdrawal by Subject|0|||
161187632|NCT00141297|582063845|FG002|Overall Study|Withdrawal by Subject|0|||
161187633|NCT00141297|582063846|FG003|Overall Study|Withdrawal by Subject|0|||
161187634|NCT00141297|582063847|FG004|Overall Study|Withdrawal by Subject|0|||
161187635|NCT00141297|582063848|FG005|Overall Study|Withdrawal by Subject|0|||
161348707|NCT05415215|582663529|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
161348708|NCT05415215|582663530|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
161187636|NCT00141297|582063849|FG006|Overall Study|Withdrawal by Subject|0|||
161187637|NCT00141297|582063850|FG007|Overall Study|Withdrawal by Subject|0|||
161187638|NCT00141297|582063851|FG008|Overall Study|Withdrawal by Subject|1|||
161187639|NCT00141297|582063852|FG009|Overall Study|Withdrawal by Subject|0|||
161187640|NCT00141297|582063843|FG000|Overall Study|Other|0|||
161187641|NCT00141297|582063844|FG001|Overall Study|Other|0|||
161187642|NCT00141297|582063845|FG002|Overall Study|Other|0|||
161187643|NCT00141297|582063846|FG003|Overall Study|Other|1|||
161187644|NCT00141297|582063847|FG004|Overall Study|Other|5|||
161187645|NCT00141297|582063848|FG005|Overall Study|Other|0|||
161187646|NCT00141297|582063849|FG006|Overall Study|Other|0|||
161187647|NCT00141297|582063850|FG007|Overall Study|Other|0|||
161187648|NCT00141297|582063851|FG008|Overall Study|Other|2|||
161187649|NCT00141297|582063852|FG009|Overall Study|Other|0|||
161187650|NCT00141297|582063843|FG000|Overall Study|Progressive Disease|2|||
161187651|NCT00141297|582063844|FG001|Overall Study|Progressive Disease|3|||
161187652|NCT00141297|582063845|FG002|Overall Study|Progressive Disease|6|||
161187653|NCT00141297|582063846|FG003|Overall Study|Progressive Disease|2|||
161187654|NCT00141297|582063847|FG004|Overall Study|Progressive Disease|15|||
161187655|NCT00141297|582063848|FG005|Overall Study|Progressive Disease|2|||
161187656|NCT00141297|582063849|FG006|Overall Study|Progressive Disease|3|||
161187657|NCT00141297|582063850|FG007|Overall Study|Progressive Disease|3|||
161187658|NCT00141297|582063851|FG008|Overall Study|Progressive Disease|15|||
161187659|NCT00141297|582063852|FG009|Overall Study|Progressive Disease|6|||
161187660|NCT00141297|582063843|FG000|Overall Study|Transitioned|0|||
161090064|NCT00196976|581719879|FG002|Primary Study|Withdrawal by Subject|1|||
161090065|NCT00196976|581719880|FG003|Primary Study|Withdrawal by Subject|1|||
161090066|NCT00196976|581719881|FG004|Primary Study|Withdrawal by Subject|2|||
161090067|NCT00196976|581719882|FG005|Primary Study|Withdrawal by Subject|1|||
161090068|NCT00196976|581719883|FG006|Primary Study|Withdrawal by Subject|0|||
161090069|NCT00196976|581719884|FG007|Primary Study|Withdrawal by Subject|0|||
161090070|NCT00196976|581719885|FG008|Primary Study|Withdrawal by Subject|0|||
161090071|NCT00196976|581719886|FG009|Primary Study|Withdrawal by Subject|1|||
161090072|NCT00196976|581719887|FG010|Primary Study|Withdrawal by Subject|0|||
161090073|NCT00196976|581719888|FG011|Primary Study|Withdrawal by Subject|0|||
161090074|NCT00196976|581719889|FG012|Primary Study|Withdrawal by Subject|0|||
161187661|NCT00141297|582063844|FG001|Overall Study|Transitioned|0|||
161187662|NCT00141297|582063845|FG002|Overall Study|Transitioned|0|||
161187663|NCT00141297|582063846|FG003|Overall Study|Transitioned|0|||
161187664|NCT00141297|582063847|FG004|Overall Study|Transitioned|1|||
161187665|NCT00141297|582063848|FG005|Overall Study|Transitioned|0|||
161187666|NCT00141297|582063849|FG006|Overall Study|Transitioned|0|||
161187667|NCT00141297|582063850|FG007|Overall Study|Transitioned|0|||
161187668|NCT00141297|582063851|FG008|Overall Study|Transitioned|0|||
161187669|NCT00141297|582063852|FG009|Overall Study|Transitioned|0|||
161187670|NCT02987205|582063853|FG000|Overall Study|Adverse Event|1|||
161187671|NCT02987205|582063853|FG000|Overall Study|Withdrawal by Subject|3|||
161187672|NCT02807376|582063854|FG000|Overall Study|Intra-operative exclusion criteria|3|||
161187673|NCT02807376|582063855|FG001|Overall Study|Intra-operative exclusion criteria|0|||
161187674|NCT02807376|582063854|FG000|Overall Study|Lost to Follow-up|0|||
161187675|NCT02807376|582063855|FG001|Overall Study|Lost to Follow-up|1|||
161187676|NCT00712712|582063870|FG000|Overall Study|Protocol Violation|11|||
161187677|NCT00712712|582063870|FG000|Overall Study|Radiofrequency not done|3|||
161187678|NCT00712712|582063870|FG000|Overall Study|Death|8|||
161187679|NCT00712712|582063870|FG000|Overall Study|Withdrawal by Subject|1|||
161187680|NCT00958191|582063871|FG000|Overall Study|Death|4|||
161187681|NCT00958191|582063871|FG000|Overall Study|Lost to Follow-up|5|||
161187682|NCT00958191|582063871|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
161187683|NCT00958191|582063871|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
161187684|NCT00958191|582063871|FG000|Overall Study|Revision of study device|4|||
161187685|NCT00958191|582063871|FG000|Overall Study|Site termination|11|||
161187686|NCT00958191|582063871|FG000|Overall Study|No 5 yr x-rays|56|||
161187687|NCT01642004|582063872|FG000|Randomization|Adverse Event unrelated to study drug|1|||
161187688|NCT01642004|582063873|FG001|Randomization|Adverse Event unrelated to study drug|0|||
161187689|NCT01642004|582063872|FG000|Randomization|Participant withdrew consent|1|||
161187690|NCT01642004|582063873|FG001|Randomization|Participant withdrew consent|6|||
161187691|NCT01642004|582063872|FG000|Randomization|No longer meets study criteria|2|||
161187692|NCT01642004|582063873|FG001|Randomization|No longer meets study criteria|2|||
161187693|NCT01642004|582063872|FG000|Treatment|Disease progression|95|||
161187694|NCT01642004|582063873|FG001|Treatment|Disease progression|79|||
161187695|NCT01642004|582063872|FG000|Treatment|Study drug toxicity|10|||
161187696|NCT01642004|582063873|FG001|Treatment|Study drug toxicity|13|||
161187697|NCT01642004|582063872|FG000|Treatment|Death|1|||
161187698|NCT01642004|582063873|FG001|Treatment|Death|1|||
161187699|NCT01642004|582063872|FG000|Treatment|Adverse event unrelated to study drug|9|||
161187700|NCT01642004|582063873|FG001|Treatment|Adverse event unrelated to study drug|13|||
161187701|NCT01642004|582063872|FG000|Treatment|Maximum clinical benefit|1|||
161187702|NCT01642004|582063873|FG001|Treatment|Maximum clinical benefit|9|||
161187703|NCT01642004|582063872|FG000|Treatment|Poor/non-compliance|1|||
161187704|NCT01642004|582063873|FG001|Treatment|Poor/non-compliance|0|||
161187705|NCT01642004|582063872|FG000|Treatment|No longer meets study criteria|1|||
161187706|NCT01642004|582063873|FG001|Treatment|No longer meets study criteria|2|||
161187707|NCT01642004|582063872|FG000|Treatment|Other reasons|2|||
161187708|NCT01642004|582063873|FG001|Treatment|Other reasons|0|||
161187709|NCT01642004|582063872|FG000|Treatment|Not reported|0|||
161187710|NCT01642004|582063873|FG001|Treatment|Not reported|3|||
161187711|NCT01642004|582063872|FG000|Treatment|Participant request to discontinue study treatment|6|||
161187712|NCT01642004|582063873|FG001|Treatment|Participant request to discontinue study treatment|4|||
161187713|NCT01642004|582063872|FG000|Treatment|Participant withdrew consent|5|||
161187714|NCT01642004|582063873|FG001|Treatment|Participant withdrew consent|5|||
161187715|NCT02718625|582063874|FG000|Overall Study|Adverse Event|0|||
161187716|NCT02718625|582063875|FG001|Overall Study|Adverse Event|1|||
161187717|NCT02718625|582063874|FG000|Overall Study|Termination of Study by Sponsor|0|||
161187718|NCT02718625|582063875|FG001|Overall Study|Termination of Study by Sponsor|1|||
161187719|NCT01818765|582063878|FG000|Overall Study|Death|2|||
161187720|NCT00811395|582063879|FG000|Extension Treatment|Adverse Event|1|||
161187721|NCT00811395|582063880|FG001|Extension Treatment|Adverse Event|2|||
161187722|NCT00811395|582063881|FG002|Extension Treatment|Adverse Event|2|||
161187723|NCT00811395|582063882|FG003|Extension Treatment|Adverse Event|2|||
161187724|NCT00811395|582063883|FG004|Extension Treatment|Adverse Event|0|||
161187725|NCT00811395|582063884|FG005|Extension Treatment|Adverse Event|1|||
161187726|NCT00811395|582063879|FG000|Extension Treatment|Progressive disease|1|||
161187727|NCT00811395|582063880|FG001|Extension Treatment|Progressive disease|1|||
161187728|NCT00811395|582063881|FG002|Extension Treatment|Progressive disease|0|||
161187729|NCT00811395|582063882|FG003|Extension Treatment|Progressive disease|0|||
161305382|NCT01938430|582498989|FG004|Overall Study|Death|0|||
161305383|NCT01938430|582498990|FG005|Overall Study|Death|0|||
161305384|NCT01938430|582498991|FG006|Overall Study|Death|1|||
161305385|NCT01938430|582498992|FG007|Overall Study|Death|1|||
161305386|NCT01938430|582498993|FG008|Overall Study|Death|2|||
161305387|NCT01938430|582498994|FG009|Overall Study|Death|3|||
161305388|NCT01938430|582498995|FG010|Overall Study|Death|0|||
161305389|NCT01938430|582498996|FG011|Overall Study|Death|0|||
161305390|NCT01938430|582498997|FG012|Overall Study|Death|0|||
161305391|NCT01938430|582498998|FG013|Overall Study|Death|0|||
161305392|NCT01938430|582498985|FG000|Overall Study|Investigator's Discretion|0|||
161305393|NCT01938430|582498986|FG001|Overall Study|Investigator's Discretion|0|||
161305394|NCT01938430|582498987|FG002|Overall Study|Investigator's Discretion|1|||
161305395|NCT01938430|582498988|FG003|Overall Study|Investigator's Discretion|0|||
161305396|NCT01938430|582498989|FG004|Overall Study|Investigator's Discretion|0|||
161305397|NCT01938430|582498990|FG005|Overall Study|Investigator's Discretion|0|||
161305398|NCT01938430|582498991|FG006|Overall Study|Investigator's Discretion|0|||
161305399|NCT01938430|582498992|FG007|Overall Study|Investigator's Discretion|0|||
161305400|NCT01938430|582498993|FG008|Overall Study|Investigator's Discretion|0|||
161305401|NCT01938430|582498994|FG009|Overall Study|Investigator's Discretion|0|||
161305402|NCT01938430|582498995|FG010|Overall Study|Investigator's Discretion|0|||
161305403|NCT01938430|582498996|FG011|Overall Study|Investigator's Discretion|0|||
161305404|NCT01938430|582498997|FG012|Overall Study|Investigator's Discretion|0|||
161305405|NCT01938430|582498998|FG013|Overall Study|Investigator's Discretion|0|||
161305406|NCT01938430|582498985|FG000|Overall Study|Lack of Efficacy|3|||
161305407|NCT01938430|582498986|FG001|Overall Study|Lack of Efficacy|1|||
161305408|NCT01938430|582498987|FG002|Overall Study|Lack of Efficacy|1|||
161305409|NCT01938430|582498988|FG003|Overall Study|Lack of Efficacy|1|||
161305410|NCT01938430|582498989|FG004|Overall Study|Lack of Efficacy|0|||
161305411|NCT01938430|582498990|FG005|Overall Study|Lack of Efficacy|0|||
161305412|NCT01938430|582498991|FG006|Overall Study|Lack of Efficacy|0|||
161305413|NCT01938430|582498992|FG007|Overall Study|Lack of Efficacy|0|||
161305414|NCT01938430|582498993|FG008|Overall Study|Lack of Efficacy|1|||
161305415|NCT01938430|582498994|FG009|Overall Study|Lack of Efficacy|0|||
161305416|NCT01938430|582498995|FG010|Overall Study|Lack of Efficacy|2|||
161305417|NCT01938430|582498996|FG011|Overall Study|Lack of Efficacy|1|||
161305418|NCT01938430|582498997|FG012|Overall Study|Lack of Efficacy|0|||
161305419|NCT01938430|582498998|FG013|Overall Study|Lack of Efficacy|0|||
161305420|NCT01938430|582498985|FG000|Overall Study|Lost to Follow-up|0|||
161305421|NCT01938430|582498986|FG001|Overall Study|Lost to Follow-up|0|||
161305422|NCT01938430|582498987|FG002|Overall Study|Lost to Follow-up|1|||
161305423|NCT01938430|582498988|FG003|Overall Study|Lost to Follow-up|0|||
161305424|NCT01938430|582498989|FG004|Overall Study|Lost to Follow-up|0|||
161305425|NCT01938430|582498990|FG005|Overall Study|Lost to Follow-up|1|||
161305426|NCT01938430|582498991|FG006|Overall Study|Lost to Follow-up|0|||
161305427|NCT01938430|582498992|FG007|Overall Study|Lost to Follow-up|0|||
161305428|NCT01938430|582498993|FG008|Overall Study|Lost to Follow-up|0|||
161305429|NCT01938430|582498994|FG009|Overall Study|Lost to Follow-up|0|||
161305430|NCT01938430|582498995|FG010|Overall Study|Lost to Follow-up|0|||
161305431|NCT01938430|582498996|FG011|Overall Study|Lost to Follow-up|0|||
161305432|NCT01938430|582498997|FG012|Overall Study|Lost to Follow-up|0|||
161305433|NCT01938430|582498998|FG013|Overall Study|Lost to Follow-up|0|||
161305434|NCT01938430|582498985|FG000|Overall Study|Withdrew Consent|0|||
161305435|NCT01938430|582498986|FG001|Overall Study|Withdrew Consent|0|||
161305436|NCT01938430|582498987|FG002|Overall Study|Withdrew Consent|0|||
161305437|NCT01938430|582498988|FG003|Overall Study|Withdrew Consent|0|||
161305438|NCT01938430|582498989|FG004|Overall Study|Withdrew Consent|0|||
161305439|NCT01938430|582498990|FG005|Overall Study|Withdrew Consent|0|||
161305440|NCT01938430|582498991|FG006|Overall Study|Withdrew Consent|0|||
161305441|NCT01938430|582498992|FG007|Overall Study|Withdrew Consent|0|||
161305442|NCT01938430|582498993|FG008|Overall Study|Withdrew Consent|1|||
161305443|NCT01938430|582498994|FG009|Overall Study|Withdrew Consent|0|||
161187730|NCT00811395|582063883|FG004|Extension Treatment|Progressive disease|0|||
161187731|NCT00811395|582063884|FG005|Extension Treatment|Progressive disease|0|||
161187732|NCT00811395|582063879|FG000|Extension Treatment|Participant did not wish to continue|0|||
161187733|NCT00811395|582063880|FG001|Extension Treatment|Participant did not wish to continue|3|||
161187734|NCT00811395|582063881|FG002|Extension Treatment|Participant did not wish to continue|0|||
161187735|NCT00811395|582063882|FG003|Extension Treatment|Participant did not wish to continue|1|||
161187736|NCT00811395|582063883|FG004|Extension Treatment|Participant did not wish to continue|0|||
161187737|NCT00811395|582063884|FG005|Extension Treatment|Participant did not wish to continue|1|||
161187738|NCT00811395|582063879|FG000|Extension Treatment|Other than above|0|||
161187739|NCT00811395|582063880|FG001|Extension Treatment|Other than above|0|||
161187740|NCT00811395|582063881|FG002|Extension Treatment|Other than above|1|||
161187741|NCT00811395|582063882|FG003|Extension Treatment|Other than above|0|||
161187742|NCT00811395|582063883|FG004|Extension Treatment|Other than above|0|||
161187743|NCT00811395|582063884|FG005|Extension Treatment|Other than above|0|||
161187744|NCT01756833|582063887|FG000|Overall Study|Withdrawal by Subject|4|||
161187745|NCT01756833|582063888|FG001|Overall Study|Withdrawal by Subject|3|||
161187746|NCT00808132|582063889|FG000|Overall Study|Adverse Event|34|||
161187747|NCT00808132|582063890|FG001|Overall Study|Adverse Event|33|||
161187748|NCT00808132|582063891|FG002|Overall Study|Adverse Event|16|||
161187749|NCT00808132|582063892|FG003|Overall Study|Adverse Event|31|||
161187750|NCT00808132|582063893|FG004|Overall Study|Adverse Event|33|||
161187751|NCT00808132|582063889|FG000|Overall Study|Death|0|||
161187752|NCT00808132|582063890|FG001|Overall Study|Death|0|||
161187753|NCT00808132|582063891|FG002|Overall Study|Death|0|||
161187754|NCT00808132|582063892|FG003|Overall Study|Death|0|||
161187755|NCT00808132|582063893|FG004|Overall Study|Death|1|||
161187756|NCT00808132|582063889|FG000|Overall Study|Physician Decision|0|||
161187757|NCT00808132|582063890|FG001|Overall Study|Physician Decision|1|||
161187758|NCT00808132|582063891|FG002|Overall Study|Physician Decision|0|||
161187759|NCT00808132|582063892|FG003|Overall Study|Physician Decision|0|||
161187760|NCT00808132|582063893|FG004|Overall Study|Physician Decision|0|||
161187761|NCT00808132|582063889|FG000|Overall Study|Lost to Follow-up|8|||
161187762|NCT00808132|582063890|FG001|Overall Study|Lost to Follow-up|10|||
161187763|NCT00808132|582063891|FG002|Overall Study|Lost to Follow-up|11|||
161187764|NCT00808132|582063892|FG003|Overall Study|Lost to Follow-up|8|||
161187765|NCT00808132|582063893|FG004|Overall Study|Lost to Follow-up|9|||
161187766|NCT00808132|582063889|FG000|Overall Study|Protocol Violation|8|||
161187767|NCT00808132|582063890|FG001|Overall Study|Protocol Violation|9|||
161187768|NCT00808132|582063891|FG002|Overall Study|Protocol Violation|4|||
161305444|NCT01938430|582498995|FG010|Overall Study|Withdrew Consent|0|||
161305445|NCT01938430|582498996|FG011|Overall Study|Withdrew Consent|0|||
161305446|NCT01938430|582498997|FG012|Overall Study|Withdrew Consent|0|||
161305447|NCT01938430|582498998|FG013|Overall Study|Withdrew Consent|0|||
161305448|NCT01613222|582499001|FG000|Overall Study|Physician Decision|1|||
161305449|NCT01613222|582499001|FG000|Overall Study|Unable to place arterial line|1|||
161305450|NCT01613222|582499001|FG000|Overall Study|Reused disposable sensors|10|||
161305451|NCT01895608|582499003|FG000|Overall Study|change in health status|0|||
161305452|NCT01895608|582499004|FG001|Overall Study|change in health status|1|||
161305453|NCT01895608|582499005|FG002|Overall Study|change in health status|1|||
161305454|NCT01895608|582499006|FG003|Overall Study|change in health status|0|||
161305455|NCT01895608|582499003|FG000|Overall Study|Withdrawal by Subject|0|||
161305456|NCT01895608|582499004|FG001|Overall Study|Withdrawal by Subject|0|||
161305457|NCT01895608|582499005|FG002|Overall Study|Withdrawal by Subject|2|||
161305458|NCT01895608|582499006|FG003|Overall Study|Withdrawal by Subject|0|||
161305459|NCT02691936|582499009|FG000|Overall Study|Withdrawal by Subject|2|||
161305460|NCT02691936|582499010|FG001|Overall Study|Withdrawal by Subject|5|||
161305461|NCT00749684|582499014|FG000|Overall Study|Death|1|||
161305462|NCT00749684|582499014|FG000|Overall Study|Adverse Event|27|||
161305463|NCT00749684|582499014|FG000|Overall Study|Participant's Wish|10|||
161305464|NCT00749684|582499014|FG000|Overall Study|Not Documented|1|||
161305465|NCT00749684|582499014|FG000|Overall Study|Progressive Desease|31|||
161305466|NCT00749684|582499014|FG000|Overall Study|Therapy according to protocol + AE|2|||
161305467|NCT00749684|582499014|FG000|Overall Study|AE+discontinuation on participants wish|1|||
161305468|NCT00749684|582499014|FG000|Overall Study|Missing|9|||
161305469|NCT03696108|582499015|FG000|Overall Study|Physician Decision|1|||
161305470|NCT03696108|582499016|FG001|Overall Study|Physician Decision|0|||
161187769|NCT00808132|582063892|FG003|Overall Study|Protocol Violation|9|||
161187770|NCT00808132|582063893|FG004|Overall Study|Protocol Violation|5|||
161187771|NCT00808132|582063889|FG000|Overall Study|Withdrawal by Subject|27|||
161187772|NCT00808132|582063890|FG001|Overall Study|Withdrawal by Subject|18|||
161187773|NCT00808132|582063891|FG002|Overall Study|Withdrawal by Subject|2|||
161187774|NCT00808132|582063892|FG003|Overall Study|Withdrawal by Subject|7|||
161187775|NCT00808132|582063893|FG004|Overall Study|Withdrawal by Subject|16|||
161187776|NCT00808132|582063889|FG000|Overall Study|Other|6|||
161187777|NCT00808132|582063890|FG001|Overall Study|Other|4|||
161187778|NCT00808132|582063891|FG002|Overall Study|Other|6|||
161187779|NCT00808132|582063892|FG003|Overall Study|Other|2|||
161187780|NCT00808132|582063893|FG004|Overall Study|Other|15|||
161187781|NCT00808132|582063889|FG000|Overall Study|Randomized, but not treated|10|||
161187782|NCT00808132|582063890|FG001|Overall Study|Randomized, but not treated|7|||
161305471|NCT03696108|582499015|FG000|Overall Study|Withdrawal by Subject|3|||
161187783|NCT00808132|582063891|FG002|Overall Study|Randomized, but not treated|9|||
161187784|NCT00808132|582063892|FG003|Overall Study|Randomized, but not treated|8|||
161187785|NCT00808132|582063893|FG004|Overall Study|Randomized, but not treated|9|||
161187786|NCT00808132|582063889|FG000|Overall Study|Unsatisfactory response|5|||
161187787|NCT00808132|582063890|FG001|Overall Study|Unsatisfactory response|6|||
161187788|NCT00808132|582063891|FG002|Overall Study|Unsatisfactory response|6|||
161187789|NCT00808132|582063892|FG003|Overall Study|Unsatisfactory response|4|||
161187790|NCT00808132|582063893|FG004|Overall Study|Unsatisfactory response|12|||
161187791|NCT01469637|582063896|FG000|First Intervention|Unacceptable behavior|0|||
161187792|NCT01469637|582063897|FG001|First Intervention|Unacceptable behavior|1|||
161187793|NCT01469637|582063896|FG000|Second Intervention|Incarcerated|1|||
161187794|NCT01469637|582063897|FG001|Second Intervention|Incarcerated|0|||
161187795|NCT01055457|582063898|FG000|Overall Study|Lost to Follow-up|0|||
161187796|NCT01055457|582063899|FG001|Overall Study|Lost to Follow-up|1|||
161187797|NCT01055457|582063900|FG002|Overall Study|Lost to Follow-up|0|||
161187798|NCT01055457|582063901|FG003|Overall Study|Lost to Follow-up|0|||
161187799|NCT01055457|582063902|FG004|Overall Study|Lost to Follow-up|0|||
161187800|NCT01055457|582063903|FG005|Overall Study|Lost to Follow-up|1|||
161187801|NCT01055457|582063904|FG006|Overall Study|Lost to Follow-up|0|||
161187802|NCT01055457|582063905|FG007|Overall Study|Lost to Follow-up|0|||
161187803|NCT01055457|582063906|FG008|Overall Study|Lost to Follow-up|0|||
161187804|NCT01055457|582063907|FG009|Overall Study|Lost to Follow-up|0|||
161187805|NCT01055457|582063898|FG000|Overall Study|Protocol Violation|0|||
161187806|NCT01055457|582063899|FG001|Overall Study|Protocol Violation|0|||
161187807|NCT01055457|582063900|FG002|Overall Study|Protocol Violation|1|||
161187808|NCT01055457|582063901|FG003|Overall Study|Protocol Violation|1|||
161187809|NCT01055457|582063902|FG004|Overall Study|Protocol Violation|1|||
161187810|NCT01055457|582063903|FG005|Overall Study|Protocol Violation|2|||
161187811|NCT01055457|582063904|FG006|Overall Study|Protocol Violation|1|||
161187812|NCT01055457|582063905|FG007|Overall Study|Protocol Violation|0|||
161187813|NCT01055457|582063906|FG008|Overall Study|Protocol Violation|0|||
161187814|NCT01055457|582063907|FG009|Overall Study|Protocol Violation|1|||
161187815|NCT01055457|582063898|FG000|Overall Study|Subject Disinterest|0|||
161187816|NCT01055457|582063899|FG001|Overall Study|Subject Disinterest|0|||
161187817|NCT01055457|582063900|FG002|Overall Study|Subject Disinterest|0|||
161187818|NCT01055457|582063901|FG003|Overall Study|Subject Disinterest|0|||
161187819|NCT01055457|582063902|FG004|Overall Study|Subject Disinterest|0|||
161187820|NCT01055457|582063903|FG005|Overall Study|Subject Disinterest|0|||
161187821|NCT01055457|582063904|FG006|Overall Study|Subject Disinterest|0|||
161187822|NCT01055457|582063905|FG007|Overall Study|Subject Disinterest|1|||
161187823|NCT01055457|582063906|FG008|Overall Study|Subject Disinterest|0|||
161187824|NCT01055457|582063907|FG009|Overall Study|Subject Disinterest|0|||
161187825|NCT01055457|582063898|FG000|Overall Study|Subject Ineligible|1|||
161187826|NCT01055457|582063899|FG001|Overall Study|Subject Ineligible|0|||
161187827|NCT01055457|582063900|FG002|Overall Study|Subject Ineligible|1|||
161187828|NCT01055457|582063901|FG003|Overall Study|Subject Ineligible|0|||
161187829|NCT01055457|582063902|FG004|Overall Study|Subject Ineligible|1|||
161187830|NCT01055457|582063903|FG005|Overall Study|Subject Ineligible|0|||
161187831|NCT01055457|582063904|FG006|Overall Study|Subject Ineligible|0|||
161187832|NCT01055457|582063905|FG007|Overall Study|Subject Ineligible|0|||
161187833|NCT01055457|582063906|FG008|Overall Study|Subject Ineligible|0|||
161187834|NCT01055457|582063907|FG009|Overall Study|Subject Ineligible|0|||
161187835|NCT01055457|582063898|FG000|Overall Study|Discomfort|0|||
161187836|NCT01055457|582063899|FG001|Overall Study|Discomfort|0|||
161187837|NCT01055457|582063900|FG002|Overall Study|Discomfort|0|||
161187838|NCT01055457|582063901|FG003|Overall Study|Discomfort|0|||
161187839|NCT01055457|582063902|FG004|Overall Study|Discomfort|1|||
161187840|NCT01055457|582063903|FG005|Overall Study|Discomfort|0|||
161187841|NCT01055457|582063904|FG006|Overall Study|Discomfort|0|||
161187842|NCT01055457|582063905|FG007|Overall Study|Discomfort|0|||
161187843|NCT01055457|582063906|FG008|Overall Study|Discomfort|0|||
161187844|NCT01055457|582063907|FG009|Overall Study|Discomfort|0|||
161187845|NCT01055457|582063898|FG000|Overall Study|Pregnancy|0|||
161187846|NCT01055457|582063899|FG001|Overall Study|Pregnancy|0|||
161187847|NCT01055457|582063900|FG002|Overall Study|Pregnancy|0|||
161187848|NCT01055457|582063901|FG003|Overall Study|Pregnancy|1|||
161187849|NCT01055457|582063902|FG004|Overall Study|Pregnancy|0|||
161187850|NCT01055457|582063903|FG005|Overall Study|Pregnancy|0|||
161187851|NCT01055457|582063904|FG006|Overall Study|Pregnancy|0|||
161187852|NCT01055457|582063905|FG007|Overall Study|Pregnancy|0|||
161187853|NCT01055457|582063906|FG008|Overall Study|Pregnancy|0|||
161187854|NCT01055457|582063907|FG009|Overall Study|Pregnancy|0|||
161187855|NCT01055457|582063898|FG000|Overall Study|Adverse Event|0|||
161187856|NCT01055457|582063899|FG001|Overall Study|Adverse Event|0|||
161187857|NCT01055457|582063900|FG002|Overall Study|Adverse Event|0|||
161187858|NCT01055457|582063901|FG003|Overall Study|Adverse Event|1|||
161187859|NCT01055457|582063902|FG004|Overall Study|Adverse Event|0|||
161187860|NCT01055457|582063903|FG005|Overall Study|Adverse Event|0|||
161187861|NCT01055457|582063904|FG006|Overall Study|Adverse Event|0|||
161187862|NCT01055457|582063905|FG007|Overall Study|Adverse Event|0|||
161187863|NCT01055457|582063906|FG008|Overall Study|Adverse Event|0|||
161187864|NCT01055457|582063907|FG009|Overall Study|Adverse Event|0|||
161187865|NCT01347840|582063910|FG000|Overall Study|Withdrawal by Subject|1|||
161187866|NCT01708915|582063913|FG000|Overall Study|Adverse Event|1|||
161187867|NCT01708915|582063914|FG001|Overall Study|Adverse Event|0|||
161187868|NCT01708915|582063915|FG002|Overall Study|Adverse Event|9|||
161187869|NCT01708915|582063916|FG003|Overall Study|Adverse Event|13|||
161187870|NCT01708915|582063913|FG000|Overall Study|Lack of Efficacy|84|||
161187871|NCT01708915|582063914|FG001|Overall Study|Lack of Efficacy|60|||
161187872|NCT01708915|582063915|FG002|Overall Study|Lack of Efficacy|35|||
161187873|NCT01708915|582063916|FG003|Overall Study|Lack of Efficacy|15|||
161187874|NCT01708915|582063913|FG000|Overall Study|Protocol Violation|0|||
161187875|NCT01708915|582063914|FG001|Overall Study|Protocol Violation|0|||
161187876|NCT01708915|582063915|FG002|Overall Study|Protocol Violation|0|||
161187877|NCT01708915|582063916|FG003|Overall Study|Protocol Violation|1|||
161187878|NCT01708915|582063913|FG000|Overall Study|Withdrawal by Subject|0|||
161187879|NCT01708915|582063914|FG001|Overall Study|Withdrawal by Subject|1|||
161187880|NCT01708915|582063915|FG002|Overall Study|Withdrawal by Subject|2|||
161187881|NCT01708915|582063916|FG003|Overall Study|Withdrawal by Subject|2|||
161187882|NCT01708915|582063913|FG000|Overall Study|Other reasons than stated above|1|||
161187883|NCT01708915|582063914|FG001|Overall Study|Other reasons than stated above|1|||
161187884|NCT01708915|582063915|FG002|Overall Study|Other reasons than stated above|0|||
161187885|NCT01708915|582063916|FG003|Overall Study|Other reasons than stated above|2|||
161187886|NCT01369069|582063917|FG000|Overall Study|Lost to Follow-up|8|||
161187887|NCT01369069|582063918|FG001|Overall Study|Lost to Follow-up|9|||
161187888|NCT01369069|582063917|FG000|Overall Study|Withdrawal by Subject|9|||
161187889|NCT01369069|582063918|FG001|Overall Study|Withdrawal by Subject|7|||
161187890|NCT01846208|582063920|FG000|Overall Study|Withdrew prior to treatment|1|||
161187891|NCT01846208|582063921|FG001|Overall Study|Withdrew prior to treatment|1|||
161187892|NCT01846208|582063922|FG002|Overall Study|Withdrew prior to treatment|1|||
161187893|NCT01846208|582063920|FG000|Overall Study|Dosing Symptoms|1|||
161187894|NCT01846208|582063921|FG001|Overall Study|Dosing Symptoms|2|||
161187895|NCT01846208|582063922|FG002|Overall Study|Dosing Symptoms|6|||
161187896|NCT01846208|582063920|FG000|Overall Study|Withdrawal by Subject|5|||
161187897|NCT01846208|582063921|FG001|Overall Study|Withdrawal by Subject|0|||
161187898|NCT01846208|582063922|FG002|Overall Study|Withdrawal by Subject|0|||
161187899|NCT01846208|582063920|FG000|Overall Study|Non-compliance|1|||
161187900|NCT01846208|582063921|FG001|Overall Study|Non-compliance|1|||
161187901|NCT01846208|582063922|FG002|Overall Study|Non-compliance|0|||
161187902|NCT01846208|582063920|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
161187903|NCT01846208|582063921|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
161187904|NCT01846208|582063922|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
161187905|NCT01846208|582063920|FG000|Overall Study|Refused SU OFC|0|||
161187906|NCT01846208|582063921|FG001|Overall Study|Refused SU OFC|0|||
161187907|NCT01846208|582063922|FG002|Overall Study|Refused SU OFC|1|||
161187908|NCT01268514|582063923|FG000|Overall Study|Adverse Event|20|||
161187909|NCT01268514|582063923|FG000|Overall Study|Death|8|||
161187910|NCT01268514|582063923|FG000|Overall Study|Lost to Follow-up|5|||
161187911|NCT01268514|582063923|FG000|Overall Study|Withdrawal by Subject|3|||
161187912|NCT01268514|582063923|FG000|Overall Study|Withdrawal by Surgeon|5|||
161187913|NCT01432938|582063924|FG000|First Intervention|Protocol Violation|1|||
161187914|NCT01432938|582063925|FG001|First Intervention|Protocol Violation|0|||
161187915|NCT01432938|582063924|FG000|First Intervention|Physician Decision|1|||
161187916|NCT01432938|582063925|FG001|First Intervention|Physician Decision|0|||
161187917|NCT01432938|582063924|FG000|Second Intervention|Adverse Event|1|||
161187918|NCT01432938|582063925|FG001|Second Intervention|Adverse Event|0|||
161187919|NCT01424306|582063926|FG000|Overall Study|Protocol Violation|0|||
161187920|NCT01424306|582063927|FG001|Overall Study|Protocol Violation|0|||
161187921|NCT01424306|582063928|FG002|Overall Study|Protocol Violation|0|||
161187922|NCT01424306|582063929|FG003|Overall Study|Protocol Violation|0|||
161187923|NCT01424306|582063930|FG004|Overall Study|Protocol Violation|1|||
161187924|NCT01424306|582063931|FG005|Overall Study|Protocol Violation|0|||
161187925|NCT01875874|582063935|FG000|Overall Study|Death|3|||
161187926|NCT01601873|582063936|FG000|Overall Study|Lost to Follow-up|2|||
161187927|NCT01601873|582063937|FG001|Overall Study|Lost to Follow-up|3|||
161187928|NCT00374127|582063938|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
161187929|NCT00374127|582063938|FG000|Overall Study|Blood could not be drawn.|2|||
161348709|NCT05415215|582663531|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
161348710|NCT05415215|582663532|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
161348711|NCT05415215|582663533|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
161348712|NCT05415215|582663534|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
161187930|NCT00374127|582063938|FG000|Overall Study|Protocol Violation|5|||
161187931|NCT00374127|582063938|FG000|Overall Study|Pregnancy|1|||
161187932|NCT00281528|582063942|FG000|Overall Study|Progressive Disease|28|||
161187933|NCT00281528|582063943|FG001|Overall Study|Progressive Disease|18|||
161187934|NCT00281528|582063944|FG002|Overall Study|Progressive Disease|27|||
161187935|NCT00281528|582063942|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
161187936|NCT00281528|582063943|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
161187937|NCT00281528|582063944|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
161187938|NCT00281528|582063942|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
161187939|NCT00281528|582063943|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
161187940|NCT00281528|582063944|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
161187941|NCT00281528|582063942|FG000|Overall Study|Physician Decision|11|||
161187942|NCT00281528|582063943|FG001|Overall Study|Physician Decision|4|||
161187943|NCT00281528|582063944|FG002|Overall Study|Physician Decision|5|||
161187944|NCT00281528|582063942|FG000|Overall Study|Protocol Violation|1|||
161187945|NCT00281528|582063943|FG001|Overall Study|Protocol Violation|0|||
161187946|NCT00281528|582063944|FG002|Overall Study|Protocol Violation|1|||
161187947|NCT00281528|582063942|FG000|Overall Study|Withdrawal by Subject|5|||
161187948|NCT00281528|582063943|FG001|Overall Study|Withdrawal by Subject|5|||
161187949|NCT00281528|582063944|FG002|Overall Study|Withdrawal by Subject|7|||
161187950|NCT00281528|582063942|FG000|Overall Study|Other|6|||
161187951|NCT00281528|582063943|FG001|Overall Study|Other|3|||
161187952|NCT00281528|582063944|FG002|Overall Study|Other|5|||
161187953|NCT02520141|582063945|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
161187954|NCT00703781|582063948|FG000|Overall Study|Withdrawal by Subject|1|||
161187955|NCT00703781|582063949|FG001|Overall Study|Withdrawal by Subject|2|||
161187956|NCT00703781|582063948|FG000|Overall Study|Cancelled surgery|1|||
161187957|NCT00703781|582063949|FG001|Overall Study|Cancelled surgery|0|||
161187958|NCT02168816|582063950|FG000|Overall Study|Lost to Follow-up|2|||
161187959|NCT02168816|582063951|FG001|Overall Study|Lost to Follow-up|2|||
161187960|NCT01225211|582063954|FG000|Overall Study|Adverse Event|0|||
161187961|NCT01225211|582063955|FG001|Overall Study|Adverse Event|0|||
161187962|NCT01225211|582063956|FG002|Overall Study|Adverse Event|1|||
161187963|NCT01225211|582063957|FG003|Overall Study|Adverse Event|0|||
161187964|NCT01225211|582063958|FG004|Overall Study|Adverse Event|0|||
161187965|NCT01225211|582063959|FG005|Overall Study|Adverse Event|0|||
161187966|NCT01225211|582063960|FG006|Overall Study|Adverse Event|0|||
161187967|NCT01225211|582063961|FG007|Overall Study|Adverse Event|0|||
161187968|NCT01225211|582063962|FG008|Overall Study|Adverse Event|0|||
161187969|NCT01225211|582063963|FG009|Overall Study|Adverse Event|1|||
161187970|NCT01225211|582063954|FG000|Overall Study|Withdrawal by Subject|0|||
161187971|NCT01225211|582063955|FG001|Overall Study|Withdrawal by Subject|0|||
161187972|NCT01225211|582063956|FG002|Overall Study|Withdrawal by Subject|0|||
161187973|NCT01225211|582063957|FG003|Overall Study|Withdrawal by Subject|0|||
161187974|NCT01225211|582063958|FG004|Overall Study|Withdrawal by Subject|0|||
161187975|NCT01225211|582063959|FG005|Overall Study|Withdrawal by Subject|0|||
161187976|NCT01225211|582063960|FG006|Overall Study|Withdrawal by Subject|1|||
161187977|NCT01225211|582063961|FG007|Overall Study|Withdrawal by Subject|0|||
161187978|NCT01225211|582063962|FG008|Overall Study|Withdrawal by Subject|1|||
161187979|NCT01225211|582063963|FG009|Overall Study|Withdrawal by Subject|3|||
161187980|NCT01225211|582063954|FG000|Overall Study|Other|0|||
161187981|NCT01225211|582063955|FG001|Overall Study|Other|0|||
161187982|NCT01225211|582063956|FG002|Overall Study|Other|0|||
161187983|NCT01225211|582063957|FG003|Overall Study|Other|0|||
161187984|NCT01225211|582063958|FG004|Overall Study|Other|0|||
161187985|NCT01225211|582063959|FG005|Overall Study|Other|0|||
161187986|NCT01225211|582063960|FG006|Overall Study|Other|0|||
161187987|NCT01225211|582063961|FG007|Overall Study|Other|0|||
161187988|NCT01225211|582063962|FG008|Overall Study|Other|0|||
161187989|NCT01225211|582063963|FG009|Overall Study|Other|1|||
161187990|NCT01984294|582063966|FG000|Overall Study|Randomized but Never Treated|0|||
161187991|NCT01984294|582063967|FG001|Overall Study|Randomized but Never Treated|0|||
161187992|NCT01984294|582063968|FG002|Overall Study|Randomized but Never Treated|1|||
161187993|NCT01984294|582063966|FG000|Overall Study|Lack of Efficacy|4|||
161187994|NCT01984294|582063967|FG001|Overall Study|Lack of Efficacy|2|||
161187995|NCT01984294|582063968|FG002|Overall Study|Lack of Efficacy|6|||
161187996|NCT01984294|582063966|FG000|Overall Study|Adverse Event|0|||
161187997|NCT01984294|582063967|FG001|Overall Study|Adverse Event|1|||
161187998|NCT01984294|582063968|FG002|Overall Study|Adverse Event|0|||
161187999|NCT01987609|582063969|FG000|Overall Study|Adverse Event|1|||
161188000|NCT02709889|582063970|FG000|Overall Study|Withdrawal by Subject|11|||
161188001|NCT02709889|582063971|FG001|Overall Study|Withdrawal by Subject|10|||
161188002|NCT02709889|582063972|FG002|Overall Study|Withdrawal by Subject|2|||
161188003|NCT02709889|582063973|FG003|Overall Study|Withdrawal by Subject|12|||
161188004|NCT02709889|582063970|FG000|Overall Study|Death|25|||
161188005|NCT02709889|582063971|FG001|Overall Study|Death|38|||
161188006|NCT02709889|582063972|FG002|Overall Study|Death|4|||
161188007|NCT02709889|582063973|FG003|Overall Study|Death|44|||
161188008|NCT02709889|582063970|FG000|Overall Study|Physician Decision|1|||
161188009|NCT02709889|582063971|FG001|Overall Study|Physician Decision|2|||
161188010|NCT02709889|582063972|FG002|Overall Study|Physician Decision|3|||
161188011|NCT02709889|582063973|FG003|Overall Study|Physician Decision|5|||
161188012|NCT02709889|582063970|FG000|Overall Study|Lost to Follow-up|2|||
161188013|NCT02709889|582063971|FG001|Overall Study|Lost to Follow-up|0|||
161188014|NCT02709889|582063972|FG002|Overall Study|Lost to Follow-up|0|||
161188015|NCT02709889|582063973|FG003|Overall Study|Lost to Follow-up|4|||
161188016|NCT02709889|582063970|FG000|Overall Study|Study Terminated by Sponsor|4|||
161188017|NCT02709889|582063971|FG001|Overall Study|Study Terminated by Sponsor|6|||
161188018|NCT02709889|582063972|FG002|Overall Study|Study Terminated by Sponsor|2|||
161188019|NCT02709889|582063973|FG003|Overall Study|Study Terminated by Sponsor|17|||
161188020|NCT02709889|582063970|FG000|Overall Study|Other, Not Specified|0|||
161188021|NCT02709889|582063971|FG001|Overall Study|Other, Not Specified|1|||
161188022|NCT02709889|582063972|FG002|Overall Study|Other, Not Specified|1|||
161188023|NCT02709889|582063973|FG003|Overall Study|Other, Not Specified|6|||
161188024|NCT01066546|582063974|FG000|Overall Study|Study terminated by sponsor|5|||
161188025|NCT00125268|582063979|FG000|Overall Study|Withdrawal by Subject|1|||
161188026|NCT00125268|582063980|FG001|Overall Study|Withdrawal by Subject|1|||
161188027|NCT00925522|582063981|FG000|Overall Study|study closed -- business decision|20|||
161188028|NCT02561572|582063986|FG000|Overall Study|Inadequate time before surgery|2|||
161188029|NCT02561572|582063987|FG001|Overall Study|Inadequate time before surgery|1|||
161188030|NCT02561572|582063986|FG000|Overall Study|Protocol Violation|0|||
161188031|NCT02561572|582063987|FG001|Overall Study|Protocol Violation|1|||
161188032|NCT02691468|582063988|FG000|Overall Study|Bronchial blocker use|2|||
161188033|NCT02691468|582063989|FG001|Overall Study|Bronchial blocker use|1|||
161188034|NCT02691468|582063988|FG000|Overall Study|Lost to Follow-up|2|||
161188035|NCT02691468|582063989|FG001|Overall Study|Lost to Follow-up|1|||
161188036|NCT02691468|582063988|FG000|Overall Study|Failure to advance FOB|2|||
161188037|NCT02691468|582063989|FG001|Overall Study|Failure to advance FOB|0|||
161188038|NCT01190020|582063992|FG000|Overall Study|Adverse Event|2|||
161188039|NCT01190020|582063993|FG001|Overall Study|Adverse Event|0|||
161188040|NCT01190020|582063992|FG000|Overall Study|Lost to Follow-up|2|||
161188041|NCT01190020|582063993|FG001|Overall Study|Lost to Follow-up|0|||
161188042|NCT01190020|582063992|FG000|Overall Study|Withdrawal by Subject|3|||
161188043|NCT01190020|582063993|FG001|Overall Study|Withdrawal by Subject|0|||
161188044|NCT04191096|582063998|FG000|Overall Study|Death|102|||
161188045|NCT04191096|582063999|FG001|Overall Study|Death|89|||
161188046|NCT04191096|582063998|FG000|Overall Study|Lost to Follow-up|1|||
161188047|NCT04191096|582063999|FG001|Overall Study|Lost to Follow-up|1|||
161188048|NCT04191096|582063998|FG000|Overall Study|Withdrawal by Subject|5|||
161188049|NCT04191096|582063999|FG001|Overall Study|Withdrawal by Subject|5|||
161188050|NCT04191096|582063998|FG000|Overall Study|Participants Ongoing|518|||
161188051|NCT04191096|582063999|FG001|Overall Study|Participants Ongoing|530|||
161188052|NCT02683668|582064003|FG000|Period 2|Withdrawal by Subject|0|||
161188053|NCT02683668|582064004|FG001|Period 2|Withdrawal by Subject|1|||
161188054|NCT02683668|582064005|FG002|Period 2|Withdrawal by Subject|0|||
161188055|NCT02390167|582065550|FG000|Overall Study|Lost to Follow-up|1|||
161188056|NCT01265719|582065552|FG000|Overall Study|Does not meet entrance criteria|0|||
161188057|NCT01265719|582065553|FG001|Overall Study|Does not meet entrance criteria|3|||
161188058|NCT01265719|582065552|FG000|Overall Study|Other reasons|2|||
161188059|NCT01265719|582065553|FG001|Overall Study|Other reasons|0|||
161188060|NCT01265719|582065552|FG000|Overall Study|Withdrawal by Subject|8|||
161188061|NCT01265719|582065553|FG001|Overall Study|Withdrawal by Subject|3|||
161188062|NCT01265719|582065552|FG000|Overall Study|Lost to Follow-up|2|||
161188063|NCT01265719|582065553|FG001|Overall Study|Lost to Follow-up|7|||
161188064|NCT01265719|582065552|FG000|Overall Study|Adverse Event|2|||
161188065|NCT01265719|582065553|FG001|Overall Study|Adverse Event|0|||
161188066|NCT00003389|582065554|FG000|Overall Study|Disease progression|6|||
161188067|NCT00003389|582065555|FG001|Overall Study|Disease progression|1|||
161188068|NCT00003389|582065554|FG000|Overall Study|Adverse Event|13|||
161188069|NCT00003389|582065555|FG001|Overall Study|Adverse Event|2|||
161188070|NCT00003389|582065554|FG000|Overall Study|Death|0|||
161188071|NCT00003389|582065555|FG001|Overall Study|Death|3|||
161188072|NCT00003389|582065554|FG000|Overall Study|Withdrawal by Subject|12|||
161188073|NCT00003389|582065555|FG001|Overall Study|Withdrawal by Subject|5|||
161188074|NCT00003389|582065554|FG000|Overall Study|Alternative therapy|2|||
161188075|NCT00003389|582065555|FG001|Overall Study|Alternative therapy|1|||
161305472|NCT03696108|582499016|FG001|Overall Study|Withdrawal by Subject|6|||
161305473|NCT03505593|582499018|FG000|Overall Study|Withdrawal by Subject|1|||
161305474|NCT03505593|582499018|FG000|Overall Study|Died before procedure|1|||
161305475|NCT03505593|582499018|FG000|Overall Study|Anatomical abnormality|1|||
161188076|NCT00003389|582065554|FG000|Overall Study|Complicating disease|1|||
161188077|NCT00003389|582065555|FG001|Overall Study|Complicating disease|0|||
161188078|NCT00003389|582065554|FG000|Overall Study|Off-treatment reason missing|31|||
161188079|NCT00003389|582065555|FG001|Overall Study|Off-treatment reason missing|21|||
161188080|NCT00003389|582065554|FG000|Overall Study|Ineligible|33|||
161188081|NCT00003389|582065555|FG001|Overall Study|Ineligible|27|||
161188082|NCT02554721|582065556|FG000|Overall Study|Adverse Event|1|||
161188083|NCT02554721|582065557|FG001|Overall Study|Adverse Event|0|||
161188084|NCT02554721|582065558|FG002|Overall Study|Adverse Event|0|||
161305476|NCT03505593|582499018|FG000|Overall Study|Unable to pass through esophagus|1|||
161188085|NCT02554721|582065559|FG003|Overall Study|Adverse Event|0|||
161188086|NCT02554721|582065560|FG004|Overall Study|Adverse Event|1|||
161188087|NCT02554721|582065556|FG000|Overall Study|Noncompliance|0|||
161188088|NCT02554721|582065557|FG001|Overall Study|Noncompliance|0|||
161188089|NCT02554721|582065558|FG002|Overall Study|Noncompliance|0|||
161188090|NCT02554721|582065559|FG003|Overall Study|Noncompliance|0|||
161188091|NCT02554721|582065560|FG004|Overall Study|Noncompliance|1|||
161188092|NCT00626327|582065566|FG000|Overall Study|Withdrawal by Subject|21|||
161188093|NCT00626327|582065567|FG001|Overall Study|Withdrawal by Subject|29|||
161188094|NCT00626327|582065568|FG002|Overall Study|Withdrawal by Subject|30|||
161188095|NCT00626327|582065566|FG000|Overall Study|Adverse Event|1|||
161188096|NCT00626327|582065567|FG001|Overall Study|Adverse Event|0|||
161188097|NCT00626327|582065568|FG002|Overall Study|Adverse Event|0|||
161188098|NCT00626327|582065566|FG000|Overall Study|Lost to Follow-up|24|||
161188099|NCT00626327|582065567|FG001|Overall Study|Lost to Follow-up|21|||
161188100|NCT00626327|582065568|FG002|Overall Study|Lost to Follow-up|23|||
161188101|NCT00626327|582065566|FG000|Overall Study|Inappropriate enrollment|4|||
161188102|NCT00626327|582065567|FG001|Overall Study|Inappropriate enrollment|5|||
161188103|NCT00626327|582065568|FG002|Overall Study|Inappropriate enrollment|3|||
161188104|NCT00626327|582065566|FG000|Overall Study|Administrative Reason|2|||
161188105|NCT00626327|582065567|FG001|Overall Study|Administrative Reason|0|||
161188106|NCT00626327|582065568|FG002|Overall Study|Administrative Reason|6|||
161188107|NCT00626327|582065566|FG000|Overall Study|Protocol Violation|26|||
161188108|NCT00626327|582065567|FG001|Overall Study|Protocol Violation|4|||
161188109|NCT00626327|582065568|FG002|Overall Study|Protocol Violation|26|||
161188110|NCT00945945|582065569|FG000|Overall Study|Adverse Event|15|||
161188111|NCT00945945|582065570|FG001|Overall Study|Adverse Event|35|||
161188112|NCT00945945|582065569|FG000|Overall Study|Withdrawal by Subject|7|||
161188113|NCT00945945|582065570|FG001|Overall Study|Withdrawal by Subject|10|||
161188114|NCT00945945|582065569|FG000|Overall Study|Lost to Follow-up|4|||
161188115|NCT00945945|582065570|FG001|Overall Study|Lost to Follow-up|5|||
161188116|NCT00945945|582065569|FG000|Overall Study|Lack of Efficacy|6|||
161188117|NCT00945945|582065570|FG001|Overall Study|Lack of Efficacy|2|||
161188118|NCT00945945|582065569|FG000|Overall Study|Protocol Violation|4|||
161188119|NCT00945945|582065570|FG001|Overall Study|Protocol Violation|2|||
161188120|NCT00945945|582065569|FG000|Overall Study|Entry Criteria Not Met|0|||
161188121|NCT00945945|582065570|FG001|Overall Study|Entry Criteria Not Met|1|||
161188122|NCT03347279|582065573|FG000|Overall Study|Withdrawal by Subject|8|||
161188123|NCT03347279|582065574|FG001|Overall Study|Withdrawal by Subject|15|||
161188124|NCT03347279|582065573|FG000|Overall Study|Death|0|||
161188125|NCT03347279|582065574|FG001|Overall Study|Death|2|||
161188126|NCT03347279|582065573|FG000|Overall Study|Lost to Follow-up|5|||
161188127|NCT03347279|582065574|FG001|Overall Study|Lost to Follow-up|2|||
161188128|NCT03347279|582065573|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
161188129|NCT03347279|582065574|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
161188130|NCT03818399|582065575|FG000|Overall Study|Lost to Follow-up|11|||
161188131|NCT03818399|582065575|FG000|Overall Study|Withdrawal by Subject|1|||
161188132|NCT03818399|582065575|FG000|Overall Study|Protocol Violation|2|||
161188133|NCT04880642|582065576|FG000|Randomization|Withdrawal by Subject|2|||
161188134|NCT04880642|582065577|FG001|Randomization|Withdrawal by Subject|3|||
161188135|NCT04880642|582065576|FG000|Treatment Period|Adverse Event|0|||
161188136|NCT04880642|582065577|FG001|Treatment Period|Adverse Event|1|||
161188137|NCT04880642|582065576|FG000|Treatment Period|Death|6|||
161188138|NCT04880642|582065577|FG001|Treatment Period|Death|6|||
161188139|NCT04880642|582065576|FG000|Treatment Period|Lost to Follow-up|1|||
161188140|NCT04880642|582065577|FG001|Treatment Period|Lost to Follow-up|0|||
161188141|NCT04880642|582065576|FG000|Treatment Period|Protocol Violation|0|||
161188142|NCT04880642|582065577|FG001|Treatment Period|Protocol Violation|1|||
161188143|NCT04880642|582065576|FG000|Treatment Period|Withdrawal by Subject|5|||
161188144|NCT04880642|582065577|FG001|Treatment Period|Withdrawal by Subject|3|||
161188145|NCT04880642|582065576|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
161188146|NCT04880642|582065577|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
161188147|NCT04880642|582065576|FG000|Follow-up|Death|4|||
161188148|NCT04880642|582065577|FG001|Follow-up|Death|3|||
161188149|NCT04880642|582065576|FG000|Follow-up|Withdrawal by Subject|1|||
161188150|NCT04880642|582065577|FG001|Follow-up|Withdrawal by Subject|0|||
161305477|NCT03505593|582499018|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
161188151|NCT03228836|582065579|FG000|Overall Study|Adverse Event|3|||
161188152|NCT03228836|582065579|FG000|Overall Study|Withdrawal by Subject|1|||
161188153|NCT03228836|582065579|FG000|Overall Study|Death|1|||
161305478|NCT03891862|582499019|FG000|Open-label Period|Adverse Event|2|||
161305479|NCT03891862|582499020|FG001|Open-label Period|Adverse Event|0|||
161188154|NCT03228836|582065579|FG000|Overall Study|Physician Decision|1|||
161188155|NCT03228836|582065579|FG000|Overall Study|Disease Progression|7|||
161188156|NCT03228836|582065579|FG000|Overall Study|Other|4|||
161188157|NCT00948389|582065580|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
161188158|NCT00948389|582065581|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
161188159|NCT00948389|582065582|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
161188160|NCT00948389|582065583|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
161188161|NCT00948389|582065584|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
161188162|NCT00948389|582065580|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
161188163|NCT00948389|582065581|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
161188164|NCT00948389|582065582|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
161188165|NCT00948389|582065583|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
161188166|NCT00948389|582065584|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
161188167|NCT00948389|582065580|FG000|Overall Study|Both Progression and Toxicity|1|||
161188168|NCT00948389|582065581|FG001|Overall Study|Both Progression and Toxicity|0|||
161188169|NCT00948389|582065582|FG002|Overall Study|Both Progression and Toxicity|0|||
161188170|NCT00948389|582065583|FG003|Overall Study|Both Progression and Toxicity|0|||
161188171|NCT00948389|582065584|FG004|Overall Study|Both Progression and Toxicity|0|||
161188172|NCT03018340|582065587|FG000|Overall Study|Adverse Event|1|||
161188173|NCT03018340|582065588|FG001|Overall Study|Adverse Event|2|||
161188174|NCT03018340|582065587|FG000|Overall Study|Withdrawal by Subject|0|||
161188175|NCT03018340|582065588|FG001|Overall Study|Withdrawal by Subject|8|||
161188176|NCT03018340|582065587|FG000|Overall Study|Lack of Efficacy|0|||
161188177|NCT03018340|582065588|FG001|Overall Study|Lack of Efficacy|1|||
161188178|NCT03018340|582065587|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
161188179|NCT03018340|582065588|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
161188180|NCT03018340|582065587|FG000|Overall Study|Lost to Follow-up|1|||
161188181|NCT03018340|582065588|FG001|Overall Study|Lost to Follow-up|7|||
161188182|NCT03018340|582065587|FG000|Overall Study|Protocol Violation|3|||
161188183|NCT03018340|582065588|FG001|Overall Study|Protocol Violation|7|||
161188184|NCT03018340|582065587|FG000|Overall Study|Not further specified|0|||
161188185|NCT03018340|582065588|FG001|Overall Study|Not further specified|1|||
161188186|NCT04652102|582065589|FG000|Overall Study|Adverse Event|14|||
161188187|NCT04652102|582065590|FG001|Overall Study|Adverse Event|13|||
161188188|NCT04652102|582065589|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
161188189|NCT04652102|582065590|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
161188190|NCT04652102|582065589|FG000|Overall Study|Physician Decision|78|||
161188191|NCT04652102|582065590|FG001|Overall Study|Physician Decision|40|||
161188192|NCT04652102|582065589|FG000|Overall Study|Study Ended by Sponsor|64|||
161188193|NCT04652102|582065590|FG001|Overall Study|Study Ended by Sponsor|17|||
161188194|NCT04652102|582065589|FG000|Overall Study|Withdrawal by Subject|4625|||
161188195|NCT04652102|582065590|FG001|Overall Study|Withdrawal by Subject|5594|||
161188196|NCT04652102|582065589|FG000|Overall Study|Lost to Follow-up|2019|||
161188197|NCT04652102|582065590|FG001|Overall Study|Lost to Follow-up|1082|||
161188198|NCT04652102|582065589|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
161188199|NCT04652102|582065590|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
161188200|NCT04652102|582065589|FG000|Overall Study|Miscellaneous|80|||
161188201|NCT04652102|582065590|FG001|Overall Study|Miscellaneous|64|||
161188202|NCT02192190|582065591|FG000|Overall Study|Adverse Event|1|||
161188203|NCT02192190|582065592|FG001|Overall Study|Adverse Event|1|||
161188204|NCT02192190|582065593|FG002|Overall Study|Adverse Event|0|||
161188205|NCT02192190|582065594|FG003|Overall Study|Adverse Event|0|||
161188206|NCT02192190|582065595|FG004|Overall Study|Adverse Event|0|||
161188207|NCT02192190|582065596|FG005|Overall Study|Adverse Event|0|||
161188208|NCT02192190|582065591|FG000|Overall Study|Lost to Follow-up|3|||
161188209|NCT02192190|582065592|FG001|Overall Study|Lost to Follow-up|3|||
161188210|NCT02192190|582065593|FG002|Overall Study|Lost to Follow-up|2|||
161188211|NCT02192190|582065594|FG003|Overall Study|Lost to Follow-up|1|||
161188212|NCT02192190|582065595|FG004|Overall Study|Lost to Follow-up|4|||
161188213|NCT02192190|582065596|FG005|Overall Study|Lost to Follow-up|3|||
161188214|NCT02192190|582065591|FG000|Overall Study|Physician Decision|2|||
161188215|NCT02192190|582065592|FG001|Overall Study|Physician Decision|0|||
161188216|NCT02192190|582065593|FG002|Overall Study|Physician Decision|0|||
161188217|NCT02192190|582065594|FG003|Overall Study|Physician Decision|0|||
161188218|NCT02192190|582065595|FG004|Overall Study|Physician Decision|0|||
161188219|NCT02192190|582065596|FG005|Overall Study|Physician Decision|0|||
161188220|NCT02192190|582065591|FG000|Overall Study|Terminated by Sponsor|43|||
161188221|NCT02192190|582065592|FG001|Overall Study|Terminated by Sponsor|23|||
161188222|NCT02192190|582065593|FG002|Overall Study|Terminated by Sponsor|20|||
161188223|NCT02192190|582065594|FG003|Overall Study|Terminated by Sponsor|23|||
161188224|NCT02192190|582065595|FG004|Overall Study|Terminated by Sponsor|21|||
161188225|NCT02192190|582065596|FG005|Overall Study|Terminated by Sponsor|23|||
161188226|NCT02192190|582065591|FG000|Overall Study|Withdrawal by Subject|4|||
161188227|NCT02192190|582065592|FG001|Overall Study|Withdrawal by Subject|1|||
161188228|NCT02192190|582065593|FG002|Overall Study|Withdrawal by Subject|2|||
161305480|NCT03891862|582499021|FG002|Open-label Period|Adverse Event|0|||
161305481|NCT03891862|582499019|FG000|Open-label Period|Protocol Violation|5|||
161188229|NCT02192190|582065594|FG003|Overall Study|Withdrawal by Subject|1|||
161305482|NCT03891862|582499020|FG001|Open-label Period|Protocol Violation|0|||
161305483|NCT03891862|582499021|FG002|Open-label Period|Protocol Violation|0|||
161188230|NCT02192190|582065595|FG004|Overall Study|Withdrawal by Subject|5|||
161188231|NCT02192190|582065596|FG005|Overall Study|Withdrawal by Subject|3|||
161188232|NCT02192190|582065591|FG000|Overall Study|Could not Keep Visit Schedule|1|||
161188233|NCT02192190|582065592|FG001|Overall Study|Could not Keep Visit Schedule|0|||
161305484|NCT03891862|582499019|FG000|Open-label Period|Withdrawal by Subject|6|||
161305485|NCT03891862|582499020|FG001|Open-label Period|Withdrawal by Subject|0|||
161188234|NCT02192190|582065593|FG002|Overall Study|Could not Keep Visit Schedule|0|||
161188235|NCT02192190|582065594|FG003|Overall Study|Could not Keep Visit Schedule|0|||
161188236|NCT02192190|582065595|FG004|Overall Study|Could not Keep Visit Schedule|0|||
161188237|NCT02192190|582065596|FG005|Overall Study|Could not Keep Visit Schedule|0|||
161188238|NCT02192190|582065591|FG000|Overall Study|Positive Drug Screen|0|||
161188239|NCT02192190|582065592|FG001|Overall Study|Positive Drug Screen|0|||
161188240|NCT02192190|582065593|FG002|Overall Study|Positive Drug Screen|0|||
161188241|NCT02192190|582065594|FG003|Overall Study|Positive Drug Screen|1|||
161188242|NCT02192190|582065595|FG004|Overall Study|Positive Drug Screen|0|||
161188243|NCT02192190|582065596|FG005|Overall Study|Positive Drug Screen|0|||
161188244|NCT02192190|582065591|FG000|Overall Study|Inadequate Pain Relief|0|||
161188245|NCT02192190|582065592|FG001|Overall Study|Inadequate Pain Relief|1|||
161188246|NCT02192190|582065593|FG002|Overall Study|Inadequate Pain Relief|1|||
161188247|NCT02192190|582065594|FG003|Overall Study|Inadequate Pain Relief|0|||
161188248|NCT02192190|582065595|FG004|Overall Study|Inadequate Pain Relief|0|||
161188249|NCT02192190|582065596|FG005|Overall Study|Inadequate Pain Relief|0|||
161188250|NCT00381706|582065597|FG000|Overall Study|Never treated|7|||
161188251|NCT00381706|582065598|FG001|Overall Study|Never treated|2|||
161188252|NCT00381706|582065599|FG002|Overall Study|Never treated|1|||
161188253|NCT02364999|582065600|FG000|Overall Study|Death|136|||
161188254|NCT02364999|582065601|FG001|Overall Study|Death|138|||
161188255|NCT02364999|582065600|FG000|Overall Study|Lost to Follow-up|10|||
161188256|NCT02364999|582065601|FG001|Overall Study|Lost to Follow-up|15|||
161188257|NCT02364999|582065600|FG000|Overall Study|Protocol Violation|3|||
161188258|NCT02364999|582065601|FG001|Overall Study|Protocol Violation|2|||
161188259|NCT02364999|582065600|FG000|Overall Study|Withdrawal by Subject|14|||
161188260|NCT02364999|582065601|FG001|Overall Study|Withdrawal by Subject|14|||
161188261|NCT02364999|582065600|FG000|Overall Study|Other|0|||
161188262|NCT02364999|582065601|FG001|Overall Study|Other|1|||
161188263|NCT02364999|582065600|FG000|Overall Study|Randomized but did not receive treatment|2|||
161188264|NCT02364999|582065601|FG001|Overall Study|Randomized but did not receive treatment|3|||
161188265|NCT01234337|582065602|FG000|Overall Study|Adverse Event|58|||
161188266|NCT01234337|582065603|FG001|Overall Study|Adverse Event|21|||
161188267|NCT01234337|582065602|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
161188268|NCT01234337|582065603|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
161188269|NCT01234337|582065602|FG000|Overall Study|Investi. decision not protocol driven|5|||
161188270|NCT01234337|582065603|FG001|Overall Study|Investi. decision not protocol driven|6|||
161188271|NCT01234337|582065602|FG000|Overall Study|Non-compliant with study medication|3|||
161188272|NCT01234337|582065603|FG001|Overall Study|Non-compliant with study medication|2|||
161188273|NCT01234337|582065602|FG000|Overall Study|Randomized but not treated|6|||
161188274|NCT01234337|582065603|FG001|Overall Study|Randomized but not treated|4|||
161188275|NCT01234337|582065602|FG000|Overall Study|Lost to Follow-up|0|||
161188276|NCT01234337|582065603|FG001|Overall Study|Lost to Follow-up|1|||
161188277|NCT01234337|582065602|FG000|Overall Study|Protocol Violation|2|||
161188278|NCT01234337|582065603|FG001|Overall Study|Protocol Violation|3|||
161188279|NCT01234337|582065602|FG000|Overall Study|Withdrawal by Subject|11|||
161188280|NCT01234337|582065603|FG001|Overall Study|Withdrawal by Subject|9|||
161188281|NCT01234337|582065602|FG000|Overall Study|Death|0|||
161188282|NCT01234337|582065603|FG001|Overall Study|Death|1|||
161188283|NCT01234337|582065602|FG000|Overall Study|Switch to commercial drug|0|||
161188284|NCT01234337|582065603|FG001|Overall Study|Switch to commercial drug|1|||
161188285|NCT00890201|582065607|FG000|Overall Study|Protocol Violation|5|||
161188286|NCT00890201|582065608|FG001|Overall Study|Protocol Violation|56|||
161188287|NCT00545584|582065613|FG000|Overall Study|Only one reason for discontinuation|62|||
161188288|NCT00545584|582065614|FG001|Overall Study|Only one reason for discontinuation|61|||
161188289|NCT00545584|582065615|FG002|Overall Study|Only one reason for discontinuation|48|||
161188290|NCT00545584|582065613|FG000|Overall Study|Two or more reasons for discontinuation|17|||
161188291|NCT00545584|582065614|FG001|Overall Study|Two or more reasons for discontinuation|19|||
161188292|NCT00545584|582065615|FG002|Overall Study|Two or more reasons for discontinuation|8|||
161188293|NCT00135694|582065616|FG000|Overall Study|Adverse Event|17|||
161188294|NCT00135694|582065617|FG001|Overall Study|Adverse Event|4|||
161188295|NCT00135694|582065618|FG002|Overall Study|Adverse Event|0|||
161188296|NCT00135694|582065616|FG000|Overall Study|Death|14|||
161188297|NCT00135694|582065617|FG001|Overall Study|Death|1|||
161188298|NCT00135694|582065618|FG002|Overall Study|Death|2|||
161188299|NCT00135694|582065616|FG000|Overall Study|Lost to Follow-up|8|||
161188300|NCT00135694|582065617|FG001|Overall Study|Lost to Follow-up|7|||
161188301|NCT00135694|582065618|FG002|Overall Study|Lost to Follow-up|1|||
161188302|NCT00135694|582065616|FG000|Overall Study|Withdrawal by Subject|41|||
161188303|NCT00135694|582065617|FG001|Overall Study|Withdrawal by Subject|7|||
161188304|NCT00135694|582065618|FG002|Overall Study|Withdrawal by Subject|4|||
161188305|NCT00135694|582065616|FG000|Overall Study|Protocol Violation|19|||
161188306|NCT00135694|582065617|FG001|Overall Study|Protocol Violation|1|||
161188307|NCT00135694|582065618|FG002|Overall Study|Protocol Violation|0|||
161188308|NCT00135694|582065616|FG000|Overall Study|Hepatitis C related reasons|39|||
161188309|NCT00135694|582065617|FG001|Overall Study|Hepatitis C related reasons|1|||
161188310|NCT00135694|582065618|FG002|Overall Study|Hepatitis C related reasons|0|||
161188311|NCT00135694|582065616|FG000|Overall Study|Ineligible for Random assignment|42|||
161188312|NCT00135694|582065617|FG001|Overall Study|Ineligible for Random assignment|0|||
161188313|NCT00135694|582065618|FG002|Overall Study|Ineligible for Random assignment|0|||
161188314|NCT02584660|582065619|FG000|Overall Study|Adverse Event|4|||
161188315|NCT02584660|582065620|FG001|Overall Study|Adverse Event|0|||
161188316|NCT02584660|582065619|FG000|Overall Study|Lost to Follow-up|3|||
161188317|NCT02584660|582065620|FG001|Overall Study|Lost to Follow-up|4|||
161188318|NCT02584660|582065619|FG000|Overall Study|Protocol Violation|0|||
161188319|NCT02584660|582065620|FG001|Overall Study|Protocol Violation|1|||
161188320|NCT02584660|582065619|FG000|Overall Study|Withdrawal by Subject|0|||
161188321|NCT02584660|582065620|FG001|Overall Study|Withdrawal by Subject|2|||
161188322|NCT02584660|582065619|FG000|Overall Study|Other|0|||
161188323|NCT02584660|582065620|FG001|Overall Study|Other|1|||
161188324|NCT02096471|582065622|FG000|Overall Study|Adverse Event|1|||
161188325|NCT02096471|582065622|FG000|Overall Study|Lack of Efficacy|7|||
161188326|NCT02096471|582065622|FG000|Overall Study|Withdrawal by Subject|3|||
161188327|NCT02096471|582065622|FG000|Overall Study|Non-Compliant|2|||
161188328|NCT02736474|582065623|FG000|Overall Study|Lost to Follow-up|0|||
161188329|NCT02736474|582065624|FG001|Overall Study|Lost to Follow-up|1|||
161188330|NCT02463331|582065625|FG000|Overall Study|Adverse Event|4|||
161188331|NCT02463331|582065626|FG001|Overall Study|Adverse Event|2|||
161188332|NCT02463331|582065625|FG000|Overall Study|Lost to Follow-up|1|||
161188333|NCT02463331|582065626|FG001|Overall Study|Lost to Follow-up|1|||
161188334|NCT02463331|582065625|FG000|Overall Study|Pregnancy|2|||
161188335|NCT02463331|582065626|FG001|Overall Study|Pregnancy|3|||
161188336|NCT02463331|582065625|FG000|Overall Study|Lack of Efficacy|6|||
161188337|NCT02463331|582065626|FG001|Overall Study|Lack of Efficacy|0|||
161188338|NCT02463331|582065625|FG000|Overall Study|Physician Decision|3|||
161188339|NCT02463331|582065626|FG001|Overall Study|Physician Decision|0|||
161188340|NCT02483611|582065627|FG000|Overall Study|Protocol Violation|0|||
161188341|NCT02483611|582065628|FG001|Overall Study|Protocol Violation|0|||
161188342|NCT02483611|582065629|FG002|Overall Study|Protocol Violation|1|||
161188343|NCT02590406|582065630|FG000|Overall Study|Adverse Event|1|||
161188344|NCT02590406|582065631|FG001|Overall Study|Adverse Event|0|||
161188345|NCT02590406|582065630|FG000|Overall Study|Saturometer malfunction|0|||
161188346|NCT02590406|582065631|FG001|Overall Study|Saturometer malfunction|1|||
161188347|NCT00537810|582065642|FG000|Overall Study|Withdrawal by Subject|4|||
161188348|NCT00537810|582065643|FG001|Overall Study|Withdrawal by Subject|11|||
161188349|NCT00537810|582065644|FG002|Overall Study|Withdrawal by Subject|4|||
161188350|NCT00537810|582065645|FG003|Overall Study|Withdrawal by Subject|3|||
161188351|NCT00537810|582065642|FG000|Overall Study|Medically withdrawn|2|||
161188352|NCT00537810|582065643|FG001|Overall Study|Medically withdrawn|2|||
161188353|NCT00537810|582065644|FG002|Overall Study|Medically withdrawn|0|||
161188354|NCT00537810|582065645|FG003|Overall Study|Medically withdrawn|1|||
161188355|NCT03452397|582065646|FG000|Overall Study|Adverse Event|1|||
161188356|NCT03452397|582065647|FG001|Overall Study|Adverse Event|0|||
161188357|NCT03452397|582065648|FG002|Overall Study|Adverse Event|0|||
161188358|NCT03452397|582065649|FG003|Overall Study|Adverse Event|0|||
161188359|NCT03452397|582065646|FG000|Overall Study|Administrative reason|0|||
161188360|NCT03452397|582065647|FG001|Overall Study|Administrative reason|0|||
161188361|NCT03452397|582065648|FG002|Overall Study|Administrative reason|1|||
161188362|NCT03452397|582065649|FG003|Overall Study|Administrative reason|1|||
161188363|NCT03452397|582065646|FG000|Overall Study|Withdrawal by Subject|0|||
161188364|NCT03452397|582065647|FG001|Overall Study|Withdrawal by Subject|0|||
161188365|NCT03452397|582065648|FG002|Overall Study|Withdrawal by Subject|1|||
161188366|NCT03452397|582065649|FG003|Overall Study|Withdrawal by Subject|0|||
161188367|NCT00410514|582065650|FG000|Overall Study|Adverse Event|2|||
161188368|NCT00410514|582065651|FG001|Overall Study|Adverse Event|2|||
161188369|NCT00410514|582065652|FG002|Overall Study|Adverse Event|2|||
161188370|NCT00410514|582065650|FG000|Overall Study|Protocol Violation|0|||
161305486|NCT03891862|582499021|FG002|Open-label Period|Withdrawal by Subject|0|||
161305487|NCT03891862|582499019|FG000|Open-label Period|Death|1|||
161305488|NCT03891862|582499020|FG001|Open-label Period|Death|0|||
161305489|NCT03891862|582499021|FG002|Open-label Period|Death|0|||
161188371|NCT00410514|582065651|FG001|Overall Study|Protocol Violation|1|||
161188372|NCT00410514|582065652|FG002|Overall Study|Protocol Violation|1|||
161188373|NCT00410514|582065650|FG000|Overall Study|Lost to Follow-up|0|||
161188374|NCT00410514|582065651|FG001|Overall Study|Lost to Follow-up|0|||
161188375|NCT00410514|582065652|FG002|Overall Study|Lost to Follow-up|2|||
161188376|NCT00410514|582065650|FG000|Overall Study|Non-compliant with study procedures|0|||
161188377|NCT00410514|582065651|FG001|Overall Study|Non-compliant with study procedures|0|||
161188378|NCT00410514|582065652|FG002|Overall Study|Non-compliant with study procedures|2|||
161305490|NCT03891862|582499019|FG000|Open-label Period|Lost to Follow-up|2|||
161188379|NCT02449915|582065654|FG000|Overall Study|Exclusion criteria - drug use|1|||
161188380|NCT02449915|582065655|FG001|Overall Study|Exclusion criteria - drug use|0|||
161188381|NCT02449915|582065654|FG000|Overall Study|Withdrawal by Subject|0|||
161188382|NCT02449915|582065655|FG001|Overall Study|Withdrawal by Subject|2|||
161305491|NCT03891862|582499020|FG001|Open-label Period|Lost to Follow-up|0|||
161188383|NCT02449915|582065654|FG000|Overall Study|Intraoperative surgical findings|1|||
161188384|NCT02449915|582065655|FG001|Overall Study|Intraoperative surgical findings|1|||
161188385|NCT02449915|582065654|FG000|Overall Study|Abnormal preop lab|0|||
161188386|NCT02449915|582065655|FG001|Overall Study|Abnormal preop lab|1|||
161188387|NCT01436357|582065656|FG000|Overall Study|Death|5|||
161188388|NCT01436357|582065657|FG001|Overall Study|Death|1|||
161188389|NCT01436357|582065656|FG000|Overall Study|Enrolled but not vaccinated|1|||
161188390|NCT01436357|582065657|FG001|Overall Study|Enrolled but not vaccinated|1|||
161188391|NCT01436357|582065656|FG000|Overall Study|Incarceration|18|||
161188392|NCT01436357|582065657|FG001|Overall Study|Incarceration|20|||
161188393|NCT01436357|582065656|FG000|Overall Study|Lost to Follow-up|67|||
161188394|NCT01436357|582065657|FG001|Overall Study|Lost to Follow-up|61|||
161188395|NCT01436357|582065656|FG000|Overall Study|Protocol Violation|1|||
161188396|NCT01436357|582065657|FG001|Overall Study|Protocol Violation|0|||
161188397|NCT01436357|582065656|FG000|Overall Study|Withdrawal by Subject|26|||
161188398|NCT01436357|582065657|FG001|Overall Study|Withdrawal by Subject|38|||
161188399|NCT01436357|582065656|FG000|Overall Study|Physician Decision|3|||
161188400|NCT01436357|582065657|FG001|Overall Study|Physician Decision|4|||
161188401|NCT01436357|582065656|FG000|Overall Study|Moved out of area|1|||
161188402|NCT01436357|582065657|FG001|Overall Study|Moved out of area|2|||
161188403|NCT01436357|582065656|FG000|Overall Study|Subject in rehab|0|||
161188404|NCT01436357|582065657|FG001|Overall Study|Subject in rehab|1|||
161188405|NCT01021293|582065668|FG000|Overall Study|Serious Adverse Event|2|||
161188406|NCT01021293|582065669|FG001|Overall Study|Serious Adverse Event|1|||
161188407|NCT01021293|582065668|FG000|Overall Study|Adverse Event|2|||
161188408|NCT01021293|582065669|FG001|Overall Study|Adverse Event|1|||
161188409|NCT01021293|582065668|FG000|Overall Study|Withdrawal by Subject|1|||
161188410|NCT01021293|582065669|FG001|Overall Study|Withdrawal by Subject|3|||
161188411|NCT01021293|582065668|FG000|Overall Study|Migrated/moved from study area|6|||
161188412|NCT01021293|582065669|FG001|Overall Study|Migrated/moved from study area|18|||
161188413|NCT01021293|582065668|FG000|Overall Study|Lost to Follow-up|1|||
161305492|NCT03891862|582499021|FG002|Open-label Period|Lost to Follow-up|0|||
161305493|NCT03891862|582499019|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
161305494|NCT03891862|582499020|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
161305495|NCT03891862|582499021|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
161305496|NCT03891862|582499019|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
161305497|NCT03891862|582499020|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
161305498|NCT03891862|582499021|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
161305499|NCT03891862|582499019|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
161305500|NCT03891862|582499020|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
161305501|NCT03891862|582499021|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
161305502|NCT03891862|582499019|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
161305503|NCT03891862|582499020|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
161305504|NCT03891862|582499021|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
161305505|NCT01194531|582499022|FG000|Overall Study|Withdrawal by Subject|1|||
161305506|NCT01194531|582499023|FG001|Overall Study|Withdrawal by Subject|0|||
161305507|NCT01194531|582499022|FG000|Overall Study|Protocol Violation|4|||
161305508|NCT01194531|582499023|FG001|Overall Study|Protocol Violation|1|||
161305509|NCT01194531|582499022|FG000|Overall Study|Physician Decision|0|||
161305510|NCT01194531|582499023|FG001|Overall Study|Physician Decision|2|||
161305511|NCT01053962|582499026|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161305512|NCT01053962|582499027|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161305513|NCT01053962|582499028|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
161305514|NCT01053962|582499029|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
161305515|NCT01053962|582499030|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
161305516|NCT01053962|582499026|FG000|Pretreatment Period|Venipuncture Failure|0|||
161305517|NCT01053962|582499027|FG001|Pretreatment Period|Venipuncture Failure|0|||
161305518|NCT01053962|582499028|FG002|Pretreatment Period|Venipuncture Failure|1|||
161305519|NCT01053962|582499029|FG003|Pretreatment Period|Venipuncture Failure|0|||
161305520|NCT01053962|582499030|FG004|Pretreatment Period|Venipuncture Failure|0|||
161305521|NCT01053962|582499026|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161305522|NCT01053962|582499027|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
161305523|NCT01053962|582499028|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161305524|NCT01053962|582499029|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161305525|NCT01053962|582499030|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
161188414|NCT01021293|582065669|FG001|Overall Study|Lost to Follow-up|1|||
161188415|NCT00631969|582065672|FG000|Overall Study|Adverse Event|3|||
161188416|NCT00631969|582065673|FG001|Overall Study|Adverse Event|1|||
161188417|NCT00631969|582065672|FG000|Overall Study|Lack of Efficacy|2|||
161188418|NCT00631969|582065673|FG001|Overall Study|Lack of Efficacy|8|||
161188419|NCT00631969|582065672|FG000|Overall Study|Lost to Follow-up|2|||
161188420|NCT00631969|582065673|FG001|Overall Study|Lost to Follow-up|1|||
161188421|NCT00631969|582065672|FG000|Overall Study|Protocol Violation|1|||
161188422|NCT00631969|582065673|FG001|Overall Study|Protocol Violation|1|||
161188423|NCT00631969|582065672|FG000|Overall Study|Consent Withdrawn|5|||
161188424|NCT00631969|582065673|FG001|Overall Study|Consent Withdrawn|7|||
161188425|NCT00631969|582065672|FG000|Overall Study|Noncompliant With Study Medication|0|||
161188426|NCT00631969|582065673|FG001|Overall Study|Noncompliant With Study Medication|1|||
161188427|NCT00631969|582065672|FG000|Overall Study|No Drug Exposure|2|||
161188428|NCT00631969|582065673|FG001|Overall Study|No Drug Exposure|2|||
161188429|NCT04223778|582065674|FG000|Overall Study|Death|1|||
161188430|NCT04223778|582065675|FG001|Overall Study|Death|1|||
161188431|NCT04223778|582065674|FG000|Overall Study|Lost to Follow-up|4|||
161188432|NCT04223778|582065675|FG001|Overall Study|Lost to Follow-up|5|||
161188433|NCT04223778|582065674|FG000|Overall Study|Physician Decision|10|||
161188434|NCT04223778|582065675|FG001|Overall Study|Physician Decision|6|||
161188435|NCT04223778|582065674|FG000|Overall Study|Withdrawal by Subject|35|||
161188436|NCT04223778|582065675|FG001|Overall Study|Withdrawal by Subject|17|||
161188437|NCT04223778|582065674|FG000|Overall Study|Not Reported|7|||
161188438|NCT04223778|582065675|FG001|Overall Study|Not Reported|8|||
161188439|NCT03893630|582065678|FG000|Overall Study|Lost to Follow-up|5|||
161188440|NCT03893630|582065679|FG001|Overall Study|Lost to Follow-up|4|||
161188441|NCT03893630|582065680|FG002|Overall Study|Lost to Follow-up|2|||
161188442|NCT03893630|582065678|FG000|Overall Study|Withdrawal by Subject|3|||
161188443|NCT03893630|582065679|FG001|Overall Study|Withdrawal by Subject|6|||
161188444|NCT03893630|582065680|FG002|Overall Study|Withdrawal by Subject|3|||
161188445|NCT03893630|582065678|FG000|Overall Study|Discontinued Intervention|0|||
161188446|NCT03893630|582065679|FG001|Overall Study|Discontinued Intervention|4|||
161188447|NCT03893630|582065680|FG002|Overall Study|Discontinued Intervention|2|||
161188448|NCT00303602|582066848|FG000|Overall Study|Adverse Event|2|||
161188449|NCT00303602|582066849|FG001|Overall Study|Adverse Event|2|||
161188450|NCT00303602|582066848|FG000|Overall Study|Withdrawal by Subject|5|||
161188451|NCT00303602|582066849|FG001|Overall Study|Withdrawal by Subject|6|||
161188452|NCT00303602|582066848|FG000|Overall Study|Lost to Follow-up|5|||
161188453|NCT00303602|582066849|FG001|Overall Study|Lost to Follow-up|2|||
161188454|NCT00303602|582066848|FG000|Overall Study|Protocol entry criteria not met|2|||
161188455|NCT00303602|582066849|FG001|Overall Study|Protocol entry criteria not met|2|||
161188456|NCT00303602|582066848|FG000|Overall Study|Physician Decision|2|||
161188457|NCT00303602|582066849|FG001|Overall Study|Physician Decision|1|||
161188458|NCT00303602|582066848|FG000|Overall Study|Noncompliance|2|||
161188459|NCT00303602|582066849|FG001|Overall Study|Noncompliance|2|||
161188460|NCT00303602|582066848|FG000|Overall Study|Protocol Violation|1|||
161188461|NCT00303602|582066849|FG001|Overall Study|Protocol Violation|0|||
161188462|NCT00750867|582066856|FG000|Overall Study|Adverse Event|2|||
161188463|NCT00394654|582066857|FG000|Overall Study|Lost to Follow-up|1|||
161188464|NCT00394654|582066858|FG001|Overall Study|Lost to Follow-up|0|||
161188465|NCT00394654|582066857|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
161188466|NCT00394654|582066858|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
161188467|NCT00474539|582066859|FG000|Infant Series|Withdrawal by Subject|3|||
161188468|NCT00474539|582066860|FG001|Infant Series|Withdrawal by Subject|4|||
161188469|NCT00474539|582066859|FG000|Infant Series|Randomization error|5|||
161188470|NCT00474539|582066860|FG001|Infant Series|Randomization error|0|||
161188471|NCT00474539|582066859|FG000|Infant Series|Lost to Follow-up|2|||
161188472|NCT00474539|582066860|FG001|Infant Series|Lost to Follow-up|1|||
161188473|NCT00474539|582066859|FG000|Infant Series|Protocol Violation|0|||
161188474|NCT00474539|582066860|FG001|Infant Series|Protocol Violation|1|||
161188475|NCT00474539|582066859|FG000|After Infant Series|Lost to Follow-up|3|||
161188476|NCT00474539|582066860|FG001|After Infant Series|Lost to Follow-up|0|||
161188477|NCT00474539|582066859|FG000|After Infant Series|Withdrawal by Subject|1|||
161188478|NCT00474539|582066860|FG001|After Infant Series|Withdrawal by Subject|0|||
161188479|NCT00474539|582066859|FG000|Toddler Dose|Protocol Violation|1|||
161188480|NCT00474539|582066860|FG001|Toddler Dose|Protocol Violation|0|||
161188481|NCT03442595|582066861|FG000|Overall Study|Lost to Follow-up|94|||
161188482|NCT03442595|582066862|FG001|Overall Study|Lost to Follow-up|0|||
161188483|NCT01060150|582066867|FG000|Overall Study|Adverse Event|6|||
161188484|NCT01060150|582066867|FG000|Overall Study|Lost to Follow-up|1|||
161188485|NCT01060150|582066867|FG000|Overall Study|Protocol Violation|6|||
161188486|NCT01060150|582066867|FG000|Overall Study|Withdrawal by Subject|8|||
161188487|NCT01060150|582066867|FG000|Overall Study|Enrolled, but not treated|2|||
161188488|NCT01836549|582066868|FG000|Overall Study|Did not receive study drug|0|||
161188489|NCT01836549|582066869|FG001|Overall Study|Did not receive study drug|0|||
161305526|NCT01053962|582499026|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161188490|NCT01836549|582066870|FG002|Overall Study|Did not receive study drug|1|||
161188491|NCT01836549|582066871|FG003|Overall Study|Did not receive study drug|0|||
161305527|NCT01053962|582499027|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161305528|NCT01053962|582499028|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161188492|NCT01836549|582066872|FG004|Overall Study|Did not receive study drug|0|||
161188493|NCT01836549|582066873|FG005|Overall Study|Did not receive study drug|0|||
161188494|NCT01836549|582066874|FG006|Overall Study|Did not receive study drug|0|||
161188495|NCT01836549|582066868|FG000|Overall Study|Patient declared ineligible|0|||
161188496|NCT01836549|582066869|FG001|Overall Study|Patient declared ineligible|0|||
161305529|NCT01053962|582499029|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
161188497|NCT01836549|582066870|FG002|Overall Study|Patient declared ineligible|0|||
161188498|NCT01836549|582066871|FG003|Overall Study|Patient declared ineligible|1|||
161188499|NCT01836549|582066872|FG004|Overall Study|Patient declared ineligible|0|||
161188500|NCT01836549|582066873|FG005|Overall Study|Patient declared ineligible|0|||
161188501|NCT01836549|582066874|FG006|Overall Study|Patient declared ineligible|0|||
161188502|NCT01836549|582066868|FG000|Overall Study|Patient inevaluable to start therapy|0|||
161188503|NCT01836549|582066869|FG001|Overall Study|Patient inevaluable to start therapy|0|||
161188504|NCT01836549|582066870|FG002|Overall Study|Patient inevaluable to start therapy|0|||
161188505|NCT01836549|582066871|FG003|Overall Study|Patient inevaluable to start therapy|0|||
161188506|NCT01836549|582066872|FG004|Overall Study|Patient inevaluable to start therapy|0|||
161188507|NCT01836549|582066873|FG005|Overall Study|Patient inevaluable to start therapy|0|||
161188508|NCT01836549|582066874|FG006|Overall Study|Patient inevaluable to start therapy|1|||
161188509|NCT00550615|582066875|FG000|Overall Study|Withdrawal by Subject|0|||
161188510|NCT00550615|582066876|FG001|Overall Study|Withdrawal by Subject|0|||
161188511|NCT00550615|582066877|FG002|Overall Study|Withdrawal by Subject|2|||
161188512|NCT00550615|582066878|FG003|Overall Study|Withdrawal by Subject|3|||
161188513|NCT00550615|582066875|FG000|Overall Study|Not evaluable|0|||
161188514|NCT00550615|582066876|FG001|Overall Study|Not evaluable|0|||
161188515|NCT00550615|582066877|FG002|Overall Study|Not evaluable|2|||
161188516|NCT00550615|582066878|FG003|Overall Study|Not evaluable|7|||
161188517|NCT02181504|582066879|FG000|Overall Study|Adverse Event|1|||
161188518|NCT02181504|582066880|FG001|Overall Study|Adverse Event|1|||
161188519|NCT02181504|582066881|FG002|Overall Study|Adverse Event|1|||
161188520|NCT00461552|582066889|FG000|Overall Study|Drug Dispensing error|0|||
161188521|NCT00461552|582066890|FG001|Overall Study|Drug Dispensing error|2|||
161188522|NCT00660816|582066891|FG000|Overall Study|Adverse Event|1|||
161188523|NCT00660816|582066892|FG001|Overall Study|Adverse Event|2|||
161188524|NCT00660816|582066891|FG000|Overall Study|Withdrawal by Subject|1|||
161188525|NCT00660816|582066892|FG001|Overall Study|Withdrawal by Subject|0|||
161188526|NCT00660816|582066891|FG000|Overall Study|Death|0|||
161188527|NCT00660816|582066892|FG001|Overall Study|Death|2|||
161188528|NCT00660816|582066891|FG000|Overall Study|Lack of Efficacy|1|||
161188529|NCT00660816|582066892|FG001|Overall Study|Lack of Efficacy|0|||
161188530|NCT00660816|582066891|FG000|Overall Study|Physician Decision|0|||
161188531|NCT00660816|582066892|FG001|Overall Study|Physician Decision|2|||
161188532|NCT00660816|582066891|FG000|Overall Study|Protocol Violation|1|||
161188533|NCT00660816|582066892|FG001|Overall Study|Protocol Violation|0|||
161188534|NCT00660816|582066891|FG000|Overall Study|Disease Progression|16|||
161188535|NCT00660816|582066892|FG001|Overall Study|Disease Progression|12|||
161188536|NCT00660816|582066891|FG000|Overall Study|Complicating Disease|0|||
161188537|NCT00660816|582066892|FG001|Overall Study|Complicating Disease|1|||
161188538|NCT00374452|582066893|FG000|Overall Study|Left clinic before intervention started|4|||
161188539|NCT00374452|582066894|FG001|Overall Study|Left clinic before intervention started|1|||
161188540|NCT00374452|582066893|FG000|Overall Study|Change in job role before intervention|0|||
161188541|NCT00374452|582066894|FG001|Overall Study|Change in job role before intervention|1|||
161188542|NCT00374452|582066893|FG000|Overall Study|Left clinic after intervention started|1|||
161188543|NCT00374452|582066894|FG001|Overall Study|Left clinic after intervention started|1|||
161188544|NCT00374452|582066893|FG000|Overall Study|Withdrawal by Subject|0|||
161188545|NCT00374452|582066894|FG001|Overall Study|Withdrawal by Subject|2|||
161188546|NCT02877134|582066895|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188547|NCT02877134|582066896|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
161188548|NCT02877134|582066897|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188549|NCT02877134|582066898|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188550|NCT02877134|582066899|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188551|NCT02877134|582066900|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
161188552|NCT02877134|582066901|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188553|NCT02877134|582066902|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188554|NCT02877134|582066903|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188555|NCT02877134|582066904|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188556|NCT02877134|582066905|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188557|NCT02877134|582066906|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
161188558|NCT02877134|582066895|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188559|NCT02877134|582066896|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
161188560|NCT02877134|582066897|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188561|NCT02877134|582066898|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
161188562|NCT02877134|582066899|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188563|NCT02877134|582066900|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188564|NCT02877134|582066901|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
161188565|NCT02877134|582066902|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188566|NCT02877134|582066903|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188567|NCT02877134|582066904|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188568|NCT02877134|582066905|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188569|NCT02877134|582066906|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
161188570|NCT02877134|582066895|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
161188571|NCT02877134|582066896|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
161188572|NCT02877134|582066897|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
161188573|NCT02877134|582066898|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
161188574|NCT02877134|582066899|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
161188575|NCT02877134|582066900|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
161188576|NCT02877134|582066901|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
161188577|NCT02877134|582066902|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161188578|NCT02877134|582066903|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161188579|NCT02877134|582066904|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161188580|NCT02877134|582066905|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161188581|NCT02877134|582066906|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
161188582|NCT02877134|582066895|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
161188583|NCT02877134|582066896|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
161188584|NCT02877134|582066897|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
161188585|NCT02877134|582066898|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
161188586|NCT02877134|582066899|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
161188587|NCT02877134|582066900|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
161188588|NCT02877134|582066901|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
161188589|NCT02877134|582066902|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
161188590|NCT02877134|582066903|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
161188591|NCT02877134|582066904|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
161188592|NCT02877134|582066905|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
161188593|NCT02877134|582066906|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
161188594|NCT02877134|582066895|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188595|NCT02877134|582066896|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188596|NCT02877134|582066897|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188597|NCT02877134|582066898|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188598|NCT02877134|582066899|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188599|NCT02877134|582066900|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188600|NCT02877134|582066901|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188601|NCT02877134|582066902|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188602|NCT02877134|582066903|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
161188603|NCT02877134|582066904|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188604|NCT02877134|582066905|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188605|NCT02877134|582066906|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
161188606|NCT02877134|582066895|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188607|NCT02877134|582066896|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188608|NCT02877134|582066897|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188609|NCT02877134|582066898|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188610|NCT02877134|582066899|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188611|NCT02877134|582066900|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188612|NCT02877134|582066901|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
161188613|NCT02877134|582066902|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
161188614|NCT02877134|582066903|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
161188615|NCT02877134|582066904|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
161188616|NCT02877134|582066905|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
161188617|NCT02877134|582066906|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
161188618|NCT02877134|582066895|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188619|NCT02877134|582066896|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161305530|NCT01053962|582499030|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
161305531|NCT01053962|582499026|FG000|Treatment Period|Lack of Efficacy|0|||
161188620|NCT02877134|582066897|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188621|NCT02877134|582066898|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188622|NCT02877134|582066899|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188623|NCT02877134|582066900|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188624|NCT02877134|582066901|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188625|NCT02877134|582066902|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161188626|NCT02877134|582066903|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161188627|NCT02877134|582066904|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
161188628|NCT02877134|582066905|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188629|NCT02877134|582066906|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
161188630|NCT02877134|582066895|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
161188631|NCT02877134|582066896|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
161188632|NCT02877134|582066897|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
161188633|NCT02877134|582066898|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
161188634|NCT02877134|582066899|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
161188635|NCT02877134|582066900|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
161188636|NCT02877134|582066901|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
161188637|NCT02877134|582066902|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
161188638|NCT02877134|582066903|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
161188639|NCT02877134|582066904|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
161188640|NCT02877134|582066905|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
161188641|NCT02877134|582066906|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
161188642|NCT00523744|582066907|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
161188643|NCT00523744|582066907|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
161188644|NCT00523744|582066907|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
161188645|NCT00523744|582066907|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
161188646|NCT00523744|582066907|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
161188647|NCT00523744|582066907|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
161188648|NCT01289028|582066908|FG000|Overall Study|Progressive Disease|49|||
161188649|NCT01289028|582066908|FG000|Overall Study|Adverse Event|14|||
161188650|NCT01289028|582066908|FG000|Overall Study|Withdrawal by Subject|6|||
161188651|NCT01289028|582066908|FG000|Overall Study|Death|4|||
161188652|NCT01289028|582066908|FG000|Overall Study|Lack of Efficacy|2|||
161188653|NCT01289028|582066908|FG000|Overall Study|No longer required|2|||
161188654|NCT01289028|582066908|FG000|Overall Study|Lost to Follow-up|2|||
161188655|NCT01289028|582066908|FG000|Overall Study|New Cancer Therapy|2|||
161188656|NCT01289028|582066908|FG000|Overall Study|Abnormal Lab Value|1|||
161188657|NCT01289028|582066908|FG000|Overall Study|Missing reason for discon|1|||
161188658|NCT00998985|582066915|FG000|Overall Study|Withdrawal by Subject|0|||
161188659|NCT00998985|582066916|FG001|Overall Study|Withdrawal by Subject|0|||
161188660|NCT00998985|582066917|FG002|Overall Study|Withdrawal by Subject|0|||
161188661|NCT00998985|582066918|FG003|Overall Study|Withdrawal by Subject|0|||
161188662|NCT00998985|582066919|FG004|Overall Study|Withdrawal by Subject|0|||
161188663|NCT00998985|582066920|FG005|Overall Study|Withdrawal by Subject|0|||
161188664|NCT00998985|582066921|FG006|Overall Study|Withdrawal by Subject|0|||
161188665|NCT00998985|582066922|FG007|Overall Study|Withdrawal by Subject|0|||
161188666|NCT00998985|582066923|FG008|Overall Study|Withdrawal by Subject|1|||
161188667|NCT00998985|582066924|FG009|Overall Study|Withdrawal by Subject|0|||
161188668|NCT00998985|582066925|FG010|Overall Study|Withdrawal by Subject|0|||
161188669|NCT00998985|582066926|FG011|Overall Study|Withdrawal by Subject|0|||
161188670|NCT00998985|582066927|FG012|Overall Study|Withdrawal by Subject|0|||
161188671|NCT00998985|582066928|FG013|Overall Study|Withdrawal by Subject|0|||
161188672|NCT00998985|582066915|FG000|Overall Study|Protocol Violation|0|||
161188673|NCT00998985|582066916|FG001|Overall Study|Protocol Violation|0|||
161188674|NCT00998985|582066917|FG002|Overall Study|Protocol Violation|0|||
161188675|NCT00998985|582066918|FG003|Overall Study|Protocol Violation|0|||
161188676|NCT00998985|582066919|FG004|Overall Study|Protocol Violation|0|||
161188677|NCT00998985|582066920|FG005|Overall Study|Protocol Violation|1|||
161188678|NCT00998985|582066921|FG006|Overall Study|Protocol Violation|0|||
161188679|NCT00998985|582066922|FG007|Overall Study|Protocol Violation|0|||
161348713|NCT05415215|582663527|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
161348714|NCT05415215|582663528|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
161348715|NCT05415215|582663529|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
161348716|NCT05415215|582663530|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
161348717|NCT05415215|582663531|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
161348718|NCT05415215|582663532|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
161348719|NCT05415215|582663533|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
161348720|NCT05415215|582663534|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
161188680|NCT00998985|582066923|FG008|Overall Study|Protocol Violation|0|||
161188681|NCT00998985|582066924|FG009|Overall Study|Protocol Violation|0|||
161188682|NCT00998985|582066925|FG010|Overall Study|Protocol Violation|0|||
161188683|NCT00998985|582066926|FG011|Overall Study|Protocol Violation|0|||
161188684|NCT00998985|582066927|FG012|Overall Study|Protocol Violation|0|||
161188685|NCT00998985|582066928|FG013|Overall Study|Protocol Violation|0|||
161188686|NCT00542425|582066935|FG000|Initial 24 Weeks|Administrative reasons|0|||
161188687|NCT00542425|582066936|FG001|Initial 24 Weeks|Administrative reasons|0|||
161348721|NCT05415215|582663527|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161348722|NCT05415215|582663528|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161348723|NCT05415215|582663529|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161188688|NCT00542425|582066937|FG002|Initial 24 Weeks|Administrative reasons|1|||
161188689|NCT00542425|582066938|FG003|Initial 24 Weeks|Administrative reasons|1|||
161348724|NCT05415215|582663530|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161348725|NCT05415215|582663531|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
161348726|NCT05415215|582663532|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161188690|NCT00542425|582066939|FG004|Initial 24 Weeks|Administrative reasons|0|||
161188691|NCT00542425|582066935|FG000|Initial 24 Weeks|Adverse Event|0|||
161188692|NCT00542425|582066936|FG001|Initial 24 Weeks|Adverse Event|1|||
161188693|NCT00542425|582066937|FG002|Initial 24 Weeks|Adverse Event|1|||
161188694|NCT00542425|582066938|FG003|Initial 24 Weeks|Adverse Event|3|||
161188695|NCT00542425|582066939|FG004|Initial 24 Weeks|Adverse Event|2|||
161188696|NCT00542425|582066935|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
161188697|NCT00542425|582066936|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
161188698|NCT00542425|582066937|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
161188699|NCT00542425|582066938|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
161188700|NCT00542425|582066939|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
161188701|NCT00542425|582066935|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
161188702|NCT00542425|582066936|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
161188703|NCT00542425|582066937|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
161188704|NCT00542425|582066938|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
161188705|NCT00542425|582066939|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
161188706|NCT00542425|582066935|FG000|Initial 24 Weeks|Non-compliance|0|||
161188707|NCT00542425|582066936|FG001|Initial 24 Weeks|Non-compliance|0|||
161188708|NCT00542425|582066937|FG002|Initial 24 Weeks|Non-compliance|0|||
161188709|NCT00542425|582066938|FG003|Initial 24 Weeks|Non-compliance|1|||
161188710|NCT00542425|582066939|FG004|Initial 24 Weeks|Non-compliance|1|||
161305532|NCT01053962|582499027|FG001|Treatment Period|Lack of Efficacy|0|||
161305533|NCT01053962|582499028|FG002|Treatment Period|Lack of Efficacy|0|||
161305534|NCT01053962|582499029|FG003|Treatment Period|Lack of Efficacy|0|||
161305535|NCT01053962|582499030|FG004|Treatment Period|Lack of Efficacy|1|||
161305536|NCT01053962|582499026|FG000|Treatment Period|Adverse Event|0|||
161305537|NCT01053962|582499027|FG001|Treatment Period|Adverse Event|0|||
161305538|NCT01053962|582499028|FG002|Treatment Period|Adverse Event|0|||
161305539|NCT01053962|582499029|FG003|Treatment Period|Adverse Event|0|||
161305540|NCT01053962|582499030|FG004|Treatment Period|Adverse Event|1|||
161305541|NCT01053962|582499026|FG000|Treatment Period|Withdrawal by Subject|0|||
161305542|NCT01053962|582499027|FG001|Treatment Period|Withdrawal by Subject|0|||
161305543|NCT01053962|582499028|FG002|Treatment Period|Withdrawal by Subject|0|||
161305544|NCT01053962|582499029|FG003|Treatment Period|Withdrawal by Subject|0|||
161305545|NCT01053962|582499030|FG004|Treatment Period|Withdrawal by Subject|1|||
161305546|NCT01053962|582499026|FG000|Treatment Period|Noncompliance with protocol|1|||
161305547|NCT01053962|582499027|FG001|Treatment Period|Noncompliance with protocol|0|||
161305548|NCT01053962|582499028|FG002|Treatment Period|Noncompliance with protocol|0|||
161305549|NCT01053962|582499029|FG003|Treatment Period|Noncompliance with protocol|0|||
161305550|NCT01053962|582499030|FG004|Treatment Period|Noncompliance with protocol|0|||
161305551|NCT04143594|582499031|FG000|Overall Study|Withdrew consent|3|||
161305552|NCT04143594|582499032|FG001|Overall Study|Withdrew consent|10|||
161305553|NCT04143594|582499033|FG002|Overall Study|Withdrew consent|3|||
161305554|NCT04143594|582499034|FG003|Overall Study|Withdrew consent|1|||
161305555|NCT04143594|582499031|FG000|Overall Study|Lost to Follow-up|3|||
161305556|NCT04143594|582499032|FG001|Overall Study|Lost to Follow-up|5|||
161305557|NCT04143594|582499033|FG002|Overall Study|Lost to Follow-up|11|||
161305558|NCT04143594|582499034|FG003|Overall Study|Lost to Follow-up|0|||
161305559|NCT04143594|582499031|FG000|Overall Study|Investigator's discretion|2|||
161305560|NCT04143594|582499032|FG001|Overall Study|Investigator's discretion|2|||
161305561|NCT04143594|582499033|FG002|Overall Study|Investigator's discretion|0|||
161305562|NCT04143594|582499034|FG003|Overall Study|Investigator's discretion|0|||
161305563|NCT04143594|582499031|FG000|Overall Study|Randomized but never treated|0|||
161305564|NCT04143594|582499032|FG001|Overall Study|Randomized but never treated|0|||
161305565|NCT04143594|582499033|FG002|Overall Study|Randomized but never treated|0|||
161305566|NCT04143594|582499034|FG003|Overall Study|Randomized but never treated|1|||
161305567|NCT04143594|582499031|FG000|Overall Study|Death|1|||
161305568|NCT04143594|582499032|FG001|Overall Study|Death|0|||
161305569|NCT04143594|582499033|FG002|Overall Study|Death|1|||
161305570|NCT04143594|582499034|FG003|Overall Study|Death|0|||
161305571|NCT04143594|582499031|FG000|Overall Study|Adverse Event|1|||
161305572|NCT04143594|582499032|FG001|Overall Study|Adverse Event|0|||
161305573|NCT04143594|582499033|FG002|Overall Study|Adverse Event|0|||
161305574|NCT04143594|582499034|FG003|Overall Study|Adverse Event|0|||
161305575|NCT04143594|582499031|FG000|Overall Study|Pregnancy|0|||
161305576|NCT04143594|582499032|FG001|Overall Study|Pregnancy|0|||
161305577|NCT04143594|582499033|FG002|Overall Study|Pregnancy|1|||
161305578|NCT04143594|582499034|FG003|Overall Study|Pregnancy|0|||
161188711|NCT00542425|582066935|FG000|Initial 24 Weeks|Protocol Violation|0|||
161188712|NCT00542425|582066936|FG001|Initial 24 Weeks|Protocol Violation|0|||
161305579|NCT04143594|582499031|FG000|Overall Study|Lack of Efficacy|1|||
161305580|NCT04143594|582499032|FG001|Overall Study|Lack of Efficacy|1|||
161188713|NCT00542425|582066937|FG002|Initial 24 Weeks|Protocol Violation|0|||
161305581|NCT04143594|582499033|FG002|Overall Study|Lack of Efficacy|0|||
161305582|NCT04143594|582499034|FG003|Overall Study|Lack of Efficacy|0|||
161305583|NCT01023256|582499037|FG000|Overall Study|Protocol Violation|2|||
161305584|NCT01023256|582499038|FG001|Overall Study|Protocol Violation|3|||
161305585|NCT01023256|582499039|FG002|Overall Study|Protocol Violation|0|||
161305586|NCT01023256|582499040|FG003|Overall Study|Protocol Violation|0|||
161305587|NCT01023256|582499037|FG000|Overall Study|Randomized but not treated|1|||
161305588|NCT01023256|582499038|FG001|Overall Study|Randomized but not treated|0|||
161305589|NCT01023256|582499039|FG002|Overall Study|Randomized but not treated|1|||
161188714|NCT00542425|582066938|FG003|Initial 24 Weeks|Protocol Violation|1|||
161188715|NCT00542425|582066939|FG004|Initial 24 Weeks|Protocol Violation|0|||
161188716|NCT00542425|582066935|FG000|Initial 24 Weeks|Refusal of treatment|2|||
161188717|NCT00542425|582066936|FG001|Initial 24 Weeks|Refusal of treatment|2|||
161188718|NCT00542425|582066937|FG002|Initial 24 Weeks|Refusal of treatment|1|||
161188719|NCT00542425|582066938|FG003|Initial 24 Weeks|Refusal of treatment|4|||
161188720|NCT00542425|582066939|FG004|Initial 24 Weeks|Refusal of treatment|1|||
161188721|NCT00542425|582066935|FG000|Initial 24 Weeks|Other|0|||
161188722|NCT00542425|582066936|FG001|Initial 24 Weeks|Other|2|||
161188723|NCT00542425|582066937|FG002|Initial 24 Weeks|Other|1|||
161188724|NCT00542425|582066938|FG003|Initial 24 Weeks|Other|0|||
161188725|NCT00542425|582066939|FG004|Initial 24 Weeks|Other|0|||
161188726|NCT00542425|582066935|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
161188727|NCT00542425|582066936|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
161188728|NCT00542425|582066937|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
161188729|NCT00542425|582066938|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
161188730|NCT00542425|582066939|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
161188731|NCT00542425|582066935|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161188732|NCT00542425|582066936|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161188733|NCT00542425|582066937|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
161188734|NCT00542425|582066938|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161188735|NCT00542425|582066939|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
161188736|NCT00542425|582066935|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161188737|NCT00542425|582066936|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
161188738|NCT00542425|582066937|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161188739|NCT00542425|582066938|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161188740|NCT00542425|582066939|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
161188741|NCT00542425|582066935|FG000|Extended 24 Weeks of Treatment|Other|1|||
161188742|NCT00542425|582066936|FG001|Extended 24 Weeks of Treatment|Other|1|||
161188743|NCT00542425|582066937|FG002|Extended 24 Weeks of Treatment|Other|0|||
161188744|NCT00542425|582066938|FG003|Extended 24 Weeks of Treatment|Other|0|||
161188745|NCT00542425|582066939|FG004|Extended 24 Weeks of Treatment|Other|1|||
161188746|NCT03344562|582066942|FG000|Overall Study|Withdrawal by Subject|2|||
161188747|NCT03344562|582066943|FG001|Overall Study|Withdrawal by Subject|0|||
161188748|NCT01610414|582066947|FG000|Study Start - Month 13|Serious Adverse Event|65|||
161188749|NCT01610414|582066948|FG001|Study Start - Month 13|Serious Adverse Event|67|||
161188750|NCT01610414|582066947|FG000|Study Start - Month 13|Adverse Event|14|||
161188751|NCT01610414|582066948|FG001|Study Start - Month 13|Adverse Event|14|||
161188752|NCT01610414|582066947|FG000|Study Start - Month 13|Protocol Violation|3|||
161188753|NCT01610414|582066948|FG001|Study Start - Month 13|Protocol Violation|1|||
161188754|NCT01610414|582066947|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
161188755|NCT01610414|582066948|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
161188756|NCT01610414|582066947|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
161188757|NCT01610414|582066948|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
161188758|NCT01610414|582066947|FG000|Study Start - Month 13|Lost to Follow-up|4|||
161188759|NCT01610414|582066948|FG001|Study Start - Month 13|Lost to Follow-up|6|||
161188760|NCT01610414|582066947|FG000|Study Start - Month 13|Suspected HZ episode|1|||
161188761|NCT01610414|582066948|FG001|Study Start - Month 13|Suspected HZ episode|3|||
161188762|NCT01610414|582066947|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
161188763|NCT01610414|582066948|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
161188764|NCT01610414|582066947|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
161188765|NCT01610414|582066948|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
161188766|NCT01610414|582066947|FG000|Month 13 - Month 25|Adverse Event|8|||
161188767|NCT01610414|582066948|FG001|Month 13 - Month 25|Adverse Event|4|||
161188768|NCT01610414|582066947|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
161188769|NCT01610414|582066948|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
161188770|NCT01610414|582066947|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
161188771|NCT01610414|582066948|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
161188772|NCT01610414|582066947|FG000|Month 13 - Month 25|Protocol Violation|0|||
161305590|NCT01023256|582499040|FG003|Overall Study|Randomized but not treated|0|||
161305591|NCT01023256|582499037|FG000|Overall Study|Other|1|||
161305592|NCT01023256|582499038|FG001|Overall Study|Other|0|||
161188773|NCT01610414|582066948|FG001|Month 13 - Month 25|Protocol Violation|2|||
161188774|NCT01610414|582066947|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
161305593|NCT01023256|582499039|FG002|Overall Study|Other|0|||
161188775|NCT01610414|582066948|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
161188776|NCT01610414|582066947|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
161188777|NCT01610414|582066948|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
161188778|NCT01610414|582066947|FG000|After Month 25|Study end not reached|48|||
161188779|NCT01610414|582066948|FG001|After Month 25|Study end not reached|53|||
161188780|NCT00472043|582066949|FG000|Overall Study|Withdrawal by Subject|1|||
161188781|NCT00472043|582066950|FG001|Overall Study|Withdrawal by Subject|0|||
161188782|NCT00472043|582066949|FG000|Overall Study|Death|1|||
161305594|NCT01023256|582499040|FG003|Overall Study|Other|2|||
161188783|NCT00472043|582066950|FG001|Overall Study|Death|0|||
161188784|NCT04009824|582066953|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
161188785|NCT04009824|582066954|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
161188786|NCT04009824|582066955|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
161188787|NCT04009824|582066956|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
161188788|NCT04009824|582066957|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
161188789|NCT01024946|582066958|FG000|Overall Study|Screen Failure|3|||
161188790|NCT01024946|582066958|FG000|Overall Study|Withdrawal by Subject|1|||
161188791|NCT01024946|582066958|FG000|Overall Study|Adverse Event|1|||
161188792|NCT03147495|582066959|FG000|Overall Study|Physician Decision|0|||
161188793|NCT03147495|582066960|FG001|Overall Study|Physician Decision|6|||
161188794|NCT02608892|582066961|FG000|Overall Study|Lost to Follow-up|1|||
161188795|NCT02608892|582066962|FG001|Overall Study|Lost to Follow-up|0|||
161188796|NCT03032523|582066963|FG000|Overall Study|Withdrawal by Subject|2|||
161188797|NCT03032523|582066964|FG001|Overall Study|Withdrawal by Subject|2|||
161188798|NCT03032523|582066963|FG000|Overall Study|Physician Decision|1|||
161188799|NCT03032523|582066964|FG001|Overall Study|Physician Decision|0|||
161188800|NCT05375838|582066965|FG000|Overall Study|Other|0|||
161188801|NCT05375838|582066966|FG001|Overall Study|Other|0|||
161188802|NCT05375838|582066967|FG002|Overall Study|Other|0|||
161188803|NCT05375838|582066968|FG003|Overall Study|Other|1|||
161188804|NCT05375838|582066969|FG004|Overall Study|Other|1|||
161188805|NCT05375838|582066970|FG005|Overall Study|Other|0|||
161188806|NCT05375838|582066965|FG000|Overall Study|Withdrawal by Subject|2|||
161188807|NCT05375838|582066966|FG001|Overall Study|Withdrawal by Subject|1|||
161188808|NCT05375838|582066967|FG002|Overall Study|Withdrawal by Subject|3|||
161188809|NCT05375838|582066968|FG003|Overall Study|Withdrawal by Subject|2|||
161188810|NCT05375838|582066969|FG004|Overall Study|Withdrawal by Subject|2|||
161188811|NCT05375838|582066970|FG005|Overall Study|Withdrawal by Subject|0|||
161188812|NCT05375838|582066965|FG000|Overall Study|Protocol Violation|0|||
161188813|NCT05375838|582066966|FG001|Overall Study|Protocol Violation|0|||
161188814|NCT05375838|582066967|FG002|Overall Study|Protocol Violation|0|||
161188815|NCT05375838|582066968|FG003|Overall Study|Protocol Violation|0|||
161188816|NCT05375838|582066969|FG004|Overall Study|Protocol Violation|1|||
161188817|NCT05375838|582066970|FG005|Overall Study|Protocol Violation|0|||
161188818|NCT05375838|582066965|FG000|Overall Study|Physician Decision|0|||
161188819|NCT05375838|582066966|FG001|Overall Study|Physician Decision|1|||
161188820|NCT05375838|582066967|FG002|Overall Study|Physician Decision|0|||
161188821|NCT05375838|582066968|FG003|Overall Study|Physician Decision|0|||
161188822|NCT05375838|582066969|FG004|Overall Study|Physician Decision|0|||
161188823|NCT05375838|582066970|FG005|Overall Study|Physician Decision|1|||
161188824|NCT05375838|582066965|FG000|Overall Study|Lost to Follow-up|2|||
161188825|NCT05375838|582066966|FG001|Overall Study|Lost to Follow-up|7|||
161188826|NCT05375838|582066967|FG002|Overall Study|Lost to Follow-up|0|||
161188827|NCT05375838|582066968|FG003|Overall Study|Lost to Follow-up|4|||
161188828|NCT05375838|582066969|FG004|Overall Study|Lost to Follow-up|2|||
161188829|NCT05375838|582066970|FG005|Overall Study|Lost to Follow-up|3|||
161188830|NCT00957723|582066971|FG000|Overall Study|Death|3|||
161188831|NCT00957723|582066971|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
161188832|NCT00957723|582066971|FG000|Overall Study|Lost to Follow-up|8|||
161188833|NCT00957723|582066971|FG000|Overall Study|Withdrawal by Subject|24|||
161188834|NCT00957723|582066971|FG000|Overall Study|Investigative Site Terminated|61|||
161188835|NCT00957723|582066971|FG000|Overall Study|Intercurrent Illness|2|||
161188836|NCT00957723|582066971|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
161188837|NCT00877890|582066972|FG000|Overall Study|Adverse Event|6|||
161188838|NCT00877890|582066973|FG001|Overall Study|Adverse Event|6|||
161188839|NCT00877890|582066972|FG000|Overall Study|Lost to Follow-up|5|||
161188840|NCT00877890|582066973|FG001|Overall Study|Lost to Follow-up|5|||
161188841|NCT00877890|582066972|FG000|Overall Study|Protocol Violation|0|||
161188842|NCT00877890|582066973|FG001|Overall Study|Protocol Violation|1|||
161188843|NCT00877890|582066972|FG000|Overall Study|Withdrawal of Consent|6|||
161188844|NCT00877890|582066973|FG001|Overall Study|Withdrawal of Consent|12|||
161305595|NCT01023256|582499037|FG000|Overall Study|Adverse Event|0|||
161305596|NCT01023256|582499038|FG001|Overall Study|Adverse Event|0|||
161305597|NCT01023256|582499039|FG002|Overall Study|Adverse Event|0|||
161188845|NCT00877890|582066972|FG000|Overall Study|Investigator Decision|0|||
161188846|NCT00877890|582066973|FG001|Overall Study|Investigator Decision|2|||
161188847|NCT00877890|582066972|FG000|Overall Study|Loss of Glucose Control|3|||
161188848|NCT00877890|582066973|FG001|Overall Study|Loss of Glucose Control|4|||
161188849|NCT00984009|582066974|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
161188850|NCT02178592|582066975|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
161188851|NCT02178592|582066976|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
161188852|NCT02178592|582066975|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
161188853|NCT02178592|582066976|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
161188854|NCT02178592|582066975|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
161188855|NCT02178592|582066976|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
161188856|NCT02178592|582066975|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
161305598|NCT01023256|582499040|FG003|Overall Study|Adverse Event|1|||
161305599|NCT01023256|582499037|FG000|Overall Study|Withdrawal by Subject|0|||
161305600|NCT01023256|582499038|FG001|Overall Study|Withdrawal by Subject|0|||
161305601|NCT01023256|582499039|FG002|Overall Study|Withdrawal by Subject|0|||
161305602|NCT01023256|582499040|FG003|Overall Study|Withdrawal by Subject|2|||
161305603|NCT03089697|582499041|FG000|Overall Study|Adverse Event|1|||
161305604|NCT03089697|582499042|FG001|Overall Study|Adverse Event|2|||
161305605|NCT03089697|582499041|FG000|Overall Study|Withdrawal by Subject|1|||
161305606|NCT03089697|582499042|FG001|Overall Study|Withdrawal by Subject|0|||
161305607|NCT00308087|582499043|FG000|Overall Study|Progressive Disease|19|||
161305608|NCT00308087|582499044|FG001|Overall Study|Progressive Disease|21|||
161305609|NCT00308087|582499043|FG000|Overall Study|Study Closure|11|||
161305610|NCT00308087|582499044|FG001|Overall Study|Study Closure|12|||
161305611|NCT00308087|582499043|FG000|Overall Study|Withdrawal by Subject|2|||
161305612|NCT00308087|582499044|FG001|Overall Study|Withdrawal by Subject|1|||
161305613|NCT00308087|582499043|FG000|Overall Study|Other|4|||
161305614|NCT00308087|582499044|FG001|Overall Study|Other|3|||
161305615|NCT01154088|582499046|FG000|Overall Study|Lost to Follow-up|4|||
161305616|NCT01154088|582499047|FG001|Overall Study|Lost to Follow-up|6|||
161305617|NCT01154088|582499048|FG002|Overall Study|Lost to Follow-up|7|||
161305618|NCT05129137|582499049|FG000|Second Period|Adverse Event|1|||
161305619|NCT05129137|582499050|FG001|Second Period|Adverse Event|0|||
161305620|NCT05129137|582499051|FG002|Second Period|Adverse Event|0|||
161305621|NCT05129137|582499052|FG003|Second Period|Adverse Event|0|||
161305622|NCT05129137|582499049|FG000|Second Period|Protocol Violation|0|||
161305623|NCT05129137|582499050|FG001|Second Period|Protocol Violation|0|||
161305624|NCT05129137|582499051|FG002|Second Period|Protocol Violation|0|||
161305625|NCT05129137|582499052|FG003|Second Period|Protocol Violation|1|||
161305626|NCT05129137|582499049|FG000|Third Period|Protocol Violation|0|||
161305627|NCT05129137|582499050|FG001|Third Period|Protocol Violation|0|||
161305628|NCT05129137|582499051|FG002|Third Period|Protocol Violation|0|||
161305629|NCT05129137|582499052|FG003|Third Period|Protocol Violation|1|||
161305630|NCT05129137|582499049|FG000|Forth Period|Protocol Violation|0|||
161305631|NCT05129137|582499050|FG001|Forth Period|Protocol Violation|1|||
161305632|NCT05129137|582499051|FG002|Forth Period|Protocol Violation|0|||
161305633|NCT05129137|582499052|FG003|Forth Period|Protocol Violation|0|||
161305634|NCT05129137|582499049|FG000|Forth Period|Withdrawal by Subject|0|||
161305635|NCT05129137|582499050|FG001|Forth Period|Withdrawal by Subject|0|||
161305636|NCT05129137|582499051|FG002|Forth Period|Withdrawal by Subject|1|||
161305637|NCT05129137|582499052|FG003|Forth Period|Withdrawal by Subject|0|||
161305638|NCT02783729|582499059|FG000|Overall Study|Lack of Efficacy|1|||
161305639|NCT02783729|582499060|FG001|Overall Study|Lack of Efficacy|0|||
161305640|NCT02783729|582499061|FG002|Overall Study|Lack of Efficacy|0|||
161305641|NCT02783729|582499062|FG003|Overall Study|Lack of Efficacy|0|||
161305642|NCT02783729|582499059|FG000|Overall Study|Adverse Event|2|||
161305643|NCT02783729|582499060|FG001|Overall Study|Adverse Event|6|||
161305644|NCT02783729|582499061|FG002|Overall Study|Adverse Event|2|||
161305645|NCT02783729|582499062|FG003|Overall Study|Adverse Event|3|||
161305646|NCT02783729|582499059|FG000|Overall Study|Other|1|||
161305647|NCT02783729|582499060|FG001|Overall Study|Other|6|||
161305648|NCT02783729|582499061|FG002|Overall Study|Other|2|||
161305649|NCT02783729|582499062|FG003|Overall Study|Other|3|||
161305650|NCT02783729|582499059|FG000|Overall Study|Withdrawal by Subject|2|||
161305651|NCT02783729|582499060|FG001|Overall Study|Withdrawal by Subject|3|||
161305652|NCT02783729|582499061|FG002|Overall Study|Withdrawal by Subject|1|||
161305653|NCT02783729|582499062|FG003|Overall Study|Withdrawal by Subject|2|||
161305654|NCT02783729|582499059|FG000|Overall Study|Participant's choice|2|||
161305655|NCT02783729|582499060|FG001|Overall Study|Participant's choice|1|||
161305656|NCT02783729|582499061|FG002|Overall Study|Participant's choice|2|||
161305657|NCT02783729|582499062|FG003|Overall Study|Participant's choice|1|||
161305658|NCT02783729|582499059|FG000|Overall Study|Lost to Follow-up|2|||
161305659|NCT02783729|582499060|FG001|Overall Study|Lost to Follow-up|1|||
161305660|NCT02783729|582499061|FG002|Overall Study|Lost to Follow-up|1|||
161305661|NCT02783729|582499062|FG003|Overall Study|Lost to Follow-up|0|||
161305662|NCT00750139|582499064|FG000|Overall Study|Adverse Event|1|||
161305663|NCT00750139|582499065|FG001|Overall Study|Adverse Event|2|||
161305664|NCT00750139|582499066|FG002|Overall Study|Adverse Event|0|||
161305665|NCT00750139|582499067|FG003|Overall Study|Adverse Event|1|||
161305666|NCT00750139|582499064|FG000|Overall Study|Lost to Follow-up|17|||
161305667|NCT00750139|582499065|FG001|Overall Study|Lost to Follow-up|12|||
161305668|NCT00750139|582499066|FG002|Overall Study|Lost to Follow-up|15|||
161305669|NCT00750139|582499067|FG003|Overall Study|Lost to Follow-up|6|||
161305670|NCT00750139|582499064|FG000|Overall Study|Withdrawal by Subject|3|||
161305671|NCT00750139|582499065|FG001|Overall Study|Withdrawal by Subject|2|||
161305672|NCT00750139|582499066|FG002|Overall Study|Withdrawal by Subject|6|||
161305673|NCT00750139|582499067|FG003|Overall Study|Withdrawal by Subject|2|||
161305674|NCT00750139|582499064|FG000|Overall Study|Physician Decision|1|||
161305675|NCT00750139|582499065|FG001|Overall Study|Physician Decision|1|||
161305676|NCT00750139|582499066|FG002|Overall Study|Physician Decision|0|||
161305677|NCT00750139|582499067|FG003|Overall Study|Physician Decision|0|||
161188857|NCT02178592|582066976|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
161188858|NCT02178592|582066975|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
161188859|NCT02178592|582066976|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
161188860|NCT02178592|582066975|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
161188861|NCT02178592|582066976|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
161188862|NCT02178592|582066975|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
161188863|NCT02178592|582066976|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
161188864|NCT02178592|582066975|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
161188865|NCT02178592|582066976|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
161188866|NCT02178592|582066975|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
161188867|NCT02178592|582066976|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
161188868|NCT02178592|582066975|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
161188869|NCT02178592|582066976|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
161188870|NCT02178592|582066975|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
161188871|NCT02178592|582066976|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
161188872|NCT02178592|582066975|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
161188873|NCT02178592|582066976|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
161188874|NCT02036476|582066987|FG000|Overall Study|Withdrawal by Subject|2|||
161188875|NCT02036476|582066987|FG000|Overall Study|Progressive Disease|4|||
161188876|NCT02036476|582066987|FG000|Overall Study|Unacceptable Toxicity|2|||
161188877|NCT02698176|582066988|FG000|Overall Study|Progressive disease|4|||
161188878|NCT02698176|582066989|FG001|Overall Study|Progressive disease|3|||
161188879|NCT02698176|582066990|FG002|Overall Study|Progressive disease|1|||
161188880|NCT02698176|582066991|FG003|Overall Study|Progressive disease|0|||
161188881|NCT02698176|582066988|FG000|Overall Study|Adverse Event|2|||
161188882|NCT02698176|582066989|FG001|Overall Study|Adverse Event|0|||
161188883|NCT02698176|582066990|FG002|Overall Study|Adverse Event|0|||
161188884|NCT02698176|582066991|FG003|Overall Study|Adverse Event|0|||
161188885|NCT02698176|582066988|FG000|Overall Study|Clinical progression|3|||
161188886|NCT02698176|582066989|FG001|Overall Study|Clinical progression|0|||
161188887|NCT02698176|582066990|FG002|Overall Study|Clinical progression|0|||
161188888|NCT02698176|582066991|FG003|Overall Study|Clinical progression|0|||
161188889|NCT02985684|582066993|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
161188890|NCT02985684|582066993|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
161188891|NCT02985684|582066993|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
161188892|NCT04335929|582068891|FG000|Overall Study|Lost to Follow-up|10|||
161188893|NCT02491463|582068895|FG000|Overall Study|Withdrawal by Subject|1|||
161188894|NCT02491463|582068896|FG001|Overall Study|Withdrawal by Subject|2|||
161188895|NCT02491463|582068897|FG002|Overall Study|Withdrawal by Subject|0|||
161188896|NCT02491463|582068898|FG003|Overall Study|Withdrawal by Subject|0|||
161188897|NCT02491463|582068895|FG000|Overall Study|Migrated/moved from study area|1|||
161188898|NCT02491463|582068896|FG001|Overall Study|Migrated/moved from study area|5|||
161188899|NCT02491463|582068897|FG002|Overall Study|Migrated/moved from study area|1|||
161188900|NCT02491463|582068898|FG003|Overall Study|Migrated/moved from study area|1|||
161188901|NCT02491463|582068895|FG000|Overall Study|Lost to Follow-up|0|||
161188902|NCT02491463|582068896|FG001|Overall Study|Lost to Follow-up|3|||
161188903|NCT02491463|582068897|FG002|Overall Study|Lost to Follow-up|3|||
161188904|NCT02491463|582068898|FG003|Overall Study|Lost to Follow-up|0|||
161188905|NCT01491802|582068899|FG000|Overall Study|Adverse Event|1|||
161188906|NCT01491802|582068900|FG001|Overall Study|Adverse Event|1|||
161188907|NCT01491802|582068899|FG000|Overall Study|Withdrawal by Subject|0|||
161188908|NCT01491802|582068900|FG001|Overall Study|Withdrawal by Subject|1|||
161188909|NCT01864746|582068903|FG000|Overall Study|Disease recurrence|25|||
161188910|NCT01864746|582068904|FG001|Overall Study|Disease recurrence|40|||
161188911|NCT01864746|582068903|FG000|Overall Study|Second primary invasive nonbreast|2|||
161188912|NCT01864746|582068904|FG001|Overall Study|Second primary invasive nonbreast|3|||
161188913|NCT01864746|582068903|FG000|Overall Study|Death|2|||
161188914|NCT01864746|582068904|FG001|Overall Study|Death|1|||
161188915|NCT01864746|582068903|FG000|Overall Study|Adverse Event|33|||
161305678|NCT00750139|582499064|FG000|Overall Study|Non-compliance|1|||
161305679|NCT00750139|582499065|FG001|Overall Study|Non-compliance|0|||
161305680|NCT00750139|582499066|FG002|Overall Study|Non-compliance|1|||
161188916|NCT01864746|582068904|FG001|Overall Study|Adverse Event|5|||
161305681|NCT00750139|582499067|FG003|Overall Study|Non-compliance|3|||
161305682|NCT00750139|582499064|FG000|Overall Study|Termination by sponsor|4|||
161305683|NCT00750139|582499065|FG001|Overall Study|Termination by sponsor|0|||
161188917|NCT01864746|582068903|FG000|Overall Study|Withdrawal by Subject|56|||
161188918|NCT01864746|582068904|FG001|Overall Study|Withdrawal by Subject|41|||
161188919|NCT01864746|582068903|FG000|Overall Study|Physician Decision|5|||
161188920|NCT01864746|582068904|FG001|Overall Study|Physician Decision|6|||
161188921|NCT00663208|582068905|FG000|Treatment Period|Lost to Follow-up|0|||
161305684|NCT00750139|582499066|FG002|Overall Study|Termination by sponsor|0|||
161305685|NCT00750139|582499067|FG003|Overall Study|Termination by sponsor|1|||
161188922|NCT00663208|582068906|FG001|Treatment Period|Lost to Follow-up|1|||
161188923|NCT00663208|582068907|FG002|Treatment Period|Lost to Follow-up|0|||
161188924|NCT00663208|582068908|FG003|Treatment Period|Lost to Follow-up|0|||
161188925|NCT00663208|582068909|FG004|Treatment Period|Lost to Follow-up|0|||
161188926|NCT00663208|582068910|FG005|Treatment Period|Lost to Follow-up|0|||
161188927|NCT00663208|582068911|FG006|Treatment Period|Lost to Follow-up|0|||
161188928|NCT00663208|582068905|FG000|Follow-up Period|Lost to Follow-up|2|||
161188929|NCT00663208|582068906|FG001|Follow-up Period|Lost to Follow-up|0|||
161188930|NCT00663208|582068907|FG002|Follow-up Period|Lost to Follow-up|3|||
161348727|NCT05415215|582663533|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161348728|NCT05415215|582663534|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
161348729|NCT05415215|582663527|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161348730|NCT05415215|582663528|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161348731|NCT05415215|582663529|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161348732|NCT05415215|582663530|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161348733|NCT05415215|582663531|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
161348734|NCT05415215|582663532|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161348735|NCT05415215|582663533|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161348736|NCT05415215|582663534|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
161348737|NCT05415215|582663527|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348738|NCT05415215|582663528|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348739|NCT05415215|582663529|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348740|NCT05415215|582663530|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348741|NCT05415215|582663531|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
161348742|NCT05415215|582663532|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348743|NCT05415215|582663533|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348744|NCT05415215|582663534|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
161348745|NCT05415215|582663527|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348746|NCT05415215|582663528|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348747|NCT05415215|582663529|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348748|NCT05415215|582663530|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348749|NCT05415215|582663531|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348750|NCT05415215|582663532|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348751|NCT05415215|582663533|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
161348752|NCT05415215|582663534|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
161348753|NCT05415215|582663527|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348754|NCT05415215|582663528|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348755|NCT05415215|582663529|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348756|NCT05415215|582663530|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348757|NCT05415215|582663531|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348758|NCT05415215|582663532|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
161348759|NCT05415215|582663533|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348760|NCT05415215|582663534|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
161348761|NCT05415215|582663527|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348762|NCT05415215|582663528|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348763|NCT05415215|582663529|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348764|NCT05415215|582663530|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348765|NCT05415215|582663531|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348766|NCT05415215|582663532|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
161348767|NCT05415215|582663533|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348768|NCT05415215|582663534|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
161348769|NCT05415215|582663527|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161348770|NCT05415215|582663528|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161348771|NCT05415215|582663529|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161348772|NCT05415215|582663530|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161348773|NCT05415215|582663531|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161348774|NCT05415215|582663532|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161348775|NCT05415215|582663533|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
161348776|NCT05415215|582663534|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
161348777|NCT05415215|582663527|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161348778|NCT05415215|582663528|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161348779|NCT05415215|582663529|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161348780|NCT05415215|582663530|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161348781|NCT05415215|582663531|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161348782|NCT05415215|582663532|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161188931|NCT00663208|582068908|FG003|Follow-up Period|Lost to Follow-up|2|||
161188932|NCT00663208|582068909|FG004|Follow-up Period|Lost to Follow-up|0|||
161188933|NCT00663208|582068910|FG005|Follow-up Period|Lost to Follow-up|0|||
161188934|NCT00663208|582068911|FG006|Follow-up Period|Lost to Follow-up|0|||
161188935|NCT00663208|582068905|FG000|Follow-up Period|Other reason|1|||
161188936|NCT00663208|582068906|FG001|Follow-up Period|Other reason|0|||
161188937|NCT00663208|582068907|FG002|Follow-up Period|Other reason|0|||
161188938|NCT00663208|582068908|FG003|Follow-up Period|Other reason|0|||
161188939|NCT00663208|582068909|FG004|Follow-up Period|Other reason|0|||
161188940|NCT00663208|582068910|FG005|Follow-up Period|Other reason|0|||
161188941|NCT00663208|582068911|FG006|Follow-up Period|Other reason|1|||
161188942|NCT01005966|582068912|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161188943|NCT01005966|582068913|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161188944|NCT01005966|582068914|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
161188945|NCT01005966|582068915|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
161188946|NCT01005966|582068916|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
161188947|NCT01005966|582068912|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161188948|NCT01005966|582068913|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161188949|NCT01005966|582068914|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
161188950|NCT01005966|582068915|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161188951|NCT01005966|582068916|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
161188952|NCT01005966|582068912|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161188953|NCT01005966|582068913|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161188954|NCT01005966|582068914|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161188955|NCT01005966|582068915|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
161188956|NCT01005966|582068916|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
161188957|NCT01005966|582068912|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
161188958|NCT01005966|582068913|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
161188959|NCT01005966|582068914|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
161188960|NCT01005966|582068915|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
161188961|NCT01005966|582068916|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
161188962|NCT01005966|582068912|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161188963|NCT01005966|582068913|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161188964|NCT01005966|582068914|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161188965|NCT01005966|582068915|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161188966|NCT01005966|582068916|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161188967|NCT01005966|582068912|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161188968|NCT01005966|582068913|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161188969|NCT01005966|582068914|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
161188970|NCT01005966|582068915|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161188971|NCT01005966|582068916|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
161188972|NCT01005966|582068912|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161188973|NCT01005966|582068913|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
161188974|NCT01005966|582068914|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161188975|NCT01005966|582068915|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
161188976|NCT01005966|582068916|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
161188977|NCT01005966|582068912|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161188978|NCT01005966|582068913|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
161188979|NCT01005966|582068914|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161188980|NCT01005966|582068915|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161188981|NCT01005966|582068916|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
161188982|NCT01005966|582068912|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
161188983|NCT01005966|582068913|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
161188984|NCT01005966|582068914|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
161188985|NCT01005966|582068915|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
161188986|NCT01005966|582068916|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
161188987|NCT01451203|582068917|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
161188988|NCT01451203|582068918|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
161188989|NCT01451203|582068917|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
161305686|NCT00750139|582499064|FG000|Overall Study|Non-specific|62|||
161305687|NCT00750139|582499065|FG001|Overall Study|Non-specific|42|||
161305688|NCT00750139|582499066|FG002|Overall Study|Non-specific|79|||
161305689|NCT00750139|582499067|FG003|Overall Study|Non-specific|33|||
161305690|NCT03085238|582499068|FG000|Overall Study|Adverse Event|2|||
161305691|NCT03085238|582499068|FG000|Overall Study|Death|2|||
161305692|NCT01992653|582499069|FG000|Overall Study|Death|0|||
161305693|NCT01992653|582499070|FG001|Overall Study|Death|0|||
161348783|NCT05415215|582663533|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
161348784|NCT05415215|582663534|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
161305694|NCT01992653|582499071|FG002|Overall Study|Death|1|||
161305695|NCT01992653|582499072|FG003|Overall Study|Death|0|||
161188990|NCT01451203|582068918|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
161188991|NCT01451203|582068917|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
161188992|NCT01451203|582068918|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
161188993|NCT01451203|582068917|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
161188994|NCT01451203|582068918|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
161188995|NCT01451203|582068917|FG000|Double-blind Treatment Period|Adverse Event|6|||
161188996|NCT01451203|582068918|FG001|Double-blind Treatment Period|Adverse Event|9|||
161188997|NCT01451203|582068917|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
161188998|NCT01451203|582068918|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
161188999|NCT01451203|582068917|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
161189000|NCT01451203|582068918|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
161189001|NCT01451203|582068917|FG000|Double-blind Treatment Period|Investigator decision|2|||
161189002|NCT01451203|582068918|FG001|Double-blind Treatment Period|Investigator decision|0|||
161189003|NCT01451203|582068917|FG000|Post-treatment Period|Consent withdrawn|2|||
161189004|NCT01451203|582068918|FG001|Post-treatment Period|Consent withdrawn|4|||
161189005|NCT01451203|582068917|FG000|Post-treatment Period|Lack of Efficacy|12|||
161189006|NCT01451203|582068918|FG001|Post-treatment Period|Lack of Efficacy|28|||
161189007|NCT01451203|582068917|FG000|Post-treatment Period|Adverse Event|0|||
161189008|NCT01451203|582068918|FG001|Post-treatment Period|Adverse Event|1|||
161189009|NCT01451203|582068917|FG000|Post-treatment Period|Investigator decision|0|||
161189010|NCT01451203|582068918|FG001|Post-treatment Period|Investigator decision|1|||
161189011|NCT00039377|582068919|FG000|Initial Registration|Adverse Event|2|||
161189012|NCT00039377|582068920|FG001|Initial Registration|Adverse Event|0|||
161189013|NCT00039377|582068921|FG002|Initial Registration|Adverse Event|0|||
161189014|NCT00039377|582068922|FG003|Initial Registration|Adverse Event|0|||
161189015|NCT00039377|582068919|FG000|Initial Registration|Relapsed|6|||
161189016|NCT00039377|582068920|FG001|Initial Registration|Relapsed|0|||
161189017|NCT00039377|582068921|FG002|Initial Registration|Relapsed|0|||
161189018|NCT00039377|582068922|FG003|Initial Registration|Relapsed|0|||
161189019|NCT00039377|582068919|FG000|Initial Registration|Received non-protocol therapy|11|||
161189020|NCT00039377|582068920|FG001|Initial Registration|Received non-protocol therapy|0|||
161189021|NCT00039377|582068921|FG002|Initial Registration|Received non-protocol therapy|0|||
161189022|NCT00039377|582068922|FG003|Initial Registration|Received non-protocol therapy|0|||
161189023|NCT00039377|582068919|FG000|Initial Registration|Withdrawal by Subject|3|||
161189024|NCT00039377|582068920|FG001|Initial Registration|Withdrawal by Subject|0|||
161189025|NCT00039377|582068921|FG002|Initial Registration|Withdrawal by Subject|0|||
161189026|NCT00039377|582068922|FG003|Initial Registration|Withdrawal by Subject|0|||
161189027|NCT01347931|582068923|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
161189028|NCT01249404|582068924|FG000|Overall Study|Study treatment not received|0|||
161189029|NCT01249404|582068925|FG001|Overall Study|Study treatment not received|1|||
161189030|NCT01249404|582068926|FG002|Overall Study|Study treatment not received|2|||
161305696|NCT01992653|582499073|FG004|Overall Study|Death|1|||
161305697|NCT01992653|582499074|FG005|Overall Study|Death|0|||
161305698|NCT01992653|582499075|FG006|Overall Study|Death|4|||
161305699|NCT01992653|582499076|FG007|Overall Study|Death|2|||
161305700|NCT01992653|582499069|FG000|Overall Study|Lost to Follow-up|0|||
161305701|NCT01992653|582499070|FG001|Overall Study|Lost to Follow-up|0|||
161305702|NCT01992653|582499071|FG002|Overall Study|Lost to Follow-up|0|||
161305703|NCT01992653|582499072|FG003|Overall Study|Lost to Follow-up|0|||
161305704|NCT01992653|582499073|FG004|Overall Study|Lost to Follow-up|0|||
161305705|NCT01992653|582499074|FG005|Overall Study|Lost to Follow-up|0|||
161305706|NCT01992653|582499075|FG006|Overall Study|Lost to Follow-up|0|||
161305707|NCT01992653|582499076|FG007|Overall Study|Lost to Follow-up|1|||
161305708|NCT01992653|582499069|FG000|Overall Study|Study Completed|0|||
161305709|NCT01992653|582499070|FG001|Overall Study|Study Completed|0|||
161305710|NCT01992653|582499071|FG002|Overall Study|Study Completed|0|||
161305711|NCT01992653|582499072|FG003|Overall Study|Study Completed|0|||
161305712|NCT01992653|582499073|FG004|Overall Study|Study Completed|0|||
161305713|NCT01992653|582499074|FG005|Overall Study|Study Completed|0|||
161305714|NCT01992653|582499075|FG006|Overall Study|Study Completed|0|||
161305715|NCT01992653|582499076|FG007|Overall Study|Study Completed|1|||
161305716|NCT01992653|582499069|FG000|Overall Study|Disease Progression|0|||
161305717|NCT01992653|582499070|FG001|Overall Study|Disease Progression|0|||
161305718|NCT01992653|582499071|FG002|Overall Study|Disease Progression|0|||
161305719|NCT01992653|582499072|FG003|Overall Study|Disease Progression|0|||
161305720|NCT01992653|582499073|FG004|Overall Study|Disease Progression|0|||
161305721|NCT01992653|582499074|FG005|Overall Study|Disease Progression|0|||
161305722|NCT01992653|582499075|FG006|Overall Study|Disease Progression|4|||
161305723|NCT01992653|582499076|FG007|Overall Study|Disease Progression|0|||
161305724|NCT01435460|582499077|FG000|Overall Study|Adverse Event|2|||
161305725|NCT01435460|582499078|FG001|Overall Study|Adverse Event|1|||
161305726|NCT01435460|582499077|FG000|Overall Study|Lost to Follow-up|6|||
161189031|NCT01249404|582068924|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
161189032|NCT01249404|582068925|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
161189033|NCT01249404|582068926|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
161305727|NCT01435460|582499078|FG001|Overall Study|Lost to Follow-up|1|||
161305728|NCT01435460|582499077|FG000|Overall Study|Withdrawal by Subject|1|||
161189034|NCT01249404|582068924|FG000|Overall Study|Adverse Event|2|||
161189035|NCT01249404|582068925|FG001|Overall Study|Adverse Event|2|||
161189036|NCT01249404|582068926|FG002|Overall Study|Adverse Event|2|||
161189037|NCT01249404|582068924|FG000|Overall Study|Withdrawal by Subject|2|||
161189038|NCT01249404|582068925|FG001|Overall Study|Withdrawal by Subject|2|||
161189039|NCT01249404|582068926|FG002|Overall Study|Withdrawal by Subject|0|||
161189040|NCT01249404|582068924|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
161189041|NCT01249404|582068925|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
161189042|NCT01249404|582068926|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
161189043|NCT01249404|582068924|FG000|Overall Study|Non compliance to visit schedule|0|||
161189044|NCT01249404|582068925|FG001|Overall Study|Non compliance to visit schedule|1|||
161189045|NCT01249404|582068926|FG002|Overall Study|Non compliance to visit schedule|0|||
161189046|NCT03890731|582068927|FG000|Overall Study|Progressive disease|1|||
161189047|NCT03890731|582068927|FG000|Overall Study|Patient's decision|1|||
161189048|NCT03890731|582068927|FG000|Overall Study|Adverse Event|4|||
161189049|NCT03758612|582068928|FG000|Washout Period|Withdrawal by Subject|0|||
161189050|NCT03758612|582068929|FG001|Washout Period|Withdrawal by Subject|0|||
161189051|NCT03758612|582068930|FG002|Washout Period|Withdrawal by Subject|2|||
161189052|NCT03758612|582068931|FG003|Washout Period|Withdrawal by Subject|0|||
161189053|NCT03758612|582068932|FG004|Washout Period|Withdrawal by Subject|0|||
161189054|NCT03758612|582068933|FG005|Washout Period|Withdrawal by Subject|0|||
161189055|NCT03758612|582068934|FG006|Washout Period|Withdrawal by Subject|0|||
161189056|NCT03758612|582068935|FG007|Washout Period|Withdrawal by Subject|0|||
161189057|NCT03758612|582068936|FG008|Washout Period|Withdrawal by Subject|0|||
161189058|NCT03758612|582068937|FG009|Washout Period|Withdrawal by Subject|0|||
161189059|NCT03758612|582068938|FG010|Washout Period|Withdrawal by Subject|0|||
161189060|NCT03758612|582068939|FG011|Washout Period|Withdrawal by Subject|0|||
161189061|NCT03758612|582068928|FG000|Period 2|Protocol Violation|0|||
161189062|NCT03758612|582068929|FG001|Period 2|Protocol Violation|0|||
161189063|NCT03758612|582068930|FG002|Period 2|Protocol Violation|0|||
161189064|NCT03758612|582068931|FG003|Period 2|Protocol Violation|0|||
161189065|NCT03758612|582068932|FG004|Period 2|Protocol Violation|1|||
161189066|NCT03758612|582068933|FG005|Period 2|Protocol Violation|0|||
161189067|NCT03758612|582068934|FG006|Period 2|Protocol Violation|0|||
161189068|NCT03758612|582068935|FG007|Period 2|Protocol Violation|0|||
161189069|NCT03758612|582068936|FG008|Period 2|Protocol Violation|0|||
161189070|NCT03758612|582068937|FG009|Period 2|Protocol Violation|0|||
161189071|NCT03758612|582068938|FG010|Period 2|Protocol Violation|0|||
161189072|NCT03758612|582068939|FG011|Period 2|Protocol Violation|0|||
161189073|NCT01716585|582068940|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
161189074|NCT01716585|582068941|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
161189075|NCT01716585|582068940|FG000|Double-blind Treatment|Adverse Event|2|||
161189076|NCT01716585|582068941|FG001|Double-blind Treatment|Adverse Event|1|||
161189077|NCT01716585|582068940|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
161189078|NCT01716585|582068941|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
161189079|NCT01716585|582068940|FG000|Double-blind Treatment|Lost to Follow-up|2|||
161189080|NCT01716585|582068941|FG001|Double-blind Treatment|Lost to Follow-up|0|||
161189081|NCT01716585|582068940|FG000|Double-blind Treatment|Subject Noncompliant|1|||
161189082|NCT01716585|582068941|FG001|Double-blind Treatment|Subject Noncompliant|0|||
161189083|NCT01716585|582068940|FG000|Double-blind Treatment|Other|1|||
161189084|NCT01716585|582068941|FG001|Double-blind Treatment|Other|0|||
161189085|NCT01716585|582068940|FG000|Open-label Treatment|Adverse Event|0|||
161189086|NCT01716585|582068941|FG001|Open-label Treatment|Adverse Event|2|||
161189087|NCT01716585|582068940|FG000|Open-label Treatment|Virologic Failure|0|||
161189088|NCT01716585|582068941|FG001|Open-label Treatment|Virologic Failure|2|||
161189089|NCT01716585|582068940|FG000|Open-label Treatment|Withdrawal by Subject|0|||
161189090|NCT01716585|582068941|FG001|Open-label Treatment|Withdrawal by Subject|3|||
161189091|NCT04235959|582068942|FG000|Overall Study|Protocol Violation|0|||
161189092|NCT04235959|582068943|FG001|Overall Study|Protocol Violation|1|||
161189093|NCT04235959|582068944|FG002|Overall Study|Protocol Violation|0|||
161305729|NCT01435460|582499078|FG001|Overall Study|Withdrawal by Subject|3|||
161189094|NCT04235959|582068942|FG000|Overall Study|Adverse Event|1|||
161189095|NCT04235959|582068943|FG001|Overall Study|Adverse Event|0|||
161189096|NCT04235959|582068944|FG002|Overall Study|Adverse Event|0|||
161189097|NCT00125138|582068945|FG000|Overall Study|Adverse Event|1|||
161305730|NCT01435460|582499077|FG000|Overall Study|Protocol Violation|0|||
161189098|NCT00125138|582068946|FG001|Overall Study|Adverse Event|0|||
161189099|NCT00125138|582068947|FG002|Overall Study|Adverse Event|3|||
161189100|NCT00125138|582068948|FG003|Overall Study|Adverse Event|2|||
161189101|NCT00125138|582068945|FG000|Overall Study|Withdrawal by Subject|2|||
161189102|NCT00125138|582068946|FG001|Overall Study|Withdrawal by Subject|3|||
161189103|NCT00125138|582068947|FG002|Overall Study|Withdrawal by Subject|1|||
161189104|NCT00125138|582068948|FG003|Overall Study|Withdrawal by Subject|1|||
161189105|NCT00125138|582068945|FG000|Overall Study|Lack of Efficacy|0|||
161189106|NCT00125138|582068946|FG001|Overall Study|Lack of Efficacy|0|||
161189107|NCT00125138|582068947|FG002|Overall Study|Lack of Efficacy|0|||
161189108|NCT00125138|582068948|FG003|Overall Study|Lack of Efficacy|1|||
161189109|NCT00125138|582068945|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
161189110|NCT00125138|582068946|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
161189111|NCT00125138|582068947|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
161189112|NCT00125138|582068948|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
161189113|NCT02967562|582068953|FG000|Overall Study|Consent not obtained|1|||
161189114|NCT02967562|582068954|FG001|Overall Study|Consent not obtained|0|||
161189115|NCT02967562|582068953|FG000|Overall Study|High leak precluding analysis|1|||
161189116|NCT02967562|582068954|FG001|Overall Study|High leak precluding analysis|1|||
161189117|NCT00405756|582068955|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
161189118|NCT00405756|582068956|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
161189119|NCT00405756|582068957|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
161189120|NCT00405756|582068955|FG000|Double-blind Treatment|Adverse Event|31|||
161189121|NCT00405756|582068956|FG001|Double-blind Treatment|Adverse Event|27|||
161189122|NCT00405756|582068957|FG002|Double-blind Treatment|Adverse Event|12|||
161189123|NCT00405756|582068955|FG000|Double-blind Treatment|Disease Progression|47|||
161189124|NCT00405756|582068956|FG001|Double-blind Treatment|Disease Progression|81|||
161189125|NCT00405756|582068957|FG002|Double-blind Treatment|Disease Progression|102|||
161189126|NCT00405756|582068955|FG000|Double-blind Treatment|Lack of Efficacy|1|||
161189127|NCT00405756|582068956|FG001|Double-blind Treatment|Lack of Efficacy|4|||
161189128|NCT00405756|582068957|FG002|Double-blind Treatment|Lack of Efficacy|2|||
161189129|NCT00405756|582068955|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
161189130|NCT00405756|582068956|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
161189131|NCT00405756|582068957|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
161189132|NCT00405756|582068955|FG000|Double-blind Treatment|Lost to Follow-up|1|||
161189133|NCT00405756|582068956|FG001|Double-blind Treatment|Lost to Follow-up|0|||
161189134|NCT00405756|582068957|FG002|Double-blind Treatment|Lost to Follow-up|0|||
161189135|NCT00405756|582068955|FG000|Double-blind Treatment|Death|4|||
161189136|NCT00405756|582068956|FG001|Double-blind Treatment|Death|4|||
161189137|NCT00405756|582068957|FG002|Double-blind Treatment|Death|4|||
161189138|NCT00405756|582068955|FG000|Double-blind Treatment|Protocol Violation|1|||
161189139|NCT00405756|582068956|FG001|Double-blind Treatment|Protocol Violation|0|||
161189140|NCT00405756|582068957|FG002|Double-blind Treatment|Protocol Violation|2|||
161189141|NCT00405756|582068955|FG000|Double-blind Treatment|Other|7|||
161189142|NCT00405756|582068956|FG001|Double-blind Treatment|Other|4|||
161189143|NCT00405756|582068957|FG002|Double-blind Treatment|Other|4|||
161189144|NCT00405756|582068955|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
161189145|NCT00405756|582068956|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
161189146|NCT00405756|582068957|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
161189147|NCT00405756|582068955|FG000|Open-label Extension|Adverse Event|1|||
161189148|NCT00405756|582068956|FG001|Open-label Extension|Adverse Event|3|||
161189149|NCT00405756|582068957|FG002|Open-label Extension|Adverse Event|7|||
161189150|NCT00405756|582068955|FG000|Open-label Extension|Disease Progression|8|||
161189151|NCT00405756|582068956|FG001|Open-label Extension|Disease Progression|23|||
161189152|NCT00405756|582068957|FG002|Open-label Extension|Disease Progression|26|||
161189153|NCT00405756|582068955|FG000|Open-label Extension|Withdrawal by Subject|2|||
161189154|NCT00405756|582068956|FG001|Open-label Extension|Withdrawal by Subject|3|||
161189155|NCT00405756|582068957|FG002|Open-label Extension|Withdrawal by Subject|3|||
161189156|NCT00405756|582068955|FG000|Open-label Extension|Death|1|||
161189157|NCT00405756|582068956|FG001|Open-label Extension|Death|2|||
161189158|NCT00405756|582068957|FG002|Open-label Extension|Death|4|||
161189159|NCT00405756|582068955|FG000|Open-label Extension|Other|0|||
161189160|NCT00405756|582068956|FG001|Open-label Extension|Other|1|||
161189161|NCT00405756|582068957|FG002|Open-label Extension|Other|7|||
161189162|NCT00405756|582068955|FG000|Follow-up|Ongoing in Follow-up Period|52|||
161189163|NCT00405756|582068956|FG001|Follow-up|Ongoing in Follow-up Period|51|||
161189164|NCT00405756|582068957|FG002|Follow-up|Ongoing in Follow-up Period|60|||
161189165|NCT00405756|582068955|FG000|Follow-up|Death|21|||
161189166|NCT00405756|582068956|FG001|Follow-up|Death|31|||
161189167|NCT00405756|582068957|FG002|Follow-up|Death|24|||
161189168|NCT00405756|582068955|FG000|Follow-up|Lost to Follow-up|2|||
161189169|NCT00405756|582068956|FG001|Follow-up|Lost to Follow-up|8|||
161189170|NCT00405756|582068957|FG002|Follow-up|Lost to Follow-up|4|||
161189171|NCT00286156|582068961|FG000|Overall Study|Missed 12 month visit|0|||
161189172|NCT00286156|582068962|FG001|Overall Study|Missed 12 month visit|0|||
161189173|NCT00286156|582068963|FG002|Overall Study|Missed 12 month visit|1|||
161189174|NCT00286156|582068961|FG000|Overall Study|AE: pulmonary embolus|0|||
161189175|NCT00286156|582068962|FG001|Overall Study|AE: pulmonary embolus|1|||
161189176|NCT00286156|582068963|FG002|Overall Study|AE: pulmonary embolus|0|||
161189177|NCT00286156|582068961|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
161189178|NCT00286156|582068962|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
161189179|NCT00286156|582068963|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
161189180|NCT00286156|582068961|FG000|Overall Study|AE: pneumonia|1|||
161189181|NCT00286156|582068962|FG001|Overall Study|AE: pneumonia|0|||
161189182|NCT00286156|582068963|FG002|Overall Study|AE: pneumonia|0|||
161305731|NCT01435460|582499078|FG001|Overall Study|Protocol Violation|1|||
161189183|NCT02870348|582068965|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
161189184|NCT01051856|582068966|FG000|Overall Study|Withdrawal by Subject|1|||
161189185|NCT01051856|582068967|FG001|Overall Study|Withdrawal by Subject|0|||
161189186|NCT00672139|582068968|FG000|Overall Study|Death|14|||
161189187|NCT00672139|582068969|FG001|Overall Study|Death|23|||
161189188|NCT00672139|582068968|FG000|Overall Study|Withdrawal by Subject|2|||
161189189|NCT00672139|582068969|FG001|Overall Study|Withdrawal by Subject|11|||
161189190|NCT00672139|582068968|FG000|Overall Study|Adverse Event|4|||
161189191|NCT00672139|582068969|FG001|Overall Study|Adverse Event|7|||
161189192|NCT00672139|582068968|FG000|Overall Study|Physician Decision|2|||
161189193|NCT00672139|582068969|FG001|Overall Study|Physician Decision|0|||
161189194|NCT00672139|582068968|FG000|Overall Study|Lack of Efficacy|4|||
161189195|NCT00672139|582068969|FG001|Overall Study|Lack of Efficacy|1|||
161189196|NCT00672139|582068968|FG000|Overall Study|Protocol Violation|1|||
161189197|NCT00672139|582068969|FG001|Overall Study|Protocol Violation|1|||
161189198|NCT00672139|582068968|FG000|Overall Study|hospice discharge, caregiver requests|3|||
161189199|NCT00672139|582068969|FG001|Overall Study|hospice discharge, caregiver requests|2|||
161189200|NCT02381795|582068970|FG000|Overall Study|Withdrawal by Subject|1|||
161189201|NCT02381795|582068970|FG000|Overall Study|Study Terminated|2|||
161189202|NCT02176226|582068973|FG000|Overall Study|Lost to Follow-up|3|||
161189203|NCT02176226|582068973|FG000|Overall Study|Withdrew prior to treatment|6|||
161189204|NCT01488994|582068978|FG000|Overall Study|Withdrawal by Subject|0|||
161189205|NCT01488994|582068979|FG001|Overall Study|Withdrawal by Subject|1|||
161189206|NCT01072500|582068980|FG000|Overall Study|Death|2|||
161189207|NCT01072500|582068981|FG001|Overall Study|Death|2|||
161189208|NCT01072500|582068980|FG000|Overall Study|Lost to Follow-up|5|||
161189209|NCT01072500|582068981|FG001|Overall Study|Lost to Follow-up|2|||
161189210|NCT01072500|582068980|FG000|Overall Study|Withdrawal by Subject|17|||
161189211|NCT01072500|582068981|FG001|Overall Study|Withdrawal by Subject|10|||
161189212|NCT02908841|582068982|FG000|Overall Study|Physician Decision|4|||
161189213|NCT02908841|582068983|FG001|Overall Study|Physician Decision|0|||
161189214|NCT00103207|582068984|FG000|Overall Study|Adverse Event|3|||
161189215|NCT00103207|582068984|FG000|Overall Study|Death|1|||
161189216|NCT00103207|582068984|FG000|Overall Study|Withdrawal by Subject|2|||
161189217|NCT00103207|582068984|FG000|Overall Study|Other complicating disease|1|||
161189218|NCT00103207|582068984|FG000|Overall Study|Ineligible|4|||
161189219|NCT00103207|582068984|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
161189220|NCT01611558|582068985|FG000|Induction Phase|Study drug toxicity|15|||
161189221|NCT01611558|582068985|FG000|Induction Phase|Disease progression|18|||
161189222|NCT01611558|582068985|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
161189223|NCT01611558|582068985|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
161189224|NCT01611558|582068985|FG000|Induction Phase|Death|1|||
161189225|NCT01611558|582068985|FG000|Maintenance Phase|Withdrawal by Subject|1|||
161189226|NCT01611558|582068985|FG000|Maintenance Phase|Elevated Uric acid|1|||
161189227|NCT03798366|582068988|FG000|Overall Study|Lost to Follow-up|0|||
161189228|NCT03798366|582068989|FG001|Overall Study|Lost to Follow-up|1|||
161189229|NCT01412333|582068993|FG000|Overall Study|Adverse Event|40|||
161189230|NCT01412333|582068994|FG001|Overall Study|Adverse Event|42|||
161189231|NCT01412333|582068993|FG000|Overall Study|Death|5|||
161189232|NCT01412333|582068994|FG001|Overall Study|Death|6|||
161189233|NCT01412333|582068993|FG000|Overall Study|Lack of Efficacy|22|||
161189234|NCT01412333|582068994|FG001|Overall Study|Lack of Efficacy|10|||
161189235|NCT01412333|582068993|FG000|Overall Study|Lost to Follow-up|15|||
161189236|NCT01412333|582068994|FG001|Overall Study|Lost to Follow-up|12|||
161189237|NCT01412333|582068993|FG000|Overall Study|Non-Compliance|3|||
161189238|NCT01412333|582068994|FG001|Overall Study|Non-Compliance|7|||
161189239|NCT01412333|582068993|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161305732|NCT01435460|582499077|FG000|Overall Study|Did not meet eligibility criteria|2|||
161305733|NCT01435460|582499078|FG001|Overall Study|Did not meet eligibility criteria|0|||
161305734|NCT01706939|582499079|FG000|Pre Randomization|Screen Failure|1|||
161305735|NCT01706939|582499080|FG001|Pre Randomization|Screen Failure|0|||
161305736|NCT01706939|582499081|FG002|Pre Randomization|Screen Failure|0|||
161305737|NCT01706939|582499079|FG000|Pre Randomization|Ineligible for Randomization|1|||
161189240|NCT01412333|582068994|FG001|Overall Study|Non-Compliance With Study Drug|1|||
161189241|NCT01412333|582068993|FG000|Overall Study|Other|30|||
161189242|NCT01412333|582068994|FG001|Overall Study|Other|33|||
161189243|NCT01412333|582068993|FG000|Overall Study|Physician Decision|11|||
161189244|NCT01412333|582068994|FG001|Overall Study|Physician Decision|16|||
161189245|NCT01412333|582068993|FG000|Overall Study|Pregnancy|6|||
161189246|NCT01412333|582068994|FG001|Overall Study|Pregnancy|4|||
161189247|NCT01412333|582068993|FG000|Overall Study|Protocol Violation|1|||
161189248|NCT01412333|582068994|FG001|Overall Study|Protocol Violation|2|||
161189249|NCT01412333|582068993|FG000|Overall Study|Study Terminated By Sponsor|3|||
161189250|NCT01412333|582068994|FG001|Overall Study|Study Terminated By Sponsor|2|||
161189251|NCT01412333|582068993|FG000|Overall Study|Withdrawal by Subject|51|||
161305738|NCT01706939|582499080|FG001|Pre Randomization|Ineligible for Randomization|0|||
161305739|NCT01706939|582499081|FG002|Pre Randomization|Ineligible for Randomization|0|||
161305740|NCT01706939|582499079|FG000|Pre Randomization|Withdrawal by Subject|1|||
161189252|NCT01412333|582068994|FG001|Overall Study|Withdrawal by Subject|54|||
161189253|NCT01412333|582068993|FG000|Overall Study|Missing|1|||
161189254|NCT01412333|582068994|FG001|Overall Study|Missing|3|||
161189255|NCT04005885|582068995|FG000|First Intervention|Withdrawal by Subject|1|||
161189256|NCT04005885|582068996|FG001|First Intervention|Withdrawal by Subject|1|||
161189257|NCT04005885|582068995|FG000|Second Intervention|Withdrawal by Subject|0|||
161189258|NCT04005885|582068996|FG001|Second Intervention|Withdrawal by Subject|2|||
161189259|NCT01117428|582068997|FG000|Overall Study|Lack of Efficacy|1|||
161189260|NCT01117428|582068998|FG001|Overall Study|Lack of Efficacy|0|||
161189261|NCT01117428|582068999|FG002|Overall Study|Lack of Efficacy|0|||
161189262|NCT01117428|582069000|FG003|Overall Study|Lack of Efficacy|0|||
161189263|NCT01117428|582069001|FG004|Overall Study|Lack of Efficacy|0|||
161189264|NCT01117428|582069002|FG005|Overall Study|Lack of Efficacy|0|||
161189265|NCT01117428|582068997|FG000|Overall Study|Adverse Event|4|||
161189266|NCT01117428|582068998|FG001|Overall Study|Adverse Event|0|||
161189267|NCT01117428|582068999|FG002|Overall Study|Adverse Event|0|||
161189268|NCT01117428|582069000|FG003|Overall Study|Adverse Event|0|||
161189269|NCT01117428|582069001|FG004|Overall Study|Adverse Event|1|||
161189270|NCT01117428|582069002|FG005|Overall Study|Adverse Event|2|||
161189271|NCT01117428|582068997|FG000|Overall Study|Death|0|||
161189272|NCT01117428|582068998|FG001|Overall Study|Death|1|||
161189273|NCT01117428|582068999|FG002|Overall Study|Death|2|||
161189274|NCT01117428|582069000|FG003|Overall Study|Death|0|||
161189275|NCT01117428|582069001|FG004|Overall Study|Death|0|||
161189276|NCT01117428|582069002|FG005|Overall Study|Death|1|||
161189277|NCT01117428|582068997|FG000|Overall Study|Physician Decision|0|||
161189278|NCT01117428|582068998|FG001|Overall Study|Physician Decision|1|||
161189279|NCT01117428|582068999|FG002|Overall Study|Physician Decision|0|||
161189280|NCT01117428|582069000|FG003|Overall Study|Physician Decision|0|||
161189281|NCT01117428|582069001|FG004|Overall Study|Physician Decision|0|||
161189282|NCT01117428|582069002|FG005|Overall Study|Physician Decision|0|||
161189283|NCT01117428|582068997|FG000|Overall Study|Withdrawal by Subject|0|||
161189284|NCT01117428|582068998|FG001|Overall Study|Withdrawal by Subject|0|||
161189285|NCT01117428|582068999|FG002|Overall Study|Withdrawal by Subject|1|||
161189286|NCT01117428|582069000|FG003|Overall Study|Withdrawal by Subject|0|||
161189287|NCT01117428|582069001|FG004|Overall Study|Withdrawal by Subject|0|||
161189288|NCT01117428|582069002|FG005|Overall Study|Withdrawal by Subject|0|||
161189289|NCT01117428|582068997|FG000|Overall Study|Progressive disease|15|||
161189290|NCT01117428|582068998|FG001|Overall Study|Progressive disease|27|||
161189291|NCT01117428|582068999|FG002|Overall Study|Progressive disease|10|||
161189292|NCT01117428|582069000|FG003|Overall Study|Progressive disease|12|||
161189293|NCT01117428|582069001|FG004|Overall Study|Progressive disease|16|||
161189294|NCT01117428|582069002|FG005|Overall Study|Progressive disease|17|||
161189295|NCT02195531|582069003|FG000|Overall Study|Withdrawal by Subject|1|||
161189296|NCT02195531|582069004|FG001|Overall Study|Withdrawal by Subject|1|||
161189297|NCT02195531|582069005|FG002|Overall Study|Withdrawal by Subject|1|||
161189298|NCT01034709|582069009|FG000|Overall Study|Protocol Violation|9|||
161189299|NCT01034709|582069010|FG001|Overall Study|Protocol Violation|16|||
161189300|NCT01657253|582069013|FG000|Overall Study|Lost to Follow-up|6|||
161189301|NCT01657253|582069014|FG001|Overall Study|Lost to Follow-up|5|||
161189302|NCT01657253|582069013|FG000|Overall Study|Withdrawal by Subject|11|||
161189303|NCT01657253|582069014|FG001|Overall Study|Withdrawal by Subject|12|||
161189304|NCT01657253|582069013|FG000|Overall Study|Adverse Event|0|||
161189305|NCT01657253|582069014|FG001|Overall Study|Adverse Event|1|||
161305741|NCT01706939|582499080|FG001|Pre Randomization|Withdrawal by Subject|0|||
161305742|NCT01706939|582499081|FG002|Pre Randomization|Withdrawal by Subject|0|||
161305743|NCT01706939|582499079|FG000|Randomization|Insufficient QoL survey compliance|0|||
161305744|NCT01706939|582499080|FG001|Randomization|Insufficient QoL survey compliance|1|||
161305745|NCT01706939|582499081|FG002|Randomization|Insufficient QoL survey compliance|1|||
161305746|NCT01706939|582499079|FG000|Randomization|Progression of disease|0|||
161305747|NCT01706939|582499080|FG001|Randomization|Progression of disease|2|||
161189306|NCT01970540|582069015|FG000|Overall Study|Non-treatment-related AE|0|||
161189307|NCT01970540|582069016|FG001|Overall Study|Non-treatment-related AE|0|||
161189308|NCT01970540|582069017|FG002|Overall Study|Non-treatment-related AE|1|||
161189309|NCT01970540|582069015|FG000|Overall Study|Progressive disease|55|||
161189310|NCT01970540|582069016|FG001|Overall Study|Progressive disease|23|||
161189311|NCT01970540|582069017|FG002|Overall Study|Progressive disease|10|||
161189312|NCT01970540|582069015|FG000|Overall Study|Treatment delay over protocol|0|||
161189313|NCT01970540|582069016|FG001|Overall Study|Treatment delay over protocol|0|||
161189314|NCT01970540|582069017|FG002|Overall Study|Treatment delay over protocol|1|||
161189315|NCT01970540|582069015|FG000|Overall Study|Physician Decision|7|||
161189316|NCT01970540|582069016|FG001|Overall Study|Physician Decision|2|||
161189317|NCT01970540|582069017|FG002|Overall Study|Physician Decision|0|||
161189318|NCT01970540|582069015|FG000|Overall Study|Clinical progression|0|||
161189319|NCT01970540|582069016|FG001|Overall Study|Clinical progression|1|||
161189320|NCT01970540|582069017|FG002|Overall Study|Clinical progression|1|||
161189321|NCT01970540|582069015|FG000|Overall Study|End of study|2|||
161189322|NCT01970540|582069016|FG001|Overall Study|End of study|0|||
161305748|NCT01706939|582499081|FG002|Randomization|Progression of disease|1|||
161189323|NCT01970540|582069017|FG002|Overall Study|End of study|2|||
161189324|NCT01970540|582069015|FG000|Overall Study|Adverse Event|0|||
161189325|NCT01970540|582069016|FG001|Overall Study|Adverse Event|2|||
161189326|NCT01970540|582069017|FG002|Overall Study|Adverse Event|1|||
161189327|NCT01970540|582069015|FG000|Overall Study|Treatment-related AE|4|||
161189328|NCT01970540|582069016|FG001|Overall Study|Treatment-related AE|0|||
161189329|NCT01970540|582069017|FG002|Overall Study|Treatment-related AE|2|||
161189330|NCT01970540|582069015|FG000|Overall Study|Withdrawal by Subject|4|||
161189331|NCT01970540|582069016|FG001|Overall Study|Withdrawal by Subject|0|||
161189332|NCT01970540|582069017|FG002|Overall Study|Withdrawal by Subject|1|||
161189333|NCT01970540|582069015|FG000|Overall Study|Clinical deterioration|1|||
161189334|NCT01970540|582069016|FG001|Overall Study|Clinical deterioration|0|||
161189335|NCT01970540|582069017|FG002|Overall Study|Clinical deterioration|0|||
161189336|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Adverse Event|30|||
161189337|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Adverse Event|25|||
161189338|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Adverse Event|23|||
161189339|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Adverse Event|14|||
161189340|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Death|0|||
161189341|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Death|0|||
161189342|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Death|1|||
161189343|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Death|0|||
161189344|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Physician Decision|0|||
161189345|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Physician Decision|1|||
161189346|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Physician Decision|0|||
161189347|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Physician Decision|1|||
161189348|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
161189349|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
161189350|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
161189351|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
161348785|NCT05415215|582663527|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161348786|NCT05415215|582663528|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161348787|NCT05415215|582663529|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161348788|NCT05415215|582663530|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161348789|NCT05415215|582663531|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161348790|NCT05415215|582663532|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
161348791|NCT05415215|582663533|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
161348792|NCT05415215|582663534|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
161348793|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348794|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348795|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348796|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348797|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348798|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348799|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
161348800|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
161348801|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348802|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348803|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348804|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348805|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348806|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348807|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
161348808|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
161348809|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161348810|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161348811|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161189352|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Other|6|||
161189353|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Other|1|||
161189354|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Other|0|||
161189355|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Other|2|||
161189356|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
161189357|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
161189358|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
161189359|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
161189360|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
161189361|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
161189362|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
161348812|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161348813|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161348814|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161189363|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
161189364|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
161189365|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
161189366|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
161189367|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
161189368|NCT00242710|582069019|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
161189369|NCT00242710|582069020|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
161189370|NCT00242710|582069021|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
161189371|NCT00242710|582069022|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
161189372|NCT00242710|582069019|FG000|Period Between Core Study and Extension|Adverse Event|2|||
161189373|NCT00242710|582069020|FG001|Period Between Core Study and Extension|Adverse Event|3|||
161189374|NCT00242710|582069021|FG002|Period Between Core Study and Extension|Adverse Event|5|||
161189375|NCT00242710|582069022|FG003|Period Between Core Study and Extension|Adverse Event|2|||
161189376|NCT00242710|582069019|FG000|Period Between Core Study and Extension|Physician Decision|1|||
161189377|NCT00242710|582069020|FG001|Period Between Core Study and Extension|Physician Decision|1|||
161189378|NCT00242710|582069021|FG002|Period Between Core Study and Extension|Physician Decision|0|||
161189379|NCT00242710|582069022|FG003|Period Between Core Study and Extension|Physician Decision|0|||
161189380|NCT00242710|582069019|FG000|Period Between Core Study and Extension|Other|24|||
161189381|NCT00242710|582069020|FG001|Period Between Core Study and Extension|Other|24|||
161189382|NCT00242710|582069021|FG002|Period Between Core Study and Extension|Other|9|||
161189383|NCT00242710|582069022|FG003|Period Between Core Study and Extension|Other|11|||
161189384|NCT00242710|582069019|FG000|Period Between Core Study and Extension|Extension not Available|17|||
161189385|NCT00242710|582069020|FG001|Period Between Core Study and Extension|Extension not Available|21|||
161189386|NCT00242710|582069021|FG002|Period Between Core Study and Extension|Extension not Available|8|||
161189387|NCT00242710|582069022|FG003|Period Between Core Study and Extension|Extension not Available|7|||
161189388|NCT00242710|582069019|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
161189389|NCT00242710|582069020|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
161189390|NCT00242710|582069021|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
161189391|NCT00242710|582069022|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
161189392|NCT00242710|582069019|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
161189393|NCT00242710|582069020|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
161189394|NCT00242710|582069021|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
161189395|NCT00242710|582069022|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
161189396|NCT00242710|582069019|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
161189397|NCT00242710|582069020|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
161189398|NCT00242710|582069021|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
161189399|NCT00242710|582069022|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
161189400|NCT00242710|582069019|FG000|Study Extension (up to Year 2)|Death|0|||
161189401|NCT00242710|582069020|FG001|Study Extension (up to Year 2)|Death|0|||
161189402|NCT00242710|582069021|FG002|Study Extension (up to Year 2)|Death|0|||
161189403|NCT00242710|582069022|FG003|Study Extension (up to Year 2)|Death|1|||
161189404|NCT00242710|582069019|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
161189405|NCT00242710|582069020|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
161189406|NCT00242710|582069021|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
161189407|NCT00242710|582069022|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
161189408|NCT00242710|582069019|FG000|Study Extension (up to Year 2)|Other|3|||
161189409|NCT00242710|582069020|FG001|Study Extension (up to Year 2)|Other|5|||
161189410|NCT00242710|582069021|FG002|Study Extension (up to Year 2)|Other|4|||
161189411|NCT00242710|582069022|FG003|Study Extension (up to Year 2)|Other|3|||
161189412|NCT00242710|582069019|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
161189413|NCT00242710|582069020|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
161189414|NCT00242710|582069021|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
161189415|NCT00242710|582069022|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
161189416|NCT00242710|582069019|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
161189417|NCT00242710|582069020|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
161348815|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
161348816|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
161348817|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161348818|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161348819|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161348820|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161189418|NCT00242710|582069021|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
161189419|NCT00242710|582069022|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
161189420|NCT01057394|582069023|FG000|Overall Study|Not eligible|0|||
161189421|NCT01057394|582069024|FG001|Overall Study|Not eligible|2|||
161189422|NCT00579527|582069025|FG000|Overall Study|Death|4|||
161189423|NCT01195636|582069026|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
161348821|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161348822|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161348823|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
161348824|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
161348825|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348826|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348827|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348828|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348829|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348830|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348831|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
161348832|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
161348833|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348834|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348835|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348836|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348837|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348838|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348839|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
161348840|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
161348841|NCT05415215|582663527|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348842|NCT05415215|582663528|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348843|NCT05415215|582663529|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348844|NCT05415215|582663530|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348845|NCT05415215|582663531|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348846|NCT05415215|582663532|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348847|NCT05415215|582663533|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
161348848|NCT05415215|582663534|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
161348849|NCT05415215|582663527|FG000|Follow-up Period|Ongoing in Follow-up|0|||
161348850|NCT05415215|582663528|FG001|Follow-up Period|Ongoing in Follow-up|0|||
161348851|NCT05415215|582663529|FG002|Follow-up Period|Ongoing in Follow-up|0|||
161348852|NCT05415215|582663530|FG003|Follow-up Period|Ongoing in Follow-up|0|||
161348853|NCT05415215|582663531|FG004|Follow-up Period|Ongoing in Follow-up|0|||
161348854|NCT05415215|582663532|FG005|Follow-up Period|Ongoing in Follow-up|44|||
161348855|NCT05415215|582663533|FG006|Follow-up Period|Ongoing in Follow-up|45|||
161348856|NCT05415215|582663534|FG007|Follow-up Period|Ongoing in Follow-up|51|||
161348857|NCT05415215|582663527|FG000|Follow-up Period|Adverse Event|0|||
161348858|NCT05415215|582663528|FG001|Follow-up Period|Adverse Event|0|||
161348859|NCT05415215|582663529|FG002|Follow-up Period|Adverse Event|0|||
161348860|NCT05415215|582663530|FG003|Follow-up Period|Adverse Event|0|||
161348861|NCT05415215|582663531|FG004|Follow-up Period|Adverse Event|0|||
161348862|NCT05415215|582663532|FG005|Follow-up Period|Adverse Event|0|||
161348863|NCT05415215|582663533|FG006|Follow-up Period|Adverse Event|1|||
161348864|NCT05415215|582663534|FG007|Follow-up Period|Adverse Event|0|||
161348865|NCT05415215|582663527|FG000|Follow-up Period|Lost to Follow-up|0|||
161348866|NCT05415215|582663528|FG001|Follow-up Period|Lost to Follow-up|0|||
161348867|NCT05415215|582663529|FG002|Follow-up Period|Lost to Follow-up|0|||
161348868|NCT05415215|582663530|FG003|Follow-up Period|Lost to Follow-up|0|||
161348869|NCT05415215|582663531|FG004|Follow-up Period|Lost to Follow-up|0|||
161348870|NCT05415215|582663532|FG005|Follow-up Period|Lost to Follow-up|1|||
161348871|NCT05415215|582663533|FG006|Follow-up Period|Lost to Follow-up|1|||
161348872|NCT05415215|582663534|FG007|Follow-up Period|Lost to Follow-up|0|||
161348873|NCT05415215|582663527|FG000|Follow-up Period|Withdrawal by Subject|0|||
161348874|NCT05415215|582663528|FG001|Follow-up Period|Withdrawal by Subject|0|||
161348875|NCT05415215|582663529|FG002|Follow-up Period|Withdrawal by Subject|0|||
161348876|NCT05415215|582663530|FG003|Follow-up Period|Withdrawal by Subject|0|||
161348877|NCT05415215|582663531|FG004|Follow-up Period|Withdrawal by Subject|0|||
161348878|NCT05415215|582663532|FG005|Follow-up Period|Withdrawal by Subject|0|||
161348879|NCT05415215|582663533|FG006|Follow-up Period|Withdrawal by Subject|0|||
161348880|NCT05415215|582663534|FG007|Follow-up Period|Withdrawal by Subject|2|||
161348881|NCT03727022|582663535|FG000|Phase A|Lost to Follow-up|2|||
161348882|NCT03727022|582663536|FG001|Phase A|Lost to Follow-up|3|||
161348883|NCT03727022|582663535|FG000|Phase A|Withdrawal by Subject|10|||
161348884|NCT03727022|582663536|FG001|Phase A|Withdrawal by Subject|9|||
161348885|NCT03727022|582663535|FG000|Phase B|Lost to Follow-up|0|||
161348886|NCT03727022|582663536|FG001|Phase B|Lost to Follow-up|1|||
161189424|NCT01195636|582069027|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
161348887|NCT03727022|582663535|FG000|Phase B|Subject Non-Compliance|1|||
161348888|NCT03727022|582663536|FG001|Phase B|Subject Non-Compliance|0|||
161348889|NCT03727022|582663535|FG000|Phase B|Withdrawal by Subject|3|||
161189425|NCT01195636|582069026|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
161189426|NCT01195636|582069027|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
161189427|NCT01195636|582069026|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161189428|NCT01195636|582069027|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
161189429|NCT01195636|582069026|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
161189430|NCT01195636|582069027|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
161189431|NCT01195636|582069026|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
161189432|NCT01195636|582069027|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
161189433|NCT01195636|582069026|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
161189434|NCT01195636|582069027|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
161189435|NCT01195636|582069026|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
161189436|NCT01195636|582069027|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
161189437|NCT01195636|582069026|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
161189438|NCT01195636|582069027|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
161189439|NCT00203294|582069028|FG000|Overall Study|Withdrawal by Subject|8|||
161189440|NCT00203294|582069029|FG001|Overall Study|Withdrawal by Subject|13|||
161189441|NCT01566981|582069039|FG000|Overall Study|Lost to Follow-up|5|||
161189442|NCT01566981|582069040|FG001|Overall Study|Lost to Follow-up|8|||
161189443|NCT02177942|582069041|FG000|Overall Study|Adverse Event|1|||
161189444|NCT02177942|582069042|FG001|Overall Study|Adverse Event|0|||
161189445|NCT02177942|582069041|FG000|Overall Study|Lost to Follow-up|1|||
161189446|NCT02177942|582069042|FG001|Overall Study|Lost to Follow-up|1|||
161189447|NCT02177942|582069041|FG000|Overall Study|Protocol Violation|4|||
161348890|NCT03727022|582663536|FG001|Phase B|Withdrawal by Subject|3|||
161348891|NCT03727022|582663535|FG000|Phase B|Site Closure|4|||
161348892|NCT03727022|582663536|FG001|Phase B|Site Closure|0|||
161348893|NCT04736199|582663537|FG000|Overall Study|Adverse Event|28|||
161348894|NCT04736199|582663538|FG001|Overall Study|Adverse Event|22|||
161348895|NCT04736199|582663537|FG000|Overall Study|Death|9|||
161348896|NCT04736199|582663538|FG001|Overall Study|Death|3|||
161348897|NCT04736199|582663537|FG000|Overall Study|Lost to Follow-up|4|||
161348898|NCT04736199|582663538|FG001|Overall Study|Lost to Follow-up|1|||
161348899|NCT04736199|582663537|FG000|Overall Study|Physician Decision|5|||
161348900|NCT04736199|582663538|FG001|Overall Study|Physician Decision|9|||
161348901|NCT04736199|582663537|FG000|Overall Study|Withdrawal by Subject|21|||
161348902|NCT04736199|582663538|FG001|Overall Study|Withdrawal by Subject|9|||
161348903|NCT04736199|582663537|FG000|Overall Study|Progressive disease|120|||
161348904|NCT04736199|582663538|FG001|Overall Study|Progressive disease|101|||
161348905|NCT04736199|582663537|FG000|Overall Study|Subject decision|13|||
161348906|NCT04736199|582663538|FG001|Overall Study|Subject decision|13|||
161348907|NCT04736199|582663537|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
161348908|NCT04736199|582663538|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
161348909|NCT04736199|582663537|FG000|Overall Study|Additional primary malignancy|1|||
161348910|NCT04736199|582663538|FG001|Overall Study|Additional primary malignancy|0|||
161348911|NCT04736199|582663537|FG000|Overall Study|Non-compliance with study drug|0|||
161348912|NCT04736199|582663538|FG001|Overall Study|Non-compliance with study drug|1|||
161348913|NCT04736199|582663537|FG000|Overall Study|Other reason|0|||
161348914|NCT04736199|582663538|FG001|Overall Study|Other reason|1|||
161348915|NCT04736199|582663537|FG000|Overall Study|Ongoing with study drug|240|||
161348916|NCT04736199|582663538|FG001|Overall Study|Ongoing with study drug|63|||
161348917|NCT04736199|582663537|FG000|Overall Study|Study drug never administered|3|||
161348918|NCT04736199|582663538|FG001|Overall Study|Study drug never administered|0|||
161348919|NCT03922802|582663539|FG000|Overall Study|Withdrawal by Subject|4|||
161348920|NCT05550818|582663540|FG000|Overall Study|Protocol Violation|1|||
161348921|NCT05550818|582663541|FG001|Overall Study|Protocol Violation|1|||
161348922|NCT05550818|582663540|FG000|Overall Study|Withdrawal by Subject|2|||
161348923|NCT05550818|582663541|FG001|Overall Study|Withdrawal by Subject|1|||
161348924|NCT04486716|582663542|FG000|Core Phase|Subject decision|6|||
161348925|NCT04486716|582663542|FG000|Core Phase|Adverse Event|5|||
161348926|NCT04486716|582663542|FG000|Core Phase|Lost to Follow-up|1|||
161189448|NCT02177942|582069042|FG001|Overall Study|Protocol Violation|6|||
161189449|NCT02177942|582069041|FG000|Overall Study|Withdrawal by Subject|71|||
161189450|NCT02177942|582069042|FG001|Overall Study|Withdrawal by Subject|81|||
161189451|NCT02405091|582069045|FG000|Overall Study|Adverse Event|16|||
161189452|NCT02405091|582069046|FG001|Overall Study|Adverse Event|10|||
161189453|NCT02405091|582069047|FG002|Overall Study|Adverse Event|0|||
161189454|NCT02405091|582069045|FG000|Overall Study|Protocol Violation|1|||
161189455|NCT02405091|582069046|FG001|Overall Study|Protocol Violation|0|||
161348927|NCT04486716|582663542|FG000|Core Phase|Physician Decision|1|||
161348928|NCT04486716|582663542|FG000|Core Phase|Enrolled subjects not treated|9|||
161348929|NCT02797522|582663543|FG000|Overall Study|Study Terminated by Sponsor|0|||
161348930|NCT02797522|582663544|FG001|Overall Study|Study Terminated by Sponsor|0|||
161348931|NCT02797522|582663545|FG002|Overall Study|Study Terminated by Sponsor|0|||
161348932|NCT02797522|582663546|FG003|Overall Study|Study Terminated by Sponsor|0|||
161348933|NCT02797522|582663547|FG004|Overall Study|Study Terminated by Sponsor|0|||
161189456|NCT02405091|582069047|FG002|Overall Study|Protocol Violation|0|||
161348934|NCT02797522|582663548|FG005|Overall Study|Study Terminated by Sponsor|0|||
161348935|NCT02797522|582663549|FG006|Overall Study|Study Terminated by Sponsor|0|||
161348936|NCT02797522|582663550|FG007|Overall Study|Study Terminated by Sponsor|4|||
161348937|NCT02797522|582663551|FG008|Overall Study|Study Terminated by Sponsor|2|||
161348938|NCT02797522|582663552|FG009|Overall Study|Study Terminated by Sponsor|4|||
161348939|NCT02797522|582663553|FG010|Overall Study|Study Terminated by Sponsor|1|||
161348940|NCT04744831|582663554|FG000|Overall Study|Adverse Event|6|||
161348941|NCT04744831|582663555|FG001|Overall Study|Adverse Event|4|||
161348942|NCT04744831|582663554|FG000|Overall Study|Clinical Progression|5|||
161348943|NCT04744831|582663555|FG001|Overall Study|Clinical Progression|5|||
161348944|NCT04744831|582663554|FG000|Overall Study|Death|2|||
161348945|NCT04744831|582663555|FG001|Overall Study|Death|1|||
161348946|NCT04744831|582663554|FG000|Overall Study|Other|5|||
161348947|NCT04744831|582663555|FG001|Overall Study|Other|1|||
161348948|NCT04744831|582663554|FG000|Overall Study|Progressive Disease|63|||
161348949|NCT04744831|582663555|FG001|Overall Study|Progressive Disease|29|||
161348950|NCT04744831|582663554|FG000|Overall Study|Withdrawal by Subject|1|||
161348951|NCT04744831|582663555|FG001|Overall Study|Withdrawal by Subject|0|||
161348952|NCT05888103|582663556|FG000|Overall Study|Participant decision|3|||
161348953|NCT05888103|582663557|FG001|Overall Study|Participant decision|3|||
161348954|NCT04987307|582663558|FG000|Overall Study|Protocol-specified criteria|2|||
161348955|NCT04987307|582663559|FG001|Overall Study|Protocol-specified criteria|0|||
161348956|NCT04987307|582663560|FG002|Overall Study|Protocol-specified criteria|0|||
161348957|NCT04987307|582663561|FG003|Overall Study|Protocol-specified criteria|3|||
161348958|NCT04987307|582663558|FG000|Overall Study|Withdrawal by Subject|34|||
161348959|NCT04987307|582663559|FG001|Overall Study|Withdrawal by Subject|30|||
161348960|NCT04987307|582663560|FG002|Overall Study|Withdrawal by Subject|29|||
161348961|NCT04987307|582663561|FG003|Overall Study|Withdrawal by Subject|35|||
161348962|NCT04987307|582663558|FG000|Overall Study|Decision by sponsor|10|||
161348963|NCT04987307|582663559|FG001|Overall Study|Decision by sponsor|13|||
161348964|NCT04987307|582663560|FG002|Overall Study|Decision by sponsor|11|||
161348965|NCT04987307|582663561|FG003|Overall Study|Decision by sponsor|9|||
161348966|NCT04987307|582663558|FG000|Overall Study|Lost to Follow-up|1|||
161348967|NCT04987307|582663559|FG001|Overall Study|Lost to Follow-up|0|||
161348968|NCT04987307|582663560|FG002|Overall Study|Lost to Follow-up|0|||
161348969|NCT04987307|582663561|FG003|Overall Study|Lost to Follow-up|0|||
161348970|NCT03031912|582663562|FG000|Overall Study|Lost to Follow-up|1|||
161348971|NCT03031912|582663563|FG001|Overall Study|Lost to Follow-up|1|||
161348972|NCT03031912|582663564|FG002|Overall Study|Lost to Follow-up|0|||
161348973|NCT03031912|582663565|FG003|Overall Study|Lost to Follow-up|1|||
161348974|NCT03031912|582663566|FG004|Overall Study|Lost to Follow-up|0|||
161348975|NCT03031912|582663567|FG005|Overall Study|Lost to Follow-up|0|||
161348976|NCT03031912|582663568|FG006|Overall Study|Lost to Follow-up|0|||
161348977|NCT03031912|582663569|FG007|Overall Study|Lost to Follow-up|0|||
161348978|NCT03031912|582663570|FG008|Overall Study|Lost to Follow-up|0|||
161348979|NCT03031912|582663571|FG009|Overall Study|Lost to Follow-up|0|||
161348980|NCT02805725|582663572|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
161348981|NCT02805725|582663573|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
161348982|NCT02805725|582663574|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
161348983|NCT02805725|582663575|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
161348984|NCT02805725|582663576|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
161348985|NCT02805725|582663572|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
161348986|NCT02805725|582663573|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
161348987|NCT02805725|582663574|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
161348988|NCT02805725|582663575|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
161348989|NCT02805725|582663576|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
161348990|NCT02805725|582663572|FG000|Phase II|Protocol Violation|0|||
161348991|NCT02805725|582663573|FG001|Phase II|Protocol Violation|0|||
161348992|NCT02805725|582663574|FG002|Phase II|Protocol Violation|0|||
161348993|NCT02805725|582663575|FG003|Phase II|Protocol Violation|0|||
161348994|NCT02805725|582663576|FG004|Phase II|Protocol Violation|6|||
161348995|NCT03650400|582663579|FG000|Overall Study|Study terminated by sponsor|0|||
161348996|NCT03650400|582663580|FG001|Overall Study|Study terminated by sponsor|5|||
161348997|NCT04097743|582663581|FG000|Overall Study|Non-compliance of the study instruction.|1|||
161348998|NCT04097743|582663582|FG001|Overall Study|Non-compliance of the study instruction.|0|||
161348999|NCT06024096|582663591|FG000|Overall Study|Lost to Follow-up|2|||
161349000|NCT06024096|582663592|FG001|Overall Study|Lost to Follow-up|5|||
161349001|NCT06024096|582663591|FG000|Overall Study|Physician Decision|0|||
161349002|NCT06024096|582663592|FG001|Overall Study|Physician Decision|1|||
161349003|NCT06024096|582663591|FG000|Overall Study|Withdrawal by Subject|2|||
161349004|NCT06024096|582663592|FG001|Overall Study|Withdrawal by Subject|3|||
161349005|NCT05541861|582663593|FG000|Overall Study|Withdrawal by Subject|0|||
161349006|NCT05541861|582663594|FG001|Overall Study|Withdrawal by Subject|0|||
161349007|NCT05541861|582663595|FG002|Overall Study|Withdrawal by Subject|0|||
161349008|NCT05541861|582663596|FG003|Overall Study|Withdrawal by Subject|0|||
161349009|NCT05541861|582663597|FG004|Overall Study|Withdrawal by Subject|0|||
161349010|NCT05541861|582663598|FG005|Overall Study|Withdrawal by Subject|0|||
161305749|NCT01046903|582499082|FG000|Overall Study|Lost to Follow-up|16|||
161305750|NCT01046903|582499082|FG000|Overall Study|Adverse Event|4|||
161305751|NCT01046903|582499082|FG000|Overall Study|Withdrawal by Subject|3|||
161305752|NCT01046903|582499082|FG000|Overall Study|Other|5|||
161305753|NCT00977314|582499083|FG000|Overall Study|Withdrawal by Subject|1|||
161305754|NCT00977314|582499084|FG001|Overall Study|Withdrawal by Subject|0|||
161305755|NCT00977314|582499083|FG000|Overall Study|Physician Decision|1|||
161305756|NCT00977314|582499084|FG001|Overall Study|Physician Decision|0|||
161305757|NCT01343277|582499085|FG000|Overall Study|Other|3|||
161305758|NCT01343277|582499086|FG001|Overall Study|Other|3|||
161305759|NCT01343277|582499085|FG000|Overall Study|Withdrawal by Subject|18|||
161305760|NCT01343277|582499086|FG001|Overall Study|Withdrawal by Subject|13|||
161305761|NCT01343277|582499085|FG000|Overall Study|Physician Decision|1|||
161305762|NCT01343277|582499086|FG001|Overall Study|Physician Decision|2|||
161305763|NCT01343277|582499085|FG000|Overall Study|Death|10|||
161305764|NCT01343277|582499086|FG001|Overall Study|Death|1|||
161305765|NCT01343277|582499085|FG000|Overall Study|Adverse Event|67|||
161305766|NCT01343277|582499086|FG001|Overall Study|Adverse Event|13|||
161305767|NCT01343277|582499085|FG000|Overall Study|Disease progression|270|||
161305768|NCT01343277|582499086|FG001|Overall Study|Disease progression|138|||
161305769|NCT01343277|582499085|FG000|Overall Study|Randomized not treated|6|||
161305770|NCT01343277|582499086|FG001|Overall Study|Randomized not treated|21|||
161305771|NCT01343277|582499085|FG000|Overall Study|Treatment ongoing|8|||
161305772|NCT01343277|582499086|FG001|Overall Study|Treatment ongoing|2|||
161305773|NCT01343277|582499085|FG000|Overall Study|Subsequent anticancer therapy|1|||
161305774|NCT01343277|582499086|FG001|Overall Study|Subsequent anticancer therapy|0|||
161305775|NCT01894100|582499089|FG000|Overall Study|Lost to Follow-up|0|||
161305776|NCT01894100|582499090|FG001|Overall Study|Lost to Follow-up|1|||
161305777|NCT01894100|582499089|FG000|Overall Study|Withdrawal by Subject|3|||
161305778|NCT01894100|582499090|FG001|Overall Study|Withdrawal by Subject|0|||
161305779|NCT00135512|582499093|FG000|Overall Study|Adverse Event|56|||
161305780|NCT00135512|582499093|FG000|Overall Study|Lack of Efficacy|25|||
161305781|NCT00135512|582499093|FG000|Overall Study|Other|42|||
161305782|NCT01094301|582499094|FG000|Trial Stage|Withdrawal by Subject|1|||
161305783|NCT01094301|582499094|FG000|Implant Stage|Adverse Event|1|||
161305784|NCT01094301|582499094|FG000|Implant Stage|Protocol Violation|1|||
161305785|NCT01094301|582499094|FG000|Implant Stage|Withdrawal by Subject|2|||
161305786|NCT01094301|582499094|FG000|Implant Stage|No return of pain|4|||
161305787|NCT04439214|582499098|FG000|Overall Study|Adverse Event|13|||
161305788|NCT04439214|582499098|FG000|Overall Study|Disease progression|16|||
161305789|NCT04439214|582499098|FG000|Overall Study|Death|1|||
161305790|NCT04439214|582499098|FG000|Overall Study|Withdrawal by Subject|2|||
161305791|NCT04439214|582499098|FG000|Overall Study|Declining health|1|||
161305792|NCT04439214|582499098|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
161305793|NCT04439214|582499098|FG000|Overall Study|Ineligible|5|||
161305794|NCT02964208|582499099|FG000|Overall Study|Death|103|||
161305795|NCT02964208|582499099|FG000|Overall Study|Withdrawal by Subject|6|||
161305796|NCT02964208|582499099|FG000|Overall Study|Lost to Follow-up|6|||
161305797|NCT02964208|582499099|FG000|Overall Study|Unsuccessful Procedure|5|||
161305798|NCT02964208|582499099|FG000|Overall Study|Device Explant|1|||
161305799|NCT02964208|582499099|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
161305800|NCT00556933|582499100|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
161305801|NCT00556933|582499101|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
161305802|NCT00556933|582499102|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
161305803|NCT00556933|582499103|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
161305804|NCT00556933|582499100|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161305805|NCT00556933|582499101|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161305806|NCT00556933|582499102|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
161305807|NCT00556933|582499103|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
161305808|NCT00556933|582499100|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
161305809|NCT00556933|582499101|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161305810|NCT00556933|582499102|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161305811|NCT00556933|582499103|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
161305812|NCT00556933|582499100|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
161305813|NCT00556933|582499101|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
161305814|NCT00556933|582499102|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
161305815|NCT00556933|582499103|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
161305816|NCT00556933|582499100|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161305817|NCT00556933|582499101|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
161305818|NCT00556933|582499102|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161305819|NCT00556933|582499103|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
161305820|NCT00556933|582499100|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161305821|NCT00556933|582499101|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
161189457|NCT02405091|582069045|FG000|Overall Study|Noncompliance|1|||
161189458|NCT02405091|582069046|FG001|Overall Study|Noncompliance|6|||
161189459|NCT02405091|582069047|FG002|Overall Study|Noncompliance|2|||
161189460|NCT02405091|582069045|FG000|Overall Study|Withdrawal by Subject|4|||
161189461|NCT02405091|582069046|FG001|Overall Study|Withdrawal by Subject|8|||
161189462|NCT02405091|582069047|FG002|Overall Study|Withdrawal by Subject|0|||
161189463|NCT02405091|582069045|FG000|Overall Study|Death|0|||
161189464|NCT02405091|582069046|FG001|Overall Study|Death|1|||
161189465|NCT02405091|582069047|FG002|Overall Study|Death|0|||
161189466|NCT02405091|582069045|FG000|Overall Study|Lost to Follow-up|5|||
161189467|NCT02405091|582069046|FG001|Overall Study|Lost to Follow-up|6|||
161189468|NCT02405091|582069047|FG002|Overall Study|Lost to Follow-up|0|||
161189469|NCT02405091|582069045|FG000|Overall Study|Physician Decision|2|||
161189470|NCT02405091|582069046|FG001|Overall Study|Physician Decision|2|||
161189471|NCT02405091|582069047|FG002|Overall Study|Physician Decision|0|||
161189472|NCT01948791|582069055|FG000|Overall Study|Adverse Event|12|||
161189473|NCT01948791|582069055|FG000|Overall Study|Lack of Efficacy|3|||
161189474|NCT01948791|582069055|FG000|Overall Study|Protocol Violation|2|||
161189475|NCT01948791|582069055|FG000|Overall Study|Withdrawal by Subject|5|||
161189476|NCT01948791|582069055|FG000|Overall Study|Lost to Follow-up|6|||
161189477|NCT01948791|582069055|FG000|Overall Study|Management issues|1|||
161189478|NCT01948791|582069055|FG000|Overall Study|Others|7|||
161189479|NCT01948791|582069055|FG000|Overall Study|Screening failure|35|||
161189480|NCT02555722|582069063|FG000|Week 2|Adverse Event|0|||
161189481|NCT02555722|582069064|FG001|Week 2|Adverse Event|1|||
161189482|NCT02555722|582069063|FG000|Week 2|Withdrawal by Subject|1|||
161189483|NCT02555722|582069064|FG001|Week 2|Withdrawal by Subject|0|||
161305822|NCT00556933|582499102|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161305823|NCT00556933|582499103|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
161305824|NCT00556933|582499100|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
161305825|NCT00556933|582499101|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
161305826|NCT00556933|582499102|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
161305827|NCT00556933|582499103|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
161305828|NCT00556933|582499100|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
161305829|NCT00556933|582499101|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
161305830|NCT00556933|582499102|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
161305831|NCT00556933|582499103|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
161305832|NCT00556933|582499100|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
161305833|NCT00556933|582499101|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
161305834|NCT00556933|582499102|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
161305835|NCT00556933|582499103|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
161305836|NCT00556933|582499100|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
161305837|NCT00556933|582499101|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
161305838|NCT00556933|582499102|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
161305839|NCT00556933|582499103|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
161305840|NCT00556933|582499100|FG000|CNI Withdrawal vs. Minimization|Death|0|||
161305841|NCT00556933|582499101|FG001|CNI Withdrawal vs. Minimization|Death|0|||
161305842|NCT00556933|582499102|FG002|CNI Withdrawal vs. Minimization|Death|0|||
161305843|NCT00556933|582499103|FG003|CNI Withdrawal vs. Minimization|Death|1|||
161305844|NCT01493284|582499113|FG000|Overall Study|Death|29|||
161305845|NCT01493284|582499113|FG000|Overall Study|Withdrawal by Subject|32|||
161305846|NCT05903924|582500683|FG000|Overall Study|Lost to Follow-up|1|||
161305847|NCT05903924|582500684|FG001|Overall Study|Lost to Follow-up|0|||
161305848|NCT05903924|582500685|FG002|Overall Study|Lost to Follow-up|0|||
161305849|NCT04338269|582500686|FG000|Overall Study|Death|86|||
161305850|NCT04338269|582500687|FG001|Overall Study|Death|89|||
161305851|NCT04338269|582500686|FG000|Overall Study|Lost to Follow-up|1|||
161305852|NCT04338269|582500687|FG001|Overall Study|Lost to Follow-up|2|||
161305853|NCT04338269|582500686|FG000|Overall Study|Physician Decision|1|||
161305854|NCT04338269|582500687|FG001|Overall Study|Physician Decision|0|||
161305855|NCT04338269|582500686|FG000|Overall Study|Withdrawal by Subject|14|||
161305856|NCT04338269|582500687|FG001|Overall Study|Withdrawal by Subject|11|||
161305857|NCT04934189|582500688|FG000|Overall Study|Lost to Follow-up|4|||
161305858|NCT04934189|582500688|FG000|Overall Study|Withdrawal by Subject|17|||
161305859|NCT03320850|582500689|FG000|Overall Study|Lost to Follow-up|0|||
161189484|NCT02555722|582069063|FG000|Month 1|Lens Discomfort|1|||
161189485|NCT02555722|582069064|FG001|Month 1|Lens Discomfort|0|||
161189486|NCT02555722|582069063|FG000|Month 2|Withdrawal by Subject|3|||
161305860|NCT03320850|582500690|FG001|Overall Study|Lost to Follow-up|0|||
161305861|NCT03320850|582500691|FG002|Overall Study|Lost to Follow-up|0|||
161305862|NCT03320850|582500692|FG003|Overall Study|Lost to Follow-up|0|||
161305863|NCT03320850|582500693|FG004|Overall Study|Lost to Follow-up|1|||
161189487|NCT02555722|582069064|FG001|Month 2|Withdrawal by Subject|0|||
161189488|NCT02555722|582069063|FG000|Month 2|Lost to Follow-up|1|||
161189489|NCT02555722|582069064|FG001|Month 2|Lost to Follow-up|0|||
161189490|NCT00702949|582069065|FG000|Overall Study|Refusal|3|||
161189491|NCT00702949|582069066|FG001|Overall Study|Refusal|2|||
161349011|NCT05541861|582663599|FG006|Overall Study|Withdrawal by Subject|2|||
161349012|NCT05541861|582663600|FG007|Overall Study|Withdrawal by Subject|0|||
161349013|NCT05541861|582663601|FG008|Overall Study|Withdrawal by Subject|0|||
161349014|NCT05541861|582663593|FG000|Overall Study|Randomized but not dosed|0|||
161349015|NCT05541861|582663594|FG001|Overall Study|Randomized but not dosed|1|||
161349016|NCT05541861|582663595|FG002|Overall Study|Randomized but not dosed|1|||
161349017|NCT05541861|582663596|FG003|Overall Study|Randomized but not dosed|0|||
161349018|NCT05541861|582663597|FG004|Overall Study|Randomized but not dosed|0|||
161349019|NCT05541861|582663598|FG005|Overall Study|Randomized but not dosed|0|||
161349020|NCT05541861|582663599|FG006|Overall Study|Randomized but not dosed|1|||
161349021|NCT05541861|582663600|FG007|Overall Study|Randomized but not dosed|0|||
161349022|NCT05541861|582663601|FG008|Overall Study|Randomized but not dosed|1|||
161349023|NCT04452877|582663608|FG000|Overall Study|Adverse Event|5|||
161349024|NCT04452877|582663608|FG000|Overall Study|Lost to Follow-up|1|||
161349025|NCT04452877|582663608|FG000|Overall Study|Physician Decision|4|||
161349026|NCT04452877|582663608|FG000|Overall Study|Progressive Disease|18|||
161349027|NCT04452877|582663608|FG000|Overall Study|Withdrawal by Subject|3|||
161349028|NCT05678959|582663609|FG000|Overall Study|Study Terminated by Sponsor|76|||
161349029|NCT05678959|582663610|FG001|Overall Study|Study Terminated by Sponsor|76|||
161189492|NCT00702949|582069067|FG002|Overall Study|Refusal|2|||
161189493|NCT00702949|582069065|FG000|Overall Study|Adverse Event|1|||
161189494|NCT00702949|582069066|FG001|Overall Study|Adverse Event|6|||
161189495|NCT00702949|582069067|FG002|Overall Study|Adverse Event|3|||
161189496|NCT00702949|582069065|FG000|Overall Study|Other Medical Reason/unknown|1|||
161189497|NCT00702949|582069066|FG001|Overall Study|Other Medical Reason/unknown|1|||
161189498|NCT00702949|582069067|FG002|Overall Study|Other Medical Reason/unknown|3|||
161189499|NCT00598585|582069068|FG000|Overall Study|Lost to Follow-up|1|||
161189500|NCT00598585|582069069|FG001|Overall Study|Lost to Follow-up|0|||
161189501|NCT01040728|582069073|FG000|Overall Study|Adverse Event|4|||
161189502|NCT01040728|582069074|FG001|Overall Study|Adverse Event|8|||
161189503|NCT01040728|582069075|FG002|Overall Study|Adverse Event|0|||
161189504|NCT01040728|582069076|FG003|Overall Study|Adverse Event|4|||
161189505|NCT01040728|582069073|FG000|Overall Study|Withdrawal by Subject|0|||
161189506|NCT01040728|582069074|FG001|Overall Study|Withdrawal by Subject|1|||
161189507|NCT01040728|582069075|FG002|Overall Study|Withdrawal by Subject|1|||
161349030|NCT05678959|582663609|FG000|Overall Study|Physician Decision|2|||
161349031|NCT05678959|582663610|FG001|Overall Study|Physician Decision|3|||
161349032|NCT05678959|582663609|FG000|Overall Study|Adverse Event|1|||
161349033|NCT05678959|582663610|FG001|Overall Study|Adverse Event|1|||
161349034|NCT05678959|582663609|FG000|Overall Study|Guardian Decision|1|||
161349035|NCT05678959|582663610|FG001|Overall Study|Guardian Decision|0|||
161189508|NCT01040728|582069076|FG003|Overall Study|Withdrawal by Subject|0|||
161189509|NCT01040728|582069073|FG000|Overall Study|Protocol Violation|0|||
161189510|NCT01040728|582069074|FG001|Overall Study|Protocol Violation|0|||
161189511|NCT01040728|582069075|FG002|Overall Study|Protocol Violation|0|||
161189512|NCT01040728|582069076|FG003|Overall Study|Protocol Violation|1|||
161189513|NCT01040728|582069073|FG000|Overall Study|Lack of Efficacy|0|||
161189514|NCT01040728|582069074|FG001|Overall Study|Lack of Efficacy|1|||
161189515|NCT01040728|582069075|FG002|Overall Study|Lack of Efficacy|0|||
161189516|NCT01040728|582069076|FG003|Overall Study|Lack of Efficacy|1|||
161189517|NCT01040728|582069073|FG000|Overall Study|Other reasons not listed above|0|||
161189518|NCT01040728|582069074|FG001|Overall Study|Other reasons not listed above|1|||
161189519|NCT01040728|582069075|FG002|Overall Study|Other reasons not listed above|0|||
161189520|NCT01040728|582069076|FG003|Overall Study|Other reasons not listed above|0|||
161349036|NCT05678959|582663609|FG000|Overall Study|Protocol Deviation|0|||
161349037|NCT05678959|582663610|FG001|Overall Study|Protocol Deviation|1|||
161349038|NCT05678959|582663609|FG000|Overall Study|Subject Decision|1|||
161349039|NCT05678959|582663610|FG001|Overall Study|Subject Decision|0|||
161349040|NCT05678959|582663609|FG000|Overall Study|Technical Problem|0|||
161349041|NCT05678959|582663610|FG001|Overall Study|Technical Problem|1|||
161349042|NCT02932410|582663611|FG000|Overall Study|Death|7|||
161189521|NCT01012037|582069077|FG000|Overall Study|Adverse Event|0|||
161189522|NCT01012037|582069078|FG001|Overall Study|Adverse Event|8|||
161189523|NCT01012037|582069079|FG002|Overall Study|Adverse Event|3|||
161189524|NCT01012037|582069077|FG000|Overall Study|Protocol Violation|0|||
161349043|NCT02932410|582663612|FG001|Overall Study|Death|6|||
161349044|NCT02932410|582663613|FG002|Overall Study|Death|0|||
161349045|NCT02932410|582663614|FG003|Overall Study|Death|0|||
161349046|NCT02932410|582663611|FG000|Overall Study|Lost to Follow-up|1|||
161349047|NCT02932410|582663612|FG001|Overall Study|Lost to Follow-up|2|||
161349048|NCT02932410|582663613|FG002|Overall Study|Lost to Follow-up|0|||
161349049|NCT02932410|582663614|FG003|Overall Study|Lost to Follow-up|0|||
161349050|NCT02932410|582663611|FG000|Overall Study|Parent/Subjects decision|6|||
161349051|NCT02932410|582663612|FG001|Overall Study|Parent/Subjects decision|6|||
161189525|NCT01012037|582069078|FG001|Overall Study|Protocol Violation|3|||
161189526|NCT01012037|582069079|FG002|Overall Study|Protocol Violation|5|||
161189527|NCT01012037|582069077|FG000|Overall Study|Withdrawal by Subject|0|||
161189528|NCT01012037|582069078|FG001|Overall Study|Withdrawal by Subject|4|||
161349052|NCT02932410|582663613|FG002|Overall Study|Parent/Subjects decision|1|||
161349053|NCT02932410|582663614|FG003|Overall Study|Parent/Subjects decision|0|||
161349054|NCT02932410|582663611|FG000|Overall Study|Physician Decision|0|||
161349055|NCT02932410|582663612|FG001|Overall Study|Physician Decision|1|||
161349056|NCT02932410|582663613|FG002|Overall Study|Physician Decision|0|||
161349057|NCT02932410|582663614|FG003|Overall Study|Physician Decision|0|||
161349058|NCT05818137|582663617|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
161349059|NCT05818137|582663617|FG000|Extension Treatment Period|Ongoing participants|44|||
161349060|NCT02065336|582663618|FG000|Extension Phase|Study Terminated by Sponsor|0|||
161349061|NCT02065336|582663619|FG001|Extension Phase|Study Terminated by Sponsor|0|||
161349062|NCT02065336|582663620|FG002|Extension Phase|Study Terminated by Sponsor|0|||
161349063|NCT02065336|582663621|FG003|Extension Phase|Study Terminated by Sponsor|0|||
161349064|NCT02065336|582663622|FG004|Extension Phase|Study Terminated by Sponsor|0|||
161349065|NCT02065336|582663623|FG005|Extension Phase|Study Terminated by Sponsor|0|||
161189529|NCT01012037|582069079|FG002|Overall Study|Withdrawal by Subject|1|||
161189530|NCT01012037|582069077|FG000|Overall Study|Other reason (not specified)|1|||
161189531|NCT01012037|582069078|FG001|Overall Study|Other reason (not specified)|1|||
161189532|NCT01012037|582069079|FG002|Overall Study|Other reason (not specified)|1|||
161189533|NCT01809327|582069082|FG000|Overall Study|Lost to Follow-up|5|||
161189534|NCT01809327|582069083|FG001|Overall Study|Lost to Follow-up|2|||
161189535|NCT01809327|582069084|FG002|Overall Study|Lost to Follow-up|4|||
161189536|NCT01809327|582069085|FG003|Overall Study|Lost to Follow-up|2|||
161189537|NCT01809327|582069086|FG004|Overall Study|Lost to Follow-up|3|||
161189538|NCT01809327|582069082|FG000|Overall Study|Withdrawal by Subject|6|||
161189539|NCT01809327|582069083|FG001|Overall Study|Withdrawal by Subject|4|||
161349066|NCT02065336|582663624|FG006|Extension Phase|Study Terminated by Sponsor|0|||
161349067|NCT02065336|582663625|FG007|Extension Phase|Study Terminated by Sponsor|0|||
161349068|NCT02065336|582663626|FG008|Extension Phase|Study Terminated by Sponsor|2|||
161349069|NCT02065336|582663627|FG009|Extension Phase|Study Terminated by Sponsor|8|||
161349070|NCT05925374|582663628|FG000|Overall Study|Lost to Follow-up|13|||
161349071|NCT03226392|582663629|FG000|Overall Study|Protocol Deviation|1|||
161349072|NCT03226392|582663630|FG001|Overall Study|Protocol Deviation|0|||
161349073|NCT03226392|582663629|FG000|Overall Study|Physician Decision|1|||
161349074|NCT03226392|582663630|FG001|Overall Study|Physician Decision|0|||
161349075|NCT03226392|582663629|FG000|Overall Study|Lost to Follow-up|1|||
161189540|NCT01809327|582069084|FG002|Overall Study|Withdrawal by Subject|4|||
161189541|NCT01809327|582069085|FG003|Overall Study|Withdrawal by Subject|2|||
161189542|NCT01809327|582069086|FG004|Overall Study|Withdrawal by Subject|5|||
161189543|NCT01809327|582069082|FG000|Overall Study|Adverse Event|4|||
161189544|NCT01809327|582069083|FG001|Overall Study|Adverse Event|3|||
161189545|NCT01809327|582069084|FG002|Overall Study|Adverse Event|7|||
161189546|NCT01809327|582069085|FG003|Overall Study|Adverse Event|4|||
161189547|NCT01809327|582069086|FG004|Overall Study|Adverse Event|8|||
161189548|NCT01809327|582069082|FG000|Overall Study|Death|1|||
161189549|NCT01809327|582069083|FG001|Overall Study|Death|0|||
161189550|NCT01809327|582069084|FG002|Overall Study|Death|0|||
161189551|NCT01809327|582069085|FG003|Overall Study|Death|0|||
161189552|NCT01809327|582069086|FG004|Overall Study|Death|0|||
161189553|NCT01809327|582069082|FG000|Overall Study|Protocol Violation|0|||
161189554|NCT01809327|582069083|FG001|Overall Study|Protocol Violation|1|||
161189555|NCT01809327|582069084|FG002|Overall Study|Protocol Violation|0|||
161189556|NCT01809327|582069085|FG003|Overall Study|Protocol Violation|0|||
161189557|NCT01809327|582069086|FG004|Overall Study|Protocol Violation|0|||
161189558|NCT01809327|582069082|FG000|Overall Study|Physician Decision|1|||
161189559|NCT01809327|582069083|FG001|Overall Study|Physician Decision|1|||
161189560|NCT01809327|582069084|FG002|Overall Study|Physician Decision|0|||
161189561|NCT01809327|582069085|FG003|Overall Study|Physician Decision|0|||
161189562|NCT01809327|582069086|FG004|Overall Study|Physician Decision|0|||
161189563|NCT01809327|582069082|FG000|Overall Study|Pregnancy|1|||
161189564|NCT01809327|582069083|FG001|Overall Study|Pregnancy|0|||
161189565|NCT01809327|582069084|FG002|Overall Study|Pregnancy|0|||
161189566|NCT01809327|582069085|FG003|Overall Study|Pregnancy|0|||
161189567|NCT01809327|582069086|FG004|Overall Study|Pregnancy|0|||
161189568|NCT01809327|582069082|FG000|Overall Study|Other|14|||
161189569|NCT01809327|582069083|FG001|Overall Study|Other|15|||
161349076|NCT03226392|582663630|FG001|Overall Study|Lost to Follow-up|0|||
161349077|NCT03226392|582663629|FG000|Overall Study|Adverse Event|1|||
161189570|NCT01809327|582069084|FG002|Overall Study|Other|7|||
161189571|NCT01809327|582069085|FG003|Overall Study|Other|4|||
161189572|NCT01809327|582069086|FG004|Overall Study|Other|9|||
161189573|NCT03196973|582069087|FG000|Overall Study|Adverse Event|1|||
161189574|NCT03196973|582069088|FG001|Overall Study|Adverse Event|1|||
161189575|NCT03196973|582069089|FG002|Overall Study|Adverse Event|2|||
161189576|NCT03196973|582069087|FG000|Overall Study|Lack of Efficacy|2|||
161189577|NCT03196973|582069088|FG001|Overall Study|Lack of Efficacy|6|||
161189578|NCT03196973|582069089|FG002|Overall Study|Lack of Efficacy|1|||
161349078|NCT03226392|582663630|FG001|Overall Study|Adverse Event|0|||
161349079|NCT03226392|582663629|FG000|Overall Study|Technical Problems|0|||
161349080|NCT03226392|582663630|FG001|Overall Study|Technical Problems|2|||
161189579|NCT03196973|582069087|FG000|Overall Study|Lost to Follow-up|4|||
161189580|NCT03196973|582069088|FG001|Overall Study|Lost to Follow-up|3|||
161189581|NCT03196973|582069089|FG002|Overall Study|Lost to Follow-up|2|||
161189582|NCT03196973|582069087|FG000|Overall Study|Consent withdrawn|2|||
161189583|NCT03196973|582069088|FG001|Overall Study|Consent withdrawn|1|||
161189584|NCT03196973|582069089|FG002|Overall Study|Consent withdrawn|0|||
161189585|NCT03196973|582069087|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
161189586|NCT03196973|582069088|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
161189587|NCT03196973|582069089|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
161189588|NCT00826540|582069090|FG000|Overall Study|ineligible|3|||
161189589|NCT00826540|582069090|FG000|Overall Study|Withdrawal by Subject|1|||
161189590|NCT01084096|582071003|FG000|Overall Study|Lost to Follow-up|1501|||
161189591|NCT01084096|582071004|FG001|Overall Study|Lost to Follow-up|1833|||
161189592|NCT01084096|582071003|FG000|Overall Study|Withdrawal by Subject|3|||
161189593|NCT01084096|582071004|FG001|Overall Study|Withdrawal by Subject|0|||
161189594|NCT01084096|582071003|FG000|Overall Study|Woman had a miscarriage|21|||
161189595|NCT01084096|582071004|FG001|Overall Study|Woman had a miscarriage|17|||
161189596|NCT00027846|582071005|FG000|Overall Study|Lost to Follow-up|0|||
161189597|NCT00027846|582071006|FG001|Overall Study|Lost to Follow-up|41|||
161189598|NCT00027846|582071007|FG002|Overall Study|Lost to Follow-up|9|||
161189599|NCT00027846|582071005|FG000|Overall Study|Withdrawal by Subject|0|||
161189600|NCT00027846|582071006|FG001|Overall Study|Withdrawal by Subject|14|||
161189601|NCT00027846|582071007|FG002|Overall Study|Withdrawal by Subject|7|||
161189602|NCT00027846|582071005|FG000|Overall Study|Ineligible for study|2|||
161189603|NCT00027846|582071006|FG001|Overall Study|Ineligible for study|6|||
161090075|NCT00196976|581719890|FG013|Primary Study|Withdrawal by Subject|0|||
161090076|NCT00196976|581719877|FG000|Primary Study|Lost to Follow-up|0|||
161090077|NCT00196976|581719878|FG001|Primary Study|Lost to Follow-up|0|||
161090078|NCT00196976|581719879|FG002|Primary Study|Lost to Follow-up|0|||
161090079|NCT00196976|581719880|FG003|Primary Study|Lost to Follow-up|0|||
161090080|NCT00196976|581719881|FG004|Primary Study|Lost to Follow-up|1|||
161090081|NCT00196976|581719882|FG005|Primary Study|Lost to Follow-up|1|||
161090082|NCT00196976|581719883|FG006|Primary Study|Lost to Follow-up|0|||
161090083|NCT00196976|581719884|FG007|Primary Study|Lost to Follow-up|2|||
161090084|NCT00196976|581719885|FG008|Primary Study|Lost to Follow-up|0|||
161090085|NCT00196976|581719886|FG009|Primary Study|Lost to Follow-up|0|||
161090086|NCT00196976|581719887|FG010|Primary Study|Lost to Follow-up|0|||
161090087|NCT00196976|581719888|FG011|Primary Study|Lost to Follow-up|0|||
161090088|NCT00196976|581719889|FG012|Primary Study|Lost to Follow-up|0|||
161090089|NCT00196976|581719890|FG013|Primary Study|Lost to Follow-up|0|||
161090090|NCT00196976|581719877|FG000|Primary Study|Other|0|||
161090091|NCT00196976|581719878|FG001|Primary Study|Other|0|||
161090092|NCT00196976|581719879|FG002|Primary Study|Other|2|||
161090093|NCT00196976|581719880|FG003|Primary Study|Other|0|||
161090094|NCT00196976|581719881|FG004|Primary Study|Other|0|||
161090095|NCT00196976|581719882|FG005|Primary Study|Other|0|||
161090096|NCT00196976|581719883|FG006|Primary Study|Other|0|||
161090097|NCT00196976|581719884|FG007|Primary Study|Other|0|||
161090098|NCT00196976|581719885|FG008|Primary Study|Other|0|||
161090099|NCT00196976|581719886|FG009|Primary Study|Other|0|||
161090100|NCT00196976|581719887|FG010|Primary Study|Other|0|||
161090101|NCT00196976|581719888|FG011|Primary Study|Other|0|||
161090102|NCT00196976|581719889|FG012|Primary Study|Other|0|||
161090103|NCT00196976|581719890|FG013|Primary Study|Other|0|||
161090104|NCT00196976|581719877|FG000|Booster Study|Withdrawal by Subject|0|||
161090105|NCT00196976|581719878|FG001|Booster Study|Withdrawal by Subject|0|||
161090106|NCT00196976|581719879|FG002|Booster Study|Withdrawal by Subject|0|||
161090107|NCT00196976|581719880|FG003|Booster Study|Withdrawal by Subject|0|||
161090108|NCT00196976|581719881|FG004|Booster Study|Withdrawal by Subject|0|||
161090109|NCT00196976|581719882|FG005|Booster Study|Withdrawal by Subject|0|||
161090110|NCT00196976|581719883|FG006|Booster Study|Withdrawal by Subject|0|||
161090111|NCT00196976|581719884|FG007|Booster Study|Withdrawal by Subject|0|||
161090112|NCT00196976|581719885|FG008|Booster Study|Withdrawal by Subject|0|||
161090113|NCT00196976|581719886|FG009|Booster Study|Withdrawal by Subject|0|||
161090114|NCT00196976|581719887|FG010|Booster Study|Withdrawal by Subject|1|||
161090115|NCT00196976|581719888|FG011|Booster Study|Withdrawal by Subject|0|||
161090116|NCT00196976|581719889|FG012|Booster Study|Withdrawal by Subject|0|||
161090117|NCT00196976|581719890|FG013|Booster Study|Withdrawal by Subject|0|||
161090118|NCT00196976|581719877|FG000|Booster Study|Lost to Follow-up|0|||
161090119|NCT00196976|581719878|FG001|Booster Study|Lost to Follow-up|0|||
161090120|NCT00196976|581719879|FG002|Booster Study|Lost to Follow-up|0|||
161090121|NCT00196976|581719880|FG003|Booster Study|Lost to Follow-up|0|||
161090122|NCT00196976|581719881|FG004|Booster Study|Lost to Follow-up|0|||
161090123|NCT00196976|581719882|FG005|Booster Study|Lost to Follow-up|0|||
161090124|NCT00196976|581719883|FG006|Booster Study|Lost to Follow-up|0|||
161090125|NCT00196976|581719884|FG007|Booster Study|Lost to Follow-up|0|||
161090126|NCT00196976|581719885|FG008|Booster Study|Lost to Follow-up|0|||
161189604|NCT00027846|582071007|FG002|Overall Study|Ineligible for study|14|||
161189605|NCT00027846|582071005|FG000|Overall Study|Entry into another COG therapeutic study|0|||
161305864|NCT03320850|582500694|FG005|Overall Study|Lost to Follow-up|2|||
161305865|NCT03320850|582500695|FG006|Overall Study|Lost to Follow-up|2|||
161305866|NCT03320850|582500696|FG007|Overall Study|Lost to Follow-up|0|||
161305867|NCT03320850|582500697|FG008|Overall Study|Lost to Follow-up|6|||
161305868|NCT03320850|582500698|FG009|Overall Study|Lost to Follow-up|4|||
161305869|NCT03320850|582500689|FG000|Overall Study|Withdrawal by Subject|0|||
161305870|NCT03320850|582500690|FG001|Overall Study|Withdrawal by Subject|0|||
161305871|NCT03320850|582500691|FG002|Overall Study|Withdrawal by Subject|0|||
161305872|NCT03320850|582500692|FG003|Overall Study|Withdrawal by Subject|0|||
161305873|NCT03320850|582500693|FG004|Overall Study|Withdrawal by Subject|1|||
161305874|NCT03320850|582500694|FG005|Overall Study|Withdrawal by Subject|2|||
161305875|NCT03320850|582500695|FG006|Overall Study|Withdrawal by Subject|4|||
161305876|NCT03320850|582500696|FG007|Overall Study|Withdrawal by Subject|5|||
161305877|NCT03320850|582500697|FG008|Overall Study|Withdrawal by Subject|2|||
161305878|NCT03320850|582500698|FG009|Overall Study|Withdrawal by Subject|1|||
161305879|NCT03320850|582500689|FG000|Overall Study|Lack of Efficacy|0|||
161305880|NCT03320850|582500690|FG001|Overall Study|Lack of Efficacy|0|||
161305881|NCT03320850|582500691|FG002|Overall Study|Lack of Efficacy|0|||
161305882|NCT03320850|582500692|FG003|Overall Study|Lack of Efficacy|1|||
161305883|NCT03320850|582500693|FG004|Overall Study|Lack of Efficacy|0|||
161305884|NCT03320850|582500694|FG005|Overall Study|Lack of Efficacy|1|||
161305885|NCT03320850|582500695|FG006|Overall Study|Lack of Efficacy|0|||
161305886|NCT03320850|582500696|FG007|Overall Study|Lack of Efficacy|2|||
161305887|NCT03320850|582500697|FG008|Overall Study|Lack of Efficacy|0|||
161305888|NCT03320850|582500698|FG009|Overall Study|Lack of Efficacy|3|||
161305889|NCT03320850|582500689|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
161305890|NCT03320850|582500690|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161305891|NCT03320850|582500691|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161305892|NCT03320850|582500692|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
161305893|NCT03320850|582500693|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161305894|NCT03320850|582500694|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
161305895|NCT03320850|582500695|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
161305896|NCT03320850|582500696|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
161305897|NCT03320850|582500697|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
161305898|NCT03320850|582500698|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
161305899|NCT03320850|582500689|FG000|Overall Study|Adverse Event|0|||
161305900|NCT03320850|582500690|FG001|Overall Study|Adverse Event|0|||
161305901|NCT03320850|582500691|FG002|Overall Study|Adverse Event|0|||
161305902|NCT03320850|582500692|FG003|Overall Study|Adverse Event|0|||
161305903|NCT03320850|582500693|FG004|Overall Study|Adverse Event|0|||
161305904|NCT03320850|582500694|FG005|Overall Study|Adverse Event|2|||
161305905|NCT03320850|582500695|FG006|Overall Study|Adverse Event|1|||
161305906|NCT03320850|582500696|FG007|Overall Study|Adverse Event|0|||
161305907|NCT03320850|582500697|FG008|Overall Study|Adverse Event|2|||
161305908|NCT03320850|582500698|FG009|Overall Study|Adverse Event|0|||
161305909|NCT03320850|582500689|FG000|Overall Study|Reason Not Specified|0|||
161305910|NCT03320850|582500690|FG001|Overall Study|Reason Not Specified|0|||
161305911|NCT03320850|582500691|FG002|Overall Study|Reason Not Specified|0|||
161305912|NCT03320850|582500692|FG003|Overall Study|Reason Not Specified|0|||
161305913|NCT03320850|582500693|FG004|Overall Study|Reason Not Specified|0|||
161305914|NCT03320850|582500694|FG005|Overall Study|Reason Not Specified|1|||
161305915|NCT03320850|582500695|FG006|Overall Study|Reason Not Specified|0|||
161305916|NCT03320850|582500696|FG007|Overall Study|Reason Not Specified|0|||
161305917|NCT03320850|582500697|FG008|Overall Study|Reason Not Specified|0|||
161305918|NCT03320850|582500698|FG009|Overall Study|Reason Not Specified|1|||
161305919|NCT02002533|582500701|FG000|Overall Study|Withdrawal by Subject|6|||
161305920|NCT02002533|582500702|FG001|Overall Study|Withdrawal by Subject|13|||
161305921|NCT02002533|582500701|FG000|Overall Study|Protocol Violation|0|||
161305922|NCT02002533|582500702|FG001|Overall Study|Protocol Violation|1|||
161305923|NCT02002533|582500701|FG000|Overall Study|Adverse Event|0|||
161305924|NCT02002533|582500702|FG001|Overall Study|Adverse Event|3|||
161305925|NCT02002533|582500701|FG000|Overall Study|Lost to Follow-up|0|||
161305926|NCT02002533|582500702|FG001|Overall Study|Lost to Follow-up|1|||
161305927|NCT02086448|582500708|FG000|Overall Study|Withdrawal by Subject|1|||
161305928|NCT02086448|582500709|FG001|Overall Study|Withdrawal by Subject|0|||
161305929|NCT02086448|582500710|FG002|Overall Study|Withdrawal by Subject|0|||
161305930|NCT02086448|582500711|FG003|Overall Study|Withdrawal by Subject|2|||
161305931|NCT01871402|582500724|FG000|Overall Study|Lost to Follow-up|1|||
161305932|NCT01871402|582500725|FG001|Overall Study|Lost to Follow-up|0|||
161305933|NCT01871402|582500724|FG000|Overall Study|Withdrawal by Subject|0|||
161305934|NCT01871402|582500725|FG001|Overall Study|Withdrawal by Subject|2|||
161305935|NCT01871402|582500724|FG000|Overall Study|Non-compliance|0|||
161305936|NCT01871402|582500725|FG001|Overall Study|Non-compliance|1|||
161305937|NCT04594941|582500726|FG000|Overall Study|Other|0|||
161305938|NCT04594941|582500727|FG001|Overall Study|Other|3|||
161305939|NCT04594941|582500728|FG002|Overall Study|Other|1|||
161305940|NCT04594941|582500729|FG003|Overall Study|Other|0|||
161189606|NCT00027846|582071006|FG001|Overall Study|Entry into another COG therapeutic study|5|||
161189607|NCT00027846|582071007|FG002|Overall Study|Entry into another COG therapeutic study|2|||
161189608|NCT00027846|582071005|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
161189609|NCT00027846|582071006|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
161189610|NCT00027846|582071007|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
161189611|NCT02033369|582071008|FG000|Overall Study|Physician Decision|1|||
161189612|NCT02033369|582071009|FG001|Overall Study|Physician Decision|2|||
161305941|NCT03408444|582500730|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
161305942|NCT03408444|582500731|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161305943|NCT03408444|582500732|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161305944|NCT03408444|582500733|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
161305945|NCT03408444|582500730|FG000|Overall Study|Lens Discomfort|0|||
161305946|NCT03408444|582500731|FG001|Overall Study|Lens Discomfort|1|||
161305947|NCT03408444|582500732|FG002|Overall Study|Lens Discomfort|0|||
161305948|NCT03408444|582500733|FG003|Overall Study|Lens Discomfort|0|||
161305949|NCT03408444|582500730|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161305950|NCT03408444|582500731|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161305951|NCT03408444|582500732|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
161305952|NCT03408444|582500733|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
161305953|NCT03408444|582500730|FG000|Overall Study|Withdrawal by Subject|0|||
161349081|NCT03226392|582663629|FG000|Overall Study|Subject/Guardian Decision|7|||
161305954|NCT03408444|582500731|FG001|Overall Study|Withdrawal by Subject|2|||
161305955|NCT03408444|582500732|FG002|Overall Study|Withdrawal by Subject|3|||
161349082|NCT03226392|582663630|FG001|Overall Study|Subject/Guardian Decision|6|||
161349083|NCT03056755|582663631|FG000|Core Phase|Progressive disease|89|||
161090127|NCT00196976|581719886|FG009|Booster Study|Lost to Follow-up|0|||
161090128|NCT00196976|581719887|FG010|Booster Study|Lost to Follow-up|1|||
161090129|NCT00196976|581719888|FG011|Booster Study|Lost to Follow-up|2|||
161090130|NCT00196976|581719889|FG012|Booster Study|Lost to Follow-up|0|||
161090131|NCT00196976|581719890|FG013|Booster Study|Lost to Follow-up|0|||
161090132|NCT01535560|581719891|FG000|Overall Study|Adverse Event|12|||
161090133|NCT01535560|581719892|FG001|Overall Study|Adverse Event|7|||
161090134|NCT01535560|581719891|FG000|Overall Study|Lost to Follow-up|1|||
161090135|NCT01535560|581719892|FG001|Overall Study|Lost to Follow-up|3|||
161090136|NCT01535560|581719891|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
161090137|NCT01535560|581719892|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
161090138|NCT01535560|581719891|FG000|Overall Study|Treatment Failure|21|||
161090139|NCT01535560|581719892|FG001|Overall Study|Treatment Failure|83|||
161090140|NCT01535560|581719891|FG000|Overall Study|Other|0|||
161090141|NCT01535560|581719892|FG001|Overall Study|Other|1|||
161090142|NCT01535560|581719891|FG000|Overall Study|Randomized in Error|0|||
161090143|NCT01535560|581719892|FG001|Overall Study|Randomized in Error|1|||
161090144|NCT02009761|581719893|FG000|Overall Study|Adverse Event|4|||
161090145|NCT02842827|581719894|FG000|Overall Study|Adverse Event|0|||
161090146|NCT02842827|581719895|FG001|Overall Study|Adverse Event|1|||
161090147|NCT02842827|581719896|FG002|Overall Study|Adverse Event|0|||
161090148|NCT02842827|581719897|FG003|Overall Study|Adverse Event|1|||
161090149|NCT02842827|581719898|FG004|Overall Study|Adverse Event|0|||
161090150|NCT02842827|581719899|FG005|Overall Study|Adverse Event|1|||
161090151|NCT02842827|581719900|FG006|Overall Study|Adverse Event|0|||
161090152|NCT02842827|581719901|FG007|Overall Study|Adverse Event|0|||
161090153|NCT02842827|581719894|FG000|Overall Study|Death|1|||
161090154|NCT02842827|581719895|FG001|Overall Study|Death|0|||
161090155|NCT02842827|581719896|FG002|Overall Study|Death|2|||
161090156|NCT02842827|581719897|FG003|Overall Study|Death|3|||
161090157|NCT02842827|581719898|FG004|Overall Study|Death|2|||
161090158|NCT02842827|581719899|FG005|Overall Study|Death|1|||
161090159|NCT02842827|581719900|FG006|Overall Study|Death|0|||
161090160|NCT02842827|581719901|FG007|Overall Study|Death|4|||
161090161|NCT02842827|581719894|FG000|Overall Study|Physician Decision|1|||
161090162|NCT02842827|581719895|FG001|Overall Study|Physician Decision|3|||
161090163|NCT02842827|581719896|FG002|Overall Study|Physician Decision|0|||
161090164|NCT02842827|581719897|FG003|Overall Study|Physician Decision|0|||
161090165|NCT02842827|581719898|FG004|Overall Study|Physician Decision|1|||
161090166|NCT02842827|581719899|FG005|Overall Study|Physician Decision|4|||
161090167|NCT02842827|581719900|FG006|Overall Study|Physician Decision|2|||
161090168|NCT02842827|581719901|FG007|Overall Study|Physician Decision|1|||
161090169|NCT02842827|581719894|FG000|Overall Study|Protocol Defined Disease Progression|0|||
161090170|NCT02842827|581719895|FG001|Overall Study|Protocol Defined Disease Progression|0|||
161090171|NCT02842827|581719896|FG002|Overall Study|Protocol Defined Disease Progression|0|||
161090172|NCT02842827|581719897|FG003|Overall Study|Protocol Defined Disease Progression|0|||
161090173|NCT02842827|581719898|FG004|Overall Study|Protocol Defined Disease Progression|0|||
161090174|NCT02842827|581719899|FG005|Overall Study|Protocol Defined Disease Progression|1|||
161090175|NCT02842827|581719900|FG006|Overall Study|Protocol Defined Disease Progression|0|||
161090176|NCT02842827|581719901|FG007|Overall Study|Protocol Defined Disease Progression|0|||
161189613|NCT02033369|582071008|FG000|Overall Study|Not a good demographic match|0|||
161189614|NCT02033369|582071009|FG001|Overall Study|Not a good demographic match|2|||
161189615|NCT02033369|582071008|FG000|Overall Study|Withdrawal by Subject|1|||
161189616|NCT02033369|582071009|FG001|Overall Study|Withdrawal by Subject|1|||
161189617|NCT02033369|582071008|FG000|Overall Study|Lost to Follow-up|1|||
161189618|NCT02033369|582071009|FG001|Overall Study|Lost to Follow-up|0|||
161189619|NCT02033369|582071008|FG000|Overall Study|Protocol Violation|2|||
161189620|NCT02033369|582071009|FG001|Overall Study|Protocol Violation|0|||
161189621|NCT02551874|582071022|FG000|Overall Study|Lost to Follow-up|0|||
161189622|NCT02551874|582071023|FG001|Overall Study|Lost to Follow-up|2|||
161189623|NCT02551874|582071022|FG000|Overall Study|Pregnancy|0|||
161189624|NCT02551874|582071023|FG001|Overall Study|Pregnancy|1|||
161189625|NCT02551874|582071022|FG000|Overall Study|Reason not reported|10|||
161189626|NCT02551874|582071023|FG001|Overall Study|Reason not reported|4|||
161189627|NCT02551874|582071022|FG000|Overall Study|Did not receive randomized treatment|0|||
161189628|NCT02551874|582071023|FG001|Overall Study|Did not receive randomized treatment|7|||
161189629|NCT02551874|582071022|FG000|Overall Study|Did not enter long-term study|18|||
161189630|NCT02551874|582071023|FG001|Overall Study|Did not enter long-term study|25|||
161189631|NCT04067310|582071025|FG000|Overall Study|Physician Decision|2|||
161189632|NCT04067310|582071026|FG001|Overall Study|Physician Decision|6|||
161189633|NCT04067310|582071025|FG000|Overall Study|Lost to Follow-up|0|||
161189634|NCT04067310|582071026|FG001|Overall Study|Lost to Follow-up|1|||
161189635|NCT04067310|582071025|FG000|Overall Study|Withdrawal by Subject|3|||
161189636|NCT04067310|582071026|FG001|Overall Study|Withdrawal by Subject|0|||
161189637|NCT01041027|582071027|FG000|Overall Study|Withdrawal by Subject|2|||
161189638|NCT01041027|582071027|FG000|Overall Study|Protocol Violation|1|||
161189639|NCT01041027|582071027|FG000|Overall Study|Delayed Radiation Therapy|1|||
161189640|NCT01041027|582071027|FG000|Overall Study|Adverse Event|4|||
161189641|NCT02528643|582071028|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
161189642|NCT02528643|582071029|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
161189643|NCT02528643|582071028|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
161189644|NCT02528643|582071029|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
161189645|NCT02528643|582071028|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
161189646|NCT02528643|582071029|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
161189647|NCT02528643|582071028|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
161189648|NCT02528643|582071029|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
161189649|NCT02528643|582071028|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
161189650|NCT02528643|582071029|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
161189651|NCT02528643|582071028|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
161189652|NCT02528643|582071029|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
161189653|NCT02528643|582071028|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
161189654|NCT02528643|582071029|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
161189655|NCT02058940|582071030|FG000|Overall Study|Discharged from Critical Care Unit|1|||
161189656|NCT04144140|582071031|FG000|Overall Study|Other|0|||
161189657|NCT04144140|582071032|FG001|Overall Study|Other|0|||
161189658|NCT04144140|582071033|FG002|Overall Study|Other|0|||
161189659|NCT04144140|582071034|FG003|Overall Study|Other|0|||
161189660|NCT04144140|582071035|FG004|Overall Study|Other|0|||
161189661|NCT04144140|582071036|FG005|Overall Study|Other|1|||
161189662|NCT04144140|582071037|FG006|Overall Study|Other|0|||
161189663|NCT02039687|582071038|FG000|Overall Study|Adverse Event|0|||
161189664|NCT02039687|582071039|FG001|Overall Study|Adverse Event|0|||
161189665|NCT02039687|582071040|FG002|Overall Study|Adverse Event|1|||
161189666|NCT02039687|582071041|FG003|Overall Study|Adverse Event|0|||
161189667|NCT02039687|582071038|FG000|Overall Study|Withdrawal by Subject|0|||
161189668|NCT02039687|582071039|FG001|Overall Study|Withdrawal by Subject|1|||
161189669|NCT02039687|582071040|FG002|Overall Study|Withdrawal by Subject|0|||
161189670|NCT02039687|582071041|FG003|Overall Study|Withdrawal by Subject|0|||
161189671|NCT02039687|582071038|FG000|Overall Study|treatment assignment could not be confir|0|||
161189672|NCT02039687|582071039|FG001|Overall Study|treatment assignment could not be confir|0|||
161189673|NCT02039687|582071040|FG002|Overall Study|treatment assignment could not be confir|2|||
161189674|NCT02039687|582071041|FG003|Overall Study|treatment assignment could not be confir|0|||
161189675|NCT00443534|582071044|FG000|Overall Study|Lack of Efficacy|67|||
161189676|NCT00443534|582071044|FG000|Overall Study|Adverse Event|16|||
161189677|NCT00443534|582071044|FG000|Overall Study|Death|9|||
161189678|NCT00443534|582071044|FG000|Overall Study|Withdrawal by Subject|8|||
161189679|NCT00443534|582071044|FG000|Overall Study|Study Terminated by Sponsor|12|||
161189680|NCT00443534|582071044|FG000|Overall Study|Other|10|||
161189681|NCT00443534|582071044|FG000|Overall Study|Enrolled, Not Treated|1|||
161189682|NCT00305773|582071046|FG000|Overall Study|Death|3|||
161189683|NCT00305773|582071047|FG001|Overall Study|Death|2|||
161189684|NCT00305773|582071046|FG000|Overall Study|Adverse Event|1|||
161189685|NCT00305773|582071047|FG001|Overall Study|Adverse Event|2|||
161189686|NCT00305773|582071046|FG000|Overall Study|Alternative Treatment|4|||
161189687|NCT00305773|582071047|FG001|Overall Study|Alternative Treatment|4|||
161349084|NCT03056755|582663632|FG001|Core Phase|Progressive disease|88|||
161349085|NCT03056755|582663633|FG002|Core Phase|Progressive disease|90|||
161349086|NCT03056755|582663631|FG000|Core Phase|Adverse Event|20|||
161349087|NCT03056755|582663632|FG001|Core Phase|Adverse Event|14|||
161349088|NCT03056755|582663633|FG002|Core Phase|Adverse Event|13|||
161349089|NCT03056755|582663631|FG000|Core Phase|Physician Decision|7|||
161349090|NCT03056755|582663632|FG001|Core Phase|Physician Decision|13|||
161349091|NCT03056755|582663633|FG002|Core Phase|Physician Decision|5|||
161349092|NCT03056755|582663631|FG000|Core Phase|Subject/guardian decision|5|||
161349093|NCT03056755|582663632|FG001|Core Phase|Subject/guardian decision|8|||
161349094|NCT03056755|582663633|FG002|Core Phase|Subject/guardian decision|4|||
161349095|NCT03056755|582663631|FG000|Core Phase|Death|3|||
161349096|NCT03056755|582663632|FG001|Core Phase|Death|2|||
161349097|NCT03056755|582663633|FG002|Core Phase|Death|4|||
161349098|NCT03056755|582663631|FG000|Core Phase|Protocol deviation|1|||
161349099|NCT03056755|582663632|FG001|Core Phase|Protocol deviation|1|||
161349100|NCT03056755|582663633|FG002|Core Phase|Protocol deviation|0|||
161349101|NCT03056755|582663631|FG000|Core Phase|Technical problems|1|||
161349102|NCT03056755|582663632|FG001|Core Phase|Technical problems|0|||
161349103|NCT03056755|582663633|FG002|Core Phase|Technical problems|0|||
161349104|NCT03056755|582663631|FG000|Extension Phase|Physician Decision|1|||
161349105|NCT03056755|582663632|FG001|Extension Phase|Physician Decision|0|||
161349106|NCT03056755|582663633|FG002|Extension Phase|Physician Decision|3|||
161349107|NCT03056755|582663631|FG000|Extension Phase|Adverse Event|0|||
161349108|NCT03056755|582663632|FG001|Extension Phase|Adverse Event|0|||
161349109|NCT03056755|582663633|FG002|Extension Phase|Adverse Event|1|||
161349110|NCT03056755|582663631|FG000|Extension Phase|Subject/guardian decision|0|||
161349111|NCT03056755|582663632|FG001|Extension Phase|Subject/guardian decision|0|||
161349112|NCT03056755|582663633|FG002|Extension Phase|Subject/guardian decision|1|||
161349113|NCT04693715|582663640|FG000|Overall Study|Adverse Events Leading to Death|2|||
161349114|NCT04693715|582663641|FG001|Overall Study|Adverse Events Leading to Death|2|||
161349115|NCT04693715|582663642|FG002|Overall Study|Adverse Events Leading to Death|4|||
161349116|NCT04693715|582663640|FG000|Overall Study|Lost to Follow-up|0|||
161349117|NCT04693715|582663641|FG001|Overall Study|Lost to Follow-up|2|||
161349118|NCT04693715|582663642|FG002|Overall Study|Lost to Follow-up|2|||
161349119|NCT04693715|582663640|FG000|Overall Study|Physician Decision|0|||
161349120|NCT04693715|582663641|FG001|Overall Study|Physician Decision|1|||
161349121|NCT04693715|582663642|FG002|Overall Study|Physician Decision|0|||
161349122|NCT04693715|582663640|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161349123|NCT04693715|582663641|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
161349124|NCT04693715|582663642|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
161349125|NCT04693715|582663640|FG000|Overall Study|Withdrawal by Subject|0|||
161349126|NCT04693715|582663641|FG001|Overall Study|Withdrawal by Subject|0|||
161349127|NCT04693715|582663642|FG002|Overall Study|Withdrawal by Subject|1|||
161349128|NCT04667949|582663650|FG000|Overall Study|Adverse Event|0|||
161349129|NCT04667949|582663651|FG001|Overall Study|Adverse Event|2|||
161349130|NCT04667949|582663650|FG000|Overall Study|Lost to Follow-up|0|||
161349131|NCT04667949|582663651|FG001|Overall Study|Lost to Follow-up|1|||
161349132|NCT04667949|582663650|FG000|Overall Study|Physician Decision|0|||
161349133|NCT04667949|582663651|FG001|Overall Study|Physician Decision|2|||
161349134|NCT04667949|582663650|FG000|Overall Study|Subject decision|1|||
161349135|NCT04667949|582663651|FG001|Overall Study|Subject decision|7|||
161349136|NCT05206370|582663652|FG000|Overall Study|Adverse Event|3|||
161349137|NCT05206370|582663653|FG001|Overall Study|Adverse Event|4|||
161349138|NCT05206370|582663654|FG002|Overall Study|Adverse Event|5|||
161349139|NCT05206370|582663652|FG000|Overall Study|Withdrawal by Subject|27|||
161349140|NCT05206370|582663653|FG001|Overall Study|Withdrawal by Subject|30|||
161349141|NCT05206370|582663654|FG002|Overall Study|Withdrawal by Subject|24|||
161349142|NCT05206370|582663652|FG000|Overall Study|Physician Decision|1|||
161349143|NCT05206370|582663653|FG001|Overall Study|Physician Decision|3|||
161349144|NCT05206370|582663654|FG002|Overall Study|Physician Decision|2|||
161189688|NCT00305773|582071046|FG000|Overall Study|Physician Decision|1|||
161189689|NCT00305773|582071047|FG001|Overall Study|Physician Decision|1|||
161349145|NCT05206370|582663652|FG000|Overall Study|Death|0|||
161349146|NCT05206370|582663653|FG001|Overall Study|Death|1|||
161349147|NCT05206370|582663654|FG002|Overall Study|Death|3|||
161349148|NCT05206370|582663652|FG000|Overall Study|Lost to Follow-up|23|||
161349149|NCT05206370|582663653|FG001|Overall Study|Lost to Follow-up|16|||
161349150|NCT05206370|582663654|FG002|Overall Study|Lost to Follow-up|14|||
161349151|NCT05206370|582663652|FG000|Overall Study|Other, Nor Specified|2|||
161349152|NCT05206370|582663653|FG001|Overall Study|Other, Nor Specified|2|||
161349153|NCT05206370|582663654|FG002|Overall Study|Other, Nor Specified|4|||
161349154|NCT04557735|582663655|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
161349155|NCT04557735|582663655|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
161349156|NCT04557735|582663655|FG000|Treatment Period (26 Weeks)|Death|5|||
161349157|NCT04557735|582663655|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
161349158|NCT04557735|582663655|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
161349159|NCT04557735|582663655|FG000|Follow-Up Period (26 Weeks)|Death|4|||
161305956|NCT03408444|582500733|FG003|Overall Study|Withdrawal by Subject|0|||
161305957|NCT03408444|582500730|FG000|Overall Study|Lost to Follow-up|0|||
161305958|NCT03408444|582500731|FG001|Overall Study|Lost to Follow-up|0|||
161305959|NCT03408444|582500732|FG002|Overall Study|Lost to Follow-up|1|||
161305960|NCT03408444|582500733|FG003|Overall Study|Lost to Follow-up|0|||
161305961|NCT03408444|582500730|FG000|Overall Study|Adverse Event|0|||
161305962|NCT03408444|582500731|FG001|Overall Study|Adverse Event|0|||
161305963|NCT03408444|582500732|FG002|Overall Study|Adverse Event|0|||
161305964|NCT03408444|582500733|FG003|Overall Study|Adverse Event|1|||
161305965|NCT03408444|582500730|FG000|Overall Study|Lens Handling Difficulties|0|||
161305966|NCT03408444|582500731|FG001|Overall Study|Lens Handling Difficulties|0|||
161305967|NCT03408444|582500732|FG002|Overall Study|Lens Handling Difficulties|1|||
161305968|NCT03408444|582500733|FG003|Overall Study|Lens Handling Difficulties|0|||
161305969|NCT03408444|582500730|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161305970|NCT03408444|582500731|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161305971|NCT03408444|582500732|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
161305972|NCT03408444|582500733|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
161305973|NCT00231114|582500734|FG000|Randomized|Withdrawal by Subject|6|||
161305974|NCT00231114|582500735|FG001|Randomized|Withdrawal by Subject|3|||
161305975|NCT00231114|582500734|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
161305976|NCT00231114|582500735|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
161305977|NCT00231114|582500734|FG000|Post-Treatment Period|Lost to Follow-up|6|||
161305978|NCT00231114|582500735|FG001|Post-Treatment Period|Lost to Follow-up|1|||
161305979|NCT00231114|582500734|FG000|Post-Treatment Period|Physician Decision|1|||
161305980|NCT00231114|582500735|FG001|Post-Treatment Period|Physician Decision|0|||
161305981|NCT00231114|582500734|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
161305982|NCT00231114|582500735|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
161305983|NCT04720911|582500737|FG000|Overall Study|Withdrawal by Subject|0|||
161305984|NCT04720911|582500738|FG001|Overall Study|Withdrawal by Subject|1|||
161305985|NCT04720911|582500739|FG002|Overall Study|Withdrawal by Subject|0|||
161305986|NCT00537316|582500740|FG000|Part 1|Adverse Event|7|||
161305987|NCT00537316|582500741|FG001|Part 1|Adverse Event|11|||
161305988|NCT00537316|582500742|FG002|Part 1|Adverse Event|8|||
161305989|NCT00537316|582500743|FG003|Part 1|Adverse Event|0|||
161305990|NCT00537316|582500744|FG004|Part 1|Adverse Event|0|||
161305991|NCT00537316|582500745|FG005|Part 1|Adverse Event|0|||
161305992|NCT00537316|582500746|FG006|Part 1|Adverse Event|0|||
161305993|NCT00537316|582500740|FG000|Part 1|Protocol defined clinical event|1|||
161305994|NCT00537316|582500741|FG001|Part 1|Protocol defined clinical event|0|||
161305995|NCT00537316|582500742|FG002|Part 1|Protocol defined clinical event|0|||
161305996|NCT00537316|582500743|FG003|Part 1|Protocol defined clinical event|0|||
161305997|NCT00537316|582500744|FG004|Part 1|Protocol defined clinical event|0|||
161305998|NCT00537316|582500745|FG005|Part 1|Protocol defined clinical event|0|||
161305999|NCT00537316|582500746|FG006|Part 1|Protocol defined clinical event|0|||
161306000|NCT00537316|582500740|FG000|Part 1|Lost to Follow-up|1|||
161306001|NCT00537316|582500741|FG001|Part 1|Lost to Follow-up|0|||
161306002|NCT00537316|582500742|FG002|Part 1|Lost to Follow-up|0|||
161306003|NCT00537316|582500743|FG003|Part 1|Lost to Follow-up|0|||
161306004|NCT00537316|582500744|FG004|Part 1|Lost to Follow-up|0|||
161306005|NCT00537316|582500745|FG005|Part 1|Lost to Follow-up|0|||
161306006|NCT00537316|582500746|FG006|Part 1|Lost to Follow-up|0|||
161306007|NCT00537316|582500740|FG000|Part 1|Withdrawal by Subject|3|||
161306008|NCT00537316|582500741|FG001|Part 1|Withdrawal by Subject|8|||
161306009|NCT00537316|582500742|FG002|Part 1|Withdrawal by Subject|4|||
161306010|NCT00537316|582500743|FG003|Part 1|Withdrawal by Subject|0|||
161306011|NCT00537316|582500744|FG004|Part 1|Withdrawal by Subject|0|||
161306012|NCT00537316|582500745|FG005|Part 1|Withdrawal by Subject|0|||
161306013|NCT00537316|582500746|FG006|Part 1|Withdrawal by Subject|0|||
161306014|NCT00537316|582500740|FG000|Part 1|Protocol Violation|1|||
161306015|NCT00537316|582500741|FG001|Part 1|Protocol Violation|5|||
161306016|NCT00537316|582500742|FG002|Part 1|Protocol Violation|1|||
161306017|NCT00537316|582500743|FG003|Part 1|Protocol Violation|0|||
161306018|NCT00537316|582500744|FG004|Part 1|Protocol Violation|0|||
161306019|NCT00537316|582500745|FG005|Part 1|Protocol Violation|0|||
161306020|NCT00537316|582500746|FG006|Part 1|Protocol Violation|0|||
161306021|NCT00537316|582500740|FG000|Part 1|Did not meet protocol eligibility|1|||
161306022|NCT00537316|582500741|FG001|Part 1|Did not meet protocol eligibility|3|||
161306023|NCT00537316|582500742|FG002|Part 1|Did not meet protocol eligibility|2|||
161306024|NCT00537316|582500743|FG003|Part 1|Did not meet protocol eligibility|0|||
161306025|NCT00537316|582500744|FG004|Part 1|Did not meet protocol eligibility|0|||
161306026|NCT00537316|582500745|FG005|Part 1|Did not meet protocol eligibility|0|||
161306027|NCT00537316|582500746|FG006|Part 1|Did not meet protocol eligibility|0|||
161306028|NCT00537316|582500740|FG000|Part 1|Administrative|0|||
161306029|NCT00537316|582500741|FG001|Part 1|Administrative|0|||
161306030|NCT00537316|582500742|FG002|Part 1|Administrative|2|||
161306031|NCT00537316|582500743|FG003|Part 1|Administrative|0|||
161306032|NCT00537316|582500744|FG004|Part 1|Administrative|0|||
161306033|NCT00537316|582500745|FG005|Part 1|Administrative|0|||
161306034|NCT00537316|582500746|FG006|Part 1|Administrative|0|||
161306035|NCT00537316|582500740|FG000|Part 2|Never entered follow-up|0|||
161349160|NCT04998851|582663656|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
161349161|NCT04998851|582663657|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
161349162|NCT04998851|582663656|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
161349163|NCT04998851|582663657|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
161349164|NCT04504630|582663658|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
161349165|NCT04504630|582663659|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
161349166|NCT04504630|582663658|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
161349167|NCT04504630|582663659|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
161349168|NCT05562934|582663660|FG000|Overall Study|Adverse Event|0|||
161349169|NCT05562934|582663661|FG001|Overall Study|Adverse Event|2|||
161349170|NCT05562934|582663662|FG002|Overall Study|Adverse Event|0|||
161349171|NCT05562934|582663663|FG003|Overall Study|Adverse Event|0|||
161349172|NCT05562934|582663664|FG004|Overall Study|Adverse Event|2|||
161349173|NCT05562934|582663660|FG000|Overall Study|Lost to Follow-up|0|||
161349174|NCT05562934|582663661|FG001|Overall Study|Lost to Follow-up|0|||
161349175|NCT05562934|582663662|FG002|Overall Study|Lost to Follow-up|0|||
161349176|NCT05562934|582663663|FG003|Overall Study|Lost to Follow-up|0|||
161349177|NCT05562934|582663664|FG004|Overall Study|Lost to Follow-up|1|||
161349178|NCT05562934|582663660|FG000|Overall Study|Protocol Violation|0|||
161349179|NCT05562934|582663661|FG001|Overall Study|Protocol Violation|0|||
161349180|NCT05562934|582663662|FG002|Overall Study|Protocol Violation|0|||
161349181|NCT05562934|582663663|FG003|Overall Study|Protocol Violation|1|||
161349182|NCT05562934|582663664|FG004|Overall Study|Protocol Violation|1|||
161349183|NCT05562934|582663660|FG000|Overall Study|Withdrawal by Subject|0|||
161349184|NCT05562934|582663661|FG001|Overall Study|Withdrawal by Subject|0|||
161349185|NCT05562934|582663662|FG002|Overall Study|Withdrawal by Subject|1|||
161349186|NCT05562934|582663663|FG003|Overall Study|Withdrawal by Subject|1|||
161349187|NCT05562934|582663664|FG004|Overall Study|Withdrawal by Subject|0|||
161349188|NCT05365217|582663665|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161349189|NCT05365217|582663666|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161349190|NCT04266301|582663669|FG000|Overall Study|Progressive Disease|111|||
161349191|NCT04266301|582663670|FG001|Overall Study|Progressive Disease|92|||
161349192|NCT04266301|582663669|FG000|Overall Study|Adverse Event|41|||
161349193|NCT04266301|582663670|FG001|Overall Study|Adverse Event|43|||
161349194|NCT04266301|582663669|FG000|Overall Study|Death|26|||
161349195|NCT04266301|582663670|FG001|Overall Study|Death|35|||
161349196|NCT04266301|582663669|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
161349197|NCT04266301|582663670|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
161349198|NCT04266301|582663669|FG000|Overall Study|Study Terminated by Sponsor|22|||
161349199|NCT04266301|582663670|FG001|Overall Study|Study Terminated by Sponsor|27|||
161349200|NCT04266301|582663669|FG000|Overall Study|Participant Decision|22|||
161349201|NCT04266301|582663670|FG001|Overall Study|Participant Decision|28|||
161349202|NCT04266301|582663669|FG000|Overall Study|Physician Decision|14|||
161349203|NCT04266301|582663670|FG001|Overall Study|Physician Decision|9|||
161349204|NCT04266301|582663669|FG000|Overall Study|New Therapy for Study Indication|2|||
161349205|NCT04266301|582663670|FG001|Overall Study|New Therapy for Study Indication|4|||
161349206|NCT04266301|582663669|FG000|Overall Study|Protocol Deviation|2|||
161349207|NCT04266301|582663670|FG001|Overall Study|Protocol Deviation|4|||
161349208|NCT04266301|582663669|FG000|Overall Study|Guardian Decision|1|||
161349209|NCT04266301|582663670|FG001|Overall Study|Guardian Decision|0|||
161349210|NCT04266301|582663669|FG000|Overall Study|Lost to Follow-up|1|||
161349211|NCT04266301|582663670|FG001|Overall Study|Lost to Follow-up|0|||
161349212|NCT04266301|582663669|FG000|Overall Study|Participants Not Treated|1|||
161349213|NCT04266301|582663670|FG001|Overall Study|Participants Not Treated|1|||
161189690|NCT00305773|582071046|FG000|Overall Study|Withdrawal by Subject|1|||
161189691|NCT00305773|582071047|FG001|Overall Study|Withdrawal by Subject|4|||
161306036|NCT00537316|582500741|FG001|Part 2|Never entered follow-up|0|||
161306037|NCT00537316|582500742|FG002|Part 2|Never entered follow-up|0|||
161306038|NCT00537316|582500743|FG003|Part 2|Never entered follow-up|0|||
161306039|NCT00537316|582500744|FG004|Part 2|Never entered follow-up|0|||
161306040|NCT00537316|582500745|FG005|Part 2|Never entered follow-up|0|||
161306041|NCT00537316|582500746|FG006|Part 2|Never entered follow-up|1|||
161306042|NCT00537316|582500740|FG000|Part 2|Adverse Event|4|||
161306043|NCT00537316|582500741|FG001|Part 2|Adverse Event|0|||
161306044|NCT00537316|582500742|FG002|Part 2|Adverse Event|2|||
161306045|NCT00537316|582500743|FG003|Part 2|Adverse Event|0|||
161306046|NCT00537316|582500744|FG004|Part 2|Adverse Event|0|||
161306047|NCT00537316|582500745|FG005|Part 2|Adverse Event|0|||
161306048|NCT00537316|582500746|FG006|Part 2|Adverse Event|0|||
161306049|NCT00537316|582500740|FG000|Part 2|Lost to Follow-up|1|||
161306050|NCT00537316|582500741|FG001|Part 2|Lost to Follow-up|0|||
161306051|NCT00537316|582500742|FG002|Part 2|Lost to Follow-up|2|||
161306052|NCT00537316|582500743|FG003|Part 2|Lost to Follow-up|0|||
161306053|NCT00537316|582500744|FG004|Part 2|Lost to Follow-up|0|||
161306054|NCT00537316|582500745|FG005|Part 2|Lost to Follow-up|0|||
161306055|NCT00537316|582500746|FG006|Part 2|Lost to Follow-up|0|||
161306056|NCT00537316|582500740|FG000|Part 2|Withdrawal by Subject|5|||
161349214|NCT03215758|582663671|FG000|Overall Study|Technical Problems|1|||
161349215|NCT03215758|582663672|FG001|Overall Study|Technical Problems|0|||
161349216|NCT03215758|582663671|FG000|Overall Study|Protocol deviation|0|||
161349217|NCT03215758|582663672|FG001|Overall Study|Protocol deviation|1|||
161349218|NCT03215758|582663671|FG000|Overall Study|Physician Decision|0|||
161349219|NCT03215758|582663672|FG001|Overall Study|Physician Decision|1|||
161349220|NCT03215758|582663671|FG000|Overall Study|Death|0|||
161349221|NCT03215758|582663672|FG001|Overall Study|Death|1|||
161349222|NCT03215758|582663671|FG000|Overall Study|Adverse Event|1|||
161349223|NCT03215758|582663672|FG001|Overall Study|Adverse Event|2|||
161349224|NCT03215758|582663671|FG000|Overall Study|Subject/Guardian Decision|3|||
161349225|NCT03215758|582663672|FG001|Overall Study|Subject/Guardian Decision|3|||
161349226|NCT03997383|582663678|FG000|Double-blind Treatment Period|Adverse Event|4|||
161349227|NCT03997383|582663679|FG001|Double-blind Treatment Period|Adverse Event|3|||
161349228|NCT03997383|582663678|FG000|Double-blind Treatment Period|Death|4|||
161349229|NCT03997383|582663679|FG001|Double-blind Treatment Period|Death|4|||
161349230|NCT03997383|582663678|FG000|Double-blind Treatment Period|Physician Decision|2|||
161349231|NCT03997383|582663679|FG001|Double-blind Treatment Period|Physician Decision|0|||
161349232|NCT03997383|582663678|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
161349233|NCT03997383|582663679|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
161349234|NCT03997383|582663678|FG000|Open-label Extension Period|Ongoing|148|||
161349235|NCT03997383|582663679|FG001|Open-label Extension Period|Ongoing|151|||
161349236|NCT03997383|582663678|FG000|Open-label Extension Period|Adverse Event|4|||
161349237|NCT03997383|582663679|FG001|Open-label Extension Period|Adverse Event|1|||
161349238|NCT03997383|582663678|FG000|Open-label Extension Period|Death|8|||
161349239|NCT03997383|582663679|FG001|Open-label Extension Period|Death|9|||
161349240|NCT03997383|582663678|FG000|Open-label Extension Period|Physician Decision|1|||
161349241|NCT03997383|582663679|FG001|Open-label Extension Period|Physician Decision|1|||
161349242|NCT03997383|582663678|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
161349243|NCT03997383|582663679|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
161349244|NCT03997383|582663678|FG000|Open-label Extension Period|Reason Not Specified|2|||
161349245|NCT03997383|582663679|FG001|Open-label Extension Period|Reason Not Specified|0|||
161349246|NCT02977988|582663683|FG000|Overall Study|Lost to Follow-up|13|||
161349247|NCT02977988|582663684|FG001|Overall Study|Lost to Follow-up|7|||
161349248|NCT05341115|582663685|FG000|Overall Study|Adverse Event|1|||
161349249|NCT05341115|582663685|FG000|Overall Study|Lost to Follow-up|1|||
161349250|NCT06038123|582663691|FG000|Overall Study|Withdrawal by Subject|1|||
161349251|NCT06038123|582663691|FG000|Overall Study|not return due to femur fracture|1|||
161349252|NCT05630001|582663692|FG000|Overall Study|Adverse Event|1|||
161349253|NCT05218499|582663693|FG000|Overall Study|Not treated|1|||
161349254|NCT05218499|582663694|FG001|Overall Study|Not treated|1|||
161349255|NCT05218499|582663695|FG002|Overall Study|Not treated|8|||
161349256|NCT05218499|582663693|FG000|Overall Study|Death|2|||
161349257|NCT05218499|582663694|FG001|Overall Study|Death|0|||
161349258|NCT05218499|582663695|FG002|Overall Study|Death|0|||
161349259|NCT05218499|582663693|FG000|Overall Study|Other than listed|3|||
161189692|NCT00305773|582071046|FG000|Overall Study|Disease Progression|1|||
161189693|NCT00305773|582071047|FG001|Overall Study|Disease Progression|3|||
161189694|NCT00305773|582071046|FG000|Overall Study|All other reasons|3|||
161189695|NCT00305773|582071047|FG001|Overall Study|All other reasons|2|||
161189696|NCT02679222|582071048|FG000|Overall Study|No time for project|1|||
161189697|NCT00303719|582071049|FG000|Overall Study|Not evaluable, prior therapies|0|||
161189698|NCT00303719|582071050|FG001|Overall Study|Not evaluable, prior therapies|30|||
161189699|NCT00303719|582071049|FG000|Overall Study|Lost to Follow-up|0|||
161189700|NCT00303719|582071050|FG001|Overall Study|Lost to Follow-up|7|||
161189701|NCT01641952|582071051|FG000|Overall Study|Lost to Follow-up|28|||
161189702|NCT01641952|582071051|FG000|Overall Study|Adverse Event|6|||
161189703|NCT02500901|582071054|FG000|Overall Study|Disease ProgressionDD|2|||
161189704|NCT01191190|582071055|FG000|Overall Study|Withdrawal by Subject|1|||
161189705|NCT00348686|582071058|FG000|Overall Study|Withdrawal by Subject|45|||
161189706|NCT00348686|582071058|FG000|Overall Study|Adverse Event|5|||
161189707|NCT00348686|582071058|FG000|Overall Study|Protocol Violation|6|||
161189708|NCT00348686|582071058|FG000|Overall Study|Lost to Follow-up|2|||
161189709|NCT00348686|582071058|FG000|Overall Study|Multiple Reasons|8|||
161189710|NCT01258738|582071061|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
161189711|NCT01258738|582071062|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
161189712|NCT01258738|582071061|FG000|Double-blind Period|Withdrawal by Subject|2|||
161189713|NCT01258738|582071062|FG001|Double-blind Period|Withdrawal by Subject|2|||
161189714|NCT01258738|582071061|FG000|Double-blind Period|Protocol Violation|1|||
161189715|NCT01258738|582071062|FG001|Double-blind Period|Protocol Violation|1|||
161189716|NCT01258738|582071061|FG000|Double-blind Period|Adverse Event|3|||
161189717|NCT01258738|582071062|FG001|Double-blind Period|Adverse Event|1|||
161349260|NCT05218499|582663694|FG001|Overall Study|Other than listed|7|||
161349261|NCT05218499|582663695|FG002|Overall Study|Other than listed|10|||
161189718|NCT01258738|582071061|FG000|Open-label Period|Did not meet inclusion criteria|0|||
161349262|NCT05218499|582663693|FG000|Overall Study|Protocol deviation|5|||
161349263|NCT05218499|582663694|FG001|Overall Study|Protocol deviation|6|||
161349264|NCT05218499|582663695|FG002|Overall Study|Protocol deviation|4|||
161189719|NCT01258738|582071062|FG001|Open-label Period|Did not meet inclusion criteria|1|||
161306057|NCT00537316|582500741|FG001|Part 2|Withdrawal by Subject|1|||
161306058|NCT00537316|582500742|FG002|Part 2|Withdrawal by Subject|4|||
161306059|NCT00537316|582500743|FG003|Part 2|Withdrawal by Subject|0|||
161306060|NCT00537316|582500744|FG004|Part 2|Withdrawal by Subject|0|||
161306061|NCT00537316|582500745|FG005|Part 2|Withdrawal by Subject|0|||
161306062|NCT00537316|582500746|FG006|Part 2|Withdrawal by Subject|0|||
161306063|NCT00537316|582500740|FG000|Part 2|Administrative|16|||
161306064|NCT00537316|582500741|FG001|Part 2|Administrative|8|||
161306065|NCT00537316|582500742|FG002|Part 2|Administrative|24|||
161306066|NCT00537316|582500743|FG003|Part 2|Administrative|3|||
161306067|NCT00537316|582500744|FG004|Part 2|Administrative|1|||
161306068|NCT00537316|582500745|FG005|Part 2|Administrative|4|||
161306069|NCT00537316|582500746|FG006|Part 2|Administrative|1|||
161306070|NCT04533412|582500748|FG000|Overall Study|Withdrawal by Subject|1|||
161306071|NCT04533412|582500749|FG001|Overall Study|Withdrawal by Subject|1|||
161306072|NCT04533412|582500748|FG000|Overall Study|Lost to Follow-up|1|||
161306073|NCT04533412|582500749|FG001|Overall Study|Lost to Follow-up|4|||
161306074|NCT03261674|582500750|FG000|Overall Study|Lost to Follow-up|6|||
161306075|NCT03261674|582500751|FG001|Overall Study|Lost to Follow-up|7|||
161306076|NCT03261674|582500750|FG000|Overall Study|Protocol Violation|1|||
161306077|NCT03261674|582500751|FG001|Overall Study|Protocol Violation|4|||
161306078|NCT03261674|582500750|FG000|Overall Study|Withdrawal by Subject|1|||
161306079|NCT03261674|582500751|FG001|Overall Study|Withdrawal by Subject|4|||
161306080|NCT03261674|582500750|FG000|Overall Study|Physician Decision|1|||
161306081|NCT03261674|582500751|FG001|Overall Study|Physician Decision|0|||
161306082|NCT00782184|582500752|FG000|Overall Study|Adverse Event|1|||
161306083|NCT00782184|582500753|FG001|Overall Study|Adverse Event|2|||
161306084|NCT00782184|582500752|FG000|Overall Study|Protocol Violation|0|||
161306085|NCT00782184|582500753|FG001|Overall Study|Protocol Violation|1|||
161306086|NCT00782184|582500752|FG000|Overall Study|Withdrawal by Subject|3|||
161306087|NCT00782184|582500753|FG001|Overall Study|Withdrawal by Subject|2|||
161306088|NCT01438294|582500754|FG000|Overall Study|Lost to Follow-up|3|||
161306089|NCT01438294|582500755|FG001|Overall Study|Lost to Follow-up|7|||
161306090|NCT01730534|582500760|FG000|Overall Study|Withdrawal by Subject|97|||
161306091|NCT01730534|582500761|FG001|Overall Study|Withdrawal by Subject|127|||
161306092|NCT01730534|582500760|FG000|Overall Study|Lost to Follow-up|12|||
161306093|NCT01730534|582500761|FG001|Overall Study|Lost to Follow-up|18|||
161306094|NCT01676896|582500762|FG000|Overall Study|Withdrawal by Subject|12|||
161306095|NCT01676896|582500763|FG001|Overall Study|Withdrawal by Subject|7|||
161306096|NCT01676896|582500764|FG002|Overall Study|Withdrawal by Subject|19|||
161306097|NCT03614078|582500765|FG000|Overall Study|Withdrawal by Subject|2|||
161306098|NCT03614078|582500766|FG001|Overall Study|Withdrawal by Subject|2|||
161306099|NCT03614078|582500767|FG002|Overall Study|Withdrawal by Subject|3|||
161306100|NCT03614078|582500765|FG000|Overall Study|Participant Did Not Return for Visit|0|||
161306101|NCT03614078|582500766|FG001|Overall Study|Participant Did Not Return for Visit|1|||
161306102|NCT03614078|582500767|FG002|Overall Study|Participant Did Not Return for Visit|0|||
161306103|NCT03614078|582500765|FG000|Overall Study|High Neutrophils|0|||
161306104|NCT03614078|582500766|FG001|Overall Study|High Neutrophils|0|||
161306105|NCT03614078|582500767|FG002|Overall Study|High Neutrophils|2|||
161306106|NCT03614078|582500765|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
161306107|NCT03614078|582500766|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
161306108|NCT03614078|582500767|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
161306109|NCT03614078|582500765|FG000|Overall Study|Exacerbation of Psoriasis|0|||
161306110|NCT03614078|582500766|FG001|Overall Study|Exacerbation of Psoriasis|1|||
161306111|NCT03614078|582500767|FG002|Overall Study|Exacerbation of Psoriasis|0|||
161306112|NCT03614078|582500765|FG000|Overall Study|Adverse Event|0|||
161306113|NCT03614078|582500766|FG001|Overall Study|Adverse Event|2|||
161306114|NCT03614078|582500767|FG002|Overall Study|Adverse Event|0|||
161306115|NCT03614078|582500765|FG000|Overall Study|Dizziness and Rash|0|||
161306116|NCT03614078|582500766|FG001|Overall Study|Dizziness and Rash|1|||
161306117|NCT03614078|582500767|FG002|Overall Study|Dizziness and Rash|0|||
161306118|NCT02833844|582500768|FG000|Double-Blind Period|Withdrawal by Subject|2|||
161306119|NCT02833844|582500769|FG001|Double-Blind Period|Withdrawal by Subject|3|||
161306120|NCT02833844|582500768|FG000|Double-Blind Period|Protocol Violation|0|||
161306121|NCT02833844|582500769|FG001|Double-Blind Period|Protocol Violation|4|||
161306122|NCT02833844|582500768|FG000|Open-Label Period|Death|0|||
161306123|NCT02833844|582500769|FG001|Open-Label Period|Death|2|||
161306124|NCT02833844|582500768|FG000|Open-Label Period|Lost to Follow-up|1|||
161306125|NCT02833844|582500769|FG001|Open-Label Period|Lost to Follow-up|0|||
161306126|NCT02833844|582500768|FG000|Open-Label Period|Withdrawal by Subject|1|||
161306127|NCT02833844|582500769|FG001|Open-Label Period|Withdrawal by Subject|0|||
161306128|NCT04323306|582500770|FG000|Overall Study|Physician Decision|1|||
161306129|NCT04323306|582500771|FG001|Overall Study|Physician Decision|0|||
161306130|NCT04323306|582500772|FG002|Overall Study|Physician Decision|0|||
161306131|NCT04323306|582500773|FG003|Overall Study|Physician Decision|0|||
161306132|NCT04323306|582500774|FG004|Overall Study|Physician Decision|0|||
161306133|NCT04323306|582500775|FG005|Overall Study|Physician Decision|0|||
161306134|NCT04323306|582500776|FG006|Overall Study|Physician Decision|0|||
161306135|NCT04323306|582500777|FG007|Overall Study|Physician Decision|0|||
161189720|NCT01258738|582071061|FG000|Open-label Period|Insufficient clinical response|5|||
161189721|NCT01258738|582071062|FG001|Open-label Period|Insufficient clinical response|3|||
161189722|NCT01258738|582071061|FG000|Open-label Period|Lost to Follow-up|0|||
161189723|NCT01258738|582071062|FG001|Open-label Period|Lost to Follow-up|2|||
161189724|NCT01258738|582071061|FG000|Open-label Period|Withdrawal by Subject|5|||
161189725|NCT01258738|582071062|FG001|Open-label Period|Withdrawal by Subject|6|||
161189726|NCT01258738|582071061|FG000|Open-label Period|Protocol Violation|2|||
161189727|NCT01258738|582071062|FG001|Open-label Period|Protocol Violation|2|||
161189728|NCT01258738|582071061|FG000|Open-label Period|Adverse Event|4|||
161189729|NCT01258738|582071062|FG001|Open-label Period|Adverse Event|5|||
161189730|NCT01258738|582071061|FG000|Open-label Period|Other Reasons|0|||
161189731|NCT01258738|582071062|FG001|Open-label Period|Other Reasons|1|||
161189732|NCT01258738|582071061|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
161189733|NCT01258738|582071062|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
161189734|NCT00689611|582071063|FG000|Overall Study|Death|6|||
161189735|NCT00689611|582071064|FG001|Overall Study|Death|9|||
161189736|NCT00689611|582071063|FG000|Overall Study|Withdrawal by Subject|8|||
161189737|NCT00689611|582071064|FG001|Overall Study|Withdrawal by Subject|9|||
161189738|NCT00689611|582071063|FG000|Overall Study|Lost to Follow-up|27|||
161189739|NCT00689611|582071064|FG001|Overall Study|Lost to Follow-up|28|||
161189740|NCT00568399|582071066|FG000|Overall Study|Death|2|||
161189741|NCT00568399|582071066|FG000|Overall Study|Adverse Event|5|||
161189742|NCT00568399|582071066|FG000|Overall Study|Withdrawal by Subject|8|||
161189743|NCT01038635|582071083|FG000|Overall Study|Disease Progression|2|||
161189744|NCT01038635|582071084|FG001|Overall Study|Disease Progression|0|||
161189745|NCT01038635|582071085|FG002|Overall Study|Disease Progression|0|||
161189746|NCT01038635|582071086|FG003|Overall Study|Disease Progression|0|||
161189747|NCT01038635|582071087|FG004|Overall Study|Disease Progression|0|||
161189748|NCT01038635|582071088|FG005|Overall Study|Disease Progression|0|||
161189749|NCT01038635|582071089|FG006|Overall Study|Disease Progression|1|||
161189750|NCT01038635|582071090|FG007|Overall Study|Disease Progression|4|||
161189751|NCT01038635|582071091|FG008|Overall Study|Disease Progression|0|||
161189752|NCT01038635|582071083|FG000|Overall Study|Death|0|||
161189753|NCT01038635|582071084|FG001|Overall Study|Death|0|||
161189754|NCT01038635|582071085|FG002|Overall Study|Death|0|||
161189755|NCT01038635|582071086|FG003|Overall Study|Death|0|||
161189756|NCT01038635|582071087|FG004|Overall Study|Death|1|||
161189757|NCT01038635|582071088|FG005|Overall Study|Death|0|||
161189758|NCT01038635|582071089|FG006|Overall Study|Death|1|||
161189759|NCT01038635|582071090|FG007|Overall Study|Death|1|||
161189760|NCT01038635|582071091|FG008|Overall Study|Death|2|||
161189761|NCT01227252|582071092|FG000|Overall Study|Sponsor Decision|0|||
161189762|NCT01227252|582071093|FG001|Overall Study|Sponsor Decision|1|||
161189763|NCT01227252|582071094|FG002|Overall Study|Sponsor Decision|0|||
161189764|NCT01227252|582071095|FG003|Overall Study|Sponsor Decision|0|||
161189765|NCT01227252|582071092|FG000|Overall Study|Lost to Follow-up|0|||
161189766|NCT01227252|582071093|FG001|Overall Study|Lost to Follow-up|1|||
161189767|NCT01227252|582071094|FG002|Overall Study|Lost to Follow-up|0|||
161189768|NCT01227252|582071095|FG003|Overall Study|Lost to Follow-up|0|||
161189769|NCT01227252|582071092|FG000|Overall Study|Withdrawal by Subject|0|||
161189770|NCT01227252|582071093|FG001|Overall Study|Withdrawal by Subject|1|||
161189771|NCT01227252|582071094|FG002|Overall Study|Withdrawal by Subject|0|||
161189772|NCT01227252|582071095|FG003|Overall Study|Withdrawal by Subject|0|||
161189773|NCT02516306|582071098|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
161189774|NCT02516306|582071099|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
161189775|NCT02607865|582071102|FG000|Overall Study|Lost to Follow-up|9|||
161189776|NCT02607865|582071103|FG001|Overall Study|Lost to Follow-up|7|||
161189777|NCT02607865|582071104|FG002|Overall Study|Lost to Follow-up|7|||
161189778|NCT02607865|582071105|FG003|Overall Study|Lost to Follow-up|5|||
161189779|NCT02607865|582071102|FG000|Overall Study|Withdrawal by Subject|18|||
161189780|NCT02607865|582071103|FG001|Overall Study|Withdrawal by Subject|18|||
161306136|NCT04323306|582500778|FG008|Overall Study|Physician Decision|0|||
161306137|NCT04323306|582500770|FG000|Overall Study|Withdrawal by Subject|0|||
161306138|NCT04323306|582500771|FG001|Overall Study|Withdrawal by Subject|0|||
161189781|NCT02607865|582071104|FG002|Overall Study|Withdrawal by Subject|17|||
161189782|NCT02607865|582071105|FG003|Overall Study|Withdrawal by Subject|8|||
161189783|NCT02607865|582071102|FG000|Overall Study|Death|5|||
161189784|NCT02607865|582071103|FG001|Overall Study|Death|4|||
161189785|NCT02607865|582071104|FG002|Overall Study|Death|1|||
161189786|NCT02607865|582071105|FG003|Overall Study|Death|3|||
161189787|NCT02607865|582071102|FG000|Overall Study|Unclassified|1|||
161189788|NCT02607865|582071103|FG001|Overall Study|Unclassified|1|||
161189789|NCT02607865|582071104|FG002|Overall Study|Unclassified|2|||
161189790|NCT02607865|582071105|FG003|Overall Study|Unclassified|0|||
161189791|NCT03227692|582071106|FG000|Overall Study|Protocol Violation|1|||
161189792|NCT03227692|582071107|FG001|Overall Study|Protocol Violation|1|||
161189793|NCT03227692|582071106|FG000|Overall Study|Lost to Follow-up|4|||
161306139|NCT04323306|582500772|FG002|Overall Study|Withdrawal by Subject|0|||
161189794|NCT03227692|582071107|FG001|Overall Study|Lost to Follow-up|2|||
161189795|NCT03227692|582071106|FG000|Overall Study|Adverse Event|0|||
161189796|NCT03227692|582071107|FG001|Overall Study|Adverse Event|2|||
161189797|NCT02447952|582071108|FG000|Overall Study|Adverse Event|2|||
161189798|NCT02447952|582071108|FG000|Overall Study|Physician Decision|1|||
161189799|NCT02447952|582071108|FG000|Overall Study|Withdrawal by Subject|4|||
161189800|NCT01683058|582071109|FG000|Overall Study|Lost to Follow-up|9|||
161189801|NCT01683058|582071109|FG000|Overall Study|Adverse Event|6|||
161189802|NCT01683058|582071109|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
161189803|NCT01683058|582071109|FG000|Overall Study|Withdrawal by Subject|7|||
161189804|NCT01683058|582071109|FG000|Overall Study|Lack of Efficacy|2|||
161189805|NCT03525613|582071114|FG000|Overall Study|Adverse Event|11|||
161189806|NCT03525613|582071115|FG001|Overall Study|Adverse Event|8|||
161189807|NCT03525613|582071116|FG002|Overall Study|Adverse Event|3|||
161189808|NCT03525613|582071117|FG003|Overall Study|Adverse Event|3|||
161189809|NCT03525613|582071114|FG000|Overall Study|Lost to Follow-up|4|||
161189810|NCT03525613|582071115|FG001|Overall Study|Lost to Follow-up|5|||
161189811|NCT03525613|582071116|FG002|Overall Study|Lost to Follow-up|3|||
161189812|NCT03525613|582071117|FG003|Overall Study|Lost to Follow-up|2|||
161189813|NCT03525613|582071114|FG000|Overall Study|Physician Decision|0|||
161189814|NCT03525613|582071115|FG001|Overall Study|Physician Decision|1|||
161189815|NCT03525613|582071116|FG002|Overall Study|Physician Decision|0|||
161189816|NCT03525613|582071117|FG003|Overall Study|Physician Decision|1|||
161189817|NCT03525613|582071114|FG000|Overall Study|Consent Withdrawal|25|||
161189818|NCT03525613|582071115|FG001|Overall Study|Consent Withdrawal|16|||
161189819|NCT03525613|582071116|FG002|Overall Study|Consent Withdrawal|12|||
161189820|NCT03525613|582071117|FG003|Overall Study|Consent Withdrawal|9|||
161189821|NCT03525613|582071114|FG000|Overall Study|Death|20|||
161189822|NCT03525613|582071115|FG001|Overall Study|Death|9|||
161189823|NCT03525613|582071116|FG002|Overall Study|Death|7|||
161189824|NCT03525613|582071117|FG003|Overall Study|Death|1|||
161189825|NCT03525613|582071114|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
161189826|NCT03525613|582071115|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
161189827|NCT03525613|582071116|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
161189828|NCT03525613|582071117|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
161189829|NCT03480360|582071118|FG000|Overall Study|Death|2|||
161189830|NCT02120469|582071125|FG000|Overall Study|HER-2/neu-amplified|1|||
161189831|NCT02120469|582071126|FG001|Overall Study|HER-2/neu-amplified|0|||
161189832|NCT02120469|582071127|FG002|Overall Study|HER-2/neu-amplified|1|||
161189833|NCT00590031|582071131|FG000|Overall Study|Adverse Event|3|||
161189834|NCT00590031|582071131|FG000|Overall Study|Withdrawal by Subject|1|||
161189835|NCT00590031|582071131|FG000|Overall Study|Metastatic Disease|1|||
161189836|NCT00590031|582071131|FG000|Overall Study|Admin Hold|1|||
161189837|NCT02802735|582071133|FG000|Overall Study|Withdrawal by Subject|0|||
161189838|NCT02802735|582071134|FG001|Overall Study|Withdrawal by Subject|1|||
161189839|NCT02802735|582071135|FG002|Overall Study|Withdrawal by Subject|0|||
161189840|NCT02802735|582071136|FG003|Overall Study|Withdrawal by Subject|0|||
161189841|NCT02802735|582071137|FG004|Overall Study|Withdrawal by Subject|0|||
161189842|NCT01166386|582071138|FG000|Overall Study|Withdrawal by Subject|3|||
161189843|NCT01166386|582071139|FG001|Overall Study|Withdrawal by Subject|5|||
161189844|NCT03922711|582071142|FG000|Overall Study|Adverse Event|3|||
161189845|NCT03922711|582071143|FG001|Overall Study|Adverse Event|2|||
161189846|NCT03922711|582071144|FG002|Overall Study|Adverse Event|2|||
161189847|NCT03922711|582071142|FG000|Overall Study|Protocol Violation|1|||
161189848|NCT03922711|582071143|FG001|Overall Study|Protocol Violation|0|||
161189849|NCT03922711|582071144|FG002|Overall Study|Protocol Violation|0|||
161189850|NCT03922711|582071142|FG000|Overall Study|Withdrawal by Subject|0|||
161189851|NCT03922711|582071143|FG001|Overall Study|Withdrawal by Subject|3|||
161189852|NCT03922711|582071144|FG002|Overall Study|Withdrawal by Subject|1|||
161189853|NCT03922711|582071142|FG000|Overall Study|Not further specified|0|||
161189854|NCT03922711|582071143|FG001|Overall Study|Not further specified|0|||
161189855|NCT03922711|582071144|FG002|Overall Study|Not further specified|1|||
161189856|NCT00420212|582071147|FG000|Overall Study|Adverse Event|22|||
161189857|NCT00420212|582071148|FG001|Overall Study|Adverse Event|40|||
161189858|NCT00420212|582071149|FG002|Overall Study|Adverse Event|36|||
161189859|NCT00420212|582071147|FG000|Overall Study|Lost to Follow-up|9|||
161189860|NCT00420212|582071148|FG001|Overall Study|Lost to Follow-up|11|||
161189861|NCT00420212|582071149|FG002|Overall Study|Lost to Follow-up|11|||
161189862|NCT00420212|582071147|FG000|Overall Study|Withdrawal by Subject|31|||
161189863|NCT00420212|582071148|FG001|Overall Study|Withdrawal by Subject|22|||
161189864|NCT00420212|582071149|FG002|Overall Study|Withdrawal by Subject|19|||
161189865|NCT00420212|582071147|FG000|Overall Study|Physician Decision|4|||
161189866|NCT00420212|582071148|FG001|Overall Study|Physician Decision|4|||
161189867|NCT00420212|582071149|FG002|Overall Study|Physician Decision|3|||
161189868|NCT00420212|582071147|FG000|Overall Study|Protocol Violation|4|||
161189869|NCT00420212|582071148|FG001|Overall Study|Protocol Violation|4|||
161189870|NCT00420212|582071149|FG002|Overall Study|Protocol Violation|8|||
161189871|NCT00420212|582071147|FG000|Overall Study|Death|0|||
161189872|NCT00420212|582071148|FG001|Overall Study|Death|0|||
161189873|NCT00420212|582071149|FG002|Overall Study|Death|1|||
161189874|NCT00420212|582071147|FG000|Overall Study|Other-Unspecified|21|||
161189875|NCT00420212|582071148|FG001|Overall Study|Other-Unspecified|14|||
161189876|NCT00420212|582071149|FG002|Overall Study|Other-Unspecified|18|||
161189877|NCT02390362|582071150|FG000|Overall Study|Withdrawal by Subject|0|||
161189878|NCT02390362|582071151|FG001|Overall Study|Withdrawal by Subject|1|||
161189879|NCT02067104|582071156|FG000|Overall Study|Study termination due to low accrual|4|||
161189880|NCT02067104|582071157|FG001|Overall Study|Study termination due to low accrual|5|||
161189881|NCT02610231|582071158|FG000|Overall Study|Withdrawal by Subject|27|||
161189882|NCT02610231|582071158|FG000|Overall Study|Adverse Event|20|||
161189883|NCT02610231|582071158|FG000|Overall Study|Death|5|||
161189884|NCT02610231|582071158|FG000|Overall Study|Surgery|2|||
161189885|NCT02610231|582071158|FG000|Overall Study|Physician Decision|1|||
161189886|NCT02610231|582071158|FG000|Overall Study|Non Compliance|2|||
161189887|NCT02610231|582071158|FG000|Overall Study|Other|3|||
161189888|NCT01279954|582071159|FG000|Overall Study|Lack of Efficacy|3|||
161189889|NCT01279954|582071160|FG001|Overall Study|Lack of Efficacy|4|||
161189890|NCT02140762|582071161|FG000|Overall Study|Adverse Event|1|||
161189891|NCT02140762|582071162|FG001|Overall Study|Adverse Event|1|||
161189892|NCT02140762|582071161|FG000|Overall Study|Lost to Follow-up|9|||
161189893|NCT02140762|582071162|FG001|Overall Study|Lost to Follow-up|5|||
161189894|NCT02140762|582071161|FG000|Overall Study|Protocol Violation|1|||
161189895|NCT02140762|582071162|FG001|Overall Study|Protocol Violation|1|||
161189896|NCT02140762|582071161|FG000|Overall Study|Withdrawal by Subject|6|||
161189897|NCT02140762|582071162|FG001|Overall Study|Withdrawal by Subject|4|||
161189898|NCT02140762|582071161|FG000|Overall Study|Other|0|||
161189899|NCT02140762|582071162|FG001|Overall Study|Other|1|||
161189900|NCT01711359|582071164|FG000|Treatment Period|Withdrawal by Subject|18|||
161189901|NCT01711359|582071165|FG001|Treatment Period|Withdrawal by Subject|7|||
161189902|NCT01711359|582071166|FG002|Treatment Period|Withdrawal by Subject|13|||
161189903|NCT01711359|582071164|FG000|Treatment Period|Lack of Efficacy|13|||
161189904|NCT01711359|582071165|FG001|Treatment Period|Lack of Efficacy|2|||
161189905|NCT01711359|582071166|FG002|Treatment Period|Lack of Efficacy|2|||
161189906|NCT01711359|582071164|FG000|Treatment Period|Adverse Event|8|||
161189907|NCT01711359|582071165|FG001|Treatment Period|Adverse Event|10|||
161189908|NCT01711359|582071166|FG002|Treatment Period|Adverse Event|24|||
161189909|NCT01711359|582071164|FG000|Treatment Period|Physician Decision|4|||
161189910|NCT01711359|582071165|FG001|Treatment Period|Physician Decision|3|||
161189911|NCT01711359|582071166|FG002|Treatment Period|Physician Decision|2|||
161189912|NCT01711359|582071164|FG000|Treatment Period|Death|3|||
161189913|NCT01711359|582071165|FG001|Treatment Period|Death|0|||
161189914|NCT01711359|582071166|FG002|Treatment Period|Death|0|||
161189915|NCT01711359|582071164|FG000|Treatment Period|Entry Criteria Not Met|1|||
161189916|NCT01711359|582071165|FG001|Treatment Period|Entry Criteria Not Met|0|||
161189917|NCT01711359|582071166|FG002|Treatment Period|Entry Criteria Not Met|0|||
161189918|NCT01711359|582071164|FG000|Treatment Period|Sponsor Decision|1|||
161189919|NCT01711359|582071165|FG001|Treatment Period|Sponsor Decision|0|||
161189920|NCT01711359|582071166|FG002|Treatment Period|Sponsor Decision|0|||
161189921|NCT01711359|582071164|FG000|Treatment Period|Lost to Follow-up|1|||
161189922|NCT01711359|582071165|FG001|Treatment Period|Lost to Follow-up|1|||
161189923|NCT01711359|582071166|FG002|Treatment Period|Lost to Follow-up|1|||
161189924|NCT01711359|582071164|FG000|Treatment Period|Randomized, Not Treated|3|||
161189925|NCT01711359|582071165|FG001|Treatment Period|Randomized, Not Treated|1|||
161189926|NCT01711359|582071166|FG002|Treatment Period|Randomized, Not Treated|0|||
161189927|NCT01385098|582071167|FG000|Overall Study|Adverse Event|10|||
161189928|NCT01385098|582071167|FG000|Overall Study|Lost to Follow-up|4|||
161189929|NCT00795717|582071168|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
161189930|NCT00795717|582071169|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
161189931|NCT00795717|582071168|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
161189932|NCT00795717|582071169|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
161189933|NCT00795717|582071168|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
161189934|NCT00795717|582071169|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
161189935|NCT00795717|582071168|FG000|Phase II|too busy|0|||
161189936|NCT00795717|582071169|FG001|Phase II|too busy|1|||
161189937|NCT04728815|582071172|FG000|Overall Study|Lost to Follow-up|3|||
161189938|NCT04728815|582071173|FG001|Overall Study|Lost to Follow-up|0|||
161189939|NCT04728815|582071174|FG002|Overall Study|Lost to Follow-up|0|||
161189940|NCT04728815|582071175|FG003|Overall Study|Lost to Follow-up|1|||
161189941|NCT04728815|582071176|FG004|Overall Study|Lost to Follow-up|1|||
161189942|NCT04728815|582071177|FG005|Overall Study|Lost to Follow-up|0|||
161189943|NCT04728815|582071178|FG006|Overall Study|Lost to Follow-up|2|||
161189944|NCT04728815|582071179|FG007|Overall Study|Lost to Follow-up|0|||
161189945|NCT04728815|582071172|FG000|Overall Study|Physician Decision|0|||
161189946|NCT04728815|582071173|FG001|Overall Study|Physician Decision|0|||
161189947|NCT04728815|582071174|FG002|Overall Study|Physician Decision|1|||
161189948|NCT04728815|582071175|FG003|Overall Study|Physician Decision|0|||
161189949|NCT04728815|582071176|FG004|Overall Study|Physician Decision|0|||
161189950|NCT04728815|582071177|FG005|Overall Study|Physician Decision|0|||
161189951|NCT04728815|582071178|FG006|Overall Study|Physician Decision|0|||
161189952|NCT04728815|582071179|FG007|Overall Study|Physician Decision|0|||
161189953|NCT04728815|582071172|FG000|Overall Study|Treatment drop|0|||
161189954|NCT04728815|582071173|FG001|Overall Study|Treatment drop|2|||
161189955|NCT04728815|582071174|FG002|Overall Study|Treatment drop|1|||
161189956|NCT04728815|582071175|FG003|Overall Study|Treatment drop|0|||
161189957|NCT04728815|582071176|FG004|Overall Study|Treatment drop|3|||
161189958|NCT04728815|582071177|FG005|Overall Study|Treatment drop|1|||
161189959|NCT04728815|582071178|FG006|Overall Study|Treatment drop|3|||
161189960|NCT04728815|582071179|FG007|Overall Study|Treatment drop|0|||
161189961|NCT04728815|582071172|FG000|Overall Study|Study drop|0|||
161189962|NCT04728815|582071173|FG001|Overall Study|Study drop|3|||
161189963|NCT04728815|582071174|FG002|Overall Study|Study drop|3|||
161189964|NCT04728815|582071175|FG003|Overall Study|Study drop|0|||
161189965|NCT04728815|582071176|FG004|Overall Study|Study drop|0|||
161189966|NCT04728815|582071177|FG005|Overall Study|Study drop|0|||
161189967|NCT04728815|582071178|FG006|Overall Study|Study drop|7|||
161189968|NCT04728815|582071179|FG007|Overall Study|Study drop|0|||
161189969|NCT05315297|582071180|FG000|Overall Study|Lost to Follow-up|6|||
161189970|NCT05315297|582071181|FG001|Overall Study|Lost to Follow-up|4|||
161189971|NCT05315297|582071180|FG000|Overall Study|Withdrawal by Subject|0|||
161189972|NCT05315297|582071181|FG001|Overall Study|Withdrawal by Subject|1|||
161189973|NCT05604781|582073145|FG000|Overall Study|Lost to Follow-up|3|||
161189974|NCT05604781|582073145|FG000|Overall Study|Adverse Event|1|||
161189975|NCT02493712|582073146|FG000|Overall Study|Withdrawal by Subject|1|||
161189976|NCT02493712|582073147|FG001|Overall Study|Withdrawal by Subject|0|||
161189977|NCT02493712|582073148|FG002|Overall Study|Withdrawal by Subject|2|||
161189978|NCT02493712|582073146|FG000|Overall Study|Protocol Violation|0|||
161189979|NCT02493712|582073147|FG001|Overall Study|Protocol Violation|0|||
161189980|NCT02493712|582073148|FG002|Overall Study|Protocol Violation|1|||
161189981|NCT02493712|582073146|FG000|Overall Study|Lost to Follow-up|1|||
161189982|NCT02493712|582073147|FG001|Overall Study|Lost to Follow-up|0|||
161189983|NCT02493712|582073148|FG002|Overall Study|Lost to Follow-up|0|||
161189984|NCT02493712|582073146|FG000|Overall Study|Physician Decision|0|||
161189985|NCT02493712|582073147|FG001|Overall Study|Physician Decision|1|||
161189986|NCT02493712|582073148|FG002|Overall Study|Physician Decision|0|||
161189987|NCT02493712|582073146|FG000|Overall Study|Lack of Efficacy|0|||
161189988|NCT02493712|582073147|FG001|Overall Study|Lack of Efficacy|5|||
161189989|NCT02493712|582073148|FG002|Overall Study|Lack of Efficacy|3|||
161189990|NCT02146274|582073149|FG000|Overall Study|Protocol Violation|73|||
161189991|NCT01640353|582073160|FG000|Overall Study|Withdrew prior to treatment|10|||
161189992|NCT01640353|582073160|FG000|Overall Study|Withdrawn from analysis at term site|12|||
161189993|NCT01640353|582073160|FG000|Overall Study|Withdrawal by Subject|5|||
161189994|NCT01640353|582073160|FG000|Overall Study|Death|2|||
161189995|NCT01640353|582073160|FG000|Overall Study|Early site termination|3|||
161189996|NCT01640353|582073160|FG000|Overall Study|Lost to Follow-up|12|||
161189997|NCT01640353|582073160|FG000|Overall Study|Physician Decision|1|||
161189998|NCT01967134|582073161|FG000|Overall Study|Lost to Follow-up|0|||
161189999|NCT01967134|582073162|FG001|Overall Study|Lost to Follow-up|1|||
161190000|NCT01967134|582073163|FG002|Overall Study|Lost to Follow-up|0|||
161190001|NCT03419741|582073164|FG000|Overall Study|Adverse Event|1|||
161190002|NCT03419741|582073165|FG001|Overall Study|Adverse Event|0|||
161190003|NCT03419741|582073164|FG000|Overall Study|Withdrawal by Subject|1|||
161190004|NCT03419741|582073165|FG001|Overall Study|Withdrawal by Subject|2|||
161190005|NCT04354870|582073166|FG000|Overall Study|Lost to Follow-up|32|||
161190006|NCT04354870|582073167|FG001|Overall Study|Lost to Follow-up|12|||
161190007|NCT04354870|582073166|FG000|Overall Study|Withdrawal by Subject|10|||
161190008|NCT04354870|582073167|FG001|Overall Study|Withdrawal by Subject|16|||
161190009|NCT04354870|582073166|FG000|Overall Study|Did not complete all study visits|6|||
161190010|NCT04354870|582073167|FG001|Overall Study|Did not complete all study visits|5|||
161190011|NCT03384316|582073168|FG000|Overall Study|Screen failure|0|||
161190012|NCT03384316|582073169|FG001|Overall Study|Screen failure|1|||
161190013|NCT00413231|582073170|FG000|0 to 30-day Post Treatment|Death|5|||
161190014|NCT00413231|582073170|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
161190015|NCT00413231|582073170|FG000|30-day to 365-day Post Treatment|Death|13|||
161190016|NCT00413231|582073170|FG000|365-day to 60-month Post Treatment|Death|36|||
161190017|NCT00413231|582073170|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
161190018|NCT00413231|582073170|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
161190019|NCT00413231|582073170|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
161190020|NCT04450394|582073175|FG000|Overall Study|Adverse Event|2|||
161190021|NCT04450394|582073176|FG001|Overall Study|Adverse Event|0|||
161190022|NCT04450394|582073177|FG002|Overall Study|Adverse Event|0|||
161190023|NCT04450394|582073175|FG000|Overall Study|Death|0|||
161190024|NCT04450394|582073176|FG001|Overall Study|Death|1|||
161190025|NCT04450394|582073177|FG002|Overall Study|Death|0|||
161190026|NCT04450394|582073175|FG000|Overall Study|Lost to Follow-up|0|||
161190027|NCT04450394|582073176|FG001|Overall Study|Lost to Follow-up|3|||
161190028|NCT04450394|582073177|FG002|Overall Study|Lost to Follow-up|0|||
161190029|NCT04450394|582073175|FG000|Overall Study|Physician Decision|0|||
161190030|NCT04450394|582073176|FG001|Overall Study|Physician Decision|1|||
161190031|NCT04450394|582073177|FG002|Overall Study|Physician Decision|0|||
161190032|NCT04450394|582073175|FG000|Overall Study|Protocol Violation|2|||
161190033|NCT04450394|582073176|FG001|Overall Study|Protocol Violation|0|||
161190034|NCT04450394|582073177|FG002|Overall Study|Protocol Violation|0|||
161190035|NCT04450394|582073175|FG000|Overall Study|Withdrawal by Subject|6|||
161190036|NCT04450394|582073176|FG001|Overall Study|Withdrawal by Subject|9|||
161190037|NCT04450394|582073177|FG002|Overall Study|Withdrawal by Subject|0|||
161190038|NCT01066819|582073181|FG000|Overall Study|Adverse Event|18|||
161190039|NCT01066819|582073182|FG001|Overall Study|Adverse Event|1|||
161190040|NCT01066819|582073183|FG002|Overall Study|Adverse Event|6|||
161190041|NCT01066819|582073184|FG003|Overall Study|Adverse Event|0|||
161190042|NCT01066819|582073185|FG004|Overall Study|Adverse Event|0|||
161190043|NCT01066819|582073186|FG005|Overall Study|Adverse Event|0|||
161190044|NCT01066819|582073181|FG000|Overall Study|Death|5|||
161190045|NCT01066819|582073182|FG001|Overall Study|Death|0|||
161190046|NCT01066819|582073183|FG002|Overall Study|Death|1|||
161190047|NCT01066819|582073184|FG003|Overall Study|Death|0|||
161190048|NCT01066819|582073185|FG004|Overall Study|Death|0|||
161190049|NCT01066819|582073186|FG005|Overall Study|Death|0|||
161190050|NCT01066819|582073181|FG000|Overall Study|Lack of Efficacy|22|||
161190051|NCT01066819|582073182|FG001|Overall Study|Lack of Efficacy|1|||
161190052|NCT01066819|582073183|FG002|Overall Study|Lack of Efficacy|2|||
161190053|NCT01066819|582073184|FG003|Overall Study|Lack of Efficacy|1|||
161190054|NCT01066819|582073185|FG004|Overall Study|Lack of Efficacy|0|||
161190055|NCT01066819|582073186|FG005|Overall Study|Lack of Efficacy|0|||
161190056|NCT01066819|582073181|FG000|Overall Study|Physician Decision|6|||
161190057|NCT01066819|582073182|FG001|Overall Study|Physician Decision|2|||
161190058|NCT01066819|582073183|FG002|Overall Study|Physician Decision|3|||
161190059|NCT01066819|582073184|FG003|Overall Study|Physician Decision|0|||
161190060|NCT01066819|582073185|FG004|Overall Study|Physician Decision|0|||
161190061|NCT01066819|582073186|FG005|Overall Study|Physician Decision|0|||
161190062|NCT01066819|582073181|FG000|Overall Study|Protocol Violation|12|||
161190063|NCT01066819|582073182|FG001|Overall Study|Protocol Violation|6|||
161190064|NCT01066819|582073183|FG002|Overall Study|Protocol Violation|0|||
161190065|NCT01066819|582073184|FG003|Overall Study|Protocol Violation|0|||
161190066|NCT01066819|582073185|FG004|Overall Study|Protocol Violation|0|||
161190067|NCT01066819|582073186|FG005|Overall Study|Protocol Violation|0|||
161190068|NCT01066819|582073181|FG000|Overall Study|Withdrawal by Subject|29|||
161190069|NCT01066819|582073182|FG001|Overall Study|Withdrawal by Subject|11|||
161190070|NCT01066819|582073183|FG002|Overall Study|Withdrawal by Subject|6|||
161190071|NCT01066819|582073184|FG003|Overall Study|Withdrawal by Subject|0|||
161190072|NCT01066819|582073185|FG004|Overall Study|Withdrawal by Subject|0|||
161190073|NCT01066819|582073186|FG005|Overall Study|Withdrawal by Subject|0|||
161190074|NCT01066819|582073181|FG000|Overall Study|Administrative|6|||
161190075|NCT01066819|582073182|FG001|Overall Study|Administrative|4|||
161190076|NCT01066819|582073183|FG002|Overall Study|Administrative|2|||
161190077|NCT01066819|582073184|FG003|Overall Study|Administrative|0|||
161190078|NCT01066819|582073185|FG004|Overall Study|Administrative|0|||
161190079|NCT01066819|582073186|FG005|Overall Study|Administrative|0|||
161190080|NCT01066819|582073181|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
161190081|NCT01066819|582073182|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
161190082|NCT01066819|582073183|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
161190083|NCT01066819|582073184|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
161190084|NCT01066819|582073185|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
161190085|NCT01066819|582073186|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
161190086|NCT01066819|582073181|FG000|Overall Study|Early termination|2|||
161190087|NCT01066819|582073182|FG001|Overall Study|Early termination|0|||
161190088|NCT01066819|582073183|FG002|Overall Study|Early termination|0|||
161190089|NCT01066819|582073184|FG003|Overall Study|Early termination|0|||
161190090|NCT01066819|582073185|FG004|Overall Study|Early termination|0|||
161190091|NCT01066819|582073186|FG005|Overall Study|Early termination|0|||
161190092|NCT01066819|582073181|FG000|Overall Study|Failed to return|298|||
161190093|NCT01066819|582073182|FG001|Overall Study|Failed to return|107|||
161190094|NCT01066819|582073183|FG002|Overall Study|Failed to return|68|||
161190095|NCT01066819|582073184|FG003|Overall Study|Failed to return|7|||
161190096|NCT01066819|582073185|FG004|Overall Study|Failed to return|2|||
161190097|NCT01066819|582073186|FG005|Overall Study|Failed to return|3|||
161190098|NCT01066819|582073181|FG000|Overall Study|Lab test not done|9|||
161190099|NCT01066819|582073182|FG001|Overall Study|Lab test not done|0|||
161190100|NCT01066819|582073183|FG002|Overall Study|Lab test not done|2|||
161190101|NCT01066819|582073184|FG003|Overall Study|Lab test not done|1|||
161190102|NCT01066819|582073185|FG004|Overall Study|Lab test not done|0|||
161190103|NCT01066819|582073186|FG005|Overall Study|Lab test not done|0|||
161190104|NCT01066819|582073181|FG000|Overall Study|Miscellaneous|28|||
161190105|NCT01066819|582073182|FG001|Overall Study|Miscellaneous|10|||
161190106|NCT01066819|582073183|FG002|Overall Study|Miscellaneous|18|||
161190107|NCT01066819|582073184|FG003|Overall Study|Miscellaneous|1|||
161190108|NCT01066819|582073185|FG004|Overall Study|Miscellaneous|0|||
161190109|NCT01066819|582073186|FG005|Overall Study|Miscellaneous|0|||
161190110|NCT01066819|582073181|FG000|Overall Study|Non responders|123|||
161190111|NCT01066819|582073182|FG001|Overall Study|Non responders|2|||
161190112|NCT01066819|582073183|FG002|Overall Study|Non responders|7|||
161190113|NCT01066819|582073184|FG003|Overall Study|Non responders|2|||
161190114|NCT01066819|582073185|FG004|Overall Study|Non responders|0|||
161190115|NCT01066819|582073186|FG005|Overall Study|Non responders|1|||
161190116|NCT01066819|582073181|FG000|Overall Study|Not categorised|9|||
161190117|NCT01066819|582073182|FG001|Overall Study|Not categorised|2|||
161190118|NCT01066819|582073183|FG002|Overall Study|Not categorised|6|||
161190119|NCT01066819|582073184|FG003|Overall Study|Not categorised|1|||
161190120|NCT01066819|582073185|FG004|Overall Study|Not categorised|0|||
161190121|NCT01066819|582073186|FG005|Overall Study|Not categorised|0|||
161190122|NCT01066819|582073181|FG000|Overall Study|Relapse|16|||
161190123|NCT01066819|582073182|FG001|Overall Study|Relapse|4|||
161190124|NCT01066819|582073183|FG002|Overall Study|Relapse|3|||
161190125|NCT01066819|582073184|FG003|Overall Study|Relapse|0|||
161190126|NCT01066819|582073185|FG004|Overall Study|Relapse|0|||
161190127|NCT01066819|582073186|FG005|Overall Study|Relapse|0|||
161190128|NCT01066819|582073181|FG000|Overall Study|Results not available|1|||
161190129|NCT01066819|582073182|FG001|Overall Study|Results not available|0|||
161190130|NCT01066819|582073183|FG002|Overall Study|Results not available|0|||
161190131|NCT01066819|582073184|FG003|Overall Study|Results not available|0|||
161190132|NCT01066819|582073185|FG004|Overall Study|Results not available|0|||
161190133|NCT01066819|582073186|FG005|Overall Study|Results not available|0|||
161190134|NCT01066819|582073181|FG000|Overall Study|Screen failure|1|||
161190135|NCT01066819|582073182|FG001|Overall Study|Screen failure|0|||
161190136|NCT01066819|582073183|FG002|Overall Study|Screen failure|0|||
161190137|NCT01066819|582073184|FG003|Overall Study|Screen failure|0|||
161190138|NCT01066819|582073185|FG004|Overall Study|Screen failure|0|||
161190139|NCT01066819|582073186|FG005|Overall Study|Screen failure|0|||
161190140|NCT01066819|582073181|FG000|Overall Study|Spontaneous cure|1|||
161190141|NCT01066819|582073182|FG001|Overall Study|Spontaneous cure|0|||
161190142|NCT01066819|582073183|FG002|Overall Study|Spontaneous cure|0|||
161190143|NCT01066819|582073184|FG003|Overall Study|Spontaneous cure|0|||
161190144|NCT01066819|582073185|FG004|Overall Study|Spontaneous cure|0|||
161190145|NCT01066819|582073186|FG005|Overall Study|Spontaneous cure|0|||
161190146|NCT01066819|582073181|FG000|Overall Study|Treatment never started|85|||
161190147|NCT01066819|582073182|FG001|Overall Study|Treatment never started|19|||
161190148|NCT01066819|582073183|FG002|Overall Study|Treatment never started|19|||
161190149|NCT01066819|582073184|FG003|Overall Study|Treatment never started|3|||
161190150|NCT01066819|582073185|FG004|Overall Study|Treatment never started|2|||
161190151|NCT01066819|582073186|FG005|Overall Study|Treatment never started|2|||
161190152|NCT01066819|582073181|FG000|Overall Study|Treatment stopped|12|||
161190153|NCT01066819|582073182|FG001|Overall Study|Treatment stopped|1|||
161190154|NCT01066819|582073183|FG002|Overall Study|Treatment stopped|2|||
161190155|NCT01066819|582073184|FG003|Overall Study|Treatment stopped|1|||
161190156|NCT01066819|582073185|FG004|Overall Study|Treatment stopped|0|||
161190157|NCT01066819|582073186|FG005|Overall Study|Treatment stopped|0|||
161190158|NCT01066819|582073181|FG000|Overall Study|Other|5|||
161190159|NCT01066819|582073182|FG001|Overall Study|Other|1|||
161190160|NCT01066819|582073183|FG002|Overall Study|Other|1|||
161190161|NCT01066819|582073184|FG003|Overall Study|Other|0|||
161190162|NCT01066819|582073185|FG004|Overall Study|Other|0|||
161190163|NCT01066819|582073186|FG005|Overall Study|Other|0|||
161190164|NCT02719028|582073187|FG000|Overall Study|Adverse Event|2|||
161190165|NCT02719028|582073188|FG001|Overall Study|Adverse Event|1|||
161190166|NCT02719028|582073189|FG002|Overall Study|Adverse Event|4|||
161190167|NCT02719028|582073190|FG003|Overall Study|Adverse Event|8|||
161190168|NCT02719028|582073187|FG000|Overall Study|Physician Decision|0|||
161190169|NCT02719028|582073188|FG001|Overall Study|Physician Decision|1|||
161190170|NCT02719028|582073189|FG002|Overall Study|Physician Decision|1|||
161190171|NCT02719028|582073190|FG003|Overall Study|Physician Decision|1|||
161190172|NCT02719028|582073187|FG000|Overall Study|Use of prohibited medication|0|||
161190173|NCT02719028|582073188|FG001|Overall Study|Use of prohibited medication|0|||
161190174|NCT02719028|582073189|FG002|Overall Study|Use of prohibited medication|1|||
161190175|NCT02719028|582073190|FG003|Overall Study|Use of prohibited medication|0|||
161190176|NCT02719028|582073187|FG000|Overall Study|Protocol Violation|0|||
161190177|NCT02719028|582073188|FG001|Overall Study|Protocol Violation|0|||
161190178|NCT02719028|582073189|FG002|Overall Study|Protocol Violation|0|||
161306140|NCT04323306|582500773|FG003|Overall Study|Withdrawal by Subject|0|||
161190179|NCT02719028|582073190|FG003|Overall Study|Protocol Violation|1|||
161190180|NCT01539720|582073194|FG000|Overall Study|Screen Fail|15|||
161190181|NCT01539720|582073195|FG001|Overall Study|Screen Fail|3|||
161190182|NCT01539720|582073194|FG000|Overall Study|Lost to Follow-up|14|||
161190183|NCT01539720|582073195|FG001|Overall Study|Lost to Follow-up|7|||
161190184|NCT00298766|582073196|FG000|Overall Study|Adverse Event|18|||
161190185|NCT00298766|582073196|FG000|Overall Study|Death|2|||
161190186|NCT00298766|582073196|FG000|Overall Study|Withdrawal by Subject|9|||
161190187|NCT00298766|582073196|FG000|Overall Study|Treatment ongoing|4|||
161190188|NCT00298766|582073196|FG000|Overall Study|Progression of amyloid markers|4|||
161190189|NCT00298766|582073196|FG000|Overall Study|Deterioration in KPS and organ function|1|||
161190190|NCT00298766|582073196|FG000|Overall Study|Subjects overall condition deterioration|4|||
161190191|NCT00298766|582073196|FG000|Overall Study|Other|4|||
161190192|NCT03287960|582073203|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
161190193|NCT03287960|582073203|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
161190194|NCT03812224|582073206|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
161190195|NCT03812224|582073207|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
161190196|NCT03812224|582073206|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
161190197|NCT03812224|582073207|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
161190198|NCT03812224|582073206|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
161190199|NCT03812224|582073207|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
161190200|NCT03812224|582073206|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
161190201|NCT03812224|582073207|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
161190202|NCT00656136|582073208|FG000|Overall Study|Progressive disease|177|||
161190203|NCT00656136|582073209|FG001|Overall Study|Progressive disease|322|||
161190204|NCT00656136|582073208|FG000|Overall Study|Other Adverse Event|5|||
161190205|NCT00656136|582073209|FG001|Overall Study|Other Adverse Event|51|||
161190206|NCT00656136|582073208|FG000|Overall Study|Protocol Violation|2|||
161190207|NCT00656136|582073209|FG001|Overall Study|Protocol Violation|3|||
161190208|NCT00656136|582073208|FG000|Overall Study|Patient refused to take study medication|7|||
161190209|NCT00656136|582073209|FG001|Overall Study|Patient refused to take study medication|10|||
161190210|NCT00656136|582073208|FG000|Overall Study|Unknown and others|4|||
161190211|NCT00656136|582073209|FG001|Overall Study|Unknown and others|4|||
161190212|NCT03633461|582073219|FG000|Overall Study|Lost to Follow-up|0|||
161190213|NCT03633461|582073220|FG001|Overall Study|Lost to Follow-up|1|||
161190214|NCT02516605|582073225|FG000|Overall Study|Protocol Violation|0|||
161190215|NCT02516605|582073226|FG001|Overall Study|Protocol Violation|0|||
161190216|NCT02516605|582073227|FG002|Overall Study|Protocol Violation|0|||
161190217|NCT02516605|582073228|FG003|Overall Study|Protocol Violation|0|||
161190218|NCT02516605|582073229|FG004|Overall Study|Protocol Violation|1|||
161190219|NCT02516605|582073225|FG000|Overall Study|Withdrawal by Subject|0|||
161190220|NCT02516605|582073226|FG001|Overall Study|Withdrawal by Subject|0|||
161190221|NCT02516605|582073227|FG002|Overall Study|Withdrawal by Subject|0|||
161190222|NCT02516605|582073228|FG003|Overall Study|Withdrawal by Subject|1|||
161190223|NCT02516605|582073229|FG004|Overall Study|Withdrawal by Subject|0|||
161190224|NCT02643420|582073230|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
161190225|NCT02643420|582073231|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
161190226|NCT02643420|582073230|FG000|Overall Study|Withdrawal by Subject|25|||
161190227|NCT02643420|582073231|FG001|Overall Study|Withdrawal by Subject|19|||
161190228|NCT02643420|582073230|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
161190229|NCT02643420|582073231|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
161190230|NCT02643420|582073230|FG000|Overall Study|Lost to Follow-up|6|||
161190231|NCT02643420|582073231|FG001|Overall Study|Lost to Follow-up|10|||
161190232|NCT02643420|582073230|FG000|Overall Study|Investigator Decision|2|||
161190233|NCT02643420|582073231|FG001|Overall Study|Investigator Decision|4|||
161190234|NCT02643420|582073230|FG000|Overall Study|Sponsor decision|1|||
161190235|NCT02643420|582073231|FG001|Overall Study|Sponsor decision|1|||
161190236|NCT02643420|582073230|FG000|Overall Study|Death|0|||
161190237|NCT02643420|582073231|FG001|Overall Study|Death|2|||
161190238|NCT02643420|582073230|FG000|Overall Study|Reason not Specified|8|||
161190239|NCT02643420|582073231|FG001|Overall Study|Reason not Specified|7|||
161190240|NCT01710709|582073232|FG000|Overall Study|Lost to Follow-up|29|||
161190241|NCT01710709|582073232|FG000|Overall Study|Adverse Event|48|||
161190242|NCT01710709|582073232|FG000|Overall Study|Participant met withdrawal criteria|33|||
161190243|NCT01710709|582073232|FG000|Overall Study|Participant withdrawn by investigator|2|||
161190244|NCT01710709|582073232|FG000|Overall Study|Withdrawal by Subject|53|||
161190245|NCT01710709|582073232|FG000|Overall Study|Protocol Violation|5|||
161190246|NCT01710709|582073232|FG000|Overall Study|Lack of Efficacy|3|||
161190247|NCT01398176|582073234|FG000|Overall Study|Lost to Follow-up|1|||
161190248|NCT01398176|582073235|FG001|Overall Study|Lost to Follow-up|3|||
161190249|NCT01398176|582073234|FG000|Overall Study|Physician Decision|2|||
161190250|NCT01398176|582073235|FG001|Overall Study|Physician Decision|3|||
161190251|NCT00542321|582073236|FG000|Overall Study|Death|0|||
161190252|NCT00542321|582073237|FG001|Overall Study|Death|1|||
161190253|NCT00253747|582073240|FG000|Overall Study|Lost to Follow-up|13|||
161190254|NCT00253747|582073241|FG001|Overall Study|Lost to Follow-up|14|||
161190255|NCT00253747|582073240|FG000|Overall Study|Withdrawal by Subject|10|||
161190256|NCT00253747|582073241|FG001|Overall Study|Withdrawal by Subject|11|||
161306141|NCT04323306|582500774|FG004|Overall Study|Withdrawal by Subject|0|||
161306142|NCT04323306|582500775|FG005|Overall Study|Withdrawal by Subject|1|||
161306143|NCT04323306|582500776|FG006|Overall Study|Withdrawal by Subject|3|||
161306144|NCT04323306|582500777|FG007|Overall Study|Withdrawal by Subject|0|||
161190257|NCT00253747|582073240|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
161190258|NCT00253747|582073241|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
161190259|NCT02275052|582073244|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161190260|NCT02275052|582073245|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
161190261|NCT02275052|582073246|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161190262|NCT02275052|582073247|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
161190263|NCT02275052|582073244|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161190264|NCT02275052|582073245|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
161190265|NCT02275052|582073246|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161190266|NCT02275052|582073247|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
161190267|NCT02275052|582073244|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
161190268|NCT02275052|582073245|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
161190269|NCT02275052|582073246|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161190270|NCT02275052|582073247|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
161190271|NCT02275052|582073244|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
161190272|NCT02275052|582073245|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161190273|NCT02275052|582073246|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161190274|NCT02275052|582073247|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
161190275|NCT02275052|582073244|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
161190276|NCT02275052|582073245|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161190277|NCT02275052|582073246|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161190278|NCT02275052|582073247|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
161190279|NCT02275052|582073244|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
161190280|NCT02275052|582073245|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161190281|NCT02275052|582073246|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161190282|NCT02275052|582073247|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
161190283|NCT02275052|582073244|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
161190284|NCT02275052|582073245|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161190285|NCT02275052|582073246|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161190286|NCT02275052|582073247|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
161190287|NCT02275052|582073244|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161190288|NCT02275052|582073245|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
161190289|NCT02275052|582073246|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
161190290|NCT02275052|582073247|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
161190291|NCT02275052|582073244|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161190292|NCT02275052|582073245|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
161190293|NCT02275052|582073246|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
161190294|NCT02275052|582073247|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
161190295|NCT02275052|582073244|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161190296|NCT02275052|582073245|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
161190297|NCT02275052|582073246|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
161190298|NCT02275052|582073247|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
161190299|NCT02275052|582073244|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161190300|NCT02275052|582073245|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161190301|NCT02275052|582073246|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
161190302|NCT02275052|582073247|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
161190303|NCT05102734|582073248|FG000|Overall Study|Did not require vasopressors|1|||
161190304|NCT05102734|582073249|FG001|Overall Study|Did not require vasopressors|0|||
161190305|NCT05102734|582073248|FG000|Overall Study|Did not have functioning PA catheter|1|||
161190306|NCT05102734|582073249|FG001|Overall Study|Did not have functioning PA catheter|0|||
161190307|NCT05102734|582073248|FG000|Overall Study|Inadequate video quality|2|||
161190308|NCT05102734|582073249|FG001|Overall Study|Inadequate video quality|0|||
161190309|NCT03055806|582073255|FG000|Overall Study|Adverse Event|0|||
161190310|NCT03055806|582073256|FG001|Overall Study|Adverse Event|0|||
161190311|NCT03055806|582073257|FG002|Overall Study|Adverse Event|1|||
161190312|NCT03055806|582073258|FG003|Overall Study|Adverse Event|1|||
161190313|NCT03055806|582073255|FG000|Overall Study|Lost to Follow-up|0|||
161190314|NCT03055806|582073256|FG001|Overall Study|Lost to Follow-up|3|||
161190315|NCT03055806|582073257|FG002|Overall Study|Lost to Follow-up|6|||
161190316|NCT03055806|582073258|FG003|Overall Study|Lost to Follow-up|7|||
161190317|NCT03055806|582073255|FG000|Overall Study|Physician Decision|1|||
161190318|NCT03055806|582073256|FG001|Overall Study|Physician Decision|0|||
161190319|NCT03055806|582073257|FG002|Overall Study|Physician Decision|0|||
161190320|NCT03055806|582073258|FG003|Overall Study|Physician Decision|1|||
161190321|NCT03055806|582073255|FG000|Overall Study|Protocol Violation|1|||
161190322|NCT03055806|582073256|FG001|Overall Study|Protocol Violation|0|||
161190323|NCT03055806|582073257|FG002|Overall Study|Protocol Violation|0|||
161190324|NCT03055806|582073258|FG003|Overall Study|Protocol Violation|0|||
161190325|NCT03055806|582073255|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
161306145|NCT04323306|582500778|FG008|Overall Study|Withdrawal by Subject|1|||
161306146|NCT00089778|582500779|FG000|Overall Study|Protocol Violation|0|||
161190326|NCT03055806|582073256|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
161306147|NCT00089778|582500780|FG001|Overall Study|Protocol Violation|0|||
161190327|NCT03055806|582073257|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
161190328|NCT03055806|582073258|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
161190329|NCT03055806|582073255|FG000|Overall Study|Withdrawal of consent to continue study|2|||
161190330|NCT03055806|582073256|FG001|Overall Study|Withdrawal of consent to continue study|3|||
161190331|NCT03055806|582073257|FG002|Overall Study|Withdrawal of consent to continue study|4|||
161190332|NCT03055806|582073258|FG003|Overall Study|Withdrawal of consent to continue study|6|||
161190333|NCT03055806|582073255|FG000|Overall Study|Partner not willing to try intercourse|1|||
161190334|NCT03055806|582073256|FG001|Overall Study|Partner not willing to try intercourse|0|||
161190335|NCT03055806|582073257|FG002|Overall Study|Partner not willing to try intercourse|0|||
161190336|NCT03055806|582073258|FG003|Overall Study|Partner not willing to try intercourse|0|||
161190337|NCT04601194|582073259|FG000|Overall Study|Lost to Follow-up|7|||
161190338|NCT02630459|582073260|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161190339|NCT02630459|582073261|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
161190340|NCT02630459|582073262|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161190341|NCT02630459|582073263|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
161190342|NCT02630459|582073264|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161190343|NCT02630459|582073265|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161190344|NCT02630459|582073266|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161190345|NCT02630459|582073267|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
161190346|NCT02630459|582073260|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190347|NCT02630459|582073261|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190348|NCT02630459|582073262|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
161190349|NCT02630459|582073263|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190350|NCT02630459|582073264|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190351|NCT02630459|582073265|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190352|NCT02630459|582073266|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190353|NCT02630459|582073267|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
161190354|NCT02630459|582073260|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
161190355|NCT02630459|582073261|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
161190356|NCT02630459|582073262|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
161190357|NCT02630459|582073263|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
161190358|NCT02630459|582073264|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161190359|NCT02630459|582073265|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161306148|NCT00089778|582500781|FG002|Overall Study|Protocol Violation|1|||
161306149|NCT04712019|582500782|FG000|Overall Study|Withdrawal by Subject|2|||
161306150|NCT04712019|582500783|FG001|Overall Study|Withdrawal by Subject|2|||
161306151|NCT04712019|582500782|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
161306152|NCT04712019|582500783|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
161306153|NCT01646021|582500784|FG000|Overall Study|Death|77|||
161306154|NCT01646021|582500785|FG001|Overall Study|Death|83|||
161306155|NCT01646021|582500784|FG000|Overall Study|Study Terminated by Sponsor|50|||
161306156|NCT01646021|582500785|FG001|Overall Study|Study Terminated by Sponsor|41|||
161306157|NCT01646021|582500784|FG000|Overall Study|Lost to Follow-up|2|||
161306158|NCT01646021|582500785|FG001|Overall Study|Lost to Follow-up|2|||
161306159|NCT01646021|582500784|FG000|Overall Study|Withdrawal by Subject|10|||
161306160|NCT01646021|582500785|FG001|Overall Study|Withdrawal by Subject|15|||
161306161|NCT02347891|582500796|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
161306162|NCT02347891|582500797|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
161306163|NCT02347891|582500796|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
161306164|NCT02347891|582500797|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
161306165|NCT00725608|582500798|FG000|Overall Study|Lost to Follow-up|60|||
161306166|NCT00725608|582500798|FG000|Overall Study|Adverse Event|14|||
161306167|NCT00725608|582500798|FG000|Overall Study|Individual reasons|86|||
161306168|NCT00725608|582500798|FG000|Overall Study|Other|7|||
161306169|NCT00614120|582500802|FG000|Overall Study|Adverse Event|9|||
161306170|NCT00614120|582500803|FG001|Overall Study|Adverse Event|22|||
161306171|NCT00614120|582500804|FG002|Overall Study|Adverse Event|30|||
161306172|NCT00614120|582500805|FG003|Overall Study|Adverse Event|3|||
161306173|NCT00614120|582500802|FG000|Overall Study|Lack of Efficacy|3|||
161306174|NCT00614120|582500803|FG001|Overall Study|Lack of Efficacy|3|||
161306175|NCT00614120|582500804|FG002|Overall Study|Lack of Efficacy|2|||
161349265|NCT05218499|582663693|FG000|Overall Study|Technical problems|0|||
161349266|NCT05218499|582663694|FG001|Overall Study|Technical problems|1|||
161349267|NCT05218499|582663695|FG002|Overall Study|Technical problems|0|||
161190360|NCT02630459|582073266|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161306176|NCT00614120|582500805|FG003|Overall Study|Lack of Efficacy|2|||
161306177|NCT00614120|582500802|FG000|Overall Study|Protocol Violation|2|||
161306178|NCT00614120|582500803|FG001|Overall Study|Protocol Violation|5|||
161349268|NCT05218499|582663693|FG000|Overall Study|Burden of trial procedures|0|||
161306179|NCT00614120|582500804|FG002|Overall Study|Protocol Violation|3|||
161349269|NCT05218499|582663694|FG001|Overall Study|Burden of trial procedures|1|||
161190361|NCT02630459|582073267|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
161190362|NCT02630459|582073260|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
161190363|NCT02630459|582073261|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190364|NCT02630459|582073262|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190365|NCT02630459|582073263|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190366|NCT02630459|582073264|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190367|NCT02630459|582073265|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190368|NCT02630459|582073266|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190369|NCT02630459|582073267|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
161190370|NCT02630459|582073260|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161190371|NCT02630459|582073261|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161190372|NCT02630459|582073262|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161190373|NCT02630459|582073263|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161190374|NCT02630459|582073264|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
161190375|NCT02630459|582073265|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
161190376|NCT02630459|582073266|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161190377|NCT02630459|582073267|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
161190378|NCT02630459|582073260|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161190379|NCT02630459|582073261|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161190380|NCT02630459|582073262|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161190381|NCT02630459|582073263|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161190382|NCT02630459|582073264|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
161190383|NCT02630459|582073265|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
161190384|NCT02630459|582073266|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161190385|NCT02630459|582073267|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
161190386|NCT02630459|582073260|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190387|NCT02630459|582073261|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190388|NCT02630459|582073262|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190389|NCT02630459|582073263|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190390|NCT02630459|582073264|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
161190391|NCT02630459|582073265|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190392|NCT02630459|582073266|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190393|NCT02630459|582073267|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
161190394|NCT00846027|582073268|FG000|Overall Study|Death|3|||
161190395|NCT00846027|582073268|FG000|Overall Study|Disease Progression|30|||
161190396|NCT00846027|582073268|FG000|Overall Study|Toxicity|12|||
161190397|NCT00846027|582073268|FG000|Overall Study|Patient Decision|7|||
161190398|NCT00846027|582073268|FG000|Overall Study|Investigator Discretion|29|||
161190399|NCT00846027|582073268|FG000|Overall Study|Protocol Violation|2|||
161190400|NCT00846027|582073268|FG000|Overall Study|Subject Not Treated|7|||
161190401|NCT04905563|582073271|FG000|Overall Study|Withdrawal by Subject|1|||
161190402|NCT04905563|582073272|FG001|Overall Study|Withdrawal by Subject|0|||
161190403|NCT04905563|582073271|FG000|Overall Study|Standard of care orders entered by resident|1|||
161190404|NCT04905563|582073272|FG001|Overall Study|Standard of care orders entered by resident|0|||
161190405|NCT04905563|582073271|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
161190406|NCT04905563|582073272|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
161190407|NCT04905563|582073271|FG000|Overall Study|Withdrawal by Subject|0|||
161190408|NCT04905563|582073272|FG001|Overall Study|Withdrawal by Subject|1|||
161190409|NCT01797302|582073273|FG000|Overall Study|Lost to Follow-up|16|||
161190410|NCT01797302|582073274|FG001|Overall Study|Lost to Follow-up|23|||
161190411|NCT01797302|582073275|FG002|Overall Study|Lost to Follow-up|22|||
161190412|NCT01797302|582073273|FG000|Overall Study|Withdrawal by Subject|1|||
161190413|NCT01797302|582073274|FG001|Overall Study|Withdrawal by Subject|3|||
161190414|NCT01797302|582073275|FG002|Overall Study|Withdrawal by Subject|4|||
161190415|NCT02418000|582073276|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
161190416|NCT02418000|582073277|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161306180|NCT00614120|582500805|FG003|Overall Study|Protocol Violation|1|||
161306181|NCT00614120|582500802|FG000|Overall Study|Withdrawal criteria|1|||
161306182|NCT00614120|582500803|FG001|Overall Study|Withdrawal criteria|0|||
161306183|NCT00614120|582500804|FG002|Overall Study|Withdrawal criteria|0|||
161306184|NCT00614120|582500805|FG003|Overall Study|Withdrawal criteria|0|||
161306185|NCT00614120|582500802|FG000|Overall Study|Withdrawal by Subject|9|||
161306186|NCT00614120|582500803|FG001|Overall Study|Withdrawal by Subject|10|||
161306187|NCT00614120|582500804|FG002|Overall Study|Withdrawal by Subject|16|||
161306188|NCT00614120|582500805|FG003|Overall Study|Withdrawal by Subject|3|||
161190417|NCT02418000|582073278|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161190418|NCT02418000|582073279|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161306189|NCT00614120|582500802|FG000|Overall Study|Did not meet trial criteria|0|||
161306190|NCT00614120|582500803|FG001|Overall Study|Did not meet trial criteria|1|||
161190419|NCT02418000|582073280|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
161190420|NCT02418000|582073276|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
161190421|NCT02418000|582073277|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161190422|NCT02418000|582073278|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161190423|NCT02418000|582073279|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161190424|NCT02418000|582073280|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
161190425|NCT02418000|582073276|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
161190426|NCT02418000|582073277|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161190427|NCT02418000|582073278|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161190428|NCT02418000|582073279|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161190429|NCT02418000|582073280|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
161190430|NCT02418000|582073276|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161190431|NCT02418000|582073277|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
161190432|NCT02418000|582073278|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161190433|NCT02418000|582073279|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161190434|NCT02418000|582073280|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
161190435|NCT02418000|582073276|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161190436|NCT02418000|582073277|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
161190437|NCT02418000|582073278|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161190438|NCT02418000|582073279|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161190439|NCT02418000|582073280|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
161190440|NCT02418000|582073276|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190441|NCT02418000|582073277|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190442|NCT02418000|582073278|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161190443|NCT02418000|582073279|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190444|NCT02418000|582073280|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190445|NCT02418000|582073276|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190446|NCT02418000|582073277|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190447|NCT02418000|582073278|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190448|NCT02418000|582073279|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161190449|NCT02418000|582073280|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190450|NCT02418000|582073276|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161190451|NCT02418000|582073277|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161190452|NCT02418000|582073278|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161190453|NCT02418000|582073279|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
161190454|NCT02418000|582073280|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
161190455|NCT02418000|582073276|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190456|NCT02418000|582073277|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190457|NCT02418000|582073278|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190458|NCT02418000|582073279|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
161190459|NCT02418000|582073280|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
161190460|NCT00106626|582073281|FG000|Overall Study|Adverse Event|5|||
161190461|NCT00106626|582073282|FG001|Overall Study|Adverse Event|4|||
161190462|NCT00106626|582073283|FG002|Overall Study|Adverse Event|3|||
161190463|NCT00106626|582073284|FG003|Overall Study|Adverse Event|3|||
161190464|NCT00106626|582073281|FG000|Overall Study|Progressive Disease|4|||
161190465|NCT00106626|582073282|FG001|Overall Study|Progressive Disease|1|||
161190466|NCT00106626|582073283|FG002|Overall Study|Progressive Disease|9|||
161190467|NCT00106626|582073284|FG003|Overall Study|Progressive Disease|10|||
161190468|NCT00106626|582073281|FG000|Overall Study|Received radiation on new therapy|1|||
161190469|NCT00106626|582073282|FG001|Overall Study|Received radiation on new therapy|0|||
161190470|NCT00106626|582073283|FG002|Overall Study|Received radiation on new therapy|0|||
161190471|NCT00106626|582073284|FG003|Overall Study|Received radiation on new therapy|0|||
161306191|NCT00614120|582500804|FG002|Overall Study|Did not meet trial criteria|1|||
161306192|NCT00614120|582500805|FG003|Overall Study|Did not meet trial criteria|1|||
161306193|NCT00614120|582500802|FG000|Overall Study|hCG positive (not pregnant)|0|||
161306194|NCT00614120|582500803|FG001|Overall Study|hCG positive (not pregnant)|0|||
161306195|NCT00614120|582500804|FG002|Overall Study|hCG positive (not pregnant)|1|||
161306196|NCT00614120|582500805|FG003|Overall Study|hCG positive (not pregnant)|0|||
161306197|NCT00614120|582500802|FG000|Overall Study|Hypoglycaemia|0|||
161306198|NCT00614120|582500803|FG001|Overall Study|Hypoglycaemia|0|||
161306199|NCT00614120|582500804|FG002|Overall Study|Hypoglycaemia|0|||
161306200|NCT00614120|582500805|FG003|Overall Study|Hypoglycaemia|1|||
161306201|NCT00614120|582500802|FG000|Overall Study|Lack of trial product|3|||
161306202|NCT00614120|582500803|FG001|Overall Study|Lack of trial product|3|||
161306203|NCT00614120|582500804|FG002|Overall Study|Lack of trial product|2|||
161306204|NCT00614120|582500805|FG003|Overall Study|Lack of trial product|0|||
161306205|NCT00614120|582500802|FG000|Overall Study|Late syphilis, latent|1|||
161306206|NCT00614120|582500803|FG001|Overall Study|Late syphilis, latent|0|||
161306207|NCT00614120|582500804|FG002|Overall Study|Late syphilis, latent|0|||
161190472|NCT00106626|582073281|FG000|Overall Study|> 14 day delay in therapy start|0|||
161190473|NCT00106626|582073282|FG001|Overall Study|> 14 day delay in therapy start|1|||
161190474|NCT00106626|582073283|FG002|Overall Study|> 14 day delay in therapy start|0|||
161190475|NCT00106626|582073284|FG003|Overall Study|> 14 day delay in therapy start|0|||
161190476|NCT03018028|582073293|FG000|Overall Study|Withdrawal by Subject|3|||
161190477|NCT03018028|582073294|FG001|Overall Study|Withdrawal by Subject|0|||
161190478|NCT03018028|582073295|FG002|Overall Study|Withdrawal by Subject|1|||
161190479|NCT03018028|582073296|FG003|Overall Study|Withdrawal by Subject|2|||
161190480|NCT03018028|582073297|FG004|Overall Study|Withdrawal by Subject|0|||
161190481|NCT02519777|582073299|FG000|Overall Study|Death|1|||
161190482|NCT02519777|582073300|FG001|Overall Study|Death|0|||
161190483|NCT02519777|582073301|FG002|Overall Study|Death|0|||
161190484|NCT02519777|582073299|FG000|Overall Study|Lost to Follow-up|0|||
161190485|NCT02519777|582073300|FG001|Overall Study|Lost to Follow-up|4|||
161190486|NCT02519777|582073301|FG002|Overall Study|Lost to Follow-up|2|||
161190487|NCT02519777|582073299|FG000|Overall Study|Withdrawal by Subject|3|||
161190488|NCT02519777|582073300|FG001|Overall Study|Withdrawal by Subject|1|||
161190489|NCT02519777|582073301|FG002|Overall Study|Withdrawal by Subject|0|||
161190490|NCT02519777|582073299|FG000|Overall Study|Severe Debilitation|1|||
161190491|NCT02519777|582073300|FG001|Overall Study|Severe Debilitation|1|||
161190492|NCT02519777|582073301|FG002|Overall Study|Severe Debilitation|1|||
161190493|NCT02519777|582073299|FG000|Overall Study|Not able to get to clinic|1|||
161190494|NCT02519777|582073300|FG001|Overall Study|Not able to get to clinic|2|||
161190495|NCT02519777|582073301|FG002|Overall Study|Not able to get to clinic|1|||
161190496|NCT01284127|582073303|FG000|Overall Study|Adverse Event|2|||
161190497|NCT01284127|582073303|FG000|Overall Study|Withdrawal by Subject|4|||
161190498|NCT01284127|582073303|FG000|Overall Study|Physician Decision|1|||
161190499|NCT00256204|582073305|FG000|Overall Study|Adverse Event|10|||
161190500|NCT00256204|582073306|FG001|Overall Study|Adverse Event|14|||
161190501|NCT00256204|582073307|FG002|Overall Study|Adverse Event|16|||
161190502|NCT00256204|582073308|FG003|Overall Study|Adverse Event|14|||
161190503|NCT00256204|582073305|FG000|Overall Study|Death|0|||
161190504|NCT00256204|582073306|FG001|Overall Study|Death|1|||
161190505|NCT00256204|582073307|FG002|Overall Study|Death|0|||
161190506|NCT00256204|582073308|FG003|Overall Study|Death|0|||
161190507|NCT00256204|582073305|FG000|Overall Study|Lost to Follow-up|1|||
161190508|NCT00256204|582073306|FG001|Overall Study|Lost to Follow-up|1|||
161190509|NCT00256204|582073307|FG002|Overall Study|Lost to Follow-up|1|||
161190510|NCT00256204|582073308|FG003|Overall Study|Lost to Follow-up|2|||
161190511|NCT00256204|582073305|FG000|Overall Study|Protocol Violation|1|||
161190512|NCT00256204|582073306|FG001|Overall Study|Protocol Violation|0|||
161190513|NCT00256204|582073307|FG002|Overall Study|Protocol Violation|2|||
161190514|NCT00256204|582073308|FG003|Overall Study|Protocol Violation|1|||
161190515|NCT00256204|582073305|FG000|Overall Study|Physician Decision|0|||
161190516|NCT00256204|582073306|FG001|Overall Study|Physician Decision|0|||
161190517|NCT00256204|582073307|FG002|Overall Study|Physician Decision|1|||
161190518|NCT00256204|582073308|FG003|Overall Study|Physician Decision|2|||
161190519|NCT00256204|582073305|FG000|Overall Study|Withdrawal by Subject|17|||
161190520|NCT00256204|582073306|FG001|Overall Study|Withdrawal by Subject|6|||
161190521|NCT00256204|582073307|FG002|Overall Study|Withdrawal by Subject|7|||
161190522|NCT00256204|582073308|FG003|Overall Study|Withdrawal by Subject|5|||
161190523|NCT00256204|582073305|FG000|Overall Study|Need for additional prohibited treatment|38|||
161190524|NCT00256204|582073306|FG001|Overall Study|Need for additional prohibited treatment|28|||
161190525|NCT00256204|582073307|FG002|Overall Study|Need for additional prohibited treatment|27|||
161190526|NCT00256204|582073308|FG003|Overall Study|Need for additional prohibited treatment|25|||
161190527|NCT01351415|582073310|FG000|Overall Study|Withdrawal by Subject|15|||
161190528|NCT01351415|582073311|FG001|Overall Study|Withdrawal by Subject|17|||
161190529|NCT01351415|582073310|FG000|Overall Study|Trial termination by the Sponsor|28|||
161190530|NCT01351415|582073311|FG001|Overall Study|Trial termination by the Sponsor|19|||
161190531|NCT01351415|582073310|FG000|Overall Study|Lost to Follow-up|5|||
161190532|NCT01351415|582073311|FG001|Overall Study|Lost to Follow-up|7|||
161190533|NCT01351415|582073310|FG000|Overall Study|Death|190|||
161190534|NCT01351415|582073311|FG001|Overall Study|Death|187|||
161190535|NCT01351415|582073310|FG000|Overall Study|Physician Decision|2|||
161190536|NCT01351415|582073311|FG001|Overall Study|Physician Decision|3|||
161190537|NCT01351415|582073310|FG000|Overall Study|Reason unknown|0|||
161306208|NCT00614120|582500805|FG003|Overall Study|Late syphilis, latent|0|||
161306209|NCT00614120|582500802|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
161306210|NCT00614120|582500803|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
161190538|NCT01351415|582073311|FG001|Overall Study|Reason unknown|2|||
161190539|NCT01351415|582073310|FG000|Overall Study|Never Started|5|||
161190540|NCT01351415|582073311|FG001|Overall Study|Never Started|5|||
161190541|NCT00247962|582073312|FG000|Overall Study|Adverse Event|15|||
161190542|NCT00247962|582073313|FG001|Overall Study|Adverse Event|12|||
161190543|NCT00247962|582073312|FG000|Overall Study|Lost to Follow-up|3|||
161190544|NCT00247962|582073313|FG001|Overall Study|Lost to Follow-up|1|||
161190545|NCT00247962|582073312|FG000|Overall Study|Physician Decision|0|||
161190546|NCT00247962|582073313|FG001|Overall Study|Physician Decision|1|||
161190547|NCT00247962|582073312|FG000|Overall Study|Protocol Violation|1|||
161190548|NCT00247962|582073313|FG001|Overall Study|Protocol Violation|1|||
161190549|NCT00247962|582073312|FG000|Overall Study|Withdrawal by Subject|3|||
161190550|NCT00247962|582073313|FG001|Overall Study|Withdrawal by Subject|2|||
161190551|NCT00247962|582073312|FG000|Overall Study|Lack of Efficacy|4|||
161190552|NCT00247962|582073313|FG001|Overall Study|Lack of Efficacy|2|||
161190553|NCT03117309|582073314|FG000|Overall Study|Not meeting inclusion criteria|0|||
161190554|NCT03117309|582073315|FG001|Overall Study|Not meeting inclusion criteria|1|||
161190555|NCT02583711|582073316|FG000|Overall Study|Withdrawal by Subject|0|||
161190556|NCT02583711|582073317|FG001|Overall Study|Withdrawal by Subject|10|||
161190557|NCT02583711|582073318|FG002|Overall Study|Withdrawal by Subject|0|||
161190558|NCT00392210|582073319|FG000|First Voiding Trial|Physician Decision|2|||
161190559|NCT00392210|582073320|FG001|First Voiding Trial|Physician Decision|2|||
161190560|NCT01021423|582073328|FG000|Overall Study|Study terminated|4|||
161190561|NCT01021423|582073329|FG001|Overall Study|Study terminated|5|||
161190562|NCT00122317|582073330|FG000|Overall Study|Death|3|||
161190563|NCT00122317|582073330|FG000|Overall Study|Adverse Event|4|||
161190564|NCT00122317|582073330|FG000|Overall Study|Physician Decision|2|||
161190565|NCT00122317|582073330|FG000|Overall Study|patient non-compliance|1|||
161190566|NCT00122317|582073330|FG000|Overall Study|Withdrawal by Subject|1|||
161190567|NCT03756285|582073331|FG000|Overall Study|Lost to Follow-up|0|||
161190568|NCT03756285|582073332|FG001|Overall Study|Lost to Follow-up|1|||
161190569|NCT03756285|582073331|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
161190570|NCT03756285|582073332|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
161190571|NCT03756285|582073331|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
161190572|NCT03756285|582073332|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
161190573|NCT06334055|582073333|FG000|Overall Study|Adverse Event|4|||
161190574|NCT06334055|582073333|FG000|Overall Study|Disqualified|72|||
161190575|NCT00957034|582073334|FG000|Overall Study|Adverse Event|0|||
161190576|NCT00957034|582073335|FG001|Overall Study|Adverse Event|1|||
161190577|NCT00957034|582073336|FG002|Overall Study|Adverse Event|1|||
161190578|NCT00957034|582073334|FG000|Overall Study|Sponsor Terminated Study|6|||
161190579|NCT00957034|582073335|FG001|Overall Study|Sponsor Terminated Study|1|||
161190580|NCT00957034|582073336|FG002|Overall Study|Sponsor Terminated Study|5|||
161190581|NCT00957034|582073334|FG000|Overall Study|Withdrawal by Subject|0|||
161190582|NCT00957034|582073335|FG001|Overall Study|Withdrawal by Subject|2|||
161190583|NCT00957034|582073336|FG002|Overall Study|Withdrawal by Subject|0|||
161190584|NCT01503229|582075189|FG000|Overall Study|Withdrew consent|1|||
161190585|NCT01354964|582075190|FG000|Overall Study|Lost to Follow-up|2|||
161190586|NCT01354964|582075191|FG001|Overall Study|Lost to Follow-up|0|||
161190587|NCT01354964|582075190|FG000|Overall Study|IV access issues|1|||
161190588|NCT01354964|582075191|FG001|Overall Study|IV access issues|1|||
161190589|NCT01354964|582075190|FG000|Overall Study|Physician Decision|1|||
161190590|NCT01354964|582075191|FG001|Overall Study|Physician Decision|0|||
161190591|NCT00711009|582075192|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
161190592|NCT00711009|582075193|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
161190593|NCT00711009|582075192|FG000|Overall Study|Withdrawal by Subject|4|||
161190594|NCT00711009|582075193|FG001|Overall Study|Withdrawal by Subject|2|||
161190595|NCT00711009|582075192|FG000|Overall Study|Lost to Follow-up|3|||
161190596|NCT00711009|582075193|FG001|Overall Study|Lost to Follow-up|9|||
161190597|NCT00711009|582075192|FG000|Overall Study|Participant Noncompliant|0|||
161190598|NCT00711009|582075193|FG001|Overall Study|Participant Noncompliant|1|||
161190599|NCT00711009|582075192|FG000|Overall Study|Virologic Failure|2|||
161190600|NCT00711009|582075193|FG001|Overall Study|Virologic Failure|1|||
161190601|NCT00711009|582075192|FG000|Overall Study|Pregnancy|1|||
161190602|NCT00711009|582075193|FG001|Overall Study|Pregnancy|0|||
161190603|NCT00711009|582075192|FG000|Overall Study|Site closing|0|||
161190604|NCT00711009|582075193|FG001|Overall Study|Site closing|1|||
161190605|NCT00711009|582075192|FG000|Overall Study|Dose adjustment|1|||
161190606|NCT00711009|582075193|FG001|Overall Study|Dose adjustment|0|||
161190607|NCT02534324|582075195|FG000|Overall Study|Protocol Violation|4|||
161190608|NCT02534324|582075196|FG001|Overall Study|Protocol Violation|1|||
161349270|NCT05218499|582663695|FG002|Overall Study|Burden of trial procedures|2|||
161349271|NCT05218499|582663693|FG000|Overall Study|Clinical disease progression|6|||
161349272|NCT05218499|582663694|FG001|Overall Study|Clinical disease progression|6|||
161349273|NCT05218499|582663695|FG002|Overall Study|Clinical disease progression|11|||
161190609|NCT02534324|582075195|FG000|Overall Study|Lost to Follow-up|20|||
161190610|NCT02534324|582075196|FG001|Overall Study|Lost to Follow-up|7|||
161190611|NCT02534324|582075195|FG000|Overall Study|Adverse Event|1|||
161190612|NCT02534324|582075196|FG001|Overall Study|Adverse Event|0|||
161190613|NCT01459016|582075197|FG000|Overall Study|Withdrawal by Subject|11|||
161190614|NCT01459016|582075197|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
161190615|NCT03922945|582075211|FG000|Overall Study|Adverse Event|1|||
161190616|NCT03922945|582075212|FG001|Overall Study|Adverse Event|1|||
161190617|NCT03922945|582075213|FG002|Overall Study|Adverse Event|2|||
161190618|NCT03922945|582075211|FG000|Overall Study|Lost to Follow-up|13|||
161190619|NCT03922945|582075212|FG001|Overall Study|Lost to Follow-up|9|||
161190620|NCT03922945|582075213|FG002|Overall Study|Lost to Follow-up|20|||
161190621|NCT03922945|582075211|FG000|Overall Study|Lack of Efficacy|2|||
161190622|NCT03922945|582075212|FG001|Overall Study|Lack of Efficacy|0|||
161190623|NCT03922945|582075213|FG002|Overall Study|Lack of Efficacy|1|||
161190624|NCT03922945|582075211|FG000|Overall Study|Protocol Non-Compliance|0|||
161190625|NCT03922945|582075212|FG001|Overall Study|Protocol Non-Compliance|0|||
161190626|NCT03922945|582075213|FG002|Overall Study|Protocol Non-Compliance|1|||
161190627|NCT03922945|582075211|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
161190628|NCT03922945|582075212|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
161190629|NCT03922945|582075213|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
161190630|NCT03922945|582075211|FG000|Overall Study|All Other Personal Reasons|1|||
161190631|NCT03922945|582075212|FG001|Overall Study|All Other Personal Reasons|1|||
161190632|NCT03922945|582075213|FG002|Overall Study|All Other Personal Reasons|2|||
161190633|NCT02889861|582075214|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
161190634|NCT00313716|582075215|FG000|Overall Study|Death|3|||
161190635|NCT00313716|582075216|FG001|Overall Study|Death|2|||
161190636|NCT00313716|582075217|FG002|Overall Study|Death|9|||
161190637|NCT00313716|582075218|FG003|Overall Study|Death|3|||
161190638|NCT00313716|582075219|FG004|Overall Study|Death|5|||
161190639|NCT00313716|582075220|FG005|Overall Study|Death|9|||
161190640|NCT00313716|582075215|FG000|Overall Study|Lost to Follow-up|2|||
161190641|NCT00313716|582075216|FG001|Overall Study|Lost to Follow-up|5|||
161190642|NCT00313716|582075217|FG002|Overall Study|Lost to Follow-up|2|||
161190643|NCT00313716|582075218|FG003|Overall Study|Lost to Follow-up|1|||
161190644|NCT00313716|582075219|FG004|Overall Study|Lost to Follow-up|0|||
161190645|NCT00313716|582075220|FG005|Overall Study|Lost to Follow-up|4|||
161190646|NCT00313716|582075215|FG000|Overall Study|Withdrawal by Subject|0|||
161190647|NCT00313716|582075216|FG001|Overall Study|Withdrawal by Subject|1|||
161190648|NCT00313716|582075217|FG002|Overall Study|Withdrawal by Subject|1|||
161190649|NCT00313716|582075218|FG003|Overall Study|Withdrawal by Subject|0|||
161190650|NCT00313716|582075219|FG004|Overall Study|Withdrawal by Subject|1|||
161190651|NCT00313716|582075220|FG005|Overall Study|Withdrawal by Subject|0|||
161190652|NCT00959192|582075240|FG000|Overall Study|Adverse Event|1|||
161190653|NCT00959192|582075241|FG001|Overall Study|Adverse Event|1|||
161190654|NCT00959192|582075242|FG002|Overall Study|Adverse Event|1|||
161190655|NCT00959192|582075243|FG003|Overall Study|Adverse Event|0|||
161190656|NCT00959192|582075240|FG000|Overall Study|Investigator Request|1|||
161190657|NCT00959192|582075241|FG001|Overall Study|Investigator Request|0|||
161190658|NCT00959192|582075242|FG002|Overall Study|Investigator Request|0|||
161190659|NCT00959192|582075243|FG003|Overall Study|Investigator Request|0|||
161190660|NCT00959192|582075240|FG000|Overall Study|Caregiver Request|0|||
161190661|NCT00959192|582075241|FG001|Overall Study|Caregiver Request|0|||
161190662|NCT00959192|582075242|FG002|Overall Study|Caregiver Request|2|||
161190663|NCT00959192|582075243|FG003|Overall Study|Caregiver Request|1|||
161190664|NCT01603615|582075244|FG000|Overall Study|Did not Receive Treatment|7|||
161190665|NCT01603615|582075244|FG000|Overall Study|Lost to Follow-up|9|||
161190666|NCT01603615|582075244|FG000|Overall Study|Personal Reasons|17|||
161190667|NCT01603615|582075244|FG000|Overall Study|Other Miscellaneous|1|||
161190668|NCT02194699|582075249|FG000|Randomised|Did not receive treatment|1|||
161190669|NCT02194699|582075250|FG001|Randomised|Did not receive treatment|5|||
161190670|NCT02194699|582075249|FG000|Randomised|Without potential for 52 weeks of IP|5|||
161190671|NCT02194699|582075250|FG001|Randomised|Without potential for 52 weeks of IP|5|||
161190672|NCT02194699|582075249|FG000|Randomised|Duplicate patient|2|||
161190673|NCT02194699|582075250|FG001|Randomised|Duplicate patient|1|||
161190674|NCT02194699|582075249|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
161190675|NCT02194699|582075250|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
161190676|NCT02194699|582075249|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
161190677|NCT02194699|582075250|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
161190678|NCT02194699|582075249|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
161190679|NCT02194699|582075250|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
161190680|NCT02194699|582075249|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
161190681|NCT02194699|582075250|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
161190682|NCT02194699|582075249|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
161190683|NCT02194699|582075250|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
161190684|NCT02194699|582075249|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
161190685|NCT02194699|582075250|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
161190686|NCT01667731|582075252|FG000|Overall Study|Enrolled but not treated|0|||
161190687|NCT01667731|582075253|FG001|Overall Study|Enrolled but not treated|0|||
161190688|NCT01667731|582075254|FG002|Overall Study|Enrolled but not treated|0|||
161190689|NCT01667731|582075255|FG003|Overall Study|Enrolled but not treated|0|||
161190690|NCT01667731|582075256|FG004|Overall Study|Enrolled but not treated|1|||
161190691|NCT01667731|582075252|FG000|Overall Study|Efficacy Failure|1|||
161190692|NCT01667731|582075253|FG001|Overall Study|Efficacy Failure|12|||
161190693|NCT01667731|582075254|FG002|Overall Study|Efficacy Failure|0|||
161190694|NCT01667731|582075255|FG003|Overall Study|Efficacy Failure|1|||
161190695|NCT01667731|582075256|FG004|Overall Study|Efficacy Failure|24|||
161190696|NCT01667731|582075252|FG000|Overall Study|Lost to Follow-up|2|||
161190697|NCT01667731|582075253|FG001|Overall Study|Lost to Follow-up|3|||
161190698|NCT01667731|582075254|FG002|Overall Study|Lost to Follow-up|1|||
161190699|NCT01667731|582075255|FG003|Overall Study|Lost to Follow-up|1|||
161190700|NCT01667731|582075256|FG004|Overall Study|Lost to Follow-up|2|||
161190701|NCT01667731|582075252|FG000|Overall Study|Subject Withdrew Consent|2|||
161190702|NCT01667731|582075253|FG001|Overall Study|Subject Withdrew Consent|0|||
161190703|NCT01667731|582075254|FG002|Overall Study|Subject Withdrew Consent|1|||
161190704|NCT01667731|582075255|FG003|Overall Study|Subject Withdrew Consent|0|||
161190705|NCT01667731|582075256|FG004|Overall Study|Subject Withdrew Consent|1|||
161190706|NCT01667731|582075252|FG000|Overall Study|Death|0|||
161190707|NCT01667731|582075253|FG001|Overall Study|Death|1|||
161190708|NCT01667731|582075254|FG002|Overall Study|Death|0|||
161190709|NCT01667731|582075255|FG003|Overall Study|Death|0|||
161190710|NCT01667731|582075256|FG004|Overall Study|Death|0|||
161190711|NCT02127970|582075265|FG000|Overall Study|Adverse Event|2|||
161190712|NCT02127970|582075266|FG001|Overall Study|Adverse Event|1|||
161190713|NCT02127970|582075265|FG000|Overall Study|Death|1|||
161190714|NCT02127970|582075266|FG001|Overall Study|Death|1|||
161190715|NCT02127970|582075265|FG000|Overall Study|Lost to Follow-up|14|||
161190716|NCT02127970|582075266|FG001|Overall Study|Lost to Follow-up|14|||
161190717|NCT02127970|582075265|FG000|Overall Study|Reason not Specified|4|||
161190718|NCT02127970|582075266|FG001|Overall Study|Reason not Specified|7|||
161190719|NCT02127970|582075265|FG000|Overall Study|Pregnancy|0|||
161190720|NCT02127970|582075266|FG001|Overall Study|Pregnancy|1|||
161190721|NCT02127970|582075265|FG000|Overall Study|Subject Withdrew Consent|5|||
161190722|NCT02127970|582075266|FG001|Overall Study|Subject Withdrew Consent|3|||
161190723|NCT01871870|582075270|FG000|Overall Study|Hardware issues|7|||
161190724|NCT01871870|582075270|FG000|Overall Study|hyperglycemia|2|||
161190725|NCT00490815|582075274|FG000|Overall Study|Adverse Event|2|||
161190726|NCT00490815|582075275|FG001|Overall Study|Adverse Event|3|||
161190727|NCT00490815|582075274|FG000|Overall Study|Withdrawal by Subject|4|||
161190728|NCT00490815|582075275|FG001|Overall Study|Withdrawal by Subject|0|||
161190729|NCT00490815|582075274|FG000|Overall Study|Lost to Follow-up|1|||
161190730|NCT00490815|582075275|FG001|Overall Study|Lost to Follow-up|3|||
161190731|NCT00490815|582075274|FG000|Overall Study|Death|1|||
161190732|NCT00490815|582075275|FG001|Overall Study|Death|3|||
161190733|NCT01904760|582075276|FG000|Overall Study|Protocol Violation|1|||
161190734|NCT01904760|582075277|FG001|Overall Study|Protocol Violation|0|||
161190735|NCT04249076|582075279|FG000|Overall Study|Adverse Event|1|||
161190736|NCT04249076|582075280|FG001|Overall Study|Adverse Event|1|||
161190737|NCT04249076|582075279|FG000|Overall Study|Protocol Violation|1|||
161190738|NCT04249076|582075280|FG001|Overall Study|Protocol Violation|2|||
161190739|NCT04249076|582075279|FG000|Overall Study|Lack of Efficacy|0|||
161190740|NCT04249076|582075280|FG001|Overall Study|Lack of Efficacy|1|||
161190741|NCT04249076|582075279|FG000|Overall Study|Withdrawal by Subject|0|||
161190742|NCT04249076|582075280|FG001|Overall Study|Withdrawal by Subject|1|||
161190743|NCT00783263|582075281|FG000|Overall Study|Adverse Event|3|||
161190744|NCT00783263|582075282|FG001|Overall Study|Adverse Event|0|||
161190745|NCT00783263|582075283|FG002|Overall Study|Adverse Event|2|||
161190746|NCT00783263|582075284|FG003|Overall Study|Adverse Event|1|||
161190747|NCT00783263|582075281|FG000|Overall Study|Lost to Follow-up|1|||
161190748|NCT00783263|582075282|FG001|Overall Study|Lost to Follow-up|1|||
161190749|NCT00783263|582075283|FG002|Overall Study|Lost to Follow-up|0|||
161190750|NCT00783263|582075284|FG003|Overall Study|Lost to Follow-up|0|||
161190751|NCT00783263|582075281|FG000|Overall Study|Withdrawal by Subject|0|||
161190752|NCT00783263|582075282|FG001|Overall Study|Withdrawal by Subject|1|||
161190753|NCT00783263|582075283|FG002|Overall Study|Withdrawal by Subject|1|||
161190754|NCT00783263|582075284|FG003|Overall Study|Withdrawal by Subject|2|||
161190755|NCT00732199|582075285|FG000|Overall Study|Withdrawal by Subject|25|||
161306211|NCT00614120|582500804|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
161306212|NCT00614120|582500805|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
161306213|NCT00614120|582500802|FG000|Overall Study|Lost to Follow-up|1|||
161190756|NCT00732199|582075286|FG001|Overall Study|Withdrawal by Subject|18|||
161190757|NCT00732199|582075285|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
161190758|NCT00732199|582075286|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
161190759|NCT03490734|582075304|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
161190760|NCT03490734|582075305|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
161190761|NCT03490734|582075306|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
161190762|NCT03490734|582075307|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
161190763|NCT03490734|582075304|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161190764|NCT03490734|582075305|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161190765|NCT03490734|582075306|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
161190766|NCT03490734|582075307|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
161190767|NCT03490734|582075304|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161190768|NCT03490734|582075305|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161190769|NCT03490734|582075306|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
161190770|NCT03490734|582075307|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
161190771|NCT03490734|582075304|FG000|Post-intervention Scan Visit|Adverse Event|2|||
161190772|NCT03490734|582075305|FG001|Post-intervention Scan Visit|Adverse Event|0|||
161190773|NCT03490734|582075306|FG002|Post-intervention Scan Visit|Adverse Event|0|||
161190774|NCT03490734|582075307|FG003|Post-intervention Scan Visit|Adverse Event|0|||
161190775|NCT03490734|582075304|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
161190776|NCT03490734|582075305|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
161190777|NCT03490734|582075306|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
161190778|NCT03490734|582075307|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
161190779|NCT03490734|582075304|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
161190780|NCT03490734|582075305|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
161190781|NCT03490734|582075306|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
161190782|NCT03490734|582075307|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
161190783|NCT00994890|582075308|FG000|Overall Study|Adverse Event|13|||
161190784|NCT00994890|582075309|FG001|Overall Study|Adverse Event|9|||
161190785|NCT00994890|582075310|FG002|Overall Study|Adverse Event|11|||
161190786|NCT00994890|582075308|FG000|Overall Study|Lack of Efficacy|0|||
161190787|NCT00994890|582075309|FG001|Overall Study|Lack of Efficacy|0|||
161190788|NCT00994890|582075310|FG002|Overall Study|Lack of Efficacy|1|||
161190789|NCT00994890|582075308|FG000|Overall Study|Lost to Follow-up|6|||
161190790|NCT00994890|582075309|FG001|Overall Study|Lost to Follow-up|1|||
161190791|NCT00994890|582075310|FG002|Overall Study|Lost to Follow-up|3|||
161190792|NCT00994890|582075308|FG000|Overall Study|No longer willing to participate|8|||
161190793|NCT00994890|582075309|FG001|Overall Study|No longer willing to participate|5|||
161190794|NCT00994890|582075310|FG002|Overall Study|No longer willing to participate|13|||
161190795|NCT00994890|582075308|FG000|Overall Study|Protocol Violation|2|||
161190796|NCT00994890|582075309|FG001|Overall Study|Protocol Violation|4|||
161190797|NCT00994890|582075310|FG002|Overall Study|Protocol Violation|0|||
161190798|NCT00994890|582075308|FG000|Overall Study|Study terminated by sponsor|199|||
161190799|NCT00994890|582075309|FG001|Overall Study|Study terminated by sponsor|201|||
161190800|NCT00994890|582075310|FG002|Overall Study|Study terminated by sponsor|197|||
161190801|NCT00994890|582075308|FG000|Overall Study|Randomized, but not treated|1|||
161190802|NCT00994890|582075309|FG001|Overall Study|Randomized, but not treated|0|||
161190803|NCT00994890|582075310|FG002|Overall Study|Randomized, but not treated|0|||
161190804|NCT00994890|582075308|FG000|Overall Study|Other|2|||
161190805|NCT00994890|582075309|FG001|Overall Study|Other|2|||
161190806|NCT00994890|582075310|FG002|Overall Study|Other|1|||
161190807|NCT00699582|582075312|FG000|Overall Study|Adverse Event|4|||
161190808|NCT00699582|582075313|FG001|Overall Study|Adverse Event|11|||
161190809|NCT00699582|582075314|FG002|Overall Study|Adverse Event|23|||
161190810|NCT00699582|582075312|FG000|Overall Study|Withdrawal by Subject|6|||
161190811|NCT00699582|582075313|FG001|Overall Study|Withdrawal by Subject|7|||
161190812|NCT00699582|582075314|FG002|Overall Study|Withdrawal by Subject|4|||
161190813|NCT00699582|582075312|FG000|Overall Study|Lack of Efficacy|1|||
161190814|NCT00699582|582075313|FG001|Overall Study|Lack of Efficacy|0|||
161190815|NCT00699582|582075314|FG002|Overall Study|Lack of Efficacy|1|||
161190816|NCT00699582|582075312|FG000|Overall Study|Progressive Disease|1|||
161190817|NCT00699582|582075313|FG001|Overall Study|Progressive Disease|0|||
161190818|NCT00699582|582075314|FG002|Overall Study|Progressive Disease|0|||
161190819|NCT00699582|582075312|FG000|Overall Study|Administrative/Other|4|||
161190820|NCT00699582|582075313|FG001|Overall Study|Administrative/Other|3|||
161190821|NCT00699582|582075314|FG002|Overall Study|Administrative/Other|0|||
161190822|NCT00699582|582075312|FG000|Overall Study|Randomized, Not Treated|2|||
161190823|NCT00699582|582075313|FG001|Overall Study|Randomized, Not Treated|1|||
161190824|NCT00699582|582075314|FG002|Overall Study|Randomized, Not Treated|0|||
161190825|NCT01849289|582075315|FG000|Overall Study|Adverse Event|3|||
161190826|NCT01849289|582075316|FG001|Overall Study|Adverse Event|3|||
161190827|NCT01849289|582075315|FG000|Overall Study|Protocol Violation|3|||
161190828|NCT01849289|582075316|FG001|Overall Study|Protocol Violation|3|||
161190829|NCT01849289|582075315|FG000|Overall Study|Withdrawal criteria|1|||
161190830|NCT01849289|582075316|FG001|Overall Study|Withdrawal criteria|0|||
161306214|NCT00614120|582500803|FG001|Overall Study|Lost to Follow-up|2|||
161190831|NCT01849289|582075315|FG000|Overall Study|Unclassified|25|||
161190832|NCT01849289|582075316|FG001|Overall Study|Unclassified|18|||
161190833|NCT01142791|582075338|FG000|Overall Study|Alternative Treatment|1|||
161190834|NCT01142791|582075339|FG001|Overall Study|Alternative Treatment|0|||
161190835|NCT01142791|582075338|FG000|Overall Study|Lost to Follow-up|1|||
161190836|NCT01142791|582075339|FG001|Overall Study|Lost to Follow-up|0|||
161190837|NCT01142791|582075338|FG000|Overall Study|Withdrawal by Subject|5|||
161190838|NCT01142791|582075339|FG001|Overall Study|Withdrawal by Subject|0|||
161190839|NCT01142791|582075338|FG000|Overall Study|Received only 1 sonication|0|||
161190840|NCT01142791|582075339|FG001|Overall Study|Received only 1 sonication|6|||
161190841|NCT02975206|582075340|FG000|Overall Study|Withdrawal by Subject|14|||
161190842|NCT02975206|582075341|FG001|Overall Study|Withdrawal by Subject|11|||
161190843|NCT02975206|582075342|FG002|Overall Study|Withdrawal by Subject|11|||
161349274|NCT05218499|582663693|FG000|Overall Study|Objective disease progression|44|||
161349275|NCT05218499|582663694|FG001|Overall Study|Objective disease progression|61|||
161349276|NCT05218499|582663695|FG002|Overall Study|Objective disease progression|42|||
161349277|NCT05218499|582663693|FG000|Overall Study|Adverse Event|11|||
161349278|NCT05218499|582663694|FG001|Overall Study|Adverse Event|36|||
161190844|NCT02975206|582075340|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
161190845|NCT02975206|582075341|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
161190846|NCT02975206|582075342|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
161190847|NCT01981096|582075344|FG000|Overall Study|Parent illness|1|||
161190848|NCT01981096|582075345|FG001|Overall Study|Parent illness|0|||
161190849|NCT01981096|582075344|FG000|Overall Study|Withdrawal by Subject|0|||
161349279|NCT05218499|582663695|FG002|Overall Study|Adverse Event|9|||
161349280|NCT05218499|582663693|FG000|Overall Study|On treatment at time of snapshot|18|||
161349281|NCT05218499|582663694|FG001|Overall Study|On treatment at time of snapshot|29|||
161349282|NCT05218499|582663695|FG002|Overall Study|On treatment at time of snapshot|0|||
161349283|NCT05386680|582663696|FG000|Overall Study|Guardian decision|2|||
161349284|NCT03946670|582663697|FG000|Overall Study|Progressive Disease|34|||
161190850|NCT01981096|582075345|FG001|Overall Study|Withdrawal by Subject|1|||
161190851|NCT01981096|582075344|FG000|Overall Study|Lost to Follow-up|2|||
161190852|NCT01981096|582075345|FG001|Overall Study|Lost to Follow-up|0|||
161190853|NCT04129242|582075347|FG000|Overall Study|Physician Decision|1|||
161190854|NCT04129242|582075348|FG001|Overall Study|Physician Decision|1|||
161190855|NCT04129242|582075347|FG000|Overall Study|Protocol Violation|0|||
161190856|NCT04129242|582075348|FG001|Overall Study|Protocol Violation|1|||
161190857|NCT01899729|582075351|FG000|Overall Study|Adverse Event|1|||
161190858|NCT01899729|582075352|FG001|Overall Study|Adverse Event|0|||
161190859|NCT01899729|582075353|FG002|Overall Study|Adverse Event|0|||
161190860|NCT01899729|582075354|FG003|Overall Study|Adverse Event|0|||
161190861|NCT01899729|582075355|FG004|Overall Study|Adverse Event|1|||
161190862|NCT01899729|582075351|FG000|Overall Study|Withdrawal by Subject|1|||
161190863|NCT01899729|582075352|FG001|Overall Study|Withdrawal by Subject|2|||
161190864|NCT01899729|582075353|FG002|Overall Study|Withdrawal by Subject|0|||
161190865|NCT01899729|582075354|FG003|Overall Study|Withdrawal by Subject|0|||
161190866|NCT01899729|582075355|FG004|Overall Study|Withdrawal by Subject|0|||
161190867|NCT01899729|582075351|FG000|Overall Study|Lack of Efficacy|0|||
161190868|NCT01899729|582075352|FG001|Overall Study|Lack of Efficacy|0|||
161190869|NCT01899729|582075353|FG002|Overall Study|Lack of Efficacy|2|||
161190870|NCT01899729|582075354|FG003|Overall Study|Lack of Efficacy|0|||
161190871|NCT01899729|582075355|FG004|Overall Study|Lack of Efficacy|1|||
161190872|NCT01454531|582075356|FG000|Overall Study|Adverse Event|14|||
161190873|NCT01454531|582075356|FG000|Overall Study|Withdrawal by Subject|5|||
161190874|NCT01454531|582075356|FG000|Overall Study|Lost to Follow-up|1|||
161190875|NCT01454531|582075356|FG000|Overall Study|Physician Decision|1|||
161190876|NCT01454531|582075356|FG000|Overall Study|Delay in IMP administration|1|||
161190877|NCT01454531|582075356|FG000|Overall Study|Other|1|||
161190878|NCT00554840|582075357|FG000|Overall Study|Physician Decision|0|||
161190879|NCT00554840|582075358|FG001|Overall Study|Physician Decision|1|||
161190880|NCT02927990|582077542|FG000|Overall Study|Protocol Violation|4|||
161190881|NCT02927990|582077542|FG000|Overall Study|Physician Decision|9|||
161190882|NCT02927990|582077542|FG000|Overall Study|Room switched and therefore no study device available|15|||
161190883|NCT02927990|582077542|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
161190884|NCT02242305|582077548|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
161190885|NCT02242305|582077549|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
161190886|NCT02242305|582077548|FG000|Overall Study|Adverse Event|1|||
161190887|NCT02242305|582077549|FG001|Overall Study|Adverse Event|0|||
161190888|NCT02242305|582077548|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
161190889|NCT02242305|582077549|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
161190890|NCT02242305|582077548|FG000|Overall Study|Subject withdraws inform consent|0|||
161190891|NCT02242305|582077549|FG001|Overall Study|Subject withdraws inform consent|4|||
161190892|NCT02242305|582077548|FG000|Overall Study|Lost to Follow-up|2|||
161190893|NCT02242305|582077549|FG001|Overall Study|Lost to Follow-up|0|||
161190894|NCT02543801|582077553|FG000|Overall Study|Protocol Violation|1|||
161190895|NCT02543801|582077554|FG001|Overall Study|Protocol Violation|2|||
161190896|NCT02543801|582077555|FG002|Overall Study|Protocol Violation|0|||
161190897|NCT02543801|582077556|FG003|Overall Study|Protocol Violation|0|||
161190898|NCT01756846|582077557|FG000|Overall Study|Lost to Follow-up|5|||
161190899|NCT01756846|582077558|FG001|Overall Study|Lost to Follow-up|10|||
161190900|NCT01756846|582077557|FG000|Overall Study|Withdrawal by Subject|1|||
161190901|NCT01756846|582077558|FG001|Overall Study|Withdrawal by Subject|2|||
161190902|NCT00082628|582077568|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161190903|NCT00082628|582077569|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
161190904|NCT00082628|582077570|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161190905|NCT00082628|582077571|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161190906|NCT00082628|582077572|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
161190907|NCT00082628|582077568|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
161190908|NCT00082628|582077569|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
161190909|NCT00082628|582077570|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161190910|NCT00082628|582077571|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161190911|NCT00082628|582077572|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
161190912|NCT00082628|582077568|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
161190913|NCT00082628|582077569|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
161190914|NCT00082628|582077570|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161190915|NCT00082628|582077571|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161190916|NCT00082628|582077572|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
161190917|NCT00082628|582077568|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
161190918|NCT00082628|582077569|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
161190919|NCT00082628|582077570|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161190920|NCT00082628|582077571|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161190921|NCT00082628|582077572|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
161190922|NCT00082628|582077568|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161190923|NCT00082628|582077569|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161190924|NCT00082628|582077570|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161190925|NCT00082628|582077571|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
161190926|NCT00082628|582077572|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
161190927|NCT00082628|582077568|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161190928|NCT00082628|582077569|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161190929|NCT00082628|582077570|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161190930|NCT00082628|582077571|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
161190931|NCT00082628|582077572|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
161190932|NCT00082628|582077568|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
161190933|NCT00082628|582077569|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
161190934|NCT00082628|582077570|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
161190935|NCT00082628|582077571|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
161190936|NCT00082628|582077572|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
161190937|NCT03481634|582077577|FG000|Overall Study|Withdrawal by Subject|16|||
161190938|NCT03481634|582077578|FG001|Overall Study|Withdrawal by Subject|19|||
161190939|NCT03481634|582077579|FG002|Overall Study|Withdrawal by Subject|14|||
161306215|NCT00614120|582500804|FG002|Overall Study|Lost to Follow-up|3|||
161306216|NCT00614120|582500805|FG003|Overall Study|Lost to Follow-up|4|||
161306217|NCT01084668|582500806|FG000|Overall Study|Lack of Efficacy|5|||
161306218|NCT01084668|582500806|FG000|Overall Study|Withdrawal by Subject|2|||
161306219|NCT01084668|582500806|FG000|Overall Study|Pregnancy|1|||
161306220|NCT01084668|582500806|FG000|Overall Study|Non-compliance|1|||
161306221|NCT02447497|582500807|FG000|Overall Study|Did not meet treatment day baseline.|6|||
161306222|NCT02447497|582500808|FG001|Overall Study|Did not meet treatment day baseline.|5|||
161306223|NCT02447497|582500809|FG002|Overall Study|Did not meet treatment day baseline.|2|||
161090177|NCT02842827|581719894|FG000|Overall Study|Participant Withdrawal of Consent|1|||
161090178|NCT02842827|581719895|FG001|Overall Study|Participant Withdrawal of Consent|2|||
161090179|NCT02842827|581719896|FG002|Overall Study|Participant Withdrawal of Consent|2|||
161090180|NCT02842827|581719897|FG003|Overall Study|Participant Withdrawal of Consent|2|||
161090181|NCT02842827|581719898|FG004|Overall Study|Participant Withdrawal of Consent|2|||
161090182|NCT02842827|581719899|FG005|Overall Study|Participant Withdrawal of Consent|1|||
161090183|NCT02842827|581719900|FG006|Overall Study|Participant Withdrawal of Consent|2|||
161090184|NCT02842827|581719901|FG007|Overall Study|Participant Withdrawal of Consent|1|||
161090185|NCT01815138|581719902|FG000|Overall Study|Withdrawal by Subject|0|||
161090186|NCT01815138|581719903|FG001|Overall Study|Withdrawal by Subject|1|||
161090187|NCT01815138|581719902|FG000|Overall Study|Physician Decision|8|||
161090188|NCT01815138|581719903|FG001|Overall Study|Physician Decision|5|||
161090189|NCT00825825|581719904|FG000|First Medication Period (14 Days)|Adverse Event|1|||
161090190|NCT00825825|581719905|FG001|First Medication Period (14 Days)|Adverse Event|0|||
161090191|NCT00825825|581719906|FG002|First Medication Period (14 Days)|Adverse Event|0|||
161090192|NCT00825825|581719907|FG003|First Medication Period (14 Days)|Adverse Event|0|||
161090193|NCT00825825|581719908|FG004|First Medication Period (14 Days)|Adverse Event|0|||
161090194|NCT00825825|581719909|FG005|First Medication Period (14 Days)|Adverse Event|1|||
161090195|NCT00825825|581719904|FG000|First Medication Period (14 Days)|Physician Decision|2|||
161090196|NCT00825825|581719905|FG001|First Medication Period (14 Days)|Physician Decision|0|||
161090197|NCT00825825|581719906|FG002|First Medication Period (14 Days)|Physician Decision|1|||
161090198|NCT00825825|581719907|FG003|First Medication Period (14 Days)|Physician Decision|0|||
161090199|NCT00825825|581719908|FG004|First Medication Period (14 Days)|Physician Decision|0|||
161190940|NCT03481634|582077577|FG000|Overall Study|Protocol Violation|1|||
161190941|NCT03481634|582077578|FG001|Overall Study|Protocol Violation|0|||
161190942|NCT03481634|582077579|FG002|Overall Study|Protocol Violation|1|||
161190943|NCT03481634|582077577|FG000|Overall Study|Progressive disease|0|||
161190944|NCT03481634|582077578|FG001|Overall Study|Progressive disease|1|||
161190945|NCT03481634|582077579|FG002|Overall Study|Progressive disease|0|||
161190946|NCT03481634|582077577|FG000|Overall Study|Physician Decision|3|||
161190947|NCT03481634|582077578|FG001|Overall Study|Physician Decision|0|||
161190948|NCT03481634|582077579|FG002|Overall Study|Physician Decision|1|||
161190949|NCT03481634|582077577|FG000|Overall Study|Lost to Follow-up|3|||
161190950|NCT03481634|582077578|FG001|Overall Study|Lost to Follow-up|4|||
161190951|NCT03481634|582077579|FG002|Overall Study|Lost to Follow-up|4|||
161190952|NCT03481634|582077577|FG000|Overall Study|Death|4|||
161190953|NCT03481634|582077578|FG001|Overall Study|Death|8|||
161190954|NCT03481634|582077579|FG002|Overall Study|Death|7|||
161190955|NCT03481634|582077577|FG000|Overall Study|Adverse Event|6|||
161190956|NCT03481634|582077578|FG001|Overall Study|Adverse Event|3|||
161190957|NCT03481634|582077579|FG002|Overall Study|Adverse Event|7|||
161190958|NCT04118127|582077586|FG000|Overall Study|Trial terminated by sponsor|0|||
161190959|NCT04118127|582077587|FG001|Overall Study|Trial terminated by sponsor|12|||
161190960|NCT04118127|582077586|FG000|Overall Study|Adverse Event|1|||
161190961|NCT04118127|582077587|FG001|Overall Study|Adverse Event|2|||
161190962|NCT04118127|582077586|FG000|Overall Study|Physician Decision|0|||
161190963|NCT04118127|582077587|FG001|Overall Study|Physician Decision|1|||
161190964|NCT04118127|582077586|FG000|Overall Study|Withdrawal by Subject|2|||
161190965|NCT04118127|582077587|FG001|Overall Study|Withdrawal by Subject|1|||
161190966|NCT04491591|582077588|FG000|Overall Study|Accidently randomized|3|||
161190967|NCT04491591|582077589|FG001|Overall Study|Accidently randomized|1|||
161190968|NCT04491591|582077590|FG002|Overall Study|Accidently randomized|0|||
161190969|NCT04491591|582077588|FG000|Overall Study|Did not complete survey|28|||
161190970|NCT04491591|582077589|FG001|Overall Study|Did not complete survey|20|||
161190971|NCT04491591|582077590|FG002|Overall Study|Did not complete survey|3|||
161190972|NCT04212221|582077593|FG000|Overall Study|Remained on Treatment|0|||
161190973|NCT04212221|582077594|FG001|Overall Study|Remained on Treatment|0|||
161190974|NCT04212221|582077595|FG002|Overall Study|Remained on Treatment|0|||
161190975|NCT04212221|582077596|FG003|Overall Study|Remained on Treatment|1|||
161190976|NCT04212221|582077597|FG004|Overall Study|Remained on Treatment|0|||
161190977|NCT04212221|582077598|FG005|Overall Study|Remained on Treatment|0|||
161190978|NCT04212221|582077599|FG006|Overall Study|Remained on Treatment|3|||
161190979|NCT04212221|582077600|FG007|Overall Study|Remained on Treatment|9|||
161190980|NCT04212221|582077593|FG000|Overall Study|Adverse Event|0|||
161190981|NCT04212221|582077594|FG001|Overall Study|Adverse Event|0|||
161190982|NCT04212221|582077595|FG002|Overall Study|Adverse Event|0|||
161190983|NCT04212221|582077596|FG003|Overall Study|Adverse Event|0|||
161190984|NCT04212221|582077597|FG004|Overall Study|Adverse Event|0|||
161190985|NCT04212221|582077598|FG005|Overall Study|Adverse Event|0|||
161190986|NCT04212221|582077599|FG006|Overall Study|Adverse Event|2|||
161190987|NCT04212221|582077600|FG007|Overall Study|Adverse Event|3|||
161190988|NCT04212221|582077593|FG000|Overall Study|Death|0|||
161190989|NCT04212221|582077594|FG001|Overall Study|Death|0|||
161190990|NCT04212221|582077595|FG002|Overall Study|Death|0|||
161190991|NCT04212221|582077596|FG003|Overall Study|Death|0|||
161190992|NCT04212221|582077597|FG004|Overall Study|Death|0|||
161190993|NCT04212221|582077598|FG005|Overall Study|Death|0|||
161190994|NCT04212221|582077599|FG006|Overall Study|Death|0|||
161190995|NCT04212221|582077600|FG007|Overall Study|Death|2|||
161190996|NCT04212221|582077593|FG000|Overall Study|Disease progression according to irRECIST|1|||
161190997|NCT04212221|582077594|FG001|Overall Study|Disease progression according to irRECIST|2|||
161190998|NCT04212221|582077595|FG002|Overall Study|Disease progression according to irRECIST|3|||
161190999|NCT04212221|582077596|FG003|Overall Study|Disease progression according to irRECIST|3|||
161191000|NCT04212221|582077597|FG004|Overall Study|Disease progression according to irRECIST|2|||
161191001|NCT04212221|582077598|FG005|Overall Study|Disease progression according to irRECIST|2|||
161191002|NCT04212221|582077599|FG006|Overall Study|Disease progression according to irRECIST|21|||
161191003|NCT04212221|582077600|FG007|Overall Study|Disease progression according to irRECIST|17|||
161306224|NCT02447497|582500810|FG003|Overall Study|Did not meet treatment day baseline.|2|||
161306225|NCT02447497|582500807|FG000|Overall Study|Dressing was compromised|0|||
161191004|NCT04212221|582077593|FG000|Overall Study|Global Deterioration of Health Status|0|||
161191005|NCT04212221|582077594|FG001|Overall Study|Global Deterioration of Health Status|0|||
161191006|NCT04212221|582077595|FG002|Overall Study|Global Deterioration of Health Status|0|||
161191007|NCT04212221|582077596|FG003|Overall Study|Global Deterioration of Health Status|0|||
161191008|NCT04212221|582077597|FG004|Overall Study|Global Deterioration of Health Status|0|||
161191009|NCT04212221|582077598|FG005|Overall Study|Global Deterioration of Health Status|0|||
161191010|NCT04212221|582077599|FG006|Overall Study|Global Deterioration of Health Status|0|||
161191011|NCT04212221|582077600|FG007|Overall Study|Global Deterioration of Health Status|2|||
161191012|NCT04212221|582077593|FG000|Overall Study|Investigator's Decision|0|||
161191013|NCT04212221|582077594|FG001|Overall Study|Investigator's Decision|0|||
161349285|NCT03946670|582663698|FG001|Overall Study|Progressive Disease|27|||
161349286|NCT03946670|582663697|FG000|Overall Study|Adverse Event|7|||
161349287|NCT03946670|582663698|FG001|Overall Study|Adverse Event|10|||
161191014|NCT04212221|582077595|FG002|Overall Study|Investigator's Decision|0|||
161191015|NCT04212221|582077596|FG003|Overall Study|Investigator's Decision|1|||
161191016|NCT04212221|582077597|FG004|Overall Study|Investigator's Decision|0|||
161191017|NCT04212221|582077598|FG005|Overall Study|Investigator's Decision|0|||
161191018|NCT04212221|582077599|FG006|Overall Study|Investigator's Decision|3|||
161349288|NCT03946670|582663697|FG000|Overall Study|Physician Decision|6|||
161349289|NCT03946670|582663698|FG001|Overall Study|Physician Decision|5|||
161349290|NCT03946670|582663697|FG000|Overall Study|Death|5|||
161349291|NCT03946670|582663698|FG001|Overall Study|Death|8|||
161349292|NCT03946670|582663697|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
161349293|NCT03946670|582663698|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
161349294|NCT03946670|582663697|FG000|Overall Study|Subject Decision|4|||
161349295|NCT03946670|582663698|FG001|Overall Study|Subject Decision|5|||
161349296|NCT03946670|582663697|FG000|Overall Study|Study Terminated By Sponsor|2|||
161349297|NCT03946670|582663698|FG001|Overall Study|Study Terminated By Sponsor|0|||
161349298|NCT03946670|582663697|FG000|Overall Study|New Therapy For Study Indication|1|||
161349299|NCT03946670|582663698|FG001|Overall Study|New Therapy For Study Indication|0|||
161349300|NCT03946670|582663697|FG000|Overall Study|Not Treated|1|||
161349301|NCT03946670|582663698|FG001|Overall Study|Not Treated|1|||
161191019|NCT04212221|582077600|FG007|Overall Study|Investigator's Decision|0|||
161191020|NCT04212221|582077593|FG000|Overall Study|Participant refused to continue treatment|0|||
161191021|NCT04212221|582077594|FG001|Overall Study|Participant refused to continue treatment|1|||
161191022|NCT04212221|582077595|FG002|Overall Study|Participant refused to continue treatment|0|||
161191023|NCT04212221|582077596|FG003|Overall Study|Participant refused to continue treatment|1|||
161191024|NCT04212221|582077597|FG004|Overall Study|Participant refused to continue treatment|1|||
161191025|NCT04212221|582077598|FG005|Overall Study|Participant refused to continue treatment|2|||
161191026|NCT04212221|582077599|FG006|Overall Study|Participant refused to continue treatment|4|||
161191027|NCT04212221|582077600|FG007|Overall Study|Participant refused to continue treatment|2|||
161191028|NCT04212221|582077593|FG000|Overall Study|Protocol Violation|0|||
161191029|NCT04212221|582077594|FG001|Overall Study|Protocol Violation|0|||
161191030|NCT04212221|582077595|FG002|Overall Study|Protocol Violation|0|||
161191031|NCT04212221|582077596|FG003|Overall Study|Protocol Violation|0|||
161191032|NCT04212221|582077597|FG004|Overall Study|Protocol Violation|0|||
161191033|NCT04212221|582077598|FG005|Overall Study|Protocol Violation|0|||
161191034|NCT04212221|582077599|FG006|Overall Study|Protocol Violation|0|||
161191035|NCT04212221|582077600|FG007|Overall Study|Protocol Violation|1|||
161191036|NCT02692560|582077605|FG000|Overall Study|Withdrawal by Subject|0|||
161191037|NCT02692560|582077606|FG001|Overall Study|Withdrawal by Subject|6|||
161191038|NCT00715949|582077609|FG000|Overall Study|could not finish first test|4|||
161191039|NCT01326910|582077610|FG000|Overall Study|Withdrawal by Subject|3|||
161191040|NCT01326910|582077611|FG001|Overall Study|Withdrawal by Subject|2|||
161191041|NCT01326910|582077610|FG000|Overall Study|Protocol Violation|1|||
161191042|NCT01326910|582077611|FG001|Overall Study|Protocol Violation|1|||
161191043|NCT02274766|582077614|FG000|Overall Study|Withdrawal by Subject|3|||
161191044|NCT02274766|582077615|FG001|Overall Study|Withdrawal by Subject|6|||
161191045|NCT02274766|582077614|FG000|Overall Study|Did Not Receive Study Drug|1|||
161191046|NCT02274766|582077615|FG001|Overall Study|Did Not Receive Study Drug|1|||
161191047|NCT02274766|582077614|FG000|Overall Study|Subject Unwilling to Proceed|0|||
161191048|NCT02274766|582077615|FG001|Overall Study|Subject Unwilling to Proceed|1|||
161191049|NCT02274766|582077614|FG000|Overall Study|Adverse Event|0|||
161191050|NCT02274766|582077615|FG001|Overall Study|Adverse Event|1|||
161191051|NCT01681836|582077620|FG000|Second Intervention|Withdrawal by Subject|0|||
161191052|NCT01681836|582077621|FG001|Second Intervention|Withdrawal by Subject|1|||
161191053|NCT02394028|582077622|FG000|Induction Phase|Adverse Event|2|||
161191054|NCT02394028|582077623|FG001|Induction Phase|Adverse Event|4|||
161191055|NCT02394028|582077624|FG002|Induction Phase|Adverse Event|1|||
161191056|NCT02394028|582077625|FG003|Induction Phase|Adverse Event|2|||
161191057|NCT02394028|582077626|FG004|Induction Phase|Adverse Event|5|||
161191058|NCT02394028|582077627|FG005|Induction Phase|Adverse Event|2|||
161191059|NCT02394028|582077628|FG006|Induction Phase|Adverse Event|0|||
161191060|NCT02394028|582077629|FG007|Induction Phase|Adverse Event|0|||
161191061|NCT02394028|582077630|FG008|Induction Phase|Adverse Event|0|||
161191062|NCT02394028|582077631|FG009|Induction Phase|Adverse Event|0|||
161191063|NCT02394028|582077632|FG010|Induction Phase|Adverse Event|0|||
161191064|NCT02394028|582077622|FG000|Induction Phase|Lack of Efficacy|3|||
161191065|NCT02394028|582077623|FG001|Induction Phase|Lack of Efficacy|6|||
161191066|NCT02394028|582077624|FG002|Induction Phase|Lack of Efficacy|2|||
161349302|NCT06433908|582663699|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
161349303|NCT06433908|582663700|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161191067|NCT02394028|582077625|FG003|Induction Phase|Lack of Efficacy|17|||
161191068|NCT02394028|582077626|FG004|Induction Phase|Lack of Efficacy|14|||
161191069|NCT02394028|582077627|FG005|Induction Phase|Lack of Efficacy|8|||
161349304|NCT06433908|582663701|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161349305|NCT06433908|582663702|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
161349306|NCT06433908|582663699|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161349307|NCT06433908|582663700|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
161349308|NCT06433908|582663701|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161349309|NCT06433908|582663702|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
161349310|NCT06433908|582663699|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161349311|NCT06433908|582663700|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161349312|NCT06433908|582663701|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
161349313|NCT06433908|582663702|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
161349314|NCT04403880|582663703|FG000|Overall Study|Death|1|||
161349315|NCT04403880|582663704|FG001|Overall Study|Death|0|||
161349316|NCT04403880|582663705|FG002|Overall Study|Death|2|||
161349317|NCT04403880|582663706|FG003|Overall Study|Death|0|||
161349318|NCT04403880|582663707|FG004|Overall Study|Death|0|||
161349319|NCT04403880|582663708|FG005|Overall Study|Death|0|||
161191070|NCT02394028|582077628|FG006|Induction Phase|Lack of Efficacy|17|||
161191071|NCT02394028|582077629|FG007|Induction Phase|Lack of Efficacy|23|||
161349320|NCT04403880|582663709|FG006|Overall Study|Death|0|||
161349321|NCT04403880|582663703|FG000|Overall Study|Physician Decision|0|||
161349322|NCT04403880|582663704|FG001|Overall Study|Physician Decision|0|||
161191072|NCT02394028|582077630|FG008|Induction Phase|Lack of Efficacy|0|||
161191073|NCT02394028|582077631|FG009|Induction Phase|Lack of Efficacy|0|||
161191074|NCT02394028|582077632|FG010|Induction Phase|Lack of Efficacy|0|||
161191075|NCT02394028|582077622|FG000|Induction Phase|Lost to Follow-up|1|||
161349323|NCT04403880|582663705|FG002|Overall Study|Physician Decision|0|||
161349324|NCT04403880|582663706|FG003|Overall Study|Physician Decision|0|||
161349325|NCT04403880|582663707|FG004|Overall Study|Physician Decision|1|||
161349326|NCT04403880|582663708|FG005|Overall Study|Physician Decision|0|||
161349327|NCT04403880|582663709|FG006|Overall Study|Physician Decision|0|||
161349328|NCT04403880|582663703|FG000|Overall Study|Lost to Follow-up|4|||
161349329|NCT04403880|582663704|FG001|Overall Study|Lost to Follow-up|3|||
161349330|NCT04403880|582663705|FG002|Overall Study|Lost to Follow-up|8|||
161191076|NCT02394028|582077623|FG001|Induction Phase|Lost to Follow-up|0|||
161191077|NCT02394028|582077624|FG002|Induction Phase|Lost to Follow-up|0|||
161191078|NCT02394028|582077625|FG003|Induction Phase|Lost to Follow-up|1|||
161191079|NCT02394028|582077626|FG004|Induction Phase|Lost to Follow-up|0|||
161191080|NCT02394028|582077627|FG005|Induction Phase|Lost to Follow-up|0|||
161191081|NCT02394028|582077628|FG006|Induction Phase|Lost to Follow-up|1|||
161191082|NCT02394028|582077629|FG007|Induction Phase|Lost to Follow-up|0|||
161191083|NCT02394028|582077630|FG008|Induction Phase|Lost to Follow-up|0|||
161191084|NCT02394028|582077631|FG009|Induction Phase|Lost to Follow-up|0|||
161191085|NCT02394028|582077632|FG010|Induction Phase|Lost to Follow-up|0|||
161191086|NCT02394028|582077622|FG000|Induction Phase|Non-compliance|0|||
161191087|NCT02394028|582077623|FG001|Induction Phase|Non-compliance|1|||
161191088|NCT02394028|582077624|FG002|Induction Phase|Non-compliance|3|||
161191089|NCT02394028|582077625|FG003|Induction Phase|Non-compliance|1|||
161191090|NCT02394028|582077626|FG004|Induction Phase|Non-compliance|3|||
161191091|NCT02394028|582077627|FG005|Induction Phase|Non-compliance|0|||
161191092|NCT02394028|582077628|FG006|Induction Phase|Non-compliance|1|||
161191093|NCT02394028|582077629|FG007|Induction Phase|Non-compliance|1|||
161191094|NCT02394028|582077630|FG008|Induction Phase|Non-compliance|0|||
161191095|NCT02394028|582077631|FG009|Induction Phase|Non-compliance|0|||
161191096|NCT02394028|582077632|FG010|Induction Phase|Non-compliance|0|||
161191097|NCT02394028|582077622|FG000|Induction Phase|Physician Decision|0|||
161191098|NCT02394028|582077623|FG001|Induction Phase|Physician Decision|0|||
161191099|NCT02394028|582077624|FG002|Induction Phase|Physician Decision|1|||
161191100|NCT02394028|582077625|FG003|Induction Phase|Physician Decision|4|||
161191101|NCT02394028|582077626|FG004|Induction Phase|Physician Decision|0|||
161191102|NCT02394028|582077627|FG005|Induction Phase|Physician Decision|2|||
161191103|NCT02394028|582077628|FG006|Induction Phase|Physician Decision|1|||
161191104|NCT02394028|582077629|FG007|Induction Phase|Physician Decision|0|||
161191105|NCT02394028|582077630|FG008|Induction Phase|Physician Decision|0|||
161191106|NCT02394028|582077631|FG009|Induction Phase|Physician Decision|0|||
161191107|NCT02394028|582077632|FG010|Induction Phase|Physician Decision|0|||
161191108|NCT02394028|582077622|FG000|Induction Phase|Protocol Violation|0|||
161349331|NCT04403880|582663706|FG003|Overall Study|Lost to Follow-up|7|||
161349332|NCT04403880|582663707|FG004|Overall Study|Lost to Follow-up|8|||
161349333|NCT04403880|582663708|FG005|Overall Study|Lost to Follow-up|1|||
161349334|NCT04403880|582663709|FG006|Overall Study|Lost to Follow-up|8|||
161349335|NCT04403880|582663703|FG000|Overall Study|Withdrawal by Subject|8|||
161349336|NCT04403880|582663704|FG001|Overall Study|Withdrawal by Subject|9|||
161191109|NCT02394028|582077623|FG001|Induction Phase|Protocol Violation|2|||
161191110|NCT02394028|582077624|FG002|Induction Phase|Protocol Violation|0|||
161191111|NCT02394028|582077625|FG003|Induction Phase|Protocol Violation|3|||
161191112|NCT02394028|582077626|FG004|Induction Phase|Protocol Violation|0|||
161191113|NCT02394028|582077627|FG005|Induction Phase|Protocol Violation|1|||
161191114|NCT02394028|582077628|FG006|Induction Phase|Protocol Violation|1|||
161191115|NCT02394028|582077629|FG007|Induction Phase|Protocol Violation|0|||
161191116|NCT02394028|582077630|FG008|Induction Phase|Protocol Violation|0|||
161191117|NCT02394028|582077631|FG009|Induction Phase|Protocol Violation|0|||
161191118|NCT02394028|582077632|FG010|Induction Phase|Protocol Violation|0|||
161191119|NCT02394028|582077622|FG000|Induction Phase|Withdrawal by Subject|1|||
161191120|NCT02394028|582077623|FG001|Induction Phase|Withdrawal by Subject|2|||
161191121|NCT02394028|582077624|FG002|Induction Phase|Withdrawal by Subject|4|||
161191122|NCT02394028|582077625|FG003|Induction Phase|Withdrawal by Subject|6|||
161191123|NCT02394028|582077626|FG004|Induction Phase|Withdrawal by Subject|7|||
161191124|NCT02394028|582077627|FG005|Induction Phase|Withdrawal by Subject|4|||
161191125|NCT02394028|582077628|FG006|Induction Phase|Withdrawal by Subject|3|||
161191126|NCT02394028|582077629|FG007|Induction Phase|Withdrawal by Subject|6|||
161191127|NCT02394028|582077630|FG008|Induction Phase|Withdrawal by Subject|0|||
161191128|NCT02394028|582077631|FG009|Induction Phase|Withdrawal by Subject|0|||
161191129|NCT02394028|582077632|FG010|Induction Phase|Withdrawal by Subject|0|||
161191130|NCT02394028|582077622|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191131|NCT02394028|582077623|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191132|NCT02394028|582077624|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191133|NCT02394028|582077625|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191134|NCT02394028|582077626|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191135|NCT02394028|582077627|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191136|NCT02394028|582077628|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
161191137|NCT02394028|582077629|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191138|NCT02394028|582077630|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191139|NCT02394028|582077631|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191140|NCT02394028|582077632|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
161191141|NCT02394028|582077622|FG000|Induction Phase|Sponsor decision|0|||
161191142|NCT02394028|582077623|FG001|Induction Phase|Sponsor decision|1|||
161191143|NCT02394028|582077624|FG002|Induction Phase|Sponsor decision|2|||
161191144|NCT02394028|582077625|FG003|Induction Phase|Sponsor decision|0|||
161191145|NCT02394028|582077626|FG004|Induction Phase|Sponsor decision|0|||
161191146|NCT02394028|582077627|FG005|Induction Phase|Sponsor decision|0|||
161191147|NCT02394028|582077628|FG006|Induction Phase|Sponsor decision|0|||
161191148|NCT02394028|582077629|FG007|Induction Phase|Sponsor decision|0|||
161191149|NCT02394028|582077630|FG008|Induction Phase|Sponsor decision|0|||
161191150|NCT02394028|582077631|FG009|Induction Phase|Sponsor decision|0|||
161191151|NCT02394028|582077632|FG010|Induction Phase|Sponsor decision|0|||
161191152|NCT02394028|582077622|FG000|Induction Phase|Technical reason|0|||
161191153|NCT02394028|582077623|FG001|Induction Phase|Technical reason|0|||
161191154|NCT02394028|582077624|FG002|Induction Phase|Technical reason|0|||
161191155|NCT02394028|582077625|FG003|Induction Phase|Technical reason|1|||
161191156|NCT02394028|582077626|FG004|Induction Phase|Technical reason|0|||
161191157|NCT02394028|582077627|FG005|Induction Phase|Technical reason|0|||
161191158|NCT02394028|582077628|FG006|Induction Phase|Technical reason|0|||
161191159|NCT02394028|582077629|FG007|Induction Phase|Technical reason|0|||
161191160|NCT02394028|582077630|FG008|Induction Phase|Technical reason|0|||
161191161|NCT02394028|582077631|FG009|Induction Phase|Technical reason|0|||
161191162|NCT02394028|582077632|FG010|Induction Phase|Technical reason|0|||
161191163|NCT02394028|582077622|FG000|Induction Phase|:ack of calculation|0|||
161191164|NCT02394028|582077623|FG001|Induction Phase|:ack of calculation|0|||
161191165|NCT02394028|582077624|FG002|Induction Phase|:ack of calculation|0|||
161191166|NCT02394028|582077625|FG003|Induction Phase|:ack of calculation|0|||
161191167|NCT02394028|582077626|FG004|Induction Phase|:ack of calculation|0|||
161191168|NCT02394028|582077627|FG005|Induction Phase|:ack of calculation|0|||
161191169|NCT02394028|582077628|FG006|Induction Phase|:ack of calculation|0|||
161191170|NCT02394028|582077629|FG007|Induction Phase|:ack of calculation|1|||
161191171|NCT02394028|582077630|FG008|Induction Phase|:ack of calculation|0|||
161191172|NCT02394028|582077631|FG009|Induction Phase|:ack of calculation|0|||
161191173|NCT02394028|582077632|FG010|Induction Phase|:ack of calculation|0|||
161191174|NCT02394028|582077622|FG000|Maintenance Phase|Protocol Violation|0|||
161191175|NCT02394028|582077623|FG001|Maintenance Phase|Protocol Violation|0|||
161191176|NCT02394028|582077624|FG002|Maintenance Phase|Protocol Violation|0|||
161191177|NCT02394028|582077625|FG003|Maintenance Phase|Protocol Violation|0|||
161191178|NCT02394028|582077626|FG004|Maintenance Phase|Protocol Violation|0|||
161191179|NCT02394028|582077627|FG005|Maintenance Phase|Protocol Violation|0|||
161191180|NCT02394028|582077628|FG006|Maintenance Phase|Protocol Violation|0|||
161191181|NCT02394028|582077629|FG007|Maintenance Phase|Protocol Violation|0|||
161191182|NCT02394028|582077630|FG008|Maintenance Phase|Protocol Violation|0|||
161191183|NCT02394028|582077631|FG009|Maintenance Phase|Protocol Violation|0|||
161191184|NCT02394028|582077632|FG010|Maintenance Phase|Protocol Violation|1|||
161191185|NCT02394028|582077622|FG000|Maintenance Phase|Physician Decision|0|||
161191186|NCT02394028|582077623|FG001|Maintenance Phase|Physician Decision|0|||
161191187|NCT02394028|582077624|FG002|Maintenance Phase|Physician Decision|0|||
161191188|NCT02394028|582077625|FG003|Maintenance Phase|Physician Decision|0|||
161191189|NCT02394028|582077626|FG004|Maintenance Phase|Physician Decision|0|||
161191190|NCT02394028|582077627|FG005|Maintenance Phase|Physician Decision|0|||
161191191|NCT02394028|582077628|FG006|Maintenance Phase|Physician Decision|0|||
161191192|NCT02394028|582077629|FG007|Maintenance Phase|Physician Decision|0|||
161191193|NCT02394028|582077630|FG008|Maintenance Phase|Physician Decision|1|||
161191194|NCT02394028|582077631|FG009|Maintenance Phase|Physician Decision|3|||
161191195|NCT02394028|582077632|FG010|Maintenance Phase|Physician Decision|2|||
161191196|NCT02394028|582077622|FG000|Maintenance Phase|Lack of Efficacy|0|||
161191197|NCT02394028|582077623|FG001|Maintenance Phase|Lack of Efficacy|0|||
161191198|NCT02394028|582077624|FG002|Maintenance Phase|Lack of Efficacy|0|||
161191199|NCT02394028|582077625|FG003|Maintenance Phase|Lack of Efficacy|0|||
161191200|NCT02394028|582077626|FG004|Maintenance Phase|Lack of Efficacy|0|||
161191201|NCT02394028|582077627|FG005|Maintenance Phase|Lack of Efficacy|0|||
161191202|NCT02394028|582077628|FG006|Maintenance Phase|Lack of Efficacy|0|||
161191203|NCT02394028|582077629|FG007|Maintenance Phase|Lack of Efficacy|0|||
161191204|NCT02394028|582077630|FG008|Maintenance Phase|Lack of Efficacy|7|||
161191205|NCT02394028|582077631|FG009|Maintenance Phase|Lack of Efficacy|25|||
161191206|NCT02394028|582077632|FG010|Maintenance Phase|Lack of Efficacy|33|||
161191207|NCT02394028|582077622|FG000|Maintenance Phase|Death|0|||
161191208|NCT02394028|582077623|FG001|Maintenance Phase|Death|0|||
161191209|NCT02394028|582077624|FG002|Maintenance Phase|Death|0|||
161191210|NCT02394028|582077625|FG003|Maintenance Phase|Death|0|||
161191211|NCT02394028|582077626|FG004|Maintenance Phase|Death|0|||
161191212|NCT02394028|582077627|FG005|Maintenance Phase|Death|0|||
161191213|NCT02394028|582077628|FG006|Maintenance Phase|Death|0|||
161191214|NCT02394028|582077629|FG007|Maintenance Phase|Death|0|||
161191215|NCT02394028|582077630|FG008|Maintenance Phase|Death|0|||
161191216|NCT02394028|582077631|FG009|Maintenance Phase|Death|0|||
161191217|NCT02394028|582077632|FG010|Maintenance Phase|Death|1|||
161191218|NCT02394028|582077622|FG000|Maintenance Phase|Adverse Event|0|||
161191219|NCT02394028|582077623|FG001|Maintenance Phase|Adverse Event|0|||
161191220|NCT02394028|582077624|FG002|Maintenance Phase|Adverse Event|0|||
161191221|NCT02394028|582077625|FG003|Maintenance Phase|Adverse Event|0|||
161191222|NCT02394028|582077626|FG004|Maintenance Phase|Adverse Event|0|||
161191223|NCT02394028|582077627|FG005|Maintenance Phase|Adverse Event|0|||
161191224|NCT02394028|582077628|FG006|Maintenance Phase|Adverse Event|0|||
161191225|NCT02394028|582077629|FG007|Maintenance Phase|Adverse Event|0|||
161191226|NCT02394028|582077630|FG008|Maintenance Phase|Adverse Event|1|||
161191227|NCT02394028|582077631|FG009|Maintenance Phase|Adverse Event|1|||
161191228|NCT02394028|582077632|FG010|Maintenance Phase|Adverse Event|3|||
161191229|NCT02394028|582077622|FG000|Maintenance Phase|Site closure|0|||
161191230|NCT02394028|582077623|FG001|Maintenance Phase|Site closure|0|||
161191231|NCT02394028|582077624|FG002|Maintenance Phase|Site closure|0|||
161191232|NCT02394028|582077625|FG003|Maintenance Phase|Site closure|0|||
161191233|NCT02394028|582077626|FG004|Maintenance Phase|Site closure|0|||
161191234|NCT02394028|582077627|FG005|Maintenance Phase|Site closure|0|||
161191235|NCT02394028|582077628|FG006|Maintenance Phase|Site closure|0|||
161191236|NCT02394028|582077629|FG007|Maintenance Phase|Site closure|0|||
161191237|NCT02394028|582077630|FG008|Maintenance Phase|Site closure|0|||
161191238|NCT02394028|582077631|FG009|Maintenance Phase|Site closure|1|||
161191239|NCT02394028|582077632|FG010|Maintenance Phase|Site closure|0|||
161191240|NCT02394028|582077622|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161191241|NCT02394028|582077623|FG001|Maintenance Phase|Withdrawal by Subject|0|||
161191242|NCT02394028|582077624|FG002|Maintenance Phase|Withdrawal by Subject|0|||
161191243|NCT02394028|582077625|FG003|Maintenance Phase|Withdrawal by Subject|0|||
161191244|NCT02394028|582077626|FG004|Maintenance Phase|Withdrawal by Subject|0|||
161191245|NCT02394028|582077627|FG005|Maintenance Phase|Withdrawal by Subject|0|||
161191246|NCT02394028|582077628|FG006|Maintenance Phase|Withdrawal by Subject|0|||
161191247|NCT02394028|582077629|FG007|Maintenance Phase|Withdrawal by Subject|0|||
161191248|NCT02394028|582077630|FG008|Maintenance Phase|Withdrawal by Subject|3|||
161191249|NCT02394028|582077631|FG009|Maintenance Phase|Withdrawal by Subject|12|||
161191250|NCT02394028|582077632|FG010|Maintenance Phase|Withdrawal by Subject|12|||
161191251|NCT00866606|582077633|FG000|Overall Study|Lost to Follow-up|3|||
161191252|NCT00866606|582077633|FG000|Overall Study|Adverse Event|1|||
161191253|NCT01058356|582077645|FG000|Overall Study|Adverse Event|5|||
161191254|NCT01058356|582077645|FG000|Overall Study|Administration of contraindicated drugs|12|||
161191255|NCT01058356|582077645|FG000|Overall Study|Withdrawal by Subject|21|||
161191256|NCT01058356|582077645|FG000|Overall Study|Lost to Follow-up|4|||
161191257|NCT02993783|582077646|FG000|Overall Study|Reason not Specified|6|||
161191258|NCT02993783|582077647|FG001|Overall Study|Reason not Specified|9|||
161191259|NCT00606021|582077648|FG000|Induction Phase|Death|73|||
161191260|NCT00606021|582077649|FG001|Induction Phase|Death|0|||
161191261|NCT00606021|582077650|FG002|Induction Phase|Death|0|||
161191262|NCT00606021|582077648|FG000|Induction Phase|Physician Decision|2|||
161191263|NCT00606021|582077649|FG001|Induction Phase|Physician Decision|0|||
161191264|NCT00606021|582077650|FG002|Induction Phase|Physician Decision|0|||
161191265|NCT00606021|582077648|FG000|Induction Phase|Withdrawal by Subject|2|||
161191266|NCT00606021|582077649|FG001|Induction Phase|Withdrawal by Subject|0|||
161191267|NCT00606021|582077650|FG002|Induction Phase|Withdrawal by Subject|0|||
161191268|NCT00606021|582077648|FG000|Induction Phase|Lost to Follow-up|10|||
161191269|NCT00606021|582077649|FG001|Induction Phase|Lost to Follow-up|0|||
161191270|NCT00606021|582077650|FG002|Induction Phase|Lost to Follow-up|0|||
161191271|NCT00606021|582077648|FG000|Maintenance Phase|Death|0|||
161191272|NCT00606021|582077649|FG001|Maintenance Phase|Death|17|||
161191273|NCT00606021|582077650|FG002|Maintenance Phase|Death|15|||
161191274|NCT00606021|582077648|FG000|Maintenance Phase|Physician Decision|0|||
161191275|NCT00606021|582077649|FG001|Maintenance Phase|Physician Decision|1|||
161191276|NCT00606021|582077650|FG002|Maintenance Phase|Physician Decision|0|||
161191277|NCT00606021|582077648|FG000|Maintenance Phase|Lost to Follow-up|0|||
161191278|NCT00606021|582077649|FG001|Maintenance Phase|Lost to Follow-up|5|||
161191279|NCT00606021|582077650|FG002|Maintenance Phase|Lost to Follow-up|2|||
161191280|NCT03480841|582077653|FG000|Overall Study|Lost to Follow-up|2|||
161191281|NCT01362049|582077654|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
161191282|NCT01362049|582077655|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
161191283|NCT01362049|582077656|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
161191284|NCT01362049|582077657|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
161191285|NCT01362049|582077654|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
161191286|NCT01362049|582077655|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
161191287|NCT01362049|582077656|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
161191288|NCT01362049|582077657|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
161191289|NCT00806494|582077661|FG000|Overall Study|Adverse Event|29|||
161191290|NCT00806494|582077661|FG000|Overall Study|Lack of Efficacy|6|||
161191291|NCT00806494|582077661|FG000|Overall Study|Lost to Follow-up|10|||
161191292|NCT00806494|582077661|FG000|Overall Study|Other|30|||
161191293|NCT00806494|582077661|FG000|Overall Study|Withdrawal by Subject|5|||
161191294|NCT02417935|582077664|FG000|Treatment Period|Adverse Event|12|||
161191295|NCT02417935|582077665|FG001|Treatment Period|Adverse Event|10|||
161191296|NCT02417935|582077664|FG000|Treatment Period|Lost to Follow-up|1|||
161191297|NCT02417935|582077665|FG001|Treatment Period|Lost to Follow-up|0|||
161191298|NCT02417935|582077664|FG000|Treatment Period|Entry Criteria not met|0|||
161191299|NCT02417935|582077665|FG001|Treatment Period|Entry Criteria not met|1|||
161191300|NCT02417935|582077664|FG000|Treatment Period|Protocol Violation|2|||
161191301|NCT02417935|582077665|FG001|Treatment Period|Protocol Violation|1|||
161191302|NCT02417935|582077664|FG000|Treatment Period|Withdrawal by Subject|3|||
161191303|NCT02417935|582077665|FG001|Treatment Period|Withdrawal by Subject|3|||
161191304|NCT02417935|582077664|FG000|Treatment Period|Physician Decision|3|||
161191305|NCT02417935|582077665|FG001|Treatment Period|Physician Decision|1|||
161191306|NCT02850276|582077666|FG000|Overall Study|screen failure|43|||
161191307|NCT02850276|582077666|FG000|Overall Study|Withdrawal by Subject|14|||
161191308|NCT02850276|582077666|FG000|Overall Study|Physician Decision|2|||
161191309|NCT02850276|582077666|FG000|Overall Study|Lost to Follow-up|2|||
161191310|NCT04815291|582077667|FG000|Overall Study|Lost to Follow-up|1|||
161191311|NCT04815291|582077667|FG000|Overall Study|Physician Decision|4|||
161191312|NCT04815291|582077667|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
161191313|NCT00989664|582077672|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
161191314|NCT00989664|582077672|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
161191315|NCT00989664|582077672|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
161191316|NCT00989664|582077672|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161191317|NCT00989664|582077672|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
161191318|NCT00989664|582077672|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
161191319|NCT00989664|582077672|FG000|Long-Term Follow-Up|Death|3|||
161191320|NCT00095836|582077673|FG000|Overall Study|Lost to Follow-up|1|||
161191321|NCT00095836|582077673|FG000|Overall Study|Adverse Event|1|||
161191322|NCT00095836|582077673|FG000|Overall Study|Death|2|||
161191323|NCT00962780|582077675|FG000|Overall Study|Death|0|||
161191324|NCT00962780|582077676|FG001|Overall Study|Death|1|||
161191325|NCT00962780|582077675|FG000|Overall Study|Protocol Violation|9|||
161191326|NCT00962780|582077676|FG001|Overall Study|Protocol Violation|4|||
161191327|NCT00962780|582077675|FG000|Overall Study|Withdrawal by Subject|1|||
161191328|NCT00962780|582077676|FG001|Overall Study|Withdrawal by Subject|8|||
161191329|NCT00962780|582077675|FG000|Overall Study|Other|0|||
161191330|NCT00962780|582077676|FG001|Overall Study|Other|1|||
161191331|NCT02646332|582077677|FG000|Overall Study|Lost to Follow-up|0|||
161191332|NCT02646332|582077678|FG001|Overall Study|Lost to Follow-up|3|||
161191333|NCT02363322|582077679|FG000|Overall Study|Lost to Follow-up|1|||
161191334|NCT02363322|582077680|FG001|Overall Study|Lost to Follow-up|0|||
161191335|NCT01775995|582077681|FG000|Overall Study|Lost to Follow-up|1|||
161191336|NCT01775995|582077682|FG001|Overall Study|Lost to Follow-up|1|||
161191337|NCT02909504|582077683|FG000|Overall Study|Adverse Event|2|||
161191338|NCT02909504|582077683|FG000|Overall Study|Lack of Efficacy|3|||
161191339|NCT02909504|582077683|FG000|Overall Study|Withdrawal by Subject|4|||
161191340|NCT02909504|582077683|FG000|Overall Study|Pregnancy|1|||
161191341|NCT02909504|582077683|FG000|Overall Study|Subject moved|1|||
161191342|NCT02909504|582077683|FG000|Overall Study|Lost to Follow-up|1|||
161191343|NCT02055976|582077684|FG000|Overall Study|Other|0|||
161191344|NCT02055976|582077685|FG001|Overall Study|Other|0|||
161191345|NCT02055976|582077686|FG002|Overall Study|Other|1|||
161191346|NCT02055976|582077687|FG003|Overall Study|Other|0|||
161191347|NCT02055976|582077688|FG004|Overall Study|Other|0|||
161191348|NCT02055976|582077689|FG005|Overall Study|Other|0|||
161191349|NCT02055976|582077690|FG006|Overall Study|Other|0|||
161191350|NCT02055976|582077691|FG007|Overall Study|Other|0|||
161349337|NCT04403880|582663705|FG002|Overall Study|Withdrawal by Subject|22|||
161349338|NCT04403880|582663706|FG003|Overall Study|Withdrawal by Subject|16|||
161349339|NCT04403880|582663707|FG004|Overall Study|Withdrawal by Subject|16|||
161349340|NCT04403880|582663708|FG005|Overall Study|Withdrawal by Subject|8|||
161349341|NCT04403880|582663709|FG006|Overall Study|Withdrawal by Subject|11|||
161349342|NCT04403880|582663703|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
161349343|NCT04403880|582663704|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
161349344|NCT04403880|582663705|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
161349345|NCT04403880|582663706|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161349346|NCT04403880|582663707|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
161191351|NCT02055976|582077692|FG008|Overall Study|Other|0|||
161191352|NCT02055976|582077684|FG000|Overall Study|Adverse Event|0|||
161191353|NCT02055976|582077685|FG001|Overall Study|Adverse Event|0|||
161191354|NCT02055976|582077686|FG002|Overall Study|Adverse Event|0|||
161191355|NCT02055976|582077687|FG003|Overall Study|Adverse Event|0|||
161191356|NCT02055976|582077688|FG004|Overall Study|Adverse Event|0|||
161191357|NCT02055976|582077689|FG005|Overall Study|Adverse Event|1|||
161191358|NCT02055976|582077690|FG006|Overall Study|Adverse Event|1|||
161191359|NCT02055976|582077691|FG007|Overall Study|Adverse Event|0|||
161191360|NCT02055976|582077692|FG008|Overall Study|Adverse Event|0|||
161191361|NCT02055976|582077684|FG000|Overall Study|Does not meet entrance criteria|0|||
161191362|NCT02055976|582077685|FG001|Overall Study|Does not meet entrance criteria|0|||
161191363|NCT02055976|582077686|FG002|Overall Study|Does not meet entrance criteria|0|||
161090200|NCT00825825|581719909|FG005|First Medication Period (14 Days)|Physician Decision|1|||
161191364|NCT02055976|582077687|FG003|Overall Study|Does not meet entrance criteria|0|||
161191365|NCT02055976|582077688|FG004|Overall Study|Does not meet entrance criteria|0|||
161191366|NCT02055976|582077689|FG005|Overall Study|Does not meet entrance criteria|0|||
161090201|NCT00825825|581719904|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
161090202|NCT00825825|581719905|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
161090203|NCT00825825|581719906|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
161090204|NCT00825825|581719907|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
161090205|NCT00825825|581719908|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
161090206|NCT00825825|581719909|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
161090207|NCT00825825|581719904|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
161090208|NCT00825825|581719905|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
161090209|NCT00825825|581719906|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
161090210|NCT00825825|581719907|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
161090211|NCT00825825|581719908|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
161090212|NCT00825825|581719909|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
161090213|NCT00825825|581719904|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
161090214|NCT00825825|581719905|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
161090215|NCT00825825|581719906|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
161090216|NCT00825825|581719907|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
161090217|NCT00825825|581719908|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
161090218|NCT00825825|581719909|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
161090219|NCT00825825|581719904|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
161090220|NCT00825825|581719905|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
161090221|NCT00825825|581719906|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
161090222|NCT00825825|581719907|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
161090223|NCT00825825|581719908|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
161090224|NCT00825825|581719909|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
161090225|NCT00825825|581719904|FG000|Third Medication Period (14 Days)|poor data quality|0|||
161090226|NCT00825825|581719905|FG001|Third Medication Period (14 Days)|poor data quality|1|||
161090227|NCT00825825|581719906|FG002|Third Medication Period (14 Days)|poor data quality|0|||
161090228|NCT00825825|581719907|FG003|Third Medication Period (14 Days)|poor data quality|0|||
161090229|NCT00825825|581719908|FG004|Third Medication Period (14 Days)|poor data quality|0|||
161090230|NCT00825825|581719909|FG005|Third Medication Period (14 Days)|poor data quality|0|||
161090231|NCT02649946|581719915|FG000|Overall Study|Withdrawal by Subject|1|||
161090232|NCT02649946|581719916|FG001|Overall Study|Withdrawal by Subject|1|||
161090233|NCT02649946|581719915|FG000|Overall Study|Death|7|||
161090234|NCT02649946|581719916|FG001|Overall Study|Death|9|||
161090235|NCT02649946|581719915|FG000|Overall Study|Physician Decision|1|||
161090236|NCT02649946|581719916|FG001|Overall Study|Physician Decision|0|||
161090237|NCT02649946|581719915|FG000|Overall Study|Lost to Follow-up|2|||
161090238|NCT02649946|581719916|FG001|Overall Study|Lost to Follow-up|1|||
161191367|NCT02055976|582077690|FG006|Overall Study|Does not meet entrance criteria|1|||
161191368|NCT02055976|582077691|FG007|Overall Study|Does not meet entrance criteria|0|||
161349347|NCT04403880|582663708|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
161349348|NCT04403880|582663709|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
161191369|NCT02055976|582077692|FG008|Overall Study|Does not meet entrance criteria|0|||
161191370|NCT02055976|582077684|FG000|Overall Study|Lost to Follow-up|0|||
161191371|NCT02055976|582077685|FG001|Overall Study|Lost to Follow-up|0|||
161191372|NCT02055976|582077686|FG002|Overall Study|Lost to Follow-up|0|||
161191373|NCT02055976|582077687|FG003|Overall Study|Lost to Follow-up|1|||
161191374|NCT02055976|582077688|FG004|Overall Study|Lost to Follow-up|0|||
161191375|NCT02055976|582077689|FG005|Overall Study|Lost to Follow-up|0|||
161191376|NCT02055976|582077690|FG006|Overall Study|Lost to Follow-up|0|||
161191377|NCT02055976|582077691|FG007|Overall Study|Lost to Follow-up|0|||
161191378|NCT02055976|582077692|FG008|Overall Study|Lost to Follow-up|0|||
161191379|NCT02504424|582077696|FG000|Overall Study|Withdrawal by Subject|2|||
161191380|NCT00426842|582077697|FG000|Overall Study|Lost to Follow-up|1|||
161191381|NCT01277666|582077700|FG000|Overall Study|Adverse Event|26|||
161191382|NCT01277666|582077701|FG001|Overall Study|Adverse Event|25|||
161191383|NCT01277666|582077702|FG002|Overall Study|Adverse Event|20|||
161191384|NCT01277666|582077700|FG000|Overall Study|Lack of Efficacy|8|||
161191385|NCT01277666|582077701|FG001|Overall Study|Lack of Efficacy|20|||
161191386|NCT01277666|582077702|FG002|Overall Study|Lack of Efficacy|12|||
161191387|NCT01277666|582077700|FG000|Overall Study|Protocol Violation|2|||
161191388|NCT01277666|582077701|FG001|Overall Study|Protocol Violation|3|||
161191389|NCT01277666|582077702|FG002|Overall Study|Protocol Violation|2|||
161191390|NCT01277666|582077700|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
161191391|NCT01277666|582077701|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
161191392|NCT01277666|582077702|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
161191393|NCT01277666|582077700|FG000|Overall Study|Lost to Follow-up|1|||
161349349|NCT04403880|582663703|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161349350|NCT04403880|582663704|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
161349351|NCT04403880|582663705|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
161349352|NCT04403880|582663706|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
161349353|NCT04403880|582663707|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161349354|NCT04403880|582663708|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
161349355|NCT04403880|582663709|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
161191394|NCT01277666|582077701|FG001|Overall Study|Lost to Follow-up|1|||
161191395|NCT01277666|582077702|FG002|Overall Study|Lost to Follow-up|2|||
161191396|NCT01277666|582077700|FG000|Overall Study|Withdrawal by Subject|7|||
161191397|NCT01277666|582077701|FG001|Overall Study|Withdrawal by Subject|8|||
161191398|NCT01277666|582077702|FG002|Overall Study|Withdrawal by Subject|6|||
161191399|NCT01277666|582077700|FG000|Overall Study|Death|0|||
161191400|NCT01277666|582077701|FG001|Overall Study|Death|0|||
161349356|NCT04403880|582663703|FG000|Overall Study|Pregnancy|2|||
161349357|NCT04403880|582663704|FG001|Overall Study|Pregnancy|0|||
161191401|NCT01277666|582077702|FG002|Overall Study|Death|1|||
161191402|NCT01657903|582077704|FG000|Overall Study|Lost to Follow-up|1|||
161349358|NCT04403880|582663705|FG002|Overall Study|Pregnancy|5|||
161349359|NCT04403880|582663706|FG003|Overall Study|Pregnancy|0|||
161349360|NCT04403880|582663707|FG004|Overall Study|Pregnancy|1|||
161349361|NCT04403880|582663708|FG005|Overall Study|Pregnancy|0|||
161349362|NCT04403880|582663709|FG006|Overall Study|Pregnancy|1|||
161349363|NCT04403880|582663703|FG000|Overall Study|Sponsor Decision|2|||
161191403|NCT01657903|582077704|FG000|Overall Study|Withdrawal by Subject|1|||
161191404|NCT02312934|582077705|FG000|Overall Study|Lost to Follow-up|1|||
161191405|NCT02312934|582077706|FG001|Overall Study|Lost to Follow-up|0|||
161191406|NCT02312934|582077705|FG000|Overall Study|Physician Decision|1|||
161191407|NCT02312934|582077706|FG001|Overall Study|Physician Decision|0|||
161349364|NCT04403880|582663704|FG001|Overall Study|Sponsor Decision|0|||
161349365|NCT04403880|582663705|FG002|Overall Study|Sponsor Decision|14|||
161349366|NCT04403880|582663706|FG003|Overall Study|Sponsor Decision|1|||
161349367|NCT04403880|582663707|FG004|Overall Study|Sponsor Decision|1|||
161349368|NCT04403880|582663708|FG005|Overall Study|Sponsor Decision|0|||
161349369|NCT04403880|582663709|FG006|Overall Study|Sponsor Decision|2|||
161349370|NCT04403880|582663703|FG000|Overall Study|Other|18|||
161349371|NCT04403880|582663704|FG001|Overall Study|Other|9|||
161349372|NCT04403880|582663705|FG002|Overall Study|Other|14|||
161349373|NCT04403880|582663706|FG003|Overall Study|Other|10|||
161349374|NCT04403880|582663707|FG004|Overall Study|Other|11|||
161349375|NCT04403880|582663708|FG005|Overall Study|Other|12|||
161349376|NCT04403880|582663709|FG006|Overall Study|Other|15|||
161349377|NCT04652726|582663710|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
161349378|NCT04652726|582663711|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
161191408|NCT02886338|582077707|FG000|Overall Study|Withdrawal by Subject|1|||
161191409|NCT03395704|582077709|FG000|Overall Study|Adverse Event|2|||
161191410|NCT03395704|582077710|FG001|Overall Study|Adverse Event|1|||
161191411|NCT03395704|582077709|FG000|Overall Study|Withdrawal by Subject|2|||
161191412|NCT03395704|582077710|FG001|Overall Study|Withdrawal by Subject|1|||
161191413|NCT03395704|582077709|FG000|Overall Study|Physician Decision|0|||
161349379|NCT04652726|582663712|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
161349380|NCT04652726|582663710|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
161349381|NCT04652726|582663711|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
161349382|NCT04652726|582663712|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
161349383|NCT03199469|582663713|FG000|Overall Study|Randomized, not treated|0|||
161349384|NCT03199469|582663714|FG001|Overall Study|Randomized, not treated|3|||
161349385|NCT03199469|582663713|FG000|Overall Study|Withdrawal by Subject|1|||
161349386|NCT03199469|582663714|FG001|Overall Study|Withdrawal by Subject|0|||
161349387|NCT03199469|582663713|FG000|Overall Study|Death|1|||
161349388|NCT03199469|582663714|FG001|Overall Study|Death|3|||
161349389|NCT03199469|582663713|FG000|Overall Study|Ongoing|5|||
161349390|NCT03199469|582663714|FG001|Overall Study|Ongoing|14|||
161349391|NCT03780725|582663717|FG000|Overall Study|Progression of disease|3|||
161349392|NCT03780725|582663718|FG001|Overall Study|Progression of disease|4|||
161349393|NCT03780725|582663717|FG000|Overall Study|Adverse Event|0|||
161349394|NCT03780725|582663718|FG001|Overall Study|Adverse Event|1|||
161349395|NCT04138277|582663719|FG000|Pretreatment|Withdrawal by Subject|1|||
161349396|NCT04138277|582663720|FG001|Pretreatment|Withdrawal by Subject|0|||
161349397|NCT04138277|582663719|FG000|Treatment|Adverse Event|6|||
161349398|NCT04138277|582663720|FG001|Treatment|Adverse Event|2|||
161349399|NCT04138277|582663719|FG000|Treatment|Lost to Follow-up|1|||
161349400|NCT04138277|582663720|FG001|Treatment|Lost to Follow-up|0|||
161349401|NCT04138277|582663719|FG000|Treatment|Pregnancy|3|||
161349402|NCT04138277|582663720|FG001|Treatment|Pregnancy|0|||
161349403|NCT04138277|582663719|FG000|Treatment|COVID-19 pandemic|1|||
161349404|NCT04138277|582663720|FG001|Treatment|COVID-19 pandemic|0|||
161349405|NCT04138277|582663719|FG000|Treatment|Withdrawal by Subject|9|||
161349406|NCT04138277|582663720|FG001|Treatment|Withdrawal by Subject|3|||
161349407|NCT04138277|582663719|FG000|Treatment|Sponsor decision|1|||
161349408|NCT04138277|582663720|FG001|Treatment|Sponsor decision|0|||
161349409|NCT04138277|582663719|FG000|Treatment|Physician Decision|1|||
161349410|NCT04138277|582663720|FG001|Treatment|Physician Decision|0|||
161349411|NCT04138277|582663719|FG000|Treatment|Worsening of condition|1|||
161349412|NCT04138277|582663720|FG001|Treatment|Worsening of condition|2|||
161349413|NCT03768414|582663721|FG000|Overall Study|Adverse Event or side effects|72|||
161349414|NCT03768414|582663722|FG001|Overall Study|Adverse Event or side effects|28|||
161349415|NCT03768414|582663721|FG000|Overall Study|Refusal unrelated to adverse event|33|||
161349416|NCT03768414|582663722|FG001|Overall Study|Refusal unrelated to adverse event|33|||
161349417|NCT03768414|582663721|FG000|Overall Study|Progression/relapse|132|||
161349418|NCT03768414|582663722|FG001|Overall Study|Progression/relapse|60|||
161349419|NCT03768414|582663721|FG000|Overall Study|Death|9|||
161349420|NCT03768414|582663722|FG001|Overall Study|Death|6|||
161349421|NCT03768414|582663721|FG000|Overall Study|Other - not protocol specified|45|||
161349422|NCT03768414|582663722|FG001|Overall Study|Other - not protocol specified|18|||
161349423|NCT03768414|582663721|FG000|Overall Study|Reason under review|3|||
161349424|NCT03768414|582663722|FG001|Overall Study|Reason under review|2|||
161349425|NCT02738008|582663725|FG000|Overall Study|Study Terminated by Sponsor|1|||
161349426|NCT02738008|582663726|FG001|Overall Study|Study Terminated by Sponsor|5|||
161349427|NCT02738008|582663727|FG002|Overall Study|Study Terminated by Sponsor|3|||
161349428|NCT02738008|582663725|FG000|Overall Study|Adverse Event|0|||
161349429|NCT02738008|582663726|FG001|Overall Study|Adverse Event|1|||
161349430|NCT02738008|582663727|FG002|Overall Study|Adverse Event|2|||
161349431|NCT03437278|582663728|FG000|Overall Study|Adverse Event|0|||
161349432|NCT03437278|582663729|FG001|Overall Study|Adverse Event|0|||
161191414|NCT03395704|582077710|FG001|Overall Study|Physician Decision|1|||
161191415|NCT01156012|582077711|FG000|Overall Study|Adverse Event|3|||
161191416|NCT01156012|582077712|FG001|Overall Study|Adverse Event|1|||
161349433|NCT03437278|582663730|FG002|Overall Study|Adverse Event|1|||
161349434|NCT03437278|582663728|FG000|Overall Study|Progressive disease|1|||
161349435|NCT03437278|582663729|FG001|Overall Study|Progressive disease|0|||
161349436|NCT03437278|582663730|FG002|Overall Study|Progressive disease|0|||
161349437|NCT03437278|582663728|FG000|Overall Study|Physician Decision|1|||
161349438|NCT03437278|582663729|FG001|Overall Study|Physician Decision|0|||
161349439|NCT03437278|582663730|FG002|Overall Study|Physician Decision|1|||
161349440|NCT05192382|582663731|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
161349441|NCT05192382|582663732|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
161349442|NCT05192382|582663733|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
161349443|NCT05192382|582663731|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
161349444|NCT05192382|582663732|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
161349445|NCT05192382|582663733|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
161349446|NCT05192382|582663731|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
161349447|NCT05192382|582663732|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
161191417|NCT01156012|582077711|FG000|Overall Study|Lost to Follow-up|1|||
161191418|NCT01156012|582077712|FG001|Overall Study|Lost to Follow-up|0|||
161349448|NCT05192382|582663733|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
161349449|NCT05192382|582663731|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
161191419|NCT01156012|582077711|FG000|Overall Study|Withdrawal by Subject|1|||
161349450|NCT05192382|582663732|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
161349451|NCT05192382|582663733|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
161349452|NCT04328727|582663736|FG000|Overall Study|Guardian Decision|1|||
161349453|NCT04328727|582663736|FG000|Overall Study|Participant decision|4|||
161349454|NCT04328727|582663736|FG000|Overall Study|Death|3|||
161349455|NCT02604199|582663737|FG000|Overall Study|Pregnancy|0|||
161349456|NCT02604199|582663738|FG001|Overall Study|Pregnancy|0|||
161349457|NCT02604199|582663739|FG002|Overall Study|Pregnancy|0|||
161349458|NCT02604199|582663740|FG003|Overall Study|Pregnancy|1|||
161349459|NCT02604199|582663737|FG000|Overall Study|Study terminated by sponsor|0|||
161349460|NCT02604199|582663738|FG001|Overall Study|Study terminated by sponsor|2|||
161349461|NCT02604199|582663739|FG002|Overall Study|Study terminated by sponsor|0|||
161349462|NCT02604199|582663740|FG003|Overall Study|Study terminated by sponsor|2|||
161349463|NCT02604199|582663737|FG000|Overall Study|Withdrawal by Subject|0|||
161349464|NCT02604199|582663738|FG001|Overall Study|Withdrawal by Subject|1|||
161349465|NCT02604199|582663739|FG002|Overall Study|Withdrawal by Subject|0|||
161349466|NCT02604199|582663740|FG003|Overall Study|Withdrawal by Subject|0|||
161349467|NCT02604212|582663741|FG000|Overall Study|Study Terminated by Sponsor|2|||
161349468|NCT02604212|582663742|FG001|Overall Study|Study Terminated by Sponsor|1|||
161349469|NCT02604212|582663743|FG002|Overall Study|Study Terminated by Sponsor|3|||
161349470|NCT02604212|582663744|FG003|Overall Study|Study Terminated by Sponsor|3|||
161349471|NCT02604212|582663741|FG000|Overall Study|Withdrawal by Subject|0|||
161349472|NCT02604212|582663742|FG001|Overall Study|Withdrawal by Subject|0|||
161349473|NCT02604212|582663743|FG002|Overall Study|Withdrawal by Subject|1|||
161349474|NCT02604212|582663744|FG003|Overall Study|Withdrawal by Subject|0|||
161349475|NCT03019406|582663745|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
161349476|NCT03019406|582663746|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
161349477|NCT03019406|582663747|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
161349478|NCT03019406|582663748|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
161349479|NCT04702776|582663752|FG000|Overall Study|Adverse Event|1|||
161349480|NCT04702776|582663753|FG001|Overall Study|Adverse Event|2|||
161349481|NCT04702776|582663754|FG002|Overall Study|Adverse Event|1|||
161349482|NCT04702776|582663752|FG000|Overall Study|Lost to Follow-up|2|||
161349483|NCT04702776|582663753|FG001|Overall Study|Lost to Follow-up|1|||
161349484|NCT04702776|582663754|FG002|Overall Study|Lost to Follow-up|4|||
161349485|NCT04702776|582663752|FG000|Overall Study|Protocol Violation|2|||
161349486|NCT04702776|582663753|FG001|Overall Study|Protocol Violation|2|||
161349487|NCT04702776|582663754|FG002|Overall Study|Protocol Violation|3|||
161349488|NCT02556736|582663755|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
161349489|NCT02556736|582663756|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
161349490|NCT02556736|582663757|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
161349491|NCT02556736|582663758|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
161349492|NCT02556736|582663755|FG000|Open Label Treatment Period|Adverse Event|0|||
161349493|NCT02556736|582663756|FG001|Open Label Treatment Period|Adverse Event|0|||
161349494|NCT02556736|582663757|FG002|Open Label Treatment Period|Adverse Event|0|||
161349495|NCT02556736|582663758|FG003|Open Label Treatment Period|Adverse Event|1|||
161349496|NCT02556736|582663755|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
161349497|NCT02556736|582663756|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
161349498|NCT02556736|582663757|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
161349499|NCT02556736|582663758|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
161349500|NCT05431387|582663771|FG000|Overall Study|Adverse Event|1|||
161349501|NCT05431387|582663772|FG001|Overall Study|Adverse Event|0|||
161349502|NCT05431387|582663771|FG000|Overall Study|Withdrawal by Subject|4|||
161349503|NCT05431387|582663772|FG001|Overall Study|Withdrawal by Subject|4|||
161349504|NCT05431387|582663771|FG000|Overall Study|Physician Decision|0|||
161349505|NCT05431387|582663772|FG001|Overall Study|Physician Decision|1|||
161349506|NCT05431387|582663771|FG000|Overall Study|Lost to Follow-up|5|||
161349507|NCT05431387|582663772|FG001|Overall Study|Lost to Follow-up|9|||
161349508|NCT05431387|582663771|FG000|Overall Study|Other, Not Specified|1|||
161349509|NCT05431387|582663772|FG001|Overall Study|Other, Not Specified|4|||
161349510|NCT05358717|582663773|FG000|Overall Study|Adverse Event|0|||
161349511|NCT05358717|582663774|FG001|Overall Study|Adverse Event|1|||
161349512|NCT05358717|582663775|FG002|Overall Study|Adverse Event|1|||
161349513|NCT05358717|582663773|FG000|Overall Study|Death|1|||
161349514|NCT05358717|582663774|FG001|Overall Study|Death|1|||
161349515|NCT05358717|582663775|FG002|Overall Study|Death|0|||
161349516|NCT05358717|582663773|FG000|Overall Study|Withdrawal by Subject|1|||
161349517|NCT05358717|582663774|FG001|Overall Study|Withdrawal by Subject|1|||
161349518|NCT05358717|582663775|FG002|Overall Study|Withdrawal by Subject|2|||
161349519|NCT05358717|582663773|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
161349520|NCT05358717|582663774|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
161349521|NCT05358717|582663775|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
161349522|NCT01302834|582663776|FG000|Overall Study|Protocol Violation|17|||
161349523|NCT01302834|582663777|FG001|Overall Study|Protocol Violation|23|||
161349524|NCT01302834|582663776|FG000|Overall Study|HIV positive|1|||
161349525|NCT01302834|582663777|FG001|Overall Study|HIV positive|3|||
161349526|NCT04257929|582663778|FG000|Overall Study|Adverse Event|1|||
161349527|NCT04257929|582663779|FG001|Overall Study|Adverse Event|0|||
161349528|NCT04257929|582663780|FG002|Overall Study|Adverse Event|1|||
161191420|NCT01156012|582077712|FG001|Overall Study|Withdrawal by Subject|0|||
161191421|NCT01156012|582077711|FG000|Overall Study|use of commercial drug instead of study|0|||
161191422|NCT01156012|582077712|FG001|Overall Study|use of commercial drug instead of study|1|||
161191423|NCT01156012|582077711|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
161191424|NCT01156012|582077712|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
161191425|NCT00960323|582080039|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
161191426|NCT01524900|582080043|FG000|Overall Study|Lost to Follow-up|3|||
161191427|NCT01524900|582080044|FG001|Overall Study|Lost to Follow-up|12|||
161191428|NCT01524900|582080045|FG002|Overall Study|Lost to Follow-up|1|||
161191429|NCT01524900|582080046|FG003|Overall Study|Lost to Follow-up|0|||
161191430|NCT01524900|582080047|FG004|Overall Study|Lost to Follow-up|0|||
161191431|NCT01524900|582080043|FG000|Overall Study|Other reason than stated above|1|||
161191432|NCT01524900|582080044|FG001|Overall Study|Other reason than stated above|1|||
161191433|NCT01524900|582080045|FG002|Overall Study|Other reason than stated above|0|||
161191434|NCT01524900|582080046|FG003|Overall Study|Other reason than stated above|0|||
161191435|NCT01524900|582080047|FG004|Overall Study|Other reason than stated above|0|||
161191436|NCT01524900|582080043|FG000|Overall Study|No reason documented|2|||
161191437|NCT01524900|582080044|FG001|Overall Study|No reason documented|1|||
161191438|NCT01524900|582080045|FG002|Overall Study|No reason documented|0|||
161191439|NCT01524900|582080046|FG003|Overall Study|No reason documented|1|||
161191440|NCT01524900|582080047|FG004|Overall Study|No reason documented|0|||
161191441|NCT00772031|582080048|FG000|Overall Study|Early termination of trial|12|||
161191442|NCT00772031|582080049|FG001|Overall Study|Early termination of trial|10|||
161191443|NCT00772031|582080048|FG000|Overall Study|Lost to Follow-up|20|||
161191444|NCT00772031|582080049|FG001|Overall Study|Lost to Follow-up|33|||
161191445|NCT00532441|582080050|FG000|Overall Study|Death|1|||
161191446|NCT00532441|582080051|FG001|Overall Study|Death|0|||
161191447|NCT00303329|582080054|FG000|Overall Study|Adverse Event|7|||
161191448|NCT00303329|582080055|FG001|Overall Study|Adverse Event|14|||
161191449|NCT00303329|582080054|FG000|Overall Study|Abnormal Laboratory Values|0|||
161191450|NCT00303329|582080055|FG001|Overall Study|Abnormal Laboratory Values|1|||
161306226|NCT02447497|582500808|FG001|Overall Study|Dressing was compromised|1|||
161306227|NCT02447497|582500809|FG002|Overall Study|Dressing was compromised|0|||
161306228|NCT02447497|582500810|FG003|Overall Study|Dressing was compromised|0|||
161306229|NCT02017912|582500811|FG000|Overall Study|Withdrawal by Subject|2|||
161306230|NCT02017912|582500812|FG001|Overall Study|Withdrawal by Subject|1|||
161306231|NCT02017912|582500811|FG000|Overall Study|miscellaneous|1|||
161306232|NCT02017912|582500812|FG001|Overall Study|miscellaneous|1|||
161306233|NCT04569968|582500813|FG000|Overall Study|Lost to Follow-up|2|||
161306234|NCT04569968|582500814|FG001|Overall Study|Lost to Follow-up|5|||
161306235|NCT04569968|582500813|FG000|Overall Study|Story of head and/or neck surgery|2|||
161306236|NCT04569968|582500814|FG001|Overall Study|Story of head and/or neck surgery|2|||
161306237|NCT04569968|582500813|FG000|Overall Study|Time of stroke onset|8|||
161306238|NCT04569968|582500814|FG001|Overall Study|Time of stroke onset|7|||
161306239|NCT04569968|582500813|FG000|Overall Study|Type of strokr|12|||
161306240|NCT04569968|582500814|FG001|Overall Study|Type of strokr|8|||
161306241|NCT04569968|582500813|FG000|Overall Study|Cooperation|8|||
161306242|NCT04569968|582500814|FG001|Overall Study|Cooperation|8|||
161306243|NCT04569968|582500813|FG000|Overall Study|Age interval|17|||
161306244|NCT04569968|582500814|FG001|Overall Study|Age interval|6|||
161306245|NCT04569968|582500813|FG000|Overall Study|Denial of participation to the study|0|||
161306246|NCT04569968|582500814|FG001|Overall Study|Denial of participation to the study|3|||
161306247|NCT04569968|582500813|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
161306248|NCT04569968|582500814|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
161306249|NCT04569968|582500813|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
161306250|NCT04569968|582500814|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
161306251|NCT04569968|582500813|FG000|Overall Study|Quarantine|1|||
161306252|NCT04569968|582500814|FG001|Overall Study|Quarantine|0|||
161306253|NCT04569968|582500813|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
161306254|NCT04569968|582500814|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
161306255|NCT04569968|582500813|FG000|Overall Study|Repetitive stroke|8|||
161306256|NCT04569968|582500814|FG001|Overall Study|Repetitive stroke|0|||
161306257|NCT04569968|582500813|FG000|Overall Study|Insufficient mastication|1|||
161306258|NCT04569968|582500814|FG001|Overall Study|Insufficient mastication|0|||
161306259|NCT04569968|582500813|FG000|Overall Study|Infection|1|||
161306260|NCT04569968|582500814|FG001|Overall Study|Infection|0|||
161306261|NCT00727844|582500815|FG000|Initial Randomization|Physician Decision|2|||
161349529|NCT04257929|582663778|FG000|Overall Study|Withdrawal by Subject|1|||
161349530|NCT04257929|582663779|FG001|Overall Study|Withdrawal by Subject|0|||
161191451|NCT00303329|582080054|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
161191452|NCT00303329|582080055|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
161306262|NCT00727844|582500816|FG001|Initial Randomization|Physician Decision|0|||
161306263|NCT00727844|582500817|FG002|Initial Randomization|Physician Decision|0|||
161349531|NCT04257929|582663780|FG002|Overall Study|Withdrawal by Subject|0|||
161191453|NCT00303329|582080054|FG000|Overall Study|Condition no longer requires study drug|0|||
161191454|NCT00303329|582080055|FG001|Overall Study|Condition no longer requires study drug|8|||
161191455|NCT00303329|582080054|FG000|Overall Study|Protocol Violation|3|||
161191456|NCT00303329|582080055|FG001|Overall Study|Protocol Violation|0|||
161191457|NCT00303329|582080054|FG000|Overall Study|Withdrawal by Subject|9|||
161191458|NCT00303329|582080055|FG001|Overall Study|Withdrawal by Subject|15|||
161191459|NCT00303329|582080054|FG000|Overall Study|Lost to Follow-up|0|||
161191460|NCT00303329|582080055|FG001|Overall Study|Lost to Follow-up|1|||
161191461|NCT00303329|582080054|FG000|Overall Study|Administrative problems|1|||
161191462|NCT00303329|582080055|FG001|Overall Study|Administrative problems|0|||
161191463|NCT00303329|582080054|FG000|Overall Study|Death|2|||
161191464|NCT00303329|582080055|FG001|Overall Study|Death|12|||
161191465|NCT00303329|582080054|FG000|Overall Study|Stopped at end of core|3|||
161191466|NCT00303329|582080055|FG001|Overall Study|Stopped at end of core|9|||
161191467|NCT00303329|582080054|FG000|Overall Study|Stopped at end of extension 1|1|||
161191468|NCT00303329|582080055|FG001|Overall Study|Stopped at end of extension 1|0|||
161191469|NCT01101321|582080056|FG000|Period 1|Withdrawal by Subject|1|||
161191470|NCT01101321|582080057|FG001|Period 1|Withdrawal by Subject|1|||
161191471|NCT01101321|582080056|FG000|Period 1|Adverse Event|3|||
161191472|NCT01101321|582080057|FG001|Period 1|Adverse Event|3|||
161191473|NCT00561912|582080058|FG000|Overall Study|ineligible|1|||
161191474|NCT03938857|582080059|FG000|Overall Study|Physician Decision|1|||
161191475|NCT03938857|582080060|FG001|Overall Study|Physician Decision|0|||
161191476|NCT03938857|582080061|FG002|Overall Study|Physician Decision|0|||
161191477|NCT03938857|582080062|FG003|Overall Study|Physician Decision|0|||
161191478|NCT01345162|582080063|FG000|Overall Study|Protocol Violation|2|||
161191479|NCT01345162|582080064|FG001|Overall Study|Protocol Violation|4|||
161191480|NCT03007472|582080065|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
161191481|NCT03007472|582080065|FG000|Overall Study|Death|2|||
161191482|NCT03007472|582080065|FG000|Overall Study|Loss to Follow Up|1|||
161191483|NCT02988115|582080066|FG000|Overall Study|Adverse Event|6|||
161191484|NCT02988115|582080067|FG001|Overall Study|Adverse Event|1|||
161191485|NCT02988115|582080066|FG000|Overall Study|Sponsor Decision|5|||
161191486|NCT02988115|582080067|FG001|Overall Study|Sponsor Decision|2|||
161191487|NCT02988115|582080066|FG000|Overall Study|Withdrawal by Subject|1|||
161191488|NCT02988115|582080067|FG001|Overall Study|Withdrawal by Subject|1|||
161191489|NCT02988115|582080066|FG000|Overall Study|Withdrawn by Mistake|1|||
161191490|NCT02988115|582080067|FG001|Overall Study|Withdrawn by Mistake|0|||
161191491|NCT02988115|582080066|FG000|Overall Study|Lost to Follow-up|1|||
161191492|NCT02988115|582080067|FG001|Overall Study|Lost to Follow-up|0|||
161191493|NCT01731951|582080068|FG000|Overall Study|Documented Disease Progression|1|||
161191494|NCT01731951|582080069|FG001|Overall Study|Documented Disease Progression|0|||
161191495|NCT01731951|582080070|FG002|Overall Study|Documented Disease Progression|0|||
161191496|NCT01731951|582080071|FG003|Overall Study|Documented Disease Progression|0|||
161191497|NCT01731951|582080072|FG004|Overall Study|Documented Disease Progression|0|||
161191498|NCT01731951|582080073|FG005|Overall Study|Documented Disease Progression|0|||
161191499|NCT01731951|582080068|FG000|Overall Study|Lost to Follow-up|2|||
161191500|NCT01731951|582080069|FG001|Overall Study|Lost to Follow-up|0|||
161191501|NCT01731951|582080070|FG002|Overall Study|Lost to Follow-up|0|||
161191502|NCT01731951|582080071|FG003|Overall Study|Lost to Follow-up|1|||
161191503|NCT01731951|582080072|FG004|Overall Study|Lost to Follow-up|3|||
161191504|NCT01731951|582080073|FG005|Overall Study|Lost to Follow-up|1|||
161191505|NCT01731951|582080068|FG000|Overall Study|Withdrawal of Consent|1|||
161191506|NCT01731951|582080069|FG001|Overall Study|Withdrawal of Consent|0|||
161191507|NCT01731951|582080070|FG002|Overall Study|Withdrawal of Consent|0|||
161191508|NCT01731951|582080071|FG003|Overall Study|Withdrawal of Consent|0|||
161191509|NCT01731951|582080072|FG004|Overall Study|Withdrawal of Consent|0|||
161191510|NCT01731951|582080073|FG005|Overall Study|Withdrawal of Consent|2|||
161191511|NCT01731951|582080068|FG000|Overall Study|Death|13|||
161349532|NCT04257929|582663778|FG000|Overall Study|COVID-19|0|||
161349533|NCT04257929|582663779|FG001|Overall Study|COVID-19|1|||
161349534|NCT04257929|582663780|FG002|Overall Study|COVID-19|1|||
161349535|NCT04257929|582663778|FG000|Overall Study|Lost to Follow-up|0|||
161349536|NCT04257929|582663779|FG001|Overall Study|Lost to Follow-up|0|||
161349537|NCT04257929|582663780|FG002|Overall Study|Lost to Follow-up|1|||
161349538|NCT05528510|582663781|FG000|Overall Study|Death|1|||
161191512|NCT01731951|582080069|FG001|Overall Study|Death|15|||
161191513|NCT01731951|582080070|FG002|Overall Study|Death|9|||
161191514|NCT01731951|582080071|FG003|Overall Study|Death|8|||
161191515|NCT01731951|582080072|FG004|Overall Study|Death|9|||
161191516|NCT01731951|582080073|FG005|Overall Study|Death|6|||
161349539|NCT05528510|582663782|FG001|Overall Study|Death|0|||
161191517|NCT00649220|582080080|FG000|Overall Study|Adverse Event|2|||
161349540|NCT05528510|582663783|FG002|Overall Study|Death|0|||
161349541|NCT05528510|582663781|FG000|Overall Study|Lost to Follow-up|1|||
161191518|NCT00649220|582080080|FG000|Overall Study|Withdrawal by Subject|1|||
161349542|NCT05528510|582663782|FG001|Overall Study|Lost to Follow-up|0|||
161349543|NCT05528510|582663783|FG002|Overall Study|Lost to Follow-up|0|||
161349544|NCT05528510|582663781|FG000|Overall Study|Withdrawal by Subject|4|||
161349545|NCT05528510|582663782|FG001|Overall Study|Withdrawal by Subject|1|||
161191519|NCT00525499|582080081|FG000|Overall Study|Lost to Follow-up|2|||
161191520|NCT00525499|582080082|FG001|Overall Study|Lost to Follow-up|4|||
161191521|NCT00525499|582080083|FG002|Overall Study|Lost to Follow-up|1|||
161191522|NCT00525499|582080084|FG003|Overall Study|Lost to Follow-up|4|||
161191523|NCT00525499|582080081|FG000|Overall Study|Adverse Event|0|||
161191524|NCT00525499|582080082|FG001|Overall Study|Adverse Event|1|||
161191525|NCT00525499|582080083|FG002|Overall Study|Adverse Event|0|||
161191526|NCT00525499|582080084|FG003|Overall Study|Adverse Event|1|||
161191527|NCT00525499|582080081|FG000|Overall Study|Withdrawal by Subject|5|||
161191528|NCT00525499|582080082|FG001|Overall Study|Withdrawal by Subject|1|||
161191529|NCT00525499|582080083|FG002|Overall Study|Withdrawal by Subject|5|||
161191530|NCT00525499|582080084|FG003|Overall Study|Withdrawal by Subject|2|||
161191531|NCT00525499|582080081|FG000|Overall Study|Protocol Violation|0|||
161191532|NCT00525499|582080082|FG001|Overall Study|Protocol Violation|1|||
161191533|NCT00525499|582080083|FG002|Overall Study|Protocol Violation|1|||
161191534|NCT00525499|582080084|FG003|Overall Study|Protocol Violation|0|||
161191535|NCT03339999|582080085|FG000|Overall Study|Adverse Event|1|||
161191536|NCT03339999|582080086|FG001|Overall Study|Adverse Event|2|||
161191537|NCT03339999|582080087|FG002|Overall Study|Adverse Event|2|||
161191538|NCT03339999|582080088|FG003|Overall Study|Adverse Event|1|||
161191539|NCT03339999|582080085|FG000|Overall Study|Lack of Efficacy|0|||
161191540|NCT03339999|582080086|FG001|Overall Study|Lack of Efficacy|1|||
161191541|NCT03339999|582080087|FG002|Overall Study|Lack of Efficacy|0|||
161191542|NCT03339999|582080088|FG003|Overall Study|Lack of Efficacy|0|||
161191543|NCT03339999|582080085|FG000|Overall Study|Lost to Follow-up|0|||
161191544|NCT03339999|582080086|FG001|Overall Study|Lost to Follow-up|0|||
161191545|NCT03339999|582080087|FG002|Overall Study|Lost to Follow-up|0|||
161191546|NCT03339999|582080088|FG003|Overall Study|Lost to Follow-up|1|||
161191547|NCT03339999|582080085|FG000|Overall Study|Study Terminated by Sponsor|6|||
161191548|NCT03339999|582080086|FG001|Overall Study|Study Terminated by Sponsor|3|||
161191549|NCT03339999|582080087|FG002|Overall Study|Study Terminated by Sponsor|4|||
161191550|NCT03339999|582080088|FG003|Overall Study|Study Terminated by Sponsor|3|||
161191551|NCT01977651|582080089|FG000|4 Month Treatment Period|Adverse Event|34|||
161191552|NCT01977651|582080089|FG000|4 Month Treatment Period|Death|3|||
161191553|NCT01977651|582080089|FG000|4 Month Treatment Period|Progressive Disease|43|||
161191554|NCT01977651|582080089|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
161191555|NCT01977651|582080089|FG000|4 Month Treatment Period|Physician Decision|4|||
161191556|NCT01977651|582080089|FG000|1 Year Extension Period|Adverse Event|14|||
161191557|NCT01977651|582080089|FG000|1 Year Extension Period|Death|10|||
161191558|NCT01977651|582080089|FG000|1 Year Extension Period|Lost to Follow-up|2|||
161191559|NCT01977651|582080089|FG000|1 Year Extension Period|Progressive Disease|86|||
161191560|NCT01977651|582080089|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
161191561|NCT01977651|582080089|FG000|1 Year Extension Period|Physician Decision|6|||
161191562|NCT01977651|582080089|FG000|1 Year Extension Period|Miscellaneous|1|||
161191563|NCT01977651|582080089|FG000|Post 1 Year Extension Period|Adverse Event|5|||
161191564|NCT01977651|582080089|FG000|Post 1 Year Extension Period|Death|13|||
161191565|NCT01977651|582080089|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
161191566|NCT01977651|582080089|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
161191567|NCT01977651|582080089|FG000|Post 1 Year Extension Period|Physician Decision|4|||
161191568|NCT01977651|582080089|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
161191569|NCT01856920|582080092|FG000|Overall Study|Disease Progression On Study|3|||
161191570|NCT01856920|582080093|FG001|Overall Study|Disease Progression On Study|4|||
161191571|NCT01856920|582080092|FG000|Overall Study|Disease Progression before Treatment|1|||
161191572|NCT01856920|582080093|FG001|Overall Study|Disease Progression before Treatment|0|||
161191573|NCT01856920|582080092|FG000|Overall Study|Ineligible|0|||
161191574|NCT01856920|582080093|FG001|Overall Study|Ineligible|1|||
161191575|NCT01856920|582080092|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
161191576|NCT01856920|582080093|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
161191577|NCT01856920|582080092|FG000|Overall Study|Refused further Treatment|5|||
161191578|NCT01856920|582080093|FG001|Overall Study|Refused further Treatment|1|||
161191579|NCT01856920|582080092|FG000|Overall Study|Other Reasons|0|||
161191580|NCT01856920|582080093|FG001|Overall Study|Other Reasons|1|||
161191581|NCT01856920|582080092|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
161191582|NCT01856920|582080093|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
161191583|NCT03287089|582080099|FG000|Overall Study|Lost to Follow-up|0|||
161191584|NCT03287089|582080100|FG001|Overall Study|Lost to Follow-up|2|||
161191585|NCT03287089|582080099|FG000|Overall Study|Physician Decision|0|||
161191586|NCT03287089|582080100|FG001|Overall Study|Physician Decision|2|||
161191587|NCT03287089|582080099|FG000|Overall Study|Withdrawal by Subject|0|||
161191588|NCT03287089|582080100|FG001|Overall Study|Withdrawal by Subject|2|||
161191589|NCT01729559|582080106|FG000|Overall Study|Protocol Violation|31|||
161191590|NCT01729559|582080107|FG001|Overall Study|Protocol Violation|28|||
161191591|NCT02906644|582080112|FG000|First 2 Weeks|Withdrawal by Subject|0|||
161191592|NCT02906644|582080113|FG001|First 2 Weeks|Withdrawal by Subject|2|||
161191593|NCT02906644|582080112|FG000|First 2 Weeks|Physician Decision|1|||
161191594|NCT02906644|582080113|FG001|First 2 Weeks|Physician Decision|1|||
161191595|NCT02906644|582080112|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
161191596|NCT02906644|582080113|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
161191597|NCT02906644|582080112|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
161191598|NCT02906644|582080113|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
161191599|NCT02452034|582080114|FG000|Overall Study|Adverse Event|0|||
161191600|NCT02452034|582080115|FG001|Overall Study|Adverse Event|0|||
161191601|NCT02452034|582080116|FG002|Overall Study|Adverse Event|0|||
161191602|NCT02452034|582080117|FG003|Overall Study|Adverse Event|0|||
161191603|NCT02452034|582080118|FG004|Overall Study|Adverse Event|0|||
161191604|NCT02452034|582080119|FG005|Overall Study|Adverse Event|1|||
161191605|NCT02452034|582080114|FG000|Overall Study|Death|0|||
161191606|NCT02452034|582080115|FG001|Overall Study|Death|0|||
161191607|NCT02452034|582080116|FG002|Overall Study|Death|0|||
161191608|NCT02452034|582080117|FG003|Overall Study|Death|0|||
161191609|NCT02452034|582080118|FG004|Overall Study|Death|1|||
161191610|NCT02452034|582080119|FG005|Overall Study|Death|1|||
161191611|NCT02452034|582080114|FG000|Overall Study|Physician Decision|0|||
161191612|NCT02452034|582080115|FG001|Overall Study|Physician Decision|1|||
161191613|NCT02452034|582080116|FG002|Overall Study|Physician Decision|1|||
161191614|NCT02452034|582080117|FG003|Overall Study|Physician Decision|0|||
161191615|NCT02452034|582080118|FG004|Overall Study|Physician Decision|0|||
161191616|NCT02452034|582080119|FG005|Overall Study|Physician Decision|0|||
161191617|NCT02452034|582080114|FG000|Overall Study|Protocol Violation|0|||
161191618|NCT02452034|582080115|FG001|Overall Study|Protocol Violation|0|||
161191619|NCT02452034|582080116|FG002|Overall Study|Protocol Violation|0|||
161191620|NCT02452034|582080117|FG003|Overall Study|Protocol Violation|0|||
161191621|NCT02452034|582080118|FG004|Overall Study|Protocol Violation|0|||
161191622|NCT02452034|582080119|FG005|Overall Study|Protocol Violation|1|||
161191623|NCT02452034|582080114|FG000|Overall Study|Screen Failure|1|||
161191624|NCT02452034|582080115|FG001|Overall Study|Screen Failure|0|||
161191625|NCT02452034|582080116|FG002|Overall Study|Screen Failure|0|||
161191626|NCT02452034|582080117|FG003|Overall Study|Screen Failure|1|||
161191627|NCT02452034|582080118|FG004|Overall Study|Screen Failure|0|||
161191628|NCT02452034|582080119|FG005|Overall Study|Screen Failure|0|||
161191629|NCT02452034|582080114|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
161191630|NCT02452034|582080115|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
161191631|NCT02452034|582080116|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
161191632|NCT02452034|582080117|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
161191633|NCT02452034|582080118|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
161191634|NCT02452034|582080119|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
161191635|NCT03672006|582080123|FG000|Overall Study|exclusion criteria met|0|||
161191636|NCT03672006|582080124|FG001|Overall Study|exclusion criteria met|1|||
161191637|NCT03288987|582080125|FG000|Overall Study|Protocol Violation|10|||
161191638|NCT03288987|582080126|FG001|Overall Study|Protocol Violation|4|||
161191639|NCT00608426|582080127|FG000|Overall Study|Death|32|||
161191640|NCT00608426|582080128|FG001|Overall Study|Death|36|||
161191641|NCT00608426|582080127|FG000|Overall Study|Lost to Follow-up|485|||
161191642|NCT00608426|582080128|FG001|Overall Study|Lost to Follow-up|521|||
161191643|NCT00608426|582080127|FG000|Overall Study|refused, health issues, wrong address|319|||
161191644|NCT00608426|582080128|FG001|Overall Study|refused, health issues, wrong address|348|||
161191645|NCT00761891|582080129|FG000|Overall Study|Withdrawal by Subject|10|||
161191646|NCT01453439|582080133|FG000|Treatment Phase|Withdrawal by Subject|13|||
161191647|NCT01453439|582080134|FG001|Treatment Phase|Withdrawal by Subject|10|||
161191648|NCT01453439|582080133|FG000|Treatment Phase|Suicidal Ideation|2|||
161191649|NCT01453439|582080134|FG001|Treatment Phase|Suicidal Ideation|0|||
161191650|NCT01453439|582080133|FG000|Treatment Phase|Need for higher level of care|1|||
161191651|NCT01453439|582080134|FG001|Treatment Phase|Need for higher level of care|1|||
161191652|NCT01453439|582080133|FG000|Treatment Phase|Therapist conflict of interest|1|||
161191653|NCT01453439|582080134|FG001|Treatment Phase|Therapist conflict of interest|0|||
161191654|NCT01453439|582080133|FG000|Follow-up|Withdrawal by Subject|0|||
161191655|NCT01453439|582080134|FG001|Follow-up|Withdrawal by Subject|1|||
161191656|NCT01453439|582080133|FG000|Follow-up|Lost to Follow-up|5|||
161191657|NCT01453439|582080134|FG001|Follow-up|Lost to Follow-up|10|||
161191658|NCT01014442|582080135|FG000|Overall Study|Adverse Event|0|||
161191659|NCT01014442|582080136|FG001|Overall Study|Adverse Event|8|||
161191660|NCT01014442|582080135|FG000|Overall Study|Withdrawal by Subject|4|||
161191661|NCT01014442|582080136|FG001|Overall Study|Withdrawal by Subject|4|||
161191662|NCT01014442|582080135|FG000|Overall Study|Protocol Violation|2|||
161191663|NCT01014442|582080136|FG001|Overall Study|Protocol Violation|5|||
161191664|NCT01014442|582080135|FG000|Overall Study|Lack of Compliance|0|||
161306264|NCT00727844|582500818|FG003|Initial Randomization|Physician Decision|0|||
161191665|NCT01014442|582080136|FG001|Overall Study|Lack of Compliance|1|||
161191666|NCT01014442|582080135|FG000|Overall Study|Unspecified Reason|1|||
161191667|NCT01014442|582080136|FG001|Overall Study|Unspecified Reason|1|||
161191668|NCT02074059|582080137|FG000|Overall Study|Death|0|||
161191669|NCT02074059|582080138|FG001|Overall Study|Death|0|||
161191670|NCT02074059|582080139|FG002|Overall Study|Death|0|||
161191671|NCT02074059|582080140|FG003|Overall Study|Death|0|||
161191672|NCT02074059|582080141|FG004|Overall Study|Death|1|||
161191673|NCT02074059|582080142|FG005|Overall Study|Death|1|||
161191674|NCT02764229|582080148|FG000|Overall Study|Withdrawal by Subject|15|||
161191675|NCT02764229|582080148|FG000|Overall Study|Adverse Event|9|||
161191676|NCT02764229|582080148|FG000|Overall Study|Physician Decision|5|||
161191677|NCT02764229|582080148|FG000|Overall Study|Lost to Follow-up|3|||
161191678|NCT02764229|582080148|FG000|Overall Study|Lack of Efficacy|1|||
161191679|NCT02764229|582080148|FG000|Overall Study|Study Stopped by Sponsor|69|||
161191680|NCT00672490|582080149|FG000|Overall Study|Withdrawal by Subject|8|||
161191681|NCT00672490|582080150|FG001|Overall Study|Withdrawal by Subject|8|||
161191682|NCT00672490|582080149|FG000|Overall Study|Lack of Compliance|2|||
161191683|NCT00672490|582080150|FG001|Overall Study|Lack of Compliance|7|||
161191684|NCT00672490|582080149|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
161191685|NCT00672490|582080150|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
161191686|NCT00672490|582080149|FG000|Overall Study|Adverse Event|5|||
161191687|NCT00672490|582080150|FG001|Overall Study|Adverse Event|8|||
161191688|NCT00672490|582080149|FG000|Overall Study|Violation of Concomitant Medicine|1|||
161191689|NCT00672490|582080150|FG001|Overall Study|Violation of Concomitant Medicine|0|||
161191690|NCT00672490|582080149|FG000|Overall Study|Intolerance|0|||
161191691|NCT00672490|582080150|FG001|Overall Study|Intolerance|2|||
161191692|NCT00672490|582080149|FG000|Overall Study|Lost to Follow-up|1|||
161191693|NCT00672490|582080150|FG001|Overall Study|Lost to Follow-up|5|||
161191694|NCT00672490|582080149|FG000|Overall Study|No reason was provided|6|||
161191695|NCT00672490|582080150|FG001|Overall Study|No reason was provided|2|||
161191696|NCT02135848|582080169|FG000|Overall Study|Adverse Event|2|||
161191697|NCT02135848|582080170|FG001|Overall Study|Adverse Event|0|||
161191698|NCT02135848|582080169|FG000|Overall Study|Withdrawal by Subject|1|||
161191699|NCT02135848|582080170|FG001|Overall Study|Withdrawal by Subject|1|||
161191700|NCT02030067|582080171|FG000|Overall Study|Disease Progression|1|||
161191701|NCT02030067|582080172|FG001|Overall Study|Disease Progression|1|||
161191702|NCT02030067|582080173|FG002|Overall Study|Disease Progression|2|||
161191703|NCT02030067|582080174|FG003|Overall Study|Disease Progression|2|||
161191704|NCT02030067|582080175|FG004|Overall Study|Disease Progression|3|||
161191705|NCT02030067|582080176|FG005|Overall Study|Disease Progression|2|||
161191706|NCT02030067|582080177|FG006|Overall Study|Disease Progression|3|||
161191707|NCT02030067|582080178|FG007|Overall Study|Disease Progression|3|||
161191708|NCT02030067|582080179|FG008|Overall Study|Disease Progression|4|||
161191709|NCT02030067|582080180|FG009|Overall Study|Disease Progression|3|||
161191710|NCT02030067|582080181|FG010|Overall Study|Disease Progression|7|||
161191711|NCT02030067|582080182|FG011|Overall Study|Disease Progression|2|||
161191712|NCT02030067|582080183|FG012|Overall Study|Disease Progression|59|||
161191713|NCT02030067|582080171|FG000|Overall Study|Withdrawal by Subject|0|||
161191714|NCT02030067|582080172|FG001|Overall Study|Withdrawal by Subject|0|||
161191715|NCT02030067|582080173|FG002|Overall Study|Withdrawal by Subject|0|||
161191716|NCT02030067|582080174|FG003|Overall Study|Withdrawal by Subject|1|||
161191717|NCT02030067|582080175|FG004|Overall Study|Withdrawal by Subject|0|||
161191718|NCT02030067|582080176|FG005|Overall Study|Withdrawal by Subject|0|||
161191719|NCT02030067|582080177|FG006|Overall Study|Withdrawal by Subject|0|||
161191720|NCT02030067|582080178|FG007|Overall Study|Withdrawal by Subject|1|||
161191721|NCT02030067|582080179|FG008|Overall Study|Withdrawal by Subject|0|||
161191722|NCT02030067|582080180|FG009|Overall Study|Withdrawal by Subject|0|||
161191723|NCT02030067|582080181|FG010|Overall Study|Withdrawal by Subject|3|||
161191724|NCT02030067|582080182|FG011|Overall Study|Withdrawal by Subject|0|||
161191725|NCT02030067|582080183|FG012|Overall Study|Withdrawal by Subject|6|||
161191726|NCT02030067|582080171|FG000|Overall Study|Physician Decision|0|||
161191727|NCT02030067|582080172|FG001|Overall Study|Physician Decision|0|||
161191728|NCT02030067|582080173|FG002|Overall Study|Physician Decision|0|||
161191729|NCT02030067|582080174|FG003|Overall Study|Physician Decision|0|||
161191730|NCT02030067|582080175|FG004|Overall Study|Physician Decision|0|||
161191731|NCT02030067|582080176|FG005|Overall Study|Physician Decision|0|||
161191732|NCT02030067|582080177|FG006|Overall Study|Physician Decision|0|||
161191733|NCT02030067|582080178|FG007|Overall Study|Physician Decision|0|||
161191734|NCT02030067|582080179|FG008|Overall Study|Physician Decision|0|||
161191735|NCT02030067|582080180|FG009|Overall Study|Physician Decision|0|||
161191736|NCT02030067|582080181|FG010|Overall Study|Physician Decision|1|||
161191737|NCT02030067|582080182|FG011|Overall Study|Physician Decision|0|||
161191738|NCT02030067|582080183|FG012|Overall Study|Physician Decision|3|||
161306265|NCT00985959|582500823|FG000|Overall Study|Adverse Event|0|||
161306266|NCT00985959|582500824|FG001|Overall Study|Adverse Event|0|||
161306267|NCT00985959|582500825|FG002|Overall Study|Adverse Event|19|||
161306268|NCT00985959|582500823|FG000|Overall Study|Withdrawal by Subject|0|||
161306269|NCT00985959|582500824|FG001|Overall Study|Withdrawal by Subject|0|||
161191739|NCT02030067|582080171|FG000|Overall Study|other reasons|0|||
161191740|NCT02030067|582080172|FG001|Overall Study|other reasons|0|||
161191741|NCT02030067|582080173|FG002|Overall Study|other reasons|0|||
161191742|NCT02030067|582080174|FG003|Overall Study|other reasons|0|||
161191743|NCT02030067|582080175|FG004|Overall Study|other reasons|0|||
161191744|NCT02030067|582080176|FG005|Overall Study|other reasons|1|||
161306270|NCT00985959|582500825|FG002|Overall Study|Withdrawal by Subject|8|||
161191745|NCT02030067|582080177|FG006|Overall Study|other reasons|0|||
161191746|NCT02030067|582080178|FG007|Overall Study|other reasons|0|||
161191747|NCT02030067|582080179|FG008|Overall Study|other reasons|2|||
161191748|NCT02030067|582080180|FG009|Overall Study|other reasons|0|||
161191749|NCT02030067|582080181|FG010|Overall Study|other reasons|0|||
161191750|NCT02030067|582080182|FG011|Overall Study|other reasons|0|||
161191751|NCT02030067|582080183|FG012|Overall Study|other reasons|4|||
161191752|NCT02030067|582080171|FG000|Overall Study|Adverse Event|0|||
161191753|NCT02030067|582080172|FG001|Overall Study|Adverse Event|0|||
161191754|NCT02030067|582080173|FG002|Overall Study|Adverse Event|0|||
161191755|NCT02030067|582080174|FG003|Overall Study|Adverse Event|0|||
161191756|NCT02030067|582080175|FG004|Overall Study|Adverse Event|0|||
161191757|NCT02030067|582080176|FG005|Overall Study|Adverse Event|0|||
161191758|NCT02030067|582080177|FG006|Overall Study|Adverse Event|0|||
161191759|NCT02030067|582080178|FG007|Overall Study|Adverse Event|0|||
161191760|NCT02030067|582080179|FG008|Overall Study|Adverse Event|0|||
161191761|NCT02030067|582080180|FG009|Overall Study|Adverse Event|0|||
161191762|NCT02030067|582080181|FG010|Overall Study|Adverse Event|0|||
161191763|NCT02030067|582080182|FG011|Overall Study|Adverse Event|1|||
161191764|NCT02030067|582080183|FG012|Overall Study|Adverse Event|8|||
161191765|NCT00265382|582080184|FG000|Overall Study|Adverse Event|21|||
161191766|NCT00265382|582080184|FG000|Overall Study|Laboratory Abnormality|1|||
161191767|NCT00265382|582080184|FG000|Overall Study|Lost to Follow-up|3|||
161191768|NCT00265382|582080184|FG000|Overall Study|Lack of Efficacy|6|||
161191769|NCT00265382|582080184|FG000|Overall Study|Miscellaneous|6|||
161191770|NCT00265382|582080184|FG000|Overall Study|Withdrawal by Subject|13|||
161191771|NCT00265382|582080184|FG000|Overall Study|Study terminated by sponsor|94|||
161191772|NCT00265382|582080184|FG000|Overall Study|Death|1|||
161191773|NCT00760994|582080191|FG000|Overall Study|Lost to Follow-up|4|||
161191774|NCT00760994|582080192|FG001|Overall Study|Lost to Follow-up|4|||
161191775|NCT00760994|582080193|FG002|Overall Study|Lost to Follow-up|3|||
161191776|NCT03258710|582080194|FG000|Overall Study|Adverse Event|1|||
161191777|NCT03258710|582080194|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161191778|NCT03258710|582080194|FG000|Overall Study|Physician Decision|1|||
161191779|NCT00545740|582080195|FG000|Overall Study|Lack of Efficacy|34|||
161191780|NCT00545740|582080196|FG001|Overall Study|Lack of Efficacy|35|||
161191781|NCT00545740|582080197|FG002|Overall Study|Lack of Efficacy|47|||
161191782|NCT00545740|582080198|FG003|Overall Study|Lack of Efficacy|36|||
161191783|NCT00545740|582080195|FG000|Overall Study|Withdrawal by Subject|17|||
161191784|NCT00545740|582080196|FG001|Overall Study|Withdrawal by Subject|15|||
161191785|NCT00545740|582080197|FG002|Overall Study|Withdrawal by Subject|16|||
161191786|NCT00545740|582080198|FG003|Overall Study|Withdrawal by Subject|18|||
161191787|NCT00545740|582080195|FG000|Overall Study|Adverse Event|10|||
161191788|NCT00545740|582080196|FG001|Overall Study|Adverse Event|18|||
161191789|NCT00545740|582080197|FG002|Overall Study|Adverse Event|19|||
161191790|NCT00545740|582080198|FG003|Overall Study|Adverse Event|9|||
161191791|NCT00545740|582080195|FG000|Overall Study|Lost to Follow-up|7|||
161191792|NCT00545740|582080196|FG001|Overall Study|Lost to Follow-up|5|||
161191793|NCT00545740|582080197|FG002|Overall Study|Lost to Follow-up|5|||
161191794|NCT00545740|582080198|FG003|Overall Study|Lost to Follow-up|6|||
161191795|NCT00545740|582080195|FG000|Overall Study|Protocol Violation|1|||
161191796|NCT00545740|582080196|FG001|Overall Study|Protocol Violation|3|||
161191797|NCT00545740|582080197|FG002|Overall Study|Protocol Violation|1|||
161191798|NCT00545740|582080198|FG003|Overall Study|Protocol Violation|0|||
161191799|NCT00545740|582080195|FG000|Overall Study|Non-compliance|0|||
161191800|NCT00545740|582080196|FG001|Overall Study|Non-compliance|2|||
161191801|NCT00545740|582080197|FG002|Overall Study|Non-compliance|1|||
161191802|NCT00545740|582080198|FG003|Overall Study|Non-compliance|0|||
161191803|NCT00545740|582080195|FG000|Overall Study|Moved|2|||
161191804|NCT00545740|582080196|FG001|Overall Study|Moved|0|||
161191805|NCT00545740|582080197|FG002|Overall Study|Moved|1|||
161191806|NCT00545740|582080198|FG003|Overall Study|Moved|0|||
161191807|NCT00545740|582080195|FG000|Overall Study|Diverticulitis attack|0|||
161191808|NCT00545740|582080196|FG001|Overall Study|Diverticulitis attack|0|||
161191809|NCT00545740|582080197|FG002|Overall Study|Diverticulitis attack|1|||
161191810|NCT00545740|582080198|FG003|Overall Study|Diverticulitis attack|1|||
161191811|NCT00545740|582080195|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
161191812|NCT00545740|582080196|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
161191813|NCT00545740|582080197|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
161191814|NCT00545740|582080198|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
161191815|NCT00545740|582080195|FG000|Overall Study|Site closure|1|||
161191816|NCT00545740|582080196|FG001|Overall Study|Site closure|0|||
161191817|NCT00545740|582080197|FG002|Overall Study|Site closure|0|||
161191818|NCT00545740|582080198|FG003|Overall Study|Site closure|0|||
161191819|NCT00545740|582080195|FG000|Overall Study|Missed visit|1|||
161191820|NCT00545740|582080196|FG001|Overall Study|Missed visit|0|||
161191821|NCT00545740|582080197|FG002|Overall Study|Missed visit|0|||
161191822|NCT00545740|582080198|FG003|Overall Study|Missed visit|0|||
161191823|NCT00545740|582080195|FG000|Overall Study|Physician Decision|0|||
161191824|NCT00545740|582080196|FG001|Overall Study|Physician Decision|0|||
161349546|NCT05528510|582663783|FG002|Overall Study|Withdrawal by Subject|3|||
161349547|NCT05528510|582663781|FG000|Overall Study|Other|2|||
161349548|NCT05528510|582663782|FG001|Overall Study|Other|2|||
161349549|NCT05528510|582663783|FG002|Overall Study|Other|1|||
161349550|NCT06036914|582663784|FG000|Overall Study|Withdrawal by Subject|1|||
161349551|NCT06036914|582663785|FG001|Overall Study|Withdrawal by Subject|0|||
161349552|NCT04697381|582663788|FG000|Extension Period|Adverse Event|0|||
161349553|NCT04697381|582663789|FG001|Extension Period|Adverse Event|0|||
161349554|NCT04697381|582663790|FG002|Extension Period|Adverse Event|3|||
161349555|NCT04697381|582663788|FG000|Extension Period|Physician Decision|0|||
161349556|NCT04697381|582663789|FG001|Extension Period|Physician Decision|0|||
161349557|NCT04697381|582663790|FG002|Extension Period|Physician Decision|2|||
161349558|NCT04697381|582663788|FG000|Extension Period|Other|0|||
161349559|NCT04697381|582663789|FG001|Extension Period|Other|0|||
161349560|NCT04697381|582663790|FG002|Extension Period|Other|1|||
161349561|NCT04837040|582665888|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
161349562|NCT04837040|582665889|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
161349563|NCT02961218|582665890|FG000|Overall Study|Lost to Follow-up|0|||
161349564|NCT02961218|582665891|FG001|Overall Study|Lost to Follow-up|2|||
161349565|NCT02961218|582665890|FG000|Overall Study|Physician Decision|0|||
161349566|NCT02961218|582665891|FG001|Overall Study|Physician Decision|2|||
161349567|NCT02961218|582665890|FG000|Overall Study|Subject/Guardian Decision|3|||
161349568|NCT02961218|582665891|FG001|Overall Study|Subject/Guardian Decision|1|||
161090239|NCT02649946|581719915|FG000|Overall Study|Erroneously enrolled|1|||
161090240|NCT02649946|581719916|FG001|Overall Study|Erroneously enrolled|0|||
161090241|NCT02649946|581719915|FG000|Overall Study|Missed 6-month follow-up visit|0|||
161090242|NCT02649946|581719916|FG001|Overall Study|Missed 6-month follow-up visit|4|||
161090243|NCT01047293|581719917|FG000|Overall Study|DLT criteria not fulfilled|1|||
161090244|NCT01047293|581719918|FG001|Overall Study|DLT criteria not fulfilled|1|||
161090245|NCT01047293|581719919|FG002|Overall Study|DLT criteria not fulfilled|0|||
161090246|NCT01047293|581719920|FG003|Overall Study|DLT criteria not fulfilled|0|||
161090247|NCT00757783|581719921|FG000|Overall Study|Adverse Event|0|||
161090248|NCT00757783|581719922|FG001|Overall Study|Adverse Event|2|||
161090249|NCT00757783|581719921|FG000|Overall Study|Lost to Follow-up|1|||
161090250|NCT00757783|581719922|FG001|Overall Study|Lost to Follow-up|1|||
161090251|NCT00757783|581719921|FG000|Overall Study|Protocol Violation|1|||
161090252|NCT00757783|581719922|FG001|Overall Study|Protocol Violation|0|||
161090253|NCT00757783|581719921|FG000|Overall Study|Withdrawal by Subject|2|||
161090254|NCT00757783|581719922|FG001|Overall Study|Withdrawal by Subject|1|||
161090255|NCT00757783|581719921|FG000|Overall Study|Other|1|||
161090256|NCT00757783|581719922|FG001|Overall Study|Other|2|||
161090257|NCT02372136|581719923|FG000|Overall Study|Death|3|||
161090258|NCT02372136|581719924|FG001|Overall Study|Death|1|||
161090259|NCT02003573|581719939|FG000|Overall Study|Progressive disease|2|||
161090260|NCT02003573|581719940|FG001|Overall Study|Progressive disease|0|||
161090261|NCT02003573|581719941|FG002|Overall Study|Progressive disease|1|||
161090262|NCT02003573|581719939|FG000|Overall Study|Other Adverse event|0|||
161090263|NCT02003573|581719940|FG001|Overall Study|Other Adverse event|1|||
161090264|NCT02003573|581719941|FG002|Overall Study|Other Adverse event|1|||
161090265|NCT02003573|581719939|FG000|Overall Study|Refuse to take trial medication|0|||
161090266|NCT02003573|581719940|FG001|Overall Study|Refuse to take trial medication|1|||
161090267|NCT02003573|581719941|FG002|Overall Study|Refuse to take trial medication|1|||
161090268|NCT02003573|581719939|FG000|Overall Study|Other than specified|1|||
161090269|NCT02003573|581719940|FG001|Overall Study|Other than specified|2|||
161090270|NCT02003573|581719941|FG002|Overall Study|Other than specified|3|||
161090271|NCT03683823|581719948|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
161090272|NCT03683823|581719949|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
161090273|NCT03683823|581719948|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
161090274|NCT03683823|581719949|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
161090275|NCT03683823|581719948|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
161090276|NCT03683823|581719949|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
161090277|NCT05026710|581719951|FG000|Overall Study|No longer met eligibility criteria|3|||
161090278|NCT05026710|581719952|FG001|Overall Study|No longer met eligibility criteria|1|||
161090279|NCT00994682|581719953|FG000|Double Bilnd|Withdrawal by Subject|5|||
161090280|NCT00994682|581719954|FG001|Double Bilnd|Withdrawal by Subject|6|||
161090281|NCT00994682|581719953|FG000|Double Bilnd|Lost to Follow-up|3|||
161090282|NCT00994682|581719954|FG001|Double Bilnd|Lost to Follow-up|3|||
161090283|NCT00994682|581719953|FG000|Double Bilnd|Adverse Event|1|||
161090284|NCT00994682|581719954|FG001|Double Bilnd|Adverse Event|0|||
161090285|NCT00994682|581719953|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
161090286|NCT00994682|581719954|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
161090287|NCT00994682|581719953|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
161090288|NCT00994682|581719954|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
161090289|NCT00994682|581719953|FG000|Pioglitazone Open Label|Physician Decision|6|||
161090290|NCT00994682|581719954|FG001|Pioglitazone Open Label|Physician Decision|1|||
161090291|NCT01323972|581719955|FG000|Overall Study|Withdrawal by Subject|1|||
161349569|NCT01856478|582665892|FG000|Overall Study|Not treated|0|||
161191825|NCT00545740|582080197|FG002|Overall Study|Physician Decision|3|||
161191826|NCT00545740|582080198|FG003|Overall Study|Physician Decision|0|||
161191827|NCT00545740|582080195|FG000|Overall Study|Accepted only monthly telephone calls|1|||
161191828|NCT00545740|582080196|FG001|Overall Study|Accepted only monthly telephone calls|0|||
161191829|NCT00545740|582080197|FG002|Overall Study|Accepted only monthly telephone calls|0|||
161191830|NCT00545740|582080198|FG003|Overall Study|Accepted only monthly telephone calls|0|||
161191831|NCT00545740|582080195|FG000|Overall Study|Sponsor decision|0|||
161191832|NCT00545740|582080196|FG001|Overall Study|Sponsor decision|1|||
161191833|NCT00545740|582080197|FG002|Overall Study|Sponsor decision|0|||
161349570|NCT01856478|582665893|FG001|Overall Study|Not treated|8|||
161349571|NCT01856478|582665892|FG000|Overall Study|Progressive disease per RECIST|146|||
161349572|NCT01856478|582665893|FG001|Overall Study|Progressive disease per RECIST|49|||
161349573|NCT01856478|582665892|FG000|Overall Study|Worsening of underlying cancer|6|||
161349574|NCT01856478|582665893|FG001|Overall Study|Worsening of underlying cancer|2|||
161349575|NCT01856478|582665892|FG000|Overall Study|Adverse events|57|||
161349576|NCT01856478|582665893|FG001|Overall Study|Adverse events|30|||
161349577|NCT01856478|582665892|FG000|Overall Study|Non-compliant with protocol|1|||
161349578|NCT01856478|582665893|FG001|Overall Study|Non-compliant with protocol|1|||
161349579|NCT01856478|582665892|FG000|Overall Study|Lost to Follow-up|1|||
161191834|NCT00545740|582080198|FG003|Overall Study|Sponsor decision|0|||
161191835|NCT00545740|582080195|FG000|Overall Study|Lack of time|0|||
161191836|NCT00545740|582080196|FG001|Overall Study|Lack of time|1|||
161191837|NCT00545740|582080197|FG002|Overall Study|Lack of time|0|||
161191838|NCT00545740|582080198|FG003|Overall Study|Lack of time|0|||
161191839|NCT00545740|582080195|FG000|Overall Study|Non-adherence to visits|0|||
161349580|NCT01856478|582665893|FG001|Overall Study|Lost to Follow-up|1|||
161349581|NCT01856478|582665892|FG000|Overall Study|Refused to continue trial medication|13|||
161349582|NCT01856478|582665893|FG001|Overall Study|Refused to continue trial medication|11|||
161349583|NCT01856478|582665892|FG000|Overall Study|Other reason than listed|4|||
161349584|NCT01856478|582665893|FG001|Overall Study|Other reason than listed|10|||
161349585|NCT05032820|582665894|FG000|Overall Study|Lost to Follow-up|1|||
161349586|NCT05032820|582665894|FG000|Overall Study|Withdrawal by Subject|1|||
161349587|NCT02486718|582665895|FG000|Enrollment Phase|Death|19|||
161349588|NCT02486718|582665896|FG001|Enrollment Phase|Death|0|||
161349589|NCT02486718|582665897|FG002|Enrollment Phase|Death|0|||
161349590|NCT02486718|582665895|FG000|Enrollment Phase|Symptomatic deterioration|1|||
161349591|NCT02486718|582665896|FG001|Enrollment Phase|Symptomatic deterioration|0|||
161349592|NCT02486718|582665897|FG002|Enrollment Phase|Symptomatic deterioration|0|||
161349593|NCT02486718|582665895|FG000|Enrollment Phase|Withdrawal by Subject|86|||
161349594|NCT02486718|582665896|FG001|Enrollment Phase|Withdrawal by Subject|0|||
161191840|NCT00545740|582080196|FG001|Overall Study|Non-adherence to visits|1|||
161191841|NCT00545740|582080197|FG002|Overall Study|Non-adherence to visits|0|||
161191842|NCT00545740|582080198|FG003|Overall Study|Non-adherence to visits|0|||
161191843|NCT00545740|582080195|FG000|Overall Study|Patient difficulties|0|||
161191844|NCT00545740|582080196|FG001|Overall Study|Patient difficulties|1|||
161191845|NCT00545740|582080197|FG002|Overall Study|Patient difficulties|0|||
161349595|NCT02486718|582665897|FG002|Enrollment Phase|Withdrawal by Subject|0|||
161349596|NCT02486718|582665895|FG000|Enrollment Phase|Protocol Violation|18|||
161349597|NCT02486718|582665896|FG001|Enrollment Phase|Protocol Violation|0|||
161349598|NCT02486718|582665897|FG002|Enrollment Phase|Protocol Violation|0|||
161349599|NCT02486718|582665895|FG000|Enrollment Phase|Physician Decision|18|||
161349600|NCT02486718|582665896|FG001|Enrollment Phase|Physician Decision|0|||
161349601|NCT02486718|582665897|FG002|Enrollment Phase|Physician Decision|0|||
161349602|NCT02486718|582665895|FG000|Enrollment Phase|Reason not provided|41|||
161349603|NCT02486718|582665896|FG001|Enrollment Phase|Reason not provided|0|||
161349604|NCT02486718|582665897|FG002|Enrollment Phase|Reason not provided|0|||
161191846|NCT00545740|582080198|FG003|Overall Study|Patient difficulties|0|||
161191847|NCT00545740|582080195|FG000|Overall Study|Husband against study|0|||
161191848|NCT00545740|582080196|FG001|Overall Study|Husband against study|0|||
161191849|NCT00545740|582080197|FG002|Overall Study|Husband against study|1|||
161191850|NCT00545740|582080198|FG003|Overall Study|Husband against study|0|||
161191851|NCT02117024|582080199|FG000|Overall Study|Progressive Disease|26|||
161191852|NCT02117024|582080200|FG001|Overall Study|Progressive Disease|9|||
161191853|NCT02117024|582080199|FG000|Overall Study|Significant Clinical Progression|7|||
161191854|NCT02117024|582080200|FG001|Overall Study|Significant Clinical Progression|4|||
161191855|NCT02117024|582080199|FG000|Overall Study|Death|5|||
161349605|NCT02486718|582665895|FG000|Enrollment Phase|Disease relapse|54|||
161349606|NCT02486718|582665896|FG001|Enrollment Phase|Disease relapse|0|||
161349607|NCT02486718|582665897|FG002|Enrollment Phase|Disease relapse|0|||
161349608|NCT02486718|582665895|FG000|Enrollment Phase|Lost to Follow-up|4|||
161349609|NCT02486718|582665896|FG001|Enrollment Phase|Lost to Follow-up|0|||
161349610|NCT02486718|582665897|FG002|Enrollment Phase|Lost to Follow-up|0|||
161349611|NCT02486718|582665895|FG000|Enrollment Phase|Adverse Event|34|||
161349612|NCT02486718|582665896|FG001|Enrollment Phase|Adverse Event|0|||
161349613|NCT02486718|582665897|FG002|Enrollment Phase|Adverse Event|0|||
161191856|NCT02117024|582080200|FG001|Overall Study|Death|0|||
161191857|NCT02117024|582080199|FG000|Overall Study|Withdrawal by Subject|3|||
161191858|NCT02117024|582080200|FG001|Overall Study|Withdrawal by Subject|1|||
161191859|NCT02117024|582080199|FG000|Overall Study|Protocol Violation|1|||
161191860|NCT02117024|582080200|FG001|Overall Study|Protocol Violation|0|||
161191861|NCT02117024|582080199|FG000|Overall Study|Adverse Event|1|||
161191862|NCT02117024|582080200|FG001|Overall Study|Adverse Event|2|||
161191863|NCT02117024|582080199|FG000|Overall Study|Randomized in Error|1|||
161191864|NCT02117024|582080200|FG001|Overall Study|Randomized in Error|0|||
161191865|NCT02117024|582080199|FG000|Overall Study|Patient returned to primary oncologist|0|||
161191866|NCT02117024|582080200|FG001|Overall Study|Patient returned to primary oncologist|1|||
161191867|NCT02117024|582080199|FG000|Overall Study|Patient took treatment break|0|||
161191868|NCT02117024|582080200|FG001|Overall Study|Patient took treatment break|1|||
161191869|NCT02117024|582080199|FG000|Overall Study|Physician Decision|0|||
161191870|NCT02117024|582080200|FG001|Overall Study|Physician Decision|2|||
161191871|NCT00565721|582080201|FG000|Overall Study|Screen Failure|2|||
161191872|NCT00565721|582080201|FG000|Overall Study|Lost to Follow-up|6|||
161191873|NCT00565721|582080201|FG000|Overall Study|Technical Problems|1|||
161191874|NCT00565721|582080201|FG000|Overall Study|Physician Decision|2|||
161191875|NCT00565721|582080201|FG000|Overall Study|Other reasons|6|||
161191876|NCT02813681|582080202|FG000|Overall Study|Physician Decision|5|||
161191877|NCT02813681|582080203|FG001|Overall Study|Physician Decision|5|||
161191878|NCT02813681|582080204|FG002|Overall Study|Physician Decision|0|||
161191879|NCT02813681|582080202|FG000|Overall Study|Lost to Follow-up|0|||
161191880|NCT02813681|582080203|FG001|Overall Study|Lost to Follow-up|1|||
161191881|NCT02813681|582080204|FG002|Overall Study|Lost to Follow-up|0|||
161191882|NCT00352027|582080205|FG000|Overall Study|Progressive disease|3|||
161191883|NCT01874288|582080206|FG000|Overall Study|Withdrawal by Subject|1|||
161191884|NCT01874288|582080207|FG001|Overall Study|Withdrawal by Subject|0|||
161191885|NCT01874288|582080208|FG002|Overall Study|Withdrawal by Subject|2|||
161191886|NCT01874288|582080209|FG003|Overall Study|Withdrawal by Subject|1|||
161191887|NCT01874288|582080210|FG004|Overall Study|Withdrawal by Subject|1|||
161191888|NCT01874288|582080206|FG000|Overall Study|Physician Decision|0|||
161191889|NCT01874288|582080207|FG001|Overall Study|Physician Decision|0|||
161191890|NCT01874288|582080208|FG002|Overall Study|Physician Decision|0|||
161191891|NCT01874288|582080209|FG003|Overall Study|Physician Decision|1|||
161191892|NCT01874288|582080210|FG004|Overall Study|Physician Decision|0|||
161191893|NCT01874288|582080206|FG000|Overall Study|Progressive disease|2|||
161191894|NCT01874288|582080207|FG001|Overall Study|Progressive disease|0|||
161191895|NCT01874288|582080208|FG002|Overall Study|Progressive disease|3|||
161191896|NCT01874288|582080209|FG003|Overall Study|Progressive disease|5|||
161191897|NCT01874288|582080210|FG004|Overall Study|Progressive disease|1|||
161191898|NCT03099304|582080211|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
161191899|NCT03099304|582080212|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
161191900|NCT03099304|582080213|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
161191901|NCT03099304|582080214|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
161191902|NCT03099304|582080215|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
161191903|NCT03099304|582080216|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
161191904|NCT03099304|582080211|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
161191905|NCT03099304|582080212|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
161191906|NCT03099304|582080213|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161191907|NCT03099304|582080214|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161191908|NCT03099304|582080215|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161191909|NCT03099304|582080216|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
161191910|NCT03099304|582080211|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
161191911|NCT03099304|582080212|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
161191912|NCT03099304|582080213|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
161191913|NCT03099304|582080214|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
161191914|NCT03099304|582080215|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
161191915|NCT03099304|582080216|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
161191916|NCT03099304|582080211|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
161191917|NCT03099304|582080212|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
161191918|NCT03099304|582080213|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
161191919|NCT03099304|582080214|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
161191920|NCT03099304|582080215|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
161191921|NCT03099304|582080216|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
161191922|NCT03099304|582080211|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161191923|NCT03099304|582080212|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161191924|NCT03099304|582080213|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
161191925|NCT03099304|582080214|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
161191926|NCT03099304|582080215|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161306271|NCT00985959|582500823|FG000|Overall Study|Progressive disease|1|||
161306272|NCT00985959|582500824|FG001|Overall Study|Progressive disease|2|||
161306273|NCT00985959|582500825|FG002|Overall Study|Progressive disease|8|||
161306274|NCT00985959|582500823|FG000|Overall Study|Unrecovered toxicity|0|||
161306275|NCT00985959|582500824|FG001|Overall Study|Unrecovered toxicity|0|||
161349614|NCT02486718|582665895|FG000|Randomized Phase|Withdrawal by Subject|0|||
161349615|NCT02486718|582665896|FG001|Randomized Phase|Withdrawal by Subject|44|||
161349616|NCT02486718|582665897|FG002|Randomized Phase|Withdrawal by Subject|47|||
161349617|NCT02486718|582665895|FG000|Randomized Phase|Protocol Violation|0|||
161349618|NCT02486718|582665896|FG001|Randomized Phase|Protocol Violation|2|||
161349619|NCT02486718|582665897|FG002|Randomized Phase|Protocol Violation|0|||
161191927|NCT03099304|582080216|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
161191928|NCT03099304|582080211|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161349620|NCT02486718|582665895|FG000|Randomized Phase|Physician Decision|0|||
161349621|NCT02486718|582665896|FG001|Randomized Phase|Physician Decision|0|||
161349622|NCT02486718|582665897|FG002|Randomized Phase|Physician Decision|3|||
161349623|NCT02486718|582665895|FG000|Randomized Phase|Lost to Follow-up|0|||
161191929|NCT03099304|582080212|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161191930|NCT03099304|582080213|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
161191931|NCT03099304|582080214|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161191932|NCT03099304|582080215|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161191933|NCT03099304|582080216|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
161191934|NCT03099304|582080211|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161191935|NCT03099304|582080212|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161191936|NCT03099304|582080213|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161191937|NCT03099304|582080214|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
161191938|NCT03099304|582080215|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161191939|NCT03099304|582080216|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
161191940|NCT03099304|582080211|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
161191941|NCT03099304|582080212|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
161191942|NCT03099304|582080213|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
161191943|NCT03099304|582080214|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
161191944|NCT03099304|582080215|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
161191945|NCT03099304|582080216|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
161191946|NCT03099304|582080211|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161191947|NCT03099304|582080212|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161191948|NCT03099304|582080213|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161191949|NCT03099304|582080214|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
161191950|NCT03099304|582080215|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
161191951|NCT03099304|582080216|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
161191952|NCT03099304|582080211|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
161191953|NCT03099304|582080212|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
161191954|NCT03099304|582080213|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
161191955|NCT03099304|582080214|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
161191956|NCT03099304|582080215|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
161191957|NCT03099304|582080216|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
161191958|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
161191959|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
161349624|NCT02486718|582665896|FG001|Randomized Phase|Lost to Follow-up|5|||
161349625|NCT02486718|582665897|FG002|Randomized Phase|Lost to Follow-up|11|||
161349626|NCT02486718|582665895|FG000|Randomized Phase|Disease Relapse|0|||
161349627|NCT02486718|582665896|FG001|Randomized Phase|Disease Relapse|1|||
161191960|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
161191961|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
161191962|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
161191963|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
161191964|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
161191965|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
161191966|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
161191967|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
161191968|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
161191969|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
161349628|NCT02486718|582665897|FG002|Randomized Phase|Disease Relapse|0|||
161349629|NCT02486718|582665895|FG000|Randomized Phase|Death|0|||
161191970|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
161191971|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
161191972|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
161191973|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
161191974|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
161191975|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
161191976|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
161191977|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
161349630|NCT02486718|582665896|FG001|Randomized Phase|Death|154|||
161191978|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
161349631|NCT02486718|582665897|FG002|Randomized Phase|Death|155|||
161349632|NCT02486718|582665895|FG000|Randomized Phase|Ongoing|0|||
161191979|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
161191980|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
161191981|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
161191982|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
161191983|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
161191984|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
161191985|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
161191986|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
161191987|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
161191988|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
161191989|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
161191990|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
161191991|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
161191992|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
161191993|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
161191994|NCT03099304|582080211|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
161191995|NCT03099304|582080212|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
161191996|NCT03099304|582080213|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
161191997|NCT03099304|582080214|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
161191998|NCT03099304|582080215|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
161191999|NCT03099304|582080216|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
161192000|NCT00636506|582080217|FG000|Overall Study|Lost to Follow-up|8|||
161192001|NCT00636506|582080217|FG000|Overall Study|Explanted|1|||
161192002|NCT00636506|582080217|FG000|Overall Study|Withdrawal by Subject|6|||
161192003|NCT00636506|582080217|FG000|Overall Study|Procedure aborted|1|||
161192004|NCT01624974|582080218|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
161192005|NCT01624974|582080219|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
161192006|NCT01624974|582080218|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
161192007|NCT01624974|582080219|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
161192008|NCT01624974|582080218|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
161192009|NCT01624974|582080219|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
161192010|NCT01624974|582080218|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
161192011|NCT01624974|582080219|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
161192012|NCT01624974|582080218|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
161192013|NCT01624974|582080219|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
161192014|NCT01624974|582080218|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
161192015|NCT01624974|582080219|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
161192016|NCT01624974|582080218|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
161192017|NCT01624974|582080219|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
161192018|NCT01624974|582080218|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
161192019|NCT01624974|582080219|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
161192020|NCT01624974|582080218|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
161192021|NCT01624974|582080219|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
161192022|NCT01624974|582080218|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
161192023|NCT01624974|582080219|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
161192024|NCT01624974|582080218|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
161192025|NCT01624974|582080219|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
161192026|NCT01624974|582080218|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
161192027|NCT01624974|582080219|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
161192028|NCT02607735|582080220|FG000|Primary Study|Randomized but Never Treated|1|||
161192029|NCT02607735|582080221|FG001|Primary Study|Randomized but Never Treated|0|||
161192030|NCT02607735|582080222|FG002|Primary Study|Randomized but Never Treated|0|||
161192031|NCT02607735|582080220|FG000|Primary Study|Lost to Follow-up|4|||
161192032|NCT02607735|582080221|FG001|Primary Study|Lost to Follow-up|0|||
161192033|NCT02607735|582080222|FG002|Primary Study|Lost to Follow-up|0|||
161192034|NCT02607735|582080220|FG000|Primary Study|Withdrew Consent|2|||
161192035|NCT02607735|582080221|FG001|Primary Study|Withdrew Consent|0|||
161192036|NCT02607735|582080222|FG002|Primary Study|Withdrew Consent|0|||
161192037|NCT02607735|582080220|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
161192038|NCT02607735|582080221|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
161192039|NCT02607735|582080222|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
161306276|NCT00985959|582500825|FG002|Overall Study|Unrecovered toxicity|7|||
161306277|NCT00985959|582500823|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
161306278|NCT00985959|582500824|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
161306279|NCT00985959|582500825|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
161306280|NCT00985959|582500823|FG000|Overall Study|Complete response observed over 2 cycles|0|||
161306281|NCT00985959|582500824|FG001|Overall Study|Complete response observed over 2 cycles|1|||
161306282|NCT00985959|582500825|FG002|Overall Study|Complete response observed over 2 cycles|4|||
161192040|NCT02607735|582080220|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
161192041|NCT02607735|582080221|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
161192042|NCT02607735|582080222|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
161192043|NCT01376908|582080223|FG000|Overall Study|Protocol Violation|1|||
161192044|NCT01376908|582080224|FG001|Overall Study|Protocol Violation|1|||
161192045|NCT01376908|582080223|FG000|Overall Study|Withdrawal by Subject|1|||
161192046|NCT01376908|582080224|FG001|Overall Study|Withdrawal by Subject|2|||
161192047|NCT00742391|582080229|FG000|Overall Study|Adverse Event|2|||
161192048|NCT00742391|582080230|FG001|Overall Study|Adverse Event|1|||
161192049|NCT00742391|582080229|FG000|Overall Study|Lost to Follow-up|1|||
161192050|NCT00742391|582080230|FG001|Overall Study|Lost to Follow-up|0|||
161192051|NCT00742391|582080229|FG000|Overall Study|Protocol Violation|1|||
161192052|NCT00742391|582080230|FG001|Overall Study|Protocol Violation|0|||
161192053|NCT04524663|582081853|FG000|Overall Study|Withdrawal by Subject|0|||
161192054|NCT04524663|582081854|FG001|Overall Study|Withdrawal by Subject|2|||
161192055|NCT00911508|582081855|FG000|Overall Study|Lost to Follow-up|27|||
161192056|NCT00911508|582081856|FG001|Overall Study|Lost to Follow-up|18|||
161192057|NCT00911508|582081855|FG000|Overall Study|Withdrawal by Subject|79|||
161192058|NCT00911508|582081856|FG001|Overall Study|Withdrawal by Subject|112|||
161192059|NCT04308668|582081857|FG000|Overall Study|Lost to Follow-up|32|||
161192060|NCT04308668|582081858|FG001|Overall Study|Lost to Follow-up|38|||
161192061|NCT04308668|582081857|FG000|Overall Study|Withdrawal by Subject|4|||
161192062|NCT04308668|582081858|FG001|Overall Study|Withdrawal by Subject|4|||
161192063|NCT01266967|582081859|FG000|Overall Study|Death|69|||
161192064|NCT01266967|582081860|FG001|Overall Study|Death|61|||
161192065|NCT01266967|582081859|FG000|Overall Study|Study Closed/Terminated|15|||
161192066|NCT01266967|582081860|FG001|Overall Study|Study Closed/Terminated|17|||
161192067|NCT01266967|582081859|FG000|Overall Study|Lost to Follow-up|2|||
161192068|NCT01266967|582081860|FG001|Overall Study|Lost to Follow-up|1|||
161192069|NCT01266967|582081859|FG000|Overall Study|Physician Decision|0|||
161192070|NCT01266967|582081860|FG001|Overall Study|Physician Decision|1|||
161192071|NCT01266967|582081859|FG000|Overall Study|Withdrawal by Subject|3|||
161192072|NCT01266967|582081860|FG001|Overall Study|Withdrawal by Subject|3|||
161192073|NCT01519700|582081861|FG000|Overall Study|Death|1|||
161192074|NCT01519700|582081862|FG001|Overall Study|Death|0|||
161192075|NCT01519700|582081863|FG002|Overall Study|Death|0|||
161192076|NCT01519700|582081864|FG003|Overall Study|Death|0|||
161192077|NCT01519700|582081861|FG000|Overall Study|Lost to Follow-up|0|||
161192078|NCT01519700|582081862|FG001|Overall Study|Lost to Follow-up|0|||
161192079|NCT01519700|582081863|FG002|Overall Study|Lost to Follow-up|1|||
161192080|NCT01519700|582081864|FG003|Overall Study|Lost to Follow-up|1|||
161192081|NCT01519700|582081861|FG000|Overall Study|Physician Decision|1|||
161192082|NCT01519700|582081862|FG001|Overall Study|Physician Decision|1|||
161192083|NCT01519700|582081863|FG002|Overall Study|Physician Decision|3|||
161192084|NCT01519700|582081864|FG003|Overall Study|Physician Decision|0|||
161192085|NCT01519700|582081861|FG000|Overall Study|Withdrawal by Subject|5|||
161192086|NCT01519700|582081862|FG001|Overall Study|Withdrawal by Subject|3|||
161192087|NCT01519700|582081863|FG002|Overall Study|Withdrawal by Subject|3|||
161192088|NCT01519700|582081864|FG003|Overall Study|Withdrawal by Subject|2|||
161192089|NCT01519700|582081861|FG000|Overall Study|Other Reason|2|||
161192090|NCT01519700|582081862|FG001|Overall Study|Other Reason|2|||
161192091|NCT01519700|582081863|FG002|Overall Study|Other Reason|0|||
161192092|NCT01519700|582081864|FG003|Overall Study|Other Reason|4|||
161192093|NCT05111548|582081865|FG000|Overall Study|Withdrawal by Subject|2|||
161192094|NCT05111548|582081866|FG001|Overall Study|Withdrawal by Subject|1|||
161192095|NCT05111548|582081865|FG000|Overall Study|Adverse Event|1|||
161192096|NCT05111548|582081866|FG001|Overall Study|Adverse Event|0|||
161192097|NCT02577107|582081873|FG000|Overall Study|Protocol deviation|0|||
161192098|NCT02577107|582081874|FG001|Overall Study|Protocol deviation|1|||
161192099|NCT00577382|582081875|FG000|Overall Study|Adverse Event|0|||
161192100|NCT00577382|582081876|FG001|Overall Study|Adverse Event|6|||
161192101|NCT00577382|582081875|FG000|Overall Study|Withdrawal by Subject|0|||
161192102|NCT00577382|582081876|FG001|Overall Study|Withdrawal by Subject|1|||
161192103|NCT00577382|582081875|FG000|Overall Study|Progressive Disease|17|||
161192104|NCT00577382|582081876|FG001|Overall Study|Progressive Disease|19|||
161192105|NCT00577382|582081875|FG000|Overall Study|Intercurrent Illness|1|||
161192106|NCT00577382|582081876|FG001|Overall Study|Intercurrent Illness|2|||
161192107|NCT00577382|582081875|FG000|Overall Study|Death|1|||
161192108|NCT00577382|582081876|FG001|Overall Study|Death|1|||
161192109|NCT00577382|582081875|FG000|Overall Study|Lost to Follow-up|2|||
161192110|NCT00577382|582081876|FG001|Overall Study|Lost to Follow-up|2|||
161192111|NCT00368069|582081878|FG000|Overall Study|Adverse Event|5|||
161192112|NCT00368069|582081879|FG001|Overall Study|Adverse Event|2|||
161192113|NCT00368069|582081878|FG000|Overall Study|Lack of Efficacy|0|||
161192114|NCT00368069|582081879|FG001|Overall Study|Lack of Efficacy|1|||
161192115|NCT00368069|582081878|FG000|Overall Study|Lost to Follow-up|1|||
161192116|NCT00368069|582081879|FG001|Overall Study|Lost to Follow-up|0|||
161192117|NCT00368069|582081878|FG000|Overall Study|Protocol Violation|0|||
161192118|NCT00368069|582081879|FG001|Overall Study|Protocol Violation|2|||
161192119|NCT00368069|582081878|FG000|Overall Study|Withdrawal of Consent|2|||
161192120|NCT00368069|582081879|FG001|Overall Study|Withdrawal of Consent|1|||
161192121|NCT00368069|582081878|FG000|Overall Study|no blood sampling possible|0|||
161192122|NCT00368069|582081879|FG001|Overall Study|no blood sampling possible|1|||
161192123|NCT03451630|582081880|FG000|Overall Study|Death|15|||
161192124|NCT03451630|582081881|FG001|Overall Study|Death|16|||
161349633|NCT02486718|582665896|FG001|Randomized Phase|Ongoing|301|||
161349634|NCT02486718|582665897|FG002|Randomized Phase|Ongoing|282|||
161349635|NCT04108208|582665898|FG000|Overall Study|Withdrawal by Subject|2|||
161349636|NCT04108208|582665899|FG001|Overall Study|Withdrawal by Subject|6|||
161349637|NCT04108208|582665898|FG000|Overall Study|other-ongoing|20|||
161349638|NCT04108208|582665899|FG001|Overall Study|other-ongoing|40|||
161349639|NCT04108208|582665898|FG000|Overall Study|Death|1|||
161349640|NCT04108208|582665899|FG001|Overall Study|Death|4|||
161349641|NCT04108208|582665898|FG000|Overall Study|Lost to Follow-up|2|||
161349642|NCT04108208|582665899|FG001|Overall Study|Lost to Follow-up|0|||
161349643|NCT04936308|582665900|FG000|Overall Study|Death|0|||
161349644|NCT04936308|582665901|FG001|Overall Study|Death|0|||
161349645|NCT04936308|582665902|FG002|Overall Study|Death|1|||
161349646|NCT04936308|582665900|FG000|Overall Study|Withdrawal by Subject|6|||
161349647|NCT04936308|582665901|FG001|Overall Study|Withdrawal by Subject|3|||
161349648|NCT04936308|582665902|FG002|Overall Study|Withdrawal by Subject|0|||
161349649|NCT04936308|582665900|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
161349650|NCT04936308|582665901|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161349651|NCT04936308|582665902|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
161349652|NCT04936308|582665900|FG000|Overall Study|Completed protocol-required follow-up|1|||
161349653|NCT04936308|582665901|FG001|Overall Study|Completed protocol-required follow-up|2|||
161349654|NCT04936308|582665902|FG002|Overall Study|Completed protocol-required follow-up|2|||
161349655|NCT04936308|582665900|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
161349656|NCT04936308|582665901|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
161349657|NCT04936308|582665902|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
161349658|NCT04936308|582665900|FG000|Overall Study|Other|3|||
161349659|NCT04936308|582665901|FG001|Overall Study|Other|0|||
161349660|NCT04936308|582665902|FG002|Overall Study|Other|2|||
161349661|NCT04770272|582665903|FG000|Overall Study|Death|1|||
161349662|NCT04770272|582665904|FG001|Overall Study|Death|0|||
161349663|NCT04770272|582665903|FG000|Overall Study|Withdrawal by Subject|11|||
161349664|NCT04770272|582665904|FG001|Overall Study|Withdrawal by Subject|12|||
161349665|NCT04770272|582665903|FG000|Overall Study|Protocol Violation|0|||
161349666|NCT04770272|582665904|FG001|Overall Study|Protocol Violation|2|||
161349667|NCT04770272|582665903|FG000|Overall Study|Adverse Event|23|||
161349668|NCT04770272|582665904|FG001|Overall Study|Adverse Event|21|||
161349669|NCT04770272|582665903|FG000|Overall Study|Physician Decision|7|||
161349670|NCT04770272|582665904|FG001|Overall Study|Physician Decision|3|||
161349671|NCT04770272|582665903|FG000|Overall Study|Disease progression|4|||
161349672|NCT04770272|582665904|FG001|Overall Study|Disease progression|8|||
161349673|NCT04770272|582665903|FG000|Overall Study|Switched to other therapy.|0|||
161349674|NCT04770272|582665904|FG001|Overall Study|Switched to other therapy.|2|||
161349675|NCT00602667|582665905|FG000|Overall Study|Still on Therapy|0|||
161349676|NCT00602667|582665906|FG001|Overall Study|Still on Therapy|2|||
161349677|NCT00602667|582665907|FG002|Overall Study|Still on Therapy|2|||
161349678|NCT00602667|582665905|FG000|Overall Study|Death|0|||
161349679|NCT00602667|582665906|FG001|Overall Study|Death|1|||
161349680|NCT00602667|582665907|FG002|Overall Study|Death|1|||
161349681|NCT00602667|582665905|FG000|Overall Study|Family request|3|||
161349682|NCT00602667|582665906|FG001|Overall Study|Family request|25|||
161349683|NCT00602667|582665907|FG002|Overall Study|Family request|6|||
161349684|NCT00602667|582665905|FG000|Overall Study|Excessive toxicity|1|||
161349685|NCT00602667|582665906|FG001|Overall Study|Excessive toxicity|1|||
161349686|NCT00602667|582665907|FG002|Overall Study|Excessive toxicity|0|||
161349687|NCT00602667|582665905|FG000|Overall Study|Second malignancy|0|||
161349688|NCT00602667|582665906|FG001|Overall Study|Second malignancy|1|||
161349689|NCT00602667|582665907|FG002|Overall Study|Second malignancy|0|||
161349690|NCT00602667|582665905|FG000|Overall Study|Physician Decision|2|||
161192125|NCT03451630|582081882|FG002|Overall Study|Death|11|||
161192126|NCT03451630|582081880|FG000|Overall Study|Lost to Follow-up|9|||
161192127|NCT03451630|582081881|FG001|Overall Study|Lost to Follow-up|0|||
161192128|NCT03451630|582081882|FG002|Overall Study|Lost to Follow-up|4|||
161192129|NCT03451630|582081880|FG000|Overall Study|Withdrawal by Subject|0|||
161192130|NCT03451630|582081881|FG001|Overall Study|Withdrawal by Subject|3|||
161349691|NCT00602667|582665906|FG001|Overall Study|Physician Decision|3|||
161349692|NCT00602667|582665907|FG002|Overall Study|Physician Decision|8|||
161349693|NCT00602667|582665905|FG000|Overall Study|Progressive disease|13|||
161349694|NCT00602667|582665906|FG001|Overall Study|Progressive disease|48|||
161349695|NCT00602667|582665907|FG002|Overall Study|Progressive disease|45|||
161349696|NCT00602667|582665905|FG000|Overall Study|Progressive disease prior to therapy|0|||
161349697|NCT00602667|582665906|FG001|Overall Study|Progressive disease prior to therapy|0|||
161349698|NCT00602667|582665907|FG002|Overall Study|Progressive disease prior to therapy|1|||
161349699|NCT02363946|582665909|FG000|Overall Study|Lost to Follow-up|0|||
161349700|NCT02363946|582665910|FG001|Overall Study|Lost to Follow-up|0|||
161349701|NCT02363946|582665911|FG002|Overall Study|Lost to Follow-up|0|||
161349702|NCT02363946|582665912|FG003|Overall Study|Lost to Follow-up|0|||
161192131|NCT03451630|582081882|FG002|Overall Study|Withdrawal by Subject|0|||
161192132|NCT03451630|582081880|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
161192133|NCT03451630|582081881|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
161192134|NCT03451630|582081882|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
161192135|NCT00529152|582081886|FG000|Overall Study|Adverse Event|2|||
161192136|NCT00529152|582081886|FG000|Overall Study|Withdrawal by Subject|2|||
161192137|NCT00529152|582081886|FG000|Overall Study|Lost to Follow-up|1|||
161192138|NCT04062240|582081890|FG000|Overall Study|equipment malfunction|1|||
161306283|NCT00985959|582500823|FG000|Overall Study|Other|0|||
161306284|NCT00985959|582500824|FG001|Overall Study|Other|0|||
161306285|NCT00985959|582500825|FG002|Overall Study|Other|11|||
161306286|NCT00979420|582500826|FG000|Overall Study|Adverse Event|1|||
161306287|NCT00979420|582500827|FG001|Overall Study|Adverse Event|0|||
161306288|NCT00979420|582500828|FG002|Overall Study|Adverse Event|0|||
161306289|NCT00979420|582500829|FG003|Overall Study|Adverse Event|0|||
161306290|NCT00979420|582500826|FG000|Overall Study|Lack of Efficacy|3|||
161306291|NCT00979420|582500827|FG001|Overall Study|Lack of Efficacy|0|||
161306292|NCT00979420|582500828|FG002|Overall Study|Lack of Efficacy|1|||
161306293|NCT00979420|582500829|FG003|Overall Study|Lack of Efficacy|1|||
161306294|NCT00979420|582500826|FG000|Overall Study|Other reasons not related to Viramune|3|||
161306295|NCT00979420|582500827|FG001|Overall Study|Other reasons not related to Viramune|0|||
161306296|NCT00979420|582500828|FG002|Overall Study|Other reasons not related to Viramune|0|||
161192139|NCT03961529|582081891|FG000|Overall Study|Adverse Event|13|||
161192140|NCT03961529|582081892|FG001|Overall Study|Adverse Event|5|||
161192141|NCT03961529|582081893|FG002|Overall Study|Adverse Event|2|||
161192142|NCT03961529|582081891|FG000|Overall Study|Withdrawal by Subject|17|||
161192143|NCT03961529|582081892|FG001|Overall Study|Withdrawal by Subject|2|||
161192144|NCT03961529|582081893|FG002|Overall Study|Withdrawal by Subject|1|||
161192145|NCT03961529|582081891|FG000|Overall Study|Withdrawal by parent/guardian|0|||
161192146|NCT03961529|582081892|FG001|Overall Study|Withdrawal by parent/guardian|7|||
161192147|NCT03961529|582081893|FG002|Overall Study|Withdrawal by parent/guardian|0|||
161192148|NCT03961529|582081891|FG000|Overall Study|Physician Decision|2|||
161192149|NCT03961529|582081892|FG001|Overall Study|Physician Decision|1|||
161192150|NCT03961529|582081893|FG002|Overall Study|Physician Decision|1|||
161306297|NCT00979420|582500829|FG003|Overall Study|Other reasons not related to Viramune|1|||
161306298|NCT02107859|582500831|FG000|Overall Study|Withdrawal by Subject|14|||
161306299|NCT02107859|582500831|FG000|Overall Study|Adverse Event|3|||
161306300|NCT02107859|582500831|FG000|Overall Study|Study closure|41|||
161306301|NCT02107859|582500831|FG000|Overall Study|Other than specified|3|||
161306302|NCT02235077|582500832|FG000|Overall Study|Death|5|||
161306303|NCT02235077|582500833|FG001|Overall Study|Death|7|||
161306304|NCT02235077|582500832|FG000|Overall Study|Lost to Follow-up|5|||
161306305|NCT02235077|582500833|FG001|Overall Study|Lost to Follow-up|6|||
161306306|NCT02235077|582500832|FG000|Overall Study|Withdrawal by Subject|8|||
161306307|NCT02235077|582500833|FG001|Overall Study|Withdrawal by Subject|5|||
161306308|NCT02235077|582500832|FG000|Overall Study|Physician Decision|0|||
161306309|NCT02235077|582500833|FG001|Overall Study|Physician Decision|1|||
161306310|NCT03852628|582500834|FG000|Overall Study|Lost to Follow-up|7|||
161306311|NCT03852628|582500835|FG001|Overall Study|Lost to Follow-up|6|||
161306312|NCT03852628|582500834|FG000|Overall Study|Lack of Efficacy|6|||
161306313|NCT03852628|582500835|FG001|Overall Study|Lack of Efficacy|6|||
161306314|NCT04013672|582500840|FG000|Overall Study|Withdrawal by Subject|3|||
161306315|NCT04013672|582500841|FG001|Overall Study|Withdrawal by Subject|0|||
161306316|NCT04013672|582500840|FG000|Overall Study|Death|1|||
161306317|NCT04013672|582500841|FG001|Overall Study|Death|0|||
161306318|NCT04013672|582500840|FG000|Overall Study|Physician Decision|5|||
161306319|NCT04013672|582500841|FG001|Overall Study|Physician Decision|0|||
161306320|NCT02847494|582500846|FG000|Overall Study|Lost to Follow-up|8|||
161306321|NCT02847494|582500847|FG001|Overall Study|Lost to Follow-up|5|||
161306322|NCT00022698|582500853|FG000|Overall Study|Adverse Event|5|||
161306323|NCT00022698|582500854|FG001|Overall Study|Adverse Event|9|||
161349703|NCT02363946|582665913|FG004|Overall Study|Lost to Follow-up|0|||
161306324|NCT00022698|582500853|FG000|Overall Study|Death|0|||
161306325|NCT00022698|582500854|FG001|Overall Study|Death|2|||
161349704|NCT02363946|582665914|FG005|Overall Study|Lost to Follow-up|0|||
161306326|NCT00022698|582500853|FG000|Overall Study|Failure to return|0|||
161306327|NCT00022698|582500854|FG001|Overall Study|Failure to return|1|||
161306328|NCT00022698|582500853|FG000|Overall Study|Refused treatment|0|||
161306329|NCT00022698|582500854|FG001|Overall Study|Refused treatment|2|||
161306330|NCT00022698|582500853|FG000|Overall Study|Insufficient therapeutic response|2|||
161306331|NCT00022698|582500854|FG001|Overall Study|Insufficient therapeutic response|14|||
161306332|NCT00022698|582500853|FG000|Overall Study|Administrative /other|1|||
161306333|NCT00022698|582500854|FG001|Overall Study|Administrative /other|7|||
161349705|NCT02363946|582665915|FG006|Overall Study|Lost to Follow-up|0|||
161192151|NCT03961529|582081891|FG000|Overall Study|Lost to Follow-up|2|||
161192152|NCT03961529|582081892|FG001|Overall Study|Lost to Follow-up|1|||
161192153|NCT03961529|582081893|FG002|Overall Study|Lost to Follow-up|0|||
161192154|NCT03961529|582081891|FG000|Overall Study|Lack of Efficacy|2|||
161192155|NCT03961529|582081892|FG001|Overall Study|Lack of Efficacy|0|||
161192156|NCT03961529|582081893|FG002|Overall Study|Lack of Efficacy|1|||
161192157|NCT03961529|582081891|FG000|Overall Study|Other|6|||
161192158|NCT03961529|582081892|FG001|Overall Study|Other|1|||
161192159|NCT03961529|582081893|FG002|Overall Study|Other|0|||
161192160|NCT03500419|582081894|FG000|Overall Study|Withdrawal by Subject|2|||
161192161|NCT03500419|582081895|FG001|Overall Study|Withdrawal by Subject|25|||
161192162|NCT01497899|582081896|FG000|Double-Blind Phase|Randomized but not Treated|1|||
161192163|NCT01497899|582081897|FG001|Double-Blind Phase|Randomized but not Treated|0|||
161192164|NCT01497899|582081898|FG002|Double-Blind Phase|Randomized but not Treated|0|||
161192165|NCT01497899|582081899|FG003|Double-Blind Phase|Randomized but not Treated|0|||
161192166|NCT01497899|582081896|FG000|Double-Blind Phase|Adverse Event|1|||
161192167|NCT01497899|582081897|FG001|Double-Blind Phase|Adverse Event|0|||
161192168|NCT01497899|582081898|FG002|Double-Blind Phase|Adverse Event|0|||
161192169|NCT01497899|582081899|FG003|Double-Blind Phase|Adverse Event|0|||
161192170|NCT01497899|582081896|FG000|Double-Blind Phase|Lack of Efficacy|0|||
161192171|NCT01497899|582081897|FG001|Double-Blind Phase|Lack of Efficacy|1|||
161192172|NCT01497899|582081898|FG002|Double-Blind Phase|Lack of Efficacy|0|||
161192173|NCT01497899|582081899|FG003|Double-Blind Phase|Lack of Efficacy|0|||
161192174|NCT01497899|582081896|FG000|Double-Blind Phase|Investigator's Discretion|1|||
161192175|NCT01497899|582081897|FG001|Double-Blind Phase|Investigator's Discretion|0|||
161192176|NCT01497899|582081898|FG002|Double-Blind Phase|Investigator's Discretion|0|||
161192177|NCT01497899|582081899|FG003|Double-Blind Phase|Investigator's Discretion|0|||
161192178|NCT01497899|582081896|FG000|Double-Blind Phase|Withdrew Consent|0|||
161192179|NCT01497899|582081897|FG001|Double-Blind Phase|Withdrew Consent|1|||
161192180|NCT01497899|582081898|FG002|Double-Blind Phase|Withdrew Consent|0|||
161192181|NCT01497899|582081899|FG003|Double-Blind Phase|Withdrew Consent|0|||
161192182|NCT01497899|582081896|FG000|Double-Blind Phase|Lost to Follow-up|3|||
161192183|NCT01497899|582081897|FG001|Double-Blind Phase|Lost to Follow-up|2|||
161192184|NCT01497899|582081898|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161192185|NCT01497899|582081899|FG003|Double-Blind Phase|Lost to Follow-up|0|||
161192186|NCT01497899|582081896|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
161192187|NCT01497899|582081897|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
161192188|NCT01497899|582081898|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
161192189|NCT01497899|582081899|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
161192190|NCT01497899|582081896|FG000|Open-Label Extension Phase|Adverse Event|1|||
161192191|NCT01497899|582081897|FG001|Open-Label Extension Phase|Adverse Event|0|||
161192192|NCT01497899|582081898|FG002|Open-Label Extension Phase|Adverse Event|0|||
161192193|NCT01497899|582081899|FG003|Open-Label Extension Phase|Adverse Event|0|||
161192194|NCT01497899|582081896|FG000|Open-Label Extension Phase|Death|1|||
161192195|NCT01497899|582081897|FG001|Open-Label Extension Phase|Death|0|||
161192196|NCT01497899|582081898|FG002|Open-Label Extension Phase|Death|0|||
161192197|NCT01497899|582081899|FG003|Open-Label Extension Phase|Death|0|||
161192198|NCT01497899|582081896|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
161192199|NCT01497899|582081897|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
161192200|NCT01497899|582081898|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
161192201|NCT01497899|582081899|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
161192202|NCT01497899|582081896|FG000|Open-Label Extension Phase|Pregnancy|0|||
161192203|NCT01497899|582081897|FG001|Open-Label Extension Phase|Pregnancy|1|||
161192204|NCT01497899|582081898|FG002|Open-Label Extension Phase|Pregnancy|1|||
161192205|NCT01497899|582081899|FG003|Open-Label Extension Phase|Pregnancy|0|||
161192206|NCT01497899|582081896|FG000|Open-Label Extension Phase|Protocol Violation|0|||
161192207|NCT01497899|582081897|FG001|Open-Label Extension Phase|Protocol Violation|0|||
161192208|NCT01497899|582081898|FG002|Open-Label Extension Phase|Protocol Violation|1|||
161192209|NCT01497899|582081899|FG003|Open-Label Extension Phase|Protocol Violation|0|||
161192210|NCT01497899|582081896|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
161192211|NCT01497899|582081897|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
161192212|NCT01497899|582081898|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
161192213|NCT01497899|582081899|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
161192214|NCT01646255|582081902|FG000|Overall Study|Adverse Event|7|||
161192215|NCT01646255|582081903|FG001|Overall Study|Adverse Event|8|||
161192216|NCT01646255|582081902|FG000|Overall Study|Lack of Efficacy|2|||
161192217|NCT01646255|582081903|FG001|Overall Study|Lack of Efficacy|0|||
161192218|NCT01646255|582081902|FG000|Overall Study|Withdrawal by Subject|10|||
161192219|NCT01646255|582081903|FG001|Overall Study|Withdrawal by Subject|6|||
161192220|NCT01646255|582081902|FG000|Overall Study|Compliance is not well|1|||
161192221|NCT01646255|582081903|FG001|Overall Study|Compliance is not well|0|||
161192222|NCT01646255|582081902|FG000|Overall Study|Inclusion Criteria Deviation|1|||
161192223|NCT01646255|582081903|FG001|Overall Study|Inclusion Criteria Deviation|0|||
161192224|NCT02142712|582081904|FG000|Overall Study|Lost to Follow-up|1|||
161192225|NCT02142712|582081905|FG001|Overall Study|Lost to Follow-up|1|||
161192226|NCT02142712|582081906|FG002|Overall Study|Lost to Follow-up|1|||
161192227|NCT02142712|582081907|FG003|Overall Study|Lost to Follow-up|0|||
161192228|NCT03607994|582081914|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
161192229|NCT03607994|582081915|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
161192230|NCT04490499|582081923|FG000|Overall Study|Withdrawal by Subject|2|||
161192231|NCT01997333|582081928|FG000|Randomization and Treatment|Disease Progression|70|||
161192232|NCT01997333|582081929|FG001|Randomization and Treatment|Disease Progression|159|||
161192233|NCT01997333|582081928|FG000|Randomization and Treatment|Adverse Event|10|||
161192234|NCT01997333|582081929|FG001|Randomization and Treatment|Adverse Event|32|||
161192235|NCT01997333|582081928|FG000|Randomization and Treatment|Physician Decision|0|||
161192236|NCT01997333|582081929|FG001|Randomization and Treatment|Physician Decision|4|||
161192237|NCT01997333|582081928|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
161192238|NCT01997333|582081929|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
161192239|NCT01997333|582081928|FG000|Randomization and Treatment|Did not receive treatment|17|||
161192240|NCT01997333|582081929|FG001|Randomization and Treatment|Did not receive treatment|5|||
161192241|NCT01997333|582081928|FG000|Survival Follow up|Withdrawal by Subject|15|||
161192242|NCT01997333|582081929|FG001|Survival Follow up|Withdrawal by Subject|6|||
161192243|NCT01997333|582081928|FG000|Survival Follow up|Lost to Follow-up|0|||
161192244|NCT01997333|582081929|FG001|Survival Follow up|Lost to Follow-up|6|||
161192245|NCT01997333|582081928|FG000|Survival Follow up|Various|1|||
161192246|NCT01997333|582081929|FG001|Survival Follow up|Various|2|||
161192247|NCT01747655|582081930|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
161192248|NCT01747655|582081931|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
161192249|NCT01747655|582081930|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
161192250|NCT01747655|582081931|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
161192251|NCT01747655|582081930|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
161192252|NCT01747655|582081931|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
161192253|NCT03769753|582081932|FG000|Overall Study|Not Treated|6|||
161192254|NCT03769753|582081932|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
161192255|NCT00684073|582081933|FG000|Selection|Selection/non-selection criteria|3|||
161192256|NCT00684073|582081933|FG000|Selection|Death|1|||
161192257|NCT00684073|582081933|FG000|Selection|noncompliance|1|||
161192258|NCT00684073|582081933|FG000|Selection|Lost to Follow-up|1|||
161192259|NCT00684073|582081933|FG000|Selection|request of the sponsor|1|||
161192260|NCT00684073|582081933|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
161192261|NCT01259388|582081935|FG000|Overall Study|Adverse Event|3|||
161192262|NCT01259388|582081936|FG001|Overall Study|Adverse Event|0|||
161192263|NCT01259388|582081935|FG000|Overall Study|Withdrawal by Subject|1|||
161192264|NCT01259388|582081936|FG001|Overall Study|Withdrawal by Subject|1|||
161192265|NCT01259388|582081935|FG000|Overall Study|Physician Decision|1|||
161192266|NCT01259388|582081936|FG001|Overall Study|Physician Decision|0|||
161192267|NCT00620815|582081937|FG000|Overall Study|Adverse Event|1|||
161192268|NCT00620815|582081938|FG001|Overall Study|Adverse Event|1|||
161192269|NCT00620815|582081939|FG002|Overall Study|Adverse Event|2|||
161192270|NCT00620815|582081937|FG000|Overall Study|Withdrawal by Subject|1|||
161192271|NCT00620815|582081938|FG001|Overall Study|Withdrawal by Subject|2|||
161192272|NCT00620815|582081939|FG002|Overall Study|Withdrawal by Subject|0|||
161192273|NCT00620815|582081937|FG000|Overall Study|Lost to Follow-up|1|||
161192274|NCT00620815|582081938|FG001|Overall Study|Lost to Follow-up|6|||
161192275|NCT00620815|582081939|FG002|Overall Study|Lost to Follow-up|3|||
161192276|NCT00620815|582081937|FG000|Overall Study|Inappropriate enrolment|0|||
161192277|NCT00620815|582081938|FG001|Overall Study|Inappropriate enrolment|0|||
161192278|NCT00620815|582081939|FG002|Overall Study|Inappropriate enrolment|1|||
161192279|NCT00620815|582081937|FG000|Overall Study|Protocol Violation|1|||
161192280|NCT00620815|582081938|FG001|Overall Study|Protocol Violation|2|||
161192281|NCT00620815|582081939|FG002|Overall Study|Protocol Violation|1|||
161192282|NCT00983827|582081940|FG000|Overall Study|Withdrawal by Subject|1|||
161192283|NCT01230827|582081941|FG000|Overall Study|Lost to Follow-up|0|||
161192284|NCT01230827|582081942|FG001|Overall Study|Lost to Follow-up|0|||
161192285|NCT01230827|582081943|FG002|Overall Study|Lost to Follow-up|1|||
161192286|NCT01230827|582081944|FG003|Overall Study|Lost to Follow-up|3|||
161192287|NCT01230827|582081941|FG000|Overall Study|Withdrawal by Subject|1|||
161192288|NCT01230827|582081942|FG001|Overall Study|Withdrawal by Subject|0|||
161192289|NCT01230827|582081943|FG002|Overall Study|Withdrawal by Subject|3|||
161192290|NCT01230827|582081944|FG003|Overall Study|Withdrawal by Subject|2|||
161192291|NCT01230827|582081941|FG000|Overall Study|Lack of Efficacy|14|||
161192292|NCT01230827|582081942|FG001|Overall Study|Lack of Efficacy|1|||
161192293|NCT01230827|582081943|FG002|Overall Study|Lack of Efficacy|2|||
161192294|NCT01230827|582081944|FG003|Overall Study|Lack of Efficacy|3|||
161192295|NCT01230827|582081941|FG000|Overall Study|Adverse Event|4|||
161192296|NCT01230827|582081942|FG001|Overall Study|Adverse Event|2|||
161192297|NCT01230827|582081943|FG002|Overall Study|Adverse Event|3|||
161192298|NCT01230827|582081944|FG003|Overall Study|Adverse Event|7|||
161192299|NCT01230827|582081941|FG000|Overall Study|Recovery|0|||
161192300|NCT01230827|582081942|FG001|Overall Study|Recovery|6|||
161192301|NCT01230827|582081943|FG002|Overall Study|Recovery|0|||
161192302|NCT01230827|582081944|FG003|Overall Study|Recovery|0|||
161192303|NCT01230827|582081941|FG000|Overall Study|Study terminated by Sponsor|0|||
161192304|NCT01230827|582081942|FG001|Overall Study|Study terminated by Sponsor|2|||
161192305|NCT01230827|582081943|FG002|Overall Study|Study terminated by Sponsor|56|||
161192306|NCT01230827|582081944|FG003|Overall Study|Study terminated by Sponsor|63|||
161192307|NCT01888367|582081947|FG000|Overall Study|Physician Decision|3|||
161192308|NCT01888367|582081948|FG001|Overall Study|Physician Decision|4|||
161192309|NCT01888367|582081949|FG002|Overall Study|Physician Decision|2|||
161192310|NCT01888367|582081947|FG000|Overall Study|Death|2|||
161192311|NCT01888367|582081948|FG001|Overall Study|Death|0|||
161349706|NCT02363946|582665916|FG007|Overall Study|Lost to Follow-up|1|||
161349707|NCT02363946|582665917|FG008|Overall Study|Lost to Follow-up|0|||
161192312|NCT01888367|582081949|FG002|Overall Study|Death|1|||
161349708|NCT02363946|582665918|FG009|Overall Study|Lost to Follow-up|0|||
161349709|NCT02363946|582665919|FG010|Overall Study|Lost to Follow-up|0|||
161349710|NCT02363946|582665920|FG011|Overall Study|Lost to Follow-up|0|||
161349711|NCT02363946|582665921|FG012|Overall Study|Lost to Follow-up|0|||
161349712|NCT02975700|582665924|FG000|Overall Study|Adverse Event|1|||
161349713|NCT02975700|582665924|FG000|Overall Study|Progressive disease|3|||
161349714|NCT02975700|582665924|FG000|Overall Study|Failed screening criteria|2|||
161349715|NCT05702918|582665925|FG000|Overall Study|Withdrawal by Subject|0|||
161349716|NCT05702918|582665926|FG001|Overall Study|Withdrawal by Subject|2|||
161349717|NCT05702918|582665925|FG000|Overall Study|Lost to Follow-up|0|||
161349718|NCT05702918|582665926|FG001|Overall Study|Lost to Follow-up|2|||
161349719|NCT05702918|582665925|FG000|Overall Study|Unrelated injury|2|||
161349720|NCT05702918|582665926|FG001|Overall Study|Unrelated injury|0|||
161349721|NCT03030261|582665929|FG000|Overall Study|Still receiving continuation therapy|5|||
161349722|NCT04765059|582665930|FG000|Overall Study|Failure to meet randomization criteria|1|||
161349723|NCT04765059|582665931|FG001|Overall Study|Failure to meet randomization criteria|0|||
161349724|NCT04765059|582665930|FG000|Overall Study|Withdrawal by Subject|1|||
161349725|NCT04765059|582665931|FG001|Overall Study|Withdrawal by Subject|4|||
161349726|NCT04765059|582665930|FG000|Overall Study|Lost to Follow-up|1|||
161349727|NCT04765059|582665931|FG001|Overall Study|Lost to Follow-up|1|||
161349728|NCT04765059|582665930|FG000|Overall Study|Death|25|||
161349729|NCT04765059|582665931|FG001|Overall Study|Death|28|||
161349730|NCT04765059|582665930|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
161349731|NCT04765059|582665931|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
161349732|NCT01615029|582665933|FG000|Overall Study|Adverse Event|1|||
161349733|NCT01615029|582665934|FG001|Overall Study|Adverse Event|0|||
161349734|NCT01615029|582665935|FG002|Overall Study|Adverse Event|3|||
161349735|NCT01615029|582665936|FG003|Overall Study|Adverse Event|0|||
161349736|NCT01615029|582665937|FG004|Overall Study|Adverse Event|4|||
161192313|NCT01888367|582081947|FG000|Overall Study|Withdrawal by Subject|1|||
161192314|NCT01888367|582081948|FG001|Overall Study|Withdrawal by Subject|0|||
161192315|NCT01888367|582081949|FG002|Overall Study|Withdrawal by Subject|1|||
161192316|NCT01888367|582081947|FG000|Overall Study|Lost to Follow-up|1|||
161192317|NCT01888367|582081948|FG001|Overall Study|Lost to Follow-up|1|||
161192318|NCT01888367|582081949|FG002|Overall Study|Lost to Follow-up|0|||
161192319|NCT01888367|582081947|FG000|Overall Study|Protocol Violation|0|||
161192320|NCT01888367|582081948|FG001|Overall Study|Protocol Violation|0|||
161192321|NCT01888367|582081949|FG002|Overall Study|Protocol Violation|1|||
161192322|NCT01888367|582081947|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
161192323|NCT01888367|582081948|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
161192324|NCT01888367|582081949|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
161192325|NCT02728804|582081950|FG000|Overall Study|Ineligible|3|||
161192326|NCT02728804|582081950|FG000|Overall Study|Did not complete baseline questionnaire|9|||
161192327|NCT02728804|582081950|FG000|Overall Study|Death|99|||
161192328|NCT00591786|582081953|FG000|Overall Study|Withdrawal of Informed Consent|0|||
161192329|NCT00591786|582081954|FG001|Overall Study|Withdrawal of Informed Consent|0|||
161192330|NCT00591786|582081955|FG002|Overall Study|Withdrawal of Informed Consent|1|||
161192331|NCT00591786|582081956|FG003|Overall Study|Withdrawal of Informed Consent|0|||
161192332|NCT00591786|582081957|FG004|Overall Study|Withdrawal of Informed Consent|0|||
161192333|NCT00591786|582081958|FG005|Overall Study|Withdrawal of Informed Consent|0|||
161192334|NCT00591786|582081959|FG006|Overall Study|Withdrawal of Informed Consent|0|||
161192335|NCT00591786|582081960|FG007|Overall Study|Withdrawal of Informed Consent|0|||
161349737|NCT01615029|582665933|FG000|Overall Study|Progressive disease|1|||
161349738|NCT01615029|582665934|FG001|Overall Study|Progressive disease|1|||
161349739|NCT01615029|582665935|FG002|Overall Study|Progressive disease|1|||
161349740|NCT01615029|582665936|FG003|Overall Study|Progressive disease|1|||
161192336|NCT00591786|582081961|FG008|Overall Study|Withdrawal of Informed Consent|0|||
161192337|NCT00591786|582081962|FG009|Overall Study|Withdrawal of Informed Consent|0|||
161192338|NCT01854918|582081963|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
161192339|NCT01854918|582081964|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
161192340|NCT01854918|582081963|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
161192341|NCT01854918|582081964|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
161192342|NCT01854918|582081963|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
161192343|NCT01854918|582081964|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
161192344|NCT01854918|582081963|FG000|SOC-controlled Period (Year 1)|Death|5|||
161192345|NCT01854918|582081964|FG001|SOC-controlled Period (Year 1)|Death|5|||
161192346|NCT01854918|582081963|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
161192347|NCT01854918|582081964|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
161192348|NCT01854918|582081963|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
161192349|NCT01854918|582081964|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
161192350|NCT01854918|582081963|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
161192351|NCT01854918|582081964|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
161192352|NCT01854918|582081963|FG000|All-IP Period (Years 2 and 3)|Death|5|||
161192353|NCT01854918|582081964|FG001|All-IP Period (Years 2 and 3)|Death|16|||
161192354|NCT01920061|582081968|FG000|Overall Study|Death|1|||
161192355|NCT01920061|582081969|FG001|Overall Study|Death|1|||
161192356|NCT01920061|582081970|FG002|Overall Study|Death|0|||
161192357|NCT01920061|582081971|FG003|Overall Study|Death|1|||
161192358|NCT01920061|582081972|FG004|Overall Study|Death|1|||
161192359|NCT01920061|582081973|FG005|Overall Study|Death|0|||
161192360|NCT01920061|582081974|FG006|Overall Study|Death|0|||
161192361|NCT01920061|582081975|FG007|Overall Study|Death|1|||
161192362|NCT01920061|582081976|FG008|Overall Study|Death|0|||
161192363|NCT01920061|582081977|FG009|Overall Study|Death|1|||
161192364|NCT01920061|582081978|FG010|Overall Study|Death|0|||
161192365|NCT01920061|582081979|FG011|Overall Study|Death|1|||
161192366|NCT01920061|582081980|FG012|Overall Study|Death|0|||
161192367|NCT01920061|582081981|FG013|Overall Study|Death|2|||
161192368|NCT01920061|582081982|FG014|Overall Study|Death|0|||
161192369|NCT01920061|582081983|FG015|Overall Study|Death|0|||
161192370|NCT01920061|582081984|FG016|Overall Study|Death|0|||
161192371|NCT01920061|582081985|FG017|Overall Study|Death|0|||
161192372|NCT01920061|582081986|FG018|Overall Study|Death|1|||
161192373|NCT01920061|582081987|FG019|Overall Study|Death|0|||
161192374|NCT01920061|582081968|FG000|Overall Study|Lost to Follow-up|0|||
161192375|NCT01920061|582081969|FG001|Overall Study|Lost to Follow-up|2|||
161192376|NCT01920061|582081970|FG002|Overall Study|Lost to Follow-up|0|||
161192377|NCT01920061|582081971|FG003|Overall Study|Lost to Follow-up|0|||
161192378|NCT01920061|582081972|FG004|Overall Study|Lost to Follow-up|0|||
161192379|NCT01920061|582081973|FG005|Overall Study|Lost to Follow-up|0|||
161192380|NCT01920061|582081974|FG006|Overall Study|Lost to Follow-up|1|||
161192381|NCT01920061|582081975|FG007|Overall Study|Lost to Follow-up|0|||
161192382|NCT01920061|582081976|FG008|Overall Study|Lost to Follow-up|0|||
161192383|NCT01920061|582081977|FG009|Overall Study|Lost to Follow-up|0|||
161192384|NCT01920061|582081978|FG010|Overall Study|Lost to Follow-up|3|||
161192385|NCT01920061|582081979|FG011|Overall Study|Lost to Follow-up|0|||
161192386|NCT01920061|582081980|FG012|Overall Study|Lost to Follow-up|0|||
161192387|NCT01920061|582081981|FG013|Overall Study|Lost to Follow-up|0|||
161192388|NCT01920061|582081982|FG014|Overall Study|Lost to Follow-up|0|||
161192389|NCT01920061|582081983|FG015|Overall Study|Lost to Follow-up|0|||
161192390|NCT01920061|582081984|FG016|Overall Study|Lost to Follow-up|0|||
161192391|NCT01920061|582081985|FG017|Overall Study|Lost to Follow-up|1|||
161192392|NCT01920061|582081986|FG018|Overall Study|Lost to Follow-up|4|||
161192393|NCT01920061|582081987|FG019|Overall Study|Lost to Follow-up|3|||
161192394|NCT01920061|582081968|FG000|Overall Study|Other|1|||
161192395|NCT01920061|582081969|FG001|Overall Study|Other|1|||
161192396|NCT01920061|582081970|FG002|Overall Study|Other|2|||
161192397|NCT01920061|582081971|FG003|Overall Study|Other|1|||
161192398|NCT01920061|582081972|FG004|Overall Study|Other|0|||
161192399|NCT01920061|582081973|FG005|Overall Study|Other|1|||
161192400|NCT01920061|582081974|FG006|Overall Study|Other|0|||
161192401|NCT01920061|582081975|FG007|Overall Study|Other|0|||
161192402|NCT01920061|582081976|FG008|Overall Study|Other|0|||
161192403|NCT01920061|582081977|FG009|Overall Study|Other|1|||
161306334|NCT03512210|582500857|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
161306335|NCT03512210|582500857|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
161192404|NCT01920061|582081978|FG010|Overall Study|Other|1|||
161192405|NCT01920061|582081979|FG011|Overall Study|Other|2|||
161192406|NCT01920061|582081980|FG012|Overall Study|Other|1|||
161192407|NCT01920061|582081981|FG013|Overall Study|Other|4|||
161192408|NCT01920061|582081982|FG014|Overall Study|Other|0|||
161192409|NCT01920061|582081983|FG015|Overall Study|Other|1|||
161192410|NCT01920061|582081984|FG016|Overall Study|Other|1|||
161192411|NCT01920061|582081985|FG017|Overall Study|Other|0|||
161192412|NCT01920061|582081986|FG018|Overall Study|Other|1|||
161192413|NCT01920061|582081987|FG019|Overall Study|Other|1|||
161192414|NCT01920061|582081968|FG000|Overall Study|Participant refused further follow-up|0|||
161192415|NCT01920061|582081969|FG001|Overall Study|Participant refused further follow-up|0|||
161192416|NCT01920061|582081970|FG002|Overall Study|Participant refused further follow-up|0|||
161192417|NCT01920061|582081971|FG003|Overall Study|Participant refused further follow-up|0|||
161192418|NCT01920061|582081972|FG004|Overall Study|Participant refused further follow-up|1|||
161192419|NCT01920061|582081973|FG005|Overall Study|Participant refused further follow-up|1|||
161192420|NCT01920061|582081974|FG006|Overall Study|Participant refused further follow-up|0|||
161192421|NCT01920061|582081975|FG007|Overall Study|Participant refused further follow-up|0|||
161192422|NCT01920061|582081976|FG008|Overall Study|Participant refused further follow-up|1|||
161192423|NCT01920061|582081977|FG009|Overall Study|Participant refused further follow-up|0|||
161192424|NCT01920061|582081978|FG010|Overall Study|Participant refused further follow-up|1|||
161192425|NCT01920061|582081979|FG011|Overall Study|Participant refused further follow-up|0|||
161192426|NCT01920061|582081980|FG012|Overall Study|Participant refused further follow-up|1|||
161192427|NCT01920061|582081981|FG013|Overall Study|Participant refused further follow-up|0|||
161192428|NCT01920061|582081982|FG014|Overall Study|Participant refused further follow-up|1|||
161192429|NCT01920061|582081983|FG015|Overall Study|Participant refused further follow-up|2|||
161192430|NCT01920061|582081984|FG016|Overall Study|Participant refused further follow-up|1|||
161192431|NCT01920061|582081985|FG017|Overall Study|Participant refused further follow-up|1|||
161192432|NCT01920061|582081986|FG018|Overall Study|Participant refused further follow-up|0|||
161192433|NCT01920061|582081987|FG019|Overall Study|Participant refused further follow-up|0|||
161192434|NCT00805142|582081990|FG000|Titration Period|Adverse Event|3|||
161192435|NCT00805142|582081991|FG001|Titration Period|Adverse Event|3|||
161192436|NCT00805142|582081990|FG000|Titration Period|Lack of Efficacy|1|||
161192437|NCT00805142|582081991|FG001|Titration Period|Lack of Efficacy|1|||
161192438|NCT00805142|582081990|FG000|Titration Period|Lost to Follow-up|0|||
161192439|NCT00805142|582081991|FG001|Titration Period|Lost to Follow-up|1|||
161192440|NCT00805142|582081990|FG000|Titration Period|Disease Progression|2|||
161192441|NCT00805142|582081991|FG001|Titration Period|Disease Progression|1|||
161192442|NCT00805142|582081990|FG000|Titration Period|Withdrawal of consent|0|||
161192443|NCT00805142|582081991|FG001|Titration Period|Withdrawal of consent|1|||
161192444|NCT00805142|582081990|FG000|Titration Period|Other|0|||
161192445|NCT00805142|582081991|FG001|Titration Period|Other|3|||
161192446|NCT00805142|582081990|FG000|Maintenance Period|Adverse Event|0|||
161192447|NCT00805142|582081991|FG001|Maintenance Period|Adverse Event|1|||
161192448|NCT00805142|582081990|FG000|Maintenance Period|Other|0|||
161192449|NCT00805142|582081991|FG001|Maintenance Period|Other|1|||
161192450|NCT00422942|582081992|FG000|Overall Study|Study terminated by Sponsor|3|||
161192451|NCT02828982|582081995|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161192452|NCT02828982|582081996|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
161192453|NCT02475564|582081997|FG000|Overall Study|Withdrawal by Subject|1|||
161192454|NCT02475564|582081998|FG001|Overall Study|Withdrawal by Subject|0|||
161192455|NCT02475564|582081997|FG000|Overall Study|Lost to Follow-up|2|||
161192456|NCT02475564|582081998|FG001|Overall Study|Lost to Follow-up|1|||
161192457|NCT02475564|582081997|FG000|Overall Study|Intense Menstrual bleeding|1|||
161192458|NCT02475564|582081998|FG001|Overall Study|Intense Menstrual bleeding|0|||
161192459|NCT02705755|582081999|FG000|Part A (6 Days)|Adverse Event|1|||
161192460|NCT02705755|582082000|FG001|Part A (6 Days)|Adverse Event|0|||
161192461|NCT02705755|582082001|FG002|Part A (6 Days)|Adverse Event|0|||
161192462|NCT02705755|582082002|FG003|Part A (6 Days)|Adverse Event|0|||
161192463|NCT02705755|582081999|FG000|Part A (6 Days)|Physician Decision|3|||
161192464|NCT02705755|582082000|FG001|Part A (6 Days)|Physician Decision|0|||
161192465|NCT02705755|582082001|FG002|Part A (6 Days)|Physician Decision|0|||
161192466|NCT02705755|582082002|FG003|Part A (6 Days)|Physician Decision|0|||
161192467|NCT02705755|582081999|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
161192468|NCT02705755|582082000|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
161192469|NCT02705755|582082001|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
161192470|NCT02705755|582082002|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
161192471|NCT02705755|582081999|FG000|Part C (20 Weeks)|Physician Decision|0|||
161192472|NCT02705755|582082000|FG001|Part C (20 Weeks)|Physician Decision|0|||
161192473|NCT02705755|582082001|FG002|Part C (20 Weeks)|Physician Decision|0|||
161192474|NCT02705755|582082002|FG003|Part C (20 Weeks)|Physician Decision|2|||
161192475|NCT02705755|582081999|FG000|Part C (20 Weeks)|Adverse Event|0|||
161192476|NCT02705755|582082000|FG001|Part C (20 Weeks)|Adverse Event|0|||
161192477|NCT02705755|582082001|FG002|Part C (20 Weeks)|Adverse Event|0|||
161192478|NCT02705755|582082002|FG003|Part C (20 Weeks)|Adverse Event|6|||
161306336|NCT03512210|582500857|FG000|Step 2:Post-MINMON|Death|2|||
161306337|NCT03512210|582500857|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
161306338|NCT03512210|582500857|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
161306339|NCT03725761|582500858|FG000|Overall Study|still on study|1|||
161306340|NCT03197467|582502819|FG000|Overall Study|Withdrawal by Subject|1|||
161306341|NCT03666533|582502820|FG000|Overall Study|Lost to Follow-up|2|||
161306342|NCT03666533|582502821|FG001|Overall Study|Lost to Follow-up|2|||
161192479|NCT02705755|582081999|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
161192480|NCT02705755|582082000|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
161306343|NCT02017717|582502822|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161306344|NCT02017717|582502823|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161306345|NCT02017717|582502824|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161192481|NCT02705755|582082001|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
161192482|NCT02705755|582082002|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
161192483|NCT01906489|582082003|FG000|Overall Study|Adverse Event|10|||
161192484|NCT01906489|582082004|FG001|Overall Study|Adverse Event|3|||
161192485|NCT01906489|582082003|FG000|Overall Study|Worsening of CKD|6|||
161192486|NCT01906489|582082004|FG001|Overall Study|Worsening of CKD|4|||
161192487|NCT01906489|582082003|FG000|Overall Study|Withdrawal by Subject|5|||
161192488|NCT01906489|582082004|FG001|Overall Study|Withdrawal by Subject|0|||
161192489|NCT01906489|582082003|FG000|Overall Study|Worsening of Anemia|1|||
161192490|NCT01906489|582082004|FG001|Overall Study|Worsening of Anemia|0|||
161192491|NCT01906489|582082003|FG000|Overall Study|Protocol Violation|0|||
161192492|NCT01906489|582082004|FG001|Overall Study|Protocol Violation|1|||
161192493|NCT01906489|582082003|FG000|Overall Study|Non- Compliance|1|||
161192494|NCT01906489|582082004|FG001|Overall Study|Non- Compliance|0|||
161192495|NCT01906489|582082003|FG000|Overall Study|Sponsor Decision|1|||
161192496|NCT01906489|582082004|FG001|Overall Study|Sponsor Decision|0|||
161192497|NCT01906489|582082003|FG000|Overall Study|Lost to Follow-up|1|||
161192498|NCT01906489|582082004|FG001|Overall Study|Lost to Follow-up|1|||
161192499|NCT01906489|582082003|FG000|Overall Study|Other|1|||
161192500|NCT01906489|582082004|FG001|Overall Study|Other|0|||
161192501|NCT03458234|582082005|FG000|Overall Study|Withdrawal by Subject|1|||
161192502|NCT04823494|582084252|FG000|Overall Study|Programming software malfunction.|1|||
161192503|NCT04823494|582084253|FG001|Overall Study|Programming software malfunction.|0|||
161192504|NCT04823494|582084252|FG000|Overall Study|Withdrawal by Subject|1|||
161192505|NCT04823494|582084253|FG001|Overall Study|Withdrawal by Subject|0|||
161192506|NCT04823494|582084252|FG000|Overall Study|Devices lost|0|||
161192507|NCT04823494|582084253|FG001|Overall Study|Devices lost|1|||
161192508|NCT03691831|582084254|FG000|Overall Study|Lost to Follow-up|16|||
161192509|NCT03691831|582084255|FG001|Overall Study|Lost to Follow-up|12|||
161192510|NCT03691831|582084254|FG000|Overall Study|Withdrawal by Subject|9|||
161192511|NCT03691831|582084255|FG001|Overall Study|Withdrawal by Subject|17|||
161192512|NCT03691831|582084254|FG000|Overall Study|Investigator Decision|2|||
161192513|NCT03691831|582084255|FG001|Overall Study|Investigator Decision|2|||
161192514|NCT01884675|582084256|FG000|Overall Study|Study closed/terminated|3|||
161192515|NCT01884675|582084257|FG001|Overall Study|Study closed/terminated|2|||
161192516|NCT03359811|582084258|FG000|Overall Study|Protocol Violation|2|||
161192517|NCT03359811|582084259|FG001|Overall Study|Protocol Violation|0|||
161192518|NCT01682876|582084262|FG000|Overall Study|Administrative reason|4|||
161192519|NCT01682876|582084263|FG001|Overall Study|Administrative reason|4|||
161192520|NCT01682876|582084264|FG002|Overall Study|Administrative reason|0|||
161192521|NCT01682876|582084265|FG003|Overall Study|Administrative reason|3|||
161192522|NCT01682876|582084262|FG000|Overall Study|Adverse Event|0|||
161192523|NCT01682876|582084263|FG001|Overall Study|Adverse Event|0|||
161192524|NCT01682876|582084264|FG002|Overall Study|Adverse Event|0|||
161192525|NCT01682876|582084265|FG003|Overall Study|Adverse Event|1|||
161192526|NCT01682876|582084262|FG000|Overall Study|Lost to Follow-up|11|||
161192527|NCT01682876|582084263|FG001|Overall Study|Lost to Follow-up|15|||
161192528|NCT01682876|582084264|FG002|Overall Study|Lost to Follow-up|9|||
161192529|NCT01682876|582084265|FG003|Overall Study|Lost to Follow-up|11|||
161192530|NCT01682876|582084262|FG000|Overall Study|Protocol Violation|1|||
161192531|NCT01682876|582084263|FG001|Overall Study|Protocol Violation|1|||
161192532|NCT01682876|582084264|FG002|Overall Study|Protocol Violation|1|||
161192533|NCT01682876|582084265|FG003|Overall Study|Protocol Violation|1|||
161192534|NCT01682876|582084262|FG000|Overall Study|Withdrawal by Subject|4|||
161192535|NCT01682876|582084263|FG001|Overall Study|Withdrawal by Subject|0|||
161192536|NCT01682876|582084264|FG002|Overall Study|Withdrawal by Subject|0|||
161192537|NCT01682876|582084265|FG003|Overall Study|Withdrawal by Subject|2|||
161192538|NCT01682876|582084262|FG000|Overall Study|Other|1|||
161192539|NCT01682876|582084263|FG001|Overall Study|Other|0|||
161192540|NCT01682876|582084264|FG002|Overall Study|Other|1|||
161192541|NCT01682876|582084265|FG003|Overall Study|Other|1|||
161192542|NCT04120116|582084266|FG000|Overall Study|Lost to Follow-up|0|||
161192543|NCT04120116|582084267|FG001|Overall Study|Lost to Follow-up|1|||
161192544|NCT04120116|582084268|FG002|Overall Study|Lost to Follow-up|0|||
161192545|NCT04120116|582084269|FG003|Overall Study|Lost to Follow-up|2|||
161192546|NCT04120116|582084266|FG000|Overall Study|Withdrawal by Subject|1|||
161192547|NCT04120116|582084267|FG001|Overall Study|Withdrawal by Subject|0|||
161192548|NCT04120116|582084268|FG002|Overall Study|Withdrawal by Subject|1|||
161192549|NCT04120116|582084269|FG003|Overall Study|Withdrawal by Subject|1|||
161192550|NCT04120116|582084266|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161192551|NCT04120116|582084267|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161192552|NCT04120116|582084268|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
161192553|NCT04120116|582084269|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
161192554|NCT02528331|582084282|FG000|Overall Study|Withdrawal by Subject|2|||
161192555|NCT00386152|582084283|FG000|Overall Study|Adverse Event|6|||
161192556|NCT00386152|582084284|FG001|Overall Study|Adverse Event|5|||
161192557|NCT00386152|582084285|FG002|Overall Study|Adverse Event|4|||
161192558|NCT00386152|582084283|FG000|Overall Study|Chang from original chemo stratification|4|||
161192559|NCT00386152|582084284|FG001|Overall Study|Chang from original chemo stratification|5|||
161192560|NCT00386152|582084285|FG002|Overall Study|Chang from original chemo stratification|6|||
161192561|NCT00386152|582084283|FG000|Overall Study|Death|3|||
161192562|NCT00386152|582084284|FG001|Overall Study|Death|0|||
161192563|NCT00386152|582084285|FG002|Overall Study|Death|1|||
161192564|NCT00386152|582084283|FG000|Overall Study|Disease progression|7|||
161192565|NCT00386152|582084284|FG001|Overall Study|Disease progression|4|||
161192566|NCT00386152|582084285|FG002|Overall Study|Disease progression|5|||
161192567|NCT00386152|582084283|FG000|Overall Study|Physician Decision|13|||
161192568|NCT00386152|582084284|FG001|Overall Study|Physician Decision|10|||
161192569|NCT00386152|582084285|FG002|Overall Study|Physician Decision|4|||
161192570|NCT00386152|582084283|FG000|Overall Study|Lost to Follow-up|1|||
161192571|NCT00386152|582084284|FG001|Overall Study|Lost to Follow-up|0|||
161192572|NCT00386152|582084285|FG002|Overall Study|Lost to Follow-up|0|||
161192573|NCT00386152|582084283|FG000|Overall Study|Completed chemotherapy|4|||
161192574|NCT00386152|582084284|FG001|Overall Study|Completed chemotherapy|5|||
161192575|NCT00386152|582084285|FG002|Overall Study|Completed chemotherapy|1|||
161192576|NCT00386152|582084283|FG000|Overall Study|Protocol Violation|3|||
161192577|NCT00386152|582084284|FG001|Overall Study|Protocol Violation|5|||
161192578|NCT00386152|582084285|FG002|Overall Study|Protocol Violation|2|||
161192579|NCT00386152|582084283|FG000|Overall Study|Withdrawal by Subject|3|||
161192580|NCT00386152|582084284|FG001|Overall Study|Withdrawal by Subject|6|||
161192581|NCT00386152|582084285|FG002|Overall Study|Withdrawal by Subject|10|||
161192582|NCT03380091|582084287|FG000|Overall Study|Withdrawal by Subject|2|||
161192583|NCT03380091|582084288|FG001|Overall Study|Withdrawal by Subject|1|||
161192584|NCT04594213|582084289|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
161192585|NCT04594213|582084290|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
161192586|NCT04594213|582084291|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
161192587|NCT04594213|582084292|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161192588|NCT04594213|582084293|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161192589|NCT04594213|582084294|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
161192590|NCT04594213|582084289|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161192591|NCT04594213|582084290|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
161192592|NCT04594213|582084291|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161192593|NCT04594213|582084292|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161192594|NCT04594213|582084293|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161192595|NCT04594213|582084294|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
161192596|NCT04594213|582084289|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161192597|NCT04594213|582084290|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161192598|NCT04594213|582084291|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
161192599|NCT04594213|582084292|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161192600|NCT04594213|582084293|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161192601|NCT04594213|582084294|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
161192602|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161192603|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161192604|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161192605|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161192606|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
161192607|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
161192608|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161192609|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161192610|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
161192611|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
161192612|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
161192613|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
161192614|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161192615|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161192616|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161192617|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161192618|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
161192619|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
161192620|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161192621|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161192622|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161192623|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
161192624|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161192625|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
161192626|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161192627|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161192628|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161192629|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
161192630|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161192631|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
161192632|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161192633|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161192634|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
161192635|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
161192636|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
161192637|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
161192638|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161192639|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161192640|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
161192641|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
161192642|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
161192643|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
161192644|NCT04594213|582084289|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
161192645|NCT04594213|582084290|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
161192646|NCT04594213|582084291|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
161192647|NCT04594213|582084292|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
161192648|NCT04594213|582084293|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
161192649|NCT04594213|582084294|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
161192650|NCT01980056|582084296|FG000|Overall Study|Death|1|||
161192651|NCT01980056|582084297|FG001|Overall Study|Death|1|||
161192652|NCT01980056|582084298|FG002|Overall Study|Death|0|||
161192653|NCT00104299|582084299|FG000|Overall Study|Adverse Event|3|||
161192654|NCT00104299|582084300|FG001|Overall Study|Adverse Event|1|||
161192655|NCT00104299|582084299|FG000|Overall Study|Death|2|||
161192656|NCT00104299|582084300|FG001|Overall Study|Death|2|||
161192657|NCT00104299|582084299|FG000|Overall Study|Withdrawal by Subject|2|||
161192658|NCT00104299|582084300|FG001|Overall Study|Withdrawal by Subject|6|||
161192659|NCT00104299|582084299|FG000|Overall Study|Physician Decision|1|||
161192660|NCT00104299|582084300|FG001|Overall Study|Physician Decision|1|||
161192661|NCT00104299|582084299|FG000|Overall Study|To have renal transplant|1|||
161192662|NCT00104299|582084300|FG001|Overall Study|To have renal transplant|0|||
161192663|NCT01707667|582084301|FG000|Period 1|expulsion of colonic sensor catheter|1|||
161192664|NCT01707667|582084302|FG001|Period 1|expulsion of colonic sensor catheter|0|||
161192665|NCT03802331|582084303|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
161192666|NCT03802331|582084304|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
161192667|NCT03432819|582084308|FG000|Overall Study|Lost to Follow-up|2|||
161192668|NCT03432819|582084309|FG001|Overall Study|Lost to Follow-up|2|||
161192669|NCT03432819|582084308|FG000|Overall Study|Withdrawal by Subject|5|||
161192670|NCT03432819|582084309|FG001|Overall Study|Withdrawal by Subject|3|||
161192671|NCT01474993|582084310|FG000|Overall Study|Lost to Follow-up|1|||
161192672|NCT01474993|582084311|FG001|Overall Study|Lost to Follow-up|2|||
161192673|NCT01474993|582084310|FG000|Overall Study|Adverse Event|0|||
161192674|NCT01474993|582084311|FG001|Overall Study|Adverse Event|1|||
161192675|NCT02041533|582084312|FG000|Pre-Treatment Period|Disease Progression|1|||
161192676|NCT02041533|582084313|FG001|Pre-Treatment Period|Disease Progression|1|||
161192677|NCT02041533|582084312|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
161192678|NCT02041533|582084313|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
161192679|NCT02041533|582084312|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
161192680|NCT02041533|582084313|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
161192681|NCT02041533|582084312|FG000|Treatment Period|Disease progression|189|||
161192682|NCT02041533|582084313|FG001|Treatment Period|Disease progression|146|||
161192683|NCT02041533|582084312|FG000|Treatment Period|Study drug toxicity|30|||
161192684|NCT02041533|582084313|FG001|Treatment Period|Study drug toxicity|34|||
161192685|NCT02041533|582084312|FG000|Treatment Period|Death|1|||
161192686|NCT02041533|582084313|FG001|Treatment Period|Death|0|||
161192687|NCT02041533|582084312|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
161192688|NCT02041533|582084313|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
161192689|NCT02041533|582084312|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
161192690|NCT02041533|582084313|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
161192691|NCT02041533|582084312|FG000|Treatment Period|Participant withdrew consent|2|||
161192692|NCT02041533|582084313|FG001|Treatment Period|Participant withdrew consent|2|||
161192693|NCT02041533|582084312|FG000|Treatment Period|Maximum clinical benefit|0|||
161306346|NCT02017717|582502825|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161306347|NCT02017717|582502826|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161306348|NCT02017717|582502827|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161306349|NCT02017717|582502828|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161192694|NCT02041533|582084313|FG001|Treatment Period|Maximum clinical benefit|18|||
161192695|NCT02041533|582084312|FG000|Treatment Period|Poor/Non-compliance|1|||
161192696|NCT02041533|582084313|FG001|Treatment Period|Poor/Non-compliance|0|||
161192697|NCT02041533|582084312|FG000|Treatment Period|Administrative reason by sponsor|1|||
161192698|NCT02041533|582084313|FG001|Treatment Period|Administrative reason by sponsor|0|||
161192699|NCT02041533|582084312|FG000|Treatment Period|Other reasons|9|||
161192700|NCT02041533|582084313|FG001|Treatment Period|Other reasons|2|||
161306350|NCT02017717|582502829|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
161192701|NCT02041533|582084312|FG000|Treatment Period|Not Reported|0|||
161192702|NCT02041533|582084313|FG001|Treatment Period|Not Reported|1|||
161192703|NCT02500706|582084314|FG000|Overall Study|Adverse Event|0|||
161192704|NCT02500706|582084315|FG001|Overall Study|Adverse Event|0|||
161192705|NCT02500706|582084316|FG002|Overall Study|Adverse Event|1|||
161192706|NCT02500706|582084314|FG000|Overall Study|Lost to Follow-up|0|||
161192707|NCT02500706|582084315|FG001|Overall Study|Lost to Follow-up|1|||
161192708|NCT02500706|582084316|FG002|Overall Study|Lost to Follow-up|1|||
161192709|NCT02500706|582084314|FG000|Overall Study|Withdrawal by Subject|4|||
161192710|NCT02500706|582084315|FG001|Overall Study|Withdrawal by Subject|6|||
161192711|NCT02500706|582084316|FG002|Overall Study|Withdrawal by Subject|4|||
161192712|NCT02500706|582084314|FG000|Overall Study|Unclassified|0|||
161192713|NCT02500706|582084315|FG001|Overall Study|Unclassified|0|||
161192714|NCT02500706|582084316|FG002|Overall Study|Unclassified|1|||
161192715|NCT01957111|582084319|FG000|Overall Study|Withdrawal by Subject|1|||
161192716|NCT01957111|582084320|FG001|Overall Study|Withdrawal by Subject|1|||
161192717|NCT03644173|582084321|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
161192718|NCT03644173|582084321|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
161192719|NCT03644173|582084321|FG000|Participants at the 1-month Follow up|Death|2|||
161192720|NCT03644173|582084321|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
161192721|NCT03323385|582084322|FG000|Overall Study|Withdrawal by Subject|1|||
161192722|NCT03323385|582084323|FG001|Overall Study|Withdrawal by Subject|2|||
161192723|NCT03323385|582084322|FG000|Overall Study|Noncompliance|0|||
161192724|NCT03323385|582084323|FG001|Overall Study|Noncompliance|1|||
161192725|NCT01000311|582084328|FG000|Overall Study|Adverse Event|2|||
161192726|NCT01000311|582084329|FG001|Overall Study|Adverse Event|5|||
161192727|NCT01000311|582084328|FG000|Overall Study|Withdrawal by Subject|16|||
161192728|NCT01000311|582084329|FG001|Overall Study|Withdrawal by Subject|24|||
161192729|NCT01000311|582084328|FG000|Overall Study|Lost to Follow-up|15|||
161192730|NCT01000311|582084329|FG001|Overall Study|Lost to Follow-up|24|||
161192731|NCT01000311|582084328|FG000|Overall Study|Protocol Violation|1|||
161192732|NCT01000311|582084329|FG001|Overall Study|Protocol Violation|2|||
161192733|NCT01000311|582084328|FG000|Overall Study|Inappropriate enrollment|2|||
161192734|NCT01000311|582084329|FG001|Overall Study|Inappropriate enrollment|0|||
161192735|NCT01000311|582084328|FG000|Overall Study|Administrative reason|9|||
161192736|NCT01000311|582084329|FG001|Overall Study|Administrative reason|15|||
161192737|NCT01468844|582084330|FG000|Overall Study|Adverse Event|1|||
161192738|NCT01468844|582084331|FG001|Overall Study|Adverse Event|0|||
161192739|NCT01468844|582084330|FG000|Overall Study|Withdrawal by Subject|1|||
161192740|NCT01468844|582084331|FG001|Overall Study|Withdrawal by Subject|0|||
161192741|NCT01241318|582084332|FG000|Overall Study|Woman: false pregnancies|27|||
161192742|NCT01241318|582084333|FG001|Overall Study|Woman: false pregnancies|15|||
161192743|NCT01241318|582084332|FG000|Overall Study|Woman: miscarriage/abortion|46|||
161192744|NCT01241318|582084333|FG001|Overall Study|Woman: miscarriage/abortion|38|||
161192745|NCT01241318|582084332|FG000|Overall Study|Withdrawal by Subject|175|||
161192746|NCT01241318|582084333|FG001|Overall Study|Withdrawal by Subject|46|||
161192747|NCT01241318|582084332|FG000|Overall Study|Lost to Follow-up|740|||
161192748|NCT01241318|582084333|FG001|Overall Study|Lost to Follow-up|455|||
161192749|NCT01241318|582084332|FG000|Overall Study|Death|2|||
161192750|NCT01241318|582084333|FG001|Overall Study|Death|4|||
161192751|NCT01241318|582084332|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
161192752|NCT01241318|582084333|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
161192753|NCT01241318|582084332|FG000|Overall Study|Woman: Stillborn infant|129|||
161192754|NCT01241318|582084333|FG001|Overall Study|Woman: Stillborn infant|146|||
161192755|NCT02355665|582084334|FG000|Overall Study|Adverse Event|16|||
161192756|NCT02355665|582084335|FG001|Overall Study|Adverse Event|24|||
161192757|NCT02355665|582084334|FG000|Overall Study|Protocol Violation|2|||
161192758|NCT02355665|582084335|FG001|Overall Study|Protocol Violation|0|||
161192759|NCT02355665|582084334|FG000|Overall Study|Withdrawal by Subject|90|||
161192760|NCT02355665|582084335|FG001|Overall Study|Withdrawal by Subject|100|||
161192761|NCT02355665|582084334|FG000|Overall Study|Lost to Follow-up|131|||
161349741|NCT01615029|582665937|FG004|Overall Study|Progressive disease|10|||
161349742|NCT01615029|582665933|FG000|Overall Study|Physician Decision|0|||
161192762|NCT02355665|582084335|FG001|Overall Study|Lost to Follow-up|103|||
161192763|NCT02355665|582084334|FG000|Overall Study|Death|4|||
161192764|NCT02355665|582084335|FG001|Overall Study|Death|2|||
161192765|NCT02355665|582084334|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
161192766|NCT02355665|582084335|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
161192767|NCT00266695|582084338|FG000|Overall Study|Adverse Event|1|||
161192768|NCT00266695|582084338|FG000|Overall Study|Death|9|||
161192769|NCT00266695|582084338|FG000|Overall Study|Physician Decision|1|||
161192770|NCT00266695|582084338|FG000|Overall Study|Lost to Follow-up|3|||
161192771|NCT00266695|582084338|FG000|Overall Study|Withdrawal by Subject|15|||
161192772|NCT02380703|582084339|FG000|Overall Study|Withdrawal by Subject|12|||
161192773|NCT02380703|582084340|FG001|Overall Study|Withdrawal by Subject|9|||
161192774|NCT02380703|582084339|FG000|Overall Study|Lost to Follow-up|12|||
161349743|NCT01615029|582665934|FG001|Overall Study|Physician Decision|0|||
161192775|NCT02380703|582084340|FG001|Overall Study|Lost to Follow-up|12|||
161192776|NCT02380703|582084339|FG000|Overall Study|Caregiver death|1|||
161192777|NCT02380703|582084340|FG001|Overall Study|Caregiver death|0|||
161192778|NCT02380703|582084339|FG000|Overall Study|Person with dementia (PWD) death|7|||
161192779|NCT02380703|582084340|FG001|Overall Study|Person with dementia (PWD) death|8|||
161192780|NCT02380703|582084339|FG000|Overall Study|Entered Long-term Care|4|||
161192781|NCT02380703|582084340|FG001|Overall Study|Entered Long-term Care|7|||
161192782|NCT02853318|582084347|FG000|Overall Study|Withdrawal by Subject|1|||
161192783|NCT01882439|582084348|FG000|Overall Study|Adverse event related to study drug|3|||
161192784|NCT01882439|582084349|FG001|Overall Study|Adverse event related to study drug|8|||
161192785|NCT01882439|582084350|FG002|Overall Study|Adverse event related to study drug|1|||
161192786|NCT01882439|582084351|FG003|Overall Study|Adverse event related to study drug|2|||
161192787|NCT01882439|582084348|FG000|Overall Study|Pregnancy|0|||
161192788|NCT01882439|582084349|FG001|Overall Study|Pregnancy|1|||
161192789|NCT01882439|582084350|FG002|Overall Study|Pregnancy|0|||
161192790|NCT01882439|582084351|FG003|Overall Study|Pregnancy|0|||
161192791|NCT01882439|582084348|FG000|Overall Study|Protocol Violation|2|||
161192792|NCT01882439|582084349|FG001|Overall Study|Protocol Violation|2|||
161192793|NCT01882439|582084350|FG002|Overall Study|Protocol Violation|0|||
161192794|NCT01882439|582084351|FG003|Overall Study|Protocol Violation|1|||
161192795|NCT01882439|582084348|FG000|Overall Study|No longer willing to participate|1|||
161192796|NCT01882439|582084349|FG001|Overall Study|No longer willing to participate|4|||
161192797|NCT01882439|582084350|FG002|Overall Study|No longer willing to participate|2|||
161192798|NCT01882439|582084351|FG003|Overall Study|No longer willing to participate|3|||
161192799|NCT01882439|582084348|FG000|Overall Study|Medication error with no associated AE|0|||
161192800|NCT01882439|582084349|FG001|Overall Study|Medication error with no associated AE|0|||
161192801|NCT01882439|582084350|FG002|Overall Study|Medication error with no associated AE|2|||
161192802|NCT01882439|582084351|FG003|Overall Study|Medication error with no associated AE|0|||
161192803|NCT01882439|582084348|FG000|Overall Study|Insufficient clinical response|1|||
161192804|NCT01882439|582084349|FG001|Overall Study|Insufficient clinical response|4|||
161192805|NCT01882439|582084350|FG002|Overall Study|Insufficient clinical response|4|||
161192806|NCT01882439|582084351|FG003|Overall Study|Insufficient clinical response|2|||
161192807|NCT01882439|582084348|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161192808|NCT01882439|582084349|FG001|Overall Study|Adverse event unrelated to study drug|2|||
161192809|NCT01882439|582084350|FG002|Overall Study|Adverse event unrelated to study drug|1|||
161192810|NCT01882439|582084351|FG003|Overall Study|Adverse event unrelated to study drug|1|||
161192811|NCT03125902|582084352|FG000|Overall Study|Adverse Event|0|||
161192812|NCT03125902|582084353|FG001|Overall Study|Adverse Event|1|||
161192813|NCT03125902|582084352|FG000|Overall Study|Death|119|||
161192814|NCT03125902|582084353|FG001|Overall Study|Death|229|||
161192815|NCT03125902|582084352|FG000|Overall Study|Lost to Follow-up|4|||
161192816|NCT03125902|582084353|FG001|Overall Study|Lost to Follow-up|13|||
161192817|NCT03125902|582084352|FG000|Overall Study|Other|0|||
161192818|NCT03125902|582084353|FG001|Overall Study|Other|4|||
161192819|NCT03125902|582084352|FG000|Overall Study|Physician Decision|2|||
161192820|NCT03125902|582084353|FG001|Overall Study|Physician Decision|1|||
161192821|NCT03125902|582084352|FG000|Overall Study|Progressive Disease|0|||
161192822|NCT03125902|582084353|FG001|Overall Study|Progressive Disease|3|||
161192823|NCT03125902|582084352|FG000|Overall Study|Study Terminated By Sponsor|74|||
161192824|NCT03125902|582084353|FG001|Overall Study|Study Terminated By Sponsor|143|||
161192825|NCT03125902|582084352|FG000|Overall Study|Withdrawal by Subject|21|||
161192826|NCT03125902|582084353|FG001|Overall Study|Withdrawal by Subject|37|||
161192827|NCT02269709|582084354|FG000|Time of Enrollment|Withdrawal by Subject|3|||
161192828|NCT02269709|582084354|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
161192829|NCT02269709|582084354|FG000|Six Month Follow-up|Lost to Follow-up|12|||
161192830|NCT04411472|582084355|FG000|Overall Study|Adverse Event|5|||
161192831|NCT04411472|582084356|FG001|Overall Study|Adverse Event|10|||
161192832|NCT04411472|582084357|FG002|Overall Study|Adverse Event|1|||
161192833|NCT04411472|582084358|FG003|Overall Study|Adverse Event|0|||
161192834|NCT04411472|582084359|FG004|Overall Study|Adverse Event|0|||
161192835|NCT04411472|582084360|FG005|Overall Study|Adverse Event|0|||
161192836|NCT04411472|582084355|FG000|Overall Study|Protocol Violation|1|||
161192837|NCT04411472|582084356|FG001|Overall Study|Protocol Violation|0|||
161192838|NCT04411472|582084357|FG002|Overall Study|Protocol Violation|0|||
161306351|NCT02017717|582502830|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
161192839|NCT04411472|582084358|FG003|Overall Study|Protocol Violation|0|||
161192840|NCT04411472|582084359|FG004|Overall Study|Protocol Violation|0|||
161192841|NCT04411472|582084360|FG005|Overall Study|Protocol Violation|0|||
161192842|NCT04411472|582084355|FG000|Overall Study|Withdrawal by Subject|0|||
161192843|NCT04411472|582084356|FG001|Overall Study|Withdrawal by Subject|1|||
161192844|NCT04411472|582084357|FG002|Overall Study|Withdrawal by Subject|0|||
161192845|NCT04411472|582084358|FG003|Overall Study|Withdrawal by Subject|1|||
161192846|NCT04411472|582084359|FG004|Overall Study|Withdrawal by Subject|0|||
161192847|NCT04411472|582084360|FG005|Overall Study|Withdrawal by Subject|0|||
161192848|NCT04411472|582084355|FG000|Overall Study|Physician Decision|1|||
161306352|NCT02017717|582502822|FG000|Before Treatment Period|Participant request to stop therapy|0|||
161192849|NCT04411472|582084356|FG001|Overall Study|Physician Decision|0|||
161192850|NCT04411472|582084357|FG002|Overall Study|Physician Decision|0|||
161192851|NCT04411472|582084358|FG003|Overall Study|Physician Decision|0|||
161192852|NCT04411472|582084359|FG004|Overall Study|Physician Decision|0|||
161192853|NCT04411472|582084360|FG005|Overall Study|Physician Decision|0|||
161192854|NCT04411472|582084355|FG000|Overall Study|Study terminated by sponsor|17|||
161192855|NCT04411472|582084356|FG001|Overall Study|Study terminated by sponsor|20|||
161192856|NCT04411472|582084357|FG002|Overall Study|Study terminated by sponsor|3|||
161192857|NCT04411472|582084358|FG003|Overall Study|Study terminated by sponsor|0|||
161192858|NCT04411472|582084359|FG004|Overall Study|Study terminated by sponsor|0|||
161192859|NCT04411472|582084360|FG005|Overall Study|Study terminated by sponsor|0|||
161192860|NCT00440232|582084363|FG000|Overall Study|Lost to Follow-up|1|||
161192861|NCT00440232|582084364|FG001|Overall Study|Lost to Follow-up|1|||
161192862|NCT00440232|582084363|FG000|Overall Study|Unable to treat within allowed time|0|||
161192863|NCT00440232|582084364|FG001|Overall Study|Unable to treat within allowed time|1|||
161192864|NCT00440232|582084363|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
161192865|NCT00440232|582084364|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
161192866|NCT00362297|582084365|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
161192867|NCT00362297|582084366|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
161192868|NCT00819052|582084367|FG000|Overall Study|Adverse Event|0|||
161192869|NCT00819052|582084368|FG001|Overall Study|Adverse Event|5|||
161192870|NCT00819052|582084367|FG000|Overall Study|Protocol Violation|1|||
161192871|NCT00819052|582084368|FG001|Overall Study|Protocol Violation|2|||
161192872|NCT00819052|582084367|FG000|Overall Study|Lost to Follow-up|1|||
161192873|NCT00819052|582084368|FG001|Overall Study|Lost to Follow-up|2|||
161192874|NCT00819052|582084367|FG000|Overall Study|Withdrawal by Subject|1|||
161192875|NCT00819052|582084368|FG001|Overall Study|Withdrawal by Subject|2|||
161192876|NCT00819052|582084367|FG000|Overall Study|Lack of Efficacy|1|||
161192877|NCT00819052|582084368|FG001|Overall Study|Lack of Efficacy|1|||
161192878|NCT00819052|582084367|FG000|Overall Study|Pregnancy|1|||
161192879|NCT00819052|582084368|FG001|Overall Study|Pregnancy|2|||
161192880|NCT00819052|582084367|FG000|Overall Study|Death or events leading to death|1|||
161192881|NCT00819052|582084368|FG001|Overall Study|Death or events leading to death|0|||
161192882|NCT00982111|582084373|FG000|Overall Study|Adverse Event|1|||
161192883|NCT00982111|582084374|FG001|Overall Study|Adverse Event|1|||
161192884|NCT00982111|582084373|FG000|Overall Study|Progressive Disease|46|||
161192885|NCT00982111|582084374|FG001|Overall Study|Progressive Disease|39|||
161192886|NCT00982111|582084373|FG000|Overall Study|Lost to Follow-up|9|||
161192887|NCT00982111|582084374|FG001|Overall Study|Lost to Follow-up|6|||
161192888|NCT00982111|582084373|FG000|Overall Study|New Anti-Cancer Therapy|5|||
161192889|NCT00982111|582084374|FG001|Overall Study|New Anti-Cancer Therapy|5|||
161192890|NCT00982111|582084373|FG000|Overall Study|Medical Decision|1|||
161192891|NCT00982111|582084374|FG001|Overall Study|Medical Decision|0|||
161192892|NCT00982111|582084373|FG000|Overall Study|Withdrawal by Subject|17|||
161192893|NCT00982111|582084374|FG001|Overall Study|Withdrawal by Subject|19|||
161192894|NCT00982111|582084373|FG000|Overall Study|Global Study End|0|||
161192895|NCT00982111|582084374|FG001|Overall Study|Global Study End|1|||
161192896|NCT00982111|582084373|FG000|Overall Study|Sponsor's Decision|0|||
161192897|NCT00982111|582084374|FG001|Overall Study|Sponsor's Decision|1|||
161192898|NCT01070381|582084375|FG000|Period 2, 1 Week of Wear|Handling|0|||
161192899|NCT01070381|582084376|FG001|Period 2, 1 Week of Wear|Handling|1|||
161192900|NCT01070381|582084375|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
161192901|NCT01070381|582084376|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
161192902|NCT02146352|582084383|FG000|Overall Study|Death|1|||
161192903|NCT02146352|582084383|FG000|Overall Study|Patient entered hospice care|1|||
161192904|NCT02918006|582084384|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
161192905|NCT02918006|582084385|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
161192906|NCT02918006|582084386|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
161192907|NCT02918006|582084384|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
161192908|NCT02918006|582084385|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
161192909|NCT02918006|582084386|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
161192910|NCT02918006|582084384|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
161192911|NCT02918006|582084385|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
161192912|NCT02918006|582084386|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
161192913|NCT02918006|582084384|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
161192914|NCT02918006|582084385|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
161192915|NCT02918006|582084386|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
161192916|NCT02918006|582084384|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
161192917|NCT02918006|582084385|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
161192918|NCT02918006|582084386|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
161192919|NCT02918006|582084384|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
161192920|NCT02918006|582084385|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
161192921|NCT02918006|582084386|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
161192922|NCT02918006|582084384|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
161192923|NCT02918006|582084385|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
161192924|NCT02918006|582084386|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
161192925|NCT02918006|582084384|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
161192926|NCT02918006|582084385|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
161192927|NCT02918006|582084386|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
161192928|NCT02918006|582084384|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
161192929|NCT02918006|582084385|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
161192930|NCT02918006|582084386|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
161192931|NCT03969589|582084387|FG000|Overall Study|Lost to Follow-up|3|||
161192932|NCT03969589|582084388|FG001|Overall Study|Lost to Follow-up|2|||
161192933|NCT03969589|582084387|FG000|Overall Study|Declined Follow-Up|0|||
161192934|NCT03969589|582084388|FG001|Overall Study|Declined Follow-Up|1|||
161192935|NCT03091920|582084392|FG000|Overall Study|Adverse Event|0|||
161192936|NCT03091920|582084393|FG001|Overall Study|Adverse Event|1|||
161192937|NCT03091920|582084394|FG002|Overall Study|Adverse Event|0|||
161192938|NCT00453349|582084395|FG000|Randomized|Adverse Event|12|||
161192939|NCT00453349|582084396|FG001|Randomized|Adverse Event|11|||
161192940|NCT00453349|582084395|FG000|Randomized|Lack of Efficacy|2|||
161192941|NCT00453349|582084396|FG001|Randomized|Lack of Efficacy|1|||
161192942|NCT00453349|582084395|FG000|Randomized|Lost to Follow-up|7|||
161192943|NCT00453349|582084396|FG001|Randomized|Lost to Follow-up|5|||
161192944|NCT00453349|582084395|FG000|Randomized|Protocol Violation|1|||
161192945|NCT00453349|582084396|FG001|Randomized|Protocol Violation|1|||
161192946|NCT00453349|582084395|FG000|Randomized|Withdrawal by Subject|3|||
161192947|NCT00453349|582084396|FG001|Randomized|Withdrawal by Subject|5|||
161192948|NCT00453349|582084395|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
161192949|NCT00453349|582084396|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
161192950|NCT00453349|582084395|FG000|Completed Study|Adverse Event|12|||
161192951|NCT00453349|582084396|FG001|Completed Study|Adverse Event|11|||
161192952|NCT00453349|582084395|FG000|Completed Study|Lack of Efficacy|2|||
161192953|NCT00453349|582084396|FG001|Completed Study|Lack of Efficacy|1|||
161192954|NCT00453349|582084395|FG000|Completed Study|Lost to Follow-up|7|||
161192955|NCT00453349|582084396|FG001|Completed Study|Lost to Follow-up|5|||
161192956|NCT00453349|582084395|FG000|Completed Study|Protocol Violation|1|||
161192957|NCT00453349|582084396|FG001|Completed Study|Protocol Violation|1|||
161192958|NCT00453349|582084395|FG000|Completed Study|Withdrawal by Subject|3|||
161192959|NCT00453349|582084396|FG001|Completed Study|Withdrawal by Subject|5|||
161192960|NCT00453349|582084395|FG000|Completed Study|Lost to follow up after study treatment|2|||
161192961|NCT00453349|582084396|FG001|Completed Study|Lost to follow up after study treatment|11|||
161192962|NCT01513460|582084398|FG000|Overall Study|Death|0|||
161192963|NCT01513460|582084399|FG001|Overall Study|Death|0|||
161192964|NCT01513460|582084400|FG002|Overall Study|Death|1|||
161192965|NCT01513460|582084398|FG000|Overall Study|Lost to Follow-up|0|||
161192966|NCT01513460|582084399|FG001|Overall Study|Lost to Follow-up|0|||
161192967|NCT01513460|582084400|FG002|Overall Study|Lost to Follow-up|2|||
161192968|NCT01513460|582084398|FG000|Overall Study|Abnormal laboratory value|1|||
161192969|NCT01513460|582084399|FG001|Overall Study|Abnormal laboratory value|0|||
161192970|NCT01513460|582084400|FG002|Overall Study|Abnormal laboratory value|1|||
161192971|NCT01513460|582084398|FG000|Overall Study|Lack of Efficacy|1|||
161192972|NCT01513460|582084399|FG001|Overall Study|Lack of Efficacy|2|||
161192973|NCT01513460|582084400|FG002|Overall Study|Lack of Efficacy|5|||
161192974|NCT01513460|582084398|FG000|Overall Study|Protocol deviations|3|||
161192975|NCT01513460|582084399|FG001|Overall Study|Protocol deviations|4|||
161192976|NCT01513460|582084400|FG002|Overall Study|Protocol deviations|3|||
161192977|NCT01513460|582084398|FG000|Overall Study|Withdrawal by Subject|7|||
161192978|NCT01513460|582084399|FG001|Overall Study|Withdrawal by Subject|8|||
161192979|NCT01513460|582084400|FG002|Overall Study|Withdrawal by Subject|21|||
161192980|NCT01513460|582084398|FG000|Overall Study|Adverse Event|16|||
161192981|NCT01513460|582084399|FG001|Overall Study|Adverse Event|18|||
161192982|NCT01513460|582084400|FG002|Overall Study|Adverse Event|23|||
161192983|NCT01513460|582084398|FG000|Overall Study|Abnormal test procedure|1|||
161192984|NCT01513460|582084399|FG001|Overall Study|Abnormal test procedure|0|||
161192985|NCT01513460|582084400|FG002|Overall Study|Abnormal test procedure|0|||
161192986|NCT00489216|582084404|FG000|Overall Study|Adverse Event|1|||
161306353|NCT02017717|582502823|FG001|Before Treatment Period|Participant request to stop therapy|0|||
161192987|NCT02198040|582085408|FG000|Overall Study|Work reasons|0|||
161192988|NCT02198040|582085409|FG001|Overall Study|Work reasons|1|||
161192989|NCT02198040|582085410|FG002|Overall Study|Work reasons|0|||
161192990|NCT02198040|582085408|FG000|Overall Study|Withdrawal by Subject|0|||
161192991|NCT02198040|582085409|FG001|Overall Study|Withdrawal by Subject|0|||
161192992|NCT02198040|582085410|FG002|Overall Study|Withdrawal by Subject|1|||
161192993|NCT00337935|582085411|FG000|Overall Study|Adverse Event|2|||
161192994|NCT00337935|582085412|FG001|Overall Study|Adverse Event|5|||
161192995|NCT00337935|582085411|FG000|Overall Study|Death|2|||
161192996|NCT00337935|582085412|FG001|Overall Study|Death|8|||
161192997|NCT00337935|582085411|FG000|Overall Study|Physician Decision|1|||
161192998|NCT00337935|582085412|FG001|Overall Study|Physician Decision|1|||
161192999|NCT00337935|582085411|FG000|Overall Study|Lost to Follow-up|0|||
161193000|NCT00337935|582085412|FG001|Overall Study|Lost to Follow-up|1|||
161193001|NCT00337935|582085411|FG000|Overall Study|Protocol Violation|4|||
161193002|NCT00337935|582085412|FG001|Overall Study|Protocol Violation|3|||
161193003|NCT00337935|582085411|FG000|Overall Study|Withdrawal by Subject|1|||
161193004|NCT00337935|582085412|FG001|Overall Study|Withdrawal by Subject|7|||
161193005|NCT00337935|582085411|FG000|Overall Study|Other|0|||
161193006|NCT00337935|582085412|FG001|Overall Study|Other|1|||
161193007|NCT00337935|582085411|FG000|Overall Study|Lack of Efficacy|0|||
161193008|NCT00337935|582085412|FG001|Overall Study|Lack of Efficacy|1|||
161193009|NCT01409382|582085413|FG000|Overall Study|Lost to Follow-up|1|||
161193010|NCT01409382|582085414|FG001|Overall Study|Lost to Follow-up|1|||
161193011|NCT01409382|582085413|FG000|Overall Study|Protocol Violation|0|||
161193012|NCT01409382|582085414|FG001|Overall Study|Protocol Violation|3|||
161193013|NCT01409382|582085413|FG000|Overall Study|Multiple pregnancy|2|||
161349744|NCT01615029|582665935|FG002|Overall Study|Physician Decision|0|||
161349745|NCT01615029|582665936|FG003|Overall Study|Physician Decision|0|||
161349746|NCT01615029|582665937|FG004|Overall Study|Physician Decision|2|||
161349747|NCT04088331|582665938|FG000|Overall Study|Lost to Follow-up|3|||
161349748|NCT04088331|582665938|FG000|Overall Study|Withdrawal by Subject|7|||
161349749|NCT04088331|582665938|FG000|Overall Study|Adverse Event|4|||
161090292|NCT01323972|581719956|FG001|Overall Study|Withdrawal by Subject|0|||
161090293|NCT01323972|581719957|FG002|Overall Study|Withdrawal by Subject|1|||
161090294|NCT01323972|581719958|FG003|Overall Study|Withdrawal by Subject|0|||
161090295|NCT01323972|581719955|FG000|Overall Study|Migrated/moved from study area|1|||
161090296|NCT01323972|581719956|FG001|Overall Study|Migrated/moved from study area|2|||
161090297|NCT01323972|581719957|FG002|Overall Study|Migrated/moved from study area|0|||
161090298|NCT01323972|581719958|FG003|Overall Study|Migrated/moved from study area|0|||
161090299|NCT01323972|581719955|FG000|Overall Study|Lost to Follow-up|0|||
161090300|NCT01323972|581719956|FG001|Overall Study|Lost to Follow-up|1|||
161090301|NCT01323972|581719957|FG002|Overall Study|Lost to Follow-up|1|||
161090302|NCT01323972|581719958|FG003|Overall Study|Lost to Follow-up|1|||
161090303|NCT03218397|581719959|FG000|Overall Study|Prior positive blood culture|8|||
161090304|NCT03218397|581719960|FG001|Overall Study|Prior positive blood culture|13|||
161090305|NCT03218397|581719959|FG000|Overall Study|Comfort care|8|||
161090306|NCT03218397|581719960|FG001|Overall Study|Comfort care|5|||
161090307|NCT03218397|581719959|FG000|Overall Study|Comfort care and positive blood culture|1|||
161090308|NCT03218397|581719960|FG001|Overall Study|Comfort care and positive blood culture|0|||
161090309|NCT03218397|581719959|FG000|Overall Study|Comfort care and mixed culture|0|||
161090310|NCT03218397|581719960|FG001|Overall Study|Comfort care and mixed culture|1|||
161090311|NCT03218397|581719959|FG000|Overall Study|Mixed culture|2|||
161090312|NCT03218397|581719960|FG001|Overall Study|Mixed culture|2|||
161090313|NCT03218397|581719959|FG000|Overall Study|Inaccessible hospital records|2|||
161090314|NCT03218397|581719960|FG001|Overall Study|Inaccessible hospital records|5|||
161090315|NCT03218397|581719959|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
161090316|NCT03218397|581719960|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
161090317|NCT03218397|581719959|FG000|Overall Study|Randomized during laboratory off hours|2|||
161090318|NCT03218397|581719960|FG001|Overall Study|Randomized during laboratory off hours|1|||
161090319|NCT01796548|581719963|FG000|Overall Study|Lost to Follow-up|1|||
161090320|NCT01796548|581719963|FG000|Overall Study|Other|2|||
161090321|NCT01049217|581719966|FG000|Overall Study|Adverse Event|2|||
161090322|NCT01049217|581719967|FG001|Overall Study|Adverse Event|1|||
161090323|NCT01049217|581719966|FG000|Overall Study|Lack of Efficacy|1|||
161090324|NCT01049217|581719967|FG001|Overall Study|Lack of Efficacy|1|||
161090325|NCT01049217|581719966|FG000|Overall Study|Lost to Follow-up|3|||
161090326|NCT01049217|581719967|FG001|Overall Study|Lost to Follow-up|8|||
161090327|NCT01049217|581719966|FG000|Overall Study|Withdrawal by Subject|4|||
161090328|NCT01049217|581719967|FG001|Overall Study|Withdrawal by Subject|3|||
161090329|NCT01049217|581719966|FG000|Overall Study|Protocol Violation|1|||
161090330|NCT01049217|581719967|FG001|Overall Study|Protocol Violation|3|||
161090331|NCT01049217|581719966|FG000|Overall Study|Pregnancy|1|||
161090332|NCT01049217|581719967|FG001|Overall Study|Pregnancy|0|||
161090333|NCT01049217|581719966|FG000|Overall Study|Study Terminated by Sponsor|43|||
161090334|NCT01049217|581719967|FG001|Overall Study|Study Terminated by Sponsor|43|||
161090335|NCT01049217|581719966|FG000|Overall Study|Other|1|||
161090336|NCT01049217|581719967|FG001|Overall Study|Other|2|||
161090337|NCT01049217|581719966|FG000|Overall Study|Randomized but not Treated|0|||
161090338|NCT01049217|581719967|FG001|Overall Study|Randomized but not Treated|2|||
161090339|NCT00589121|581719968|FG000|Overall Study|Protocol Violation|2|||
161090340|NCT00589121|581719969|FG001|Overall Study|Protocol Violation|6|||
161090341|NCT00589121|581719968|FG000|Overall Study|No protocol treatment received|0|||
161090342|NCT00589121|581719969|FG001|Overall Study|No protocol treatment received|1|||
161090343|NCT03141905|581719970|FG000|Overall Study|Death|3|||
161090344|NCT03141905|581719971|FG001|Overall Study|Death|2|||
161090345|NCT03141905|581719970|FG000|Overall Study|Withdrawal by Subject|1|||
161090346|NCT03141905|581719971|FG001|Overall Study|Withdrawal by Subject|0|||
161090347|NCT03141905|581719970|FG000|Overall Study|Lost to Follow-up|3|||
161090348|NCT03141905|581719971|FG001|Overall Study|Lost to Follow-up|7|||
161349750|NCT03500172|582665943|FG000|Period 1: Baseline Randomization|Death|0|||
161193014|NCT01409382|582085414|FG001|Overall Study|Multiple pregnancy|4|||
161193015|NCT01409382|582085413|FG000|Overall Study|Still pregnant when study ended|13|||
161193016|NCT01409382|582085414|FG001|Overall Study|Still pregnant when study ended|2|||
161193017|NCT01409382|582085413|FG000|Overall Study|Did not manage to get pregnant|64|||
161193018|NCT01409382|582085414|FG001|Overall Study|Did not manage to get pregnant|70|||
161193019|NCT01409382|582085413|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
161193020|NCT01409382|582085414|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
161193021|NCT00965458|582085419|FG000|Overall Study|Adverse Event|1|||
161193022|NCT00965458|582085420|FG001|Overall Study|Adverse Event|0|||
161193023|NCT00965458|582085419|FG000|Overall Study|Lost to Follow-up|1|||
161193024|NCT00965458|582085420|FG001|Overall Study|Lost to Follow-up|3|||
161193025|NCT00965458|582085419|FG000|Overall Study|Withdrawal by Subject|0|||
161193026|NCT00965458|582085420|FG001|Overall Study|Withdrawal by Subject|1|||
161193027|NCT01846039|582085421|FG000|Overall Study|Protocol Violation|1|||
161193028|NCT01846039|582085421|FG000|Overall Study|Subject Withdrew Consent|1|||
161193029|NCT00508872|582085426|FG000|Overall Study|Lost to Follow-up|1|||
161193030|NCT00508872|582085426|FG000|Overall Study|Physician Decision|1|||
161193031|NCT00883896|582085427|FG000|Overall Study|Lost to Follow-up|0|||
161193032|NCT00883896|582085428|FG001|Overall Study|Lost to Follow-up|0|||
161193033|NCT00883896|582085429|FG002|Overall Study|Lost to Follow-up|0|||
161193034|NCT00883896|582085430|FG003|Overall Study|Lost to Follow-up|2|||
161193035|NCT00883896|582085427|FG000|Overall Study|Withdrawal by Subject|5|||
161193036|NCT00883896|582085428|FG001|Overall Study|Withdrawal by Subject|0|||
161193037|NCT00883896|582085429|FG002|Overall Study|Withdrawal by Subject|1|||
161193038|NCT00883896|582085430|FG003|Overall Study|Withdrawal by Subject|3|||
161193039|NCT00883896|582085427|FG000|Overall Study|Lack of Efficacy|0|||
161193040|NCT00883896|582085428|FG001|Overall Study|Lack of Efficacy|0|||
161193041|NCT00883896|582085429|FG002|Overall Study|Lack of Efficacy|0|||
161193042|NCT00883896|582085430|FG003|Overall Study|Lack of Efficacy|2|||
161193043|NCT00883896|582085427|FG000|Overall Study|Other|1|||
161193044|NCT00883896|582085428|FG001|Overall Study|Other|0|||
161193045|NCT00883896|582085429|FG002|Overall Study|Other|0|||
161193046|NCT00883896|582085430|FG003|Overall Study|Other|0|||
161193047|NCT02210559|582085431|FG000|Overall Study|Progressive Disease|3|||
161193048|NCT02210559|582085432|FG001|Overall Study|Progressive Disease|2|||
161193049|NCT02210559|582085431|FG000|Overall Study|Adverse Event|2|||
161193050|NCT02210559|582085432|FG001|Overall Study|Adverse Event|2|||
161193051|NCT02210559|582085431|FG000|Overall Study|Physician Decision|1|||
161193052|NCT02210559|582085432|FG001|Overall Study|Physician Decision|0|||
161193053|NCT02210559|582085431|FG000|Overall Study|Withdrawal by Subject|0|||
161193054|NCT02210559|582085432|FG001|Overall Study|Withdrawal by Subject|1|||
161193055|NCT02210559|582085431|FG000|Overall Study|Other than specified|0|||
161193056|NCT02210559|582085432|FG001|Overall Study|Other than specified|1|||
161193057|NCT02546193|582085433|FG000|Overall Study|Withdrawal by Subject|2|||
161193058|NCT02546193|582085434|FG001|Overall Study|Withdrawal by Subject|0|||
161193059|NCT02546193|582085435|FG002|Overall Study|Withdrawal by Subject|1|||
161193060|NCT02546193|582085436|FG003|Overall Study|Withdrawal by Subject|0|||
161193061|NCT02546193|582085433|FG000|Overall Study|Not eligible at time of induction|4|||
161193062|NCT02546193|582085434|FG001|Overall Study|Not eligible at time of induction|6|||
161193063|NCT02546193|582085435|FG002|Overall Study|Not eligible at time of induction|1|||
161193064|NCT02546193|582085436|FG003|Overall Study|Not eligible at time of induction|0|||
161193065|NCT00792467|582085437|FG000|Overall Study|progression of disease|17|||
161193066|NCT00792467|582085437|FG000|Overall Study|Adverse Event|1|||
161193067|NCT00792467|582085437|FG000|Overall Study|patient request|1|||
161193068|NCT00792467|582085437|FG000|Overall Study|Lost to Follow-up|1|||
161193069|NCT00792467|582085437|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
161193070|NCT00792467|582085437|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
161193071|NCT01287403|582085441|FG000|1st Intervention (1 Day)|Adverse Event|1|||
161193072|NCT01098266|582085442|FG000|Overall Study|Physician Decision|1|||
161193073|NCT01098266|582085443|FG001|Overall Study|Physician Decision|0|||
161193074|NCT01098266|582085442|FG000|Overall Study|Death|3|||
161193075|NCT01098266|582085443|FG001|Overall Study|Death|2|||
161193076|NCT01098266|582085442|FG000|Overall Study|Withdrawal by Subject|3|||
161193077|NCT01098266|582085443|FG001|Overall Study|Withdrawal by Subject|5|||
161306354|NCT02017717|582502824|FG002|Before Treatment Period|Participant request to stop therapy|0|||
161193078|NCT00438815|582085444|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
161193079|NCT00438815|582085444|FG000|Overall Study|3-month follow-up no longer required|12|||
161193080|NCT00438815|582085444|FG000|Overall Study|Noncompliance with protocol requirements|9|||
161193081|NCT00438815|582085444|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
161193082|NCT00438815|582085444|FG000|Overall Study|Lost to Follow-up|6|||
161193083|NCT00438815|582085444|FG000|Overall Study|Withdrawal by Subject|6|||
161193084|NCT00438815|582085444|FG000|Overall Study|Death|1|||
161193085|NCT01733758|582085445|FG000|Overall Study|Adverse Event|5|||
161193086|NCT01733758|582085446|FG001|Overall Study|Adverse Event|7|||
161193087|NCT01733758|582085447|FG002|Overall Study|Adverse Event|8|||
161193088|NCT01733758|582085448|FG003|Overall Study|Adverse Event|1|||
161193089|NCT01733758|582085445|FG000|Overall Study|Withdrawal by Subject|1|||
161193090|NCT01733758|582085446|FG001|Overall Study|Withdrawal by Subject|1|||
161193091|NCT01733758|582085447|FG002|Overall Study|Withdrawal by Subject|5|||
161193092|NCT01733758|582085448|FG003|Overall Study|Withdrawal by Subject|3|||
161193093|NCT01733758|582085445|FG000|Overall Study|Persistent Hyperglycemia|3|||
161193094|NCT01733758|582085446|FG001|Overall Study|Persistent Hyperglycemia|2|||
161193095|NCT01733758|582085447|FG002|Overall Study|Persistent Hyperglycemia|0|||
161193096|NCT01733758|582085448|FG003|Overall Study|Persistent Hyperglycemia|0|||
161193097|NCT01733758|582085445|FG000|Overall Study|Protocol Violation|0|||
161193098|NCT01733758|582085446|FG001|Overall Study|Protocol Violation|1|||
161193099|NCT01733758|582085447|FG002|Overall Study|Protocol Violation|2|||
161193100|NCT01733758|582085448|FG003|Overall Study|Protocol Violation|2|||
161193101|NCT01733758|582085445|FG000|Overall Study|Non-compliance|1|||
161193102|NCT01733758|582085446|FG001|Overall Study|Non-compliance|0|||
161193103|NCT01733758|582085447|FG002|Overall Study|Non-compliance|0|||
161193104|NCT01733758|582085448|FG003|Overall Study|Non-compliance|0|||
161193105|NCT01733758|582085445|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
161193106|NCT01733758|582085446|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
161193107|NCT01733758|582085447|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
161193108|NCT01733758|582085448|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
161193109|NCT01733758|582085445|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
161193110|NCT01733758|582085446|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
161193111|NCT01733758|582085447|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
161193112|NCT01733758|582085448|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
161193113|NCT02545270|582085453|FG000|Overall Study|technical difficulties|0|||
161193114|NCT02545270|582085454|FG001|Overall Study|technical difficulties|1|||
161193115|NCT02545270|582085455|FG002|Overall Study|technical difficulties|0|||
161193116|NCT02545270|582085453|FG000|Overall Study|Videos being too similar to other|0|||
161193117|NCT02545270|582085454|FG001|Overall Study|Videos being too similar to other|0|||
161193118|NCT02545270|582085455|FG002|Overall Study|Videos being too similar to other|2|||
161193119|NCT00727246|582085456|FG000|Overall Study|could not complete MRI|0|||
161193120|NCT00727246|582085457|FG001|Overall Study|could not complete MRI|1|||
161193121|NCT00727246|582085458|FG002|Overall Study|could not complete MRI|0|||
161193122|NCT00727246|582085459|FG003|Overall Study|could not complete MRI|1|||
161193123|NCT00727246|582085456|FG000|Overall Study|incidental finding|0|||
161193124|NCT00727246|582085457|FG001|Overall Study|incidental finding|0|||
161193125|NCT00727246|582085458|FG002|Overall Study|incidental finding|0|||
161193126|NCT00727246|582085459|FG003|Overall Study|incidental finding|1|||
161193127|NCT00727246|582085456|FG000|Overall Study|withdrawn|0|||
161193128|NCT00727246|582085457|FG001|Overall Study|withdrawn|0|||
161193129|NCT00727246|582085458|FG002|Overall Study|withdrawn|1|||
161193130|NCT00727246|582085459|FG003|Overall Study|withdrawn|0|||
161193131|NCT00661362|582085460|FG000|Overall Study|Adverse Event|5|||
161193132|NCT00661362|582085461|FG001|Overall Study|Adverse Event|4|||
161193133|NCT00661362|582085460|FG000|Overall Study|Incorrect enrollment|2|||
161193134|NCT00661362|582085461|FG001|Overall Study|Incorrect enrollment|0|||
161193135|NCT00661362|582085460|FG000|Overall Study|Study specific discontinuation criteria|4|||
161193136|NCT00661362|582085461|FG001|Overall Study|Study specific discontinuation criteria|11|||
161193137|NCT00661362|582085460|FG000|Overall Study|Withdrawal by Subject|13|||
161193138|NCT00661362|582085461|FG001|Overall Study|Withdrawal by Subject|23|||
161193139|NCT00661362|582085460|FG000|Overall Study|Lost to Follow-up|3|||
161193140|NCT00661362|582085461|FG001|Overall Study|Lost to Follow-up|1|||
161193141|NCT00661362|582085460|FG000|Overall Study|Severe non-compliance to protocol|0|||
161193142|NCT00661362|582085461|FG001|Overall Study|Severe non-compliance to protocol|1|||
161193143|NCT00661362|582085460|FG000|Overall Study|Safety reasons|1|||
161193144|NCT00661362|582085461|FG001|Overall Study|Safety reasons|0|||
161193145|NCT00661362|582085460|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
161193146|NCT00661362|582085461|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
161193147|NCT00535262|582085464|FG000|Overall Study|No funding|3|||
161193148|NCT04382066|582085467|FG000|Overall Study|Adverse Event|1|||
161193149|NCT04382066|582085468|FG001|Overall Study|Adverse Event|0|||
161193150|NCT04382066|582085469|FG002|Overall Study|Adverse Event|0|||
161193151|NCT04382066|582085467|FG000|Overall Study|Death|1|||
161193152|NCT04382066|582085468|FG001|Overall Study|Death|0|||
161193153|NCT04382066|582085469|FG002|Overall Study|Death|1|||
161193154|NCT04225026|582085476|FG000|Overall Study|Withdrawal by Subject|4|||
161193155|NCT04225026|582085476|FG000|Overall Study|Adverse Event|1|||
161193156|NCT04225026|582085476|FG000|Overall Study|Other|1|||
161193157|NCT04225026|582085476|FG000|Overall Study|Death|11|||
161193158|NCT04225026|582085476|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
161193159|NCT04738123|582085479|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
161193160|NCT04738123|582085480|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
161193161|NCT04738123|582085479|FG000|Overall Study|Progressive Disease|0|||
161193162|NCT04738123|582085480|FG001|Overall Study|Progressive Disease|4|||
161193163|NCT04738123|582085479|FG000|Overall Study|Adverse Event|8|||
161193164|NCT04738123|582085480|FG001|Overall Study|Adverse Event|7|||
161193165|NCT04738123|582085479|FG000|Overall Study|Other Reasons|0|||
161193166|NCT04738123|582085480|FG001|Overall Study|Other Reasons|1|||
161193167|NCT04738123|582085479|FG000|Overall Study|Suicidal or assaultive behavior|0|||
161193168|NCT04738123|582085480|FG001|Overall Study|Suicidal or assaultive behavior|2|||
161193169|NCT04738123|582085479|FG000|Overall Study|Protocol Violation|2|||
161193170|NCT04738123|582085480|FG001|Overall Study|Protocol Violation|2|||
161193171|NCT04738123|582085479|FG000|Overall Study|Consent Withdrawn|35|||
161193172|NCT04738123|582085480|FG001|Overall Study|Consent Withdrawn|22|||
161193173|NCT00779506|582085481|FG000|Overall Study|Screening Failed|2|||
161193174|NCT00779506|582085481|FG000|Overall Study|Adverse Event|4|||
161193175|NCT00779506|582085481|FG000|Overall Study|Lack of Efficacy|11|||
161193176|NCT00779506|582085481|FG000|Overall Study|Protocol Violation|5|||
161193177|NCT00779506|582085481|FG000|Overall Study|Withdrawal by Subject|6|||
161193178|NCT00779506|582085481|FG000|Overall Study|Lost to Follow-up|1|||
161193179|NCT03982069|582085482|FG000|Overall Study|Lost to Follow-up|5|||
161193180|NCT03982069|582085483|FG001|Overall Study|Lost to Follow-up|5|||
161193181|NCT03982069|582085484|FG002|Overall Study|Lost to Follow-up|3|||
161193182|NCT03982069|582085485|FG003|Overall Study|Lost to Follow-up|5|||
161193183|NCT03982069|582085482|FG000|Overall Study|Physician Decision|0|||
161193184|NCT03982069|582085483|FG001|Overall Study|Physician Decision|1|||
161193185|NCT03982069|582085484|FG002|Overall Study|Physician Decision|0|||
161193186|NCT03982069|582085485|FG003|Overall Study|Physician Decision|0|||
161193187|NCT03982069|582085482|FG000|Overall Study|Withdrawal by Subject|2|||
161193188|NCT03982069|582085483|FG001|Overall Study|Withdrawal by Subject|1|||
161193189|NCT03982069|582085484|FG002|Overall Study|Withdrawal by Subject|5|||
161193190|NCT03982069|582085485|FG003|Overall Study|Withdrawal by Subject|2|||
161193191|NCT03982069|582085482|FG000|Overall Study|Specimen loss|3|||
161193192|NCT03982069|582085483|FG001|Overall Study|Specimen loss|3|||
161193193|NCT03982069|582085484|FG002|Overall Study|Specimen loss|1|||
161193194|NCT03982069|582085485|FG003|Overall Study|Specimen loss|1|||
161193195|NCT00787527|582085488|FG000|Overall Study|Toxicity|3|||
161193196|NCT00083616|582085489|FG000|Overall Study|Disease Progression|16|||
161193197|NCT00083616|582085489|FG000|Overall Study|Lost to Follow-up|1|||
161193198|NCT00083616|582085489|FG000|Overall Study|Physician Decision|2|||
161193199|NCT00083616|582085489|FG000|Overall Study|Withdrawal by Subject|3|||
161193200|NCT00083616|582085489|FG000|Overall Study|Ineligibility determined|2|||
161193201|NCT00083616|582085489|FG000|Overall Study|Non-compliance|1|||
161193202|NCT00083616|582085489|FG000|Overall Study|Other|6|||
161193203|NCT00914940|582085490|FG000|D0 to D100 Post-transplant|Death|2|||
161193204|NCT00914940|582085490|FG000|D101 to 2 Years Post-transplant|Death|8|||
161193205|NCT00914940|582085490|FG000|2 Years to 5 Years Post-transplant|Death|3|||
161193206|NCT01724021|582085491|FG000|Overall Study|Adverse Event|11|||
161193207|NCT01724021|582085492|FG001|Overall Study|Adverse Event|6|||
161193208|NCT01724021|582085491|FG000|Overall Study|Death|46|||
161193209|NCT01724021|582085492|FG001|Overall Study|Death|58|||
161193210|NCT01724021|582085491|FG000|Overall Study|Participant request/ Withdrew consent|18|||
161193211|NCT01724021|582085492|FG001|Overall Study|Participant request/ Withdrew consent|14|||
161193212|NCT01724021|582085491|FG000|Overall Study|Lost to Follow-up|15|||
161193213|NCT01724021|582085492|FG001|Overall Study|Lost to Follow-up|15|||
161193214|NCT01724021|582085491|FG000|Overall Study|Reason Not Specified|36|||
161193215|NCT01724021|582085492|FG001|Overall Study|Reason Not Specified|39|||
161193216|NCT01724021|582085491|FG000|Overall Study|Missing|1|||
161193217|NCT01724021|582085492|FG001|Overall Study|Missing|1|||
161193218|NCT01078389|582087947|FG000|Overall Study|Adverse Event|10|||
161193219|NCT01078389|582087948|FG001|Overall Study|Adverse Event|6|||
161193220|NCT01078389|582087947|FG000|Overall Study|Major Protocol Deviation|2|||
161193221|NCT01078389|582087948|FG001|Overall Study|Major Protocol Deviation|0|||
161193222|NCT01078389|582087947|FG000|Overall Study|Lost to Follow-up|23|||
161193223|NCT01078389|582087948|FG001|Overall Study|Lost to Follow-up|23|||
161193224|NCT01078389|582087947|FG000|Overall Study|Voluntary Withdrawal|20|||
161193225|NCT01078389|582087948|FG001|Overall Study|Voluntary Withdrawal|36|||
161193226|NCT01078389|582087947|FG000|Overall Study|Other|9|||
161193227|NCT01078389|582087948|FG001|Overall Study|Other|2|||
161193228|NCT03726320|582087949|FG000|Overall Study|Lost to Follow-up|2|||
161193229|NCT03726320|582087950|FG001|Overall Study|Lost to Follow-up|4|||
161193230|NCT03726320|582087951|FG002|Overall Study|Lost to Follow-up|0|||
161193231|NCT03726320|582087949|FG000|Overall Study|Time Constraints|4|||
161193232|NCT03726320|582087950|FG001|Overall Study|Time Constraints|1|||
161193233|NCT03726320|582087951|FG002|Overall Study|Time Constraints|0|||
161193234|NCT03726320|582087949|FG000|Overall Study|Ineligible after enrollment|3|||
161193235|NCT03726320|582087950|FG001|Overall Study|Ineligible after enrollment|3|||
161193236|NCT03726320|582087951|FG002|Overall Study|Ineligible after enrollment|0|||
161193237|NCT03726320|582087949|FG000|Overall Study|Clinic / insurance issue|2|||
161193238|NCT03726320|582087950|FG001|Overall Study|Clinic / insurance issue|0|||
161193239|NCT03726320|582087951|FG002|Overall Study|Clinic / insurance issue|0|||
161193240|NCT03726320|582087949|FG000|Overall Study|Language barrier|1|||
161193241|NCT03726320|582087950|FG001|Overall Study|Language barrier|0|||
161193242|NCT03726320|582087951|FG002|Overall Study|Language barrier|0|||
161193243|NCT03726320|582087949|FG000|Overall Study|Provider left the clinic|0|||
161193244|NCT03726320|582087950|FG001|Overall Study|Provider left the clinic|0|||
161193245|NCT03726320|582087951|FG002|Overall Study|Provider left the clinic|1|||
161193246|NCT02361307|582087954|FG000|Overall Study|Unstable medical condition.|0|||
161193247|NCT02361307|582087955|FG001|Overall Study|Unstable medical condition.|1|||
161193248|NCT01189201|582087960|FG000|Overall Study|Adverse Event|1|||
161193249|NCT01277757|582087961|FG000|Overall Study|Disease Progression|1|||
161193250|NCT01277757|582087961|FG000|Overall Study|Withdrawal by Subject|1|||
161193251|NCT00240331|582087967|FG000|Overall Study|Withdrawal by Subject|125|||
161193252|NCT00240331|582087968|FG001|Overall Study|Withdrawal by Subject|132|||
161193253|NCT00240331|582087967|FG000|Overall Study|Option selected by investigator|1|||
161193254|NCT00240331|582087968|FG001|Overall Study|Option selected by investigator|2|||
161193255|NCT01233076|582087969|FG000|Period 2, One Week|Lost to Follow-up|1|||
161193256|NCT01233076|582087970|FG001|Period 2, One Week|Lost to Follow-up|0|||
161193257|NCT04563845|582087971|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193258|NCT04563845|582087972|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193259|NCT04563845|582087973|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193260|NCT04563845|582087974|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193261|NCT04563845|582087975|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193262|NCT04563845|582087976|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193263|NCT04563845|582087977|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193264|NCT04563845|582087978|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
161193265|NCT04563845|582087979|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193266|NCT04563845|582087980|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193267|NCT04563845|582087981|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193268|NCT04563845|582087982|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193269|NCT04563845|582087983|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193270|NCT04563845|582087984|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
161193271|NCT04563845|582087971|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193272|NCT04563845|582087972|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193273|NCT04563845|582087973|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193274|NCT04563845|582087974|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193275|NCT04563845|582087975|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
161193276|NCT04563845|582087976|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193277|NCT04563845|582087977|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193278|NCT04563845|582087978|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193279|NCT04563845|582087979|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193280|NCT04563845|582087980|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193281|NCT04563845|582087981|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193282|NCT04563845|582087982|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193283|NCT04563845|582087983|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193284|NCT04563845|582087984|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
161193285|NCT01020812|582087985|FG000|Overall Study|Physician Decision|1|||
161193286|NCT01020812|582087985|FG000|Overall Study|Withdrawal by Subject|1|||
161193287|NCT01020812|582087985|FG000|Overall Study|Protocol Violation|1|||
161193288|NCT00421928|582087988|FG000|Overall Study|Adverse Event|61|||
161193289|NCT00421928|582087989|FG001|Overall Study|Adverse Event|140|||
161193290|NCT00421928|582087990|FG002|Overall Study|Adverse Event|22|||
161193291|NCT00421928|582087988|FG000|Overall Study|Lost to Follow-up|5|||
161193292|NCT00421928|582087989|FG001|Overall Study|Lost to Follow-up|0|||
161193293|NCT00421928|582087990|FG002|Overall Study|Lost to Follow-up|3|||
161193294|NCT00421928|582087988|FG000|Overall Study|Withdrawal by Subject|50|||
161193295|NCT00421928|582087989|FG001|Overall Study|Withdrawal by Subject|48|||
161193296|NCT00421928|582087990|FG002|Overall Study|Withdrawal by Subject|43|||
161193297|NCT00421928|582087988|FG000|Overall Study|Lack of Efficacy|15|||
161193298|NCT00421928|582087989|FG001|Overall Study|Lack of Efficacy|7|||
161193299|NCT00421928|582087990|FG002|Overall Study|Lack of Efficacy|35|||
161193300|NCT00421928|582087988|FG000|Overall Study|Study drug non-compliant|6|||
161193301|NCT00421928|582087989|FG001|Overall Study|Study drug non-compliant|7|||
161306355|NCT02017717|582502825|FG003|Before Treatment Period|Participant request to stop therapy|0|||
161306356|NCT02017717|582502826|FG004|Before Treatment Period|Participant request to stop therapy|0|||
161306357|NCT02017717|582502827|FG005|Before Treatment Period|Participant request to stop therapy|0|||
161306358|NCT02017717|582502828|FG006|Before Treatment Period|Participant request to stop therapy|0|||
161306359|NCT02017717|582502829|FG007|Before Treatment Period|Participant request to stop therapy|0|||
161306360|NCT02017717|582502830|FG008|Before Treatment Period|Participant request to stop therapy|5|||
161193302|NCT00421928|582087990|FG002|Overall Study|Study drug non-compliant|4|||
161193303|NCT00421928|582087988|FG000|Overall Study|All other|26|||
161193304|NCT00421928|582087989|FG001|Overall Study|All other|21|||
161193305|NCT00421928|582087990|FG002|Overall Study|All other|27|||
161193306|NCT00421928|582087988|FG000|Overall Study|Death|0|||
161193307|NCT00421928|582087989|FG001|Overall Study|Death|1|||
161193308|NCT00421928|582087990|FG002|Overall Study|Death|0|||
161193309|NCT00346775|582087991|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
161349751|NCT03500172|582665944|FG001|Period 1: Baseline Randomization|Death|0|||
161349752|NCT03500172|582665945|FG002|Period 1: Baseline Randomization|Death|0|||
161349753|NCT03500172|582665946|FG003|Period 1: Baseline Randomization|Death|0|||
161349754|NCT03500172|582665947|FG004|Period 1: Baseline Randomization|Death|0|||
161349755|NCT03500172|582665948|FG005|Period 1: Baseline Randomization|Death|0|||
161349756|NCT03500172|582665949|FG006|Period 1: Baseline Randomization|Death|0|||
161349757|NCT03500172|582665950|FG007|Period 1: Baseline Randomization|Death|0|||
161349758|NCT03500172|582665951|FG008|Period 1: Baseline Randomization|Death|0|||
161349759|NCT03500172|582665952|FG009|Period 1: Baseline Randomization|Death|2|||
161349760|NCT03500172|582665953|FG010|Period 1: Baseline Randomization|Death|0|||
161349761|NCT03500172|582665943|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
161349762|NCT03500172|582665944|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
161349763|NCT03500172|582665945|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
161349764|NCT03500172|582665946|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
161349765|NCT03500172|582665947|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
161349766|NCT03500172|582665948|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
161349767|NCT03500172|582665949|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
161349768|NCT03500172|582665950|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
161349769|NCT03500172|582665951|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
161349770|NCT03500172|582665952|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
161349771|NCT03500172|582665953|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
161349772|NCT03500172|582665943|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
161349773|NCT03500172|582665944|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
161193310|NCT00346775|582087992|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
161193311|NCT00346775|582087991|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
161193312|NCT00346775|582087992|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
161193313|NCT00346775|582087991|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
161193314|NCT00346775|582087992|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
161193315|NCT02946515|582087993|FG000|Overall Study|Lost to Follow-up|2|||
161193316|NCT02946515|582087994|FG001|Overall Study|Lost to Follow-up|1|||
161193317|NCT01096017|582088002|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
161193318|NCT01096017|582088003|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
161193319|NCT04177862|582088007|FG000|Overall Study|Protocol Violation|2|||
161193320|NCT04177862|582088008|FG001|Overall Study|Protocol Violation|7|||
161193321|NCT05637515|582088009|FG000|Overall Study|Withdrawal by Subject|17|||
161193322|NCT05637515|582088010|FG001|Overall Study|Withdrawal by Subject|17|||
161349774|NCT03500172|582665945|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
161349775|NCT03500172|582665946|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
161349776|NCT03500172|582665947|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
161349777|NCT03500172|582665948|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
161349778|NCT03500172|582665949|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
161349779|NCT03500172|582665950|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
161349780|NCT03500172|582665951|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
161349781|NCT03500172|582665952|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
161349782|NCT03500172|582665953|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
161349783|NCT03500172|582665943|FG000|Period 2: Re-Randomization|Death|0|||
161193323|NCT04516291|582088012|FG000|Treatment Period (24 Weeks)|Other|1|||
161193324|NCT04516291|582088013|FG001|Treatment Period (24 Weeks)|Other|0|||
161193325|NCT04516291|582088014|FG002|Treatment Period (24 Weeks)|Other|0|||
161193326|NCT04516291|582088015|FG003|Treatment Period (24 Weeks)|Other|2|||
161193327|NCT04516291|582088016|FG004|Treatment Period (24 Weeks)|Other|2|||
161193328|NCT04516291|582088017|FG005|Treatment Period (24 Weeks)|Other|4|||
161193329|NCT04516291|582088018|FG006|Treatment Period (24 Weeks)|Other|2|||
161193330|NCT04516291|582088019|FG007|Treatment Period (24 Weeks)|Other|0|||
161193331|NCT04516291|582088012|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161193332|NCT04516291|582088013|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
161193333|NCT04516291|582088014|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161193334|NCT04516291|582088015|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161193335|NCT04516291|582088016|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161193336|NCT04516291|582088017|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161193337|NCT04516291|582088018|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161193338|NCT04516291|582088019|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161193339|NCT04516291|582088012|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
161193340|NCT04516291|582088013|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
161349784|NCT03500172|582665944|FG001|Period 2: Re-Randomization|Death|0|||
161349785|NCT03500172|582665945|FG002|Period 2: Re-Randomization|Death|0|||
161349786|NCT03500172|582665946|FG003|Period 2: Re-Randomization|Death|4|||
161349787|NCT03500172|582665947|FG004|Period 2: Re-Randomization|Death|2|||
161349788|NCT03500172|582665948|FG005|Period 2: Re-Randomization|Death|0|||
161193341|NCT04516291|582088014|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
161193342|NCT04516291|582088015|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
161193343|NCT04516291|582088016|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
161193344|NCT04516291|582088017|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
161193345|NCT04516291|582088018|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
161193346|NCT04516291|582088019|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
161193347|NCT04516291|582088012|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193348|NCT04516291|582088013|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
161193349|NCT04516291|582088014|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193350|NCT04516291|582088015|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193351|NCT04516291|582088016|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193352|NCT04516291|582088017|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193353|NCT04516291|582088018|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193354|NCT04516291|582088019|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
161193355|NCT04516291|582088012|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
161193356|NCT04516291|582088013|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
161193357|NCT04516291|582088014|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
161193358|NCT04516291|582088015|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
161193359|NCT04516291|582088016|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
161193360|NCT04516291|582088017|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
161193361|NCT04516291|582088018|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
161193362|NCT04516291|582088019|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
161193363|NCT04516291|582088012|FG000|Follow-up Period (12 Weeks)|Other|0|||
161193364|NCT04516291|582088013|FG001|Follow-up Period (12 Weeks)|Other|1|||
161193365|NCT04516291|582088014|FG002|Follow-up Period (12 Weeks)|Other|0|||
161193366|NCT04516291|582088015|FG003|Follow-up Period (12 Weeks)|Other|2|||
161193367|NCT04516291|582088016|FG004|Follow-up Period (12 Weeks)|Other|0|||
161193368|NCT04516291|582088017|FG005|Follow-up Period (12 Weeks)|Other|0|||
161193369|NCT04516291|582088018|FG006|Follow-up Period (12 Weeks)|Other|0|||
161193370|NCT04516291|582088019|FG007|Follow-up Period (12 Weeks)|Other|0|||
161193371|NCT04516291|582088012|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193372|NCT04516291|582088013|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193373|NCT04516291|582088014|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193374|NCT04516291|582088015|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193375|NCT04516291|582088016|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
161193376|NCT04516291|582088017|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193377|NCT04516291|582088018|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193378|NCT04516291|582088019|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
161193379|NCT04516291|582088012|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
161193380|NCT04516291|582088013|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
161193381|NCT04516291|582088014|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
161193382|NCT04516291|582088015|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
161193383|NCT04516291|582088016|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
161193384|NCT04516291|582088017|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
161193385|NCT04516291|582088018|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
161193386|NCT04516291|582088019|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
161193387|NCT01855607|582088020|FG000|Overall Study|Withdrawal by Subject|1|||
161193388|NCT01855607|582088020|FG000|Overall Study|Study was terminated|11|||
161193389|NCT02181634|582088021|FG000|Overall Study|Lack of Efficacy|33|||
161193390|NCT02181634|582088021|FG000|Overall Study|Adverse Event|17|||
161193391|NCT02181634|582088021|FG000|Overall Study|Physician Decision|8|||
161193392|NCT02181634|582088021|FG000|Overall Study|Withdrawal by Subject|5|||
161193393|NCT02181634|582088021|FG000|Overall Study|Death|2|||
161193394|NCT02181634|582088021|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
161193395|NCT02181634|582088021|FG000|Overall Study|Ineligible|1|||
161193396|NCT02181634|582088021|FG000|Overall Study|Max number of dose reduction|1|||
161193397|NCT02181634|582088021|FG000|Overall Study|Symptomatic progression|1|||
161193398|NCT02181634|582088021|FG000|Overall Study|Patient opted to proceed to surgery|1|||
161193399|NCT03824704|582088027|FG000|Overall Study|Study Terminated by Sponsor|1|||
161193400|NCT02155660|582088035|FG000|Overall Study|Other Reason|8|||
161193401|NCT02155660|582088036|FG001|Overall Study|Other Reason|6|||
161193402|NCT02155660|582088037|FG002|Overall Study|Other Reason|10|||
161193403|NCT02155660|582088038|FG003|Overall Study|Other Reason|10|||
161193404|NCT02155660|582088035|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161193405|NCT02155660|582088036|FG001|Overall Study|Study-specific withdrawal criteria|1|||
161193406|NCT02155660|582088037|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161306361|NCT02017717|582502822|FG000|Before Treatment Period|Participant withdrew consent|0|||
161306362|NCT02017717|582502823|FG001|Before Treatment Period|Participant withdrew consent|0|||
161306363|NCT02017717|582502824|FG002|Before Treatment Period|Participant withdrew consent|0|||
161193407|NCT02155660|582088038|FG003|Overall Study|Study-specific withdrawal criteria|1|||
161193408|NCT02155660|582088035|FG000|Overall Study|Severe non-compliance|0|||
161193409|NCT02155660|582088036|FG001|Overall Study|Severe non-compliance|4|||
161193410|NCT02155660|582088037|FG002|Overall Study|Severe non-compliance|0|||
161193411|NCT02155660|582088038|FG003|Overall Study|Severe non-compliance|1|||
161306364|NCT02017717|582502825|FG003|Before Treatment Period|Participant withdrew consent|0|||
161193412|NCT02155660|582088035|FG000|Overall Study|Adverse Event|2|||
161193413|NCT02155660|582088036|FG001|Overall Study|Adverse Event|6|||
161193414|NCT02155660|582088037|FG002|Overall Study|Adverse Event|3|||
161193415|NCT02155660|582088038|FG003|Overall Study|Adverse Event|1|||
161193416|NCT02155660|582088035|FG000|Overall Study|Lost to Follow-up|3|||
161193417|NCT02155660|582088036|FG001|Overall Study|Lost to Follow-up|6|||
161193418|NCT02155660|582088037|FG002|Overall Study|Lost to Follow-up|5|||
161193419|NCT02155660|582088038|FG003|Overall Study|Lost to Follow-up|8|||
161193420|NCT02155660|582088035|FG000|Overall Study|Death|17|||
161193421|NCT02155660|582088036|FG001|Overall Study|Death|19|||
161193422|NCT02155660|582088037|FG002|Overall Study|Death|17|||
161193423|NCT02155660|582088038|FG003|Overall Study|Death|19|||
161193424|NCT02155660|582088035|FG000|Overall Study|Withdrawal by Subject|28|||
161193425|NCT02155660|582088036|FG001|Overall Study|Withdrawal by Subject|31|||
161193426|NCT02155660|582088037|FG002|Overall Study|Withdrawal by Subject|24|||
161193427|NCT02155660|582088038|FG003|Overall Study|Withdrawal by Subject|21|||
161193428|NCT03730987|582088039|FG000|Overall Study|Lost to Follow-up|2|||
161193429|NCT03730987|582088040|FG001|Overall Study|Lost to Follow-up|0|||
161193430|NCT03730987|582088041|FG002|Overall Study|Lost to Follow-up|2|||
161193431|NCT03730987|582088042|FG003|Overall Study|Lost to Follow-up|0|||
161193432|NCT02087085|582088043|FG000|Overall Study|Adverse Event|10|||
161193433|NCT02087085|582088044|FG001|Overall Study|Adverse Event|14|||
161193434|NCT02087085|582088043|FG000|Overall Study|Lack of Efficacy|4|||
161193435|NCT02087085|582088044|FG001|Overall Study|Lack of Efficacy|3|||
161193436|NCT02087085|582088043|FG000|Overall Study|Lost to Follow-up|6|||
161193437|NCT02087085|582088044|FG001|Overall Study|Lost to Follow-up|4|||
161193438|NCT02087085|582088043|FG000|Overall Study|Withdrawal by Subject|9|||
161193439|NCT02087085|582088044|FG001|Overall Study|Withdrawal by Subject|11|||
161193440|NCT02087085|582088043|FG000|Overall Study|Protocol Violation|1|||
161193441|NCT02087085|582088044|FG001|Overall Study|Protocol Violation|0|||
161193442|NCT02087085|582088043|FG000|Overall Study|Study Terminated by Sponsor|87|||
161193443|NCT02087085|582088044|FG001|Overall Study|Study Terminated by Sponsor|80|||
161193444|NCT02087085|582088043|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161193445|NCT02087085|582088044|FG001|Overall Study|Other Miscellaneous Reasons|4|||
161193446|NCT02505945|582088045|FG000|Overall Study|Withdrawal by Subject|13|||
161193447|NCT02505945|582088046|FG001|Overall Study|Withdrawal by Subject|2|||
161193448|NCT02505945|582088045|FG000|Overall Study|Adverse Event|1|||
161193449|NCT02505945|582088046|FG001|Overall Study|Adverse Event|0|||
161193450|NCT02505945|582088045|FG000|Overall Study|Physician Decision|2|||
161193451|NCT02505945|582088046|FG001|Overall Study|Physician Decision|1|||
161193452|NCT02505945|582088045|FG000|Overall Study|Lost to Follow-up|6|||
161193453|NCT02505945|582088046|FG001|Overall Study|Lost to Follow-up|1|||
161193454|NCT00635804|582088047|FG000|Overall Study|Adverse Event|0|||
161193455|NCT00635804|582088048|FG001|Overall Study|Adverse Event|0|||
161193456|NCT00635804|582088049|FG002|Overall Study|Adverse Event|0|||
161193457|NCT00635804|582088050|FG003|Overall Study|Adverse Event|0|||
161193458|NCT00635804|582088051|FG004|Overall Study|Adverse Event|0|||
161193459|NCT00635804|582088052|FG005|Overall Study|Adverse Event|1|||
161193460|NCT00635804|582088053|FG006|Overall Study|Adverse Event|0|||
161193461|NCT00635804|582088054|FG007|Overall Study|Adverse Event|0|||
161193462|NCT00635804|582088047|FG000|Overall Study|Withdrawal by Subject|1|||
161193463|NCT00635804|582088048|FG001|Overall Study|Withdrawal by Subject|0|||
161193464|NCT00635804|582088049|FG002|Overall Study|Withdrawal by Subject|0|||
161193465|NCT00635804|582088050|FG003|Overall Study|Withdrawal by Subject|0|||
161193466|NCT00635804|582088051|FG004|Overall Study|Withdrawal by Subject|0|||
161193467|NCT00635804|582088052|FG005|Overall Study|Withdrawal by Subject|0|||
161193468|NCT00635804|582088053|FG006|Overall Study|Withdrawal by Subject|0|||
161193469|NCT00635804|582088054|FG007|Overall Study|Withdrawal by Subject|0|||
161193470|NCT01425268|582088062|FG000|Overall Study|Withdrawal by Subject|2|||
161193471|NCT01425268|582088063|FG001|Overall Study|Withdrawal by Subject|0|||
161193472|NCT01425268|582088062|FG000|Overall Study|Sponsor Decision|5|||
161193473|NCT01425268|582088063|FG001|Overall Study|Sponsor Decision|0|||
161193474|NCT01425268|582088062|FG000|Overall Study|Physician Decision|1|||
161193475|NCT01425268|582088063|FG001|Overall Study|Physician Decision|0|||
161193476|NCT00719706|582088064|FG000|Overall Study|Adverse Event|5|||
161193477|NCT00719706|582088065|FG001|Overall Study|Adverse Event|4|||
161193478|NCT00719706|582088064|FG000|Overall Study|Withdrawal by Subject|1|||
161193479|NCT00719706|582088065|FG001|Overall Study|Withdrawal by Subject|2|||
161306365|NCT02017717|582502826|FG004|Before Treatment Period|Participant withdrew consent|0|||
161349789|NCT03500172|582665949|FG006|Period 2: Re-Randomization|Death|5|||
161193480|NCT00719706|582088064|FG000|Overall Study|Protocol Violation|3|||
161193481|NCT00719706|582088065|FG001|Overall Study|Protocol Violation|0|||
161193482|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
161193483|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
161193484|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
161193485|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
161193486|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
161193487|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
161193488|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
161193489|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
161193490|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
161193491|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
161193492|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
161193493|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
161193494|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
161193495|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
161193496|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
161193497|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|Other|6|||
161193498|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|Other|6|||
161193499|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|Other|7|||
161193500|NCT02681094|582088066|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
161193501|NCT02681094|582088067|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
161193502|NCT02681094|582088068|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
161193503|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|Participant decision|7|||
161193504|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|Participant decision|10|||
161193505|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|Participant decision|9|||
161193506|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
161193507|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
161193508|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
161193509|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
161193510|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
161193511|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
161193512|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
161193513|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
161193514|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
161193515|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
161193516|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
161193517|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
161193518|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|Other|6|||
161193519|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|Other|6|||
161193520|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|Other|7|||
161193521|NCT02681094|582088066|FG000|2 - Enrolled Participants Set|No treatment given|0|||
161193522|NCT02681094|582088067|FG001|2 - Enrolled Participants Set|No treatment given|1|||
161193523|NCT02681094|582088068|FG002|2 - Enrolled Participants Set|No treatment given|1|||
161193524|NCT01072175|582088069|FG000|Part A (Drug-Drug Interaction)|Death|1|||
161193525|NCT01072175|582088070|FG001|Part A (Drug-Drug Interaction)|Death|0|||
161193526|NCT01072175|582088071|FG002|Part A (Drug-Drug Interaction)|Death|0|||
161193527|NCT01072175|582088072|FG003|Part A (Drug-Drug Interaction)|Death|0|||
161193528|NCT01072175|582088073|FG004|Part A (Drug-Drug Interaction)|Death|0|||
161193529|NCT01072175|582088074|FG005|Part A (Drug-Drug Interaction)|Death|0|||
161193530|NCT01072175|582088075|FG006|Part A (Drug-Drug Interaction)|Death|0|||
161193531|NCT01072175|582088076|FG007|Part A (Drug-Drug Interaction)|Death|0|||
161193532|NCT01072175|582088077|FG008|Part A (Drug-Drug Interaction)|Death|0|||
161193533|NCT01072175|582088078|FG009|Part A (Drug-Drug Interaction)|Death|0|||
161193534|NCT01072175|582088079|FG010|Part A (Drug-Drug Interaction)|Death|0|||
161193535|NCT01072175|582088080|FG011|Part A (Drug-Drug Interaction)|Death|0|||
161193536|NCT01072175|582088081|FG012|Part A (Drug-Drug Interaction)|Death|0|||
161193537|NCT01072175|582088069|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
161193538|NCT01072175|582088070|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193539|NCT01072175|582088071|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193540|NCT01072175|582088072|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193541|NCT01072175|582088073|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193542|NCT01072175|582088074|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193543|NCT01072175|582088075|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193544|NCT01072175|582088076|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193545|NCT01072175|582088077|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193546|NCT01072175|582088078|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193547|NCT01072175|582088079|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193548|NCT01072175|582088080|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193549|NCT01072175|582088081|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
161193550|NCT01072175|582088069|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
161193551|NCT01072175|582088070|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193552|NCT01072175|582088071|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193553|NCT01072175|582088072|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193554|NCT01072175|582088073|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193555|NCT01072175|582088074|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193556|NCT01072175|582088075|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193557|NCT01072175|582088076|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193558|NCT01072175|582088077|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193559|NCT01072175|582088078|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193560|NCT01072175|582088079|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193561|NCT01072175|582088080|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193562|NCT01072175|582088081|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
161193563|NCT01072175|582088069|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
161193564|NCT01072175|582088070|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
161193565|NCT01072175|582088071|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
161193566|NCT01072175|582088072|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
161193567|NCT01072175|582088073|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
161193568|NCT01072175|582088074|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
161193569|NCT01072175|582088075|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
161193570|NCT01072175|582088076|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
161193571|NCT01072175|582088077|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
161193572|NCT01072175|582088078|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
161193573|NCT01072175|582088079|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
161193574|NCT01072175|582088080|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
161193575|NCT01072175|582088081|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
161193576|NCT01072175|582088069|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193577|NCT01072175|582088070|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193578|NCT01072175|582088071|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
161193579|NCT01072175|582088072|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193580|NCT01072175|582088073|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
161193581|NCT01072175|582088074|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193582|NCT01072175|582088075|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193583|NCT01072175|582088076|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193584|NCT01072175|582088077|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193585|NCT01072175|582088078|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193586|NCT01072175|582088079|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193587|NCT01072175|582088080|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193588|NCT01072175|582088081|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
161193589|NCT01072175|582088069|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193590|NCT01072175|582088070|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
161193591|NCT01072175|582088071|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193592|NCT01072175|582088072|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
161193593|NCT01072175|582088073|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
161193594|NCT01072175|582088074|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193595|NCT01072175|582088075|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193596|NCT01072175|582088076|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193597|NCT01072175|582088077|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193598|NCT01072175|582088078|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193599|NCT01072175|582088079|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193600|NCT01072175|582088080|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193601|NCT01072175|582088081|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
161193602|NCT01072175|582088069|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193603|NCT01072175|582088070|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193604|NCT01072175|582088071|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
161193605|NCT01072175|582088072|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
161193606|NCT01072175|582088073|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
161193607|NCT01072175|582088074|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193608|NCT01072175|582088075|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193609|NCT01072175|582088076|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193610|NCT01072175|582088077|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193611|NCT01072175|582088078|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193612|NCT01072175|582088079|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161306366|NCT02017717|582502827|FG005|Before Treatment Period|Participant withdrew consent|0|||
161306367|NCT02017717|582502828|FG006|Before Treatment Period|Participant withdrew consent|2|||
161306368|NCT02017717|582502829|FG007|Before Treatment Period|Participant withdrew consent|0|||
161306369|NCT02017717|582502830|FG008|Before Treatment Period|Participant withdrew consent|11|||
161306370|NCT02017717|582502822|FG000|Before Treatment Period|Lost to Follow-up|0|||
161193613|NCT01072175|582088080|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161193614|NCT01072175|582088081|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
161306371|NCT02017717|582502823|FG001|Before Treatment Period|Lost to Follow-up|0|||
161193615|NCT01072175|582088069|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193616|NCT01072175|582088070|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
161193617|NCT01072175|582088071|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193618|NCT01072175|582088072|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
161193619|NCT01072175|582088073|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
161193620|NCT01072175|582088074|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193621|NCT01072175|582088075|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193622|NCT01072175|582088076|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193623|NCT01072175|582088077|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193624|NCT01072175|582088078|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193625|NCT01072175|582088079|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193626|NCT01072175|582088080|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193627|NCT01072175|582088081|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
161193628|NCT01072175|582088069|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
161193629|NCT01072175|582088070|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
161193630|NCT01072175|582088071|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
161193631|NCT01072175|582088072|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
161193632|NCT01072175|582088073|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
161193633|NCT01072175|582088074|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
161193634|NCT01072175|582088075|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
161193635|NCT01072175|582088076|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
161193636|NCT01072175|582088077|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
161193637|NCT01072175|582088078|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
161193638|NCT01072175|582088079|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
161193639|NCT01072175|582088080|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
161193640|NCT01072175|582088081|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
161193641|NCT01072175|582088069|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193642|NCT01072175|582088070|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193643|NCT01072175|582088071|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193644|NCT01072175|582088072|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193645|NCT01072175|582088073|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193646|NCT01072175|582088074|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161193647|NCT01072175|582088075|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161193648|NCT01072175|582088076|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
161193649|NCT01072175|582088077|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193650|NCT01072175|582088078|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193651|NCT01072175|582088079|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193652|NCT01072175|582088080|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193653|NCT01072175|582088081|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
161193654|NCT01072175|582088069|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193655|NCT01072175|582088070|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193656|NCT01072175|582088071|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193657|NCT01072175|582088072|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193658|NCT01072175|582088073|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193659|NCT01072175|582088074|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193660|NCT01072175|582088075|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
161193661|NCT01072175|582088076|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
161193662|NCT01072175|582088077|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193663|NCT01072175|582088078|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193664|NCT01072175|582088079|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193665|NCT01072175|582088080|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193666|NCT01072175|582088081|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
161193667|NCT01072175|582088069|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193668|NCT01072175|582088070|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193669|NCT01072175|582088071|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193670|NCT01072175|582088072|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193671|NCT01072175|582088073|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193672|NCT01072175|582088074|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
161193673|NCT01072175|582088075|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
161193674|NCT01072175|582088076|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
161193675|NCT01072175|582088077|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193676|NCT01072175|582088078|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193677|NCT01072175|582088079|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193678|NCT01072175|582088080|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161306372|NCT02017717|582502824|FG002|Before Treatment Period|Lost to Follow-up|0|||
161306373|NCT02017717|582502825|FG003|Before Treatment Period|Lost to Follow-up|0|||
161193679|NCT01072175|582088081|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
161193680|NCT01072175|582088069|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193681|NCT01072175|582088070|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193682|NCT01072175|582088071|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193683|NCT01072175|582088072|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193684|NCT01072175|582088073|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193685|NCT01072175|582088074|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
161193686|NCT01072175|582088075|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
161193687|NCT01072175|582088076|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193688|NCT01072175|582088077|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193689|NCT01072175|582088078|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193690|NCT01072175|582088079|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193691|NCT01072175|582088080|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193692|NCT01072175|582088081|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
161193693|NCT01072175|582088069|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193694|NCT01072175|582088070|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193695|NCT01072175|582088071|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193696|NCT01072175|582088072|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193697|NCT01072175|582088073|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193698|NCT01072175|582088074|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193699|NCT01072175|582088075|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193700|NCT01072175|582088076|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193701|NCT01072175|582088077|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
161193702|NCT01072175|582088078|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193703|NCT01072175|582088079|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193704|NCT01072175|582088080|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193705|NCT01072175|582088081|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
161193706|NCT01072175|582088069|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193707|NCT01072175|582088070|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193708|NCT01072175|582088071|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193709|NCT01072175|582088072|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193710|NCT01072175|582088073|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193711|NCT01072175|582088074|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193712|NCT01072175|582088075|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193713|NCT01072175|582088076|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193714|NCT01072175|582088077|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
161193715|NCT01072175|582088078|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193716|NCT01072175|582088079|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193717|NCT01072175|582088080|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193718|NCT01072175|582088081|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
161193719|NCT01072175|582088069|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193720|NCT01072175|582088070|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193721|NCT01072175|582088071|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193722|NCT01072175|582088072|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193723|NCT01072175|582088073|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193724|NCT01072175|582088074|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193725|NCT01072175|582088075|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193726|NCT01072175|582088076|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193727|NCT01072175|582088077|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
161193728|NCT01072175|582088078|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193729|NCT01072175|582088079|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193730|NCT01072175|582088080|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193731|NCT01072175|582088081|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
161193732|NCT01072175|582088069|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193733|NCT01072175|582088070|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193734|NCT01072175|582088071|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193735|NCT01072175|582088072|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193736|NCT01072175|582088073|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193737|NCT01072175|582088074|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193738|NCT01072175|582088075|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193739|NCT01072175|582088076|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193740|NCT01072175|582088077|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
161193741|NCT01072175|582088078|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193742|NCT01072175|582088079|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193743|NCT01072175|582088080|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193744|NCT01072175|582088081|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
161193745|NCT01072175|582088069|FG000|Part D (HPMC Capsules)|Death|0|||
161193746|NCT01072175|582088070|FG001|Part D (HPMC Capsules)|Death|0|||
161193747|NCT01072175|582088071|FG002|Part D (HPMC Capsules)|Death|0|||
161193748|NCT01072175|582088072|FG003|Part D (HPMC Capsules)|Death|0|||
161193749|NCT01072175|582088073|FG004|Part D (HPMC Capsules)|Death|0|||
161193750|NCT01072175|582088074|FG005|Part D (HPMC Capsules)|Death|0|||
161193751|NCT01072175|582088075|FG006|Part D (HPMC Capsules)|Death|0|||
161193752|NCT01072175|582088076|FG007|Part D (HPMC Capsules)|Death|0|||
161193753|NCT01072175|582088077|FG008|Part D (HPMC Capsules)|Death|0|||
161193754|NCT01072175|582088078|FG009|Part D (HPMC Capsules)|Death|10|||
161193755|NCT01072175|582088079|FG010|Part D (HPMC Capsules)|Death|12|||
161193756|NCT01072175|582088080|FG011|Part D (HPMC Capsules)|Death|28|||
161193757|NCT01072175|582088081|FG012|Part D (HPMC Capsules)|Death|26|||
161193758|NCT01072175|582088069|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
161193759|NCT01072175|582088070|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
161193760|NCT01072175|582088071|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
161193761|NCT01072175|582088072|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
161193762|NCT01072175|582088073|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
161193763|NCT01072175|582088074|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
161193764|NCT01072175|582088075|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
161193765|NCT01072175|582088076|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
161193766|NCT01072175|582088077|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
161193767|NCT01072175|582088078|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
161193768|NCT01072175|582088079|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
161193769|NCT01072175|582088080|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
161193770|NCT01072175|582088081|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
161193771|NCT01072175|582088069|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193772|NCT01072175|582088070|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193773|NCT01072175|582088071|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193774|NCT01072175|582088072|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193775|NCT01072175|582088073|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193776|NCT01072175|582088074|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193777|NCT01072175|582088075|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193778|NCT01072175|582088076|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193779|NCT01072175|582088077|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193780|NCT01072175|582088078|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
161193781|NCT01072175|582088079|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
161193782|NCT01072175|582088080|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
161193783|NCT01072175|582088081|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
161193784|NCT01072175|582088069|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193785|NCT01072175|582088070|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193786|NCT01072175|582088071|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193787|NCT01072175|582088072|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193788|NCT01072175|582088073|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193789|NCT01072175|582088074|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193790|NCT01072175|582088075|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193791|NCT01072175|582088076|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193792|NCT01072175|582088077|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
161193793|NCT01072175|582088078|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
161193794|NCT01072175|582088079|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
161193795|NCT01072175|582088080|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
161193796|NCT01072175|582088081|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
161193797|NCT01072175|582088069|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193798|NCT01072175|582088070|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193799|NCT01072175|582088071|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193800|NCT01072175|582088072|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193801|NCT01072175|582088073|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193802|NCT01072175|582088074|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193803|NCT01072175|582088075|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193804|NCT01072175|582088076|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193805|NCT01072175|582088077|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193806|NCT01072175|582088078|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193807|NCT01072175|582088079|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
161193808|NCT01072175|582088080|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
161193809|NCT01072175|582088081|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
161193810|NCT02839330|582088082|FG000|Overall Study|Adverse Event|0|||
161193811|NCT02839330|582088083|FG001|Overall Study|Adverse Event|1|||
161193812|NCT02839330|582088084|FG002|Overall Study|Adverse Event|2|||
161193813|NCT02839330|582088085|FG003|Overall Study|Adverse Event|2|||
161193814|NCT02839330|582088082|FG000|Overall Study|Death|4|||
161193815|NCT02839330|582088083|FG001|Overall Study|Death|6|||
161193816|NCT02839330|582088084|FG002|Overall Study|Death|1|||
161193817|NCT02839330|582088085|FG003|Overall Study|Death|1|||
161193818|NCT02839330|582088082|FG000|Overall Study|Withdrawal by Subject|27|||
161193819|NCT02839330|582088083|FG001|Overall Study|Withdrawal by Subject|19|||
161193820|NCT02839330|582088084|FG002|Overall Study|Withdrawal by Subject|11|||
161193821|NCT02839330|582088085|FG003|Overall Study|Withdrawal by Subject|13|||
161193822|NCT02839330|582088082|FG000|Overall Study|Lost to Follow-up|22|||
161193823|NCT02839330|582088083|FG001|Overall Study|Lost to Follow-up|27|||
161193824|NCT02839330|582088084|FG002|Overall Study|Lost to Follow-up|29|||
161193825|NCT02839330|582088085|FG003|Overall Study|Lost to Follow-up|25|||
161193826|NCT02839330|582088082|FG000|Overall Study|Administrative Reason|0|||
161193827|NCT02839330|582088083|FG001|Overall Study|Administrative Reason|0|||
161193828|NCT02839330|582088084|FG002|Overall Study|Administrative Reason|0|||
161193829|NCT02839330|582088085|FG003|Overall Study|Administrative Reason|1|||
161193830|NCT02839330|582088082|FG000|Overall Study|Protocol Violation|1|||
161193831|NCT02839330|582088083|FG001|Overall Study|Protocol Violation|2|||
161193832|NCT02839330|582088084|FG002|Overall Study|Protocol Violation|2|||
161193833|NCT02839330|582088085|FG003|Overall Study|Protocol Violation|3|||
161193834|NCT02839330|582088082|FG000|Overall Study|Other reason, not specified|4|||
161193835|NCT02839330|582088083|FG001|Overall Study|Other reason, not specified|3|||
161193836|NCT02839330|582088084|FG002|Overall Study|Other reason, not specified|3|||
161193837|NCT02839330|582088085|FG003|Overall Study|Other reason, not specified|6|||
161193838|NCT00682539|582088086|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
161193839|NCT00682539|582088087|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
161193840|NCT00682539|582088088|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
161193841|NCT00682539|582088086|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
161193842|NCT00682539|582088087|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
161193843|NCT00682539|582088088|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
161193844|NCT02477215|582088098|FG000|Dose Escalation Phase|Physician Decision|1|||
161193845|NCT02477215|582088099|FG001|Dose Escalation Phase|Physician Decision|2|||
161193846|NCT02477215|582088100|FG002|Dose Escalation Phase|Physician Decision|0|||
161193847|NCT02477215|582088098|FG000|Fixed Dose Phase|Physician Decision|0|||
161193848|NCT02477215|582088099|FG001|Fixed Dose Phase|Physician Decision|7|||
161193849|NCT02477215|582088100|FG002|Fixed Dose Phase|Physician Decision|0|||
161193850|NCT00310440|582088101|FG000|Overall Study|Lost to Follow-up|17|||
161193851|NCT00310440|582088102|FG001|Overall Study|Lost to Follow-up|8|||
161193852|NCT00310440|582088101|FG000|Overall Study|Withdrawal by Subject|2|||
161193853|NCT00310440|582088102|FG001|Overall Study|Withdrawal by Subject|1|||
161193854|NCT00310440|582088101|FG000|Overall Study|Missed 12 Month Visit|7|||
161193855|NCT00310440|582088102|FG001|Overall Study|Missed 12 Month Visit|4|||
161193856|NCT01654666|582088112|FG000|Overall Study|Protocol Violation|7|||
161193857|NCT01654666|582088113|FG001|Overall Study|Protocol Violation|4|||
161193858|NCT01654666|582088114|FG002|Overall Study|Protocol Violation|8|||
161193859|NCT01654666|582088112|FG000|Overall Study|Lost to Follow-up|4|||
161193860|NCT01654666|582088113|FG001|Overall Study|Lost to Follow-up|5|||
161193861|NCT01654666|582088114|FG002|Overall Study|Lost to Follow-up|5|||
161193862|NCT01654666|582088112|FG000|Overall Study|Withdrawal by Subject|4|||
161193863|NCT01654666|582088113|FG001|Overall Study|Withdrawal by Subject|4|||
161193864|NCT01654666|582088114|FG002|Overall Study|Withdrawal by Subject|1|||
161193865|NCT01616173|582088115|FG000|Overall Study|Lost to Follow-up|0|||
161193866|NCT01616173|582088116|FG001|Overall Study|Lost to Follow-up|2|||
161193867|NCT01616173|582088117|FG002|Overall Study|Lost to Follow-up|0|||
161193868|NCT01430559|582088124|FG000|Overall Study|Adverse Event|7|||
161193869|NCT01430559|582088125|FG001|Overall Study|Adverse Event|3|||
161193870|NCT01430559|582088124|FG000|Overall Study|Entry criteria not met|1|||
161193871|NCT01430559|582088125|FG001|Overall Study|Entry criteria not met|1|||
161193872|NCT01430559|582088124|FG000|Overall Study|Lost to Follow-up|1|||
161193873|NCT01430559|582088125|FG001|Overall Study|Lost to Follow-up|0|||
161193874|NCT01430559|582088124|FG000|Overall Study|Medication error|1|||
161193875|NCT01430559|582088125|FG001|Overall Study|Medication error|0|||
161193876|NCT01430559|582088124|FG000|Overall Study|Withdrawal by Subject|3|||
161193877|NCT01430559|582088125|FG001|Overall Study|Withdrawal by Subject|2|||
161193878|NCT01430559|582088124|FG000|Overall Study|Protocol Violation|1|||
161193879|NCT01430559|582088125|FG001|Overall Study|Protocol Violation|0|||
161193880|NCT01430559|582088124|FG000|Overall Study|Other|3|||
161193881|NCT01430559|582088125|FG001|Overall Study|Other|3|||
161193882|NCT01430559|582088124|FG000|Overall Study|Randomized, Not Treated|3|||
161193883|NCT01430559|582088125|FG001|Overall Study|Randomized, Not Treated|3|||
161349790|NCT03500172|582665950|FG007|Period 2: Re-Randomization|Death|2|||
161193884|NCT01177943|582088126|FG000|First Intervention|Withdrawal by Subject|2|||
161193885|NCT01177943|582088127|FG001|First Intervention|Withdrawal by Subject|0|||
161193886|NCT01220024|582088128|FG000|Overall Study|Lost to Follow-up|1|||
161193887|NCT01220024|582088129|FG001|Overall Study|Lost to Follow-up|1|||
161193888|NCT00779142|582088130|FG000|Overall Study|Screen Failures|3|||
161193889|NCT03137433|582088132|FG000|Overall Study|Withdrawal by Subject|11|||
161193890|NCT03137433|582088133|FG001|Overall Study|Withdrawal by Subject|11|||
161193891|NCT03137433|582088132|FG000|Overall Study|Lost to Follow-up|5|||
161193892|NCT03137433|582088133|FG001|Overall Study|Lost to Follow-up|6|||
161193893|NCT03137433|582088132|FG000|Overall Study|Physician Decision|2|||
161193894|NCT03137433|582088133|FG001|Overall Study|Physician Decision|0|||
161193895|NCT03137433|582088132|FG000|Overall Study|Moved out of study area|1|||
161193896|NCT03137433|582088133|FG001|Overall Study|Moved out of study area|0|||
161193897|NCT03137433|582088132|FG000|Overall Study|Too far out of window due to COVID|0|||
161193898|NCT03137433|582088133|FG001|Overall Study|Too far out of window due to COVID|1|||
161193899|NCT01288911|582088134|FG000|Double-blind Period|Death|11|||
161193900|NCT01288911|582088135|FG001|Double-blind Period|Death|7|||
161193901|NCT01288911|582088134|FG000|Double-blind Period|Lost to Follow-up|0|||
161193902|NCT01288911|582088135|FG001|Double-blind Period|Lost to Follow-up|2|||
161193903|NCT01288911|582088134|FG000|Double-blind Period|Progressive Disease|75|||
161193904|NCT01288911|582088135|FG001|Double-blind Period|Progressive Disease|103|||
161193905|NCT01288911|582088134|FG000|Double-blind Period|Protocol Violation|1|||
161193906|NCT01288911|582088135|FG001|Double-blind Period|Protocol Violation|0|||
161193907|NCT01288911|582088134|FG000|Double-blind Period|Withdrawal by Subject|25|||
161193908|NCT01288911|582088135|FG001|Double-blind Period|Withdrawal by Subject|26|||
161193909|NCT01288911|582088134|FG000|Double-blind Period|Miscellaneous Reason|29|||
161193910|NCT01288911|582088135|FG001|Double-blind Period|Miscellaneous Reason|42|||
161193911|NCT01288911|582088134|FG000|Double-blind Period|Randomized but never received study drug|1|||
161193912|NCT01288911|582088135|FG001|Double-blind Period|Randomized but never received study drug|2|||
161193913|NCT01288911|582088134|FG000|Open-label Period (All Enzalutamide)|Death|0|||
161193914|NCT01288911|582088135|FG001|Open-label Period (All Enzalutamide)|Death|1|||
161193915|NCT01288911|582088134|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
161193916|NCT01288911|582088135|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
161193917|NCT01288911|582088134|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
161193918|NCT01288911|582088135|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
161193919|NCT01288911|582088134|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
161193920|NCT01288911|582088135|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
161193921|NCT01288911|582088134|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
161193922|NCT01288911|582088135|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
161193923|NCT01288911|582088134|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
161193924|NCT01288911|582088135|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
161193925|NCT03742271|582088138|FG000|Overall Study|Unsatisfactory Visual Response|1|||
161193926|NCT03742271|582088138|FG000|Overall Study|Withdrawal by Subject|3|||
161193927|NCT03742271|582088138|FG000|Overall Study|Lost to Follow-up|4|||
161193928|NCT03742271|582088138|FG000|Overall Study|Failed Insertion & removal|3|||
161193929|NCT03742271|582088138|FG000|Overall Study|Protocol Violation|1|||
161193930|NCT01843933|582088139|FG000|Overall Study|Data lost|6|||
161193931|NCT01843933|582088140|FG001|Overall Study|Data lost|4|||
161193932|NCT00554229|582088141|FG000|Overall Study|Lost to Follow-up|3|||
161193933|NCT00554229|582088142|FG001|Overall Study|Lost to Follow-up|6|||
161193934|NCT00554229|582088141|FG000|Overall Study|Withdrawal by Subject|29|||
161193935|NCT00554229|582088142|FG001|Overall Study|Withdrawal by Subject|37|||
161193936|NCT00554229|582088141|FG000|Overall Study|Adverse Event|71|||
161193937|NCT00554229|582088142|FG001|Overall Study|Adverse Event|39|||
161193938|NCT00554229|582088141|FG000|Overall Study|Protocol Violation|3|||
161193939|NCT00554229|582088142|FG001|Overall Study|Protocol Violation|3|||
161193940|NCT00554229|582088141|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
161193941|NCT00554229|582088142|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
161193942|NCT00554229|582088141|FG000|Overall Study|Randomised but no treatment received|1|||
161193943|NCT00554229|582088142|FG001|Overall Study|Randomised but no treatment received|0|||
161193944|NCT00939094|582088145|FG000|Overall Study|Adverse Event|9|||
161193945|NCT00939094|582088146|FG001|Overall Study|Adverse Event|0|||
161193946|NCT00939094|582088145|FG000|Overall Study|Withdrawal by Subject|1|||
161193947|NCT00939094|582088146|FG001|Overall Study|Withdrawal by Subject|6|||
161193948|NCT00939094|582088145|FG000|Overall Study|Lost to Follow-up|1|||
161193949|NCT00939094|582088146|FG001|Overall Study|Lost to Follow-up|1|||
161193950|NCT00939094|582088145|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161193951|NCT00939094|582088146|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
161193952|NCT00939094|582088145|FG000|Overall Study|Severe non-compliance to protocol|0|||
161193953|NCT00939094|582088146|FG001|Overall Study|Severe non-compliance to protocol|1|||
161193954|NCT00939094|582088145|FG000|Overall Study|Study stopped by sponsor|0|||
161193955|NCT00939094|582088146|FG001|Overall Study|Study stopped by sponsor|2|||
161193956|NCT00939094|582088145|FG000|Overall Study|Abnormal ECG findings|1|||
161193957|NCT00939094|582088146|FG001|Overall Study|Abnormal ECG findings|0|||
161193958|NCT00690612|582089747|FG000|Overall Study|Adverse Event|1|||
161193959|NCT00690612|582089747|FG000|Overall Study|Withdrawal by Subject|2|||
161193960|NCT03808298|582089748|FG000|Overall Study|Adverse Event|3|||
161193961|NCT03808298|582089748|FG000|Overall Study|Physician Decision|1|||
161193962|NCT03808298|582089748|FG000|Overall Study|Withdrawal by Subject|1|||
161193963|NCT03808298|582089748|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
161193964|NCT01858701|582089751|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
161193965|NCT01858701|582089752|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
161306374|NCT02017717|582502826|FG004|Before Treatment Period|Lost to Follow-up|0|||
161306375|NCT02017717|582502827|FG005|Before Treatment Period|Lost to Follow-up|0|||
161193966|NCT01858701|582089751|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
161193967|NCT01858701|582089752|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
161193968|NCT01858701|582089751|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
161193969|NCT01858701|582089752|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
161193970|NCT01858701|582089751|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
161193971|NCT01858701|582089752|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
161193972|NCT01674010|582089753|FG000|Open Treatment Phase 1|Adverse Event|10|||
161193973|NCT01674010|582089754|FG001|Open Treatment Phase 1|Adverse Event|0|||
161193974|NCT01674010|582089755|FG002|Open Treatment Phase 1|Adverse Event|0|||
161193975|NCT01674010|582089753|FG000|Open Treatment Phase 1|Death|1|||
161193976|NCT01674010|582089754|FG001|Open Treatment Phase 1|Death|0|||
161193977|NCT01674010|582089755|FG002|Open Treatment Phase 1|Death|0|||
161193978|NCT01674010|582089753|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
161193979|NCT01674010|582089754|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
161193980|NCT01674010|582089755|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
161193981|NCT01674010|582089753|FG000|Open Treatment Phase 1|Physician Decision|9|||
161193982|NCT01674010|582089754|FG001|Open Treatment Phase 1|Physician Decision|0|||
161193983|NCT01674010|582089755|FG002|Open Treatment Phase 1|Physician Decision|0|||
161193984|NCT01674010|582089753|FG000|Open Treatment Phase 1|Protocol Violation|7|||
161193985|NCT01674010|582089754|FG001|Open Treatment Phase 1|Protocol Violation|0|||
161193986|NCT01674010|582089755|FG002|Open Treatment Phase 1|Protocol Violation|0|||
161193987|NCT01674010|582089753|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
161193988|NCT01674010|582089754|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
161193989|NCT01674010|582089755|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
161193990|NCT01674010|582089753|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
161193991|NCT01674010|582089754|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
161193992|NCT01674010|582089755|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
161193993|NCT01674010|582089753|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
161193994|NCT01674010|582089754|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
161193995|NCT01674010|582089755|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
161193996|NCT01674010|582089753|FG000|Randomization Phase 2|Adverse Event|0|||
161306376|NCT02017717|582502828|FG006|Before Treatment Period|Lost to Follow-up|0|||
161306377|NCT02017717|582502829|FG007|Before Treatment Period|Lost to Follow-up|0|||
161306378|NCT02017717|582502830|FG008|Before Treatment Period|Lost to Follow-up|1|||
161306379|NCT02017717|582502822|FG000|Before Treatment Period|Participant no longer met criteria|0|||
161306380|NCT02017717|582502823|FG001|Before Treatment Period|Participant no longer met criteria|0|||
161306381|NCT02017717|582502824|FG002|Before Treatment Period|Participant no longer met criteria|0|||
161306382|NCT02017717|582502825|FG003|Before Treatment Period|Participant no longer met criteria|0|||
161306383|NCT02017717|582502826|FG004|Before Treatment Period|Participant no longer met criteria|0|||
161306384|NCT02017717|582502827|FG005|Before Treatment Period|Participant no longer met criteria|1|||
161306385|NCT02017717|582502828|FG006|Before Treatment Period|Participant no longer met criteria|0|||
161306386|NCT02017717|582502829|FG007|Before Treatment Period|Participant no longer met criteria|1|||
161306387|NCT02017717|582502830|FG008|Before Treatment Period|Participant no longer met criteria|2|||
161306388|NCT02017717|582502822|FG000|Before Treatment Period|other reason|0|||
161306389|NCT02017717|582502823|FG001|Before Treatment Period|other reason|0|||
161306390|NCT02017717|582502824|FG002|Before Treatment Period|other reason|0|||
161306391|NCT02017717|582502825|FG003|Before Treatment Period|other reason|0|||
161306392|NCT02017717|582502826|FG004|Before Treatment Period|other reason|0|||
161306393|NCT02017717|582502827|FG005|Before Treatment Period|other reason|0|||
161306394|NCT02017717|582502828|FG006|Before Treatment Period|other reason|0|||
161306395|NCT02017717|582502829|FG007|Before Treatment Period|other reason|0|||
161306396|NCT02017717|582502830|FG008|Before Treatment Period|other reason|1|||
161306397|NCT02017717|582502822|FG000|Treatment Period|Disease progression|7|||
161306398|NCT02017717|582502823|FG001|Treatment Period|Disease progression|9|||
161306399|NCT02017717|582502824|FG002|Treatment Period|Disease progression|12|||
161306400|NCT02017717|582502825|FG003|Treatment Period|Disease progression|20|||
161306401|NCT02017717|582502826|FG004|Treatment Period|Disease progression|26|||
161306402|NCT02017717|582502827|FG005|Treatment Period|Disease progression|16|||
161306403|NCT02017717|582502828|FG006|Treatment Period|Disease progression|22|||
161306404|NCT02017717|582502829|FG007|Treatment Period|Disease progression|165|||
161306405|NCT02017717|582502830|FG008|Treatment Period|Disease progression|135|||
161306406|NCT02017717|582502822|FG000|Treatment Period|Study drug toxicity|3|||
161306407|NCT02017717|582502823|FG001|Treatment Period|Study drug toxicity|0|||
161306408|NCT02017717|582502824|FG002|Treatment Period|Study drug toxicity|1|||
161306409|NCT02017717|582502825|FG003|Treatment Period|Study drug toxicity|4|||
161306410|NCT02017717|582502826|FG004|Treatment Period|Study drug toxicity|4|||
161193997|NCT01674010|582089754|FG001|Randomization Phase 2|Adverse Event|1|||
161193998|NCT01674010|582089755|FG002|Randomization Phase 2|Adverse Event|1|||
161193999|NCT01674010|582089753|FG000|Randomization Phase 2|Lost to Follow-up|0|||
161194000|NCT01674010|582089754|FG001|Randomization Phase 2|Lost to Follow-up|1|||
161306411|NCT02017717|582502827|FG005|Treatment Period|Study drug toxicity|5|||
161306412|NCT02017717|582502828|FG006|Treatment Period|Study drug toxicity|3|||
161194001|NCT01674010|582089755|FG002|Randomization Phase 2|Lost to Follow-up|2|||
161194002|NCT01674010|582089753|FG000|Randomization Phase 2|Mood episode recurrence|0|||
161194003|NCT01674010|582089754|FG001|Randomization Phase 2|Mood episode recurrence|8|||
161194004|NCT01674010|582089755|FG002|Randomization Phase 2|Mood episode recurrence|2|||
161194005|NCT01674010|582089753|FG000|Randomization Phase 2|Physician Decision|0|||
161194006|NCT01674010|582089754|FG001|Randomization Phase 2|Physician Decision|0|||
161194007|NCT01674010|582089755|FG002|Randomization Phase 2|Physician Decision|2|||
161194008|NCT01674010|582089753|FG000|Randomization Phase 2|Pregnancy|0|||
161194009|NCT01674010|582089754|FG001|Randomization Phase 2|Pregnancy|1|||
161194010|NCT01674010|582089755|FG002|Randomization Phase 2|Pregnancy|1|||
161194011|NCT01674010|582089753|FG000|Randomization Phase 2|Protocol Violation|0|||
161194012|NCT01674010|582089754|FG001|Randomization Phase 2|Protocol Violation|1|||
161194013|NCT01674010|582089755|FG002|Randomization Phase 2|Protocol Violation|1|||
161194014|NCT01674010|582089753|FG000|Randomization Phase 2|Sponsor Decision|0|||
161194015|NCT01674010|582089754|FG001|Randomization Phase 2|Sponsor Decision|42|||
161194016|NCT01674010|582089755|FG002|Randomization Phase 2|Sponsor Decision|45|||
161194017|NCT01674010|582089753|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
161194018|NCT01674010|582089754|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
161194019|NCT01674010|582089755|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
161194020|NCT01801475|582089762|FG000|Overall Study|Withdrawal by Subject|0|||
161194021|NCT01801475|582089763|FG001|Overall Study|Withdrawal by Subject|0|||
161194022|NCT01801475|582089764|FG002|Overall Study|Withdrawal by Subject|0|||
161194023|NCT01801475|582089765|FG003|Overall Study|Withdrawal by Subject|0|||
161194024|NCT01801475|582089766|FG004|Overall Study|Withdrawal by Subject|1|||
161194025|NCT01786707|582089769|FG000|Overall Study|Lost to Follow-up|1|||
161194026|NCT01786707|582089770|FG001|Overall Study|Lost to Follow-up|1|||
161194027|NCT01545375|582089779|FG000|Overall Study|Adverse Event|2|||
161349791|NCT03500172|582665951|FG008|Period 2: Re-Randomization|Death|0|||
161349792|NCT03500172|582665952|FG009|Period 2: Re-Randomization|Death|0|||
161349793|NCT03500172|582665953|FG010|Period 2: Re-Randomization|Death|0|||
161349794|NCT04300309|582665954|FG000|Overall Study|Lost to Follow-up|1|||
161349795|NCT04300309|582665955|FG001|Overall Study|Lost to Follow-up|0|||
161349796|NCT03171545|582665958|FG000|Baseline|Withdrawal by Subject|0|||
161194028|NCT01545375|582089780|FG001|Overall Study|Adverse Event|1|||
161194029|NCT01545375|582089779|FG000|Overall Study|Lost to Follow-up|34|||
161194030|NCT01545375|582089780|FG001|Overall Study|Lost to Follow-up|31|||
161194031|NCT01545375|582089779|FG000|Overall Study|Protocol Violation|3|||
161194032|NCT01545375|582089780|FG001|Overall Study|Protocol Violation|3|||
161194033|NCT01545375|582089779|FG000|Overall Study|Withdrawal by Subject|58|||
161194034|NCT01545375|582089780|FG001|Overall Study|Withdrawal by Subject|55|||
161194035|NCT00594958|582089782|FG000|Overall Study|Withdrawal by Subject|1|||
161194036|NCT00594958|582089783|FG001|Overall Study|Withdrawal by Subject|0|||
161194037|NCT00594958|582089784|FG002|Overall Study|Withdrawal by Subject|1|||
161194038|NCT00594958|582089782|FG000|Overall Study|Adverse Event|4|||
161194039|NCT00594958|582089783|FG001|Overall Study|Adverse Event|1|||
161194040|NCT00594958|582089784|FG002|Overall Study|Adverse Event|2|||
161194041|NCT00594958|582089782|FG000|Overall Study|Pregnancy|0|||
161194042|NCT00594958|582089783|FG001|Overall Study|Pregnancy|2|||
161194043|NCT00594958|582089784|FG002|Overall Study|Pregnancy|0|||
161194044|NCT00594958|582089782|FG000|Overall Study|Protocol Violation|1|||
161194045|NCT00594958|582089783|FG001|Overall Study|Protocol Violation|0|||
161194046|NCT00594958|582089784|FG002|Overall Study|Protocol Violation|2|||
161194047|NCT00594958|582089782|FG000|Overall Study|Lost to Follow-up|5|||
161194048|NCT00594958|582089783|FG001|Overall Study|Lost to Follow-up|0|||
161194049|NCT00594958|582089784|FG002|Overall Study|Lost to Follow-up|3|||
161194050|NCT00594958|582089782|FG000|Overall Study|administrative|3|||
161194051|NCT00594958|582089783|FG001|Overall Study|administrative|0|||
161194052|NCT00594958|582089784|FG002|Overall Study|administrative|2|||
161194053|NCT03233009|582089785|FG000|Overall Study|Lost to Follow-up|1|||
161194054|NCT03039686|582089786|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
161194055|NCT03039686|582089787|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
161194056|NCT03039686|582089788|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
161194057|NCT03039686|582089786|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
161306413|NCT02017717|582502829|FG007|Treatment Period|Study drug toxicity|7|||
161306414|NCT02017717|582502830|FG008|Treatment Period|Study drug toxicity|11|||
161306415|NCT02017717|582502822|FG000|Treatment Period|Death|0|||
161306416|NCT02017717|582502823|FG001|Treatment Period|Death|0|||
161306417|NCT02017717|582502824|FG002|Treatment Period|Death|1|||
161306418|NCT02017717|582502825|FG003|Treatment Period|Death|0|||
161306419|NCT02017717|582502826|FG004|Treatment Period|Death|0|||
161306420|NCT02017717|582502827|FG005|Treatment Period|Death|2|||
161306421|NCT02017717|582502828|FG006|Treatment Period|Death|0|||
161306422|NCT02017717|582502829|FG007|Treatment Period|Death|0|||
161306423|NCT02017717|582502830|FG008|Treatment Period|Death|0|||
161306424|NCT02017717|582502822|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
161306425|NCT02017717|582502823|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
161306426|NCT02017717|582502824|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
161194058|NCT03039686|582089787|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
161194059|NCT03039686|582089788|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
161194060|NCT03039686|582089786|FG000|Double-blind Period|Withdrawal by Subject|2|||
161194061|NCT03039686|582089787|FG001|Double-blind Period|Withdrawal by Subject|2|||
161194062|NCT03039686|582089788|FG002|Double-blind Period|Withdrawal by Subject|1|||
161194063|NCT03039686|582089786|FG000|Double-blind Period|Death|0|||
161194064|NCT03039686|582089787|FG001|Double-blind Period|Death|0|||
161194065|NCT03039686|582089788|FG002|Double-blind Period|Death|1|||
161194066|NCT03039686|582089786|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
161194067|NCT03039686|582089787|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
161194068|NCT03039686|582089788|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
161194069|NCT03039686|582089786|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
161194070|NCT03039686|582089787|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
161194071|NCT03039686|582089788|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
161194072|NCT03039686|582089786|FG000|Open Label Period|Withdrawal by Subject|0|||
161194073|NCT03039686|582089787|FG001|Open Label Period|Withdrawal by Subject|3|||
161194074|NCT03039686|582089788|FG002|Open Label Period|Withdrawal by Subject|1|||
161194075|NCT02158949|582089789|FG000|Overall Study|Withdrawal by Subject|1|||
161194076|NCT02158949|582089790|FG001|Overall Study|Withdrawal by Subject|0|||
161194077|NCT02158949|582089789|FG000|Overall Study|Lost to Follow-up|5|||
161194078|NCT02158949|582089790|FG001|Overall Study|Lost to Follow-up|11|||
161194079|NCT00134563|582089791|FG000|Overall Study|Not treated due to protocol violation|0|||
161194080|NCT00134563|582089792|FG001|Overall Study|Not treated due to protocol violation|1|||
161194081|NCT00134563|582089793|FG002|Overall Study|Not treated due to protocol violation|1|||
161194082|NCT00134563|582089791|FG000|Overall Study|Adverse Event|29|||
161194083|NCT00134563|582089792|FG001|Overall Study|Adverse Event|37|||
161194084|NCT00134563|582089793|FG002|Overall Study|Adverse Event|38|||
161194085|NCT00134563|582089791|FG000|Overall Study|Lack of Efficacy|24|||
161194086|NCT00134563|582089792|FG001|Overall Study|Lack of Efficacy|14|||
161194087|NCT00134563|582089793|FG002|Overall Study|Lack of Efficacy|17|||
161194088|NCT00134563|582089791|FG000|Overall Study|Protocol Violation|3|||
161194089|NCT00134563|582089792|FG001|Overall Study|Protocol Violation|2|||
161194090|NCT00134563|582089793|FG002|Overall Study|Protocol Violation|5|||
161194091|NCT00134563|582089791|FG000|Overall Study|Lost to Follow-up|4|||
161194092|NCT00134563|582089792|FG001|Overall Study|Lost to Follow-up|0|||
161194093|NCT00134563|582089793|FG002|Overall Study|Lost to Follow-up|2|||
161194094|NCT00134563|582089791|FG000|Overall Study|progressive disease|11|||
161194095|NCT00134563|582089792|FG001|Overall Study|progressive disease|4|||
161194096|NCT00134563|582089793|FG002|Overall Study|progressive disease|2|||
161194097|NCT00134563|582089791|FG000|Overall Study|did not wish to continue|33|||
161194098|NCT00134563|582089792|FG001|Overall Study|did not wish to continue|32|||
161194099|NCT00134563|582089793|FG002|Overall Study|did not wish to continue|26|||
161194100|NCT00134563|582089791|FG000|Overall Study|Reason other than above|0|||
161194101|NCT00134563|582089792|FG001|Overall Study|Reason other than above|2|||
161194102|NCT00134563|582089793|FG002|Overall Study|Reason other than above|5|||
161194103|NCT02406586|582089794|FG000|Overall Study|Lost to Follow-up|0|||
161194104|NCT02406586|582089795|FG001|Overall Study|Lost to Follow-up|4|||
161194105|NCT02406586|582089796|FG002|Overall Study|Lost to Follow-up|2|||
161194106|NCT02406586|582089794|FG000|Overall Study|Withdrawal by Subject|1|||
161194107|NCT02406586|582089795|FG001|Overall Study|Withdrawal by Subject|0|||
161194108|NCT02406586|582089796|FG002|Overall Study|Withdrawal by Subject|0|||
161194109|NCT03382639|582089797|FG000|Overall Study|Adverse Event|2|||
161194110|NCT03382639|582089798|FG001|Overall Study|Adverse Event|0|||
161194111|NCT03382639|582089799|FG002|Overall Study|Adverse Event|1|||
161194112|NCT03382639|582089800|FG003|Overall Study|Adverse Event|1|||
161194113|NCT03382639|582089797|FG000|Overall Study|Lost to Follow-up|1|||
161194114|NCT03382639|582089798|FG001|Overall Study|Lost to Follow-up|0|||
161194115|NCT03382639|582089799|FG002|Overall Study|Lost to Follow-up|0|||
161194116|NCT03382639|582089800|FG003|Overall Study|Lost to Follow-up|0|||
161349797|NCT03171545|582665959|FG001|Baseline|Withdrawal by Subject|0|||
161349798|NCT03171545|582665960|FG002|Baseline|Withdrawal by Subject|1|||
161349799|NCT03171545|582665961|FG003|Baseline|Withdrawal by Subject|2|||
161194117|NCT03382639|582089797|FG000|Overall Study|Withdrawal by Subject|4|||
161194118|NCT03382639|582089798|FG001|Overall Study|Withdrawal by Subject|3|||
161194119|NCT03382639|582089799|FG002|Overall Study|Withdrawal by Subject|2|||
161194120|NCT03382639|582089800|FG003|Overall Study|Withdrawal by Subject|3|||
161194121|NCT03382639|582089797|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
161194122|NCT03382639|582089798|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
161194123|NCT03382639|582089799|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
161194124|NCT03382639|582089800|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
161194125|NCT03382639|582089797|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
161194126|NCT03382639|582089798|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
161194127|NCT03382639|582089799|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
161194128|NCT03382639|582089800|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
161194129|NCT03382639|582089797|FG000|Overall Study|Other|2|||
161194130|NCT03382639|582089798|FG001|Overall Study|Other|0|||
161194131|NCT03382639|582089799|FG002|Overall Study|Other|0|||
161194132|NCT03382639|582089800|FG003|Overall Study|Other|3|||
161194133|NCT00285857|582089803|FG000|Overall Study|Withdrawal by Subject|2|||
161194134|NCT00285857|582089803|FG000|Overall Study|Inadequate initial breast cytology|1|||
161194135|NCT00285857|582089803|FG000|Overall Study|Adverse Event|1|||
161194136|NCT00475657|582089809|FG000|Overall Study|Death|1|||
161194137|NCT00475657|582089809|FG000|Overall Study|Sponsor's Decision|3|||
161194138|NCT00408408|582089810|FG000|Overall Study|No follow up data|2|||
161194139|NCT00408408|582089811|FG001|Overall Study|No follow up data|3|||
161194140|NCT00408408|582089812|FG002|Overall Study|No follow up data|0|||
161194141|NCT00408408|582089813|FG003|Overall Study|No follow up data|7|||
161194142|NCT00408408|582089814|FG004|Overall Study|No follow up data|5|||
161194143|NCT00408408|582089815|FG005|Overall Study|No follow up data|3|||
161194144|NCT02898662|582089820|FG000|Overall Study|Adverse Event|1|||
161194145|NCT02898662|582089821|FG001|Overall Study|Adverse Event|0|||
161194146|NCT02898662|582089820|FG000|Overall Study|Loss of asthma control|23|||
161194147|NCT02898662|582089821|FG001|Overall Study|Loss of asthma control|24|||
161194148|NCT02898662|582089820|FG000|Overall Study|Withdrawal by Subject|4|||
161194149|NCT02898662|582089821|FG001|Overall Study|Withdrawal by Subject|1|||
161194150|NCT02898662|582089820|FG000|Overall Study|Technical issue|0|||
161194151|NCT02898662|582089821|FG001|Overall Study|Technical issue|1|||
161194152|NCT02898662|582089820|FG000|Overall Study|Randomized in error|0|||
161194153|NCT02898662|582089821|FG001|Overall Study|Randomized in error|1|||
161194154|NCT02898662|582089820|FG000|Overall Study|Subject decision|1|||
161194155|NCT02898662|582089821|FG001|Overall Study|Subject decision|0|||
161194156|NCT02898662|582089820|FG000|Overall Study|Other|0|||
161194157|NCT02898662|582089821|FG001|Overall Study|Other|1|||
161194158|NCT00399542|582089822|FG000|Overall Study|Adverse Event|18|||
161194159|NCT00399542|582089823|FG001|Overall Study|Adverse Event|15|||
161194160|NCT00399542|582089822|FG000|Overall Study|Protocol Violation|13|||
161194161|NCT00399542|582089823|FG001|Overall Study|Protocol Violation|3|||
161194162|NCT00399542|582089822|FG000|Overall Study|Withdrawal by Subject|28|||
161194163|NCT00399542|582089823|FG001|Overall Study|Withdrawal by Subject|10|||
161194164|NCT00399542|582089822|FG000|Overall Study|Lack of Efficacy|18|||
161194165|NCT00399542|582089823|FG001|Overall Study|Lack of Efficacy|8|||
161194166|NCT00399542|582089822|FG000|Overall Study|Lost to Follow-up|6|||
161194167|NCT00399542|582089823|FG001|Overall Study|Lost to Follow-up|6|||
161194168|NCT00399542|582089822|FG000|Overall Study|Other|1|||
161194169|NCT00399542|582089823|FG001|Overall Study|Other|0|||
161194170|NCT00399542|582089822|FG000|Overall Study|Physician Decision|0|||
161194171|NCT00399542|582089823|FG001|Overall Study|Physician Decision|1|||
161194172|NCT00917553|582089824|FG000|Overall Study|Lost to Follow-up|2|||
161194173|NCT00917553|582089825|FG001|Overall Study|Lost to Follow-up|1|||
161194174|NCT03172026|582089826|FG000|Overall Study|Withdrawal by Subject|1|||
161194175|NCT03172026|582089827|FG001|Overall Study|Withdrawal by Subject|0|||
161194176|NCT03172026|582089826|FG000|Overall Study|COVID restrictions|1|||
161194177|NCT03172026|582089827|FG001|Overall Study|COVID restrictions|0|||
161194178|NCT00504595|582089828|FG000|Overall Study|Lack of Efficacy|1|||
161194179|NCT00504595|582089829|FG001|Overall Study|Lack of Efficacy|0|||
161194180|NCT00504595|582089830|FG002|Overall Study|Lack of Efficacy|0|||
161194181|NCT00504595|582089831|FG003|Overall Study|Lack of Efficacy|0|||
161194182|NCT00504595|582089828|FG000|Overall Study|Other|0|||
161194183|NCT00504595|582089829|FG001|Overall Study|Other|0|||
161194184|NCT00504595|582089830|FG002|Overall Study|Other|2|||
161194185|NCT00504595|582089831|FG003|Overall Study|Other|0|||
161194186|NCT00174460|582089833|FG000|Overall Study|Withdrawal by Subject|0|||
161194187|NCT00174460|582089834|FG001|Overall Study|Withdrawal by Subject|1|||
161194188|NCT00579059|582089835|FG000|Overall Study|Study Canceled at 1 Year|21|||
161194189|NCT00579059|582089836|FG001|Overall Study|Study Canceled at 1 Year|10|||
161194190|NCT04652245|582089837|FG000|Wash-Out Period|Adverse Event|0|||
161194191|NCT04652245|582089838|FG001|Wash-Out Period|Adverse Event|2|||
161194192|NCT04652245|582089837|FG000|Wash-Out Period|Withdrawal by Subject|0|||
161194193|NCT04652245|582089838|FG001|Wash-Out Period|Withdrawal by Subject|2|||
161194194|NCT02543918|582089843|FG000|Overall Study|Never treated|0|||
161194195|NCT02543918|582089844|FG001|Overall Study|Never treated|1|||
161194196|NCT02543918|582089843|FG000|Overall Study|Lost to Follow-up|1|||
161194197|NCT02543918|582089844|FG001|Overall Study|Lost to Follow-up|1|||
161194198|NCT02543918|582089843|FG000|Overall Study|Withdrawal by Subject|1|||
161306427|NCT02017717|582502825|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
161306428|NCT02017717|582502826|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
161306429|NCT02017717|582502827|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
161306430|NCT02017717|582502828|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
161194199|NCT02543918|582089844|FG001|Overall Study|Withdrawal by Subject|1|||
161194200|NCT02543918|582089843|FG000|Overall Study|Adverse Event|1|||
161194201|NCT02543918|582089844|FG001|Overall Study|Adverse Event|1|||
161194202|NCT00486720|582089849|FG000|Overall Study|Adverse Event|1|||
161194203|NCT00486720|582089850|FG001|Overall Study|Adverse Event|2|||
161194204|NCT00486720|582089849|FG000|Overall Study|Lack of Efficacy|4|||
161194205|NCT00486720|582089850|FG001|Overall Study|Lack of Efficacy|6|||
161194206|NCT00486720|582089849|FG000|Overall Study|Physician Decision|1|||
161194207|NCT00486720|582089850|FG001|Overall Study|Physician Decision|2|||
161194208|NCT00486720|582089849|FG000|Overall Study|Protocol Violation|1|||
161194209|NCT00486720|582089850|FG001|Overall Study|Protocol Violation|0|||
161194210|NCT00486720|582089849|FG000|Overall Study|Withdrawal by Subject|3|||
161194211|NCT00486720|582089850|FG001|Overall Study|Withdrawal by Subject|1|||
161194212|NCT00486720|582089849|FG000|Overall Study|Progressive Disease|0|||
161194213|NCT00486720|582089850|FG001|Overall Study|Progressive Disease|1|||
161194214|NCT02452892|582089851|FG000|Week 1 Initial Randommization|Adverse Event|1|||
161194215|NCT02452892|582089852|FG001|Week 1 Initial Randommization|Adverse Event|0|||
161194216|NCT02452892|582089853|FG002|Week 1 Initial Randommization|Adverse Event|0|||
161194217|NCT02452892|582089854|FG003|Week 1 Initial Randommization|Adverse Event|0|||
161194218|NCT02452892|582089851|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
161194219|NCT02452892|582089852|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
161194220|NCT02452892|582089853|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
161194221|NCT02452892|582089854|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
161194222|NCT02452892|582089851|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161194223|NCT02452892|582089852|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161194224|NCT02452892|582089853|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
161194225|NCT02452892|582089854|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
161194226|NCT02452892|582089851|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
161194227|NCT02452892|582089852|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161194228|NCT02452892|582089853|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161194229|NCT02452892|582089854|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
161194230|NCT02452892|582089851|FG000|Follow-up|Withdrawal by Subject|0|||
161194231|NCT02452892|582089852|FG001|Follow-up|Withdrawal by Subject|0|||
161194232|NCT02452892|582089853|FG002|Follow-up|Withdrawal by Subject|0|||
161194233|NCT02452892|582089854|FG003|Follow-up|Withdrawal by Subject|1|||
161194234|NCT02452892|582089851|FG000|Follow-up|Subject left town on Day 42|1|||
161194235|NCT02452892|582089852|FG001|Follow-up|Subject left town on Day 42|0|||
161194236|NCT02452892|582089853|FG002|Follow-up|Subject left town on Day 42|0|||
161194237|NCT02452892|582089854|FG003|Follow-up|Subject left town on Day 42|0|||
161194238|NCT01005875|582089860|FG000|Overall Study|Death|3|||
161194239|NCT00606931|582089861|FG000|Overall Study|Withdrawal by Subject|3|||
161194240|NCT05047601|582089862|FG000|Overall Study|Lost to Follow-up|9|||
161194241|NCT05047601|582089863|FG001|Overall Study|Lost to Follow-up|11|||
161194242|NCT05047601|582089864|FG002|Overall Study|Lost to Follow-up|7|||
161194243|NCT05047601|582089862|FG000|Overall Study|Withdrawal by Subject|25|||
161194244|NCT05047601|582089863|FG001|Overall Study|Withdrawal by Subject|36|||
161194245|NCT05047601|582089864|FG002|Overall Study|Withdrawal by Subject|23|||
161194246|NCT05047601|582089862|FG000|Overall Study|Other|10|||
161194247|NCT05047601|582089863|FG001|Overall Study|Other|6|||
161194248|NCT05047601|582089864|FG002|Overall Study|Other|5|||
161194249|NCT00286234|582089865|FG000|Overall Study|Protocol Violation|1|||
161194250|NCT00286234|582089866|FG001|Overall Study|Protocol Violation|2|||
161194251|NCT00286234|582089867|FG002|Overall Study|Protocol Violation|0|||
161194252|NCT00286234|582089868|FG003|Overall Study|Protocol Violation|1|||
161194253|NCT00286234|582089865|FG000|Overall Study|Physician Decision|1|||
161194254|NCT00286234|582089866|FG001|Overall Study|Physician Decision|0|||
161194255|NCT00286234|582089867|FG002|Overall Study|Physician Decision|0|||
161194256|NCT00286234|582089868|FG003|Overall Study|Physician Decision|1|||
161194257|NCT00286234|582089865|FG000|Overall Study|Adverse Event|0|||
161194258|NCT00286234|582089866|FG001|Overall Study|Adverse Event|0|||
161194259|NCT00286234|582089867|FG002|Overall Study|Adverse Event|0|||
161194260|NCT00286234|582089868|FG003|Overall Study|Adverse Event|1|||
161194261|NCT00286234|582089865|FG000|Overall Study|Adverse Event|0|||
161194262|NCT00286234|582089866|FG001|Overall Study|Adverse Event|0|||
161194263|NCT00286234|582089867|FG002|Overall Study|Adverse Event|0|||
161194264|NCT00286234|582089868|FG003|Overall Study|Adverse Event|1|||
161194265|NCT02924129|582089877|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
161194266|NCT02924129|582089878|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
161194267|NCT02924129|582089877|FG000|Overall Study|Withdrawal by Subject|2|||
161194268|NCT02924129|582089878|FG001|Overall Study|Withdrawal by Subject|2|||
161194269|NCT02924129|582089877|FG000|Overall Study|Physician Decision|1|||
161194270|NCT02924129|582089878|FG001|Overall Study|Physician Decision|0|||
161194271|NCT02924129|582089877|FG000|Overall Study|Missed Visit|0|||
161194272|NCT02924129|582089878|FG001|Overall Study|Missed Visit|1|||
161194273|NCT03137173|582089886|FG000|Overall Study|Withdrawal by Subject|8|||
161194274|NCT03137173|582089887|FG001|Overall Study|Withdrawal by Subject|13|||
161194275|NCT03137173|582089886|FG000|Overall Study|Death|1|||
161194276|NCT03137173|582089887|FG001|Overall Study|Death|3|||
161194277|NCT03137173|582089886|FG000|Overall Study|Physician Decision|1|||
161194278|NCT03137173|582089887|FG001|Overall Study|Physician Decision|0|||
161194279|NCT03137173|582089886|FG000|Overall Study|Lost to Follow-up|13|||
161194280|NCT03137173|582089887|FG001|Overall Study|Lost to Follow-up|18|||
161194281|NCT03137173|582089886|FG000|Overall Study|Other reasons|3|||
161194282|NCT03137173|582089887|FG001|Overall Study|Other reasons|2|||
161194283|NCT05060003|582089888|FG000|Overall Study|ctDNA negative|7|||
161194284|NCT03524664|582089889|FG000|Overall Study|Withdrawal by Subject|1|||
161194285|NCT03524664|582089890|FG001|Overall Study|Withdrawal by Subject|2|||
161194286|NCT03524664|582089889|FG000|Overall Study|Lost to Follow-up|4|||
161194287|NCT03524664|582089890|FG001|Overall Study|Lost to Follow-up|13|||
161349800|NCT03171545|582665958|FG000|Baseline|Transferred out of clinic|4|||
161349801|NCT03171545|582665959|FG001|Baseline|Transferred out of clinic|0|||
161349802|NCT03171545|582665960|FG002|Baseline|Transferred out of clinic|2|||
161349803|NCT03171545|582665961|FG003|Baseline|Transferred out of clinic|0|||
161349804|NCT03171545|582665958|FG000|Baseline|Death|1|||
161349805|NCT03171545|582665959|FG001|Baseline|Death|2|||
161349806|NCT03171545|582665960|FG002|Baseline|Death|1|||
161194288|NCT01482598|582089891|FG000|Overall Study|Death|7|||
161194289|NCT01482598|582089892|FG001|Overall Study|Death|10|||
161194290|NCT01482598|582089891|FG000|Overall Study|Physician Decision|0|||
161194291|NCT01482598|582089892|FG001|Overall Study|Physician Decision|3|||
161194292|NCT01482598|582089891|FG000|Overall Study|Withdrawal by Subject|4|||
161194293|NCT01482598|582089892|FG001|Overall Study|Withdrawal by Subject|5|||
161194294|NCT01482598|582089891|FG000|Overall Study|Lost to Follow-up|5|||
161194295|NCT01482598|582089892|FG001|Overall Study|Lost to Follow-up|4|||
161194296|NCT01373294|582089893|FG000|Overall Study|Adverse Event|1|||
161194297|NCT01373294|582089894|FG001|Overall Study|Adverse Event|0|||
161194298|NCT02694562|582089895|FG000|Overall Study|Death|8|||
161194299|NCT02694562|582089895|FG000|Overall Study|Protocol Violation|4|||
161194300|NCT02694562|582089895|FG000|Overall Study|Lost to Follow-up|3|||
161194301|NCT02694562|582089895|FG000|Overall Study|Screen Failure|2|||
161194302|NCT02694562|582089895|FG000|Overall Study|Physician Decision|1|||
161194303|NCT00423267|582089896|FG000|Period A|Withdrawal by Subject|0|||
161194304|NCT00423267|582089897|FG001|Period A|Withdrawal by Subject|1|||
161194305|NCT00423267|582089896|FG000|Period A|Non-compliance with protocol|1|||
161194306|NCT00423267|582089897|FG001|Period A|Non-compliance with protocol|0|||
161194307|NCT00423267|582089896|FG000|Period A|Administrative|1|||
161194308|NCT00423267|582089897|FG001|Period A|Administrative|0|||
161194309|NCT03702166|582089898|FG000|Overall Study|Lost to Follow-up|1|||
161194310|NCT03702166|582089898|FG000|Overall Study|Withdrawal by Subject|1|||
161194311|NCT01333865|582089899|FG000|Overall Study|Adverse Event|2|||
161194312|NCT03512028|582089902|FG000|Overall Study|Withdrawal by Subject|2|||
161194313|NCT03512028|582089903|FG001|Overall Study|Withdrawal by Subject|0|||
161194314|NCT03512028|582089902|FG000|Overall Study|Protocol Violation|2|||
161194315|NCT03512028|582089903|FG001|Overall Study|Protocol Violation|0|||
161194316|NCT00517634|582089908|FG000|Second Treatment Period|Withdrawal by Subject|0|||
161194317|NCT00517634|582089909|FG001|Second Treatment Period|Withdrawal by Subject|0|||
161194318|NCT00517634|582089910|FG002|Second Treatment Period|Withdrawal by Subject|0|||
161194319|NCT00517634|582089911|FG003|Second Treatment Period|Withdrawal by Subject|0|||
161194320|NCT00517634|582089912|FG004|Second Treatment Period|Withdrawal by Subject|1|||
161194321|NCT00517634|582089913|FG005|Second Treatment Period|Withdrawal by Subject|0|||
161194322|NCT03143855|582089914|FG000|Overall Study|Withdrawal by Subject|4|||
161194323|NCT03143855|582089915|FG001|Overall Study|Withdrawal by Subject|3|||
161194324|NCT03143855|582089914|FG000|Overall Study|Protocol Violation|1|||
161194325|NCT03143855|582089915|FG001|Overall Study|Protocol Violation|0|||
161194326|NCT03143855|582089914|FG000|Overall Study|Participant experienced withdrawal|0|||
161194327|NCT03143855|582089915|FG001|Overall Study|Participant experienced withdrawal|1|||
161194328|NCT00701064|582089916|FG000|Overall Study|Protocol Violation|1|||
161194329|NCT00701064|582089917|FG001|Overall Study|Protocol Violation|1|||
161194330|NCT00701064|582089916|FG000|Overall Study|Withdrawal by Subject|1|||
161194331|NCT00701064|582089917|FG001|Overall Study|Withdrawal by Subject|1|||
161194332|NCT00701064|582089916|FG000|Overall Study|initiated other PTSD treatment|2|||
161194333|NCT00701064|582089917|FG001|Overall Study|initiated other PTSD treatment|2|||
161194334|NCT02098733|582089918|FG000|Overall Study|Data Not Available|5|||
161194335|NCT02098733|582089918|FG000|Overall Study|Lost to Follow-up|5|||
161194336|NCT01002573|582091629|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
161349807|NCT03171545|582665961|FG003|Baseline|Death|5|||
161349808|NCT03171545|582665958|FG000|Baseline|Recovered renal function|0|||
161349809|NCT03171545|582665959|FG001|Baseline|Recovered renal function|0|||
161194337|NCT01002573|582091630|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
161194338|NCT02028182|582091631|FG000|Overall Study|Protocol Violation|2|||
161194339|NCT01684930|582091634|FG000|Overall Study|Withdrawal by Subject|3|||
161194340|NCT01684930|582091635|FG001|Overall Study|Withdrawal by Subject|1|||
161194341|NCT01336647|582091637|FG000|Overall Study|Lost to Follow-up|4|||
161194342|NCT01336647|582091638|FG001|Overall Study|Lost to Follow-up|1|||
161194343|NCT01336647|582091639|FG002|Overall Study|Lost to Follow-up|3|||
161194344|NCT02713490|582091640|FG000|Overall Study|Withdrawal by Subject|2|||
161194345|NCT02713490|582091641|FG001|Overall Study|Withdrawal by Subject|1|||
161194346|NCT02713490|582091640|FG000|Overall Study|Did not receive study drug|1|||
161194347|NCT02713490|582091641|FG001|Overall Study|Did not receive study drug|0|||
161194348|NCT02713490|582091640|FG000|Overall Study|Met exclusion criteria|0|||
161194349|NCT02713490|582091641|FG001|Overall Study|Met exclusion criteria|1|||
161194350|NCT01714726|582091642|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
161194351|NCT01714726|582091643|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
161194352|NCT01714726|582091644|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
161194353|NCT01714726|582091645|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
161194354|NCT01714726|582091642|FG000|Double-Blinded Induction Period|Adverse Event|0|||
161194355|NCT01714726|582091643|FG001|Double-Blinded Induction Period|Adverse Event|1|||
161194356|NCT01714726|582091644|FG002|Double-Blinded Induction Period|Adverse Event|0|||
161194357|NCT01714726|582091645|FG003|Double-Blinded Induction Period|Adverse Event|0|||
161194358|NCT01714726|582091642|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
161194359|NCT01714726|582091643|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
161194360|NCT01714726|582091644|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
161194361|NCT01714726|582091645|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
161194362|NCT01714726|582091642|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
161194363|NCT01714726|582091643|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
161194364|NCT01714726|582091644|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
161194365|NCT01714726|582091645|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
161194366|NCT01714726|582091642|FG000|Open-Label Period|Other|0|||
161194367|NCT01714726|582091643|FG001|Open-Label Period|Other|0|||
161194368|NCT01714726|582091644|FG002|Open-Label Period|Other|1|||
161194369|NCT01714726|582091645|FG003|Open-Label Period|Other|3|||
161194370|NCT01714726|582091642|FG000|Open-Label Period|Adverse Event|0|||
161194371|NCT01714726|582091643|FG001|Open-Label Period|Adverse Event|0|||
161194372|NCT01714726|582091644|FG002|Open-Label Period|Adverse Event|1|||
161194373|NCT01714726|582091645|FG003|Open-Label Period|Adverse Event|0|||
161194374|NCT01714726|582091642|FG000|Open-Label Period|Withdrawal by Subject|0|||
161194375|NCT01714726|582091643|FG001|Open-Label Period|Withdrawal by Subject|0|||
161194376|NCT01714726|582091644|FG002|Open-Label Period|Withdrawal by Subject|9|||
161194377|NCT01714726|582091645|FG003|Open-Label Period|Withdrawal by Subject|19|||
161194378|NCT01714726|582091642|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
161194379|NCT01714726|582091643|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
161194380|NCT01714726|582091644|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
161194381|NCT01714726|582091645|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
161194382|NCT01714726|582091642|FG000|Open-Label Period|Lost to Follow-up|0|||
161194383|NCT01714726|582091643|FG001|Open-Label Period|Lost to Follow-up|0|||
161194384|NCT01714726|582091644|FG002|Open-Label Period|Lost to Follow-up|3|||
161194385|NCT01714726|582091645|FG003|Open-Label Period|Lost to Follow-up|4|||
161194386|NCT00548340|582091647|FG000|Overall Study|Protocol Violation|2|||
161194387|NCT00548340|582091648|FG001|Overall Study|Protocol Violation|3|||
161194388|NCT00548340|582091649|FG002|Overall Study|Protocol Violation|3|||
161194389|NCT00548340|582091647|FG000|Overall Study|Adverse Event|2|||
161194390|NCT00548340|582091648|FG001|Overall Study|Adverse Event|2|||
161194391|NCT00548340|582091649|FG002|Overall Study|Adverse Event|2|||
161194392|NCT00548340|582091647|FG000|Overall Study|Lost to Follow-up|1|||
161194393|NCT00548340|582091648|FG001|Overall Study|Lost to Follow-up|1|||
161194394|NCT00548340|582091649|FG002|Overall Study|Lost to Follow-up|0|||
161194395|NCT00548340|582091647|FG000|Overall Study|Withdrawal by Subject|2|||
161194396|NCT00548340|582091648|FG001|Overall Study|Withdrawal by Subject|4|||
161194397|NCT00548340|582091649|FG002|Overall Study|Withdrawal by Subject|3|||
161349810|NCT03171545|582665960|FG002|Baseline|Recovered renal function|1|||
161349811|NCT03171545|582665961|FG003|Baseline|Recovered renal function|0|||
161349812|NCT03171545|582665958|FG000|Baseline|Received transplant|0|||
161194398|NCT00548340|582091647|FG000|Overall Study|Other|1|||
161194399|NCT00548340|582091648|FG001|Overall Study|Other|1|||
161194400|NCT00548340|582091649|FG002|Overall Study|Other|1|||
161194401|NCT02600559|582091650|FG000|Overall Study|Withdrawal by Subject|3|||
161194402|NCT02600559|582091650|FG000|Overall Study|Lost to Follow-up|20|||
161194403|NCT02392078|582091655|FG000|Overall Study|Did not have procedure|32|||
161194404|NCT02392078|582091656|FG001|Overall Study|Did not have procedure|43|||
161194405|NCT02392078|582091657|FG002|Overall Study|Did not have procedure|20|||
161194406|NCT02392078|582091658|FG003|Overall Study|Did not have procedure|1|||
161349813|NCT03171545|582665959|FG001|Baseline|Received transplant|0|||
161194407|NCT02079077|582091659|FG000|Overall Study|Lost to Follow-up|5|||
161194408|NCT02079077|582091660|FG001|Overall Study|Lost to Follow-up|7|||
161194409|NCT02079077|582091659|FG000|Overall Study|Became STIs Positive|1|||
161194410|NCT02079077|582091660|FG001|Overall Study|Became STIs Positive|2|||
161194411|NCT03868410|582091663|FG000|Overall Study|Physician Decision|0|||
161194412|NCT03868410|582091664|FG001|Overall Study|Physician Decision|1|||
161194413|NCT02624713|582091671|FG000|Overall Study|Lost to Follow-up|14|||
161194414|NCT02624713|582091672|FG001|Overall Study|Lost to Follow-up|0|||
161194415|NCT00148109|582091673|FG000|Overall Study|Lack of Efficacy|10|||
161349814|NCT03171545|582665960|FG002|Baseline|Received transplant|1|||
161349815|NCT03171545|582665961|FG003|Baseline|Received transplant|0|||
161194416|NCT00148109|582091674|FG001|Overall Study|Lack of Efficacy|18|||
161194417|NCT00148109|582091673|FG000|Overall Study|Adverse Event|0|||
161194418|NCT00148109|582091674|FG001|Overall Study|Adverse Event|2|||
161194419|NCT00148109|582091673|FG000|Overall Study|Withdrawal by Subject|2|||
161194420|NCT00148109|582091674|FG001|Overall Study|Withdrawal by Subject|0|||
161194421|NCT06104423|582091675|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
161194422|NCT06104423|582091676|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
161194423|NCT06104423|582091677|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
161194424|NCT06104423|582091675|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
161194425|NCT06104423|582091676|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
161194426|NCT06104423|582091677|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
161194427|NCT00351611|582091682|FG000|Overall Study|Adverse Event|11|||
161349816|NCT03171545|582665958|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
161349817|NCT03171545|582665959|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
161349818|NCT03171545|582665960|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
161349819|NCT03171545|582665961|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
161349820|NCT03171545|582665958|FG000|Intervention|Withdrawal by Subject|2|||
161349821|NCT03171545|582665959|FG001|Intervention|Withdrawal by Subject|0|||
161349822|NCT03171545|582665960|FG002|Intervention|Withdrawal by Subject|0|||
161349823|NCT03171545|582665961|FG003|Intervention|Withdrawal by Subject|4|||
161349824|NCT03171545|582665958|FG000|Intervention|Transferred out of clinic|12|||
161349825|NCT03171545|582665959|FG001|Intervention|Transferred out of clinic|9|||
161349826|NCT03171545|582665960|FG002|Intervention|Transferred out of clinic|17|||
161349827|NCT03171545|582665961|FG003|Intervention|Transferred out of clinic|9|||
161349828|NCT03171545|582665958|FG000|Intervention|Death|26|||
161349829|NCT03171545|582665959|FG001|Intervention|Death|16|||
161349830|NCT03171545|582665960|FG002|Intervention|Death|29|||
161349831|NCT03171545|582665961|FG003|Intervention|Death|14|||
161349832|NCT03171545|582665958|FG000|Intervention|Received transplant|7|||
161349833|NCT03171545|582665959|FG001|Intervention|Received transplant|5|||
161349834|NCT03171545|582665960|FG002|Intervention|Received transplant|3|||
161349835|NCT03171545|582665961|FG003|Intervention|Received transplant|6|||
161349836|NCT03171545|582665958|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
161349837|NCT03171545|582665959|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
161349838|NCT03171545|582665960|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
161349839|NCT03171545|582665961|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
161349840|NCT03171545|582665958|FG000|Intervention|Lost to Follow-up|0|||
161349841|NCT03171545|582665959|FG001|Intervention|Lost to Follow-up|1|||
161349842|NCT03171545|582665960|FG002|Intervention|Lost to Follow-up|0|||
161349843|NCT03171545|582665961|FG003|Intervention|Lost to Follow-up|0|||
161349844|NCT03171545|582665958|FG000|Follow up|Withdrawal by Subject|1|||
161349845|NCT03171545|582665959|FG001|Follow up|Withdrawal by Subject|1|||
161349846|NCT03171545|582665960|FG002|Follow up|Withdrawal by Subject|0|||
161306431|NCT02017717|582502829|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
161306432|NCT02017717|582502830|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
161306433|NCT02017717|582502822|FG000|Treatment Period|Participant request to stop therapy|0|||
161306434|NCT02017717|582502823|FG001|Treatment Period|Participant request to stop therapy|0|||
161306435|NCT02017717|582502824|FG002|Treatment Period|Participant request to stop therapy|3|||
161306436|NCT02017717|582502825|FG003|Treatment Period|Participant request to stop therapy|6|||
161306437|NCT02017717|582502826|FG004|Treatment Period|Participant request to stop therapy|0|||
161306438|NCT02017717|582502827|FG005|Treatment Period|Participant request to stop therapy|2|||
161306439|NCT02017717|582502828|FG006|Treatment Period|Participant request to stop therapy|1|||
161306440|NCT02017717|582502829|FG007|Treatment Period|Participant request to stop therapy|4|||
161306441|NCT02017717|582502830|FG008|Treatment Period|Participant request to stop therapy|7|||
161306442|NCT02017717|582502822|FG000|Treatment Period|Participant withdrew consent|0|||
161306443|NCT02017717|582502823|FG001|Treatment Period|Participant withdrew consent|0|||
161306444|NCT02017717|582502824|FG002|Treatment Period|Participant withdrew consent|1|||
161306445|NCT02017717|582502825|FG003|Treatment Period|Participant withdrew consent|0|||
161306446|NCT02017717|582502826|FG004|Treatment Period|Participant withdrew consent|0|||
161306447|NCT02017717|582502827|FG005|Treatment Period|Participant withdrew consent|2|||
161306448|NCT02017717|582502828|FG006|Treatment Period|Participant withdrew consent|0|||
161306449|NCT02017717|582502829|FG007|Treatment Period|Participant withdrew consent|1|||
161306450|NCT02017717|582502830|FG008|Treatment Period|Participant withdrew consent|4|||
161306451|NCT02017717|582502822|FG000|Treatment Period|Participant no longer met criteria|0|||
161306452|NCT02017717|582502823|FG001|Treatment Period|Participant no longer met criteria|0|||
161306453|NCT02017717|582502824|FG002|Treatment Period|Participant no longer met criteria|0|||
161306454|NCT02017717|582502825|FG003|Treatment Period|Participant no longer met criteria|0|||
161349847|NCT03171545|582665961|FG003|Follow up|Withdrawal by Subject|0|||
161349848|NCT03171545|582665958|FG000|Follow up|Transferred out of clinic|4|||
161349849|NCT03171545|582665959|FG001|Follow up|Transferred out of clinic|4|||
161349850|NCT03171545|582665960|FG002|Follow up|Transferred out of clinic|12|||
161349851|NCT03171545|582665961|FG003|Follow up|Transferred out of clinic|7|||
161349852|NCT03171545|582665958|FG000|Follow up|Death|18|||
161349853|NCT03171545|582665959|FG001|Follow up|Death|12|||
161349854|NCT03171545|582665960|FG002|Follow up|Death|5|||
161349855|NCT03171545|582665961|FG003|Follow up|Death|8|||
161349856|NCT03171545|582665958|FG000|Follow up|Received transplant|4|||
161349857|NCT03171545|582665959|FG001|Follow up|Received transplant|1|||
161349858|NCT03171545|582665960|FG002|Follow up|Received transplant|0|||
161349859|NCT03171545|582665961|FG003|Follow up|Received transplant|1|||
161349860|NCT03171545|582665958|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
161349861|NCT03171545|582665959|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
161349862|NCT03171545|582665960|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
161349863|NCT03171545|582665961|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
161349864|NCT03171545|582665958|FG000|Follow up|Lost to Follow-up|1|||
161349865|NCT03171545|582665959|FG001|Follow up|Lost to Follow-up|2|||
161349866|NCT03171545|582665960|FG002|Follow up|Lost to Follow-up|3|||
161349867|NCT03171545|582665961|FG003|Follow up|Lost to Follow-up|1|||
161349868|NCT05213624|582665962|FG000|Overall Study|Adverse Event|0|||
161349869|NCT05213624|582665963|FG001|Overall Study|Adverse Event|3|||
161349870|NCT05213624|582665964|FG002|Overall Study|Adverse Event|0|||
161349871|NCT05213624|582665965|FG003|Overall Study|Adverse Event|0|||
161349872|NCT05213624|582665962|FG000|Overall Study|Protocol deviation|0|||
161349873|NCT05213624|582665963|FG001|Overall Study|Protocol deviation|2|||
161349874|NCT05213624|582665964|FG002|Overall Study|Protocol deviation|0|||
161349875|NCT05213624|582665965|FG003|Overall Study|Protocol deviation|0|||
161349876|NCT05213624|582665962|FG000|Overall Study|Withdrawal by Subject|0|||
161349877|NCT05213624|582665963|FG001|Overall Study|Withdrawal by Subject|0|||
161349878|NCT05213624|582665964|FG002|Overall Study|Withdrawal by Subject|0|||
161349879|NCT05213624|582665965|FG003|Overall Study|Withdrawal by Subject|1|||
161349880|NCT05213624|582665962|FG000|Overall Study|Not treated|0|||
161349881|NCT05213624|582665963|FG001|Overall Study|Not treated|1|||
161349882|NCT05213624|582665964|FG002|Overall Study|Not treated|2|||
161349883|NCT05213624|582665965|FG003|Overall Study|Not treated|2|||
161349884|NCT02441686|582665972|FG000|Induction|Adverse Event|4|||
161349885|NCT02441686|582665972|FG000|Induction|Complicating disease|1|||
161349886|NCT02441686|582665972|FG000|Induction|Physician Decision|1|||
161349887|NCT02441686|582665972|FG000|Induction|Withdrawal by Subject|1|||
161349888|NCT02441686|582665972|FG000|Induction|Did not receive treatment|1|||
161349889|NCT02441686|582665972|FG000|Maintenance|Remaining on Treatment|23|||
161349890|NCT02441686|582665972|FG000|Maintenance|Physician Decision|1|||
161349891|NCT02441686|582665972|FG000|Maintenance|Adverse Event|3|||
161349892|NCT02441686|582665972|FG000|Maintenance|Progressive Disease|10|||
161349893|NCT02441686|582665972|FG000|Maintenance|Withdrawal by Subject|1|||
161349894|NCT04647526|582665973|FG000|Overall Study|Death|13|||
161349895|NCT04647526|582665974|FG001|Overall Study|Death|76|||
161349896|NCT04647526|582665975|FG002|Overall Study|Death|32|||
161349897|NCT04647526|582665976|FG003|Overall Study|Death|0|||
161349898|NCT04647526|582665973|FG000|Overall Study|Lost to Follow-up|1|||
161349899|NCT04647526|582665974|FG001|Overall Study|Lost to Follow-up|0|||
161349900|NCT04647526|582665975|FG002|Overall Study|Lost to Follow-up|1|||
161349901|NCT04647526|582665976|FG003|Overall Study|Lost to Follow-up|0|||
161349902|NCT04647526|582665973|FG000|Overall Study|Withdrawal by Subject|4|||
161349903|NCT04647526|582665974|FG001|Overall Study|Withdrawal by Subject|15|||
161349904|NCT04647526|582665975|FG002|Overall Study|Withdrawal by Subject|8|||
161349905|NCT04647526|582665976|FG003|Overall Study|Withdrawal by Subject|1|||
161349906|NCT04647526|582665973|FG000|Overall Study|Incorrect enrollment|0|||
161349907|NCT04647526|582665974|FG001|Overall Study|Incorrect enrollment|1|||
161349908|NCT04647526|582665975|FG002|Overall Study|Incorrect enrollment|1|||
161349909|NCT04647526|582665976|FG003|Overall Study|Incorrect enrollment|0|||
161349910|NCT04647526|582665973|FG000|Overall Study|Physician Decision|0|||
161349911|NCT04647526|582665974|FG001|Overall Study|Physician Decision|1|||
161349912|NCT04647526|582665975|FG002|Overall Study|Physician Decision|1|||
161349913|NCT04647526|582665976|FG003|Overall Study|Physician Decision|0|||
161349914|NCT04647526|582665973|FG000|Overall Study|Ongoing|9|||
161349915|NCT04647526|582665974|FG001|Overall Study|Ongoing|183|||
161349916|NCT04647526|582665975|FG002|Overall Study|Ongoing|93|||
161349917|NCT04647526|582665976|FG003|Overall Study|Ongoing|15|||
161349918|NCT03298451|582665977|FG000|Overall Study|Death|275|||
161349919|NCT03298451|582665978|FG001|Overall Study|Death|260|||
161349920|NCT03298451|582665979|FG002|Overall Study|Death|122|||
161349921|NCT03298451|582665980|FG003|Overall Study|Death|280|||
161349922|NCT03298451|582665977|FG000|Overall Study|Lost to Follow-up|1|||
161349923|NCT03298451|582665978|FG001|Overall Study|Lost to Follow-up|1|||
161349924|NCT03298451|582665979|FG002|Overall Study|Lost to Follow-up|0|||
161349925|NCT03298451|582665980|FG003|Overall Study|Lost to Follow-up|7|||
161349926|NCT03298451|582665977|FG000|Overall Study|Withdrawal by Subject|9|||
161349927|NCT03298451|582665978|FG001|Overall Study|Withdrawal by Subject|7|||
161349928|NCT03298451|582665979|FG002|Overall Study|Withdrawal by Subject|1|||
161349929|NCT03298451|582665980|FG003|Overall Study|Withdrawal by Subject|20|||
161349930|NCT04150029|582665981|FG000|Overall Study|Disease Relapse|0|||
161349931|NCT04150029|582665982|FG001|Overall Study|Disease Relapse|18|||
161349932|NCT04150029|582665981|FG000|Overall Study|Progressive Disease|2|||
161349933|NCT04150029|582665982|FG001|Overall Study|Progressive Disease|16|||
161349934|NCT04150029|582665981|FG000|Overall Study|Adverse Event|1|||
161306455|NCT02017717|582502826|FG004|Treatment Period|Participant no longer met criteria|0|||
161306456|NCT02017717|582502827|FG005|Treatment Period|Participant no longer met criteria|0|||
161306457|NCT02017717|582502828|FG006|Treatment Period|Participant no longer met criteria|0|||
161306458|NCT02017717|582502829|FG007|Treatment Period|Participant no longer met criteria|0|||
161306459|NCT02017717|582502830|FG008|Treatment Period|Participant no longer met criteria|1|||
161306460|NCT02017717|582502822|FG000|Treatment Period|Other reasons|0|||
161306461|NCT02017717|582502823|FG001|Treatment Period|Other reasons|0|||
161306462|NCT02017717|582502824|FG002|Treatment Period|Other reasons|0|||
161306463|NCT02017717|582502825|FG003|Treatment Period|Other reasons|1|||
161306464|NCT02017717|582502826|FG004|Treatment Period|Other reasons|0|||
161306465|NCT02017717|582502827|FG005|Treatment Period|Other reasons|1|||
161306466|NCT02017717|582502828|FG006|Treatment Period|Other reasons|1|||
161306467|NCT02017717|582502829|FG007|Treatment Period|Other reasons|1|||
161306468|NCT02017717|582502830|FG008|Treatment Period|Other reasons|1|||
161306469|NCT02017717|582502822|FG000|Treatment Period|Maximum clinical benefit|0|||
161306470|NCT02017717|582502823|FG001|Treatment Period|Maximum clinical benefit|0|||
161306471|NCT02017717|582502824|FG002|Treatment Period|Maximum clinical benefit|0|||
161306472|NCT02017717|582502825|FG003|Treatment Period|Maximum clinical benefit|0|||
161306473|NCT02017717|582502826|FG004|Treatment Period|Maximum clinical benefit|0|||
161306474|NCT02017717|582502827|FG005|Treatment Period|Maximum clinical benefit|0|||
161306475|NCT02017717|582502828|FG006|Treatment Period|Maximum clinical benefit|0|||
161306476|NCT02017717|582502829|FG007|Treatment Period|Maximum clinical benefit|0|||
161306477|NCT02017717|582502830|FG008|Treatment Period|Maximum clinical benefit|1|||
161306478|NCT02017717|582502822|FG000|Treatment Period|Not reported|0|||
161306479|NCT02017717|582502823|FG001|Treatment Period|Not reported|1|||
161306480|NCT02017717|582502824|FG002|Treatment Period|Not reported|0|||
161306481|NCT02017717|582502825|FG003|Treatment Period|Not reported|0|||
161306482|NCT02017717|582502826|FG004|Treatment Period|Not reported|0|||
161306483|NCT02017717|582502827|FG005|Treatment Period|Not reported|0|||
161306484|NCT02017717|582502828|FG006|Treatment Period|Not reported|0|||
161306485|NCT02017717|582502829|FG007|Treatment Period|Not reported|0|||
161306486|NCT02017717|582502830|FG008|Treatment Period|Not reported|0|||
161306487|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
161306488|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
161306489|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
161306490|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
161306491|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
161306492|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
161306493|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
161306494|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
161306495|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
161306496|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
161306497|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
161306498|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
161306499|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
161306500|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
161306501|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
161306502|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
161306503|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
161306504|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
161306505|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
161306506|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
161306507|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
161306508|NCT04488419|582502832|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
161306509|NCT04488419|582502833|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
161306510|NCT04488419|582502834|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
161306511|NCT04488419|582502832|FG000|Primary Analysis Population|Adverse Event|6|||
161306512|NCT04488419|582502833|FG001|Primary Analysis Population|Adverse Event|9|||
161306513|NCT04488419|582502834|FG002|Primary Analysis Population|Adverse Event|0|||
161306514|NCT04488419|582502832|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
161306515|NCT04488419|582502833|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
161306516|NCT04488419|582502834|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
161306517|NCT04488419|582502832|FG000|Primary Analysis Population|Protocol Violation|1|||
161306518|NCT04488419|582502833|FG001|Primary Analysis Population|Protocol Violation|1|||
161306519|NCT04488419|582502834|FG002|Primary Analysis Population|Protocol Violation|0|||
161306520|NCT04488419|582502832|FG000|Primary Analysis Population|Undetermined|7|||
161306521|NCT04488419|582502833|FG001|Primary Analysis Population|Undetermined|3|||
161306522|NCT04488419|582502834|FG002|Primary Analysis Population|Undetermined|0|||
161306523|NCT04488419|582502832|FG000|Primary Analysis Population|>1 Reason|2|||
161306524|NCT04488419|582502833|FG001|Primary Analysis Population|>1 Reason|4|||
161306525|NCT04488419|582502834|FG002|Primary Analysis Population|>1 Reason|0|||
161349935|NCT04150029|582665982|FG001|Overall Study|Adverse Event|11|||
161349936|NCT04150029|582665981|FG000|Overall Study|Physician Decision|0|||
161349937|NCT04150029|582665982|FG001|Overall Study|Physician Decision|10|||
161349938|NCT04150029|582665981|FG000|Overall Study|Study Terminated by Sponsor|1|||
161349939|NCT04150029|582665982|FG001|Overall Study|Study Terminated by Sponsor|10|||
161349940|NCT04150029|582665981|FG000|Overall Study|Death|0|||
161349941|NCT04150029|582665982|FG001|Overall Study|Death|8|||
161349942|NCT04150029|582665981|FG000|Overall Study|Participant Decision|0|||
161349943|NCT04150029|582665982|FG001|Overall Study|Participant Decision|7|||
161349944|NCT04150029|582665981|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
161349945|NCT04150029|582665982|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
161349946|NCT01602380|582665983|FG000|Overall Study|Death|147|||
161349947|NCT01602380|582665984|FG001|Overall Study|Death|145|||
161349948|NCT01602380|582665983|FG000|Overall Study|Withdrawal by Subject|39|||
161349949|NCT01602380|582665984|FG001|Overall Study|Withdrawal by Subject|41|||
161349950|NCT01602380|582665983|FG000|Overall Study|Lost to Follow-up|15|||
161349951|NCT01602380|582665984|FG001|Overall Study|Lost to Follow-up|12|||
161349952|NCT01602380|582665983|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161349953|NCT01602380|582665984|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
161349954|NCT01602380|582665983|FG000|Overall Study|Other|2|||
161349955|NCT01602380|582665984|FG001|Overall Study|Other|0|||
161349956|NCT04409457|582665989|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
161349957|NCT04409457|582665990|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
161349958|NCT04409457|582665991|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161349959|NCT04409457|582665992|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161349960|NCT04409457|582665993|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161349961|NCT04409457|582665994|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
161349962|NCT04409457|582665989|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
161349963|NCT04409457|582665990|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
161349964|NCT04409457|582665991|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
161349965|NCT04409457|582665992|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
161349966|NCT04409457|582665993|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
161349967|NCT04409457|582665994|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
161349968|NCT04409457|582665989|FG000|Randomization|Withdrawal by Subject|0|||
161349969|NCT04409457|582665990|FG001|Randomization|Withdrawal by Subject|0|||
161349970|NCT04409457|582665991|FG002|Randomization|Withdrawal by Subject|0|||
161349971|NCT04409457|582665992|FG003|Randomization|Withdrawal by Subject|0|||
161349972|NCT04409457|582665993|FG004|Randomization|Withdrawal by Subject|1|||
161349973|NCT04409457|582665994|FG005|Randomization|Withdrawal by Subject|0|||
161349974|NCT04409457|582665989|FG000|Randomization|Incidental MRI finding at scan 1|0|||
161349975|NCT04409457|582665990|FG001|Randomization|Incidental MRI finding at scan 1|0|||
161349976|NCT04409457|582665991|FG002|Randomization|Incidental MRI finding at scan 1|0|||
161349977|NCT04409457|582665992|FG003|Randomization|Incidental MRI finding at scan 1|1|||
161349978|NCT04409457|582665993|FG004|Randomization|Incidental MRI finding at scan 1|0|||
161349979|NCT04409457|582665994|FG005|Randomization|Incidental MRI finding at scan 1|1|||
161349980|NCT04409457|582665989|FG000|Randomization|Technical/equipment error at scan 1|0|||
161349981|NCT04409457|582665990|FG001|Randomization|Technical/equipment error at scan 1|0|||
161349982|NCT04409457|582665991|FG002|Randomization|Technical/equipment error at scan 1|0|||
161349983|NCT04409457|582665992|FG003|Randomization|Technical/equipment error at scan 1|0|||
161349984|NCT04409457|582665993|FG004|Randomization|Technical/equipment error at scan 1|0|||
161349985|NCT04409457|582665994|FG005|Randomization|Technical/equipment error at scan 1|1|||
161349986|NCT04865770|582665995|FG000|Overall Study|Withdrawal by Subject|3|||
161349987|NCT04865770|582665996|FG001|Overall Study|Withdrawal by Subject|0|||
161349988|NCT04865770|582665995|FG000|Overall Study|Physician Decision|9|||
161349989|NCT04865770|582665996|FG001|Overall Study|Physician Decision|0|||
161349990|NCT04865770|582665995|FG000|Overall Study|Death|1|||
161349991|NCT04865770|582665996|FG001|Overall Study|Death|1|||
161349992|NCT05497284|582665997|FG000|Overall Study|Adverse Event|1|||
161349993|NCT05497284|582665998|FG001|Overall Study|Adverse Event|0|||
161349994|NCT05497284|582665997|FG000|Overall Study|Physician Decision|0|||
161349995|NCT05497284|582665998|FG001|Overall Study|Physician Decision|1|||
161349996|NCT05497284|582665997|FG000|Overall Study|Study terminated by sponsor|7|||
161349997|NCT05497284|582665998|FG001|Overall Study|Study terminated by sponsor|4|||
161349998|NCT05497284|582665997|FG000|Overall Study|Subject Decision|0|||
161349999|NCT05497284|582665998|FG001|Overall Study|Subject Decision|1|||
161350000|NCT03816891|582666000|FG000|Double-Blind Period|Withdrawal by Subject|1|||
161350001|NCT03816891|582666001|FG001|Double-Blind Period|Withdrawal by Subject|2|||
161350002|NCT03816891|582666002|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161350003|NCT03816891|582666003|FG003|Double-Blind Period|Withdrawal by Subject|2|||
161350004|NCT03816891|582666004|FG004|Double-Blind Period|Withdrawal by Subject|0|||
161350005|NCT03816891|582666005|FG005|Double-Blind Period|Withdrawal by Subject|0|||
161350006|NCT03816891|582666000|FG000|Double-Blind Period|Adverse Event|0|||
161350007|NCT03816891|582666001|FG001|Double-Blind Period|Adverse Event|0|||
161350008|NCT03816891|582666002|FG002|Double-Blind Period|Adverse Event|2|||
161350009|NCT03816891|582666003|FG003|Double-Blind Period|Adverse Event|0|||
161350010|NCT03816891|582666004|FG004|Double-Blind Period|Adverse Event|0|||
161350011|NCT03816891|582666005|FG005|Double-Blind Period|Adverse Event|0|||
161350012|NCT03816891|582666000|FG000|Double-Blind Period|Lost to Follow-up|2|||
161350013|NCT03816891|582666001|FG001|Double-Blind Period|Lost to Follow-up|0|||
161350014|NCT03816891|582666002|FG002|Double-Blind Period|Lost to Follow-up|0|||
161350015|NCT03816891|582666003|FG003|Double-Blind Period|Lost to Follow-up|0|||
161350016|NCT03816891|582666004|FG004|Double-Blind Period|Lost to Follow-up|0|||
161350017|NCT03816891|582666005|FG005|Double-Blind Period|Lost to Follow-up|1|||
161350018|NCT03816891|582666000|FG000|Double-Blind Period|Physician Decision|0|||
161350019|NCT03816891|582666001|FG001|Double-Blind Period|Physician Decision|0|||
161350020|NCT03816891|582666002|FG002|Double-Blind Period|Physician Decision|0|||
161350021|NCT03816891|582666003|FG003|Double-Blind Period|Physician Decision|1|||
161350022|NCT03816891|582666004|FG004|Double-Blind Period|Physician Decision|0|||
161350023|NCT03816891|582666005|FG005|Double-Blind Period|Physician Decision|0|||
161350024|NCT03816891|582666000|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161350025|NCT03816891|582666001|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161350026|NCT03816891|582666002|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161350027|NCT03816891|582666003|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161350028|NCT03816891|582666004|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
161350029|NCT03816891|582666005|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
161350030|NCT03816891|582666000|FG000|Double-Blind Period|Other|1|||
161350031|NCT03816891|582666001|FG001|Double-Blind Period|Other|0|||
161350032|NCT03816891|582666002|FG002|Double-Blind Period|Other|0|||
161350033|NCT03816891|582666003|FG003|Double-Blind Period|Other|0|||
161350034|NCT03816891|582666004|FG004|Double-Blind Period|Other|0|||
161350035|NCT03816891|582666005|FG005|Double-Blind Period|Other|0|||
161350036|NCT03816891|582666000|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161350037|NCT03816891|582666001|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161350038|NCT03816891|582666002|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
161350039|NCT03816891|582666003|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
161350040|NCT03816891|582666004|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
161350041|NCT03816891|582666005|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
161306526|NCT01482065|582502837|FG000|Overall Study|Withdrawal by Subject|0|||
161306527|NCT01482065|582502838|FG001|Overall Study|Withdrawal by Subject|1|||
161306528|NCT03728426|582502839|FG000|Overall Study|Death|3|||
161306529|NCT02682823|582502840|FG000|Overall Study|Withdrawal by Subject|0|||
161306530|NCT02682823|582502841|FG001|Overall Study|Withdrawal by Subject|0|||
161306531|NCT02682823|582502842|FG002|Overall Study|Withdrawal by Subject|1|||
161306532|NCT02682823|582502843|FG003|Overall Study|Withdrawal by Subject|0|||
161306533|NCT02682823|582502844|FG004|Overall Study|Withdrawal by Subject|1|||
161306534|NCT02682823|582502840|FG000|Overall Study|Protocol Deviation|0|||
161306535|NCT02682823|582502841|FG001|Overall Study|Protocol Deviation|1|||
161306536|NCT02682823|582502842|FG002|Overall Study|Protocol Deviation|0|||
161306537|NCT02682823|582502843|FG003|Overall Study|Protocol Deviation|0|||
161306538|NCT02682823|582502844|FG004|Overall Study|Protocol Deviation|0|||
161306539|NCT02682823|582502840|FG000|Overall Study|Adverse Event|0|||
161306540|NCT02682823|582502841|FG001|Overall Study|Adverse Event|0|||
161306541|NCT02682823|582502842|FG002|Overall Study|Adverse Event|0|||
161306542|NCT02682823|582502843|FG003|Overall Study|Adverse Event|1|||
161306543|NCT02682823|582502844|FG004|Overall Study|Adverse Event|0|||
161306544|NCT01995175|582502845|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
161306545|NCT01995175|582502845|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
161306546|NCT01995175|582502845|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
161306547|NCT01995175|582502845|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
161306548|NCT01995175|582502845|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
161306549|NCT01995175|582502845|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
161306550|NCT01995175|582502845|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
161306551|NCT01995175|582502845|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
161306552|NCT01995175|582502845|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
161306553|NCT01741792|582502846|FG000|Overall Study|Death|6|||
161306554|NCT01741792|582502847|FG001|Overall Study|Death|1|||
161306555|NCT01741792|582502848|FG002|Overall Study|Death|12|||
161306556|NCT02353442|582502851|FG000|Overall Study|Withdrawal by Subject|3|||
161306557|NCT02353442|582502852|FG001|Overall Study|Withdrawal by Subject|4|||
161306558|NCT01075646|582502853|FG000|Overall Study|Lost to Follow-up|4|||
161306559|NCT01075646|582502854|FG001|Overall Study|Lost to Follow-up|3|||
161306560|NCT01075646|582502855|FG002|Overall Study|Lost to Follow-up|1|||
161306561|NCT01075646|582502856|FG003|Overall Study|Lost to Follow-up|2|||
161306562|NCT02004886|582502860|FG000|Overall Study|Adverse Event|0|||
161350042|NCT03816891|582666000|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
161350043|NCT03816891|582666001|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
161350044|NCT03816891|582666002|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161350045|NCT03816891|582666003|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161350046|NCT03816891|582666004|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
161350047|NCT03816891|582666005|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
161350048|NCT03816891|582666000|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161350049|NCT03816891|582666001|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161350050|NCT03816891|582666002|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
161194428|NCT00351611|582091683|FG001|Overall Study|Adverse Event|3|||
161350051|NCT03816891|582666003|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161350052|NCT03816891|582666004|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
161350053|NCT03816891|582666005|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
161350054|NCT03816891|582666000|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161350055|NCT03816891|582666001|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161350056|NCT03816891|582666002|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161350057|NCT03816891|582666003|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
161350058|NCT03816891|582666004|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
161350059|NCT03816891|582666005|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
161350060|NCT03816891|582666000|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
161350061|NCT03816891|582666001|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
161350062|NCT03816891|582666002|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
161350063|NCT03816891|582666003|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
161350064|NCT03816891|582666004|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
161350065|NCT03816891|582666005|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
161350066|NCT02577029|582666006|FG000|Overall Study|Adverse Event|1|||
161350067|NCT02577029|582666007|FG001|Overall Study|Adverse Event|0|||
161350068|NCT02577029|582666008|FG002|Overall Study|Adverse Event|2|||
161350069|NCT02577029|582666009|FG003|Overall Study|Adverse Event|0|||
161350070|NCT02577029|582666010|FG004|Overall Study|Adverse Event|1|||
161350071|NCT02577029|582666011|FG005|Overall Study|Adverse Event|0|||
161350072|NCT02577029|582666012|FG006|Overall Study|Adverse Event|0|||
161350073|NCT02577029|582666013|FG007|Overall Study|Adverse Event|0|||
161350074|NCT02577029|582666006|FG000|Overall Study|Withdrawal by Subject|0|||
161350075|NCT02577029|582666007|FG001|Overall Study|Withdrawal by Subject|0|||
161350076|NCT02577029|582666008|FG002|Overall Study|Withdrawal by Subject|0|||
161350077|NCT02577029|582666009|FG003|Overall Study|Withdrawal by Subject|0|||
161350078|NCT02577029|582666010|FG004|Overall Study|Withdrawal by Subject|0|||
161350079|NCT02577029|582666011|FG005|Overall Study|Withdrawal by Subject|1|||
161350080|NCT02577029|582666012|FG006|Overall Study|Withdrawal by Subject|0|||
161350081|NCT02577029|582666013|FG007|Overall Study|Withdrawal by Subject|0|||
161350082|NCT02577029|582666006|FG000|Overall Study|Sponsor Termination of the Study|9|||
161350083|NCT02577029|582666007|FG001|Overall Study|Sponsor Termination of the Study|2|||
161350084|NCT02577029|582666008|FG002|Overall Study|Sponsor Termination of the Study|5|||
161350085|NCT02577029|582666009|FG003|Overall Study|Sponsor Termination of the Study|12|||
161350086|NCT02577029|582666010|FG004|Overall Study|Sponsor Termination of the Study|10|||
161350087|NCT02577029|582666011|FG005|Overall Study|Sponsor Termination of the Study|12|||
161350088|NCT02577029|582666012|FG006|Overall Study|Sponsor Termination of the Study|12|||
161350089|NCT02577029|582666013|FG007|Overall Study|Sponsor Termination of the Study|12|||
161350090|NCT00124306|582666031|FG000|Overall Study|Adverse Event|7|||
161350091|NCT00124306|582666032|FG001|Overall Study|Adverse Event|2|||
161350092|NCT00124306|582666031|FG000|Overall Study|Lost to Follow-up|10|||
161350093|NCT00124306|582666032|FG001|Overall Study|Lost to Follow-up|6|||
161350094|NCT00124306|582666031|FG000|Overall Study|Lack of Efficacy|3|||
161350095|NCT00124306|582666032|FG001|Overall Study|Lack of Efficacy|6|||
161350096|NCT00124306|582666031|FG000|Overall Study|Personal constraints|0|||
161350097|NCT00124306|582666032|FG001|Overall Study|Personal constraints|2|||
161350098|NCT00124306|582666031|FG000|Overall Study|Use of unacceptable medication|1|||
161350099|NCT00124306|582666032|FG001|Overall Study|Use of unacceptable medication|0|||
161350100|NCT00124306|582666031|FG000|Overall Study|Abnormal lab result|0|||
161350101|NCT00124306|582666032|FG001|Overall Study|Abnormal lab result|1|||
161350102|NCT00124306|582666031|FG000|Overall Study|Other|2|||
161350103|NCT00124306|582666032|FG001|Overall Study|Other|0|||
161350104|NCT03369704|582666034|FG000|Treatment Epoch|technical problems|1|||
161350105|NCT03369704|582666035|FG001|Treatment Epoch|technical problems|0|||
161194429|NCT00351611|582091682|FG000|Overall Study|Death|1|||
161194430|NCT00351611|582091683|FG001|Overall Study|Death|0|||
161194431|NCT00351611|582091682|FG000|Overall Study|Lost to Follow-up|1|||
161194432|NCT00351611|582091683|FG001|Overall Study|Lost to Follow-up|0|||
161194433|NCT00351611|582091682|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
161194434|NCT00351611|582091683|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
161350106|NCT03369704|582666034|FG000|Treatment Epoch|Protocol Violation|1|||
161350107|NCT03369704|582666035|FG001|Treatment Epoch|Protocol Violation|0|||
161350108|NCT03369704|582666034|FG000|Treatment Epoch|Lost to Follow-up|0|||
161350109|NCT03369704|582666035|FG001|Treatment Epoch|Lost to Follow-up|1|||
161350110|NCT03369704|582666034|FG000|Treatment Epoch|Lack of Efficacy|0|||
161350111|NCT03369704|582666035|FG001|Treatment Epoch|Lack of Efficacy|2|||
161350112|NCT03369704|582666034|FG000|Treatment Epoch|Adverse Event|2|||
161350113|NCT03369704|582666035|FG001|Treatment Epoch|Adverse Event|0|||
161194435|NCT00351611|582091682|FG000|Overall Study|Other|1|||
161194436|NCT00351611|582091683|FG001|Overall Study|Other|0|||
161194437|NCT00351611|582091682|FG000|Overall Study|Protocol Violation|0|||
161194438|NCT00351611|582091683|FG001|Overall Study|Protocol Violation|2|||
161194439|NCT01589185|582091684|FG000|Overall Study|Death|1|||
161194440|NCT01589185|582091685|FG001|Overall Study|Death|2|||
161194441|NCT01589185|582091686|FG002|Overall Study|Death|2|||
161194442|NCT01589185|582091687|FG003|Overall Study|Death|0|||
161194443|NCT01589185|582091688|FG004|Overall Study|Death|1|||
161194444|NCT01589185|582091684|FG000|Overall Study|Lost to Follow-up|1|||
161194445|NCT01589185|582091685|FG001|Overall Study|Lost to Follow-up|0|||
161194446|NCT01589185|582091686|FG002|Overall Study|Lost to Follow-up|2|||
161194447|NCT01589185|582091687|FG003|Overall Study|Lost to Follow-up|3|||
161194448|NCT01589185|582091688|FG004|Overall Study|Lost to Follow-up|0|||
161194449|NCT02708524|582091689|FG000|Overall Study|Adverse Event|0|||
161194450|NCT02708524|582091690|FG001|Overall Study|Adverse Event|1|||
161194451|NCT02708524|582091691|FG002|Overall Study|Adverse Event|0|||
161194452|NCT02708524|582091692|FG003|Overall Study|Adverse Event|0|||
161194453|NCT02708524|582091689|FG000|Overall Study|Lens Discomfort|1|||
161194454|NCT02708524|582091690|FG001|Overall Study|Lens Discomfort|0|||
161194455|NCT02708524|582091691|FG002|Overall Study|Lens Discomfort|1|||
161194456|NCT02708524|582091692|FG003|Overall Study|Lens Discomfort|0|||
161194457|NCT02708524|582091689|FG000|Overall Study|Lost to Follow-up|1|||
161194458|NCT02708524|582091690|FG001|Overall Study|Lost to Follow-up|1|||
161194459|NCT02708524|582091691|FG002|Overall Study|Lost to Follow-up|1|||
161194460|NCT02708524|582091692|FG003|Overall Study|Lost to Follow-up|0|||
161194461|NCT02708524|582091689|FG000|Overall Study|Protocol Violation|0|||
161194462|NCT02708524|582091690|FG001|Overall Study|Protocol Violation|1|||
161194463|NCT02708524|582091691|FG002|Overall Study|Protocol Violation|0|||
161194464|NCT02708524|582091692|FG003|Overall Study|Protocol Violation|0|||
161194465|NCT02708524|582091689|FG000|Overall Study|Withdrawal by Subject|1|||
161194466|NCT02708524|582091690|FG001|Overall Study|Withdrawal by Subject|1|||
161194467|NCT02708524|582091691|FG002|Overall Study|Withdrawal by Subject|0|||
161194468|NCT02708524|582091692|FG003|Overall Study|Withdrawal by Subject|0|||
161194469|NCT02708524|582091689|FG000|Overall Study|Dispensed incorrect study lens|0|||
161194470|NCT02708524|582091690|FG001|Overall Study|Dispensed incorrect study lens|1|||
161194471|NCT02708524|582091691|FG002|Overall Study|Dispensed incorrect study lens|1|||
161194472|NCT02708524|582091692|FG003|Overall Study|Dispensed incorrect study lens|0|||
161194473|NCT02708524|582091689|FG000|Overall Study|Did not wear lens at final visit|0|||
161194474|NCT02708524|582091690|FG001|Overall Study|Did not wear lens at final visit|1|||
161194475|NCT02708524|582091691|FG002|Overall Study|Did not wear lens at final visit|0|||
161194476|NCT02708524|582091692|FG003|Overall Study|Did not wear lens at final visit|0|||
161194477|NCT02708524|582091689|FG000|Overall Study|Subject lost study lens|1|||
161194478|NCT02708524|582091690|FG001|Overall Study|Subject lost study lens|0|||
161194479|NCT02708524|582091691|FG002|Overall Study|Subject lost study lens|0|||
161194480|NCT02708524|582091692|FG003|Overall Study|Subject lost study lens|0|||
161194481|NCT03781167|582091698|FG000|Overall Study|Adverse Event|23|||
161194482|NCT03781167|582091699|FG001|Overall Study|Adverse Event|25|||
161194483|NCT03781167|582091698|FG000|Overall Study|Withdrew consent|16|||
161194484|NCT03781167|582091699|FG001|Overall Study|Withdrew consent|12|||
161194485|NCT03781167|582091698|FG000|Overall Study|Lost to Follow-up|0|||
161194486|NCT03781167|582091699|FG001|Overall Study|Lost to Follow-up|1|||
161194487|NCT03781167|582091698|FG000|Overall Study|Lack of Efficacy|4|||
161194488|NCT03781167|582091699|FG001|Overall Study|Lack of Efficacy|5|||
161194489|NCT03781167|582091698|FG000|Overall Study|Difficulty with drug delivery system|2|||
161194490|NCT03781167|582091699|FG001|Overall Study|Difficulty with drug delivery system|3|||
161194491|NCT03781167|582091698|FG000|Overall Study|Other, not specified|2|||
161194492|NCT03781167|582091699|FG001|Overall Study|Other, not specified|2|||
161194493|NCT00462501|582091700|FG000|Overall Study|Not treated|3|||
161194494|NCT00462501|582091700|FG000|Overall Study|Adverse Event|2|||
161194495|NCT00679354|582091705|FG000|Overall Study|Death|3|||
161194496|NCT00679354|582091705|FG000|Overall Study|Lack of Efficacy|22|||
161194497|NCT00679354|582091705|FG000|Overall Study|Physician Decision|4|||
161194498|NCT00679354|582091705|FG000|Overall Study|Ineligible|1|||
161194499|NCT01258803|582091706|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161194500|NCT01258803|582091707|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161194501|NCT01258803|582091708|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161306563|NCT02004886|582502861|FG001|Overall Study|Adverse Event|1|||
161306564|NCT02004886|582502862|FG002|Overall Study|Adverse Event|0|||
161306565|NCT02004886|582502863|FG003|Overall Study|Adverse Event|0|||
161194502|NCT01258803|582091709|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161194503|NCT01258803|582091710|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
161194504|NCT01258803|582091711|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
161194505|NCT01258803|582091706|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161194506|NCT01258803|582091707|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
161194507|NCT01258803|582091708|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161194508|NCT01258803|582091709|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161194509|NCT01258803|582091710|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161194510|NCT01258803|582091711|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
161194511|NCT01258803|582091706|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161194512|NCT01258803|582091707|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161194513|NCT01258803|582091708|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
161194514|NCT01258803|582091709|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161194515|NCT01258803|582091710|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161194516|NCT01258803|582091711|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
161194517|NCT01552408|582091712|FG000|Overall Study|Lost to Follow-up|2|||
161194518|NCT01552408|582091713|FG001|Overall Study|Lost to Follow-up|0|||
161194519|NCT01552408|582091712|FG000|Overall Study|Relocation|0|||
161194520|NCT01552408|582091713|FG001|Overall Study|Relocation|1|||
161194521|NCT01552408|582091712|FG000|Overall Study|Withdrawal by Subject|2|||
161194522|NCT01552408|582091713|FG001|Overall Study|Withdrawal by Subject|1|||
161194523|NCT04047472|582091718|FG000|Overall Study|Adverse Event|3|||
161194524|NCT04047472|582091719|FG001|Overall Study|Adverse Event|3|||
161194525|NCT04047472|582091718|FG000|Overall Study|Death|0|||
161194526|NCT04047472|582091719|FG001|Overall Study|Death|1|||
161194527|NCT04047472|582091718|FG000|Overall Study|Lost to Follow-up|1|||
161194528|NCT04047472|582091719|FG001|Overall Study|Lost to Follow-up|0|||
161194529|NCT04047472|582091718|FG000|Overall Study|Physician Decision|1|||
161194530|NCT04047472|582091719|FG001|Overall Study|Physician Decision|2|||
161194531|NCT04047472|582091718|FG000|Overall Study|Protocol Violation|1|||
161194532|NCT04047472|582091719|FG001|Overall Study|Protocol Violation|0|||
161194533|NCT04047472|582091718|FG000|Overall Study|Withdrawal by Subject|10|||
161194534|NCT04047472|582091719|FG001|Overall Study|Withdrawal by Subject|10|||
161194535|NCT01218477|582091720|FG000|Overall Study|Disease progression|2|||
161194536|NCT01218477|582091721|FG001|Overall Study|Disease progression|3|||
161194537|NCT01218477|582091722|FG002|Overall Study|Disease progression|6|||
161194538|NCT01218477|582091723|FG003|Overall Study|Disease progression|2|||
161194539|NCT01218477|582091720|FG000|Overall Study|Study drug toxicity|0|||
161194540|NCT01218477|582091721|FG001|Overall Study|Study drug toxicity|2|||
161194541|NCT01218477|582091722|FG002|Overall Study|Study drug toxicity|5|||
161194542|NCT01218477|582091723|FG003|Overall Study|Study drug toxicity|0|||
161194543|NCT01218477|582091720|FG000|Overall Study|No longer meets study criteria|1|||
161194544|NCT01218477|582091721|FG001|Overall Study|No longer meets study criteria|0|||
161194545|NCT01218477|582091722|FG002|Overall Study|No longer meets study criteria|0|||
161194546|NCT01218477|582091723|FG003|Overall Study|No longer meets study criteria|0|||
161194547|NCT01218477|582091720|FG000|Overall Study|Withdrawal by Subject|0|||
161194548|NCT01218477|582091721|FG001|Overall Study|Withdrawal by Subject|0|||
161194549|NCT01218477|582091722|FG002|Overall Study|Withdrawal by Subject|1|||
161194550|NCT01218477|582091723|FG003|Overall Study|Withdrawal by Subject|0|||
161194551|NCT01218477|582091720|FG000|Overall Study|Prepared for cell transplantation|0|||
161194552|NCT01218477|582091721|FG001|Overall Study|Prepared for cell transplantation|1|||
161194553|NCT01218477|582091722|FG002|Overall Study|Prepared for cell transplantation|1|||
161194554|NCT01218477|582091723|FG003|Overall Study|Prepared for cell transplantation|0|||
161194555|NCT01218477|582091720|FG000|Overall Study|Administrative reason by sponsor|0|||
161194556|NCT01218477|582091721|FG001|Overall Study|Administrative reason by sponsor|0|||
161194557|NCT01218477|582091722|FG002|Overall Study|Administrative reason by sponsor|1|||
161194558|NCT01218477|582091723|FG003|Overall Study|Administrative reason by sponsor|0|||
161194559|NCT01218477|582091720|FG000|Overall Study|Maximum clinical benefit|0|||
161194560|NCT01218477|582091721|FG001|Overall Study|Maximum clinical benefit|2|||
161194561|NCT01218477|582091722|FG002|Overall Study|Maximum clinical benefit|0|||
161194562|NCT01218477|582091723|FG003|Overall Study|Maximum clinical benefit|0|||
161194563|NCT01303159|582091727|FG000|Overall Study|Death|16|||
161194564|NCT01303159|582091727|FG000|Overall Study|Study Termination|7|||
161306566|NCT02004886|582502860|FG000|Overall Study|Unable to attend future visits|1|||
161306567|NCT02004886|582502861|FG001|Overall Study|Unable to attend future visits|0|||
161306568|NCT02004886|582502862|FG002|Overall Study|Unable to attend future visits|0|||
161306569|NCT02004886|582502863|FG003|Overall Study|Unable to attend future visits|0|||
161306570|NCT05239494|582502864|FG000|Overall Study|Lost to Follow-up|1|||
161306571|NCT02892422|582502865|FG000|Overall Study|Enrolled not treated|4|||
161306572|NCT02892422|582502865|FG000|Overall Study|Adverse Event|38|||
161306573|NCT02892422|582502865|FG000|Overall Study|Lack of Efficacy|32|||
161306574|NCT02892422|582502865|FG000|Overall Study|Non-compliance with study drug|11|||
161194565|NCT01016912|582091730|FG000|End of Treatment Period|Lack of Efficacy|0|||
161194566|NCT01016912|582091731|FG001|End of Treatment Period|Lack of Efficacy|1|||
161194567|NCT01016912|582091732|FG002|End of Treatment Period|Lack of Efficacy|0|||
161194568|NCT01016912|582091733|FG003|End of Treatment Period|Lack of Efficacy|4|||
161194569|NCT01016912|582091734|FG004|End of Treatment Period|Lack of Efficacy|4|||
161194570|NCT01016912|582091730|FG000|End of Treatment Period|Adverse Event|0|||
161194571|NCT01016912|582091731|FG001|End of Treatment Period|Adverse Event|1|||
161194572|NCT01016912|582091732|FG002|End of Treatment Period|Adverse Event|1|||
161194573|NCT01016912|582091733|FG003|End of Treatment Period|Adverse Event|0|||
161306575|NCT02892422|582502865|FG000|Overall Study|Protocol Violation|4|||
161194574|NCT01016912|582091734|FG004|End of Treatment Period|Adverse Event|0|||
161306576|NCT02892422|582502865|FG000|Overall Study|Withdrawal by Subject|56|||
161194575|NCT01016912|582091730|FG000|End of Treatment Period|Completed double-blind period only|0|||
161194576|NCT01016912|582091731|FG001|End of Treatment Period|Completed double-blind period only|1|||
161194577|NCT01016912|582091732|FG002|End of Treatment Period|Completed double-blind period only|0|||
161194578|NCT01016912|582091733|FG003|End of Treatment Period|Completed double-blind period only|0|||
161194579|NCT01016912|582091734|FG004|End of Treatment Period|Completed double-blind period only|0|||
161194580|NCT01016912|582091730|FG000|Follow-up Period|Other reason|0|||
161194581|NCT01016912|582091731|FG001|Follow-up Period|Other reason|0|||
161194582|NCT01016912|582091732|FG002|Follow-up Period|Other reason|1|||
161194583|NCT01016912|582091733|FG003|Follow-up Period|Other reason|1|||
161194584|NCT01016912|582091734|FG004|Follow-up Period|Other reason|0|||
161194585|NCT00496782|582091738|FG000|Overall Study|Protocol Violation|1|||
161194586|NCT00496782|582091739|FG001|Overall Study|Protocol Violation|2|||
161194587|NCT01853397|582091743|FG000|Overall Study|Withdrawal by Subject|0|||
161194588|NCT01853397|582091744|FG001|Overall Study|Withdrawal by Subject|0|||
161194589|NCT01853397|582091745|FG002|Overall Study|Withdrawal by Subject|0|||
161194590|NCT01853397|582091746|FG003|Overall Study|Withdrawal by Subject|1|||
161194591|NCT01853397|582091743|FG000|Overall Study|Subject Noncompliance|0|||
161194592|NCT01853397|582091744|FG001|Overall Study|Subject Noncompliance|0|||
161194593|NCT01853397|582091745|FG002|Overall Study|Subject Noncompliance|0|||
161194594|NCT01853397|582091746|FG003|Overall Study|Subject Noncompliance|1|||
161194595|NCT02132312|582091747|FG000|Overall Study|Adverse Event|2|||
161194596|NCT02132312|582091748|FG001|Overall Study|Adverse Event|0|||
161194597|NCT02132312|582091747|FG000|Overall Study|Physician Decision|1|||
161194598|NCT02132312|582091748|FG001|Overall Study|Physician Decision|1|||
161194599|NCT02132312|582091747|FG000|Overall Study|Protocol Violation|0|||
161194600|NCT02132312|582091748|FG001|Overall Study|Protocol Violation|1|||
161194601|NCT02132312|582091747|FG000|Overall Study|Withdrawal by Subject|1|||
161194602|NCT02132312|582091748|FG001|Overall Study|Withdrawal by Subject|0|||
161194603|NCT02132312|582091747|FG000|Overall Study|Lost to Follow-up|2|||
161194604|NCT02132312|582091748|FG001|Overall Study|Lost to Follow-up|1|||
161194605|NCT01632345|582091749|FG000|Treatment: Part I|Adverse Event|1|||
161194606|NCT01632345|582091750|FG001|Treatment: Part I|Adverse Event|4|||
161194607|NCT01632345|582091751|FG002|Treatment: Part I|Adverse Event|2|||
161194608|NCT01632345|582091752|FG003|Treatment: Part I|Adverse Event|1|||
161194609|NCT01632345|582091753|FG004|Treatment: Part I|Adverse Event|3|||
161194610|NCT01632345|582091754|FG005|Treatment: Part I|Adverse Event|0|||
161194611|NCT01632345|582091755|FG006|Treatment: Part I|Adverse Event|0|||
161194612|NCT01632345|582091749|FG000|Treatment: Part I|Lack of Efficacy|0|||
161194613|NCT01632345|582091750|FG001|Treatment: Part I|Lack of Efficacy|1|||
161194614|NCT01632345|582091751|FG002|Treatment: Part I|Lack of Efficacy|0|||
161194615|NCT01632345|582091752|FG003|Treatment: Part I|Lack of Efficacy|1|||
161194616|NCT01632345|582091753|FG004|Treatment: Part I|Lack of Efficacy|1|||
161194617|NCT01632345|582091754|FG005|Treatment: Part I|Lack of Efficacy|0|||
161194618|NCT01632345|582091755|FG006|Treatment: Part I|Lack of Efficacy|0|||
161194619|NCT01632345|582091749|FG000|Treatment: Part I|Lost to Follow-up|3|||
161194620|NCT01632345|582091750|FG001|Treatment: Part I|Lost to Follow-up|2|||
161194621|NCT01632345|582091751|FG002|Treatment: Part I|Lost to Follow-up|1|||
161194622|NCT01632345|582091752|FG003|Treatment: Part I|Lost to Follow-up|3|||
161194623|NCT01632345|582091753|FG004|Treatment: Part I|Lost to Follow-up|4|||
161194624|NCT01632345|582091754|FG005|Treatment: Part I|Lost to Follow-up|0|||
161194625|NCT01632345|582091755|FG006|Treatment: Part I|Lost to Follow-up|0|||
161194626|NCT01632345|582091749|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
161194627|NCT01632345|582091750|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
161194628|NCT01632345|582091751|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
161194629|NCT01632345|582091752|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
161194630|NCT01632345|582091753|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
161194631|NCT01632345|582091754|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
161306577|NCT02892422|582502865|FG000|Overall Study|Lost to Follow-up|5|||
161306578|NCT02892422|582502865|FG000|Overall Study|sponsor information 16159A results|21|||
161194632|NCT01632345|582091755|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
161194633|NCT01632345|582091749|FG000|Treatment: Part I|Physician Decision|2|||
161194634|NCT01632345|582091750|FG001|Treatment: Part I|Physician Decision|1|||
161194635|NCT01632345|582091751|FG002|Treatment: Part I|Physician Decision|0|||
161194636|NCT01632345|582091752|FG003|Treatment: Part I|Physician Decision|0|||
161194637|NCT01632345|582091753|FG004|Treatment: Part I|Physician Decision|1|||
161194638|NCT01632345|582091754|FG005|Treatment: Part I|Physician Decision|0|||
161194639|NCT01632345|582091755|FG006|Treatment: Part I|Physician Decision|0|||
161194640|NCT01632345|582091749|FG000|Treatment: Part I|Pregnancy|0|||
161194641|NCT01632345|582091750|FG001|Treatment: Part I|Pregnancy|1|||
161194642|NCT01632345|582091751|FG002|Treatment: Part I|Pregnancy|0|||
161194643|NCT01632345|582091752|FG003|Treatment: Part I|Pregnancy|0|||
161194644|NCT01632345|582091753|FG004|Treatment: Part I|Pregnancy|0|||
161194645|NCT01632345|582091754|FG005|Treatment: Part I|Pregnancy|0|||
161194646|NCT01632345|582091755|FG006|Treatment: Part I|Pregnancy|0|||
161194647|NCT01632345|582091749|FG000|Treatment: Part I|Protocol Deviation|0|||
161194648|NCT01632345|582091750|FG001|Treatment: Part I|Protocol Deviation|0|||
161350114|NCT03369704|582666034|FG000|Follow-up Epoch|Lost to Follow-up|1|||
161350115|NCT03369704|582666035|FG001|Follow-up Epoch|Lost to Follow-up|0|||
161350116|NCT04379518|582666038|FG000|Overall Study|Physician Decision|2|||
161350117|NCT04379518|582666039|FG001|Overall Study|Physician Decision|0|||
161350118|NCT04379518|582666040|FG002|Overall Study|Physician Decision|0|||
161350119|NCT04379518|582666041|FG003|Overall Study|Physician Decision|0|||
161350120|NCT04379518|582666042|FG004|Overall Study|Physician Decision|0|||
161350121|NCT04379518|582666038|FG000|Overall Study|Withdrawal by Subject|1|||
161350122|NCT04379518|582666039|FG001|Overall Study|Withdrawal by Subject|0|||
161350123|NCT04379518|582666040|FG002|Overall Study|Withdrawal by Subject|0|||
161350124|NCT04379518|582666041|FG003|Overall Study|Withdrawal by Subject|0|||
161350125|NCT04379518|582666042|FG004|Overall Study|Withdrawal by Subject|0|||
161350126|NCT05666505|582666043|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
161350127|NCT05135000|582666501|FG000|Overall Study|Adverse Event|2|||
161350128|NCT05135000|582666502|FG001|Overall Study|Adverse Event|0|||
161350129|NCT05135000|582666501|FG000|Overall Study|Lost to Follow-up|1|||
161350130|NCT05135000|582666502|FG001|Overall Study|Lost to Follow-up|0|||
161350131|NCT05135000|582666501|FG000|Overall Study|Study Terminated by Sponsor|6|||
161350132|NCT05135000|582666502|FG001|Overall Study|Study Terminated by Sponsor|3|||
161350133|NCT03596645|582666505|FG000|Overall Study|Adverse Event|17|||
161350134|NCT03596645|582666506|FG001|Overall Study|Adverse Event|0|||
161350135|NCT03596645|582666505|FG000|Overall Study|Lack of Efficacy|8|||
161350136|NCT03596645|582666506|FG001|Overall Study|Lack of Efficacy|0|||
161350137|NCT03596645|582666505|FG000|Overall Study|Lost to Follow-up|1|||
161350138|NCT03596645|582666506|FG001|Overall Study|Lost to Follow-up|1|||
161350139|NCT03596645|582666505|FG000|Overall Study|Physician Decision|1|||
161350140|NCT03596645|582666506|FG001|Overall Study|Physician Decision|1|||
161350141|NCT03596645|582666505|FG000|Overall Study|Protocol Violation|1|||
161350142|NCT03596645|582666506|FG001|Overall Study|Protocol Violation|0|||
161350143|NCT03596645|582666505|FG000|Overall Study|Initiated Prohibited Medication|1|||
161350144|NCT03596645|582666506|FG001|Overall Study|Initiated Prohibited Medication|0|||
161350145|NCT03596645|582666505|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
161350146|NCT03596645|582666506|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
161350147|NCT03596645|582666505|FG000|Overall Study|No mucosal healing achieved|1|||
161350148|NCT03596645|582666506|FG001|Overall Study|No mucosal healing achieved|0|||
161350149|NCT03596645|582666505|FG000|Overall Study|Disease progression|1|||
161350150|NCT03596645|582666506|FG001|Overall Study|Disease progression|0|||
161350151|NCT03596645|582666505|FG000|Overall Study|Ongoing|37|||
161350152|NCT03596645|582666506|FG001|Overall Study|Ongoing|12|||
161350153|NCT03596645|582666505|FG000|Overall Study|Randomized but not treated|0|||
161350154|NCT03596645|582666506|FG001|Overall Study|Randomized but not treated|1|||
161350155|NCT04153149|582666867|FG000|Double Blind Period|Death|63|||
161350156|NCT04153149|582666868|FG001|Double Blind Period|Death|49|||
161350157|NCT04153149|582666869|FG002|Double Blind Period|Death|0|||
161350158|NCT04153149|582666870|FG003|Double Blind Period|Death|0|||
161350159|NCT04153149|582666867|FG000|Double Blind Period|Withdrawal by Subject|16|||
161350160|NCT04153149|582666868|FG001|Double Blind Period|Withdrawal by Subject|11|||
161350161|NCT04153149|582666869|FG002|Double Blind Period|Withdrawal by Subject|0|||
161350162|NCT04153149|582666870|FG003|Double Blind Period|Withdrawal by Subject|0|||
161350163|NCT04153149|582666867|FG000|Double Blind Period|Adverse Event|6|||
161350164|NCT04153149|582666868|FG001|Double Blind Period|Adverse Event|2|||
161350165|NCT04153149|582666869|FG002|Double Blind Period|Adverse Event|0|||
161350166|NCT04153149|582666870|FG003|Double Blind Period|Adverse Event|0|||
161350167|NCT04153149|582666867|FG000|Double Blind Period|Lost to Follow-up|2|||
161350168|NCT04153149|582666868|FG001|Double Blind Period|Lost to Follow-up|1|||
161350169|NCT04153149|582666869|FG002|Double Blind Period|Lost to Follow-up|0|||
161350170|NCT04153149|582666870|FG003|Double Blind Period|Lost to Follow-up|0|||
161350171|NCT04153149|582666867|FG000|Double Blind Period|Withdrawal by guardian|0|||
161350172|NCT04153149|582666868|FG001|Double Blind Period|Withdrawal by guardian|2|||
161350173|NCT04153149|582666869|FG002|Double Blind Period|Withdrawal by guardian|0|||
161350174|NCT04153149|582666870|FG003|Double Blind Period|Withdrawal by guardian|0|||
161350175|NCT04153149|582666867|FG000|Double Blind Period|Reason Not Specified|5|||
161350176|NCT04153149|582666868|FG001|Double Blind Period|Reason Not Specified|4|||
161350177|NCT04153149|582666869|FG002|Double Blind Period|Reason Not Specified|0|||
161350178|NCT04153149|582666870|FG003|Double Blind Period|Reason Not Specified|0|||
161350179|NCT04153149|582666867|FG000|Double Blind Period|Physician Decision|2|||
161350180|NCT04153149|582666868|FG001|Double Blind Period|Physician Decision|0|||
161350181|NCT04153149|582666869|FG002|Double Blind Period|Physician Decision|0|||
161350182|NCT04153149|582666870|FG003|Double Blind Period|Physician Decision|0|||
161350183|NCT04153149|582666867|FG000|Open Label Extension Period|Death|0|||
161350184|NCT04153149|582666868|FG001|Open Label Extension Period|Death|0|||
161350185|NCT04153149|582666869|FG002|Open Label Extension Period|Death|7|||
161350186|NCT04153149|582666870|FG003|Open Label Extension Period|Death|3|||
161350187|NCT04153149|582666867|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
161350188|NCT04153149|582666868|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
161350189|NCT04153149|582666869|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
161350190|NCT04153149|582666870|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
161306579|NCT02892422|582502865|FG000|Overall Study|withdrawal of consent|13|||
161306580|NCT02892422|582502865|FG000|Overall Study|exclusion criteria met|3|||
161306581|NCT02892422|582502865|FG000|Overall Study|moving elsewhere|4|||
161306582|NCT02892422|582502865|FG000|Overall Study|non-compliance|10|||
161306583|NCT02892422|582502865|FG000|Overall Study|patient legally incapable|1|||
161306584|NCT02892422|582502865|FG000|Overall Study|patient decision|7|||
161306585|NCT02892422|582502865|FG000|Overall Study|Investigator decision|1|||
161306586|NCT02855359|582502866|FG000|Overall Study|Death|2|||
161306587|NCT02855359|582502867|FG001|Overall Study|Death|2|||
161306588|NCT02855359|582502868|FG002|Overall Study|Death|0|||
161306589|NCT02855359|582502869|FG003|Overall Study|Death|0|||
161306590|NCT02855359|582502866|FG000|Overall Study|Study Termination by Sponsor|9|||
161306591|NCT02855359|582502867|FG001|Overall Study|Study Termination by Sponsor|11|||
161306592|NCT02855359|582502868|FG002|Overall Study|Study Termination by Sponsor|0|||
161306593|NCT02855359|582502869|FG003|Overall Study|Study Termination by Sponsor|0|||
161306594|NCT03155178|582502870|FG000|Overall Study|Did not meet treatment day baseline|7|||
161306595|NCT03155178|582502871|FG001|Overall Study|Did not meet treatment day baseline|7|||
161306596|NCT03155178|582502872|FG002|Overall Study|Did not meet treatment day baseline|7|||
161306597|NCT03155178|582502873|FG003|Overall Study|Did not meet treatment day baseline|7|||
161306598|NCT00759785|582502874|FG000|Overall Study|Participant sample not evaluable|11|||
161306599|NCT00759785|582502875|FG001|Overall Study|Participant sample not evaluable|2|||
161306600|NCT00759785|582502874|FG000|Overall Study|Participant sample lost|0|||
161306601|NCT00759785|582502875|FG001|Overall Study|Participant sample lost|1|||
161306602|NCT00759785|582502874|FG000|Overall Study|Protocol Violation|1|||
161306603|NCT00759785|582502875|FG001|Overall Study|Protocol Violation|0|||
161306604|NCT00759785|582502874|FG000|Overall Study|Physician Decision|0|||
161306605|NCT00759785|582502875|FG001|Overall Study|Physician Decision|1|||
161306606|NCT00759785|582502874|FG000|Overall Study|Withdrawal by Subject|0|||
161306607|NCT00759785|582502875|FG001|Overall Study|Withdrawal by Subject|1|||
161306608|NCT03729570|582502879|FG000|Overall Study|Lost to Follow-up|16|||
161306609|NCT03729570|582502880|FG001|Overall Study|Lost to Follow-up|20|||
161306610|NCT03729570|582502879|FG000|Overall Study|Seroconversion|5|||
161306611|NCT03729570|582502880|FG001|Overall Study|Seroconversion|0|||
161306612|NCT03729570|582502879|FG000|Overall Study|Moved out of the city|1|||
161306613|NCT03729570|582502880|FG001|Overall Study|Moved out of the city|0|||
161306614|NCT03729570|582502879|FG000|Overall Study|Time Conflict|1|||
161306615|NCT03729570|582502880|FG001|Overall Study|Time Conflict|0|||
161306616|NCT03729570|582502879|FG000|Overall Study|Time Commitment|2|||
161306617|NCT03729570|582502880|FG001|Overall Study|Time Commitment|0|||
161306618|NCT03729570|582502879|FG000|Overall Study|Bad Experience|0|||
161306619|NCT03729570|582502880|FG001|Overall Study|Bad Experience|1|||
161306620|NCT03729570|582502879|FG000|Overall Study|No reason provided|2|||
161306621|NCT03729570|582502880|FG001|Overall Study|No reason provided|1|||
161306622|NCT03729570|582502879|FG000|Overall Study|Family Conflict|0|||
161306623|NCT03729570|582502880|FG001|Overall Study|Family Conflict|1|||
161306624|NCT03729570|582502879|FG000|Overall Study|Did not want to continue taking medications|0|||
161306625|NCT03729570|582502880|FG001|Overall Study|Did not want to continue taking medications|1|||
161306626|NCT03729570|582502879|FG000|Overall Study|Found another PrEP provider|1|||
161306627|NCT03729570|582502880|FG001|Overall Study|Found another PrEP provider|0|||
161306628|NCT03729570|582502879|FG000|Overall Study|Did not enjoy being in the control group|0|||
161306629|NCT03729570|582502880|FG001|Overall Study|Did not enjoy being in the control group|1|||
161306630|NCT00631410|582502881|FG000|Overall Study|Adverse Event|1|||
161306631|NCT00631410|582502882|FG001|Overall Study|Adverse Event|3|||
161306632|NCT00631410|582502881|FG000|Overall Study|Objective Progression or Relapse|4|||
161306633|NCT00631410|582502882|FG001|Overall Study|Objective Progression or Relapse|3|||
161306634|NCT00631410|582502881|FG000|Overall Study|Surgery|1|||
161306635|NCT00631410|582502882|FG001|Overall Study|Surgery|0|||
161306636|NCT02858180|582502883|FG000|Overall Study|Lost to Follow-up|0|||
161306637|NCT02858180|582502884|FG001|Overall Study|Lost to Follow-up|2|||
161306638|NCT01054196|582502885|FG000|Overall Study|Physician Decision|0|||
161306639|NCT01054196|582502886|FG001|Overall Study|Physician Decision|0|||
161306640|NCT01054196|582502887|FG002|Overall Study|Physician Decision|0|||
161306641|NCT01054196|582502888|FG003|Overall Study|Physician Decision|1|||
161306642|NCT01054196|582502889|FG004|Overall Study|Physician Decision|0|||
161306643|NCT01054196|582502890|FG005|Overall Study|Physician Decision|0|||
161306644|NCT01054196|582502891|FG006|Overall Study|Physician Decision|1|||
161306645|NCT03843632|582502896|FG000|Overall Study|Withdrawal by Subject|1|||
161306646|NCT03843632|582502897|FG001|Overall Study|Withdrawal by Subject|0|||
161306647|NCT03843632|582502898|FG002|Overall Study|Withdrawal by Subject|0|||
161306648|NCT03843632|582502899|FG003|Overall Study|Withdrawal by Subject|0|||
161306649|NCT01820572|582502900|FG000|Randomization|Not Treated|2|||
161306650|NCT01820572|582502901|FG001|Randomization|Not Treated|1|||
161306651|NCT01820572|582502900|FG000|Treatment Period|Adverse Event|12|||
161306652|NCT01820572|582502901|FG001|Treatment Period|Adverse Event|7|||
161306653|NCT01820572|582502900|FG000|Treatment Period|Death|3|||
161306654|NCT01820572|582502901|FG001|Treatment Period|Death|3|||
161306655|NCT01820572|582502900|FG000|Treatment Period|Lack of Efficacy|1|||
161306656|NCT01820572|582502901|FG001|Treatment Period|Lack of Efficacy|0|||
161350191|NCT04153149|582666867|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161350192|NCT04153149|582666868|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161350193|NCT04153149|582666869|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
161350194|NCT04153149|582666870|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
161350195|NCT04153149|582666867|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
161350196|NCT04153149|582666868|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
161194649|NCT01632345|582091751|FG002|Treatment: Part I|Protocol Deviation|1|||
161194650|NCT01632345|582091752|FG003|Treatment: Part I|Protocol Deviation|1|||
161194651|NCT01632345|582091753|FG004|Treatment: Part I|Protocol Deviation|0|||
161194652|NCT01632345|582091754|FG005|Treatment: Part I|Protocol Deviation|0|||
161194653|NCT01632345|582091755|FG006|Treatment: Part I|Protocol Deviation|0|||
161194654|NCT01632345|582091749|FG000|Treatment: Part I|Withdrawal by Subject|3|||
161194655|NCT01632345|582091750|FG001|Treatment: Part I|Withdrawal by Subject|4|||
161194656|NCT01632345|582091751|FG002|Treatment: Part I|Withdrawal by Subject|4|||
161194657|NCT01632345|582091752|FG003|Treatment: Part I|Withdrawal by Subject|1|||
161194658|NCT01632345|582091753|FG004|Treatment: Part I|Withdrawal by Subject|4|||
161194659|NCT01632345|582091754|FG005|Treatment: Part I|Withdrawal by Subject|0|||
161194660|NCT01632345|582091755|FG006|Treatment: Part I|Withdrawal by Subject|0|||
161194661|NCT01632345|582091749|FG000|Treatment: Part II|Adverse Event|0|||
161194662|NCT01632345|582091750|FG001|Treatment: Part II|Adverse Event|0|||
161194663|NCT01632345|582091751|FG002|Treatment: Part II|Adverse Event|0|||
161194664|NCT01632345|582091752|FG003|Treatment: Part II|Adverse Event|0|||
161194665|NCT01632345|582091753|FG004|Treatment: Part II|Adverse Event|0|||
161194666|NCT01632345|582091754|FG005|Treatment: Part II|Adverse Event|3|||
161194667|NCT01632345|582091755|FG006|Treatment: Part II|Adverse Event|8|||
161194668|NCT01632345|582091749|FG000|Treatment: Part II|Lost to Follow-up|0|||
161194669|NCT01632345|582091750|FG001|Treatment: Part II|Lost to Follow-up|0|||
161194670|NCT01632345|582091751|FG002|Treatment: Part II|Lost to Follow-up|0|||
161194671|NCT01632345|582091752|FG003|Treatment: Part II|Lost to Follow-up|0|||
161194672|NCT01632345|582091753|FG004|Treatment: Part II|Lost to Follow-up|0|||
161194673|NCT01632345|582091754|FG005|Treatment: Part II|Lost to Follow-up|3|||
161194674|NCT01632345|582091755|FG006|Treatment: Part II|Lost to Follow-up|1|||
161194675|NCT01632345|582091749|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
161194676|NCT01632345|582091750|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
161194677|NCT01632345|582091751|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
161194678|NCT01632345|582091752|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
161194679|NCT01632345|582091753|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
161194680|NCT01632345|582091754|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
161194681|NCT01632345|582091755|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
161194682|NCT01632345|582091749|FG000|Treatment: Part II|Withdrawal by Subject|0|||
161194683|NCT01632345|582091750|FG001|Treatment: Part II|Withdrawal by Subject|0|||
161194684|NCT01632345|582091751|FG002|Treatment: Part II|Withdrawal by Subject|0|||
161194685|NCT01632345|582091752|FG003|Treatment: Part II|Withdrawal by Subject|0|||
161194686|NCT01632345|582091753|FG004|Treatment: Part II|Withdrawal by Subject|0|||
161194687|NCT01632345|582091754|FG005|Treatment: Part II|Withdrawal by Subject|2|||
161194688|NCT01632345|582091755|FG006|Treatment: Part II|Withdrawal by Subject|2|||
161194689|NCT00089505|582091756|FG000|Overall Study|Death|4|||
161194690|NCT00089505|582091757|FG001|Overall Study|Death|1|||
161194691|NCT00089505|582091758|FG002|Overall Study|Death|5|||
161194692|NCT00089505|582091759|FG003|Overall Study|Death|8|||
161194693|NCT00089505|582091756|FG000|Overall Study|Withdrawal by Subject|3|||
161194694|NCT00089505|582091757|FG001|Overall Study|Withdrawal by Subject|0|||
161194695|NCT00089505|582091758|FG002|Overall Study|Withdrawal by Subject|6|||
161194696|NCT00089505|582091759|FG003|Overall Study|Withdrawal by Subject|6|||
161194697|NCT00089505|582091756|FG000|Overall Study|Lost to Follow-up|1|||
161194698|NCT00089505|582091757|FG001|Overall Study|Lost to Follow-up|1|||
161194699|NCT00089505|582091758|FG002|Overall Study|Lost to Follow-up|9|||
161194700|NCT00089505|582091759|FG003|Overall Study|Lost to Follow-up|7|||
161194701|NCT00089505|582091756|FG000|Overall Study|Physician Decision|1|||
161194702|NCT00089505|582091757|FG001|Overall Study|Physician Decision|0|||
161194703|NCT00089505|582091758|FG002|Overall Study|Physician Decision|0|||
161194704|NCT00089505|582091759|FG003|Overall Study|Physician Decision|0|||
161194705|NCT00089505|582091756|FG000|Overall Study|Protocol Violation|0|||
161194706|NCT00089505|582091757|FG001|Overall Study|Protocol Violation|0|||
161194707|NCT00089505|582091758|FG002|Overall Study|Protocol Violation|1|||
161194708|NCT00089505|582091759|FG003|Overall Study|Protocol Violation|0|||
161194709|NCT02431559|582091760|FG000|Overall Study|Adverse Event|0|||
161194710|NCT02431559|582091761|FG001|Overall Study|Adverse Event|1|||
161194711|NCT02431559|582091762|FG002|Overall Study|Adverse Event|0|||
161194712|NCT02431559|582091763|FG003|Overall Study|Adverse Event|4|||
161194713|NCT02431559|582091760|FG000|Overall Study|Progressive disease|2|||
161194714|NCT02431559|582091761|FG001|Overall Study|Progressive disease|1|||
161194715|NCT02431559|582091762|FG002|Overall Study|Progressive disease|4|||
161194716|NCT02431559|582091763|FG003|Overall Study|Progressive disease|22|||
161194717|NCT02431559|582091760|FG000|Overall Study|Withdrawal by Subject|0|||
161194718|NCT02431559|582091761|FG001|Overall Study|Withdrawal by Subject|1|||
161194719|NCT02431559|582091762|FG002|Overall Study|Withdrawal by Subject|0|||
161194720|NCT02431559|582091763|FG003|Overall Study|Withdrawal by Subject|4|||
161194721|NCT02431559|582091760|FG000|Overall Study|Physician Decision|0|||
161194722|NCT02431559|582091761|FG001|Overall Study|Physician Decision|0|||
161194723|NCT02431559|582091762|FG002|Overall Study|Physician Decision|0|||
161194724|NCT02431559|582091763|FG003|Overall Study|Physician Decision|1|||
161194725|NCT00302731|582091766|FG000|Overall Study|Lost to Follow-up|1|||
161194726|NCT00302731|582091767|FG001|Overall Study|Lost to Follow-up|2|||
161194727|NCT00302731|582091768|FG002|Overall Study|Lost to Follow-up|0|||
161194728|NCT00302731|582091769|FG003|Overall Study|Lost to Follow-up|0|||
161194729|NCT00302731|582091766|FG000|Overall Study|Adverse Event|0|||
161194730|NCT00302731|582091767|FG001|Overall Study|Adverse Event|2|||
161194731|NCT00302731|582091768|FG002|Overall Study|Adverse Event|2|||
161194732|NCT00302731|582091769|FG003|Overall Study|Adverse Event|0|||
161194733|NCT00302731|582091766|FG000|Overall Study|Withdrawal by Subject|1|||
161194734|NCT00302731|582091767|FG001|Overall Study|Withdrawal by Subject|1|||
161194735|NCT00302731|582091768|FG002|Overall Study|Withdrawal by Subject|0|||
161194736|NCT00302731|582091769|FG003|Overall Study|Withdrawal by Subject|0|||
161194737|NCT00302731|582091766|FG000|Overall Study|Protocol Violation|1|||
161194738|NCT00302731|582091767|FG001|Overall Study|Protocol Violation|0|||
161194739|NCT00302731|582091768|FG002|Overall Study|Protocol Violation|0|||
161194740|NCT00302731|582091769|FG003|Overall Study|Protocol Violation|0|||
161194741|NCT00302731|582091766|FG000|Overall Study|cancer unrelated to study discovered|1|||
161194742|NCT00302731|582091767|FG001|Overall Study|cancer unrelated to study discovered|0|||
161194743|NCT00302731|582091768|FG002|Overall Study|cancer unrelated to study discovered|1|||
161194744|NCT00302731|582091769|FG003|Overall Study|cancer unrelated to study discovered|0|||
161194745|NCT01610752|582091770|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
161194746|NCT01610752|582091771|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
161194747|NCT01610752|582091772|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
161194748|NCT00283062|582091773|FG000|Overall Study|Did not receive any study medication|5|||
161194749|NCT00283062|582091774|FG001|Overall Study|Did not receive any study medication|4|||
161194750|NCT00283062|582091775|FG002|Overall Study|Did not receive any study medication|36|||
161194751|NCT00283062|582091776|FG003|Overall Study|Did not receive any study medication|45|||
161194752|NCT00283062|582091773|FG000|Overall Study|Adverse Event|2|||
161194753|NCT00283062|582091774|FG001|Overall Study|Adverse Event|0|||
161194754|NCT00283062|582091775|FG002|Overall Study|Adverse Event|1|||
161194755|NCT00283062|582091776|FG003|Overall Study|Adverse Event|0|||
161194756|NCT00283062|582091773|FG000|Overall Study|Lost to Follow-up|1|||
161194757|NCT00283062|582091774|FG001|Overall Study|Lost to Follow-up|0|||
161194758|NCT00283062|582091775|FG002|Overall Study|Lost to Follow-up|1|||
161194759|NCT00283062|582091776|FG003|Overall Study|Lost to Follow-up|0|||
161194760|NCT00283062|582091773|FG000|Overall Study|Progressive disease|0|||
161194761|NCT00283062|582091774|FG001|Overall Study|Progressive disease|0|||
161194762|NCT00283062|582091775|FG002|Overall Study|Progressive disease|1|||
161194763|NCT00283062|582091776|FG003|Overall Study|Progressive disease|0|||
161194764|NCT00283062|582091773|FG000|Overall Study|Participant did not wish to continue|3|||
161194765|NCT00283062|582091774|FG001|Overall Study|Participant did not wish to continue|2|||
161194766|NCT00283062|582091775|FG002|Overall Study|Participant did not wish to continue|1|||
161194767|NCT00283062|582091776|FG003|Overall Study|Participant did not wish to continue|0|||
161194768|NCT00283062|582091773|FG000|Overall Study|Undefined|0|||
161194769|NCT00283062|582091774|FG001|Overall Study|Undefined|1|||
161194770|NCT00283062|582091775|FG002|Overall Study|Undefined|1|||
161194771|NCT00283062|582091776|FG003|Overall Study|Undefined|4|||
161194772|NCT00283062|582091773|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
161194773|NCT00283062|582091774|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
161194774|NCT00283062|582091775|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
161194775|NCT00283062|582091776|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
161194776|NCT00252499|582091777|FG000|Overall Study|Lost to Follow-up|1|||
161194777|NCT00252499|582091778|FG001|Overall Study|Lost to Follow-up|0|||
161194778|NCT00252499|582091779|FG002|Overall Study|Lost to Follow-up|0|||
161194779|NCT01535638|582091780|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
161194780|NCT01535638|582091781|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
161194781|NCT01535638|582091782|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
161194782|NCT01535638|582091783|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
161194783|NCT01535638|582091784|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
161194784|NCT01535638|582091785|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
161194785|NCT01535638|582091780|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
161194786|NCT01535638|582091781|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
161194787|NCT01535638|582091782|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
161194788|NCT01535638|582091783|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
161194789|NCT01535638|582091784|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
161194790|NCT01535638|582091785|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
161194791|NCT00827112|582091786|FG000|Overall Study|Adverse Event|2|||
161194792|NCT00827112|582091787|FG001|Overall Study|Adverse Event|0|||
161194793|NCT00827112|582091786|FG000|Overall Study|Lack of Efficacy|2|||
161194794|NCT00827112|582091787|FG001|Overall Study|Lack of Efficacy|0|||
161194795|NCT00827112|582091786|FG000|Overall Study|Lost to Follow-up|3|||
161194796|NCT00827112|582091787|FG001|Overall Study|Lost to Follow-up|2|||
161194797|NCT00827112|582091786|FG000|Overall Study|Pregnancy|0|||
161194798|NCT00827112|582091787|FG001|Overall Study|Pregnancy|1|||
161194799|NCT00827112|582091786|FG000|Overall Study|Protocol Violation|0|||
161194800|NCT00827112|582091787|FG001|Overall Study|Protocol Violation|2|||
161194801|NCT00827112|582091786|FG000|Overall Study|Withdrawal by Subject|2|||
161194802|NCT00827112|582091787|FG001|Overall Study|Withdrawal by Subject|1|||
161194803|NCT00827112|582091786|FG000|Overall Study|Randomized but not treated|5|||
161194804|NCT00827112|582091787|FG001|Overall Study|Randomized but not treated|3|||
161194805|NCT00827112|582091786|FG000|Overall Study|Other|1|||
161194806|NCT00827112|582091787|FG001|Overall Study|Other|3|||
161194807|NCT03529162|582091790|FG000|Overall Study|Lost to Follow-up|2|||
161194808|NCT03529162|582091791|FG001|Overall Study|Lost to Follow-up|2|||
161194809|NCT00784836|582091792|FG000|Overall Study|Early Study Termination|3|||
161194810|NCT02613910|582091793|FG000|Overall Study|Termination of study|1|||
161194811|NCT03077646|582091794|FG000|Overall Study|Lost to Follow-up|29|||
161194812|NCT03077646|582091795|FG001|Overall Study|Lost to Follow-up|30|||
161194813|NCT03077646|582091796|FG002|Overall Study|Lost to Follow-up|31|||
161194814|NCT00765726|582091797|FG000|Overall Study|Withdrawal by Subject|1|||
161194815|NCT00765726|582091797|FG000|Overall Study|Discontinuation of study by sponsor|8|||
161194816|NCT02993731|582091798|FG000|Overall Study|Study Termination|101|||
161194817|NCT02993731|582091799|FG001|Overall Study|Study Termination|105|||
161194818|NCT02545504|582091805|FG000|Overall Study|Death|174|||
161194819|NCT02545504|582091806|FG001|Overall Study|Death|168|||
161194820|NCT02545504|582091805|FG000|Overall Study|Unknown reason|30|||
161194821|NCT02545504|582091806|FG001|Overall Study|Unknown reason|32|||
161194822|NCT02545504|582091805|FG000|Overall Study|Withdrew consent|9|||
161194823|NCT02545504|582091806|FG001|Overall Study|Withdrew consent|11|||
161194824|NCT02545504|582091805|FG000|Overall Study|Investigator's discretion|3|||
161194825|NCT02545504|582091806|FG001|Overall Study|Investigator's discretion|1|||
161194826|NCT02545504|582091805|FG000|Overall Study|Lost to Follow-up|2|||
161194827|NCT02545504|582091806|FG001|Overall Study|Lost to Follow-up|2|||
161194828|NCT01945866|582093666|FG000|Overall Study|Eyes did not complete or were dropped|2|||
161194829|NCT01945866|582093667|FG001|Overall Study|Eyes did not complete or were dropped|0|||
161194830|NCT01018680|582093668|FG000|Overall Study|Adverse Event|23|||
161194831|NCT01018680|582093669|FG001|Overall Study|Adverse Event|40|||
161194832|NCT01018680|582093668|FG000|Overall Study|Withdrawal by Subject|10|||
161194833|NCT01018680|582093669|FG001|Overall Study|Withdrawal by Subject|10|||
161194834|NCT01018680|582093668|FG000|Overall Study|Protocol Violation|5|||
161194835|NCT01018680|582093669|FG001|Overall Study|Protocol Violation|8|||
161194836|NCT01018680|582093668|FG000|Overall Study|Sponsor Decision|6|||
161194837|NCT01018680|582093669|FG001|Overall Study|Sponsor Decision|7|||
161194838|NCT01018680|582093668|FG000|Overall Study|Lack of Efficacy|8|||
161194839|NCT01018680|582093669|FG001|Overall Study|Lack of Efficacy|2|||
161194840|NCT01018680|582093668|FG000|Overall Study|Lost to Follow-up|5|||
161194841|NCT01018680|582093669|FG001|Overall Study|Lost to Follow-up|3|||
161194842|NCT01018680|582093668|FG000|Overall Study|Entry Criteria Not Met|1|||
161194843|NCT01018680|582093669|FG001|Overall Study|Entry Criteria Not Met|4|||
161194844|NCT01018680|582093668|FG000|Overall Study|Physician Decision|3|||
161194845|NCT01018680|582093669|FG001|Overall Study|Physician Decision|1|||
161194846|NCT02930889|582093670|FG000|Overall Study|Lost to Follow-up|2|||
161194847|NCT02930889|582093670|FG000|Overall Study|Withdrawal by Subject|6|||
161194848|NCT02930889|582093670|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
161194849|NCT04398030|582093671|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
161194850|NCT04398030|582093672|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
161194851|NCT04398030|582093671|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
161194852|NCT04398030|582093672|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
161194853|NCT05056311|582093673|FG000|Overall Study|Lost to Follow-up|14|||
161194854|NCT05056311|582093673|FG000|Overall Study|Withdrawal by Subject|1|||
161194855|NCT05056311|582093673|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
161194856|NCT00679042|582093681|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
161194857|NCT00679042|582093681|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
161194858|NCT00679042|582093681|FG000|5-Year Follow Up|Death|1|||
161194859|NCT00679042|582093681|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
161194860|NCT00679042|582093681|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
161194861|NCT00379639|582093682|FG000|Overall Study|Disease Progression|3|||
161194862|NCT00379639|582093683|FG001|Overall Study|Disease Progression|3|||
161194863|NCT00379639|582093684|FG002|Overall Study|Disease Progression|3|||
161194864|NCT00379639|582093685|FG003|Overall Study|Disease Progression|4|||
161194865|NCT00379639|582093686|FG004|Overall Study|Disease Progression|4|||
161350197|NCT04153149|582666869|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
161194866|NCT00379639|582093682|FG000|Overall Study|Physician Decision|0|||
161194867|NCT00379639|582093683|FG001|Overall Study|Physician Decision|2|||
161194868|NCT00379639|582093684|FG002|Overall Study|Physician Decision|1|||
161194869|NCT00379639|582093685|FG003|Overall Study|Physician Decision|1|||
161194870|NCT00379639|582093686|FG004|Overall Study|Physician Decision|0|||
161194871|NCT00379639|582093682|FG000|Overall Study|Symptomatic Deterioration|0|||
161194872|NCT00379639|582093683|FG001|Overall Study|Symptomatic Deterioration|0|||
161194873|NCT00379639|582093684|FG002|Overall Study|Symptomatic Deterioration|1|||
161194874|NCT00379639|582093685|FG003|Overall Study|Symptomatic Deterioration|0|||
161194875|NCT00379639|582093686|FG004|Overall Study|Symptomatic Deterioration|1|||
161194876|NCT00379639|582093682|FG000|Overall Study|Adverse Event|0|||
161194877|NCT00379639|582093683|FG001|Overall Study|Adverse Event|0|||
161194878|NCT00379639|582093684|FG002|Overall Study|Adverse Event|1|||
161194879|NCT00379639|582093685|FG003|Overall Study|Adverse Event|0|||
161194880|NCT00379639|582093686|FG004|Overall Study|Adverse Event|1|||
161194881|NCT00379639|582093682|FG000|Overall Study|Lost to Follow-up|0|||
161194882|NCT00379639|582093683|FG001|Overall Study|Lost to Follow-up|0|||
161194883|NCT00379639|582093684|FG002|Overall Study|Lost to Follow-up|0|||
161194884|NCT00379639|582093685|FG003|Overall Study|Lost to Follow-up|1|||
161194885|NCT00379639|582093686|FG004|Overall Study|Lost to Follow-up|0|||
161194886|NCT00379639|582093682|FG000|Overall Study|Other|0|||
161194887|NCT00379639|582093683|FG001|Overall Study|Other|0|||
161194888|NCT00379639|582093684|FG002|Overall Study|Other|3|||
161194889|NCT00379639|582093685|FG003|Overall Study|Other|0|||
161194890|NCT00379639|582093686|FG004|Overall Study|Other|0|||
161194891|NCT00761735|582093690|FG000|Overall Study|Lost to Follow-up|6|||
161194892|NCT00761735|582093690|FG000|Overall Study|Withdrawal by Subject|6|||
161194893|NCT00761735|582093690|FG000|Overall Study|Non-compliance with protocol|1|||
161194894|NCT00761735|582093690|FG000|Overall Study|Administrative|1|||
161194895|NCT03326323|582093700|FG000|Overall Study|Unable to receive ANH protocol|3|||
161194896|NCT00920582|582093701|FG000|Overall Study|Lost to Follow-up|5|||
161194897|NCT00920582|582093702|FG001|Overall Study|Lost to Follow-up|1|||
161194898|NCT00920582|582093703|FG002|Overall Study|Lost to Follow-up|2|||
161194899|NCT00920582|582093704|FG003|Overall Study|Lost to Follow-up|0|||
161194900|NCT00920582|582093701|FG000|Overall Study|Withdrawal by Subject|5|||
161194901|NCT00920582|582093702|FG001|Overall Study|Withdrawal by Subject|4|||
161194902|NCT00920582|582093703|FG002|Overall Study|Withdrawal by Subject|6|||
161194903|NCT00920582|582093704|FG003|Overall Study|Withdrawal by Subject|3|||
161194904|NCT00920582|582093701|FG000|Overall Study|Protocol Violation|1|||
161194905|NCT00920582|582093702|FG001|Overall Study|Protocol Violation|0|||
161194906|NCT00920582|582093703|FG002|Overall Study|Protocol Violation|0|||
161194907|NCT00920582|582093704|FG003|Overall Study|Protocol Violation|0|||
161194908|NCT00920582|582093701|FG000|Overall Study|Other|2|||
161194909|NCT00920582|582093702|FG001|Overall Study|Other|1|||
161194910|NCT00920582|582093703|FG002|Overall Study|Other|3|||
161194911|NCT00920582|582093704|FG003|Overall Study|Other|2|||
161194912|NCT00851721|582093705|FG000|Overall Study|planned surgery|1|||
161194913|NCT00851721|582093706|FG001|Overall Study|planned surgery|0|||
161194914|NCT00851721|582093705|FG000|Overall Study|Death|1|||
161194915|NCT00851721|582093706|FG001|Overall Study|Death|0|||
161194916|NCT00851721|582093705|FG000|Overall Study|Adverse Event|0|||
161194917|NCT00851721|582093706|FG001|Overall Study|Adverse Event|1|||
161194918|NCT01333501|582093707|FG000|Overall Study|Adverse Event|3|||
161194919|NCT01333501|582093708|FG001|Overall Study|Adverse Event|1|||
161194920|NCT01333501|582093707|FG000|Overall Study|Abnormal laboratory value|2|||
161194921|NCT01333501|582093708|FG001|Overall Study|Abnormal laboratory value|1|||
161194922|NCT01333501|582093707|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
161194923|NCT01333501|582093708|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
161194924|NCT01333501|582093707|FG000|Overall Study|Withdrawn consent|3|||
161194925|NCT01333501|582093708|FG001|Overall Study|Withdrawn consent|12|||
161194926|NCT04034225|582093709|FG000|Overall Study|Death|3|||
161194927|NCT04034225|582093709|FG000|Overall Study|Withdrawal by Subject|2|||
161194928|NCT04034225|582093709|FG000|Overall Study|Study termination by Sponsor|18|||
161194929|NCT04034225|582093709|FG000|Overall Study|Physician Decision|1|||
161194930|NCT04034225|582093709|FG000|Overall Study|Lack of Efficacy|1|||
161194931|NCT00955682|582093710|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
161194932|NCT00955682|582093711|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
161350198|NCT04153149|582666870|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
161350199|NCT04522973|582666871|FG000|Overall Study|Lost to Follow-up|4|||
161350200|NCT04522973|582666871|FG000|Overall Study|Could not adhere to study schedule|1|||
161194933|NCT04246996|582093719|FG000|Overall Study|Physician Decision|1|||
161194934|NCT04246996|582093720|FG001|Overall Study|Physician Decision|1|||
161350201|NCT04007796|582666872|FG000|Overall Study|Exclusion criterion met during the trial|1|||
161194935|NCT04246996|582093719|FG000|Overall Study|Did not meet eligibility criteria|1|||
161194936|NCT04246996|582093720|FG001|Overall Study|Did not meet eligibility criteria|4|||
161194937|NCT01348828|582093722|FG000|Overall Study|Death|20|||
161194938|NCT01348828|582093722|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
161350202|NCT04007796|582666873|FG001|Overall Study|Exclusion criterion met during the trial|1|||
161194939|NCT01348828|582093722|FG000|Overall Study|Conversion|2|||
161194940|NCT01348828|582093722|FG000|Overall Study|missed visit|1|||
161194941|NCT02442284|582093724|FG000|Overall Study|Adverse Event|1|||
161194942|NCT02442284|582093724|FG000|Overall Study|Withdrew Consent|2|||
161194943|NCT02442284|582093724|FG000|Overall Study|Lost to Follow-up|3|||
161194944|NCT02442284|582093724|FG000|Overall Study|Other|1|||
161194945|NCT01365468|582093728|FG000|Overall Study|Physician Decision|1|||
161194946|NCT01365468|582093729|FG001|Overall Study|Physician Decision|0|||
161194947|NCT01365468|582093728|FG000|Overall Study|Disease progression|1|||
161194948|NCT01365468|582093729|FG001|Overall Study|Disease progression|0|||
161194949|NCT01365468|582093728|FG000|Overall Study|Lost to Follow-up|2|||
161194950|NCT01365468|582093729|FG001|Overall Study|Lost to Follow-up|0|||
161194951|NCT01521494|582093732|FG000|Overall Study|Adverse Event|1|||
161194952|NCT01521494|582093733|FG001|Overall Study|Adverse Event|2|||
161194953|NCT01521494|582093734|FG002|Overall Study|Adverse Event|9|||
161194954|NCT01521494|582093735|FG003|Overall Study|Adverse Event|6|||
161194955|NCT01521494|582093736|FG004|Overall Study|Adverse Event|2|||
161194956|NCT01521494|582093732|FG000|Overall Study|Lack of Efficacy|0|||
161194957|NCT01521494|582093733|FG001|Overall Study|Lack of Efficacy|0|||
161194958|NCT01521494|582093734|FG002|Overall Study|Lack of Efficacy|0|||
161194959|NCT01521494|582093735|FG003|Overall Study|Lack of Efficacy|0|||
161194960|NCT01521494|582093736|FG004|Overall Study|Lack of Efficacy|2|||
161194961|NCT01521494|582093732|FG000|Overall Study|Withdrawal by Subject|1|||
161194962|NCT01521494|582093733|FG001|Overall Study|Withdrawal by Subject|1|||
161194963|NCT01521494|582093734|FG002|Overall Study|Withdrawal by Subject|0|||
161194964|NCT01521494|582093735|FG003|Overall Study|Withdrawal by Subject|2|||
161194965|NCT01521494|582093736|FG004|Overall Study|Withdrawal by Subject|0|||
161194966|NCT01521494|582093732|FG000|Overall Study|Decrease in serum phosphate|0|||
161194967|NCT01521494|582093733|FG001|Overall Study|Decrease in serum phosphate|2|||
161194968|NCT01521494|582093734|FG002|Overall Study|Decrease in serum phosphate|3|||
161194969|NCT01521494|582093735|FG003|Overall Study|Decrease in serum phosphate|12|||
161194970|NCT01521494|582093736|FG004|Overall Study|Decrease in serum phosphate|0|||
161194971|NCT01521494|582093732|FG000|Overall Study|Decrease in serum calcium|0|||
161194972|NCT01521494|582093733|FG001|Overall Study|Decrease in serum calcium|0|||
161194973|NCT01521494|582093734|FG002|Overall Study|Decrease in serum calcium|0|||
161194974|NCT01521494|582093735|FG003|Overall Study|Decrease in serum calcium|1|||
161194975|NCT01521494|582093736|FG004|Overall Study|Decrease in serum calcium|1|||
161194976|NCT01521494|582093732|FG000|Overall Study|Physician Decision|0|||
161194977|NCT01521494|582093733|FG001|Overall Study|Physician Decision|0|||
161194978|NCT01521494|582093734|FG002|Overall Study|Physician Decision|0|||
161194979|NCT01521494|582093735|FG003|Overall Study|Physician Decision|0|||
161194980|NCT01521494|582093736|FG004|Overall Study|Physician Decision|2|||
161194981|NCT00877929|582093737|FG000|Overall Study|Adverse Event|11|||
161194982|NCT00877929|582093738|FG001|Overall Study|Adverse Event|20|||
161194983|NCT00877929|582093737|FG000|Overall Study|Protocol Violation|3|||
161194984|NCT00877929|582093738|FG001|Overall Study|Protocol Violation|3|||
161194985|NCT00877929|582093737|FG000|Overall Study|Lost to Follow-up|0|||
161194986|NCT00877929|582093738|FG001|Overall Study|Lost to Follow-up|1|||
161194987|NCT00877929|582093737|FG000|Overall Study|Withdrawal by Subject|4|||
161194988|NCT00877929|582093738|FG001|Overall Study|Withdrawal by Subject|4|||
161194989|NCT00877929|582093737|FG000|Overall Study|Lack of Efficacy|0|||
161194990|NCT00877929|582093738|FG001|Overall Study|Lack of Efficacy|1|||
161194991|NCT00877929|582093737|FG000|Overall Study|Other reason (not specified)|2|||
161194992|NCT00877929|582093738|FG001|Overall Study|Other reason (not specified)|6|||
161194993|NCT01140646|582093739|FG000|Overall Study|Adverse Event|4|||
161194994|NCT01140646|582093739|FG000|Overall Study|Refused Further Treatment|5|||
161194995|NCT00689728|582093743|FG000|Double-Blind Treatment|Adverse Event|1|||
161194996|NCT00689728|582093744|FG001|Double-Blind Treatment|Adverse Event|0|||
161194997|NCT00689728|582093745|FG002|Double-Blind Treatment|Adverse Event|0|||
161194998|NCT00689728|582093743|FG000|Double-Blind Treatment|Protocol Violation|0|||
161194999|NCT00689728|582093744|FG001|Double-Blind Treatment|Protocol Violation|0|||
161195000|NCT00689728|582093745|FG002|Double-Blind Treatment|Protocol Violation|1|||
161195001|NCT00689728|582093743|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
161195002|NCT00689728|582093744|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
161195003|NCT00689728|582093745|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
161195004|NCT00689728|582093743|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
161195005|NCT00689728|582093744|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
161195006|NCT00689728|582093745|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
161195007|NCT00689728|582093743|FG000|Rescue|Adverse Event|0|||
161195008|NCT00689728|582093744|FG001|Rescue|Adverse Event|1|||
161195009|NCT00689728|582093745|FG002|Rescue|Adverse Event|0|||
161195010|NCT00689728|582093743|FG000|Rescue|Withdrawal by Subject|1|||
161195011|NCT00689728|582093744|FG001|Rescue|Withdrawal by Subject|1|||
161195012|NCT00689728|582093745|FG002|Rescue|Withdrawal by Subject|1|||
161195013|NCT00689728|582093743|FG000|Optional Follow-Up|Adverse Event|1|||
161195014|NCT00689728|582093744|FG001|Optional Follow-Up|Adverse Event|0|||
161195015|NCT00689728|582093745|FG002|Optional Follow-Up|Adverse Event|0|||
161195016|NCT00689728|582093743|FG000|Optional Follow-Up|Lack of Efficacy|0|||
161195017|NCT00689728|582093744|FG001|Optional Follow-Up|Lack of Efficacy|1|||
161195018|NCT00689728|582093745|FG002|Optional Follow-Up|Lack of Efficacy|1|||
161195019|NCT00689728|582093743|FG000|Optional Follow-Up|Lost to Follow-up|0|||
161195020|NCT00689728|582093744|FG001|Optional Follow-Up|Lost to Follow-up|1|||
161195021|NCT00689728|582093745|FG002|Optional Follow-Up|Lost to Follow-up|1|||
161090349|NCT03141905|581719970|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
161090350|NCT03141905|581719971|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
161090351|NCT05180500|581719972|FG000|Overall Study|Adverse Event|1|||
161090352|NCT05180500|581719973|FG001|Overall Study|Adverse Event|0|||
161090353|NCT05180500|581719972|FG000|Overall Study|Withdrawal by Subject|2|||
161090354|NCT05180500|581719973|FG001|Overall Study|Withdrawal by Subject|0|||
161090355|NCT04927884|581719978|FG000|Overall Study|Progressive Disease|2|||
161090356|NCT01775124|581719979|FG000|Core Period|Disease Progression|0|||
161090357|NCT01775124|581719980|FG001|Core Period|Disease Progression|1|||
161090358|NCT01775124|581719979|FG000|Core Period|Physician Decision|1|||
161090359|NCT01775124|581719980|FG001|Core Period|Physician Decision|1|||
161090360|NCT01775124|581719979|FG000|Core Period|Death|0|||
161090361|NCT01775124|581719980|FG001|Core Period|Death|1|||
161090362|NCT01775124|581719979|FG000|Core Period|Administrative problems|1|||
161090363|NCT01775124|581719980|FG001|Core Period|Administrative problems|0|||
161090364|NCT01775124|581719979|FG000|Core Period|Withdrawal by Subject|4|||
161090365|NCT01775124|581719980|FG001|Core Period|Withdrawal by Subject|2|||
161090366|NCT01775124|581719979|FG000|Core Period|Adverse Event|5|||
161090367|NCT01775124|581719980|FG001|Core Period|Adverse Event|5|||
161090368|NCT01775124|581719979|FG000|Extension Period|Adverse Event|3|||
161090369|NCT01775124|581719980|FG001|Extension Period|Adverse Event|2|||
161090370|NCT01775124|581719979|FG000|Extension Period|Physician Decision|0|||
161090371|NCT01775124|581719980|FG001|Extension Period|Physician Decision|2|||
161090372|NCT01775124|581719979|FG000|Extension Period|Administrative problems|0|||
161090373|NCT01775124|581719980|FG001|Extension Period|Administrative problems|1|||
161090374|NCT01775124|581719979|FG000|Extension Period|Lost to Follow-up|0|||
161090375|NCT01775124|581719980|FG001|Extension Period|Lost to Follow-up|1|||
161090376|NCT01775124|581719979|FG000|Extension Period|Withdrawal by Subject|9|||
161090377|NCT01775124|581719980|FG001|Extension Period|Withdrawal by Subject|12|||
161090378|NCT00727311|581719981|FG000|Overall Study|Did not receive drug|316|||
161090379|NCT00727311|581719981|FG000|Overall Study|Missing end of therapy data|205|||
161090380|NCT00727311|581719981|FG000|Overall Study|Adverse Event|58|||
161090381|NCT00727311|581719981|FG000|Overall Study|Lack of Efficacy|242|||
161090382|NCT00727311|581719981|FG000|Overall Study|Lost to Follow-up|73|||
161090383|NCT00727311|581719981|FG000|Overall Study|Withdrawal by Subject|77|||
161090384|NCT00727311|581719981|FG000|Overall Study|Other|97|||
161090385|NCT00727311|581719981|FG000|Overall Study|Multiple reasons|39|||
161090386|NCT00031551|581721616|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
161090387|NCT00031551|581721617|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
161090388|NCT01919814|581721620|FG000|Overall Study|Adverse Event|1|||
161090389|NCT01919814|581721621|FG001|Overall Study|Adverse Event|0|||
161090390|NCT01919814|581721620|FG000|Overall Study|Protocol Violation|1|||
161090391|NCT01919814|581721621|FG001|Overall Study|Protocol Violation|0|||
161090392|NCT01919814|581721620|FG000|Overall Study|Withdrawal by Subject|1|||
161090393|NCT01919814|581721621|FG001|Overall Study|Withdrawal by Subject|0|||
161090394|NCT02164383|581721622|FG000|Overall Study|Lost to Follow-up|1|||
161090395|NCT02164383|581721623|FG001|Overall Study|Lost to Follow-up|0|||
161090396|NCT01036763|581721624|FG000|Overall Study|Adverse Event|25|||
161090397|NCT01036763|581721624|FG000|Overall Study|Lost to Follow-up|28|||
161090398|NCT01036763|581721624|FG000|Overall Study|Other reason (not specified)|40|||
161090399|NCT01672723|581721625|FG000|First Intervention|Adverse Event|3|||
161090400|NCT01672723|581721626|FG001|First Intervention|Adverse Event|0|||
161090401|NCT00743275|581721627|FG000|Overall Study|Protocol Violation|0|||
161090402|NCT00743275|581721628|FG001|Overall Study|Protocol Violation|1|||
161090403|NCT01177722|581721634|FG000|Overall Study|Serious Adverse Event|0|||
161090404|NCT01177722|581721635|FG001|Overall Study|Serious Adverse Event|0|||
161090405|NCT01177722|581721636|FG002|Overall Study|Serious Adverse Event|1|||
161090406|NCT01177722|581721637|FG003|Overall Study|Serious Adverse Event|0|||
161090407|NCT01177722|581721634|FG000|Overall Study|Protocol Violation|0|||
161090408|NCT01177722|581721635|FG001|Overall Study|Protocol Violation|0|||
161090409|NCT01177722|581721636|FG002|Overall Study|Protocol Violation|1|||
161090410|NCT01177722|581721637|FG003|Overall Study|Protocol Violation|0|||
161090411|NCT01177722|581721634|FG000|Overall Study|Lost to Follow-up|3|||
161090412|NCT01177722|581721635|FG001|Overall Study|Lost to Follow-up|4|||
161090413|NCT01177722|581721636|FG002|Overall Study|Lost to Follow-up|3|||
161090414|NCT01177722|581721637|FG003|Overall Study|Lost to Follow-up|1|||
161090415|NCT01177722|581721634|FG000|Overall Study|Withdrawal by Subject|10|||
161090416|NCT01177722|581721635|FG001|Overall Study|Withdrawal by Subject|6|||
161090417|NCT01177722|581721636|FG002|Overall Study|Withdrawal by Subject|4|||
161090418|NCT01177722|581721637|FG003|Overall Study|Withdrawal by Subject|6|||
161090419|NCT02831387|581721638|FG000|Overall Study|Withdrawal by Subject|1|||
161090420|NCT02831387|581721639|FG001|Overall Study|Withdrawal by Subject|1|||
161090421|NCT02831387|581721638|FG000|Overall Study|Discontinued due to stock recovery|0|||
161090422|NCT02831387|581721639|FG001|Overall Study|Discontinued due to stock recovery|1|||
161090423|NCT00192647|581721640|FG000|Overall Study|Death|1|||
161090424|NCT00192647|581721641|FG001|Overall Study|Death|1|||
161090425|NCT00192647|581721640|FG000|Overall Study|Adverse Event|35|||
161090426|NCT00192647|581721641|FG001|Overall Study|Adverse Event|29|||
161195022|NCT00689728|582093743|FG000|Optional Follow-Up|Protocol Violation|0|||
161195023|NCT00689728|582093744|FG001|Optional Follow-Up|Protocol Violation|0|||
161195024|NCT00689728|582093745|FG002|Optional Follow-Up|Protocol Violation|1|||
161195025|NCT00689728|582093743|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
161195026|NCT00689728|582093744|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
161195027|NCT00689728|582093745|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
161195028|NCT00842829|582093748|FG000|Dose Titration Period|Adverse Event|11|||
161195029|NCT00842829|582093749|FG001|Dose Titration Period|Adverse Event|10|||
161195030|NCT00842829|582093750|FG002|Dose Titration Period|Adverse Event|0|||
161195031|NCT00842829|582093748|FG000|Dose Titration Period|Lack of Efficacy|4|||
161195032|NCT00842829|582093749|FG001|Dose Titration Period|Lack of Efficacy|1|||
161195033|NCT00842829|582093750|FG002|Dose Titration Period|Lack of Efficacy|0|||
161195034|NCT00842829|582093748|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
161195035|NCT00842829|582093749|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
161195036|NCT00842829|582093750|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
161195037|NCT00842829|582093748|FG000|Dose Titration Period|Withdrawal by Subject|2|||
161195038|NCT00842829|582093749|FG001|Dose Titration Period|Withdrawal by Subject|6|||
161195039|NCT00842829|582093750|FG002|Dose Titration Period|Withdrawal by Subject|0|||
161195040|NCT00842829|582093748|FG000|Dose Titration Period|Other|5|||
161195041|NCT00842829|582093749|FG001|Dose Titration Period|Other|4|||
161195042|NCT00842829|582093750|FG002|Dose Titration Period|Other|0|||
161195043|NCT00842829|582093748|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
161195044|NCT00842829|582093749|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
161195045|NCT00842829|582093750|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
161195046|NCT00842829|582093748|FG000|Dose Titration Period|Non-compliance to study drug|2|||
161195047|NCT00842829|582093749|FG001|Dose Titration Period|Non-compliance to study drug|1|||
161195048|NCT00842829|582093750|FG002|Dose Titration Period|Non-compliance to study drug|0|||
161195049|NCT00842829|582093748|FG000|Treatment Period|Adverse Event|0|||
161195050|NCT00842829|582093749|FG001|Treatment Period|Adverse Event|0|||
161195051|NCT00842829|582093750|FG002|Treatment Period|Adverse Event|15|||
161195052|NCT00842829|582093748|FG000|Treatment Period|Lack of Efficacy|0|||
161195053|NCT00842829|582093749|FG001|Treatment Period|Lack of Efficacy|0|||
161195054|NCT00842829|582093750|FG002|Treatment Period|Lack of Efficacy|6|||
161195055|NCT00842829|582093748|FG000|Treatment Period|Unstable persistent cancer pain|0|||
161195056|NCT00842829|582093749|FG001|Treatment Period|Unstable persistent cancer pain|0|||
161195057|NCT00842829|582093750|FG002|Treatment Period|Unstable persistent cancer pain|5|||
161195058|NCT00842829|582093748|FG000|Treatment Period|Withdrawal by Subject|0|||
161195059|NCT00842829|582093749|FG001|Treatment Period|Withdrawal by Subject|0|||
161195060|NCT00842829|582093750|FG002|Treatment Period|Withdrawal by Subject|11|||
161090427|NCT00192647|581721640|FG000|Overall Study|Laboratory Test Abnormality|4|||
161090428|NCT00192647|581721641|FG001|Overall Study|Laboratory Test Abnormality|2|||
161090429|NCT00192647|581721640|FG000|Overall Study|Insufficient Therapeutic Response|53|||
161090430|NCT00192647|581721641|FG001|Overall Study|Insufficient Therapeutic Response|83|||
161090431|NCT00192647|581721640|FG000|Overall Study|Entry Criteria Violation|6|||
161090432|NCT00192647|581721641|FG001|Overall Study|Entry Criteria Violation|6|||
161090433|NCT00192647|581721640|FG000|Overall Study|Protocol Violation|3|||
161090434|NCT00192647|581721641|FG001|Overall Study|Protocol Violation|1|||
161090435|NCT00192647|581721640|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
161090436|NCT00192647|581721641|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
161090437|NCT00192647|581721640|FG000|Overall Study|Failure to Return|11|||
161090438|NCT00192647|581721641|FG001|Overall Study|Failure to Return|13|||
161090439|NCT00192647|581721640|FG000|Overall Study|Other/Administrative|5|||
161090440|NCT00192647|581721641|FG001|Overall Study|Other/Administrative|3|||
161090441|NCT01828073|581721642|FG000|Overall Study|Lost to Follow-up|1|||
161090442|NCT01828073|581721643|FG001|Overall Study|Lost to Follow-up|2|||
161090443|NCT01201317|581721651|FG000|Overall Study|Withdrawal by Subject|5|||
161090444|NCT01201317|581721652|FG001|Overall Study|Withdrawal by Subject|0|||
161090445|NCT01201317|581721653|FG002|Overall Study|Withdrawal by Subject|3|||
161090446|NCT01201317|581721651|FG000|Overall Study|Adverse Event|2|||
161090447|NCT01201317|581721652|FG001|Overall Study|Adverse Event|2|||
161090448|NCT01201317|581721653|FG002|Overall Study|Adverse Event|2|||
161090449|NCT01201317|581721651|FG000|Overall Study|Screen failure|1|||
161090450|NCT01201317|581721652|FG001|Overall Study|Screen failure|1|||
161090451|NCT01201317|581721653|FG002|Overall Study|Screen failure|0|||
161090452|NCT01201317|581721651|FG000|Overall Study|Protocol Violation|0|||
161090453|NCT01201317|581721652|FG001|Overall Study|Protocol Violation|1|||
161090454|NCT01201317|581721653|FG002|Overall Study|Protocol Violation|1|||
161090455|NCT01201317|581721651|FG000|Overall Study|Death|0|||
161090456|NCT01201317|581721652|FG001|Overall Study|Death|1|||
161090457|NCT01201317|581721653|FG002|Overall Study|Death|0|||
161090458|NCT01201317|581721651|FG000|Overall Study|Study-specific withdrawal criteria|0|||
161090459|NCT01201317|581721652|FG001|Overall Study|Study-specific withdrawal criteria|0|||
161090460|NCT01201317|581721653|FG002|Overall Study|Study-specific withdrawal criteria|1|||
161090461|NCT01201317|581721651|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
161090462|NCT01201317|581721652|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
161195061|NCT00842829|582093748|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
161195062|NCT00842829|582093749|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
161195063|NCT00842829|582093750|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
161195064|NCT00842829|582093748|FG000|Treatment Period|Protocol Violation|0|||
161195065|NCT00842829|582093749|FG001|Treatment Period|Protocol Violation|0|||
161195066|NCT00842829|582093750|FG002|Treatment Period|Protocol Violation|2|||
161195067|NCT00842829|582093748|FG000|Treatment Period|Other|0|||
161195068|NCT00842829|582093749|FG001|Treatment Period|Other|0|||
161195069|NCT00842829|582093750|FG002|Treatment Period|Other|18|||
161195070|NCT00842829|582093748|FG000|Treatment Period|Non-compliance to study procedures|0|||
161195071|NCT00842829|582093749|FG001|Treatment Period|Non-compliance to study procedures|0|||
161195072|NCT00842829|582093750|FG002|Treatment Period|Non-compliance to study procedures|4|||
161195073|NCT00842829|582093748|FG000|Treatment Period|Unclear completion status|0|||
161195074|NCT00842829|582093749|FG001|Treatment Period|Unclear completion status|0|||
161195075|NCT00842829|582093750|FG002|Treatment Period|Unclear completion status|1|||
161195076|NCT00842829|582093748|FG000|Continuation Period|Adverse Event|0|||
161195077|NCT00842829|582093749|FG001|Continuation Period|Adverse Event|0|||
161195078|NCT00842829|582093750|FG002|Continuation Period|Adverse Event|32|||
161195079|NCT00842829|582093748|FG000|Continuation Period|Lack of Efficacy|0|||
161195080|NCT00842829|582093749|FG001|Continuation Period|Lack of Efficacy|0|||
161195081|NCT00842829|582093750|FG002|Continuation Period|Lack of Efficacy|6|||
161195082|NCT00842829|582093748|FG000|Continuation Period|Unstable persistent cancer pain|0|||
161195083|NCT00842829|582093749|FG001|Continuation Period|Unstable persistent cancer pain|0|||
161195084|NCT00842829|582093750|FG002|Continuation Period|Unstable persistent cancer pain|3|||
161195085|NCT00842829|582093748|FG000|Continuation Period|Withdrawal by Subject|0|||
161195086|NCT00842829|582093749|FG001|Continuation Period|Withdrawal by Subject|0|||
161195087|NCT00842829|582093750|FG002|Continuation Period|Withdrawal by Subject|10|||
161195088|NCT00842829|582093748|FG000|Continuation Period|Other|0|||
161195089|NCT00842829|582093749|FG001|Continuation Period|Other|0|||
161195090|NCT00842829|582093750|FG002|Continuation Period|Other|7|||
161195091|NCT00842829|582093748|FG000|Continuation Period|Non-compliance to study procedures|0|||
161195092|NCT00842829|582093749|FG001|Continuation Period|Non-compliance to study procedures|0|||
161195093|NCT00842829|582093750|FG002|Continuation Period|Non-compliance to study procedures|2|||
161195094|NCT00842829|582093748|FG000|Continuation Period|Non-compliance to study drug|0|||
161195095|NCT00842829|582093749|FG001|Continuation Period|Non-compliance to study drug|0|||
161195096|NCT00842829|582093750|FG002|Continuation Period|Non-compliance to study drug|1|||
161195097|NCT00660829|582093756|FG000|Overall Study|Adverse Event|3|||
161195098|NCT00660829|582093757|FG001|Overall Study|Adverse Event|4|||
161195099|NCT00660829|582093756|FG000|Overall Study|Lack of Efficacy|2|||
161195100|NCT00660829|582093757|FG001|Overall Study|Lack of Efficacy|3|||
161195101|NCT00660829|582093756|FG000|Overall Study|Non-Compliance|0|||
161195102|NCT00660829|582093757|FG001|Overall Study|Non-Compliance|4|||
161195103|NCT00660829|582093756|FG000|Overall Study|Withdrawal by Subject|1|||
161195104|NCT00660829|582093757|FG001|Overall Study|Withdrawal by Subject|2|||
161195105|NCT00660829|582093756|FG000|Overall Study|Lost to Follow-up|3|||
161195106|NCT00660829|582093757|FG001|Overall Study|Lost to Follow-up|2|||
161195107|NCT00660829|582093756|FG000|Overall Study|Other|9|||
161195108|NCT00660829|582093757|FG001|Overall Study|Other|4|||
161195109|NCT02127931|582093760|FG000|Overall Study|Glitch in Game|1|||
161195110|NCT03417999|582093761|FG000|Overall Study|Withdrawal by Subject|1|||
161195111|NCT03417999|582093762|FG001|Overall Study|Withdrawal by Subject|0|||
161195112|NCT03417999|582093763|FG002|Overall Study|Withdrawal by Subject|0|||
161195113|NCT03417999|582093761|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
161195114|NCT03417999|582093762|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
161195115|NCT03417999|582093763|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
161195116|NCT03417999|582093761|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
161195117|NCT03417999|582093762|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
161195118|NCT03417999|582093763|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
161195119|NCT03417999|582093761|FG000|Overall Study|Inadequate study staff available to process samples|0|||
161195120|NCT03417999|582093762|FG001|Overall Study|Inadequate study staff available to process samples|0|||
161195121|NCT03417999|582093763|FG002|Overall Study|Inadequate study staff available to process samples|1|||
161306657|NCT01820572|582502900|FG000|Treatment Period|poor/non compliance|0|||
161306658|NCT01820572|582502901|FG001|Treatment Period|poor/non compliance|3|||
161306659|NCT01820572|582502900|FG000|Treatment Period|request to discontinue|6|||
161195122|NCT02612194|582093768|FG000|Overall Study|Death|5|||
161195123|NCT02612194|582093769|FG001|Overall Study|Death|0|||
161195124|NCT02612194|582093770|FG002|Overall Study|Death|2|||
161195125|NCT02612194|582093768|FG000|Overall Study|Early Study Termination|1|||
161195126|NCT02612194|582093769|FG001|Overall Study|Early Study Termination|0|||
161195127|NCT02612194|582093770|FG002|Overall Study|Early Study Termination|0|||
161195128|NCT02539160|582093771|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
161306660|NCT01820572|582502901|FG001|Treatment Period|request to discontinue|11|||
161306661|NCT01820572|582502900|FG000|Treatment Period|No longer meets study criteria|3|||
161195129|NCT02539160|582093772|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
161195130|NCT02539160|582093773|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
161195131|NCT02539160|582093774|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
161195132|NCT02539160|582093771|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
161195133|NCT02539160|582093772|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
161195134|NCT02539160|582093773|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
161195135|NCT02539160|582093774|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
161195136|NCT02539160|582093771|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
161195137|NCT02539160|582093772|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
161195138|NCT02539160|582093773|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
161195139|NCT02539160|582093774|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
161195140|NCT01681004|582093775|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
161195141|NCT01681004|582093776|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
161195142|NCT01681004|582093775|FG000|Study Completion|Lost to Follow-up|8|||
161195143|NCT01681004|582093776|FG001|Study Completion|Lost to Follow-up|3|||
161195144|NCT01681004|582093775|FG000|Study Completion|Physician Decision|1|||
161195145|NCT01681004|582093776|FG001|Study Completion|Physician Decision|3|||
161195146|NCT01681004|582093775|FG000|Study Completion|Site Termination|2|||
161195147|NCT01681004|582093776|FG001|Study Completion|Site Termination|1|||
161195148|NCT01681004|582093775|FG000|Study Completion|Death|1|||
161195149|NCT01681004|582093776|FG001|Study Completion|Death|1|||
161195150|NCT00372905|582093777|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
161195151|NCT00372905|582093778|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161195152|NCT00372905|582093779|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161195153|NCT00372905|582093780|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
161195154|NCT00372905|582093777|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161195155|NCT00372905|582093778|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161195156|NCT00372905|582093779|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
161195157|NCT00372905|582093780|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
161195158|NCT00372905|582093777|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161195159|NCT00372905|582093778|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161195160|NCT00372905|582093779|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
161195161|NCT00372905|582093780|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
161195162|NCT00372905|582093777|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161195163|NCT00372905|582093778|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161195164|NCT00372905|582093779|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
161195165|NCT00372905|582093780|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
161195166|NCT00372905|582093777|FG000|Follow up Until Relapse or Progression|Study closed|0|||
161195167|NCT00372905|582093778|FG001|Follow up Until Relapse or Progression|Study closed|0|||
161195168|NCT00372905|582093779|FG002|Follow up Until Relapse or Progression|Study closed|0|||
161195169|NCT00372905|582093780|FG003|Follow up Until Relapse or Progression|Study closed|3|||
161195170|NCT00372905|582093777|FG000|Follow up Until Relapse or Progression|Other|0|||
161195171|NCT00372905|582093778|FG001|Follow up Until Relapse or Progression|Other|1|||
161195172|NCT00372905|582093779|FG002|Follow up Until Relapse or Progression|Other|0|||
161195173|NCT00372905|582093780|FG003|Follow up Until Relapse or Progression|Other|0|||
161195174|NCT01728454|582093781|FG000|Stage 1 and 2|Pregnancy|1|||
161195175|NCT01728454|582093782|FG001|Stage 1 and 2|Pregnancy|0|||
161195176|NCT01728454|582093783|FG002|Stage 1 and 2|Pregnancy|0|||
161306662|NCT01820572|582502901|FG001|Treatment Period|No longer meets study criteria|10|||
161306663|NCT01820572|582502900|FG000|Treatment Period|withdrew consent|1|||
161306664|NCT01820572|582502901|FG001|Treatment Period|withdrew consent|2|||
161306665|NCT00595517|582502902|FG000|Overall Study|Adverse Event|6|||
161090463|NCT01201317|581721653|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
161090464|NCT01201317|581721651|FG000|Overall Study|Decrease in renal function|0|||
161090465|NCT01201317|581721652|FG001|Overall Study|Decrease in renal function|1|||
161090466|NCT01201317|581721653|FG002|Overall Study|Decrease in renal function|0|||
161090467|NCT01201317|581721651|FG000|Overall Study|Lack of Efficacy|1|||
161090468|NCT01201317|581721652|FG001|Overall Study|Lack of Efficacy|0|||
161090469|NCT01201317|581721653|FG002|Overall Study|Lack of Efficacy|0|||
161090470|NCT01201317|581721651|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
161090471|NCT01201317|581721652|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
161090472|NCT01201317|581721653|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
161090473|NCT00876928|581721655|FG000|Overall Study|Lost to Follow-up|2|||
161090474|NCT00876928|581721656|FG001|Overall Study|Lost to Follow-up|5|||
161090475|NCT00876928|581721655|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
161090476|NCT00876928|581721656|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
161090477|NCT02795429|581721657|FG000|Overall Study|Adverse Event|1|||
161090478|NCT02795429|581721658|FG001|Overall Study|Adverse Event|2|||
161090479|NCT02795429|581721659|FG002|Overall Study|Adverse Event|1|||
161090480|NCT02795429|581721660|FG003|Overall Study|Adverse Event|2|||
161090481|NCT02795429|581721661|FG004|Overall Study|Adverse Event|1|||
161090482|NCT02795429|581721657|FG000|Overall Study|Death|1|||
161090483|NCT02795429|581721658|FG001|Overall Study|Death|0|||
161195177|NCT01728454|582093781|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
161195178|NCT01728454|582093782|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
161195179|NCT01728454|582093783|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
161195180|NCT01728454|582093781|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
161195181|NCT01728454|582093782|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
161195182|NCT01728454|582093783|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
161195183|NCT01728454|582093781|FG000|Stage 1 and 2|Lost to Follow-up|1|||
161195184|NCT01728454|582093782|FG001|Stage 1 and 2|Lost to Follow-up|1|||
161195185|NCT01728454|582093783|FG002|Stage 1 and 2|Lost to Follow-up|0|||
161195186|NCT01728454|582093781|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
161195187|NCT01728454|582093782|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
161195188|NCT01728454|582093783|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
161195189|NCT01728454|582093781|FG000|Stage 3|Reason Missing|0|||
161195190|NCT01728454|582093782|FG001|Stage 3|Reason Missing|0|||
161195191|NCT01728454|582093783|FG002|Stage 3|Reason Missing|1|||
161195192|NCT01728454|582093781|FG000|Stage 3|Subject Required Other Treatment|0|||
161195193|NCT01728454|582093782|FG001|Stage 3|Subject Required Other Treatment|1|||
161195194|NCT01728454|582093783|FG002|Stage 3|Subject Required Other Treatment|0|||
161195195|NCT01728454|582093781|FG000|Stage 3|Pregnancy|1|||
161195196|NCT01728454|582093782|FG001|Stage 3|Pregnancy|0|||
161195197|NCT01728454|582093783|FG002|Stage 3|Pregnancy|0|||
161195198|NCT01728454|582093781|FG000|Stage 3|Withdrew Consent|1|||
161195199|NCT01728454|582093782|FG001|Stage 3|Withdrew Consent|0|||
161195200|NCT01728454|582093783|FG002|Stage 3|Withdrew Consent|1|||
161195201|NCT01728454|582093781|FG000|Stage 3|Non-compliance with Protocol|0|||
161195202|NCT01728454|582093782|FG001|Stage 3|Non-compliance with Protocol|0|||
161195203|NCT01728454|582093783|FG002|Stage 3|Non-compliance with Protocol|1|||
161195204|NCT01728454|582093781|FG000|Stage 3|Lost to Follow-up|0|||
161195205|NCT01728454|582093782|FG001|Stage 3|Lost to Follow-up|3|||
161195206|NCT01728454|582093783|FG002|Stage 3|Lost to Follow-up|1|||
161195207|NCT01728454|582093781|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
161195208|NCT01728454|582093782|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
161195209|NCT01728454|582093783|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
161195210|NCT00689299|582093786|FG000|Overall Study|Adverse Event|2|||
161195211|NCT00689299|582093787|FG001|Overall Study|Adverse Event|1|||
161195212|NCT00689299|582093788|FG002|Overall Study|Adverse Event|1|||
161195213|NCT00689299|582093786|FG000|Overall Study|Lost to Follow-up|0|||
161195214|NCT00689299|582093787|FG001|Overall Study|Lost to Follow-up|1|||
161195215|NCT00689299|582093788|FG002|Overall Study|Lost to Follow-up|1|||
161195216|NCT00689299|582093786|FG000|Overall Study|Withdrawal by Subject|4|||
161195217|NCT00689299|582093787|FG001|Overall Study|Withdrawal by Subject|1|||
161195218|NCT00689299|582093788|FG002|Overall Study|Withdrawal by Subject|3|||
161195219|NCT00689299|582093786|FG000|Overall Study|Protocol Violation|1|||
161195220|NCT00689299|582093787|FG001|Overall Study|Protocol Violation|0|||
161195221|NCT00689299|582093788|FG002|Overall Study|Protocol Violation|0|||
161195222|NCT01190839|582093791|FG000|Overall Study|Adverse Event|32|||
161195223|NCT01190839|582093792|FG001|Overall Study|Adverse Event|41|||
161195224|NCT01190839|582093791|FG000|Overall Study|Protocol Violation|2|||
161195225|NCT01190839|582093792|FG001|Overall Study|Protocol Violation|2|||
161195226|NCT01190839|582093791|FG000|Overall Study|Lost to Follow-up|7|||
161195227|NCT01190839|582093792|FG001|Overall Study|Lost to Follow-up|1|||
161195228|NCT01190839|582093791|FG000|Overall Study|Death|1|||
161195229|NCT01190839|582093792|FG001|Overall Study|Death|0|||
161195230|NCT01190839|582093791|FG000|Overall Study|Trial stopped by Sponsor|71|||
161195231|NCT01190839|582093792|FG001|Overall Study|Trial stopped by Sponsor|68|||
161195232|NCT01190839|582093791|FG000|Overall Study|Undefined|35|||
161195233|NCT01190839|582093792|FG001|Overall Study|Undefined|31|||
161195234|NCT01190839|582093791|FG000|Overall Study|Randomized but not treated|2|||
161195235|NCT01190839|582093792|FG001|Overall Study|Randomized but not treated|4|||
161195236|NCT00695318|582093797|FG000|Overall Study|Lost to Follow-up|1|||
161195237|NCT00695318|582093798|FG001|Overall Study|Lost to Follow-up|0|||
161195238|NCT00695318|582093797|FG000|Overall Study|Withdrawal by Subject|2|||
161195239|NCT00695318|582093798|FG001|Overall Study|Withdrawal by Subject|0|||
161195240|NCT00695318|582093797|FG000|Overall Study|Death|1|||
161195241|NCT00695318|582093798|FG001|Overall Study|Death|1|||
161195242|NCT00695318|582093797|FG000|Overall Study|Study Terminated|1|||
161195243|NCT00695318|582093798|FG001|Overall Study|Study Terminated|0|||
161195244|NCT02058966|582093799|FG000|Open-Label Methamphetamine|Adverse Event|1|||
161195245|NCT02058966|582093799|FG000|First Intervention|Withdrawal by Subject|1|||
161195246|NCT01265511|582093800|FG000|Overall Study|Lack of Efficacy|2|||
161195247|NCT01265511|582093801|FG001|Overall Study|Lack of Efficacy|1|||
161195248|NCT01265511|582093800|FG000|Overall Study|Met stopping rules|0|||
161195249|NCT01265511|582093801|FG001|Overall Study|Met stopping rules|2|||
161195250|NCT01362062|582093802|FG000|Overall Study|Adverse Event|1|||
161195251|NCT01362062|582093803|FG001|Overall Study|Adverse Event|0|||
161195252|NCT01362062|582093802|FG000|Overall Study|Lost to Follow-up|11|||
161195253|NCT01362062|582093803|FG001|Overall Study|Lost to Follow-up|0|||
161195254|NCT01362062|582093802|FG000|Overall Study|Withdrawal by Subject|2|||
161195255|NCT01362062|582093803|FG001|Overall Study|Withdrawal by Subject|0|||
161195256|NCT01362062|582093802|FG000|Overall Study|Non-compliant participant|2|||
161195257|NCT01362062|582093803|FG001|Overall Study|Non-compliant participant|0|||
161195258|NCT01362062|582093802|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
161195259|NCT01362062|582093803|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
161195260|NCT01362062|582093802|FG000|Overall Study|Had significant improvement|9|||
161195261|NCT01362062|582093803|FG001|Overall Study|Had significant improvement|0|||
161195262|NCT00434876|582093804|FG000|Overall Study|Lost to Follow-up|1|||
161195263|NCT00434876|582093805|FG001|Overall Study|Lost to Follow-up|1|||
161195264|NCT00758394|582093806|FG000|2nd Intervention Order|Lost to Follow-up|0|||
161195265|NCT00758394|582093807|FG001|2nd Intervention Order|Lost to Follow-up|1|||
161195266|NCT00758394|582093808|FG002|2nd Intervention Order|Lost to Follow-up|0|||
161195267|NCT00758394|582093809|FG003|2nd Intervention Order|Lost to Follow-up|0|||
161195268|NCT00758394|582093806|FG000|3rd Intervention|Lost to Follow-up|1|||
161195269|NCT00758394|582093807|FG001|3rd Intervention|Lost to Follow-up|0|||
161195270|NCT00758394|582093808|FG002|3rd Intervention|Lost to Follow-up|0|||
161195271|NCT00758394|582093809|FG003|3rd Intervention|Lost to Follow-up|1|||
161195272|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
161195273|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
161195274|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
161195275|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
161195276|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
161195277|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
161195278|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
161195279|NCT00950755|582093813|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
161195280|NCT00950755|582093813|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
161195281|NCT00950755|582093813|FG000|Long-Term Follow-Up|Death|8|||
161195282|NCT00508820|582093814|FG000|Overall Study|Adverse Event|6|||
161195283|NCT00508820|582093815|FG001|Overall Study|Adverse Event|10|||
161195284|NCT00508820|582093814|FG000|Overall Study|Death|6|||
161195285|NCT00508820|582093815|FG001|Overall Study|Death|8|||
161195286|NCT00508820|582093814|FG000|Overall Study|Lost to Follow-up|1|||
161195287|NCT00508820|582093815|FG001|Overall Study|Lost to Follow-up|1|||
161195288|NCT00508820|582093814|FG000|Overall Study|Physician Decision|8|||
161195289|NCT00508820|582093815|FG001|Overall Study|Physician Decision|2|||
161195290|NCT00508820|582093814|FG000|Overall Study|Pregnancy|0|||
161195291|NCT00508820|582093815|FG001|Overall Study|Pregnancy|2|||
161195292|NCT00508820|582093814|FG000|Overall Study|Protocol Violation|2|||
161195293|NCT00508820|582093815|FG001|Overall Study|Protocol Violation|0|||
161195294|NCT00508820|582093814|FG000|Overall Study|Withdrawal by Subject|10|||
161195295|NCT00508820|582093815|FG001|Overall Study|Withdrawal by Subject|12|||
161195296|NCT00508820|582093814|FG000|Overall Study|Other|11|||
161195297|NCT00508820|582093815|FG001|Overall Study|Other|2|||
161195298|NCT00508820|582093814|FG000|Overall Study|Noncompliance|1|||
161195299|NCT00508820|582093815|FG001|Overall Study|Noncompliance|0|||
161195300|NCT00508820|582093814|FG000|Overall Study|Requirement for alternative therapy|7|||
161195301|NCT00508820|582093815|FG001|Overall Study|Requirement for alternative therapy|15|||
161195302|NCT00508820|582093814|FG000|Overall Study|Protocol-specified Criteria|3|||
161195303|NCT00508820|582093815|FG001|Overall Study|Protocol-specified Criteria|12|||
161195304|NCT02926833|582095305|FG000|Overall Study|Death|1|||
161195305|NCT02926833|582095306|FG001|Overall Study|Death|1|||
161195306|NCT02926833|582095307|FG002|Overall Study|Death|2|||
161195307|NCT02926833|582095308|FG003|Overall Study|Death|13|||
161195308|NCT02926833|582095305|FG000|Overall Study|Lost to Follow-up|1|||
161195309|NCT02926833|582095306|FG001|Overall Study|Lost to Follow-up|2|||
161195310|NCT02926833|582095307|FG002|Overall Study|Lost to Follow-up|0|||
161195311|NCT02926833|582095308|FG003|Overall Study|Lost to Follow-up|3|||
161195312|NCT02926833|582095305|FG000|Overall Study|Full Consent Withdrawal|0|||
161195313|NCT02926833|582095306|FG001|Overall Study|Full Consent Withdrawal|0|||
161350203|NCT04007796|582666872|FG000|Overall Study|Withdrawal by Subject|1|||
161350204|NCT04007796|582666873|FG001|Overall Study|Withdrawal by Subject|0|||
161350205|NCT03573401|582666874|FG000|Overall Study|Withdrawal by Subject|2|||
161350206|NCT03573401|582666875|FG001|Overall Study|Withdrawal by Subject|0|||
161350207|NCT03573401|582666874|FG000|Overall Study|Subject non-compliance with study schedule|1|||
161350208|NCT03573401|582666875|FG001|Overall Study|Subject non-compliance with study schedule|0|||
161195314|NCT02926833|582095307|FG002|Overall Study|Full Consent Withdrawal|0|||
161195315|NCT02926833|582095308|FG003|Overall Study|Full Consent Withdrawal|2|||
161195316|NCT02926833|582095305|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
161195317|NCT02926833|582095306|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
161195318|NCT02926833|582095307|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
161195319|NCT02926833|582095308|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
161195320|NCT02926833|582095305|FG000|Overall Study|Investigator Decision|0|||
161195321|NCT02926833|582095306|FG001|Overall Study|Investigator Decision|1|||
161195322|NCT02926833|582095307|FG002|Overall Study|Investigator Decision|0|||
161195323|NCT02926833|582095308|FG003|Overall Study|Investigator Decision|0|||
161195324|NCT02926833|582095305|FG000|Overall Study|Adverse Event|0|||
161195325|NCT02926833|582095306|FG001|Overall Study|Adverse Event|0|||
161195326|NCT02926833|582095307|FG002|Overall Study|Adverse Event|1|||
161195327|NCT02926833|582095308|FG003|Overall Study|Adverse Event|0|||
161195328|NCT02926833|582095305|FG000|Overall Study|Partial Withdrawal of Consent|0|||
161195329|NCT02926833|582095306|FG001|Overall Study|Partial Withdrawal of Consent|0|||
161195330|NCT02926833|582095307|FG002|Overall Study|Partial Withdrawal of Consent|0|||
161195331|NCT02926833|582095308|FG003|Overall Study|Partial Withdrawal of Consent|1|||
161195332|NCT01004822|582095309|FG000|Overall Study|Objective progression or relapse|3|||
161195333|NCT01004822|582095310|FG001|Overall Study|Objective progression or relapse|3|||
161195334|NCT01004822|582095311|FG002|Overall Study|Objective progression or relapse|0|||
161195335|NCT01004822|582095312|FG003|Overall Study|Objective progression or relapse|1|||
161195336|NCT01004822|582095313|FG004|Overall Study|Objective progression or relapse|2|||
161195337|NCT01004822|582095314|FG005|Overall Study|Objective progression or relapse|2|||
161195338|NCT01004822|582095315|FG006|Overall Study|Objective progression or relapse|1|||
161195339|NCT01004822|582095316|FG007|Overall Study|Objective progression or relapse|4|||
161195340|NCT01004822|582095309|FG000|Overall Study|Global deterioration of health status|0|||
161195341|NCT01004822|582095310|FG001|Overall Study|Global deterioration of health status|0|||
161195342|NCT01004822|582095311|FG002|Overall Study|Global deterioration of health status|0|||
161195343|NCT01004822|582095312|FG003|Overall Study|Global deterioration of health status|1|||
161195344|NCT01004822|582095313|FG004|Overall Study|Global deterioration of health status|0|||
161195345|NCT01004822|582095314|FG005|Overall Study|Global deterioration of health status|0|||
161195346|NCT01004822|582095315|FG006|Overall Study|Global deterioration of health status|1|||
161195347|NCT01004822|582095316|FG007|Overall Study|Global deterioration of health status|0|||
161195348|NCT01004822|582095309|FG000|Overall Study|No longer willing to continue|0|||
161195349|NCT01004822|582095310|FG001|Overall Study|No longer willing to continue|0|||
161195350|NCT01004822|582095311|FG002|Overall Study|No longer willing to continue|0|||
161195351|NCT01004822|582095312|FG003|Overall Study|No longer willing to continue|1|||
161195352|NCT01004822|582095313|FG004|Overall Study|No longer willing to continue|2|||
161195353|NCT01004822|582095314|FG005|Overall Study|No longer willing to continue|1|||
161195354|NCT01004822|582095315|FG006|Overall Study|No longer willing to continue|1|||
161195355|NCT01004822|582095316|FG007|Overall Study|No longer willing to continue|0|||
161195356|NCT01004822|582095309|FG000|Overall Study|Adverse Event|0|||
161195357|NCT01004822|582095310|FG001|Overall Study|Adverse Event|0|||
161195358|NCT01004822|582095311|FG002|Overall Study|Adverse Event|0|||
161195359|NCT01004822|582095312|FG003|Overall Study|Adverse Event|0|||
161195360|NCT01004822|582095313|FG004|Overall Study|Adverse Event|0|||
161195361|NCT01004822|582095314|FG005|Overall Study|Adverse Event|0|||
161195362|NCT01004822|582095315|FG006|Overall Study|Adverse Event|1|||
161195363|NCT01004822|582095316|FG007|Overall Study|Adverse Event|1|||
161195364|NCT01004822|582095309|FG000|Overall Study|Other|0|||
161195365|NCT01004822|582095310|FG001|Overall Study|Other|0|||
161195366|NCT01004822|582095311|FG002|Overall Study|Other|4|||
161195367|NCT01004822|582095312|FG003|Overall Study|Other|1|||
161195368|NCT01004822|582095313|FG004|Overall Study|Other|0|||
161195369|NCT01004822|582095314|FG005|Overall Study|Other|1|||
161195370|NCT01004822|582095315|FG006|Overall Study|Other|0|||
161195371|NCT01004822|582095316|FG007|Overall Study|Other|0|||
161195372|NCT03159455|582095319|FG000|Overall Study|Adverse Event|0|||
161195373|NCT03159455|582095320|FG001|Overall Study|Adverse Event|0|||
161195374|NCT03159455|582095321|FG002|Overall Study|Adverse Event|0|||
161195375|NCT03159455|582095322|FG003|Overall Study|Adverse Event|0|||
161195376|NCT03159455|582095323|FG004|Overall Study|Adverse Event|0|||
161195377|NCT03159455|582095324|FG005|Overall Study|Adverse Event|1|||
161195378|NCT03799198|582095330|FG000|Overall Study|Lost to Follow-up|4|||
161195379|NCT03799198|582095331|FG001|Overall Study|Lost to Follow-up|8|||
161195380|NCT03799198|582095330|FG000|Overall Study|Death|0|||
161195381|NCT03799198|582095331|FG001|Overall Study|Death|1|||
161195382|NCT00960869|582095333|FG000|Overall Study|Adverse Event|17|||
161195383|NCT00960869|582095334|FG001|Overall Study|Adverse Event|26|||
161195384|NCT00960869|582095333|FG000|Overall Study|Withdrawal by Subject|16|||
161195385|NCT00960869|582095334|FG001|Overall Study|Withdrawal by Subject|14|||
161195386|NCT00960869|582095333|FG000|Overall Study|Lost to Follow-up|1|||
161195387|NCT00960869|582095334|FG001|Overall Study|Lost to Follow-up|4|||
161195388|NCT00960869|582095333|FG000|Overall Study|Misc|19|||
161195389|NCT00960869|582095334|FG001|Overall Study|Misc|18|||
161195390|NCT02501642|582095335|FG000|Overall Study|Lost to Follow-up|7|||
161195391|NCT02501642|582095336|FG001|Overall Study|Lost to Follow-up|11|||
161195392|NCT01153971|582095340|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
161195393|NCT01153971|582095340|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
161195394|NCT01153971|582095340|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
161195395|NCT01153971|582095340|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
161195396|NCT01153971|582095340|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
161195397|NCT01153971|582095340|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
161195398|NCT01153971|582095340|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
161195399|NCT03410693|582095341|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
161195400|NCT03410693|582095342|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
161195401|NCT03410693|582095341|FG000|Overall Study|Disc trt: Lost to follow up|0|||
161195402|NCT03410693|582095342|FG001|Overall Study|Disc trt: Lost to follow up|1|||
161195403|NCT03410693|582095341|FG000|Overall Study|Disc trt: radiological progression|58|||
161195404|NCT03410693|582095342|FG001|Overall Study|Disc trt: radiological progression|50|||
161195405|NCT03410693|582095341|FG000|Overall Study|Disc trt: Other|1|||
161195406|NCT03410693|582095342|FG001|Overall Study|Disc trt: Other|0|||
161195407|NCT03410693|582095341|FG000|Overall Study|Study drug never administered|1|||
161195408|NCT03410693|582095342|FG001|Overall Study|Study drug never administered|6|||
161195409|NCT03410693|582095341|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
161195410|NCT03410693|582095342|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
161195411|NCT03410693|582095341|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
161195412|NCT03410693|582095342|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
161195413|NCT03410693|582095341|FG000|Overall Study|Disc trt: Physician decision|0|||
161195414|NCT03410693|582095342|FG001|Overall Study|Disc trt: Physician decision|5|||
161195415|NCT03410693|582095341|FG000|Overall Study|Disc trt: clinical progression|1|||
161195416|NCT03410693|582095342|FG001|Overall Study|Disc trt: clinical progression|5|||
161195417|NCT03410693|582095341|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
161195418|NCT03410693|582095342|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
161195419|NCT00953576|582095343|FG000|Overall Study|Adverse Event|0|||
161195420|NCT00953576|582095344|FG001|Overall Study|Adverse Event|1|||
161195421|NCT00953576|582095343|FG000|Overall Study|Ineligible after Consent|2|||
161195422|NCT00953576|582095344|FG001|Overall Study|Ineligible after Consent|0|||
161195423|NCT00501969|582095345|FG000|Overall Study|Major Protocol Violation|4|||
161195424|NCT00501969|582095345|FG000|Overall Study|Lack of Efficacy|29|||
161195425|NCT00501969|582095345|FG000|Overall Study|Adverse Event|76|||
161195426|NCT00501969|582095345|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
161195427|NCT00501969|582095345|FG000|Overall Study|Subject withdrew consent|51|||
161195428|NCT00501969|582095345|FG000|Overall Study|Lost to Follow-up|4|||
161195429|NCT00501969|582095345|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
161195430|NCT00501969|582095345|FG000|Overall Study|Other: Sponsors Request|10|||
161195431|NCT00501969|582095345|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
161195432|NCT00501969|582095345|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
161195433|NCT00501969|582095345|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
161195434|NCT00501969|582095345|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
161195435|NCT00501969|582095345|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
161195436|NCT00501969|582095345|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
161195437|NCT00501969|582095345|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
161195438|NCT00501969|582095345|FG000|Overall Study|Other: As Required by Local EC|2|||
161195439|NCT00501969|582095345|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
161195440|NCT00501969|582095345|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
161195441|NCT00665366|582095346|FG000|Overall Study|Lack of Efficacy|11|||
161195442|NCT00665366|582095347|FG001|Overall Study|Lack of Efficacy|10|||
161195443|NCT00665366|582095346|FG000|Overall Study|Adverse Event|25|||
161195444|NCT00665366|582095347|FG001|Overall Study|Adverse Event|23|||
161195445|NCT00665366|582095346|FG000|Overall Study|Withdrawal by Subject|11|||
161195446|NCT00665366|582095347|FG001|Overall Study|Withdrawal by Subject|14|||
161195447|NCT00665366|582095346|FG000|Overall Study|Lost to Follow-up|3|||
161195448|NCT00665366|582095347|FG001|Overall Study|Lost to Follow-up|5|||
161195449|NCT00665366|582095346|FG000|Overall Study|Poor compliance/noncompliance|3|||
161195450|NCT00665366|582095347|FG001|Overall Study|Poor compliance/noncompliance|5|||
161195451|NCT00665366|582095346|FG000|Overall Study|Pregnancy|1|||
161195452|NCT00665366|582095347|FG001|Overall Study|Pregnancy|0|||
161195453|NCT00665366|582095346|FG000|Overall Study|No longer meets study criteria|0|||
161195454|NCT00665366|582095347|FG001|Overall Study|No longer meets study criteria|1|||
161195455|NCT00665366|582095346|FG000|Overall Study|Other reasons|4|||
161195456|NCT00665366|582095347|FG001|Overall Study|Other reasons|1|||
161195457|NCT03628781|582095348|FG000|Overall Study|Lost to Follow-up|16|||
161195458|NCT03628781|582095349|FG001|Overall Study|Lost to Follow-up|8|||
161195459|NCT03628781|582095348|FG000|Overall Study|Withdrawal by Subject|16|||
161195460|NCT03628781|582095349|FG001|Overall Study|Withdrawal by Subject|1|||
161195461|NCT03778021|582095350|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
161195462|NCT03778021|582095351|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
161195463|NCT02687815|582095352|FG000|Overall Study|Lost to Follow-up|2|||
161195464|NCT02687815|582095353|FG001|Overall Study|Lost to Follow-up|4|||
161195465|NCT02687815|582095352|FG000|Overall Study|Withdrawal by Subject|2|||
161195466|NCT02687815|582095353|FG001|Overall Study|Withdrawal by Subject|4|||
161195467|NCT01238861|582095360|FG000|Overall Study|Lost to Follow-up|4|||
161195468|NCT01238861|582095361|FG001|Overall Study|Lost to Follow-up|2|||
161195469|NCT01238861|582095362|FG002|Overall Study|Lost to Follow-up|3|||
161195470|NCT01238861|582095363|FG003|Overall Study|Lost to Follow-up|1|||
161195471|NCT01238861|582095364|FG004|Overall Study|Lost to Follow-up|1|||
161195472|NCT01238861|582095365|FG005|Overall Study|Lost to Follow-up|2|||
161195473|NCT01238861|582095360|FG000|Overall Study|Unplanned surgery|1|||
161195474|NCT01238861|582095361|FG001|Overall Study|Unplanned surgery|0|||
161195475|NCT01238861|582095362|FG002|Overall Study|Unplanned surgery|0|||
161195476|NCT01238861|582095363|FG003|Overall Study|Unplanned surgery|0|||
161195477|NCT01238861|582095364|FG004|Overall Study|Unplanned surgery|0|||
161195478|NCT01238861|582095365|FG005|Overall Study|Unplanned surgery|0|||
161195479|NCT01238861|582095360|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161195480|NCT01238861|582095361|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161195481|NCT01238861|582095362|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161195482|NCT01238861|582095363|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
161195483|NCT01238861|582095364|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161195484|NCT01238861|582095365|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
161195485|NCT01238861|582095360|FG000|Overall Study|Incorrect enrollment/randomization|0|||
161195486|NCT01238861|582095361|FG001|Overall Study|Incorrect enrollment/randomization|0|||
161195487|NCT01238861|582095362|FG002|Overall Study|Incorrect enrollment/randomization|1|||
161195488|NCT01238861|582095363|FG003|Overall Study|Incorrect enrollment/randomization|0|||
161195489|NCT01238861|582095364|FG004|Overall Study|Incorrect enrollment/randomization|1|||
161195490|NCT01238861|582095365|FG005|Overall Study|Incorrect enrollment/randomization|0|||
161195491|NCT01238861|582095360|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
161195492|NCT01238861|582095361|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
161195493|NCT01238861|582095362|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
161195494|NCT01238861|582095363|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
161195495|NCT01238861|582095364|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
161195496|NCT01238861|582095365|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
161195497|NCT01238861|582095360|FG000|Overall Study|Subject moved out of state/area|0|||
161195498|NCT01238861|582095361|FG001|Overall Study|Subject moved out of state/area|0|||
161195499|NCT01238861|582095362|FG002|Overall Study|Subject moved out of state/area|1|||
161195500|NCT01238861|582095363|FG003|Overall Study|Subject moved out of state/area|1|||
161195501|NCT01238861|582095364|FG004|Overall Study|Subject moved out of state/area|0|||
161195502|NCT01238861|582095365|FG005|Overall Study|Subject moved out of state/area|0|||
161195503|NCT01238861|582095360|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
161195504|NCT01238861|582095361|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
161195505|NCT01238861|582095362|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
161195506|NCT01238861|582095363|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
161195507|NCT01238861|582095364|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
161195508|NCT01238861|582095365|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
161195509|NCT01238861|582095360|FG000|Overall Study|Personal problems|0|||
161195510|NCT01238861|582095361|FG001|Overall Study|Personal problems|0|||
161195511|NCT01238861|582095362|FG002|Overall Study|Personal problems|0|||
161195512|NCT01238861|582095363|FG003|Overall Study|Personal problems|1|||
161195513|NCT01238861|582095364|FG004|Overall Study|Personal problems|0|||
161195514|NCT01238861|582095365|FG005|Overall Study|Personal problems|0|||
161195515|NCT01238861|582095360|FG000|Overall Study|Unable to continue visits|0|||
161195516|NCT01238861|582095361|FG001|Overall Study|Unable to continue visits|0|||
161195517|NCT01238861|582095362|FG002|Overall Study|Unable to continue visits|0|||
161195518|NCT01238861|582095363|FG003|Overall Study|Unable to continue visits|1|||
161195519|NCT01238861|582095364|FG004|Overall Study|Unable to continue visits|0|||
161195520|NCT01238861|582095365|FG005|Overall Study|Unable to continue visits|1|||
161195521|NCT01238861|582095360|FG000|Overall Study|Serious adverse event|0|||
161195522|NCT01238861|582095361|FG001|Overall Study|Serious adverse event|0|||
161195523|NCT01238861|582095362|FG002|Overall Study|Serious adverse event|0|||
161195524|NCT01238861|582095363|FG003|Overall Study|Serious adverse event|0|||
161195525|NCT01238861|582095364|FG004|Overall Study|Serious adverse event|0|||
161195526|NCT01238861|582095365|FG005|Overall Study|Serious adverse event|1|||
161195527|NCT01238861|582095360|FG000|Overall Study|Lack of compliance|0|||
161195528|NCT01238861|582095361|FG001|Overall Study|Lack of compliance|0|||
161195529|NCT01238861|582095362|FG002|Overall Study|Lack of compliance|0|||
161195530|NCT01238861|582095363|FG003|Overall Study|Lack of compliance|0|||
161195531|NCT01238861|582095364|FG004|Overall Study|Lack of compliance|0|||
161195532|NCT01238861|582095365|FG005|Overall Study|Lack of compliance|1|||
161195533|NCT01238861|582095360|FG000|Overall Study|Adverse Event|0|||
161350209|NCT03573401|582666874|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
161350210|NCT03573401|582666875|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
161350211|NCT03573401|582666874|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
161350212|NCT03573401|582666875|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
161195534|NCT01238861|582095361|FG001|Overall Study|Adverse Event|1|||
161195535|NCT01238861|582095362|FG002|Overall Study|Adverse Event|0|||
161195536|NCT01238861|582095363|FG003|Overall Study|Adverse Event|0|||
161195537|NCT01238861|582095364|FG004|Overall Study|Adverse Event|0|||
161195538|NCT01238861|582095365|FG005|Overall Study|Adverse Event|0|||
161195539|NCT01238861|582095360|FG000|Overall Study|Withdrawal by Subject|6|||
161195540|NCT01238861|582095361|FG001|Overall Study|Withdrawal by Subject|5|||
161195541|NCT01238861|582095362|FG002|Overall Study|Withdrawal by Subject|4|||
161195542|NCT01238861|582095363|FG003|Overall Study|Withdrawal by Subject|8|||
161195543|NCT01238861|582095364|FG004|Overall Study|Withdrawal by Subject|10|||
161195544|NCT01238861|582095365|FG005|Overall Study|Withdrawal by Subject|9|||
161195545|NCT01269346|582095366|FG000|Treatment Phase|Disease progression|3|||
161195546|NCT01269346|582095366|FG000|Treatment Phase|Adverse Event|3|||
161195547|NCT01269346|582095366|FG000|Treatment Phase|Withdrawal by Subject|1|||
161195548|NCT01269346|582095366|FG000|Treatment Phase|Other|2|||
161195549|NCT01269346|582095366|FG000|Extension Phase|Adverse Event|6|||
161195550|NCT01269346|582095366|FG000|Extension Phase|Withdrawal by Subject|4|||
161195551|NCT01269346|582095366|FG000|Extension Phase|Disease progression|22|||
161195552|NCT01269346|582095366|FG000|Extension Phase|Physician decision or participant choice|9|||
161195553|NCT01269346|582095366|FG000|Extension Phase|Clinical progression|1|||
161195554|NCT01269346|582095366|FG000|Extension Phase|Started a prohibited con med|1|||
161195555|NCT00247416|582095367|FG000|Overall Study|3 patients were found to be ineligible|1|||
161195556|NCT00247416|582095368|FG001|Overall Study|3 patients were found to be ineligible|2|||
161195557|NCT02660489|582095377|FG000|Overall Study|Lost to Follow-up|1|||
161195558|NCT02660489|582095378|FG001|Overall Study|Lost to Follow-up|1|||
161195559|NCT02660489|582095377|FG000|Overall Study|Adverse Event|1|||
161195560|NCT02660489|582095378|FG001|Overall Study|Adverse Event|3|||
161195561|NCT02660489|582095377|FG000|Overall Study|no rhinovirus infection|4|||
161195562|NCT02660489|582095378|FG001|Overall Study|no rhinovirus infection|4|||
161195563|NCT02322866|582095379|FG000|Overall Study|Adverse Event|6|||
161195564|NCT02322866|582095380|FG001|Overall Study|Adverse Event|11|||
161195565|NCT02322866|582095379|FG000|Overall Study|Withdrawal of Consent|16|||
161195566|NCT02322866|582095380|FG001|Overall Study|Withdrawal of Consent|25|||
161195567|NCT02322866|582095379|FG000|Overall Study|Lost to Follow-up|36|||
161195568|NCT02322866|582095380|FG001|Overall Study|Lost to Follow-up|39|||
161195569|NCT02322866|582095379|FG000|Overall Study|Protocol Violation|1|||
161195570|NCT02322866|582095380|FG001|Overall Study|Protocol Violation|0|||
161195571|NCT02322866|582095379|FG000|Overall Study|Noncompliance with Treatment|3|||
161195572|NCT02322866|582095380|FG001|Overall Study|Noncompliance with Treatment|4|||
161195573|NCT02322866|582095379|FG000|Overall Study|Lack of Efficacy|3|||
161195574|NCT02322866|582095380|FG001|Overall Study|Lack of Efficacy|1|||
161195575|NCT02322866|582095379|FG000|Overall Study|Other Miscellaneous Reasons|6|||
161195576|NCT02322866|582095380|FG001|Overall Study|Other Miscellaneous Reasons|6|||
161195577|NCT03735680|582095383|FG000|Overall Study|Withdrawal by Subject|0|||
161195578|NCT03735680|582095384|FG001|Overall Study|Withdrawal by Subject|1|||
161195579|NCT03735680|582095385|FG002|Overall Study|Withdrawal by Subject|0|||
161195580|NCT03735680|582095386|FG003|Overall Study|Withdrawal by Subject|0|||
161195581|NCT03735680|582095387|FG004|Overall Study|Withdrawal by Subject|0|||
161195582|NCT03735680|582095388|FG005|Overall Study|Withdrawal by Subject|1|||
161195583|NCT03735680|582095383|FG000|Overall Study|Patient unable or unwilling to continue|0|||
161195584|NCT03735680|582095384|FG001|Overall Study|Patient unable or unwilling to continue|0|||
161195585|NCT03735680|582095385|FG002|Overall Study|Patient unable or unwilling to continue|1|||
161195586|NCT03735680|582095386|FG003|Overall Study|Patient unable or unwilling to continue|0|||
161195587|NCT03735680|582095387|FG004|Overall Study|Patient unable or unwilling to continue|0|||
161195588|NCT03735680|582095388|FG005|Overall Study|Patient unable or unwilling to continue|0|||
161195589|NCT03472586|582095402|FG000|Overall Study|Physician Decision|6|||
161350213|NCT05579249|582666876|FG000|Overall Study|Withdrawal by Subject|1|||
161195590|NCT03472586|582095402|FG000|Overall Study|Death|6|||
161195591|NCT03472586|582095402|FG000|Overall Study|Adverse Event|1|||
161195592|NCT01342445|582095403|FG000|Overall Study|Experienced side effects|0|||
161195593|NCT01342445|582095404|FG001|Overall Study|Experienced side effects|2|||
161195594|NCT02957149|582095407|FG000|Overall Study|Withdrawal by Subject|5|||
161195595|NCT06045026|582095408|FG000|Overall Study|Lost to Follow-up|60|||
161195596|NCT06045026|582095408|FG000|Overall Study|Adverse Event|12|||
161195597|NCT06045026|582095408|FG000|Overall Study|Withdrawal by Subject|3|||
161195598|NCT06045026|582095408|FG000|Overall Study|Enrollment closed|1|||
161195599|NCT01928758|582095409|FG000|Overall Study|Lost to Follow-up|14|||
161195600|NCT01928758|582095410|FG001|Overall Study|Lost to Follow-up|9|||
161195601|NCT01928758|582095409|FG000|Overall Study|Withdrawal by Subject|5|||
161195602|NCT01928758|582095410|FG001|Overall Study|Withdrawal by Subject|2|||
161195603|NCT01928758|582095409|FG000|Overall Study|Adverse Event|3|||
161195604|NCT01928758|582095410|FG001|Overall Study|Adverse Event|5|||
161195605|NCT01928758|582095409|FG000|Overall Study|Protocol Violation|3|||
161195606|NCT01928758|582095410|FG001|Overall Study|Protocol Violation|4|||
161195607|NCT02718131|582095411|FG000|Overall Study|Withdrawal by Subject|1|||
161350214|NCT05579249|582666877|FG001|Overall Study|Withdrawal by Subject|3|||
161195608|NCT02718131|582095412|FG001|Overall Study|Withdrawal by Subject|0|||
161195609|NCT02718131|582095411|FG000|Overall Study|Adverse Event|1|||
161195610|NCT02718131|582095412|FG001|Overall Study|Adverse Event|0|||
161195611|NCT02718131|582095411|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
161195612|NCT02718131|582095412|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
161195613|NCT02452320|582095413|FG000|Overall Study|Adverse Event|0|||
161195614|NCT02452320|582095414|FG001|Overall Study|Adverse Event|1|||
161195615|NCT03198559|582095415|FG000|Overall Study|Adverse Event|2|||
161195616|NCT03737812|582095416|FG000|Overall Study|Withdrawal by Subject|1|||
161195617|NCT03737812|582095417|FG001|Overall Study|Withdrawal by Subject|2|||
161195618|NCT03737812|582095418|FG002|Overall Study|Withdrawal by Subject|1|||
161195619|NCT03737812|582095416|FG000|Overall Study|Sponsor Discontinued the Study|4|||
161195620|NCT03737812|582095417|FG001|Overall Study|Sponsor Discontinued the Study|3|||
161195621|NCT03737812|582095418|FG002|Overall Study|Sponsor Discontinued the Study|2|||
161195622|NCT03737812|582095416|FG000|Overall Study|Adverse Event|0|||
161195623|NCT03737812|582095417|FG001|Overall Study|Adverse Event|1|||
161195624|NCT03737812|582095418|FG002|Overall Study|Adverse Event|0|||
161195625|NCT03737812|582095416|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
161195626|NCT03737812|582095417|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
161195627|NCT03737812|582095418|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
161195628|NCT01474291|582095422|FG000|Overall Study|Not Evaluable for Efficacy|26|||
161195629|NCT01474291|582095422|FG000|Overall Study|Lack of Treatment Efficacy|88|||
161195630|NCT01474291|582095422|FG000|Overall Study|Adverse Event|53|||
161195631|NCT01474291|582095422|FG000|Overall Study|Lost to Follow-up|29|||
161195632|NCT01474291|582095422|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
161195633|NCT01474291|582095422|FG000|Overall Study|No Reason Reported|10|||
161195634|NCT01474291|582095422|FG000|Overall Study|Death|2|||
161195635|NCT03471507|582095423|FG000|Overall Study|Lost to Follow-up|1|||
161195636|NCT03471507|582095424|FG001|Overall Study|Lost to Follow-up|3|||
161195637|NCT03471507|582095423|FG000|Overall Study|Physician Decision|0|||
161195638|NCT03471507|582095424|FG001|Overall Study|Physician Decision|1|||
161195639|NCT03471507|582095423|FG000|Overall Study|Withdrawal by Subject|2|||
161195640|NCT03471507|582095424|FG001|Overall Study|Withdrawal by Subject|1|||
161195641|NCT01399619|582095426|FG000|Overall Study|Adverse Event|10|||
161195642|NCT01399619|582095427|FG001|Overall Study|Adverse Event|0|||
161195643|NCT01399619|582095428|FG002|Overall Study|Adverse Event|4|||
161195644|NCT01399619|582095429|FG003|Overall Study|Adverse Event|10|||
161195645|NCT01399619|582095426|FG000|Overall Study|Lack of Efficacy|9|||
161195646|NCT01399619|582095427|FG001|Overall Study|Lack of Efficacy|0|||
161195647|NCT01399619|582095428|FG002|Overall Study|Lack of Efficacy|5|||
161195648|NCT01399619|582095429|FG003|Overall Study|Lack of Efficacy|0|||
161195649|NCT01399619|582095426|FG000|Overall Study|Withdrawal by Subject|6|||
161195650|NCT01399619|582095427|FG001|Overall Study|Withdrawal by Subject|0|||
161195651|NCT01399619|582095428|FG002|Overall Study|Withdrawal by Subject|3|||
161195652|NCT01399619|582095429|FG003|Overall Study|Withdrawal by Subject|4|||
161195653|NCT01399619|582095426|FG000|Overall Study|Protocol Violation|0|||
161195654|NCT01399619|582095427|FG001|Overall Study|Protocol Violation|0|||
161195655|NCT01399619|582095428|FG002|Overall Study|Protocol Violation|0|||
161195656|NCT01399619|582095429|FG003|Overall Study|Protocol Violation|1|||
161195657|NCT01399619|582095426|FG000|Overall Study|Not treated|0|||
161195658|NCT01399619|582095427|FG001|Overall Study|Not treated|0|||
161195659|NCT01399619|582095428|FG002|Overall Study|Not treated|0|||
161195660|NCT01399619|582095429|FG003|Overall Study|Not treated|2|||
161195661|NCT02557308|582095432|FG000|Overall Study|Withdrawal by Subject|11|||
161195662|NCT02557308|582095433|FG001|Overall Study|Withdrawal by Subject|3|||
161195663|NCT02557308|582095434|FG002|Overall Study|Withdrawal by Subject|2|||
161195664|NCT02557308|582095435|FG003|Overall Study|Withdrawal by Subject|0|||
161195665|NCT02557308|582095436|FG004|Overall Study|Withdrawal by Subject|1|||
161195666|NCT02557308|582095437|FG005|Overall Study|Withdrawal by Subject|0|||
161195667|NCT02557308|582095438|FG006|Overall Study|Withdrawal by Subject|10|||
161195668|NCT02557308|582095439|FG007|Overall Study|Withdrawal by Subject|1|||
161195669|NCT02557308|582095432|FG000|Overall Study|Disease Progression|0|||
161195670|NCT02557308|582095433|FG001|Overall Study|Disease Progression|1|||
161350215|NCT05579249|582666876|FG000|Overall Study|Lost to Follow-up|33|||
161350216|NCT05579249|582666877|FG001|Overall Study|Lost to Follow-up|52|||
161350217|NCT05579249|582666876|FG000|Overall Study|Physician Decision|2|||
161350218|NCT05579249|582666877|FG001|Overall Study|Physician Decision|2|||
161350219|NCT05579249|582666876|FG000|Overall Study|Death|0|||
161350220|NCT05579249|582666877|FG001|Overall Study|Death|2|||
161195671|NCT02557308|582095434|FG002|Overall Study|Disease Progression|0|||
161195672|NCT02557308|582095435|FG003|Overall Study|Disease Progression|0|||
161350221|NCT05028517|582666878|FG000|Overall Study|Lost to Follow-up|13|||
161195673|NCT02557308|582095436|FG004|Overall Study|Disease Progression|0|||
161195674|NCT02557308|582095437|FG005|Overall Study|Disease Progression|0|||
161195675|NCT02557308|582095438|FG006|Overall Study|Disease Progression|0|||
161195676|NCT02557308|582095439|FG007|Overall Study|Disease Progression|0|||
161195677|NCT02557308|582095432|FG000|Overall Study|Lack of Efficacy|3|||
161195678|NCT02557308|582095433|FG001|Overall Study|Lack of Efficacy|0|||
161195679|NCT02557308|582095434|FG002|Overall Study|Lack of Efficacy|0|||
161195680|NCT02557308|582095435|FG003|Overall Study|Lack of Efficacy|0|||
161195681|NCT02557308|582095436|FG004|Overall Study|Lack of Efficacy|0|||
161195682|NCT02557308|582095437|FG005|Overall Study|Lack of Efficacy|0|||
161195683|NCT02557308|582095438|FG006|Overall Study|Lack of Efficacy|1|||
161195684|NCT02557308|582095439|FG007|Overall Study|Lack of Efficacy|0|||
161195685|NCT02557308|582095432|FG000|Overall Study|Adverse Event|4|||
161195686|NCT02557308|582095433|FG001|Overall Study|Adverse Event|1|||
161195687|NCT02557308|582095434|FG002|Overall Study|Adverse Event|2|||
161195688|NCT02557308|582095435|FG003|Overall Study|Adverse Event|0|||
161195689|NCT02557308|582095436|FG004|Overall Study|Adverse Event|0|||
161195690|NCT02557308|582095437|FG005|Overall Study|Adverse Event|0|||
161195691|NCT02557308|582095438|FG006|Overall Study|Adverse Event|4|||
161195692|NCT02557308|582095439|FG007|Overall Study|Adverse Event|1|||
161195693|NCT02557308|582095432|FG000|Overall Study|Lost to Follow-up|2|||
161195694|NCT02557308|582095433|FG001|Overall Study|Lost to Follow-up|0|||
161195695|NCT02557308|582095434|FG002|Overall Study|Lost to Follow-up|1|||
161195696|NCT02557308|582095435|FG003|Overall Study|Lost to Follow-up|0|||
161195697|NCT02557308|582095436|FG004|Overall Study|Lost to Follow-up|0|||
161195698|NCT02557308|582095437|FG005|Overall Study|Lost to Follow-up|0|||
161195699|NCT02557308|582095438|FG006|Overall Study|Lost to Follow-up|2|||
161195700|NCT02557308|582095439|FG007|Overall Study|Lost to Follow-up|0|||
161195701|NCT02557308|582095432|FG000|Overall Study|Death|1|||
161195702|NCT02557308|582095433|FG001|Overall Study|Death|0|||
161195703|NCT02557308|582095434|FG002|Overall Study|Death|0|||
161195704|NCT02557308|582095435|FG003|Overall Study|Death|0|||
161195705|NCT02557308|582095436|FG004|Overall Study|Death|0|||
161195706|NCT02557308|582095437|FG005|Overall Study|Death|0|||
161195707|NCT02557308|582095438|FG006|Overall Study|Death|0|||
161195708|NCT02557308|582095439|FG007|Overall Study|Death|0|||
161195709|NCT02557308|582095432|FG000|Overall Study|Study Close|98|||
161195710|NCT02557308|582095433|FG001|Overall Study|Study Close|18|||
161195711|NCT02557308|582095434|FG002|Overall Study|Study Close|5|||
161195712|NCT02557308|582095435|FG003|Overall Study|Study Close|3|||
161195713|NCT02557308|582095436|FG004|Overall Study|Study Close|1|||
161195714|NCT02557308|582095437|FG005|Overall Study|Study Close|0|||
161195715|NCT02557308|582095438|FG006|Overall Study|Study Close|123|||
161195716|NCT02557308|582095439|FG007|Overall Study|Study Close|5|||
161195717|NCT02557308|582095432|FG000|Overall Study|Except for study close|5|||
161195718|NCT02557308|582095433|FG001|Overall Study|Except for study close|0|||
161195719|NCT02557308|582095434|FG002|Overall Study|Except for study close|0|||
161195720|NCT02557308|582095435|FG003|Overall Study|Except for study close|0|||
161195721|NCT02557308|582095436|FG004|Overall Study|Except for study close|3|||
161195722|NCT02557308|582095437|FG005|Overall Study|Except for study close|0|||
161195723|NCT02557308|582095438|FG006|Overall Study|Except for study close|6|||
161195724|NCT02557308|582095439|FG007|Overall Study|Except for study close|10|||
161195725|NCT03911401|582095440|FG000|Overall Study|Adverse Event|1|||
161195726|NCT03911401|582095441|FG001|Overall Study|Adverse Event|2|||
161195727|NCT03911401|582095442|FG002|Overall Study|Adverse Event|5|||
161195728|NCT03911401|582095440|FG000|Overall Study|Lack of Efficacy|1|||
161195729|NCT03911401|582095441|FG001|Overall Study|Lack of Efficacy|1|||
161195730|NCT03911401|582095442|FG002|Overall Study|Lack of Efficacy|8|||
161195731|NCT03911401|582095440|FG000|Overall Study|Physician Decision|0|||
161195732|NCT03911401|582095441|FG001|Overall Study|Physician Decision|0|||
161195733|NCT03911401|582095442|FG002|Overall Study|Physician Decision|1|||
161195734|NCT03911401|582095440|FG000|Overall Study|Withdrawal by Subject|1|||
161195735|NCT03911401|582095441|FG001|Overall Study|Withdrawal by Subject|2|||
161195736|NCT03911401|582095442|FG002|Overall Study|Withdrawal by Subject|0|||
161195737|NCT03911401|582095440|FG000|Overall Study|Withdrawal by parent/guardian|4|||
161195738|NCT03911401|582095441|FG001|Overall Study|Withdrawal by parent/guardian|4|||
161195739|NCT03911401|582095442|FG002|Overall Study|Withdrawal by parent/guardian|11|||
161195740|NCT02046993|582095446|FG000|Overall Study|Withdrawal by Subject|2|||
161195741|NCT02046993|582095447|FG001|Overall Study|Withdrawal by Subject|10|||
161195742|NCT02046993|582095446|FG000|Overall Study|Lost to Follow-up|1|||
161195743|NCT02046993|582095447|FG001|Overall Study|Lost to Follow-up|1|||
161195744|NCT03417245|582095448|FG000|Overall Study|Adverse Event|1|||
161195745|NCT03417245|582095449|FG001|Overall Study|Adverse Event|0|||
161195746|NCT03417245|582095448|FG000|Overall Study|Protocol Violation|1|||
161195747|NCT03417245|582095449|FG001|Overall Study|Protocol Violation|0|||
161195748|NCT03417245|582095448|FG000|Overall Study|Withdrawal by Subject|1|||
161195749|NCT03417245|582095449|FG001|Overall Study|Withdrawal by Subject|1|||
161195750|NCT00598442|582095454|FG000|Overall Study|Adverse Event|3|||
161195751|NCT00598442|582095455|FG001|Overall Study|Adverse Event|0|||
161195752|NCT00598442|582095456|FG002|Overall Study|Adverse Event|0|||
161195753|NCT00598442|582095454|FG000|Overall Study|Death|19|||
161195754|NCT00598442|582095455|FG001|Overall Study|Death|11|||
161195755|NCT00598442|582095456|FG002|Overall Study|Death|11|||
161195756|NCT00598442|582095454|FG000|Overall Study|Lost to Follow-up|4|||
161195757|NCT00598442|582095455|FG001|Overall Study|Lost to Follow-up|3|||
161195758|NCT00598442|582095456|FG002|Overall Study|Lost to Follow-up|3|||
161195759|NCT00598442|582095454|FG000|Overall Study|Physician Decision|2|||
161195760|NCT00598442|582095455|FG001|Overall Study|Physician Decision|1|||
161195761|NCT00598442|582095456|FG002|Overall Study|Physician Decision|1|||
161195762|NCT00598442|582095454|FG000|Overall Study|Withdrawal by Subject|8|||
161195763|NCT00598442|582095455|FG001|Overall Study|Withdrawal by Subject|16|||
161195764|NCT00598442|582095456|FG002|Overall Study|Withdrawal by Subject|6|||
161195765|NCT00598442|582095454|FG000|Overall Study|Noncompliance|0|||
161195766|NCT00598442|582095455|FG001|Overall Study|Noncompliance|2|||
161195767|NCT00598442|582095456|FG002|Overall Study|Noncompliance|1|||
161195768|NCT00598442|582095454|FG000|Overall Study|Relocation|1|||
161195769|NCT00598442|582095455|FG001|Overall Study|Relocation|4|||
161195770|NCT00598442|582095456|FG002|Overall Study|Relocation|0|||
161195771|NCT00598442|582095454|FG000|Overall Study|Renal transplant|0|||
161195772|NCT00598442|582095455|FG001|Overall Study|Renal transplant|0|||
161195773|NCT00598442|582095456|FG002|Overall Study|Renal transplant|1|||
161195774|NCT00598442|582095454|FG000|Overall Study|Site closed by sponsor|5|||
161195775|NCT00598442|582095455|FG001|Overall Study|Site closed by sponsor|2|||
161195776|NCT00598442|582095456|FG002|Overall Study|Site closed by sponsor|1|||
161195777|NCT00598442|582095454|FG000|Overall Study|Started dialysis|1|||
161195778|NCT00598442|582095455|FG001|Overall Study|Started dialysis|0|||
161195779|NCT00598442|582095456|FG002|Overall Study|Started dialysis|0|||
161195780|NCT01590628|582095470|FG000|Overall Study|Death|2|||
161195781|NCT01590628|582095471|FG001|Overall Study|Death|0|||
161195782|NCT03764813|582095472|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
161195783|NCT03764813|582095473|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
161195784|NCT03764813|582095474|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
161195785|NCT03764813|582095475|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
161195786|NCT00267202|582095476|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
161195787|NCT00267202|582095477|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
161195788|NCT00267202|582095476|FG000|Overall Study|Withdrawal by Subject|12|||
161195789|NCT00267202|582095477|FG001|Overall Study|Withdrawal by Subject|15|||
161195790|NCT00267202|582095476|FG000|Overall Study|Adverse Event|13|||
161195791|NCT00267202|582095477|FG001|Overall Study|Adverse Event|7|||
161195792|NCT00267202|582095476|FG000|Overall Study|Protocol Violation|2|||
161195793|NCT00267202|582095477|FG001|Overall Study|Protocol Violation|3|||
161195794|NCT00267202|582095476|FG000|Overall Study|Administrative problems|2|||
161195795|NCT00267202|582095477|FG001|Overall Study|Administrative problems|1|||
161195796|NCT00267202|582095476|FG000|Overall Study|Lost to Follow-up|3|||
161195797|NCT00267202|582095477|FG001|Overall Study|Lost to Follow-up|0|||
161195798|NCT04533204|582095482|FG000|Overall Study|Unable to understand training instructions|1|||
161195799|NCT04533204|582095483|FG001|Overall Study|Unable to understand training instructions|1|||
161195800|NCT01789476|582096981|FG000|Overall Study|Lack of Efficacy|6|||
161195801|NCT01789476|582096982|FG001|Overall Study|Lack of Efficacy|2|||
161195802|NCT01789476|582096981|FG000|Overall Study|Adverse Event|1|||
161195803|NCT01789476|582096982|FG001|Overall Study|Adverse Event|0|||
161195804|NCT01789476|582096981|FG000|Overall Study|Unable to get IV access|1|||
161195805|NCT01789476|582096982|FG001|Overall Study|Unable to get IV access|0|||
161195806|NCT03053102|582096983|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
161195807|NCT03053102|582096983|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
161195808|NCT01798056|582096984|FG000|Overall Study|Serious Adverse Event|13|||
161195809|NCT01798056|582096985|FG001|Overall Study|Serious Adverse Event|12|||
161195810|NCT01798056|582096984|FG000|Overall Study|Withdrawal by Subject|12|||
161195811|NCT01798056|582096985|FG001|Overall Study|Withdrawal by Subject|9|||
161195812|NCT01798056|582096984|FG000|Overall Study|Migrated/moved from study area|1|||
161195813|NCT01798056|582096985|FG001|Overall Study|Migrated/moved from study area|1|||
161195814|NCT01798056|582096984|FG000|Overall Study|Lost to Follow-up|1|||
161195815|NCT01798056|582096985|FG001|Overall Study|Lost to Follow-up|1|||
161195816|NCT01798056|582096984|FG000|Overall Study|Other|0|||
161195817|NCT01798056|582096985|FG001|Overall Study|Other|2|||
161195818|NCT05064436|582096990|FG000|Overall Study|Other Reasons|1|||
161195819|NCT05064436|582096991|FG001|Overall Study|Other Reasons|0|||
161195820|NCT04511533|582096997|FG000|Treatment|Other|2|||
161195821|NCT04511533|582096997|FG000|Treatment|Withdrawal by Subject|11|||
161195822|NCT04511533|582096997|FG000|Treatment|Death|5|||
161195823|NCT04511533|582096997|FG000|Treatment|Physician Decision|1|||
161195824|NCT04511533|582096997|FG000|Treatment|Progressive Disease|61|||
161195825|NCT04511533|582096997|FG000|Follow-Up|Other|7|||
161195826|NCT04511533|582096997|FG000|Follow-Up|Withdrawal by Subject|5|||
161195827|NCT04511533|582096997|FG000|Follow-Up|Lost to Follow-up|2|||
161195828|NCT04511533|582096997|FG000|Follow-Up|Death|4|||
161195829|NCT01224171|582096998|FG000|Overall Study|Adverse Event|8|||
161195830|NCT01224171|582096999|FG001|Overall Study|Adverse Event|4|||
161195831|NCT01224171|582096998|FG000|Overall Study|Protocol Violation|0|||
161195832|NCT01224171|582096999|FG001|Overall Study|Protocol Violation|1|||
161195833|NCT01224171|582096998|FG000|Overall Study|Lack of Efficacy|5|||
161195834|NCT01224171|582096999|FG001|Overall Study|Lack of Efficacy|1|||
161195835|NCT01224171|582096998|FG000|Overall Study|Withdrawal of Consent|2|||
161195836|NCT01224171|582096999|FG001|Overall Study|Withdrawal of Consent|4|||
161195837|NCT01224171|582096998|FG000|Overall Study|Lost to Follow-up|0|||
161195838|NCT01224171|582096999|FG001|Overall Study|Lost to Follow-up|3|||
161195839|NCT01097057|582097000|FG000|Overall Study|Physician Decision|3|||
161195840|NCT01270139|582097001|FG000|Overall Study|Adverse Event|8|||
161195841|NCT01270139|582097002|FG001|Overall Study|Adverse Event|17|||
161195842|NCT01270139|582097003|FG002|Overall Study|Adverse Event|18|||
161195843|NCT01270139|582097001|FG000|Overall Study|Lost to Follow-up|10|||
161195844|NCT01270139|582097002|FG001|Overall Study|Lost to Follow-up|9|||
161195845|NCT01270139|582097003|FG002|Overall Study|Lost to Follow-up|2|||
161195846|NCT01161173|582097012|FG000|Overall Study|Protocol Violation|13|||
161195847|NCT01161173|582097012|FG000|Overall Study|Lost to Follow-up|7|||
161195848|NCT01161173|582097012|FG000|Overall Study|Progressive Disease|82|||
161195849|NCT01161173|582097012|FG000|Overall Study|Withdrawal of Consent|5|||
161195850|NCT01161173|582097012|FG000|Overall Study|Unacceptable Toxicity|21|||
161195851|NCT01161173|582097012|FG000|Overall Study|Death|194|||
161195852|NCT01161173|582097012|FG000|Overall Study|End of Study|2|||
161195853|NCT01161173|582097012|FG000|Overall Study|Reasons Not Specified|23|||
161195854|NCT01911546|582097013|FG000|Overall Study|Lost to Follow-up|1|||
161195855|NCT01911546|582097013|FG000|Overall Study|Everolimus was discontinued|5|||
161195856|NCT01319422|582097015|FG000|Overall Study|Withdrawal by Subject|1|||
161195857|NCT01319422|582097016|FG001|Overall Study|Withdrawal by Subject|0|||
161195858|NCT02918968|582097017|FG000|1st Line AAT|Progressive disease|9|||
161195859|NCT02918968|582097018|FG001|1st Line AAT|Progressive disease|4|||
161195860|NCT02918968|582097017|FG000|1st Line AAT|Adverse Event|12|||
161195861|NCT02918968|582097018|FG001|1st Line AAT|Adverse Event|3|||
161195862|NCT02918968|582097017|FG000|1st Line AAT|Physician Decision|4|||
161195863|NCT02918968|582097018|FG001|1st Line AAT|Physician Decision|2|||
161195864|NCT02918968|582097017|FG000|1st Line AAT|Withdrawal by Subject|2|||
161195865|NCT02918968|582097018|FG001|1st Line AAT|Withdrawal by Subject|1|||
161195866|NCT02918968|582097017|FG000|1st Line AAT|Lost to Follow-up|0|||
161195867|NCT02918968|582097018|FG001|1st Line AAT|Lost to Follow-up|1|||
161195868|NCT02918968|582097017|FG000|1st Line AAT|Death|1|||
161195869|NCT02918968|582097018|FG001|1st Line AAT|Death|0|||
161195870|NCT02918968|582097017|FG000|1st Line AAT|Miscellaneous|1|||
161195871|NCT02918968|582097018|FG001|1st Line AAT|Miscellaneous|0|||
161195872|NCT02918968|582097017|FG000|2nd Line AAT|Progressive disease|21|||
161195873|NCT02918968|582097018|FG001|2nd Line AAT|Progressive disease|3|||
161195874|NCT02918968|582097017|FG000|2nd Line AAT|Adverse Event|2|||
161195875|NCT02918968|582097018|FG001|2nd Line AAT|Adverse Event|5|||
161195876|NCT02918968|582097017|FG000|2nd Line AAT|Physician Decision|0|||
161195877|NCT02918968|582097018|FG001|2nd Line AAT|Physician Decision|1|||
161195878|NCT02918968|582097017|FG000|2nd Line AAT|Withdrawal by Subject|2|||
161195879|NCT02918968|582097018|FG001|2nd Line AAT|Withdrawal by Subject|2|||
161195880|NCT02918968|582097017|FG000|2nd Line AAT|Death|0|||
161195881|NCT02918968|582097018|FG001|2nd Line AAT|Death|1|||
161195882|NCT05602818|582097019|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
161195883|NCT05602818|582097020|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
161195884|NCT05602818|582097021|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
161195885|NCT05602818|582097022|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
161195886|NCT05602818|582097023|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
161195887|NCT05602818|582097024|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
161195888|NCT05602818|582097025|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
161195889|NCT05602818|582097026|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
161195890|NCT05602818|582097027|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
161195891|NCT05602818|582097028|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
161195892|NCT05602818|582097029|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
161195893|NCT05602818|582097030|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
161195894|NCT05602818|582097019|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
161195895|NCT05602818|582097020|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
161195896|NCT05602818|582097021|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195897|NCT05602818|582097022|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195898|NCT05602818|582097023|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195899|NCT05602818|582097024|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195900|NCT05602818|582097025|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195901|NCT05602818|582097026|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195902|NCT05602818|582097027|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195903|NCT05602818|582097028|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195904|NCT05602818|582097029|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195905|NCT05602818|582097030|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
161195906|NCT05602818|582097019|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
161195907|NCT05602818|582097020|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195908|NCT05602818|582097021|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195909|NCT05602818|582097022|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195910|NCT05602818|582097023|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195911|NCT05602818|582097024|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195912|NCT05602818|582097025|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195913|NCT05602818|582097026|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195914|NCT05602818|582097027|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195915|NCT05602818|582097028|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195916|NCT05602818|582097029|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195917|NCT05602818|582097030|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
161195918|NCT05602818|582097019|FG000|Qualification Phase (3 Days)|Other|1|||
161195919|NCT05602818|582097020|FG001|Qualification Phase (3 Days)|Other|0|||
161195920|NCT05602818|582097021|FG002|Qualification Phase (3 Days)|Other|0|||
161195921|NCT05602818|582097022|FG003|Qualification Phase (3 Days)|Other|0|||
161195922|NCT05602818|582097023|FG004|Qualification Phase (3 Days)|Other|0|||
161195923|NCT05602818|582097024|FG005|Qualification Phase (3 Days)|Other|0|||
161195924|NCT05602818|582097025|FG006|Qualification Phase (3 Days)|Other|0|||
161195925|NCT05602818|582097026|FG007|Qualification Phase (3 Days)|Other|0|||
161195926|NCT05602818|582097027|FG008|Qualification Phase (3 Days)|Other|0|||
161195927|NCT05602818|582097028|FG009|Qualification Phase (3 Days)|Other|0|||
161195928|NCT05602818|582097029|FG010|Qualification Phase (3 Days)|Other|0|||
161195929|NCT05602818|582097030|FG011|Qualification Phase (3 Days)|Other|0|||
161195930|NCT05602818|582097019|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195931|NCT05602818|582097020|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
161195932|NCT05602818|582097021|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195933|NCT05602818|582097022|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195934|NCT05602818|582097023|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195935|NCT05602818|582097024|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195936|NCT05602818|582097025|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195937|NCT05602818|582097026|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195938|NCT05602818|582097027|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195939|NCT05602818|582097028|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195940|NCT05602818|582097029|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195941|NCT05602818|582097030|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
161195942|NCT05602818|582097019|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
161195943|NCT05602818|582097020|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
161195944|NCT05602818|582097021|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
161195945|NCT05602818|582097022|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
161195946|NCT05602818|582097023|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
161195947|NCT05602818|582097024|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
161195948|NCT05602818|582097025|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
161195949|NCT05602818|582097026|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
161195950|NCT05602818|582097027|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
161195951|NCT05602818|582097028|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
161195952|NCT05602818|582097029|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
161195953|NCT05602818|582097030|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
161195954|NCT05602818|582097019|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195955|NCT05602818|582097020|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195956|NCT05602818|582097021|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195957|NCT05602818|582097022|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195958|NCT05602818|582097023|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195959|NCT05602818|582097024|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195960|NCT05602818|582097025|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195961|NCT05602818|582097026|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195962|NCT05602818|582097027|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195963|NCT05602818|582097028|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
161195964|NCT05602818|582097029|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
161195965|NCT05602818|582097030|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
161195966|NCT05602818|582097019|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
161195967|NCT05602818|582097020|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
161195968|NCT05602818|582097021|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
161195969|NCT05602818|582097022|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
161195970|NCT05602818|582097023|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
161195971|NCT05602818|582097024|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
161195972|NCT05602818|582097025|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
161195973|NCT05602818|582097026|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
161350222|NCT05028517|582666879|FG001|Overall Study|Lost to Follow-up|20|||
161350223|NCT05028517|582666880|FG002|Overall Study|Lost to Follow-up|12|||
161195974|NCT05602818|582097027|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
161195975|NCT05602818|582097028|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
161195976|NCT05602818|582097029|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
161195977|NCT05602818|582097030|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
161195978|NCT00750061|582097031|FG000|Overall Study|Adverse Event|2|||
161195979|NCT00750061|582097032|FG001|Overall Study|Adverse Event|0|||
161195980|NCT00750061|582097031|FG000|Overall Study|Withdrawal by Subject|0|||
161195981|NCT00750061|582097032|FG001|Overall Study|Withdrawal by Subject|1|||
161195982|NCT00750061|582097031|FG000|Overall Study|Physician Decision|0|||
161195983|NCT00750061|582097032|FG001|Overall Study|Physician Decision|1|||
161195984|NCT03814499|582097035|FG000|Overall Study|Lost to Follow-up|3|||
161195985|NCT00229931|582097039|FG000|Overall Study|Death|1|||
161195986|NCT00229931|582097040|FG001|Overall Study|Death|0|||
161195987|NCT00229931|582097039|FG000|Overall Study|Lost to Follow-up|3|||
161195988|NCT00229931|582097040|FG001|Overall Study|Lost to Follow-up|2|||
161195989|NCT02992743|582097041|FG000|Overall Study|Withdrawal by Subject|1|||
161195990|NCT02992743|582097042|FG001|Overall Study|Withdrawal by Subject|1|||
161195991|NCT02992743|582097041|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
161195992|NCT02992743|582097042|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
161195993|NCT02992743|582097041|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
161195994|NCT02992743|582097042|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
161195995|NCT02992743|582097041|FG000|Overall Study|No measurable disease|1|||
161195996|NCT02992743|582097042|FG001|Overall Study|No measurable disease|0|||
161195997|NCT02992743|582097041|FG000|Overall Study|Lost to Follow-up|0|||
161195998|NCT02992743|582097042|FG001|Overall Study|Lost to Follow-up|1|||
161195999|NCT00381680|582097043|FG000|Overall Study|Adverse Event|9|||
161196000|NCT00381680|582097044|FG001|Overall Study|Adverse Event|3|||
161196001|NCT00381680|582097043|FG000|Overall Study|Death|10|||
161196002|NCT00381680|582097044|FG001|Overall Study|Death|7|||
161196003|NCT00381680|582097043|FG000|Overall Study|Lost to Follow-up|3|||
161196004|NCT00381680|582097044|FG001|Overall Study|Lost to Follow-up|2|||
161196005|NCT00381680|582097043|FG000|Overall Study|Physician Decision|25|||
161196006|NCT00381680|582097044|FG001|Overall Study|Physician Decision|6|||
161196007|NCT00381680|582097043|FG000|Overall Study|Withdrawal by Subject|3|||
161196008|NCT00381680|582097044|FG001|Overall Study|Withdrawal by Subject|1|||
161196009|NCT00381680|582097043|FG000|Overall Study|Entry onto another COG Trial|1|||
161196010|NCT00381680|582097044|FG001|Overall Study|Entry onto another COG Trial|2|||
161196011|NCT00381680|582097043|FG000|Overall Study|Alternative Therapy|11|||
161196012|NCT00381680|582097044|FG001|Overall Study|Alternative Therapy|5|||
161196013|NCT00381680|582097043|FG000|Overall Study|Secondary Malignancy|3|||
161196014|NCT00381680|582097044|FG001|Overall Study|Secondary Malignancy|0|||
161196015|NCT00381680|582097043|FG000|Overall Study|Delay initiation|1|||
161196016|NCT00381680|582097044|FG001|Overall Study|Delay initiation|0|||
161196017|NCT00381680|582097043|FG000|Overall Study|Stem Cell Transplant|26|||
161196018|NCT00381680|582097044|FG001|Overall Study|Stem Cell Transplant|10|||
161196019|NCT00381680|582097043|FG000|Overall Study|Relapse|18|||
161196020|NCT00381680|582097044|FG001|Overall Study|Relapse|9|||
161196021|NCT00381680|582097043|FG000|Overall Study|Induction Failure|4|||
161196022|NCT00381680|582097044|FG001|Overall Study|Induction Failure|1|||
161196023|NCT00381680|582097043|FG000|Overall Study|Progression|1|||
161196024|NCT00381680|582097044|FG001|Overall Study|Progression|1|||
161196025|NCT00381680|582097043|FG000|Overall Study|Other not otherwise specified|7|||
161196026|NCT00381680|582097044|FG001|Overall Study|Other not otherwise specified|2|||
161196027|NCT00381680|582097043|FG000|Overall Study|Ineligible|3|||
161196028|NCT00381680|582097044|FG001|Overall Study|Ineligible|1|||
161196029|NCT03290131|582097045|FG000|Overall Study|Adverse Event|22|||
161196030|NCT03290131|582097046|FG001|Overall Study|Adverse Event|57|||
161196031|NCT03290131|582097047|FG002|Overall Study|Adverse Event|11|||
161196032|NCT03290131|582097045|FG000|Overall Study|Withdrawal by Subject|18|||
161196033|NCT03290131|582097046|FG001|Overall Study|Withdrawal by Subject|13|||
161196034|NCT03290131|582097047|FG002|Overall Study|Withdrawal by Subject|8|||
161196035|NCT03290131|582097045|FG000|Overall Study|MS Relapse|2|||
161196036|NCT03290131|582097046|FG001|Overall Study|MS Relapse|1|||
161196037|NCT03290131|582097047|FG002|Overall Study|MS Relapse|0|||
161196038|NCT03290131|582097045|FG000|Overall Study|Unknown reason|0|||
161196039|NCT03290131|582097046|FG001|Overall Study|Unknown reason|1|||
161196040|NCT03290131|582097047|FG002|Overall Study|Unknown reason|0|||
161196041|NCT03099096|582097050|FG000|Overall Study|Adverse Event|1|||
161196042|NCT03099096|582097050|FG000|Overall Study|Physician Decision|1|||
161196043|NCT00361504|582097053|FG000|Overall Study|Withdrawal by Subject|94|||
161196044|NCT00361504|582097054|FG001|Overall Study|Withdrawal by Subject|31|||
161196045|NCT00361504|582097053|FG000|Overall Study|Lost to Follow-up|40|||
161196046|NCT00361504|582097054|FG001|Overall Study|Lost to Follow-up|7|||
161196047|NCT00361504|582097053|FG000|Overall Study|Adverse Event|203|||
161196048|NCT00361504|582097054|FG001|Overall Study|Adverse Event|82|||
161196049|NCT00361504|582097053|FG000|Overall Study|Lack of Efficacy|72|||
161196050|NCT00361504|582097054|FG001|Overall Study|Lack of Efficacy|7|||
161306666|NCT00595517|582502902|FG000|Overall Study|Withdrawal by Subject|4|||
161306667|NCT00595517|582502902|FG000|Overall Study|Protocol Violation|2|||
161196051|NCT00361504|582097053|FG000|Overall Study|Resolution of Pain|2|||
161196052|NCT00361504|582097054|FG001|Overall Study|Resolution of Pain|0|||
161196053|NCT00361504|582097053|FG000|Overall Study|Study medication non compliant|42|||
161196054|NCT00361504|582097054|FG001|Overall Study|Study medication non compliant|15|||
161196055|NCT00361504|582097053|FG000|Overall Study|All other|28|||
161196056|NCT00361504|582097054|FG001|Overall Study|All other|3|||
161196057|NCT01374516|582097057|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
161196058|NCT01374516|582097058|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
161196059|NCT01374516|582097057|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
161306668|NCT00595517|582502902|FG000|Overall Study|Recurrence of ulcer|5|||
161306669|NCT00595517|582502902|FG000|Overall Study|usage of prohibited treatment|1|||
161196060|NCT01374516|582097058|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
161196061|NCT01374516|582097057|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
161196062|NCT01374516|582097058|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
161196063|NCT01374516|582097057|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
161196064|NCT01374516|582097058|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
161196065|NCT01374516|582097057|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
161196066|NCT01374516|582097058|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
161196067|NCT01374516|582097057|FG000|Surveillance Expansion Period|Protocol Violation|386|||
161196068|NCT01374516|582097058|FG001|Surveillance Expansion Period|Protocol Violation|217|||
161196069|NCT01374516|582097057|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
161196070|NCT01374516|582097058|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
161196071|NCT01374516|582097057|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
161196072|NCT01374516|582097058|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
161196073|NCT01374516|582097057|FG000|Surveillance Expansion Period|Serious adverse event|20|||
161196074|NCT01374516|582097058|FG001|Surveillance Expansion Period|Serious adverse event|5|||
161196075|NCT00450814|582097066|FG000|Overall Study|Failed to complete the initial therapy|0|||
161196076|NCT00450814|582097067|FG001|Overall Study|Failed to complete the initial therapy|0|||
161196077|NCT00450814|582097068|FG002|Overall Study|Failed to complete the initial therapy|0|||
161196078|NCT00450814|582097069|FG003|Overall Study|Failed to complete the initial therapy|1|||
161196079|NCT00450814|582097070|FG004|Overall Study|Failed to complete the initial therapy|1|||
161196080|NCT00450814|582097071|FG005|Overall Study|Failed to complete the initial therapy|1|||
161196081|NCT00450814|582097072|FG006|Overall Study|Failed to complete the initial therapy|0|||
161196082|NCT00450814|582097073|FG007|Overall Study|Failed to complete the initial therapy|0|||
161196083|NCT00450814|582097074|FG008|Overall Study|Failed to complete the initial therapy|0|||
161196084|NCT00450814|582097075|FG009|Overall Study|Failed to complete the initial therapy|0|||
161196085|NCT00450814|582097076|FG010|Overall Study|Failed to complete the initial therapy|0|||
161196086|NCT00450814|582097066|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
161196087|NCT00450814|582097067|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
161196088|NCT00450814|582097068|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
161196089|NCT00450814|582097069|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
161196090|NCT00450814|582097070|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
161196091|NCT00450814|582097071|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
161196092|NCT00450814|582097072|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
161196093|NCT00450814|582097073|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
161196094|NCT00450814|582097074|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
161196095|NCT00450814|582097075|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
161196096|NCT00450814|582097076|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
161196097|NCT03602976|582097081|FG000|Overall Study|Withdrawal by Subject|1|||
161196098|NCT04837807|582097082|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
161196099|NCT04837807|582097083|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
161196100|NCT04629534|582097084|FG000|Overall Study|Physician Decision|1|||
161196101|NCT04629534|582097085|FG001|Overall Study|Physician Decision|0|||
161196102|NCT04629534|582097084|FG000|Overall Study|Protocol Violation|0|||
161196103|NCT04629534|582097085|FG001|Overall Study|Protocol Violation|2|||
161196104|NCT03732534|582097086|FG000|Overall Study|Study terminated by Sponsor|6|||
161196105|NCT03125382|582097087|FG000|Randomization|screening failure|1|||
161196106|NCT03125382|582097088|FG001|Randomization|screening failure|4|||
161196107|NCT03125382|582097089|FG002|Randomization|screening failure|2|||
161196108|NCT03125382|582097090|FG003|Randomization|screening failure|0|||
161196109|NCT03125382|582097087|FG000|Follow-up|Death|1|||
161196110|NCT03125382|582097088|FG001|Follow-up|Death|2|||
161196111|NCT03125382|582097089|FG002|Follow-up|Death|1|||
161196112|NCT03125382|582097090|FG003|Follow-up|Death|2|||
161196113|NCT03125382|582097087|FG000|Follow-up|Lost to Follow-up|1|||
161196114|NCT03125382|582097088|FG001|Follow-up|Lost to Follow-up|4|||
161196115|NCT03125382|582097089|FG002|Follow-up|Lost to Follow-up|3|||
161196116|NCT03125382|582097090|FG003|Follow-up|Lost to Follow-up|1|||
161196117|NCT03907072|582097091|FG000|Overall Study|Study Terminated by Sponsor|2|||
161196118|NCT03907072|582097092|FG001|Overall Study|Study Terminated by Sponsor|2|||
161196119|NCT03907072|582097093|FG002|Overall Study|Study Terminated by Sponsor|2|||
161196120|NCT00612456|582097094|FG000|Overall Study|Adverse Event|1|||
161196121|NCT00612456|582097095|FG001|Overall Study|Adverse Event|0|||
161196122|NCT00612456|582097096|FG002|Overall Study|Adverse Event|0|||
161196123|NCT00612456|582097094|FG000|Overall Study|Lack of Efficacy|1|||
161196124|NCT00612456|582097095|FG001|Overall Study|Lack of Efficacy|1|||
161196125|NCT00612456|582097096|FG002|Overall Study|Lack of Efficacy|0|||
161196126|NCT00612456|582097094|FG000|Overall Study|Withdrawal by Subject|0|||
161196127|NCT00612456|582097095|FG001|Overall Study|Withdrawal by Subject|1|||
161196128|NCT00612456|582097096|FG002|Overall Study|Withdrawal by Subject|0|||
161196129|NCT00265109|582097099|FG000|Overall Study|Withdrawal by Subject|5|||
161196130|NCT00265109|582097099|FG000|Overall Study|Adverse Event|1|||
161196131|NCT02463097|582097100|FG000|Overall Study|Withdrawal by Subject|1|||
161196132|NCT00808665|582097101|FG000|Overall Study|Withdrawal by Subject|1|||
161196133|NCT00808665|582097102|FG001|Overall Study|Withdrawal by Subject|0|||
161196134|NCT00808665|582097101|FG000|Overall Study|only required minimally invasive surgery|1|||
161196135|NCT00808665|582097102|FG001|Overall Study|only required minimally invasive surgery|0|||
161196136|NCT00808665|582097101|FG000|Overall Study|surgery cancelled|1|||
161196137|NCT00808665|582097102|FG001|Overall Study|surgery cancelled|0|||
161196138|NCT00808665|582097101|FG000|Overall Study|required an additional procedure|0|||
161196139|NCT00808665|582097102|FG001|Overall Study|required an additional procedure|1|||
161196140|NCT00808665|582097101|FG000|Overall Study|Physician Decision|3|||
161196141|NCT00808665|582097102|FG001|Overall Study|Physician Decision|1|||
161196142|NCT00808665|582097101|FG000|Overall Study|Medication stopped by resident|0|||
161196143|NCT00808665|582097102|FG001|Overall Study|Medication stopped by resident|1|||
161196144|NCT01757821|582097103|FG000|Overall Study|Adverse Event|1|||
161196145|NCT03831282|582097106|FG000|Overall Study|Could not place sensor|1|||
161196146|NCT00334893|582097107|FG000|Overall Study|Not Treated|1|||
161196147|NCT00334893|582097108|FG001|Overall Study|Not Treated|0|||
161196148|NCT03556202|582097113|FG000|Extension Treatment Period|Adverse Event|18|||
161196149|NCT03556202|582097114|FG001|Extension Treatment Period|Adverse Event|14|||
161196150|NCT03556202|582097115|FG002|Extension Treatment Period|Adverse Event|9|||
161196151|NCT03556202|582097113|FG000|Extension Treatment Period|Death|2|||
161196152|NCT03556202|582097114|FG001|Extension Treatment Period|Death|6|||
161196153|NCT03556202|582097115|FG002|Extension Treatment Period|Death|0|||
161196154|NCT03556202|582097113|FG000|Extension Treatment Period|Lack of Efficacy|5|||
161196155|NCT03556202|582097114|FG001|Extension Treatment Period|Lack of Efficacy|12|||
161196156|NCT03556202|582097115|FG002|Extension Treatment Period|Lack of Efficacy|18|||
161196157|NCT03556202|582097113|FG000|Extension Treatment Period|Lost to Follow-up|9|||
161196158|NCT03556202|582097114|FG001|Extension Treatment Period|Lost to Follow-up|20|||
161196159|NCT03556202|582097115|FG002|Extension Treatment Period|Lost to Follow-up|2|||
161196160|NCT03556202|582097113|FG000|Extension Treatment Period|Pregnancy|2|||
161196161|NCT03556202|582097114|FG001|Extension Treatment Period|Pregnancy|4|||
161196162|NCT03556202|582097115|FG002|Extension Treatment Period|Pregnancy|3|||
161196163|NCT03556202|582097113|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
161196164|NCT03556202|582097114|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
161196165|NCT03556202|582097115|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
161196166|NCT03556202|582097113|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
161196167|NCT03556202|582097114|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
161196168|NCT03556202|582097115|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
161196169|NCT03556202|582097113|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
161196170|NCT03556202|582097114|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
161196171|NCT03556202|582097115|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
161196172|NCT03556202|582097113|FG000|Extension Treatment Period|Physician Decision|0|||
161196173|NCT03556202|582097114|FG001|Extension Treatment Period|Physician Decision|8|||
161196174|NCT03556202|582097115|FG002|Extension Treatment Period|Physician Decision|2|||
161196175|NCT03556202|582097113|FG000|Extension Treatment Period|Protocol Violation|0|||
161196176|NCT03556202|582097114|FG001|Extension Treatment Period|Protocol Violation|1|||
161196177|NCT03556202|582097115|FG002|Extension Treatment Period|Protocol Violation|1|||
161196178|NCT03556202|582097113|FG000|Extension Treatment Period|Sponsor Decision|0|||
161196179|NCT03556202|582097114|FG001|Extension Treatment Period|Sponsor Decision|1|||
161196180|NCT03556202|582097115|FG002|Extension Treatment Period|Sponsor Decision|0|||
161196181|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
161196182|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
161196183|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
161196184|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Death|1|||
161196185|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Death|0|||
161196186|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Death|0|||
161196187|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
161196188|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
161196189|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
161196190|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
161196191|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
161196192|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
161350224|NCT05028517|582666878|FG000|Overall Study|Withdrawal by Subject|0|||
161196193|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
161196194|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
161196195|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
161196196|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
161196197|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
161350225|NCT05028517|582666879|FG001|Overall Study|Withdrawal by Subject|0|||
161350226|NCT05028517|582666880|FG002|Overall Study|Withdrawal by Subject|1|||
161196198|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
161196199|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
161196200|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
161196201|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
161196202|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
161196203|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
161196204|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
161196205|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
161196206|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
161196207|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
161196208|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
161196209|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
161196210|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
161196211|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
161196212|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
161196213|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
161196214|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
161196215|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
161196216|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
161196217|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
161196218|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
161196219|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
161196220|NCT03556202|582097113|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
161196221|NCT03556202|582097114|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
161196222|NCT03556202|582097115|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
161196223|NCT00678652|582097116|FG000|Overall Study|Protocol Violation|2|||
161196224|NCT00678652|582097117|FG001|Overall Study|Protocol Violation|0|||
161196225|NCT00678652|582097118|FG002|Overall Study|Protocol Violation|0|||
161196226|NCT00678652|582097119|FG003|Overall Study|Protocol Violation|0|||
161196227|NCT00678652|582097116|FG000|Overall Study|Pregnancy|0|||
161196228|NCT00678652|582097117|FG001|Overall Study|Pregnancy|0|||
161196229|NCT00678652|582097118|FG002|Overall Study|Pregnancy|1|||
161196230|NCT00678652|582097119|FG003|Overall Study|Pregnancy|0|||
161196231|NCT00678652|582097116|FG000|Overall Study|Relocation|1|||
161196232|NCT00678652|582097117|FG001|Overall Study|Relocation|0|||
161196233|NCT00678652|582097118|FG002|Overall Study|Relocation|0|||
161196234|NCT00678652|582097119|FG003|Overall Study|Relocation|0|||
161196235|NCT05146999|582097120|FG000|Overall Study|Withdrew consent|6|||
161196236|NCT05146999|582097121|FG001|Overall Study|Withdrew consent|1|||
161196237|NCT05146999|582097120|FG000|Overall Study|Lost to Follow-up|3|||
161196238|NCT05146999|582097121|FG001|Overall Study|Lost to Follow-up|2|||
161196239|NCT05146999|582097120|FG000|Overall Study|Other|1|||
161196240|NCT05146999|582097121|FG001|Overall Study|Other|3|||
161196241|NCT03319160|582097122|FG000|Overall Study|Data not available.|7|||
161196242|NCT00665002|582097123|FG000|Overall Study|Progression/relapse during treatment|11|||
161196243|NCT00665002|582097123|FG000|Overall Study|Cytogenetic resistance|1|||
161196244|NCT03604159|582097124|FG000|Overall Study|Lost to Follow-up|6|||
161196245|NCT03604159|582097125|FG001|Overall Study|Lost to Follow-up|7|||
161196246|NCT02260791|582097129|FG000|Overall Study|Lost to Follow-up|4|||
161196247|NCT02260791|582097130|FG001|Overall Study|Lost to Follow-up|4|||
161196248|NCT02260791|582097129|FG000|Overall Study|Lack of Efficacy|2|||
161196249|NCT02260791|582097130|FG001|Overall Study|Lack of Efficacy|1|||
161196250|NCT02260791|582097129|FG000|Overall Study|Adverse Event|13|||
161196251|NCT02260791|582097130|FG001|Overall Study|Adverse Event|9|||
161196252|NCT02260791|582097129|FG000|Overall Study|Death|1|||
161196253|NCT02260791|582097130|FG001|Overall Study|Death|0|||
161196254|NCT02260791|582097129|FG000|Overall Study|Withdrawal by Subject|11|||
161196255|NCT02260791|582097130|FG001|Overall Study|Withdrawal by Subject|16|||
161196256|NCT02260791|582097129|FG000|Overall Study|Screen failure|0|||
161196257|NCT02260791|582097130|FG001|Overall Study|Screen failure|1|||
161196258|NCT02260791|582097129|FG000|Overall Study|Protocol deviation|2|||
161196259|NCT02260791|582097130|FG001|Overall Study|Protocol deviation|3|||
161196260|NCT01411917|582097131|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
161196261|NCT01411917|582097132|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
161196262|NCT02354599|582097135|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
161196263|NCT02354599|582097136|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
161196264|NCT02354599|582097137|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
161196265|NCT02354599|582097138|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
161196266|NCT02354599|582097139|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
161196267|NCT02354599|582097140|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
161196268|NCT02354599|582097135|FG000|Overall Study|Withdrawal by Subject|1|||
161196269|NCT02354599|582097136|FG001|Overall Study|Withdrawal by Subject|1|||
161196270|NCT02354599|582097137|FG002|Overall Study|Withdrawal by Subject|0|||
161350227|NCT05089656|582666881|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
161350228|NCT05089656|582666882|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
161196271|NCT02354599|582097138|FG003|Overall Study|Withdrawal by Subject|0|||
161196272|NCT02354599|582097139|FG004|Overall Study|Withdrawal by Subject|0|||
161196273|NCT02354599|582097140|FG005|Overall Study|Withdrawal by Subject|0|||
161196274|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Death|2|||
161196275|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Death|0|||
161196276|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Adverse Event|33|||
161196277|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Adverse Event|31|||
161196278|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
161196279|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
161196280|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
161196281|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
161196282|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
161196283|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
161196284|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Other|7|||
161196285|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Other|8|||
161196286|NCT00280059|582097141|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
161196287|NCT00280059|582097142|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
161196288|NCT00495794|582097145|FG000|Overall Study|Pharmacist did not activate patient|522|||
161196289|NCT00495794|582097146|FG001|Overall Study|Pharmacist did not activate patient|0|||
161196290|NCT01302366|582099264|FG000|Overall Study|patient choice or noncompliance|5|||
161196291|NCT00198107|582099267|FG000|Double-Blind Period|Adverse Event|1|||
161196292|NCT00198107|582099268|FG001|Double-Blind Period|Adverse Event|1|||
161196293|NCT00198107|582099269|FG002|Double-Blind Period|Adverse Event|0|||
161196294|NCT00198107|582099267|FG000|Double-Blind Period|Lack of Efficacy|2|||
161196295|NCT00198107|582099268|FG001|Double-Blind Period|Lack of Efficacy|0|||
161196296|NCT00198107|582099269|FG002|Double-Blind Period|Lack of Efficacy|0|||
161196297|NCT00198107|582099267|FG000|Double-Blind Period|Lost to Follow-up|2|||
161196298|NCT00198107|582099268|FG001|Double-Blind Period|Lost to Follow-up|1|||
161196299|NCT00198107|582099269|FG002|Double-Blind Period|Lost to Follow-up|0|||
161196300|NCT00198107|582099267|FG000|Double-Blind Period|Physician Decision|1|||
161196301|NCT00198107|582099268|FG001|Double-Blind Period|Physician Decision|0|||
161196302|NCT00198107|582099269|FG002|Double-Blind Period|Physician Decision|0|||
161196303|NCT00198107|582099267|FG000|Double-Blind Period|Withdrawal by Subject|0|||
161196304|NCT00198107|582099268|FG001|Double-Blind Period|Withdrawal by Subject|1|||
161196305|NCT00198107|582099269|FG002|Double-Blind Period|Withdrawal by Subject|0|||
161196306|NCT00198107|582099267|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
161196307|NCT00198107|582099268|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
161196308|NCT00198107|582099269|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
161196309|NCT02513732|582099270|FG000|Overall Study|Lost to Follow-up|11|||
161196310|NCT02513732|582099270|FG000|Overall Study|Death|9|||
161196311|NCT02513732|582099270|FG000|Overall Study|Changing hospital|2|||
161196312|NCT00467051|582099271|FG000|Overall Study|Adverse Event|2|||
161196313|NCT00934661|582099272|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
161196314|NCT00934661|582099273|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
161196315|NCT01846442|582099278|FG000|Overall Study|Adverse Event|2|||
161196316|NCT01846442|582099279|FG001|Overall Study|Adverse Event|4|||
161196317|NCT01846442|582099280|FG002|Overall Study|Adverse Event|2|||
161196318|NCT01846442|582099281|FG003|Overall Study|Adverse Event|1|||
161196319|NCT01846442|582099278|FG000|Overall Study|Lost to Follow-up|0|||
161196320|NCT01846442|582099279|FG001|Overall Study|Lost to Follow-up|0|||
161196321|NCT01846442|582099280|FG002|Overall Study|Lost to Follow-up|1|||
161196322|NCT01846442|582099281|FG003|Overall Study|Lost to Follow-up|0|||
161196323|NCT01846442|582099278|FG000|Overall Study|Withdrawal by Subject|3|||
161196324|NCT01846442|582099279|FG001|Overall Study|Withdrawal by Subject|2|||
161196325|NCT01846442|582099280|FG002|Overall Study|Withdrawal by Subject|0|||
161196326|NCT01846442|582099281|FG003|Overall Study|Withdrawal by Subject|1|||
161196327|NCT01846442|582099278|FG000|Overall Study|Left the city/Lost medication|1|||
161196328|NCT01846442|582099279|FG001|Overall Study|Left the city/Lost medication|0|||
161196329|NCT01846442|582099280|FG002|Overall Study|Left the city/Lost medication|1|||
161196330|NCT01846442|582099281|FG003|Overall Study|Left the city/Lost medication|1|||
161196331|NCT02777554|582099284|FG000|Overall Study|Adverse Event|4|||
161196332|NCT02777554|582099285|FG001|Overall Study|Adverse Event|4|||
161196333|NCT02777554|582099286|FG002|Overall Study|Adverse Event|0|||
161196334|NCT02777554|582099287|FG003|Overall Study|Adverse Event|1|||
161196335|NCT02777554|582099288|FG004|Overall Study|Adverse Event|0|||
161196336|NCT02777554|582099289|FG005|Overall Study|Adverse Event|0|||
161196337|NCT02777554|582099284|FG000|Overall Study|Withdrawal by Subject|3|||
161196338|NCT02777554|582099285|FG001|Overall Study|Withdrawal by Subject|1|||
161196339|NCT02777554|582099286|FG002|Overall Study|Withdrawal by Subject|1|||
161196340|NCT02777554|582099287|FG003|Overall Study|Withdrawal by Subject|0|||
161196341|NCT02777554|582099288|FG004|Overall Study|Withdrawal by Subject|0|||
161196342|NCT02777554|582099289|FG005|Overall Study|Withdrawal by Subject|0|||
161196343|NCT02777554|582099284|FG000|Overall Study|Discharged early due to hurricane|22|||
161196344|NCT02777554|582099285|FG001|Overall Study|Discharged early due to hurricane|20|||
161196345|NCT02777554|582099286|FG002|Overall Study|Discharged early due to hurricane|0|||
161196346|NCT02777554|582099287|FG003|Overall Study|Discharged early due to hurricane|0|||
161196347|NCT02777554|582099288|FG004|Overall Study|Discharged early due to hurricane|0|||
161196348|NCT02777554|582099289|FG005|Overall Study|Discharged early due to hurricane|0|||
161196349|NCT02777554|582099284|FG000|Overall Study|Other - Miscellaneous|1|||
161196350|NCT02777554|582099285|FG001|Overall Study|Other - Miscellaneous|0|||
161196351|NCT02777554|582099286|FG002|Overall Study|Other - Miscellaneous|0|||
161196352|NCT02777554|582099287|FG003|Overall Study|Other - Miscellaneous|0|||
161196353|NCT02777554|582099288|FG004|Overall Study|Other - Miscellaneous|0|||
161196354|NCT02777554|582099289|FG005|Overall Study|Other - Miscellaneous|0|||
161196355|NCT02147132|582099290|FG000|Overall Study|Lost to Follow-up|1|||
161196356|NCT02147132|582099291|FG001|Overall Study|Lost to Follow-up|0|||
161196357|NCT02147132|582099292|FG002|Overall Study|Lost to Follow-up|0|||
161196358|NCT02147132|582099293|FG003|Overall Study|Lost to Follow-up|0|||
161196359|NCT01013207|582099294|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
161196360|NCT01541644|582099299|FG000|Overall Study|Withdrawal by Subject|3|||
161196361|NCT01458535|582099302|FG000|Overall Study|Other|0|||
161196362|NCT01458535|582099303|FG001|Overall Study|Other|0|||
161196363|NCT01458535|582099304|FG002|Overall Study|Other|0|||
161196364|NCT01458535|582099305|FG003|Overall Study|Other|0|||
161196365|NCT01458535|582099306|FG004|Overall Study|Other|1|||
161196366|NCT01458535|582099307|FG005|Overall Study|Other|1|||
161350229|NCT05089656|582666881|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
161350230|NCT05089656|582666882|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
161350231|NCT05089656|582666881|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
161350232|NCT05089656|582666882|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
161196367|NCT01458535|582099302|FG000|Overall Study|Withdrawal by Subject|0|||
161196368|NCT01458535|582099303|FG001|Overall Study|Withdrawal by Subject|0|||
161196369|NCT01458535|582099304|FG002|Overall Study|Withdrawal by Subject|2|||
161196370|NCT01458535|582099305|FG003|Overall Study|Withdrawal by Subject|0|||
161196371|NCT01458535|582099306|FG004|Overall Study|Withdrawal by Subject|1|||
161196372|NCT01458535|582099307|FG005|Overall Study|Withdrawal by Subject|1|||
161196373|NCT01458535|582099302|FG000|Overall Study|Lost to Follow-up|0|||
161196374|NCT01458535|582099303|FG001|Overall Study|Lost to Follow-up|2|||
161196375|NCT01458535|582099304|FG002|Overall Study|Lost to Follow-up|0|||
161196376|NCT01458535|582099305|FG003|Overall Study|Lost to Follow-up|3|||
161196377|NCT01458535|582099306|FG004|Overall Study|Lost to Follow-up|2|||
161196378|NCT01458535|582099307|FG005|Overall Study|Lost to Follow-up|2|||
161196379|NCT01458535|582099302|FG000|Overall Study|Adverse Event|0|||
161196380|NCT01458535|582099303|FG001|Overall Study|Adverse Event|0|||
161196381|NCT01458535|582099304|FG002|Overall Study|Adverse Event|0|||
161196382|NCT01458535|582099305|FG003|Overall Study|Adverse Event|1|||
161196383|NCT01458535|582099306|FG004|Overall Study|Adverse Event|0|||
161196384|NCT01458535|582099307|FG005|Overall Study|Adverse Event|0|||
161196385|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
161196386|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
161196387|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196388|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196389|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196390|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196391|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196392|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196393|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196394|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196395|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196396|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
161196397|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161196398|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196399|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196400|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196401|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196402|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196403|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161350233|NCT05089656|582666881|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
161350234|NCT05089656|582666882|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
161350235|NCT02535416|582666886|FG000|Overall Study|Family bereavement overseas|1|||
161350236|NCT02535416|582666887|FG001|Overall Study|Family bereavement overseas|0|||
161196404|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196405|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196406|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196407|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
161196408|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
161196409|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196410|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
161196411|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196412|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196413|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196414|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196415|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196416|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196417|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196418|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196419|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196420|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
161196421|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
161196422|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
161196423|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
161196424|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
161196425|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
161196426|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
161196427|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
161196428|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
161196429|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
161196430|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
161196431|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
161196432|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
161196433|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196434|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196435|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196436|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196437|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196438|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
161196439|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196440|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196441|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196442|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196443|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196444|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
161196445|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196446|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196447|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196448|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196449|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196450|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
161196451|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196452|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196453|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196454|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196455|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196456|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
161196457|NCT00151775|582099308|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196458|NCT00151775|582099309|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196459|NCT00151775|582099310|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196460|NCT00151775|582099311|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196461|NCT00151775|582099312|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196462|NCT00151775|582099313|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196463|NCT00151775|582099314|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
161196464|NCT00151775|582099315|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196465|NCT00151775|582099316|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196466|NCT00151775|582099317|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196467|NCT00151775|582099318|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196468|NCT00151775|582099319|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
161196469|NCT00151775|582099308|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196470|NCT00151775|582099309|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196471|NCT00151775|582099310|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196472|NCT00151775|582099311|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196473|NCT00151775|582099312|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196474|NCT00151775|582099313|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
161196475|NCT00151775|582099314|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196476|NCT00151775|582099315|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196477|NCT00151775|582099316|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196478|NCT00151775|582099317|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196479|NCT00151775|582099318|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196480|NCT00151775|582099319|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
161196481|NCT00151775|582099308|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
161196482|NCT00151775|582099309|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
161196483|NCT00151775|582099310|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
161196484|NCT00151775|582099311|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
161196485|NCT00151775|582099312|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
161196486|NCT00151775|582099313|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
161196487|NCT00151775|582099314|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
161196488|NCT00151775|582099315|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
161196489|NCT00151775|582099316|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
161196490|NCT00151775|582099317|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
161196491|NCT00151775|582099318|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
161196492|NCT00151775|582099319|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
161196493|NCT00151775|582099308|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196494|NCT00151775|582099309|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196495|NCT00151775|582099310|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196496|NCT00151775|582099311|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196497|NCT00151775|582099312|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196498|NCT00151775|582099313|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196499|NCT00151775|582099314|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
161196500|NCT00151775|582099315|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196501|NCT00151775|582099316|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196502|NCT00151775|582099317|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196503|NCT00151775|582099318|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196504|NCT00151775|582099319|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
161196505|NCT00151775|582099308|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196506|NCT00151775|582099309|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196507|NCT00151775|582099310|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
161196508|NCT00151775|582099311|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196509|NCT00151775|582099312|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196510|NCT00151775|582099313|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196511|NCT00151775|582099314|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196512|NCT00151775|582099315|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196513|NCT00151775|582099316|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196514|NCT00151775|582099317|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196515|NCT00151775|582099318|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196516|NCT00151775|582099319|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
161196517|NCT00151775|582099308|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196518|NCT00151775|582099309|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196519|NCT00151775|582099310|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
161196520|NCT00151775|582099311|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196521|NCT00151775|582099312|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196522|NCT00151775|582099313|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196523|NCT00151775|582099314|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196524|NCT00151775|582099315|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196525|NCT00151775|582099316|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196526|NCT00151775|582099317|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196527|NCT00151775|582099318|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196528|NCT00151775|582099319|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
161196529|NCT00151775|582099308|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196530|NCT00151775|582099309|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196531|NCT00151775|582099310|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196532|NCT00151775|582099311|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196533|NCT00151775|582099312|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196534|NCT00151775|582099313|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196535|NCT00151775|582099314|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196536|NCT00151775|582099315|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196537|NCT00151775|582099316|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196538|NCT00151775|582099317|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196539|NCT00151775|582099318|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
161196540|NCT00151775|582099319|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
161306670|NCT00595517|582502902|FG000|Overall Study|No intention to attend regularly|1|||
161196541|NCT00151775|582099308|FG000|Period 4: Open Label|Increased blood pressure|0|||
161196542|NCT00151775|582099309|FG001|Period 4: Open Label|Increased blood pressure|0|||
161196543|NCT00151775|582099310|FG002|Period 4: Open Label|Increased blood pressure|0|||
161196544|NCT00151775|582099311|FG003|Period 4: Open Label|Increased blood pressure|0|||
161196545|NCT00151775|582099312|FG004|Period 4: Open Label|Increased blood pressure|1|||
161196546|NCT00151775|582099313|FG005|Period 4: Open Label|Increased blood pressure|0|||
161196547|NCT00151775|582099314|FG006|Period 4: Open Label|Increased blood pressure|0|||
161196548|NCT00151775|582099315|FG007|Period 4: Open Label|Increased blood pressure|0|||
161196549|NCT00151775|582099316|FG008|Period 4: Open Label|Increased blood pressure|0|||
161196550|NCT00151775|582099317|FG009|Period 4: Open Label|Increased blood pressure|1|||
161196551|NCT00151775|582099318|FG010|Period 4: Open Label|Increased blood pressure|0|||
161196552|NCT00151775|582099319|FG011|Period 4: Open Label|Increased blood pressure|0|||
161196553|NCT00151775|582099308|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
161196554|NCT00151775|582099309|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
161196555|NCT00151775|582099310|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
161196556|NCT00151775|582099311|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
161196557|NCT00151775|582099312|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
161196558|NCT00151775|582099313|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
161196559|NCT00151775|582099314|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
161196560|NCT00151775|582099315|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
161196561|NCT00151775|582099316|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
161196562|NCT00151775|582099317|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
161196563|NCT00151775|582099318|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
161196564|NCT00151775|582099319|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
161196565|NCT00151775|582099308|FG000|Period 4: Open Label|Adverse Event|0|||
161196566|NCT00151775|582099309|FG001|Period 4: Open Label|Adverse Event|0|||
161196567|NCT00151775|582099310|FG002|Period 4: Open Label|Adverse Event|0|||
161196568|NCT00151775|582099311|FG003|Period 4: Open Label|Adverse Event|0|||
161196569|NCT00151775|582099312|FG004|Period 4: Open Label|Adverse Event|1|||
161196570|NCT00151775|582099313|FG005|Period 4: Open Label|Adverse Event|0|||
161196571|NCT00151775|582099314|FG006|Period 4: Open Label|Adverse Event|0|||
161196572|NCT00151775|582099315|FG007|Period 4: Open Label|Adverse Event|0|||
161196573|NCT00151775|582099316|FG008|Period 4: Open Label|Adverse Event|0|||
161196574|NCT00151775|582099317|FG009|Period 4: Open Label|Adverse Event|2|||
161196575|NCT00151775|582099318|FG010|Period 4: Open Label|Adverse Event|0|||
161196576|NCT00151775|582099319|FG011|Period 4: Open Label|Adverse Event|0|||
161196577|NCT00151775|582099308|FG000|Period 4: Open Label|Lost to Follow-up|0|||
161196578|NCT00151775|582099309|FG001|Period 4: Open Label|Lost to Follow-up|0|||
161196579|NCT00151775|582099310|FG002|Period 4: Open Label|Lost to Follow-up|0|||
161196580|NCT00151775|582099311|FG003|Period 4: Open Label|Lost to Follow-up|0|||
161196581|NCT00151775|582099312|FG004|Period 4: Open Label|Lost to Follow-up|17|||
161196582|NCT00151775|582099313|FG005|Period 4: Open Label|Lost to Follow-up|0|||
161196583|NCT00151775|582099314|FG006|Period 4: Open Label|Lost to Follow-up|0|||
161196584|NCT00151775|582099315|FG007|Period 4: Open Label|Lost to Follow-up|0|||
161196585|NCT00151775|582099316|FG008|Period 4: Open Label|Lost to Follow-up|0|||
161196586|NCT00151775|582099317|FG009|Period 4: Open Label|Lost to Follow-up|7|||
161196587|NCT00151775|582099318|FG010|Period 4: Open Label|Lost to Follow-up|0|||
161196588|NCT00151775|582099319|FG011|Period 4: Open Label|Lost to Follow-up|0|||
161196589|NCT00151775|582099308|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
161196590|NCT00151775|582099309|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
161196591|NCT00151775|582099310|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
161196592|NCT00151775|582099311|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
161196593|NCT00151775|582099312|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
161196594|NCT00151775|582099313|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
161196595|NCT00151775|582099314|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
161196596|NCT00151775|582099315|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
161196597|NCT00151775|582099316|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
161196598|NCT00151775|582099317|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
161196599|NCT00151775|582099318|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
161196600|NCT00151775|582099319|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
161196601|NCT00151775|582099308|FG000|Period 4: Open Label|Other|0|||
161196602|NCT00151775|582099309|FG001|Period 4: Open Label|Other|0|||
161196603|NCT00151775|582099310|FG002|Period 4: Open Label|Other|0|||
161196604|NCT00151775|582099311|FG003|Period 4: Open Label|Other|0|||
161196605|NCT00151775|582099312|FG004|Period 4: Open Label|Other|1|||
161196606|NCT00151775|582099313|FG005|Period 4: Open Label|Other|0|||
161196607|NCT00151775|582099314|FG006|Period 4: Open Label|Other|0|||
161196608|NCT00151775|582099315|FG007|Period 4: Open Label|Other|0|||
161196609|NCT00151775|582099316|FG008|Period 4: Open Label|Other|0|||
161196610|NCT00151775|582099317|FG009|Period 4: Open Label|Other|3|||
161196611|NCT00151775|582099318|FG010|Period 4: Open Label|Other|0|||
161196612|NCT00151775|582099319|FG011|Period 4: Open Label|Other|0|||
161196613|NCT00151775|582099308|FG000|Period 4: Open Label|Physician Decision|0|||
161196614|NCT00151775|582099309|FG001|Period 4: Open Label|Physician Decision|0|||
161196615|NCT00151775|582099310|FG002|Period 4: Open Label|Physician Decision|0|||
161196616|NCT00151775|582099311|FG003|Period 4: Open Label|Physician Decision|0|||
161196617|NCT00151775|582099312|FG004|Period 4: Open Label|Physician Decision|0|||
161196618|NCT00151775|582099313|FG005|Period 4: Open Label|Physician Decision|0|||
161196619|NCT00151775|582099314|FG006|Period 4: Open Label|Physician Decision|0|||
161196620|NCT00151775|582099315|FG007|Period 4: Open Label|Physician Decision|0|||
161196621|NCT00151775|582099316|FG008|Period 4: Open Label|Physician Decision|0|||
161196622|NCT00151775|582099317|FG009|Period 4: Open Label|Physician Decision|2|||
161196623|NCT00151775|582099318|FG010|Period 4: Open Label|Physician Decision|0|||
161196624|NCT00151775|582099319|FG011|Period 4: Open Label|Physician Decision|0|||
161196625|NCT00151775|582099308|FG000|Period 4: Open Label|Protocol Violation|0|||
161196626|NCT00151775|582099309|FG001|Period 4: Open Label|Protocol Violation|0|||
161196627|NCT00151775|582099310|FG002|Period 4: Open Label|Protocol Violation|0|||
161196628|NCT00151775|582099311|FG003|Period 4: Open Label|Protocol Violation|0|||
161196629|NCT00151775|582099312|FG004|Period 4: Open Label|Protocol Violation|1|||
161196630|NCT00151775|582099313|FG005|Period 4: Open Label|Protocol Violation|0|||
161196631|NCT00151775|582099314|FG006|Period 4: Open Label|Protocol Violation|0|||
161196632|NCT00151775|582099315|FG007|Period 4: Open Label|Protocol Violation|0|||
161196633|NCT00151775|582099316|FG008|Period 4: Open Label|Protocol Violation|0|||
161196634|NCT00151775|582099317|FG009|Period 4: Open Label|Protocol Violation|0|||
161196635|NCT00151775|582099318|FG010|Period 4: Open Label|Protocol Violation|0|||
161196636|NCT00151775|582099319|FG011|Period 4: Open Label|Protocol Violation|0|||
161196637|NCT00474994|582099320|FG000|Overall Study|Patient Not treated|1|||
161196638|NCT00474994|582099320|FG000|Overall Study|Patient evaluable for toxicity only|3|||
161196639|NCT00474994|582099320|FG000|Overall Study|Patient found to be ineligible|1|||
161196640|NCT00278473|582099321|FG000|Overall Study|drop out|4|||
161196641|NCT00278473|582099322|FG001|Overall Study|drop out|3|||
161196642|NCT00761761|582099323|FG000|Overall Study|Lost to Follow-up|3|||
161196643|NCT00761761|582099324|FG001|Overall Study|Lost to Follow-up|1|||
161196644|NCT00761761|582099323|FG000|Overall Study|Withdrawal by Subject|3|||
161196645|NCT00761761|582099324|FG001|Overall Study|Withdrawal by Subject|0|||
161196646|NCT04001790|582099325|FG000|Overall Study|Withdrawal by Subject|1|||
161196647|NCT04001790|582099326|FG001|Overall Study|Withdrawal by Subject|2|||
161196648|NCT01711736|582099327|FG000|Overall Study|Lost to Follow-up|4|||
161196649|NCT01711736|582099328|FG001|Overall Study|Lost to Follow-up|1|||
161196650|NCT01711736|582099327|FG000|Overall Study|Withdrawal by Subject|6|||
161196651|NCT01711736|582099328|FG001|Overall Study|Withdrawal by Subject|6|||
161196652|NCT01711736|582099327|FG000|Overall Study|Migrated/moved from study area|2|||
161196653|NCT01711736|582099328|FG001|Overall Study|Migrated/moved from study area|1|||
161196654|NCT02706327|582099329|FG000|Overall Study|Lost to Follow-up|1|||
161196655|NCT02706327|582099330|FG001|Overall Study|Lost to Follow-up|1|||
161196656|NCT02706327|582099331|FG002|Overall Study|Lost to Follow-up|2|||
161196657|NCT02652793|582099334|FG000|Overall Study|Adverse Event|1|||
161196658|NCT02652793|582099334|FG000|Overall Study|Lost to Follow-up|2|||
161196659|NCT02652793|582099334|FG000|Overall Study|Withdrawal by Subject|1|||
161196660|NCT04963231|582099335|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
161196661|NCT04963231|582099336|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
161196662|NCT04963231|582099337|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
161196663|NCT04963231|582099335|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
161196664|NCT04963231|582099336|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
161196665|NCT04963231|582099337|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
161196666|NCT04963231|582099335|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
161196667|NCT04963231|582099336|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
161196668|NCT04963231|582099337|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
161196669|NCT04963231|582099335|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
161196670|NCT04963231|582099336|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
161196671|NCT04963231|582099337|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
161196672|NCT04963231|582099335|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
161196673|NCT04963231|582099336|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
161196674|NCT04963231|582099337|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
161196675|NCT04963231|582099335|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
161196676|NCT04963231|582099336|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
161196677|NCT04963231|582099337|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
161196678|NCT04963231|582099335|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
161196679|NCT04963231|582099336|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
161196680|NCT04963231|582099337|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
161196681|NCT01059175|582099338|FG000|Overall Study|Death|17|||
161196682|NCT01059175|582099339|FG001|Overall Study|Death|17|||
161196683|NCT01059175|582099338|FG000|Overall Study|Adverse Event|4|||
161196684|NCT01059175|582099339|FG001|Overall Study|Adverse Event|2|||
161196685|NCT01059175|582099338|FG000|Overall Study|Lost to Follow-up|0|||
161196686|NCT01059175|582099339|FG001|Overall Study|Lost to Follow-up|1|||
161196687|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Adverse Event|4|||
161196688|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Adverse Event|3|||
161196689|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Adverse Event|0|||
161196690|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Adverse Event|0|||
161196691|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Death|24|||
161196692|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Death|9|||
161196693|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Death|0|||
161196694|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Death|0|||
161196695|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
161196696|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
161196697|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
161196698|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
161196699|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Physician Decision|4|||
161196700|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Physician Decision|1|||
161196701|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Physician Decision|0|||
161196702|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Physician Decision|0|||
161196703|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Progressive disease|1|||
161196704|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Progressive disease|0|||
161196705|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Progressive disease|0|||
161196706|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Progressive disease|0|||
161196707|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
161196708|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
161196709|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
161196710|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
161196711|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
161196712|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161196713|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161196714|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
161306671|NCT00387010|582502905|FG000|Dose Titration Period|Adverse Event|12|||
161090484|NCT02795429|581721659|FG002|Overall Study|Death|1|||
161090485|NCT02795429|581721660|FG003|Overall Study|Death|2|||
161090486|NCT02795429|581721661|FG004|Overall Study|Death|1|||
161090487|NCT02795429|581721657|FG000|Overall Study|Physician Decision|0|||
161090488|NCT02795429|581721658|FG001|Overall Study|Physician Decision|0|||
161090489|NCT02795429|581721659|FG002|Overall Study|Physician Decision|2|||
161090490|NCT02795429|581721660|FG003|Overall Study|Physician Decision|1|||
161090491|NCT02795429|581721661|FG004|Overall Study|Physician Decision|5|||
161090492|NCT02795429|581721657|FG000|Overall Study|Progressive disease|3|||
161090493|NCT02795429|581721658|FG001|Overall Study|Progressive disease|7|||
161090494|NCT02795429|581721659|FG002|Overall Study|Progressive disease|6|||
161090495|NCT02795429|581721660|FG003|Overall Study|Progressive disease|26|||
161090496|NCT02795429|581721661|FG004|Overall Study|Progressive disease|20|||
161090497|NCT02795429|581721657|FG000|Overall Study|Subject/guardian decision|1|||
161090498|NCT02795429|581721658|FG001|Overall Study|Subject/guardian decision|1|||
161090499|NCT02795429|581721659|FG002|Overall Study|Subject/guardian decision|1|||
161090500|NCT02795429|581721660|FG003|Overall Study|Subject/guardian decision|1|||
161090501|NCT02795429|581721661|FG004|Overall Study|Subject/guardian decision|3|||
161090502|NCT05220254|581721662|FG000|Overall Study|Withdrawal by Subject|4|||
161090503|NCT05220254|581721662|FG000|Overall Study|Removed due to ineligibility|1|||
161090504|NCT05220254|581721662|FG000|Overall Study|Lost to Follow-up|7|||
161090505|NCT01557283|581721665|FG000|Overall Study|Lost to Follow-up|7|||
161090506|NCT01557283|581721665|FG000|Overall Study|Non-responder|19|||
161090507|NCT01557283|581721665|FG000|Overall Study|Adverse Event|7|||
161090508|NCT01557283|581721665|FG000|Overall Study|Lack of Efficacy|1|||
161090509|NCT01557283|581721665|FG000|Overall Study|Non-compliance|1|||
161090510|NCT01557283|581721665|FG000|Overall Study|Withdrawal by Subject|1|||
161090511|NCT01557283|581721665|FG000|Overall Study|Participant's weight too high for dose|1|||
161090512|NCT01557283|581721665|FG000|Overall Study|Worsening of psoriasis|1|||
161090513|NCT01557283|581721665|FG000|Overall Study|Other|6|||
161090514|NCT01765192|581721669|FG000|Treatment Period 1|Adverse Event|0|||
161090515|NCT01765192|581721670|FG001|Treatment Period 1|Adverse Event|1|||
161090516|NCT01765192|581721669|FG000|Washout Period|Voluntary Withdrawal|1|||
161090517|NCT01765192|581721670|FG001|Washout Period|Voluntary Withdrawal|1|||
161090518|NCT01765192|581721669|FG000|Washout Period|Reason not specified|1|||
161090519|NCT01765192|581721670|FG001|Washout Period|Reason not specified|0|||
161090520|NCT01765192|581721669|FG000|Treatment Period 2|Reason not specified|0|||
161090521|NCT01765192|581721670|FG001|Treatment Period 2|Reason not specified|2|||
161090522|NCT01765192|581721669|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
161090523|NCT01765192|581721670|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
161090524|NCT01016977|581721673|FG000|Overall Study|Lost to Follow-up|1|||
161090525|NCT01016977|581721674|FG001|Overall Study|Lost to Follow-up|0|||
161090526|NCT01016977|581721673|FG000|Overall Study|Withdrawal by Subject|2|||
161090527|NCT01016977|581721674|FG001|Overall Study|Withdrawal by Subject|2|||
161090528|NCT02080221|581721675|FG000|Overall Study|Withdrawal by Subject|1|||
161196715|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
161196716|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
161196717|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
161196718|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
161196719|NCT04579666|582099340|FG000|RTP (Up to Week 52)|Other|2|||
161196720|NCT04579666|582099341|FG001|RTP (Up to Week 52)|Other|0|||
161196721|NCT04579666|582099342|FG002|RTP (Up to Week 52)|Other|0|||
161196722|NCT04579666|582099343|FG003|RTP (Up to Week 52)|Other|0|||
161196723|NCT04579666|582099340|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161196724|NCT04579666|582099341|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161196725|NCT04579666|582099342|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
161196726|NCT04579666|582099343|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
161196727|NCT04579666|582099340|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
161196728|NCT04579666|582099341|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
161196729|NCT04579666|582099342|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
161196730|NCT04579666|582099343|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
161196731|NCT04579666|582099340|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
161196732|NCT04579666|582099341|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
161196733|NCT04579666|582099342|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
161196734|NCT04579666|582099343|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
161196735|NCT04579666|582099340|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
161196736|NCT04579666|582099341|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
161196737|NCT04579666|582099342|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
161196738|NCT04579666|582099343|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
161196739|NCT04579666|582099340|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
161196740|NCT04579666|582099341|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
161196741|NCT04579666|582099342|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
161196742|NCT04579666|582099343|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
161196743|NCT05450198|582099344|FG000|Overall Study|Withdrawal by Subject|1|||
161196744|NCT05450198|582099345|FG001|Overall Study|Withdrawal by Subject|1|||
161196745|NCT05450198|582099346|FG002|Overall Study|Withdrawal by Subject|2|||
161196746|NCT05450198|582099347|FG003|Overall Study|Withdrawal by Subject|0|||
161196747|NCT05450198|582099344|FG000|Overall Study|Lost to Follow-up|1|||
161196748|NCT05450198|582099345|FG001|Overall Study|Lost to Follow-up|0|||
161196749|NCT05450198|582099346|FG002|Overall Study|Lost to Follow-up|2|||
161196750|NCT05450198|582099347|FG003|Overall Study|Lost to Follow-up|1|||
161196751|NCT01982942|582099348|FG000|Overall Study|Adverse Event|10|||
161196752|NCT01982942|582099349|FG001|Overall Study|Adverse Event|5|||
161196753|NCT01982942|582099348|FG000|Overall Study|Lost to Follow-up|4|||
161196754|NCT01982942|582099349|FG001|Overall Study|Lost to Follow-up|3|||
161196755|NCT01982942|582099348|FG000|Overall Study|Multiple sclerosis progression|3|||
161196756|NCT01982942|582099349|FG001|Overall Study|Multiple sclerosis progression|2|||
161196757|NCT01982942|582099348|FG000|Overall Study|Wanted to try therapy not permitted|1|||
161196758|NCT01982942|582099349|FG001|Overall Study|Wanted to try therapy not permitted|0|||
161196759|NCT01982942|582099348|FG000|Overall Study|Subject declined future visits|0|||
161196760|NCT01982942|582099349|FG001|Overall Study|Subject declined future visits|1|||
161196761|NCT01982942|582099348|FG000|Overall Study|Left geographical area|2|||
161196762|NCT01982942|582099349|FG001|Overall Study|Left geographical area|0|||
161196763|NCT01982942|582099348|FG000|Overall Study|Too many pills|1|||
161196764|NCT01982942|582099349|FG001|Overall Study|Too many pills|0|||
161196765|NCT01982942|582099348|FG000|Overall Study|MS Relapse|0|||
161196766|NCT01982942|582099349|FG001|Overall Study|MS Relapse|1|||
161196767|NCT01982942|582099348|FG000|Overall Study|Chose to join a stem cell trial|0|||
161196768|NCT01982942|582099349|FG001|Overall Study|Chose to join a stem cell trial|1|||
161196769|NCT01982942|582099348|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
161196770|NCT01982942|582099349|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
161196771|NCT02213666|582099352|FG000|Overall Study|Withdrawal by Subject|1|||
161196772|NCT02190604|582099353|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196773|NCT02190604|582099354|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196774|NCT02190604|582099355|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196775|NCT02190604|582099356|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196776|NCT02190604|582099357|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196777|NCT02190604|582099358|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196778|NCT02190604|582099359|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161306672|NCT00387010|582502905|FG000|Dose Titration Period|Lack of Efficacy|5|||
161196779|NCT02190604|582099360|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196780|NCT02190604|582099361|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196781|NCT02190604|582099362|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196782|NCT02190604|582099363|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196783|NCT02190604|582099364|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196784|NCT02190604|582099365|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196785|NCT02190604|582099366|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196786|NCT02190604|582099367|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
161196787|NCT02190604|582099368|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196788|NCT02190604|582099369|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196789|NCT02190604|582099370|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196790|NCT02190604|582099371|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
161196791|NCT02190604|582099353|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196792|NCT02190604|582099354|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196793|NCT02190604|582099355|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196794|NCT02190604|582099356|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196795|NCT02190604|582099357|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196796|NCT02190604|582099358|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196797|NCT02190604|582099359|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196798|NCT02190604|582099360|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196799|NCT02190604|582099361|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196800|NCT02190604|582099362|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196801|NCT02190604|582099363|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196802|NCT02190604|582099364|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196803|NCT02190604|582099365|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196804|NCT02190604|582099366|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
161196805|NCT02190604|582099367|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196806|NCT02190604|582099368|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196807|NCT02190604|582099369|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196808|NCT02190604|582099370|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196809|NCT02190604|582099371|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
161196810|NCT02797951|582099372|FG000|Overall Study|Adverse Event|4|||
161196811|NCT02797951|582099372|FG000|Overall Study|Death|1|||
161196812|NCT02797951|582099372|FG000|Overall Study|Lack of Efficacy|19|||
161196813|NCT02797951|582099372|FG000|Overall Study|Lost to Follow-up|4|||
161196814|NCT02797951|582099372|FG000|Overall Study|Physician Decision|6|||
161196815|NCT02797951|582099372|FG000|Overall Study|Withdrawal by Subject|15|||
161196816|NCT01901393|582099373|FG000|Overall Study|Adverse Event|1|||
161196817|NCT01901393|582099374|FG001|Overall Study|Adverse Event|0|||
161196818|NCT00383292|582099381|FG000|Overall Study|Adverse Event|4|||
161196819|NCT00383292|582099382|FG001|Overall Study|Adverse Event|1|||
161196820|NCT00383292|582099383|FG002|Overall Study|Adverse Event|2|||
161196821|NCT00383292|582099381|FG000|Overall Study|Death|3|||
161196822|NCT00383292|582099382|FG001|Overall Study|Death|3|||
161196823|NCT00383292|582099383|FG002|Overall Study|Death|3|||
161196824|NCT00383292|582099381|FG000|Overall Study|Physician Decision|4|||
161196825|NCT00383292|582099382|FG001|Overall Study|Physician Decision|0|||
161196826|NCT00383292|582099383|FG002|Overall Study|Physician Decision|1|||
161196827|NCT00383292|582099381|FG000|Overall Study|Withdrawal by Subject|3|||
161196828|NCT00383292|582099382|FG001|Overall Study|Withdrawal by Subject|2|||
161196829|NCT00383292|582099383|FG002|Overall Study|Withdrawal by Subject|2|||
161196830|NCT00383292|582099381|FG000|Overall Study|Other|1|||
161196831|NCT00383292|582099382|FG001|Overall Study|Other|0|||
161196832|NCT00383292|582099383|FG002|Overall Study|Other|0|||
161196833|NCT00697255|582099384|FG000|Stage 1a|Insufficient ovarian response|1|||
161196834|NCT00697255|582099385|FG001|Stage 1a|Insufficient ovarian response|0|||
161196835|NCT00697255|582099384|FG000|Stage 1a|Multifollicular growth|1|||
161196836|NCT00697255|582099385|FG001|Stage 1a|Multifollicular growth|0|||
161196837|NCT00697255|582099384|FG000|Stage 1a|Not growing of dominant follicle|1|||
161196838|NCT00697255|582099385|FG001|Stage 1a|Not growing of dominant follicle|0|||
161196839|NCT00697255|582099384|FG000|Stage 1b|Not growing of dominant follicle|0|||
161196840|NCT00697255|582099385|FG001|Stage 1b|Not growing of dominant follicle|1|||
161196841|NCT00697255|582099384|FG000|Stage 1b|Insufficient ovarian response|0|||
161196842|NCT00697255|582099385|FG001|Stage 1b|Insufficient ovarian response|1|||
161196843|NCT05664672|582099395|FG000|Overall Study|Adverse Event|0|||
161196844|NCT05664672|582099396|FG001|Overall Study|Adverse Event|0|||
161196845|NCT05664672|582099397|FG002|Overall Study|Adverse Event|0|||
161196846|NCT05664672|582099398|FG003|Overall Study|Adverse Event|0|||
161196847|NCT05664672|582099399|FG004|Overall Study|Adverse Event|0|||
161196848|NCT05664672|582099400|FG005|Overall Study|Adverse Event|1|||
161196849|NCT05664672|582099395|FG000|Overall Study|Withdrawal by Subject|0|||
161196850|NCT05664672|582099396|FG001|Overall Study|Withdrawal by Subject|1|||
161196851|NCT05664672|582099397|FG002|Overall Study|Withdrawal by Subject|3|||
161196852|NCT05664672|582099398|FG003|Overall Study|Withdrawal by Subject|0|||
161196853|NCT05664672|582099399|FG004|Overall Study|Withdrawal by Subject|5|||
161196854|NCT05664672|582099400|FG005|Overall Study|Withdrawal by Subject|6|||
161196855|NCT05664672|582099395|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
161196856|NCT05664672|582099396|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
161196857|NCT05664672|582099397|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
161196858|NCT05664672|582099398|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
161196859|NCT05664672|582099399|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
161196860|NCT05664672|582099400|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
161196861|NCT05664672|582099395|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
161196862|NCT05664672|582099396|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161196863|NCT05664672|582099397|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161196864|NCT05664672|582099398|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161196865|NCT05664672|582099399|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161196866|NCT05664672|582099400|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
161196867|NCT00736840|582099405|FG000|Overall Study|Lost to Follow-up|13|||
161196868|NCT02815670|582099406|FG000|Overall Study|Prematurely discontinued of the trial|1|||
161196869|NCT01815099|582099409|FG000|Overall Study|Lack of Efficacy|1|||
161196870|NCT01815099|582099409|FG000|Overall Study|unable to attend study visits|1|||
161196871|NCT01475214|582099410|FG000|Overall Study|Lost to Follow-up|1|||
161196872|NCT01475214|582099411|FG001|Overall Study|Lost to Follow-up|0|||
161196873|NCT01475214|582099412|FG002|Overall Study|Lost to Follow-up|1|||
161196874|NCT01475214|582099410|FG000|Overall Study|Physician Decision|2|||
161196875|NCT01475214|582099411|FG001|Overall Study|Physician Decision|0|||
161196876|NCT01475214|582099412|FG002|Overall Study|Physician Decision|0|||
161196877|NCT01475214|582099410|FG000|Overall Study|Withdrawal by Subject|2|||
161196878|NCT01475214|582099411|FG001|Overall Study|Withdrawal by Subject|4|||
161196879|NCT01475214|582099412|FG002|Overall Study|Withdrawal by Subject|1|||
161196880|NCT00643851|582099413|FG000|Overall Study|Death|0|||
161196881|NCT00643851|582099414|FG001|Overall Study|Death|1|||
161196882|NCT00643851|582099415|FG002|Overall Study|Death|0|||
161196883|NCT00643851|582099413|FG000|Overall Study|Lack of Efficacy|0|||
161196884|NCT00643851|582099414|FG001|Overall Study|Lack of Efficacy|1|||
161196885|NCT00643851|582099415|FG002|Overall Study|Lack of Efficacy|0|||
161196886|NCT00643851|582099413|FG000|Overall Study|Adverse Event|2|||
161196887|NCT00643851|582099414|FG001|Overall Study|Adverse Event|6|||
161196888|NCT00643851|582099415|FG002|Overall Study|Adverse Event|6|||
161196889|NCT00643851|582099413|FG000|Overall Study|Lost to Follow-up|4|||
161196890|NCT00643851|582099414|FG001|Overall Study|Lost to Follow-up|6|||
161196891|NCT00643851|582099415|FG002|Overall Study|Lost to Follow-up|9|||
161196892|NCT00643851|582099413|FG000|Overall Study|Withdrawal by Subject|8|||
161196893|NCT00643851|582099414|FG001|Overall Study|Withdrawal by Subject|15|||
161196894|NCT00643851|582099415|FG002|Overall Study|Withdrawal by Subject|9|||
161196895|NCT00643851|582099413|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
161196896|NCT00643851|582099414|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
161196897|NCT00643851|582099415|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
161196898|NCT03289676|582099416|FG000|Overall Study|Withdrawal by Subject|2|||
161196899|NCT03289676|582099417|FG001|Overall Study|Withdrawal by Subject|0|||
161196900|NCT03289676|582099416|FG000|Overall Study|Protocol Violation|2|||
161196901|NCT03289676|582099417|FG001|Overall Study|Protocol Violation|0|||
161196902|NCT03289676|582099416|FG000|Overall Study|Lost to Follow-up|0|||
161196903|NCT03289676|582099417|FG001|Overall Study|Lost to Follow-up|1|||
161196904|NCT04806334|582099420|FG000|Overall Study|Withdrawal by Subject|1|||
161196905|NCT01636076|582099421|FG000|Overall Study|Terminated by sponsor|1|||
161196906|NCT01636076|582099422|FG001|Overall Study|Terminated by sponsor|1|||
161196907|NCT01636076|582099421|FG000|Overall Study|Lack of Efficacy|0|||
161196908|NCT01636076|582099422|FG001|Overall Study|Lack of Efficacy|1|||
161196909|NCT01636076|582099421|FG000|Overall Study|Lost to Follow-up|1|||
161196910|NCT01636076|582099422|FG001|Overall Study|Lost to Follow-up|0|||
161196911|NCT01636076|582099421|FG000|Overall Study|Physician Decision|1|||
161196912|NCT01636076|582099422|FG001|Overall Study|Physician Decision|1|||
161196913|NCT01636076|582099421|FG000|Overall Study|Non-compliance with study treatment|1|||
161196914|NCT01636076|582099422|FG001|Overall Study|Non-compliance with study treatment|1|||
161196915|NCT01636076|582099421|FG000|Overall Study|Adverse Event|6|||
161196916|NCT01636076|582099422|FG001|Overall Study|Adverse Event|11|||
161196917|NCT01636076|582099421|FG000|Overall Study|Withdrawal by Subject|7|||
161196918|NCT01636076|582099422|FG001|Overall Study|Withdrawal by Subject|10|||
161196919|NCT01159665|582099423|FG000|Overall Study|Withdrawal by Subject|0|||
161196920|NCT01159665|582099424|FG001|Overall Study|Withdrawal by Subject|1|||
161196921|NCT01159665|582099425|FG002|Overall Study|Withdrawal by Subject|0|||
161196922|NCT01159665|582099426|FG003|Overall Study|Withdrawal by Subject|0|||
161196923|NCT01159665|582099427|FG004|Overall Study|Withdrawal by Subject|0|||
161196924|NCT01159665|582099428|FG005|Overall Study|Withdrawal by Subject|0|||
161196925|NCT01130831|582099429|FG000|Overall Study|Withdrawal by Subject|7|||
161196926|NCT01130831|582099429|FG000|Overall Study|Death|4|||
161196927|NCT01130831|582099429|FG000|Overall Study|Information was missing|3|||
161196928|NCT00951912|582099430|FG000|Overall Study|Lack of Efficacy|1|||
161196929|NCT00951912|582099431|FG001|Overall Study|Lack of Efficacy|0|||
161196930|NCT00951912|582099432|FG002|Overall Study|Lack of Efficacy|0|||
161196931|NCT00951912|582099430|FG000|Overall Study|Adverse Event|0|||
161306673|NCT00387010|582502905|FG000|Dose Titration Period|Withdrawal by Subject|3|||
161196932|NCT00951912|582099431|FG001|Overall Study|Adverse Event|1|||
161196933|NCT00951912|582099432|FG002|Overall Study|Adverse Event|1|||
161196934|NCT00951912|582099430|FG000|Overall Study|Lost to Follow-up|2|||
161196935|NCT00951912|582099431|FG001|Overall Study|Lost to Follow-up|2|||
161306674|NCT00387010|582502905|FG000|Dose Titration Period|Protocol Violation|1|||
161196936|NCT00951912|582099432|FG002|Overall Study|Lost to Follow-up|0|||
161196937|NCT00951912|582099430|FG000|Overall Study|Physician Decision|1|||
161196938|NCT00951912|582099431|FG001|Overall Study|Physician Decision|0|||
161196939|NCT00951912|582099432|FG002|Overall Study|Physician Decision|1|||
161196940|NCT00951912|582099430|FG000|Overall Study|Withdrawal by Subject|1|||
161196941|NCT00951912|582099431|FG001|Overall Study|Withdrawal by Subject|1|||
161196942|NCT00951912|582099432|FG002|Overall Study|Withdrawal by Subject|0|||
161196943|NCT00951912|582099430|FG000|Overall Study|Other:Depression|1|||
161196944|NCT00951912|582099431|FG001|Overall Study|Other:Depression|0|||
161196945|NCT00951912|582099432|FG002|Overall Study|Other:Depression|0|||
161196946|NCT00951912|582099430|FG000|Overall Study|Other: Colon cancer|1|||
161196947|NCT00951912|582099431|FG001|Overall Study|Other: Colon cancer|0|||
161196948|NCT00951912|582099432|FG002|Overall Study|Other: Colon cancer|0|||
161196949|NCT00951912|582099430|FG000|Overall Study|Other: Stroke|0|||
161196950|NCT00951912|582099431|FG001|Overall Study|Other: Stroke|1|||
161196951|NCT00951912|582099432|FG002|Overall Study|Other: Stroke|0|||
161196952|NCT02173158|582099434|FG000|Efficacy Phase|Adverse Event|1|||
161196953|NCT01377194|582099435|FG000|Overall Study|Adverse Event|3|||
161196954|NCT01377194|582099436|FG001|Overall Study|Adverse Event|12|||
161196955|NCT01377194|582099437|FG002|Overall Study|Adverse Event|19|||
161196956|NCT01377194|582099435|FG000|Overall Study|Lack of Efficacy|3|||
161196957|NCT01377194|582099436|FG001|Overall Study|Lack of Efficacy|3|||
161196958|NCT01377194|582099437|FG002|Overall Study|Lack of Efficacy|3|||
161196959|NCT01377194|582099435|FG000|Overall Study|Protocol Violation|4|||
161196960|NCT01377194|582099436|FG001|Overall Study|Protocol Violation|10|||
161196961|NCT01377194|582099437|FG002|Overall Study|Protocol Violation|6|||
161196962|NCT01377194|582099435|FG000|Overall Study|Withdrawal by Subject|8|||
161196963|NCT01377194|582099436|FG001|Overall Study|Withdrawal by Subject|10|||
161196964|NCT01377194|582099437|FG002|Overall Study|Withdrawal by Subject|7|||
161196965|NCT01377194|582099435|FG000|Overall Study|Lost to Follow-up|14|||
161196966|NCT01377194|582099436|FG001|Overall Study|Lost to Follow-up|8|||
161196967|NCT01377194|582099437|FG002|Overall Study|Lost to Follow-up|11|||
161196968|NCT01977573|582099440|FG000|Overall Study|Adverse Event|7|||
161196969|NCT01977573|582099441|FG001|Overall Study|Adverse Event|0|||
161196970|NCT01977573|582099442|FG002|Overall Study|Adverse Event|2|||
161196971|NCT01977573|582099443|FG003|Overall Study|Adverse Event|1|||
161196972|NCT01977573|582099440|FG000|Overall Study|Lost to Follow-up|1|||
161196973|NCT01977573|582099441|FG001|Overall Study|Lost to Follow-up|0|||
161196974|NCT01977573|582099442|FG002|Overall Study|Lost to Follow-up|0|||
161196975|NCT01977573|582099443|FG003|Overall Study|Lost to Follow-up|1|||
161196976|NCT01977573|582099440|FG000|Overall Study|Physician Decision|1|||
161196977|NCT01977573|582099441|FG001|Overall Study|Physician Decision|0|||
161196978|NCT01977573|582099442|FG002|Overall Study|Physician Decision|0|||
161196979|NCT01977573|582099443|FG003|Overall Study|Physician Decision|0|||
161196980|NCT01977573|582099440|FG000|Overall Study|Protocol Violation|3|||
161196981|NCT01977573|582099441|FG001|Overall Study|Protocol Violation|1|||
161196982|NCT01977573|582099442|FG002|Overall Study|Protocol Violation|0|||
161196983|NCT01977573|582099443|FG003|Overall Study|Protocol Violation|0|||
161196984|NCT01977573|582099440|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
161196985|NCT01977573|582099441|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
161196986|NCT01977573|582099442|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
161196987|NCT01977573|582099443|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
161196988|NCT01977573|582099440|FG000|Overall Study|Withdrawal by Subject|6|||
161196989|NCT01977573|582099441|FG001|Overall Study|Withdrawal by Subject|1|||
161196990|NCT01977573|582099442|FG002|Overall Study|Withdrawal by Subject|1|||
161196991|NCT01977573|582099443|FG003|Overall Study|Withdrawal by Subject|1|||
161196992|NCT00323479|582099444|FG000|Overall Study|Adverse Event|2|||
161196993|NCT00323479|582099444|FG000|Overall Study|Withdrawal by Subject|2|||
161196994|NCT00323479|582099444|FG000|Overall Study|Protocol Violation|3|||
161196995|NCT00323479|582099444|FG000|Overall Study|house moving|1|||
161196996|NCT00967343|582099448|FG000|Overall Study|Study termination by sponsor|12|||
161196997|NCT00967343|582099448|FG000|Overall Study|Death|24|||
161196998|NCT00967343|582099448|FG000|Overall Study|Relapse|1|||
161196999|NCT00967343|582099448|FG000|Overall Study|Lost to Follow-up|1|||
161197000|NCT03044730|582099450|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
161197001|NCT03044730|582099450|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
161197002|NCT03044730|582099450|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
161197003|NCT03044730|582099450|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
161197004|NCT03044730|582099450|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
161197005|NCT03044730|582099450|FG000|Cycles 4 and Beyond|Adverse Event|1|||
161197006|NCT03044730|582099450|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
161197007|NCT03044730|582099450|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
161197008|NCT03044730|582099450|FG000|On Follow-up for 2 Years|Death|17|||
161197023|NCT04576702|582101011|FG000|Overall Study|Death|1|||
161197024|NCT04576702|582101012|FG001|Overall Study|Death|0|||
161197025|NCT04576702|582101013|FG002|Overall Study|Death|0|||
161197026|NCT04576702|582101014|FG003|Overall Study|Death|0|||
161197027|NCT04576702|582101011|FG000|Overall Study|Withdrawal by Subject|0|||
161197028|NCT04576702|582101012|FG001|Overall Study|Withdrawal by Subject|2|||
161197029|NCT04576702|582101013|FG002|Overall Study|Withdrawal by Subject|1|||
161197030|NCT04576702|582101014|FG003|Overall Study|Withdrawal by Subject|0|||
161197031|NCT04576702|582101011|FG000|Overall Study|Lost to Follow-up|3|||
161197032|NCT04576702|582101012|FG001|Overall Study|Lost to Follow-up|3|||
161197033|NCT04576702|582101013|FG002|Overall Study|Lost to Follow-up|3|||
161197034|NCT04576702|582101014|FG003|Overall Study|Lost to Follow-up|4|||
161197035|NCT01151085|582101015|FG000|Overall Study|Lost to Follow-up|31|||
161197036|NCT01151085|582101015|FG000|Overall Study|Protocol Violation|25|||
161197037|NCT01243762|582101016|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161197038|NCT01243762|582101017|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
161197039|NCT01243762|582101018|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161197040|NCT01243762|582101019|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161197041|NCT01243762|582101020|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
161197042|NCT01243762|582101021|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
161197043|NCT01243762|582101022|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
161197044|NCT01243762|582101016|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161197045|NCT01243762|582101017|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
161197046|NCT01243762|582101018|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161197047|NCT01243762|582101019|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
161197048|NCT01243762|582101020|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161197049|NCT01243762|582101021|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161197050|NCT01243762|582101022|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
161197051|NCT01243762|582101016|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
161197052|NCT01243762|582101017|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
161197053|NCT01243762|582101018|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
161197054|NCT01243762|582101019|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
161197055|NCT01243762|582101020|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
161197056|NCT01243762|582101021|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
161197057|NCT01243762|582101022|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
161197058|NCT01243762|582101016|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161197059|NCT01243762|582101017|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
161197060|NCT01243762|582101018|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161197061|NCT01243762|582101019|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161197062|NCT01243762|582101020|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161197063|NCT01243762|582101021|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161197064|NCT01243762|582101022|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
161197065|NCT01243762|582101016|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161197066|NCT01243762|582101017|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
161197067|NCT01243762|582101018|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161197068|NCT01243762|582101019|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161197069|NCT01243762|582101020|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161197070|NCT01243762|582101021|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
161197071|NCT01243762|582101022|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
161197072|NCT01243762|582101016|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
161197073|NCT01243762|582101017|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
161197074|NCT01243762|582101018|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
161197075|NCT01243762|582101019|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
161197076|NCT01243762|582101020|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
161197077|NCT01243762|582101021|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
161197078|NCT01243762|582101022|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
161306675|NCT00387010|582502905|FG000|Dose Titration Period|Lost to Follow-up|2|||
161197079|NCT01243762|582101016|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161197080|NCT01243762|582101017|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
161197081|NCT01243762|582101018|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161197082|NCT01243762|582101019|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161306676|NCT00387010|582502905|FG000|Dose Titration Period|Noncompliance with study medication|8|||
161306677|NCT00387010|582502905|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
161306678|NCT00387010|582502905|FG000|Treatment Period|Adverse Event|4|||
161197083|NCT01243762|582101020|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
161197084|NCT01243762|582101021|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161197085|NCT01243762|582101022|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
161197086|NCT01243762|582101016|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161197087|NCT01243762|582101017|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161197088|NCT01243762|582101018|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161197089|NCT01243762|582101019|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
161197090|NCT01243762|582101020|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
161197091|NCT01243762|582101021|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161197092|NCT01243762|582101022|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
161197093|NCT02059265|582101023|FG000|Overall Study|Ineligible|4|||
161197094|NCT00998166|582101024|FG000|Overall Study|Early Study Termination|8|||
161197095|NCT02985996|582101028|FG000|Overall Study|Withdrawal by Subject|0|||
161197096|NCT02985996|582101029|FG001|Overall Study|Withdrawal by Subject|0|||
161197097|NCT02985996|582101030|FG002|Overall Study|Withdrawal by Subject|1|||
161197098|NCT02985996|582101031|FG003|Overall Study|Withdrawal by Subject|0|||
161197099|NCT02985996|582101032|FG004|Overall Study|Withdrawal by Subject|0|||
161197100|NCT02985996|582101028|FG000|Overall Study|Protocol Violation|0|||
161197101|NCT02985996|582101029|FG001|Overall Study|Protocol Violation|1|||
161197102|NCT02985996|582101030|FG002|Overall Study|Protocol Violation|0|||
161197103|NCT02985996|582101031|FG003|Overall Study|Protocol Violation|0|||
161197104|NCT02985996|582101032|FG004|Overall Study|Protocol Violation|0|||
161197105|NCT00401726|582101033|FG000|Overall Study|Adverse Event|34|||
161197106|NCT00401726|582101034|FG001|Overall Study|Adverse Event|45|||
161197107|NCT00401726|582101033|FG000|Overall Study|Death|0|||
161197108|NCT00401726|582101034|FG001|Overall Study|Death|3|||
161197109|NCT00401726|582101033|FG000|Overall Study|Sponsor Request|0|||
161197110|NCT00401726|582101034|FG001|Overall Study|Sponsor Request|1|||
161197111|NCT00401726|582101033|FG000|Overall Study|Physician Decision|3|||
161197112|NCT00401726|582101034|FG001|Overall Study|Physician Decision|6|||
161197113|NCT00401726|582101033|FG000|Overall Study|Lost to Follow-up|23|||
161197114|NCT00401726|582101034|FG001|Overall Study|Lost to Follow-up|20|||
161197115|NCT00401726|582101033|FG000|Overall Study|Protocol Violation|6|||
161197116|NCT00401726|582101034|FG001|Overall Study|Protocol Violation|3|||
161197117|NCT00401726|582101033|FG000|Overall Study|Withdrawal by Subject|18|||
161197118|NCT00401726|582101034|FG001|Overall Study|Withdrawal by Subject|24|||
161197119|NCT00401726|582101033|FG000|Overall Study|Lack of Efficacy|4|||
161197120|NCT00401726|582101034|FG001|Overall Study|Lack of Efficacy|6|||
161197121|NCT00401726|582101033|FG000|Overall Study|Protocol Deviation|9|||
161197122|NCT00401726|582101034|FG001|Overall Study|Protocol Deviation|4|||
161197123|NCT00814502|582101037|FG000|Overall Study|Adverse Event|1|||
161197124|NCT00814502|582101038|FG001|Overall Study|Adverse Event|0|||
161197125|NCT00814502|582101037|FG000|Overall Study|Withdrawal by Subject|0|||
161197126|NCT00814502|582101038|FG001|Overall Study|Withdrawal by Subject|2|||
161197127|NCT03735849|582101040|FG000|Overall Study|Lost to Follow-up|1|||
161197128|NCT03735849|582101041|FG001|Overall Study|Lost to Follow-up|0|||
161197129|NCT03735849|582101042|FG002|Overall Study|Lost to Follow-up|0|||
161197130|NCT03735849|582101040|FG000|Overall Study|Participant unable to adhere to visit|1|||
161197131|NCT03735849|582101041|FG001|Overall Study|Participant unable to adhere to visit|0|||
161197132|NCT03735849|582101042|FG002|Overall Study|Participant unable to adhere to visit|0|||
161197133|NCT03735849|582101040|FG000|Overall Study|Not Randomized|0|||
161197134|NCT03735849|582101041|FG001|Overall Study|Not Randomized|0|||
161197135|NCT03735849|582101042|FG002|Overall Study|Not Randomized|4|||
161197136|NCT04585906|582101045|FG000|Overall Study|Lost to Follow-up|8|||
161197137|NCT04585906|582101046|FG001|Overall Study|Lost to Follow-up|5|||
161197138|NCT04626947|582101047|FG000|Overall Study|Study terminated|14|||
161197139|NCT01428882|582101058|FG000|Overall Study|Lack of Efficacy|2|||
161197140|NCT01428882|582101059|FG001|Overall Study|Lack of Efficacy|7|||
161197141|NCT01428882|582101058|FG000|Overall Study|Protocol Violation|4|||
161197142|NCT01428882|582101059|FG001|Overall Study|Protocol Violation|3|||
161197143|NCT01694849|582101066|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
161197144|NCT01694849|582101067|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
161197145|NCT01694849|582101068|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
161306679|NCT00387010|582502905|FG000|Treatment Period|Withdrawal by Subject|1|||
161197146|NCT01694849|582101066|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
161197147|NCT01694849|582101067|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
161197148|NCT01694849|582101068|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
161197149|NCT01694849|582101066|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
161197150|NCT01694849|582101067|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
161197151|NCT01694849|582101068|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
161197152|NCT01694849|582101066|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
161197153|NCT01694849|582101067|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
161197154|NCT01694849|582101068|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
161197155|NCT01694849|582101066|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
161197156|NCT01694849|582101067|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
161197157|NCT01694849|582101068|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
161197158|NCT01694849|582101066|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
161197159|NCT01694849|582101067|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
161197160|NCT01694849|582101068|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
161197161|NCT01694849|582101066|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
161197162|NCT01694849|582101067|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
161197163|NCT01694849|582101068|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
161197164|NCT01694849|582101066|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
161197165|NCT01694849|582101067|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
161197166|NCT01694849|582101068|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
161197167|NCT01326312|582101069|FG000|Overall Study|Adverse Event|11|||
161197168|NCT01326312|582101070|FG001|Overall Study|Adverse Event|11|||
161197169|NCT01326312|582101071|FG002|Overall Study|Adverse Event|1|||
161197170|NCT01326312|582101069|FG000|Overall Study|Withdrawal by Subject|1|||
161197171|NCT01326312|582101070|FG001|Overall Study|Withdrawal by Subject|2|||
161197172|NCT01326312|582101071|FG002|Overall Study|Withdrawal by Subject|1|||
161197173|NCT01326312|582101069|FG000|Overall Study|Protocol Violation|0|||
161197174|NCT01326312|582101070|FG001|Overall Study|Protocol Violation|1|||
161197175|NCT01326312|582101071|FG002|Overall Study|Protocol Violation|0|||
161197176|NCT01326312|582101069|FG000|Overall Study|Lack of Efficacy|13|||
161197177|NCT01326312|582101070|FG001|Overall Study|Lack of Efficacy|7|||
161197178|NCT01326312|582101071|FG002|Overall Study|Lack of Efficacy|1|||
161197179|NCT01326312|582101069|FG000|Overall Study|Death|1|||
161197180|NCT01326312|582101070|FG001|Overall Study|Death|0|||
161197181|NCT01326312|582101071|FG002|Overall Study|Death|1|||
161197182|NCT01326312|582101069|FG000|Overall Study|progressive disease|0|||
161197183|NCT01326312|582101070|FG001|Overall Study|progressive disease|1|||
161197184|NCT01326312|582101071|FG002|Overall Study|progressive disease|1|||
161197185|NCT01326312|582101069|FG000|Overall Study|Study terminated by Sponsor|8|||
161197186|NCT01326312|582101070|FG001|Overall Study|Study terminated by Sponsor|32|||
161197187|NCT01326312|582101071|FG002|Overall Study|Study terminated by Sponsor|46|||
161197188|NCT01326312|582101069|FG000|Overall Study|Treatment arm terminated|19|||
161197189|NCT01326312|582101070|FG001|Overall Study|Treatment arm terminated|0|||
161197190|NCT01326312|582101071|FG002|Overall Study|Treatment arm terminated|0|||
161197191|NCT01326312|582101069|FG000|Overall Study|QTc > 500|0|||
161197192|NCT01326312|582101070|FG001|Overall Study|QTc > 500|1|||
161197193|NCT01326312|582101071|FG002|Overall Study|QTc > 500|0|||
161197194|NCT02243306|582101072|FG000|Overall Study|Adverse Event|0|||
161197195|NCT02243306|582101073|FG001|Overall Study|Adverse Event|1|||
161197196|NCT02243306|582101072|FG000|Overall Study|Other: Reached stopping criteria|0|||
161197197|NCT02243306|582101073|FG001|Overall Study|Other: Reached stopping criteria|1|||
161197198|NCT02243306|582101072|FG000|Overall Study|Physician Decision|0|||
161197199|NCT02243306|582101073|FG001|Overall Study|Physician Decision|1|||
161197200|NCT02221882|582101074|FG000|Overall Study|Withdrawal by Subject|0|||
161197201|NCT02221882|582101075|FG001|Overall Study|Withdrawal by Subject|0|||
161197202|NCT02221882|582101076|FG002|Overall Study|Withdrawal by Subject|4|||
161197203|NCT02221882|582101077|FG003|Overall Study|Withdrawal by Subject|2|||
161197204|NCT02221882|582101078|FG004|Overall Study|Withdrawal by Subject|2|||
161197205|NCT02221882|582101079|FG005|Overall Study|Withdrawal by Subject|2|||
161197206|NCT02221882|582101074|FG000|Overall Study|Death|0|||
161197207|NCT02221882|582101075|FG001|Overall Study|Death|1|||
161197208|NCT02221882|582101076|FG002|Overall Study|Death|0|||
161197209|NCT02221882|582101077|FG003|Overall Study|Death|0|||
161197210|NCT02221882|582101078|FG004|Overall Study|Death|0|||
161197211|NCT02221882|582101079|FG005|Overall Study|Death|0|||
161197212|NCT04095039|582101082|FG000|Overall Study|Withdrawal by Subject|2|||
161197213|NCT04095039|582101083|FG001|Overall Study|Withdrawal by Subject|16|||
161197214|NCT04095039|582101082|FG000|Overall Study|Transplanted|21|||
161197215|NCT04095039|582101083|FG001|Overall Study|Transplanted|24|||
161197216|NCT04095039|582101082|FG000|Overall Study|Transferred to Non-study Facility|47|||
161197217|NCT04095039|582101083|FG001|Overall Study|Transferred to Non-study Facility|44|||
161197218|NCT04095039|582101082|FG000|Overall Study|Withdrawal from internvention target|0|||
161197219|NCT04095039|582101083|FG001|Overall Study|Withdrawal from internvention target|2|||
161197220|NCT04095039|582101082|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
161197221|NCT04095039|582101083|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
161197222|NCT04095039|582101082|FG000|Overall Study|Cacliphylaxis|0|||
161197223|NCT04095039|582101083|FG001|Overall Study|Cacliphylaxis|1|||
161306680|NCT00387010|582502905|FG000|Treatment Period|Noncompliance with study medication|2|||
161197224|NCT04095039|582101082|FG000|Overall Study|Pregnancy|1|||
161306681|NCT00387010|582502905|FG000|Treatment Period|Noncompliance with study procedures|3|||
161197225|NCT04095039|582101083|FG001|Overall Study|Pregnancy|0|||
161197226|NCT04768881|582101084|FG000|Overall Study|Completed Study Follow-up|0|||
161197227|NCT04768881|582101085|FG001|Overall Study|Completed Study Follow-up|2|||
161197228|NCT04768881|582101084|FG000|Overall Study|Death|3|||
161197229|NCT04768881|582101085|FG001|Overall Study|Death|2|||
161197230|NCT04768881|582101084|FG000|Overall Study|Study Terminated by Sponsor|2|||
161197231|NCT04768881|582101085|FG001|Overall Study|Study Terminated by Sponsor|2|||
161197232|NCT04768881|582101084|FG000|Overall Study|Withdrawal by Subject|2|||
161197233|NCT04768881|582101085|FG001|Overall Study|Withdrawal by Subject|0|||
161197234|NCT04768881|582101084|FG000|Overall Study|Other|2|||
161197235|NCT04768881|582101085|FG001|Overall Study|Other|0|||
161197236|NCT02370173|582101088|FG000|Overall Study|Protocol Violation|1|||
161197237|NCT02370173|582101089|FG001|Overall Study|Protocol Violation|1|||
161197238|NCT02370173|582101088|FG000|Overall Study|Withdrawal by Subject|2|||
161197239|NCT02370173|582101089|FG001|Overall Study|Withdrawal by Subject|2|||
161197240|NCT04236986|582101090|FG000|Overall Study|Withdrawal by Subject|3|||
161197241|NCT04236986|582101091|FG001|Overall Study|Withdrawal by Subject|1|||
161197242|NCT00307736|582101094|FG000|Overall Study|Adverse Event|0|||
161197243|NCT00307736|582101095|FG001|Overall Study|Adverse Event|0|||
161197244|NCT00307736|582101096|FG002|Overall Study|Adverse Event|1|||
161197245|NCT00307736|582101097|FG003|Overall Study|Adverse Event|3|||
161197246|NCT00307736|582101094|FG000|Overall Study|Withdrawal by Subject|0|||
161197247|NCT00307736|582101095|FG001|Overall Study|Withdrawal by Subject|0|||
161197248|NCT00307736|582101096|FG002|Overall Study|Withdrawal by Subject|2|||
161197249|NCT00307736|582101097|FG003|Overall Study|Withdrawal by Subject|0|||
161197250|NCT01365182|582101104|FG000|Overall Study|Withdrawal by Subject|10|||
161197251|NCT01365182|582101105|FG001|Overall Study|Withdrawal by Subject|13|||
161197252|NCT01365182|582101106|FG002|Overall Study|Withdrawal by Subject|12|||
161197253|NCT01728194|582101109|FG000|Overall Study|Lost to Follow-up|4|||
161197254|NCT01728194|582101110|FG001|Overall Study|Lost to Follow-up|3|||
161197255|NCT01728194|582101109|FG000|Overall Study|Physician Decision|4|||
161197256|NCT01728194|582101110|FG001|Overall Study|Physician Decision|0|||
161197257|NCT01728194|582101109|FG000|Overall Study|Withdrawal by Subject|7|||
161197258|NCT01728194|582101110|FG001|Overall Study|Withdrawal by Subject|3|||
161197259|NCT01728194|582101109|FG000|Overall Study|Perceived Medication Side Effects|4|||
161197260|NCT01728194|582101110|FG001|Overall Study|Perceived Medication Side Effects|0|||
161197261|NCT01728194|582101109|FG000|Overall Study|Family Member Request|1|||
161197262|NCT01728194|582101110|FG001|Overall Study|Family Member Request|0|||
161197263|NCT02309372|582101111|FG000|Overall Study|Lost to Follow-up|3|||
161197264|NCT02309372|582101112|FG001|Overall Study|Lost to Follow-up|2|||
161197265|NCT02576652|582101117|FG000|Overall Study|Withdrawal by Subject|2|||
161197266|NCT02811640|582101118|FG000|Overall Study|Technology malfunction|2|||
161197267|NCT00553319|582101129|FG000|Overall Study|Lost to Follow-up|10|||
161197268|NCT00553319|582101130|FG001|Overall Study|Lost to Follow-up|9|||
161197269|NCT00553319|582101131|FG002|Overall Study|Lost to Follow-up|5|||
161197270|NCT00553319|582101129|FG000|Overall Study|wanted treatment elsewhere|2|||
161197271|NCT00553319|582101130|FG001|Overall Study|wanted treatment elsewhere|1|||
161197272|NCT00553319|582101131|FG002|Overall Study|wanted treatment elsewhere|1|||
161197273|NCT00553319|582101129|FG000|Overall Study|non-compliance|0|||
161197274|NCT00553319|582101130|FG001|Overall Study|non-compliance|0|||
161197275|NCT00553319|582101131|FG002|Overall Study|non-compliance|2|||
161197276|NCT00553319|582101129|FG000|Overall Study|incarceration|1|||
161197277|NCT00553319|582101130|FG001|Overall Study|incarceration|0|||
161197278|NCT00553319|582101131|FG002|Overall Study|incarceration|0|||
161197279|NCT00553319|582101129|FG000|Overall Study|moved|1|||
161197280|NCT00553319|582101130|FG001|Overall Study|moved|0|||
161197281|NCT00553319|582101131|FG002|Overall Study|moved|1|||
161197282|NCT04369742|582101136|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
161197283|NCT04369742|582101137|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
161197284|NCT04369742|582101136|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
161197285|NCT04369742|582101137|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
161197286|NCT00465894|582101138|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
161197287|NCT00465894|582101139|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
161197288|NCT00465894|582101138|FG000|Treatment For 12 Weeks|Family Issues|1|||
161197289|NCT00465894|582101139|FG001|Treatment For 12 Weeks|Family Issues|1|||
161197290|NCT00465894|582101138|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
161197291|NCT00465894|582101139|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
161197292|NCT01207427|582101141|FG000|Double-blind Treatment Period|Adverse Event|0|||
161197293|NCT01207427|582101142|FG001|Double-blind Treatment Period|Adverse Event|1|||
161197294|NCT01207427|582101143|FG002|Double-blind Treatment Period|Adverse Event|0|||
161197295|NCT01207427|582101141|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161197296|NCT01207427|582101142|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
161197297|NCT01207427|582101143|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
161197298|NCT01207427|582101141|FG000|Double-blind Treatment Period|Protocol Violation|2|||
161197299|NCT01207427|582101142|FG001|Double-blind Treatment Period|Protocol Violation|1|||
161306682|NCT00387010|582502905|FG000|Treatment Period|Participant reported study drug stolen|1|||
161306683|NCT01167881|582502908|FG000|Overall Study|Adverse Event|47|||
161197300|NCT01207427|582101143|FG002|Double-blind Treatment Period|Protocol Violation|1|||
161306684|NCT01167881|582502909|FG001|Overall Study|Adverse Event|51|||
161197301|NCT01207427|582101141|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
161197302|NCT01207427|582101142|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161197303|NCT01207427|582101143|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161197304|NCT00422227|582101144|FG000|Overall Study|Adverse Event|3|||
161197305|NCT00422227|582101145|FG001|Overall Study|Adverse Event|8|||
161197306|NCT00422227|582101144|FG000|Overall Study|Lost to Follow-up|1|||
161197307|NCT00422227|582101145|FG001|Overall Study|Lost to Follow-up|3|||
161197308|NCT00422227|582101144|FG000|Overall Study|Withdrawal by Subject|0|||
161197309|NCT00422227|582101145|FG001|Overall Study|Withdrawal by Subject|4|||
161197310|NCT00686894|582101146|FG000|Overall Study|Relapse|2|||
161197311|NCT00686894|582101146|FG000|Overall Study|Protocol Violation|4|||
161197312|NCT01230489|582101147|FG000|Overall Study|Death|2|||
161197313|NCT01230489|582101147|FG000|Overall Study|Adverse Event|2|||
161197314|NCT01230489|582101147|FG000|Overall Study|Treatment modality changed|1|||
161197315|NCT03996694|582103086|FG000|First Washout (7 Days)|positive urine drug screen|0|||
161197316|NCT03996694|582103087|FG001|First Washout (7 Days)|positive urine drug screen|0|||
161197317|NCT03996694|582103088|FG002|First Washout (7 Days)|positive urine drug screen|1|||
161197318|NCT03996694|582103089|FG003|First Washout (7 Days)|positive urine drug screen|0|||
161197319|NCT03996694|582103090|FG004|First Washout (7 Days)|positive urine drug screen|0|||
161197320|NCT03996694|582103091|FG005|First Washout (7 Days)|positive urine drug screen|0|||
161197321|NCT03996694|582103086|FG000|First Washout (7 Days)|Adverse Event|0|||
161197322|NCT03996694|582103087|FG001|First Washout (7 Days)|Adverse Event|1|||
161197323|NCT03996694|582103088|FG002|First Washout (7 Days)|Adverse Event|0|||
161197324|NCT03996694|582103089|FG003|First Washout (7 Days)|Adverse Event|0|||
161197325|NCT03996694|582103090|FG004|First Washout (7 Days)|Adverse Event|0|||
161197326|NCT03996694|582103091|FG005|First Washout (7 Days)|Adverse Event|0|||
161197327|NCT03996694|582103086|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
161197328|NCT03996694|582103087|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
161197329|NCT03996694|582103088|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
161197330|NCT03996694|582103089|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
161197331|NCT03996694|582103090|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
161197332|NCT03996694|582103091|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
161197333|NCT03996694|582103086|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
161197334|NCT03996694|582103087|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
161197335|NCT03996694|582103088|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
161197336|NCT03996694|582103089|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
161197337|NCT03996694|582103090|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
161197338|NCT03996694|582103091|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
161197339|NCT03323034|582103092|FG000|Overall Study|Lack of Efficacy|5|||
161197340|NCT03323034|582103093|FG001|Overall Study|Lack of Efficacy|5|||
161197341|NCT03323034|582103094|FG002|Overall Study|Lack of Efficacy|6|||
161197342|NCT03323034|582103095|FG003|Overall Study|Lack of Efficacy|5|||
161197343|NCT03323034|582103096|FG004|Overall Study|Lack of Efficacy|5|||
161197344|NCT03323034|582103092|FG000|Overall Study|Physician Decision|0|||
161197345|NCT03323034|582103093|FG001|Overall Study|Physician Decision|0|||
161197346|NCT03323034|582103094|FG002|Overall Study|Physician Decision|0|||
161197347|NCT03323034|582103095|FG003|Overall Study|Physician Decision|0|||
161197348|NCT03323034|582103096|FG004|Overall Study|Physician Decision|1|||
161197349|NCT03323034|582103092|FG000|Overall Study|Withdrawal by Subject|1|||
161197350|NCT03323034|582103093|FG001|Overall Study|Withdrawal by Subject|1|||
161197351|NCT03323034|582103094|FG002|Overall Study|Withdrawal by Subject|0|||
161197352|NCT03323034|582103095|FG003|Overall Study|Withdrawal by Subject|1|||
161197353|NCT03323034|582103096|FG004|Overall Study|Withdrawal by Subject|0|||
161197354|NCT02646566|582103097|FG000|Overall Study|Lost to Follow-up|5|||
161197355|NCT02646566|582103098|FG001|Overall Study|Lost to Follow-up|4|||
161197356|NCT02646566|582103099|FG002|Overall Study|Lost to Follow-up|5|||
161197357|NCT02646566|582103097|FG000|Overall Study|Treatment failure|1|||
161197358|NCT02646566|582103098|FG001|Overall Study|Treatment failure|0|||
161197359|NCT02646566|582103099|FG002|Overall Study|Treatment failure|0|||
161197360|NCT00003526|582103100|FG000|Overall Study|Not evaluable|6|||
161197361|NCT01050998|582103101|FG000|Overall Study|Adverse Event|1|||
161197362|NCT01050998|582103102|FG001|Overall Study|Adverse Event|0|||
161197363|NCT01050998|582103103|FG002|Overall Study|Adverse Event|1|||
161197364|NCT01050998|582103104|FG003|Overall Study|Adverse Event|0|||
161197365|NCT01050998|582103105|FG004|Overall Study|Adverse Event|2|||
161197366|NCT01050998|582103101|FG000|Overall Study|Withdrawal by Subject|0|||
161197367|NCT01050998|582103102|FG001|Overall Study|Withdrawal by Subject|0|||
161197368|NCT01050998|582103103|FG002|Overall Study|Withdrawal by Subject|0|||
161197369|NCT01050998|582103104|FG003|Overall Study|Withdrawal by Subject|1|||
161197370|NCT01050998|582103105|FG004|Overall Study|Withdrawal by Subject|3|||
161197371|NCT01050998|582103101|FG000|Overall Study|Other|3|||
161197372|NCT01050998|582103102|FG001|Overall Study|Other|2|||
161197373|NCT01050998|582103103|FG002|Overall Study|Other|1|||
161197374|NCT01050998|582103104|FG003|Overall Study|Other|1|||
161197375|NCT01050998|582103105|FG004|Overall Study|Other|5|||
161197376|NCT01050998|582103101|FG000|Overall Study|Data integrity issues|0|||
161197377|NCT01050998|582103102|FG001|Overall Study|Data integrity issues|0|||
161197378|NCT01050998|582103103|FG002|Overall Study|Data integrity issues|1|||
161197379|NCT01050998|582103104|FG003|Overall Study|Data integrity issues|1|||
161197380|NCT01050998|582103105|FG004|Overall Study|Data integrity issues|4|||
161197381|NCT04246593|582103108|FG000|Overall Study|Withdrawal by Subject|14|||
161090529|NCT02080221|581721675|FG000|Overall Study|Clinical Progression of Disease|1|||
161090530|NCT05081388|581721681|FG000|Overall Study|Adverse Event|1|||
161090531|NCT05081388|581721682|FG001|Overall Study|Adverse Event|0|||
161090532|NCT05081388|581721683|FG002|Overall Study|Adverse Event|0|||
161090533|NCT05081388|581721684|FG003|Overall Study|Adverse Event|0|||
161090534|NCT05081388|581721685|FG004|Overall Study|Adverse Event|0|||
161090535|NCT05081388|581721681|FG000|Overall Study|Lost to Follow-up|0|||
161090536|NCT05081388|581721682|FG001|Overall Study|Lost to Follow-up|1|||
161090537|NCT05081388|581721683|FG002|Overall Study|Lost to Follow-up|0|||
161090538|NCT05081388|581721684|FG003|Overall Study|Lost to Follow-up|0|||
161090539|NCT05081388|581721685|FG004|Overall Study|Lost to Follow-up|0|||
161090540|NCT05081388|581721681|FG000|Overall Study|Subject decision|0|||
161090541|NCT05081388|581721682|FG001|Overall Study|Subject decision|0|||
161090542|NCT05081388|581721683|FG002|Overall Study|Subject decision|0|||
161090543|NCT05081388|581721684|FG003|Overall Study|Subject decision|1|||
161090544|NCT05081388|581721685|FG004|Overall Study|Subject decision|0|||
161090545|NCT04279392|581721686|FG000|Overall Study|Physician Decision|1|||
161090546|NCT04279392|581721687|FG001|Overall Study|Physician Decision|0|||
161090547|NCT01981473|581721688|FG000|Overall Study|Incorrect diagnosis of RA|0|||
161090548|NCT01981473|581721689|FG001|Overall Study|Incorrect diagnosis of RA|0|||
161090549|NCT01981473|581721690|FG002|Overall Study|Incorrect diagnosis of RA|1|||
161090550|NCT01981473|581721688|FG000|Overall Study|Received treatment for < 6 months|0|||
161090551|NCT01981473|581721689|FG001|Overall Study|Received treatment for < 6 months|0|||
161090552|NCT01981473|581721690|FG002|Overall Study|Received treatment for < 6 months|1|||
161090553|NCT01981473|581721688|FG000|Overall Study|Received treatment for >24 months|2|||
161090554|NCT01981473|581721689|FG001|Overall Study|Received treatment for >24 months|0|||
161090555|NCT01981473|581721690|FG002|Overall Study|Received treatment for >24 months|6|||
161090556|NCT00738582|581721691|FG000|Combination Therapy|Completed Combination Therapy|1|||
161090557|NCT00738582|581721692|FG001|Combination Therapy|Completed Combination Therapy|0|||
161090558|NCT00738582|581721691|FG000|Combination Therapy|Physician Decision|1|||
161090559|NCT00738582|581721692|FG001|Combination Therapy|Physician Decision|0|||
161090560|NCT00738582|581721691|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
161090561|NCT00738582|581721692|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
161090562|NCT00738582|581721691|FG000|Combination Therapy|Other|5|||
161090563|NCT00738582|581721692|FG001|Combination Therapy|Other|0|||
161090564|NCT00738582|581721691|FG000|Combination Therapy|Adverse Event|16|||
161090565|NCT00738582|581721692|FG001|Combination Therapy|Adverse Event|0|||
161090566|NCT00738582|581721691|FG000|Combination Therapy|Progressive Disease|9|||
161090567|NCT00738582|581721692|FG001|Combination Therapy|Progressive Disease|0|||
161090568|NCT00738582|581721691|FG000|Maintenance Therapy|Other|0|||
161090569|NCT00738582|581721692|FG001|Maintenance Therapy|Other|2|||
161090570|NCT00738582|581721691|FG000|Maintenance Therapy|Adverse Event|0|||
161090571|NCT00738582|581721692|FG001|Maintenance Therapy|Adverse Event|6|||
161090572|NCT00738582|581721691|FG000|Maintenance Therapy|Progressive Disease|0|||
161090573|NCT00738582|581721692|FG001|Maintenance Therapy|Progressive Disease|47|||
161090574|NCT00738582|581721691|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
161090575|NCT00738582|581721692|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
161090576|NCT00903006|581721695|FG000|Overall Study|Withdrawal by Subject|2|||
161090577|NCT00903006|581721696|FG001|Overall Study|Withdrawal by Subject|0|||
161090578|NCT00903006|581721697|FG002|Overall Study|Withdrawal by Subject|0|||
161090579|NCT00903006|581721698|FG003|Overall Study|Withdrawal by Subject|0|||
161090580|NCT00903006|581721695|FG000|Overall Study|Progressive Disease|0|||
161090581|NCT00903006|581721696|FG001|Overall Study|Progressive Disease|3|||
161090582|NCT00903006|581721697|FG002|Overall Study|Progressive Disease|1|||
161090583|NCT00903006|581721698|FG003|Overall Study|Progressive Disease|0|||
161090584|NCT03405792|581721699|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
161090585|NCT03405792|581721700|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
161090586|NCT03405792|581721699|FG000|Overall Study|o Did not receive pembrolizumab|1|||
161090587|NCT03405792|581721700|FG001|Overall Study|o Did not receive pembrolizumab|0|||
161090588|NCT04882995|581721701|FG000|Overall Study|Withdrawal by Subject|1|||
161090589|NCT04882995|581721702|FG001|Overall Study|Withdrawal by Subject|2|||
161090590|NCT04882995|581721701|FG000|Overall Study|Protocol Violation|4|||
161090591|NCT04882995|581721702|FG001|Overall Study|Protocol Violation|4|||
161090592|NCT04882995|581721701|FG000|Overall Study|Surgery postponed due to COVID|1|||
161090593|NCT04882995|581721702|FG001|Overall Study|Surgery postponed due to COVID|1|||
161090594|NCT00372229|581721703|FG000|Study Phase|Graft loss|0|||
161090595|NCT00372229|581721704|FG001|Study Phase|Graft loss|3|||
161090596|NCT00372229|581721703|FG000|Study Phase|Protocol Violation|3|||
161090597|NCT00372229|581721704|FG001|Study Phase|Protocol Violation|4|||
161090598|NCT00372229|581721703|FG000|Study Phase|Consent withdrawn|16|||
161090599|NCT00372229|581721704|FG001|Study Phase|Consent withdrawn|14|||
161090600|NCT00372229|581721703|FG000|Study Phase|Refused treatment/did not cooperate|3|||
161090601|NCT00372229|581721704|FG001|Study Phase|Refused treatment/did not cooperate|1|||
161090602|NCT00372229|581721703|FG000|Study Phase|Death|3|||
161306685|NCT01167881|582502908|FG000|Overall Study|Lack of Efficacy|4|||
161306686|NCT01167881|582502909|FG001|Overall Study|Lack of Efficacy|7|||
161306687|NCT01167881|582502908|FG000|Overall Study|Non compliant with protocol|9|||
161306688|NCT01167881|582502909|FG001|Overall Study|Non compliant with protocol|18|||
161306689|NCT01167881|582502908|FG000|Overall Study|Lost to Follow-up|19|||
161306690|NCT01167881|582502909|FG001|Overall Study|Lost to Follow-up|20|||
161306691|NCT01167881|582502908|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
161306692|NCT01167881|582502909|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
161306693|NCT01167881|582502908|FG000|Overall Study|Not treated|4|||
161090603|NCT00372229|581721704|FG001|Study Phase|Death|2|||
161090604|NCT00372229|581721703|FG000|Study Phase|Reason not specified|3|||
161090605|NCT00372229|581721704|FG001|Study Phase|Reason not specified|2|||
161090606|NCT00372229|581721703|FG000|Study Phase|Lost to Follow-up|3|||
161090607|NCT00372229|581721704|FG001|Study Phase|Lost to Follow-up|3|||
161090608|NCT00372229|581721703|FG000|Follow-Up Phase|Graft loss|8|||
161090609|NCT00372229|581721704|FG001|Follow-Up Phase|Graft loss|7|||
161090610|NCT00372229|581721703|FG000|Follow-Up Phase|Consent withdrawn|13|||
161090611|NCT00372229|581721704|FG001|Follow-Up Phase|Consent withdrawn|19|||
161090612|NCT00372229|581721703|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
161090613|NCT00372229|581721704|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
161090614|NCT00372229|581721703|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
161090615|NCT00372229|581721704|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
161090616|NCT00372229|581721703|FG000|Follow-Up Phase|Death|9|||
161090617|NCT00372229|581721704|FG001|Follow-Up Phase|Death|12|||
161090618|NCT00372229|581721703|FG000|Follow-Up Phase|Administrative|1|||
161090619|NCT00372229|581721704|FG001|Follow-Up Phase|Administrative|0|||
161090620|NCT00372229|581721703|FG000|Follow-Up Phase|Reason not specified|2|||
161090621|NCT00372229|581721704|FG001|Follow-Up Phase|Reason not specified|3|||
161090622|NCT00372229|581721703|FG000|Follow-Up Phase|Lost to Follow-up|12|||
161090623|NCT00372229|581721704|FG001|Follow-Up Phase|Lost to Follow-up|10|||
161090624|NCT01347762|581721705|FG000|Overall Study|Lost to Follow-up|0|||
161090625|NCT01347762|581721706|FG001|Overall Study|Lost to Follow-up|1|||
161090626|NCT01347762|581721707|FG002|Overall Study|Lost to Follow-up|6|||
161090627|NCT01347762|581721708|FG003|Overall Study|Lost to Follow-up|5|||
161090628|NCT01347762|581721705|FG000|Overall Study|Withdrawal by Subject|4|||
161090629|NCT01347762|581721706|FG001|Overall Study|Withdrawal by Subject|1|||
161090630|NCT01347762|581721707|FG002|Overall Study|Withdrawal by Subject|3|||
161090631|NCT01347762|581721708|FG003|Overall Study|Withdrawal by Subject|3|||
161090632|NCT03235284|581721709|FG000|Overall Study|Adverse Event|1|||
161090633|NCT03235284|581721710|FG001|Overall Study|Adverse Event|2|||
161090634|NCT03235284|581721711|FG002|Overall Study|Adverse Event|1|||
161090635|NCT05478499|581721712|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
161090636|NCT05478499|581721713|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
161090637|NCT05478499|581721712|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
161090638|NCT05478499|581721713|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
161090639|NCT05478499|581721712|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
161090640|NCT05478499|581721713|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
161090641|NCT05478499|581721712|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
161090642|NCT05478499|581721713|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
161090643|NCT05478499|581721712|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
161090644|NCT05478499|581721713|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
161090645|NCT05478499|581721712|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
161090646|NCT05478499|581721713|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
161090647|NCT05478499|581721712|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
161090648|NCT05478499|581721713|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
161090649|NCT05478499|581721712|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
161090650|NCT05478499|581721713|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
161090651|NCT05478499|581721712|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
161090652|NCT05478499|581721713|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
161090653|NCT05478499|581721712|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
161090654|NCT05478499|581721713|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
161090655|NCT05478499|581721712|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
161090656|NCT05478499|581721713|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
161090657|NCT00249002|581721714|FG000|Overall Study|Adverse Event|2|||
161090658|NCT00249002|581721714|FG000|Overall Study|Study cancellation|3|||
161090659|NCT00249002|581721714|FG000|Overall Study|Other|2|||
161090660|NCT02476279|581721715|FG000|Overall Study|Lost to Follow-up|1|||
161090661|NCT02476279|581721716|FG001|Overall Study|Lost to Follow-up|1|||
161090662|NCT03451162|581721717|FG000|Overall Study|Lost to Follow-up|1|||
161090663|NCT03451162|581721718|FG001|Overall Study|Lost to Follow-up|0|||
161090664|NCT03451162|581721719|FG002|Overall Study|Lost to Follow-up|0|||
161090665|NCT03451162|581721720|FG003|Overall Study|Lost to Follow-up|0|||
161090666|NCT03451162|581721721|FG004|Overall Study|Lost to Follow-up|0|||
161197382|NCT04246593|582103109|FG001|Overall Study|Withdrawal by Subject|13|||
161197383|NCT04246593|582103108|FG000|Overall Study|Lost to Follow-up|124|||
161197384|NCT04246593|582103109|FG001|Overall Study|Lost to Follow-up|71|||
161197385|NCT04246593|582103108|FG000|Overall Study|Moved out of area/became ineligible|3|||
161197386|NCT04246593|582103109|FG001|Overall Study|Moved out of area/became ineligible|1|||
161197387|NCT04246593|582103108|FG000|Overall Study|Reason unknown|4|||
161197388|NCT04246593|582103109|FG001|Overall Study|Reason unknown|2|||
161197389|NCT01012765|582103112|FG000|Treatment Period 1|Adverse Event|1|||
161197390|NCT01012765|582103113|FG001|Treatment Period 1|Adverse Event|0|||
161197391|NCT01012765|582103114|FG002|Treatment Period 1|Adverse Event|1|||
161197392|NCT01012765|582103115|FG003|Treatment Period 1|Adverse Event|0|||
161197393|NCT01012765|582103116|FG004|Treatment Period 1|Adverse Event|0|||
161197394|NCT01012765|582103117|FG005|Treatment Period 1|Adverse Event|0|||
161197395|NCT01012765|582103112|FG000|Treatment Period 1|Withdrawal by Subject|2|||
161197396|NCT01012765|582103113|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161197397|NCT01012765|582103114|FG002|Treatment Period 1|Withdrawal by Subject|0|||
161197398|NCT01012765|582103115|FG003|Treatment Period 1|Withdrawal by Subject|0|||
161197399|NCT01012765|582103116|FG004|Treatment Period 1|Withdrawal by Subject|0|||
161197400|NCT01012765|582103117|FG005|Treatment Period 1|Withdrawal by Subject|0|||
161197401|NCT01012765|582103112|FG000|Treatment Period 1|Administrative problems|0|||
161197402|NCT01012765|582103113|FG001|Treatment Period 1|Administrative problems|0|||
161197403|NCT01012765|582103114|FG002|Treatment Period 1|Administrative problems|1|||
161197404|NCT01012765|582103115|FG003|Treatment Period 1|Administrative problems|1|||
161197405|NCT01012765|582103116|FG004|Treatment Period 1|Administrative problems|1|||
161197406|NCT01012765|582103117|FG005|Treatment Period 1|Administrative problems|0|||
161197407|NCT01012765|582103112|FG000|Treatment Period 1|Protocol Violation|0|||
161197408|NCT01012765|582103113|FG001|Treatment Period 1|Protocol Violation|0|||
161197409|NCT01012765|582103114|FG002|Treatment Period 1|Protocol Violation|0|||
161197410|NCT01012765|582103115|FG003|Treatment Period 1|Protocol Violation|2|||
161197411|NCT01012765|582103116|FG004|Treatment Period 1|Protocol Violation|1|||
161197412|NCT01012765|582103117|FG005|Treatment Period 1|Protocol Violation|0|||
161197413|NCT01012765|582103112|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161197414|NCT01012765|582103113|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161197415|NCT01012765|582103114|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161197416|NCT01012765|582103115|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161197417|NCT01012765|582103116|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
161197418|NCT01012765|582103117|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
161197419|NCT01012765|582103112|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161197420|NCT01012765|582103113|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161197421|NCT01012765|582103114|FG002|Treatment Period 2|Withdrawal by Subject|1|||
161197422|NCT01012765|582103115|FG003|Treatment Period 2|Withdrawal by Subject|0|||
161197423|NCT01012765|582103116|FG004|Treatment Period 2|Withdrawal by Subject|1|||
161197424|NCT01012765|582103117|FG005|Treatment Period 2|Withdrawal by Subject|0|||
161197425|NCT01012765|582103112|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
161197426|NCT01012765|582103113|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
161197427|NCT01012765|582103114|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
161197428|NCT01012765|582103115|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
161197429|NCT01012765|582103116|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
161197430|NCT01012765|582103117|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
161197431|NCT01012765|582103112|FG000|Treatment Period 2|Adverse Event|0|||
161197432|NCT01012765|582103113|FG001|Treatment Period 2|Adverse Event|1|||
161197433|NCT01012765|582103114|FG002|Treatment Period 2|Adverse Event|1|||
161197434|NCT01012765|582103115|FG003|Treatment Period 2|Adverse Event|0|||
161197435|NCT01012765|582103116|FG004|Treatment Period 2|Adverse Event|0|||
161197436|NCT01012765|582103117|FG005|Treatment Period 2|Adverse Event|0|||
161197437|NCT01012765|582103112|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161197438|NCT01012765|582103113|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
161197439|NCT01012765|582103114|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
161197440|NCT01012765|582103115|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161197441|NCT01012765|582103116|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161197442|NCT01012765|582103117|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
161197443|NCT04668157|582103125|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
161197444|NCT04668157|582103126|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
161197445|NCT04668157|582103125|FG000|Treatment Period (52 Weeks)|Other|0|||
161197446|NCT04668157|582103126|FG001|Treatment Period (52 Weeks)|Other|2|||
161197447|NCT02283411|582103131|FG000|Overall Study|Withdrawal by Subject|3|||
161197448|NCT02283411|582103131|FG000|Overall Study|Screen Failed|28|||
161197449|NCT05437211|582103132|FG000|Overall Study|Patient's decision|1|||
161197450|NCT05437211|582103133|FG001|Overall Study|Patient's decision|1|||
161197451|NCT03282123|582103135|FG000|Overall Study|Withdrawal by Subject|5|||
161197452|NCT03457701|582103136|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161197453|NCT03457701|582103137|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161306694|NCT01167881|582502909|FG001|Overall Study|Not treated|0|||
161197454|NCT03457701|582103136|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
161197455|NCT03457701|582103137|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
161197456|NCT03329404|582103138|FG000|Overall Study|The study was suspended.|1|||
161197457|NCT03329404|582103139|FG001|Overall Study|The study was suspended.|4|||
161197458|NCT00796367|582103143|FG000|Overall Study|Adverse Event|6|||
161197459|NCT00796367|582103144|FG001|Overall Study|Adverse Event|4|||
161197460|NCT00796367|582103145|FG002|Overall Study|Adverse Event|7|||
161197461|NCT00796367|582103143|FG000|Overall Study|Lost to Follow-up|5|||
161197462|NCT00796367|582103144|FG001|Overall Study|Lost to Follow-up|4|||
161197463|NCT00796367|582103145|FG002|Overall Study|Lost to Follow-up|21|||
161197464|NCT00796367|582103143|FG000|Overall Study|Withdrawal by Subject|9|||
161197465|NCT00796367|582103144|FG001|Overall Study|Withdrawal by Subject|11|||
161197466|NCT00796367|582103145|FG002|Overall Study|Withdrawal by Subject|12|||
161197467|NCT00796367|582103143|FG000|Overall Study|Lack of Efficacy|2|||
161197468|NCT00796367|582103144|FG001|Overall Study|Lack of Efficacy|1|||
161197469|NCT00796367|582103145|FG002|Overall Study|Lack of Efficacy|0|||
161197470|NCT00796367|582103143|FG000|Overall Study|non compliance|3|||
161197471|NCT00796367|582103144|FG001|Overall Study|non compliance|1|||
161197472|NCT00796367|582103145|FG002|Overall Study|non compliance|1|||
161197473|NCT00796367|582103143|FG000|Overall Study|Pregnancy|1|||
161197474|NCT00796367|582103144|FG001|Overall Study|Pregnancy|0|||
161197475|NCT00796367|582103145|FG002|Overall Study|Pregnancy|1|||
161197476|NCT00796367|582103143|FG000|Overall Study|Requirement for restricted medication|2|||
161197477|NCT00796367|582103144|FG001|Overall Study|Requirement for restricted medication|0|||
161197478|NCT00796367|582103145|FG002|Overall Study|Requirement for restricted medication|2|||
161197479|NCT00796367|582103143|FG000|Overall Study|other|2|||
161197480|NCT00796367|582103144|FG001|Overall Study|other|4|||
161197481|NCT00796367|582103145|FG002|Overall Study|other|3|||
161197482|NCT01463631|582103146|FG000|Overall Study|Withdrawal by Subject|0|||
161197483|NCT01463631|582103147|FG001|Overall Study|Withdrawal by Subject|0|||
161197484|NCT01463631|582103148|FG002|Overall Study|Withdrawal by Subject|0|||
161197485|NCT01463631|582103149|FG003|Overall Study|Withdrawal by Subject|1|||
161197486|NCT01463631|582103146|FG000|Overall Study|Death|0|||
161197487|NCT01463631|582103147|FG001|Overall Study|Death|0|||
161197488|NCT01463631|582103148|FG002|Overall Study|Death|1|||
161197489|NCT01463631|582103149|FG003|Overall Study|Death|0|||
161197490|NCT01463631|582103146|FG000|Overall Study|Progressive Disease|0|||
161197491|NCT01463631|582103147|FG001|Overall Study|Progressive Disease|0|||
161197492|NCT01463631|582103148|FG002|Overall Study|Progressive Disease|0|||
161197493|NCT01463631|582103149|FG003|Overall Study|Progressive Disease|5|||
161197494|NCT04409262|582103167|FG000|Overall Study|Adverse Event|0|||
161197495|NCT04409262|582103168|FG001|Overall Study|Adverse Event|2|||
161197496|NCT04409262|582103167|FG000|Overall Study|Death|55|||
161197497|NCT04409262|582103168|FG001|Overall Study|Death|97|||
161197498|NCT04409262|582103167|FG000|Overall Study|Lost to Follow-up|12|||
161197499|NCT04409262|582103168|FG001|Overall Study|Lost to Follow-up|23|||
161197500|NCT04409262|582103167|FG000|Overall Study|Lack of Staff|0|||
161197501|NCT04409262|582103168|FG001|Overall Study|Lack of Staff|1|||
161197502|NCT04409262|582103167|FG000|Overall Study|Protocol Violation|3|||
161197503|NCT04409262|582103168|FG001|Overall Study|Protocol Violation|1|||
161197504|NCT04409262|582103167|FG000|Overall Study|Withdrawal by Subject|5|||
161197505|NCT04409262|582103168|FG001|Overall Study|Withdrawal by Subject|10|||
161197506|NCT01326481|582103174|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
161197507|NCT04794491|582103175|FG000|Overall Study|Adverse Event|1|||
161197508|NCT04794491|582103175|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
161197509|NCT04794491|582103175|FG000|Overall Study|Noncompliance With Study Intervention|1|||
161197510|NCT04794491|582103175|FG000|Overall Study|Withdrawal by Subject|2|||
161197511|NCT00948896|582103176|FG000|Randomization to 24 Months of Age|Death|1|||
161197512|NCT00948896|582103177|FG001|Randomization to 24 Months of Age|Death|0|||
161197513|NCT00948896|582103178|FG002|Randomization to 24 Months of Age|Death|0|||
161197514|NCT00948896|582103179|FG003|Randomization to 24 Months of Age|Death|0|||
161197515|NCT00948896|582103180|FG004|Randomization to 24 Months of Age|Death|2|||
161197516|NCT00948896|582103181|FG005|Randomization to 24 Months of Age|Death|1|||
161197517|NCT00948896|582103182|FG006|Randomization to 24 Months of Age|Death|2|||
161350237|NCT02535416|582666888|FG002|Overall Study|Family bereavement overseas|0|||
161350238|NCT02535416|582666889|FG003|Overall Study|Family bereavement overseas|0|||
161350239|NCT02535416|582666890|FG004|Overall Study|Family bereavement overseas|0|||
161197518|NCT00948896|582103183|FG007|Randomization to 24 Months of Age|Death|1|||
161197519|NCT00948896|582103176|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
161197520|NCT00948896|582103177|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
161197521|NCT00948896|582103178|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
161350240|NCT02535416|582666891|FG005|Overall Study|Family bereavement overseas|0|||
161197522|NCT00948896|582103179|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
161197523|NCT00948896|582103180|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161197524|NCT00948896|582103181|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
161197525|NCT00948896|582103182|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161197526|NCT00948896|582103183|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
161197527|NCT00948896|582103176|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
161197528|NCT00948896|582103177|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
161197529|NCT00948896|582103178|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
161197530|NCT00948896|582103179|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
161197531|NCT00948896|582103180|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161197532|NCT00948896|582103181|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161197533|NCT00948896|582103182|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
161197534|NCT00948896|582103183|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
161197535|NCT00948896|582103176|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
161197536|NCT00948896|582103177|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
161197537|NCT00948896|582103178|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
161197538|NCT00948896|582103179|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
161197539|NCT00948896|582103180|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
161197540|NCT00948896|582103181|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
161197541|NCT00948896|582103182|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
161197542|NCT00948896|582103183|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
161197543|NCT00948896|582103176|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161197544|NCT00948896|582103177|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
161197545|NCT00948896|582103178|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
161197546|NCT00948896|582103179|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
161197547|NCT00948896|582103180|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161197548|NCT00948896|582103181|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
161197549|NCT00948896|582103182|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161197550|NCT00948896|582103183|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
161197551|NCT00948896|582103176|FG000|24 Months of Age to 36 Months of Age|Death|0|||
161197552|NCT00948896|582103177|FG001|24 Months of Age to 36 Months of Age|Death|2|||
161197553|NCT00948896|582103178|FG002|24 Months of Age to 36 Months of Age|Death|2|||
161197554|NCT00948896|582103179|FG003|24 Months of Age to 36 Months of Age|Death|0|||
161197555|NCT00948896|582103180|FG004|24 Months of Age to 36 Months of Age|Death|0|||
161197556|NCT00948896|582103181|FG005|24 Months of Age to 36 Months of Age|Death|1|||
161197557|NCT00948896|582103182|FG006|24 Months of Age to 36 Months of Age|Death|0|||
161197558|NCT00948896|582103183|FG007|24 Months of Age to 36 Months of Age|Death|0|||
161197559|NCT00948896|582103176|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161197560|NCT00948896|582103177|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161197561|NCT00948896|582103178|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161197562|NCT00948896|582103179|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
161197563|NCT00948896|582103180|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161197564|NCT00948896|582103181|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161197565|NCT00948896|582103182|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161197566|NCT00948896|582103183|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
161197567|NCT00948896|582103176|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
161197568|NCT00948896|582103177|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161197569|NCT00948896|582103178|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
161197570|NCT00948896|582103179|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161197571|NCT00948896|582103180|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
161197572|NCT00948896|582103181|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161197573|NCT00948896|582103182|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161197574|NCT00948896|582103183|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
161197575|NCT00948896|582103176|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161197576|NCT00948896|582103177|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161197577|NCT00948896|582103178|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
161197578|NCT00948896|582103179|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161197579|NCT00948896|582103180|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161197580|NCT00948896|582103181|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
161197581|NCT00948896|582103182|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161197582|NCT00948896|582103183|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
161197583|NCT00948896|582103176|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197584|NCT00948896|582103177|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197585|NCT00948896|582103178|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197586|NCT00948896|582103179|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
161197587|NCT00948896|582103180|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197588|NCT00948896|582103181|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197589|NCT00948896|582103182|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197590|NCT00948896|582103183|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
161197591|NCT00945815|582103184|FG000|Overall Study|Death|3|||
161197592|NCT00945815|582103184|FG000|Overall Study|Not protocol specified|1|||
161197593|NCT00945815|582103184|FG000|Overall Study|Ineligible|3|||
161197594|NCT00945815|582103184|FG000|Overall Study|Did not begin protocol therapy|1|||
161197595|NCT01990339|582103189|FG000|Overall Study|Data Not Available|49|||
161197596|NCT01990339|582103189|FG000|Overall Study|Voluntary Withdrawal|1402|||
161197597|NCT01990339|582103189|FG000|Overall Study|Lost to Follow-up|861|||
161197598|NCT01038609|582103190|FG000|Overall Study|Adverse Event|0|||
161197599|NCT01038609|582103191|FG001|Overall Study|Adverse Event|0|||
161197600|NCT01038609|582103192|FG002|Overall Study|Adverse Event|1|||
161197601|NCT01038609|582103193|FG003|Overall Study|Adverse Event|0|||
161197602|NCT01038609|582103194|FG004|Overall Study|Adverse Event|0|||
161197603|NCT01038609|582103190|FG000|Overall Study|Dosing Error|0|||
161197604|NCT01038609|582103191|FG001|Overall Study|Dosing Error|0|||
161197605|NCT01038609|582103192|FG002|Overall Study|Dosing Error|0|||
161197606|NCT01038609|582103193|FG003|Overall Study|Dosing Error|1|||
161197607|NCT01038609|582103194|FG004|Overall Study|Dosing Error|1|||
161197608|NCT01038609|582103190|FG000|Overall Study|Death in the Family|1|||
161197609|NCT01038609|582103191|FG001|Overall Study|Death in the Family|0|||
161197610|NCT01038609|582103192|FG002|Overall Study|Death in the Family|0|||
161197611|NCT01038609|582103193|FG003|Overall Study|Death in the Family|0|||
161197612|NCT01038609|582103194|FG004|Overall Study|Death in the Family|0|||
161197613|NCT01038609|582103190|FG000|Overall Study|Refusal of Blood Draws|0|||
161197614|NCT01038609|582103191|FG001|Overall Study|Refusal of Blood Draws|1|||
161197615|NCT01038609|582103192|FG002|Overall Study|Refusal of Blood Draws|0|||
161197616|NCT01038609|582103193|FG003|Overall Study|Refusal of Blood Draws|0|||
161197617|NCT01038609|582103194|FG004|Overall Study|Refusal of Blood Draws|0|||
161197618|NCT00242658|582103197|FG000|Overall Study|Lost to Follow-up|22|||
161197619|NCT00242658|582103198|FG001|Overall Study|Lost to Follow-up|19|||
161197620|NCT04604015|582103199|FG000|Overall Study|Incomplete Data Collection|33|||
161197621|NCT01314261|582103200|FG000|Overall Study|Adverse Event|1|||
161197622|NCT01314261|582103201|FG001|Overall Study|Adverse Event|0|||
161197623|NCT01314261|582103202|FG002|Overall Study|Adverse Event|0|||
161197624|NCT01314261|582103203|FG003|Overall Study|Adverse Event|0|||
161197625|NCT01314261|582103200|FG000|Overall Study|Withdrawal by Subject|0|||
161197626|NCT01314261|582103201|FG001|Overall Study|Withdrawal by Subject|3|||
161197627|NCT01314261|582103202|FG002|Overall Study|Withdrawal by Subject|1|||
161197628|NCT01314261|582103203|FG003|Overall Study|Withdrawal by Subject|0|||
161197629|NCT01314261|582103200|FG000|Overall Study|Lost to Follow-up|1|||
161197630|NCT01314261|582103201|FG001|Overall Study|Lost to Follow-up|0|||
161197631|NCT01314261|582103202|FG002|Overall Study|Lost to Follow-up|2|||
161197632|NCT01314261|582103203|FG003|Overall Study|Lost to Follow-up|2|||
161197633|NCT01314261|582103200|FG000|Overall Study|Virologic Failure|0|||
161197634|NCT01314261|582103201|FG001|Overall Study|Virologic Failure|1|||
161197635|NCT01314261|582103202|FG002|Overall Study|Virologic Failure|0|||
161197636|NCT01314261|582103203|FG003|Overall Study|Virologic Failure|1|||
161197637|NCT02129192|582103204|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
161197638|NCT02129192|582103205|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
161197639|NCT01231620|582103206|FG000|Overall Study|Physician Decision|3|||
161197640|NCT01231620|582103207|FG001|Overall Study|Physician Decision|5|||
161197641|NCT01231620|582103208|FG002|Overall Study|Physician Decision|10|||
161197642|NCT01231620|582103206|FG000|Overall Study|Death|12|||
161197643|NCT01231620|582103207|FG001|Overall Study|Death|14|||
161197644|NCT01231620|582103208|FG002|Overall Study|Death|11|||
161197645|NCT01231620|582103206|FG000|Overall Study|Adverse Event|2|||
161197646|NCT01231620|582103207|FG001|Overall Study|Adverse Event|2|||
161197647|NCT01231620|582103208|FG002|Overall Study|Adverse Event|1|||
161197648|NCT01231620|582103206|FG000|Overall Study|Withdrawal by Subject|6|||
161197649|NCT01231620|582103207|FG001|Overall Study|Withdrawal by Subject|6|||
161197650|NCT01231620|582103208|FG002|Overall Study|Withdrawal by Subject|8|||
161350241|NCT02535416|582666892|FG006|Overall Study|Family bereavement overseas|0|||
161350242|NCT02535416|582666893|FG007|Overall Study|Family bereavement overseas|0|||
161350243|NCT02535416|582666894|FG008|Overall Study|Family bereavement overseas|0|||
161350244|NCT04514341|582666895|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
161350245|NCT04514341|582666896|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
161197651|NCT01231620|582103206|FG000|Overall Study|Lost to Follow-up|3|||
161197652|NCT01231620|582103207|FG001|Overall Study|Lost to Follow-up|4|||
161197653|NCT01231620|582103208|FG002|Overall Study|Lost to Follow-up|9|||
161197654|NCT04557189|582103222|FG000|Overall Study|Adverse Event|0|||
161197655|NCT04557189|582103223|FG001|Overall Study|Adverse Event|1|||
161350246|NCT04514341|582666895|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
161197656|NCT04557189|582103222|FG000|Overall Study|Lost to Follow-up|1|||
161197657|NCT04557189|582103223|FG001|Overall Study|Lost to Follow-up|1|||
161197658|NCT04557189|582103222|FG000|Overall Study|Withdrawal by Subject|2|||
161197659|NCT04557189|582103223|FG001|Overall Study|Withdrawal by Subject|1|||
161197660|NCT04557189|582103222|FG000|Overall Study|Reason not Specified|3|||
161197661|NCT04557189|582103223|FG001|Overall Study|Reason not Specified|6|||
161197662|NCT03590613|582103224|FG000|Period 2, 4 Days|Physician Decision|0|||
161197663|NCT03590613|582103225|FG001|Period 2, 4 Days|Physician Decision|0|||
161197664|NCT03590613|582103226|FG002|Period 2, 4 Days|Physician Decision|0|||
161197665|NCT03590613|582103227|FG003|Period 2, 4 Days|Physician Decision|1|||
161197666|NCT03575975|582103229|FG000|Overall Study|Lost to Follow-up|1|||
161197667|NCT03575975|582103230|FG001|Overall Study|Lost to Follow-up|0|||
161197668|NCT03575975|582103231|FG002|Overall Study|Lost to Follow-up|0|||
161197669|NCT02441517|582103232|FG000|Overall Study|Lost to Follow-up|1|||
161197670|NCT02441517|582103232|FG000|Overall Study|Withdrawal by Subject|2|||
161197671|NCT02441517|582103232|FG000|Overall Study|Study Terminated by Sponsor|1|||
161197672|NCT00129220|582103233|FG000|Study Period II|Adverse Event|9|||
161197673|NCT00129220|582103234|FG001|Study Period II|Adverse Event|5|||
161197674|NCT00129220|582103235|FG002|Study Period II|Adverse Event|7|||
161197675|NCT00129220|582103233|FG000|Study Period II|Lack of Efficacy|15|||
161197676|NCT00129220|582103234|FG001|Study Period II|Lack of Efficacy|1|||
161197677|NCT00129220|582103235|FG002|Study Period II|Lack of Efficacy|28|||
161197678|NCT00129220|582103233|FG000|Study Period II|Entry Criteria Not Met|2|||
161197679|NCT00129220|582103234|FG001|Study Period II|Entry Criteria Not Met|0|||
161197680|NCT00129220|582103235|FG002|Study Period II|Entry Criteria Not Met|2|||
161197681|NCT00129220|582103233|FG000|Study Period II|Protocol Violation|4|||
161197682|NCT00129220|582103234|FG001|Study Period II|Protocol Violation|2|||
161197683|NCT00129220|582103235|FG002|Study Period II|Protocol Violation|1|||
161197684|NCT00129220|582103233|FG000|Study Period II|Physician Decision|0|||
161197685|NCT00129220|582103234|FG001|Study Period II|Physician Decision|1|||
161197686|NCT00129220|582103235|FG002|Study Period II|Physician Decision|0|||
161197687|NCT00129220|582103233|FG000|Study Period II|Withdrawal by Subject|1|||
161197688|NCT00129220|582103234|FG001|Study Period II|Withdrawal by Subject|3|||
161197689|NCT00129220|582103235|FG002|Study Period II|Withdrawal by Subject|4|||
161197690|NCT00129220|582103233|FG000|Study Period II|Reason Not Specified|2|||
161197691|NCT00129220|582103234|FG001|Study Period II|Reason Not Specified|0|||
161197692|NCT00129220|582103235|FG002|Study Period II|Reason Not Specified|5|||
161197693|NCT00129220|582103233|FG000|Study Period III|Adverse Event|1|||
161197694|NCT00129220|582103234|FG001|Study Period III|Adverse Event|0|||
161197695|NCT00129220|582103235|FG002|Study Period III|Adverse Event|3|||
161197696|NCT00129220|582103233|FG000|Study Period III|Protocol Violation|1|||
161197697|NCT00129220|582103234|FG001|Study Period III|Protocol Violation|1|||
161197698|NCT00129220|582103235|FG002|Study Period III|Protocol Violation|2|||
161197699|NCT00129220|582103233|FG000|Study Period III|Withdrawal by Subject|1|||
161197700|NCT00129220|582103234|FG001|Study Period III|Withdrawal by Subject|0|||
161197701|NCT00129220|582103235|FG002|Study Period III|Withdrawal by Subject|3|||
161197702|NCT00129220|582103233|FG000|Study Period III|Sponsor Decision|1|||
161197703|NCT00129220|582103234|FG001|Study Period III|Sponsor Decision|0|||
161197704|NCT00129220|582103235|FG002|Study Period III|Sponsor Decision|0|||
161197705|NCT00129220|582103233|FG000|Study Period III|Reason Not Specified|9|||
161197706|NCT00129220|582103234|FG001|Study Period III|Reason Not Specified|0|||
161197707|NCT00129220|582103235|FG002|Study Period III|Reason Not Specified|2|||
161197708|NCT00540228|582103237|FG000|Overall Study|Adverse Event|2|||
161197709|NCT00540228|582103238|FG001|Overall Study|Adverse Event|0|||
161197710|NCT00540228|582103239|FG002|Overall Study|Adverse Event|0|||
161197711|NCT00540228|582103240|FG003|Overall Study|Adverse Event|0|||
161197712|NCT00540228|582103241|FG004|Overall Study|Adverse Event|0|||
161197713|NCT00540228|582103237|FG000|Overall Study|Lost to Follow-up|1|||
161197714|NCT00540228|582103238|FG001|Overall Study|Lost to Follow-up|1|||
161197715|NCT00540228|582103239|FG002|Overall Study|Lost to Follow-up|0|||
161197716|NCT00540228|582103240|FG003|Overall Study|Lost to Follow-up|0|||
161197717|NCT00540228|582103241|FG004|Overall Study|Lost to Follow-up|0|||
161197718|NCT01883362|582103242|FG000|Treatment|Adverse Event|1|||
161197719|NCT01883362|582103243|FG001|Treatment|Adverse Event|8|||
161197720|NCT01883362|582103242|FG000|Treatment|Withdrawal by Subject|6|||
161197721|NCT01883362|582103243|FG001|Treatment|Withdrawal by Subject|2|||
161197722|NCT01883362|582103242|FG000|Treatment|Administrative problems|4|||
161197723|NCT01883362|582103243|FG001|Treatment|Administrative problems|1|||
161197724|NCT01883362|582103242|FG000|Treatment|Relapse|4|||
161197725|NCT01883362|582103243|FG001|Treatment|Relapse|2|||
161197726|NCT01883362|582103242|FG000|Treatment|Randomized, not treated|1|||
161197727|NCT01883362|582103243|FG001|Treatment|Randomized, not treated|1|||
161197728|NCT01883362|582103242|FG000|Post Treatment Follow-up|Protocol Violation|0|||
161197729|NCT01883362|582103243|FG001|Post Treatment Follow-up|Protocol Violation|1|||
161197730|NCT01883362|582103242|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
161197731|NCT01883362|582103243|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
161197732|NCT01883362|582103242|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
161197733|NCT01883362|582103243|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
161197734|NCT01883362|582103242|FG000|Post Treatment Follow-up|Administrative problems|2|||
161197735|NCT01883362|582103243|FG001|Post Treatment Follow-up|Administrative problems|0|||
161197736|NCT01883362|582103242|FG000|Post Treatment Follow-up|Death|8|||
161197737|NCT01883362|582103243|FG001|Post Treatment Follow-up|Death|4|||
161197738|NCT01883362|582103242|FG000|Post Treatment Follow-up|Relapse|1|||
161197739|NCT01883362|582103243|FG001|Post Treatment Follow-up|Relapse|2|||
161197740|NCT01349816|582103244|FG000|Overall Study|Withdrawal by Subject|4|||
161197741|NCT01349816|582103244|FG000|Overall Study|Physician Decision|1|||
161197742|NCT01349816|582103244|FG000|Overall Study|Adverse Event|14|||
161197743|NCT01349816|582103244|FG000|Overall Study|Lost to Follow-up|2|||
161197744|NCT01349816|582103244|FG000|Overall Study|Protocol Violation|1|||
161197745|NCT01349816|582103244|FG000|Overall Study|Protocol-specified criteria|8|||
161197746|NCT01383317|582103245|FG000|Overall Study|Lost to Follow-up|2|||
161197747|NCT01383317|582103246|FG001|Overall Study|Lost to Follow-up|1|||
161197748|NCT01383317|582103245|FG000|Overall Study|Death|1|||
161197749|NCT01383317|582103246|FG001|Overall Study|Death|0|||
161197750|NCT01383317|582103245|FG000|Overall Study|Adverse Event|0|||
161197751|NCT01383317|582103246|FG001|Overall Study|Adverse Event|1|||
161197752|NCT02569996|582103247|FG000|Overall Study|Adverse Event|6|||
161197753|NCT02569996|582103247|FG000|Overall Study|Physician Decision|3|||
161197754|NCT02569996|582103247|FG000|Overall Study|Progression of the disease|18|||
161197755|NCT02569996|582103247|FG000|Overall Study|New anti-lymphoma treatment|1|||
161197756|NCT02569996|582103247|FG000|Overall Study|Non-compliance|9|||
161197757|NCT02569996|582103247|FG000|Overall Study|Withdrawal by Subject|5|||
161197758|NCT02569996|582103247|FG000|Overall Study|Lost to Follow-up|5|||
161197759|NCT02569996|582103247|FG000|Overall Study|Complete remission|7|||
161197760|NCT02569996|582103247|FG000|Overall Study|Unknown reason|1|||
161197761|NCT02911285|582103250|FG000|Overall Study|Lost to Follow-up|8|||
161197762|NCT02911285|582103251|FG001|Overall Study|Lost to Follow-up|5|||
161197763|NCT02911285|582103250|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
161197764|NCT02911285|582103251|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
161197765|NCT02451137|582103253|FG000|Overall Study|Randomized but not treated|19|||
161197766|NCT02451137|582103254|FG001|Overall Study|Randomized but not treated|27|||
161197767|NCT02451137|582103253|FG000|Overall Study|Adverse Event|43|||
161197768|NCT02451137|582103254|FG001|Overall Study|Adverse Event|42|||
161197769|NCT02451137|582103253|FG000|Overall Study|Lack of Efficacy|4|||
161197770|NCT02451137|582103254|FG001|Overall Study|Lack of Efficacy|9|||
161197771|NCT02451137|582103253|FG000|Overall Study|Participant decision:discontinue insulin|41|||
161197772|NCT02451137|582103254|FG001|Overall Study|Participant decision:discontinue insulin|43|||
161197773|NCT02451137|582103253|FG000|Overall Study|Hypoglycemia|2|||
161197774|NCT02451137|582103254|FG001|Overall Study|Hypoglycemia|1|||
161197775|NCT02451137|582103253|FG000|Overall Study|Investigator's decision|23|||
161197776|NCT02451137|582103254|FG001|Overall Study|Investigator's decision|19|||
161197777|NCT02451137|582103253|FG000|Overall Study|Lost to Follow-up|53|||
161197778|NCT02451137|582103254|FG001|Overall Study|Lost to Follow-up|61|||
161197779|NCT02451137|582103253|FG000|Overall Study|Physician Decision|6|||
161197780|NCT02451137|582103254|FG001|Overall Study|Physician Decision|5|||
161197781|NCT02451137|582103253|FG000|Overall Study|Sponsor decision|13|||
161197782|NCT02451137|582103254|FG001|Overall Study|Sponsor decision|25|||
161197783|NCT02451137|582103253|FG000|Overall Study|Withdrawal by Subject|40|||
161197784|NCT02451137|582103254|FG001|Overall Study|Withdrawal by Subject|63|||
161197785|NCT02451137|582103253|FG000|Overall Study|Other than specified above|2|||
161197786|NCT02451137|582103254|FG001|Overall Study|Other than specified above|3|||
161197787|NCT00869362|582105198|FG000|Overall Study|Death|0|||
161197788|NCT00869362|582105199|FG001|Overall Study|Death|2|||
161197789|NCT00869362|582105198|FG000|Overall Study|Lost to Follow-up|1|||
161197790|NCT00869362|582105199|FG001|Overall Study|Lost to Follow-up|3|||
161197791|NCT02842736|582105200|FG000|Overall Study|Lost to Follow-up|13|||
161197792|NCT02842736|582105200|FG000|Overall Study|Intervention for menstrual bleeding|17|||
161197793|NCT02842736|582105200|FG000|Overall Study|Withdrawal by Subject|4|||
161197794|NCT02842736|582105200|FG000|Overall Study|Pregnancy|3|||
161197795|NCT02842736|582105200|FG000|Overall Study|Hysterectomy for fibroids|2|||
161197796|NCT02842736|582105200|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
161197797|NCT02842736|582105200|FG000|Overall Study|IUD: Mirena|1|||
161197798|NCT02389621|582105202|FG000|Treatment Period|Withdrawal by Subject|1|||
161197799|NCT02389621|582105203|FG001|Treatment Period|Withdrawal by Subject|1|||
161197800|NCT02389621|582105202|FG000|Posttreatment Period|Adverse Event|3|||
161197801|NCT02389621|582105203|FG001|Posttreatment Period|Adverse Event|1|||
161197802|NCT02389621|582105202|FG000|Posttreatment Period|Withdrawal by Subject|3|||
161197803|NCT02389621|582105203|FG001|Posttreatment Period|Withdrawal by Subject|2|||
161197804|NCT02389621|582105202|FG000|Posttreatment Period|Lost to Follow-up|1|||
161197805|NCT02389621|582105203|FG001|Posttreatment Period|Lost to Follow-up|1|||
161197806|NCT02389621|582105202|FG000|Posttreatment Period|Other - Miscellaneous|2|||
161197807|NCT02389621|582105203|FG001|Posttreatment Period|Other - Miscellaneous|0|||
161197808|NCT02815540|582105210|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
161197809|NCT04887922|582105218|FG000|1st Randomization|Decided not to have surgery|0|||
161197810|NCT04887922|582105219|FG001|1st Randomization|Decided not to have surgery|1|||
161197811|NCT04887922|582105220|FG002|1st Randomization|Decided not to have surgery|0|||
161197812|NCT04887922|582105221|FG003|1st Randomization|Decided not to have surgery|0|||
161197813|NCT04887922|582105222|FG004|1st Randomization|Decided not to have surgery|0|||
161197814|NCT00953017|582105223|FG000|Overall Study|DId not show up for colonoscopy|4|||
161197815|NCT00953017|582105224|FG001|Overall Study|DId not show up for colonoscopy|4|||
161197816|NCT00953017|582105225|FG002|Overall Study|DId not show up for colonoscopy|5|||
161197817|NCT00953017|582105226|FG003|Overall Study|DId not show up for colonoscopy|4|||
161197818|NCT00953017|582105223|FG000|Overall Study|Incomplete data|1|||
161197819|NCT00953017|582105224|FG001|Overall Study|Incomplete data|1|||
161197820|NCT00953017|582105225|FG002|Overall Study|Incomplete data|0|||
161197821|NCT00953017|582105226|FG003|Overall Study|Incomplete data|0|||
161197822|NCT00953017|582105223|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
161197823|NCT00953017|582105224|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
161197824|NCT00953017|582105225|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
161197825|NCT00953017|582105226|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
161197826|NCT00953017|582105223|FG000|Overall Study|Brown stool prior to procedure|0|||
161197827|NCT00953017|582105224|FG001|Overall Study|Brown stool prior to procedure|0|||
161197828|NCT00953017|582105225|FG002|Overall Study|Brown stool prior to procedure|1|||
161197829|NCT00953017|582105226|FG003|Overall Study|Brown stool prior to procedure|0|||
161197830|NCT00798161|582105229|FG000|Overall Study|Adverse Event|3|||
161197831|NCT00798161|582105230|FG001|Overall Study|Adverse Event|4|||
161197832|NCT00798161|582105231|FG002|Overall Study|Adverse Event|6|||
161197833|NCT00798161|582105232|FG003|Overall Study|Adverse Event|6|||
161197834|NCT00798161|582105233|FG004|Overall Study|Adverse Event|5|||
161197835|NCT00798161|582105234|FG005|Overall Study|Adverse Event|2|||
161197836|NCT00798161|582105235|FG006|Overall Study|Adverse Event|4|||
161197837|NCT00798161|582105229|FG000|Overall Study|Protocol Violation|2|||
161197838|NCT00798161|582105230|FG001|Overall Study|Protocol Violation|1|||
161197839|NCT00798161|582105231|FG002|Overall Study|Protocol Violation|3|||
161197840|NCT00798161|582105232|FG003|Overall Study|Protocol Violation|3|||
161197841|NCT00798161|582105233|FG004|Overall Study|Protocol Violation|3|||
161197842|NCT00798161|582105234|FG005|Overall Study|Protocol Violation|2|||
161197843|NCT00798161|582105235|FG006|Overall Study|Protocol Violation|0|||
161197844|NCT00798161|582105229|FG000|Overall Study|Lost to Follow-up|1|||
161197845|NCT00798161|582105230|FG001|Overall Study|Lost to Follow-up|3|||
161197846|NCT00798161|582105231|FG002|Overall Study|Lost to Follow-up|4|||
161197847|NCT00798161|582105232|FG003|Overall Study|Lost to Follow-up|3|||
161197848|NCT00798161|582105233|FG004|Overall Study|Lost to Follow-up|4|||
161197849|NCT00798161|582105234|FG005|Overall Study|Lost to Follow-up|0|||
161197850|NCT00798161|582105235|FG006|Overall Study|Lost to Follow-up|0|||
161197851|NCT00798161|582105229|FG000|Overall Study|Withdrawal by Subject|5|||
161197852|NCT00798161|582105230|FG001|Overall Study|Withdrawal by Subject|4|||
161197853|NCT00798161|582105231|FG002|Overall Study|Withdrawal by Subject|5|||
161197854|NCT00798161|582105232|FG003|Overall Study|Withdrawal by Subject|4|||
161197855|NCT00798161|582105233|FG004|Overall Study|Withdrawal by Subject|2|||
161197856|NCT00798161|582105234|FG005|Overall Study|Withdrawal by Subject|3|||
161197857|NCT00798161|582105235|FG006|Overall Study|Withdrawal by Subject|1|||
161197858|NCT00798161|582105229|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
161197859|NCT00798161|582105230|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
161197860|NCT00798161|582105231|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
161197861|NCT00798161|582105232|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
161197862|NCT00798161|582105233|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
161197863|NCT00798161|582105234|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
161197864|NCT00798161|582105235|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
161197865|NCT00594568|582105236|FG000|Initial Treatment|Adverse Event|51|||
161197866|NCT00594568|582105237|FG001|Initial Treatment|Adverse Event|121|||
161197867|NCT00594568|582105238|FG002|Initial Treatment|Adverse Event|144|||
161197868|NCT00594568|582105236|FG000|Initial Treatment|Death|6|||
161197869|NCT00594568|582105237|FG001|Initial Treatment|Death|11|||
161197870|NCT00594568|582105238|FG002|Initial Treatment|Death|15|||
161197871|NCT00594568|582105236|FG000|Initial Treatment|Lost to Follow-up|4|||
161197872|NCT00594568|582105237|FG001|Initial Treatment|Lost to Follow-up|1|||
161197873|NCT00594568|582105238|FG002|Initial Treatment|Lost to Follow-up|4|||
161197874|NCT00594568|582105236|FG000|Initial Treatment|Physician Decision|3|||
161197875|NCT00594568|582105237|FG001|Initial Treatment|Physician Decision|2|||
161197876|NCT00594568|582105238|FG002|Initial Treatment|Physician Decision|4|||
161197877|NCT00594568|582105236|FG000|Initial Treatment|Protocol Violation|2|||
161197878|NCT00594568|582105237|FG001|Initial Treatment|Protocol Violation|2|||
161197879|NCT00594568|582105238|FG002|Initial Treatment|Protocol Violation|5|||
161197880|NCT00594568|582105236|FG000|Initial Treatment|Withdrawal by Subject|25|||
161197881|NCT00594568|582105237|FG001|Initial Treatment|Withdrawal by Subject|31|||
161197882|NCT00594568|582105238|FG002|Initial Treatment|Withdrawal by Subject|46|||
161197883|NCT00594568|582105236|FG000|Initial Treatment|Sponsor decision|193|||
161197884|NCT00594568|582105237|FG001|Initial Treatment|Sponsor decision|142|||
161197885|NCT00594568|582105238|FG002|Initial Treatment|Sponsor decision|147|||
161197886|NCT00594568|582105236|FG000|Initial Treatment|Caregiver decision|21|||
161197887|NCT00594568|582105237|FG001|Initial Treatment|Caregiver decision|36|||
161197888|NCT00594568|582105238|FG002|Initial Treatment|Caregiver decision|36|||
161197889|NCT00594568|582105236|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
161197890|NCT00594568|582105237|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
161197891|NCT00594568|582105238|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
161306695|NCT01167881|582502908|FG000|Overall Study|Other not defined above|31|||
161197892|NCT00594568|582105236|FG000|Initial Treatment|Entry criteria exclusion|0|||
161197893|NCT00594568|582105237|FG001|Initial Treatment|Entry criteria exclusion|1|||
161197894|NCT00594568|582105238|FG002|Initial Treatment|Entry criteria exclusion|1|||
161197895|NCT00594568|582105236|FG000|Delayed Start|Death|0|||
161197896|NCT00594568|582105237|FG001|Delayed Start|Death|0|||
161197897|NCT00594568|582105238|FG002|Delayed Start|Death|1|||
161197898|NCT00594568|582105236|FG000|Delayed Start|Adverse Event|12|||
161197899|NCT00594568|582105237|FG001|Delayed Start|Adverse Event|2|||
161197900|NCT00594568|582105238|FG002|Delayed Start|Adverse Event|2|||
161197901|NCT00594568|582105236|FG000|Delayed Start|Withdrawal by Subject|4|||
161197902|NCT00594568|582105237|FG001|Delayed Start|Withdrawal by Subject|3|||
161197903|NCT00594568|582105238|FG002|Delayed Start|Withdrawal by Subject|0|||
161197904|NCT00594568|582105236|FG000|Delayed Start|Physician Decision|0|||
161197905|NCT00594568|582105237|FG001|Delayed Start|Physician Decision|0|||
161197906|NCT00594568|582105238|FG002|Delayed Start|Physician Decision|1|||
161197907|NCT00594568|582105236|FG000|Delayed Start|Lost to Follow-up|0|||
161197908|NCT00594568|582105237|FG001|Delayed Start|Lost to Follow-up|0|||
161197909|NCT00594568|582105238|FG002|Delayed Start|Lost to Follow-up|1|||
161197910|NCT00594568|582105236|FG000|Delayed Start|Caregiver Decision|5|||
161197911|NCT00594568|582105237|FG001|Delayed Start|Caregiver Decision|6|||
161197912|NCT00594568|582105238|FG002|Delayed Start|Caregiver Decision|2|||
161197913|NCT00594568|582105236|FG000|Delayed Start|Sponsor Decision|77|||
161197914|NCT00594568|582105237|FG001|Delayed Start|Sponsor Decision|66|||
161197915|NCT00594568|582105238|FG002|Delayed Start|Sponsor Decision|59|||
161197916|NCT00594568|582105236|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
161197917|NCT00594568|582105237|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
161197918|NCT00594568|582105238|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
161197919|NCT00594568|582105236|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
161197920|NCT00594568|582105237|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161197921|NCT00594568|582105238|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
161197922|NCT00594568|582105236|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
161197923|NCT00594568|582105237|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
161197924|NCT00594568|582105238|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
161197925|NCT00594568|582105236|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
161197926|NCT00594568|582105237|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
161197927|NCT00594568|582105238|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
161197928|NCT00594568|582105236|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
161197929|NCT00594568|582105237|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
161197930|NCT00594568|582105238|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
161197931|NCT00594568|582105236|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
161197932|NCT00594568|582105237|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
161197933|NCT00594568|582105238|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
161197934|NCT01366846|582105242|FG000|Overall Study|Withdrawal by Subject|2|||
161197935|NCT01366846|582105243|FG001|Overall Study|Withdrawal by Subject|0|||
161197936|NCT01366846|582105244|FG002|Overall Study|Withdrawal by Subject|0|||
161197937|NCT01366846|582105245|FG003|Overall Study|Withdrawal by Subject|0|||
161197938|NCT01366846|582105242|FG000|Overall Study|Communication Difficulties|1|||
161197939|NCT01366846|582105243|FG001|Overall Study|Communication Difficulties|4|||
161197940|NCT01366846|582105244|FG002|Overall Study|Communication Difficulties|0|||
161197941|NCT01366846|582105245|FG003|Overall Study|Communication Difficulties|1|||
161197942|NCT01366846|582105242|FG000|Overall Study|Scheduling Conflicts|0|||
161197943|NCT01366846|582105243|FG001|Overall Study|Scheduling Conflicts|0|||
161197944|NCT01366846|582105244|FG002|Overall Study|Scheduling Conflicts|1|||
161197945|NCT01366846|582105245|FG003|Overall Study|Scheduling Conflicts|0|||
161197946|NCT00290511|582105246|FG000|Overall Study|Adverse Event|1|||
161197947|NCT00290511|582105246|FG000|Overall Study|Death|1|||
161197948|NCT00290511|582105246|FG000|Overall Study|Physician Decision|1|||
161197949|NCT00290511|582105246|FG000|Overall Study|Withdrawal by Subject|1|||
161197950|NCT04341727|582105251|FG000|Overall Study|Withdrawal by Subject|0|||
161197951|NCT04341727|582105252|FG001|Overall Study|Withdrawal by Subject|0|||
161197952|NCT04341727|582105253|FG002|Overall Study|Withdrawal by Subject|1|||
161197953|NCT04341727|582105254|FG003|Overall Study|Withdrawal by Subject|0|||
161197954|NCT04341727|582105251|FG000|Overall Study|Lost to Follow-up|0|||
161197955|NCT04341727|582105252|FG001|Overall Study|Lost to Follow-up|0|||
161197956|NCT04341727|582105253|FG002|Overall Study|Lost to Follow-up|0|||
161197957|NCT04341727|582105254|FG003|Overall Study|Lost to Follow-up|1|||
161197958|NCT00447265|582105255|FG000|Overall Study|Physician Decision|1|||
161197959|NCT00447265|582105256|FG001|Overall Study|Physician Decision|0|||
161306696|NCT01167881|582502909|FG001|Overall Study|Other not defined above|55|||
161197960|NCT00503035|582105257|FG000|Overall Study|Lost to Follow-up|2|||
161197961|NCT00503035|582105257|FG000|Overall Study|Physician Decision|3|||
161197962|NCT00503035|582105257|FG000|Overall Study|Ineligible|15|||
161197963|NCT04311411|582105260|FG000|Overall Study|Adverse Event|2|||
161306697|NCT01668173|582502914|FG000|Overall Study|Adverse Event|3|||
161306698|NCT01668173|582502914|FG000|Overall Study|Trial suspension|4|||
161306699|NCT01295827|582502915|FG000|Overall Study|Adverse Event|1|||
161306700|NCT01295827|582502916|FG001|Overall Study|Adverse Event|2|||
161306701|NCT01295827|582502917|FG002|Overall Study|Adverse Event|2|||
161306702|NCT01295827|582502918|FG003|Overall Study|Adverse Event|1|||
161306703|NCT01295827|582502919|FG004|Overall Study|Adverse Event|1|||
161306704|NCT01295827|582502920|FG005|Overall Study|Adverse Event|4|||
161306705|NCT01295827|582502921|FG006|Overall Study|Adverse Event|15|||
161306706|NCT01295827|582502922|FG007|Overall Study|Adverse Event|49|||
161306707|NCT01295827|582502923|FG008|Overall Study|Adverse Event|22|||
161306708|NCT01295827|582502924|FG009|Overall Study|Adverse Event|7|||
161306709|NCT01295827|582502925|FG010|Overall Study|Adverse Event|50|||
161306710|NCT01295827|582502926|FG011|Overall Study|Adverse Event|21|||
161306711|NCT01295827|582502927|FG012|Overall Study|Adverse Event|0|||
161306712|NCT01295827|582502928|FG013|Overall Study|Adverse Event|0|||
161306713|NCT01295827|582502929|FG014|Overall Study|Adverse Event|0|||
161306714|NCT01295827|582502915|FG000|Overall Study|Lost to Follow-up|0|||
161306715|NCT01295827|582502916|FG001|Overall Study|Lost to Follow-up|0|||
161306716|NCT01295827|582502917|FG002|Overall Study|Lost to Follow-up|3|||
161306717|NCT01295827|582502918|FG003|Overall Study|Lost to Follow-up|0|||
161306718|NCT01295827|582502919|FG004|Overall Study|Lost to Follow-up|1|||
161090667|NCT03451162|581721717|FG000|Overall Study|Physician Decision|0|||
161090668|NCT03451162|581721718|FG001|Overall Study|Physician Decision|1|||
161090669|NCT03451162|581721719|FG002|Overall Study|Physician Decision|0|||
161090670|NCT03451162|581721720|FG003|Overall Study|Physician Decision|0|||
161090671|NCT03451162|581721721|FG004|Overall Study|Physician Decision|0|||
161090672|NCT03451162|581721717|FG000|Overall Study|Withdrawal by Subject|1|||
161090673|NCT03451162|581721718|FG001|Overall Study|Withdrawal by Subject|1|||
161090674|NCT03451162|581721719|FG002|Overall Study|Withdrawal by Subject|0|||
161090675|NCT03451162|581721720|FG003|Overall Study|Withdrawal by Subject|0|||
161090676|NCT03451162|581721721|FG004|Overall Study|Withdrawal by Subject|0|||
161090677|NCT01952054|581721722|FG000|Overall Study|Physician Decision|1|||
161090678|NCT01100034|581721723|FG000|Overall Study|Lost to Follow-up|11|||
161090679|NCT01100034|581721723|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
161090680|NCT01100034|581721723|FG000|Overall Study|Withdrawal by Subject|4|||
161090681|NCT01100034|581721723|FG000|Overall Study|Sponsor decision|21|||
161090682|NCT01100034|581721723|FG000|Overall Study|Participated in another clinical trial|1|||
161090683|NCT01100034|581721723|FG000|Overall Study|Participants moved to another hospital|4|||
161090684|NCT01100034|581721723|FG000|Overall Study|Site closed due to non-responsiveness|1|||
161090685|NCT00402597|581721724|FG000|Overall Study|Death|15|||
161090686|NCT00402597|581721725|FG001|Overall Study|Death|7|||
161090687|NCT00402597|581721726|FG002|Overall Study|Death|6|||
161090688|NCT00402597|581721727|FG003|Overall Study|Death|4|||
161090689|NCT00402597|581721728|FG004|Overall Study|Death|6|||
161090690|NCT00402597|581721724|FG000|Overall Study|Adverse Event|81|||
161090691|NCT00402597|581721725|FG001|Overall Study|Adverse Event|18|||
161090692|NCT00402597|581721726|FG002|Overall Study|Adverse Event|106|||
161090693|NCT00402597|581721727|FG003|Overall Study|Adverse Event|39|||
161090694|NCT00402597|581721728|FG004|Overall Study|Adverse Event|71|||
161090695|NCT00402597|581721724|FG000|Overall Study|Lost to Follow-up|8|||
161090696|NCT00402597|581721725|FG001|Overall Study|Lost to Follow-up|1|||
161090697|NCT00402597|581721726|FG002|Overall Study|Lost to Follow-up|8|||
161090698|NCT00402597|581721727|FG003|Overall Study|Lost to Follow-up|2|||
161090699|NCT00402597|581721728|FG004|Overall Study|Lost to Follow-up|3|||
161090700|NCT00402597|581721724|FG000|Overall Study|Withdrawal by Subject|57|||
161090701|NCT00402597|581721725|FG001|Overall Study|Withdrawal by Subject|16|||
161090702|NCT00402597|581721726|FG002|Overall Study|Withdrawal by Subject|65|||
161090703|NCT00402597|581721727|FG003|Overall Study|Withdrawal by Subject|15|||
161090704|NCT00402597|581721728|FG004|Overall Study|Withdrawal by Subject|24|||
161090705|NCT00402597|581721724|FG000|Overall Study|reason not specified|30|||
161090706|NCT00402597|581721725|FG001|Overall Study|reason not specified|4|||
161090707|NCT00402597|581721726|FG002|Overall Study|reason not specified|27|||
161090708|NCT00402597|581721727|FG003|Overall Study|reason not specified|14|||
161090709|NCT00402597|581721728|FG004|Overall Study|reason not specified|20|||
161090710|NCT01831856|581721729|FG000|Overall Study|Adverse Event|5|||
161090711|NCT01831856|581721730|FG001|Overall Study|Adverse Event|8|||
161090712|NCT01831856|581721729|FG000|Overall Study|Lack of Efficacy|13|||
161090713|NCT01831856|581721730|FG001|Overall Study|Lack of Efficacy|11|||
161090714|NCT01831856|581721729|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
161090715|NCT01831856|581721730|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
161090716|NCT05208866|581721732|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
161090717|NCT00836095|581721735|FG000|Overall Study|Physician Decision|0|||
161090718|NCT00836095|581721736|FG001|Overall Study|Physician Decision|3|||
161090719|NCT01602562|581721738|FG000|Overall Study|Adverse Event|3|||
161090720|NCT01602562|581721739|FG001|Overall Study|Adverse Event|1|||
161306719|NCT01295827|582502920|FG005|Overall Study|Lost to Follow-up|0|||
161306720|NCT01295827|582502921|FG006|Overall Study|Lost to Follow-up|4|||
161306721|NCT01295827|582502922|FG007|Overall Study|Lost to Follow-up|8|||
161306722|NCT01295827|582502923|FG008|Overall Study|Lost to Follow-up|7|||
161306723|NCT01295827|582502924|FG009|Overall Study|Lost to Follow-up|4|||
161306724|NCT01295827|582502925|FG010|Overall Study|Lost to Follow-up|7|||
161306725|NCT01295827|582502926|FG011|Overall Study|Lost to Follow-up|3|||
161306726|NCT01295827|582502927|FG012|Overall Study|Lost to Follow-up|0|||
161306727|NCT01295827|582502928|FG013|Overall Study|Lost to Follow-up|0|||
161306728|NCT01295827|582502929|FG014|Overall Study|Lost to Follow-up|0|||
161306729|NCT01295827|582502915|FG000|Overall Study|Not Reported|0|||
161306730|NCT01295827|582502916|FG001|Overall Study|Not Reported|0|||
161306731|NCT01295827|582502917|FG002|Overall Study|Not Reported|0|||
161306732|NCT01295827|582502918|FG003|Overall Study|Not Reported|1|||
161306733|NCT01295827|582502919|FG004|Overall Study|Not Reported|0|||
161306734|NCT01295827|582502920|FG005|Overall Study|Not Reported|0|||
161306735|NCT01295827|582502921|FG006|Overall Study|Not Reported|24|||
161306736|NCT01295827|582502922|FG007|Overall Study|Not Reported|58|||
161306737|NCT01295827|582502923|FG008|Overall Study|Not Reported|41|||
161306738|NCT01295827|582502924|FG009|Overall Study|Not Reported|2|||
161306739|NCT01295827|582502925|FG010|Overall Study|Not Reported|23|||
161306740|NCT01295827|582502926|FG011|Overall Study|Not Reported|13|||
161306741|NCT01295827|582502927|FG012|Overall Study|Not Reported|0|||
161306742|NCT01295827|582502928|FG013|Overall Study|Not Reported|0|||
161306743|NCT01295827|582502929|FG014|Overall Study|Not Reported|0|||
161306744|NCT01295827|582502915|FG000|Overall Study|Progressive Disease|2|||
161306745|NCT01295827|582502916|FG001|Overall Study|Progressive Disease|1|||
161306746|NCT01295827|582502917|FG002|Overall Study|Progressive Disease|5|||
161306747|NCT01295827|582502918|FG003|Overall Study|Progressive Disease|2|||
161306748|NCT01295827|582502919|FG004|Overall Study|Progressive Disease|0|||
161306749|NCT01295827|582502920|FG005|Overall Study|Progressive Disease|1|||
161306750|NCT01295827|582502921|FG006|Overall Study|Progressive Disease|87|||
161306751|NCT01295827|582502922|FG007|Overall Study|Progressive Disease|144|||
161306752|NCT01295827|582502923|FG008|Overall Study|Progressive Disease|85|||
161306753|NCT01295827|582502924|FG009|Overall Study|Progressive Disease|40|||
161306754|NCT01295827|582502925|FG010|Overall Study|Progressive Disease|175|||
161306755|NCT01295827|582502926|FG011|Overall Study|Progressive Disease|136|||
161306756|NCT01295827|582502927|FG012|Overall Study|Progressive Disease|0|||
161306757|NCT01295827|582502928|FG013|Overall Study|Progressive Disease|0|||
161306758|NCT01295827|582502929|FG014|Overall Study|Progressive Disease|0|||
161306759|NCT01295827|582502915|FG000|Overall Study|Screen Failure|0|||
161306760|NCT01295827|582502916|FG001|Overall Study|Screen Failure|0|||
161306761|NCT01295827|582502917|FG002|Overall Study|Screen Failure|0|||
161306762|NCT01295827|582502918|FG003|Overall Study|Screen Failure|0|||
161306763|NCT01295827|582502919|FG004|Overall Study|Screen Failure|0|||
161306764|NCT01295827|582502920|FG005|Overall Study|Screen Failure|0|||
161306765|NCT01295827|582502921|FG006|Overall Study|Screen Failure|2|||
161306766|NCT01295827|582502922|FG007|Overall Study|Screen Failure|2|||
161306767|NCT01295827|582502923|FG008|Overall Study|Screen Failure|2|||
161306768|NCT01295827|582502924|FG009|Overall Study|Screen Failure|0|||
161306769|NCT01295827|582502925|FG010|Overall Study|Screen Failure|1|||
161306770|NCT01295827|582502926|FG011|Overall Study|Screen Failure|0|||
161306771|NCT01295827|582502927|FG012|Overall Study|Screen Failure|0|||
161306772|NCT01295827|582502928|FG013|Overall Study|Screen Failure|0|||
161306773|NCT01295827|582502929|FG014|Overall Study|Screen Failure|0|||
161306774|NCT01295827|582502915|FG000|Overall Study|Withdrawal by Subject|1|||
161306775|NCT01295827|582502916|FG001|Overall Study|Withdrawal by Subject|0|||
161306776|NCT01295827|582502917|FG002|Overall Study|Withdrawal by Subject|2|||
161306777|NCT01295827|582502918|FG003|Overall Study|Withdrawal by Subject|0|||
161306778|NCT01295827|582502919|FG004|Overall Study|Withdrawal by Subject|0|||
161306779|NCT01295827|582502920|FG005|Overall Study|Withdrawal by Subject|1|||
161306780|NCT01295827|582502921|FG006|Overall Study|Withdrawal by Subject|13|||
161306781|NCT01295827|582502922|FG007|Overall Study|Withdrawal by Subject|35|||
161306782|NCT01295827|582502923|FG008|Overall Study|Withdrawal by Subject|11|||
161306783|NCT01295827|582502924|FG009|Overall Study|Withdrawal by Subject|2|||
161306784|NCT01295827|582502925|FG010|Overall Study|Withdrawal by Subject|18|||
161306785|NCT01295827|582502926|FG011|Overall Study|Withdrawal by Subject|13|||
161306786|NCT01295827|582502927|FG012|Overall Study|Withdrawal by Subject|0|||
161306787|NCT01295827|582502928|FG013|Overall Study|Withdrawal by Subject|0|||
161306788|NCT01295827|582502929|FG014|Overall Study|Withdrawal by Subject|0|||
161306789|NCT01295827|582502915|FG000|Overall Study|Other|0|||
161306790|NCT01295827|582502916|FG001|Overall Study|Other|0|||
161306791|NCT01295827|582502917|FG002|Overall Study|Other|0|||
161306792|NCT01295827|582502918|FG003|Overall Study|Other|0|||
161306793|NCT01295827|582502919|FG004|Overall Study|Other|0|||
161306794|NCT01295827|582502920|FG005|Overall Study|Other|0|||
161306795|NCT01295827|582502921|FG006|Overall Study|Other|1|||
161306796|NCT01295827|582502922|FG007|Overall Study|Other|1|||
161306797|NCT01295827|582502923|FG008|Overall Study|Other|1|||
161306798|NCT01295827|582502924|FG009|Overall Study|Other|0|||
161306799|NCT01295827|582502925|FG010|Overall Study|Other|2|||
161306800|NCT01295827|582502926|FG011|Overall Study|Other|0|||
161306801|NCT01295827|582502927|FG012|Overall Study|Other|0|||
161306802|NCT01295827|582502928|FG013|Overall Study|Other|0|||
161306803|NCT01295827|582502929|FG014|Overall Study|Other|0|||
161306804|NCT00101166|582502930|FG000|Overall Study|progressive disease|10|||
161306805|NCT01868022|582502931|FG000|Overall Study|Withdrawal by Subject|0|||
161350247|NCT04514341|582666896|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
161197964|NCT04311411|582105261|FG001|Overall Study|Adverse Event|3|||
161197965|NCT04311411|582105262|FG002|Overall Study|Adverse Event|2|||
161197966|NCT04311411|582105260|FG000|Overall Study|Withdrawal by Subject|3|||
161197967|NCT04311411|582105261|FG001|Overall Study|Withdrawal by Subject|3|||
161197968|NCT04311411|582105262|FG002|Overall Study|Withdrawal by Subject|0|||
161197969|NCT01976663|582105266|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
161197970|NCT01976663|582105266|FG000|Overall Study|Personal Reasons|6|||
161197971|NCT01976663|582105266|FG000|Overall Study|Withdrawal by Subject|4|||
161197972|NCT01976663|582105266|FG000|Overall Study|Screen Failure|3|||
161197973|NCT01976663|582105266|FG000|Overall Study|Adverse Event|2|||
161197974|NCT01976663|582105266|FG000|Overall Study|Lost to Follow-up|3|||
161197975|NCT05028816|582105267|FG000|Overall Study|Lost to Follow-up|5|||
161197976|NCT05028816|582105268|FG001|Overall Study|Lost to Follow-up|3|||
161197977|NCT05028816|582105267|FG000|Overall Study|Withdrawal by Subject|4|||
161197978|NCT05028816|582105268|FG001|Overall Study|Withdrawal by Subject|1|||
161197979|NCT05028816|582105267|FG000|Overall Study|Physician Decision|1|||
161197980|NCT05028816|582105268|FG001|Overall Study|Physician Decision|0|||
161197981|NCT04780776|582105274|FG000|Titration Week 1-5|Lost to Follow-up|2|||
161197982|NCT04780776|582105275|FG001|Titration Week 1-5|Lost to Follow-up|8|||
161197983|NCT04780776|582105274|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
161197984|NCT04780776|582105275|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
161197985|NCT04780776|582105274|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
161197986|NCT04780776|582105275|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
161197987|NCT03113760|582105277|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
161197988|NCT03113760|582105278|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161197989|NCT03113760|582105279|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161197990|NCT03113760|582105280|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
161197991|NCT03113760|582105277|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
161197992|NCT03113760|582105278|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161197993|NCT03113760|582105279|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161197994|NCT03113760|582105280|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
161197995|NCT03113760|582105277|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
161197996|NCT03113760|582105278|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
161197997|NCT03113760|582105279|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
161197998|NCT03113760|582105280|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
161197999|NCT00423137|582105284|FG000|Overall Study|Lost to Follow-up|0|||
161198000|NCT00423137|582105285|FG001|Overall Study|Lost to Follow-up|0|||
161198001|NCT00423137|582105286|FG002|Overall Study|Lost to Follow-up|1|||
161198002|NCT00423137|582105287|FG003|Overall Study|Lost to Follow-up|0|||
161198003|NCT00423137|582105284|FG000|Overall Study|Protocol Violation|0|||
161198004|NCT00423137|582105285|FG001|Overall Study|Protocol Violation|0|||
161198005|NCT00423137|582105286|FG002|Overall Study|Protocol Violation|0|||
161198006|NCT00423137|582105287|FG003|Overall Study|Protocol Violation|1|||
161198007|NCT00423137|582105284|FG000|Overall Study|Adverse Event Study disease worse|1|||
161198008|NCT00423137|582105285|FG001|Overall Study|Adverse Event Study disease worse|0|||
161198009|NCT00423137|582105286|FG002|Overall Study|Adverse Event Study disease worse|3|||
161198010|NCT00423137|582105287|FG003|Overall Study|Adverse Event Study disease worse|1|||
161198011|NCT00423137|582105284|FG000|Overall Study|Adverse Event Other|0|||
161198012|NCT00423137|582105285|FG001|Overall Study|Adverse Event Other|0|||
161198013|NCT00423137|582105286|FG002|Overall Study|Adverse Event Other|2|||
161198014|NCT00423137|582105287|FG003|Overall Study|Adverse Event Other|0|||
161198015|NCT03246152|582105288|FG000|Overall Study|Lost to Follow-up|2|||
161198016|NCT03246152|582105288|FG000|Overall Study|Protocol Violation|1|||
161198017|NCT00465101|582105290|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
161198018|NCT00465101|582105290|FG000|Overall Study|Change in health precluded follow up|4|||
161198019|NCT00465101|582105290|FG000|Overall Study|Did not meet study criteria|4|||
161198020|NCT00465101|582105290|FG000|Overall Study|Lost to Follow-up|5|||
161198021|NCT00465101|582105290|FG000|Overall Study|Other|6|||
161198022|NCT00465101|582105290|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
161198023|NCT00465101|582105290|FG000|Overall Study|Patient postponed procedure|1|||
161198024|NCT00465101|582105290|FG000|Overall Study|Site closed due to IRB expiration|1|||
161198025|NCT00465101|582105290|FG000|Overall Study|Unable to obtain IRB approval|1|||
161198026|NCT00465101|582105290|FG000|Overall Study|Death|3|||
161198027|NCT00465101|582105290|FG000|Overall Study|Withdrawal by Subject|25|||
161198028|NCT00465101|582105290|FG000|Overall Study|Physician Decision|1|||
161198029|NCT00465101|582105290|FG000|Overall Study|Withdrew consent prior to procedure|3|||
161198030|NCT02067728|582105293|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
161198031|NCT02067728|582105294|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
161198032|NCT02067728|582105293|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
161198033|NCT02067728|582105294|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
161198034|NCT02067728|582105293|FG000|6 Month Measurements|Unable to attend|114|||
161198035|NCT02067728|582105294|FG001|6 Month Measurements|Unable to attend|97|||
161198036|NCT00933543|582105296|FG000|Overall Study|Adverse Event|2|||
161198037|NCT00933543|582105297|FG001|Overall Study|Adverse Event|1|||
161198038|NCT00933543|582105296|FG000|Overall Study|Lost to Follow-up|0|||
161198039|NCT00933543|582105297|FG001|Overall Study|Lost to Follow-up|1|||
161198040|NCT00933543|582105296|FG000|Overall Study|Withdrawal by Subject|0|||
161198041|NCT00933543|582105297|FG001|Overall Study|Withdrawal by Subject|1|||
161198042|NCT00933543|582105296|FG000|Overall Study|Lack of Efficacy|0|||
161198043|NCT00933543|582105297|FG001|Overall Study|Lack of Efficacy|3|||
161198044|NCT00933543|582105296|FG000|Overall Study|Other|1|||
161306806|NCT01868022|582502932|FG001|Overall Study|Withdrawal by Subject|0|||
161306807|NCT01868022|582502933|FG002|Overall Study|Withdrawal by Subject|1|||
161306808|NCT01868022|582502934|FG003|Overall Study|Withdrawal by Subject|1|||
161306809|NCT01868022|582502935|FG004|Overall Study|Withdrawal by Subject|0|||
161306810|NCT01868022|582502936|FG005|Overall Study|Withdrawal by Subject|0|||
161306811|NCT01868022|582502937|FG006|Overall Study|Withdrawal by Subject|0|||
161306812|NCT01868022|582502938|FG007|Overall Study|Withdrawal by Subject|1|||
161306813|NCT01868022|582502939|FG008|Overall Study|Withdrawal by Subject|0|||
161306814|NCT01868022|582502931|FG000|Overall Study|Adverse Event|0|||
161306815|NCT01868022|582502932|FG001|Overall Study|Adverse Event|0|||
161306816|NCT01868022|582502933|FG002|Overall Study|Adverse Event|0|||
161306817|NCT01868022|582502934|FG003|Overall Study|Adverse Event|0|||
161306818|NCT01868022|582502935|FG004|Overall Study|Adverse Event|2|||
161306819|NCT01868022|582502936|FG005|Overall Study|Adverse Event|0|||
161306820|NCT01868022|582502937|FG006|Overall Study|Adverse Event|0|||
161306821|NCT01868022|582502938|FG007|Overall Study|Adverse Event|2|||
161306822|NCT01868022|582502939|FG008|Overall Study|Adverse Event|2|||
161306823|NCT01868022|582502931|FG000|Overall Study|Physician Decision|0|||
161306824|NCT01868022|582502932|FG001|Overall Study|Physician Decision|0|||
161306825|NCT01868022|582502933|FG002|Overall Study|Physician Decision|0|||
161306826|NCT01868022|582502934|FG003|Overall Study|Physician Decision|0|||
161306827|NCT01868022|582502935|FG004|Overall Study|Physician Decision|0|||
161306828|NCT01868022|582502936|FG005|Overall Study|Physician Decision|1|||
161306829|NCT01868022|582502937|FG006|Overall Study|Physician Decision|0|||
161306830|NCT01868022|582502938|FG007|Overall Study|Physician Decision|2|||
161306831|NCT01868022|582502939|FG008|Overall Study|Physician Decision|0|||
161306832|NCT01868022|582502931|FG000|Overall Study|Study closed/terminated|0|||
161306833|NCT01868022|582502932|FG001|Overall Study|Study closed/terminated|0|||
161306834|NCT01868022|582502933|FG002|Overall Study|Study closed/terminated|0|||
161306835|NCT01868022|582502934|FG003|Overall Study|Study closed/terminated|0|||
161306836|NCT01868022|582502935|FG004|Overall Study|Study closed/terminated|0|||
161306837|NCT01868022|582502936|FG005|Overall Study|Study closed/terminated|0|||
161306838|NCT01868022|582502937|FG006|Overall Study|Study closed/terminated|0|||
161306839|NCT01868022|582502938|FG007|Overall Study|Study closed/terminated|1|||
161306840|NCT01868022|582502939|FG008|Overall Study|Study closed/terminated|0|||
161306841|NCT01868022|582502931|FG000|Overall Study|Ongoing|0|||
161306842|NCT01868022|582502932|FG001|Overall Study|Ongoing|0|||
161306843|NCT01868022|582502933|FG002|Overall Study|Ongoing|0|||
161306844|NCT01868022|582502934|FG003|Overall Study|Ongoing|0|||
161306845|NCT01868022|582502935|FG004|Overall Study|Ongoing|0|||
161306846|NCT01868022|582502936|FG005|Overall Study|Ongoing|0|||
161306847|NCT01868022|582502937|FG006|Overall Study|Ongoing|0|||
161306848|NCT01868022|582502938|FG007|Overall Study|Ongoing|3|||
161306849|NCT01868022|582502939|FG008|Overall Study|Ongoing|0|||
161306850|NCT03226769|582502942|FG000|Overall Study|Withdrawal by Subject|0|||
161306851|NCT03226769|582502943|FG001|Overall Study|Withdrawal by Subject|1|||
161306852|NCT02640677|582502944|FG000|Overall Study|Lost to Follow-up|1|||
161306853|NCT02640677|582502944|FG000|Overall Study|Withdrawal by Subject|1|||
161306854|NCT01516008|582502951|FG000|Overall Study|Adverse Event|0|||
161306855|NCT01516008|582502952|FG001|Overall Study|Adverse Event|2|||
161306856|NCT01516008|582502953|FG002|Overall Study|Adverse Event|7|||
161306857|NCT01516008|582502951|FG000|Overall Study|Lack of Efficacy|44|||
161306858|NCT01516008|582502952|FG001|Overall Study|Lack of Efficacy|14|||
161350248|NCT04573881|582666897|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
161198045|NCT00933543|582105297|FG001|Overall Study|Other|1|||
161198046|NCT04988035|582105299|FG000|Overall Study|Death|19|||
161198047|NCT04988035|582105300|FG001|Overall Study|Death|13|||
161306859|NCT01516008|582502953|FG002|Overall Study|Lack of Efficacy|10|||
161306860|NCT01516008|582502951|FG000|Overall Study|Protocol Violation|1|||
161306861|NCT01516008|582502952|FG001|Overall Study|Protocol Violation|0|||
161306862|NCT01516008|582502953|FG002|Overall Study|Protocol Violation|0|||
161198048|NCT04988035|582105299|FG000|Overall Study|Lost to Follow-up|12|||
161306863|NCT01516008|582502951|FG000|Overall Study|Reason not specified|0|||
161306864|NCT01516008|582502952|FG001|Overall Study|Reason not specified|0|||
161306865|NCT01516008|582502953|FG002|Overall Study|Reason not specified|1|||
161306866|NCT04553471|582502954|FG000|Overall Study|Did not start treatment on protocol|3|||
161306867|NCT04553471|582502954|FG000|Overall Study|Death|1|||
161306868|NCT01217476|582502955|FG000|Overall Study|Adverse Event|6|||
161306869|NCT01217476|582502956|FG001|Overall Study|Adverse Event|1|||
161306870|NCT01217476|582502955|FG000|Overall Study|Physician Decision|0|||
161306871|NCT01217476|582502956|FG001|Overall Study|Physician Decision|1|||
161198049|NCT04988035|582105300|FG001|Overall Study|Lost to Follow-up|6|||
161198050|NCT04988035|582105299|FG000|Overall Study|Protocol Violation|0|||
161198051|NCT04988035|582105300|FG001|Overall Study|Protocol Violation|1|||
161198052|NCT04988035|582105299|FG000|Overall Study|Withdrawal by Subject|2|||
161198053|NCT04988035|582105300|FG001|Overall Study|Withdrawal by Subject|4|||
161198054|NCT04988035|582105299|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
161198055|NCT04988035|582105300|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
161198056|NCT03532048|582105301|FG000|Overall Study|Lost to Follow-up|12|||
161198057|NCT03532048|582105302|FG001|Overall Study|Lost to Follow-up|17|||
161198058|NCT03532048|582105301|FG000|Overall Study|Withdrawal by Subject|7|||
161198059|NCT03532048|582105302|FG001|Overall Study|Withdrawal by Subject|0|||
161198060|NCT04113746|582105310|FG000|Overall Study|Lost to Follow-up|4|||
161198061|NCT04113746|582105311|FG001|Overall Study|Lost to Follow-up|4|||
161198062|NCT00499694|582105312|FG000|Overall Study|Patient never received treatment.|1|||
161198063|NCT00234533|582105315|FG000|Overall Study|Withdrawal by Subject|6|||
161198064|NCT00234533|582105315|FG000|Overall Study|Adverse Event|2|||
161198065|NCT00234533|582105315|FG000|Overall Study|Enrolled but not treated|3|||
161198066|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
161198067|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
161198068|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
161198069|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
161198070|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
161198071|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
161198072|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
161198073|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
161198074|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
161198075|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
161198076|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
161198077|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
161198078|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
161198079|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
161198080|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
161198081|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
161198082|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
161198083|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
161198084|NCT00570492|582105316|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
161198085|NCT00570492|582105317|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
161198086|NCT00570492|582105318|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
161198087|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
161198088|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
161198089|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
161198090|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
161198091|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
161198092|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
161198093|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
161198094|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
161198095|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
161198096|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
161198097|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
161198098|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
161198099|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
161198100|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
161198101|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
161198102|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161198103|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
161198104|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
161198105|NCT00570492|582105316|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
161198106|NCT00570492|582105317|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
161198107|NCT00570492|582105318|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
161198108|NCT00976989|582105319|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
161198109|NCT00976989|582105320|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
161198110|NCT00976989|582105321|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
161198111|NCT00976989|582105319|FG000|Overall Study|Death|5|||
161198112|NCT00976989|582105320|FG001|Overall Study|Death|7|||
161198113|NCT00976989|582105321|FG002|Overall Study|Death|10|||
161198114|NCT00976989|582105319|FG000|Overall Study|Refused Treatment|4|||
161198115|NCT00976989|582105320|FG001|Overall Study|Refused Treatment|3|||
161198116|NCT00976989|582105321|FG002|Overall Study|Refused Treatment|5|||
161198117|NCT00976989|582105319|FG000|Overall Study|Failure to Return|2|||
161198118|NCT00976989|582105320|FG001|Overall Study|Failure to Return|1|||
161198119|NCT00976989|582105321|FG002|Overall Study|Failure to Return|0|||
161306872|NCT01217476|582502955|FG000|Overall Study|Withdrawal by Subject|3|||
161306873|NCT01217476|582502956|FG001|Overall Study|Withdrawal by Subject|3|||
161306874|NCT01217476|582502955|FG000|Overall Study|Surgery on the Target Limb|0|||
161306875|NCT01217476|582502956|FG001|Overall Study|Surgery on the Target Limb|2|||
161306876|NCT01217476|582502955|FG000|Overall Study|Protocol Deviation|1|||
161306877|NCT01217476|582502956|FG001|Overall Study|Protocol Deviation|0|||
161306878|NCT01217476|582502955|FG000|Overall Study|Other|2|||
161306879|NCT01217476|582502956|FG001|Overall Study|Other|0|||
161306880|NCT03033602|582502957|FG000|Overall Study|Withdrawal by Subject|11|||
161306881|NCT03033602|582502958|FG001|Overall Study|Withdrawal by Subject|21|||
161306882|NCT03033602|582502957|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
161306883|NCT03033602|582502958|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
161306884|NCT01441765|582502959|FG000|Overall Study|Death|1|||
161306885|NCT01441765|582502960|FG001|Overall Study|Death|0|||
161306886|NCT00813813|582502962|FG000|Overall Study|Withdrawal by Subject|1|||
161306887|NCT00813813|582502963|FG001|Overall Study|Withdrawal by Subject|1|||
161306888|NCT00813813|582502962|FG000|Overall Study|Lost to Follow-up|2|||
161198120|NCT00976989|582105319|FG000|Overall Study|Recurrence of Disease|0|||
161198121|NCT00976989|582105320|FG001|Overall Study|Recurrence of Disease|1|||
161198122|NCT00976989|582105321|FG002|Overall Study|Recurrence of Disease|0|||
161198123|NCT00976989|582105319|FG000|Overall Study|Other|1|||
161198124|NCT00976989|582105320|FG001|Overall Study|Other|0|||
161198125|NCT00976989|582105321|FG002|Overall Study|Other|1|||
161198126|NCT00908375|582105322|FG000|Overall Study|Withdrawal by Subject|2|||
161090721|NCT01602562|581721738|FG000|Overall Study|Physician Decision|1|||
161198127|NCT00908375|582105323|FG001|Overall Study|Withdrawal by Subject|4|||
161198128|NCT00908375|582105322|FG000|Overall Study|Lost to Follow-up|8|||
161198129|NCT00908375|582105323|FG001|Overall Study|Lost to Follow-up|6|||
161198130|NCT00903357|582105324|FG000|First Intervention|Withdrawal by Subject|5|||
161198131|NCT00903357|582105325|FG001|First Intervention|Withdrawal by Subject|3|||
161198132|NCT00903357|582105324|FG000|First Intervention|Flu|0|||
161306889|NCT00813813|582502963|FG001|Overall Study|Lost to Follow-up|7|||
161306890|NCT00813813|582502962|FG000|Overall Study|Other|0|||
161306891|NCT00813813|582502963|FG001|Overall Study|Other|1|||
161306892|NCT02778074|582502965|FG000|Overall Study|Lost to Follow-up|7|||
161306893|NCT02778074|582502966|FG001|Overall Study|Lost to Follow-up|10|||
161306894|NCT01684943|582502969|FG000|Overall Study|Inadequate Venous Access|3|||
161306895|NCT01684943|582502970|FG001|Overall Study|Inadequate Venous Access|0|||
161306896|NCT01684943|582502971|FG002|Overall Study|Inadequate Venous Access|0|||
161306897|NCT01684943|582502969|FG000|Overall Study|Principal Investigator Determination|1|||
161306898|NCT01684943|582502970|FG001|Overall Study|Principal Investigator Determination|0|||
161306899|NCT01684943|582502971|FG002|Overall Study|Principal Investigator Determination|0|||
161306900|NCT01684943|582502969|FG000|Overall Study|Excluded from Analysis|1|||
161306901|NCT01684943|582502970|FG001|Overall Study|Excluded from Analysis|1|||
161306902|NCT01684943|582502971|FG002|Overall Study|Excluded from Analysis|1|||
161306903|NCT01684943|582502969|FG000|Overall Study|Lost to Follow-up|3|||
161306904|NCT01684943|582502970|FG001|Overall Study|Lost to Follow-up|0|||
161306905|NCT01684943|582502971|FG002|Overall Study|Lost to Follow-up|0|||
161306906|NCT01684943|582502969|FG000|Overall Study|Planning Pregnancy|1|||
161306907|NCT01684943|582502970|FG001|Overall Study|Planning Pregnancy|0|||
161306908|NCT01684943|582502971|FG002|Overall Study|Planning Pregnancy|0|||
161306909|NCT00325156|582502972|FG000|Overall Study|Protocol Violation|8|||
161306910|NCT00325156|582502972|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
161306911|NCT00325156|582502972|FG000|Overall Study|Migrated/moved from study area|12|||
161306912|NCT00325156|582502972|FG000|Overall Study|Adverse event, non-fatal|3|||
161306913|NCT00325156|582502972|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
161306914|NCT00325156|582502972|FG000|Overall Study|Other|1|||
161306915|NCT00325156|582502972|FG000|Overall Study|Withdrawal by Subject|31|||
161306916|NCT03489707|582502973|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
161306917|NCT03489707|582502974|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
161306918|NCT03489707|582502973|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
161306919|NCT03489707|582502974|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
161306920|NCT04064411|582502975|FG000|Overall Study|Adverse Event|29|||
161306921|NCT04064411|582502976|FG001|Overall Study|Adverse Event|19|||
161306922|NCT04064411|582502975|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
161306923|NCT04064411|582502976|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
161306924|NCT04064411|582502975|FG000|Overall Study|Protocol Deviation|0|||
161306925|NCT04064411|582502976|FG001|Overall Study|Protocol Deviation|2|||
161306926|NCT04064411|582502975|FG000|Overall Study|Withdrawal by Subject|25|||
161306927|NCT04064411|582502976|FG001|Overall Study|Withdrawal by Subject|29|||
161306928|NCT04064411|582502975|FG000|Overall Study|Lost to Follow-up|5|||
161306929|NCT04064411|582502976|FG001|Overall Study|Lost to Follow-up|2|||
161306930|NCT04064411|582502975|FG000|Overall Study|Other than Specified|4|||
161306931|NCT04064411|582502976|FG001|Overall Study|Other than Specified|1|||
161306932|NCT04064411|582502975|FG000|Overall Study|Death|1|||
161306933|NCT04064411|582502976|FG001|Overall Study|Death|0|||
161306934|NCT03395184|582502977|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
161306935|NCT03395184|582502978|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
161306936|NCT03395184|582502979|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
161306937|NCT03395184|582502980|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161306938|NCT03395184|582502981|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161306939|NCT03395184|582502982|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161306940|NCT03395184|582502983|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
161306941|NCT03395184|582502977|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161306942|NCT03395184|582502978|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
161306943|NCT03395184|582502979|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
161198133|NCT00903357|582105325|FG001|First Intervention|Flu|1|||
161198134|NCT00903357|582105324|FG000|Wash Out Period of 2 Weeks|Flu|0|||
161198135|NCT00903357|582105325|FG001|Wash Out Period of 2 Weeks|Flu|1|||
161198136|NCT00903357|582105324|FG000|Second Intervention|Lost to Follow-up|1|||
161198137|NCT00903357|582105325|FG001|Second Intervention|Lost to Follow-up|0|||
161198138|NCT02279888|582105327|FG000|Overall Study|Death|326|||
161198139|NCT02279888|582105327|FG000|Overall Study|Withdrawal by Subject|38|||
161198140|NCT02279888|582105327|FG000|Overall Study|Lost to Follow-up|21|||
161198141|NCT02279888|582105327|FG000|Overall Study|Physician Decision|62|||
161198142|NCT02279888|582105327|FG000|Overall Study|Subject Non-compliance|43|||
161306944|NCT03395184|582502980|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161306945|NCT03395184|582502981|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161306946|NCT03395184|582502982|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161306947|NCT03395184|582502983|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
161198143|NCT02279888|582105327|FG000|Overall Study|Not implanted|14|||
161198144|NCT02279888|582105327|FG000|Overall Study|Visit not performed|26|||
161198145|NCT01484691|582105328|FG000|Overall Study|Withdrawal by Subject|1|||
161198146|NCT01484691|582105329|FG001|Overall Study|Withdrawal by Subject|1|||
161198147|NCT01484691|582105330|FG002|Overall Study|Withdrawal by Subject|1|||
161198148|NCT01484691|582105328|FG000|Overall Study|Physician Decision|0|||
161198149|NCT01484691|582105329|FG001|Overall Study|Physician Decision|2|||
161198150|NCT01484691|582105330|FG002|Overall Study|Physician Decision|1|||
161198151|NCT03480243|582105333|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
161198152|NCT03480243|582105333|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
161198153|NCT03958045|582105334|FG000|Overall Study|Withdrawal by Subject|1|||
161198154|NCT01683565|582105335|FG000|Overall Study|Lost to Follow-up|2|||
161198155|NCT01683565|582105336|FG001|Overall Study|Lost to Follow-up|0|||
161198156|NCT01683565|582105335|FG000|Overall Study|Discontinued Intervention|1|||
161198157|NCT01683565|582105336|FG001|Overall Study|Discontinued Intervention|1|||
161198158|NCT00764465|582105337|FG000|Overall Study|Adverse Event|2|||
161198159|NCT00764465|582105338|FG001|Overall Study|Adverse Event|0|||
161198160|NCT00764465|582105339|FG002|Overall Study|Adverse Event|0|||
161198161|NCT00764465|582105340|FG003|Overall Study|Adverse Event|1|||
161198162|NCT00764465|582105341|FG004|Overall Study|Adverse Event|1|||
161198163|NCT00764465|582105342|FG005|Overall Study|Adverse Event|1|||
161198164|NCT00764465|582105337|FG000|Overall Study|Withdrawal by Subject|0|||
161198165|NCT00764465|582105338|FG001|Overall Study|Withdrawal by Subject|1|||
161198166|NCT00764465|582105339|FG002|Overall Study|Withdrawal by Subject|1|||
161198167|NCT00764465|582105340|FG003|Overall Study|Withdrawal by Subject|0|||
161198168|NCT00764465|582105341|FG004|Overall Study|Withdrawal by Subject|0|||
161198169|NCT00764465|582105342|FG005|Overall Study|Withdrawal by Subject|0|||
161198170|NCT00674440|582105343|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
161198171|NCT00674440|582105343|FG000|Overall Study|did not have surgery, so unevaluable|7|||
161198172|NCT00674440|582105343|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
161198173|NCT01590810|582105344|FG000|Overall Study|Physician Decision|0|||
161198174|NCT01590810|582105345|FG001|Overall Study|Physician Decision|1|||
161198175|NCT01590810|582105346|FG002|Overall Study|Physician Decision|1|||
161198176|NCT01590810|582105347|FG003|Overall Study|Physician Decision|0|||
161198177|NCT01590810|582105348|FG004|Overall Study|Physician Decision|0|||
161198178|NCT01087944|582105349|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
161198179|NCT01087944|582105350|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
161198180|NCT01087944|582105349|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
161198181|NCT01087944|582105350|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
161198182|NCT01731600|582105351|FG000|Overall Study|Adverse Event|2|||
161198183|NCT01731600|582105352|FG001|Overall Study|Adverse Event|0|||
161198184|NCT01731600|582105351|FG000|Overall Study|Withdrawal criteria|1|||
161198185|NCT01731600|582105352|FG001|Overall Study|Withdrawal criteria|0|||
161198186|NCT01731600|582105351|FG000|Overall Study|Other reasons|3|||
161198187|NCT01731600|582105352|FG001|Overall Study|Other reasons|0|||
161198188|NCT03280628|582107361|FG000|Overall Study|Lost to Follow-up|8|||
161198189|NCT03280628|582107362|FG001|Overall Study|Lost to Follow-up|6|||
161198190|NCT03280628|582107363|FG002|Overall Study|Lost to Follow-up|11|||
161198191|NCT02163759|582107370|FG000|Overall Study|Withdrawal by Subject|1|||
161198192|NCT02163759|582107371|FG001|Overall Study|Withdrawal by Subject|5|||
161198193|NCT02163759|582107372|FG002|Overall Study|Withdrawal by Subject|1|||
161198194|NCT02163759|582107370|FG000|Overall Study|Adverse Event|0|||
161198195|NCT02163759|582107371|FG001|Overall Study|Adverse Event|0|||
161198196|NCT02163759|582107372|FG002|Overall Study|Adverse Event|1|||
161198197|NCT02163759|582107370|FG000|Overall Study|Death|0|||
161198198|NCT02163759|582107371|FG001|Overall Study|Death|0|||
161198199|NCT02163759|582107372|FG002|Overall Study|Death|1|||
161198200|NCT01479777|582107377|FG000|Overall Study|Physician Decision|2|||
161198201|NCT00451191|582107378|FG000|Overall Study|withdrawal or received alternate tx|15|||
161198202|NCT00451191|582107379|FG001|Overall Study|withdrawal or received alternate tx|11|||
161198203|NCT00656669|582107387|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
161198204|NCT00656669|582107387|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
161198205|NCT00656669|582107387|FG000|AC (Cycles 6-9)|Adverse Event|1|||
161198206|NCT00656669|582107387|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
161198207|NCT03575806|582107392|FG000|Overall Study|Withdrawal by Subject|0|||
161306948|NCT03395184|582502977|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
161306949|NCT03395184|582502978|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
161198208|NCT03575806|582107393|FG001|Overall Study|Withdrawal by Subject|2|||
161198209|NCT03575806|582107392|FG000|Overall Study|Protocol Violation|0|||
161198210|NCT03575806|582107393|FG001|Overall Study|Protocol Violation|2|||
161198211|NCT00219349|582107394|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
161198212|NCT00219349|582107394|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
161198213|NCT00219349|582107394|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
161198214|NCT00219349|582107394|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
161198215|NCT01241591|582107396|FG000|Overall Study|Lack of Efficacy|5|||
161306950|NCT03395184|582502979|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161198216|NCT01241591|582107397|FG001|Overall Study|Lack of Efficacy|2|||
161198217|NCT01241591|582107398|FG002|Overall Study|Lack of Efficacy|2|||
161198218|NCT01241591|582107399|FG003|Overall Study|Lack of Efficacy|3|||
161198219|NCT01241591|582107396|FG000|Overall Study|Protocol Violation|5|||
161198220|NCT01241591|582107397|FG001|Overall Study|Protocol Violation|2|||
161198221|NCT01241591|582107398|FG002|Overall Study|Protocol Violation|3|||
161198222|NCT01241591|582107399|FG003|Overall Study|Protocol Violation|0|||
161198223|NCT01241591|582107396|FG000|Overall Study|Lost to Follow-up|1|||
161198224|NCT01241591|582107397|FG001|Overall Study|Lost to Follow-up|2|||
161198225|NCT01241591|582107398|FG002|Overall Study|Lost to Follow-up|2|||
161198226|NCT01241591|582107399|FG003|Overall Study|Lost to Follow-up|2|||
161198227|NCT01241591|582107396|FG000|Overall Study|Screen Failure|3|||
161198228|NCT01241591|582107397|FG001|Overall Study|Screen Failure|2|||
161198229|NCT01241591|582107398|FG002|Overall Study|Screen Failure|1|||
161198230|NCT01241591|582107399|FG003|Overall Study|Screen Failure|0|||
161198231|NCT01241591|582107396|FG000|Overall Study|Withdrawal by Subject|6|||
161198232|NCT01241591|582107397|FG001|Overall Study|Withdrawal by Subject|4|||
161198233|NCT01241591|582107398|FG002|Overall Study|Withdrawal by Subject|2|||
161198234|NCT01241591|582107399|FG003|Overall Study|Withdrawal by Subject|2|||
161198235|NCT01241591|582107396|FG000|Overall Study|Other|0|||
161198236|NCT01241591|582107397|FG001|Overall Study|Other|1|||
161198237|NCT01241591|582107398|FG002|Overall Study|Other|0|||
161198238|NCT01241591|582107399|FG003|Overall Study|Other|1|||
161198239|NCT01241591|582107396|FG000|Overall Study|Adverse Event|3|||
161198240|NCT01241591|582107397|FG001|Overall Study|Adverse Event|11|||
161198241|NCT01241591|582107398|FG002|Overall Study|Adverse Event|12|||
161198242|NCT01241591|582107399|FG003|Overall Study|Adverse Event|4|||
161198243|NCT01945034|582107400|FG000|Overall Study|Medication Error|0|||
161198244|NCT01945034|582107401|FG001|Overall Study|Medication Error|1|||
161198245|NCT01945034|582107402|FG002|Overall Study|Medication Error|0|||
161198246|NCT01945034|582107400|FG000|Overall Study|Withdrawal by Subject|0|||
161198247|NCT01945034|582107401|FG001|Overall Study|Withdrawal by Subject|3|||
161198248|NCT01945034|582107402|FG002|Overall Study|Withdrawal by Subject|1|||
161198249|NCT01945034|582107400|FG000|Overall Study|Other|0|||
161198250|NCT01945034|582107401|FG001|Overall Study|Other|1|||
161198251|NCT01945034|582107402|FG002|Overall Study|Other|3|||
161198252|NCT01945034|582107400|FG000|Overall Study|Lost to Follow-up|0|||
161198253|NCT01945034|582107401|FG001|Overall Study|Lost to Follow-up|0|||
161198254|NCT01945034|582107402|FG002|Overall Study|Lost to Follow-up|2|||
161198255|NCT01945034|582107400|FG000|Overall Study|Protocol Violation|1|||
161198256|NCT01945034|582107401|FG001|Overall Study|Protocol Violation|0|||
161198257|NCT01945034|582107402|FG002|Overall Study|Protocol Violation|1|||
161198258|NCT01300741|582107406|FG000|Overall Study|Lens deposits|1|||
161198259|NCT01300741|582107406|FG000|Overall Study|Lost to Follow-up|1|||
161198260|NCT01300741|582107406|FG000|Overall Study|Discomfort|1|||
161198261|NCT04854421|582107407|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
161198262|NCT04854421|582107408|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
161198263|NCT00718809|582107410|FG000|Overall Study|Disease progression|9|||
161198264|NCT00718809|582107411|FG001|Overall Study|Disease progression|7|||
161198265|NCT00718809|582107410|FG000|Overall Study|Adverse Event|1|||
161198266|NCT00718809|582107411|FG001|Overall Study|Adverse Event|1|||
161198267|NCT00718809|582107410|FG000|Overall Study|Withdrawal by Subject|0|||
161198268|NCT00718809|582107411|FG001|Overall Study|Withdrawal by Subject|1|||
161198269|NCT00718809|582107410|FG000|Overall Study|Lost to Follow-up|1|||
161198270|NCT00718809|582107411|FG001|Overall Study|Lost to Follow-up|0|||
161306951|NCT03395184|582502980|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161306952|NCT03395184|582502981|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161306953|NCT03395184|582502982|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161306954|NCT03395184|582502983|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
161306955|NCT03395184|582502977|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161306956|NCT03395184|582502978|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
161306957|NCT03395184|582502979|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161306958|NCT03395184|582502980|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161306959|NCT03395184|582502981|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161306960|NCT03395184|582502982|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161306961|NCT03395184|582502983|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
161306962|NCT03395184|582502977|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
161306963|NCT03395184|582502978|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161306964|NCT03395184|582502979|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
161306965|NCT03395184|582502980|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161306966|NCT03395184|582502981|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161306967|NCT03395184|582502982|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161306968|NCT03395184|582502983|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
161306969|NCT03395184|582502977|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
161198271|NCT00718809|582107410|FG000|Overall Study|Noncompliance|1|||
161198272|NCT00718809|582107411|FG001|Overall Study|Noncompliance|0|||
161090722|NCT01602562|581721739|FG001|Overall Study|Physician Decision|1|||
161090723|NCT01602562|581721738|FG000|Overall Study|Withdrawal by Subject|1|||
161090724|NCT01602562|581721739|FG001|Overall Study|Withdrawal by Subject|1|||
161090725|NCT04964414|581721740|FG000|Overall Study|Lost to Follow-up|10|||
161090726|NCT04964414|581721741|FG001|Overall Study|Lost to Follow-up|8|||
161090727|NCT04964414|581721740|FG000|Overall Study|Withdrawal by Subject|1|||
161090728|NCT04964414|581721741|FG001|Overall Study|Withdrawal by Subject|1|||
161090729|NCT03881553|581721742|FG000|Overall Study|Discharged prior to participation|1|||
161090730|NCT03881553|581721743|FG001|Overall Study|Discharged prior to participation|1|||
161090731|NCT03881553|581721744|FG002|Overall Study|Discharged prior to participation|0|||
161090732|NCT03881553|581721742|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
161090733|NCT03881553|581721743|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
161090734|NCT03881553|581721744|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
161090735|NCT00609765|581721745|FG000|Overall Study|Study ended prior to 12 months|1|||
161090736|NCT03265938|581721748|FG000|Overall Study|Withdrawal by Subject|1|||
161090737|NCT03265938|581721748|FG000|Overall Study|Physician Decision|1|||
161090738|NCT03265938|581721748|FG000|Overall Study|friable mass|6|||
161090739|NCT00705523|581721749|FG000|Overall Study|Lost to Follow-up|2|||
161090740|NCT00705523|581721750|FG001|Overall Study|Lost to Follow-up|3|||
161090741|NCT02471833|581721751|FG000|Overall Study|Lost to Follow-up|1|||
161090742|NCT02471833|581721752|FG001|Overall Study|Lost to Follow-up|0|||
161090743|NCT02471833|581721753|FG002|Overall Study|Lost to Follow-up|0|||
161090744|NCT02471833|581721751|FG000|Overall Study|Withdrawal by Subject|2|||
161090745|NCT02471833|581721752|FG001|Overall Study|Withdrawal by Subject|1|||
161090746|NCT02471833|581721753|FG002|Overall Study|Withdrawal by Subject|5|||
161090747|NCT02673515|581721754|FG000|Overall Study|Lack of motivation|2|||
161090748|NCT02673515|581721755|FG001|Overall Study|Lack of motivation|1|||
161090749|NCT01946438|581721756|FG000|Overall Study|Adverse Event|0|||
161090750|NCT01946438|581721757|FG001|Overall Study|Adverse Event|0|||
161090751|NCT01946438|581721758|FG002|Overall Study|Adverse Event|0|||
161090752|NCT01946438|581721759|FG003|Overall Study|Adverse Event|1|||
161090753|NCT01946438|581721756|FG000|Overall Study|Serious Adverse event|1|||
161090754|NCT01946438|581721757|FG001|Overall Study|Serious Adverse event|0|||
161090755|NCT01946438|581721758|FG002|Overall Study|Serious Adverse event|0|||
161090756|NCT01946438|581721759|FG003|Overall Study|Serious Adverse event|0|||
161090757|NCT01946438|581721756|FG000|Overall Study|Protocol Violation|0|||
161090758|NCT01946438|581721757|FG001|Overall Study|Protocol Violation|0|||
161090759|NCT01946438|581721758|FG002|Overall Study|Protocol Violation|1|||
161090760|NCT01946438|581721759|FG003|Overall Study|Protocol Violation|0|||
161090761|NCT01946438|581721756|FG000|Overall Study|Withdrawal by Subject|1|||
161090762|NCT01946438|581721757|FG001|Overall Study|Withdrawal by Subject|0|||
161090763|NCT01946438|581721758|FG002|Overall Study|Withdrawal by Subject|0|||
161090764|NCT01946438|581721759|FG003|Overall Study|Withdrawal by Subject|0|||
161090765|NCT02412371|581721762|FG000|Overall Study|Withdrawal by Subject|0|||
161090766|NCT02412371|581721763|FG001|Overall Study|Withdrawal by Subject|2|||
161090767|NCT02412371|581721764|FG002|Overall Study|Withdrawal by Subject|0|||
161090768|NCT02412371|581721765|FG003|Overall Study|Withdrawal by Subject|1|||
161090769|NCT02412371|581721766|FG004|Overall Study|Withdrawal by Subject|1|||
161090770|NCT02412371|581721767|FG005|Overall Study|Withdrawal by Subject|0|||
161090771|NCT02412371|581721762|FG000|Overall Study|Sponsor Discontinued Study|1|||
161090772|NCT02412371|581721763|FG001|Overall Study|Sponsor Discontinued Study|4|||
161090773|NCT02412371|581721764|FG002|Overall Study|Sponsor Discontinued Study|6|||
161090774|NCT02412371|581721765|FG003|Overall Study|Sponsor Discontinued Study|4|||
161090775|NCT02412371|581721766|FG004|Overall Study|Sponsor Discontinued Study|5|||
161090776|NCT02412371|581721767|FG005|Overall Study|Sponsor Discontinued Study|0|||
161090777|NCT02412371|581721762|FG000|Overall Study|Death|4|||
161090778|NCT02412371|581721763|FG001|Overall Study|Death|2|||
161090779|NCT02412371|581721764|FG002|Overall Study|Death|1|||
161090780|NCT02412371|581721765|FG003|Overall Study|Death|3|||
161090781|NCT02412371|581721766|FG004|Overall Study|Death|5|||
161090782|NCT02412371|581721767|FG005|Overall Study|Death|2|||
161090783|NCT02412371|581721762|FG000|Overall Study|Other|2|||
161090784|NCT02412371|581721763|FG001|Overall Study|Other|1|||
161090785|NCT02412371|581721764|FG002|Overall Study|Other|0|||
161090786|NCT02412371|581721765|FG003|Overall Study|Other|0|||
161090787|NCT02412371|581721766|FG004|Overall Study|Other|1|||
161090788|NCT02412371|581721767|FG005|Overall Study|Other|3|||
161090789|NCT02523599|581721768|FG000|Overall Study|Adverse Event|1|||
161090790|NCT02523599|581721769|FG001|Overall Study|Adverse Event|0|||
161090791|NCT02523599|581721768|FG000|Overall Study|Physician Decision|1|||
161090792|NCT02523599|581721769|FG001|Overall Study|Physician Decision|0|||
161090793|NCT02523599|581721768|FG000|Overall Study|Lost to Follow-up|4|||
161090794|NCT02523599|581721769|FG001|Overall Study|Lost to Follow-up|1|||
161090795|NCT02523599|581721768|FG000|Overall Study|Did not return for Day 30 visit|2|||
161090796|NCT02523599|581721769|FG001|Overall Study|Did not return for Day 30 visit|0|||
161198273|NCT00463385|582107412|FG000|Overall Study|Other|4|||
161198274|NCT00463385|582107413|FG001|Overall Study|Other|3|||
161198275|NCT00463385|582107414|FG002|Overall Study|Other|6|||
161198276|NCT00463385|582107415|FG003|Overall Study|Other|4|||
161198277|NCT00463385|582107412|FG000|Overall Study|Adverse Event|5|||
161198278|NCT00463385|582107413|FG001|Overall Study|Adverse Event|8|||
161198279|NCT00463385|582107414|FG002|Overall Study|Adverse Event|4|||
161198280|NCT00463385|582107415|FG003|Overall Study|Adverse Event|2|||
161198281|NCT00463385|582107412|FG000|Overall Study|Lack of Efficacy|6|||
161198282|NCT00463385|582107413|FG001|Overall Study|Lack of Efficacy|6|||
161198283|NCT00463385|582107414|FG002|Overall Study|Lack of Efficacy|7|||
161198284|NCT00463385|582107415|FG003|Overall Study|Lack of Efficacy|9|||
161198285|NCT00463385|582107412|FG000|Overall Study|Withdrawal by Subject|3|||
161198286|NCT00463385|582107413|FG001|Overall Study|Withdrawal by Subject|3|||
161198287|NCT00463385|582107414|FG002|Overall Study|Withdrawal by Subject|3|||
161198288|NCT00463385|582107415|FG003|Overall Study|Withdrawal by Subject|4|||
161198289|NCT00463385|582107412|FG000|Overall Study|Lost to Follow-up|0|||
161198290|NCT00463385|582107413|FG001|Overall Study|Lost to Follow-up|0|||
161198291|NCT00463385|582107414|FG002|Overall Study|Lost to Follow-up|0|||
161198292|NCT00463385|582107415|FG003|Overall Study|Lost to Follow-up|1|||
161198293|NCT00463385|582107412|FG000|Overall Study|Death|2|||
161198294|NCT00463385|582107413|FG001|Overall Study|Death|1|||
161198295|NCT00463385|582107414|FG002|Overall Study|Death|2|||
161198296|NCT00463385|582107415|FG003|Overall Study|Death|0|||
161198297|NCT00463385|582107412|FG000|Overall Study|Missing|2|||
161198298|NCT00463385|582107413|FG001|Overall Study|Missing|0|||
161198299|NCT00463385|582107414|FG002|Overall Study|Missing|0|||
161198300|NCT00463385|582107415|FG003|Overall Study|Missing|2|||
161198301|NCT00463385|582107412|FG000|Overall Study|1 participant received commercial drug|0|||
161198302|NCT00463385|582107413|FG001|Overall Study|1 participant received commercial drug|1|||
161198303|NCT00463385|582107414|FG002|Overall Study|1 participant received commercial drug|0|||
161198304|NCT00463385|582107415|FG003|Overall Study|1 participant received commercial drug|0|||
161198305|NCT00726882|582107416|FG000|Overall Study|Withdrawal by Subject|5|||
161198306|NCT00726882|582107416|FG000|Overall Study|Lost to Follow-up|7|||
161198307|NCT00726882|582107416|FG000|Overall Study|Other|10|||
161198308|NCT00344968|582107417|FG000|Overall Study|Adverse Event|5|||
161198309|NCT00344968|582107418|FG001|Overall Study|Adverse Event|4|||
161198310|NCT00344968|582107419|FG002|Overall Study|Adverse Event|15|||
161198311|NCT00344968|582107417|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
161198312|NCT00344968|582107418|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
161198313|NCT00344968|582107419|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
161198314|NCT00344968|582107417|FG000|Overall Study|Protocol Violation|2|||
161198315|NCT00344968|582107418|FG001|Overall Study|Protocol Violation|2|||
161198316|NCT00344968|582107419|FG002|Overall Study|Protocol Violation|5|||
161198317|NCT00344968|582107417|FG000|Overall Study|Withdrawal by Subject|14|||
161198318|NCT00344968|582107418|FG001|Overall Study|Withdrawal by Subject|31|||
161198319|NCT00344968|582107419|FG002|Overall Study|Withdrawal by Subject|27|||
161198320|NCT00344968|582107417|FG000|Overall Study|Lost to Follow-up|24|||
161198321|NCT00344968|582107418|FG001|Overall Study|Lost to Follow-up|37|||
161198322|NCT00344968|582107419|FG002|Overall Study|Lost to Follow-up|37|||
161198323|NCT00344968|582107417|FG000|Overall Study|Death|11|||
161198324|NCT00344968|582107418|FG001|Overall Study|Death|27|||
161198325|NCT00344968|582107419|FG002|Overall Study|Death|31|||
161198326|NCT00344968|582107417|FG000|Overall Study|Other|0|||
161198327|NCT00344968|582107418|FG001|Overall Study|Other|1|||
161198328|NCT00344968|582107419|FG002|Overall Study|Other|0|||
161198329|NCT02526017|582107420|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198330|NCT02526017|582107421|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198331|NCT02526017|582107422|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198332|NCT02526017|582107423|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198333|NCT02526017|582107424|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
161198334|NCT02526017|582107425|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198335|NCT02526017|582107426|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198336|NCT02526017|582107427|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198337|NCT02526017|582107428|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
161198338|NCT01548573|582107429|FG000|Overall Study|Death|3|||
161198339|NCT01548573|582107429|FG000|Overall Study|Withdrawal by Subject|2|||
161198340|NCT04196023|582107439|FG000|Overall Study|Withdrawal by Subject|0|||
161198341|NCT04196023|582107440|FG001|Overall Study|Withdrawal by Subject|1|||
161198342|NCT04196023|582107439|FG000|Overall Study|Adverse Event|3|||
161198343|NCT04196023|582107440|FG001|Overall Study|Adverse Event|1|||
161198344|NCT04196023|582107439|FG000|Overall Study|Lost to Follow-up|0|||
161198345|NCT04196023|582107440|FG001|Overall Study|Lost to Follow-up|1|||
161198346|NCT04359758|582107447|FG000|Overall Study|Protocol Violation|3|||
161198347|NCT04359758|582107448|FG001|Overall Study|Protocol Violation|2|||
161306970|NCT03395184|582502978|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
161306971|NCT03395184|582502979|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
161306972|NCT03395184|582502980|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
161306973|NCT03395184|582502981|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
161306974|NCT03395184|582502982|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
161306975|NCT03395184|582502983|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
161306976|NCT03395184|582502977|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
161306977|NCT03395184|582502978|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
161306978|NCT03395184|582502979|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
161306979|NCT03395184|582502980|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
161306980|NCT03395184|582502981|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
161306981|NCT03395184|582502982|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
161306982|NCT03395184|582502983|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
161306983|NCT03395184|582502977|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161306984|NCT03395184|582502978|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161306985|NCT03395184|582502979|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
161306986|NCT03395184|582502980|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
161306987|NCT03395184|582502981|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
161306988|NCT03395184|582502982|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
161198348|NCT03358407|582107452|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198349|NCT03358407|582107453|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198350|NCT03358407|582107454|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
161198351|NCT03358407|582107455|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161306989|NCT03395184|582502983|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
161198352|NCT03358407|582107456|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198353|NCT03358407|582107457|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198354|NCT03358407|582107458|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198355|NCT03358407|582107459|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198356|NCT03358407|582107460|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161198357|NCT03358407|582107461|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
161306990|NCT03395184|582502977|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161306991|NCT03395184|582502978|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161306992|NCT03395184|582502979|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161198358|NCT03358407|582107452|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198359|NCT03358407|582107453|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198360|NCT03358407|582107454|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198361|NCT03358407|582107455|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198362|NCT03358407|582107456|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161198363|NCT03358407|582107457|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198364|NCT03358407|582107458|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198365|NCT03358407|582107459|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198366|NCT03358407|582107460|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161306993|NCT03395184|582502980|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161306994|NCT03395184|582502981|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
161306995|NCT03395184|582502982|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161306996|NCT03395184|582502983|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
161306997|NCT03395184|582502977|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161306998|NCT03395184|582502978|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161306999|NCT03395184|582502979|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
161307000|NCT03395184|582502980|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
161307001|NCT03395184|582502981|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
161307002|NCT03395184|582502982|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
161307003|NCT03395184|582502983|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
161307004|NCT03395184|582502977|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161307005|NCT03395184|582502978|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161307006|NCT03395184|582502979|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161307007|NCT03395184|582502980|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
161307008|NCT03395184|582502981|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161307009|NCT03395184|582502982|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
161307010|NCT03395184|582502983|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
161307011|NCT03395184|582502977|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161307012|NCT03395184|582502978|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161307013|NCT03395184|582502979|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
161307014|NCT03395184|582502980|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
161307015|NCT03395184|582502981|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
161307016|NCT03395184|582502982|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
161307017|NCT03395184|582502983|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
161307018|NCT03963232|582502987|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
161307019|NCT03963232|582502988|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
161307020|NCT03963232|582502987|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
161307021|NCT03963232|582502988|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
161307022|NCT03963232|582502987|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
161307023|NCT03963232|582502988|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
161307024|NCT03963232|582502987|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
161307025|NCT03963232|582502988|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
161307026|NCT03963232|582502987|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
161307027|NCT03963232|582502988|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
161307028|NCT03963232|582502987|FG000|Open-Label Treatment Phase|Adverse Event|1|||
161307029|NCT03963232|582502988|FG001|Open-Label Treatment Phase|Adverse Event|2|||
161307030|NCT03963232|582502987|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
161307031|NCT03963232|582502988|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
161307032|NCT03963232|582502987|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
161307033|NCT03963232|582502988|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
161307034|NCT03963232|582502987|FG000|Open-Label Treatment Phase|Pregnancy|1|||
161307035|NCT03963232|582502988|FG001|Open-Label Treatment Phase|Pregnancy|0|||
161307036|NCT03963232|582502987|FG000|Follow-up Phase|Withdrawal by Subject|7|||
161307037|NCT03963232|582502988|FG001|Follow-up Phase|Withdrawal by Subject|5|||
161307038|NCT03963232|582502987|FG000|Follow-up Phase|Protocol Violation|0|||
161307039|NCT03963232|582502988|FG001|Follow-up Phase|Protocol Violation|2|||
161307040|NCT03963232|582502987|FG000|Follow-up Phase|Adverse Event|0|||
161307041|NCT03963232|582502988|FG001|Follow-up Phase|Adverse Event|1|||
161307042|NCT03963232|582502987|FG000|Follow-up Phase|Lost to Follow-up|0|||
161307043|NCT03963232|582502988|FG001|Follow-up Phase|Lost to Follow-up|1|||
161307044|NCT03617770|582502989|FG000|Overall Study|Lost to Follow-up|1|||
161307045|NCT03617770|582502990|FG001|Overall Study|Lost to Follow-up|0|||
161198367|NCT03358407|582107461|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161307046|NCT00356135|582502991|FG000|Overall Study|Protocol Violation|1|||
161307047|NCT00356135|582502992|FG001|Overall Study|Protocol Violation|0|||
161307048|NCT00356135|582502993|FG002|Overall Study|Protocol Violation|0|||
161307049|NCT00356135|582502991|FG000|Overall Study|Adverse Event|1|||
161307050|NCT00356135|582502992|FG001|Overall Study|Adverse Event|0|||
161307051|NCT00356135|582502993|FG002|Overall Study|Adverse Event|0|||
161198368|NCT03358407|582107452|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198369|NCT03358407|582107453|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198370|NCT03358407|582107454|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198371|NCT03358407|582107455|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198372|NCT03358407|582107456|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198373|NCT03358407|582107457|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
161198374|NCT03358407|582107458|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198375|NCT03358407|582107459|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
161198376|NCT03358407|582107460|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198377|NCT03358407|582107461|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
161198378|NCT03358407|582107452|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198379|NCT03358407|582107453|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198380|NCT03358407|582107454|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198381|NCT03358407|582107455|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198382|NCT03358407|582107456|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198383|NCT03358407|582107457|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
161198384|NCT03358407|582107458|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198385|NCT03358407|582107459|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
161198386|NCT03358407|582107460|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198387|NCT03358407|582107461|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
161198388|NCT03358407|582107452|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198389|NCT03358407|582107453|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198390|NCT03358407|582107454|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198391|NCT03358407|582107455|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198392|NCT03358407|582107456|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198393|NCT03358407|582107457|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161198394|NCT03358407|582107458|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
161198395|NCT03358407|582107459|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198396|NCT03358407|582107460|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198397|NCT03358407|582107461|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
161198398|NCT03358407|582107452|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198399|NCT03358407|582107453|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198400|NCT03358407|582107454|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198401|NCT03358407|582107455|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198402|NCT03358407|582107456|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198403|NCT03358407|582107457|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
161198404|NCT03358407|582107458|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
161198405|NCT03358407|582107459|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
161198406|NCT03358407|582107460|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198407|NCT03358407|582107461|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
161198408|NCT00483574|582107462|FG000|Overall Study|Adverse Event|6|||
161198409|NCT00483574|582107463|FG001|Overall Study|Adverse Event|0|||
161198410|NCT00483574|582107462|FG000|Overall Study|Protocol Violation|28|||
161198411|NCT00483574|582107463|FG001|Overall Study|Protocol Violation|9|||
161198412|NCT00483574|582107462|FG000|Overall Study|Lost to Follow-up|16|||
161198413|NCT00483574|582107463|FG001|Overall Study|Lost to Follow-up|4|||
161198414|NCT00483574|582107462|FG000|Overall Study|Withdrawal by Subject|52|||
161198415|NCT00483574|582107463|FG001|Overall Study|Withdrawal by Subject|0|||
161198416|NCT03605758|582107464|FG000|Overall Study|Lost to Follow-up|2|||
161198417|NCT03605758|582107465|FG001|Overall Study|Lost to Follow-up|1|||
161198418|NCT03605758|582107464|FG000|Overall Study|Illness|0|||
161198419|NCT03605758|582107465|FG001|Overall Study|Illness|1|||
161198420|NCT03605758|582107464|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
161198421|NCT03605758|582107465|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
161198422|NCT04753606|582107468|FG000|Overall Study|Adverse Event|1|||
161198423|NCT04753606|582107469|FG001|Overall Study|Adverse Event|0|||
161198424|NCT04753606|582107470|FG002|Overall Study|Adverse Event|0|||
161198425|NCT00489411|582107471|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
161198426|NCT00489411|582107472|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
161198427|NCT00489411|582107471|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
161198428|NCT00489411|582107472|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
161198429|NCT00489411|582107471|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
161198430|NCT00489411|582107472|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
161198431|NCT00489411|582107471|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
161198432|NCT00489411|582107472|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
161307052|NCT00356135|582502991|FG000|Overall Study|Lost to Follow-up|0|||
161198433|NCT00489411|582107471|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
161198434|NCT00489411|582107472|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
161198435|NCT01748162|582107473|FG000|Overall Study|no additional croup episodes to evaluate|2|||
161198436|NCT01748162|582107474|FG001|Overall Study|no additional croup episodes to evaluate|2|||
161198437|NCT01748162|582107473|FG000|Overall Study|participant consented but did not begin|0|||
161198438|NCT01748162|582107474|FG001|Overall Study|participant consented but did not begin|1|||
161198439|NCT01748162|582107473|FG000|Overall Study|reasons not available|3|||
161198440|NCT01748162|582107474|FG001|Overall Study|reasons not available|2|||
161198441|NCT03219372|582107475|FG000|Overall Study|Withdrawal by Subject|1|||
161198442|NCT03219372|582107476|FG001|Overall Study|Withdrawal by Subject|0|||
161198443|NCT03841331|582107477|FG000|Overall Study|Withdrawal by Subject|4|||
161198444|NCT03841331|582107478|FG001|Overall Study|Withdrawal by Subject|9|||
161198445|NCT03841331|582107477|FG000|Overall Study|Lost to Follow-up|5|||
161198446|NCT03841331|582107478|FG001|Overall Study|Lost to Follow-up|1|||
161198447|NCT04145531|582107479|FG000|Part A|Adverse Event|2|||
161198448|NCT04145531|582107480|FG001|Part A|Adverse Event|12|||
161198449|NCT04145531|582107481|FG002|Part A|Adverse Event|6|||
161198450|NCT04145531|582107482|FG003|Part A|Adverse Event|0|||
161198451|NCT04145531|582107479|FG000|Part A|Death|1|||
161198452|NCT04145531|582107480|FG001|Part A|Death|2|||
161198453|NCT04145531|582107481|FG002|Part A|Death|0|||
161198454|NCT04145531|582107482|FG003|Part A|Death|0|||
161198455|NCT04145531|582107479|FG000|Part A|Physician Decision|2|||
161198456|NCT04145531|582107480|FG001|Part A|Physician Decision|5|||
161198457|NCT04145531|582107481|FG002|Part A|Physician Decision|2|||
161198458|NCT04145531|582107482|FG003|Part A|Physician Decision|0|||
161198459|NCT04145531|582107479|FG000|Part A|Progressive disease|0|||
161198460|NCT04145531|582107480|FG001|Part A|Progressive disease|2|||
161198461|NCT04145531|582107481|FG002|Part A|Progressive disease|1|||
161198462|NCT04145531|582107482|FG003|Part A|Progressive disease|0|||
161198463|NCT04145531|582107479|FG000|Part A|Protocol deviation|0|||
161198464|NCT04145531|582107480|FG001|Part A|Protocol deviation|0|||
161198465|NCT04145531|582107481|FG002|Part A|Protocol deviation|1|||
161198466|NCT04145531|582107482|FG003|Part A|Protocol deviation|0|||
161198467|NCT04145531|582107479|FG000|Part A|Withdrawal by parent or guardian|1|||
161198468|NCT04145531|582107480|FG001|Part A|Withdrawal by parent or guardian|0|||
161198469|NCT04145531|582107481|FG002|Part A|Withdrawal by parent or guardian|0|||
161198470|NCT04145531|582107482|FG003|Part A|Withdrawal by parent or guardian|0|||
161198471|NCT04145531|582107479|FG000|Part A|Withdrawal by participant|0|||
161198472|NCT04145531|582107480|FG001|Part A|Withdrawal by participant|0|||
161198473|NCT04145531|582107481|FG002|Part A|Withdrawal by participant|1|||
161198474|NCT04145531|582107482|FG003|Part A|Withdrawal by participant|0|||
161198475|NCT04145531|582107479|FG000|Part A|Other|0|||
161198476|NCT04145531|582107480|FG001|Part A|Other|0|||
161198477|NCT04145531|582107481|FG002|Part A|Other|1|||
161198478|NCT04145531|582107482|FG003|Part A|Other|0|||
161198479|NCT04145531|582107479|FG000|Part B|Adverse Event|0|||
161198480|NCT04145531|582107480|FG001|Part B|Adverse Event|0|||
161198481|NCT04145531|582107481|FG002|Part B|Adverse Event|0|||
161198482|NCT04145531|582107482|FG003|Part B|Adverse Event|21|||
161198483|NCT04145531|582107479|FG000|Part B|Physician Decision|0|||
161198484|NCT04145531|582107480|FG001|Part B|Physician Decision|0|||
161198485|NCT04145531|582107481|FG002|Part B|Physician Decision|0|||
161198486|NCT04145531|582107482|FG003|Part B|Physician Decision|7|||
161198487|NCT04145531|582107479|FG000|Part B|Progressive disease|0|||
161198488|NCT04145531|582107480|FG001|Part B|Progressive disease|0|||
161198489|NCT04145531|582107481|FG002|Part B|Progressive disease|0|||
161198490|NCT04145531|582107482|FG003|Part B|Progressive disease|1|||
161198491|NCT04145531|582107479|FG000|Part B|Recurrent disease|0|||
161198492|NCT04145531|582107480|FG001|Part B|Recurrent disease|0|||
161198493|NCT04145531|582107481|FG002|Part B|Recurrent disease|0|||
161198494|NCT04145531|582107482|FG003|Part B|Recurrent disease|1|||
161198495|NCT04145531|582107479|FG000|Part B|Withdrawal by parent or guardian|0|||
161198496|NCT04145531|582107480|FG001|Part B|Withdrawal by parent or guardian|0|||
161198497|NCT04145531|582107481|FG002|Part B|Withdrawal by parent or guardian|0|||
161198498|NCT04145531|582107482|FG003|Part B|Withdrawal by parent or guardian|3|||
161198499|NCT04145531|582107479|FG000|Part B|Withdrawal by participant|0|||
161198500|NCT04145531|582107480|FG001|Part B|Withdrawal by participant|0|||
161198501|NCT04145531|582107481|FG002|Part B|Withdrawal by participant|0|||
161198502|NCT04145531|582107482|FG003|Part B|Withdrawal by participant|1|||
161198503|NCT04145531|582107479|FG000|Part B|Other|0|||
161198504|NCT04145531|582107480|FG001|Part B|Other|0|||
161198505|NCT04145531|582107481|FG002|Part B|Other|0|||
161198506|NCT04145531|582107482|FG003|Part B|Other|1|||
161198507|NCT00442572|582107487|FG000|Overall Study|Relapse|8|||
161198508|NCT00442572|582107488|FG001|Overall Study|Relapse|1|||
161198509|NCT00442572|582107487|FG000|Overall Study|Lost to Follow-up|0|||
161198510|NCT00442572|582107488|FG001|Overall Study|Lost to Follow-up|1|||
161198511|NCT00442572|582107487|FG000|Overall Study|Withdrawal by Subject|0|||
161198512|NCT00442572|582107488|FG001|Overall Study|Withdrawal by Subject|1|||
161198513|NCT04366258|582107489|FG000|Baseline Assessments|Screen Failure|21|||
161198514|NCT04366258|582107489|FG000|Baseline Assessments|Early Termination|3|||
161198515|NCT03557775|582107491|FG000|Overall Study|Withdrawal by Subject|1|||
161198516|NCT03557775|582107492|FG001|Overall Study|Withdrawal by Subject|2|||
161198517|NCT03557775|582107493|FG002|Overall Study|Withdrawal by Subject|4|||
161198518|NCT03557775|582107491|FG000|Overall Study|Physician Decision|0|||
161198519|NCT03557775|582107492|FG001|Overall Study|Physician Decision|1|||
161198520|NCT03557775|582107493|FG002|Overall Study|Physician Decision|0|||
161198521|NCT00308555|582107494|FG000|Overall Study|Withdrawal by Subject|1|||
161198522|NCT00308555|582107495|FG001|Overall Study|Withdrawal by Subject|0|||
161198523|NCT00308555|582107494|FG000|Overall Study|Physician Decision|2|||
161198524|NCT00308555|582107495|FG001|Overall Study|Physician Decision|0|||
161198525|NCT00276458|582107496|FG000|Overall Study|Adverse Event|0|||
161198526|NCT00276458|582107497|FG001|Overall Study|Adverse Event|2|||
161198527|NCT00276458|582107496|FG000|Overall Study|Lost to Follow-up|2|||
161198528|NCT00276458|582107497|FG001|Overall Study|Lost to Follow-up|2|||
161198529|NCT00276458|582107496|FG000|Overall Study|Protocol Violation|4|||
161198530|NCT00276458|582107497|FG001|Overall Study|Protocol Violation|3|||
161198531|NCT01977625|582107505|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
161198532|NCT01977625|582107506|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161198533|NCT01977625|582107505|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161198534|NCT01977625|582107506|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161198535|NCT00429026|582107508|FG000|Overall Study|Inevaluable for response.|40|||
161198536|NCT04338685|582107511|FG000|Overall Study|Death|3|||
161198537|NCT04338685|582107512|FG001|Overall Study|Death|4|||
161198538|NCT04338685|582107513|FG002|Overall Study|Death|2|||
161198539|NCT04338685|582107514|FG003|Overall Study|Death|4|||
161198540|NCT04338685|582107515|FG004|Overall Study|Death|4|||
161198541|NCT04338685|582107516|FG005|Overall Study|Death|8|||
161198542|NCT04338685|582107517|FG006|Overall Study|Death|1|||
161198543|NCT04338685|582107518|FG007|Overall Study|Death|0|||
161198544|NCT04338685|582107519|FG008|Overall Study|Death|0|||
161198545|NCT04338685|582107511|FG000|Overall Study|Study terminated by Sponsor|0|||
161307053|NCT00356135|582502992|FG001|Overall Study|Lost to Follow-up|0|||
161307054|NCT00356135|582502993|FG002|Overall Study|Lost to Follow-up|1|||
161307055|NCT00356135|582502991|FG000|Overall Study|Physician Decision|1|||
161307056|NCT00356135|582502992|FG001|Overall Study|Physician Decision|1|||
161307057|NCT00356135|582502993|FG002|Overall Study|Physician Decision|1|||
161307058|NCT00356135|582502991|FG000|Overall Study|Subject non-compliance|1|||
161307059|NCT00356135|582502992|FG001|Overall Study|Subject non-compliance|1|||
161307060|NCT00356135|582502993|FG002|Overall Study|Subject non-compliance|3|||
161307061|NCT01672710|582502994|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
161307062|NCT01672710|582502995|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
161307063|NCT01672710|582502994|FG000|3 Month Follow up|Lost to Follow-up|2|||
161307064|NCT01672710|582502995|FG001|3 Month Follow up|Lost to Follow-up|3|||
161307065|NCT01672710|582502994|FG000|3 Month Follow up|follow up due after termination date|4|||
161307066|NCT01672710|582502995|FG001|3 Month Follow up|follow up due after termination date|1|||
161307067|NCT05033262|582503001|FG000|Overall Study|Lost to Follow-up|1|||
161307068|NCT05033262|582503002|FG001|Overall Study|Lost to Follow-up|0|||
161307069|NCT05033262|582503003|FG002|Overall Study|Lost to Follow-up|0|||
161307070|NCT05033262|582503004|FG003|Overall Study|Lost to Follow-up|1|||
161307071|NCT05270395|582503005|FG000|Overall Study|Lost to Follow-up|2|||
161307072|NCT05270395|582503006|FG001|Overall Study|Lost to Follow-up|2|||
161198546|NCT04338685|582107512|FG001|Overall Study|Study terminated by Sponsor|0|||
161198547|NCT04338685|582107513|FG002|Overall Study|Study terminated by Sponsor|1|||
161198548|NCT04338685|582107514|FG003|Overall Study|Study terminated by Sponsor|4|||
161198549|NCT04338685|582107515|FG004|Overall Study|Study terminated by Sponsor|0|||
161198550|NCT04338685|582107516|FG005|Overall Study|Study terminated by Sponsor|5|||
161198551|NCT04338685|582107517|FG006|Overall Study|Study terminated by Sponsor|2|||
161307073|NCT05270395|582503005|FG000|Overall Study|Death|1|||
161307074|NCT05270395|582503006|FG001|Overall Study|Death|2|||
161307075|NCT05270395|582503005|FG000|Overall Study|Study Team Withdrew|1|||
161307076|NCT05270395|582503006|FG001|Overall Study|Study Team Withdrew|0|||
161307077|NCT04743804|582505210|FG000|Overall Study|Other|1|||
161307078|NCT04743804|582505211|FG001|Overall Study|Other|0|||
161307079|NCT04743804|582505210|FG000|Overall Study|Withdrawal by Subject|0|||
161307080|NCT04743804|582505211|FG001|Overall Study|Withdrawal by Subject|1|||
161307081|NCT04743804|582505210|FG000|Overall Study|Study Terminated by Sponsor|1|||
161307082|NCT04743804|582505211|FG001|Overall Study|Study Terminated by Sponsor|4|||
161307083|NCT04743804|582505210|FG000|Overall Study|Physician Decision|0|||
161307084|NCT04743804|582505211|FG001|Overall Study|Physician Decision|1|||
161307085|NCT04743804|582505210|FG000|Overall Study|Death|3|||
161307086|NCT04743804|582505211|FG001|Overall Study|Death|0|||
161307087|NCT00970632|582505217|FG000|Overall Study|Adverse Event|2|||
161307088|NCT00970632|582505218|FG001|Overall Study|Adverse Event|2|||
161307089|NCT00970632|582505219|FG002|Overall Study|Adverse Event|1|||
161307090|NCT00970632|582505217|FG000|Overall Study|Lack of Efficacy|3|||
161307091|NCT00970632|582505218|FG001|Overall Study|Lack of Efficacy|0|||
161307092|NCT00970632|582505219|FG002|Overall Study|Lack of Efficacy|0|||
161307093|NCT00970632|582505217|FG000|Overall Study|Lost to Follow-up|3|||
161307094|NCT00970632|582505218|FG001|Overall Study|Lost to Follow-up|0|||
161307095|NCT00970632|582505219|FG002|Overall Study|Lost to Follow-up|2|||
161307096|NCT00970632|582505217|FG000|Overall Study|Protocol Violation|8|||
161307097|NCT00970632|582505218|FG001|Overall Study|Protocol Violation|5|||
161307098|NCT00970632|582505219|FG002|Overall Study|Protocol Violation|8|||
161307099|NCT00970632|582505217|FG000|Overall Study|Withdrawal by Subject|7|||
161307100|NCT00970632|582505218|FG001|Overall Study|Withdrawal by Subject|6|||
161307101|NCT00970632|582505219|FG002|Overall Study|Withdrawal by Subject|4|||
161090797|NCT01892540|581721770|FG000|Overall Study|Did not complete PET/MRI|0|||
161090798|NCT01892540|581721771|FG001|Overall Study|Did not complete PET/MRI|0|||
161090799|NCT01892540|581721772|FG002|Overall Study|Did not complete PET/MRI|2|||
161090800|NCT01892540|581721770|FG000|Overall Study|Did not fit in scanner|0|||
161090801|NCT01892540|581721771|FG001|Overall Study|Did not fit in scanner|0|||
161090802|NCT01892540|581721772|FG002|Overall Study|Did not fit in scanner|1|||
161090803|NCT01370590|581721773|FG000|Period 1|Adverse Event|8|||
161090804|NCT01370590|581721774|FG001|Period 1|Adverse Event|4|||
161090805|NCT01370590|581721773|FG000|Period 1|Lost to Follow-up|2|||
161090806|NCT01370590|581721774|FG001|Period 1|Lost to Follow-up|2|||
161090807|NCT01370590|581721773|FG000|Period 1|Protocol Violation|2|||
161090808|NCT01370590|581721774|FG001|Period 1|Protocol Violation|2|||
161090809|NCT01370590|581721773|FG000|Period 1|Withdrawal by Subject|4|||
161090810|NCT01370590|581721774|FG001|Period 1|Withdrawal by Subject|2|||
161090811|NCT01370590|581721773|FG000|Period 1|Could not access randomization system|0|||
161090812|NCT01370590|581721774|FG001|Period 1|Could not access randomization system|1|||
161090813|NCT01370590|581721773|FG000|Crossover Washout Period|Adverse Event|1|||
161090814|NCT01370590|581721774|FG001|Crossover Washout Period|Adverse Event|4|||
161090815|NCT01370590|581721773|FG000|Crossover Washout Period|Lost to Follow-up|2|||
161090816|NCT01370590|581721774|FG001|Crossover Washout Period|Lost to Follow-up|0|||
161090817|NCT01370590|581721773|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
161090818|NCT01370590|581721774|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
161090819|NCT01370590|581721773|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
161090820|NCT01370590|581721774|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
161090821|NCT01370590|581721773|FG000|Period 2|Adverse Event|0|||
161090822|NCT01370590|581721774|FG001|Period 2|Adverse Event|1|||
161090823|NCT01370590|581721773|FG000|Period 2|Withdrawal by Subject|1|||
161090824|NCT01370590|581721774|FG001|Period 2|Withdrawal by Subject|1|||
161090825|NCT03992846|581721775|FG000|Overall Study|Adverse Event|8|||
161090826|NCT03992846|581721776|FG001|Overall Study|Adverse Event|6|||
161090827|NCT03992846|581721777|FG002|Overall Study|Adverse Event|3|||
161090828|NCT03992846|581721775|FG000|Overall Study|Lost to Follow-up|0|||
161090829|NCT03992846|581721776|FG001|Overall Study|Lost to Follow-up|1|||
161090830|NCT03992846|581721777|FG002|Overall Study|Lost to Follow-up|1|||
161090831|NCT03992846|581721775|FG000|Overall Study|Pregnancy|2|||
161090832|NCT03992846|581721776|FG001|Overall Study|Pregnancy|0|||
161090833|NCT03992846|581721777|FG002|Overall Study|Pregnancy|1|||
161090834|NCT03992846|581721775|FG000|Overall Study|Protocol Violation|1|||
161090835|NCT03992846|581721776|FG001|Overall Study|Protocol Violation|2|||
161090836|NCT03992846|581721777|FG002|Overall Study|Protocol Violation|0|||
161090837|NCT03992846|581721775|FG000|Overall Study|Withdrawal by Subject|8|||
161090838|NCT03992846|581721776|FG001|Overall Study|Withdrawal by Subject|10|||
161090839|NCT03992846|581721777|FG002|Overall Study|Withdrawal by Subject|20|||
161090840|NCT03992846|581721775|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
161090841|NCT03992846|581721776|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
161198552|NCT04338685|582107518|FG007|Overall Study|Study terminated by Sponsor|4|||
161198553|NCT04338685|582107519|FG008|Overall Study|Study terminated by Sponsor|1|||
161198554|NCT04338685|582107511|FG000|Overall Study|Withdrawal by Subject|1|||
161198555|NCT04338685|582107512|FG001|Overall Study|Withdrawal by Subject|2|||
161198556|NCT04338685|582107513|FG002|Overall Study|Withdrawal by Subject|0|||
161198557|NCT04338685|582107514|FG003|Overall Study|Withdrawal by Subject|2|||
161198558|NCT04338685|582107515|FG004|Overall Study|Withdrawal by Subject|0|||
161198559|NCT04338685|582107516|FG005|Overall Study|Withdrawal by Subject|5|||
161198560|NCT04338685|582107517|FG006|Overall Study|Withdrawal by Subject|1|||
161198561|NCT04338685|582107518|FG007|Overall Study|Withdrawal by Subject|1|||
161198562|NCT04338685|582107519|FG008|Overall Study|Withdrawal by Subject|0|||
161198563|NCT02967055|582107520|FG000|Overall Study|Excluded|40|||
161198564|NCT02967055|582107520|FG000|Overall Study|Screen fail|3|||
161198565|NCT02967055|582107520|FG000|Overall Study|Lost to Follow-up|2|||
161198566|NCT02967055|582107520|FG000|Overall Study|Stopped due to side effects|3|||
161198567|NCT02967055|582107520|FG000|Overall Study|Stopped due to drug cost|1|||
161198568|NCT00752206|582107521|FG000|Overall Study|Disease progression|8|||
161198569|NCT00752206|582107522|FG001|Overall Study|Disease progression|11|||
161198570|NCT00752206|582107521|FG000|Overall Study|Pregnancy|1|||
161198571|NCT00752206|582107522|FG001|Overall Study|Pregnancy|0|||
161198572|NCT04365387|582107523|FG000|Overall Study|Adverse Event|4|||
161198573|NCT04365387|582107524|FG001|Overall Study|Adverse Event|2|||
161198574|NCT04365387|582107523|FG000|Overall Study|Participants request|14|||
161198575|NCT04365387|582107524|FG001|Overall Study|Participants request|14|||
161198576|NCT04365387|582107523|FG000|Overall Study|Lost to Follow-up|8|||
161198577|NCT04365387|582107524|FG001|Overall Study|Lost to Follow-up|5|||
161198578|NCT04365387|582107523|FG000|Overall Study|Protocol deviation|3|||
161198579|NCT04365387|582107524|FG001|Overall Study|Protocol deviation|4|||
161198580|NCT04365387|582107523|FG000|Overall Study|Participant compliance with visit schedule|1|||
161198581|NCT04365387|582107524|FG001|Overall Study|Participant compliance with visit schedule|0|||
161198582|NCT04365387|582107523|FG000|Overall Study|Participant incarcerated|1|||
161198583|NCT04365387|582107524|FG001|Overall Study|Participant incarcerated|0|||
161198584|NCT04365387|582107523|FG000|Overall Study|Participant moved out of town (relocated)|0|||
161198585|NCT04365387|582107524|FG001|Overall Study|Participant moved out of town (relocated)|1|||
161198586|NCT04365387|582107523|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
161198587|NCT04365387|582107524|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
161198588|NCT04365387|582107523|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
161198589|NCT04365387|582107524|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
161307102|NCT00970632|582505217|FG000|Overall Study|Entry criteria not met|0|||
161307103|NCT00970632|582505218|FG001|Overall Study|Entry criteria not met|2|||
161307104|NCT00970632|582505219|FG002|Overall Study|Entry criteria not met|2|||
161307105|NCT00970632|582505217|FG000|Overall Study|Sponsor decision|1|||
161307106|NCT00970632|582505218|FG001|Overall Study|Sponsor decision|0|||
161307107|NCT00970632|582505219|FG002|Overall Study|Sponsor decision|1|||
161307108|NCT01286168|582505224|FG000|Overall Study|Withdrawal by Subject|1|||
161307109|NCT01286168|582505224|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
161307110|NCT02487771|582505225|FG000|Overall Study|Lost to Follow-up|2|||
161307111|NCT02487771|582505226|FG001|Overall Study|Lost to Follow-up|3|||
161307112|NCT02487771|582505225|FG000|Overall Study|Moved out of area|5|||
161307113|NCT02487771|582505226|FG001|Overall Study|Moved out of area|6|||
161307114|NCT02487771|582505225|FG000|Overall Study|Withdrawal by Subject|3|||
161307115|NCT02487771|582505226|FG001|Overall Study|Withdrawal by Subject|5|||
161307116|NCT01942486|582505229|FG000|Overall Study|Lost to Follow-up|27|||
161307117|NCT02424630|582505232|FG000|Overall Study|No rotator cuff tear|1|||
161307118|NCT02424630|582505233|FG001|Overall Study|No rotator cuff tear|2|||
161307119|NCT02424630|582505232|FG000|Overall Study|Open procedure|0|||
161307120|NCT02424630|582505233|FG001|Overall Study|Open procedure|1|||
161307121|NCT02045862|582505234|FG000|Overall Study|Death|0|||
161307122|NCT02045862|582505235|FG001|Overall Study|Death|0|||
161307123|NCT02045862|582505236|FG002|Overall Study|Death|1|||
161307124|NCT02045862|582505234|FG000|Overall Study|Miscellaneous|5|||
161307125|NCT02045862|582505235|FG001|Overall Study|Miscellaneous|0|||
161307126|NCT02045862|582505236|FG002|Overall Study|Miscellaneous|8|||
161307127|NCT02045862|582505234|FG000|Overall Study|Withdrawal by Patient|18|||
161307128|NCT02045862|582505235|FG001|Overall Study|Withdrawal by Patient|27|||
161198590|NCT01195662|582107527|FG000|Double Blind Treatment Period|Adverse Event|4|||
161198591|NCT01195662|582107528|FG001|Double Blind Treatment Period|Adverse Event|1|||
161198592|NCT01195662|582107529|FG002|Double Blind Treatment Period|Adverse Event|2|||
161198593|NCT01195662|582107527|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
161198594|NCT01195662|582107528|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
161198595|NCT01195662|582107529|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
161307129|NCT02045862|582505236|FG002|Overall Study|Withdrawal by Patient|57|||
161307130|NCT02045862|582505234|FG000|Overall Study|Protocol Violation|0|||
161307131|NCT02045862|582505235|FG001|Overall Study|Protocol Violation|0|||
161307132|NCT02045862|582505236|FG002|Overall Study|Protocol Violation|6|||
161307133|NCT02045862|582505234|FG000|Overall Study|Lack of Efficacy|8|||
161198596|NCT01195662|582107527|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
161198597|NCT01195662|582107528|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
161198598|NCT01195662|582107529|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
161198599|NCT01195662|582107527|FG000|Double Blind Treatment Period|Administrative reason|2|||
161198600|NCT01195662|582107528|FG001|Double Blind Treatment Period|Administrative reason|1|||
161307134|NCT02045862|582505235|FG001|Overall Study|Lack of Efficacy|4|||
161307135|NCT02045862|582505236|FG002|Overall Study|Lack of Efficacy|13|||
161307136|NCT02045862|582505234|FG000|Overall Study|Randomized but not Received Study Drug|0|||
161307137|NCT02045862|582505235|FG001|Overall Study|Randomized but not Received Study Drug|2|||
161307138|NCT02045862|582505236|FG002|Overall Study|Randomized but not Received Study Drug|8|||
161307139|NCT02045862|582505234|FG000|Overall Study|Adverse Event|7|||
161307140|NCT02045862|582505235|FG001|Overall Study|Adverse Event|5|||
161307141|NCT02045862|582505236|FG002|Overall Study|Adverse Event|27|||
161307142|NCT02045862|582505234|FG000|Overall Study|Lost to Follow-up|1|||
161307143|NCT02045862|582505235|FG001|Overall Study|Lost to Follow-up|2|||
161307144|NCT02045862|582505236|FG002|Overall Study|Lost to Follow-up|6|||
161307145|NCT02691013|582505239|FG000|Overall Study|Withdrawal by Subject|3|||
161307146|NCT02691013|582505240|FG001|Overall Study|Withdrawal by Subject|0|||
161307147|NCT02111785|582505241|FG000|Overall Study|Death|0|||
161307148|NCT02111785|582505242|FG001|Overall Study|Death|1|||
161307149|NCT02111785|582505243|FG002|Overall Study|Death|0|||
161307150|NCT02111785|582505244|FG003|Overall Study|Death|0|||
161307151|NCT04507256|582505245|FG000|Overall Study|Withdrawal by Subject|1|||
161307152|NCT04507256|582505246|FG001|Overall Study|Withdrawal by Subject|0|||
161307153|NCT04507256|582505247|FG002|Overall Study|Withdrawal by Subject|0|||
161307154|NCT04507256|582505248|FG003|Overall Study|Withdrawal by Subject|1|||
161307155|NCT04507256|582505249|FG004|Overall Study|Withdrawal by Subject|0|||
161307156|NCT04507256|582505250|FG005|Overall Study|Withdrawal by Subject|0|||
161307157|NCT02822573|582505254|FG000|Overall Study|Lost to Follow-up|5|||
161307158|NCT02822573|582505255|FG001|Overall Study|Lost to Follow-up|3|||
161307159|NCT02822573|582505254|FG000|Overall Study|Physician Decision|1|||
161307160|NCT02822573|582505255|FG001|Overall Study|Physician Decision|1|||
161307161|NCT02822573|582505254|FG000|Overall Study|Withdrawal by Subject|9|||
161307162|NCT02822573|582505255|FG001|Overall Study|Withdrawal by Subject|5|||
161198601|NCT01195662|582107529|FG002|Double Blind Treatment Period|Administrative reason|1|||
161198602|NCT01195662|582107527|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
161198603|NCT01195662|582107528|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
161198604|NCT01195662|582107529|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
161198605|NCT01195662|582107527|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
161198606|NCT01195662|582107528|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
161198607|NCT01195662|582107529|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
161198608|NCT01195662|582107527|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
161198609|NCT01195662|582107528|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
161198610|NCT01195662|582107529|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
161198611|NCT01195662|582107527|FG000|Double Blind Treatment Period|Non-specified|3|||
161198612|NCT01195662|582107528|FG001|Double Blind Treatment Period|Non-specified|0|||
161198613|NCT01195662|582107529|FG002|Double Blind Treatment Period|Non-specified|0|||
161198614|NCT01195662|582107527|FG000|Double Blind Treatment Period|Missing disposition information|0|||
161198615|NCT01195662|582107528|FG001|Double Blind Treatment Period|Missing disposition information|1|||
161198616|NCT01195662|582107529|FG002|Double Blind Treatment Period|Missing disposition information|1|||
161198617|NCT01195662|582107527|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
161198618|NCT01195662|582107528|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
161198619|NCT01195662|582107529|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
161198620|NCT01195662|582107527|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
161198621|NCT01195662|582107528|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
161198622|NCT01195662|582107529|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
161198623|NCT02161380|582107530|FG000|Overall Study|Lost to Follow-up|0|||
161198624|NCT02161380|582107531|FG001|Overall Study|Lost to Follow-up|1|||
161198625|NCT02161380|582107532|FG002|Overall Study|Lost to Follow-up|0|||
161198626|NCT02161380|582107533|FG003|Overall Study|Lost to Follow-up|0|||
161198627|NCT01393444|582107544|FG000|Overall Study|Withdrawal by Subject|1|||
161198628|NCT01393444|582107544|FG000|Overall Study|Determined ineligible during screening.|2|||
161198629|NCT03039699|582107545|FG000|Overall Study|Incorrect inclusion|5|||
161198630|NCT03039699|582107546|FG001|Overall Study|Incorrect inclusion|4|||
161307163|NCT02822573|582505254|FG000|Overall Study|Protocol Violation|6|||
161307164|NCT02822573|582505255|FG001|Overall Study|Protocol Violation|4|||
161198631|NCT03039699|582107545|FG000|Overall Study|Lack of data to assess study endpoint|5|||
161198632|NCT03039699|582107546|FG001|Overall Study|Lack of data to assess study endpoint|3|||
161198633|NCT03039699|582107545|FG000|Overall Study|Bacterial infection|12|||
161307165|NCT02822573|582505254|FG000|Overall Study|Too sick or ill|2|||
161307166|NCT02822573|582505255|FG001|Overall Study|Too sick or ill|1|||
161307167|NCT02822573|582505254|FG000|Overall Study|Disease Progression|1|||
161307168|NCT02822573|582505255|FG001|Overall Study|Disease Progression|1|||
161307169|NCT02822573|582505254|FG000|Overall Study|No reason given|6|||
161307170|NCT02822573|582505255|FG001|Overall Study|No reason given|4|||
161198634|NCT03039699|582107546|FG001|Overall Study|Bacterial infection|28|||
161198635|NCT01397409|582107547|FG000|Stage 2|Adverse Event|0|||
161198636|NCT01397409|582107548|FG001|Stage 2|Adverse Event|0|||
161198637|NCT01397409|582107549|FG002|Stage 2|Adverse Event|0|||
161198638|NCT01397409|582107550|FG003|Stage 2|Adverse Event|0|||
161198639|NCT01397409|582107551|FG004|Stage 2|Adverse Event|6|||
161198640|NCT01397409|582107552|FG005|Stage 2|Adverse Event|3|||
161198641|NCT01397409|582107553|FG006|Stage 2|Adverse Event|0|||
161198642|NCT01397409|582107554|FG007|Stage 2|Adverse Event|0|||
161198643|NCT01397409|582107555|FG008|Stage 2|Adverse Event|0|||
161198644|NCT01397409|582107556|FG009|Stage 2|Adverse Event|0|||
161198645|NCT01397409|582107547|FG000|Stage 2|Personal Reasons|0|||
161198646|NCT01397409|582107548|FG001|Stage 2|Personal Reasons|0|||
161198647|NCT01397409|582107549|FG002|Stage 2|Personal Reasons|0|||
161198648|NCT01397409|582107550|FG003|Stage 2|Personal Reasons|0|||
161198649|NCT01397409|582107551|FG004|Stage 2|Personal Reasons|1|||
161198650|NCT01397409|582107552|FG005|Stage 2|Personal Reasons|0|||
161198651|NCT01397409|582107553|FG006|Stage 2|Personal Reasons|0|||
161198652|NCT01397409|582107554|FG007|Stage 2|Personal Reasons|0|||
161198653|NCT01397409|582107555|FG008|Stage 2|Personal Reasons|0|||
161198654|NCT01397409|582107556|FG009|Stage 2|Personal Reasons|0|||
161198655|NCT01397409|582107547|FG000|Stage 2|Other Miscellaneous Reasons|0|||
161198656|NCT01397409|582107548|FG001|Stage 2|Other Miscellaneous Reasons|0|||
161198657|NCT01397409|582107549|FG002|Stage 2|Other Miscellaneous Reasons|0|||
161198658|NCT01397409|582107550|FG003|Stage 2|Other Miscellaneous Reasons|0|||
161198659|NCT01397409|582107551|FG004|Stage 2|Other Miscellaneous Reasons|1|||
161198660|NCT01397409|582107552|FG005|Stage 2|Other Miscellaneous Reasons|1|||
161198661|NCT01397409|582107553|FG006|Stage 2|Other Miscellaneous Reasons|0|||
161198662|NCT01397409|582107554|FG007|Stage 2|Other Miscellaneous Reasons|0|||
161198663|NCT01397409|582107555|FG008|Stage 2|Other Miscellaneous Reasons|0|||
161198664|NCT01397409|582107556|FG009|Stage 2|Other Miscellaneous Reasons|0|||
161198665|NCT01397409|582107547|FG000|Stage 3|Adverse Event|0|||
161198666|NCT01397409|582107548|FG001|Stage 3|Adverse Event|0|||
161198667|NCT01397409|582107549|FG002|Stage 3|Adverse Event|0|||
161198668|NCT01397409|582107550|FG003|Stage 3|Adverse Event|0|||
161198669|NCT01397409|582107551|FG004|Stage 3|Adverse Event|0|||
161198670|NCT01397409|582107552|FG005|Stage 3|Adverse Event|0|||
161198671|NCT01397409|582107553|FG006|Stage 3|Adverse Event|0|||
161198672|NCT01397409|582107554|FG007|Stage 3|Adverse Event|1|||
161198673|NCT01397409|582107555|FG008|Stage 3|Adverse Event|0|||
161198674|NCT01397409|582107556|FG009|Stage 3|Adverse Event|0|||
161198675|NCT01397409|582107547|FG000|Stage 3|Other Miscellaneous Reasons|0|||
161198676|NCT01397409|582107548|FG001|Stage 3|Other Miscellaneous Reasons|0|||
161198677|NCT01397409|582107549|FG002|Stage 3|Other Miscellaneous Reasons|0|||
161198678|NCT01397409|582107550|FG003|Stage 3|Other Miscellaneous Reasons|0|||
161198679|NCT01397409|582107551|FG004|Stage 3|Other Miscellaneous Reasons|0|||
161198680|NCT01397409|582107552|FG005|Stage 3|Other Miscellaneous Reasons|0|||
161198681|NCT01397409|582107553|FG006|Stage 3|Other Miscellaneous Reasons|0|||
161198682|NCT01397409|582107554|FG007|Stage 3|Other Miscellaneous Reasons|1|||
161198683|NCT01397409|582107555|FG008|Stage 3|Other Miscellaneous Reasons|0|||
161198684|NCT01397409|582107556|FG009|Stage 3|Other Miscellaneous Reasons|0|||
161198685|NCT03418727|582107557|FG000|Overall Study|Adverse Event|1|||
161198686|NCT03418727|582107558|FG001|Overall Study|Adverse Event|2|||
161198687|NCT03418727|582107559|FG002|Overall Study|Adverse Event|0|||
161198688|NCT03418727|582107557|FG000|Overall Study|Withdrawal by Subject|0|||
161198689|NCT03418727|582107558|FG001|Overall Study|Withdrawal by Subject|0|||
161198690|NCT03418727|582107559|FG002|Overall Study|Withdrawal by Subject|2|||
161198691|NCT01791543|582107560|FG000|Overall Study|Lost to Follow-up|1|||
161198692|NCT01791543|582107560|FG000|Overall Study|Adverse Event|1|||
161198693|NCT01740297|582108997|FG000|Overall Study|Withdrawal by Subject|4|||
161198694|NCT01740297|582108998|FG001|Overall Study|Withdrawal by Subject|16|||
161198695|NCT01740297|582108999|FG002|Overall Study|Withdrawal by Subject|17|||
161198696|NCT01740297|582108997|FG000|Overall Study|Death|8|||
161198697|NCT01740297|582108998|FG001|Overall Study|Death|46|||
161198698|NCT01740297|582108999|FG002|Overall Study|Death|40|||
161198699|NCT01740297|582108997|FG000|Overall Study|Lost to Follow-up|1|||
161198700|NCT01740297|582108998|FG001|Overall Study|Lost to Follow-up|2|||
161198701|NCT01740297|582108999|FG002|Overall Study|Lost to Follow-up|4|||
161198702|NCT00761462|582109004|FG000|Treatment|Subjects never received study medication|23|||
161198703|NCT00761462|582109005|FG001|Treatment|Subjects never received study medication|12|||
161198704|NCT00761462|582109004|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
161198705|NCT00761462|582109005|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
161198706|NCT00761462|582109004|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
161198707|NCT00761462|582109005|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
161198708|NCT00761462|582109004|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
161198709|NCT00761462|582109005|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
161198710|NCT00700115|582109010|FG000|Overall Study|Withdrawal by Subject|1|||
161198711|NCT00700115|582109011|FG001|Overall Study|Withdrawal by Subject|0|||
161198712|NCT00700115|582109010|FG000|Overall Study|Lost to Follow-up|0|||
161198713|NCT00700115|582109011|FG001|Overall Study|Lost to Follow-up|1|||
161198714|NCT00449761|582109016|FG000|Overall Study|Disease progression|12|||
161198715|NCT00449761|582109016|FG000|Overall Study|Death|5|||
161198716|NCT00449761|582109016|FG000|Overall Study|New cancer therapy|1|||
161198717|NCT00536991|582109018|FG000|Overall Study|Withdrawal by Subject|10|||
161307171|NCT02677038|582505261|FG000|Overall Study|Physician Decision|1|||
161307172|NCT02677038|582505261|FG000|Overall Study|Withdrawal by Subject|1|||
161307173|NCT02777970|582505265|FG000|Overall Study|Lost to Follow-up|0|||
161307174|NCT02777970|582505266|FG001|Overall Study|Lost to Follow-up|1|||
161307175|NCT02777970|582505267|FG002|Overall Study|Lost to Follow-up|0|||
161307176|NCT02777970|582505265|FG000|Overall Study|Protocol Violation|1|||
161307177|NCT02777970|582505266|FG001|Overall Study|Protocol Violation|0|||
161307178|NCT02777970|582505267|FG002|Overall Study|Protocol Violation|0|||
161307179|NCT02083185|582505275|FG000|Overall Study|Lost to Follow-up|0|||
161307180|NCT02083185|582505276|FG001|Overall Study|Lost to Follow-up|3|||
161307181|NCT02083185|582505277|FG002|Overall Study|Lost to Follow-up|0|||
161307182|NCT02083185|582505275|FG000|Overall Study|Withdrawal by Subject|9|||
161307183|NCT02083185|582505276|FG001|Overall Study|Withdrawal by Subject|15|||
161307184|NCT02083185|582505277|FG002|Overall Study|Withdrawal by Subject|1|||
161307185|NCT02083185|582505275|FG000|Overall Study|Death|2|||
161307186|NCT02083185|582505276|FG001|Overall Study|Death|2|||
161307187|NCT02083185|582505277|FG002|Overall Study|Death|1|||
161307188|NCT02083185|582505275|FG000|Overall Study|Reason not Specified|9|||
161307189|NCT02083185|582505276|FG001|Overall Study|Reason not Specified|6|||
161307190|NCT02083185|582505277|FG002|Overall Study|Reason not Specified|5|||
161307191|NCT02083185|582505275|FG000|Overall Study|Study Terminated by Sponsor|0|||
161307192|NCT02083185|582505276|FG001|Overall Study|Study Terminated by Sponsor|1|||
161307193|NCT02083185|582505277|FG002|Overall Study|Study Terminated by Sponsor|0|||
161307194|NCT02083185|582505275|FG000|Overall Study|Did not Receive Study Drug|0|||
161307195|NCT02083185|582505276|FG001|Overall Study|Did not Receive Study Drug|2|||
161307196|NCT02083185|582505277|FG002|Overall Study|Did not Receive Study Drug|0|||
161307197|NCT03419598|582505278|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
161307198|NCT02474589|582505279|FG000|Overall Study|Adverse Event|6|||
161307199|NCT02474589|582505280|FG001|Overall Study|Adverse Event|2|||
161307200|NCT02474589|582505279|FG000|Overall Study|Lost to Follow-up|6|||
161307201|NCT02474589|582505280|FG001|Overall Study|Lost to Follow-up|1|||
161307202|NCT02474589|582505279|FG000|Overall Study|Protocol Violation|4|||
161307203|NCT02474589|582505280|FG001|Overall Study|Protocol Violation|1|||
161307204|NCT02474589|582505279|FG000|Overall Study|Withdrawal by Subject|4|||
161307205|NCT02474589|582505280|FG001|Overall Study|Withdrawal by Subject|0|||
161307206|NCT02474589|582505279|FG000|Overall Study|Inability to complete study procedures|5|||
161307207|NCT02474589|582505280|FG001|Overall Study|Inability to complete study procedures|1|||
161307208|NCT00380081|582505283|FG000|Overall Study|Withdrawal by Subject|0|||
161307209|NCT00380081|582505284|FG001|Overall Study|Withdrawal by Subject|0|||
161307210|NCT00380081|582505285|FG002|Overall Study|Withdrawal by Subject|0|||
161307211|NCT00380081|582505286|FG003|Overall Study|Withdrawal by Subject|0|||
161307212|NCT00380081|582505287|FG004|Overall Study|Withdrawal by Subject|1|||
161307213|NCT00380081|582505288|FG005|Overall Study|Withdrawal by Subject|0|||
161307214|NCT00380081|582505283|FG000|Overall Study|Family Emergency|0|||
161307215|NCT00380081|582505284|FG001|Overall Study|Family Emergency|0|||
161307216|NCT00380081|582505285|FG002|Overall Study|Family Emergency|0|||
161307217|NCT00380081|582505286|FG003|Overall Study|Family Emergency|0|||
161307218|NCT00380081|582505287|FG004|Overall Study|Family Emergency|0|||
161307219|NCT00380081|582505288|FG005|Overall Study|Family Emergency|1|||
161307220|NCT02231879|582505289|FG000|Overall Study|Adverse Event|2|||
161307221|NCT02231879|582505290|FG001|Overall Study|Adverse Event|1|||
161307222|NCT02231879|582505289|FG000|Overall Study|Lack of Efficacy|0|||
161307223|NCT02231879|582505290|FG001|Overall Study|Lack of Efficacy|1|||
161198718|NCT00536991|582109018|FG000|Overall Study|Physician Decision|1|||
161307224|NCT00189306|582505291|FG000|Treatment Period|Withdrawal by Subject|2|||
161307225|NCT00189306|582505291|FG000|Treatment Period|Adverse Event|2|||
161307226|NCT00189306|582505291|FG000|Treatment Period|Protocol Violation|1|||
161307227|NCT00189306|582505291|FG000|Posttreatment Period|Death|1|||
161307228|NCT00189306|582505291|FG000|Posttreatment Period|Withdrawal by Subject|2|||
161307229|NCT00189306|582505291|FG000|Posttreatment Period|Noncompliance|1|||
161307230|NCT00189306|582505291|FG000|Posttreatment Period|Target lesion excised|1|||
161307231|NCT00189306|582505291|FG000|Posttreatment Period|Protocol Violation|1|||
161307232|NCT00189306|582505291|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
161307233|NCT00189306|582505291|FG000|Posttreatment Period|Local skin reaction/sign|1|||
161198719|NCT00536991|582109018|FG000|Overall Study|patient ineligible|2|||
161198720|NCT00054639|582109019|FG000|Overall Study|Lack of Efficacy|1|||
161198721|NCT00054639|582109019|FG000|Overall Study|Physician Decision|1|||
161307234|NCT00189306|582505291|FG000|Long-Term Follow-up|Adverse Event|2|||
161307235|NCT00189306|582505291|FG000|Long-Term Follow-up|Death|4|||
161307236|NCT00189306|582505291|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
161307237|NCT00189306|582505291|FG000|Long-Term Follow-up|Intercurrent disease|2|||
161198722|NCT01600755|582109020|FG000|Overall Study|Withdrawal by Subject|6|||
161198723|NCT00938392|582109025|FG000|Overall Study|Adverse Event|0|||
161198724|NCT00938392|582109026|FG001|Overall Study|Adverse Event|1|||
161198725|NCT00938392|582109025|FG000|Overall Study|Withdrawal by Subject|0|||
161198726|NCT00938392|582109026|FG001|Overall Study|Withdrawal by Subject|1|||
161198727|NCT00938392|582109025|FG000|Overall Study|Lost to Follow-up|2|||
161307238|NCT00189306|582505291|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
161307239|NCT00189306|582505291|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
161307240|NCT00459706|582505292|FG000|Overall Study|Adverse Event|19|||
161307241|NCT00459706|582505293|FG001|Overall Study|Adverse Event|13|||
161307242|NCT00459706|582505292|FG000|Overall Study|Withdrawal by Subject|1|||
161307243|NCT00459706|582505293|FG001|Overall Study|Withdrawal by Subject|6|||
161307244|NCT00459706|582505292|FG000|Overall Study|Physician Decision|2|||
161307245|NCT00459706|582505293|FG001|Overall Study|Physician Decision|0|||
161307246|NCT00459706|582505292|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
161307247|NCT00459706|582505293|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
161307248|NCT00459706|582505292|FG000|Overall Study|Protocol Violation|2|||
161307249|NCT00459706|582505293|FG001|Overall Study|Protocol Violation|1|||
161307250|NCT00459706|582505292|FG000|Overall Study|Failed to Return|1|||
161307251|NCT00459706|582505293|FG001|Overall Study|Failed to Return|0|||
161307252|NCT00459706|582505292|FG000|Overall Study|Other|0|||
161307253|NCT00459706|582505293|FG001|Overall Study|Other|1|||
161307254|NCT03640481|582505294|FG000|Overall Study|Death|14|||
161307255|NCT03640481|582505295|FG001|Overall Study|Death|14|||
161307256|NCT03640481|582505296|FG002|Overall Study|Death|0|||
161307257|NCT03640481|582505297|FG003|Overall Study|Death|0|||
161307258|NCT03640481|582505294|FG000|Overall Study|Lost to Follow-up|2|||
161307259|NCT03640481|582505295|FG001|Overall Study|Lost to Follow-up|0|||
161307260|NCT03640481|582505296|FG002|Overall Study|Lost to Follow-up|0|||
161307261|NCT03640481|582505297|FG003|Overall Study|Lost to Follow-up|0|||
161307262|NCT03640481|582505294|FG000|Overall Study|Site terminated by sponsor|1|||
161307263|NCT03640481|582505295|FG001|Overall Study|Site terminated by sponsor|3|||
161307264|NCT03640481|582505296|FG002|Overall Study|Site terminated by sponsor|0|||
161307265|NCT03640481|582505297|FG003|Overall Study|Site terminated by sponsor|0|||
161307266|NCT03640481|582505294|FG000|Overall Study|Study terminated by sponsor|29|||
161307267|NCT03640481|582505295|FG001|Overall Study|Study terminated by sponsor|42|||
161307268|NCT03640481|582505296|FG002|Overall Study|Study terminated by sponsor|1|||
161307269|NCT03640481|582505297|FG003|Overall Study|Study terminated by sponsor|0|||
161307270|NCT03640481|582505294|FG000|Overall Study|Withdrawal by Subject|5|||
161307271|NCT03640481|582505295|FG001|Overall Study|Withdrawal by Subject|4|||
161307272|NCT03640481|582505296|FG002|Overall Study|Withdrawal by Subject|0|||
161307273|NCT03640481|582505297|FG003|Overall Study|Withdrawal by Subject|1|||
161307274|NCT03640481|582505294|FG000|Overall Study|Other|26|||
161307275|NCT03640481|582505295|FG001|Overall Study|Other|12|||
161307276|NCT03640481|582505296|FG002|Overall Study|Other|1|||
161307277|NCT03640481|582505297|FG003|Overall Study|Other|0|||
161307278|NCT03640481|582505294|FG000|Overall Study|Randomized, but not treated|1|||
161307279|NCT03640481|582505295|FG001|Overall Study|Randomized, but not treated|3|||
161307280|NCT03640481|582505296|FG002|Overall Study|Randomized, but not treated|0|||
161307281|NCT03640481|582505297|FG003|Overall Study|Randomized, but not treated|0|||
161307282|NCT01322035|582505298|FG000|Overall Study|Lost to Follow-up|8|||
161307283|NCT01322035|582505299|FG001|Overall Study|Lost to Follow-up|3|||
161198728|NCT00938392|582109026|FG001|Overall Study|Lost to Follow-up|2|||
161198729|NCT00122954|582109027|FG000|Overall Study|Withdrawal by Subject|2|||
161198730|NCT00122954|582109028|FG001|Overall Study|Withdrawal by Subject|2|||
161198731|NCT00122954|582109027|FG000|Overall Study|Protocol Violation|0|||
161198732|NCT00122954|582109028|FG001|Overall Study|Protocol Violation|1|||
161198733|NCT00558831|582109029|FG000|Overall Study|Lost to Follow-up|1|||
161198734|NCT02204449|582109030|FG000|Overall Study|Lost to Follow-up|7|||
161198735|NCT02204449|582109031|FG001|Overall Study|Lost to Follow-up|9|||
161198736|NCT02204449|582109030|FG000|Overall Study|Death|0|||
161198737|NCT02204449|582109031|FG001|Overall Study|Death|1|||
161198738|NCT02204449|582109030|FG000|Overall Study|Withdrawal by Subject|0|||
161198739|NCT02204449|582109031|FG001|Overall Study|Withdrawal by Subject|1|||
161198740|NCT02856282|582109032|FG000|Overall Study|Withdrawal by Subject|1|||
161198741|NCT00057330|582109033|FG000|Overall Study|Adverse Event|9|||
161307284|NCT00535847|582505300|FG000|Overall Study|Adverse Event|5|||
161307285|NCT00535847|582505301|FG001|Overall Study|Adverse Event|3|||
161307286|NCT00535847|582505302|FG002|Overall Study|Adverse Event|2|||
161198742|NCT00057330|582109034|FG001|Overall Study|Adverse Event|12|||
161198743|NCT00057330|582109033|FG000|Overall Study|Death|1|||
161198744|NCT00057330|582109034|FG001|Overall Study|Death|0|||
161307287|NCT00535847|582505300|FG000|Overall Study|Non compliance|1|||
161307288|NCT00535847|582505301|FG001|Overall Study|Non compliance|1|||
161307289|NCT00535847|582505302|FG002|Overall Study|Non compliance|0|||
161198745|NCT00057330|582109033|FG000|Overall Study|Protocol Violation|1|||
161307290|NCT00535847|582505300|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
161307291|NCT00535847|582505301|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
161307292|NCT00535847|582505302|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
161198746|NCT00057330|582109034|FG001|Overall Study|Protocol Violation|1|||
161198747|NCT00057330|582109033|FG000|Overall Study|Withdrawal by Subject|115|||
161198748|NCT00057330|582109034|FG001|Overall Study|Withdrawal by Subject|84|||
161198749|NCT00057330|582109033|FG000|Overall Study|Lost to Follow-up|745|||
161198750|NCT00057330|582109034|FG001|Overall Study|Lost to Follow-up|617|||
161198751|NCT00057330|582109033|FG000|Overall Study|Physician Decision|1|||
161198752|NCT00057330|582109034|FG001|Overall Study|Physician Decision|0|||
161198753|NCT00057330|582109033|FG000|Overall Study|Other|260|||
161198754|NCT00057330|582109034|FG001|Overall Study|Other|206|||
161198755|NCT01491737|582109038|FG000|Overall Study|Withdrawal by Subject|20|||
161198756|NCT01491737|582109039|FG001|Overall Study|Withdrawal by Subject|17|||
161198757|NCT01491737|582109038|FG000|Overall Study|Lost to Follow-up|2|||
161198758|NCT01491737|582109039|FG001|Overall Study|Lost to Follow-up|10|||
161198759|NCT01491737|582109038|FG000|Overall Study|Death|63|||
161198760|NCT01491737|582109039|FG001|Overall Study|Death|57|||
161198761|NCT01491737|582109038|FG000|Overall Study|Study Termination by Sponsor|36|||
161198762|NCT01491737|582109039|FG001|Overall Study|Study Termination by Sponsor|36|||
161198763|NCT01491737|582109038|FG000|Overall Study|Reason Not Specified|8|||
161198764|NCT01491737|582109039|FG001|Overall Study|Reason Not Specified|9|||
161198765|NCT00494234|582109042|FG000|Overall Study|Withdrawal by Subject|1|||
161198766|NCT00494234|582109043|FG001|Overall Study|Withdrawal by Subject|0|||
161198767|NCT00494234|582109042|FG000|Overall Study|Disease progression|11|||
161198768|NCT00494234|582109043|FG001|Overall Study|Disease progression|8|||
161198769|NCT00494234|582109042|FG000|Overall Study|Death|2|||
161198770|NCT00494234|582109043|FG001|Overall Study|Death|1|||
161198771|NCT02743117|582109047|FG000|Overall Study|Lost to Follow-up|0|||
161307293|NCT01546168|582505305|FG000|Overall Study|Lost to Follow-up|1|||
161307294|NCT01546168|582505306|FG001|Overall Study|Lost to Follow-up|0|||
161307295|NCT01546168|582505305|FG000|Overall Study|Withdrawal by Subject|1|||
161307296|NCT01546168|582505306|FG001|Overall Study|Withdrawal by Subject|0|||
161307297|NCT01546168|582505305|FG000|Overall Study|ineligible after signing consent|2|||
161307298|NCT01546168|582505306|FG001|Overall Study|ineligible after signing consent|0|||
161307299|NCT02850016|582505307|FG000|Overall Study|Withdrawal by Subject|1|||
161307300|NCT02850016|582505308|FG001|Overall Study|Withdrawal by Subject|2|||
161307301|NCT00070018|582505313|FG000|Overall Study|Adverse Event|2|||
161307302|NCT00070018|582505313|FG000|Overall Study|Lack of Efficacy|1|||
161307303|NCT00070018|582505313|FG000|Overall Study|Withdrawal by Subject|1|||
161307304|NCT02939716|582505314|FG000|Overall Study|scanner failure|0|||
161307305|NCT02939716|582505315|FG001|Overall Study|scanner failure|0|||
161307306|NCT02939716|582505316|FG002|Overall Study|scanner failure|0|||
161307307|NCT02939716|582505317|FG003|Overall Study|scanner failure|1|||
161307308|NCT02939716|582505318|FG004|Overall Study|scanner failure|1|||
161307309|NCT02939716|582505319|FG005|Overall Study|scanner failure|1|||
161307310|NCT04240457|582505322|FG000|Overall Study|Lost to Follow-up|5|||
161307311|NCT04240457|582505323|FG001|Overall Study|Lost to Follow-up|1|||
161307312|NCT00844480|582505328|FG000|Overall Study|Withdrawal by Subject|2|||
161307313|NCT00844480|582505329|FG001|Overall Study|Withdrawal by Subject|3|||
161307314|NCT03197870|582505334|FG000|Overall Study|Adverse Event|9|||
161307315|NCT03197870|582505335|FG001|Overall Study|Adverse Event|4|||
161307316|NCT03197870|582505336|FG002|Overall Study|Adverse Event|6|||
161307317|NCT03197870|582505334|FG000|Overall Study|Withdrawal by Subject|2|||
161307318|NCT03197870|582505335|FG001|Overall Study|Withdrawal by Subject|3|||
161307319|NCT03197870|582505336|FG002|Overall Study|Withdrawal by Subject|0|||
161307320|NCT03197870|582505334|FG000|Overall Study|Lost to Follow-up|2|||
161307321|NCT03197870|582505335|FG001|Overall Study|Lost to Follow-up|2|||
161307322|NCT03197870|582505336|FG002|Overall Study|Lost to Follow-up|0|||
161307323|NCT03197870|582505334|FG000|Overall Study|data not available|1|||
161307324|NCT03197870|582505335|FG001|Overall Study|data not available|1|||
161307325|NCT03197870|582505336|FG002|Overall Study|data not available|0|||
161307326|NCT01618019|582505338|FG000|Overall Study|Withdrawal by Subject|14|||
161307327|NCT01618019|582505339|FG001|Overall Study|Withdrawal by Subject|14|||
161307328|NCT02288091|582505340|FG000|Overall Study|Lost to Follow-up|1|||
161307329|NCT02288091|582505340|FG000|Overall Study|Screen fail|7|||
161307330|NCT00520481|582505342|FG000|Overall Study|Adverse Event|4|||
161307331|NCT00520481|582505343|FG001|Overall Study|Adverse Event|1|||
161307332|NCT00520481|582505342|FG000|Overall Study|Withdrawal by Subject|3|||
161307333|NCT00520481|582505343|FG001|Overall Study|Withdrawal by Subject|0|||
161307334|NCT04442269|582505351|FG000|Overall Study|Adverse Event|1|||
161307335|NCT04442269|582505352|FG001|Overall Study|Adverse Event|0|||
161307336|NCT04442269|582505351|FG000|Overall Study|Death|0|||
161307337|NCT04442269|582505352|FG001|Overall Study|Death|1|||
161307338|NCT04442269|582505351|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
161307339|NCT04442269|582505352|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
161307340|NCT04442269|582505351|FG000|Overall Study|Lost to Follow-up|1|||
161307341|NCT04442269|582505352|FG001|Overall Study|Lost to Follow-up|0|||
161307342|NCT04442269|582505351|FG000|Overall Study|Withdrawal by Subject|3|||
161198772|NCT02743117|582109048|FG001|Overall Study|Lost to Follow-up|1|||
161198773|NCT02743117|582109047|FG000|Overall Study|Other|1|||
161198774|NCT02743117|582109048|FG001|Overall Study|Other|0|||
161198775|NCT00779857|582109049|FG000|Overall Study|Death|1|||
161198776|NCT00779857|582109049|FG000|Overall Study|Withdrawal by Subject|3|||
161198777|NCT00779857|582109049|FG000|Overall Study|Missed Visit|2|||
161198778|NCT04640168|582109050|FG000|Overall Study|Withdrawal by Subject|8|||
161198779|NCT04640168|582109051|FG001|Overall Study|Withdrawal by Subject|7|||
161198780|NCT04640168|582109050|FG000|Overall Study|Lost to Follow-up|1|||
161198781|NCT04640168|582109051|FG001|Overall Study|Lost to Follow-up|0|||
161198782|NCT04640168|582109050|FG000|Overall Study|Enrolled but not treated|12|||
161198783|NCT04640168|582109051|FG001|Overall Study|Enrolled but not treated|12|||
161198784|NCT00978120|582109055|FG000|Overall Study|Death|0|||
161198785|NCT00978120|582109056|FG001|Overall Study|Death|0|||
161198786|NCT00978120|582109057|FG002|Overall Study|Death|0|||
161198787|NCT00978120|582109058|FG003|Overall Study|Death|1|||
161198788|NCT00978120|582109055|FG000|Overall Study|Lost to Follow-up|0|||
161198789|NCT00978120|582109056|FG001|Overall Study|Lost to Follow-up|0|||
161198790|NCT00978120|582109057|FG002|Overall Study|Lost to Follow-up|3|||
161198791|NCT00978120|582109058|FG003|Overall Study|Lost to Follow-up|0|||
161198792|NCT00978120|582109055|FG000|Overall Study|Withdrawal by Subject|2|||
161198793|NCT00978120|582109056|FG001|Overall Study|Withdrawal by Subject|0|||
161198794|NCT00978120|582109057|FG002|Overall Study|Withdrawal by Subject|0|||
161198795|NCT00978120|582109058|FG003|Overall Study|Withdrawal by Subject|0|||
161198796|NCT00978120|582109055|FG000|Overall Study|Moved out of state|0|||
161198797|NCT00978120|582109056|FG001|Overall Study|Moved out of state|0|||
161198798|NCT00978120|582109057|FG002|Overall Study|Moved out of state|0|||
161198799|NCT00978120|582109058|FG003|Overall Study|Moved out of state|1|||
161198800|NCT03205046|582109060|FG000|Overall Study|Death|10|||
161198801|NCT03205046|582109061|FG001|Overall Study|Death|6|||
161198802|NCT03205046|582109060|FG000|Overall Study|Withdrawal by Subject|1|||
161198803|NCT03205046|582109061|FG001|Overall Study|Withdrawal by Subject|2|||
161198804|NCT03205046|582109060|FG000|Overall Study|Lost to Follow-up|0|||
161198805|NCT03205046|582109061|FG001|Overall Study|Lost to Follow-up|1|||
161198806|NCT03205046|582109060|FG000|Overall Study|Study terminated by sponsor|2|||
161198807|NCT03205046|582109061|FG001|Overall Study|Study terminated by sponsor|1|||
161198808|NCT01023815|582109062|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
161198809|NCT01023815|582109063|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161198810|NCT01023815|582109064|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161198811|NCT01023815|582109065|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
161198812|NCT01023815|582109062|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
161198813|NCT01023815|582109063|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
161198814|NCT01023815|582109064|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
161198815|NCT01023815|582109065|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
161198816|NCT01023815|582109062|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
161198817|NCT01023815|582109063|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
161198818|NCT01023815|582109064|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
161198819|NCT01023815|582109065|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
161198820|NCT01023815|582109062|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
161198821|NCT01023815|582109063|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
161198822|NCT01023815|582109064|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
161198823|NCT01023815|582109065|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
161198824|NCT01023815|582109062|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161198825|NCT01023815|582109063|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
161198826|NCT01023815|582109064|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161198827|NCT01023815|582109065|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
161198828|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
161198829|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
161198830|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
161198831|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
161198832|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
161198833|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Death|1|||
161198834|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Death|0|||
161198835|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Death|0|||
161198836|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Death|0|||
161198837|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Death|0|||
161198838|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
161198839|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
161198840|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
161198841|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
161198842|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
161198843|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
161198844|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
161198845|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
161198846|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
161090842|NCT03992846|581721777|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
161307343|NCT04442269|582505352|FG001|Overall Study|Withdrawal by Subject|2|||
161307344|NCT04442269|582505351|FG000|Overall Study|Protocol Deviation|0|||
161307345|NCT04442269|582505352|FG001|Overall Study|Protocol Deviation|1|||
161307346|NCT04442269|582505351|FG000|Overall Study|Travel Limitations|1|||
161307347|NCT04442269|582505352|FG001|Overall Study|Travel Limitations|1|||
161307348|NCT00430352|582505356|FG000|Overall Study|Disease progression|58|||
161307349|NCT00430352|582505356|FG000|Overall Study|Withdrawal by Subject|11|||
161307350|NCT00430352|582505356|FG000|Overall Study|Adverse Event|16|||
161307351|NCT00430352|582505356|FG000|Overall Study|Death|5|||
161307352|NCT00430352|582505356|FG000|Overall Study|Other|48|||
161307353|NCT03099694|582505357|FG000|Overall Study|Withdrawal by Subject|11|||
161307354|NCT03099694|582505358|FG001|Overall Study|Withdrawal by Subject|13|||
161307355|NCT03099694|582505357|FG000|Overall Study|Lost to Follow-up|9|||
161307356|NCT03099694|582505358|FG001|Overall Study|Lost to Follow-up|5|||
161307357|NCT04326439|582505359|FG000|Overall Study|Withdrawal by Subject|1|||
161307358|NCT04326439|582505360|FG001|Overall Study|Withdrawal by Subject|0|||
161307359|NCT04326439|582505359|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
161307360|NCT04326439|582505360|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
161307361|NCT04326439|582505359|FG000|Overall Study|Relapse after Induction 2|0|||
161307362|NCT04326439|582505360|FG001|Overall Study|Relapse after Induction 2|1|||
161307363|NCT04326439|582505359|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
161307364|NCT04326439|582505360|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
161307365|NCT01931956|582505362|FG000|Overall Study|Death|42|||
161307366|NCT01931956|582505363|FG001|Overall Study|Death|7|||
161307367|NCT01931956|582505364|FG002|Overall Study|Death|379|||
161307368|NCT01931956|582505365|FG003|Overall Study|Death|96|||
161307369|NCT01931956|582505362|FG000|Overall Study|Withdrawal by Subject|5|||
161307370|NCT01931956|582505363|FG001|Overall Study|Withdrawal by Subject|0|||
161307371|NCT01931956|582505364|FG002|Overall Study|Withdrawal by Subject|70|||
161307372|NCT01931956|582505365|FG003|Overall Study|Withdrawal by Subject|30|||
161307373|NCT01931956|582505362|FG000|Overall Study|Lost to Follow-up|2|||
161307374|NCT01931956|582505363|FG001|Overall Study|Lost to Follow-up|0|||
161307375|NCT01931956|582505364|FG002|Overall Study|Lost to Follow-up|11|||
161307376|NCT01931956|582505365|FG003|Overall Study|Lost to Follow-up|7|||
161307377|NCT01931956|582505362|FG000|Overall Study|Expected|2|||
161307378|NCT01931956|582505363|FG001|Overall Study|Expected|0|||
161307379|NCT01931956|582505364|FG002|Overall Study|Expected|6|||
161307380|NCT01931956|582505365|FG003|Overall Study|Expected|0|||
161307381|NCT01931956|582505362|FG000|Overall Study|Not due|0|||
161307382|NCT01931956|582505363|FG001|Overall Study|Not due|0|||
161307383|NCT01931956|582505364|FG002|Overall Study|Not due|21|||
161307384|NCT01931956|582505365|FG003|Overall Study|Not due|0|||
161307385|NCT02294175|582505366|FG000|Overall Study|Withdrawal by Subject|1|||
161307386|NCT02294175|582505367|FG001|Overall Study|Withdrawal by Subject|2|||
161307387|NCT02294175|582505366|FG000|Overall Study|pt taking excluded medication|3|||
161307388|NCT02294175|582505367|FG001|Overall Study|pt taking excluded medication|1|||
161307389|NCT02294175|582505366|FG000|Overall Study|Protocol Violation|1|||
161307390|NCT02294175|582505367|FG001|Overall Study|Protocol Violation|0|||
161307391|NCT02294175|582505366|FG000|Overall Study|Lost to Follow-up|0|||
161307392|NCT02294175|582505367|FG001|Overall Study|Lost to Follow-up|1|||
161307393|NCT02294175|582505366|FG000|Overall Study|wound healed|0|||
161307394|NCT02294175|582505367|FG001|Overall Study|wound healed|2|||
161307395|NCT01901653|582505368|FG000|Overall Study|Death|2|||
161307396|NCT01901653|582505369|FG001|Overall Study|Death|1|||
161307397|NCT01901653|582505370|FG002|Overall Study|Death|8|||
161307398|NCT01901653|582505371|FG003|Overall Study|Death|3|||
161307399|NCT01901653|582505372|FG004|Overall Study|Death|2|||
161307400|NCT01901653|582505373|FG005|Overall Study|Death|2|||
161307401|NCT01901653|582505374|FG006|Overall Study|Death|6|||
161307402|NCT01901653|582505375|FG007|Overall Study|Death|9|||
161307403|NCT01901653|582505376|FG008|Overall Study|Death|1|||
161307404|NCT01901653|582505377|FG009|Overall Study|Death|16|||
161307405|NCT01901653|582505378|FG010|Overall Study|Death|2|||
161307406|NCT01901653|582505379|FG011|Overall Study|Death|15|||
161307407|NCT01901653|582505380|FG012|Overall Study|Death|4|||
161307408|NCT01901653|582505368|FG000|Overall Study|Lost to Follow-up|1|||
161307409|NCT01901653|582505369|FG001|Overall Study|Lost to Follow-up|0|||
161307410|NCT01901653|582505370|FG002|Overall Study|Lost to Follow-up|2|||
161307411|NCT01901653|582505371|FG003|Overall Study|Lost to Follow-up|0|||
161307412|NCT01901653|582505372|FG004|Overall Study|Lost to Follow-up|0|||
161307413|NCT01901653|582505373|FG005|Overall Study|Lost to Follow-up|1|||
161307414|NCT01901653|582505374|FG006|Overall Study|Lost to Follow-up|0|||
161307415|NCT01901653|582505375|FG007|Overall Study|Lost to Follow-up|1|||
161307416|NCT01901653|582505376|FG008|Overall Study|Lost to Follow-up|0|||
161307417|NCT01901653|582505377|FG009|Overall Study|Lost to Follow-up|0|||
161307418|NCT01901653|582505378|FG010|Overall Study|Lost to Follow-up|0|||
161307419|NCT01901653|582505379|FG011|Overall Study|Lost to Follow-up|0|||
161307420|NCT01901653|582505380|FG012|Overall Study|Lost to Follow-up|0|||
161307421|NCT01901653|582505368|FG000|Overall Study|Withdrawal by Subject|0|||
161307422|NCT01901653|582505369|FG001|Overall Study|Withdrawal by Subject|0|||
161307423|NCT01901653|582505370|FG002|Overall Study|Withdrawal by Subject|0|||
161307424|NCT01901653|582505371|FG003|Overall Study|Withdrawal by Subject|0|||
161307425|NCT01901653|582505372|FG004|Overall Study|Withdrawal by Subject|0|||
161307426|NCT01901653|582505373|FG005|Overall Study|Withdrawal by Subject|0|||
161307427|NCT01901653|582505374|FG006|Overall Study|Withdrawal by Subject|1|||
161307428|NCT01901653|582505375|FG007|Overall Study|Withdrawal by Subject|0|||
161307429|NCT01901653|582505376|FG008|Overall Study|Withdrawal by Subject|0|||
161307430|NCT01901653|582505377|FG009|Overall Study|Withdrawal by Subject|0|||
161307431|NCT01901653|582505378|FG010|Overall Study|Withdrawal by Subject|0|||
161307432|NCT01901653|582505379|FG011|Overall Study|Withdrawal by Subject|0|||
161307433|NCT01901653|582505380|FG012|Overall Study|Withdrawal by Subject|0|||
161307434|NCT01901653|582505368|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
161307435|NCT01901653|582505369|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
161307436|NCT01901653|582505370|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
161307437|NCT01901653|582505371|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
161307438|NCT01901653|582505372|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
161307439|NCT01901653|582505373|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
161307440|NCT01901653|582505374|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
161307441|NCT01901653|582505375|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
161307442|NCT01901653|582505376|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
161307443|NCT01901653|582505377|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
161307444|NCT01901653|582505378|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
161307445|NCT01901653|582505379|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
161307446|NCT01901653|582505380|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
161307447|NCT02548351|582505381|FG000|Overall Study|Withdrawal by Subject|149|||
161307448|NCT02548351|582505382|FG001|Overall Study|Withdrawal by Subject|154|||
161307449|NCT02548351|582505383|FG002|Overall Study|Withdrawal by Subject|152|||
161307450|NCT02548351|582505381|FG000|Overall Study|Death|11|||
161307451|NCT02548351|582505382|FG001|Overall Study|Death|15|||
161307452|NCT02548351|582505383|FG002|Overall Study|Death|12|||
161307453|NCT02548351|582505381|FG000|Overall Study|Adverse Event|22|||
161307454|NCT02548351|582505382|FG001|Overall Study|Adverse Event|56|||
161307455|NCT02548351|582505383|FG002|Overall Study|Adverse Event|36|||
161307456|NCT02548351|582505381|FG000|Overall Study|Study Terminated by Sponsor|549|||
161307457|NCT02548351|582505382|FG001|Overall Study|Study Terminated by Sponsor|509|||
161307458|NCT02548351|582505383|FG002|Overall Study|Study Terminated by Sponsor|528|||
161307459|NCT02548351|582505381|FG000|Overall Study|Site Closure|14|||
161307460|NCT02548351|582505382|FG001|Overall Study|Site Closure|5|||
161307461|NCT02548351|582505383|FG002|Overall Study|Site Closure|7|||
161307462|NCT02548351|582505381|FG000|Overall Study|Non-compliance with Study Drug|4|||
161307463|NCT02548351|582505382|FG001|Overall Study|Non-compliance with Study Drug|2|||
161307464|NCT02548351|582505383|FG002|Overall Study|Non-compliance with Study Drug|0|||
161307465|NCT02548351|582505381|FG000|Overall Study|Protocol Violation|2|||
161307466|NCT02548351|582505382|FG001|Overall Study|Protocol Violation|1|||
161307467|NCT02548351|582505383|FG002|Overall Study|Protocol Violation|2|||
161307468|NCT02548351|582505381|FG000|Overall Study|Physician Decision|11|||
161307469|NCT02548351|582505382|FG001|Overall Study|Physician Decision|18|||
161307470|NCT02548351|582505383|FG002|Overall Study|Physician Decision|11|||
161307471|NCT02548351|582505381|FG000|Overall Study|Lost to Follow-up|43|||
161307472|NCT02548351|582505382|FG001|Overall Study|Lost to Follow-up|50|||
161307473|NCT02548351|582505383|FG002|Overall Study|Lost to Follow-up|57|||
161307474|NCT02548351|582505381|FG000|Overall Study|Other|19|||
161307475|NCT02548351|582505382|FG001|Overall Study|Other|16|||
161307476|NCT02548351|582505383|FG002|Overall Study|Other|20|||
161307477|NCT02548351|582505381|FG000|Overall Study|Missing|1|||
161307478|NCT02548351|582505382|FG001|Overall Study|Missing|1|||
161307479|NCT02548351|582505383|FG002|Overall Study|Missing|0|||
161307480|NCT02805660|582505384|FG000|Overall Study|Death|5|||
161307481|NCT02805660|582505385|FG001|Overall Study|Death|2|||
161307482|NCT02805660|582505386|FG002|Overall Study|Death|9|||
161307483|NCT02805660|582505387|FG003|Overall Study|Death|5|||
161307484|NCT02805660|582505388|FG004|Overall Study|Death|0|||
161307485|NCT02805660|582505389|FG005|Overall Study|Death|14|||
161307486|NCT02805660|582505390|FG006|Overall Study|Death|12|||
161307487|NCT02805660|582505384|FG000|Overall Study|Lost to Follow-up|0|||
161307488|NCT02805660|582505385|FG001|Overall Study|Lost to Follow-up|1|||
161307489|NCT02805660|582505386|FG002|Overall Study|Lost to Follow-up|1|||
161307490|NCT02805660|582505387|FG003|Overall Study|Lost to Follow-up|2|||
161307491|NCT02805660|582505388|FG004|Overall Study|Lost to Follow-up|0|||
161307492|NCT02805660|582505389|FG005|Overall Study|Lost to Follow-up|0|||
161307493|NCT02805660|582505390|FG006|Overall Study|Lost to Follow-up|0|||
161307494|NCT02805660|582505384|FG000|Overall Study|Withdrawal by Subject|0|||
161307495|NCT02805660|582505385|FG001|Overall Study|Withdrawal by Subject|0|||
161307496|NCT02805660|582505386|FG002|Overall Study|Withdrawal by Subject|0|||
161307497|NCT02805660|582505387|FG003|Overall Study|Withdrawal by Subject|3|||
161307498|NCT02805660|582505388|FG004|Overall Study|Withdrawal by Subject|1|||
161307499|NCT02805660|582505389|FG005|Overall Study|Withdrawal by Subject|0|||
161198847|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
161198848|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161198849|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
161198850|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
161198851|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161198852|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
161198853|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161198854|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
161198855|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
161198856|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161198857|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
161198858|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
161198859|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
161198860|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161198861|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161198862|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
161198863|NCT00634933|582109068|FG000|Part A: Baseline to Week 24|Other|1|||
161198864|NCT00634933|582109069|FG001|Part A: Baseline to Week 24|Other|8|||
161198865|NCT00634933|582109070|FG002|Part A: Baseline to Week 24|Other|5|||
161198866|NCT00634933|582109071|FG003|Part A: Baseline to Week 24|Other|0|||
161198867|NCT00634933|582109072|FG004|Part A: Baseline to Week 24|Other|0|||
161198868|NCT00634933|582109068|FG000|Between Part A and Part B|Physician Decision|0|||
161198869|NCT00634933|582109069|FG001|Between Part A and Part B|Physician Decision|1|||
161198870|NCT00634933|582109070|FG002|Between Part A and Part B|Physician Decision|0|||
161198871|NCT00634933|582109071|FG003|Between Part A and Part B|Physician Decision|0|||
161198872|NCT00634933|582109072|FG004|Between Part A and Part B|Physician Decision|0|||
161198873|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
161198874|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
161198875|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
161198876|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
161198877|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
161198878|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
161198879|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
161198880|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
161198881|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
161307500|NCT02805660|582505390|FG006|Overall Study|Withdrawal by Subject|2|||
161307501|NCT02805660|582505384|FG000|Overall Study|Study terminated by Sponsor|0|||
161307502|NCT02805660|582505385|FG001|Overall Study|Study terminated by Sponsor|0|||
161307503|NCT02805660|582505386|FG002|Overall Study|Study terminated by Sponsor|1|||
161307504|NCT02805660|582505387|FG003|Overall Study|Study terminated by Sponsor|4|||
161307505|NCT02805660|582505388|FG004|Overall Study|Study terminated by Sponsor|2|||
161307506|NCT02805660|582505389|FG005|Overall Study|Study terminated by Sponsor|3|||
161307507|NCT02805660|582505390|FG006|Overall Study|Study terminated by Sponsor|1|||
161307508|NCT02805660|582505384|FG000|Overall Study|Miscellaneous|0|||
161307509|NCT02805660|582505385|FG001|Overall Study|Miscellaneous|1|||
161307510|NCT02805660|582505386|FG002|Overall Study|Miscellaneous|0|||
161307511|NCT02805660|582505387|FG003|Overall Study|Miscellaneous|4|||
161307512|NCT02805660|582505388|FG004|Overall Study|Miscellaneous|0|||
161307513|NCT02805660|582505389|FG005|Overall Study|Miscellaneous|6|||
161307514|NCT02805660|582505390|FG006|Overall Study|Miscellaneous|4|||
161307515|NCT02572076|582505391|FG000|Overall Study|Protocol Violation|1|||
161307516|NCT03055494|582507098|FG000|Overall Study|Lost to Follow-up|6|||
161307517|NCT03055494|582507099|FG001|Overall Study|Lost to Follow-up|0|||
161307518|NCT03055494|582507098|FG000|Overall Study|Physician Decision|2|||
161307519|NCT03055494|582507099|FG001|Overall Study|Physician Decision|0|||
161307520|NCT03055494|582507098|FG000|Overall Study|Withdrawal by Subject|1|||
161307521|NCT03055494|582507099|FG001|Overall Study|Withdrawal by Subject|0|||
161307522|NCT03055494|582507098|FG000|Overall Study|Adverse Event|0|||
161307523|NCT03055494|582507099|FG001|Overall Study|Adverse Event|1|||
161307524|NCT03055494|582507098|FG000|Overall Study|Non-compliance with study treatment|1|||
161307525|NCT03055494|582507099|FG001|Overall Study|Non-compliance with study treatment|0|||
161307526|NCT00197002|582507100|FG000|Overall Study|Adverse Event|0|||
161307527|NCT00197002|582507101|FG001|Overall Study|Adverse Event|1|||
161307528|NCT00197002|582507102|FG002|Overall Study|Adverse Event|0|||
161307529|NCT00197002|582507100|FG000|Overall Study|Protocol Violation|1|||
161307530|NCT00197002|582507101|FG001|Overall Study|Protocol Violation|0|||
161307531|NCT00197002|582507102|FG002|Overall Study|Protocol Violation|2|||
161307532|NCT00197002|582507100|FG000|Overall Study|Withdrawal by Subject|9|||
161307533|NCT00197002|582507101|FG001|Overall Study|Withdrawal by Subject|5|||
161307534|NCT00197002|582507102|FG002|Overall Study|Withdrawal by Subject|7|||
161307535|NCT00197002|582507100|FG000|Overall Study|Migrated/moved from study area|3|||
161307536|NCT00197002|582507101|FG001|Overall Study|Migrated/moved from study area|5|||
161307537|NCT00197002|582507102|FG002|Overall Study|Migrated/moved from study area|1|||
161198882|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
161198883|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
161198884|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
161198885|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
161198886|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
161198887|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
161198888|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
161198889|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
161198890|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
161198891|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
161198892|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
161198893|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161307538|NCT00197002|582507100|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
161307539|NCT00197002|582507101|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
161307540|NCT00197002|582507102|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
161307541|NCT00197002|582507100|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
161307542|NCT00197002|582507101|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
161307543|NCT00197002|582507102|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
161307544|NCT00197002|582507100|FG000|Overall Study|Others|3|||
161307545|NCT00197002|582507101|FG001|Overall Study|Others|1|||
161307546|NCT00197002|582507102|FG002|Overall Study|Others|1|||
161307547|NCT02515994|582507103|FG000|Overall Study|Protocol Violation|3|||
161307548|NCT02515994|582507104|FG001|Overall Study|Protocol Violation|5|||
161307549|NCT02515994|582507103|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
161307550|NCT02515994|582507104|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
161307551|NCT02515994|582507103|FG000|Overall Study|Adverse Event|3|||
161307552|NCT02515994|582507104|FG001|Overall Study|Adverse Event|1|||
161307553|NCT02515994|582507103|FG000|Overall Study|Withdrawal by Subject|2|||
161307554|NCT02515994|582507104|FG001|Overall Study|Withdrawal by Subject|0|||
161307555|NCT01424514|582507105|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
161307556|NCT01424514|582507106|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
161307557|NCT01424514|582507105|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
161307558|NCT01424514|582507106|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
161307559|NCT04598451|582507107|FG000|Overall Study|Adverse Event|3|||
161307560|NCT04598451|582507108|FG001|Overall Study|Adverse Event|2|||
161307561|NCT04598451|582507107|FG000|Overall Study|Withdrawal by Subject|3|||
161307562|NCT04598451|582507108|FG001|Overall Study|Withdrawal by Subject|7|||
161307563|NCT04598451|582507107|FG000|Overall Study|Lost to Follow-up|2|||
161307564|NCT04598451|582507108|FG001|Overall Study|Lost to Follow-up|0|||
161307565|NCT04598451|582507107|FG000|Overall Study|Physician Decision|4|||
161307566|NCT04598451|582507108|FG001|Overall Study|Physician Decision|1|||
161307567|NCT04598451|582507107|FG000|Overall Study|Requires Prohibited Medication|1|||
161307568|NCT04598451|582507108|FG001|Overall Study|Requires Prohibited Medication|0|||
161307569|NCT04598451|582507107|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
161307570|NCT04598451|582507108|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
161307571|NCT02653170|582507109|FG000|Overall Study|Withdrawal by Subject|3|||
161307572|NCT02653170|582507110|FG001|Overall Study|Withdrawal by Subject|8|||
161307573|NCT02653170|582507111|FG002|Overall Study|Withdrawal by Subject|3|||
161307574|NCT02653170|582507109|FG000|Overall Study|withdrawn by study team|2|||
161307575|NCT02653170|582507110|FG001|Overall Study|withdrawn by study team|4|||
161307576|NCT02653170|582507111|FG002|Overall Study|withdrawn by study team|5|||
161307577|NCT02653170|582507109|FG000|Overall Study|Lost to Follow-up|12|||
161307578|NCT02653170|582507110|FG001|Overall Study|Lost to Follow-up|4|||
161307579|NCT02653170|582507111|FG002|Overall Study|Lost to Follow-up|10|||
161307580|NCT01632150|582507112|FG000|Overall Study|Disease progression|27|||
161307581|NCT01632150|582507112|FG000|Overall Study|Study drug toxicity|1|||
161307582|NCT01632150|582507112|FG000|Overall Study|Unrelated adverse event|7|||
161307583|NCT01632150|582507112|FG000|Overall Study|Withdrawal by Subject|2|||
161307584|NCT01632150|582507112|FG000|Overall Study|Patient underwent autologous transplant|1|||
161307585|NCT01632150|582507112|FG000|Overall Study|Moved to compassionate program|2|||
161307586|NCT02879994|582507115|FG000|Overall Study|off treatment early|7|||
161307587|NCT02879994|582507115|FG000|Overall Study|Adverse Event|2|||
161307588|NCT02879994|582507115|FG000|Overall Study|Death|2|||
161307589|NCT02143791|582507116|FG000|Enrolled|Withdrawal by Subject|4|||
161307590|NCT02143791|582507116|FG000|Trial Stimulation|Lack of Efficacy|21|||
161307591|NCT02143791|582507116|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
161307592|NCT02143791|582507116|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
161307593|NCT02143791|582507116|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
161307594|NCT02143791|582507116|FG000|Any Programming (3-6 Months)|Missing Data|1|||
161307595|NCT02143791|582507116|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
161307596|NCT04984681|582507121|FG000|Overall Study|Lost to Follow-up|3|||
161307597|NCT04984681|582507122|FG001|Overall Study|Lost to Follow-up|1|||
161307598|NCT04327661|582507123|FG000|Overall Study|Withdrawal by Subject|1|||
161307599|NCT04327661|582507124|FG001|Overall Study|Withdrawal by Subject|0|||
161307600|NCT04327661|582507125|FG002|Overall Study|Withdrawal by Subject|0|||
161307601|NCT03391232|582507126|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
161307602|NCT03391232|582507127|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
161307603|NCT03391232|582507126|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
161307604|NCT03391232|582507127|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
161307605|NCT02091960|582507128|FG000|Overall Study|Death|7|||
161307606|NCT02091960|582507128|FG000|Overall Study|Withdrawal by Subject|1|||
161307607|NCT02091960|582507128|FG000|Overall Study|Miscellaneous Reasons|37|||
161307608|NCT02637895|582507139|FG000|Overall Study|Lost to Follow-up|4|||
161307609|NCT02637895|582507140|FG001|Overall Study|Lost to Follow-up|0|||
161307610|NCT02637895|582507139|FG000|Overall Study|Protocol Violation|0|||
161307611|NCT02637895|582507140|FG001|Overall Study|Protocol Violation|1|||
161307612|NCT02637895|582507139|FG000|Overall Study|Lack of Efficacy|1|||
161307613|NCT02637895|582507140|FG001|Overall Study|Lack of Efficacy|0|||
161307614|NCT02637895|582507139|FG000|Overall Study|Withdrawal by Subject|1|||
161307615|NCT02637895|582507140|FG001|Overall Study|Withdrawal by Subject|1|||
161307616|NCT02637895|582507139|FG000|Overall Study|Abnormal baseline lab|0|||
161307617|NCT02637895|582507140|FG001|Overall Study|Abnormal baseline lab|1|||
161307618|NCT00984061|582507143|FG000|Clarithromycin Alone|Protocol Violation|1|||
161307619|NCT05139303|582507144|FG000|Overall Study|Lost to Follow-up|3|||
161307620|NCT05139303|582507145|FG001|Overall Study|Lost to Follow-up|0|||
161307621|NCT05139303|582507144|FG000|Overall Study|Adverse Event|1|||
161307622|NCT05139303|582507145|FG001|Overall Study|Adverse Event|0|||
161307623|NCT00761280|582507146|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
161307624|NCT00761280|582507147|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
161307625|NCT00761280|582507146|FG000|Randomization to First Dose|Sponsor decision|1|||
161307626|NCT00761280|582507147|FG001|Randomization to First Dose|Sponsor decision|0|||
161307627|NCT00761280|582507146|FG000|Randomization to First Dose|Other|1|||
161307628|NCT00761280|582507147|FG001|Randomization to First Dose|Other|0|||
161307629|NCT00761280|582507146|FG000|First Dose to End of Study|End of trial|5|||
161307630|NCT00761280|582507147|FG001|First Dose to End of Study|End of trial|5|||
161307631|NCT00761280|582507146|FG000|First Dose to End of Study|Progressive disease|5|||
161307632|NCT00761280|582507147|FG001|First Dose to End of Study|Progressive disease|3|||
161307633|NCT00761280|582507146|FG000|First Dose to End of Study|Sponsor decision|1|||
161307634|NCT00761280|582507147|FG001|First Dose to End of Study|Sponsor decision|2|||
161307635|NCT00761280|582507146|FG000|First Dose to End of Study|Death|1|||
161307636|NCT00761280|582507147|FG001|First Dose to End of Study|Death|0|||
161307637|NCT00761280|582507146|FG000|First Dose to End of Study|Lost to Follow-up|0|||
161307638|NCT00761280|582507147|FG001|First Dose to End of Study|Lost to Follow-up|1|||
161307639|NCT03875482|582507151|FG000|Overall Study|Adverse Event|0|||
161307640|NCT03875482|582507152|FG001|Overall Study|Adverse Event|1|||
161307641|NCT03875482|582507151|FG000|Overall Study|Withdrew consent|5|||
161307642|NCT03875482|582507152|FG001|Overall Study|Withdrew consent|6|||
161307643|NCT03875482|582507151|FG000|Overall Study|Lost to Follow-up|8|||
161307644|NCT03875482|582507152|FG001|Overall Study|Lost to Follow-up|2|||
161307645|NCT03875482|582507151|FG000|Overall Study|Lack of Efficacy|0|||
161307646|NCT03875482|582507152|FG001|Overall Study|Lack of Efficacy|11|||
161307647|NCT04777201|582507153|FG000|Main Study|Withdrawal by Subject|19|||
161307648|NCT04777201|582507154|FG001|Main Study|Withdrawal by Subject|27|||
161307649|NCT04777201|582507155|FG002|Main Study|Withdrawal by Subject|0|||
161307650|NCT04777201|582507153|FG000|Main Study|Death|13|||
161307651|NCT04777201|582507154|FG001|Main Study|Death|27|||
161307652|NCT04777201|582507155|FG002|Main Study|Death|0|||
161307653|NCT04777201|582507153|FG000|Main Study|Subject missed the safety follow-up visit|9|||
161307654|NCT04777201|582507154|FG001|Main Study|Subject missed the safety follow-up visit|10|||
161307655|NCT04777201|582507155|FG002|Main Study|Subject missed the safety follow-up visit|0|||
161307656|NCT04777201|582507153|FG000|Main Study|Physician Decision|8|||
161307657|NCT04777201|582507154|FG001|Main Study|Physician Decision|10|||
161307658|NCT04777201|582507155|FG002|Main Study|Physician Decision|0|||
161307659|NCT04777201|582507153|FG000|Main Study|Adverse Event|8|||
161307660|NCT04777201|582507154|FG001|Main Study|Adverse Event|8|||
161307661|NCT04777201|582507155|FG002|Main Study|Adverse Event|0|||
161307662|NCT04777201|582507153|FG000|Main Study|Lost to Follow-up|9|||
161307663|NCT04777201|582507154|FG001|Main Study|Lost to Follow-up|4|||
161307664|NCT04777201|582507155|FG002|Main Study|Lost to Follow-up|0|||
161307665|NCT04777201|582507153|FG000|Main Study|Reason not specified|3|||
161307666|NCT04777201|582507154|FG001|Main Study|Reason not specified|3|||
161307667|NCT04777201|582507155|FG002|Main Study|Reason not specified|0|||
161307668|NCT04777201|582507153|FG000|Main Study|Lack of Efficacy|1|||
161307669|NCT04777201|582507154|FG001|Main Study|Lack of Efficacy|1|||
161307670|NCT04777201|582507155|FG002|Main Study|Lack of Efficacy|0|||
161307671|NCT04777201|582507153|FG000|Main Study|Protocol Violation|1|||
161307672|NCT04777201|582507154|FG001|Main Study|Protocol Violation|0|||
161307673|NCT04777201|582507155|FG002|Main Study|Protocol Violation|0|||
161307674|NCT04777201|582507153|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
161307675|NCT04777201|582507154|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
161307676|NCT04777201|582507155|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
161307677|NCT04777201|582507153|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
161307678|NCT04777201|582507154|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
161307679|NCT04777201|582507155|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
161307680|NCT04777201|582507153|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
161307681|NCT04777201|582507154|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
161307682|NCT04777201|582507155|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
161307683|NCT04777201|582507153|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
161307684|NCT04777201|582507154|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
161307685|NCT04777201|582507155|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
161307686|NCT04777201|582507153|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
161307687|NCT04777201|582507154|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
161307688|NCT04777201|582507155|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
161307689|NCT04777201|582507153|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
161307690|NCT04777201|582507154|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
161307691|NCT04777201|582507155|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
161307692|NCT00507819|582507158|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
161307693|NCT00507819|582507159|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
161307694|NCT02256982|582507162|FG000|Overall Study|Disease Progression|0|||
161307695|NCT02256982|582507163|FG001|Overall Study|Disease Progression|1|||
161307696|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Adverse Event|6|||
161307697|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Adverse Event|14|||
161307698|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Death|3|||
161307699|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Death|1|||
161307700|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
161307701|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
161307702|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
161307703|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
161307704|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
161307705|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
161307706|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
161307707|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
161307708|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
161307709|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
161307710|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Physician Decision|2|||
161307711|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Physician Decision|4|||
161307712|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Pregnancy|2|||
161307713|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Pregnancy|1|||
161307714|NCT02275780|582507164|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
161307715|NCT02275780|582507165|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
161307716|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
161307717|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
161307718|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
161307719|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
161307720|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
161307721|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
161307722|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
161307723|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
161307724|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
161307725|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
161307726|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
161307727|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
161307728|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
161307729|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
161307730|NCT02275780|582507164|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
161307731|NCT02275780|582507165|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
161307732|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
161307733|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
161307734|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
161307735|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
161307736|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
161307737|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
161307738|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
161307739|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
161307740|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
161307741|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
161307742|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
161198894|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161198895|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
161198896|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
161198897|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
161198898|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161198899|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
161198900|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
161307743|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
161307744|NCT02275780|582507164|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
161307745|NCT02275780|582507165|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
161307746|NCT02275780|582507164|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
161307747|NCT02275780|582507165|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
161307748|NCT02275780|582507164|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
161307749|NCT02275780|582507165|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
161307750|NCT02275780|582507164|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
161307751|NCT02275780|582507165|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
161307752|NCT02275780|582507164|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
161307753|NCT02275780|582507165|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
161307754|NCT02275780|582507164|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
161307755|NCT02275780|582507165|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
161307756|NCT02275780|582507164|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
161307757|NCT02275780|582507165|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
161307758|NCT01054300|582507172|FG000|Period 1|Adverse Event|1|||
161307759|NCT01054300|582507173|FG001|Period 1|Adverse Event|0|||
161307760|NCT01054300|582507174|FG002|Period 1|Adverse Event|0|||
161307761|NCT01054300|582507175|FG003|Period 1|Adverse Event|0|||
161307762|NCT01054300|582507172|FG000|Period 2|Withdrawal by Subject|0|||
161307763|NCT01054300|582507173|FG001|Period 2|Withdrawal by Subject|0|||
161307764|NCT01054300|582507174|FG002|Period 2|Withdrawal by Subject|1|||
161307765|NCT01054300|582507175|FG003|Period 2|Withdrawal by Subject|0|||
161307766|NCT01899742|582507178|FG000|Overall Study|Adverse Event|5|||
161307767|NCT01899742|582507179|FG001|Overall Study|Adverse Event|4|||
161307768|NCT01899742|582507178|FG000|Overall Study|Lack of Efficacy|1|||
161307769|NCT01899742|582507179|FG001|Overall Study|Lack of Efficacy|5|||
161307770|NCT01899742|582507178|FG000|Overall Study|Protocol Violation|2|||
161307771|NCT01899742|582507179|FG001|Overall Study|Protocol Violation|2|||
161307772|NCT01899742|582507178|FG000|Overall Study|Withdrawal by Subject|9|||
161307773|NCT01899742|582507179|FG001|Overall Study|Withdrawal by Subject|5|||
161307774|NCT00738881|582507183|FG000|Overall Study|Withdrawal by Subject|0|||
161307775|NCT00738881|582507184|FG001|Overall Study|Withdrawal by Subject|2|||
161307776|NCT02662764|582507185|FG000|Overall Study|Adverse Event|6|||
161307777|NCT02662764|582507185|FG000|Overall Study|Lack of Efficacy|8|||
161307778|NCT02662764|582507185|FG000|Overall Study|Protocol Violation|1|||
161307779|NCT02662764|582507185|FG000|Overall Study|Withdrawal by Subject|5|||
161307780|NCT02662764|582507185|FG000|Overall Study|Device failure|4|||
161198901|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161198902|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
161198903|NCT00634933|582109068|FG000|Part B: Week 24 to Week 52|Other|0|||
161307781|NCT02662764|582507185|FG000|Overall Study|Patient changed treatment|1|||
161307782|NCT02662764|582507185|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
161307783|NCT00177307|582507187|FG000|Overall Study|Withdrawal by Subject|1|||
161307784|NCT01282164|582507190|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
161307785|NCT01282164|582507191|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
161307786|NCT03671564|582507192|FG000|Overall Study|Progressive Disease|3|||
161307787|NCT03671564|582507193|FG001|Overall Study|Progressive Disease|5|||
161307788|NCT03671564|582507194|FG002|Overall Study|Progressive Disease|3|||
161307789|NCT03671564|582507192|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
161307790|NCT03671564|582507193|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
161307791|NCT03671564|582507194|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
161307792|NCT03671564|582507192|FG000|Overall Study|Withdrawal by Subject|1|||
161307793|NCT03671564|582507193|FG001|Overall Study|Withdrawal by Subject|1|||
161307794|NCT03671564|582507194|FG002|Overall Study|Withdrawal by Subject|0|||
161307795|NCT04521621|582507195|FG000|Overall Study|Death|17|||
161307796|NCT04521621|582507196|FG001|Overall Study|Death|8|||
161307797|NCT04521621|582507197|FG002|Overall Study|Death|8|||
161307798|NCT04521621|582507198|FG003|Overall Study|Death|5|||
161307799|NCT04521621|582507199|FG004|Overall Study|Death|2|||
161307800|NCT04521621|582507200|FG005|Overall Study|Death|7|||
161307801|NCT04521621|582507201|FG006|Overall Study|Death|0|||
161307802|NCT04521621|582507202|FG007|Overall Study|Death|0|||
161307803|NCT04521621|582507195|FG000|Overall Study|Study Terminated by Sponsor|4|||
161307804|NCT04521621|582507196|FG001|Overall Study|Study Terminated by Sponsor|6|||
161307805|NCT04521621|582507197|FG002|Overall Study|Study Terminated by Sponsor|8|||
161307806|NCT04521621|582507198|FG003|Overall Study|Study Terminated by Sponsor|0|||
161307807|NCT04521621|582507199|FG004|Overall Study|Study Terminated by Sponsor|1|||
161307808|NCT04521621|582507200|FG005|Overall Study|Study Terminated by Sponsor|7|||
161307809|NCT04521621|582507201|FG006|Overall Study|Study Terminated by Sponsor|0|||
161307810|NCT04521621|582507202|FG007|Overall Study|Study Terminated by Sponsor|0|||
161307811|NCT04521621|582507195|FG000|Overall Study|Withdrawal by Subject|0|||
161307812|NCT04521621|582507196|FG001|Overall Study|Withdrawal by Subject|0|||
161307813|NCT04521621|582507197|FG002|Overall Study|Withdrawal by Subject|1|||
161307814|NCT04521621|582507198|FG003|Overall Study|Withdrawal by Subject|1|||
161307815|NCT04521621|582507199|FG004|Overall Study|Withdrawal by Subject|0|||
161307816|NCT04521621|582507200|FG005|Overall Study|Withdrawal by Subject|0|||
161307817|NCT04521621|582507201|FG006|Overall Study|Withdrawal by Subject|0|||
161307818|NCT04521621|582507202|FG007|Overall Study|Withdrawal by Subject|0|||
161307819|NCT04521621|582507195|FG000|Overall Study|Allocated in error without study intervention|1|||
161307820|NCT04521621|582507196|FG001|Overall Study|Allocated in error without study intervention|0|||
161307821|NCT04521621|582507197|FG002|Overall Study|Allocated in error without study intervention|0|||
161307822|NCT04521621|582507198|FG003|Overall Study|Allocated in error without study intervention|0|||
161307823|NCT04521621|582507199|FG004|Overall Study|Allocated in error without study intervention|0|||
161307824|NCT04521621|582507200|FG005|Overall Study|Allocated in error without study intervention|0|||
161307825|NCT04521621|582507201|FG006|Overall Study|Allocated in error without study intervention|0|||
161307826|NCT04521621|582507202|FG007|Overall Study|Allocated in error without study intervention|0|||
161307827|NCT02541669|582507209|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161307828|NCT02541669|582507210|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161307829|NCT02541669|582507211|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161307830|NCT02541669|582507212|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
161307831|NCT02541669|582507213|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
161307832|NCT00834639|582507216|FG000|Second Intervention|Physician Decision|0|||
161307833|NCT00834639|582507217|FG001|Second Intervention|Physician Decision|2|||
161307834|NCT04739722|582507218|FG000|Overall Study|Lost to Follow-up|5301|||
161307835|NCT04739722|582507218|FG000|Overall Study|Withdrawal by Subject|42|||
161307836|NCT04739722|582507218|FG000|Overall Study|Non Average-risk|1157|||
161307837|NCT01968707|582507222|FG000|Overall Study|Did not meet treatment day baseline|49|||
161307838|NCT01968707|582507223|FG001|Overall Study|Did not meet treatment day baseline|12|||
161307839|NCT01968707|582507224|FG002|Overall Study|Did not meet treatment day baseline|41|||
161307840|NCT01968707|582507225|FG003|Overall Study|Did not meet treatment day baseline|44|||
161307841|NCT01968707|582507226|FG004|Overall Study|Did not meet treatment day baseline|36|||
161307842|NCT01968707|582507227|FG005|Overall Study|Did not meet treatment day baseline|11|||
161307843|NCT01968707|582507228|FG006|Overall Study|Did not meet treatment day baseline|34|||
161307844|NCT01968707|582507229|FG007|Overall Study|Did not meet treatment day baseline|35|||
161307845|NCT01508130|582507236|FG000|Overall Study|Adverse Event|81|||
161307846|NCT01508130|582507237|FG001|Overall Study|Adverse Event|28|||
161307847|NCT01508130|582507236|FG000|Overall Study|Death|3|||
161307848|NCT01508130|582507237|FG001|Overall Study|Death|1|||
161307849|NCT01508130|582507236|FG000|Overall Study|Protocol Violation|2|||
161307850|NCT01508130|582507237|FG001|Overall Study|Protocol Violation|0|||
161307851|NCT01508130|582507236|FG000|Overall Study|Lost to Follow-up|25|||
161307852|NCT01508130|582507237|FG001|Overall Study|Lost to Follow-up|2|||
161307853|NCT01508130|582507236|FG000|Overall Study|Withdrawal by Subject|3|||
161307854|NCT01508130|582507237|FG001|Overall Study|Withdrawal by Subject|3|||
161307855|NCT01508130|582507236|FG000|Overall Study|Subject's substantial non-compliance|25|||
161307856|NCT01508130|582507237|FG001|Overall Study|Subject's substantial non-compliance|9|||
161307857|NCT01508130|582507236|FG000|Overall Study|Insufficient therapeutic response|74|||
161307858|NCT01508130|582507237|FG001|Overall Study|Insufficient therapeutic response|23|||
161307859|NCT01508130|582507236|FG000|Overall Study|Administrative|14|||
161307860|NCT01508130|582507237|FG001|Overall Study|Administrative|3|||
161307861|NCT03403751|582507247|FG000|Overall Study|Death|5|||
161307862|NCT03403751|582507248|FG001|Overall Study|Death|6|||
161307863|NCT03403751|582507247|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
161307864|NCT03403751|582507248|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
161307865|NCT03802565|582507249|FG000|Overall Study|Adverse Event|0|||
161307866|NCT03802565|582507250|FG001|Overall Study|Adverse Event|1|||
161307867|NCT03802565|582507251|FG002|Overall Study|Adverse Event|2|||
161307868|NCT03802565|582507252|FG003|Overall Study|Adverse Event|1|||
161307869|NCT03802565|582507253|FG004|Overall Study|Adverse Event|1|||
161307870|NCT03802565|582507249|FG000|Overall Study|Withdrawal by Subject|2|||
161307871|NCT03802565|582507250|FG001|Overall Study|Withdrawal by Subject|2|||
161307872|NCT03802565|582507251|FG002|Overall Study|Withdrawal by Subject|2|||
161307873|NCT03802565|582507252|FG003|Overall Study|Withdrawal by Subject|0|||
161307874|NCT03802565|582507253|FG004|Overall Study|Withdrawal by Subject|1|||
161307875|NCT03802565|582507249|FG000|Overall Study|Protocol Violation|2|||
161307876|NCT03802565|582507250|FG001|Overall Study|Protocol Violation|1|||
161307877|NCT03802565|582507251|FG002|Overall Study|Protocol Violation|4|||
161307878|NCT03802565|582507252|FG003|Overall Study|Protocol Violation|5|||
161307879|NCT03802565|582507253|FG004|Overall Study|Protocol Violation|1|||
161307880|NCT03802565|582507249|FG000|Overall Study|Lost to Follow-up|0|||
161307881|NCT03802565|582507250|FG001|Overall Study|Lost to Follow-up|0|||
161307882|NCT03802565|582507251|FG002|Overall Study|Lost to Follow-up|1|||
161307883|NCT03802565|582507252|FG003|Overall Study|Lost to Follow-up|0|||
161307884|NCT03802565|582507253|FG004|Overall Study|Lost to Follow-up|0|||
161307885|NCT03802565|582507249|FG000|Overall Study|Subjects Related to Each Other|1|||
161307886|NCT03802565|582507250|FG001|Overall Study|Subjects Related to Each Other|0|||
161307887|NCT03802565|582507251|FG002|Overall Study|Subjects Related to Each Other|0|||
161307888|NCT03802565|582507252|FG003|Overall Study|Subjects Related to Each Other|2|||
161307889|NCT03802565|582507253|FG004|Overall Study|Subjects Related to Each Other|1|||
161307890|NCT03802565|582507249|FG000|Overall Study|Elevated Enzymes|0|||
161307891|NCT03802565|582507250|FG001|Overall Study|Elevated Enzymes|0|||
161307892|NCT03802565|582507251|FG002|Overall Study|Elevated Enzymes|0|||
161307893|NCT03802565|582507252|FG003|Overall Study|Elevated Enzymes|0|||
161307894|NCT03802565|582507253|FG004|Overall Study|Elevated Enzymes|2|||
161307895|NCT00471718|582507256|FG000|Overall Study|Adverse Event|3|||
161307896|NCT00471718|582507256|FG000|Overall Study|other complicating disease|1|||
161307897|NCT00471718|582507256|FG000|Overall Study|disease progression|22|||
161307898|NCT00471718|582507256|FG000|Overall Study|Withdrawal by Subject|1|||
161307899|NCT01446237|582507257|FG000|Overall Study|Adverse Event|1|||
161307900|NCT01446237|582507257|FG000|Overall Study|Lost to Follow-up|2|||
161307901|NCT01446237|582507257|FG000|Overall Study|Withdrawal by Subject|7|||
161307902|NCT01817582|582507279|FG000|Overall Study|Withdrawal by Subject|0|||
161307903|NCT01817582|582507280|FG001|Overall Study|Withdrawal by Subject|1|||
161307904|NCT01817582|582507281|FG002|Overall Study|Withdrawal by Subject|0|||
161307905|NCT01817582|582507279|FG000|Overall Study|Participant revealed masked treatment|1|||
161307906|NCT01817582|582507280|FG001|Overall Study|Participant revealed masked treatment|0|||
161307907|NCT01817582|582507281|FG002|Overall Study|Participant revealed masked treatment|0|||
161307908|NCT01817582|582507279|FG000|Overall Study|Randomized but exclusion criteria met|1|||
161307909|NCT01817582|582507280|FG001|Overall Study|Randomized but exclusion criteria met|0|||
161307910|NCT01817582|582507281|FG002|Overall Study|Randomized but exclusion criteria met|0|||
161307911|NCT03053063|582507282|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
161307912|NCT03053063|582507283|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
161307913|NCT03053063|582507284|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
161307914|NCT03053063|582507285|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
161307915|NCT03053063|582507282|FG000|Randomized Phase|Withdrew consent|8|||
161307916|NCT03053063|582507283|FG001|Randomized Phase|Withdrew consent|11|||
161307917|NCT03053063|582507284|FG002|Randomized Phase|Withdrew consent|5|||
161307918|NCT03053063|582507285|FG003|Randomized Phase|Withdrew consent|0|||
161307919|NCT03053063|582507282|FG000|Randomized Phase|Investigator's Discretion|8|||
161307920|NCT03053063|582507283|FG001|Randomized Phase|Investigator's Discretion|6|||
161307921|NCT03053063|582507284|FG002|Randomized Phase|Investigator's Discretion|2|||
161307922|NCT03053063|582507285|FG003|Randomized Phase|Investigator's Discretion|0|||
161307923|NCT03053063|582507282|FG000|Randomized Phase|Lost to Follow-up|3|||
161307924|NCT03053063|582507283|FG001|Randomized Phase|Lost to Follow-up|5|||
161307925|NCT03053063|582507284|FG002|Randomized Phase|Lost to Follow-up|1|||
161307926|NCT03053063|582507285|FG003|Randomized Phase|Lost to Follow-up|0|||
161307927|NCT03053063|582507282|FG000|Randomized Phase|Adverse Event|0|||
161307928|NCT03053063|582507283|FG001|Randomized Phase|Adverse Event|1|||
161198904|NCT00634933|582109069|FG001|Part B: Week 24 to Week 52|Other|0|||
161198905|NCT00634933|582109070|FG002|Part B: Week 24 to Week 52|Other|5|||
161198906|NCT00634933|582109071|FG003|Part B: Week 24 to Week 52|Other|0|||
161198907|NCT00634933|582109072|FG004|Part B: Week 24 to Week 52|Other|1|||
161198908|NCT02304484|582109073|FG000|Overall Study|Death|9|||
161198909|NCT02304484|582109073|FG000|Overall Study|Withdrawal by Subject|14|||
161198910|NCT02304484|582109073|FG000|Overall Study|Lost to Follow-up|2|||
161198911|NCT01539512|582109074|FG000|Overall Study|Adverse Event|9|||
161198912|NCT01539512|582109075|FG001|Overall Study|Adverse Event|7|||
161198913|NCT01539512|582109074|FG000|Overall Study|Physician Decision|1|||
161198914|NCT01539512|582109075|FG001|Overall Study|Physician Decision|1|||
161198915|NCT01539512|582109074|FG000|Overall Study|Withdrawal by Subject|12|||
161198916|NCT01539512|582109075|FG001|Overall Study|Withdrawal by Subject|5|||
161198917|NCT01539512|582109074|FG000|Overall Study|Richter's Transformation|1|||
161198918|NCT01539512|582109075|FG001|Overall Study|Richter's Transformation|0|||
161198919|NCT03522506|582109076|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161198920|NCT03522506|582109077|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161198921|NCT03522506|582109078|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
161198922|NCT03522506|582109079|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
161198923|NCT03522506|582109076|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161198924|NCT03522506|582109077|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161198925|NCT03522506|582109078|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
161198926|NCT03522506|582109079|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
161198927|NCT05770401|582109080|FG000|Overall Study|Lost to Follow-up|5|||
161198928|NCT05770401|582109081|FG001|Overall Study|Lost to Follow-up|4|||
161198929|NCT01250418|582109082|FG000|Overall Study|monitor data failure|1|||
161198930|NCT01250418|582109083|FG001|Overall Study|monitor data failure|1|||
161198931|NCT01298323|582109086|FG000|Overall Study|Adverse Event|2|||
161198932|NCT01298323|582109087|FG001|Overall Study|Adverse Event|4|||
161198933|NCT01298323|582109086|FG000|Overall Study|Death|11|||
161198934|NCT01298323|582109087|FG001|Overall Study|Death|16|||
161198935|NCT01298323|582109086|FG000|Overall Study|Lost to Follow-up|1|||
161198936|NCT01298323|582109087|FG001|Overall Study|Lost to Follow-up|0|||
161198937|NCT01298323|582109086|FG000|Overall Study|Withdrawal by Subject|6|||
161198938|NCT01298323|582109087|FG001|Overall Study|Withdrawal by Subject|3|||
161198939|NCT01298323|582109086|FG000|Overall Study|Protocol Violation|1|||
161198940|NCT01298323|582109087|FG001|Overall Study|Protocol Violation|0|||
161198941|NCT01298323|582109086|FG000|Overall Study|Other|10|||
161198942|NCT01298323|582109087|FG001|Overall Study|Other|9|||
161198943|NCT01298323|582109086|FG000|Overall Study|Ongoing|55|||
161198944|NCT01298323|582109087|FG001|Overall Study|Ongoing|55|||
161198945|NCT01298323|582109086|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161198946|NCT01298323|582109087|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
161198947|NCT01761565|582109088|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
161198948|NCT02400281|582109090|FG000|Overall Study|Adverse Event|0|||
161198949|NCT02400281|582109091|FG001|Overall Study|Adverse Event|0|||
161198950|NCT02400281|582109092|FG002|Overall Study|Adverse Event|1|||
161198951|NCT02400281|582109093|FG003|Overall Study|Adverse Event|0|||
161198952|NCT02400281|582109094|FG004|Overall Study|Adverse Event|1|||
161198953|NCT02400281|582109095|FG005|Overall Study|Adverse Event|0|||
161198954|NCT02400281|582109090|FG000|Overall Study|Physician Decision|0|||
161198955|NCT02400281|582109091|FG001|Overall Study|Physician Decision|0|||
161198956|NCT02400281|582109092|FG002|Overall Study|Physician Decision|1|||
161198957|NCT02400281|582109093|FG003|Overall Study|Physician Decision|0|||
161198958|NCT02400281|582109094|FG004|Overall Study|Physician Decision|0|||
161198959|NCT02400281|582109095|FG005|Overall Study|Physician Decision|0|||
161198960|NCT04524507|582109096|FG000|Overall Study|Lost to Follow-up|2|||
161198961|NCT04524507|582109097|FG001|Overall Study|Lost to Follow-up|4|||
161198962|NCT04524507|582109096|FG000|Overall Study|Withdrawal by Subject|2|||
161198963|NCT04524507|582109097|FG001|Overall Study|Withdrawal by Subject|9|||
161198964|NCT04524507|582109096|FG000|Overall Study|Death|2|||
161198965|NCT04524507|582109097|FG001|Overall Study|Death|10|||
161198966|NCT00412360|582109098|FG000|Overall Study|Lost to Follow-up|0|||
161198967|NCT00412360|582109099|FG001|Overall Study|Lost to Follow-up|1|||
161307929|NCT03053063|582507284|FG002|Randomized Phase|Adverse Event|0|||
161307930|NCT03053063|582507285|FG003|Randomized Phase|Adverse Event|0|||
161307931|NCT03053063|582507282|FG000|Randomized Phase|Randomized but Never Treated|1|||
161307932|NCT03053063|582507283|FG001|Randomized Phase|Randomized but Never Treated|3|||
161307933|NCT03053063|582507284|FG002|Randomized Phase|Randomized but Never Treated|2|||
161307934|NCT03053063|582507285|FG003|Randomized Phase|Randomized but Never Treated|0|||
161307935|NCT03053063|582507282|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
161307936|NCT03053063|582507283|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
161307937|NCT03053063|582507284|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
161307938|NCT03053063|582507285|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
161307939|NCT03053063|582507282|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
161307940|NCT03053063|582507283|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
161307941|NCT03053063|582507284|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
161307942|NCT03053063|582507285|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
161307943|NCT03053063|582507282|FG000|Open-Label Phase|Death|0|||
161307944|NCT03053063|582507283|FG001|Open-Label Phase|Death|0|||
161307945|NCT03053063|582507284|FG002|Open-Label Phase|Death|0|||
161307946|NCT03053063|582507285|FG003|Open-Label Phase|Death|2|||
161307947|NCT03053063|582507282|FG000|Open-Label Phase|Investigator's discretion|0|||
161307948|NCT03053063|582507283|FG001|Open-Label Phase|Investigator's discretion|0|||
161307949|NCT03053063|582507284|FG002|Open-Label Phase|Investigator's discretion|0|||
161307950|NCT03053063|582507285|FG003|Open-Label Phase|Investigator's discretion|2|||
161307951|NCT02600845|582507286|FG000|Overall Study|Reason Not Specified|3|||
161307952|NCT02600845|582507286|FG000|Overall Study|Non-compliance with Study Procedures|10|||
161307953|NCT02600845|582507286|FG000|Overall Study|Consent Withdrawal|5|||
161307954|NCT05072106|582509449|FG000|Overall Study|Progressive disease|3|||
161307955|NCT05072106|582509450|FG001|Overall Study|Progressive disease|3|||
161307956|NCT05072106|582509449|FG000|Overall Study|Compassionate use|3|||
161307957|NCT05072106|582509450|FG001|Overall Study|Compassionate use|1|||
161307958|NCT05072106|582509449|FG000|Overall Study|Withdrawal by Subject|1|||
161307959|NCT05072106|582509450|FG001|Overall Study|Withdrawal by Subject|0|||
161307960|NCT03839459|582509451|FG000|Overall Study|Withdrawal by Subject|2|||
161307961|NCT03839459|582509451|FG000|Overall Study|progression of disease|3|||
161307962|NCT04240886|582509452|FG000|Treatment Phase|Death|4|||
161307963|NCT04240886|582509452|FG000|Treatment Phase|Discontinuation by Subject|1|||
161307964|NCT04240886|582509452|FG000|Treatment Phase|Adverse Event|5|||
161307965|NCT04240886|582509452|FG000|Follow-up Phase|Withdrawal by Subject|1|||
161307966|NCT04240886|582509452|FG000|Follow-up Phase|Discontinuation by Subject|1|||
161307967|NCT04240886|582509452|FG000|Follow-up Phase|Death|2|||
161307968|NCT03339726|582509457|FG000|Overall Study|Withdrawal by Subject|1|||
161307969|NCT03339726|582509458|FG001|Overall Study|Withdrawal by Subject|0|||
161307970|NCT03339726|582509459|FG002|Overall Study|Withdrawal by Subject|0|||
161307971|NCT03339726|582509457|FG000|Overall Study|Lost to Follow-up|0|||
161198968|NCT00412360|582109098|FG000|Overall Study|Not Transplanted|1|||
161198969|NCT00412360|582109099|FG001|Overall Study|Not Transplanted|2|||
161198970|NCT03655951|582109100|FG000|Overall Study|Lost to Follow-up|39|||
161198971|NCT03655951|582109101|FG001|Overall Study|Lost to Follow-up|20|||
161198972|NCT03655951|582109100|FG000|Overall Study|Withdrawal by Subject|0|||
161198973|NCT03655951|582109101|FG001|Overall Study|Withdrawal by Subject|1|||
161198974|NCT01078974|582109106|FG000|Overall Study|Adverse Event|3|||
161198975|NCT03145207|582109109|FG000|Overall Study|volunteer started taking allergy shots|1|||
161198976|NCT03145207|582109109|FG000|Overall Study|baseline blood pressure high|1|||
161198977|NCT01790633|582109110|FG000|Overall Study|Protocol Violation|1|||
161198978|NCT01790633|582109111|FG001|Overall Study|Protocol Violation|2|||
161198979|NCT01790633|582109110|FG000|Overall Study|Did not have serology performed|47|||
161198980|NCT01790633|582109111|FG001|Overall Study|Did not have serology performed|0|||
161198981|NCT01790633|582109110|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
161198982|NCT01790633|582109111|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
161307972|NCT03339726|582509458|FG001|Overall Study|Lost to Follow-up|1|||
161307973|NCT03339726|582509459|FG002|Overall Study|Lost to Follow-up|0|||
161307974|NCT04542499|582509465|FG000|Overall Study|Adverse Event|23|||
161307975|NCT04542499|582509466|FG001|Overall Study|Adverse Event|43|||
161307976|NCT04542499|582509465|FG000|Overall Study|Lack of Efficacy|5|||
161307977|NCT04542499|582509466|FG001|Overall Study|Lack of Efficacy|2|||
161307978|NCT04542499|582509465|FG000|Overall Study|Lost to Follow-up|3|||
161307979|NCT04542499|582509466|FG001|Overall Study|Lost to Follow-up|4|||
161307980|NCT04542499|582509465|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
161307981|NCT04542499|582509466|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
161307982|NCT04542499|582509465|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
161307983|NCT04542499|582509466|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
161307984|NCT04542499|582509465|FG000|Overall Study|Non-Compliance with Study Drug|0|||
161307985|NCT04542499|582509466|FG001|Overall Study|Non-Compliance with Study Drug|2|||
161307986|NCT04542499|582509465|FG000|Overall Study|Physician Decision|0|||
161307987|NCT04542499|582509466|FG001|Overall Study|Physician Decision|1|||
161307988|NCT04542499|582509465|FG000|Overall Study|Site Terminated by Sponsor|3|||
161307989|NCT04542499|582509466|FG001|Overall Study|Site Terminated by Sponsor|5|||
161307990|NCT04542499|582509465|FG000|Overall Study|Withdrawal by Subject|12|||
161307991|NCT04542499|582509466|FG001|Overall Study|Withdrawal by Subject|33|||
161307992|NCT04542499|582509465|FG000|Overall Study|Other|2|||
161307993|NCT04542499|582509466|FG001|Overall Study|Other|2|||
161307994|NCT04035434|582509472|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161307995|NCT04035434|582509473|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161307996|NCT04035434|582509474|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161307997|NCT04035434|582509475|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
161307998|NCT04035434|582509476|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161307999|NCT04035434|582509477|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308000|NCT04035434|582509478|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308001|NCT04035434|582509479|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308002|NCT04035434|582509480|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308003|NCT04035434|582509481|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308004|NCT04035434|582509482|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161308005|NCT04035434|582509483|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161308006|NCT04035434|582509484|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308007|NCT04035434|582509472|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161308008|NCT04035434|582509473|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161308009|NCT04035434|582509474|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
161308010|NCT04035434|582509475|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161308011|NCT04035434|582509476|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
161308012|NCT04035434|582509477|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161308013|NCT04035434|582509478|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
161308014|NCT04035434|582509479|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161308015|NCT04035434|582509480|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161308016|NCT04035434|582509481|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
161308017|NCT04035434|582509482|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
161198983|NCT01396434|582109113|FG000|Overall Study|Lost to Follow-up|1|||
161198984|NCT01396434|582109114|FG001|Overall Study|Lost to Follow-up|0|||
161198985|NCT01396434|582109115|FG002|Overall Study|Lost to Follow-up|0|||
161198986|NCT01396434|582109113|FG000|Overall Study|Other|10|||
161198987|NCT01396434|582109114|FG001|Overall Study|Other|0|||
161198988|NCT01396434|582109115|FG002|Overall Study|Other|0|||
161198989|NCT04678557|582109116|FG000|Overall Study|Withdrawal by Subject|1|||
161198990|NCT04678557|582109117|FG001|Overall Study|Withdrawal by Subject|0|||
161198991|NCT04678557|582109116|FG000|Overall Study|Lack of Efficacy|0|||
161198992|NCT04678557|582109117|FG001|Overall Study|Lack of Efficacy|13|||
161198993|NCT04678557|582109116|FG000|Overall Study|Safety Evaluation|0|||
161198994|NCT04678557|582109117|FG001|Overall Study|Safety Evaluation|1|||
161198995|NCT00563706|582110918|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
161198996|NCT00563706|582110919|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161198997|NCT00563706|582110920|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161198998|NCT00563706|582110921|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161198999|NCT00563706|582110922|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161199000|NCT00563706|582110923|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161199001|NCT00563706|582110924|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
161199002|NCT00563706|582110925|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
161199003|NCT00563706|582110926|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
161199004|NCT00563706|582110918|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161199005|NCT00563706|582110919|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161199006|NCT00563706|582110920|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161199007|NCT00563706|582110921|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
161199008|NCT00563706|582110922|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161308018|NCT04035434|582509483|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
161308019|NCT04035434|582509484|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
161308020|NCT04035434|582509472|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308021|NCT04035434|582509473|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161308022|NCT04035434|582509474|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161308023|NCT04035434|582509475|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308024|NCT04035434|582509476|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161308025|NCT04035434|582509477|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161308026|NCT04035434|582509478|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308027|NCT04035434|582509479|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308028|NCT04035434|582509480|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161308029|NCT04035434|582509481|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
161308030|NCT04035434|582509482|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308031|NCT04035434|582509483|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
161308032|NCT04035434|582509484|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
161308033|NCT04035434|582509472|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308034|NCT04035434|582509473|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308035|NCT04035434|582509474|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308036|NCT04035434|582509475|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
161308037|NCT04035434|582509476|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308038|NCT04035434|582509477|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308039|NCT04035434|582509478|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308040|NCT04035434|582509479|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308041|NCT04035434|582509480|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308042|NCT04035434|582509481|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308043|NCT04035434|582509482|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308044|NCT04035434|582509483|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308045|NCT04035434|582509484|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
161308046|NCT04035434|582509472|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308047|NCT04035434|582509473|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308048|NCT04035434|582509474|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308049|NCT04035434|582509475|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308050|NCT04035434|582509476|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308051|NCT04035434|582509477|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
161308052|NCT04035434|582509478|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
161199009|NCT00563706|582110923|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161199010|NCT00563706|582110924|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
161199011|NCT00563706|582110925|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
161199012|NCT00563706|582110926|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
161199013|NCT00563706|582110918|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
161199014|NCT00563706|582110919|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161199015|NCT00563706|582110920|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
161308053|NCT04035434|582509479|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308054|NCT04035434|582509480|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308055|NCT04035434|582509481|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308056|NCT04035434|582509482|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308057|NCT04035434|582509483|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308058|NCT04035434|582509484|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
161308059|NCT04035434|582509472|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308060|NCT04035434|582509473|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308061|NCT04035434|582509474|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308062|NCT04035434|582509475|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308063|NCT04035434|582509476|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308064|NCT04035434|582509477|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161308065|NCT04035434|582509478|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
161308066|NCT04035434|582509479|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308067|NCT04035434|582509480|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308068|NCT04035434|582509481|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308069|NCT04035434|582509482|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308070|NCT04035434|582509483|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308071|NCT04035434|582509484|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
161308072|NCT04035434|582509472|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308073|NCT04035434|582509473|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308074|NCT04035434|582509474|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308075|NCT04035434|582509475|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308076|NCT04035434|582509476|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308077|NCT04035434|582509477|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
161308078|NCT04035434|582509478|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
161308079|NCT04035434|582509479|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308080|NCT04035434|582509480|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308081|NCT04035434|582509481|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308082|NCT04035434|582509482|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308083|NCT04035434|582509483|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308084|NCT04035434|582509484|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
161308085|NCT04322539|582509485|FG000|Overall Study|Adverse Event|2|||
161308086|NCT04322539|582509486|FG001|Overall Study|Adverse Event|0|||
161308087|NCT04322539|582509485|FG000|Overall Study|Death|411|||
161308088|NCT04322539|582509486|FG001|Overall Study|Death|203|||
161308089|NCT04322539|582509485|FG000|Overall Study|Lost to Follow-up|3|||
161308090|NCT04322539|582509486|FG001|Overall Study|Lost to Follow-up|1|||
161308091|NCT04322539|582509485|FG000|Overall Study|Withdrawal of consent|14|||
161308092|NCT04322539|582509486|FG001|Overall Study|Withdrawal of consent|8|||
161308093|NCT04322539|582509485|FG000|Overall Study|Radiological Disease Progression|6|||
161308094|NCT04322539|582509486|FG001|Overall Study|Radiological Disease Progression|0|||
161308095|NCT04322539|582509485|FG000|Overall Study|Sponsor Decision|19|||
161308096|NCT04322539|582509486|FG001|Overall Study|Sponsor Decision|14|||
161308097|NCT04322539|582509485|FG000|Overall Study|Other|6|||
161308098|NCT04322539|582509486|FG001|Overall Study|Other|4|||
161308099|NCT02759055|582509489|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
161308100|NCT02759055|582509490|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
161308101|NCT04161079|582509491|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
161308102|NCT04045132|582509495|FG000|Overall Study|Lost to Follow-up|3|||
161308103|NCT04045132|582509496|FG001|Overall Study|Lost to Follow-up|6|||
161308104|NCT04063657|582509497|FG000|Overall Study|Lost to Follow-up|1|||
161308105|NCT04063657|582509498|FG001|Overall Study|Lost to Follow-up|0|||
161308106|NCT01473394|582509499|FG000|Overall Study|Adverse Event|13|||
161308107|NCT01473394|582509500|FG001|Overall Study|Adverse Event|16|||
161308108|NCT01473394|582509499|FG000|Overall Study|Insufficient Therapeutic Response|4|||
161308109|NCT01473394|582509500|FG001|Overall Study|Insufficient Therapeutic Response|1|||
161308110|NCT01473394|582509499|FG000|Overall Study|Protocol Violation|7|||
161308111|NCT01473394|582509500|FG001|Overall Study|Protocol Violation|5|||
161308112|NCT01473394|582509499|FG000|Overall Study|Withdrew Consent|12|||
161308113|NCT01473394|582509500|FG001|Overall Study|Withdrew Consent|10|||
161308114|NCT01473394|582509499|FG000|Overall Study|Lost to Follow-up|9|||
161308115|NCT01473394|582509500|FG001|Overall Study|Lost to Follow-up|11|||
161308116|NCT00552032|582509501|FG000|Overall Study|Withdrawal by Subject|2|||
161308117|NCT00552032|582509502|FG001|Overall Study|Withdrawal by Subject|2|||
161308118|NCT00552032|582509501|FG000|Overall Study|Protocol Violation|7|||
161308119|NCT00552032|582509502|FG001|Overall Study|Protocol Violation|12|||
161308120|NCT00552032|582509501|FG000|Overall Study|Lost to Follow-up|8|||
161308121|NCT00552032|582509502|FG001|Overall Study|Lost to Follow-up|5|||
161308122|NCT05845567|582509508|FG000|Overall Study|Withdrawal by Subject|1|||
161308123|NCT01104246|582509513|FG000|Overall Study|Withdrawal by Subject|1|||
161308124|NCT01104246|582509513|FG000|Overall Study|did not meet inclusion criteria|4|||
161308125|NCT05178641|582509514|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
161308126|NCT05178641|582509515|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
161308127|NCT05178641|582509514|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
161308128|NCT05178641|582509515|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
161308129|NCT01869699|582509518|FG000|Overall Study|Withdrawal by Subject|1|||
161308130|NCT01869699|582509519|FG001|Overall Study|Withdrawal by Subject|0|||
161308131|NCT01083186|582509524|FG000|Overall Study|Lost to Follow-up|48|||
161308132|NCT01083186|582509524|FG000|Overall Study|Consent Withdrawal|7|||
161308133|NCT01083186|582509524|FG000|Overall Study|Death|3|||
161308134|NCT01083186|582509524|FG000|Overall Study|Adverse Event|3|||
161308135|NCT01083186|582509524|FG000|Overall Study|Lack of Efficacy|2|||
161308136|NCT01083186|582509524|FG000|Overall Study|Hemodialysis Initiation|28|||
161308137|NCT01083186|582509524|FG000|Overall Study|Administrative Reasons|2|||
161308138|NCT01083186|582509524|FG000|Overall Study|Non-compliance to Study Treatment|1|||
161308139|NCT01867294|582509535|FG000|Overall Study|Withdrawal by Subject|1|||
161308140|NCT01867294|582509536|FG001|Overall Study|Withdrawal by Subject|1|||
161308141|NCT01867294|582509537|FG002|Overall Study|Withdrawal by Subject|0|||
161308142|NCT01867294|582509538|FG003|Overall Study|Withdrawal by Subject|0|||
161308143|NCT02062944|582509539|FG000|Overall Study|Lost to Follow-up|1|||
161308144|NCT02062944|582509539|FG000|Overall Study|New hemotological disorder identified|1|||
161308145|NCT02062944|582509539|FG000|Overall Study|Uncontrolled Hypertension|1|||
161308146|NCT02062944|582509539|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
161308147|NCT00278148|582509540|FG000|Phase II - Expansion Phase|Disease progression|0|||
161308148|NCT00278148|582509541|FG001|Phase II - Expansion Phase|Disease progression|0|||
161308149|NCT00278148|582509542|FG002|Phase II - Expansion Phase|Disease progression|4|||
161308150|NCT00278148|582509540|FG000|Phase II - Expansion Phase|Adverse Event|0|||
161308151|NCT00278148|582509541|FG001|Phase II - Expansion Phase|Adverse Event|0|||
161308152|NCT00278148|582509542|FG002|Phase II - Expansion Phase|Adverse Event|2|||
161308153|NCT02035748|582509543|FG000|Overall Study|Adverse Event|5|||
161308154|NCT02035748|582509543|FG000|Overall Study|Death|3|||
161308155|NCT02035748|582509543|FG000|Overall Study|Lost to Follow-up|2|||
161308156|NCT02035748|582509543|FG000|Overall Study|Physician Decision|3|||
161308157|NCT02035748|582509543|FG000|Overall Study|Withdrawal by Subject|6|||
161308158|NCT02035748|582509543|FG000|Overall Study|Progressive Disease|1|||
161308159|NCT01740128|582509544|FG000|Overall Study|Pregnancy|0|||
161308160|NCT01740128|582509545|FG001|Overall Study|Pregnancy|1|||
161308161|NCT01740128|582509544|FG000|Overall Study|Protocol Violation|1|||
161308162|NCT01740128|582509545|FG001|Overall Study|Protocol Violation|2|||
161308163|NCT01740128|582509544|FG000|Overall Study|Lost to Follow-up|2|||
161308164|NCT01740128|582509545|FG001|Overall Study|Lost to Follow-up|2|||
161308165|NCT01740128|582509544|FG000|Overall Study|Withdrawal by Subject|1|||
161308166|NCT01740128|582509545|FG001|Overall Study|Withdrawal by Subject|0|||
161308167|NCT01740128|582509544|FG000|Overall Study|Insufficient protocol compliance|2|||
161308168|NCT01740128|582509545|FG001|Overall Study|Insufficient protocol compliance|2|||
161308169|NCT01041976|582509546|FG000|Overall Study|Withdrawal by Subject|3|||
161308170|NCT01041976|582509547|FG001|Overall Study|Withdrawal by Subject|0|||
161308171|NCT01041976|582509546|FG000|Overall Study|Incarceration|2|||
161308172|NCT01041976|582509547|FG001|Overall Study|Incarceration|0|||
161308173|NCT01041976|582509546|FG000|Overall Study|Death|0|||
161308174|NCT01041976|582509547|FG001|Overall Study|Death|4|||
161308175|NCT02658734|582509548|FG000|Overall Study|Adverse Event|2|||
161308176|NCT02658734|582509548|FG000|Overall Study|Death|4|||
161308177|NCT02658734|582509548|FG000|Overall Study|Lost to Follow-up|7|||
161308178|NCT02658734|582509548|FG000|Overall Study|Withdrawal of Consent|16|||
161308179|NCT02658734|582509548|FG000|Overall Study|Disease Progression|28|||
161308180|NCT00976209|582509551|FG000|Treatment Period 1|Protocol Violation|1|||
161308181|NCT00976209|582509552|FG001|Treatment Period 1|Protocol Violation|0|||
161308182|NCT00976209|582509551|FG000|Treatment Period 1|Lost to Follow-up|2|||
161308183|NCT00976209|582509552|FG001|Treatment Period 1|Lost to Follow-up|0|||
161308184|NCT00976209|582509551|FG000|Treatment Period 1|Other|0|||
161308185|NCT00976209|582509552|FG001|Treatment Period 1|Other|1|||
161308186|NCT00976209|582509551|FG000|Wash-out Period|Adverse Event|1|||
161308187|NCT00976209|582509552|FG001|Wash-out Period|Adverse Event|2|||
161308188|NCT00976209|582509551|FG000|Wash-out Period|Lost to Follow-up|1|||
161308189|NCT00976209|582509552|FG001|Wash-out Period|Lost to Follow-up|0|||
161308190|NCT00976209|582509551|FG000|Wash-out Period|Protocol Violation|1|||
161308191|NCT00976209|582509552|FG001|Wash-out Period|Protocol Violation|0|||
161308192|NCT00976209|582509551|FG000|Wash-out Period|Other|1|||
161308193|NCT00976209|582509552|FG001|Wash-out Period|Other|0|||
161308194|NCT00976209|582509551|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161308195|NCT00976209|582509552|FG001|Treatment Period 2|Withdrawal by Subject|1|||
161308196|NCT00976209|582509551|FG000|Treatment Period 2|Lost to Follow-up|0|||
161308197|NCT00976209|582509552|FG001|Treatment Period 2|Lost to Follow-up|1|||
161308198|NCT00574249|582509553|FG000|Overall Study|Adverse Event|6|||
161308199|NCT00574249|582509554|FG001|Overall Study|Adverse Event|18|||
161308200|NCT00574249|582509553|FG000|Overall Study|Lack of Efficacy|5|||
161308201|NCT00574249|582509554|FG001|Overall Study|Lack of Efficacy|3|||
161308202|NCT00574249|582509553|FG000|Overall Study|Lost to Follow-up|4|||
161308203|NCT00574249|582509554|FG001|Overall Study|Lost to Follow-up|3|||
161308204|NCT00574249|582509553|FG000|Overall Study|Protocol Violation|5|||
161308205|NCT00574249|582509554|FG001|Overall Study|Protocol Violation|2|||
161308206|NCT00574249|582509553|FG000|Overall Study|History of carcinoma|1|||
161308207|NCT00574249|582509554|FG001|Overall Study|History of carcinoma|0|||
161308208|NCT00574249|582509553|FG000|Overall Study|Withdrawal by Subject|3|||
161308209|NCT00574249|582509554|FG001|Overall Study|Withdrawal by Subject|0|||
161308210|NCT00574249|582509553|FG000|Overall Study|Physician Decision|1|||
161308211|NCT00574249|582509554|FG001|Overall Study|Physician Decision|0|||
161308212|NCT00574249|582509553|FG000|Overall Study|Pregnancy|1|||
161308213|NCT00574249|582509554|FG001|Overall Study|Pregnancy|0|||
161308214|NCT00574249|582509553|FG000|Overall Study|Excluded by company|0|||
161308215|NCT00574249|582509554|FG001|Overall Study|Excluded by company|1|||
161308216|NCT00574249|582509553|FG000|Overall Study|PPD test taken twice|0|||
161308217|NCT00574249|582509554|FG001|Overall Study|PPD test taken twice|1|||
161308218|NCT01542034|582509555|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
161308219|NCT01542034|582509556|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
161308220|NCT01542034|582509555|FG000|Overall Study|Administrative decision|0|||
161308221|NCT01542034|582509556|FG001|Overall Study|Administrative decision|3|||
161308222|NCT01542034|582509555|FG000|Overall Study|Subject Noncompliance|1|||
161308223|NCT01542034|582509556|FG001|Overall Study|Subject Noncompliance|0|||
161308224|NCT01542034|582509555|FG000|Overall Study|Adverse Event|2|||
161308225|NCT01542034|582509556|FG001|Overall Study|Adverse Event|2|||
161308226|NCT01542034|582509555|FG000|Overall Study|Lost to Follow-up|7|||
161308227|NCT01542034|582509556|FG001|Overall Study|Lost to Follow-up|6|||
161308228|NCT02612610|582509557|FG000|Overall Study|Withdrawal by Subject|1|||
161308229|NCT02612610|582509558|FG001|Overall Study|Withdrawal by Subject|1|||
161308230|NCT02612610|582509559|FG002|Overall Study|Withdrawal by Subject|0|||
161308231|NCT02612610|582509560|FG003|Overall Study|Withdrawal by Subject|2|||
161308232|NCT02612610|582509557|FG000|Overall Study|Adverse Event|2|||
161308233|NCT02612610|582509558|FG001|Overall Study|Adverse Event|2|||
161308234|NCT02612610|582509559|FG002|Overall Study|Adverse Event|3|||
161199016|NCT00563706|582110921|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
161199017|NCT00563706|582110922|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
161199018|NCT00563706|582110923|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161199019|NCT00563706|582110924|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
161199020|NCT00563706|582110925|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
161199021|NCT00563706|582110926|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
161199022|NCT00563706|582110918|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
161308235|NCT02612610|582509560|FG003|Overall Study|Adverse Event|10|||
161308236|NCT02612610|582509557|FG000|Overall Study|Lost to Follow-up|0|||
161308237|NCT02612610|582509558|FG001|Overall Study|Lost to Follow-up|1|||
161308238|NCT02612610|582509559|FG002|Overall Study|Lost to Follow-up|0|||
161308239|NCT02612610|582509560|FG003|Overall Study|Lost to Follow-up|0|||
161308240|NCT02612610|582509557|FG000|Overall Study|Protocol Violation|0|||
161308241|NCT02612610|582509558|FG001|Overall Study|Protocol Violation|1|||
161308242|NCT02612610|582509559|FG002|Overall Study|Protocol Violation|1|||
161308243|NCT02612610|582509560|FG003|Overall Study|Protocol Violation|0|||
161308244|NCT02612610|582509557|FG000|Overall Study|Lack of Efficacy|1|||
161308245|NCT02612610|582509558|FG001|Overall Study|Lack of Efficacy|2|||
161308246|NCT02612610|582509559|FG002|Overall Study|Lack of Efficacy|0|||
161308247|NCT02612610|582509560|FG003|Overall Study|Lack of Efficacy|1|||
161308248|NCT02612610|582509557|FG000|Overall Study|Physician Decision|0|||
161308249|NCT02612610|582509558|FG001|Overall Study|Physician Decision|1|||
161308250|NCT02612610|582509559|FG002|Overall Study|Physician Decision|0|||
161308251|NCT02612610|582509560|FG003|Overall Study|Physician Decision|0|||
161308252|NCT02612610|582509557|FG000|Overall Study|Noncompliance|1|||
161308253|NCT02612610|582509558|FG001|Overall Study|Noncompliance|0|||
161308254|NCT02612610|582509559|FG002|Overall Study|Noncompliance|0|||
161308255|NCT02612610|582509560|FG003|Overall Study|Noncompliance|0|||
161308256|NCT02612610|582509557|FG000|Overall Study|Cough Improvement|0|||
161308257|NCT02612610|582509558|FG001|Overall Study|Cough Improvement|0|||
161308258|NCT02612610|582509559|FG002|Overall Study|Cough Improvement|1|||
161308259|NCT02612610|582509560|FG003|Overall Study|Cough Improvement|0|||
161308260|NCT01546571|582509563|FG000|Overall Study|Adverse Event|1|||
161308261|NCT01546571|582509564|FG001|Overall Study|Adverse Event|0|||
161308262|NCT01546571|582509565|FG002|Overall Study|Adverse Event|0|||
161308263|NCT01546571|582509566|FG003|Overall Study|Adverse Event|1|||
161308264|NCT01546571|582509567|FG004|Overall Study|Adverse Event|0|||
161308265|NCT01546571|582509563|FG000|Overall Study|assigned placebo in Part A|0|||
161308266|NCT01546571|582509564|FG001|Overall Study|assigned placebo in Part A|0|||
161308267|NCT01546571|582509565|FG002|Overall Study|assigned placebo in Part A|22|||
161308268|NCT01546571|582509566|FG003|Overall Study|assigned placebo in Part A|0|||
161308269|NCT01546571|582509567|FG004|Overall Study|assigned placebo in Part A|0|||
161308270|NCT01546571|582509563|FG000|Overall Study|Death|0|||
161308271|NCT01546571|582509564|FG001|Overall Study|Death|1|||
161308272|NCT01546571|582509565|FG002|Overall Study|Death|0|||
161308273|NCT01546571|582509566|FG003|Overall Study|Death|0|||
161308274|NCT01546571|582509567|FG004|Overall Study|Death|0|||
161308275|NCT01546571|582509563|FG000|Overall Study|Lost to Follow-up|0|||
161308276|NCT01546571|582509564|FG001|Overall Study|Lost to Follow-up|0|||
161308277|NCT01546571|582509565|FG002|Overall Study|Lost to Follow-up|2|||
161308278|NCT01546571|582509566|FG003|Overall Study|Lost to Follow-up|2|||
161308279|NCT01546571|582509567|FG004|Overall Study|Lost to Follow-up|3|||
161308280|NCT01546571|582509563|FG000|Overall Study|Pregnancy|0|||
161308281|NCT01546571|582509564|FG001|Overall Study|Pregnancy|0|||
161308282|NCT01546571|582509565|FG002|Overall Study|Pregnancy|0|||
161308283|NCT01546571|582509566|FG003|Overall Study|Pregnancy|1|||
161308284|NCT01546571|582509567|FG004|Overall Study|Pregnancy|0|||
161308285|NCT01546571|582509563|FG000|Overall Study|Disease Progression|20|||
161308286|NCT01546571|582509564|FG001|Overall Study|Disease Progression|18|||
161308287|NCT01546571|582509565|FG002|Overall Study|Disease Progression|15|||
161308288|NCT01546571|582509566|FG003|Overall Study|Disease Progression|73|||
161308289|NCT01546571|582509567|FG004|Overall Study|Disease Progression|37|||
161308290|NCT01546571|582509563|FG000|Overall Study|Withdrawal by Subject|1|||
161308291|NCT01546571|582509564|FG001|Overall Study|Withdrawal by Subject|2|||
161308292|NCT01546571|582509565|FG002|Overall Study|Withdrawal by Subject|4|||
161308293|NCT01546571|582509566|FG003|Overall Study|Withdrawal by Subject|9|||
161308294|NCT01546571|582509567|FG004|Overall Study|Withdrawal by Subject|2|||
161308295|NCT01546571|582509563|FG000|Overall Study|Intercurrent Illness|1|||
161308296|NCT01546571|582509564|FG001|Overall Study|Intercurrent Illness|2|||
161308297|NCT01546571|582509565|FG002|Overall Study|Intercurrent Illness|0|||
161308298|NCT01546571|582509566|FG003|Overall Study|Intercurrent Illness|0|||
161308299|NCT01546571|582509567|FG004|Overall Study|Intercurrent Illness|0|||
161308300|NCT01546571|582509563|FG000|Overall Study|Other Cancers|0|||
161308301|NCT01546571|582509564|FG001|Overall Study|Other Cancers|0|||
161308302|NCT01546571|582509565|FG002|Overall Study|Other Cancers|0|||
161308303|NCT01546571|582509566|FG003|Overall Study|Other Cancers|3|||
161308304|NCT01546571|582509567|FG004|Overall Study|Other Cancers|1|||
161308305|NCT01546571|582509563|FG000|Overall Study|Other|0|||
161308306|NCT01546571|582509564|FG001|Overall Study|Other|0|||
161199023|NCT00563706|582110919|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161199024|NCT00563706|582110920|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161199025|NCT00563706|582110921|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161199026|NCT00563706|582110922|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161308307|NCT01546571|582509565|FG002|Overall Study|Other|3|||
161308308|NCT01546571|582509566|FG003|Overall Study|Other|0|||
161308309|NCT01546571|582509567|FG004|Overall Study|Other|0|||
161308310|NCT00478699|582509568|FG000|Overall Study|Inclusion Error|1|||
161308311|NCT00478699|582509569|FG001|Overall Study|Inclusion Error|7|||
161308312|NCT00478699|582509568|FG000|Overall Study|Not receive study treatment|6|||
161308313|NCT00478699|582509569|FG001|Overall Study|Not receive study treatment|30|||
161308314|NCT01252563|582509573|FG000|Overall Study|Contract Deviation|41|||
161308315|NCT01252563|582509573|FG000|Overall Study|Centralized Registration Deviation|30|||
161308316|NCT01252563|582509573|FG000|Overall Study|Lost to Follow-up|161|||
161308317|NCT01252563|582509573|FG000|Overall Study|No visit after first day of treatment|194|||
161308318|NCT01252563|582509573|FG000|Overall Study|No drug administration|6|||
161308319|NCT01866657|582509574|FG000|Overall Study|Surgery canceled|2|||
161308320|NCT01866657|582509575|FG001|Overall Study|Surgery canceled|0|||
161308321|NCT01880086|582509581|FG000|Overall Study|Lost to Follow-up|1|||
161308322|NCT01880086|582509582|FG001|Overall Study|Lost to Follow-up|1|||
161199027|NCT00563706|582110923|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161199028|NCT00563706|582110924|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161199029|NCT00563706|582110925|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
161199030|NCT00563706|582110926|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
161199031|NCT00563706|582110918|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199032|NCT00563706|582110919|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199033|NCT00563706|582110920|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199034|NCT00563706|582110921|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199035|NCT00563706|582110922|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199036|NCT00563706|582110923|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199037|NCT00563706|582110924|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
161199038|NCT00563706|582110925|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
161199039|NCT00563706|582110926|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
161199040|NCT02985541|582110931|FG000|Overall Study|Withdrawal by Subject|33|||
161199041|NCT02985541|582110931|FG000|Overall Study|Lost to Follow-up|26|||
161199042|NCT02985541|582110931|FG000|Overall Study|Adverse Event|27|||
161199043|NCT02985541|582110931|FG000|Overall Study|Physician Decision|2|||
161199044|NCT02985541|582110931|FG000|Overall Study|Pregnancy|2|||
161199045|NCT02985541|582110931|FG000|Overall Study|Wish for pregnancy|44|||
161199046|NCT02985541|582110931|FG000|Overall Study|Other reason|5|||
161199047|NCT02985541|582110931|FG000|Overall Study|Not valid for analysis|2|||
161199048|NCT02383966|582110932|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
161199049|NCT02383966|582110933|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
161199050|NCT02383966|582110932|FG000|Overall Study|Randomized, but not treated|1|||
161199051|NCT02383966|582110933|FG001|Overall Study|Randomized, but not treated|3|||
161308323|NCT00978250|582509586|FG000|Overall Study|Late determination of ineligibility|0|||
161308324|NCT00978250|582509587|FG001|Overall Study|Late determination of ineligibility|1|||
161308325|NCT00978250|582509588|FG002|Overall Study|Late determination of ineligibility|0|||
161308326|NCT00978250|582509589|FG003|Overall Study|Late determination of ineligibility|1|||
161308327|NCT05174949|582509592|FG000|Overall Study|Physician Decision|1|||
161308328|NCT05174949|582509593|FG001|Overall Study|Physician Decision|2|||
161308329|NCT05174949|582509594|FG002|Overall Study|Physician Decision|0|||
161308330|NCT05174949|582509595|FG003|Overall Study|Physician Decision|1|||
161308331|NCT05174949|582509596|FG004|Overall Study|Physician Decision|0|||
161308332|NCT05174949|582509597|FG005|Overall Study|Physician Decision|0|||
161308333|NCT05174949|582509592|FG000|Overall Study|Withdrawal by Subject|0|||
161308334|NCT05174949|582509593|FG001|Overall Study|Withdrawal by Subject|1|||
161308335|NCT05174949|582509594|FG002|Overall Study|Withdrawal by Subject|0|||
161308336|NCT05174949|582509595|FG003|Overall Study|Withdrawal by Subject|0|||
161308337|NCT05174949|582509596|FG004|Overall Study|Withdrawal by Subject|0|||
161308338|NCT05174949|582509597|FG005|Overall Study|Withdrawal by Subject|0|||
161308339|NCT05174949|582509592|FG000|Overall Study|Lost to Follow-up|0|||
161308340|NCT05174949|582509593|FG001|Overall Study|Lost to Follow-up|0|||
161308341|NCT05174949|582509594|FG002|Overall Study|Lost to Follow-up|0|||
161308342|NCT05174949|582509595|FG003|Overall Study|Lost to Follow-up|1|||
161308343|NCT05174949|582509596|FG004|Overall Study|Lost to Follow-up|0|||
161308344|NCT05174949|582509597|FG005|Overall Study|Lost to Follow-up|0|||
161308345|NCT02951533|582509598|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
161308346|NCT02951533|582509599|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
161308347|NCT02951533|582509600|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
161308348|NCT02951533|582509598|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
161308349|NCT02951533|582509599|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
161308350|NCT02951533|582509600|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
161308351|NCT02951533|582509598|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
161308352|NCT02951533|582509599|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
161308353|NCT02951533|582509600|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
161308354|NCT02951533|582509598|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
161308355|NCT02951533|582509599|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
161308356|NCT02951533|582509600|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
161308357|NCT02951533|582509598|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
161308358|NCT02951533|582509599|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
161308359|NCT02951533|582509600|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
161308360|NCT02951533|582509598|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
161308361|NCT02951533|582509599|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
161308362|NCT02951533|582509600|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
161308363|NCT02951533|582509598|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
161308364|NCT02951533|582509599|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
161308365|NCT02951533|582509600|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
161308366|NCT02951533|582509598|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
161308367|NCT02951533|582509599|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
161308368|NCT02951533|582509600|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
161308369|NCT02951533|582509598|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
161308370|NCT02951533|582509599|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
161308371|NCT02951533|582509600|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
161308372|NCT02951533|582509598|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
161308373|NCT02951533|582509599|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
161308374|NCT02951533|582509600|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
161308375|NCT02951533|582509598|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
161308376|NCT02951533|582509599|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
161308377|NCT02951533|582509600|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
161308378|NCT02029989|582509601|FG000|Overall Study|Withdrawal by Subject|1|||
161308379|NCT02029989|582509602|FG001|Overall Study|Withdrawal by Subject|0|||
161308380|NCT02029989|582509601|FG000|Overall Study|Withdrawal: Fear of needles|1|||
161308381|NCT02029989|582509602|FG001|Overall Study|Withdrawal: Fear of needles|0|||
161308382|NCT02029989|582509601|FG000|Overall Study|Change of location|2|||
161308383|NCT02029989|582509602|FG001|Overall Study|Change of location|3|||
161308384|NCT02029989|582509601|FG000|Overall Study|Physician Decision|2|||
161308385|NCT02029989|582509602|FG001|Overall Study|Physician Decision|0|||
161308386|NCT02029989|582509601|FG000|Overall Study|Lost to Follow-up|9|||
161308387|NCT02029989|582509602|FG001|Overall Study|Lost to Follow-up|7|||
161308388|NCT02029989|582509601|FG000|Overall Study|Death|0|||
161308389|NCT02029989|582509602|FG001|Overall Study|Death|1|||
161308390|NCT02029989|582509601|FG000|Overall Study|Protocol Violation|1|||
161308391|NCT02029989|582509602|FG001|Overall Study|Protocol Violation|0|||
161308392|NCT04351373|582509603|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
161308393|NCT01123941|582509609|FG000|Overall Study|Lost to Follow-up|2|||
161308394|NCT01123941|582509610|FG001|Overall Study|Lost to Follow-up|1|||
161308395|NCT05036668|582509611|FG000|Overall Study|lost to follow Up|0|||
161308396|NCT05036668|582509612|FG001|Overall Study|lost to follow Up|0|||
161308397|NCT05036668|582509613|FG002|Overall Study|lost to follow Up|1|||
161308398|NCT01537068|582509614|FG000|Overall Study|Lost to Follow-up|2|||
161308399|NCT01537068|582509615|FG001|Overall Study|Lost to Follow-up|1|||
161308400|NCT01537068|582509614|FG000|Overall Study|Adverse Event|0|||
161308401|NCT01537068|582509615|FG001|Overall Study|Adverse Event|1|||
161308402|NCT01537068|582509614|FG000|Overall Study|Withdrawal by Subject|1|||
161308403|NCT01537068|582509615|FG001|Overall Study|Withdrawal by Subject|1|||
161308404|NCT01537068|582509614|FG000|Overall Study|Lack of Efficacy|1|||
161308405|NCT01537068|582509615|FG001|Overall Study|Lack of Efficacy|0|||
161308406|NCT00072280|582509617|FG000|Treatment|Found ineligible|1|||
161308407|NCT00072280|582509618|FG001|Treatment|Found ineligible|2|||
161308408|NCT00072280|582509617|FG000|Follow-up|Early termination of study|2|||
161308409|NCT00072280|582509618|FG001|Follow-up|Early termination of study|2|||
161308410|NCT00833482|582509620|FG000|Days 11-20|Adverse Event|0|||
161308411|NCT00833482|582509621|FG001|Days 11-20|Adverse Event|2|||
161308412|NCT00833482|582509622|FG002|Days 11-20|Adverse Event|0|||
161308413|NCT00833482|582509623|FG003|Days 11-20|Adverse Event|0|||
161308414|NCT00833482|582509624|FG004|Days 11-20|Adverse Event|0|||
161308415|NCT00833482|582509625|FG005|Days 11-20|Adverse Event|0|||
161308416|NCT00833482|582509620|FG000|Days 11-20|Withdrawal by Subject|0|||
161308417|NCT00833482|582509621|FG001|Days 11-20|Withdrawal by Subject|1|||
161308418|NCT00833482|582509622|FG002|Days 11-20|Withdrawal by Subject|0|||
161308419|NCT00833482|582509623|FG003|Days 11-20|Withdrawal by Subject|0|||
161308420|NCT00833482|582509624|FG004|Days 11-20|Withdrawal by Subject|0|||
161308421|NCT00833482|582509625|FG005|Days 11-20|Withdrawal by Subject|0|||
161308422|NCT00833482|582509620|FG000|Days 21-30|Adverse Event|0|||
161308423|NCT00833482|582509621|FG001|Days 21-30|Adverse Event|0|||
161308424|NCT00833482|582509622|FG002|Days 21-30|Adverse Event|1|||
161308425|NCT00833482|582509623|FG003|Days 21-30|Adverse Event|0|||
161199052|NCT01361308|582110941|FG000|Overall Study|Withdrawal by Subject|9|||
161199053|NCT01361308|582110942|FG001|Overall Study|Withdrawal by Subject|13|||
161199054|NCT01361308|582110941|FG000|Overall Study|Physician Decision|3|||
161199055|NCT01361308|582110942|FG001|Overall Study|Physician Decision|3|||
161199056|NCT01361308|582110941|FG000|Overall Study|Lack of Efficacy|2|||
161199057|NCT01361308|582110942|FG001|Overall Study|Lack of Efficacy|0|||
161199058|NCT01361308|582110941|FG000|Overall Study|Protocol Violation|1|||
161199059|NCT01361308|582110942|FG001|Overall Study|Protocol Violation|0|||
161199060|NCT01361308|582110941|FG000|Overall Study|Lost to Follow-up|5|||
161199061|NCT01361308|582110942|FG001|Overall Study|Lost to Follow-up|4|||
161199062|NCT01361308|582110941|FG000|Overall Study|Adverse Event|8|||
161199063|NCT01361308|582110942|FG001|Overall Study|Adverse Event|4|||
161199064|NCT01361308|582110941|FG000|Overall Study|Eligibility Criteria Not Met|2|||
161199065|NCT01361308|582110942|FG001|Overall Study|Eligibility Criteria Not Met|3|||
161199066|NCT01361308|582110941|FG000|Overall Study|Failed C-SSRS|5|||
161199067|NCT01361308|582110942|FG001|Overall Study|Failed C-SSRS|2|||
161199068|NCT01361308|582110941|FG000|Overall Study|Other|0|||
161199069|NCT01361308|582110942|FG001|Overall Study|Other|1|||
161199070|NCT03839693|582110947|FG000|Overall Study|Lost to Follow-up|0|||
161199071|NCT03839693|582110948|FG001|Overall Study|Lost to Follow-up|2|||
161199072|NCT03839693|582110949|FG002|Overall Study|Lost to Follow-up|2|||
161199073|NCT03839693|582110947|FG000|Overall Study|Withdrawal by Subject|1|||
161199074|NCT03839693|582110948|FG001|Overall Study|Withdrawal by Subject|0|||
161199075|NCT03839693|582110949|FG002|Overall Study|Withdrawal by Subject|2|||
161199076|NCT03839693|582110947|FG000|Overall Study|subject moved out of the area|1|||
161199077|NCT03839693|582110948|FG001|Overall Study|subject moved out of the area|0|||
161199078|NCT03839693|582110949|FG002|Overall Study|subject moved out of the area|0|||
161199079|NCT00270205|582110958|FG000|Overall Study|Lost to Follow-up|1|||
161199080|NCT00270205|582110959|FG001|Overall Study|Lost to Follow-up|0|||
161199081|NCT00270205|582110960|FG002|Overall Study|Lost to Follow-up|0|||
161199082|NCT00270205|582110961|FG003|Overall Study|Lost to Follow-up|1|||
161199083|NCT00066573|582110962|FG000|Overall Study|Did not received protocol treatment|28|||
161199084|NCT00066573|582110963|FG001|Overall Study|Did not received protocol treatment|28|||
161199085|NCT02503215|582110964|FG000|Overall Study|Unable to wear compression stockings|1|||
161199086|NCT02503215|582110964|FG000|Overall Study|Unable to use positive airway pressure|2|||
161199087|NCT02983305|582110969|FG000|Overall Study|incomplete data|2|||
161199088|NCT02983305|582110970|FG001|Overall Study|incomplete data|0|||
161199089|NCT00706901|582110971|FG000|Overall Study|Lost to Follow-up|2|||
161199090|NCT00706901|582110972|FG001|Overall Study|Lost to Follow-up|3|||
161199091|NCT00706901|582110973|FG002|Overall Study|Lost to Follow-up|2|||
161199092|NCT00706901|582110971|FG000|Overall Study|Withdrawal by Subject|4|||
161199093|NCT00706901|582110972|FG001|Overall Study|Withdrawal by Subject|2|||
161199094|NCT00706901|582110973|FG002|Overall Study|Withdrawal by Subject|5|||
161308426|NCT00833482|582509624|FG004|Days 21-30|Adverse Event|0|||
161308427|NCT00833482|582509625|FG005|Days 21-30|Adverse Event|0|||
161308428|NCT00833482|582509620|FG000|Days 21-30|Withdrawal by Subject|0|||
161308429|NCT00833482|582509621|FG001|Days 21-30|Withdrawal by Subject|0|||
161308430|NCT00833482|582509622|FG002|Days 21-30|Withdrawal by Subject|0|||
161308431|NCT00833482|582509623|FG003|Days 21-30|Withdrawal by Subject|0|||
161308432|NCT00833482|582509624|FG004|Days 21-30|Withdrawal by Subject|1|||
161308433|NCT00833482|582509625|FG005|Days 21-30|Withdrawal by Subject|0|||
161308434|NCT02234596|582509626|FG000|Overall Study|Participant not treated|2|||
161308435|NCT03569293|582511932|FG000|Overall Study|Adverse Event|4|||
161308436|NCT03569293|582511933|FG001|Overall Study|Adverse Event|1|||
161308437|NCT03569293|582511934|FG002|Overall Study|Adverse Event|5|||
161308438|NCT03569293|582511935|FG003|Overall Study|Adverse Event|1|||
161308439|NCT03569293|582511936|FG004|Overall Study|Adverse Event|0|||
161308440|NCT03569293|582511937|FG005|Overall Study|Adverse Event|0|||
161308441|NCT03569293|582511932|FG000|Overall Study|Withdrawal by Subject|16|||
161308442|NCT03569293|582511933|FG001|Overall Study|Withdrawal by Subject|2|||
161308443|NCT03569293|582511934|FG002|Overall Study|Withdrawal by Subject|4|||
161308444|NCT03569293|582511935|FG003|Overall Study|Withdrawal by Subject|1|||
161308445|NCT03569293|582511936|FG004|Overall Study|Withdrawal by Subject|0|||
161308446|NCT03569293|582511937|FG005|Overall Study|Withdrawal by Subject|0|||
161308447|NCT03569293|582511932|FG000|Overall Study|Lost to Follow-up|1|||
161308448|NCT03569293|582511933|FG001|Overall Study|Lost to Follow-up|3|||
161308449|NCT03569293|582511934|FG002|Overall Study|Lost to Follow-up|1|||
161308450|NCT03569293|582511935|FG003|Overall Study|Lost to Follow-up|1|||
161308451|NCT03569293|582511936|FG004|Overall Study|Lost to Follow-up|0|||
161308452|NCT03569293|582511937|FG005|Overall Study|Lost to Follow-up|0|||
161308453|NCT03569293|582511932|FG000|Overall Study|Other|8|||
161308454|NCT03569293|582511933|FG001|Overall Study|Other|2|||
161308455|NCT03569293|582511934|FG002|Overall Study|Other|1|||
161308456|NCT03569293|582511935|FG003|Overall Study|Other|1|||
161308457|NCT03569293|582511936|FG004|Overall Study|Other|0|||
161308458|NCT03569293|582511937|FG005|Overall Study|Other|0|||
161308459|NCT03569293|582511932|FG000|Overall Study|Ongoing at Time of Analysis|8|||
161308460|NCT03569293|582511933|FG001|Overall Study|Ongoing at Time of Analysis|1|||
161308461|NCT03569293|582511934|FG002|Overall Study|Ongoing at Time of Analysis|3|||
161308462|NCT03569293|582511935|FG003|Overall Study|Ongoing at Time of Analysis|0|||
161308463|NCT03569293|582511936|FG004|Overall Study|Ongoing at Time of Analysis|0|||
161308464|NCT03569293|582511937|FG005|Overall Study|Ongoing at Time of Analysis|0|||
161308465|NCT05376241|582511948|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
161308466|NCT05376241|582511948|FG000|Overall Study|103 did not complete the survey|103|||
161308467|NCT05376241|582511948|FG000|Overall Study|17 failed 2 attention check questions|17|||
161308468|NCT03036098|582511949|FG000|Pre-Treatment|Other Reasons|1|||
161308469|NCT03036098|582511950|FG001|Pre-Treatment|Other Reasons|2|||
161308470|NCT03036098|582511951|FG002|Pre-Treatment|Other Reasons|0|||
161308471|NCT03036098|582511952|FG003|Pre-Treatment|Other Reasons|5|||
161308472|NCT03036098|582511949|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
161308473|NCT03036098|582511950|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
161308474|NCT03036098|582511951|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
161308475|NCT03036098|582511952|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
161308476|NCT03036098|582511949|FG000|Pre-Treatment|Withdrawal by Subject|1|||
161308477|NCT03036098|582511950|FG001|Pre-Treatment|Withdrawal by Subject|14|||
161308478|NCT03036098|582511951|FG002|Pre-Treatment|Withdrawal by Subject|0|||
161308479|NCT03036098|582511952|FG003|Pre-Treatment|Withdrawal by Subject|5|||
161308480|NCT03036098|582511949|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
161308481|NCT03036098|582511950|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
161308482|NCT03036098|582511951|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
161308483|NCT03036098|582511952|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
161308484|NCT03036098|582511949|FG000|Treatment|Disease Progression|130|||
161308485|NCT03036098|582511950|FG001|Treatment|Disease Progression|77|||
161308486|NCT03036098|582511951|FG002|Treatment|Disease Progression|168|||
161308487|NCT03036098|582511952|FG003|Treatment|Disease Progression|50|||
161308488|NCT03036098|582511949|FG000|Treatment|Study Drug Toxicity|95|||
161308489|NCT03036098|582511950|FG001|Treatment|Study Drug Toxicity|45|||
161308490|NCT03036098|582511951|FG002|Treatment|Study Drug Toxicity|26|||
161308491|NCT03036098|582511952|FG003|Treatment|Study Drug Toxicity|22|||
161308492|NCT03036098|582511949|FG000|Treatment|Death|9|||
161308493|NCT03036098|582511950|FG001|Treatment|Death|3|||
161308494|NCT03036098|582511951|FG002|Treatment|Death|1|||
161308495|NCT03036098|582511952|FG003|Treatment|Death|2|||
161308496|NCT03036098|582511949|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
161308497|NCT03036098|582511950|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
161308498|NCT03036098|582511951|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
161308499|NCT03036098|582511952|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
161308500|NCT03036098|582511949|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
161308501|NCT03036098|582511950|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
161308502|NCT03036098|582511951|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
161199095|NCT00706901|582110971|FG000|Overall Study|In Jail|1|||
161199096|NCT00706901|582110972|FG001|Overall Study|In Jail|0|||
161199097|NCT00706901|582110973|FG002|Overall Study|In Jail|1|||
161199098|NCT00706901|582110971|FG000|Overall Study|Death|1|||
161199099|NCT00706901|582110972|FG001|Overall Study|Death|0|||
161199100|NCT00706901|582110973|FG002|Overall Study|Death|0|||
161199101|NCT00822237|582110974|FG000|Dose 1 Vaccination|Not vaccinated|3|||
161199102|NCT00822237|582110975|FG001|Dose 1 Vaccination|Not vaccinated|0|||
161199103|NCT00822237|582110974|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
161199104|NCT00822237|582110975|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
161199105|NCT00822237|582110974|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
161199106|NCT00822237|582110975|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
161199107|NCT00822237|582110974|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
161199108|NCT00822237|582110975|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
161199109|NCT00822237|582110974|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
161199110|NCT00822237|582110975|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
161199111|NCT03433482|582110976|FG000|Overall Study|Lost to Follow-up|1|||
161199112|NCT03433482|582110977|FG001|Overall Study|Lost to Follow-up|0|||
161199113|NCT03433482|582110978|FG002|Overall Study|Lost to Follow-up|1|||
161199114|NCT03433482|582110979|FG003|Overall Study|Lost to Follow-up|1|||
161199115|NCT03433482|582110976|FG000|Overall Study|Withdrawal by Subject|0|||
161199116|NCT03433482|582110977|FG001|Overall Study|Withdrawal by Subject|0|||
161199117|NCT03433482|582110978|FG002|Overall Study|Withdrawal by Subject|1|||
161199118|NCT03433482|582110979|FG003|Overall Study|Withdrawal by Subject|0|||
161199119|NCT03433482|582110976|FG000|Overall Study|Unknown reason|0|||
161199120|NCT03433482|582110977|FG001|Overall Study|Unknown reason|0|||
161199121|NCT03433482|582110978|FG002|Overall Study|Unknown reason|2|||
161199122|NCT03433482|582110979|FG003|Overall Study|Unknown reason|0|||
161199123|NCT00437294|582110980|FG000|Overall Study|Adverse Event|5|||
161199124|NCT00437294|582110981|FG001|Overall Study|Adverse Event|4|||
161199125|NCT00437294|582110980|FG000|Overall Study|Death|5|||
161199126|NCT00437294|582110981|FG001|Overall Study|Death|2|||
161199127|NCT00437294|582110980|FG000|Overall Study|Physician Decision|0|||
161199128|NCT00437294|582110981|FG001|Overall Study|Physician Decision|3|||
161199129|NCT00437294|582110980|FG000|Overall Study|Withdrawal by Subject|5|||
161199130|NCT00437294|582110981|FG001|Overall Study|Withdrawal by Subject|0|||
161199131|NCT00437294|582110980|FG000|Overall Study|Progressive Disease|19|||
161199132|NCT00437294|582110981|FG001|Overall Study|Progressive Disease|23|||
161199133|NCT00437294|582110980|FG000|Overall Study|Sponsor Decision|8|||
161199134|NCT00437294|582110981|FG001|Overall Study|Sponsor Decision|9|||
161199135|NCT00437294|582110980|FG000|Overall Study|Protocol Violation|0|||
161199136|NCT00437294|582110981|FG001|Overall Study|Protocol Violation|1|||
161199137|NCT00437294|582110980|FG000|Overall Study|Entry criteria not met|1|||
161199138|NCT00437294|582110981|FG001|Overall Study|Entry criteria not met|1|||
161199139|NCT02222246|582110986|FG000|Overall Study|No Emergency Department Visits|27|||
161199140|NCT02222246|582110987|FG001|Overall Study|No Emergency Department Visits|26|||
161199141|NCT02222246|582110986|FG000|Overall Study|Physician Decision|0|||
161199142|NCT02222246|582110987|FG001|Overall Study|Physician Decision|1|||
161199143|NCT01646268|582110988|FG000|Overall Study|Adverse Event|6|||
161199144|NCT01646268|582110989|FG001|Overall Study|Adverse Event|7|||
161199145|NCT01646268|582110988|FG000|Overall Study|Lack of Efficacy|1|||
161199146|NCT01646268|582110989|FG001|Overall Study|Lack of Efficacy|3|||
161199147|NCT01646268|582110988|FG000|Overall Study|Protocol Violation|0|||
161199148|NCT01646268|582110989|FG001|Overall Study|Protocol Violation|1|||
161199149|NCT01646268|582110988|FG000|Overall Study|Withdrawal by Subject|2|||
161199150|NCT01646268|582110989|FG001|Overall Study|Withdrawal by Subject|5|||
161199151|NCT01646268|582110988|FG000|Overall Study|Other|2|||
161199152|NCT01646268|582110989|FG001|Overall Study|Other|0|||
161199153|NCT01473602|582110995|FG000|Overall Study|Adverse Event|1|||
161199154|NCT01473602|582110996|FG001|Overall Study|Adverse Event|2|||
161199155|NCT01473602|582110995|FG000|Overall Study|Death|0|||
161199156|NCT01473602|582110996|FG001|Overall Study|Death|1|||
161199157|NCT01473602|582110995|FG000|Overall Study|Lost to Follow-up|1|||
161199158|NCT01473602|582110996|FG001|Overall Study|Lost to Follow-up|1|||
161199159|NCT01473602|582110995|FG000|Overall Study|Withdrawal by Subject|5|||
161199160|NCT01473602|582110996|FG001|Overall Study|Withdrawal by Subject|4|||
161199161|NCT01473602|582110995|FG000|Overall Study|Physician Decision|1|||
161199162|NCT01473602|582110996|FG001|Overall Study|Physician Decision|0|||
161199163|NCT00560573|582110998|FG000|Overall Study|Death|4|||
161199164|NCT00560573|582110999|FG001|Overall Study|Death|1|||
161199165|NCT00560573|582111000|FG002|Overall Study|Death|4|||
161199166|NCT00560573|582111001|FG003|Overall Study|Death|5|||
161199167|NCT00560573|582111002|FG004|Overall Study|Death|1|||
161199168|NCT00560573|582111003|FG005|Overall Study|Death|10|||
161199169|NCT00560573|582110998|FG000|Overall Study|Lost to Follow-up|0|||
161199170|NCT00560573|582110999|FG001|Overall Study|Lost to Follow-up|0|||
161199171|NCT00560573|582111000|FG002|Overall Study|Lost to Follow-up|0|||
161199172|NCT00560573|582111001|FG003|Overall Study|Lost to Follow-up|1|||
161199173|NCT00560573|582111002|FG004|Overall Study|Lost to Follow-up|1|||
161199174|NCT00560573|582111003|FG005|Overall Study|Lost to Follow-up|0|||
161308503|NCT03036098|582511952|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
161308504|NCT03036098|582511949|FG000|Treatment|Withdrawal by Subject|2|||
161308505|NCT03036098|582511950|FG001|Treatment|Withdrawal by Subject|9|||
161308506|NCT03036098|582511951|FG002|Treatment|Withdrawal by Subject|2|||
161308507|NCT03036098|582511952|FG003|Treatment|Withdrawal by Subject|4|||
161308508|NCT03036098|582511949|FG000|Treatment|Maximum Clinical Benefit|6|||
161308509|NCT03036098|582511950|FG001|Treatment|Maximum Clinical Benefit|1|||
161308510|NCT03036098|582511951|FG002|Treatment|Maximum Clinical Benefit|6|||
161308511|NCT03036098|582511952|FG003|Treatment|Maximum Clinical Benefit|10|||
161308512|NCT03036098|582511949|FG000|Treatment|Poor/Non Compliance|1|||
161308513|NCT03036098|582511950|FG001|Treatment|Poor/Non Compliance|2|||
161308514|NCT03036098|582511951|FG002|Treatment|Poor/Non Compliance|0|||
161308515|NCT03036098|582511952|FG003|Treatment|Poor/Non Compliance|1|||
161308516|NCT03036098|582511949|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
161308517|NCT03036098|582511950|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
161308518|NCT03036098|582511951|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
161308519|NCT03036098|582511952|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
161308520|NCT03036098|582511949|FG000|Treatment|Administrative Reason by Sponsor|1|||
161308521|NCT03036098|582511950|FG001|Treatment|Administrative Reason by Sponsor|0|||
161308522|NCT03036098|582511951|FG002|Treatment|Administrative Reason by Sponsor|2|||
161308523|NCT03036098|582511952|FG003|Treatment|Administrative Reason by Sponsor|1|||
161308524|NCT03036098|582511949|FG000|Treatment|Other Reasons|31|||
161308525|NCT03036098|582511950|FG001|Treatment|Other Reasons|5|||
161308526|NCT03036098|582511951|FG002|Treatment|Other Reasons|21|||
161308527|NCT03036098|582511952|FG003|Treatment|Other Reasons|8|||
161308528|NCT03036098|582511949|FG000|Treatment|Ongoing Treatment|0|||
161308529|NCT03036098|582511950|FG001|Treatment|Ongoing Treatment|0|||
161308530|NCT03036098|582511951|FG002|Treatment|Ongoing Treatment|23|||
161308531|NCT03036098|582511952|FG003|Treatment|Ongoing Treatment|0|||
161308532|NCT02276053|582511955|FG000|Overall Study|Death|2|||
161308533|NCT02276053|582511955|FG000|Overall Study|Adverse Event|5|||
161308534|NCT02276053|582511955|FG000|Overall Study|Lack of Efficacy|2|||
161308535|NCT02276053|582511955|FG000|Overall Study|Withdrawal by Subject|1|||
161308536|NCT02276053|582511955|FG000|Overall Study|Patient does not meet selection criteria|3|||
161308537|NCT02276053|582511955|FG000|Overall Study|Patient needs to increase baseline AED|1|||
161308538|NCT01632904|582511956|FG000|Overall Study|Adverse Event|4|||
161308539|NCT01632904|582511957|FG001|Overall Study|Adverse Event|1|||
161308540|NCT01632904|582511956|FG000|Overall Study|Physician Decision|0|||
161308541|NCT01632904|582511957|FG001|Overall Study|Physician Decision|1|||
161308542|NCT01632904|582511956|FG000|Overall Study|Subject decision|3|||
161308543|NCT01632904|582511957|FG001|Overall Study|Subject decision|2|||
161308544|NCT01632904|582511956|FG000|Overall Study|Disease Progression|0|||
161308545|NCT01632904|582511957|FG001|Overall Study|Disease Progression|1|||
161308546|NCT01632904|582511956|FG000|Overall Study|Reason for discontinuation not available|0|||
161308547|NCT01632904|582511957|FG001|Overall Study|Reason for discontinuation not available|1|||
161308548|NCT02059434|582511958|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
161308549|NCT02059434|582511959|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
161308550|NCT02059434|582511960|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
161308551|NCT02059434|582511961|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
161308552|NCT02059434|582511962|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
161308553|NCT02059434|582511963|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
161308554|NCT02059434|582511964|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
161308555|NCT02059434|582511965|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
161308556|NCT02059434|582511966|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
161308557|NCT02059434|582511958|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
161308558|NCT02059434|582511959|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
161308559|NCT02059434|582511960|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
161308560|NCT02059434|582511961|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
161308561|NCT02059434|582511962|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
161308562|NCT02059434|582511963|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
161308563|NCT02059434|582511964|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
161308564|NCT02059434|582511965|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
161308565|NCT02059434|582511966|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
161308566|NCT02059434|582511958|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
161308567|NCT02059434|582511959|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
161308568|NCT02059434|582511960|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
161308569|NCT02059434|582511961|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
161308570|NCT02059434|582511962|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
161308571|NCT02059434|582511963|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
161308572|NCT02059434|582511964|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
161308573|NCT02059434|582511965|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
161308574|NCT02059434|582511966|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
161308575|NCT02059434|582511958|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
161308576|NCT02059434|582511959|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
161308577|NCT02059434|582511960|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
161308578|NCT02059434|582511961|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
161308579|NCT02059434|582511962|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
161308580|NCT02059434|582511963|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
161308581|NCT02059434|582511964|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
161308582|NCT02059434|582511965|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
161308583|NCT02059434|582511966|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
161308584|NCT02059434|582511958|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308585|NCT02059434|582511959|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308586|NCT02059434|582511960|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308587|NCT02059434|582511961|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308588|NCT02059434|582511962|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308589|NCT02059434|582511963|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308590|NCT02059434|582511964|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308591|NCT02059434|582511965|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
161308592|NCT02059434|582511966|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
161308593|NCT01004406|582511971|FG000|Overall Study|Withdrawal by Subject|2|||
161308594|NCT01004406|582511972|FG001|Overall Study|Withdrawal by Subject|0|||
161308595|NCT01004406|582511971|FG000|Overall Study|Lost to Follow-up|1|||
161308596|NCT01004406|582511972|FG001|Overall Study|Lost to Follow-up|0|||
161308597|NCT02928770|582511973|FG000|Overall Study|Withdrawal by Subject|2|||
161308598|NCT03201874|582511974|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
161308599|NCT03201874|582511975|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
161308600|NCT03201874|582511974|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
161308601|NCT03201874|582511975|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
161308602|NCT02907593|582511978|FG000|Overall Study|Withdrawal by Subject|0|||
161199175|NCT00560573|582110998|FG000|Overall Study|Withdrawal by Subject|0|||
161199176|NCT00560573|582110999|FG001|Overall Study|Withdrawal by Subject|0|||
161199177|NCT00560573|582111000|FG002|Overall Study|Withdrawal by Subject|0|||
161199178|NCT00560573|582111001|FG003|Overall Study|Withdrawal by Subject|1|||
161199179|NCT00560573|582111002|FG004|Overall Study|Withdrawal by Subject|1|||
161199180|NCT00560573|582111003|FG005|Overall Study|Withdrawal by Subject|0|||
161199181|NCT00560573|582110998|FG000|Overall Study|Other|2|||
161199182|NCT00560573|582110999|FG001|Overall Study|Other|2|||
161199183|NCT00560573|582111000|FG002|Overall Study|Other|2|||
161199184|NCT00560573|582111001|FG003|Overall Study|Other|3|||
161199185|NCT00560573|582111002|FG004|Overall Study|Other|3|||
161199186|NCT00560573|582111003|FG005|Overall Study|Other|3|||
161199187|NCT00560573|582110998|FG000|Overall Study|Enrolled, not treated|0|||
161199188|NCT00560573|582110999|FG001|Overall Study|Enrolled, not treated|0|||
161199189|NCT00560573|582111000|FG002|Overall Study|Enrolled, not treated|0|||
161199190|NCT00560573|582111001|FG003|Overall Study|Enrolled, not treated|0|||
161199191|NCT00560573|582111002|FG004|Overall Study|Enrolled, not treated|1|||
161199192|NCT00560573|582111003|FG005|Overall Study|Enrolled, not treated|0|||
161199193|NCT01422876|582111007|FG000|Week 24|Lost to Follow-up|1|||
161199194|NCT01422876|582111008|FG001|Week 24|Lost to Follow-up|1|||
161199195|NCT01422876|582111009|FG002|Week 24|Lost to Follow-up|2|||
161199196|NCT01422876|582111010|FG003|Week 24|Lost to Follow-up|4|||
161199197|NCT01422876|582111011|FG004|Week 24|Lost to Follow-up|2|||
161199198|NCT01422876|582111012|FG005|Week 24|Lost to Follow-up|0|||
161199199|NCT01422876|582111013|FG006|Week 24|Lost to Follow-up|1|||
161199200|NCT01422876|582111014|FG007|Week 24|Lost to Follow-up|3|||
161199201|NCT01422876|582111015|FG008|Week 24|Lost to Follow-up|3|||
161199202|NCT01422876|582111016|FG009|Week 24|Lost to Follow-up|4|||
161199203|NCT01422876|582111007|FG000|Week 24|Consent withdrawn|5|||
161199204|NCT01422876|582111008|FG001|Week 24|Consent withdrawn|1|||
161199205|NCT01422876|582111009|FG002|Week 24|Consent withdrawn|3|||
161199206|NCT01422876|582111010|FG003|Week 24|Consent withdrawn|4|||
161199207|NCT01422876|582111011|FG004|Week 24|Consent withdrawn|5|||
161199208|NCT01422876|582111012|FG005|Week 24|Consent withdrawn|6|||
161199209|NCT01422876|582111013|FG006|Week 24|Consent withdrawn|5|||
161199210|NCT01422876|582111014|FG007|Week 24|Consent withdrawn|4|||
161199211|NCT01422876|582111015|FG008|Week 24|Consent withdrawn|3|||
161199212|NCT01422876|582111016|FG009|Week 24|Consent withdrawn|6|||
161199213|NCT01422876|582111007|FG000|Week 24|Death|0|||
161199214|NCT01422876|582111008|FG001|Week 24|Death|1|||
161199215|NCT01422876|582111009|FG002|Week 24|Death|0|||
161199216|NCT01422876|582111010|FG003|Week 24|Death|0|||
161199217|NCT01422876|582111011|FG004|Week 24|Death|0|||
161199218|NCT01422876|582111012|FG005|Week 24|Death|0|||
161199219|NCT01422876|582111013|FG006|Week 24|Death|0|||
161199220|NCT01422876|582111014|FG007|Week 24|Death|0|||
161199221|NCT01422876|582111015|FG008|Week 24|Death|0|||
161199222|NCT01422876|582111016|FG009|Week 24|Death|0|||
161199223|NCT01422876|582111007|FG000|Week 52|Lost to Follow-up|3|||
161199224|NCT01422876|582111008|FG001|Week 52|Lost to Follow-up|5|||
161199225|NCT01422876|582111009|FG002|Week 52|Lost to Follow-up|7|||
161199226|NCT01422876|582111010|FG003|Week 52|Lost to Follow-up|5|||
161199227|NCT01422876|582111011|FG004|Week 52|Lost to Follow-up|8|||
161199228|NCT01422876|582111012|FG005|Week 52|Lost to Follow-up|5|||
161199229|NCT01422876|582111013|FG006|Week 52|Lost to Follow-up|5|||
161199230|NCT01422876|582111014|FG007|Week 52|Lost to Follow-up|8|||
161199231|NCT01422876|582111015|FG008|Week 52|Lost to Follow-up|7|||
161199232|NCT01422876|582111016|FG009|Week 52|Lost to Follow-up|8|||
161199233|NCT01422876|582111007|FG000|Week 52|Consent withdrawn|9|||
161199234|NCT01422876|582111008|FG001|Week 52|Consent withdrawn|4|||
161199235|NCT01422876|582111009|FG002|Week 52|Consent withdrawn|6|||
161199236|NCT01422876|582111010|FG003|Week 52|Consent withdrawn|12|||
161199237|NCT01422876|582111011|FG004|Week 52|Consent withdrawn|7|||
161199238|NCT01422876|582111012|FG005|Week 52|Consent withdrawn|12|||
161199239|NCT01422876|582111013|FG006|Week 52|Consent withdrawn|10|||
161199240|NCT01422876|582111014|FG007|Week 52|Consent withdrawn|12|||
161199241|NCT01422876|582111015|FG008|Week 52|Consent withdrawn|13|||
161199242|NCT01422876|582111016|FG009|Week 52|Consent withdrawn|9|||
161199243|NCT01422876|582111007|FG000|Week 52|Death|0|||
161199244|NCT01422876|582111008|FG001|Week 52|Death|1|||
161199245|NCT01422876|582111009|FG002|Week 52|Death|0|||
161199246|NCT01422876|582111010|FG003|Week 52|Death|1|||
161199247|NCT01422876|582111011|FG004|Week 52|Death|0|||
161199248|NCT01422876|582111012|FG005|Week 52|Death|0|||
161199249|NCT01422876|582111013|FG006|Week 52|Death|1|||
161199250|NCT01422876|582111014|FG007|Week 52|Death|3|||
161199251|NCT01422876|582111015|FG008|Week 52|Death|1|||
161199252|NCT01422876|582111016|FG009|Week 52|Death|0|||
161199253|NCT01308476|582111017|FG000|Overall Study|Lost to Follow-up|2|||
161199254|NCT01308476|582111018|FG001|Overall Study|Lost to Follow-up|2|||
161199255|NCT01308476|582111017|FG000|Overall Study|Other|1|||
161199256|NCT01308476|582111018|FG001|Overall Study|Other|0|||
161199257|NCT03772574|582111019|FG000|Overall Study|Protocol Violation|2|||
161199258|NCT03772574|582111020|FG001|Overall Study|Protocol Violation|0|||
161199259|NCT03772574|582111021|FG002|Overall Study|Protocol Violation|0|||
161199260|NCT03772574|582111019|FG000|Overall Study|Discomfort|0|||
161199261|NCT03772574|582111020|FG001|Overall Study|Discomfort|5|||
161199262|NCT03772574|582111021|FG002|Overall Study|Discomfort|4|||
161199263|NCT00812968|582111024|FG000|Overall Study|Relapse after erythroid response|6|||
161199264|NCT00812968|582111024|FG000|Overall Study|Disease progression|1|||
161199265|NCT00812968|582111024|FG000|Overall Study|No further treatment required|1|||
161199266|NCT00812968|582111024|FG000|Overall Study|Study closed due to marketing approval|3|||
161199267|NCT02696382|582111025|FG000|Overall Study|Death|7|||
161199268|NCT02696382|582111026|FG001|Overall Study|Death|2|||
161199269|NCT02696382|582111025|FG000|Overall Study|Withdrawal by Subject|5|||
161199270|NCT02696382|582111026|FG001|Overall Study|Withdrawal by Subject|12|||
161199271|NCT02696382|582111025|FG000|Overall Study|Lost to Follow-up|4|||
161199272|NCT02696382|582111026|FG001|Overall Study|Lost to Follow-up|7|||
161199273|NCT00505765|582111032|FG000|Overall Study|Withdrawal by Subject|1|||
161199274|NCT00505765|582111033|FG001|Overall Study|Withdrawal by Subject|0|||
161199275|NCT00505765|582111034|FG002|Overall Study|Withdrawal by Subject|0|||
161199276|NCT00505765|582111032|FG000|Overall Study|Adverse Event|1|||
161199277|NCT00505765|582111033|FG001|Overall Study|Adverse Event|2|||
161199278|NCT00505765|582111034|FG002|Overall Study|Adverse Event|0|||
161199279|NCT00505765|582111032|FG000|Overall Study|Noncompliance|0|||
161199280|NCT00505765|582111033|FG001|Overall Study|Noncompliance|1|||
161199281|NCT00505765|582111034|FG002|Overall Study|Noncompliance|3|||
161199282|NCT01207219|582111036|FG000|Overall Study|changed diagnosis during study period|5|||
161199283|NCT01207219|582111037|FG001|Overall Study|changed diagnosis during study period|3|||
161199284|NCT01207219|582111038|FG002|Overall Study|changed diagnosis during study period|1|||
161199285|NCT01207219|582111036|FG000|Overall Study|Lost to Follow-up|6|||
161199286|NCT01207219|582111037|FG001|Overall Study|Lost to Follow-up|8|||
161199287|NCT01207219|582111038|FG002|Overall Study|Lost to Follow-up|6|||
161199288|NCT01012609|582111039|FG000|Overall Study|Withdrawal by Subject|1|||
161199289|NCT01012609|582111040|FG001|Overall Study|Withdrawal by Subject|1|||
161199290|NCT01453296|582111041|FG000|Treatment Period 1|Adverse Event|0|||
161199291|NCT01453296|582111042|FG001|Treatment Period 1|Adverse Event|1|||
161199292|NCT01453296|582111041|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
161199293|NCT01453296|582111042|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
161199294|NCT01453296|582111041|FG000|Treatment Period 2|Adverse Event|1|||
161199295|NCT01453296|582111042|FG001|Treatment Period 2|Adverse Event|0|||
161199296|NCT01453296|582111041|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161199297|NCT01453296|582111042|FG001|Treatment Period 2|Withdrawal by Subject|0|||
161199298|NCT00620776|582111043|FG000|Overall Study|Did not receive treatment|3|||
161199299|NCT00620776|582111044|FG001|Overall Study|Did not receive treatment|5|||
161199300|NCT00620776|582111043|FG000|Overall Study|Adverse Event|2|||
161199301|NCT00620776|582111044|FG001|Overall Study|Adverse Event|3|||
161199302|NCT00620776|582111043|FG000|Overall Study|Lack of Efficacy|2|||
161199303|NCT00620776|582111044|FG001|Overall Study|Lack of Efficacy|1|||
161199304|NCT00620776|582111043|FG000|Overall Study|Lost to Follow-up|2|||
161199305|NCT00620776|582111044|FG001|Overall Study|Lost to Follow-up|5|||
161199306|NCT00620776|582111043|FG000|Overall Study|Withdrawal by Subject|3|||
161199307|NCT00620776|582111044|FG001|Overall Study|Withdrawal by Subject|2|||
161199308|NCT04983589|582111045|FG000|Overall Study|Withdrawal by Subject|0|||
161199309|NCT04983589|582111046|FG001|Overall Study|Withdrawal by Subject|3|||
161199310|NCT04983589|582111045|FG000|Overall Study|COVID-19 Infection|1|||
161199311|NCT04983589|582111046|FG001|Overall Study|COVID-19 Infection|0|||
161199312|NCT04983589|582111045|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
161199313|NCT04983589|582111046|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
161199314|NCT00924820|582111047|FG000|Overall Study|Death|2|||
161199315|NCT00924820|582111047|FG000|Overall Study|Ineligible, Screen Failure|5|||
161199316|NCT00761969|582111048|FG000|Overall Study|Death|112|||
161199317|NCT00761969|582111049|FG001|Overall Study|Death|47|||
161199318|NCT00761969|582111048|FG000|Overall Study|Lost to Follow-up|88|||
161199319|NCT00761969|582111049|FG001|Overall Study|Lost to Follow-up|93|||
161199320|NCT01725217|582111050|FG000|Overall Study|Withdrawal by Subject|1|||
161199321|NCT01725217|582111051|FG001|Overall Study|Withdrawal by Subject|0|||
161199322|NCT01725217|582111052|FG002|Overall Study|Withdrawal by Subject|0|||
161199323|NCT00585468|582111053|FG000|First Intervention|Withdrawal by Subject|1|||
161199324|NCT00585468|582111054|FG001|First Intervention|Withdrawal by Subject|1|||
161199325|NCT02940392|582111059|FG000|Overall Study|Lost to Follow-up|3|||
161199326|NCT02940392|582111059|FG000|Overall Study|Retreatment|3|||
161199327|NCT02940392|582111059|FG000|Overall Study|Death|2|||
161199328|NCT00762073|582111062|FG000|Overall Study|Lack of Efficacy|1|||
161199329|NCT00762073|582111063|FG001|Overall Study|Lack of Efficacy|1|||
161199330|NCT00762073|582111064|FG002|Overall Study|Lack of Efficacy|0|||
161199331|NCT00762073|582111065|FG003|Overall Study|Lack of Efficacy|0|||
161199332|NCT00762073|582111062|FG000|Overall Study|Adverse Event|1|||
161199333|NCT00762073|582111063|FG001|Overall Study|Adverse Event|0|||
161199334|NCT00762073|582111064|FG002|Overall Study|Adverse Event|1|||
161199335|NCT00762073|582111065|FG003|Overall Study|Adverse Event|1|||
161199336|NCT00762073|582111062|FG000|Overall Study|Significant Subject Noncompliance|0|||
161199337|NCT00762073|582111063|FG001|Overall Study|Significant Subject Noncompliance|1|||
161199338|NCT00762073|582111064|FG002|Overall Study|Significant Subject Noncompliance|0|||
161199339|NCT00762073|582111065|FG003|Overall Study|Significant Subject Noncompliance|1|||
161199340|NCT00762073|582111062|FG000|Overall Study|Withdrawal by Subject|1|||
161199341|NCT00762073|582111063|FG001|Overall Study|Withdrawal by Subject|2|||
161199342|NCT00762073|582111064|FG002|Overall Study|Withdrawal by Subject|1|||
161199343|NCT00762073|582111065|FG003|Overall Study|Withdrawal by Subject|1|||
161199344|NCT00762073|582111062|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
161199345|NCT00762073|582111063|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
161199346|NCT00762073|582111064|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
161199347|NCT00762073|582111065|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
161199348|NCT01068418|582111066|FG000|Overall Study|Physician Decision|12|||
161199349|NCT02319642|582111067|FG000|Overall Study|Adverse Event|2|||
161199350|NCT02319642|582111068|FG001|Overall Study|Adverse Event|4|||
161199351|NCT02319642|582111067|FG000|Overall Study|Lack of Efficacy|1|||
161199352|NCT02319642|582111068|FG001|Overall Study|Lack of Efficacy|1|||
161199353|NCT02319642|582111067|FG000|Overall Study|Withdrawal by Subject|1|||
161199354|NCT02319642|582111068|FG001|Overall Study|Withdrawal by Subject|1|||
161199355|NCT01265875|582111069|FG000|Overall Study|Uncooperative/unreliable|1|||
161199356|NCT01049360|582111072|FG000|Period 1|Adverse Event|0|||
161199357|NCT01049360|582111073|FG001|Period 1|Adverse Event|1|||
161199358|NCT01049360|582111074|FG002|Period 1|Adverse Event|0|||
161199359|NCT01049360|582111075|FG003|Period 1|Adverse Event|1|||
161199360|NCT01049360|582111076|FG004|Period 1|Adverse Event|0|||
161199361|NCT01049360|582111077|FG005|Period 1|Adverse Event|0|||
161199362|NCT01049360|582111078|FG006|Period 1|Adverse Event|0|||
161199363|NCT01049360|582111079|FG007|Period 1|Adverse Event|1|||
161199364|NCT01049360|582111080|FG008|Period 1|Adverse Event|0|||
161199365|NCT01049360|582111081|FG009|Period 1|Adverse Event|0|||
161199366|NCT01049360|582111082|FG010|Period 1|Adverse Event|0|||
161199367|NCT01049360|582111083|FG011|Period 1|Adverse Event|0|||
161199368|NCT01049360|582111084|FG012|Period 1|Adverse Event|1|||
161199369|NCT01049360|582111085|FG013|Period 1|Adverse Event|1|||
161199370|NCT01049360|582111086|FG014|Period 1|Adverse Event|0|||
161199371|NCT01049360|582111087|FG015|Period 1|Adverse Event|0|||
161199372|NCT01049360|582111088|FG016|Period 1|Adverse Event|1|||
161199373|NCT01049360|582111089|FG017|Period 1|Adverse Event|0|||
161199374|NCT01049360|582111090|FG018|Period 1|Adverse Event|1|||
161199375|NCT01049360|582111091|FG019|Period 1|Adverse Event|0|||
161199376|NCT01049360|582111072|FG000|Period 1|Did not meet inc/exc criteria|0|||
161199377|NCT01049360|582111073|FG001|Period 1|Did not meet inc/exc criteria|0|||
161199378|NCT01049360|582111074|FG002|Period 1|Did not meet inc/exc criteria|0|||
161199379|NCT01049360|582111075|FG003|Period 1|Did not meet inc/exc criteria|0|||
161199380|NCT01049360|582111076|FG004|Period 1|Did not meet inc/exc criteria|0|||
161199381|NCT01049360|582111077|FG005|Period 1|Did not meet inc/exc criteria|0|||
161199382|NCT01049360|582111078|FG006|Period 1|Did not meet inc/exc criteria|0|||
161199383|NCT01049360|582111079|FG007|Period 1|Did not meet inc/exc criteria|1|||
161199384|NCT01049360|582111080|FG008|Period 1|Did not meet inc/exc criteria|1|||
161199385|NCT01049360|582111081|FG009|Period 1|Did not meet inc/exc criteria|0|||
161199386|NCT01049360|582111082|FG010|Period 1|Did not meet inc/exc criteria|0|||
161199387|NCT01049360|582111083|FG011|Period 1|Did not meet inc/exc criteria|0|||
161199388|NCT01049360|582111084|FG012|Period 1|Did not meet inc/exc criteria|0|||
161199389|NCT01049360|582111085|FG013|Period 1|Did not meet inc/exc criteria|0|||
161199390|NCT01049360|582111086|FG014|Period 1|Did not meet inc/exc criteria|0|||
161199391|NCT01049360|582111087|FG015|Period 1|Did not meet inc/exc criteria|0|||
161199392|NCT01049360|582111088|FG016|Period 1|Did not meet inc/exc criteria|0|||
161199393|NCT01049360|582111089|FG017|Period 1|Did not meet inc/exc criteria|0|||
161199394|NCT01049360|582111090|FG018|Period 1|Did not meet inc/exc criteria|0|||
161199395|NCT01049360|582111091|FG019|Period 1|Did not meet inc/exc criteria|0|||
161199396|NCT01049360|582111072|FG000|Period 1|Withdrawal by Subject|0|||
161308603|NCT02907593|582511979|FG001|Overall Study|Withdrawal by Subject|0|||
161308604|NCT02907593|582511980|FG002|Overall Study|Withdrawal by Subject|1|||
161308605|NCT02907593|582511981|FG003|Overall Study|Withdrawal by Subject|0|||
161308606|NCT01944670|582511982|FG000|Overall Study|Lost to Follow-up|2|||
161308607|NCT05128773|582511991|FG000|Overall Study|Sponsor decision to terminate study|3|||
161308608|NCT05906836|582511993|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
161308609|NCT05906836|582511993|FG000|Overall Study|Lost to Follow-up|1|||
161308610|NCT04488497|582511994|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
161308611|NCT04488497|582511995|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
161199397|NCT01049360|582111073|FG001|Period 1|Withdrawal by Subject|0|||
161199398|NCT01049360|582111074|FG002|Period 1|Withdrawal by Subject|0|||
161199399|NCT01049360|582111075|FG003|Period 1|Withdrawal by Subject|0|||
161199400|NCT01049360|582111076|FG004|Period 1|Withdrawal by Subject|0|||
161199401|NCT01049360|582111077|FG005|Period 1|Withdrawal by Subject|0|||
161199402|NCT01049360|582111078|FG006|Period 1|Withdrawal by Subject|0|||
161199403|NCT01049360|582111079|FG007|Period 1|Withdrawal by Subject|0|||
161199404|NCT01049360|582111080|FG008|Period 1|Withdrawal by Subject|1|||
161199405|NCT01049360|582111081|FG009|Period 1|Withdrawal by Subject|0|||
161199406|NCT01049360|582111082|FG010|Period 1|Withdrawal by Subject|1|||
161199407|NCT01049360|582111083|FG011|Period 1|Withdrawal by Subject|0|||
161199408|NCT01049360|582111084|FG012|Period 1|Withdrawal by Subject|1|||
161308612|NCT04488497|582511994|FG000|Intervention|Physician Decision|2|||
161090843|NCT03057977|581723753|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
161090844|NCT03057977|581723754|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
161090845|NCT03057977|581723753|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
161090846|NCT03057977|581723754|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
161090847|NCT03057977|581723753|FG000|Discontinuation From Treatment|Protocol Violation|6|||
161090848|NCT03057977|581723754|FG001|Discontinuation From Treatment|Protocol Violation|5|||
161090849|NCT03057977|581723753|FG000|Discontinuation From Treatment|Not treated|4|||
161090850|NCT03057977|581723754|FG001|Discontinuation From Treatment|Not treated|0|||
161090851|NCT03057977|581723753|FG000|Discontinuation From Treatment|Adverse Event|343|||
161090852|NCT03057977|581723754|FG001|Discontinuation From Treatment|Adverse Event|337|||
161090853|NCT03057977|581723753|FG000|Discontinuation From Treatment|Reason Unknown|0|||
161090854|NCT03057977|581723754|FG001|Discontinuation From Treatment|Reason Unknown|1|||
161090855|NCT03057977|581723753|FG000|Discontinuation From Treatment|Personal Reasons|1|||
161090856|NCT03057977|581723754|FG001|Discontinuation From Treatment|Personal Reasons|1|||
161090857|NCT03057977|581723753|FG000|Discontinuation From Treatment|Unblinded medication|1|||
161090858|NCT03057977|581723754|FG001|Discontinuation From Treatment|Unblinded medication|0|||
161090859|NCT03057977|581723753|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
161090860|NCT03057977|581723754|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
161090861|NCT03057977|581723753|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
161090862|NCT03057977|581723754|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
161090863|NCT03057977|581723753|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
161090864|NCT03057977|581723754|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
161090865|NCT03057977|581723753|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
161090866|NCT03057977|581723754|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
161090867|NCT03057977|581723753|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
161090868|NCT03057977|581723754|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
161090869|NCT03057977|581723753|FG000|Discontinuation From Treatment|Not attending study visit|3|||
161090870|NCT03057977|581723754|FG001|Discontinuation From Treatment|Not attending study visit|10|||
161090871|NCT03057977|581723753|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
161090872|NCT03057977|581723754|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
161199409|NCT01049360|582111085|FG013|Period 1|Withdrawal by Subject|0|||
161199410|NCT01049360|582111086|FG014|Period 1|Withdrawal by Subject|0|||
161199411|NCT01049360|582111087|FG015|Period 1|Withdrawal by Subject|0|||
161199412|NCT01049360|582111088|FG016|Period 1|Withdrawal by Subject|0|||
161199413|NCT01049360|582111089|FG017|Period 1|Withdrawal by Subject|0|||
161199414|NCT01049360|582111090|FG018|Period 1|Withdrawal by Subject|0|||
161199415|NCT01049360|582111091|FG019|Period 1|Withdrawal by Subject|0|||
161199416|NCT01049360|582111072|FG000|Period 2|Protocol Violation|0|||
161199417|NCT01049360|582111073|FG001|Period 2|Protocol Violation|0|||
161199418|NCT01049360|582111074|FG002|Period 2|Protocol Violation|0|||
161199419|NCT01049360|582111075|FG003|Period 2|Protocol Violation|1|||
161199420|NCT01049360|582111076|FG004|Period 2|Protocol Violation|0|||
161199421|NCT01049360|582111077|FG005|Period 2|Protocol Violation|0|||
161199422|NCT01049360|582111078|FG006|Period 2|Protocol Violation|0|||
161199423|NCT01049360|582111079|FG007|Period 2|Protocol Violation|0|||
161199424|NCT01049360|582111080|FG008|Period 2|Protocol Violation|0|||
161199425|NCT01049360|582111081|FG009|Period 2|Protocol Violation|0|||
161199426|NCT01049360|582111082|FG010|Period 2|Protocol Violation|0|||
161199427|NCT01049360|582111083|FG011|Period 2|Protocol Violation|0|||
161199428|NCT01049360|582111084|FG012|Period 2|Protocol Violation|0|||
161199429|NCT01049360|582111085|FG013|Period 2|Protocol Violation|0|||
161199430|NCT01049360|582111086|FG014|Period 2|Protocol Violation|1|||
161199431|NCT01049360|582111087|FG015|Period 2|Protocol Violation|1|||
161199432|NCT01049360|582111088|FG016|Period 2|Protocol Violation|0|||
161199433|NCT01049360|582111089|FG017|Period 2|Protocol Violation|0|||
161308613|NCT04488497|582511995|FG001|Intervention|Physician Decision|1|||
161308614|NCT04488497|582511994|FG000|Intervention|Withdrawal by Subject|5|||
161308615|NCT04488497|582511995|FG001|Intervention|Withdrawal by Subject|6|||
161308616|NCT04488497|582511994|FG000|Intervention|Lost to Follow-up|2|||
161308617|NCT04488497|582511995|FG001|Intervention|Lost to Follow-up|0|||
161308618|NCT04488497|582511994|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
161308619|NCT04488497|582511995|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
161308620|NCT04488497|582511994|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
161308621|NCT04488497|582511995|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
161308622|NCT00623597|582511996|FG000|Overall Study|Failed to return|1|||
161308623|NCT00623597|582511997|FG001|Overall Study|Failed to return|0|||
161308624|NCT01451164|582511998|FG000|Overall Study|Adverse Event|19|||
161308625|NCT01451164|582511999|FG001|Overall Study|Adverse Event|12|||
161308626|NCT01451164|582512000|FG002|Overall Study|Adverse Event|18|||
161308627|NCT01451164|582512001|FG003|Overall Study|Adverse Event|21|||
161308628|NCT01451164|582511998|FG000|Overall Study|Withdrawal Criteria|1|||
161308629|NCT01451164|582511999|FG001|Overall Study|Withdrawal Criteria|1|||
161308630|NCT01451164|582512000|FG002|Overall Study|Withdrawal Criteria|1|||
161308631|NCT01451164|582512001|FG003|Overall Study|Withdrawal Criteria|1|||
161308632|NCT01451164|582511998|FG000|Overall Study|Physician Decision|2|||
161308633|NCT01451164|582511999|FG001|Overall Study|Physician Decision|0|||
161308634|NCT01451164|582512000|FG002|Overall Study|Physician Decision|1|||
161308635|NCT01451164|582512001|FG003|Overall Study|Physician Decision|0|||
161308636|NCT01451164|582511998|FG000|Overall Study|Withdrawal by Subject|14|||
161308637|NCT01451164|582511999|FG001|Overall Study|Withdrawal by Subject|11|||
161308638|NCT01451164|582512000|FG002|Overall Study|Withdrawal by Subject|16|||
161308639|NCT01451164|582512001|FG003|Overall Study|Withdrawal by Subject|17|||
161308640|NCT01451164|582511998|FG000|Overall Study|Protocol Violation|0|||
161308641|NCT01451164|582511999|FG001|Overall Study|Protocol Violation|1|||
161308642|NCT01451164|582512000|FG002|Overall Study|Protocol Violation|0|||
161308643|NCT01451164|582512001|FG003|Overall Study|Protocol Violation|0|||
161308644|NCT01451164|582511998|FG000|Overall Study|Lack of Efficacy|7|||
161308645|NCT01451164|582511999|FG001|Overall Study|Lack of Efficacy|9|||
161308646|NCT01451164|582512000|FG002|Overall Study|Lack of Efficacy|9|||
161308647|NCT01451164|582512001|FG003|Overall Study|Lack of Efficacy|7|||
161308648|NCT01214252|582512005|FG000|Overall Study|Not eligible per protocol|82|||
161308649|NCT01877551|582512010|FG000|Overall Study|Physician Decision|0|||
161308650|NCT01877551|582512011|FG001|Overall Study|Physician Decision|1|||
161308651|NCT02659514|582512012|FG000|Overall Study|Adverse Event|3|||
161308652|NCT02659514|582512013|FG001|Overall Study|Adverse Event|12|||
161308653|NCT02659514|582512012|FG000|Overall Study|Disease Progression|23|||
161308654|NCT02659514|582512013|FG001|Overall Study|Disease Progression|13|||
161308655|NCT02659514|582512012|FG000|Overall Study|Withdrawal by Subject|0|||
161308656|NCT02659514|582512013|FG001|Overall Study|Withdrawal by Subject|4|||
161308657|NCT02659514|582512012|FG000|Overall Study|Lost to Follow-up|0|||
161308658|NCT02659514|582512013|FG001|Overall Study|Lost to Follow-up|1|||
161308659|NCT02659514|582512012|FG000|Overall Study|Death|6|||
161308660|NCT02659514|582512013|FG001|Overall Study|Death|1|||
161308661|NCT02659514|582512012|FG000|Overall Study|Reason Unspecified|0|||
161308662|NCT02659514|582512013|FG001|Overall Study|Reason Unspecified|3|||
161308663|NCT03409107|582512014|FG000|Overall Study|Withdrawal by Subject|4|||
161308664|NCT03409107|582512015|FG001|Overall Study|Withdrawal by Subject|2|||
161308665|NCT03409107|582512014|FG000|Overall Study|Physician Decision|1|||
161308666|NCT03409107|582512015|FG001|Overall Study|Physician Decision|0|||
161308667|NCT03409107|582512014|FG000|Overall Study|Lost to Follow-up|7|||
161308668|NCT03409107|582512015|FG001|Overall Study|Lost to Follow-up|2|||
161308669|NCT03409107|582512014|FG000|Overall Study|Adverse Event|5|||
161308670|NCT03409107|582512015|FG001|Overall Study|Adverse Event|3|||
161308671|NCT05007041|582512025|FG000|Overall Study|Missing Diary Entries|0|||
161308672|NCT05007041|582512026|FG001|Overall Study|Missing Diary Entries|1|||
161308673|NCT00705718|582512027|FG000|Overall Study|Death|6|||
161308674|NCT00705718|582512028|FG001|Overall Study|Death|6|||
161308675|NCT00705718|582512027|FG000|Overall Study|Not due for Visit|0|||
161308676|NCT00705718|582512028|FG001|Overall Study|Not due for Visit|12|||
161308677|NCT00705718|582512027|FG000|Overall Study|Follow up not done|1|||
161308678|NCT00705718|582512028|FG001|Overall Study|Follow up not done|4|||
161308679|NCT01459718|582512032|FG000|Overall Study|Physician Decision|1|||
161308680|NCT01459718|582512032|FG000|Overall Study|Lost to Follow-up|1|||
161308681|NCT01459718|582512032|FG000|Overall Study|Adverse Event|1|||
161308682|NCT01258075|582512033|FG000|Overall Study|Adverse Event|8|||
161308683|NCT01258075|582512034|FG001|Overall Study|Adverse Event|3|||
161308684|NCT01258075|582512033|FG000|Overall Study|Lost to Follow-up|11|||
161308685|NCT01258075|582512034|FG001|Overall Study|Lost to Follow-up|6|||
161308686|NCT01258075|582512033|FG000|Overall Study|Withdrawal by Subject|10|||
161308687|NCT01258075|582512034|FG001|Overall Study|Withdrawal by Subject|7|||
161308688|NCT01258075|582512033|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
161308689|NCT01258075|582512034|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
161308690|NCT01258075|582512033|FG000|Overall Study|Other|12|||
161308691|NCT01258075|582512034|FG001|Overall Study|Other|5|||
161308692|NCT04021121|582512039|FG000|Overall Study|Death|3|||
161308693|NCT04021121|582512040|FG001|Overall Study|Death|3|||
161308694|NCT04021121|582512041|FG002|Overall Study|Death|5|||
161308695|NCT04021121|582512042|FG003|Overall Study|Death|4|||
161308696|NCT06011161|582512043|FG000|Overall Study|Withdrawal by Subject|2|||
161308697|NCT06011161|582512043|FG000|Overall Study|Lost to Follow-up|5|||
161308698|NCT02291601|582512046|FG000|Abdomen|Did not qualify|333|||
161308699|NCT02291601|582512047|FG001|Abdomen|Did not qualify|54|||
161308700|NCT02291601|582512048|FG002|Abdomen|Did not qualify|339|||
161308701|NCT02291601|582512046|FG000|Groin|Did not qualify|183|||
161308702|NCT02291601|582512047|FG001|Groin|Did not qualify|30|||
161308703|NCT02291601|582512048|FG002|Groin|Did not qualify|177|||
161308704|NCT01597375|582512056|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
161308705|NCT01597375|582512057|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
161308706|NCT01597375|582512056|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
161308707|NCT01597375|582512057|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
161308708|NCT01597375|582512056|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
161308709|NCT01597375|582512057|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
161308710|NCT01597375|582512056|FG000|Washout (2 Weeks)|Adverse Event|1|||
161308711|NCT01597375|582512057|FG001|Washout (2 Weeks)|Adverse Event|0|||
161308712|NCT01597375|582512056|FG000|Second Intervention|Failed to react at both Aspirin|1|||
161308713|NCT01597375|582512057|FG001|Second Intervention|Failed to react at both Aspirin|1|||
161308714|NCT04017832|582512060|FG000|Overall Study|Withdrawal by Subject|13|||
161308715|NCT04017832|582512061|FG001|Overall Study|Withdrawal by Subject|12|||
161308716|NCT04017832|582512062|FG002|Overall Study|Withdrawal by Subject|21|||
161308717|NCT04017832|582512063|FG003|Overall Study|Withdrawal by Subject|7|||
161308718|NCT04017832|582512060|FG000|Overall Study|Lost to Follow-up|0|||
161308719|NCT04017832|582512061|FG001|Overall Study|Lost to Follow-up|3|||
161308720|NCT04017832|582512062|FG002|Overall Study|Lost to Follow-up|3|||
161308721|NCT04017832|582512063|FG003|Overall Study|Lost to Follow-up|1|||
161308722|NCT04017832|582512060|FG000|Overall Study|Physician Decision|1|||
161308723|NCT04017832|582512061|FG001|Overall Study|Physician Decision|1|||
161308724|NCT04017832|582512062|FG002|Overall Study|Physician Decision|1|||
161308725|NCT04017832|582512063|FG003|Overall Study|Physician Decision|1|||
161308726|NCT04017832|582512060|FG000|Overall Study|Death|2|||
161308727|NCT04017832|582512061|FG001|Overall Study|Death|2|||
161308728|NCT04017832|582512062|FG002|Overall Study|Death|1|||
161308729|NCT04017832|582512063|FG003|Overall Study|Death|0|||
161308730|NCT02375555|582512064|FG000|Induction Period|Adverse Event|7|||
161308731|NCT02375555|582512064|FG000|Induction Period|Withdrawal by Subject|2|||
161308732|NCT02375555|582512064|FG000|Induction Period|Other|1|||
161308733|NCT02375555|582512064|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
161308734|NCT02375555|582512064|FG000|Maintenance Period|Adverse Event|2|||
161308735|NCT02375555|582512064|FG000|Maintenance Period|Withdrawal by Subject|4|||
161308736|NCT02375555|582512064|FG000|Maintenance Period|Death|1|||
161308737|NCT02375555|582512064|FG000|Maintenance Period|Disease Progression|5|||
161308738|NCT02375555|582512064|FG000|Maintenance Period|Patient Non-compliance|1|||
161308739|NCT02375555|582512064|FG000|Maintenance Period|Still on maintenance|16|||
161308740|NCT01744184|582512070|FG000|Overall Study|Adverse Event|1|||
161308741|NCT01744184|582512071|FG001|Overall Study|Adverse Event|0|||
161308742|NCT01744184|582512070|FG000|Overall Study|Withdrawal by Subject|0|||
161308743|NCT01744184|582512071|FG001|Overall Study|Withdrawal by Subject|1|||
161308744|NCT02091986|582512072|FG000|Overall Study|7 rand in error 1 patient decision|2|||
161308745|NCT02091986|582512073|FG001|Overall Study|7 rand in error 1 patient decision|3|||
161308746|NCT02091986|582512074|FG002|Overall Study|7 rand in error 1 patient decision|3|||
161308747|NCT02091986|582512072|FG000|Overall Study|Lost to Follow-up|1|||
161308748|NCT02091986|582512073|FG001|Overall Study|Lost to Follow-up|0|||
161308749|NCT02091986|582512074|FG002|Overall Study|Lost to Follow-up|0|||
161308750|NCT02091986|582512072|FG000|Overall Study|Withdrawal by Subject|4|||
161308751|NCT02091986|582512073|FG001|Overall Study|Withdrawal by Subject|8|||
161308752|NCT02091986|582512074|FG002|Overall Study|Withdrawal by Subject|3|||
161308753|NCT02091986|582512072|FG000|Overall Study|Adverse Event|0|||
161308754|NCT02091986|582512073|FG001|Overall Study|Adverse Event|0|||
161308755|NCT02091986|582512074|FG002|Overall Study|Adverse Event|2|||
161308756|NCT02841280|582512075|FG000|Overall Study|Adverse Event|2|||
161308757|NCT02841280|582512076|FG001|Overall Study|Adverse Event|1|||
161308758|NCT02841280|582512075|FG000|Overall Study|Death|1|||
161308759|NCT02841280|582512076|FG001|Overall Study|Death|0|||
161308760|NCT02841280|582512075|FG000|Overall Study|Lost to Follow-up|2|||
161308761|NCT02841280|582512076|FG001|Overall Study|Lost to Follow-up|2|||
161308762|NCT02841280|582512075|FG000|Overall Study|Withdrawal by Subject|7|||
161308763|NCT02841280|582512076|FG001|Overall Study|Withdrawal by Subject|3|||
161308764|NCT02841280|582512075|FG000|Overall Study|Stop Point: BP above threshold|2|||
161308765|NCT02841280|582512076|FG001|Overall Study|Stop Point: BP above threshold|0|||
161308766|NCT00125242|582512077|FG000|Overall Study|did not qualify|7|||
161308767|NCT00125242|582512078|FG001|Overall Study|did not qualify|2|||
161308768|NCT01664949|582512079|FG000|Overall Study|Adverse Event|11|||
161308769|NCT01664949|582512080|FG001|Overall Study|Adverse Event|12|||
161308770|NCT01664949|582512079|FG000|Overall Study|Lack of Efficacy|1|||
161199434|NCT01049360|582111090|FG018|Period 2|Protocol Violation|0|||
161199435|NCT01049360|582111091|FG019|Period 2|Protocol Violation|0|||
161199436|NCT01049360|582111072|FG000|Period 2|Adverse Event|0|||
161199437|NCT01049360|582111073|FG001|Period 2|Adverse Event|1|||
161199438|NCT01049360|582111074|FG002|Period 2|Adverse Event|0|||
161199439|NCT01049360|582111075|FG003|Period 2|Adverse Event|0|||
161199440|NCT01049360|582111076|FG004|Period 2|Adverse Event|0|||
161199441|NCT01049360|582111077|FG005|Period 2|Adverse Event|0|||
161199442|NCT01049360|582111078|FG006|Period 2|Adverse Event|0|||
161199443|NCT01049360|582111079|FG007|Period 2|Adverse Event|0|||
161308771|NCT01664949|582512080|FG001|Overall Study|Lack of Efficacy|1|||
161308772|NCT01664949|582512079|FG000|Overall Study|Lost to Follow-up|1|||
161308773|NCT01664949|582512080|FG001|Overall Study|Lost to Follow-up|2|||
161308774|NCT01664949|582512079|FG000|Overall Study|Personal Reasons|3|||
161308775|NCT01664949|582512080|FG001|Overall Study|Personal Reasons|4|||
161308776|NCT01664949|582512079|FG000|Overall Study|Protocol Violation|5|||
161308777|NCT01664949|582512080|FG001|Overall Study|Protocol Violation|5|||
161308778|NCT01664949|582512079|FG000|Overall Study|Other Miscellaneous Reasons|3|||
161308779|NCT01664949|582512080|FG001|Overall Study|Other Miscellaneous Reasons|1|||
161308780|NCT02727777|582512087|FG000|Overall Study|Screen Failure|2|||
161308781|NCT02727777|582512088|FG001|Overall Study|Screen Failure|0|||
161308782|NCT02727777|582512089|FG002|Overall Study|Screen Failure|0|||
161308783|NCT02727777|582512087|FG000|Overall Study|Progressive disease|2|||
161308784|NCT02727777|582512088|FG001|Overall Study|Progressive disease|0|||
161308785|NCT02727777|582512089|FG002|Overall Study|Progressive disease|0|||
161308786|NCT00957268|582512090|FG000|Overall Study|Voluntary Withdrawal|0|||
161308787|NCT00957268|582512091|FG001|Overall Study|Voluntary Withdrawal|0|||
161308788|NCT00957268|582512092|FG002|Overall Study|Voluntary Withdrawal|1|||
161308789|NCT00957268|582512093|FG003|Overall Study|Voluntary Withdrawal|0|||
161308790|NCT00957268|582512094|FG004|Overall Study|Voluntary Withdrawal|0|||
161308791|NCT03003494|582512095|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
161308792|NCT01738503|582512096|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
161308793|NCT01738503|582512097|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
161308794|NCT01738503|582512098|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
161308795|NCT01738503|582512099|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
161308796|NCT01738503|582512100|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
161308797|NCT01738503|582512101|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
161308798|NCT01738503|582512102|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
161308799|NCT01738503|582512096|FG000|Treatment Period|Adverse Event|0|||
161308800|NCT01738503|582512097|FG001|Treatment Period|Adverse Event|1|||
161308801|NCT01738503|582512098|FG002|Treatment Period|Adverse Event|0|||
161308802|NCT01738503|582512099|FG003|Treatment Period|Adverse Event|1|||
161308803|NCT01738503|582512100|FG004|Treatment Period|Adverse Event|2|||
161308804|NCT01738503|582512101|FG005|Treatment Period|Adverse Event|2|||
161308805|NCT01738503|582512102|FG006|Treatment Period|Adverse Event|2|||
161308806|NCT01738503|582512096|FG000|Treatment Period|Lost to Follow-up|0|||
161308807|NCT01738503|582512097|FG001|Treatment Period|Lost to Follow-up|0|||
161308808|NCT01738503|582512098|FG002|Treatment Period|Lost to Follow-up|3|||
161308809|NCT01738503|582512099|FG003|Treatment Period|Lost to Follow-up|4|||
161308810|NCT01738503|582512100|FG004|Treatment Period|Lost to Follow-up|1|||
161308811|NCT01738503|582512101|FG005|Treatment Period|Lost to Follow-up|1|||
161308812|NCT01738503|582512102|FG006|Treatment Period|Lost to Follow-up|5|||
161308813|NCT01738503|582512096|FG000|Treatment Period|Withdrawal by Subject|0|||
161308814|NCT01738503|582512097|FG001|Treatment Period|Withdrawal by Subject|1|||
161308815|NCT01738503|582512098|FG002|Treatment Period|Withdrawal by Subject|0|||
161308816|NCT01738503|582512099|FG003|Treatment Period|Withdrawal by Subject|1|||
161308817|NCT01738503|582512100|FG004|Treatment Period|Withdrawal by Subject|1|||
161308818|NCT01738503|582512101|FG005|Treatment Period|Withdrawal by Subject|1|||
161308819|NCT01738503|582512102|FG006|Treatment Period|Withdrawal by Subject|1|||
161308820|NCT01738503|582512096|FG000|Treatment Period|Protocol Violation|0|||
161308821|NCT01738503|582512097|FG001|Treatment Period|Protocol Violation|3|||
161308822|NCT01738503|582512098|FG002|Treatment Period|Protocol Violation|1|||
161308823|NCT01738503|582512099|FG003|Treatment Period|Protocol Violation|0|||
161308824|NCT01738503|582512100|FG004|Treatment Period|Protocol Violation|4|||
161308825|NCT01738503|582512101|FG005|Treatment Period|Protocol Violation|2|||
161308826|NCT01738503|582512102|FG006|Treatment Period|Protocol Violation|0|||
161308827|NCT01738503|582512096|FG000|Treatment Period|Other|0|||
161308828|NCT01738503|582512097|FG001|Treatment Period|Other|0|||
161308829|NCT01738503|582512098|FG002|Treatment Period|Other|1|||
161199444|NCT01049360|582111080|FG008|Period 2|Adverse Event|1|||
161308830|NCT01738503|582512099|FG003|Treatment Period|Other|0|||
161308831|NCT01738503|582512100|FG004|Treatment Period|Other|0|||
161308832|NCT01738503|582512101|FG005|Treatment Period|Other|0|||
161308833|NCT01738503|582512102|FG006|Treatment Period|Other|0|||
161199445|NCT01049360|582111081|FG009|Period 2|Adverse Event|0|||
161199446|NCT01049360|582111082|FG010|Period 2|Adverse Event|0|||
161199447|NCT01049360|582111083|FG011|Period 2|Adverse Event|0|||
161308834|NCT01738503|582512096|FG000|PET Imaging Sub-study|Adverse Event|0|||
161308835|NCT01738503|582512097|FG001|PET Imaging Sub-study|Adverse Event|0|||
161199448|NCT01049360|582111084|FG012|Period 2|Adverse Event|0|||
161199449|NCT01049360|582111085|FG013|Period 2|Adverse Event|0|||
161199450|NCT01049360|582111086|FG014|Period 2|Adverse Event|0|||
161199451|NCT01049360|582111087|FG015|Period 2|Adverse Event|0|||
161199452|NCT01049360|582111088|FG016|Period 2|Adverse Event|0|||
161199453|NCT01049360|582111089|FG017|Period 2|Adverse Event|0|||
161199454|NCT01049360|582111090|FG018|Period 2|Adverse Event|0|||
161199455|NCT01049360|582111091|FG019|Period 2|Adverse Event|1|||
161199456|NCT01049360|582111072|FG000|Period 2|Withdrawal by Subject|0|||
161199457|NCT01049360|582111073|FG001|Period 2|Withdrawal by Subject|0|||
161199458|NCT01049360|582111074|FG002|Period 2|Withdrawal by Subject|0|||
161199459|NCT01049360|582111075|FG003|Period 2|Withdrawal by Subject|1|||
161199460|NCT01049360|582111076|FG004|Period 2|Withdrawal by Subject|0|||
161199461|NCT01049360|582111077|FG005|Period 2|Withdrawal by Subject|0|||
161199462|NCT01049360|582111078|FG006|Period 2|Withdrawal by Subject|0|||
161199463|NCT01049360|582111079|FG007|Period 2|Withdrawal by Subject|0|||
161199464|NCT01049360|582111080|FG008|Period 2|Withdrawal by Subject|0|||
161199465|NCT01049360|582111081|FG009|Period 2|Withdrawal by Subject|0|||
161199466|NCT01049360|582111082|FG010|Period 2|Withdrawal by Subject|0|||
161199467|NCT01049360|582111083|FG011|Period 2|Withdrawal by Subject|0|||
161199468|NCT01049360|582111084|FG012|Period 2|Withdrawal by Subject|0|||
161199469|NCT01049360|582111085|FG013|Period 2|Withdrawal by Subject|0|||
161199470|NCT01049360|582111086|FG014|Period 2|Withdrawal by Subject|1|||
161199471|NCT01049360|582111087|FG015|Period 2|Withdrawal by Subject|0|||
161199472|NCT01049360|582111088|FG016|Period 2|Withdrawal by Subject|0|||
161199473|NCT01049360|582111089|FG017|Period 2|Withdrawal by Subject|0|||
161199474|NCT01049360|582111090|FG018|Period 2|Withdrawal by Subject|0|||
161199475|NCT01049360|582111091|FG019|Period 2|Withdrawal by Subject|1|||
161199476|NCT01049360|582111072|FG000|Period 2|Lack of Efficacy|0|||
161199477|NCT01049360|582111073|FG001|Period 2|Lack of Efficacy|0|||
161199478|NCT01049360|582111074|FG002|Period 2|Lack of Efficacy|0|||
161199479|NCT01049360|582111075|FG003|Period 2|Lack of Efficacy|0|||
161199480|NCT01049360|582111076|FG004|Period 2|Lack of Efficacy|0|||
161199481|NCT01049360|582111077|FG005|Period 2|Lack of Efficacy|1|||
161199482|NCT01049360|582111078|FG006|Period 2|Lack of Efficacy|0|||
161199483|NCT01049360|582111079|FG007|Period 2|Lack of Efficacy|0|||
161199484|NCT01049360|582111080|FG008|Period 2|Lack of Efficacy|0|||
161199485|NCT01049360|582111081|FG009|Period 2|Lack of Efficacy|0|||
161199486|NCT01049360|582111082|FG010|Period 2|Lack of Efficacy|0|||
161199487|NCT01049360|582111083|FG011|Period 2|Lack of Efficacy|0|||
161199488|NCT01049360|582111084|FG012|Period 2|Lack of Efficacy|0|||
161199489|NCT01049360|582111085|FG013|Period 2|Lack of Efficacy|0|||
161199490|NCT01049360|582111086|FG014|Period 2|Lack of Efficacy|0|||
161199491|NCT01049360|582111087|FG015|Period 2|Lack of Efficacy|0|||
161199492|NCT01049360|582111088|FG016|Period 2|Lack of Efficacy|0|||
161199493|NCT01049360|582111089|FG017|Period 2|Lack of Efficacy|0|||
161199494|NCT01049360|582111090|FG018|Period 2|Lack of Efficacy|0|||
161199495|NCT01049360|582111091|FG019|Period 2|Lack of Efficacy|0|||
161199496|NCT01049360|582111072|FG000|Period 4|Protocol Violation|0|||
161199497|NCT01049360|582111073|FG001|Period 4|Protocol Violation|0|||
161199498|NCT01049360|582111074|FG002|Period 4|Protocol Violation|0|||
161199499|NCT01049360|582111075|FG003|Period 4|Protocol Violation|0|||
161199500|NCT01049360|582111076|FG004|Period 4|Protocol Violation|0|||
161199501|NCT01049360|582111077|FG005|Period 4|Protocol Violation|0|||
161199502|NCT01049360|582111078|FG006|Period 4|Protocol Violation|0|||
161199503|NCT01049360|582111079|FG007|Period 4|Protocol Violation|0|||
161199504|NCT01049360|582111080|FG008|Period 4|Protocol Violation|0|||
161199505|NCT01049360|582111081|FG009|Period 4|Protocol Violation|0|||
161199506|NCT01049360|582111082|FG010|Period 4|Protocol Violation|0|||
161199507|NCT01049360|582111083|FG011|Period 4|Protocol Violation|0|||
161199508|NCT01049360|582111084|FG012|Period 4|Protocol Violation|0|||
161199509|NCT01049360|582111085|FG013|Period 4|Protocol Violation|0|||
161199510|NCT01049360|582111086|FG014|Period 4|Protocol Violation|0|||
161199511|NCT01049360|582111087|FG015|Period 4|Protocol Violation|0|||
161199512|NCT01049360|582111088|FG016|Period 4|Protocol Violation|0|||
161199513|NCT01049360|582111089|FG017|Period 4|Protocol Violation|1|||
161199514|NCT01049360|582111090|FG018|Period 4|Protocol Violation|0|||
161199515|NCT01049360|582111091|FG019|Period 4|Protocol Violation|0|||
161199516|NCT01049360|582111072|FG000|Period 4|Withdrawal by Subject|0|||
161199517|NCT01049360|582111073|FG001|Period 4|Withdrawal by Subject|0|||
161199518|NCT01049360|582111074|FG002|Period 4|Withdrawal by Subject|0|||
161199519|NCT01049360|582111075|FG003|Period 4|Withdrawal by Subject|1|||
161199520|NCT01049360|582111076|FG004|Period 4|Withdrawal by Subject|0|||
161199521|NCT01049360|582111077|FG005|Period 4|Withdrawal by Subject|0|||
161199522|NCT01049360|582111078|FG006|Period 4|Withdrawal by Subject|0|||
161199523|NCT01049360|582111079|FG007|Period 4|Withdrawal by Subject|0|||
161199524|NCT01049360|582111080|FG008|Period 4|Withdrawal by Subject|0|||
161199525|NCT01049360|582111081|FG009|Period 4|Withdrawal by Subject|0|||
161199526|NCT01049360|582111082|FG010|Period 4|Withdrawal by Subject|0|||
161199527|NCT01049360|582111083|FG011|Period 4|Withdrawal by Subject|0|||
161199528|NCT01049360|582111084|FG012|Period 4|Withdrawal by Subject|0|||
161199529|NCT01049360|582111085|FG013|Period 4|Withdrawal by Subject|0|||
161199530|NCT01049360|582111086|FG014|Period 4|Withdrawal by Subject|0|||
161199531|NCT01049360|582111087|FG015|Period 4|Withdrawal by Subject|0|||
161199532|NCT01049360|582111088|FG016|Period 4|Withdrawal by Subject|0|||
161199533|NCT01049360|582111089|FG017|Period 4|Withdrawal by Subject|0|||
161199534|NCT01049360|582111090|FG018|Period 4|Withdrawal by Subject|0|||
161199535|NCT01049360|582111091|FG019|Period 4|Withdrawal by Subject|0|||
161199536|NCT05147311|582111094|FG000|Overall Study|Did not complete survey|2|||
161199537|NCT05147311|582111095|FG001|Overall Study|Did not complete survey|1|||
161199538|NCT05147311|582111094|FG000|Overall Study|Patient too sick|1|||
161199539|NCT05147311|582111095|FG001|Overall Study|Patient too sick|2|||
161199540|NCT05147311|582111094|FG000|Overall Study|Death|0|||
161199541|NCT05147311|582111095|FG001|Overall Study|Death|1|||
161199542|NCT05147311|582111094|FG000|Overall Study|Declined survey|1|||
161199543|NCT05147311|582111095|FG001|Overall Study|Declined survey|0|||
161199544|NCT00145795|582111097|FG000|Overall Study|Adverse Event|1|||
161199545|NCT00145795|582111098|FG001|Overall Study|Adverse Event|0|||
161199546|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Adverse Event|6|||
161199547|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Adverse Event|6|||
161199548|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Death|14|||
161199549|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Death|11|||
161199550|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
161199551|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
161199552|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
161199553|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
161199554|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
161199555|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
161199556|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Disease Progression|1|||
161199557|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Disease Progression|0|||
161199558|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
161199559|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
161199560|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
161199561|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
161199562|NCT04419558|582111099|FG000|DB Period (48 Weeks)|Participant Decision|4|||
161199563|NCT04419558|582111100|FG001|DB Period (48 Weeks)|Participant Decision|3|||
161199564|NCT04419558|582111099|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
161199565|NCT04419558|582111100|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
161199566|NCT04419558|582111099|FG000|OLE Period (48 Weeks)|Death|4|||
161199567|NCT04419558|582111100|FG001|OLE Period (48 Weeks)|Death|6|||
161199568|NCT04419558|582111099|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
161199569|NCT04419558|582111100|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
161199570|NCT04419558|582111099|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
161199571|NCT04419558|582111100|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
161199572|NCT01015118|582111104|FG000|Overall Study|Protocol Violation|5|||
161199573|NCT01015118|582111105|FG001|Overall Study|Protocol Violation|6|||
161199574|NCT01015118|582111104|FG000|Overall Study|Withdrawal by Subject|103|||
161199575|NCT01015118|582111105|FG001|Overall Study|Withdrawal by Subject|27|||
161199576|NCT01015118|582111104|FG000|Overall Study|Other Adverse Event (AE)|141|||
161199577|NCT01015118|582111105|FG001|Overall Study|Other Adverse Event (AE)|33|||
161199578|NCT01015118|582111104|FG000|Overall Study|Worsening or AE of underlying disease|5|||
161199579|NCT01015118|582111105|FG001|Overall Study|Worsening or AE of underlying disease|4|||
161199580|NCT01015118|582111104|FG000|Overall Study|Progressive disease|364|||
161199581|NCT01015118|582111105|FG001|Overall Study|Progressive disease|229|||
161199582|NCT01015118|582111104|FG000|Overall Study|Not treated|9|||
161199583|NCT01015118|582111105|FG001|Overall Study|Not treated|5|||
161199584|NCT01015118|582111104|FG000|Overall Study|Other than stated above|42|||
161199585|NCT01015118|582111105|FG001|Overall Study|Other than stated above|23|||
161199586|NCT02388906|582111110|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
161199587|NCT02388906|582111111|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
161199588|NCT02388906|582111110|FG000|Treatment Period|Disease progression|121|||
161199589|NCT02388906|582111111|FG001|Treatment Period|Disease progression|100|||
161199590|NCT02388906|582111110|FG000|Treatment Period|Study drug toxicity|41|||
161199591|NCT02388906|582111111|FG001|Treatment Period|Study drug toxicity|208|||
161199592|NCT02388906|582111110|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
161199593|NCT02388906|582111111|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
161199594|NCT02388906|582111110|FG000|Treatment Period|Participant request to stop treatment|5|||
161199595|NCT02388906|582111111|FG001|Treatment Period|Participant request to stop treatment|9|||
161199596|NCT02388906|582111110|FG000|Treatment Period|Participant withdrew consent|2|||
161199597|NCT02388906|582111111|FG001|Treatment Period|Participant withdrew consent|3|||
161199598|NCT02388906|582111110|FG000|Treatment Period|Poor/non-compliance|0|||
161199599|NCT02388906|582111111|FG001|Treatment Period|Poor/non-compliance|1|||
161199600|NCT02388906|582111110|FG000|Treatment Period|Participant no longer meets study criteria|0|||
161199601|NCT02388906|582111111|FG001|Treatment Period|Participant no longer meets study criteria|1|||
161199602|NCT02388906|582111110|FG000|Treatment Period|Other reasons|3|||
161199603|NCT02388906|582111111|FG001|Treatment Period|Other reasons|3|||
161199604|NCT00509223|582112912|FG000|Overall Study|Lost to Follow-up|1|||
161199605|NCT00509223|582112913|FG001|Overall Study|Lost to Follow-up|1|||
161199606|NCT00509223|582112912|FG000|Overall Study|Adverse Event|1|||
161199607|NCT00509223|582112913|FG001|Overall Study|Adverse Event|1|||
161199608|NCT00509223|582112912|FG000|Overall Study|Withdrawal by Subject|25|||
161199609|NCT00509223|582112913|FG001|Overall Study|Withdrawal by Subject|6|||
161199610|NCT00509223|582112912|FG000|Overall Study|Including: subject change of address|5|||
161199611|NCT00509223|582112913|FG001|Overall Study|Including: subject change of address|2|||
161199612|NCT00509223|582112912|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
161199613|NCT00509223|582112913|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
161199614|NCT02064231|582112914|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
161199615|NCT02064231|582112915|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
161199616|NCT02064231|582112916|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
161199617|NCT02064231|582112917|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
161199618|NCT02064231|582112914|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
161199619|NCT02064231|582112915|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
161199620|NCT02064231|582112916|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
161199621|NCT02064231|582112917|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
161199622|NCT02064231|582112914|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
161199623|NCT02064231|582112915|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
161199624|NCT02064231|582112916|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
161199625|NCT02064231|582112917|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
161199626|NCT02064231|582112914|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
161199627|NCT02064231|582112915|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
161199628|NCT02064231|582112916|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
161199629|NCT02064231|582112917|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
161199630|NCT01339273|582112918|FG000|Overall Study|Lost to Follow-up|8|||
161199631|NCT01339273|582112919|FG001|Overall Study|Lost to Follow-up|8|||
161199632|NCT04478994|582112920|FG000|Overall Study|Withdrawal by Subject|1|||
161199633|NCT04478994|582112921|FG001|Overall Study|Withdrawal by Subject|1|||
161199634|NCT00518531|582112922|FG000|Treatment Period 1|Adverse Event|5|||
161199635|NCT00518531|582112923|FG001|Treatment Period 1|Adverse Event|0|||
161199636|NCT00518531|582112922|FG000|Treatment Period 1|Lost to Follow-up|5|||
161199637|NCT00518531|582112923|FG001|Treatment Period 1|Lost to Follow-up|3|||
161199638|NCT00518531|582112922|FG000|Treatment Period 1|Physician Decision|1|||
161199639|NCT00518531|582112923|FG001|Treatment Period 1|Physician Decision|0|||
161199640|NCT00518531|582112922|FG000|Treatment Period 1|Protocol Violation|2|||
161199641|NCT00518531|582112923|FG001|Treatment Period 1|Protocol Violation|0|||
161199642|NCT00518531|582112922|FG000|Treatment Period 1|Withdrawal by Subject|4|||
161199643|NCT00518531|582112923|FG001|Treatment Period 1|Withdrawal by Subject|6|||
161199644|NCT00518531|582112922|FG000|Treatment Period 1|Early crossover|1|||
161199645|NCT00518531|582112923|FG001|Treatment Period 1|Early crossover|3|||
161199646|NCT00518531|582112922|FG000|Treatment Period 2|Withdrawal by Subject|0|||
161199647|NCT00518531|582112923|FG001|Treatment Period 2|Withdrawal by Subject|8|||
161199648|NCT00518531|582112922|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
161199649|NCT00518531|582112923|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
161199650|NCT00518531|582112922|FG000|Treatment Period 2|Adverse Event|1|||
161199651|NCT00518531|582112923|FG001|Treatment Period 2|Adverse Event|7|||
161199652|NCT00518531|582112922|FG000|Treatment Period 2|Protocol-specified criteria|0|||
161199653|NCT00518531|582112923|FG001|Treatment Period 2|Protocol-specified criteria|1|||
161199654|NCT00518531|582112922|FG000|Treatment Period 2|Non-compliance|1|||
161199655|NCT00518531|582112923|FG001|Treatment Period 2|Non-compliance|2|||
161199656|NCT00457249|582112924|FG000|Overall Study|Lost to Follow-up|3|||
161199657|NCT00457249|582112925|FG001|Overall Study|Lost to Follow-up|0|||
161199658|NCT00457249|582112924|FG000|Overall Study|Protocol Violation|4|||
161199659|NCT00457249|582112925|FG001|Overall Study|Protocol Violation|1|||
161199660|NCT00457249|582112924|FG000|Overall Study|Withdrawal by Subject|3|||
161199661|NCT00457249|582112925|FG001|Overall Study|Withdrawal by Subject|1|||
161199662|NCT00457249|582112924|FG000|Overall Study|Serious Adverse Events|2|||
161199663|NCT00457249|582112925|FG001|Overall Study|Serious Adverse Events|0|||
161199664|NCT04621227|582112928|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
161199665|NCT04621227|582112928|FG000|Period 3 (29 Days)|Adverse Event|1|||
161199666|NCT04621227|582112928|FG000|Period 8 (2 Days)|Adverse Event|1|||
161199667|NCT02916056|582112929|FG000|Overall Study|Adverse Event|6|||
161199668|NCT02916056|582112929|FG000|Overall Study|Lost to Follow-up|1|||
161199669|NCT02916056|582112929|FG000|Overall Study|Other|12|||
161199670|NCT02916056|582112929|FG000|Overall Study|Protocol Violation|1|||
161199671|NCT02916056|582112929|FG000|Overall Study|Withdrawal by Subject|8|||
161199672|NCT02916056|582112929|FG000|Overall Study|Study Terminated by Sponsor|269|||
161199673|NCT00124709|582112930|FG000|Overall Study|Randomized but did not take medication|3|||
161199674|NCT00124709|582112931|FG001|Overall Study|Randomized but did not take medication|1|||
161199675|NCT00124709|582112930|FG000|Overall Study|Adverse Event|3|||
161199676|NCT00124709|582112931|FG001|Overall Study|Adverse Event|0|||
161199677|NCT00124709|582112930|FG000|Overall Study|Lack of Efficacy|5|||
161199678|NCT00124709|582112931|FG001|Overall Study|Lack of Efficacy|10|||
161199679|NCT00124709|582112930|FG000|Overall Study|Protocol Violation|3|||
161199680|NCT00124709|582112931|FG001|Overall Study|Protocol Violation|5|||
161199681|NCT00124709|582112930|FG000|Overall Study|Withdrawal by Subject|127|||
161199682|NCT00124709|582112931|FG001|Overall Study|Withdrawal by Subject|136|||
161199683|NCT00124709|582112930|FG000|Overall Study|Lost to Follow-up|114|||
161199684|NCT00124709|582112931|FG001|Overall Study|Lost to Follow-up|120|||
161199685|NCT01728376|582112932|FG000|Overall Study|Adverse Event|1|||
161199686|NCT01728376|582112933|FG001|Overall Study|Adverse Event|1|||
161199687|NCT01728376|582112934|FG002|Overall Study|Adverse Event|1|||
161199688|NCT01728376|582112935|FG003|Overall Study|Adverse Event|1|||
161199689|NCT01728376|582112936|FG004|Overall Study|Adverse Event|1|||
161199690|NCT01728376|582112937|FG005|Overall Study|Adverse Event|0|||
161199691|NCT01728376|582112932|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
161199692|NCT01728376|582112933|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
161199693|NCT01728376|582112934|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
161199694|NCT01728376|582112935|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
161308836|NCT01738503|582512098|FG002|PET Imaging Sub-study|Adverse Event|0|||
161308837|NCT01738503|582512099|FG003|PET Imaging Sub-study|Adverse Event|0|||
161308838|NCT01738503|582512100|FG004|PET Imaging Sub-study|Adverse Event|0|||
161308839|NCT01738503|582512101|FG005|PET Imaging Sub-study|Adverse Event|1|||
161308840|NCT01738503|582512102|FG006|PET Imaging Sub-study|Adverse Event|0|||
161308841|NCT01738503|582512096|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161308842|NCT01738503|582512097|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161308843|NCT01738503|582512098|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161308844|NCT01738503|582512099|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161308845|NCT01738503|582512100|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
161308846|NCT01738503|582512101|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
161308847|NCT01738503|582512102|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
161308848|NCT01340027|582512103|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
161308849|NCT01340027|582512104|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
161308850|NCT01340027|582512105|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
161308851|NCT01340027|582512106|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
161308852|NCT01340027|582512107|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
161308853|NCT01340027|582512108|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
161308854|NCT01340027|582512109|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
161308855|NCT01340027|582512110|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
161308856|NCT01340027|582512111|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
161308857|NCT01340027|582512112|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
161308858|NCT01340027|582512113|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
161308859|NCT01340027|582512114|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
161308860|NCT01340027|582512103|FG000|Overall Study|Adverse Event|0|||
161308861|NCT01340027|582512104|FG001|Overall Study|Adverse Event|1|||
161308862|NCT01340027|582512105|FG002|Overall Study|Adverse Event|2|||
161308863|NCT01340027|582512106|FG003|Overall Study|Adverse Event|0|||
161308864|NCT01340027|582512107|FG004|Overall Study|Adverse Event|1|||
161308865|NCT01340027|582512108|FG005|Overall Study|Adverse Event|2|||
161308866|NCT01340027|582512109|FG006|Overall Study|Adverse Event|2|||
161308867|NCT01340027|582512110|FG007|Overall Study|Adverse Event|1|||
161308868|NCT01340027|582512111|FG008|Overall Study|Adverse Event|4|||
161308869|NCT01340027|582512112|FG009|Overall Study|Adverse Event|1|||
161308870|NCT01340027|582512113|FG010|Overall Study|Adverse Event|1|||
161308871|NCT01340027|582512114|FG011|Overall Study|Adverse Event|3|||
161308872|NCT01340027|582512103|FG000|Overall Study|Lack of Efficacy|0|||
161308873|NCT01340027|582512104|FG001|Overall Study|Lack of Efficacy|0|||
161308874|NCT01340027|582512105|FG002|Overall Study|Lack of Efficacy|0|||
161308875|NCT01340027|582512106|FG003|Overall Study|Lack of Efficacy|0|||
161308876|NCT01340027|582512107|FG004|Overall Study|Lack of Efficacy|0|||
161308877|NCT01340027|582512108|FG005|Overall Study|Lack of Efficacy|0|||
161308878|NCT01340027|582512109|FG006|Overall Study|Lack of Efficacy|1|||
161308879|NCT01340027|582512110|FG007|Overall Study|Lack of Efficacy|1|||
161308880|NCT01340027|582512111|FG008|Overall Study|Lack of Efficacy|1|||
161308881|NCT01340027|582512112|FG009|Overall Study|Lack of Efficacy|0|||
161308882|NCT01340027|582512113|FG010|Overall Study|Lack of Efficacy|0|||
161308883|NCT01340027|582512114|FG011|Overall Study|Lack of Efficacy|0|||
161308884|NCT01340027|582512103|FG000|Overall Study|Lost to Follow-up|0|||
161308885|NCT01340027|582512104|FG001|Overall Study|Lost to Follow-up|1|||
161308886|NCT01340027|582512105|FG002|Overall Study|Lost to Follow-up|0|||
161308887|NCT01340027|582512106|FG003|Overall Study|Lost to Follow-up|0|||
161308888|NCT01340027|582512107|FG004|Overall Study|Lost to Follow-up|0|||
161308889|NCT01340027|582512108|FG005|Overall Study|Lost to Follow-up|0|||
161308890|NCT01340027|582512109|FG006|Overall Study|Lost to Follow-up|1|||
161308891|NCT01340027|582512110|FG007|Overall Study|Lost to Follow-up|0|||
161308892|NCT01340027|582512111|FG008|Overall Study|Lost to Follow-up|0|||
161308893|NCT01340027|582512112|FG009|Overall Study|Lost to Follow-up|1|||
161090873|NCT03057977|581723753|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
161090874|NCT03057977|581723754|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
161090875|NCT03057977|581723753|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
161090876|NCT03057977|581723754|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
161090877|NCT03057977|581723753|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
161090878|NCT03057977|581723754|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
161090879|NCT03057977|581723753|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
161090880|NCT03057977|581723754|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
161090881|NCT01350336|581723755|FG000|Overall Study|Lost to Follow-up|31|||
161090882|NCT01350336|581723755|FG000|Overall Study|Withdrawal by Subject|14|||
161090883|NCT01350336|581723755|FG000|Overall Study|Physician Decision|8|||
161090884|NCT01350336|581723755|FG000|Overall Study|Death|4|||
161308894|NCT01340027|582512113|FG010|Overall Study|Lost to Follow-up|0|||
161308895|NCT01340027|582512114|FG011|Overall Study|Lost to Follow-up|0|||
161308896|NCT01340027|582512103|FG000|Overall Study|Protocol Violation|1|||
161308897|NCT01340027|582512104|FG001|Overall Study|Protocol Violation|2|||
161090885|NCT01171807|581723756|FG000|Overall Study|Treatment failure|2|||
161090886|NCT01171807|581723757|FG001|Overall Study|Treatment failure|4|||
161090887|NCT01171807|581723756|FG000|Overall Study|Non compliance|1|||
161090888|NCT01171807|581723757|FG001|Overall Study|Non compliance|0|||
161090889|NCT01171807|581723756|FG000|Overall Study|Lost to Follow-up|3|||
161090890|NCT01171807|581723757|FG001|Overall Study|Lost to Follow-up|0|||
161090891|NCT01901341|581723758|FG000|Overall Study|Adverse Event|4|||
161090892|NCT01901341|581723759|FG001|Overall Study|Adverse Event|2|||
161090893|NCT01901341|581723758|FG000|Overall Study|Lack of Efficacy|0|||
161090894|NCT01901341|581723759|FG001|Overall Study|Lack of Efficacy|2|||
161199695|NCT01728376|582112936|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
161199696|NCT01728376|582112937|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
161199697|NCT01728376|582112932|FG000|Overall Study|No relevant bacteria|2|||
161199698|NCT01728376|582112933|FG001|Overall Study|No relevant bacteria|0|||
161199699|NCT01728376|582112934|FG002|Overall Study|No relevant bacteria|0|||
161199700|NCT01728376|582112935|FG003|Overall Study|No relevant bacteria|0|||
161199701|NCT01728376|582112936|FG004|Overall Study|No relevant bacteria|1|||
161199702|NCT01728376|582112937|FG005|Overall Study|No relevant bacteria|1|||
161199703|NCT01728376|582112932|FG000|Overall Study|Did not receive treatment|0|||
161199704|NCT01728376|582112933|FG001|Overall Study|Did not receive treatment|1|||
161199705|NCT01728376|582112934|FG002|Overall Study|Did not receive treatment|0|||
161199706|NCT01728376|582112935|FG003|Overall Study|Did not receive treatment|0|||
161199707|NCT01728376|582112936|FG004|Overall Study|Did not receive treatment|0|||
161199708|NCT01728376|582112937|FG005|Overall Study|Did not receive treatment|0|||
161199709|NCT01728376|582112932|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161199710|NCT01728376|582112933|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161199711|NCT01728376|582112934|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161199712|NCT01728376|582112935|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
161199713|NCT01728376|582112936|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
161199714|NCT01728376|582112937|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
161199715|NCT02094573|582112939|FG000|Overall Study|Adverse Event|4|||
161199716|NCT02094573|582112940|FG001|Overall Study|Adverse Event|14|||
161199717|NCT02094573|582112939|FG000|Overall Study|Clinical Progressive Disease|9|||
161199718|NCT02094573|582112940|FG001|Overall Study|Clinical Progressive Disease|13|||
161199719|NCT02094573|582112939|FG000|Overall Study|Death|11|||
161199720|NCT02094573|582112940|FG001|Overall Study|Death|3|||
161199721|NCT02094573|582112939|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
161199722|NCT02094573|582112940|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
161199723|NCT02094573|582112939|FG000|Overall Study|Non-compliance with Study Drug|1|||
161199724|NCT02094573|582112940|FG001|Overall Study|Non-compliance with Study Drug|1|||
161199725|NCT02094573|582112939|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
161199726|NCT02094573|582112940|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
161199727|NCT02094573|582112939|FG000|Overall Study|Physician Decision|4|||
161199728|NCT02094573|582112940|FG001|Overall Study|Physician Decision|4|||
161199729|NCT02094573|582112939|FG000|Overall Study|Site Terminated by Sponsor|10|||
161199730|NCT02094573|582112940|FG001|Overall Study|Site Terminated by Sponsor|17|||
161199731|NCT02094573|582112939|FG000|Overall Study|Withdrawal by Subject|6|||
161199732|NCT02094573|582112940|FG001|Overall Study|Withdrawal by Subject|8|||
161199733|NCT02094573|582112939|FG000|Overall Study|Randomized but not Treated|3|||
161199734|NCT02094573|582112940|FG001|Overall Study|Randomized but not Treated|0|||
161199735|NCT02411110|582112941|FG000|Treatment Period 1|Adverse Event|4|||
161199736|NCT02411110|582112942|FG001|Treatment Period 1|Adverse Event|2|||
161199737|NCT02411110|582112941|FG000|Treatment Period 1|Lost to Follow-up|1|||
161199738|NCT02411110|582112942|FG001|Treatment Period 1|Lost to Follow-up|0|||
161199739|NCT02411110|582112941|FG000|Treatment Period 1|Personal Reasons|2|||
161199740|NCT02411110|582112942|FG001|Treatment Period 1|Personal Reasons|5|||
161199741|NCT02411110|582112941|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
161199742|NCT02411110|582112942|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
161199743|NCT02411110|582112941|FG000|Treatment Period 2|Adverse Event|1|||
161199744|NCT02411110|582112942|FG001|Treatment Period 2|Adverse Event|0|||
161199745|NCT02411110|582112941|FG000|Treatment Period 2|Lost to Follow-up|0|||
161199746|NCT02411110|582112942|FG001|Treatment Period 2|Lost to Follow-up|2|||
161199747|NCT02411110|582112941|FG000|Treatment Period 2|Personal Reasons|0|||
161199748|NCT02411110|582112942|FG001|Treatment Period 2|Personal Reasons|2|||
161199749|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161199750|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
161199751|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
161199752|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161199753|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161199754|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161199755|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161199756|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161199757|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
161199758|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
161199759|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161199760|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161199761|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161199762|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161199763|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
161199764|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
161199765|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
161199766|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161199767|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161199768|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161199769|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161199770|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
161199771|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
161199772|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
161199773|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161199774|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161199775|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161199776|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161199777|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
161199778|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161199779|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161199780|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161199781|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161199782|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161199783|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
161199784|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161199785|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161199786|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
161199787|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161199788|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161199789|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161199790|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
161199791|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161199792|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161199793|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
161199794|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161199795|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161199796|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161199797|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
161199798|NCT04242446|582112943|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161199799|NCT04242446|582112944|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
161199800|NCT04242446|582112945|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
161199801|NCT04242446|582112946|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161199802|NCT04242446|582112947|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161199803|NCT04242446|582112948|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161199804|NCT04242446|582112949|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161199805|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161199806|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161199807|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161199808|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
161199809|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
161199810|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
161199811|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
161199812|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161199813|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161199814|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161199815|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
161199816|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
161199817|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
161199818|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
161199819|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161199820|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161199821|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161199822|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161199823|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161199824|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161199825|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161199826|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161308898|NCT01340027|582512105|FG002|Overall Study|Protocol Violation|0|||
161199827|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161199828|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161199829|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161199830|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
161199831|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161199832|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161199833|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161199834|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161199835|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161199836|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
161199837|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
161199838|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
161199839|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
161199840|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161199841|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161199842|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161199843|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
161199844|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161199845|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161199846|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
161199847|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161199848|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161199849|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161199850|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161199851|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
161199852|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161199853|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
161308899|NCT01340027|582512106|FG003|Overall Study|Protocol Violation|0|||
161308900|NCT01340027|582512107|FG004|Overall Study|Protocol Violation|6|||
161308901|NCT01340027|582512108|FG005|Overall Study|Protocol Violation|0|||
161308902|NCT01340027|582512109|FG006|Overall Study|Protocol Violation|0|||
161308903|NCT01340027|582512110|FG007|Overall Study|Protocol Violation|1|||
161308904|NCT01340027|582512111|FG008|Overall Study|Protocol Violation|2|||
161308905|NCT01340027|582512112|FG009|Overall Study|Protocol Violation|2|||
161308906|NCT01340027|582512113|FG010|Overall Study|Protocol Violation|0|||
161308907|NCT01340027|582512114|FG011|Overall Study|Protocol Violation|0|||
161308908|NCT01340027|582512103|FG000|Overall Study|Withdrawal by Subject|4|||
161308909|NCT01340027|582512104|FG001|Overall Study|Withdrawal by Subject|3|||
161308910|NCT01340027|582512105|FG002|Overall Study|Withdrawal by Subject|1|||
161308911|NCT01340027|582512106|FG003|Overall Study|Withdrawal by Subject|3|||
161308912|NCT01340027|582512107|FG004|Overall Study|Withdrawal by Subject|3|||
161308913|NCT01340027|582512108|FG005|Overall Study|Withdrawal by Subject|2|||
161308914|NCT01340027|582512109|FG006|Overall Study|Withdrawal by Subject|3|||
161308915|NCT01340027|582512110|FG007|Overall Study|Withdrawal by Subject|4|||
161308916|NCT01340027|582512111|FG008|Overall Study|Withdrawal by Subject|1|||
161308917|NCT01340027|582512112|FG009|Overall Study|Withdrawal by Subject|2|||
161308918|NCT01340027|582512113|FG010|Overall Study|Withdrawal by Subject|0|||
161308919|NCT01340027|582512114|FG011|Overall Study|Withdrawal by Subject|1|||
161308920|NCT01340027|582512103|FG000|Overall Study|Miscellaneous|0|||
161308921|NCT01340027|582512104|FG001|Overall Study|Miscellaneous|0|||
161308922|NCT01340027|582512105|FG002|Overall Study|Miscellaneous|0|||
161308923|NCT01340027|582512106|FG003|Overall Study|Miscellaneous|1|||
161308924|NCT01340027|582512107|FG004|Overall Study|Miscellaneous|0|||
161308925|NCT01340027|582512108|FG005|Overall Study|Miscellaneous|0|||
161308926|NCT01340027|582512109|FG006|Overall Study|Miscellaneous|0|||
161308927|NCT01340027|582512110|FG007|Overall Study|Miscellaneous|0|||
161308928|NCT01340027|582512111|FG008|Overall Study|Miscellaneous|0|||
161308929|NCT01340027|582512112|FG009|Overall Study|Miscellaneous|0|||
161308930|NCT01340027|582512113|FG010|Overall Study|Miscellaneous|1|||
161308931|NCT01340027|582512114|FG011|Overall Study|Miscellaneous|0|||
161308932|NCT03005327|582512115|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161199854|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161199855|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161199856|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161199857|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161199858|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
161199859|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161199860|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
161199861|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161308933|NCT03005327|582512116|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161308934|NCT03005327|582512117|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
161308935|NCT03005327|582512118|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
161308936|NCT03005327|582512115|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161308937|NCT03005327|582512116|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
161308938|NCT03005327|582512117|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161308939|NCT03005327|582512118|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
161308940|NCT01794793|582512120|FG000|Treatment Period|Withdrawal by Subject|24|||
161308941|NCT01794793|582512120|FG000|Treatment Period|Lack of Efficacy|22|||
161308942|NCT01794793|582512120|FG000|Treatment Period|Adverse Event|17|||
161308943|NCT01794793|582512120|FG000|Treatment Period|Physician Decision|14|||
161308944|NCT01794793|582512120|FG000|Treatment Period|Lost to Follow-up|7|||
161308945|NCT01794793|582512120|FG000|Treatment Period|Death|6|||
161308946|NCT01794793|582512120|FG000|Treatment Period|Protocol Violation|5|||
161308947|NCT01794793|582512120|FG000|Treatment Period|administrative problem|3|||
161308948|NCT01794793|582512120|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
161308949|NCT01794793|582512120|FG000|Post-treatment Follow-up|Adverse Event|8|||
161308950|NCT01794793|582512120|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
161308951|NCT01794793|582512120|FG000|Post-treatment Follow-up|administrative problem|5|||
161308952|NCT01794793|582512120|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
161308953|NCT01794793|582512120|FG000|Post-treatment Follow-up|Protocol Violation|3|||
161308954|NCT04852679|582512121|FG000|Main Intervention Period|Withdrawal by Subject|3|||
161308955|NCT04852679|582512121|FG000|Main Intervention Period|Adverse Event|1|||
161308956|NCT04852679|582512121|FG000|Main Intervention Period|Progressive Disease|16|||
161308957|NCT04852679|582512121|FG000|Main Intervention Period|Refused study visit|1|||
161308958|NCT04852679|582512121|FG000|Independent Injection Period|Missed study visit|1|||
161308959|NCT02000882|582513239|FG000|Overall Study|Adverse Event|3|||
161308960|NCT02000882|582513239|FG000|Overall Study|Physician Decision|2|||
161308961|NCT02000882|582513239|FG000|Overall Study|Withdrawal by Subject|1|||
161308962|NCT02417961|582513243|FG000|Overall Study|Adverse Event|1|||
161308963|NCT02417961|582513243|FG000|Overall Study|Lost to Follow-up|1|||
161308964|NCT02417961|582513243|FG000|Overall Study|Withdrawal by Subject|2|||
161308965|NCT01390428|582513244|FG000|Overall Study|Elective Surgery|0|||
161308966|NCT01390428|582513245|FG001|Overall Study|Elective Surgery|0|||
161308967|NCT01390428|582513246|FG002|Overall Study|Elective Surgery|0|||
161308968|NCT01390428|582513247|FG003|Overall Study|Elective Surgery|0|||
161308969|NCT01390428|582513248|FG004|Overall Study|Elective Surgery|1|||
161308970|NCT01390428|582513249|FG005|Overall Study|Elective Surgery|0|||
161308971|NCT01390428|582513244|FG000|Overall Study|Withdrawal by Subject|0|||
161308972|NCT01390428|582513245|FG001|Overall Study|Withdrawal by Subject|0|||
161308973|NCT01390428|582513246|FG002|Overall Study|Withdrawal by Subject|1|||
161308974|NCT01390428|582513247|FG003|Overall Study|Withdrawal by Subject|0|||
161308975|NCT01390428|582513248|FG004|Overall Study|Withdrawal by Subject|0|||
161308976|NCT01390428|582513249|FG005|Overall Study|Withdrawal by Subject|0|||
161308977|NCT05079750|582513250|FG000|Overall Study|Lost to Follow-up|0|||
161308978|NCT05079750|582513251|FG001|Overall Study|Lost to Follow-up|0|||
161308979|NCT05079750|582513252|FG002|Overall Study|Lost to Follow-up|1|||
161308980|NCT05091346|582513255|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
161308981|NCT05091346|582513256|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
161308982|NCT05091346|582513257|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
161308983|NCT05091346|582513258|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
161308984|NCT05091346|582513259|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
161308985|NCT05091346|582513255|FG000|Overall Study|Death|6|||
161308986|NCT05091346|582513256|FG001|Overall Study|Death|5|||
161308987|NCT05091346|582513257|FG002|Overall Study|Death|8|||
161308988|NCT05091346|582513258|FG003|Overall Study|Death|16|||
161308989|NCT05091346|582513259|FG004|Overall Study|Death|26|||
161308990|NCT05091346|582513255|FG000|Overall Study|Lost to Follow-up|0|||
161308991|NCT05091346|582513256|FG001|Overall Study|Lost to Follow-up|0|||
161308992|NCT05091346|582513257|FG002|Overall Study|Lost to Follow-up|0|||
161308993|NCT05091346|582513258|FG003|Overall Study|Lost to Follow-up|1|||
161308994|NCT05091346|582513259|FG004|Overall Study|Lost to Follow-up|0|||
161308995|NCT05091346|582513255|FG000|Overall Study|Withdrawal by Subject|0|||
161308996|NCT05091346|582513256|FG001|Overall Study|Withdrawal by Subject|1|||
161308997|NCT05091346|582513257|FG002|Overall Study|Withdrawal by Subject|2|||
161308998|NCT05091346|582513258|FG003|Overall Study|Withdrawal by Subject|2|||
161308999|NCT05091346|582513259|FG004|Overall Study|Withdrawal by Subject|1|||
161309000|NCT05897827|582513260|FG000|Overall Study|Lost to Follow-up|33|||
161309001|NCT05897827|582513261|FG001|Overall Study|Lost to Follow-up|14|||
161309002|NCT05897827|582513260|FG000|Overall Study|Withdrawal by Subject|1|||
161309003|NCT05897827|582513261|FG001|Overall Study|Withdrawal by Subject|1|||
161309004|NCT01752634|582513262|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161309005|NCT01752634|582513263|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161309006|NCT01752634|582513264|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
161309007|NCT01752634|582513265|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
161309008|NCT01752634|582513266|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
161309009|NCT01752634|582513267|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
161309010|NCT01752634|582513262|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161309011|NCT01752634|582513263|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
161309012|NCT01752634|582513264|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161309013|NCT01752634|582513265|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161309014|NCT01752634|582513266|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161309015|NCT01752634|582513267|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
161309016|NCT01752634|582513262|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
161309017|NCT01752634|582513263|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
161309018|NCT01752634|582513264|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161309019|NCT01752634|582513265|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161309020|NCT01752634|582513266|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
161309021|NCT01752634|582513267|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
161309022|NCT01752634|582513262|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
161309023|NCT01752634|582513263|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161309024|NCT01752634|582513264|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
161309025|NCT01752634|582513265|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161309026|NCT01752634|582513266|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
161309027|NCT01752634|582513267|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
161309028|NCT01752634|582513262|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
161309029|NCT01752634|582513263|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
161309030|NCT01752634|582513264|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
161309031|NCT01752634|582513265|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
161309032|NCT01752634|582513266|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
161309033|NCT01752634|582513267|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
161309034|NCT01752634|582513262|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
161309035|NCT01752634|582513263|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
161309036|NCT01752634|582513264|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
161309037|NCT01752634|582513265|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
161309038|NCT01752634|582513266|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
161309039|NCT01752634|582513267|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
161309040|NCT01752634|582513262|FG000|Week 24 to Week 260|Physician Decision|1|||
161309041|NCT01752634|582513263|FG001|Week 24 to Week 260|Physician Decision|2|||
161309042|NCT01752634|582513264|FG002|Week 24 to Week 260|Physician Decision|4|||
161309043|NCT01752634|582513265|FG003|Week 24 to Week 260|Physician Decision|2|||
161309044|NCT01752634|582513266|FG004|Week 24 to Week 260|Physician Decision|1|||
161309045|NCT01752634|582513267|FG005|Week 24 to Week 260|Physician Decision|0|||
161309046|NCT01752634|582513262|FG000|Week 24 to Week 260|Death|0|||
161309047|NCT01752634|582513263|FG001|Week 24 to Week 260|Death|1|||
161309048|NCT01752634|582513264|FG002|Week 24 to Week 260|Death|0|||
161309049|NCT01752634|582513265|FG003|Week 24 to Week 260|Death|0|||
161309050|NCT01752634|582513266|FG004|Week 24 to Week 260|Death|0|||
161309051|NCT01752634|582513267|FG005|Week 24 to Week 260|Death|0|||
161309052|NCT01752634|582513262|FG000|Week 24 to Week 260|Pregnancy|0|||
161309053|NCT01752634|582513263|FG001|Week 24 to Week 260|Pregnancy|0|||
161309054|NCT01752634|582513264|FG002|Week 24 to Week 260|Pregnancy|1|||
161309055|NCT01752634|582513265|FG003|Week 24 to Week 260|Pregnancy|0|||
161309056|NCT01752634|582513266|FG004|Week 24 to Week 260|Pregnancy|0|||
161090895|NCT01901341|581723758|FG000|Overall Study|Lost to Follow-up|0|||
161309057|NCT01752634|582513267|FG005|Week 24 to Week 260|Pregnancy|0|||
161309058|NCT01752634|582513262|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
161309059|NCT01752634|582513263|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
161309060|NCT01752634|582513264|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
161309061|NCT01752634|582513265|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
161090896|NCT01901341|581723759|FG001|Overall Study|Lost to Follow-up|1|||
161309062|NCT01752634|582513266|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
161309063|NCT01752634|582513267|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
161309064|NCT01752634|582513262|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
161309065|NCT01752634|582513263|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
161199862|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161199863|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161199864|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161199865|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
161199866|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161199867|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
161199868|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161199869|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161199870|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161199871|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161199872|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
161199873|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161199874|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
161199875|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161199876|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161199877|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161199878|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161199879|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
161199880|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161199881|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
161199882|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161199883|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161199884|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161199885|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161199886|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161199887|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
161199888|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
161199889|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161199890|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161199891|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161199892|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161199893|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161199894|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
161199895|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
161199896|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161199897|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161199898|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161199899|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161199900|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161199901|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
161199902|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
161199903|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161199904|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161199905|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161199906|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161199907|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161199908|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
161199909|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
161199910|NCT04242446|582112943|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161199911|NCT04242446|582112944|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161199912|NCT04242446|582112945|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161199913|NCT04242446|582112946|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161199914|NCT04242446|582112947|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161199915|NCT04242446|582112948|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
161199916|NCT04242446|582112949|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
161199917|NCT05644756|582112950|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
161199918|NCT05644756|582112950|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
161199919|NCT03927989|582112954|FG000|Overall Study|Withdrawal by Subject|0|||
161199920|NCT03927989|582112955|FG001|Overall Study|Withdrawal by Subject|1|||
161199921|NCT03992456|582112956|FG000|Overall Study|Withdrawal by Subject|1|||
161199922|NCT03992456|582112957|FG001|Overall Study|Withdrawal by Subject|0|||
161199923|NCT03992456|582112956|FG000|Overall Study|Disease progression|4|||
161199924|NCT03992456|582112957|FG001|Overall Study|Disease progression|5|||
161199925|NCT03992456|582112956|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
161199926|NCT03992456|582112957|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
161199927|NCT03155269|582112958|FG000|Overall Study|Withdrawal by Subject|4|||
161199928|NCT03155269|582112959|FG001|Overall Study|Withdrawal by Subject|5|||
161199929|NCT03155269|582112958|FG000|Overall Study|Lost to Follow-up|1|||
161199930|NCT03155269|582112959|FG001|Overall Study|Lost to Follow-up|2|||
161199931|NCT00910000|582112960|FG000|Overall Study|Adverse Event|0|||
161199932|NCT00910000|582112961|FG001|Overall Study|Adverse Event|3|||
161199933|NCT00910000|582112962|FG002|Overall Study|Adverse Event|2|||
161199934|NCT00910000|582112963|FG003|Overall Study|Adverse Event|2|||
161199935|NCT00910000|582112964|FG004|Overall Study|Adverse Event|0|||
161199936|NCT00910000|582112965|FG005|Overall Study|Adverse Event|1|||
161199937|NCT00910000|582112960|FG000|Overall Study|Withdrawal by Subject|0|||
161199938|NCT00910000|582112961|FG001|Overall Study|Withdrawal by Subject|0|||
161199939|NCT00910000|582112962|FG002|Overall Study|Withdrawal by Subject|1|||
161199940|NCT00910000|582112963|FG003|Overall Study|Withdrawal by Subject|0|||
161199941|NCT00910000|582112964|FG004|Overall Study|Withdrawal by Subject|1|||
161199942|NCT00910000|582112965|FG005|Overall Study|Withdrawal by Subject|0|||
161199943|NCT04637815|582112968|FG000|Overall Study|Death|1|||
161199944|NCT04637815|582112969|FG001|Overall Study|Death|0|||
161199945|NCT04637815|582112968|FG000|Overall Study|Lost to Follow-up|5|||
161199946|NCT04637815|582112969|FG001|Overall Study|Lost to Follow-up|2|||
161199947|NCT00483119|582112972|FG000|Overall Study|Adverse Event|0|||
161199948|NCT00483119|582112973|FG001|Overall Study|Adverse Event|1|||
161199949|NCT00483119|582112972|FG000|Overall Study|Physician Decision|1|||
161199950|NCT00483119|582112973|FG001|Overall Study|Physician Decision|0|||
161199951|NCT02331680|582112974|FG000|Overall Study|Adverse Event|3|||
161199952|NCT02331680|582112975|FG001|Overall Study|Adverse Event|0|||
161199953|NCT02331680|582112976|FG002|Overall Study|Adverse Event|2|||
161199954|NCT02331680|582112974|FG000|Overall Study|Physician Decision|1|||
161199955|NCT02331680|582112975|FG001|Overall Study|Physician Decision|1|||
161199956|NCT02331680|582112976|FG002|Overall Study|Physician Decision|2|||
161199957|NCT02331680|582112974|FG000|Overall Study|Withdrawal by Subject|0|||
161199958|NCT02331680|582112975|FG001|Overall Study|Withdrawal by Subject|1|||
161199959|NCT02331680|582112976|FG002|Overall Study|Withdrawal by Subject|2|||
161199960|NCT02331680|582112974|FG000|Overall Study|Met withdrawal criteria|2|||
161199961|NCT02331680|582112975|FG001|Overall Study|Met withdrawal criteria|2|||
161199962|NCT02331680|582112976|FG002|Overall Study|Met withdrawal criteria|5|||
161199963|NCT02331680|582112974|FG000|Overall Study|Non-compliance with study drug|0|||
161199964|NCT02331680|582112975|FG001|Overall Study|Non-compliance with study drug|0|||
161199965|NCT02331680|582112976|FG002|Overall Study|Non-compliance with study drug|1|||
161199966|NCT02331680|582112974|FG000|Overall Study|Protocol Violation|0|||
161199967|NCT02331680|582112975|FG001|Overall Study|Protocol Violation|0|||
161199968|NCT02331680|582112976|FG002|Overall Study|Protocol Violation|3|||
161199969|NCT02219477|582112977|FG000|Overall Study|Adverse Event|0|||
161199970|NCT02219477|582112978|FG001|Overall Study|Adverse Event|1|||
161199971|NCT02219477|582112979|FG002|Overall Study|Adverse Event|1|||
161199972|NCT02219477|582112977|FG000|Overall Study|Withdrawal by Subject|0|||
161199973|NCT02219477|582112978|FG001|Overall Study|Withdrawal by Subject|1|||
161199974|NCT02219477|582112979|FG002|Overall Study|Withdrawal by Subject|0|||
161199975|NCT00596466|582112980|FG000|Overall Study|Lack of Efficacy|5|||
161199976|NCT00596466|582112980|FG000|Overall Study|Adverse Event|4|||
161199977|NCT00596466|582112980|FG000|Overall Study|Withdrawal by Subject|2|||
161199978|NCT00596466|582112980|FG000|Overall Study|Protocol Violation|2|||
161199979|NCT00596466|582112980|FG000|Overall Study|Unpecified|2|||
161199980|NCT00596466|582112980|FG000|Overall Study|Enrolled, not treated|2|||
161199981|NCT01891669|582112981|FG000|Overall Study|Death|0|||
161199982|NCT01891669|582112982|FG001|Overall Study|Death|0|||
161199983|NCT01891669|582112983|FG002|Overall Study|Death|0|||
161199984|NCT01891669|582112984|FG003|Overall Study|Death|0|||
161199985|NCT01891669|582112985|FG004|Overall Study|Death|0|||
161199986|NCT01891669|582112986|FG005|Overall Study|Death|0|||
161199987|NCT01891669|582112987|FG006|Overall Study|Death|0|||
161199988|NCT01891669|582112988|FG007|Overall Study|Death|1|||
161199989|NCT01891669|582112989|FG008|Overall Study|Death|0|||
161199990|NCT01891669|582112990|FG009|Overall Study|Death|1|||
161199991|NCT01891669|582112981|FG000|Overall Study|Withdrawal by Subject|1|||
161199992|NCT01891669|582112982|FG001|Overall Study|Withdrawal by Subject|1|||
161309066|NCT01752634|582513264|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
161309067|NCT01752634|582513265|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
161309068|NCT01752634|582513266|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
161309069|NCT01752634|582513267|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
161309070|NCT01752634|582513262|FG000|Week 24 to Week 260|Adverse Event|4|||
161309071|NCT01752634|582513263|FG001|Week 24 to Week 260|Adverse Event|8|||
161309072|NCT01752634|582513264|FG002|Week 24 to Week 260|Adverse Event|8|||
161309073|NCT01752634|582513265|FG003|Week 24 to Week 260|Adverse Event|4|||
161309074|NCT01752634|582513266|FG004|Week 24 to Week 260|Adverse Event|2|||
161309075|NCT01752634|582513267|FG005|Week 24 to Week 260|Adverse Event|0|||
161309076|NCT04250714|582513271|FG000|Overall Study|Treatment - withdrawal by subject|14|||
161309077|NCT04250714|582513271|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
161309078|NCT04250714|582513271|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
161309079|NCT04250714|582513271|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
161309080|NCT04250714|582513271|FG000|Overall Study|Treatment - Death|1|||
161309081|NCT04250714|582513271|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
161309082|NCT04250714|582513271|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
161309083|NCT04250714|582513271|FG000|Overall Study|Attempt|2|||
161309084|NCT04250714|582513271|FG000|Overall Study|Intent|7|||
161309085|NCT04697056|582513272|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
161309086|NCT04697056|582513273|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
161309087|NCT01702532|582513274|FG000|Overall Study|Adverse Event|0|||
161309088|NCT01702532|582513275|FG001|Overall Study|Adverse Event|1|||
161309089|NCT03617861|582513276|FG000|Second Intervention (1 Day)|Adverse Event|0|||
161309090|NCT03617861|582513277|FG001|Second Intervention (1 Day)|Adverse Event|0|||
161309091|NCT03617861|582513278|FG002|Second Intervention (1 Day)|Adverse Event|1|||
161309092|NCT03617861|582513279|FG003|Second Intervention (1 Day)|Adverse Event|0|||
161309093|NCT02963558|582513282|FG000|Overall Study|Withdrawn by investigator|1|||
161309094|NCT02963558|582513283|FG001|Overall Study|Withdrawn by investigator|0|||
161309095|NCT02963558|582513282|FG000|Overall Study|Withdrawal by Subject|0|||
161309096|NCT02963558|582513283|FG001|Overall Study|Withdrawal by Subject|1|||
161309097|NCT01371877|582513284|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
161309098|NCT01371877|582513285|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
161309099|NCT05932225|582513288|FG000|Overall Study|Lost to Follow-up|0|||
161309100|NCT05932225|582513289|FG001|Overall Study|Lost to Follow-up|1|||
161309101|NCT05932225|582513290|FG002|Overall Study|Lost to Follow-up|0|||
161309102|NCT05932225|582513288|FG000|Overall Study|Withdrawal by Subject|1|||
161309103|NCT05932225|582513289|FG001|Overall Study|Withdrawal by Subject|0|||
161309104|NCT05932225|582513290|FG002|Overall Study|Withdrawal by Subject|0|||
161309105|NCT05932225|582513288|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
161309106|NCT05932225|582513289|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
161309107|NCT05932225|582513290|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
161309108|NCT00345878|582513293|FG000|Overall Study|Adverse Event|1|||
161309109|NCT00345878|582513294|FG001|Overall Study|Adverse Event|0|||
161309110|NCT00345878|582513293|FG000|Overall Study|Lost to Follow-up|2|||
161309111|NCT00345878|582513294|FG001|Overall Study|Lost to Follow-up|1|||
161309112|NCT00345878|582513293|FG000|Overall Study|Other|1|||
161309113|NCT00345878|582513294|FG001|Overall Study|Other|0|||
161199993|NCT01891669|582112983|FG002|Overall Study|Withdrawal by Subject|0|||
161309114|NCT00308750|582513295|FG000|Overall Study|Adverse Event|9|||
161309115|NCT00308750|582513296|FG001|Overall Study|Adverse Event|9|||
161309116|NCT00308750|582513297|FG002|Overall Study|Adverse Event|13|||
161309117|NCT00308750|582513295|FG000|Overall Study|Withdrawal by Subject|6|||
161199994|NCT01891669|582112984|FG003|Overall Study|Withdrawal by Subject|0|||
161199995|NCT01891669|582112985|FG004|Overall Study|Withdrawal by Subject|0|||
161199996|NCT01891669|582112986|FG005|Overall Study|Withdrawal by Subject|0|||
161199997|NCT01891669|582112987|FG006|Overall Study|Withdrawal by Subject|1|||
161199998|NCT01891669|582112988|FG007|Overall Study|Withdrawal by Subject|2|||
161309118|NCT00308750|582513296|FG001|Overall Study|Withdrawal by Subject|2|||
161090897|NCT01901341|581723758|FG000|Overall Study|Protocol Violation|2|||
161090898|NCT01901341|581723759|FG001|Overall Study|Protocol Violation|0|||
161090899|NCT01901341|581723758|FG000|Overall Study|Study Terminated by Sponsor|13|||
161090900|NCT01901341|581723759|FG001|Overall Study|Study Terminated by Sponsor|15|||
161090901|NCT01901341|581723758|FG000|Overall Study|Withdrawal by Subject|1|||
161090902|NCT01901341|581723759|FG001|Overall Study|Withdrawal by Subject|1|||
161090903|NCT04964388|581723760|FG000|Overall Study|Lost to Follow-up|3|||
161090904|NCT04964388|581723761|FG001|Overall Study|Lost to Follow-up|2|||
161199999|NCT01891669|582112989|FG008|Overall Study|Withdrawal by Subject|1|||
161200000|NCT01891669|582112990|FG009|Overall Study|Withdrawal by Subject|1|||
161200001|NCT01891669|582112981|FG000|Overall Study|Other|1|||
161200002|NCT01891669|582112982|FG001|Overall Study|Other|0|||
161200003|NCT01891669|582112983|FG002|Overall Study|Other|0|||
161200004|NCT01891669|582112984|FG003|Overall Study|Other|0|||
161200005|NCT01891669|582112985|FG004|Overall Study|Other|0|||
161200006|NCT01891669|582112986|FG005|Overall Study|Other|0|||
161200007|NCT01891669|582112987|FG006|Overall Study|Other|0|||
161200008|NCT01891669|582112988|FG007|Overall Study|Other|1|||
161200009|NCT01891669|582112989|FG008|Overall Study|Other|0|||
161200010|NCT01891669|582112990|FG009|Overall Study|Other|0|||
161200011|NCT00402298|582112999|FG000|Overall Study|Withdrawal by Subject|1|||
161200012|NCT00402298|582113000|FG001|Overall Study|Withdrawal by Subject|0|||
161200013|NCT00480077|582113001|FG000|Overall Study|Death|19|||
161200014|NCT00480077|582113002|FG001|Overall Study|Death|15|||
161200015|NCT00480077|582113001|FG000|Overall Study|early exit|12|||
161200016|NCT00480077|582113002|FG001|Overall Study|early exit|11|||
161200017|NCT00262119|582113005|FG000|Overall Study|Lost to Follow-up|38|||
161200018|NCT00262119|582113006|FG001|Overall Study|Lost to Follow-up|51|||
161200019|NCT00262119|582113007|FG002|Overall Study|Lost to Follow-up|42|||
161200020|NCT00262119|582113005|FG000|Overall Study|Death|20|||
161200021|NCT00262119|582113006|FG001|Overall Study|Death|19|||
161200022|NCT00262119|582113007|FG002|Overall Study|Death|16|||
161200023|NCT00071006|582113008|FG000|Overall Study|Lack of Efficacy|7|||
161200024|NCT00071006|582113008|FG000|Overall Study|Adverse Event|1|||
161200025|NCT00071006|582113008|FG000|Overall Study|Withdrawal by Subject|1|||
161200026|NCT00071006|582113008|FG000|Overall Study|Other|3|||
161200027|NCT00859313|582113009|FG000|Overall Study|Lack of Efficacy|2|||
161200028|NCT00859313|582113009|FG000|Overall Study|Adverse Event|1|||
161200029|NCT00859313|582113009|FG000|Overall Study|staff error|1|||
161200030|NCT05261126|582113014|FG000|Overall Study|Death|0|||
161200031|NCT05261126|582113015|FG001|Overall Study|Death|0|||
161200032|NCT05261126|582113016|FG002|Overall Study|Death|1|||
161200033|NCT05261126|582113017|FG003|Overall Study|Death|0|||
161200034|NCT05261126|582113018|FG004|Overall Study|Death|0|||
161200035|NCT05261126|582113014|FG000|Overall Study|Lost to Follow-up|0|||
161200036|NCT05261126|582113015|FG001|Overall Study|Lost to Follow-up|0|||
161200037|NCT05261126|582113016|FG002|Overall Study|Lost to Follow-up|0|||
161200038|NCT05261126|582113017|FG003|Overall Study|Lost to Follow-up|0|||
161200039|NCT05261126|582113018|FG004|Overall Study|Lost to Follow-up|1|||
161200040|NCT05261126|582113014|FG000|Overall Study|Physician Decision|1|||
161200041|NCT05261126|582113015|FG001|Overall Study|Physician Decision|0|||
161200042|NCT05261126|582113016|FG002|Overall Study|Physician Decision|0|||
161200043|NCT05261126|582113017|FG003|Overall Study|Physician Decision|0|||
161200044|NCT05261126|582113018|FG004|Overall Study|Physician Decision|0|||
161200045|NCT05261126|582113014|FG000|Overall Study|Screen Failure|0|||
161200046|NCT05261126|582113015|FG001|Overall Study|Screen Failure|0|||
161200047|NCT05261126|582113016|FG002|Overall Study|Screen Failure|0|||
161200048|NCT05261126|582113017|FG003|Overall Study|Screen Failure|0|||
161200049|NCT05261126|582113018|FG004|Overall Study|Screen Failure|1|||
161200050|NCT05261126|582113014|FG000|Overall Study|Withdrawal by Subject|1|||
161200051|NCT05261126|582113015|FG001|Overall Study|Withdrawal by Subject|0|||
161200052|NCT05261126|582113016|FG002|Overall Study|Withdrawal by Subject|1|||
161200053|NCT05261126|582113017|FG003|Overall Study|Withdrawal by Subject|1|||
161200054|NCT05261126|582113018|FG004|Overall Study|Withdrawal by Subject|0|||
161200055|NCT05261126|582113014|FG000|Overall Study|Not Recorded|0|||
161200056|NCT05261126|582113015|FG001|Overall Study|Not Recorded|0|||
161200057|NCT05261126|582113016|FG002|Overall Study|Not Recorded|0|||
161200058|NCT05261126|582113017|FG003|Overall Study|Not Recorded|1|||
161200059|NCT05261126|582113018|FG004|Overall Study|Not Recorded|0|||
161200060|NCT05939388|582113019|FG000|Overall Study|Lost to Follow-up|1|||
161200061|NCT03901274|582113020|FG000|Overall Study|Lost to Follow-up|120|||
161200062|NCT03901274|582113021|FG001|Overall Study|Lost to Follow-up|124|||
161200063|NCT03901274|582113020|FG000|Overall Study|Withdrawal by Subject|0|||
161200064|NCT03901274|582113021|FG001|Overall Study|Withdrawal by Subject|6|||
161200065|NCT04527380|582113028|FG000|Overall Study|Lack of Efficacy|0|||
161200066|NCT04527380|582113029|FG001|Overall Study|Lack of Efficacy|1|||
161200067|NCT04527380|582113028|FG000|Overall Study|Withdrawal by Subject|1|||
161200068|NCT04527380|582113029|FG001|Overall Study|Withdrawal by Subject|0|||
161200069|NCT04479358|582113030|FG000|Overall Study|Withdrawal by Subject|0|||
161200070|NCT04479358|582113031|FG001|Overall Study|Withdrawal by Subject|0|||
161200071|NCT04479358|582113032|FG002|Overall Study|Withdrawal by Subject|1|||
161200072|NCT04479358|582113033|FG003|Overall Study|Withdrawal by Subject|0|||
161200073|NCT04479358|582113034|FG004|Overall Study|Withdrawal by Subject|0|||
161200074|NCT04479358|582113035|FG005|Overall Study|Withdrawal by Subject|1|||
161090905|NCT00250679|581723762|FG000|Overall Study|Adverse Event|12|||
161090906|NCT00250679|581723763|FG001|Overall Study|Adverse Event|15|||
161090907|NCT00250679|581723764|FG002|Overall Study|Adverse Event|16|||
161090908|NCT00250679|581723762|FG000|Overall Study|Protocol Violation|2|||
161090909|NCT00250679|581723763|FG001|Overall Study|Protocol Violation|4|||
161090910|NCT00250679|581723764|FG002|Overall Study|Protocol Violation|3|||
161090911|NCT00250679|581723762|FG000|Overall Study|Withdrawal by Subject|15|||
161090912|NCT00250679|581723763|FG001|Overall Study|Withdrawal by Subject|18|||
161090913|NCT00250679|581723764|FG002|Overall Study|Withdrawal by Subject|15|||
161309119|NCT00308750|582513297|FG002|Overall Study|Withdrawal by Subject|3|||
161309120|NCT00308750|582513295|FG000|Overall Study|Physician Decision|3|||
161309121|NCT00308750|582513296|FG001|Overall Study|Physician Decision|4|||
161309122|NCT00308750|582513297|FG002|Overall Study|Physician Decision|3|||
161309123|NCT00308750|582513295|FG000|Overall Study|Sponsor Decision|1|||
161309124|NCT00308750|582513296|FG001|Overall Study|Sponsor Decision|0|||
161309125|NCT00308750|582513297|FG002|Overall Study|Sponsor Decision|0|||
161309126|NCT00308750|582513295|FG000|Overall Study|Disease Progression|47|||
161309127|NCT00308750|582513296|FG001|Overall Study|Disease Progression|24|||
161309128|NCT00308750|582513297|FG002|Overall Study|Disease Progression|28|||
161309129|NCT00308750|582513295|FG000|Overall Study|Unrelated Complication|3|||
161309130|NCT00308750|582513296|FG001|Overall Study|Unrelated Complication|0|||
161309131|NCT00308750|582513297|FG002|Overall Study|Unrelated Complication|1|||
161309132|NCT00308750|582513295|FG000|Overall Study|Death|1|||
161309133|NCT00308750|582513296|FG001|Overall Study|Death|0|||
161309134|NCT00308750|582513297|FG002|Overall Study|Death|1|||
161309135|NCT00308750|582513295|FG000|Overall Study|Protocol Violation|1|||
161309136|NCT00308750|582513296|FG001|Overall Study|Protocol Violation|0|||
161309137|NCT00308750|582513297|FG002|Overall Study|Protocol Violation|0|||
161309138|NCT00308750|582513295|FG000|Overall Study|New Primary Disease Identified|1|||
161309139|NCT00308750|582513296|FG001|Overall Study|New Primary Disease Identified|1|||
161309140|NCT00308750|582513297|FG002|Overall Study|New Primary Disease Identified|0|||
161309141|NCT02045732|582513298|FG000|Overall Study|At the discretion of the investigator|1|||
161309142|NCT02045732|582513299|FG001|Overall Study|At the discretion of the investigator|1|||
161309143|NCT00348790|582513300|FG000|Completed Treatment|Withdrawal by Subject|4|||
161309144|NCT00348790|582513300|FG000|Completed Treatment|Disease progression|14|||
161309145|NCT00348790|582513300|FG000|Completed Treatment|Adverse Event|4|||
161309146|NCT00348790|582513300|FG000|Completed Treatment|Required surgery|2|||
161309147|NCT00348790|582513300|FG000|Completed Treatment|Unable to travel to study site|1|||
161309148|NCT01185509|582513304|FG000|Overall Study|Progression/Relapse|9|||
161309149|NCT01185509|582513305|FG001|Overall Study|Progression/Relapse|15|||
161309150|NCT01185509|582513304|FG000|Overall Study|Physician Decision|2|||
161309151|NCT01185509|582513305|FG001|Overall Study|Physician Decision|2|||
161309152|NCT01185509|582513304|FG000|Overall Study|Withdrawal by Subject|0|||
161309153|NCT01185509|582513305|FG001|Overall Study|Withdrawal by Subject|1|||
161309154|NCT01185509|582513304|FG000|Overall Study|Death|0|||
161309155|NCT01185509|582513305|FG001|Overall Study|Death|1|||
161309156|NCT01185509|582513304|FG000|Overall Study|Intercurrent Illness|0|||
161309157|NCT01185509|582513305|FG001|Overall Study|Intercurrent Illness|1|||
161309158|NCT03687372|582513306|FG000|Overall Study|Lost to Follow-up|12|||
161309159|NCT03687372|582513307|FG001|Overall Study|Lost to Follow-up|21|||
161309160|NCT03687372|582513306|FG000|Overall Study|Withdrawal by Subject|4|||
161309161|NCT03687372|582513307|FG001|Overall Study|Withdrawal by Subject|17|||
161309162|NCT03687372|582513306|FG000|Overall Study|Investigator Decision|1|||
161309163|NCT03687372|582513307|FG001|Overall Study|Investigator Decision|1|||
161309164|NCT01088243|582513311|FG000|Overall Study|Adverse Event|1|||
161309165|NCT01088243|582513312|FG001|Overall Study|Adverse Event|0|||
161309166|NCT04495816|582513321|FG000|Overall Study|Lost to Follow-up|10|||
161200075|NCT05116241|582113050|FG000|Study|Withdrawal by Subject|5|||
161200076|NCT05116241|582113051|FG001|Study|Withdrawal by Subject|2|||
161200077|NCT05116241|582113052|FG002|Study|Withdrawal by Subject|1|||
161200078|NCT05116241|582113050|FG000|Study|Lost to Follow-up|0|||
161200079|NCT05116241|582113051|FG001|Study|Lost to Follow-up|2|||
161200080|NCT05116241|582113052|FG002|Study|Lost to Follow-up|2|||
161200081|NCT04410991|582113057|FG000|Overall Study|Poor compliance to protocol|5|||
161200082|NCT04410991|582113058|FG001|Overall Study|Poor compliance to protocol|4|||
161200083|NCT04410991|582113057|FG000|Overall Study|Withdrawal by Subject|59|||
161200084|NCT04410991|582113058|FG001|Overall Study|Withdrawal by Subject|55|||
161200085|NCT04410991|582113057|FG000|Overall Study|Other|10|||
161200086|NCT04410991|582113058|FG001|Overall Study|Other|4|||
161200087|NCT00938366|582113068|FG000|Overall Study|Withdrawal by Subject|1|||
161200088|NCT00938366|582113069|FG001|Overall Study|Withdrawal by Subject|0|||
161200089|NCT01215968|582113070|FG000|Overall Study|Adverse Event|0|||
161200090|NCT01215968|582113071|FG001|Overall Study|Adverse Event|2|||
161200091|NCT01215968|582113070|FG000|Overall Study|Protocol Violation|2|||
161200092|NCT01215968|582113071|FG001|Overall Study|Protocol Violation|4|||
161200093|NCT01215968|582113070|FG000|Overall Study|Not received study drug|0|||
161200094|NCT01215968|582113071|FG001|Overall Study|Not received study drug|1|||
161200095|NCT05966129|582113072|FG000|Overall Study|Death|1|||
161200096|NCT05966129|582113073|FG001|Overall Study|Death|2|||
161200097|NCT05966129|582113072|FG000|Overall Study|Lost to Follow-up|63|||
161200098|NCT05966129|582113073|FG001|Overall Study|Lost to Follow-up|66|||
161200099|NCT05966129|582113072|FG000|Overall Study|Protocol Violation|1|||
161200100|NCT05966129|582113073|FG001|Overall Study|Protocol Violation|0|||
161200101|NCT05966129|582113072|FG000|Overall Study|Withdrawal by Subject|26|||
161200102|NCT05966129|582113073|FG001|Overall Study|Withdrawal by Subject|25|||
161200103|NCT05966129|582113072|FG000|Overall Study|Surgery not completed|63|||
161200104|NCT05966129|582113073|FG001|Overall Study|Surgery not completed|69|||
161200105|NCT05966129|582113072|FG000|Overall Study|Surgery logistics issue|2|||
161200106|NCT05966129|582113073|FG001|Overall Study|Surgery logistics issue|1|||
161309167|NCT04495816|582513322|FG001|Overall Study|Lost to Follow-up|4|||
161309168|NCT04495816|582513321|FG000|Overall Study|Withdrawal by Subject|3|||
161309169|NCT04495816|582513322|FG001|Overall Study|Withdrawal by Subject|5|||
161309170|NCT02370667|582513323|FG000|Overall Study|Lost to Follow-up|0|||
161309171|NCT02370667|582513324|FG001|Overall Study|Lost to Follow-up|1|||
161309172|NCT02370667|582513325|FG002|Overall Study|Lost to Follow-up|0|||
161309173|NCT03536949|582513326|FG000|Overall Study|Adverse Event|4|||
161309174|NCT03536949|582513327|FG001|Overall Study|Adverse Event|0|||
161309175|NCT03536949|582513326|FG000|Overall Study|Lost to Follow-up|2|||
161309176|NCT03536949|582513327|FG001|Overall Study|Lost to Follow-up|1|||
161309177|NCT03536949|582513326|FG000|Overall Study|Withdrawal by Subject|6|||
161309178|NCT03536949|582513327|FG001|Overall Study|Withdrawal by Subject|0|||
161309179|NCT03536949|582513326|FG000|Overall Study|Non-compliance|2|||
161309180|NCT03536949|582513327|FG001|Overall Study|Non-compliance|1|||
161309181|NCT00423189|582513331|FG000|Overall Study|Death|0|||
161309182|NCT00423189|582513332|FG001|Overall Study|Death|1|||
161309183|NCT00423189|582513333|FG002|Overall Study|Death|0|||
161309184|NCT03787303|582513334|FG000|Overall Study|Death|1|||
161309185|NCT03787303|582513334|FG000|Overall Study|Premature Termination of Study|1|||
161309186|NCT01826370|582513337|FG000|Overall Study|Protocol Violation|6|||
161309187|NCT01826370|582513337|FG000|Overall Study|Lost to Follow-up|12|||
161309188|NCT01826370|582513337|FG000|Overall Study|Other reason not defined above|2|||
161309189|NCT04416737|582513338|FG000|Week 1 (First Injection)|Physician Decision|0|||
161309190|NCT04416737|582513339|FG001|Week 1 (First Injection)|Physician Decision|1|||
161309191|NCT03332628|582513340|FG000|Overall Study|Physician Decision|2|||
161309192|NCT00381043|582513355|FG000|Overall Study|Lost to Follow-up|8|||
161309193|NCT00381043|582513356|FG001|Overall Study|Lost to Follow-up|6|||
161309194|NCT00381043|582513355|FG000|Overall Study|Withdrawal by Subject|3|||
161309195|NCT00381043|582513356|FG001|Overall Study|Withdrawal by Subject|1|||
161309196|NCT00381043|582513355|FG000|Overall Study|wanted more care|0|||
161309197|NCT00381043|582513356|FG001|Overall Study|wanted more care|1|||
161309198|NCT00381043|582513355|FG000|Overall Study|incarcerated|1|||
161200107|NCT05182840|582113074|FG000|Run-in Period|Not treated|0|||
161200108|NCT05182840|582113075|FG001|Run-in Period|Not treated|1|||
161200109|NCT05182840|582113076|FG002|Run-in Period|Not treated|0|||
161309199|NCT00381043|582513356|FG001|Overall Study|incarcerated|0|||
161309200|NCT03045276|582513358|FG000|Intervention Phase|Withdrawal by Subject|7|||
161200110|NCT05182840|582113077|FG003|Run-in Period|Not treated|0|||
161200111|NCT05182840|582113078|FG004|Run-in Period|Not treated|0|||
161200112|NCT05182840|582113079|FG005|Run-in Period|Not treated|0|||
161200113|NCT05182840|582113080|FG006|Run-in Period|Not treated|0|||
161200114|NCT05182840|582113081|FG007|Run-in Period|Not treated|0|||
161200115|NCT05182840|582113082|FG008|Run-in Period|Not treated|0|||
161200116|NCT05182840|582113083|FG009|Run-in Period|Not treated|0|||
161200117|NCT05182840|582113074|FG000|Run-in Period|Other reason but not sponsor termination|14|||
161200118|NCT05182840|582113075|FG001|Run-in Period|Other reason but not sponsor termination|18|||
161309201|NCT03045276|582513359|FG001|Intervention Phase|Withdrawal by Subject|2|||
161309202|NCT03045276|582513360|FG002|Intervention Phase|Withdrawal by Subject|3|||
161200119|NCT05182840|582113076|FG002|Run-in Period|Other reason but not sponsor termination|0|||
161200120|NCT05182840|582113077|FG003|Run-in Period|Other reason but not sponsor termination|0|||
161200121|NCT05182840|582113078|FG004|Run-in Period|Other reason but not sponsor termination|0|||
161200122|NCT05182840|582113079|FG005|Run-in Period|Other reason but not sponsor termination|0|||
161200123|NCT05182840|582113080|FG006|Run-in Period|Other reason but not sponsor termination|0|||
161200124|NCT05182840|582113081|FG007|Run-in Period|Other reason but not sponsor termination|0|||
161200125|NCT05182840|582113082|FG008|Run-in Period|Other reason but not sponsor termination|0|||
161200126|NCT05182840|582113083|FG009|Run-in Period|Other reason but not sponsor termination|0|||
161200127|NCT05182840|582113074|FG000|Run-in Period|No reason available|2|||
161200128|NCT05182840|582113075|FG001|Run-in Period|No reason available|2|||
161200129|NCT05182840|582113076|FG002|Run-in Period|No reason available|0|||
161200130|NCT05182840|582113077|FG003|Run-in Period|No reason available|0|||
161200131|NCT05182840|582113078|FG004|Run-in Period|No reason available|0|||
161200132|NCT05182840|582113079|FG005|Run-in Period|No reason available|0|||
161200133|NCT05182840|582113080|FG006|Run-in Period|No reason available|0|||
161200134|NCT05182840|582113081|FG007|Run-in Period|No reason available|0|||
161200135|NCT05182840|582113082|FG008|Run-in Period|No reason available|0|||
161200136|NCT05182840|582113083|FG009|Run-in Period|No reason available|0|||
161200137|NCT05182840|582113074|FG000|Run-in Period|Burden of study procedures|2|||
161200138|NCT05182840|582113075|FG001|Run-in Period|Burden of study procedures|2|||
161200139|NCT05182840|582113076|FG002|Run-in Period|Burden of study procedures|0|||
161200140|NCT05182840|582113077|FG003|Run-in Period|Burden of study procedures|0|||
161309203|NCT03045276|582513361|FG003|Intervention Phase|Withdrawal by Subject|7|||
161309204|NCT03045276|582513358|FG000|Intervention Phase|Developed exclusionary criteria|3|||
161309205|NCT03045276|582513359|FG001|Intervention Phase|Developed exclusionary criteria|3|||
161309206|NCT03045276|582513360|FG002|Intervention Phase|Developed exclusionary criteria|0|||
161309207|NCT03045276|582513361|FG003|Intervention Phase|Developed exclusionary criteria|0|||
161309208|NCT03045276|582513358|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
161309209|NCT03045276|582513359|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
161309210|NCT03045276|582513360|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
161309211|NCT03045276|582513361|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
161309212|NCT03045276|582513358|FG000|Follow-Up Phase|Lost to Follow-up|0|||
161309213|NCT03045276|582513359|FG001|Follow-Up Phase|Lost to Follow-up|1|||
161309214|NCT03045276|582513360|FG002|Follow-Up Phase|Lost to Follow-up|0|||
161309215|NCT03045276|582513361|FG003|Follow-Up Phase|Lost to Follow-up|1|||
161309216|NCT03045276|582513358|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
161309217|NCT03045276|582513359|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
161309218|NCT03045276|582513360|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
161309219|NCT03045276|582513361|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
161309220|NCT02496091|582513366|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
161309221|NCT02272842|582513367|FG000|Overall Study|Lost to Follow-up|8|||
161309222|NCT02272842|582513368|FG001|Overall Study|Lost to Follow-up|8|||
161309223|NCT02272842|582513367|FG000|Overall Study|Withdrawal by Subject|8|||
161309224|NCT02272842|582513368|FG001|Overall Study|Withdrawal by Subject|2|||
161309225|NCT01984892|582513371|FG000|Overall Study|Progressive disease|7|||
161309226|NCT01358578|582515425|FG000|Induction Period|Adverse Event|2|||
161309227|NCT01358578|582515426|FG001|Induction Period|Adverse Event|4|||
161309228|NCT01358578|582515427|FG002|Induction Period|Adverse Event|2|||
161309229|NCT01358578|582515428|FG003|Induction Period|Adverse Event|6|||
161309230|NCT01358578|582515429|FG004|Induction Period|Adverse Event|0|||
161309231|NCT01358578|582515430|FG005|Induction Period|Adverse Event|0|||
161309232|NCT01358578|582515425|FG000|Induction Period|Lack of Efficacy|0|||
161309233|NCT01358578|582515426|FG001|Induction Period|Lack of Efficacy|0|||
161309234|NCT01358578|582515427|FG002|Induction Period|Lack of Efficacy|9|||
161309235|NCT01358578|582515428|FG003|Induction Period|Lack of Efficacy|1|||
161309236|NCT01358578|582515429|FG004|Induction Period|Lack of Efficacy|0|||
161309237|NCT01358578|582515430|FG005|Induction Period|Lack of Efficacy|0|||
161309238|NCT01358578|582515425|FG000|Induction Period|Lost to Follow-up|0|||
161200141|NCT05182840|582113078|FG004|Run-in Period|Burden of study procedures|0|||
161200142|NCT05182840|582113079|FG005|Run-in Period|Burden of study procedures|0|||
161200143|NCT05182840|582113080|FG006|Run-in Period|Burden of study procedures|0|||
161309239|NCT01358578|582515426|FG001|Induction Period|Lost to Follow-up|0|||
161309240|NCT01358578|582515427|FG002|Induction Period|Lost to Follow-up|1|||
161200144|NCT05182840|582113081|FG007|Run-in Period|Burden of study procedures|0|||
161200145|NCT05182840|582113082|FG008|Run-in Period|Burden of study procedures|0|||
161200146|NCT05182840|582113083|FG009|Run-in Period|Burden of study procedures|0|||
161200147|NCT05182840|582113074|FG000|Run-in Period|Change of residence|1|||
161200148|NCT05182840|582113075|FG001|Run-in Period|Change of residence|0|||
161200149|NCT05182840|582113076|FG002|Run-in Period|Change of residence|0|||
161200150|NCT05182840|582113077|FG003|Run-in Period|Change of residence|0|||
161200151|NCT05182840|582113078|FG004|Run-in Period|Change of residence|0|||
161200152|NCT05182840|582113079|FG005|Run-in Period|Change of residence|0|||
161200153|NCT05182840|582113080|FG006|Run-in Period|Change of residence|0|||
161200154|NCT05182840|582113081|FG007|Run-in Period|Change of residence|0|||
161200155|NCT05182840|582113082|FG008|Run-in Period|Change of residence|0|||
161200156|NCT05182840|582113083|FG009|Run-in Period|Change of residence|0|||
161200157|NCT05182840|582113074|FG000|Run-in Period|Adverse Event|5|||
161200158|NCT05182840|582113075|FG001|Run-in Period|Adverse Event|5|||
161200159|NCT05182840|582113076|FG002|Run-in Period|Adverse Event|0|||
161200160|NCT05182840|582113077|FG003|Run-in Period|Adverse Event|0|||
161200161|NCT05182840|582113078|FG004|Run-in Period|Adverse Event|0|||
161200162|NCT05182840|582113079|FG005|Run-in Period|Adverse Event|0|||
161200163|NCT05182840|582113080|FG006|Run-in Period|Adverse Event|0|||
161200164|NCT05182840|582113081|FG007|Run-in Period|Adverse Event|0|||
161200165|NCT05182840|582113082|FG008|Run-in Period|Adverse Event|0|||
161200166|NCT05182840|582113083|FG009|Run-in Period|Adverse Event|0|||
161200167|NCT05182840|582113074|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
161200168|NCT05182840|582113075|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
161200169|NCT05182840|582113076|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200170|NCT05182840|582113077|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200171|NCT05182840|582113078|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200172|NCT05182840|582113079|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200173|NCT05182840|582113080|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200174|NCT05182840|582113081|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200175|NCT05182840|582113082|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200176|NCT05182840|582113083|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
161200177|NCT05182840|582113074|FG000|Treatment Period|Reason missing|0|||
161200178|NCT05182840|582113075|FG001|Treatment Period|Reason missing|0|||
161200179|NCT05182840|582113076|FG002|Treatment Period|Reason missing|1|||
161200180|NCT05182840|582113077|FG003|Treatment Period|Reason missing|0|||
161200181|NCT05182840|582113078|FG004|Treatment Period|Reason missing|0|||
161200182|NCT05182840|582113079|FG005|Treatment Period|Reason missing|0|||
161200183|NCT05182840|582113080|FG006|Treatment Period|Reason missing|0|||
161200184|NCT05182840|582113081|FG007|Treatment Period|Reason missing|0|||
161200185|NCT05182840|582113082|FG008|Treatment Period|Reason missing|0|||
161200186|NCT05182840|582113083|FG009|Treatment Period|Reason missing|0|||
161200187|NCT05182840|582113074|FG000|Treatment Period|Other but not sponsor termination|0|||
161200188|NCT05182840|582113075|FG001|Treatment Period|Other but not sponsor termination|0|||
161200189|NCT05182840|582113076|FG002|Treatment Period|Other but not sponsor termination|8|||
161200190|NCT05182840|582113077|FG003|Treatment Period|Other but not sponsor termination|6|||
161200191|NCT05182840|582113078|FG004|Treatment Period|Other but not sponsor termination|6|||
161200192|NCT05182840|582113079|FG005|Treatment Period|Other but not sponsor termination|7|||
161200193|NCT05182840|582113080|FG006|Treatment Period|Other but not sponsor termination|5|||
161200194|NCT05182840|582113081|FG007|Treatment Period|Other but not sponsor termination|8|||
161200195|NCT05182840|582113082|FG008|Treatment Period|Other but not sponsor termination|7|||
161200196|NCT05182840|582113083|FG009|Treatment Period|Other but not sponsor termination|2|||
161200197|NCT05182840|582113074|FG000|Treatment Period|Protocol deviation|0|||
161200198|NCT05182840|582113075|FG001|Treatment Period|Protocol deviation|0|||
161200199|NCT05182840|582113076|FG002|Treatment Period|Protocol deviation|0|||
161200200|NCT05182840|582113077|FG003|Treatment Period|Protocol deviation|0|||
161200201|NCT05182840|582113078|FG004|Treatment Period|Protocol deviation|0|||
161200202|NCT05182840|582113079|FG005|Treatment Period|Protocol deviation|0|||
161200203|NCT05182840|582113080|FG006|Treatment Period|Protocol deviation|0|||
161200204|NCT05182840|582113081|FG007|Treatment Period|Protocol deviation|0|||
161200205|NCT05182840|582113082|FG008|Treatment Period|Protocol deviation|1|||
161200206|NCT05182840|582113083|FG009|Treatment Period|Protocol deviation|0|||
161200207|NCT05182840|582113074|FG000|Treatment Period|No reason available|0|||
161200208|NCT05182840|582113075|FG001|Treatment Period|No reason available|0|||
161200209|NCT05182840|582113076|FG002|Treatment Period|No reason available|0|||
161200210|NCT05182840|582113077|FG003|Treatment Period|No reason available|1|||
161200211|NCT05182840|582113078|FG004|Treatment Period|No reason available|0|||
161309241|NCT01358578|582515428|FG003|Induction Period|Lost to Follow-up|4|||
161309242|NCT01358578|582515429|FG004|Induction Period|Lost to Follow-up|0|||
161309243|NCT01358578|582515430|FG005|Induction Period|Lost to Follow-up|0|||
161309244|NCT01358578|582515425|FG000|Induction Period|Physician Decision|2|||
161309245|NCT01358578|582515426|FG001|Induction Period|Physician Decision|1|||
161309246|NCT01358578|582515427|FG002|Induction Period|Physician Decision|2|||
161309247|NCT01358578|582515428|FG003|Induction Period|Physician Decision|0|||
161309248|NCT01358578|582515429|FG004|Induction Period|Physician Decision|0|||
161309249|NCT01358578|582515430|FG005|Induction Period|Physician Decision|0|||
161309250|NCT01358578|582515425|FG000|Induction Period|Protocol Deviation|3|||
161309251|NCT01358578|582515426|FG001|Induction Period|Protocol Deviation|5|||
161309252|NCT01358578|582515427|FG002|Induction Period|Protocol Deviation|0|||
161309253|NCT01358578|582515428|FG003|Induction Period|Protocol Deviation|3|||
161309254|NCT01358578|582515429|FG004|Induction Period|Protocol Deviation|0|||
161309255|NCT01358578|582515430|FG005|Induction Period|Protocol Deviation|0|||
161309256|NCT01358578|582515425|FG000|Induction Period|technical problems|0|||
161309257|NCT01358578|582515426|FG001|Induction Period|technical problems|0|||
161309258|NCT01358578|582515427|FG002|Induction Period|technical problems|1|||
161309259|NCT01358578|582515428|FG003|Induction Period|technical problems|1|||
161309260|NCT01358578|582515429|FG004|Induction Period|technical problems|0|||
161309261|NCT01358578|582515430|FG005|Induction Period|technical problems|0|||
161309262|NCT01358578|582515425|FG000|Induction Period|Withdrawal by Subject|5|||
161309263|NCT01358578|582515426|FG001|Induction Period|Withdrawal by Subject|5|||
161309264|NCT01358578|582515427|FG002|Induction Period|Withdrawal by Subject|10|||
161309265|NCT01358578|582515428|FG003|Induction Period|Withdrawal by Subject|6|||
161309266|NCT01358578|582515429|FG004|Induction Period|Withdrawal by Subject|0|||
161309267|NCT01358578|582515430|FG005|Induction Period|Withdrawal by Subject|0|||
161309268|NCT01358578|582515425|FG000|Maintenance Period|Adverse Event|2|||
161309269|NCT01358578|582515426|FG001|Maintenance Period|Adverse Event|7|||
161309270|NCT01358578|582515427|FG002|Maintenance Period|Adverse Event|0|||
161309271|NCT01358578|582515428|FG003|Maintenance Period|Adverse Event|6|||
161309272|NCT01358578|582515429|FG004|Maintenance Period|Adverse Event|4|||
161309273|NCT01358578|582515430|FG005|Maintenance Period|Adverse Event|3|||
161309274|NCT01358578|582515425|FG000|Maintenance Period|Lack of Efficacy|10|||
161309275|NCT01358578|582515426|FG001|Maintenance Period|Lack of Efficacy|2|||
161309276|NCT01358578|582515427|FG002|Maintenance Period|Lack of Efficacy|0|||
161309277|NCT01358578|582515428|FG003|Maintenance Period|Lack of Efficacy|11|||
161309278|NCT01358578|582515429|FG004|Maintenance Period|Lack of Efficacy|3|||
161309279|NCT01358578|582515430|FG005|Maintenance Period|Lack of Efficacy|0|||
161309280|NCT01358578|582515425|FG000|Maintenance Period|Lost to Follow-up|4|||
161309281|NCT01358578|582515426|FG001|Maintenance Period|Lost to Follow-up|0|||
161309282|NCT01358578|582515427|FG002|Maintenance Period|Lost to Follow-up|0|||
161309283|NCT01358578|582515428|FG003|Maintenance Period|Lost to Follow-up|5|||
161309284|NCT01358578|582515429|FG004|Maintenance Period|Lost to Follow-up|1|||
161309285|NCT01358578|582515430|FG005|Maintenance Period|Lost to Follow-up|1|||
161309286|NCT01358578|582515425|FG000|Maintenance Period|Non-compliance with study treatment|3|||
161309287|NCT01358578|582515426|FG001|Maintenance Period|Non-compliance with study treatment|1|||
161309288|NCT01358578|582515427|FG002|Maintenance Period|Non-compliance with study treatment|0|||
161309289|NCT01358578|582515428|FG003|Maintenance Period|Non-compliance with study treatment|2|||
161309290|NCT01358578|582515429|FG004|Maintenance Period|Non-compliance with study treatment|1|||
161309291|NCT01358578|582515430|FG005|Maintenance Period|Non-compliance with study treatment|2|||
161309292|NCT01358578|582515425|FG000|Maintenance Period|Physician Decision|0|||
161309293|NCT01358578|582515426|FG001|Maintenance Period|Physician Decision|1|||
161200212|NCT05182840|582113079|FG005|Treatment Period|No reason available|2|||
161200213|NCT05182840|582113080|FG006|Treatment Period|No reason available|0|||
161309294|NCT01358578|582515427|FG002|Maintenance Period|Physician Decision|0|||
161309295|NCT01358578|582515428|FG003|Maintenance Period|Physician Decision|1|||
161309296|NCT01358578|582515429|FG004|Maintenance Period|Physician Decision|0|||
161200214|NCT05182840|582113081|FG007|Treatment Period|No reason available|1|||
161200215|NCT05182840|582113082|FG008|Treatment Period|No reason available|0|||
161309297|NCT01358578|582515430|FG005|Maintenance Period|Physician Decision|0|||
161309298|NCT01358578|582515425|FG000|Maintenance Period|Pregnancy|1|||
161309299|NCT01358578|582515426|FG001|Maintenance Period|Pregnancy|0|||
161309300|NCT01358578|582515427|FG002|Maintenance Period|Pregnancy|0|||
161309301|NCT01358578|582515428|FG003|Maintenance Period|Pregnancy|0|||
161309302|NCT01358578|582515429|FG004|Maintenance Period|Pregnancy|0|||
161309303|NCT01358578|582515430|FG005|Maintenance Period|Pregnancy|0|||
161309304|NCT01358578|582515425|FG000|Maintenance Period|Protocol deviation|7|||
161309305|NCT01358578|582515426|FG001|Maintenance Period|Protocol deviation|4|||
161309306|NCT01358578|582515427|FG002|Maintenance Period|Protocol deviation|0|||
161309307|NCT01358578|582515428|FG003|Maintenance Period|Protocol deviation|2|||
161309308|NCT01358578|582515429|FG004|Maintenance Period|Protocol deviation|2|||
161309309|NCT01358578|582515430|FG005|Maintenance Period|Protocol deviation|2|||
161309310|NCT01358578|582515425|FG000|Maintenance Period|Withdrawal by Subject|12|||
161309311|NCT01358578|582515426|FG001|Maintenance Period|Withdrawal by Subject|7|||
161309312|NCT01358578|582515427|FG002|Maintenance Period|Withdrawal by Subject|2|||
161309313|NCT01358578|582515428|FG003|Maintenance Period|Withdrawal by Subject|15|||
161309314|NCT01358578|582515429|FG004|Maintenance Period|Withdrawal by Subject|6|||
161309315|NCT01358578|582515430|FG005|Maintenance Period|Withdrawal by Subject|3|||
161309316|NCT01358578|582515425|FG000|Follow-up Period|Adverse Event|1|||
161309317|NCT01358578|582515426|FG001|Follow-up Period|Adverse Event|1|||
161309318|NCT01358578|582515427|FG002|Follow-up Period|Adverse Event|0|||
161309319|NCT01358578|582515428|FG003|Follow-up Period|Adverse Event|0|||
161309320|NCT01358578|582515429|FG004|Follow-up Period|Adverse Event|0|||
161309321|NCT01358578|582515430|FG005|Follow-up Period|Adverse Event|0|||
161309322|NCT01358578|582515425|FG000|Follow-up Period|Lack of Efficacy|3|||
161309323|NCT01358578|582515426|FG001|Follow-up Period|Lack of Efficacy|0|||
161309324|NCT01358578|582515427|FG002|Follow-up Period|Lack of Efficacy|4|||
161309325|NCT01358578|582515428|FG003|Follow-up Period|Lack of Efficacy|1|||
161309326|NCT01358578|582515429|FG004|Follow-up Period|Lack of Efficacy|0|||
161309327|NCT01358578|582515430|FG005|Follow-up Period|Lack of Efficacy|0|||
161309328|NCT01358578|582515425|FG000|Follow-up Period|Lost to Follow-up|0|||
161309329|NCT01358578|582515426|FG001|Follow-up Period|Lost to Follow-up|1|||
161309330|NCT01358578|582515427|FG002|Follow-up Period|Lost to Follow-up|0|||
161309331|NCT01358578|582515428|FG003|Follow-up Period|Lost to Follow-up|4|||
161309332|NCT01358578|582515429|FG004|Follow-up Period|Lost to Follow-up|0|||
161309333|NCT01358578|582515430|FG005|Follow-up Period|Lost to Follow-up|0|||
161309334|NCT01358578|582515425|FG000|Follow-up Period|non- compliance with study treatment|1|||
161309335|NCT01358578|582515426|FG001|Follow-up Period|non- compliance with study treatment|0|||
161309336|NCT01358578|582515427|FG002|Follow-up Period|non- compliance with study treatment|0|||
161309337|NCT01358578|582515428|FG003|Follow-up Period|non- compliance with study treatment|0|||
161309338|NCT01358578|582515429|FG004|Follow-up Period|non- compliance with study treatment|0|||
161309339|NCT01358578|582515430|FG005|Follow-up Period|non- compliance with study treatment|0|||
161309340|NCT01358578|582515425|FG000|Follow-up Period|Pregnancy|1|||
161309341|NCT01358578|582515426|FG001|Follow-up Period|Pregnancy|0|||
161309342|NCT01358578|582515427|FG002|Follow-up Period|Pregnancy|0|||
161309343|NCT01358578|582515428|FG003|Follow-up Period|Pregnancy|0|||
161309344|NCT01358578|582515429|FG004|Follow-up Period|Pregnancy|0|||
161309345|NCT01358578|582515430|FG005|Follow-up Period|Pregnancy|0|||
161309346|NCT01358578|582515425|FG000|Follow-up Period|Withdrawal by Subject|3|||
161309347|NCT01358578|582515426|FG001|Follow-up Period|Withdrawal by Subject|3|||
161309348|NCT01358578|582515427|FG002|Follow-up Period|Withdrawal by Subject|1|||
161309349|NCT01358578|582515428|FG003|Follow-up Period|Withdrawal by Subject|12|||
161309350|NCT01358578|582515429|FG004|Follow-up Period|Withdrawal by Subject|0|||
161309351|NCT01358578|582515430|FG005|Follow-up Period|Withdrawal by Subject|0|||
161309352|NCT01358578|582515425|FG000|Follow-up Period|Physician Decision|1|||
161309353|NCT01358578|582515426|FG001|Follow-up Period|Physician Decision|1|||
161309354|NCT01358578|582515427|FG002|Follow-up Period|Physician Decision|0|||
161309355|NCT01358578|582515428|FG003|Follow-up Period|Physician Decision|2|||
161309356|NCT01358578|582515429|FG004|Follow-up Period|Physician Decision|0|||
161309357|NCT01358578|582515430|FG005|Follow-up Period|Physician Decision|0|||
161309358|NCT01643798|582515431|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
161309359|NCT01643798|582515432|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
161309360|NCT03605849|582515433|FG000|Overall Study|Adverse Event|20|||
161309361|NCT03605849|582515434|FG001|Overall Study|Adverse Event|21|||
161309362|NCT03605849|582515435|FG002|Overall Study|Adverse Event|29|||
161309363|NCT03605849|582515436|FG003|Overall Study|Adverse Event|11|||
161309364|NCT03605849|582515433|FG000|Overall Study|Lack of Efficacy|4|||
161309365|NCT03605849|582515434|FG001|Overall Study|Lack of Efficacy|7|||
161309366|NCT03605849|582515435|FG002|Overall Study|Lack of Efficacy|9|||
161309367|NCT03605849|582515436|FG003|Overall Study|Lack of Efficacy|2|||
161309368|NCT03605849|582515433|FG000|Overall Study|Lost to Follow-up|8|||
161309369|NCT03605849|582515434|FG001|Overall Study|Lost to Follow-up|8|||
161309370|NCT03605849|582515435|FG002|Overall Study|Lost to Follow-up|14|||
161309371|NCT03605849|582515436|FG003|Overall Study|Lost to Follow-up|11|||
161309372|NCT03605849|582515433|FG000|Overall Study|Non-compliance With IMP|6|||
161309373|NCT03605849|582515434|FG001|Overall Study|Non-compliance With IMP|5|||
161309374|NCT03605849|582515435|FG002|Overall Study|Non-compliance With IMP|2|||
161309375|NCT03605849|582515436|FG003|Overall Study|Non-compliance With IMP|1|||
161200216|NCT05182840|582113083|FG009|Treatment Period|No reason available|0|||
161200217|NCT05182840|582113074|FG000|Treatment Period|Burden of study procedures|0|||
161200218|NCT05182840|582113075|FG001|Treatment Period|Burden of study procedures|0|||
161200219|NCT05182840|582113076|FG002|Treatment Period|Burden of study procedures|0|||
161200220|NCT05182840|582113077|FG003|Treatment Period|Burden of study procedures|0|||
161200221|NCT05182840|582113078|FG004|Treatment Period|Burden of study procedures|1|||
161200222|NCT05182840|582113079|FG005|Treatment Period|Burden of study procedures|0|||
161200223|NCT05182840|582113080|FG006|Treatment Period|Burden of study procedures|0|||
161200224|NCT05182840|582113081|FG007|Treatment Period|Burden of study procedures|0|||
161200225|NCT05182840|582113082|FG008|Treatment Period|Burden of study procedures|0|||
161200226|NCT05182840|582113083|FG009|Treatment Period|Burden of study procedures|0|||
161200227|NCT05182840|582113074|FG000|Treatment Period|Change of residence|0|||
161200228|NCT05182840|582113075|FG001|Treatment Period|Change of residence|0|||
161200229|NCT05182840|582113076|FG002|Treatment Period|Change of residence|0|||
161200230|NCT05182840|582113077|FG003|Treatment Period|Change of residence|0|||
161200231|NCT05182840|582113078|FG004|Treatment Period|Change of residence|0|||
161200232|NCT05182840|582113079|FG005|Treatment Period|Change of residence|1|||
161200233|NCT05182840|582113080|FG006|Treatment Period|Change of residence|0|||
161200234|NCT05182840|582113081|FG007|Treatment Period|Change of residence|0|||
161200235|NCT05182840|582113082|FG008|Treatment Period|Change of residence|0|||
161200236|NCT05182840|582113083|FG009|Treatment Period|Change of residence|0|||
161200237|NCT05182840|582113074|FG000|Treatment Period|Adverse Event|0|||
161200238|NCT05182840|582113075|FG001|Treatment Period|Adverse Event|0|||
161200239|NCT05182840|582113076|FG002|Treatment Period|Adverse Event|4|||
161200240|NCT05182840|582113077|FG003|Treatment Period|Adverse Event|16|||
161200241|NCT05182840|582113078|FG004|Treatment Period|Adverse Event|12|||
161200242|NCT05182840|582113079|FG005|Treatment Period|Adverse Event|6|||
161200243|NCT05182840|582113080|FG006|Treatment Period|Adverse Event|4|||
161200244|NCT05182840|582113081|FG007|Treatment Period|Adverse Event|8|||
161200245|NCT05182840|582113082|FG008|Treatment Period|Adverse Event|16|||
161200246|NCT05182840|582113083|FG009|Treatment Period|Adverse Event|5|||
161200247|NCT05182840|582113074|FG000|Treatment Period|Not treated with study drug|0|||
161200248|NCT05182840|582113075|FG001|Treatment Period|Not treated with study drug|0|||
161200249|NCT05182840|582113076|FG002|Treatment Period|Not treated with study drug|0|||
161200250|NCT05182840|582113077|FG003|Treatment Period|Not treated with study drug|1|||
161200251|NCT05182840|582113078|FG004|Treatment Period|Not treated with study drug|0|||
161200252|NCT05182840|582113079|FG005|Treatment Period|Not treated with study drug|0|||
161200253|NCT05182840|582113080|FG006|Treatment Period|Not treated with study drug|1|||
161200254|NCT05182840|582113081|FG007|Treatment Period|Not treated with study drug|1|||
161200255|NCT05182840|582113082|FG008|Treatment Period|Not treated with study drug|0|||
161200256|NCT05182840|582113083|FG009|Treatment Period|Not treated with study drug|0|||
161200257|NCT02396849|582113087|FG000|Overall Study|Lost to Follow-up|1|||
161200258|NCT02396849|582113088|FG001|Overall Study|Lost to Follow-up|1|||
161200259|NCT02396849|582113087|FG000|Overall Study|Did not tolerate intervention|1|||
161200260|NCT02396849|582113088|FG001|Overall Study|Did not tolerate intervention|1|||
161200261|NCT03328325|582113089|FG000|Overall Study|Lost to Follow-up|4|||
161200262|NCT03328325|582113089|FG000|Overall Study|Physician Decision|1|||
161200263|NCT03328325|582113089|FG000|Overall Study|Withdrawal by Subject|3|||
161200264|NCT03328325|582113089|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
161200265|NCT00931515|582113090|FG000|Overall Study|Lost to Follow-up|2|||
161200266|NCT00931515|582113091|FG001|Overall Study|Lost to Follow-up|5|||
161200267|NCT00985114|582113092|FG000|Overall Study|Adverse Event|1|||
161200268|NCT00985114|582113093|FG001|Overall Study|Adverse Event|0|||
161200269|NCT00985114|582113092|FG000|Overall Study|Withdrawal by Subject|0|||
161200270|NCT00985114|582113093|FG001|Overall Study|Withdrawal by Subject|2|||
161200271|NCT02950831|582113094|FG000|Overall Study|Lost to Follow-up|1|||
161200272|NCT02950831|582113094|FG000|Overall Study|Withdrawal by Subject|3|||
161200273|NCT02950831|582113094|FG000|Overall Study|stimulation trail failure|5|||
161200274|NCT00157157|582113102|FG000|Overall Study|Withdrawal by Subject|6|||
161200275|NCT00157157|582113102|FG000|Overall Study|Physician Decision|1|||
161200276|NCT00157157|582113102|FG000|Overall Study|Lost to Follow-up|1|||
161200277|NCT00157157|582113102|FG000|Overall Study|Enrolled in another study|1|||
161309376|NCT03605849|582515433|FG000|Overall Study|Protocol Deviation|1|||
161309377|NCT03605849|582515434|FG001|Overall Study|Protocol Deviation|2|||
161309378|NCT03605849|582515435|FG002|Overall Study|Protocol Deviation|1|||
161200278|NCT00157157|582113102|FG000|Overall Study|Met exclusion criteria|1|||
161200279|NCT00157157|582113102|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
161309379|NCT03605849|582515436|FG003|Overall Study|Protocol Deviation|3|||
161200280|NCT02260804|582113103|FG000|Induction Study Period|Protocol Violation|2|||
161200281|NCT02260804|582113104|FG001|Induction Study Period|Protocol Violation|0|||
161200282|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
161200283|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
161200284|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
161309380|NCT03605849|582515433|FG000|Overall Study|Withdrawal by Subject|33|||
161309381|NCT03605849|582515434|FG001|Overall Study|Withdrawal by Subject|28|||
161200285|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
161200286|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
161200287|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
161200288|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
161200289|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
161200290|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
161200291|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
161200292|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
161200293|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
161200294|NCT02260804|582113103|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
161200295|NCT02260804|582113104|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
161200296|NCT02260804|582113103|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
161200297|NCT02260804|582113104|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
161200298|NCT02260804|582113103|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
161200299|NCT02260804|582113104|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
161200300|NCT02260804|582113103|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
161200301|NCT02260804|582113104|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
161200302|NCT04888377|582115441|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
161200303|NCT04888377|582115442|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
161200304|NCT04888377|582115441|FG000|Overall Study|Physician Decision|6|||
161200305|NCT04888377|582115442|FG001|Overall Study|Physician Decision|6|||
161200306|NCT04888377|582115441|FG000|Overall Study|Withdrawal by Subject|7|||
161200307|NCT04888377|582115442|FG001|Overall Study|Withdrawal by Subject|3|||
161200308|NCT00526162|582115443|FG000|Overall Study|Device not implanted|3|||
161200309|NCT05279807|582115444|FG000|Overall Study|Withdrawal by Subject|1|||
161200310|NCT05279807|582115445|FG001|Overall Study|Withdrawal by Subject|0|||
161200311|NCT05279807|582115444|FG000|Overall Study|Adverse Event|0|||
161200312|NCT05279807|582115445|FG001|Overall Study|Adverse Event|1|||
161200313|NCT05279807|582115444|FG000|Overall Study|Laboratory Abnormal Results|1|||
161200314|NCT05279807|582115445|FG001|Overall Study|Laboratory Abnormal Results|0|||
161200315|NCT05299359|582115450|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
161200316|NCT05299359|582115451|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
161200317|NCT05299359|582115450|FG000|Main Part: Day 1 up to Day 366|Other|2|||
161200318|NCT05299359|582115451|FG001|Main Part: Day 1 up to Day 366|Other|0|||
161200319|NCT05299359|582115450|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
161200320|NCT05299359|582115451|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
161200321|NCT05299359|582115450|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
161200322|NCT05299359|582115451|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
161200323|NCT05299359|582115450|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
161200324|NCT05299359|582115451|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
161200325|NCT05299359|582115450|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
161200326|NCT05299359|582115451|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
161200327|NCT05299359|582115450|FG000|Extension Part: Day 1 to Day 366|Other|0|||
161200328|NCT05299359|582115451|FG001|Extension Part: Day 1 to Day 366|Other|1|||
161200329|NCT03587116|582115452|FG000|Overall Study|Lost to Follow-up|0|||
161200330|NCT03587116|582115453|FG001|Overall Study|Lost to Follow-up|1|||
161200331|NCT03587116|582115452|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
161200332|NCT03587116|582115453|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
161200333|NCT03587116|582115452|FG000|Overall Study|Withdrawal by Subject|4|||
161200334|NCT03587116|582115453|FG001|Overall Study|Withdrawal by Subject|0|||
161200335|NCT05993299|582115456|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
161200336|NCT05993299|582115456|FG000|Overall Study|Ongoing|4|||
161200337|NCT03110107|582115457|FG000|Treatment Period|Disease Progression|3|||
161200338|NCT03110107|582115458|FG001|Treatment Period|Disease Progression|9|||
161200339|NCT03110107|582115459|FG002|Treatment Period|Disease Progression|8|||
161200340|NCT03110107|582115460|FG003|Treatment Period|Disease Progression|11|||
161200341|NCT03110107|582115461|FG004|Treatment Period|Disease Progression|8|||
161200342|NCT03110107|582115462|FG005|Treatment Period|Disease Progression|4|||
161200343|NCT03110107|582115463|FG006|Treatment Period|Disease Progression|6|||
161200344|NCT03110107|582115464|FG007|Treatment Period|Disease Progression|7|||
161200345|NCT03110107|582115465|FG008|Treatment Period|Disease Progression|2|||
161200346|NCT03110107|582115466|FG009|Treatment Period|Disease Progression|10|||
161200347|NCT03110107|582115467|FG010|Treatment Period|Disease Progression|5|||
161200348|NCT03110107|582115468|FG011|Treatment Period|Disease Progression|2|||
161200349|NCT03110107|582115469|FG012|Treatment Period|Disease Progression|0|||
161200350|NCT03110107|582115470|FG013|Treatment Period|Disease Progression|5|||
161200351|NCT03110107|582115471|FG014|Treatment Period|Disease Progression|14|||
161200352|NCT03110107|582115472|FG015|Treatment Period|Disease Progression|14|||
161200353|NCT03110107|582115473|FG016|Treatment Period|Disease Progression|4|||
161200354|NCT03110107|582115474|FG017|Treatment Period|Disease Progression|3|||
161309382|NCT03605849|582515435|FG002|Overall Study|Withdrawal by Subject|30|||
161309383|NCT03605849|582515436|FG003|Overall Study|Withdrawal by Subject|28|||
161309384|NCT03605849|582515433|FG000|Overall Study|Site Terminated by Sponsor|0|||
161309385|NCT03605849|582515434|FG001|Overall Study|Site Terminated by Sponsor|0|||
161309386|NCT03605849|582515435|FG002|Overall Study|Site Terminated by Sponsor|0|||
161309387|NCT03605849|582515436|FG003|Overall Study|Site Terminated by Sponsor|1|||
161309388|NCT03605849|582515433|FG000|Overall Study|Physician Decision|2|||
161309389|NCT03605849|582515434|FG001|Overall Study|Physician Decision|1|||
161309390|NCT03605849|582515435|FG002|Overall Study|Physician Decision|2|||
161309391|NCT03605849|582515436|FG003|Overall Study|Physician Decision|1|||
161309392|NCT03605849|582515433|FG000|Overall Study|Enrolled, but not Treated|2|||
161309393|NCT03605849|582515434|FG001|Overall Study|Enrolled, but not Treated|2|||
161309394|NCT03605849|582515435|FG002|Overall Study|Enrolled, but not Treated|3|||
161309395|NCT03605849|582515436|FG003|Overall Study|Enrolled, but not Treated|2|||
161309396|NCT03605849|582515433|FG000|Overall Study|Other (COVID-19 Related)|0|||
161309397|NCT03605849|582515434|FG001|Overall Study|Other (COVID-19 Related)|1|||
161309398|NCT03605849|582515435|FG002|Overall Study|Other (COVID-19 Related)|1|||
161309399|NCT03605849|582515436|FG003|Overall Study|Other (COVID-19 Related)|0|||
161309400|NCT03605849|582515433|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
161309401|NCT03605849|582515434|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
161309402|NCT03605849|582515435|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
161309403|NCT03605849|582515436|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
161309404|NCT01911780|582515437|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
161309405|NCT01911780|582515438|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
161309406|NCT01911780|582515437|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
161309407|NCT01911780|582515438|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
161309408|NCT01911780|582515437|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
161309409|NCT01911780|582515438|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
161309410|NCT01911780|582515437|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
161309411|NCT01911780|582515438|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
161309412|NCT01911780|582515437|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
161309413|NCT01911780|582515438|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
161309414|NCT01911780|582515437|FG000|Extension Period (52 Weeks)|Personal reason|1|||
161309415|NCT01911780|582515438|FG001|Extension Period (52 Weeks)|Personal reason|1|||
161309416|NCT05014815|582515441|FG000|Overall Study|Death|63|||
161309417|NCT05014815|582515442|FG001|Overall Study|Death|70|||
161309418|NCT05014815|582515441|FG000|Overall Study|Withdrawal by Subject|10|||
161309419|NCT05014815|582515442|FG001|Overall Study|Withdrawal by Subject|10|||
161309420|NCT05014815|582515441|FG000|Overall Study|Lost to Follow-up|4|||
161309421|NCT05014815|582515442|FG001|Overall Study|Lost to Follow-up|2|||
161090914|NCT00250679|581723762|FG000|Overall Study|Lost to Follow-up|3|||
161090915|NCT00250679|581723763|FG001|Overall Study|Lost to Follow-up|4|||
161090916|NCT00250679|581723764|FG002|Overall Study|Lost to Follow-up|2|||
161090917|NCT00250679|581723762|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
161090918|NCT00250679|581723763|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
161090919|NCT00250679|581723764|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
161090920|NCT00250679|581723762|FG000|Overall Study|Lack of Efficacy|0|||
161090921|NCT00250679|581723763|FG001|Overall Study|Lack of Efficacy|1|||
161090922|NCT00250679|581723764|FG002|Overall Study|Lack of Efficacy|3|||
161090923|NCT00250679|581723762|FG000|Overall Study|Technical Holter issues|1|||
161090924|NCT00250679|581723763|FG001|Overall Study|Technical Holter issues|0|||
161090925|NCT00250679|581723764|FG002|Overall Study|Technical Holter issues|2|||
161090926|NCT00250679|581723762|FG000|Overall Study|Moved|1|||
161090927|NCT00250679|581723763|FG001|Overall Study|Moved|1|||
161090928|NCT00250679|581723764|FG002|Overall Study|Moved|0|||
161090929|NCT00250679|581723762|FG000|Overall Study|Non-compliance|1|||
161090930|NCT00250679|581723763|FG001|Overall Study|Non-compliance|1|||
161090931|NCT00250679|581723764|FG002|Overall Study|Non-compliance|0|||
161090932|NCT00250679|581723762|FG000|Overall Study|various single events: hip surgery,diary|3|||
161090933|NCT00250679|581723763|FG001|Overall Study|various single events: hip surgery,diary|1|||
161090934|NCT00250679|581723764|FG002|Overall Study|various single events: hip surgery,diary|1|||
161090935|NCT00448279|581723766|FG000|Overall Study|Lost to Follow-up|2|||
161090936|NCT00448279|581723767|FG001|Overall Study|Lost to Follow-up|2|||
161090937|NCT00448279|581723766|FG000|Overall Study|Adverse Event|1|||
161090938|NCT00448279|581723767|FG001|Overall Study|Adverse Event|1|||
161090939|NCT00448279|581723766|FG000|Overall Study|Disease progression|16|||
161090940|NCT00448279|581723767|FG001|Overall Study|Disease progression|18|||
161090941|NCT00448279|581723766|FG000|Overall Study|Withdrawal by Subject|4|||
161090942|NCT00448279|581723767|FG001|Overall Study|Withdrawal by Subject|3|||
161309422|NCT05014815|582515441|FG000|Overall Study|Physician Decision|2|||
161309423|NCT05014815|582515442|FG001|Overall Study|Physician Decision|4|||
161309424|NCT06303167|582515453|FG000|Overall Study|Ineligible|1|||
161309425|NCT06303167|582515453|FG000|Overall Study|Never start protocol therapy|2|||
161090943|NCT00448279|581723766|FG000|Overall Study|Other|6|||
161090944|NCT00448279|581723767|FG001|Overall Study|Other|4|||
161090945|NCT00448279|581723766|FG000|Overall Study|Protocol Violation|0|||
161200355|NCT03110107|582115475|FG018|Treatment Period|Disease Progression|16|||
161200356|NCT03110107|582115476|FG019|Treatment Period|Disease Progression|14|||
161200357|NCT03110107|582115477|FG020|Treatment Period|Disease Progression|12|||
161200358|NCT03110107|582115478|FG021|Treatment Period|Disease Progression|16|||
161200359|NCT03110107|582115479|FG022|Treatment Period|Disease Progression|18|||
161200360|NCT03110107|582115480|FG023|Treatment Period|Disease Progression|13|||
161200361|NCT03110107|582115481|FG024|Treatment Period|Disease Progression|16|||
161200362|NCT03110107|582115482|FG025|Treatment Period|Disease Progression|31|||
161309426|NCT06303167|582515453|FG000|Overall Study|Disease progression|16|||
161309427|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Death|117|||
161309428|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Death|197|||
161309429|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
161309430|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
161309431|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
161309432|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
161309433|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
161309434|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
161309435|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
161309436|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
161309437|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
161309438|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
161309439|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
161309440|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
161309441|NCT02677896|582515454|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
161309442|NCT02677896|582515455|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
161309443|NCT02677896|582515454|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
161309444|NCT02677896|582515455|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
161309445|NCT02677896|582515454|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
161309446|NCT02677896|582515455|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
161309447|NCT02677896|582515454|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
161309448|NCT02677896|582515455|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
161309449|NCT02677896|582515454|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
161309450|NCT02677896|582515455|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
161309451|NCT02677896|582515454|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
161309452|NCT02677896|582515455|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
161309453|NCT02677896|582515454|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
161309454|NCT02677896|582515455|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
161309455|NCT00655733|582515461|FG000|Overall Study|Lost to Follow-up|2|||
161309456|NCT00655733|582515462|FG001|Overall Study|Lost to Follow-up|2|||
161309457|NCT00655733|582515461|FG000|Overall Study|Adverse Event|2|||
161309458|NCT00655733|582515462|FG001|Overall Study|Adverse Event|2|||
161309459|NCT00655733|582515461|FG000|Overall Study|Withdrawal by Subject|3|||
161309460|NCT00655733|582515462|FG001|Overall Study|Withdrawal by Subject|3|||
161309461|NCT00655733|582515461|FG000|Overall Study|Physician Decision|0|||
161309462|NCT00655733|582515462|FG001|Overall Study|Physician Decision|1|||
161309463|NCT01482962|582515466|FG000|Overall Study|Progressive Disease|65|||
161200363|NCT03110107|582115457|FG000|Treatment Period|Study drug toxicity|1|||
161200364|NCT03110107|582115458|FG001|Treatment Period|Study drug toxicity|0|||
161200365|NCT03110107|582115459|FG002|Treatment Period|Study drug toxicity|1|||
161200366|NCT03110107|582115460|FG003|Treatment Period|Study drug toxicity|2|||
161200367|NCT03110107|582115461|FG004|Treatment Period|Study drug toxicity|0|||
161200368|NCT03110107|582115462|FG005|Treatment Period|Study drug toxicity|3|||
161200369|NCT03110107|582115463|FG006|Treatment Period|Study drug toxicity|1|||
161200370|NCT03110107|582115464|FG007|Treatment Period|Study drug toxicity|1|||
161200371|NCT03110107|582115465|FG008|Treatment Period|Study drug toxicity|3|||
161200372|NCT03110107|582115466|FG009|Treatment Period|Study drug toxicity|2|||
161200373|NCT03110107|582115467|FG010|Treatment Period|Study drug toxicity|0|||
161200374|NCT03110107|582115468|FG011|Treatment Period|Study drug toxicity|2|||
161200375|NCT03110107|582115469|FG012|Treatment Period|Study drug toxicity|0|||
161200376|NCT03110107|582115470|FG013|Treatment Period|Study drug toxicity|0|||
161200377|NCT03110107|582115471|FG014|Treatment Period|Study drug toxicity|2|||
161309464|NCT01482962|582515467|FG001|Overall Study|Progressive Disease|53|||
161309465|NCT01482962|582515466|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
161309466|NCT01482962|582515467|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
161309467|NCT01482962|582515466|FG000|Overall Study|Adverse Event|18|||
161200378|NCT03110107|582115472|FG015|Treatment Period|Study drug toxicity|3|||
161200379|NCT03110107|582115473|FG016|Treatment Period|Study drug toxicity|3|||
161200380|NCT03110107|582115474|FG017|Treatment Period|Study drug toxicity|3|||
161200381|NCT03110107|582115475|FG018|Treatment Period|Study drug toxicity|1|||
161200382|NCT03110107|582115476|FG019|Treatment Period|Study drug toxicity|2|||
161309468|NCT01482962|582515467|FG001|Overall Study|Adverse Event|22|||
161200383|NCT03110107|582115477|FG020|Treatment Period|Study drug toxicity|2|||
161200384|NCT03110107|582115478|FG021|Treatment Period|Study drug toxicity|0|||
161200385|NCT03110107|582115479|FG022|Treatment Period|Study drug toxicity|2|||
161200386|NCT03110107|582115480|FG023|Treatment Period|Study drug toxicity|6|||
161200387|NCT03110107|582115481|FG024|Treatment Period|Study drug toxicity|7|||
161200388|NCT03110107|582115482|FG025|Treatment Period|Study drug toxicity|6|||
161200389|NCT03110107|582115457|FG000|Treatment Period|Death|0|||
161200390|NCT03110107|582115458|FG001|Treatment Period|Death|0|||
161200391|NCT03110107|582115459|FG002|Treatment Period|Death|0|||
161200392|NCT03110107|582115460|FG003|Treatment Period|Death|0|||
161200393|NCT03110107|582115461|FG004|Treatment Period|Death|0|||
161200394|NCT03110107|582115462|FG005|Treatment Period|Death|0|||
161200395|NCT03110107|582115463|FG006|Treatment Period|Death|0|||
161200396|NCT03110107|582115464|FG007|Treatment Period|Death|0|||
161200397|NCT03110107|582115465|FG008|Treatment Period|Death|0|||
161200398|NCT03110107|582115466|FG009|Treatment Period|Death|0|||
161200399|NCT03110107|582115467|FG010|Treatment Period|Death|0|||
161200400|NCT03110107|582115468|FG011|Treatment Period|Death|0|||
161200401|NCT03110107|582115469|FG012|Treatment Period|Death|1|||
161200402|NCT03110107|582115470|FG013|Treatment Period|Death|0|||
161200403|NCT03110107|582115471|FG014|Treatment Period|Death|0|||
161200404|NCT03110107|582115472|FG015|Treatment Period|Death|0|||
161200405|NCT03110107|582115473|FG016|Treatment Period|Death|0|||
161200406|NCT03110107|582115474|FG017|Treatment Period|Death|0|||
161200407|NCT03110107|582115475|FG018|Treatment Period|Death|0|||
161200408|NCT03110107|582115476|FG019|Treatment Period|Death|0|||
161200409|NCT03110107|582115477|FG020|Treatment Period|Death|0|||
161200410|NCT03110107|582115478|FG021|Treatment Period|Death|0|||
161200411|NCT03110107|582115479|FG022|Treatment Period|Death|0|||
161200412|NCT03110107|582115480|FG023|Treatment Period|Death|0|||
161309469|NCT01482962|582515466|FG000|Overall Study|Withdrawal by Participant|8|||
161309470|NCT01482962|582515467|FG001|Overall Study|Withdrawal by Participant|13|||
161309471|NCT01482962|582515466|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
161309472|NCT01482962|582515467|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
161309473|NCT01482962|582515466|FG000|Overall Study|Other Reason|1|||
161309474|NCT01482962|582515467|FG001|Overall Study|Other Reason|5|||
161309475|NCT01482962|582515466|FG000|Overall Study|Study Terminated by Sponsor|5|||
161309476|NCT01482962|582515467|FG001|Overall Study|Study Terminated by Sponsor|2|||
161309477|NCT01482962|582515466|FG000|Overall Study|Did not Receive Study Drug|1|||
161309478|NCT01482962|582515467|FG001|Overall Study|Did not Receive Study Drug|6|||
161309479|NCT02407457|582515468|FG000|1 Month|Death|3|||
161309480|NCT02407457|582515469|FG001|1 Month|Death|0|||
161309481|NCT02407457|582515468|FG000|1 Month|Lost to Follow-up|1|||
161309482|NCT02407457|582515469|FG001|1 Month|Lost to Follow-up|1|||
161309483|NCT02407457|582515468|FG000|1 Month|missed visit|2|||
161309484|NCT02407457|582515469|FG001|1 Month|missed visit|5|||
161309485|NCT02407457|582515468|FG000|6-Month|Death|2|||
161309486|NCT02407457|582515469|FG001|6-Month|Death|8|||
161309487|NCT02407457|582515468|FG000|6-Month|Lost to Follow-up|2|||
161309488|NCT02407457|582515469|FG001|6-Month|Lost to Follow-up|2|||
161309489|NCT02407457|582515468|FG000|6-Month|missed visit|16|||
161309490|NCT02407457|582515469|FG001|6-Month|missed visit|14|||
161309491|NCT02407457|582515468|FG000|6-Month|Open Repair|0|||
161309492|NCT02407457|582515469|FG001|6-Month|Open Repair|1|||
161309493|NCT02407457|582515468|FG000|1 Year|Death|6|||
161309494|NCT02407457|582515469|FG001|1 Year|Death|11|||
161309495|NCT02407457|582515468|FG000|1 Year|Lost to Follow-up|3|||
161309496|NCT02407457|582515469|FG001|1 Year|Lost to Follow-up|2|||
161309497|NCT02407457|582515468|FG000|1 Year|Missed Visit|24|||
161309498|NCT02407457|582515469|FG001|1 Year|Missed Visit|14|||
161309499|NCT02407457|582515468|FG000|1 Year|Open Repair|0|||
161309500|NCT02407457|582515469|FG001|1 Year|Open Repair|1|||
161309501|NCT02407457|582515468|FG000|2-year|Death|14|||
161309502|NCT02407457|582515469|FG001|2-year|Death|8|||
161309503|NCT02407457|582515468|FG000|2-year|Lost to Follow-up|7|||
161309504|NCT02407457|582515469|FG001|2-year|Lost to Follow-up|10|||
161309505|NCT02407457|582515468|FG000|2-year|Missed Visit|13|||
161309506|NCT02407457|582515469|FG001|2-year|Missed Visit|15|||
161200413|NCT03110107|582115481|FG024|Treatment Period|Death|0|||
161200414|NCT03110107|582115482|FG025|Treatment Period|Death|0|||
161200415|NCT03110107|582115457|FG000|Treatment Period|Adverse Event|0|||
161200416|NCT03110107|582115458|FG001|Treatment Period|Adverse Event|0|||
161200417|NCT03110107|582115459|FG002|Treatment Period|Adverse Event|1|||
161309507|NCT02407457|582515468|FG000|2-year|Open Repair|0|||
161200418|NCT03110107|582115460|FG003|Treatment Period|Adverse Event|0|||
161200419|NCT03110107|582115461|FG004|Treatment Period|Adverse Event|0|||
161200420|NCT03110107|582115462|FG005|Treatment Period|Adverse Event|2|||
161309508|NCT02407457|582515469|FG001|2-year|Open Repair|2|||
161309509|NCT02407457|582515468|FG000|3-year|Death|11|||
161309510|NCT02407457|582515469|FG001|3-year|Death|10|||
161309511|NCT02407457|582515468|FG000|3-year|Lost to Follow-up|9|||
161309512|NCT02407457|582515469|FG001|3-year|Lost to Follow-up|10|||
161309513|NCT02407457|582515468|FG000|3-year|Missed Visit|19|||
161309514|NCT02407457|582515469|FG001|3-year|Missed Visit|16|||
161309515|NCT02407457|582515468|FG000|4-year|Death|18|||
161309516|NCT02407457|582515469|FG001|4-year|Death|10|||
161200421|NCT03110107|582115463|FG006|Treatment Period|Adverse Event|0|||
161200422|NCT03110107|582115464|FG007|Treatment Period|Adverse Event|2|||
161200423|NCT03110107|582115465|FG008|Treatment Period|Adverse Event|0|||
161200424|NCT03110107|582115466|FG009|Treatment Period|Adverse Event|1|||
161200425|NCT03110107|582115467|FG010|Treatment Period|Adverse Event|0|||
161200426|NCT03110107|582115468|FG011|Treatment Period|Adverse Event|0|||
161200427|NCT03110107|582115469|FG012|Treatment Period|Adverse Event|0|||
161200428|NCT03110107|582115470|FG013|Treatment Period|Adverse Event|0|||
161200429|NCT03110107|582115471|FG014|Treatment Period|Adverse Event|0|||
161200430|NCT03110107|582115472|FG015|Treatment Period|Adverse Event|2|||
161200431|NCT03110107|582115473|FG016|Treatment Period|Adverse Event|0|||
161200432|NCT03110107|582115474|FG017|Treatment Period|Adverse Event|1|||
161200433|NCT03110107|582115475|FG018|Treatment Period|Adverse Event|2|||
161200434|NCT03110107|582115476|FG019|Treatment Period|Adverse Event|1|||
161200435|NCT03110107|582115477|FG020|Treatment Period|Adverse Event|4|||
161200436|NCT03110107|582115478|FG021|Treatment Period|Adverse Event|2|||
161200437|NCT03110107|582115479|FG022|Treatment Period|Adverse Event|2|||
161200438|NCT03110107|582115480|FG023|Treatment Period|Adverse Event|2|||
161200439|NCT03110107|582115481|FG024|Treatment Period|Adverse Event|2|||
161200440|NCT03110107|582115482|FG025|Treatment Period|Adverse Event|4|||
161200441|NCT03110107|582115457|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
161200442|NCT03110107|582115458|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
161200443|NCT03110107|582115459|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
161200444|NCT03110107|582115460|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
161200445|NCT03110107|582115461|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
161200446|NCT03110107|582115462|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
161200447|NCT03110107|582115463|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
161200448|NCT03110107|582115464|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
161200449|NCT03110107|582115465|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
161200450|NCT03110107|582115466|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
161200451|NCT03110107|582115467|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
161200452|NCT03110107|582115468|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
161200453|NCT03110107|582115469|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
161200454|NCT03110107|582115470|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
161200455|NCT03110107|582115471|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
161200456|NCT03110107|582115472|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
161200457|NCT03110107|582115473|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
161200458|NCT03110107|582115474|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
161200459|NCT03110107|582115475|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
161200460|NCT03110107|582115476|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
161200461|NCT03110107|582115477|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
161200462|NCT03110107|582115478|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
161200463|NCT03110107|582115479|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
161200464|NCT03110107|582115480|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
161200465|NCT03110107|582115481|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
161200466|NCT03110107|582115482|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
161200467|NCT03110107|582115457|FG000|Treatment Period|Participant withdrew consent|0|||
161200468|NCT03110107|582115458|FG001|Treatment Period|Participant withdrew consent|0|||
161200469|NCT03110107|582115459|FG002|Treatment Period|Participant withdrew consent|1|||
161200470|NCT03110107|582115460|FG003|Treatment Period|Participant withdrew consent|0|||
161200471|NCT03110107|582115461|FG004|Treatment Period|Participant withdrew consent|4|||
161200472|NCT03110107|582115462|FG005|Treatment Period|Participant withdrew consent|3|||
161200473|NCT03110107|582115463|FG006|Treatment Period|Participant withdrew consent|0|||
161309517|NCT02407457|582515468|FG000|4-year|Lost to Follow-up|10|||
161309518|NCT02407457|582515469|FG001|4-year|Lost to Follow-up|12|||
161309519|NCT02407457|582515468|FG000|4-year|Missed Visit|18|||
161309520|NCT02407457|582515469|FG001|4-year|Missed Visit|16|||
161309521|NCT02407457|582515468|FG000|5-year|Death|10|||
161309522|NCT02407457|582515469|FG001|5-year|Death|3|||
161309523|NCT02407457|582515468|FG000|5-year|Lost to Follow-up|22|||
161309524|NCT02407457|582515469|FG001|5-year|Lost to Follow-up|13|||
161309525|NCT02407457|582515468|FG000|5-year|Missed Visit|9|||
161200474|NCT03110107|582115464|FG007|Treatment Period|Participant withdrew consent|0|||
161200475|NCT03110107|582115465|FG008|Treatment Period|Participant withdrew consent|0|||
161200476|NCT03110107|582115466|FG009|Treatment Period|Participant withdrew consent|1|||
161200477|NCT03110107|582115467|FG010|Treatment Period|Participant withdrew consent|0|||
161309526|NCT02407457|582515469|FG001|5-year|Missed Visit|1|||
161309527|NCT02954653|582515472|FG000|Overall Study|Death|3|||
161309528|NCT02954653|582515473|FG001|Overall Study|Death|1|||
161309529|NCT02954653|582515474|FG002|Overall Study|Death|0|||
161200478|NCT03110107|582115468|FG011|Treatment Period|Participant withdrew consent|0|||
161200479|NCT03110107|582115469|FG012|Treatment Period|Participant withdrew consent|0|||
161200480|NCT03110107|582115470|FG013|Treatment Period|Participant withdrew consent|0|||
161200481|NCT03110107|582115471|FG014|Treatment Period|Participant withdrew consent|0|||
161200482|NCT03110107|582115472|FG015|Treatment Period|Participant withdrew consent|0|||
161200483|NCT03110107|582115473|FG016|Treatment Period|Participant withdrew consent|0|||
161200484|NCT03110107|582115474|FG017|Treatment Period|Participant withdrew consent|0|||
161200485|NCT03110107|582115475|FG018|Treatment Period|Participant withdrew consent|0|||
161200486|NCT03110107|582115476|FG019|Treatment Period|Participant withdrew consent|1|||
161200487|NCT03110107|582115477|FG020|Treatment Period|Participant withdrew consent|0|||
161200488|NCT03110107|582115478|FG021|Treatment Period|Participant withdrew consent|2|||
161200489|NCT03110107|582115479|FG022|Treatment Period|Participant withdrew consent|0|||
161200490|NCT03110107|582115480|FG023|Treatment Period|Participant withdrew consent|0|||
161200491|NCT03110107|582115481|FG024|Treatment Period|Participant withdrew consent|0|||
161200492|NCT03110107|582115482|FG025|Treatment Period|Participant withdrew consent|2|||
161200493|NCT03110107|582115457|FG000|Treatment Period|Participants no longer meets study criteria|0|||
161200494|NCT03110107|582115458|FG001|Treatment Period|Participants no longer meets study criteria|0|||
161200495|NCT03110107|582115459|FG002|Treatment Period|Participants no longer meets study criteria|0|||
161200496|NCT03110107|582115460|FG003|Treatment Period|Participants no longer meets study criteria|0|||
161200497|NCT03110107|582115461|FG004|Treatment Period|Participants no longer meets study criteria|0|||
161200498|NCT03110107|582115462|FG005|Treatment Period|Participants no longer meets study criteria|0|||
161200499|NCT03110107|582115463|FG006|Treatment Period|Participants no longer meets study criteria|0|||
161200500|NCT03110107|582115464|FG007|Treatment Period|Participants no longer meets study criteria|0|||
161200501|NCT03110107|582115465|FG008|Treatment Period|Participants no longer meets study criteria|0|||
161200502|NCT03110107|582115466|FG009|Treatment Period|Participants no longer meets study criteria|0|||
161200503|NCT03110107|582115467|FG010|Treatment Period|Participants no longer meets study criteria|0|||
161200504|NCT03110107|582115468|FG011|Treatment Period|Participants no longer meets study criteria|0|||
161200505|NCT03110107|582115469|FG012|Treatment Period|Participants no longer meets study criteria|0|||
161200506|NCT03110107|582115470|FG013|Treatment Period|Participants no longer meets study criteria|0|||
161200507|NCT03110107|582115471|FG014|Treatment Period|Participants no longer meets study criteria|0|||
161200508|NCT03110107|582115472|FG015|Treatment Period|Participants no longer meets study criteria|0|||
161200509|NCT03110107|582115473|FG016|Treatment Period|Participants no longer meets study criteria|0|||
161200510|NCT03110107|582115474|FG017|Treatment Period|Participants no longer meets study criteria|0|||
161200511|NCT03110107|582115475|FG018|Treatment Period|Participants no longer meets study criteria|0|||
161200512|NCT03110107|582115476|FG019|Treatment Period|Participants no longer meets study criteria|0|||
161200513|NCT03110107|582115477|FG020|Treatment Period|Participants no longer meets study criteria|0|||
161200514|NCT03110107|582115478|FG021|Treatment Period|Participants no longer meets study criteria|0|||
161309530|NCT02954653|582515475|FG003|Overall Study|Death|0|||
161309531|NCT02954653|582515476|FG004|Overall Study|Death|0|||
161309532|NCT02954653|582515477|FG005|Overall Study|Death|0|||
161309533|NCT02954653|582515478|FG006|Overall Study|Death|0|||
161309534|NCT02954653|582515479|FG007|Overall Study|Death|0|||
161309535|NCT02954653|582515480|FG008|Overall Study|Death|0|||
161309536|NCT02954653|582515472|FG000|Overall Study|Randomized but did not receive treatment|1|||
161309537|NCT02954653|582515473|FG001|Overall Study|Randomized but did not receive treatment|0|||
161309538|NCT02954653|582515474|FG002|Overall Study|Randomized but did not receive treatment|0|||
161309539|NCT02954653|582515475|FG003|Overall Study|Randomized but did not receive treatment|0|||
161309540|NCT02954653|582515476|FG004|Overall Study|Randomized but did not receive treatment|0|||
161309541|NCT02954653|582515477|FG005|Overall Study|Randomized but did not receive treatment|0|||
161309542|NCT02954653|582515478|FG006|Overall Study|Randomized but did not receive treatment|0|||
161309543|NCT02954653|582515479|FG007|Overall Study|Randomized but did not receive treatment|0|||
161309544|NCT02954653|582515480|FG008|Overall Study|Randomized but did not receive treatment|0|||
161309545|NCT02954653|582515472|FG000|Overall Study|Started another anti-cancer therapy|0|||
161309546|NCT02954653|582515473|FG001|Overall Study|Started another anti-cancer therapy|1|||
161309547|NCT02954653|582515474|FG002|Overall Study|Started another anti-cancer therapy|0|||
161309548|NCT02954653|582515475|FG003|Overall Study|Started another anti-cancer therapy|0|||
161309549|NCT02954653|582515476|FG004|Overall Study|Started another anti-cancer therapy|0|||
161309550|NCT02954653|582515477|FG005|Overall Study|Started another anti-cancer therapy|0|||
161309551|NCT02954653|582515478|FG006|Overall Study|Started another anti-cancer therapy|0|||
161309552|NCT02954653|582515479|FG007|Overall Study|Started another anti-cancer therapy|0|||
161200515|NCT03110107|582115479|FG022|Treatment Period|Participants no longer meets study criteria|0|||
161200516|NCT03110107|582115480|FG023|Treatment Period|Participants no longer meets study criteria|1|||
161309553|NCT02954653|582515480|FG008|Overall Study|Started another anti-cancer therapy|0|||
161309554|NCT02954653|582515472|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
161090946|NCT00448279|581723767|FG001|Overall Study|Protocol Violation|1|||
161090947|NCT04776148|581723768|FG000|Overall Study|Death|249|||
161090948|NCT04776148|581723769|FG001|Overall Study|Death|260|||
161090949|NCT04776148|581723768|FG000|Overall Study|Lost to Follow-up|0|||
161090950|NCT04776148|581723769|FG001|Overall Study|Lost to Follow-up|1|||
161090951|NCT04776148|581723768|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
161090952|NCT04776148|581723769|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
161090953|NCT04776148|581723768|FG000|Overall Study|Withdrawal by Subject|3|||
161090954|NCT04776148|581723769|FG001|Overall Study|Withdrawal by Subject|4|||
161090955|NCT04776148|581723768|FG000|Overall Study|Sponsor Decision|30|||
161090956|NCT04776148|581723769|FG001|Overall Study|Sponsor Decision|15|||
161090957|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
161090958|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
161090959|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
161090960|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
161090961|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
161090962|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
161090963|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
161090964|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
161090965|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
161090966|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
161090967|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
161090968|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
161090969|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
161090970|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
161090971|NCT00757588|581723770|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
161090972|NCT00757588|581723771|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
161090973|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
161090974|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
161200517|NCT03110107|582115481|FG024|Treatment Period|Participants no longer meets study criteria|0|||
161200518|NCT03110107|582115482|FG025|Treatment Period|Participants no longer meets study criteria|0|||
161200519|NCT03110107|582115457|FG000|Treatment Period|Other Reasons|0|||
161200520|NCT03110107|582115458|FG001|Treatment Period|Other Reasons|0|||
161200521|NCT03110107|582115459|FG002|Treatment Period|Other Reasons|1|||
161200522|NCT03110107|582115460|FG003|Treatment Period|Other Reasons|1|||
161200523|NCT03110107|582115461|FG004|Treatment Period|Other Reasons|0|||
161200524|NCT03110107|582115462|FG005|Treatment Period|Other Reasons|1|||
161200525|NCT03110107|582115463|FG006|Treatment Period|Other Reasons|0|||
161200526|NCT03110107|582115464|FG007|Treatment Period|Other Reasons|0|||
161200527|NCT03110107|582115465|FG008|Treatment Period|Other Reasons|0|||
161200528|NCT03110107|582115466|FG009|Treatment Period|Other Reasons|0|||
161200529|NCT03110107|582115467|FG010|Treatment Period|Other Reasons|0|||
161200530|NCT03110107|582115468|FG011|Treatment Period|Other Reasons|0|||
161200531|NCT03110107|582115469|FG012|Treatment Period|Other Reasons|0|||
161200532|NCT03110107|582115470|FG013|Treatment Period|Other Reasons|0|||
161200533|NCT03110107|582115471|FG014|Treatment Period|Other Reasons|0|||
161200534|NCT03110107|582115472|FG015|Treatment Period|Other Reasons|0|||
161200535|NCT03110107|582115473|FG016|Treatment Period|Other Reasons|0|||
161200536|NCT03110107|582115474|FG017|Treatment Period|Other Reasons|0|||
161200537|NCT03110107|582115475|FG018|Treatment Period|Other Reasons|0|||
161200538|NCT03110107|582115476|FG019|Treatment Period|Other Reasons|0|||
161200539|NCT03110107|582115477|FG020|Treatment Period|Other Reasons|0|||
161200540|NCT03110107|582115478|FG021|Treatment Period|Other Reasons|0|||
161200541|NCT03110107|582115479|FG022|Treatment Period|Other Reasons|0|||
161200542|NCT03110107|582115480|FG023|Treatment Period|Other Reasons|0|||
161200543|NCT03110107|582115481|FG024|Treatment Period|Other Reasons|1|||
161200544|NCT03110107|582115482|FG025|Treatment Period|Other Reasons|0|||
161200545|NCT03985982|582115483|FG000|Double-Blind Phase|Lost to Follow-up|4|||
161200546|NCT03985982|582115484|FG001|Double-Blind Phase|Lost to Follow-up|3|||
161200547|NCT03985982|582115485|FG002|Double-Blind Phase|Lost to Follow-up|0|||
161200548|NCT03985982|582115483|FG000|Double-Blind Phase|Physician Decision|1|||
161309555|NCT02954653|582515473|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
161309556|NCT02954653|582515474|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
161309557|NCT02954653|582515475|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
161309558|NCT02954653|582515476|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
161309559|NCT02954653|582515477|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
161309560|NCT02954653|582515478|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
161309561|NCT02954653|582515479|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
161309562|NCT02954653|582515480|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
161309563|NCT04329091|582515483|FG000|Overall Study|Physician Decision|5|||
161309564|NCT01210495|582515486|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
161309565|NCT01210495|582515487|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
161309566|NCT01210495|582515488|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
161309567|NCT01210495|582515489|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
161309568|NCT01210495|582515486|FG000|Overall Study|Death|14|||
161309569|NCT01210495|582515487|FG001|Overall Study|Death|7|||
161309570|NCT01210495|582515488|FG002|Overall Study|Death|112|||
161309571|NCT01210495|582515489|FG003|Overall Study|Death|54|||
161309572|NCT01210495|582515486|FG000|Overall Study|Study Terminated by Sponsor|0|||
161309573|NCT01210495|582515487|FG001|Overall Study|Study Terminated by Sponsor|0|||
161309574|NCT01210495|582515488|FG002|Overall Study|Study Terminated by Sponsor|4|||
161309575|NCT01210495|582515489|FG003|Overall Study|Study Terminated by Sponsor|11|||
161309576|NCT01210495|582515486|FG000|Overall Study|Lost to Follow-up|0|||
161309577|NCT01210495|582515487|FG001|Overall Study|Lost to Follow-up|0|||
161309578|NCT01210495|582515488|FG002|Overall Study|Lost to Follow-up|1|||
161309579|NCT01210495|582515489|FG003|Overall Study|Lost to Follow-up|1|||
161309580|NCT01210495|582515486|FG000|Overall Study|Other unspecified|0|||
161309581|NCT01210495|582515487|FG001|Overall Study|Other unspecified|0|||
161309582|NCT01210495|582515488|FG002|Overall Study|Other unspecified|6|||
161309583|NCT01210495|582515489|FG003|Overall Study|Other unspecified|0|||
161309584|NCT04489381|582515500|FG000|Overall Study|Lost to Follow-up|2|||
161309585|NCT04489381|582515501|FG001|Overall Study|Lost to Follow-up|3|||
161200549|NCT03985982|582115484|FG001|Double-Blind Phase|Physician Decision|0|||
161200550|NCT03985982|582115485|FG002|Double-Blind Phase|Physician Decision|0|||
161200551|NCT03985982|582115483|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
161309586|NCT04489381|582515500|FG000|Overall Study|Withdrawal by Subject|1|||
161309587|NCT04489381|582515501|FG001|Overall Study|Withdrawal by Subject|0|||
161200552|NCT03985982|582115484|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
161200553|NCT03985982|582115485|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
161200554|NCT03985982|582115483|FG000|Double-Blind Phase|COVID-19|1|||
161200555|NCT03985982|582115484|FG001|Double-Blind Phase|COVID-19|0|||
161200556|NCT03985982|582115485|FG002|Double-Blind Phase|COVID-19|0|||
161200557|NCT03985982|582115483|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
161200558|NCT03985982|582115484|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
161200559|NCT03985982|582115485|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
161200560|NCT03985982|582115483|FG000|Open-Label Phase|Lost to Follow-up|0|||
161200561|NCT03985982|582115484|FG001|Open-Label Phase|Lost to Follow-up|0|||
161200562|NCT03985982|582115485|FG002|Open-Label Phase|Lost to Follow-up|13|||
161200563|NCT03985982|582115483|FG000|Open-Label Phase|Physician Decision|0|||
161200564|NCT03985982|582115484|FG001|Open-Label Phase|Physician Decision|0|||
161200565|NCT03985982|582115485|FG002|Open-Label Phase|Physician Decision|2|||
161200566|NCT03985982|582115483|FG000|Open-Label Phase|Withdrawal by Subject|0|||
161200567|NCT03985982|582115484|FG001|Open-Label Phase|Withdrawal by Subject|0|||
161200568|NCT03985982|582115485|FG002|Open-Label Phase|Withdrawal by Subject|11|||
161200569|NCT03526549|582115487|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
161200570|NCT03526549|582115488|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
161200571|NCT03526549|582115487|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
161200572|NCT03526549|582115488|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
161200573|NCT03526549|582115487|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
161200574|NCT03526549|582115488|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
161200575|NCT03526549|582115487|FG000|Open-label Phase|Adverse Event|4|||
161200576|NCT03526549|582115488|FG001|Open-label Phase|Adverse Event|0|||
161200577|NCT03526549|582115487|FG000|Open-label Phase|Withdrawal by Subject|54|||
161200578|NCT03526549|582115488|FG001|Open-label Phase|Withdrawal by Subject|0|||
161200579|NCT03526549|582115487|FG000|Open-label Phase|Lost to Follow-up|35|||
161200580|NCT03526549|582115488|FG001|Open-label Phase|Lost to Follow-up|0|||
161200581|NCT03526549|582115487|FG000|Open-label Phase|Other than Specified|5|||
161200582|NCT03526549|582115488|FG001|Open-label Phase|Other than Specified|0|||
161200583|NCT05981365|582115489|FG000|Period 1|Adverse Event|1|||
161200584|NCT05981365|582115490|FG001|Period 1|Adverse Event|0|||
161200585|NCT02593175|582115493|FG000|Overall Study|Adverse Event|5|||
161200586|NCT02593175|582115493|FG000|Overall Study|Disease progression|4|||
161200587|NCT00478933|582115497|FG000|Overall Study|Protocol Violation|22|||
161200588|NCT00478933|582115497|FG000|Overall Study|Informed consent not verified|3|||
161200589|NCT00478933|582115497|FG000|Overall Study|Inadequate data available|53|||
161200590|NCT00643006|582115499|FG000|Overall Study|Lost to Follow-up|5|||
161200591|NCT00643006|582115500|FG001|Overall Study|Lost to Follow-up|4|||
161200592|NCT02506101|582115501|FG000|Overall Study|Transportation issues|1|||
161200593|NCT02506101|582115502|FG001|Overall Study|Transportation issues|0|||
161200594|NCT02506101|582115501|FG000|Overall Study|No enrollment and staff unavailability|1|||
161200595|NCT02506101|582115502|FG001|Overall Study|No enrollment and staff unavailability|0|||
161200596|NCT03586427|582115506|FG000|Overall Study|Lost to Follow-up|0|||
161200597|NCT03586427|582115507|FG001|Overall Study|Lost to Follow-up|3|||
161200598|NCT03586427|582115508|FG002|Overall Study|Lost to Follow-up|1|||
161200599|NCT03586427|582115509|FG003|Overall Study|Lost to Follow-up|3|||
161309588|NCT03199612|582515502|FG000|Overall Study|Adverse Event|1|||
161309589|NCT03199612|582515503|FG001|Overall Study|Adverse Event|0|||
161309590|NCT02543892|582515504|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
161309591|NCT02543892|582515505|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
161309592|NCT02543892|582515506|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
161309593|NCT02543892|582515507|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
161309594|NCT02543892|582515508|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
161309595|NCT02543892|582515509|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
161309596|NCT02543892|582515510|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
161309597|NCT02543892|582515511|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
161309598|NCT02543892|582515504|FG000|Received Vaccination 2|Physician Decision|0|||
161309599|NCT02543892|582515505|FG001|Received Vaccination 2|Physician Decision|0|||
161309600|NCT02543892|582515506|FG002|Received Vaccination 2|Physician Decision|0|||
161200600|NCT03586427|582115510|FG004|Overall Study|Lost to Follow-up|3|||
161200601|NCT03586427|582115506|FG000|Overall Study|Withdrawal by Subject|0|||
161200602|NCT03586427|582115507|FG001|Overall Study|Withdrawal by Subject|1|||
161200603|NCT03586427|582115508|FG002|Overall Study|Withdrawal by Subject|2|||
161200604|NCT03586427|582115509|FG003|Overall Study|Withdrawal by Subject|1|||
161200605|NCT03586427|582115510|FG004|Overall Study|Withdrawal by Subject|1|||
161200606|NCT03586427|582115506|FG000|Overall Study|Adverse Event|0|||
161200607|NCT03586427|582115507|FG001|Overall Study|Adverse Event|0|||
161200608|NCT03586427|582115508|FG002|Overall Study|Adverse Event|1|||
161200609|NCT03586427|582115509|FG003|Overall Study|Adverse Event|0|||
161200610|NCT03586427|582115510|FG004|Overall Study|Adverse Event|0|||
161200611|NCT03586427|582115506|FG000|Overall Study|Protocol Violation|0|||
161200612|NCT03586427|582115507|FG001|Overall Study|Protocol Violation|0|||
161200613|NCT03586427|582115508|FG002|Overall Study|Protocol Violation|1|||
161200614|NCT03586427|582115509|FG003|Overall Study|Protocol Violation|0|||
161200615|NCT03586427|582115510|FG004|Overall Study|Protocol Violation|1|||
161200616|NCT03586427|582115506|FG000|Overall Study|Noncompliance with study drug|0|||
161200617|NCT03586427|582115507|FG001|Overall Study|Noncompliance with study drug|0|||
161200618|NCT03586427|582115508|FG002|Overall Study|Noncompliance with study drug|1|||
161200619|NCT03586427|582115509|FG003|Overall Study|Noncompliance with study drug|0|||
161200620|NCT03586427|582115510|FG004|Overall Study|Noncompliance with study drug|0|||
161200621|NCT03193996|582115513|FG000|Overall Study|Withdrawal by Subject|4|||
161200622|NCT03193996|582115513|FG000|Overall Study|Lost to Follow-up|4|||
161200623|NCT03193996|582115513|FG000|Overall Study|Physician Decision|2|||
161200624|NCT03193996|582115513|FG000|Overall Study|Pregnancy|1|||
161200625|NCT03193996|582115513|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
161200626|NCT03193996|582115513|FG000|Overall Study|Complicating disease|1|||
161200627|NCT00593385|582115516|FG000|Overall Study|Death|14|||
161200628|NCT00593385|582115516|FG000|Overall Study|Lost to Follow-up|17|||
161200629|NCT00593385|582115516|FG000|Overall Study|Withdrawal by Subject|9|||
161200630|NCT01471197|582115517|FG000|Overall Study|Disease Progression|4|||
161200631|NCT01471197|582115518|FG001|Overall Study|Disease Progression|2|||
161200632|NCT01471197|582115517|FG000|Overall Study|Death|1|||
161200633|NCT01471197|582115518|FG001|Overall Study|Death|0|||
161200634|NCT01471197|582115517|FG000|Overall Study|Study Drug Toxicity|1|||
161200635|NCT01471197|582115518|FG001|Overall Study|Study Drug Toxicity|0|||
161200636|NCT01353586|582115522|FG000|Overall Study|Procedure terminated prior to ablation|3|||
161200637|NCT01353586|582115523|FG001|Overall Study|Procedure terminated prior to ablation|0|||
161200638|NCT01353586|582115522|FG000|Overall Study|Never had insertion of study catheter|4|||
161200639|NCT01353586|582115523|FG001|Overall Study|Never had insertion of study catheter|1|||
161200640|NCT01353586|582115522|FG000|Overall Study|Neurological exam not done|0|||
161200641|NCT01353586|582115523|FG001|Overall Study|Neurological exam not done|1|||
161200642|NCT03253809|582115526|FG000|Overall Study|Unable to obtain study related data|14|||
161200643|NCT00326625|582115531|FG000|Overall Study|Adverse Event|20|||
161200644|NCT00326625|582115532|FG001|Overall Study|Adverse Event|9|||
161200645|NCT00326625|582115531|FG000|Overall Study|Withdrawal by Subject|15|||
161200646|NCT00326625|582115532|FG001|Overall Study|Withdrawal by Subject|12|||
161200647|NCT00326625|582115531|FG000|Overall Study|Death|18|||
161200648|NCT00326625|582115532|FG001|Overall Study|Death|16|||
161200649|NCT00326625|582115531|FG000|Overall Study|Lost to Follow-up|1|||
161200650|NCT00326625|582115532|FG001|Overall Study|Lost to Follow-up|0|||
161200651|NCT00326625|582115531|FG000|Overall Study|prescheduled medical intervention|0|||
161200652|NCT00326625|582115532|FG001|Overall Study|prescheduled medical intervention|1|||
161200653|NCT02594384|582115533|FG000|Overall Study|Disease Progression|3|||
161200654|NCT02594384|582115534|FG001|Overall Study|Disease Progression|7|||
161200655|NCT02594384|582115535|FG002|Overall Study|Disease Progression|0|||
161200656|NCT02594384|582115536|FG003|Overall Study|Disease Progression|2|||
161200657|NCT02594384|582115537|FG004|Overall Study|Disease Progression|2|||
161200658|NCT02594384|582115538|FG005|Overall Study|Disease Progression|12|||
161200659|NCT02594384|582115539|FG006|Overall Study|Disease Progression|5|||
161200660|NCT02594384|582115540|FG007|Overall Study|Disease Progression|5|||
161200661|NCT02594384|582115533|FG000|Overall Study|Adverse Event|0|||
161200662|NCT02594384|582115534|FG001|Overall Study|Adverse Event|1|||
161200663|NCT02594384|582115535|FG002|Overall Study|Adverse Event|4|||
161200664|NCT02594384|582115536|FG003|Overall Study|Adverse Event|1|||
161200665|NCT02594384|582115537|FG004|Overall Study|Adverse Event|0|||
161200666|NCT02594384|582115538|FG005|Overall Study|Adverse Event|6|||
161200667|NCT02594384|582115539|FG006|Overall Study|Adverse Event|1|||
161200668|NCT02594384|582115540|FG007|Overall Study|Adverse Event|1|||
161200669|NCT02594384|582115533|FG000|Overall Study|Withdrawal by Subject|0|||
161200670|NCT02594384|582115534|FG001|Overall Study|Withdrawal by Subject|0|||
161200671|NCT02594384|582115535|FG002|Overall Study|Withdrawal by Subject|0|||
161200672|NCT02594384|582115536|FG003|Overall Study|Withdrawal by Subject|1|||
161200673|NCT02594384|582115537|FG004|Overall Study|Withdrawal by Subject|0|||
161200674|NCT02594384|582115538|FG005|Overall Study|Withdrawal by Subject|0|||
161200675|NCT02594384|582115539|FG006|Overall Study|Withdrawal by Subject|0|||
161200676|NCT02594384|582115540|FG007|Overall Study|Withdrawal by Subject|1|||
161200677|NCT02594384|582115533|FG000|Overall Study|Physician Decision|0|||
161309601|NCT02543892|582515507|FG003|Received Vaccination 2|Physician Decision|0|||
161309602|NCT02543892|582515508|FG004|Received Vaccination 2|Physician Decision|0|||
161309603|NCT02543892|582515509|FG005|Received Vaccination 2|Physician Decision|1|||
161200678|NCT02594384|582115534|FG001|Overall Study|Physician Decision|0|||
161200679|NCT02594384|582115535|FG002|Overall Study|Physician Decision|0|||
161200680|NCT02594384|582115536|FG003|Overall Study|Physician Decision|0|||
161200681|NCT02594384|582115537|FG004|Overall Study|Physician Decision|0|||
161200682|NCT02594384|582115538|FG005|Overall Study|Physician Decision|1|||
161200683|NCT02594384|582115539|FG006|Overall Study|Physician Decision|2|||
161200684|NCT02594384|582115540|FG007|Overall Study|Physician Decision|0|||
161200685|NCT02594384|582115533|FG000|Overall Study|Progressive Leukocytosis|0|||
161200686|NCT02594384|582115534|FG001|Overall Study|Progressive Leukocytosis|0|||
161200687|NCT02594384|582115535|FG002|Overall Study|Progressive Leukocytosis|1|||
161200688|NCT02594384|582115536|FG003|Overall Study|Progressive Leukocytosis|0|||
161200689|NCT02594384|582115537|FG004|Overall Study|Progressive Leukocytosis|0|||
161200690|NCT02594384|582115538|FG005|Overall Study|Progressive Leukocytosis|0|||
161200691|NCT02594384|582115539|FG006|Overall Study|Progressive Leukocytosis|0|||
161200692|NCT02594384|582115540|FG007|Overall Study|Progressive Leukocytosis|0|||
161200693|NCT02594384|582115533|FG000|Overall Study|Lack of Efficacy|0|||
161200694|NCT02594384|582115534|FG001|Overall Study|Lack of Efficacy|0|||
161200695|NCT02594384|582115535|FG002|Overall Study|Lack of Efficacy|0|||
161200696|NCT02594384|582115536|FG003|Overall Study|Lack of Efficacy|0|||
161200697|NCT02594384|582115537|FG004|Overall Study|Lack of Efficacy|1|||
161200698|NCT02594384|582115538|FG005|Overall Study|Lack of Efficacy|0|||
161200699|NCT02594384|582115539|FG006|Overall Study|Lack of Efficacy|0|||
161200700|NCT02594384|582115540|FG007|Overall Study|Lack of Efficacy|0|||
161200701|NCT02594384|582115533|FG000|Overall Study|Substantial noncompliance|0|||
161200702|NCT02594384|582115534|FG001|Overall Study|Substantial noncompliance|0|||
161200703|NCT02594384|582115535|FG002|Overall Study|Substantial noncompliance|0|||
161200704|NCT02594384|582115536|FG003|Overall Study|Substantial noncompliance|0|||
161200705|NCT02594384|582115537|FG004|Overall Study|Substantial noncompliance|0|||
161200706|NCT02594384|582115538|FG005|Overall Study|Substantial noncompliance|0|||
161200707|NCT02594384|582115539|FG006|Overall Study|Substantial noncompliance|1|||
161200708|NCT02594384|582115540|FG007|Overall Study|Substantial noncompliance|0|||
161200709|NCT03919669|582115543|FG000|Overall Study|Withdrawal by Subject|1|||
161200710|NCT03919669|582115544|FG001|Overall Study|Withdrawal by Subject|0|||
161200711|NCT03919669|582115545|FG002|Overall Study|Withdrawal by Subject|0|||
161200712|NCT00625846|582115546|FG000|Overall Study|Withdrawal by Subject|2|||
161200713|NCT00625846|582115547|FG001|Overall Study|Withdrawal by Subject|0|||
161200714|NCT00625846|582115548|FG002|Overall Study|Withdrawal by Subject|1|||
161200715|NCT00625846|582115549|FG003|Overall Study|Withdrawal by Subject|2|||
161200716|NCT02686749|582115550|FG000|Overall Study|terminated for poor enrollment|2|||
161200717|NCT02686749|582115551|FG001|Overall Study|terminated for poor enrollment|2|||
161200718|NCT04409509|582115552|FG000|Overall Study|Failure to meet randomization requirement|1|||
161200719|NCT04409509|582115553|FG001|Overall Study|Failure to meet randomization requirement|0|||
161200720|NCT04409509|582115552|FG000|Overall Study|Adverse Event|0|||
161200721|NCT04409509|582115553|FG001|Overall Study|Adverse Event|1|||
161200722|NCT04409509|582115552|FG000|Overall Study|Death|11|||
161200723|NCT04409509|582115553|FG001|Overall Study|Death|10|||
161200724|NCT04409509|582115552|FG000|Overall Study|Non-compliance with study drug|0|||
161200725|NCT04409509|582115553|FG001|Overall Study|Non-compliance with study drug|1|||
161200726|NCT04409509|582115552|FG000|Overall Study|Lost to Follow-up|0|||
161200727|NCT04409509|582115553|FG001|Overall Study|Lost to Follow-up|3|||
161200728|NCT04409509|582115552|FG000|Overall Study|Withdrawal by Subject|0|||
161200729|NCT04409509|582115553|FG001|Overall Study|Withdrawal by Subject|3|||
161200730|NCT04409509|582115552|FG000|Overall Study|Randomized by mistake|0|||
161200731|NCT04409509|582115553|FG001|Overall Study|Randomized by mistake|1|||
161200732|NCT04409509|582115552|FG000|Overall Study|Other|1|||
161200733|NCT04409509|582115553|FG001|Overall Study|Other|1|||
161200734|NCT04668066|582115554|FG000|Part 1: Treatment Phase|Adverse Event|0|||
161200735|NCT04668066|582115555|FG001|Part 1: Treatment Phase|Adverse Event|0|||
161200736|NCT04668066|582115556|FG002|Part 1: Treatment Phase|Adverse Event|0|||
161200737|NCT04668066|582115557|FG003|Part 1: Treatment Phase|Adverse Event|0|||
161200738|NCT04668066|582115558|FG004|Part 1: Treatment Phase|Adverse Event|0|||
161200739|NCT04668066|582115559|FG005|Part 1: Treatment Phase|Adverse Event|0|||
161200740|NCT04668066|582115560|FG006|Part 1: Treatment Phase|Adverse Event|0|||
161200741|NCT04668066|582115561|FG007|Part 1: Treatment Phase|Adverse Event|0|||
161200742|NCT04668066|582115562|FG008|Part 1: Treatment Phase|Adverse Event|0|||
161200743|NCT04668066|582115563|FG009|Part 1: Treatment Phase|Adverse Event|0|||
161200744|NCT04668066|582115564|FG010|Part 1: Treatment Phase|Adverse Event|0|||
161200745|NCT04668066|582115565|FG011|Part 1: Treatment Phase|Adverse Event|1|||
161309604|NCT02543892|582515510|FG006|Received Vaccination 2|Physician Decision|0|||
161309605|NCT02543892|582515511|FG007|Received Vaccination 2|Physician Decision|0|||
161200746|NCT04668066|582115566|FG012|Part 1: Treatment Phase|Adverse Event|1|||
161200747|NCT04668066|582115567|FG013|Part 1: Treatment Phase|Adverse Event|0|||
161200748|NCT04668066|582115568|FG014|Part 1: Treatment Phase|Adverse Event|0|||
161309606|NCT02543892|582515504|FG000|Received Vaccination 2|Adverse Event|0|||
161309607|NCT02543892|582515505|FG001|Received Vaccination 2|Adverse Event|1|||
161200749|NCT04668066|582115569|FG015|Part 1: Treatment Phase|Adverse Event|0|||
161200750|NCT04668066|582115570|FG016|Part 1: Treatment Phase|Adverse Event|0|||
161200751|NCT04668066|582115571|FG017|Part 1: Treatment Phase|Adverse Event|0|||
161200752|NCT04668066|582115572|FG018|Part 1: Treatment Phase|Adverse Event|0|||
161200753|NCT04668066|582115554|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200754|NCT04668066|582115555|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200755|NCT04668066|582115556|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
161200756|NCT04668066|582115557|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200757|NCT04668066|582115558|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200758|NCT04668066|582115559|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200759|NCT04668066|582115560|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200760|NCT04668066|582115561|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200761|NCT04668066|582115562|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200762|NCT04668066|582115563|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200763|NCT04668066|582115564|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200764|NCT04668066|582115565|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200765|NCT04668066|582115566|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200766|NCT04668066|582115567|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200767|NCT04668066|582115568|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200768|NCT04668066|582115569|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200769|NCT04668066|582115570|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200770|NCT04668066|582115571|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200771|NCT04668066|582115572|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
161200772|NCT04668066|582115554|FG000|Part 1: Treatment Phase|Other|0|||
161200773|NCT04668066|582115555|FG001|Part 1: Treatment Phase|Other|0|||
161200774|NCT04668066|582115556|FG002|Part 1: Treatment Phase|Other|0|||
161200775|NCT04668066|582115557|FG003|Part 1: Treatment Phase|Other|0|||
161200776|NCT04668066|582115558|FG004|Part 1: Treatment Phase|Other|0|||
161200777|NCT04668066|582115559|FG005|Part 1: Treatment Phase|Other|0|||
161200778|NCT04668066|582115560|FG006|Part 1: Treatment Phase|Other|0|||
161200779|NCT04668066|582115561|FG007|Part 1: Treatment Phase|Other|0|||
161200780|NCT04668066|582115562|FG008|Part 1: Treatment Phase|Other|0|||
161200781|NCT04668066|582115563|FG009|Part 1: Treatment Phase|Other|0|||
161200782|NCT04668066|582115564|FG010|Part 1: Treatment Phase|Other|0|||
161200783|NCT04668066|582115565|FG011|Part 1: Treatment Phase|Other|1|||
161200784|NCT04668066|582115566|FG012|Part 1: Treatment Phase|Other|0|||
161200785|NCT04668066|582115567|FG013|Part 1: Treatment Phase|Other|0|||
161200786|NCT04668066|582115568|FG014|Part 1: Treatment Phase|Other|0|||
161200787|NCT04668066|582115569|FG015|Part 1: Treatment Phase|Other|0|||
161200788|NCT04668066|582115570|FG016|Part 1: Treatment Phase|Other|0|||
161200789|NCT04668066|582115571|FG017|Part 1: Treatment Phase|Other|0|||
161200790|NCT04668066|582115572|FG018|Part 1: Treatment Phase|Other|0|||
161200791|NCT04668066|582115554|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200792|NCT04668066|582115555|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200793|NCT04668066|582115556|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200794|NCT04668066|582115557|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200795|NCT04668066|582115558|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200796|NCT04668066|582115559|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200797|NCT04668066|582115560|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200798|NCT04668066|582115561|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200799|NCT04668066|582115562|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200800|NCT04668066|582115563|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200801|NCT04668066|582115564|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200802|NCT04668066|582115565|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200803|NCT04668066|582115566|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
161200804|NCT04668066|582115567|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200805|NCT04668066|582115568|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200806|NCT04668066|582115569|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
161200807|NCT04668066|582115570|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200808|NCT04668066|582115571|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200809|NCT04668066|582115572|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
161200810|NCT04668066|582115554|FG000|Part 1: Follow-Up|Adverse Event|0|||
161200811|NCT04668066|582115555|FG001|Part 1: Follow-Up|Adverse Event|0|||
161200812|NCT04668066|582115556|FG002|Part 1: Follow-Up|Adverse Event|0|||
161200813|NCT04668066|582115557|FG003|Part 1: Follow-Up|Adverse Event|0|||
161200814|NCT04668066|582115558|FG004|Part 1: Follow-Up|Adverse Event|0|||
161200815|NCT04668066|582115559|FG005|Part 1: Follow-Up|Adverse Event|0|||
161200816|NCT04668066|582115560|FG006|Part 1: Follow-Up|Adverse Event|0|||
161200817|NCT04668066|582115561|FG007|Part 1: Follow-Up|Adverse Event|0|||
161200818|NCT04668066|582115562|FG008|Part 1: Follow-Up|Adverse Event|0|||
161200819|NCT04668066|582115563|FG009|Part 1: Follow-Up|Adverse Event|0|||
161200820|NCT04668066|582115564|FG010|Part 1: Follow-Up|Adverse Event|0|||
161200821|NCT04668066|582115565|FG011|Part 1: Follow-Up|Adverse Event|1|||
161200822|NCT04668066|582115566|FG012|Part 1: Follow-Up|Adverse Event|0|||
161200823|NCT04668066|582115567|FG013|Part 1: Follow-Up|Adverse Event|0|||
161200824|NCT04668066|582115568|FG014|Part 1: Follow-Up|Adverse Event|0|||
161200825|NCT04668066|582115569|FG015|Part 1: Follow-Up|Adverse Event|0|||
161200826|NCT04668066|582115570|FG016|Part 1: Follow-Up|Adverse Event|0|||
161200827|NCT04668066|582115571|FG017|Part 1: Follow-Up|Adverse Event|0|||
161200828|NCT04668066|582115572|FG018|Part 1: Follow-Up|Adverse Event|0|||
161200829|NCT04668066|582115554|FG000|Part 1: Follow-Up|Other|0|||
161200830|NCT04668066|582115555|FG001|Part 1: Follow-Up|Other|0|||
161200831|NCT04668066|582115556|FG002|Part 1: Follow-Up|Other|0|||
161200832|NCT04668066|582115557|FG003|Part 1: Follow-Up|Other|0|||
161200833|NCT04668066|582115558|FG004|Part 1: Follow-Up|Other|0|||
161200834|NCT04668066|582115559|FG005|Part 1: Follow-Up|Other|0|||
161200835|NCT04668066|582115560|FG006|Part 1: Follow-Up|Other|0|||
161200836|NCT04668066|582115561|FG007|Part 1: Follow-Up|Other|0|||
161200837|NCT04668066|582115562|FG008|Part 1: Follow-Up|Other|0|||
161200838|NCT04668066|582115563|FG009|Part 1: Follow-Up|Other|0|||
161200839|NCT04668066|582115564|FG010|Part 1: Follow-Up|Other|0|||
161200840|NCT04668066|582115565|FG011|Part 1: Follow-Up|Other|1|||
161200841|NCT04668066|582115566|FG012|Part 1: Follow-Up|Other|1|||
161200842|NCT04668066|582115567|FG013|Part 1: Follow-Up|Other|0|||
161200843|NCT04668066|582115568|FG014|Part 1: Follow-Up|Other|0|||
161200844|NCT04668066|582115569|FG015|Part 1: Follow-Up|Other|0|||
161200845|NCT04668066|582115570|FG016|Part 1: Follow-Up|Other|0|||
161200846|NCT04668066|582115571|FG017|Part 1: Follow-Up|Other|0|||
161200847|NCT04668066|582115572|FG018|Part 1: Follow-Up|Other|0|||
161200848|NCT04668066|582115554|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200849|NCT04668066|582115555|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200850|NCT04668066|582115556|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200851|NCT04668066|582115557|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200852|NCT04668066|582115558|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200853|NCT04668066|582115559|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200854|NCT04668066|582115560|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200855|NCT04668066|582115561|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200856|NCT04668066|582115562|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200857|NCT04668066|582115563|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200858|NCT04668066|582115564|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200859|NCT04668066|582115565|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200860|NCT04668066|582115566|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
161200861|NCT04668066|582115567|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200862|NCT04668066|582115568|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200863|NCT04668066|582115569|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
161200864|NCT04668066|582115570|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200865|NCT04668066|582115571|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200866|NCT04668066|582115572|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
161200867|NCT04668066|582115554|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200868|NCT04668066|582115555|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200869|NCT04668066|582115556|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200870|NCT04668066|582115557|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200871|NCT04668066|582115558|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200872|NCT04668066|582115559|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200873|NCT04668066|582115560|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200874|NCT04668066|582115561|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200875|NCT04668066|582115562|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200876|NCT04668066|582115563|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200877|NCT04668066|582115564|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200878|NCT04668066|582115565|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200879|NCT04668066|582115566|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200880|NCT04668066|582115567|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200881|NCT04668066|582115568|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200882|NCT04668066|582115569|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200883|NCT04668066|582115570|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200884|NCT04668066|582115571|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
161200885|NCT04668066|582115572|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
161200886|NCT04668066|582115554|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200887|NCT04668066|582115555|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200888|NCT04668066|582115556|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200889|NCT04668066|582115557|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200890|NCT04668066|582115558|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200891|NCT04668066|582115559|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200892|NCT04668066|582115560|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200893|NCT04668066|582115561|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200894|NCT04668066|582115562|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200895|NCT04668066|582115563|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200896|NCT04668066|582115564|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200897|NCT04668066|582115565|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200898|NCT04668066|582115566|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200899|NCT04668066|582115567|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
161309608|NCT02543892|582515506|FG002|Received Vaccination 2|Adverse Event|0|||
161309609|NCT02543892|582515507|FG003|Received Vaccination 2|Adverse Event|0|||
161200900|NCT04668066|582115568|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
161309610|NCT02543892|582515508|FG004|Received Vaccination 2|Adverse Event|0|||
161200901|NCT04668066|582115569|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200902|NCT04668066|582115570|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200903|NCT04668066|582115571|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
161200904|NCT04668066|582115572|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
161200905|NCT04668066|582115554|FG000|Part 2: Treatment Phase|Other|0|||
161200906|NCT04668066|582115555|FG001|Part 2: Treatment Phase|Other|0|||
161200907|NCT04668066|582115556|FG002|Part 2: Treatment Phase|Other|0|||
161200908|NCT04668066|582115557|FG003|Part 2: Treatment Phase|Other|0|||
161200909|NCT04668066|582115558|FG004|Part 2: Treatment Phase|Other|0|||
161200910|NCT04668066|582115559|FG005|Part 2: Treatment Phase|Other|0|||
161200911|NCT04668066|582115560|FG006|Part 2: Treatment Phase|Other|0|||
161200912|NCT04668066|582115561|FG007|Part 2: Treatment Phase|Other|0|||
161200913|NCT04668066|582115562|FG008|Part 2: Treatment Phase|Other|0|||
161200914|NCT04668066|582115563|FG009|Part 2: Treatment Phase|Other|0|||
161200915|NCT04668066|582115564|FG010|Part 2: Treatment Phase|Other|0|||
161200916|NCT04668066|582115565|FG011|Part 2: Treatment Phase|Other|0|||
161200917|NCT04668066|582115566|FG012|Part 2: Treatment Phase|Other|0|||
161200918|NCT04668066|582115567|FG013|Part 2: Treatment Phase|Other|0|||
161200919|NCT04668066|582115568|FG014|Part 2: Treatment Phase|Other|0|||
161200920|NCT04668066|582115569|FG015|Part 2: Treatment Phase|Other|0|||
161200921|NCT04668066|582115570|FG016|Part 2: Treatment Phase|Other|0|||
161200922|NCT04668066|582115571|FG017|Part 2: Treatment Phase|Other|0|||
161200923|NCT04668066|582115572|FG018|Part 2: Treatment Phase|Other|1|||
161200924|NCT04668066|582115554|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200925|NCT04668066|582115555|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200926|NCT04668066|582115556|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200927|NCT04668066|582115557|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200928|NCT04668066|582115558|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200929|NCT04668066|582115559|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200930|NCT04668066|582115560|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200931|NCT04668066|582115561|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200932|NCT04668066|582115562|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200933|NCT04668066|582115563|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200934|NCT04668066|582115564|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200935|NCT04668066|582115565|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200936|NCT04668066|582115566|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200937|NCT04668066|582115567|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200938|NCT04668066|582115568|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200939|NCT04668066|582115569|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200940|NCT04668066|582115570|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200941|NCT04668066|582115571|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
161200942|NCT04668066|582115572|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
161200943|NCT02369874|582115573|FG000|Overall Study|Lost to Follow-up|2|||
161200944|NCT02369874|582115574|FG001|Overall Study|Lost to Follow-up|2|||
161200945|NCT02369874|582115575|FG002|Overall Study|Lost to Follow-up|2|||
161200946|NCT02369874|582115573|FG000|Overall Study|Withdrawal by Subject|7|||
161200947|NCT02369874|582115574|FG001|Overall Study|Withdrawal by Subject|9|||
161200948|NCT02369874|582115575|FG002|Overall Study|Withdrawal by Subject|27|||
161200949|NCT02369874|582115573|FG000|Overall Study|Miscellaneous|1|||
161200950|NCT02369874|582115574|FG001|Overall Study|Miscellaneous|1|||
161200951|NCT02369874|582115575|FG002|Overall Study|Miscellaneous|0|||
161200952|NCT02369874|582115573|FG000|Overall Study|On Treatment/Off Study|34|||
161200953|NCT02369874|582115574|FG001|Overall Study|On Treatment/Off Study|45|||
161200954|NCT02369874|582115575|FG002|Overall Study|On Treatment/Off Study|32|||
161200955|NCT02058849|582115576|FG000|Overall Study|Hospitalization|1|||
161200956|NCT02058849|582115577|FG001|Overall Study|Hospitalization|1|||
161200957|NCT02058849|582115576|FG000|Overall Study|Death|1|||
161200958|NCT02058849|582115577|FG001|Overall Study|Death|0|||
161200959|NCT02058849|582115576|FG000|Overall Study|Lost to Follow-up|1|||
161200960|NCT02058849|582115577|FG001|Overall Study|Lost to Follow-up|0|||
161200961|NCT02058849|582115576|FG000|Overall Study|Withdrawal by Subject|4|||
161200962|NCT02058849|582115577|FG001|Overall Study|Withdrawal by Subject|0|||
161200963|NCT04505592|582115578|FG000|Overall Study|Death|2|||
161200964|NCT04505592|582115579|FG001|Overall Study|Death|1|||
161200965|NCT04298229|582115585|FG000|Overall Study|Physician Decision|1|||
161200966|NCT04298229|582115586|FG001|Overall Study|Physician Decision|1|||
161200967|NCT04298229|582115585|FG000|Overall Study|Withdrawal by Subject|1|||
161200968|NCT04298229|582115586|FG001|Overall Study|Withdrawal by Subject|1|||
161200969|NCT04298229|582115585|FG000|Overall Study|Did not receive IV loop diuretics|2|||
161200970|NCT04298229|582115586|FG001|Overall Study|Did not receive IV loop diuretics|0|||
161200971|NCT05570604|582115587|FG000|Overall Study|Lost to Follow-up|1|||
161309611|NCT02543892|582515509|FG005|Received Vaccination 2|Adverse Event|0|||
161309612|NCT02543892|582515510|FG006|Received Vaccination 2|Adverse Event|0|||
161309613|NCT02543892|582515511|FG007|Received Vaccination 2|Adverse Event|0|||
161309614|NCT02543892|582515504|FG000|Had Immunology Data|Withdrawal by Subject|0|||
161309615|NCT02543892|582515505|FG001|Had Immunology Data|Withdrawal by Subject|0|||
161309616|NCT02543892|582515506|FG002|Had Immunology Data|Withdrawal by Subject|0|||
161200972|NCT05570604|582115588|FG001|Overall Study|Lost to Follow-up|5|||
161200973|NCT05570604|582115587|FG000|Overall Study|Illness|2|||
161200974|NCT05570604|582115588|FG001|Overall Study|Illness|2|||
161200975|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161200976|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
161200977|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
161200978|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161200979|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161309617|NCT02543892|582515507|FG003|Had Immunology Data|Withdrawal by Subject|0|||
161200980|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161200981|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
161200982|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161200983|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161200984|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
161200985|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161200986|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161200987|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161200988|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
161200989|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
161200990|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161200991|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
161200992|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161200993|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161200994|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161200995|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
161200996|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
161200997|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161200998|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
161200999|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161201000|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161201001|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161201002|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
161201003|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
161201004|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
161201005|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
161201006|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161201007|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161201008|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161201009|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
161201010|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161201011|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161201012|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
161201013|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161201014|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161201015|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161201016|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
161201017|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161201018|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161201019|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
161201020|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161201021|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161201022|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161201023|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
161201024|NCT04242498|582115591|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161201025|NCT04242498|582115592|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
161201026|NCT04242498|582115593|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
161201027|NCT04242498|582115594|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161201028|NCT04242498|582115595|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161201029|NCT04242498|582115596|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161201030|NCT04242498|582115597|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
161201031|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161201032|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161201033|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161201034|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
161201035|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
161201036|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
161201037|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
161201038|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161201039|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161201040|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161201041|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
161201042|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
161201043|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
161201044|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
161201045|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161201046|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161201047|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161201048|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161201049|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
161201050|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
161201051|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
161201052|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161201053|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161201054|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
161201055|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161201056|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
161201057|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
161201058|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
161201059|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161201060|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161201061|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
161201062|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
161201063|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
161201064|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
161201065|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
161201066|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161201067|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161201068|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161201069|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161201070|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
161201071|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161201072|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
161201073|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161201074|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161201075|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161201076|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161201077|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161201078|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
161201079|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
161201080|NCT04242498|582115591|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161201081|NCT04242498|582115592|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161201082|NCT04242498|582115593|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161201083|NCT04242498|582115594|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161201084|NCT04242498|582115595|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
161201085|NCT04242498|582115596|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
161201086|NCT04242498|582115597|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
161201087|NCT01958619|582115598|FG000|Overall Study|Protocol Violation|2|||
161201088|NCT01958619|582115599|FG001|Overall Study|Protocol Violation|0|||
161201089|NCT01958619|582115600|FG002|Overall Study|Protocol Violation|1|||
161201090|NCT01958619|582115601|FG003|Overall Study|Protocol Violation|0|||
161201091|NCT01054443|582115602|FG000|Overall Study|Withdrawal by Subject|0|||
161201092|NCT01054443|582115603|FG001|Overall Study|Withdrawal by Subject|0|||
161201093|NCT01054443|582115604|FG002|Overall Study|Withdrawal by Subject|0|||
161201094|NCT01054443|582115605|FG003|Overall Study|Withdrawal by Subject|1|||
161201095|NCT01119118|582115607|FG000|Overall Study|Adverse Event|1|||
161309618|NCT02543892|582515508|FG004|Had Immunology Data|Withdrawal by Subject|0|||
161309619|NCT02543892|582515509|FG005|Had Immunology Data|Withdrawal by Subject|0|||
161309620|NCT02543892|582515510|FG006|Had Immunology Data|Withdrawal by Subject|1|||
161309621|NCT02543892|582515511|FG007|Had Immunology Data|Withdrawal by Subject|0|||
161201096|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
161201097|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
161201098|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
161201099|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
161201100|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
161201101|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
161201102|NCT00828009|582115608|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
161201103|NCT00828009|582115608|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
161201104|NCT00828009|582115608|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
161201105|NCT00828009|582115608|FG000|Step 2 - Maintenance Therapy|Death|1|||
161201106|NCT00828009|582115608|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
161201107|NCT00828009|582115608|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
161201108|NCT00828009|582115608|FG000|Step 2 - Maintenance Therapy|Other|1|||
161201109|NCT03099265|582116923|FG000|Overall Study|Adverse Event|1|||
161201110|NCT00396318|582116931|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
161201111|NCT00602927|582116932|FG000|Period 1: 13 Days|Protocol Violation|2|||
161201112|NCT00602927|582116933|FG001|Period 1: 13 Days|Protocol Violation|4|||
161201113|NCT00602927|582116932|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
161201114|NCT00602927|582116933|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
161201115|NCT00602927|582116932|FG000|Period 1: 13 Days|Time|1|||
161201116|NCT00602927|582116933|FG001|Period 1: 13 Days|Time|0|||
161201117|NCT00602927|582116932|FG000|Period 1: 13 Days|Claustrophobia|0|||
161201118|NCT00602927|582116933|FG001|Period 1: 13 Days|Claustrophobia|1|||
161201119|NCT00602927|582116932|FG000|Period 2: 14 Days|Protocol Violation|0|||
161201120|NCT00602927|582116933|FG001|Period 2: 14 Days|Protocol Violation|2|||
161201121|NCT00602927|582116932|FG000|Period 3: 13 Days|Protocol Violation|0|||
161201122|NCT00602927|582116933|FG001|Period 3: 13 Days|Protocol Violation|1|||
161201123|NCT00602927|582116932|FG000|Period 3: 13 Days|MRI data quality|2|||
161201124|NCT00602927|582116933|FG001|Period 3: 13 Days|MRI data quality|2|||
161201125|NCT01741259|582116940|FG000|Overall Study|Protocol Violation|6|||
161201126|NCT01741259|582116941|FG001|Overall Study|Protocol Violation|4|||
161201127|NCT01741259|582116940|FG000|Overall Study|Withdrawal by Subject|0|||
161201128|NCT01741259|582116941|FG001|Overall Study|Withdrawal by Subject|2|||
161201129|NCT05604521|582116945|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
161201130|NCT05604521|582116946|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
161201131|NCT05604521|582116945|FG000|Overall Study|Adverse Event|1|||
161201132|NCT05604521|582116946|FG001|Overall Study|Adverse Event|0|||
161201133|NCT02875340|582116947|FG000|Overall Study|Death|2|||
161201134|NCT02875340|582116947|FG000|Overall Study|Withdrawal by Subject|2|||
161201135|NCT02875340|582116947|FG000|Overall Study|Physician Decision|3|||
161201136|NCT02875340|582116947|FG000|Overall Study|Adverse Event|1|||
161201137|NCT01160770|582116948|FG000|Overall Study|Adverse Event|10|||
161201138|NCT01160770|582116948|FG000|Overall Study|Protocol Violation|2|||
161201139|NCT01160770|582116948|FG000|Overall Study|Subject/parent/caregiver request|33|||
161201140|NCT01160770|582116948|FG000|Overall Study|Physician Decision|1|||
161201141|NCT01160770|582116948|FG000|Overall Study|Lost to Follow-up|7|||
161201142|NCT01160770|582116948|FG000|Overall Study|Study termination or sponsor request|1|||
161201143|NCT01160770|582116948|FG000|Overall Study|Death|9|||
161201144|NCT01160770|582116948|FG000|Overall Study|Lack of Efficacy|15|||
161201145|NCT01160770|582116948|FG000|Overall Study|Other Reasons|1|||
161201146|NCT00242567|582116949|FG000|Overall Study|Adverse Event|70|||
161201147|NCT00242567|582116950|FG001|Overall Study|Adverse Event|43|||
161201148|NCT00242567|582116949|FG000|Overall Study|Disease Progression|17|||
161309622|NCT01199822|582515514|FG000|Overall Study|Investigator discontinued therapy|0|||
161309623|NCT01199822|582515515|FG001|Overall Study|Investigator discontinued therapy|1|||
161309624|NCT01199822|582515516|FG002|Overall Study|Investigator discontinued therapy|0|||
161309625|NCT00785213|582515517|FG000|Quinine Sulfate Alone|Adverse Event|4|||
161309626|NCT00785213|582515517|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
161309627|NCT01500213|582515518|FG000|Overall Study|Adverse Event|35|||
161309628|NCT01500213|582515519|FG001|Overall Study|Adverse Event|35|||
161309629|NCT01500213|582515518|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
161309630|NCT01500213|582515519|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
161309631|NCT01500213|582515518|FG000|Overall Study|Withdrawal by Subject|28|||
161309632|NCT01500213|582515519|FG001|Overall Study|Withdrawal by Subject|37|||
161201149|NCT00242567|582116950|FG001|Overall Study|Disease Progression|22|||
161201150|NCT00242567|582116949|FG000|Overall Study|Symptomatic deterioration|9|||
161201151|NCT00242567|582116950|FG001|Overall Study|Symptomatic deterioration|3|||
161201152|NCT00242567|582116949|FG000|Overall Study|Lack of Efficacy|2|||
161201153|NCT00242567|582116950|FG001|Overall Study|Lack of Efficacy|2|||
161201154|NCT00242567|582116949|FG000|Overall Study|Lost to Follow-up|9|||
161309633|NCT01500213|582515518|FG000|Overall Study|Death|7|||
161309634|NCT01500213|582515519|FG001|Overall Study|Death|3|||
161309635|NCT01500213|582515518|FG000|Overall Study|Disease Progression|13|||
161309636|NCT01500213|582515519|FG001|Overall Study|Disease Progression|21|||
161201155|NCT00242567|582116950|FG001|Overall Study|Lost to Follow-up|19|||
161201156|NCT00242567|582116949|FG000|Overall Study|Withdrawal by Subject|33|||
161201157|NCT00242567|582116950|FG001|Overall Study|Withdrawal by Subject|28|||
161201158|NCT00242567|582116949|FG000|Overall Study|Protocol Violation|12|||
161201159|NCT00242567|582116950|FG001|Overall Study|Protocol Violation|12|||
161201160|NCT00242567|582116949|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
161201161|NCT00242567|582116950|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
161201162|NCT00242567|582116949|FG000|Overall Study|Other|14|||
161201163|NCT00242567|582116950|FG001|Overall Study|Other|9|||
161201164|NCT00630994|582116951|FG000|Overall Study|Adverse Event|1|||
161201165|NCT00630994|582116951|FG000|Overall Study|Disease Progression|1|||
161201166|NCT00630994|582116951|FG000|Overall Study|Lack of Efficacy|1|||
161201167|NCT00630994|582116951|FG000|Overall Study|Other|1|||
161201168|NCT05553600|582116954|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
161201169|NCT05553600|582116955|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
161201170|NCT05553600|582116956|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
161201171|NCT05553600|582116957|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
161201172|NCT05553600|582116954|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
161201173|NCT05553600|582116955|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
161201174|NCT05553600|582116956|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
161201175|NCT05553600|582116957|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
161201176|NCT05553600|582116954|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161201177|NCT05553600|582116955|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161201178|NCT05553600|582116956|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
161201179|NCT05553600|582116957|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
161201180|NCT05553600|582116954|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
161201181|NCT05553600|582116955|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
161201182|NCT05553600|582116956|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
161201183|NCT05553600|582116957|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
161201184|NCT05553600|582116954|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
161201185|NCT05553600|582116955|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
161201186|NCT05553600|582116956|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
161201187|NCT05553600|582116957|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
161201188|NCT05553600|582116954|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161201189|NCT05553600|582116955|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161201190|NCT05553600|582116956|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
161201191|NCT05553600|582116957|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
161201192|NCT05553600|582116954|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
161201193|NCT05553600|582116955|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
161201194|NCT05553600|582116956|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
161201195|NCT05553600|582116957|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
161201196|NCT05553600|582116954|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
161201197|NCT05553600|582116955|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
161201198|NCT05553600|582116956|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
161201199|NCT05553600|582116957|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
161201200|NCT05553600|582116954|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
161201201|NCT05553600|582116955|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
161201202|NCT05553600|582116956|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
161201203|NCT05553600|582116957|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
161201204|NCT05553600|582116954|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
161201205|NCT05553600|582116955|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
161201206|NCT05553600|582116956|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
161201207|NCT05553600|582116957|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
161201208|NCT05553600|582116954|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
161201209|NCT05553600|582116955|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
161201210|NCT05553600|582116956|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
161201211|NCT05553600|582116957|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
161201212|NCT05553600|582116954|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
161201213|NCT05553600|582116955|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
161201214|NCT05553600|582116956|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
161201215|NCT05553600|582116957|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
161201216|NCT00924313|582116962|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
161201217|NCT01298362|582116963|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
161201218|NCT01298362|582116964|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
161201219|NCT02871921|582116967|FG000|Overall Study|Withdrawal by Subject|34|||
161201220|NCT02871921|582116968|FG001|Overall Study|Withdrawal by Subject|27|||
161201221|NCT02871921|582116969|FG002|Overall Study|Withdrawal by Subject|27|||
161201222|NCT02871921|582116970|FG003|Overall Study|Withdrawal by Subject|30|||
161201223|NCT00890409|582116976|FG000|Overall Study|Lost to Follow-up|20|||
161201224|NCT00890409|582116977|FG001|Overall Study|Lost to Follow-up|21|||
161201225|NCT02353572|582116978|FG000|Overall Study|Withdrawal by Subject|1|||
161201226|NCT02353572|582116978|FG000|Overall Study|Study terminated|2|||
161201227|NCT00455923|582116979|FG000|Overall Study|Pregnancy|0|||
161201228|NCT00455923|582116980|FG001|Overall Study|Pregnancy|2|||
161201229|NCT00455923|582116979|FG000|Overall Study|Other|3|||
161201230|NCT00455923|582116980|FG001|Overall Study|Other|1|||
161201231|NCT02060188|582116992|FG000|Overall Study|Disease Progression|36|||
161201232|NCT02060188|582116993|FG001|Overall Study|Disease Progression|42|||
161201233|NCT02060188|582116994|FG002|Overall Study|Disease Progression|8|||
161201234|NCT02060188|582116995|FG003|Overall Study|Disease Progression|5|||
161201235|NCT02060188|582116996|FG004|Overall Study|Disease Progression|6|||
161201236|NCT02060188|582116997|FG005|Overall Study|Disease Progression|3|||
161201237|NCT02060188|582116998|FG006|Overall Study|Disease Progression|23|||
161201238|NCT02060188|582116999|FG007|Overall Study|Disease Progression|20|||
161201239|NCT02060188|582117000|FG008|Overall Study|Disease Progression|43|||
161201240|NCT02060188|582116992|FG000|Overall Study|Study Drug Toxicity|10|||
161201241|NCT02060188|582116993|FG001|Overall Study|Study Drug Toxicity|18|||
161201242|NCT02060188|582116994|FG002|Overall Study|Study Drug Toxicity|7|||
161201243|NCT02060188|582116995|FG003|Overall Study|Study Drug Toxicity|4|||
161201244|NCT02060188|582116996|FG004|Overall Study|Study Drug Toxicity|3|||
161201245|NCT02060188|582116997|FG005|Overall Study|Study Drug Toxicity|0|||
161201246|NCT02060188|582116998|FG006|Overall Study|Study Drug Toxicity|2|||
161201247|NCT02060188|582116999|FG007|Overall Study|Study Drug Toxicity|5|||
161201248|NCT02060188|582117000|FG008|Overall Study|Study Drug Toxicity|0|||
161201249|NCT02060188|582116992|FG000|Overall Study|Adverse event unrelated to study drug|2|||
161201250|NCT02060188|582116993|FG001|Overall Study|Adverse event unrelated to study drug|5|||
161201251|NCT02060188|582116994|FG002|Overall Study|Adverse event unrelated to study drug|6|||
161201252|NCT02060188|582116995|FG003|Overall Study|Adverse event unrelated to study drug|0|||
161201253|NCT02060188|582116996|FG004|Overall Study|Adverse event unrelated to study drug|1|||
161201254|NCT02060188|582116997|FG005|Overall Study|Adverse event unrelated to study drug|0|||
161201255|NCT02060188|582116998|FG006|Overall Study|Adverse event unrelated to study drug|4|||
161201256|NCT02060188|582116999|FG007|Overall Study|Adverse event unrelated to study drug|4|||
161201257|NCT02060188|582117000|FG008|Overall Study|Adverse event unrelated to study drug|1|||
161201258|NCT02060188|582116992|FG000|Overall Study|Participant request to discontinue study treatment|7|||
161201259|NCT02060188|582116993|FG001|Overall Study|Participant request to discontinue study treatment|7|||
161201260|NCT02060188|582116994|FG002|Overall Study|Participant request to discontinue study treatment|4|||
161201261|NCT02060188|582116995|FG003|Overall Study|Participant request to discontinue study treatment|0|||
161201262|NCT02060188|582116996|FG004|Overall Study|Participant request to discontinue study treatment|0|||
161201263|NCT02060188|582116997|FG005|Overall Study|Participant request to discontinue study treatment|0|||
161201264|NCT02060188|582116998|FG006|Overall Study|Participant request to discontinue study treatment|1|||
161201265|NCT02060188|582116999|FG007|Overall Study|Participant request to discontinue study treatment|1|||
161201266|NCT02060188|582117000|FG008|Overall Study|Participant request to discontinue study treatment|0|||
161201267|NCT02060188|582116992|FG000|Overall Study|Participant withdrew consent|3|||
161201268|NCT02060188|582116993|FG001|Overall Study|Participant withdrew consent|0|||
161201269|NCT02060188|582116994|FG002|Overall Study|Participant withdrew consent|0|||
161201270|NCT02060188|582116995|FG003|Overall Study|Participant withdrew consent|0|||
161201271|NCT02060188|582116996|FG004|Overall Study|Participant withdrew consent|0|||
161201272|NCT02060188|582116997|FG005|Overall Study|Participant withdrew consent|0|||
161201273|NCT02060188|582116998|FG006|Overall Study|Participant withdrew consent|0|||
161201274|NCT02060188|582116999|FG007|Overall Study|Participant withdrew consent|0|||
161201275|NCT02060188|582117000|FG008|Overall Study|Participant withdrew consent|0|||
161201276|NCT02060188|582116992|FG000|Overall Study|Maximum clinical benefit|13|||
161201277|NCT02060188|582116993|FG001|Overall Study|Maximum clinical benefit|38|||
161201278|NCT02060188|582116994|FG002|Overall Study|Maximum clinical benefit|19|||
161309637|NCT01500213|582515518|FG000|Overall Study|Protocol Violation|19|||
161309638|NCT01500213|582515519|FG001|Overall Study|Protocol Violation|19|||
161309639|NCT01500213|582515518|FG000|Overall Study|Physician Decision|12|||
161309640|NCT01500213|582515519|FG001|Overall Study|Physician Decision|10|||
161309641|NCT01500213|582515518|FG000|Overall Study|Lack of Efficacy|9|||
161201279|NCT02060188|582116995|FG003|Overall Study|Maximum clinical benefit|0|||
161201280|NCT02060188|582116996|FG004|Overall Study|Maximum clinical benefit|0|||
161201281|NCT02060188|582116997|FG005|Overall Study|Maximum clinical benefit|0|||
161201282|NCT02060188|582116998|FG006|Overall Study|Maximum clinical benefit|0|||
161201283|NCT02060188|582116999|FG007|Overall Study|Maximum clinical benefit|10|||
161201284|NCT02060188|582117000|FG008|Overall Study|Maximum clinical benefit|0|||
161201285|NCT02060188|582116992|FG000|Overall Study|Other reason|3|||
161201286|NCT02060188|582116993|FG001|Overall Study|Other reason|7|||
161201287|NCT02060188|582116994|FG002|Overall Study|Other reason|0|||
161309642|NCT01500213|582515519|FG001|Overall Study|Lack of Efficacy|7|||
161309643|NCT01500213|582515518|FG000|Overall Study|Lost to Follow-up|3|||
161201288|NCT02060188|582116995|FG003|Overall Study|Other reason|1|||
161201289|NCT02060188|582116996|FG004|Overall Study|Other reason|0|||
161201290|NCT02060188|582116997|FG005|Overall Study|Other reason|0|||
161201291|NCT02060188|582116998|FG006|Overall Study|Other reason|0|||
161201292|NCT02060188|582116999|FG007|Overall Study|Other reason|9|||
161201293|NCT02060188|582117000|FG008|Overall Study|Other reason|0|||
161201294|NCT02060188|582116992|FG000|Overall Study|Death|0|||
161201295|NCT02060188|582116993|FG001|Overall Study|Death|1|||
161201296|NCT02060188|582116994|FG002|Overall Study|Death|0|||
161201297|NCT02060188|582116995|FG003|Overall Study|Death|0|||
161201298|NCT02060188|582116996|FG004|Overall Study|Death|0|||
161201299|NCT02060188|582116997|FG005|Overall Study|Death|0|||
161201300|NCT02060188|582116998|FG006|Overall Study|Death|0|||
161201301|NCT02060188|582116999|FG007|Overall Study|Death|1|||
161201302|NCT02060188|582117000|FG008|Overall Study|Death|0|||
161201303|NCT02060188|582116992|FG000|Overall Study|Administrative reasons by sponsor|0|||
161201304|NCT02060188|582116993|FG001|Overall Study|Administrative reasons by sponsor|1|||
161201305|NCT02060188|582116994|FG002|Overall Study|Administrative reasons by sponsor|0|||
161201306|NCT02060188|582116995|FG003|Overall Study|Administrative reasons by sponsor|0|||
161201307|NCT02060188|582116996|FG004|Overall Study|Administrative reasons by sponsor|0|||
161201308|NCT02060188|582116997|FG005|Overall Study|Administrative reasons by sponsor|0|||
161201309|NCT02060188|582116998|FG006|Overall Study|Administrative reasons by sponsor|0|||
161201310|NCT02060188|582116999|FG007|Overall Study|Administrative reasons by sponsor|0|||
161201311|NCT02060188|582117000|FG008|Overall Study|Administrative reasons by sponsor|0|||
161201312|NCT02060188|582116992|FG000|Overall Study|Lost to Follow-up|0|||
161201313|NCT02060188|582116993|FG001|Overall Study|Lost to Follow-up|0|||
161201314|NCT02060188|582116994|FG002|Overall Study|Lost to Follow-up|1|||
161201315|NCT02060188|582116995|FG003|Overall Study|Lost to Follow-up|0|||
161201316|NCT02060188|582116996|FG004|Overall Study|Lost to Follow-up|0|||
161201317|NCT02060188|582116997|FG005|Overall Study|Lost to Follow-up|0|||
161201318|NCT02060188|582116998|FG006|Overall Study|Lost to Follow-up|0|||
161201319|NCT02060188|582116999|FG007|Overall Study|Lost to Follow-up|0|||
161201320|NCT02060188|582117000|FG008|Overall Study|Lost to Follow-up|0|||
161201321|NCT03707145|582117001|FG000|Overall Study|Lost to Follow-up|0|||
161201322|NCT03707145|582117002|FG001|Overall Study|Lost to Follow-up|1|||
161309644|NCT01500213|582515519|FG001|Overall Study|Lost to Follow-up|6|||
161309645|NCT01500213|582515518|FG000|Overall Study|Other Reasons|7|||
161309646|NCT01500213|582515519|FG001|Overall Study|Other Reasons|5|||
161309647|NCT02386345|582515520|FG000|Overall Study|Not treated|14|||
161309648|NCT02386345|582515520|FG000|Overall Study|Lost to Follow-up|1|||
161309649|NCT02386345|582515520|FG000|Overall Study|Adverse Event|5|||
161309650|NCT02386345|582515520|FG000|Overall Study|Repeat Procedure|10|||
161309651|NCT02386345|582515520|FG000|Overall Study|Did not complete 12-month follow-up|72|||
161309652|NCT04027075|582515521|FG000|Overall Study|Lost to Follow-up|41|||
161309653|NCT04027075|582515522|FG001|Overall Study|Lost to Follow-up|22|||
161309654|NCT03448939|582515523|FG000|Overall Study|Adverse Event|5|||
161309655|NCT03448939|582515524|FG001|Overall Study|Adverse Event|1|||
161309656|NCT03448939|582515523|FG000|Overall Study|Lost to Follow-up|6|||
161309657|NCT03448939|582515524|FG001|Overall Study|Lost to Follow-up|6|||
161309658|NCT03448939|582515523|FG000|Overall Study|Pregnancy|1|||
161309659|NCT03448939|582515524|FG001|Overall Study|Pregnancy|1|||
161309660|NCT03448939|582515523|FG000|Overall Study|Withdrawal by Subject|9|||
161309661|NCT03448939|582515524|FG001|Overall Study|Withdrawal by Subject|3|||
161201323|NCT03707145|582117003|FG002|Overall Study|Lost to Follow-up|1|||
161201324|NCT03707145|582117004|FG003|Overall Study|Lost to Follow-up|0|||
161201325|NCT04221477|582117005|FG000|Overall Study|Adverse Event|1|||
161201326|NCT04221477|582117006|FG001|Overall Study|Adverse Event|1|||
161201327|NCT04221477|582117005|FG000|Overall Study|Death|5|||
161309662|NCT01259375|582515525|FG000|Overall Study|Adverse Event|1|||
161309663|NCT00986986|582515526|FG000|Overall Study|Lost to Follow-up|0|||
161309664|NCT00986986|582515527|FG001|Overall Study|Lost to Follow-up|1|||
161201328|NCT04221477|582117006|FG001|Overall Study|Death|4|||
161201329|NCT04221477|582117005|FG000|Overall Study|Lack of Efficacy|1|||
161201330|NCT04221477|582117006|FG001|Overall Study|Lack of Efficacy|2|||
161201331|NCT04221477|582117005|FG000|Overall Study|Lost to Follow-up|1|||
161201332|NCT04221477|582117006|FG001|Overall Study|Lost to Follow-up|2|||
161201333|NCT04221477|582117005|FG000|Overall Study|Non-compliance with Study Drug|1|||
161201334|NCT04221477|582117006|FG001|Overall Study|Non-compliance with Study Drug|0|||
161201335|NCT04221477|582117005|FG000|Overall Study|Reason not Specified|0|||
161201336|NCT04221477|582117006|FG001|Overall Study|Reason not Specified|5|||
161201337|NCT04221477|582117005|FG000|Overall Study|Physician Decision|0|||
161201338|NCT04221477|582117006|FG001|Overall Study|Physician Decision|6|||
161201339|NCT04221477|582117005|FG000|Overall Study|Withdrawal by Subject|10|||
161201340|NCT04221477|582117006|FG001|Overall Study|Withdrawal by Subject|14|||
161201341|NCT04221477|582117005|FG000|Overall Study|Ongoing in the Study|116|||
161201342|NCT04221477|582117006|FG001|Overall Study|Ongoing in the Study|102|||
161201343|NCT02242942|582117007|FG000|Overall Study|Death|17|||
161201344|NCT02242942|582117008|FG001|Overall Study|Death|20|||
161201345|NCT02242942|582117009|FG002|Overall Study|Death|2|||
161201346|NCT02242942|582117007|FG000|Overall Study|Physician Decision|1|||
161201347|NCT02242942|582117008|FG001|Overall Study|Physician Decision|0|||
161201348|NCT02242942|582117009|FG002|Overall Study|Physician Decision|0|||
161201349|NCT02242942|582117007|FG000|Overall Study|Withdrawal by Subject|8|||
161201350|NCT02242942|582117008|FG001|Overall Study|Withdrawal by Subject|10|||
161201351|NCT02242942|582117009|FG002|Overall Study|Withdrawal by Subject|0|||
161201352|NCT02242942|582117007|FG000|Overall Study|On-going in Study|190|||
161201353|NCT02242942|582117008|FG001|Overall Study|On-going in Study|186|||
161201354|NCT02242942|582117009|FG002|Overall Study|On-going in Study|11|||
161201355|NCT04784455|582117010|FG000|Overall Study|Death|4|||
161201356|NCT04882085|582117011|FG000|Overall Study|Death|6|||
161201357|NCT04882085|582117012|FG001|Overall Study|Death|9|||
161201358|NCT04882085|582117011|FG000|Overall Study|Withdrawal by Subject|0|||
161201359|NCT04882085|582117012|FG001|Overall Study|Withdrawal by Subject|3|||
161201360|NCT04882085|582117011|FG000|Overall Study|Randomized not treated|1|||
161201361|NCT04882085|582117012|FG001|Overall Study|Randomized not treated|0|||
161201362|NCT04455620|582117016|FG000|Overall Study|Withdrawal by Subject|0|||
161201363|NCT04455620|582117017|FG001|Overall Study|Withdrawal by Subject|0|||
161201364|NCT04455620|582117018|FG002|Overall Study|Withdrawal by Subject|2|||
161201365|NCT04455620|582117019|FG003|Overall Study|Withdrawal by Subject|0|||
161201366|NCT04455620|582117020|FG004|Overall Study|Withdrawal by Subject|1|||
161201367|NCT04455620|582117016|FG000|Overall Study|Lost to Follow-up|0|||
161201368|NCT04455620|582117017|FG001|Overall Study|Lost to Follow-up|0|||
161201369|NCT04455620|582117018|FG002|Overall Study|Lost to Follow-up|1|||
161201370|NCT04455620|582117019|FG003|Overall Study|Lost to Follow-up|1|||
161201371|NCT04455620|582117020|FG004|Overall Study|Lost to Follow-up|0|||
161201372|NCT04455620|582117016|FG000|Overall Study|Death|1|||
161201373|NCT04455620|582117017|FG001|Overall Study|Death|6|||
161201374|NCT04455620|582117018|FG002|Overall Study|Death|20|||
161201375|NCT04455620|582117019|FG003|Overall Study|Death|1|||
161201376|NCT04455620|582117020|FG004|Overall Study|Death|7|||
161201377|NCT04455620|582117016|FG000|Overall Study|Study Termination|0|||
161201378|NCT04455620|582117017|FG001|Overall Study|Study Termination|2|||
161201379|NCT04455620|582117018|FG002|Overall Study|Study Termination|1|||
161201380|NCT04455620|582117019|FG003|Overall Study|Study Termination|0|||
161201381|NCT04455620|582117020|FG004|Overall Study|Study Termination|6|||
161201382|NCT05681715|582117021|FG000|Training Period (6-weeks)|Adverse Event|3|||
161201383|NCT05681715|582117022|FG001|Training Period (6-weeks)|Adverse Event|0|||
161201384|NCT05681715|582117023|FG002|Training Period (6-weeks)|Adverse Event|0|||
161201385|NCT05681715|582117021|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
161201386|NCT05681715|582117022|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
161201387|NCT05681715|582117023|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
161201388|NCT05681715|582117021|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
161201389|NCT05681715|582117022|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
161201390|NCT05681715|582117023|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
161201391|NCT05681715|582117021|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
161309665|NCT00628095|582515528|FG000|Overall Study|Adverse Event|5|||
161309666|NCT00628095|582515529|FG001|Overall Study|Adverse Event|3|||
161309667|NCT00628095|582515528|FG000|Overall Study|Lack of Efficacy|0|||
161309668|NCT00628095|582515529|FG001|Overall Study|Lack of Efficacy|3|||
161309669|NCT00628095|582515528|FG000|Overall Study|Withdrawal by Subject|2|||
161309670|NCT00628095|582515529|FG001|Overall Study|Withdrawal by Subject|0|||
161201392|NCT05681715|582117022|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
161201393|NCT05681715|582117023|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
161309671|NCT00628095|582515528|FG000|Overall Study|Other|0|||
161201394|NCT05681715|582117021|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
161201395|NCT05681715|582117022|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
161309672|NCT00628095|582515529|FG001|Overall Study|Other|1|||
161309673|NCT01043705|582515534|FG000|Overall Study|Death|28|||
161201396|NCT05681715|582117023|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
161201397|NCT05681715|582117021|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
161201398|NCT05681715|582117022|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
161201399|NCT05681715|582117023|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
161201400|NCT05681715|582117021|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
161201401|NCT05681715|582117022|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
161201402|NCT05681715|582117023|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
161201403|NCT05681715|582117021|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
161201404|NCT05681715|582117022|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
161201405|NCT05681715|582117023|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
161201406|NCT05643573|582117024|FG000|Overall Study|Adverse Event|117|||
161201407|NCT05643573|582117025|FG001|Overall Study|Adverse Event|90|||
161201408|NCT05643573|582117024|FG000|Overall Study|Death|53|||
161201409|NCT05643573|582117025|FG001|Overall Study|Death|57|||
161201410|NCT05643573|582117024|FG000|Overall Study|Lost to Follow-up|6|||
161201411|NCT05643573|582117025|FG001|Overall Study|Lost to Follow-up|3|||
161201412|NCT05643573|582117024|FG000|Overall Study|Other|18|||
161201413|NCT05643573|582117025|FG001|Overall Study|Other|15|||
161201414|NCT05643573|582117024|FG000|Overall Study|Outcome event|64|||
161201415|NCT05643573|582117025|FG001|Overall Study|Outcome event|36|||
161201416|NCT05643573|582117024|FG000|Overall Study|Physician Decision|33|||
161201417|NCT05643573|582117025|FG001|Overall Study|Physician Decision|19|||
161201418|NCT05643573|582117024|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
161201419|NCT05643573|582117025|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
161201420|NCT05643573|582117024|FG000|Overall Study|Site terminated by sponsor|10|||
161201421|NCT05643573|582117025|FG001|Overall Study|Site terminated by sponsor|10|||
161201422|NCT05643573|582117024|FG000|Overall Study|Study terminated by sponsor|1|||
161201423|NCT05643573|582117025|FG001|Overall Study|Study terminated by sponsor|0|||
161201424|NCT05643573|582117024|FG000|Overall Study|Withdrawal by Subject|178|||
161201425|NCT05643573|582117025|FG001|Overall Study|Withdrawal by Subject|130|||
161201426|NCT02268214|582117032|FG000|Overall Study|Subject no longer meets study criteria|0|||
161201427|NCT02268214|582117033|FG001|Overall Study|Subject no longer meets study criteria|2|||
161201428|NCT02268214|582117034|FG002|Overall Study|Subject no longer meets study criteria|0|||
161201429|NCT02268214|582117032|FG000|Overall Study|Pregnancy|2|||
161201430|NCT02268214|582117033|FG001|Overall Study|Pregnancy|2|||
161201431|NCT02268214|582117034|FG002|Overall Study|Pregnancy|1|||
161201432|NCT02268214|582117032|FG000|Overall Study|Lost to Follow-up|3|||
161201433|NCT02268214|582117033|FG001|Overall Study|Lost to Follow-up|3|||
161201434|NCT02268214|582117034|FG002|Overall Study|Lost to Follow-up|4|||
161201435|NCT02268214|582117032|FG000|Overall Study|Lack of Efficacy|1|||
161201436|NCT02268214|582117033|FG001|Overall Study|Lack of Efficacy|0|||
161201437|NCT02268214|582117034|FG002|Overall Study|Lack of Efficacy|2|||
161201438|NCT02268214|582117032|FG000|Overall Study|Adverse Event|11|||
161201439|NCT02268214|582117033|FG001|Overall Study|Adverse Event|14|||
161201440|NCT02268214|582117034|FG002|Overall Study|Adverse Event|9|||
161201441|NCT02268214|582117032|FG000|Overall Study|Withdrawal by Subject|4|||
161201442|NCT02268214|582117033|FG001|Overall Study|Withdrawal by Subject|5|||
161201443|NCT02268214|582117034|FG002|Overall Study|Withdrawal by Subject|10|||
161201444|NCT02268214|582117032|FG000|Overall Study|Subject request to discontinue treatment|10|||
161201445|NCT02268214|582117033|FG001|Overall Study|Subject request to discontinue treatment|8|||
161201446|NCT02268214|582117034|FG002|Overall Study|Subject request to discontinue treatment|6|||
161201447|NCT02268214|582117032|FG000|Overall Study|Poor/non-compliance|2|||
161201448|NCT02268214|582117033|FG001|Overall Study|Poor/non-compliance|1|||
161201449|NCT02268214|582117034|FG002|Overall Study|Poor/non-compliance|2|||
161201450|NCT02268214|582117032|FG000|Overall Study|Other reasons|7|||
161201451|NCT02268214|582117033|FG001|Overall Study|Other reasons|3|||
161201452|NCT02268214|582117034|FG002|Overall Study|Other reasons|3|||
161201453|NCT02268214|582117032|FG000|Overall Study|Not entering long-term period|2|||
161201454|NCT02268214|582117033|FG001|Overall Study|Not entering long-term period|3|||
161201455|NCT02268214|582117034|FG002|Overall Study|Not entering long-term period|5|||
161201456|NCT03205605|582117042|FG000|Overall Study|Withdrawal by Subject|1|||
161201457|NCT03795233|582117043|FG000|Overall Study|Withdrawal by Subject|2|||
161201458|NCT03795233|582117044|FG001|Overall Study|Withdrawal by Subject|1|||
161201459|NCT03795233|582117043|FG000|Overall Study|Lost to Follow-up|1|||
161201460|NCT03795233|582117044|FG001|Overall Study|Lost to Follow-up|0|||
161201461|NCT03795233|582117043|FG000|Overall Study|Death|1|||
161201462|NCT03795233|582117044|FG001|Overall Study|Death|0|||
161201463|NCT02756182|582117045|FG000|Overall Study|StudyTechnical Difficulties|4|||
161201464|NCT01965600|582117049|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
161201465|NCT01965600|582117050|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
161201466|NCT01965600|582117051|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
161201467|NCT01965600|582117052|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
161201468|NCT01965600|582117049|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161201469|NCT01965600|582117050|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
161201470|NCT01965600|582117051|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161201471|NCT01965600|582117052|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
161201472|NCT01965600|582117049|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
161201473|NCT01965600|582117050|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161201474|NCT01965600|582117051|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161201475|NCT01965600|582117052|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
161201476|NCT01965600|582117049|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
161201477|NCT01965600|582117050|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
161201478|NCT01965600|582117051|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
161201479|NCT01965600|582117052|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
161201480|NCT01965600|582117049|FG000|Second Intervention|Study terminated by Sponsor|0|||
161201481|NCT01965600|582117050|FG001|Second Intervention|Study terminated by Sponsor|0|||
161201482|NCT01965600|582117051|FG002|Second Intervention|Study terminated by Sponsor|2|||
161201483|NCT01965600|582117052|FG003|Second Intervention|Study terminated by Sponsor|2|||
161201484|NCT02711306|582117056|FG000|Overall Study|Withdrawal by Subject|2|||
161201485|NCT02711306|582117057|FG001|Overall Study|Withdrawal by Subject|2|||
161201486|NCT00157820|582117058|FG000|Randomized|Physician Decision|4|||
161201487|NCT00157820|582117059|FG001|Randomized|Physician Decision|2|||
161201488|NCT00157820|582117060|FG002|Randomized|Physician Decision|3|||
161201489|NCT00157820|582117058|FG000|Randomized|Withdrawal by Subject|1|||
161201490|NCT00157820|582117059|FG001|Randomized|Withdrawal by Subject|2|||
161201491|NCT00157820|582117060|FG002|Randomized|Withdrawal by Subject|3|||
161201492|NCT00157820|582117058|FG000|Randomized|Protocol Violation|2|||
161201493|NCT00157820|582117059|FG001|Randomized|Protocol Violation|1|||
161201494|NCT00157820|582117060|FG002|Randomized|Protocol Violation|2|||
161201495|NCT00157820|582117058|FG000|1st 8 Month|Death|7|||
161201496|NCT00157820|582117059|FG001|1st 8 Month|Death|8|||
161201497|NCT00157820|582117060|FG002|1st 8 Month|Death|3|||
161201498|NCT00157820|582117058|FG000|1st 8 Month|Lost to Follow-up|1|||
161201499|NCT00157820|582117059|FG001|1st 8 Month|Lost to Follow-up|2|||
161201500|NCT00157820|582117060|FG002|1st 8 Month|Lost to Follow-up|1|||
161201501|NCT00157820|582117058|FG000|1st 8 Month|Premature cross-over|0|||
161201502|NCT00157820|582117059|FG001|1st 8 Month|Premature cross-over|2|||
161201503|NCT00157820|582117060|FG002|1st 8 Month|Premature cross-over|2|||
161201504|NCT00157820|582117058|FG000|2nd 8 Months|Death|3|||
161201505|NCT00157820|582117059|FG001|2nd 8 Months|Death|1|||
161201506|NCT00157820|582117060|FG002|2nd 8 Months|Death|3|||
161201507|NCT00157820|582117058|FG000|2nd 8 Months|Lost to Follow-up|1|||
161201508|NCT00157820|582117059|FG001|2nd 8 Months|Lost to Follow-up|5|||
161201509|NCT00157820|582117060|FG002|2nd 8 Months|Lost to Follow-up|2|||
161201510|NCT00157820|582117058|FG000|2nd 8 Months|Premature cross-over|1|||
161201511|NCT00157820|582117059|FG001|2nd 8 Months|Premature cross-over|7|||
161201512|NCT00157820|582117060|FG002|2nd 8 Months|Premature cross-over|9|||
161201513|NCT01676818|582117061|FG000|Overall Study|Physician Decision|1|||
161201514|NCT01676818|582117061|FG000|Overall Study|Withdrawal by Subject|1|||
161201515|NCT01100073|582118339|FG000|Overall Study|Lack of Efficacy|4|||
161201516|NCT01100073|582118339|FG000|Overall Study|Insufficient Tolerability|21|||
161201517|NCT01100073|582118339|FG000|Overall Study|Withdrawal by Subject|13|||
161201518|NCT01100073|582118339|FG000|Overall Study|Lost to Follow-up|39|||
161201519|NCT01100073|582118339|FG000|Overall Study|Lack of effect + patient's wish|2|||
161201520|NCT01100073|582118339|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
161201521|NCT01100073|582118339|FG000|Overall Study|Other|8|||
161201522|NCT01100073|582118339|FG000|Overall Study|Missing|5|||
161201523|NCT01656850|582118340|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
161201524|NCT01656850|582118341|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
161201525|NCT00326118|582118342|FG000|Active Phase|Withdrawal by Subject|4|||
161201526|NCT00326118|582118343|FG001|Active Phase|Withdrawal by Subject|1|||
161201527|NCT02525627|582118352|FG000|Overall Study|Revision|1|||
161201528|NCT02525627|582118353|FG001|Overall Study|Revision|1|||
161201529|NCT02525627|582118352|FG000|Overall Study|Withdrawal by Subject|1|||
161201530|NCT02525627|582118353|FG001|Overall Study|Withdrawal by Subject|2|||
161201531|NCT02525627|582118352|FG000|Overall Study|Death|1|||
161201532|NCT02525627|582118353|FG001|Overall Study|Death|0|||
161201533|NCT02525627|582118352|FG000|Overall Study|Site terminated|11|||
161201534|NCT02525627|582118353|FG001|Overall Study|Site terminated|10|||
161201535|NCT05027958|582118356|FG000|Overall Study|Lost to Follow-up|1|||
161201536|NCT05027958|582118357|FG001|Overall Study|Lost to Follow-up|1|||
161201537|NCT05027958|582118356|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
161201538|NCT05027958|582118357|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
161201539|NCT05027958|582118356|FG000|Overall Study|Physician Decision|1|||
161201540|NCT05027958|582118357|FG001|Overall Study|Physician Decision|4|||
161201541|NCT05027958|582118356|FG000|Overall Study|Adverse Event|0|||
161201542|NCT05027958|582118357|FG001|Overall Study|Adverse Event|1|||
161309674|NCT01043705|582515535|FG001|Overall Study|Death|60|||
161201543|NCT01244516|582118358|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
161201544|NCT01244516|582118359|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
161201545|NCT01244516|582118360|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
161201546|NCT01244516|582118358|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
161201547|NCT01244516|582118359|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
161201548|NCT01244516|582118360|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
161201549|NCT01244516|582118358|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
161201550|NCT01244516|582118359|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
161201551|NCT01244516|582118360|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
161201552|NCT01244516|582118358|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
161201553|NCT01244516|582118359|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
161201554|NCT01244516|582118360|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
161201555|NCT01244516|582118358|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
161201556|NCT01244516|582118359|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
161201557|NCT01244516|582118360|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
161201558|NCT01244516|582118358|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
161201559|NCT01244516|582118359|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
161201560|NCT01244516|582118360|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
161201561|NCT01244516|582118358|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
161201562|NCT01244516|582118359|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
161201563|NCT01244516|582118360|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
161201564|NCT03664024|582118361|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
161201565|NCT03664024|582118361|FG000|Overall Study|Lost to Follow-up|2|||
161201566|NCT03664024|582118361|FG000|Overall Study|Withdrawal by Subject|2|||
161201567|NCT03664024|582118361|FG000|Overall Study|Death|80|||
161201568|NCT03075826|582118363|FG000|Overall Study|Withdrawal by Subject|1|||
161201569|NCT03075826|582118363|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
161201570|NCT04456998|582118368|FG000|Overall Study|Adverse Event|0|||
161201571|NCT04456998|582118369|FG001|Overall Study|Adverse Event|4|||
161201572|NCT04456998|582118368|FG000|Overall Study|Protocol Deviation|0|||
161201573|NCT04456998|582118369|FG001|Overall Study|Protocol Deviation|1|||
161201574|NCT04456998|582118368|FG000|Overall Study|Withdrawal by Subject|0|||
161201575|NCT04456998|582118369|FG001|Overall Study|Withdrawal by Subject|1|||
161201576|NCT04228107|582118373|FG000|Overall Study|Protocol Violation|1|||
161201577|NCT04228107|582118374|FG001|Overall Study|Protocol Violation|0|||
161201578|NCT04228107|582118373|FG000|Overall Study|Withdrawal by Subject|6|||
161201579|NCT04228107|582118374|FG001|Overall Study|Withdrawal by Subject|0|||
161201580|NCT04228107|582118373|FG000|Overall Study|Lost to Follow-up|18|||
161201581|NCT04228107|582118374|FG001|Overall Study|Lost to Follow-up|0|||
161201582|NCT04228107|582118373|FG000|Overall Study|No controller use data|1|||
161201583|NCT04228107|582118374|FG001|Overall Study|No controller use data|0|||
161201584|NCT04228107|582118373|FG000|Overall Study|No medication data collected|1|||
161201585|NCT04228107|582118374|FG001|Overall Study|No medication data collected|0|||
161201586|NCT00965562|582118375|FG000|Overall Study|Lost to Follow-up|1|||
161201587|NCT00965562|582118376|FG001|Overall Study|Lost to Follow-up|2|||
161201588|NCT00965562|582118377|FG002|Overall Study|Lost to Follow-up|3|||
161201589|NCT00965562|582118375|FG000|Overall Study|Withdrawal by Subject|2|||
161201590|NCT00965562|582118376|FG001|Overall Study|Withdrawal by Subject|2|||
161201591|NCT00965562|582118377|FG002|Overall Study|Withdrawal by Subject|0|||
161201592|NCT03792633|582118378|FG000|Overall Study|Alternative Treatment|17|||
161201593|NCT03792633|582118379|FG001|Overall Study|Alternative Treatment|19|||
161201594|NCT03792633|582118378|FG000|Overall Study|Death|2|||
161201595|NCT03792633|582118379|FG001|Overall Study|Death|0|||
161201596|NCT03792633|582118378|FG000|Overall Study|Disease progression|8|||
161201597|NCT03792633|582118379|FG001|Overall Study|Disease progression|9|||
161201598|NCT03792633|582118378|FG000|Overall Study|Lost to Follow-up|1|||
161201599|NCT03792633|582118379|FG001|Overall Study|Lost to Follow-up|1|||
161201600|NCT03792633|582118378|FG000|Overall Study|Screen fail|1|||
161201601|NCT03792633|582118379|FG001|Overall Study|Screen fail|0|||
161201602|NCT03792633|582118378|FG000|Overall Study|Second malignancy|0|||
161201603|NCT03792633|582118379|FG001|Overall Study|Second malignancy|1|||
161201604|NCT00145119|582118380|FG000|Overall Study|Death|45|||
161201605|NCT05455684|582118381|FG000|Overall Study|Withdrawal by Subject|7|||
161201606|NCT05455684|582118382|FG001|Overall Study|Withdrawal by Subject|4|||
161201607|NCT05455684|582118381|FG000|Overall Study|Lost to Follow-up|3|||
161201608|NCT05455684|582118382|FG001|Overall Study|Lost to Follow-up|3|||
161201609|NCT05455684|582118381|FG000|Overall Study|Adverse Event|2|||
161201610|NCT05455684|582118382|FG001|Overall Study|Adverse Event|3|||
161201611|NCT05455684|582118381|FG000|Overall Study|Protocol Violation|1|||
161201612|NCT05455684|582118382|FG001|Overall Study|Protocol Violation|1|||
161201613|NCT05455684|582118381|FG000|Overall Study|Non-Compliant with study drug|0|||
161201614|NCT05455684|582118382|FG001|Overall Study|Non-Compliant with study drug|1|||
161201615|NCT05455684|582118381|FG000|Overall Study|Other|1|||
161201616|NCT05455684|582118382|FG001|Overall Study|Other|2|||
161201617|NCT05455684|582118381|FG000|Overall Study|Randomized but not treated|1|||
161201618|NCT05455684|582118382|FG001|Overall Study|Randomized but not treated|0|||
161201619|NCT05204563|582118383|FG000|Overall Study|Other than Specified|2|||
161201620|NCT05204563|582118384|FG001|Overall Study|Other than Specified|1|||
161201621|NCT05204563|582118383|FG000|Overall Study|Death|18|||
161201622|NCT05204563|582118384|FG001|Overall Study|Death|4|||
161201623|NCT05204563|582118383|FG000|Overall Study|Lost to Follow-up|6|||
161201624|NCT05204563|582118384|FG001|Overall Study|Lost to Follow-up|3|||
161201625|NCT05204563|582118383|FG000|Overall Study|Withdrawal by Subject|12|||
161201626|NCT05204563|582118384|FG001|Overall Study|Withdrawal by Subject|3|||
161201627|NCT05204563|582118383|FG000|Overall Study|Enrolled, Not Treated|1|||
161201628|NCT05204563|582118384|FG001|Overall Study|Enrolled, Not Treated|0|||
161201629|NCT04411641|582118385|FG000|DB Period|Other|7|||
161201630|NCT04411641|582118386|FG001|DB Period|Other|27|||
161201631|NCT04411641|582118387|FG002|DB Period|Other|0|||
161201632|NCT04411641|582118388|FG003|DB Period|Other|0|||
161201633|NCT04411641|582118385|FG000|DB Period|Withdrawal by Subject|67|||
161201634|NCT04411641|582118386|FG001|DB Period|Withdrawal by Subject|122|||
161201635|NCT04411641|582118387|FG002|DB Period|Withdrawal by Subject|0|||
161201636|NCT04411641|582118388|FG003|DB Period|Withdrawal by Subject|0|||
161201637|NCT04411641|582118385|FG000|DB Period|Progressive disease|76|||
161201638|NCT04411641|582118386|FG001|DB Period|Progressive disease|116|||
161201639|NCT04411641|582118387|FG002|DB Period|Progressive disease|0|||
161201640|NCT04411641|582118388|FG003|DB Period|Progressive disease|0|||
161201641|NCT04411641|582118385|FG000|DB Period|Poor compliance to protocol|1|||
161201642|NCT04411641|582118386|FG001|DB Period|Poor compliance to protocol|5|||
161201643|NCT04411641|582118387|FG002|DB Period|Poor compliance to protocol|0|||
161201644|NCT04411641|582118388|FG003|DB Period|Poor compliance to protocol|0|||
161201645|NCT04411641|582118385|FG000|DB Period|Lack of Efficacy|19|||
161201646|NCT04411641|582118386|FG001|DB Period|Lack of Efficacy|19|||
161201647|NCT04411641|582118387|FG002|DB Period|Lack of Efficacy|0|||
161201648|NCT04411641|582118388|FG003|DB Period|Lack of Efficacy|0|||
161201649|NCT04411641|582118385|FG000|DB Period|Adverse Event|13|||
161201650|NCT04411641|582118386|FG001|DB Period|Adverse Event|29|||
161201651|NCT04411641|582118387|FG002|DB Period|Adverse Event|0|||
161201652|NCT04411641|582118388|FG003|DB Period|Adverse Event|0|||
161201653|NCT04411641|582118385|FG000|DB Period|Randomized and not treated|2|||
161201654|NCT04411641|582118386|FG001|DB Period|Randomized and not treated|2|||
161201655|NCT04411641|582118387|FG002|DB Period|Randomized and not treated|0|||
161201656|NCT04411641|582118388|FG003|DB Period|Randomized and not treated|0|||
161201657|NCT04411641|582118385|FG000|OL|Withdrawal by Subject|0|||
161201658|NCT04411641|582118386|FG001|OL|Withdrawal by Subject|0|||
161201659|NCT04411641|582118387|FG002|OL|Withdrawal by Subject|6|||
161201660|NCT04411641|582118388|FG003|OL|Withdrawal by Subject|17|||
161201661|NCT04411641|582118385|FG000|OL|Progressive disease|0|||
161201662|NCT04411641|582118386|FG001|OL|Progressive disease|0|||
161201663|NCT04411641|582118387|FG002|OL|Progressive disease|1|||
161201664|NCT04411641|582118388|FG003|OL|Progressive disease|2|||
161201665|NCT04411641|582118385|FG000|OL|Poor compliance to protocol|0|||
161201666|NCT04411641|582118386|FG001|OL|Poor compliance to protocol|0|||
161201667|NCT04411641|582118387|FG002|OL|Poor compliance to protocol|1|||
161201668|NCT04411641|582118388|FG003|OL|Poor compliance to protocol|0|||
161201669|NCT04411641|582118385|FG000|OL|Adverse Event|0|||
161201670|NCT04411641|582118386|FG001|OL|Adverse Event|0|||
161201671|NCT04411641|582118387|FG002|OL|Adverse Event|1|||
161201672|NCT04411641|582118388|FG003|OL|Adverse Event|0|||
161201673|NCT04411641|582118385|FG000|OL|Other|0|||
161201674|NCT04411641|582118386|FG001|OL|Other|0|||
161201675|NCT04411641|582118387|FG002|OL|Other|0|||
161201676|NCT04411641|582118388|FG003|OL|Other|6|||
161201677|NCT04342390|582118389|FG000|Overall Study|Lost to Follow-up|3|||
161201678|NCT04342390|582118390|FG001|Overall Study|Lost to Follow-up|0|||
161201679|NCT02951130|582118391|FG000|Overall Study|Protocol Violation|1|||
161201680|NCT02951130|582118392|FG001|Overall Study|Protocol Violation|1|||
161201681|NCT04584294|582118393|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
161201682|NCT04584294|582118394|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
161201683|NCT04584294|582118393|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
161201684|NCT04584294|582118394|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
161201685|NCT04584294|582118393|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
161201686|NCT04584294|582118394|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
161201687|NCT04584294|582118393|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
161201688|NCT04584294|582118394|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
161201689|NCT04584294|582118393|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
161201690|NCT04584294|582118394|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
161201691|NCT04584294|582118393|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
161201692|NCT04584294|582118394|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
161201693|NCT02500732|582118400|FG000|Overall Study|Physician Decision|0|||
161201694|NCT02500732|582118401|FG001|Overall Study|Physician Decision|1|||
161201695|NCT01233284|582118411|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
161201696|NCT01233284|582118412|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161201697|NCT01233284|582118413|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161201698|NCT01233284|582118414|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161201699|NCT01233284|582118415|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
161201700|NCT01233284|582118411|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161201701|NCT01233284|582118412|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
161201702|NCT01233284|582118413|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161201703|NCT01233284|582118414|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161201704|NCT01233284|582118415|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
161201705|NCT01233284|582118411|FG000|Period 1 (4 Weeks)|Other|0|||
161201706|NCT01233284|582118412|FG001|Period 1 (4 Weeks)|Other|0|||
161201707|NCT01233284|582118413|FG002|Period 1 (4 Weeks)|Other|1|||
161201708|NCT01233284|582118414|FG003|Period 1 (4 Weeks)|Other|0|||
161201709|NCT01233284|582118415|FG004|Period 1 (4 Weeks)|Other|0|||
161201710|NCT01233284|582118411|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161201711|NCT01233284|582118412|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161201712|NCT01233284|582118413|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
161201713|NCT01233284|582118414|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161201714|NCT01233284|582118415|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
161201715|NCT01233284|582118411|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161201716|NCT01233284|582118412|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161201717|NCT01233284|582118413|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
161201718|NCT01233284|582118414|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161201719|NCT01233284|582118415|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
161201720|NCT01233284|582118411|FG000|Period 3 (4 Weeks)|Other|0|||
161201721|NCT01233284|582118412|FG001|Period 3 (4 Weeks)|Other|0|||
161201722|NCT01233284|582118413|FG002|Period 3 (4 Weeks)|Other|0|||
161201723|NCT01233284|582118414|FG003|Period 3 (4 Weeks)|Other|1|||
161201724|NCT01233284|582118415|FG004|Period 3 (4 Weeks)|Other|0|||
161201725|NCT01233284|582118411|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
161201726|NCT01233284|582118412|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
161201727|NCT01233284|582118413|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
161201728|NCT01233284|582118414|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
161201729|NCT01233284|582118415|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
161201730|NCT01233284|582118411|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161201731|NCT01233284|582118412|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161201732|NCT01233284|582118413|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161201733|NCT01233284|582118414|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
161201734|NCT01233284|582118415|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
161201735|NCT03759340|582118416|FG000|Overall Study|Adverse Event|2|||
161201736|NCT03759340|582118416|FG000|Overall Study|Lost to Follow-up|1|||
161201737|NCT03759340|582118416|FG000|Overall Study|Withdrawal by Subject|15|||
161201738|NCT03759340|582118416|FG000|Overall Study|Study Terminated by Sponsor|38|||
161201739|NCT01003691|582118417|FG000|Overall Study|Adverse Event|0|||
161201740|NCT01003691|582118418|FG001|Overall Study|Adverse Event|0|||
161201741|NCT01003691|582118419|FG002|Overall Study|Adverse Event|0|||
161201742|NCT01003691|582118420|FG003|Overall Study|Adverse Event|1|||
161201743|NCT01869959|582118424|FG000|Randomization Period|Physician Decision|0|||
161201744|NCT01869959|582118425|FG001|Randomization Period|Physician Decision|0|||
161201745|NCT01869959|582118426|FG002|Randomization Period|Physician Decision|0|||
161201746|NCT01869959|582118427|FG003|Randomization Period|Physician Decision|0|||
161201747|NCT01869959|582118428|FG004|Randomization Period|Physician Decision|1|||
161201748|NCT01869959|582118424|FG000|Treatment Period|Adverse Event|1|||
161201749|NCT01869959|582118425|FG001|Treatment Period|Adverse Event|0|||
161201750|NCT01869959|582118426|FG002|Treatment Period|Adverse Event|3|||
161201751|NCT01869959|582118427|FG003|Treatment Period|Adverse Event|1|||
161201752|NCT01869959|582118428|FG004|Treatment Period|Adverse Event|0|||
161201753|NCT01869959|582118424|FG000|Treatment Period|Sponsor decision|0|||
161201754|NCT01869959|582118425|FG001|Treatment Period|Sponsor decision|1|||
161201755|NCT01869959|582118426|FG002|Treatment Period|Sponsor decision|0|||
161201756|NCT01869959|582118427|FG003|Treatment Period|Sponsor decision|1|||
161201757|NCT01869959|582118428|FG004|Treatment Period|Sponsor decision|0|||
161201758|NCT01869959|582118424|FG000|Treatment Period|Withdrawal by Subject|0|||
161201759|NCT01869959|582118425|FG001|Treatment Period|Withdrawal by Subject|1|||
161201760|NCT01869959|582118426|FG002|Treatment Period|Withdrawal by Subject|0|||
161201761|NCT01869959|582118427|FG003|Treatment Period|Withdrawal by Subject|0|||
161201762|NCT01869959|582118428|FG004|Treatment Period|Withdrawal by Subject|0|||
161201763|NCT04814654|582118429|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
161201764|NCT04814654|582118430|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
161201765|NCT04814654|582118431|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
161201766|NCT02207413|582118437|FG000|Overall Study|Withdrawal by Subject|1|||
161201767|NCT02207413|582118438|FG001|Overall Study|Withdrawal by Subject|0|||
161201768|NCT02207413|582118439|FG002|Overall Study|Withdrawal by Subject|0|||
161201769|NCT02207413|582118440|FG003|Overall Study|Withdrawal by Subject|0|||
161201770|NCT02207413|582118441|FG004|Overall Study|Withdrawal by Subject|3|||
161201771|NCT02207413|582118442|FG005|Overall Study|Withdrawal by Subject|7|||
161201772|NCT02207413|582118437|FG000|Overall Study|Lost to Follow-up|0|||
161201773|NCT02207413|582118438|FG001|Overall Study|Lost to Follow-up|0|||
161201774|NCT02207413|582118439|FG002|Overall Study|Lost to Follow-up|0|||
161201775|NCT02207413|582118440|FG003|Overall Study|Lost to Follow-up|1|||
161201776|NCT02207413|582118441|FG004|Overall Study|Lost to Follow-up|1|||
161201777|NCT02207413|582118442|FG005|Overall Study|Lost to Follow-up|5|||
161201778|NCT02207413|582118437|FG000|Overall Study|Adverse Event|0|||
161201779|NCT02207413|582118438|FG001|Overall Study|Adverse Event|0|||
161201780|NCT02207413|582118439|FG002|Overall Study|Adverse Event|0|||
161201781|NCT02207413|582118440|FG003|Overall Study|Adverse Event|0|||
161201782|NCT02207413|582118441|FG004|Overall Study|Adverse Event|2|||
161201783|NCT02207413|582118442|FG005|Overall Study|Adverse Event|1|||
161201784|NCT02207413|582118437|FG000|Overall Study|Migrated/moved from study area|0|||
161201785|NCT02207413|582118438|FG001|Overall Study|Migrated/moved from study area|0|||
161201786|NCT02207413|582118439|FG002|Overall Study|Migrated/moved from study area|0|||
161201787|NCT02207413|582118440|FG003|Overall Study|Migrated/moved from study area|0|||
161201788|NCT02207413|582118441|FG004|Overall Study|Migrated/moved from study area|1|||
161201789|NCT02207413|582118442|FG005|Overall Study|Migrated/moved from study area|0|||
161201790|NCT01519635|582120255|FG000|Overall Study|Withdrawal by Subject|0|||
161201791|NCT01519635|582120256|FG001|Overall Study|Withdrawal by Subject|1|||
161201792|NCT01519635|582120255|FG000|Overall Study|No possibility to put a catheter|1|||
161201793|NCT01519635|582120256|FG001|Overall Study|No possibility to put a catheter|2|||
161201794|NCT00347776|582120257|FG000|1.5 Month Follow-up|Death|2|||
161201795|NCT00347776|582120258|FG001|1.5 Month Follow-up|Death|0|||
161201796|NCT00347776|582120259|FG002|1.5 Month Follow-up|Death|0|||
161201797|NCT00347776|582120257|FG000|1.5 Month Follow-up|reached the endpoint|12|||
161201798|NCT00347776|582120258|FG001|1.5 Month Follow-up|reached the endpoint|8|||
161201799|NCT00347776|582120259|FG002|1.5 Month Follow-up|reached the endpoint|12|||
161201800|NCT00347776|582120257|FG000|6 Month Follow-up|Death|2|||
161201801|NCT00347776|582120258|FG001|6 Month Follow-up|Death|1|||
161201802|NCT00347776|582120259|FG002|6 Month Follow-up|Death|3|||
161201803|NCT00347776|582120257|FG000|6 Month Follow-up|reached endpont|20|||
161201804|NCT00347776|582120258|FG001|6 Month Follow-up|reached endpont|12|||
161201805|NCT00347776|582120259|FG002|6 Month Follow-up|reached endpont|15|||
161201806|NCT00347776|582120257|FG000|12 Month Follow-up|Lost to Follow-up|7|||
161201807|NCT00347776|582120258|FG001|12 Month Follow-up|Lost to Follow-up|6|||
161201808|NCT00347776|582120259|FG002|12 Month Follow-up|Lost to Follow-up|6|||
161201809|NCT00347776|582120257|FG000|12 Month Follow-up|Death|3|||
161201810|NCT00347776|582120258|FG001|12 Month Follow-up|Death|4|||
161201811|NCT00347776|582120259|FG002|12 Month Follow-up|Death|4|||
161201812|NCT00347776|582120257|FG000|12 Month Follow-up|Reached endpoint|13|||
161201813|NCT00347776|582120258|FG001|12 Month Follow-up|Reached endpoint|6|||
161201814|NCT00347776|582120259|FG002|12 Month Follow-up|Reached endpoint|9|||
161201815|NCT00299546|582120260|FG000|Overall Study|Death|3|||
161201816|NCT00299546|582120261|FG001|Overall Study|Death|2|||
161201817|NCT00299546|582120262|FG002|Overall Study|Death|0|||
161201818|NCT00299546|582120260|FG000|Overall Study|Lost to Follow-up|2|||
161201819|NCT00299546|582120261|FG001|Overall Study|Lost to Follow-up|2|||
161201820|NCT00299546|582120262|FG002|Overall Study|Lost to Follow-up|5|||
161201821|NCT00299546|582120260|FG000|Overall Study|Adverse Event|37|||
161201822|NCT00299546|582120261|FG001|Overall Study|Adverse Event|22|||
161201823|NCT00299546|582120262|FG002|Overall Study|Adverse Event|27|||
161201824|NCT00299546|582120260|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
161201825|NCT00299546|582120261|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
161201826|NCT00299546|582120262|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
161201827|NCT00299546|582120260|FG000|Overall Study|Other|24|||
161201828|NCT00299546|582120261|FG001|Overall Study|Other|26|||
161201829|NCT00299546|582120262|FG002|Overall Study|Other|19|||
161201830|NCT00299546|582120260|FG000|Overall Study|Not treated|0|||
161201831|NCT00299546|582120261|FG001|Overall Study|Not treated|1|||
161201832|NCT00299546|582120262|FG002|Overall Study|Not treated|1|||
161201833|NCT00968539|582120263|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
161201834|NCT00968539|582120264|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
161201835|NCT02074982|582120265|FG000|Overall Study|Adverse Event|15|||
161201836|NCT02074982|582120266|FG001|Overall Study|Adverse Event|7|||
161201837|NCT02074982|582120265|FG000|Overall Study|Lack of Efficacy|6|||
161201838|NCT02074982|582120266|FG001|Overall Study|Lack of Efficacy|1|||
161201839|NCT02074982|582120265|FG000|Overall Study|Lost to Follow-up|9|||
161201840|NCT02074982|582120266|FG001|Overall Study|Lost to Follow-up|10|||
161201841|NCT02074982|582120265|FG000|Overall Study|Non-compliance with study treatment|0|||
161201842|NCT02074982|582120266|FG001|Overall Study|Non-compliance with study treatment|2|||
161201843|NCT02074982|582120265|FG000|Overall Study|Physician Decision|1|||
161201844|NCT02074982|582120266|FG001|Overall Study|Physician Decision|1|||
161201845|NCT02074982|582120265|FG000|Overall Study|Pregnancy|1|||
161201846|NCT02074982|582120266|FG001|Overall Study|Pregnancy|2|||
161201847|NCT02074982|582120265|FG000|Overall Study|Protocol deviation|4|||
161201848|NCT02074982|582120266|FG001|Overall Study|Protocol deviation|3|||
161201849|NCT02074982|582120265|FG000|Overall Study|Technical problems|0|||
161201850|NCT02074982|582120266|FG001|Overall Study|Technical problems|2|||
161201851|NCT02074982|582120265|FG000|Overall Study|Subject/guardian decision|15|||
161201852|NCT02074982|582120266|FG001|Overall Study|Subject/guardian decision|24|||
161201853|NCT02074982|582120265|FG000|Overall Study|Death|0|||
161201854|NCT02074982|582120266|FG001|Overall Study|Death|2|||
161201855|NCT00848965|582120272|FG000|Overall Study|Adverse Event|1|||
161201856|NCT00848965|582120272|FG000|Overall Study|Withdrawal by Subject|1|||
161201857|NCT03710824|582120273|FG000|Overall Study|Withdrawal by Subject|1|||
161201858|NCT03710824|582120273|FG000|Overall Study|Lost to Follow-up|3|||
161201859|NCT03710824|582120273|FG000|Overall Study|Adverse Event|25|||
161201860|NCT03710824|582120273|FG000|Overall Study|Treatment discontinuation|2|||
161201861|NCT02329834|582120274|FG000|Overall Study|Physician Decision|1|||
161201862|NCT02329834|582120275|FG001|Overall Study|Physician Decision|0|||
161201863|NCT01605370|582120278|FG000|Overall Study|Adverse Event|1|||
161201864|NCT01605370|582120279|FG001|Overall Study|Adverse Event|0|||
161201865|NCT00578448|582120280|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
161201866|NCT00578448|582120280|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
161201867|NCT00578448|582120280|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
161309675|NCT01043705|582515536|FG002|Overall Study|Death|26|||
161309676|NCT01043705|582515534|FG000|Overall Study|Lost to Follow-up|27|||
161309677|NCT01043705|582515535|FG001|Overall Study|Lost to Follow-up|12|||
161309678|NCT01043705|582515536|FG002|Overall Study|Lost to Follow-up|0|||
161309679|NCT01043705|582515534|FG000|Overall Study|Multiple Reasons|4|||
161090975|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
161309680|NCT01043705|582515535|FG001|Overall Study|Multiple Reasons|7|||
161309681|NCT01043705|582515536|FG002|Overall Study|Multiple Reasons|0|||
161309682|NCT01043705|582515534|FG000|Overall Study|Protocol Violation|2|||
161309683|NCT01043705|582515535|FG001|Overall Study|Protocol Violation|1|||
161309684|NCT01043705|582515536|FG002|Overall Study|Protocol Violation|0|||
161309685|NCT01043705|582515534|FG000|Overall Study|Withdrawal by Subject|8|||
161309686|NCT01043705|582515535|FG001|Overall Study|Withdrawal by Subject|6|||
161309687|NCT01043705|582515536|FG002|Overall Study|Withdrawal by Subject|0|||
161309688|NCT01043705|582515534|FG000|Overall Study|Site Closure|8|||
161309689|NCT01043705|582515535|FG001|Overall Study|Site Closure|0|||
161309690|NCT01043705|582515536|FG002|Overall Study|Site Closure|0|||
161309691|NCT01043705|582515534|FG000|Overall Study|Subsequent Procedure|9|||
161309692|NCT01043705|582515535|FG001|Overall Study|Subsequent Procedure|24|||
161309693|NCT01043705|582515536|FG002|Overall Study|Subsequent Procedure|29|||
161309694|NCT01043705|582515534|FG000|Overall Study|Adverse Event|0|||
161309695|NCT01043705|582515535|FG001|Overall Study|Adverse Event|2|||
161309696|NCT01043705|582515536|FG002|Overall Study|Adverse Event|0|||
161309697|NCT01043705|582515534|FG000|Overall Study|Screen Fail|21|||
161309698|NCT01043705|582515535|FG001|Overall Study|Screen Fail|0|||
161309699|NCT01043705|582515536|FG002|Overall Study|Screen Fail|0|||
161309700|NCT01043705|582515534|FG000|Overall Study|Other|0|||
161309701|NCT01043705|582515535|FG001|Overall Study|Other|19|||
161309702|NCT01043705|582515536|FG002|Overall Study|Other|25|||
161309703|NCT02003963|582515540|FG000|Overall Study|Lost to Follow-up|2|||
161309704|NCT02003963|582515541|FG001|Overall Study|Lost to Follow-up|1|||
161309705|NCT01195844|582515542|FG000|Overall Study|Fecal sample not collected|40|||
161309706|NCT01801280|582515543|FG000|Period 1|Withdrawal by Subject|0|||
161309707|NCT01801280|582515544|FG001|Period 1|Withdrawal by Subject|1|||
161309708|NCT01801280|582515545|FG002|Period 1|Withdrawal by Subject|0|||
161309709|NCT01801280|582515546|FG003|Period 1|Withdrawal by Subject|0|||
161309710|NCT01801280|582515543|FG000|Period 2|Withdrawal by Subject|1|||
161309711|NCT01801280|582515544|FG001|Period 2|Withdrawal by Subject|0|||
161309712|NCT01801280|582515545|FG002|Period 2|Withdrawal by Subject|0|||
161309713|NCT01801280|582515546|FG003|Period 2|Withdrawal by Subject|0|||
161309714|NCT01801280|582515543|FG000|Period 4|Protocol Violation|0|||
161309715|NCT01801280|582515544|FG001|Period 4|Protocol Violation|0|||
161309716|NCT01801280|582515545|FG002|Period 4|Protocol Violation|1|||
161309717|NCT01801280|582515546|FG003|Period 4|Protocol Violation|0|||
161309718|NCT00176644|582515547|FG000|Overall Study|Withdrawal by Subject|1|||
161309719|NCT00581542|582515548|FG000|Overall Study|they met an exclusion criteria|2|||
161309720|NCT00581542|582515549|FG001|Overall Study|they met an exclusion criteria|2|||
161309721|NCT00581542|582515548|FG000|Overall Study|Lost to Follow-up|9|||
161309722|NCT00581542|582515549|FG001|Overall Study|Lost to Follow-up|21|||
161309723|NCT05020366|582515550|FG000|Overall Study|Lost to Follow-up|2|||
161309724|NCT05020366|582515551|FG001|Overall Study|Lost to Follow-up|0|||
161309725|NCT05020366|582515550|FG000|Overall Study|Withdrawal by Subject|2|||
161309726|NCT05020366|582515551|FG001|Overall Study|Withdrawal by Subject|0|||
161309727|NCT00195494|582515556|FG000|Year 1|Adverse Event|0|||
161309728|NCT00195494|582515557|FG001|Year 1|Adverse Event|0|||
161309729|NCT00195494|582515558|FG002|Year 1|Adverse Event|0|||
161309730|NCT00195494|582515559|FG003|Year 1|Adverse Event|0|||
161309731|NCT00195494|582515560|FG004|Year 1|Adverse Event|34|||
161309732|NCT00195494|582515561|FG005|Year 1|Adverse Event|27|||
161309733|NCT00195494|582515556|FG000|Year 1|System Toxicity|0|||
161309734|NCT00195494|582515557|FG001|Year 1|System Toxicity|0|||
161309735|NCT00195494|582515558|FG002|Year 1|System Toxicity|0|||
161309736|NCT00195494|582515559|FG003|Year 1|System Toxicity|0|||
161309737|NCT00195494|582515560|FG004|Year 1|System Toxicity|0|||
161090976|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
161090977|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
161090978|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
161090979|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
161090980|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
161090981|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
161090982|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
161309738|NCT00195494|582515561|FG005|Year 1|System Toxicity|1|||
161309739|NCT00195494|582515556|FG000|Year 1|Lack of Efficacy|0|||
161309740|NCT00195494|582515557|FG001|Year 1|Lack of Efficacy|0|||
161309741|NCT00195494|582515558|FG002|Year 1|Lack of Efficacy|0|||
161309742|NCT00195494|582515559|FG003|Year 1|Lack of Efficacy|0|||
161309743|NCT00195494|582515560|FG004|Year 1|Lack of Efficacy|24|||
161309744|NCT00195494|582515561|FG005|Year 1|Lack of Efficacy|9|||
161309745|NCT00195494|582515556|FG000|Year 1|Compliance|0|||
161309746|NCT00195494|582515557|FG001|Year 1|Compliance|0|||
161309747|NCT00195494|582515558|FG002|Year 1|Compliance|0|||
161201868|NCT00578448|582120280|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
161201869|NCT01976104|582120284|FG000|Overall Study|Adverse Event|0|||
161201870|NCT01976104|582120285|FG001|Overall Study|Adverse Event|0|||
161201871|NCT01976104|582120286|FG002|Overall Study|Adverse Event|1|||
161201872|NCT01976104|582120287|FG003|Overall Study|Adverse Event|0|||
161201873|NCT01976104|582120284|FG000|Overall Study|Lost to Follow-up|3|||
161201874|NCT01976104|582120285|FG001|Overall Study|Lost to Follow-up|0|||
161201875|NCT01976104|582120286|FG002|Overall Study|Lost to Follow-up|1|||
161201876|NCT01976104|582120287|FG003|Overall Study|Lost to Follow-up|1|||
161201877|NCT01976104|582120284|FG000|Overall Study|Subject Choice|0|||
161201878|NCT01976104|582120285|FG001|Overall Study|Subject Choice|1|||
161201879|NCT01976104|582120286|FG002|Overall Study|Subject Choice|0|||
161201880|NCT01976104|582120287|FG003|Overall Study|Subject Choice|1|||
161201881|NCT01976104|582120284|FG000|Overall Study|Withdrawal by Subject|3|||
161201882|NCT01976104|582120285|FG001|Overall Study|Withdrawal by Subject|0|||
161201883|NCT01976104|582120286|FG002|Overall Study|Withdrawal by Subject|0|||
161201884|NCT01976104|582120287|FG003|Overall Study|Withdrawal by Subject|1|||
161201885|NCT01976104|582120284|FG000|Overall Study|Other|0|||
161201886|NCT01976104|582120285|FG001|Overall Study|Other|1|||
161201887|NCT01976104|582120286|FG002|Overall Study|Other|0|||
161201888|NCT01976104|582120287|FG003|Overall Study|Other|0|||
161201889|NCT01317199|582120288|FG000|Dose-escalation Phase 1|Physician Decision|5|||
161201890|NCT01317199|582120289|FG001|Dose-escalation Phase 1|Physician Decision|0|||
161201891|NCT01317199|582120290|FG002|Dose-escalation Phase 1|Physician Decision|0|||
161201892|NCT01317199|582120291|FG003|Dose-escalation Phase 1|Physician Decision|0|||
161201893|NCT01317199|582120288|FG000|Dose-escalation Phase 1|Disease progression|1|||
161201894|NCT01317199|582120289|FG001|Dose-escalation Phase 1|Disease progression|0|||
161201895|NCT01317199|582120290|FG002|Dose-escalation Phase 1|Disease progression|0|||
161201896|NCT01317199|582120291|FG003|Dose-escalation Phase 1|Disease progression|0|||
161201897|NCT01317199|582120288|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
161201898|NCT01317199|582120289|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161201899|NCT01317199|582120290|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161201900|NCT01317199|582120291|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
161201901|NCT01317199|582120288|FG000|Randomized Phase 2|Disease progression|0|||
161201902|NCT01317199|582120289|FG001|Randomized Phase 2|Disease progression|3|||
161201903|NCT01317199|582120290|FG002|Randomized Phase 2|Disease progression|7|||
161201904|NCT01317199|582120291|FG003|Randomized Phase 2|Disease progression|5|||
161201905|NCT01317199|582120288|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
161201906|NCT01317199|582120289|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
161201907|NCT01317199|582120290|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
161201908|NCT01317199|582120291|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
161201909|NCT01317199|582120288|FG000|Randomized Phase 2|Adverse Event|0|||
161201910|NCT01317199|582120289|FG001|Randomized Phase 2|Adverse Event|0|||
161201911|NCT01317199|582120290|FG002|Randomized Phase 2|Adverse Event|0|||
161201912|NCT01317199|582120291|FG003|Randomized Phase 2|Adverse Event|1|||
161201913|NCT01317199|582120288|FG000|Randomized Phase 2|Comorbidities|0|||
161201914|NCT01317199|582120289|FG001|Randomized Phase 2|Comorbidities|2|||
161201915|NCT01317199|582120290|FG002|Randomized Phase 2|Comorbidities|2|||
161201916|NCT01317199|582120291|FG003|Randomized Phase 2|Comorbidities|2|||
161201917|NCT01317199|582120288|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
161201918|NCT01317199|582120289|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
161201919|NCT01317199|582120290|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
161201920|NCT01317199|582120291|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
161201921|NCT01317199|582120288|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
161201922|NCT01317199|582120289|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
161201923|NCT01317199|582120290|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
161201924|NCT01317199|582120291|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
161201925|NCT01317199|582120288|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
161201926|NCT01317199|582120289|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
161201927|NCT01317199|582120290|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
161201928|NCT01317199|582120291|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
161201929|NCT01317199|582120288|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
161201930|NCT01317199|582120289|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
161201931|NCT01317199|582120290|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
161201932|NCT01317199|582120291|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
161201933|NCT01283009|582120292|FG000|Overall Study|Death|83|||
161201934|NCT01283009|582120293|FG001|Overall Study|Death|78|||
161201935|NCT01283009|582120292|FG000|Overall Study|Study ended early|23|||
161201936|NCT01283009|582120293|FG001|Overall Study|Study ended early|26|||
161309748|NCT00195494|582515559|FG003|Year 1|Compliance|0|||
161309749|NCT00195494|582515560|FG004|Year 1|Compliance|5|||
161309750|NCT00195494|582515561|FG005|Year 1|Compliance|1|||
161309751|NCT00195494|582515556|FG000|Year 1|Lost to Follow-up|0|||
161309752|NCT00195494|582515557|FG001|Year 1|Lost to Follow-up|0|||
161309753|NCT00195494|582515558|FG002|Year 1|Lost to Follow-up|0|||
161309754|NCT00195494|582515559|FG003|Year 1|Lost to Follow-up|0|||
161309755|NCT00195494|582515560|FG004|Year 1|Lost to Follow-up|1|||
161309756|NCT00195494|582515561|FG005|Year 1|Lost to Follow-up|0|||
161309757|NCT00195494|582515556|FG000|Year 1|Missed >4 consecutive doses|0|||
161309758|NCT00195494|582515557|FG001|Year 1|Missed >4 consecutive doses|0|||
161309759|NCT00195494|582515558|FG002|Year 1|Missed >4 consecutive doses|0|||
161309760|NCT00195494|582515559|FG003|Year 1|Missed >4 consecutive doses|0|||
161309761|NCT00195494|582515560|FG004|Year 1|Missed >4 consecutive doses|3|||
161201937|NCT01283009|582120292|FG000|Overall Study|Withdrawal by Subject|10|||
161309762|NCT00195494|582515561|FG005|Year 1|Missed >4 consecutive doses|2|||
161309763|NCT00195494|582515556|FG000|Year 1|Protocol deviation|0|||
161201938|NCT01283009|582120293|FG001|Overall Study|Withdrawal by Subject|8|||
161201939|NCT01283009|582120292|FG000|Overall Study|Physician Decision|1|||
161309764|NCT00195494|582515557|FG001|Year 1|Protocol deviation|0|||
161309765|NCT00195494|582515558|FG002|Year 1|Protocol deviation|0|||
161309766|NCT00195494|582515559|FG003|Year 1|Protocol deviation|0|||
161309767|NCT00195494|582515560|FG004|Year 1|Protocol deviation|2|||
161309768|NCT00195494|582515561|FG005|Year 1|Protocol deviation|3|||
161309769|NCT00195494|582515556|FG000|Year 1|Physician Decision|0|||
161309770|NCT00195494|582515557|FG001|Year 1|Physician Decision|0|||
161201940|NCT01283009|582120293|FG001|Overall Study|Physician Decision|1|||
161201941|NCT01283009|582120292|FG000|Overall Study|Lost to Follow-up|1|||
161201942|NCT01283009|582120293|FG001|Overall Study|Lost to Follow-up|0|||
161201943|NCT01283009|582120292|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
161201944|NCT01283009|582120293|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
161201945|NCT01353209|582120294|FG000|Overall Study|Adverse Event|1|||
161201946|NCT01353209|582120295|FG001|Overall Study|Adverse Event|1|||
161201947|NCT01301625|582120308|FG000|Overall Study|Death|5|||
161201948|NCT01301625|582120308|FG000|Overall Study|Not Due|21|||
161201949|NCT01301625|582120308|FG000|Overall Study|Expected|8|||
161201950|NCT01301625|582120308|FG000|Overall Study|Lost to Follow-up|1|||
161201951|NCT00183170|582120314|FG000|First Intervention|Did not complete study|1|||
161201952|NCT00183170|582120315|FG001|First Intervention|Did not complete study|0|||
161201953|NCT00183170|582120314|FG000|First Intervention|Did not meet targeted BrAC|1|||
161201954|NCT00183170|582120315|FG001|First Intervention|Did not meet targeted BrAC|0|||
161201955|NCT00183170|582120314|FG000|Washout 1 Week|Did not complete study|6|||
161201956|NCT00183170|582120315|FG001|Washout 1 Week|Did not complete study|8|||
161201957|NCT00183170|582120314|FG000|Second Intervention|Did not complete study|1|||
161201958|NCT00183170|582120315|FG001|Second Intervention|Did not complete study|0|||
161201959|NCT00183170|582120314|FG000|Second Intervention|Did not meet targeted BrAC|0|||
161201960|NCT00183170|582120315|FG001|Second Intervention|Did not meet targeted BrAC|2|||
161201961|NCT05102162|582120316|FG000|Overall Study|Withdrawal by Subject|3|||
161201962|NCT05102162|582120317|FG001|Overall Study|Withdrawal by Subject|0|||
161201963|NCT05102162|582120316|FG000|Overall Study|Baseline cultures negative|4|||
161201964|NCT05102162|582120317|FG001|Overall Study|Baseline cultures negative|2|||
161201965|NCT05102162|582120316|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
161201966|NCT05102162|582120317|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
161201967|NCT05102162|582120316|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
161201968|NCT05102162|582120317|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
161201969|NCT02181673|582120320|FG000|Up to Week 24|Adverse Event|2|||
161201970|NCT02181673|582120321|FG001|Up to Week 24|Adverse Event|0|||
161201971|NCT02181673|582120322|FG002|Up to Week 24|Adverse Event|3|||
161201972|NCT02181673|582120320|FG000|Up to Week 24|Death|1|||
161201973|NCT02181673|582120321|FG001|Up to Week 24|Death|0|||
161201974|NCT02181673|582120322|FG002|Up to Week 24|Death|0|||
161201975|NCT02181673|582120320|FG000|Up to Week 24|Lack of Efficacy|1|||
161201976|NCT02181673|582120321|FG001|Up to Week 24|Lack of Efficacy|0|||
161201977|NCT02181673|582120322|FG002|Up to Week 24|Lack of Efficacy|0|||
161201978|NCT02181673|582120320|FG000|Up to Week 24|Lost to Follow-up|1|||
161201979|NCT02181673|582120321|FG001|Up to Week 24|Lost to Follow-up|0|||
161201980|NCT02181673|582120322|FG002|Up to Week 24|Lost to Follow-up|0|||
161201981|NCT02181673|582120320|FG000|Up to Week 24|Physician Decision|0|||
161201982|NCT02181673|582120321|FG001|Up to Week 24|Physician Decision|0|||
161201983|NCT02181673|582120322|FG002|Up to Week 24|Physician Decision|3|||
161201984|NCT02181673|582120320|FG000|Up to Week 24|Withdrawal by Subject|10|||
161201985|NCT02181673|582120321|FG001|Up to Week 24|Withdrawal by Subject|0|||
161201986|NCT02181673|582120322|FG002|Up to Week 24|Withdrawal by Subject|1|||
161201987|NCT02181673|582120320|FG000|Up to Week 24|Other|2|||
161201988|NCT02181673|582120321|FG001|Up to Week 24|Other|0|||
161201989|NCT02181673|582120322|FG002|Up to Week 24|Other|3|||
161201990|NCT02181673|582120320|FG000|Up to Week 24|Randomized not Treated|0|||
161201991|NCT02181673|582120321|FG001|Up to Week 24|Randomized not Treated|0|||
161201992|NCT02181673|582120322|FG002|Up to Week 24|Randomized not Treated|1|||
161201993|NCT02181673|582120320|FG000|Week 24-Week 60|Adverse Event|0|||
161201994|NCT02181673|582120321|FG001|Week 24-Week 60|Adverse Event|4|||
161201995|NCT02181673|582120322|FG002|Week 24-Week 60|Adverse Event|10|||
161201996|NCT02181673|582120320|FG000|Week 24-Week 60|Other|0|||
161201997|NCT02181673|582120321|FG001|Week 24-Week 60|Other|2|||
161201998|NCT02181673|582120322|FG002|Week 24-Week 60|Other|1|||
161201999|NCT02181673|582120320|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
161202000|NCT02181673|582120321|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
161202001|NCT02181673|582120322|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
161202002|NCT02181673|582120320|FG000|Week 24-Week 60|Pregnancy|0|||
161202003|NCT02181673|582120321|FG001|Week 24-Week 60|Pregnancy|0|||
161202004|NCT02181673|582120322|FG002|Week 24-Week 60|Pregnancy|1|||
161202005|NCT02181673|582120320|FG000|Week 24-Week 60|Lack of Efficacy|0|||
161202006|NCT02181673|582120321|FG001|Week 24-Week 60|Lack of Efficacy|0|||
161202007|NCT02181673|582120322|FG002|Week 24-Week 60|Lack of Efficacy|1|||
161202008|NCT02181673|582120320|FG000|Week 24-Week 60|Lost to Follow-up|0|||
161202009|NCT02181673|582120321|FG001|Week 24-Week 60|Lost to Follow-up|0|||
161202010|NCT02181673|582120322|FG002|Week 24-Week 60|Lost to Follow-up|1|||
161202011|NCT02181673|582120320|FG000|Week 24-Week 60|Physician Decision|0|||
161202012|NCT02181673|582120321|FG001|Week 24-Week 60|Physician Decision|0|||
161202013|NCT02181673|582120322|FG002|Week 24-Week 60|Physician Decision|1|||
161202014|NCT00433771|582120323|FG000|Overall Study|screen fail|14|||
161202015|NCT00433771|582120323|FG000|Overall Study|Treated and later found to be ineligible|2|||
161202016|NCT00433771|582120323|FG000|Overall Study|Death|2|||
161202017|NCT00433771|582120323|FG000|Overall Study|Failure to deploy stent|1|||
161202018|NCT00138658|582120324|FG000|Overall Study|Adverse Event|23|||
161202019|NCT00138658|582120324|FG000|Overall Study|Death|1|||
161202020|NCT00138658|582120324|FG000|Overall Study|Disease Progression|21|||
161202021|NCT00138658|582120324|FG000|Overall Study|Physician Decision|11|||
161202022|NCT00138658|582120324|FG000|Overall Study|Withdrawal by Subject|5|||
161202023|NCT00337727|582120329|FG000|Overall Study|Adverse Event|5|||
161202024|NCT00337727|582120330|FG001|Overall Study|Adverse Event|3|||
161202025|NCT00337727|582120329|FG000|Overall Study|Lost to Follow-up|5|||
161202026|NCT00337727|582120330|FG001|Overall Study|Lost to Follow-up|4|||
161202027|NCT00337727|582120329|FG000|Overall Study|Physician Decision|1|||
161202028|NCT00337727|582120330|FG001|Overall Study|Physician Decision|0|||
161202029|NCT00337727|582120329|FG000|Overall Study|Protocol Violation|4|||
161202030|NCT00337727|582120330|FG001|Overall Study|Protocol Violation|0|||
161202031|NCT00337727|582120329|FG000|Overall Study|Withdrawal by Subject|3|||
161202032|NCT00337727|582120330|FG001|Overall Study|Withdrawal by Subject|5|||
161202033|NCT00320801|582120331|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
161202034|NCT00320801|582120332|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
161202035|NCT00320801|582120333|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
161202036|NCT00320801|582120334|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
161202037|NCT00320801|582120331|FG000|Open-label Run-in Period|Adverse Event|33|||
161202038|NCT00320801|582120332|FG001|Open-label Run-in Period|Adverse Event|0|||
161202039|NCT00320801|582120333|FG002|Open-label Run-in Period|Adverse Event|0|||
161202040|NCT00320801|582120334|FG003|Open-label Run-in Period|Adverse Event|0|||
161202041|NCT00320801|582120331|FG000|Open-label Run-in Period|Administrative|10|||
161202042|NCT00320801|582120332|FG001|Open-label Run-in Period|Administrative|0|||
161202043|NCT00320801|582120333|FG002|Open-label Run-in Period|Administrative|0|||
161202044|NCT00320801|582120334|FG003|Open-label Run-in Period|Administrative|0|||
161202045|NCT00320801|582120331|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
161202046|NCT00320801|582120332|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
161202047|NCT00320801|582120333|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
161202048|NCT00320801|582120334|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
161202049|NCT00320801|582120331|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
161202050|NCT00320801|582120332|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
161202051|NCT00320801|582120333|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
161202052|NCT00320801|582120334|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
161202053|NCT00320801|582120331|FG000|Open-label Run-in Period|Did not qualify|1|||
161202054|NCT00320801|582120332|FG001|Open-label Run-in Period|Did not qualify|0|||
161202055|NCT00320801|582120333|FG002|Open-label Run-in Period|Did not qualify|0|||
161202056|NCT00320801|582120334|FG003|Open-label Run-in Period|Did not qualify|0|||
161202057|NCT00320801|582120331|FG000|Double-blind Phase|Withdrawal by Subject|0|||
161202058|NCT00320801|582120332|FG001|Double-blind Phase|Withdrawal by Subject|0|||
161202059|NCT00320801|582120333|FG002|Double-blind Phase|Withdrawal by Subject|1|||
161202060|NCT00320801|582120334|FG003|Double-blind Phase|Withdrawal by Subject|0|||
161202061|NCT00320801|582120331|FG000|Double-blind Phase|Adverse Event|0|||
161202062|NCT00320801|582120332|FG001|Double-blind Phase|Adverse Event|2|||
161202063|NCT00320801|582120333|FG002|Double-blind Phase|Adverse Event|8|||
161202064|NCT00320801|582120334|FG003|Double-blind Phase|Adverse Event|0|||
161202065|NCT00320801|582120331|FG000|Double-blind Phase|Administrative|0|||
161202066|NCT00320801|582120332|FG001|Double-blind Phase|Administrative|0|||
161202067|NCT00320801|582120333|FG002|Double-blind Phase|Administrative|4|||
161202068|NCT00320801|582120334|FG003|Double-blind Phase|Administrative|0|||
161202069|NCT00320801|582120331|FG000|Double-blind Phase|Lack of Efficacy|0|||
161309771|NCT00195494|582515558|FG002|Year 1|Physician Decision|0|||
161309772|NCT00195494|582515559|FG003|Year 1|Physician Decision|0|||
161309773|NCT00195494|582515560|FG004|Year 1|Physician Decision|1|||
161309774|NCT00195494|582515561|FG005|Year 1|Physician Decision|0|||
161309775|NCT00195494|582515556|FG000|Year 1|Withdrawal by Subject|0|||
161202070|NCT00320801|582120332|FG001|Double-blind Phase|Lack of Efficacy|9|||
161202071|NCT00320801|582120333|FG002|Double-blind Phase|Lack of Efficacy|1|||
161309776|NCT00195494|582515557|FG001|Year 1|Withdrawal by Subject|0|||
161309777|NCT00195494|582515558|FG002|Year 1|Withdrawal by Subject|0|||
161309778|NCT00195494|582515559|FG003|Year 1|Withdrawal by Subject|0|||
161202072|NCT00320801|582120334|FG003|Double-blind Phase|Lack of Efficacy|0|||
161202073|NCT00320801|582120331|FG000|Extension Phase|Withdrawal by Subject|0|||
161202074|NCT00320801|582120332|FG001|Extension Phase|Withdrawal by Subject|0|||
161202075|NCT00320801|582120333|FG002|Extension Phase|Withdrawal by Subject|0|||
161202076|NCT00320801|582120334|FG003|Extension Phase|Withdrawal by Subject|6|||
161202077|NCT00320801|582120331|FG000|Extension Phase|Adverse Event|0|||
161202078|NCT00320801|582120332|FG001|Extension Phase|Adverse Event|0|||
161202079|NCT00320801|582120333|FG002|Extension Phase|Adverse Event|0|||
161202080|NCT00320801|582120334|FG003|Extension Phase|Adverse Event|8|||
161202081|NCT00320801|582120331|FG000|Extension Phase|Administrative|0|||
161202082|NCT00320801|582120332|FG001|Extension Phase|Administrative|0|||
161202083|NCT00320801|582120333|FG002|Extension Phase|Administrative|0|||
161202084|NCT00320801|582120334|FG003|Extension Phase|Administrative|29|||
161309779|NCT00195494|582515560|FG004|Year 1|Withdrawal by Subject|8|||
161309780|NCT00195494|582515561|FG005|Year 1|Withdrawal by Subject|9|||
161309781|NCT00195494|582515556|FG000|Year 1|Protocol Violation|0|||
161202085|NCT00320801|582120331|FG000|Extension Phase|Lack of Efficacy|0|||
161202086|NCT00320801|582120332|FG001|Extension Phase|Lack of Efficacy|0|||
161202087|NCT00320801|582120333|FG002|Extension Phase|Lack of Efficacy|0|||
161202088|NCT00320801|582120334|FG003|Extension Phase|Lack of Efficacy|2|||
161202089|NCT00320801|582120331|FG000|Extension Phase|Lost to Follow-up|0|||
161202090|NCT00320801|582120332|FG001|Extension Phase|Lost to Follow-up|0|||
161202091|NCT00320801|582120333|FG002|Extension Phase|Lost to Follow-up|0|||
161202092|NCT00320801|582120334|FG003|Extension Phase|Lost to Follow-up|3|||
161202093|NCT00491322|582120336|FG000|Overall Study|Protocol Violation|1|||
161202094|NCT00491322|582120337|FG001|Overall Study|Protocol Violation|0|||
161202095|NCT00491322|582120336|FG000|Overall Study|Pregnancy|0|||
161202096|NCT00491322|582120337|FG001|Overall Study|Pregnancy|1|||
161202097|NCT06067191|582120341|FG000|Overall Study|Withdrawal by Subject|0|||
161202098|NCT06067191|582120342|FG001|Overall Study|Withdrawal by Subject|1|||
161202099|NCT00807040|582120345|FG000|Overall Study|Death|24|||
161202100|NCT00807040|582120346|FG001|Overall Study|Death|29|||
161202101|NCT00807040|582120345|FG000|Overall Study|Withdrawal by Subject|8|||
161202102|NCT00807040|582120346|FG001|Overall Study|Withdrawal by Subject|6|||
161202103|NCT00807040|582120345|FG000|Overall Study|Lost to Follow-up|4|||
161202104|NCT00807040|582120346|FG001|Overall Study|Lost to Follow-up|6|||
161202105|NCT01067339|582120347|FG000|Overall Study|Withdrawal by Subject|6|||
161202106|NCT01067339|582120348|FG001|Overall Study|Withdrawal by Subject|5|||
161202107|NCT00572910|582120351|FG000|Overall Study|Adverse Event|1|||
161202108|NCT00572910|582120352|FG001|Overall Study|Adverse Event|2|||
161202109|NCT00572910|582120353|FG002|Overall Study|Adverse Event|0|||
161202110|NCT00572910|582120354|FG003|Overall Study|Adverse Event|2|||
161202111|NCT00572910|582120355|FG004|Overall Study|Adverse Event|0|||
161202112|NCT00572910|582120356|FG005|Overall Study|Adverse Event|0|||
161202113|NCT00572910|582120357|FG006|Overall Study|Adverse Event|4|||
161202114|NCT00572910|582120358|FG007|Overall Study|Adverse Event|2|||
161202115|NCT00572910|582120359|FG008|Overall Study|Adverse Event|1|||
161202116|NCT00572910|582120360|FG009|Overall Study|Adverse Event|3|||
161202117|NCT00572910|582120361|FG010|Overall Study|Adverse Event|2|||
161202118|NCT00572910|582120351|FG000|Overall Study|Lost to Follow-up|0|||
161202119|NCT00572910|582120352|FG001|Overall Study|Lost to Follow-up|1|||
161202120|NCT00572910|582120353|FG002|Overall Study|Lost to Follow-up|1|||
161202121|NCT00572910|582120354|FG003|Overall Study|Lost to Follow-up|2|||
161202122|NCT00572910|582120355|FG004|Overall Study|Lost to Follow-up|1|||
161202123|NCT00572910|582120356|FG005|Overall Study|Lost to Follow-up|0|||
161202124|NCT00572910|582120357|FG006|Overall Study|Lost to Follow-up|0|||
161202125|NCT00572910|582120358|FG007|Overall Study|Lost to Follow-up|0|||
161202126|NCT00572910|582120359|FG008|Overall Study|Lost to Follow-up|0|||
161202127|NCT00572910|582120360|FG009|Overall Study|Lost to Follow-up|1|||
161202128|NCT00572910|582120361|FG010|Overall Study|Lost to Follow-up|0|||
161202129|NCT00572910|582120351|FG000|Overall Study|Withdrawal by Subject|3|||
161202130|NCT00572910|582120352|FG001|Overall Study|Withdrawal by Subject|0|||
161202131|NCT00572910|582120353|FG002|Overall Study|Withdrawal by Subject|1|||
161202132|NCT00572910|582120354|FG003|Overall Study|Withdrawal by Subject|0|||
161202133|NCT00572910|582120355|FG004|Overall Study|Withdrawal by Subject|1|||
161202134|NCT00572910|582120356|FG005|Overall Study|Withdrawal by Subject|3|||
161202135|NCT00572910|582120357|FG006|Overall Study|Withdrawal by Subject|0|||
161202136|NCT00572910|582120358|FG007|Overall Study|Withdrawal by Subject|2|||
161202137|NCT00572910|582120359|FG008|Overall Study|Withdrawal by Subject|2|||
161202138|NCT00572910|582120360|FG009|Overall Study|Withdrawal by Subject|2|||
161202139|NCT00572910|582120361|FG010|Overall Study|Withdrawal by Subject|1|||
161202140|NCT01870921|582120364|FG000|Overall Study|Subject decision|80|||
161202141|NCT01870921|582120364|FG000|Overall Study|Severe non-compliance to protocol|7|||
161202142|NCT01870921|582120364|FG000|Overall Study|Subject Lost to Follow up|2|||
161202143|NCT01870921|582120364|FG000|Overall Study|Other|1|||
161202144|NCT00806416|582120365|FG000|Period 1 - Part I|Adverse Event|0|||
161202145|NCT00806416|582120366|FG001|Period 1 - Part I|Adverse Event|1|||
161202146|NCT00806416|582120367|FG002|Period 1 - Part I|Adverse Event|0|||
161202147|NCT00806416|582120368|FG003|Period 1 - Part I|Adverse Event|0|||
161202148|NCT00806416|582120365|FG000|Period 1 - Part I|Lost to Follow-up|0|||
161202149|NCT00806416|582120366|FG001|Period 1 - Part I|Lost to Follow-up|2|||
161202150|NCT00806416|582120367|FG002|Period 1 - Part I|Lost to Follow-up|0|||
161202151|NCT00806416|582120368|FG003|Period 1 - Part I|Lost to Follow-up|0|||
161309782|NCT00195494|582515557|FG001|Year 1|Protocol Violation|0|||
161202152|NCT00806416|582120365|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
161202153|NCT00806416|582120366|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
161202154|NCT00806416|582120367|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
161202155|NCT00806416|582120368|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
161202156|NCT00806416|582120365|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
161202157|NCT00806416|582120366|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
161202158|NCT00806416|582120367|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
161202159|NCT00806416|582120368|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
161202160|NCT01102972|582120374|FG000|Overall Study|Adverse Event|8|||
161202161|NCT01102972|582120375|FG001|Overall Study|Adverse Event|2|||
161202162|NCT01102972|582120374|FG000|Overall Study|Lack of Efficacy|2|||
161202163|NCT01102972|582120375|FG001|Overall Study|Lack of Efficacy|1|||
161202164|NCT01102972|582120374|FG000|Overall Study|Protocol Violation|1|||
161202165|NCT01102972|582120375|FG001|Overall Study|Protocol Violation|0|||
161202166|NCT01102972|582120374|FG000|Overall Study|Lost to Follow-up|10|||
161202167|NCT01102972|582120375|FG001|Overall Study|Lost to Follow-up|5|||
161202168|NCT01102972|582120374|FG000|Overall Study|Investigator Discretion|2|||
161202169|NCT01102972|582120375|FG001|Overall Study|Investigator Discretion|0|||
161202170|NCT01102972|582120374|FG000|Overall Study|Withdrawal by Subject|6|||
161202171|NCT01102972|582120375|FG001|Overall Study|Withdrawal by Subject|6|||
161202172|NCT01157065|582120379|FG000|Overall Study|Death|0|||
161202173|NCT01157065|582120380|FG001|Overall Study|Death|1|||
161202174|NCT05275673|582120383|FG000|Overall Study|Study Termination by Sponsor|2|||
161202175|NCT05275673|582120384|FG001|Overall Study|Study Termination by Sponsor|3|||
161202176|NCT05275673|582120383|FG000|Overall Study|Death|1|||
161202177|NCT05275673|582120384|FG001|Overall Study|Death|0|||
161202178|NCT05275673|582120383|FG000|Overall Study|Withdrawal by Subject|1|||
161202179|NCT05275673|582120384|FG001|Overall Study|Withdrawal by Subject|0|||
161202180|NCT02325739|582120385|FG000|Phase I Part|Adverse Event|1|||
161202181|NCT02325739|582120386|FG001|Phase I Part|Adverse Event|0|||
161202182|NCT02325739|582120387|FG002|Phase I Part|Adverse Event|1|||
161202183|NCT02325739|582120388|FG003|Phase I Part|Adverse Event|2|||
161202184|NCT02325739|582120389|FG004|Phase I Part|Adverse Event|3|||
161202185|NCT02325739|582120390|FG005|Phase I Part|Adverse Event|1|||
161202186|NCT02325739|582120391|FG006|Phase I Part|Adverse Event|0|||
161202187|NCT02325739|582120392|FG007|Phase I Part|Adverse Event|2|||
161202188|NCT02325739|582120393|FG008|Phase I Part|Adverse Event|0|||
161202189|NCT02325739|582120394|FG009|Phase I Part|Adverse Event|0|||
161202190|NCT02325739|582120395|FG010|Phase I Part|Adverse Event|0|||
161202191|NCT02325739|582120385|FG000|Phase I Part|Progressive disease|9|||
161202192|NCT02325739|582120386|FG001|Phase I Part|Progressive disease|6|||
161202193|NCT02325739|582120387|FG002|Phase I Part|Progressive disease|3|||
161202194|NCT02325739|582120388|FG003|Phase I Part|Progressive disease|23|||
161202195|NCT02325739|582120389|FG004|Phase I Part|Progressive disease|14|||
161202196|NCT02325739|582120390|FG005|Phase I Part|Progressive disease|6|||
161202197|NCT02325739|582120391|FG006|Phase I Part|Progressive disease|6|||
161202198|NCT02325739|582120392|FG007|Phase I Part|Progressive disease|3|||
161202199|NCT02325739|582120393|FG008|Phase I Part|Progressive disease|0|||
161202200|NCT02325739|582120394|FG009|Phase I Part|Progressive disease|0|||
161202201|NCT02325739|582120395|FG010|Phase I Part|Progressive disease|0|||
161202202|NCT02325739|582120385|FG000|Phase I Part|Subject/guardian decision|1|||
161202203|NCT02325739|582120386|FG001|Phase I Part|Subject/guardian decision|0|||
161202204|NCT02325739|582120387|FG002|Phase I Part|Subject/guardian decision|1|||
161202205|NCT02325739|582120388|FG003|Phase I Part|Subject/guardian decision|1|||
161202206|NCT02325739|582120389|FG004|Phase I Part|Subject/guardian decision|0|||
161202207|NCT02325739|582120390|FG005|Phase I Part|Subject/guardian decision|0|||
161202208|NCT02325739|582120391|FG006|Phase I Part|Subject/guardian decision|0|||
161202209|NCT02325739|582120392|FG007|Phase I Part|Subject/guardian decision|1|||
161202210|NCT02325739|582120393|FG008|Phase I Part|Subject/guardian decision|0|||
161202211|NCT02325739|582120394|FG009|Phase I Part|Subject/guardian decision|0|||
161202212|NCT02325739|582120395|FG010|Phase I Part|Subject/guardian decision|0|||
161202213|NCT02325739|582120385|FG000|Phase I Part|Death|0|||
161202214|NCT02325739|582120386|FG001|Phase I Part|Death|0|||
161202215|NCT02325739|582120387|FG002|Phase I Part|Death|0|||
161202216|NCT02325739|582120388|FG003|Phase I Part|Death|0|||
161202217|NCT02325739|582120389|FG004|Phase I Part|Death|2|||
161202218|NCT02325739|582120390|FG005|Phase I Part|Death|0|||
161202219|NCT02325739|582120391|FG006|Phase I Part|Death|0|||
161202220|NCT02325739|582120392|FG007|Phase I Part|Death|0|||
161202221|NCT02325739|582120393|FG008|Phase I Part|Death|0|||
161202222|NCT02325739|582120394|FG009|Phase I Part|Death|0|||
161202223|NCT02325739|582120395|FG010|Phase I Part|Death|0|||
161202224|NCT02325739|582120385|FG000|Phase II Part|Adverse Event|0|||
161202225|NCT02325739|582120386|FG001|Phase II Part|Adverse Event|0|||
161202226|NCT02325739|582120387|FG002|Phase II Part|Adverse Event|0|||
161202227|NCT02325739|582120388|FG003|Phase II Part|Adverse Event|0|||
161202228|NCT02325739|582120389|FG004|Phase II Part|Adverse Event|0|||
161202229|NCT02325739|582120390|FG005|Phase II Part|Adverse Event|0|||
161202230|NCT02325739|582120391|FG006|Phase II Part|Adverse Event|0|||
161202231|NCT02325739|582120392|FG007|Phase II Part|Adverse Event|0|||
161202232|NCT02325739|582120393|FG008|Phase II Part|Adverse Event|4|||
161202233|NCT02325739|582120394|FG009|Phase II Part|Adverse Event|5|||
161202234|NCT02325739|582120395|FG010|Phase II Part|Adverse Event|1|||
161202235|NCT02325739|582120385|FG000|Phase II Part|Physician Decision|0|||
161202236|NCT02325739|582120386|FG001|Phase II Part|Physician Decision|0|||
161202237|NCT02325739|582120387|FG002|Phase II Part|Physician Decision|0|||
161202238|NCT02325739|582120388|FG003|Phase II Part|Physician Decision|0|||
161202239|NCT02325739|582120389|FG004|Phase II Part|Physician Decision|0|||
161202240|NCT02325739|582120390|FG005|Phase II Part|Physician Decision|0|||
161202241|NCT02325739|582120391|FG006|Phase II Part|Physician Decision|0|||
161202242|NCT02325739|582120392|FG007|Phase II Part|Physician Decision|0|||
161202243|NCT02325739|582120393|FG008|Phase II Part|Physician Decision|0|||
161202244|NCT02325739|582120394|FG009|Phase II Part|Physician Decision|1|||
161202245|NCT02325739|582120395|FG010|Phase II Part|Physician Decision|0|||
161202246|NCT02325739|582120385|FG000|Phase II Part|Progressive disease|0|||
161202247|NCT02325739|582120386|FG001|Phase II Part|Progressive disease|0|||
161202248|NCT02325739|582120387|FG002|Phase II Part|Progressive disease|0|||
161202249|NCT02325739|582120388|FG003|Phase II Part|Progressive disease|0|||
161202250|NCT02325739|582120389|FG004|Phase II Part|Progressive disease|0|||
161202251|NCT02325739|582120390|FG005|Phase II Part|Progressive disease|0|||
161202252|NCT02325739|582120391|FG006|Phase II Part|Progressive disease|0|||
161202253|NCT02325739|582120392|FG007|Phase II Part|Progressive disease|0|||
161202254|NCT02325739|582120393|FG008|Phase II Part|Progressive disease|22|||
161202255|NCT02325739|582120394|FG009|Phase II Part|Progressive disease|29|||
161202256|NCT02325739|582120395|FG010|Phase II Part|Progressive disease|18|||
161202257|NCT02325739|582120385|FG000|Phase II Part|Subject/guardian decision|0|||
161202258|NCT02325739|582120386|FG001|Phase II Part|Subject/guardian decision|0|||
161202259|NCT02325739|582120387|FG002|Phase II Part|Subject/guardian decision|0|||
161202260|NCT02325739|582120388|FG003|Phase II Part|Subject/guardian decision|0|||
161202261|NCT02325739|582120389|FG004|Phase II Part|Subject/guardian decision|0|||
161202262|NCT02325739|582120390|FG005|Phase II Part|Subject/guardian decision|0|||
161202263|NCT02325739|582120391|FG006|Phase II Part|Subject/guardian decision|0|||
161202264|NCT02325739|582120392|FG007|Phase II Part|Subject/guardian decision|0|||
161202265|NCT02325739|582120393|FG008|Phase II Part|Subject/guardian decision|4|||
161202266|NCT02325739|582120394|FG009|Phase II Part|Subject/guardian decision|1|||
161202267|NCT02325739|582120395|FG010|Phase II Part|Subject/guardian decision|1|||
161202268|NCT03426995|582120396|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202269|NCT03426995|582120397|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202270|NCT03426995|582120398|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
161202271|NCT03426995|582120399|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202272|NCT03426995|582120400|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202273|NCT03426995|582120401|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202274|NCT03426995|582120402|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202275|NCT03426995|582120403|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202276|NCT03426995|582120404|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202277|NCT03426995|582120405|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202278|NCT03426995|582120406|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202279|NCT03426995|582120407|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202280|NCT03426995|582120408|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202281|NCT03426995|582120409|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202282|NCT03426995|582120410|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202283|NCT03426995|582120411|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202284|NCT03426995|582120412|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202285|NCT03426995|582120413|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202286|NCT03426995|582120414|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
161202287|NCT03426995|582120396|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202288|NCT03426995|582120397|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202289|NCT03426995|582120398|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202290|NCT03426995|582120399|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202291|NCT03426995|582120400|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202292|NCT03426995|582120401|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
161202293|NCT03426995|582120402|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202294|NCT03426995|582120403|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202295|NCT03426995|582120404|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202296|NCT03426995|582120405|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202297|NCT03426995|582120406|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202298|NCT03426995|582120407|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202299|NCT03426995|582120408|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202300|NCT03426995|582120409|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202301|NCT03426995|582120410|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202302|NCT03426995|582120411|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202303|NCT03426995|582120412|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202304|NCT03426995|582120413|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202305|NCT03426995|582120414|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
161202306|NCT03426995|582120396|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202307|NCT03426995|582120397|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202308|NCT03426995|582120398|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202309|NCT03426995|582120399|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202310|NCT03426995|582120400|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
161202311|NCT03426995|582120401|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
161202312|NCT03426995|582120402|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202313|NCT03426995|582120403|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202314|NCT03426995|582120404|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202315|NCT03426995|582120405|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202316|NCT03426995|582120406|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202317|NCT03426995|582120407|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202318|NCT03426995|582120408|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202319|NCT03426995|582120409|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202320|NCT03426995|582120410|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202321|NCT03426995|582120411|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202322|NCT03426995|582120412|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202323|NCT03426995|582120413|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202324|NCT03426995|582120414|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
161202325|NCT03426995|582120396|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202326|NCT03426995|582120397|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202327|NCT03426995|582120398|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202328|NCT03426995|582120399|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202329|NCT03426995|582120400|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202330|NCT03426995|582120401|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202331|NCT03426995|582120402|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202332|NCT03426995|582120403|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202333|NCT03426995|582120404|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202334|NCT03426995|582120405|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202335|NCT03426995|582120406|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
161202336|NCT03426995|582120407|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202337|NCT03426995|582120408|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202338|NCT03426995|582120409|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202339|NCT03426995|582120410|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202340|NCT03426995|582120411|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202341|NCT03426995|582120412|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202342|NCT03426995|582120413|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202343|NCT03426995|582120414|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
161202344|NCT03426995|582120396|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202345|NCT03426995|582120397|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202346|NCT03426995|582120398|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202347|NCT03426995|582120399|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202348|NCT03426995|582120400|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202349|NCT03426995|582120401|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202350|NCT03426995|582120402|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202351|NCT03426995|582120403|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
161202352|NCT03426995|582120404|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202353|NCT03426995|582120405|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202354|NCT03426995|582120406|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202355|NCT03426995|582120407|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202356|NCT03426995|582120408|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202357|NCT03426995|582120409|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202358|NCT03426995|582120410|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202359|NCT03426995|582120411|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202360|NCT03426995|582120412|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202361|NCT03426995|582120413|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202362|NCT03426995|582120414|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
161202363|NCT03426995|582120396|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202364|NCT03426995|582120397|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202365|NCT03426995|582120398|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202366|NCT03426995|582120399|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202367|NCT03426995|582120400|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202368|NCT03426995|582120401|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202369|NCT03426995|582120402|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202370|NCT03426995|582120403|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202371|NCT03426995|582120404|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202372|NCT03426995|582120405|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202373|NCT03426995|582120406|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202374|NCT03426995|582120407|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202375|NCT03426995|582120408|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202376|NCT03426995|582120409|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202377|NCT03426995|582120410|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
161202378|NCT03426995|582120411|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
161202379|NCT03426995|582120412|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202380|NCT03426995|582120413|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202381|NCT03426995|582120414|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
161202382|NCT03426995|582120396|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202383|NCT03426995|582120397|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202384|NCT03426995|582120398|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202385|NCT03426995|582120399|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202386|NCT03426995|582120400|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202387|NCT03426995|582120401|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202388|NCT03426995|582120402|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202389|NCT03426995|582120403|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202390|NCT03426995|582120404|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202391|NCT03426995|582120405|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202392|NCT03426995|582120406|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202393|NCT03426995|582120407|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202394|NCT03426995|582120408|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202395|NCT03426995|582120409|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202396|NCT03426995|582120410|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
161309783|NCT00195494|582515558|FG002|Year 1|Protocol Violation|0|||
161309784|NCT00195494|582515559|FG003|Year 1|Protocol Violation|0|||
161309785|NCT00195494|582515560|FG004|Year 1|Protocol Violation|1|||
161309786|NCT00195494|582515561|FG005|Year 1|Protocol Violation|1|||
161309787|NCT00195494|582515556|FG000|Year 2|Adverse Event|3|||
161309788|NCT00195494|582515557|FG001|Year 2|Adverse Event|7|||
161309789|NCT00195494|582515558|FG002|Year 2|Adverse Event|5|||
161309790|NCT00195494|582515559|FG003|Year 2|Adverse Event|9|||
161309791|NCT00195494|582515560|FG004|Year 2|Adverse Event|0|||
161309792|NCT00195494|582515561|FG005|Year 2|Adverse Event|0|||
161309793|NCT00195494|582515556|FG000|Year 2|Lack of Efficacy|0|||
161309794|NCT00195494|582515557|FG001|Year 2|Lack of Efficacy|1|||
161309795|NCT00195494|582515558|FG002|Year 2|Lack of Efficacy|7|||
161309796|NCT00195494|582515559|FG003|Year 2|Lack of Efficacy|7|||
161309797|NCT00195494|582515560|FG004|Year 2|Lack of Efficacy|0|||
161309798|NCT00195494|582515561|FG005|Year 2|Lack of Efficacy|0|||
161309799|NCT00195494|582515556|FG000|Year 2|Compliance|1|||
161309800|NCT00195494|582515557|FG001|Year 2|Compliance|0|||
161309801|NCT00195494|582515558|FG002|Year 2|Compliance|0|||
161309802|NCT00195494|582515559|FG003|Year 2|Compliance|2|||
161309803|NCT00195494|582515560|FG004|Year 2|Compliance|0|||
161309804|NCT00195494|582515561|FG005|Year 2|Compliance|0|||
161309805|NCT00195494|582515556|FG000|Year 2|Lost to Follow-up|0|||
161309806|NCT00195494|582515557|FG001|Year 2|Lost to Follow-up|0|||
161309807|NCT00195494|582515558|FG002|Year 2|Lost to Follow-up|1|||
161309808|NCT00195494|582515559|FG003|Year 2|Lost to Follow-up|1|||
161309809|NCT00195494|582515560|FG004|Year 2|Lost to Follow-up|0|||
161309810|NCT00195494|582515561|FG005|Year 2|Lost to Follow-up|0|||
161309811|NCT00195494|582515556|FG000|Year 2|Missed >4 consecutive doses|1|||
161309812|NCT00195494|582515557|FG001|Year 2|Missed >4 consecutive doses|1|||
161309813|NCT00195494|582515558|FG002|Year 2|Missed >4 consecutive doses|1|||
161309814|NCT00195494|582515559|FG003|Year 2|Missed >4 consecutive doses|0|||
161309815|NCT00195494|582515560|FG004|Year 2|Missed >4 consecutive doses|0|||
161309816|NCT00195494|582515561|FG005|Year 2|Missed >4 consecutive doses|0|||
161309817|NCT00195494|582515556|FG000|Year 2|Protocol deviation|0|||
161309818|NCT00195494|582515557|FG001|Year 2|Protocol deviation|1|||
161309819|NCT00195494|582515558|FG002|Year 2|Protocol deviation|0|||
161309820|NCT00195494|582515559|FG003|Year 2|Protocol deviation|0|||
161309821|NCT00195494|582515560|FG004|Year 2|Protocol deviation|0|||
161309822|NCT00195494|582515561|FG005|Year 2|Protocol deviation|0|||
161309823|NCT00195494|582515556|FG000|Year 2|Physician Decision|1|||
161309824|NCT00195494|582515557|FG001|Year 2|Physician Decision|1|||
161309825|NCT00195494|582515558|FG002|Year 2|Physician Decision|0|||
161309826|NCT00195494|582515559|FG003|Year 2|Physician Decision|0|||
161309827|NCT00195494|582515560|FG004|Year 2|Physician Decision|0|||
161309828|NCT00195494|582515561|FG005|Year 2|Physician Decision|0|||
161309829|NCT00195494|582515556|FG000|Year 2|Withdrawal by Subject|1|||
161309830|NCT00195494|582515557|FG001|Year 2|Withdrawal by Subject|5|||
161309831|NCT00195494|582515558|FG002|Year 2|Withdrawal by Subject|4|||
161309832|NCT00195494|582515559|FG003|Year 2|Withdrawal by Subject|3|||
161309833|NCT00195494|582515560|FG004|Year 2|Withdrawal by Subject|0|||
161309834|NCT00195494|582515561|FG005|Year 2|Withdrawal by Subject|0|||
161309835|NCT00195494|582515556|FG000|Year 2|System toxicity|0|||
161309836|NCT00195494|582515557|FG001|Year 2|System toxicity|0|||
161309837|NCT00195494|582515558|FG002|Year 2|System toxicity|0|||
161309838|NCT00195494|582515559|FG003|Year 2|System toxicity|1|||
161309839|NCT00195494|582515560|FG004|Year 2|System toxicity|0|||
161309840|NCT00195494|582515561|FG005|Year 2|System toxicity|0|||
161309841|NCT05083923|582515569|FG000|Overall Study|Adverse Event|2|||
161309842|NCT05083923|582515570|FG001|Overall Study|Adverse Event|0|||
161309843|NCT05083923|582515569|FG000|Overall Study|Lack of Efficacy|1|||
161309844|NCT05083923|582515570|FG001|Overall Study|Lack of Efficacy|3|||
161309845|NCT05083923|582515569|FG000|Overall Study|Withdrawal by Subject|2|||
161309846|NCT05083923|582515570|FG001|Overall Study|Withdrawal by Subject|6|||
161309847|NCT05083923|582515569|FG000|Overall Study|Reason Not Specified|0|||
161309848|NCT05083923|582515570|FG001|Overall Study|Reason Not Specified|1|||
161309849|NCT02880865|582515571|FG000|Overall Study|Adverse Event|1|||
161309850|NCT02880865|582515572|FG001|Overall Study|Adverse Event|0|||
161309851|NCT02880865|582515571|FG000|Overall Study|Withdrawal by Subject|0|||
161309852|NCT02880865|582515572|FG001|Overall Study|Withdrawal by Subject|2|||
161309853|NCT02880865|582515571|FG000|Overall Study|Physician Decision|0|||
161309854|NCT02880865|582515572|FG001|Overall Study|Physician Decision|1|||
161309855|NCT01190267|582515575|FG000|Overall Study|Adverse Event|10|||
161309856|NCT01190267|582515576|FG001|Overall Study|Adverse Event|0|||
161309857|NCT01190267|582515575|FG000|Overall Study|Treatment Failure|8|||
161309858|NCT01190267|582515576|FG001|Overall Study|Treatment Failure|2|||
161309859|NCT01190267|582515575|FG000|Overall Study|Lost to Follow-up|2|||
161309860|NCT01190267|582515576|FG001|Overall Study|Lost to Follow-up|0|||
161309861|NCT01190267|582515575|FG000|Overall Study|Withdrawal by Subject|13|||
161309862|NCT01190267|582515576|FG001|Overall Study|Withdrawal by Subject|1|||
161309863|NCT01190267|582515575|FG000|Overall Study|Protocol Violation|8|||
161309864|NCT01190267|582515576|FG001|Overall Study|Protocol Violation|1|||
161309865|NCT04687072|582515586|FG000|Overall Study|Adverse Event|2|||
161309866|NCT04687072|582515587|FG001|Overall Study|Adverse Event|0|||
161309867|NCT04687072|582515586|FG000|Overall Study|Death|1|||
161309868|NCT04687072|582515587|FG001|Overall Study|Death|0|||
161309869|NCT04687072|582515586|FG000|Overall Study|Lack of Efficacy|2|||
161309870|NCT04687072|582515587|FG001|Overall Study|Lack of Efficacy|1|||
161309871|NCT04687072|582515586|FG000|Overall Study|Physician Decision|1|||
161309872|NCT04687072|582515587|FG001|Overall Study|Physician Decision|0|||
161309873|NCT04687072|582515586|FG000|Overall Study|Pregnancy|1|||
161309874|NCT04687072|582515587|FG001|Overall Study|Pregnancy|0|||
161309875|NCT04687072|582515586|FG000|Overall Study|Requires Prohibited Medication|2|||
161309876|NCT04687072|582515587|FG001|Overall Study|Requires Prohibited Medication|0|||
161309877|NCT04687072|582515586|FG000|Overall Study|Withdrawal of Consent|11|||
161309878|NCT04687072|582515587|FG001|Overall Study|Withdrawal of Consent|6|||
161309879|NCT04687072|582515586|FG000|Overall Study|Miscellaneous|4|||
161309880|NCT04687072|582515587|FG001|Overall Study|Miscellaneous|1|||
161309881|NCT01263782|582515589|FG000|Overall Study|Death|0|||
161309882|NCT01263782|582515590|FG001|Overall Study|Death|0|||
161309883|NCT01263782|582515591|FG002|Overall Study|Death|1|||
161309884|NCT01263782|582515592|FG003|Overall Study|Death|0|||
161202397|NCT03426995|582120411|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
161202398|NCT03426995|582120412|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202399|NCT03426995|582120413|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202400|NCT03426995|582120414|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
161202401|NCT00227591|582120415|FG000|Overall Study|Withdrawal by Subject|1|||
161202402|NCT02335411|582120416|FG000|Overall Study|Death|223|||
161202403|NCT02335411|582120417|FG001|Overall Study|Death|22|||
161202404|NCT02335411|582120418|FG002|Overall Study|Death|26|||
161202405|NCT02335411|582120416|FG000|Overall Study|Physician Decision|3|||
161202406|NCT02335411|582120417|FG001|Overall Study|Physician Decision|0|||
161202407|NCT02335411|582120418|FG002|Overall Study|Physician Decision|0|||
161202408|NCT02335411|582120416|FG000|Overall Study|Protocol Violation|1|||
161202409|NCT02335411|582120417|FG001|Overall Study|Protocol Violation|0|||
161202410|NCT02335411|582120418|FG002|Overall Study|Protocol Violation|0|||
161202411|NCT02335411|582120416|FG000|Overall Study|Withdrawal by Subject|11|||
161202412|NCT02335411|582120417|FG001|Overall Study|Withdrawal by Subject|0|||
161202413|NCT02335411|582120418|FG002|Overall Study|Withdrawal by Subject|3|||
161202414|NCT02335411|582120416|FG000|Overall Study|Sponsor Decision|12|||
161202415|NCT02335411|582120417|FG001|Overall Study|Sponsor Decision|3|||
161202416|NCT02335411|582120418|FG002|Overall Study|Sponsor Decision|2|||
161202417|NCT02335411|582120416|FG000|Overall Study|Adverse Event|9|||
161202418|NCT02335411|582120417|FG001|Overall Study|Adverse Event|0|||
161202419|NCT02335411|582120418|FG002|Overall Study|Adverse Event|0|||
161202420|NCT01886105|582120419|FG000|Overall Study|Lack of Efficacy|3|||
161202421|NCT01360021|582120422|FG000|Overall Study|Eligibility criteria + other|2|||
161202422|NCT01360021|582120423|FG001|Overall Study|Eligibility criteria + other|1|||
161202423|NCT01360021|582120424|FG002|Overall Study|Eligibility criteria + other|1|||
161202424|NCT01360021|582120422|FG000|Overall Study|Protocol Violation|0|||
161202425|NCT01360021|582120423|FG001|Overall Study|Protocol Violation|0|||
161202426|NCT01360021|582120424|FG002|Overall Study|Protocol Violation|1|||
161202427|NCT01360021|582120422|FG000|Overall Study|Withdrawal by Subject|4|||
161202428|NCT01360021|582120423|FG001|Overall Study|Withdrawal by Subject|0|||
161202429|NCT01360021|582120424|FG002|Overall Study|Withdrawal by Subject|2|||
161202430|NCT01360021|582120422|FG000|Overall Study|Adverse Event|2|||
161202431|NCT01360021|582120423|FG001|Overall Study|Adverse Event|3|||
161202432|NCT01360021|582120424|FG002|Overall Study|Adverse Event|3|||
161090983|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
161090984|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
161090985|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
161090986|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
161090987|NCT00757588|581723770|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
161090988|NCT00757588|581723771|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
161090989|NCT02563522|581723772|FG000|Overall Study|Adverse Event|2|||
161090990|NCT02563522|581723773|FG001|Overall Study|Adverse Event|3|||
161090991|NCT02563522|581723772|FG000|Overall Study|Lost to Follow-up|1|||
161090992|NCT02563522|581723773|FG001|Overall Study|Lost to Follow-up|0|||
161090993|NCT02563522|581723772|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
161090994|NCT02563522|581723773|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
161090995|NCT01052103|581723774|FG000|Overall Study|Adverse Event|10|||
161090996|NCT01052103|581723775|FG001|Overall Study|Adverse Event|6|||
161090997|NCT01052103|581723774|FG000|Overall Study|Entry Criteria Not Met|3|||
161090998|NCT01052103|581723775|FG001|Overall Study|Entry Criteria Not Met|1|||
161090999|NCT01052103|581723774|FG000|Overall Study|Lost to Follow-up|3|||
161091000|NCT01052103|581723775|FG001|Overall Study|Lost to Follow-up|5|||
161091001|NCT01052103|581723774|FG000|Overall Study|Protocol Violation|10|||
161091002|NCT01052103|581723775|FG001|Overall Study|Protocol Violation|4|||
161091003|NCT01052103|581723774|FG000|Overall Study|Scheduling conflict|2|||
161091004|NCT01052103|581723775|FG001|Overall Study|Scheduling conflict|1|||
161091005|NCT01052103|581723774|FG000|Overall Study|Sponsor Decision|2|||
161091006|NCT01052103|581723775|FG001|Overall Study|Sponsor Decision|0|||
161091007|NCT01052103|581723774|FG000|Overall Study|Withdrawal by Subject|3|||
161091008|NCT01052103|581723775|FG001|Overall Study|Withdrawal by Subject|6|||
161091009|NCT01052103|581723774|FG000|Overall Study|Perceived Lack of Efficacy|1|||
161091010|NCT01052103|581723775|FG001|Overall Study|Perceived Lack of Efficacy|0|||
161091011|NCT00666679|581723779|FG000|First Intervention|Lost to Follow-up|1|||
161091012|NCT00666679|581723780|FG001|First Intervention|Lost to Follow-up|0|||
161091013|NCT00666679|581723779|FG000|First Intervention|Protocol Violation|1|||
161091014|NCT00666679|581723780|FG001|First Intervention|Protocol Violation|0|||
161091015|NCT00666679|581723779|FG000|First Intervention|Withdrawal by Subject|1|||
161091016|NCT00666679|581723780|FG001|First Intervention|Withdrawal by Subject|0|||
161091017|NCT00666679|581723779|FG000|First Intervention|Randomized did not start treatment|1|||
161091018|NCT00666679|581723780|FG001|First Intervention|Randomized did not start treatment|1|||
161091019|NCT00666679|581723779|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
161091020|NCT00666679|581723780|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
161091021|NCT00666679|581723779|FG000|Washout Period of 1 Week|Protocol Violation|0|||
161202433|NCT00650806|582120427|FG000|Overall Study|Adverse Event|0|||
161202434|NCT00650806|582120428|FG001|Overall Study|Adverse Event|5|||
161309885|NCT01263782|582515589|FG000|Overall Study|Progressive disease|0|||
161202435|NCT00650806|582120429|FG002|Overall Study|Adverse Event|3|||
161202436|NCT00650806|582120430|FG003|Overall Study|Adverse Event|4|||
161202437|NCT00650806|582120427|FG000|Overall Study|Lost to Follow-up|7|||
161202438|NCT00650806|582120428|FG001|Overall Study|Lost to Follow-up|6|||
161202439|NCT00650806|582120429|FG002|Overall Study|Lost to Follow-up|11|||
161202440|NCT00650806|582120430|FG003|Overall Study|Lost to Follow-up|10|||
161202441|NCT00650806|582120427|FG000|Overall Study|Protocol Violation|0|||
161202442|NCT00650806|582120428|FG001|Overall Study|Protocol Violation|0|||
161202443|NCT00650806|582120429|FG002|Overall Study|Protocol Violation|0|||
161202444|NCT00650806|582120430|FG003|Overall Study|Protocol Violation|1|||
161202445|NCT00650806|582120427|FG000|Overall Study|Pregnancy|0|||
161202446|NCT00650806|582120428|FG001|Overall Study|Pregnancy|0|||
161202447|NCT00650806|582120429|FG002|Overall Study|Pregnancy|0|||
161202448|NCT00650806|582120430|FG003|Overall Study|Pregnancy|1|||
161202449|NCT00650806|582120427|FG000|Overall Study|Withdrawal by Subject|7|||
161202450|NCT00650806|582120428|FG001|Overall Study|Withdrawal by Subject|5|||
161202451|NCT00650806|582120429|FG002|Overall Study|Withdrawal by Subject|8|||
161202452|NCT00650806|582120430|FG003|Overall Study|Withdrawal by Subject|6|||
161202453|NCT00650806|582120427|FG000|Overall Study|Noncompliance with study drug regimen|1|||
161202454|NCT00650806|582120428|FG001|Overall Study|Noncompliance with study drug regimen|1|||
161202455|NCT00650806|582120429|FG002|Overall Study|Noncompliance with study drug regimen|0|||
161202456|NCT00650806|582120430|FG003|Overall Study|Noncompliance with study drug regimen|0|||
161202457|NCT00650806|582120427|FG000|Overall Study|Study terminated by sponsor|2|||
161202458|NCT00650806|582120428|FG001|Overall Study|Study terminated by sponsor|3|||
161202459|NCT00650806|582120429|FG002|Overall Study|Study terminated by sponsor|5|||
161202460|NCT00650806|582120430|FG003|Overall Study|Study terminated by sponsor|4|||
161202461|NCT00650806|582120427|FG000|Overall Study|Other|1|||
161202462|NCT00650806|582120428|FG001|Overall Study|Other|1|||
161202463|NCT00650806|582120429|FG002|Overall Study|Other|2|||
161202464|NCT00650806|582120430|FG003|Overall Study|Other|0|||
161202465|NCT04075656|582120435|FG000|Overall Study|Withdrawal by Subject|5|||
161202466|NCT04075656|582120436|FG001|Overall Study|Withdrawal by Subject|5|||
161202467|NCT03505606|582122160|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
161202468|NCT03505606|582122161|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
161202469|NCT03505606|582122162|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
161202470|NCT03505606|582122160|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
161202471|NCT03505606|582122161|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
161202472|NCT03505606|582122162|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
161202473|NCT03505606|582122160|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
161202474|NCT03505606|582122161|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
161202475|NCT03505606|582122162|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
161202476|NCT03505606|582122160|FG000|Overall Study|Poor compliance with refractive correction|0|||
161202477|NCT03505606|582122161|FG001|Overall Study|Poor compliance with refractive correction|0|||
161202478|NCT03505606|582122162|FG002|Overall Study|Poor compliance with refractive correction|1|||
161202479|NCT03505606|582122160|FG000|Overall Study|Insufficient anisometropia|0|||
161202480|NCT03505606|582122161|FG001|Overall Study|Insufficient anisometropia|0|||
161202481|NCT03505606|582122162|FG002|Overall Study|Insufficient anisometropia|2|||
161202482|NCT03505606|582122160|FG000|Overall Study|Ectopia Lentis|0|||
161202483|NCT03505606|582122161|FG001|Overall Study|Ectopia Lentis|0|||
161202484|NCT03505606|582122162|FG002|Overall Study|Ectopia Lentis|1|||
161202485|NCT03505606|582122160|FG000|Overall Study|alternation of amblyopic eye|0|||
161202486|NCT03505606|582122161|FG001|Overall Study|alternation of amblyopic eye|1|||
161202487|NCT03505606|582122162|FG002|Overall Study|alternation of amblyopic eye|0|||
161202488|NCT02087865|582122165|FG000|Overall Study|Withdrawal by Subject|6|||
161202489|NCT02087865|582122166|FG001|Overall Study|Withdrawal by Subject|0|||
161202490|NCT02087865|582122167|FG002|Overall Study|Withdrawal by Subject|1|||
161202491|NCT02087865|582122165|FG000|Overall Study|Lost to Follow-up|0|||
161202492|NCT02087865|582122166|FG001|Overall Study|Lost to Follow-up|0|||
161202493|NCT02087865|582122167|FG002|Overall Study|Lost to Follow-up|1|||
161202494|NCT02087865|582122165|FG000|Overall Study|Drug Non-compliance|0|||
161202495|NCT02087865|582122166|FG001|Overall Study|Drug Non-compliance|2|||
161202496|NCT02087865|582122167|FG002|Overall Study|Drug Non-compliance|0|||
161202497|NCT02087865|582122165|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
161202498|NCT02087865|582122166|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
161202499|NCT02087865|582122167|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
161202500|NCT01392469|582122168|FG000|Overall Study|Adverse Event|2|||
161202501|NCT01392469|582122168|FG000|Overall Study|Withdrawal by Subject|1|||
161202502|NCT01392469|582122168|FG000|Overall Study|Protocol Violation|1|||
161309886|NCT01263782|582515590|FG001|Overall Study|Progressive disease|0|||
161202503|NCT04292171|582122171|FG000|Overall Study|Pharmacy error|2|||
161309887|NCT01263782|582515591|FG002|Overall Study|Progressive disease|0|||
161202504|NCT04292171|582122172|FG001|Overall Study|Pharmacy error|0|||
161202505|NCT04292171|582122171|FG000|Overall Study|Delivered prior to procedure|0|||
161202506|NCT04292171|582122172|FG001|Overall Study|Delivered prior to procedure|1|||
161202507|NCT04633434|582122173|FG000|Overall Study|Lost to Follow-up|32|||
161202508|NCT04633434|582122174|FG001|Overall Study|Lost to Follow-up|32|||
161202509|NCT02116309|582122187|FG000|Overall Study|Lost to Follow-up|0|||
161202510|NCT02116309|582122188|FG001|Overall Study|Lost to Follow-up|1|||
161202511|NCT03292731|582122189|FG000|Overall Study|Protocol Violation|4|||
161202512|NCT03292731|582122190|FG001|Overall Study|Protocol Violation|11|||
161202513|NCT03292731|582122191|FG002|Overall Study|Protocol Violation|1|||
161202514|NCT00471237|582122192|FG000|Overall Study|Adverse Event|6|||
161202515|NCT00471237|582122193|FG001|Overall Study|Adverse Event|5|||
161202516|NCT00471237|582122194|FG002|Overall Study|Adverse Event|4|||
161202517|NCT00471237|582122195|FG003|Overall Study|Adverse Event|8|||
161202518|NCT00471237|582122196|FG004|Overall Study|Adverse Event|7|||
161202519|NCT00471237|582122197|FG005|Overall Study|Adverse Event|5|||
161202520|NCT00471237|582122198|FG006|Overall Study|Adverse Event|0|||
161202521|NCT00471237|582122192|FG000|Overall Study|Lost to Follow-up|1|||
161202522|NCT00471237|582122193|FG001|Overall Study|Lost to Follow-up|1|||
161202523|NCT00471237|582122194|FG002|Overall Study|Lost to Follow-up|0|||
161202524|NCT00471237|582122195|FG003|Overall Study|Lost to Follow-up|2|||
161202525|NCT00471237|582122196|FG004|Overall Study|Lost to Follow-up|3|||
161202526|NCT00471237|582122197|FG005|Overall Study|Lost to Follow-up|0|||
161202527|NCT00471237|582122198|FG006|Overall Study|Lost to Follow-up|0|||
161202528|NCT00471237|582122192|FG000|Overall Study|Protocol Violation|3|||
161202529|NCT00471237|582122193|FG001|Overall Study|Protocol Violation|6|||
161202530|NCT00471237|582122194|FG002|Overall Study|Protocol Violation|3|||
161202531|NCT00471237|582122195|FG003|Overall Study|Protocol Violation|2|||
161202532|NCT00471237|582122196|FG004|Overall Study|Protocol Violation|2|||
161202533|NCT00471237|582122197|FG005|Overall Study|Protocol Violation|4|||
161202534|NCT00471237|582122198|FG006|Overall Study|Protocol Violation|1|||
161202535|NCT00471237|582122192|FG000|Overall Study|Withdrawal by Subject|8|||
161202536|NCT00471237|582122193|FG001|Overall Study|Withdrawal by Subject|6|||
161202537|NCT00471237|582122194|FG002|Overall Study|Withdrawal by Subject|5|||
161202538|NCT00471237|582122195|FG003|Overall Study|Withdrawal by Subject|8|||
161202539|NCT00471237|582122196|FG004|Overall Study|Withdrawal by Subject|7|||
161202540|NCT00471237|582122197|FG005|Overall Study|Withdrawal by Subject|4|||
161202541|NCT00471237|582122198|FG006|Overall Study|Withdrawal by Subject|2|||
161202542|NCT00471237|582122192|FG000|Overall Study|Sponsor terminated study|20|||
161202543|NCT00471237|582122193|FG001|Overall Study|Sponsor terminated study|23|||
161202544|NCT00471237|582122194|FG002|Overall Study|Sponsor terminated study|19|||
161202545|NCT00471237|582122195|FG003|Overall Study|Sponsor terminated study|22|||
161202546|NCT00471237|582122196|FG004|Overall Study|Sponsor terminated study|18|||
161202547|NCT00471237|582122197|FG005|Overall Study|Sponsor terminated study|24|||
161202548|NCT00471237|582122198|FG006|Overall Study|Sponsor terminated study|0|||
161202549|NCT00471237|582122192|FG000|Overall Study|Non-compliance|0|||
161202550|NCT00471237|582122193|FG001|Overall Study|Non-compliance|1|||
161202551|NCT00471237|582122194|FG002|Overall Study|Non-compliance|0|||
161202552|NCT00471237|582122195|FG003|Overall Study|Non-compliance|1|||
161202553|NCT00471237|582122196|FG004|Overall Study|Non-compliance|0|||
161202554|NCT00471237|582122197|FG005|Overall Study|Non-compliance|0|||
161202555|NCT00471237|582122198|FG006|Overall Study|Non-compliance|0|||
161202556|NCT00471237|582122192|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
161202557|NCT00471237|582122193|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
161202558|NCT00471237|582122194|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
161202559|NCT00471237|582122195|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
161202560|NCT00471237|582122196|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
161202561|NCT00471237|582122197|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
161202562|NCT00471237|582122198|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
161202563|NCT00471237|582122192|FG000|Overall Study|Early stopping due to non-efficacy|1|||
161202564|NCT00471237|582122193|FG001|Overall Study|Early stopping due to non-efficacy|0|||
161202565|NCT00471237|582122194|FG002|Overall Study|Early stopping due to non-efficacy|0|||
161202566|NCT00471237|582122195|FG003|Overall Study|Early stopping due to non-efficacy|0|||
161202567|NCT00471237|582122196|FG004|Overall Study|Early stopping due to non-efficacy|1|||
161202568|NCT00471237|582122197|FG005|Overall Study|Early stopping due to non-efficacy|0|||
161202569|NCT00471237|582122198|FG006|Overall Study|Early stopping due to non-efficacy|0|||
161202570|NCT00471237|582122192|FG000|Overall Study|Participant planned to travel to abraod|1|||
161202571|NCT00471237|582122193|FG001|Overall Study|Participant planned to travel to abraod|0|||
161202572|NCT00471237|582122194|FG002|Overall Study|Participant planned to travel to abraod|0|||
161202573|NCT00471237|582122195|FG003|Overall Study|Participant planned to travel to abraod|0|||
161202574|NCT00471237|582122196|FG004|Overall Study|Participant planned to travel to abraod|0|||
161202575|NCT00471237|582122197|FG005|Overall Study|Participant planned to travel to abraod|1|||
161202576|NCT00471237|582122198|FG006|Overall Study|Participant planned to travel to abraod|0|||
161202577|NCT00471237|582122192|FG000|Overall Study|High parathyroid hormone|0|||
161202578|NCT00471237|582122193|FG001|Overall Study|High parathyroid hormone|0|||
161202579|NCT00471237|582122194|FG002|Overall Study|High parathyroid hormone|1|||
161202580|NCT00471237|582122195|FG003|Overall Study|High parathyroid hormone|0|||
161202581|NCT00471237|582122196|FG004|Overall Study|High parathyroid hormone|0|||
161202582|NCT00471237|582122197|FG005|Overall Study|High parathyroid hormone|0|||
161202583|NCT00471237|582122198|FG006|Overall Study|High parathyroid hormone|0|||
161202584|NCT00471237|582122192|FG000|Overall Study|Participant lost medication|0|||
161202585|NCT00471237|582122193|FG001|Overall Study|Participant lost medication|0|||
161202586|NCT00471237|582122194|FG002|Overall Study|Participant lost medication|0|||
161202587|NCT00471237|582122195|FG003|Overall Study|Participant lost medication|0|||
161202588|NCT00471237|582122196|FG004|Overall Study|Participant lost medication|1|||
161202589|NCT00471237|582122197|FG005|Overall Study|Participant lost medication|0|||
161202590|NCT00471237|582122198|FG006|Overall Study|Participant lost medication|0|||
161202591|NCT00471237|582122192|FG000|Overall Study|Administration of prohibited medicine|0|||
161202592|NCT00471237|582122193|FG001|Overall Study|Administration of prohibited medicine|0|||
161202593|NCT00471237|582122194|FG002|Overall Study|Administration of prohibited medicine|0|||
161202594|NCT00471237|582122195|FG003|Overall Study|Administration of prohibited medicine|0|||
161202595|NCT00471237|582122196|FG004|Overall Study|Administration of prohibited medicine|1|||
161202596|NCT00471237|582122197|FG005|Overall Study|Administration of prohibited medicine|0|||
161202597|NCT00471237|582122198|FG006|Overall Study|Administration of prohibited medicine|0|||
161202598|NCT00471237|582122192|FG000|Overall Study|Participant shifted residence|0|||
161202599|NCT00471237|582122193|FG001|Overall Study|Participant shifted residence|0|||
161202600|NCT00471237|582122194|FG002|Overall Study|Participant shifted residence|0|||
161202601|NCT00471237|582122195|FG003|Overall Study|Participant shifted residence|0|||
161202602|NCT00471237|582122196|FG004|Overall Study|Participant shifted residence|1|||
161202603|NCT00471237|582122197|FG005|Overall Study|Participant shifted residence|0|||
161202604|NCT00471237|582122198|FG006|Overall Study|Participant shifted residence|0|||
161202605|NCT00471237|582122192|FG000|Overall Study|Participant's decision|0|||
161202606|NCT00471237|582122193|FG001|Overall Study|Participant's decision|0|||
161202607|NCT00471237|582122194|FG002|Overall Study|Participant's decision|0|||
161202608|NCT00471237|582122195|FG003|Overall Study|Participant's decision|0|||
161202609|NCT00471237|582122196|FG004|Overall Study|Participant's decision|0|||
161202610|NCT00471237|582122197|FG005|Overall Study|Participant's decision|1|||
161202611|NCT00471237|582122198|FG006|Overall Study|Participant's decision|0|||
161202612|NCT00348348|582122199|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
161202613|NCT00348348|582122200|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
161202614|NCT00348348|582122199|FG000|Overall Study|Lack of Efficacy|1|||
161202615|NCT00348348|582122200|FG001|Overall Study|Lack of Efficacy|1|||
161202616|NCT00348348|582122199|FG000|Overall Study|Lost to Follow-up|8|||
161202617|NCT00348348|582122200|FG001|Overall Study|Lost to Follow-up|10|||
161202618|NCT00348348|582122199|FG000|Overall Study|Withdrawal by Subject|4|||
161202619|NCT00348348|582122200|FG001|Overall Study|Withdrawal by Subject|1|||
161202620|NCT00348348|582122199|FG000|Overall Study|Other|7|||
161202621|NCT00348348|582122200|FG001|Overall Study|Other|4|||
161202622|NCT00348348|582122199|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
161202623|NCT00348348|582122200|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
161202624|NCT00348348|582122199|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
161202625|NCT00348348|582122200|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
161202626|NCT00348348|582122199|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
161202627|NCT00348348|582122200|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
161202628|NCT00348348|582122199|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
161202629|NCT00348348|582122200|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
161202630|NCT00348348|582122199|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
161202631|NCT00348348|582122200|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
161202632|NCT00348348|582122199|FG000|Overall Study|Adverse event probably related to study|1|||
161202633|NCT00348348|582122200|FG001|Overall Study|Adverse event probably related to study|0|||
161202634|NCT03237325|582122201|FG000|Overall Study|Lost to Follow-up|3|||
161202635|NCT03237325|582122202|FG001|Overall Study|Lost to Follow-up|5|||
161202636|NCT03237325|582122201|FG000|Overall Study|Physician Decision|2|||
161202637|NCT03237325|582122202|FG001|Overall Study|Physician Decision|4|||
161202638|NCT03237325|582122201|FG000|Overall Study|Withdrawal by Subject|9|||
161202639|NCT03237325|582122202|FG001|Overall Study|Withdrawal by Subject|12|||
161202640|NCT03237325|582122201|FG000|Overall Study|Noncompliance with Study Procedures|1|||
161202641|NCT03237325|582122202|FG001|Overall Study|Noncompliance with Study Procedures|1|||
161202642|NCT03237325|582122201|FG000|Overall Study|Termination by Sponsor|0|||
161202643|NCT03237325|582122202|FG001|Overall Study|Termination by Sponsor|1|||
161202644|NCT03237325|582122201|FG000|Overall Study|Reason other than described|0|||
161202645|NCT03237325|582122202|FG001|Overall Study|Reason other than described|2|||
161202646|NCT02684370|582122203|FG000|Part A|Adverse Event|2|||
161202647|NCT02684370|582122204|FG001|Part A|Adverse Event|0|||
161202648|NCT02684370|582122205|FG002|Part A|Adverse Event|1|||
161202649|NCT02684370|582122206|FG003|Part A|Adverse Event|0|||
161202650|NCT02684370|582122207|FG004|Part A|Adverse Event|0|||
161202651|NCT02684370|582122208|FG005|Part A|Adverse Event|0|||
161202652|NCT02684370|582122203|FG000|Part A|Lost to Follow-up|1|||
161202653|NCT02684370|582122204|FG001|Part A|Lost to Follow-up|1|||
161202654|NCT02684370|582122205|FG002|Part A|Lost to Follow-up|0|||
161202655|NCT02684370|582122206|FG003|Part A|Lost to Follow-up|0|||
161202656|NCT02684370|582122207|FG004|Part A|Lost to Follow-up|0|||
161202657|NCT02684370|582122208|FG005|Part A|Lost to Follow-up|0|||
161202658|NCT02684370|582122203|FG000|Part A|Subject Withdrawal|1|||
161202659|NCT02684370|582122204|FG001|Part A|Subject Withdrawal|0|||
161202660|NCT02684370|582122205|FG002|Part A|Subject Withdrawal|3|||
161202661|NCT02684370|582122206|FG003|Part A|Subject Withdrawal|0|||
161202662|NCT02684370|582122207|FG004|Part A|Subject Withdrawal|0|||
161202663|NCT02684370|582122208|FG005|Part A|Subject Withdrawal|0|||
161202664|NCT02684370|582122203|FG000|Part A|Other|0|||
161202665|NCT02684370|582122204|FG001|Part A|Other|0|||
161202666|NCT02684370|582122205|FG002|Part A|Other|1|||
161202667|NCT02684370|582122206|FG003|Part A|Other|0|||
161202668|NCT02684370|582122207|FG004|Part A|Other|0|||
161202669|NCT02684370|582122208|FG005|Part A|Other|0|||
161202670|NCT02684370|582122203|FG000|Part B|Adverse Event|0|||
161202671|NCT02684370|582122204|FG001|Part B|Adverse Event|0|||
161202672|NCT02684370|582122205|FG002|Part B|Adverse Event|0|||
161202673|NCT02684370|582122206|FG003|Part B|Adverse Event|0|||
161202674|NCT02684370|582122207|FG004|Part B|Adverse Event|2|||
161202675|NCT02684370|582122208|FG005|Part B|Adverse Event|1|||
161202676|NCT02684370|582122203|FG000|Part B|Lost to Follow-up|0|||
161202677|NCT02684370|582122204|FG001|Part B|Lost to Follow-up|0|||
161202678|NCT02684370|582122205|FG002|Part B|Lost to Follow-up|0|||
161202679|NCT02684370|582122206|FG003|Part B|Lost to Follow-up|1|||
161202680|NCT02684370|582122207|FG004|Part B|Lost to Follow-up|2|||
161202681|NCT02684370|582122208|FG005|Part B|Lost to Follow-up|5|||
161202682|NCT02684370|582122203|FG000|Part B|Subject Withdrawal|0|||
161202683|NCT02684370|582122204|FG001|Part B|Subject Withdrawal|0|||
161202684|NCT02684370|582122205|FG002|Part B|Subject Withdrawal|0|||
161202685|NCT02684370|582122206|FG003|Part B|Subject Withdrawal|1|||
161202686|NCT02684370|582122207|FG004|Part B|Subject Withdrawal|1|||
161202687|NCT02684370|582122208|FG005|Part B|Subject Withdrawal|2|||
161202688|NCT00627094|582122214|FG000|Overall Study|Adverse Event|8|||
161202689|NCT00627094|582122215|FG001|Overall Study|Adverse Event|7|||
161202690|NCT00627094|582122214|FG000|Overall Study|Lost to Follow-up|1|||
161202691|NCT00627094|582122215|FG001|Overall Study|Lost to Follow-up|0|||
161202692|NCT00627094|582122214|FG000|Overall Study|Withdrawal by Subject|1|||
161202693|NCT00627094|582122215|FG001|Overall Study|Withdrawal by Subject|1|||
161202694|NCT00627094|582122214|FG000|Overall Study|ulcer healed|1|||
161309888|NCT01263782|582515592|FG003|Overall Study|Progressive disease|1|||
161309889|NCT01263782|582515589|FG000|Overall Study|Too early|0|||
161309890|NCT01263782|582515590|FG001|Overall Study|Too early|0|||
161309891|NCT01263782|582515591|FG002|Overall Study|Too early|1|||
161309892|NCT01263782|582515592|FG003|Overall Study|Too early|0|||
161309893|NCT01263782|582515589|FG000|Overall Study|Inevaluable|0|||
161309894|NCT01263782|582515590|FG001|Overall Study|Inevaluable|0|||
161309895|NCT01263782|582515591|FG002|Overall Study|Inevaluable|1|||
161309896|NCT01263782|582515592|FG003|Overall Study|Inevaluable|0|||
161309897|NCT00915876|582515593|FG000|Overall Study|Adverse Event|0|||
161309898|NCT00915876|582515594|FG001|Overall Study|Adverse Event|1|||
161309899|NCT04545567|582515599|FG000|Overall Study|tested positive for SARS-co-V2|1|||
161309900|NCT04545567|582515600|FG001|Overall Study|tested positive for SARS-co-V2|1|||
161309901|NCT04545567|582515599|FG000|Overall Study|Withdrawal by Subject|0|||
161309902|NCT04545567|582515600|FG001|Overall Study|Withdrawal by Subject|1|||
161309903|NCT04464720|582515603|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
161309904|NCT04413552|582515608|FG000|Overall Study|Adverse Event|0|||
161309905|NCT04413552|582515609|FG001|Overall Study|Adverse Event|0|||
161309906|NCT04413552|582515610|FG002|Overall Study|Adverse Event|0|||
161309907|NCT04413552|582515611|FG003|Overall Study|Adverse Event|0|||
161309908|NCT04413552|582515612|FG004|Overall Study|Adverse Event|0|||
161309909|NCT04413552|582515613|FG005|Overall Study|Adverse Event|0|||
161309910|NCT04413552|582515614|FG006|Overall Study|Adverse Event|1|||
161309911|NCT04413552|582515615|FG007|Overall Study|Adverse Event|0|||
161309912|NCT04413552|582515616|FG008|Overall Study|Adverse Event|0|||
161309913|NCT04413552|582515617|FG009|Overall Study|Adverse Event|0|||
161309914|NCT05723328|582515618|FG000|Overall Study|Investigator's Decision|5|||
161309915|NCT05723328|582515619|FG001|Overall Study|Investigator's Decision|2|||
161309916|NCT03495154|582515622|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
161309917|NCT03495154|582515622|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
161309918|NCT03495154|582515622|FG000|Overall Study|Screen Failures During Surgery|6|||
161309919|NCT03495154|582515622|FG000|Overall Study|Death|2|||
161309920|NCT03495154|582515622|FG000|Overall Study|Lost to Follow-up|16|||
161309921|NCT03495154|582515622|FG000|Overall Study|Withdrawal by Subject|2|||
161309922|NCT03495154|582515622|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
161309923|NCT01294696|582515630|FG000|Overall Study|Screening failures|7|||
161309924|NCT01294696|582515630|FG000|Overall Study|Protocol Violation|8|||
161309925|NCT01294696|582515630|FG000|Overall Study|Missing BPI Response|7|||
161309926|NCT01294696|582515630|FG000|Overall Study|Site closure|52|||
161309927|NCT04599933|582516955|FG000|Overall Study|Adverse Event|4|||
161309928|NCT04599933|582516956|FG001|Overall Study|Adverse Event|1|||
161309929|NCT04599933|582516955|FG000|Overall Study|Withdrawal by Subject|4|||
161309930|NCT04599933|582516956|FG001|Overall Study|Withdrawal by Subject|2|||
161309931|NCT04599933|582516955|FG000|Overall Study|Lost to Follow-up|0|||
161309932|NCT04599933|582516956|FG001|Overall Study|Lost to Follow-up|1|||
161309933|NCT04599933|582516955|FG000|Overall Study|Physician Decision|0|||
161309934|NCT04599933|582516956|FG001|Overall Study|Physician Decision|1|||
161202695|NCT00627094|582122215|FG001|Overall Study|ulcer healed|7|||
161202696|NCT00627094|582122214|FG000|Overall Study|Other reason|1|||
161202697|NCT00627094|582122215|FG001|Overall Study|Other reason|0|||
161202698|NCT01165424|582122222|FG000|Overall Study|Clinical adverse experiences|1|||
161202699|NCT01165424|582122222|FG000|Overall Study|Laboratory adverse experiences|1|||
161202700|NCT01165424|582122222|FG000|Overall Study|Did not meet entry criteria|1|||
161202701|NCT01165424|582122222|FG000|Overall Study|Participant moved (relocated)|1|||
161202702|NCT04139642|582122223|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
161309935|NCT04599933|582516955|FG000|Overall Study|Screen Failure|1|||
161309936|NCT04599933|582516956|FG001|Overall Study|Screen Failure|2|||
161309937|NCT02339155|582516965|FG000|Overall Study|Adverse Event|0|||
161309938|NCT02339155|582516966|FG001|Overall Study|Adverse Event|6|||
161202703|NCT04139642|582122224|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
161202704|NCT02050373|582122232|FG000|Overall Study|Adverse Event|4|||
161202705|NCT02050373|582122233|FG001|Overall Study|Adverse Event|7|||
161202706|NCT02050373|582122232|FG000|Overall Study|Death|3|||
161202707|NCT02050373|582122233|FG001|Overall Study|Death|3|||
161202708|NCT01179191|582122237|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
161202709|NCT01179191|582122237|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
161202710|NCT01179191|582122237|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
161202711|NCT01179191|582122237|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
161202712|NCT01179191|582122237|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
161202713|NCT01179191|582122237|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
161202714|NCT01179191|582122237|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
161202715|NCT01179191|582122237|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
161202716|NCT01179191|582122237|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
161202717|NCT01179191|582122237|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
161202718|NCT01179191|582122237|FG000|Maintenance Phase (8 Weeks)|Other|66|||
161202719|NCT01833897|582122245|FG000|Overall Study|Lack of Efficacy|1|||
161202720|NCT02596009|582122248|FG000|Overall Study|Administrative problems|0|||
161202721|NCT02596009|582122249|FG001|Overall Study|Administrative problems|1|||
161202722|NCT02596009|582122250|FG002|Overall Study|Administrative problems|0|||
161202723|NCT02596009|582122251|FG003|Overall Study|Administrative problems|0|||
161202724|NCT02596009|582122252|FG004|Overall Study|Administrative problems|0|||
161202725|NCT02596009|582122253|FG005|Overall Study|Administrative problems|0|||
161202726|NCT04755283|582122257|FG000|Overall Study|Withdrawal by Subject|14|||
161202727|NCT04755283|582122258|FG001|Overall Study|Withdrawal by Subject|3|||
161202728|NCT04755283|582122259|FG002|Overall Study|Withdrawal by Subject|6|||
161202729|NCT04755283|582122257|FG000|Overall Study|Lost to Follow-up|0|||
161202730|NCT04755283|582122258|FG001|Overall Study|Lost to Follow-up|0|||
161202731|NCT04755283|582122259|FG002|Overall Study|Lost to Follow-up|1|||
161202732|NCT04755283|582122257|FG000|Overall Study|Death|31|||
161202733|NCT04755283|582122258|FG001|Overall Study|Death|36|||
161202734|NCT04755283|582122259|FG002|Overall Study|Death|34|||
161202735|NCT03179462|582122262|FG000|Overall Study|screening failure|1|||
161202736|NCT03179462|582122263|FG001|Overall Study|screening failure|2|||
161202737|NCT03179462|582122264|FG002|Overall Study|screening failure|0|||
161202738|NCT04410978|582122273|FG000|Overall Study|Poor compliance to protocol|2|||
161202739|NCT04410978|582122274|FG001|Overall Study|Poor compliance to protocol|4|||
161202740|NCT04410978|582122273|FG000|Overall Study|Withdrawal by Subject|64|||
161202741|NCT04410978|582122274|FG001|Overall Study|Withdrawal by Subject|66|||
161202742|NCT04410978|582122273|FG000|Overall Study|Other|6|||
161202743|NCT04410978|582122274|FG001|Overall Study|Other|7|||
161202744|NCT04410978|582122273|FG000|Overall Study|Missing study status|1|||
161202745|NCT04410978|582122274|FG001|Overall Study|Missing study status|0|||
161202746|NCT02684162|582122275|FG000|Overall Study|Physician Decision|0|||
161202747|NCT02684162|582122276|FG001|Overall Study|Physician Decision|1|||
161202748|NCT02684162|582122277|FG002|Overall Study|Physician Decision|0|||
161202749|NCT05153629|582122278|FG000|Overall Study|Withdrawal by Subject|0|||
161202750|NCT05153629|582122279|FG001|Overall Study|Withdrawal by Subject|2|||
161202751|NCT04089566|582122284|FG000|Overall Study|Death|0|||
161202752|NCT04089566|582122285|FG001|Overall Study|Death|6|||
161202753|NCT04089566|582122286|FG002|Overall Study|Death|10|||
161202754|NCT04089566|582122287|FG003|Overall Study|Death|0|||
161202755|NCT04089566|582122288|FG004|Overall Study|Death|0|||
161202756|NCT04089566|582122289|FG005|Overall Study|Death|0|||
161202757|NCT04089566|582122284|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
161202758|NCT04089566|582122285|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
161202759|NCT04089566|582122286|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
161202760|NCT04089566|582122287|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
161202761|NCT04089566|582122288|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
161202762|NCT04089566|582122289|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
161202763|NCT04089566|582122284|FG000|Overall Study|Reason not Specified|0|||
161202764|NCT04089566|582122285|FG001|Overall Study|Reason not Specified|4|||
161202765|NCT04089566|582122286|FG002|Overall Study|Reason not Specified|4|||
161202766|NCT04089566|582122287|FG003|Overall Study|Reason not Specified|1|||
161202767|NCT04089566|582122288|FG004|Overall Study|Reason not Specified|0|||
161202768|NCT04089566|582122289|FG005|Overall Study|Reason not Specified|0|||
161202769|NCT01083121|582122290|FG000|Overall Study|Use of Humira outside the approved label|81|||
161202770|NCT05403502|582122292|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
161202771|NCT05403502|582122292|FG000|Humalog Lead-In Period|Physician Decision|2|||
161202772|NCT05403502|582122292|FG000|Humalog Lead-In Period|Protocol Violation|1|||
161202773|NCT05403502|582122292|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
161202774|NCT05403502|582122292|FG000|Lyumjev Treatment Period|Physician Decision|2|||
161202775|NCT01058707|582122293|FG000|Overall Study|Disease Progression|15|||
161202776|NCT01058707|582122294|FG001|Overall Study|Disease Progression|20|||
161202777|NCT01058707|582122295|FG002|Overall Study|Disease Progression|20|||
161202778|NCT01058707|582122296|FG003|Overall Study|Disease Progression|15|||
161202779|NCT01058707|582122297|FG004|Overall Study|Disease Progression|23|||
161202780|NCT01058707|582122298|FG005|Overall Study|Disease Progression|10|||
161202781|NCT01058707|582122299|FG006|Overall Study|Disease Progression|12|||
161202782|NCT01058707|582122293|FG000|Overall Study|Adverse Event|11|||
161202783|NCT01058707|582122294|FG001|Overall Study|Adverse Event|4|||
161202784|NCT01058707|582122295|FG002|Overall Study|Adverse Event|7|||
161202785|NCT01058707|582122296|FG003|Overall Study|Adverse Event|6|||
161202786|NCT01058707|582122297|FG004|Overall Study|Adverse Event|7|||
161202787|NCT01058707|582122298|FG005|Overall Study|Adverse Event|3|||
161202788|NCT01058707|582122299|FG006|Overall Study|Adverse Event|1|||
161202789|NCT01058707|582122293|FG000|Overall Study|Subject Decision|5|||
161202790|NCT01058707|582122294|FG001|Overall Study|Subject Decision|3|||
161202791|NCT01058707|582122295|FG002|Overall Study|Subject Decision|3|||
161202792|NCT01058707|582122296|FG003|Overall Study|Subject Decision|1|||
161202793|NCT01058707|582122297|FG004|Overall Study|Subject Decision|2|||
161202794|NCT01058707|582122298|FG005|Overall Study|Subject Decision|3|||
161202795|NCT01058707|582122299|FG006|Overall Study|Subject Decision|6|||
161202796|NCT01058707|582122293|FG000|Overall Study|Lost to Follow-up|0|||
161202797|NCT01058707|582122294|FG001|Overall Study|Lost to Follow-up|0|||
161202798|NCT01058707|582122295|FG002|Overall Study|Lost to Follow-up|1|||
161202799|NCT01058707|582122296|FG003|Overall Study|Lost to Follow-up|0|||
161202800|NCT01058707|582122297|FG004|Overall Study|Lost to Follow-up|0|||
161309939|NCT02339155|582516965|FG000|Overall Study|Death|1|||
161309940|NCT02339155|582516966|FG001|Overall Study|Death|1|||
161309941|NCT02339155|582516965|FG000|Overall Study|Lost to Follow-up|8|||
161309942|NCT02339155|582516966|FG001|Overall Study|Lost to Follow-up|9|||
161309943|NCT02339155|582516965|FG000|Overall Study|Physician Decision|2|||
161309944|NCT02339155|582516966|FG001|Overall Study|Physician Decision|1|||
161309945|NCT02339155|582516965|FG000|Overall Study|Withdrawal by Subject|4|||
161309946|NCT02339155|582516966|FG001|Overall Study|Withdrawal by Subject|4|||
161309947|NCT03226678|582516973|FG000|Part A (Core Study Phase)|Adverse Event|0|||
161309948|NCT03226678|582516974|FG001|Part A (Core Study Phase)|Adverse Event|1|||
161309949|NCT03226678|582516975|FG002|Part A (Core Study Phase)|Adverse Event|0|||
161309950|NCT03226678|582516976|FG003|Part A (Core Study Phase)|Adverse Event|0|||
161309951|NCT03226678|582516977|FG004|Part A (Core Study Phase)|Adverse Event|0|||
161309952|NCT03226678|582516978|FG005|Part A (Core Study Phase)|Adverse Event|0|||
161309953|NCT03226678|582516973|FG000|Part A (Core Study Phase)|Death|0|||
161309954|NCT03226678|582516974|FG001|Part A (Core Study Phase)|Death|0|||
161309955|NCT03226678|582516975|FG002|Part A (Core Study Phase)|Death|1|||
161309956|NCT03226678|582516976|FG003|Part A (Core Study Phase)|Death|0|||
161309957|NCT03226678|582516977|FG004|Part A (Core Study Phase)|Death|0|||
161309958|NCT03226678|582516978|FG005|Part A (Core Study Phase)|Death|0|||
161309959|NCT03226678|582516973|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
161309960|NCT03226678|582516974|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
161309961|NCT03226678|582516975|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
161309962|NCT03226678|582516976|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
161309963|NCT03226678|582516977|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
161309964|NCT03226678|582516978|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
161309965|NCT03226678|582516973|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161309966|NCT03226678|582516974|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161309967|NCT03226678|582516975|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
161309968|NCT03226678|582516976|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161309969|NCT03226678|582516977|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161309970|NCT03226678|582516978|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
161309971|NCT03226678|582516973|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161309972|NCT03226678|582516974|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161309973|NCT03226678|582516975|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161309974|NCT03226678|582516976|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
161309975|NCT03226678|582516977|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161309976|NCT03226678|582516978|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
161309977|NCT03226678|582516973|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
161309978|NCT03226678|582516974|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
161309979|NCT03226678|582516975|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161309980|NCT03226678|582516976|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161309981|NCT03226678|582516977|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161309982|NCT03226678|582516978|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
161309983|NCT03226678|582516973|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161309984|NCT03226678|582516974|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161309985|NCT03226678|582516975|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161309986|NCT03226678|582516976|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
161309987|NCT03226678|582516977|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
161309988|NCT03226678|582516978|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
161309989|NCT03226678|582516973|FG000|Part B (Long-Term Extension Phase)|Death|0|||
161202801|NCT01058707|582122298|FG005|Overall Study|Lost to Follow-up|0|||
161202802|NCT01058707|582122299|FG006|Overall Study|Lost to Follow-up|0|||
161202803|NCT01058707|582122293|FG000|Overall Study|Reason Not Specified|0|||
161202804|NCT01058707|582122294|FG001|Overall Study|Reason Not Specified|3|||
161202805|NCT01058707|582122295|FG002|Overall Study|Reason Not Specified|2|||
161202806|NCT01058707|582122296|FG003|Overall Study|Reason Not Specified|0|||
161202807|NCT01058707|582122297|FG004|Overall Study|Reason Not Specified|7|||
161202808|NCT01058707|582122298|FG005|Overall Study|Reason Not Specified|1|||
161202809|NCT01058707|582122299|FG006|Overall Study|Reason Not Specified|7|||
161202810|NCT00167414|582122300|FG000|Overall Study|Death|10|||
161202811|NCT01593761|582122301|FG000|Overall Study|Lost to Follow-up|1|||
161202812|NCT01593761|582122301|FG000|Overall Study|culture negative for MRSA at baseline|5|||
161202813|NCT01593761|582122301|FG000|Overall Study|positive for hepatitis C virus|1|||
161202814|NCT01593761|582122301|FG000|Overall Study|secondary cellulitis|1|||
161202815|NCT00795886|582122306|FG000|Overall Study|Death|10|||
161202816|NCT05554471|582122307|FG000|Overall Study|Physician Decision|2|||
161202817|NCT05554471|582122308|FG001|Overall Study|Physician Decision|1|||
161202818|NCT05554471|582122307|FG000|Overall Study|Lost to Follow-up|2|||
161202819|NCT05554471|582122308|FG001|Overall Study|Lost to Follow-up|1|||
161202820|NCT05554471|582122307|FG000|Overall Study|Death|0|||
161202821|NCT05554471|582122308|FG001|Overall Study|Death|1|||
161202822|NCT02576951|582122309|FG000|Overall Study|Lost to Follow-up|0|||
161202823|NCT02576951|582122310|FG001|Overall Study|Lost to Follow-up|0|||
161202824|NCT02576951|582122311|FG002|Overall Study|Lost to Follow-up|2|||
161202825|NCT02576951|582122312|FG003|Overall Study|Lost to Follow-up|2|||
161202826|NCT02576951|582122309|FG000|Overall Study|Withdrawal by Subject|1|||
161202827|NCT02576951|582122310|FG001|Overall Study|Withdrawal by Subject|0|||
161202828|NCT02576951|582122311|FG002|Overall Study|Withdrawal by Subject|0|||
161202829|NCT02576951|582122312|FG003|Overall Study|Withdrawal by Subject|2|||
161202830|NCT02576951|582122309|FG000|Overall Study|Protocol Violation|0|||
161202831|NCT02576951|582122310|FG001|Overall Study|Protocol Violation|0|||
161202832|NCT02576951|582122311|FG002|Overall Study|Protocol Violation|0|||
161202833|NCT02576951|582122312|FG003|Overall Study|Protocol Violation|1|||
161202834|NCT00223990|582122313|FG000|Overall Study|Moved from area|2|||
161202835|NCT00223990|582122314|FG001|Overall Study|Moved from area|1|||
161202836|NCT00223990|582122313|FG000|Overall Study|Withdrawal by Subject|4|||
161202837|NCT00223990|582122314|FG001|Overall Study|Withdrawal by Subject|8|||
161202838|NCT00223990|582122313|FG000|Overall Study|Lost to Follow-up|1|||
161202839|NCT00223990|582122314|FG001|Overall Study|Lost to Follow-up|0|||
161202840|NCT03387423|582124301|FG000|Overall Study|Lost to Follow-up|16|||
161202841|NCT03387423|582124302|FG001|Overall Study|Lost to Follow-up|12|||
161202842|NCT03387423|582124303|FG002|Overall Study|Lost to Follow-up|1|||
161202843|NCT03387423|582124304|FG003|Overall Study|Lost to Follow-up|0|||
161202844|NCT03387423|582124301|FG000|Overall Study|Other|0|||
161202845|NCT03387423|582124302|FG001|Overall Study|Other|3|||
161202846|NCT03387423|582124303|FG002|Overall Study|Other|0|||
161202847|NCT03387423|582124304|FG003|Overall Study|Other|0|||
161202848|NCT03387423|582124301|FG000|Overall Study|Administrative Reason|166|||
161202849|NCT03387423|582124302|FG001|Overall Study|Administrative Reason|89|||
161202850|NCT03387423|582124303|FG002|Overall Study|Administrative Reason|17|||
161202851|NCT03387423|582124304|FG003|Overall Study|Administrative Reason|19|||
161202852|NCT03387423|582124301|FG000|Overall Study|Revocation Consent|76|||
161202853|NCT03387423|582124302|FG001|Overall Study|Revocation Consent|32|||
161202854|NCT03387423|582124303|FG002|Overall Study|Revocation Consent|3|||
161202855|NCT03387423|582124304|FG003|Overall Study|Revocation Consent|5|||
161202856|NCT03926728|582124307|FG000|Overall Study|Withdrawal by Subject|0|||
161202857|NCT03926728|582124308|FG001|Overall Study|Withdrawal by Subject|1|||
161202858|NCT03926728|582124309|FG002|Overall Study|Withdrawal by Subject|1|||
161202859|NCT03926728|582124310|FG003|Overall Study|Withdrawal by Subject|0|||
161202860|NCT03926728|582124311|FG004|Overall Study|Withdrawal by Subject|0|||
161202861|NCT03926728|582124312|FG005|Overall Study|Withdrawal by Subject|1|||
161202862|NCT03926728|582124313|FG006|Overall Study|Withdrawal by Subject|1|||
161202863|NCT03926728|582124314|FG007|Overall Study|Withdrawal by Subject|0|||
161202864|NCT03926728|582124315|FG008|Overall Study|Withdrawal by Subject|0|||
161202865|NCT03926728|582124316|FG009|Overall Study|Withdrawal by Subject|1|||
161202866|NCT03926728|582124317|FG010|Overall Study|Withdrawal by Subject|0|||
161202867|NCT03926728|582124318|FG011|Overall Study|Withdrawal by Subject|0|||
161202868|NCT03669640|582124323|FG000|Overall Study|Study Terminated by Sponsor|0|||
161202869|NCT03669640|582124324|FG001|Overall Study|Study Terminated by Sponsor|0|||
161202870|NCT03669640|582124325|FG002|Overall Study|Study Terminated by Sponsor|0|||
161202871|NCT03669640|582124326|FG003|Overall Study|Study Terminated by Sponsor|0|||
161202872|NCT03669640|582124327|FG004|Overall Study|Study Terminated by Sponsor|1|||
161202873|NCT03669640|582124328|FG005|Overall Study|Study Terminated by Sponsor|0|||
161202874|NCT03669640|582124323|FG000|Overall Study|Lost to Follow-up|0|||
161202875|NCT03669640|582124324|FG001|Overall Study|Lost to Follow-up|0|||
161202876|NCT03669640|582124325|FG002|Overall Study|Lost to Follow-up|2|||
161202877|NCT03669640|582124326|FG003|Overall Study|Lost to Follow-up|0|||
161202878|NCT03669640|582124327|FG004|Overall Study|Lost to Follow-up|0|||
161202879|NCT03669640|582124328|FG005|Overall Study|Lost to Follow-up|0|||
161202880|NCT03669640|582124323|FG000|Overall Study|Death|0|||
161202881|NCT03669640|582124324|FG001|Overall Study|Death|0|||
161202882|NCT03669640|582124325|FG002|Overall Study|Death|1|||
161202883|NCT03669640|582124326|FG003|Overall Study|Death|0|||
161202884|NCT03669640|582124327|FG004|Overall Study|Death|0|||
161202885|NCT03669640|582124328|FG005|Overall Study|Death|0|||
161202886|NCT03669640|582124323|FG000|Overall Study|Withdrawal by Subject|1|||
161202887|NCT03669640|582124324|FG001|Overall Study|Withdrawal by Subject|2|||
161202888|NCT03669640|582124325|FG002|Overall Study|Withdrawal by Subject|1|||
161202889|NCT03669640|582124326|FG003|Overall Study|Withdrawal by Subject|0|||
161202890|NCT03669640|582124327|FG004|Overall Study|Withdrawal by Subject|1|||
161202891|NCT03669640|582124328|FG005|Overall Study|Withdrawal by Subject|3|||
161202892|NCT03669640|582124323|FG000|Overall Study|Protocol Violation|1|||
161202893|NCT03669640|582124324|FG001|Overall Study|Protocol Violation|0|||
161202894|NCT03669640|582124325|FG002|Overall Study|Protocol Violation|0|||
161202895|NCT03669640|582124326|FG003|Overall Study|Protocol Violation|0|||
161202896|NCT03669640|582124327|FG004|Overall Study|Protocol Violation|0|||
161202897|NCT03669640|582124328|FG005|Overall Study|Protocol Violation|0|||
161202898|NCT03669640|582124323|FG000|Overall Study|Physician Decision|0|||
161202899|NCT03669640|582124324|FG001|Overall Study|Physician Decision|2|||
161202900|NCT03669640|582124325|FG002|Overall Study|Physician Decision|0|||
161309990|NCT03226678|582516974|FG001|Part B (Long-Term Extension Phase)|Death|0|||
161309991|NCT03226678|582516975|FG002|Part B (Long-Term Extension Phase)|Death|0|||
161309992|NCT03226678|582516976|FG003|Part B (Long-Term Extension Phase)|Death|0|||
161309993|NCT03226678|582516977|FG004|Part B (Long-Term Extension Phase)|Death|0|||
161309994|NCT03226678|582516978|FG005|Part B (Long-Term Extension Phase)|Death|1|||
161309995|NCT03226678|582516973|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161309996|NCT03226678|582516974|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161309997|NCT03226678|582516975|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161309998|NCT03226678|582516976|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161309999|NCT03226678|582516977|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
161310000|NCT03226678|582516978|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
161310001|NCT03226678|582516973|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161310002|NCT03226678|582516974|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161310003|NCT03226678|582516975|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161310004|NCT03226678|582516976|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
161310005|NCT03226678|582516977|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
161310006|NCT03226678|582516978|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
161310007|NCT03226678|582516973|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161310008|NCT03226678|582516974|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161310009|NCT03226678|582516975|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161310010|NCT03226678|582516976|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161310011|NCT03226678|582516977|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
161310012|NCT03226678|582516978|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
161310013|NCT00916344|582516985|FG000|Overall Study|Death|2|||
161310014|NCT00916344|582516985|FG000|Overall Study|ICD upgrade|1|||
161310015|NCT00916344|582516985|FG000|Overall Study|Drop-out|5|||
161310016|NCT03602391|582516986|FG000|Overall Study|COVID-19|7|||
161310017|NCT03602391|582516987|FG001|Overall Study|COVID-19|6|||
161310018|NCT00108485|582516992|FG000|Overall Study|Withdrawal by Subject|3|||
161310019|NCT00108485|582516993|FG001|Overall Study|Withdrawal by Subject|0|||
161310020|NCT00108485|582516992|FG000|Overall Study|Lost to Follow-up|0|||
161310021|NCT00108485|582516993|FG001|Overall Study|Lost to Follow-up|2|||
161310022|NCT00878969|582516998|FG000|Overall Study|Physician Decision|5|||
161310023|NCT00878969|582516999|FG001|Overall Study|Physician Decision|3|||
161310024|NCT00878969|582517000|FG002|Overall Study|Physician Decision|2|||
161310025|NCT00878969|582516998|FG000|Overall Study|Withdrawal by Subject|1|||
161310026|NCT00878969|582516999|FG001|Overall Study|Withdrawal by Subject|6|||
161310027|NCT00878969|582517000|FG002|Overall Study|Withdrawal by Subject|3|||
161310028|NCT00878969|582516998|FG000|Overall Study|kidney transplant|2|||
161310029|NCT00878969|582516999|FG001|Overall Study|kidney transplant|3|||
161310030|NCT00878969|582517000|FG002|Overall Study|kidney transplant|2|||
161310031|NCT00878969|582516998|FG000|Overall Study|Adverse Event|3|||
161310032|NCT00878969|582516999|FG001|Overall Study|Adverse Event|1|||
161310033|NCT00878969|582517000|FG002|Overall Study|Adverse Event|2|||
161310034|NCT00878969|582516998|FG000|Overall Study|Lost to Follow-up|2|||
161310035|NCT00878969|582516999|FG001|Overall Study|Lost to Follow-up|1|||
161310036|NCT00878969|582517000|FG002|Overall Study|Lost to Follow-up|0|||
161202901|NCT03669640|582124326|FG003|Overall Study|Physician Decision|0|||
161202902|NCT03669640|582124327|FG004|Overall Study|Physician Decision|0|||
161202903|NCT03669640|582124328|FG005|Overall Study|Physician Decision|0|||
161202904|NCT03669640|582124323|FG000|Overall Study|Disease Relapse|1|||
161202905|NCT03669640|582124324|FG001|Overall Study|Disease Relapse|0|||
161202906|NCT03669640|582124325|FG002|Overall Study|Disease Relapse|0|||
161202907|NCT03669640|582124326|FG003|Overall Study|Disease Relapse|0|||
161202908|NCT03669640|582124327|FG004|Overall Study|Disease Relapse|0|||
161202909|NCT03669640|582124328|FG005|Overall Study|Disease Relapse|0|||
161202910|NCT03669640|582124323|FG000|Overall Study|Adverse Event|2|||
161202911|NCT03669640|582124324|FG001|Overall Study|Adverse Event|1|||
161202912|NCT03669640|582124325|FG002|Overall Study|Adverse Event|0|||
161202913|NCT03669640|582124326|FG003|Overall Study|Adverse Event|0|||
161202914|NCT03669640|582124327|FG004|Overall Study|Adverse Event|1|||
161202915|NCT03669640|582124328|FG005|Overall Study|Adverse Event|0|||
161202916|NCT03993288|582124331|FG000|Overall Study|Lost to Follow-up|2|||
161202917|NCT03993288|582124332|FG001|Overall Study|Lost to Follow-up|1|||
161202918|NCT03993288|582124331|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
161202919|NCT03993288|582124332|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
161202920|NCT03993288|582124331|FG000|Overall Study|wrong randomization|0|||
161202921|NCT03993288|582124332|FG001|Overall Study|wrong randomization|1|||
161202922|NCT03993288|582124331|FG000|Overall Study|improper enrollment|0|||
161202923|NCT03993288|582124332|FG001|Overall Study|improper enrollment|1|||
161202924|NCT03993288|582124331|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
161202925|NCT03993288|582124332|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
161202926|NCT03993288|582124331|FG000|Overall Study|developed SAE|2|||
161202927|NCT03993288|582124332|FG001|Overall Study|developed SAE|0|||
161202928|NCT03993288|582124331|FG000|Overall Study|consent withdrawal|1|||
161202929|NCT03993288|582124332|FG001|Overall Study|consent withdrawal|0|||
161202930|NCT03993288|582124331|FG000|Overall Study|did not follow the treatment schedule|1|||
161202931|NCT03993288|582124332|FG001|Overall Study|did not follow the treatment schedule|0|||
161202932|NCT03993288|582124331|FG000|Overall Study|did not follow the treatment regimen|1|||
161202933|NCT03993288|582124332|FG001|Overall Study|did not follow the treatment regimen|0|||
161202934|NCT03993288|582124331|FG000|Overall Study|Adverse Event|1|||
161202935|NCT03993288|582124332|FG001|Overall Study|Adverse Event|0|||
161202936|NCT03993288|582124331|FG000|Overall Study|Withdrawal by Subject|1|||
161202937|NCT03993288|582124332|FG001|Overall Study|Withdrawal by Subject|1|||
161202938|NCT02729545|582124333|FG000|Overall Study|Pregnancy|1|||
161202939|NCT02729545|582124334|FG001|Overall Study|Pregnancy|1|||
161202940|NCT02729545|582124333|FG000|Overall Study|Lost to Follow-up|0|||
161202941|NCT02729545|582124334|FG001|Overall Study|Lost to Follow-up|1|||
161202942|NCT02729545|582124333|FG000|Overall Study|Withdrawal by Subject|2|||
161202943|NCT02729545|582124334|FG001|Overall Study|Withdrawal by Subject|3|||
161202944|NCT03533608|582124335|FG000|Overall Study|Withdrawal by Subject|3|||
161202945|NCT03533608|582124335|FG000|Overall Study|Physician Decision|2|||
161202946|NCT01389024|582124336|FG000|Overall Study|Withdrawal by Subject|0|||
161202947|NCT01389024|582124337|FG001|Overall Study|Withdrawal by Subject|1|||
161202948|NCT01389024|582124336|FG000|Overall Study|Lost to Follow-up|1|||
161202949|NCT01389024|582124337|FG001|Overall Study|Lost to Follow-up|0|||
161202950|NCT03443973|582124339|FG000|Double-blind Treatment Period|Adverse Event|5|||
161202951|NCT03443973|582124340|FG001|Double-blind Treatment Period|Adverse Event|19|||
161202952|NCT03443973|582124341|FG002|Double-blind Treatment Period|Adverse Event|0|||
161202953|NCT03443973|582124342|FG003|Double-blind Treatment Period|Adverse Event|0|||
161202954|NCT03443973|582124339|FG000|Double-blind Treatment Period|Death|5|||
161202955|NCT03443973|582124340|FG001|Double-blind Treatment Period|Death|7|||
161202956|NCT03443973|582124341|FG002|Double-blind Treatment Period|Death|0|||
161202957|NCT03443973|582124342|FG003|Double-blind Treatment Period|Death|0|||
161202958|NCT03443973|582124339|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
161202959|NCT03443973|582124340|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
161202960|NCT03443973|582124341|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
161202961|NCT03443973|582124342|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
161202962|NCT03443973|582124339|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
161202963|NCT03443973|582124340|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
161202964|NCT03443973|582124341|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
161202965|NCT03443973|582124342|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
161202966|NCT03443973|582124339|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
161202967|NCT03443973|582124340|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
161202968|NCT03443973|582124341|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
161202969|NCT03443973|582124342|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
161202970|NCT03443973|582124339|FG000|Double-blind Treatment Period|Physician Decision|5|||
161202971|NCT03443973|582124340|FG001|Double-blind Treatment Period|Physician Decision|6|||
161202972|NCT03443973|582124341|FG002|Double-blind Treatment Period|Physician Decision|0|||
161202973|NCT03443973|582124342|FG003|Double-blind Treatment Period|Physician Decision|0|||
161202974|NCT03443973|582124339|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
161202975|NCT03443973|582124340|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
161202976|NCT03443973|582124341|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
161202977|NCT03443973|582124342|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
161202978|NCT03443973|582124339|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
161202979|NCT03443973|582124340|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
161202980|NCT03443973|582124341|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161202981|NCT03443973|582124342|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
161202982|NCT03443973|582124339|FG000|Open-label Extension Period|Reason Not Specified|0|||
161202983|NCT03443973|582124340|FG001|Open-label Extension Period|Reason Not Specified|0|||
161202984|NCT03443973|582124341|FG002|Open-label Extension Period|Reason Not Specified|3|||
161202985|NCT03443973|582124342|FG003|Open-label Extension Period|Reason Not Specified|0|||
161202986|NCT03443973|582124339|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
161202987|NCT03443973|582124340|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
161202988|NCT03443973|582124341|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
161202989|NCT03443973|582124342|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
161202990|NCT04930536|582124343|FG000|Overall Study|Adverse Event|1|||
161202991|NCT04930536|582124344|FG001|Overall Study|Adverse Event|0|||
161202992|NCT04930536|582124343|FG000|Overall Study|Disease Progression|2|||
161202993|NCT04930536|582124344|FG001|Overall Study|Disease Progression|0|||
161202994|NCT04930536|582124343|FG000|Overall Study|Patient Decision|4|||
161202995|NCT04930536|582124344|FG001|Overall Study|Patient Decision|2|||
161202996|NCT04930536|582124343|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
161202997|NCT04930536|582124344|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
161202998|NCT01432600|582124345|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
161202999|NCT01432600|582124346|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
161203000|NCT01432600|582124347|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
161203001|NCT00398632|582124348|FG000|Overall Study|Withdrawal by Subject|1|||
161203002|NCT00398632|582124348|FG000|Overall Study|Lack of Efficacy|1|||
161203003|NCT00267020|582124349|FG000|Overall Study|Adverse Event|22|||
161203004|NCT00267020|582124350|FG001|Overall Study|Adverse Event|5|||
161203005|NCT00267020|582124349|FG000|Overall Study|Death|2|||
161203006|NCT00267020|582124350|FG001|Overall Study|Death|1|||
161203007|NCT00267020|582124349|FG000|Overall Study|Withdrawal by Subject|17|||
161203008|NCT00267020|582124350|FG001|Overall Study|Withdrawal by Subject|7|||
161203009|NCT00267020|582124349|FG000|Overall Study|Physician Decision|3|||
161203010|NCT00267020|582124350|FG001|Overall Study|Physician Decision|2|||
161203011|NCT00267020|582124349|FG000|Overall Study|Disease Progression|39|||
161203012|NCT00267020|582124350|FG001|Overall Study|Disease Progression|25|||
161203013|NCT00267020|582124349|FG000|Overall Study|Unrelated Complication|1|||
161203014|NCT00267020|582124350|FG001|Overall Study|Unrelated Complication|1|||
161203015|NCT00267020|582124349|FG000|Overall Study|Sponsor Request|1|||
161203016|NCT00267020|582124350|FG001|Overall Study|Sponsor Request|0|||
161203017|NCT00267020|582124349|FG000|Overall Study|Other|1|||
161203018|NCT00267020|582124350|FG001|Overall Study|Other|2|||
161203019|NCT00640614|582124354|FG000|Overall Study|Lost to Follow-up|1|||
161203020|NCT00640614|582124355|FG001|Overall Study|Lost to Follow-up|0|||
161203021|NCT00529802|582124356|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
161203022|NCT00529802|582124356|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
161203023|NCT00529802|582124356|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
161203024|NCT00529802|582124356|FG000|Evaluable for Primary Endpoint|Death|1|||
161203025|NCT00529802|582124356|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
161203026|NCT00529802|582124356|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
161203027|NCT00529802|582124356|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
161203028|NCT02209454|582124360|FG000|Second Period|Adverse Event|1|||
161203029|NCT02209454|582124361|FG001|Second Period|Adverse Event|0|||
161203030|NCT00366678|582124362|FG000|Infant Series|Withdrawal by Subject|8|||
161203031|NCT00366678|582124363|FG001|Infant Series|Withdrawal by Subject|6|||
161203032|NCT00366678|582124364|FG002|Infant Series|Withdrawal by Subject|0|||
161203033|NCT00366678|582124362|FG000|Infant Series|Protocol Violation|4|||
161203034|NCT00366678|582124363|FG001|Infant Series|Protocol Violation|3|||
161203035|NCT00366678|582124364|FG002|Infant Series|Protocol Violation|0|||
161203036|NCT00366678|582124362|FG000|Infant Series|Failed to return|1|||
161203037|NCT00366678|582124363|FG001|Infant Series|Failed to return|1|||
161203038|NCT00366678|582124364|FG002|Infant Series|Failed to return|0|||
161203039|NCT00366678|582124362|FG000|Infant Series|Adverse Event|1|||
161203040|NCT00366678|582124363|FG001|Infant Series|Adverse Event|0|||
161203041|NCT00366678|582124364|FG002|Infant Series|Adverse Event|0|||
161203042|NCT00366678|582124362|FG000|After Infant|Withdrawal by Subject|8|||
161203043|NCT00366678|582124363|FG001|After Infant|Withdrawal by Subject|4|||
161203044|NCT00366678|582124364|FG002|After Infant|Withdrawal by Subject|0|||
161203045|NCT00366678|582124362|FG000|After Infant|Lost to Follow-up|2|||
161203046|NCT00366678|582124363|FG001|After Infant|Lost to Follow-up|1|||
161203047|NCT00366678|582124364|FG002|After Infant|Lost to Follow-up|0|||
161203048|NCT00366678|582124362|FG000|After Infant|Failed to return|5|||
161203049|NCT00366678|582124363|FG001|After Infant|Failed to return|5|||
161203050|NCT00366678|582124364|FG002|After Infant|Failed to return|0|||
161203051|NCT00366678|582124362|FG000|After Infant|Adverse Event|1|||
161203052|NCT00366678|582124363|FG001|After Infant|Adverse Event|0|||
161203053|NCT00366678|582124364|FG002|After Infant|Adverse Event|0|||
161203054|NCT00366678|582124362|FG000|After Infant|Protocol Violation|1|||
161203055|NCT00366678|582124363|FG001|After Infant|Protocol Violation|0|||
161203056|NCT00366678|582124364|FG002|After Infant|Protocol Violation|0|||
161203057|NCT00366678|582124362|FG000|Toddler Dose|Protocol Violation|2|||
161203058|NCT00366678|582124363|FG001|Toddler Dose|Protocol Violation|1|||
161203059|NCT00366678|582124364|FG002|Toddler Dose|Protocol Violation|0|||
161310037|NCT00878969|582516998|FG000|Overall Study|Protocol Violation|2|||
161310038|NCT00878969|582516999|FG001|Overall Study|Protocol Violation|0|||
161310039|NCT00878969|582517000|FG002|Overall Study|Protocol Violation|0|||
161310040|NCT00878969|582516998|FG000|Overall Study|Death|0|||
161310041|NCT00878969|582516999|FG001|Overall Study|Death|0|||
161310042|NCT00878969|582517000|FG002|Overall Study|Death|2|||
161310043|NCT00878969|582516998|FG000|Overall Study|Pregnancy|0|||
161310044|NCT00878969|582516999|FG001|Overall Study|Pregnancy|1|||
161310045|NCT00878969|582517000|FG002|Overall Study|Pregnancy|0|||
161310046|NCT01701193|582517003|FG000|Overall Study|Withdrawal by Subject|2|||
161310047|NCT01701193|582517004|FG001|Overall Study|Withdrawal by Subject|2|||
161310048|NCT01701193|582517005|FG002|Overall Study|Withdrawal by Subject|1|||
161310049|NCT01701193|582517006|FG003|Overall Study|Withdrawal by Subject|2|||
161310050|NCT01701193|582517003|FG000|Overall Study|Adverse Event|1|||
161310051|NCT01701193|582517004|FG001|Overall Study|Adverse Event|0|||
161310052|NCT01701193|582517005|FG002|Overall Study|Adverse Event|0|||
161310053|NCT01701193|582517006|FG003|Overall Study|Adverse Event|0|||
161310054|NCT03054064|582517007|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
161310055|NCT03054064|582517007|FG000|Overall Study|Investigator Decision|2|||
161310056|NCT03054064|582517007|FG000|Overall Study|Bladder Issue|1|||
161310057|NCT03054064|582517007|FG000|Overall Study|High Blood Pressure|1|||
161310058|NCT03054064|582517007|FG000|Overall Study|Change in Status|1|||
161310059|NCT01527487|582517008|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
161310060|NCT01527487|582517009|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
161310061|NCT01527487|582517008|FG000|Overall Study|Disease Progression|4|||
161310062|NCT01527487|582517009|FG001|Overall Study|Disease Progression|1|||
161310063|NCT01527487|582517008|FG000|Overall Study|Adverse Event|1|||
161310064|NCT01527487|582517009|FG001|Overall Study|Adverse Event|1|||
161310065|NCT01527487|582517008|FG000|Overall Study|Death|0|||
161310066|NCT01527487|582517009|FG001|Overall Study|Death|1|||
161310067|NCT01384019|582517010|FG000|Overall Study|Withdrawal by Subject|3|||
161310068|NCT01384019|582517011|FG001|Overall Study|Withdrawal by Subject|0|||
161310069|NCT01384019|582517010|FG000|Overall Study|Death|1|||
161310070|NCT01384019|582517011|FG001|Overall Study|Death|0|||
161310071|NCT01384019|582517010|FG000|Overall Study|MRI refusal|6|||
161310072|NCT01384019|582517011|FG001|Overall Study|MRI refusal|6|||
161310073|NCT00081731|582517014|FG000|Overall Study|scientific integrity issue|8|||
161310074|NCT00081731|582517015|FG001|Overall Study|scientific integrity issue|8|||
161310075|NCT03973918|582517019|FG000|Overall Study|Adverse Event|0|||
161310076|NCT03973918|582517020|FG001|Overall Study|Adverse Event|0|||
161310077|NCT03973918|582517021|FG002|Overall Study|Adverse Event|0|||
161310078|NCT03973918|582517022|FG003|Overall Study|Adverse Event|1|||
161310079|NCT03973918|582517019|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161310080|NCT03973918|582517020|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
161310081|NCT03973918|582517021|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161310082|NCT03973918|582517022|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
161310083|NCT04050124|582517023|FG000|Overall Study|Death|1|||
161310084|NCT04050124|582517024|FG001|Overall Study|Death|0|||
161310085|NCT04601103|582517027|FG000|Overall Study|Needed crown & cleaning|0|||
161310086|NCT04601103|582517028|FG001|Overall Study|Needed crown & cleaning|0|||
161310087|NCT04601103|582517029|FG002|Overall Study|Needed crown & cleaning|1|||
161310088|NCT04601103|582517027|FG000|Overall Study|study was terminated|18|||
161310089|NCT04601103|582517028|FG001|Overall Study|study was terminated|18|||
161310090|NCT04601103|582517029|FG002|Overall Study|study was terminated|16|||
161203060|NCT00366678|582124362|FG000|Toddler Dose|Failed to return|1|||
161203061|NCT00366678|582124363|FG001|Toddler Dose|Failed to return|0|||
161203062|NCT00366678|582124364|FG002|Toddler Dose|Failed to return|0|||
161203063|NCT00366678|582124362|FG000|Toddler Dose|Withdrawal by Subject|1|||
161203064|NCT00366678|582124363|FG001|Toddler Dose|Withdrawal by Subject|0|||
161203065|NCT00366678|582124364|FG002|Toddler Dose|Withdrawal by Subject|0|||
161203066|NCT00366678|582124362|FG000|Toddler Dose|protocol deviation|1|||
161203067|NCT00366678|582124363|FG001|Toddler Dose|protocol deviation|0|||
161203068|NCT00366678|582124364|FG002|Toddler Dose|protocol deviation|0|||
161203069|NCT04465916|582124368|FG000|Overall Study|Withdrawal by Subject|0|||
161203070|NCT04465916|582124369|FG001|Overall Study|Withdrawal by Subject|1|||
161203071|NCT00297882|582124378|FG000|Day 14|Lack of Efficacy|12|||
161203072|NCT00297882|582124379|FG001|Day 14|Lack of Efficacy|49|||
161203073|NCT00297882|582124378|FG000|Day 28|Lost to Follow-up|13|||
161203074|NCT00297882|582124379|FG001|Day 28|Lost to Follow-up|23|||
161203075|NCT00297882|582124378|FG000|Day 28|Lack of Efficacy|3|||
161203076|NCT00297882|582124379|FG001|Day 28|Lack of Efficacy|0|||
161203077|NCT04242264|582124380|FG000|Overall Study|Lost to Follow-up|2|||
161203078|NCT04242264|582124381|FG001|Overall Study|Lost to Follow-up|2|||
161203079|NCT04242264|582124382|FG002|Overall Study|Lost to Follow-up|1|||
161203080|NCT04242264|582124383|FG003|Overall Study|Lost to Follow-up|1|||
161203081|NCT04242264|582124380|FG000|Overall Study|Withdrawal by Subject|1|||
161310091|NCT01068626|582517037|FG000|Overall Study|Adverse Event|3|||
161310092|NCT01068626|582517038|FG001|Overall Study|Adverse Event|0|||
161310093|NCT01068626|582517037|FG000|Overall Study|Withdrawal by Subject|0|||
161310094|NCT01068626|582517038|FG001|Overall Study|Withdrawal by Subject|2|||
161310095|NCT01785849|582517039|FG000|Overall Study|Death|7|||
161310096|NCT01785849|582517040|FG001|Overall Study|Death|9|||
161310097|NCT01785849|582517039|FG000|Overall Study|Protocol Specified Criteria|29|||
161310098|NCT01785849|582517040|FG001|Overall Study|Protocol Specified Criteria|1|||
161310099|NCT01785849|582517039|FG000|Overall Study|Withdrawal by Subject|15|||
161310100|NCT01785849|582517040|FG001|Overall Study|Withdrawal by Subject|12|||
161310101|NCT01785849|582517039|FG000|Overall Study|Sponsor Decision|0|||
161310102|NCT01785849|582517040|FG001|Overall Study|Sponsor Decision|1|||
161310103|NCT01785849|582517039|FG000|Overall Study|Lost to Follow-up|10|||
161310104|NCT01785849|582517040|FG001|Overall Study|Lost to Follow-up|11|||
161310105|NCT03932331|582517042|FG000|Overall Study|Death|0|||
161310106|NCT03932331|582517043|FG001|Overall Study|Death|7|||
161310107|NCT03932331|582517044|FG002|Overall Study|Death|2|||
161310108|NCT03932331|582517042|FG000|Overall Study|Withdrawal by Subject|0|||
161310109|NCT03932331|582517043|FG001|Overall Study|Withdrawal by Subject|3|||
161310110|NCT03932331|582517044|FG002|Overall Study|Withdrawal by Subject|0|||
161310111|NCT03932331|582517042|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
161310112|NCT03932331|582517043|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
161310113|NCT03932331|582517044|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
161310114|NCT03932331|582517042|FG000|Overall Study|Progressive disease|3|||
161310115|NCT03932331|582517043|FG001|Overall Study|Progressive disease|0|||
161310116|NCT03932331|582517044|FG002|Overall Study|Progressive disease|0|||
161310117|NCT03932331|582517042|FG000|Overall Study|Lung infection|1|||
161310118|NCT03932331|582517043|FG001|Overall Study|Lung infection|0|||
161310119|NCT03932331|582517044|FG002|Overall Study|Lung infection|0|||
161310120|NCT03932331|582517042|FG000|Overall Study|Other|0|||
161310121|NCT03932331|582517043|FG001|Overall Study|Other|0|||
161310122|NCT03932331|582517044|FG002|Overall Study|Other|58|||
161310123|NCT00347919|582517045|FG000|Overall Study|Lost to Follow-up|11|||
161310124|NCT00347919|582517046|FG001|Overall Study|Lost to Follow-up|13|||
161310125|NCT00347919|582517047|FG002|Overall Study|Lost to Follow-up|0|||
161310126|NCT00347919|582517045|FG000|Overall Study|Withdrawal by Subject|6|||
161310127|NCT00347919|582517046|FG001|Overall Study|Withdrawal by Subject|8|||
161310128|NCT00347919|582517047|FG002|Overall Study|Withdrawal by Subject|0|||
161310129|NCT00347919|582517045|FG000|Overall Study|Physician Decision|1|||
161310130|NCT00347919|582517046|FG001|Overall Study|Physician Decision|1|||
161310131|NCT00347919|582517047|FG002|Overall Study|Physician Decision|0|||
161310132|NCT00347919|582517045|FG000|Overall Study|Sponsor terminated study|15|||
161310133|NCT00347919|582517046|FG001|Overall Study|Sponsor terminated study|10|||
161310134|NCT00347919|582517047|FG002|Overall Study|Sponsor terminated study|16|||
161310135|NCT00347919|582517045|FG000|Overall Study|Death|35|||
161310136|NCT00347919|582517046|FG001|Overall Study|Death|42|||
161310137|NCT00347919|582517047|FG002|Overall Study|Death|19|||
161310138|NCT00347919|582517045|FG000|Overall Study|Par. Started Other Treatment|1|||
161310139|NCT00347919|582517046|FG001|Overall Study|Par. Started Other Treatment|1|||
161310140|NCT00347919|582517047|FG002|Overall Study|Par. Started Other Treatment|1|||
161310141|NCT00347919|582517045|FG000|Overall Study|Missing|2|||
161310142|NCT00347919|582517046|FG001|Overall Study|Missing|1|||
161310143|NCT00347919|582517047|FG002|Overall Study|Missing|2|||
161310144|NCT03379753|582517048|FG000|Overall Study|Withdrawal by Subject|2|||
161310145|NCT03379753|582517049|FG001|Overall Study|Withdrawal by Subject|1|||
161310146|NCT03379753|582517048|FG000|Overall Study|not having correct procedure|1|||
161310147|NCT03379753|582517049|FG001|Overall Study|not having correct procedure|2|||
161310148|NCT03379753|582517048|FG000|Overall Study|No primary outcome|12|||
161310149|NCT03379753|582517049|FG001|Overall Study|No primary outcome|22|||
161310150|NCT04450407|582517057|FG000|Overall Study|Withdrawal by Subject|10|||
161310151|NCT04450407|582517058|FG001|Overall Study|Withdrawal by Subject|1|||
161310152|NCT04450407|582517059|FG002|Overall Study|Withdrawal by Subject|4|||
161203082|NCT04242264|582124381|FG001|Overall Study|Withdrawal by Subject|0|||
161203083|NCT04242264|582124382|FG002|Overall Study|Withdrawal by Subject|0|||
161203084|NCT04242264|582124383|FG003|Overall Study|Withdrawal by Subject|0|||
161203085|NCT04221373|582124384|FG000|Overall Study|Physician Decision|4|||
161203086|NCT04221373|582124385|FG001|Overall Study|Physician Decision|0|||
161203087|NCT00577031|582124389|FG000|Overall Study|Adverse Event|52|||
161203088|NCT00577031|582124389|FG000|Overall Study|Progression of disease|93|||
161203089|NCT00577031|582124389|FG000|Overall Study|Protocol Violation|5|||
161203090|NCT00577031|582124389|FG000|Overall Study|Participant withdrew consent|13|||
161203091|NCT00577031|582124389|FG000|Overall Study|Participant non-compliance|5|||
161203092|NCT00577031|582124389|FG000|Overall Study|Need for surgery|17|||
161203093|NCT00577031|582124389|FG000|Overall Study|Medical decision|14|||
161203094|NCT00577031|582124389|FG000|Overall Study|Death|6|||
161203095|NCT00557830|582124390|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
161203096|NCT00557830|582124391|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
161203097|NCT00557830|582124392|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
161203098|NCT00557830|582124390|FG000|Screening Treatment Phase|Adverse Event|2|||
161203099|NCT00557830|582124391|FG001|Screening Treatment Phase|Adverse Event|0|||
161203100|NCT00557830|582124392|FG002|Screening Treatment Phase|Adverse Event|0|||
161203101|NCT00557830|582124390|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
161203102|NCT00557830|582124391|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
161203103|NCT00557830|582124392|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
161203104|NCT00538473|582124394|FG000|Overall Study|Adverse Event|1|||
161203105|NCT00538473|582124395|FG001|Overall Study|Adverse Event|0|||
161203106|NCT01569074|582124396|FG000|Overall Study|Study stopped|6|||
161203107|NCT01569074|582124397|FG001|Overall Study|Study stopped|6|||
161203108|NCT01569074|582124398|FG002|Overall Study|Study stopped|8|||
161203109|NCT01569074|582124399|FG003|Overall Study|Study stopped|7|||
161203110|NCT01569074|582124400|FG004|Overall Study|Study stopped|7|||
161203111|NCT01569074|582124396|FG000|Overall Study|Study-specific discontinuation criteria|0|||
161203112|NCT01569074|582124397|FG001|Overall Study|Study-specific discontinuation criteria|1|||
161203113|NCT01569074|582124398|FG002|Overall Study|Study-specific discontinuation criteria|0|||
161203114|NCT01569074|582124399|FG003|Overall Study|Study-specific discontinuation criteria|0|||
161203115|NCT01569074|582124400|FG004|Overall Study|Study-specific discontinuation criteria|0|||
161203116|NCT01569074|582124396|FG000|Overall Study|Severe non-compliance to protocol|0|||
161203117|NCT01569074|582124397|FG001|Overall Study|Severe non-compliance to protocol|0|||
161203118|NCT01569074|582124398|FG002|Overall Study|Severe non-compliance to protocol|1|||
161310153|NCT04450407|582517057|FG000|Overall Study|Adverse Event|0|||
161310154|NCT04450407|582517058|FG001|Overall Study|Adverse Event|0|||
161310155|NCT04450407|582517059|FG002|Overall Study|Adverse Event|1|||
161310156|NCT04450407|582517057|FG000|Overall Study|Lost to Follow-up|1|||
161310157|NCT04450407|582517058|FG001|Overall Study|Lost to Follow-up|0|||
161310158|NCT04450407|582517059|FG002|Overall Study|Lost to Follow-up|0|||
161310159|NCT04450407|582517057|FG000|Overall Study|Physician Decision|0|||
161310160|NCT04450407|582517058|FG001|Overall Study|Physician Decision|0|||
161310161|NCT04450407|582517059|FG002|Overall Study|Physician Decision|1|||
161310162|NCT04450407|582517057|FG000|Overall Study|Pregnancy|1|||
161310163|NCT04450407|582517058|FG001|Overall Study|Pregnancy|0|||
161310164|NCT04450407|582517059|FG002|Overall Study|Pregnancy|0|||
161310165|NCT04450407|582517057|FG000|Overall Study|Protocol Violation|2|||
161310166|NCT04450407|582517058|FG001|Overall Study|Protocol Violation|0|||
161310167|NCT04450407|582517059|FG002|Overall Study|Protocol Violation|0|||
161310168|NCT04450407|582517057|FG000|Overall Study|Investigational site terminated by sponsor|3|||
161310169|NCT04450407|582517058|FG001|Overall Study|Investigational site terminated by sponsor|0|||
161310170|NCT04450407|582517059|FG002|Overall Study|Investigational site terminated by sponsor|2|||
161310171|NCT00794040|582517061|FG000|Overall Study|Withdrawal by Subject|3|||
161310172|NCT00794040|582517062|FG001|Overall Study|Withdrawal by Subject|4|||
161310173|NCT00794040|582517061|FG000|Overall Study|Physician Decision|0|||
161310174|NCT00794040|582517062|FG001|Overall Study|Physician Decision|1|||
161310175|NCT04696354|582517065|FG000|Overall Study|Study termination|6|||
161310176|NCT04696354|582517066|FG001|Overall Study|Study termination|6|||
161310177|NCT03626363|582517070|FG000|Overall Study|Protocol Violation|4|||
161310178|NCT03626363|582517071|FG001|Overall Study|Protocol Violation|0|||
161310179|NCT03626363|582517070|FG000|Overall Study|Lost to Follow-up|5|||
161310180|NCT03626363|582517071|FG001|Overall Study|Lost to Follow-up|7|||
161310181|NCT00533702|582517072|FG000|Overall Study|Withdrawal by Subject|3|||
161310182|NCT00533702|582517073|FG001|Overall Study|Withdrawal by Subject|1|||
161310183|NCT00533702|582517072|FG000|Overall Study|Found ineligible after randomization|2|||
161310184|NCT00533702|582517073|FG001|Overall Study|Found ineligible after randomization|1|||
161310185|NCT00965341|582517074|FG000|Overall Study|Withdrew consent|1|||
161310186|NCT00965341|582517075|FG001|Overall Study|Withdrew consent|5|||
161203119|NCT01569074|582124399|FG003|Overall Study|Severe non-compliance to protocol|0|||
161203120|NCT01569074|582124400|FG004|Overall Study|Severe non-compliance to protocol|0|||
161203121|NCT01569074|582124396|FG000|Overall Study|eg change in circumstances|0|||
161310187|NCT00965341|582517074|FG000|Overall Study|Lost to Follow-up|1|||
161310188|NCT00965341|582517075|FG001|Overall Study|Lost to Follow-up|0|||
161203122|NCT01569074|582124397|FG001|Overall Study|eg change in circumstances|2|||
161203123|NCT01569074|582124398|FG002|Overall Study|eg change in circumstances|0|||
161203124|NCT01569074|582124399|FG003|Overall Study|eg change in circumstances|1|||
161203125|NCT01569074|582124400|FG004|Overall Study|eg change in circumstances|1|||
161203126|NCT01569074|582124396|FG000|Overall Study|Adverse Event|1|||
161203127|NCT01569074|582124397|FG001|Overall Study|Adverse Event|0|||
161203128|NCT01569074|582124398|FG002|Overall Study|Adverse Event|3|||
161203129|NCT01569074|582124399|FG003|Overall Study|Adverse Event|0|||
161203130|NCT01569074|582124400|FG004|Overall Study|Adverse Event|0|||
161203131|NCT00669110|582124401|FG000|Overall Study|Adverse Event|4|||
161203132|NCT00669110|582124402|FG001|Overall Study|Adverse Event|3|||
161203133|NCT00669110|582124401|FG000|Overall Study|Caregiver request|3|||
161203134|NCT00669110|582124402|FG001|Overall Study|Caregiver request|2|||
161203135|NCT00669110|582124401|FG000|Overall Study|Physician Decision|0|||
161203136|NCT00669110|582124402|FG001|Overall Study|Physician Decision|1|||
161203137|NCT00669110|582124401|FG000|Overall Study|Lost to Follow-up|1|||
161203138|NCT00669110|582124402|FG001|Overall Study|Lost to Follow-up|0|||
161203139|NCT00669110|582124401|FG000|Overall Study|Protocol Violation|0|||
161203140|NCT00669110|582124402|FG001|Overall Study|Protocol Violation|5|||
161203141|NCT00669110|582124401|FG000|Overall Study|Withdrawal by Subject|0|||
161203142|NCT00669110|582124402|FG001|Overall Study|Withdrawal by Subject|2|||
161203143|NCT05168657|582124405|FG000|Overall Study|Adverse Event|0|||
161203144|NCT05168657|582124406|FG001|Overall Study|Adverse Event|0|||
161203145|NCT05168657|582124407|FG002|Overall Study|Adverse Event|1|||
161203146|NCT05168657|582124408|FG003|Overall Study|Adverse Event|0|||
161203147|NCT05168657|582124409|FG004|Overall Study|Adverse Event|0|||
161203148|NCT05168657|582124410|FG005|Overall Study|Adverse Event|0|||
161203149|NCT05168657|582124411|FG006|Overall Study|Adverse Event|0|||
161203150|NCT05168657|582124412|FG007|Overall Study|Adverse Event|0|||
161203151|NCT00962013|582124413|FG000|Overall Study|Did not have surgery|1|||
161203152|NCT00962013|582124413|FG000|Overall Study|Death|8|||
161203153|NCT00962013|582124413|FG000|Overall Study|Lost to Follow-up|12|||
161203154|NCT00962013|582124413|FG000|Overall Study|Unable/Unwilling to return|6|||
161203155|NCT00962013|582124413|FG000|Overall Study|Withdrawal by Subject|8|||
161203156|NCT00962013|582124413|FG000|Overall Study|Removal of study device|3|||
161203157|NCT00962013|582124413|FG000|Overall Study|Site Termination|24|||
161203158|NCT00962013|582124413|FG000|Overall Study|No 5 year evaluation|6|||
161203159|NCT03843775|582124416|FG000|Overall Study|Adverse Event|1|||
161203160|NCT03843775|582124417|FG001|Overall Study|Adverse Event|1|||
161203161|NCT03843775|582124416|FG000|Overall Study|Lack of Efficacy|2|||
161203162|NCT03843775|582124417|FG001|Overall Study|Lack of Efficacy|6|||
161203163|NCT03843775|582124416|FG000|Overall Study|Withdrawal by Subject|0|||
161203164|NCT03843775|582124417|FG001|Overall Study|Withdrawal by Subject|1|||
161203165|NCT00530621|582124420|FG000|Overall Study|Adverse Event|11|||
161203166|NCT00530621|582124421|FG001|Overall Study|Adverse Event|8|||
161203167|NCT00530621|582124420|FG000|Overall Study|Physician Decision|2|||
161203168|NCT00530621|582124421|FG001|Overall Study|Physician Decision|4|||
161203169|NCT00530621|582124420|FG000|Overall Study|Progressive Disease (PD)|47|||
161203170|NCT00530621|582124421|FG001|Overall Study|Progressive Disease (PD)|40|||
161203171|NCT00530621|582124420|FG000|Overall Study|Sponsor Decision|12|||
161203172|NCT00530621|582124421|FG001|Overall Study|Sponsor Decision|15|||
161203173|NCT00530621|582124420|FG000|Overall Study|Subject Decision|4|||
161203174|NCT00530621|582124421|FG001|Overall Study|Subject Decision|7|||
161203175|NCT00530621|582124420|FG000|Overall Study|Death|3|||
161310189|NCT00965341|582517074|FG000|Overall Study|Transportation issues|4|||
161310190|NCT00965341|582517075|FG001|Overall Study|Transportation issues|3|||
161310191|NCT01970475|582517076|FG000|Overall Study|Withdrawal by Subject|11|||
161310192|NCT01970475|582517077|FG001|Overall Study|Withdrawal by Subject|6|||
161310193|NCT01970475|582517076|FG000|Overall Study|Adverse Event|7|||
161310194|NCT01970475|582517077|FG001|Overall Study|Adverse Event|3|||
161310195|NCT01970475|582517076|FG000|Overall Study|Lost to Follow-up|2|||
161310196|NCT01970475|582517077|FG001|Overall Study|Lost to Follow-up|2|||
161310197|NCT01970475|582517076|FG000|Overall Study|Protocol Violation|1|||
161310198|NCT01970475|582517077|FG001|Overall Study|Protocol Violation|0|||
161310199|NCT00960986|582517078|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
161310200|NCT00960986|582517079|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
161310201|NCT00960986|582517080|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
161203176|NCT00530621|582124421|FG001|Overall Study|Death|6|||
161203177|NCT00530621|582124420|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
161203178|NCT00530621|582124421|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
161203179|NCT04611152|582124422|FG000|Overall Study|Adverse Event|9|||
161203180|NCT04611152|582124423|FG001|Overall Study|Adverse Event|8|||
161203181|NCT04611152|582124422|FG000|Overall Study|Non-compliance with study schedule|1|||
161203182|NCT04611152|582124423|FG001|Overall Study|Non-compliance with study schedule|3|||
161203183|NCT04611152|582124422|FG000|Overall Study|Withdrawal by Subject|5|||
161203184|NCT04611152|582124423|FG001|Overall Study|Withdrawal by Subject|6|||
161203185|NCT04611152|582124422|FG000|Overall Study|Lost to Follow-up|11|||
161203186|NCT04611152|582124423|FG001|Overall Study|Lost to Follow-up|2|||
161203187|NCT03917654|582124432|FG000|Year 1|Withdrawal by Subject|1|||
161203188|NCT03917654|582124433|FG001|Year 1|Withdrawal by Subject|0|||
161203189|NCT03917654|582124434|FG002|Year 1|Withdrawal by Subject|0|||
161203190|NCT03917654|582124435|FG003|Year 1|Withdrawal by Subject|0|||
161203191|NCT03917654|582124436|FG004|Year 1|Withdrawal by Subject|0|||
161203192|NCT03917654|582124437|FG005|Year 1|Withdrawal by Subject|1|||
161203193|NCT03917654|582124438|FG006|Year 1|Withdrawal by Subject|6|||
161203194|NCT03917654|582124439|FG007|Year 1|Withdrawal by Subject|2|||
161203195|NCT03917654|582124440|FG008|Year 1|Withdrawal by Subject|5|||
161203196|NCT03917654|582124441|FG009|Year 1|Withdrawal by Subject|3|||
161203197|NCT03917654|582124442|FG010|Year 1|Withdrawal by Subject|1|||
161203198|NCT03917654|582124443|FG011|Year 1|Withdrawal by Subject|0|||
161203199|NCT03917654|582124432|FG000|Year 1|Travel|0|||
161203200|NCT03917654|582124433|FG001|Year 1|Travel|1|||
161203201|NCT03917654|582124434|FG002|Year 1|Travel|1|||
161203202|NCT03917654|582124435|FG003|Year 1|Travel|0|||
161203203|NCT03917654|582124436|FG004|Year 1|Travel|4|||
161203204|NCT03917654|582124437|FG005|Year 1|Travel|4|||
161203205|NCT03917654|582124438|FG006|Year 1|Travel|10|||
161203206|NCT03917654|582124439|FG007|Year 1|Travel|8|||
161203207|NCT03917654|582124440|FG008|Year 1|Travel|2|||
161203208|NCT03917654|582124441|FG009|Year 1|Travel|5|||
161203209|NCT03917654|582124442|FG010|Year 1|Travel|3|||
161203210|NCT03917654|582124443|FG011|Year 1|Travel|3|||
161203211|NCT03917654|582124432|FG000|Year 1|Subject moved away from site|0|||
161203212|NCT03917654|582124433|FG001|Year 1|Subject moved away from site|1|||
161203213|NCT03917654|582124434|FG002|Year 1|Subject moved away from site|0|||
161203214|NCT03917654|582124435|FG003|Year 1|Subject moved away from site|0|||
161203215|NCT03917654|582124436|FG004|Year 1|Subject moved away from site|0|||
161203216|NCT03917654|582124437|FG005|Year 1|Subject moved away from site|0|||
161203217|NCT03917654|582124438|FG006|Year 1|Subject moved away from site|1|||
161203218|NCT03917654|582124439|FG007|Year 1|Subject moved away from site|2|||
161203219|NCT03917654|582124440|FG008|Year 1|Subject moved away from site|1|||
161203220|NCT03917654|582124441|FG009|Year 1|Subject moved away from site|0|||
161203221|NCT03917654|582124442|FG010|Year 1|Subject moved away from site|0|||
161203222|NCT03917654|582124443|FG011|Year 1|Subject moved away from site|3|||
161203223|NCT03917654|582124432|FG000|Year 1|Spouse/Family member request|0|||
161203224|NCT03917654|582124433|FG001|Year 1|Spouse/Family member request|0|||
161203225|NCT03917654|582124434|FG002|Year 1|Spouse/Family member request|1|||
161203226|NCT03917654|582124435|FG003|Year 1|Spouse/Family member request|0|||
161203227|NCT03917654|582124436|FG004|Year 1|Spouse/Family member request|1|||
161203228|NCT03917654|582124437|FG005|Year 1|Spouse/Family member request|0|||
161203229|NCT03917654|582124438|FG006|Year 1|Spouse/Family member request|0|||
161203230|NCT03917654|582124439|FG007|Year 1|Spouse/Family member request|2|||
161203231|NCT03917654|582124440|FG008|Year 1|Spouse/Family member request|0|||
161203232|NCT03917654|582124441|FG009|Year 1|Spouse/Family member request|0|||
161203233|NCT03917654|582124442|FG010|Year 1|Spouse/Family member request|0|||
161203234|NCT03917654|582124443|FG011|Year 1|Spouse/Family member request|1|||
161203235|NCT03917654|582124432|FG000|Year 1|Death|0|||
161310202|NCT00960986|582517081|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
161310203|NCT00960986|582517078|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
161310204|NCT00960986|582517079|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
161310205|NCT00960986|582517080|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
161310206|NCT00960986|582517081|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
161310207|NCT00960986|582517078|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
161310208|NCT00960986|582517079|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
161310209|NCT00960986|582517080|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
161310210|NCT00960986|582517081|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
161310211|NCT00960986|582517078|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161310212|NCT00960986|582517079|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
161310213|NCT00960986|582517080|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161310214|NCT00960986|582517081|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
161310215|NCT00960986|582517078|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
161203236|NCT03917654|582124433|FG001|Year 1|Death|0|||
161203237|NCT03917654|582124434|FG002|Year 1|Death|0|||
161203238|NCT03917654|582124435|FG003|Year 1|Death|0|||
161203239|NCT03917654|582124436|FG004|Year 1|Death|0|||
161203240|NCT03917654|582124437|FG005|Year 1|Death|0|||
161203241|NCT03917654|582124438|FG006|Year 1|Death|0|||
161203242|NCT03917654|582124439|FG007|Year 1|Death|0|||
161203243|NCT03917654|582124440|FG008|Year 1|Death|1|||
161203244|NCT03917654|582124441|FG009|Year 1|Death|1|||
161203245|NCT03917654|582124442|FG010|Year 1|Death|0|||
161203246|NCT03917654|582124443|FG011|Year 1|Death|0|||
161203247|NCT03917654|582124432|FG000|Year 1|Lost to Follow-up|0|||
161203248|NCT03917654|582124433|FG001|Year 1|Lost to Follow-up|0|||
161203249|NCT03917654|582124434|FG002|Year 1|Lost to Follow-up|0|||
161203250|NCT03917654|582124435|FG003|Year 1|Lost to Follow-up|0|||
161203251|NCT03917654|582124436|FG004|Year 1|Lost to Follow-up|0|||
161203252|NCT03917654|582124437|FG005|Year 1|Lost to Follow-up|0|||
161203253|NCT03917654|582124438|FG006|Year 1|Lost to Follow-up|2|||
161203254|NCT03917654|582124439|FG007|Year 1|Lost to Follow-up|0|||
161203255|NCT03917654|582124440|FG008|Year 1|Lost to Follow-up|0|||
161203256|NCT03917654|582124441|FG009|Year 1|Lost to Follow-up|0|||
161203257|NCT03917654|582124442|FG010|Year 1|Lost to Follow-up|0|||
161203258|NCT03917654|582124443|FG011|Year 1|Lost to Follow-up|0|||
161203259|NCT03917654|582124432|FG000|Year 1|Missed visits|0|||
161203260|NCT03917654|582124433|FG001|Year 1|Missed visits|0|||
161203261|NCT03917654|582124434|FG002|Year 1|Missed visits|0|||
161203262|NCT03917654|582124435|FG003|Year 1|Missed visits|0|||
161203263|NCT03917654|582124436|FG004|Year 1|Missed visits|0|||
161203264|NCT03917654|582124437|FG005|Year 1|Missed visits|0|||
161203265|NCT03917654|582124438|FG006|Year 1|Missed visits|0|||
161203266|NCT03917654|582124439|FG007|Year 1|Missed visits|0|||
161203267|NCT03917654|582124440|FG008|Year 1|Missed visits|0|||
161203268|NCT03917654|582124441|FG009|Year 1|Missed visits|0|||
161203269|NCT03917654|582124442|FG010|Year 1|Missed visits|1|||
161203270|NCT03917654|582124443|FG011|Year 1|Missed visits|1|||
161203271|NCT03917654|582124432|FG000|Year 1|Pregnancy|0|||
161203272|NCT03917654|582124433|FG001|Year 1|Pregnancy|0|||
161203273|NCT03917654|582124434|FG002|Year 1|Pregnancy|0|||
161203274|NCT03917654|582124435|FG003|Year 1|Pregnancy|0|||
161203275|NCT03917654|582124436|FG004|Year 1|Pregnancy|0|||
161203276|NCT03917654|582124437|FG005|Year 1|Pregnancy|0|||
161203277|NCT03917654|582124438|FG006|Year 1|Pregnancy|0|||
161203278|NCT03917654|582124439|FG007|Year 1|Pregnancy|1|||
161203279|NCT03917654|582124440|FG008|Year 1|Pregnancy|0|||
161203280|NCT03917654|582124441|FG009|Year 1|Pregnancy|1|||
161203281|NCT03917654|582124442|FG010|Year 1|Pregnancy|0|||
161203282|NCT03917654|582124443|FG011|Year 1|Pregnancy|0|||
161203283|NCT03917654|582124432|FG000|Year 2|Travel|1|||
161203284|NCT03917654|582124433|FG001|Year 2|Travel|0|||
161203285|NCT03917654|582124434|FG002|Year 2|Travel|0|||
161203286|NCT03917654|582124435|FG003|Year 2|Travel|0|||
161310216|NCT00960986|582517079|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
161310217|NCT00960986|582517080|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
161310218|NCT00960986|582517081|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
161310219|NCT00960986|582517078|FG000|Period 3 (7-week Therapy Period)|Death|0|||
161310220|NCT00960986|582517079|FG001|Period 3 (7-week Therapy Period)|Death|0|||
161310221|NCT00960986|582517080|FG002|Period 3 (7-week Therapy Period)|Death|1|||
161310222|NCT00960986|582517081|FG003|Period 3 (7-week Therapy Period)|Death|0|||
161310223|NCT00960986|582517078|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161310224|NCT00960986|582517079|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161310225|NCT00960986|582517080|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
161310226|NCT00960986|582517081|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
161310227|NCT00960986|582517078|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
161310228|NCT00960986|582517079|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
161310229|NCT00960986|582517080|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
161310230|NCT00960986|582517081|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
161310231|NCT00960986|582517078|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161310232|NCT00960986|582517079|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161310233|NCT00960986|582517080|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
161310234|NCT00960986|582517081|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
161310235|NCT00960986|582517078|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
161310236|NCT00960986|582517079|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
161310237|NCT00960986|582517080|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
161310238|NCT00960986|582517081|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
161310239|NCT01077739|582517082|FG000|Overall Study|Premature withdrawal|1|||
161310240|NCT01077739|582517083|FG001|Overall Study|Premature withdrawal|3|||
161310241|NCT01077739|582517082|FG000|Overall Study|Withdrawal by Subject|1|||
161203287|NCT03917654|582124436|FG004|Year 2|Travel|1|||
161203288|NCT03917654|582124437|FG005|Year 2|Travel|1|||
161203289|NCT03917654|582124438|FG006|Year 2|Travel|2|||
161310242|NCT01077739|582517083|FG001|Overall Study|Withdrawal by Subject|0|||
161310243|NCT01077739|582517082|FG000|Overall Study|Death|0|||
161310244|NCT01077739|582517083|FG001|Overall Study|Death|3|||
161203290|NCT03917654|582124439|FG007|Year 2|Travel|1|||
161203291|NCT03917654|582124440|FG008|Year 2|Travel|0|||
161203292|NCT03917654|582124441|FG009|Year 2|Travel|1|||
161203293|NCT03917654|582124442|FG010|Year 2|Travel|0|||
161203294|NCT03917654|582124443|FG011|Year 2|Travel|1|||
161203295|NCT03917654|582124432|FG000|Year 2|Married|1|||
161203296|NCT03917654|582124433|FG001|Year 2|Married|0|||
161203297|NCT03917654|582124434|FG002|Year 2|Married|0|||
161203298|NCT03917654|582124435|FG003|Year 2|Married|0|||
161203299|NCT03917654|582124436|FG004|Year 2|Married|0|||
161203300|NCT03917654|582124437|FG005|Year 2|Married|0|||
161203301|NCT03917654|582124438|FG006|Year 2|Married|1|||
161203302|NCT03917654|582124439|FG007|Year 2|Married|1|||
161203303|NCT03917654|582124440|FG008|Year 2|Married|0|||
161203304|NCT03917654|582124441|FG009|Year 2|Married|0|||
161203305|NCT03917654|582124442|FG010|Year 2|Married|0|||
161203306|NCT03917654|582124443|FG011|Year 2|Married|0|||
161310245|NCT01077739|582517082|FG000|Overall Study|Unacceptable toxicity|1|||
161203307|NCT03917654|582124432|FG000|Year 2|Subject moved away from site|1|||
161203308|NCT03917654|582124433|FG001|Year 2|Subject moved away from site|0|||
161203309|NCT03917654|582124434|FG002|Year 2|Subject moved away from site|0|||
161203310|NCT03917654|582124435|FG003|Year 2|Subject moved away from site|0|||
161203311|NCT03917654|582124436|FG004|Year 2|Subject moved away from site|1|||
161203312|NCT03917654|582124437|FG005|Year 2|Subject moved away from site|0|||
161203313|NCT03917654|582124438|FG006|Year 2|Subject moved away from site|2|||
161203314|NCT03917654|582124439|FG007|Year 2|Subject moved away from site|3|||
161203315|NCT03917654|582124440|FG008|Year 2|Subject moved away from site|0|||
161203316|NCT03917654|582124441|FG009|Year 2|Subject moved away from site|2|||
161203317|NCT03917654|582124442|FG010|Year 2|Subject moved away from site|0|||
161203318|NCT03917654|582124443|FG011|Year 2|Subject moved away from site|1|||
161203319|NCT03917654|582124432|FG000|Year 2|Year 2 Screening failure|0|||
161203320|NCT03917654|582124433|FG001|Year 2|Year 2 Screening failure|1|||
161203321|NCT03917654|582124434|FG002|Year 2|Year 2 Screening failure|0|||
161203322|NCT03917654|582124435|FG003|Year 2|Year 2 Screening failure|0|||
161203323|NCT03917654|582124436|FG004|Year 2|Year 2 Screening failure|2|||
161203324|NCT03917654|582124437|FG005|Year 2|Year 2 Screening failure|0|||
161203325|NCT03917654|582124438|FG006|Year 2|Year 2 Screening failure|4|||
161203326|NCT03917654|582124439|FG007|Year 2|Year 2 Screening failure|3|||
161203327|NCT03917654|582124440|FG008|Year 2|Year 2 Screening failure|10|||
161203328|NCT03917654|582124441|FG009|Year 2|Year 2 Screening failure|2|||
161203329|NCT03917654|582124442|FG010|Year 2|Year 2 Screening failure|1|||
161203330|NCT03917654|582124443|FG011|Year 2|Year 2 Screening failure|1|||
161203331|NCT03917654|582124432|FG000|Year 2|Death|0|||
161203332|NCT03917654|582124433|FG001|Year 2|Death|0|||
161203333|NCT03917654|582124434|FG002|Year 2|Death|0|||
161203334|NCT03917654|582124435|FG003|Year 2|Death|0|||
161203335|NCT03917654|582124436|FG004|Year 2|Death|0|||
161203336|NCT03917654|582124437|FG005|Year 2|Death|1|||
161203337|NCT03917654|582124438|FG006|Year 2|Death|0|||
161203338|NCT03917654|582124439|FG007|Year 2|Death|0|||
161203339|NCT03917654|582124440|FG008|Year 2|Death|1|||
161203340|NCT03917654|582124441|FG009|Year 2|Death|1|||
161203341|NCT03917654|582124442|FG010|Year 2|Death|0|||
161203342|NCT03917654|582124443|FG011|Year 2|Death|0|||
161203343|NCT03917654|582124432|FG000|Year 2|Withdrawal by Subject|0|||
161203344|NCT03917654|582124433|FG001|Year 2|Withdrawal by Subject|0|||
161203345|NCT03917654|582124434|FG002|Year 2|Withdrawal by Subject|0|||
161203346|NCT03917654|582124435|FG003|Year 2|Withdrawal by Subject|0|||
161203347|NCT03917654|582124436|FG004|Year 2|Withdrawal by Subject|0|||
161203348|NCT03917654|582124437|FG005|Year 2|Withdrawal by Subject|0|||
161203349|NCT03917654|582124438|FG006|Year 2|Withdrawal by Subject|3|||
161203350|NCT03917654|582124439|FG007|Year 2|Withdrawal by Subject|0|||
161203351|NCT03917654|582124440|FG008|Year 2|Withdrawal by Subject|2|||
161203352|NCT03917654|582124441|FG009|Year 2|Withdrawal by Subject|5|||
161203353|NCT03917654|582124442|FG010|Year 2|Withdrawal by Subject|0|||
161203354|NCT03917654|582124443|FG011|Year 2|Withdrawal by Subject|0|||
161203355|NCT03917654|582124432|FG000|Year 2|Spouse/family member request|0|||
161203356|NCT03917654|582124433|FG001|Year 2|Spouse/family member request|0|||
161203357|NCT03917654|582124434|FG002|Year 2|Spouse/family member request|0|||
161203358|NCT03917654|582124435|FG003|Year 2|Spouse/family member request|0|||
161203359|NCT03917654|582124436|FG004|Year 2|Spouse/family member request|0|||
161203360|NCT03917654|582124437|FG005|Year 2|Spouse/family member request|0|||
161203361|NCT03917654|582124438|FG006|Year 2|Spouse/family member request|1|||
161203362|NCT03917654|582124439|FG007|Year 2|Spouse/family member request|0|||
161203363|NCT03917654|582124440|FG008|Year 2|Spouse/family member request|0|||
161203364|NCT03917654|582124441|FG009|Year 2|Spouse/family member request|0|||
161203365|NCT03917654|582124442|FG010|Year 2|Spouse/family member request|0|||
161203366|NCT03917654|582124443|FG011|Year 2|Spouse/family member request|0|||
161203367|NCT03917654|582124432|FG000|Year 2|Lost to Follow-up|0|||
161203368|NCT03917654|582124433|FG001|Year 2|Lost to Follow-up|0|||
161203369|NCT03917654|582124434|FG002|Year 2|Lost to Follow-up|0|||
161203370|NCT03917654|582124435|FG003|Year 2|Lost to Follow-up|0|||
161203371|NCT03917654|582124436|FG004|Year 2|Lost to Follow-up|0|||
161203372|NCT03917654|582124437|FG005|Year 2|Lost to Follow-up|0|||
161203373|NCT03917654|582124438|FG006|Year 2|Lost to Follow-up|1|||
161203374|NCT03917654|582124439|FG007|Year 2|Lost to Follow-up|0|||
161203375|NCT03917654|582124440|FG008|Year 2|Lost to Follow-up|1|||
161203376|NCT03917654|582124441|FG009|Year 2|Lost to Follow-up|0|||
161203377|NCT03917654|582124442|FG010|Year 2|Lost to Follow-up|0|||
161203378|NCT03917654|582124443|FG011|Year 2|Lost to Follow-up|1|||
161203379|NCT03917654|582124432|FG000|Year 2|Adverse Event|0|||
161203380|NCT03917654|582124433|FG001|Year 2|Adverse Event|0|||
161203381|NCT03917654|582124434|FG002|Year 2|Adverse Event|0|||
161203382|NCT03917654|582124435|FG003|Year 2|Adverse Event|0|||
161203383|NCT03917654|582124436|FG004|Year 2|Adverse Event|0|||
161203384|NCT03917654|582124437|FG005|Year 2|Adverse Event|0|||
161203385|NCT03917654|582124438|FG006|Year 2|Adverse Event|0|||
161203386|NCT03917654|582124439|FG007|Year 2|Adverse Event|0|||
161203387|NCT03917654|582124440|FG008|Year 2|Adverse Event|0|||
161203388|NCT03917654|582124441|FG009|Year 2|Adverse Event|1|||
161203389|NCT03917654|582124442|FG010|Year 2|Adverse Event|0|||
161203390|NCT03917654|582124443|FG011|Year 2|Adverse Event|0|||
161203391|NCT05012943|582124444|FG000|Overall Study|Adverse Event|2|||
161203392|NCT05012943|582124445|FG001|Overall Study|Adverse Event|1|||
161203393|NCT05012943|582124446|FG002|Overall Study|Adverse Event|0|||
161203394|NCT05012943|582124444|FG000|Overall Study|Withdrawal by Subject|1052|||
161203395|NCT05012943|582124445|FG001|Overall Study|Withdrawal by Subject|1006|||
161203396|NCT05012943|582124446|FG002|Overall Study|Withdrawal by Subject|20|||
161203397|NCT05012943|582124444|FG000|Overall Study|Death|25|||
161203398|NCT05012943|582124445|FG001|Overall Study|Death|17|||
161203399|NCT05012943|582124446|FG002|Overall Study|Death|4|||
161203400|NCT05012943|582124444|FG000|Overall Study|Lost to Follow-up|11|||
161203401|NCT05012943|582124445|FG001|Overall Study|Lost to Follow-up|24|||
161203402|NCT05012943|582124446|FG002|Overall Study|Lost to Follow-up|3|||
161203403|NCT05012943|582124444|FG000|Overall Study|Physician Decision|1|||
161203404|NCT05012943|582124445|FG001|Overall Study|Physician Decision|1|||
161203405|NCT05012943|582124446|FG002|Overall Study|Physician Decision|0|||
161203406|NCT05012943|582124444|FG000|Overall Study|Other than Specified|2|||
161203407|NCT05012943|582124445|FG001|Overall Study|Other than Specified|1|||
161203408|NCT05012943|582124446|FG002|Overall Study|Other than Specified|0|||
161203409|NCT00400985|582124448|FG000|Overall Study|Withdrawal by Subject|5|||
161203410|NCT00400985|582124448|FG000|Overall Study|system modification|8|||
161203411|NCT00400985|582124448|FG000|Overall Study|Death|30|||
161203412|NCT00400985|582124448|FG000|Overall Study|Lost to Follow-up|9|||
161203413|NCT05048875|582124450|FG000|Overall Study|Withdrawal by Subject|1|||
161203414|NCT05048875|582124451|FG001|Overall Study|Withdrawal by Subject|0|||
161203415|NCT05048875|582124452|FG002|Overall Study|Withdrawal by Subject|0|||
161203416|NCT05048875|582124453|FG003|Overall Study|Withdrawal by Subject|0|||
161203417|NCT05048875|582124454|FG004|Overall Study|Withdrawal by Subject|0|||
161203418|NCT05048875|582124455|FG005|Overall Study|Withdrawal by Subject|0|||
161203419|NCT05048875|582124456|FG006|Overall Study|Withdrawal by Subject|0|||
161203420|NCT05048875|582124457|FG007|Overall Study|Withdrawal by Subject|0|||
161203421|NCT05048875|582124450|FG000|Overall Study|Adverse Event|0|||
161203422|NCT05048875|582124451|FG001|Overall Study|Adverse Event|0|||
161203423|NCT05048875|582124452|FG002|Overall Study|Adverse Event|0|||
161203424|NCT05048875|582124453|FG003|Overall Study|Adverse Event|1|||
161203425|NCT05048875|582124454|FG004|Overall Study|Adverse Event|0|||
161203426|NCT05048875|582124455|FG005|Overall Study|Adverse Event|0|||
161203427|NCT05048875|582124456|FG006|Overall Study|Adverse Event|0|||
161203428|NCT05048875|582124457|FG007|Overall Study|Adverse Event|0|||
161203429|NCT02255422|582124459|FG000|Overall Study|Withdrawal by Subject|0|||
161203430|NCT02255422|582124460|FG001|Overall Study|Withdrawal by Subject|0|||
161203431|NCT02255422|582124461|FG002|Overall Study|Withdrawal by Subject|0|||
161203432|NCT02255422|582124462|FG003|Overall Study|Withdrawal by Subject|0|||
161203433|NCT02255422|582124463|FG004|Overall Study|Withdrawal by Subject|0|||
161203434|NCT02255422|582124464|FG005|Overall Study|Withdrawal by Subject|0|||
161203435|NCT02255422|582124465|FG006|Overall Study|Withdrawal by Subject|2|||
161203436|NCT02255422|582124459|FG000|Overall Study|Lost to Follow-up|0|||
161203437|NCT02255422|582124460|FG001|Overall Study|Lost to Follow-up|0|||
161203438|NCT02255422|582124461|FG002|Overall Study|Lost to Follow-up|1|||
161203439|NCT02255422|582124462|FG003|Overall Study|Lost to Follow-up|0|||
161203440|NCT02255422|582124463|FG004|Overall Study|Lost to Follow-up|0|||
161203441|NCT02255422|582124464|FG005|Overall Study|Lost to Follow-up|0|||
161203442|NCT02255422|582124465|FG006|Overall Study|Lost to Follow-up|0|||
161203443|NCT02851069|582124471|FG000|Overall Study|Failure to Return|3|||
161310246|NCT01077739|582517083|FG001|Overall Study|Unacceptable toxicity|2|||
161310247|NCT01077739|582517082|FG000|Overall Study|Other|2|||
161310248|NCT01077739|582517083|FG001|Overall Study|Other|2|||
161310249|NCT00877071|582517084|FG000|Overall Study|disease progression|2|||
161310250|NCT01317797|582517087|FG000|Overall Study|Other|0|||
161310251|NCT01317797|582517088|FG001|Overall Study|Other|1|||
161310252|NCT01317797|582517089|FG002|Overall Study|Other|0|||
161310253|NCT01317797|582517087|FG000|Overall Study|Withdrawal of Patient|0|||
161310254|NCT01317797|582517088|FG001|Overall Study|Withdrawal of Patient|0|||
161203444|NCT02851069|582124471|FG000|Overall Study|Other|3|||
161203445|NCT03743571|582124477|FG000|Overall Study|Withdrawal by Subject|1|||
161203446|NCT03743571|582124478|FG001|Overall Study|Withdrawal by Subject|1|||
161203447|NCT03743571|582124477|FG000|Overall Study|Lost to Follow-up|1|||
161203448|NCT03743571|582124478|FG001|Overall Study|Lost to Follow-up|2|||
161203449|NCT01489865|582124479|FG000|Overall Study|Progression of Disease|4|||
161203450|NCT01489865|582124480|FG001|Overall Study|Progression of Disease|2|||
161203451|NCT01489865|582124481|FG002|Overall Study|Progression of Disease|2|||
161203452|NCT01489865|582124482|FG003|Overall Study|Progression of Disease|3|||
161203453|NCT01489865|582124483|FG004|Overall Study|Progression of Disease|1|||
161203454|NCT01489865|582124484|FG005|Overall Study|Progression of Disease|6|||
161203455|NCT01489865|582124485|FG006|Overall Study|Progression of Disease|3|||
161203456|NCT01489865|582124486|FG007|Overall Study|Progression of Disease|0|||
161310255|NCT01317797|582517089|FG002|Overall Study|Withdrawal of Patient|1|||
161310256|NCT03026530|582517093|FG000|Overall Study|Lost to Follow-up|19|||
161203457|NCT01489865|582124487|FG008|Overall Study|Progression of Disease|23|||
161203458|NCT01489865|582124479|FG000|Overall Study|Adverse Event|2|||
161203459|NCT01489865|582124480|FG001|Overall Study|Adverse Event|0|||
161203460|NCT01489865|582124481|FG002|Overall Study|Adverse Event|0|||
161203461|NCT01489865|582124482|FG003|Overall Study|Adverse Event|0|||
161203462|NCT01489865|582124483|FG004|Overall Study|Adverse Event|1|||
161203463|NCT01489865|582124484|FG005|Overall Study|Adverse Event|0|||
161203464|NCT01489865|582124485|FG006|Overall Study|Adverse Event|2|||
161203465|NCT01489865|582124486|FG007|Overall Study|Adverse Event|0|||
161203466|NCT01489865|582124487|FG008|Overall Study|Adverse Event|5|||
161203467|NCT01489865|582124479|FG000|Overall Study|Death|0|||
161203468|NCT01489865|582124480|FG001|Overall Study|Death|1|||
161203469|NCT01489865|582124481|FG002|Overall Study|Death|0|||
161203470|NCT01489865|582124482|FG003|Overall Study|Death|0|||
161203471|NCT01489865|582124483|FG004|Overall Study|Death|1|||
161203472|NCT01489865|582124484|FG005|Overall Study|Death|0|||
161203473|NCT01489865|582124485|FG006|Overall Study|Death|0|||
161203474|NCT01489865|582124486|FG007|Overall Study|Death|0|||
161203475|NCT01489865|582124487|FG008|Overall Study|Death|2|||
161203476|NCT01489865|582124479|FG000|Overall Study|Withdrawal by Subject|0|||
161203477|NCT01489865|582124480|FG001|Overall Study|Withdrawal by Subject|0|||
161203478|NCT01489865|582124481|FG002|Overall Study|Withdrawal by Subject|0|||
161203479|NCT01489865|582124482|FG003|Overall Study|Withdrawal by Subject|0|||
161203480|NCT01489865|582124483|FG004|Overall Study|Withdrawal by Subject|0|||
161203481|NCT01489865|582124484|FG005|Overall Study|Withdrawal by Subject|1|||
161203482|NCT01489865|582124485|FG006|Overall Study|Withdrawal by Subject|1|||
161203483|NCT01489865|582124486|FG007|Overall Study|Withdrawal by Subject|0|||
161310257|NCT03026530|582517094|FG001|Overall Study|Lost to Follow-up|24|||
161310258|NCT03026530|582517093|FG000|Overall Study|Protocol Violation|2|||
161310259|NCT03026530|582517094|FG001|Overall Study|Protocol Violation|5|||
161310260|NCT03721835|582517095|FG000|Overall Study|Participant not able to return|1|||
161310261|NCT03721835|582517095|FG000|Overall Study|Lost to Follow-up|1|||
161310262|NCT03721835|582517095|FG000|Overall Study|Revision of the components of the study device|2|||
161310263|NCT03721835|582517095|FG000|Overall Study|Sponsor terminated study|6|||
161310264|NCT03721835|582517095|FG000|Overall Study|Death|1|||
161310265|NCT03721835|582517095|FG000|Overall Study|Sponsor decision|1|||
161310266|NCT02100670|582517096|FG000|Overall Study|Adverse Event|10|||
161310267|NCT02100670|582517097|FG001|Overall Study|Adverse Event|3|||
161310268|NCT02100670|582517098|FG002|Overall Study|Adverse Event|3|||
161310269|NCT02100670|582517099|FG003|Overall Study|Adverse Event|0|||
161310270|NCT02100670|582517096|FG000|Overall Study|Lost to Follow-up|1|||
161310271|NCT02100670|582517097|FG001|Overall Study|Lost to Follow-up|0|||
161310272|NCT02100670|582517098|FG002|Overall Study|Lost to Follow-up|0|||
161310273|NCT02100670|582517099|FG003|Overall Study|Lost to Follow-up|0|||
161310274|NCT02100670|582517096|FG000|Overall Study|Protocol Violation|0|||
161310275|NCT02100670|582517097|FG001|Overall Study|Protocol Violation|1|||
161310276|NCT02100670|582517098|FG002|Overall Study|Protocol Violation|0|||
161310277|NCT02100670|582517099|FG003|Overall Study|Protocol Violation|1|||
161310278|NCT02100670|582517096|FG000|Overall Study|Withdrawal of Consent|0|||
161310279|NCT02100670|582517097|FG001|Overall Study|Withdrawal of Consent|1|||
161310280|NCT02100670|582517098|FG002|Overall Study|Withdrawal of Consent|1|||
161310281|NCT02100670|582517099|FG003|Overall Study|Withdrawal of Consent|0|||
161310282|NCT02100670|582517096|FG000|Overall Study|No swelling no pain|1|||
161310283|NCT02100670|582517097|FG001|Overall Study|No swelling no pain|0|||
161310284|NCT02100670|582517098|FG002|Overall Study|No swelling no pain|0|||
161310285|NCT02100670|582517099|FG003|Overall Study|No swelling no pain|0|||
161310286|NCT02100670|582517096|FG000|Overall Study|Poor Efficacy|0|||
161310287|NCT02100670|582517097|FG001|Overall Study|Poor Efficacy|1|||
161310288|NCT02100670|582517098|FG002|Overall Study|Poor Efficacy|0|||
161310289|NCT02100670|582517099|FG003|Overall Study|Poor Efficacy|0|||
161310290|NCT02100670|582517096|FG000|Overall Study|Physician Decision|0|||
161310291|NCT02100670|582517097|FG001|Overall Study|Physician Decision|1|||
161310292|NCT02100670|582517098|FG002|Overall Study|Physician Decision|0|||
161310293|NCT02100670|582517099|FG003|Overall Study|Physician Decision|0|||
161310294|NCT02100670|582517096|FG000|Overall Study|Withdrawal by Subject|1|||
161310295|NCT02100670|582517097|FG001|Overall Study|Withdrawal by Subject|0|||
161310296|NCT02100670|582517098|FG002|Overall Study|Withdrawal by Subject|0|||
161310297|NCT02100670|582517099|FG003|Overall Study|Withdrawal by Subject|0|||
161310298|NCT05741346|582518564|FG000|Overall Study|Withdrawn due to termination of study|28|||
161203484|NCT01489865|582124487|FG008|Overall Study|Withdrawal by Subject|2|||
161203485|NCT01489865|582124479|FG000|Overall Study|Shifted|0|||
161203486|NCT01489865|582124480|FG001|Overall Study|Shifted|0|||
161203487|NCT01489865|582124481|FG002|Overall Study|Shifted|1|||
161203488|NCT01489865|582124482|FG003|Overall Study|Shifted|0|||
161203489|NCT01489865|582124483|FG004|Overall Study|Shifted|0|||
161203490|NCT01489865|582124484|FG005|Overall Study|Shifted|0|||
161310299|NCT04439357|582518565|FG000|Overall Study|Disease Progression|4|||
161310300|NCT01668966|582518574|FG000|Overall Study|Withdrawal by Subject|1|||
161310301|NCT01668966|582518574|FG000|Overall Study|Death|1|||
161310302|NCT01668966|582518574|FG000|Overall Study|Not treated|2|||
161310303|NCT01573767|582518575|FG000|Overall Study|Adverse Event|0|||
161310304|NCT01573767|582518576|FG001|Overall Study|Adverse Event|1|||
161310305|NCT01573767|582518577|FG002|Overall Study|Adverse Event|0|||
161310306|NCT01573767|582518578|FG003|Overall Study|Adverse Event|1|||
161310307|NCT01573767|582518575|FG000|Overall Study|Lack of Efficacy|18|||
161310308|NCT01573767|582518576|FG001|Overall Study|Lack of Efficacy|15|||
161310309|NCT01573767|582518577|FG002|Overall Study|Lack of Efficacy|12|||
161310310|NCT01573767|582518578|FG003|Overall Study|Lack of Efficacy|17|||
161310311|NCT01573767|582518575|FG000|Overall Study|Protocol Violation|3|||
161310312|NCT01573767|582518576|FG001|Overall Study|Protocol Violation|1|||
161310313|NCT01573767|582518577|FG002|Overall Study|Protocol Violation|1|||
161310314|NCT01573767|582518578|FG003|Overall Study|Protocol Violation|3|||
161310315|NCT01573767|582518575|FG000|Overall Study|Lost to Follow-up|0|||
161310316|NCT01573767|582518576|FG001|Overall Study|Lost to Follow-up|1|||
161310317|NCT01573767|582518577|FG002|Overall Study|Lost to Follow-up|1|||
161310318|NCT01573767|582518578|FG003|Overall Study|Lost to Follow-up|1|||
161310319|NCT01573767|582518575|FG000|Overall Study|Physician Decision|1|||
161310320|NCT01573767|582518576|FG001|Overall Study|Physician Decision|2|||
161310321|NCT01573767|582518577|FG002|Overall Study|Physician Decision|0|||
161310322|NCT01573767|582518578|FG003|Overall Study|Physician Decision|2|||
161310323|NCT01573767|582518575|FG000|Overall Study|Withdrawal by Subject|0|||
161310324|NCT01573767|582518576|FG001|Overall Study|Withdrawal by Subject|1|||
161310325|NCT01573767|582518577|FG002|Overall Study|Withdrawal by Subject|0|||
161310326|NCT01573767|582518578|FG003|Overall Study|Withdrawal by Subject|0|||
161310327|NCT04247880|582518579|FG000|Overall Study|Lost to Follow-up|24|||
161310328|NCT04247880|582518580|FG001|Overall Study|Lost to Follow-up|17|||
161310329|NCT04247880|582518579|FG000|Overall Study|Withdrawal by Subject|3|||
161310330|NCT04247880|582518580|FG001|Overall Study|Withdrawal by Subject|0|||
161310331|NCT02122770|582518581|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
161310332|NCT02122770|582518582|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161310333|NCT02122770|582518583|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
161310334|NCT02122770|582518584|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
161310335|NCT02122770|582518585|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161310336|NCT02122770|582518586|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
161310337|NCT02122770|582518581|FG000|Part A: Drug-drug Interaction 2|Other|0|||
161310338|NCT02122770|582518582|FG001|Part A: Drug-drug Interaction 2|Other|0|||
161310339|NCT02122770|582518583|FG002|Part A: Drug-drug Interaction 2|Other|1|||
161310340|NCT02122770|582518584|FG003|Part A: Drug-drug Interaction 2|Other|0|||
161310341|NCT02122770|582518585|FG004|Part A: Drug-drug Interaction 2|Other|0|||
161310342|NCT02122770|582518586|FG005|Part A: Drug-drug Interaction 2|Other|0|||
161310343|NCT02122770|582518581|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161310344|NCT02122770|582518582|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
161310345|NCT02122770|582518583|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161310346|NCT02122770|582518584|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161310347|NCT02122770|582518585|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161310348|NCT02122770|582518586|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
161310349|NCT02122770|582518581|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
161310350|NCT02122770|582518582|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
161310351|NCT02122770|582518583|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161310352|NCT02122770|582518584|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
161310353|NCT02122770|582518585|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161310354|NCT02122770|582518586|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
161310355|NCT02122770|582518581|FG000|Part B: Standard of Care|Adverse Event|0|||
161310356|NCT02122770|582518582|FG001|Part B: Standard of Care|Adverse Event|0|||
161310357|NCT02122770|582518583|FG002|Part B: Standard of Care|Adverse Event|0|||
161310358|NCT02122770|582518584|FG003|Part B: Standard of Care|Adverse Event|0|||
161310359|NCT02122770|582518585|FG004|Part B: Standard of Care|Adverse Event|4|||
161310360|NCT02122770|582518586|FG005|Part B: Standard of Care|Adverse Event|1|||
161310361|NCT02122770|582518581|FG000|Part B: Standard of Care|Other|0|||
161310362|NCT02122770|582518582|FG001|Part B: Standard of Care|Other|0|||
161310363|NCT02122770|582518583|FG002|Part B: Standard of Care|Other|0|||
161310364|NCT02122770|582518584|FG003|Part B: Standard of Care|Other|0|||
161310365|NCT02122770|582518585|FG004|Part B: Standard of Care|Other|0|||
161310366|NCT02122770|582518586|FG005|Part B: Standard of Care|Other|2|||
161310367|NCT02122770|582518581|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
161310368|NCT02122770|582518582|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
161310369|NCT02122770|582518583|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
161310370|NCT02122770|582518584|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
161310371|NCT02122770|582518585|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
161310372|NCT02122770|582518586|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
161310373|NCT02122770|582518581|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
161310374|NCT02122770|582518582|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
161310375|NCT02122770|582518583|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
161310376|NCT02122770|582518584|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
161310377|NCT02122770|582518585|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
161310378|NCT02122770|582518586|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
161310379|NCT02122770|582518581|FG000|Part B: Standard of Care|Progressive Disease|0|||
161310380|NCT02122770|582518582|FG001|Part B: Standard of Care|Progressive Disease|0|||
161310381|NCT02122770|582518583|FG002|Part B: Standard of Care|Progressive Disease|0|||
161310382|NCT02122770|582518584|FG003|Part B: Standard of Care|Progressive Disease|0|||
161310383|NCT02122770|582518585|FG004|Part B: Standard of Care|Progressive Disease|10|||
161310384|NCT02122770|582518586|FG005|Part B: Standard of Care|Progressive Disease|8|||
161310385|NCT00250458|582518588|FG000|Overall Study|Lost to Follow-up|4|||
161310386|NCT00250458|582518589|FG001|Overall Study|Lost to Follow-up|2|||
161310387|NCT00250458|582518588|FG000|Overall Study|Protocol Violation|0|||
161310388|NCT00250458|582518589|FG001|Overall Study|Protocol Violation|1|||
161310389|NCT00250458|582518588|FG000|Overall Study|Withdrawal by Subject|4|||
161310390|NCT00250458|582518589|FG001|Overall Study|Withdrawal by Subject|2|||
161310391|NCT00250458|582518588|FG000|Overall Study|Lack of Migraine Attack|20|||
161310392|NCT00250458|582518589|FG001|Overall Study|Lack of Migraine Attack|9|||
161310393|NCT00250458|582518588|FG000|Overall Study|Qualifying migraine but did not treat|3|||
161310394|NCT00250458|582518589|FG001|Overall Study|Qualifying migraine but did not treat|3|||
161310395|NCT00250458|582518588|FG000|Overall Study|Other|1|||
161310396|NCT00250458|582518589|FG001|Overall Study|Other|0|||
161310397|NCT06137703|582518590|FG000|Overall Study|Other|0|||
161310398|NCT06137703|582518591|FG001|Overall Study|Other|1|||
161310399|NCT06137703|582518592|FG002|Overall Study|Other|0|||
161310400|NCT06137703|582518593|FG003|Overall Study|Other|0|||
161310401|NCT06137703|582518590|FG000|Overall Study|Adverse Event|0|||
161310402|NCT06137703|582518591|FG001|Overall Study|Adverse Event|0|||
161310403|NCT06137703|582518592|FG002|Overall Study|Adverse Event|1|||
161310404|NCT06137703|582518593|FG003|Overall Study|Adverse Event|0|||
161310405|NCT00767039|582518596|FG000|Overall Study|Death|5|||
161310406|NCT00767039|582518597|FG001|Overall Study|Death|2|||
161310407|NCT01472757|582518599|FG000|Overall Study|Withdrawal by Subject|1|||
161310408|NCT01472757|582518600|FG001|Overall Study|Withdrawal by Subject|2|||
161310409|NCT01472757|582518601|FG002|Overall Study|Withdrawal by Subject|2|||
161310410|NCT01472757|582518602|FG003|Overall Study|Withdrawal by Subject|0|||
161310411|NCT01472757|582518599|FG000|Overall Study|Asthma exacerbation|4|||
161310412|NCT01472757|582518600|FG001|Overall Study|Asthma exacerbation|1|||
161310413|NCT01472757|582518601|FG002|Overall Study|Asthma exacerbation|2|||
161310414|NCT01472757|582518602|FG003|Overall Study|Asthma exacerbation|1|||
161310415|NCT01472757|582518599|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
161310416|NCT01472757|582518600|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
161310417|NCT01472757|582518601|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
161310418|NCT01472757|582518602|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
161310419|NCT01472757|582518599|FG000|Overall Study|Protocol Violation|3|||
161310420|NCT01472757|582518600|FG001|Overall Study|Protocol Violation|2|||
161310421|NCT01472757|582518601|FG002|Overall Study|Protocol Violation|4|||
161310422|NCT01472757|582518602|FG003|Overall Study|Protocol Violation|4|||
161310423|NCT01472757|582518599|FG000|Overall Study|Other reasons|1|||
161310424|NCT01472757|582518600|FG001|Overall Study|Other reasons|0|||
161310425|NCT01472757|582518601|FG002|Overall Study|Other reasons|2|||
161310426|NCT01472757|582518602|FG003|Overall Study|Other reasons|2|||
161310427|NCT02505334|582518603|FG000|Main Treatment Period|Adverse Event|3|||
161310428|NCT02505334|582518604|FG001|Main Treatment Period|Adverse Event|3|||
161310429|NCT02505334|582518603|FG000|Main Treatment Period|Lack of Efficacy|7|||
161310430|NCT02505334|582518604|FG001|Main Treatment Period|Lack of Efficacy|17|||
161310431|NCT02505334|582518603|FG000|Main Treatment Period|Protocol Violation|0|||
161310432|NCT02505334|582518604|FG001|Main Treatment Period|Protocol Violation|1|||
161310433|NCT02505334|582518603|FG000|Main Treatment Period|Withdrawal by Subject|1|||
161310434|NCT02505334|582518604|FG001|Main Treatment Period|Withdrawal by Subject|8|||
161310435|NCT02505334|582518603|FG000|Main Treatment Period|Unclassified|4|||
161310436|NCT02505334|582518604|FG001|Main Treatment Period|Unclassified|10|||
161310437|NCT02505334|582518603|FG000|Extension Treatment Period|Adverse Event|5|||
161310438|NCT02505334|582518604|FG001|Extension Treatment Period|Adverse Event|0|||
161310439|NCT02505334|582518603|FG000|Extension Treatment Period|Lack of Efficacy|4|||
161310440|NCT02505334|582518604|FG001|Extension Treatment Period|Lack of Efficacy|0|||
161310441|NCT02505334|582518603|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
161310442|NCT02505334|582518604|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
161310443|NCT02505334|582518603|FG000|Extension Treatment Period|Unclassified|3|||
161310444|NCT02505334|582518604|FG001|Extension Treatment Period|Unclassified|0|||
161310445|NCT01549041|582518607|FG000|Overall Study|Lack of Efficacy|2|||
161310446|NCT01549041|582518608|FG001|Overall Study|Lack of Efficacy|4|||
161310447|NCT01549041|582518607|FG000|Overall Study|Adverse Event|0|||
161310448|NCT01549041|582518608|FG001|Overall Study|Adverse Event|4|||
161310449|NCT00597506|582518609|FG000|Overall Study|Subject is being followed for survival|1|||
161310450|NCT01629823|582518616|FG000|Trial Period|Missed visit|11|||
161310451|NCT01629823|582518617|FG001|Trial Period|Missed visit|9|||
161310452|NCT01629823|582518618|FG002|Trial Period|Missed visit|8|||
161310453|NCT01629823|582518616|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161310454|NCT01629823|582518617|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161310455|NCT01629823|582518618|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
161310456|NCT01629823|582518616|FG000|Trial Period|Pregnancy|1|||
161203491|NCT01489865|582124485|FG006|Overall Study|Shifted|0|||
161203492|NCT01489865|582124486|FG007|Overall Study|Shifted|0|||
161203493|NCT01489865|582124487|FG008|Overall Study|Shifted|0|||
161203494|NCT04115488|582124488|FG000|Overall Study|Adverse Event|8|||
161203495|NCT04115488|582124489|FG001|Overall Study|Adverse Event|4|||
161203496|NCT04115488|582124488|FG000|Overall Study|Withdrawal by Subject|3|||
161203497|NCT04115488|582124489|FG001|Overall Study|Withdrawal by Subject|6|||
161203498|NCT04115488|582124488|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
161203499|NCT04115488|582124489|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
161203500|NCT04115488|582124488|FG000|Overall Study|Patient 's location change|1|||
161203501|NCT04115488|582124489|FG001|Overall Study|Patient 's location change|0|||
161203502|NCT04115488|582124488|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
161203503|NCT04115488|582124489|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
161203504|NCT00885677|582124490|FG000|Overall Study|Death|40|||
161203505|NCT00885677|582124491|FG001|Overall Study|Death|34|||
161203506|NCT00885677|582124490|FG000|Overall Study|Lost to Follow-up|15|||
161203507|NCT00885677|582124491|FG001|Overall Study|Lost to Follow-up|13|||
161203508|NCT00885677|582124490|FG000|Overall Study|Protocol Violation|54|||
161203509|NCT00885677|582124491|FG001|Overall Study|Protocol Violation|54|||
161203510|NCT00885677|582124490|FG000|Overall Study|premature study closure|41|||
161203511|NCT00885677|582124491|FG001|Overall Study|premature study closure|44|||
161203512|NCT00885677|582124490|FG000|Overall Study|device/lead revision or replacement|7|||
161203513|NCT00885677|582124491|FG001|Overall Study|device/lead revision or replacement|6|||
161203514|NCT00885677|582124490|FG000|Overall Study|Heart transplantation|1|||
161203515|NCT00885677|582124491|FG001|Overall Study|Heart transplantation|0|||
161203516|NCT00885677|582124490|FG000|Overall Study|Inclusion/exclusion not met|25|||
161203517|NCT00885677|582124491|FG001|Overall Study|Inclusion/exclusion not met|27|||
161203518|NCT00972309|582124492|FG000|Overall Study|Switched to alternative treatment|0|||
161203519|NCT00972309|582124493|FG001|Overall Study|Switched to alternative treatment|2|||
161203520|NCT00972309|582124492|FG000|Overall Study|Refused further treatment|0|||
161203521|NCT00972309|582124493|FG001|Overall Study|Refused further treatment|1|||
161203522|NCT00972309|582124492|FG000|Overall Study|Late determination of ineligibility|0|||
161203523|NCT00972309|582124493|FG001|Overall Study|Late determination of ineligibility|1|||
161203524|NCT00972309|582124492|FG000|Overall Study|Second malignancy|1|||
161203525|NCT00972309|582124493|FG001|Overall Study|Second malignancy|1|||
161203526|NCT00972309|582124492|FG000|Overall Study|Visa issues|0|||
161203527|NCT00972309|582124493|FG001|Overall Study|Visa issues|1|||
161203528|NCT00972309|582124492|FG000|Overall Study|Secondary cancer (SCC)|0|||
161203529|NCT00972309|582124493|FG001|Overall Study|Secondary cancer (SCC)|1|||
161203530|NCT00972309|582124492|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
161203531|NCT00972309|582124493|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
161203532|NCT00972309|582124492|FG000|Overall Study|Lost to Follow-up|1|||
161203533|NCT00972309|582124493|FG001|Overall Study|Lost to Follow-up|1|||
161203534|NCT00972309|582124492|FG000|Overall Study|Disease progression on study|10|||
161203535|NCT00972309|582124493|FG001|Overall Study|Disease progression on study|4|||
161203536|NCT01875731|582124508|FG000|Overall Study|Fail to obtain lab sample|1|||
161203537|NCT01875731|582124509|FG001|Overall Study|Fail to obtain lab sample|0|||
161203538|NCT03417102|582124510|FG000|Overall Study|Adverse Event|0|||
161203539|NCT03417102|582124511|FG001|Overall Study|Adverse Event|1|||
161203540|NCT03417102|582124510|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
161203541|NCT03417102|582124511|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
161203542|NCT03417102|582124510|FG000|Overall Study|Other|0|||
161203543|NCT03417102|582124511|FG001|Overall Study|Other|1|||
161203544|NCT02062385|582124515|FG000|Overall Study|Adverse Event|19|||
161203545|NCT02062385|582124516|FG001|Overall Study|Adverse Event|13|||
161203546|NCT02062385|582124517|FG002|Overall Study|Adverse Event|1|||
161203547|NCT02062385|582124518|FG003|Overall Study|Adverse Event|0|||
161203548|NCT02062385|582124515|FG000|Overall Study|Protocol Violation|1|||
161203549|NCT02062385|582124516|FG001|Overall Study|Protocol Violation|0|||
161203550|NCT02062385|582124517|FG002|Overall Study|Protocol Violation|0|||
161203551|NCT02062385|582124518|FG003|Overall Study|Protocol Violation|0|||
161203552|NCT02062385|582124515|FG000|Overall Study|Incomplete EPI by database lock|2|||
161203553|NCT02062385|582124516|FG001|Overall Study|Incomplete EPI by database lock|0|||
161203554|NCT02062385|582124517|FG002|Overall Study|Incomplete EPI by database lock|0|||
161203555|NCT02062385|582124518|FG003|Overall Study|Incomplete EPI by database lock|0|||
161203556|NCT02062385|582124515|FG000|Overall Study|Moved|10|||
161203557|NCT02062385|582124516|FG001|Overall Study|Moved|11|||
161203558|NCT02062385|582124517|FG002|Overall Study|Moved|1|||
161203559|NCT02062385|582124518|FG003|Overall Study|Moved|0|||
161203560|NCT02062385|582124515|FG000|Overall Study|Withdrawn by parent/guardian|46|||
161203561|NCT02062385|582124516|FG001|Overall Study|Withdrawn by parent/guardian|41|||
161203562|NCT02062385|582124517|FG002|Overall Study|Withdrawn by parent/guardian|9|||
161203563|NCT02062385|582124518|FG003|Overall Study|Withdrawn by parent/guardian|8|||
161203564|NCT02062385|582124515|FG000|Overall Study|Death|0|||
161203565|NCT02062385|582124516|FG001|Overall Study|Death|0|||
161203566|NCT02062385|582124517|FG002|Overall Study|Death|0|||
161310457|NCT01629823|582518617|FG001|Trial Period|Pregnancy|0|||
161310458|NCT01629823|582518618|FG002|Trial Period|Pregnancy|0|||
161310459|NCT01629823|582518616|FG000|Trial Period|Adverse Event|0|||
161310460|NCT01629823|582518617|FG001|Trial Period|Adverse Event|1|||
161310461|NCT01629823|582518618|FG002|Trial Period|Adverse Event|0|||
161310462|NCT01629823|582518616|FG000|Trial Period|Out-of-window visit|0|||
161310463|NCT01629823|582518617|FG001|Trial Period|Out-of-window visit|2|||
161310464|NCT01629823|582518618|FG002|Trial Period|Out-of-window visit|0|||
161310465|NCT01629823|582518616|FG000|Trial Period|Failed to hold medication|0|||
161310466|NCT01629823|582518617|FG001|Trial Period|Failed to hold medication|0|||
161310467|NCT01629823|582518618|FG002|Trial Period|Failed to hold medication|1|||
161310468|NCT01629823|582518616|FG000|Washout Period|Safety|2|||
161310469|NCT01629823|582518617|FG001|Washout Period|Safety|5|||
161310470|NCT01629823|582518618|FG002|Washout Period|Safety|0|||
161310471|NCT01629823|582518616|FG000|Washout Period|Pregnancy|1|||
161310472|NCT01629823|582518617|FG001|Washout Period|Pregnancy|0|||
161310473|NCT01629823|582518618|FG002|Washout Period|Pregnancy|0|||
161310474|NCT01629823|582518616|FG000|Washout Period|Protocol Violation|0|||
161310475|NCT01629823|582518617|FG001|Washout Period|Protocol Violation|1|||
161310476|NCT01629823|582518618|FG002|Washout Period|Protocol Violation|0|||
161310477|NCT00525902|582518620|FG000|Overall Study|Lack of Efficacy|1|||
161310478|NCT03747302|582518621|FG000|Overall Study|Withdrawal by Subject|1|||
161310479|NCT03747302|582518622|FG001|Overall Study|Withdrawal by Subject|2|||
161310480|NCT00738062|582518625|FG000|Open Label Treatment|Lack of Efficacy|5|||
161310481|NCT00738062|582518626|FG001|Open Label Treatment|Lack of Efficacy|0|||
161310482|NCT00738062|582518627|FG002|Open Label Treatment|Lack of Efficacy|0|||
161310483|NCT00738062|582518625|FG000|Open Label Treatment|Adverse Event|11|||
161310484|NCT00738062|582518626|FG001|Open Label Treatment|Adverse Event|0|||
161310485|NCT00738062|582518627|FG002|Open Label Treatment|Adverse Event|0|||
161310486|NCT00738062|582518625|FG000|Open Label Treatment|Protocol Violation|2|||
161310487|NCT00738062|582518626|FG001|Open Label Treatment|Protocol Violation|0|||
161310488|NCT00738062|582518627|FG002|Open Label Treatment|Protocol Violation|0|||
161310489|NCT00738062|582518625|FG000|Open Label Treatment|Withdrawal by Subject|9|||
161310490|NCT00738062|582518626|FG001|Open Label Treatment|Withdrawal by Subject|0|||
161310491|NCT00738062|582518627|FG002|Open Label Treatment|Withdrawal by Subject|0|||
161203567|NCT02062385|582124518|FG003|Overall Study|Death|1|||
161203568|NCT02062385|582124515|FG000|Overall Study|Lost to Follow-up|0|||
161203569|NCT02062385|582124516|FG001|Overall Study|Lost to Follow-up|0|||
161203570|NCT02062385|582124517|FG002|Overall Study|Lost to Follow-up|1|||
161203571|NCT02062385|582124518|FG003|Overall Study|Lost to Follow-up|0|||
161203572|NCT03188991|582124519|FG000|Overall Study|Withdrawal by Subject|0|||
161203573|NCT03188991|582124520|FG001|Overall Study|Withdrawal by Subject|0|||
161203574|NCT03188991|582124521|FG002|Overall Study|Withdrawal by Subject|0|||
161203575|NCT03188991|582124522|FG003|Overall Study|Withdrawal by Subject|1|||
161203576|NCT01319994|582126341|FG000|Overall Study|Protocol Violation|7|||
161203577|NCT01319994|582126342|FG001|Overall Study|Protocol Violation|6|||
161203578|NCT01340794|582126343|FG000|Overall Study|Withdrawal by Subject|0|||
161203579|NCT01340794|582126344|FG001|Overall Study|Withdrawal by Subject|1|||
161203580|NCT02674568|582126350|FG000|Overall Study|Withdrawal by Subject|5|||
161203581|NCT02674568|582126350|FG000|Overall Study|Death|303|||
161203582|NCT02674568|582126350|FG000|Overall Study|Physician Decision|2|||
161203583|NCT02674568|582126350|FG000|Overall Study|Lost to Follow-up|9|||
161203584|NCT02674568|582126350|FG000|Overall Study|Other, Not Specified|20|||
161203585|NCT01808508|582126353|FG000|Overall Study|Lost to Follow-up|1|||
161203586|NCT01808508|582126354|FG001|Overall Study|Lost to Follow-up|0|||
161203587|NCT01808508|582126355|FG002|Overall Study|Lost to Follow-up|0|||
161203588|NCT01118949|582126356|FG000|Overall Study|Adverse Event|5|||
161203589|NCT01118949|582126356|FG000|Overall Study|Withdrawal by Subject|4|||
161203590|NCT00648739|582126357|FG000|Overall Study|Adverse Event|1|||
161203591|NCT00648739|582126358|FG001|Overall Study|Adverse Event|0|||
161203592|NCT00648739|582126359|FG002|Overall Study|Adverse Event|1|||
161203593|NCT00648739|582126360|FG003|Overall Study|Adverse Event|2|||
161203594|NCT00648739|582126361|FG004|Overall Study|Adverse Event|1|||
161203595|NCT00648739|582126362|FG005|Overall Study|Adverse Event|0|||
161203596|NCT00648739|582126363|FG006|Overall Study|Adverse Event|0|||
161203597|NCT00648739|582126357|FG000|Overall Study|Withdrawal by Subject|1|||
161203598|NCT00648739|582126358|FG001|Overall Study|Withdrawal by Subject|0|||
161203599|NCT00648739|582126359|FG002|Overall Study|Withdrawal by Subject|1|||
161203600|NCT00648739|582126360|FG003|Overall Study|Withdrawal by Subject|0|||
161203601|NCT00648739|582126361|FG004|Overall Study|Withdrawal by Subject|0|||
161203602|NCT00648739|582126362|FG005|Overall Study|Withdrawal by Subject|2|||
161203603|NCT00648739|582126363|FG006|Overall Study|Withdrawal by Subject|0|||
161203604|NCT00648739|582126357|FG000|Overall Study|Lack of Efficacy|0|||
161203605|NCT00648739|582126358|FG001|Overall Study|Lack of Efficacy|0|||
161203606|NCT00648739|582126359|FG002|Overall Study|Lack of Efficacy|0|||
161203607|NCT00648739|582126360|FG003|Overall Study|Lack of Efficacy|0|||
161203608|NCT00648739|582126361|FG004|Overall Study|Lack of Efficacy|1|||
161203609|NCT00648739|582126362|FG005|Overall Study|Lack of Efficacy|2|||
161203610|NCT00648739|582126363|FG006|Overall Study|Lack of Efficacy|0|||
161203611|NCT00648739|582126357|FG000|Overall Study|Investigator Considered it Advisable|0|||
161203612|NCT00648739|582126358|FG001|Overall Study|Investigator Considered it Advisable|0|||
161203613|NCT00648739|582126359|FG002|Overall Study|Investigator Considered it Advisable|0|||
161203614|NCT00648739|582126360|FG003|Overall Study|Investigator Considered it Advisable|0|||
161203615|NCT00648739|582126361|FG004|Overall Study|Investigator Considered it Advisable|0|||
161203616|NCT00648739|582126362|FG005|Overall Study|Investigator Considered it Advisable|1|||
161203617|NCT00648739|582126363|FG006|Overall Study|Investigator Considered it Advisable|1|||
161203618|NCT00648739|582126357|FG000|Overall Study|Death|0|||
161203619|NCT00648739|582126358|FG001|Overall Study|Death|1|||
161203620|NCT00648739|582126359|FG002|Overall Study|Death|0|||
161203621|NCT00648739|582126360|FG003|Overall Study|Death|0|||
161203622|NCT00648739|582126361|FG004|Overall Study|Death|0|||
161310492|NCT00738062|582518625|FG000|Open Label Treatment|Investigator Decision|1|||
161310493|NCT00738062|582518626|FG001|Open Label Treatment|Investigator Decision|0|||
161310494|NCT00738062|582518627|FG002|Open Label Treatment|Investigator Decision|0|||
161310495|NCT00738062|582518625|FG000|Open-Label Extension|Adverse Event|5|||
161310496|NCT00738062|582518626|FG001|Open-Label Extension|Adverse Event|0|||
161310497|NCT00738062|582518627|FG002|Open-Label Extension|Adverse Event|0|||
161310498|NCT00738062|582518625|FG000|Open-Label Extension|Physician Decision|1|||
161310499|NCT00738062|582518626|FG001|Open-Label Extension|Physician Decision|0|||
161310500|NCT00738062|582518627|FG002|Open-Label Extension|Physician Decision|0|||
161310501|NCT00738062|582518625|FG000|Open-Label Extension|Lack of Efficacy|2|||
161310502|NCT00738062|582518626|FG001|Open-Label Extension|Lack of Efficacy|0|||
161310503|NCT00738062|582518627|FG002|Open-Label Extension|Lack of Efficacy|0|||
161310504|NCT00738062|582518625|FG000|Open-Label Extension|Withdrawal by Subject|6|||
161310505|NCT00738062|582518626|FG001|Open-Label Extension|Withdrawal by Subject|0|||
161310506|NCT00738062|582518627|FG002|Open-Label Extension|Withdrawal by Subject|0|||
161310507|NCT00738062|582518625|FG000|Open-Label Extension|Protocol Violation|1|||
161310508|NCT00738062|582518626|FG001|Open-Label Extension|Protocol Violation|0|||
161310509|NCT00738062|582518627|FG002|Open-Label Extension|Protocol Violation|0|||
161310510|NCT00738062|582518625|FG000|Open-Label Extension|Study Terminated|2|||
161310511|NCT00738062|582518626|FG001|Open-Label Extension|Study Terminated|0|||
161310512|NCT00738062|582518627|FG002|Open-Label Extension|Study Terminated|0|||
161310513|NCT00526331|582518628|FG000|Overall Study|Sponsor Termination|55|||
161310514|NCT00455520|582518630|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
161203623|NCT00648739|582126362|FG005|Overall Study|Death|0|||
161203624|NCT00648739|582126363|FG006|Overall Study|Death|0|||
161203625|NCT00648739|582126357|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
161203626|NCT00648739|582126358|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
161310515|NCT00455520|582518631|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
161310516|NCT00455520|582518630|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
161310517|NCT00455520|582518631|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
161203627|NCT00648739|582126359|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
161203628|NCT00648739|582126360|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
161203629|NCT00648739|582126361|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
161203630|NCT00648739|582126362|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
161203631|NCT00648739|582126363|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
161203632|NCT00648739|582126357|FG000|Overall Study|Follow-up Visits Not Completed|0|||
161203633|NCT00648739|582126358|FG001|Overall Study|Follow-up Visits Not Completed|1|||
161203634|NCT00648739|582126359|FG002|Overall Study|Follow-up Visits Not Completed|0|||
161203635|NCT00648739|582126360|FG003|Overall Study|Follow-up Visits Not Completed|0|||
161203636|NCT00648739|582126361|FG004|Overall Study|Follow-up Visits Not Completed|0|||
161203637|NCT00648739|582126362|FG005|Overall Study|Follow-up Visits Not Completed|0|||
161203638|NCT00648739|582126363|FG006|Overall Study|Follow-up Visits Not Completed|0|||
161203639|NCT04362761|582126374|FG000|Part A (48 Weeks)|Adverse Event|2|||
161203640|NCT04362761|582126374|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
161203641|NCT04362761|582126374|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
161203642|NCT04362761|582126374|FG000|Part A (48 Weeks)|Other|5|||
161203643|NCT04362761|582126374|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
161203644|NCT04362761|582126374|FG000|Part B (86 Weeks)|Other|4|||
161203645|NCT01473589|582126380|FG000|Overall Study|Adverse Event|1|||
161203646|NCT01473589|582126381|FG001|Overall Study|Adverse Event|1|||
161203647|NCT01473589|582126380|FG000|Overall Study|Death|2|||
161203648|NCT01473589|582126381|FG001|Overall Study|Death|0|||
161203649|NCT01473589|582126380|FG000|Overall Study|Lost to Follow-up|2|||
161203650|NCT01473589|582126381|FG001|Overall Study|Lost to Follow-up|2|||
161203651|NCT01473589|582126380|FG000|Overall Study|Protocol Violation|1|||
161203652|NCT01473589|582126381|FG001|Overall Study|Protocol Violation|0|||
161203653|NCT01473589|582126380|FG000|Overall Study|Withdrawal by Subject|5|||
161203654|NCT01473589|582126381|FG001|Overall Study|Withdrawal by Subject|11|||
161203655|NCT01473589|582126380|FG000|Overall Study|Physician Decision|0|||
161203656|NCT01473589|582126381|FG001|Overall Study|Physician Decision|1|||
161203657|NCT01473589|582126380|FG000|Overall Study|Entry criteria not met|0|||
161203658|NCT01473589|582126381|FG001|Overall Study|Entry criteria not met|1|||
161203659|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
161203660|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161203661|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161203662|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
161203663|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
161203664|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
161203665|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
161203666|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
161203667|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
161203668|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161203669|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161203670|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
161203671|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
161203672|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
161203673|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
161203674|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
161203675|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
161203676|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161203677|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161203678|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
161203679|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
161203680|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
161203681|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
161203682|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
161203683|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
161203684|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161203685|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161203686|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
161203687|NCT01299272|582126386|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
161203688|NCT01299272|582126387|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
161203689|NCT01299272|582126388|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
161203690|NCT01299272|582126389|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
161203691|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161203692|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
161203693|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161203694|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
161203695|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161203696|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
161203697|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161203698|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
161203699|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
161203700|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
161203701|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
161203702|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
161203703|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161203704|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
161203705|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161203706|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
161203707|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161203708|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
161203709|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161203710|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
161203711|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161203712|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
161203713|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161203714|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
161203715|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161203716|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
161203717|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161203718|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
161203719|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161203720|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
161203721|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161203722|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
161203723|NCT01299272|582126386|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
161203724|NCT01299272|582126387|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
161203725|NCT01299272|582126388|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
161203726|NCT01299272|582126389|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
161203727|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
161203728|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
161203729|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
161203730|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
161203731|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
161203732|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
161203733|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
161203734|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
161203735|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
161203736|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
161203737|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
161203738|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
161203739|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
161203740|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
161203741|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
161203742|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
161203743|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
161203744|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
161203745|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
161203746|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
161203747|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
161203748|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
161203749|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
161203750|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
161203751|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
161203752|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
161203753|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
161203754|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
161203755|NCT01299272|582126386|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
161203756|NCT01299272|582126387|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
161203757|NCT01299272|582126388|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
161203758|NCT01299272|582126389|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
161203759|NCT00464308|582126390|FG000|Overall Study|Adverse Event|22|||
161203760|NCT00464308|582126391|FG001|Overall Study|Adverse Event|27|||
161203761|NCT00464308|582126392|FG002|Overall Study|Adverse Event|16|||
161203762|NCT00464308|582126390|FG000|Overall Study|Lost to Follow-up|29|||
161203763|NCT00464308|582126391|FG001|Overall Study|Lost to Follow-up|19|||
161203764|NCT00464308|582126392|FG002|Overall Study|Lost to Follow-up|20|||
161203765|NCT00464308|582126390|FG000|Overall Study|Patient discontinued and other reasons|17|||
161203766|NCT00464308|582126391|FG001|Overall Study|Patient discontinued and other reasons|17|||
161203767|NCT00464308|582126392|FG002|Overall Study|Patient discontinued and other reasons|23|||
161203768|NCT00464308|582126390|FG000|Overall Study|Physician Decision|1|||
161203769|NCT00464308|582126391|FG001|Overall Study|Physician Decision|0|||
161203770|NCT00464308|582126392|FG002|Overall Study|Physician Decision|0|||
161203771|NCT01721200|582126393|FG000|Overall Study|Lost to Follow-up|3|||
161203772|NCT01721200|582126394|FG001|Overall Study|Lost to Follow-up|5|||
161203773|NCT01513759|582126395|FG000|Overall Study|Protocol Violation|4|||
161203774|NCT01513759|582126395|FG000|Overall Study|Death during catheter placement|1|||
161203775|NCT03606109|582126396|FG000|Overall Study|Lost to Follow-up|2|||
161203776|NCT03606109|582126397|FG001|Overall Study|Lost to Follow-up|1|||
161203777|NCT03722849|582126398|FG000|Overall Study|Withdrawal by Subject|1|||
161203778|NCT03722849|582126399|FG001|Overall Study|Withdrawal by Subject|1|||
161203779|NCT00915473|582126400|FG000|Screening|Withdrawal by Subject|1|||
161203780|NCT00915473|582126401|FG001|Screening|Withdrawal by Subject|0|||
161203781|NCT00915473|582126400|FG000|4-week Follow Up|Lost to Follow-up|1|||
161203782|NCT00915473|582126401|FG001|4-week Follow Up|Lost to Follow-up|5|||
161203783|NCT03286426|582126402|FG000|Overall Study|Physician Decision|3|||
161203784|NCT01817764|582126403|FG000|Overall Study|Adverse Event|7|||
161203785|NCT01817764|582126404|FG001|Overall Study|Adverse Event|10|||
161203786|NCT01817764|582126403|FG000|Overall Study|Lack of Efficacy|9|||
161203787|NCT01817764|582126404|FG001|Overall Study|Lack of Efficacy|7|||
161203788|NCT01817764|582126403|FG000|Overall Study|Protocol Violation|7|||
161203789|NCT01817764|582126404|FG001|Overall Study|Protocol Violation|5|||
161203790|NCT01817764|582126403|FG000|Overall Study|Lost to Follow-up|1|||
161203791|NCT01817764|582126404|FG001|Overall Study|Lost to Follow-up|4|||
161203792|NCT01817764|582126403|FG000|Overall Study|Withdrawal by Subject|10|||
161203793|NCT01817764|582126404|FG001|Overall Study|Withdrawal by Subject|12|||
161203794|NCT01956123|582126405|FG000|COS Cycle 2|Protocol Violation|8|||
161203795|NCT01956123|582126406|FG001|COS Cycle 2|Protocol Violation|3|||
161203796|NCT01956123|582126407|FG002|COS Cycle 2|Protocol Violation|0|||
161203797|NCT01956123|582126408|FG003|COS Cycle 2|Protocol Violation|0|||
161203798|NCT01956123|582126405|FG000|COS Cycle 2|Adverse Event|3|||
161203799|NCT01956123|582126406|FG001|COS Cycle 2|Adverse Event|4|||
161203800|NCT01956123|582126407|FG002|COS Cycle 2|Adverse Event|0|||
161203801|NCT01956123|582126408|FG003|COS Cycle 2|Adverse Event|0|||
161203802|NCT01956123|582126405|FG000|COS Cycle 2|Personal Reasons|2|||
161203803|NCT01956123|582126406|FG001|COS Cycle 2|Personal Reasons|0|||
161203804|NCT01956123|582126407|FG002|COS Cycle 2|Personal Reasons|0|||
161203805|NCT01956123|582126408|FG003|COS Cycle 2|Personal Reasons|0|||
161203806|NCT01956123|582126405|FG000|COS Cycle 2|Withdrawal by Subject|1|||
161203807|NCT01956123|582126406|FG001|COS Cycle 2|Withdrawal by Subject|0|||
161203808|NCT01956123|582126407|FG002|COS Cycle 2|Withdrawal by Subject|0|||
161203809|NCT01956123|582126408|FG003|COS Cycle 2|Withdrawal by Subject|0|||
161203810|NCT01956123|582126405|FG000|COS Cycle 3|Protocol Violation|0|||
161203811|NCT01956123|582126406|FG001|COS Cycle 3|Protocol Violation|0|||
161203812|NCT01956123|582126407|FG002|COS Cycle 3|Protocol Violation|2|||
161203813|NCT01956123|582126408|FG003|COS Cycle 3|Protocol Violation|1|||
161203814|NCT01956123|582126405|FG000|COS Cycle 3|Adverse Event|0|||
161203815|NCT01956123|582126406|FG001|COS Cycle 3|Adverse Event|0|||
161203816|NCT01956123|582126407|FG002|COS Cycle 3|Adverse Event|3|||
161203817|NCT01956123|582126408|FG003|COS Cycle 3|Adverse Event|0|||
161203818|NCT01956123|582126405|FG000|COS Cycle 3|Personal Reasons|0|||
161203819|NCT01956123|582126406|FG001|COS Cycle 3|Personal Reasons|0|||
161203820|NCT01956123|582126407|FG002|COS Cycle 3|Personal Reasons|1|||
161203821|NCT01956123|582126408|FG003|COS Cycle 3|Personal Reasons|0|||
161203822|NCT01956123|582126405|FG000|COS Cycle 3|Withdrawal by Subject|0|||
161203823|NCT01956123|582126406|FG001|COS Cycle 3|Withdrawal by Subject|0|||
161203824|NCT01956123|582126407|FG002|COS Cycle 3|Withdrawal by Subject|0|||
161203825|NCT01956123|582126408|FG003|COS Cycle 3|Withdrawal by Subject|1|||
161203826|NCT00826176|582126421|FG000|Overall Study|Lost to Follow-up|1|||
161203827|NCT00826176|582126422|FG001|Overall Study|Lost to Follow-up|0|||
161203828|NCT00826176|582126421|FG000|Overall Study|Subject Withdrew Consent|3|||
161203829|NCT00826176|582126422|FG001|Overall Study|Subject Withdrew Consent|0|||
161203830|NCT00826176|582126421|FG000|Overall Study|Administrative|9|||
161203831|NCT00826176|582126422|FG001|Overall Study|Administrative|0|||
161203832|NCT00740480|582126423|FG000|Overall Study|Adverse Event|1|||
161203833|NCT00740480|582126423|FG000|Overall Study|Physician Decision|1|||
161203834|NCT03079869|582126426|FG000|Overall Study|Adverse Event|6|||
161203835|NCT03079869|582126427|FG001|Overall Study|Adverse Event|8|||
161203836|NCT03079869|582126426|FG000|Overall Study|Withdrawal by Subject|4|||
161203837|NCT03079869|582126427|FG001|Overall Study|Withdrawal by Subject|1|||
161203838|NCT03079869|582126426|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
161203839|NCT03079869|582126427|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
161203840|NCT01325701|582126428|FG000|Overall Study|Adverse Event|12|||
161203841|NCT01325701|582126429|FG001|Overall Study|Adverse Event|0|||
161203842|NCT01325701|582126428|FG000|Overall Study|Protocol Violation|1|||
161203843|NCT01325701|582126429|FG001|Overall Study|Protocol Violation|0|||
161203844|NCT01325701|582126428|FG000|Overall Study|Physician Decision|2|||
161203845|NCT01325701|582126429|FG001|Overall Study|Physician Decision|2|||
161203846|NCT01325701|582126428|FG000|Overall Study|Withdrawal by Subject|2|||
161203847|NCT01325701|582126429|FG001|Overall Study|Withdrawal by Subject|1|||
161203848|NCT01325701|582126428|FG000|Overall Study|Rollerover Extension Study|4|||
161203849|NCT01325701|582126429|FG001|Overall Study|Rollerover Extension Study|0|||
161203850|NCT01005680|582126435|FG000|Overall Study|Lost to Follow-up|4|||
161203851|NCT01005680|582126436|FG001|Overall Study|Lost to Follow-up|6|||
161203852|NCT01005680|582126435|FG000|Overall Study|Withdrawal by Subject|1|||
161203853|NCT01005680|582126436|FG001|Overall Study|Withdrawal by Subject|4|||
161203854|NCT01005680|582126435|FG000|Overall Study|Physician Decision|1|||
161203855|NCT01005680|582126436|FG001|Overall Study|Physician Decision|1|||
161203856|NCT04484805|582126439|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
161203857|NCT04484805|582126440|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
161203858|NCT04484805|582126439|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
161203859|NCT04484805|582126440|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
161203860|NCT02118896|582126441|FG000|Overall Study|Death|4|||
161203861|NCT02118896|582126442|FG001|Overall Study|Death|0|||
161203862|NCT02118896|582126443|FG002|Overall Study|Death|4|||
161203863|NCT02118896|582126444|FG003|Overall Study|Death|6|||
161203864|NCT02118896|582126445|FG004|Overall Study|Death|3|||
161203865|NCT02118896|582126446|FG005|Overall Study|Death|1|||
161203866|NCT02118896|582126447|FG006|Overall Study|Death|0|||
161203867|NCT02118896|582126448|FG007|Overall Study|Death|0|||
161203868|NCT02118896|582126449|FG008|Overall Study|Death|0|||
161203869|NCT02118896|582126450|FG009|Overall Study|Death|0|||
161203870|NCT02118896|582126441|FG000|Overall Study|Adverse Event|5|||
161203871|NCT02118896|582126442|FG001|Overall Study|Adverse Event|4|||
161203872|NCT02118896|582126443|FG002|Overall Study|Adverse Event|4|||
161203873|NCT02118896|582126444|FG003|Overall Study|Adverse Event|5|||
161203874|NCT02118896|582126445|FG004|Overall Study|Adverse Event|5|||
161203875|NCT02118896|582126446|FG005|Overall Study|Adverse Event|9|||
161203876|NCT02118896|582126447|FG006|Overall Study|Adverse Event|1|||
161310518|NCT00455520|582518630|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
161310519|NCT00455520|582518631|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
161310520|NCT00455520|582518630|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
161203877|NCT02118896|582126448|FG007|Overall Study|Adverse Event|1|||
161203878|NCT02118896|582126449|FG008|Overall Study|Adverse Event|4|||
161203879|NCT02118896|582126450|FG009|Overall Study|Adverse Event|0|||
161203880|NCT02118896|582126441|FG000|Overall Study|Consent withdrawn|2|||
161203881|NCT02118896|582126442|FG001|Overall Study|Consent withdrawn|0|||
161203882|NCT02118896|582126443|FG002|Overall Study|Consent withdrawn|3|||
161203883|NCT02118896|582126444|FG003|Overall Study|Consent withdrawn|4|||
161203884|NCT02118896|582126445|FG004|Overall Study|Consent withdrawn|1|||
161203885|NCT02118896|582126446|FG005|Overall Study|Consent withdrawn|4|||
161203886|NCT02118896|582126447|FG006|Overall Study|Consent withdrawn|0|||
161203887|NCT02118896|582126448|FG007|Overall Study|Consent withdrawn|0|||
161203888|NCT02118896|582126449|FG008|Overall Study|Consent withdrawn|0|||
161203889|NCT02118896|582126450|FG009|Overall Study|Consent withdrawn|0|||
161203890|NCT02118896|582126441|FG000|Overall Study|Non-compliance|2|||
161203891|NCT02118896|582126442|FG001|Overall Study|Non-compliance|1|||
161203892|NCT02118896|582126443|FG002|Overall Study|Non-compliance|1|||
161203893|NCT02118896|582126444|FG003|Overall Study|Non-compliance|5|||
161203894|NCT02118896|582126445|FG004|Overall Study|Non-compliance|0|||
161203895|NCT02118896|582126446|FG005|Overall Study|Non-compliance|1|||
161203896|NCT02118896|582126447|FG006|Overall Study|Non-compliance|0|||
161203897|NCT02118896|582126448|FG007|Overall Study|Non-compliance|1|||
161203898|NCT02118896|582126449|FG008|Overall Study|Non-compliance|0|||
161203899|NCT02118896|582126450|FG009|Overall Study|Non-compliance|0|||
161203900|NCT02118896|582126441|FG000|Overall Study|Pregnancy|1|||
161203901|NCT02118896|582126442|FG001|Overall Study|Pregnancy|1|||
161203902|NCT02118896|582126443|FG002|Overall Study|Pregnancy|0|||
161203903|NCT02118896|582126444|FG003|Overall Study|Pregnancy|0|||
161203904|NCT02118896|582126445|FG004|Overall Study|Pregnancy|1|||
161203905|NCT02118896|582126446|FG005|Overall Study|Pregnancy|3|||
161203906|NCT02118896|582126447|FG006|Overall Study|Pregnancy|1|||
161203907|NCT02118896|582126448|FG007|Overall Study|Pregnancy|0|||
161203908|NCT02118896|582126449|FG008|Overall Study|Pregnancy|0|||
161203909|NCT02118896|582126450|FG009|Overall Study|Pregnancy|0|||
161203910|NCT02118896|582126441|FG000|Overall Study|Lost to Follow-up|1|||
161203911|NCT02118896|582126442|FG001|Overall Study|Lost to Follow-up|2|||
161203912|NCT02118896|582126443|FG002|Overall Study|Lost to Follow-up|1|||
161203913|NCT02118896|582126444|FG003|Overall Study|Lost to Follow-up|0|||
161203914|NCT02118896|582126445|FG004|Overall Study|Lost to Follow-up|2|||
161203915|NCT02118896|582126446|FG005|Overall Study|Lost to Follow-up|1|||
161203916|NCT02118896|582126447|FG006|Overall Study|Lost to Follow-up|0|||
161203917|NCT02118896|582126448|FG007|Overall Study|Lost to Follow-up|0|||
161203918|NCT02118896|582126449|FG008|Overall Study|Lost to Follow-up|0|||
161203919|NCT02118896|582126450|FG009|Overall Study|Lost to Follow-up|0|||
161203920|NCT02118896|582126441|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
161203921|NCT02118896|582126442|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
161203922|NCT02118896|582126443|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
161203923|NCT02118896|582126444|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161203924|NCT02118896|582126445|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
161203925|NCT02118896|582126446|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161203926|NCT02118896|582126447|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161203927|NCT02118896|582126448|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161203928|NCT02118896|582126449|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
161203929|NCT02118896|582126450|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
161203930|NCT02118896|582126441|FG000|Overall Study|Prohibited medication|0|||
161203931|NCT02118896|582126442|FG001|Overall Study|Prohibited medication|0|||
161203932|NCT02118896|582126443|FG002|Overall Study|Prohibited medication|0|||
161203933|NCT02118896|582126444|FG003|Overall Study|Prohibited medication|0|||
161203934|NCT02118896|582126445|FG004|Overall Study|Prohibited medication|1|||
161203935|NCT02118896|582126446|FG005|Overall Study|Prohibited medication|3|||
161203936|NCT02118896|582126447|FG006|Overall Study|Prohibited medication|0|||
161203937|NCT02118896|582126448|FG007|Overall Study|Prohibited medication|0|||
161203938|NCT02118896|582126449|FG008|Overall Study|Prohibited medication|0|||
161203939|NCT02118896|582126450|FG009|Overall Study|Prohibited medication|0|||
161203940|NCT02118896|582126441|FG000|Overall Study|Miscellaneous|1|||
161203941|NCT02118896|582126442|FG001|Overall Study|Miscellaneous|2|||
161203942|NCT02118896|582126443|FG002|Overall Study|Miscellaneous|0|||
161203943|NCT02118896|582126444|FG003|Overall Study|Miscellaneous|2|||
161203944|NCT02118896|582126445|FG004|Overall Study|Miscellaneous|0|||
161203945|NCT02118896|582126446|FG005|Overall Study|Miscellaneous|4|||
161203946|NCT02118896|582126447|FG006|Overall Study|Miscellaneous|0|||
161203947|NCT02118896|582126448|FG007|Overall Study|Miscellaneous|0|||
161203948|NCT02118896|582126449|FG008|Overall Study|Miscellaneous|0|||
161203949|NCT02118896|582126450|FG009|Overall Study|Miscellaneous|0|||
161203950|NCT00539006|582126454|FG000|Pre-treatment|Other|0|||
161203951|NCT00539006|582126455|FG001|Pre-treatment|Other|1|||
161203952|NCT00539006|582126456|FG002|Pre-treatment|Other|0|||
161203953|NCT00539006|582126457|FG003|Pre-treatment|Other|0|||
161203954|NCT00539006|582126454|FG000|Treatment Period 1|Lost to Follow-up|0|||
161203955|NCT00539006|582126455|FG001|Treatment Period 1|Lost to Follow-up|0|||
161203956|NCT00539006|582126456|FG002|Treatment Period 1|Lost to Follow-up|1|||
161203957|NCT00539006|582126457|FG003|Treatment Period 1|Lost to Follow-up|0|||
161203958|NCT00539006|582126454|FG000|Treatment Period 1|Protocol Violation|0|||
161203959|NCT00539006|582126455|FG001|Treatment Period 1|Protocol Violation|0|||
161203960|NCT00539006|582126456|FG002|Treatment Period 1|Protocol Violation|1|||
161203961|NCT00539006|582126457|FG003|Treatment Period 1|Protocol Violation|0|||
161203962|NCT00539006|582126454|FG000|Treatment Period 1|Lack of Efficacy|0|||
161203963|NCT00539006|582126455|FG001|Treatment Period 1|Lack of Efficacy|0|||
161203964|NCT00539006|582126456|FG002|Treatment Period 1|Lack of Efficacy|0|||
161203965|NCT00539006|582126457|FG003|Treatment Period 1|Lack of Efficacy|1|||
161203966|NCT00539006|582126454|FG000|Washout|Adverse Event|2|||
161203967|NCT00539006|582126455|FG001|Washout|Adverse Event|1|||
161203968|NCT00539006|582126456|FG002|Washout|Adverse Event|0|||
161203969|NCT00539006|582126457|FG003|Washout|Adverse Event|0|||
161203970|NCT00539006|582126454|FG000|Washout|Protocol Violation|1|||
161203971|NCT00539006|582126455|FG001|Washout|Protocol Violation|1|||
161203972|NCT00539006|582126456|FG002|Washout|Protocol Violation|0|||
161203973|NCT00539006|582126457|FG003|Washout|Protocol Violation|0|||
161203974|NCT00539006|582126454|FG000|Washout|Withdrawal by Subject|0|||
161203975|NCT00539006|582126455|FG001|Washout|Withdrawal by Subject|2|||
161203976|NCT00539006|582126456|FG002|Washout|Withdrawal by Subject|0|||
161203977|NCT00539006|582126457|FG003|Washout|Withdrawal by Subject|0|||
161203978|NCT00539006|582126454|FG000|Washout|Failed to meet continuation criteria|16|||
161203979|NCT00539006|582126455|FG001|Washout|Failed to meet continuation criteria|5|||
161203980|NCT00539006|582126456|FG002|Washout|Failed to meet continuation criteria|14|||
161203981|NCT00539006|582126457|FG003|Washout|Failed to meet continuation criteria|6|||
161203982|NCT00539006|582126454|FG000|Washout|Other|1|||
161203983|NCT00539006|582126455|FG001|Washout|Other|1|||
161203984|NCT00539006|582126456|FG002|Washout|Other|2|||
161203985|NCT00539006|582126457|FG003|Washout|Other|3|||
161203986|NCT00539006|582126454|FG000|Treatment Period 2|Protocol Violation|1|||
161203987|NCT00539006|582126455|FG001|Treatment Period 2|Protocol Violation|0|||
161203988|NCT00539006|582126456|FG002|Treatment Period 2|Protocol Violation|0|||
161203989|NCT00539006|582126457|FG003|Treatment Period 2|Protocol Violation|0|||
161203990|NCT00539006|582126454|FG000|Treatment Period 2|Other|0|||
161203991|NCT00539006|582126455|FG001|Treatment Period 2|Other|1|||
161203992|NCT00539006|582126456|FG002|Treatment Period 2|Other|0|||
161203993|NCT00539006|582126457|FG003|Treatment Period 2|Other|0|||
161203994|NCT03733301|582126458|FG000|Overall Study|Screen Fail|1|||
161203995|NCT03733301|582126459|FG001|Overall Study|Screen Fail|0|||
161203996|NCT03733301|582126460|FG002|Overall Study|Screen Fail|0|||
161203997|NCT03733301|582126458|FG000|Overall Study|Non-compliance|1|||
161203998|NCT03733301|582126459|FG001|Overall Study|Non-compliance|0|||
161203999|NCT03733301|582126460|FG002|Overall Study|Non-compliance|0|||
161204000|NCT03733301|582126458|FG000|Overall Study|Lack of Efficacy|2|||
161204001|NCT03733301|582126459|FG001|Overall Study|Lack of Efficacy|3|||
161204002|NCT03733301|582126460|FG002|Overall Study|Lack of Efficacy|0|||
161204003|NCT03733301|582126458|FG000|Overall Study|Adverse Event|0|||
161204004|NCT03733301|582126459|FG001|Overall Study|Adverse Event|1|||
161204005|NCT03733301|582126460|FG002|Overall Study|Adverse Event|3|||
161204006|NCT03733301|582126458|FG000|Overall Study|Withdrawal by Subject|3|||
161204007|NCT03733301|582126459|FG001|Overall Study|Withdrawal by Subject|5|||
161204008|NCT03733301|582126460|FG002|Overall Study|Withdrawal by Subject|1|||
161204009|NCT01965431|582126461|FG000|Overall Study|Adverse Event|0|||
161204010|NCT01965431|582126462|FG001|Overall Study|Adverse Event|1|||
161204011|NCT01965431|582126463|FG002|Overall Study|Adverse Event|0|||
161204012|NCT01965431|582126464|FG003|Overall Study|Adverse Event|0|||
161204013|NCT01965431|582126465|FG004|Overall Study|Adverse Event|0|||
161204014|NCT01965431|582126466|FG005|Overall Study|Adverse Event|0|||
161204015|NCT01965431|582126461|FG000|Overall Study|Other than stated above|6|||
161204016|NCT01965431|582126462|FG001|Overall Study|Other than stated above|5|||
161204017|NCT01965431|582126463|FG002|Overall Study|Other than stated above|6|||
161204018|NCT01965431|582126464|FG003|Overall Study|Other than stated above|6|||
161310521|NCT00455520|582518631|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
161204019|NCT01965431|582126465|FG004|Overall Study|Other than stated above|6|||
161310522|NCT00455520|582518630|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
161310523|NCT00455520|582518631|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
161310524|NCT00455520|582518630|FG000|Open Label Tapentadol Extended Release|All other|33|||
161310525|NCT00455520|582518631|FG001|Open Label Tapentadol Extended Release|All other|0|||
161310526|NCT00455520|582518630|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
161310527|NCT00455520|582518631|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
161310528|NCT00455520|582518630|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
161310529|NCT00455520|582518631|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
161310530|NCT00455520|582518630|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
161310531|NCT00455520|582518631|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
161310532|NCT00455520|582518630|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
161310533|NCT00455520|582518631|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
161204020|NCT01965431|582126466|FG005|Overall Study|Other than stated above|6|||
161204021|NCT04635631|582126467|FG000|Overall Study|Adverse Event|1|||
161204022|NCT04635631|582126467|FG000|Overall Study|Progressive disease|13|||
161204023|NCT04635631|582126467|FG000|Overall Study|Withdrawal by Subject|1|||
161204024|NCT00943826|582126468|FG000|Concurrent Phase|Adverse Event|50|||
161204025|NCT00943826|582126469|FG001|Concurrent Phase|Adverse Event|27|||
161204026|NCT00943826|582126468|FG000|Concurrent Phase|Withdrew consent|3|||
161204027|NCT00943826|582126469|FG001|Concurrent Phase|Withdrew consent|7|||
161204028|NCT00943826|582126468|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
161204029|NCT00943826|582126469|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
161204030|NCT00943826|582126468|FG000|Concurrent Phase|Administrative reasons|2|||
161204031|NCT00943826|582126469|FG001|Concurrent Phase|Administrative reasons|1|||
161204032|NCT00943826|582126468|FG000|Concurrent Phase|Protocol Violation|1|||
161204033|NCT00943826|582126469|FG001|Concurrent Phase|Protocol Violation|0|||
161204034|NCT00943826|582126468|FG000|Maintenance Phase|Adverse Event|31|||
161204035|NCT00943826|582126469|FG001|Maintenance Phase|Adverse Event|30|||
161204036|NCT00943826|582126468|FG000|Maintenance Phase|Withdrew consent|2|||
161204037|NCT00943826|582126469|FG001|Maintenance Phase|Withdrew consent|4|||
161204038|NCT00943826|582126468|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
161204039|NCT00943826|582126469|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
161204040|NCT00943826|582126468|FG000|Maintenance Phase|Administrative reasons|4|||
161204041|NCT00943826|582126469|FG001|Maintenance Phase|Administrative reasons|1|||
161204042|NCT00943826|582126468|FG000|Maintenance Phase|Failure to return|0|||
161204043|NCT00943826|582126469|FG001|Maintenance Phase|Failure to return|1|||
161204044|NCT00943826|582126468|FG000|Monotherapy Phase|Adverse Event|42|||
161204045|NCT00943826|582126469|FG001|Monotherapy Phase|Adverse Event|5|||
161204046|NCT00943826|582126468|FG000|Monotherapy Phase|Administrative reasons|11|||
161204047|NCT00943826|582126469|FG001|Monotherapy Phase|Administrative reasons|5|||
161204048|NCT00943826|582126468|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
161204049|NCT00943826|582126469|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
161204050|NCT00943826|582126468|FG000|Monotherapy Phase|Withdrew Consent|2|||
161204051|NCT00943826|582126469|FG001|Monotherapy Phase|Withdrew Consent|3|||
161204052|NCT00943826|582126468|FG000|Monotherapy Phase|Failure to return|2|||
161204053|NCT00943826|582126469|FG001|Monotherapy Phase|Failure to return|1|||
161204054|NCT00943826|582126468|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
161204055|NCT00943826|582126469|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
161310534|NCT00455520|582518630|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
161310535|NCT00455520|582518631|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
161310536|NCT00455520|582518630|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
161310537|NCT00455520|582518631|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
161310538|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
161310539|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
161310540|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
161310541|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
161310542|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|Death|1|||
161310543|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|Death|1|||
161310544|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
161310545|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
161310546|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
161310547|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
161310548|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
161310549|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
161310550|NCT00033657|582518632|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
161310551|NCT00033657|582518633|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
161310552|NCT00033657|582518632|FG000|Surgical Resection|not complete resection|0|||
161310553|NCT00033657|582518633|FG001|Surgical Resection|not complete resection|3|||
161310554|NCT00033657|582518632|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
161310555|NCT00033657|582518633|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
161310556|NCT00033657|582518632|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
161310557|NCT00033657|582518633|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
161310558|NCT00033657|582518632|FG000|Adjuvant Chemotherapy|Death|2|||
161310559|NCT00033657|582518633|FG001|Adjuvant Chemotherapy|Death|1|||
161310560|NCT00033657|582518632|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
161310561|NCT00033657|582518633|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
161310562|NCT00033657|582518632|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
161310563|NCT00033657|582518633|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
161310564|NCT00033657|582518632|FG000|Adjuvant Chemotherapy|Other|0|||
161310565|NCT00033657|582518633|FG001|Adjuvant Chemotherapy|Other|2|||
161310566|NCT03235115|582518634|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161310567|NCT03235115|582518635|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161310568|NCT03235115|582518636|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161310569|NCT03235115|582518637|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161310570|NCT03235115|582518638|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
161310571|NCT03235115|582518639|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
161310572|NCT00503997|582518641|FG000|Overall Study|disease progression|1|||
161310573|NCT00503997|582518641|FG000|Overall Study|Adverse Event|5|||
161310574|NCT00503997|582518641|FG000|Overall Study|Death|1|||
161310575|NCT00503997|582518641|FG000|Overall Study|Withdrawal by Subject|1|||
161310576|NCT00656851|582518646|FG000|Overall Study|Withdrawal by Subject|0|||
161310577|NCT00656851|582518647|FG001|Overall Study|Withdrawal by Subject|4|||
161310578|NCT05020899|582518649|FG000|8 Week Follow-up|Lost to Follow-up|3|||
161310579|NCT05020899|582518650|FG001|8 Week Follow-up|Lost to Follow-up|6|||
161310580|NCT05020899|582518649|FG000|12 Week Follow-up|Lost to Follow-up|1|||
161310581|NCT05020899|582518650|FG001|12 Week Follow-up|Lost to Follow-up|0|||
161310582|NCT05020899|582518649|FG000|12 Week Follow-up|Death|0|||
161310583|NCT05020899|582518650|FG001|12 Week Follow-up|Death|1|||
161310584|NCT01032239|582518651|FG000|Overall Study|Lost to Follow-up|3|||
161310585|NCT01032239|582518652|FG001|Overall Study|Lost to Follow-up|2|||
161310586|NCT01032239|582518651|FG000|Overall Study|Withdrawal by Subject|2|||
161310587|NCT01032239|582518652|FG001|Overall Study|Withdrawal by Subject|3|||
161310588|NCT01032239|582518651|FG000|Overall Study|Death|1|||
161310589|NCT01032239|582518652|FG001|Overall Study|Death|0|||
161310590|NCT01032239|582518651|FG000|Overall Study|Protocol Violation|1|||
161310591|NCT01032239|582518652|FG001|Overall Study|Protocol Violation|0|||
161310592|NCT00204477|582518655|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
161310593|NCT00204477|582518656|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
161310594|NCT00204477|582518655|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
161310595|NCT00204477|582518656|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
161310596|NCT01940900|582518657|FG000|Overall Study|Physician Decision|4|||
161310597|NCT01940900|582518658|FG001|Overall Study|Physician Decision|0|||
161310598|NCT01940900|582518657|FG000|Overall Study|Adverse Event|10|||
161310599|NCT01940900|582518658|FG001|Overall Study|Adverse Event|15|||
161310600|NCT01940900|582518657|FG000|Overall Study|Withdrawal by Subject|11|||
161310601|NCT01940900|582518658|FG001|Overall Study|Withdrawal by Subject|15|||
161310602|NCT01940900|582518657|FG000|Overall Study|Lost to Follow-up|1|||
161310603|NCT01940900|582518658|FG001|Overall Study|Lost to Follow-up|0|||
161310604|NCT01940900|582518657|FG000|Overall Study|Sponsor Decision|1|||
161310605|NCT01940900|582518658|FG001|Overall Study|Sponsor Decision|0|||
161310606|NCT01940900|582518657|FG000|Overall Study|subject non-compliance|1|||
161310607|NCT01940900|582518658|FG001|Overall Study|subject non-compliance|1|||
161204056|NCT00943826|582126468|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
161204057|NCT00943826|582126469|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
161204058|NCT00943826|582126468|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
161204059|NCT00943826|582126469|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
161204060|NCT00943826|582126468|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
161204061|NCT00943826|582126469|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
161204062|NCT04764669|582126470|FG000|Overall Study|Adverse Event|1|||
161204063|NCT04764669|582126471|FG001|Overall Study|Adverse Event|0|||
161204064|NCT04764669|582126472|FG002|Overall Study|Adverse Event|1|||
161204065|NCT04764669|582126473|FG003|Overall Study|Adverse Event|0|||
161204066|NCT04764669|582126470|FG000|Overall Study|Subject Choice|0|||
161204067|NCT04764669|582126471|FG001|Overall Study|Subject Choice|0|||
161204068|NCT04764669|582126472|FG002|Overall Study|Subject Choice|1|||
161204069|NCT04764669|582126473|FG003|Overall Study|Subject Choice|0|||
161204070|NCT04764669|582126470|FG000|Overall Study|Withdrawal by Subject|2|||
161204071|NCT04764669|582126471|FG001|Overall Study|Withdrawal by Subject|0|||
161204072|NCT04764669|582126472|FG002|Overall Study|Withdrawal by Subject|0|||
161204073|NCT04764669|582126473|FG003|Overall Study|Withdrawal by Subject|0|||
161204074|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
161204075|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
161204076|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
161204077|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
161204078|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
161310608|NCT01940900|582518657|FG000|Overall Study|other|1|||
161310609|NCT01940900|582518658|FG001|Overall Study|other|0|||
161310610|NCT04713592|582518661|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161310611|NCT04713592|582518662|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
161310612|NCT04713592|582518663|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161310613|NCT04713592|582518664|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
161310614|NCT04713592|582518661|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
161310615|NCT04713592|582518662|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
161310616|NCT04713592|582518663|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
161310617|NCT04713592|582518664|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
161310618|NCT04713592|582518661|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
161310619|NCT04713592|582518662|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
161310620|NCT04713592|582518663|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
161310621|NCT04713592|582518664|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
161310622|NCT04713592|582518661|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161310623|NCT04713592|582518662|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161310624|NCT04713592|582518663|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
161310625|NCT04713592|582518664|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
161310626|NCT04713592|582518661|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
161310627|NCT04713592|582518662|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
161310628|NCT04713592|582518663|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
161310629|NCT04713592|582518664|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
161310630|NCT04713592|582518661|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161310631|NCT04713592|582518662|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161310632|NCT04713592|582518663|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161310633|NCT04713592|582518664|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161310634|NCT04713592|582518661|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
161310635|NCT04713592|582518662|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
161310636|NCT04713592|582518663|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
161310637|NCT04713592|582518664|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
161310638|NCT02225366|582518667|FG000|Overall Study|Lack of Efficacy|1|||
161310639|NCT02225366|582518668|FG001|Overall Study|Lack of Efficacy|0|||
161310640|NCT02431806|582518671|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
161310641|NCT02431806|582518672|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
161310642|NCT02431806|582518673|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
161310643|NCT02431806|582518674|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
161310644|NCT02431806|582518671|FG000|Double-blind Treatment Period|Adverse Event|4|||
161310645|NCT02431806|582518672|FG001|Double-blind Treatment Period|Adverse Event|7|||
161310646|NCT02431806|582518673|FG002|Double-blind Treatment Period|Adverse Event|11|||
161310647|NCT02431806|582518674|FG003|Double-blind Treatment Period|Adverse Event|7|||
161310648|NCT02431806|582518671|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
161310649|NCT02431806|582518672|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161310650|NCT02431806|582518673|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
161310651|NCT02431806|582518674|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
161204079|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
161204080|NCT00566631|582126475|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
161204081|NCT00566631|582126475|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
161204082|NCT00566631|582126475|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
161204083|NCT00566631|582126475|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
161204084|NCT00566631|582126475|FG000|Part 2: Extension Phase|Adverse Event|11|||
161204085|NCT00566631|582126475|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
161204086|NCT00566631|582126475|FG000|Part 2: Extension Phase|Death|1|||
161204087|NCT00566631|582126475|FG000|Part 2: Extension Phase|Other|5|||
161204088|NCT00877799|582126476|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
161204089|NCT00877799|582126477|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
161204090|NCT00877799|582126478|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
161204091|NCT00877799|582126479|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
161204092|NCT00877799|582126480|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
161204093|NCT00877799|582126476|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
161204094|NCT00877799|582126477|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
161204095|NCT00877799|582126478|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
161204096|NCT00877799|582126479|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
161204097|NCT00877799|582126480|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
161204098|NCT00877799|582126476|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161204099|NCT00877799|582126477|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
161204100|NCT00877799|582126478|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161204101|NCT00877799|582126479|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161204102|NCT00877799|582126480|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
161204103|NCT00877799|582126476|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161204104|NCT00877799|582126477|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161204105|NCT00877799|582126478|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161204106|NCT00877799|582126479|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
161204107|NCT00877799|582126480|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
161204108|NCT00877799|582126476|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161204109|NCT00877799|582126477|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161204110|NCT00877799|582126478|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
161204111|NCT00877799|582126479|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
161204112|NCT00877799|582126480|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
161204113|NCT04054011|582126481|FG000|Overall Study|COVID|3|||
161204114|NCT00592007|582126482|FG000|Overall Study|Withdrawal by Subject|1|||
161204115|NCT00592007|582126482|FG000|Overall Study|patient ineligible (out of lab range)|1|||
161204116|NCT00595127|582126483|FG000|Overall Study|Death|6|||
161204117|NCT00595127|582126483|FG000|Overall Study|Relapsed|3|||
161204118|NCT00595127|582126483|FG000|Overall Study|joined another trial|1|||
161204119|NCT01785472|582126484|FG000|Overall Study|Adverse Event|5|||
161204120|NCT01785472|582126485|FG001|Overall Study|Adverse Event|4|||
161204121|NCT01785472|582126486|FG002|Overall Study|Adverse Event|6|||
161204122|NCT01785472|582126484|FG000|Overall Study|Lack of Efficacy|2|||
161204123|NCT01785472|582126485|FG001|Overall Study|Lack of Efficacy|0|||
161204124|NCT01785472|582126486|FG002|Overall Study|Lack of Efficacy|1|||
161204125|NCT01785472|582126484|FG000|Overall Study|Lost to Follow-up|1|||
161204126|NCT01785472|582126485|FG001|Overall Study|Lost to Follow-up|2|||
161204127|NCT01785472|582126486|FG002|Overall Study|Lost to Follow-up|0|||
161204128|NCT01785472|582126484|FG000|Overall Study|Physician Decision|1|||
161204129|NCT01785472|582126485|FG001|Overall Study|Physician Decision|1|||
161204130|NCT01785472|582126486|FG002|Overall Study|Physician Decision|1|||
161204131|NCT01785472|582126484|FG000|Overall Study|Protocol deviation|0|||
161204132|NCT01785472|582126485|FG001|Overall Study|Protocol deviation|2|||
161204133|NCT01785472|582126486|FG002|Overall Study|Protocol deviation|2|||
161204134|NCT01785472|582126484|FG000|Overall Study|Subject/guardian decision|15|||
161204135|NCT01785472|582126485|FG001|Overall Study|Subject/guardian decision|10|||
161204136|NCT01785472|582126486|FG002|Overall Study|Subject/guardian decision|11|||
161204137|NCT01785472|582126484|FG000|Overall Study|Technical problems|0|||
161204138|NCT01785472|582126485|FG001|Overall Study|Technical problems|0|||
161204139|NCT01785472|582126486|FG002|Overall Study|Technical problems|1|||
161204140|NCT01803464|582126488|FG000|Overall Study|Incomplete data|0|||
161204141|NCT01803464|582126489|FG001|Overall Study|Incomplete data|0|||
161204142|NCT01803464|582126490|FG002|Overall Study|Incomplete data|4|||
161204143|NCT01803464|582126491|FG003|Overall Study|Incomplete data|0|||
161204144|NCT01803464|582126488|FG000|Overall Study|Withdrawal by Subject|1|||
161204145|NCT01803464|582126489|FG001|Overall Study|Withdrawal by Subject|0|||
161204146|NCT01803464|582126490|FG002|Overall Study|Withdrawal by Subject|0|||
161204147|NCT01803464|582126491|FG003|Overall Study|Withdrawal by Subject|0|||
161204148|NCT01275170|582126502|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
161204149|NCT01275170|582126503|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204150|NCT01275170|582126504|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204151|NCT01275170|582126505|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204152|NCT01275170|582126506|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204153|NCT01275170|582126507|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204154|NCT01275170|582126508|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204155|NCT01275170|582126509|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
161204156|NCT00605839|582126510|FG000|Overall Study|Protocol Violation|1|||
161204157|NCT00605839|582126511|FG001|Overall Study|Protocol Violation|0|||
161204158|NCT00605839|582126512|FG002|Overall Study|Protocol Violation|0|||
161204159|NCT04636437|582126516|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
161204160|NCT04636437|582126517|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
161204161|NCT04636437|582126518|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
161204162|NCT04636437|582126516|FG000|Overall Study|Started weight loss drug/program|2|||
161204163|NCT04636437|582126517|FG001|Overall Study|Started weight loss drug/program|1|||
161204164|NCT04636437|582126518|FG002|Overall Study|Started weight loss drug/program|1|||
161204165|NCT04636437|582126516|FG000|Overall Study|Lost to Follow-up|3|||
161204166|NCT04636437|582126517|FG001|Overall Study|Lost to Follow-up|1|||
161204167|NCT04636437|582126518|FG002|Overall Study|Lost to Follow-up|4|||
161204168|NCT04636437|582126516|FG000|Overall Study|Participant or physician decision|3|||
161204169|NCT04636437|582126517|FG001|Overall Study|Participant or physician decision|1|||
161204170|NCT04636437|582126518|FG002|Overall Study|Participant or physician decision|1|||
161204171|NCT00816166|582126519|FG000|Overall Study|Lost to Follow-up|6|||
161204172|NCT00816166|582126520|FG001|Overall Study|Lost to Follow-up|10|||
161204173|NCT00816166|582126519|FG000|Overall Study|Death|4|||
161204174|NCT00816166|582126520|FG001|Overall Study|Death|2|||
161204175|NCT01071278|582126521|FG000|Overall Study|Premature Discontinuation|254|||
161204176|NCT01071278|582126521|FG000|Overall Study|Completion Status Unknown|459|||
161204177|NCT00352664|582126522|FG000|Overall Study|Withdrawal by Subject|7|||
161204178|NCT00352664|582126523|FG001|Overall Study|Withdrawal by Subject|0|||
161204179|NCT01821391|582126524|FG000|Overall Study|Adverse Event|1|||
161204180|NCT01821391|582126525|FG001|Overall Study|Adverse Event|0|||
161204181|NCT03255226|582128260|FG000|Overall Study|Adverse Event|2|||
161204182|NCT03255226|582128260|FG000|Overall Study|Physician Decision|3|||
161204183|NCT03255226|582128260|FG000|Overall Study|Withdrawal by Subject|1|||
161204184|NCT03255226|582128260|FG000|Overall Study|Serum or blood sodium increased|4|||
161204185|NCT03255226|582128260|FG000|Overall Study|Serum or blood potassium increased|4|||
161204186|NCT01017731|582128261|FG000|Overall Study|Lost to Follow-up|2|||
161204187|NCT01017731|582128261|FG000|Overall Study|Withdrawal by Subject|3|||
161204188|NCT01017731|582128261|FG000|Overall Study|Physician Decision|2|||
161204189|NCT01017731|582128261|FG000|Overall Study|Adverse Event|1|||
161204190|NCT01035229|582128262|FG000|Overall Study|Adverse Event|61|||
161204191|NCT01035229|582128263|FG001|Overall Study|Adverse Event|14|||
161204192|NCT01035229|582128262|FG000|Overall Study|Withdrawal by Subject|20|||
161204193|NCT01035229|582128263|FG001|Overall Study|Withdrawal by Subject|7|||
161204194|NCT01035229|582128262|FG000|Overall Study|Lost to Follow-up|1|||
161204195|NCT01035229|582128263|FG001|Overall Study|Lost to Follow-up|0|||
161204196|NCT01035229|582128262|FG000|Overall Study|Administrative problems|1|||
161204197|NCT01035229|582128263|FG001|Overall Study|Administrative problems|1|||
161204198|NCT01035229|582128262|FG000|Overall Study|Death|13|||
161204199|NCT01035229|582128263|FG001|Overall Study|Death|5|||
161204200|NCT01035229|582128262|FG000|Overall Study|New cancer therapy|2|||
161204201|NCT01035229|582128263|FG001|Overall Study|New cancer therapy|0|||
161204202|NCT01035229|582128262|FG000|Overall Study|Protocol Violation|0|||
161204203|NCT01035229|582128263|FG001|Overall Study|Protocol Violation|2|||
161204204|NCT01035229|582128262|FG000|Overall Study|Sponsor's decision to end study|3|||
161204205|NCT01035229|582128263|FG001|Overall Study|Sponsor's decision to end study|3|||
161204206|NCT01035229|582128262|FG000|Overall Study|Disease Progression|261|||
161204207|NCT01035229|582128263|FG001|Overall Study|Disease Progression|152|||
161204208|NCT00685763|582128265|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
161204209|NCT00685763|582128265|FG000|Overall Study|Protocol Violation|1|||
161204210|NCT00698009|582128269|FG000|Overall Study|Withdrawal by Subject|1|||
161204211|NCT00564486|582128273|FG000|Overall Study|Adverse Event|0|||
161204212|NCT00564486|582128274|FG001|Overall Study|Adverse Event|1|||
161204213|NCT00564486|582128275|FG002|Overall Study|Adverse Event|0|||
161204214|NCT00564486|582128276|FG003|Overall Study|Adverse Event|0|||
161204215|NCT00564486|582128273|FG000|Overall Study|Withdrawal by Subject|4|||
161204216|NCT00564486|582128274|FG001|Overall Study|Withdrawal by Subject|0|||
161204217|NCT00564486|582128275|FG002|Overall Study|Withdrawal by Subject|0|||
161204218|NCT00564486|582128276|FG003|Overall Study|Withdrawal by Subject|5|||
161204219|NCT00564486|582128273|FG000|Overall Study|Subject refused to have blood drawn|0|||
161204220|NCT00564486|582128274|FG001|Overall Study|Subject refused to have blood drawn|0|||
161204221|NCT00564486|582128275|FG002|Overall Study|Subject refused to have blood drawn|1|||
161204222|NCT00564486|582128276|FG003|Overall Study|Subject refused to have blood drawn|0|||
161204223|NCT00564486|582128273|FG000|Overall Study|Lost to Follow-up|3|||
161204224|NCT00564486|582128274|FG001|Overall Study|Lost to Follow-up|0|||
161204225|NCT00564486|582128275|FG002|Overall Study|Lost to Follow-up|2|||
161204226|NCT00564486|582128276|FG003|Overall Study|Lost to Follow-up|2|||
161204227|NCT03862807|582128277|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
161204228|NCT00798707|582128278|FG000|Overall Study|Adverse Event|6|||
161204229|NCT00798707|582128279|FG001|Overall Study|Adverse Event|8|||
161204230|NCT00798707|582128280|FG002|Overall Study|Adverse Event|8|||
161204231|NCT00798707|582128278|FG000|Overall Study|Failed to return|2|||
161204232|NCT00798707|582128279|FG001|Overall Study|Failed to return|2|||
161204233|NCT00798707|582128280|FG002|Overall Study|Failed to return|0|||
161204234|NCT00798707|582128278|FG000|Overall Study|Investigator|0|||
161204235|NCT00798707|582128279|FG001|Overall Study|Investigator|1|||
161204236|NCT00798707|582128280|FG002|Overall Study|Investigator|2|||
161204237|NCT00798707|582128278|FG000|Overall Study|Lack of Efficacy|2|||
161204238|NCT00798707|582128279|FG001|Overall Study|Lack of Efficacy|2|||
161204239|NCT00798707|582128280|FG002|Overall Study|Lack of Efficacy|1|||
161204240|NCT00798707|582128278|FG000|Overall Study|Lost to Follow-up|5|||
161204241|NCT00798707|582128279|FG001|Overall Study|Lost to Follow-up|6|||
161204242|NCT00798707|582128280|FG002|Overall Study|Lost to Follow-up|6|||
161204243|NCT00798707|582128278|FG000|Overall Study|Other|0|||
161204244|NCT00798707|582128279|FG001|Overall Study|Other|1|||
161204245|NCT00798707|582128280|FG002|Overall Study|Other|0|||
161204246|NCT00798707|582128278|FG000|Overall Study|Protocol Violation|4|||
161204247|NCT00798707|582128279|FG001|Overall Study|Protocol Violation|0|||
161204248|NCT00798707|582128280|FG002|Overall Study|Protocol Violation|2|||
161204249|NCT00798707|582128278|FG000|Overall Study|Withdrawal by Subject|3|||
161204250|NCT00798707|582128279|FG001|Overall Study|Withdrawal by Subject|8|||
161204251|NCT00798707|582128280|FG002|Overall Study|Withdrawal by Subject|2|||
161204252|NCT00798707|582128278|FG000|Overall Study|Randomized not treated|4|||
161204253|NCT00798707|582128279|FG001|Overall Study|Randomized not treated|5|||
161204254|NCT00798707|582128280|FG002|Overall Study|Randomized not treated|1|||
161204255|NCT03457727|582128282|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161204256|NCT03457727|582128283|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161204257|NCT03457727|582128284|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
161204258|NCT03457727|582128285|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
161204259|NCT00929201|582128286|FG000|Period 1|Withdrawal by Subject|0|||
161204260|NCT00929201|582128287|FG001|Period 1|Withdrawal by Subject|1|||
161204261|NCT00568776|582128291|FG000|Overall Study|Adverse Event|8|||
161204262|NCT00568776|582128292|FG001|Overall Study|Adverse Event|8|||
161204263|NCT00568776|582128293|FG002|Overall Study|Adverse Event|10|||
161204264|NCT00568776|582128294|FG003|Overall Study|Adverse Event|8|||
161204265|NCT00568776|582128291|FG000|Overall Study|Death|0|||
161204266|NCT00568776|582128292|FG001|Overall Study|Death|1|||
161204267|NCT00568776|582128293|FG002|Overall Study|Death|4|||
161204268|NCT00568776|582128294|FG003|Overall Study|Death|3|||
161204269|NCT00568776|582128291|FG000|Overall Study|Physician Decision|0|||
161204270|NCT00568776|582128292|FG001|Overall Study|Physician Decision|2|||
161204271|NCT00568776|582128293|FG002|Overall Study|Physician Decision|0|||
161204272|NCT00568776|582128294|FG003|Overall Study|Physician Decision|0|||
161204273|NCT00568776|582128291|FG000|Overall Study|Lack of Efficacy|2|||
161204274|NCT00568776|582128292|FG001|Overall Study|Lack of Efficacy|2|||
161204275|NCT00568776|582128293|FG002|Overall Study|Lack of Efficacy|2|||
161204276|NCT00568776|582128294|FG003|Overall Study|Lack of Efficacy|4|||
161204277|NCT00568776|582128291|FG000|Overall Study|Lost to Follow-up|1|||
161204278|NCT00568776|582128292|FG001|Overall Study|Lost to Follow-up|1|||
161204279|NCT00568776|582128293|FG002|Overall Study|Lost to Follow-up|1|||
161204280|NCT00568776|582128294|FG003|Overall Study|Lost to Follow-up|1|||
161204281|NCT00568776|582128291|FG000|Overall Study|Protocol Violation|1|||
161204282|NCT00568776|582128292|FG001|Overall Study|Protocol Violation|0|||
161204283|NCT00568776|582128293|FG002|Overall Study|Protocol Violation|1|||
161204284|NCT00568776|582128294|FG003|Overall Study|Protocol Violation|1|||
161204285|NCT00568776|582128291|FG000|Overall Study|Withdrawal by Subject|13|||
161204286|NCT00568776|582128292|FG001|Overall Study|Withdrawal by Subject|15|||
161204287|NCT00568776|582128293|FG002|Overall Study|Withdrawal by Subject|13|||
161310652|NCT02431806|582518671|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
161310653|NCT02431806|582518672|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
161204288|NCT00568776|582128294|FG003|Overall Study|Withdrawal by Subject|7|||
161204289|NCT00568776|582128291|FG000|Overall Study|Loss of Caregiver|0|||
161204290|NCT00568776|582128292|FG001|Overall Study|Loss of Caregiver|2|||
161204291|NCT00568776|582128293|FG002|Overall Study|Loss of Caregiver|1|||
161204292|NCT00568776|582128294|FG003|Overall Study|Loss of Caregiver|2|||
161204293|NCT00568776|582128291|FG000|Overall Study|Sponsor Decision|2|||
161204294|NCT00568776|582128292|FG001|Overall Study|Sponsor Decision|2|||
161204295|NCT00568776|582128293|FG002|Overall Study|Sponsor Decision|41|||
161204296|NCT00568776|582128294|FG003|Overall Study|Sponsor Decision|42|||
161204297|NCT00568776|582128291|FG000|Overall Study|Miscellaeneous|3|||
161204298|NCT00568776|582128292|FG001|Overall Study|Miscellaeneous|3|||
161204299|NCT00568776|582128293|FG002|Overall Study|Miscellaeneous|1|||
161204300|NCT00568776|582128294|FG003|Overall Study|Miscellaeneous|4|||
161204301|NCT03576131|582128295|FG000|Overall Study|Investigator decision|0|||
161204302|NCT03576131|582128296|FG001|Overall Study|Investigator decision|0|||
161204303|NCT03576131|582128297|FG002|Overall Study|Investigator decision|0|||
161204304|NCT03576131|582128298|FG003|Overall Study|Investigator decision|1|||
161204305|NCT03576131|582128299|FG004|Overall Study|Investigator decision|0|||
161204306|NCT03576131|582128300|FG005|Overall Study|Investigator decision|1|||
161204307|NCT03576131|582128301|FG006|Overall Study|Investigator decision|0|||
161204308|NCT03576131|582128302|FG007|Overall Study|Investigator decision|0|||
161204309|NCT03576131|582128295|FG000|Overall Study|Withdrawal by Subject|1|||
161204310|NCT03576131|582128296|FG001|Overall Study|Withdrawal by Subject|1|||
161204311|NCT03576131|582128297|FG002|Overall Study|Withdrawal by Subject|0|||
161204312|NCT03576131|582128298|FG003|Overall Study|Withdrawal by Subject|1|||
161204313|NCT03576131|582128299|FG004|Overall Study|Withdrawal by Subject|2|||
161204314|NCT03576131|582128300|FG005|Overall Study|Withdrawal by Subject|3|||
161204315|NCT03576131|582128301|FG006|Overall Study|Withdrawal by Subject|1|||
161204316|NCT03576131|582128302|FG007|Overall Study|Withdrawal by Subject|0|||
161204317|NCT03576131|582128295|FG000|Overall Study|Death|3|||
161204318|NCT03576131|582128296|FG001|Overall Study|Death|3|||
161204319|NCT03576131|582128297|FG002|Overall Study|Death|1|||
161204320|NCT03576131|582128298|FG003|Overall Study|Death|5|||
161204321|NCT03576131|582128299|FG004|Overall Study|Death|4|||
161204322|NCT03576131|582128300|FG005|Overall Study|Death|1|||
161204323|NCT03576131|582128301|FG006|Overall Study|Death|0|||
161204324|NCT03576131|582128302|FG007|Overall Study|Death|1|||
161204325|NCT03576131|582128295|FG000|Overall Study|New anti-cancer treatment|5|||
161204326|NCT03576131|582128296|FG001|Overall Study|New anti-cancer treatment|1|||
161204327|NCT03576131|582128297|FG002|Overall Study|New anti-cancer treatment|2|||
161204328|NCT03576131|582128298|FG003|Overall Study|New anti-cancer treatment|3|||
161204329|NCT03576131|582128299|FG004|Overall Study|New anti-cancer treatment|0|||
161204330|NCT03576131|582128300|FG005|Overall Study|New anti-cancer treatment|0|||
161204331|NCT03576131|582128301|FG006|Overall Study|New anti-cancer treatment|0|||
161204332|NCT03576131|582128302|FG007|Overall Study|New anti-cancer treatment|0|||
161204333|NCT03576131|582128295|FG000|Overall Study|Unspecified reason|0|||
161204334|NCT03576131|582128296|FG001|Overall Study|Unspecified reason|0|||
161204335|NCT03576131|582128297|FG002|Overall Study|Unspecified reason|1|||
161204336|NCT03576131|582128298|FG003|Overall Study|Unspecified reason|1|||
161204337|NCT03576131|582128299|FG004|Overall Study|Unspecified reason|1|||
161204338|NCT03576131|582128300|FG005|Overall Study|Unspecified reason|1|||
161204339|NCT03576131|582128301|FG006|Overall Study|Unspecified reason|0|||
161204340|NCT03576131|582128302|FG007|Overall Study|Unspecified reason|0|||
161204341|NCT03576131|582128295|FG000|Overall Study|Subject non-compliance|0|||
161204342|NCT03576131|582128296|FG001|Overall Study|Subject non-compliance|0|||
161204343|NCT03576131|582128297|FG002|Overall Study|Subject non-compliance|0|||
161204344|NCT03576131|582128298|FG003|Overall Study|Subject non-compliance|0|||
161204345|NCT03576131|582128299|FG004|Overall Study|Subject non-compliance|0|||
161204346|NCT03576131|582128300|FG005|Overall Study|Subject non-compliance|1|||
161204347|NCT03576131|582128301|FG006|Overall Study|Subject non-compliance|0|||
161204348|NCT03576131|582128302|FG007|Overall Study|Subject non-compliance|0|||
161204349|NCT01569594|582128307|FG000|Overall Study|Physician Decision|4|||
161204350|NCT01569594|582128307|FG000|Overall Study|Death|13|||
161204351|NCT01569594|582128307|FG000|Overall Study|Lost to Follow-up|22|||
161204352|NCT01569594|582128307|FG000|Overall Study|Adverse Event|2|||
161204353|NCT01569594|582128307|FG000|Overall Study|Withdrawal by Subject|13|||
161204354|NCT01569594|582128307|FG000|Overall Study|Other|4|||
161204355|NCT01569594|582128307|FG000|Overall Study|No ECM used|9|||
161204356|NCT02860039|582128312|FG000|Overall Study|Death|4|||
161204357|NCT02860039|582128313|FG001|Overall Study|Death|0|||
161204358|NCT02860039|582128312|FG000|Overall Study|Lost to Follow-up|2|||
161204359|NCT02860039|582128313|FG001|Overall Study|Lost to Follow-up|2|||
161204360|NCT02860039|582128312|FG000|Overall Study|Protocol Violation|3|||
161204361|NCT02860039|582128313|FG001|Overall Study|Protocol Violation|1|||
161204362|NCT02860039|582128312|FG000|Overall Study|Withdrawal by Subject|1|||
161204363|NCT02860039|582128313|FG001|Overall Study|Withdrawal by Subject|0|||
161204364|NCT02860039|582128312|FG000|Overall Study|Not otherwise eligible|1|||
161204365|NCT02860039|582128313|FG001|Overall Study|Not otherwise eligible|1|||
161204366|NCT02723786|582128316|FG000|Overall Study|Lost to Follow-up|1|||
161204367|NCT03170271|582128319|FG000|Overall Study|Adverse Event|7|||
161204368|NCT03170271|582128320|FG001|Overall Study|Adverse Event|2|||
161204369|NCT03170271|582128319|FG000|Overall Study|Lost to Follow-up|0|||
161204370|NCT03170271|582128320|FG001|Overall Study|Lost to Follow-up|1|||
161204371|NCT03170271|582128319|FG000|Overall Study|Physician Decision|1|||
161204372|NCT03170271|582128320|FG001|Overall Study|Physician Decision|0|||
161204373|NCT03170271|582128319|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
161310654|NCT02431806|582518673|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
161310655|NCT02431806|582518674|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
161310656|NCT02431806|582518671|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
161204374|NCT03170271|582128320|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
161204375|NCT03170271|582128319|FG000|Overall Study|Withdrawal by Subject|17|||
161204376|NCT03170271|582128320|FG001|Overall Study|Withdrawal by Subject|5|||
161204377|NCT03170271|582128319|FG000|Overall Study|Other|2|||
161204378|NCT03170271|582128320|FG001|Overall Study|Other|2|||
161204379|NCT03170271|582128319|FG000|Overall Study|Randomized in error|4|||
161204380|NCT03170271|582128320|FG001|Overall Study|Randomized in error|0|||
161204381|NCT01036594|582128332|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
161204382|NCT01036594|582128333|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
161204383|NCT01036594|582128332|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
161204384|NCT01036594|582128333|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
161204385|NCT01036594|582128332|FG000|Week 12 Evaluation|Adverse Event|5|||
161204386|NCT01036594|582128333|FG001|Week 12 Evaluation|Adverse Event|0|||
161204387|NCT01036594|582128332|FG000|Week 12 Evaluation|Physician Decision|1|||
161204388|NCT01036594|582128333|FG001|Week 12 Evaluation|Physician Decision|0|||
161204389|NCT01036594|582128332|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
161204390|NCT01036594|582128333|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
161204391|NCT01036594|582128332|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
161204392|NCT01036594|582128333|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
161204393|NCT01036594|582128332|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
161204394|NCT01036594|582128333|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
161204395|NCT01036594|582128332|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
161204396|NCT01036594|582128333|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
161204397|NCT01036594|582128332|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
161204398|NCT01036594|582128333|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
161204399|NCT03345485|582128336|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
161204400|NCT03345485|582128337|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
161204401|NCT03345485|582128338|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
161204402|NCT03345485|582128339|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
161204403|NCT03345485|582128340|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
161204404|NCT03345485|582128341|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
161204405|NCT03345485|582128342|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
161204406|NCT03345485|582128343|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
161204407|NCT03345485|582128344|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
161204408|NCT03345485|582128345|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
161204409|NCT03345485|582128346|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
161204410|NCT03345485|582128347|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
161204411|NCT03345485|582128348|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
161204412|NCT03020966|582128349|FG000|Overall Study|Withdrawal by Subject|2|||
161204413|NCT03020966|582128350|FG001|Overall Study|Withdrawal by Subject|0|||
161204414|NCT01856257|582128351|FG000|Overall Study|Death|2|||
161204415|NCT01856257|582128352|FG001|Overall Study|Death|0|||
161204416|NCT01856257|582128353|FG002|Overall Study|Death|0|||
161204417|NCT01856257|582128354|FG003|Overall Study|Death|0|||
161204418|NCT01856257|582128351|FG000|Overall Study|Physician Decision|0|||
161204419|NCT01856257|582128352|FG001|Overall Study|Physician Decision|0|||
161204420|NCT01856257|582128353|FG002|Overall Study|Physician Decision|0|||
161204421|NCT01856257|582128354|FG003|Overall Study|Physician Decision|1|||
161204422|NCT01856257|582128351|FG000|Overall Study|Withdrawal by Subject|1|||
161204423|NCT01856257|582128352|FG001|Overall Study|Withdrawal by Subject|1|||
161204424|NCT01856257|582128353|FG002|Overall Study|Withdrawal by Subject|0|||
161204425|NCT01856257|582128354|FG003|Overall Study|Withdrawal by Subject|0|||
161204426|NCT01856257|582128351|FG000|Overall Study|Donor complication|0|||
161204427|NCT01856257|582128352|FG001|Overall Study|Donor complication|0|||
161204428|NCT01856257|582128353|FG002|Overall Study|Donor complication|0|||
161204429|NCT01856257|582128354|FG003|Overall Study|Donor complication|1|||
161204430|NCT01125358|582128358|FG000|Overall Study|Adverse Event|3|||
161204431|NCT01125358|582128359|FG001|Overall Study|Adverse Event|0|||
161204432|NCT01125358|582128360|FG002|Overall Study|Adverse Event|0|||
161204433|NCT01125358|582128361|FG003|Overall Study|Adverse Event|2|||
161204434|NCT01125358|582128358|FG000|Overall Study|Perceived Lack of Efficacy|6|||
161204435|NCT01125358|582128359|FG001|Overall Study|Perceived Lack of Efficacy|3|||
161204436|NCT01125358|582128360|FG002|Overall Study|Perceived Lack of Efficacy|7|||
161204437|NCT01125358|582128361|FG003|Overall Study|Perceived Lack of Efficacy|4|||
161204438|NCT01125358|582128358|FG000|Overall Study|Protocol Violation|1|||
161204439|NCT01125358|582128359|FG001|Overall Study|Protocol Violation|0|||
161204440|NCT01125358|582128360|FG002|Overall Study|Protocol Violation|0|||
161204441|NCT01125358|582128361|FG003|Overall Study|Protocol Violation|0|||
161204442|NCT01125358|582128358|FG000|Overall Study|Sponsor Decision|0|||
161204443|NCT01125358|582128359|FG001|Overall Study|Sponsor Decision|0|||
161204444|NCT01125358|582128360|FG002|Overall Study|Sponsor Decision|1|||
161204445|NCT01125358|582128361|FG003|Overall Study|Sponsor Decision|1|||
161204446|NCT01125358|582128358|FG000|Overall Study|Withdrawal by Subject|2|||
161204447|NCT01125358|582128359|FG001|Overall Study|Withdrawal by Subject|1|||
161204448|NCT01125358|582128360|FG002|Overall Study|Withdrawal by Subject|1|||
161204449|NCT01125358|582128361|FG003|Overall Study|Withdrawal by Subject|1|||
161204450|NCT01060007|582128362|FG000|Overall Study|Withdrawal by Subject|1|||
161204451|NCT01060007|582128362|FG000|Overall Study|Inevaluable for response at surgery|3|||
161204452|NCT04935931|582128366|FG000|Overall Study|Withdrawal by Subject|1|||
161204453|NCT00424632|582128367|FG000|Overall Study|Death|0|||
161204454|NCT00424632|582128368|FG001|Overall Study|Death|0|||
161204455|NCT00424632|582128369|FG002|Overall Study|Death|0|||
161204456|NCT00424632|582128370|FG003|Overall Study|Death|0|||
161204457|NCT00424632|582128371|FG004|Overall Study|Death|0|||
161204458|NCT00424632|582128372|FG005|Overall Study|Death|2|||
161204459|NCT00424632|582128373|FG006|Overall Study|Death|0|||
161204460|NCT00424632|582128374|FG007|Overall Study|Death|0|||
161204461|NCT00424632|582128375|FG008|Overall Study|Death|0|||
161204462|NCT00424632|582128376|FG009|Overall Study|Death|0|||
161204463|NCT00424632|582128367|FG000|Overall Study|Adverse Event|0|||
161204464|NCT00424632|582128368|FG001|Overall Study|Adverse Event|0|||
161204465|NCT00424632|582128369|FG002|Overall Study|Adverse Event|0|||
161204466|NCT00424632|582128370|FG003|Overall Study|Adverse Event|0|||
161204467|NCT00424632|582128371|FG004|Overall Study|Adverse Event|0|||
161204468|NCT00424632|582128372|FG005|Overall Study|Adverse Event|0|||
161204469|NCT00424632|582128373|FG006|Overall Study|Adverse Event|0|||
161204470|NCT00424632|582128374|FG007|Overall Study|Adverse Event|0|||
161204471|NCT00424632|582128375|FG008|Overall Study|Adverse Event|3|||
161204472|NCT00424632|582128376|FG009|Overall Study|Adverse Event|2|||
161204473|NCT00424632|582128367|FG000|Overall Study|Global deterioration of health status|0|||
161204474|NCT00424632|582128368|FG001|Overall Study|Global deterioration of health status|0|||
161204475|NCT00424632|582128369|FG002|Overall Study|Global deterioration of health status|0|||
161204476|NCT00424632|582128370|FG003|Overall Study|Global deterioration of health status|1|||
161204477|NCT00424632|582128371|FG004|Overall Study|Global deterioration of health status|1|||
161204478|NCT00424632|582128372|FG005|Overall Study|Global deterioration of health status|0|||
161204479|NCT00424632|582128373|FG006|Overall Study|Global deterioration of health status|0|||
161204480|NCT00424632|582128374|FG007|Overall Study|Global deterioration of health status|0|||
161204481|NCT00424632|582128375|FG008|Overall Study|Global deterioration of health status|0|||
161204482|NCT00424632|582128376|FG009|Overall Study|Global deterioration of health status|0|||
161204483|NCT00424632|582128367|FG000|Overall Study|Objective progression or relapse|1|||
161204484|NCT00424632|582128368|FG001|Overall Study|Objective progression or relapse|1|||
161204485|NCT00424632|582128369|FG002|Overall Study|Objective progression or relapse|1|||
161204486|NCT00424632|582128370|FG003|Overall Study|Objective progression or relapse|2|||
161204487|NCT00424632|582128371|FG004|Overall Study|Objective progression or relapse|2|||
161204488|NCT00424632|582128372|FG005|Overall Study|Objective progression or relapse|13|||
161204489|NCT00424632|582128373|FG006|Overall Study|Objective progression or relapse|7|||
161204490|NCT00424632|582128374|FG007|Overall Study|Objective progression or relapse|3|||
161204491|NCT00424632|582128375|FG008|Overall Study|Objective progression or relapse|12|||
161204492|NCT00424632|582128376|FG009|Overall Study|Objective progression or relapse|4|||
161204493|NCT00424632|582128367|FG000|Overall Study|Other|0|||
161204494|NCT00424632|582128368|FG001|Overall Study|Other|0|||
161204495|NCT00424632|582128369|FG002|Overall Study|Other|0|||
161204496|NCT00424632|582128370|FG003|Overall Study|Other|1|||
161204497|NCT00424632|582128371|FG004|Overall Study|Other|0|||
161204498|NCT00424632|582128372|FG005|Overall Study|Other|0|||
161204499|NCT00424632|582128373|FG006|Overall Study|Other|0|||
161204500|NCT00424632|582128374|FG007|Overall Study|Other|0|||
161204501|NCT00424632|582128375|FG008|Overall Study|Other|1|||
161204502|NCT00424632|582128376|FG009|Overall Study|Other|0|||
161204503|NCT02628418|582128377|FG000|Overall Study|Lost to Follow-up|1|||
161204504|NCT02628418|582128378|FG001|Overall Study|Lost to Follow-up|2|||
161204505|NCT03159611|582128382|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
161204506|NCT03159611|582128383|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
161204507|NCT03159611|582128382|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
161204508|NCT03159611|582128383|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
161204509|NCT03159611|582128382|FG000|Overall Study|Protocol Violation|7|||
161204510|NCT03159611|582128383|FG001|Overall Study|Protocol Violation|4|||
161204511|NCT03159611|582128382|FG000|Overall Study|Adverse Event|1|||
161310657|NCT02431806|582518672|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
161310658|NCT02431806|582518673|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
161310659|NCT02431806|582518674|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
161310660|NCT02431806|582518671|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
161310661|NCT02431806|582518672|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
161310662|NCT02431806|582518673|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
161310663|NCT02431806|582518674|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
161310664|NCT02431806|582518671|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
161310665|NCT02431806|582518672|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
161310666|NCT02431806|582518673|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
161310667|NCT02431806|582518674|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
161310668|NCT01382225|582518675|FG000|Overall Study|Adverse Event|3|||
161204512|NCT03159611|582128383|FG001|Overall Study|Adverse Event|0|||
161204513|NCT03159611|582128382|FG000|Overall Study|Withdrawal by Subject|1|||
161204514|NCT03159611|582128383|FG001|Overall Study|Withdrawal by Subject|1|||
161204515|NCT03159611|582128382|FG000|Overall Study|Non-compliance with protocol requirement|3|||
161204516|NCT03159611|582128383|FG001|Overall Study|Non-compliance with protocol requirement|2|||
161204517|NCT03159611|582128382|FG000|Overall Study|Inability to perform procedures|1|||
161204518|NCT03159611|582128383|FG001|Overall Study|Inability to perform procedures|0|||
161204519|NCT01984229|582128384|FG000|Safety Follow-up Period|Adverse Event|1|||
161204520|NCT01984229|582128385|FG001|Safety Follow-up Period|Adverse Event|1|||
161204521|NCT01984229|582128384|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
161204522|NCT01984229|582128385|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
161204523|NCT02072174|582128386|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
161204524|NCT02072174|582128387|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
161204525|NCT02072174|582128386|FG000|Overall Study|Protocol Violation|16|||
161204526|NCT02072174|582128387|FG001|Overall Study|Protocol Violation|23|||
161204527|NCT02072174|582128386|FG000|Overall Study|Physician Decision|0|||
161204528|NCT02072174|582128387|FG001|Overall Study|Physician Decision|1|||
161204529|NCT02072174|582128386|FG000|Overall Study|Non-compliance with protocol requirement|2|||
161204530|NCT02072174|582128387|FG001|Overall Study|Non-compliance with protocol requirement|0|||
161204531|NCT05674721|582128389|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
161204532|NCT05674721|582128390|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
161204533|NCT05674721|582128389|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
161204534|NCT05674721|582128390|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
161204535|NCT01418365|582128398|FG000|First Intervention|Withdrawal by Subject|0|||
161204536|NCT01418365|582128399|FG001|First Intervention|Withdrawal by Subject|1|||
161204537|NCT01418365|582128398|FG000|First Intervention|Non-compliance|1|||
161204538|NCT01418365|582128399|FG001|First Intervention|Non-compliance|0|||
161204539|NCT01418365|582128398|FG000|Second Intervention|Withdrawal by Subject|0|||
161204540|NCT01418365|582128399|FG001|Second Intervention|Withdrawal by Subject|1|||
161204541|NCT04150107|582128404|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
161204542|NCT04150107|582128405|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
161204543|NCT04150107|582128404|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
161204544|NCT04150107|582128405|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
161204545|NCT00440193|582128406|FG000|Treatment Period|Adverse Event|74|||
161204546|NCT00440193|582128407|FG001|Treatment Period|Adverse Event|67|||
161204547|NCT00440193|582128406|FG000|Treatment Period|Death|19|||
161204548|NCT00440193|582128407|FG001|Treatment Period|Death|22|||
161204549|NCT00440193|582128406|FG000|Treatment Period|Lack of Efficacy|0|||
161204550|NCT00440193|582128407|FG001|Treatment Period|Lack of Efficacy|1|||
161204551|NCT00440193|582128406|FG000|Treatment Period|Lost to Follow-up|12|||
161204552|NCT00440193|582128407|FG001|Treatment Period|Lost to Follow-up|18|||
161204553|NCT00440193|582128406|FG000|Treatment Period|Physician Decision|3|||
161204554|NCT00440193|582128407|FG001|Treatment Period|Physician Decision|6|||
161204555|NCT00440193|582128406|FG000|Treatment Period|Protocol Violation|16|||
161204556|NCT00440193|582128407|FG001|Treatment Period|Protocol Violation|19|||
161204557|NCT00440193|582128406|FG000|Treatment Period|Withdrawal by Subject|36|||
161204558|NCT00440193|582128407|FG001|Treatment Period|Withdrawal by Subject|77|||
161204559|NCT00440193|582128406|FG000|Treatment Period|Clinical endpoint reached|28|||
161204560|NCT00440193|582128407|FG001|Treatment Period|Clinical endpoint reached|25|||
161204561|NCT00440193|582128406|FG000|Treatment Period|Study terminated by sponsor|102|||
161204562|NCT00440193|582128407|FG001|Treatment Period|Study terminated by sponsor|94|||
161204563|NCT00440193|582128406|FG000|Treatment Period|Protocol driven decision point|2|||
161204564|NCT00440193|582128407|FG001|Treatment Period|Protocol driven decision point|2|||
161204565|NCT00440193|582128406|FG000|Treatment Period|Switch to commercial drug|0|||
161204566|NCT00440193|582128407|FG001|Treatment Period|Switch to commercial drug|2|||
161204567|NCT00440193|582128406|FG000|Treatment Period|Technical problems|1|||
161204568|NCT00440193|582128407|FG001|Treatment Period|Technical problems|1|||
161204569|NCT00440193|582128406|FG000|Treatment Period|Participant convenience|5|||
161204570|NCT00440193|582128407|FG001|Treatment Period|Participant convenience|2|||
161204571|NCT00440193|582128406|FG000|Treatment Period|Participant did not receive treatment|7|||
161204572|NCT00440193|582128407|FG001|Treatment Period|Participant did not receive treatment|13|||
161204573|NCT00440193|582128406|FG000|Treatment Period|Site closed by investigator|0|||
161204574|NCT00440193|582128407|FG001|Treatment Period|Site closed by investigator|2|||
161204575|NCT00440193|582128406|FG000|Observational Period|Adverse Event|2|||
161204576|NCT00440193|582128407|FG001|Observational Period|Adverse Event|2|||
161204577|NCT00440193|582128406|FG000|Observational Period|Death|15|||
161204578|NCT00440193|582128407|FG001|Observational Period|Death|20|||
161204579|NCT00440193|582128406|FG000|Observational Period|Lost to Follow-up|12|||
161204580|NCT00440193|582128407|FG001|Observational Period|Lost to Follow-up|8|||
161204581|NCT00440193|582128406|FG000|Observational Period|Protocol Violation|1|||
161204582|NCT00440193|582128407|FG001|Observational Period|Protocol Violation|0|||
161204583|NCT00440193|582128406|FG000|Observational Period|Withdrawal by Subject|11|||
161204584|NCT00440193|582128407|FG001|Observational Period|Withdrawal by Subject|8|||
161204585|NCT00440193|582128406|FG000|Observational Period|Physician Decision|1|||
161204586|NCT00440193|582128407|FG001|Observational Period|Physician Decision|0|||
161204587|NCT00440193|582128406|FG000|Observational Period|Clinical endpoint reached|1|||
161204588|NCT00440193|582128407|FG001|Observational Period|Clinical endpoint reached|0|||
161204589|NCT00440193|582128406|FG000|Observational Period|Participant convenience|2|||
161204590|NCT00440193|582128407|FG001|Observational Period|Participant convenience|0|||
161204591|NCT00824993|582128408|FG000|Overall Study|Withdrawal by Subject|1|||
161204592|NCT00824993|582128409|FG001|Overall Study|Withdrawal by Subject|1|||
161204593|NCT00824993|582128408|FG000|Overall Study|Malignancy Relapse|9|||
161204594|NCT00824993|582128409|FG001|Overall Study|Malignancy Relapse|10|||
161204595|NCT00824993|582128408|FG000|Overall Study|Rapid Bone Loss|0|||
161204596|NCT00824993|582128409|FG001|Overall Study|Rapid Bone Loss|1|||
161204597|NCT00824993|582128408|FG000|Overall Study|Non-Compliant|2|||
161204598|NCT00824993|582128409|FG001|Overall Study|Non-Compliant|1|||
161204599|NCT00824993|582128408|FG000|Overall Study|Insurance Issue|2|||
161204600|NCT00824993|582128409|FG001|Overall Study|Insurance Issue|1|||
161204601|NCT00824993|582128408|FG000|Overall Study|Death|0|||
161204602|NCT00824993|582128409|FG001|Overall Study|Death|3|||
161204603|NCT00834366|582128410|FG000|Treatment Period 1|Adverse Event|1|||
161204604|NCT00834366|582128411|FG001|Treatment Period 1|Adverse Event|1|||
161204605|NCT01608321|582128412|FG000|Overall Study|Withdrawal by Subject|1|||
161204606|NCT01608321|582128413|FG001|Overall Study|Withdrawal by Subject|0|||
161204607|NCT03222856|582128414|FG000|Overall Study|Adverse Event|6|||
161204608|NCT03222856|582128414|FG000|Overall Study|Death|1|||
161204609|NCT03514121|582129639|FG000|Overall Study|Withdrawal by Subject|0|||
161204610|NCT03514121|582129640|FG001|Overall Study|Withdrawal by Subject|0|||
161204611|NCT03514121|582129641|FG002|Overall Study|Withdrawal by Subject|0|||
161204612|NCT03514121|582129642|FG003|Overall Study|Withdrawal by Subject|0|||
161204613|NCT03514121|582129643|FG004|Overall Study|Withdrawal by Subject|1|||
161204614|NCT03514121|582129644|FG005|Overall Study|Withdrawal by Subject|2|||
161204615|NCT03514121|582129645|FG006|Overall Study|Withdrawal by Subject|1|||
161204616|NCT03514121|582129646|FG007|Overall Study|Withdrawal by Subject|1|||
161204617|NCT03514121|582129647|FG008|Overall Study|Withdrawal by Subject|7|||
161204618|NCT03514121|582129648|FG009|Overall Study|Withdrawal by Subject|2|||
161204619|NCT03514121|582129639|FG000|Overall Study|Death|0|||
161204620|NCT03514121|582129640|FG001|Overall Study|Death|0|||
161204621|NCT03514121|582129641|FG002|Overall Study|Death|0|||
161204622|NCT03514121|582129642|FG003|Overall Study|Death|0|||
161204623|NCT03514121|582129643|FG004|Overall Study|Death|0|||
161204624|NCT03514121|582129644|FG005|Overall Study|Death|3|||
161204625|NCT03514121|582129645|FG006|Overall Study|Death|2|||
161204626|NCT03514121|582129646|FG007|Overall Study|Death|1|||
161204627|NCT03514121|582129647|FG008|Overall Study|Death|26|||
161204628|NCT03514121|582129648|FG009|Overall Study|Death|3|||
161204629|NCT03514121|582129639|FG000|Overall Study|Lost to Follow-up|0|||
161204630|NCT03514121|582129640|FG001|Overall Study|Lost to Follow-up|0|||
161204631|NCT03514121|582129641|FG002|Overall Study|Lost to Follow-up|1|||
161204632|NCT03514121|582129642|FG003|Overall Study|Lost to Follow-up|0|||
161204633|NCT03514121|582129643|FG004|Overall Study|Lost to Follow-up|0|||
161204634|NCT03514121|582129644|FG005|Overall Study|Lost to Follow-up|0|||
161204635|NCT03514121|582129645|FG006|Overall Study|Lost to Follow-up|0|||
161204636|NCT03514121|582129646|FG007|Overall Study|Lost to Follow-up|0|||
161204637|NCT03514121|582129647|FG008|Overall Study|Lost to Follow-up|1|||
161204638|NCT03514121|582129648|FG009|Overall Study|Lost to Follow-up|0|||
161204639|NCT03514121|582129639|FG000|Overall Study|Adverse Event|0|||
161204640|NCT03514121|582129640|FG001|Overall Study|Adverse Event|0|||
161204641|NCT03514121|582129641|FG002|Overall Study|Adverse Event|0|||
161204642|NCT03514121|582129642|FG003|Overall Study|Adverse Event|0|||
161204643|NCT03514121|582129643|FG004|Overall Study|Adverse Event|0|||
161204644|NCT03514121|582129644|FG005|Overall Study|Adverse Event|0|||
161204645|NCT03514121|582129645|FG006|Overall Study|Adverse Event|1|||
161204646|NCT03514121|582129646|FG007|Overall Study|Adverse Event|0|||
161204647|NCT03514121|582129647|FG008|Overall Study|Adverse Event|0|||
161204648|NCT03514121|582129648|FG009|Overall Study|Adverse Event|0|||
161204649|NCT03514121|582129639|FG000|Overall Study|Other|0|||
161204650|NCT03514121|582129640|FG001|Overall Study|Other|1|||
161204651|NCT03514121|582129641|FG002|Overall Study|Other|1|||
161204652|NCT03514121|582129642|FG003|Overall Study|Other|0|||
161204653|NCT03514121|582129643|FG004|Overall Study|Other|1|||
161204654|NCT03514121|582129644|FG005|Overall Study|Other|2|||
161204655|NCT03514121|582129645|FG006|Overall Study|Other|3|||
161204656|NCT03514121|582129646|FG007|Overall Study|Other|2|||
161204657|NCT03514121|582129647|FG008|Overall Study|Other|7|||
161204658|NCT03514121|582129648|FG009|Overall Study|Other|3|||
161204659|NCT03514121|582129639|FG000|Overall Study|Study termination by Sponsor|0|||
161204660|NCT03514121|582129640|FG001|Overall Study|Study termination by Sponsor|0|||
161204661|NCT03514121|582129641|FG002|Overall Study|Study termination by Sponsor|0|||
161204662|NCT03514121|582129642|FG003|Overall Study|Study termination by Sponsor|0|||
161204663|NCT03514121|582129643|FG004|Overall Study|Study termination by Sponsor|0|||
161204664|NCT03514121|582129644|FG005|Overall Study|Study termination by Sponsor|0|||
161204665|NCT03514121|582129645|FG006|Overall Study|Study termination by Sponsor|0|||
161204666|NCT03514121|582129646|FG007|Overall Study|Study termination by Sponsor|0|||
161204667|NCT03514121|582129647|FG008|Overall Study|Study termination by Sponsor|11|||
161204668|NCT03514121|582129648|FG009|Overall Study|Study termination by Sponsor|3|||
161204669|NCT03514121|582129639|FG000|Overall Study|Investigator decision|0|||
161204670|NCT03514121|582129640|FG001|Overall Study|Investigator decision|0|||
161204671|NCT03514121|582129641|FG002|Overall Study|Investigator decision|0|||
161204672|NCT03514121|582129642|FG003|Overall Study|Investigator decision|0|||
161204673|NCT03514121|582129643|FG004|Overall Study|Investigator decision|0|||
161204674|NCT03514121|582129644|FG005|Overall Study|Investigator decision|0|||
161204675|NCT03514121|582129645|FG006|Overall Study|Investigator decision|0|||
161204676|NCT03514121|582129646|FG007|Overall Study|Investigator decision|0|||
161204677|NCT03514121|582129647|FG008|Overall Study|Investigator decision|1|||
161204678|NCT03514121|582129648|FG009|Overall Study|Investigator decision|0|||
161204679|NCT01777191|582129653|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
161204680|NCT01777191|582129654|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
161204681|NCT01777191|582129653|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
161204682|NCT01777191|582129654|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
161204683|NCT01777191|582129653|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
161204684|NCT01777191|582129654|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
161204685|NCT01777191|582129653|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
161204686|NCT01777191|582129654|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
161204687|NCT01777191|582129653|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
161204688|NCT01777191|582129654|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
161204689|NCT01777191|582129653|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
161204690|NCT01777191|582129654|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
161204691|NCT01777191|582129653|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
161204692|NCT01777191|582129654|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
161204693|NCT01777191|582129653|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
161204694|NCT01777191|582129654|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
161204695|NCT01777191|582129653|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
161204696|NCT01777191|582129654|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
161204697|NCT01777191|582129653|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
161204698|NCT01777191|582129654|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
161204699|NCT01777191|582129653|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
161204700|NCT01777191|582129654|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
161204701|NCT03286400|582129655|FG000|Overall Study|Death|10|||
161204702|NCT03286400|582129655|FG000|Overall Study|Lost to Follow-up|10|||
161204703|NCT03286400|582129655|FG000|Overall Study|Physician Decision|1|||
161204704|NCT03286400|582129655|FG000|Overall Study|Scheduling difficulty|4|||
161204705|NCT00734617|582129658|FG000|Overall Study|Adverse Event|4|||
161204706|NCT00734617|582129659|FG001|Overall Study|Adverse Event|7|||
161204707|NCT00734617|582129658|FG000|Overall Study|Withdrawal by Subject|103|||
161204708|NCT00734617|582129659|FG001|Overall Study|Withdrawal by Subject|95|||
161204709|NCT00388674|582129664|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
161204710|NCT00388674|582129665|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
161204711|NCT00388674|582129664|FG000|Initial Treatment|Adverse Event|22|||
161204712|NCT00388674|582129665|FG001|Initial Treatment|Adverse Event|87|||
161204713|NCT00388674|582129664|FG000|Initial Treatment|Death|215|||
161204714|NCT00388674|582129665|FG001|Initial Treatment|Death|216|||
161204715|NCT00388674|582129664|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
161204716|NCT00388674|582129665|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
161204717|NCT00388674|582129664|FG000|Initial Treatment|HCC|12|||
161204718|NCT00388674|582129665|FG001|Initial Treatment|HCC|20|||
161204719|NCT00388674|582129664|FG000|Initial Treatment|Lost to Follow-up|526|||
161204720|NCT00388674|582129665|FG001|Initial Treatment|Lost to Follow-up|624|||
161204721|NCT00388674|582129664|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
161204722|NCT00388674|582129665|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
161204723|NCT00388674|582129664|FG000|Initial Treatment|Never Treated with Study Medication|1|||
161204724|NCT00388674|582129665|FG001|Initial Treatment|Never Treated with Study Medication|7|||
161204725|NCT00388674|582129664|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
161204726|NCT00388674|582129665|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
161204727|NCT00388674|582129664|FG000|Initial Treatment|Not Defined|125|||
161204728|NCT00388674|582129665|FG001|Initial Treatment|Not Defined|172|||
161204729|NCT00388674|582129664|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
161204730|NCT00388674|582129665|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
161204731|NCT00388674|582129664|FG000|Initial Treatment|Pregnancy|26|||
161204732|NCT00388674|582129665|FG001|Initial Treatment|Pregnancy|16|||
161204733|NCT00388674|582129664|FG000|Initial Treatment|Study Drug Toxicity|5|||
161204734|NCT00388674|582129665|FG001|Initial Treatment|Study Drug Toxicity|92|||
161204735|NCT00388674|582129664|FG000|Initial Treatment|Participant Request|501|||
161204736|NCT00388674|582129665|FG001|Initial Treatment|Participant Request|673|||
161204737|NCT00388674|582129664|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
161204738|NCT00388674|582129665|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
161204739|NCT00388674|582129664|FG000|Initial Treatment|Not Reported|10|||
161204740|NCT00388674|582129665|FG001|Initial Treatment|Not Reported|12|||
161204741|NCT00388674|582129664|FG000|End of Study|Administrative Reason By Sponsor|299|||
161204742|NCT00388674|582129665|FG001|End of Study|Administrative Reason By Sponsor|253|||
161204743|NCT00388674|582129664|FG000|End of Study|Death|239|||
161204744|NCT00388674|582129665|FG001|End of Study|Death|262|||
161204745|NCT00388674|582129664|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
161204746|NCT00388674|582129665|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
161204747|NCT00388674|582129664|FG000|End of Study|HCC|8|||
161204748|NCT00388674|582129665|FG001|End of Study|HCC|7|||
161204749|NCT00388674|582129664|FG000|End of Study|Lost to Follow-up|587|||
161204750|NCT00388674|582129665|FG001|End of Study|Lost to Follow-up|715|||
161204751|NCT00388674|582129664|FG000|End of Study|Malignancy (Non-HCC)|1|||
161204752|NCT00388674|582129665|FG001|End of Study|Malignancy (Non-HCC)|1|||
161204753|NCT00388674|582129664|FG000|End of Study|Non-Study Related Comorbidities|3|||
161310669|NCT01382225|582518676|FG001|Overall Study|Adverse Event|2|||
161310670|NCT01382225|582518675|FG000|Overall Study|Protocol Violation|2|||
161310671|NCT01382225|582518676|FG001|Overall Study|Protocol Violation|1|||
161310672|NCT01382225|582518675|FG000|Overall Study|Subject Withdrew Consent|5|||
161310673|NCT01382225|582518676|FG001|Overall Study|Subject Withdrew Consent|2|||
161310674|NCT01382225|582518675|FG000|Overall Study|Other|4|||
161310675|NCT01382225|582518676|FG001|Overall Study|Other|2|||
161310676|NCT01797081|582518679|FG000|Overall Study|Adverse Event|1|||
161204754|NCT00388674|582129665|FG001|End of Study|Non-Study Related Comorbidities|4|||
161204755|NCT00388674|582129664|FG000|End of Study|Not Defined|135|||
161204756|NCT00388674|582129665|FG001|End of Study|Not Defined|214|||
161204757|NCT00388674|582129664|FG000|End of Study|Participant Withdrew Consent|437|||
161204758|NCT00388674|582129665|FG001|End of Study|Participant Withdrew Consent|673|||
161310677|NCT01797081|582518680|FG001|Overall Study|Adverse Event|0|||
161310678|NCT01797081|582518681|FG002|Overall Study|Adverse Event|1|||
161310679|NCT01797081|582518682|FG003|Overall Study|Adverse Event|0|||
161204759|NCT00388674|582129664|FG000|End of Study|No Off-Treatment Status Data|22|||
161204760|NCT00388674|582129665|FG001|End of Study|No Off-Treatment Status Data|30|||
161204761|NCT00388674|582129664|FG000|End of Study|Not Reported|0|||
161204762|NCT00388674|582129665|FG001|End of Study|Not Reported|1|||
161310680|NCT01797081|582518679|FG000|Overall Study|Pregnancy|1|||
161310681|NCT01797081|582518680|FG001|Overall Study|Pregnancy|0|||
161204763|NCT00996632|582129672|FG000|Overall Study|Physician Decision|0|||
161204764|NCT00996632|582129673|FG001|Overall Study|Physician Decision|0|||
161204765|NCT01563029|582129674|FG000|Overall Study|Adverse Event|1|||
161204766|NCT01563029|582129675|FG001|Overall Study|Adverse Event|0|||
161204767|NCT01563029|582129676|FG002|Overall Study|Adverse Event|1|||
161204768|NCT01563029|582129677|FG003|Overall Study|Adverse Event|2|||
161204769|NCT01563029|582129678|FG004|Overall Study|Adverse Event|1|||
161204770|NCT01563029|582129674|FG000|Overall Study|Lack of Efficacy|42|||
161204771|NCT01563029|582129675|FG001|Overall Study|Lack of Efficacy|16|||
161204772|NCT01563029|582129676|FG002|Overall Study|Lack of Efficacy|23|||
161204773|NCT01563029|582129677|FG003|Overall Study|Lack of Efficacy|21|||
161204774|NCT01563029|582129678|FG004|Overall Study|Lack of Efficacy|19|||
161204775|NCT01563029|582129674|FG000|Overall Study|Protocol Violation|1|||
161204776|NCT01563029|582129675|FG001|Overall Study|Protocol Violation|2|||
161204777|NCT01563029|582129676|FG002|Overall Study|Protocol Violation|3|||
161204778|NCT01563029|582129677|FG003|Overall Study|Protocol Violation|1|||
161204779|NCT01563029|582129678|FG004|Overall Study|Protocol Violation|3|||
161204780|NCT01563029|582129674|FG000|Overall Study|Protocol defined stopping criteria|1|||
161204781|NCT01563029|582129675|FG001|Overall Study|Protocol defined stopping criteria|0|||
161204782|NCT01563029|582129676|FG002|Overall Study|Protocol defined stopping criteria|0|||
161204783|NCT01563029|582129677|FG003|Overall Study|Protocol defined stopping criteria|0|||
161204784|NCT01563029|582129678|FG004|Overall Study|Protocol defined stopping criteria|0|||
161204785|NCT01563029|582129674|FG000|Overall Study|Lost to Follow-up|1|||
161204786|NCT01563029|582129675|FG001|Overall Study|Lost to Follow-up|0|||
161204787|NCT01563029|582129676|FG002|Overall Study|Lost to Follow-up|1|||
161204788|NCT01563029|582129677|FG003|Overall Study|Lost to Follow-up|1|||
161204789|NCT01563029|582129678|FG004|Overall Study|Lost to Follow-up|1|||
161204790|NCT01563029|582129674|FG000|Overall Study|Physician Decision|3|||
161204791|NCT01563029|582129675|FG001|Overall Study|Physician Decision|5|||
161204792|NCT01563029|582129676|FG002|Overall Study|Physician Decision|2|||
161204793|NCT01563029|582129677|FG003|Overall Study|Physician Decision|4|||
161204794|NCT01563029|582129678|FG004|Overall Study|Physician Decision|2|||
161204795|NCT01563029|582129674|FG000|Overall Study|Withdrawal by Subject|4|||
161204796|NCT01563029|582129675|FG001|Overall Study|Withdrawal by Subject|1|||
161204797|NCT01563029|582129676|FG002|Overall Study|Withdrawal by Subject|3|||
161204798|NCT01563029|582129677|FG003|Overall Study|Withdrawal by Subject|4|||
161204799|NCT01563029|582129678|FG004|Overall Study|Withdrawal by Subject|3|||
161204800|NCT03069365|582129679|FG000|Overall Study|Adverse Event|1|||
161204801|NCT02780115|582129680|FG000|Overall Study|Withdrawal by Subject|0|||
161204802|NCT02780115|582129681|FG001|Overall Study|Withdrawal by Subject|1|||
161204803|NCT02780115|582129682|FG002|Overall Study|Withdrawal by Subject|1|||
161204804|NCT02780115|582129683|FG003|Overall Study|Withdrawal by Subject|0|||
161204805|NCT02780115|582129684|FG004|Overall Study|Withdrawal by Subject|0|||
161204806|NCT02780115|582129680|FG000|Overall Study|Adverse Event|0|||
161204807|NCT02780115|582129681|FG001|Overall Study|Adverse Event|0|||
161204808|NCT02780115|582129682|FG002|Overall Study|Adverse Event|0|||
161204809|NCT02780115|582129683|FG003|Overall Study|Adverse Event|1|||
161204810|NCT02780115|582129684|FG004|Overall Study|Adverse Event|1|||
161204811|NCT00769132|582129685|FG000|Period 1|Adverse Event|1|||
161204812|NCT00769132|582129686|FG001|Period 1|Adverse Event|0|||
161204813|NCT00769132|582129687|FG002|Period 1|Adverse Event|0|||
161204814|NCT00769132|582129688|FG003|Period 1|Adverse Event|1|||
161204815|NCT00769132|582129685|FG000|Period 2|Withdrawal by Subject|0|||
161204816|NCT00769132|582129686|FG001|Period 2|Withdrawal by Subject|0|||
161204817|NCT00769132|582129687|FG002|Period 2|Withdrawal by Subject|0|||
161204818|NCT00769132|582129688|FG003|Period 2|Withdrawal by Subject|1|||
161204819|NCT00769132|582129685|FG000|Period 3|Withdrawal by Subject|1|||
161204820|NCT00769132|582129686|FG001|Period 3|Withdrawal by Subject|0|||
161204821|NCT00769132|582129687|FG002|Period 3|Withdrawal by Subject|0|||
161204822|NCT00769132|582129688|FG003|Period 3|Withdrawal by Subject|0|||
161204823|NCT00769132|582129685|FG000|Period 4|Withdrawal by Subject|0|||
161204824|NCT00769132|582129686|FG001|Period 4|Withdrawal by Subject|1|||
161204825|NCT00769132|582129687|FG002|Period 4|Withdrawal by Subject|0|||
161204826|NCT00769132|582129688|FG003|Period 4|Withdrawal by Subject|0|||
161204827|NCT00499252|582129689|FG000|Overall Study|Adverse Event|3|||
161204828|NCT00499252|582129689|FG000|Overall Study|Refused further treatment|2|||
161204829|NCT00499252|582129689|FG000|Overall Study|Ineligible|4|||
161204830|NCT00499252|582129689|FG000|Overall Study|<no further label>|3|||
161204831|NCT02230332|582129690|FG000|Overall Study|Adverse Event|2|||
161204832|NCT02230332|582129691|FG001|Overall Study|Adverse Event|1|||
161204833|NCT02230332|582129690|FG000|Overall Study|Lost to Follow-up|1|||
161204834|NCT02230332|582129691|FG001|Overall Study|Lost to Follow-up|0|||
161204835|NCT02230332|582129690|FG000|Overall Study|Protocol Violation|1|||
161204836|NCT02230332|582129691|FG001|Overall Study|Protocol Violation|0|||
161204837|NCT01260194|582129693|FG000|Overall Study|Withdrawal of Consent|1|||
161204838|NCT01257737|582129698|FG000|Overall Study|Lost to Follow-up|1|||
161204839|NCT01257737|582129699|FG001|Overall Study|Lost to Follow-up|2|||
161204840|NCT01257737|582129698|FG000|Overall Study|Liver transplant|1|||
161204841|NCT01257737|582129699|FG001|Overall Study|Liver transplant|0|||
161204842|NCT01257737|582129698|FG000|Overall Study|Relocation out of the country|0|||
161204843|NCT01257737|582129699|FG001|Overall Study|Relocation out of the country|1|||
161204844|NCT01257737|582129698|FG000|Overall Study|Withdrew from study|0|||
161204845|NCT01257737|582129699|FG001|Overall Study|Withdrew from study|1|||
161204846|NCT00127192|582129708|FG000|Overall Study|Adverse Event|0|||
161204847|NCT00127192|582129709|FG001|Overall Study|Adverse Event|1|||
161204848|NCT00127192|582129710|FG002|Overall Study|Adverse Event|1|||
161204849|NCT00127192|582129711|FG003|Overall Study|Adverse Event|1|||
161204850|NCT00127192|582129712|FG004|Overall Study|Adverse Event|0|||
161204851|NCT00127192|582129708|FG000|Overall Study|Lack of Efficacy|2|||
161204852|NCT00127192|582129709|FG001|Overall Study|Lack of Efficacy|0|||
161204853|NCT00127192|582129710|FG002|Overall Study|Lack of Efficacy|0|||
161204854|NCT00127192|582129711|FG003|Overall Study|Lack of Efficacy|0|||
161204855|NCT00127192|582129712|FG004|Overall Study|Lack of Efficacy|2|||
161204856|NCT00127192|582129708|FG000|Overall Study|Withdrawal by Subject|0|||
161204857|NCT00127192|582129709|FG001|Overall Study|Withdrawal by Subject|0|||
161204858|NCT00127192|582129710|FG002|Overall Study|Withdrawal by Subject|1|||
161204859|NCT00127192|582129711|FG003|Overall Study|Withdrawal by Subject|0|||
161204860|NCT00127192|582129712|FG004|Overall Study|Withdrawal by Subject|3|||
161204861|NCT00127192|582129708|FG000|Overall Study|Adverse event in pre-treatment period|1|||
161204862|NCT00127192|582129709|FG001|Overall Study|Adverse event in pre-treatment period|0|||
161204863|NCT00127192|582129710|FG002|Overall Study|Adverse event in pre-treatment period|0|||
161204864|NCT00127192|582129711|FG003|Overall Study|Adverse event in pre-treatment period|0|||
161204865|NCT00127192|582129712|FG004|Overall Study|Adverse event in pre-treatment period|0|||
161204866|NCT01612780|582129717|FG000|Overall Study|Treatment not completed|1|||
161204867|NCT01612780|582129717|FG000|Overall Study|Withdrawal by Subject|5|||
161204868|NCT03466060|582129718|FG000|Period 1|Test Lens Damage|0|||
161204869|NCT03466060|582129719|FG001|Period 1|Test Lens Damage|2|||
161204870|NCT03466060|582129720|FG002|Period 1|Test Lens Damage|0|||
161204871|NCT03466060|582129721|FG003|Period 1|Test Lens Damage|0|||
161204872|NCT03466060|582129722|FG004|Period 1|Test Lens Damage|0|||
161204873|NCT03466060|582129723|FG005|Period 1|Test Lens Damage|0|||
161204874|NCT03466060|582129718|FG000|Period 1|Withdrawal by Subject|0|||
161204875|NCT03466060|582129719|FG001|Period 1|Withdrawal by Subject|0|||
161204876|NCT03466060|582129720|FG002|Period 1|Withdrawal by Subject|2|||
161204877|NCT03466060|582129721|FG003|Period 1|Withdrawal by Subject|0|||
161204878|NCT03466060|582129722|FG004|Period 1|Withdrawal by Subject|0|||
161204879|NCT03466060|582129723|FG005|Period 1|Withdrawal by Subject|0|||
161204880|NCT03466060|582129718|FG000|Period 1|Lost to Follow-up|0|||
161204881|NCT03466060|582129719|FG001|Period 1|Lost to Follow-up|0|||
161204882|NCT03466060|582129720|FG002|Period 1|Lost to Follow-up|0|||
161204883|NCT03466060|582129721|FG003|Period 1|Lost to Follow-up|1|||
161204884|NCT03466060|582129722|FG004|Period 1|Lost to Follow-up|0|||
161204885|NCT03466060|582129723|FG005|Period 1|Lost to Follow-up|0|||
161204886|NCT03466060|582129718|FG000|Period 1|Grade 2 Conjunctivitis|0|||
161204887|NCT03466060|582129719|FG001|Period 1|Grade 2 Conjunctivitis|0|||
161204888|NCT03466060|582129720|FG002|Period 1|Grade 2 Conjunctivitis|1|||
161204889|NCT03466060|582129721|FG003|Period 1|Grade 2 Conjunctivitis|0|||
161204890|NCT03466060|582129722|FG004|Period 1|Grade 2 Conjunctivitis|0|||
161204891|NCT03466060|582129723|FG005|Period 1|Grade 2 Conjunctivitis|0|||
161204892|NCT03466060|582129718|FG000|Period 2|Lens Handling Difficulties|0|||
161204893|NCT03466060|582129719|FG001|Period 2|Lens Handling Difficulties|0|||
161204894|NCT03466060|582129720|FG002|Period 2|Lens Handling Difficulties|1|||
161204895|NCT03466060|582129721|FG003|Period 2|Lens Handling Difficulties|0|||
161204896|NCT03466060|582129722|FG004|Period 2|Lens Handling Difficulties|0|||
161204897|NCT03466060|582129723|FG005|Period 2|Lens Handling Difficulties|0|||
161204898|NCT02985515|582129724|FG000|Olfaction Testing|Lost to Follow-up|0|||
161204899|NCT02985515|582129725|FG001|Olfaction Testing|Lost to Follow-up|5|||
161204900|NCT02985515|582129724|FG000|Olfaction Testing|Protocol Violation|0|||
161204901|NCT02985515|582129725|FG001|Olfaction Testing|Protocol Violation|3|||
161204902|NCT01610284|582129726|FG000|Randomization Phase|Adverse Event|1|||
161204903|NCT01610284|582129727|FG001|Randomization Phase|Adverse Event|0|||
161310682|NCT01797081|582518681|FG002|Overall Study|Pregnancy|0|||
161310683|NCT01797081|582518682|FG003|Overall Study|Pregnancy|0|||
161310684|NCT01797081|582518679|FG000|Overall Study|Personal Reasons|12|||
161310685|NCT01797081|582518680|FG001|Overall Study|Personal Reasons|4|||
161310686|NCT01797081|582518681|FG002|Overall Study|Personal Reasons|4|||
161310687|NCT01797081|582518682|FG003|Overall Study|Personal Reasons|8|||
161310688|NCT01797081|582518679|FG000|Overall Study|Protocol Violation|0|||
161310689|NCT01797081|582518680|FG001|Overall Study|Protocol Violation|0|||
161310690|NCT01797081|582518681|FG002|Overall Study|Protocol Violation|0|||
161310691|NCT01797081|582518682|FG003|Overall Study|Protocol Violation|1|||
161310692|NCT05513703|582518687|FG000|Overall Study|Death|4|||
161310693|NCT05513703|582518687|FG000|Overall Study|Study terminated by sponsor|5|||
161310694|NCT02484651|582518690|FG000|Overall Study|Patients' data files were corrupted.|1|||
161310695|NCT02484651|582518691|FG001|Overall Study|Patients' data files were corrupted.|1|||
161310696|NCT02484651|582518690|FG000|Overall Study|BIS monitoring failed.|1|||
161310697|NCT02484651|582518691|FG001|Overall Study|BIS monitoring failed.|1|||
161310698|NCT02484651|582518690|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
161204904|NCT01610284|582129726|FG000|Randomization Phase|Physician Decision|1|||
161204905|NCT01610284|582129727|FG001|Randomization Phase|Physician Decision|1|||
161204906|NCT01610284|582129726|FG000|Randomization Phase|Death|0|||
161204907|NCT01610284|582129727|FG001|Randomization Phase|Death|1|||
161204908|NCT01610284|582129726|FG000|Treatment Phase|Adverse Event|80|||
161204909|NCT01610284|582129727|FG001|Treatment Phase|Adverse Event|12|||
161204910|NCT01610284|582129726|FG000|Treatment Phase|Lost to Follow-up|1|||
161204911|NCT01610284|582129727|FG001|Treatment Phase|Lost to Follow-up|0|||
161204912|NCT01610284|582129726|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
161204913|NCT01610284|582129727|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
161204914|NCT01610284|582129726|FG000|Treatment Phase|Physician Decision|27|||
161204915|NCT01610284|582129727|FG001|Treatment Phase|Physician Decision|24|||
161204916|NCT01610284|582129726|FG000|Treatment Phase|Progressive Disease|377|||
161204917|NCT01610284|582129727|FG001|Treatment Phase|Progressive Disease|486|||
161204918|NCT01610284|582129726|FG000|Treatment Phase|Protocol Deviation|2|||
161204919|NCT01610284|582129727|FG001|Treatment Phase|Protocol Deviation|3|||
161204920|NCT01610284|582129726|FG000|Treatment Phase|Study terminated by Sponsor|18|||
161204921|NCT01610284|582129727|FG001|Treatment Phase|Study terminated by Sponsor|15|||
161204922|NCT01610284|582129726|FG000|Treatment Phase|Subject/Guardian Decision|55|||
161204923|NCT01610284|582129727|FG001|Treatment Phase|Subject/Guardian Decision|23|||
161204924|NCT01610284|582129726|FG000|Treatment Phase|Death|6|||
161204925|NCT01610284|582129727|FG001|Treatment Phase|Death|5|||
161204926|NCT01610284|582129726|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
161204927|NCT01610284|582129727|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
161204928|NCT01610284|582129726|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
161204929|NCT01610284|582129727|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
161204930|NCT01610284|582129726|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
161204931|NCT01610284|582129727|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
161204932|NCT01610284|582129726|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
161204933|NCT01610284|582129727|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
161204934|NCT01610284|582129726|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
161204935|NCT01610284|582129727|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
161204936|NCT01610284|582129726|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
161204937|NCT01610284|582129727|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
161204938|NCT03506425|582129735|FG000|Overall Study|Adverse Event|1|||
161204939|NCT03506425|582129736|FG001|Overall Study|Adverse Event|3|||
161204940|NCT03506425|582129737|FG002|Overall Study|Adverse Event|0|||
161204941|NCT03506425|582129735|FG000|Overall Study|Death|1|||
161204942|NCT03506425|582129736|FG001|Overall Study|Death|0|||
161204943|NCT03506425|582129737|FG002|Overall Study|Death|0|||
161204944|NCT03506425|582129735|FG000|Overall Study|Withdrawal by Subject|0|||
161204945|NCT03506425|582129736|FG001|Overall Study|Withdrawal by Subject|0|||
161204946|NCT03506425|582129737|FG002|Overall Study|Withdrawal by Subject|1|||
161204947|NCT02057549|582129739|FG000|Overall Study|Lost to Follow-up|1|||
161204948|NCT02057549|582129740|FG001|Overall Study|Lost to Follow-up|0|||
161204949|NCT02057549|582129739|FG000|Overall Study|Physician Decision|1|||
161310699|NCT02484651|582518691|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
161310700|NCT01419080|582518692|FG000|Overall Study|Withdrawal by Subject|75|||
161310701|NCT01419080|582518692|FG000|Overall Study|Death|30|||
161310702|NCT01419080|582518692|FG000|Overall Study|Lost to Follow-up|23|||
161310703|NCT01419080|582518692|FG000|Overall Study|Too Ill|3|||
161310704|NCT01698879|582518693|FG000|Overall Study|Withdrawal by Subject|1|||
161310705|NCT01698879|582518694|FG001|Overall Study|Withdrawal by Subject|0|||
161310706|NCT01698879|582518695|FG002|Overall Study|Withdrawal by Subject|0|||
161310707|NCT04972968|582518696|FG000|Overall Study|Adverse Event|3|||
161310708|NCT04972968|582518697|FG001|Overall Study|Adverse Event|1|||
161310709|NCT04972968|582518698|FG002|Overall Study|Adverse Event|1|||
161310710|NCT04972968|582518699|FG003|Overall Study|Adverse Event|7|||
161310711|NCT04972968|582518696|FG000|Overall Study|Lack of Efficacy|2|||
161310712|NCT04972968|582518697|FG001|Overall Study|Lack of Efficacy|1|||
161310713|NCT04972968|582518698|FG002|Overall Study|Lack of Efficacy|0|||
161310714|NCT04972968|582518699|FG003|Overall Study|Lack of Efficacy|0|||
161310715|NCT04972968|582518696|FG000|Overall Study|Withdrawal by Subject|7|||
161310716|NCT04972968|582518697|FG001|Overall Study|Withdrawal by Subject|4|||
161310717|NCT04972968|582518698|FG002|Overall Study|Withdrawal by Subject|3|||
161310718|NCT04972968|582518699|FG003|Overall Study|Withdrawal by Subject|2|||
161310719|NCT04972968|582518696|FG000|Overall Study|Study Terminated by Sponsor|25|||
161310720|NCT04972968|582518697|FG001|Overall Study|Study Terminated by Sponsor|28|||
161310721|NCT04972968|582518698|FG002|Overall Study|Study Terminated by Sponsor|32|||
161310722|NCT04972968|582518699|FG003|Overall Study|Study Terminated by Sponsor|27|||
161310723|NCT04972968|582518696|FG000|Overall Study|Other|1|||
161310724|NCT04972968|582518697|FG001|Overall Study|Other|0|||
161310725|NCT04972968|582518698|FG002|Overall Study|Other|1|||
161310726|NCT04972968|582518699|FG003|Overall Study|Other|1|||
161310727|NCT00150800|582518700|FG000|Overall Study|Adverse Event|89|||
161204950|NCT02057549|582129740|FG001|Overall Study|Physician Decision|0|||
161204951|NCT02057549|582129739|FG000|Overall Study|Withdrawal by Subject|1|||
161204952|NCT02057549|582129740|FG001|Overall Study|Withdrawal by Subject|0|||
161204953|NCT03319368|582129743|FG000|Overall Study|Discharge swabs not collected from resident|57|||
161204954|NCT03319368|582129744|FG001|Overall Study|Discharge swabs not collected from resident|46|||
161204955|NCT03409328|582129752|FG000|Overall Study|Lost to Follow-up|6|||
161204956|NCT03409328|582129753|FG001|Overall Study|Lost to Follow-up|3|||
161204957|NCT02998645|582129754|FG000|Treatment Period 1|Adverse Event|6|||
161204958|NCT02998645|582129754|FG000|Treatment Period 1|Death|5|||
161204959|NCT02998645|582129754|FG000|Treatment Period 1|Technical Problems|4|||
161204960|NCT02998645|582129754|FG000|Treatment Period 1|Lack of Efficacy|2|||
161204961|NCT02998645|582129754|FG000|Treatment Period 1|Progressive disease|1|||
161204962|NCT02998645|582129754|FG000|Treatment Period 1|Subject/guardian decision|1|||
161204963|NCT02998645|582129754|FG000|Treatment Period 2|Lack of Efficacy|5|||
161204964|NCT02998645|582129754|FG000|Treatment Period 2|Adverse Event|2|||
161204965|NCT02998645|582129754|FG000|Treatment Period 2|Progressive disease|2|||
161204966|NCT02998645|582129754|FG000|Treatment Period 2|Physician Decision|1|||
161204967|NCT00478673|582129755|FG000|30-Days Post-Procedure|Death|2|||
161204968|NCT00478673|582129755|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
161204969|NCT00478673|582129755|FG000|30-Days Post-Procedure|Missed Visit|7|||
161204970|NCT00478673|582129755|FG000|12-Months Post-Procedure|Death|23|||
161204971|NCT00478673|582129755|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
161204972|NCT00478673|582129755|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
161204973|NCT00478673|582129755|FG000|12-Months Post-Procedure|Missed Visit|25|||
161204974|NCT00478673|582129755|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
161204975|NCT03701516|582129756|FG000|Period 1|Lost to Follow-up|0|||
161204976|NCT03701516|582129757|FG001|Period 1|Lost to Follow-up|1|||
161204977|NCT03701516|582129756|FG000|Period 1|Adverse Event|0|||
161204978|NCT03701516|582129757|FG001|Period 1|Adverse Event|2|||
161204979|NCT03701516|582129756|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
161204980|NCT03701516|582129757|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
161204981|NCT03701516|582129756|FG000|Period 1|Non Compliance to Protocol|2|||
161204982|NCT03701516|582129757|FG001|Period 1|Non Compliance to Protocol|1|||
161204983|NCT03701516|582129756|FG000|Period 1|Withdrawal by Subject|0|||
161204984|NCT03701516|582129757|FG001|Period 1|Withdrawal by Subject|1|||
161204985|NCT03701516|582129756|FG000|Period 2|failed to meet all eligibility creiteria|1|||
161204986|NCT03701516|582129757|FG001|Period 2|failed to meet all eligibility creiteria|0|||
161204987|NCT03701516|582129756|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
161204988|NCT03701516|582129757|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
161204989|NCT03930615|582129758|FG000|Overall Study|Death|9|||
161204990|NCT03930615|582129759|FG001|Overall Study|Death|3|||
161204991|NCT03930615|582129758|FG000|Overall Study|Lost to Follow-up|1|||
161204992|NCT03930615|582129759|FG001|Overall Study|Lost to Follow-up|2|||
161204993|NCT03930615|582129758|FG000|Overall Study|Physician Decision|3|||
161204994|NCT03930615|582129759|FG001|Overall Study|Physician Decision|4|||
161204995|NCT03930615|582129758|FG000|Overall Study|Withdrawal by Subject|13|||
161204996|NCT03930615|582129759|FG001|Overall Study|Withdrawal by Subject|2|||
161204997|NCT03930615|582129758|FG000|Overall Study|Not treated|1|||
161204998|NCT03930615|582129759|FG001|Overall Study|Not treated|1|||
161204999|NCT03644927|582129760|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
161205000|NCT03644927|582129761|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
161205001|NCT00956813|582129762|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
161205002|NCT00956813|582129763|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
161205003|NCT00956813|582129762|FG000|Flaxseed and Placebo|Ineligible|3|||
161205004|NCT00956813|582129763|FG001|Flaxseed and Placebo|Ineligible|1|||
161205005|NCT02380248|582129764|FG000|Overall Study|Lost to Follow-up|11|||
161205006|NCT02380248|582129764|FG000|Overall Study|Withdrawal by Subject|3|||
161205007|NCT02864953|582129765|FG000|Overall Study|Adverse Event|22|||
161205008|NCT02864953|582129766|FG001|Overall Study|Adverse Event|19|||
161205009|NCT02864953|582129765|FG000|Overall Study|Withdrawal by Subject|1|||
161205010|NCT02864953|582129766|FG001|Overall Study|Withdrawal by Subject|0|||
161205011|NCT02864953|582129765|FG000|Overall Study|Physician Decision|4|||
161205012|NCT02864953|582129766|FG001|Overall Study|Physician Decision|2|||
161205013|NCT02864953|582129765|FG000|Overall Study|Death|3|||
161205014|NCT02864953|582129766|FG001|Overall Study|Death|13|||
161205015|NCT02864953|582129765|FG000|Overall Study|Reason not specified|14|||
161205016|NCT02864953|582129766|FG001|Overall Study|Reason not specified|12|||
161205017|NCT02864953|582129765|FG000|Overall Study|Withdrew Prior to Dosing|9|||
161205018|NCT02864953|582129766|FG001|Overall Study|Withdrew Prior to Dosing|8|||
161205019|NCT00358670|582129767|FG000|Overall Study|Adverse Event|26|||
161205020|NCT00358670|582129768|FG001|Overall Study|Adverse Event|29|||
161205021|NCT00358670|582129767|FG000|Overall Study|Lack of Efficacy|20|||
161205022|NCT00358670|582129768|FG001|Overall Study|Lack of Efficacy|23|||
161205023|NCT00358670|582129767|FG000|Overall Study|Protocol Violation|6|||
161205024|NCT00358670|582129768|FG001|Overall Study|Protocol Violation|9|||
161205025|NCT00358670|582129767|FG000|Overall Study|Lost to Follow-up|4|||
161205026|NCT00358670|582129768|FG001|Overall Study|Lost to Follow-up|5|||
161205027|NCT00358670|582129767|FG000|Overall Study|Withdrawal by Subject|13|||
161205028|NCT00358670|582129768|FG001|Overall Study|Withdrawal by Subject|24|||
161205029|NCT00358670|582129767|FG000|Overall Study|Protocol Defined Clinical Event|0|||
161205030|NCT00358670|582129768|FG001|Overall Study|Protocol Defined Clinical Event|1|||
161205031|NCT00358670|582129767|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
161205032|NCT00358670|582129768|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
161205033|NCT00358670|582129767|FG000|Overall Study|Administrative|153|||
161205034|NCT00358670|582129768|FG001|Overall Study|Administrative|125|||
161205035|NCT00981019|582129769|FG000|Overall Study|Did not respond|65|||
161205036|NCT00981019|582129769|FG000|Overall Study|Did not match target population|94|||
161205037|NCT00981019|582129769|FG000|Overall Study|Inadvertent exclusion|239|||
161205038|NCT00981019|582129769|FG000|Overall Study|Hit the survey after closure|79|||
161205039|NCT00865306|582129770|FG000|Controlled Trial|Lost to Follow-up|1|||
161205040|NCT00865306|582129771|FG001|Controlled Trial|Lost to Follow-up|1|||
161205041|NCT00865306|582129770|FG000|Controlled Trial|Difficulty commuting|2|||
161205042|NCT00865306|582129771|FG001|Controlled Trial|Difficulty commuting|0|||
161205043|NCT00865306|582129770|FG000|Controlled Trial|Improved btw baseline and first session|1|||
161205044|NCT00865306|582129771|FG001|Controlled Trial|Improved btw baseline and first session|0|||
161205045|NCT00865306|582129770|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
161205046|NCT00865306|582129771|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
161205047|NCT00865306|582129770|FG000|Controlled Trial|Withdrawal by Subject|0|||
161205048|NCT00865306|582129771|FG001|Controlled Trial|Withdrawal by Subject|1|||
161205049|NCT05083559|582129773|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
161205050|NCT05083559|582129774|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
161205051|NCT05083559|582129773|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
161205052|NCT05083559|582129774|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
161205053|NCT05083559|582129773|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
161205054|NCT05083559|582129774|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
161205055|NCT02704130|582129775|FG000|Overall Study|Physician Decision|5|||
161205056|NCT02704130|582129776|FG001|Overall Study|Physician Decision|3|||
161205057|NCT01023022|582129779|FG000|Overall Study|Death|5|||
161205058|NCT01023022|582129779|FG000|Overall Study|Lost to Follow-up|7|||
161205059|NCT01023022|582129779|FG000|Overall Study|due to technical issues|2|||
161205060|NCT00359073|582131248|FG000|Overall Study|Withdrawal by Subject|1|||
161205061|NCT00359073|582131249|FG001|Overall Study|Withdrawal by Subject|1|||
161205062|NCT00359073|582131248|FG000|Overall Study|Eligibility criteria no longer met|3|||
161205063|NCT00359073|582131249|FG001|Overall Study|Eligibility criteria no longer met|0|||
161205064|NCT00359073|582131248|FG000|Overall Study|developed RV16 antibody|0|||
161205065|NCT00359073|582131249|FG001|Overall Study|developed RV16 antibody|1|||
161205066|NCT01371006|582131250|FG000|Overall Study|Adverse Event|1|||
161205067|NCT01371006|582131251|FG001|Overall Study|Adverse Event|0|||
161205068|NCT00684645|582131252|FG000|Overall Study|Death|2|||
161205069|NCT00684645|582131252|FG000|Overall Study|Progressive disease|67|||
161205070|NCT00684645|582131252|FG000|Overall Study|Adverse Event|27|||
161205071|NCT00684645|582131252|FG000|Overall Study|Lost to Follow-up|3|||
161205072|NCT00684645|582131252|FG000|Overall Study|Other|15|||
161205073|NCT01819467|582131255|FG000|Overall Study|Physician Decision|20|||
161205074|NCT01819467|582131256|FG001|Overall Study|Physician Decision|9|||
161205075|NCT03515837|582131257|FG000|Overall Study|Death|219|||
161205076|NCT03515837|582131258|FG001|Overall Study|Death|227|||
161205077|NCT03515837|582131257|FG000|Overall Study|Lost to Follow-up|0|||
161205078|NCT03515837|582131258|FG001|Overall Study|Lost to Follow-up|1|||
161205079|NCT03515837|582131257|FG000|Overall Study|Withdrawal by Subject|0|||
161205080|NCT03515837|582131258|FG001|Overall Study|Withdrawal by Subject|4|||
161205081|NCT03515837|582131257|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
161205082|NCT03515837|582131258|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
161205083|NCT02325401|582131259|FG000|Overall Study|Withdrawal by Subject|0|||
161310728|NCT00150800|582518700|FG000|Overall Study|Death|18|||
161310729|NCT00150800|582518700|FG000|Overall Study|Lack of Efficacy|166|||
161310730|NCT00150800|582518700|FG000|Overall Study|Lost to Follow-up|58|||
161310731|NCT00150800|582518700|FG000|Overall Study|Subject's choice|90|||
161310732|NCT00150800|582518700|FG000|Overall Study|No compliance|18|||
161310733|NCT00150800|582518700|FG000|Overall Study|IP misshandling|1|||
161310734|NCT00150800|582518700|FG000|Overall Study|Site closure|24|||
161310735|NCT00150800|582518700|FG000|Overall Study|Protocol non-adherence|2|||
161310736|NCT00150800|582518700|FG000|Overall Study|Nobody to accompany patient|1|||
161310737|NCT00150800|582518700|FG000|Overall Study|Distance too long for patient|1|||
161205084|NCT02325401|582131260|FG001|Overall Study|Withdrawal by Subject|1|||
161205085|NCT02325401|582131261|FG002|Overall Study|Withdrawal by Subject|1|||
161205086|NCT00391092|582131262|FG000|Overall Study|Death|78|||
161205087|NCT00391092|582131263|FG001|Overall Study|Death|81|||
161205088|NCT00391092|582131262|FG000|Overall Study|Lost to Follow-up|13|||
161205089|NCT00391092|582131263|FG001|Overall Study|Lost to Follow-up|18|||
161205090|NCT00391092|582131262|FG000|Overall Study|Alive on treatment|29|||
161205091|NCT00391092|582131263|FG001|Overall Study|Alive on treatment|33|||
161205092|NCT00391092|582131262|FG000|Overall Study|Alive in follow-up|88|||
161205093|NCT00391092|582131263|FG001|Overall Study|Alive in follow-up|84|||
161205094|NCT02545868|582131264|FG000|Overall Study|Lack of Efficacy|1|||
161205095|NCT02545868|582131265|FG001|Overall Study|Lack of Efficacy|1|||
161205096|NCT02545868|582131266|FG002|Overall Study|Lack of Efficacy|0|||
161205097|NCT02545868|582131264|FG000|Overall Study|Lost to Follow-up|1|||
161205098|NCT02545868|582131265|FG001|Overall Study|Lost to Follow-up|5|||
161205099|NCT02545868|582131266|FG002|Overall Study|Lost to Follow-up|1|||
161205100|NCT02545868|582131264|FG000|Overall Study|Non-compliance|1|||
161205101|NCT02545868|582131265|FG001|Overall Study|Non-compliance|1|||
161205102|NCT02545868|582131266|FG002|Overall Study|Non-compliance|1|||
161205103|NCT02545868|582131264|FG000|Overall Study|Treatment change|21|||
161205104|NCT02545868|582131265|FG001|Overall Study|Treatment change|19|||
161205105|NCT02545868|582131266|FG002|Overall Study|Treatment change|22|||
161205106|NCT02545868|582131264|FG000|Overall Study|Physician Decision|1|||
161205107|NCT02545868|582131265|FG001|Overall Study|Physician Decision|1|||
161205108|NCT02545868|582131266|FG002|Overall Study|Physician Decision|1|||
161205109|NCT02545868|582131264|FG000|Overall Study|Withdrawal by Subject|6|||
161205110|NCT02545868|582131265|FG001|Overall Study|Withdrawal by Subject|7|||
161205111|NCT02545868|582131266|FG002|Overall Study|Withdrawal by Subject|9|||
161205112|NCT01856686|582131271|FG000|Overall Study|Lost to Follow-up|5|||
161205113|NCT01856686|582131272|FG001|Overall Study|Lost to Follow-up|11|||
161205114|NCT00602979|582131275|FG000|Overall Study|Lost to Follow-up|3|||
161205115|NCT00602979|582131276|FG001|Overall Study|Lost to Follow-up|2|||
161205116|NCT00602979|582131277|FG002|Overall Study|Lost to Follow-up|3|||
161205117|NCT00602979|582131278|FG003|Overall Study|Lost to Follow-up|2|||
161205118|NCT00602979|582131279|FG004|Overall Study|Lost to Follow-up|3|||
161205119|NCT00602979|582131275|FG000|Overall Study|Failed Intubation|0|||
161205120|NCT00602979|582131276|FG001|Overall Study|Failed Intubation|1|||
161205121|NCT00602979|582131277|FG002|Overall Study|Failed Intubation|0|||
161205122|NCT00602979|582131278|FG003|Overall Study|Failed Intubation|1|||
161205123|NCT00602979|582131279|FG004|Overall Study|Failed Intubation|0|||
161205124|NCT01461369|582131282|FG000|Overall Study|Lack of Efficacy|2|||
161205125|NCT01461369|582131283|FG001|Overall Study|Lack of Efficacy|0|||
161205126|NCT01461369|582131284|FG002|Overall Study|Lack of Efficacy|6|||
161205127|NCT01461369|582131282|FG000|Overall Study|Lost to Follow-up|0|||
161205128|NCT01461369|582131283|FG001|Overall Study|Lost to Follow-up|0|||
161205129|NCT01461369|582131284|FG002|Overall Study|Lost to Follow-up|3|||
161205130|NCT01461369|582131282|FG000|Overall Study|Adverse Event|9|||
161205131|NCT01461369|582131283|FG001|Overall Study|Adverse Event|12|||
161205132|NCT01461369|582131284|FG002|Overall Study|Adverse Event|4|||
161205133|NCT01461369|582131282|FG000|Overall Study|Protocol Violation|1|||
161205134|NCT01461369|582131283|FG001|Overall Study|Protocol Violation|2|||
161205135|NCT01461369|582131284|FG002|Overall Study|Protocol Violation|2|||
161205136|NCT01461369|582131282|FG000|Overall Study|Withdrawal by Subject|1|||
161205137|NCT01461369|582131283|FG001|Overall Study|Withdrawal by Subject|3|||
161205138|NCT01461369|582131284|FG002|Overall Study|Withdrawal by Subject|2|||
161205139|NCT03692078|582131287|FG000|Overall Study|Adverse Event|0|||
161205140|NCT03692078|582131288|FG001|Overall Study|Adverse Event|0|||
161205141|NCT03692078|582131289|FG002|Overall Study|Adverse Event|0|||
161205142|NCT03692078|582131290|FG003|Overall Study|Adverse Event|0|||
161205143|NCT03692078|582131291|FG004|Overall Study|Adverse Event|0|||
161205144|NCT03692078|582131292|FG005|Overall Study|Adverse Event|1|||
161205145|NCT03692078|582131293|FG006|Overall Study|Adverse Event|0|||
161205146|NCT03692078|582131287|FG000|Overall Study|Enrollment Closed|5|||
161205147|NCT03692078|582131288|FG001|Overall Study|Enrollment Closed|0|||
161205148|NCT03692078|582131289|FG002|Overall Study|Enrollment Closed|0|||
161205149|NCT03692078|582131290|FG003|Overall Study|Enrollment Closed|0|||
161205150|NCT03692078|582131291|FG004|Overall Study|Enrollment Closed|0|||
161205151|NCT03692078|582131292|FG005|Overall Study|Enrollment Closed|0|||
161205152|NCT03692078|582131293|FG006|Overall Study|Enrollment Closed|0|||
161310738|NCT00150800|582518700|FG000|Overall Study|Neurosurgery|2|||
161310739|NCT00150800|582518700|FG000|Overall Study|BRV monotherapy|1|||
161310740|NCT00150800|582518700|FG000|Overall Study|Visit refusal|3|||
161310741|NCT00150800|582518700|FG000|Overall Study|Sponsor's request|2|||
161310742|NCT00150800|582518700|FG000|Overall Study|Generalized Epilepsy|1|||
161310743|NCT00150800|582518700|FG000|Overall Study|Moved from area/country|8|||
161310744|NCT00150800|582518700|FG000|Overall Study|PI retiring|2|||
161310745|NCT00150800|582518700|FG000|Overall Study|PI leaving site|2|||
161310746|NCT00150800|582518700|FG000|Overall Study|Patient insurance|1|||
161310747|NCT00150800|582518700|FG000|Overall Study|Surgical intervention|4|||
161310748|NCT00150800|582518700|FG000|Overall Study|Pregnancy planned|1|||
161205153|NCT03692078|582131287|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
161205154|NCT03692078|582131288|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
161205155|NCT03692078|582131289|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
161205156|NCT03692078|582131290|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
161205157|NCT03692078|582131291|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
161205158|NCT03692078|582131292|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
161205159|NCT03692078|582131293|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
161205160|NCT03692078|582131287|FG000|Overall Study|Withdrawal by Subject|0|||
161205161|NCT03692078|582131288|FG001|Overall Study|Withdrawal by Subject|2|||
161205162|NCT03692078|582131289|FG002|Overall Study|Withdrawal by Subject|0|||
161205163|NCT03692078|582131290|FG003|Overall Study|Withdrawal by Subject|1|||
161205164|NCT03692078|582131291|FG004|Overall Study|Withdrawal by Subject|5|||
161205165|NCT03692078|582131292|FG005|Overall Study|Withdrawal by Subject|3|||
161205166|NCT03692078|582131293|FG006|Overall Study|Withdrawal by Subject|3|||
161205167|NCT01615822|582131297|FG000|Period 1|Withdrawal by Subject|0|||
161205168|NCT01615822|582131298|FG001|Period 1|Withdrawal by Subject|1|||
161205169|NCT01615822|582131299|FG002|Period 1|Withdrawal by Subject|0|||
161205170|NCT01615822|582131297|FG000|Period 1|Adverse Event|1|||
161205171|NCT01615822|582131298|FG001|Period 1|Adverse Event|1|||
161205172|NCT01615822|582131299|FG002|Period 1|Adverse Event|0|||
161205173|NCT01615822|582131297|FG000|Period 2|Lost to Follow-up|0|||
161205174|NCT01615822|582131298|FG001|Period 2|Lost to Follow-up|1|||
161205175|NCT01615822|582131299|FG002|Period 2|Lost to Follow-up|2|||
161205176|NCT02861534|582131300|FG000|Overall Study|Death|541|||
161205177|NCT02861534|582131301|FG001|Overall Study|Death|552|||
161205178|NCT02861534|582131300|FG000|Overall Study|Lost to Follow-up|14|||
161205179|NCT02861534|582131301|FG001|Overall Study|Lost to Follow-up|14|||
161205180|NCT02861534|582131300|FG000|Overall Study|Site Terminated by Sponsor|4|||
161205181|NCT02861534|582131301|FG001|Overall Study|Site Terminated by Sponsor|3|||
161205182|NCT02861534|582131300|FG000|Overall Study|Withdrawal by Subject|15|||
161205183|NCT02861534|582131301|FG001|Overall Study|Withdrawal by Subject|18|||
161205184|NCT02886494|582131302|FG000|Overall Study|Adverse Event|1|||
161205185|NCT02886494|582131303|FG001|Overall Study|Adverse Event|0|||
161205186|NCT02886494|582131302|FG000|Overall Study|Withdrawal by Subject|12|||
161205187|NCT02886494|582131303|FG001|Overall Study|Withdrawal by Subject|3|||
161205188|NCT02886494|582131302|FG000|Overall Study|Protocol Violation|4|||
161205189|NCT02886494|582131303|FG001|Overall Study|Protocol Violation|1|||
161205190|NCT00916617|582131306|FG000|Overall Study|Adverse Event|3|||
161205191|NCT00916617|582131307|FG001|Overall Study|Adverse Event|2|||
161205192|NCT00916617|582131308|FG002|Overall Study|Adverse Event|6|||
161205193|NCT00916617|582131309|FG003|Overall Study|Adverse Event|3|||
161205194|NCT00916617|582131306|FG000|Overall Study|Withdrawal by Subject|3|||
161205195|NCT00916617|582131307|FG001|Overall Study|Withdrawal by Subject|2|||
161205196|NCT00916617|582131308|FG002|Overall Study|Withdrawal by Subject|0|||
161205197|NCT00916617|582131309|FG003|Overall Study|Withdrawal by Subject|1|||
161205198|NCT00916617|582131306|FG000|Overall Study|Caregiver Request|3|||
161205199|NCT00916617|582131307|FG001|Overall Study|Caregiver Request|2|||
161205200|NCT00916617|582131308|FG002|Overall Study|Caregiver Request|1|||
161205201|NCT00916617|582131309|FG003|Overall Study|Caregiver Request|0|||
161205202|NCT00916617|582131306|FG000|Overall Study|Physician Decision|1|||
161205203|NCT00916617|582131307|FG001|Overall Study|Physician Decision|1|||
161205204|NCT00916617|582131308|FG002|Overall Study|Physician Decision|0|||
161205205|NCT00916617|582131309|FG003|Overall Study|Physician Decision|0|||
161205206|NCT00916617|582131306|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
161205207|NCT00916617|582131307|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
161205208|NCT00916617|582131308|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
161205209|NCT00916617|582131309|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
161205210|NCT00916617|582131306|FG000|Overall Study|Lost to Follow-up|2|||
161205211|NCT00916617|582131307|FG001|Overall Study|Lost to Follow-up|1|||
161205212|NCT00916617|582131308|FG002|Overall Study|Lost to Follow-up|0|||
161205213|NCT00916617|582131309|FG003|Overall Study|Lost to Follow-up|0|||
161205214|NCT00916617|582131306|FG000|Overall Study|Lack of Efficacy|1|||
161205215|NCT00916617|582131307|FG001|Overall Study|Lack of Efficacy|0|||
161205216|NCT00916617|582131308|FG002|Overall Study|Lack of Efficacy|0|||
161205217|NCT00916617|582131309|FG003|Overall Study|Lack of Efficacy|0|||
161205218|NCT00916617|582131306|FG000|Overall Study|Other|2|||
161205219|NCT00916617|582131307|FG001|Overall Study|Other|0|||
161205220|NCT00916617|582131308|FG002|Overall Study|Other|0|||
161205221|NCT00916617|582131309|FG003|Overall Study|Other|2|||
161205222|NCT00537056|582131313|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
161205223|NCT00244881|582131314|FG000|Overall Study|Withdrawal by Subject|3|||
161205224|NCT00445458|582131315|FG000|Overall Study|Disease Progression|3|||
161205225|NCT00445458|582131316|FG001|Overall Study|Disease Progression|4|||
161205226|NCT00445458|582131317|FG002|Overall Study|Disease Progression|54|||
161205227|NCT00445458|582131318|FG003|Overall Study|Disease Progression|27|||
161205228|NCT00445458|582131315|FG000|Overall Study|Withdrawal by Subject|0|||
161205229|NCT00445458|582131316|FG001|Overall Study|Withdrawal by Subject|0|||
161205230|NCT00445458|582131317|FG002|Overall Study|Withdrawal by Subject|7|||
161205231|NCT00445458|582131318|FG003|Overall Study|Withdrawal by Subject|0|||
161205232|NCT00445458|582131315|FG000|Overall Study|Adverse Event|0|||
161205233|NCT00445458|582131316|FG001|Overall Study|Adverse Event|0|||
161205234|NCT00445458|582131317|FG002|Overall Study|Adverse Event|3|||
161205235|NCT00445458|582131318|FG003|Overall Study|Adverse Event|0|||
161205236|NCT00445458|582131315|FG000|Overall Study|Death|0|||
161205237|NCT00445458|582131316|FG001|Overall Study|Death|1|||
161205238|NCT00445458|582131317|FG002|Overall Study|Death|2|||
161205239|NCT00445458|582131318|FG003|Overall Study|Death|0|||
161205240|NCT00445458|582131315|FG000|Overall Study|Physician Decision|0|||
161205241|NCT00445458|582131316|FG001|Overall Study|Physician Decision|0|||
161205242|NCT00445458|582131317|FG002|Overall Study|Physician Decision|1|||
161205243|NCT00445458|582131318|FG003|Overall Study|Physician Decision|1|||
161205244|NCT00445458|582131315|FG000|Overall Study|Surgery|0|||
161205245|NCT00445458|582131316|FG001|Overall Study|Surgery|0|||
161205246|NCT00445458|582131317|FG002|Overall Study|Surgery|1|||
161205247|NCT00445458|582131318|FG003|Overall Study|Surgery|0|||
161205248|NCT01393626|582131322|FG000|Overall Study|Adverse Event|2|||
161205249|NCT01393626|582131323|FG001|Overall Study|Adverse Event|1|||
161205250|NCT01393626|582131324|FG002|Overall Study|Adverse Event|5|||
161205251|NCT01393626|582131325|FG003|Overall Study|Adverse Event|0|||
161205252|NCT01393626|582131322|FG000|Overall Study|Did not meet entrance criteria|1|||
161205253|NCT01393626|582131323|FG001|Overall Study|Did not meet entrance criteria|0|||
161205254|NCT01393626|582131324|FG002|Overall Study|Did not meet entrance criteria|0|||
161205255|NCT01393626|582131325|FG003|Overall Study|Did not meet entrance criteria|0|||
161205256|NCT01393626|582131322|FG000|Overall Study|Lack of Efficacy|6|||
161205257|NCT01393626|582131323|FG001|Overall Study|Lack of Efficacy|6|||
161205258|NCT01393626|582131324|FG002|Overall Study|Lack of Efficacy|4|||
161205259|NCT01393626|582131325|FG003|Overall Study|Lack of Efficacy|1|||
161205260|NCT01393626|582131322|FG000|Overall Study|Lost to Follow-up|1|||
161205261|NCT01393626|582131323|FG001|Overall Study|Lost to Follow-up|1|||
161205262|NCT01393626|582131324|FG002|Overall Study|Lost to Follow-up|1|||
161205263|NCT01393626|582131325|FG003|Overall Study|Lost to Follow-up|0|||
161205264|NCT01393626|582131322|FG000|Overall Study|Withdrawal by Subject|6|||
161205265|NCT01393626|582131323|FG001|Overall Study|Withdrawal by Subject|4|||
161205266|NCT01393626|582131324|FG002|Overall Study|Withdrawal by Subject|0|||
161205267|NCT01393626|582131325|FG003|Overall Study|Withdrawal by Subject|0|||
161205268|NCT01393626|582131322|FG000|Overall Study|Other|1|||
161205269|NCT01393626|582131323|FG001|Overall Study|Other|0|||
161205270|NCT01393626|582131324|FG002|Overall Study|Other|0|||
161205271|NCT01393626|582131325|FG003|Overall Study|Other|0|||
161205272|NCT01393626|582131322|FG000|Overall Study|Protocol Violation|1|||
161205273|NCT01393626|582131323|FG001|Overall Study|Protocol Violation|0|||
161205274|NCT01393626|582131324|FG002|Overall Study|Protocol Violation|2|||
161205275|NCT01393626|582131325|FG003|Overall Study|Protocol Violation|0|||
161205276|NCT02426125|582131326|FG000|Overall Study|Lost to Follow-up|14|||
161205277|NCT02426125|582131327|FG001|Overall Study|Lost to Follow-up|12|||
161205278|NCT02426125|582131326|FG000|Overall Study|Withdrawal by Subject|13|||
161205279|NCT02426125|582131327|FG001|Overall Study|Withdrawal by Subject|14|||
161205280|NCT02426125|582131326|FG000|Overall Study|Death|185|||
161205281|NCT02426125|582131327|FG001|Overall Study|Death|200|||
161205282|NCT02426125|582131326|FG000|Overall Study|Randomized, But Never Treated|5|||
161205283|NCT02426125|582131327|FG001|Overall Study|Randomized, But Never Treated|2|||
161205284|NCT00077766|582131330|FG000|Overall Study|Adverse Event|1|||
161205285|NCT00077766|582131331|FG001|Overall Study|Adverse Event|1|||
161205286|NCT00077766|582131330|FG000|Overall Study|Withdrawal by Subject|4|||
161205287|NCT00077766|582131331|FG001|Overall Study|Withdrawal by Subject|3|||
161205288|NCT00077766|582131330|FG000|Overall Study|Death|12|||
161205289|NCT00077766|582131331|FG001|Overall Study|Death|10|||
161205290|NCT00077766|582131330|FG000|Overall Study|Lost to Follow-up|2|||
161205291|NCT00077766|582131331|FG001|Overall Study|Lost to Follow-up|0|||
161205292|NCT00077766|582131330|FG000|Overall Study|Protocol Violation|1|||
161205293|NCT00077766|582131331|FG001|Overall Study|Protocol Violation|0|||
161310749|NCT00150800|582518700|FG000|Overall Study|PI discontinuation request|1|||
161310750|NCT03649178|582518701|FG000|Overall Study|Adverse Event|1|||
161310751|NCT03649178|582518702|FG001|Overall Study|Adverse Event|2|||
161310752|NCT03649178|582518701|FG000|Overall Study|Withdrawal by Subject|0|||
161205294|NCT00077766|582131330|FG000|Overall Study|Kidney Transplantation|9|||
161205295|NCT00077766|582131331|FG001|Overall Study|Kidney Transplantation|5|||
161205296|NCT00077766|582131330|FG000|Overall Study|Transplantation|5|||
161205297|NCT00077766|582131331|FG001|Overall Study|Transplantation|1|||
161205298|NCT00077766|582131330|FG000|Overall Study|Investigators Discretion|1|||
161205299|NCT00077766|582131331|FG001|Overall Study|Investigators Discretion|0|||
161205300|NCT00077766|582131330|FG000|Overall Study|Participant's decision|1|||
161205301|NCT00077766|582131331|FG001|Overall Study|Participant's decision|0|||
161205302|NCT00077766|582131330|FG000|Overall Study|Dialysis Discontinued|1|||
161205303|NCT00077766|582131331|FG001|Overall Study|Dialysis Discontinued|0|||
161205304|NCT00077766|582131330|FG000|Overall Study|Dialysis|0|||
161205305|NCT00077766|582131331|FG001|Overall Study|Dialysis|1|||
161205306|NCT00077766|582131330|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
161205307|NCT00077766|582131331|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
161205308|NCT00077766|582131330|FG000|Overall Study|Started Nocturnal Dialysis|0|||
161205309|NCT00077766|582131331|FG001|Overall Study|Started Nocturnal Dialysis|1|||
161205310|NCT00077766|582131330|FG000|Overall Study|Stop Dialysis|0|||
161205311|NCT00077766|582131331|FG001|Overall Study|Stop Dialysis|1|||
161205312|NCT00077766|582131330|FG000|Overall Study|Participants Vacation|2|||
161205313|NCT00077766|582131331|FG001|Overall Study|Participants Vacation|1|||
161205314|NCT02575807|582131336|FG000|Overall Study|Death|8|||
161205315|NCT02575807|582131337|FG001|Overall Study|Death|3|||
161205316|NCT02575807|582131338|FG002|Overall Study|Death|7|||
161205317|NCT02575807|582131339|FG003|Overall Study|Death|0|||
161205318|NCT02575807|582131340|FG004|Overall Study|Death|1|||
161205319|NCT02575807|582131336|FG000|Overall Study|Study terminated by Sponsor|0|||
161205320|NCT02575807|582131337|FG001|Overall Study|Study terminated by Sponsor|1|||
161205321|NCT02575807|582131338|FG002|Overall Study|Study terminated by Sponsor|7|||
161205322|NCT02575807|582131339|FG003|Overall Study|Study terminated by Sponsor|0|||
161205323|NCT02575807|582131340|FG004|Overall Study|Study terminated by Sponsor|1|||
161205324|NCT02575807|582131336|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
161205325|NCT02575807|582131337|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
161205326|NCT02575807|582131338|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
161205327|NCT02575807|582131339|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
161205328|NCT02575807|582131340|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
161205329|NCT02575807|582131336|FG000|Overall Study|Terminated due to physician decision|0|||
161205330|NCT02575807|582131337|FG001|Overall Study|Terminated due to physician decision|0|||
161205331|NCT02575807|582131338|FG002|Overall Study|Terminated due to physician decision|1|||
161205332|NCT02575807|582131339|FG003|Overall Study|Terminated due to physician decision|0|||
161205333|NCT02575807|582131340|FG004|Overall Study|Terminated due to physician decision|0|||
161205334|NCT02575807|582131336|FG000|Overall Study|Subject ineligible - medical implant|0|||
161205335|NCT02575807|582131337|FG001|Overall Study|Subject ineligible - medical implant|0|||
161205336|NCT02575807|582131338|FG002|Overall Study|Subject ineligible - medical implant|0|||
161205337|NCT02575807|582131339|FG003|Overall Study|Subject ineligible - medical implant|1|||
161205338|NCT02575807|582131340|FG004|Overall Study|Subject ineligible - medical implant|0|||
161205339|NCT02575807|582131336|FG000|Overall Study|Withdrawal by Subject|0|||
161205340|NCT02575807|582131337|FG001|Overall Study|Withdrawal by Subject|0|||
161205341|NCT02575807|582131338|FG002|Overall Study|Withdrawal by Subject|1|||
161205342|NCT02575807|582131339|FG003|Overall Study|Withdrawal by Subject|1|||
161205343|NCT02575807|582131340|FG004|Overall Study|Withdrawal by Subject|2|||
161205344|NCT02180659|582131341|FG000|Overall Study|Adverse Event|1|||
161205345|NCT02180659|582131342|FG001|Overall Study|Adverse Event|0|||
161205346|NCT02180659|582131341|FG000|Overall Study|Lost to Follow-up|4|||
161205347|NCT02180659|582131342|FG001|Overall Study|Lost to Follow-up|2|||
161205348|NCT02180659|582131341|FG000|Overall Study|Subject incarcerated during conduct|1|||
161205349|NCT02180659|582131342|FG001|Overall Study|Subject incarcerated during conduct|0|||
161205350|NCT02180659|582131341|FG000|Overall Study|Withdrawal by Subject|0|||
161205351|NCT02180659|582131342|FG001|Overall Study|Withdrawal by Subject|2|||
161205352|NCT02180659|582131341|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
161205353|NCT02180659|582131342|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
161310753|NCT03649178|582518702|FG001|Overall Study|Withdrawal by Subject|2|||
161310754|NCT03649178|582518701|FG000|Overall Study|COVID regulation required halt in protocol|1|||
161310755|NCT03649178|582518702|FG001|Overall Study|COVID regulation required halt in protocol|0|||
161310756|NCT01095978|582518707|FG000|Overall Study|Did not take Klacid SR|2|||
161310757|NCT01095978|582518707|FG000|Overall Study|Adverse Event|1|||
161310758|NCT00710684|582518713|FG000|Overall Study|Adverse Event|11|||
161310759|NCT00710684|582518714|FG001|Overall Study|Adverse Event|19|||
161310760|NCT00710684|582518715|FG002|Overall Study|Adverse Event|16|||
161310761|NCT00710684|582518713|FG000|Overall Study|Lack of Efficacy|4|||
161310762|NCT00710684|582518714|FG001|Overall Study|Lack of Efficacy|3|||
161310763|NCT00710684|582518715|FG002|Overall Study|Lack of Efficacy|5|||
161310764|NCT00710684|582518713|FG000|Overall Study|Protocol Violation|5|||
161310765|NCT00710684|582518714|FG001|Overall Study|Protocol Violation|5|||
161310766|NCT00710684|582518715|FG002|Overall Study|Protocol Violation|5|||
161310767|NCT00710684|582518713|FG000|Overall Study|Lost to Follow-up|4|||
161310768|NCT00710684|582518714|FG001|Overall Study|Lost to Follow-up|6|||
161310769|NCT00710684|582518715|FG002|Overall Study|Lost to Follow-up|7|||
161310770|NCT00710684|582518713|FG000|Overall Study|Physician Decision|0|||
161310771|NCT00710684|582518714|FG001|Overall Study|Physician Decision|2|||
161310772|NCT00710684|582518715|FG002|Overall Study|Physician Decision|4|||
161310773|NCT00710684|582518713|FG000|Overall Study|Withdrawal by Subject|24|||
161205354|NCT01154673|582131343|FG000|Overall Study|Lost to Follow-up|1|||
161205355|NCT01154673|582131344|FG001|Overall Study|Lost to Follow-up|0|||
161310774|NCT00710684|582518714|FG001|Overall Study|Withdrawal by Subject|18|||
161310775|NCT00710684|582518715|FG002|Overall Study|Withdrawal by Subject|11|||
161310776|NCT00710684|582518713|FG000|Overall Study|Missing|1|||
161310777|NCT00710684|582518714|FG001|Overall Study|Missing|0|||
161310778|NCT00710684|582518715|FG002|Overall Study|Missing|0|||
161310779|NCT00710684|582518713|FG000|Overall Study|Did not continue after week 24|25|||
161205356|NCT01154673|582131343|FG000|Overall Study|moved out of province|1|||
161205357|NCT01154673|582131344|FG001|Overall Study|moved out of province|0|||
161205358|NCT01216319|582131349|FG000|Overall Study|Lost to Follow-up|2|||
161205359|NCT01216319|582131349|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
161205360|NCT03128931|582131351|FG000|Overall Study|Physician Decision|1|||
161205361|NCT03128931|582131351|FG000|Overall Study|Equipment Issues|3|||
161205362|NCT03151226|582131352|FG000|Overall Study|Withdrawal by Subject|2|||
161205363|NCT03151226|582131352|FG000|Overall Study|not wear device correctly|1|||
161205364|NCT00903409|582131353|FG000|Overall Study|Adverse Event|11|||
161205365|NCT00903409|582131354|FG001|Overall Study|Adverse Event|9|||
161205366|NCT00903409|582131353|FG000|Overall Study|Non-compliance with Protocol|1|||
161205367|NCT00903409|582131354|FG001|Overall Study|Non-compliance with Protocol|1|||
161205368|NCT00903409|582131353|FG000|Overall Study|Laboratory Abnormality|2|||
161205369|NCT00903409|582131354|FG001|Overall Study|Laboratory Abnormality|0|||
161205370|NCT00903409|582131353|FG000|Overall Study|Withdrawal by Subject|8|||
161205371|NCT00903409|582131354|FG001|Overall Study|Withdrawal by Subject|8|||
161205372|NCT00903409|582131353|FG000|Overall Study|Other|2|||
161205373|NCT00903409|582131354|FG001|Overall Study|Other|3|||
161205374|NCT00903409|582131353|FG000|Overall Study|Lost to Follow-up|2|||
161205375|NCT00903409|582131354|FG001|Overall Study|Lost to Follow-up|6|||
161205376|NCT00797316|582131355|FG000|Overall Study|Administrative problems|1|||
161205377|NCT00797316|582131356|FG001|Overall Study|Administrative problems|0|||
161205378|NCT00797316|582131355|FG000|Overall Study|Adverse Event|5|||
161205379|NCT00797316|582131356|FG001|Overall Study|Adverse Event|3|||
161205380|NCT00797316|582131355|FG000|Overall Study|Lost to Follow-up|4|||
161205381|NCT00797316|582131356|FG001|Overall Study|Lost to Follow-up|8|||
161205382|NCT00797316|582131355|FG000|Overall Study|Protocol Deviation|1|||
161205383|NCT00797316|582131356|FG001|Overall Study|Protocol Deviation|2|||
161205384|NCT00797316|582131355|FG000|Overall Study|Patient withdrew consent|12|||
161205385|NCT00797316|582131356|FG001|Overall Study|Patient withdrew consent|6|||
161205386|NCT00797316|582131355|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
161205387|NCT00797316|582131356|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
161205388|NCT00402779|582131359|FG000|Overall Study|Screen Failure|77|||
161205389|NCT00402779|582131360|FG001|Overall Study|Screen Failure|76|||
161205390|NCT03239340|582131361|FG000|Overall Study|Other|26|||
161205391|NCT03239340|582131361|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
161310780|NCT00710684|582518714|FG001|Overall Study|Did not continue after week 24|21|||
161310781|NCT00710684|582518715|FG002|Overall Study|Did not continue after week 24|16|||
161310782|NCT04778059|582518716|FG000|Overall Study|Death|2|||
161310783|NCT04778059|582518717|FG001|Overall Study|Death|2|||
161310784|NCT04778059|582518718|FG002|Overall Study|Death|1|||
161310785|NCT04778059|582518719|FG003|Overall Study|Death|1|||
161310786|NCT04778059|582518720|FG004|Overall Study|Death|1|||
161310787|NCT04778059|582518716|FG000|Overall Study|Lost to Follow-up|0|||
161310788|NCT04778059|582518717|FG001|Overall Study|Lost to Follow-up|0|||
161310789|NCT04778059|582518718|FG002|Overall Study|Lost to Follow-up|0|||
161310790|NCT04778059|582518719|FG003|Overall Study|Lost to Follow-up|0|||
161310791|NCT04778059|582518720|FG004|Overall Study|Lost to Follow-up|1|||
161310792|NCT04778059|582518716|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
161310793|NCT04778059|582518717|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
161310794|NCT04778059|582518718|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
161310795|NCT04778059|582518719|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
161310796|NCT04778059|582518720|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
161310797|NCT02832375|582518721|FG000|Overall Study|Lost to Follow-up|1|||
161310798|NCT02832375|582518722|FG001|Overall Study|Lost to Follow-up|0|||
161310799|NCT02832375|582518721|FG000|Overall Study|Withdrawal of Consent|1|||
161310800|NCT02832375|582518722|FG001|Overall Study|Withdrawal of Consent|0|||
161310801|NCT00514904|582518723|FG000|Overall Study|Withdrawal by Subject|3|||
161310802|NCT00514904|582518724|FG001|Overall Study|Withdrawal by Subject|2|||
161310803|NCT00514904|582518723|FG000|Overall Study|Lost to Follow-up|21|||
161310804|NCT00514904|582518724|FG001|Overall Study|Lost to Follow-up|3|||
161310805|NCT00084318|582518725|FG000|Overall Study|Withdrawal by Subject|5|||
161310806|NCT00084318|582518726|FG001|Overall Study|Withdrawal by Subject|2|||
161310807|NCT00084318|582518725|FG000|Overall Study|Protocol Violation|15|||
161310808|NCT00084318|582518726|FG001|Overall Study|Protocol Violation|11|||
161310809|NCT00084318|582518725|FG000|Overall Study|No protocol treatment|2|||
161310810|NCT00084318|582518726|FG001|Overall Study|No protocol treatment|0|||
161310811|NCT00549601|582520395|FG000|Randomized|Protocol Violation|0|||
161310812|NCT00549601|582520396|FG001|Randomized|Protocol Violation|0|||
161310813|NCT00549601|582520397|FG002|Randomized|Protocol Violation|1|||
161310814|NCT00549601|582520395|FG000|Randomized|Withdrawal by Subject|0|||
161310815|NCT00549601|582520396|FG001|Randomized|Withdrawal by Subject|1|||
161310816|NCT00549601|582520397|FG002|Randomized|Withdrawal by Subject|1|||
161205392|NCT03239340|582131361|FG000|Overall Study|Death|40|||
161205393|NCT03239340|582131361|FG000|Overall Study|Lost to Follow-up|2|||
161310817|NCT00549601|582520395|FG000|Received Study Drug|Adverse Event|2|||
161310818|NCT00549601|582520396|FG001|Received Study Drug|Adverse Event|5|||
161205394|NCT03239340|582131361|FG000|Overall Study|Physician Decision|16|||
161205395|NCT03239340|582131361|FG000|Overall Study|Withdrawal by Subject|27|||
161205396|NCT03539952|582131363|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
161205397|NCT03539952|582131364|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
161205398|NCT03539952|582131363|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
161205399|NCT03539952|582131364|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
161205400|NCT03539952|582131363|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
161205401|NCT03539952|582131364|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
161205402|NCT03539952|582131363|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
161205403|NCT03539952|582131364|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
161205404|NCT03539952|582131363|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
161205405|NCT03539952|582131364|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
161205406|NCT03539952|582131363|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
161205407|NCT03539952|582131364|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
161205408|NCT03539952|582131363|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
161205409|NCT03539952|582131364|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
161205410|NCT02184988|582131365|FG000|Overall Study|Pregnancy|2|||
161205411|NCT02184988|582131365|FG000|Overall Study|Adverse Event|2|||
161205412|NCT02184988|582131365|FG000|Overall Study|moving away/travelling/unable to complet|6|||
161205413|NCT02184988|582131365|FG000|Overall Study|work scheduling issues|4|||
161205414|NCT02184988|582131365|FG000|Overall Study|various other reasons|9|||
161205415|NCT02184988|582131365|FG000|Overall Study|Lost to Follow-up|32|||
161205416|NCT03075215|582131366|FG000|12-Month Primary Endpoint|Death|152|||
161205417|NCT03075215|582131366|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
161205418|NCT03075215|582131366|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
161205419|NCT03075215|582131366|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
161205420|NCT02146365|582131369|FG000|Overall Study|Lost to Follow-up|2|||
161205421|NCT02146365|582131370|FG001|Overall Study|Lost to Follow-up|1|||
161205422|NCT02146365|582131371|FG002|Overall Study|Lost to Follow-up|3|||
161310819|NCT00549601|582520397|FG002|Received Study Drug|Adverse Event|1|||
161310820|NCT00549601|582520395|FG000|Received Study Drug|Death|0|||
161310821|NCT00549601|582520396|FG001|Received Study Drug|Death|1|||
161310822|NCT00549601|582520397|FG002|Received Study Drug|Death|0|||
161310823|NCT00549601|582520395|FG000|Received Study Drug|Lost to Follow-up|0|||
161310824|NCT00549601|582520396|FG001|Received Study Drug|Lost to Follow-up|1|||
161310825|NCT00549601|582520397|FG002|Received Study Drug|Lost to Follow-up|1|||
161310826|NCT00549601|582520395|FG000|Received Study Drug|Protocol Violation|3|||
161310827|NCT00549601|582520396|FG001|Received Study Drug|Protocol Violation|4|||
161310828|NCT00549601|582520397|FG002|Received Study Drug|Protocol Violation|1|||
161310829|NCT00549601|582520395|FG000|Received Study Drug|Withdrawal by Subject|2|||
161310830|NCT00549601|582520396|FG001|Received Study Drug|Withdrawal by Subject|0|||
161310831|NCT00549601|582520397|FG002|Received Study Drug|Withdrawal by Subject|1|||
161205423|NCT02146365|582131372|FG003|Overall Study|Lost to Follow-up|3|||
161205424|NCT02146365|582131373|FG004|Overall Study|Lost to Follow-up|1|||
161205425|NCT02146365|582131374|FG005|Overall Study|Lost to Follow-up|1|||
161310832|NCT01458951|582520415|FG000|Overall Study|Other|1|||
161310833|NCT01458951|582520416|FG001|Overall Study|Other|0|||
161310834|NCT01458951|582520417|FG002|Overall Study|Other|0|||
161310835|NCT01458951|582520415|FG000|Overall Study|Protocol Violation|5|||
161205426|NCT02146365|582131375|FG006|Overall Study|Lost to Follow-up|0|||
161205427|NCT02146365|582131376|FG007|Overall Study|Lost to Follow-up|1|||
161205428|NCT02146365|582131369|FG000|Overall Study|Withdrawal by Subject|1|||
161205429|NCT02146365|582131370|FG001|Overall Study|Withdrawal by Subject|2|||
161205430|NCT02146365|582131371|FG002|Overall Study|Withdrawal by Subject|1|||
161205431|NCT02146365|582131372|FG003|Overall Study|Withdrawal by Subject|5|||
161205432|NCT02146365|582131373|FG004|Overall Study|Withdrawal by Subject|1|||
161205433|NCT02146365|582131374|FG005|Overall Study|Withdrawal by Subject|0|||
161205434|NCT02146365|582131375|FG006|Overall Study|Withdrawal by Subject|0|||
161205435|NCT02146365|582131376|FG007|Overall Study|Withdrawal by Subject|0|||
161205436|NCT02146365|582131369|FG000|Overall Study|Unable to Comply with Protocol|0|||
161205437|NCT02146365|582131370|FG001|Overall Study|Unable to Comply with Protocol|1|||
161205438|NCT02146365|582131371|FG002|Overall Study|Unable to Comply with Protocol|1|||
161205439|NCT02146365|582131372|FG003|Overall Study|Unable to Comply with Protocol|0|||
161205440|NCT02146365|582131373|FG004|Overall Study|Unable to Comply with Protocol|0|||
161205441|NCT02146365|582131374|FG005|Overall Study|Unable to Comply with Protocol|0|||
161205442|NCT02146365|582131375|FG006|Overall Study|Unable to Comply with Protocol|0|||
161205443|NCT02146365|582131376|FG007|Overall Study|Unable to Comply with Protocol|0|||
161205444|NCT02146365|582131369|FG000|Overall Study|Other|1|||
161205445|NCT02146365|582131370|FG001|Overall Study|Other|0|||
161205446|NCT02146365|582131371|FG002|Overall Study|Other|2|||
161205447|NCT02146365|582131372|FG003|Overall Study|Other|1|||
161205448|NCT02146365|582131373|FG004|Overall Study|Other|0|||
161205449|NCT02146365|582131374|FG005|Overall Study|Other|0|||
161205450|NCT02146365|582131375|FG006|Overall Study|Other|0|||
161205451|NCT02146365|582131376|FG007|Overall Study|Other|0|||
161205452|NCT05378269|582133536|FG000|Overall Study|Protocol Violation|1|||
161205453|NCT05378269|582133537|FG001|Overall Study|Protocol Violation|0|||
161205454|NCT05378269|582133538|FG002|Overall Study|Protocol Violation|2|||
161205455|NCT05378269|582133539|FG003|Overall Study|Protocol Violation|0|||
161205456|NCT05378269|582133540|FG004|Overall Study|Protocol Violation|0|||
161205457|NCT03256526|582133541|FG000|Overall Study|Adverse Event|1|||
161205458|NCT03256526|582133542|FG001|Overall Study|Adverse Event|0|||
161205459|NCT03256526|582133543|FG002|Overall Study|Adverse Event|1|||
161205460|NCT03256526|582133541|FG000|Overall Study|Lost to Follow-up|1|||
161205461|NCT03256526|582133542|FG001|Overall Study|Lost to Follow-up|0|||
161205462|NCT03256526|582133543|FG002|Overall Study|Lost to Follow-up|2|||
161205463|NCT00891527|582133544|FG000|Overall Study|Withdrawal by Subject|2|||
161205464|NCT01186744|582133545|FG000|Overall Study|Lack of Efficacy|156|||
161205465|NCT01186744|582133546|FG001|Overall Study|Lack of Efficacy|99|||
161205466|NCT01186744|582133547|FG002|Overall Study|Lack of Efficacy|0|||
161205467|NCT01186744|582133548|FG003|Overall Study|Lack of Efficacy|2|||
161205468|NCT01186744|582133549|FG004|Overall Study|Lack of Efficacy|2|||
161205469|NCT01186744|582133550|FG005|Overall Study|Lack of Efficacy|5|||
161205470|NCT01186744|582133545|FG000|Overall Study|Protocol Violation|1|||
161205471|NCT01186744|582133546|FG001|Overall Study|Protocol Violation|2|||
161205472|NCT01186744|582133547|FG002|Overall Study|Protocol Violation|0|||
161205473|NCT01186744|582133548|FG003|Overall Study|Protocol Violation|1|||
161205474|NCT01186744|582133549|FG004|Overall Study|Protocol Violation|1|||
161205475|NCT01186744|582133550|FG005|Overall Study|Protocol Violation|2|||
161205476|NCT01186744|582133545|FG000|Overall Study|Lost to Follow-up|15|||
161205477|NCT01186744|582133546|FG001|Overall Study|Lost to Follow-up|16|||
161205478|NCT01186744|582133547|FG002|Overall Study|Lost to Follow-up|2|||
161205479|NCT01186744|582133548|FG003|Overall Study|Lost to Follow-up|1|||
161205480|NCT01186744|582133549|FG004|Overall Study|Lost to Follow-up|1|||
161205481|NCT01186744|582133550|FG005|Overall Study|Lost to Follow-up|4|||
161205482|NCT01186744|582133545|FG000|Overall Study|Screen failure|1|||
161205483|NCT01186744|582133546|FG001|Overall Study|Screen failure|1|||
161205484|NCT01186744|582133547|FG002|Overall Study|Screen failure|0|||
161205485|NCT01186744|582133548|FG003|Overall Study|Screen failure|1|||
161205486|NCT01186744|582133549|FG004|Overall Study|Screen failure|0|||
161205487|NCT01186744|582133550|FG005|Overall Study|Screen failure|0|||
161205488|NCT01186744|582133545|FG000|Overall Study|Withdrawal by Subject|14|||
161205489|NCT01186744|582133546|FG001|Overall Study|Withdrawal by Subject|10|||
161205490|NCT01186744|582133547|FG002|Overall Study|Withdrawal by Subject|2|||
161205491|NCT01186744|582133548|FG003|Overall Study|Withdrawal by Subject|5|||
161205492|NCT01186744|582133549|FG004|Overall Study|Withdrawal by Subject|0|||
161205493|NCT01186744|582133550|FG005|Overall Study|Withdrawal by Subject|6|||
161205494|NCT01186744|582133545|FG000|Overall Study|Study terminated by Sponsor|1|||
161205495|NCT01186744|582133546|FG001|Overall Study|Study terminated by Sponsor|0|||
161205496|NCT01186744|582133547|FG002|Overall Study|Study terminated by Sponsor|0|||
161205497|NCT01186744|582133548|FG003|Overall Study|Study terminated by Sponsor|0|||
161205498|NCT01186744|582133549|FG004|Overall Study|Study terminated by Sponsor|0|||
161205499|NCT01186744|582133550|FG005|Overall Study|Study terminated by Sponsor|0|||
161205500|NCT01186744|582133545|FG000|Overall Study|Other|9|||
161205501|NCT01186744|582133546|FG001|Overall Study|Other|10|||
161205502|NCT01186744|582133547|FG002|Overall Study|Other|1|||
161205503|NCT01186744|582133548|FG003|Overall Study|Other|2|||
161205504|NCT01186744|582133549|FG004|Overall Study|Other|1|||
161205505|NCT01186744|582133550|FG005|Overall Study|Other|5|||
161205506|NCT01186744|582133545|FG000|Overall Study|Adverse Event|10|||
161205507|NCT01186744|582133546|FG001|Overall Study|Adverse Event|14|||
161205508|NCT01186744|582133547|FG002|Overall Study|Adverse Event|1|||
161205509|NCT01186744|582133548|FG003|Overall Study|Adverse Event|0|||
161205510|NCT01186744|582133549|FG004|Overall Study|Adverse Event|1|||
161205511|NCT01186744|582133550|FG005|Overall Study|Adverse Event|4|||
161205512|NCT01186744|582133545|FG000|Overall Study|Death|1|||
161205513|NCT01186744|582133546|FG001|Overall Study|Death|0|||
161205514|NCT01186744|582133547|FG002|Overall Study|Death|0|||
161205515|NCT01186744|582133548|FG003|Overall Study|Death|0|||
161205516|NCT01186744|582133549|FG004|Overall Study|Death|0|||
161205517|NCT01186744|582133550|FG005|Overall Study|Death|0|||
161205518|NCT02406742|582133554|FG000|Overall Study|Progression of Disease|5|||
161205519|NCT02406742|582133555|FG001|Overall Study|Progression of Disease|1|||
161205520|NCT02406742|582133556|FG002|Overall Study|Progression of Disease|6|||
161205521|NCT02406742|582133554|FG000|Overall Study|Adverse Event|3|||
161205522|NCT02406742|582133555|FG001|Overall Study|Adverse Event|0|||
161205523|NCT02406742|582133556|FG002|Overall Study|Adverse Event|2|||
161205524|NCT02406742|582133554|FG000|Overall Study|Death|1|||
161205525|NCT02406742|582133555|FG001|Overall Study|Death|0|||
161205526|NCT02406742|582133556|FG002|Overall Study|Death|0|||
161205527|NCT02406742|582133554|FG000|Overall Study|Lack of Efficacy|0|||
161205528|NCT02406742|582133555|FG001|Overall Study|Lack of Efficacy|0|||
161205529|NCT02406742|582133556|FG002|Overall Study|Lack of Efficacy|1|||
161205530|NCT02406742|582133554|FG000|Overall Study|Withdrawal by Participant|1|||
161205531|NCT02406742|582133555|FG001|Overall Study|Withdrawal by Participant|2|||
161205532|NCT02406742|582133556|FG002|Overall Study|Withdrawal by Participant|0|||
161205533|NCT02406742|582133554|FG000|Overall Study|Physician Decision|1|||
161205534|NCT02406742|582133555|FG001|Overall Study|Physician Decision|2|||
161205535|NCT02406742|582133556|FG002|Overall Study|Physician Decision|1|||
161205536|NCT02406742|582133554|FG000|Overall Study|Transition to other treatment|2|||
161205537|NCT02406742|582133555|FG001|Overall Study|Transition to other treatment|0|||
161205538|NCT02406742|582133556|FG002|Overall Study|Transition to other treatment|1|||
161205539|NCT02406742|582133554|FG000|Overall Study|Other Reasons|1|||
161205540|NCT02406742|582133555|FG001|Overall Study|Other Reasons|11|||
161205541|NCT02406742|582133556|FG002|Overall Study|Other Reasons|5|||
161205542|NCT00765999|582133557|FG000|Overall Study|Adverse Event|203|||
161205543|NCT00765999|582133557|FG000|Overall Study|Insufficient Therapeutic Response|100|||
161205544|NCT00765999|582133557|FG000|Overall Study|Protocol Violation|95|||
161205545|NCT00765999|582133557|FG000|Overall Study|Consent Withdrawn|202|||
161205546|NCT00765999|582133557|FG000|Overall Study|Lost to Follow-up|131|||
161205547|NCT00765999|582133557|FG000|Overall Study|Study Terminated by Sponsor|2|||
161205548|NCT00765999|582133557|FG000|Overall Study|Other Miscellaneous Reasons|51|||
161205549|NCT02367729|582133560|FG000|Overall Study|Organic disorder diagnosed|2|||
161205550|NCT02367729|582133561|FG001|Overall Study|Organic disorder diagnosed|1|||
161205551|NCT02367729|582133560|FG000|Overall Study|Adverse Event|1|||
161205552|NCT02367729|582133561|FG001|Overall Study|Adverse Event|2|||
161205553|NCT02367729|582133560|FG000|Overall Study|Withdrawal by Subject|0|||
161205554|NCT02367729|582133561|FG001|Overall Study|Withdrawal by Subject|5|||
161205555|NCT00759174|582133562|FG000|Overall Study|Other|0|||
161205556|NCT00759174|582133563|FG001|Overall Study|Other|2|||
161205557|NCT01890109|582133564|FG000|Overall Study|Withdrawal by Subject|0|||
161205558|NCT01890109|582133565|FG001|Overall Study|Withdrawal by Subject|3|||
161205559|NCT01890109|582133564|FG000|Overall Study|Lost to Follow-up|1|||
161205560|NCT01890109|582133565|FG001|Overall Study|Lost to Follow-up|2|||
161205561|NCT01643928|582133566|FG000|Overall Study|Lost to Follow-up|1|||
161205562|NCT01643928|582133567|FG001|Overall Study|Lost to Follow-up|0|||
161205563|NCT01643928|582133568|FG002|Overall Study|Lost to Follow-up|2|||
161205564|NCT01643928|582133569|FG003|Overall Study|Lost to Follow-up|0|||
161205565|NCT01643928|582133570|FG004|Overall Study|Lost to Follow-up|0|||
161205566|NCT01643928|582133566|FG000|Overall Study|Withdrawal by Subject|2|||
161205567|NCT01643928|582133567|FG001|Overall Study|Withdrawal by Subject|0|||
161205568|NCT01643928|582133568|FG002|Overall Study|Withdrawal by Subject|0|||
161205569|NCT01643928|582133569|FG003|Overall Study|Withdrawal by Subject|1|||
161205570|NCT01643928|582133570|FG004|Overall Study|Withdrawal by Subject|0|||
161205571|NCT01643928|582133566|FG000|Overall Study|Pregnancy|0|||
161205572|NCT01643928|582133567|FG001|Overall Study|Pregnancy|0|||
161205573|NCT01643928|582133568|FG002|Overall Study|Pregnancy|0|||
161205574|NCT01643928|582133569|FG003|Overall Study|Pregnancy|1|||
161310836|NCT01458951|582520416|FG001|Overall Study|Protocol Violation|1|||
161310837|NCT01458951|582520417|FG002|Overall Study|Protocol Violation|0|||
161310838|NCT01458951|582520415|FG000|Overall Study|Withdrawal by Subject|2|||
161310839|NCT01458951|582520416|FG001|Overall Study|Withdrawal by Subject|0|||
161310840|NCT01458951|582520417|FG002|Overall Study|Withdrawal by Subject|2|||
161310841|NCT01458951|582520415|FG000|Overall Study|Adverse Event|7|||
161310842|NCT01458951|582520416|FG001|Overall Study|Adverse Event|0|||
161310843|NCT01458951|582520417|FG002|Overall Study|Adverse Event|2|||
161310844|NCT01458951|582520415|FG000|Overall Study|Insufficient Clinical Response|17|||
161310845|NCT01458951|582520416|FG001|Overall Study|Insufficient Clinical Response|0|||
161310846|NCT01458951|582520417|FG002|Overall Study|Insufficient Clinical Response|11|||
161310847|NCT01846221|582520420|FG000|Overall Study|Catheter Failure|2|||
161310848|NCT01846221|582520421|FG001|Overall Study|Catheter Failure|0|||
161310849|NCT01846221|582520420|FG000|Overall Study|Age Exclusion|1|||
161310850|NCT01846221|582520421|FG001|Overall Study|Age Exclusion|0|||
161310851|NCT04392167|582520422|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
161310852|NCT03427268|582520423|FG000|Overall Study|Progressive disease|25|||
161310853|NCT03427268|582520423|FG000|Overall Study|Never treated|2|||
161310854|NCT03427268|582520423|FG000|Overall Study|Compassionate use|1|||
161310855|NCT03427268|582520423|FG000|Overall Study|Withdrawal by Subject|1|||
161310856|NCT03427268|582520423|FG000|Overall Study|Adverse Event|3|||
161310857|NCT03117881|582520424|FG000|Baseline|Withdrawal by Subject|21|||
161310858|NCT03117881|582520425|FG001|Baseline|Withdrawal by Subject|10|||
161310859|NCT03117881|582520426|FG002|Baseline|Withdrawal by Subject|0|||
161310860|NCT03117881|582520424|FG000|Baseline|Lost to Follow-up|22|||
161310861|NCT03117881|582520425|FG001|Baseline|Lost to Follow-up|25|||
161310862|NCT03117881|582520426|FG002|Baseline|Lost to Follow-up|0|||
161310863|NCT03117881|582520424|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
161310864|NCT03117881|582520425|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
161310865|NCT03117881|582520426|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
161310866|NCT03117881|582520424|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
161310867|NCT03117881|582520425|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
161310868|NCT03117881|582520426|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
161310869|NCT03117881|582520424|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
161310870|NCT03117881|582520425|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
161310871|NCT03117881|582520426|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
161310872|NCT03117881|582520424|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
161310873|NCT03117881|582520425|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
161310874|NCT03117881|582520426|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
161310875|NCT03117881|582520424|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
161310876|NCT03117881|582520425|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
161310877|NCT03117881|582520426|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
161310878|NCT03117881|582520424|FG000|6-Month Follow-Up|Did not complete test|53|||
161310879|NCT03117881|582520425|FG001|6-Month Follow-Up|Did not complete test|25|||
161310880|NCT03117881|582520426|FG002|6-Month Follow-Up|Did not complete test|7|||
161310881|NCT03117881|582520424|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
161310882|NCT03117881|582520425|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
161310883|NCT03117881|582520426|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
161310884|NCT03117881|582520424|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
161310885|NCT03117881|582520425|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
161310886|NCT03117881|582520426|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
161310887|NCT03117881|582520424|FG000|12-Month Follow-Up|Did not complete test|40|||
161310888|NCT03117881|582520425|FG001|12-Month Follow-Up|Did not complete test|0|||
161310889|NCT03117881|582520426|FG002|12-Month Follow-Up|Did not complete test|0|||
161310890|NCT04076059|582520432|FG000|Double Blind Phase|Progressive disease|22|||
161310891|NCT04076059|582520433|FG001|Double Blind Phase|Progressive disease|26|||
161310892|NCT04076059|582520434|FG002|Double Blind Phase|Progressive disease|0|||
161310893|NCT04076059|582520432|FG000|Double Blind Phase|Withdrawal by Subject|4|||
161310894|NCT04076059|582520433|FG001|Double Blind Phase|Withdrawal by Subject|11|||
161310895|NCT04076059|582520434|FG002|Double Blind Phase|Withdrawal by Subject|0|||
161310896|NCT04076059|582520432|FG000|Double Blind Phase|Death|1|||
161310897|NCT04076059|582520433|FG001|Double Blind Phase|Death|1|||
161310898|NCT04076059|582520434|FG002|Double Blind Phase|Death|0|||
161310899|NCT04076059|582520432|FG000|Double Blind Phase|Lost to Follow-up|1|||
161310900|NCT04076059|582520433|FG001|Double Blind Phase|Lost to Follow-up|0|||
161310901|NCT04076059|582520434|FG002|Double Blind Phase|Lost to Follow-up|0|||
161310902|NCT04076059|582520432|FG000|Double Blind Phase|Adverse Event|5|||
161310903|NCT04076059|582520433|FG001|Double Blind Phase|Adverse Event|1|||
161310904|NCT04076059|582520434|FG002|Double Blind Phase|Adverse Event|0|||
161310905|NCT04076059|582520432|FG000|Double Blind Phase|Ongoing Participants|82|||
161310906|NCT04076059|582520433|FG001|Double Blind Phase|Ongoing Participants|18|||
161310907|NCT04076059|582520434|FG002|Double Blind Phase|Ongoing Participants|0|||
161310908|NCT04076059|582520432|FG000|Double Blind Phase|Miscellaneous|3|||
161310909|NCT04076059|582520433|FG001|Double Blind Phase|Miscellaneous|1|||
161310910|NCT04076059|582520434|FG002|Double Blind Phase|Miscellaneous|0|||
161205575|NCT01643928|582133570|FG004|Overall Study|Pregnancy|0|||
161205576|NCT01643928|582133566|FG000|Overall Study|Other|5|||
161205577|NCT01643928|582133567|FG001|Overall Study|Other|1|||
161205578|NCT01643928|582133568|FG002|Overall Study|Other|1|||
161205579|NCT01643928|582133569|FG003|Overall Study|Other|0|||
161205580|NCT01643928|582133570|FG004|Overall Study|Other|0|||
161205581|NCT01643928|582133566|FG000|Overall Study|Adverse Event|2|||
161205582|NCT01643928|582133567|FG001|Overall Study|Adverse Event|1|||
161205583|NCT01643928|582133568|FG002|Overall Study|Adverse Event|0|||
161205584|NCT01643928|582133569|FG003|Overall Study|Adverse Event|1|||
161205585|NCT01643928|582133570|FG004|Overall Study|Adverse Event|2|||
161205586|NCT02086968|582133576|FG000|Overall Study|Adverse Event|1|||
161205587|NCT02086968|582133577|FG001|Overall Study|Adverse Event|5|||
161205588|NCT02086968|582133576|FG000|Overall Study|Lost to Follow-up|2|||
161205589|NCT02086968|582133577|FG001|Overall Study|Lost to Follow-up|3|||
161205590|NCT02086968|582133576|FG000|Overall Study|Study drug received outside protocol|0|||
161310911|NCT04076059|582520432|FG000|Double Blind Phase|Protocol Deviation|1|||
161310912|NCT04076059|582520433|FG001|Double Blind Phase|Protocol Deviation|1|||
161310913|NCT04076059|582520434|FG002|Double Blind Phase|Protocol Deviation|0|||
161310914|NCT04076059|582520432|FG000|Double Blind Phase|Did not take study drug|1|||
161310915|NCT04076059|582520433|FG001|Double Blind Phase|Did not take study drug|1|||
161310916|NCT04076059|582520434|FG002|Double Blind Phase|Did not take study drug|0|||
161310917|NCT04076059|582520432|FG000|Open Label Phase|Progressive disease|0|||
161310918|NCT04076059|582520433|FG001|Open Label Phase|Progressive disease|0|||
161310919|NCT04076059|582520434|FG002|Open Label Phase|Progressive disease|7|||
161310920|NCT04076059|582520432|FG000|Open Label Phase|Withdrawal by Subject|0|||
161310921|NCT04076059|582520433|FG001|Open Label Phase|Withdrawal by Subject|0|||
161310922|NCT04076059|582520434|FG002|Open Label Phase|Withdrawal by Subject|3|||
161310923|NCT04076059|582520432|FG000|Open Label Phase|Death|0|||
161310924|NCT04076059|582520433|FG001|Open Label Phase|Death|0|||
161310925|NCT04076059|582520434|FG002|Open Label Phase|Death|2|||
161310926|NCT04076059|582520432|FG000|Open Label Phase|Ongoing Participants|0|||
161310927|NCT04076059|582520433|FG001|Open Label Phase|Ongoing Participants|0|||
161310928|NCT04076059|582520434|FG002|Open Label Phase|Ongoing Participants|11|||
161310929|NCT04186806|582520435|FG000|Period 1: 7 Days|Adverse Event|1|||
161310930|NCT04186806|582520436|FG001|Period 1: 7 Days|Adverse Event|0|||
161310931|NCT02720744|582520438|FG000|Overall Study|Protocol Violation|0|||
161310932|NCT02720744|582520439|FG001|Overall Study|Protocol Violation|2|||
161310933|NCT02720744|582520438|FG000|Overall Study|Pregnancy|2|||
161310934|NCT02720744|582520439|FG001|Overall Study|Pregnancy|0|||
161310935|NCT02720744|582520438|FG000|Overall Study|Lack of Efficacy|2|||
161310936|NCT02720744|582520439|FG001|Overall Study|Lack of Efficacy|8|||
161310937|NCT02720744|582520438|FG000|Overall Study|Adverse Event|21|||
161310938|NCT02720744|582520439|FG001|Overall Study|Adverse Event|3|||
161310939|NCT02720744|582520438|FG000|Overall Study|Withdrawal by Subject|11|||
161310940|NCT02720744|582520439|FG001|Overall Study|Withdrawal by Subject|11|||
161310941|NCT02720744|582520438|FG000|Overall Study|Lost to follow up|2|||
161310942|NCT02720744|582520439|FG001|Overall Study|Lost to follow up|0|||
161310943|NCT02720744|582520438|FG000|Overall Study|Non Compliance with Investigational Product|0|||
161310944|NCT02720744|582520439|FG001|Overall Study|Non Compliance with Investigational Product|1|||
161310945|NCT02720744|582520438|FG000|Overall Study|Excluded Concomitant Medication|0|||
161310946|NCT02720744|582520439|FG001|Overall Study|Excluded Concomitant Medication|1|||
161310947|NCT00741091|582520440|FG000|Overall Study|Death|13|||
161310948|NCT00741091|582520440|FG000|Overall Study|Lost to Follow-up|16|||
161310949|NCT00741091|582520440|FG000|Overall Study|Withdrawal by Subject|6|||
161310950|NCT00741091|582520440|FG000|Overall Study|Missed Visit|22|||
161310951|NCT01801358|582520441|FG000|Overall Study|Adverse Event|0|||
161310952|NCT01801358|582520442|FG001|Overall Study|Adverse Event|2|||
161310953|NCT01801358|582520443|FG002|Overall Study|Adverse Event|1|||
161310954|NCT01801358|582520444|FG003|Overall Study|Adverse Event|0|||
161310955|NCT01801358|582520445|FG004|Overall Study|Adverse Event|0|||
161310956|NCT01801358|582520446|FG005|Overall Study|Adverse Event|1|||
161310957|NCT01801358|582520441|FG000|Overall Study|Physician Decision|0|||
161310958|NCT01801358|582520442|FG001|Overall Study|Physician Decision|0|||
161310959|NCT01801358|582520443|FG002|Overall Study|Physician Decision|1|||
161310960|NCT01801358|582520444|FG003|Overall Study|Physician Decision|0|||
161310961|NCT01801358|582520445|FG004|Overall Study|Physician Decision|0|||
161310962|NCT01801358|582520446|FG005|Overall Study|Physician Decision|0|||
161310963|NCT01801358|582520441|FG000|Overall Study|Progressive Disease|6|||
161310964|NCT01801358|582520442|FG001|Overall Study|Progressive Disease|4|||
161310965|NCT01801358|582520443|FG002|Overall Study|Progressive Disease|4|||
161310966|NCT01801358|582520444|FG003|Overall Study|Progressive Disease|5|||
161310967|NCT01801358|582520445|FG004|Overall Study|Progressive Disease|6|||
161310968|NCT01801358|582520446|FG005|Overall Study|Progressive Disease|5|||
161310969|NCT01801358|582520441|FG000|Overall Study|Withdrawal by Subject|0|||
161310970|NCT01801358|582520442|FG001|Overall Study|Withdrawal by Subject|0|||
161310971|NCT01801358|582520443|FG002|Overall Study|Withdrawal by Subject|0|||
161310972|NCT01801358|582520444|FG003|Overall Study|Withdrawal by Subject|1|||
161205591|NCT02086968|582133577|FG001|Overall Study|Study drug received outside protocol|1|||
161310973|NCT01801358|582520445|FG004|Overall Study|Withdrawal by Subject|0|||
161310974|NCT01801358|582520446|FG005|Overall Study|Withdrawal by Subject|2|||
161310975|NCT01892085|582520447|FG000|Overall Study|Death|4|||
161310976|NCT01892085|582520448|FG001|Overall Study|Death|1|||
161310977|NCT01892085|582520449|FG002|Overall Study|Death|3|||
161310978|NCT01892085|582520447|FG000|Overall Study|Withdrawal by Subject|2|||
161310979|NCT01892085|582520448|FG001|Overall Study|Withdrawal by Subject|0|||
161205592|NCT02086968|582133576|FG000|Overall Study|Physician Decision|4|||
161205593|NCT02086968|582133577|FG001|Overall Study|Physician Decision|0|||
161205594|NCT02086968|582133576|FG000|Overall Study|Withdrawal by Subject|1|||
161205595|NCT02086968|582133577|FG001|Overall Study|Withdrawal by Subject|4|||
161205596|NCT00203892|582133579|FG000|Overall Study|Physician Decision|1|||
161205597|NCT00203892|582133580|FG001|Overall Study|Physician Decision|2|||
161205598|NCT00203892|582133581|FG002|Overall Study|Physician Decision|0|||
161205599|NCT00203892|582133579|FG000|Overall Study|Death|1|||
161205600|NCT00203892|582133580|FG001|Overall Study|Death|0|||
161205601|NCT00203892|582133581|FG002|Overall Study|Death|0|||
161205602|NCT00556166|582133583|FG000|Overall Study|Withdrawal by Subject|1|||
161205603|NCT03359473|582133584|FG000|Overall Study|Adverse Event|0|||
161205604|NCT03359473|582133585|FG001|Overall Study|Adverse Event|2|||
161205605|NCT03359473|582133586|FG002|Overall Study|Adverse Event|5|||
161205606|NCT03359473|582133587|FG003|Overall Study|Adverse Event|3|||
161205607|NCT03359473|582133584|FG000|Overall Study|Lost to Follow-up|0|||
161205608|NCT03359473|582133585|FG001|Overall Study|Lost to Follow-up|1|||
161205609|NCT03359473|582133586|FG002|Overall Study|Lost to Follow-up|0|||
161205610|NCT03359473|582133587|FG003|Overall Study|Lost to Follow-up|0|||
161205611|NCT03359473|582133584|FG000|Overall Study|Physician Decision|0|||
161205612|NCT03359473|582133585|FG001|Overall Study|Physician Decision|1|||
161205613|NCT03359473|582133586|FG002|Overall Study|Physician Decision|0|||
161205614|NCT03359473|582133587|FG003|Overall Study|Physician Decision|1|||
161205615|NCT03359473|582133584|FG000|Overall Study|Withdrawal by Subject|1|||
161205616|NCT03359473|582133585|FG001|Overall Study|Withdrawal by Subject|2|||
161205617|NCT03359473|582133586|FG002|Overall Study|Withdrawal by Subject|1|||
161205618|NCT03359473|582133587|FG003|Overall Study|Withdrawal by Subject|0|||
161205619|NCT03359473|582133584|FG000|Overall Study|Protocol-defined stopping criteria|1|||
161205620|NCT03359473|582133585|FG001|Overall Study|Protocol-defined stopping criteria|0|||
161205621|NCT03359473|582133586|FG002|Overall Study|Protocol-defined stopping criteria|0|||
161205622|NCT03359473|582133587|FG003|Overall Study|Protocol-defined stopping criteria|1|||
161205623|NCT04101721|582133591|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
161205624|NCT04101721|582133592|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
161205625|NCT04101721|582133591|FG000|Overall Study|Death|0|||
161205626|NCT04101721|582133592|FG001|Overall Study|Death|1|||
161205627|NCT04101721|582133591|FG000|Overall Study|Lost to Follow-up|0|||
161205628|NCT04101721|582133592|FG001|Overall Study|Lost to Follow-up|3|||
161205629|NCT01215955|582133593|FG000|Overall Study|Adverse Event|1|||
161205630|NCT01215955|582133594|FG001|Overall Study|Adverse Event|4|||
161205631|NCT01215955|582133595|FG002|Overall Study|Adverse Event|2|||
161205632|NCT01215955|582133596|FG003|Overall Study|Adverse Event|3|||
161205633|NCT01215955|582133593|FG000|Overall Study|Death|2|||
161205634|NCT01215955|582133594|FG001|Overall Study|Death|0|||
161205635|NCT01215955|582133595|FG002|Overall Study|Death|1|||
161205636|NCT01215955|582133596|FG003|Overall Study|Death|3|||
161205637|NCT01215955|582133593|FG000|Overall Study|Entry Criteria Not Met|1|||
161205638|NCT01215955|582133594|FG001|Overall Study|Entry Criteria Not Met|3|||
161205639|NCT01215955|582133595|FG002|Overall Study|Entry Criteria Not Met|4|||
161205640|NCT01215955|582133596|FG003|Overall Study|Entry Criteria Not Met|7|||
161205641|NCT01215955|582133593|FG000|Overall Study|Lack of Efficacy|1|||
161205642|NCT01215955|582133594|FG001|Overall Study|Lack of Efficacy|2|||
161205643|NCT01215955|582133595|FG002|Overall Study|Lack of Efficacy|1|||
161205644|NCT01215955|582133596|FG003|Overall Study|Lack of Efficacy|0|||
161205645|NCT01215955|582133593|FG000|Overall Study|Lost to Follow-up|4|||
161205646|NCT01215955|582133594|FG001|Overall Study|Lost to Follow-up|4|||
161205647|NCT01215955|582133595|FG002|Overall Study|Lost to Follow-up|8|||
161205648|NCT01215955|582133596|FG003|Overall Study|Lost to Follow-up|9|||
161205649|NCT01215955|582133593|FG000|Overall Study|Physician Decision|4|||
161205650|NCT01215955|582133594|FG001|Overall Study|Physician Decision|10|||
161205651|NCT01215955|582133595|FG002|Overall Study|Physician Decision|8|||
161205652|NCT01215955|582133596|FG003|Overall Study|Physician Decision|11|||
161205653|NCT01215955|582133593|FG000|Overall Study|Protocol Violation|17|||
161205654|NCT01215955|582133594|FG001|Overall Study|Protocol Violation|13|||
161205655|NCT01215955|582133595|FG002|Overall Study|Protocol Violation|8|||
161205656|NCT01215955|582133596|FG003|Overall Study|Protocol Violation|8|||
161205657|NCT01215955|582133593|FG000|Overall Study|Sponsor Decision|1|||
161205658|NCT01215955|582133594|FG001|Overall Study|Sponsor Decision|2|||
161205659|NCT01215955|582133595|FG002|Overall Study|Sponsor Decision|0|||
161310980|NCT01892085|582520449|FG002|Overall Study|Withdrawal by Subject|2|||
161310981|NCT03769675|582520450|FG000|Overall Study|Lost to Follow-up|1|||
161310982|NCT02844907|582520451|FG000|With Dexamethasone|No IV access|1|||
161205660|NCT01215955|582133596|FG003|Overall Study|Sponsor Decision|1|||
161205661|NCT01215955|582133593|FG000|Overall Study|Withdrawal by Subject|14|||
161205662|NCT01215955|582133594|FG001|Overall Study|Withdrawal by Subject|15|||
161205663|NCT01215955|582133595|FG002|Overall Study|Withdrawal by Subject|13|||
161205664|NCT01215955|582133596|FG003|Overall Study|Withdrawal by Subject|9|||
161205665|NCT01215955|582133593|FG000|Overall Study|Quality Issues|0|||
161205666|NCT01215955|582133594|FG001|Overall Study|Quality Issues|0|||
161205667|NCT01215955|582133595|FG002|Overall Study|Quality Issues|3|||
161205668|NCT01215955|582133596|FG003|Overall Study|Quality Issues|2|||
161205669|NCT05013749|582133597|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
161205670|NCT05013749|582133598|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
161205671|NCT05013749|582133597|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
161310983|NCT02945254|582520455|FG000|Overall Study|Lost to Follow-up|1|||
161205672|NCT05013749|582133598|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
161205673|NCT02858076|582133599|FG000|Overall Study|Death|6|||
161205674|NCT02858076|582133600|FG001|Overall Study|Death|3|||
161205675|NCT02858076|582133599|FG000|Overall Study|Withdrawal by Subject|1|||
161205676|NCT02858076|582133600|FG001|Overall Study|Withdrawal by Subject|5|||
161205677|NCT02858076|582133599|FG000|Overall Study|Lost to Follow-up|2|||
161205678|NCT02858076|582133600|FG001|Overall Study|Lost to Follow-up|7|||
161205679|NCT02858076|582133599|FG000|Overall Study|Completed Out of Window|1|||
161205680|NCT02858076|582133600|FG001|Overall Study|Completed Out of Window|3|||
161205681|NCT02643394|582133601|FG000|Overall Study|Protocol Violation|4|||
161205682|NCT02643394|582133602|FG001|Overall Study|Protocol Violation|5|||
161205683|NCT00943384|582133603|FG000|Overall Study|Dispositioned prior to treatment|23|||
161205684|NCT00943384|582133603|FG000|Overall Study|Treated off protocol-protocol violation|5|||
161205685|NCT00943384|582133603|FG000|Overall Study|Lost to Follow-up|16|||
161205686|NCT00943384|582133603|FG000|Overall Study|Withdrawal by Subject|5|||
161205687|NCT00096200|582133604|FG000|Overall Study|Adverse Event|0|||
161205688|NCT00096200|582133605|FG001|Overall Study|Adverse Event|4|||
161205689|NCT00096200|582133606|FG002|Overall Study|Adverse Event|0|||
161205690|NCT00096200|582133604|FG000|Overall Study|Withdrawal by Subject|1|||
161205691|NCT00096200|582133605|FG001|Overall Study|Withdrawal by Subject|2|||
161205692|NCT00096200|582133606|FG002|Overall Study|Withdrawal by Subject|0|||
161205693|NCT00096200|582133604|FG000|Overall Study|Ineligible pathology|0|||
161205694|NCT00096200|582133605|FG001|Overall Study|Ineligible pathology|1|||
161205695|NCT00096200|582133606|FG002|Overall Study|Ineligible pathology|0|||
161205696|NCT00938015|582133611|FG000|Overall Study|Death|2|||
161205697|NCT00938015|582133611|FG000|Overall Study|Lost to Follow-up|32|||
161205698|NCT00938015|582133611|FG000|Overall Study|Adverse Event|32|||
161205699|NCT00938015|582133611|FG000|Overall Study|Non-responder|52|||
161205700|NCT00938015|582133611|FG000|Overall Study|Reason not related to Etanercept|29|||
161205701|NCT02341482|582133612|FG000|Overall Study|Adverse Event|1|||
161205702|NCT03186794|582133613|FG000|Overall Study|Physician Decision|2|||
161205703|NCT03186794|582133613|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
161205704|NCT03000075|582133617|FG000|Part A|Adverse Event|4|||
161205705|NCT03000075|582133618|FG001|Part A|Adverse Event|0|||
161205706|NCT03000075|582133619|FG002|Part A|Adverse Event|0|||
161205707|NCT03000075|582133620|FG003|Part A|Adverse Event|0|||
161205708|NCT03000075|582133621|FG004|Part A|Adverse Event|0|||
161205709|NCT03000075|582133622|FG005|Part A|Adverse Event|0|||
161205710|NCT03000075|582133623|FG006|Part A|Adverse Event|0|||
161205711|NCT03000075|582133617|FG000|Part B|Not dosed due to AE|0|||
161205712|NCT03000075|582133618|FG001|Part B|Not dosed due to AE|0|||
161205713|NCT03000075|582133619|FG002|Part B|Not dosed due to AE|0|||
161205714|NCT03000075|582133620|FG003|Part B|Not dosed due to AE|0|||
161205715|NCT03000075|582133621|FG004|Part B|Not dosed due to AE|0|||
161205716|NCT03000075|582133622|FG005|Part B|Not dosed due to AE|2|||
161205717|NCT03000075|582133623|FG006|Part B|Not dosed due to AE|1|||
161205718|NCT03000075|582133617|FG000|Part B|Adverse Event|0|||
161205719|NCT03000075|582133618|FG001|Part B|Adverse Event|0|||
161205720|NCT03000075|582133619|FG002|Part B|Adverse Event|0|||
161205721|NCT03000075|582133620|FG003|Part B|Adverse Event|0|||
161205722|NCT03000075|582133621|FG004|Part B|Adverse Event|1|||
161205723|NCT03000075|582133622|FG005|Part B|Adverse Event|0|||
161205724|NCT03000075|582133623|FG006|Part B|Adverse Event|0|||
161205725|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
161205726|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
161205727|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Death|5|||
161205728|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Death|2|||
161205729|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
161205730|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
161205731|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
161205732|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
161205733|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
161205734|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
161205735|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Relapse|1|||
161205736|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Relapse|0|||
161205737|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
161205738|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
161205739|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
161205740|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
161205741|NCT00111007|582133624|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
161205742|NCT00111007|582133625|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
161205743|NCT00111007|582133624|FG000|Active Follow-up|Adverse Event|1|||
161205744|NCT00111007|582133625|FG001|Active Follow-up|Adverse Event|0|||
161205745|NCT00111007|582133624|FG000|Active Follow-up|Death|2|||
161205746|NCT00111007|582133625|FG001|Active Follow-up|Death|0|||
161205747|NCT00111007|582133624|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
161205748|NCT00111007|582133625|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
161205749|NCT00111007|582133624|FG000|Long Term Follow-up|Death|34|||
161205750|NCT00111007|582133625|FG001|Long Term Follow-up|Death|39|||
161205751|NCT00111007|582133624|FG000|Long Term Follow-up|Lost to Follow-up|1|||
161205752|NCT00111007|582133625|FG001|Long Term Follow-up|Lost to Follow-up|1|||
161205753|NCT00111007|582133624|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
161205754|NCT00111007|582133625|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
161205755|NCT00111007|582133624|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
161205756|NCT00111007|582133625|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
161205757|NCT00111007|582133624|FG000|Long Term Follow-up|Missing|10|||
161205758|NCT00111007|582133625|FG001|Long Term Follow-up|Missing|3|||
161205759|NCT01495793|582133626|FG000|Overall Study|Lost to Follow-up|1|||
161205760|NCT01495793|582133626|FG000|Overall Study|Violation of inclusion criteria|1|||
161205761|NCT03014570|582133627|FG000|Overall Study|COVID-19 Restrictions|38|||
161205762|NCT03014570|582133628|FG001|Overall Study|COVID-19 Restrictions|24|||
161205763|NCT03014570|582133627|FG000|Overall Study|Death|70|||
161205764|NCT03014570|582133628|FG001|Overall Study|Death|79|||
161205765|NCT03014570|582133627|FG000|Overall Study|Transfer from facility|11|||
161205766|NCT03014570|582133628|FG001|Overall Study|Transfer from facility|14|||
161205767|NCT03014570|582133627|FG000|Overall Study|Hospitalized|5|||
161205768|NCT03014570|582133628|FG001|Overall Study|Hospitalized|3|||
161205769|NCT03014570|582133627|FG000|Overall Study|Transfer within facility|1|||
161205770|NCT03014570|582133628|FG001|Overall Study|Transfer within facility|0|||
161205771|NCT03014570|582133627|FG000|Overall Study|Site refusal|0|||
161205772|NCT03014570|582133628|FG001|Overall Study|Site refusal|11|||
161205773|NCT00518011|582133629|FG000|Overall Study|Death|1|||
161205774|NCT00518011|582133630|FG001|Overall Study|Death|1|||
161205775|NCT00518011|582133629|FG000|Overall Study|Adverse Event|2|||
161205776|NCT00518011|582133630|FG001|Overall Study|Adverse Event|3|||
161205777|NCT00518011|582133629|FG000|Overall Study|Disease Progression|2|||
161205778|NCT00518011|582133630|FG001|Overall Study|Disease Progression|2|||
161205779|NCT00518011|582133629|FG000|Overall Study|Other Reasons|3|||
161205780|NCT00518011|582133630|FG001|Overall Study|Other Reasons|2|||
161205781|NCT00518011|582133629|FG000|Overall Study|Withdrawal by Subject|1|||
161205782|NCT00518011|582133630|FG001|Overall Study|Withdrawal by Subject|0|||
161205783|NCT00090259|582133631|FG000|Overall Study|Lost to Follow-up|30|||
161205784|NCT00090259|582133632|FG001|Overall Study|Lost to Follow-up|26|||
161205785|NCT00090259|582133631|FG000|Overall Study|Withdrawal by Subject|21|||
161205786|NCT00090259|582133632|FG001|Overall Study|Withdrawal by Subject|15|||
161205787|NCT00090259|582133631|FG000|Overall Study|Investigator site closed|11|||
161205788|NCT00090259|582133632|FG001|Overall Study|Investigator site closed|7|||
161205789|NCT04797637|582133636|FG000|Overall Study|Lost to Follow-up|23|||
161205790|NCT04797637|582133637|FG001|Overall Study|Lost to Follow-up|32|||
161205791|NCT04797637|582133636|FG000|Overall Study|Withdrawal by Subject|0|||
161205792|NCT04797637|582133637|FG001|Overall Study|Withdrawal by Subject|1|||
161205793|NCT03083639|582133638|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
161205794|NCT03083639|582133639|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
161205795|NCT03083639|582133638|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
161205796|NCT03083639|582133639|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
161205797|NCT00960687|582133643|FG000|Washout Period of 7 Days|Adverse Event|3|||
161205798|NCT00960687|582133644|FG001|Washout Period of 7 Days|Adverse Event|2|||
161205799|NCT00960687|582133643|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
161205800|NCT00960687|582133644|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
161205801|NCT03611751|582133648|FG000|Pre-treatment|Randomized but not treated|1|||
161205802|NCT03611751|582133649|FG001|Pre-treatment|Randomized but not treated|1|||
161205803|NCT03611751|582133650|FG002|Pre-treatment|Randomized but not treated|0|||
161205804|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
161205805|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
161205806|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
161205807|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
161205808|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
161205809|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
161205810|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
161205811|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
161205812|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
161205813|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
161205814|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
161205815|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
161205816|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
161205817|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
161205818|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
161205819|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
161205820|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
161205821|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
161205822|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
161205823|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
161205824|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
161205825|NCT03611751|582133648|FG000|Treatment Week 0 - Week 16|Death|0|||
161205826|NCT03611751|582133649|FG001|Treatment Week 0 - Week 16|Death|0|||
161205827|NCT03611751|582133650|FG002|Treatment Week 0 - Week 16|Death|1|||
161205828|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
161205829|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
161205830|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
161205831|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
161205832|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
161205833|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
161205834|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
161205835|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161205836|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
161205837|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
161205838|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
161205839|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
161205840|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
161205841|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
161205842|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
161205843|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
161205844|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
161205845|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
161205846|NCT03611751|582133648|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
161205847|NCT03611751|582133649|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
161205848|NCT03611751|582133650|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
161205849|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
161205850|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
161205851|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
161205852|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
161205853|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
161205854|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
161205855|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
161205856|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
161205857|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
161205858|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
161205859|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
161205860|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
161205861|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
161205862|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
161205863|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
161205864|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
161205865|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
161205866|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
161205867|NCT03611751|582133648|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
161310984|NCT02945254|582520456|FG001|Overall Study|Lost to Follow-up|0|||
161310985|NCT02945254|582520455|FG000|Overall Study|Withdrawal by Subject|1|||
161310986|NCT02945254|582520456|FG001|Overall Study|Withdrawal by Subject|0|||
161310987|NCT01711619|582520457|FG000|Overall Study|Early study termination|10|||
161310988|NCT01711619|582520458|FG001|Overall Study|Early study termination|14|||
161310989|NCT01711619|582520457|FG000|Overall Study|Withdrawal by Subject|3|||
161310990|NCT01711619|582520458|FG001|Overall Study|Withdrawal by Subject|7|||
161310991|NCT01711619|582520457|FG000|Overall Study|Protocol Violation|2|||
161310992|NCT01711619|582520458|FG001|Overall Study|Protocol Violation|3|||
161310993|NCT01711619|582520457|FG000|Overall Study|Adverse Event|2|||
161310994|NCT01711619|582520458|FG001|Overall Study|Adverse Event|0|||
161310995|NCT01711619|582520457|FG000|Overall Study|Lost to Follow-up|1|||
161310996|NCT01711619|582520458|FG001|Overall Study|Lost to Follow-up|0|||
161310997|NCT00783224|582520459|FG000|Overall Study|Adverse Event|0|||
161310998|NCT00783224|582520460|FG001|Overall Study|Adverse Event|0|||
161310999|NCT00783224|582520461|FG002|Overall Study|Adverse Event|1|||
161311000|NCT00783224|582520462|FG003|Overall Study|Adverse Event|0|||
161311001|NCT00783224|582520459|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
161311002|NCT00783224|582520460|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
161311003|NCT00783224|582520461|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
161311004|NCT00783224|582520462|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
161311005|NCT00783224|582520459|FG000|Overall Study|Inappropriate as a study subject|0|||
161311006|NCT00783224|582520460|FG001|Overall Study|Inappropriate as a study subject|0|||
161311007|NCT00783224|582520461|FG002|Overall Study|Inappropriate as a study subject|0|||
161311008|NCT00783224|582520462|FG003|Overall Study|Inappropriate as a study subject|1|||
161311009|NCT03422159|582520463|FG000|Overall Study|Exclusion due to terminal disease|2|||
161311010|NCT03422159|582520464|FG001|Overall Study|Exclusion due to terminal disease|1|||
161311011|NCT04631107|582520465|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
161311012|NCT04631107|582520465|FG000|Second Intervention (1 Night)|Adverse Event|1|||
161311013|NCT04631107|582520465|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
161311014|NCT04631107|582520465|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
161311015|NCT00087126|582520469|FG000|Overall Study|Ineligible - second primary|1|||
161311016|NCT00087126|582520469|FG000|Overall Study|Never treated|1|||
161311017|NCT01432275|582520470|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
161311018|NCT01432275|582520471|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
161311019|NCT01432275|582520470|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
161311020|NCT01432275|582520471|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
161311021|NCT01432275|582520470|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
161311022|NCT01432275|582520471|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
161311023|NCT01432275|582520470|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
161311024|NCT01432275|582520471|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
161311025|NCT01432275|582520470|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
161311026|NCT01432275|582520471|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
161311027|NCT01432275|582520470|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
161311028|NCT01432275|582520471|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
161311029|NCT01432275|582520470|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
161311030|NCT01432275|582520471|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
161311031|NCT01432275|582520470|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
161311032|NCT01432275|582520471|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
161311033|NCT01432275|582520470|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
161311034|NCT01432275|582520471|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
161311035|NCT01935700|582520476|FG000|Overall Study|Withdrawal by Subject|1|||
161311036|NCT01935700|582520477|FG001|Overall Study|Withdrawal by Subject|0|||
161311037|NCT01935700|582520476|FG000|Overall Study|Physician Decision|4|||
161311038|NCT01935700|582520477|FG001|Overall Study|Physician Decision|0|||
161311039|NCT01935128|582520478|FG000|Overall Study|Death|1|||
161311040|NCT01935128|582520478|FG000|Overall Study|Adverse Event|6|||
161311041|NCT00096993|582520481|FG000|Overall Study|Death|1|||
161311042|NCT00096993|582520482|FG001|Overall Study|Death|0|||
161311043|NCT00096993|582520481|FG000|Overall Study|Disease progression|56|||
161311044|NCT00096993|582520482|FG001|Overall Study|Disease progression|53|||
161311045|NCT00096993|582520481|FG000|Overall Study|Adverse Event|2|||
161311046|NCT00096993|582520482|FG001|Overall Study|Adverse Event|8|||
161311047|NCT00096993|582520481|FG000|Overall Study|Subject's decision|3|||
161311048|NCT00096993|582520482|FG001|Overall Study|Subject's decision|1|||
161311049|NCT00096993|582520481|FG000|Overall Study|Physician Decision|2|||
161311050|NCT00096993|582520482|FG001|Overall Study|Physician Decision|1|||
161311051|NCT00096993|582520481|FG000|Overall Study|Non-compliance|0|||
161311052|NCT00096993|582520482|FG001|Overall Study|Non-compliance|1|||
161311053|NCT00096993|582520481|FG000|Overall Study|Other unspecified|1|||
161091022|NCT00666679|581723780|FG001|Washout Period of 1 Week|Protocol Violation|1|||
161091023|NCT00666679|581723779|FG000|Second Intervention|Adverse Event|1|||
161091024|NCT00666679|581723780|FG001|Second Intervention|Adverse Event|0|||
161091025|NCT00666679|581723779|FG000|Second Intervention|Death|0|||
161091026|NCT00666679|581723780|FG001|Second Intervention|Death|1|||
161091027|NCT00918580|581723781|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
161091028|NCT00918580|581723781|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
161091029|NCT00918580|581723781|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
161205868|NCT03611751|582133649|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
161205869|NCT03611751|582133650|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
161205870|NCT02666768|582133653|FG000|Overall Study|Withdrawal by Subject|4|||
161205871|NCT03728257|582133654|FG000|Overall Study|Death|3|||
161205872|NCT03728257|582133655|FG001|Overall Study|Death|0|||
161205873|NCT03940742|582133656|FG000|Overall Study|Lost to Follow-up|0|||
161205874|NCT03940742|582133657|FG001|Overall Study|Lost to Follow-up|0|||
161205875|NCT03940742|582133658|FG002|Overall Study|Lost to Follow-up|0|||
161205876|NCT03940742|582133659|FG003|Overall Study|Lost to Follow-up|1|||
161205877|NCT04993339|582133660|FG000|Overall Study|Lost to Follow-up|0|||
161205878|NCT04993339|582133661|FG001|Overall Study|Lost to Follow-up|1|||
161205879|NCT04993339|582133660|FG000|Overall Study|no MRI scan|3|||
161205880|NCT04993339|582133661|FG001|Overall Study|no MRI scan|1|||
161205881|NCT00690573|582133668|FG000|Overall Study|Lack of Efficacy|8|||
161205882|NCT00690573|582133668|FG000|Overall Study|Withdrawal by Subject|1|||
161205883|NCT00777920|582133669|FG000|Overall Study|Adverse Event|39|||
161205884|NCT00777920|582133669|FG000|Overall Study|Withdrawal of Consent|4|||
161205885|NCT00777920|582133669|FG000|Overall Study|Lost to Follow-up|1|||
161205886|NCT00777920|582133669|FG000|Overall Study|Investigator's discretion|1|||
161205887|NCT00777920|582133669|FG000|Overall Study|Clinical status did not improve|1|||
161205888|NCT00777920|582133669|FG000|Overall Study|Other, not specified|4|||
161205889|NCT02332655|582133670|FG000|Overall Study|Lack of Efficacy|1|||
161205890|NCT01843660|582133671|FG000|Overall Study|Other|30|||
161205891|NCT01977482|582133672|FG000|Overall Study|Adverse Event|0|||
161205892|NCT01977482|582133673|FG001|Overall Study|Adverse Event|1|||
161205893|NCT01977482|582133674|FG002|Overall Study|Adverse Event|1|||
161205894|NCT01977482|582133675|FG003|Overall Study|Adverse Event|0|||
161205895|NCT01977482|582133676|FG004|Overall Study|Adverse Event|2|||
161205896|NCT01977482|582133677|FG005|Overall Study|Adverse Event|0|||
161205897|NCT01977482|582133672|FG000|Overall Study|Lost to Follow-up|1|||
161205898|NCT01977482|582133673|FG001|Overall Study|Lost to Follow-up|0|||
161205899|NCT01977482|582133674|FG002|Overall Study|Lost to Follow-up|0|||
161205900|NCT01977482|582133675|FG003|Overall Study|Lost to Follow-up|0|||
161205901|NCT01977482|582133676|FG004|Overall Study|Lost to Follow-up|0|||
161205902|NCT01977482|582133677|FG005|Overall Study|Lost to Follow-up|0|||
161205903|NCT01977482|582133672|FG000|Overall Study|Physician Decision|0|||
161205904|NCT01977482|582133673|FG001|Overall Study|Physician Decision|1|||
161205905|NCT01977482|582133674|FG002|Overall Study|Physician Decision|0|||
161205906|NCT01977482|582133675|FG003|Overall Study|Physician Decision|0|||
161205907|NCT01977482|582133676|FG004|Overall Study|Physician Decision|0|||
161205908|NCT01977482|582133677|FG005|Overall Study|Physician Decision|0|||
161205909|NCT01977482|582133672|FG000|Overall Study|Protocol Violation|0|||
161205910|NCT01977482|582133673|FG001|Overall Study|Protocol Violation|0|||
161205911|NCT01977482|582133674|FG002|Overall Study|Protocol Violation|1|||
161205912|NCT01977482|582133675|FG003|Overall Study|Protocol Violation|0|||
161205913|NCT01977482|582133676|FG004|Overall Study|Protocol Violation|0|||
161205914|NCT01977482|582133677|FG005|Overall Study|Protocol Violation|0|||
161311054|NCT00096993|582520482|FG001|Overall Study|Other unspecified|1|||
161311055|NCT01162122|582520485|FG000|Overall Study|Withdrawal by Subject|52|||
161311056|NCT01162122|582520486|FG001|Overall Study|Withdrawal by Subject|43|||
161311057|NCT01162122|582520485|FG000|Overall Study|Lost to Follow-up|73|||
161311058|NCT01162122|582520486|FG001|Overall Study|Lost to Follow-up|91|||
161311059|NCT01162122|582520485|FG000|Overall Study|Adverse Event|3|||
161311060|NCT01162122|582520486|FG001|Overall Study|Adverse Event|2|||
161311061|NCT01162122|582520485|FG000|Overall Study|Death|51|||
161311062|NCT01162122|582520486|FG001|Overall Study|Death|46|||
161311063|NCT01162122|582520485|FG000|Overall Study|Protocol Violation|2|||
161311064|NCT01162122|582520486|FG001|Overall Study|Protocol Violation|2|||
161311065|NCT01162122|582520485|FG000|Overall Study|Inappropriate enrollment|5|||
161311066|NCT01162122|582520486|FG001|Overall Study|Inappropriate enrollment|4|||
161311067|NCT01162122|582520485|FG000|Overall Study|Administrative reason|1|||
161311068|NCT01162122|582520486|FG001|Overall Study|Administrative reason|1|||
161311069|NCT01162122|582520485|FG000|Overall Study|Unable to classify|3|||
161311070|NCT01162122|582520486|FG001|Overall Study|Unable to classify|7|||
161311071|NCT01162122|582520485|FG000|Overall Study|Missing primary reason|1|||
161311072|NCT01162122|582520486|FG001|Overall Study|Missing primary reason|0|||
161311073|NCT02020512|582520487|FG000|Overall Study|Adverse Event|1|||
161311074|NCT02020512|582520487|FG000|Overall Study|Lost to Follow-up|3|||
161311075|NCT02020512|582520487|FG000|Overall Study|Protocol Violation|4|||
161311076|NCT00835679|582520488|FG000|Overall Study|Withdrawal by Subject|1|||
161311077|NCT00835679|582520489|FG001|Overall Study|Withdrawal by Subject|0|||
161311078|NCT00835679|582520490|FG002|Overall Study|Withdrawal by Subject|0|||
161311079|NCT00835679|582520491|FG003|Overall Study|Withdrawal by Subject|0|||
161311080|NCT00955968|582520495|FG000|Overall Study|Death|2|||
161311081|NCT00955968|582520496|FG001|Overall Study|Death|4|||
161311082|NCT00955968|582520495|FG000|Overall Study|Withdrawal by Subject|35|||
161311083|NCT00955968|582520496|FG001|Overall Study|Withdrawal by Subject|31|||
161311084|NCT00955968|582520495|FG000|Overall Study|Lost to Follow-up|45|||
161311085|NCT00955968|582520496|FG001|Overall Study|Lost to Follow-up|39|||
161311086|NCT00955968|582520495|FG000|Overall Study|Site closed|55|||
161311087|NCT00955968|582520496|FG001|Overall Study|Site closed|52|||
161205915|NCT01977482|582133672|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161311088|NCT03782298|582520500|FG000|Overall Study|Protocol Deviation|4|||
161311089|NCT00742508|582520501|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
161311090|NCT00742508|582520502|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
161311091|NCT00742508|582520501|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
161311092|NCT00742508|582520502|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
161205916|NCT01977482|582133673|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
161205917|NCT01977482|582133674|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
161205918|NCT01977482|582133675|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
161205919|NCT01977482|582133676|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161205920|NCT01977482|582133677|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
161205921|NCT01977482|582133672|FG000|Overall Study|Withdrawal by Subject|2|||
161205922|NCT01977482|582133673|FG001|Overall Study|Withdrawal by Subject|4|||
161205923|NCT01977482|582133674|FG002|Overall Study|Withdrawal by Subject|1|||
161205924|NCT01977482|582133675|FG003|Overall Study|Withdrawal by Subject|3|||
161205925|NCT01977482|582133676|FG004|Overall Study|Withdrawal by Subject|1|||
161205926|NCT01977482|582133677|FG005|Overall Study|Withdrawal by Subject|5|||
161205927|NCT01525407|582133684|FG000|Overall Study|Change in recipient treatment plan|2|||
161205928|NCT01525407|582133685|FG001|Overall Study|Change in recipient treatment plan|2|||
161205929|NCT01525407|582133684|FG000|Overall Study|Withdrawal by Subject|0|||
161205930|NCT01525407|582133685|FG001|Overall Study|Withdrawal by Subject|1|||
161205931|NCT01525407|582133684|FG000|Overall Study|Transplant was delayed|0|||
161205932|NCT01525407|582133685|FG001|Overall Study|Transplant was delayed|1|||
161205933|NCT01525407|582133684|FG000|Overall Study|Delay in Transplant|1|||
161205934|NCT01525407|582133685|FG001|Overall Study|Delay in Transplant|0|||
161205935|NCT01721369|582133686|FG000|Overall Study|Not initial etiological diagnosis|12|||
161205936|NCT01964898|582134674|FG000|Overall Study|ineligible post-randomization|1|||
161205937|NCT01964898|582134675|FG001|Overall Study|ineligible post-randomization|1|||
161205938|NCT01964898|582134674|FG000|Overall Study|did not receive the allocated interventi|2|||
161205939|NCT01964898|582134675|FG001|Overall Study|did not receive the allocated interventi|1|||
161205940|NCT01964898|582134674|FG000|Overall Study|Lost to Follow-up|3|||
161205941|NCT01964898|582134675|FG001|Overall Study|Lost to Follow-up|5|||
161205942|NCT01964898|582134674|FG000|Overall Study|Withdrawal by Subject|1|||
161205943|NCT01964898|582134675|FG001|Overall Study|Withdrawal by Subject|0|||
161205944|NCT02428231|582134678|FG000|Overall Study|Other|10|||
161205945|NCT02428231|582134679|FG001|Overall Study|Other|16|||
161205946|NCT02428231|582134678|FG000|Overall Study|Required Symptomatic Therapy|0|||
161205947|NCT02428231|582134679|FG001|Overall Study|Required Symptomatic Therapy|1|||
161205948|NCT02428231|582134678|FG000|Overall Study|Adverse Event|3|||
161205949|NCT02428231|582134679|FG001|Overall Study|Adverse Event|0|||
161205950|NCT02957682|582134682|FG000|Overall Study|Adverse Event|64|||
161205951|NCT02957682|582134683|FG001|Overall Study|Adverse Event|67|||
161205952|NCT02957682|582134682|FG000|Overall Study|Poor Compliance to Protocol|30|||
161205953|NCT02957682|582134683|FG001|Overall Study|Poor Compliance to Protocol|26|||
161205954|NCT02957682|582134682|FG000|Overall Study|Physician Decision|4|||
161205955|NCT02957682|582134683|FG001|Overall Study|Physician Decision|4|||
161205956|NCT02957682|582134682|FG000|Overall Study|Study Terminated by Sponsor|4|||
161205957|NCT02957682|582134683|FG001|Overall Study|Study Terminated by Sponsor|3|||
161205958|NCT02957682|582134682|FG000|Overall Study|Subject Moved|10|||
161205959|NCT02957682|582134683|FG001|Overall Study|Subject Moved|16|||
161205960|NCT02957682|582134682|FG000|Overall Study|Withdrawal by Subject|64|||
161205961|NCT02957682|582134683|FG001|Overall Study|Withdrawal by Subject|33|||
161205962|NCT02957682|582134682|FG000|Overall Study|Related to IMP Administration|3|||
161205963|NCT02957682|582134683|FG001|Overall Study|Related to IMP Administration|6|||
161205964|NCT02957682|582134682|FG000|Overall Study|Non-disclosed|16|||
161205965|NCT02957682|582134683|FG001|Overall Study|Non-disclosed|12|||
161205966|NCT02957682|582134682|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
161205967|NCT02957682|582134683|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
161205968|NCT02953262|582134685|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
161205969|NCT02953262|582134686|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
161205970|NCT02953262|582134687|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
161205971|NCT02953262|582134688|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
161205972|NCT00934622|582134689|FG000|Overall Study|Lost to Follow-up|7|||
161205973|NCT00934622|582134689|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
161205974|NCT03284424|582134690|FG000|Overall Study|Death|70|||
161205975|NCT03284424|582134691|FG001|Overall Study|Death|24|||
161205976|NCT03284424|582134690|FG000|Overall Study|Lost to Follow-up|3|||
161205977|NCT03284424|582134691|FG001|Overall Study|Lost to Follow-up|1|||
161205978|NCT03284424|582134690|FG000|Overall Study|Physician Decision|1|||
161205979|NCT03284424|582134691|FG001|Overall Study|Physician Decision|2|||
161205980|NCT03284424|582134690|FG000|Overall Study|Withdrawal by Subject|4|||
161205981|NCT03284424|582134691|FG001|Overall Study|Withdrawal by Subject|5|||
161205982|NCT03284424|582134690|FG000|Overall Study|Sponsor's decision|27|||
161205983|NCT03284424|582134691|FG001|Overall Study|Sponsor's decision|22|||
161205984|NCT03349437|582134692|FG000|Screening|Screen Fail|4|||
161205985|NCT03349437|582134693|FG001|Screening|Screen Fail|0|||
161205986|NCT03349437|582134694|FG002|Screening|Screen Fail|0|||
161205987|NCT03349437|582134692|FG000|Screening|Withdrawn|1|||
161205988|NCT03349437|582134693|FG001|Screening|Withdrawn|0|||
161205989|NCT03349437|582134694|FG002|Screening|Withdrawn|0|||
161205990|NCT05302414|582134696|FG000|Pretest to Posttest|Lost to Follow-up|12|||
161205991|NCT05302414|582134697|FG001|Pretest to Posttest|Lost to Follow-up|8|||
161205992|NCT05302414|582134698|FG002|Pretest to Posttest|Lost to Follow-up|8|||
161205993|NCT05302414|582134696|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161205994|NCT05302414|582134697|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161205995|NCT05302414|582134698|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
161205996|NCT03829462|582134701|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
161205997|NCT03829462|582134702|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
161205998|NCT03829462|582134701|FG000|Overall Study|No treatment due to progression disease|0|||
161205999|NCT03829462|582134702|FG001|Overall Study|No treatment due to progression disease|1|||
161206000|NCT02362646|582134706|FG000|Overall Study|Death|15|||
161206001|NCT02362646|582134707|FG001|Overall Study|Death|8|||
161206002|NCT02362646|582134706|FG000|Overall Study|Withdrawal by Subject|2|||
161206003|NCT02362646|582134707|FG001|Overall Study|Withdrawal by Subject|2|||
161206004|NCT02362646|582134706|FG000|Overall Study|received transplant|21|||
161206005|NCT02362646|582134707|FG001|Overall Study|received transplant|14|||
161206006|NCT00929864|582134711|FG000|Overall Study|Death|1|||
161206007|NCT00929864|582134712|FG001|Overall Study|Death|1|||
161206008|NCT00929864|582134711|FG000|Overall Study|Adverse Event|11|||
161206009|NCT00929864|582134712|FG001|Overall Study|Adverse Event|30|||
161206010|NCT00929864|582134711|FG000|Overall Study|Lack of Efficacy|19|||
161206011|NCT00929864|582134712|FG001|Overall Study|Lack of Efficacy|16|||
161206012|NCT00929864|582134711|FG000|Overall Study|Lost to Follow-up|7|||
161206013|NCT00929864|582134712|FG001|Overall Study|Lost to Follow-up|12|||
161206014|NCT00929864|582134711|FG000|Overall Study|Withdrawal by Subject|20|||
161206015|NCT00929864|582134712|FG001|Overall Study|Withdrawal by Subject|9|||
161206016|NCT00929864|582134711|FG000|Overall Study|No longer met criteria|2|||
161206017|NCT00929864|582134712|FG001|Overall Study|No longer met criteria|1|||
161206018|NCT00929864|582134711|FG000|Overall Study|Poor or non-compliance|3|||
161206019|NCT00929864|582134712|FG001|Overall Study|Poor or non-compliance|3|||
161206020|NCT00929864|582134711|FG000|Overall Study|Pregnancy|0|||
161206021|NCT00929864|582134712|FG001|Overall Study|Pregnancy|3|||
161206022|NCT00929864|582134711|FG000|Overall Study|Administrative reason by Sponsor|1|||
161206023|NCT00929864|582134712|FG001|Overall Study|Administrative reason by Sponsor|1|||
161206024|NCT00929864|582134711|FG000|Overall Study|Non-specified|2|||
161206025|NCT00929864|582134712|FG001|Overall Study|Non-specified|7|||
161206026|NCT03428217|582134714|FG000|Overall Study|Death|89|||
161206027|NCT03428217|582134715|FG001|Overall Study|Death|93|||
161311093|NCT00742508|582520501|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
161311094|NCT00742508|582520502|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
161311095|NCT00742508|582520501|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
161311096|NCT00742508|582520502|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
161311097|NCT00742508|582520501|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
161311098|NCT00742508|582520502|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
161311099|NCT01793688|582520503|FG000|Overall Study|Protocol Violation|2|||
161311100|NCT03619902|582520504|FG000|Overall Study|Termination of Study by Investigator|1|||
161311101|NCT03619902|582520504|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
161311102|NCT03814720|582520507|FG000|Overall Study|Lost to Follow-up|0|||
161311103|NCT03814720|582520508|FG001|Overall Study|Lost to Follow-up|1|||
161311104|NCT03814720|582520509|FG002|Overall Study|Lost to Follow-up|0|||
161311105|NCT03814720|582520510|FG003|Overall Study|Lost to Follow-up|0|||
161311106|NCT03814720|582520511|FG004|Overall Study|Lost to Follow-up|0|||
161311107|NCT02419612|582520512|FG000|Short-term Treatment Period|Adverse Event|1|||
161311108|NCT02419612|582520513|FG001|Short-term Treatment Period|Adverse Event|1|||
161311109|NCT02419612|582520512|FG000|Short-term Treatment Period|Death|0|||
161311110|NCT02419612|582520513|FG001|Short-term Treatment Period|Death|2|||
161311111|NCT02419612|582520512|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
161311112|NCT02419612|582520513|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
161311113|NCT02419612|582520512|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
161311114|NCT02419612|582520513|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
161311115|NCT02419612|582520512|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
161311116|NCT02419612|582520513|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
161311117|NCT02419612|582520512|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
161311118|NCT02419612|582520513|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
161311119|NCT02419612|582520512|FG000|Short-term Treatment Period|Worsening of liver function|0|||
161311120|NCT02419612|582520513|FG001|Short-term Treatment Period|Worsening of liver function|1|||
161311121|NCT02419612|582520512|FG000|Short-term Treatment Period|Subject moved out of state|0|||
161311122|NCT02419612|582520513|FG001|Short-term Treatment Period|Subject moved out of state|1|||
161311123|NCT02419612|582520512|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
161311124|NCT02419612|582520513|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
161311125|NCT02419612|582520512|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
161311126|NCT02419612|582520513|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
161311127|NCT02419612|582520512|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
161311128|NCT02419612|582520513|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
161311129|NCT02419612|582520512|FG000|Long-term Treatment Period|Death|0|||
161311130|NCT02419612|582520513|FG001|Long-term Treatment Period|Death|1|||
161311131|NCT02419612|582520512|FG000|Long-term Treatment Period|Adverse Event|0|||
161311132|NCT02419612|582520513|FG001|Long-term Treatment Period|Adverse Event|5|||
161311133|NCT02419612|582520512|FG000|Long-term Treatment Period|Other|4|||
161311134|NCT02419612|582520513|FG001|Long-term Treatment Period|Other|4|||
161311135|NCT02419612|582520512|FG000|Long-term Treatment Period|Subject Decision|2|||
161311136|NCT02419612|582520513|FG001|Long-term Treatment Period|Subject Decision|4|||
161311137|NCT02419612|582520512|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
161311138|NCT02419612|582520513|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
161311139|NCT02135107|582520514|FG000|Treatment Period|Withdrawal by Subject|11|||
161311140|NCT02135107|582520515|FG001|Treatment Period|Withdrawal by Subject|0|||
161311141|NCT02135107|582520516|FG002|Treatment Period|Withdrawal by Subject|0|||
161311142|NCT02135107|582520517|FG003|Treatment Period|Withdrawal by Subject|0|||
161311143|NCT02135107|582520514|FG000|Treatment Period|Adverse Event|5|||
161311144|NCT02135107|582520515|FG001|Treatment Period|Adverse Event|2|||
161311145|NCT02135107|582520516|FG002|Treatment Period|Adverse Event|0|||
161311146|NCT02135107|582520517|FG003|Treatment Period|Adverse Event|0|||
161311147|NCT02135107|582520514|FG000|Treatment Period|Pregnancy|1|||
161311148|NCT02135107|582520515|FG001|Treatment Period|Pregnancy|0|||
161311149|NCT02135107|582520516|FG002|Treatment Period|Pregnancy|0|||
161311150|NCT02135107|582520517|FG003|Treatment Period|Pregnancy|0|||
161311151|NCT02135107|582520514|FG000|Treatment Period|Other|115|||
161311152|NCT02135107|582520515|FG001|Treatment Period|Other|24|||
161311153|NCT02135107|582520516|FG002|Treatment Period|Other|0|||
161311154|NCT02135107|582520517|FG003|Treatment Period|Other|0|||
161311155|NCT02135107|582520514|FG000|Maintenance Therapy Period|Adverse Event|0|||
161311156|NCT02135107|582520515|FG001|Maintenance Therapy Period|Adverse Event|0|||
161311157|NCT02135107|582520516|FG002|Maintenance Therapy Period|Adverse Event|3|||
161311158|NCT02135107|582520517|FG003|Maintenance Therapy Period|Adverse Event|7|||
161311159|NCT02135107|582520514|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
161311160|NCT02135107|582520515|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
161311161|NCT02135107|582520516|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
161311162|NCT02135107|582520517|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
161311163|NCT02135107|582520514|FG000|Maintenance Therapy Period|Pregnancy|0|||
161311164|NCT02135107|582520515|FG001|Maintenance Therapy Period|Pregnancy|0|||
161206028|NCT03428217|582134714|FG000|Overall Study|Withdrawal by Subject|8|||
161206029|NCT03428217|582134715|FG001|Overall Study|Withdrawal by Subject|7|||
161206030|NCT03428217|582134714|FG000|Overall Study|Lost to Follow-up|1|||
161206031|NCT03428217|582134715|FG001|Overall Study|Lost to Follow-up|3|||
161206032|NCT03428217|582134714|FG000|Overall Study|Study terminated by sponsor|124|||
161206033|NCT03428217|582134715|FG001|Overall Study|Study terminated by sponsor|118|||
161206034|NCT03428217|582134714|FG000|Overall Study|Other, Not Specified|1|||
161206035|NCT03428217|582134715|FG001|Overall Study|Other, Not Specified|0|||
161206036|NCT00621309|582134716|FG000|Overall Study|Withdrawal by Subject|2|||
161206037|NCT00621309|582134717|FG001|Overall Study|Withdrawal by Subject|0|||
161206038|NCT00621309|582134718|FG002|Overall Study|Withdrawal by Subject|1|||
161206039|NCT00621309|582134719|FG003|Overall Study|Withdrawal by Subject|1|||
161206040|NCT00621309|582134720|FG004|Overall Study|Withdrawal by Subject|1|||
161206041|NCT00621309|582134721|FG005|Overall Study|Withdrawal by Subject|1|||
161206042|NCT00905437|582134722|FG000|Overall Study|Adverse Event|3|||
161206043|NCT00905437|582134723|FG001|Overall Study|Adverse Event|2|||
161206044|NCT00905437|582134722|FG000|Overall Study|Lost to Follow-up|0|||
161206045|NCT00905437|582134723|FG001|Overall Study|Lost to Follow-up|1|||
161206046|NCT00905437|582134722|FG000|Overall Study|Withdrawal by Subject|0|||
161206047|NCT00905437|582134723|FG001|Overall Study|Withdrawal by Subject|1|||
161206048|NCT00905437|582134722|FG000|Overall Study|Other|5|||
161206049|NCT00905437|582134723|FG001|Overall Study|Other|6|||
161206050|NCT05246111|582134724|FG000|Period 01|NOT ELIGIBLE IC5|1|||
161206051|NCT05246111|582134725|FG001|Period 01|NOT ELIGIBLE IC5|0|||
161206052|NCT01306968|582134726|FG000|Overall Study|Lost to Follow-up|1|||
161206053|NCT01306968|582134727|FG001|Overall Study|Lost to Follow-up|1|||
161206054|NCT01306968|582134728|FG002|Overall Study|Lost to Follow-up|0|||
161206055|NCT01306968|582134729|FG003|Overall Study|Lost to Follow-up|0|||
161206056|NCT01306968|582134726|FG000|Overall Study|Physician Decision|0|||
161206057|NCT01306968|582134727|FG001|Overall Study|Physician Decision|1|||
161206058|NCT01306968|582134728|FG002|Overall Study|Physician Decision|0|||
161206059|NCT01306968|582134729|FG003|Overall Study|Physician Decision|0|||
161206060|NCT01306968|582134726|FG000|Overall Study|Relocated and left active duty|0|||
161206061|NCT01306968|582134727|FG001|Overall Study|Relocated and left active duty|1|||
161206062|NCT01306968|582134728|FG002|Overall Study|Relocated and left active duty|1|||
161206063|NCT01306968|582134729|FG003|Overall Study|Relocated and left active duty|1|||
161206064|NCT01306968|582134726|FG000|Overall Study|Withdrew - time commitment|0|||
161206065|NCT01306968|582134727|FG001|Overall Study|Withdrew - time commitment|0|||
161206066|NCT01306968|582134728|FG002|Overall Study|Withdrew - time commitment|0|||
161206067|NCT01306968|582134729|FG003|Overall Study|Withdrew - time commitment|2|||
161206068|NCT01306968|582134726|FG000|Overall Study|Withdrew over privacy concerns|0|||
161206069|NCT01306968|582134727|FG001|Overall Study|Withdrew over privacy concerns|0|||
161311165|NCT02135107|582520516|FG002|Maintenance Therapy Period|Pregnancy|0|||
161311166|NCT02135107|582520517|FG003|Maintenance Therapy Period|Pregnancy|1|||
161311167|NCT02135107|582520514|FG000|Maintenance Therapy Period|Other|0|||
161311168|NCT02135107|582520515|FG001|Maintenance Therapy Period|Other|0|||
161311169|NCT02135107|582520516|FG002|Maintenance Therapy Period|Other|7|||
161311170|NCT02135107|582520517|FG003|Maintenance Therapy Period|Other|8|||
161311171|NCT00474045|582520524|FG000|Overall Study|Adverse Event|18|||
161311172|NCT00474045|582520525|FG001|Overall Study|Adverse Event|8|||
161311173|NCT00474045|582520524|FG000|Overall Study|Unclassified|1|||
161311174|NCT00474045|582520525|FG001|Overall Study|Unclassified|3|||
161311175|NCT00474045|582520524|FG000|Overall Study|Lack of Efficacy|0|||
161311176|NCT00474045|582520525|FG001|Overall Study|Lack of Efficacy|9|||
161311177|NCT00474045|582520524|FG000|Overall Study|Lost to Follow-up|1|||
161311178|NCT00474045|582520525|FG001|Overall Study|Lost to Follow-up|1|||
161311179|NCT00474045|582520524|FG000|Overall Study|Protocol Violation|10|||
161311180|NCT00474045|582520525|FG001|Overall Study|Protocol Violation|12|||
161311181|NCT00474045|582520524|FG000|Overall Study|Withdrawal by Subject|16|||
161311182|NCT00474045|582520525|FG001|Overall Study|Withdrawal by Subject|18|||
161311183|NCT00474045|582520524|FG000|Overall Study|Withdrawal criteria|60|||
161311184|NCT00474045|582520525|FG001|Overall Study|Withdrawal criteria|50|||
161311185|NCT02009397|582520526|FG000|Overall Study|Protocol Violation|6|||
161311186|NCT02009397|582520526|FG000|Overall Study|Death|8|||
161311187|NCT02009397|582520526|FG000|Overall Study|Lost to Follow-up|6|||
161311188|NCT02278120|582520531|FG000|Treatment Period|Progressive disease|234|||
161311189|NCT02278120|582520532|FG001|Treatment Period|Progressive disease|260|||
161311190|NCT02278120|582520531|FG000|Treatment Period|Subject/guardian decision|23|||
161311191|NCT02278120|582520532|FG001|Treatment Period|Subject/guardian decision|20|||
161311192|NCT02278120|582520531|FG000|Treatment Period|Adverse Event|16|||
161311193|NCT02278120|582520532|FG001|Treatment Period|Adverse Event|14|||
161311194|NCT02278120|582520531|FG000|Treatment Period|Physician Decision|14|||
161311195|NCT02278120|582520532|FG001|Treatment Period|Physician Decision|27|||
161311196|NCT02278120|582520531|FG000|Treatment Period|Death|3|||
161311197|NCT02278120|582520532|FG001|Treatment Period|Death|3|||
161311198|NCT02278120|582520531|FG000|Treatment Period|Lost to Follow-up|2|||
161311199|NCT02278120|582520532|FG001|Treatment Period|Lost to Follow-up|0|||
161311200|NCT02278120|582520531|FG000|Treatment Period|Protocol deviation|0|||
161206070|NCT01306968|582134728|FG002|Overall Study|Withdrew over privacy concerns|0|||
161206071|NCT01306968|582134729|FG003|Overall Study|Withdrew over privacy concerns|1|||
161206072|NCT02736695|582134730|FG000|Overall Study|Ineligible|6|||
161206073|NCT02736695|582134731|FG001|Overall Study|Ineligible|0|||
161206074|NCT01329562|582134734|FG000|Overall Study|Protocol Violation|5|||
161206075|NCT01329562|582134735|FG001|Overall Study|Protocol Violation|3|||
161206076|NCT01329562|582134734|FG000|Overall Study|Lost to Follow-up|1|||
161206077|NCT01329562|582134735|FG001|Overall Study|Lost to Follow-up|1|||
161206078|NCT01329562|582134734|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
161206079|NCT01329562|582134735|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
161206080|NCT01329562|582134734|FG000|Overall Study|Physician Decision|0|||
161206081|NCT01329562|582134735|FG001|Overall Study|Physician Decision|1|||
161206082|NCT03252015|582134736|FG000|Overall Study|Withdrawal by Subject|0|||
161206083|NCT03252015|582134737|FG001|Overall Study|Withdrawal by Subject|1|||
161206084|NCT03252015|582134738|FG002|Overall Study|Withdrawal by Subject|1|||
161206085|NCT03252015|582134739|FG003|Overall Study|Withdrawal by Subject|0|||
161206086|NCT03252015|582134736|FG000|Overall Study|Adverse Event|1|||
161206087|NCT03252015|582134737|FG001|Overall Study|Adverse Event|0|||
161206088|NCT03252015|582134738|FG002|Overall Study|Adverse Event|0|||
161206089|NCT03252015|582134739|FG003|Overall Study|Adverse Event|1|||
161206090|NCT00061568|582134740|FG000|Overall Study|Lost to Follow-up|12|||
161206091|NCT00061568|582134741|FG001|Overall Study|Lost to Follow-up|0|||
161206092|NCT00061568|582134740|FG000|Overall Study|Death|6|||
161206093|NCT00061568|582134741|FG001|Overall Study|Death|0|||
161206094|NCT00061568|582134740|FG000|Overall Study|Withdrawal by Subject|1|||
161206095|NCT00061568|582134741|FG001|Overall Study|Withdrawal by Subject|0|||
161206096|NCT01381068|582134742|FG000|Overall Study|Death|1|||
161206097|NCT01381068|582134743|FG001|Overall Study|Death|0|||
161206098|NCT01907516|582134748|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
161206099|NCT01907516|582134749|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
161206100|NCT01907516|582134748|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
161206101|NCT01907516|582134749|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
161206102|NCT01907516|582134748|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
161206103|NCT01907516|582134749|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
161206104|NCT01907516|582134748|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
161206105|NCT01907516|582134749|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
161206106|NCT00975000|582134753|FG000|Overall Study|Other|1|||
161206107|NCT00975000|582134754|FG001|Overall Study|Other|0|||
161206108|NCT00975000|582134753|FG000|Overall Study|Adverse Event|1|||
161206109|NCT00975000|582134754|FG001|Overall Study|Adverse Event|1|||
161206110|NCT00975000|582134753|FG000|Overall Study|Withdrawal by Subject|2|||
161206111|NCT00975000|582134754|FG001|Overall Study|Withdrawal by Subject|2|||
161206112|NCT00975000|582134753|FG000|Overall Study|Lost to Follow-up|0|||
161206113|NCT00975000|582134754|FG001|Overall Study|Lost to Follow-up|1|||
161206114|NCT00975000|582134753|FG000|Overall Study|Protocol-specified Criteria|1|||
161206115|NCT00975000|582134754|FG001|Overall Study|Protocol-specified Criteria|0|||
161206116|NCT00975000|582134753|FG000|Overall Study|Non-compliance|0|||
161206117|NCT00975000|582134754|FG001|Overall Study|Non-compliance|1|||
161206118|NCT02392377|582134755|FG000|Overall Study|Withdrawal by Subject|0|||
161206119|NCT02392377|582134756|FG001|Overall Study|Withdrawal by Subject|1|||
161206120|NCT01126359|582134759|FG000|First Intervention (20-minutes)|Physician Decision|0|||
161206121|NCT01126359|582134760|FG001|First Intervention (20-minutes)|Physician Decision|1|||
161206122|NCT00902486|582134761|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161206123|NCT00902486|582134762|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
161206124|NCT00902486|582134763|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
161206125|NCT00902486|582134764|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161206126|NCT00902486|582134765|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
161206127|NCT00902486|582134766|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
161206128|NCT00902486|582134761|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
161206129|NCT00902486|582134762|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161206130|NCT00902486|582134763|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161206131|NCT00902486|582134764|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161206132|NCT00902486|582134765|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
161206133|NCT00902486|582134766|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
161206134|NCT00902486|582134761|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161206135|NCT00902486|582134762|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161206136|NCT00902486|582134763|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161206137|NCT00902486|582134764|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
161206138|NCT00902486|582134765|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
161206139|NCT00902486|582134766|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
161206140|NCT00902486|582134761|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161206141|NCT00902486|582134762|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161206142|NCT00902486|582134763|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161206143|NCT00902486|582134764|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
161206144|NCT00902486|582134765|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161206145|NCT00902486|582134766|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
161206146|NCT00902486|582134761|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161206147|NCT00902486|582134762|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161206148|NCT00902486|582134763|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161206149|NCT00902486|582134764|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
161206150|NCT00902486|582134765|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161206151|NCT00902486|582134766|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
161206152|NCT00902486|582134761|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161311201|NCT02278120|582520532|FG001|Treatment Period|Protocol deviation|2|||
161311202|NCT02278120|582520531|FG000|Treatment Period|Study terminated as per protocol|43|||
161311203|NCT02278120|582520532|FG001|Treatment Period|Study terminated as per protocol|11|||
161311204|NCT02278120|582520531|FG000|Post-treatment Efficacy Follow-up|Death|0|||
161311205|NCT02278120|582520532|FG001|Post-treatment Efficacy Follow-up|Death|1|||
161311206|NCT02278120|582520531|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
161311207|NCT02278120|582520532|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
161311208|NCT02278120|582520531|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
161311209|NCT02278120|582520532|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
161311210|NCT02278120|582520531|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
161311211|NCT02278120|582520532|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
161311212|NCT02278120|582520531|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161311213|NCT02278120|582520532|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
161311214|NCT00808639|582520536|FG000|Overall Study|Disease progression before surgery.|1|||
161311215|NCT01966068|582520537|FG000|Overall Study|Withdrawal by Subject|57|||
161311216|NCT01966068|582520537|FG000|Overall Study|Lost to Follow-up|81|||
161311217|NCT03197324|582520540|FG000|Overall Study|Adverse Event|0|||
161311218|NCT03197324|582520541|FG001|Overall Study|Adverse Event|1|||
161311219|NCT03589976|582520543|FG000|Overall Study|Death|5|||
161311220|NCT03589976|582520544|FG001|Overall Study|Death|1|||
161311221|NCT03589976|582520543|FG000|Overall Study|Adverse Event|5|||
161311222|NCT03589976|582520544|FG001|Overall Study|Adverse Event|1|||
161311223|NCT03589976|582520543|FG000|Overall Study|Withdrawal by Subject|4|||
161311224|NCT03589976|582520544|FG001|Overall Study|Withdrawal by Subject|1|||
161311225|NCT03589976|582520543|FG000|Overall Study|Lost to Follow-up|1|||
161311226|NCT03589976|582520544|FG001|Overall Study|Lost to Follow-up|0|||
161311227|NCT03589976|582520543|FG000|Overall Study|Other|4|||
161311228|NCT03589976|582520544|FG001|Overall Study|Other|3|||
161311229|NCT00908596|582522172|FG000|Overall Study|Other reasons|46|||
161311230|NCT00908596|582522173|FG001|Overall Study|Other reasons|6|||
161311231|NCT00908596|582522174|FG002|Overall Study|Other reasons|2|||
161311232|NCT00908596|582522175|FG003|Overall Study|Other reasons|0|||
161311233|NCT00908596|582522172|FG000|Overall Study|Lost to Follow-up|0|||
161311234|NCT00908596|582522173|FG001|Overall Study|Lost to Follow-up|1|||
161311235|NCT00908596|582522174|FG002|Overall Study|Lost to Follow-up|12|||
161311236|NCT00908596|582522175|FG003|Overall Study|Lost to Follow-up|4|||
161311237|NCT00908596|582522172|FG000|Overall Study|Death|0|||
161311238|NCT00908596|582522173|FG001|Overall Study|Death|5|||
161311239|NCT00908596|582522174|FG002|Overall Study|Death|57|||
161311240|NCT00908596|582522175|FG003|Overall Study|Death|32|||
161311241|NCT00908596|582522172|FG000|Overall Study|Protocol Violation|1|||
161311242|NCT00908596|582522173|FG001|Overall Study|Protocol Violation|0|||
161311243|NCT00908596|582522174|FG002|Overall Study|Protocol Violation|0|||
161311244|NCT00908596|582522175|FG003|Overall Study|Protocol Violation|0|||
161311245|NCT00908596|582522172|FG000|Overall Study|Withdrawal by Subject|0|||
161311246|NCT00908596|582522173|FG001|Overall Study|Withdrawal by Subject|1|||
161311247|NCT00908596|582522174|FG002|Overall Study|Withdrawal by Subject|3|||
161311248|NCT00908596|582522175|FG003|Overall Study|Withdrawal by Subject|1|||
161311249|NCT00224406|582522176|FG000|Overall Study|Re-transplant|0|||
161311250|NCT00224406|582522177|FG001|Overall Study|Re-transplant|2|||
161311251|NCT00224406|582522176|FG000|Overall Study|Death|0|||
161311252|NCT00224406|582522177|FG001|Overall Study|Death|1|||
161311253|NCT00224406|582522176|FG000|Overall Study|Transplant cancelled|0|||
161311254|NCT00224406|582522177|FG001|Overall Study|Transplant cancelled|4|||
161311255|NCT00224406|582522176|FG000|Overall Study|Drug not delivered|2|||
161311256|NCT00224406|582522177|FG001|Overall Study|Drug not delivered|0|||
161311257|NCT00224406|582522176|FG000|Overall Study|Other|4|||
161311258|NCT00224406|582522177|FG001|Overall Study|Other|0|||
161311259|NCT00224406|582522176|FG000|Overall Study|Transplant cancelled|3|||
161311260|NCT00224406|582522177|FG001|Overall Study|Transplant cancelled|0|||
161311261|NCT01556997|582522180|FG000|Overall Study|Adverse Event|10|||
161311262|NCT01556997|582522181|FG001|Overall Study|Adverse Event|12|||
161311263|NCT01556997|582522182|FG002|Overall Study|Adverse Event|12|||
161311264|NCT01556997|582522180|FG000|Overall Study|Lost to Follow-up|6|||
161311265|NCT01556997|582522181|FG001|Overall Study|Lost to Follow-up|6|||
161311266|NCT01556997|582522182|FG002|Overall Study|Lost to Follow-up|4|||
161311267|NCT01556997|582522180|FG000|Overall Study|Physician Decision|1|||
161311268|NCT01556997|582522181|FG001|Overall Study|Physician Decision|1|||
161311269|NCT01556997|582522182|FG002|Overall Study|Physician Decision|1|||
161206153|NCT00902486|582134762|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161206154|NCT00902486|582134763|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161206155|NCT00902486|582134764|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
161206156|NCT00902486|582134765|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
161206157|NCT00902486|582134766|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
161206158|NCT00902486|582134761|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161206159|NCT00902486|582134762|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161206160|NCT00902486|582134763|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
161206161|NCT00902486|582134764|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
161206162|NCT00902486|582134765|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161206163|NCT00902486|582134766|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
161206164|NCT00902486|582134761|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161311270|NCT01556997|582522180|FG000|Overall Study|Withdrawal by Subject|7|||
161311271|NCT01556997|582522181|FG001|Overall Study|Withdrawal by Subject|6|||
161311272|NCT01556997|582522182|FG002|Overall Study|Withdrawal by Subject|8|||
161311273|NCT01556997|582522180|FG000|Overall Study|Other|2|||
161311274|NCT01556997|582522181|FG001|Overall Study|Other|3|||
161311275|NCT01556997|582522182|FG002|Overall Study|Other|7|||
161311276|NCT05459558|582522186|FG000|Overall Study|Adverse Event|1|||
161311277|NCT05459558|582522187|FG001|Overall Study|Adverse Event|0|||
161311278|NCT05459558|582522188|FG002|Overall Study|Adverse Event|0|||
161311279|NCT05459558|582522186|FG000|Overall Study|Scheduling issue|0|||
161311280|NCT05459558|582522187|FG001|Overall Study|Scheduling issue|1|||
161311281|NCT05459558|582522188|FG002|Overall Study|Scheduling issue|3|||
161311282|NCT05459558|582522186|FG000|Overall Study|Withdrawal by Subject|0|||
161311283|NCT05459558|582522187|FG001|Overall Study|Withdrawal by Subject|0|||
161311284|NCT05459558|582522188|FG002|Overall Study|Withdrawal by Subject|2|||
161311285|NCT01250171|582522195|FG000|Overall Study|Administrative reasons|1|||
161311286|NCT01250171|582522196|FG001|Overall Study|Administrative reasons|0|||
161311287|NCT01250171|582522197|FG002|Overall Study|Administrative reasons|0|||
161311288|NCT04676412|582522198|FG000|Overall Study|Death|28|||
161311289|NCT04676412|582522199|FG001|Overall Study|Death|31|||
161311290|NCT04676412|582522198|FG000|Overall Study|Lost to Follow-up|1|||
161311291|NCT04676412|582522199|FG001|Overall Study|Lost to Follow-up|2|||
161311292|NCT04676412|582522198|FG000|Overall Study|Sponsor Decision|20|||
161311293|NCT04676412|582522199|FG001|Overall Study|Sponsor Decision|23|||
161311294|NCT04676412|582522198|FG000|Overall Study|Withdrawal by Subject|0|||
161311295|NCT04676412|582522199|FG001|Overall Study|Withdrawal by Subject|2|||
161311296|NCT04550832|582522200|FG000|Overall Study|Adverse Event|0|||
161311297|NCT04550832|582522201|FG001|Overall Study|Adverse Event|0|||
161311298|NCT04550832|582522202|FG002|Overall Study|Adverse Event|2|||
161311299|NCT04550832|582522203|FG003|Overall Study|Adverse Event|0|||
161311300|NCT04550832|582522204|FG004|Overall Study|Adverse Event|1|||
161311301|NCT04823130|582522205|FG000|Overall Study|Withdrawal by Subject|2|||
161311302|NCT04823130|582522206|FG001|Overall Study|Withdrawal by Subject|3|||
161311303|NCT04823130|582522205|FG000|Overall Study|Failure to meet inclusion criteria|6|||
161311304|NCT04823130|582522206|FG001|Overall Study|Failure to meet inclusion criteria|4|||
161311305|NCT04823130|582522205|FG000|Overall Study|Other-unspecified|1|||
161311306|NCT04823130|582522206|FG001|Overall Study|Other-unspecified|0|||
161311307|NCT02304380|582522212|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161311308|NCT02304380|582522213|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161311309|NCT02304380|582522214|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161311310|NCT02304380|582522215|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
161311311|NCT02304380|582522216|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161311312|NCT02304380|582522217|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
161311313|NCT01027897|582522218|FG000|Overall Study|Protocol Violation|1|||
161311314|NCT01027897|582522218|FG000|Overall Study|Withdrawal by Subject|1|||
161311315|NCT00328094|582522219|FG000|Overall Study|Physician Decision|3|||
161311316|NCT00328094|582522220|FG001|Overall Study|Physician Decision|3|||
161311317|NCT00473824|582522221|FG000|Overall Study|Virologic Breakthrough|1|||
161311318|NCT00473824|582522222|FG001|Overall Study|Virologic Breakthrough|0|||
161311319|NCT00473824|582522221|FG000|Overall Study|Adverse Event|1|||
161311320|NCT00473824|582522222|FG001|Overall Study|Adverse Event|0|||
161311321|NCT00473824|582522221|FG000|Overall Study|Death|1|||
161311322|NCT00473824|582522222|FG001|Overall Study|Death|0|||
161311323|NCT00473824|582522221|FG000|Overall Study|Lost to Follow-up|1|||
161311324|NCT00473824|582522222|FG001|Overall Study|Lost to Follow-up|0|||
161311325|NCT00473824|582522221|FG000|Overall Study|Withdrawal by physician|1|||
161311326|NCT00473824|582522222|FG001|Overall Study|Withdrawal by physician|0|||
161311327|NCT01349322|582522223|FG000|Overall Study|Protocol Violation|45|||
161311328|NCT01349322|582522224|FG001|Overall Study|Protocol Violation|47|||
161311329|NCT00480493|582522227|FG000|Overall Study|moved|2|||
161311330|NCT00480493|582522228|FG001|Overall Study|moved|7|||
161311331|NCT02772276|582522229|FG000|Overall Study|Lost to Follow-up|0|||
161311332|NCT02772276|582522230|FG001|Overall Study|Lost to Follow-up|0|||
161311333|NCT02772276|582522231|FG002|Overall Study|Lost to Follow-up|0|||
161311334|NCT02772276|582522232|FG003|Overall Study|Lost to Follow-up|0|||
161311335|NCT02772276|582522233|FG004|Overall Study|Lost to Follow-up|0|||
161311336|NCT02772276|582522234|FG005|Overall Study|Lost to Follow-up|0|||
161311337|NCT02772276|582522235|FG006|Overall Study|Lost to Follow-up|1|||
161311338|NCT02772276|582522236|FG007|Overall Study|Lost to Follow-up|0|||
161311339|NCT02772276|582522237|FG008|Overall Study|Lost to Follow-up|0|||
161311340|NCT02772276|582522238|FG009|Overall Study|Lost to Follow-up|0|||
161311341|NCT02772276|582522239|FG010|Overall Study|Lost to Follow-up|0|||
161311342|NCT02772276|582522240|FG011|Overall Study|Lost to Follow-up|0|||
161311343|NCT02772276|582522241|FG012|Overall Study|Lost to Follow-up|0|||
161311344|NCT02772276|582522229|FG000|Overall Study|Withdrew consent|0|||
161311345|NCT02772276|582522230|FG001|Overall Study|Withdrew consent|0|||
161311346|NCT02772276|582522231|FG002|Overall Study|Withdrew consent|0|||
161311347|NCT02772276|582522232|FG003|Overall Study|Withdrew consent|0|||
161311348|NCT02772276|582522233|FG004|Overall Study|Withdrew consent|0|||
161311349|NCT02772276|582522234|FG005|Overall Study|Withdrew consent|0|||
161311350|NCT02772276|582522235|FG006|Overall Study|Withdrew consent|0|||
161311351|NCT02772276|582522236|FG007|Overall Study|Withdrew consent|1|||
161311352|NCT02772276|582522237|FG008|Overall Study|Withdrew consent|0|||
161311353|NCT02772276|582522238|FG009|Overall Study|Withdrew consent|0|||
161311354|NCT02772276|582522239|FG010|Overall Study|Withdrew consent|0|||
161311355|NCT02772276|582522240|FG011|Overall Study|Withdrew consent|0|||
161311356|NCT02772276|582522241|FG012|Overall Study|Withdrew consent|0|||
161311357|NCT00550862|582522242|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
161311358|NCT00550862|582522243|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
161311359|NCT00550862|582522244|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
161311360|NCT00550862|582522245|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
161311361|NCT00550862|582522246|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
161311362|NCT00550862|582522242|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
161311363|NCT00550862|582522243|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161311364|NCT00550862|582522244|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
161311365|NCT00550862|582522245|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161311366|NCT00550862|582522246|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
161311367|NCT00550862|582522242|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161311368|NCT00550862|582522243|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161311369|NCT00550862|582522244|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
161311370|NCT00550862|582522245|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161311371|NCT00550862|582522246|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
161311372|NCT00550862|582522242|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161311373|NCT00550862|582522243|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161311374|NCT00550862|582522244|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
161311375|NCT00550862|582522245|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161311376|NCT00550862|582522246|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
161311377|NCT00550862|582522242|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161311378|NCT00550862|582522243|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
161311379|NCT00550862|582522244|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161311380|NCT00550862|582522245|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161311381|NCT00550862|582522246|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
161311382|NCT00550862|582522242|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161311383|NCT00550862|582522243|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161311384|NCT00550862|582522244|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161311385|NCT00550862|582522245|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
161311386|NCT00550862|582522246|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
161311387|NCT00550862|582522242|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161311388|NCT00550862|582522243|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161311389|NCT00550862|582522244|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161311390|NCT00550862|582522245|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
161311391|NCT00550862|582522246|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
161311392|NCT00550862|582522242|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161311393|NCT00550862|582522243|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161311394|NCT00550862|582522244|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161311395|NCT00550862|582522245|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
161311396|NCT00550862|582522246|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
161311397|NCT00550862|582522242|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
161311398|NCT00550862|582522243|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
161091030|NCT00918580|581723781|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
161311399|NCT00550862|582522244|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
161311400|NCT00550862|582522245|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
161311401|NCT00550862|582522246|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
161311402|NCT00550862|582522242|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161311403|NCT00550862|582522243|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161311404|NCT00550862|582522244|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161311405|NCT00550862|582522245|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
161311406|NCT00550862|582522246|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
161311407|NCT02248974|582522250|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
161311408|NCT02248974|582522251|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
161311409|NCT02248974|582522250|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
161311410|NCT02248974|582522251|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
161311411|NCT02248974|582522250|FG000|1-Day Follow-Up|Enrolled in another study|1|||
161311412|NCT02248974|582522251|FG001|1-Day Follow-Up|Enrolled in another study|0|||
161091031|NCT00918580|581723781|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
161091032|NCT00918580|581723781|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
161091033|NCT00918580|581723781|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
161311413|NCT02248974|582522250|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
161311414|NCT02248974|582522251|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
161311415|NCT02248974|582522250|FG000|1-Week Follow-Up|Enrolled in another study|1|||
161311416|NCT02248974|582522251|FG001|1-Week Follow-Up|Enrolled in another study|1|||
161311417|NCT02248974|582522250|FG000|1-Week Follow-Up|Transferred to another facility|1|||
161311418|NCT02248974|582522251|FG001|1-Week Follow-Up|Transferred to another facility|0|||
161311419|NCT02248974|582522250|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
161311420|NCT02248974|582522251|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
161311421|NCT02248974|582522250|FG000|1-Week Follow-Up|Death|1|||
161311422|NCT02248974|582522251|FG001|1-Week Follow-Up|Death|1|||
161311423|NCT02248974|582522250|FG000|1-Week Follow-Up|Excluded because of age|0|||
161311424|NCT02248974|582522251|FG001|1-Week Follow-Up|Excluded because of age|1|||
161311425|NCT02248974|582522250|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
161311426|NCT02248974|582522251|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
161311427|NCT02248974|582522250|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
161311428|NCT02248974|582522251|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
161311429|NCT02248974|582522250|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
161311430|NCT02248974|582522251|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
161311431|NCT02248974|582522250|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
161311432|NCT02248974|582522251|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
161311433|NCT02248974|582522250|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
161311434|NCT02248974|582522251|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
161311435|NCT03488225|582522253|FG000|Overall Study|Off Protocol Therapy|2|||
161311436|NCT03488225|582522253|FG000|Overall Study|Stem Cell Transplant|2|||
161311437|NCT04093492|582522254|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
161091034|NCT00701220|581723782|FG000|Overall Study|Withdrawal by Subject|0|||
161091035|NCT00701220|581723783|FG001|Overall Study|Withdrawal by Subject|2|||
161091036|NCT00701220|581723782|FG000|Overall Study|Protocol Violation|2|||
161091037|NCT00701220|581723783|FG001|Overall Study|Protocol Violation|0|||
161091038|NCT00211185|581723784|FG000|Overall Study|Death|2|||
161091039|NCT00211185|581723784|FG000|Overall Study|Disease progression|7|||
161206165|NCT00902486|582134762|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161206166|NCT00902486|582134763|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161206167|NCT00902486|582134764|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161206168|NCT00902486|582134765|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
161206169|NCT00902486|582134766|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
161206170|NCT00902486|582134761|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161206171|NCT00902486|582134762|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161091040|NCT00211185|581723784|FG000|Overall Study|Withdrawal by Subject|6|||
161206172|NCT00902486|582134763|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161206173|NCT00902486|582134764|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
161091041|NCT00211185|581723784|FG000|Overall Study|Physician Decision|5|||
161091042|NCT00069108|581723785|FG000|Overall Study|Withdrawal by Subject|5|||
161206174|NCT00902486|582134765|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161206175|NCT00902486|582134766|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
161206176|NCT00902486|582134761|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161206177|NCT00902486|582134762|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161206178|NCT00902486|582134763|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
161206179|NCT00902486|582134764|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161206180|NCT00902486|582134765|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161206181|NCT00902486|582134766|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
161206182|NCT00902486|582134761|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
161206183|NCT00902486|582134762|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
161206184|NCT00902486|582134763|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
161206185|NCT00902486|582134764|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
161206186|NCT00902486|582134765|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
161206187|NCT00902486|582134766|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
161206188|NCT00209560|582134767|FG000|Overall Study|Lack of Efficacy|1|||
161206189|NCT00209560|582134768|FG001|Overall Study|Lack of Efficacy|0|||
161206190|NCT04439110|582134769|FG000|Overall Study|Ineligible|2|||
161206191|NCT04439110|582134769|FG000|Overall Study|Adverse Event|4|||
161206192|NCT04439110|582134769|FG000|Overall Study|Death|2|||
161206193|NCT04439110|582134769|FG000|Overall Study|Disease proression|25|||
161206194|NCT04439110|582134769|FG000|Overall Study|Withdrawal by Subject|1|||
161206195|NCT04439110|582134769|FG000|Overall Study|Alternative therapy|1|||
161206196|NCT04439110|582134769|FG000|Overall Study|Other complicating disease|1|||
161206197|NCT04439110|582134769|FG000|Overall Study|Personal reasons|1|||
161206198|NCT04439110|582134769|FG000|Overall Study|Still on treatment|1|||
161206199|NCT01298661|582134770|FG000|Overall Study|Withdrawal by Subject|2|||
161206200|NCT01298661|582134771|FG001|Overall Study|Withdrawal by Subject|0|||
161206201|NCT01298661|582134772|FG002|Overall Study|Withdrawal by Subject|2|||
161206202|NCT00526227|582134775|FG000|Overall Study|Device not implanted|1|||
161206203|NCT00526227|582134775|FG000|Overall Study|Death|1|||
161206204|NCT05257109|582134776|FG000|Overall Study|Withdrawal by Subject|1|||
161206205|NCT05257109|582134777|FG001|Overall Study|Withdrawal by Subject|0|||
161206206|NCT05257109|582134778|FG002|Overall Study|Withdrawal by Subject|0|||
161206207|NCT05257109|582134779|FG003|Overall Study|Withdrawal by Subject|0|||
161206208|NCT00858234|582136343|FG000|Overall Study|Adverse Event|6|||
161206209|NCT00858234|582136343|FG000|Overall Study|Progressive disease|2|||
161206210|NCT00858234|582136343|FG000|Overall Study|Status unknown|1|||
161206211|NCT01678924|582136344|FG000|Overall Study|Adverse Event|1|||
161206212|NCT01678924|582136345|FG001|Overall Study|Adverse Event|1|||
161206213|NCT01678924|582136346|FG002|Overall Study|Adverse Event|0|||
161206214|NCT01678924|582136347|FG003|Overall Study|Adverse Event|1|||
161206215|NCT01678924|582136344|FG000|Overall Study|Lack of Efficacy|7|||
161206216|NCT01678924|582136345|FG001|Overall Study|Lack of Efficacy|2|||
161206217|NCT01678924|582136346|FG002|Overall Study|Lack of Efficacy|0|||
161206218|NCT01678924|582136347|FG003|Overall Study|Lack of Efficacy|5|||
161206219|NCT01678924|582136344|FG000|Overall Study|Lost to Follow-up|0|||
161206220|NCT01678924|582136345|FG001|Overall Study|Lost to Follow-up|4|||
161206221|NCT01678924|582136346|FG002|Overall Study|Lost to Follow-up|0|||
161206222|NCT01678924|582136347|FG003|Overall Study|Lost to Follow-up|2|||
161206223|NCT01678924|582136344|FG000|Overall Study|Personal Reasons|2|||
161206224|NCT01678924|582136345|FG001|Overall Study|Personal Reasons|2|||
161206225|NCT01678924|582136346|FG002|Overall Study|Personal Reasons|2|||
161206226|NCT01678924|582136347|FG003|Overall Study|Personal Reasons|7|||
161206227|NCT01678924|582136344|FG000|Overall Study|Withdrawal by Subject|0|||
161206228|NCT01678924|582136345|FG001|Overall Study|Withdrawal by Subject|3|||
161206229|NCT01678924|582136346|FG002|Overall Study|Withdrawal by Subject|0|||
161206230|NCT01678924|582136347|FG003|Overall Study|Withdrawal by Subject|2|||
161206231|NCT01678924|582136344|FG000|Overall Study|Unable to attend scheduled visits|0|||
161206232|NCT01678924|582136345|FG001|Overall Study|Unable to attend scheduled visits|0|||
161311438|NCT04093492|582522255|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
161311439|NCT04093492|582522256|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
161206233|NCT01678924|582136346|FG002|Overall Study|Unable to attend scheduled visits|0|||
161206234|NCT01678924|582136347|FG003|Overall Study|Unable to attend scheduled visits|1|||
161206235|NCT02253654|582136348|FG000|Overall Study|Withdrawal by Subject|12|||
161206236|NCT02253654|582136349|FG001|Overall Study|Withdrawal by Subject|4|||
161206237|NCT02253654|582136348|FG000|Overall Study|Decision by Sponsor|1|||
161206238|NCT02253654|582136349|FG001|Overall Study|Decision by Sponsor|1|||
161206239|NCT02253654|582136348|FG000|Overall Study|Lost to Follow-up|2|||
161206240|NCT02253654|582136349|FG001|Overall Study|Lost to Follow-up|5|||
161206241|NCT02253654|582136348|FG000|Overall Study|Death|4|||
161206242|NCT02253654|582136349|FG001|Overall Study|Death|7|||
161206243|NCT02253654|582136348|FG000|Overall Study|Did Not Receive Study Treatment|4|||
161206244|NCT02253654|582136349|FG001|Overall Study|Did Not Receive Study Treatment|1|||
161206245|NCT01614925|582136350|FG000|Overall Study|Withdrawal by Subject|1|||
161206246|NCT01614925|582136351|FG001|Overall Study|Withdrawal by Subject|0|||
161206247|NCT01614925|582136350|FG000|Overall Study|Protocol Violation|3|||
161206248|NCT01614925|582136351|FG001|Overall Study|Protocol Violation|2|||
161206249|NCT01652573|582136361|FG000|Overall Study|Adverse Event|0|||
161206250|NCT01652573|582136362|FG001|Overall Study|Adverse Event|1|||
161206251|NCT00468312|582136365|FG000|Overall Study|Adverse Event|2|||
161091043|NCT00069108|581723786|FG001|Overall Study|Withdrawal by Subject|9|||
161091044|NCT00069108|581723785|FG000|Overall Study|Adverse Event|64|||
161091045|NCT00069108|581723786|FG001|Overall Study|Adverse Event|42|||
161206252|NCT00468312|582136366|FG001|Overall Study|Adverse Event|1|||
161206253|NCT00468312|582136365|FG000|Overall Study|Lack of Efficacy|0|||
161206254|NCT00468312|582136366|FG001|Overall Study|Lack of Efficacy|1|||
161206255|NCT00468312|582136365|FG000|Overall Study|Withdrawal by Subject|0|||
161206256|NCT00468312|582136366|FG001|Overall Study|Withdrawal by Subject|1|||
161206257|NCT00468312|582136365|FG000|Overall Study|Protocol Violation|2|||
161206258|NCT00468312|582136366|FG001|Overall Study|Protocol Violation|1|||
161206259|NCT00468312|582136365|FG000|Overall Study|Did not meet protocol eligibility|0|||
161206260|NCT00468312|582136366|FG001|Overall Study|Did not meet protocol eligibility|1|||
161206261|NCT01052038|582136367|FG000|Overall Study|Lost to Follow-up|2|||
161206262|NCT01052038|582136368|FG001|Overall Study|Lost to Follow-up|3|||
161206263|NCT01052038|582136369|FG002|Overall Study|Lost to Follow-up|1|||
161206264|NCT01052038|582136367|FG000|Overall Study|Protocol Violation|2|||
161206265|NCT01052038|582136368|FG001|Overall Study|Protocol Violation|3|||
161206266|NCT01052038|582136369|FG002|Overall Study|Protocol Violation|3|||
161206267|NCT03976076|582136370|FG000|Overall Study|Withdrawal by Subject|2|||
161206268|NCT03343054|582136373|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
161206269|NCT03343054|582136374|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
161206270|NCT03343054|582136375|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
161206271|NCT03343054|582136373|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
161206272|NCT03343054|582136374|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
161206273|NCT03343054|582136375|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
161206274|NCT03343054|582136373|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
161206275|NCT03343054|582136374|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
161206276|NCT03343054|582136375|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
161206277|NCT03343054|582136373|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
161206278|NCT03343054|582136374|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
161206279|NCT03343054|582136375|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
161206280|NCT00981409|582136380|FG000|Overall Study|Adverse Event|4|||
161206281|NCT00981409|582136381|FG001|Overall Study|Adverse Event|0|||
161206282|NCT00981409|582136380|FG000|Overall Study|Protocol Violation|0|||
161206283|NCT00981409|582136381|FG001|Overall Study|Protocol Violation|1|||
161206284|NCT00981409|582136380|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
161206285|NCT00981409|582136381|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
161206286|NCT00450177|582136382|FG000|Overall Study|Adverse Event|7|||
161206287|NCT00450177|582136383|FG001|Overall Study|Adverse Event|4|||
161206288|NCT00450177|582136382|FG000|Overall Study|Withdrawal by Subject|1|||
161206289|NCT00450177|582136383|FG001|Overall Study|Withdrawal by Subject|6|||
161206290|NCT00450177|582136382|FG000|Overall Study|Withdrawal by Primary Team|1|||
161206291|NCT00450177|582136383|FG001|Overall Study|Withdrawal by Primary Team|1|||
161206292|NCT03869684|582136386|FG000|Overall Study|Adverse Event|0|||
161206293|NCT03869684|582136387|FG001|Overall Study|Adverse Event|3|||
161206294|NCT03869684|582136388|FG002|Overall Study|Adverse Event|1|||
161206295|NCT03869684|582136386|FG000|Overall Study|Withdrawal by Subject|1|||
161206296|NCT03869684|582136387|FG001|Overall Study|Withdrawal by Subject|0|||
161206297|NCT03869684|582136388|FG002|Overall Study|Withdrawal by Subject|0|||
161206298|NCT03869684|582136386|FG000|Overall Study|Lost to Follow-up|1|||
161206299|NCT03869684|582136387|FG001|Overall Study|Lost to Follow-up|0|||
161206300|NCT03869684|582136388|FG002|Overall Study|Lost to Follow-up|0|||
161206301|NCT03869684|582136386|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
161206302|NCT03869684|582136387|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
161206303|NCT03869684|582136388|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
161206304|NCT05723835|582136393|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
161206305|NCT05723835|582136394|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
161206306|NCT05723835|582136395|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
161206307|NCT05723835|582136396|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
161206308|NCT05723835|582136397|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
161206309|NCT05723835|582136398|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
161206310|NCT05723835|582136399|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
161206311|NCT05723835|582136400|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
161206312|NCT05226286|582136401|FG000|Overall Study|Screen failures prior to implant|62|||
161206313|NCT05226286|582136401|FG000|Overall Study|Withdrawal by Subject|13|||
161206314|NCT05226286|582136401|FG000|Overall Study|Lost to Follow-up|3|||
161206315|NCT05226286|582136401|FG000|Overall Study|Physician Decision|1|||
161206316|NCT05226286|582136401|FG000|Overall Study|Adverse Event|1|||
161206317|NCT05226286|582136401|FG000|Overall Study|Death|1|||
161206318|NCT05226286|582136401|FG000|Overall Study|Device explant with no planned replacement|1|||
161311440|NCT04093492|582522257|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
161311441|NCT04093492|582522254|FG000|25 Weeks Gestational Age (GA)|No response|5|||
161206319|NCT05226286|582136401|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
161206320|NCT05226286|582136401|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
161206321|NCT00602641|582136402|FG000|Overall Study|Never started protocol therapy|6|||
161206322|NCT00602641|582136403|FG001|Overall Study|Never started protocol therapy|2|||
161206323|NCT00602641|582136402|FG000|Overall Study|Still on treatment at time of analysis|8|||
161206324|NCT00602641|582136403|FG001|Overall Study|Still on treatment at time of analysis|15|||
161206325|NCT00602641|582136402|FG000|Overall Study|Adverse Event|62|||
161206326|NCT00602641|582136403|FG001|Overall Study|Adverse Event|53|||
161206327|NCT00602641|582136402|FG000|Overall Study|Disease progression|38|||
161206328|NCT00602641|582136403|FG001|Overall Study|Disease progression|55|||
161206329|NCT00602641|582136402|FG000|Overall Study|Death|6|||
161206330|NCT00602641|582136403|FG001|Overall Study|Death|5|||
161206331|NCT00602641|582136402|FG000|Overall Study|Withdrawal by Subject|15|||
161206332|NCT00602641|582136403|FG001|Overall Study|Withdrawal by Subject|12|||
161206333|NCT00602641|582136402|FG000|Overall Study|Alternative therapy|5|||
161206334|NCT00602641|582136403|FG001|Overall Study|Alternative therapy|2|||
161206335|NCT00602641|582136402|FG000|Overall Study|Other Complicating Disease|5|||
161206336|NCT00602641|582136403|FG001|Overall Study|Other Complicating Disease|2|||
161206337|NCT00602641|582136402|FG000|Overall Study|Physician Decision|5|||
161206338|NCT00602641|582136403|FG001|Overall Study|Physician Decision|4|||
161206339|NCT00602641|582136402|FG000|Overall Study|Administrative Closure|1|||
161206340|NCT00602641|582136403|FG001|Overall Study|Administrative Closure|1|||
161206341|NCT00602641|582136402|FG000|Overall Study|Other|3|||
161206342|NCT00602641|582136403|FG001|Overall Study|Other|1|||
161206343|NCT03901352|582136404|FG000|Double-blind Phase|Adverse Event|6|||
161206344|NCT03901352|582136405|FG001|Double-blind Phase|Adverse Event|4|||
161206345|NCT03901352|582136404|FG000|Double-blind Phase|Death|1|||
161206346|NCT03901352|582136405|FG001|Double-blind Phase|Death|0|||
161206347|NCT03901352|582136404|FG000|Double-blind Phase|Lack of Efficacy|0|||
161206348|NCT03901352|582136405|FG001|Double-blind Phase|Lack of Efficacy|1|||
161206349|NCT03901352|582136404|FG000|Double-blind Phase|Protocol Violation|0|||
161206350|NCT03901352|582136405|FG001|Double-blind Phase|Protocol Violation|1|||
161206351|NCT03901352|582136404|FG000|Double-blind Phase|Withdrawal by Subject|10|||
161206352|NCT03901352|582136405|FG001|Double-blind Phase|Withdrawal by Subject|8|||
161206353|NCT03901352|582136404|FG000|Open-label Extension Phase|Adverse Event|24|||
161206354|NCT03901352|582136405|FG001|Open-label Extension Phase|Adverse Event|0|||
161206355|NCT03901352|582136404|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
161206356|NCT03901352|582136405|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
161206357|NCT03901352|582136404|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
161206358|NCT03901352|582136405|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
161206359|NCT03901352|582136404|FG000|Open-label Extension Phase|Other|1|||
161206360|NCT03901352|582136405|FG001|Open-label Extension Phase|Other|0|||
161206361|NCT01826201|582136408|FG000|Overall Study|Non compliance with protocol|4|||
161206362|NCT03901339|582136409|FG000|Overall Study|Death|220|||
161206363|NCT03901339|582136410|FG001|Overall Study|Death|192|||
161206364|NCT03901339|582136409|FG000|Overall Study|Informed consent withdrawn|13|||
161206365|NCT03901339|582136410|FG001|Overall Study|Informed consent withdrawn|40|||
161206366|NCT03901339|582136409|FG000|Overall Study|Sponsor request|30|||
161206367|NCT03901339|582136410|FG001|Overall Study|Sponsor request|23|||
161206368|NCT03901339|582136409|FG000|Overall Study|Reason not specified|5|||
161091046|NCT00069108|581723785|FG000|Overall Study|Death|6|||
161206369|NCT03901339|582136410|FG001|Overall Study|Reason not specified|7|||
161206370|NCT03901339|582136409|FG000|Overall Study|Lost to Follow-up|4|||
161206371|NCT03901339|582136410|FG001|Overall Study|Lost to Follow-up|7|||
161206372|NCT03901339|582136409|FG000|Overall Study|Covid19|0|||
161206373|NCT03901339|582136410|FG001|Overall Study|Covid19|2|||
161206374|NCT01988337|582136413|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
161206375|NCT02742818|582136414|FG000|Overall Study|Adverse Event|0|||
161206376|NCT02742818|582136415|FG001|Overall Study|Adverse Event|1|||
161206377|NCT02742818|582136414|FG000|Overall Study|Protocol Violation|0|||
161206378|NCT02742818|582136415|FG001|Overall Study|Protocol Violation|1|||
161206379|NCT04701658|582136416|FG000|Overall Study|Lost to Follow-up|6|||
161206380|NCT00457418|582136417|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
161206381|NCT00457418|582136417|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
161091047|NCT00069108|581723786|FG001|Overall Study|Death|6|||
161091048|NCT00069108|581723785|FG000|Overall Study|Administration|15|||
161091049|NCT00069108|581723786|FG001|Overall Study|Administration|4|||
161091050|NCT00069108|581723785|FG000|Overall Study|Insufficient therapy|117|||
161091051|NCT00069108|581723786|FG001|Overall Study|Insufficient therapy|144|||
161091052|NCT00069108|581723785|FG000|Overall Study|Violation criteria|1|||
161091053|NCT00069108|581723786|FG001|Overall Study|Violation criteria|4|||
161091054|NCT00069108|581723785|FG000|Overall Study|Refused treatment|5|||
161091055|NCT00069108|581723786|FG001|Overall Study|Refused treatment|10|||
161091056|NCT01411215|581723787|FG000|Overall Study|Adverse Event|1|||
161091057|NCT01411215|581723788|FG001|Overall Study|Adverse Event|2|||
161091058|NCT01411215|581723787|FG000|Overall Study|Lack of Efficacy|2|||
161091059|NCT01411215|581723788|FG001|Overall Study|Lack of Efficacy|4|||
161091060|NCT01411215|581723787|FG000|Overall Study|Lost to Follow-up|12|||
161311442|NCT04093492|582522255|FG001|25 Weeks Gestational Age (GA)|No response|5|||
161311443|NCT04093492|582522256|FG002|25 Weeks Gestational Age (GA)|No response|5|||
161311444|NCT04093492|582522257|FG003|25 Weeks Gestational Age (GA)|No response|2|||
161311445|NCT04093492|582522254|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161311446|NCT04093492|582522255|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161311447|NCT04093492|582522256|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
161311448|NCT04093492|582522257|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
161311449|NCT04093492|582522254|FG000|30 Weeks GA|Delivered before assessment|1|||
161311450|NCT04093492|582522255|FG001|30 Weeks GA|Delivered before assessment|2|||
161311451|NCT04093492|582522256|FG002|30 Weeks GA|Delivered before assessment|0|||
161311452|NCT04093492|582522257|FG003|30 Weeks GA|Delivered before assessment|0|||
161311453|NCT04093492|582522254|FG000|30 Weeks GA|No response|7|||
161311454|NCT04093492|582522255|FG001|30 Weeks GA|No response|5|||
161311455|NCT04093492|582522256|FG002|30 Weeks GA|No response|5|||
161311456|NCT04093492|582522257|FG003|30 Weeks GA|No response|2|||
161311457|NCT04093492|582522254|FG000|30 Weeks GA|Lost to Follow-up|0|||
161311458|NCT04093492|582522255|FG001|30 Weeks GA|Lost to Follow-up|1|||
161311459|NCT04093492|582522256|FG002|30 Weeks GA|Lost to Follow-up|0|||
161311460|NCT04093492|582522257|FG003|30 Weeks GA|Lost to Follow-up|0|||
161311461|NCT04093492|582522254|FG000|34 Weeks GA|Delivered before assessment|6|||
161311462|NCT04093492|582522255|FG001|34 Weeks GA|Delivered before assessment|3|||
161311463|NCT04093492|582522256|FG002|34 Weeks GA|Delivered before assessment|0|||
161311464|NCT04093492|582522257|FG003|34 Weeks GA|Delivered before assessment|0|||
161311465|NCT04093492|582522254|FG000|34 Weeks GA|No response|0|||
161311466|NCT04093492|582522255|FG001|34 Weeks GA|No response|7|||
161311467|NCT04093492|582522256|FG002|34 Weeks GA|No response|5|||
161311468|NCT04093492|582522257|FG003|34 Weeks GA|No response|3|||
161311469|NCT04093492|582522254|FG000|34 Weeks GA|Lost to Follow-up|0|||
161311470|NCT04093492|582522255|FG001|34 Weeks GA|Lost to Follow-up|1|||
161311471|NCT04093492|582522256|FG002|34 Weeks GA|Lost to Follow-up|0|||
161311472|NCT04093492|582522257|FG003|34 Weeks GA|Lost to Follow-up|0|||
161311473|NCT01739764|582522259|FG000|Overall Study|Adverse Event|0|||
161311474|NCT01739764|582522260|FG001|Overall Study|Adverse Event|3|||
161311475|NCT01739764|582522261|FG002|Overall Study|Adverse Event|4|||
161311476|NCT01739764|582522259|FG000|Overall Study|Death|4|||
161311477|NCT01739764|582522260|FG001|Overall Study|Death|6|||
161311478|NCT01739764|582522261|FG002|Overall Study|Death|38|||
161311479|NCT01739764|582522259|FG000|Overall Study|Lost to Follow-up|0|||
161311480|NCT01739764|582522260|FG001|Overall Study|Lost to Follow-up|0|||
161311481|NCT01739764|582522261|FG002|Overall Study|Lost to Follow-up|5|||
161311482|NCT01739764|582522259|FG000|Overall Study|Non-Compliance|0|||
161311483|NCT01739764|582522260|FG001|Overall Study|Non-Compliance|0|||
161311484|NCT01739764|582522261|FG002|Overall Study|Non-Compliance|1|||
161311485|NCT01739764|582522259|FG000|Overall Study|Multiple Reasons|3|||
161311486|NCT01739764|582522260|FG001|Overall Study|Multiple Reasons|2|||
161311487|NCT01739764|582522261|FG002|Overall Study|Multiple Reasons|3|||
161311488|NCT01739764|582522259|FG000|Overall Study|Physician Decision|2|||
161311489|NCT01739764|582522260|FG001|Overall Study|Physician Decision|2|||
161311490|NCT01739764|582522261|FG002|Overall Study|Physician Decision|4|||
161311491|NCT01739764|582522259|FG000|Overall Study|Progressive Disease|3|||
161311492|NCT01739764|582522260|FG001|Overall Study|Progressive Disease|5|||
161311493|NCT01739764|582522261|FG002|Overall Study|Progressive Disease|16|||
161311494|NCT01739764|582522259|FG000|Overall Study|Protocol Violation|0|||
161311495|NCT01739764|582522260|FG001|Overall Study|Protocol Violation|0|||
161311496|NCT01739764|582522261|FG002|Overall Study|Protocol Violation|2|||
161311497|NCT01739764|582522259|FG000|Overall Study|Study Terminated by Sponsor|8|||
161311498|NCT01739764|582522260|FG001|Overall Study|Study Terminated by Sponsor|13|||
161311499|NCT01739764|582522261|FG002|Overall Study|Study Terminated by Sponsor|26|||
161311500|NCT01739764|582522259|FG000|Overall Study|Withdrawal by Subject|6|||
161311501|NCT01739764|582522260|FG001|Overall Study|Withdrawal by Subject|5|||
161311502|NCT01739764|582522261|FG002|Overall Study|Withdrawal by Subject|27|||
161311503|NCT00404924|582522262|FG000|Overall Study|Adverse Event|75|||
161311504|NCT00404924|582522263|FG001|Overall Study|Adverse Event|16|||
161311505|NCT00404924|582522262|FG000|Overall Study|Condition under investigation worsened|475|||
161311506|NCT00404924|582522263|FG001|Overall Study|Condition under investigation worsened|264|||
161311507|NCT00404924|582522262|FG000|Overall Study|Lost to Follow-up|1|||
161311508|NCT00404924|582522263|FG001|Overall Study|Lost to Follow-up|1|||
161311509|NCT00404924|582522262|FG000|Overall Study|Withdrawal by Subject|26|||
161311510|NCT00404924|582522263|FG001|Overall Study|Withdrawal by Subject|13|||
161311511|NCT00404924|582522262|FG000|Overall Study|Other|25|||
161311512|NCT00404924|582522263|FG001|Overall Study|Other|11|||
161311513|NCT00404924|582522262|FG000|Overall Study|Randomised but not received treatment|1|||
161311514|NCT00404924|582522263|FG001|Overall Study|Randomised but not received treatment|1|||
161311515|NCT00513357|582522268|FG000|Overall Study|did not receive allocated placebo|2|||
161311516|NCT00513357|582522269|FG001|Overall Study|did not receive allocated placebo|3|||
161311517|NCT00513357|582522268|FG000|Overall Study|Adverse Event|4|||
161311518|NCT00513357|582522269|FG001|Overall Study|Adverse Event|2|||
161311519|NCT00513357|582522268|FG000|Overall Study|Death|2|||
161311520|NCT00513357|582522269|FG001|Overall Study|Death|0|||
161206382|NCT00457418|582136417|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
161206383|NCT00457418|582136417|FG000|Post PK Maintenance|Adverse Event|10|||
161206384|NCT00457418|582136417|FG000|Post PK Maintenance|Progression of Disease|6|||
161206385|NCT00457418|582136417|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
161206386|NCT00457418|582136417|FG000|Post PK Maintenance|Lost to Follow-up|1|||
161206387|NCT03387735|582136420|FG000|Overall Study|Lost to Follow-up|4|||
161206388|NCT03387735|582136421|FG001|Overall Study|Lost to Follow-up|8|||
161206389|NCT03387735|582136420|FG000|Overall Study|Death|4|||
161206390|NCT03387735|582136421|FG001|Overall Study|Death|8|||
161206391|NCT03099161|582136422|FG000|Overall Study|Adverse Event|0|||
161206392|NCT03099161|582136423|FG001|Overall Study|Adverse Event|0|||
161206393|NCT03099161|582136424|FG002|Overall Study|Adverse Event|2|||
161206394|NCT03099161|582136422|FG000|Overall Study|Physician Decision|2|||
161206395|NCT03099161|582136423|FG001|Overall Study|Physician Decision|0|||
161206396|NCT03099161|582136424|FG002|Overall Study|Physician Decision|0|||
161206397|NCT03099161|582136422|FG000|Overall Study|Progressive Disease|1|||
161206398|NCT03099161|582136423|FG001|Overall Study|Progressive Disease|4|||
161206399|NCT03099161|582136424|FG002|Overall Study|Progressive Disease|1|||
161206400|NCT00110084|582136427|FG000|Overall Study|Adverse Event|9|||
161206401|NCT00110084|582136427|FG000|Overall Study|Death|1|||
161206402|NCT00110084|582136427|FG000|Overall Study|Patient Refusal|10|||
161206403|NCT00110084|582136427|FG000|Overall Study|Alternate Therapy|5|||
161206404|NCT00110084|582136427|FG000|Overall Study|Intercurrent Illness|1|||
161206405|NCT00110084|582136427|FG000|Overall Study|Other|2|||
161206406|NCT04854707|582136429|FG000|Overall Study|Lack of Efficacy|78|||
161206407|NCT04854707|582136430|FG001|Overall Study|Lack of Efficacy|59|||
161206408|NCT04854707|582136431|FG002|Overall Study|Lack of Efficacy|30|||
161206409|NCT00742859|582136433|FG000|Overall Study|Adverse Event|5|||
161206410|NCT00742859|582136434|FG001|Overall Study|Adverse Event|6|||
161206411|NCT00742859|582136435|FG002|Overall Study|Adverse Event|3|||
161206412|NCT00742859|582136436|FG003|Overall Study|Adverse Event|1|||
161206413|NCT00742859|582136433|FG000|Overall Study|Death|1|||
161206414|NCT00742859|582136434|FG001|Overall Study|Death|0|||
161206415|NCT00742859|582136435|FG002|Overall Study|Death|0|||
161206416|NCT00742859|582136436|FG003|Overall Study|Death|1|||
161206417|NCT00742859|582136433|FG000|Overall Study|Physician Decision|1|||
161206418|NCT00742859|582136434|FG001|Overall Study|Physician Decision|2|||
161206419|NCT00742859|582136435|FG002|Overall Study|Physician Decision|0|||
161206420|NCT00742859|582136436|FG003|Overall Study|Physician Decision|0|||
161206421|NCT00742859|582136433|FG000|Overall Study|Withdrawal by Subject|4|||
161206422|NCT00742859|582136434|FG001|Overall Study|Withdrawal by Subject|2|||
161206423|NCT00742859|582136435|FG002|Overall Study|Withdrawal by Subject|4|||
161206424|NCT00742859|582136436|FG003|Overall Study|Withdrawal by Subject|1|||
161206425|NCT00742859|582136433|FG000|Overall Study|Endpoint|0|||
161206426|NCT00742859|582136434|FG001|Overall Study|Endpoint|1|||
161206427|NCT00742859|582136435|FG002|Overall Study|Endpoint|1|||
161206428|NCT00742859|582136436|FG003|Overall Study|Endpoint|2|||
161206429|NCT00742859|582136433|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
161206430|NCT00742859|582136434|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
161206431|NCT00742859|582136435|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
161206432|NCT00742859|582136436|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
161206433|NCT00742859|582136433|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
161206434|NCT00742859|582136434|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
161206435|NCT00742859|582136435|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
161206436|NCT00742859|582136436|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
161206437|NCT00742859|582136433|FG000|Overall Study|Sponsor request patient out of town|0|||
161206438|NCT00742859|582136434|FG001|Overall Study|Sponsor request patient out of town|0|||
161206439|NCT00742859|582136435|FG002|Overall Study|Sponsor request patient out of town|1|||
161206440|NCT00742859|582136436|FG003|Overall Study|Sponsor request patient out of town|1|||
161206441|NCT00742859|582136433|FG000|Overall Study|Site error|0|||
161206442|NCT00742859|582136434|FG001|Overall Study|Site error|0|||
161206443|NCT00742859|582136435|FG002|Overall Study|Site error|1|||
161206444|NCT00742859|582136436|FG003|Overall Study|Site error|1|||
161206445|NCT01346501|582136440|FG000|Overall Study|Initiated Other Biological Agents|3|||
161206446|NCT01346501|582136441|FG001|Overall Study|Initiated Other Biological Agents|1|||
161206447|NCT01346501|582136440|FG000|Overall Study|Other|8|||
161206448|NCT01346501|582136441|FG001|Overall Study|Other|12|||
161206449|NCT02564952|582136444|FG000|Overall Study|Adverse Event|6|||
161206450|NCT02564952|582136444|FG000|Overall Study|Lost to Follow-up|1|||
161206451|NCT02564952|582136444|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
161206452|NCT02564952|582136444|FG000|Overall Study|Withdrawal by Subject|1|||
161206453|NCT02564952|582136444|FG000|Overall Study|Low Efficacy|1|||
161206454|NCT02564952|582136444|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
161206455|NCT01071083|582136451|FG000|Overall Study|Adverse Event|1|||
161206456|NCT01071083|582136452|FG001|Overall Study|Adverse Event|0|||
161206457|NCT01071083|582136453|FG002|Overall Study|Adverse Event|1|||
161206458|NCT01071083|582136454|FG003|Overall Study|Adverse Event|0|||
161206459|NCT01071083|582136455|FG004|Overall Study|Adverse Event|1|||
161206460|NCT01071083|582136451|FG000|Overall Study|Withdrawal by Subject|3|||
161206461|NCT01071083|582136452|FG001|Overall Study|Withdrawal by Subject|0|||
161206462|NCT01071083|582136453|FG002|Overall Study|Withdrawal by Subject|2|||
161206463|NCT01071083|582136454|FG003|Overall Study|Withdrawal by Subject|0|||
161206464|NCT01071083|582136455|FG004|Overall Study|Withdrawal by Subject|3|||
161206465|NCT01071083|582136451|FG000|Overall Study|Physician Decision|1|||
161206466|NCT01071083|582136452|FG001|Overall Study|Physician Decision|0|||
161206467|NCT01071083|582136453|FG002|Overall Study|Physician Decision|0|||
161206468|NCT01071083|582136454|FG003|Overall Study|Physician Decision|1|||
161206469|NCT01071083|582136455|FG004|Overall Study|Physician Decision|1|||
161206470|NCT01071083|582136451|FG000|Overall Study|Early Rescue|1|||
161206471|NCT01071083|582136452|FG001|Overall Study|Early Rescue|0|||
161206472|NCT01071083|582136453|FG002|Overall Study|Early Rescue|0|||
161206473|NCT01071083|582136454|FG003|Overall Study|Early Rescue|0|||
161206474|NCT01071083|582136455|FG004|Overall Study|Early Rescue|1|||
161311521|NCT00513357|582522268|FG000|Overall Study|Withdrawal by Subject|5|||
161311522|NCT00513357|582522269|FG001|Overall Study|Withdrawal by Subject|4|||
161311523|NCT00513357|582522268|FG000|Overall Study|Disease Progression|2|||
161311524|NCT00513357|582522269|FG001|Overall Study|Disease Progression|1|||
161311525|NCT00435487|582522278|FG000|Overall Study|Death|3|||
161311526|NCT00435487|582522279|FG001|Overall Study|Death|4|||
161311527|NCT00435487|582522278|FG000|Overall Study|Adverse Event|0|||
161311528|NCT00435487|582522279|FG001|Overall Study|Adverse Event|3|||
161311529|NCT00435487|582522278|FG000|Overall Study|Lost to Follow-up|2|||
161311530|NCT00435487|582522279|FG001|Overall Study|Lost to Follow-up|2|||
161311531|NCT00435487|582522278|FG000|Overall Study|Other|5|||
161311532|NCT00435487|582522279|FG001|Overall Study|Other|2|||
161311533|NCT00435487|582522278|FG000|Overall Study|Withdrawal by Subject|2|||
161311534|NCT00435487|582522279|FG001|Overall Study|Withdrawal by Subject|1|||
161311535|NCT00435487|582522278|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
161311536|NCT00435487|582522279|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
161311537|NCT00435487|582522278|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
161311538|NCT00435487|582522279|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
161311539|NCT02537431|582522289|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
161311540|NCT05238025|582522290|FG000|Overall Study|Adverse Event|2|||
161311541|NCT05238025|582522291|FG001|Overall Study|Adverse Event|2|||
161311542|NCT05238025|582522290|FG000|Overall Study|Lost to Follow-up|334|||
161311543|NCT05238025|582522291|FG001|Overall Study|Lost to Follow-up|339|||
161311544|NCT05238025|582522290|FG000|Overall Study|Withdrawal by Subject|203|||
161311545|NCT05238025|582522291|FG001|Overall Study|Withdrawal by Subject|222|||
161311546|NCT05238025|582522290|FG000|Overall Study|Physician Decision|20|||
161311547|NCT05238025|582522291|FG001|Overall Study|Physician Decision|8|||
161311548|NCT05238025|582522290|FG000|Overall Study|Protocol Violation|6|||
161311549|NCT05238025|582522291|FG001|Overall Study|Protocol Violation|2|||
161311550|NCT05238025|582522290|FG000|Overall Study|Death|38|||
161311551|NCT05238025|582522291|FG001|Overall Study|Death|32|||
161311552|NCT05238025|582522290|FG000|Overall Study|Study terminated by Sponsor|6358|||
161311553|NCT05238025|582522291|FG001|Overall Study|Study terminated by Sponsor|6358|||
161311554|NCT05238025|582522290|FG000|Overall Study|Other Reason|669|||
161311555|NCT05238025|582522291|FG001|Overall Study|Other Reason|690|||
161311556|NCT00191282|582522294|FG000|Overall Study|Adverse Event|5|||
161311557|NCT00191282|582522295|FG001|Overall Study|Adverse Event|6|||
161311558|NCT00191282|582522294|FG000|Overall Study|Death|51|||
161311559|NCT00191282|582522295|FG001|Overall Study|Death|51|||
161311560|NCT00191282|582522294|FG000|Overall Study|Lack of Efficacy|11|||
161311561|NCT00191282|582522295|FG001|Overall Study|Lack of Efficacy|6|||
161311562|NCT00191282|582522294|FG000|Overall Study|Noncompliance|14|||
161311563|NCT00191282|582522295|FG001|Overall Study|Noncompliance|17|||
161311564|NCT00191282|582522294|FG000|Overall Study|Patient moved|11|||
161311565|NCT00191282|582522295|FG001|Overall Study|Patient moved|14|||
161311566|NCT00191282|582522294|FG000|Overall Study|Withdrawal by Subject|59|||
161311567|NCT00191282|582522295|FG001|Overall Study|Withdrawal by Subject|44|||
161311568|NCT00191282|582522294|FG000|Overall Study|Physician Decision|18|||
161311569|NCT00191282|582522295|FG001|Overall Study|Physician Decision|15|||
161311570|NCT00191282|582522294|FG000|Overall Study|Protocol entry criteria not met|14|||
161311571|NCT00191282|582522295|FG001|Overall Study|Protocol entry criteria not met|9|||
161311572|NCT00191282|582522294|FG000|Overall Study|Protocol Violation|9|||
161311573|NCT00191282|582522295|FG001|Overall Study|Protocol Violation|12|||
161311574|NCT00191282|582522294|FG000|Overall Study|Severity of outcome|2|||
161311575|NCT00191282|582522295|FG001|Overall Study|Severity of outcome|5|||
161311576|NCT00191282|582522294|FG000|Overall Study|Sponsor's decision|2|||
161311577|NCT00191282|582522295|FG001|Overall Study|Sponsor's decision|2|||
161311578|NCT00191282|582522294|FG000|Overall Study|Lost to Follow-up|24|||
161311579|NCT00191282|582522295|FG001|Overall Study|Lost to Follow-up|31|||
161311580|NCT00102531|582522296|FG000|Overall Study|Adverse Event|0|||
161311581|NCT00102531|582522297|FG001|Overall Study|Adverse Event|1|||
161311582|NCT00102531|582522296|FG000|Overall Study|Disease Progression|5|||
161311583|NCT00102531|582522297|FG001|Overall Study|Disease Progression|9|||
161311584|NCT00102531|582522296|FG000|Overall Study|Physician Decision|0|||
161311585|NCT00102531|582522297|FG001|Overall Study|Physician Decision|1|||
161311586|NCT04756154|582522298|FG000|Overall Study|Did not meet treatment day baseline|30|||
161311587|NCT04756154|582522299|FG001|Overall Study|Did not meet treatment day baseline|28|||
161311588|NCT04756154|582522300|FG002|Overall Study|Did not meet treatment day baseline|7|||
161311589|NCT04756154|582522298|FG000|Overall Study|Did not return for final sample collection|1|||
161311590|NCT04756154|582522299|FG001|Overall Study|Did not return for final sample collection|1|||
161311591|NCT04756154|582522300|FG002|Overall Study|Did not return for final sample collection|0|||
161311592|NCT01790828|582522301|FG000|Overall Study|Other|34|||
161311593|NCT02089334|582522303|FG000|Overall Study|Withdrawal by Subject|0|||
161311594|NCT02089334|582522304|FG001|Overall Study|Withdrawal by Subject|0|||
161311595|NCT02089334|582522305|FG002|Overall Study|Withdrawal by Subject|0|||
161311596|NCT02089334|582522306|FG003|Overall Study|Withdrawal by Subject|2|||
161311597|NCT02089334|582522303|FG000|Overall Study|Adverse Event|0|||
161311598|NCT02089334|582522304|FG001|Overall Study|Adverse Event|0|||
161311599|NCT02089334|582522305|FG002|Overall Study|Adverse Event|0|||
161311600|NCT02089334|582522306|FG003|Overall Study|Adverse Event|2|||
161311601|NCT02089334|582522303|FG000|Overall Study|Progressive disease|0|||
161311602|NCT02089334|582522304|FG001|Overall Study|Progressive disease|0|||
161311603|NCT02089334|582522305|FG002|Overall Study|Progressive disease|0|||
161311604|NCT02089334|582522306|FG003|Overall Study|Progressive disease|2|||
161311605|NCT02089334|582522303|FG000|Overall Study|Physician Decision|0|||
161311606|NCT02089334|582522304|FG001|Overall Study|Physician Decision|0|||
161311607|NCT02089334|582522305|FG002|Overall Study|Physician Decision|1|||
161311608|NCT02089334|582522306|FG003|Overall Study|Physician Decision|1|||
161311609|NCT00954512|582522317|FG000|Overall Study|Withdrawal by Subject|0|||
161311610|NCT00954512|582522318|FG001|Overall Study|Withdrawal by Subject|0|||
161311611|NCT00954512|582522319|FG002|Overall Study|Withdrawal by Subject|0|||
161311612|NCT00954512|582522320|FG003|Overall Study|Withdrawal by Subject|0|||
161311613|NCT00954512|582522321|FG004|Overall Study|Withdrawal by Subject|0|||
161311614|NCT00954512|582522322|FG005|Overall Study|Withdrawal by Subject|1|||
161311615|NCT00954512|582522317|FG000|Overall Study|Adverse Event|0|||
161311616|NCT00954512|582522318|FG001|Overall Study|Adverse Event|0|||
161311617|NCT00954512|582522319|FG002|Overall Study|Adverse Event|0|||
161311618|NCT00954512|582522320|FG003|Overall Study|Adverse Event|0|||
161311619|NCT00954512|582522321|FG004|Overall Study|Adverse Event|1|||
161311620|NCT00954512|582522322|FG005|Overall Study|Adverse Event|2|||
161311621|NCT00954512|582522317|FG000|Overall Study|Physician Decision|0|||
161311622|NCT00954512|582522318|FG001|Overall Study|Physician Decision|1|||
161311623|NCT00954512|582522319|FG002|Overall Study|Physician Decision|0|||
161311624|NCT00954512|582522320|FG003|Overall Study|Physician Decision|1|||
161311625|NCT00954512|582522321|FG004|Overall Study|Physician Decision|0|||
161311626|NCT00954512|582522322|FG005|Overall Study|Physician Decision|0|||
161311627|NCT00954512|582522317|FG000|Overall Study|Symptomatic Deterioration|0|||
161311628|NCT00954512|582522318|FG001|Overall Study|Symptomatic Deterioration|1|||
161311629|NCT00954512|582522319|FG002|Overall Study|Symptomatic Deterioration|0|||
161311630|NCT00954512|582522320|FG003|Overall Study|Symptomatic Deterioration|0|||
161311631|NCT00954512|582522321|FG004|Overall Study|Symptomatic Deterioration|2|||
161311632|NCT00954512|582522322|FG005|Overall Study|Symptomatic Deterioration|0|||
161311633|NCT00954512|582522317|FG000|Overall Study|Progression of Disease|2|||
161311634|NCT00954512|582522318|FG001|Overall Study|Progression of Disease|1|||
161311635|NCT00954512|582522319|FG002|Overall Study|Progression of Disease|0|||
161311636|NCT00954512|582522320|FG003|Overall Study|Progression of Disease|1|||
161311637|NCT00954512|582522321|FG004|Overall Study|Progression of Disease|1|||
161311638|NCT00954512|582522322|FG005|Overall Study|Progression of Disease|1|||
161311639|NCT01173055|582522324|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
161311640|NCT01173055|582522325|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
161311641|NCT01173055|582522324|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
161311642|NCT01173055|582522325|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
161311643|NCT04814368|582522326|FG000|Overall Study|Study Terminated by Sponsor|0|||
161311644|NCT04814368|582522327|FG001|Overall Study|Study Terminated by Sponsor|3|||
161311645|NCT04814368|582522328|FG002|Overall Study|Study Terminated by Sponsor|0|||
161311646|NCT04814368|582522329|FG003|Overall Study|Study Terminated by Sponsor|2|||
161311647|NCT04814368|582522326|FG000|Overall Study|Subject Decision|1|||
161311648|NCT04814368|582522327|FG001|Overall Study|Subject Decision|2|||
161311649|NCT04814368|582522328|FG002|Overall Study|Subject Decision|0|||
161311650|NCT04814368|582522329|FG003|Overall Study|Subject Decision|0|||
161311651|NCT04216589|582522331|FG000|Overall Study|Withdrawal by Subject|2|||
161311652|NCT04216589|582522331|FG000|Overall Study|Protocol Violation|1|||
161311653|NCT04216589|582522331|FG000|Overall Study|Incarceration|1|||
161311654|NCT03315455|582524795|FG000|Overall Study|Ongoing in the Study|13|||
161311655|NCT03315455|582524796|FG001|Overall Study|Ongoing in the Study|24|||
161311656|NCT03315455|582524797|FG002|Overall Study|Ongoing in the Study|17|||
161311657|NCT03315455|582524798|FG003|Overall Study|Ongoing in the Study|15|||
161311658|NCT03315455|582524795|FG000|Overall Study|Withdrawal by Subject|0|||
161311659|NCT03315455|582524796|FG001|Overall Study|Withdrawal by Subject|1|||
161311660|NCT03315455|582524797|FG002|Overall Study|Withdrawal by Subject|0|||
161311661|NCT03315455|582524798|FG003|Overall Study|Withdrawal by Subject|0|||
161311662|NCT01143064|582524801|FG000|Overall Study|Death|109|||
161311663|NCT01143064|582524802|FG001|Overall Study|Death|91|||
161311664|NCT01143064|582524801|FG000|Overall Study|Adverse Event|0|||
161311665|NCT01143064|582524802|FG001|Overall Study|Adverse Event|1|||
161311666|NCT01143064|582524801|FG000|Overall Study|Withdrawal by Subject|7|||
161311667|NCT01143064|582524802|FG001|Overall Study|Withdrawal by Subject|5|||
161311668|NCT01143064|582524801|FG000|Overall Study|Lost to Follow-up|17|||
161311669|NCT01143064|582524802|FG001|Overall Study|Lost to Follow-up|14|||
161311670|NCT01143064|582524801|FG000|Overall Study|Physician Decision|0|||
161311671|NCT01143064|582524802|FG001|Overall Study|Physician Decision|4|||
161311672|NCT02453282|582524803|FG000|Overall Study|Death|275|||
161311673|NCT02453282|582524804|FG001|Overall Study|Death|277|||
161311674|NCT02453282|582524805|FG002|Overall Study|Death|296|||
161311675|NCT02453282|582524803|FG000|Overall Study|Lost to Follow-up|1|||
161311676|NCT02453282|582524804|FG001|Overall Study|Lost to Follow-up|0|||
161091061|NCT01411215|581723788|FG001|Overall Study|Lost to Follow-up|18|||
161311677|NCT02453282|582524805|FG002|Overall Study|Lost to Follow-up|2|||
161311678|NCT02453282|582524803|FG000|Overall Study|Withdrawal by Subject|12|||
161311679|NCT02453282|582524804|FG001|Overall Study|Withdrawal by Subject|10|||
161311680|NCT02453282|582524805|FG002|Overall Study|Withdrawal by Subject|11|||
161311681|NCT02453282|582524803|FG000|Overall Study|Participants ongoing at data cut-off|85|||
161311682|NCT02453282|582524804|FG001|Overall Study|Participants ongoing at data cut-off|84|||
161311683|NCT02453282|582524805|FG002|Overall Study|Participants ongoing at data cut-off|62|||
161311684|NCT02453282|582524803|FG000|Overall Study|Other|1|||
161311685|NCT02453282|582524804|FG001|Overall Study|Other|1|||
161311686|NCT02453282|582524805|FG002|Overall Study|Other|1|||
161311687|NCT00985426|582524806|FG000|Overall Study|Adverse Event|0|||
161311688|NCT00985426|582524807|FG001|Overall Study|Adverse Event|1|||
161311689|NCT00985426|582524806|FG000|Overall Study|Subject Non-Compliance|3|||
161311690|NCT00985426|582524807|FG001|Overall Study|Subject Non-Compliance|3|||
161311691|NCT00985426|582524806|FG000|Overall Study|Withdrawal by Subject|12|||
161311692|NCT00985426|582524807|FG001|Overall Study|Withdrawal by Subject|16|||
161311693|NCT00985426|582524806|FG000|Overall Study|Lost to Follow-up|8|||
161311694|NCT00985426|582524807|FG001|Overall Study|Lost to Follow-up|10|||
161311695|NCT00985426|582524806|FG000|Overall Study|Death|7|||
161311696|NCT00985426|582524807|FG001|Overall Study|Death|3|||
161311697|NCT00985426|582524806|FG000|Overall Study|Protocol Violation|2|||
161311698|NCT00985426|582524807|FG001|Overall Study|Protocol Violation|0|||
161311699|NCT00985426|582524806|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
161311700|NCT00985426|582524807|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
161311701|NCT02327013|582524808|FG000|Overall Study|Adverse Event|4|||
161311702|NCT02327013|582524809|FG001|Overall Study|Adverse Event|4|||
161311703|NCT02327013|582524810|FG002|Overall Study|Adverse Event|3|||
161311704|NCT02327013|582524811|FG003|Overall Study|Adverse Event|0|||
161311705|NCT02327013|582524812|FG004|Overall Study|Adverse Event|1|||
161311706|NCT02327013|582524808|FG000|Overall Study|Lack of Efficacy|2|||
161311707|NCT02327013|582524809|FG001|Overall Study|Lack of Efficacy|0|||
161311708|NCT02327013|582524810|FG002|Overall Study|Lack of Efficacy|5|||
161311709|NCT02327013|582524811|FG003|Overall Study|Lack of Efficacy|0|||
161311710|NCT02327013|582524812|FG004|Overall Study|Lack of Efficacy|1|||
161311711|NCT02327013|582524808|FG000|Overall Study|Non-compliance with IMP|1|||
161311712|NCT02327013|582524809|FG001|Overall Study|Non-compliance with IMP|2|||
161311713|NCT02327013|582524810|FG002|Overall Study|Non-compliance with IMP|7|||
161311714|NCT02327013|582524811|FG003|Overall Study|Non-compliance with IMP|0|||
161311715|NCT02327013|582524812|FG004|Overall Study|Non-compliance with IMP|0|||
161311716|NCT02327013|582524808|FG000|Overall Study|Withdrawal of Consent|1|||
161311717|NCT02327013|582524809|FG001|Overall Study|Withdrawal of Consent|0|||
161311718|NCT02327013|582524810|FG002|Overall Study|Withdrawal of Consent|3|||
161311719|NCT02327013|582524811|FG003|Overall Study|Withdrawal of Consent|0|||
161311720|NCT02327013|582524812|FG004|Overall Study|Withdrawal of Consent|0|||
161311721|NCT02327013|582524808|FG000|Overall Study|Lost to Follow-up|2|||
161311722|NCT02327013|582524809|FG001|Overall Study|Lost to Follow-up|4|||
161311723|NCT02327013|582524810|FG002|Overall Study|Lost to Follow-up|5|||
161311724|NCT02327013|582524811|FG003|Overall Study|Lost to Follow-up|0|||
161311725|NCT02327013|582524812|FG004|Overall Study|Lost to Follow-up|0|||
161311726|NCT02327013|582524808|FG000|Overall Study|Administrative or other reason(s)|1|||
161311727|NCT02327013|582524809|FG001|Overall Study|Administrative or other reason(s)|5|||
161311728|NCT02327013|582524810|FG002|Overall Study|Administrative or other reason(s)|11|||
161311729|NCT02327013|582524811|FG003|Overall Study|Administrative or other reason(s)|1|||
161311730|NCT02327013|582524812|FG004|Overall Study|Administrative or other reason(s)|1|||
161311731|NCT02327013|582524808|FG000|Overall Study|Protocol Violation|0|||
161311732|NCT02327013|582524809|FG001|Overall Study|Protocol Violation|0|||
161311733|NCT02327013|582524810|FG002|Overall Study|Protocol Violation|3|||
161311734|NCT02327013|582524811|FG003|Overall Study|Protocol Violation|0|||
161311735|NCT02327013|582524812|FG004|Overall Study|Protocol Violation|1|||
161311736|NCT02327013|582524808|FG000|Overall Study|Withdrawal before treatment|2|||
161311737|NCT02327013|582524809|FG001|Overall Study|Withdrawal before treatment|1|||
161311738|NCT02327013|582524810|FG002|Overall Study|Withdrawal before treatment|5|||
161311739|NCT02327013|582524811|FG003|Overall Study|Withdrawal before treatment|0|||
161311740|NCT02327013|582524812|FG004|Overall Study|Withdrawal before treatment|0|||
161311741|NCT02380859|582524815|FG000|Overall Study|Withdrawal by Subject|2|||
161311742|NCT02380859|582524816|FG001|Overall Study|Withdrawal by Subject|0|||
161311743|NCT01661933|582524817|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
161311744|NCT01661933|582524817|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
161311745|NCT03385304|582524818|FG000|Overall Study|Death|19|||
161311746|NCT03385304|582524819|FG001|Overall Study|Death|7|||
161311747|NCT03385304|582524818|FG000|Overall Study|Lost to Follow-up|17|||
161311748|NCT03385304|582524819|FG001|Overall Study|Lost to Follow-up|14|||
161311749|NCT03385304|582524818|FG000|Overall Study|Withdrawal by Subject|3|||
161311750|NCT03385304|582524819|FG001|Overall Study|Withdrawal by Subject|2|||
161311751|NCT03385304|582524818|FG000|Overall Study|Incarceration|2|||
161311752|NCT03385304|582524819|FG001|Overall Study|Incarceration|3|||
161311753|NCT04258254|582524820|FG000|Overall Study|Withdrawal by Subject|0|||
161206475|NCT01071083|582136451|FG000|Overall Study|Subject Moved|0|||
161206476|NCT01071083|582136452|FG001|Overall Study|Subject Moved|1|||
161206477|NCT01071083|582136453|FG002|Overall Study|Subject Moved|0|||
161206478|NCT01071083|582136454|FG003|Overall Study|Subject Moved|0|||
161206479|NCT01071083|582136455|FG004|Overall Study|Subject Moved|0|||
161206480|NCT01071083|582136451|FG000|Overall Study|Images Not Usable (Motion)|0|||
161206481|NCT01071083|582136452|FG001|Overall Study|Images Not Usable (Motion)|1|||
161206482|NCT01071083|582136453|FG002|Overall Study|Images Not Usable (Motion)|0|||
161206483|NCT01071083|582136454|FG003|Overall Study|Images Not Usable (Motion)|0|||
161206484|NCT01071083|582136455|FG004|Overall Study|Images Not Usable (Motion)|0|||
161206485|NCT01071083|582136451|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
161206486|NCT01071083|582136452|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
161206487|NCT01071083|582136453|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
161206488|NCT01071083|582136454|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
161206489|NCT01071083|582136455|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
161206490|NCT01071083|582136451|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
161206491|NCT01071083|582136452|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
161206492|NCT01071083|582136453|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
161206493|NCT01071083|582136454|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
161206494|NCT01071083|582136455|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
161206495|NCT01071083|582136451|FG000|Overall Study|Subject Refused to Continue|1|||
161206496|NCT01071083|582136452|FG001|Overall Study|Subject Refused to Continue|0|||
161206497|NCT01071083|582136453|FG002|Overall Study|Subject Refused to Continue|0|||
161206498|NCT01071083|582136454|FG003|Overall Study|Subject Refused to Continue|0|||
161206499|NCT01071083|582136455|FG004|Overall Study|Subject Refused to Continue|0|||
161206500|NCT03972709|582136456|FG000|Overall Study|Withdrawal by Subject|18|||
161206501|NCT03972709|582136457|FG001|Overall Study|Withdrawal by Subject|7|||
161206502|NCT03972709|582136458|FG002|Overall Study|Withdrawal by Subject|14|||
161206503|NCT03972709|582136456|FG000|Overall Study|Study Terminated by Sponsor|48|||
161206504|NCT03972709|582136457|FG001|Overall Study|Study Terminated by Sponsor|25|||
161206505|NCT03972709|582136458|FG002|Overall Study|Study Terminated by Sponsor|50|||
161206506|NCT03972709|582136456|FG000|Overall Study|Physician Decision|1|||
161206507|NCT03972709|582136457|FG001|Overall Study|Physician Decision|0|||
161206508|NCT03972709|582136458|FG002|Overall Study|Physician Decision|0|||
161206509|NCT03972709|582136456|FG000|Overall Study|COVID-19|0|||
161206510|NCT03972709|582136457|FG001|Overall Study|COVID-19|1|||
161206511|NCT03972709|582136458|FG002|Overall Study|COVID-19|1|||
161206512|NCT03972709|582136456|FG000|Overall Study|Lost to Follow-up|6|||
161206513|NCT03972709|582136457|FG001|Overall Study|Lost to Follow-up|1|||
161206514|NCT03972709|582136458|FG002|Overall Study|Lost to Follow-up|2|||
161206515|NCT03972709|582136456|FG000|Overall Study|Death|5|||
161206516|NCT03972709|582136457|FG001|Overall Study|Death|1|||
161206517|NCT03972709|582136458|FG002|Overall Study|Death|4|||
161206518|NCT03972709|582136456|FG000|Overall Study|Adverse Event|3|||
161206519|NCT03972709|582136457|FG001|Overall Study|Adverse Event|1|||
161206520|NCT03972709|582136458|FG002|Overall Study|Adverse Event|4|||
161206521|NCT03972709|582136456|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
161206522|NCT03972709|582136457|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
161206523|NCT03972709|582136458|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
161206524|NCT03972709|582136456|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
161206525|NCT03972709|582136457|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
161206526|NCT03972709|582136458|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
161206527|NCT03972709|582136456|FG000|Overall Study|Subject Unable to be Contacted|0|||
161206528|NCT03972709|582136457|FG001|Overall Study|Subject Unable to be Contacted|1|||
161206529|NCT03972709|582136458|FG002|Overall Study|Subject Unable to be Contacted|0|||
161206530|NCT03972709|582136456|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
161206531|NCT03972709|582136457|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
161206532|NCT03972709|582136458|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
161206533|NCT03972709|582136456|FG000|Overall Study|Subject Moved|0|||
161206534|NCT03972709|582136457|FG001|Overall Study|Subject Moved|1|||
161206535|NCT03972709|582136458|FG002|Overall Study|Subject Moved|0|||
161206536|NCT03972709|582136456|FG000|Overall Study|Missed Study Visits|1|||
161206537|NCT03972709|582136457|FG001|Overall Study|Missed Study Visits|0|||
161206538|NCT03972709|582136458|FG002|Overall Study|Missed Study Visits|0|||
161206539|NCT01523301|582136459|FG000|Overall Study|Adverse Event|25|||
161206540|NCT01523301|582136460|FG001|Overall Study|Adverse Event|16|||
161206541|NCT01523301|582136459|FG000|Overall Study|Lack of Efficacy|0|||
161311754|NCT04258254|582524821|FG001|Overall Study|Withdrawal by Subject|1|||
161206542|NCT01523301|582136460|FG001|Overall Study|Lack of Efficacy|2|||
161206543|NCT01523301|582136459|FG000|Overall Study|Protocol Violation|3|||
161206544|NCT01523301|582136460|FG001|Overall Study|Protocol Violation|4|||
161206545|NCT01523301|582136459|FG000|Overall Study|Lost to Follow-up|1|||
161206546|NCT01523301|582136460|FG001|Overall Study|Lost to Follow-up|0|||
161206547|NCT01523301|582136459|FG000|Overall Study|Withdrawal by Subject|6|||
161311755|NCT04258254|582524822|FG002|Overall Study|Withdrawal by Subject|0|||
161311756|NCT01120249|582524823|FG000|Overall Study|No protocol treatment received|21|||
161311757|NCT01120249|582524824|FG001|Overall Study|No protocol treatment received|15|||
161311758|NCT01120249|582524823|FG000|Overall Study|Disease recurrence|107|||
161311759|NCT01120249|582524824|FG001|Overall Study|Disease recurrence|57|||
161311760|NCT01120249|582524823|FG000|Overall Study|Death|1|||
161311761|NCT01120249|582524824|FG001|Overall Study|Death|0|||
161311762|NCT01120249|582524823|FG000|Overall Study|Adverse Event|40|||
161311763|NCT01120249|582524824|FG001|Overall Study|Adverse Event|276|||
161311764|NCT01120249|582524823|FG000|Overall Study|Participant refusal|34|||
161311765|NCT01120249|582524824|FG001|Overall Study|Participant refusal|42|||
161311766|NCT01120249|582524823|FG000|Overall Study|Other reasons, not protocol specified|29|||
161311767|NCT01120249|582524824|FG001|Overall Study|Other reasons, not protocol specified|22|||
161311768|NCT00723190|582524829|FG000|Overall Study|Withdrawal by Subject|45|||
161311769|NCT00723190|582524829|FG000|Overall Study|Lost to Follow-up|37|||
161311770|NCT00723190|582524829|FG000|Overall Study|Adverse Event|18|||
161311771|NCT00723190|582524829|FG000|Overall Study|Lack of Efficacy|16|||
161311772|NCT00723190|582524829|FG000|Overall Study|Protocol Violation|15|||
161311773|NCT00723190|582524829|FG000|Overall Study|Other-Premature Discontinuation|9|||
161311774|NCT00723190|582524829|FG000|Overall Study|Other-Not included in safety population|2|||
161311775|NCT04472026|582524833|FG000|Overall Study|Lost to Follow-up|5|||
161311776|NCT01404208|582524834|FG000|Overall Study|Discontinued|3|||
161311777|NCT01404208|582524835|FG001|Overall Study|Discontinued|0|||
161311778|NCT03436199|582524840|FG000|Overall Study|Adverse Event|15|||
161311779|NCT03436199|582524841|FG001|Overall Study|Adverse Event|40|||
161311780|NCT03436199|582524842|FG002|Overall Study|Adverse Event|7|||
161311781|NCT03436199|582524840|FG000|Overall Study|Withdrawal by Subject|4|||
161311782|NCT03436199|582524841|FG001|Overall Study|Withdrawal by Subject|10|||
161311783|NCT03436199|582524842|FG002|Overall Study|Withdrawal by Subject|3|||
161311784|NCT03436199|582524840|FG000|Overall Study|Lost to Follow-up|1|||
161311785|NCT03436199|582524841|FG001|Overall Study|Lost to Follow-up|0|||
161311786|NCT03436199|582524842|FG002|Overall Study|Lost to Follow-up|2|||
161311787|NCT03436199|582524840|FG000|Overall Study|Protocol Violation|1|||
161311788|NCT03436199|582524841|FG001|Overall Study|Protocol Violation|1|||
161311789|NCT03436199|582524842|FG002|Overall Study|Protocol Violation|0|||
161311790|NCT03436199|582524840|FG000|Overall Study|Physician Decision|0|||
161311791|NCT03436199|582524841|FG001|Overall Study|Physician Decision|1|||
161311792|NCT03436199|582524842|FG002|Overall Study|Physician Decision|0|||
161311793|NCT03436199|582524840|FG000|Overall Study|Could not return to clinic|1|||
161311794|NCT03436199|582524841|FG001|Overall Study|Could not return to clinic|0|||
161311795|NCT03436199|582524842|FG002|Overall Study|Could not return to clinic|0|||
161311796|NCT03436199|582524840|FG000|Overall Study|Withdrawn per physician|0|||
161311797|NCT03436199|582524841|FG001|Overall Study|Withdrawn per physician|1|||
161311798|NCT03436199|582524842|FG002|Overall Study|Withdrawn per physician|0|||
161311799|NCT00085098|582524843|FG000|Overall Study|Withdrawal by Subject|0|||
161311800|NCT00085098|582524844|FG001|Overall Study|Withdrawal by Subject|1|||
161311801|NCT00085098|582524843|FG000|Overall Study|Ineligible|1|||
161311802|NCT00085098|582524844|FG001|Overall Study|Ineligible|1|||
161311803|NCT01886781|582524849|FG000|Overall Study|Protocol Violation|5|||
161311804|NCT01886781|582524850|FG001|Overall Study|Protocol Violation|0|||
161311805|NCT01886781|582524849|FG000|Overall Study|Adverse Event|1|||
161311806|NCT01886781|582524850|FG001|Overall Study|Adverse Event|0|||
161311807|NCT01886781|582524849|FG000|Overall Study|Lost to Follow-up|5|||
161311808|NCT01886781|582524850|FG001|Overall Study|Lost to Follow-up|0|||
161311809|NCT01886781|582524849|FG000|Overall Study|Withdrawal by Subject|2|||
161311810|NCT01886781|582524850|FG001|Overall Study|Withdrawal by Subject|1|||
161311811|NCT01886781|582524849|FG000|Overall Study|Worsening of symptoms|1|||
161311812|NCT01886781|582524850|FG001|Overall Study|Worsening of symptoms|1|||
161311813|NCT00772005|582524853|FG000|Overall Study|Adverse Event|9|||
161311814|NCT00772005|582524854|FG001|Overall Study|Adverse Event|14|||
161311815|NCT00772005|582524855|FG002|Overall Study|Adverse Event|10|||
161311816|NCT00772005|582524856|FG003|Overall Study|Adverse Event|13|||
161311817|NCT00772005|582524853|FG000|Overall Study|Lack of Efficacy|0|||
161311818|NCT00772005|582524854|FG001|Overall Study|Lack of Efficacy|1|||
161311819|NCT00772005|582524855|FG002|Overall Study|Lack of Efficacy|0|||
161311820|NCT00772005|582524856|FG003|Overall Study|Lack of Efficacy|0|||
161311821|NCT00772005|582524853|FG000|Overall Study|Withdrawal by Subject|3|||
161311822|NCT00772005|582524854|FG001|Overall Study|Withdrawal by Subject|7|||
161311823|NCT00772005|582524855|FG002|Overall Study|Withdrawal by Subject|10|||
161311824|NCT00772005|582524856|FG003|Overall Study|Withdrawal by Subject|2|||
161311825|NCT00772005|582524853|FG000|Overall Study|Protocol Violation|2|||
161311826|NCT00772005|582524854|FG001|Overall Study|Protocol Violation|4|||
161311827|NCT00772005|582524855|FG002|Overall Study|Protocol Violation|1|||
161311828|NCT00772005|582524856|FG003|Overall Study|Protocol Violation|6|||
161311829|NCT00772005|582524853|FG000|Overall Study|Lost to Follow-up|7|||
161311830|NCT00772005|582524854|FG001|Overall Study|Lost to Follow-up|3|||
161311831|NCT00772005|582524855|FG002|Overall Study|Lost to Follow-up|6|||
161311832|NCT00772005|582524856|FG003|Overall Study|Lost to Follow-up|3|||
161311833|NCT00772005|582524853|FG000|Overall Study|Non-compliance with study procedures|1|||
161311834|NCT00772005|582524854|FG001|Overall Study|Non-compliance with study procedures|1|||
161311835|NCT00772005|582524855|FG002|Overall Study|Non-compliance with study procedures|0|||
161311836|NCT00772005|582524856|FG003|Overall Study|Non-compliance with study procedures|1|||
161311837|NCT00772005|582524853|FG000|Overall Study|Non-compliance with drug administration|3|||
161311838|NCT00772005|582524854|FG001|Overall Study|Non-compliance with drug administration|0|||
161311839|NCT00772005|582524855|FG002|Overall Study|Non-compliance with drug administration|1|||
161311840|NCT00772005|582524856|FG003|Overall Study|Non-compliance with drug administration|1|||
161311841|NCT01273155|582524860|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
161311842|NCT01273155|582524861|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
161311843|NCT01273155|582524862|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
161311844|NCT01273155|582524863|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
161311845|NCT01273155|582524864|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
161311846|NCT01273155|582524865|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
161311847|NCT01273155|582524866|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
161311848|NCT01273155|582524860|FG000|Overall Study|Change in liver function/no longer eval.|0|||
161311849|NCT01273155|582524861|FG001|Overall Study|Change in liver function/no longer eval.|1|||
161311850|NCT01273155|582524862|FG002|Overall Study|Change in liver function/no longer eval.|0|||
161311851|NCT01273155|582524863|FG003|Overall Study|Change in liver function/no longer eval.|0|||
161311852|NCT01273155|582524864|FG004|Overall Study|Change in liver function/no longer eval.|1|||
161311853|NCT01273155|582524865|FG005|Overall Study|Change in liver function/no longer eval.|0|||
161311854|NCT01273155|582524866|FG006|Overall Study|Change in liver function/no longer eval.|0|||
161311855|NCT01273155|582524860|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
161311856|NCT01273155|582524861|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
161311857|NCT01273155|582524862|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
161311858|NCT01273155|582524863|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
161311859|NCT01273155|582524864|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
161311860|NCT01273155|582524865|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
161311861|NCT01273155|582524866|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
161311862|NCT01273155|582524860|FG000|Overall Study|Died during Cycle 1|0|||
161311863|NCT01273155|582524861|FG001|Overall Study|Died during Cycle 1|0|||
161311864|NCT01273155|582524862|FG002|Overall Study|Died during Cycle 1|1|||
161311865|NCT01273155|582524863|FG003|Overall Study|Died during Cycle 1|1|||
161311866|NCT01273155|582524864|FG004|Overall Study|Died during Cycle 1|0|||
161311867|NCT01273155|582524865|FG005|Overall Study|Died during Cycle 1|2|||
161311868|NCT01273155|582524866|FG006|Overall Study|Died during Cycle 1|2|||
161311869|NCT01273155|582524860|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
161311870|NCT01273155|582524861|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
161311871|NCT01273155|582524862|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
161311872|NCT01273155|582524863|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
161311873|NCT01273155|582524864|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
161311874|NCT01273155|582524865|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
161311875|NCT01273155|582524866|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
161311876|NCT01440569|582524867|FG000|Main Study|Enrolled but not treated|1|||
161311877|NCT01440569|582524868|FG001|Main Study|Enrolled but not treated|0|||
161311878|NCT01440569|582524867|FG000|Main Study|Adverse Event|9|||
161311879|NCT01440569|582524868|FG001|Main Study|Adverse Event|0|||
161311880|NCT01440569|582524867|FG000|Main Study|Pregnancy|1|||
161311881|NCT01440569|582524868|FG001|Main Study|Pregnancy|0|||
161311882|NCT01440569|582524867|FG000|Main Study|Investigator's Discretion|1|||
161311883|NCT01440569|582524868|FG001|Main Study|Investigator's Discretion|1|||
161311884|NCT01440569|582524867|FG000|Main Study|Withdrew Consent|7|||
161311885|NCT01440569|582524868|FG001|Main Study|Withdrew Consent|1|||
161311886|NCT01440569|582524867|FG000|Main Study|Lost to Follow-up|13|||
161311887|NCT01440569|582524868|FG001|Main Study|Lost to Follow-up|2|||
161311888|NCT01440569|582524867|FG000|Main Study|Subject Non-Compliance|3|||
161311889|NCT01440569|582524868|FG001|Main Study|Subject Non-Compliance|0|||
161311890|NCT01440569|582524867|FG000|Main Study|Protocol Violation|1|||
161311891|NCT01440569|582524868|FG001|Main Study|Protocol Violation|0|||
161311892|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Adverse Event|3|||
161311893|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Adverse Event|0|||
161311894|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Pregnancy|1|||
161311895|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Pregnancy|0|||
161311896|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
161311897|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
161311898|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
161311899|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
161311900|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
161311901|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
161311902|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
161311903|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
161311904|NCT01440569|582524867|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
161311905|NCT01440569|582524868|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
161311906|NCT01438814|582524870|FG000|Overall Study|Adverse Event|3|||
161311907|NCT01438814|582524871|FG001|Overall Study|Adverse Event|3|||
161311908|NCT01438814|582524870|FG000|Overall Study|Protocol Violation|1|||
161311909|NCT01438814|582524871|FG001|Overall Study|Protocol Violation|2|||
161311910|NCT01438814|582524870|FG000|Overall Study|Lost to Follow-up|4|||
161311911|NCT01438814|582524871|FG001|Overall Study|Lost to Follow-up|3|||
161311912|NCT01438814|582524870|FG000|Overall Study|Withdrawal by Subject|4|||
161311913|NCT01438814|582524871|FG001|Overall Study|Withdrawal by Subject|2|||
161311914|NCT01438814|582524870|FG000|Overall Study|Other|2|||
161311915|NCT01438814|582524871|FG001|Overall Study|Other|4|||
161311916|NCT03887117|582524879|FG000|Overall Study|Discontinued prematurely|0|||
161311917|NCT03887117|582524880|FG001|Overall Study|Discontinued prematurely|1|||
161311918|NCT03887117|582524881|FG002|Overall Study|Discontinued prematurely|1|||
161311919|NCT03887117|582524882|FG003|Overall Study|Discontinued prematurely|2|||
161311920|NCT02584959|582524883|FG000|Period 1|Withdrawn from study|3|||
161311921|NCT02584959|582524884|FG001|Period 1|Withdrawn from study|4|||
161311922|NCT02584959|582524885|FG002|Period 1|Withdrawn from study|0|||
161311923|NCT02584959|582524883|FG000|Period 2|Withdrawn from study|6|||
161311924|NCT02584959|582524884|FG001|Period 2|Withdrawn from study|1|||
161311925|NCT02584959|582524885|FG002|Period 2|Withdrawn from study|2|||
161311926|NCT04908475|582524886|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
161311927|NCT04908475|582524887|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161311928|NCT04908475|582524888|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161311929|NCT04908475|582524889|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161311930|NCT04908475|582524890|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161311931|NCT04908475|582524891|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
161311932|NCT04908475|582524886|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
161311933|NCT04908475|582524887|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161311934|NCT04908475|582524888|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161311935|NCT04908475|582524889|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161311936|NCT04908475|582524890|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161311937|NCT04908475|582524891|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
161311938|NCT04908475|582524886|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
161311939|NCT04908475|582524887|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161311940|NCT04908475|582524888|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161311941|NCT04908475|582524889|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161311942|NCT04908475|582524890|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161311943|NCT04908475|582524891|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
161311944|NCT04908475|582524886|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161311945|NCT04908475|582524887|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
161311946|NCT04908475|582524888|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
161311947|NCT04908475|582524889|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
161311948|NCT04908475|582524890|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161311949|NCT04908475|582524891|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
161311950|NCT04908475|582524886|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
161311951|NCT04908475|582524887|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
161311952|NCT04908475|582524888|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
161311953|NCT04908475|582524889|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
161311954|NCT04908475|582524890|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
161311955|NCT04908475|582524891|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
161311956|NCT04908475|582524886|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
161311957|NCT04908475|582524887|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
161311958|NCT04908475|582524888|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
161311959|NCT04908475|582524889|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
161311960|NCT04908475|582524890|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
161311961|NCT04908475|582524891|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
161311962|NCT00926536|582524892|FG000|Overall Study|Physician Decision|1|||
161311963|NCT00926536|582524893|FG001|Overall Study|Physician Decision|2|||
161311964|NCT05087966|582524894|FG000|Overall Study|Lost to Follow-up|1|||
161311965|NCT05087966|582524894|FG000|Overall Study|Withdrawal by Subject|5|||
161311966|NCT01267201|582524896|FG000|First Intervention Period|Withdrawal by Subject|1|||
161311967|NCT01267201|582524897|FG001|First Intervention Period|Withdrawal by Subject|0|||
161311968|NCT01267201|582524898|FG002|First Intervention Period|Withdrawal by Subject|0|||
161311969|NCT01267201|582524899|FG003|First Intervention Period|Withdrawal by Subject|0|||
161311970|NCT01267201|582524900|FG004|First Intervention Period|Withdrawal by Subject|0|||
161311971|NCT01267201|582524901|FG005|First Intervention Period|Withdrawal by Subject|0|||
161311972|NCT01267201|582524896|FG000|Second Intervention Period|Withdrawal by Subject|0|||
161311973|NCT01267201|582524897|FG001|Second Intervention Period|Withdrawal by Subject|1|||
161311974|NCT01267201|582524898|FG002|Second Intervention Period|Withdrawal by Subject|0|||
161311975|NCT01267201|582524899|FG003|Second Intervention Period|Withdrawal by Subject|0|||
161311976|NCT01267201|582524900|FG004|Second Intervention Period|Withdrawal by Subject|0|||
161311977|NCT01267201|582524901|FG005|Second Intervention Period|Withdrawal by Subject|0|||
161311978|NCT00483704|582524902|FG000|Randomization|Withdrawal by Subject|19|||
161311979|NCT00483704|582524903|FG001|Randomization|Withdrawal by Subject|28|||
161311980|NCT00483704|582524904|FG002|Randomization|Withdrawal by Subject|18|||
161311981|NCT00483704|582524902|FG000|Randomization|Protocol Violation|14|||
161311982|NCT00483704|582524903|FG001|Randomization|Protocol Violation|25|||
161311983|NCT00483704|582524904|FG002|Randomization|Protocol Violation|22|||
161311984|NCT00483704|582524902|FG000|Randomization|Lost to Follow-up|14|||
161311985|NCT00483704|582524903|FG001|Randomization|Lost to Follow-up|14|||
161311986|NCT00483704|582524904|FG002|Randomization|Lost to Follow-up|19|||
161311987|NCT00483704|582524902|FG000|Randomization|Pregnancy|1|||
161311988|NCT00483704|582524903|FG001|Randomization|Pregnancy|0|||
161311989|NCT00483704|582524904|FG002|Randomization|Pregnancy|0|||
161311990|NCT00483704|582524902|FG000|Randomization|Physician Decision|2|||
161311991|NCT00483704|582524903|FG001|Randomization|Physician Decision|4|||
161311992|NCT00483704|582524904|FG002|Randomization|Physician Decision|0|||
161311993|NCT00483704|582524902|FG000|Randomization|Progressive disease|0|||
161311994|NCT00483704|582524903|FG001|Randomization|Progressive disease|0|||
161311995|NCT00483704|582524904|FG002|Randomization|Progressive disease|1|||
161311996|NCT00483704|582524902|FG000|Randomization|Lack of qualifying migraines|21|||
161311997|NCT00483704|582524903|FG001|Randomization|Lack of qualifying migraines|25|||
161311998|NCT00483704|582524904|FG002|Randomization|Lack of qualifying migraines|31|||
161311999|NCT00483704|582524902|FG000|Treatment|Lack of qualifying migraines|101|||
161312000|NCT00483704|582524903|FG001|Treatment|Lack of qualifying migraines|99|||
161312001|NCT00483704|582524904|FG002|Treatment|Lack of qualifying migraines|116|||
161312002|NCT00483704|582524902|FG000|Treatment|Adverse Event|3|||
161312003|NCT00483704|582524903|FG001|Treatment|Adverse Event|5|||
161312004|NCT00483704|582524904|FG002|Treatment|Adverse Event|4|||
161312005|NCT00483704|582524902|FG000|Treatment|Withdrawal by Subject|16|||
161312006|NCT00483704|582524903|FG001|Treatment|Withdrawal by Subject|12|||
161312007|NCT00483704|582524904|FG002|Treatment|Withdrawal by Subject|21|||
161312008|NCT00483704|582524902|FG000|Treatment|Protocol Violation|6|||
161312009|NCT00483704|582524903|FG001|Treatment|Protocol Violation|3|||
161312010|NCT00483704|582524904|FG002|Treatment|Protocol Violation|5|||
161312011|NCT00483704|582524902|FG000|Treatment|Lost to Follow-up|2|||
161312012|NCT00483704|582524903|FG001|Treatment|Lost to Follow-up|7|||
161312013|NCT00483704|582524904|FG002|Treatment|Lost to Follow-up|5|||
161312014|NCT00483704|582524902|FG000|Treatment|Lack of Efficacy|1|||
161312015|NCT00483704|582524903|FG001|Treatment|Lack of Efficacy|1|||
161312016|NCT00483704|582524904|FG002|Treatment|Lack of Efficacy|1|||
161312017|NCT00483704|582524902|FG000|Treatment|Pregnancy|0|||
161312018|NCT00483704|582524903|FG001|Treatment|Pregnancy|1|||
161312019|NCT00483704|582524904|FG002|Treatment|Pregnancy|0|||
161312020|NCT00483704|582524902|FG000|Treatment|Physician Decision|0|||
161312021|NCT00483704|582524903|FG001|Treatment|Physician Decision|1|||
161312022|NCT00483704|582524904|FG002|Treatment|Physician Decision|4|||
161312023|NCT04272606|582524905|FG000|Overall Study|Protocol Violation|1|||
161312024|NCT04272606|582524906|FG001|Overall Study|Protocol Violation|1|||
161312025|NCT04272606|582524905|FG000|Overall Study|Physician Decision|0|||
161312026|NCT04272606|582524906|FG001|Overall Study|Physician Decision|1|||
161312027|NCT03912428|582524907|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161312028|NCT03912428|582524908|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
161312029|NCT03912428|582524909|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161312030|NCT03912428|582524910|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
161312031|NCT03912428|582524907|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
161312032|NCT03912428|582524908|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
161312033|NCT03912428|582524909|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
161312034|NCT03912428|582524910|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
161312035|NCT03912428|582524907|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161312036|NCT03912428|582524908|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161312037|NCT03912428|582524909|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
161312038|NCT03912428|582524910|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
161312039|NCT01037127|582524912|FG000|Overall Study|Lost to Follow-up|2|||
161312040|NCT01037127|582524913|FG001|Overall Study|Lost to Follow-up|4|||
161312041|NCT01037127|582524912|FG000|Overall Study|Physician Decision|1|||
161312042|NCT01037127|582524913|FG001|Overall Study|Physician Decision|0|||
161312043|NCT01037127|582524912|FG000|Overall Study|Study Closed Terminated|2|||
161312044|NCT01037127|582524913|FG001|Overall Study|Study Closed Terminated|17|||
161312045|NCT04325698|582524914|FG000|Overall Study|Study Terminated By Sponsor|1|||
161312046|NCT04325698|582524915|FG001|Overall Study|Study Terminated By Sponsor|1|||
161312047|NCT04325698|582524914|FG000|Overall Study|Withdrawal by Subject|0|||
161312048|NCT04325698|582524915|FG001|Overall Study|Withdrawal by Subject|2|||
161312049|NCT04253782|582524916|FG000|Overall Study|Death|2|||
161312050|NCT04253782|582524917|FG001|Overall Study|Death|0|||
161312051|NCT02326298|582524922|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312052|NCT02326298|582524923|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312053|NCT02326298|582524924|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
161312054|NCT02326298|582524925|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312055|NCT02326298|582524926|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312056|NCT02326298|582524927|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312057|NCT02326298|582524928|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312058|NCT02326298|582524929|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312059|NCT02326298|582524930|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312060|NCT02326298|582524931|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312061|NCT02326298|582524932|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312062|NCT02326298|582524933|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312063|NCT02326298|582524934|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312064|NCT02326298|582524935|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
161312065|NCT02326298|582524922|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
161312066|NCT02326298|582524923|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312067|NCT02326298|582524924|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312068|NCT02326298|582524925|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312069|NCT02326298|582524926|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312070|NCT02326298|582524927|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312071|NCT02326298|582524928|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312072|NCT02326298|582524929|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312073|NCT02326298|582524930|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312074|NCT02326298|582524931|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312075|NCT02326298|582524932|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312076|NCT02326298|582524933|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312077|NCT02326298|582524934|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312078|NCT02326298|582524935|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
161312079|NCT02326298|582524922|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161312080|NCT02326298|582524923|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
161312081|NCT02326298|582524924|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312082|NCT02326298|582524925|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312083|NCT02326298|582524926|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312084|NCT02326298|582524927|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312085|NCT02326298|582524928|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312086|NCT02326298|582524929|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312087|NCT02326298|582524930|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312088|NCT02326298|582524931|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312089|NCT02326298|582524932|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312090|NCT02326298|582524933|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312091|NCT02326298|582524934|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312092|NCT02326298|582524935|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
161312093|NCT02326298|582524922|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
161312094|NCT02326298|582524923|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
161312095|NCT02326298|582524924|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312096|NCT02326298|582524925|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312097|NCT02326298|582524926|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312098|NCT02326298|582524927|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312099|NCT02326298|582524928|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312100|NCT02326298|582524929|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312101|NCT02326298|582524930|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312102|NCT02326298|582524931|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312103|NCT02326298|582524932|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312104|NCT02326298|582524933|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312105|NCT02326298|582524934|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312106|NCT02326298|582524935|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
161312107|NCT02326298|582524922|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312108|NCT02326298|582524923|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312109|NCT02326298|582524924|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
161312110|NCT02326298|582524925|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312111|NCT02326298|582524926|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312112|NCT02326298|582524927|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312113|NCT02326298|582524928|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312114|NCT02326298|582524929|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312115|NCT02326298|582524930|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312116|NCT02326298|582524931|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312117|NCT02326298|582524932|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312118|NCT02326298|582524933|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312119|NCT02326298|582524934|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312120|NCT02326298|582524935|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
161312121|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312122|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312123|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312124|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312125|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312126|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161312127|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
161312128|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161312129|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161312130|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
161312131|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312132|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312133|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312134|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
161312135|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312136|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312137|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312138|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312139|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312140|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
161312141|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
161312142|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312143|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
161312144|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312145|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312146|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312147|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312148|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
161312149|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312150|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312151|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312152|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312153|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312154|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
161312155|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312156|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312157|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312158|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312159|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312160|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312161|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312162|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
161312163|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312164|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312165|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312166|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312167|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312168|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312169|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
161312170|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312171|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312172|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312173|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312174|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312175|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312176|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
161312177|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312178|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312179|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312180|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312181|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312182|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312183|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312184|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
161312185|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312186|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312187|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312188|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312189|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312190|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
161312191|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312192|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312193|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312194|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312195|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312196|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312197|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
161312198|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
161312199|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312200|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312201|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312202|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312203|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312204|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
161312205|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312206|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312207|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312208|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312209|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312210|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312211|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312212|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
161312213|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312214|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312215|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312216|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312217|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312218|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
161312219|NCT02326298|582524922|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312220|NCT02326298|582524923|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312221|NCT02326298|582524924|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312222|NCT02326298|582524925|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312223|NCT02326298|582524926|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312224|NCT02326298|582524927|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
161312225|NCT02326298|582524928|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312226|NCT02326298|582524929|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312227|NCT02326298|582524930|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312228|NCT02326298|582524931|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312229|NCT02326298|582524932|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312230|NCT02326298|582524933|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312231|NCT02326298|582524934|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312232|NCT02326298|582524935|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
161312233|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
161312234|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
161312235|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
161312236|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
161312237|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
161312238|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
161312239|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
161312240|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
161312241|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
161312242|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
161312243|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
161312244|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
161312245|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
161312246|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
161312247|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312248|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312249|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312250|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312251|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312252|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312253|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312254|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312255|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312256|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312257|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161312258|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161312259|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
161312260|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
161091062|NCT01411215|581723787|FG000|Overall Study|Did not meet entrance criteria|0|||
161091063|NCT01411215|581723788|FG001|Overall Study|Did not meet entrance criteria|1|||
161091064|NCT01411215|581723787|FG000|Overall Study|Study terminated by sponsor|2|||
161091065|NCT01411215|581723788|FG001|Overall Study|Study terminated by sponsor|15|||
161091066|NCT01411215|581723787|FG000|Overall Study|Protocol Violation|3|||
161091067|NCT01411215|581723788|FG001|Overall Study|Protocol Violation|5|||
161091068|NCT01411215|581723787|FG000|Overall Study|Withdrawal by Subject|34|||
161091069|NCT01411215|581723788|FG001|Overall Study|Withdrawal by Subject|21|||
161091070|NCT01411215|581723787|FG000|Overall Study|Other|12|||
161091071|NCT01411215|581723788|FG001|Overall Study|Other|17|||
161091072|NCT01411215|581723787|FG000|Overall Study|Screen failure|0|||
161312261|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312262|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312263|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312264|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312265|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312266|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312267|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312268|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312269|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312270|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312271|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312272|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161312273|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
161312274|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
161312275|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312276|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312277|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312278|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312279|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312280|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312281|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312282|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312283|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312284|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312285|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312286|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312287|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
161312288|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
161312289|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312290|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312291|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312292|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312293|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312294|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312295|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312296|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312297|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312298|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312299|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
161312300|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
161312301|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
161312302|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
161312303|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312304|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312305|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312306|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312307|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312308|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312309|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312310|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312311|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312312|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312313|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
161312314|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
161312315|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
161312316|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
161312317|NCT02326298|582524922|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312318|NCT02326298|582524923|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312319|NCT02326298|582524924|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312320|NCT02326298|582524925|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312321|NCT02326298|582524926|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312322|NCT02326298|582524927|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312323|NCT02326298|582524928|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312324|NCT02326298|582524929|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312325|NCT02326298|582524930|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312326|NCT02326298|582524931|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312327|NCT02326298|582524932|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
161312328|NCT02326298|582524933|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
161312329|NCT02326298|582524934|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
161312330|NCT02326298|582524935|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
161312331|NCT02889835|582524936|FG000|Overall Study|Lost to Follow-up|13|||
161312332|NCT02889835|582524937|FG001|Overall Study|Lost to Follow-up|13|||
161312333|NCT02889835|582524938|FG002|Overall Study|Lost to Follow-up|13|||
161312334|NCT02889835|582524936|FG000|Overall Study|Withdrawal by Subject|2|||
161312335|NCT02889835|582524937|FG001|Overall Study|Withdrawal by Subject|2|||
161312336|NCT02889835|582524938|FG002|Overall Study|Withdrawal by Subject|2|||
161312337|NCT02889835|582524936|FG000|Overall Study|Protocol Violation|1|||
161312338|NCT02889835|582524937|FG001|Overall Study|Protocol Violation|1|||
161312339|NCT02889835|582524938|FG002|Overall Study|Protocol Violation|1|||
161312340|NCT02889835|582524936|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
161312341|NCT02889835|582524937|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
161312342|NCT02889835|582524938|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
161312343|NCT02889835|582524936|FG000|Overall Study|Death|1|||
161312344|NCT02889835|582524937|FG001|Overall Study|Death|1|||
161312345|NCT02889835|582524938|FG002|Overall Study|Death|1|||
161312346|NCT02342548|582524941|FG000|Overall Study|Adverse Event|12|||
161312347|NCT02342548|582524942|FG001|Overall Study|Adverse Event|17|||
161312348|NCT02342548|582524943|FG002|Overall Study|Adverse Event|13|||
161312349|NCT02342548|582524941|FG000|Overall Study|Lost to Follow-up|0|||
161312350|NCT02342548|582524942|FG001|Overall Study|Lost to Follow-up|1|||
161312351|NCT02342548|582524943|FG002|Overall Study|Lost to Follow-up|0|||
161312352|NCT02342548|582524941|FG000|Overall Study|Study terminated by sponsor|20|||
161312353|NCT02342548|582524942|FG001|Overall Study|Study terminated by sponsor|39|||
161312354|NCT02342548|582524943|FG002|Overall Study|Study terminated by sponsor|25|||
161312355|NCT02342548|582524941|FG000|Overall Study|Protocol Violation|0|||
161312356|NCT02342548|582524942|FG001|Overall Study|Protocol Violation|1|||
161312357|NCT02342548|582524943|FG002|Overall Study|Protocol Violation|0|||
161312358|NCT02342548|582524941|FG000|Overall Study|Withdrawal by Subject|1|||
161312359|NCT02342548|582524942|FG001|Overall Study|Withdrawal by Subject|3|||
161312360|NCT02342548|582524943|FG002|Overall Study|Withdrawal by Subject|4|||
161312361|NCT02342548|582524941|FG000|Overall Study|Other|1|||
161312362|NCT02342548|582524942|FG001|Overall Study|Other|1|||
161312363|NCT02342548|582524943|FG002|Overall Study|Other|1|||
161312364|NCT02987972|582524944|FG000|Overall Study|Adverse Event|1|||
161312365|NCT02987972|582524945|FG001|Overall Study|Adverse Event|1|||
161312366|NCT02987972|582524946|FG002|Overall Study|Adverse Event|0|||
161312367|NCT02987972|582524944|FG000|Overall Study|Death|1|||
161312368|NCT02987972|582524945|FG001|Overall Study|Death|0|||
161312369|NCT02987972|582524946|FG002|Overall Study|Death|0|||
161312370|NCT02987972|582524944|FG000|Overall Study|Lack of Efficacy|9|||
161312371|NCT02987972|582524945|FG001|Overall Study|Lack of Efficacy|12|||
161312372|NCT02987972|582524946|FG002|Overall Study|Lack of Efficacy|12|||
161312373|NCT02987972|582524944|FG000|Overall Study|Lost to Follow-up|7|||
161312374|NCT02987972|582524945|FG001|Overall Study|Lost to Follow-up|8|||
161312375|NCT02987972|582524946|FG002|Overall Study|Lost to Follow-up|4|||
161312376|NCT02987972|582524944|FG000|Overall Study|Physician Decision|1|||
161312377|NCT02987972|582524945|FG001|Overall Study|Physician Decision|6|||
161312378|NCT02987972|582524946|FG002|Overall Study|Physician Decision|0|||
161312379|NCT02987972|582524944|FG000|Overall Study|Protocol Violation|2|||
161312380|NCT02987972|582524945|FG001|Overall Study|Protocol Violation|1|||
161312381|NCT02987972|582524946|FG002|Overall Study|Protocol Violation|5|||
161312382|NCT02987972|582524944|FG000|Overall Study|Withdrawal by Subject|22|||
161312383|NCT02987972|582524945|FG001|Overall Study|Withdrawal by Subject|17|||
161312384|NCT02987972|582524946|FG002|Overall Study|Withdrawal by Subject|21|||
161312385|NCT01047332|582524949|FG000|Overall Study|SEMS Obstruction|11|||
161312386|NCT01047332|582524950|FG001|Overall Study|SEMS Obstruction|20|||
161312387|NCT01047332|582524949|FG000|Overall Study|Died Unobstructed|38|||
161312388|NCT01047332|582524950|FG001|Overall Study|Died Unobstructed|41|||
161312389|NCT01047332|582524949|FG000|Overall Study|Lost to Follow-up|8|||
161312390|NCT01047332|582524950|FG001|Overall Study|Lost to Follow-up|3|||
161312391|NCT03521817|582524951|FG000|Overall Study|Protocol Violation|0|||
161312392|NCT03521817|582524952|FG001|Overall Study|Protocol Violation|1|||
161312393|NCT00787917|582524953|FG000|Blinded Treatment|Adverse Event|1|||
161312394|NCT00787917|582524954|FG001|Blinded Treatment|Adverse Event|0|||
161312395|NCT00787917|582524953|FG000|Blinded Treatment|Lack of Efficacy|1|||
161312396|NCT00787917|582524954|FG001|Blinded Treatment|Lack of Efficacy|0|||
161312397|NCT00787917|582524953|FG000|Blinded Treatment|Administrative problems|3|||
161312398|NCT00787917|582524954|FG001|Blinded Treatment|Administrative problems|2|||
161312399|NCT00787917|582524953|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
161312400|NCT00787917|582524954|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
161312401|NCT00787917|582524953|FG000|Open Label|Administrative problems|3|||
161312402|NCT00787917|582524954|FG001|Open Label|Administrative problems|0|||
161312403|NCT05685732|582524956|FG000|Overall Study|Withdrawal by Subject|2|||
161312404|NCT05685732|582524957|FG001|Overall Study|Withdrawal by Subject|0|||
161312405|NCT05685732|582524958|FG002|Overall Study|Withdrawal by Subject|2|||
161312406|NCT05685732|582524959|FG003|Overall Study|Withdrawal by Subject|3|||
161312407|NCT05685732|582524956|FG000|Overall Study|Protocol Violation|1|||
161312408|NCT05685732|582524957|FG001|Overall Study|Protocol Violation|2|||
161312409|NCT05685732|582524958|FG002|Overall Study|Protocol Violation|4|||
161312410|NCT05685732|582524959|FG003|Overall Study|Protocol Violation|1|||
161312411|NCT05685732|582524956|FG000|Overall Study|Lost to Follow-up|5|||
161312412|NCT05685732|582524957|FG001|Overall Study|Lost to Follow-up|1|||
161312413|NCT05685732|582524958|FG002|Overall Study|Lost to Follow-up|3|||
161312414|NCT05685732|582524959|FG003|Overall Study|Lost to Follow-up|1|||
161312415|NCT05685732|582524956|FG000|Overall Study|Adverse Event|2|||
161312416|NCT05685732|582524957|FG001|Overall Study|Adverse Event|1|||
161312417|NCT05685732|582524958|FG002|Overall Study|Adverse Event|0|||
161312418|NCT05685732|582524959|FG003|Overall Study|Adverse Event|0|||
161312419|NCT05685732|582524956|FG000|Overall Study|Physician Decision|1|||
161312420|NCT05685732|582524957|FG001|Overall Study|Physician Decision|0|||
161312421|NCT05685732|582524958|FG002|Overall Study|Physician Decision|0|||
161312422|NCT05685732|582524959|FG003|Overall Study|Physician Decision|0|||
161312423|NCT02640404|582524960|FG000|Overall Study|Protocol Violation|1|||
161312424|NCT02640404|582524961|FG001|Overall Study|Protocol Violation|0|||
161312425|NCT02640404|582524960|FG000|Overall Study|Withdrawal by Subject|1|||
161312426|NCT02640404|582524961|FG001|Overall Study|Withdrawal by Subject|0|||
161312427|NCT00778102|582524962|FG000|Overall Study|Adverse Event|8|||
161312428|NCT00778102|582524963|FG001|Overall Study|Adverse Event|5|||
161312429|NCT00778102|582524962|FG000|Overall Study|Death|1|||
161312430|NCT00778102|582524963|FG001|Overall Study|Death|1|||
161312431|NCT00778102|582524962|FG000|Overall Study|Lost to Follow-up|1|||
161312432|NCT00778102|582524963|FG001|Overall Study|Lost to Follow-up|0|||
161312433|NCT00778102|582524962|FG000|Overall Study|Violation of Selection Criteria|1|||
161206548|NCT01523301|582136460|FG001|Overall Study|Withdrawal by Subject|8|||
161206549|NCT01523301|582136459|FG000|Overall Study|Other Reason|0|||
161206550|NCT01523301|582136460|FG001|Overall Study|Other Reason|2|||
161206551|NCT01339000|582136461|FG000|Overall Study|study closed due to lack of drug supply|1|||
161206552|NCT01339000|582136462|FG001|Overall Study|study closed due to lack of drug supply|0|||
161206553|NCT00728988|582136463|FG000|Overall Study|Not Treated|2|||
161206554|NCT00728988|582136464|FG001|Overall Study|Not Treated|2|||
161206555|NCT00728988|582136463|FG000|Overall Study|Death|1|||
161206556|NCT00728988|582136464|FG001|Overall Study|Death|1|||
161206557|NCT00728988|582136463|FG000|Overall Study|Adverse Event|3|||
161206558|NCT00728988|582136464|FG001|Overall Study|Adverse Event|2|||
161206559|NCT00728988|582136463|FG000|Overall Study|Other|85|||
161206560|NCT00728988|582136464|FG001|Overall Study|Other|77|||
161206561|NCT00728988|582136463|FG000|Overall Study|Withdrawal by Subject|2|||
161206562|NCT00728988|582136464|FG001|Overall Study|Withdrawal by Subject|6|||
161206563|NCT02017535|582136467|FG000|Overall Study|Withdrawal by Subject|1|||
161206564|NCT02017535|582136468|FG001|Overall Study|Withdrawal by Subject|0|||
161206565|NCT02017535|582136469|FG002|Overall Study|Withdrawal by Subject|0|||
161206566|NCT02017535|582136470|FG003|Overall Study|Withdrawal by Subject|0|||
161206567|NCT05511428|582136471|FG000|Overall Study|Withdrawal by Subject|1|||
161206568|NCT05511428|582136471|FG000|Overall Study|Adverse Event|1|||
161206569|NCT04088734|582136472|FG000|Overall Study|Other, Not Specified|5|||
161206570|NCT00664066|582136477|FG000|Overall Study|Study terminated|3|||
161206571|NCT03332212|582136481|FG000|Overall Study|Not treated|0|||
161206572|NCT03332212|582136482|FG001|Overall Study|Not treated|1|||
161206573|NCT03332212|582136483|FG002|Overall Study|Not treated|0|||
161206574|NCT03332212|582136484|FG003|Overall Study|Not treated|0|||
161206575|NCT03332212|582136481|FG000|Overall Study|Adverse Event|0|||
161206576|NCT03332212|582136482|FG001|Overall Study|Adverse Event|0|||
161206577|NCT03332212|582136483|FG002|Overall Study|Adverse Event|0|||
161206578|NCT03332212|582136484|FG003|Overall Study|Adverse Event|1|||
161206579|NCT03332212|582136481|FG000|Overall Study|worsening of disease under study|1|||
161206580|NCT03332212|582136482|FG001|Overall Study|worsening of disease under study|1|||
161206581|NCT03332212|582136483|FG002|Overall Study|worsening of disease under study|0|||
161206582|NCT03332212|582136484|FG003|Overall Study|worsening of disease under study|0|||
161206583|NCT03889197|582136485|FG000|Overall Study|Withdrawal by Subject|1|||
161206584|NCT03889197|582136486|FG001|Overall Study|Withdrawal by Subject|0|||
161206585|NCT03889197|582136485|FG000|Overall Study|Physician Decision|0|||
161206586|NCT03889197|582136486|FG001|Overall Study|Physician Decision|1|||
161206587|NCT03889197|582136485|FG000|Overall Study|met exclusion criteria|0|||
161206588|NCT03889197|582136486|FG001|Overall Study|met exclusion criteria|1|||
161206589|NCT03889197|582136485|FG000|Overall Study|Protocol Violation|1|||
161206590|NCT03889197|582136486|FG001|Overall Study|Protocol Violation|0|||
161206591|NCT03193190|582136491|FG000|Stage 1|Arm Terminated by Sponsor|0|||
161206592|NCT03193190|582136492|FG001|Stage 1|Arm Terminated by Sponsor|0|||
161206593|NCT03193190|582136493|FG002|Stage 1|Arm Terminated by Sponsor|0|||
161206594|NCT03193190|582136494|FG003|Stage 1|Arm Terminated by Sponsor|1|||
161206595|NCT03193190|582136495|FG004|Stage 1|Arm Terminated by Sponsor|0|||
161206596|NCT03193190|582136496|FG005|Stage 1|Arm Terminated by Sponsor|2|||
161206597|NCT03193190|582136497|FG006|Stage 1|Arm Terminated by Sponsor|0|||
161206598|NCT03193190|582136498|FG007|Stage 1|Arm Terminated by Sponsor|0|||
161206599|NCT03193190|582136499|FG008|Stage 1|Arm Terminated by Sponsor|0|||
161206600|NCT03193190|582136500|FG009|Stage 1|Arm Terminated by Sponsor|0|||
161206601|NCT03193190|582136501|FG010|Stage 1|Arm Terminated by Sponsor|0|||
161206602|NCT03193190|582136502|FG011|Stage 1|Arm Terminated by Sponsor|0|||
161206603|NCT03193190|582136503|FG012|Stage 1|Arm Terminated by Sponsor|0|||
161206604|NCT03193190|582136504|FG013|Stage 1|Arm Terminated by Sponsor|0|||
161206605|NCT03193190|582136505|FG014|Stage 1|Arm Terminated by Sponsor|0|||
161206606|NCT03193190|582136506|FG015|Stage 1|Arm Terminated by Sponsor|0|||
161206607|NCT03193190|582136491|FG000|Stage 1|Death|22|||
161206608|NCT03193190|582136492|FG001|Stage 1|Death|8|||
161206609|NCT03193190|582136493|FG002|Stage 1|Death|23|||
161206610|NCT03193190|582136494|FG003|Stage 1|Death|14|||
161206611|NCT03193190|582136495|FG004|Stage 1|Death|34|||
161206612|NCT03193190|582136496|FG005|Stage 1|Death|28|||
161206613|NCT03193190|582136497|FG006|Stage 1|Death|19|||
161206614|NCT03193190|582136498|FG007|Stage 1|Death|21|||
161206615|NCT03193190|582136499|FG008|Stage 1|Death|14|||
161206616|NCT03193190|582136500|FG009|Stage 1|Death|10|||
161206617|NCT03193190|582136501|FG010|Stage 1|Death|59|||
161206618|NCT03193190|582136502|FG011|Stage 1|Death|14|||
161206619|NCT03193190|582136503|FG012|Stage 1|Death|14|||
161206620|NCT03193190|582136504|FG013|Stage 1|Death|0|||
161206621|NCT03193190|582136505|FG014|Stage 1|Death|0|||
161206622|NCT03193190|582136506|FG015|Stage 1|Death|0|||
161206623|NCT03193190|582136491|FG000|Stage 1|Lost to Follow-up|2|||
161206624|NCT03193190|582136492|FG001|Stage 1|Lost to Follow-up|1|||
161206625|NCT03193190|582136493|FG002|Stage 1|Lost to Follow-up|1|||
161206626|NCT03193190|582136494|FG003|Stage 1|Lost to Follow-up|0|||
161206627|NCT03193190|582136495|FG004|Stage 1|Lost to Follow-up|0|||
161206628|NCT03193190|582136496|FG005|Stage 1|Lost to Follow-up|0|||
161206629|NCT03193190|582136497|FG006|Stage 1|Lost to Follow-up|1|||
161206630|NCT03193190|582136498|FG007|Stage 1|Lost to Follow-up|0|||
161312434|NCT00778102|582524963|FG001|Overall Study|Violation of Selection Criteria|1|||
161312435|NCT00778102|582524962|FG000|Overall Study|Protocol Violation|0|||
161312436|NCT00778102|582524963|FG001|Overall Study|Protocol Violation|1|||
161312437|NCT00778102|582524962|FG000|Overall Study|Refused Treatment|2|||
161312438|NCT00778102|582524963|FG001|Overall Study|Refused Treatment|3|||
161312439|NCT00778102|582524962|FG000|Overall Study|Withdrawal by Subject|1|||
161312440|NCT00778102|582524963|FG001|Overall Study|Withdrawal by Subject|1|||
161312441|NCT00778102|582524962|FG000|Overall Study|Administrative Reason|7|||
161312442|NCT00778102|582524963|FG001|Overall Study|Administrative Reason|10|||
161312443|NCT05397171|582524964|FG000|Overall Study|Death|2|||
161312444|NCT05397171|582524965|FG001|Overall Study|Death|3|||
161312445|NCT05397171|582524966|FG002|Overall Study|Death|3|||
161312446|NCT05397171|582524964|FG000|Overall Study|Study Terminated By Sponsor|1|||
161312447|NCT05397171|582524965|FG001|Overall Study|Study Terminated By Sponsor|2|||
161312448|NCT05397171|582524966|FG002|Overall Study|Study Terminated By Sponsor|3|||
161312449|NCT05397171|582524964|FG000|Overall Study|Withdrawal by Subject|0|||
161312450|NCT05397171|582524965|FG001|Overall Study|Withdrawal by Subject|1|||
161312451|NCT05397171|582524966|FG002|Overall Study|Withdrawal by Subject|1|||
161312452|NCT01328548|582524967|FG000|Overall Study|Death|3|||
161312453|NCT01328548|582524968|FG001|Overall Study|Death|0|||
161312454|NCT01328548|582524967|FG000|Overall Study|Protocol Violation|1|||
161312455|NCT01328548|582524968|FG001|Overall Study|Protocol Violation|0|||
161312456|NCT02824562|582526503|FG000|Overall Study|Lost to Follow-up|3|||
161312457|NCT02824562|582526504|FG001|Overall Study|Lost to Follow-up|4|||
161312458|NCT02824562|582526503|FG000|Overall Study|Death|0|||
161312459|NCT02824562|582526504|FG001|Overall Study|Death|1|||
161312460|NCT02921750|582526505|FG000|Overall Study|Adverse Event|1|||
161312461|NCT02921750|582526506|FG001|Overall Study|Adverse Event|2|||
161312462|NCT02921750|582526505|FG000|Overall Study|Withdrawal by Subject|1|||
161312463|NCT02921750|582526506|FG001|Overall Study|Withdrawal by Subject|1|||
161312464|NCT02921750|582526505|FG000|Overall Study|Lost to Follow-up|3|||
161312465|NCT02921750|582526506|FG001|Overall Study|Lost to Follow-up|3|||
161312466|NCT02921750|582526505|FG000|Overall Study|Wound healed|3|||
161312467|NCT02921750|582526506|FG001|Overall Study|Wound healed|3|||
161312468|NCT02921750|582526505|FG000|Overall Study|Serious Adverse Event|1|||
161312469|NCT02921750|582526506|FG001|Overall Study|Serious Adverse Event|2|||
161312470|NCT03309696|582526508|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
161312471|NCT03309696|582526509|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
161312472|NCT03309696|582526510|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
161312473|NCT03309696|582526511|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
161312474|NCT02638129|582526512|FG000|Overall Study|Study terminated|28|||
161312475|NCT02638129|582526513|FG001|Overall Study|Study terminated|30|||
161312476|NCT02368210|582526516|FG000|Overall Study|Withdrawal by Subject|1|||
161312477|NCT02368210|582526517|FG001|Overall Study|Withdrawal by Subject|0|||
161312478|NCT02368210|582526516|FG000|Overall Study|Adverse Event|0|||
161312479|NCT02368210|582526517|FG001|Overall Study|Adverse Event|1|||
161312480|NCT00078949|582526518|FG000|Overall Study|No treated|4|||
161312481|NCT00078949|582526519|FG001|Overall Study|No treated|5|||
161312482|NCT00078949|582526520|FG002|Overall Study|No treated|3|||
161312483|NCT00078949|582526521|FG003|Overall Study|No treated|3|||
161312484|NCT00577005|582526522|FG000|Overall Study|Lost to Follow-up|3|||
161312485|NCT00577005|582526523|FG001|Overall Study|Lost to Follow-up|2|||
161312486|NCT00577005|582526522|FG000|Overall Study|Withdrawal by Subject|2|||
161312487|NCT00577005|582526523|FG001|Overall Study|Withdrawal by Subject|1|||
161312488|NCT02667626|582526524|FG000|Overall Study|Withdrawal by Subject|0|||
161312489|NCT02667626|582526525|FG001|Overall Study|Withdrawal by Subject|1|||
161312490|NCT00590538|582526526|FG000|Overall Study|Study terminated before completed|2|||
161312491|NCT02309723|582526527|FG000|Overall Study|Withdrawal by Subject|24|||
161312492|NCT02309723|582526528|FG001|Overall Study|Withdrawal by Subject|23|||
161312493|NCT02309723|582526529|FG002|Overall Study|Withdrawal by Subject|24|||
161312494|NCT02560623|582526530|FG000|Overall Study|Unable to swallow sponge|0|||
161312495|NCT02560623|582526531|FG001|Overall Study|Unable to swallow sponge|1|||
161312496|NCT02560623|582526532|FG002|Overall Study|Unable to swallow sponge|0|||
161312497|NCT02560623|582526533|FG003|Overall Study|Unable to swallow sponge|0|||
161312498|NCT02560623|582526530|FG000|Overall Study|Intervention prior to sponge administration|0|||
161312499|NCT02560623|582526531|FG001|Overall Study|Intervention prior to sponge administration|1|||
161312500|NCT02560623|582526532|FG002|Overall Study|Intervention prior to sponge administration|0|||
161312501|NCT02560623|582526533|FG003|Overall Study|Intervention prior to sponge administration|0|||
161312502|NCT01125813|582526534|FG000|Overall Study|Death|1|||
161312503|NCT01125813|582526534|FG000|Overall Study|Withdrawal by Subject|1|||
161312504|NCT01125813|582526534|FG000|Overall Study|Screen Failures|4|||
161312505|NCT01565668|582526535|FG000|Overall Study|Death|2|||
161312506|NCT01565668|582526536|FG001|Overall Study|Death|1|||
161312507|NCT01565668|582526535|FG000|Overall Study|Lack of Efficacy|4|||
161312508|NCT01565668|582526536|FG001|Overall Study|Lack of Efficacy|2|||
161312509|NCT01565668|582526535|FG000|Overall Study|Participant went on Hospice Care|1|||
161312510|NCT01565668|582526536|FG001|Overall Study|Participant went on Hospice Care|0|||
161312511|NCT01565668|582526535|FG000|Overall Study|Adverse Event|6|||
161312512|NCT01565668|582526536|FG001|Overall Study|Adverse Event|1|||
161312513|NCT01565668|582526535|FG000|Overall Study|Randomized, but never received drug|0|||
161312514|NCT01565668|582526536|FG001|Overall Study|Randomized, but never received drug|2|||
161312515|NCT01565668|582526535|FG000|Overall Study|Progressive disease|13|||
161312516|NCT01565668|582526536|FG001|Overall Study|Progressive disease|14|||
161312517|NCT01565668|582526535|FG000|Overall Study|Withdrawal by Subject|1|||
161312518|NCT01565668|582526536|FG001|Overall Study|Withdrawal by Subject|3|||
161312519|NCT01565668|582526535|FG000|Overall Study|HSCT Transplant|11|||
161312520|NCT01565668|582526536|FG001|Overall Study|HSCT Transplant|15|||
161312521|NCT01097421|582526537|FG000|Overall Study|Adverse Event|8|||
161312522|NCT01097421|582526537|FG000|Overall Study|Protocol Violation|2|||
161312523|NCT01097421|582526537|FG000|Overall Study|Lost to Follow-up|1|||
161312524|NCT01097421|582526537|FG000|Overall Study|Withdrawal by Subject|3|||
161312525|NCT02382796|582526538|FG000|Overall Study|Global deterioration of health status|1|||
161312526|NCT02382796|582526538|FG000|Overall Study|Objective progression or relapse|3|||
161312527|NCT02382796|582526538|FG000|Overall Study|Commercial dacomitinib became available|3|||
161312528|NCT03077659|582526539|FG000|Overall Study|Withdrawal by Subject|0|||
161312529|NCT03077659|582526540|FG001|Overall Study|Withdrawal by Subject|0|||
161312530|NCT03077659|582526541|FG002|Overall Study|Withdrawal by Subject|1|||
161312531|NCT02258542|582526542|FG000|Overall Study|eg. not made to the visit|7|||
161312532|NCT02258542|582526543|FG001|Overall Study|eg. not made to the visit|4|||
161312533|NCT02258542|582526544|FG002|Overall Study|eg. not made to the visit|0|||
161312534|NCT02258542|582526545|FG003|Overall Study|eg. not made to the visit|1|||
161312535|NCT02258542|582526542|FG000|Overall Study|study specific discount. criteria|1|||
161312536|NCT02258542|582526543|FG001|Overall Study|study specific discount. criteria|1|||
161312537|NCT02258542|582526544|FG002|Overall Study|study specific discount. criteria|0|||
161312538|NCT02258542|582526545|FG003|Overall Study|study specific discount. criteria|0|||
161312539|NCT02258542|582526542|FG000|Overall Study|Withdrawal by Subject|20|||
161312540|NCT02258542|582526543|FG001|Overall Study|Withdrawal by Subject|20|||
161312541|NCT02258542|582526544|FG002|Overall Study|Withdrawal by Subject|7|||
161312542|NCT02258542|582526545|FG003|Overall Study|Withdrawal by Subject|1|||
161312543|NCT02258542|582526542|FG000|Overall Study|Lost to Follow-up|5|||
161312544|NCT02258542|582526543|FG001|Overall Study|Lost to Follow-up|12|||
161312545|NCT02258542|582526544|FG002|Overall Study|Lost to Follow-up|1|||
161312546|NCT02258542|582526545|FG003|Overall Study|Lost to Follow-up|2|||
161312547|NCT02258542|582526542|FG000|Overall Study|Death|5|||
161312548|NCT02258542|582526543|FG001|Overall Study|Death|4|||
161312549|NCT02258542|582526544|FG002|Overall Study|Death|0|||
161312550|NCT02258542|582526545|FG003|Overall Study|Death|1|||
161312551|NCT02258542|582526542|FG000|Overall Study|Adverse Event|3|||
161312552|NCT02258542|582526543|FG001|Overall Study|Adverse Event|4|||
161312553|NCT02258542|582526544|FG002|Overall Study|Adverse Event|0|||
161312554|NCT02258542|582526545|FG003|Overall Study|Adverse Event|0|||
161312555|NCT02258542|582526542|FG000|Overall Study|Protocol Violation|1|||
161312556|NCT02258542|582526543|FG001|Overall Study|Protocol Violation|2|||
161312557|NCT02258542|582526544|FG002|Overall Study|Protocol Violation|0|||
161312558|NCT02258542|582526545|FG003|Overall Study|Protocol Violation|0|||
161312559|NCT02258542|582526542|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
161312560|NCT02258542|582526543|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
161312561|NCT02258542|582526544|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
161312562|NCT02258542|582526545|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
161312563|NCT01472965|582526552|FG000|Overall Study|Withdrawal by Subject|1|||
161312564|NCT01472965|582526553|FG001|Overall Study|Withdrawal by Subject|0|||
161312565|NCT00334802|582526557|FG000|Overall Study|Progressive Disease|2|||
161312566|NCT00334802|582526558|FG001|Overall Study|Progressive Disease|24|||
161312567|NCT00334802|582526557|FG000|Overall Study|Toxicity|1|||
161312568|NCT00334802|582526558|FG001|Overall Study|Toxicity|5|||
161312569|NCT00334802|582526557|FG000|Overall Study|Lack of Efficacy|1|||
161312570|NCT00334802|582526558|FG001|Overall Study|Lack of Efficacy|3|||
161312571|NCT00334802|582526557|FG000|Overall Study|Patient Condition Aggrevated|1|||
161312572|NCT00334802|582526558|FG001|Overall Study|Patient Condition Aggrevated|0|||
161312573|NCT00334802|582526557|FG000|Overall Study|Physician Decision|1|||
161312574|NCT00334802|582526558|FG001|Overall Study|Physician Decision|0|||
161312575|NCT00334802|582526557|FG000|Overall Study|Withdrawal by Subject|0|||
161312576|NCT00334802|582526558|FG001|Overall Study|Withdrawal by Subject|4|||
161312577|NCT00334802|582526557|FG000|Overall Study|Adverse Event|0|||
161312578|NCT00334802|582526558|FG001|Overall Study|Adverse Event|3|||
161312579|NCT00334802|582526557|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
161312580|NCT00334802|582526558|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
161312581|NCT00980018|582526564|FG000|Overall Study|Adverse Event|8|||
161312582|NCT00980018|582526564|FG000|Overall Study|Patient withdrew consent|3|||
161312583|NCT00980018|582526564|FG000|Overall Study|Lost to Follow-up|1|||
161312584|NCT00551161|582526565|FG000|Overall Study|Withdrawal by Subject|1|||
161312585|NCT00934856|582526566|FG000|Feasibility Part|Progressive disease|4|||
161312586|NCT00934856|582526567|FG001|Feasibility Part|Progressive disease|4|||
161312587|NCT00934856|582526568|FG002|Feasibility Part|Progressive disease|2|||
161312588|NCT00934856|582526569|FG003|Feasibility Part|Progressive disease|3|||
161312589|NCT00934856|582526570|FG004|Feasibility Part|Progressive disease|0|||
161312590|NCT00934856|582526571|FG005|Feasibility Part|Progressive disease|0|||
161312591|NCT00934856|582526566|FG000|Feasibility Part|Physician Decision|0|||
161312592|NCT00934856|582526567|FG001|Feasibility Part|Physician Decision|0|||
161312593|NCT00934856|582526568|FG002|Feasibility Part|Physician Decision|1|||
161312594|NCT00934856|582526569|FG003|Feasibility Part|Physician Decision|0|||
161312595|NCT00934856|582526570|FG004|Feasibility Part|Physician Decision|0|||
161312596|NCT00934856|582526571|FG005|Feasibility Part|Physician Decision|0|||
161312597|NCT00934856|582526566|FG000|Feasibility Part|Adverse Event|1|||
161312598|NCT00934856|582526567|FG001|Feasibility Part|Adverse Event|1|||
161312599|NCT00934856|582526568|FG002|Feasibility Part|Adverse Event|0|||
161312600|NCT00934856|582526569|FG003|Feasibility Part|Adverse Event|1|||
161312601|NCT00934856|582526570|FG004|Feasibility Part|Adverse Event|0|||
161312602|NCT00934856|582526571|FG005|Feasibility Part|Adverse Event|2|||
161312603|NCT00934856|582526566|FG000|Feasibility Part|Withdrawal by Subject|0|||
161312604|NCT00934856|582526567|FG001|Feasibility Part|Withdrawal by Subject|0|||
161312605|NCT00934856|582526568|FG002|Feasibility Part|Withdrawal by Subject|0|||
161312606|NCT00934856|582526569|FG003|Feasibility Part|Withdrawal by Subject|1|||
161312607|NCT00934856|582526570|FG004|Feasibility Part|Withdrawal by Subject|0|||
161312608|NCT00934856|582526571|FG005|Feasibility Part|Withdrawal by Subject|1|||
161312609|NCT00934856|582526566|FG000|Extension Part|Adverse Event|0|||
161312610|NCT00934856|582526567|FG001|Extension Part|Adverse Event|0|||
161312611|NCT00934856|582526568|FG002|Extension Part|Adverse Event|0|||
161312612|NCT00934856|582526569|FG003|Extension Part|Adverse Event|1|||
161312613|NCT00934856|582526570|FG004|Extension Part|Adverse Event|4|||
161312614|NCT00934856|582526571|FG005|Extension Part|Adverse Event|4|||
161312615|NCT00934856|582526566|FG000|Extension Part|Progressive disease|0|||
161312616|NCT00934856|582526567|FG001|Extension Part|Progressive disease|0|||
161312617|NCT00934856|582526568|FG002|Extension Part|Progressive disease|0|||
161312618|NCT00934856|582526569|FG003|Extension Part|Progressive disease|1|||
161312619|NCT00934856|582526570|FG004|Extension Part|Progressive disease|0|||
161312620|NCT00934856|582526571|FG005|Extension Part|Progressive disease|0|||
161312621|NCT00934856|582526566|FG000|Extension Part|Non-compliance with drug|0|||
161312622|NCT00934856|582526567|FG001|Extension Part|Non-compliance with drug|0|||
161312623|NCT00934856|582526568|FG002|Extension Part|Non-compliance with drug|0|||
161312624|NCT00934856|582526569|FG003|Extension Part|Non-compliance with drug|0|||
161312625|NCT00934856|582526570|FG004|Extension Part|Non-compliance with drug|0|||
161312626|NCT00934856|582526571|FG005|Extension Part|Non-compliance with drug|1|||
161312627|NCT01256385|582526572|FG000|Overall Study|Physician Decision|1|||
161312628|NCT01256385|582526573|FG001|Overall Study|Physician Decision|1|||
161312629|NCT01256385|582526572|FG000|Overall Study|Withdrawal by Subject|2|||
161312630|NCT01256385|582526573|FG001|Overall Study|Withdrawal by Subject|2|||
161312631|NCT03430895|582526578|FG000|Overall Study|Not Treated|2|||
161312632|NCT01645891|582526581|FG000|Overall Study|Adverse Event|6|||
161312633|NCT01645891|582526582|FG001|Overall Study|Adverse Event|10|||
161312634|NCT01645891|582526581|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
161312635|NCT01645891|582526582|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
161312636|NCT01645891|582526581|FG000|Overall Study|Withdrawal by Subject|3|||
161312637|NCT01645891|582526582|FG001|Overall Study|Withdrawal by Subject|3|||
161312638|NCT01645891|582526581|FG000|Overall Study|Protocol Violation|4|||
161312639|NCT01645891|582526582|FG001|Overall Study|Protocol Violation|0|||
161312640|NCT01645891|582526581|FG000|Overall Study|Lost to Follow-up|4|||
161312641|NCT01645891|582526582|FG001|Overall Study|Lost to Follow-up|1|||
161312642|NCT01645891|582526581|FG000|Overall Study|Death|0|||
161312643|NCT01645891|582526582|FG001|Overall Study|Death|2|||
161312644|NCT00138073|582526585|FG000|Overall Study|lack of resources|55|||
161312645|NCT03301740|582526586|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
161312646|NCT03301740|582526587|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
161312647|NCT03301740|582526586|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
161312648|NCT03301740|582526587|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
161312649|NCT02847182|582526588|FG000|Overall Study|Withdrawal by Subject|0|||
161312650|NCT02847182|582526589|FG001|Overall Study|Withdrawal by Subject|1|||
161312651|NCT01306045|582526590|FG000|Met General Eligibility Criteria|Screen failures|193|||
161312652|NCT01306045|582526591|FG001|Met General Eligibility Criteria|Screen failures|11|||
161312653|NCT01306045|582526592|FG002|Met General Eligibility Criteria|Screen failures|8|||
161312654|NCT03191864|582526593|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
161312655|NCT03191864|582526594|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
161312656|NCT03191864|582526595|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
161312657|NCT03191864|582526596|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
161312658|NCT03191864|582526597|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
161312659|NCT03191864|582526598|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
161312660|NCT03191864|582526593|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161312661|NCT03191864|582526594|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161312662|NCT03191864|582526595|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161312663|NCT03191864|582526596|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161312664|NCT03191864|582526597|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
161312665|NCT03191864|582526598|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
161312666|NCT03191864|582526593|FG000|Baseline Symptom Assessment|Adverse Event|0|||
161312667|NCT03191864|582526594|FG001|Baseline Symptom Assessment|Adverse Event|0|||
161312668|NCT03191864|582526595|FG002|Baseline Symptom Assessment|Adverse Event|0|||
161312669|NCT03191864|582526596|FG003|Baseline Symptom Assessment|Adverse Event|0|||
161312670|NCT03191864|582526597|FG004|Baseline Symptom Assessment|Adverse Event|0|||
161312671|NCT03191864|582526598|FG005|Baseline Symptom Assessment|Adverse Event|2|||
161312672|NCT03191864|582526593|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161312673|NCT03191864|582526594|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161312674|NCT03191864|582526595|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161312675|NCT03191864|582526596|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161312676|NCT03191864|582526597|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
161312677|NCT03191864|582526598|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
161312678|NCT03191864|582526593|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161312679|NCT03191864|582526594|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161312680|NCT03191864|582526595|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161319511|NCT03383692|582555345|FG000|Overall Study|Progressive disease as per RECIST|3|||
161091073|NCT01411215|581723788|FG001|Overall Study|Screen failure|1|||
161312681|NCT03191864|582526596|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161312682|NCT03191864|582526597|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
161312683|NCT03191864|582526598|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
161312684|NCT03191864|582526593|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161312685|NCT03191864|582526594|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161312686|NCT03191864|582526595|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
161312687|NCT03191864|582526596|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161312688|NCT03191864|582526597|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
161312689|NCT03191864|582526598|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
161312690|NCT03191864|582526593|FG000|Part 1 - Induction|Adverse Event|0|||
161312691|NCT03191864|582526594|FG001|Part 1 - Induction|Adverse Event|2|||
161312692|NCT03191864|582526595|FG002|Part 1 - Induction|Adverse Event|0|||
161312693|NCT03191864|582526596|FG003|Part 1 - Induction|Adverse Event|1|||
161312694|NCT03191864|582526597|FG004|Part 1 - Induction|Adverse Event|0|||
161312695|NCT03191864|582526598|FG005|Part 1 - Induction|Adverse Event|2|||
161312696|NCT03191864|582526593|FG000|Part 1 - Induction|Randomized but never dosed|0|||
161312697|NCT03191864|582526594|FG001|Part 1 - Induction|Randomized but never dosed|0|||
161312698|NCT03191864|582526595|FG002|Part 1 - Induction|Randomized but never dosed|1|||
161312699|NCT03191864|582526596|FG003|Part 1 - Induction|Randomized but never dosed|0|||
161312700|NCT03191864|582526597|FG004|Part 1 - Induction|Randomized but never dosed|0|||
161312701|NCT03191864|582526598|FG005|Part 1 - Induction|Randomized but never dosed|0|||
161312702|NCT03191864|582526593|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
161312703|NCT03191864|582526594|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
161312704|NCT03191864|582526595|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
161312705|NCT03191864|582526596|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
161312706|NCT03191864|582526597|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
161312707|NCT03191864|582526598|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
161312708|NCT03191864|582526593|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161312709|NCT03191864|582526594|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161312710|NCT03191864|582526595|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
161312711|NCT03191864|582526596|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161312712|NCT03191864|582526597|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161312713|NCT03191864|582526598|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
161312714|NCT03191864|582526593|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
161312715|NCT03191864|582526594|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161312716|NCT03191864|582526595|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161312717|NCT03191864|582526596|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161312718|NCT03191864|582526597|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161312719|NCT03191864|582526598|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
161312720|NCT03191864|582526593|FG000|Part 2 - Maintenance|Physician Decision|1|||
161312721|NCT03191864|582526594|FG001|Part 2 - Maintenance|Physician Decision|0|||
161312722|NCT03191864|582526595|FG002|Part 2 - Maintenance|Physician Decision|0|||
161312723|NCT03191864|582526596|FG003|Part 2 - Maintenance|Physician Decision|0|||
161312724|NCT03191864|582526597|FG004|Part 2 - Maintenance|Physician Decision|0|||
161312725|NCT03191864|582526598|FG005|Part 2 - Maintenance|Physician Decision|0|||
161312726|NCT03191864|582526593|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
161312727|NCT03191864|582526594|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
161091074|NCT00903630|581723789|FG000|Phase 2|Adverse Event|0|||
161312728|NCT03191864|582526595|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
161312729|NCT03191864|582526596|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
161312730|NCT03191864|582526597|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
161312731|NCT03191864|582526598|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
161312732|NCT03191864|582526593|FG000|Part 2 - Maintenance|Adverse Event|0|||
161312733|NCT03191864|582526594|FG001|Part 2 - Maintenance|Adverse Event|0|||
161312734|NCT03191864|582526595|FG002|Part 2 - Maintenance|Adverse Event|0|||
161312735|NCT03191864|582526596|FG003|Part 2 - Maintenance|Adverse Event|0|||
161312736|NCT03191864|582526597|FG004|Part 2 - Maintenance|Adverse Event|1|||
161312737|NCT03191864|582526598|FG005|Part 2 - Maintenance|Adverse Event|0|||
161312738|NCT03191864|582526593|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
161312739|NCT03191864|582526594|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
161312740|NCT03191864|582526595|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
161312741|NCT03191864|582526596|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
161312742|NCT03191864|582526597|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
161312743|NCT03191864|582526598|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
161312744|NCT03191864|582526593|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161312745|NCT03191864|582526594|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161312746|NCT03191864|582526595|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161312747|NCT03191864|582526596|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161312748|NCT03191864|582526597|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
161312749|NCT03191864|582526598|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
161312750|NCT02044874|582526599|FG000|Overall Study|Adverse Event|5|||
161312751|NCT02044874|582526600|FG001|Overall Study|Adverse Event|6|||
161312752|NCT02044874|582526601|FG002|Overall Study|Adverse Event|6|||
161312753|NCT02044874|582526599|FG000|Overall Study|Withdrawal by Subject|8|||
161312754|NCT02044874|582526600|FG001|Overall Study|Withdrawal by Subject|16|||
161312755|NCT02044874|582526601|FG002|Overall Study|Withdrawal by Subject|23|||
161312756|NCT02044874|582526599|FG000|Overall Study|Physician Decision|0|||
161312757|NCT02044874|582526600|FG001|Overall Study|Physician Decision|2|||
161312758|NCT02044874|582526601|FG002|Overall Study|Physician Decision|1|||
161312759|NCT02044874|582526599|FG000|Overall Study|Lost to Follow-up|10|||
161312760|NCT02044874|582526600|FG001|Overall Study|Lost to Follow-up|27|||
161312761|NCT02044874|582526601|FG002|Overall Study|Lost to Follow-up|21|||
161312762|NCT02044874|582526599|FG000|Overall Study|Sponsor Decision|0|||
161312763|NCT02044874|582526600|FG001|Overall Study|Sponsor Decision|1|||
161312764|NCT02044874|582526601|FG002|Overall Study|Sponsor Decision|1|||
161312765|NCT02044874|582526599|FG000|Overall Study|Other|7|||
161312766|NCT02044874|582526600|FG001|Overall Study|Other|3|||
161312767|NCT02044874|582526601|FG002|Overall Study|Other|8|||
161312768|NCT05072964|582526602|FG000|Overall Study|Withdrawal by Subject|4|||
161312769|NCT05072964|582526602|FG000|Overall Study|Death|1|||
161312770|NCT00415597|582526603|FG000|Enrollment|Withdrawal by Subject|1|||
161312771|NCT00415597|582526603|FG000|Enrollment|Protocol Violation|1|||
161312772|NCT00415597|582526603|FG000|Treatment|Adverse Event|110|||
161312773|NCT00415597|582526603|FG000|Treatment|Lack of Efficacy|39|||
161312774|NCT00415597|582526603|FG000|Treatment|Protocol Violation|67|||
161312775|NCT00415597|582526603|FG000|Treatment|Physician Decision|3|||
161312776|NCT00415597|582526603|FG000|Treatment|Withdrawal by Subject|51|||
161312777|NCT00415597|582526603|FG000|Treatment|Lost to Follow-up|28|||
161312778|NCT00415597|582526603|FG000|Treatment|Drug Screen|2|||
161312779|NCT00415597|582526603|FG000|Treatment|Administrative|3|||
161312780|NCT00415597|582526603|FG000|Treatment|Sponsor Decision|1|||
161312781|NCT00415597|582526603|FG000|Treatment|Multiple Reasons|1|||
161312782|NCT02172040|582526609|FG000|Overall Study|Adverse Event|0|||
161312783|NCT02172040|582526610|FG001|Overall Study|Adverse Event|2|||
161312784|NCT02172040|582526611|FG002|Overall Study|Adverse Event|0|||
161312785|NCT02172040|582526612|FG003|Overall Study|Adverse Event|0|||
161312786|NCT02172040|582526609|FG000|Overall Study|Protocol Violation|0|||
161312787|NCT02172040|582526610|FG001|Overall Study|Protocol Violation|1|||
161312788|NCT02172040|582526611|FG002|Overall Study|Protocol Violation|0|||
161312789|NCT02172040|582526612|FG003|Overall Study|Protocol Violation|0|||
161312790|NCT02172040|582526609|FG000|Overall Study|Withdrawal by Subject|0|||
161312791|NCT02172040|582526610|FG001|Overall Study|Withdrawal by Subject|0|||
161312792|NCT02172040|582526611|FG002|Overall Study|Withdrawal by Subject|1|||
161312793|NCT02172040|582526612|FG003|Overall Study|Withdrawal by Subject|0|||
161312794|NCT02172040|582526609|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
161091075|NCT00903630|581723790|FG001|Phase 2|Adverse Event|0|||
161312795|NCT02172040|582526610|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
161312796|NCT02172040|582526611|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
161312797|NCT02172040|582526612|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
161312798|NCT02172040|582526609|FG000|Overall Study|Family emergency abroad|0|||
161312799|NCT02172040|582526610|FG001|Overall Study|Family emergency abroad|0|||
161312800|NCT02172040|582526611|FG002|Overall Study|Family emergency abroad|0|||
161312801|NCT02172040|582526612|FG003|Overall Study|Family emergency abroad|1|||
161312802|NCT04908202|582526613|FG000|Pre-Treatment Period|OTHER REASONS|3|||
161312803|NCT04908202|582526614|FG001|Pre-Treatment Period|OTHER REASONS|1|||
161312804|NCT04908202|582526615|FG002|Pre-Treatment Period|OTHER REASONS|0|||
161206631|NCT03193190|582136499|FG008|Stage 1|Lost to Follow-up|0|||
161206632|NCT03193190|582136500|FG009|Stage 1|Lost to Follow-up|0|||
161206633|NCT03193190|582136501|FG010|Stage 1|Lost to Follow-up|0|||
161206634|NCT03193190|582136502|FG011|Stage 1|Lost to Follow-up|0|||
161206635|NCT03193190|582136503|FG012|Stage 1|Lost to Follow-up|0|||
161206636|NCT03193190|582136504|FG013|Stage 1|Lost to Follow-up|0|||
161206637|NCT03193190|582136505|FG014|Stage 1|Lost to Follow-up|0|||
161206638|NCT03193190|582136506|FG015|Stage 1|Lost to Follow-up|0|||
161206639|NCT03193190|582136491|FG000|Stage 1|Reason not Specified|1|||
161206640|NCT03193190|582136492|FG001|Stage 1|Reason not Specified|0|||
161206641|NCT03193190|582136493|FG002|Stage 1|Reason not Specified|0|||
161206642|NCT03193190|582136494|FG003|Stage 1|Reason not Specified|1|||
161206643|NCT03193190|582136495|FG004|Stage 1|Reason not Specified|0|||
161206644|NCT03193190|582136496|FG005|Stage 1|Reason not Specified|1|||
161206645|NCT03193190|582136497|FG006|Stage 1|Reason not Specified|2|||
161206646|NCT03193190|582136498|FG007|Stage 1|Reason not Specified|2|||
161206647|NCT03193190|582136499|FG008|Stage 1|Reason not Specified|0|||
161206648|NCT03193190|582136500|FG009|Stage 1|Reason not Specified|1|||
161206649|NCT03193190|582136501|FG010|Stage 1|Reason not Specified|3|||
161206650|NCT03193190|582136502|FG011|Stage 1|Reason not Specified|0|||
161206651|NCT03193190|582136503|FG012|Stage 1|Reason not Specified|1|||
161206652|NCT03193190|582136504|FG013|Stage 1|Reason not Specified|0|||
161206653|NCT03193190|582136505|FG014|Stage 1|Reason not Specified|0|||
161206654|NCT03193190|582136506|FG015|Stage 1|Reason not Specified|0|||
161206655|NCT03193190|582136491|FG000|Stage 1|Physician Decision|0|||
161206656|NCT03193190|582136492|FG001|Stage 1|Physician Decision|0|||
161206657|NCT03193190|582136493|FG002|Stage 1|Physician Decision|0|||
161206658|NCT03193190|582136494|FG003|Stage 1|Physician Decision|0|||
161206659|NCT03193190|582136495|FG004|Stage 1|Physician Decision|0|||
161206660|NCT03193190|582136496|FG005|Stage 1|Physician Decision|0|||
161206661|NCT03193190|582136497|FG006|Stage 1|Physician Decision|0|||
161206662|NCT03193190|582136498|FG007|Stage 1|Physician Decision|0|||
161206663|NCT03193190|582136499|FG008|Stage 1|Physician Decision|0|||
161206664|NCT03193190|582136500|FG009|Stage 1|Physician Decision|0|||
161206665|NCT03193190|582136501|FG010|Stage 1|Physician Decision|0|||
161206666|NCT03193190|582136502|FG011|Stage 1|Physician Decision|1|||
161206667|NCT03193190|582136503|FG012|Stage 1|Physician Decision|0|||
161206668|NCT03193190|582136504|FG013|Stage 1|Physician Decision|0|||
161206669|NCT03193190|582136505|FG014|Stage 1|Physician Decision|0|||
161206670|NCT03193190|582136506|FG015|Stage 1|Physician Decision|0|||
161206671|NCT03193190|582136491|FG000|Stage 1|Progressive Disease|1|||
161206672|NCT03193190|582136492|FG001|Stage 1|Progressive Disease|0|||
161206673|NCT03193190|582136493|FG002|Stage 1|Progressive Disease|0|||
161206674|NCT03193190|582136494|FG003|Stage 1|Progressive Disease|0|||
161206675|NCT03193190|582136495|FG004|Stage 1|Progressive Disease|0|||
161206676|NCT03193190|582136496|FG005|Stage 1|Progressive Disease|0|||
161206677|NCT03193190|582136497|FG006|Stage 1|Progressive Disease|0|||
161206678|NCT03193190|582136498|FG007|Stage 1|Progressive Disease|0|||
161206679|NCT03193190|582136499|FG008|Stage 1|Progressive Disease|0|||
161206680|NCT03193190|582136500|FG009|Stage 1|Progressive Disease|0|||
161206681|NCT03193190|582136501|FG010|Stage 1|Progressive Disease|0|||
161206682|NCT03193190|582136502|FG011|Stage 1|Progressive Disease|0|||
161206683|NCT03193190|582136503|FG012|Stage 1|Progressive Disease|0|||
161206684|NCT03193190|582136504|FG013|Stage 1|Progressive Disease|0|||
161206685|NCT03193190|582136505|FG014|Stage 1|Progressive Disease|0|||
161206686|NCT03193190|582136506|FG015|Stage 1|Progressive Disease|0|||
161206687|NCT03193190|582136491|FG000|Stage 1|Study Terminated By Sponsor|3|||
161206688|NCT03193190|582136492|FG001|Stage 1|Study Terminated By Sponsor|0|||
161206689|NCT03193190|582136493|FG002|Stage 1|Study Terminated By Sponsor|0|||
161206690|NCT03193190|582136494|FG003|Stage 1|Study Terminated By Sponsor|0|||
161206691|NCT03193190|582136495|FG004|Stage 1|Study Terminated By Sponsor|6|||
161206692|NCT03193190|582136496|FG005|Stage 1|Study Terminated By Sponsor|0|||
161206693|NCT03193190|582136497|FG006|Stage 1|Study Terminated By Sponsor|0|||
161206694|NCT03193190|582136498|FG007|Stage 1|Study Terminated By Sponsor|0|||
161206695|NCT03193190|582136499|FG008|Stage 1|Study Terminated By Sponsor|0|||
161206696|NCT03193190|582136500|FG009|Stage 1|Study Terminated By Sponsor|0|||
161206697|NCT03193190|582136501|FG010|Stage 1|Study Terminated By Sponsor|0|||
161206698|NCT03193190|582136502|FG011|Stage 1|Study Terminated By Sponsor|0|||
161206699|NCT03193190|582136503|FG012|Stage 1|Study Terminated By Sponsor|0|||
161206700|NCT03193190|582136504|FG013|Stage 1|Study Terminated By Sponsor|0|||
161206701|NCT03193190|582136505|FG014|Stage 1|Study Terminated By Sponsor|0|||
161206702|NCT03193190|582136506|FG015|Stage 1|Study Terminated By Sponsor|0|||
161206703|NCT03193190|582136491|FG000|Stage 1|Withdrawal by Subject|6|||
161206704|NCT03193190|582136492|FG001|Stage 1|Withdrawal by Subject|0|||
161206705|NCT03193190|582136493|FG002|Stage 1|Withdrawal by Subject|1|||
161206706|NCT03193190|582136494|FG003|Stage 1|Withdrawal by Subject|0|||
161206707|NCT03193190|582136495|FG004|Stage 1|Withdrawal by Subject|2|||
161206708|NCT03193190|582136496|FG005|Stage 1|Withdrawal by Subject|0|||
161206709|NCT03193190|582136497|FG006|Stage 1|Withdrawal by Subject|3|||
161206710|NCT03193190|582136498|FG007|Stage 1|Withdrawal by Subject|2|||
161206711|NCT03193190|582136499|FG008|Stage 1|Withdrawal by Subject|2|||
161312805|NCT04908202|582526616|FG003|Pre-Treatment Period|OTHER REASONS|0|||
161312806|NCT04908202|582526613|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
161312807|NCT04908202|582526614|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312808|NCT04908202|582526615|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312809|NCT04908202|582526616|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312810|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
161312811|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
161312812|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161312813|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
161312814|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
161312815|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
161312816|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
161312817|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
161312818|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161312819|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
161312820|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161312821|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161312822|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
161312823|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
161312824|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312825|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312826|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161312827|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
161312828|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161312829|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
161312830|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161312831|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161312832|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161312833|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161312834|NCT04908202|582526613|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
161312835|NCT04908202|582526614|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
161312836|NCT04908202|582526615|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
161312837|NCT04908202|582526616|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
161312838|NCT04908202|582526613|FG000|Active Treatment Period|OTHER REASONS|0|||
161312839|NCT04908202|582526614|FG001|Active Treatment Period|OTHER REASONS|0|||
161312840|NCT04908202|582526615|FG002|Active Treatment Period|OTHER REASONS|1|||
161312841|NCT04908202|582526616|FG003|Active Treatment Period|OTHER REASONS|3|||
161312842|NCT04908202|582526613|FG000|Active Treatment Period|Lack of Efficacy|0|||
161312843|NCT04908202|582526614|FG001|Active Treatment Period|Lack of Efficacy|0|||
161312844|NCT04908202|582526615|FG002|Active Treatment Period|Lack of Efficacy|4|||
161312845|NCT04908202|582526616|FG003|Active Treatment Period|Lack of Efficacy|5|||
161312846|NCT04908202|582526613|FG000|Active Treatment Period|Adverse Event|0|||
161312847|NCT04908202|582526614|FG001|Active Treatment Period|Adverse Event|0|||
161312848|NCT04908202|582526615|FG002|Active Treatment Period|Adverse Event|5|||
161312849|NCT04908202|582526616|FG003|Active Treatment Period|Adverse Event|8|||
161312850|NCT04908202|582526613|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161312851|NCT04908202|582526614|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
161312852|NCT04908202|582526615|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161312853|NCT04908202|582526616|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
161312854|NCT04908202|582526613|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312855|NCT04908202|582526614|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
161312856|NCT04908202|582526615|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
161312857|NCT04908202|582526616|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
161312858|NCT04908202|582526613|FG000|Active Treatment Period|Lost to Follow-up|0|||
161312859|NCT04908202|582526614|FG001|Active Treatment Period|Lost to Follow-up|0|||
161312860|NCT04908202|582526615|FG002|Active Treatment Period|Lost to Follow-up|2|||
161312861|NCT04908202|582526616|FG003|Active Treatment Period|Lost to Follow-up|2|||
161312862|NCT04908202|582526613|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161312863|NCT04908202|582526614|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161312864|NCT04908202|582526615|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
161312865|NCT04908202|582526616|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
161312866|NCT04908202|582526613|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161312867|NCT04908202|582526614|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
161312868|NCT04908202|582526615|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161312869|NCT04908202|582526616|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
161312870|NCT04908202|582526613|FG000|Active Treatment Period|ONGOING Treatment|0|||
161312871|NCT04908202|582526614|FG001|Active Treatment Period|ONGOING Treatment|0|||
161312872|NCT04908202|582526615|FG002|Active Treatment Period|ONGOING Treatment|117|||
161312873|NCT04908202|582526616|FG003|Active Treatment Period|ONGOING Treatment|114|||
161312874|NCT04506905|582526619|FG000|Overall Study|Lost to Follow-up|1|||
161312875|NCT04506905|582526620|FG001|Overall Study|Lost to Follow-up|0|||
161312876|NCT04506905|582526621|FG002|Overall Study|Lost to Follow-up|0|||
161312877|NCT04506905|582526622|FG003|Overall Study|Lost to Follow-up|1|||
161312878|NCT04506905|582526623|FG004|Overall Study|Lost to Follow-up|0|||
161312879|NCT04506905|582526624|FG005|Overall Study|Lost to Follow-up|0|||
161312880|NCT04506905|582526625|FG006|Overall Study|Lost to Follow-up|0|||
161312881|NCT04506905|582526626|FG007|Overall Study|Lost to Follow-up|0|||
161312882|NCT04506905|582526627|FG008|Overall Study|Lost to Follow-up|0|||
161312883|NCT04506905|582526619|FG000|Overall Study|Withdrawal by Subject|0|||
161312884|NCT04506905|582526620|FG001|Overall Study|Withdrawal by Subject|0|||
161312885|NCT04506905|582526621|FG002|Overall Study|Withdrawal by Subject|0|||
161312886|NCT04506905|582526622|FG003|Overall Study|Withdrawal by Subject|2|||
161312887|NCT04506905|582526623|FG004|Overall Study|Withdrawal by Subject|0|||
161312888|NCT04506905|582526624|FG005|Overall Study|Withdrawal by Subject|0|||
161312889|NCT04506905|582526625|FG006|Overall Study|Withdrawal by Subject|0|||
161312890|NCT04506905|582526626|FG007|Overall Study|Withdrawal by Subject|0|||
161312891|NCT04506905|582526627|FG008|Overall Study|Withdrawal by Subject|0|||
161312892|NCT01709864|582528251|FG000|Overall Study|Physician Decision|0|||
161312893|NCT01709864|582528252|FG001|Overall Study|Physician Decision|1|||
161312894|NCT01709864|582528251|FG000|Overall Study|subject/guardian decision|5|||
161312895|NCT01709864|582528252|FG001|Overall Study|subject/guardian decision|6|||
161312896|NCT01709864|582528251|FG000|Overall Study|Lost to Follow-up|1|||
161312897|NCT01709864|582528252|FG001|Overall Study|Lost to Follow-up|0|||
161312898|NCT01709864|582528251|FG000|Overall Study|non-compliance with study treatment|1|||
161312899|NCT01709864|582528252|FG001|Overall Study|non-compliance with study treatment|1|||
161312900|NCT01709864|582528251|FG000|Overall Study|Adverse Event|0|||
161312901|NCT01709864|582528252|FG001|Overall Study|Adverse Event|2|||
161312902|NCT01709864|582528251|FG000|Overall Study|Death|0|||
161312903|NCT01709864|582528252|FG001|Overall Study|Death|1|||
161312904|NCT01066793|582528253|FG000|Overall Study|Death|4|||
161312905|NCT01066793|582528254|FG001|Overall Study|Death|1|||
161312906|NCT01066793|582528255|FG002|Overall Study|Death|1|||
161312907|NCT01066793|582528256|FG003|Overall Study|Death|0|||
161312908|NCT01066793|582528257|FG004|Overall Study|Death|0|||
161312909|NCT01066793|582528258|FG005|Overall Study|Death|0|||
161312910|NCT01066793|582528253|FG000|Overall Study|Lack of Efficacy|2|||
161312911|NCT01066793|582528254|FG001|Overall Study|Lack of Efficacy|1|||
161312912|NCT01066793|582528255|FG002|Overall Study|Lack of Efficacy|0|||
161312913|NCT01066793|582528256|FG003|Overall Study|Lack of Efficacy|0|||
161312914|NCT01066793|582528257|FG004|Overall Study|Lack of Efficacy|0|||
161312915|NCT01066793|582528258|FG005|Overall Study|Lack of Efficacy|0|||
161312916|NCT01066793|582528253|FG000|Overall Study|Lost to Follow-up|180|||
161312917|NCT01066793|582528254|FG001|Overall Study|Lost to Follow-up|39|||
161312918|NCT01066793|582528255|FG002|Overall Study|Lost to Follow-up|82|||
161312919|NCT01066793|582528256|FG003|Overall Study|Lost to Follow-up|16|||
161312920|NCT01066793|582528257|FG004|Overall Study|Lost to Follow-up|0|||
161312921|NCT01066793|582528258|FG005|Overall Study|Lost to Follow-up|1|||
161312922|NCT01066793|582528253|FG000|Overall Study|Physician Decision|3|||
161312923|NCT01066793|582528254|FG001|Overall Study|Physician Decision|0|||
161312924|NCT01066793|582528255|FG002|Overall Study|Physician Decision|0|||
161312925|NCT01066793|582528256|FG003|Overall Study|Physician Decision|0|||
161312926|NCT01066793|582528257|FG004|Overall Study|Physician Decision|0|||
161312927|NCT01066793|582528258|FG005|Overall Study|Physician Decision|0|||
161312928|NCT01066793|582528253|FG000|Overall Study|Protocol Violation|3|||
161312929|NCT01066793|582528254|FG001|Overall Study|Protocol Violation|2|||
161312930|NCT01066793|582528255|FG002|Overall Study|Protocol Violation|2|||
161312931|NCT01066793|582528256|FG003|Overall Study|Protocol Violation|0|||
161312932|NCT01066793|582528257|FG004|Overall Study|Protocol Violation|0|||
161312933|NCT01066793|582528258|FG005|Overall Study|Protocol Violation|0|||
161312934|NCT01066793|582528253|FG000|Overall Study|Withdrawal by Subject|7|||
161312935|NCT01066793|582528254|FG001|Overall Study|Withdrawal by Subject|4|||
161312936|NCT01066793|582528255|FG002|Overall Study|Withdrawal by Subject|1|||
161312937|NCT01066793|582528256|FG003|Overall Study|Withdrawal by Subject|0|||
161312938|NCT01066793|582528257|FG004|Overall Study|Withdrawal by Subject|0|||
161312939|NCT01066793|582528258|FG005|Overall Study|Withdrawal by Subject|0|||
161312940|NCT01066793|582528253|FG000|Overall Study|Early Termination|3|||
161312941|NCT01066793|582528254|FG001|Overall Study|Early Termination|0|||
161312942|NCT01066793|582528255|FG002|Overall Study|Early Termination|0|||
161312943|NCT01066793|582528256|FG003|Overall Study|Early Termination|0|||
161312944|NCT01066793|582528257|FG004|Overall Study|Early Termination|0|||
161312945|NCT01066793|582528258|FG005|Overall Study|Early Termination|0|||
161312946|NCT01066793|582528253|FG000|Overall Study|Lab test not done|7|||
161312947|NCT01066793|582528254|FG001|Overall Study|Lab test not done|0|||
161312948|NCT01066793|582528255|FG002|Overall Study|Lab test not done|0|||
161312949|NCT01066793|582528256|FG003|Overall Study|Lab test not done|1|||
161312950|NCT01066793|582528257|FG004|Overall Study|Lab test not done|0|||
161312951|NCT01066793|582528258|FG005|Overall Study|Lab test not done|0|||
161312952|NCT01066793|582528253|FG000|Overall Study|Miscellaneous|4|||
161312953|NCT01066793|582528254|FG001|Overall Study|Miscellaneous|5|||
161312954|NCT01066793|582528255|FG002|Overall Study|Miscellaneous|6|||
161312955|NCT01066793|582528256|FG003|Overall Study|Miscellaneous|0|||
161312956|NCT01066793|582528257|FG004|Overall Study|Miscellaneous|0|||
161312957|NCT01066793|582528258|FG005|Overall Study|Miscellaneous|0|||
161312958|NCT01066793|582528253|FG000|Overall Study|Non-responders|104|||
161312959|NCT01066793|582528254|FG001|Overall Study|Non-responders|5|||
161312960|NCT01066793|582528255|FG002|Overall Study|Non-responders|11|||
161312961|NCT01066793|582528256|FG003|Overall Study|Non-responders|25|||
161312962|NCT01066793|582528257|FG004|Overall Study|Non-responders|0|||
161312963|NCT01066793|582528258|FG005|Overall Study|Non-responders|0|||
161312964|NCT01066793|582528253|FG000|Overall Study|Other|15|||
161312965|NCT01066793|582528254|FG001|Overall Study|Other|5|||
161312966|NCT01066793|582528255|FG002|Overall Study|Other|6|||
161312967|NCT01066793|582528256|FG003|Overall Study|Other|2|||
161312968|NCT01066793|582528257|FG004|Overall Study|Other|0|||
161312969|NCT01066793|582528258|FG005|Overall Study|Other|0|||
161312970|NCT01066793|582528253|FG000|Overall Study|Relapse|20|||
161312971|NCT01066793|582528254|FG001|Overall Study|Relapse|8|||
161312972|NCT01066793|582528255|FG002|Overall Study|Relapse|2|||
161312973|NCT01066793|582528256|FG003|Overall Study|Relapse|3|||
161312974|NCT01066793|582528257|FG004|Overall Study|Relapse|0|||
161312975|NCT01066793|582528258|FG005|Overall Study|Relapse|0|||
161312976|NCT01066793|582528253|FG000|Overall Study|Result Not Available|1|||
161312977|NCT01066793|582528254|FG001|Overall Study|Result Not Available|0|||
161312978|NCT01066793|582528255|FG002|Overall Study|Result Not Available|0|||
161312979|NCT01066793|582528256|FG003|Overall Study|Result Not Available|0|||
161312980|NCT01066793|582528257|FG004|Overall Study|Result Not Available|0|||
161312981|NCT01066793|582528258|FG005|Overall Study|Result Not Available|0|||
161312982|NCT01066793|582528253|FG000|Overall Study|Treatment Interrupted|1|||
161312983|NCT01066793|582528254|FG001|Overall Study|Treatment Interrupted|1|||
161312984|NCT01066793|582528255|FG002|Overall Study|Treatment Interrupted|0|||
161312985|NCT01066793|582528256|FG003|Overall Study|Treatment Interrupted|0|||
161312986|NCT01066793|582528257|FG004|Overall Study|Treatment Interrupted|0|||
161312987|NCT01066793|582528258|FG005|Overall Study|Treatment Interrupted|0|||
161312988|NCT01066793|582528253|FG000|Overall Study|Treatment Never Started|18|||
161312989|NCT01066793|582528254|FG001|Overall Study|Treatment Never Started|5|||
161312990|NCT01066793|582528255|FG002|Overall Study|Treatment Never Started|4|||
161312991|NCT01066793|582528256|FG003|Overall Study|Treatment Never Started|1|||
161312992|NCT01066793|582528257|FG004|Overall Study|Treatment Never Started|0|||
161312993|NCT01066793|582528258|FG005|Overall Study|Treatment Never Started|0|||
161312994|NCT01066793|582528253|FG000|Overall Study|Treatment Stopped|2|||
161312995|NCT01066793|582528254|FG001|Overall Study|Treatment Stopped|1|||
161312996|NCT01066793|582528255|FG002|Overall Study|Treatment Stopped|0|||
161312997|NCT01066793|582528256|FG003|Overall Study|Treatment Stopped|1|||
161312998|NCT01066793|582528257|FG004|Overall Study|Treatment Stopped|0|||
161312999|NCT01066793|582528258|FG005|Overall Study|Treatment Stopped|0|||
161313000|NCT02697916|582528260|FG000|Overall Study|Death|357|||
161313001|NCT02697916|582528261|FG001|Overall Study|Death|315|||
161313002|NCT02697916|582528260|FG000|Overall Study|Withdrawal by Subject|221|||
161313003|NCT02697916|582528261|FG001|Overall Study|Withdrawal by Subject|393|||
161313004|NCT02864316|582528262|FG000|Overall Study|Progressive Disease|2|||
161313005|NCT02864316|582528263|FG001|Overall Study|Progressive Disease|1|||
161313006|NCT02864316|582528262|FG000|Overall Study|Adverse Event|0|||
161313007|NCT02864316|582528263|FG001|Overall Study|Adverse Event|1|||
161313008|NCT03030118|582528268|FG000|Overall Study|Achieved SLE Diagnosis|11|||
161313009|NCT03030118|582528269|FG001|Overall Study|Achieved SLE Diagnosis|10|||
161313010|NCT03030118|582528268|FG000|Overall Study|Adverse Event|1|||
161313011|NCT03030118|582528269|FG001|Overall Study|Adverse Event|1|||
161313012|NCT03030118|582528268|FG000|Overall Study|Pregnancy|2|||
161313013|NCT03030118|582528269|FG001|Overall Study|Pregnancy|2|||
161313014|NCT03030118|582528268|FG000|Overall Study|Lost to Follow-up|5|||
161313015|NCT03030118|582528269|FG001|Overall Study|Lost to Follow-up|6|||
161313016|NCT03030118|582528268|FG000|Overall Study|Concomitant Medications|1|||
161313017|NCT03030118|582528269|FG001|Overall Study|Concomitant Medications|1|||
161313018|NCT03030118|582528268|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
161313019|NCT03030118|582528269|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
161313020|NCT03030118|582528268|FG000|Overall Study|Other|2|||
161313021|NCT03030118|582528269|FG001|Overall Study|Other|0|||
161313022|NCT03030118|582528268|FG000|Overall Study|Withdrawal by Subject|26|||
161313023|NCT03030118|582528269|FG001|Overall Study|Withdrawal by Subject|21|||
161313024|NCT03030118|582528268|FG000|Overall Study|Protocol Violation|1|||
161091076|NCT00903630|581723791|FG002|Phase 2|Adverse Event|1|||
161313025|NCT03030118|582528269|FG001|Overall Study|Protocol Violation|6|||
161313026|NCT04643964|582528270|FG000|Overall Study|Lost to Follow-up|55|||
161313027|NCT04643964|582528271|FG001|Overall Study|Lost to Follow-up|59|||
161313028|NCT04643964|582528272|FG002|Overall Study|Lost to Follow-up|54|||
161313029|NCT04643964|582528273|FG003|Overall Study|Lost to Follow-up|129|||
161313030|NCT04643964|582528274|FG004|Overall Study|Lost to Follow-up|48|||
161313031|NCT04643964|582528270|FG000|Overall Study|Failed attention check|1|||
161313032|NCT04643964|582528271|FG001|Overall Study|Failed attention check|8|||
161313033|NCT04643964|582528272|FG002|Overall Study|Failed attention check|2|||
161313034|NCT04643964|582528273|FG003|Overall Study|Failed attention check|14|||
161313035|NCT04643964|582528274|FG004|Overall Study|Failed attention check|11|||
161313036|NCT02607280|582528276|FG000|Overall Study|Adverse Event|4|||
161313037|NCT02607280|582528277|FG001|Overall Study|Adverse Event|0|||
161313038|NCT02607280|582528276|FG000|Overall Study|Decrease in CrCl <15|0|||
161313039|NCT02607280|582528277|FG001|Overall Study|Decrease in CrCl <15|1|||
161313040|NCT02539134|582528280|FG000|Overall Study|Lost to Follow-up|1|||
161313041|NCT02539134|582528281|FG001|Overall Study|Lost to Follow-up|0|||
161313042|NCT02539134|582528282|FG002|Overall Study|Lost to Follow-up|0|||
161313043|NCT02539134|582528283|FG003|Overall Study|Lost to Follow-up|0|||
161313044|NCT02539134|582528284|FG004|Overall Study|Lost to Follow-up|0|||
161313045|NCT02539134|582528285|FG005|Overall Study|Lost to Follow-up|0|||
161313046|NCT02255552|582528286|FG000|Overall Study|Participants enrolled into another study|0|||
161313047|NCT02255552|582528287|FG001|Overall Study|Participants enrolled into another study|11|||
161313048|NCT02255552|582528286|FG000|Overall Study|Withdrawal by Subject|1|||
161313049|NCT02255552|582528287|FG001|Overall Study|Withdrawal by Subject|4|||
161313050|NCT01447446|582528288|FG000|Overall Study|Death|6|||
161313051|NCT01447446|582528289|FG001|Overall Study|Death|3|||
161313052|NCT01447446|582528290|FG002|Overall Study|Death|2|||
161313053|NCT01447446|582528291|FG003|Overall Study|Death|1|||
161313054|NCT01447446|582528292|FG004|Overall Study|Death|7|||
161313055|NCT01447446|582528293|FG005|Overall Study|Death|0|||
161313056|NCT01447446|582528288|FG000|Overall Study|Adverse Event|3|||
161313057|NCT01447446|582528289|FG001|Overall Study|Adverse Event|0|||
161313058|NCT01447446|582528290|FG002|Overall Study|Adverse Event|1|||
161313059|NCT01447446|582528291|FG003|Overall Study|Adverse Event|0|||
161313060|NCT01447446|582528292|FG004|Overall Study|Adverse Event|2|||
161313061|NCT01447446|582528293|FG005|Overall Study|Adverse Event|0|||
161313062|NCT01447446|582528288|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
161313063|NCT01447446|582528289|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
161313064|NCT01447446|582528290|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
161313065|NCT01447446|582528291|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
161313066|NCT01447446|582528292|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
161313067|NCT01447446|582528293|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
161313068|NCT01447446|582528288|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
161313069|NCT01447446|582528289|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
161313070|NCT01447446|582528290|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
161313071|NCT01447446|582528291|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
161313072|NCT01447446|582528292|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
161313073|NCT01447446|582528293|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
161313074|NCT01447446|582528288|FG000|Overall Study|Administrative/Other|34|||
161313075|NCT01447446|582528289|FG001|Overall Study|Administrative/Other|9|||
161313076|NCT01447446|582528290|FG002|Overall Study|Administrative/Other|10|||
161313077|NCT01447446|582528291|FG003|Overall Study|Administrative/Other|2|||
161313078|NCT01447446|582528292|FG004|Overall Study|Administrative/Other|33|||
161313079|NCT01447446|582528293|FG005|Overall Study|Administrative/Other|4|||
161313080|NCT01447446|582528288|FG000|Overall Study|SVR12 Assessment|13|||
161313081|NCT01447446|582528289|FG001|Overall Study|SVR12 Assessment|1|||
161313082|NCT01447446|582528290|FG002|Overall Study|SVR12 Assessment|2|||
161313083|NCT01447446|582528291|FG003|Overall Study|SVR12 Assessment|1|||
161313084|NCT01447446|582528292|FG004|Overall Study|SVR12 Assessment|5|||
161313085|NCT01447446|582528293|FG005|Overall Study|SVR12 Assessment|5|||
161313086|NCT01447446|582528288|FG000|Overall Study|New Treatment Started|8|||
161313087|NCT01447446|582528289|FG001|Overall Study|New Treatment Started|2|||
161313088|NCT01447446|582528290|FG002|Overall Study|New Treatment Started|1|||
161313089|NCT01447446|582528291|FG003|Overall Study|New Treatment Started|0|||
161313090|NCT01447446|582528292|FG004|Overall Study|New Treatment Started|2|||
161313091|NCT01447446|582528293|FG005|Overall Study|New Treatment Started|0|||
161313092|NCT01447446|582528288|FG000|Overall Study|Reason not Specified|1|||
161313093|NCT01447446|582528289|FG001|Overall Study|Reason not Specified|1|||
161313094|NCT01447446|582528290|FG002|Overall Study|Reason not Specified|1|||
161313095|NCT01447446|582528291|FG003|Overall Study|Reason not Specified|1|||
161313096|NCT01447446|582528292|FG004|Overall Study|Reason not Specified|1|||
161313097|NCT01447446|582528293|FG005|Overall Study|Reason not Specified|0|||
161313098|NCT02052596|582528294|FG000|Active Phase|Adverse Event|3|||
161313099|NCT02052596|582528295|FG001|Active Phase|Adverse Event|2|||
161313100|NCT02052596|582528294|FG000|Active Phase|Lost to Follow-up|8|||
161313101|NCT02052596|582528295|FG001|Active Phase|Lost to Follow-up|11|||
161313102|NCT02052596|582528294|FG000|Active Phase|Protocol Violation|1|||
161313103|NCT02052596|582528295|FG001|Active Phase|Protocol Violation|2|||
161313104|NCT02052596|582528294|FG000|Active Phase|Withdrawal by Subject|3|||
161313105|NCT02052596|582528295|FG001|Active Phase|Withdrawal by Subject|4|||
161091077|NCT03305731|581723794|FG000|Overall Study|Protocol Violation|1|||
161313106|NCT02052596|582528294|FG000|Active Phase|Enrolled in error|1|||
161313107|NCT02052596|582528295|FG001|Active Phase|Enrolled in error|0|||
161313108|NCT02052596|582528294|FG000|Active Phase|Lost due to Crohn's disease|0|||
161313109|NCT02052596|582528295|FG001|Active Phase|Lost due to Crohn's disease|1|||
161313110|NCT02052596|582528294|FG000|Safety Phase|Adverse Event|6|||
161313111|NCT02052596|582528295|FG001|Safety Phase|Adverse Event|3|||
161313112|NCT02052596|582528294|FG000|Safety Phase|Lost to Follow-up|11|||
161313113|NCT02052596|582528295|FG001|Safety Phase|Lost to Follow-up|18|||
161313114|NCT02052596|582528294|FG000|Safety Phase|Protocol Violation|1|||
161313115|NCT02052596|582528295|FG001|Safety Phase|Protocol Violation|2|||
161313116|NCT02052596|582528294|FG000|Safety Phase|Withdrawal by Subject|8|||
161313117|NCT02052596|582528295|FG001|Safety Phase|Withdrawal by Subject|11|||
161313118|NCT02052596|582528294|FG000|Safety Phase|Enrolled in error|1|||
161313119|NCT02052596|582528295|FG001|Safety Phase|Enrolled in error|0|||
161313120|NCT02052596|582528294|FG000|Safety Phase|Lost due to Crohn's disease|0|||
161313121|NCT02052596|582528295|FG001|Safety Phase|Lost due to Crohn's disease|1|||
161313122|NCT00558896|582528296|FG000|Overall Study|Adverse Event|1|||
161313123|NCT00558896|582528297|FG001|Overall Study|Adverse Event|1|||
161313124|NCT00558896|582528298|FG002|Overall Study|Adverse Event|1|||
161313125|NCT00558896|582528299|FG003|Overall Study|Adverse Event|3|||
161313126|NCT00558896|582528300|FG004|Overall Study|Adverse Event|4|||
161313127|NCT00558896|582528301|FG005|Overall Study|Adverse Event|10|||
161313128|NCT00558896|582528302|FG006|Overall Study|Adverse Event|3|||
161313129|NCT00558896|582528296|FG000|Overall Study|Death|3|||
161313130|NCT00558896|582528297|FG001|Overall Study|Death|0|||
161313131|NCT00558896|582528298|FG002|Overall Study|Death|2|||
161313132|NCT00558896|582528299|FG003|Overall Study|Death|3|||
161313133|NCT00558896|582528300|FG004|Overall Study|Death|2|||
161313134|NCT00558896|582528301|FG005|Overall Study|Death|2|||
161313135|NCT00558896|582528302|FG006|Overall Study|Death|6|||
161313136|NCT00558896|582528296|FG000|Overall Study|Withdrawal by Subject|2|||
161313137|NCT00558896|582528297|FG001|Overall Study|Withdrawal by Subject|1|||
161313138|NCT00558896|582528298|FG002|Overall Study|Withdrawal by Subject|1|||
161313139|NCT00558896|582528299|FG003|Overall Study|Withdrawal by Subject|1|||
161313140|NCT00558896|582528300|FG004|Overall Study|Withdrawal by Subject|1|||
161313141|NCT00558896|582528301|FG005|Overall Study|Withdrawal by Subject|5|||
161313142|NCT00558896|582528302|FG006|Overall Study|Withdrawal by Subject|5|||
161313143|NCT00558896|582528296|FG000|Overall Study|Alternative Treatment|2|||
161313144|NCT00558896|582528297|FG001|Overall Study|Alternative Treatment|2|||
161313145|NCT00558896|582528298|FG002|Overall Study|Alternative Treatment|0|||
161313146|NCT00558896|582528299|FG003|Overall Study|Alternative Treatment|2|||
161313147|NCT00558896|582528300|FG004|Overall Study|Alternative Treatment|6|||
161313148|NCT00558896|582528301|FG005|Overall Study|Alternative Treatment|7|||
161313149|NCT00558896|582528302|FG006|Overall Study|Alternative Treatment|1|||
161206712|NCT03193190|582136500|FG009|Stage 1|Withdrawal by Subject|4|||
161206713|NCT03193190|582136501|FG010|Stage 1|Withdrawal by Subject|9|||
161206714|NCT03193190|582136502|FG011|Stage 1|Withdrawal by Subject|1|||
161206715|NCT03193190|582136503|FG012|Stage 1|Withdrawal by Subject|0|||
161206716|NCT03193190|582136504|FG013|Stage 1|Withdrawal by Subject|0|||
161206717|NCT03193190|582136505|FG014|Stage 1|Withdrawal by Subject|0|||
161206718|NCT03193190|582136506|FG015|Stage 1|Withdrawal by Subject|0|||
161206719|NCT03193190|582136491|FG000|Stage 2|Death|0|||
161206720|NCT03193190|582136492|FG001|Stage 2|Death|0|||
161206721|NCT03193190|582136493|FG002|Stage 2|Death|0|||
161206722|NCT03193190|582136494|FG003|Stage 2|Death|0|||
161206723|NCT03193190|582136495|FG004|Stage 2|Death|0|||
161206724|NCT03193190|582136496|FG005|Stage 2|Death|0|||
161206725|NCT03193190|582136497|FG006|Stage 2|Death|0|||
161206726|NCT03193190|582136498|FG007|Stage 2|Death|0|||
161206727|NCT03193190|582136499|FG008|Stage 2|Death|0|||
161206728|NCT03193190|582136500|FG009|Stage 2|Death|0|||
161206729|NCT03193190|582136501|FG010|Stage 2|Death|0|||
161206730|NCT03193190|582136502|FG011|Stage 2|Death|0|||
161206731|NCT03193190|582136503|FG012|Stage 2|Death|0|||
161206732|NCT03193190|582136504|FG013|Stage 2|Death|14|||
161206733|NCT03193190|582136505|FG014|Stage 2|Death|4|||
161206734|NCT03193190|582136506|FG015|Stage 2|Death|1|||
161206735|NCT03193190|582136491|FG000|Stage 2|Lost to Follow-up|0|||
161206736|NCT03193190|582136492|FG001|Stage 2|Lost to Follow-up|0|||
161206737|NCT03193190|582136493|FG002|Stage 2|Lost to Follow-up|0|||
161206738|NCT03193190|582136494|FG003|Stage 2|Lost to Follow-up|0|||
161206739|NCT03193190|582136495|FG004|Stage 2|Lost to Follow-up|0|||
161206740|NCT03193190|582136496|FG005|Stage 2|Lost to Follow-up|0|||
161206741|NCT03193190|582136497|FG006|Stage 2|Lost to Follow-up|0|||
161206742|NCT03193190|582136498|FG007|Stage 2|Lost to Follow-up|0|||
161206743|NCT03193190|582136499|FG008|Stage 2|Lost to Follow-up|0|||
161206744|NCT03193190|582136500|FG009|Stage 2|Lost to Follow-up|0|||
161206745|NCT03193190|582136501|FG010|Stage 2|Lost to Follow-up|0|||
161206746|NCT03193190|582136502|FG011|Stage 2|Lost to Follow-up|0|||
161206747|NCT03193190|582136503|FG012|Stage 2|Lost to Follow-up|0|||
161206748|NCT03193190|582136504|FG013|Stage 2|Lost to Follow-up|0|||
161206749|NCT03193190|582136505|FG014|Stage 2|Lost to Follow-up|1|||
161206750|NCT03193190|582136506|FG015|Stage 2|Lost to Follow-up|0|||
161206751|NCT03193190|582136491|FG000|Stage 2|Withdrawal by Subject|0|||
161206752|NCT03193190|582136492|FG001|Stage 2|Withdrawal by Subject|0|||
161206753|NCT03193190|582136493|FG002|Stage 2|Withdrawal by Subject|0|||
161206754|NCT03193190|582136494|FG003|Stage 2|Withdrawal by Subject|0|||
161206755|NCT03193190|582136495|FG004|Stage 2|Withdrawal by Subject|0|||
161206756|NCT03193190|582136496|FG005|Stage 2|Withdrawal by Subject|0|||
161206757|NCT03193190|582136497|FG006|Stage 2|Withdrawal by Subject|0|||
161206758|NCT03193190|582136498|FG007|Stage 2|Withdrawal by Subject|0|||
161206759|NCT03193190|582136499|FG008|Stage 2|Withdrawal by Subject|0|||
161206760|NCT03193190|582136500|FG009|Stage 2|Withdrawal by Subject|0|||
161206761|NCT03193190|582136501|FG010|Stage 2|Withdrawal by Subject|0|||
161206762|NCT03193190|582136502|FG011|Stage 2|Withdrawal by Subject|0|||
161206763|NCT03193190|582136503|FG012|Stage 2|Withdrawal by Subject|0|||
161206764|NCT03193190|582136504|FG013|Stage 2|Withdrawal by Subject|1|||
161206765|NCT03193190|582136505|FG014|Stage 2|Withdrawal by Subject|1|||
161206766|NCT03193190|582136506|FG015|Stage 2|Withdrawal by Subject|0|||
161206767|NCT01607398|582138011|FG000|Overall Study|Adverse Event|0|||
161206768|NCT01607398|582138012|FG001|Overall Study|Adverse Event|2|||
161206769|NCT01607398|582138011|FG000|Overall Study|Severe COPD|2|||
161206770|NCT01607398|582138012|FG001|Overall Study|Severe COPD|0|||
161206771|NCT02675426|582138013|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
161206772|NCT02675426|582138014|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
161206773|NCT02675426|582138015|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
161206774|NCT02675426|582138016|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
161206775|NCT02675426|582138013|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
161206776|NCT02675426|582138014|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
161206777|NCT02675426|582138015|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
161206778|NCT02675426|582138016|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
161206779|NCT02675426|582138013|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
161206780|NCT02675426|582138014|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
161206781|NCT02675426|582138015|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
161206782|NCT02675426|582138016|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
161206783|NCT02675426|582138013|FG000|Period 1: Week 1 to Week 12|Other|2|||
161206784|NCT02675426|582138014|FG001|Period 1: Week 1 to Week 12|Other|1|||
161206785|NCT02675426|582138015|FG002|Period 1: Week 1 to Week 12|Other|0|||
161206786|NCT02675426|582138016|FG003|Period 1: Week 1 to Week 12|Other|2|||
161206787|NCT02675426|582138013|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
161206788|NCT02675426|582138014|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
161206789|NCT02675426|582138015|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
161206790|NCT02675426|582138016|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
161206791|NCT02675426|582138013|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
161206792|NCT02675426|582138014|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
161206793|NCT02675426|582138015|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
161313150|NCT00558896|582528296|FG000|Overall Study|Physician discretion|3|||
161313151|NCT00558896|582528297|FG001|Overall Study|Physician discretion|2|||
161313152|NCT00558896|582528298|FG002|Overall Study|Physician discretion|1|||
161313153|NCT00558896|582528299|FG003|Overall Study|Physician discretion|2|||
161313154|NCT00558896|582528300|FG004|Overall Study|Physician discretion|1|||
161313155|NCT00558896|582528301|FG005|Overall Study|Physician discretion|3|||
161313156|NCT00558896|582528302|FG006|Overall Study|Physician discretion|3|||
161313157|NCT00558896|582528296|FG000|Overall Study|Continues on treatment|10|||
161313158|NCT00558896|582528297|FG001|Overall Study|Continues on treatment|1|||
161313159|NCT00558896|582528298|FG002|Overall Study|Continues on treatment|0|||
161313160|NCT00558896|582528299|FG003|Overall Study|Continues on treatment|1|||
161313161|NCT00558896|582528300|FG004|Overall Study|Continues on treatment|9|||
161313162|NCT00558896|582528301|FG005|Overall Study|Continues on treatment|25|||
161313163|NCT00558896|582528302|FG006|Overall Study|Continues on treatment|6|||
161313164|NCT04829331|582528305|FG000|Overall Study|Lost to Follow-up|1|||
161313165|NCT04829331|582528306|FG001|Overall Study|Lost to Follow-up|0|||
161313166|NCT03181503|582528310|FG000|Overall Study|Adverse Event|2|||
161313167|NCT03181503|582528311|FG001|Overall Study|Adverse Event|2|||
161313168|NCT03181503|582528310|FG000|Overall Study|Protocol Violation|1|||
161313169|NCT03181503|582528311|FG001|Overall Study|Protocol Violation|0|||
161313170|NCT03181503|582528310|FG000|Overall Study|Withdrawal by Subject|3|||
161313171|NCT03181503|582528311|FG001|Overall Study|Withdrawal by Subject|0|||
161313172|NCT03181503|582528310|FG000|Overall Study|Lost to Follow-up|1|||
161313173|NCT03181503|582528311|FG001|Overall Study|Lost to Follow-up|1|||
161313174|NCT00943670|582528316|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
161313175|NCT00943670|582528316|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
161313176|NCT00943670|582528316|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
161313177|NCT00943670|582528316|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
161313178|NCT00943670|582528316|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
161313179|NCT00943670|582528316|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
161313180|NCT00943670|582528316|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
161313181|NCT00943670|582528316|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
161313182|NCT00943670|582528316|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
161313183|NCT00943670|582528316|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
161313184|NCT04526574|582528317|FG000|Overall Study|Protocol Violation|3|||
161313185|NCT04526574|582528318|FG001|Overall Study|Protocol Violation|1|||
161313186|NCT04526574|582528317|FG000|Overall Study|Withdrawal by Subject|12|||
161313187|NCT04526574|582528318|FG001|Overall Study|Withdrawal by Subject|9|||
161313188|NCT04526574|582528317|FG000|Overall Study|Other|1|||
161313189|NCT04526574|582528318|FG001|Overall Study|Other|2|||
161313190|NCT04526574|582528317|FG000|Overall Study|Adverse Event|1|||
161313191|NCT04526574|582528318|FG001|Overall Study|Adverse Event|1|||
161313192|NCT04526574|582528317|FG000|Overall Study|Death|2|||
161313193|NCT04526574|582528318|FG001|Overall Study|Death|3|||
161313194|NCT04526574|582528317|FG000|Overall Study|Lost to Follow-up|9|||
161313195|NCT04526574|582528318|FG001|Overall Study|Lost to Follow-up|9|||
161313196|NCT04526574|582528317|FG000|Overall Study|No longer meets eligibility criteria|8|||
161313197|NCT04526574|582528318|FG001|Overall Study|No longer meets eligibility criteria|8|||
161313198|NCT01032070|582528319|FG000|Overall Study|Disease progression|13|||
161313199|NCT01032070|582528320|FG001|Overall Study|Disease progression|8|||
161313200|NCT01032070|582528319|FG000|Overall Study|Medical or ethical reasons|0|||
161313201|NCT01032070|582528320|FG001|Overall Study|Medical or ethical reasons|2|||
161313202|NCT01032070|582528319|FG000|Overall Study|Withdrawal by Subject|0|||
161313203|NCT01032070|582528320|FG001|Overall Study|Withdrawal by Subject|2|||
161313204|NCT04068688|582528321|FG000|Overall Study|Lost to Follow-up|1|||
161313205|NCT04068688|582528322|FG001|Overall Study|Lost to Follow-up|1|||
161313206|NCT04068688|582528323|FG002|Overall Study|Lost to Follow-up|0|||
161313207|NCT04068688|582528324|FG003|Overall Study|Lost to Follow-up|0|||
161313208|NCT04068688|582528325|FG004|Overall Study|Lost to Follow-up|5|||
161313209|NCT04068688|582528326|FG005|Overall Study|Lost to Follow-up|5|||
161313210|NCT04068688|582528327|FG006|Overall Study|Lost to Follow-up|0|||
161313211|NCT04068688|582528328|FG007|Overall Study|Lost to Follow-up|0|||
161313212|NCT04068688|582528329|FG008|Overall Study|Lost to Follow-up|1|||
161313213|NCT04068688|582528330|FG009|Overall Study|Lost to Follow-up|0|||
161313214|NCT04068688|582528321|FG000|Overall Study|Withdrawal by Subject|1|||
161313215|NCT04068688|582528322|FG001|Overall Study|Withdrawal by Subject|1|||
161313216|NCT04068688|582528323|FG002|Overall Study|Withdrawal by Subject|0|||
161313217|NCT04068688|582528324|FG003|Overall Study|Withdrawal by Subject|0|||
161313218|NCT04068688|582528325|FG004|Overall Study|Withdrawal by Subject|0|||
161313219|NCT04068688|582528326|FG005|Overall Study|Withdrawal by Subject|0|||
161313220|NCT04068688|582528327|FG006|Overall Study|Withdrawal by Subject|0|||
161313221|NCT04068688|582528328|FG007|Overall Study|Withdrawal by Subject|0|||
161313222|NCT04068688|582528329|FG008|Overall Study|Withdrawal by Subject|0|||
161313223|NCT04068688|582528330|FG009|Overall Study|Withdrawal by Subject|0|||
161313224|NCT04068688|582528321|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
161313225|NCT04068688|582528322|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
161313226|NCT04068688|582528323|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313227|NCT04068688|582528324|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313228|NCT04068688|582528325|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313229|NCT04068688|582528326|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313230|NCT04068688|582528327|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313231|NCT04068688|582528328|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161319512|NCT03383692|582555346|FG001|Overall Study|Progressive disease as per RECIST|3|||
161313232|NCT04068688|582528329|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313233|NCT04068688|582528330|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
161313234|NCT04679051|582528331|FG000|Overall Study|felt tired after restricted time in bed|3|||
161313235|NCT04679051|582528332|FG001|Overall Study|felt tired after restricted time in bed|0|||
161313236|NCT04679051|582528331|FG000|Overall Study|discomfort with blood pressure cuff|2|||
161313237|NCT04679051|582528332|FG001|Overall Study|discomfort with blood pressure cuff|0|||
161313238|NCT04679051|582528331|FG000|Overall Study|scheduling conflict|1|||
161313239|NCT04679051|582528332|FG001|Overall Study|scheduling conflict|1|||
161313240|NCT04679051|582528331|FG000|Overall Study|Protocol Violation|0|||
161313241|NCT04679051|582528332|FG001|Overall Study|Protocol Violation|4|||
161313242|NCT02554318|582528333|FG000|Overall Study|Withdrawal by Subject|10|||
161313243|NCT02554318|582528334|FG001|Overall Study|Withdrawal by Subject|8|||
161313244|NCT02332239|582528337|FG000|Overall Study|Lost to Follow-up|4|||
161313245|NCT02332239|582528338|FG001|Overall Study|Lost to Follow-up|6|||
161313246|NCT00894790|582528339|FG000|Overall Study|Protocol Violation|0|||
161313247|NCT00894790|582528340|FG001|Overall Study|Protocol Violation|1|||
161313248|NCT00894790|582528339|FG000|Overall Study|Lost to Follow-up|0|||
161313249|NCT00894790|582528340|FG001|Overall Study|Lost to Follow-up|1|||
161313250|NCT00894790|582528339|FG000|Overall Study|Did not meet entrance criteria|1|||
161313251|NCT00894790|582528340|FG001|Overall Study|Did not meet entrance criteria|0|||
161313252|NCT00396877|582528341|FG000|Overall Study|Lost to Follow-up|2|||
161313253|NCT00396877|582528342|FG001|Overall Study|Lost to Follow-up|1|||
161313254|NCT00396877|582528341|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
161313255|NCT00396877|582528342|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
161313256|NCT02273908|582528350|FG000|Overall Study|Adverse Event|16|||
161313257|NCT02273908|582528351|FG001|Overall Study|Adverse Event|0|||
161313258|NCT02273908|582528350|FG000|Overall Study|Lost to Follow-up|10|||
161313259|NCT02273908|582528351|FG001|Overall Study|Lost to Follow-up|1|||
161313260|NCT02273908|582528350|FG000|Overall Study|Did not meet entrance criteria|3|||
161313261|NCT02273908|582528351|FG001|Overall Study|Did not meet entrance criteria|2|||
161313262|NCT02273908|582528350|FG000|Overall Study|Withdrawal by Subject|4|||
161313263|NCT02273908|582528351|FG001|Overall Study|Withdrawal by Subject|2|||
161313264|NCT00422422|582528352|FG000|Overall Study|Lack of Efficacy|1|||
161313265|NCT00422422|582528352|FG000|Overall Study|Protocol Violation|1|||
161313266|NCT00422422|582528352|FG000|Overall Study|Withdrawal by Subject|2|||
161313267|NCT00422422|582528352|FG000|Overall Study|SAE, non-fatal|1|||
161313268|NCT00422422|582528352|FG000|Overall Study|AE, non-serious non-fatal|5|||
161313269|NCT03301844|582528353|FG000|Overall Study|suspected colon cancer|1|||
161313270|NCT03301844|582528354|FG001|Overall Study|suspected colon cancer|1|||
161313271|NCT00501059|582528355|FG000|Overall Study|Protocol Violation|80|||
161313272|NCT00501059|582528356|FG001|Overall Study|Protocol Violation|69|||
161313273|NCT00501059|582528355|FG000|Overall Study|Death|140|||
161313274|NCT00501059|582528356|FG001|Overall Study|Death|137|||
161313275|NCT00501059|582528355|FG000|Overall Study|Other|236|||
161313276|NCT00501059|582528356|FG001|Overall Study|Other|239|||
161313277|NCT00501059|582528355|FG000|Overall Study|Missing end-of-study page|91|||
161313278|NCT00501059|582528356|FG001|Overall Study|Missing end-of-study page|92|||
161313279|NCT00501059|582528355|FG000|Overall Study|Clinical endpoint reached|110|||
161313280|NCT00501059|582528356|FG001|Overall Study|Clinical endpoint reached|123|||
161313281|NCT00501059|582528355|FG000|Overall Study|Insufficient therapeutic effect|4|||
161313282|NCT00501059|582528356|FG001|Overall Study|Insufficient therapeutic effect|5|||
161313283|NCT00501059|582528355|FG000|Overall Study|Consent withdrawn by subject|817|||
161313284|NCT00501059|582528356|FG001|Overall Study|Consent withdrawn by subject|873|||
161313285|NCT00501059|582528355|FG000|Overall Study|Non-compliant with study treatment|23|||
161313286|NCT00501059|582528356|FG001|Overall Study|Non-compliant with study treatment|16|||
161313287|NCT00501059|582528355|FG000|Overall Study|Reason not given|3|||
161313288|NCT00501059|582528356|FG001|Overall Study|Reason not given|1|||
161313289|NCT00501059|582528355|FG000|Overall Study|Adverse Event|129|||
161313290|NCT00501059|582528356|FG001|Overall Study|Adverse Event|122|||
161313291|NCT00501059|582528355|FG000|Overall Study|Lost to Follow-up|210|||
161313292|NCT00501059|582528356|FG001|Overall Study|Lost to Follow-up|198|||
161313293|NCT00501059|582528355|FG000|Overall Study|Not treated|25|||
161313294|NCT00501059|582528356|FG001|Overall Study|Not treated|17|||
161313295|NCT02637713|582528364|FG000|Overall Study|Screen Failure|2|||
161313296|NCT02345889|582528365|FG000|Overall Study|Inadequate Bowel Prep|17|||
161313297|NCT02345889|582528366|FG001|Overall Study|Inadequate Bowel Prep|16|||
161313298|NCT02345889|582528367|FG002|Overall Study|Inadequate Bowel Prep|18|||
161091078|NCT03658668|581723795|FG000|Overall Study|Time Commitment|1|||
161313299|NCT02345889|582528368|FG003|Overall Study|Inadequate Bowel Prep|14|||
161313300|NCT02345889|582528365|FG000|Overall Study|Polyposis identified during procedure|1|||
161313301|NCT02345889|582528366|FG001|Overall Study|Polyposis identified during procedure|1|||
161313302|NCT02345889|582528367|FG002|Overall Study|Polyposis identified during procedure|0|||
161313303|NCT02345889|582528368|FG003|Overall Study|Polyposis identified during procedure|1|||
161313304|NCT02345889|582528365|FG000|Overall Study|Recognized ineligible post-randomization|1|||
161313305|NCT02345889|582528366|FG001|Overall Study|Recognized ineligible post-randomization|0|||
161313306|NCT02345889|582528367|FG002|Overall Study|Recognized ineligible post-randomization|2|||
161313307|NCT02345889|582528368|FG003|Overall Study|Recognized ineligible post-randomization|1|||
161313308|NCT02345889|582528365|FG000|Overall Study|Ulcerative Colitis identified|1|||
161313309|NCT02345889|582528366|FG001|Overall Study|Ulcerative Colitis identified|0|||
161313310|NCT02345889|582528367|FG002|Overall Study|Ulcerative Colitis identified|0|||
161313311|NCT02345889|582528368|FG003|Overall Study|Ulcerative Colitis identified|0|||
161313312|NCT02345889|582528365|FG000|Overall Study|Cecum not intubated|1|||
161313313|NCT02345889|582528366|FG001|Overall Study|Cecum not intubated|0|||
161313314|NCT02345889|582528367|FG002|Overall Study|Cecum not intubated|0|||
161313315|NCT02345889|582528368|FG003|Overall Study|Cecum not intubated|0|||
161313316|NCT00962091|582528369|FG000|Overall Study|Withdrawal by Subject|1|||
161313317|NCT00962091|582528370|FG001|Overall Study|Withdrawal by Subject|2|||
161313318|NCT00962091|582528371|FG002|Overall Study|Withdrawal by Subject|1|||
161313319|NCT00962091|582528372|FG003|Overall Study|Withdrawal by Subject|1|||
161313320|NCT00962091|582528373|FG004|Overall Study|Withdrawal by Subject|0|||
161313321|NCT00962091|582528374|FG005|Overall Study|Withdrawal by Subject|1|||
161313322|NCT00962091|582528375|FG006|Overall Study|Withdrawal by Subject|0|||
161313323|NCT00962091|582528369|FG000|Overall Study|Adverse Event|0|||
161313324|NCT00962091|582528370|FG001|Overall Study|Adverse Event|0|||
161313325|NCT00962091|582528371|FG002|Overall Study|Adverse Event|0|||
161313326|NCT00962091|582528372|FG003|Overall Study|Adverse Event|0|||
161313327|NCT00962091|582528373|FG004|Overall Study|Adverse Event|0|||
161313328|NCT00962091|582528374|FG005|Overall Study|Adverse Event|0|||
161313329|NCT00962091|582528375|FG006|Overall Study|Adverse Event|1|||
161313330|NCT02093390|582528382|FG000|Overall Study|Withdrawal by Subject|0|||
161313331|NCT02093390|582528383|FG001|Overall Study|Withdrawal by Subject|1|||
161313332|NCT00073983|582528384|FG000|Overall Study|not evaluable|1|||
161313333|NCT03976323|582528387|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
161313334|NCT03976323|582528388|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161313335|NCT03976323|582528389|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
161313336|NCT03976323|582528387|FG000|Induction Phase|Death|80|||
161313337|NCT03976323|582528388|FG001|Induction Phase|Death|0|||
161313338|NCT03976323|582528389|FG002|Induction Phase|Death|0|||
161313339|NCT03976323|582528387|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
161313340|NCT03976323|582528388|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
161313341|NCT03976323|582528389|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
161313342|NCT03976323|582528387|FG000|Maintenance Phase|Withdrawal by Subject|0|||
161313343|NCT03976323|582528388|FG001|Maintenance Phase|Withdrawal by Subject|9|||
161313344|NCT03976323|582528389|FG002|Maintenance Phase|Withdrawal by Subject|3|||
161313345|NCT03976323|582528387|FG000|Maintenance Phase|Physician Decision|0|||
161313346|NCT03976323|582528388|FG001|Maintenance Phase|Physician Decision|0|||
161313347|NCT03976323|582528389|FG002|Maintenance Phase|Physician Decision|1|||
161313348|NCT03976323|582528387|FG000|Maintenance Phase|Death|0|||
161313349|NCT03976323|582528388|FG001|Maintenance Phase|Death|228|||
161313350|NCT03976323|582528389|FG002|Maintenance Phase|Death|234|||
161313351|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
161313352|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
161313353|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
161313354|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
161313355|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
161313356|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
161313357|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
161313358|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
161313359|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
161313360|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
161313361|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
161313362|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
161313363|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
161313364|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
161313365|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
161313366|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
161313367|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
161313368|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
161313369|NCT02294461|582528390|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
161313370|NCT02294461|582528391|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
161313371|NCT02294461|582528392|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
161313372|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
161313373|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
161313374|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
161313375|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
161313376|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
161313377|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
161313378|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
161313379|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
161313380|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
161313381|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
161313382|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
161313383|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
161313384|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
161313385|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
161313386|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
161313387|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
161313388|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
161313389|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
161313390|NCT02294461|582528390|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
161313391|NCT02294461|582528391|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
161313392|NCT02294461|582528392|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
161313393|NCT03800836|582528393|FG000|Overall Study|Other|2|||
161313394|NCT03800836|582528394|FG001|Overall Study|Other|1|||
161313395|NCT03800836|582528395|FG002|Overall Study|Other|0|||
161313396|NCT03800836|582528396|FG003|Overall Study|Other|2|||
161313397|NCT03800836|582528397|FG004|Overall Study|Other|0|||
161313398|NCT03800836|582528398|FG005|Overall Study|Other|1|||
161313399|NCT03800836|582528393|FG000|Overall Study|Lost to Follow-up|2|||
161313400|NCT03800836|582528394|FG001|Overall Study|Lost to Follow-up|0|||
161313401|NCT03800836|582528395|FG002|Overall Study|Lost to Follow-up|1|||
161313402|NCT03800836|582528396|FG003|Overall Study|Lost to Follow-up|1|||
161313403|NCT03800836|582528397|FG004|Overall Study|Lost to Follow-up|3|||
161313404|NCT03800836|582528398|FG005|Overall Study|Lost to Follow-up|0|||
161313405|NCT03800836|582528393|FG000|Overall Study|Withdrawal by Subject|1|||
161313406|NCT03800836|582528394|FG001|Overall Study|Withdrawal by Subject|0|||
161313407|NCT03800836|582528395|FG002|Overall Study|Withdrawal by Subject|0|||
161313408|NCT03800836|582528396|FG003|Overall Study|Withdrawal by Subject|0|||
161313409|NCT03800836|582528397|FG004|Overall Study|Withdrawal by Subject|0|||
161313410|NCT03800836|582528398|FG005|Overall Study|Withdrawal by Subject|0|||
161313411|NCT03800836|582528393|FG000|Overall Study|Physician Decision|31|||
161313412|NCT03800836|582528394|FG001|Overall Study|Physician Decision|3|||
161313413|NCT03800836|582528395|FG002|Overall Study|Physician Decision|6|||
161313414|NCT03800836|582528396|FG003|Overall Study|Physician Decision|4|||
161313415|NCT03800836|582528397|FG004|Overall Study|Physician Decision|4|||
161313416|NCT03800836|582528398|FG005|Overall Study|Physician Decision|5|||
161313417|NCT03800836|582528393|FG000|Overall Study|Death|34|||
161313418|NCT03800836|582528394|FG001|Overall Study|Death|16|||
161313419|NCT03800836|582528395|FG002|Overall Study|Death|5|||
161313420|NCT03800836|582528396|FG003|Overall Study|Death|5|||
161313421|NCT03800836|582528397|FG004|Overall Study|Death|10|||
161313422|NCT03800836|582528398|FG005|Overall Study|Death|0|||
161313423|NCT03800836|582528393|FG000|Overall Study|Symptomatic Deterioration|1|||
161313424|NCT03800836|582528394|FG001|Overall Study|Symptomatic Deterioration|0|||
161313425|NCT03800836|582528395|FG002|Overall Study|Symptomatic Deterioration|1|||
161313426|NCT03800836|582528396|FG003|Overall Study|Symptomatic Deterioration|0|||
161313427|NCT03800836|582528397|FG004|Overall Study|Symptomatic Deterioration|0|||
161313428|NCT03800836|582528398|FG005|Overall Study|Symptomatic Deterioration|0|||
161313429|NCT05916131|582529887|FG000|Overall Study|Lost to Follow-up|0|||
161313430|NCT05916131|582529888|FG001|Overall Study|Lost to Follow-up|0|||
161313431|NCT05916131|582529889|FG002|Overall Study|Lost to Follow-up|1|||
161313432|NCT05916131|582529890|FG003|Overall Study|Lost to Follow-up|0|||
161313433|NCT02949908|582529891|FG000|Overall Study|Study termination|2|||
161313434|NCT05323994|582529892|FG000|Overall Study|Protocol Violation|1|||
161313435|NCT00454818|582529893|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
161313436|NCT00454818|582529894|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161313437|NCT00454818|582529895|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161313438|NCT00454818|582529896|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161313439|NCT00454818|582529897|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
161313440|NCT00454818|582529893|FG000|Phase I: Open-label Dose-escalation|Death|0|||
161313441|NCT00454818|582529894|FG001|Phase I: Open-label Dose-escalation|Death|1|||
161313442|NCT00454818|582529895|FG002|Phase I: Open-label Dose-escalation|Death|0|||
161313443|NCT00454818|582529896|FG003|Phase I: Open-label Dose-escalation|Death|0|||
161313444|NCT00454818|582529897|FG004|Phase I: Open-label Dose-escalation|Death|0|||
161313445|NCT00454818|582529893|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161313446|NCT00454818|582529894|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161313447|NCT00454818|582529895|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
161313448|NCT00454818|582529896|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
161313449|NCT00454818|582529897|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
161313450|NCT00454818|582529893|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161313451|NCT00454818|582529894|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
161313452|NCT00454818|582529895|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161313453|NCT00454818|582529896|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
161313454|NCT00454818|582529897|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
161313455|NCT00454818|582529893|FG000|Phase 2: Randomized Double-blind|Death|0|||
161313456|NCT00454818|582529894|FG001|Phase 2: Randomized Double-blind|Death|1|||
161313457|NCT00454818|582529895|FG002|Phase 2: Randomized Double-blind|Death|0|||
161313458|NCT00454818|582529896|FG003|Phase 2: Randomized Double-blind|Death|0|||
161313459|NCT00454818|582529897|FG004|Phase 2: Randomized Double-blind|Death|1|||
161313460|NCT00454818|582529893|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161313461|NCT00454818|582529894|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161313462|NCT00454818|582529895|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
161313463|NCT00454818|582529896|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
161313464|NCT00454818|582529897|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
161313465|NCT00454818|582529893|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161313466|NCT00454818|582529894|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161313467|NCT00454818|582529895|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
161313468|NCT00454818|582529896|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
161313469|NCT00454818|582529897|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
161313470|NCT00616603|582529898|FG000|Overall Study|Physician Decision|2|||
161313471|NCT00616603|582529899|FG001|Overall Study|Physician Decision|0|||
161313472|NCT00616603|582529900|FG002|Overall Study|Physician Decision|2|||
161313473|NCT00766467|582529902|FG000|Overall Study|Withdrawal by Subject|7|||
161313474|NCT00766467|582529903|FG001|Overall Study|Withdrawal by Subject|2|||
161313475|NCT00766467|582529902|FG000|Overall Study|Adverse Event|1|||
161313476|NCT00766467|582529903|FG001|Overall Study|Adverse Event|1|||
161313477|NCT00766467|582529902|FG000|Overall Study|Protocol Violation|2|||
161313478|NCT00766467|582529903|FG001|Overall Study|Protocol Violation|4|||
161313479|NCT00766467|582529902|FG000|Overall Study|Tumor Progression on Study|0|||
161313480|NCT00766467|582529903|FG001|Overall Study|Tumor Progression on Study|1|||
161313481|NCT00766467|582529902|FG000|Overall Study|Physician Decision|1|||
161313482|NCT00766467|582529903|FG001|Overall Study|Physician Decision|0|||
161313483|NCT02604550|582529909|FG000|Overall Study|Lost to Follow-up|7|||
161313484|NCT02604550|582529910|FG001|Overall Study|Lost to Follow-up|6|||
161313485|NCT02604550|582529909|FG000|Overall Study|Withdrawal by Subject|0|||
161313486|NCT02604550|582529910|FG001|Overall Study|Withdrawal by Subject|1|||
161313487|NCT02604550|582529909|FG000|Overall Study|Incomplete data using paper journal|18|||
161313488|NCT02604550|582529910|FG001|Overall Study|Incomplete data using paper journal|19|||
161313489|NCT00908076|582529911|FG000|Overall Study|Lack of Efficacy|1|||
161313490|NCT00908076|582529912|FG001|Overall Study|Lack of Efficacy|1|||
161313491|NCT00662558|582529913|FG000|Overall Study|Adverse Event|21|||
161313492|NCT00662558|582529914|FG001|Overall Study|Adverse Event|59|||
161313493|NCT00662558|582529913|FG000|Overall Study|Lack of Efficacy|4|||
161313494|NCT00662558|582529914|FG001|Overall Study|Lack of Efficacy|7|||
161313495|NCT00662558|582529913|FG000|Overall Study|Lost to Follow-up|13|||
161313496|NCT00662558|582529914|FG001|Overall Study|Lost to Follow-up|10|||
161313497|NCT00662558|582529913|FG000|Overall Study|Other|9|||
161313498|NCT00662558|582529914|FG001|Overall Study|Other|14|||
161313499|NCT00662558|582529913|FG000|Overall Study|Withdrawal by Subject|7|||
161313500|NCT00662558|582529914|FG001|Overall Study|Withdrawal by Subject|12|||
161313501|NCT00662558|582529913|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
161313502|NCT00662558|582529914|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
161313503|NCT03329248|582529924|FG000|Overall Study|Progressive Disease|6|||
161313504|NCT00987402|582529925|FG000|Overall Study|Insufficient data entry|86|||
161313505|NCT00987402|582529926|FG001|Overall Study|Insufficient data entry|98|||
161313506|NCT03000530|582529930|FG000|Overall Study|Adverse Event|0|||
161313507|NCT03000530|582529931|FG001|Overall Study|Adverse Event|0|||
161313508|NCT03000530|582529932|FG002|Overall Study|Adverse Event|2|||
161313509|NCT03000530|582529930|FG000|Overall Study|Lost to Follow-up|0|||
161313510|NCT03000530|582529931|FG001|Overall Study|Lost to Follow-up|3|||
161313511|NCT03000530|582529932|FG002|Overall Study|Lost to Follow-up|1|||
161313512|NCT03000530|582529930|FG000|Overall Study|Withdrawal by Subject|0|||
161313513|NCT03000530|582529931|FG001|Overall Study|Withdrawal by Subject|2|||
161313514|NCT03000530|582529932|FG002|Overall Study|Withdrawal by Subject|1|||
161313515|NCT01672294|582529933|FG000|Overall Study|Withdrawal by Subject|4|||
161313516|NCT01672294|582529934|FG001|Overall Study|Withdrawal by Subject|4|||
161313517|NCT01672294|582529935|FG002|Overall Study|Withdrawal by Subject|4|||
161313518|NCT01672294|582529936|FG003|Overall Study|Withdrawal by Subject|4|||
161313519|NCT01672294|582529933|FG000|Overall Study|Excluded by study|1|||
161313520|NCT01672294|582529934|FG001|Overall Study|Excluded by study|1|||
161313521|NCT01672294|582529935|FG002|Overall Study|Excluded by study|0|||
161313522|NCT01672294|582529936|FG003|Overall Study|Excluded by study|0|||
161313523|NCT01672294|582529933|FG000|Overall Study|Lost to Follow-up|1|||
161313524|NCT01672294|582529934|FG001|Overall Study|Lost to Follow-up|16|||
161313525|NCT01672294|582529935|FG002|Overall Study|Lost to Follow-up|7|||
161313526|NCT01672294|582529936|FG003|Overall Study|Lost to Follow-up|9|||
161313527|NCT01285492|582529937|FG000|Overall Study|Adverse Event|11|||
161313528|NCT01285492|582529938|FG001|Overall Study|Adverse Event|0|||
161313529|NCT01285492|582529937|FG000|Overall Study|Protocol Violation|3|||
161313530|NCT01285492|582529938|FG001|Overall Study|Protocol Violation|0|||
161313531|NCT01285492|582529937|FG000|Overall Study|Withdrawal by Subject|2|||
161313532|NCT01285492|582529938|FG001|Overall Study|Withdrawal by Subject|1|||
161313533|NCT01285492|582529937|FG000|Overall Study|Death|1|||
161313534|NCT01285492|582529938|FG001|Overall Study|Death|0|||
161313535|NCT03379792|582529939|FG000|Overall Study|Physician Decision|0|||
161313536|NCT03379792|582529940|FG001|Overall Study|Physician Decision|0|||
161313537|NCT03379792|582529941|FG002|Overall Study|Physician Decision|0|||
161313538|NCT03379792|582529942|FG003|Overall Study|Physician Decision|1|||
161313539|NCT03379792|582529943|FG004|Overall Study|Physician Decision|0|||
161313540|NCT03379792|582529944|FG005|Overall Study|Physician Decision|0|||
161313541|NCT03379792|582529939|FG000|Overall Study|Withdrawal by Subject|0|||
161313542|NCT03379792|582529940|FG001|Overall Study|Withdrawal by Subject|0|||
161313543|NCT03379792|582529941|FG002|Overall Study|Withdrawal by Subject|0|||
161313544|NCT03379792|582529942|FG003|Overall Study|Withdrawal by Subject|0|||
161313545|NCT03379792|582529943|FG004|Overall Study|Withdrawal by Subject|1|||
161313546|NCT03379792|582529944|FG005|Overall Study|Withdrawal by Subject|1|||
161313547|NCT01121536|582529945|FG000|Overall Study|Adverse Event|63|||
161313548|NCT01121536|582529945|FG000|Overall Study|Lack of Efficacy|35|||
161313549|NCT01121536|582529945|FG000|Overall Study|Withdrawal by Subject|65|||
161313550|NCT01121536|582529945|FG000|Overall Study|Protocol Violation|20|||
161313551|NCT01121536|582529945|FG000|Overall Study|Noncompliance with study medication|12|||
161313552|NCT01121536|582529945|FG000|Overall Study|Noncompliance with study procedures|9|||
161313553|NCT01121536|582529945|FG000|Overall Study|Lost to Follow-up|39|||
161313554|NCT01121536|582529945|FG000|Overall Study|Other|118|||
161313555|NCT02649426|582529947|FG000|Overall Study|Follow-up on going|1|||
161313556|NCT02649426|582529948|FG001|Overall Study|Follow-up on going|26|||
161313557|NCT02649426|582529949|FG002|Overall Study|Follow-up on going|28|||
161313558|NCT02649426|582529950|FG003|Overall Study|Follow-up on going|31|||
161313559|NCT01606202|582529951|FG000|Overall Study|Adverse Event|5|||
161313560|NCT01606202|582529952|FG001|Overall Study|Adverse Event|0|||
161313561|NCT01606202|582529951|FG000|Overall Study|Withdrawal by Subject|2|||
161313562|NCT01606202|582529952|FG001|Overall Study|Withdrawal by Subject|1|||
161313563|NCT01606202|582529951|FG000|Overall Study|Personal problems|0|||
161313564|NCT01606202|582529952|FG001|Overall Study|Personal problems|1|||
161313565|NCT01606202|582529951|FG000|Overall Study|Problems with administration|0|||
161313566|NCT01606202|582529952|FG001|Overall Study|Problems with administration|1|||
161313567|NCT00306787|582529953|FG000|Overall Study|Discontinued without taking study drug|208|||
161313568|NCT00306787|582529954|FG001|Overall Study|Discontinued without taking study drug|215|||
161313569|NCT00306787|582529953|FG000|Overall Study|Adverse Event|1|||
161313570|NCT00306787|582529954|FG001|Overall Study|Adverse Event|1|||
161313571|NCT00306787|582529953|FG000|Overall Study|Lack of Efficacy|1|||
161313572|NCT00306787|582529954|FG001|Overall Study|Lack of Efficacy|0|||
161313573|NCT00306787|582529953|FG000|Overall Study|Protocol Violation|8|||
161313574|NCT00306787|582529954|FG001|Overall Study|Protocol Violation|10|||
161313575|NCT00306787|582529953|FG000|Overall Study|Withdrawal by Subject|2|||
161313576|NCT00306787|582529954|FG001|Overall Study|Withdrawal by Subject|9|||
161313577|NCT00306787|582529953|FG000|Overall Study|Lost to Follow-up|9|||
161313578|NCT00306787|582529954|FG001|Overall Study|Lost to Follow-up|6|||
161313579|NCT00306787|582529953|FG000|Overall Study|Administrative problems|4|||
161313580|NCT00306787|582529954|FG001|Overall Study|Administrative problems|0|||
161313581|NCT00306787|582529953|FG000|Overall Study|Abnormal laboratory value(s)|1|||
161313582|NCT00306787|582529954|FG001|Overall Study|Abnormal laboratory value(s)|0|||
161313583|NCT00369161|582529955|FG000|Overall Study|Adverse Event|15|||
161313584|NCT00369161|582529956|FG001|Overall Study|Adverse Event|13|||
161313585|NCT00369161|582529955|FG000|Overall Study|Abnormal laboratory value|0|||
161313586|NCT00369161|582529956|FG001|Overall Study|Abnormal laboratory value|1|||
161313587|NCT00369161|582529955|FG000|Overall Study|Lack of Efficacy|3|||
161313588|NCT00369161|582529956|FG001|Overall Study|Lack of Efficacy|1|||
161313589|NCT00369161|582529955|FG000|Overall Study|Protocol Violation|0|||
161313590|NCT00369161|582529956|FG001|Overall Study|Protocol Violation|2|||
161313591|NCT00369161|582529955|FG000|Overall Study|Withdrawal by Subject|2|||
161313592|NCT00369161|582529956|FG001|Overall Study|Withdrawal by Subject|3|||
161313593|NCT00369161|582529955|FG000|Overall Study|Death|1|||
161313594|NCT00369161|582529956|FG001|Overall Study|Death|2|||
161313595|NCT00369161|582529955|FG000|Overall Study|Graft loss|4|||
161313596|NCT00369161|582529956|FG001|Overall Study|Graft loss|0|||
161313597|NCT00369161|582529955|FG000|Overall Study|Administrative Problem|2|||
161313598|NCT00369161|582529956|FG001|Overall Study|Administrative Problem|2|||
161313599|NCT01870297|582529959|FG000|Overall Study|Adverse Event|0|||
161313600|NCT01870297|582529960|FG001|Overall Study|Adverse Event|0|||
161313601|NCT01870297|582529961|FG002|Overall Study|Adverse Event|0|||
161313602|NCT01870297|582529962|FG003|Overall Study|Adverse Event|0|||
161313603|NCT01870297|582529963|FG004|Overall Study|Adverse Event|2|||
161313604|NCT01870297|582529964|FG005|Overall Study|Adverse Event|0|||
161313605|NCT01870297|582529965|FG006|Overall Study|Adverse Event|0|||
161313606|NCT01870297|582529959|FG000|Overall Study|Lost to Follow-up|0|||
161313607|NCT01870297|582529960|FG001|Overall Study|Lost to Follow-up|1|||
161313608|NCT01870297|582529961|FG002|Overall Study|Lost to Follow-up|1|||
161313609|NCT01870297|582529962|FG003|Overall Study|Lost to Follow-up|0|||
161313610|NCT01870297|582529963|FG004|Overall Study|Lost to Follow-up|0|||
161313611|NCT01870297|582529964|FG005|Overall Study|Lost to Follow-up|0|||
161313612|NCT01870297|582529965|FG006|Overall Study|Lost to Follow-up|0|||
161313613|NCT01870297|582529959|FG000|Overall Study|Withdrawal by Subject|0|||
161313614|NCT01870297|582529960|FG001|Overall Study|Withdrawal by Subject|0|||
161313615|NCT01870297|582529961|FG002|Overall Study|Withdrawal by Subject|0|||
161313616|NCT01870297|582529962|FG003|Overall Study|Withdrawal by Subject|0|||
161313617|NCT01870297|582529963|FG004|Overall Study|Withdrawal by Subject|1|||
161313618|NCT01870297|582529964|FG005|Overall Study|Withdrawal by Subject|1|||
161313619|NCT01870297|582529965|FG006|Overall Study|Withdrawal by Subject|1|||
161313620|NCT01870297|582529959|FG000|Overall Study|Sponsor Decision|0|||
161313621|NCT01870297|582529960|FG001|Overall Study|Sponsor Decision|6|||
161313622|NCT01870297|582529961|FG002|Overall Study|Sponsor Decision|0|||
161313623|NCT01870297|582529962|FG003|Overall Study|Sponsor Decision|0|||
161313624|NCT01870297|582529963|FG004|Overall Study|Sponsor Decision|0|||
161313625|NCT01870297|582529964|FG005|Overall Study|Sponsor Decision|0|||
161313626|NCT01870297|582529965|FG006|Overall Study|Sponsor Decision|1|||
161313627|NCT00337779|582529966|FG000|Overall Study|Withdrawal by Subject|10|||
161313628|NCT00337779|582529967|FG001|Overall Study|Withdrawal by Subject|12|||
161313629|NCT00337779|582529966|FG000|Overall Study|Sponsor decision|1|||
161313630|NCT00337779|582529967|FG001|Overall Study|Sponsor decision|1|||
161313631|NCT00337779|582529966|FG000|Overall Study|Physician Decision|3|||
161313632|NCT00337779|582529967|FG001|Overall Study|Physician Decision|6|||
161313633|NCT00337779|582529966|FG000|Overall Study|Protocol Violation|1|||
161313634|NCT00337779|582529967|FG001|Overall Study|Protocol Violation|1|||
161313635|NCT00337779|582529966|FG000|Overall Study|Lost to Follow-up|6|||
161313636|NCT00337779|582529967|FG001|Overall Study|Lost to Follow-up|5|||
161313637|NCT00337779|582529966|FG000|Overall Study|Adverse Event|28|||
161313638|NCT00337779|582529967|FG001|Overall Study|Adverse Event|51|||
161313639|NCT00337779|582529966|FG000|Overall Study|Pregnancy|3|||
161313640|NCT00337779|582529967|FG001|Overall Study|Pregnancy|2|||
161313641|NCT00337779|582529966|FG000|Overall Study|Death|0|||
161313642|NCT00337779|582529967|FG001|Overall Study|Death|1|||
161313643|NCT01593254|582529970|FG000|Overall Study|Disease progression|2|||
161313644|NCT01593254|582529971|FG001|Overall Study|Disease progression|7|||
161313645|NCT01593254|582529970|FG000|Overall Study|Study drug toxicity|6|||
161313646|NCT01593254|582529971|FG001|Overall Study|Study drug toxicity|20|||
161313647|NCT01593254|582529970|FG000|Overall Study|Death|3|||
161313648|NCT01593254|582529971|FG001|Overall Study|Death|3|||
161313649|NCT01593254|582529970|FG000|Overall Study|AE unrelated to study drug|0|||
161313650|NCT01593254|582529971|FG001|Overall Study|AE unrelated to study drug|1|||
161313651|NCT01593254|582529970|FG000|Overall Study|participant request to discontinue study treatment|1|||
161313652|NCT01593254|582529971|FG001|Overall Study|participant request to discontinue study treatment|3|||
161313653|NCT01593254|582529970|FG000|Overall Study|participant withdrew consent|0|||
161313654|NCT01593254|582529971|FG001|Overall Study|participant withdrew consent|9|||
161313655|NCT01593254|582529970|FG000|Overall Study|lost to follow up|1|||
161313656|NCT01593254|582529971|FG001|Overall Study|lost to follow up|6|||
161313657|NCT01593254|582529970|FG000|Overall Study|maximum clinical benefit|1|||
161313658|NCT01593254|582529971|FG001|Overall Study|maximum clinical benefit|2|||
161313659|NCT01593254|582529970|FG000|Overall Study|Poor/non compliance|1|||
161313660|NCT01593254|582529971|FG001|Overall Study|Poor/non compliance|1|||
161313661|NCT01593254|582529970|FG000|Overall Study|Pregnancy|0|||
161313662|NCT01593254|582529971|FG001|Overall Study|Pregnancy|3|||
161313663|NCT01593254|582529970|FG000|Overall Study|participant no longer meets study criteria|1|||
161313664|NCT01593254|582529971|FG001|Overall Study|participant no longer meets study criteria|1|||
161313665|NCT01593254|582529970|FG000|Overall Study|Admin reason by sponsor|7|||
161313666|NCT01593254|582529971|FG001|Overall Study|Admin reason by sponsor|3|||
161313667|NCT01593254|582529970|FG000|Overall Study|Imatinib treatment failure|2|||
161313668|NCT01593254|582529971|FG001|Overall Study|Imatinib treatment failure|0|||
161313669|NCT01593254|582529970|FG000|Overall Study|Other Reasons|61|||
161313670|NCT01593254|582529971|FG001|Overall Study|Other Reasons|115|||
161313671|NCT02124759|582529974|FG000|Overall Study|Withdrawal by Subject|3|||
161313672|NCT02124759|582529975|FG001|Overall Study|Withdrawal by Subject|1|||
161313673|NCT02124759|582529976|FG002|Overall Study|Withdrawal by Subject|1|||
161313674|NCT02124759|582529974|FG000|Overall Study|Screen Fail|2|||
161313675|NCT02124759|582529975|FG001|Overall Study|Screen Fail|2|||
161313676|NCT02124759|582529976|FG002|Overall Study|Screen Fail|3|||
161313677|NCT04249622|582529977|FG000|Overall Study|Withdrawal by Subject|1|||
161313678|NCT04249622|582529978|FG001|Overall Study|Withdrawal by Subject|1|||
161313679|NCT04249622|582529977|FG000|Overall Study|Alternative therapy|1|||
161313680|NCT04249622|582529978|FG001|Overall Study|Alternative therapy|0|||
161313681|NCT04249622|582529977|FG000|Overall Study|Discontinuation of pertuzumab|1|||
161313682|NCT04249622|582529978|FG001|Overall Study|Discontinuation of pertuzumab|0|||
161313683|NCT03689543|582529981|FG000|Overall Study|Adverse Event|0|||
161313684|NCT03689543|582529982|FG001|Overall Study|Adverse Event|0|||
161313685|NCT03689543|582529983|FG002|Overall Study|Adverse Event|1|||
161313686|NCT00932451|582529984|FG000|Overall Study|Withdrawal by Subject|69|||
161313687|NCT00932451|582529984|FG000|Overall Study|Lost to Follow-up|22|||
161313688|NCT00932451|582529984|FG000|Overall Study|Death|726|||
161313689|NCT00932451|582529984|FG000|Overall Study|Other reasons|5|||
161313690|NCT00586508|582529985|FG000|Overall Study|Progressive disease|52|||
161313691|NCT00586508|582529986|FG001|Overall Study|Progressive disease|8|||
161313692|NCT00586508|582529985|FG000|Overall Study|Death|0|||
161313693|NCT00586508|582529986|FG001|Overall Study|Death|1|||
161313694|NCT00586508|582529985|FG000|Overall Study|Adverse Event|12|||
161313695|NCT00586508|582529986|FG001|Overall Study|Adverse Event|4|||
161313696|NCT00586508|582529985|FG000|Overall Study|Withdrawal by Subject|4|||
161313697|NCT00586508|582529986|FG001|Overall Study|Withdrawal by Subject|0|||
161313698|NCT01294371|582529987|FG000|Overall Study|Adverse Event|1|||
161313699|NCT01294371|582529987|FG000|Overall Study|Withdrawal by Subject|12|||
161313700|NCT01294371|582529987|FG000|Overall Study|Lost to Follow-up|6|||
161313701|NCT01294371|582529987|FG000|Overall Study|Administrative Reason|1|||
161313702|NCT01294371|582529987|FG000|Overall Study|Other|14|||
161313703|NCT02968433|582529988|FG000|Overall Study|Withdrawal by Subject|1|||
161313704|NCT05619536|582529989|FG000|Overall Study|Withdrawal by Subject|0|||
161313705|NCT05619536|582529990|FG001|Overall Study|Withdrawal by Subject|1|||
161313706|NCT05619536|582529991|FG002|Overall Study|Withdrawal by Subject|0|||
161313707|NCT05619536|582529992|FG003|Overall Study|Withdrawal by Subject|1|||
161313708|NCT05619536|582529989|FG000|Overall Study|Lost to Follow-up|0|||
161313709|NCT05619536|582529990|FG001|Overall Study|Lost to Follow-up|1|||
161313710|NCT05619536|582529991|FG002|Overall Study|Lost to Follow-up|1|||
161313711|NCT05619536|582529992|FG003|Overall Study|Lost to Follow-up|0|||
161313712|NCT00875433|582529993|FG000|Overall Study|Progressive disease|41|||
161313713|NCT00875433|582529993|FG000|Overall Study|Other Adverse Event|14|||
161313714|NCT00875433|582529993|FG000|Overall Study|Withdrawal by Subject|2|||
161313715|NCT00875433|582529993|FG000|Overall Study|Other|3|||
161313716|NCT00725101|582529994|FG000|Overall Study|Death|3|||
161313717|NCT00725101|582529994|FG000|Overall Study|Lost to Follow-up|353|||
161313718|NCT00725101|582529994|FG000|Overall Study|Protocol Violation|1|||
161313719|NCT00725101|582529994|FG000|Overall Study|Withdrawal by Subject|127|||
161313720|NCT00725101|582529994|FG000|Overall Study|not specified/no reason given|11|||
161313721|NCT03325894|582529995|FG000|Overall Study|Adverse Event|2|||
161313722|NCT03325894|582529996|FG001|Overall Study|Adverse Event|3|||
161313723|NCT03325894|582529995|FG000|Overall Study|Protocol Violation|1|||
161313724|NCT03325894|582529996|FG001|Overall Study|Protocol Violation|2|||
161313725|NCT03325894|582529995|FG000|Overall Study|Withdrawal by Subject|10|||
161313726|NCT03325894|582529996|FG001|Overall Study|Withdrawal by Subject|6|||
161313727|NCT03325894|582529995|FG000|Overall Study|Lost to Follow-up|4|||
161313728|NCT03325894|582529996|FG001|Overall Study|Lost to Follow-up|9|||
161313729|NCT03325894|582529995|FG000|Overall Study|Lack of Efficacy|8|||
161313730|NCT03325894|582529996|FG001|Overall Study|Lack of Efficacy|14|||
161313731|NCT03325894|582529995|FG000|Overall Study|Study Terminated by Sponsor|38|||
161313732|NCT03325894|582529996|FG001|Overall Study|Study Terminated by Sponsor|43|||
161313733|NCT03325894|582529995|FG000|Overall Study|Other (Not received Treatment)|1|||
161313734|NCT03325894|582529996|FG001|Overall Study|Other (Not received Treatment)|0|||
161313735|NCT01592292|582529999|FG000|Overall Study|Follow-up loss|3|||
161313736|NCT01592292|582530000|FG001|Overall Study|Follow-up loss|3|||
161313737|NCT01592292|582530001|FG002|Overall Study|Follow-up loss|1|||
161313738|NCT01592292|582530002|FG003|Overall Study|Follow-up loss|0|||
161313739|NCT01592292|582529999|FG000|Overall Study|Withdrew consent|2|||
161313740|NCT01592292|582530000|FG001|Overall Study|Withdrew consent|1|||
161313741|NCT01592292|582530001|FG002|Overall Study|Withdrew consent|0|||
161313742|NCT01592292|582530002|FG003|Overall Study|Withdrew consent|0|||
161313743|NCT01592292|582529999|FG000|Overall Study|Other|1|||
161313744|NCT01592292|582530000|FG001|Overall Study|Other|1|||
161313745|NCT01592292|582530001|FG002|Overall Study|Other|2|||
161313746|NCT01592292|582530002|FG003|Overall Study|Other|1|||
161313747|NCT03482167|582530005|FG000|Allocated to Intervention|Physician Decision|1|||
161313748|NCT03482167|582530006|FG001|Allocated to Intervention|Physician Decision|2|||
161313749|NCT03482167|582530005|FG000|Received Intervention|Adverse Event|3|||
161313750|NCT03482167|582530006|FG001|Received Intervention|Adverse Event|1|||
161313751|NCT03482167|582530005|FG000|Received Intervention|Physician Decision|1|||
161313752|NCT03482167|582530006|FG001|Received Intervention|Physician Decision|1|||
161313753|NCT03482167|582530005|FG000|Received Intervention|Withdrawal by Subject|1|||
161313754|NCT03482167|582530006|FG001|Received Intervention|Withdrawal by Subject|0|||
161313755|NCT00622336|582530009|FG000|Treatment Phase|Progression of Disease|181|||
161313756|NCT00622336|582530009|FG000|Treatment Phase|Adverse Event|46|||
161313757|NCT00622336|582530009|FG000|Treatment Phase|Other|40|||
161313758|NCT00622336|582530009|FG000|Treatment Phase|Death|14|||
161313759|NCT00622336|582530009|FG000|Treatment Phase|Lack of therapeutic effect|13|||
161313760|NCT00622336|582530009|FG000|Treatment Phase|Withdrawal by Subject|13|||
161313761|NCT00622336|582530009|FG000|Treatment Phase|Lost to Follow-up|2|||
161313762|NCT00622336|582530009|FG000|Extension Phase|Adverse Event|2|||
161313763|NCT00622336|582530009|FG000|Extension Phase|Progressive Disease|6|||
161313764|NCT00622336|582530009|FG000|Extension Phase|Lack of therapeutic effect|2|||
161313765|NCT00622336|582530009|FG000|Extension Phase|Withdrawal by Subject|1|||
161313766|NCT00622336|582530009|FG000|Extension Phase|Lost to Follow-up|1|||
161313767|NCT00622336|582530009|FG000|Extension Phase|Other|9|||
161313768|NCT00819780|582530010|FG000|Overall Study|Did not receive study drug|3|||
161313769|NCT00819780|582530011|FG001|Overall Study|Did not receive study drug|4|||
161313770|NCT00819780|582530010|FG000|Overall Study|Still in treatment|25|||
161313771|NCT00819780|582530011|FG001|Overall Study|Still in treatment|17|||
161313772|NCT04148287|582530016|FG000|Overall Study|Death|2|||
161313773|NCT00106639|582530018|FG000|Overall Study|Adverse Event|3|||
161313774|NCT00106639|582530019|FG001|Overall Study|Adverse Event|4|||
161313775|NCT00106639|582530020|FG002|Overall Study|Adverse Event|1|||
161313776|NCT00106639|582530018|FG000|Overall Study|Protocol Violation|0|||
161313777|NCT00106639|582530019|FG001|Overall Study|Protocol Violation|1|||
161313778|NCT00106639|582530020|FG002|Overall Study|Protocol Violation|0|||
161313779|NCT00106639|582530018|FG000|Overall Study|Withdrawal by Subject|0|||
161313780|NCT00106639|582530019|FG001|Overall Study|Withdrawal by Subject|1|||
161313781|NCT00106639|582530020|FG002|Overall Study|Withdrawal by Subject|0|||
161313782|NCT00106639|582530018|FG000|Overall Study|Participant defaulted|0|||
161313783|NCT00106639|582530019|FG001|Overall Study|Participant defaulted|1|||
161313784|NCT00106639|582530020|FG002|Overall Study|Participant defaulted|1|||
161313785|NCT02923245|582530021|FG000|Overall Study|ultrasound order was cancelled|2|||
161313786|NCT02923245|582530022|FG001|Overall Study|ultrasound order was cancelled|1|||
161313787|NCT03774394|582532312|FG000|Overall Study|Withdrawal by Subject|2|||
161313788|NCT03774394|582532313|FG001|Overall Study|Withdrawal by Subject|0|||
161313789|NCT03334422|582532314|FG000|Overall Study|Adverse Event|1|||
161313790|NCT03334422|582532315|FG001|Overall Study|Adverse Event|3|||
161313791|NCT03334422|582532316|FG002|Overall Study|Adverse Event|2|||
161313792|NCT03334422|582532317|FG003|Overall Study|Adverse Event|2|||
161313793|NCT03334422|582532314|FG000|Overall Study|Lack of Efficacy|10|||
161313794|NCT03334422|582532315|FG001|Overall Study|Lack of Efficacy|2|||
161313795|NCT03334422|582532316|FG002|Overall Study|Lack of Efficacy|7|||
161313796|NCT03334422|582532317|FG003|Overall Study|Lack of Efficacy|3|||
161313797|NCT03334422|582532314|FG000|Overall Study|Withdrawal by Subject|8|||
161313798|NCT03334422|582532315|FG001|Overall Study|Withdrawal by Subject|3|||
161313799|NCT03334422|582532316|FG002|Overall Study|Withdrawal by Subject|1|||
161313800|NCT03334422|582532317|FG003|Overall Study|Withdrawal by Subject|0|||
161313801|NCT03334422|582532314|FG000|Overall Study|Lost to Follow-up|0|||
161313802|NCT03334422|582532315|FG001|Overall Study|Lost to Follow-up|0|||
161313803|NCT03334422|582532316|FG002|Overall Study|Lost to Follow-up|0|||
161313804|NCT03334422|582532317|FG003|Overall Study|Lost to Follow-up|1|||
161313805|NCT03334422|582532314|FG000|Overall Study|Inability to obtain laboratory samples|0|||
161313806|NCT03334422|582532315|FG001|Overall Study|Inability to obtain laboratory samples|1|||
161313807|NCT03334422|582532316|FG002|Overall Study|Inability to obtain laboratory samples|0|||
161313808|NCT03334422|582532317|FG003|Overall Study|Inability to obtain laboratory samples|0|||
161313809|NCT03334422|582532314|FG000|Overall Study|Pregnancy|0|||
161313810|NCT03334422|582532315|FG001|Overall Study|Pregnancy|1|||
161313811|NCT03334422|582532316|FG002|Overall Study|Pregnancy|0|||
161313812|NCT03334422|582532317|FG003|Overall Study|Pregnancy|0|||
161313813|NCT01313221|582532318|FG000|Overall Study|Protocol Violation|0|||
161313814|NCT01313221|582532319|FG001|Overall Study|Protocol Violation|1|||
161313815|NCT01313221|582532320|FG002|Overall Study|Protocol Violation|1|||
161313816|NCT01313221|582532318|FG000|Overall Study|Non-compliance|3|||
161313817|NCT01313221|582532319|FG001|Overall Study|Non-compliance|0|||
161313818|NCT01313221|582532320|FG002|Overall Study|Non-compliance|2|||
161313819|NCT01313221|582532318|FG000|Overall Study|Withdrawal by Subject|2|||
161313820|NCT01313221|582532319|FG001|Overall Study|Withdrawal by Subject|3|||
161313821|NCT01313221|582532320|FG002|Overall Study|Withdrawal by Subject|5|||
161313822|NCT01313221|582532318|FG000|Overall Study|Requirement for alternative therapy|0|||
161313823|NCT01313221|582532319|FG001|Overall Study|Requirement for alternative therapy|1|||
161313824|NCT01313221|582532320|FG002|Overall Study|Requirement for alternative therapy|1|||
161313825|NCT01313221|582532318|FG000|Overall Study|Lost to Follow-up|6|||
161313826|NCT01313221|582532319|FG001|Overall Study|Lost to Follow-up|3|||
161313827|NCT01313221|582532320|FG002|Overall Study|Lost to Follow-up|1|||
161313828|NCT01313221|582532318|FG000|Overall Study|Other|1|||
161313829|NCT01313221|582532319|FG001|Overall Study|Other|0|||
161313830|NCT01313221|582532320|FG002|Overall Study|Other|0|||
161313831|NCT01313221|582532318|FG000|Overall Study|Adverse Event|0|||
161313832|NCT01313221|582532319|FG001|Overall Study|Adverse Event|0|||
161313833|NCT01313221|582532320|FG002|Overall Study|Adverse Event|7|||
161313834|NCT01313221|582532318|FG000|Overall Study|Disease progression|0|||
161313835|NCT01313221|582532319|FG001|Overall Study|Disease progression|0|||
161313836|NCT01313221|582532320|FG002|Overall Study|Disease progression|2|||
161313837|NCT01313221|582532318|FG000|Overall Study|Physician Decision|0|||
161313838|NCT01313221|582532319|FG001|Overall Study|Physician Decision|0|||
161313839|NCT01313221|582532320|FG002|Overall Study|Physician Decision|2|||
161313840|NCT01313221|582532318|FG000|Overall Study|Pregnancy|0|||
161313841|NCT01313221|582532319|FG001|Overall Study|Pregnancy|0|||
161313842|NCT01313221|582532320|FG002|Overall Study|Pregnancy|2|||
161313843|NCT00994214|582532321|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161313844|NCT00994214|582532322|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
161313845|NCT00994214|582532323|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161313846|NCT00994214|582532324|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
161313847|NCT00994214|582532321|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161313848|NCT00994214|582532322|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161313849|NCT00994214|582532323|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
161313850|NCT00994214|582532324|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
161313851|NCT00994214|582532321|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
161313852|NCT00994214|582532322|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161313853|NCT00994214|582532323|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161313854|NCT00994214|582532324|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
161313855|NCT00994214|582532321|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
161313856|NCT00994214|582532322|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
161313857|NCT00994214|582532323|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
161313858|NCT00994214|582532324|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
161313859|NCT00994214|582532321|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161313860|NCT00994214|582532322|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161313861|NCT00994214|582532323|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
161313862|NCT00994214|582532324|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
161313863|NCT00994214|582532321|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
161313864|NCT00994214|582532322|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
161313865|NCT00994214|582532323|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
161313866|NCT00994214|582532324|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
161313867|NCT03246061|582532325|FG000|Overall Study|Still in follow-up|15|||
161313868|NCT03246061|582532326|FG001|Overall Study|Still in follow-up|21|||
161313869|NCT04710368|582532331|FG000|Overall Study|Withdrawal by Subject|9|||
161313870|NCT04710368|582532331|FG000|Overall Study|Lost to Follow-up|4|||
161313871|NCT04710368|582532331|FG000|Overall Study|Death|2|||
161313872|NCT04710368|582532331|FG000|Overall Study|Patient preference|11|||
161313873|NCT04710368|582532331|FG000|Overall Study|Treatment discontinuation|1|||
161313874|NCT01777139|582532334|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
161313875|NCT01777139|582532335|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
161313876|NCT01777139|582532334|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
161313877|NCT01777139|582532335|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
161313878|NCT01777139|582532334|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
161313879|NCT01777139|582532335|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
161313880|NCT01777139|582532334|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
161313881|NCT01777139|582532335|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
161313882|NCT01777139|582532334|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
161313883|NCT01777139|582532335|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
161313884|NCT01777139|582532334|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
161313885|NCT01777139|582532335|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
161313886|NCT01777139|582532334|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
161313887|NCT01777139|582532335|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
161313888|NCT01777139|582532334|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
161313889|NCT01777139|582532335|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
161313890|NCT01887288|582532337|FG000|Overall Study|The study was terminated and the PI has|16|||
161313891|NCT05625477|582532338|FG000|Overall Study|Lost to Follow-up|2|||
161313892|NCT05625477|582532339|FG001|Overall Study|Lost to Follow-up|2|||
161313893|NCT05625477|582532340|FG002|Overall Study|Lost to Follow-up|1|||
161313894|NCT05625477|582532341|FG003|Overall Study|Lost to Follow-up|1|||
161313895|NCT05625477|582532342|FG004|Overall Study|Lost to Follow-up|0|||
161313896|NCT05625477|582532338|FG000|Overall Study|Covid quarantine|1|||
161313897|NCT05625477|582532339|FG001|Overall Study|Covid quarantine|0|||
161313898|NCT05625477|582532340|FG002|Overall Study|Covid quarantine|0|||
161313899|NCT05625477|582532341|FG003|Overall Study|Covid quarantine|0|||
161313900|NCT05625477|582532342|FG004|Overall Study|Covid quarantine|0|||
161313901|NCT04849416|582532343|FG000|Overall Study|Ongoing Treatment|12|||
161313902|NCT04849416|582532344|FG001|Overall Study|Ongoing Treatment|5|||
161313903|NCT04849416|582532345|FG002|Overall Study|Ongoing Treatment|3|||
161313904|NCT04849416|582532343|FG000|Overall Study|On Post-Treatment Follow-up|8|||
161313905|NCT04849416|582532344|FG001|Overall Study|On Post-Treatment Follow-up|9|||
161313906|NCT04849416|582532345|FG002|Overall Study|On Post-Treatment Follow-up|10|||
161313907|NCT04849416|582532343|FG000|Overall Study|Withdrawal by Subject|0|||
161313908|NCT04849416|582532344|FG001|Overall Study|Withdrawal by Subject|0|||
161313909|NCT04849416|582532345|FG002|Overall Study|Withdrawal by Subject|1|||
161313910|NCT04849416|582532343|FG000|Overall Study|Lost to Follow-up|1|||
161313911|NCT04849416|582532344|FG001|Overall Study|Lost to Follow-up|0|||
161313912|NCT04849416|582532345|FG002|Overall Study|Lost to Follow-up|0|||
161313913|NCT01092637|582532346|FG000|Overall Study|Death|47|||
161313914|NCT01092637|582532347|FG001|Overall Study|Death|49|||
161313915|NCT01716520|582532348|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
161313916|NCT01716520|582532349|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
161313917|NCT01716520|582532350|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
161313918|NCT01716520|582532351|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
161313919|NCT01716520|582532352|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
161313920|NCT01716520|582532353|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
161313921|NCT01716520|582532348|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161313922|NCT01716520|582532349|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
161313923|NCT01716520|582532350|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
161313924|NCT01716520|582532351|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161313925|NCT01716520|582532352|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
161313926|NCT01716520|582532353|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
161313927|NCT01716520|582532348|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161313928|NCT01716520|582532349|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
161313929|NCT01716520|582532350|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161313930|NCT01716520|582532351|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161313931|NCT01716520|582532352|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161313932|NCT01716520|582532353|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
161313933|NCT01716520|582532348|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161313934|NCT01716520|582532349|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
161313935|NCT01716520|582532350|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161313936|NCT01716520|582532351|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161313937|NCT01716520|582532352|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161313938|NCT01716520|582532353|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
161313939|NCT01716520|582532348|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161313940|NCT01716520|582532349|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161313941|NCT01716520|582532350|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161313942|NCT01716520|582532351|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161313943|NCT01716520|582532352|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
161313944|NCT01716520|582532353|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
161313945|NCT01716520|582532348|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161313946|NCT01716520|582532349|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161313947|NCT01716520|582532350|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
161313948|NCT01716520|582532351|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161313949|NCT01716520|582532352|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
161313950|NCT01716520|582532353|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
161313951|NCT01716520|582532348|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
161313952|NCT01716520|582532349|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
161313953|NCT01716520|582532350|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
161313954|NCT01716520|582532351|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
161313955|NCT01716520|582532352|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
161313956|NCT01716520|582532353|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
161313957|NCT01716520|582532348|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161313958|NCT01716520|582532349|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161313959|NCT01716520|582532350|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161313960|NCT01716520|582532351|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161313961|NCT01716520|582532352|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
161313962|NCT01716520|582532353|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
161313963|NCT01716520|582532348|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161313964|NCT01716520|582532349|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161313965|NCT01716520|582532350|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161313966|NCT01716520|582532351|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
161313967|NCT01716520|582532352|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161313968|NCT01716520|582532353|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
161091079|NCT03658668|581723796|FG001|Overall Study|Time Commitment|1|||
161313969|NCT01716520|582532348|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161313970|NCT01716520|582532349|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161313971|NCT01716520|582532350|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161313972|NCT01716520|582532351|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161313973|NCT01716520|582532352|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
161313974|NCT01716520|582532353|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
161313975|NCT01716520|582532348|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
161313976|NCT01716520|582532349|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161313977|NCT01716520|582532350|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161313978|NCT01716520|582532351|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161313979|NCT01716520|582532352|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161313980|NCT01716520|582532353|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
161313981|NCT01716520|582532348|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161313982|NCT01716520|582532349|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161313983|NCT01716520|582532350|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161313984|NCT01716520|582532351|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161313985|NCT01716520|582532352|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
161313986|NCT01716520|582532353|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
161313987|NCT01716520|582532348|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161313988|NCT01716520|582532349|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
161206794|NCT02675426|582138016|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
161206795|NCT02675426|582138013|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
161206796|NCT02675426|582138014|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
161206797|NCT02675426|582138015|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
161206798|NCT02675426|582138016|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
161206799|NCT02675426|582138013|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
161206800|NCT02675426|582138014|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
161206801|NCT02675426|582138015|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
161206802|NCT02675426|582138016|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
161206803|NCT02675426|582138013|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
161206804|NCT02675426|582138014|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
161206805|NCT02675426|582138015|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
161206806|NCT02675426|582138016|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
161206807|NCT02675426|582138013|FG000|Period 2: Week 12 to Week 260|Other|8|||
161206808|NCT02675426|582138014|FG001|Period 2: Week 12 to Week 260|Other|12|||
161206809|NCT02675426|582138015|FG002|Period 2: Week 12 to Week 260|Other|23|||
161206810|NCT02675426|582138016|FG003|Period 2: Week 12 to Week 260|Other|15|||
161206811|NCT01784419|582138017|FG000|Overall Study|Adverse Event|3|||
161206812|NCT02237118|582138018|FG000|Overall Study|Protocol Violation|0|||
161206813|NCT02237118|582138019|FG001|Overall Study|Protocol Violation|1|||
161206814|NCT02237118|582138018|FG000|Overall Study|consent withdrawn|1|||
161206815|NCT02237118|582138019|FG001|Overall Study|consent withdrawn|0|||
161206816|NCT00080288|582138020|FG000|Overall Study|Adverse Event|7|||
161206817|NCT00080288|582138021|FG001|Overall Study|Adverse Event|4|||
161206818|NCT00080288|582138020|FG000|Overall Study|Lost to Follow-up|3|||
161206819|NCT00080288|582138021|FG001|Overall Study|Lost to Follow-up|5|||
161206820|NCT00080288|582138020|FG000|Overall Study|Physician Decision|6|||
161206821|NCT00080288|582138021|FG001|Overall Study|Physician Decision|2|||
161206822|NCT00080288|582138020|FG000|Overall Study|Withdrawal by Subject|3|||
161206823|NCT00080288|582138021|FG001|Overall Study|Withdrawal by Subject|16|||
161206824|NCT00080288|582138020|FG000|Overall Study|Miscellaneous|11|||
161206825|NCT00080288|582138021|FG001|Overall Study|Miscellaneous|11|||
161206826|NCT03044431|582138024|FG000|Overall Study|Lost to Follow-up|59|||
161206827|NCT00569231|582138025|FG000|Overall Study|Study unrelated surgery|1|||
161206828|NCT00569231|582138025|FG000|Overall Study|Airfare expense|2|||
161206829|NCT00569231|582138025|FG000|Overall Study|Withdrawal by Subject|1|||
161206830|NCT00569231|582138025|FG000|Overall Study|Car accident injury|1|||
161206831|NCT00569231|582138025|FG000|Overall Study|Non-compliance|2|||
161206832|NCT03456726|582138026|FG000|Overall Study|Disease Progression|6|||
161206833|NCT03456726|582138027|FG001|Overall Study|Disease Progression|1|||
161206834|NCT03456726|582138026|FG000|Overall Study|Adverse Event|4|||
161206835|NCT03456726|582138027|FG001|Overall Study|Adverse Event|2|||
161206836|NCT03456726|582138026|FG000|Overall Study|Withdrawal by Subject|1|||
161206837|NCT03456726|582138027|FG001|Overall Study|Withdrawal by Subject|0|||
161206838|NCT03456726|582138026|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
161206839|NCT03456726|582138027|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
161206840|NCT04470622|582138028|FG000|Overall Study|Withdrawal by Subject|0|||
161206841|NCT04470622|582138029|FG001|Overall Study|Withdrawal by Subject|1|||
161206842|NCT04470622|582138028|FG000|Overall Study|Screen Failure|0|||
161206843|NCT04470622|582138029|FG001|Overall Study|Screen Failure|1|||
161206844|NCT04470622|582138028|FG000|Overall Study|Death|0|||
161206845|NCT04470622|582138029|FG001|Overall Study|Death|1|||
161206846|NCT02576054|582138032|FG000|Overall Study|Withdrawal by Subject|1|||
161206847|NCT03978117|582138033|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
161206848|NCT03978117|582138034|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
161206849|NCT03978117|582138033|FG000|Overall Study|Lost to Follow-up|4|||
161206850|NCT03978117|582138034|FG001|Overall Study|Lost to Follow-up|4|||
161206851|NCT00791154|582138035|FG000|Overall Study|Noncompliance|0|||
161206852|NCT00791154|582138036|FG001|Overall Study|Noncompliance|1|||
161206853|NCT00791154|582138037|FG002|Overall Study|Noncompliance|0|||
161206854|NCT00791154|582138038|FG003|Overall Study|Noncompliance|0|||
161206855|NCT00791154|582138039|FG004|Overall Study|Noncompliance|1|||
161206856|NCT00791154|582138040|FG005|Overall Study|Noncompliance|1|||
161206857|NCT00791154|582138041|FG006|Overall Study|Noncompliance|1|||
161206858|NCT00791154|582138035|FG000|Overall Study|Adverse Event|0|||
161206859|NCT00791154|582138036|FG001|Overall Study|Adverse Event|0|||
161206860|NCT00791154|582138037|FG002|Overall Study|Adverse Event|0|||
161206861|NCT00791154|582138038|FG003|Overall Study|Adverse Event|0|||
161206862|NCT00791154|582138039|FG004|Overall Study|Adverse Event|2|||
161206863|NCT00791154|582138040|FG005|Overall Study|Adverse Event|0|||
161206864|NCT00791154|582138041|FG006|Overall Study|Adverse Event|1|||
161206865|NCT00791154|582138035|FG000|Overall Study|Full Consent withdrawn|1|||
161206866|NCT00791154|582138036|FG001|Overall Study|Full Consent withdrawn|3|||
161206867|NCT00791154|582138037|FG002|Overall Study|Full Consent withdrawn|0|||
161313989|NCT01716520|582532350|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161313990|NCT01716520|582532351|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161313991|NCT01716520|582532352|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161313992|NCT01716520|582532353|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
161313993|NCT01716520|582532348|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161313994|NCT01716520|582532349|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161313995|NCT01716520|582532350|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161313996|NCT01716520|582532351|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161313997|NCT01716520|582532352|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
161313998|NCT01716520|582532353|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
161313999|NCT01716520|582532348|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161314000|NCT01716520|582532349|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161314001|NCT01716520|582532350|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
161314002|NCT01716520|582532351|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161314003|NCT01716520|582532352|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161314004|NCT01716520|582532353|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
161314005|NCT04105010|582532356|FG000|Overall Study|Death|3|||
161314006|NCT04105010|582532357|FG001|Overall Study|Death|1|||
161314007|NCT04105010|582532358|FG002|Overall Study|Death|1|||
161314008|NCT04105010|582532359|FG003|Overall Study|Death|54|||
161314009|NCT04105010|582532356|FG000|Overall Study|Lost to Follow-up|0|||
161314010|NCT04105010|582532357|FG001|Overall Study|Lost to Follow-up|0|||
161314011|NCT04105010|582532358|FG002|Overall Study|Lost to Follow-up|0|||
161314012|NCT04105010|582532359|FG003|Overall Study|Lost to Follow-up|4|||
161314013|NCT04105010|582532356|FG000|Overall Study|Withdrawal by Subject|8|||
161314014|NCT04105010|582532357|FG001|Overall Study|Withdrawal by Subject|1|||
161314015|NCT04105010|582532358|FG002|Overall Study|Withdrawal by Subject|1|||
161314016|NCT04105010|582532359|FG003|Overall Study|Withdrawal by Subject|4|||
161314017|NCT04105010|582532356|FG000|Overall Study|Other reason|4|||
161314018|NCT04105010|582532357|FG001|Overall Study|Other reason|7|||
161314019|NCT04105010|582532358|FG002|Overall Study|Other reason|0|||
161314020|NCT04105010|582532359|FG003|Overall Study|Other reason|19|||
161314021|NCT01211483|582532360|FG000|Phase 1b|Death|6|||
161314022|NCT01211483|582532361|FG001|Phase 1b|Death|0|||
161314023|NCT01211483|582532362|FG002|Phase 1b|Death|0|||
161314024|NCT01211483|582532363|FG003|Phase 1b|Death|0|||
161314025|NCT01211483|582532360|FG000|Phase 1b|Withdrawal by Subject|1|||
161314026|NCT01211483|582532361|FG001|Phase 1b|Withdrawal by Subject|0|||
161314027|NCT01211483|582532362|FG002|Phase 1b|Withdrawal by Subject|0|||
161314028|NCT01211483|582532363|FG003|Phase 1b|Withdrawal by Subject|0|||
161314029|NCT01211483|582532360|FG000|Phase 2|Lost to Follow-up|0|||
161314030|NCT01211483|582532361|FG001|Phase 2|Lost to Follow-up|1|||
161314031|NCT01211483|582532362|FG002|Phase 2|Lost to Follow-up|1|||
161314032|NCT01211483|582532363|FG003|Phase 2|Lost to Follow-up|2|||
161314033|NCT01211483|582532360|FG000|Phase 2|Death|0|||
161314034|NCT01211483|582532361|FG001|Phase 2|Death|64|||
161314035|NCT01211483|582532362|FG002|Phase 2|Death|53|||
161314036|NCT01211483|582532363|FG003|Phase 2|Death|53|||
161314037|NCT01211483|582532360|FG000|Phase 2|Withdrawal by Subject|0|||
161314038|NCT01211483|582532361|FG001|Phase 2|Withdrawal by Subject|1|||
161314039|NCT01211483|582532362|FG002|Phase 2|Withdrawal by Subject|10|||
161314040|NCT01211483|582532363|FG003|Phase 2|Withdrawal by Subject|5|||
161314041|NCT01211483|582532360|FG000|Phase 2|Study terminated by Sponsor|0|||
161314042|NCT01211483|582532361|FG001|Phase 2|Study terminated by Sponsor|6|||
161314043|NCT01211483|582532362|FG002|Phase 2|Study terminated by Sponsor|8|||
161314044|NCT01211483|582532363|FG003|Phase 2|Study terminated by Sponsor|11|||
161314045|NCT01675154|582532364|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161314046|NCT01675154|582532365|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
161314047|NCT01675154|582532366|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161314048|NCT01675154|582532367|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
161314049|NCT02971800|582532370|FG000|Overall Study|Protocol Violation|1|||
161314050|NCT02971800|582532370|FG000|Overall Study|Withdrawal by Subject|1|||
161314051|NCT02971800|582532370|FG000|Overall Study|Exclusion criteria prior intervention|1|||
161314052|NCT02971800|582532370|FG000|Overall Study|Number evaluable participant already reached|4|||
161314053|NCT01149421|582532372|FG000|Overall Study|Adverse Event|22|||
161314054|NCT01149421|582532373|FG001|Overall Study|Adverse Event|6|||
161314055|NCT01149421|582532374|FG002|Overall Study|Adverse Event|11|||
161314056|NCT01149421|582532372|FG000|Overall Study|Withdrawal by Subject|20|||
161314057|NCT01149421|582532373|FG001|Overall Study|Withdrawal by Subject|12|||
161314058|NCT01149421|582532374|FG002|Overall Study|Withdrawal by Subject|13|||
161314059|NCT01149421|582532372|FG000|Overall Study|Sponsor Decision|0|||
161314060|NCT01149421|582532373|FG001|Overall Study|Sponsor Decision|1|||
161314061|NCT01149421|582532374|FG002|Overall Study|Sponsor Decision|1|||
161314062|NCT01149421|582532372|FG000|Overall Study|Lost to Follow-up|2|||
161314063|NCT01149421|582532373|FG001|Overall Study|Lost to Follow-up|4|||
161314064|NCT01149421|582532374|FG002|Overall Study|Lost to Follow-up|5|||
161314065|NCT01149421|582532372|FG000|Overall Study|Physician Decision|5|||
161314066|NCT01149421|582532373|FG001|Overall Study|Physician Decision|3|||
161314067|NCT01149421|582532374|FG002|Overall Study|Physician Decision|6|||
161314068|NCT01149421|582532372|FG000|Overall Study|Entry Criteria Not Met|1|||
161314069|NCT01149421|582532373|FG001|Overall Study|Entry Criteria Not Met|1|||
161314070|NCT01149421|582532374|FG002|Overall Study|Entry Criteria Not Met|2|||
161314071|NCT01149421|582532372|FG000|Overall Study|Protocol Violation|2|||
161314072|NCT01149421|582532373|FG001|Overall Study|Protocol Violation|2|||
161314073|NCT01149421|582532374|FG002|Overall Study|Protocol Violation|6|||
161314074|NCT03738800|582532377|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
161314075|NCT03738800|582532378|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
161314076|NCT03738800|582532379|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
161314077|NCT03738800|582532377|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
161314078|NCT03738800|582532378|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
161314079|NCT03738800|582532379|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
161314080|NCT03738800|582532377|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
161314081|NCT03738800|582532378|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
161314082|NCT03738800|582532379|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
161314083|NCT02223819|582532382|FG000|Overall Study|Lost to Follow-up|2|||
161314084|NCT01917344|582532384|FG000|Overall Study|Withdrawal by Subject|1|||
161314085|NCT03435224|582532385|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
161314086|NCT00367484|582532386|FG000|Overall Study|Adverse Event|7|||
161314087|NCT00367484|582532386|FG000|Overall Study|Withdrew informed consent|5|||
161314088|NCT00367484|582532386|FG000|Overall Study|Travel to USA|1|||
161314089|NCT00367484|582532386|FG000|Overall Study|Lost to Follow-up|1|||
161314090|NCT00367484|582532386|FG000|Overall Study|Protocol Violation|1|||
161314091|NCT00367484|582532386|FG000|Overall Study|The choice of the patient|1|||
161314092|NCT00367484|582532386|FG000|Overall Study|Lack of Efficacy|1|||
161314093|NCT00412217|582532387|FG000|Overall Study|Insufficient Data Available|8|||
161314094|NCT00412217|582532388|FG001|Overall Study|Insufficient Data Available|3|||
161314095|NCT00412217|582532387|FG000|Overall Study|Death|5|||
161314096|NCT00412217|582532388|FG001|Overall Study|Death|4|||
161314097|NCT00412217|582532387|FG000|Overall Study|Disease Progression|2|||
161314098|NCT00412217|582532388|FG001|Overall Study|Disease Progression|3|||
161314099|NCT00412217|582532387|FG000|Overall Study|Investigator Decision|1|||
161314100|NCT00412217|582532388|FG001|Overall Study|Investigator Decision|0|||
161314101|NCT00412217|582532387|FG000|Overall Study|Withdrawal by Subject|2|||
161314102|NCT00412217|582532388|FG001|Overall Study|Withdrawal by Subject|0|||
161314103|NCT00412217|582532387|FG000|Overall Study|Lost to Follow-up|1|||
161314104|NCT00412217|582532388|FG001|Overall Study|Lost to Follow-up|4|||
161314105|NCT00412217|582532387|FG000|Overall Study|Study Terminated by Sponsor|26|||
161314106|NCT00412217|582532388|FG001|Overall Study|Study Terminated by Sponsor|33|||
161314107|NCT00412217|582532387|FG000|Overall Study|Other|1|||
161314108|NCT00412217|582532388|FG001|Overall Study|Other|1|||
161314109|NCT01777295|582532389|FG000|Overall Study|Withdrawal by Subject|2|||
161314110|NCT01777295|582532390|FG001|Overall Study|Withdrawal by Subject|2|||
161314111|NCT01777295|582532389|FG000|Overall Study|Pregnancy|0|||
161314112|NCT01777295|582532390|FG001|Overall Study|Pregnancy|1|||
161314113|NCT01777295|582532389|FG000|Overall Study|Personal problem|1|||
161314114|NCT01777295|582532390|FG001|Overall Study|Personal problem|0|||
161314115|NCT01777295|582532389|FG000|Overall Study|Investigator call for AEs check|1|||
161314116|NCT01777295|582532390|FG001|Overall Study|Investigator call for AEs check|0|||
161314117|NCT02609724|582532391|FG000|Overall Study|Death|2|||
161314118|NCT02609724|582532392|FG001|Overall Study|Death|0|||
161314119|NCT02609724|582532393|FG002|Overall Study|Death|1|||
161314120|NCT02609724|582532391|FG000|Overall Study|Withdrawal by Subject|1|||
161314121|NCT02609724|582532392|FG001|Overall Study|Withdrawal by Subject|2|||
161314122|NCT02609724|582532393|FG002|Overall Study|Withdrawal by Subject|3|||
161314123|NCT02609724|582532391|FG000|Overall Study|Illness|2|||
161314124|NCT02609724|582532392|FG001|Overall Study|Illness|1|||
161314125|NCT02609724|582532393|FG002|Overall Study|Illness|0|||
161314126|NCT04007107|582532398|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161314127|NCT04007107|582532399|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
161314128|NCT04007107|582532400|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161314129|NCT04007107|582532401|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
161314130|NCT00426660|582532407|FG000|Overall Study|Death|14|||
161314131|NCT00426660|582532407|FG000|Overall Study|Adverse Event|23|||
161314132|NCT00426660|582532407|FG000|Overall Study|Insufficient Clinical Response|22|||
161314133|NCT00426660|582532407|FG000|Overall Study|Lost to Follow-up|15|||
161314134|NCT00426660|582532407|FG000|Overall Study|Other|23|||
161314135|NCT00426660|582532407|FG000|Overall Study|Withdrawal by Subject|18|||
161314136|NCT00426660|582532407|FG000|Overall Study|Protocol Violation|1|||
161314137|NCT00426660|582532407|FG000|Overall Study|Enrolled Not Treated|15|||
161314138|NCT00006305|582532408|FG000|Overall Study|Withdrawal by Subject|17|||
161314139|NCT00006305|582532409|FG001|Overall Study|Withdrawal by Subject|10|||
161314140|NCT00006305|582532410|FG002|Overall Study|Withdrawal by Subject|15|||
161314141|NCT00006305|582532411|FG003|Overall Study|Withdrawal by Subject|14|||
161314142|NCT00329641|582532412|FG000|Overall Study|Did not start treatment|1|||
161314143|NCT00329641|582532412|FG000|Overall Study|Not eligible|1|||
161314144|NCT00329641|582532412|FG000|Overall Study|Adverse Event|3|||
161314145|NCT00329641|582532412|FG000|Overall Study|Other reason, not protocol specified|1|||
161314146|NCT00115037|582532413|FG000|Phase1|Lost to Follow-up|16|||
161314147|NCT00115037|582532414|FG001|Phase1|Lost to Follow-up|23|||
161314148|NCT00115037|582532415|FG002|Phase1|Lost to Follow-up|0|||
161314149|NCT00115037|582532416|FG003|Phase1|Lost to Follow-up|0|||
161314150|NCT00115037|582532417|FG004|Phase1|Lost to Follow-up|0|||
161314151|NCT00115037|582532418|FG005|Phase1|Lost to Follow-up|0|||
161314152|NCT00115037|582532413|FG000|Phase1|Withdrawal by Subject|9|||
161314153|NCT00115037|582532414|FG001|Phase1|Withdrawal by Subject|4|||
161314154|NCT00115037|582532415|FG002|Phase1|Withdrawal by Subject|0|||
161314155|NCT00115037|582532416|FG003|Phase1|Withdrawal by Subject|0|||
161091080|NCT04634825|581723797|FG000|Overall Study|Death|10|||
161091081|NCT04634825|581723798|FG001|Overall Study|Death|3|||
161091082|NCT04634825|581723797|FG000|Overall Study|Lost to Follow-up|1|||
161314156|NCT00115037|582532417|FG004|Phase1|Withdrawal by Subject|0|||
161314157|NCT00115037|582532418|FG005|Phase1|Withdrawal by Subject|0|||
161314158|NCT00115037|582532413|FG000|Phase2|Death|0|||
161314159|NCT00115037|582532414|FG001|Phase2|Death|0|||
161314160|NCT00115037|582532415|FG002|Phase2|Death|1|||
161314161|NCT00115037|582532416|FG003|Phase2|Death|0|||
161314162|NCT00115037|582532417|FG004|Phase2|Death|0|||
161314163|NCT00115037|582532418|FG005|Phase2|Death|1|||
161314164|NCT00115037|582532413|FG000|Phase2|Withdrawal by Subject|0|||
161314165|NCT00115037|582532414|FG001|Phase2|Withdrawal by Subject|0|||
161314166|NCT00115037|582532415|FG002|Phase2|Withdrawal by Subject|2|||
161314167|NCT00115037|582532416|FG003|Phase2|Withdrawal by Subject|1|||
161314168|NCT00115037|582532417|FG004|Phase2|Withdrawal by Subject|2|||
161314169|NCT00115037|582532418|FG005|Phase2|Withdrawal by Subject|1|||
161314170|NCT00115037|582532413|FG000|Phase2|Lost to Follow-up|0|||
161314171|NCT00115037|582532414|FG001|Phase2|Lost to Follow-up|0|||
161314172|NCT00115037|582532415|FG002|Phase2|Lost to Follow-up|12|||
161314173|NCT00115037|582532416|FG003|Phase2|Lost to Follow-up|14|||
161314174|NCT00115037|582532417|FG004|Phase2|Lost to Follow-up|4|||
161314175|NCT00115037|582532418|FG005|Phase2|Lost to Follow-up|10|||
161314176|NCT01398410|582532419|FG000|Overall Study|Adverse Event|12|||
161314177|NCT01398410|582532420|FG001|Overall Study|Adverse Event|16|||
161314178|NCT01398410|582532419|FG000|Overall Study|Participants Choice|8|||
161314179|NCT01398410|582532420|FG001|Overall Study|Participants Choice|11|||
161314180|NCT01398410|582532419|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
161314181|NCT01398410|582532420|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
161314182|NCT01398410|582532419|FG000|Overall Study|Other|36|||
161314183|NCT01398410|582532420|FG001|Overall Study|Other|29|||
161314184|NCT02470403|582532421|FG000|Overall Study|Adverse Event|1|||
161314185|NCT02470403|582532422|FG001|Overall Study|Adverse Event|0|||
161314186|NCT02470403|582532423|FG002|Overall Study|Adverse Event|0|||
161314187|NCT02470403|582532424|FG003|Overall Study|Adverse Event|0|||
161314188|NCT02470403|582532425|FG004|Overall Study|Adverse Event|0|||
161314189|NCT02470403|582532421|FG000|Overall Study|Lost to Follow-up|0|||
161314190|NCT02470403|582532422|FG001|Overall Study|Lost to Follow-up|1|||
161314191|NCT02470403|582532423|FG002|Overall Study|Lost to Follow-up|0|||
161314192|NCT02470403|582532424|FG003|Overall Study|Lost to Follow-up|0|||
161314193|NCT02470403|582532425|FG004|Overall Study|Lost to Follow-up|0|||
161314194|NCT02470403|582532421|FG000|Overall Study|Subject/guardian decision|1|||
161314195|NCT02470403|582532422|FG001|Overall Study|Subject/guardian decision|0|||
161314196|NCT02470403|582532423|FG002|Overall Study|Subject/guardian decision|0|||
161314197|NCT02470403|582532424|FG003|Overall Study|Subject/guardian decision|4|||
161314198|NCT02470403|582532425|FG004|Overall Study|Subject/guardian decision|0|||
161314199|NCT02631070|582532426|FG000|Overall Study|Withdrawal by Subject|35|||
161314200|NCT02631070|582532427|FG001|Overall Study|Withdrawal by Subject|13|||
161091083|NCT04634825|581723798|FG001|Overall Study|Lost to Follow-up|0|||
161314201|NCT02631070|582532426|FG000|Overall Study|Death|45|||
161314202|NCT02631070|582532427|FG001|Overall Study|Death|24|||
161314203|NCT02631070|582532426|FG000|Overall Study|Lost to Follow-up|5|||
161314204|NCT02631070|582532427|FG001|Overall Study|Lost to Follow-up|1|||
161314205|NCT02631070|582532426|FG000|Overall Study|Transition to rollover protocol|52|||
161314206|NCT02631070|582532427|FG001|Overall Study|Transition to rollover protocol|21|||
161314207|NCT02631070|582532426|FG000|Overall Study|Other reasons|12|||
161314208|NCT02631070|582532427|FG001|Overall Study|Other reasons|5|||
161314209|NCT03515629|582532428|FG000|Overall Study|Death|0|||
161314210|NCT03515629|582532429|FG001|Overall Study|Death|1|||
161314211|NCT03515629|582532430|FG002|Overall Study|Death|1|||
161314212|NCT03515629|582532428|FG000|Overall Study|Progressive disease|0|||
161314213|NCT03515629|582532429|FG001|Overall Study|Progressive disease|1|||
161314214|NCT03515629|582532430|FG002|Overall Study|Progressive disease|0|||
161314215|NCT01522235|582532431|FG000|Overall Study|Physician Decision|1|||
161314216|NCT01522235|582532432|FG001|Overall Study|Physician Decision|1|||
161314217|NCT03597022|582532435|FG000|Overall Study|Premature termination of the study|7|||
161314218|NCT03597022|582532436|FG001|Overall Study|Premature termination of the study|7|||
161314219|NCT03597022|582532437|FG002|Overall Study|Premature termination of the study|8|||
161314220|NCT03597022|582532435|FG000|Overall Study|Serious adverse event|1|||
161314221|NCT03597022|582532436|FG001|Overall Study|Serious adverse event|1|||
161314222|NCT03597022|582532437|FG002|Overall Study|Serious adverse event|0|||
161314223|NCT05385224|582532438|FG000|Overall Study|Unable to swallow capsule|2|||
161314224|NCT05385224|582532438|FG000|Overall Study|Withdrawal by Subject|2|||
161314225|NCT05385224|582532438|FG000|Overall Study|Did not meet study criteria|1|||
161314226|NCT01430624|582532439|FG000|Overall Study|Lost to Follow-up|23|||
161314227|NCT01430624|582532440|FG001|Overall Study|Lost to Follow-up|29|||
161314228|NCT01430624|582532441|FG002|Overall Study|Lost to Follow-up|27|||
161314229|NCT01430624|582532439|FG000|Overall Study|technical or eligibility|5|||
161314230|NCT01430624|582532440|FG001|Overall Study|technical or eligibility|5|||
161314231|NCT01430624|582532441|FG002|Overall Study|technical or eligibility|2|||
161314232|NCT00401960|582532446|FG000|Overall Study|Lost to Follow-up|3|||
161314233|NCT00401960|582532447|FG001|Overall Study|Lost to Follow-up|0|||
161314234|NCT00401960|582532446|FG000|Overall Study|Death|2|||
161314235|NCT00401960|582532447|FG001|Overall Study|Death|0|||
161314236|NCT01096589|582532453|FG000|Overall Study|Adverse Event|2|||
161314237|NCT01096589|582532454|FG001|Overall Study|Adverse Event|1|||
161314238|NCT01096589|582532455|FG002|Overall Study|Adverse Event|2|||
161314239|NCT01096589|582532456|FG003|Overall Study|Adverse Event|1|||
161314240|NCT01096589|582532453|FG000|Overall Study|Withdrawal by Subject|2|||
161314241|NCT01096589|582532454|FG001|Overall Study|Withdrawal by Subject|1|||
161314242|NCT01096589|582532455|FG002|Overall Study|Withdrawal by Subject|1|||
161314243|NCT01096589|582532456|FG003|Overall Study|Withdrawal by Subject|1|||
161314244|NCT01096589|582532453|FG000|Overall Study|Compliance with protocol|0|||
161314245|NCT01096589|582532454|FG001|Overall Study|Compliance with protocol|0|||
161314246|NCT01096589|582532455|FG002|Overall Study|Compliance with protocol|1|||
161314247|NCT01096589|582532456|FG003|Overall Study|Compliance with protocol|0|||
161314248|NCT01096589|582532453|FG000|Overall Study|found treatment exhausting|0|||
161314249|NCT01096589|582532454|FG001|Overall Study|found treatment exhausting|0|||
161314250|NCT01096589|582532455|FG002|Overall Study|found treatment exhausting|0|||
161314251|NCT01096589|582532456|FG003|Overall Study|found treatment exhausting|1|||
161314252|NCT00948506|582532457|FG000|Overall Study|Withdrawal by Subject|3|||
161314253|NCT00948506|582532458|FG001|Overall Study|Withdrawal by Subject|1|||
161314254|NCT03233204|582532460|FG000|Overall Study|Adverse Event|1|||
161314255|NCT03233204|582532460|FG000|Overall Study|Death|1|||
161314256|NCT03233204|582532460|FG000|Overall Study|Withdrawal by Subject|1|||
161314257|NCT03233204|582532460|FG000|Overall Study|Progressive Disease|3|||
161314258|NCT02680834|582532462|FG000|Overall Study|Physician Decision|5|||
161314259|NCT02680834|582532463|FG001|Overall Study|Physician Decision|2|||
161314260|NCT02680834|582532462|FG000|Overall Study|Withdrawal by Subject|6|||
161314261|NCT02680834|582532463|FG001|Overall Study|Withdrawal by Subject|0|||
161314262|NCT02680834|582532462|FG000|Overall Study|Lost to Follow-up|0|||
161314263|NCT02680834|582532463|FG001|Overall Study|Lost to Follow-up|1|||
161314264|NCT02520427|582532464|FG000|Overall Study|Decision by sponsor|0|||
161314265|NCT02520427|582532465|FG001|Overall Study|Decision by sponsor|0|||
161314266|NCT02520427|582532466|FG002|Overall Study|Decision by sponsor|0|||
161314267|NCT02520427|582532467|FG003|Overall Study|Decision by sponsor|0|||
161314268|NCT02520427|582532468|FG004|Overall Study|Decision by sponsor|0|||
161314269|NCT02520427|582532469|FG005|Overall Study|Decision by sponsor|0|||
161314270|NCT02520427|582532470|FG006|Overall Study|Decision by sponsor|0|||
161314271|NCT02520427|582532471|FG007|Overall Study|Decision by sponsor|0|||
161314272|NCT02520427|582532472|FG008|Overall Study|Decision by sponsor|1|||
161314273|NCT02520427|582532473|FG009|Overall Study|Decision by sponsor|1|||
161314274|NCT02520427|582532474|FG010|Overall Study|Decision by sponsor|0|||
161314275|NCT02520427|582532475|FG011|Overall Study|Decision by sponsor|0|||
161314276|NCT02520427|582532476|FG012|Overall Study|Decision by sponsor|0|||
161314277|NCT02520427|582532477|FG013|Overall Study|Decision by sponsor|0|||
161314278|NCT02520427|582532478|FG014|Overall Study|Decision by sponsor|0|||
161314279|NCT02520427|582532479|FG015|Overall Study|Decision by sponsor|0|||
161314280|NCT02520427|582532480|FG016|Overall Study|Decision by sponsor|0|||
161314281|NCT02520427|582532481|FG017|Overall Study|Decision by sponsor|0|||
161314282|NCT02520427|582532482|FG018|Overall Study|Decision by sponsor|0|||
161314283|NCT02520427|582532483|FG019|Overall Study|Decision by sponsor|0|||
161314284|NCT02520427|582532484|FG020|Overall Study|Decision by sponsor|0|||
161314285|NCT02520427|582532485|FG021|Overall Study|Decision by sponsor|0|||
161314286|NCT02520427|582532486|FG022|Overall Study|Decision by sponsor|0|||
161314287|NCT02520427|582532487|FG023|Overall Study|Decision by sponsor|0|||
161314288|NCT02520427|582532488|FG024|Overall Study|Decision by sponsor|0|||
161314289|NCT02520427|582532489|FG025|Overall Study|Decision by sponsor|0|||
161314290|NCT02520427|582532464|FG000|Overall Study|Withdrawal by Subject|0|||
161314291|NCT02520427|582532465|FG001|Overall Study|Withdrawal by Subject|0|||
161314292|NCT02520427|582532466|FG002|Overall Study|Withdrawal by Subject|1|||
161314293|NCT02520427|582532467|FG003|Overall Study|Withdrawal by Subject|0|||
161314294|NCT02520427|582532468|FG004|Overall Study|Withdrawal by Subject|0|||
161314295|NCT02520427|582532469|FG005|Overall Study|Withdrawal by Subject|0|||
161314296|NCT02520427|582532470|FG006|Overall Study|Withdrawal by Subject|0|||
161314297|NCT02520427|582532471|FG007|Overall Study|Withdrawal by Subject|0|||
161314298|NCT02520427|582532472|FG008|Overall Study|Withdrawal by Subject|0|||
161314299|NCT02520427|582532473|FG009|Overall Study|Withdrawal by Subject|0|||
161314300|NCT02520427|582532474|FG010|Overall Study|Withdrawal by Subject|0|||
161314301|NCT02520427|582532475|FG011|Overall Study|Withdrawal by Subject|0|||
161314302|NCT02520427|582532476|FG012|Overall Study|Withdrawal by Subject|1|||
161314303|NCT02520427|582532477|FG013|Overall Study|Withdrawal by Subject|1|||
161314304|NCT02520427|582532478|FG014|Overall Study|Withdrawal by Subject|1|||
161314305|NCT02520427|582532479|FG015|Overall Study|Withdrawal by Subject|0|||
161314306|NCT02520427|582532480|FG016|Overall Study|Withdrawal by Subject|1|||
161314307|NCT02520427|582532481|FG017|Overall Study|Withdrawal by Subject|0|||
161314308|NCT02520427|582532482|FG018|Overall Study|Withdrawal by Subject|0|||
161314309|NCT02520427|582532483|FG019|Overall Study|Withdrawal by Subject|3|||
161314310|NCT02520427|582532484|FG020|Overall Study|Withdrawal by Subject|2|||
161314311|NCT02520427|582532485|FG021|Overall Study|Withdrawal by Subject|0|||
161314312|NCT02520427|582532486|FG022|Overall Study|Withdrawal by Subject|0|||
161314313|NCT02520427|582532487|FG023|Overall Study|Withdrawal by Subject|0|||
161314314|NCT02520427|582532488|FG024|Overall Study|Withdrawal by Subject|0|||
161314315|NCT02520427|582532489|FG025|Overall Study|Withdrawal by Subject|0|||
161314316|NCT02520427|582532464|FG000|Overall Study|Death|1|||
161314317|NCT02520427|582532465|FG001|Overall Study|Death|0|||
161314318|NCT02520427|582532466|FG002|Overall Study|Death|0|||
161314319|NCT02520427|582532467|FG003|Overall Study|Death|0|||
161314320|NCT02520427|582532468|FG004|Overall Study|Death|0|||
161314321|NCT02520427|582532469|FG005|Overall Study|Death|0|||
161314322|NCT02520427|582532470|FG006|Overall Study|Death|0|||
161314323|NCT02520427|582532471|FG007|Overall Study|Death|0|||
161314324|NCT02520427|582532472|FG008|Overall Study|Death|0|||
161314325|NCT02520427|582532473|FG009|Overall Study|Death|0|||
161314326|NCT02520427|582532474|FG010|Overall Study|Death|0|||
161314327|NCT02520427|582532475|FG011|Overall Study|Death|0|||
161314328|NCT02520427|582532476|FG012|Overall Study|Death|0|||
161314329|NCT02520427|582532477|FG013|Overall Study|Death|0|||
161314330|NCT02520427|582532478|FG014|Overall Study|Death|0|||
161314331|NCT02520427|582532479|FG015|Overall Study|Death|0|||
161314332|NCT02520427|582532480|FG016|Overall Study|Death|2|||
161314333|NCT02520427|582532481|FG017|Overall Study|Death|1|||
161314334|NCT02520427|582532482|FG018|Overall Study|Death|3|||
161314335|NCT02520427|582532483|FG019|Overall Study|Death|2|||
161314336|NCT02520427|582532484|FG020|Overall Study|Death|0|||
161314337|NCT02520427|582532485|FG021|Overall Study|Death|0|||
161314338|NCT02520427|582532486|FG022|Overall Study|Death|1|||
161314339|NCT02520427|582532487|FG023|Overall Study|Death|0|||
161314340|NCT02520427|582532488|FG024|Overall Study|Death|1|||
161314341|NCT02520427|582532489|FG025|Overall Study|Death|0|||
161314342|NCT00793624|582532490|FG000|Overall Study|Adverse Event|18|||
161314343|NCT00793624|582532491|FG001|Overall Study|Adverse Event|16|||
161314344|NCT00793624|582532492|FG002|Overall Study|Adverse Event|15|||
161314345|NCT00793624|582532493|FG003|Overall Study|Adverse Event|20|||
161314346|NCT00793624|582532490|FG000|Overall Study|Lost to Follow-up|2|||
161314347|NCT00793624|582532491|FG001|Overall Study|Lost to Follow-up|2|||
161314348|NCT00793624|582532492|FG002|Overall Study|Lost to Follow-up|4|||
161314349|NCT00793624|582532493|FG003|Overall Study|Lost to Follow-up|0|||
161314350|NCT00793624|582532490|FG000|Overall Study|Withdrawal by Subject|20|||
161314351|NCT00793624|582532491|FG001|Overall Study|Withdrawal by Subject|9|||
161314352|NCT00793624|582532492|FG002|Overall Study|Withdrawal by Subject|11|||
161314353|NCT00793624|582532493|FG003|Overall Study|Withdrawal by Subject|14|||
161314354|NCT00793624|582532490|FG000|Overall Study|Lack of Efficacy|9|||
161314355|NCT00793624|582532491|FG001|Overall Study|Lack of Efficacy|2|||
161314356|NCT00793624|582532492|FG002|Overall Study|Lack of Efficacy|1|||
161314357|NCT00793624|582532493|FG003|Overall Study|Lack of Efficacy|3|||
161314358|NCT00793624|582532490|FG000|Overall Study|Non compliance with protocol|2|||
161314359|NCT00793624|582532491|FG001|Overall Study|Non compliance with protocol|3|||
161314360|NCT00793624|582532492|FG002|Overall Study|Non compliance with protocol|2|||
161314361|NCT00793624|582532493|FG003|Overall Study|Non compliance with protocol|3|||
161314362|NCT00793624|582532490|FG000|Overall Study|Other reason not described above|6|||
161314363|NCT00793624|582532491|FG001|Overall Study|Other reason not described above|4|||
161314364|NCT00793624|582532492|FG002|Overall Study|Other reason not described above|6|||
161314365|NCT00793624|582532493|FG003|Overall Study|Other reason not described above|3|||
161314366|NCT00157248|582532494|FG000|Overall Study|Adverse Event|36|||
161314367|NCT00157248|582532495|FG001|Overall Study|Adverse Event|25|||
161314368|NCT00157248|582532496|FG002|Overall Study|Adverse Event|13|||
161314369|NCT00157248|582532497|FG003|Overall Study|Adverse Event|33|||
161314370|NCT00157248|582532494|FG000|Overall Study|Protocol Violation|4|||
161314371|NCT00157248|582532495|FG001|Overall Study|Protocol Violation|0|||
161314372|NCT00157248|582532496|FG002|Overall Study|Protocol Violation|2|||
161314373|NCT00157248|582532497|FG003|Overall Study|Protocol Violation|2|||
161314374|NCT00157248|582532494|FG000|Overall Study|Lost to Follow-up|0|||
161314375|NCT00157248|582532495|FG001|Overall Study|Lost to Follow-up|1|||
161314376|NCT00157248|582532496|FG002|Overall Study|Lost to Follow-up|0|||
161314377|NCT00157248|582532497|FG003|Overall Study|Lost to Follow-up|0|||
161314378|NCT00157248|582532494|FG000|Overall Study|Withdrawal by Subject|1|||
161314379|NCT00157248|582532495|FG001|Overall Study|Withdrawal by Subject|4|||
161314380|NCT00157248|582532496|FG002|Overall Study|Withdrawal by Subject|3|||
161314381|NCT00157248|582532497|FG003|Overall Study|Withdrawal by Subject|3|||
161314382|NCT00157248|582532494|FG000|Overall Study|site closures, subject moving|7|||
161314383|NCT00157248|582532495|FG001|Overall Study|site closures, subject moving|7|||
161314384|NCT00157248|582532496|FG002|Overall Study|site closures, subject moving|3|||
161314385|NCT00157248|582532497|FG003|Overall Study|site closures, subject moving|9|||
161314386|NCT00232596|582532498|FG000|6-Week Titration Phase|Adverse Event|6|||
161314387|NCT00232596|582532499|FG001|6-Week Titration Phase|Adverse Event|19|||
161314388|NCT00232596|582532498|FG000|6-Week Titration Phase|Failed to Return|2|||
161314389|NCT00232596|582532499|FG001|6-Week Titration Phase|Failed to Return|1|||
161314390|NCT00232596|582532498|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
161314391|NCT00232596|582532499|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
161314392|NCT00232596|582532498|FG000|6-Week Titration Phase|Protocol Violation|1|||
161314393|NCT00232596|582532499|FG001|6-Week Titration Phase|Protocol Violation|3|||
161314394|NCT00232596|582532498|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
161314395|NCT00232596|582532499|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
161314396|NCT00232596|582532498|FG000|6-Week Titration Phase|Other|3|||
161314397|NCT00232596|582532499|FG001|6-Week Titration Phase|Other|3|||
161314398|NCT00232596|582532498|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
161314399|NCT00232596|582532499|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
161314400|NCT00232596|582532498|FG000|12-Week Maintenance Phase|Adverse Event|7|||
161314401|NCT00232596|582532499|FG001|12-Week Maintenance Phase|Adverse Event|22|||
161314402|NCT00232596|582532498|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
161314403|NCT00232596|582532499|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
161314404|NCT00232596|582532498|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
161314405|NCT00232596|582532499|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
161314406|NCT00232596|582532498|FG000|12-Week Maintenance Phase|Other|1|||
161314407|NCT00232596|582532499|FG001|12-Week Maintenance Phase|Other|3|||
161314408|NCT01712334|582532500|FG000|Treatment Period 1|Randomized in Error|0|||
161314409|NCT01712334|582532501|FG001|Treatment Period 1|Randomized in Error|2|||
161314410|NCT03467763|582532504|FG000|Overall Study|Lost to Follow-up|1|||
161314411|NCT03467763|582532504|FG000|Overall Study|Protocol Violation|2|||
161314412|NCT01447927|582532505|FG000|Overall Study|Adverse Event|4|||
161314413|NCT01447927|582532506|FG001|Overall Study|Adverse Event|3|||
161314414|NCT01447927|582532505|FG000|Overall Study|Withdrawal by Subject|1|||
161314415|NCT01447927|582532506|FG001|Overall Study|Withdrawal by Subject|0|||
161314416|NCT02073565|582532507|FG000|Cohort A|Withdrawal by Subject|1|||
161314417|NCT02073565|582532508|FG001|Cohort A|Withdrawal by Subject|0|||
161314418|NCT02073565|582532507|FG000|Cohort B|Withdrawal by Subject|1|||
161314419|NCT02073565|582532508|FG001|Cohort B|Withdrawal by Subject|2|||
161314420|NCT02073565|582532507|FG000|Cohort C|Withdrawal by Subject|0|||
161314421|NCT02073565|582532508|FG001|Cohort C|Withdrawal by Subject|2|||
161314422|NCT02073565|582532507|FG000|Cohort C|Lost to Follow-up|0|||
161314423|NCT02073565|582532508|FG001|Cohort C|Lost to Follow-up|2|||
161314424|NCT04102865|582532509|FG000|Overall Study|Adverse Event|4|||
161314425|NCT04102865|582532510|FG001|Overall Study|Adverse Event|0|||
161314426|NCT04102865|582532509|FG000|Overall Study|Lost to Follow-up|1|||
161314427|NCT04102865|582532510|FG001|Overall Study|Lost to Follow-up|0|||
161314428|NCT04102865|582532509|FG000|Overall Study|Withdrawal by Subject|2|||
161314429|NCT04102865|582532510|FG001|Overall Study|Withdrawal by Subject|0|||
161314430|NCT01764997|582532515|FG000|Run-in Period|Adverse Event|15|||
161314431|NCT01764997|582532516|FG001|Run-in Period|Adverse Event|0|||
161314432|NCT01764997|582532517|FG002|Run-in Period|Adverse Event|0|||
161314433|NCT01764997|582532518|FG003|Run-in Period|Adverse Event|0|||
161314434|NCT01764997|582532519|FG004|Run-in Period|Adverse Event|0|||
161314435|NCT01764997|582532515|FG000|Run-in Period|Lack of Efficacy|5|||
161314436|NCT01764997|582532516|FG001|Run-in Period|Lack of Efficacy|0|||
161314437|NCT01764997|582532517|FG002|Run-in Period|Lack of Efficacy|0|||
161314438|NCT01764997|582532518|FG003|Run-in Period|Lack of Efficacy|0|||
161314439|NCT01764997|582532519|FG004|Run-in Period|Lack of Efficacy|0|||
161314440|NCT01764997|582532515|FG000|Run-in Period|Poor compliance to protocol|1|||
161314441|NCT01764997|582532516|FG001|Run-in Period|Poor compliance to protocol|0|||
161314442|NCT01764997|582532517|FG002|Run-in Period|Poor compliance to protocol|0|||
161314443|NCT01764997|582532518|FG003|Run-in Period|Poor compliance to protocol|0|||
161314444|NCT01764997|582532519|FG004|Run-in Period|Poor compliance to protocol|0|||
161314445|NCT01764997|582532515|FG000|Run-in Period|Other than specified above|17|||
161314446|NCT01764997|582532516|FG001|Run-in Period|Other than specified above|0|||
161314447|NCT01764997|582532517|FG002|Run-in Period|Other than specified above|0|||
161314448|NCT01764997|582532518|FG003|Run-in Period|Other than specified above|0|||
161314449|NCT01764997|582532519|FG004|Run-in Period|Other than specified above|0|||
161314450|NCT01764997|582532515|FG000|Study Drug Treatment Period|Adverse Event|0|||
161314451|NCT01764997|582532516|FG001|Study Drug Treatment Period|Adverse Event|1|||
161314452|NCT01764997|582532517|FG002|Study Drug Treatment Period|Adverse Event|0|||
161314453|NCT01764997|582532518|FG003|Study Drug Treatment Period|Adverse Event|0|||
161314454|NCT01764997|582532519|FG004|Study Drug Treatment Period|Adverse Event|24|||
161314455|NCT01764997|582532515|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
161314456|NCT01764997|582532516|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
161314457|NCT01764997|582532517|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
161314458|NCT01764997|582532518|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
161314459|NCT01764997|582532519|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
161314460|NCT01764997|582532515|FG000|Study Drug Treatment Period|Other than specified above|0|||
161314461|NCT01764997|582532516|FG001|Study Drug Treatment Period|Other than specified above|0|||
161314462|NCT01764997|582532517|FG002|Study Drug Treatment Period|Other than specified above|0|||
161314463|NCT01764997|582532518|FG003|Study Drug Treatment Period|Other than specified above|0|||
161314464|NCT01764997|582532519|FG004|Study Drug Treatment Period|Other than specified above|10|||
161314465|NCT02913105|582534647|FG000|Overall Study|Adverse Event|11|||
161314466|NCT02913105|582534648|FG001|Overall Study|Adverse Event|0|||
161314467|NCT02913105|582534649|FG002|Overall Study|Adverse Event|4|||
161314468|NCT02913105|582534647|FG000|Overall Study|Non-Compliance With Study Drug|0|||
161314469|NCT02913105|582534648|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161314470|NCT02913105|582534649|FG002|Overall Study|Non-Compliance With Study Drug|1|||
161314471|NCT02913105|582534647|FG000|Overall Study|Reason Not Specified|3|||
161314472|NCT02913105|582534648|FG001|Overall Study|Reason Not Specified|1|||
161314473|NCT02913105|582534649|FG002|Overall Study|Reason Not Specified|1|||
161314474|NCT02913105|582534647|FG000|Overall Study|Physician Decision|1|||
161314475|NCT02913105|582534648|FG001|Overall Study|Physician Decision|1|||
161314476|NCT02913105|582534649|FG002|Overall Study|Physician Decision|0|||
161314477|NCT02913105|582534647|FG000|Overall Study|Withdrawal by Subject|0|||
161314478|NCT02913105|582534648|FG001|Overall Study|Withdrawal by Subject|3|||
161314479|NCT02913105|582534649|FG002|Overall Study|Withdrawal by Subject|1|||
161314480|NCT02168777|582534650|FG000|Overall Study|Withdrawal by Subject|1|||
161314481|NCT02168777|582534651|FG001|Overall Study|Withdrawal by Subject|0|||
161314482|NCT02168777|582534652|FG002|Overall Study|Withdrawal by Subject|2|||
161314483|NCT02168777|582534650|FG000|Overall Study|Adverse Event|1|||
161314484|NCT02168777|582534651|FG001|Overall Study|Adverse Event|0|||
161314485|NCT02168777|582534652|FG002|Overall Study|Adverse Event|1|||
161314486|NCT02168777|582534650|FG000|Overall Study|Disease recurrence|0|||
161314487|NCT02168777|582534651|FG001|Overall Study|Disease recurrence|0|||
161314488|NCT02168777|582534652|FG002|Overall Study|Disease recurrence|1|||
161314489|NCT02168777|582534650|FG000|Overall Study|Radiological disease progression|0|||
161314490|NCT02168777|582534651|FG001|Overall Study|Radiological disease progression|5|||
161314491|NCT02168777|582534652|FG002|Overall Study|Radiological disease progression|5|||
161314492|NCT02168777|582534650|FG000|Overall Study|Clinical disease progression|0|||
161314493|NCT02168777|582534651|FG001|Overall Study|Clinical disease progression|1|||
161314494|NCT02168777|582534652|FG002|Overall Study|Clinical disease progression|2|||
161314495|NCT02168777|582534650|FG000|Overall Study|Other reason|0|||
161314496|NCT02168777|582534651|FG001|Overall Study|Other reason|1|||
161314497|NCT02168777|582534652|FG002|Overall Study|Other reason|0|||
161314498|NCT05243563|582534653|FG000|Overall Study|Withdrawal by Subject|1|||
161314499|NCT05243563|582534654|FG001|Overall Study|Withdrawal by Subject|0|||
161314500|NCT05243563|582534653|FG000|Overall Study|Physician Decision|1|||
161314501|NCT05243563|582534654|FG001|Overall Study|Physician Decision|0|||
161314502|NCT00441363|582534655|FG000|Overall Study|Adverse Event|4|||
161314503|NCT00441363|582534656|FG001|Overall Study|Adverse Event|2|||
161314504|NCT00441363|582534655|FG000|Overall Study|Withdrawal by Subject|3|||
161314505|NCT00441363|582534656|FG001|Overall Study|Withdrawal by Subject|4|||
161314506|NCT00441363|582534655|FG000|Overall Study|Physician Decision|6|||
161314507|NCT00441363|582534656|FG001|Overall Study|Physician Decision|7|||
161314508|NCT00441363|582534655|FG000|Overall Study|Lost to Follow-up|2|||
161314509|NCT00441363|582534656|FG001|Overall Study|Lost to Follow-up|2|||
161314510|NCT00441363|582534655|FG000|Overall Study|Other|2|||
161314511|NCT00441363|582534656|FG001|Overall Study|Other|0|||
161314512|NCT02437188|582534659|FG000|Overall Study|Randomized but did not receive surgery|4|||
161314513|NCT02437188|582534660|FG001|Overall Study|Randomized but did not receive surgery|8|||
161314514|NCT02437188|582534659|FG000|Overall Study|Adverse Event|0|||
161314515|NCT02437188|582534660|FG001|Overall Study|Adverse Event|1|||
161314516|NCT01663857|582534661|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
161314517|NCT01663857|582534662|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
161314518|NCT01663857|582534663|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
161314519|NCT01663857|582534664|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
161314520|NCT01663857|582534661|FG000|Overall Study|Lost to Follow-up|0|||
161314521|NCT01663857|582534662|FG001|Overall Study|Lost to Follow-up|0|||
161314522|NCT01663857|582534663|FG002|Overall Study|Lost to Follow-up|3|||
161314523|NCT01663857|582534664|FG003|Overall Study|Lost to Follow-up|1|||
161314524|NCT01172808|582534667|FG000|Overall Study|Adverse Event|8|||
161314525|NCT01172808|582534668|FG001|Overall Study|Adverse Event|4|||
161314526|NCT01172808|582534669|FG002|Overall Study|Adverse Event|8|||
161314527|NCT01172808|582534670|FG003|Overall Study|Adverse Event|3|||
161314528|NCT01172808|582534667|FG000|Overall Study|Lack of Efficacy|1|||
161314529|NCT01172808|582534668|FG001|Overall Study|Lack of Efficacy|0|||
161314530|NCT01172808|582534669|FG002|Overall Study|Lack of Efficacy|0|||
161314531|NCT01172808|582534670|FG003|Overall Study|Lack of Efficacy|0|||
161314532|NCT01172808|582534667|FG000|Overall Study|Protocol Violation|2|||
161314533|NCT01172808|582534668|FG001|Overall Study|Protocol Violation|2|||
161314534|NCT01172808|582534669|FG002|Overall Study|Protocol Violation|2|||
161314535|NCT01172808|582534670|FG003|Overall Study|Protocol Violation|0|||
161314536|NCT01172808|582534667|FG000|Overall Study|Lost to Follow-up|0|||
161314537|NCT01172808|582534668|FG001|Overall Study|Lost to Follow-up|1|||
161314538|NCT01172808|582534669|FG002|Overall Study|Lost to Follow-up|1|||
161314539|NCT01172808|582534670|FG003|Overall Study|Lost to Follow-up|3|||
161314540|NCT01172808|582534667|FG000|Overall Study|Withdrawal by Subject|4|||
161314541|NCT01172808|582534668|FG001|Overall Study|Withdrawal by Subject|1|||
161314542|NCT01172808|582534669|FG002|Overall Study|Withdrawal by Subject|3|||
161314543|NCT01172808|582534670|FG003|Overall Study|Withdrawal by Subject|2|||
161314544|NCT01172808|582534667|FG000|Overall Study|Other|6|||
161314545|NCT01172808|582534668|FG001|Overall Study|Other|5|||
161314546|NCT01172808|582534669|FG002|Overall Study|Other|9|||
161314547|NCT01172808|582534670|FG003|Overall Study|Other|7|||
161314548|NCT02578940|582534677|FG000|Overall Study|Screening failure|5|||
161314549|NCT02578940|582534677|FG000|Overall Study|Lost to Follow-up|1|||
161314550|NCT01911793|582534678|FG000|Overall Study|Physician Decision|1|||
161314551|NCT01911793|582534679|FG001|Overall Study|Physician Decision|5|||
161314552|NCT03959488|582534686|FG000|Season 1|Other|6|||
161314553|NCT03959488|582534687|FG001|Season 1|Other|7|||
161314554|NCT03959488|582534688|FG002|Season 1|Other|0|||
161314555|NCT03959488|582534689|FG003|Season 1|Other|0|||
161314556|NCT03959488|582534690|FG004|Season 1|Other|0|||
161314557|NCT03959488|582534686|FG000|Season 1|Withdrawal by parent/guardian|43|||
161314558|NCT03959488|582534687|FG001|Season 1|Withdrawal by parent/guardian|28|||
161314559|NCT03959488|582534688|FG002|Season 1|Withdrawal by parent/guardian|0|||
161314560|NCT03959488|582534689|FG003|Season 1|Withdrawal by parent/guardian|0|||
161314561|NCT03959488|582534690|FG004|Season 1|Withdrawal by parent/guardian|0|||
161314562|NCT03959488|582534686|FG000|Season 1|Due to COVID-19 pandemic|2|||
161314563|NCT03959488|582534687|FG001|Season 1|Due to COVID-19 pandemic|3|||
161314564|NCT03959488|582534688|FG002|Season 1|Due to COVID-19 pandemic|0|||
161314565|NCT03959488|582534689|FG003|Season 1|Due to COVID-19 pandemic|0|||
161314566|NCT03959488|582534690|FG004|Season 1|Due to COVID-19 pandemic|0|||
161314567|NCT03959488|582534686|FG000|Season 1|Lost to Follow-up|17|||
161314568|NCT03959488|582534687|FG001|Season 1|Lost to Follow-up|7|||
161314569|NCT03959488|582534688|FG002|Season 1|Lost to Follow-up|0|||
161314570|NCT03959488|582534689|FG003|Season 1|Lost to Follow-up|0|||
161314571|NCT03959488|582534690|FG004|Season 1|Lost to Follow-up|0|||
161314572|NCT03959488|582534686|FG000|Season 1|Death|5|||
161314573|NCT03959488|582534687|FG001|Season 1|Death|1|||
161314574|NCT03959488|582534688|FG002|Season 1|Death|0|||
161314575|NCT03959488|582534689|FG003|Season 1|Death|0|||
161314576|NCT03959488|582534690|FG004|Season 1|Death|0|||
161314577|NCT03959488|582534686|FG000|Season 2|Other|0|||
161314578|NCT03959488|582534687|FG001|Season 2|Other|0|||
161314579|NCT03959488|582534688|FG002|Season 2|Other|2|||
161314580|NCT03959488|582534689|FG003|Season 2|Other|0|||
161314581|NCT03959488|582534690|FG004|Season 2|Other|0|||
161314582|NCT03959488|582534686|FG000|Season 2|Withdrawal by parent/guardian|0|||
161314583|NCT03959488|582534687|FG001|Season 2|Withdrawal by parent/guardian|0|||
161314584|NCT03959488|582534688|FG002|Season 2|Withdrawal by parent/guardian|3|||
161314585|NCT03959488|582534689|FG003|Season 2|Withdrawal by parent/guardian|1|||
161314586|NCT03959488|582534690|FG004|Season 2|Withdrawal by parent/guardian|1|||
161314587|NCT03959488|582534686|FG000|Season 2|Lost to Follow-up|0|||
161314588|NCT03959488|582534687|FG001|Season 2|Lost to Follow-up|0|||
161314589|NCT03959488|582534688|FG002|Season 2|Lost to Follow-up|1|||
161314590|NCT03959488|582534689|FG003|Season 2|Lost to Follow-up|0|||
161314591|NCT03959488|582534690|FG004|Season 2|Lost to Follow-up|1|||
161314592|NCT00290693|582534691|FG000|Overall Study|Withdrawal by Subject|2|||
161314593|NCT03341936|582534694|FG000|Overall Study|Ineligible|1|||
161314594|NCT03341936|582534694|FG000|Overall Study|Disease Progression|2|||
161314595|NCT03341936|582534694|FG000|Overall Study|Withdrew Consent|4|||
161314596|NCT03341936|582534694|FG000|Overall Study|Non-Compliance|1|||
161314597|NCT03341936|582534694|FG000|Overall Study|Physician Decision|1|||
161314598|NCT03341936|582534694|FG000|Overall Study|Withdrawal by Subject|1|||
161314599|NCT03341936|582534694|FG000|Overall Study|Other|1|||
161314600|NCT00981058|582534705|FG000|Overall Study|Progressive Disease|38|||
161314601|NCT00981058|582534706|FG001|Overall Study|Progressive Disease|31|||
161314602|NCT00981058|582534705|FG000|Overall Study|Lost to Follow-up|3|||
161314603|NCT00981058|582534706|FG001|Overall Study|Lost to Follow-up|2|||
161314604|NCT00981058|582534705|FG000|Overall Study|Physician Decision|4|||
161314605|NCT00981058|582534706|FG001|Overall Study|Physician Decision|5|||
161314606|NCT00981058|582534705|FG000|Overall Study|Randomization Error|0|||
161314607|NCT00981058|582534706|FG001|Overall Study|Randomization Error|1|||
161314608|NCT00981058|582534705|FG000|Overall Study|Withdrawal by Subject|24|||
161314609|NCT00981058|582534706|FG001|Overall Study|Withdrawal by Subject|22|||
161314610|NCT02667587|582534707|FG000|Pre-Treatment|Not reported|1|||
161314611|NCT02667587|582534708|FG001|Pre-Treatment|Not reported|0|||
161314612|NCT02667587|582534707|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
161314613|NCT02667587|582534708|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
161314614|NCT02667587|582534707|FG000|Pre-Treatment|Participant withdrew consent|0|||
161314615|NCT02667587|582534708|FG001|Pre-Treatment|Participant withdrew consent|1|||
161314616|NCT02667587|582534707|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
161206868|NCT00791154|582138038|FG003|Overall Study|Full Consent withdrawn|0|||
161206869|NCT00791154|582138039|FG004|Overall Study|Full Consent withdrawn|1|||
161206870|NCT00791154|582138040|FG005|Overall Study|Full Consent withdrawn|3|||
161206871|NCT00791154|582138041|FG006|Overall Study|Full Consent withdrawn|1|||
161206872|NCT00791154|582138035|FG000|Overall Study|Lost to Follow-up|0|||
161206873|NCT00791154|582138036|FG001|Overall Study|Lost to Follow-up|0|||
161206874|NCT00791154|582138037|FG002|Overall Study|Lost to Follow-up|0|||
161206875|NCT00791154|582138038|FG003|Overall Study|Lost to Follow-up|1|||
161206876|NCT00791154|582138039|FG004|Overall Study|Lost to Follow-up|2|||
161206877|NCT00791154|582138040|FG005|Overall Study|Lost to Follow-up|0|||
161206878|NCT00791154|582138041|FG006|Overall Study|Lost to Follow-up|4|||
161206879|NCT00791154|582138035|FG000|Overall Study|Death|5|||
161206880|NCT00791154|582138036|FG001|Overall Study|Death|4|||
161206881|NCT00791154|582138037|FG002|Overall Study|Death|4|||
161206882|NCT00791154|582138038|FG003|Overall Study|Death|7|||
161206883|NCT00791154|582138039|FG004|Overall Study|Death|54|||
161206884|NCT00791154|582138040|FG005|Overall Study|Death|54|||
161206885|NCT00791154|582138041|FG006|Overall Study|Death|52|||
161206886|NCT00791154|582138035|FG000|Overall Study|Other event|0|||
161206887|NCT00791154|582138036|FG001|Overall Study|Other event|0|||
161206888|NCT00791154|582138037|FG002|Overall Study|Other event|2|||
161206889|NCT00791154|582138038|FG003|Overall Study|Other event|0|||
161206890|NCT00791154|582138039|FG004|Overall Study|Other event|2|||
161206891|NCT00791154|582138040|FG005|Overall Study|Other event|4|||
161206892|NCT00791154|582138041|FG006|Overall Study|Other event|2|||
161206893|NCT00953927|582138042|FG000|Overall Study|Lost to Follow-up|61|||
161206894|NCT00953927|582138043|FG001|Overall Study|Lost to Follow-up|65|||
161206895|NCT00953927|582138042|FG000|Overall Study|Withdrawal by Subject|36|||
161206896|NCT00953927|582138043|FG001|Overall Study|Withdrawal by Subject|25|||
161206897|NCT00953927|582138042|FG000|Overall Study|Death|7|||
161206898|NCT00953927|582138043|FG001|Overall Study|Death|4|||
161206899|NCT00953927|582138042|FG000|Overall Study|Other study discontinuation|1|||
161206900|NCT00953927|582138043|FG001|Overall Study|Other study discontinuation|1|||
161206901|NCT01396161|582138044|FG000|Overall Study|Withdrawal by Subject|0|||
161206902|NCT01396161|582138045|FG001|Overall Study|Withdrawal by Subject|0|||
161206903|NCT01396161|582138046|FG002|Overall Study|Withdrawal by Subject|0|||
161206904|NCT01396161|582138047|FG003|Overall Study|Withdrawal by Subject|0|||
161206905|NCT01396161|582138048|FG004|Overall Study|Withdrawal by Subject|1|||
161206906|NCT01396161|582138049|FG005|Overall Study|Withdrawal by Subject|0|||
161206907|NCT01396161|582138050|FG006|Overall Study|Withdrawal by Subject|0|||
161206908|NCT01396161|582138044|FG000|Overall Study|Other|0|||
161206909|NCT01396161|582138045|FG001|Overall Study|Other|0|||
161206910|NCT01396161|582138046|FG002|Overall Study|Other|0|||
161206911|NCT01396161|582138047|FG003|Overall Study|Other|0|||
161206912|NCT01396161|582138048|FG004|Overall Study|Other|0|||
161206913|NCT01396161|582138049|FG005|Overall Study|Other|0|||
161206914|NCT01396161|582138050|FG006|Overall Study|Other|1|||
161206915|NCT02962739|582138051|FG000|Overall Study|Withdrawal by Subject|0|||
161206916|NCT02962739|582138052|FG001|Overall Study|Withdrawal by Subject|1|||
161206917|NCT02962739|582138053|FG002|Overall Study|Withdrawal by Subject|0|||
161206918|NCT02962739|582138054|FG003|Overall Study|Withdrawal by Subject|0|||
161206919|NCT02962739|582138055|FG004|Overall Study|Withdrawal by Subject|0|||
161206920|NCT02962739|582138056|FG005|Overall Study|Withdrawal by Subject|0|||
161206921|NCT02962739|582138051|FG000|Overall Study|Protocol Violation|0|||
161206922|NCT02962739|582138052|FG001|Overall Study|Protocol Violation|0|||
161206923|NCT02962739|582138053|FG002|Overall Study|Protocol Violation|1|||
161314617|NCT02667587|582534708|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
161206924|NCT02962739|582138054|FG003|Overall Study|Protocol Violation|0|||
161314618|NCT02667587|582534707|FG000|End of Treatment|Disease Progression|193|||
161314619|NCT02667587|582534708|FG001|End of Treatment|Disease Progression|226|||
161314620|NCT02667587|582534707|FG000|End of Treatment|Study Drug Toxicity|75|||
161314621|NCT02667587|582534708|FG001|End of Treatment|Study Drug Toxicity|19|||
161314622|NCT02667587|582534707|FG000|End of Treatment|Death|2|||
161314623|NCT02667587|582534708|FG001|End of Treatment|Death|1|||
161314624|NCT02667587|582534707|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
161314625|NCT02667587|582534708|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
161314626|NCT02667587|582534707|FG000|End of Treatment|participant request to discontinue treatment|33|||
161314627|NCT02667587|582534708|FG001|End of Treatment|participant request to discontinue treatment|35|||
161314628|NCT02667587|582534707|FG000|End of Treatment|participant withdrew consent|5|||
161314629|NCT02667587|582534708|FG001|End of Treatment|participant withdrew consent|6|||
161314630|NCT02667587|582534707|FG000|End of Treatment|Lost to Follow-up|1|||
161314631|NCT02667587|582534708|FG001|End of Treatment|Lost to Follow-up|2|||
161314632|NCT02667587|582534707|FG000|End of Treatment|maximum clinical benefit|4|||
161314633|NCT02667587|582534708|FG001|End of Treatment|maximum clinical benefit|4|||
161314634|NCT02667587|582534707|FG000|End of Treatment|poor or non compliant|0|||
161314635|NCT02667587|582534708|FG001|End of Treatment|poor or non compliant|1|||
161314636|NCT02667587|582534707|FG000|End of Treatment|participant no longer meets study criteria|1|||
161314637|NCT02667587|582534708|FG001|End of Treatment|participant no longer meets study criteria|1|||
161314638|NCT02667587|582534707|FG000|End of Treatment|administrative reason by sponsor|1|||
161314639|NCT02667587|582534708|FG001|End of Treatment|administrative reason by sponsor|29|||
161314640|NCT02667587|582534707|FG000|End of Treatment|other reasonse|21|||
161314641|NCT02667587|582534708|FG001|End of Treatment|other reasonse|10|||
161314642|NCT02542293|582534709|FG000|Overall Study|Death|367|||
161314643|NCT02542293|582534710|FG001|Overall Study|Death|377|||
161314644|NCT02542293|582534709|FG000|Overall Study|Withdrawal by Subject|8|||
161314645|NCT02542293|582534710|FG001|Overall Study|Withdrawal by Subject|19|||
161314646|NCT04529850|582534711|FG000|Overall Study|Death|2|||
161314647|NCT04529850|582534711|FG000|Overall Study|Physician Decision|1|||
161314648|NCT04529850|582534711|FG000|Overall Study|Withdrawal by Subject|2|||
161314649|NCT00593606|582534714|FG000|Overall Study|Adverse Event|13|||
161314650|NCT00593606|582534714|FG000|Overall Study|Withdrawal by Subject|1|||
161314651|NCT00593606|582534714|FG000|Overall Study|Protocol Violation|3|||
161314652|NCT00593606|582534714|FG000|Overall Study|Lost to Follow-up|2|||
161314653|NCT00593606|582534714|FG000|Overall Study|Run-In Failure|5|||
161314654|NCT00593606|582534714|FG000|Overall Study|Screen Failure|3|||
161314655|NCT02278367|582534715|FG000|Overall Study|Physician Decision|5|||
161314656|NCT02278367|582534716|FG001|Overall Study|Physician Decision|0|||
161314657|NCT02278367|582534715|FG000|Overall Study|Withdrawal by Subject|5|||
161314658|NCT02278367|582534716|FG001|Overall Study|Withdrawal by Subject|0|||
161314659|NCT00869557|582534719|FG000|Randomized Phase|Lost to Follow-up|2|||
161314660|NCT00869557|582534720|FG001|Randomized Phase|Lost to Follow-up|1|||
161314661|NCT00869557|582534719|FG000|Randomized Phase|Investigator's Discretion|1|||
161314662|NCT00869557|582534720|FG001|Randomized Phase|Investigator's Discretion|0|||
161314663|NCT00869557|582534719|FG000|Randomized Phase|Withdrew Consent|0|||
161314664|NCT00869557|582534720|FG001|Randomized Phase|Withdrew Consent|1|||
161314665|NCT00869557|582534719|FG000|Extension Phase|Adverse Event|2|||
161314666|NCT00869557|582534720|FG001|Extension Phase|Adverse Event|2|||
161314667|NCT00869557|582534719|FG000|Extension Phase|Lack of Efficacy|1|||
161314668|NCT00869557|582534720|FG001|Extension Phase|Lack of Efficacy|0|||
161314669|NCT00869557|582534719|FG000|Extension Phase|Lost to Follow-up|3|||
161314670|NCT00869557|582534720|FG001|Extension Phase|Lost to Follow-up|1|||
161314671|NCT00869557|582534719|FG000|Extension Phase|Investigator's Discretion|2|||
161314672|NCT00869557|582534720|FG001|Extension Phase|Investigator's Discretion|0|||
161314673|NCT00869557|582534719|FG000|Extension Phase|Withdrew Consent|2|||
161314674|NCT00869557|582534720|FG001|Extension Phase|Withdrew Consent|0|||
161314675|NCT01472939|582534721|FG000|Overall Study|Adverse Event|3|||
161314676|NCT01472939|582534722|FG001|Overall Study|Adverse Event|7|||
161314677|NCT01472939|582534723|FG002|Overall Study|Adverse Event|7|||
161314678|NCT01472939|582534724|FG003|Overall Study|Adverse Event|14|||
161314679|NCT01472939|582534721|FG000|Overall Study|Lack of Efficacy|1|||
161314680|NCT01472939|582534722|FG001|Overall Study|Lack of Efficacy|0|||
161314681|NCT01472939|582534723|FG002|Overall Study|Lack of Efficacy|0|||
161314682|NCT01472939|582534724|FG003|Overall Study|Lack of Efficacy|1|||
161314683|NCT01472939|582534721|FG000|Overall Study|Lost to Follow-up|3|||
161314684|NCT01472939|582534722|FG001|Overall Study|Lost to Follow-up|0|||
161314685|NCT01472939|582534723|FG002|Overall Study|Lost to Follow-up|2|||
161314686|NCT01472939|582534724|FG003|Overall Study|Lost to Follow-up|0|||
161314687|NCT01472939|582534721|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161314688|NCT01472939|582534722|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161314689|NCT01472939|582534723|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
161314690|NCT01472939|582534724|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
161314691|NCT01472939|582534721|FG000|Overall Study|Prohibited Medication|0|||
161314692|NCT01472939|582534722|FG001|Overall Study|Prohibited Medication|1|||
161314693|NCT01472939|582534723|FG002|Overall Study|Prohibited Medication|0|||
161314694|NCT01472939|582534724|FG003|Overall Study|Prohibited Medication|0|||
161314695|NCT01472939|582534721|FG000|Overall Study|Withdrawal By PI|1|||
161314696|NCT01472939|582534722|FG001|Overall Study|Withdrawal By PI|0|||
161314697|NCT01472939|582534723|FG002|Overall Study|Withdrawal By PI|0|||
161314698|NCT01472939|582534724|FG003|Overall Study|Withdrawal By PI|0|||
161314699|NCT01472939|582534721|FG000|Overall Study|Protocol Violation|3|||
161314700|NCT01472939|582534722|FG001|Overall Study|Protocol Violation|3|||
161314701|NCT01472939|582534723|FG002|Overall Study|Protocol Violation|0|||
161314702|NCT01472939|582534724|FG003|Overall Study|Protocol Violation|1|||
161314703|NCT01472939|582534721|FG000|Overall Study|Withdrawal by Subject|9|||
161314704|NCT01472939|582534722|FG001|Overall Study|Withdrawal by Subject|3|||
161314705|NCT01472939|582534723|FG002|Overall Study|Withdrawal by Subject|1|||
161314706|NCT01472939|582534724|FG003|Overall Study|Withdrawal by Subject|4|||
161314707|NCT00114738|582534725|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
161314708|NCT00114738|582534726|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
161314709|NCT00114738|582534727|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
161314710|NCT00114738|582534725|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
161314711|NCT00114738|582534726|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
161314712|NCT00114738|582534727|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
161314713|NCT00114738|582534725|FG000|Screening for Randomization|Neuropathy|17|||
161314714|NCT00114738|582534726|FG001|Screening for Randomization|Neuropathy|0|||
161314715|NCT00114738|582534727|FG002|Screening for Randomization|Neuropathy|0|||
161314716|NCT00114738|582534725|FG000|Screening for Randomization|Progressive disease|2|||
161314717|NCT00114738|582534726|FG001|Screening for Randomization|Progressive disease|0|||
161314718|NCT00114738|582534727|FG002|Screening for Randomization|Progressive disease|0|||
161314719|NCT00114738|582534725|FG000|Screening for Randomization|CNS Hemorrhage|1|||
161314720|NCT00114738|582534726|FG001|Screening for Randomization|CNS Hemorrhage|0|||
161314721|NCT00114738|582534727|FG002|Screening for Randomization|CNS Hemorrhage|0|||
161314722|NCT00114738|582534725|FG000|Screening for Randomization|Other|1|||
161314723|NCT00114738|582534726|FG001|Screening for Randomization|Other|0|||
161314724|NCT00114738|582534727|FG002|Screening for Randomization|Other|0|||
161314725|NCT05940077|582534728|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
161314726|NCT01492101|582534729|FG000|Overall Study|Death|323|||
161314727|NCT01492101|582534730|FG001|Overall Study|Death|322|||
161314728|NCT01492101|582534729|FG000|Overall Study|Withdrawal by Subject|14|||
161314729|NCT01492101|582534730|FG001|Overall Study|Withdrawal by Subject|18|||
161314730|NCT01492101|582534729|FG000|Overall Study|Lost to Follow-up|0|||
161314731|NCT01492101|582534730|FG001|Overall Study|Lost to Follow-up|2|||
161314732|NCT01004432|582534731|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
161314733|NCT01004432|582534732|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161314734|NCT01004432|582534733|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161314735|NCT01004432|582534734|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161314736|NCT01004432|582534735|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
161314737|NCT01004432|582534731|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
161314738|NCT01004432|582534732|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161314739|NCT01004432|582534733|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161314740|NCT01004432|582534734|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161314741|NCT01004432|582534735|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
161314742|NCT01004432|582534731|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
161314743|NCT01004432|582534732|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161314744|NCT01004432|582534733|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161314745|NCT01004432|582534734|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161314746|NCT01004432|582534735|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
161314747|NCT01004432|582534731|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
161314748|NCT01004432|582534732|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161314749|NCT01004432|582534733|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161314750|NCT01004432|582534734|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161314751|NCT01004432|582534735|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
161314752|NCT01004432|582534731|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
161314753|NCT01004432|582534732|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161314754|NCT01004432|582534733|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161314755|NCT01004432|582534734|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161314756|NCT01004432|582534735|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
161314757|NCT01004432|582534731|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
161314758|NCT01004432|582534732|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
161314759|NCT01004432|582534733|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
161314760|NCT01004432|582534734|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
161314761|NCT01004432|582534735|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
161314762|NCT01004432|582534731|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
161314763|NCT01004432|582534732|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
161314764|NCT01004432|582534733|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
161314765|NCT01004432|582534734|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
161314766|NCT01004432|582534735|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
161314767|NCT01004432|582534731|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
161314768|NCT01004432|582534732|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
161314769|NCT01004432|582534733|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
161314770|NCT01004432|582534734|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
161314771|NCT01004432|582534735|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
161314772|NCT01004432|582534731|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161314773|NCT01004432|582534732|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161314774|NCT01004432|582534733|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161314775|NCT01004432|582534734|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
161314776|NCT01004432|582534735|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
161314777|NCT01004432|582534731|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
161314778|NCT01004432|582534732|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
161314779|NCT01004432|582534733|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
161314780|NCT01004432|582534734|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
161314781|NCT01004432|582534735|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
161314782|NCT01004432|582534731|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
161314783|NCT01004432|582534732|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
161314784|NCT01004432|582534733|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
161314785|NCT01004432|582534734|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
161314786|NCT01004432|582534735|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
161314787|NCT01004432|582534731|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161314788|NCT01004432|582534732|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161314789|NCT01004432|582534733|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161314790|NCT01004432|582534734|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
161314791|NCT01004432|582534735|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
161314792|NCT01004432|582534731|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161314793|NCT01004432|582534732|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161314794|NCT01004432|582534733|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161314795|NCT01004432|582534734|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
161314796|NCT01004432|582534735|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
161314797|NCT01004432|582534731|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161314798|NCT01004432|582534732|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161314799|NCT01004432|582534733|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161314800|NCT01004432|582534734|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
161314801|NCT01004432|582534735|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
161314802|NCT01004432|582534731|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161314803|NCT01004432|582534732|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161314804|NCT01004432|582534733|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161314805|NCT01004432|582534734|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
161314806|NCT01004432|582534735|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
161314807|NCT03570554|582534740|FG000|Overall Study|Non-compliance with study drug|0|||
161314808|NCT03570554|582534741|FG001|Overall Study|Non-compliance with study drug|0|||
161314809|NCT03570554|582534742|FG002|Overall Study|Non-compliance with study drug|1|||
161314810|NCT03570554|582534743|FG003|Overall Study|Non-compliance with study drug|0|||
161314811|NCT03570554|582534740|FG000|Overall Study|Adverse Event|0|||
161314812|NCT03570554|582534741|FG001|Overall Study|Adverse Event|0|||
161314813|NCT03570554|582534742|FG002|Overall Study|Adverse Event|0|||
161314814|NCT03570554|582534743|FG003|Overall Study|Adverse Event|1|||
161314815|NCT02719353|582534746|FG000|First Intervention|Physician Decision|0|||
161314816|NCT02719353|582534747|FG001|First Intervention|Physician Decision|1|||
161314817|NCT03114657|582534748|FG000|Overall Study|Adverse Event|9|||
161314818|NCT03114657|582534749|FG001|Overall Study|Adverse Event|6|||
161314819|NCT03114657|582534748|FG000|Overall Study|Death|4|||
161314820|NCT03114657|582534749|FG001|Overall Study|Death|0|||
161314821|NCT03114657|582534748|FG000|Overall Study|Multiple Reasons|1|||
161314822|NCT03114657|582534749|FG001|Overall Study|Multiple Reasons|2|||
161314823|NCT03114657|582534748|FG000|Overall Study|Physician Decision|2|||
161314824|NCT03114657|582534749|FG001|Overall Study|Physician Decision|2|||
161314825|NCT03114657|582534748|FG000|Overall Study|Study Terminated By Sponsor|355|||
161314826|NCT03114657|582534749|FG001|Overall Study|Study Terminated By Sponsor|374|||
161314827|NCT03114657|582534748|FG000|Overall Study|Symptomatic Deterioration|0|||
161314828|NCT03114657|582534749|FG001|Overall Study|Symptomatic Deterioration|1|||
161314829|NCT03114657|582534748|FG000|Overall Study|Withdrawal by Subject|28|||
161314830|NCT03114657|582534749|FG001|Overall Study|Withdrawal by Subject|22|||
161314831|NCT04245202|582534750|FG000|Overall Study|Lack of Efficacy|10|||
161314832|NCT04245202|582534751|FG001|Overall Study|Lack of Efficacy|1|||
161314833|NCT00717275|582534752|FG000|Overall Study|Premature study termination.|3|||
161314834|NCT04521114|582534758|FG000|Overall Study|Lost to Follow-up|1|||
161314835|NCT04521114|582534759|FG001|Overall Study|Lost to Follow-up|2|||
161314836|NCT04521114|582534760|FG002|Overall Study|Lost to Follow-up|0|||
161314837|NCT04521114|582534758|FG000|Overall Study|Withdrawal by Subject|1|||
161314838|NCT04521114|582534759|FG001|Overall Study|Withdrawal by Subject|2|||
161314839|NCT04521114|582534760|FG002|Overall Study|Withdrawal by Subject|2|||
161314840|NCT04521114|582534758|FG000|Overall Study|Adverse Event|1|||
161314841|NCT04521114|582534759|FG001|Overall Study|Adverse Event|0|||
161314842|NCT04521114|582534760|FG002|Overall Study|Adverse Event|0|||
161314843|NCT04521114|582534758|FG000|Overall Study|Sponsor Wish|1|||
161314844|NCT04521114|582534759|FG001|Overall Study|Sponsor Wish|0|||
161314845|NCT04521114|582534760|FG002|Overall Study|Sponsor Wish|0|||
161314846|NCT04521114|582534758|FG000|Overall Study|Withdrawal of Consent|2|||
161314847|NCT04521114|582534759|FG001|Overall Study|Withdrawal of Consent|2|||
161314848|NCT04521114|582534760|FG002|Overall Study|Withdrawal of Consent|0|||
161314849|NCT01362517|582534761|FG000|Overall Study|Protocol Violation|1|||
161314850|NCT01362517|582534761|FG000|Overall Study|Lost to Follow-up|1|||
161314851|NCT01133288|582534764|FG000|Eligibility Assessment|met exclusion criteria|5|||
161314852|NCT01133288|582534764|FG000|Intervention Allocation|study terminated|2|||
161314853|NCT03209518|582534765|FG000|Overall Study|Case Report Forms Uncollected|1|||
161314854|NCT03209518|582534765|FG000|Overall Study|Protocol Deviation|1|||
161314855|NCT00236899|582534766|FG000|Overall Study|Adverse Event (Study Related)|1|||
161314856|NCT00236899|582534767|FG001|Overall Study|Adverse Event (Study Related)|1|||
161314857|NCT00236899|582534768|FG002|Overall Study|Adverse Event (Study Related)|2|||
161314858|NCT00236899|582534769|FG003|Overall Study|Adverse Event (Study Related)|1|||
161314859|NCT00236899|582534766|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
161314860|NCT00236899|582534767|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
161314861|NCT00236899|582534768|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
161314862|NCT00236899|582534769|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
161314863|NCT00236899|582534766|FG000|Overall Study|Death (Study Disease)|1|||
161314864|NCT00236899|582534767|FG001|Overall Study|Death (Study Disease)|4|||
161314865|NCT00236899|582534768|FG002|Overall Study|Death (Study Disease)|0|||
161314866|NCT00236899|582534769|FG003|Overall Study|Death (Study Disease)|0|||
161314867|NCT00236899|582534766|FG000|Overall Study|Death (Not Study Related)|2|||
161314868|NCT00236899|582534767|FG001|Overall Study|Death (Not Study Related)|0|||
161314869|NCT00236899|582534768|FG002|Overall Study|Death (Not Study Related)|0|||
161314870|NCT00236899|582534769|FG003|Overall Study|Death (Not Study Related)|0|||
161314871|NCT00236899|582534766|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
161314872|NCT00236899|582534767|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
161314873|NCT00236899|582534768|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
161314874|NCT00236899|582534769|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
161314875|NCT00236899|582534766|FG000|Overall Study|Lost to Follow-up|0|||
161314876|NCT00236899|582534767|FG001|Overall Study|Lost to Follow-up|1|||
161314877|NCT00236899|582534768|FG002|Overall Study|Lost to Follow-up|0|||
161314878|NCT00236899|582534769|FG003|Overall Study|Lost to Follow-up|0|||
161314879|NCT00236899|582534766|FG000|Overall Study|Entry Criteria Exclusion|0|||
161314880|NCT00236899|582534767|FG001|Overall Study|Entry Criteria Exclusion|1|||
161314881|NCT00236899|582534768|FG002|Overall Study|Entry Criteria Exclusion|1|||
161314882|NCT00236899|582534769|FG003|Overall Study|Entry Criteria Exclusion|0|||
161314883|NCT00236899|582534766|FG000|Overall Study|Protocol Violation|1|||
161314884|NCT00236899|582534767|FG001|Overall Study|Protocol Violation|0|||
161314885|NCT00236899|582534768|FG002|Overall Study|Protocol Violation|0|||
161314886|NCT00236899|582534769|FG003|Overall Study|Protocol Violation|0|||
161314887|NCT00236899|582534766|FG000|Overall Study|Withdrawal by Subject|6|||
161314888|NCT00236899|582534767|FG001|Overall Study|Withdrawal by Subject|4|||
161314889|NCT00236899|582534768|FG002|Overall Study|Withdrawal by Subject|5|||
161314890|NCT00236899|582534769|FG003|Overall Study|Withdrawal by Subject|2|||
161314891|NCT00236899|582534766|FG000|Overall Study|Physician Decision|7|||
161314892|NCT00236899|582534767|FG001|Overall Study|Physician Decision|8|||
161314893|NCT00236899|582534768|FG002|Overall Study|Physician Decision|7|||
161314894|NCT00236899|582534769|FG003|Overall Study|Physician Decision|6|||
161314895|NCT00236899|582534766|FG000|Overall Study|Satisfactory Response|2|||
161314896|NCT00236899|582534767|FG001|Overall Study|Satisfactory Response|0|||
161314897|NCT00236899|582534768|FG002|Overall Study|Satisfactory Response|0|||
161314898|NCT00236899|582534769|FG003|Overall Study|Satisfactory Response|1|||
161314899|NCT00236899|582534766|FG000|Overall Study|Lack of Efficacy|18|||
161314900|NCT00236899|582534767|FG001|Overall Study|Lack of Efficacy|18|||
161314901|NCT00236899|582534768|FG002|Overall Study|Lack of Efficacy|25|||
161314902|NCT00236899|582534769|FG003|Overall Study|Lack of Efficacy|23|||
161314903|NCT02565706|582534774|FG000|Overall Study|Withdrawal by Subject|5|||
161314904|NCT02565706|582534775|FG001|Overall Study|Withdrawal by Subject|7|||
161314905|NCT02565706|582534776|FG002|Overall Study|Withdrawal by Subject|7|||
161314906|NCT02565706|582534777|FG003|Overall Study|Withdrawal by Subject|11|||
161314907|NCT02565706|582534774|FG000|Overall Study|Lost to Follow-up|72|||
161314908|NCT02565706|582534775|FG001|Overall Study|Lost to Follow-up|75|||
161314909|NCT02565706|582534776|FG002|Overall Study|Lost to Follow-up|82|||
161314910|NCT02565706|582534777|FG003|Overall Study|Lost to Follow-up|74|||
161314911|NCT01281956|582534781|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
161314912|NCT01281956|582534782|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
161314913|NCT03677934|582534788|FG000|Overall Study|Adverse Event|1|||
161314914|NCT03677934|582534789|FG001|Overall Study|Adverse Event|1|||
161314915|NCT03677934|582534788|FG000|Overall Study|Death|8|||
161314916|NCT03677934|582534789|FG001|Overall Study|Death|4|||
161314917|NCT03677934|582534788|FG000|Overall Study|Lost to Follow-up|3|||
161314918|NCT03677934|582534789|FG001|Overall Study|Lost to Follow-up|0|||
161314919|NCT03677934|582534788|FG000|Overall Study|Non-Compliance With Study Drug|1|||
161314920|NCT03677934|582534789|FG001|Overall Study|Non-Compliance With Study Drug|0|||
161314921|NCT03677934|582534788|FG000|Overall Study|Physician Decision|0|||
161314922|NCT03677934|582534789|FG001|Overall Study|Physician Decision|1|||
161314923|NCT03677934|582534788|FG000|Overall Study|Withdrawal by Subject|1|||
161314924|NCT03677934|582534789|FG001|Overall Study|Withdrawal by Subject|7|||
161314925|NCT04769739|582534790|FG000|Overall Study|Colorectal cancer obstruction|2|||
161314926|NCT04769739|582534791|FG001|Overall Study|Colorectal cancer obstruction|0|||
161314927|NCT04769739|582534792|FG002|Overall Study|Colorectal cancer obstruction|0|||
161314928|NCT04769739|582534793|FG003|Overall Study|Colorectal cancer obstruction|0|||
161314929|NCT04769739|582534790|FG000|Overall Study|Failed cecal intubation|1|||
161314930|NCT04769739|582534791|FG001|Overall Study|Failed cecal intubation|0|||
161314931|NCT04769739|582534792|FG002|Overall Study|Failed cecal intubation|0|||
161314932|NCT04769739|582534793|FG003|Overall Study|Failed cecal intubation|1|||
161314933|NCT04769739|582534790|FG000|Overall Study|Poor bowel preparation|0|||
161314934|NCT04769739|582534791|FG001|Overall Study|Poor bowel preparation|0|||
161314935|NCT04769739|582534792|FG002|Overall Study|Poor bowel preparation|0|||
161314936|NCT04769739|582534793|FG003|Overall Study|Poor bowel preparation|1|||
161314937|NCT03627416|582534813|FG000|Overall Study|Adverse Event|0|||
161314938|NCT03627416|582534814|FG001|Overall Study|Adverse Event|1|||
161314939|NCT02079636|582534815|FG000|Overall Study|Death|2|||
161314940|NCT02079636|582534816|FG001|Overall Study|Death|1|||
161314941|NCT02079636|582534817|FG002|Overall Study|Death|0|||
161314942|NCT02079636|582534818|FG003|Overall Study|Death|5|||
161314943|NCT02079636|582534819|FG004|Overall Study|Death|1|||
161314944|NCT02079636|582534820|FG005|Overall Study|Death|2|||
161314945|NCT02079636|582534821|FG006|Overall Study|Death|1|||
161314946|NCT02079636|582534822|FG007|Overall Study|Death|0|||
161314947|NCT02079636|582534823|FG008|Overall Study|Death|0|||
161314948|NCT02079636|582534824|FG009|Overall Study|Death|0|||
161314949|NCT02079636|582534825|FG010|Overall Study|Death|0|||
161314950|NCT02079636|582534826|FG011|Overall Study|Death|1|||
161314951|NCT02079636|582534827|FG012|Overall Study|Death|1|||
161314952|NCT02079636|582534828|FG013|Overall Study|Death|0|||
161314953|NCT02079636|582534829|FG014|Overall Study|Death|2|||
161314954|NCT02079636|582534815|FG000|Overall Study|Adverse Event|1|||
161314955|NCT02079636|582534816|FG001|Overall Study|Adverse Event|1|||
161314956|NCT02079636|582534817|FG002|Overall Study|Adverse Event|0|||
161314957|NCT02079636|582534818|FG003|Overall Study|Adverse Event|1|||
161314958|NCT02079636|582534819|FG004|Overall Study|Adverse Event|1|||
161314959|NCT02079636|582534820|FG005|Overall Study|Adverse Event|2|||
161314960|NCT02079636|582534821|FG006|Overall Study|Adverse Event|0|||
161314961|NCT02079636|582534822|FG007|Overall Study|Adverse Event|0|||
161314962|NCT02079636|582534823|FG008|Overall Study|Adverse Event|0|||
161314963|NCT02079636|582534824|FG009|Overall Study|Adverse Event|0|||
161314964|NCT02079636|582534825|FG010|Overall Study|Adverse Event|0|||
161314965|NCT02079636|582534826|FG011|Overall Study|Adverse Event|0|||
161314966|NCT02079636|582534827|FG012|Overall Study|Adverse Event|0|||
161314967|NCT02079636|582534828|FG013|Overall Study|Adverse Event|0|||
161314968|NCT02079636|582534829|FG014|Overall Study|Adverse Event|0|||
161314969|NCT02079636|582534815|FG000|Overall Study|Progressive disease|0|||
161314970|NCT02079636|582534816|FG001|Overall Study|Progressive disease|0|||
161314971|NCT02079636|582534817|FG002|Overall Study|Progressive disease|0|||
161314972|NCT02079636|582534818|FG003|Overall Study|Progressive disease|2|||
161314973|NCT02079636|582534819|FG004|Overall Study|Progressive disease|0|||
161314974|NCT02079636|582534820|FG005|Overall Study|Progressive disease|0|||
161314975|NCT02079636|582534821|FG006|Overall Study|Progressive disease|0|||
161314976|NCT02079636|582534822|FG007|Overall Study|Progressive disease|0|||
161314977|NCT02079636|582534823|FG008|Overall Study|Progressive disease|0|||
161314978|NCT02079636|582534824|FG009|Overall Study|Progressive disease|0|||
161314979|NCT02079636|582534825|FG010|Overall Study|Progressive disease|0|||
161314980|NCT02079636|582534826|FG011|Overall Study|Progressive disease|0|||
161314981|NCT02079636|582534827|FG012|Overall Study|Progressive disease|1|||
161314982|NCT02079636|582534828|FG013|Overall Study|Progressive disease|0|||
161314983|NCT02079636|582534829|FG014|Overall Study|Progressive disease|0|||
161314984|NCT02079636|582534815|FG000|Overall Study|Withdrawal by Subject|0|||
161314985|NCT02079636|582534816|FG001|Overall Study|Withdrawal by Subject|0|||
161314986|NCT02079636|582534817|FG002|Overall Study|Withdrawal by Subject|0|||
161314987|NCT02079636|582534818|FG003|Overall Study|Withdrawal by Subject|4|||
161314988|NCT02079636|582534819|FG004|Overall Study|Withdrawal by Subject|0|||
161314989|NCT02079636|582534820|FG005|Overall Study|Withdrawal by Subject|1|||
161314990|NCT02079636|582534821|FG006|Overall Study|Withdrawal by Subject|0|||
161314991|NCT02079636|582534822|FG007|Overall Study|Withdrawal by Subject|0|||
161314992|NCT02079636|582534823|FG008|Overall Study|Withdrawal by Subject|0|||
161314993|NCT02079636|582534824|FG009|Overall Study|Withdrawal by Subject|2|||
161314994|NCT02079636|582534825|FG010|Overall Study|Withdrawal by Subject|1|||
161314995|NCT02079636|582534826|FG011|Overall Study|Withdrawal by Subject|1|||
161314996|NCT02079636|582534827|FG012|Overall Study|Withdrawal by Subject|1|||
161314997|NCT02079636|582534828|FG013|Overall Study|Withdrawal by Subject|0|||
161314998|NCT02079636|582534829|FG014|Overall Study|Withdrawal by Subject|2|||
161314999|NCT02079636|582534815|FG000|Overall Study|Physician Decision|0|||
161315000|NCT02079636|582534816|FG001|Overall Study|Physician Decision|0|||
161315001|NCT02079636|582534817|FG002|Overall Study|Physician Decision|0|||
161315002|NCT02079636|582534818|FG003|Overall Study|Physician Decision|0|||
161315003|NCT02079636|582534819|FG004|Overall Study|Physician Decision|0|||
161315004|NCT02079636|582534820|FG005|Overall Study|Physician Decision|1|||
161315005|NCT02079636|582534821|FG006|Overall Study|Physician Decision|0|||
161315006|NCT02079636|582534822|FG007|Overall Study|Physician Decision|0|||
161315007|NCT02079636|582534823|FG008|Overall Study|Physician Decision|0|||
161315008|NCT02079636|582534824|FG009|Overall Study|Physician Decision|1|||
161315009|NCT02079636|582534825|FG010|Overall Study|Physician Decision|1|||
161315010|NCT02079636|582534826|FG011|Overall Study|Physician Decision|0|||
161315011|NCT02079636|582534827|FG012|Overall Study|Physician Decision|0|||
161315012|NCT02079636|582534828|FG013|Overall Study|Physician Decision|0|||
161315013|NCT02079636|582534829|FG014|Overall Study|Physician Decision|1|||
161315014|NCT02079636|582534815|FG000|Overall Study|Lost to Follow-up|0|||
161315015|NCT02079636|582534816|FG001|Overall Study|Lost to Follow-up|0|||
161315016|NCT02079636|582534817|FG002|Overall Study|Lost to Follow-up|0|||
161315017|NCT02079636|582534818|FG003|Overall Study|Lost to Follow-up|0|||
161315018|NCT02079636|582534819|FG004|Overall Study|Lost to Follow-up|0|||
161315019|NCT02079636|582534820|FG005|Overall Study|Lost to Follow-up|0|||
161315020|NCT02079636|582534821|FG006|Overall Study|Lost to Follow-up|0|||
161315021|NCT02079636|582534822|FG007|Overall Study|Lost to Follow-up|1|||
161315022|NCT02079636|582534823|FG008|Overall Study|Lost to Follow-up|0|||
161315023|NCT02079636|582534824|FG009|Overall Study|Lost to Follow-up|0|||
161315024|NCT02079636|582534825|FG010|Overall Study|Lost to Follow-up|0|||
161315025|NCT02079636|582534826|FG011|Overall Study|Lost to Follow-up|0|||
161315026|NCT02079636|582534827|FG012|Overall Study|Lost to Follow-up|0|||
161315027|NCT02079636|582534828|FG013|Overall Study|Lost to Follow-up|0|||
161315028|NCT02079636|582534829|FG014|Overall Study|Lost to Follow-up|0|||
161315029|NCT00637806|582534830|FG000|Double-blind Phase|Study Discontinued|2|||
161315030|NCT00637806|582534831|FG001|Double-blind Phase|Study Discontinued|0|||
161315031|NCT00637806|582534832|FG002|Double-blind Phase|Study Discontinued|1|||
161315032|NCT00637806|582534833|FG003|Double-blind Phase|Study Discontinued|0|||
161315033|NCT00637806|582534830|FG000|Extension Phase|Study Discontinued|0|||
161315034|NCT00637806|582534831|FG001|Extension Phase|Study Discontinued|0|||
161315035|NCT00637806|582534832|FG002|Extension Phase|Study Discontinued|0|||
161315036|NCT00637806|582534833|FG003|Extension Phase|Study Discontinued|1|||
161315037|NCT00561470|582534834|FG000|Overall Study|Adverse Event|74|||
161315038|NCT00561470|582534835|FG001|Overall Study|Adverse Event|163|||
161315039|NCT00561470|582534834|FG000|Overall Study|Disease progression|437|||
161315040|NCT00561470|582534835|FG001|Overall Study|Disease progression|305|||
161315041|NCT00561470|582534834|FG000|Overall Study|poor compliance to protocol|4|||
161315042|NCT00561470|582534835|FG001|Overall Study|poor compliance to protocol|4|||
161315043|NCT00561470|582534834|FG000|Overall Study|Lost to Follow-up|2|||
161315044|NCT00561470|582534835|FG001|Overall Study|Lost to Follow-up|0|||
161315045|NCT00561470|582534834|FG000|Overall Study|Physician Decision|21|||
161315046|NCT00561470|582534835|FG001|Overall Study|Physician Decision|20|||
161315047|NCT00561470|582534834|FG000|Overall Study|Consent Withdrawn|2|||
161315048|NCT00561470|582534835|FG001|Overall Study|Consent Withdrawn|6|||
161315049|NCT00561470|582534834|FG000|Overall Study|Subject request|43|||
161315050|NCT00561470|582534835|FG001|Overall Study|Subject request|77|||
161315051|NCT00561470|582534834|FG000|Overall Study|Metastatic surgery|10|||
161315052|NCT00561470|582534835|FG001|Overall Study|Metastatic surgery|12|||
161315053|NCT00561470|582534834|FG000|Overall Study|Unauthorized procedure|3|||
161315054|NCT00561470|582534835|FG001|Overall Study|Unauthorized procedure|1|||
161315055|NCT00561470|582534834|FG000|Overall Study|Randomized but not treated|5|||
161315056|NCT00561470|582534835|FG001|Overall Study|Randomized but not treated|5|||
161315057|NCT00561470|582534834|FG000|Overall Study|Missed visit window|1|||
161315058|NCT00561470|582534835|FG001|Overall Study|Missed visit window|4|||
161315059|NCT00561470|582534834|FG000|Overall Study|Planning surgery|1|||
161315060|NCT00561470|582534835|FG001|Overall Study|Planning surgery|1|||
161315061|NCT00561470|582534834|FG000|Overall Study|Ongoing Treatment|11|||
161315062|NCT00561470|582534835|FG001|Overall Study|Ongoing Treatment|14|||
161315063|NCT02028169|582534836|FG000|Overall Study|Lost to Follow-up|21|||
161315064|NCT02028169|582534836|FG000|Overall Study|Lack of Efficacy|2|||
161315065|NCT02028169|582534836|FG000|Overall Study|Withdrawal by Subject|2|||
161315066|NCT02028169|582534836|FG000|Overall Study|Adverse Event|1|||
161315067|NCT02028169|582534836|FG000|Overall Study|Cessation of Drug|1|||
161315068|NCT02028169|582534836|FG000|Overall Study|Concomitant Medication Usage|1|||
161315069|NCT02240069|582534839|FG000|Overall Study|Withdrawal by Subject|5|||
161315070|NCT02240069|582534840|FG001|Overall Study|Withdrawal by Subject|5|||
161315071|NCT02240069|582534841|FG002|Overall Study|Withdrawal by Subject|2|||
161315072|NCT01876979|582534842|FG000|Overall Study|Physician Decision|2|||
161315073|NCT01876979|582534843|FG001|Overall Study|Physician Decision|3|||
161315074|NCT02407054|582534845|FG000|Overall Study|Adverse Event|1|||
161315075|NCT02407054|582534846|FG001|Overall Study|Adverse Event|4|||
161315076|NCT02407054|582534847|FG002|Overall Study|Adverse Event|1|||
161315077|NCT02407054|582534845|FG000|Overall Study|Non-compliance with Study|0|||
161315078|NCT02407054|582534846|FG001|Overall Study|Non-compliance with Study|2|||
161315079|NCT02407054|582534847|FG002|Overall Study|Non-compliance with Study|1|||
161315080|NCT02407054|582534845|FG000|Overall Study|Physician Decision|1|||
161315081|NCT02407054|582534846|FG001|Overall Study|Physician Decision|3|||
161315082|NCT02407054|582534847|FG002|Overall Study|Physician Decision|3|||
161315083|NCT02407054|582534845|FG000|Overall Study|Withdrawal by Subject|5|||
161315084|NCT02407054|582534846|FG001|Overall Study|Withdrawal by Subject|9|||
161315085|NCT02407054|582534847|FG002|Overall Study|Withdrawal by Subject|2|||
161315086|NCT00932698|582534848|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
161315087|NCT00932698|582534849|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
161315088|NCT00932698|582534850|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
161315089|NCT00932698|582534851|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
161315090|NCT00932698|582534852|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
161315091|NCT00932698|582534853|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
161315092|NCT00932698|582534854|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
161315093|NCT00932698|582534855|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
161315094|NCT00932698|582534856|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
161315095|NCT00932698|582534857|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
161315096|NCT00932698|582534858|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
161315097|NCT00932698|582534848|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315098|NCT00932698|582534849|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161315099|NCT00932698|582534850|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315100|NCT00932698|582534851|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161315101|NCT00932698|582534852|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315102|NCT00932698|582534853|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161315103|NCT00932698|582534854|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
161315104|NCT00932698|582534855|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315105|NCT00932698|582534856|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315106|NCT00932698|582534857|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315107|NCT00932698|582534858|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
161315108|NCT00932698|582534848|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
161315109|NCT00932698|582534849|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
161315110|NCT00932698|582534850|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
161315111|NCT00932698|582534851|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
161315112|NCT00932698|582534852|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
161315113|NCT00932698|582534853|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
161315114|NCT00932698|582534854|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
161315115|NCT00932698|582534855|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
161315116|NCT00932698|582534856|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
161315117|NCT00932698|582534857|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
161315118|NCT00932698|582534858|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
161315119|NCT00932698|582534848|FG000|Part 1 (Dose Escalation)|Other|0|||
161315120|NCT00932698|582534849|FG001|Part 1 (Dose Escalation)|Other|0|||
161315121|NCT00932698|582534850|FG002|Part 1 (Dose Escalation)|Other|1|||
161315122|NCT00932698|582534851|FG003|Part 1 (Dose Escalation)|Other|0|||
161315123|NCT00932698|582534852|FG004|Part 1 (Dose Escalation)|Other|0|||
161315124|NCT00932698|582534853|FG005|Part 1 (Dose Escalation)|Other|0|||
161315125|NCT00932698|582534854|FG006|Part 1 (Dose Escalation)|Other|1|||
161315126|NCT00932698|582534855|FG007|Part 1 (Dose Escalation)|Other|0|||
161315127|NCT00932698|582534856|FG008|Part 1 (Dose Escalation)|Other|0|||
161315128|NCT00932698|582534857|FG009|Part 1 (Dose Escalation)|Other|0|||
161315129|NCT00932698|582534858|FG010|Part 1 (Dose Escalation)|Other|0|||
161315130|NCT00932698|582534848|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315131|NCT00932698|582534849|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315132|NCT00932698|582534850|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315133|NCT00932698|582534851|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315134|NCT00932698|582534852|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315135|NCT00932698|582534853|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315136|NCT00932698|582534854|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
161315137|NCT00932698|582534855|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
161315138|NCT00932698|582534856|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
161315139|NCT00932698|582534857|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
161315140|NCT00932698|582534858|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
161315141|NCT00932698|582534848|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315142|NCT00932698|582534849|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315143|NCT00932698|582534850|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315144|NCT00932698|582534851|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315145|NCT00932698|582534852|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315146|NCT00932698|582534853|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315147|NCT00932698|582534854|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315148|NCT00932698|582534855|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
161315149|NCT00932698|582534856|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
161315150|NCT00932698|582534857|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
161315151|NCT00932698|582534858|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
161315152|NCT00932698|582534848|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
161315153|NCT00932698|582534849|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
161315154|NCT00932698|582534850|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
161315155|NCT00932698|582534851|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
161315156|NCT00932698|582534852|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
161315157|NCT00932698|582534853|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
161315158|NCT00932698|582534854|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
161315159|NCT00932698|582534855|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
161315160|NCT00932698|582534856|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
161315161|NCT00932698|582534857|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
161315162|NCT00932698|582534858|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
161315163|NCT03046056|582536578|FG000|Overall Study|Non-responder at Week 10|6|||
161315164|NCT03046056|582536579|FG001|Overall Study|Non-responder at Week 10|6|||
161315165|NCT03046056|582536580|FG002|Overall Study|Non-responder at Week 10|4|||
161315166|NCT03046056|582536578|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
161315167|NCT03046056|582536579|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
161315168|NCT03046056|582536580|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
161315169|NCT03046056|582536578|FG000|Overall Study|Adverse Event|1|||
161315170|NCT03046056|582536579|FG001|Overall Study|Adverse Event|5|||
161315171|NCT03046056|582536580|FG002|Overall Study|Adverse Event|0|||
161315172|NCT03046056|582536578|FG000|Overall Study|Non-compliance With Study Drug|0|||
161315173|NCT03046056|582536579|FG001|Overall Study|Non-compliance With Study Drug|0|||
161315174|NCT03046056|582536580|FG002|Overall Study|Non-compliance With Study Drug|2|||
161315175|NCT03046056|582536578|FG000|Overall Study|Protocol Violation|1|||
161315176|NCT03046056|582536579|FG001|Overall Study|Protocol Violation|1|||
161315177|NCT03046056|582536580|FG002|Overall Study|Protocol Violation|0|||
161315178|NCT03046056|582536578|FG000|Overall Study|Investigator's Discretion|0|||
161315179|NCT03046056|582536579|FG001|Overall Study|Investigator's Discretion|1|||
161315180|NCT03046056|582536580|FG002|Overall Study|Investigator's Discretion|0|||
161315181|NCT03046056|582536578|FG000|Overall Study|Withdrew Consent|1|||
161315182|NCT03046056|582536579|FG001|Overall Study|Withdrew Consent|0|||
161315183|NCT03046056|582536580|FG002|Overall Study|Withdrew Consent|0|||
161315184|NCT03089853|582536581|FG000|Overall Study|Lost to Follow-up|2|||
161315185|NCT03089853|582536582|FG001|Overall Study|Lost to Follow-up|1|||
161315186|NCT01317004|582536583|FG000|Overall Study|Withdrawal by Subject|1|||
161315187|NCT01317004|582536584|FG001|Overall Study|Withdrawal by Subject|4|||
161315188|NCT01317004|582536583|FG000|Overall Study|Protocol Violation|0|||
161315189|NCT01317004|582536584|FG001|Overall Study|Protocol Violation|2|||
161315190|NCT01317004|582536583|FG000|Overall Study|Adverse Event|3|||
161315191|NCT01317004|582536584|FG001|Overall Study|Adverse Event|3|||
161315192|NCT01344759|582536587|FG000|Overall Study|Patients failed to reach sedation level|0|||
161315193|NCT01344759|582536588|FG001|Overall Study|Patients failed to reach sedation level|2|||
161315194|NCT02661061|582536590|FG000|Overall Study|Lack of Efficacy|1|||
161315195|NCT02661061|582536591|FG001|Overall Study|Lack of Efficacy|1|||
161315196|NCT02661061|582536590|FG000|Overall Study|Withdrawal by Subject|1|||
161315197|NCT02661061|582536591|FG001|Overall Study|Withdrawal by Subject|1|||
161315198|NCT01393106|582536592|FG000|Overall Study|Adverse Event|3|||
161315199|NCT01393106|582536592|FG000|Overall Study|Withdrawal by Subject|1|||
161315200|NCT01393106|582536592|FG000|Overall Study|Lack of Efficacy|1|||
161315201|NCT01698268|582536594|FG000|Overall Study|Physician Decision|2|||
161315202|NCT01698268|582536595|FG001|Overall Study|Physician Decision|1|||
161315203|NCT02263729|582536596|FG000|Overall Study|Lost to Follow-up|1|||
161315204|NCT02263729|582536597|FG001|Overall Study|Lost to Follow-up|1|||
161315205|NCT04591015|582536598|FG000|Overall Study|Death|6|||
161315206|NCT04591015|582536599|FG001|Overall Study|Death|4|||
161315207|NCT04591015|582536598|FG000|Overall Study|Withdrawal by Subject|6|||
161315208|NCT04591015|582536599|FG001|Overall Study|Withdrawal by Subject|3|||
161315209|NCT04591015|582536598|FG000|Overall Study|Lost to Follow-up|16|||
161315210|NCT04591015|582536599|FG001|Overall Study|Lost to Follow-up|11|||
161315211|NCT02509078|582536600|FG000|Overall Study|Protocol Violation|1|||
161315212|NCT02509078|582536601|FG001|Overall Study|Protocol Violation|1|||
161315213|NCT00631163|582536603|FG000|Number of Participants in Year 1|Adverse Event|12|||
161315214|NCT00631163|582536603|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
161315215|NCT00631163|582536603|FG000|Number of Participants in Year 1|Death|6|||
161315216|NCT00631163|582536603|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
161315217|NCT00631163|582536603|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
161315218|NCT00631163|582536603|FG000|Number of Participants in Year 1|Administrative problems|6|||
161315219|NCT00631163|582536603|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
161315220|NCT00631163|582536603|FG000|Number of Participants in Year 2|Adverse Event|1|||
161315221|NCT00631163|582536603|FG000|Number of Participants in Year 2|Protocol Violation|1|||
161315222|NCT00631163|582536603|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
161315223|NCT02290925|582536604|FG000|First Period of Three Months|Lost to Follow-up|2|||
161315224|NCT02290925|582536605|FG001|First Period of Three Months|Lost to Follow-up|1|||
161315225|NCT02290925|582536604|FG000|First Period of Three Months|Death|1|||
161315226|NCT02290925|582536605|FG001|First Period of Three Months|Death|0|||
161315227|NCT02290925|582536604|FG000|First Period of Three Months|Insulin Started|1|||
161315228|NCT02290925|582536605|FG001|First Period of Three Months|Insulin Started|1|||
161315229|NCT02290925|582536604|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
161315230|NCT02290925|582536605|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
161315231|NCT02290925|582536604|FG000|Second Period of 3 Months|insulin started|0|||
161315232|NCT02290925|582536605|FG001|Second Period of 3 Months|insulin started|1|||
161315233|NCT00388297|582536617|FG000|Overall Study|Lost to Follow-up|16|||
161315234|NCT00388297|582536618|FG001|Overall Study|Lost to Follow-up|12|||
161315235|NCT00388297|582536619|FG002|Overall Study|Lost to Follow-up|11|||
161315236|NCT00388297|582536620|FG003|Overall Study|Lost to Follow-up|8|||
161315237|NCT02696434|582536623|FG000|Overall Study|Adverse Event|3|||
161315238|NCT02696434|582536624|FG001|Overall Study|Adverse Event|1|||
161315239|NCT02696434|582536623|FG000|Overall Study|Lost to Follow-up|5|||
161315240|NCT02696434|582536624|FG001|Overall Study|Lost to Follow-up|4|||
161315241|NCT02696434|582536623|FG000|Overall Study|Withdrawal by Subject|14|||
161315242|NCT02696434|582536624|FG001|Overall Study|Withdrawal by Subject|12|||
161315243|NCT02696434|582536623|FG000|Overall Study|Physician Decision|0|||
161315244|NCT02696434|582536624|FG001|Overall Study|Physician Decision|1|||
161315245|NCT00316914|582536630|FG000|Overall Study|Withdrawal by Subject|5|||
161315246|NCT00316914|582536631|FG001|Overall Study|Withdrawal by Subject|3|||
161315247|NCT00316914|582536630|FG000|Overall Study|Adverse Event|8|||
161315248|NCT00316914|582536631|FG001|Overall Study|Adverse Event|7|||
161315249|NCT00316914|582536630|FG000|Overall Study|Other Problems|6|||
161315250|NCT00316914|582536631|FG001|Overall Study|Other Problems|11|||
161315251|NCT00316914|582536630|FG000|Overall Study|Missing end of treatment documentation|14|||
161315252|NCT00316914|582536631|FG001|Overall Study|Missing end of treatment documentation|15|||
161315253|NCT02284568|582536632|FG000|Overall Study|Adverse Event|2|||
161315254|NCT02284568|582536633|FG001|Overall Study|Adverse Event|9|||
161315255|NCT02284568|582536634|FG002|Overall Study|Adverse Event|4|||
161315256|NCT02284568|582536632|FG000|Overall Study|Withdrawal by Subject|22|||
161315257|NCT02284568|582536633|FG001|Overall Study|Withdrawal by Subject|21|||
161315258|NCT02284568|582536634|FG002|Overall Study|Withdrawal by Subject|1|||
161315259|NCT02284568|582536632|FG000|Overall Study|Noncompliance with study drug admin|1|||
161315260|NCT02284568|582536633|FG001|Overall Study|Noncompliance with study drug admin|2|||
161315261|NCT02284568|582536634|FG002|Overall Study|Noncompliance with study drug admin|0|||
161315262|NCT02284568|582536632|FG000|Overall Study|Noncompliance|1|||
161315263|NCT02284568|582536633|FG001|Overall Study|Noncompliance|0|||
161315264|NCT02284568|582536634|FG002|Overall Study|Noncompliance|0|||
161315265|NCT02284568|582536632|FG000|Overall Study|Protocol Violation|0|||
161315266|NCT02284568|582536633|FG001|Overall Study|Protocol Violation|1|||
161315267|NCT02284568|582536634|FG002|Overall Study|Protocol Violation|0|||
161315268|NCT02284568|582536632|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
161315269|NCT02284568|582536633|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
161315270|NCT02284568|582536634|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
161315271|NCT02284568|582536632|FG000|Overall Study|Lost to Follow-up|0|||
161315272|NCT02284568|582536633|FG001|Overall Study|Lost to Follow-up|3|||
161315273|NCT02284568|582536634|FG002|Overall Study|Lost to Follow-up|0|||
161315274|NCT02284568|582536632|FG000|Overall Study|Lack of Efficacy|4|||
161315275|NCT02284568|582536633|FG001|Overall Study|Lack of Efficacy|7|||
161315276|NCT02284568|582536634|FG002|Overall Study|Lack of Efficacy|0|||
161315277|NCT02284568|582536632|FG000|Overall Study|Other|1|||
161315278|NCT02284568|582536633|FG001|Overall Study|Other|2|||
161315279|NCT02284568|582536634|FG002|Overall Study|Other|0|||
161315280|NCT02284568|582536632|FG000|Overall Study|Withdrew before taking study drug|0|||
161315281|NCT02284568|582536633|FG001|Overall Study|Withdrew before taking study drug|1|||
161315282|NCT02284568|582536634|FG002|Overall Study|Withdrew before taking study drug|0|||
161315283|NCT00980174|582536638|FG000|Overall Study|Withdrawal by Subject|1|||
161315284|NCT00980174|582536639|FG001|Overall Study|Withdrawal by Subject|4|||
161315285|NCT00980174|582536638|FG000|Overall Study|Adverse Event|0|||
161315286|NCT00980174|582536639|FG001|Overall Study|Adverse Event|3|||
161315287|NCT00980174|582536638|FG000|Overall Study|Ineligibility determined|2|||
161315288|NCT00980174|582536639|FG001|Overall Study|Ineligibility determined|1|||
161315289|NCT00980174|582536638|FG000|Overall Study|Death|1|||
161315290|NCT00980174|582536639|FG001|Overall Study|Death|1|||
161315291|NCT00980174|582536638|FG000|Overall Study|Other|0|||
161315292|NCT00980174|582536639|FG001|Overall Study|Other|1|||
161315293|NCT01546038|582536641|FG000|Overall Study|Death|15|||
161315294|NCT01546038|582536642|FG001|Overall Study|Death|6|||
161315295|NCT01546038|582536643|FG002|Overall Study|Death|4|||
161315296|NCT01546038|582536644|FG003|Overall Study|Death|2|||
161315297|NCT01546038|582536645|FG004|Overall Study|Death|9|||
161315298|NCT01546038|582536646|FG005|Overall Study|Death|3|||
161315299|NCT01546038|582536647|FG006|Overall Study|Death|46|||
161315300|NCT01546038|582536648|FG007|Overall Study|Death|76|||
161315301|NCT01546038|582536649|FG008|Overall Study|Death|39|||
161315302|NCT01546038|582536641|FG000|Overall Study|Lost to Follow-up|0|||
161315303|NCT01546038|582536642|FG001|Overall Study|Lost to Follow-up|0|||
161315304|NCT01546038|582536643|FG002|Overall Study|Lost to Follow-up|0|||
161315305|NCT01546038|582536644|FG003|Overall Study|Lost to Follow-up|0|||
161315306|NCT01546038|582536645|FG004|Overall Study|Lost to Follow-up|1|||
161315307|NCT01546038|582536646|FG005|Overall Study|Lost to Follow-up|0|||
161315308|NCT01546038|582536647|FG006|Overall Study|Lost to Follow-up|2|||
161315309|NCT01546038|582536648|FG007|Overall Study|Lost to Follow-up|1|||
161315310|NCT01546038|582536649|FG008|Overall Study|Lost to Follow-up|0|||
161315311|NCT01546038|582536641|FG000|Overall Study|Withdrawal by Subject|1|||
161315312|NCT01546038|582536642|FG001|Overall Study|Withdrawal by Subject|0|||
161315313|NCT01546038|582536643|FG002|Overall Study|Withdrawal by Subject|0|||
161315314|NCT01546038|582536644|FG003|Overall Study|Withdrawal by Subject|1|||
161315315|NCT01546038|582536645|FG004|Overall Study|Withdrawal by Subject|0|||
161315316|NCT01546038|582536646|FG005|Overall Study|Withdrawal by Subject|1|||
161315317|NCT01546038|582536647|FG006|Overall Study|Withdrawal by Subject|3|||
161315318|NCT01546038|582536648|FG007|Overall Study|Withdrawal by Subject|3|||
161315319|NCT01546038|582536649|FG008|Overall Study|Withdrawal by Subject|1|||
161315320|NCT01546038|582536641|FG000|Overall Study|: Randomized, not treated|0|||
161315321|NCT01546038|582536642|FG001|Overall Study|: Randomized, not treated|0|||
161315322|NCT01546038|582536643|FG002|Overall Study|: Randomized, not treated|0|||
161315323|NCT01546038|582536644|FG003|Overall Study|: Randomized, not treated|0|||
161315324|NCT01546038|582536645|FG004|Overall Study|: Randomized, not treated|0|||
161315325|NCT01546038|582536646|FG005|Overall Study|: Randomized, not treated|0|||
161315326|NCT01546038|582536647|FG006|Overall Study|: Randomized, not treated|2|||
161315327|NCT01546038|582536648|FG007|Overall Study|: Randomized, not treated|4|||
161315328|NCT01546038|582536649|FG008|Overall Study|: Randomized, not treated|3|||
161315329|NCT00424021|582536650|FG000|NCT00046319 Study Period|Adverse Event|1|||
161315330|NCT00424021|582536651|FG001|NCT00046319 Study Period|Adverse Event|0|||
161315331|NCT00424021|582536652|FG002|NCT00046319 Study Period|Adverse Event|1|||
161315332|NCT00424021|582536653|FG003|NCT00046319 Study Period|Adverse Event|1|||
161315333|NCT00424021|582536650|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
161315334|NCT00424021|582536651|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
161315335|NCT00424021|582536652|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
161315336|NCT00424021|582536653|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
161315337|NCT00424021|582536650|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
161315338|NCT00424021|582536651|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
161315339|NCT00424021|582536652|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
161315340|NCT00424021|582536653|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
161315341|NCT00424021|582536650|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
161315342|NCT00424021|582536651|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
161315343|NCT00424021|582536652|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
161315344|NCT00424021|582536653|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
161315345|NCT00424021|582536650|FG000|AMB-220-E Study Period|Adverse Event|1|||
161315346|NCT00424021|582536651|FG001|AMB-220-E Study Period|Adverse Event|1|||
161315347|NCT00424021|582536652|FG002|AMB-220-E Study Period|Adverse Event|3|||
161315348|NCT00424021|582536653|FG003|AMB-220-E Study Period|Adverse Event|7|||
161315349|NCT00424021|582536650|FG000|AMB-220-E Study Period|Death|0|||
161315350|NCT00424021|582536651|FG001|AMB-220-E Study Period|Death|0|||
161315351|NCT00424021|582536652|FG002|AMB-220-E Study Period|Death|1|||
161315352|NCT00424021|582536653|FG003|AMB-220-E Study Period|Death|1|||
161315353|NCT00424021|582536650|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
161315354|NCT00424021|582536651|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
161315355|NCT00424021|582536652|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
161315356|NCT00424021|582536653|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
161315357|NCT00424021|582536650|FG000|AMB-220-E Study Period|Physician Decision|0|||
161315358|NCT00424021|582536651|FG001|AMB-220-E Study Period|Physician Decision|0|||
161315359|NCT00424021|582536652|FG002|AMB-220-E Study Period|Physician Decision|0|||
161315360|NCT00424021|582536653|FG003|AMB-220-E Study Period|Physician Decision|1|||
161315361|NCT03769194|582536654|FG000|Overall Study|Withdrawal by Subject|0|||
161315362|NCT03769194|582536655|FG001|Overall Study|Withdrawal by Subject|7|||
161315363|NCT03769194|582536656|FG002|Overall Study|Withdrawal by Subject|4|||
161315364|NCT03769194|582536657|FG003|Overall Study|Withdrawal by Subject|1|||
161315365|NCT03769194|582536654|FG000|Overall Study|moved from study area|0|||
161315366|NCT03769194|582536655|FG001|Overall Study|moved from study area|2|||
161315367|NCT03769194|582536656|FG002|Overall Study|moved from study area|1|||
161315368|NCT03769194|582536657|FG003|Overall Study|moved from study area|1|||
161315369|NCT03769194|582536654|FG000|Overall Study|Lost to Follow-up|3|||
161315370|NCT03769194|582536655|FG001|Overall Study|Lost to Follow-up|6|||
161315371|NCT03769194|582536656|FG002|Overall Study|Lost to Follow-up|3|||
161315372|NCT03769194|582536657|FG003|Overall Study|Lost to Follow-up|6|||
161315373|NCT03769194|582536654|FG000|Overall Study|other|1|||
161315374|NCT03769194|582536655|FG001|Overall Study|other|3|||
161315375|NCT03769194|582536656|FG002|Overall Study|other|0|||
161315376|NCT03769194|582536657|FG003|Overall Study|other|1|||
161315377|NCT00312572|582536659|FG000|Overall Study|Adverse Event|10|||
161315378|NCT00312572|582536660|FG001|Overall Study|Adverse Event|16|||
161315379|NCT00312572|582536659|FG000|Overall Study|Lost to Follow-up|1|||
161315380|NCT00312572|582536660|FG001|Overall Study|Lost to Follow-up|1|||
161315381|NCT00312572|582536659|FG000|Overall Study|Administrative|4|||
161315382|NCT00312572|582536660|FG001|Overall Study|Administrative|2|||
161315383|NCT00312572|582536659|FG000|Overall Study|Lack of Efficacy|1|||
161315384|NCT00312572|582536660|FG001|Overall Study|Lack of Efficacy|2|||
161315385|NCT02614131|582536665|FG000|Overall Study|Withdrawal by Subject|1|||
161315386|NCT02614131|582536666|FG001|Overall Study|Withdrawal by Subject|0|||
161315387|NCT02614131|582536667|FG002|Overall Study|Withdrawal by Subject|0|||
161315388|NCT02614131|582536668|FG003|Overall Study|Withdrawal by Subject|0|||
161315389|NCT02614131|582536669|FG004|Overall Study|Withdrawal by Subject|0|||
161315390|NCT02614131|582536670|FG005|Overall Study|Withdrawal by Subject|0|||
161315391|NCT02614131|582536671|FG006|Overall Study|Withdrawal by Subject|0|||
161315392|NCT02614131|582536665|FG000|Overall Study|Adverse Event|0|||
161315393|NCT02614131|582536666|FG001|Overall Study|Adverse Event|0|||
161315394|NCT02614131|582536667|FG002|Overall Study|Adverse Event|0|||
161315395|NCT02614131|582536668|FG003|Overall Study|Adverse Event|0|||
161315396|NCT02614131|582536669|FG004|Overall Study|Adverse Event|0|||
161315397|NCT02614131|582536670|FG005|Overall Study|Adverse Event|0|||
161315398|NCT02614131|582536671|FG006|Overall Study|Adverse Event|1|||
161315399|NCT01832818|582536672|FG000|Overall Study|Lost to Follow-up|6|||
161315400|NCT00568334|582536673|FG000|Overall Study|Withdrawal by Subject|0|||
161315401|NCT00568334|582536674|FG001|Overall Study|Withdrawal by Subject|1|||
161315402|NCT00568334|582536673|FG000|Overall Study|Lost to Follow-up|1|||
161315403|NCT00568334|582536674|FG001|Overall Study|Lost to Follow-up|0|||
161315404|NCT01897571|582536675|FG000|Overall Study|Lost to Follow-up|3|||
161315405|NCT01897571|582536676|FG001|Overall Study|Lost to Follow-up|0|||
161315406|NCT01897571|582536677|FG002|Overall Study|Lost to Follow-up|0|||
161315407|NCT01897571|582536678|FG003|Overall Study|Lost to Follow-up|0|||
161315408|NCT01897571|582536679|FG004|Overall Study|Lost to Follow-up|2|||
161315409|NCT01897571|582536680|FG005|Overall Study|Lost to Follow-up|0|||
161315410|NCT01897571|582536681|FG006|Overall Study|Lost to Follow-up|0|||
161315411|NCT01897571|582536682|FG007|Overall Study|Lost to Follow-up|0|||
161315412|NCT01897571|582536683|FG008|Overall Study|Lost to Follow-up|1|||
161315413|NCT01897571|582536684|FG009|Overall Study|Lost to Follow-up|2|||
161315414|NCT01897571|582536685|FG010|Overall Study|Lost to Follow-up|4|||
161315415|NCT01897571|582536675|FG000|Overall Study|Withdrawal by Subject|0|||
161315416|NCT01897571|582536676|FG001|Overall Study|Withdrawal by Subject|0|||
161315417|NCT01897571|582536677|FG002|Overall Study|Withdrawal by Subject|0|||
161315418|NCT01897571|582536678|FG003|Overall Study|Withdrawal by Subject|0|||
161315419|NCT01897571|582536679|FG004|Overall Study|Withdrawal by Subject|0|||
161315420|NCT01897571|582536680|FG005|Overall Study|Withdrawal by Subject|0|||
161315421|NCT01897571|582536681|FG006|Overall Study|Withdrawal by Subject|0|||
161315422|NCT01897571|582536682|FG007|Overall Study|Withdrawal by Subject|1|||
161315423|NCT01897571|582536683|FG008|Overall Study|Withdrawal by Subject|4|||
161315424|NCT01897571|582536684|FG009|Overall Study|Withdrawal by Subject|3|||
161315425|NCT01897571|582536685|FG010|Overall Study|Withdrawal by Subject|1|||
161315426|NCT01897571|582536675|FG000|Overall Study|Other|1|||
161315427|NCT01897571|582536676|FG001|Overall Study|Other|0|||
161315428|NCT01897571|582536677|FG002|Overall Study|Other|0|||
161315429|NCT01897571|582536678|FG003|Overall Study|Other|3|||
161315430|NCT01897571|582536679|FG004|Overall Study|Other|3|||
161315431|NCT01897571|582536680|FG005|Overall Study|Other|4|||
161315432|NCT01897571|582536681|FG006|Overall Study|Other|7|||
161315433|NCT01897571|582536682|FG007|Overall Study|Other|0|||
161315434|NCT01897571|582536683|FG008|Overall Study|Other|0|||
161315435|NCT01897571|582536684|FG009|Overall Study|Other|0|||
161315436|NCT01897571|582536685|FG010|Overall Study|Other|0|||
161315437|NCT01897571|582536675|FG000|Overall Study|Enrolled in rollover study|0|||
161315438|NCT01897571|582536676|FG001|Overall Study|Enrolled in rollover study|0|||
161315439|NCT01897571|582536677|FG002|Overall Study|Enrolled in rollover study|0|||
161315440|NCT01897571|582536678|FG003|Overall Study|Enrolled in rollover study|0|||
161315441|NCT01897571|582536679|FG004|Overall Study|Enrolled in rollover study|0|||
161315442|NCT01897571|582536680|FG005|Overall Study|Enrolled in rollover study|0|||
161315443|NCT01897571|582536681|FG006|Overall Study|Enrolled in rollover study|0|||
161315444|NCT01897571|582536682|FG007|Overall Study|Enrolled in rollover study|9|||
161315445|NCT01897571|582536683|FG008|Overall Study|Enrolled in rollover study|7|||
161315446|NCT01897571|582536684|FG009|Overall Study|Enrolled in rollover study|9|||
161315447|NCT01897571|582536685|FG010|Overall Study|Enrolled in rollover study|1|||
161315448|NCT01897571|582536675|FG000|Overall Study|Death|2|||
161315449|NCT01897571|582536676|FG001|Overall Study|Death|2|||
161315450|NCT01897571|582536677|FG002|Overall Study|Death|3|||
161315451|NCT01897571|582536678|FG003|Overall Study|Death|6|||
161315452|NCT01897571|582536679|FG004|Overall Study|Death|7|||
161315453|NCT01897571|582536680|FG005|Overall Study|Death|9|||
161315454|NCT01897571|582536681|FG006|Overall Study|Death|5|||
161315455|NCT01897571|582536682|FG007|Overall Study|Death|22|||
161315456|NCT01897571|582536683|FG008|Overall Study|Death|23|||
161315457|NCT01897571|582536684|FG009|Overall Study|Death|129|||
161315458|NCT01897571|582536685|FG010|Overall Study|Death|59|||
161315459|NCT01797094|582536686|FG000|Overall Study|Adverse Event|1|||
161315460|NCT01797094|582536687|FG001|Overall Study|Adverse Event|1|||
161315461|NCT01797094|582536686|FG000|Overall Study|Personal Reasons|4|||
161315462|NCT01797094|582536687|FG001|Overall Study|Personal Reasons|0|||
161315463|NCT01797094|582536686|FG000|Overall Study|Protocol Violation|0|||
161315464|NCT01797094|582536687|FG001|Overall Study|Protocol Violation|1|||
161315465|NCT01797094|582536686|FG000|Overall Study|Other Miscellaneous Reasons|1|||
161315466|NCT01797094|582536687|FG001|Overall Study|Other Miscellaneous Reasons|0|||
161315467|NCT03217968|582536688|FG000|Overall Study|Withdrawal by Subject|4|||
161315468|NCT03217968|582536688|FG000|Overall Study|Lost to Follow-up|1|||
161315469|NCT03217968|582536688|FG000|Overall Study|Protocol Violation|6|||
161315470|NCT03008278|582536689|FG000|Overall Study|Progressive Disease|0|||
161315471|NCT03008278|582536690|FG001|Overall Study|Progressive Disease|0|||
161315472|NCT03008278|582536691|FG002|Overall Study|Progressive Disease|32|||
161315473|NCT03008278|582536689|FG000|Overall Study|Adverse Event|0|||
161315474|NCT03008278|582536690|FG001|Overall Study|Adverse Event|0|||
161315475|NCT03008278|582536691|FG002|Overall Study|Adverse Event|4|||
161315476|NCT03008278|582536689|FG000|Overall Study|Withdrawal by Subject|0|||
161315477|NCT03008278|582536690|FG001|Overall Study|Withdrawal by Subject|0|||
161315478|NCT03008278|582536691|FG002|Overall Study|Withdrawal by Subject|3|||
161315479|NCT03008278|582536689|FG000|Overall Study|Physician Decision|0|||
161315480|NCT03008278|582536690|FG001|Overall Study|Physician Decision|2|||
161315481|NCT03008278|582536691|FG002|Overall Study|Physician Decision|0|||
161315482|NCT01074255|582536692|FG000|Overall Study|Did not receive EMEND|2|||
161315483|NCT01389258|582536693|FG000|Overall Study|Lost to Follow-up|5|||
161315484|NCT03313310|582536694|FG000|Phase 2|Lost to Follow-up|4|||
161315485|NCT03313310|582536695|FG001|Phase 2|Lost to Follow-up|0|||
161315486|NCT03313310|582536694|FG000|Phase 3|Lost to Follow-up|0|||
161315487|NCT03313310|582536695|FG001|Phase 3|Lost to Follow-up|1|||
161315488|NCT03170609|582536698|FG000|Overall Study|Death|0|||
161315489|NCT03170609|582536699|FG001|Overall Study|Death|0|||
161315490|NCT03170609|582536700|FG002|Overall Study|Death|1|||
161315491|NCT03170609|582536701|FG003|Overall Study|Death|0|||
161315492|NCT03170609|582536702|FG004|Overall Study|Death|0|||
161315493|NCT03170609|582536703|FG005|Overall Study|Death|0|||
161315494|NCT03170609|582536704|FG006|Overall Study|Death|0|||
161315495|NCT03170609|582536698|FG000|Overall Study|Withdrawal by Subject|1|||
161315496|NCT03170609|582536699|FG001|Overall Study|Withdrawal by Subject|2|||
161315497|NCT03170609|582536700|FG002|Overall Study|Withdrawal by Subject|0|||
161315498|NCT03170609|582536701|FG003|Overall Study|Withdrawal by Subject|0|||
161315499|NCT03170609|582536702|FG004|Overall Study|Withdrawal by Subject|0|||
161315500|NCT03170609|582536703|FG005|Overall Study|Withdrawal by Subject|0|||
161315501|NCT03170609|582536704|FG006|Overall Study|Withdrawal by Subject|1|||
161315502|NCT03170609|582536698|FG000|Overall Study|Lost to Follow-up|1|||
161315503|NCT03170609|582536699|FG001|Overall Study|Lost to Follow-up|0|||
161315504|NCT03170609|582536700|FG002|Overall Study|Lost to Follow-up|5|||
161315505|NCT03170609|582536701|FG003|Overall Study|Lost to Follow-up|2|||
161315506|NCT03170609|582536702|FG004|Overall Study|Lost to Follow-up|1|||
161315507|NCT03170609|582536703|FG005|Overall Study|Lost to Follow-up|1|||
161315508|NCT03170609|582536704|FG006|Overall Study|Lost to Follow-up|0|||
161315509|NCT03170609|582536698|FG000|Overall Study|Other|1|||
161315510|NCT03170609|582536699|FG001|Overall Study|Other|0|||
161315511|NCT03170609|582536700|FG002|Overall Study|Other|0|||
161315512|NCT03170609|582536701|FG003|Overall Study|Other|0|||
161315513|NCT03170609|582536702|FG004|Overall Study|Other|0|||
161315514|NCT03170609|582536703|FG005|Overall Study|Other|1|||
161315515|NCT03170609|582536704|FG006|Overall Study|Other|0|||
161315516|NCT01904903|582536714|FG000|Overall Study|Withdrawal by Subject|1|||
161315517|NCT00314132|582536715|FG000|Overall Study|Lost to Follow-up|3|||
161315518|NCT00314132|582536716|FG001|Overall Study|Lost to Follow-up|13|||
161315519|NCT00314132|582536715|FG000|Overall Study|Withdrawal by Subject|3|||
161315520|NCT00314132|582536716|FG001|Overall Study|Withdrawal by Subject|5|||
161315521|NCT00314132|582536715|FG000|Overall Study|Adverse Event|1|||
161315522|NCT00314132|582536716|FG001|Overall Study|Adverse Event|0|||
161315523|NCT00314132|582536715|FG000|Overall Study|Physician Decision|1|||
161315524|NCT00314132|582536716|FG001|Overall Study|Physician Decision|0|||
161315525|NCT01634659|582536718|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
161315526|NCT01634659|582536719|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
161315527|NCT01634659|582536718|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
161315528|NCT01634659|582536719|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
161315529|NCT02918552|582536720|FG000|Overall Study|Failed Pharmacokinetics|1|||
161315530|NCT02918552|582536721|FG001|Overall Study|Failed Pharmacokinetics|0|||
161315531|NCT02918552|582536720|FG000|Overall Study|Withdrawal by Subject|0|||
161315532|NCT02918552|582536721|FG001|Overall Study|Withdrawal by Subject|1|||
161315533|NCT02918552|582536720|FG000|Overall Study|Lost to Follow-up|0|||
161315534|NCT02918552|582536721|FG001|Overall Study|Lost to Follow-up|1|||
161315535|NCT04395274|582536722|FG000|Overall Study|Lost to Follow-up|20|||
161315536|NCT04395274|582536723|FG001|Overall Study|Lost to Follow-up|11|||
161315537|NCT04395274|582536722|FG000|Overall Study|Withdrawal by Subject|13|||
161315538|NCT04395274|582536723|FG001|Overall Study|Withdrawal by Subject|10|||
161315539|NCT04395274|582536722|FG000|Overall Study|Moved Abroad|0|||
161315540|NCT04395274|582536723|FG001|Overall Study|Moved Abroad|1|||
161315541|NCT00335959|582536724|FG000|Overall Study|Adverse Event|2|||
161315542|NCT00335959|582536724|FG000|Overall Study|Ineligible|1|||
161315543|NCT00824382|582536727|FG000|Overall Study|Adverse Event|4|||
161315544|NCT00824382|582536728|FG001|Overall Study|Adverse Event|1|||
161315545|NCT00824382|582536729|FG002|Overall Study|Adverse Event|1|||
161315546|NCT00824382|582536730|FG003|Overall Study|Adverse Event|4|||
161315547|NCT00824382|582536727|FG000|Overall Study|Protocol Violation|1|||
161315548|NCT00824382|582536728|FG001|Overall Study|Protocol Violation|0|||
161315549|NCT00824382|582536729|FG002|Overall Study|Protocol Violation|0|||
161315550|NCT00824382|582536730|FG003|Overall Study|Protocol Violation|1|||
161315551|NCT00824382|582536727|FG000|Overall Study|Investigator's decision|0|||
161315552|NCT00824382|582536728|FG001|Overall Study|Investigator's decision|1|||
161315553|NCT00824382|582536729|FG002|Overall Study|Investigator's decision|2|||
161315554|NCT00824382|582536730|FG003|Overall Study|Investigator's decision|0|||
161315555|NCT02908074|582536732|FG000|Overall Study|sponsor/ICON decision|0|||
161315556|NCT02908074|582536733|FG001|Overall Study|sponsor/ICON decision|0|||
161315557|NCT02908074|582536734|FG002|Overall Study|sponsor/ICON decision|1|||
161315558|NCT02908074|582536735|FG003|Overall Study|sponsor/ICON decision|0|||
161315559|NCT02908074|582536736|FG004|Overall Study|sponsor/ICON decision|0|||
161315560|NCT02908074|582536737|FG005|Overall Study|sponsor/ICON decision|0|||
161315561|NCT02908074|582536732|FG000|Overall Study|Protocol Violation|0|||
161315562|NCT02908074|582536733|FG001|Overall Study|Protocol Violation|1|||
161315563|NCT02908074|582536734|FG002|Overall Study|Protocol Violation|0|||
161315564|NCT02908074|582536735|FG003|Overall Study|Protocol Violation|0|||
161315565|NCT02908074|582536736|FG004|Overall Study|Protocol Violation|0|||
161315566|NCT02908074|582536737|FG005|Overall Study|Protocol Violation|0|||
161315567|NCT02908074|582536732|FG000|Overall Study|Adverse Event|5|||
161315568|NCT02908074|582536733|FG001|Overall Study|Adverse Event|2|||
161315569|NCT02908074|582536734|FG002|Overall Study|Adverse Event|0|||
161315570|NCT02908074|582536735|FG003|Overall Study|Adverse Event|0|||
161315571|NCT02908074|582536736|FG004|Overall Study|Adverse Event|1|||
161315572|NCT02908074|582536737|FG005|Overall Study|Adverse Event|0|||
161315573|NCT02908074|582536732|FG000|Overall Study|AESI|1|||
161315574|NCT02908074|582536733|FG001|Overall Study|AESI|0|||
161315575|NCT02908074|582536734|FG002|Overall Study|AESI|1|||
161315576|NCT02908074|582536735|FG003|Overall Study|AESI|0|||
161315577|NCT02908074|582536736|FG004|Overall Study|AESI|1|||
161315578|NCT02908074|582536737|FG005|Overall Study|AESI|0|||
161315579|NCT02908074|582536732|FG000|Overall Study|Discontinuation criteria per protocol|0|||
161315580|NCT02908074|582536733|FG001|Overall Study|Discontinuation criteria per protocol|0|||
161315581|NCT02908074|582536734|FG002|Overall Study|Discontinuation criteria per protocol|1|||
161315582|NCT02908074|582536735|FG003|Overall Study|Discontinuation criteria per protocol|0|||
161315583|NCT02908074|582536736|FG004|Overall Study|Discontinuation criteria per protocol|0|||
161315584|NCT02908074|582536737|FG005|Overall Study|Discontinuation criteria per protocol|1|||
161315585|NCT02908074|582536732|FG000|Overall Study|Withdrawal by Subject|3|||
161315586|NCT02908074|582536733|FG001|Overall Study|Withdrawal by Subject|2|||
161315587|NCT02908074|582536734|FG002|Overall Study|Withdrawal by Subject|2|||
161315588|NCT02908074|582536735|FG003|Overall Study|Withdrawal by Subject|2|||
161315589|NCT02908074|582536736|FG004|Overall Study|Withdrawal by Subject|2|||
161315590|NCT02908074|582536737|FG005|Overall Study|Withdrawal by Subject|2|||
161315591|NCT02908074|582536732|FG000|Overall Study|Lost to Follow-up|0|||
161315592|NCT02908074|582536733|FG001|Overall Study|Lost to Follow-up|1|||
161315593|NCT02908074|582536734|FG002|Overall Study|Lost to Follow-up|1|||
161315594|NCT02908074|582536735|FG003|Overall Study|Lost to Follow-up|1|||
161315595|NCT02908074|582536736|FG004|Overall Study|Lost to Follow-up|0|||
161315596|NCT02908074|582536737|FG005|Overall Study|Lost to Follow-up|1|||
161315597|NCT02227368|582538058|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
161315598|NCT02227368|582538059|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
161315599|NCT02227368|582538058|FG000|Overall Study|Lost to Follow-up|1|||
161315600|NCT02227368|582538059|FG001|Overall Study|Lost to Follow-up|0|||
161315601|NCT02227368|582538058|FG000|Overall Study|Adverse Event|1|||
161315602|NCT02227368|582538059|FG001|Overall Study|Adverse Event|0|||
161315603|NCT01890759|582538061|FG000|Overall Study|Protocol Violation|0|||
161315604|NCT01890759|582538062|FG001|Overall Study|Protocol Violation|2|||
161315605|NCT01890759|582538061|FG000|Overall Study|Lost to Follow-up|0|||
161315606|NCT01890759|582538062|FG001|Overall Study|Lost to Follow-up|2|||
161315607|NCT01890759|582538061|FG000|Overall Study|Withdrawal by Subject|2|||
161315608|NCT01890759|582538062|FG001|Overall Study|Withdrawal by Subject|8|||
161315609|NCT04114656|582538063|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
161315610|NCT04114656|582538064|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
161315611|NCT04114656|582538063|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
161315612|NCT04114656|582538064|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
161315613|NCT04114656|582538063|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
161315614|NCT04114656|582538064|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
161315615|NCT04114656|582538063|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
161315616|NCT04114656|582538064|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
161315617|NCT04114656|582538063|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
161315618|NCT04114656|582538064|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
161315619|NCT00703326|582538065|FG000|Overall Study|Lost to Follow-up|47|||
161315620|NCT00703326|582538066|FG001|Overall Study|Lost to Follow-up|18|||
161315621|NCT00703326|582538065|FG000|Overall Study|Withdrawal by Subject|54|||
161315622|NCT00703326|582538066|FG001|Overall Study|Withdrawal by Subject|20|||
161315623|NCT00703326|582538065|FG000|Overall Study|Adverse Event|1|||
161315624|NCT00703326|582538066|FG001|Overall Study|Adverse Event|0|||
161315625|NCT02732015|582538067|FG000|Overall Study|Lost to Follow-up|0|||
161315626|NCT02732015|582538068|FG001|Overall Study|Lost to Follow-up|1|||
161315627|NCT03052920|582538069|FG000|Overall Study|Withdrawal by Subject|1|||
161315628|NCT01980628|582538070|FG000|Overall Study|Adverse Event|12|||
161315629|NCT01980628|582538070|FG000|Overall Study|Physician Decision|5|||
161315630|NCT01980628|582538070|FG000|Overall Study|Withdrawal by Subject|4|||
161315631|NCT01980628|582538070|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
161315632|NCT05437640|582538073|FG000|Washout (1 Week)|Adverse Event|1|||
161315633|NCT05437640|582538074|FG001|Washout (1 Week)|Adverse Event|0|||
161315634|NCT02474355|582538075|FG000|Overall Study|Other|43|||
161315635|NCT02474355|582538075|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
161315636|NCT02474355|582538075|FG000|Overall Study|Lost to Follow-up|98|||
161315637|NCT02474355|582538075|FG000|Overall Study|Withdrawal by Subject|124|||
161315638|NCT02474355|582538075|FG000|Overall Study|Death|1361|||
161315639|NCT03015194|582538076|FG000|Overall Study|Death|10|||
161315640|NCT03015194|582538076|FG000|Overall Study|Withdrawal by Subject|2|||
161315641|NCT01937715|582538080|FG000|Overall Study|Death|0|||
161315642|NCT01937715|582538081|FG001|Overall Study|Death|0|||
161315643|NCT01937715|582538082|FG002|Overall Study|Death|0|||
161315644|NCT01937715|582538083|FG003|Overall Study|Death|1|||
161315645|NCT01937715|582538084|FG004|Overall Study|Death|0|||
161315646|NCT01937715|582538080|FG000|Overall Study|Withdrawal by Subject|0|||
161315647|NCT01937715|582538081|FG001|Overall Study|Withdrawal by Subject|1|||
161315648|NCT01937715|582538082|FG002|Overall Study|Withdrawal by Subject|0|||
161315649|NCT01937715|582538083|FG003|Overall Study|Withdrawal by Subject|0|||
161315650|NCT01937715|582538084|FG004|Overall Study|Withdrawal by Subject|2|||
161315651|NCT01937715|582538080|FG000|Overall Study|Other|0|||
161315652|NCT01937715|582538081|FG001|Overall Study|Other|0|||
161315653|NCT01937715|582538082|FG002|Overall Study|Other|0|||
161315654|NCT01937715|582538083|FG003|Overall Study|Other|3|||
161315655|NCT01937715|582538084|FG004|Overall Study|Other|0|||
161315656|NCT00433017|582538087|FG000|Overall Study|Adverse Event|5|||
161315657|NCT00433017|582538088|FG001|Overall Study|Adverse Event|3|||
161315658|NCT00433017|582538087|FG000|Overall Study|Withdrawal by Subject|4|||
161315659|NCT00433017|582538088|FG001|Overall Study|Withdrawal by Subject|5|||
161315660|NCT00433017|582538087|FG000|Overall Study|Lost to Follow-up|3|||
161315661|NCT00433017|582538088|FG001|Overall Study|Lost to Follow-up|4|||
161315662|NCT00433017|582538087|FG000|Overall Study|Administrative problems|80|||
161315663|NCT00433017|582538088|FG001|Overall Study|Administrative problems|86|||
161315664|NCT00433017|582538087|FG000|Overall Study|Protocol Violation|1|||
161315665|NCT00433017|582538088|FG001|Overall Study|Protocol Violation|0|||
161315666|NCT00433017|582538087|FG000|Overall Study|Death|2|||
161315667|NCT00433017|582538088|FG001|Overall Study|Death|2|||
161315668|NCT00433017|582538087|FG000|Overall Study|Subject no longer requires study drug|1|||
161315669|NCT00433017|582538088|FG001|Overall Study|Subject no longer requires study drug|1|||
161315670|NCT00153816|582538089|FG000|Overall Study|Death|6|||
161315671|NCT00153816|582538090|FG001|Overall Study|Death|5|||
161315672|NCT00153816|582538091|FG002|Overall Study|Death|4|||
161315673|NCT00153816|582538092|FG003|Overall Study|Death|6|||
161315674|NCT00153816|582538093|FG004|Overall Study|Death|0|||
161315675|NCT00153816|582538094|FG005|Overall Study|Death|2|||
161315676|NCT00153816|582538089|FG000|Overall Study|Lost to Follow-up|7|||
161315677|NCT00153816|582538090|FG001|Overall Study|Lost to Follow-up|8|||
161315678|NCT00153816|582538091|FG002|Overall Study|Lost to Follow-up|5|||
161315679|NCT00153816|582538092|FG003|Overall Study|Lost to Follow-up|8|||
161315680|NCT00153816|582538093|FG004|Overall Study|Lost to Follow-up|7|||
161315681|NCT00153816|582538094|FG005|Overall Study|Lost to Follow-up|9|||
161315682|NCT00153816|582538089|FG000|Overall Study|Withdrawal by Subject|9|||
161315683|NCT00153816|582538090|FG001|Overall Study|Withdrawal by Subject|9|||
161315684|NCT00153816|582538091|FG002|Overall Study|Withdrawal by Subject|9|||
161315685|NCT00153816|582538092|FG003|Overall Study|Withdrawal by Subject|4|||
161315686|NCT00153816|582538093|FG004|Overall Study|Withdrawal by Subject|1|||
161315687|NCT00153816|582538094|FG005|Overall Study|Withdrawal by Subject|5|||
161315688|NCT00153816|582538089|FG000|Overall Study|Follow-up exam not done|8|||
161315689|NCT00153816|582538090|FG001|Overall Study|Follow-up exam not done|7|||
161315690|NCT00153816|582538091|FG002|Overall Study|Follow-up exam not done|11|||
161315691|NCT00153816|582538092|FG003|Overall Study|Follow-up exam not done|10|||
161315692|NCT00153816|582538093|FG004|Overall Study|Follow-up exam not done|8|||
161315693|NCT00153816|582538094|FG005|Overall Study|Follow-up exam not done|9|||
161315694|NCT00153816|582538089|FG000|Overall Study|Follow-up exam done, histology missing|2|||
161315695|NCT00153816|582538090|FG001|Overall Study|Follow-up exam done, histology missing|3|||
161315696|NCT00153816|582538091|FG002|Overall Study|Follow-up exam done, histology missing|3|||
161315697|NCT00153816|582538092|FG003|Overall Study|Follow-up exam done, histology missing|3|||
161315698|NCT00153816|582538093|FG004|Overall Study|Follow-up exam done, histology missing|1|||
161315699|NCT00153816|582538094|FG005|Overall Study|Follow-up exam done, histology missing|2|||
161315700|NCT03594955|582538097|FG000|Overall Study|Adverse Event|1|||
161315701|NCT03594955|582538097|FG000|Overall Study|Progressive disease|5|||
161315702|NCT03594955|582538097|FG000|Overall Study|Sponsor's decision|1|||
161315703|NCT02131636|582538104|FG000|Overall Study|Personal Reasons|4|||
161315704|NCT02131636|582538105|FG001|Overall Study|Personal Reasons|4|||
161315705|NCT02131636|582538104|FG000|Overall Study|Lost to Follow-up|4|||
161315706|NCT02131636|582538105|FG001|Overall Study|Lost to Follow-up|0|||
161315707|NCT02131636|582538104|FG000|Overall Study|Adverse Event|4|||
161315708|NCT02131636|582538105|FG001|Overall Study|Adverse Event|1|||
161315709|NCT06226649|582538106|FG000|Overall Study|Withdrawal by Subject|4|||
161315710|NCT06226649|582538107|FG001|Overall Study|Withdrawal by Subject|1|||
161315711|NCT02305446|582538112|FG000|Overall Study|Adverse Event|1|||
161315712|NCT00427999|582538115|FG000|Overall Study|Adverse Event|6|||
161315713|NCT00427999|582538115|FG000|Overall Study|Abnormal laboratory values|1|||
161315714|NCT00427999|582538115|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
161315715|NCT00427999|582538115|FG000|Overall Study|Protocol Violation|2|||
161315716|NCT00427999|582538115|FG000|Overall Study|Withdrawal by Subject|9|||
161315717|NCT00427999|582538115|FG000|Overall Study|Death|1|||
161315718|NCT00460265|582538116|FG000|Overall Study|Lost to Follow-up|14|||
161315719|NCT00460265|582538117|FG001|Overall Study|Lost to Follow-up|15|||
161315720|NCT00460265|582538116|FG000|Overall Study|Physician Decision|1|||
161315721|NCT00460265|582538117|FG001|Overall Study|Physician Decision|2|||
161315722|NCT00460265|582538116|FG000|Overall Study|Withdrawal by Subject|10|||
161315723|NCT00460265|582538117|FG001|Overall Study|Withdrawal by Subject|25|||
161315724|NCT00460265|582538116|FG000|Overall Study|Ongoing|60|||
161315725|NCT00460265|582538117|FG001|Overall Study|Ongoing|47|||
161315726|NCT01420679|582538127|FG000|Overall Study|Disease Progression|3|||
161315727|NCT01420679|582538128|FG001|Overall Study|Disease Progression|2|||
161315728|NCT01420679|582538127|FG000|Overall Study|Adverse Event|4|||
161315729|NCT01420679|582538128|FG001|Overall Study|Adverse Event|0|||
161315730|NCT01420679|582538127|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
161315731|NCT01420679|582538128|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
161315732|NCT01420679|582538127|FG000|Overall Study|Patient Decision|1|||
161315733|NCT01420679|582538128|FG001|Overall Study|Patient Decision|0|||
161315734|NCT01420679|582538127|FG000|Overall Study|Investigator Decision|1|||
161315735|NCT01420679|582538128|FG001|Overall Study|Investigator Decision|2|||
161315736|NCT01420679|582538127|FG000|Overall Study|Sponsor Decision|3|||
161315737|NCT01420679|582538128|FG001|Overall Study|Sponsor Decision|3|||
161315738|NCT01420679|582538127|FG000|Overall Study|Other|1|||
161315739|NCT01420679|582538128|FG001|Overall Study|Other|0|||
161315740|NCT03956615|582538129|FG000|Overall Study|No multiple myeloma confirmed|2|||
161315741|NCT03956615|582538129|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
161315742|NCT03956615|582538129|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
161315743|NCT03956615|582538129|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
161315744|NCT01069419|582538130|FG000|Overall Study|Adverse Event|233|||
161315745|NCT01069419|582538130|FG000|Overall Study|Lack of Efficacy|332|||
161315746|NCT01069419|582538130|FG000|Overall Study|Lost to Follow-up|49|||
161315747|NCT01069419|582538130|FG000|Overall Study|Remission of disease|11|||
161315748|NCT01069419|582538130|FG000|Overall Study|Withdrawal by Subject|34|||
161315749|NCT01069419|582538130|FG000|Overall Study|Other Reason|43|||
161315750|NCT01069419|582538130|FG000|Overall Study|Missing termination information|13|||
161315751|NCT01179737|582538133|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
161315752|NCT01179737|582538134|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
161315753|NCT01179737|582538135|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
161315754|NCT01179737|582538136|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
161315755|NCT01179737|582538133|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
161315756|NCT01179737|582538134|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
161315757|NCT01179737|582538135|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
161315758|NCT01179737|582538136|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
161315759|NCT01179737|582538133|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
161315760|NCT01179737|582538134|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
161315761|NCT01179737|582538135|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
161315762|NCT01179737|582538136|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
161315763|NCT01179737|582538133|FG000|Cohort 1 & Cohort 2|Death|0|||
161315764|NCT01179737|582538134|FG001|Cohort 1 & Cohort 2|Death|0|||
161315765|NCT01179737|582538135|FG002|Cohort 1 & Cohort 2|Death|1|||
161315766|NCT01179737|582538136|FG003|Cohort 1 & Cohort 2|Death|0|||
161315767|NCT01179737|582538133|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161315768|NCT01179737|582538134|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
161315769|NCT01179737|582538135|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161315770|NCT01179737|582538136|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
161315771|NCT01179737|582538133|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
161315772|NCT01179737|582538134|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
161315773|NCT01179737|582538135|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
161315774|NCT01179737|582538136|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
161315775|NCT01179737|582538133|FG000|Extension|The study was terminated|3|||
161315776|NCT01179737|582538134|FG001|Extension|The study was terminated|0|||
161315777|NCT01179737|582538135|FG002|Extension|The study was terminated|0|||
161315778|NCT01179737|582538136|FG003|Extension|The study was terminated|0|||
161315779|NCT01254721|582538137|FG000|Overall Study|Lost to Follow-up|0|||
161315780|NCT01254721|582538138|FG001|Overall Study|Lost to Follow-up|4|||
161315781|NCT01254721|582538137|FG000|Overall Study|Lack of Efficacy|4|||
161315782|NCT01254721|582538138|FG001|Overall Study|Lack of Efficacy|2|||
161315783|NCT01254721|582538137|FG000|Overall Study|Death|0|||
161315784|NCT01254721|582538138|FG001|Overall Study|Death|1|||
161315785|NCT01254721|582538137|FG000|Overall Study|technical problum|1|||
161315786|NCT01254721|582538138|FG001|Overall Study|technical problum|0|||
161315787|NCT01254721|582538137|FG000|Overall Study|Adverse Event|2|||
161315788|NCT01254721|582538138|FG001|Overall Study|Adverse Event|3|||
161315789|NCT01254721|582538137|FG000|Overall Study|Withdrawal by Subject|8|||
161315790|NCT01254721|582538138|FG001|Overall Study|Withdrawal by Subject|11|||
161315791|NCT01254721|582538137|FG000|Overall Study|Wrongly randomization|0|||
161315792|NCT01254721|582538138|FG001|Overall Study|Wrongly randomization|1|||
161315793|NCT01853696|582538139|FG000|Overall Study|Withdrawal by Subject|1|||
161315794|NCT01853696|582538140|FG001|Overall Study|Withdrawal by Subject|1|||
161315795|NCT01853696|582538139|FG000|Overall Study|Lost to Follow-up|5|||
161315796|NCT01853696|582538140|FG001|Overall Study|Lost to Follow-up|4|||
161315797|NCT01167634|582538141|FG000|Overall Study|Lost to Follow-up|1|||
161315798|NCT01167634|582538142|FG001|Overall Study|Lost to Follow-up|3|||
161315799|NCT01167634|582538143|FG002|Overall Study|Lost to Follow-up|3|||
161315800|NCT01167634|582538144|FG003|Overall Study|Lost to Follow-up|4|||
161315801|NCT01167634|582538141|FG000|Overall Study|Withdrawal by Subject|1|||
161315802|NCT01167634|582538142|FG001|Overall Study|Withdrawal by Subject|1|||
161315803|NCT01167634|582538143|FG002|Overall Study|Withdrawal by Subject|0|||
161315804|NCT01167634|582538144|FG003|Overall Study|Withdrawal by Subject|0|||
161315805|NCT03003000|582538145|FG000|Overall Study|Adverse Event|1|||
161315806|NCT03003000|582538146|FG001|Overall Study|Adverse Event|2|||
161315807|NCT03003000|582538147|FG002|Overall Study|Adverse Event|3|||
161315808|NCT03003000|582538145|FG000|Overall Study|Lack of Efficacy|1|||
161315809|NCT03003000|582538146|FG001|Overall Study|Lack of Efficacy|0|||
161315810|NCT03003000|582538147|FG002|Overall Study|Lack of Efficacy|0|||
161315811|NCT03003000|582538145|FG000|Overall Study|Non-compliant with protocol|0|||
161315812|NCT03003000|582538146|FG001|Overall Study|Non-compliant with protocol|1|||
161315813|NCT03003000|582538147|FG002|Overall Study|Non-compliant with protocol|1|||
161315814|NCT03003000|582538145|FG000|Overall Study|Refused to continue medication|2|||
161315815|NCT03003000|582538146|FG001|Overall Study|Refused to continue medication|0|||
161315816|NCT03003000|582538147|FG002|Overall Study|Refused to continue medication|0|||
161315817|NCT03003000|582538145|FG000|Overall Study|Other than listed|1|||
161315818|NCT03003000|582538146|FG001|Overall Study|Other than listed|1|||
161315819|NCT03003000|582538147|FG002|Overall Study|Other than listed|1|||
161315820|NCT04933617|582538149|FG000|Dose Escalation|Early closure of study|0|||
161315821|NCT04933617|582538150|FG001|Dose Escalation|Early closure of study|3|||
161315822|NCT04933617|582538151|FG002|Dose Escalation|Early closure of study|0|||
161315823|NCT04933617|582538152|FG003|Dose Escalation|Early closure of study|0|||
161315824|NCT04933617|582538153|FG004|Dose Escalation|Early closure of study|0|||
161315825|NCT05268016|582538154|FG000|Overall Study|Unacceptable toxicity or AE|2|||
161315826|NCT05268016|582538155|FG001|Overall Study|Unacceptable toxicity or AE|2|||
161315827|NCT05268016|582538156|FG002|Overall Study|Unacceptable toxicity or AE|4|||
161315828|NCT05268016|582538157|FG003|Overall Study|Unacceptable toxicity or AE|3|||
161315829|NCT05268016|582538158|FG004|Overall Study|Unacceptable toxicity or AE|1|||
161315830|NCT05268016|582538154|FG000|Overall Study|Withdrawal by Subject|1|||
161315831|NCT05268016|582538155|FG001|Overall Study|Withdrawal by Subject|3|||
161315832|NCT05268016|582538156|FG002|Overall Study|Withdrawal by Subject|2|||
161315833|NCT05268016|582538157|FG003|Overall Study|Withdrawal by Subject|2|||
161315834|NCT05268016|582538158|FG004|Overall Study|Withdrawal by Subject|1|||
161315835|NCT05268016|582538154|FG000|Overall Study|Lost to Follow-up|4|||
161315836|NCT05268016|582538155|FG001|Overall Study|Lost to Follow-up|7|||
161315837|NCT05268016|582538156|FG002|Overall Study|Lost to Follow-up|1|||
161315838|NCT05268016|582538157|FG003|Overall Study|Lost to Follow-up|3|||
161315839|NCT05268016|582538158|FG004|Overall Study|Lost to Follow-up|5|||
161315840|NCT05268016|582538154|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
161315841|NCT05268016|582538155|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161315842|NCT05268016|582538156|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161315843|NCT05268016|582538157|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
161315844|NCT05268016|582538158|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
161315845|NCT05268016|582538154|FG000|Overall Study|Lack of Efficacy|0|||
161315846|NCT05268016|582538155|FG001|Overall Study|Lack of Efficacy|0|||
161315847|NCT05268016|582538156|FG002|Overall Study|Lack of Efficacy|0|||
161315848|NCT05268016|582538157|FG003|Overall Study|Lack of Efficacy|0|||
161315849|NCT05268016|582538158|FG004|Overall Study|Lack of Efficacy|4|||
161315850|NCT05268016|582538154|FG000|Overall Study|Physician Decision|0|||
161315851|NCT05268016|582538155|FG001|Overall Study|Physician Decision|0|||
161315852|NCT05268016|582538156|FG002|Overall Study|Physician Decision|0|||
161315853|NCT05268016|582538157|FG003|Overall Study|Physician Decision|1|||
161315854|NCT05268016|582538158|FG004|Overall Study|Physician Decision|0|||
161315855|NCT05268016|582538154|FG000|Overall Study|Other|1|||
161315856|NCT05268016|582538155|FG001|Overall Study|Other|0|||
161315857|NCT05268016|582538156|FG002|Overall Study|Other|1|||
161315858|NCT05268016|582538157|FG003|Overall Study|Other|2|||
161315859|NCT05268016|582538158|FG004|Overall Study|Other|0|||
161315860|NCT01217385|582538160|FG000|Overall Study|Withdrawal by Subject|3|||
161315861|NCT01217385|582538160|FG000|Overall Study|DOSI not performed/not eval|12|||
161315862|NCT01217385|582538160|FG000|Overall Study|Central Path not Available|1|||
161315863|NCT01217385|582538160|FG000|Overall Study|Normal Breast TOI not available|10|||
161315864|NCT00090987|582538161|FG000|Overall Study|Adverse Event|5|||
161315865|NCT00090987|582538161|FG000|Overall Study|Lack of Efficacy|7|||
161315866|NCT00090987|582538161|FG000|Overall Study|Withdrawal by Subject|3|||
161315867|NCT00090987|582538161|FG000|Overall Study|alternative therapy|1|||
161315868|NCT00090987|582538161|FG000|Overall Study|Non-compliance|4|||
161315869|NCT00090987|582538161|FG000|Overall Study|Incarcerated|1|||
161315870|NCT00990665|582538166|FG000|Overall Study|Unsuccessful Implant|8|||
161315871|NCT00990665|582538166|FG000|Overall Study|Death|29|||
161315872|NCT00990665|582538166|FG000|Overall Study|Heart Transplant|1|||
161315873|NCT00990665|582538166|FG000|Overall Study|Withdrawal by Subject|6|||
161315874|NCT00990665|582538166|FG000|Overall Study|Lost to Follow-up|1|||
161315875|NCT00990665|582538166|FG000|Overall Study|System Explant|3|||
161315876|NCT00957905|582538167|FG000|Part B|Not Treated|0|||
161315877|NCT00957905|582538168|FG001|Part B|Not Treated|1|||
161315878|NCT00957905|582538167|FG000|Part B|Physician Decision|0|||
161315879|NCT00957905|582538168|FG001|Part B|Physician Decision|1|||
161315880|NCT00957905|582538167|FG000|Part B|Death|0|||
161315881|NCT00957905|582538168|FG001|Part B|Death|1|||
161315882|NCT00957905|582538167|FG000|Part B|Protocol Violation|0|||
161315883|NCT00957905|582538168|FG001|Part B|Protocol Violation|1|||
161315884|NCT01260584|582538185|FG000|Period 1|Protocol Violation|0|||
161315885|NCT01260584|582538186|FG001|Period 1|Protocol Violation|0|||
161315886|NCT01260584|582538187|FG002|Period 1|Protocol Violation|1|||
161315887|NCT01260584|582538188|FG003|Period 1|Protocol Violation|1|||
161315888|NCT01260584|582538185|FG000|Period 1|Adverse Event|0|||
161315889|NCT01260584|582538186|FG001|Period 1|Adverse Event|0|||
161315890|NCT01260584|582538187|FG002|Period 1|Adverse Event|1|||
161315891|NCT01260584|582538188|FG003|Period 1|Adverse Event|0|||
161315892|NCT01260584|582538185|FG000|Period 2|Protocol Violation|0|||
161315893|NCT01260584|582538186|FG001|Period 2|Protocol Violation|2|||
161315894|NCT01260584|582538187|FG002|Period 2|Protocol Violation|3|||
161315895|NCT01260584|582538188|FG003|Period 2|Protocol Violation|1|||
161315896|NCT01260584|582538185|FG000|Period 2|Adverse Event|1|||
161315897|NCT01260584|582538186|FG001|Period 2|Adverse Event|0|||
161315898|NCT01260584|582538187|FG002|Period 2|Adverse Event|2|||
161315899|NCT01260584|582538188|FG003|Period 2|Adverse Event|0|||
161315900|NCT01260584|582538185|FG000|Period 2|Withdrawal by Subject|0|||
161315901|NCT01260584|582538186|FG001|Period 2|Withdrawal by Subject|1|||
161315902|NCT01260584|582538187|FG002|Period 2|Withdrawal by Subject|0|||
161315903|NCT01260584|582538188|FG003|Period 2|Withdrawal by Subject|0|||
161315904|NCT00045734|582538189|FG000|Overall Study|Protocol Violation|1|||
161315905|NCT02069093|582538190|FG000|Overall Study|Disease progression|14|||
161315906|NCT02069093|582538190|FG000|Overall Study|New cancer therapy|1|||
161315907|NCT02069093|582538190|FG000|Overall Study|Death|1|||
161315908|NCT02069093|582538190|FG000|Overall Study|Administrative problems|1|||
161315909|NCT02069093|582538190|FG000|Overall Study|Withdrawal by Subject|2|||
161315910|NCT02069093|582538190|FG000|Overall Study|Abnormal laboratory values|1|||
161315911|NCT02069093|582538190|FG000|Overall Study|Adverse Event|10|||
161315912|NCT01969084|582538194|FG000|Overall Study|Adverse Event|0|||
161315913|NCT01969084|582538195|FG001|Overall Study|Adverse Event|1|||
161315914|NCT01362244|582538196|FG000|Overall Study|Adverse Event|3|||
161315915|NCT01362244|582538197|FG001|Overall Study|Adverse Event|5|||
161315916|NCT01362244|582538196|FG000|Overall Study|Lack of Efficacy|5|||
161315917|NCT01362244|582538197|FG001|Overall Study|Lack of Efficacy|11|||
161315918|NCT01362244|582538196|FG000|Overall Study|Lost to Follow-up|0|||
161315919|NCT01362244|582538197|FG001|Overall Study|Lost to Follow-up|2|||
161315920|NCT01362244|582538196|FG000|Overall Study|Protocol Violation|5|||
161315921|NCT01362244|582538197|FG001|Overall Study|Protocol Violation|1|||
161315922|NCT01362244|582538196|FG000|Overall Study|Withdrawal by Subject|2|||
161315923|NCT01362244|582538197|FG001|Overall Study|Withdrawal by Subject|1|||
161315924|NCT01362244|582538196|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
161315925|NCT01362244|582538197|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
161315926|NCT01362244|582538196|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
161315927|NCT01362244|582538197|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
161315928|NCT01253174|582538198|FG000|Period 1|Randomized but not treated|0|||
161315929|NCT01253174|582538199|FG001|Period 1|Randomized but not treated|1|||
161315930|NCT01253174|582538200|FG002|Period 1|Randomized but not treated|1|||
161315931|NCT01253174|582538201|FG003|Period 1|Randomized but not treated|0|||
161315932|NCT01253174|582538202|FG004|Period 1|Randomized but not treated|1|||
161315933|NCT01253174|582538203|FG005|Period 1|Randomized but not treated|0|||
161315934|NCT01253174|582538198|FG000|Period 2|Adverse Event|0|||
161315935|NCT01253174|582538199|FG001|Period 2|Adverse Event|0|||
161315936|NCT01253174|582538200|FG002|Period 2|Adverse Event|1|||
161315937|NCT01253174|582538201|FG003|Period 2|Adverse Event|0|||
161315938|NCT01253174|582538202|FG004|Period 2|Adverse Event|0|||
161315939|NCT01253174|582538203|FG005|Period 2|Adverse Event|0|||
161315940|NCT01253174|582538198|FG000|Period 3|Withdrawal by Subject|0|||
161315941|NCT01253174|582538199|FG001|Period 3|Withdrawal by Subject|1|||
161315942|NCT01253174|582538200|FG002|Period 3|Withdrawal by Subject|0|||
161315943|NCT01253174|582538201|FG003|Period 3|Withdrawal by Subject|0|||
161315944|NCT01253174|582538202|FG004|Period 3|Withdrawal by Subject|1|||
161315945|NCT01253174|582538203|FG005|Period 3|Withdrawal by Subject|0|||
161315946|NCT01253174|582538198|FG000|Period 3|Pregnancy|0|||
161315947|NCT01253174|582538199|FG001|Period 3|Pregnancy|0|||
161315948|NCT01253174|582538200|FG002|Period 3|Pregnancy|1|||
161315949|NCT01253174|582538201|FG003|Period 3|Pregnancy|0|||
161315950|NCT01253174|582538202|FG004|Period 3|Pregnancy|0|||
161315951|NCT01253174|582538203|FG005|Period 3|Pregnancy|0|||
161315952|NCT02267135|582538204|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
161315953|NCT02267135|582538205|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
161315954|NCT02267135|582538204|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
161315955|NCT02267135|582538205|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
161315956|NCT02267135|582538204|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
161315957|NCT02267135|582538205|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
161315958|NCT02267135|582538204|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
161315959|NCT02267135|582538205|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
161315960|NCT02267135|582538204|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
161315961|NCT02267135|582538205|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
161315962|NCT03806231|582538206|FG000|Overall Study|Physician Decision|1|||
161315963|NCT03806231|582538207|FG001|Overall Study|Physician Decision|0|||
161315964|NCT03806231|582538206|FG000|Overall Study|Withdrawal by Subject|1|||
161315965|NCT03806231|582538207|FG001|Overall Study|Withdrawal by Subject|0|||
161315966|NCT02919267|582538208|FG000|Overall Study|Protocol Violation|0|||
161315967|NCT02919267|582538209|FG001|Overall Study|Protocol Violation|3|||
161315968|NCT02919267|582538210|FG002|Overall Study|Protocol Violation|3|||
161315969|NCT02919267|582538211|FG003|Overall Study|Protocol Violation|4|||
161315970|NCT00467961|582538212|FG000|Overall Study|Technical Failures|5|||
161315971|NCT00467961|582538212|FG000|Overall Study|Disease Progression|2|||
161315972|NCT00394433|582538214|FG000|Overall Study|Adverse Event|2|||
161315973|NCT00394433|582538214|FG000|Overall Study|Alternative Therapy|1|||
161315974|NCT00642954|582539927|FG000|Overall Study|Progressive Disease|3|||
161315975|NCT00642954|582539928|FG001|Overall Study|Progressive Disease|3|||
161315976|NCT00642954|582539929|FG002|Overall Study|Progressive Disease|3|||
161315977|NCT00642954|582539930|FG003|Overall Study|Progressive Disease|3|||
161315978|NCT00642954|582539931|FG004|Overall Study|Progressive Disease|9|||
161315979|NCT00642954|582539927|FG000|Overall Study|Withdrawal by Subject|0|||
161315980|NCT00642954|582539928|FG001|Overall Study|Withdrawal by Subject|0|||
161315981|NCT00642954|582539929|FG002|Overall Study|Withdrawal by Subject|0|||
161315982|NCT00642954|582539930|FG003|Overall Study|Withdrawal by Subject|0|||
161315983|NCT00642954|582539931|FG004|Overall Study|Withdrawal by Subject|1|||
161315984|NCT00642954|582539927|FG000|Overall Study|Adverse Event|1|||
161315985|NCT00642954|582539928|FG001|Overall Study|Adverse Event|1|||
161315986|NCT00642954|582539929|FG002|Overall Study|Adverse Event|0|||
161315987|NCT00642954|582539930|FG003|Overall Study|Adverse Event|0|||
161315988|NCT00642954|582539931|FG004|Overall Study|Adverse Event|6|||
161315989|NCT03539484|582539934|FG000|Overall Study|Death|1|||
161315990|NCT03539484|582539935|FG001|Overall Study|Death|0|||
161315991|NCT03539484|582539936|FG002|Overall Study|Death|0|||
161315992|NCT03539484|582539937|FG003|Overall Study|Death|2|||
161315993|NCT03539484|582539938|FG004|Overall Study|Death|8|||
161315994|NCT03539484|582539939|FG005|Overall Study|Death|3|||
161315995|NCT03539484|582539940|FG006|Overall Study|Death|0|||
161315996|NCT03539484|582539934|FG000|Overall Study|Lost to Follow-up|0|||
161315997|NCT03539484|582539935|FG001|Overall Study|Lost to Follow-up|1|||
161315998|NCT03539484|582539936|FG002|Overall Study|Lost to Follow-up|0|||
161315999|NCT03539484|582539937|FG003|Overall Study|Lost to Follow-up|0|||
161316000|NCT03539484|582539938|FG004|Overall Study|Lost to Follow-up|1|||
161316001|NCT03539484|582539939|FG005|Overall Study|Lost to Follow-up|0|||
161316002|NCT03539484|582539940|FG006|Overall Study|Lost to Follow-up|0|||
161316003|NCT03539484|582539934|FG000|Overall Study|Withdrawal by Subject|0|||
161316004|NCT03539484|582539935|FG001|Overall Study|Withdrawal by Subject|0|||
161316005|NCT03539484|582539936|FG002|Overall Study|Withdrawal by Subject|0|||
161316006|NCT03539484|582539937|FG003|Overall Study|Withdrawal by Subject|0|||
161316007|NCT03539484|582539938|FG004|Overall Study|Withdrawal by Subject|2|||
161316008|NCT03539484|582539939|FG005|Overall Study|Withdrawal by Subject|0|||
161316009|NCT03539484|582539940|FG006|Overall Study|Withdrawal by Subject|1|||
161316010|NCT03539484|582539934|FG000|Overall Study|Study Terminated by Sponsor|0|||
161316011|NCT03539484|582539935|FG001|Overall Study|Study Terminated by Sponsor|0|||
161316012|NCT03539484|582539936|FG002|Overall Study|Study Terminated by Sponsor|1|||
161316013|NCT03539484|582539937|FG003|Overall Study|Study Terminated by Sponsor|1|||
161316014|NCT03539484|582539938|FG004|Overall Study|Study Terminated by Sponsor|2|||
161316015|NCT03539484|582539939|FG005|Overall Study|Study Terminated by Sponsor|2|||
161316016|NCT03539484|582539940|FG006|Overall Study|Study Terminated by Sponsor|1|||
161316017|NCT02173379|582539941|FG000|Overall Study|Lost to Follow-up|89|||
161316018|NCT02173379|582539942|FG001|Overall Study|Lost to Follow-up|81|||
161316019|NCT02173379|582539941|FG000|Overall Study|Withdrawal by Subject|24|||
161316020|NCT02173379|582539942|FG001|Overall Study|Withdrawal by Subject|29|||
161316021|NCT02173379|582539941|FG000|Overall Study|Physician Decision|8|||
161316022|NCT02173379|582539942|FG001|Overall Study|Physician Decision|8|||
161316023|NCT02173379|582539941|FG000|Overall Study|Death|75|||
161316024|NCT02173379|582539942|FG001|Overall Study|Death|72|||
161316025|NCT02173379|582539941|FG000|Overall Study|Other Reason|1|||
161316026|NCT02173379|582539942|FG001|Overall Study|Other Reason|0|||
161316027|NCT01636947|582539944|FG000|Overall Study|Not Treated|2|||
161316028|NCT01636947|582539945|FG001|Overall Study|Not Treated|2|||
161316029|NCT01636947|582539944|FG000|Overall Study|Lost to Follow-up|4|||
161316030|NCT01636947|582539945|FG001|Overall Study|Lost to Follow-up|0|||
161316031|NCT01636947|582539944|FG000|Overall Study|Protocol Violation|1|||
161316032|NCT01636947|582539945|FG001|Overall Study|Protocol Violation|1|||
161316033|NCT01636947|582539944|FG000|Overall Study|Withdrawal by Subject|3|||
161316034|NCT01636947|582539945|FG001|Overall Study|Withdrawal by Subject|3|||
161316035|NCT01636947|582539944|FG000|Overall Study|Adverse Event|1|||
161316036|NCT01636947|582539945|FG001|Overall Study|Adverse Event|1|||
161316037|NCT01636947|582539944|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
161316038|NCT01636947|582539945|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
161316039|NCT02956057|582539950|FG000|Overall Study|Discontinued intervention|14|||
161316040|NCT02956057|582539951|FG001|Overall Study|Discontinued intervention|10|||
161316041|NCT02956057|582539952|FG002|Overall Study|Discontinued intervention|7|||
161316042|NCT02956057|582539953|FG003|Overall Study|Discontinued intervention|14|||
161316043|NCT02956057|582539954|FG004|Overall Study|Discontinued intervention|4|||
161316044|NCT02956057|582539955|FG005|Overall Study|Discontinued intervention|17|||
161316045|NCT02956057|582539950|FG000|Overall Study|Lost to Follow-up|0|||
161316046|NCT02956057|582539951|FG001|Overall Study|Lost to Follow-up|2|||
161316047|NCT02956057|582539952|FG002|Overall Study|Lost to Follow-up|1|||
161316048|NCT02956057|582539953|FG003|Overall Study|Lost to Follow-up|1|||
161316049|NCT02956057|582539954|FG004|Overall Study|Lost to Follow-up|1|||
161316050|NCT02956057|582539955|FG005|Overall Study|Lost to Follow-up|0|||
161316051|NCT01955109|582539960|FG000|Overall Study|Adverse Event|2|||
161316052|NCT01955109|582539961|FG001|Overall Study|Adverse Event|0|||
161316053|NCT01955109|582539960|FG000|Overall Study|Participant unwilling to continue|35|||
161316054|NCT01955109|582539961|FG001|Overall Study|Participant unwilling to continue|7|||
161316055|NCT01955109|582539960|FG000|Overall Study|Physician Decision|2|||
161316056|NCT01955109|582539961|FG001|Overall Study|Physician Decision|0|||
161316057|NCT01955109|582539960|FG000|Overall Study|Lost to Follow-up|3|||
161316058|NCT01955109|582539961|FG001|Overall Study|Lost to Follow-up|1|||
161316059|NCT01955109|582539960|FG000|Overall Study|Non-compliance|3|||
161316060|NCT01955109|582539961|FG001|Overall Study|Non-compliance|1|||
161316061|NCT00904839|582539962|FG000|Overall Study|Adverse Event|0|||
161316062|NCT00904839|582539963|FG001|Overall Study|Adverse Event|5|||
161316063|NCT00904839|582539964|FG002|Overall Study|Adverse Event|4|||
161316064|NCT00904839|582539962|FG000|Overall Study|Protocol Violation|0|||
161316065|NCT00904839|582539963|FG001|Overall Study|Protocol Violation|1|||
161316066|NCT00904839|582539964|FG002|Overall Study|Protocol Violation|1|||
161316067|NCT00904839|582539962|FG000|Overall Study|Lost to Follow-up|0|||
161316068|NCT00904839|582539963|FG001|Overall Study|Lost to Follow-up|1|||
161316069|NCT00904839|582539964|FG002|Overall Study|Lost to Follow-up|2|||
161316070|NCT00904839|582539962|FG000|Overall Study|Withdrawal by Subject|0|||
161316071|NCT00904839|582539963|FG001|Overall Study|Withdrawal by Subject|2|||
161316072|NCT00904839|582539964|FG002|Overall Study|Withdrawal by Subject|0|||
161316073|NCT00904839|582539962|FG000|Overall Study|Not treated|1|||
161316074|NCT00904839|582539963|FG001|Overall Study|Not treated|0|||
161316075|NCT00904839|582539964|FG002|Overall Study|Not treated|1|||
161316076|NCT00904839|582539962|FG000|Overall Study|Other than above|0|||
161316077|NCT00904839|582539963|FG001|Overall Study|Other than above|9|||
161316078|NCT00904839|582539964|FG002|Overall Study|Other than above|7|||
161316079|NCT00553358|582539967|FG000|Overall Study|Randomized but did not receive treatment|3|||
161316080|NCT00553358|582539968|FG001|Overall Study|Randomized but did not receive treatment|3|||
161316081|NCT00553358|582539969|FG002|Overall Study|Randomized but did not receive treatment|1|||
161316082|NCT00553358|582539967|FG000|Overall Study|Lost to Follow-up|22|||
161316083|NCT00553358|582539968|FG001|Overall Study|Lost to Follow-up|26|||
161316084|NCT00553358|582539969|FG002|Overall Study|Lost to Follow-up|18|||
161316085|NCT00553358|582539967|FG000|Overall Study|Withdrew completely|23|||
161316086|NCT00553358|582539968|FG001|Overall Study|Withdrew completely|33|||
161316087|NCT00553358|582539969|FG002|Overall Study|Withdrew completely|34|||
161316088|NCT00553358|582539967|FG000|Overall Study|Died during clinical follow-up|25|||
161316089|NCT00553358|582539968|FG001|Overall Study|Died during clinical follow-up|29|||
161316090|NCT00553358|582539969|FG002|Overall Study|Died during clinical follow-up|32|||
161316091|NCT00553358|582539967|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
161316092|NCT00553358|582539968|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
161316093|NCT00553358|582539969|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
161316094|NCT00553358|582539967|FG000|Overall Study|Died after clinical follow-up ended|1|||
161316095|NCT00553358|582539968|FG001|Overall Study|Died after clinical follow-up ended|2|||
161316096|NCT00553358|582539969|FG002|Overall Study|Died after clinical follow-up ended|0|||
161316097|NCT00553358|582539967|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161316098|NCT00553358|582539968|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161316099|NCT00553358|582539969|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
161316100|NCT02854605|582539974|FG000|Overall Study|Adverse Event|1|||
161316101|NCT02854605|582539975|FG001|Overall Study|Adverse Event|5|||
161316102|NCT02854605|582539976|FG002|Overall Study|Adverse Event|2|||
161316103|NCT02854605|582539974|FG000|Overall Study|Lost to Follow-up|0|||
161316104|NCT02854605|582539975|FG001|Overall Study|Lost to Follow-up|2|||
161316105|NCT02854605|582539976|FG002|Overall Study|Lost to Follow-up|0|||
161316106|NCT02854605|582539974|FG000|Overall Study|Withdrew Consent|1|||
161316107|NCT02854605|582539975|FG001|Overall Study|Withdrew Consent|0|||
161316108|NCT02854605|582539976|FG002|Overall Study|Withdrew Consent|1|||
161316109|NCT02854605|582539974|FG000|Overall Study|Investigator's Discretion|1|||
161316110|NCT02854605|582539975|FG001|Overall Study|Investigator's Discretion|0|||
161316111|NCT02854605|582539976|FG002|Overall Study|Investigator's Discretion|0|||
161316112|NCT02854605|582539974|FG000|Overall Study|Protocol Violation|0|||
161316113|NCT02854605|582539975|FG001|Overall Study|Protocol Violation|0|||
161316114|NCT02854605|582539976|FG002|Overall Study|Protocol Violation|1|||
161316115|NCT02191046|582539977|FG000|Overall Study|low compliance|5|||
161316116|NCT02191046|582539978|FG001|Overall Study|low compliance|1|||
161316117|NCT00089635|582539979|FG000|Overall Study|Adverse Event|2|||
161316118|NCT00089635|582539979|FG000|Overall Study|Death|17|||
161316119|NCT00089635|582539979|FG000|Overall Study|Disease Progression|12|||
161316120|NCT00089635|582539979|FG000|Overall Study|Lost to Follow-up|3|||
161316121|NCT00089635|582539979|FG000|Overall Study|Withdrawal by Subject|6|||
161316122|NCT00089635|582539979|FG000|Overall Study|Ineligibility determined|1|||
161316123|NCT00089635|582539979|FG000|Overall Study|Other|2|||
161316124|NCT02943785|582539980|FG000|Overall Study|Adverse Event|112|||
161316125|NCT02943785|582539981|FG001|Overall Study|Adverse Event|97|||
161316126|NCT02943785|582539980|FG000|Overall Study|Withdrawal by Subject|63|||
161316127|NCT02943785|582539981|FG001|Overall Study|Withdrawal by Subject|126|||
161316128|NCT02943785|582539980|FG000|Overall Study|Physician Decision|23|||
161316129|NCT02943785|582539981|FG001|Overall Study|Physician Decision|47|||
161316130|NCT02943785|582539980|FG000|Overall Study|Death|46|||
161316131|NCT02943785|582539981|FG001|Overall Study|Death|46|||
161316132|NCT02943785|582539980|FG000|Overall Study|Lost to Follow-up|1|||
161316133|NCT02943785|582539981|FG001|Overall Study|Lost to Follow-up|0|||
161316134|NCT02943785|582539980|FG000|Overall Study|Other|16|||
161316135|NCT02943785|582539981|FG001|Overall Study|Other|19|||
161316136|NCT02943785|582539980|FG000|Overall Study|Did not receive any study medication|21|||
161316137|NCT02943785|582539981|FG001|Overall Study|Did not receive any study medication|28|||
161316138|NCT02603107|582539982|FG000|Randomized Phase|Withdrew consent|8|||
161316139|NCT02603107|582539983|FG001|Randomized Phase|Withdrew consent|15|||
161316140|NCT02603107|582539982|FG000|Randomized Phase|Lost to Follow-up|1|||
161316141|NCT02603107|582539983|FG001|Randomized Phase|Lost to Follow-up|3|||
161316142|NCT02603107|582539982|FG000|Randomized Phase|Adverse Event|2|||
161316143|NCT02603107|582539983|FG001|Randomized Phase|Adverse Event|0|||
161316144|NCT02603107|582539982|FG000|Randomized Phase|Death|1|||
161316145|NCT02603107|582539983|FG001|Randomized Phase|Death|1|||
161316146|NCT02603107|582539982|FG000|Randomized Phase|Non-compliance with study drug|1|||
161316147|NCT02603107|582539983|FG001|Randomized Phase|Non-compliance with study drug|1|||
161316148|NCT02603107|582539982|FG000|Randomized Phase|Investigator's discretion|0|||
161316149|NCT02603107|582539983|FG001|Randomized Phase|Investigator's discretion|1|||
161316150|NCT02603107|582539982|FG000|Randomized Phase|Lack of Efficacy|1|||
161316151|NCT02603107|582539983|FG001|Randomized Phase|Lack of Efficacy|0|||
161316152|NCT02603107|582539982|FG000|Randomized Phase|Protocol Violation|1|||
161316153|NCT02603107|582539983|FG001|Randomized Phase|Protocol Violation|0|||
161316154|NCT02603107|582539982|FG000|Optional Extension Phase|Lost to Follow-up|3|||
161316155|NCT02603107|582539983|FG001|Optional Extension Phase|Lost to Follow-up|3|||
161316156|NCT02603107|582539982|FG000|Optional Extension Phase|Withdrew consent|3|||
161316157|NCT02603107|582539983|FG001|Optional Extension Phase|Withdrew consent|2|||
161316158|NCT02603107|582539982|FG000|Optional Extension Phase|Investigator's discretion|2|||
161316159|NCT02603107|582539983|FG001|Optional Extension Phase|Investigator's discretion|2|||
161316160|NCT02603107|582539982|FG000|Optional Extension Phase|Pregnancy|0|||
161316161|NCT02603107|582539983|FG001|Optional Extension Phase|Pregnancy|3|||
161316162|NCT02603107|582539982|FG000|Optional Extension Phase|Adverse Event|0|||
161316163|NCT02603107|582539983|FG001|Optional Extension Phase|Adverse Event|2|||
161316164|NCT02603107|582539982|FG000|Optional Extension Phase|Not treated in extension phase|0|||
161316165|NCT02603107|582539983|FG001|Optional Extension Phase|Not treated in extension phase|1|||
161316166|NCT02603107|582539982|FG000|Optional Extension Phase|Protocol Violation|1|||
161316167|NCT02603107|582539983|FG001|Optional Extension Phase|Protocol Violation|0|||
161316168|NCT00821015|582539986|FG000|Overall Study|Lost to Follow-up|12|||
161316169|NCT01887678|582539992|FG000|Overall Study|Adverse Event|4|||
161316170|NCT01887678|582539993|FG001|Overall Study|Adverse Event|6|||
161316171|NCT01887678|582539992|FG000|Overall Study|Exceeded rescue medication dosage|4|||
161316172|NCT01887678|582539993|FG001|Overall Study|Exceeded rescue medication dosage|5|||
161316173|NCT01887678|582539992|FG000|Overall Study|Withdrawal of consent|3|||
161316174|NCT01887678|582539993|FG001|Overall Study|Withdrawal of consent|4|||
161316175|NCT01887678|582539992|FG000|Overall Study|Lost to Follow-up|4|||
161316176|NCT01887678|582539993|FG001|Overall Study|Lost to Follow-up|2|||
161316177|NCT01887678|582539992|FG000|Overall Study|Deterioration of clinical condition|0|||
161316178|NCT01887678|582539993|FG001|Overall Study|Deterioration of clinical condition|4|||
161316179|NCT01887678|582539992|FG000|Overall Study|Lack of Efficacy|1|||
161316180|NCT01887678|582539993|FG001|Overall Study|Lack of Efficacy|2|||
161316181|NCT01887678|582539992|FG000|Overall Study|Non-compliance|0|||
161316182|NCT01887678|582539993|FG001|Overall Study|Non-compliance|3|||
161316183|NCT01887678|582539992|FG000|Overall Study|Specified|1|||
161316184|NCT01887678|582539993|FG001|Overall Study|Specified|2|||
161316185|NCT03013985|582539994|FG000|Overall Study|Protocol Violation|2|||
161316186|NCT03013985|582539995|FG001|Overall Study|Protocol Violation|2|||
161316187|NCT03013985|582539994|FG000|Overall Study|Withdrawal by Subject|14|||
161316188|NCT03013985|582539995|FG001|Overall Study|Withdrawal by Subject|17|||
161316189|NCT00270231|582539997|FG000|First Intervention|Lost to Follow-up|1|||
161316190|NCT00270231|582539998|FG001|First Intervention|Lost to Follow-up|1|||
161316191|NCT00270231|582539997|FG000|Washout Period|Lost to Follow-up|1|||
161316192|NCT00270231|582539998|FG001|Washout Period|Lost to Follow-up|0|||
161316193|NCT00270231|582539997|FG000|Second Intervention|Lost to Follow-up|0|||
161316194|NCT00270231|582539998|FG001|Second Intervention|Lost to Follow-up|1|||
161316195|NCT02603562|582539999|FG000|Overall Study|Lost to Follow-up|1|||
161316196|NCT00574795|582540001|FG000|Infant Series|Withdrawal by Subject|2|||
161316197|NCT00574795|582540001|FG000|Infant Series|Protocol Violation|2|||
161316198|NCT00574795|582540001|FG000|Infant Series|Adverse Event|1|||
161316199|NCT00574795|582540001|FG000|After Infant Series|Withdrawal by Subject|1|||
161316200|NCT00574795|582540001|FG000|After Infant Series|Adverse Event|2|||
161316201|NCT00574795|582540001|FG000|Toddler Dose|Withdrawal by Subject|1|||
161316202|NCT02638259|582540002|FG000|Treatment Period 1|Adverse Event|1|||
161316203|NCT02638259|582540003|FG001|Treatment Period 1|Adverse Event|5|||
161316204|NCT02638259|582540002|FG000|Treatment Period 1|Death|0|||
161316205|NCT02638259|582540003|FG001|Treatment Period 1|Death|1|||
161316206|NCT02638259|582540002|FG000|Treatment Period 1|Lack of Efficacy|0|||
161316207|NCT02638259|582540003|FG001|Treatment Period 1|Lack of Efficacy|1|||
161316208|NCT02638259|582540002|FG000|Treatment Period 1|Protocol Violation|0|||
161316209|NCT02638259|582540003|FG001|Treatment Period 1|Protocol Violation|3|||
161316210|NCT02638259|582540002|FG000|Treatment Period 1|Withdrawal by Subject|4|||
161316211|NCT02638259|582540003|FG001|Treatment Period 1|Withdrawal by Subject|6|||
161316212|NCT02638259|582540002|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
161316213|NCT02638259|582540003|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
161316214|NCT02638259|582540002|FG000|Treatment Period 2|Adverse Event|5|||
161316215|NCT02638259|582540003|FG001|Treatment Period 2|Adverse Event|4|||
161316216|NCT02638259|582540002|FG000|Treatment Period 2|Withdrawal by Subject|1|||
161316217|NCT02638259|582540003|FG001|Treatment Period 2|Withdrawal by Subject|7|||
161316218|NCT04299048|582540004|FG000|Overall Study|Death|1|||
161316219|NCT04299048|582540004|FG000|Overall Study|Global deterioration of health status|2|||
161316220|NCT04299048|582540004|FG000|Overall Study|Enrolled and not treated|1|||
161316221|NCT00634049|582540005|FG000|Overall Study|Never received study drug|1|||
161316222|NCT00634049|582540005|FG000|Overall Study|Died prior to receiving study drug|1|||
161316223|NCT00634049|582540005|FG000|Overall Study|Screening failure|1|||
161316224|NCT01717391|582540006|FG000|Overall Study|Withdrawal by Subject|5|||
161316225|NCT01717391|582540006|FG000|Overall Study|Physician Decision|1|||
161316226|NCT01717391|582540006|FG000|Overall Study|FLT technical failure|3|||
161316227|NCT03434249|582540010|FG000|Overall Study|Adverse Event|1|||
161316228|NCT03434249|582540011|FG001|Overall Study|Adverse Event|0|||
161316229|NCT03434249|582540010|FG000|Overall Study|Lost to Follow-up|0|||
161316230|NCT03434249|582540011|FG001|Overall Study|Lost to Follow-up|1|||
161316231|NCT03434249|582540010|FG000|Overall Study|Non-compliance of family|2|||
161316232|NCT03434249|582540011|FG001|Overall Study|Non-compliance of family|1|||
161316233|NCT03434249|582540010|FG000|Overall Study|Difficulties in completing daily diary|2|||
161316234|NCT03434249|582540011|FG001|Overall Study|Difficulties in completing daily diary|1|||
161316235|NCT01001598|582540012|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
161316236|NCT01001598|582540012|FG000|Overall Study|Adverse Event|1|||
161316237|NCT02920177|582540016|FG000|Overall Study|Withdrawal by Subject|1|||
161316238|NCT02920177|582540017|FG001|Overall Study|Withdrawal by Subject|1|||
161316239|NCT02920177|582540016|FG000|Overall Study|Physician Decision|1|||
161316240|NCT02920177|582540017|FG001|Overall Study|Physician Decision|0|||
161316241|NCT02920177|582540016|FG000|Overall Study|Lost to Follow-up|0|||
161316242|NCT02920177|582540017|FG001|Overall Study|Lost to Follow-up|1|||
161316243|NCT03164265|582540018|FG000|Overall Study|Physician Decision|3|||
161316244|NCT04907227|582540019|FG000|Overall Study|Death|12|||
161316245|NCT04907227|582540020|FG001|Overall Study|Death|8|||
161316246|NCT04907227|582540019|FG000|Overall Study|Withdrawal by Subject|2|||
161316247|NCT04907227|582540020|FG001|Overall Study|Withdrawal by Subject|2|||
161316248|NCT04907227|582540019|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
161316249|NCT04907227|582540020|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
161316250|NCT04907227|582540019|FG000|Overall Study|Sponsor Decision|25|||
161316251|NCT04907227|582540020|FG001|Overall Study|Sponsor Decision|30|||
161316252|NCT04907227|582540019|FG000|Overall Study|Physician Decision|1|||
161316253|NCT04907227|582540020|FG001|Overall Study|Physician Decision|0|||
161316254|NCT02208050|582540023|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
161316255|NCT02208050|582540024|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
161316256|NCT00721279|582540026|FG000|Overall Study|Lack of Efficacy|6|||
161316257|NCT00721279|582540027|FG001|Overall Study|Lack of Efficacy|3|||
161316258|NCT00721279|582540026|FG000|Overall Study|Tolerability insufficient|5|||
161316259|NCT00721279|582540027|FG001|Overall Study|Tolerability insufficient|2|||
161316260|NCT00721279|582540026|FG000|Overall Study|Withdrawal by Subject|13|||
161316261|NCT00721279|582540027|FG001|Overall Study|Withdrawal by Subject|3|||
161316262|NCT00721279|582540026|FG000|Overall Study|Other|12|||
161316263|NCT00721279|582540027|FG001|Overall Study|Other|16|||
161316264|NCT03673345|582540028|FG000|Overall Study|Lost to Follow-up|1|||
161316265|NCT03673345|582540029|FG001|Overall Study|Lost to Follow-up|0|||
161316266|NCT03673345|582540030|FG002|Overall Study|Lost to Follow-up|3|||
161316267|NCT03673345|582540031|FG003|Overall Study|Lost to Follow-up|3|||
161316268|NCT03673345|582540032|FG004|Overall Study|Lost to Follow-up|2|||
161316269|NCT03673345|582540033|FG005|Overall Study|Lost to Follow-up|1|||
161316270|NCT03673345|582540034|FG006|Overall Study|Lost to Follow-up|0|||
161316271|NCT03673345|582540035|FG007|Overall Study|Lost to Follow-up|0|||
161316272|NCT03673345|582540028|FG000|Overall Study|Withdrawal by Subject|1|||
161316273|NCT03673345|582540029|FG001|Overall Study|Withdrawal by Subject|0|||
161316274|NCT03673345|582540030|FG002|Overall Study|Withdrawal by Subject|4|||
161316275|NCT03673345|582540031|FG003|Overall Study|Withdrawal by Subject|2|||
161316276|NCT03673345|582540032|FG004|Overall Study|Withdrawal by Subject|0|||
161316277|NCT03673345|582540033|FG005|Overall Study|Withdrawal by Subject|0|||
161316278|NCT03673345|582540034|FG006|Overall Study|Withdrawal by Subject|0|||
161316279|NCT03673345|582540035|FG007|Overall Study|Withdrawal by Subject|0|||
161316280|NCT03673345|582540028|FG000|Overall Study|Physician Decision|0|||
161316281|NCT03673345|582540029|FG001|Overall Study|Physician Decision|0|||
161316282|NCT03673345|582540030|FG002|Overall Study|Physician Decision|2|||
161316283|NCT03673345|582540031|FG003|Overall Study|Physician Decision|0|||
161316284|NCT03673345|582540032|FG004|Overall Study|Physician Decision|0|||
161316285|NCT03673345|582540033|FG005|Overall Study|Physician Decision|0|||
161316286|NCT03673345|582540034|FG006|Overall Study|Physician Decision|0|||
161316287|NCT03673345|582540035|FG007|Overall Study|Physician Decision|0|||
161316288|NCT04608344|582540036|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
161316289|NCT04608344|582540037|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
161316290|NCT04608344|582540036|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
161316291|NCT04608344|582540037|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
161316292|NCT02429310|582540038|FG000|Overall Study|Lost to Follow-up|1|||
161316293|NCT02429310|582540039|FG001|Overall Study|Lost to Follow-up|2|||
161316294|NCT02429310|582540038|FG000|Overall Study|Protocol Violation|1|||
161316295|NCT02429310|582540039|FG001|Overall Study|Protocol Violation|1|||
161316296|NCT03646305|582540040|FG000|Overall Study|Lost to Follow-up|4|||
161316297|NCT03646305|582540041|FG001|Overall Study|Lost to Follow-up|2|||
161316298|NCT03646305|582540042|FG002|Overall Study|Lost to Follow-up|2|||
161316299|NCT03646305|582540043|FG003|Overall Study|Lost to Follow-up|1|||
161316300|NCT03646305|582540040|FG000|Overall Study|Withdrawal by Subject|1|||
161316301|NCT03646305|582540041|FG001|Overall Study|Withdrawal by Subject|0|||
161316302|NCT03646305|582540042|FG002|Overall Study|Withdrawal by Subject|0|||
161316303|NCT03646305|582540043|FG003|Overall Study|Withdrawal by Subject|1|||
161316304|NCT01554176|582540044|FG000|Treatment Phase|Protocol Violation|1|||
161316305|NCT01554176|582540045|FG001|Treatment Phase|Protocol Violation|2|||
161316306|NCT01554176|582540046|FG002|Treatment Phase|Protocol Violation|0|||
161316307|NCT01554176|582540047|FG003|Treatment Phase|Protocol Violation|0|||
161316308|NCT01554176|582540048|FG004|Treatment Phase|Protocol Violation|0|||
161316309|NCT01554176|582540044|FG000|Treatment Phase|Physician Decision|1|||
161316310|NCT01554176|582540045|FG001|Treatment Phase|Physician Decision|1|||
161316311|NCT01554176|582540046|FG002|Treatment Phase|Physician Decision|0|||
161316312|NCT01554176|582540047|FG003|Treatment Phase|Physician Decision|0|||
161316313|NCT01554176|582540048|FG004|Treatment Phase|Physician Decision|0|||
161316314|NCT01554176|582540044|FG000|Treatment Phase|Lack of Efficacy|0|||
161316315|NCT01554176|582540045|FG001|Treatment Phase|Lack of Efficacy|1|||
161316316|NCT01554176|582540046|FG002|Treatment Phase|Lack of Efficacy|0|||
161316317|NCT01554176|582540047|FG003|Treatment Phase|Lack of Efficacy|0|||
161316318|NCT01554176|582540048|FG004|Treatment Phase|Lack of Efficacy|0|||
161316319|NCT01554176|582540044|FG000|Treatment Phase|Adverse event, non-fatal|1|||
161316320|NCT01554176|582540045|FG001|Treatment Phase|Adverse event, non-fatal|1|||
161316321|NCT01554176|582540046|FG002|Treatment Phase|Adverse event, non-fatal|0|||
161316322|NCT01554176|582540047|FG003|Treatment Phase|Adverse event, non-fatal|0|||
161316323|NCT01554176|582540048|FG004|Treatment Phase|Adverse event, non-fatal|0|||
161316324|NCT01554176|582540044|FG000|Treatment Phase|Non-compliance with study drug|1|||
161316325|NCT01554176|582540045|FG001|Treatment Phase|Non-compliance with study drug|0|||
161316326|NCT01554176|582540046|FG002|Treatment Phase|Non-compliance with study drug|0|||
161316327|NCT01554176|582540047|FG003|Treatment Phase|Non-compliance with study drug|0|||
161316328|NCT01554176|582540048|FG004|Treatment Phase|Non-compliance with study drug|0|||
161316329|NCT01554176|582540044|FG000|Treatment Phase|Withdrawal by Subject|1|||
161316330|NCT01554176|582540045|FG001|Treatment Phase|Withdrawal by Subject|0|||
161316331|NCT01554176|582540046|FG002|Treatment Phase|Withdrawal by Subject|0|||
161316332|NCT01554176|582540047|FG003|Treatment Phase|Withdrawal by Subject|0|||
161316333|NCT01554176|582540048|FG004|Treatment Phase|Withdrawal by Subject|0|||
161316334|NCT01554176|582540044|FG000|Treatment Phase|Lost to Follow-up|3|||
161316335|NCT01554176|582540045|FG001|Treatment Phase|Lost to Follow-up|0|||
161316336|NCT01554176|582540046|FG002|Treatment Phase|Lost to Follow-up|0|||
161316337|NCT01554176|582540047|FG003|Treatment Phase|Lost to Follow-up|0|||
161316338|NCT01554176|582540048|FG004|Treatment Phase|Lost to Follow-up|0|||
161316339|NCT01554176|582540044|FG000|Run-out Phase|Protocol Violation|0|||
161316340|NCT01554176|582540045|FG001|Run-out Phase|Protocol Violation|0|||
161316341|NCT01554176|582540046|FG002|Run-out Phase|Protocol Violation|0|||
161316342|NCT01554176|582540047|FG003|Run-out Phase|Protocol Violation|1|||
161316343|NCT01554176|582540048|FG004|Run-out Phase|Protocol Violation|0|||
161316344|NCT02678000|582540051|FG000|PART 2|Adverse Event|0|||
161316345|NCT02678000|582540052|FG001|PART 2|Adverse Event|0|||
161316346|NCT02678000|582540053|FG002|PART 2|Adverse Event|2|||
161316347|NCT02678000|582540054|FG003|PART 2|Adverse Event|1|||
161316348|NCT02678000|582540055|FG004|PART 2|Adverse Event|0|||
161316349|NCT02678000|582540051|FG000|PART 2|Withdrawal by Subject|0|||
161316350|NCT02678000|582540052|FG001|PART 2|Withdrawal by Subject|0|||
161316351|NCT02678000|582540053|FG002|PART 2|Withdrawal by Subject|1|||
161316352|NCT02678000|582540054|FG003|PART 2|Withdrawal by Subject|0|||
161316353|NCT02678000|582540055|FG004|PART 2|Withdrawal by Subject|0|||
161316354|NCT03053427|582540056|FG000|Overall Study|Adverse Event|4|||
161316355|NCT03053427|582540057|FG001|Overall Study|Adverse Event|4|||
161316356|NCT03053427|582540056|FG000|Overall Study|Lack of Efficacy|1|||
161316357|NCT03053427|582540057|FG001|Overall Study|Lack of Efficacy|3|||
161316358|NCT03053427|582540056|FG000|Overall Study|Lost to Follow-up|2|||
161316359|NCT03053427|582540057|FG001|Overall Study|Lost to Follow-up|2|||
161316360|NCT03053427|582540056|FG000|Overall Study|Worsening of the target disease|0|||
161316361|NCT03053427|582540057|FG001|Overall Study|Worsening of the target disease|1|||
161316362|NCT03053427|582540056|FG000|Overall Study|Protocol Deviation|3|||
161316363|NCT03053427|582540057|FG001|Overall Study|Protocol Deviation|3|||
161316364|NCT03053427|582540056|FG000|Overall Study|Withdrawal by Subject|3|||
161316365|NCT03053427|582540057|FG001|Overall Study|Withdrawal by Subject|2|||
161316366|NCT03053427|582540056|FG000|Overall Study|Miscellaneous|0|||
161316367|NCT03053427|582540057|FG001|Overall Study|Miscellaneous|1|||
161316368|NCT02510820|582542241|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
161316369|NCT02510820|582542242|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
161316370|NCT02510820|582542241|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
161316371|NCT02510820|582542242|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
161316372|NCT01533688|582542243|FG000|Overall Study|Withdrawal by Subject|5|||
161316373|NCT01533688|582542244|FG001|Overall Study|Withdrawal by Subject|4|||
161316374|NCT01533688|582542245|FG002|Overall Study|Withdrawal by Subject|3|||
161316375|NCT01533688|582542243|FG000|Overall Study|Medically unstable|1|||
161316376|NCT01533688|582542244|FG001|Overall Study|Medically unstable|3|||
161316377|NCT01533688|582542245|FG002|Overall Study|Medically unstable|3|||
161316378|NCT01533688|582542243|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
161316379|NCT01533688|582542244|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
161316380|NCT01533688|582542245|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
161316381|NCT02190721|582542246|FG000|Overall Study|Patient was out of the city|0|||
161316382|NCT02190721|582542247|FG001|Overall Study|Patient was out of the city|1|||
161316383|NCT02190721|582542248|FG002|Overall Study|Patient was out of the city|0|||
161316384|NCT01760447|582542249|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
161316385|NCT01760447|582542250|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
161316386|NCT01760447|582542251|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
161316387|NCT01760447|582542252|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
161316388|NCT01760447|582542249|FG000|Weeks 0-20|Withdrawal by Subject|2|||
161316389|NCT01760447|582542250|FG001|Weeks 0-20|Withdrawal by Subject|0|||
161316390|NCT01760447|582542251|FG002|Weeks 0-20|Withdrawal by Subject|1|||
161316391|NCT01760447|582542252|FG003|Weeks 0-20|Withdrawal by Subject|0|||
161316392|NCT01760447|582542249|FG000|Weeks 0-20|Lost to Follow-up|1|||
161316393|NCT01760447|582542250|FG001|Weeks 0-20|Lost to Follow-up|0|||
161316394|NCT01760447|582542251|FG002|Weeks 0-20|Lost to Follow-up|1|||
161316395|NCT01760447|582542252|FG003|Weeks 0-20|Lost to Follow-up|1|||
161316396|NCT01760447|582542249|FG000|Weeks 0-20|Randomized but not treated|0|||
161316397|NCT01760447|582542250|FG001|Weeks 0-20|Randomized but not treated|0|||
161316398|NCT01760447|582542251|FG002|Weeks 0-20|Randomized but not treated|2|||
161316399|NCT01760447|582542252|FG003|Weeks 0-20|Randomized but not treated|0|||
161316400|NCT01760447|582542249|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161316401|NCT01760447|582542250|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161316402|NCT01760447|582542251|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
161316403|NCT01760447|582542252|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
161316404|NCT01760447|582542249|FG000|Weeks 20-54|Withdrawal by Subject|2|||
161316405|NCT01760447|582542250|FG001|Weeks 20-54|Withdrawal by Subject|1|||
161316406|NCT01760447|582542251|FG002|Weeks 20-54|Withdrawal by Subject|1|||
161316407|NCT01760447|582542252|FG003|Weeks 20-54|Withdrawal by Subject|2|||
161316408|NCT01760447|582542249|FG000|Weeks 20-54|Lost to Follow-up|0|||
161316409|NCT01760447|582542250|FG001|Weeks 20-54|Lost to Follow-up|0|||
161316410|NCT01760447|582542251|FG002|Weeks 20-54|Lost to Follow-up|1|||
161316411|NCT01760447|582542252|FG003|Weeks 20-54|Lost to Follow-up|2|||
161316412|NCT01214668|582542253|FG000|Overall Study|Adverse Event|0|||
161316413|NCT01214668|582542254|FG001|Overall Study|Adverse Event|1|||
161316414|NCT01214668|582542255|FG002|Overall Study|Adverse Event|0|||
161316415|NCT01214668|582542256|FG003|Overall Study|Adverse Event|2|||
161316416|NCT01214668|582542257|FG004|Overall Study|Adverse Event|1|||
161316417|NCT01214668|582542258|FG005|Overall Study|Adverse Event|1|||
161316418|NCT01214668|582542253|FG000|Overall Study|Death|0|||
161316419|NCT01214668|582542254|FG001|Overall Study|Death|0|||
161316420|NCT01214668|582542255|FG002|Overall Study|Death|1|||
161316421|NCT01214668|582542256|FG003|Overall Study|Death|0|||
161316422|NCT01214668|582542257|FG004|Overall Study|Death|0|||
161316423|NCT01214668|582542258|FG005|Overall Study|Death|0|||
161316424|NCT01214668|582542253|FG000|Overall Study|Progressive Disease|4|||
161316425|NCT01214668|582542254|FG001|Overall Study|Progressive Disease|2|||
161316426|NCT01214668|582542255|FG002|Overall Study|Progressive Disease|5|||
161316427|NCT01214668|582542256|FG003|Overall Study|Progressive Disease|4|||
161316428|NCT01214668|582542257|FG004|Overall Study|Progressive Disease|4|||
161316429|NCT01214668|582542258|FG005|Overall Study|Progressive Disease|5|||
161316430|NCT01214668|582542253|FG000|Overall Study|Withdrawal by Subject|0|||
161316431|NCT01214668|582542254|FG001|Overall Study|Withdrawal by Subject|0|||
161316432|NCT01214668|582542255|FG002|Overall Study|Withdrawal by Subject|0|||
161316433|NCT01214668|582542256|FG003|Overall Study|Withdrawal by Subject|0|||
161316434|NCT01214668|582542257|FG004|Overall Study|Withdrawal by Subject|1|||
161316435|NCT01214668|582542258|FG005|Overall Study|Withdrawal by Subject|0|||
161316436|NCT02907619|582542259|FG000|Overall Study|Study terminated by sponsor|18|||
161316437|NCT02907619|582542260|FG001|Overall Study|Study terminated by sponsor|18|||
161316438|NCT02907619|582542261|FG002|Overall Study|Study terminated by sponsor|19|||
161316439|NCT02907619|582542259|FG000|Overall Study|Death|0|||
161316440|NCT02907619|582542260|FG001|Overall Study|Death|0|||
161316441|NCT02907619|582542261|FG002|Overall Study|Death|1|||
161316442|NCT02907619|582542259|FG000|Overall Study|Withdrawal by Subject|1|||
161316443|NCT02907619|582542260|FG001|Overall Study|Withdrawal by Subject|1|||
161316444|NCT02907619|582542261|FG002|Overall Study|Withdrawal by Subject|0|||
161316445|NCT02907619|582542259|FG000|Overall Study|Other|0|||
161316446|NCT02907619|582542260|FG001|Overall Study|Other|1|||
161316447|NCT02907619|582542261|FG002|Overall Study|Other|0|||
161316448|NCT03326518|582542262|FG000|Overall Study|Protocol Violation|1|||
161316449|NCT03326518|582542263|FG001|Overall Study|Protocol Violation|0|||
161316450|NCT03326518|582542264|FG002|Overall Study|Protocol Violation|0|||
161316451|NCT03326518|582542262|FG000|Overall Study|Withdrawal by Subject|1|||
161316452|NCT03326518|582542263|FG001|Overall Study|Withdrawal by Subject|0|||
161316453|NCT03326518|582542264|FG002|Overall Study|Withdrawal by Subject|0|||
161316454|NCT03326518|582542262|FG000|Overall Study|Lost to Follow-up|1|||
161316455|NCT03326518|582542263|FG001|Overall Study|Lost to Follow-up|0|||
161316456|NCT03326518|582542264|FG002|Overall Study|Lost to Follow-up|1|||
161316457|NCT06439095|582542265|FG000|Overall Study|Lost to Follow-up|2|||
161316458|NCT03484403|582542267|FG000|Overall Study|Withdrawal by Subject|6|||
161316459|NCT03484403|582542268|FG001|Overall Study|Withdrawal by Subject|4|||
161316460|NCT01937884|582542270|FG000|Overall Study|Withdrawal by Subject|1|||
161316461|NCT01937884|582542271|FG001|Overall Study|Withdrawal by Subject|0|||
161316462|NCT01964716|582542283|FG000|Overall Study|Withdrawal by Subject|2|||
161316463|NCT01964716|582542284|FG001|Overall Study|Withdrawal by Subject|3|||
161316464|NCT01964716|582542283|FG000|Overall Study|Lost to Follow-up|1|||
161316465|NCT01964716|582542284|FG001|Overall Study|Lost to Follow-up|2|||
161316466|NCT01964716|582542283|FG000|Overall Study|No longer met eligibility criteria|1|||
161316467|NCT01964716|582542284|FG001|Overall Study|No longer met eligibility criteria|1|||
161316468|NCT01964716|582542283|FG000|Overall Study|Death|1|||
161316469|NCT01964716|582542284|FG001|Overall Study|Death|0|||
161316470|NCT02147067|582542285|FG000|Overall Study|Withdrawal by Subject|2|||
161316471|NCT02147067|582542286|FG001|Overall Study|Withdrawal by Subject|2|||
161316472|NCT03411902|582542287|FG000|Overall Study|Lost to Follow-up|3|||
161316473|NCT03411902|582542288|FG001|Overall Study|Lost to Follow-up|0|||
161316474|NCT00791492|582542291|FG000|Overall Study|Withdrawal by Subject|1|||
161316475|NCT00791492|582542292|FG001|Overall Study|Withdrawal by Subject|2|||
161316476|NCT00791492|582542291|FG000|Overall Study|Liver transplantation|5|||
161316477|NCT00791492|582542292|FG001|Overall Study|Liver transplantation|1|||
161316478|NCT01370616|582542293|FG000|Overall Study|Adverse Event|11|||
161316479|NCT01370616|582542294|FG001|Overall Study|Adverse Event|16|||
161316480|NCT01370616|582542293|FG000|Overall Study|Death|1|||
161316481|NCT01370616|582542294|FG001|Overall Study|Death|0|||
161316482|NCT01370616|582542293|FG000|Overall Study|Lack of Efficacy|6|||
161316483|NCT01370616|582542294|FG001|Overall Study|Lack of Efficacy|2|||
161316484|NCT01370616|582542293|FG000|Overall Study|Lost to Follow-up|0|||
161316485|NCT01370616|582542294|FG001|Overall Study|Lost to Follow-up|3|||
161316486|NCT01370616|582542293|FG000|Overall Study|Physician Decision|6|||
161316487|NCT01370616|582542294|FG001|Overall Study|Physician Decision|6|||
161316488|NCT01370616|582542293|FG000|Overall Study|Progressive Disease|0|||
161316489|NCT01370616|582542294|FG001|Overall Study|Progressive Disease|1|||
161316490|NCT01370616|582542293|FG000|Overall Study|Recovery|1|||
161316491|NCT01370616|582542294|FG001|Overall Study|Recovery|0|||
161316492|NCT01370616|582542293|FG000|Overall Study|Technical Problems|3|||
161316493|NCT01370616|582542294|FG001|Overall Study|Technical Problems|5|||
161316494|NCT01370616|582542293|FG000|Overall Study|Withdrawal by Subject|34|||
161316495|NCT01370616|582542294|FG001|Overall Study|Withdrawal by Subject|34|||
161316496|NCT01693185|582542301|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
161316497|NCT01693185|582542302|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
161316498|NCT00419159|582542303|FG000|Overall Study|Adverse Event|7|||
161316499|NCT00419159|582542304|FG001|Overall Study|Adverse Event|15|||
161316500|NCT00419159|582542303|FG000|Overall Study|Abnormal laboratory value(s)|0|||
161316501|NCT00419159|582542304|FG001|Overall Study|Abnormal laboratory value(s)|2|||
161316502|NCT00419159|582542303|FG000|Overall Study|Subject's no longer requires study drug|0|||
161316503|NCT00419159|582542304|FG001|Overall Study|Subject's no longer requires study drug|1|||
161316504|NCT00419159|582542303|FG000|Overall Study|Protocol Violation|1|||
161316505|NCT00419159|582542304|FG001|Overall Study|Protocol Violation|0|||
161316506|NCT00419159|582542303|FG000|Overall Study|Withdrawal by Subject|10|||
161316507|NCT00419159|582542304|FG001|Overall Study|Withdrawal by Subject|3|||
161316508|NCT00419159|582542303|FG000|Overall Study|Lost to Follow-up|0|||
161316509|NCT00419159|582542304|FG001|Overall Study|Lost to Follow-up|1|||
161316510|NCT00419159|582542303|FG000|Overall Study|Death|2|||
161316511|NCT00419159|582542304|FG001|Overall Study|Death|2|||
161316512|NCT00419159|582542303|FG000|Overall Study|Disease progression|79|||
161316513|NCT00419159|582542304|FG001|Overall Study|Disease progression|76|||
161316514|NCT01017601|582542305|FG000|Overall Study|Disease Progression|12|||
161316515|NCT01017601|582542306|FG001|Overall Study|Disease Progression|12|||
161316516|NCT01017601|582542305|FG000|Overall Study|Withdrawal by Subject|0|||
161316517|NCT01017601|582542306|FG001|Overall Study|Withdrawal by Subject|1|||
161316518|NCT00076999|582542307|FG000|Overall Study|Adverse Event|2|||
161316519|NCT00076999|582542308|FG001|Overall Study|Adverse Event|8|||
161316520|NCT00076999|582542309|FG002|Overall Study|Adverse Event|6|||
161316521|NCT00076999|582542310|FG003|Overall Study|Adverse Event|0|||
161316522|NCT00076999|582542311|FG004|Overall Study|Adverse Event|2|||
161316523|NCT00076999|582542307|FG000|Overall Study|Protocol Violation|0|||
161316524|NCT00076999|582542308|FG001|Overall Study|Protocol Violation|3|||
161316525|NCT00076999|582542309|FG002|Overall Study|Protocol Violation|4|||
161316526|NCT00076999|582542310|FG003|Overall Study|Protocol Violation|0|||
161316527|NCT00076999|582542311|FG004|Overall Study|Protocol Violation|9|||
161316528|NCT00076999|582542307|FG000|Overall Study|Lost to Follow-up|2|||
161316529|NCT00076999|582542308|FG001|Overall Study|Lost to Follow-up|1|||
161316530|NCT00076999|582542309|FG002|Overall Study|Lost to Follow-up|0|||
161316531|NCT00076999|582542310|FG003|Overall Study|Lost to Follow-up|0|||
161316532|NCT00076999|582542311|FG004|Overall Study|Lost to Follow-up|0|||
161316533|NCT00076999|582542307|FG000|Overall Study|Withdrawal by Subject|0|||
161316534|NCT00076999|582542308|FG001|Overall Study|Withdrawal by Subject|4|||
161316535|NCT00076999|582542309|FG002|Overall Study|Withdrawal by Subject|3|||
161316536|NCT00076999|582542310|FG003|Overall Study|Withdrawal by Subject|0|||
161316537|NCT00076999|582542311|FG004|Overall Study|Withdrawal by Subject|1|||
161316538|NCT00076999|582542307|FG000|Overall Study|Other reason (not specified)|8|||
161316539|NCT00076999|582542308|FG001|Overall Study|Other reason (not specified)|8|||
161316540|NCT00076999|582542309|FG002|Overall Study|Other reason (not specified)|4|||
161316541|NCT00076999|582542310|FG003|Overall Study|Other reason (not specified)|1|||
161316542|NCT00076999|582542311|FG004|Overall Study|Other reason (not specified)|13|||
161316543|NCT00803205|582542313|FG000|Overall Study|Adverse Event|7|||
161316544|NCT00803205|582542314|FG001|Overall Study|Adverse Event|2|||
161316545|NCT00803205|582542313|FG000|Overall Study|Lost to Follow-up|1|||
161316546|NCT00803205|582542314|FG001|Overall Study|Lost to Follow-up|0|||
161316547|NCT00803205|582542313|FG000|Overall Study|Withdrawal by Subject|9|||
161316548|NCT00803205|582542314|FG001|Overall Study|Withdrawal by Subject|9|||
161316549|NCT00803205|582542313|FG000|Overall Study|Physician Decision|1|||
161316550|NCT00803205|582542314|FG001|Overall Study|Physician Decision|0|||
161316551|NCT00803205|582542313|FG000|Overall Study|Protocol Violation|1|||
161316552|NCT00803205|582542314|FG001|Overall Study|Protocol Violation|1|||
161316553|NCT00803205|582542313|FG000|Overall Study|Medical Monitor Decision|1|||
161316554|NCT00803205|582542314|FG001|Overall Study|Medical Monitor Decision|0|||
161316555|NCT00803205|582542313|FG000|Overall Study|Acquired a Lung Infection|0|||
161316556|NCT00803205|582542314|FG001|Overall Study|Acquired a Lung Infection|1|||
161316557|NCT00803205|582542313|FG000|Overall Study|Sponsor Decision|0|||
161316558|NCT00803205|582542314|FG001|Overall Study|Sponsor Decision|1|||
161316559|NCT01857102|582542315|FG000|Period 1|No longer meets Eligibility Criteria|0|||
161316560|NCT01857102|582542316|FG001|Period 1|No longer meets Eligibility Criteria|2|||
161316561|NCT01857102|582542315|FG000|Period 1|Lost to Follow-up|0|||
161316562|NCT01857102|582542316|FG001|Period 1|Lost to Follow-up|3|||
161316563|NCT01857102|582542315|FG000|Period 1|Unsatisfactory Lens Fit|1|||
161316564|NCT01857102|582542316|FG001|Period 1|Unsatisfactory Lens Fit|0|||
161316565|NCT01857102|582542315|FG000|Period 1|Unsatisfactory Visual Response|1|||
161316566|NCT01857102|582542316|FG001|Period 1|Unsatisfactory Visual Response|0|||
161316567|NCT01857102|582542315|FG000|Period 1|Physician Decision|1|||
161316568|NCT01857102|582542316|FG001|Period 1|Physician Decision|0|||
161316569|NCT01857102|582542315|FG000|Period 2|Lens Discomfort|1|||
161316570|NCT01857102|582542316|FG001|Period 2|Lens Discomfort|0|||
161316571|NCT01857102|582542315|FG000|Period 2|Unsatisfactory Lens Fit|1|||
161316572|NCT01857102|582542316|FG001|Period 2|Unsatisfactory Lens Fit|0|||
161316573|NCT02735096|582542322|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
161316574|NCT01080391|582542330|FG000|Overall Study|Randomized but not treated|7|||
161316575|NCT01080391|582542331|FG001|Overall Study|Randomized but not treated|4|||
161316576|NCT01534208|582542335|FG000|Overall Study|Lost to Follow-up|19|||
161316577|NCT01534208|582542336|FG001|Overall Study|Lost to Follow-up|14|||
161316578|NCT01534208|582542335|FG000|Overall Study|Withdrawal by Subject|6|||
161316579|NCT01534208|582542336|FG001|Overall Study|Withdrawal by Subject|20|||
161316580|NCT01534208|582542335|FG000|Overall Study|Adverse Event|15|||
161316581|NCT01534208|582542336|FG001|Overall Study|Adverse Event|8|||
161316582|NCT01534208|582542335|FG000|Overall Study|Physician Decision|2|||
161316583|NCT01534208|582542336|FG001|Overall Study|Physician Decision|0|||
161316584|NCT01534208|582542335|FG000|Overall Study|Lack of Efficacy|0|||
161316585|NCT01534208|582542336|FG001|Overall Study|Lack of Efficacy|3|||
161316586|NCT01534208|582542335|FG000|Overall Study|Protocol Violation|2|||
161316587|NCT01534208|582542336|FG001|Overall Study|Protocol Violation|2|||
161316588|NCT01534208|582542335|FG000|Overall Study|Sponsor decision|4|||
161316589|NCT01534208|582542336|FG001|Overall Study|Sponsor decision|1|||
161316590|NCT01534208|582542335|FG000|Overall Study|Subject relocation|2|||
161316591|NCT01534208|582542336|FG001|Overall Study|Subject relocation|0|||
161316592|NCT01534208|582542335|FG000|Overall Study|Lab assessment|2|||
161316593|NCT01534208|582542336|FG001|Overall Study|Lab assessment|1|||
161316594|NCT01534208|582542335|FG000|Overall Study|Eligibility error|3|||
161316595|NCT01534208|582542336|FG001|Overall Study|Eligibility error|0|||
161316596|NCT01534208|582542335|FG000|Overall Study|PCP decision|1|||
161316597|NCT01534208|582542336|FG001|Overall Study|PCP decision|0|||
161316598|NCT01534208|582542335|FG000|Overall Study|Needed prohibited meds|1|||
161316599|NCT01534208|582542336|FG001|Overall Study|Needed prohibited meds|0|||
161316600|NCT02117713|582542347|FG000|Week 48|Adverse Event|4|||
161316601|NCT02117713|582542347|FG000|Week 48|Withdrawal by caregiver|2|||
161316602|NCT02117713|582542347|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
161316603|NCT02117713|582542347|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
161316604|NCT02117713|582542347|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
161316605|NCT02117713|582542347|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
161316606|NCT03578146|582542348|FG000|Overall Study|Did Not Receive Treatment|1|||
161316607|NCT03578146|582542349|FG001|Overall Study|Did Not Receive Treatment|0|||
161316608|NCT03578146|582542350|FG002|Overall Study|Did Not Receive Treatment|0|||
161316609|NCT03578146|582542351|FG003|Overall Study|Did Not Receive Treatment|0|||
161316610|NCT03578146|582542352|FG004|Overall Study|Did Not Receive Treatment|0|||
161316611|NCT03578146|582542353|FG005|Overall Study|Did Not Receive Treatment|2|||
161316612|NCT03578146|582542348|FG000|Overall Study|Lost to Follow-up|0|||
161316613|NCT03578146|582542349|FG001|Overall Study|Lost to Follow-up|1|||
161316614|NCT03578146|582542350|FG002|Overall Study|Lost to Follow-up|1|||
161316615|NCT03578146|582542351|FG003|Overall Study|Lost to Follow-up|0|||
161316616|NCT03578146|582542352|FG004|Overall Study|Lost to Follow-up|0|||
161316617|NCT03578146|582542353|FG005|Overall Study|Lost to Follow-up|1|||
161316618|NCT01094782|582542355|FG000|Overall Study|Withdrawal by Subject|5|||
161316619|NCT01094782|582542356|FG001|Overall Study|Withdrawal by Subject|5|||
161316620|NCT01094782|582542357|FG002|Overall Study|Withdrawal by Subject|1|||
161316621|NCT01094782|582542358|FG003|Overall Study|Withdrawal by Subject|5|||
161316622|NCT01094782|582542359|FG004|Overall Study|Withdrawal by Subject|5|||
161316623|NCT01094782|582542360|FG005|Overall Study|Withdrawal by Subject|0|||
161316624|NCT01094782|582542355|FG000|Overall Study|Lost to Follow-up|1|||
161316625|NCT01094782|582542356|FG001|Overall Study|Lost to Follow-up|0|||
161316626|NCT01094782|582542357|FG002|Overall Study|Lost to Follow-up|0|||
161316627|NCT01094782|582542358|FG003|Overall Study|Lost to Follow-up|2|||
161316628|NCT01094782|582542359|FG004|Overall Study|Lost to Follow-up|1|||
161316629|NCT01094782|582542360|FG005|Overall Study|Lost to Follow-up|4|||
161316630|NCT01094782|582542355|FG000|Overall Study|Positive Drug Screen|2|||
161316631|NCT01094782|582542356|FG001|Overall Study|Positive Drug Screen|2|||
161316632|NCT01094782|582542357|FG002|Overall Study|Positive Drug Screen|1|||
161316633|NCT01094782|582542358|FG003|Overall Study|Positive Drug Screen|1|||
161316634|NCT01094782|582542359|FG004|Overall Study|Positive Drug Screen|3|||
161316635|NCT01094782|582542360|FG005|Overall Study|Positive Drug Screen|2|||
161316636|NCT01094782|582542355|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
161316637|NCT01094782|582542356|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
161316638|NCT01094782|582542357|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
161316639|NCT01094782|582542358|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
161316640|NCT01094782|582542359|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
161316641|NCT01094782|582542360|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
161316642|NCT01094782|582542355|FG000|Overall Study|Unable to Complete Questionnaires|0|||
161316643|NCT01094782|582542356|FG001|Overall Study|Unable to Complete Questionnaires|1|||
161316644|NCT01094782|582542357|FG002|Overall Study|Unable to Complete Questionnaires|0|||
161316645|NCT01094782|582542358|FG003|Overall Study|Unable to Complete Questionnaires|0|||
161316646|NCT01094782|582542359|FG004|Overall Study|Unable to Complete Questionnaires|0|||
161316647|NCT01094782|582542360|FG005|Overall Study|Unable to Complete Questionnaires|0|||
161316648|NCT01094782|582542355|FG000|Overall Study|Healthy Subject Had Pain|0|||
161316649|NCT01094782|582542356|FG001|Overall Study|Healthy Subject Had Pain|1|||
161316650|NCT01094782|582542357|FG002|Overall Study|Healthy Subject Had Pain|0|||
161316651|NCT01094782|582542358|FG003|Overall Study|Healthy Subject Had Pain|0|||
161316652|NCT01094782|582542359|FG004|Overall Study|Healthy Subject Had Pain|0|||
161316653|NCT01094782|582542360|FG005|Overall Study|Healthy Subject Had Pain|0|||
161316654|NCT01094782|582542355|FG000|Overall Study|Hypertension|0|||
161316655|NCT01094782|582542356|FG001|Overall Study|Hypertension|0|||
161316656|NCT01094782|582542357|FG002|Overall Study|Hypertension|1|||
161316657|NCT01094782|582542358|FG003|Overall Study|Hypertension|0|||
161316658|NCT01094782|582542359|FG004|Overall Study|Hypertension|0|||
161316659|NCT01094782|582542360|FG005|Overall Study|Hypertension|0|||
161316660|NCT01094782|582542355|FG000|Overall Study|Wrong Pain Condition|0|||
161316661|NCT01094782|582542356|FG001|Overall Study|Wrong Pain Condition|0|||
161316662|NCT01094782|582542357|FG002|Overall Study|Wrong Pain Condition|0|||
161316663|NCT01094782|582542358|FG003|Overall Study|Wrong Pain Condition|2|||
161316664|NCT01094782|582542359|FG004|Overall Study|Wrong Pain Condition|1|||
161316665|NCT01094782|582542360|FG005|Overall Study|Wrong Pain Condition|1|||
161316666|NCT01094782|582542355|FG000|Overall Study|Recent Interventional Injection|0|||
161316667|NCT01094782|582542356|FG001|Overall Study|Recent Interventional Injection|0|||
161316668|NCT01094782|582542357|FG002|Overall Study|Recent Interventional Injection|0|||
161316669|NCT01094782|582542358|FG003|Overall Study|Recent Interventional Injection|0|||
161316670|NCT01094782|582542359|FG004|Overall Study|Recent Interventional Injection|0|||
161316671|NCT01094782|582542360|FG005|Overall Study|Recent Interventional Injection|1|||
161316672|NCT01094782|582542355|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161316673|NCT01094782|582542356|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161316674|NCT01094782|582542357|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161316675|NCT01094782|582542358|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161316676|NCT01094782|582542359|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
161316677|NCT01094782|582542360|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
161316678|NCT01094782|582542355|FG000|Overall Study|Noncompliance With Study Schedule|0|||
161316679|NCT01094782|582542356|FG001|Overall Study|Noncompliance With Study Schedule|0|||
161316680|NCT01094782|582542357|FG002|Overall Study|Noncompliance With Study Schedule|0|||
161316681|NCT01094782|582542358|FG003|Overall Study|Noncompliance With Study Schedule|1|||
161316682|NCT01094782|582542359|FG004|Overall Study|Noncompliance With Study Schedule|0|||
161316683|NCT01094782|582542360|FG005|Overall Study|Noncompliance With Study Schedule|0|||
161316684|NCT03423147|582542365|FG000|Overall Study|Lost to Follow-up|5|||
161316685|NCT03423147|582542366|FG001|Overall Study|Lost to Follow-up|8|||
161316686|NCT03423147|582542365|FG000|Overall Study|Withdrawal by Subject|1|||
161316687|NCT03423147|582542366|FG001|Overall Study|Withdrawal by Subject|0|||
161316688|NCT03423147|582542365|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
161316689|NCT03423147|582542366|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
161316690|NCT03423147|582542365|FG000|Overall Study|Age < 18|1|||
161316691|NCT03423147|582542366|FG001|Overall Study|Age < 18|0|||
161316692|NCT03423147|582542365|FG000|Overall Study|No Trial of Labor|0|||
161316693|NCT03423147|582542366|FG001|Overall Study|No Trial of Labor|1|||
161316694|NCT02450552|582542368|FG000|Overall Study|Withdrawal by Subject|4|||
161316695|NCT02450552|582542369|FG001|Overall Study|Withdrawal by Subject|0|||
161316696|NCT02450552|582542370|FG002|Overall Study|Withdrawal by Subject|4|||
161316697|NCT02450552|582542368|FG000|Overall Study|Physician Decision|1|||
161316698|NCT02450552|582542369|FG001|Overall Study|Physician Decision|0|||
161316699|NCT02450552|582542370|FG002|Overall Study|Physician Decision|1|||
161316700|NCT01625689|582542371|FG000|Overall Study|Migration|2|||
161316701|NCT01625689|582542372|FG001|Overall Study|Migration|1|||
161316702|NCT03723070|582542377|FG000|Overall Study|Lost to Follow-up|2|||
161316703|NCT03723070|582542377|FG000|Overall Study|Physician Decision|1|||
161316704|NCT03723070|582542377|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
161316705|NCT05153148|582542378|FG000|Overall Study|Adverse Event|1|||
161316706|NCT05153148|582542379|FG001|Overall Study|Adverse Event|0|||
161316707|NCT05153148|582542380|FG002|Overall Study|Adverse Event|3|||
161316708|NCT05153148|582542381|FG003|Overall Study|Adverse Event|5|||
161316709|NCT05153148|582542378|FG000|Overall Study|Lost to Follow-up|1|||
161316710|NCT05153148|582542379|FG001|Overall Study|Lost to Follow-up|1|||
161316711|NCT05153148|582542380|FG002|Overall Study|Lost to Follow-up|2|||
161316712|NCT05153148|582542381|FG003|Overall Study|Lost to Follow-up|0|||
161316713|NCT05153148|582542378|FG000|Overall Study|Withdrawal by Subject|6|||
161316714|NCT05153148|582542379|FG001|Overall Study|Withdrawal by Subject|8|||
161316715|NCT05153148|582542380|FG002|Overall Study|Withdrawal by Subject|6|||
161316716|NCT05153148|582542381|FG003|Overall Study|Withdrawal by Subject|8|||
161316717|NCT05153148|582542378|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161316718|NCT05153148|582542379|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161316719|NCT05153148|582542380|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
161316720|NCT05153148|582542381|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
161316721|NCT05153148|582542378|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161316722|NCT05153148|582542379|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161316723|NCT05153148|582542380|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
161316724|NCT05153148|582542381|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
161316725|NCT05153148|582542378|FG000|Overall Study|Reason not Specified|1|||
161316726|NCT05153148|582542379|FG001|Overall Study|Reason not Specified|1|||
161316727|NCT05153148|582542380|FG002|Overall Study|Reason not Specified|1|||
161316728|NCT05153148|582542381|FG003|Overall Study|Reason not Specified|1|||
161316729|NCT01732471|582542382|FG000|Overall Study|Withdrawal by Subject|1|||
161316730|NCT00474786|582542383|FG000|Overall Study|Not Meeting Study Criteria|0|||
161316731|NCT00474786|582542384|FG001|Overall Study|Not Meeting Study Criteria|1|||
161316732|NCT00474786|582542383|FG000|Overall Study|Investigator Request|2|||
161316733|NCT00474786|582542384|FG001|Overall Study|Investigator Request|1|||
161316734|NCT00474786|582542383|FG000|Overall Study|Death|189|||
161316735|NCT00474786|582542384|FG001|Overall Study|Death|170|||
161316736|NCT00474786|582542383|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
161316737|NCT00474786|582542384|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
161316738|NCT00474786|582542383|FG000|Overall Study|Lost to Follow-up|4|||
161316739|NCT00474786|582542384|FG001|Overall Study|Lost to Follow-up|7|||
161316740|NCT00474786|582542383|FG000|Overall Study|Protocol Violation|2|||
161316741|NCT00474786|582542384|FG001|Overall Study|Protocol Violation|0|||
161316742|NCT00474786|582542383|FG000|Overall Study|Withdrawal by Subject|15|||
161316743|NCT00474786|582542384|FG001|Overall Study|Withdrawal by Subject|15|||
161316744|NCT00474786|582542383|FG000|Overall Study|Other|5|||
161316745|NCT00474786|582542384|FG001|Overall Study|Other|0|||
161316746|NCT02892513|582542385|FG000|Overall Study|Withdrawal by Subject|0|||
161316747|NCT02892513|582542386|FG001|Overall Study|Withdrawal by Subject|1|||
161316748|NCT00900731|582542387|FG000|Overall Study|Adverse Event|31|||
161316749|NCT00900731|582542388|FG001|Overall Study|Adverse Event|27|||
161316750|NCT00900731|582542387|FG000|Overall Study|Withdrawal by Subject|8|||
161316751|NCT00900731|582542388|FG001|Overall Study|Withdrawal by Subject|7|||
161316752|NCT00900731|582542387|FG000|Overall Study|Protocol Deviation|8|||
161316753|NCT00900731|582542388|FG001|Overall Study|Protocol Deviation|11|||
161316754|NCT00900731|582542387|FG000|Overall Study|Administrative Problems|5|||
161316755|NCT00900731|582542388|FG001|Overall Study|Administrative Problems|4|||
161316756|NCT00900731|582542387|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
161316757|NCT00900731|582542388|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
161316758|NCT00900731|582542387|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
161316759|NCT00900731|582542388|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
161316760|NCT00900731|582542387|FG000|Overall Study|Lost to Follow-up|2|||
161316761|NCT00900731|582542388|FG001|Overall Study|Lost to Follow-up|3|||
161316762|NCT00900731|582542387|FG000|Overall Study|Lack of Efficacy|1|||
161316763|NCT00900731|582542388|FG001|Overall Study|Lack of Efficacy|3|||
161316764|NCT00900731|582542387|FG000|Overall Study|Death|0|||
161316765|NCT00900731|582542388|FG001|Overall Study|Death|2|||
161316766|NCT00131365|582542389|FG000|Overall Study|Withdrawal by Subject|1|||
161316767|NCT00131365|582542389|FG000|Overall Study|Alternative treatment|3|||
161316768|NCT05249127|582542390|FG000|Overall Study|Protocol Violation|13|||
161316769|NCT05249127|582542390|FG000|Overall Study|Physician Decision|4|||
161316770|NCT05249127|582542390|FG000|Overall Study|Withdrawal by Subject|2|||
161316771|NCT05249127|582542390|FG000|Overall Study|Participant Non-compliance|1|||
161316772|NCT01324570|582542391|FG000|Overall Study|Adverse Event|4|||
161316773|NCT01324570|582542392|FG001|Overall Study|Adverse Event|7|||
161316774|NCT01324570|582542391|FG000|Overall Study|Withdrawal by Subject|0|||
161316775|NCT01324570|582542392|FG001|Overall Study|Withdrawal by Subject|3|||
161316776|NCT01324570|582542391|FG000|Overall Study|Lack of Efficacy|0|||
161316777|NCT01324570|582542392|FG001|Overall Study|Lack of Efficacy|1|||
161316778|NCT01324570|582542391|FG000|Overall Study|Confirmed or suspected diversion|0|||
161316779|NCT01324570|582542392|FG001|Overall Study|Confirmed or suspected diversion|1|||
161316780|NCT01324570|582542391|FG000|Overall Study|Administrative|0|||
161316781|NCT01324570|582542392|FG001|Overall Study|Administrative|2|||
161316782|NCT02607306|582542395|FG000|Overall Study|Adverse Event|8|||
161316783|NCT02607306|582542396|FG001|Overall Study|Adverse Event|6|||
161316784|NCT02607306|582542397|FG002|Overall Study|Adverse Event|6|||
161316785|NCT02607306|582542395|FG000|Overall Study|Unclassified|1|||
161316786|NCT02607306|582542396|FG001|Overall Study|Unclassified|4|||
161316787|NCT02607306|582542397|FG002|Overall Study|Unclassified|0|||
161316788|NCT02607306|582542395|FG000|Overall Study|Withdrawal by Subject|8|||
161316789|NCT02607306|582542396|FG001|Overall Study|Withdrawal by Subject|10|||
161316790|NCT02607306|582542397|FG002|Overall Study|Withdrawal by Subject|2|||
161316791|NCT02607306|582542395|FG000|Overall Study|Lack of Efficacy|0|||
161316792|NCT02607306|582542396|FG001|Overall Study|Lack of Efficacy|1|||
161316793|NCT02607306|582542397|FG002|Overall Study|Lack of Efficacy|1|||
161316794|NCT02607306|582542395|FG000|Overall Study|Protocol Violation|4|||
161316795|NCT02607306|582542396|FG001|Overall Study|Protocol Violation|2|||
161316796|NCT02607306|582542397|FG002|Overall Study|Protocol Violation|1|||
161316797|NCT02360475|582542398|FG000|Overall Study|Lost to Follow-up|4|||
161316798|NCT02360475|582542399|FG001|Overall Study|Lost to Follow-up|12|||
161316799|NCT02360475|582542400|FG002|Overall Study|Lost to Follow-up|6|||
161316800|NCT02360475|582542401|FG003|Overall Study|Lost to Follow-up|4|||
161316801|NCT02360475|582542398|FG000|Overall Study|Withdrawal by Subject|0|||
161316802|NCT02360475|582542399|FG001|Overall Study|Withdrawal by Subject|1|||
161316803|NCT02360475|582542400|FG002|Overall Study|Withdrawal by Subject|2|||
161316804|NCT02360475|582542401|FG003|Overall Study|Withdrawal by Subject|0|||
161316805|NCT02360475|582542398|FG000|Overall Study|Migrated/moved from study area|0|||
161316806|NCT02360475|582542399|FG001|Overall Study|Migrated/moved from study area|0|||
161316807|NCT02360475|582542400|FG002|Overall Study|Migrated/moved from study area|0|||
161316808|NCT02360475|582542401|FG003|Overall Study|Migrated/moved from study area|1|||
161316809|NCT04438499|582542403|FG000|Overall Study|Lack of Efficacy|3|||
161316810|NCT01859949|582544169|FG000|Overall Study|Family Matters|0|||
161316811|NCT01859949|582544170|FG001|Overall Study|Family Matters|1|||
161316812|NCT01859949|582544169|FG000|Overall Study|Physician Decision|2|||
161316813|NCT01859949|582544170|FG001|Overall Study|Physician Decision|4|||
161316814|NCT01859949|582544169|FG000|Overall Study|Withdrawal by Subject|11|||
161316815|NCT01859949|582544170|FG001|Overall Study|Withdrawal by Subject|10|||
161316816|NCT01859949|582544169|FG000|Overall Study|Protocol Violation|1|||
161316817|NCT01859949|582544170|FG001|Overall Study|Protocol Violation|1|||
161316818|NCT01859949|582544169|FG000|Overall Study|Adverse Event|0|||
161316819|NCT01859949|582544170|FG001|Overall Study|Adverse Event|1|||
161316820|NCT04003623|582544171|FG000|Overall Study|Withdrawal by Subject|1|||
161316821|NCT04003623|582544172|FG001|Overall Study|Withdrawal by Subject|0|||
161316822|NCT03307837|582544177|FG000|Overall Study|Withdrawal by Subject|0|||
161316823|NCT03307837|582544178|FG001|Overall Study|Withdrawal by Subject|0|||
161316824|NCT03307837|582544179|FG002|Overall Study|Withdrawal by Subject|1|||
161316825|NCT03307837|582544180|FG003|Overall Study|Withdrawal by Subject|0|||
161316826|NCT03307837|582544181|FG004|Overall Study|Withdrawal by Subject|0|||
161316827|NCT03307837|582544182|FG005|Overall Study|Withdrawal by Subject|1|||
161316828|NCT03307837|582544177|FG000|Overall Study|Lost to Follow-up|1|||
161316829|NCT03307837|582544178|FG001|Overall Study|Lost to Follow-up|1|||
161316830|NCT03307837|582544179|FG002|Overall Study|Lost to Follow-up|0|||
161316831|NCT03307837|582544180|FG003|Overall Study|Lost to Follow-up|0|||
161316832|NCT03307837|582544181|FG004|Overall Study|Lost to Follow-up|0|||
161316833|NCT03307837|582544182|FG005|Overall Study|Lost to Follow-up|1|||
161316834|NCT01744483|582544183|FG000|Overall Study|Death|9|||
161316835|NCT01744483|582544184|FG001|Overall Study|Death|4|||
161316836|NCT01744483|582544185|FG002|Overall Study|Death|11|||
161316837|NCT01744483|582544183|FG000|Overall Study|Lost to Follow-up|8|||
161316838|NCT01744483|582544184|FG001|Overall Study|Lost to Follow-up|9|||
161316839|NCT01744483|582544185|FG002|Overall Study|Lost to Follow-up|11|||
161316840|NCT01744483|582544183|FG000|Overall Study|Protocol Violation|1|||
161316841|NCT01744483|582544184|FG001|Overall Study|Protocol Violation|2|||
161316842|NCT01744483|582544185|FG002|Overall Study|Protocol Violation|1|||
161316843|NCT01744483|582544183|FG000|Overall Study|Withdrawal by Subject|4|||
161316844|NCT01744483|582544184|FG001|Overall Study|Withdrawal by Subject|6|||
161316845|NCT01744483|582544185|FG002|Overall Study|Withdrawal by Subject|2|||
161316846|NCT01744483|582544183|FG000|Overall Study|No ICU Admit|5|||
161316847|NCT01744483|582544184|FG001|Overall Study|No ICU Admit|1|||
161316848|NCT01744483|582544185|FG002|Overall Study|No ICU Admit|2|||
161316849|NCT01744483|582544183|FG000|Overall Study|Routed to OSH|2|||
161316850|NCT01744483|582544184|FG001|Overall Study|Routed to OSH|0|||
161316851|NCT01744483|582544185|FG002|Overall Study|Routed to OSH|1|||
161316852|NCT03041467|582544186|FG000|Overall Study|Death|46|||
161316853|NCT03041467|582544187|FG001|Overall Study|Death|39|||
161316854|NCT03041467|582544186|FG000|Overall Study|Withdrawal by Subject|36|||
161316855|NCT03041467|582544187|FG001|Overall Study|Withdrawal by Subject|37|||
161316856|NCT03041467|582544186|FG000|Overall Study|Lost to Follow-up|6|||
161316857|NCT03041467|582544187|FG001|Overall Study|Lost to Follow-up|8|||
161316858|NCT03041467|582544186|FG000|Overall Study|Declined consent for study extension|21|||
161316859|NCT03041467|582544187|FG001|Overall Study|Declined consent for study extension|33|||
161316860|NCT03041467|582544186|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
161316861|NCT03041467|582544187|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
161316862|NCT00734656|582544191|FG000|Lab Session 1|Withdrawal by Subject|2|||
161316863|NCT00734656|582544192|FG001|Lab Session 1|Withdrawal by Subject|0|||
161316864|NCT00734656|582544193|FG002|Lab Session 1|Withdrawal by Subject|0|||
161316865|NCT00734656|582544194|FG003|Lab Session 1|Withdrawal by Subject|0|||
161316866|NCT00734656|582544191|FG000|Washout 1|Withdrawal by Subject|1|||
161316867|NCT00734656|582544192|FG001|Washout 1|Withdrawal by Subject|5|||
161316868|NCT00734656|582544193|FG002|Washout 1|Withdrawal by Subject|2|||
161316869|NCT00734656|582544194|FG003|Washout 1|Withdrawal by Subject|3|||
161316870|NCT00734656|582544191|FG000|Lab Session 2|Withdrawal by Subject|1|||
161316871|NCT00734656|582544192|FG001|Lab Session 2|Withdrawal by Subject|0|||
161316872|NCT00734656|582544193|FG002|Lab Session 2|Withdrawal by Subject|0|||
161316873|NCT00734656|582544194|FG003|Lab Session 2|Withdrawal by Subject|1|||
161316874|NCT00734656|582544191|FG000|Washout 2|Withdrawal by Subject|1|||
161316875|NCT00734656|582544192|FG001|Washout 2|Withdrawal by Subject|1|||
161316876|NCT00734656|582544193|FG002|Washout 2|Withdrawal by Subject|1|||
161316877|NCT00734656|582544194|FG003|Washout 2|Withdrawal by Subject|0|||
161316878|NCT00734656|582544191|FG000|Washout 3|Withdrawal by Subject|1|||
161316879|NCT00734656|582544192|FG001|Washout 3|Withdrawal by Subject|0|||
161316880|NCT00734656|582544193|FG002|Washout 3|Withdrawal by Subject|0|||
161316881|NCT00734656|582544194|FG003|Washout 3|Withdrawal by Subject|1|||
161316882|NCT00734656|582544191|FG000|Lab Session 4|Withdrawal by Subject|0|||
161316883|NCT00734656|582544192|FG001|Lab Session 4|Withdrawal by Subject|0|||
161316884|NCT00734656|582544193|FG002|Lab Session 4|Withdrawal by Subject|0|||
161316885|NCT00734656|582544194|FG003|Lab Session 4|Withdrawal by Subject|1|||
161316886|NCT03214679|582544197|FG000|Overall Study|Lost to Follow-up|12|||
161316887|NCT03214679|582544198|FG001|Overall Study|Lost to Follow-up|14|||
161316888|NCT03214679|582544197|FG000|Overall Study|not eligible|2|||
161316889|NCT03214679|582544198|FG001|Overall Study|not eligible|0|||
161316890|NCT01754766|582544206|FG000|Overall Study|Personal reasons|1|||
161316891|NCT01754766|582544207|FG001|Overall Study|Personal reasons|1|||
161316892|NCT01754766|582544208|FG002|Overall Study|Personal reasons|0|||
161316893|NCT02469168|582544210|FG000|Overall Study|Trial closed|1|||
161316894|NCT02469168|582544211|FG001|Overall Study|Trial closed|0|||
161316895|NCT00298363|582544212|FG000|Overall Study|Lost to Follow-up|0|||
161316896|NCT00298363|582544213|FG001|Overall Study|Lost to Follow-up|0|||
161316897|NCT00298363|582544214|FG002|Overall Study|Lost to Follow-up|1|||
161316898|NCT00298363|582544212|FG000|Overall Study|Physician Decision|4|||
161316899|NCT00298363|582544213|FG001|Overall Study|Physician Decision|1|||
161316900|NCT00298363|582544214|FG002|Overall Study|Physician Decision|0|||
161316901|NCT00298363|582544212|FG000|Overall Study|Protocol Violation|1|||
161316902|NCT00298363|582544213|FG001|Overall Study|Protocol Violation|1|||
161316903|NCT00298363|582544214|FG002|Overall Study|Protocol Violation|0|||
161316904|NCT00298363|582544212|FG000|Overall Study|Withdrawal by Subject|5|||
161316905|NCT00298363|582544213|FG001|Overall Study|Withdrawal by Subject|1|||
161316906|NCT00298363|582544214|FG002|Overall Study|Withdrawal by Subject|3|||
161316907|NCT00298363|582544212|FG000|Overall Study|Adverse Event|5|||
161316908|NCT00298363|582544213|FG001|Overall Study|Adverse Event|2|||
161316909|NCT00298363|582544214|FG002|Overall Study|Adverse Event|2|||
161316910|NCT00298363|582544212|FG000|Overall Study|Lack of Efficacy|2|||
161316911|NCT00298363|582544213|FG001|Overall Study|Lack of Efficacy|3|||
161316912|NCT00298363|582544214|FG002|Overall Study|Lack of Efficacy|0|||
161206925|NCT02962739|582138055|FG004|Overall Study|Protocol Violation|1|||
161316913|NCT00135356|582544215|FG000|Overall Study|Adverse Event|6|||
161316914|NCT00135356|582544216|FG001|Overall Study|Adverse Event|2|||
161316915|NCT00135356|582544215|FG000|Overall Study|Lack of Efficacy|2|||
161316916|NCT00135356|582544216|FG001|Overall Study|Lack of Efficacy|0|||
161316917|NCT00135356|582544215|FG000|Overall Study|Lost to Follow-up|3|||
161316918|NCT00135356|582544216|FG001|Overall Study|Lost to Follow-up|1|||
161316919|NCT00135356|582544215|FG000|Overall Study|Surgery for abdominal fat|1|||
161316920|NCT00135356|582544216|FG001|Overall Study|Surgery for abdominal fat|0|||
161316921|NCT00135356|582544215|FG000|Overall Study|Change in antiviral regimen|0|||
161316922|NCT00135356|582544216|FG001|Overall Study|Change in antiviral regimen|1|||
161316923|NCT00135356|582544215|FG000|Overall Study|Poor/noncompliance|1|||
161316924|NCT00135356|582544216|FG001|Overall Study|Poor/noncompliance|1|||
161316925|NCT00135356|582544215|FG000|Overall Study|No longer meets study criteria|2|||
161316926|NCT00135356|582544216|FG001|Overall Study|No longer meets study criteria|0|||
161316927|NCT00135356|582544215|FG000|Overall Study|Withdrawal by Subject|2|||
161316928|NCT00135356|582544216|FG001|Overall Study|Withdrawal by Subject|4|||
161316929|NCT02412878|582544217|FG000|Overall Study|Withdrawal by Subject|19|||
161316930|NCT02412878|582544218|FG001|Overall Study|Withdrawal by Subject|10|||
161316931|NCT02412878|582544217|FG000|Overall Study|Lost to Follow-up|2|||
161316932|NCT02412878|582544218|FG001|Overall Study|Lost to Follow-up|3|||
161316933|NCT04676152|582544220|FG000|Overall Study|screen fail|9|||
161316934|NCT01306214|582544221|FG000|Overall Study|Death|0|||
161316935|NCT01306214|582544222|FG001|Overall Study|Death|0|||
161316936|NCT01306214|582544223|FG002|Overall Study|Death|1|||
161316937|NCT01306214|582544221|FG000|Overall Study|Lost to Follow-up|3|||
161316938|NCT01306214|582544222|FG001|Overall Study|Lost to Follow-up|5|||
161316939|NCT01306214|582544223|FG002|Overall Study|Lost to Follow-up|4|||
161316940|NCT01306214|582544221|FG000|Overall Study|Withdrawal by Subject|24|||
161316941|NCT01306214|582544222|FG001|Overall Study|Withdrawal by Subject|22|||
161316942|NCT01306214|582544223|FG002|Overall Study|Withdrawal by Subject|16|||
161316943|NCT01306214|582544221|FG000|Overall Study|Not treated|1|||
161316944|NCT01306214|582544222|FG001|Overall Study|Not treated|1|||
161316945|NCT01306214|582544223|FG002|Overall Study|Not treated|1|||
161316946|NCT02686814|582544224|FG000|Overall Study|Physician Decision|14|||
161316947|NCT02686814|582544224|FG000|Overall Study|Withdrawal by Subject|4|||
161316948|NCT02686814|582544224|FG000|Overall Study|Death|1|||
161316949|NCT01908582|582544226|FG000|Period 2|Physician Decision|1|||
161316950|NCT01908582|582544226|FG000|Period 2|Withdrawal by Subject|1|||
161316951|NCT00424593|582544227|FG000|Acute Double-Blind Period|Adverse Event|16|||
161316952|NCT00424593|582544228|FG001|Acute Double-Blind Period|Adverse Event|7|||
161316953|NCT00424593|582544227|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
161316954|NCT00424593|582544228|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
161316955|NCT00424593|582544227|FG000|Acute Double-Blind Period|Protocol Violation|2|||
161316956|NCT00424593|582544228|FG001|Acute Double-Blind Period|Protocol Violation|2|||
161316957|NCT00424593|582544227|FG000|Acute Double-Blind Period|Physician Decision|1|||
161316958|NCT00424593|582544228|FG001|Acute Double-Blind Period|Physician Decision|2|||
161316959|NCT00424593|582544227|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
161316960|NCT00424593|582544228|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
161316961|NCT00424593|582544227|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
161316962|NCT00424593|582544228|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
161316963|NCT00424593|582544227|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
161316964|NCT00424593|582544228|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
161316965|NCT00424593|582544227|FG000|Dose-Blind Extension Period|Adverse Event|18|||
161316966|NCT00424593|582544228|FG001|Dose-Blind Extension Period|Adverse Event|0|||
161316967|NCT00424593|582544227|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
161316968|NCT00424593|582544228|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
161316969|NCT00424593|582544227|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
161316970|NCT00424593|582544228|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
161316971|NCT00424593|582544227|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
161316972|NCT00424593|582544228|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
161316973|NCT00424593|582544227|FG000|Dose-Blind Extension Period|Physician Decision|3|||
161316974|NCT00424593|582544228|FG001|Dose-Blind Extension Period|Physician Decision|0|||
161316975|NCT02065518|582544229|FG000|Overall Study|Lost to Follow-up|3|||
161316976|NCT02065518|582544230|FG001|Overall Study|Lost to Follow-up|4|||
161316977|NCT02065518|582544231|FG002|Overall Study|Lost to Follow-up|0|||
161316978|NCT02065518|582544232|FG003|Overall Study|Lost to Follow-up|3|||
161316979|NCT02065518|582544229|FG000|Overall Study|Withdrawal by Subject|3|||
161316980|NCT02065518|582544230|FG001|Overall Study|Withdrawal by Subject|4|||
161316981|NCT02065518|582544231|FG002|Overall Study|Withdrawal by Subject|9|||
161316982|NCT02065518|582544232|FG003|Overall Study|Withdrawal by Subject|2|||
161316983|NCT01066663|582544234|FG000|Overall Study|Adverse Event|0|||
161316984|NCT01066663|582544235|FG001|Overall Study|Adverse Event|0|||
161316985|NCT01066663|582544236|FG002|Overall Study|Adverse Event|1|||
161316986|NCT01090050|582544237|FG000|Overall Study|Lost to Follow-up|0|||
161316987|NCT01090050|582544238|FG001|Overall Study|Lost to Follow-up|1|||
161316988|NCT01090050|582544237|FG000|Overall Study|Lack of Efficacy|1|||
161316989|NCT01090050|582544238|FG001|Overall Study|Lack of Efficacy|5|||
161316990|NCT01090050|582544237|FG000|Overall Study|Physician Decision|0|||
161316991|NCT01090050|582544238|FG001|Overall Study|Physician Decision|1|||
161316992|NCT02232061|582544239|FG000|Overall Study|Administrative problems|1|||
161316993|NCT02232061|582544239|FG000|Overall Study|Withdrawal by Subject|1|||
161316994|NCT00571103|582544240|FG000|Overall Study|Withdrawal by Subject|1|||
161316995|NCT00571103|582544240|FG000|Overall Study|Lost to Follow-up|1|||
161316996|NCT02368886|582544241|FG000|Overall Study|Cancel|1|||
161316997|NCT02368886|582544242|FG001|Overall Study|Cancel|1|||
161316998|NCT02368886|582544243|FG002|Overall Study|Cancel|1|||
161316999|NCT02368886|582544244|FG003|Overall Study|Cancel|3|||
161317000|NCT02368886|582544241|FG000|Overall Study|Ineligible|0|||
161317001|NCT02368886|582544242|FG001|Overall Study|Ineligible|0|||
161317002|NCT02368886|582544243|FG002|Overall Study|Ineligible|0|||
161317003|NCT02368886|582544244|FG003|Overall Study|Ineligible|1|||
161317004|NCT04278924|582544246|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
161317005|NCT04278924|582544247|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
161317006|NCT04278924|582544248|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161317007|NCT04278924|582544249|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
161317008|NCT04278924|582544250|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161317009|NCT04278924|582544251|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161317010|NCT04278924|582544252|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
161317011|NCT04278924|582544246|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
161317012|NCT04278924|582544247|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
161317013|NCT04278924|582544248|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
161317014|NCT04278924|582544249|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
161317015|NCT04278924|582544250|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
161317016|NCT04278924|582544251|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
161317017|NCT04278924|582544252|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
161317018|NCT04767529|582544253|FG000|Overall Study|Adverse Event|0|||
161317019|NCT04767529|582544254|FG001|Overall Study|Adverse Event|4|||
161317020|NCT04767529|582544255|FG002|Overall Study|Adverse Event|3|||
161317021|NCT04767529|582544253|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
161317022|NCT04767529|582544254|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
161317023|NCT04767529|582544255|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
161317024|NCT04767529|582544253|FG000|Overall Study|Required use of a prohibited medication|0|||
161317025|NCT04767529|582544254|FG001|Overall Study|Required use of a prohibited medication|1|||
161317026|NCT04767529|582544255|FG002|Overall Study|Required use of a prohibited medication|0|||
161317027|NCT04767529|582544253|FG000|Overall Study|Withdrawal by Subject|7|||
161317028|NCT04767529|582544254|FG001|Overall Study|Withdrawal by Subject|5|||
161317029|NCT04767529|582544255|FG002|Overall Study|Withdrawal by Subject|4|||
161317030|NCT04767529|582544253|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
161317031|NCT04767529|582544254|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
161317032|NCT04767529|582544255|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
161317033|NCT04767529|582544253|FG000|Overall Study|Lost to Follow-up|0|||
161317034|NCT04767529|582544254|FG001|Overall Study|Lost to Follow-up|2|||
161317035|NCT04767529|582544255|FG002|Overall Study|Lost to Follow-up|3|||
161317036|NCT04847232|582544256|FG000|Overall Study|Death|123|||
161317037|NCT04847232|582544257|FG001|Overall Study|Death|115|||
161317038|NCT04847232|582544256|FG000|Overall Study|Lost to Follow-up|3|||
161317039|NCT04847232|582544257|FG001|Overall Study|Lost to Follow-up|10|||
161206926|NCT02962739|582138056|FG005|Overall Study|Protocol Violation|0|||
161206927|NCT00414011|582138057|FG000|Overall Study|Physician Decision|3|||
161206928|NCT00414011|582138057|FG000|Overall Study|Withdrawal by Subject|2|||
161206929|NCT04056299|582138058|FG000|Overall Study|Sponsor discontinued study|3|||
161206930|NCT04056299|582138059|FG001|Overall Study|Sponsor discontinued study|3|||
161206931|NCT01227954|582138064|FG000|Overall Study|Protocol Violation|6|||
161206932|NCT01227954|582138064|FG000|Overall Study|No protocol treatment|7|||
161206933|NCT00078312|582138065|FG000|Overall Study|Adverse Event|43|||
161206934|NCT00078312|582138065|FG000|Overall Study|Lack of Efficacy|15|||
161206935|NCT00078312|582138065|FG000|Overall Study|Lost to Follow-up|41|||
161206936|NCT00078312|582138065|FG000|Overall Study|Physician Decision|9|||
161206937|NCT00078312|582138065|FG000|Overall Study|Protocol Violation|3|||
161206938|NCT00078312|582138065|FG000|Overall Study|Withdrawal by Subject|33|||
161206939|NCT00078312|582138065|FG000|Overall Study|Miscellaneous|33|||
161206940|NCT00756652|582138070|FG000|Original Phase|Withdrawal by Subject|864|||
161206941|NCT00756652|582138071|FG001|Original Phase|Withdrawal by Subject|23|||
161206942|NCT00756652|582138070|FG000|Original Phase|Lost to Follow-up|601|||
161206943|NCT00756652|582138071|FG001|Original Phase|Lost to Follow-up|0|||
161206944|NCT00756652|582138070|FG000|Original Phase|Other Discontinuation|797|||
161206945|NCT00756652|582138071|FG001|Original Phase|Other Discontinuation|5|||
161206946|NCT00756652|582138070|FG000|Original Phase|Participant Noncompliance|18622|||
161206947|NCT00756652|582138071|FG001|Original Phase|Participant Noncompliance|424|||
161206948|NCT00756652|582138070|FG000|Original Phase|Unknown Discontinuation Reason|2|||
161317040|NCT04847232|582544256|FG000|Overall Study|Withdrawal by Subject|73|||
161317041|NCT04847232|582544257|FG001|Overall Study|Withdrawal by Subject|101|||
161317042|NCT04847232|582544256|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
161317043|NCT04847232|582544257|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
161317044|NCT02476916|582544258|FG000|Core Period|Adverse Event|2|||
161317045|NCT02476916|582544259|FG001|Core Period|Adverse Event|2|||
161317046|NCT02476916|582544258|FG000|Core Period|Investigator decision|1|||
161317047|NCT02476916|582544259|FG001|Core Period|Investigator decision|1|||
161317048|NCT02476916|582544258|FG000|Core Period|Withdrawal by Subject|3|||
161317049|NCT02476916|582544259|FG001|Core Period|Withdrawal by Subject|0|||
161317050|NCT02476916|582544258|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
161317051|NCT02476916|582544259|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
161317052|NCT02476916|582544258|FG000|Extension Period|On Treatment|12|||
161317053|NCT02476916|582544259|FG001|Extension Period|On Treatment|17|||
161317054|NCT06010732|582544260|FG000|Crossover Period 1|Protocol Violation|0|||
161317055|NCT06010732|582544261|FG001|Crossover Period 1|Protocol Violation|0|||
161317056|NCT06010732|582544262|FG002|Crossover Period 1|Protocol Violation|1|||
161317057|NCT06010732|582544263|FG003|Crossover Period 1|Protocol Violation|0|||
161317058|NCT06010732|582544264|FG004|Crossover Period 1|Protocol Violation|1|||
161317059|NCT06010732|582544265|FG005|Crossover Period 1|Protocol Violation|0|||
161317060|NCT06010732|582544260|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161317061|NCT06010732|582544261|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
161317062|NCT06010732|582544262|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161317063|NCT06010732|582544263|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161317064|NCT06010732|582544264|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161317065|NCT06010732|582544265|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
161317066|NCT06010732|582544260|FG000|Crossover Period 2|Adverse Event|0|||
161317067|NCT06010732|582544261|FG001|Crossover Period 2|Adverse Event|1|||
161317068|NCT06010732|582544262|FG002|Crossover Period 2|Adverse Event|0|||
161317069|NCT06010732|582544263|FG003|Crossover Period 2|Adverse Event|0|||
161317070|NCT06010732|582544264|FG004|Crossover Period 2|Adverse Event|0|||
161317071|NCT06010732|582544265|FG005|Crossover Period 2|Adverse Event|0|||
161317072|NCT06010732|582544260|FG000|Crossover Period 2|broken denture|0|||
161317073|NCT06010732|582544261|FG001|Crossover Period 2|broken denture|0|||
161317074|NCT06010732|582544262|FG002|Crossover Period 2|broken denture|1|||
161317075|NCT06010732|582544263|FG003|Crossover Period 2|broken denture|0|||
161317076|NCT06010732|582544264|FG004|Crossover Period 2|broken denture|0|||
161317077|NCT06010732|582544265|FG005|Crossover Period 2|broken denture|0|||
161317078|NCT00253370|582544267|FG000|Overall Study|Adverse Event|18|||
161317079|NCT00253370|582544267|FG000|Overall Study|Disease progression|13|||
161317080|NCT00253370|582544267|FG000|Overall Study|Death|2|||
161317081|NCT00253370|582544267|FG000|Overall Study|Withdrawal by Subject|6|||
161317082|NCT00253370|582544267|FG000|Overall Study|Non-protocol therapy|1|||
161317083|NCT00253370|582544267|FG000|Overall Study|Physician Decision|1|||
161317084|NCT00253370|582544267|FG000|Overall Study|Protocol Violation|1|||
161317085|NCT00253370|582544267|FG000|Overall Study|Abdominal pain due to disease|1|||
161317086|NCT03699540|582544268|FG000|Overall Study|Lost to Follow-up|1|||
161317087|NCT02697591|582544269|FG000|Overall Study|Lost to Follow-up|0|||
161317088|NCT02697591|582544270|FG001|Overall Study|Lost to Follow-up|0|||
161317089|NCT02697591|582544271|FG002|Overall Study|Lost to Follow-up|0|||
161317090|NCT02697591|582544272|FG003|Overall Study|Lost to Follow-up|0|||
161317091|NCT02697591|582544273|FG004|Overall Study|Lost to Follow-up|0|||
161317092|NCT02697591|582544274|FG005|Overall Study|Lost to Follow-up|1|||
161317093|NCT02697591|582544275|FG006|Overall Study|Lost to Follow-up|1|||
161317094|NCT02697591|582544276|FG007|Overall Study|Lost to Follow-up|0|||
161317095|NCT02697591|582544277|FG008|Overall Study|Lost to Follow-up|0|||
161317096|NCT02697591|582544278|FG009|Overall Study|Lost to Follow-up|1|||
161317097|NCT02697591|582544269|FG000|Overall Study|Withdrawal by Subject|1|||
161317098|NCT02697591|582544270|FG001|Overall Study|Withdrawal by Subject|1|||
161317099|NCT02697591|582544271|FG002|Overall Study|Withdrawal by Subject|2|||
161317100|NCT02697591|582544272|FG003|Overall Study|Withdrawal by Subject|1|||
161317101|NCT02697591|582544273|FG004|Overall Study|Withdrawal by Subject|7|||
161317102|NCT02697591|582544274|FG005|Overall Study|Withdrawal by Subject|6|||
161317103|NCT02697591|582544275|FG006|Overall Study|Withdrawal by Subject|9|||
161317104|NCT02697591|582544276|FG007|Overall Study|Withdrawal by Subject|1|||
161317105|NCT02697591|582544277|FG008|Overall Study|Withdrawal by Subject|6|||
161317106|NCT02697591|582544278|FG009|Overall Study|Withdrawal by Subject|10|||
161317107|NCT02697591|582544269|FG000|Overall Study|Physician Decision|1|||
161317108|NCT02697591|582544270|FG001|Overall Study|Physician Decision|0|||
161317109|NCT02697591|582544271|FG002|Overall Study|Physician Decision|0|||
161317110|NCT02697591|582544272|FG003|Overall Study|Physician Decision|0|||
161317111|NCT02697591|582544273|FG004|Overall Study|Physician Decision|1|||
161317112|NCT02697591|582544274|FG005|Overall Study|Physician Decision|2|||
161317113|NCT02697591|582544275|FG006|Overall Study|Physician Decision|0|||
161317114|NCT02697591|582544276|FG007|Overall Study|Physician Decision|0|||
161317115|NCT02697591|582544277|FG008|Overall Study|Physician Decision|1|||
161317116|NCT02697591|582544278|FG009|Overall Study|Physician Decision|1|||
161317117|NCT02697591|582544269|FG000|Overall Study|Death|2|||
161317118|NCT02697591|582544270|FG001|Overall Study|Death|3|||
161317119|NCT02697591|582544271|FG002|Overall Study|Death|1|||
161317120|NCT02697591|582544272|FG003|Overall Study|Death|1|||
161317121|NCT02697591|582544273|FG004|Overall Study|Death|4|||
161317122|NCT02697591|582544274|FG005|Overall Study|Death|5|||
161317123|NCT02697591|582544275|FG006|Overall Study|Death|3|||
161317124|NCT02697591|582544276|FG007|Overall Study|Death|1|||
161317125|NCT02697591|582544277|FG008|Overall Study|Death|1|||
161317126|NCT02697591|582544278|FG009|Overall Study|Death|5|||
161317127|NCT02697591|582544269|FG000|Overall Study|Reason not Specified|0|||
161317128|NCT02697591|582544270|FG001|Overall Study|Reason not Specified|0|||
161317129|NCT02697591|582544271|FG002|Overall Study|Reason not Specified|0|||
161317130|NCT02697591|582544272|FG003|Overall Study|Reason not Specified|1|||
161317131|NCT02697591|582544273|FG004|Overall Study|Reason not Specified|1|||
161317132|NCT02697591|582544274|FG005|Overall Study|Reason not Specified|2|||
161317133|NCT02697591|582544275|FG006|Overall Study|Reason not Specified|3|||
161317134|NCT02697591|582544276|FG007|Overall Study|Reason not Specified|1|||
161317135|NCT02697591|582544277|FG008|Overall Study|Reason not Specified|1|||
161317136|NCT02697591|582544278|FG009|Overall Study|Reason not Specified|3|||
161317137|NCT00004088|582544280|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
161317138|NCT00004088|582544280|FG000|Overall Study|Withdrawal by Subject|1|||
161317139|NCT00004088|582544280|FG000|Overall Study|Protocol Violation|3|||
161317140|NCT00004088|582544280|FG000|Overall Study|Physician Decision|1|||
161317141|NCT02636699|582544281|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
161317142|NCT02636699|582544282|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
161317143|NCT02636699|582544283|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
161317144|NCT02636699|582544281|FG000|Screening Period|Withdrawal by Subject|0|||
161317145|NCT02636699|582544282|FG001|Screening Period|Withdrawal by Subject|0|||
161317146|NCT02636699|582544283|FG002|Screening Period|Withdrawal by Subject|23|||
161317147|NCT02636699|582544281|FG000|Screening Period|Adverse Event|0|||
161317148|NCT02636699|582544282|FG001|Screening Period|Adverse Event|0|||
161317149|NCT02636699|582544283|FG002|Screening Period|Adverse Event|1|||
161317150|NCT02636699|582544281|FG000|Screening Period|Other not specified|0|||
161317151|NCT02636699|582544282|FG001|Screening Period|Other not specified|0|||
161317152|NCT02636699|582544283|FG002|Screening Period|Other not specified|3|||
161317153|NCT02636699|582544281|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
161317154|NCT02636699|582544282|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
161317155|NCT02636699|582544283|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
161317156|NCT02636699|582544281|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
161317157|NCT02636699|582544282|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
161317158|NCT02636699|582544283|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
161317159|NCT02636699|582544281|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
161317160|NCT02636699|582544282|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
161317161|NCT02636699|582544283|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
161317162|NCT02636699|582544281|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
161317163|NCT02636699|582544282|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
161317164|NCT02636699|582544283|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
161317165|NCT02636699|582544281|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
161317166|NCT02636699|582544282|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
161317167|NCT02636699|582544283|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
161317168|NCT02636699|582544281|FG000|Treatment and Follow-up Periods|Other|3|||
161317169|NCT02636699|582544282|FG001|Treatment and Follow-up Periods|Other|1|||
161317170|NCT02636699|582544283|FG002|Treatment and Follow-up Periods|Other|0|||
161317171|NCT00624832|582544284|FG000|Overall Study|Adverse Event|0|||
161317172|NCT00624832|582544285|FG001|Overall Study|Adverse Event|1|||
161317173|NCT00624832|582544286|FG002|Overall Study|Adverse Event|0|||
161317174|NCT00624832|582544287|FG003|Overall Study|Adverse Event|1|||
161317175|NCT00624832|582544284|FG000|Overall Study|Abnormal Laboratory Value|2|||
161317176|NCT00624832|582544285|FG001|Overall Study|Abnormal Laboratory Value|0|||
161317177|NCT00624832|582544286|FG002|Overall Study|Abnormal Laboratory Value|0|||
161317178|NCT00624832|582544287|FG003|Overall Study|Abnormal Laboratory Value|0|||
161317179|NCT01939223|582544288|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
161317180|NCT01939223|582544289|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
161317181|NCT01939223|582544288|FG000|Overall Study|Disease recurrence (radiological)|1|||
161317182|NCT01939223|582544289|FG001|Overall Study|Disease recurrence (radiological)|3|||
161317183|NCT01939223|582544288|FG000|Overall Study|Study stopped by Sponsor|5|||
161317184|NCT01939223|582544289|FG001|Overall Study|Study stopped by Sponsor|7|||
161317185|NCT01939223|582544288|FG000|Overall Study|Withdrawal by Subject|6|||
161317186|NCT01939223|582544289|FG001|Overall Study|Withdrawal by Subject|0|||
161317187|NCT04379700|582544290|FG000|Overall Study|Withdrawal by Subject|10|||
161317188|NCT04379700|582544290|FG000|Overall Study|Screen Fail|4|||
161317189|NCT04379700|582544290|FG000|Overall Study|Lost to Follow-up|3|||
161317190|NCT03624569|582544292|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
161317191|NCT03624569|582544293|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
161317192|NCT03624569|582544292|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
161317193|NCT03624569|582544293|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
161317194|NCT03004924|582544322|FG000|Overall Study|Adverse Event|6|||
161317195|NCT03004924|582544323|FG001|Overall Study|Adverse Event|5|||
161317196|NCT03004924|582544324|FG002|Overall Study|Adverse Event|10|||
161317197|NCT03004924|582544322|FG000|Overall Study|Protocol Violation|4|||
161317198|NCT03004924|582544323|FG001|Overall Study|Protocol Violation|0|||
161317199|NCT03004924|582544324|FG002|Overall Study|Protocol Violation|1|||
161317200|NCT03004924|582544322|FG000|Overall Study|Withdrawal by Subject|5|||
161317201|NCT03004924|582544323|FG001|Overall Study|Withdrawal by Subject|3|||
161317202|NCT03004924|582544324|FG002|Overall Study|Withdrawal by Subject|5|||
161317203|NCT03004924|582544322|FG000|Overall Study|Lost to Follow-up|6|||
161317204|NCT03004924|582544323|FG001|Overall Study|Lost to Follow-up|1|||
161317205|NCT03004924|582544324|FG002|Overall Study|Lost to Follow-up|4|||
161317206|NCT03004924|582544322|FG000|Overall Study|Lack of Efficacy|2|||
161317207|NCT03004924|582544323|FG001|Overall Study|Lack of Efficacy|4|||
161317208|NCT03004924|582544324|FG002|Overall Study|Lack of Efficacy|2|||
161317209|NCT03004924|582544322|FG000|Overall Study|Physician Decision|1|||
161317210|NCT03004924|582544323|FG001|Overall Study|Physician Decision|0|||
161317211|NCT03004924|582544324|FG002|Overall Study|Physician Decision|1|||
161317212|NCT03004924|582544322|FG000|Overall Study|Withdrawal by parent/guardian|1|||
161317213|NCT03004924|582544323|FG001|Overall Study|Withdrawal by parent/guardian|0|||
161317214|NCT03004924|582544324|FG002|Overall Study|Withdrawal by parent/guardian|2|||
161317215|NCT03004924|582544322|FG000|Overall Study|Screen Failure|1|||
161317216|NCT03004924|582544323|FG001|Overall Study|Screen Failure|0|||
161317217|NCT03004924|582544324|FG002|Overall Study|Screen Failure|0|||
161317218|NCT03004924|582544322|FG000|Overall Study|Pregnancy|0|||
161317219|NCT03004924|582544323|FG001|Overall Study|Pregnancy|1|||
161317220|NCT03004924|582544324|FG002|Overall Study|Pregnancy|0|||
161317221|NCT03004924|582544322|FG000|Overall Study|Terminated by Sponsor|0|||
161317222|NCT03004924|582544323|FG001|Overall Study|Terminated by Sponsor|0|||
161317223|NCT03004924|582544324|FG002|Overall Study|Terminated by Sponsor|1|||
161317224|NCT03004924|582544322|FG000|Overall Study|Missed Study Visit|0|||
161317225|NCT03004924|582544323|FG001|Overall Study|Missed Study Visit|0|||
161317226|NCT03004924|582544324|FG002|Overall Study|Missed Study Visit|2|||
161317227|NCT03004924|582544322|FG000|Overall Study|HSV1 Positive|1|||
161317228|NCT03004924|582544323|FG001|Overall Study|HSV1 Positive|0|||
161317229|NCT03004924|582544324|FG002|Overall Study|HSV1 Positive|0|||
161317230|NCT00672841|582544333|FG000|Overall Study|Comfort care|1|||
161317231|NCT00672841|582544334|FG001|Overall Study|Comfort care|4|||
161317232|NCT00672841|582544333|FG000|Overall Study|icteric specimens|0|||
161317233|NCT00672841|582544334|FG001|Overall Study|icteric specimens|3|||
161317234|NCT00672841|582544333|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
161317235|NCT00672841|582544334|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
161317236|NCT00672841|582544333|FG000|Overall Study|Adverse Event|0|||
161317237|NCT00672841|582544334|FG001|Overall Study|Adverse Event|3|||
161317238|NCT00672841|582544333|FG000|Overall Study|Pregnancy|0|||
161317239|NCT00672841|582544334|FG001|Overall Study|Pregnancy|1|||
161317240|NCT02083653|582544335|FG000|Overall Study|Randomized but not Treated|0|||
161317241|NCT02083653|582544336|FG001|Overall Study|Randomized but not Treated|2|||
161317242|NCT02083653|582544337|FG002|Overall Study|Randomized but not Treated|7|||
161317243|NCT02083653|582544335|FG000|Overall Study|Adverse Event|12|||
161317244|NCT02083653|582544336|FG001|Overall Study|Adverse Event|5|||
161317245|NCT02083653|582544337|FG002|Overall Study|Adverse Event|4|||
161317246|NCT02083653|582544335|FG000|Overall Study|Lost to Follow-up|1|||
161317247|NCT02083653|582544336|FG001|Overall Study|Lost to Follow-up|0|||
161317248|NCT02083653|582544337|FG002|Overall Study|Lost to Follow-up|0|||
161317249|NCT02083653|582544335|FG000|Overall Study|Death|2|||
161317250|NCT02083653|582544336|FG001|Overall Study|Death|2|||
161317251|NCT02083653|582544337|FG002|Overall Study|Death|2|||
161317252|NCT02083653|582544335|FG000|Overall Study|Progressive Disease|65|||
161317253|NCT02083653|582544336|FG001|Overall Study|Progressive Disease|73|||
161317254|NCT02083653|582544337|FG002|Overall Study|Progressive Disease|63|||
161317255|NCT02083653|582544335|FG000|Overall Study|Withdrawal by Subject|2|||
161317256|NCT02083653|582544336|FG001|Overall Study|Withdrawal by Subject|1|||
161317257|NCT02083653|582544337|FG002|Overall Study|Withdrawal by Subject|2|||
161317258|NCT02083653|582544335|FG000|Overall Study|Other Events|0|||
161317259|NCT02083653|582544336|FG001|Overall Study|Other Events|2|||
161317260|NCT02083653|582544337|FG002|Overall Study|Other Events|2|||
161317261|NCT02083653|582544335|FG000|Overall Study|Reason Missing|0|||
161317262|NCT02083653|582544336|FG001|Overall Study|Reason Missing|0|||
161317263|NCT02083653|582544337|FG002|Overall Study|Reason Missing|4|||
161317264|NCT02073656|582544338|FG000|Primary Study|Lost to Follow-up|6|||
161317265|NCT02073656|582544338|FG000|Primary Study|Death|1|||
161317266|NCT02073656|582544338|FG000|Primary Study|Withdrew Consent|1|||
161317267|NCT02536781|582544339|FG000|Overall Study|Lost to Follow-up|2|||
161317268|NCT02536781|582544340|FG001|Overall Study|Lost to Follow-up|0|||
161317269|NCT05079230|582544341|FG000|Overall Study|Study Terminated by Sponsor|101|||
161317270|NCT05079230|582544342|FG001|Overall Study|Study Terminated by Sponsor|102|||
161317271|NCT05079230|582544341|FG000|Overall Study|Death|72|||
161317272|NCT05079230|582544342|FG001|Overall Study|Death|66|||
161317273|NCT05079230|582544341|FG000|Overall Study|Withdrew Consent|16|||
161317274|NCT05079230|582544342|FG001|Overall Study|Withdrew Consent|18|||
161317275|NCT05079230|582544341|FG000|Overall Study|Lost to Follow-up|0|||
161317276|NCT05079230|582544342|FG001|Overall Study|Lost to Follow-up|3|||
161317277|NCT01524783|582544343|FG000|Blinded Period|Adverse Event|64|||
161317278|NCT01524783|582544344|FG001|Blinded Period|Adverse Event|7|||
161317279|NCT01524783|582544345|FG002|Blinded Period|Adverse Event|0|||
161317280|NCT01524783|582544343|FG000|Blinded Period|Disease Progression|89|||
161317281|NCT01524783|582544344|FG001|Blinded Period|Disease Progression|75|||
161317282|NCT01524783|582544345|FG002|Blinded Period|Disease Progression|0|||
161317283|NCT01524783|582544343|FG000|Blinded Period|Withdrawal by Subject|19|||
161317284|NCT01524783|582544344|FG001|Blinded Period|Withdrawal by Subject|6|||
161317285|NCT01524783|582544345|FG002|Blinded Period|Withdrawal by Subject|0|||
161317286|NCT01524783|582544343|FG000|Blinded Period|Protocol deviation|2|||
161317287|NCT01524783|582544344|FG001|Blinded Period|Protocol deviation|1|||
161317288|NCT01524783|582544345|FG002|Blinded Period|Protocol deviation|0|||
161317289|NCT01524783|582544343|FG000|Blinded Period|Death|5|||
161317290|NCT01524783|582544344|FG001|Blinded Period|Death|2|||
161317291|NCT01524783|582544345|FG002|Blinded Period|Death|0|||
161317292|NCT01524783|582544343|FG000|Open-label Period|Disease progression|13|||
161317293|NCT01524783|582544344|FG001|Open-label Period|Disease progression|0|||
161317294|NCT01524783|582544345|FG002|Open-label Period|Disease progression|2|||
161317295|NCT01524783|582544343|FG000|Open-label Period|Administrative problems|5|||
161317296|NCT01524783|582544344|FG001|Open-label Period|Administrative problems|0|||
161317297|NCT01524783|582544345|FG002|Open-label Period|Administrative problems|2|||
161317298|NCT01524783|582544343|FG000|Open-label Period|Adverse Event|5|||
161317299|NCT01524783|582544344|FG001|Open-label Period|Adverse Event|0|||
161317300|NCT01524783|582544345|FG002|Open-label Period|Adverse Event|1|||
161317301|NCT01524783|582544343|FG000|Open-label Period|Withdrawal by Subject|2|||
161317302|NCT01524783|582544344|FG001|Open-label Period|Withdrawal by Subject|0|||
161317303|NCT01524783|582544345|FG002|Open-label Period|Withdrawal by Subject|1|||
161317304|NCT01524783|582544343|FG000|Open-label Period|Protocol deviation|1|||
161317305|NCT01524783|582544344|FG001|Open-label Period|Protocol deviation|0|||
161317306|NCT01524783|582544345|FG002|Open-label Period|Protocol deviation|0|||
161317307|NCT02054910|582544350|FG000|Overall Study|Lost to Follow-up|4|||
161317308|NCT02054910|582544351|FG001|Overall Study|Lost to Follow-up|1|||
161317309|NCT00207727|582544352|FG000|Overall Study|Withdrawal by Subject|0|||
161317310|NCT00207727|582544353|FG001|Overall Study|Withdrawal by Subject|0|||
161317311|NCT00207727|582544354|FG002|Overall Study|Withdrawal by Subject|0|||
161317312|NCT00207727|582544355|FG003|Overall Study|Withdrawal by Subject|0|||
161317313|NCT00207727|582544356|FG004|Overall Study|Withdrawal by Subject|1|||
161317314|NCT00207727|582544352|FG000|Overall Study|Lost to Follow-up|0|||
161317315|NCT00207727|582544353|FG001|Overall Study|Lost to Follow-up|1|||
161317316|NCT00207727|582544354|FG002|Overall Study|Lost to Follow-up|0|||
161317317|NCT00207727|582544355|FG003|Overall Study|Lost to Follow-up|0|||
161317318|NCT00207727|582544356|FG004|Overall Study|Lost to Follow-up|0|||
161317319|NCT00207727|582544352|FG000|Overall Study|Other|38|||
161317320|NCT00207727|582544353|FG001|Overall Study|Other|41|||
161317321|NCT00207727|582544354|FG002|Overall Study|Other|41|||
161317322|NCT00207727|582544355|FG003|Overall Study|Other|37|||
161317323|NCT00207727|582544356|FG004|Overall Study|Other|33|||
161317324|NCT03759366|582544357|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
161317325|NCT03759366|582544357|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
161317326|NCT03759366|582544357|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
161317327|NCT03759366|582544357|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
161317328|NCT03759366|582544357|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
161317329|NCT03759366|582544357|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
161317330|NCT03759366|582544357|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
161317331|NCT00539032|582544358|FG000|Overall Study|Withdrawal by Subject|2|||
161317332|NCT00539032|582544359|FG001|Overall Study|Withdrawal by Subject|1|||
161317333|NCT01153009|582546180|FG000|Overall Study|Adverse Event|4|||
161317334|NCT01153009|582546181|FG001|Overall Study|Adverse Event|14|||
161317335|NCT01153009|582546182|FG002|Overall Study|Adverse Event|14|||
161317336|NCT01153009|582546183|FG003|Overall Study|Adverse Event|10|||
161317337|NCT01153009|582546180|FG000|Overall Study|Lack of Efficacy|9|||
161317338|NCT01153009|582546181|FG001|Overall Study|Lack of Efficacy|0|||
161317339|NCT01153009|582546182|FG002|Overall Study|Lack of Efficacy|2|||
161317340|NCT01153009|582546183|FG003|Overall Study|Lack of Efficacy|1|||
161317341|NCT01153009|582546180|FG000|Overall Study|Noncompliance with Study Medication|1|||
161317342|NCT01153009|582546181|FG001|Overall Study|Noncompliance with Study Medication|3|||
161317343|NCT01153009|582546182|FG002|Overall Study|Noncompliance with Study Medication|4|||
161317344|NCT01153009|582546183|FG003|Overall Study|Noncompliance with Study Medication|1|||
161317345|NCT01153009|582546180|FG000|Overall Study|Protocol Deviations|4|||
161317346|NCT01153009|582546181|FG001|Overall Study|Protocol Deviations|3|||
161317347|NCT01153009|582546182|FG002|Overall Study|Protocol Deviations|3|||
161317348|NCT01153009|582546183|FG003|Overall Study|Protocol Deviations|2|||
161317349|NCT01153009|582546180|FG000|Overall Study|Withdrawal of Consent|5|||
161317350|NCT01153009|582546181|FG001|Overall Study|Withdrawal of Consent|5|||
161317351|NCT01153009|582546182|FG002|Overall Study|Withdrawal of Consent|4|||
161317352|NCT01153009|582546183|FG003|Overall Study|Withdrawal of Consent|6|||
161317353|NCT01153009|582546180|FG000|Overall Study|Lost to Follow-up|8|||
161317354|NCT01153009|582546181|FG001|Overall Study|Lost to Follow-up|8|||
161317355|NCT01153009|582546182|FG002|Overall Study|Lost to Follow-up|11|||
161317356|NCT01153009|582546183|FG003|Overall Study|Lost to Follow-up|15|||
161317357|NCT01153009|582546180|FG000|Overall Study|Other|1|||
161317358|NCT01153009|582546181|FG001|Overall Study|Other|1|||
161317359|NCT01153009|582546182|FG002|Overall Study|Other|3|||
161317360|NCT01153009|582546183|FG003|Overall Study|Other|2|||
161317361|NCT04494425|582546186|FG000|Overall Study|Death|160|||
161317362|NCT04494425|582546187|FG001|Overall Study|Death|166|||
161317363|NCT04494425|582546186|FG000|Overall Study|Withdrawal by Subject|10|||
161317364|NCT04494425|582546187|FG001|Overall Study|Withdrawal by Subject|40|||
161317365|NCT04494425|582546186|FG000|Overall Study|Other|1|||
161317366|NCT04494425|582546187|FG001|Overall Study|Other|1|||
161317367|NCT04494425|582546186|FG000|Overall Study|Ongoing at the time of PCD|265|||
161317368|NCT04494425|582546187|FG001|Overall Study|Ongoing at the time of PCD|223|||
161317369|NCT01270321|582546189|FG000|Overall Study|Death|3|||
161317370|NCT01270321|582546190|FG001|Overall Study|Death|1|||
161317371|NCT01270321|582546191|FG002|Overall Study|Death|4|||
161317372|NCT01270321|582546189|FG000|Overall Study|Adverse Event|7|||
161317373|NCT01270321|582546190|FG001|Overall Study|Adverse Event|9|||
161317374|NCT01270321|582546191|FG002|Overall Study|Adverse Event|5|||
161317375|NCT01190189|582546196|FG000|Overall Study|Lost to Follow-up|4|||
161317376|NCT01190189|582546196|FG000|Overall Study|Withdrawal by Subject|1|||
161317377|NCT01190189|582546196|FG000|Overall Study|Migrated/moved from study area|1|||
161317378|NCT00762034|582546200|FG000|Induction Period|Protocol Violation|1|||
161317379|NCT00762034|582546201|FG001|Induction Period|Protocol Violation|2|||
161317380|NCT00762034|582546200|FG000|Induction Period|Entry Criterion Not Met|12|||
161317381|NCT00762034|582546201|FG001|Induction Period|Entry Criterion Not Met|11|||
161317382|NCT00762034|582546200|FG000|Induction Period|Adverse Event|27|||
161317383|NCT00762034|582546201|FG001|Induction Period|Adverse Event|38|||
161317384|NCT00762034|582546200|FG000|Induction Period|Lost to Follow-up|1|||
161317385|NCT00762034|582546201|FG001|Induction Period|Lost to Follow-up|1|||
161317386|NCT00762034|582546200|FG000|Induction Period|Progressive Disease|73|||
161317387|NCT00762034|582546201|FG001|Induction Period|Progressive Disease|55|||
161317388|NCT00762034|582546200|FG000|Induction Period|Physician Decision|21|||
161317389|NCT00762034|582546201|FG001|Induction Period|Physician Decision|20|||
161317390|NCT00762034|582546200|FG000|Induction Period|Withdrawal by Subject|15|||
161317391|NCT00762034|582546201|FG001|Induction Period|Withdrawal by Subject|19|||
161317392|NCT00762034|582546200|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
161317393|NCT00762034|582546201|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
161317394|NCT00762034|582546200|FG000|Induction Period|Deaths Due to Study Disease|9|||
161317395|NCT00762034|582546201|FG001|Induction Period|Deaths Due to Study Disease|9|||
161317396|NCT00762034|582546200|FG000|Maintenance Period|Protocol Violation|1|||
161317397|NCT00762034|582546201|FG001|Maintenance Period|Protocol Violation|3|||
161317398|NCT00762034|582546200|FG000|Maintenance Period|Entry Criterion Not Met|0|||
161317399|NCT00762034|582546201|FG001|Maintenance Period|Entry Criterion Not Met|2|||
161317400|NCT00762034|582546200|FG000|Maintenance Period|Adverse Event|42|||
161317401|NCT00762034|582546201|FG001|Maintenance Period|Adverse Event|26|||
161317402|NCT00762034|582546200|FG000|Maintenance Period|Progressive Disease|186|||
161317403|NCT00762034|582546201|FG001|Maintenance Period|Progressive Disease|224|||
161317404|NCT00762034|582546200|FG000|Maintenance Period|Physician Decision|25|||
161317405|NCT00762034|582546201|FG001|Maintenance Period|Physician Decision|20|||
161317406|NCT00762034|582546200|FG000|Maintenance Period|Withdrawal by Subject|34|||
161317407|NCT00762034|582546201|FG001|Maintenance Period|Withdrawal by Subject|14|||
161317408|NCT00762034|582546200|FG000|Maintenance Period|Death not due to study disease|2|||
161317409|NCT00762034|582546201|FG001|Maintenance Period|Death not due to study disease|5|||
161317410|NCT00762034|582546200|FG000|Maintenance Period|Death due to study disease|3|||
161317411|NCT00762034|582546201|FG001|Maintenance Period|Death due to study disease|3|||
161317412|NCT00762034|582546200|FG000|Maintenance Period|Other|1|||
161317413|NCT00762034|582546201|FG001|Maintenance Period|Other|1|||
161317414|NCT04228965|582546202|FG000|Overall Study|Lost to Follow-up|26|||
161317415|NCT04228965|582546203|FG001|Overall Study|Lost to Follow-up|11|||
161317416|NCT04228965|582546202|FG000|Overall Study|Withdrawal by Subject|18|||
161317417|NCT04228965|582546203|FG001|Overall Study|Withdrawal by Subject|5|||
161317418|NCT02442206|582546204|FG000|Period 1|Adverse Event|1|||
161317419|NCT02442206|582546205|FG001|Period 1|Adverse Event|1|||
161317420|NCT02442206|582546204|FG000|Period 1|withdrew consent|0|||
161317421|NCT02442206|582546205|FG001|Period 1|withdrew consent|1|||
161317422|NCT02442206|582546204|FG000|Period 1|COPD exacerbation|0|||
161317423|NCT02442206|582546205|FG001|Period 1|COPD exacerbation|1|||
161317424|NCT02442206|582546204|FG000|Period 2|Adverse Event|1|||
161317425|NCT02442206|582546205|FG001|Period 2|Adverse Event|0|||
161317426|NCT01026818|582546212|FG000|Screening Period|Entry Criteria Not Met|105|||
161317427|NCT01026818|582546213|FG001|Screening Period|Entry Criteria Not Met|0|||
161317428|NCT01026818|582546214|FG002|Screening Period|Entry Criteria Not Met|0|||
161317429|NCT01026818|582546215|FG003|Screening Period|Entry Criteria Not Met|0|||
161317430|NCT01026818|582546212|FG000|Screening Period|Withdrawal by Subject|49|||
161317431|NCT01026818|582546213|FG001|Screening Period|Withdrawal by Subject|0|||
161317432|NCT01026818|582546214|FG002|Screening Period|Withdrawal by Subject|0|||
161317433|NCT01026818|582546215|FG003|Screening Period|Withdrawal by Subject|0|||
161317434|NCT01026818|582546212|FG000|Screening Period|Protocol Deviation|3|||
161317435|NCT01026818|582546213|FG001|Screening Period|Protocol Deviation|0|||
161317436|NCT01026818|582546214|FG002|Screening Period|Protocol Deviation|0|||
161317437|NCT01026818|582546215|FG003|Screening Period|Protocol Deviation|0|||
161317438|NCT01026818|582546212|FG000|Screening Period|Adverse Event|2|||
161317439|NCT01026818|582546213|FG001|Screening Period|Adverse Event|0|||
161317440|NCT01026818|582546214|FG002|Screening Period|Adverse Event|0|||
161317441|NCT01026818|582546215|FG003|Screening Period|Adverse Event|0|||
161317442|NCT01026818|582546212|FG000|Screening Period|Physician Decision|1|||
161317443|NCT01026818|582546213|FG001|Screening Period|Physician Decision|0|||
161317444|NCT01026818|582546214|FG002|Screening Period|Physician Decision|0|||
161317445|NCT01026818|582546215|FG003|Screening Period|Physician Decision|0|||
161317446|NCT01026818|582546212|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
161317447|NCT01026818|582546213|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
161317448|NCT01026818|582546214|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
161317449|NCT01026818|582546215|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
161317450|NCT01026818|582546212|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
161317451|NCT01026818|582546213|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
161317452|NCT01026818|582546214|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
161317453|NCT01026818|582546215|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
161317454|NCT01026818|582546212|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
161317455|NCT01026818|582546213|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
161317456|NCT01026818|582546214|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
161317457|NCT01026818|582546215|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
161317458|NCT01026818|582546212|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
161317459|NCT01026818|582546213|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
161317460|NCT01026818|582546214|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
161317461|NCT01026818|582546215|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
161317462|NCT01026818|582546212|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
161317463|NCT01026818|582546213|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
161317464|NCT01026818|582546214|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
161317465|NCT01026818|582546215|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
161317466|NCT01026818|582546212|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
161317467|NCT01026818|582546213|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
161317468|NCT01026818|582546214|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
161317469|NCT01026818|582546215|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
161317470|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
161317471|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
161317472|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
161317473|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
161317474|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
161317475|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
161317476|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
161317477|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
161317478|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161317479|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
161317480|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161317481|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
161317482|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
161317483|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
161317484|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
161317485|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
161317486|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
161317487|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
161317488|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
161317489|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
161317490|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161317491|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
161317492|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161317493|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
161317494|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
161317495|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
161317496|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
161317497|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
161317498|NCT01026818|582546212|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161317499|NCT01026818|582546213|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161317500|NCT01026818|582546214|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
161317501|NCT01026818|582546215|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
161317502|NCT01026818|582546212|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161317503|NCT01026818|582546213|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
161317504|NCT01026818|582546214|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161317505|NCT01026818|582546215|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
161317506|NCT01026818|582546212|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161317507|NCT01026818|582546213|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
161317508|NCT01026818|582546214|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161317509|NCT01026818|582546215|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
161317510|NCT01026818|582546212|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
161317511|NCT01026818|582546213|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
161317512|NCT01026818|582546214|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
161317513|NCT01026818|582546215|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
161317514|NCT01026818|582546212|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
161317515|NCT01026818|582546213|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
161317516|NCT01026818|582546214|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
161317517|NCT01026818|582546215|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
161317518|NCT01026818|582546212|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
161317519|NCT01026818|582546213|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
161317520|NCT01026818|582546214|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
161317521|NCT01026818|582546215|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
161317522|NCT03300050|582546218|FG000|Overall Study|Lost to Follow-up|2|||
161317523|NCT03300050|582546219|FG001|Overall Study|Lost to Follow-up|1|||
161317524|NCT03300050|582546220|FG002|Overall Study|Lost to Follow-up|0|||
161317525|NCT03300050|582546221|FG003|Overall Study|Lost to Follow-up|0|||
161317526|NCT03300050|582546222|FG004|Overall Study|Lost to Follow-up|1|||
161317527|NCT03300050|582546218|FG000|Overall Study|Withdrawal by Subject|1|||
161317528|NCT03300050|582546219|FG001|Overall Study|Withdrawal by Subject|1|||
161317529|NCT03300050|582546220|FG002|Overall Study|Withdrawal by Subject|1|||
161317530|NCT03300050|582546221|FG003|Overall Study|Withdrawal by Subject|0|||
161317531|NCT03300050|582546222|FG004|Overall Study|Withdrawal by Subject|0|||
161317532|NCT03300050|582546218|FG000|Overall Study|Death|0|||
161317533|NCT03300050|582546219|FG001|Overall Study|Death|0|||
161317534|NCT03300050|582546220|FG002|Overall Study|Death|1|||
161317535|NCT03300050|582546221|FG003|Overall Study|Death|0|||
161317536|NCT03300050|582546222|FG004|Overall Study|Death|0|||
161317537|NCT03300050|582546218|FG000|Overall Study|Not Eligible at Randomization|0|||
161317538|NCT03300050|582546219|FG001|Overall Study|Not Eligible at Randomization|0|||
161317539|NCT03300050|582546220|FG002|Overall Study|Not Eligible at Randomization|1|||
161317540|NCT03300050|582546221|FG003|Overall Study|Not Eligible at Randomization|1|||
161317541|NCT03300050|582546222|FG004|Overall Study|Not Eligible at Randomization|0|||
161317542|NCT01375374|582546223|FG000|Overall Study|Adverse Event|1|||
161317543|NCT03297021|582546224|FG000|Overall Study|Incomplete/illegible data sheet|4|||
161317544|NCT03297021|582546225|FG001|Overall Study|Incomplete/illegible data sheet|2|||
161317545|NCT03297021|582546226|FG002|Overall Study|Incomplete/illegible data sheet|3|||
161317546|NCT03297021|582546224|FG000|Overall Study|Missing Post-Op Data|1|||
161317547|NCT03297021|582546225|FG001|Overall Study|Missing Post-Op Data|2|||
161317548|NCT03297021|582546226|FG002|Overall Study|Missing Post-Op Data|1|||
161317549|NCT02784288|582546228|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
161317550|NCT02757625|582546229|FG000|Overall Study|Investigator's discretion|0|||
161317551|NCT02757625|582546230|FG001|Overall Study|Investigator's discretion|0|||
161317552|NCT02757625|582546231|FG002|Overall Study|Investigator's discretion|1|||
161317553|NCT02757625|582546232|FG003|Overall Study|Investigator's discretion|0|||
161317554|NCT02757625|582546229|FG000|Overall Study|Adverse Event|0|||
161317555|NCT02757625|582546230|FG001|Overall Study|Adverse Event|0|||
161317556|NCT02757625|582546231|FG002|Overall Study|Adverse Event|1|||
161317557|NCT02757625|582546232|FG003|Overall Study|Adverse Event|0|||
161317558|NCT02734862|582546233|FG000|Part A|Death|3|||
161317559|NCT02734862|582546234|FG001|Part A|Death|4|||
161317560|NCT02734862|582546235|FG002|Part A|Death|6|||
161317561|NCT02734862|582546233|FG000|Part A|Lost to Follow-up|2|||
161317562|NCT02734862|582546234|FG001|Part A|Lost to Follow-up|1|||
161317563|NCT02734862|582546235|FG002|Part A|Lost to Follow-up|1|||
161317564|NCT02734862|582546233|FG000|Part A|Withdrawal by Subject|1|||
161317565|NCT02734862|582546234|FG001|Part A|Withdrawal by Subject|1|||
161317566|NCT02734862|582546235|FG002|Part A|Withdrawal by Subject|2|||
161317567|NCT02734862|582546233|FG000|Part A|Physician Decision|2|||
161317568|NCT02734862|582546234|FG001|Part A|Physician Decision|0|||
161317569|NCT02734862|582546235|FG002|Part A|Physician Decision|1|||
161317570|NCT02734862|582546233|FG000|Part A|Adverse Event|2|||
161317571|NCT02734862|582546234|FG001|Part A|Adverse Event|0|||
161317572|NCT02734862|582546235|FG002|Part A|Adverse Event|1|||
161317573|NCT02734862|582546233|FG000|Part A|Noncompliance|1|||
161317574|NCT02734862|582546234|FG001|Part A|Noncompliance|1|||
161317575|NCT02734862|582546235|FG002|Part A|Noncompliance|0|||
161317576|NCT02734862|582546233|FG000|Part A|Other|1|||
161317577|NCT02734862|582546234|FG001|Part A|Other|1|||
161317578|NCT02734862|582546235|FG002|Part A|Other|3|||
161317579|NCT02734862|582546233|FG000|Part B|Death|8|||
161317580|NCT02734862|582546234|FG001|Part B|Death|3|||
161317581|NCT02734862|582546235|FG002|Part B|Death|5|||
161317582|NCT02734862|582546233|FG000|Part B|Lost to Follow-up|2|||
161317583|NCT02734862|582546234|FG001|Part B|Lost to Follow-up|2|||
161317584|NCT02734862|582546235|FG002|Part B|Lost to Follow-up|0|||
161317585|NCT02734862|582546233|FG000|Part B|Withdrawal by Subject|3|||
161317586|NCT02734862|582546234|FG001|Part B|Withdrawal by Subject|1|||
161317587|NCT02734862|582546235|FG002|Part B|Withdrawal by Subject|0|||
161317588|NCT02734862|582546233|FG000|Part B|Other|0|||
161317589|NCT02734862|582546234|FG001|Part B|Other|1|||
161317590|NCT02734862|582546235|FG002|Part B|Other|0|||
161317591|NCT00564278|582546236|FG000|Overall Study|Lost to Follow-up|35|||
161317592|NCT00564278|582546237|FG001|Overall Study|Lost to Follow-up|33|||
161317593|NCT00564278|582546236|FG000|Overall Study|Physician Decision|1|||
161317594|NCT00564278|582546237|FG001|Overall Study|Physician Decision|2|||
161317595|NCT00564278|582546236|FG000|Overall Study|Withdrawal by Subject|11|||
161317596|NCT00564278|582546237|FG001|Overall Study|Withdrawal by Subject|7|||
161317597|NCT00560703|582546238|FG000|Overall Study|Adverse Event|0|||
161317598|NCT00560703|582546239|FG001|Overall Study|Adverse Event|2|||
161317599|NCT00560703|582546238|FG000|Overall Study|Protocol Violation|0|||
161317600|NCT00560703|582546239|FG001|Overall Study|Protocol Violation|2|||
161317601|NCT00560703|582546238|FG000|Overall Study|Withdrawal by Subject|0|||
161317602|NCT00560703|582546239|FG001|Overall Study|Withdrawal by Subject|1|||
161317603|NCT00560703|582546238|FG000|Overall Study|non-compliance|0|||
161317604|NCT00560703|582546239|FG001|Overall Study|non-compliance|1|||
161317605|NCT02095197|582546240|FG000|Overall Study|Lost to Follow-up|0|||
161317606|NCT02095197|582546241|FG001|Overall Study|Lost to Follow-up|3|||
161317607|NCT02779075|582546242|FG000|Overall Study|Withdrawal by Subject|1|||
161317608|NCT02779075|582546243|FG001|Overall Study|Withdrawal by Subject|3|||
161317609|NCT02779075|582546242|FG000|Overall Study|IV lost during 2nd study|1|||
161317610|NCT02779075|582546243|FG001|Overall Study|IV lost during 2nd study|0|||
161317611|NCT02714036|582546244|FG000|Overall Study|Adverse Event|9|||
161317612|NCT02714036|582546245|FG001|Overall Study|Adverse Event|2|||
161317613|NCT02714036|582546244|FG000|Overall Study|Withdrawal by Subject|3|||
161317614|NCT02714036|582546245|FG001|Overall Study|Withdrawal by Subject|2|||
161317615|NCT01618916|582546246|FG000|Overall Study|Adverse Event|1|||
161317616|NCT01618916|582546247|FG001|Overall Study|Adverse Event|0|||
161317617|NCT01618916|582546248|FG002|Overall Study|Adverse Event|0|||
161317618|NCT01618916|582546249|FG003|Overall Study|Adverse Event|0|||
161317619|NCT01618916|582546250|FG004|Overall Study|Adverse Event|0|||
161317620|NCT01618916|582546251|FG005|Overall Study|Adverse Event|0|||
161317621|NCT01618916|582546246|FG000|Overall Study|Withdrawal by Subject|0|||
161317622|NCT01618916|582546247|FG001|Overall Study|Withdrawal by Subject|1|||
161317623|NCT01618916|582546248|FG002|Overall Study|Withdrawal by Subject|1|||
161317624|NCT01618916|582546249|FG003|Overall Study|Withdrawal by Subject|0|||
161317625|NCT01618916|582546250|FG004|Overall Study|Withdrawal by Subject|1|||
161317626|NCT01618916|582546251|FG005|Overall Study|Withdrawal by Subject|0|||
161317627|NCT01618916|582546246|FG000|Overall Study|Lost to Follow-up|1|||
161317628|NCT01618916|582546247|FG001|Overall Study|Lost to Follow-up|0|||
161317629|NCT01618916|582546248|FG002|Overall Study|Lost to Follow-up|0|||
161317630|NCT01618916|582546249|FG003|Overall Study|Lost to Follow-up|2|||
161317631|NCT01618916|582546250|FG004|Overall Study|Lost to Follow-up|0|||
161317632|NCT01618916|582546251|FG005|Overall Study|Lost to Follow-up|0|||
161317633|NCT01490697|582546257|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
161317634|NCT01490697|582546258|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
161317635|NCT00090584|582546259|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
161317636|NCT00090584|582546260|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
161317637|NCT00090584|582546259|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
161317638|NCT00090584|582546260|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
161317639|NCT00379808|582546261|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
161317640|NCT00379808|582546262|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
161317641|NCT01048099|582546271|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
161317642|NCT01048099|582546271|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
161317643|NCT00508157|582546272|FG000|Overall Study|Adverse Event|0|||
161317644|NCT00508157|582546273|FG001|Overall Study|Adverse Event|1|||
161317645|NCT00508157|582546272|FG000|Overall Study|Subject Withdrew Consent|1|||
161317646|NCT00508157|582546273|FG001|Overall Study|Subject Withdrew Consent|0|||
161317647|NCT00508157|582546272|FG000|Overall Study|Lost to Follow-up|1|||
161317648|NCT00508157|582546273|FG001|Overall Study|Lost to Follow-up|0|||
161317649|NCT00508157|582546272|FG000|Overall Study|Subject no longer met study criteria|0|||
161317650|NCT00508157|582546273|FG001|Overall Study|Subject no longer met study criteria|1|||
161317651|NCT00508157|582546272|FG000|Overall Study|Other known cause|0|||
161317652|NCT00508157|582546273|FG001|Overall Study|Other known cause|1|||
161317653|NCT01987232|582546274|FG000|Overall Study|Ongoing in Study|0|||
161317654|NCT01987232|582546275|FG001|Overall Study|Ongoing in Study|0|||
161317655|NCT01987232|582546276|FG002|Overall Study|Ongoing in Study|0|||
161317656|NCT01987232|582546277|FG003|Overall Study|Ongoing in Study|1|||
161317657|NCT01987232|582546278|FG004|Overall Study|Ongoing in Study|0|||
161317658|NCT01731470|582546281|FG000|Overall Study|Withdrawal by Subject|1|||
161317659|NCT01731470|582546281|FG000|Overall Study|Did not meet study criteria|1|||
161317660|NCT02258334|582546284|FG000|Overall Study|Adverse Event|1|||
161317661|NCT02258334|582546285|FG001|Overall Study|Adverse Event|0|||
161317662|NCT02258334|582546286|FG002|Overall Study|Adverse Event|0|||
161317663|NCT02258334|582546287|FG003|Overall Study|Adverse Event|0|||
161317664|NCT03564795|582546294|FG000|Overall Study|Withdrawal by Subject|3|||
161317665|NCT03564795|582546294|FG000|Overall Study|Lost to Follow-up|6|||
161317666|NCT03564795|582546294|FG000|Overall Study|Physician Decision|2|||
161317667|NCT00564395|582546295|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
161317668|NCT00564395|582546296|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
161317669|NCT00564395|582546295|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
161317670|NCT00564395|582546296|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
161317671|NCT00477607|582546302|FG000|Overall Study|Lost to Follow-up|7|||
161317672|NCT00477607|582546303|FG001|Overall Study|Lost to Follow-up|7|||
161317673|NCT03611582|582546313|FG000|Overall Study|Adverse Event|26|||
161317674|NCT03611582|582546314|FG001|Overall Study|Adverse Event|6|||
161317675|NCT03611582|582546313|FG000|Overall Study|Protocol Violation|0|||
161317676|NCT03611582|582546314|FG001|Overall Study|Protocol Violation|1|||
161317677|NCT03611582|582546313|FG000|Overall Study|Pregnancy|1|||
161317678|NCT03611582|582546314|FG001|Overall Study|Pregnancy|2|||
161317679|NCT03611582|582546313|FG000|Overall Study|Lack of Efficacy|0|||
161317680|NCT03611582|582546314|FG001|Overall Study|Lack of Efficacy|1|||
161317681|NCT03611582|582546313|FG000|Overall Study|At the discretion of the investigator|1|||
161317682|NCT03611582|582546314|FG001|Overall Study|At the discretion of the investigator|0|||
161317683|NCT03611582|582546313|FG000|Overall Study|Safety concern as judged by the investigator|1|||
161317684|NCT03611582|582546314|FG001|Overall Study|Safety concern as judged by the investigator|2|||
161317685|NCT03611582|582546313|FG000|Overall Study|Withdrawal by Subject|4|||
161317686|NCT03611582|582546314|FG001|Overall Study|Withdrawal by Subject|3|||
161317687|NCT03611582|582546313|FG000|Overall Study|Lost to Follow-up|18|||
161317688|NCT03611582|582546314|FG001|Overall Study|Lost to Follow-up|7|||
161317689|NCT03611582|582546313|FG000|Overall Study|other|17|||
161317690|NCT03611582|582546314|FG001|Overall Study|other|16|||
161317691|NCT00463840|582546315|FG000|Overall Study|Disease progression|7|||
161317692|NCT00463840|582546315|FG000|Overall Study|Withdrawal by Subject|2|||
161317693|NCT00463840|582546315|FG000|Overall Study|Adverse Event|3|||
161317694|NCT00866333|582546316|FG000|Overall Study|Withdrawal of consent|0|||
161317695|NCT00866333|582546317|FG001|Overall Study|Withdrawal of consent|1|||
161317696|NCT00866333|582546318|FG002|Overall Study|Withdrawal of consent|2|||
161317697|NCT00866333|582546316|FG000|Overall Study|Reason not Specified|3|||
161317698|NCT00866333|582546317|FG001|Overall Study|Reason not Specified|1|||
161317699|NCT00866333|582546318|FG002|Overall Study|Reason not Specified|1|||
161317700|NCT00866333|582546316|FG000|Overall Study|Study Terminated by Sponsor|2|||
161317701|NCT00866333|582546317|FG001|Overall Study|Study Terminated by Sponsor|5|||
161317702|NCT00866333|582546318|FG002|Overall Study|Study Terminated by Sponsor|9|||
161317703|NCT01653327|582546319|FG000|Overall Study|Withdrawal by Subject|1|||
161317704|NCT00422292|582546320|FG000|Overall Study|Serious adverse events|1|||
161317705|NCT00422292|582546321|FG001|Overall Study|Serious adverse events|4|||
161317706|NCT00422292|582546322|FG002|Overall Study|Serious adverse events|0|||
161317707|NCT00422292|582546323|FG003|Overall Study|Serious adverse events|0|||
161317708|NCT00422292|582546320|FG000|Overall Study|Adverse Event|1|||
161317709|NCT00422292|582546321|FG001|Overall Study|Adverse Event|0|||
161317710|NCT00422292|582546322|FG002|Overall Study|Adverse Event|1|||
161317711|NCT00422292|582546323|FG003|Overall Study|Adverse Event|0|||
161317712|NCT00422292|582546320|FG000|Overall Study|Protocol Violation|4|||
161317713|NCT00422292|582546321|FG001|Overall Study|Protocol Violation|25|||
161317714|NCT00422292|582546322|FG002|Overall Study|Protocol Violation|8|||
161317715|NCT00422292|582546323|FG003|Overall Study|Protocol Violation|5|||
161317716|NCT00422292|582546320|FG000|Overall Study|Lost to Follow-up|6|||
161317717|NCT00422292|582546321|FG001|Overall Study|Lost to Follow-up|12|||
161317718|NCT00422292|582546322|FG002|Overall Study|Lost to Follow-up|6|||
161317719|NCT00422292|582546323|FG003|Overall Study|Lost to Follow-up|6|||
161317720|NCT00422292|582546320|FG000|Overall Study|Withdrawal by Subject|6|||
161317721|NCT00422292|582546321|FG001|Overall Study|Withdrawal by Subject|25|||
161317722|NCT00422292|582546322|FG002|Overall Study|Withdrawal by Subject|7|||
161317723|NCT00422292|582546323|FG003|Overall Study|Withdrawal by Subject|13|||
161317724|NCT02243046|582546324|FG000|Overall Study|Lost to Follow-up|1|||
161317725|NCT02243046|582546325|FG001|Overall Study|Lost to Follow-up|1|||
161317726|NCT02243046|582546326|FG002|Overall Study|Lost to Follow-up|4|||
161317727|NCT01687283|582548177|FG000|Overall Study|Adverse Event|11|||
161317728|NCT01687283|582548178|FG001|Overall Study|Adverse Event|4|||
161317729|NCT01687283|582548177|FG000|Overall Study|Lack of Efficacy|3|||
161317730|NCT01687283|582548178|FG001|Overall Study|Lack of Efficacy|1|||
161317731|NCT01687283|582548177|FG000|Overall Study|Protocol Violation|1|||
161317732|NCT01687283|582548178|FG001|Overall Study|Protocol Violation|3|||
161317733|NCT01687283|582548177|FG000|Overall Study|protocol defined stopping criteria|8|||
161317734|NCT01687283|582548178|FG001|Overall Study|protocol defined stopping criteria|10|||
161317735|NCT01687283|582548177|FG000|Overall Study|Lost to Follow-up|1|||
161317736|NCT01687283|582548178|FG001|Overall Study|Lost to Follow-up|1|||
161317737|NCT01687283|582548177|FG000|Overall Study|Investigator discretion|2|||
161317738|NCT01687283|582548178|FG001|Overall Study|Investigator discretion|0|||
161317739|NCT01687283|582548177|FG000|Overall Study|Withdrawal by Subject|9|||
161317740|NCT01687283|582548178|FG001|Overall Study|Withdrawal by Subject|8|||
161317741|NCT00410072|582548182|FG000|Day 1 to Week 48|Adverse Event|1|||
161317742|NCT00410072|582548183|FG001|Day 1 to Week 48|Adverse Event|2|||
161317743|NCT00410072|582548182|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
161317744|NCT00410072|582548183|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
161317745|NCT00410072|582548182|FG000|Day 1 to Week 48|Other|0|||
161317746|NCT00410072|582548183|FG001|Day 1 to Week 48|Other|1|||
161317747|NCT00410072|582548182|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
161317748|NCT00410072|582548183|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
161317749|NCT00410072|582548182|FG000|Day 1 to Week 48|Pregnancy|0|||
161317750|NCT00410072|582548183|FG001|Day 1 to Week 48|Pregnancy|2|||
161317751|NCT00410072|582548182|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
161317752|NCT00410072|582548183|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
161317753|NCT00410072|582548182|FG000|After Week 48 to Week 96|Adverse Event|1|||
161317754|NCT00410072|582548183|FG001|After Week 48 to Week 96|Adverse Event|2|||
161317755|NCT00410072|582548182|FG000|After Week 48 to Week 96|Death|0|||
161317756|NCT00410072|582548183|FG001|After Week 48 to Week 96|Death|1|||
161317757|NCT00410072|582548182|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
161317758|NCT00410072|582548183|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
161317759|NCT00410072|582548182|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
161317760|NCT00410072|582548183|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
161317761|NCT00410072|582548182|FG000|After Week 48 to Week 96|Other|2|||
161317762|NCT00410072|582548183|FG001|After Week 48 to Week 96|Other|0|||
161317763|NCT00410072|582548182|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
161317764|NCT00410072|582548183|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
161317765|NCT00410072|582548182|FG000|After Week 48 to Week 96|Pregnancy|0|||
161317766|NCT00410072|582548183|FG001|After Week 48 to Week 96|Pregnancy|2|||
161317767|NCT00410072|582548182|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
161317768|NCT00410072|582548183|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
161317769|NCT01471444|582548184|FG000|Overall Study|Physician Decision|3|||
161317770|NCT01471444|582548185|FG001|Overall Study|Physician Decision|2|||
161317771|NCT01471444|582548184|FG000|Overall Study|Withdrawal by Subject|0|||
161317772|NCT01471444|582548185|FG001|Overall Study|Withdrawal by Subject|1|||
161317773|NCT03915626|582548186|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
161317774|NCT01709409|582548189|FG000|Overall Study|Protocol Violation|1|||
161317775|NCT01709409|582548190|FG001|Overall Study|Protocol Violation|0|||
161317776|NCT04571385|582548191|FG000|Overall Study|Participant non-compliance|1|||
161317777|NCT04571385|582548192|FG001|Overall Study|Participant non-compliance|0|||
161317778|NCT04571385|582548193|FG002|Overall Study|Participant non-compliance|0|||
161317779|NCT04571385|582548191|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
161317780|NCT04571385|582548192|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
161317781|NCT04571385|582548193|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
161317782|NCT04571385|582548191|FG000|Overall Study|Screen failure|0|||
161317783|NCT04571385|582548192|FG001|Overall Study|Screen failure|0|||
161317784|NCT04571385|582548193|FG002|Overall Study|Screen failure|1|||
161317785|NCT05025332|582548194|FG000|Screening|Screen failure|12|||
161317786|NCT05025332|582548194|FG000|Treatment & Follow Up|Protocol Violation|1|||
161317787|NCT05025332|582548194|FG000|Treatment & Follow Up|Adverse Event|4|||
161317788|NCT01928199|582548197|FG000|Overall Study|Lost to Follow-up|2|||
161317789|NCT01928199|582548198|FG001|Overall Study|Lost to Follow-up|1|||
161317790|NCT01928199|582548197|FG000|Overall Study|Withdrawal by Subject|3|||
161317791|NCT01928199|582548198|FG001|Overall Study|Withdrawal by Subject|5|||
161317792|NCT01641471|582548199|FG000|Overall Study|Withdrawal by Subject|19|||
161317793|NCT01641471|582548200|FG001|Overall Study|Withdrawal by Subject|19|||
161317794|NCT01641471|582548199|FG000|Overall Study|Lost to Follow-up|2|||
161317795|NCT01641471|582548200|FG001|Overall Study|Lost to Follow-up|4|||
161317796|NCT01641471|582548199|FG000|Overall Study|Protocol Violation|2|||
161317797|NCT01641471|582548200|FG001|Overall Study|Protocol Violation|4|||
161317798|NCT02499263|582548201|FG000|Overall Study|Lost to Follow-up|9|||
161317799|NCT02499263|582548201|FG000|Overall Study|Participant's withdrawal of consent|4|||
161317800|NCT02499263|582548201|FG000|Overall Study|Lack of Efficacy|22|||
161317801|NCT02499263|582548201|FG000|Overall Study|investigator's judgment|12|||
161317802|NCT02499263|582548201|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
161317803|NCT02499263|582548201|FG000|Overall Study|Participant's decision|3|||
161317804|NCT02499263|582548201|FG000|Overall Study|Pregnancy|1|||
161317805|NCT01108237|582548202|FG000|Overall Study|No alignment data|2|||
161317806|NCT01108237|582548203|FG001|Overall Study|No alignment data|15|||
161317807|NCT01108237|582548202|FG000|Overall Study|Did not meet criteria for analysis|7|||
161317808|NCT01108237|582548203|FG001|Overall Study|Did not meet criteria for analysis|0|||
161317809|NCT00790556|582548204|FG000|Treatment Period 1|Physician Decision|1|||
161317810|NCT00790556|582548205|FG001|Treatment Period 1|Physician Decision|0|||
161317811|NCT00790556|582548204|FG000|Treatment Period 1|Withdrawal by Subject|1|||
161317812|NCT00790556|582548205|FG001|Treatment Period 1|Withdrawal by Subject|0|||
161317813|NCT04401202|582548207|FG000|Overall Study|Lost to Follow-up|2|||
161317814|NCT04401202|582548208|FG001|Overall Study|Lost to Follow-up|2|||
161317815|NCT04401202|582548207|FG000|Overall Study|Adverse Event|0|||
161317816|NCT04401202|582548208|FG001|Overall Study|Adverse Event|1|||
161317817|NCT04401202|582548207|FG000|Overall Study|Hospitalized|4|||
161317818|NCT04401202|582548208|FG001|Overall Study|Hospitalized|1|||
161317819|NCT05697627|582548212|FG000|Overall Study|Adverse Event|1|||
161317820|NCT04122625|582548213|FG000|Part A (up to 2.92 Years)|Death|2|||
161317821|NCT04122625|582548214|FG001|Part A (up to 2.92 Years)|Death|4|||
161317822|NCT04122625|582548215|FG002|Part A (up to 2.92 Years)|Death|0|||
161317823|NCT04122625|582548216|FG003|Part A (up to 2.92 Years)|Death|0|||
161317824|NCT04122625|582548217|FG004|Part A (up to 2.92 Years)|Death|0|||
161317825|NCT04122625|582548218|FG005|Part A (up to 2.92 Years)|Death|0|||
161317826|NCT04122625|582548213|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161317827|NCT04122625|582548214|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161317828|NCT04122625|582548215|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
161317829|NCT04122625|582548216|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
161317830|NCT04122625|582548217|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
161317831|NCT04122625|582548218|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
161317832|NCT04122625|582548213|FG000|Part B (up to 2.33 Years)|Death|0|||
161317833|NCT04122625|582548214|FG001|Part B (up to 2.33 Years)|Death|0|||
161317834|NCT04122625|582548215|FG002|Part B (up to 2.33 Years)|Death|5|||
161317835|NCT04122625|582548216|FG003|Part B (up to 2.33 Years)|Death|7|||
161317836|NCT04122625|582548217|FG004|Part B (up to 2.33 Years)|Death|6|||
161317837|NCT04122625|582548218|FG005|Part B (up to 2.33 Years)|Death|7|||
161317838|NCT02722746|582548219|FG000|Overall Study|Withdrawal by Subject|0|||
161317839|NCT02722746|582548220|FG001|Overall Study|Withdrawal by Subject|1|||
161317840|NCT02722746|582548221|FG002|Overall Study|Withdrawal by Subject|0|||
161317841|NCT02722746|582548219|FG000|Overall Study|Protocol Violation|8|||
161317842|NCT02722746|582548220|FG001|Overall Study|Protocol Violation|4|||
161317843|NCT02722746|582548221|FG002|Overall Study|Protocol Violation|6|||
161317844|NCT02700698|582548228|FG000|Overall Study|Withdrawal by Subject|1|||
161317845|NCT02700698|582548229|FG001|Overall Study|Withdrawal by Subject|0|||
161317846|NCT00703118|582548232|FG000|Overall Study|Adverse Event|1|||
161317847|NCT00703118|582548233|FG001|Overall Study|Adverse Event|2|||
161317848|NCT00703118|582548234|FG002|Overall Study|Adverse Event|2|||
161317849|NCT00703118|582548232|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
161317850|NCT00703118|582548233|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
161317851|NCT00703118|582548234|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
161317852|NCT00703118|582548232|FG000|Overall Study|Lost to Follow-up|6|||
161317853|NCT00703118|582548233|FG001|Overall Study|Lost to Follow-up|4|||
161317854|NCT00703118|582548234|FG002|Overall Study|Lost to Follow-up|4|||
161317855|NCT00703118|582548232|FG000|Overall Study|Withdrawal by Subject|8|||
161317856|NCT00703118|582548233|FG001|Overall Study|Withdrawal by Subject|7|||
161317857|NCT00703118|582548234|FG002|Overall Study|Withdrawal by Subject|13|||
161317858|NCT00703118|582548232|FG000|Overall Study|Other|0|||
161317859|NCT00703118|582548233|FG001|Overall Study|Other|0|||
161317860|NCT00703118|582548234|FG002|Overall Study|Other|1|||
161317861|NCT04165135|582548235|FG000|Overall Study|Protocol Violation|10|||
161317862|NCT04165135|582548235|FG000|Overall Study|Participants withdrawal of consent|5|||
161317863|NCT00530790|582548236|FG000|Overall Study|Adverse Event|2|||
161317864|NCT00530790|582548236|FG000|Overall Study|Withdrawal by Subject|2|||
161317865|NCT00530790|582548236|FG000|Overall Study|Physician Decision|1|||
161317866|NCT05053035|582548243|FG000|Overall Study|Withdrawal by Subject|1|||
161317867|NCT05053035|582548244|FG001|Overall Study|Withdrawal by Subject|0|||
161317868|NCT00438256|582548245|FG000|Overall Study|Ineligible for Resection|2|||
161317869|NCT00438256|582548246|FG001|Overall Study|Ineligible for Resection|1|||
161317870|NCT00438256|582548247|FG002|Overall Study|Ineligible for Resection|1|||
161317871|NCT00438256|582548248|FG003|Overall Study|Ineligible for Resection|7|||
161317872|NCT00438256|582548245|FG000|Overall Study|Excluded final Diagnosis|0|||
161317873|NCT00438256|582548246|FG001|Overall Study|Excluded final Diagnosis|0|||
161317874|NCT00438256|582548247|FG002|Overall Study|Excluded final Diagnosis|0|||
161317875|NCT00438256|582548248|FG003|Overall Study|Excluded final Diagnosis|2|||
161317876|NCT02005627|582548249|FG000|Overall Study|Lost to Follow-up|1|||
161317877|NCT02005627|582548250|FG001|Overall Study|Lost to Follow-up|2|||
161317878|NCT02005627|582548249|FG000|Overall Study|Withdrawal by Subject|1|||
161317879|NCT02005627|582548250|FG001|Overall Study|Withdrawal by Subject|2|||
161317880|NCT00938587|582548256|FG000|Overall Study|Adverse Event|2|||
161317881|NCT00938587|582548257|FG001|Overall Study|Adverse Event|0|||
161317882|NCT00938587|582548258|FG002|Overall Study|Adverse Event|0|||
161317883|NCT00938587|582548259|FG003|Overall Study|Adverse Event|2|||
161317884|NCT00938587|582548256|FG000|Overall Study|Did not meet entrance criteria|0|||
161317885|NCT00938587|582548257|FG001|Overall Study|Did not meet entrance criteria|0|||
161317886|NCT00938587|582548258|FG002|Overall Study|Did not meet entrance criteria|1|||
161317887|NCT00938587|582548259|FG003|Overall Study|Did not meet entrance criteria|0|||
161317888|NCT00938587|582548256|FG000|Overall Study|Withdrawal by Subject|1|||
161317889|NCT00938587|582548257|FG001|Overall Study|Withdrawal by Subject|1|||
161317890|NCT00938587|582548258|FG002|Overall Study|Withdrawal by Subject|0|||
161317891|NCT00938587|582548259|FG003|Overall Study|Withdrawal by Subject|0|||
161317892|NCT00849290|582548260|FG000|Overall Study|Adverse Event|3|||
161317893|NCT00849290|582548260|FG000|Overall Study|Death|14|||
161317894|NCT00849290|582548260|FG000|Overall Study|Withdrawal by Subject|11|||
161317895|NCT00849290|582548260|FG000|Overall Study|Lost to Follow-up|2|||
161317896|NCT00849290|582548260|FG000|Overall Study|Protocol Violation|5|||
161317897|NCT00849290|582548260|FG000|Overall Study|Disease Progression|20|||
161317898|NCT01464619|582548265|FG000|Overall Study|Lost to Follow-up|3|||
161317899|NCT01464619|582548266|FG001|Overall Study|Lost to Follow-up|4|||
161317900|NCT02819440|582548269|FG000|Overall Study|Adverse Event|3|||
161317901|NCT02819440|582548270|FG001|Overall Study|Adverse Event|1|||
161317902|NCT02819440|582548269|FG000|Overall Study|Lost to Follow-up|1|||
161317903|NCT02819440|582548270|FG001|Overall Study|Lost to Follow-up|3|||
161317904|NCT02819440|582548269|FG000|Overall Study|Withdrawal by Subject|9|||
161317905|NCT02819440|582548270|FG001|Overall Study|Withdrawal by Subject|8|||
161317906|NCT02334384|582548278|FG000|Overall Study|Lost to Follow-up|1|||
161317907|NCT02334384|582548279|FG001|Overall Study|Lost to Follow-up|1|||
161317908|NCT00055497|582548280|FG000|Overall Study|Adverse Event|1|||
161317909|NCT00055497|582548281|FG001|Overall Study|Adverse Event|1|||
161317910|NCT00055497|582548282|FG002|Overall Study|Adverse Event|1|||
161317911|NCT00055497|582548283|FG003|Overall Study|Adverse Event|28|||
161317912|NCT00055497|582548280|FG000|Overall Study|Withdrawal by Subject|3|||
161317913|NCT00055497|582548281|FG001|Overall Study|Withdrawal by Subject|1|||
161317914|NCT00055497|582548282|FG002|Overall Study|Withdrawal by Subject|1|||
161317915|NCT00055497|582548283|FG003|Overall Study|Withdrawal by Subject|15|||
161317916|NCT00055497|582548280|FG000|Overall Study|Lost to Follow-up|0|||
161317917|NCT00055497|582548281|FG001|Overall Study|Lost to Follow-up|1|||
161317918|NCT00055497|582548282|FG002|Overall Study|Lost to Follow-up|0|||
161317919|NCT00055497|582548283|FG003|Overall Study|Lost to Follow-up|5|||
161317920|NCT00055497|582548280|FG000|Overall Study|Protocol Violation|0|||
161317921|NCT00055497|582548281|FG001|Overall Study|Protocol Violation|0|||
161317922|NCT00055497|582548282|FG002|Overall Study|Protocol Violation|0|||
161317923|NCT00055497|582548283|FG003|Overall Study|Protocol Violation|3|||
161317924|NCT00055497|582548280|FG000|Overall Study|Lack of Efficacy|1|||
161317925|NCT00055497|582548281|FG001|Overall Study|Lack of Efficacy|0|||
161317926|NCT00055497|582548282|FG002|Overall Study|Lack of Efficacy|0|||
161317927|NCT00055497|582548283|FG003|Overall Study|Lack of Efficacy|27|||
161317928|NCT00055497|582548280|FG000|Overall Study|Administrative Reasons|0|||
161317929|NCT00055497|582548281|FG001|Overall Study|Administrative Reasons|0|||
161317930|NCT00055497|582548282|FG002|Overall Study|Administrative Reasons|0|||
161317931|NCT00055497|582548283|FG003|Overall Study|Administrative Reasons|1|||
161317932|NCT00055497|582548280|FG000|Overall Study|Other|0|||
161317933|NCT00055497|582548281|FG001|Overall Study|Other|0|||
161317934|NCT00055497|582548282|FG002|Overall Study|Other|0|||
161317935|NCT00055497|582548283|FG003|Overall Study|Other|11|||
161317936|NCT00048165|582548284|FG000|Completed 6 Months Study|Administration/Other|8|||
161317937|NCT00048165|582548285|FG001|Completed 6 Months Study|Administration/Other|8|||
161317938|NCT00048165|582548284|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
161317939|NCT00048165|582548285|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
161317940|NCT00048165|582548284|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
161317941|NCT00048165|582548285|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
161317942|NCT00048165|582548284|FG000|Completed 6 Months Study|Death|12|||
161317943|NCT00048165|582548285|FG001|Completed 6 Months Study|Death|6|||
161317944|NCT00048165|582548284|FG000|Completed 6 Months Study|Insufficient therapy|1|||
161317945|NCT00048165|582548285|FG001|Completed 6 Months Study|Insufficient therapy|4|||
161317946|NCT00048165|582548284|FG000|Completed 6 Months Study|Other violation|4|||
161317947|NCT00048165|582548285|FG001|Completed 6 Months Study|Other violation|6|||
161317948|NCT00048165|582548284|FG000|Completed 6 Months Study|Refused treatment|5|||
161317949|NCT00048165|582548285|FG001|Completed 6 Months Study|Refused treatment|5|||
161317950|NCT00048165|582548284|FG000|Completed 6 Months Study|Violation criteria|0|||
161317951|NCT00048165|582548285|FG001|Completed 6 Months Study|Violation criteria|2|||
161317952|NCT00048165|582548284|FG000|Completed 6 Months Study|Did not receive study drug|6|||
161317953|NCT00048165|582548285|FG001|Completed 6 Months Study|Did not receive study drug|6|||
161317954|NCT00048165|582548284|FG000|Completed 12 Months Study|Administration/Other|0|||
161317955|NCT00048165|582548285|FG001|Completed 12 Months Study|Administration/Other|2|||
161317956|NCT00048165|582548284|FG000|Completed 12 Months Study|Death|2|||
161317957|NCT00048165|582548285|FG001|Completed 12 Months Study|Death|1|||
161317958|NCT00048165|582548284|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
161317959|NCT00048165|582548285|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
161317960|NCT00731731|582548286|FG000|Overall Study|Protocol Violation|0|||
161317961|NCT00731731|582548287|FG001|Overall Study|Protocol Violation|0|||
161317962|NCT00731731|582548288|FG002|Overall Study|Protocol Violation|1|||
161317963|NCT00731731|582548286|FG000|Overall Study|Cancel prior to treatment|0|||
161317964|NCT00731731|582548287|FG001|Overall Study|Cancel prior to treatment|0|||
161317965|NCT00731731|582548288|FG002|Overall Study|Cancel prior to treatment|2|||
161317966|NCT01084538|582548289|FG000|Overall Study|Drug not available|30|||
161317967|NCT01084538|582548289|FG000|Overall Study|Adverse Event|9|||
161317968|NCT01084538|582548289|FG000|Overall Study|Kidney transplant|6|||
161317969|NCT01084538|582548289|FG000|Overall Study|Serious Adverse Event|3|||
161317970|NCT01084538|582548289|FG000|Overall Study|Lack of effectiveness|2|||
161317971|NCT01084538|582548289|FG000|Overall Study|Patient noncompliance|2|||
161317972|NCT01084538|582548289|FG000|Overall Study|Hyperphosphatemia|2|||
161317973|NCT01084538|582548289|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
161317974|NCT01084538|582548289|FG000|Overall Study|Change of residence|2|||
161317975|NCT01084538|582548289|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
161317976|NCT01084538|582548289|FG000|Overall Study|Reason unknown|8|||
161317977|NCT03742258|582548294|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
161317978|NCT03742258|582548295|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
161317979|NCT03742258|582548296|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
161317980|NCT03742258|582548294|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
161317981|NCT03742258|582548295|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
161317982|NCT03742258|582548296|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
161317983|NCT03742258|582548294|FG000|Survival Follow-Up|Still in Follow-up|0|||
161317984|NCT03742258|582548295|FG001|Survival Follow-Up|Still in Follow-up|0|||
161317985|NCT03742258|582548296|FG002|Survival Follow-Up|Still in Follow-up|2|||
161317986|NCT01952080|582548298|FG000|Overall Study|Withdrawal by Subject|0|||
161317987|NCT01952080|582548299|FG001|Overall Study|Withdrawal by Subject|0|||
161317988|NCT01952080|582548300|FG002|Overall Study|Withdrawal by Subject|0|||
161317989|NCT01952080|582548301|FG003|Overall Study|Withdrawal by Subject|1|||
161317990|NCT01952080|582548298|FG000|Overall Study|Protocol Non-compliance|0|||
161317991|NCT01952080|582548299|FG001|Overall Study|Protocol Non-compliance|1|||
161317992|NCT01952080|582548300|FG002|Overall Study|Protocol Non-compliance|0|||
161317993|NCT01952080|582548301|FG003|Overall Study|Protocol Non-compliance|0|||
161317994|NCT01333956|582548302|FG000|Overall Study|Lost to Follow-up|1|||
161317995|NCT01333956|582548303|FG001|Overall Study|Lost to Follow-up|2|||
161317996|NCT01333956|582548304|FG002|Overall Study|Lost to Follow-up|0|||
161317997|NCT01333956|582548305|FG003|Overall Study|Lost to Follow-up|1|||
161317998|NCT01333956|582548302|FG000|Overall Study|Unable to complete study procedure|1|||
161317999|NCT01333956|582548303|FG001|Overall Study|Unable to complete study procedure|0|||
161318000|NCT01333956|582548304|FG002|Overall Study|Unable to complete study procedure|0|||
161318001|NCT01333956|582548305|FG003|Overall Study|Unable to complete study procedure|1|||
161318002|NCT01333956|582548302|FG000|Overall Study|Withdrawal by Subject|0|||
161318003|NCT01333956|582548303|FG001|Overall Study|Withdrawal by Subject|2|||
161318004|NCT01333956|582548304|FG002|Overall Study|Withdrawal by Subject|1|||
161318005|NCT01333956|582548305|FG003|Overall Study|Withdrawal by Subject|0|||
161318006|NCT02134353|582548306|FG000|Overall Study|Adverse Event|10|||
161318007|NCT02134353|582548307|FG001|Overall Study|Adverse Event|6|||
161318008|NCT02134353|582548306|FG000|Overall Study|Lost to Follow-up|1|||
161318009|NCT02134353|582548307|FG001|Overall Study|Lost to Follow-up|1|||
161318010|NCT02134353|582548306|FG000|Overall Study|Lack of Efficacy|2|||
161318011|NCT02134353|582548307|FG001|Overall Study|Lack of Efficacy|1|||
161318012|NCT02134353|582548306|FG000|Overall Study|Withdrawal by Subject|12|||
161318013|NCT02134353|582548307|FG001|Overall Study|Withdrawal by Subject|13|||
161318014|NCT02134353|582548306|FG000|Overall Study|Death|0|||
161318015|NCT02134353|582548307|FG001|Overall Study|Death|1|||
161318016|NCT02134353|582548306|FG000|Overall Study|Pregnancy|0|||
161318017|NCT02134353|582548307|FG001|Overall Study|Pregnancy|1|||
161318018|NCT02134353|582548306|FG000|Overall Study|Relocation|1|||
161318019|NCT02134353|582548307|FG001|Overall Study|Relocation|0|||
161318020|NCT02134353|582548306|FG000|Overall Study|Other - Patient's Choice|0|||
161318021|NCT02134353|582548307|FG001|Overall Study|Other - Patient's Choice|1|||
161318022|NCT03426436|582548310|FG000|Overall Study|Incorrect lead placement|12|||
161318023|NCT03426436|582548310|FG000|Overall Study|Withdrawal by Subject|2|||
161318024|NCT03426436|582548310|FG000|Overall Study|Consent issue|1|||
161318025|NCT03426436|582548310|FG000|Overall Study|ECGs not saved|4|||
161318026|NCT00432276|582548311|FG000|Overall Study|Hyperglycemic Rescue|44|||
161318027|NCT00432276|582548312|FG001|Overall Study|Hyperglycemic Rescue|87|||
161318028|NCT00432276|582548311|FG000|Overall Study|Adverse Event|13|||
161318029|NCT00432276|582548312|FG001|Overall Study|Adverse Event|16|||
161318030|NCT00432276|582548311|FG000|Overall Study|Protocol Violation|25|||
161318031|NCT00432276|582548312|FG001|Overall Study|Protocol Violation|20|||
161318032|NCT00432276|582548311|FG000|Overall Study|Lost to Follow-up|6|||
161318033|NCT00432276|582548312|FG001|Overall Study|Lost to Follow-up|2|||
161318034|NCT00432276|582548311|FG000|Overall Study|Withdrawal by Subject|25|||
161318035|NCT00432276|582548312|FG001|Overall Study|Withdrawal by Subject|20|||
161318036|NCT00432276|582548311|FG000|Overall Study|Physician Decision|6|||
161318037|NCT00432276|582548312|FG001|Overall Study|Physician Decision|8|||
161318038|NCT00432276|582548311|FG000|Overall Study|Other|2|||
161318039|NCT00432276|582548312|FG001|Overall Study|Other|3|||
161318040|NCT00594386|582548313|FG000|Overall Study|Major protocol violation|2|||
161318041|NCT00594386|582548313|FG000|Overall Study|Lack of Efficacy|12|||
161318042|NCT00594386|582548313|FG000|Overall Study|Adverse Event|68|||
161318043|NCT00594386|582548313|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
161318044|NCT00594386|582548313|FG000|Overall Study|Subject withdrew consent|35|||
161318045|NCT00594386|582548313|FG000|Overall Study|Study ended per sponsor|115|||
161318046|NCT00594386|582548313|FG000|Overall Study|Lost to Follow-up|6|||
161318047|NCT00594386|582548313|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
161318048|NCT00594386|582548313|FG000|Overall Study|Other: Subject moved to Seattle|1|||
161318049|NCT00594386|582548313|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
161318050|NCT00594386|582548313|FG000|Overall Study|Other: Study terminated per investigator|2|||
161318051|NCT00594386|582548313|FG000|Overall Study|Other: Sponsor closure of study|1|||
161318052|NCT00594386|582548313|FG000|Overall Study|Other: Site terminated participation|1|||
161318053|NCT00594386|582548313|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
161318054|NCT00594386|582548313|FG000|Overall Study|Other: Loss of drivers license|1|||
161318055|NCT01210144|582548317|FG000|Overall Study|Lack of ovarian response|1|||
161318056|NCT01210144|582548318|FG001|Overall Study|Lack of ovarian response|0|||
161318057|NCT01210144|582548317|FG000|Overall Study|No fertilization|1|||
161318058|NCT01210144|582548318|FG001|Overall Study|No fertilization|0|||
161318059|NCT01210144|582548317|FG000|Overall Study|No transfer|1|||
161318060|NCT01210144|582548318|FG001|Overall Study|No transfer|0|||
161318061|NCT02655419|582548323|FG000|Overall Study|Enrolled but not treated|1|||
161318062|NCT02655419|582548324|FG001|Overall Study|Enrolled but not treated|5|||
161318063|NCT02655419|582548323|FG000|Overall Study|Withdrawal by Subject|4|||
161318064|NCT02655419|582548324|FG001|Overall Study|Withdrawal by Subject|1|||
161318065|NCT02655419|582548323|FG000|Overall Study|Other|0|||
161318066|NCT02655419|582548324|FG001|Overall Study|Other|1|||
161318067|NCT00505661|582548329|FG000|Overall Study|Not Eligible|4|||
161318068|NCT01783821|582548331|FG000|Overall Study|Screen Failure|1|||
161318069|NCT01783821|582548332|FG001|Overall Study|Screen Failure|1|||
161318070|NCT01573754|582548333|FG000|Overall Study|Noncompliance or remission not achieved|3|||
161318071|NCT01573754|582548334|FG001|Overall Study|Noncompliance or remission not achieved|15|||
161318072|NCT02333383|582548335|FG000|Overall Study|Adalimumab discontinuation|21|||
161318073|NCT02333383|582548335|FG000|Overall Study|Lost to Follow-up|15|||
161318074|NCT02333383|582548335|FG000|Overall Study|Withdrawal by Subject|3|||
161318075|NCT02333383|582548335|FG000|Overall Study|Transfer to another hospital|2|||
161318076|NCT04918355|582548338|FG000|Overall Study|no qualifying health encounter|497|||
161318077|NCT04918355|582548339|FG001|Overall Study|no qualifying health encounter|192|||
161318078|NCT04918355|582548340|FG002|Overall Study|no qualifying health encounter|438|||
161318079|NCT04918355|582548341|FG003|Overall Study|no qualifying health encounter|424|||
161318080|NCT04683939|582548342|FG000|Overall Study|Study termination by the sponsor|0|||
161318081|NCT04683939|582548343|FG001|Overall Study|Study termination by the sponsor|1|||
161318082|NCT04683939|582548344|FG002|Overall Study|Study termination by the sponsor|2|||
161318083|NCT04683939|582548345|FG003|Overall Study|Study termination by the sponsor|2|||
161318084|NCT04683939|582548342|FG000|Overall Study|Death|1|||
161318085|NCT04683939|582548343|FG001|Overall Study|Death|1|||
161318086|NCT04683939|582548344|FG002|Overall Study|Death|2|||
161318087|NCT04683939|582548345|FG003|Overall Study|Death|1|||
161318088|NCT04683939|582548342|FG000|Overall Study|Withdrawal by Subject|1|||
161318089|NCT04683939|582548343|FG001|Overall Study|Withdrawal by Subject|0|||
161318090|NCT04683939|582548344|FG002|Overall Study|Withdrawal by Subject|0|||
161318091|NCT04683939|582548345|FG003|Overall Study|Withdrawal by Subject|0|||
161318092|NCT04683939|582548342|FG000|Overall Study|Physician Decision|1|||
161318093|NCT04683939|582548343|FG001|Overall Study|Physician Decision|0|||
161318094|NCT04683939|582548344|FG002|Overall Study|Physician Decision|0|||
161318095|NCT04683939|582548345|FG003|Overall Study|Physician Decision|0|||
161318096|NCT04683939|582548342|FG000|Overall Study|Lost to Follow-up|0|||
161318097|NCT04683939|582548343|FG001|Overall Study|Lost to Follow-up|1|||
161318098|NCT04683939|582548344|FG002|Overall Study|Lost to Follow-up|0|||
161318099|NCT04683939|582548345|FG003|Overall Study|Lost to Follow-up|0|||
161318100|NCT04852276|582548346|FG000|Overall Study|Death|2|||
161318101|NCT04852276|582548347|FG001|Overall Study|Death|0|||
161318102|NCT04852276|582548346|FG000|Overall Study|Lost to Follow-up|15|||
161318103|NCT04852276|582548347|FG001|Overall Study|Lost to Follow-up|9|||
161318104|NCT04852276|582548346|FG000|Overall Study|Withdrawal by Subject|26|||
161318105|NCT04852276|582548347|FG001|Overall Study|Withdrawal by Subject|6|||
161318106|NCT00904917|582550491|FG000|Overall Study|Lost to Follow-up|2|||
161318107|NCT00904917|582550492|FG001|Overall Study|Lost to Follow-up|2|||
161318108|NCT00904917|582550493|FG002|Overall Study|Lost to Follow-up|2|||
161318109|NCT00904917|582550494|FG003|Overall Study|Lost to Follow-up|2|||
161318110|NCT00497146|582550495|FG000|Treatment Period|Adverse Event|6|||
161318111|NCT00497146|582550496|FG001|Treatment Period|Adverse Event|2|||
161318112|NCT00497146|582550495|FG000|Treatment Period|Withdrawal by Subject|5|||
161318113|NCT00497146|582550496|FG001|Treatment Period|Withdrawal by Subject|9|||
161318114|NCT00497146|582550495|FG000|Treatment Period|Lost to Follow-up|1|||
161318115|NCT00497146|582550496|FG001|Treatment Period|Lost to Follow-up|3|||
161318116|NCT00497146|582550495|FG000|Treatment Period|Required dialysis|4|||
161318117|NCT00497146|582550496|FG001|Treatment Period|Required dialysis|1|||
161318118|NCT00497146|582550495|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
161318119|NCT00497146|582550496|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
161318120|NCT00497146|582550495|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
161318121|NCT00497146|582550496|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
161318122|NCT00497146|582550495|FG000|Treatment Period|Other Reason|2|||
161318123|NCT00497146|582550496|FG001|Treatment Period|Other Reason|3|||
161318124|NCT00497146|582550495|FG000|Long-term Follow-up Period|Adverse Event|2|||
161318125|NCT00497146|582550496|FG001|Long-term Follow-up Period|Adverse Event|2|||
161318126|NCT00497146|582550495|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
161318127|NCT00497146|582550496|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
161318128|NCT00497146|582550495|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
161318129|NCT00497146|582550496|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
161318130|NCT00497146|582550495|FG000|Long-term Follow-up Period|Other|0|||
161318131|NCT00497146|582550496|FG001|Long-term Follow-up Period|Other|1|||
161318132|NCT02107313|582550499|FG000|Overall Study|One participant did not do the FED cohor|0|||
161318133|NCT02107313|582550500|FG001|Overall Study|One participant did not do the FED cohor|1|||
161318134|NCT01031004|582550503|FG000|Overall Study|Protocol Violation|0|||
161318135|NCT01031004|582550504|FG001|Overall Study|Protocol Violation|1|||
161318136|NCT01031004|582550503|FG000|Overall Study|Lost to Follow-up|1|||
161318137|NCT01031004|582550504|FG001|Overall Study|Lost to Follow-up|0|||
161318138|NCT04575584|582550505|FG000|Overall Study|Death|6|||
161318139|NCT04575584|582550506|FG001|Overall Study|Death|4|||
161318140|NCT04575584|582550507|FG002|Overall Study|Death|6|||
161318141|NCT04575584|582550508|FG003|Overall Study|Death|2|||
161318142|NCT04575584|582550509|FG004|Overall Study|Death|0|||
161318143|NCT04575584|582550510|FG005|Overall Study|Death|0|||
161318144|NCT04575584|582550505|FG000|Overall Study|Lost to Follow-up|1|||
161318145|NCT04575584|582550506|FG001|Overall Study|Lost to Follow-up|1|||
161318146|NCT04575584|582550507|FG002|Overall Study|Lost to Follow-up|1|||
161318147|NCT04575584|582550508|FG003|Overall Study|Lost to Follow-up|1|||
161318148|NCT04575584|582550509|FG004|Overall Study|Lost to Follow-up|0|||
161318149|NCT04575584|582550510|FG005|Overall Study|Lost to Follow-up|0|||
161318150|NCT04575584|582550505|FG000|Overall Study|Physician Decision|0|||
161318151|NCT04575584|582550506|FG001|Overall Study|Physician Decision|1|||
161318152|NCT04575584|582550507|FG002|Overall Study|Physician Decision|1|||
161318153|NCT04575584|582550508|FG003|Overall Study|Physician Decision|1|||
161318154|NCT04575584|582550509|FG004|Overall Study|Physician Decision|0|||
161318155|NCT04575584|582550510|FG005|Overall Study|Physician Decision|0|||
161318156|NCT04575584|582550505|FG000|Overall Study|Withdrawal by Subject|7|||
161318157|NCT04575584|582550506|FG001|Overall Study|Withdrawal by Subject|9|||
161318158|NCT04575584|582550507|FG002|Overall Study|Withdrawal by Subject|5|||
161318159|NCT04575584|582550508|FG003|Overall Study|Withdrawal by Subject|3|||
161318160|NCT04575584|582550509|FG004|Overall Study|Withdrawal by Subject|0|||
161318161|NCT04575584|582550510|FG005|Overall Study|Withdrawal by Subject|0|||
161318162|NCT04575584|582550505|FG000|Overall Study|Not recorded|0|||
161318163|NCT04575584|582550506|FG001|Overall Study|Not recorded|0|||
161318164|NCT04575584|582550507|FG002|Overall Study|Not recorded|0|||
161318165|NCT04575584|582550508|FG003|Overall Study|Not recorded|1|||
161318166|NCT04575584|582550509|FG004|Overall Study|Not recorded|0|||
161318167|NCT04575584|582550510|FG005|Overall Study|Not recorded|0|||
161318168|NCT02634801|582550511|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
161318169|NCT02634801|582550512|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
161318170|NCT02634801|582550513|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
161318171|NCT02634801|582550511|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
161318172|NCT02634801|582550512|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
161318173|NCT02634801|582550513|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
161318174|NCT02634801|582550511|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
161318175|NCT02634801|582550512|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
161318176|NCT02634801|582550513|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
161318177|NCT02634801|582550511|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
161318178|NCT02634801|582550512|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
161318179|NCT02634801|582550513|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
161318180|NCT02634801|582550511|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
161318181|NCT02634801|582550512|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
161318182|NCT02634801|582550513|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
161318183|NCT02634801|582550511|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
161318184|NCT02634801|582550512|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
161318185|NCT02634801|582550513|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
161318186|NCT02634801|582550511|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
161318187|NCT02634801|582550512|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
161318188|NCT02634801|582550513|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
161318189|NCT02634801|582550511|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161318190|NCT02634801|582550512|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161318191|NCT02634801|582550513|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
161318192|NCT02634801|582550511|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
161318193|NCT02634801|582550512|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
161318194|NCT02634801|582550513|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
161318195|NCT02634801|582550511|FG000|Follow-up Period|Lost to Follow-up|3|||
161318196|NCT02634801|582550512|FG001|Follow-up Period|Lost to Follow-up|1|||
161318197|NCT02634801|582550513|FG002|Follow-up Period|Lost to Follow-up|2|||
161318198|NCT02634801|582550511|FG000|Follow-up Period|Physician Decision|0|||
161318199|NCT02634801|582550512|FG001|Follow-up Period|Physician Decision|0|||
161318200|NCT02634801|582550513|FG002|Follow-up Period|Physician Decision|1|||
161318201|NCT02634801|582550511|FG000|Follow-up Period|Withdrawal by Subject|1|||
161318202|NCT02634801|582550512|FG001|Follow-up Period|Withdrawal by Subject|2|||
161318203|NCT02634801|582550513|FG002|Follow-up Period|Withdrawal by Subject|5|||
161318204|NCT02634801|582550511|FG000|Follow-up Period|Adverse Event|1|||
161318205|NCT02634801|582550512|FG001|Follow-up Period|Adverse Event|5|||
161318206|NCT02634801|582550513|FG002|Follow-up Period|Adverse Event|0|||
161318207|NCT00199849|582550521|FG000|Overall Study|Unrelated illness or complication|0|||
161318208|NCT00199849|582550522|FG001|Overall Study|Unrelated illness or complication|1|||
161318209|NCT00199849|582550523|FG002|Overall Study|Unrelated illness or complication|0|||
161318210|NCT00199849|582550521|FG000|Overall Study|Progressive disease requiring intervention|0|||
161318211|NCT00199849|582550522|FG001|Overall Study|Progressive disease requiring intervention|0|||
161318212|NCT00199849|582550523|FG002|Overall Study|Progressive disease requiring intervention|1|||
161318213|NCT00199849|582550521|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
161318214|NCT00199849|582550522|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
161318215|NCT00199849|582550523|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
161318216|NCT02164318|582550524|FG000|Overall Study|Withdrawal by Subject|0|||
161318217|NCT02164318|582550525|FG001|Overall Study|Withdrawal by Subject|1|||
161318218|NCT02164318|582550526|FG002|Overall Study|Withdrawal by Subject|0|||
161318219|NCT02164318|582550527|FG003|Overall Study|Withdrawal by Subject|1|||
161318220|NCT00662311|582550528|FG000|Overall Study|Respiratory Infection|1|||
161318221|NCT00662311|582550529|FG001|Overall Study|Respiratory Infection|0|||
161318222|NCT00662311|582550530|FG002|Overall Study|Respiratory Infection|0|||
161318223|NCT02335346|582550531|FG000|Overall Study|Adverse Event|11|||
161318224|NCT02335346|582550531|FG000|Overall Study|Withdrawal by Subject|1|||
161318225|NCT01548768|582550532|FG000|Overall Study|Withdrawal by Subject|0|||
161318226|NCT01548768|582550533|FG001|Overall Study|Withdrawal by Subject|2|||
161318227|NCT01548768|582550534|FG002|Overall Study|Withdrawal by Subject|1|||
161318228|NCT01548768|582550535|FG003|Overall Study|Withdrawal by Subject|0|||
161318229|NCT01548768|582550532|FG000|Overall Study|Physician Decision|1|||
161318230|NCT01548768|582550533|FG001|Overall Study|Physician Decision|0|||
161318231|NCT01548768|582550534|FG002|Overall Study|Physician Decision|0|||
161318232|NCT01548768|582550535|FG003|Overall Study|Physician Decision|0|||
161318233|NCT01548768|582550532|FG000|Overall Study|Adverse Event|0|||
161318234|NCT01548768|582550533|FG001|Overall Study|Adverse Event|0|||
161318235|NCT01548768|582550534|FG002|Overall Study|Adverse Event|0|||
161318236|NCT01548768|582550535|FG003|Overall Study|Adverse Event|1|||
161318237|NCT01548768|582550532|FG000|Overall Study|Non-Compliance|0|||
161318238|NCT01548768|582550533|FG001|Overall Study|Non-Compliance|0|||
161318239|NCT01548768|582550534|FG002|Overall Study|Non-Compliance|0|||
161318240|NCT01548768|582550535|FG003|Overall Study|Non-Compliance|3|||
161318241|NCT02178358|582550538|FG000|Overall Study|Withdrawal by Subject|0|||
161318242|NCT02178358|582550539|FG001|Overall Study|Withdrawal by Subject|2|||
161318243|NCT02178358|582550540|FG002|Overall Study|Withdrawal by Subject|2|||
161318244|NCT02178358|582550538|FG000|Overall Study|Lost to Follow-up|1|||
161318245|NCT02178358|582550539|FG001|Overall Study|Lost to Follow-up|0|||
161318246|NCT02178358|582550540|FG002|Overall Study|Lost to Follow-up|0|||
161318247|NCT00645671|582550542|FG000|Overall Study|Protocol Violation|1|||
161318248|NCT00645671|582550543|FG001|Overall Study|Protocol Violation|0|||
161318249|NCT00645671|582550542|FG000|Overall Study|Withdrawal by Subject|0|||
161318250|NCT00645671|582550543|FG001|Overall Study|Withdrawal by Subject|4|||
161318251|NCT00645671|582550542|FG000|Overall Study|Adverse Event|0|||
161318252|NCT00645671|582550543|FG001|Overall Study|Adverse Event|1|||
161318253|NCT00645671|582550542|FG000|Overall Study|Physician Decision|0|||
161318254|NCT00645671|582550543|FG001|Overall Study|Physician Decision|1|||
161318255|NCT00493311|582550544|FG000|Overall Study|Need for rescue medication|2|||
161318256|NCT00493311|582550545|FG001|Overall Study|Need for rescue medication|2|||
161318257|NCT03077607|582550548|FG000|Period 1 (15 Days)|Adverse Event|1|||
161318258|NCT03077607|582550549|FG001|Period 1 (15 Days)|Adverse Event|0|||
161318259|NCT03077607|582550548|FG000|Period 1 (15 Days)|Death|1|||
161318260|NCT03077607|582550549|FG001|Period 1 (15 Days)|Death|0|||
161318261|NCT03077607|582550548|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
161318262|NCT03077607|582550549|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
161318263|NCT03077607|582550548|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
161318264|NCT03077607|582550549|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
161318265|NCT01005901|582550550|FG000|Overall Study|Withdrawal by Subject|38|||
161318266|NCT01005901|582550551|FG001|Overall Study|Withdrawal by Subject|14|||
161318267|NCT01005901|582550550|FG000|Overall Study|Adverse Event|30|||
161318268|NCT01005901|582550551|FG001|Overall Study|Adverse Event|16|||
161318269|NCT01005901|582550550|FG000|Overall Study|Administrative problems|21|||
161318270|NCT01005901|582550551|FG001|Overall Study|Administrative problems|13|||
161318271|NCT01005901|582550550|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
161318272|NCT01005901|582550551|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
161318273|NCT01005901|582550550|FG000|Overall Study|Protocol Violation|4|||
161318274|NCT01005901|582550551|FG001|Overall Study|Protocol Violation|3|||
161318275|NCT01005901|582550550|FG000|Overall Study|Death|2|||
161318276|NCT01005901|582550551|FG001|Overall Study|Death|3|||
161318277|NCT01005901|582550550|FG000|Overall Study|Lost to Follow-up|1|||
161318278|NCT01005901|582550551|FG001|Overall Study|Lost to Follow-up|2|||
161318279|NCT01005901|582550550|FG000|Overall Study|Patient's inability to use the device|1|||
161318280|NCT01005901|582550551|FG001|Overall Study|Patient's inability to use the device|1|||
161318281|NCT01005901|582550550|FG000|Overall Study|No longer requires study drug|0|||
161318282|NCT01005901|582550551|FG001|Overall Study|No longer requires study drug|1|||
161318283|NCT05600036|582550556|FG000|Overall Study|Adverse Event|0|||
161318284|NCT05600036|582550557|FG001|Overall Study|Adverse Event|2|||
161318285|NCT05600036|582550558|FG002|Overall Study|Adverse Event|1|||
161318286|NCT05600036|582550559|FG003|Overall Study|Adverse Event|0|||
161318287|NCT05600036|582550560|FG004|Overall Study|Adverse Event|1|||
161318288|NCT05600036|582550561|FG005|Overall Study|Adverse Event|0|||
161318289|NCT05600036|582550556|FG000|Overall Study|Lost to Follow-up|0|||
161318290|NCT05600036|582550557|FG001|Overall Study|Lost to Follow-up|2|||
161318291|NCT05600036|582550558|FG002|Overall Study|Lost to Follow-up|1|||
161318292|NCT05600036|582550559|FG003|Overall Study|Lost to Follow-up|1|||
161318293|NCT05600036|582550560|FG004|Overall Study|Lost to Follow-up|0|||
161318294|NCT05600036|582550561|FG005|Overall Study|Lost to Follow-up|0|||
161318295|NCT05600036|582550556|FG000|Overall Study|Protocol Violation|0|||
161318296|NCT05600036|582550557|FG001|Overall Study|Protocol Violation|0|||
161318297|NCT05600036|582550558|FG002|Overall Study|Protocol Violation|2|||
161318298|NCT05600036|582550559|FG003|Overall Study|Protocol Violation|0|||
161318299|NCT05600036|582550560|FG004|Overall Study|Protocol Violation|0|||
161318300|NCT05600036|582550561|FG005|Overall Study|Protocol Violation|0|||
161318301|NCT05600036|582550556|FG000|Overall Study|Withdrawal by Subject|0|||
161318302|NCT05600036|582550557|FG001|Overall Study|Withdrawal by Subject|1|||
161318303|NCT05600036|582550558|FG002|Overall Study|Withdrawal by Subject|2|||
161318304|NCT05600036|582550559|FG003|Overall Study|Withdrawal by Subject|0|||
161318305|NCT05600036|582550560|FG004|Overall Study|Withdrawal by Subject|3|||
161318306|NCT05600036|582550561|FG005|Overall Study|Withdrawal by Subject|5|||
161318307|NCT05600036|582550556|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161318308|NCT05600036|582550557|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161318309|NCT05600036|582550558|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161318310|NCT05600036|582550559|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
161318311|NCT05600036|582550560|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161318312|NCT05600036|582550561|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
161318313|NCT05600036|582550556|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161318314|NCT05600036|582550557|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
161318315|NCT05600036|582550558|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161318316|NCT05600036|582550559|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161318317|NCT05600036|582550560|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161318318|NCT05600036|582550561|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
161318319|NCT05600036|582550556|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161318320|NCT05600036|582550557|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161318321|NCT05600036|582550558|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161318322|NCT05600036|582550559|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
161318323|NCT05600036|582550560|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161318324|NCT05600036|582550561|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
161318325|NCT00715520|582550562|FG000|Overall Study|Screen failure|8|||
161318326|NCT00715520|582550563|FG001|Overall Study|Screen failure|1|||
161318327|NCT00715520|582550564|FG002|Overall Study|Screen failure|1|||
161318328|NCT00715520|582550562|FG000|Overall Study|Withdrawal by Subject|2|||
161318329|NCT00715520|582550563|FG001|Overall Study|Withdrawal by Subject|0|||
161318330|NCT00715520|582550564|FG002|Overall Study|Withdrawal by Subject|1|||
161318331|NCT01006590|582550565|FG000|Overall Study|Adverse Event|2|||
161318332|NCT01006590|582550566|FG001|Overall Study|Adverse Event|3|||
161318333|NCT01006590|582550565|FG000|Overall Study|Death|1|||
161318334|NCT01006590|582550566|FG001|Overall Study|Death|1|||
161318335|NCT01006590|582550565|FG000|Overall Study|Lost to Follow-up|1|||
161318336|NCT01006590|582550566|FG001|Overall Study|Lost to Follow-up|1|||
161318337|NCT01006590|582550565|FG000|Overall Study|Protocol Violation|1|||
161318338|NCT01006590|582550566|FG001|Overall Study|Protocol Violation|0|||
161318339|NCT01006590|582550565|FG000|Overall Study|Withdrawal by Subject|4|||
161318340|NCT01006590|582550566|FG001|Overall Study|Withdrawal by Subject|2|||
161318341|NCT01006590|582550565|FG000|Overall Study|Study specific discontinuation criteria|16|||
161318342|NCT01006590|582550566|FG001|Overall Study|Study specific discontinuation criteria|23|||
161318343|NCT01006590|582550565|FG000|Overall Study|Other|3|||
161318344|NCT01006590|582550566|FG001|Overall Study|Other|2|||
161318345|NCT03332095|582550567|FG000|Overall Study|Lost to Follow-up|1|||
161318346|NCT03332095|582550568|FG001|Overall Study|Lost to Follow-up|0|||
161318347|NCT03332095|582550567|FG000|Overall Study|Pregnancy|0|||
161318348|NCT03332095|582550568|FG001|Overall Study|Pregnancy|1|||
161318349|NCT04942210|582550572|FG000|Overall Study|Adverse Event|0|||
161318350|NCT04942210|582550573|FG001|Overall Study|Adverse Event|1|||
161318351|NCT04942210|582550572|FG000|Overall Study|Protocol Deviation|4|||
161318352|NCT04942210|582550573|FG001|Overall Study|Protocol Deviation|1|||
161318353|NCT04942210|582550572|FG000|Overall Study|Withdrawal by Subject|5|||
161318354|NCT04942210|582550573|FG001|Overall Study|Withdrawal by Subject|2|||
161318355|NCT04942210|582550572|FG000|Overall Study|Lost to Follow-up|16|||
161318356|NCT04942210|582550573|FG001|Overall Study|Lost to Follow-up|7|||
161318357|NCT04942210|582550572|FG000|Overall Study|Ongoing at the time of DBL date|60|||
161318358|NCT04942210|582550573|FG001|Overall Study|Ongoing at the time of DBL date|25|||
161318359|NCT04942210|582550572|FG000|Overall Study|Randomized but did not receive vaccination|3|||
161318360|NCT04942210|582550573|FG001|Overall Study|Randomized but did not receive vaccination|0|||
161318361|NCT04348500|582550574|FG000|Overall Study|Death|2|||
161318362|NCT04348500|582550575|FG001|Overall Study|Death|2|||
161318363|NCT04348500|582550574|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
161318364|NCT04348500|582550575|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
161318365|NCT02776670|582550576|FG000|Overall Study|Adverse Event|0|||
161318366|NCT02776670|582550577|FG001|Overall Study|Adverse Event|2|||
161318367|NCT02776670|582550576|FG000|Overall Study|Protocol Violation|0|||
161318368|NCT02776670|582550577|FG001|Overall Study|Protocol Violation|2|||
161318369|NCT02776670|582550576|FG000|Overall Study|Withdrawal by Subject|0|||
161318370|NCT02776670|582550577|FG001|Overall Study|Withdrawal by Subject|1|||
161318371|NCT02776670|582550576|FG000|Overall Study|Other - Reason not given|0|||
161318372|NCT02776670|582550577|FG001|Overall Study|Other - Reason not given|1|||
161318373|NCT00957424|582550586|FG000|Overall Study|Lost to Follow-up|19|||
161318374|NCT00957424|582550586|FG000|Overall Study|Protocol Violation|3|||
161318375|NCT00957424|582550586|FG000|Overall Study|Withdrawal by Subject|1|||
161318376|NCT01038752|582550587|FG000|Overall Study|Tumor Progression|2|||
161318377|NCT01038752|582550588|FG001|Overall Study|Tumor Progression|2|||
161318378|NCT01038752|582550587|FG000|Overall Study|Lost to Follow-up|3|||
161318379|NCT01038752|582550588|FG001|Overall Study|Lost to Follow-up|3|||
161318380|NCT03760458|582550598|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
161318381|NCT03760458|582550599|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
161318382|NCT03760458|582550600|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161318383|NCT03760458|582550601|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161318384|NCT03760458|582550602|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
161318385|NCT00750919|582550603|FG000|Overall Study|Adverse Event|9|||
161318386|NCT00750919|582550603|FG000|Overall Study|Withdrawal by Subject|1|||
161318387|NCT00750919|582550603|FG000|Overall Study|Lack of Efficacy|8|||
161318388|NCT00750919|582550603|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
161318389|NCT00750919|582550603|FG000|Overall Study|Other|36|||
161318390|NCT03913104|582550608|FG000|Overall Study|Lost to Follow-up|20|||
161318391|NCT03913104|582550608|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
161318392|NCT03913104|582550608|FG000|Overall Study|Withdrawal by Subject|2|||
161318393|NCT00048997|582550609|FG000|Overall Study|Protocol Violation|7|||
161318394|NCT00048997|582550610|FG001|Overall Study|Protocol Violation|2|||
161318395|NCT00048997|582550609|FG000|Overall Study|Withdrawal by Subject|6|||
161318396|NCT00048997|582550610|FG001|Overall Study|Withdrawal by Subject|1|||
161318397|NCT03304184|582550617|FG000|Overall Study|Withdrawal by Subject|1|||
161318398|NCT03304184|582550618|FG001|Overall Study|Withdrawal by Subject|2|||
161318399|NCT03420222|582550621|FG000|Overall Study|Withdrawal by Subject|5|||
161318400|NCT03420222|582550622|FG001|Overall Study|Withdrawal by Subject|0|||
161318401|NCT03420222|582550621|FG000|Overall Study|Physician Decision|0|||
161318402|NCT03420222|582550622|FG001|Overall Study|Physician Decision|1|||
161318403|NCT02112877|582550623|FG000|Overall Study|Withdrawal by Subject|1|||
161318404|NCT02112877|582550624|FG001|Overall Study|Withdrawal by Subject|7|||
161318405|NCT02112877|582550623|FG000|Overall Study|Visit Missed|1|||
161318406|NCT02112877|582550624|FG001|Overall Study|Visit Missed|6|||
161318407|NCT00187278|582550626|FG000|Overall Study|Protocol Violation|10|||
161318408|NCT00187278|582550627|FG001|Overall Study|Protocol Violation|13|||
161318409|NCT01578499|582550628|FG000|Overall Study|Reason not Specified|0|||
161318410|NCT01578499|582550629|FG001|Overall Study|Reason not Specified|1|||
161318411|NCT01578499|582550628|FG000|Overall Study|Lost to Follow-up|2|||
161318412|NCT01578499|582550629|FG001|Overall Study|Lost to Follow-up|1|||
161318413|NCT01578499|582550628|FG000|Overall Study|Withdrawal by Subject|10|||
161318414|NCT01578499|582550629|FG001|Overall Study|Withdrawal by Subject|16|||
161318415|NCT01578499|582550628|FG000|Overall Study|Death|20|||
161318416|NCT01578499|582550629|FG001|Overall Study|Death|25|||
161318417|NCT01578499|582550628|FG000|Overall Study|Died and End of Study Page not Completed|2|||
161318418|NCT01578499|582550629|FG001|Overall Study|Died and End of Study Page not Completed|0|||
161318419|NCT00862459|582550631|FG000|Overall Study|Lost to Follow-up|1|||
161318420|NCT00862459|582550632|FG001|Overall Study|Lost to Follow-up|2|||
161318421|NCT00862459|582550633|FG002|Overall Study|Lost to Follow-up|2|||
161318422|NCT00862459|582550631|FG000|Overall Study|Protocol Violation|1|||
161318423|NCT00862459|582550632|FG001|Overall Study|Protocol Violation|0|||
161318424|NCT00862459|582550633|FG002|Overall Study|Protocol Violation|0|||
161318425|NCT00862459|582550631|FG000|Overall Study|Withdrawal by Subject|1|||
161318426|NCT00862459|582550632|FG001|Overall Study|Withdrawal by Subject|1|||
161318427|NCT00862459|582550633|FG002|Overall Study|Withdrawal by Subject|3|||
161318428|NCT00862459|582550631|FG000|Overall Study|Adverse Event|0|||
161318429|NCT00862459|582550632|FG001|Overall Study|Adverse Event|1|||
161318430|NCT00862459|582550633|FG002|Overall Study|Adverse Event|0|||
161318431|NCT00862459|582550631|FG000|Overall Study|Personal reasons|1|||
161318432|NCT00862459|582550632|FG001|Overall Study|Personal reasons|0|||
161318433|NCT00862459|582550633|FG002|Overall Study|Personal reasons|0|||
161318434|NCT00862459|582550631|FG000|Overall Study|Operation|1|||
161318435|NCT00862459|582550632|FG001|Overall Study|Operation|1|||
161318436|NCT00862459|582550633|FG002|Overall Study|Operation|0|||
161318437|NCT00862459|582550631|FG000|Overall Study|Intravenous (IV) site problems|1|||
161318438|NCT00862459|582550632|FG001|Overall Study|Intravenous (IV) site problems|0|||
161318439|NCT00862459|582550633|FG002|Overall Study|Intravenous (IV) site problems|1|||
161318440|NCT00862459|582550631|FG000|Overall Study|Unable to hold still for imaging|0|||
161318441|NCT00862459|582550632|FG001|Overall Study|Unable to hold still for imaging|1|||
161318442|NCT00862459|582550633|FG002|Overall Study|Unable to hold still for imaging|0|||
161318443|NCT00862459|582550631|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
161318444|NCT00862459|582550632|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
161318445|NCT00862459|582550633|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
161318446|NCT00862459|582550631|FG000|Overall Study|Administrative problems|0|||
161318447|NCT00862459|582550632|FG001|Overall Study|Administrative problems|1|||
161318448|NCT00862459|582550633|FG002|Overall Study|Administrative problems|0|||
161318449|NCT00655681|582550634|FG000|Overall Study|Lost to Follow-up|1|||
161318450|NCT00655681|582550635|FG001|Overall Study|Lost to Follow-up|1|||
161318451|NCT03168919|582550636|FG000|Overall Study|Withdrawal by Subject|2|||
161318452|NCT01085136|582550637|FG000|Part A|Other Adverse event|223|||
161318453|NCT01085136|582550638|FG001|Part A|Other Adverse event|0|||
161318454|NCT01085136|582550639|FG002|Part A|Other Adverse event|0|||
161318455|NCT01085136|582550637|FG000|Part A|Protocol Violation|3|||
161318456|NCT01085136|582550638|FG001|Part A|Protocol Violation|0|||
161318457|NCT01085136|582550639|FG002|Part A|Protocol Violation|0|||
161318458|NCT01085136|582550637|FG000|Part A|Lost to Follow-up|3|||
161318459|NCT01085136|582550638|FG001|Part A|Lost to Follow-up|0|||
161318460|NCT01085136|582550639|FG002|Part A|Lost to Follow-up|0|||
161318461|NCT01085136|582550637|FG000|Part A|Refusal to continue trial medication|64|||
161318462|NCT01085136|582550638|FG001|Part A|Refusal to continue trial medication|0|||
161318463|NCT01085136|582550639|FG002|Part A|Refusal to continue trial medication|0|||
161318464|NCT01085136|582550637|FG000|Part A|Other reason not defined above|30|||
161318465|NCT01085136|582550638|FG001|Part A|Other reason not defined above|0|||
161318466|NCT01085136|582550639|FG002|Part A|Other reason not defined above|0|||
161318467|NCT01085136|582550637|FG000|Part B|Other AE|0|||
161318468|NCT01085136|582550638|FG001|Part B|Other AE|29|||
161318469|NCT01085136|582550639|FG002|Part B|Other AE|8|||
161318470|NCT01085136|582550637|FG000|Part B|Refusal to continue trial medication|0|||
161318471|NCT01085136|582550638|FG001|Part B|Refusal to continue trial medication|12|||
161318472|NCT01085136|582550639|FG002|Part B|Refusal to continue trial medication|7|||
161318473|NCT01085136|582550637|FG000|Part B|Not treated|0|||
161318474|NCT01085136|582550638|FG001|Part B|Not treated|4|||
161318475|NCT01085136|582550639|FG002|Part B|Not treated|8|||
161318476|NCT01085136|582550637|FG000|Part B|Other reason not defined above|0|||
161318477|NCT01085136|582550638|FG001|Part B|Other reason not defined above|6|||
161318478|NCT01085136|582550639|FG002|Part B|Other reason not defined above|3|||
161318479|NCT04226495|582550640|FG000|Overall Study|Withdrawal by Subject|3|||
161318480|NCT04226495|582550641|FG001|Overall Study|Withdrawal by Subject|3|||
161318481|NCT04226495|582550640|FG000|Overall Study|PI discretion|3|||
161318482|NCT04226495|582550641|FG001|Overall Study|PI discretion|4|||
161318483|NCT04459598|582550642|FG000|Overall Study|Adverse Event|1|||
161318484|NCT04459598|582550643|FG001|Overall Study|Adverse Event|1|||
161318485|NCT02440854|582550649|FG000|Overall Study|Relocation of patient|1|||
161318486|NCT02440854|582550649|FG000|Overall Study|Death|6|||
161318487|NCT02440854|582550649|FG000|Overall Study|Lost to Follow-up|10|||
161318488|NCT02440854|582550649|FG000|Overall Study|Afatinib discontinuation|46|||
161318489|NCT02440854|582550649|FG000|Overall Study|stopped study at earlier timepoint|14|||
161318490|NCT02440854|582550649|FG000|Overall Study|Study medication not received|1|||
161318491|NCT02440854|582550649|FG000|Overall Study|Violation of inclusion criteria|2|||
161318492|NCT02669082|582550650|FG000|Overall Study|Adverse Event|1|||
161318493|NCT00582426|582551882|FG000|Overall Study|Lost to Follow-up|0|||
161318494|NCT00582426|582551883|FG001|Overall Study|Lost to Follow-up|2|||
161318495|NCT00582426|582551882|FG000|Overall Study|Adverse Event|4|||
161318496|NCT00582426|582551883|FG001|Overall Study|Adverse Event|2|||
161318497|NCT00582426|582551882|FG000|Overall Study|Protocol Violation|6|||
161318498|NCT00582426|582551883|FG001|Overall Study|Protocol Violation|2|||
161318499|NCT00582426|582551882|FG000|Overall Study|Death|4|||
161318500|NCT00582426|582551883|FG001|Overall Study|Death|3|||
161318501|NCT00582426|582551882|FG000|Overall Study|Withdrawal by Subject|3|||
161318502|NCT00582426|582551883|FG001|Overall Study|Withdrawal by Subject|2|||
161318503|NCT00582426|582551882|FG000|Overall Study|Disease Progression|2|||
161318504|NCT00582426|582551883|FG001|Overall Study|Disease Progression|2|||
161318505|NCT00582426|582551882|FG000|Overall Study|Use of illicit drugs|1|||
161318506|NCT00582426|582551883|FG001|Overall Study|Use of illicit drugs|0|||
161318507|NCT04727528|582551886|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
161318508|NCT04727528|582551887|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
161318509|NCT04727528|582551886|FG000|Open-label Period|Randomized who did not receive treatment|1|||
161318510|NCT04727528|582551887|FG001|Open-label Period|Randomized who did not receive treatment|0|||
161318511|NCT04727528|582551886|FG000|Double-blind Treatment Phase|Adverse Event|0|||
161318512|NCT04727528|582551887|FG001|Double-blind Treatment Phase|Adverse Event|1|||
161318513|NCT04727528|582551886|FG000|Double-blind Treatment Phase|Death|0|||
161318514|NCT04727528|582551887|FG001|Double-blind Treatment Phase|Death|1|||
161318515|NCT04727528|582551886|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
161318516|NCT04727528|582551887|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
161318517|NCT04727528|582551886|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
161318518|NCT04727528|582551887|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
161318519|NCT04727528|582551886|FG000|Double-blind Treatment Phase|Physician Decision|0|||
161318520|NCT04727528|582551887|FG001|Double-blind Treatment Phase|Physician Decision|1|||
161318521|NCT04727528|582551886|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
161318522|NCT04727528|582551887|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
161318523|NCT01964989|582551891|FG000|Overall Study|Protocol Violation|3|||
161318524|NCT01964989|582551892|FG001|Overall Study|Protocol Violation|4|||
161318525|NCT01964989|582551891|FG000|Overall Study|Administrative Reason|103|||
161318526|NCT01964989|582551892|FG001|Overall Study|Administrative Reason|95|||
161318527|NCT01964989|582551891|FG000|Overall Study|Adverse Event|0|||
161318528|NCT01964989|582551892|FG001|Overall Study|Adverse Event|1|||
161318529|NCT01964989|582551891|FG000|Overall Study|Death|1|||
161318530|NCT01964989|582551892|FG001|Overall Study|Death|3|||
161318531|NCT01964989|582551891|FG000|Overall Study|Withdrawal by Subject|156|||
161318532|NCT01964989|582551892|FG001|Overall Study|Withdrawal by Subject|160|||
161318533|NCT01964989|582551891|FG000|Overall Study|Lost to Follow-up|254|||
161318534|NCT01964989|582551892|FG001|Overall Study|Lost to Follow-up|232|||
161318535|NCT01964989|582551891|FG000|Overall Study|Other|267|||
161318536|NCT01964989|582551892|FG001|Overall Study|Other|252|||
161318537|NCT02769312|582551893|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
161318538|NCT02769312|582551894|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
161318539|NCT02769312|582551893|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
161318540|NCT02769312|582551894|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
161318541|NCT02769312|582551893|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
161318542|NCT02769312|582551894|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
161318543|NCT02769312|582551893|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
161318544|NCT02769312|582551894|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
161318545|NCT02769312|582551893|FG000|Follow-up|Lost to Follow-up|1|||
161318546|NCT02769312|582551894|FG001|Follow-up|Lost to Follow-up|1|||
161318547|NCT01148459|582551897|FG000|Overall Study|Serious Adverse Event|5|||
161318548|NCT01148459|582551898|FG001|Overall Study|Serious Adverse Event|4|||
161318549|NCT01148459|582551897|FG000|Overall Study|Withdrawal by Subject|1|||
161318550|NCT01148459|582551898|FG001|Overall Study|Withdrawal by Subject|0|||
161318551|NCT01148459|582551897|FG000|Overall Study|Migrated/moved from study area|3|||
161318552|NCT01148459|582551898|FG001|Overall Study|Migrated/moved from study area|6|||
161318553|NCT01148459|582551897|FG000|Overall Study|Lost to Follow-up|2|||
161318554|NCT01148459|582551898|FG001|Overall Study|Lost to Follow-up|0|||
161318555|NCT01148459|582551897|FG000|Overall Study|Refusal|1|||
161318556|NCT01148459|582551898|FG001|Overall Study|Refusal|0|||
161318557|NCT01148459|582551897|FG000|Overall Study|Failure to comply with study procedures|0|||
161318558|NCT01148459|582551898|FG001|Overall Study|Failure to comply with study procedures|1|||
161318559|NCT02496039|582551899|FG000|Overall Study|Adverse Event|3|||
161318560|NCT02496039|582551899|FG000|Overall Study|Protocol Violation|1|||
161318561|NCT00948922|582551900|FG000|Overall Study|Did not start study treatment|2|||
161318562|NCT00948922|582551901|FG001|Overall Study|Did not start study treatment|5|||
161318563|NCT00948922|582551902|FG002|Overall Study|Did not start study treatment|0|||
161318564|NCT00948922|582551900|FG000|Overall Study|Withdrawal by Subject|0|||
161318565|NCT00948922|582551901|FG001|Overall Study|Withdrawal by Subject|2|||
161318566|NCT00948922|582551902|FG002|Overall Study|Withdrawal by Subject|1|||
161318567|NCT00948922|582551900|FG000|Overall Study|Death|3|||
161318568|NCT00948922|582551901|FG001|Overall Study|Death|0|||
161318569|NCT00948922|582551902|FG002|Overall Study|Death|0|||
161318570|NCT00948922|582551900|FG000|Overall Study|Disease progression|0|||
161318571|NCT00948922|582551901|FG001|Overall Study|Disease progression|1|||
161318572|NCT00948922|582551902|FG002|Overall Study|Disease progression|0|||
161318573|NCT00948922|582551900|FG000|Overall Study|Insurance issues|1|||
161318574|NCT00948922|582551901|FG001|Overall Study|Insurance issues|0|||
161318575|NCT00948922|582551902|FG002|Overall Study|Insurance issues|0|||
161318576|NCT00948922|582551900|FG000|Overall Study|Transplant eligibility issues|2|||
161318577|NCT00948922|582551901|FG001|Overall Study|Transplant eligibility issues|3|||
161318578|NCT00948922|582551902|FG002|Overall Study|Transplant eligibility issues|0|||
161318579|NCT00948922|582551900|FG000|Overall Study|Not evaluable at time of analysis|0|||
161318580|NCT00948922|582551901|FG001|Overall Study|Not evaluable at time of analysis|3|||
161318581|NCT00948922|582551902|FG002|Overall Study|Not evaluable at time of analysis|0|||
161318582|NCT04854057|582551903|FG000|Overall Study|Adverse Event|0|||
161318583|NCT04854057|582551904|FG001|Overall Study|Adverse Event|1|||
161318584|NCT02131233|582551905|FG000|Overall Study|Not Treated|2|||
161318585|NCT02131233|582551906|FG001|Overall Study|Not Treated|3|||
161318586|NCT02131233|582551905|FG000|Overall Study|Adverse Event|7|||
161318587|NCT02131233|582551906|FG001|Overall Study|Adverse Event|6|||
161318588|NCT02131233|582551905|FG000|Overall Study|Death|0|||
161318589|NCT02131233|582551906|FG001|Overall Study|Death|1|||
161318590|NCT02131233|582551905|FG000|Overall Study|Lack of Efficacy|6|||
161318591|NCT02131233|582551906|FG001|Overall Study|Lack of Efficacy|3|||
161318592|NCT02131233|582551905|FG000|Overall Study|Lost to Follow-up|14|||
161318593|NCT02131233|582551906|FG001|Overall Study|Lost to Follow-up|13|||
161318594|NCT02131233|582551905|FG000|Overall Study|Non-Compliance With Study Drug|8|||
161318595|NCT02131233|582551906|FG001|Overall Study|Non-Compliance With Study Drug|5|||
161318596|NCT02131233|582551905|FG000|Overall Study|Physician Decision|7|||
161318597|NCT02131233|582551906|FG001|Overall Study|Physician Decision|0|||
161318598|NCT02131233|582551905|FG000|Overall Study|Pregnancy|4|||
161318599|NCT02131233|582551906|FG001|Overall Study|Pregnancy|0|||
161318600|NCT02131233|582551905|FG000|Overall Study|Withdrawal by Subject|18|||
161318601|NCT02131233|582551906|FG001|Overall Study|Withdrawal by Subject|11|||
161318602|NCT05114564|582551908|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
161318603|NCT05114564|582551909|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
161318604|NCT05114564|582551908|FG000|First Intervention|Adverse Event|0|||
161318605|NCT05114564|582551909|FG001|First Intervention|Adverse Event|1|||
161318606|NCT00255840|582551910|FG000|Overall Study|Lost to Follow-up|10|||
161318607|NCT00255840|582551911|FG001|Overall Study|Lost to Follow-up|14|||
161318608|NCT00255840|582551910|FG000|Overall Study|Discontinued intervention|53|||
161318609|NCT00255840|582551911|FG001|Overall Study|Discontinued intervention|56|||
161318610|NCT01280682|582551912|FG000|Overall Study|Lost to Follow-up|0|||
161318611|NCT01280682|582551913|FG001|Overall Study|Lost to Follow-up|6|||
161318612|NCT01280682|582551912|FG000|Overall Study|Withdrawal by Subject|0|||
161318613|NCT01280682|582551913|FG001|Overall Study|Withdrawal by Subject|7|||
161318614|NCT00431067|582551919|FG000|Overall Study|Other Adverse Event|9|||
161318615|NCT00431067|582551919|FG000|Overall Study|Progressive disease|30|||
161318616|NCT00431067|582551919|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
161318617|NCT00548249|582551920|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
161318618|NCT00548249|582551921|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161318619|NCT00548249|582551922|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161318620|NCT00548249|582551923|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
161318621|NCT00548249|582551924|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
161318622|NCT00548249|582551920|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
161318623|NCT00548249|582551921|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
161318624|NCT00548249|582551922|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
161318625|NCT00548249|582551923|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
161318626|NCT00548249|582551924|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
161318627|NCT00548249|582551920|FG000|Overall Study|Protocol Violation|1|||
161318628|NCT00548249|582551921|FG001|Overall Study|Protocol Violation|1|||
161318629|NCT00548249|582551922|FG002|Overall Study|Protocol Violation|4|||
161318630|NCT00548249|582551923|FG003|Overall Study|Protocol Violation|0|||
161318631|NCT00548249|582551924|FG004|Overall Study|Protocol Violation|3|||
161318632|NCT00548249|582551920|FG000|Overall Study|Miscellaneous|2|||
161318633|NCT00548249|582551921|FG001|Overall Study|Miscellaneous|3|||
161318634|NCT00548249|582551922|FG002|Overall Study|Miscellaneous|2|||
161318635|NCT00548249|582551923|FG003|Overall Study|Miscellaneous|0|||
161318636|NCT00548249|582551924|FG004|Overall Study|Miscellaneous|2|||
161318637|NCT00548249|582551920|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
161318638|NCT00548249|582551921|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
161318639|NCT00548249|582551922|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
161318640|NCT00548249|582551923|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
161318641|NCT00548249|582551924|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
161318642|NCT00548249|582551920|FG000|Overall Study|Adverse Event|2|||
161318643|NCT00548249|582551921|FG001|Overall Study|Adverse Event|2|||
161318644|NCT00548249|582551922|FG002|Overall Study|Adverse Event|0|||
161318645|NCT00548249|582551923|FG003|Overall Study|Adverse Event|1|||
161318646|NCT00548249|582551924|FG004|Overall Study|Adverse Event|1|||
161318647|NCT00548249|582551920|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
161318648|NCT00548249|582551921|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
161318649|NCT00548249|582551922|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
161318650|NCT00548249|582551923|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
161318651|NCT00548249|582551924|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
161318652|NCT00548249|582551920|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
161318653|NCT00548249|582551921|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
161318654|NCT00548249|582551922|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
161318655|NCT00548249|582551923|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
161318656|NCT00548249|582551924|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
161318657|NCT00548249|582551920|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161318658|NCT00548249|582551921|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161318659|NCT00548249|582551922|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161318660|NCT00548249|582551923|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
161318661|NCT00548249|582551924|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
161318662|NCT00548249|582551920|FG000|Overall Study|Prolonged hospitalization|0|||
161318663|NCT00548249|582551921|FG001|Overall Study|Prolonged hospitalization|0|||
161318664|NCT00548249|582551922|FG002|Overall Study|Prolonged hospitalization|2|||
161318665|NCT00548249|582551923|FG003|Overall Study|Prolonged hospitalization|1|||
161318666|NCT00548249|582551924|FG004|Overall Study|Prolonged hospitalization|0|||
161318667|NCT00548249|582551920|FG000|Overall Study|Withdrawal by Subject|2|||
161318668|NCT00548249|582551921|FG001|Overall Study|Withdrawal by Subject|0|||
161318669|NCT00548249|582551922|FG002|Overall Study|Withdrawal by Subject|0|||
161318670|NCT00548249|582551923|FG003|Overall Study|Withdrawal by Subject|0|||
161318671|NCT00548249|582551924|FG004|Overall Study|Withdrawal by Subject|0|||
161318672|NCT00548249|582551920|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161318673|NCT00548249|582551921|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
161318674|NCT00548249|582551922|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161318675|NCT00548249|582551923|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
161318676|NCT00548249|582551924|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
161318677|NCT00548249|582551920|FG000|Overall Study|Sponsor's request|0|||
161318678|NCT00548249|582551921|FG001|Overall Study|Sponsor's request|0|||
161318679|NCT00548249|582551922|FG002|Overall Study|Sponsor's request|0|||
161318680|NCT00548249|582551923|FG003|Overall Study|Sponsor's request|1|||
161318681|NCT00548249|582551924|FG004|Overall Study|Sponsor's request|0|||
161318682|NCT00080483|582551926|FG000|Overall Study|Lost to Follow-up|1|||
161318683|NCT00080483|582551927|FG001|Overall Study|Lost to Follow-up|1|||
161318684|NCT00080483|582551926|FG000|Overall Study|Physician Decision|1|||
161318685|NCT00080483|582551927|FG001|Overall Study|Physician Decision|1|||
161318686|NCT01119846|582551930|FG000|Overall Study|Adverse Event|1|||
161318687|NCT01119846|582551931|FG001|Overall Study|Adverse Event|0|||
161318688|NCT01119846|582551932|FG002|Overall Study|Adverse Event|6|||
161318689|NCT01119846|582551930|FG000|Overall Study|Physician Decision|1|||
161318690|NCT01119846|582551931|FG001|Overall Study|Physician Decision|0|||
161318691|NCT01119846|582551932|FG002|Overall Study|Physician Decision|0|||
161318692|NCT01119846|582551930|FG000|Overall Study|Protocol Violation|0|||
161318693|NCT01119846|582551931|FG001|Overall Study|Protocol Violation|0|||
161318694|NCT01119846|582551932|FG002|Overall Study|Protocol Violation|1|||
161318695|NCT01119846|582551930|FG000|Overall Study|Withdrawal by Subject|0|||
161318696|NCT01119846|582551931|FG001|Overall Study|Withdrawal by Subject|0|||
161318697|NCT01119846|582551932|FG002|Overall Study|Withdrawal by Subject|4|||
161318698|NCT00002525|582551933|FG000|Overall Study|Adverse Event|36|||
161318699|NCT00002525|582551934|FG001|Overall Study|Adverse Event|0|||
161318700|NCT00002525|582551933|FG000|Overall Study|Death|5|||
161318701|NCT00002525|582551934|FG001|Overall Study|Death|0|||
161318702|NCT00002525|582551933|FG000|Overall Study|Withdrawal by Subject|11|||
161318703|NCT00002525|582551934|FG001|Overall Study|Withdrawal by Subject|0|||
161318704|NCT00002525|582551933|FG000|Overall Study|Start non-protocol therapy|1|||
161318705|NCT00002525|582551934|FG001|Overall Study|Start non-protocol therapy|0|||
161318706|NCT00002525|582551933|FG000|Overall Study|Other complicating disease|1|||
161318707|NCT00002525|582551934|FG001|Overall Study|Other complicating disease|0|||
161318708|NCT00002525|582551933|FG000|Overall Study|Duke's A, B1, D disease|92|||
161318709|NCT00002525|582551934|FG001|Overall Study|Duke's A, B1, D disease|0|||
161318710|NCT00002525|582551933|FG000|Overall Study|Error|6|||
161318711|NCT00002525|582551934|FG001|Overall Study|Error|0|||
161318712|NCT00002525|582551933|FG000|Overall Study|Other|26|||
161318713|NCT00002525|582551934|FG001|Overall Study|Other|0|||
161318714|NCT00002525|582551933|FG000|Overall Study|Never start protocol therapy|8|||
161318715|NCT00002525|582551934|FG001|Overall Study|Never start protocol therapy|0|||
161318716|NCT04527978|582551936|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
161318717|NCT04527978|582551937|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
161318718|NCT01380691|582551946|FG000|Washout (7 Days)|Protocol Violation|0|||
161318719|NCT01380691|582551947|FG001|Washout (7 Days)|Protocol Violation|0|||
161318720|NCT01380691|582551948|FG002|Washout (7 Days)|Protocol Violation|0|||
161318721|NCT01380691|582551949|FG003|Washout (7 Days)|Protocol Violation|1|||
161318722|NCT01380691|582551946|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
161318723|NCT01380691|582551947|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
161318724|NCT01380691|582551948|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
161318725|NCT01380691|582551949|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
161318726|NCT03084315|582551950|FG000|Overall Study|Lost to Follow-up|8|||
161318727|NCT03084315|582551951|FG001|Overall Study|Lost to Follow-up|7|||
161318728|NCT03084315|582551950|FG000|Overall Study|Withdrawal by Subject|2|||
161318729|NCT03084315|582551951|FG001|Overall Study|Withdrawal by Subject|2|||
161318730|NCT04424914|582551954|FG000|Overall Study|Other|0|||
161318731|NCT04424914|582551955|FG001|Overall Study|Other|0|||
161318732|NCT04424914|582551956|FG002|Overall Study|Other|28|||
161318733|NCT04424914|582551954|FG000|Overall Study|Withdrawal by Subject|3|||
161318734|NCT04424914|582551955|FG001|Overall Study|Withdrawal by Subject|0|||
161318735|NCT04424914|582551956|FG002|Overall Study|Withdrawal by Subject|0|||
161318736|NCT04424914|582551954|FG000|Overall Study|Study terminated by sponsor|23|||
161318737|NCT04424914|582551955|FG001|Overall Study|Study terminated by sponsor|7|||
161318738|NCT04424914|582551956|FG002|Overall Study|Study terminated by sponsor|0|||
161318739|NCT04424914|582551954|FG000|Overall Study|Lost to Follow-up|0|||
161318740|NCT04424914|582551955|FG001|Overall Study|Lost to Follow-up|0|||
161318741|NCT04424914|582551956|FG002|Overall Study|Lost to Follow-up|1|||
161318742|NCT04424914|582551954|FG000|Overall Study|Death|3|||
161318743|NCT04424914|582551955|FG001|Overall Study|Death|1|||
161318744|NCT04424914|582551956|FG002|Overall Study|Death|0|||
161318745|NCT00460746|582551957|FG000|Overall Study|Adverse Event|1|||
161318746|NCT00460746|582551957|FG000|Overall Study|Lost to Follow-up|1|||
161318747|NCT02791438|582551958|FG000|Treatment Period|Adverse Event|1|||
161318748|NCT02791438|582551959|FG001|Treatment Period|Adverse Event|0|||
161318749|NCT02791438|582551958|FG000|Treatment Period|Withdrawal by Subject|0|||
161318750|NCT02791438|582551959|FG001|Treatment Period|Withdrawal by Subject|1|||
161318751|NCT02791438|582551958|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
161318752|NCT02791438|582551959|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
161318753|NCT01603394|582551961|FG000|Overall Study|Adverse Event|1|||
161318754|NCT00394771|582551962|FG000|Overall Study|Did not meet protocol requirements|1|||
161318755|NCT00394771|582551963|FG001|Overall Study|Did not meet protocol requirements|0|||
161318756|NCT00394771|582551964|FG002|Overall Study|Did not meet protocol requirements|2|||
161318757|NCT00394771|582551965|FG003|Overall Study|Did not meet protocol requirements|0|||
161318758|NCT00394771|582551962|FG000|Overall Study|Protocol Violation|2|||
161318759|NCT00394771|582551963|FG001|Overall Study|Protocol Violation|4|||
161318760|NCT00394771|582551964|FG002|Overall Study|Protocol Violation|9|||
161318761|NCT00394771|582551965|FG003|Overall Study|Protocol Violation|7|||
161318762|NCT00394771|582551962|FG000|Overall Study|Withdrawal by Subject|10|||
161318763|NCT00394771|582551963|FG001|Overall Study|Withdrawal by Subject|6|||
161318764|NCT00394771|582551964|FG002|Overall Study|Withdrawal by Subject|8|||
161318765|NCT00394771|582551965|FG003|Overall Study|Withdrawal by Subject|12|||
161318766|NCT00394771|582551962|FG000|Overall Study|Adverse Event|10|||
161318767|NCT00394771|582551963|FG001|Overall Study|Adverse Event|5|||
161318768|NCT00394771|582551964|FG002|Overall Study|Adverse Event|12|||
161318769|NCT00394771|582551965|FG003|Overall Study|Adverse Event|8|||
161318770|NCT00394771|582551962|FG000|Overall Study|Participant pregnant|0|||
161318771|NCT00394771|582551963|FG001|Overall Study|Participant pregnant|1|||
161318772|NCT00394771|582551964|FG002|Overall Study|Participant pregnant|2|||
161318773|NCT00394771|582551965|FG003|Overall Study|Participant pregnant|2|||
161318774|NCT00394771|582551962|FG000|Overall Study|Lost to Follow-up|15|||
161318775|NCT00394771|582551963|FG001|Overall Study|Lost to Follow-up|15|||
161318776|NCT00394771|582551964|FG002|Overall Study|Lost to Follow-up|13|||
161318777|NCT00394771|582551965|FG003|Overall Study|Lost to Follow-up|10|||
161318778|NCT00394771|582551962|FG000|Overall Study|Other|3|||
161318779|NCT00394771|582551963|FG001|Overall Study|Other|3|||
161318780|NCT00394771|582551964|FG002|Overall Study|Other|1|||
161318781|NCT00394771|582551965|FG003|Overall Study|Other|0|||
161318782|NCT02906033|582551966|FG000|Baseline|Protocol Violation|37|||
161318783|NCT02906033|582551967|FG001|Baseline|Protocol Violation|33|||
161318784|NCT02906033|582551966|FG000|Follow-up|Lost to Follow-up|46|||
161318785|NCT02906033|582551967|FG001|Follow-up|Lost to Follow-up|62|||
161318786|NCT00358956|582551978|FG000|Overall Study|Adverse Event|3|||
161318787|NCT00358956|582551978|FG000|Overall Study|condition under investigation worsened|4|||
161318788|NCT00358956|582551978|FG000|Overall Study|Withdrawal by Subject|1|||
161318789|NCT03782974|582551979|FG000|Overall Study|Withdrawal by Subject|7|||
161318790|NCT03782974|582551980|FG001|Overall Study|Withdrawal by Subject|7|||
161318791|NCT03782974|582551979|FG000|Overall Study|Pregnancy|1|||
161318792|NCT03782974|582551980|FG001|Overall Study|Pregnancy|0|||
161318793|NCT04607980|582551985|FG000|Overall Study|Adverse Event|3|||
161318794|NCT04607980|582551986|FG001|Overall Study|Adverse Event|4|||
161318795|NCT04607980|582551985|FG000|Overall Study|Death|0|||
161318796|NCT04607980|582551986|FG001|Overall Study|Death|1|||
161318797|NCT04607980|582551985|FG000|Overall Study|Withdrawal by Subject|2|||
161318798|NCT04607980|582551986|FG001|Overall Study|Withdrawal by Subject|5|||
161318799|NCT04607980|582551985|FG000|Overall Study|Lost to Follow-up|4|||
161318800|NCT04607980|582551986|FG001|Overall Study|Lost to Follow-up|8|||
161318801|NCT04607980|582551985|FG000|Overall Study|Protocol Violation|0|||
161318802|NCT04607980|582551986|FG001|Overall Study|Protocol Violation|3|||
161318803|NCT04607980|582551985|FG000|Overall Study|Other|3|||
161318804|NCT04607980|582551986|FG001|Overall Study|Other|0|||
161318805|NCT00448812|582551987|FG000|Year 2|Missed visit but remained in study|4|||
161318806|NCT00448812|582551988|FG001|Year 2|Missed visit but remained in study|1|||
161318807|NCT00448812|582551987|FG000|Year 3|Withdrawal by Subject|1|||
161318808|NCT00448812|582551988|FG001|Year 3|Withdrawal by Subject|3|||
161318809|NCT00448812|582551987|FG000|Year 3|Lost to Follow-up|1|||
161318810|NCT00448812|582551988|FG001|Year 3|Lost to Follow-up|0|||
161318811|NCT00448812|582551987|FG000|Year 3|Missed visit but remained in study|2|||
161318812|NCT00448812|582551988|FG001|Year 3|Missed visit but remained in study|0|||
161318813|NCT00448812|582551987|FG000|Year 5|Missed visit but remained in study|1|||
161318814|NCT00448812|582551988|FG001|Year 5|Missed visit but remained in study|0|||
161318815|NCT01854879|582551989|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
161318816|NCT01854879|582551989|FG000|Overall Study|screen fail|3|||
161318817|NCT01854879|582551989|FG000|Overall Study|incomplete data set|1|||
161318818|NCT02012959|582551990|FG000|Treatment Phase A|Adverse Event|2|||
161318819|NCT02012959|582551991|FG001|Treatment Phase A|Adverse Event|0|||
161318820|NCT02012959|582551992|FG002|Treatment Phase A|Adverse Event|0|||
161318821|NCT02012959|582551993|FG003|Treatment Phase A|Adverse Event|0|||
161318822|NCT02012959|582551994|FG004|Treatment Phase A|Adverse Event|0|||
161318823|NCT00385827|582553436|FG000|Part 1|Adverse Event|1|||
161318824|NCT00385827|582553437|FG001|Part 1|Adverse Event|0|||
161318825|NCT00385827|582553438|FG002|Part 1|Adverse Event|0|||
161318826|NCT00385827|582553436|FG000|Part 1|Death|2|||
161318827|NCT00385827|582553437|FG001|Part 1|Death|0|||
161318828|NCT00385827|582553438|FG002|Part 1|Death|0|||
161318829|NCT00385827|582553436|FG000|Part 1|Lack of Efficacy|5|||
161318830|NCT00385827|582553437|FG001|Part 1|Lack of Efficacy|0|||
161318831|NCT00385827|582553438|FG002|Part 1|Lack of Efficacy|0|||
161318832|NCT00385827|582553436|FG000|Part 1|Other|1|||
161318833|NCT00385827|582553437|FG001|Part 1|Other|0|||
161318834|NCT00385827|582553438|FG002|Part 1|Other|0|||
161318835|NCT00385827|582553436|FG000|Part 2|Adverse Event|0|||
161318836|NCT00385827|582553437|FG001|Part 2|Adverse Event|6|||
161318837|NCT00385827|582553438|FG002|Part 2|Adverse Event|10|||
161318838|NCT00385827|582553436|FG000|Part 2|Death|0|||
161318839|NCT00385827|582553437|FG001|Part 2|Death|0|||
161318840|NCT00385827|582553438|FG002|Part 2|Death|2|||
161318841|NCT00385827|582553436|FG000|Part 2|Lack of Efficacy|0|||
161318842|NCT00385827|582553437|FG001|Part 2|Lack of Efficacy|14|||
161318843|NCT00385827|582553438|FG002|Part 2|Lack of Efficacy|13|||
161318844|NCT00385827|582553436|FG000|Part 2|Randomized but not treated|0|||
161318845|NCT00385827|582553437|FG001|Part 2|Randomized but not treated|2|||
161318846|NCT00385827|582553438|FG002|Part 2|Randomized but not treated|2|||
161318847|NCT00385827|582553436|FG000|Part 2|Other|0|||
161318848|NCT00385827|582553437|FG001|Part 2|Other|11|||
161318849|NCT00385827|582553438|FG002|Part 2|Other|21|||
161318850|NCT01421147|582553439|FG000|Treatment Period|Adverse Event|2|||
161318851|NCT01421147|582553440|FG001|Treatment Period|Adverse Event|3|||
161318852|NCT01421147|582553439|FG000|Treatment Period|Lost to Follow-up|2|||
161318853|NCT01421147|582553440|FG001|Treatment Period|Lost to Follow-up|1|||
161318854|NCT01421147|582553439|FG000|Treatment Period|Physician Decision|2|||
161318855|NCT01421147|582553440|FG001|Treatment Period|Physician Decision|2|||
161318856|NCT01421147|582553439|FG000|Treatment Period|Withdrawal by Subject|10|||
161318857|NCT01421147|582553440|FG001|Treatment Period|Withdrawal by Subject|5|||
161318858|NCT01421147|582553439|FG000|Extension Period|Adverse Event|0|||
161318859|NCT01421147|582553440|FG001|Extension Period|Adverse Event|2|||
161318860|NCT01421147|582553439|FG000|Extension Period|Death|0|||
161318861|NCT01421147|582553440|FG001|Extension Period|Death|1|||
161318862|NCT01421147|582553439|FG000|Extension Period|Lost to Follow-up|2|||
161318863|NCT01421147|582553440|FG001|Extension Period|Lost to Follow-up|5|||
161318864|NCT01421147|582553439|FG000|Extension Period|Physician Decision|1|||
161318865|NCT01421147|582553440|FG001|Extension Period|Physician Decision|0|||
161318866|NCT01421147|582553439|FG000|Extension Period|Withdrawal by Subject|5|||
161318867|NCT01421147|582553440|FG001|Extension Period|Withdrawal by Subject|3|||
161318868|NCT04985942|582553441|FG000|Overall Study|Adverse Event|14|||
161318869|NCT04985942|582553442|FG001|Overall Study|Adverse Event|2|||
161318870|NCT04985942|582553441|FG000|Overall Study|Lack of Efficacy|0|||
161318871|NCT04985942|582553442|FG001|Overall Study|Lack of Efficacy|3|||
161318872|NCT04985942|582553441|FG000|Overall Study|Lost to Follow-up|1|||
161318873|NCT04985942|582553442|FG001|Overall Study|Lost to Follow-up|1|||
161318874|NCT04985942|582553441|FG000|Overall Study|Protocol Violation|1|||
161318875|NCT04985942|582553442|FG001|Overall Study|Protocol Violation|1|||
161318876|NCT04985942|582553441|FG000|Overall Study|Withdrawal by Subject|5|||
161318877|NCT04985942|582553442|FG001|Overall Study|Withdrawal by Subject|4|||
161318878|NCT03630705|582553443|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
161318879|NCT03630705|582553444|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
161318880|NCT03630705|582553445|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
161318881|NCT03630705|582553446|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
161318882|NCT03630705|582553443|FG000|Overall Study|Lost to Follow-up|1|||
161318883|NCT03630705|582553444|FG001|Overall Study|Lost to Follow-up|2|||
161318884|NCT03630705|582553445|FG002|Overall Study|Lost to Follow-up|0|||
161318885|NCT03630705|582553446|FG003|Overall Study|Lost to Follow-up|0|||
161318886|NCT01467271|582553465|FG000|Overall Study|Death|84|||
161318887|NCT01467271|582553465|FG000|Overall Study|Lost to Follow-up|83|||
161318888|NCT01467271|582553465|FG000|Overall Study|Retraction of patient's consent|21|||
161318889|NCT01467271|582553465|FG000|Overall Study|Other reason|14|||
161318890|NCT02815267|582553485|FG000|Double-Blind Phase|Adverse Event|0|||
161318891|NCT02815267|582553486|FG001|Double-Blind Phase|Adverse Event|3|||
161318892|NCT02815267|582553485|FG000|Double-Blind Phase|Lost to Follow-up|17|||
161318893|NCT02815267|582553486|FG001|Double-Blind Phase|Lost to Follow-up|9|||
161318894|NCT02815267|582553485|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
161318895|NCT02815267|582553486|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
161318896|NCT02815267|582553485|FG000|Double-Blind Phase|Protocol Violation|3|||
161318897|NCT02815267|582553486|FG001|Double-Blind Phase|Protocol Violation|2|||
161318898|NCT02815267|582553485|FG000|Double-Blind Phase|Site withdrawal|1|||
161318899|NCT02815267|582553486|FG001|Double-Blind Phase|Site withdrawal|6|||
161318900|NCT02815267|582553485|FG000|Double-Blind Phase|Received a disallowed medication|1|||
161318901|NCT02815267|582553486|FG001|Double-Blind Phase|Received a disallowed medication|1|||
161318902|NCT02815267|582553485|FG000|Open-Label Phase|Adverse Event|1|||
161318903|NCT02815267|582553486|FG001|Open-Label Phase|Adverse Event|1|||
161318904|NCT02815267|582553485|FG000|Open-Label Phase|Lost to Follow-up|23|||
161318905|NCT02815267|582553486|FG001|Open-Label Phase|Lost to Follow-up|9|||
161318906|NCT02815267|582553485|FG000|Open-Label Phase|Withdrawal by Subject|24|||
161318907|NCT02815267|582553486|FG001|Open-Label Phase|Withdrawal by Subject|13|||
161318908|NCT02815267|582553485|FG000|Open-Label Phase|Protocol Violation|0|||
161318909|NCT02815267|582553486|FG001|Open-Label Phase|Protocol Violation|1|||
161318910|NCT02815267|582553485|FG000|Open-Label Phase|Administrative|21|||
161318911|NCT02815267|582553486|FG001|Open-Label Phase|Administrative|12|||
161318912|NCT02815267|582553485|FG000|Open-Label Phase|Other|2|||
161318913|NCT02815267|582553486|FG001|Open-Label Phase|Other|5|||
161318914|NCT04126317|582553500|FG000|Overall Study|Adverse Event|0|||
161318915|NCT04126317|582553501|FG001|Overall Study|Adverse Event|1|||
161318916|NCT04126317|582553500|FG000|Overall Study|Withdrawal by Subject|4|||
161318917|NCT04126317|582553501|FG001|Overall Study|Withdrawal by Subject|1|||
161318918|NCT00660595|582553502|FG000|Overall Study|Lost to Follow-up|0|||
161318919|NCT00660595|582553503|FG001|Overall Study|Lost to Follow-up|1|||
161318920|NCT00660595|582553502|FG000|Overall Study|Did not consent to participate in study|12|||
161318921|NCT00660595|582553503|FG001|Overall Study|Did not consent to participate in study|8|||
161318922|NCT00660595|582553502|FG000|Overall Study|Participant left hospital|1|||
161318923|NCT00660595|582553503|FG001|Overall Study|Participant left hospital|0|||
161318924|NCT00660595|582553502|FG000|Overall Study|Non Specified reasons|5|||
161318925|NCT00660595|582553503|FG001|Overall Study|Non Specified reasons|0|||
161318926|NCT00339833|582553514|FG000|Overall Study|Withdrawal by Subject|1|||
161318927|NCT00339833|582553515|FG001|Overall Study|Withdrawal by Subject|2|||
161318928|NCT00339833|582553514|FG000|Overall Study|toothache|0|||
161318929|NCT00339833|582553515|FG001|Overall Study|toothache|1|||
161318930|NCT00339833|582553514|FG000|Overall Study|indigestion|0|||
161318931|NCT00339833|582553515|FG001|Overall Study|indigestion|1|||
161318932|NCT00339833|582553514|FG000|Overall Study|Chest pain|0|||
161318933|NCT00339833|582553515|FG001|Overall Study|Chest pain|1|||
161318934|NCT00339833|582553514|FG000|Overall Study|minor infection|0|||
161318935|NCT00339833|582553515|FG001|Overall Study|minor infection|1|||
161318936|NCT00339833|582553514|FG000|Overall Study|Poor venous access|2|||
161318937|NCT00339833|582553515|FG001|Overall Study|Poor venous access|2|||
161318938|NCT00339833|582553514|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
161318939|NCT00339833|582553515|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
161318940|NCT00339833|582553514|FG000|Overall Study|Error in data records|1|||
161318941|NCT00339833|582553515|FG001|Overall Study|Error in data records|0|||
161318942|NCT00217581|582553516|FG000|Overall Study|Withdrawal by Subject|1|||
161318943|NCT02829047|582553517|FG000|Overall Study|Withdrawal by Subject|1|||
161318944|NCT01204918|582553537|FG000|Overall Study|Withdrawal by Subject|4|||
161318945|NCT01204918|582553538|FG001|Overall Study|Withdrawal by Subject|10|||
161318946|NCT01204918|582553539|FG002|Overall Study|Withdrawal by Subject|5|||
161318947|NCT00269477|582553544|FG000|Overall Study|Protocol Violation|5|||
161318948|NCT00269477|582553545|FG001|Overall Study|Protocol Violation|5|||
161318949|NCT00269477|582553546|FG002|Overall Study|Protocol Violation|1|||
161318950|NCT00269477|582553547|FG003|Overall Study|Protocol Violation|0|||
161318951|NCT00269477|582553544|FG000|Overall Study|Missed post-vaccination blood draw|0|||
161318952|NCT00269477|582553545|FG001|Overall Study|Missed post-vaccination blood draw|1|||
161318953|NCT00269477|582553546|FG002|Overall Study|Missed post-vaccination blood draw|0|||
161318954|NCT00269477|582553547|FG003|Overall Study|Missed post-vaccination blood draw|0|||
161318955|NCT02007278|582553548|FG000|Overall Study|Failure to comply with an eligibility|0|||
161318956|NCT02007278|582553549|FG001|Overall Study|Failure to comply with an eligibility|1|||
161318957|NCT02007278|582553548|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
161318958|NCT02007278|582553549|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
161318959|NCT02007278|582553548|FG000|Overall Study|Incorrect medication administration|1|||
161318960|NCT02007278|582553549|FG001|Overall Study|Incorrect medication administration|0|||
161318961|NCT02007278|582553548|FG000|Overall Study|Mis-randomization|1|||
161318962|NCT02007278|582553549|FG001|Overall Study|Mis-randomization|1|||
161318963|NCT01404949|582553550|FG000|Overall Study|Not Treated|1|||
161318964|NCT02886884|582553554|FG000|Follow-up|Withdrawal by Subject|0|||
161318965|NCT02886884|582553555|FG001|Follow-up|Withdrawal by Subject|0|||
161318966|NCT02886884|582553556|FG002|Follow-up|Withdrawal by Subject|0|||
161318967|NCT02886884|582553557|FG003|Follow-up|Withdrawal by Subject|1|||
161318968|NCT02651688|582553560|FG000|Overall Study|Non-compliance|0|||
161318969|NCT02651688|582553561|FG001|Overall Study|Non-compliance|0|||
161318970|NCT02651688|582553562|FG002|Overall Study|Non-compliance|1|||
161318971|NCT02651688|582553560|FG000|Overall Study|Principal Investigator (PI) decision|0|||
161318972|NCT02651688|582553561|FG001|Overall Study|Principal Investigator (PI) decision|2|||
161318973|NCT02651688|582553562|FG002|Overall Study|Principal Investigator (PI) decision|0|||
161318974|NCT02651688|582553560|FG000|Overall Study|Lost to Follow-up|1|||
161318975|NCT02651688|582553561|FG001|Overall Study|Lost to Follow-up|3|||
161318976|NCT02651688|582553562|FG002|Overall Study|Lost to Follow-up|0|||
161318977|NCT02651688|582553560|FG000|Overall Study|Withdrawal by Subject|1|||
161318978|NCT02651688|582553561|FG001|Overall Study|Withdrawal by Subject|0|||
161318979|NCT02651688|582553562|FG002|Overall Study|Withdrawal by Subject|2|||
161318980|NCT00625183|582553563|FG000|Overall Study|Disease Progression|1|||
161318981|NCT01429441|582553564|FG000|Overall Study|Adverse Event|5|||
161318982|NCT01429441|582553565|FG001|Overall Study|Adverse Event|1|||
161318983|NCT01429441|582553564|FG000|Overall Study|Death|0|||
161318984|NCT01429441|582553565|FG001|Overall Study|Death|2|||
161318985|NCT01429441|582553564|FG000|Overall Study|Lost to Follow-up|5|||
161318986|NCT01429441|582553565|FG001|Overall Study|Lost to Follow-up|2|||
161318987|NCT01429441|582553564|FG000|Overall Study|Physician Decision|1|||
161318988|NCT01429441|582553565|FG001|Overall Study|Physician Decision|0|||
161318989|NCT01429441|582553564|FG000|Overall Study|Withdrawal by Subject|27|||
161318990|NCT01429441|582553565|FG001|Overall Study|Withdrawal by Subject|18|||
161318991|NCT01606748|582553571|FG000|Overall Study|Adverse Event|1|||
161318992|NCT01606748|582553572|FG001|Overall Study|Adverse Event|0|||
161318993|NCT01606748|582553571|FG000|Overall Study|Progressive Disease|1|||
161318994|NCT01606748|582553572|FG001|Overall Study|Progressive Disease|0|||
161318995|NCT01606748|582553571|FG000|Overall Study|Withdrawal by Subject|1|||
161318996|NCT01606748|582553572|FG001|Overall Study|Withdrawal by Subject|0|||
161318997|NCT02670382|582553574|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
161318998|NCT02670382|582553575|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
161318999|NCT03244618|582553576|FG000|Overall Study|Lost to Follow-up|3|||
161319000|NCT03244618|582553577|FG001|Overall Study|Lost to Follow-up|4|||
161319001|NCT03244618|582553576|FG000|Overall Study|Protocol Violation|4|||
161319002|NCT03244618|582553577|FG001|Overall Study|Protocol Violation|3|||
161319003|NCT03244618|582553576|FG000|Overall Study|Withdrawal by Subject|0|||
161319004|NCT03244618|582553577|FG001|Overall Study|Withdrawal by Subject|2|||
161319005|NCT02155322|582553581|FG000|Overall Study|Adverse Event|1|||
161319006|NCT02155322|582553581|FG000|Overall Study|Physician Decision|1|||
161319007|NCT02155322|582553581|FG000|Overall Study|Relapse/Recurrence|8|||
161319008|NCT02155322|582553581|FG000|Overall Study|Withdrawal by Subject|4|||
161319009|NCT04776018|582553588|FG000|Overall Study|Death|0|||
161319010|NCT04776018|582553589|FG001|Overall Study|Death|1|||
161319011|NCT04776018|582553590|FG002|Overall Study|Death|4|||
161319012|NCT04776018|582553591|FG003|Overall Study|Death|1|||
161319013|NCT04776018|582553592|FG004|Overall Study|Death|4|||
161319014|NCT04776018|582553593|FG005|Overall Study|Death|0|||
161319015|NCT04776018|582553594|FG006|Overall Study|Death|0|||
161319016|NCT04776018|582553588|FG000|Overall Study|Study terminated by sponsor|2|||
161319017|NCT04776018|582553589|FG001|Overall Study|Study terminated by sponsor|1|||
161319018|NCT04776018|582553590|FG002|Overall Study|Study terminated by sponsor|4|||
161319019|NCT04776018|582553591|FG003|Overall Study|Study terminated by sponsor|0|||
161319020|NCT04776018|582553592|FG004|Overall Study|Study terminated by sponsor|3|||
161319021|NCT04776018|582553593|FG005|Overall Study|Study terminated by sponsor|0|||
161319022|NCT04776018|582553594|FG006|Overall Study|Study terminated by sponsor|0|||
161319023|NCT04776018|582553588|FG000|Overall Study|Withdrawal by Subject|1|||
161319024|NCT04776018|582553589|FG001|Overall Study|Withdrawal by Subject|0|||
161319025|NCT04776018|582553590|FG002|Overall Study|Withdrawal by Subject|0|||
161319026|NCT04776018|582553591|FG003|Overall Study|Withdrawal by Subject|2|||
161319027|NCT04776018|582553592|FG004|Overall Study|Withdrawal by Subject|1|||
161319028|NCT04776018|582553593|FG005|Overall Study|Withdrawal by Subject|0|||
161319029|NCT04776018|582553594|FG006|Overall Study|Withdrawal by Subject|0|||
161319030|NCT04776018|582553588|FG000|Overall Study|Other|0|||
161319031|NCT04776018|582553589|FG001|Overall Study|Other|1|||
161319032|NCT04776018|582553590|FG002|Overall Study|Other|1|||
161319033|NCT04776018|582553591|FG003|Overall Study|Other|0|||
161319034|NCT04776018|582553592|FG004|Overall Study|Other|0|||
161319035|NCT04776018|582553593|FG005|Overall Study|Other|0|||
161319036|NCT04776018|582553594|FG006|Overall Study|Other|0|||
161319037|NCT04776018|582553588|FG000|Overall Study|Lost to Follow-up|0|||
161319038|NCT04776018|582553589|FG001|Overall Study|Lost to Follow-up|0|||
161319039|NCT04776018|582553590|FG002|Overall Study|Lost to Follow-up|1|||
161319040|NCT04776018|582553591|FG003|Overall Study|Lost to Follow-up|0|||
161319041|NCT04776018|582553592|FG004|Overall Study|Lost to Follow-up|0|||
161319042|NCT04776018|582553593|FG005|Overall Study|Lost to Follow-up|0|||
161319043|NCT04776018|582553594|FG006|Overall Study|Lost to Follow-up|0|||
161319044|NCT03417024|582553597|FG000|Overall Study|Study Termination prior to follow-up|11|||
161319045|NCT03417024|582553597|FG000|Overall Study|Physician Decision|2|||
161319046|NCT02195427|582553598|FG000|Overall Study|Did not consent to study extension|13|||
161319047|NCT02195427|582553599|FG001|Overall Study|Did not consent to study extension|9|||
161319048|NCT02195427|582553598|FG000|Overall Study|Withdrawal by Subject|4|||
161319049|NCT02195427|582553599|FG001|Overall Study|Withdrawal by Subject|2|||
161319050|NCT02195427|582553598|FG000|Overall Study|Lost to Follow-up|0|||
161319051|NCT02195427|582553599|FG001|Overall Study|Lost to Follow-up|1|||
161319052|NCT02195427|582553598|FG000|Overall Study|Protocol Violation|7|||
161319053|NCT02195427|582553599|FG001|Overall Study|Protocol Violation|14|||
161319054|NCT02195427|582553598|FG000|Overall Study|Conditional re-treatment at W52|2|||
161319055|NCT02195427|582553599|FG001|Overall Study|Conditional re-treatment at W52|1|||
161319056|NCT00386425|582553600|FG000|Overall Study|Physician Decision|3|||
161319057|NCT00386425|582553601|FG001|Overall Study|Physician Decision|0|||
161319058|NCT00386425|582553602|FG002|Overall Study|Physician Decision|0|||
161319059|NCT00386425|582553600|FG000|Overall Study|Withdrawal by Subject|0|||
161319060|NCT00386425|582553601|FG001|Overall Study|Withdrawal by Subject|1|||
161319061|NCT00386425|582553602|FG002|Overall Study|Withdrawal by Subject|0|||
161319062|NCT01907217|582553605|FG000|Overall Study|Withdrawal by Subject|0|||
161319063|NCT01907217|582553606|FG001|Overall Study|Withdrawal by Subject|2|||
161319064|NCT03396822|582555228|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
161319065|NCT03396822|582555228|FG000|Overall Study|Physician Decision|1|||
161319066|NCT00171158|582555229|FG000|Core Study|Death|27|||
161319067|NCT00171158|582555229|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
161319068|NCT00171158|582555229|FG000|Core Study|Protocol Violation|4|||
161319069|NCT00171158|582555229|FG000|Core Study|Administrative problems|1|||
161319070|NCT00171158|582555229|FG000|Core Study|Adverse event, non-fatal|21|||
161319071|NCT00171158|582555229|FG000|Core Study|Consent withdrawn by subject|6|||
161319072|NCT00171158|582555229|FG000|Core Study|No longer required drug (BMT)|14|||
161319073|NCT00171158|582555229|FG000|Core Study|Abnormal Laboratory Values|2|||
161319074|NCT00171158|582555229|FG000|Core Study|Lost to Follow-up|1|||
161319075|NCT00171158|582555229|FG000|E2 Extension|Other|7|||
161319076|NCT02757352|582555234|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
161319077|NCT02757352|582555235|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319078|NCT02757352|582555236|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
161319079|NCT02757352|582555237|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319080|NCT02757352|582555238|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319081|NCT02757352|582555239|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319082|NCT02757352|582555240|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319083|NCT02757352|582555241|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319084|NCT02757352|582555242|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319085|NCT02757352|582555243|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
161319086|NCT02757352|582555234|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319087|NCT02757352|582555235|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319088|NCT02757352|582555236|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
161319089|NCT02757352|582555237|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319090|NCT02757352|582555238|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319091|NCT02757352|582555239|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319092|NCT02757352|582555240|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319093|NCT02757352|582555241|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319094|NCT02757352|582555242|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319095|NCT02757352|582555243|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
161319096|NCT02757352|582555234|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
161319097|NCT02757352|582555235|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
161319098|NCT02757352|582555236|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
161319099|NCT02757352|582555237|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319100|NCT02757352|582555238|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319101|NCT02757352|582555239|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319102|NCT02757352|582555240|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319103|NCT02757352|582555241|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319104|NCT02757352|582555242|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319105|NCT02757352|582555243|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
161319106|NCT02757352|582555234|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319107|NCT02757352|582555235|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
161319108|NCT02757352|582555236|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319109|NCT02757352|582555237|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319110|NCT02757352|582555238|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319111|NCT02757352|582555239|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161206949|NCT00756652|582138071|FG001|Original Phase|Unknown Discontinuation Reason|0|||
161206950|NCT00756652|582138070|FG000|Original Phase|Participants without data|3259|||
161206951|NCT00756652|582138071|FG001|Original Phase|Participants without data|466|||
161206952|NCT00756652|582138070|FG000|Original Phase|Death|168|||
161206953|NCT00756652|582138071|FG001|Original Phase|Death|1|||
161319112|NCT02757352|582555240|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319113|NCT02757352|582555241|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319114|NCT02757352|582555242|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319115|NCT02757352|582555243|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
161319116|NCT02757352|582555234|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319117|NCT02757352|582555235|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161319118|NCT02757352|582555236|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319119|NCT02757352|582555237|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319120|NCT02757352|582555238|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319121|NCT02757352|582555239|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319122|NCT02757352|582555240|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319123|NCT02757352|582555241|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319124|NCT02757352|582555242|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319125|NCT02757352|582555243|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319126|NCT02757352|582555234|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161319127|NCT02757352|582555235|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161319128|NCT02757352|582555236|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
161319129|NCT02757352|582555237|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319130|NCT02757352|582555238|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319131|NCT02757352|582555239|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319132|NCT02757352|582555240|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319133|NCT02757352|582555241|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319134|NCT02757352|582555242|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319135|NCT02757352|582555243|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319136|NCT02757352|582555234|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
161319137|NCT02757352|582555235|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
161319138|NCT02757352|582555236|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
161319139|NCT02757352|582555237|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319140|NCT02757352|582555238|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319141|NCT02757352|582555239|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319142|NCT02757352|582555240|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319143|NCT02757352|582555241|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319144|NCT02757352|582555242|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319145|NCT02757352|582555243|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
161319146|NCT02757352|582555234|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319147|NCT02757352|582555235|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319148|NCT02757352|582555236|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319149|NCT02757352|582555237|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
161319150|NCT02757352|582555238|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319151|NCT02757352|582555239|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
161319152|NCT02757352|582555240|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319153|NCT02757352|582555241|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319154|NCT02757352|582555242|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319155|NCT02757352|582555243|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
161319156|NCT02757352|582555234|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319157|NCT02757352|582555235|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319158|NCT02757352|582555236|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319159|NCT02757352|582555237|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
161319160|NCT02757352|582555238|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
161319161|NCT02757352|582555239|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
161319162|NCT02757352|582555240|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319163|NCT02757352|582555241|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319164|NCT02757352|582555242|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319165|NCT02757352|582555243|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
161319166|NCT02757352|582555234|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319167|NCT02757352|582555235|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319168|NCT02757352|582555236|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319169|NCT02757352|582555237|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319170|NCT02757352|582555238|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
161319171|NCT02757352|582555239|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319172|NCT02757352|582555240|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319173|NCT02757352|582555241|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319174|NCT02757352|582555242|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161206954|NCT00756652|582138070|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
161206955|NCT00756652|582138071|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
161206956|NCT00756652|582138070|FG000|Re-Op Phase|Withdrawal by Subject|62|||
161206957|NCT00756652|582138071|FG001|Re-Op Phase|Withdrawal by Subject|0|||
161206958|NCT00756652|582138070|FG000|Re-Op Phase|Death|6|||
161206959|NCT00756652|582138071|FG001|Re-Op Phase|Death|0|||
161206960|NCT00756652|582138070|FG000|Re-Op Phase|Lost to Follow-up|340|||
161206961|NCT00756652|582138071|FG001|Re-Op Phase|Lost to Follow-up|0|||
161206962|NCT00756652|582138070|FG000|Re-Op Phase|Site Closed|2454|||
161206963|NCT00756652|582138071|FG001|Re-Op Phase|Site Closed|0|||
161206964|NCT00756652|582138070|FG000|Re-Op Phase|Withdrawn after explant|14|||
161206965|NCT00756652|582138071|FG001|Re-Op Phase|Withdrawn after explant|0|||
161206966|NCT00038467|582138076|FG000|Overall Study|Adverse Event|170|||
161206967|NCT00038467|582138077|FG001|Overall Study|Adverse Event|145|||
161206968|NCT00038467|582138076|FG000|Overall Study|Withdrawal by Subject|150|||
161091084|NCT04634825|581723797|FG000|Overall Study|Study terminated by sponsor|35|||
161091085|NCT04634825|581723798|FG001|Overall Study|Study terminated by sponsor|11|||
161091086|NCT04634825|581723797|FG000|Overall Study|Withdrawal by Subject|2|||
161091087|NCT04634825|581723798|FG001|Overall Study|Withdrawal by Subject|0|||
161091088|NCT01718353|581723806|FG000|Overall Study|Lost to Follow-up|0|||
161206969|NCT00038467|582138077|FG001|Overall Study|Withdrawal by Subject|107|||
161206970|NCT00038467|582138076|FG000|Overall Study|Protocol Violation|19|||
161206971|NCT00038467|582138077|FG001|Overall Study|Protocol Violation|22|||
161206972|NCT00038467|582138076|FG000|Overall Study|Death|22|||
161206973|NCT00038467|582138077|FG001|Overall Study|Death|16|||
161206974|NCT00038467|582138076|FG000|Overall Study|Lost to Follow-up|15|||
161206975|NCT00038467|582138077|FG001|Overall Study|Lost to Follow-up|10|||
161206976|NCT00038467|582138076|FG000|Overall Study|Recurrence|109|||
161206977|NCT00038467|582138077|FG001|Overall Study|Recurrence|179|||
161206978|NCT00038467|582138076|FG000|Overall Study|Randomized, but not treated|31|||
161206979|NCT00038467|582138077|FG001|Overall Study|Randomized, but not treated|35|||
161206980|NCT00038467|582138076|FG000|Overall Study|Other|26|||
161206981|NCT00038467|582138077|FG001|Overall Study|Other|28|||
161206982|NCT04732728|582138078|FG000|Overall Study|Death|12|||
161206983|NCT04732728|582138078|FG000|Overall Study|Withdrawn|136|||
161206984|NCT05349188|582138079|FG000|Overall Study|Withdrawal by Subject|1|||
161206985|NCT05349188|582138080|FG001|Overall Study|Withdrawal by Subject|0|||
161206986|NCT00481871|582138081|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
161206987|NCT00481871|582138082|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
161206988|NCT00481871|582138083|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
161206989|NCT00481871|582138084|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
161206990|NCT00481871|582138085|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
161206991|NCT00644228|582138095|FG000|Randomization & Eligibility|Ineligible|31|||
161206992|NCT00644228|582138096|FG001|Randomization & Eligibility|Ineligible|21|||
161206993|NCT00644228|582138095|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
161206994|NCT00644228|582138096|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
161206995|NCT00644228|582138095|FG000|Randomization & Eligibility|Invalid Consent|0|||
161206996|NCT00644228|582138096|FG001|Randomization & Eligibility|Invalid Consent|1|||
161206997|NCT00644228|582138095|FG000|Induction Therapy|Adverse Event|22|||
161206998|NCT00644228|582138096|FG001|Induction Therapy|Adverse Event|55|||
161206999|NCT00644228|582138095|FG000|Induction Therapy|Withdrawal by Subject|10|||
161207000|NCT00644228|582138096|FG001|Induction Therapy|Withdrawal by Subject|3|||
161207001|NCT00644228|582138095|FG000|Induction Therapy|Progression/Relapse|24|||
161207002|NCT00644228|582138096|FG001|Induction Therapy|Progression/Relapse|12|||
161207003|NCT00644228|582138095|FG000|Induction Therapy|Death|3|||
161207004|NCT00644228|582138096|FG001|Induction Therapy|Death|7|||
161207005|NCT00644228|582138095|FG000|Induction Therapy|Not Protocol-Specified|24|||
161207006|NCT00644228|582138096|FG001|Induction Therapy|Not Protocol-Specified|28|||
161207007|NCT00644228|582138095|FG000|Maintenance|Adverse Event|27|||
161207008|NCT00644228|582138096|FG001|Maintenance|Adverse Event|31|||
161207009|NCT00644228|582138095|FG000|Maintenance|Withdrawal by Subject|6|||
161207010|NCT00644228|582138096|FG001|Maintenance|Withdrawal by Subject|4|||
161207011|NCT00644228|582138095|FG000|Maintenance|Progression/Relapse|67|||
161319175|NCT02757352|582555243|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
161319176|NCT02757352|582555234|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319177|NCT02757352|582555235|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319178|NCT02757352|582555236|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319179|NCT02757352|582555237|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319180|NCT02757352|582555238|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319181|NCT02757352|582555239|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
161319182|NCT02757352|582555240|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319183|NCT02757352|582555241|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319184|NCT02757352|582555242|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319185|NCT02757352|582555243|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
161319186|NCT02757352|582555234|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319187|NCT02757352|582555235|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319188|NCT02757352|582555236|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319189|NCT02757352|582555237|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
161319190|NCT02757352|582555238|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161319191|NCT02757352|582555239|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
161319192|NCT02757352|582555240|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319193|NCT02757352|582555241|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319194|NCT02757352|582555242|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319195|NCT02757352|582555243|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
161319196|NCT02757352|582555234|FG000|Follow-Up Period|Adverse Event|0|||
161319197|NCT02757352|582555235|FG001|Follow-Up Period|Adverse Event|0|||
161319198|NCT02757352|582555236|FG002|Follow-Up Period|Adverse Event|0|||
161319199|NCT02757352|582555237|FG003|Follow-Up Period|Adverse Event|0|||
161319200|NCT02757352|582555238|FG004|Follow-Up Period|Adverse Event|0|||
161319201|NCT02757352|582555239|FG005|Follow-Up Period|Adverse Event|0|||
161319202|NCT02757352|582555240|FG006|Follow-Up Period|Adverse Event|1|||
161319203|NCT02757352|582555241|FG007|Follow-Up Period|Adverse Event|0|||
161319204|NCT02757352|582555242|FG008|Follow-Up Period|Adverse Event|2|||
161319205|NCT02757352|582555243|FG009|Follow-Up Period|Adverse Event|0|||
161319206|NCT02757352|582555234|FG000|Follow-Up Period|Lost to Follow-up|0|||
161319207|NCT02757352|582555235|FG001|Follow-Up Period|Lost to Follow-up|0|||
161319208|NCT02757352|582555236|FG002|Follow-Up Period|Lost to Follow-up|0|||
161319209|NCT02757352|582555237|FG003|Follow-Up Period|Lost to Follow-up|0|||
161319210|NCT02757352|582555238|FG004|Follow-Up Period|Lost to Follow-up|0|||
161319211|NCT02757352|582555239|FG005|Follow-Up Period|Lost to Follow-up|0|||
161319212|NCT02757352|582555240|FG006|Follow-Up Period|Lost to Follow-up|0|||
161207012|NCT00644228|582138096|FG001|Maintenance|Progression/Relapse|42|||
161207013|NCT00644228|582138095|FG000|Maintenance|Death|3|||
161207014|NCT00644228|582138096|FG001|Maintenance|Death|3|||
161207015|NCT00644228|582138095|FG000|Maintenance|Not Protocol-Specified|14|||
161207016|NCT00644228|582138096|FG001|Maintenance|Not Protocol-Specified|15|||
161207017|NCT00644228|582138095|FG000|Maintenance|On Treatment|26|||
161207018|NCT00644228|582138096|FG001|Maintenance|On Treatment|40|||
161207019|NCT06078124|582138097|FG000|Overall Study|Lost to Follow-up|14|||
161207020|NCT06078124|582138098|FG001|Overall Study|Lost to Follow-up|14|||
161207021|NCT04050293|582138099|FG000|Overall Study|Lost to Follow-up|1|||
161207022|NCT04050293|582138100|FG001|Overall Study|Lost to Follow-up|2|||
161207023|NCT04050293|582138099|FG000|Overall Study|Withdrawal by Subject|2|||
161207024|NCT04050293|582138100|FG001|Overall Study|Withdrawal by Subject|0|||
161207025|NCT03532295|582138104|FG000|Overall Study|Did not start treatment|0|||
161207026|NCT03532295|582138105|FG001|Overall Study|Did not start treatment|2|||
161207027|NCT05004181|582138109|FG000|Overall Study|Withdrawal of consent|0|||
161207028|NCT05004181|582138110|FG001|Overall Study|Withdrawal of consent|0|||
161207029|NCT05004181|582138111|FG002|Overall Study|Withdrawal of consent|1|||
161207030|NCT05004181|582138112|FG003|Overall Study|Withdrawal of consent|3|||
161207031|NCT05004181|582138113|FG004|Overall Study|Withdrawal of consent|3|||
161207032|NCT05004181|582138114|FG005|Overall Study|Withdrawal of consent|0|||
161207033|NCT05004181|582138115|FG006|Overall Study|Withdrawal of consent|30|||
161207034|NCT05004181|582138116|FG007|Overall Study|Withdrawal of consent|9|||
161207035|NCT05004181|582138117|FG008|Overall Study|Withdrawal of consent|3|||
161207036|NCT05004181|582138118|FG009|Overall Study|Withdrawal of consent|2|||
161207037|NCT05004181|582138119|FG010|Overall Study|Withdrawal of consent|5|||
161207038|NCT05004181|582138120|FG011|Overall Study|Withdrawal of consent|1|||
161207039|NCT05004181|582138109|FG000|Overall Study|Lost to Follow-up|2|||
161207040|NCT05004181|582138110|FG001|Overall Study|Lost to Follow-up|4|||
161207041|NCT05004181|582138111|FG002|Overall Study|Lost to Follow-up|2|||
161207042|NCT05004181|582138112|FG003|Overall Study|Lost to Follow-up|3|||
161207043|NCT05004181|582138113|FG004|Overall Study|Lost to Follow-up|5|||
161207044|NCT05004181|582138114|FG005|Overall Study|Lost to Follow-up|2|||
161207045|NCT05004181|582138115|FG006|Overall Study|Lost to Follow-up|15|||
161207046|NCT05004181|582138116|FG007|Overall Study|Lost to Follow-up|12|||
161207047|NCT05004181|582138117|FG008|Overall Study|Lost to Follow-up|38|||
161207048|NCT05004181|582138118|FG009|Overall Study|Lost to Follow-up|6|||
161207049|NCT05004181|582138119|FG010|Overall Study|Lost to Follow-up|6|||
161207050|NCT05004181|582138120|FG011|Overall Study|Lost to Follow-up|0|||
161207051|NCT05004181|582138109|FG000|Overall Study|Death|0|||
161207052|NCT05004181|582138110|FG001|Overall Study|Death|0|||
161207053|NCT05004181|582138111|FG002|Overall Study|Death|0|||
161207054|NCT05004181|582138112|FG003|Overall Study|Death|0|||
161207055|NCT05004181|582138113|FG004|Overall Study|Death|0|||
161207056|NCT05004181|582138114|FG005|Overall Study|Death|0|||
161207057|NCT05004181|582138115|FG006|Overall Study|Death|1|||
161207058|NCT05004181|582138116|FG007|Overall Study|Death|0|||
161207059|NCT05004181|582138117|FG008|Overall Study|Death|2|||
161207060|NCT05004181|582138118|FG009|Overall Study|Death|0|||
161207061|NCT05004181|582138119|FG010|Overall Study|Death|0|||
161207062|NCT05004181|582138120|FG011|Overall Study|Death|0|||
161207063|NCT05004181|582138109|FG000|Overall Study|Physician Decision|0|||
161207064|NCT05004181|582138110|FG001|Overall Study|Physician Decision|0|||
161207065|NCT05004181|582138111|FG002|Overall Study|Physician Decision|0|||
161319213|NCT02757352|582555241|FG007|Follow-Up Period|Lost to Follow-up|0|||
161319214|NCT02757352|582555242|FG008|Follow-Up Period|Lost to Follow-up|1|||
161319215|NCT02757352|582555243|FG009|Follow-Up Period|Lost to Follow-up|0|||
161319216|NCT02757352|582555234|FG000|Follow-Up Period|Lack of Efficacy|0|||
161319217|NCT02757352|582555235|FG001|Follow-Up Period|Lack of Efficacy|0|||
161319218|NCT02757352|582555236|FG002|Follow-Up Period|Lack of Efficacy|0|||
161319219|NCT02757352|582555237|FG003|Follow-Up Period|Lack of Efficacy|0|||
161319220|NCT02757352|582555238|FG004|Follow-Up Period|Lack of Efficacy|0|||
161319221|NCT02757352|582555239|FG005|Follow-Up Period|Lack of Efficacy|0|||
161319222|NCT02757352|582555240|FG006|Follow-Up Period|Lack of Efficacy|0|||
161319223|NCT02757352|582555241|FG007|Follow-Up Period|Lack of Efficacy|0|||
161207066|NCT05004181|582138112|FG003|Overall Study|Physician Decision|0|||
161319224|NCT02757352|582555242|FG008|Follow-Up Period|Lack of Efficacy|1|||
161319225|NCT02757352|582555243|FG009|Follow-Up Period|Lack of Efficacy|1|||
161319226|NCT02757352|582555234|FG000|Follow-Up Period|Withdrawal by Subject|0|||
161319227|NCT02757352|582555235|FG001|Follow-Up Period|Withdrawal by Subject|0|||
161319228|NCT02757352|582555236|FG002|Follow-Up Period|Withdrawal by Subject|0|||
161319229|NCT02757352|582555237|FG003|Follow-Up Period|Withdrawal by Subject|0|||
161319230|NCT02757352|582555238|FG004|Follow-Up Period|Withdrawal by Subject|0|||
161319231|NCT02757352|582555239|FG005|Follow-Up Period|Withdrawal by Subject|0|||
161207067|NCT05004181|582138113|FG004|Overall Study|Physician Decision|0|||
161207068|NCT05004181|582138114|FG005|Overall Study|Physician Decision|0|||
161207069|NCT05004181|582138115|FG006|Overall Study|Physician Decision|2|||
161319232|NCT02757352|582555240|FG006|Follow-Up Period|Withdrawal by Subject|0|||
161319233|NCT02757352|582555241|FG007|Follow-Up Period|Withdrawal by Subject|1|||
161319234|NCT02757352|582555242|FG008|Follow-Up Period|Withdrawal by Subject|6|||
161319235|NCT02757352|582555243|FG009|Follow-Up Period|Withdrawal by Subject|2|||
161319236|NCT03536663|582555244|FG000|Endexo|Protocol Violation|1|||
161319237|NCT01128400|582555245|FG000|Overall Study|Lost to Follow-up|1|||
161319238|NCT01128400|582555246|FG001|Overall Study|Lost to Follow-up|0|||
161319239|NCT01128400|582555247|FG002|Overall Study|Lost to Follow-up|1|||
161319240|NCT01128400|582555245|FG000|Overall Study|Screening failure|1|||
161319241|NCT01128400|582555246|FG001|Overall Study|Screening failure|0|||
161319242|NCT01128400|582555247|FG002|Overall Study|Screening failure|0|||
161319243|NCT01128400|582555245|FG000|Overall Study|were not invited to participate on taste|0|||
161319244|NCT01128400|582555246|FG001|Overall Study|were not invited to participate on taste|0|||
161319245|NCT01128400|582555247|FG002|Overall Study|were not invited to participate on taste|15|||
161319246|NCT01128400|582555245|FG000|Overall Study|Excluded due to sinus problems|0|||
161319247|NCT01128400|582555246|FG001|Overall Study|Excluded due to sinus problems|1|||
161319248|NCT01128400|582555247|FG002|Overall Study|Excluded due to sinus problems|0|||
161319249|NCT04750278|582555248|FG000|Overall Study|Death|9|||
161319250|NCT04750278|582555249|FG001|Overall Study|Death|10|||
161319251|NCT04750278|582555250|FG002|Overall Study|Death|10|||
161319252|NCT04750278|582555248|FG000|Overall Study|Withdrawal by Subject|4|||
161319253|NCT04750278|582555249|FG001|Overall Study|Withdrawal by Subject|1|||
161319254|NCT04750278|582555250|FG002|Overall Study|Withdrawal by Subject|2|||
161319255|NCT04750278|582555248|FG000|Overall Study|Lost to Follow-up|1|||
161319256|NCT04750278|582555249|FG001|Overall Study|Lost to Follow-up|1|||
161319257|NCT04750278|582555250|FG002|Overall Study|Lost to Follow-up|1|||
161319258|NCT04750278|582555248|FG000|Overall Study|Pregnancy|1|||
161319259|NCT04750278|582555249|FG001|Overall Study|Pregnancy|0|||
161319260|NCT04750278|582555250|FG002|Overall Study|Pregnancy|0|||
161319261|NCT04750278|582555248|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
161319262|NCT04750278|582555249|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
161319263|NCT04750278|582555250|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
161319264|NCT04750278|582555248|FG000|Overall Study|Non-compliance|0|||
161319265|NCT04750278|582555249|FG001|Overall Study|Non-compliance|0|||
161319266|NCT04750278|582555250|FG002|Overall Study|Non-compliance|1|||
161319267|NCT04750278|582555248|FG000|Overall Study|Transfer to Outside Facility|0|||
161319268|NCT04750278|582555249|FG001|Overall Study|Transfer to Outside Facility|2|||
161319269|NCT04750278|582555250|FG002|Overall Study|Transfer to Outside Facility|1|||
161319270|NCT04750278|582555248|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
161319271|NCT04750278|582555249|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
161319272|NCT04750278|582555250|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
161319273|NCT04750278|582555248|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
161319274|NCT04750278|582555249|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
161319275|NCT04750278|582555250|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
161319276|NCT01212159|582555251|FG000|Overall Study|Withdrawal by Subject|12|||
161319277|NCT01212159|582555252|FG001|Overall Study|Withdrawal by Subject|12|||
161319278|NCT01299896|582555253|FG000|Overall Study|Withdrawal by Subject|1|||
161319279|NCT01299896|582555254|FG001|Overall Study|Withdrawal by Subject|7|||
161319280|NCT01299896|582555253|FG000|Overall Study|Lost to Follow-up|0|||
161319281|NCT01299896|582555254|FG001|Overall Study|Lost to Follow-up|11|||
161319282|NCT03782571|582555260|FG000|Period 1|Withdrawal by Subject|1|||
161319283|NCT03782571|582555261|FG001|Period 1|Withdrawal by Subject|0|||
161319284|NCT03782571|582555262|FG002|Period 1|Withdrawal by Subject|0|||
161319285|NCT03782571|582555263|FG003|Period 1|Withdrawal by Subject|0|||
161319286|NCT03782571|582555260|FG000|Period 3|Subject Unable to Attend V5|1|||
161319287|NCT03782571|582555261|FG001|Period 3|Subject Unable to Attend V5|0|||
161319288|NCT03782571|582555262|FG002|Period 3|Subject Unable to Attend V5|0|||
161319289|NCT03782571|582555263|FG003|Period 3|Subject Unable to Attend V5|0|||
161319290|NCT03782571|582555260|FG000|Period 3|Adverse Event|1|||
161319291|NCT03782571|582555261|FG001|Period 3|Adverse Event|0|||
161319292|NCT03782571|582555262|FG002|Period 3|Adverse Event|0|||
161319293|NCT03782571|582555263|FG003|Period 3|Adverse Event|0|||
161319294|NCT03504189|582555264|FG000|Overall Study|Withdrawal by Subject|1|||
161319295|NCT03504189|582555264|FG000|Overall Study|Screening Failure|1|||
161319296|NCT03504189|582555264|FG000|Overall Study|Device Failure|2|||
161319297|NCT03488563|582555265|FG000|Overall Study|Lost to Follow-up|7|||
161319298|NCT03488563|582555266|FG001|Overall Study|Lost to Follow-up|6|||
161319299|NCT03488563|582555267|FG002|Overall Study|Lost to Follow-up|7|||
161319300|NCT03488563|582555265|FG000|Overall Study|Withdrawal by Subject|8|||
161319301|NCT03488563|582555266|FG001|Overall Study|Withdrawal by Subject|7|||
161319302|NCT03488563|582555267|FG002|Overall Study|Withdrawal by Subject|7|||
161319303|NCT03488563|582555265|FG000|Overall Study|Physician Decision|0|||
161319304|NCT03488563|582555266|FG001|Overall Study|Physician Decision|0|||
161319305|NCT03488563|582555267|FG002|Overall Study|Physician Decision|1|||
161319306|NCT03488563|582555265|FG000|Overall Study|Protocol Violation|3|||
161319307|NCT03488563|582555266|FG001|Overall Study|Protocol Violation|2|||
161319308|NCT03488563|582555267|FG002|Overall Study|Protocol Violation|6|||
161319309|NCT03488563|582555265|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
161319310|NCT03488563|582555266|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
161319311|NCT03488563|582555267|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
161207070|NCT05004181|582138116|FG007|Overall Study|Physician Decision|0|||
161207071|NCT05004181|582138117|FG008|Overall Study|Physician Decision|7|||
161207072|NCT05004181|582138118|FG009|Overall Study|Physician Decision|0|||
161207073|NCT05004181|582138119|FG010|Overall Study|Physician Decision|0|||
161207074|NCT05004181|582138120|FG011|Overall Study|Physician Decision|0|||
161207075|NCT05004181|582138109|FG000|Overall Study|Withdrawal by Subject|2|||
161207076|NCT05004181|582138110|FG001|Overall Study|Withdrawal by Subject|3|||
161207077|NCT05004181|582138111|FG002|Overall Study|Withdrawal by Subject|2|||
161207078|NCT05004181|582138112|FG003|Overall Study|Withdrawal by Subject|2|||
161207079|NCT05004181|582138113|FG004|Overall Study|Withdrawal by Subject|4|||
161207080|NCT05004181|582138114|FG005|Overall Study|Withdrawal by Subject|2|||
161207081|NCT05004181|582138115|FG006|Overall Study|Withdrawal by Subject|4|||
161319312|NCT03488563|582555265|FG000|Overall Study|Use of prohibited medication|2|||
161319313|NCT03488563|582555266|FG001|Overall Study|Use of prohibited medication|0|||
161319314|NCT03488563|582555267|FG002|Overall Study|Use of prohibited medication|0|||
161319315|NCT03488563|582555265|FG000|Overall Study|Adverse Event|1|||
161319316|NCT03488563|582555266|FG001|Overall Study|Adverse Event|0|||
161319317|NCT03488563|582555267|FG002|Overall Study|Adverse Event|1|||
161207082|NCT05004181|582138116|FG007|Overall Study|Withdrawal by Subject|22|||
161207083|NCT05004181|582138117|FG008|Overall Study|Withdrawal by Subject|8|||
161319513|NCT03383692|582555345|FG000|Overall Study|Clinical progression|0|||
161319514|NCT03383692|582555346|FG001|Overall Study|Clinical progression|1|||
161319515|NCT03383692|582555345|FG000|Overall Study|Adverse Event|3|||
161319516|NCT03383692|582555346|FG001|Overall Study|Adverse Event|0|||
161319517|NCT03816007|582555348|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
161319518|NCT03816007|582555349|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
161319519|NCT03816007|582555348|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
161319520|NCT03816007|582555349|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
161319521|NCT03816007|582555348|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
161319522|NCT03816007|582555349|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
161319523|NCT02179749|582555353|FG000|Overall Study|Adverse Event|0|||
161319524|NCT02179749|582555354|FG001|Overall Study|Adverse Event|0|||
161319525|NCT02179749|582555355|FG002|Overall Study|Adverse Event|1|||
161319526|NCT02179749|582555353|FG000|Overall Study|Withdrawal by Subject|0|||
161319527|NCT02179749|582555354|FG001|Overall Study|Withdrawal by Subject|0|||
161319528|NCT02179749|582555355|FG002|Overall Study|Withdrawal by Subject|1|||
161319529|NCT01810783|582555356|FG000|Overall Study|Adverse Event|32|||
161319530|NCT01810783|582555356|FG000|Overall Study|Withdrawal by Subject|22|||
161319531|NCT01810783|582555356|FG000|Overall Study|Lack of Efficacy|12|||
161319532|NCT01810783|582555356|FG000|Overall Study|Lost to Follow-up|10|||
161319533|NCT01810783|582555356|FG000|Overall Study|Protocol Violation|5|||
161319534|NCT01810783|582555356|FG000|Overall Study|Non-compliance with IMP|4|||
161319535|NCT01810783|582555356|FG000|Overall Study|Adminstrative or other reason(s)|23|||
161319536|NCT01810783|582555356|FG000|Overall Study|Enrolled, not treated|1|||
161319537|NCT00793546|582555357|FG000|Overall Study|Death|3|||
161319538|NCT00793546|582555358|FG001|Overall Study|Death|0|||
161319539|NCT00793546|582555357|FG000|Overall Study|Lost to Follow-up|1|||
161319540|NCT00793546|582555358|FG001|Overall Study|Lost to Follow-up|0|||
161319541|NCT00793546|582555357|FG000|Overall Study|Withdrawal by Subject|1|||
161319542|NCT00793546|582555358|FG001|Overall Study|Withdrawal by Subject|1|||
161319543|NCT00793546|582555357|FG000|Overall Study|Study Terminated by Sponsor|8|||
161319544|NCT00793546|582555358|FG001|Overall Study|Study Terminated by Sponsor|27|||
161319545|NCT00793546|582555357|FG000|Overall Study|Other|1|||
161319546|NCT00793546|582555358|FG001|Overall Study|Other|0|||
161319547|NCT00630747|582555359|FG000|Overall Study|Death|1|||
161319548|NCT00630747|582555359|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
161319549|NCT00630747|582555359|FG000|Overall Study|Returned to country of origin|1|||
161319550|NCT01210352|582555360|FG000|Overall Study|Adverse Event|0|||
161319551|NCT01210352|582555361|FG001|Overall Study|Adverse Event|0|||
161319552|NCT01210352|582555362|FG002|Overall Study|Adverse Event|0|||
161319553|NCT01210352|582555363|FG003|Overall Study|Adverse Event|0|||
161319554|NCT01210352|582555364|FG004|Overall Study|Adverse Event|0|||
161319555|NCT01210352|582555365|FG005|Overall Study|Adverse Event|0|||
161319556|NCT01210352|582555366|FG006|Overall Study|Adverse Event|0|||
161319557|NCT01210352|582555367|FG007|Overall Study|Adverse Event|2|||
161319558|NCT01210352|582555368|FG008|Overall Study|Adverse Event|1|||
161319559|NCT01210352|582555360|FG000|Overall Study|Lack of Efficacy|0|||
161319560|NCT01210352|582555361|FG001|Overall Study|Lack of Efficacy|0|||
161319561|NCT01210352|582555362|FG002|Overall Study|Lack of Efficacy|0|||
161319562|NCT01210352|582555363|FG003|Overall Study|Lack of Efficacy|0|||
161319563|NCT01210352|582555364|FG004|Overall Study|Lack of Efficacy|0|||
161319564|NCT01210352|582555365|FG005|Overall Study|Lack of Efficacy|0|||
161319565|NCT01210352|582555366|FG006|Overall Study|Lack of Efficacy|1|||
161319566|NCT01210352|582555367|FG007|Overall Study|Lack of Efficacy|0|||
161319567|NCT01210352|582555368|FG008|Overall Study|Lack of Efficacy|0|||
161319568|NCT01210352|582555360|FG000|Overall Study|Physician Decision|0|||
161319569|NCT01210352|582555361|FG001|Overall Study|Physician Decision|0|||
161319570|NCT01210352|582555362|FG002|Overall Study|Physician Decision|0|||
161319571|NCT01210352|582555363|FG003|Overall Study|Physician Decision|0|||
161319572|NCT01210352|582555364|FG004|Overall Study|Physician Decision|0|||
161319573|NCT01210352|582555365|FG005|Overall Study|Physician Decision|0|||
161319574|NCT01210352|582555366|FG006|Overall Study|Physician Decision|0|||
161319575|NCT01210352|582555367|FG007|Overall Study|Physician Decision|1|||
161319576|NCT01210352|582555368|FG008|Overall Study|Physician Decision|2|||
161319577|NCT01210352|582555360|FG000|Overall Study|Withdrawal by Subject|0|||
161319578|NCT01210352|582555361|FG001|Overall Study|Withdrawal by Subject|0|||
161319579|NCT01210352|582555362|FG002|Overall Study|Withdrawal by Subject|1|||
161319580|NCT01210352|582555363|FG003|Overall Study|Withdrawal by Subject|0|||
161319581|NCT01210352|582555364|FG004|Overall Study|Withdrawal by Subject|0|||
161319582|NCT01210352|582555365|FG005|Overall Study|Withdrawal by Subject|0|||
161319583|NCT01210352|582555366|FG006|Overall Study|Withdrawal by Subject|1|||
161319584|NCT01210352|582555367|FG007|Overall Study|Withdrawal by Subject|0|||
161319585|NCT01210352|582555368|FG008|Overall Study|Withdrawal by Subject|1|||
161319586|NCT01210352|582555360|FG000|Overall Study|Patient Discharged Early|0|||
161319587|NCT01210352|582555361|FG001|Overall Study|Patient Discharged Early|0|||
161319588|NCT01210352|582555362|FG002|Overall Study|Patient Discharged Early|1|||
161319589|NCT01210352|582555363|FG003|Overall Study|Patient Discharged Early|0|||
161319590|NCT01210352|582555364|FG004|Overall Study|Patient Discharged Early|0|||
161319591|NCT01210352|582555365|FG005|Overall Study|Patient Discharged Early|0|||
161319592|NCT01210352|582555366|FG006|Overall Study|Patient Discharged Early|0|||
161319593|NCT01210352|582555367|FG007|Overall Study|Patient Discharged Early|0|||
161319594|NCT01210352|582555368|FG008|Overall Study|Patient Discharged Early|0|||
161319595|NCT03338569|582555369|FG000|Overall Study|Physician Decision|8|||
161319596|NCT03338569|582555370|FG001|Overall Study|Physician Decision|3|||
161319597|NCT03338569|582555369|FG000|Overall Study|Withdrawal by Subject|0|||
161319598|NCT03338569|582555370|FG001|Overall Study|Withdrawal by Subject|1|||
161319599|NCT03338569|582555369|FG000|Overall Study|Lost to Follow-up|0|||
161319600|NCT03338569|582555370|FG001|Overall Study|Lost to Follow-up|1|||
161319601|NCT02526160|582557078|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
161319602|NCT02526160|582557079|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
161319603|NCT02526160|582557078|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
161319604|NCT02526160|582557079|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
161319605|NCT02526160|582557078|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
161319606|NCT02526160|582557079|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
161319607|NCT02526160|582557078|FG000|Open-Label Treatment Extension Period I|Death|0|||
161319608|NCT02526160|582557079|FG001|Open-Label Treatment Extension Period I|Death|1|||
161319609|NCT02526160|582557078|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
161319610|NCT02526160|582557079|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
161319611|NCT02526160|582557078|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
161319612|NCT02526160|582557079|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
161319613|NCT02526160|582557078|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
161319614|NCT02526160|582557079|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
161319615|NCT02526160|582557078|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
161319616|NCT02526160|582557079|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
161319617|NCT04227405|582557080|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
161319618|NCT04227405|582557081|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
161319619|NCT04227405|582557080|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
161319620|NCT04227405|582557081|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
161319621|NCT04227405|582557080|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
161319622|NCT04227405|582557081|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
161319623|NCT01502956|582557082|FG000|Overall Study|Death|0|||
161319624|NCT01502956|582557083|FG001|Overall Study|Death|2|||
161319625|NCT01502956|582557082|FG000|Overall Study|Lost to Follow-up|14|||
161319626|NCT01502956|582557083|FG001|Overall Study|Lost to Follow-up|11|||
161319627|NCT01502956|582557082|FG000|Overall Study|Physician Decision|2|||
161319628|NCT01502956|582557083|FG001|Overall Study|Physician Decision|3|||
161319629|NCT01502956|582557082|FG000|Overall Study|Withdrawal by Subject|8|||
161319630|NCT01502956|582557083|FG001|Overall Study|Withdrawal by Subject|10|||
161319631|NCT01616758|582557084|FG000|Overall Study|Adverse Event|1|||
161319632|NCT01616758|582557084|FG000|Overall Study|Withdrawal by Subject|2|||
161319633|NCT01616758|582557084|FG000|Overall Study|Disease progression|18|||
161319634|NCT01616758|582557084|FG000|Overall Study|Study termination by Sponsor|1|||
161319635|NCT04076319|582557089|FG000|Overall Study|Withdrawal by Subject|2|||
161319636|NCT04076319|582557090|FG001|Overall Study|Withdrawal by Subject|0|||
161319637|NCT04076319|582557089|FG000|Overall Study|Death|1|||
161319638|NCT04076319|582557090|FG001|Overall Study|Death|0|||
161319639|NCT01054222|582557091|FG000|Overall Study|Lack of Efficacy|1|||
161319640|NCT01054222|582557091|FG000|Overall Study|Lost to Follow-up|4|||
161319641|NCT01054222|582557091|FG000|Overall Study|Withdrawal by Subject|6|||
161319642|NCT03252145|582557095|FG000|Overall Study|Withdrawal by Subject|1|||
161319643|NCT03252145|582557096|FG001|Overall Study|Withdrawal by Subject|0|||
161319644|NCT03252145|582557095|FG000|Overall Study|Complicating Disease|1|||
161319645|NCT03252145|582557096|FG001|Overall Study|Complicating Disease|2|||
161319646|NCT01763827|582557100|FG000|Overall Study|Withdrawal by Subject|1|||
161319647|NCT01763827|582557101|FG001|Overall Study|Withdrawal by Subject|0|||
161319648|NCT01763827|582557102|FG002|Overall Study|Withdrawal by Subject|0|||
161319649|NCT01763827|582557103|FG003|Overall Study|Withdrawal by Subject|0|||
161319650|NCT01763827|582557104|FG004|Overall Study|Withdrawal by Subject|2|||
161319651|NCT01763827|582557105|FG005|Overall Study|Withdrawal by Subject|0|||
161319652|NCT01763827|582557100|FG000|Overall Study|Decision by sponsor|2|||
161319653|NCT01763827|582557101|FG001|Overall Study|Decision by sponsor|0|||
161319654|NCT01763827|582557102|FG002|Overall Study|Decision by sponsor|3|||
161319655|NCT01763827|582557103|FG003|Overall Study|Decision by sponsor|0|||
161319656|NCT01763827|582557104|FG004|Overall Study|Decision by sponsor|2|||
161319657|NCT01763827|582557105|FG005|Overall Study|Decision by sponsor|1|||
161319658|NCT01763827|582557100|FG000|Overall Study|Lost to Follow-up|0|||
161319659|NCT01763827|582557101|FG001|Overall Study|Lost to Follow-up|1|||
161319660|NCT01763827|582557102|FG002|Overall Study|Lost to Follow-up|1|||
161319661|NCT01763827|582557103|FG003|Overall Study|Lost to Follow-up|1|||
161319662|NCT01763827|582557104|FG004|Overall Study|Lost to Follow-up|2|||
161319663|NCT01763827|582557105|FG005|Overall Study|Lost to Follow-up|1|||
161319664|NCT02187029|582557108|FG000|Overall Study|Adverse Event|0|||
161319665|NCT02187029|582557109|FG001|Overall Study|Adverse Event|1|||
161319666|NCT02187029|582557110|FG002|Overall Study|Adverse Event|1|||
161319667|NCT02187029|582557111|FG003|Overall Study|Adverse Event|0|||
161319668|NCT02187029|582557108|FG000|Overall Study|Study Terminated by Sponsor|0|||
161319669|NCT02187029|582557109|FG001|Overall Study|Study Terminated by Sponsor|0|||
161319670|NCT02187029|582557110|FG002|Overall Study|Study Terminated by Sponsor|10|||
161319671|NCT02187029|582557111|FG003|Overall Study|Study Terminated by Sponsor|3|||
161319672|NCT02187029|582557108|FG000|Overall Study|Withdrawal by Subject|1|||
161319673|NCT02187029|582557109|FG001|Overall Study|Withdrawal by Subject|0|||
161319674|NCT02187029|582557110|FG002|Overall Study|Withdrawal by Subject|0|||
161319675|NCT02187029|582557111|FG003|Overall Study|Withdrawal by Subject|0|||
161319676|NCT02985021|582557112|FG000|Overall Study|Inability to comply with study procedures|1|||
161319677|NCT04105842|582557113|FG000|Overall Study|Withdrawal by Subject|2|||
161319678|NCT01535443|582557119|FG000|Overall Study|Physician Decision|3|||
161319679|NCT00760487|582557121|FG000|Overall Study|Unilateral implantation|3|||
161319680|NCT02260817|582557125|FG000|Overall Study|Lost to Follow-up|0|||
161319681|NCT02260817|582557126|FG001|Overall Study|Lost to Follow-up|14|||
161319682|NCT02260817|582557125|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
161319683|NCT02260817|582557126|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
161319684|NCT02260817|582557125|FG000|Overall Study|Observation, no biopsy|0|||
161319685|NCT02260817|582557126|FG001|Overall Study|Observation, no biopsy|1|||
161319686|NCT02260817|582557125|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
161319687|NCT02260817|582557126|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
161319688|NCT02260817|582557125|FG000|Overall Study|Protocol Violation|0|||
161319689|NCT02260817|582557126|FG001|Overall Study|Protocol Violation|14|||
161319690|NCT03299101|582557127|FG000|Overall Study|Lost to Follow-up|1|||
161319691|NCT03299101|582557127|FG000|Overall Study|Withdrawal by Subject|5|||
161319692|NCT03299101|582557127|FG000|Overall Study|Surgery was changed|3|||
161319693|NCT03299101|582557127|FG000|Overall Study|Not enough time to complete prehab|1|||
161319694|NCT04217317|582557130|FG000|Overall Study|Lack of Efficacy|4|||
161319695|NCT04217317|582557130|FG000|Overall Study|Physician Decision|1|||
161319696|NCT00329745|582557131|FG000|Overall Study|Protocol Violation|1|||
161319697|NCT00329745|582557132|FG001|Overall Study|Protocol Violation|0|||
161319698|NCT00329745|582557131|FG000|Overall Study|Withdrawal by Subject|0|||
161319699|NCT00329745|582557132|FG001|Overall Study|Withdrawal by Subject|1|||
161319700|NCT00329745|582557131|FG000|Overall Study|Lost to Follow-up|86|||
161319701|NCT00329745|582557132|FG001|Overall Study|Lost to Follow-up|101|||
161319702|NCT03146741|582557133|FG000|Overall Study|Txp with non-HCV+ heart|4|||
161319703|NCT03146741|582557133|FG000|Overall Study|Listeted for MOT|2|||
161319704|NCT03146741|582557133|FG000|Overall Study|Physician Decision|2|||
161319705|NCT03146741|582557133|FG000|Overall Study|Awaiting txp|2|||
161319706|NCT03224624|582557134|FG000|Overall Study|Lost to Follow-up|9|||
161319707|NCT03224624|582557135|FG001|Overall Study|Lost to Follow-up|4|||
161319708|NCT03224624|582557134|FG000|Overall Study|Death|1|||
161319709|NCT03224624|582557135|FG001|Overall Study|Death|0|||
161319710|NCT01424241|582557138|FG000|Overall Study|Withdrawal by Subject|1|||
161319711|NCT01424241|582557138|FG000|Overall Study|Time constraints|2|||
161319712|NCT03585712|582557144|FG000|Treatment Period 1|Protocol Violation|1|||
161319713|NCT03585712|582557145|FG001|Treatment Period 1|Protocol Violation|0|||
161319714|NCT03585712|582557146|FG002|Treatment Period 1|Protocol Violation|0|||
161319715|NCT03585712|582557144|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
161319716|NCT03585712|582557145|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
161319717|NCT03585712|582557146|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
161319718|NCT03585712|582557144|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
161319719|NCT03585712|582557145|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
161319720|NCT03585712|582557146|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
161319721|NCT03585712|582557144|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
161319722|NCT03585712|582557145|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
161319723|NCT03585712|582557146|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
161319724|NCT03517449|582557149|FG000|Overall Study|Death|184|||
161319725|NCT03517449|582557150|FG001|Overall Study|Death|236|||
161319726|NCT03517449|582557149|FG000|Overall Study|Lost to Follow-up|0|||
161319727|NCT03517449|582557150|FG001|Overall Study|Lost to Follow-up|2|||
161319728|NCT03517449|582557149|FG000|Overall Study|Withdrawal by Subject|7|||
161319729|NCT03517449|582557150|FG001|Overall Study|Withdrawal by Subject|26|||
161319730|NCT03517449|582557149|FG000|Overall Study|Participants Ongoing|220|||
161319731|NCT03517449|582557150|FG001|Overall Study|Participants Ongoing|152|||
161319732|NCT02347072|582557154|FG000|Overall Study|Adverse Event|2|||
161319733|NCT02347072|582557154|FG000|Overall Study|Withdrawal by Subject|6|||
161319734|NCT02347072|582557154|FG000|Overall Study|Physician Decision|1|||
161319735|NCT02347072|582557154|FG000|Overall Study|Lost to Follow-up|2|||
161319736|NCT02347072|582557154|FG000|Overall Study|Protocol Violation|1|||
161319737|NCT02347072|582557154|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
161319738|NCT03230838|582557159|FG000|Overall Study|Withdrawal by Subject|3|||
161319739|NCT03230838|582557160|FG001|Overall Study|Withdrawal by Subject|0|||
161319740|NCT03230838|582557159|FG000|Overall Study|Temperature excursion|1|||
161319741|NCT03230838|582557160|FG001|Overall Study|Temperature excursion|0|||
161319742|NCT02324699|582557161|FG000|Overall Study|study terminated|1|||
161319743|NCT01607346|582557162|FG000|Overall Study|Adverse Event|3|||
161319744|NCT01098162|582557163|FG000|Overall Study|Adverse Event|37|||
161319745|NCT01098162|582557163|FG000|Overall Study|Lack of Efficacy|4|||
161319746|NCT01098162|582557163|FG000|Overall Study|Wish of Patient|7|||
161319747|NCT01098162|582557163|FG000|Overall Study|Lost to Follow-up|9|||
161319748|NCT01098162|582557163|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
161319749|NCT01098162|582557163|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
161319750|NCT01098162|582557163|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
161319751|NCT01098162|582557163|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
161319752|NCT01098162|582557163|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
161319753|NCT01098162|582557163|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
161319754|NCT01098162|582557163|FG000|Overall Study|Other Reason|1|||
161319755|NCT01098162|582557163|FG000|Overall Study|Reason Unknown|26|||
161319756|NCT01605825|582557164|FG000|Overall Study|Adverse Event|4|||
161319757|NCT01605825|582557165|FG001|Overall Study|Adverse Event|2|||
161319758|NCT01605825|582557164|FG000|Overall Study|Withdrawal by Subject|0|||
161319759|NCT01605825|582557165|FG001|Overall Study|Withdrawal by Subject|1|||
161319760|NCT01605825|582557164|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
161319761|NCT01605825|582557165|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
161319762|NCT01605825|582557164|FG000|Overall Study|Non-Compliance with Protocol|3|||
161319763|NCT01605825|582557165|FG001|Overall Study|Non-Compliance with Protocol|0|||
161319764|NCT02279745|582557166|FG000|Overall Study|Adverse Event|7|||
161319765|NCT02279745|582557166|FG000|Overall Study|Death|6|||
161319766|NCT02279745|582557166|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
161319767|NCT02279745|582557166|FG000|Overall Study|Withdrawal by Subject|2|||
161319768|NCT02279745|582557166|FG000|Overall Study|Pregnancy|1|||
161319769|NCT02279745|582557166|FG000|Overall Study|Study Non-compliance|1|||
161319770|NCT02279745|582557166|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
161319771|NCT00380718|582557167|FG000|Overall Study|Adverse Event|1|||
161319772|NCT00380718|582557167|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
161319773|NCT01706575|582557169|FG000|Overall Study|Participant Withdrew Consent|4|||
161319774|NCT01706575|582557169|FG000|Overall Study|Lost to Follow-up|2|||
161319775|NCT01706575|582557169|FG000|Overall Study|Started but not Treated|6|||
161319776|NCT01215435|582557173|FG000|Overall Study|Adverse Event|1|||
161319777|NCT01215435|582557174|FG001|Overall Study|Adverse Event|0|||
161319778|NCT01215435|582557173|FG000|Overall Study|Protocol Violation|2|||
161319779|NCT01215435|582557174|FG001|Overall Study|Protocol Violation|0|||
161319780|NCT01215435|582557173|FG000|Overall Study|Withdrawal Criteria|8|||
161319781|NCT01215435|582557174|FG001|Overall Study|Withdrawal Criteria|11|||
161319782|NCT01215435|582557173|FG000|Overall Study|Lost to Follow-up|3|||
161319783|NCT01215435|582557174|FG001|Overall Study|Lost to Follow-up|0|||
161319784|NCT01215435|582557173|FG000|Overall Study|Unclassified|5|||
161319785|NCT01215435|582557174|FG001|Overall Study|Unclassified|5|||
161319786|NCT00840034|582557175|FG000|Acute Treatment Phase|Adverse Event|6|||
161319787|NCT00840034|582557176|FG001|Acute Treatment Phase|Adverse Event|8|||
161319788|NCT00840034|582557175|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
161319789|NCT00840034|582557176|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
161319790|NCT00840034|582557175|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
161319791|NCT00840034|582557176|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
161319792|NCT00840034|582557175|FG000|Acute Treatment Phase|Physician Decision|0|||
161319793|NCT00840034|582557176|FG001|Acute Treatment Phase|Physician Decision|1|||
161319794|NCT00840034|582557175|FG000|Acute Treatment Phase|Protocol Violation|2|||
161319795|NCT00840034|582557176|FG001|Acute Treatment Phase|Protocol Violation|4|||
161319796|NCT00840034|582557175|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
161319797|NCT00840034|582557176|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
161319798|NCT00840034|582557175|FG000|Taper Phase|Adverse Event|1|||
161319799|NCT00840034|582557176|FG001|Taper Phase|Adverse Event|0|||
161319800|NCT00840034|582557175|FG000|Taper Phase|Lost to Follow-up|1|||
161319801|NCT00840034|582557176|FG001|Taper Phase|Lost to Follow-up|1|||
161319802|NCT00840034|582557175|FG000|Taper Phase|Withdrawal by Subject|1|||
161319803|NCT00840034|582557176|FG001|Taper Phase|Withdrawal by Subject|1|||
161319804|NCT02839876|582557181|FG000|Overall Study|Protocol Violation|10|||
161319805|NCT02839876|582557182|FG001|Overall Study|Protocol Violation|11|||
161319806|NCT01156051|582557183|FG000|Overall Study|Lost to Follow-up|1|||
161319807|NCT01156051|582557184|FG001|Overall Study|Lost to Follow-up|0|||
161319808|NCT01156051|582557183|FG000|Overall Study|patient not compliant with protocol|0|||
161319809|NCT01156051|582557184|FG001|Overall Study|patient not compliant with protocol|1|||
161319810|NCT00094536|582557185|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
161319811|NCT00094536|582557185|FG000|Treatment and Follow-up|Adverse Event|4|||
161319812|NCT00094536|582557185|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
161319813|NCT00094536|582557185|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
161319814|NCT00094536|582557185|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
161319815|NCT00094536|582557185|FG000|Treatment and Follow-up|Subject non-compliance|9|||
161319816|NCT00094536|582557185|FG000|Treatment and Follow-up|Unable to attend visits|1|||
161319817|NCT02620384|582557186|FG000|Overall Study|Adverse Event|2|||
161319818|NCT02620384|582557187|FG001|Overall Study|Adverse Event|1|||
161319819|NCT02620384|582557186|FG000|Overall Study|Discharged prior to 2nd dose|2|||
161319820|NCT02620384|582557187|FG001|Overall Study|Discharged prior to 2nd dose|5|||
161319821|NCT02620384|582557186|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
161319822|NCT02620384|582557187|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
161319823|NCT02071082|582557188|FG000|Overall Study|Enrolled and Never Treated|1|||
161319824|NCT02071082|582557189|FG001|Overall Study|Enrolled and Never Treated|1|||
161319825|NCT02071082|582557188|FG000|Overall Study|Adverse Event|0|||
161319826|NCT02071082|582557189|FG001|Overall Study|Adverse Event|1|||
161319827|NCT02071082|582557188|FG000|Overall Study|Withdrew Consent|0|||
161319828|NCT02071082|582557189|FG001|Overall Study|Withdrew Consent|4|||
161319829|NCT02071082|582557188|FG000|Overall Study|Lost to Follow-up|1|||
161319830|NCT02071082|582557189|FG001|Overall Study|Lost to Follow-up|1|||
161319831|NCT02101359|582557190|FG000|Overall Study|Not included|23|||
161319832|NCT02101359|582557191|FG001|Overall Study|Not included|13|||
161319833|NCT02101359|582557190|FG000|Overall Study|Withdrawal by Subject|5|||
161319834|NCT02101359|582557191|FG001|Overall Study|Withdrawal by Subject|4|||
161319835|NCT02101359|582557190|FG000|Overall Study|Lost to Follow-up|1|||
161319836|NCT02101359|582557191|FG001|Overall Study|Lost to Follow-up|0|||
161319837|NCT02101359|582557190|FG000|Overall Study|Protocol Violation|0|||
161319838|NCT02101359|582557191|FG001|Overall Study|Protocol Violation|2|||
161319839|NCT00494221|582557192|FG000|Overall Study|Death|15|||
161319840|NCT00494221|582557193|FG001|Overall Study|Death|9|||
161319841|NCT00494221|582557194|FG002|Overall Study|Death|14|||
161319842|NCT00494221|582557192|FG000|Overall Study|Withdrawal by Subject|1|||
161319843|NCT00494221|582557193|FG001|Overall Study|Withdrawal by Subject|2|||
161319844|NCT00494221|582557194|FG002|Overall Study|Withdrawal by Subject|0|||
161319845|NCT01900431|582557199|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
161319846|NCT01900431|582557200|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
161319847|NCT01900431|582557201|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
161319848|NCT01900431|582557199|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
161319849|NCT01900431|582557200|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
161319850|NCT01900431|582557201|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
161319851|NCT01900431|582557199|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
161319852|NCT01900431|582557200|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
161319853|NCT01900431|582557201|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
161319854|NCT01900431|582557199|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
161319855|NCT01900431|582557200|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
161319856|NCT01900431|582557201|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
161319857|NCT01900431|582557199|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
161319858|NCT01900431|582557200|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
161319859|NCT01900431|582557201|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
161319860|NCT01900431|582557199|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
161319861|NCT01900431|582557200|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
161319862|NCT01900431|582557201|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
161319863|NCT01900431|582557199|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
161319864|NCT01900431|582557200|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
161319865|NCT01900431|582557201|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
161319866|NCT01900431|582557199|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
161319867|NCT01900431|582557200|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
161319868|NCT01900431|582557201|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
161319869|NCT01900431|582557199|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
161091328|NCT01551212|581723887|FG000|Overall Study|Administrative problems|1|||
161091329|NCT01551212|581723888|FG001|Overall Study|Administrative problems|2|||
161091330|NCT01551212|581723887|FG000|Overall Study|Lost to Follow-up|0|||
161091331|NCT01551212|581723888|FG001|Overall Study|Lost to Follow-up|1|||
161091332|NCT01551212|581723887|FG000|Overall Study|Protocol Violation|0|||
161091333|NCT01551212|581723888|FG001|Overall Study|Protocol Violation|1|||
161091334|NCT01551212|581723887|FG000|Overall Study|Withdrawal by Subject|0|||
161091335|NCT01551212|581723888|FG001|Overall Study|Withdrawal by Subject|7|||
161091336|NCT01551212|581723887|FG000|Overall Study|Death|2|||
161091337|NCT01551212|581723888|FG001|Overall Study|Death|4|||
161091338|NCT01551212|581723887|FG000|Overall Study|Never Received Study Treatment|2|||
161091339|NCT01551212|581723888|FG001|Overall Study|Never Received Study Treatment|4|||
161091340|NCT04217590|581723889|FG000|Overall Study|Other|1|||
161091341|NCT04217590|581723890|FG001|Overall Study|Other|1|||
161091342|NCT04217590|581723889|FG000|Overall Study|Withdrawal by Subject|3|||
161091343|NCT04217590|581723890|FG001|Overall Study|Withdrawal by Subject|1|||
161091344|NCT04217590|581723889|FG000|Overall Study|Death|0|||
161091345|NCT04217590|581723890|FG001|Overall Study|Death|1|||
161091346|NCT01013285|581723891|FG000|Overall Study|Death|48|||
161091347|NCT01013285|581723892|FG001|Overall Study|Death|89|||
161091348|NCT01395888|581723893|FG000|2-week Run-in Period|Adverse Event|2|||
161091349|NCT01395888|581723894|FG001|2-week Run-in Period|Adverse Event|0|||
161091350|NCT01395888|581723895|FG002|2-week Run-in Period|Adverse Event|0|||
161091351|NCT01395888|581723893|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
161091352|NCT01395888|581723894|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
161091353|NCT01395888|581723895|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
161091354|NCT01395888|581723893|FG000|2-week Run-in Period|Lost to Follow-up|1|||
161091355|NCT01395888|581723894|FG001|2-week Run-in Period|Lost to Follow-up|0|||
161091356|NCT01395888|581723895|FG002|2-week Run-in Period|Lost to Follow-up|0|||
161091357|NCT01395888|581723893|FG000|2-week Run-in Period|Protocol Violation|2|||
161091358|NCT01395888|581723894|FG001|2-week Run-in Period|Protocol Violation|0|||
161091359|NCT01395888|581723895|FG002|2-week Run-in Period|Protocol Violation|0|||
161091360|NCT01395888|581723893|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
161091361|NCT01395888|581723894|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
161091362|NCT01395888|581723895|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
161091363|NCT01395888|581723893|FG000|Treatment Period (TP)|Adverse Event|0|||
161091364|NCT01395888|581723894|FG001|Treatment Period (TP)|Adverse Event|7|||
161091365|NCT01395888|581723895|FG002|Treatment Period (TP)|Adverse Event|6|||
161091366|NCT01395888|581723893|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
161091367|NCT01395888|581723894|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
161091368|NCT01395888|581723895|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
161091369|NCT01395888|581723893|FG000|Treatment Period (TP)|Protocol Violation|0|||
161091370|NCT01395888|581723894|FG001|Treatment Period (TP)|Protocol Violation|1|||
161091371|NCT01395888|581723895|FG002|Treatment Period (TP)|Protocol Violation|5|||
161091372|NCT01395888|581723893|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
161091373|NCT01395888|581723894|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
161091374|NCT01395888|581723895|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
161091375|NCT01395888|581723893|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
161091376|NCT01395888|581723894|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
161091377|NCT01395888|581723895|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
161091378|NCT02457559|581723896|FG000|Overall Study|Progressive Disease|1|||
161091379|NCT02457559|581723897|FG001|Overall Study|Progressive Disease|2|||
161091380|NCT02457559|581723898|FG002|Overall Study|Progressive Disease|3|||
161091381|NCT02457559|581723899|FG003|Overall Study|Progressive Disease|0|||
161091382|NCT02457559|581723900|FG004|Overall Study|Progressive Disease|0|||
161091383|NCT02457559|581723901|FG005|Overall Study|Progressive Disease|2|||
161091384|NCT02457559|581723902|FG006|Overall Study|Progressive Disease|1|||
161091385|NCT02457559|581723903|FG007|Overall Study|Progressive Disease|0|||
161091386|NCT02457559|581723904|FG008|Overall Study|Progressive Disease|1|||
161091387|NCT02457559|581723905|FG009|Overall Study|Progressive Disease|1|||
161091388|NCT02457559|581723906|FG010|Overall Study|Progressive Disease|1|||
161091389|NCT02457559|581723896|FG000|Overall Study|Investigator's Discretion|0|||
161091390|NCT02457559|581723897|FG001|Overall Study|Investigator's Discretion|0|||
161091391|NCT02457559|581723898|FG002|Overall Study|Investigator's Discretion|2|||
161091392|NCT02457559|581723899|FG003|Overall Study|Investigator's Discretion|0|||
161091393|NCT02457559|581723900|FG004|Overall Study|Investigator's Discretion|1|||
161091394|NCT02457559|581723901|FG005|Overall Study|Investigator's Discretion|0|||
161091395|NCT02457559|581723902|FG006|Overall Study|Investigator's Discretion|1|||
161091396|NCT02457559|581723903|FG007|Overall Study|Investigator's Discretion|0|||
161091397|NCT02457559|581723904|FG008|Overall Study|Investigator's Discretion|1|||
161091398|NCT02457559|581723905|FG009|Overall Study|Investigator's Discretion|0|||
161091399|NCT02457559|581723906|FG010|Overall Study|Investigator's Discretion|1|||
161091400|NCT02457559|581723896|FG000|Overall Study|Adverse Event|0|||
161091401|NCT02457559|581723897|FG001|Overall Study|Adverse Event|1|||
161091402|NCT02457559|581723898|FG002|Overall Study|Adverse Event|2|||
161091403|NCT02457559|581723899|FG003|Overall Study|Adverse Event|0|||
161091404|NCT02457559|581723900|FG004|Overall Study|Adverse Event|0|||
161091405|NCT02457559|581723901|FG005|Overall Study|Adverse Event|0|||
161091406|NCT02457559|581723902|FG006|Overall Study|Adverse Event|0|||
161091407|NCT02457559|581723903|FG007|Overall Study|Adverse Event|0|||
161091408|NCT02457559|581723904|FG008|Overall Study|Adverse Event|0|||
161091409|NCT02457559|581723905|FG009|Overall Study|Adverse Event|0|||
161091410|NCT02457559|581723906|FG010|Overall Study|Adverse Event|0|||
161091411|NCT02457559|581723896|FG000|Overall Study|Reason not Specified|1|||
161091412|NCT02457559|581723897|FG001|Overall Study|Reason not Specified|0|||
161091413|NCT02457559|581723898|FG002|Overall Study|Reason not Specified|0|||
161091414|NCT02457559|581723899|FG003|Overall Study|Reason not Specified|0|||
161091415|NCT02457559|581723900|FG004|Overall Study|Reason not Specified|0|||
161091416|NCT02457559|581723901|FG005|Overall Study|Reason not Specified|0|||
161091417|NCT02457559|581723902|FG006|Overall Study|Reason not Specified|0|||
161091418|NCT02457559|581723903|FG007|Overall Study|Reason not Specified|0|||
161091419|NCT02457559|581723904|FG008|Overall Study|Reason not Specified|0|||
161091420|NCT02457559|581723905|FG009|Overall Study|Reason not Specified|2|||
161091421|NCT02457559|581723906|FG010|Overall Study|Reason not Specified|0|||
161091422|NCT02457559|581723896|FG000|Overall Study|Death|0|||
161091423|NCT02457559|581723897|FG001|Overall Study|Death|0|||
161091424|NCT02457559|581723898|FG002|Overall Study|Death|0|||
161091425|NCT02457559|581723899|FG003|Overall Study|Death|0|||
161091426|NCT02457559|581723900|FG004|Overall Study|Death|0|||
161091427|NCT02457559|581723901|FG005|Overall Study|Death|0|||
161091428|NCT02457559|581723902|FG006|Overall Study|Death|0|||
161091429|NCT02457559|581723903|FG007|Overall Study|Death|0|||
161091430|NCT02457559|581723904|FG008|Overall Study|Death|1|||
161091431|NCT02457559|581723905|FG009|Overall Study|Death|1|||
161091432|NCT02457559|581723906|FG010|Overall Study|Death|0|||
161091433|NCT05590884|581723907|FG000|Overall Study|Withdrawal by Subject|1|||
161091434|NCT05590884|581723908|FG001|Overall Study|Withdrawal by Subject|0|||
161091435|NCT05590884|581723909|FG002|Overall Study|Withdrawal by Subject|0|||
161091436|NCT04134845|581723919|FG000|Overall Study|withdrawl by PI|12|||
161091437|NCT04134845|581723920|FG001|Overall Study|withdrawl by PI|5|||
161091438|NCT03110224|581723921|FG000|Overall Study|Death|3|||
161091439|NCT03110224|581723921|FG000|Overall Study|Lost to Follow-up|132|||
161091440|NCT03110224|581723921|FG000|Overall Study|Physician Decision|2|||
161091441|NCT03110224|581723921|FG000|Overall Study|Site Closed by Physician|35|||
161091442|NCT03110224|581723921|FG000|Overall Study|Site Closed by Sponsor|202|||
161091443|NCT03110224|581723921|FG000|Overall Study|Withdrawal by Subject|9|||
161091444|NCT05195489|581726130|FG000|Overall Study|Lost to Follow-up|1|||
161091445|NCT05195489|581726131|FG001|Overall Study|Lost to Follow-up|0|||
161091446|NCT05195489|581726130|FG000|Overall Study|Protocol Violation|0|||
161091447|NCT05195489|581726131|FG001|Overall Study|Protocol Violation|2|||
161091448|NCT05195489|581726130|FG000|Overall Study|Withdrawal by Subject|1|||
161091449|NCT05195489|581726131|FG001|Overall Study|Withdrawal by Subject|1|||
161091450|NCT05195489|581726130|FG000|Overall Study|Removed|0|||
161091451|NCT05195489|581726131|FG001|Overall Study|Removed|1|||
161091452|NCT00409773|581726133|FG000|Overall Study|Adverse Event|3|||
161091453|NCT00409773|581726134|FG001|Overall Study|Adverse Event|4|||
161091454|NCT00409773|581726135|FG002|Overall Study|Adverse Event|4|||
161091455|NCT00409773|581726136|FG003|Overall Study|Adverse Event|2|||
161091456|NCT00409773|581726137|FG004|Overall Study|Adverse Event|6|||
161091457|NCT00409773|581726133|FG000|Overall Study|Lost to Follow-up|6|||
161091458|NCT00409773|581726134|FG001|Overall Study|Lost to Follow-up|1|||
161091459|NCT00409773|581726135|FG002|Overall Study|Lost to Follow-up|2|||
161091460|NCT00409773|581726136|FG003|Overall Study|Lost to Follow-up|3|||
161091461|NCT00409773|581726137|FG004|Overall Study|Lost to Follow-up|1|||
161091462|NCT00409773|581726133|FG000|Overall Study|Physician Decision|0|||
161091463|NCT00409773|581726134|FG001|Overall Study|Physician Decision|0|||
161091464|NCT00409773|581726135|FG002|Overall Study|Physician Decision|0|||
161091465|NCT00409773|581726136|FG003|Overall Study|Physician Decision|2|||
161091466|NCT00409773|581726137|FG004|Overall Study|Physician Decision|0|||
161091467|NCT00409773|581726133|FG000|Overall Study|Protocol Violation|0|||
161091468|NCT00409773|581726134|FG001|Overall Study|Protocol Violation|2|||
161091469|NCT00409773|581726135|FG002|Overall Study|Protocol Violation|3|||
161091470|NCT00409773|581726136|FG003|Overall Study|Protocol Violation|3|||
161091471|NCT00409773|581726137|FG004|Overall Study|Protocol Violation|1|||
161319870|NCT01900431|582557200|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
161319871|NCT01900431|582557201|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
161319872|NCT01841567|582557202|FG000|Overall Study|Adverse Event|3|||
161319873|NCT02732327|582557205|FG000|Overall Study|Protocol Violation|0|||
161319874|NCT02732327|582557206|FG001|Overall Study|Protocol Violation|1|||
161319875|NCT00435019|582557207|FG000|Overall Study|Adverse Event|1|||
161319876|NCT00435019|582557208|FG001|Overall Study|Adverse Event|0|||
161319877|NCT00435019|582557207|FG000|Overall Study|Lack of Efficacy|1|||
161319878|NCT00435019|582557208|FG001|Overall Study|Lack of Efficacy|2|||
161319879|NCT00435019|582557207|FG000|Overall Study|Protocol Violation|3|||
161319880|NCT00435019|582557208|FG001|Overall Study|Protocol Violation|1|||
161319881|NCT00435019|582557207|FG000|Overall Study|Personal reasons for withdrawal|8|||
161319882|NCT00435019|582557208|FG001|Overall Study|Personal reasons for withdrawal|7|||
161319883|NCT04503668|582557209|FG000|Overall Study|Incomplete data|4|||
161319884|NCT04503668|582557210|FG001|Overall Study|Incomplete data|3|||
161319885|NCT04503668|582557209|FG000|Overall Study|Withdrawal by Subject|1|||
161319886|NCT04503668|582557210|FG001|Overall Study|Withdrawal by Subject|1|||
161319887|NCT04503668|582557209|FG000|Overall Study|Adverse Event|2|||
161319888|NCT04503668|582557210|FG001|Overall Study|Adverse Event|0|||
161319889|NCT02306694|582557211|FG000|Overall Study|Withdrawal by Subject|3|||
161319890|NCT02306694|582557211|FG000|Overall Study|Lost to Follow-up|1|||
161319891|NCT00603382|582557212|FG000|Overall Study|Adverse Event|0|||
161319892|NCT00603382|582557213|FG001|Overall Study|Adverse Event|1|||
161319893|NCT00603382|582557214|FG002|Overall Study|Adverse Event|1|||
161319894|NCT00603382|582557215|FG003|Overall Study|Adverse Event|2|||
161091472|NCT00409773|581726133|FG000|Overall Study|Withdrawal by Subject|0|||
161091473|NCT00409773|581726134|FG001|Overall Study|Withdrawal by Subject|0|||
161091474|NCT00409773|581726135|FG002|Overall Study|Withdrawal by Subject|0|||
161091475|NCT00409773|581726136|FG003|Overall Study|Withdrawal by Subject|2|||
161091476|NCT00409773|581726137|FG004|Overall Study|Withdrawal by Subject|1|||
161091477|NCT00409773|581726133|FG000|Overall Study|Lack of Eligibility|0|||
161091478|NCT00409773|581726134|FG001|Overall Study|Lack of Eligibility|0|||
161091479|NCT00409773|581726135|FG002|Overall Study|Lack of Eligibility|0|||
161091480|NCT00409773|581726136|FG003|Overall Study|Lack of Eligibility|0|||
161091481|NCT00409773|581726137|FG004|Overall Study|Lack of Eligibility|1|||
161091482|NCT01201343|581726138|FG000|Overall Study|Adverse Event|6|||
161091483|NCT01201343|581726138|FG000|Overall Study|Withdrawal by Subject|5|||
161091484|NCT01201343|581726138|FG000|Overall Study|Lost to Follow-up|2|||
161091485|NCT01201343|581726138|FG000|Overall Study|Lack of Efficacy|2|||
161319895|NCT00603382|582557216|FG004|Overall Study|Adverse Event|1|||
161319896|NCT00603382|582557217|FG005|Overall Study|Adverse Event|2|||
161319897|NCT00603382|582557212|FG000|Overall Study|Lack of Efficacy|14|||
161319898|NCT00603382|582557213|FG001|Overall Study|Lack of Efficacy|9|||
161319899|NCT00603382|582557214|FG002|Overall Study|Lack of Efficacy|3|||
161319900|NCT00603382|582557215|FG003|Overall Study|Lack of Efficacy|6|||
161319901|NCT00603382|582557216|FG004|Overall Study|Lack of Efficacy|6|||
161319902|NCT00603382|582557217|FG005|Overall Study|Lack of Efficacy|11|||
161319903|NCT00603382|582557212|FG000|Overall Study|Protocol Violation|1|||
161319904|NCT00603382|582557213|FG001|Overall Study|Protocol Violation|0|||
161319905|NCT00603382|582557214|FG002|Overall Study|Protocol Violation|1|||
161319906|NCT00603382|582557215|FG003|Overall Study|Protocol Violation|2|||
161319907|NCT00603382|582557216|FG004|Overall Study|Protocol Violation|1|||
161319908|NCT00603382|582557217|FG005|Overall Study|Protocol Violation|0|||
161319909|NCT00603382|582557212|FG000|Overall Study|Lost to Follow-up|0|||
161319910|NCT00603382|582557213|FG001|Overall Study|Lost to Follow-up|1|||
161319911|NCT00603382|582557214|FG002|Overall Study|Lost to Follow-up|1|||
161319912|NCT00603382|582557215|FG003|Overall Study|Lost to Follow-up|1|||
161319913|NCT00603382|582557216|FG004|Overall Study|Lost to Follow-up|0|||
161319914|NCT00603382|582557217|FG005|Overall Study|Lost to Follow-up|1|||
161319915|NCT00603382|582557212|FG000|Overall Study|Physician Decision|0|||
161319916|NCT00603382|582557213|FG001|Overall Study|Physician Decision|0|||
161319917|NCT00603382|582557214|FG002|Overall Study|Physician Decision|2|||
161319918|NCT00603382|582557215|FG003|Overall Study|Physician Decision|0|||
161319919|NCT00603382|582557216|FG004|Overall Study|Physician Decision|1|||
161319920|NCT00603382|582557217|FG005|Overall Study|Physician Decision|3|||
161319921|NCT00603382|582557212|FG000|Overall Study|Withdrawal by Subject|3|||
161319922|NCT00603382|582557213|FG001|Overall Study|Withdrawal by Subject|3|||
161319923|NCT00603382|582557214|FG002|Overall Study|Withdrawal by Subject|1|||
161319924|NCT00603382|582557215|FG003|Overall Study|Withdrawal by Subject|1|||
161319925|NCT00603382|582557216|FG004|Overall Study|Withdrawal by Subject|0|||
161319926|NCT00603382|582557217|FG005|Overall Study|Withdrawal by Subject|1|||
161319927|NCT01078298|582557220|FG000|Overall Study|Lost to Follow-up|12|||
161319928|NCT01078298|582557221|FG001|Overall Study|Lost to Follow-up|13|||
161319929|NCT01078298|582557220|FG000|Overall Study|Withdrawal by Subject|31|||
161319930|NCT01078298|582557221|FG001|Overall Study|Withdrawal by Subject|33|||
161319931|NCT01078298|582557220|FG000|Overall Study|Protocol Violation|6|||
161319932|NCT01078298|582557221|FG001|Overall Study|Protocol Violation|6|||
161319933|NCT01078298|582557220|FG000|Overall Study|Adverse Event|6|||
161319934|NCT01078298|582557221|FG001|Overall Study|Adverse Event|5|||
161319935|NCT01078298|582557220|FG000|Overall Study|Death|2|||
161319936|NCT01078298|582557221|FG001|Overall Study|Death|0|||
161319937|NCT01078298|582557220|FG000|Overall Study|Did not meet entrance criteria|0|||
161091486|NCT01201343|581726138|FG000|Overall Study|Participant wrongly included in trial|1|||
161091487|NCT01201343|581726138|FG000|Overall Study|Randomized, not treated|3|||
161091488|NCT01440374|581726139|FG000|Part 1: Open-label Phase|Adverse Event|5|||
161091489|NCT01440374|581726140|FG001|Part 1: Open-label Phase|Adverse Event|0|||
161091490|NCT01440374|581726141|FG002|Part 1: Open-label Phase|Adverse Event|0|||
161091491|NCT01440374|581726142|FG003|Part 1: Open-label Phase|Adverse Event|0|||
161091492|NCT01440374|581726139|FG000|Part 1: Open-label Phase|Physician Decision|1|||
161091493|NCT01440374|581726140|FG001|Part 1: Open-label Phase|Physician Decision|0|||
161091494|NCT01440374|581726141|FG002|Part 1: Open-label Phase|Physician Decision|0|||
161091495|NCT01440374|581726142|FG003|Part 1: Open-label Phase|Physician Decision|0|||
161091496|NCT01440374|581726139|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
161091497|NCT01440374|581726140|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
161091498|NCT01440374|581726141|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
161091499|NCT01440374|581726142|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
161091500|NCT01440374|581726139|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
161091501|NCT01440374|581726140|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
161091502|NCT01440374|581726141|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
161091503|NCT01440374|581726142|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
161091504|NCT01440374|581726139|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
161091505|NCT01440374|581726140|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
161091506|NCT01440374|581726141|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
161091507|NCT01440374|581726142|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
161091508|NCT01440374|581726139|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
161091509|NCT01440374|581726140|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
161091510|NCT01440374|581726141|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
161091511|NCT01440374|581726142|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
161091512|NCT01440374|581726139|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
161091513|NCT01440374|581726140|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
161091514|NCT01440374|581726141|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
161091515|NCT01440374|581726142|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
161091516|NCT01440374|581726139|FG000|Part 2; Double-blind Phase|Not treated|0|||
161091517|NCT01440374|581726140|FG001|Part 2; Double-blind Phase|Not treated|0|||
161091518|NCT01440374|581726141|FG002|Part 2; Double-blind Phase|Not treated|1|||
161091519|NCT01440374|581726142|FG003|Part 2; Double-blind Phase|Not treated|0|||
161091520|NCT01440374|581726139|FG000|Part 3: Extension|Withdrawal by Subject|0|||
161091521|NCT01440374|581726140|FG001|Part 3: Extension|Withdrawal by Subject|0|||
161091522|NCT01440374|581726141|FG002|Part 3: Extension|Withdrawal by Subject|0|||
161091523|NCT01440374|581726142|FG003|Part 3: Extension|Withdrawal by Subject|5|||
161091524|NCT01440374|581726139|FG000|Part 3: Extension|Adverse Event|0|||
161091525|NCT01440374|581726140|FG001|Part 3: Extension|Adverse Event|0|||
161091526|NCT01440374|581726141|FG002|Part 3: Extension|Adverse Event|0|||
161091527|NCT01440374|581726142|FG003|Part 3: Extension|Adverse Event|13|||
161091528|NCT01440374|581726139|FG000|Part 3: Extension|Physician Decision|0|||
161091529|NCT01440374|581726140|FG001|Part 3: Extension|Physician Decision|0|||
161091530|NCT01440374|581726141|FG002|Part 3: Extension|Physician Decision|0|||
161091531|NCT01440374|581726142|FG003|Part 3: Extension|Physician Decision|14|||
161091532|NCT04812548|581726144|FG000|Overall Study|Adverse Event|2|||
161091533|NCT04812548|581726145|FG001|Overall Study|Adverse Event|7|||
161091534|NCT04812548|581726144|FG000|Overall Study|HSCT Planned|2|||
161091535|NCT04812548|581726145|FG001|Overall Study|HSCT Planned|3|||
161091536|NCT04812548|581726144|FG000|Overall Study|Progressive Disease|0|||
161091537|NCT04812548|581726145|FG001|Overall Study|Progressive Disease|2|||
161091538|NCT04812548|581726144|FG000|Overall Study|Death|0|||
161091539|NCT04812548|581726145|FG001|Overall Study|Death|1|||
161091540|NCT04812548|581726144|FG000|Overall Study|Post Study Access to Treatment|0|||
161091541|NCT04812548|581726145|FG001|Overall Study|Post Study Access to Treatment|1|||
161091542|NCT04812548|581726144|FG000|Overall Study|Withdrawal by Subject|0|||
161091543|NCT04812548|581726145|FG001|Overall Study|Withdrawal by Subject|1|||
161091544|NCT04812548|581726144|FG000|Overall Study|Physician Decision|1|||
161091545|NCT04812548|581726145|FG001|Overall Study|Physician Decision|0|||
161091546|NCT02141984|581726146|FG000|Overall Study|Lack of Efficacy|2|||
161091547|NCT02079610|581726147|FG000|Overall Study|Withdrawal by Subject|1|||
161091548|NCT02079610|581726148|FG001|Overall Study|Withdrawal by Subject|1|||
161091549|NCT01716117|581726149|FG000|Overall Study|Death|5|||
161091550|NCT01716117|581726150|FG001|Overall Study|Death|2|||
161091551|NCT01716117|581726149|FG000|Overall Study|Withdrawal by Subject|2|||
161091552|NCT01716117|581726150|FG001|Overall Study|Withdrawal by Subject|0|||
161091553|NCT03645057|581726152|FG000|Randomization to Baseline|Lost to Follow-up|1|||
161091554|NCT03645057|581726153|FG001|Randomization to Baseline|Lost to Follow-up|0|||
161091555|NCT03645057|581726154|FG002|Randomization to Baseline|Lost to Follow-up|1|||
161091556|NCT03645057|581726155|FG003|Randomization to Baseline|Lost to Follow-up|0|||
161091557|NCT03645057|581726152|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
161091558|NCT03645057|581726153|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
161091559|NCT03645057|581726154|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
161091560|NCT03645057|581726155|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
161091561|NCT03645057|581726152|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
161091562|NCT03645057|581726153|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
161091563|NCT03645057|581726154|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
161091564|NCT03645057|581726155|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
161091565|NCT03645057|581726152|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
161091566|NCT03645057|581726153|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
161091567|NCT03645057|581726154|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
161091568|NCT03645057|581726155|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
161091569|NCT03907410|581726159|FG000|Overall Study|Lost to Follow-up|4|||
161091570|NCT03907410|581726160|FG001|Overall Study|Lost to Follow-up|1|||
161091571|NCT03907410|581726161|FG002|Overall Study|Lost to Follow-up|1|||
161091572|NCT03907410|581726159|FG000|Overall Study|Lost to follow-up and research burden|0|||
161091573|NCT03907410|581726160|FG001|Overall Study|Lost to follow-up and research burden|0|||
161091574|NCT03907410|581726161|FG002|Overall Study|Lost to follow-up and research burden|1|||
161091575|NCT01155375|581726162|FG000|Overall Study|Adverse Event|1|||
161091576|NCT01155375|581726163|FG001|Overall Study|Adverse Event|0|||
161091577|NCT04335812|581726164|FG000|Overall Study|Withdrawal by Subject|1|||
161091578|NCT04335812|581726165|FG001|Overall Study|Withdrawal by Subject|3|||
161091579|NCT04335812|581726164|FG000|Overall Study|Lost to Follow-up|12|||
161091580|NCT04335812|581726165|FG001|Overall Study|Lost to Follow-up|12|||
161091581|NCT04335812|581726164|FG000|Overall Study|Did not engage in the intervention|22|||
161091582|NCT04335812|581726165|FG001|Overall Study|Did not engage in the intervention|18|||
161091583|NCT00799513|581726169|FG000|Overall Study|Physician Decision|1|||
161091584|NCT00799513|581726169|FG000|Overall Study|Adverse Event|1|||
161091585|NCT04874415|581726170|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091586|NCT04874415|581726171|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091587|NCT04874415|581726172|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091588|NCT04874415|581726173|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091589|NCT04874415|581726174|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091590|NCT04874415|581726175|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091591|NCT04874415|581726176|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161091592|NCT04874415|581726177|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091593|NCT04874415|581726178|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
161091594|NCT04874415|581726179|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161091595|NCT04874415|581726180|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091596|NCT04874415|581726181|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161091597|NCT04874415|581726182|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161091598|NCT04874415|581726183|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
161091599|NCT04874415|581726184|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
161091600|NCT04874415|581726185|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
161091601|NCT04874415|581726170|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091602|NCT04874415|581726171|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091603|NCT04874415|581726172|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091604|NCT04874415|581726173|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091605|NCT04874415|581726174|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091606|NCT04874415|581726175|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091607|NCT04874415|581726176|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091608|NCT04874415|581726177|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091609|NCT04874415|581726178|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091610|NCT04874415|581726179|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
161091611|NCT04874415|581726180|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091612|NCT04874415|581726181|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091613|NCT04874415|581726182|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091614|NCT04874415|581726183|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091615|NCT04874415|581726184|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
161091616|NCT04874415|581726185|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
161091617|NCT04874415|581726170|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091618|NCT04874415|581726171|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091619|NCT04874415|581726172|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091620|NCT04874415|581726173|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091621|NCT04874415|581726174|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
161091622|NCT04874415|581726175|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091623|NCT04874415|581726176|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091624|NCT04874415|581726177|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091625|NCT04874415|581726178|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091626|NCT04874415|581726179|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091627|NCT04874415|581726180|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091628|NCT04874415|581726181|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091629|NCT04874415|581726182|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091630|NCT04874415|581726183|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161319938|NCT01078298|582557221|FG001|Overall Study|Did not meet entrance criteria|1|||
161319939|NCT01078298|582557220|FG000|Overall Study|Other|24|||
161319940|NCT01078298|582557221|FG001|Overall Study|Other|32|||
161319941|NCT00742027|582557222|FG000|Overall Study|Disease Progression|76|||
161319942|NCT00742027|582557222|FG000|Overall Study|New Cancer Therapy|19|||
161319943|NCT00742027|582557222|FG000|Overall Study|Withdrawal by Subject|18|||
161319944|NCT00742027|582557222|FG000|Overall Study|Death|7|||
161319945|NCT00742027|582557222|FG000|Overall Study|Lost to Follow-up|4|||
161319946|NCT00742027|582557222|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
161319947|NCT00742027|582557222|FG000|Overall Study|Missing|2|||
161319948|NCT00742027|582557222|FG000|Overall Study|Administrative Problems|1|||
161319949|NCT01180049|582557223|FG000|Overall Study|Other|9|||
161319950|NCT01180049|582557224|FG001|Overall Study|Other|7|||
161319951|NCT01180049|582557223|FG000|Overall Study|Lost to Follow-up|8|||
161319952|NCT01180049|582557224|FG001|Overall Study|Lost to Follow-up|6|||
161319953|NCT01180049|582557223|FG000|Overall Study|Death|36|||
161319954|NCT01180049|582557224|FG001|Overall Study|Death|35|||
161319955|NCT01764659|582557225|FG000|Overall Study|Death|1|||
161319956|NCT01764659|582557225|FG000|Overall Study|Physician Decision|1|||
161319957|NCT00398216|582558805|FG000|Overall Study|Adverse Event|4|||
161319958|NCT00398216|582558806|FG001|Overall Study|Adverse Event|2|||
161319959|NCT00398216|582558807|FG002|Overall Study|Adverse Event|5|||
161319960|NCT00398216|582558808|FG003|Overall Study|Adverse Event|7|||
161319961|NCT00398216|582558809|FG004|Overall Study|Adverse Event|2|||
161319962|NCT00398216|582558805|FG000|Overall Study|Protocol Violation|2|||
161319963|NCT00398216|582558806|FG001|Overall Study|Protocol Violation|4|||
161319964|NCT00398216|582558807|FG002|Overall Study|Protocol Violation|5|||
161319965|NCT00398216|582558808|FG003|Overall Study|Protocol Violation|7|||
161319966|NCT00398216|582558809|FG004|Overall Study|Protocol Violation|5|||
161319967|NCT00398216|582558805|FG000|Overall Study|Lost to Follow-up|1|||
161319968|NCT00398216|582558806|FG001|Overall Study|Lost to Follow-up|6|||
161319969|NCT00398216|582558807|FG002|Overall Study|Lost to Follow-up|4|||
161319970|NCT00398216|582558808|FG003|Overall Study|Lost to Follow-up|4|||
161319971|NCT00398216|582558809|FG004|Overall Study|Lost to Follow-up|1|||
161319972|NCT00398216|582558805|FG000|Overall Study|Death|0|||
161319973|NCT00398216|582558806|FG001|Overall Study|Death|3|||
161319974|NCT00398216|582558807|FG002|Overall Study|Death|0|||
161319975|NCT00398216|582558808|FG003|Overall Study|Death|0|||
161319976|NCT00398216|582558809|FG004|Overall Study|Death|0|||
161319977|NCT00398216|582558805|FG000|Overall Study|Withdrawal by Subject|1|||
161319978|NCT00398216|582558806|FG001|Overall Study|Withdrawal by Subject|0|||
161319979|NCT00398216|582558807|FG002|Overall Study|Withdrawal by Subject|3|||
161319980|NCT00398216|582558808|FG003|Overall Study|Withdrawal by Subject|1|||
161319981|NCT00398216|582558809|FG004|Overall Study|Withdrawal by Subject|2|||
161319982|NCT00398216|582558805|FG000|Overall Study|administrative reasons|3|||
161319983|NCT00398216|582558806|FG001|Overall Study|administrative reasons|4|||
161319984|NCT00398216|582558807|FG002|Overall Study|administrative reasons|4|||
161319985|NCT00398216|582558808|FG003|Overall Study|administrative reasons|3|||
161319986|NCT00398216|582558809|FG004|Overall Study|administrative reasons|3|||
161319987|NCT00398216|582558805|FG000|Overall Study|entrance criteria|0|||
161319988|NCT00398216|582558806|FG001|Overall Study|entrance criteria|0|||
161319989|NCT00398216|582558807|FG002|Overall Study|entrance criteria|0|||
161319990|NCT00398216|582558808|FG003|Overall Study|entrance criteria|0|||
161319991|NCT00398216|582558809|FG004|Overall Study|entrance criteria|2|||
161319992|NCT02207400|582558810|FG000|Overall Study|Adverse Event|1|||
161319993|NCT02207400|582558811|FG001|Overall Study|Adverse Event|1|||
161319994|NCT02207400|582558810|FG000|Overall Study|Lost to Follow-up|6|||
161319995|NCT02207400|582558811|FG001|Overall Study|Lost to Follow-up|7|||
161319996|NCT02207400|582558810|FG000|Overall Study|Protocol Violation|1|||
161319997|NCT02207400|582558811|FG001|Overall Study|Protocol Violation|1|||
161319998|NCT02207400|582558810|FG000|Overall Study|Withdrawal by Subject|8|||
161319999|NCT02207400|582558811|FG001|Overall Study|Withdrawal by Subject|4|||
161320000|NCT02207400|582558810|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
161320001|NCT02207400|582558811|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
161320002|NCT04304508|582558812|FG000|Overall Study|Subject Decision|29|||
161320003|NCT04304508|582558813|FG001|Overall Study|Subject Decision|39|||
161320004|NCT04304508|582558814|FG002|Overall Study|Subject Decision|37|||
161320005|NCT04304508|582558815|FG003|Overall Study|Subject Decision|48|||
161320006|NCT04304508|582558812|FG000|Overall Study|Death|6|||
161091631|NCT04874415|581726184|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161320007|NCT04304508|582558813|FG001|Overall Study|Death|1|||
161320008|NCT04304508|582558814|FG002|Overall Study|Death|8|||
161320009|NCT04304508|582558815|FG003|Overall Study|Death|5|||
161320010|NCT04304508|582558812|FG000|Overall Study|Non-compliance With Study Drug|3|||
161320011|NCT04304508|582558813|FG001|Overall Study|Non-compliance With Study Drug|1|||
161320012|NCT04304508|582558814|FG002|Overall Study|Non-compliance With Study Drug|2|||
161320013|NCT04304508|582558815|FG003|Overall Study|Non-compliance With Study Drug|0|||
161320014|NCT04304508|582558812|FG000|Overall Study|Switching To Other Therapy|1|||
161320015|NCT04304508|582558813|FG001|Overall Study|Switching To Other Therapy|1|||
161320016|NCT04304508|582558814|FG002|Overall Study|Switching To Other Therapy|1|||
161320017|NCT04304508|582558815|FG003|Overall Study|Switching To Other Therapy|2|||
161320018|NCT04304508|582558812|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
161320019|NCT04304508|582558813|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
161320020|NCT04304508|582558814|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
161320021|NCT04304508|582558815|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
161320022|NCT04304508|582558812|FG000|Overall Study|Withdrawal by Subject|7|||
161320023|NCT04304508|582558813|FG001|Overall Study|Withdrawal by Subject|5|||
161320024|NCT04304508|582558814|FG002|Overall Study|Withdrawal by Subject|11|||
161320025|NCT04304508|582558815|FG003|Overall Study|Withdrawal by Subject|6|||
161320026|NCT04304508|582558812|FG000|Overall Study|Logistical Difficulties|2|||
161320027|NCT04304508|582558813|FG001|Overall Study|Logistical Difficulties|2|||
161320028|NCT04304508|582558814|FG002|Overall Study|Logistical Difficulties|3|||
161320029|NCT04304508|582558815|FG003|Overall Study|Logistical Difficulties|2|||
161320030|NCT04304508|582558812|FG000|Overall Study|Missing Information|1|||
161320031|NCT04304508|582558813|FG001|Overall Study|Missing Information|2|||
161320032|NCT04304508|582558814|FG002|Overall Study|Missing Information|1|||
161320033|NCT04304508|582558815|FG003|Overall Study|Missing Information|3|||
161320034|NCT04304508|582558812|FG000|Overall Study|Other|7|||
161320035|NCT04304508|582558813|FG001|Overall Study|Other|6|||
161320036|NCT04304508|582558814|FG002|Overall Study|Other|5|||
161320037|NCT04304508|582558815|FG003|Overall Study|Other|4|||
161320038|NCT04304508|582558812|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
161320039|NCT04304508|582558813|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161320040|NCT04304508|582558814|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161320041|NCT04304508|582558815|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
161320042|NCT04304508|582558812|FG000|Overall Study|Physician Decision|3|||
161320043|NCT04304508|582558813|FG001|Overall Study|Physician Decision|4|||
161320044|NCT04304508|582558814|FG002|Overall Study|Physician Decision|9|||
161320045|NCT04304508|582558815|FG003|Overall Study|Physician Decision|7|||
161320046|NCT04304508|582558812|FG000|Overall Study|Study drug never administered|10|||
161320047|NCT04304508|582558813|FG001|Overall Study|Study drug never administered|4|||
161320048|NCT04304508|582558814|FG002|Overall Study|Study drug never administered|4|||
161320049|NCT04304508|582558815|FG003|Overall Study|Study drug never administered|4|||
161320050|NCT04304508|582558812|FG000|Overall Study|Adverse Event|49|||
161320051|NCT04304508|582558813|FG001|Overall Study|Adverse Event|50|||
161320052|NCT04304508|582558814|FG002|Overall Study|Adverse Event|51|||
161320053|NCT04304508|582558815|FG003|Overall Study|Adverse Event|56|||
161320054|NCT04304508|582558812|FG000|Overall Study|Lost to Follow-up|1|||
161320055|NCT04304508|582558813|FG001|Overall Study|Lost to Follow-up|5|||
161320056|NCT04304508|582558814|FG002|Overall Study|Lost to Follow-up|2|||
161320057|NCT04304508|582558815|FG003|Overall Study|Lost to Follow-up|3|||
161320058|NCT02113007|582558816|FG000|Overall Study|Progressive disease|2|||
161320059|NCT00885378|582558817|FG000|Overall Study|Lack of Efficacy|2|||
161320060|NCT00885378|582558818|FG001|Overall Study|Lack of Efficacy|2|||
161320061|NCT00885378|582558817|FG000|Overall Study|Withdrawal by Subject|1|||
161320062|NCT00885378|582558818|FG001|Overall Study|Withdrawal by Subject|2|||
161320063|NCT00885378|582558817|FG000|Overall Study|Lost to Follow-up|1|||
161320064|NCT00885378|582558818|FG001|Overall Study|Lost to Follow-up|2|||
161320065|NCT00885378|582558817|FG000|Overall Study|Poor/Noncompliance|2|||
161320066|NCT00885378|582558818|FG001|Overall Study|Poor/Noncompliance|2|||
161320067|NCT00885378|582558817|FG000|Overall Study|Protocol Violation|2|||
161320068|NCT00885378|582558818|FG001|Overall Study|Protocol Violation|0|||
161320069|NCT03091738|582558819|FG000|Overall Study|Adverse Event|1|||
161320070|NCT03091738|582558819|FG000|Overall Study|Lost to Follow-up|1|||
161320071|NCT04446429|582558824|FG000|Overall Study|Lost to Follow-up|6|||
161320072|NCT04446429|582558825|FG001|Overall Study|Lost to Follow-up|0|||
161320073|NCT05205005|582558826|FG000|Overall Study|Withdrawal by Subject|1|||
161320074|NCT05205005|582558827|FG001|Overall Study|Withdrawal by Subject|0|||
161320075|NCT05205005|582558826|FG000|Overall Study|Adverse Event|1|||
161320076|NCT05205005|582558827|FG001|Overall Study|Adverse Event|0|||
161320077|NCT03042910|582558828|FG000|Overall Study|Adverse Event|1|||
161320078|NCT03042910|582558828|FG000|Overall Study|Disease Progression|2|||
161320079|NCT03042910|582558828|FG000|Overall Study|Withdrawal by Subject|3|||
161320080|NCT03042910|582558828|FG000|Overall Study|Enrolled but not treated|1|||
161320081|NCT02187861|582558829|FG000|Overall Study|Adverse Event|2|||
161320082|NCT02187861|582558830|FG001|Overall Study|Adverse Event|1|||
161320083|NCT02187861|582558831|FG002|Overall Study|Adverse Event|2|||
161320084|NCT02187861|582558832|FG003|Overall Study|Adverse Event|1|||
161320085|NCT02187861|582558829|FG000|Overall Study|Death|0|||
161320086|NCT02187861|582558830|FG001|Overall Study|Death|3|||
161320087|NCT02187861|582558831|FG002|Overall Study|Death|1|||
161320088|NCT02187861|582558832|FG003|Overall Study|Death|2|||
161320089|NCT02187861|582558829|FG000|Overall Study|Physician Decision|0|||
161320090|NCT02187861|582558830|FG001|Overall Study|Physician Decision|1|||
161320091|NCT02187861|582558831|FG002|Overall Study|Physician Decision|0|||
161320092|NCT02187861|582558832|FG003|Overall Study|Physician Decision|3|||
161320093|NCT02187861|582558829|FG000|Overall Study|Progressive Disease|4|||
161320094|NCT02187861|582558830|FG001|Overall Study|Progressive Disease|42|||
161320095|NCT02187861|582558831|FG002|Overall Study|Progressive Disease|19|||
161320096|NCT02187861|582558832|FG003|Overall Study|Progressive Disease|22|||
161320097|NCT02187861|582558829|FG000|Overall Study|Withdrawal by Subject|0|||
161320098|NCT02187861|582558830|FG001|Overall Study|Withdrawal by Subject|0|||
161320099|NCT02187861|582558831|FG002|Overall Study|Withdrawal by Subject|3|||
161320100|NCT02187861|582558832|FG003|Overall Study|Withdrawal by Subject|3|||
161320101|NCT02187861|582558829|FG000|Overall Study|Other|0|||
161320102|NCT02187861|582558830|FG001|Overall Study|Other|1|||
161320103|NCT02187861|582558831|FG002|Overall Study|Other|7|||
161320104|NCT02187861|582558832|FG003|Overall Study|Other|1|||
161320105|NCT01491841|582558834|FG000|Overall Study|Screen Failure|10|||
161320106|NCT01491841|582558834|FG000|Overall Study|Withdrawal by Subject|1|||
161320107|NCT04399889|582558836|FG000|Overall Study|Death|5|||
161320108|NCT04399889|582558837|FG001|Overall Study|Death|1|||
161320109|NCT04399889|582558838|FG002|Overall Study|Death|1|||
161320110|NCT00707980|582558839|FG000|Overall Study|Adverse Event|49|||
161320111|NCT00707980|582558839|FG000|Overall Study|Lack of Efficacy|35|||
161320112|NCT00707980|582558839|FG000|Overall Study|Non-Compliance with Study Drug|28|||
161320113|NCT00707980|582558839|FG000|Overall Study|Protocol Deviations|19|||
161320114|NCT00707980|582558839|FG000|Overall Study|Withdrawal of Consent|81|||
161320115|NCT00707980|582558839|FG000|Overall Study|Lost to Follow-up|59|||
161320116|NCT00707980|582558839|FG000|Overall Study|Other|39|||
161320117|NCT01152996|582558840|FG000|Overall Study|Withdrawal by Subject|142|||
161320118|NCT01152996|582558840|FG000|Overall Study|Adverse Event|115|||
161320119|NCT01152996|582558840|FG000|Overall Study|Lost to Follow-up|112|||
161320120|NCT01152996|582558840|FG000|Overall Study|Lack of Efficacy|68|||
161091632|NCT04874415|581726185|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
161091633|NCT05062759|581726188|FG000|Overall Study|Death|0|||
161091634|NCT05062759|581726189|FG001|Overall Study|Death|1|||
161091635|NCT05062759|581726188|FG000|Overall Study|Lost to Follow-up|1|||
161091636|NCT05062759|581726189|FG001|Overall Study|Lost to Follow-up|0|||
161091637|NCT04981366|581726190|FG000|Overall Study|Withdrawal by Subject|5|||
161091638|NCT04981366|581726191|FG001|Overall Study|Withdrawal by Subject|4|||
161091639|NCT04981366|581726192|FG002|Overall Study|Withdrawal by Subject|8|||
161091640|NCT04981366|581726190|FG000|Overall Study|Health issues unrelated to the trial|1|||
161091641|NCT04981366|581726191|FG001|Overall Study|Health issues unrelated to the trial|2|||
161091642|NCT04981366|581726192|FG002|Overall Study|Health issues unrelated to the trial|0|||
161091643|NCT04371198|581726193|FG000|Overall Study|inadequate sample|4|||
161091644|NCT01112306|581726194|FG000|Overall Study|Death|175|||
161091645|NCT01112306|581726194|FG000|Overall Study|Lost to Follow-up|9|||
161320121|NCT01152996|582558840|FG000|Overall Study|Noncompliance|41|||
161320122|NCT01152996|582558840|FG000|Overall Study|Other|36|||
161320123|NCT01152996|582558840|FG000|Overall Study|Protocol Violation|22|||
161320124|NCT01152996|582558840|FG000|Overall Study|Elevated liver enzymes|1|||
161320125|NCT00460239|582558841|FG000|Overall Study|Physician Decision|0|||
161320126|NCT00460239|582558842|FG001|Overall Study|Physician Decision|1|||
161320127|NCT00460239|582558843|FG002|Overall Study|Physician Decision|0|||
161320128|NCT00460239|582558844|FG003|Overall Study|Physician Decision|0|||
161320129|NCT00460239|582558845|FG004|Overall Study|Physician Decision|0|||
161320130|NCT00460239|582558846|FG005|Overall Study|Physician Decision|2|||
161320131|NCT00460239|582558847|FG006|Overall Study|Physician Decision|0|||
161320132|NCT00460239|582558848|FG007|Overall Study|Physician Decision|0|||
161320133|NCT00460239|582558849|FG008|Overall Study|Physician Decision|0|||
161320134|NCT00460239|582558841|FG000|Overall Study|Withdrawal by Subject|0|||
161320135|NCT00460239|582558842|FG001|Overall Study|Withdrawal by Subject|0|||
161320136|NCT00460239|582558843|FG002|Overall Study|Withdrawal by Subject|0|||
161320137|NCT00460239|582558844|FG003|Overall Study|Withdrawal by Subject|0|||
161320138|NCT00460239|582558845|FG004|Overall Study|Withdrawal by Subject|0|||
161320139|NCT00460239|582558846|FG005|Overall Study|Withdrawal by Subject|1|||
161320140|NCT00460239|582558847|FG006|Overall Study|Withdrawal by Subject|0|||
161320141|NCT00460239|582558848|FG007|Overall Study|Withdrawal by Subject|0|||
161320142|NCT00460239|582558849|FG008|Overall Study|Withdrawal by Subject|0|||
161320143|NCT02087943|582558851|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
161320144|NCT02087943|582558852|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
161320145|NCT02087943|582558853|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
161320146|NCT02087943|582558854|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
161320147|NCT02087943|582558855|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
161320148|NCT02087943|582558851|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
161320149|NCT02087943|582558852|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
161320150|NCT02087943|582558853|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
161320151|NCT02087943|582558854|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
161320152|NCT02087943|582558855|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
161320153|NCT02087943|582558851|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
161320154|NCT02087943|582558852|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
161320155|NCT02087943|582558853|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
161320156|NCT02087943|582558854|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
161320157|NCT02087943|582558855|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
161320158|NCT02087943|582558851|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
161320159|NCT02087943|582558852|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161320160|NCT02087943|582558853|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
161320161|NCT02087943|582558854|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161320162|NCT02087943|582558855|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
161320163|NCT02087943|582558851|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161320164|NCT02087943|582558852|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
161320165|NCT02087943|582558853|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161320166|NCT02087943|582558854|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161320167|NCT02087943|582558855|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
161320168|NCT02087943|582558851|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
161320169|NCT02087943|582558852|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
161320170|NCT02087943|582558853|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
161320171|NCT02087943|582558854|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
161320172|NCT02087943|582558855|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
161320173|NCT02087943|582558851|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
161320174|NCT02087943|582558852|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
161320175|NCT02087943|582558853|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
161320176|NCT02087943|582558854|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
161320177|NCT02087943|582558855|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
161320178|NCT02087943|582558851|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161320179|NCT02087943|582558852|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161320180|NCT02087943|582558853|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
161320181|NCT02087943|582558854|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161320182|NCT02087943|582558855|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
161320183|NCT02087943|582558851|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161320184|NCT02087943|582558852|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161320185|NCT02087943|582558853|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161320186|NCT02087943|582558854|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
161320187|NCT02087943|582558855|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
161320188|NCT02087943|582558851|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161091646|NCT01112306|581726194|FG000|Overall Study|Withdrawal by Subject|31|||
161091647|NCT01112306|581726194|FG000|Overall Study|Other|70|||
161091648|NCT00881608|581726195|FG000|Overall Study|Study prematurely terminated|11|||
161091649|NCT03214094|581726196|FG000|Overall Study|Case Report Forms Uncollected|14|||
161091650|NCT03214094|581726196|FG000|Overall Study|Protocol Deviation|46|||
161091651|NCT02208999|581726201|FG000|Overall Study|Lost to Follow-up|1|||
161091652|NCT00319839|581726202|FG000|Overall Study|Adverse Event|5|||
161091653|NCT00319839|581726202|FG000|Overall Study|Withdrawal by Subject|1|||
161091654|NCT00986674|581726203|FG000|Overall Study|Lack of Efficacy|28|||
161091655|NCT00986674|581726204|FG001|Overall Study|Lack of Efficacy|25|||
161091656|NCT00986674|581726205|FG002|Overall Study|Lack of Efficacy|23|||
161091657|NCT00986674|581726203|FG000|Overall Study|Adverse Event|4|||
161091658|NCT00986674|581726204|FG001|Overall Study|Adverse Event|8|||
161091659|NCT00986674|581726205|FG002|Overall Study|Adverse Event|9|||
161091660|NCT00986674|581726203|FG000|Overall Study|Death|5|||
161091661|NCT00986674|581726204|FG001|Overall Study|Death|0|||
161091662|NCT00986674|581726205|FG002|Overall Study|Death|4|||
161091663|NCT00986674|581726203|FG000|Overall Study|Withdrawal by Subject|6|||
161091664|NCT00986674|581726204|FG001|Overall Study|Withdrawal by Subject|2|||
161091665|NCT00986674|581726205|FG002|Overall Study|Withdrawal by Subject|1|||
161320189|NCT02087943|582558852|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161320190|NCT02087943|582558853|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
161320191|NCT02087943|582558854|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
161320192|NCT02087943|582558855|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
161320193|NCT01690299|582558856|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
161320194|NCT01690299|582558857|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
161320195|NCT01690299|582558858|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
161320196|NCT01690299|582558859|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161091666|NCT00986674|581726203|FG000|Overall Study|alternative therapy|0|||
161091667|NCT00986674|581726204|FG001|Overall Study|alternative therapy|0|||
161091668|NCT00986674|581726205|FG002|Overall Study|alternative therapy|1|||
161091669|NCT00986674|581726203|FG000|Overall Study|not start protocol therapy|4|||
161091670|NCT00986674|581726204|FG001|Overall Study|not start protocol therapy|3|||
161091671|NCT00986674|581726205|FG002|Overall Study|not start protocol therapy|1|||
161091672|NCT00986674|581726203|FG000|Overall Study|unknown/not specify|0|||
161091673|NCT00986674|581726204|FG001|Overall Study|unknown/not specify|7|||
161091674|NCT00986674|581726205|FG002|Overall Study|unknown/not specify|9|||
161091675|NCT01853137|581726206|FG000|Overall Study|Lost to Follow-up|4|||
161091676|NCT01853137|581726207|FG001|Overall Study|Lost to Follow-up|1|||
161091677|NCT00690820|581726208|FG000|Period 1|Withdrawal by Subject|0|||
161091678|NCT00690820|581726209|FG001|Period 1|Withdrawal by Subject|1|||
161091679|NCT04025580|581726210|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
161091680|NCT04025580|581726211|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
161091681|NCT04025580|581726212|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
161091682|NCT00966277|581726213|FG000|Overall Study|Withdrawal by Subject|3|||
161091683|NCT00966277|581726214|FG001|Overall Study|Withdrawal by Subject|0|||
161091684|NCT00966277|581726213|FG000|Overall Study|Ineligible|1|||
161091685|NCT00966277|581726214|FG001|Overall Study|Ineligible|3|||
161091686|NCT00966277|581726213|FG000|Overall Study|Treatment Plan Changed|0|||
161091687|NCT00966277|581726214|FG001|Overall Study|Treatment Plan Changed|1|||
161091688|NCT01249274|581726215|FG000|Overall Study|Lost to Follow-up|3|||
161091689|NCT01249274|581726216|FG001|Overall Study|Lost to Follow-up|4|||
161091690|NCT01249274|581726215|FG000|Overall Study|Received inpatient substance treatment|1|||
161091691|NCT01249274|581726216|FG001|Overall Study|Received inpatient substance treatment|2|||
161091692|NCT01127139|581726217|FG000|Overall Study|Adverse Event|40|||
161091693|NCT01127139|581726217|FG000|Overall Study|Incompliance|12|||
161091694|NCT01127139|581726217|FG000|Overall Study|Lack of Efficacy|4|||
161091695|NCT01127139|581726217|FG000|Overall Study|Reason not specified|1|||
161091696|NCT01136772|581726218|FG000|Overall Study|Adverse Event|15|||
161091697|NCT01136772|581726219|FG001|Overall Study|Adverse Event|14|||
161091698|NCT01136772|581726218|FG000|Overall Study|Lack of Efficacy|42|||
161091699|NCT01136772|581726219|FG001|Overall Study|Lack of Efficacy|39|||
161091700|NCT01136772|581726218|FG000|Overall Study|Administrative|14|||
161091701|NCT01136772|581726219|FG001|Overall Study|Administrative|12|||
161091702|NCT01136772|581726218|FG000|Overall Study|Withdrawal by Subject|33|||
161091703|NCT01136772|581726219|FG001|Overall Study|Withdrawal by Subject|36|||
161091704|NCT01136772|581726218|FG000|Overall Study|Did not receive injection|10|||
161091705|NCT01136772|581726219|FG001|Overall Study|Did not receive injection|7|||
161091706|NCT01136772|581726218|FG000|Overall Study|Did not follow up after first injection|2|||
161091707|NCT01136772|581726219|FG001|Overall Study|Did not follow up after first injection|2|||
161091708|NCT01498653|581726220|FG000|Overall Study|Adverse Event|2|||
161091709|NCT01498653|581726221|FG001|Overall Study|Adverse Event|2|||
161091710|NCT01498653|581726220|FG000|Overall Study|Lack of Efficacy|12|||
161091711|NCT01498653|581726221|FG001|Overall Study|Lack of Efficacy|26|||
161091712|NCT01498653|581726220|FG000|Overall Study|Protocol Violation|0|||
161091713|NCT01498653|581726221|FG001|Overall Study|Protocol Violation|4|||
161091714|NCT01498653|581726220|FG000|Overall Study|Lost to Follow-up|1|||
161091715|NCT01498653|581726221|FG001|Overall Study|Lost to Follow-up|0|||
161091716|NCT01498653|581726220|FG000|Overall Study|Physician Decision|2|||
161091717|NCT01498653|581726221|FG001|Overall Study|Physician Decision|0|||
161091718|NCT01498653|581726220|FG000|Overall Study|Withdrawal by Subject|2|||
161091719|NCT01498653|581726221|FG001|Overall Study|Withdrawal by Subject|3|||
161091720|NCT02070588|581726227|FG000|Overall Study|Withdrawal by Subject|29|||
161091721|NCT02070588|581726228|FG001|Overall Study|Withdrawal by Subject|1|||
161091722|NCT02070588|581726229|FG002|Overall Study|Withdrawal by Subject|0|||
161091723|NCT02070588|581726227|FG000|Overall Study|Writhdrawal due to early termination|9|||
161091724|NCT02070588|581726228|FG001|Overall Study|Writhdrawal due to early termination|0|||
161091725|NCT02070588|581726229|FG002|Overall Study|Writhdrawal due to early termination|0|||
161091726|NCT02070588|581726227|FG000|Overall Study|Adverse Event|1|||
161091727|NCT02070588|581726228|FG001|Overall Study|Adverse Event|0|||
161091728|NCT02070588|581726229|FG002|Overall Study|Adverse Event|0|||
161091729|NCT03421431|581726230|FG000|Overall Study|Adverse Event|2|||
161091730|NCT03421431|581726231|FG001|Overall Study|Adverse Event|1|||
161091731|NCT03421431|581726232|FG002|Overall Study|Adverse Event|12|||
161091732|NCT03421431|581726230|FG000|Overall Study|Lost to Follow-up|1|||
161091733|NCT03421431|581726231|FG001|Overall Study|Lost to Follow-up|1|||
161091734|NCT03421431|581726232|FG002|Overall Study|Lost to Follow-up|1|||
161091735|NCT03421431|581726230|FG000|Overall Study|Withdrawal by Subject|3|||
161091736|NCT03421431|581726231|FG001|Overall Study|Withdrawal by Subject|2|||
161091737|NCT03421431|581726232|FG002|Overall Study|Withdrawal by Subject|1|||
161091738|NCT03421431|581726230|FG000|Overall Study|Protocol Violation|0|||
161320197|NCT01690299|582558860|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161320198|NCT01690299|582558861|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
161320199|NCT01690299|582558856|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
161320200|NCT01690299|582558857|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161320201|NCT01690299|582558858|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161320202|NCT01690299|582558859|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161320203|NCT01690299|582558860|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161320204|NCT01690299|582558861|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
161320205|NCT01690299|582558856|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
161320206|NCT01690299|582558857|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
161320207|NCT01690299|582558858|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161320208|NCT01690299|582558859|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161320209|NCT01690299|582558860|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161320210|NCT01690299|582558861|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
161320211|NCT01690299|582558856|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
161320212|NCT01690299|582558857|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
161320213|NCT01690299|582558858|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
161320214|NCT01690299|582558859|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161320215|NCT01690299|582558860|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161320216|NCT01690299|582558861|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
161320217|NCT01690299|582558856|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161320218|NCT01690299|582558857|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161320219|NCT01690299|582558858|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
161320220|NCT01690299|582558859|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
161320221|NCT01690299|582558860|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
161320222|NCT01690299|582558861|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
161320223|NCT01690299|582558856|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161320224|NCT01690299|582558857|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161320225|NCT01690299|582558858|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
161320226|NCT01690299|582558859|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
161320227|NCT01690299|582558860|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
161320228|NCT01690299|582558861|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
161320229|NCT01690299|582558856|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161320230|NCT01690299|582558857|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161320231|NCT01690299|582558858|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161320232|NCT01690299|582558859|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
161320233|NCT01690299|582558860|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
161320234|NCT01690299|582558861|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
161320235|NCT01690299|582558856|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161320236|NCT01690299|582558857|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161320237|NCT01690299|582558858|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
161320238|NCT01690299|582558859|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
161320239|NCT01690299|582558860|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
161320240|NCT01690299|582558861|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
161320241|NCT01690299|582558856|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161320242|NCT01690299|582558857|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161320243|NCT01690299|582558858|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
161320244|NCT01690299|582558859|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
161320245|NCT01690299|582558860|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
161320246|NCT01690299|582558861|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
161320247|NCT01690299|582558856|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161320248|NCT01690299|582558857|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161320249|NCT01690299|582558858|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161091739|NCT03421431|581726231|FG001|Overall Study|Protocol Violation|1|||
161091740|NCT03421431|581726232|FG002|Overall Study|Protocol Violation|0|||
161091741|NCT03421431|581726230|FG000|Overall Study|Participant met Stopping Rules|0|||
161320250|NCT01690299|582558859|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161320251|NCT01690299|582558860|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
161320252|NCT01690299|582558861|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
161320253|NCT01882803|582558866|FG000|Overall Study|Disease Progression|1|||
161320254|NCT01882803|582558866|FG000|Overall Study|Withdrawal by Subject|9|||
161320255|NCT01882803|582558866|FG000|Overall Study|Death|68|||
161320256|NCT01882803|582558866|FG000|Overall Study|Physician Decision|3|||
161320257|NCT01882803|582558866|FG000|Overall Study|Lost to Follow-up|3|||
161320258|NCT01882803|582558866|FG000|Overall Study|Follow-up Completed|39|||
161320259|NCT01882803|582558866|FG000|Overall Study|Study Terminated by the Sponsor|6|||
161320260|NCT02869893|582558867|FG000|Overall Study|participant aversion to IV|5|||
161320261|NCT02869893|582558867|FG000|Overall Study|participant fear of MRI scanner|2|||
161320262|NCT01563913|582558868|FG000|Overall Study|Physician Decision|1|||
161091742|NCT03421431|581726231|FG001|Overall Study|Participant met Stopping Rules|1|||
161320263|NCT01563913|582558869|FG001|Overall Study|Physician Decision|0|||
161320264|NCT01563913|582558868|FG000|Overall Study|Spouse Passed Away|1|||
161320265|NCT01563913|582558869|FG001|Overall Study|Spouse Passed Away|0|||
161320266|NCT03066778|582558870|FG000|Overall Study|Death|195|||
161320267|NCT03066778|582558871|FG001|Overall Study|Death|205|||
161320268|NCT03066778|582558870|FG000|Overall Study|Withdrawal by Subject|5|||
161320269|NCT03066778|582558871|FG001|Overall Study|Withdrawal by Subject|7|||
161320270|NCT00551525|582558872|FG000|Overall Study|Protocol Violation|5|||
161320271|NCT05259917|582558878|FG000|Overall Study|Protocol Violation|0|||
161320272|NCT05259917|582558879|FG001|Overall Study|Protocol Violation|0|||
161320273|NCT05259917|582558880|FG002|Overall Study|Protocol Violation|1|||
161320274|NCT05259917|582558881|FG003|Overall Study|Protocol Violation|0|||
161320275|NCT05259917|582558882|FG004|Overall Study|Protocol Violation|0|||
161320276|NCT05259917|582558883|FG005|Overall Study|Protocol Violation|0|||
161320277|NCT05259917|582558878|FG000|Overall Study|Lost to Follow-up|0|||
161320278|NCT05259917|582558879|FG001|Overall Study|Lost to Follow-up|0|||
161320279|NCT05259917|582558880|FG002|Overall Study|Lost to Follow-up|1|||
161320280|NCT05259917|582558881|FG003|Overall Study|Lost to Follow-up|0|||
161320281|NCT05259917|582558882|FG004|Overall Study|Lost to Follow-up|0|||
161320282|NCT05259917|582558883|FG005|Overall Study|Lost to Follow-up|1|||
161320283|NCT05259917|582558878|FG000|Overall Study|Physician Decision|0|||
161320284|NCT05259917|582558879|FG001|Overall Study|Physician Decision|1|||
161320285|NCT05259917|582558880|FG002|Overall Study|Physician Decision|0|||
161320286|NCT05259917|582558881|FG003|Overall Study|Physician Decision|0|||
161320287|NCT05259917|582558882|FG004|Overall Study|Physician Decision|0|||
161320288|NCT05259917|582558883|FG005|Overall Study|Physician Decision|0|||
161320289|NCT05259917|582558878|FG000|Overall Study|Withdrawal by Subject|0|||
161091743|NCT03421431|581726232|FG002|Overall Study|Participant met Stopping Rules|0|||
161091744|NCT02216357|581726233|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
161091745|NCT02216357|581726234|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
161091746|NCT00141726|581726235|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
161091747|NCT00235326|581726244|FG000|Overall Study|Lost to Follow-up|746|||
161091748|NCT00235326|581726245|FG001|Overall Study|Lost to Follow-up|1400|||
161091749|NCT01790126|581726248|FG000|Overall Study|PSA Progression|12|||
161091750|NCT01790126|581726249|FG001|Overall Study|PSA Progression|16|||
161091751|NCT01790126|581726250|FG002|Overall Study|PSA Progression|16|||
161091752|NCT01790126|581726248|FG000|Overall Study|Other|5|||
161091753|NCT01790126|581726249|FG001|Overall Study|Other|4|||
161091754|NCT01790126|581726250|FG002|Overall Study|Other|8|||
161091755|NCT01790126|581726248|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
161091756|NCT01790126|581726249|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
161091757|NCT01790126|581726250|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
161091758|NCT01790126|581726248|FG000|Overall Study|Withdrawal by Physician|1|||
161091759|NCT01790126|581726249|FG001|Overall Study|Withdrawal by Physician|1|||
161091760|NCT01790126|581726250|FG002|Overall Study|Withdrawal by Physician|2|||
161091761|NCT01790126|581726248|FG000|Overall Study|Withdrawal by Subject|3|||
161091762|NCT01790126|581726249|FG001|Overall Study|Withdrawal by Subject|1|||
161091763|NCT01790126|581726250|FG002|Overall Study|Withdrawal by Subject|2|||
161091764|NCT01790126|581726248|FG000|Overall Study|Lost to Follow-up|1|||
161091765|NCT01790126|581726249|FG001|Overall Study|Lost to Follow-up|0|||
161091766|NCT01790126|581726250|FG002|Overall Study|Lost to Follow-up|1|||
161091767|NCT01790126|581726248|FG000|Overall Study|Adverse Event|0|||
161091768|NCT01790126|581726249|FG001|Overall Study|Adverse Event|2|||
161091769|NCT01790126|581726250|FG002|Overall Study|Adverse Event|0|||
161091770|NCT01790126|581726248|FG000|Overall Study|Death|2|||
161091771|NCT01790126|581726249|FG001|Overall Study|Death|0|||
161091772|NCT01790126|581726250|FG002|Overall Study|Death|0|||
161091773|NCT01790126|581726248|FG000|Overall Study|Radiographic Progression|3|||
161091774|NCT01790126|581726249|FG001|Overall Study|Radiographic Progression|1|||
161091775|NCT01790126|581726250|FG002|Overall Study|Radiographic Progression|0|||
161091776|NCT00455325|581726251|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
161091777|NCT00455325|581726252|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
161091778|NCT00455325|581726253|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
161091779|NCT00455325|581726254|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
161091780|NCT00455325|581726251|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
161091781|NCT00455325|581726252|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
161091782|NCT00455325|581726253|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
161091783|NCT00455325|581726254|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
161091784|NCT00455325|581726251|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
161091785|NCT00455325|581726252|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
161091786|NCT00455325|581726253|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
161091787|NCT00455325|581726254|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
161091788|NCT00455325|581726251|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
161091789|NCT00455325|581726252|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
161091790|NCT00455325|581726253|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
161091791|NCT00455325|581726254|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
161091792|NCT00455325|581726251|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
161091793|NCT00455325|581726252|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
161091794|NCT00455325|581726253|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
161091795|NCT00455325|581726254|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
161091796|NCT00455325|581726251|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
161091797|NCT00455325|581726252|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
161091798|NCT00455325|581726253|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
161091799|NCT00455325|581726254|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
161091800|NCT00455325|581726251|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
161091801|NCT00455325|581726252|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
161091802|NCT00455325|581726253|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
161091803|NCT00455325|581726254|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
161091804|NCT02435966|581726255|FG000|Overall Study|Withdrawal by Subject|0|||
161091805|NCT02435966|581726256|FG001|Overall Study|Withdrawal by Subject|1|||
161091806|NCT02435966|581726257|FG002|Overall Study|Withdrawal by Subject|0|||
161091807|NCT00928746|581726261|FG000|Overall Study|Adverse Event|2|||
161091808|NCT00928746|581726261|FG000|Overall Study|Protocol Violation|1|||
161091809|NCT00928746|581726261|FG000|Overall Study|Withdrawal by Subject|1|||
161091810|NCT00928746|581726261|FG000|Overall Study|Other|2|||
161091811|NCT02745392|581726266|FG000|Overall Study|Lost to Follow-up|0|||
161091812|NCT02745392|581726267|FG001|Overall Study|Lost to Follow-up|1|||
161091813|NCT02745392|581726268|FG002|Overall Study|Lost to Follow-up|0|||
161091814|NCT02745392|581726269|FG003|Overall Study|Lost to Follow-up|0|||
161091815|NCT02004353|581726274|FG000|Overall Study|Voluntary participation|1334|||
161091816|NCT01691768|581726275|FG000|Overall Study|Death|0|||
161091817|NCT01691768|581726276|FG001|Overall Study|Death|2|||
161091818|NCT01691768|581726275|FG000|Overall Study|Lost to Follow-up|4|||
161091819|NCT01691768|581726276|FG001|Overall Study|Lost to Follow-up|3|||
161091820|NCT01691768|581726275|FG000|Overall Study|Withdrawal by Subject|10|||
161091821|NCT01691768|581726276|FG001|Overall Study|Withdrawal by Subject|9|||
161091822|NCT01691768|581726275|FG000|Overall Study|Relocated|0|||
161091823|NCT01691768|581726276|FG001|Overall Study|Relocated|1|||
161091824|NCT01691768|581726275|FG000|Overall Study|Investigator decision|1|||
161091825|NCT01691768|581726276|FG001|Overall Study|Investigator decision|1|||
161091826|NCT01007448|581726287|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
161091827|NCT01007448|581726288|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
161091828|NCT01007448|581726287|FG000|Overall Study|Staph Skin Infection Flare|1|||
161091829|NCT01007448|581726288|FG001|Overall Study|Staph Skin Infection Flare|0|||
161091830|NCT01007448|581726287|FG000|Overall Study|Participant Leaving the Country|1|||
161091831|NCT01007448|581726288|FG001|Overall Study|Participant Leaving the Country|0|||
161091832|NCT01007448|581726287|FG000|Overall Study|Participant Given Prohibited Medication|1|||
161091833|NCT01007448|581726288|FG001|Overall Study|Participant Given Prohibited Medication|0|||
161091834|NCT01007448|581726287|FG000|Overall Study|Progressive Disease|1|||
161091835|NCT01007448|581726288|FG001|Overall Study|Progressive Disease|2|||
161091836|NCT01007448|581726287|FG000|Overall Study|Lack of Efficacy|2|||
161091837|NCT01007448|581726288|FG001|Overall Study|Lack of Efficacy|0|||
161091838|NCT01007448|581726287|FG000|Overall Study|Withdrawal by Subject|2|||
161091839|NCT01007448|581726288|FG001|Overall Study|Withdrawal by Subject|3|||
161091840|NCT01007448|581726287|FG000|Overall Study|Adverse Event|1|||
161091841|NCT01007448|581726288|FG001|Overall Study|Adverse Event|4|||
161091842|NCT02481947|581726289|FG000|Overall Study|Withdrawal by Subject|24|||
161091843|NCT02481947|581726290|FG001|Overall Study|Withdrawal by Subject|10|||
161091844|NCT02481947|581726289|FG000|Overall Study|Lost to Follow-up|11|||
161091845|NCT02481947|581726290|FG001|Overall Study|Lost to Follow-up|5|||
161091846|NCT02481947|581726289|FG000|Overall Study|Adverse Event|6|||
161091847|NCT02481947|581726290|FG001|Overall Study|Adverse Event|11|||
161091848|NCT02481947|581726289|FG000|Overall Study|Physician Decision|4|||
161091849|NCT02481947|581726290|FG001|Overall Study|Physician Decision|5|||
161091850|NCT02481947|581726289|FG000|Overall Study|Protocol Violation|1|||
161091851|NCT02481947|581726290|FG001|Overall Study|Protocol Violation|5|||
161091852|NCT02751320|581726291|FG000|Overall Study|Adverse Event|2|||
161091853|NCT02751320|581726291|FG000|Overall Study|Withdrawal by Subject|1|||
161091854|NCT03426605|581726292|FG000|Overall Study|AML relapse or progression|2|||
161091855|NCT03426605|581726293|FG001|Overall Study|AML relapse or progression|1|||
161091856|NCT03426605|581726294|FG002|Overall Study|AML relapse or progression|2|||
161091857|NCT03426605|581726295|FG003|Overall Study|AML relapse or progression|2|||
161091858|NCT03426605|581726292|FG000|Overall Study|Treatment failure|3|||
161091859|NCT03426605|581726293|FG001|Overall Study|Treatment failure|2|||
161091860|NCT03426605|581726294|FG002|Overall Study|Treatment failure|0|||
161091861|NCT03426605|581726295|FG003|Overall Study|Treatment failure|0|||
161091862|NCT03426605|581726292|FG000|Overall Study|Adverse Event|1|||
161091863|NCT03426605|581726293|FG001|Overall Study|Adverse Event|0|||
161091864|NCT03426605|581726294|FG002|Overall Study|Adverse Event|1|||
161091865|NCT03426605|581726295|FG003|Overall Study|Adverse Event|1|||
161091866|NCT03426605|581726292|FG000|Overall Study|Withdrawal by Subject|0|||
161091867|NCT03426605|581726293|FG001|Overall Study|Withdrawal by Subject|0|||
161091868|NCT03426605|581726294|FG002|Overall Study|Withdrawal by Subject|1|||
161091869|NCT03426605|581726295|FG003|Overall Study|Withdrawal by Subject|1|||
161091870|NCT01920854|581726298|FG000|Overall Study|Withdrawal by Subject|1|||
161091871|NCT01920854|581726299|FG001|Overall Study|Withdrawal by Subject|0|||
161091872|NCT01920854|581726300|FG002|Overall Study|Withdrawal by Subject|0|||
161091873|NCT01920854|581726301|FG003|Overall Study|Withdrawal by Subject|0|||
161091874|NCT01920854|581726302|FG004|Overall Study|Withdrawal by Subject|1|||
161091875|NCT01920854|581726303|FG005|Overall Study|Withdrawal by Subject|0|||
161091876|NCT01920854|581726304|FG006|Overall Study|Withdrawal by Subject|1|||
161091877|NCT02027623|581726305|FG000|Overall Study|Lost to Follow-up|3|||
161091878|NCT02027623|581726306|FG001|Overall Study|Lost to Follow-up|3|||
161091879|NCT02027623|581726305|FG000|Overall Study|Withdrawal by Subject|6|||
161091880|NCT02027623|581726306|FG001|Overall Study|Withdrawal by Subject|9|||
161091881|NCT01886378|581726307|FG000|Overall Study|Adverse Event|1|||
161091882|NCT01886378|581726307|FG000|Overall Study|Withdrawal by Subject|4|||
161091883|NCT03333837|581726317|FG000|Overall Study|Adverse Event|2|||
161091884|NCT03333837|581726318|FG001|Overall Study|Adverse Event|1|||
161091885|NCT03333837|581726319|FG002|Overall Study|Adverse Event|1|||
161091886|NCT03333837|581726320|FG003|Overall Study|Adverse Event|1|||
161091887|NCT03333837|581726321|FG004|Overall Study|Adverse Event|0|||
161091888|NCT03333837|581726317|FG000|Overall Study|Caregiver withdrew|0|||
161091889|NCT03333837|581726318|FG001|Overall Study|Caregiver withdrew|2|||
161091890|NCT03333837|581726319|FG002|Overall Study|Caregiver withdrew|1|||
161091891|NCT03333837|581726320|FG003|Overall Study|Caregiver withdrew|0|||
161091892|NCT03333837|581726321|FG004|Overall Study|Caregiver withdrew|0|||
161091893|NCT03333837|581726317|FG000|Overall Study|Withdrawal by Subject|0|||
161091894|NCT03333837|581726318|FG001|Overall Study|Withdrawal by Subject|0|||
161091895|NCT03333837|581726319|FG002|Overall Study|Withdrawal by Subject|1|||
161091896|NCT03333837|581726320|FG003|Overall Study|Withdrawal by Subject|1|||
161091897|NCT03333837|581726321|FG004|Overall Study|Withdrawal by Subject|3|||
161091898|NCT03333837|581726317|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161091899|NCT03333837|581726318|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161091900|NCT03333837|581726319|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
161091901|NCT03333837|581726320|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161091902|NCT03333837|581726321|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
161091903|NCT02232243|581726325|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
161091904|NCT02232243|581726326|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
161091905|NCT02232243|581726327|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
161091906|NCT00704405|581726328|FG000|Overall Study (NC Population)|Adverse Event|1|||
161091907|NCT00704405|581726329|FG001|Overall Study (NC Population)|Adverse Event|0|||
161091908|NCT00704405|581726330|FG002|Overall Study (NC Population)|Adverse Event|0|||
161091909|NCT00704405|581726331|FG003|Overall Study (NC Population)|Adverse Event|0|||
161091910|NCT00704405|581726332|FG004|Overall Study (NC Population)|Adverse Event|0|||
161091911|NCT00704405|581726328|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
161091912|NCT00704405|581726329|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
161091913|NCT00704405|581726330|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
161091914|NCT00704405|581726331|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
161091915|NCT00704405|581726332|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
161091916|NCT00704405|581726328|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
161091917|NCT00704405|581726329|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
161091918|NCT00704405|581726330|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
161091919|NCT00704405|581726331|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
161091920|NCT00704405|581726332|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
161091921|NCT00704405|581726328|FG000|Overall Study (NC Population)|Other|0|||
161091922|NCT00704405|581726329|FG001|Overall Study (NC Population)|Other|0|||
161091923|NCT00704405|581726330|FG002|Overall Study (NC Population)|Other|0|||
161091924|NCT00704405|581726331|FG003|Overall Study (NC Population)|Other|0|||
161091925|NCT00704405|581726332|FG004|Overall Study (NC Population)|Other|1|||
161091926|NCT00704405|581726328|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
161091927|NCT00704405|581726329|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
161091928|NCT00704405|581726330|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
161091929|NCT00704405|581726331|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
161091930|NCT00704405|581726332|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
161091931|NCT00704405|581726328|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
161091932|NCT00704405|581726329|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
161091933|NCT00704405|581726330|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
161091934|NCT00704405|581726331|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
161091935|NCT00704405|581726332|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
161091936|NCT02374671|581726333|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
161091937|NCT02374671|581726334|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
161091938|NCT02374671|581726335|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
161091939|NCT02374671|581726333|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
161091940|NCT02374671|581726334|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
161091941|NCT02374671|581726335|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
161091942|NCT02374671|581726333|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
161091943|NCT02374671|581726334|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
161091944|NCT02374671|581726335|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
161091945|NCT02374671|581726333|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
161091946|NCT02374671|581726334|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
161091947|NCT02374671|581726335|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
161091948|NCT02374671|581726333|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
161091949|NCT02374671|581726334|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161091950|NCT02374671|581726335|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
161091951|NCT03169101|581726339|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
161091952|NCT03169101|581726340|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
161091953|NCT03169101|581726341|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
161091954|NCT03169101|581726342|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
161091955|NCT02641496|581726345|FG000|Overall Study|Lost to Follow-up|13|||
161091956|NCT02641496|581726346|FG001|Overall Study|Lost to Follow-up|12|||
161091957|NCT02641496|581726345|FG000|Overall Study|Withdrawal by Subject|1|||
161091958|NCT02641496|581726346|FG001|Overall Study|Withdrawal by Subject|0|||
161091959|NCT01912456|581727705|FG000|Period 1|Physician Decision|0|||
161091960|NCT01912456|581727706|FG001|Period 1|Physician Decision|0|||
161091961|NCT01912456|581727707|FG002|Period 1|Physician Decision|1|||
161091962|NCT01912456|581727708|FG003|Period 1|Physician Decision|0|||
161091963|NCT01912456|581727705|FG000|Period 1|non-compliance|1|||
161091964|NCT01912456|581727706|FG001|Period 1|non-compliance|0|||
161091965|NCT01912456|581727707|FG002|Period 1|non-compliance|0|||
161091966|NCT01912456|581727708|FG003|Period 1|non-compliance|1|||
161091967|NCT01912456|581727705|FG000|Period 1|Adverse Event|1|||
161091968|NCT01912456|581727706|FG001|Period 1|Adverse Event|0|||
161091969|NCT01912456|581727707|FG002|Period 1|Adverse Event|0|||
161091970|NCT01912456|581727708|FG003|Period 1|Adverse Event|1|||
161091971|NCT01912456|581727705|FG000|Period 1|Withdrawal by Subject|0|||
161091972|NCT01912456|581727706|FG001|Period 1|Withdrawal by Subject|1|||
161091973|NCT01912456|581727707|FG002|Period 1|Withdrawal by Subject|1|||
161091974|NCT01912456|581727708|FG003|Period 1|Withdrawal by Subject|1|||
161091975|NCT01912456|581727705|FG000|Period 2|Lack of Efficacy|0|||
161091976|NCT01912456|581727706|FG001|Period 2|Lack of Efficacy|2|||
161091977|NCT01912456|581727707|FG002|Period 2|Lack of Efficacy|0|||
161091978|NCT01912456|581727708|FG003|Period 2|Lack of Efficacy|0|||
161091979|NCT01912456|581727705|FG000|Period 2|Adverse Event|0|||
161091980|NCT01912456|581727706|FG001|Period 2|Adverse Event|0|||
161091981|NCT01912456|581727707|FG002|Period 2|Adverse Event|0|||
161091982|NCT01912456|581727708|FG003|Period 2|Adverse Event|1|||
161091983|NCT01340196|581727709|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
161091984|NCT00171704|581727715|FG000|Overall Study|Adverse Event|24|||
161091985|NCT00171704|581727716|FG001|Overall Study|Adverse Event|33|||
161091986|NCT00171704|581727715|FG000|Overall Study|Disease Progression|14|||
161091987|NCT00171704|581727716|FG001|Overall Study|Disease Progression|9|||
161091988|NCT00171704|581727715|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
161091989|NCT00171704|581727716|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
161091990|NCT00171704|581727715|FG000|Overall Study|Administrative Problems|2|||
161091991|NCT00171704|581727716|FG001|Overall Study|Administrative Problems|1|||
161091992|NCT00171704|581727715|FG000|Overall Study|Death|2|||
161091993|NCT00171704|581727716|FG001|Overall Study|Death|2|||
161091994|NCT00171704|581727715|FG000|Overall Study|Withdrawal by Subject|1|||
161091995|NCT00171704|581727716|FG001|Overall Study|Withdrawal by Subject|3|||
161091996|NCT00171704|581727715|FG000|Overall Study|Protocol Violation|0|||
161091997|NCT00171704|581727716|FG001|Overall Study|Protocol Violation|1|||
161091998|NCT00320541|581727720|FG000|Overall Study|Adverse Event|21|||
161091999|NCT00320541|581727721|FG001|Overall Study|Adverse Event|19|||
161092000|NCT00320541|581727720|FG000|Overall Study|Protocol Violation|0|||
161092001|NCT00320541|581727721|FG001|Overall Study|Protocol Violation|1|||
161092002|NCT00320541|581727720|FG000|Overall Study|Withdrawal by Subject|12|||
161092003|NCT00320541|581727721|FG001|Overall Study|Withdrawal by Subject|16|||
161092004|NCT00320541|581727720|FG000|Overall Study|Physician Decision|9|||
161092005|NCT00320541|581727721|FG001|Overall Study|Physician Decision|13|||
161092006|NCT00320541|581727720|FG000|Overall Study|Other|3|||
161092007|NCT00320541|581727721|FG001|Overall Study|Other|4|||
161092008|NCT00320541|581727720|FG000|Overall Study|Sponsor Decision|2|||
161092009|NCT00320541|581727721|FG001|Overall Study|Sponsor Decision|1|||
161092010|NCT00320541|581727720|FG000|Overall Study|Death due to Study Disease|1|||
161092011|NCT00320541|581727721|FG001|Overall Study|Death due to Study Disease|3|||
161092012|NCT00320541|581727720|FG000|Overall Study|Death due to Adverse Event(s)|1|||
161092013|NCT00320541|581727721|FG001|Overall Study|Death due to Adverse Event(s)|0|||
161092014|NCT00320541|581727720|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
161092015|NCT00320541|581727721|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
161092016|NCT01620255|581727727|FG000|Overall Study|Withdrawal by Subject|4|||
161092017|NCT01620255|581727728|FG001|Overall Study|Withdrawal by Subject|1|||
161092018|NCT01620255|581727729|FG002|Overall Study|Withdrawal by Subject|1|||
161092019|NCT01620255|581727730|FG003|Overall Study|Withdrawal by Subject|2|||
161092020|NCT01620255|581727731|FG004|Overall Study|Withdrawal by Subject|4|||
161092021|NCT01620255|581727727|FG000|Overall Study|Participant underwent fecal transplant|0|||
161092022|NCT01620255|581727728|FG001|Overall Study|Participant underwent fecal transplant|0|||
161092023|NCT01620255|581727729|FG002|Overall Study|Participant underwent fecal transplant|1|||
161092024|NCT01620255|581727730|FG003|Overall Study|Participant underwent fecal transplant|0|||
161092025|NCT01620255|581727731|FG004|Overall Study|Participant underwent fecal transplant|0|||
161092026|NCT01620255|581727727|FG000|Overall Study|Non-compliance|0|||
161092027|NCT01620255|581727728|FG001|Overall Study|Non-compliance|1|||
161092028|NCT01620255|581727729|FG002|Overall Study|Non-compliance|0|||
161092029|NCT01620255|581727730|FG003|Overall Study|Non-compliance|0|||
161092030|NCT01620255|581727731|FG004|Overall Study|Non-compliance|0|||
161092031|NCT01620255|581727727|FG000|Overall Study|Adverse Event|0|||
161092032|NCT01620255|581727728|FG001|Overall Study|Adverse Event|4|||
161092033|NCT01620255|581727729|FG002|Overall Study|Adverse Event|0|||
161092034|NCT01620255|581727730|FG003|Overall Study|Adverse Event|1|||
161092035|NCT01620255|581727731|FG004|Overall Study|Adverse Event|1|||
161092036|NCT01620255|581727727|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
161092037|NCT01620255|581727728|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
161092038|NCT01620255|581727729|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
161092039|NCT01620255|581727730|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
161092040|NCT01620255|581727731|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
161092041|NCT01873495|581727738|FG000|Overall Study|Withdrawal by Subject|1|||
161092042|NCT01873495|581727738|FG000|Overall Study|Physician Decision|3|||
161092043|NCT01873495|581727738|FG000|Overall Study|Adverse Event|1|||
161092044|NCT01873495|581727738|FG000|Overall Study|Removed for Transplantation|1|||
161092045|NCT01873495|581727738|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
161092046|NCT03864146|581727739|FG000|Overall Study|Lost to Follow-up|14|||
161092047|NCT03864146|581727740|FG001|Overall Study|Lost to Follow-up|23|||
161092048|NCT03864146|581727739|FG000|Overall Study|Withdrawal by Subject|3|||
161092049|NCT03864146|581727740|FG001|Overall Study|Withdrawal by Subject|2|||
161092050|NCT00655486|581727742|FG000|Overall Study|Adverse Event|10|||
161092051|NCT00655486|581727742|FG000|Overall Study|Lack of Efficacy|8|||
161092052|NCT00655486|581727742|FG000|Overall Study|Withdrawal by Subject|4|||
161092053|NCT00655486|581727742|FG000|Overall Study|Protocol Violation|1|||
161092054|NCT00655486|581727742|FG000|Overall Study|Unsatisfactory compliance|2|||
161092055|NCT00655486|581727742|FG000|Overall Study|Other: Pregnancy|1|||
161092056|NCT00655486|581727742|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
161092057|NCT00655486|581727742|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
161092058|NCT00310037|581727743|FG000|Overall Study|Adverse Event|7|||
161092059|NCT00310037|581727744|FG001|Overall Study|Adverse Event|14|||
161092060|NCT00310037|581727743|FG000|Overall Study|Withdrawal by Subject|4|||
161092061|NCT00310037|581727744|FG001|Overall Study|Withdrawal by Subject|3|||
161092062|NCT00310037|581727743|FG000|Overall Study|Progression|6|||
161092063|NCT00310037|581727744|FG001|Overall Study|Progression|0|||
161092064|NCT00310037|581727743|FG000|Overall Study|Non-protocol treatment|1|||
161092065|NCT00310037|581727744|FG001|Overall Study|Non-protocol treatment|0|||
161092066|NCT00440999|581727755|FG000|Overall Study|Adverse Event|0|||
161092067|NCT00440999|581727756|FG001|Overall Study|Adverse Event|2|||
161092068|NCT00440999|581727755|FG000|Overall Study|Lack of Efficacy|6|||
161092069|NCT00440999|581727756|FG001|Overall Study|Lack of Efficacy|7|||
161092070|NCT00440999|581727755|FG000|Overall Study|Lost to Follow-up|19|||
161092071|NCT00440999|581727756|FG001|Overall Study|Lost to Follow-up|12|||
161092072|NCT00440999|581727755|FG000|Overall Study|Protocol Violation|1|||
161092073|NCT00440999|581727756|FG001|Overall Study|Protocol Violation|0|||
161092074|NCT00440999|581727755|FG000|Overall Study|Withdrawal by Subject|2|||
161092075|NCT00440999|581727756|FG001|Overall Study|Withdrawal by Subject|5|||
161092076|NCT00440999|581727755|FG000|Overall Study|Subjets missed the visit|1|||
161092077|NCT00440999|581727756|FG001|Overall Study|Subjets missed the visit|0|||
161092078|NCT00440999|581727755|FG000|Overall Study|Mixed infection at entry|1|||
161092079|NCT00440999|581727756|FG001|Overall Study|Mixed infection at entry|0|||
161092080|NCT00440999|581727755|FG000|Overall Study|P. falciparum malaria|5|||
161092081|NCT00440999|581727756|FG001|Overall Study|P. falciparum malaria|14|||
161092082|NCT00440999|581727755|FG000|Overall Study|Subj left hosp without inform staff|0|||
161092083|NCT00440999|581727756|FG001|Overall Study|Subj left hosp without inform staff|1|||
161092084|NCT05559099|581727759|FG000|Overall Study|Death|5|||
161092085|NCT05559099|581727760|FG001|Overall Study|Death|4|||
161092086|NCT05559099|581727759|FG000|Overall Study|Lost to Follow-up|0|||
161092087|NCT05559099|581727760|FG001|Overall Study|Lost to Follow-up|2|||
161092088|NCT05559099|581727759|FG000|Overall Study|Adverse Event|1|||
161092089|NCT05559099|581727760|FG001|Overall Study|Adverse Event|1|||
161092090|NCT04018092|581727761|FG000|Overall Study|Withdrawal by Subject|1|||
161092091|NCT04018092|581727762|FG001|Overall Study|Withdrawal by Subject|1|||
161092092|NCT04018092|581727761|FG000|Overall Study|Withdrawal by Subject|1|||
161092093|NCT04018092|581727762|FG001|Overall Study|Withdrawal by Subject|1|||
161092094|NCT04218084|581727763|FG000|Overall Study|Adverse Event|7|||
161092095|NCT04218084|581727764|FG001|Overall Study|Adverse Event|2|||
161092096|NCT04218084|581727763|FG000|Overall Study|Withdrawal of Consent|4|||
161092097|NCT04218084|581727764|FG001|Overall Study|Withdrawal of Consent|5|||
161092098|NCT04218084|581727763|FG000|Overall Study|Physician Decision|1|||
161092099|NCT04218084|581727764|FG001|Overall Study|Physician Decision|1|||
161092100|NCT04218084|581727763|FG000|Overall Study|Lost to Follow-up|1|||
161092101|NCT04218084|581727764|FG001|Overall Study|Lost to Follow-up|1|||
161092102|NCT04218084|581727763|FG000|Overall Study|Non-compliance with study drug|1|||
161092103|NCT04218084|581727764|FG001|Overall Study|Non-compliance with study drug|1|||
161092104|NCT04218084|581727763|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
161092105|NCT04218084|581727764|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
161092106|NCT04218084|581727763|FG000|Overall Study|Other|0|||
161092107|NCT04218084|581727764|FG001|Overall Study|Other|1|||
161092108|NCT04218084|581727763|FG000|Overall Study|Ongoing at data cut-off date|62|||
161092109|NCT04218084|581727764|FG001|Overall Study|Ongoing at data cut-off date|58|||
161092110|NCT06469242|581727765|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
161092111|NCT06469242|581727766|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
161092112|NCT06469242|581727765|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
161092113|NCT06469242|581727766|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
161092114|NCT05041101|581727767|FG000|Overall Study|Adverse Event|1|||
161092115|NCT05041101|581727768|FG001|Overall Study|Adverse Event|0|||
161092116|NCT05041101|581727769|FG002|Overall Study|Adverse Event|0|||
161092117|NCT05041101|581727767|FG000|Overall Study|Diease Progression|5|||
161092118|NCT05041101|581727768|FG001|Overall Study|Diease Progression|0|||
161092119|NCT05041101|581727769|FG002|Overall Study|Diease Progression|0|||
161092120|NCT01205152|581727770|FG000|Overall Study|Death|1|||
161092121|NCT02783768|581727771|FG000|Overall Study|Lost to Follow-up|1|||
161092122|NCT02783768|581727772|FG001|Overall Study|Lost to Follow-up|0|||
161092123|NCT00842985|581727773|FG000|Screening|Did not meet entrance requirements|27|||
161092124|NCT00842985|581727773|FG000|First Intervention|Withdrawal by Subject|3|||
161092125|NCT00842985|581727773|FG000|First Intervention|Protocol Violation|3|||
161092126|NCT00842985|581727773|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
161092127|NCT00842985|581727773|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
161092128|NCT01037244|581727774|FG000|Overall Study|Adverse Event|3|||
161092129|NCT01037244|581727775|FG001|Overall Study|Adverse Event|2|||
161092130|NCT01037244|581727776|FG002|Overall Study|Adverse Event|6|||
161092131|NCT01037244|581727777|FG003|Overall Study|Adverse Event|3|||
161092132|NCT01037244|581727774|FG000|Overall Study|Lack of Efficacy|1|||
161092133|NCT01037244|581727775|FG001|Overall Study|Lack of Efficacy|1|||
161092134|NCT01037244|581727776|FG002|Overall Study|Lack of Efficacy|0|||
161092135|NCT01037244|581727777|FG003|Overall Study|Lack of Efficacy|1|||
161092136|NCT01037244|581727774|FG000|Overall Study|Lost to Follow-up|3|||
161092137|NCT01037244|581727775|FG001|Overall Study|Lost to Follow-up|3|||
161092138|NCT01037244|581727776|FG002|Overall Study|Lost to Follow-up|4|||
161092139|NCT01037244|581727777|FG003|Overall Study|Lost to Follow-up|4|||
161092140|NCT01037244|581727774|FG000|Overall Study|Withdrawal by Subject|1|||
161092141|NCT01037244|581727775|FG001|Overall Study|Withdrawal by Subject|5|||
161092142|NCT01037244|581727776|FG002|Overall Study|Withdrawal by Subject|3|||
161092143|NCT01037244|581727777|FG003|Overall Study|Withdrawal by Subject|5|||
161092144|NCT01037244|581727774|FG000|Overall Study|Partner Withdrew Consent|2|||
161092145|NCT01037244|581727775|FG001|Overall Study|Partner Withdrew Consent|1|||
161092146|NCT01037244|581727776|FG002|Overall Study|Partner Withdrew Consent|0|||
161092147|NCT01037244|581727777|FG003|Overall Study|Partner Withdrew Consent|0|||
161092148|NCT01037244|581727774|FG000|Overall Study|Various|3|||
161092149|NCT01037244|581727775|FG001|Overall Study|Various|2|||
161092150|NCT01037244|581727776|FG002|Overall Study|Various|1|||
161092151|NCT01037244|581727777|FG003|Overall Study|Various|1|||
161092152|NCT00848926|581727778|FG000|Treatment Period|Progressive disease|45|||
161092153|NCT00848926|581727778|FG000|Treatment Period|Adverse Event|20|||
161092154|NCT00848926|581727778|FG000|Treatment Period|Physician Decision|12|||
161092155|NCT00848926|581727778|FG000|Treatment Period|Withdrawal by Subject|7|||
161092156|NCT00848926|581727778|FG000|Follow-up Period|Lost to Follow-up|7|||
161092157|NCT00848926|581727778|FG000|Follow-up Period|Withdrawal by Subject|3|||
161092158|NCT00848926|581727778|FG000|Follow-up Period|Other|2|||
161092159|NCT01122862|581727779|FG000|Period 1|Protocol Violation|0|||
161092160|NCT01122862|581727780|FG001|Period 1|Protocol Violation|1|||
161092161|NCT01122862|581727781|FG002|Period 1|Protocol Violation|0|||
161092162|NCT01122862|581727779|FG000|Period 2|Adverse Event|0|||
161092163|NCT01122862|581727780|FG001|Period 2|Adverse Event|0|||
161092164|NCT01122862|581727781|FG002|Period 2|Adverse Event|1|||
161092165|NCT01477333|581727784|FG000|Overall Study|Adverse Event|1|||
161092166|NCT01477333|581727784|FG000|Overall Study|Withdrawal by Subject|1|||
161092167|NCT01477333|581727784|FG000|Overall Study|Clinical Deterioration|1|||
161092168|NCT01178671|581727785|FG000|Overall Study|Adverse Event|4|||
161092169|NCT01178671|581727786|FG001|Overall Study|Adverse Event|6|||
161092170|NCT01178671|581727785|FG000|Overall Study|Protocol Violation|1|||
161092171|NCT01178671|581727786|FG001|Overall Study|Protocol Violation|1|||
161092172|NCT01178671|581727785|FG000|Overall Study|Lack of Efficacy|0|||
161092173|NCT01178671|581727786|FG001|Overall Study|Lack of Efficacy|1|||
161092174|NCT01178671|581727785|FG000|Overall Study|Lost to Follow-up|3|||
161092175|NCT01178671|581727786|FG001|Overall Study|Lost to Follow-up|1|||
161092176|NCT01178671|581727785|FG000|Overall Study|Physician Decision|4|||
161092177|NCT01178671|581727786|FG001|Overall Study|Physician Decision|6|||
161092178|NCT04620811|581727787|FG000|Overall Study|Withdrawal by Subject|18|||
161092179|NCT04620811|581727788|FG001|Overall Study|Withdrawal by Subject|15|||
161092180|NCT04620811|581727787|FG000|Overall Study|Adverse Event|6|||
161092181|NCT04620811|581727788|FG001|Overall Study|Adverse Event|11|||
161092182|NCT04620811|581727787|FG000|Overall Study|Lost to Follow-up|4|||
161092183|NCT04620811|581727788|FG001|Overall Study|Lost to Follow-up|8|||
161092184|NCT04620811|581727787|FG000|Overall Study|Physician Decision|1|||
161092185|NCT04620811|581727788|FG001|Overall Study|Physician Decision|4|||
161092186|NCT04620811|581727787|FG000|Overall Study|Sponsor Decision|0|||
161092187|NCT04620811|581727788|FG001|Overall Study|Sponsor Decision|1|||
161092188|NCT04620811|581727787|FG000|Overall Study|Elevation of ALT or AST|1|||
161092189|NCT04620811|581727788|FG001|Overall Study|Elevation of ALT or AST|0|||
161092190|NCT04620811|581727787|FG000|Overall Study|Other|3|||
161092191|NCT04620811|581727788|FG001|Overall Study|Other|5|||
161092192|NCT01078675|581727789|FG000|Overall Study|Withdrawal by Subject|7|||
161092193|NCT01078675|581727790|FG001|Overall Study|Withdrawal by Subject|3|||
161092194|NCT01078675|581727789|FG000|Overall Study|Protocol Violation|56|||
161092195|NCT01078675|581727790|FG001|Overall Study|Protocol Violation|0|||
161092196|NCT01078675|581727789|FG000|Overall Study|Provided in CRF for specific reasons|2|||
161092197|NCT01078675|581727790|FG001|Overall Study|Provided in CRF for specific reasons|3|||
161092198|NCT01078675|581727789|FG000|Overall Study|Adverse Event|3|||
161092199|NCT01078675|581727790|FG001|Overall Study|Adverse Event|0|||
161092200|NCT02513303|581727791|FG000|Overall Study|Withdrawal by Subject|9|||
161092201|NCT02513303|581727792|FG001|Overall Study|Withdrawal by Subject|7|||
161092202|NCT02513303|581727793|FG002|Overall Study|Withdrawal by Subject|2|||
161092203|NCT02513303|581727791|FG000|Overall Study|Lost to Follow-up|2|||
161092204|NCT02513303|581727792|FG001|Overall Study|Lost to Follow-up|4|||
161092205|NCT02513303|581727793|FG002|Overall Study|Lost to Follow-up|0|||
161092206|NCT02513303|581727791|FG000|Overall Study|Adverse Event|0|||
161092207|NCT02513303|581727792|FG001|Overall Study|Adverse Event|1|||
161092208|NCT02513303|581727793|FG002|Overall Study|Adverse Event|0|||
161092209|NCT02513303|581727791|FG000|Overall Study|Physician Decision|1|||
161092210|NCT02513303|581727792|FG001|Overall Study|Physician Decision|1|||
161092211|NCT02513303|581727793|FG002|Overall Study|Physician Decision|0|||
161092212|NCT02513303|581727791|FG000|Overall Study|Death|8|||
161092213|NCT02513303|581727792|FG001|Overall Study|Death|4|||
161092214|NCT02513303|581727793|FG002|Overall Study|Death|2|||
161092215|NCT00679627|581727794|FG000|Overall Study|Death|41|||
161092216|NCT00679627|581727795|FG001|Overall Study|Death|29|||
161092217|NCT00679627|581727794|FG000|Overall Study|Adverse Event|43|||
161092218|NCT00679627|581727795|FG001|Overall Study|Adverse Event|53|||
161092219|NCT00679627|581727794|FG000|Overall Study|Withdrawal by Subject|168|||
161092220|NCT00679627|581727795|FG001|Overall Study|Withdrawal by Subject|172|||
161092221|NCT00679627|581727794|FG000|Overall Study|Lost to Follow-up|22|||
161092222|NCT00679627|581727795|FG001|Overall Study|Lost to Follow-up|26|||
161092223|NCT00679627|581727794|FG000|Overall Study|Early Study Closure|425|||
161092224|NCT00679627|581727795|FG001|Overall Study|Early Study Closure|405|||
161092225|NCT00490724|581727797|FG000|Period I|Physician Decision|0|||
161092226|NCT00490724|581727798|FG001|Period I|Physician Decision|0|||
161092227|NCT00490724|581727799|FG002|Period I|Physician Decision|1|||
161092228|NCT00490724|581727797|FG000|Period II|Treatment Discontinuation|3|||
161092229|NCT00490724|581727798|FG001|Period II|Treatment Discontinuation|1|||
161092230|NCT00490724|581727799|FG002|Period II|Treatment Discontinuation|3|||
161092231|NCT03866473|581727801|FG000|Phase 1|Death|1|||
161092232|NCT03866473|581727802|FG001|Phase 1|Death|0|||
161092233|NCT03866473|581727801|FG000|Phase 2|Death|0|||
161092234|NCT03866473|581727802|FG001|Phase 2|Death|2|||
161092235|NCT03866473|581727801|FG000|Phase 2|Dropped|1|||
161092236|NCT03866473|581727802|FG001|Phase 2|Dropped|1|||
161092237|NCT03866473|581727801|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
161092238|NCT03866473|581727802|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
161092239|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
161092240|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
161092241|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
161092242|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
161092243|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
161092244|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
161092245|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
161092246|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
161092247|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
161092248|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
161092249|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
161092250|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
161092251|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
161092252|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
161092253|NCT00600886|581727803|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
161092254|NCT00600886|581727804|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
161092255|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
161092256|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
161092257|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
161092258|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
161092259|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
161092260|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
161092261|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
161092262|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
161092263|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
161092264|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
161092265|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
161092266|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
161092267|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Death|1|||
161092268|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Death|1|||
161092269|NCT00600886|581727803|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
161092270|NCT00600886|581727804|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
161092271|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
161092272|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
161092273|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
161092274|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
161092275|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
161092276|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
161092277|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
161092278|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
161092279|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
161092280|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
161092281|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
161092282|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
161092283|NCT00600886|581727803|FG000|Extension - After Crossover (CAS)|Death|1|||
161092284|NCT00600886|581727804|FG001|Extension - After Crossover (CAS)|Death|0|||
161092285|NCT02053792|581727805|FG000|Overall Study|Physician Decision|0|||
161092286|NCT02053792|581727806|FG001|Overall Study|Physician Decision|1|||
161092287|NCT02053792|581727805|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
161092288|NCT02053792|581727806|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
161092289|NCT02053792|581727805|FG000|Overall Study|Lack of Efficacy|1|||
161092290|NCT02053792|581727806|FG001|Overall Study|Lack of Efficacy|0|||
161092291|NCT02053792|581727805|FG000|Overall Study|Adverse Event|1|||
161092292|NCT02053792|581727806|FG001|Overall Study|Adverse Event|0|||
161092293|NCT02053792|581727805|FG000|Overall Study|Withdrawal by Subject|2|||
161092294|NCT02053792|581727806|FG001|Overall Study|Withdrawal by Subject|2|||
161092295|NCT02053792|581727805|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
161092296|NCT02053792|581727806|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
161092297|NCT02053792|581727805|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
161092298|NCT02053792|581727806|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
161092299|NCT01028027|581727807|FG000|Overall Study|Lost to Follow-up|4|||
161092300|NCT01028027|581727808|FG001|Overall Study|Lost to Follow-up|1|||
161092301|NCT01028027|581727807|FG000|Overall Study|Withdrawal by Subject|5|||
161092302|NCT01028027|581727808|FG001|Overall Study|Withdrawal by Subject|3|||
161092303|NCT01028027|581727807|FG000|Overall Study|Adverse Event|4|||
161092304|NCT01028027|581727808|FG001|Overall Study|Adverse Event|7|||
161092305|NCT01028027|581727807|FG000|Overall Study|Protocol Violation|3|||
161092306|NCT01028027|581727808|FG001|Overall Study|Protocol Violation|1|||
161092307|NCT01028027|581727807|FG000|Overall Study|Lack of Efficacy|0|||
161092308|NCT01028027|581727808|FG001|Overall Study|Lack of Efficacy|1|||
161092309|NCT04443153|581727811|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
161092310|NCT04443153|581727812|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
161092311|NCT04443153|581727811|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
161092312|NCT04443153|581727812|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
161092313|NCT04443153|581727811|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
161092314|NCT04443153|581727812|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
161092315|NCT04443153|581727811|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
161092316|NCT04443153|581727812|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
161092317|NCT05227703|581727814|FG000|Overall Study|Adverse Event|2|||
161092318|NCT05227703|581727815|FG001|Overall Study|Adverse Event|6|||
161092319|NCT05227703|581727816|FG002|Overall Study|Adverse Event|4|||
161092320|NCT05227703|581727814|FG000|Overall Study|Lack of Efficacy|4|||
161092321|NCT05227703|581727815|FG001|Overall Study|Lack of Efficacy|0|||
161092322|NCT05227703|581727816|FG002|Overall Study|Lack of Efficacy|1|||
161092323|NCT05227703|581727814|FG000|Overall Study|Physician Decision|2|||
161092324|NCT05227703|581727815|FG001|Overall Study|Physician Decision|2|||
161092325|NCT05227703|581727816|FG002|Overall Study|Physician Decision|1|||
161092326|NCT05227703|581727814|FG000|Overall Study|Protocol Violation|2|||
161092327|NCT05227703|581727815|FG001|Overall Study|Protocol Violation|1|||
161092328|NCT05227703|581727816|FG002|Overall Study|Protocol Violation|0|||
161092329|NCT05227703|581727814|FG000|Overall Study|Withdrawal by Subject|17|||
161092330|NCT05227703|581727815|FG001|Overall Study|Withdrawal by Subject|26|||
161092331|NCT05227703|581727816|FG002|Overall Study|Withdrawal by Subject|32|||
161092332|NCT05227703|581727814|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
161092333|NCT05227703|581727815|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
161092334|NCT05227703|581727816|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
161092335|NCT05227703|581727814|FG000|Overall Study|Other|1|||
161092336|NCT05227703|581727815|FG001|Overall Study|Other|1|||
161092337|NCT05227703|581727816|FG002|Overall Study|Other|0|||
161092338|NCT03035201|581727819|FG000|Overall Study|Death|9|||
161092339|NCT03035201|581727820|FG001|Overall Study|Death|12|||
161092340|NCT03035201|581727821|FG002|Overall Study|Death|9|||
161092341|NCT03035201|581727822|FG003|Overall Study|Death|10|||
161092342|NCT03035201|581727819|FG000|Overall Study|Withdrawal by Subject|51|||
161092343|NCT03035201|581727820|FG001|Overall Study|Withdrawal by Subject|49|||
161092344|NCT03035201|581727821|FG002|Overall Study|Withdrawal by Subject|37|||
161092345|NCT03035201|581727822|FG003|Overall Study|Withdrawal by Subject|46|||
161092346|NCT03035201|581727819|FG000|Overall Study|Lost to Follow-up|67|||
161092347|NCT03035201|581727820|FG001|Overall Study|Lost to Follow-up|51|||
161092348|NCT03035201|581727821|FG002|Overall Study|Lost to Follow-up|64|||
161092349|NCT03035201|581727822|FG003|Overall Study|Lost to Follow-up|69|||
161092350|NCT05328167|581727830|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
161092351|NCT05328167|581727830|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
161092352|NCT03727438|581727831|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
161092353|NCT03727438|581727832|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
161092354|NCT03727438|581727831|FG000|Intervention Period|Excluded (health)|1|||
161092355|NCT03727438|581727832|FG001|Intervention Period|Excluded (health)|0|||
161092356|NCT03727438|581727831|FG000|Intervention Period|Withdrawal by Subject|3|||
161092357|NCT03727438|581727832|FG001|Intervention Period|Withdrawal by Subject|1|||
161092358|NCT03727438|581727831|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
161092359|NCT03727438|581727832|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
161092360|NCT03727438|581727831|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
161092361|NCT03727438|581727832|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
161092362|NCT03727438|581727831|FG000|8 Week Assessment|Withdrawal by Subject|6|||
161092363|NCT03727438|581727832|FG001|8 Week Assessment|Withdrawal by Subject|1|||
161092364|NCT03727438|581727831|FG000|6 mo Assessment|did not complete assessment|10|||
161092365|NCT03727438|581727832|FG001|6 mo Assessment|did not complete assessment|11|||
161092366|NCT06729606|581727833|FG000|Overall Study|Adverse Event|0|||
161092367|NCT06729606|581727834|FG001|Overall Study|Adverse Event|2|||
161092368|NCT06729606|581727833|FG000|Overall Study|Death|1|||
161092369|NCT06729606|581727834|FG001|Overall Study|Death|0|||
161092370|NCT06729606|581727833|FG000|Overall Study|Physician Decision|0|||
161092371|NCT06729606|581727834|FG001|Overall Study|Physician Decision|1|||
161092372|NCT06729606|581727833|FG000|Overall Study|Withdrawal by Subject|2|||
161092373|NCT06729606|581727834|FG001|Overall Study|Withdrawal by Subject|4|||
161092374|NCT03170349|581727835|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
161092375|NCT03170349|581727835|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
161092376|NCT03170349|581727835|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
161092377|NCT03170349|581727835|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
161092378|NCT03170349|581727835|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
161092379|NCT03170349|581727835|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
161092380|NCT03170349|581727835|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
161092381|NCT03170349|581727835|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
161092382|NCT03170349|581727835|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
161092383|NCT03170349|581727835|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
161092384|NCT03170349|581727835|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
161092385|NCT03170349|581727835|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
161092386|NCT03170349|581727835|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
161092387|NCT03170349|581727835|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
161092388|NCT03170349|581727835|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
161092389|NCT03170349|581727835|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
161320290|NCT05259917|582558879|FG001|Overall Study|Withdrawal by Subject|1|||
161320291|NCT05259917|582558880|FG002|Overall Study|Withdrawal by Subject|0|||
161320292|NCT05259917|582558881|FG003|Overall Study|Withdrawal by Subject|0|||
161320293|NCT05259917|582558882|FG004|Overall Study|Withdrawal by Subject|1|||
161320294|NCT05259917|582558883|FG005|Overall Study|Withdrawal by Subject|1|||
161320295|NCT05259917|582558878|FG000|Overall Study|Trial Termination by Sponsor|7|||
161320296|NCT05259917|582558879|FG001|Overall Study|Trial Termination by Sponsor|2|||
161320297|NCT05259917|582558880|FG002|Overall Study|Trial Termination by Sponsor|3|||
161320298|NCT05259917|582558881|FG003|Overall Study|Trial Termination by Sponsor|5|||
161320299|NCT05259917|582558882|FG004|Overall Study|Trial Termination by Sponsor|11|||
161320300|NCT05259917|582558883|FG005|Overall Study|Trial Termination by Sponsor|4|||
161320301|NCT05259917|582558878|FG000|Overall Study|Other|1|||
161320302|NCT05259917|582558879|FG001|Overall Study|Other|0|||
161320303|NCT05259917|582558880|FG002|Overall Study|Other|2|||
161320304|NCT05259917|582558881|FG003|Overall Study|Other|0|||
161320305|NCT05259917|582558882|FG004|Overall Study|Other|0|||
161320306|NCT05259917|582558883|FG005|Overall Study|Other|0|||
161320307|NCT00303472|582558888|FG000|Treatment Period|Adverse Event|0|||
161320308|NCT00303472|582558889|FG001|Treatment Period|Adverse Event|0|||
161320309|NCT00303472|582558890|FG002|Treatment Period|Adverse Event|0|||
161320310|NCT00303472|582558891|FG003|Treatment Period|Adverse Event|0|||
161320311|NCT00303472|582558892|FG004|Treatment Period|Adverse Event|1|||
161320312|NCT00303472|582558893|FG005|Treatment Period|Adverse Event|0|||
161320313|NCT00303472|582558894|FG006|Treatment Period|Adverse Event|0|||
161320314|NCT00303472|582558888|FG000|Treatment Period|Death|0|||
161320315|NCT00303472|582558889|FG001|Treatment Period|Death|0|||
161320316|NCT00303472|582558890|FG002|Treatment Period|Death|0|||
161320317|NCT00303472|582558891|FG003|Treatment Period|Death|1|||
161320318|NCT00303472|582558892|FG004|Treatment Period|Death|0|||
161320319|NCT00303472|582558893|FG005|Treatment Period|Death|0|||
161320320|NCT00303472|582558894|FG006|Treatment Period|Death|1|||
161320321|NCT00303472|582558888|FG000|Treatment Period|Withdrawal by Subject|0|||
161320322|NCT00303472|582558889|FG001|Treatment Period|Withdrawal by Subject|0|||
161320323|NCT00303472|582558890|FG002|Treatment Period|Withdrawal by Subject|0|||
161320324|NCT00303472|582558891|FG003|Treatment Period|Withdrawal by Subject|1|||
161320325|NCT00303472|582558892|FG004|Treatment Period|Withdrawal by Subject|0|||
161320326|NCT00303472|582558893|FG005|Treatment Period|Withdrawal by Subject|1|||
161320327|NCT00303472|582558894|FG006|Treatment Period|Withdrawal by Subject|0|||
161320328|NCT00303472|582558888|FG000|Treatment Period|Other|0|||
161320329|NCT00303472|582558889|FG001|Treatment Period|Other|0|||
161320330|NCT00303472|582558890|FG002|Treatment Period|Other|0|||
161320331|NCT00303472|582558891|FG003|Treatment Period|Other|0|||
161320332|NCT00303472|582558892|FG004|Treatment Period|Other|1|||
161320333|NCT00303472|582558893|FG005|Treatment Period|Other|0|||
161320334|NCT00303472|582558894|FG006|Treatment Period|Other|1|||
161320335|NCT00303472|582558888|FG000|Treatment Period|Disease Progression (to AML)|0|||
161320336|NCT00303472|582558889|FG001|Treatment Period|Disease Progression (to AML)|0|||
161320337|NCT00303472|582558890|FG002|Treatment Period|Disease Progression (to AML)|0|||
161320338|NCT00303472|582558891|FG003|Treatment Period|Disease Progression (to AML)|0|||
161320339|NCT00303472|582558892|FG004|Treatment Period|Disease Progression (to AML)|1|||
161320340|NCT00303472|582558893|FG005|Treatment Period|Disease Progression (to AML)|0|||
161320341|NCT00303472|582558894|FG006|Treatment Period|Disease Progression (to AML)|0|||
161320342|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Adverse Event|1|||
161320343|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Adverse Event|0|||
161320344|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Adverse Event|1|||
161320345|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Adverse Event|0|||
161320346|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Adverse Event|0|||
161320347|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Adverse Event|0|||
161320348|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Adverse Event|0|||
161320349|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Death|2|||
161320350|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Death|0|||
161320351|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Death|1|||
161320352|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Death|0|||
161320353|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Death|0|||
161320354|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Death|0|||
161320355|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Death|0|||
161320356|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
161320357|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
161320358|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
161320359|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
161320360|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
161320361|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
161320362|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
161320363|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Physician Decision|0|||
161320364|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Physician Decision|4|||
161320365|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Physician Decision|2|||
161320366|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Physician Decision|3|||
161320367|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Physician Decision|2|||
161320368|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Physician Decision|0|||
161320369|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Physician Decision|0|||
161320370|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161320371|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161320372|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161320373|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
161320374|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
161320375|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161320376|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
161320377|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Other|0|||
161320378|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Other|2|||
161320379|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Other|4|||
161320380|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Other|2|||
161320381|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Other|1|||
161320382|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Other|0|||
161320383|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Other|0|||
161320384|NCT00303472|582558888|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
161320385|NCT00303472|582558889|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161320386|NCT00303472|582558890|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161320387|NCT00303472|582558891|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161320388|NCT00303472|582558892|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161320389|NCT00303472|582558893|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
161320390|NCT00303472|582558894|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
161320391|NCT01808222|582558895|FG000|Overall Study|mpMR scan was not performed|1|||
161320392|NCT04318132|582558898|FG000|Overall Study|Protocol Violation|0|||
161320393|NCT04318132|582558899|FG001|Overall Study|Protocol Violation|0|||
161320394|NCT04318132|582558900|FG002|Overall Study|Protocol Violation|3|||
161320395|NCT04318132|582558901|FG003|Overall Study|Protocol Violation|0|||
161320396|NCT00621517|582558902|FG000|Overall Study|Lost to Follow-up|3|||
161320397|NCT00621517|582558903|FG001|Overall Study|Lost to Follow-up|3|||
161320398|NCT00621517|582558902|FG000|Overall Study|Withdrawal by Subject|3|||
161320399|NCT00621517|582558903|FG001|Overall Study|Withdrawal by Subject|4|||
161320400|NCT00621517|582558902|FG000|Overall Study|Adverse Event|1|||
161320401|NCT00621517|582558903|FG001|Overall Study|Adverse Event|0|||
161320402|NCT03628716|582558904|FG000|Overall Study|Adverse Event|1|||
161320403|NCT03628716|582558905|FG001|Overall Study|Adverse Event|1|||
161320404|NCT03628716|582558904|FG000|Overall Study|Death|1|||
161320405|NCT03628716|582558905|FG001|Overall Study|Death|0|||
161320406|NCT03628716|582558904|FG000|Overall Study|Lack of Efficacy|15|||
161320407|NCT03628716|582558905|FG001|Overall Study|Lack of Efficacy|20|||
161320408|NCT03628716|582558904|FG000|Overall Study|Withdrawal by Subject|1|||
161320409|NCT03628716|582558905|FG001|Overall Study|Withdrawal by Subject|2|||
161320410|NCT03628716|582558904|FG000|Overall Study|Study Terminated by Sponsor|1|||
161320411|NCT03628716|582558905|FG001|Overall Study|Study Terminated by Sponsor|0|||
161320412|NCT00856843|582558906|FG000|Overall Study|Withdrawal by Subject|1|||
161320413|NCT00856843|582558907|FG001|Overall Study|Withdrawal by Subject|5|||
161320414|NCT00856843|582558906|FG000|Overall Study|Lack of Efficacy|1|||
161320415|NCT00856843|582558907|FG001|Overall Study|Lack of Efficacy|0|||
161320416|NCT03172364|582558908|FG000|Overall Study|Adverse Event|1|||
161320417|NCT03172364|582558909|FG001|Overall Study|Adverse Event|1|||
161320418|NCT03172364|582558908|FG000|Overall Study|Protocol Violation|1|||
161320419|NCT03172364|582558909|FG001|Overall Study|Protocol Violation|0|||
161320420|NCT00583102|582558910|FG000|Overall Study|Adverse Event|3|||
161320421|NCT00659776|582558915|FG000|Overall Study|Withdrawal by Subject|12|||
161320422|NCT00659776|582558916|FG001|Overall Study|Withdrawal by Subject|2|||
161320423|NCT00659776|582558917|FG002|Overall Study|Withdrawal by Subject|0|||
161320424|NCT00628927|582558920|FG000|Overall Study|Problems performing blood draw|6|||
161320425|NCT00628927|582558921|FG001|Overall Study|Problems performing blood draw|0|||
161320426|NCT00628927|582558920|FG000|Overall Study|Lost to Follow-up|1|||
161320427|NCT00628927|582558921|FG001|Overall Study|Lost to Follow-up|0|||
161320428|NCT00628927|582558920|FG000|Overall Study|Equipment failure|1|||
161320429|NCT00628927|582558921|FG001|Overall Study|Equipment failure|0|||
161320430|NCT01738191|582558922|FG000|Overall Study|Withdrawal by Subject|4|||
161320431|NCT01738191|582558923|FG001|Overall Study|Withdrawal by Subject|1|||
161320432|NCT02483572|582558924|FG000|Overall Study|Withdrawal by Subject|1|||
161320433|NCT02483572|582558925|FG001|Overall Study|Withdrawal by Subject|0|||
161320434|NCT02483572|582558924|FG000|Overall Study|Lost to Follow-up|1|||
161320435|NCT02483572|582558925|FG001|Overall Study|Lost to Follow-up|0|||
161320436|NCT02483572|582558924|FG000|Overall Study|Physician Decision|0|||
161320437|NCT02483572|582558925|FG001|Overall Study|Physician Decision|1|||
161320438|NCT01298141|582558929|FG000|Overall Study|Adverse Event|3|||
161320439|NCT01298141|582558929|FG000|Overall Study|Refusal of Required Study Procedures|1|||
161320440|NCT01298141|582558929|FG000|Overall Study|Withdrawal by Subject|6|||
161320441|NCT01298141|582558929|FG000|Overall Study|Termination of Study by the Investigator|5|||
161320442|NCT01298141|582558929|FG000|Overall Study|Other|5|||
161320443|NCT01298141|582558929|FG000|Overall Study|Lost to Follow-up|1|||
161320444|NCT01298141|582558929|FG000|Overall Study|Death|6|||
161320445|NCT01298141|582558929|FG000|Overall Study|Not treated|4|||
161320446|NCT00350779|582558930|FG000|Overall Study|Adverse Event|4|||
161320447|NCT00350779|582558931|FG001|Overall Study|Adverse Event|2|||
161320448|NCT00350779|582558930|FG000|Overall Study|Lack of Efficacy|0|||
161320449|NCT00350779|582558931|FG001|Overall Study|Lack of Efficacy|4|||
161320450|NCT00350779|582558930|FG000|Overall Study|Lost to Follow-up|2|||
161320451|NCT00350779|582558931|FG001|Overall Study|Lost to Follow-up|0|||
161320452|NCT00350779|582558930|FG000|Overall Study|Physician Decision|2|||
161320453|NCT00350779|582558931|FG001|Overall Study|Physician Decision|4|||
161320454|NCT00350779|582558930|FG000|Overall Study|Protocol Violation|3|||
161320455|NCT00350779|582558931|FG001|Overall Study|Protocol Violation|1|||
161320456|NCT00350779|582558930|FG000|Overall Study|Withdrawal by Subject|9|||
161320457|NCT00350779|582558931|FG001|Overall Study|Withdrawal by Subject|8|||
161320458|NCT00350779|582558930|FG000|Overall Study|Patient Moved|2|||
161320459|NCT00350779|582558931|FG001|Overall Study|Patient Moved|1|||
161320460|NCT00350779|582558930|FG000|Overall Study|Non-compliance with study procedures|0|||
161320461|NCT00350779|582558931|FG001|Overall Study|Non-compliance with study procedures|1|||
161320462|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
161320463|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320464|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320465|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320466|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320467|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320468|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320469|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320470|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
161320471|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161320472|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
161320473|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
161320474|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
161320475|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161320476|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
161320477|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
161320478|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161320479|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
161320480|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
161320481|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
161320482|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
161320483|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
161320484|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
161320485|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
161320486|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
161320487|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
161320488|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
161320489|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
161320490|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
161320491|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161320492|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161320493|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161320494|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161320495|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
161320496|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
161320497|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
161320498|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320499|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320500|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320501|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
161320502|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320503|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
161320504|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320505|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320506|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
161320507|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161320508|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161320509|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161320510|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161320511|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161320512|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
161320513|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161320514|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161320515|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
161320516|NCT00528372|582558932|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
161320517|NCT00528372|582558933|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161320518|NCT00528372|582558934|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161320519|NCT00528372|582558935|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
161320520|NCT00528372|582558936|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161320521|NCT00528372|582558937|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161320522|NCT00528372|582558938|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161320523|NCT00528372|582558939|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
161320524|NCT00528372|582558940|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
161320525|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
161320526|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
161320527|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
161320528|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161320529|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161320530|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
161320531|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
161320532|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
161320533|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
161320534|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
161320535|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
161320536|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
161320537|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161320538|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
161320539|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
161320540|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
161320541|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161320542|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
161320543|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
161320544|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
161320545|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
161320546|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
161320547|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
161320548|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
161320549|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
161320550|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
161320551|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
161320552|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
161320553|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
161320554|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161320555|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161320556|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
161320557|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
161320558|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
161320559|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
161320560|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
161320561|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161320562|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161320563|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161320564|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161320565|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161320566|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161320567|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
161320568|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161320569|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
161320570|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320571|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320572|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320573|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320574|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
161320575|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
161320576|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320577|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320578|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
161320579|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161320580|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161320581|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161320582|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161320583|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161320584|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161320585|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161320586|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
161320587|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
161320588|NCT00528372|582558932|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161320589|NCT00528372|582558933|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161320590|NCT00528372|582558934|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
161320591|NCT00528372|582558935|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
161320592|NCT00528372|582558936|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
161320593|NCT00528372|582558937|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
161320594|NCT00528372|582558938|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
161320595|NCT00528372|582558939|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
161320596|NCT00528372|582558940|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
161320597|NCT01289574|582558941|FG000|Overall Study|Lack of Efficacy|4|||
161320598|NCT01289574|582558942|FG001|Overall Study|Lack of Efficacy|0|||
161320599|NCT01289574|582558943|FG002|Overall Study|Lack of Efficacy|1|||
161320600|NCT01289574|582558941|FG000|Overall Study|Lost to Follow-up|2|||
161320601|NCT01289574|582558942|FG001|Overall Study|Lost to Follow-up|0|||
161320602|NCT01289574|582558943|FG002|Overall Study|Lost to Follow-up|1|||
161320603|NCT01289574|582558941|FG000|Overall Study|Withdrawal by Subject|1|||
161320604|NCT01289574|582558942|FG001|Overall Study|Withdrawal by Subject|1|||
161320605|NCT01289574|582558943|FG002|Overall Study|Withdrawal by Subject|1|||
161320606|NCT01289574|582558941|FG000|Overall Study|Adverse Event|0|||
161320607|NCT01289574|582558942|FG001|Overall Study|Adverse Event|1|||
161320608|NCT01289574|582558943|FG002|Overall Study|Adverse Event|0|||
161320609|NCT01289574|582558941|FG000|Overall Study|Subject wanted alternate treatment|0|||
161320610|NCT01289574|582558942|FG001|Overall Study|Subject wanted alternate treatment|1|||
161320611|NCT01289574|582558943|FG002|Overall Study|Subject wanted alternate treatment|0|||
161320612|NCT02432144|582558944|FG000|Overall Study|Participant Non-Compliance|1|||
161320613|NCT00262002|582558945|FG000|Overall Study|Adverse Event|2|||
161320614|NCT00262002|582558946|FG001|Overall Study|Adverse Event|1|||
161320615|NCT00262002|582558947|FG002|Overall Study|Adverse Event|0|||
161320616|NCT00262002|582558948|FG003|Overall Study|Adverse Event|0|||
161320617|NCT00262002|582558949|FG004|Overall Study|Adverse Event|0|||
161320618|NCT00262002|582558950|FG005|Overall Study|Adverse Event|1|||
161320619|NCT00262002|582558951|FG006|Overall Study|Adverse Event|0|||
161320620|NCT00262002|582558945|FG000|Overall Study|Withdrawal by Subject|4|||
161320621|NCT00262002|582558946|FG001|Overall Study|Withdrawal by Subject|2|||
161320622|NCT00262002|582558947|FG002|Overall Study|Withdrawal by Subject|0|||
161320623|NCT00262002|582558948|FG003|Overall Study|Withdrawal by Subject|1|||
161320624|NCT00262002|582558949|FG004|Overall Study|Withdrawal by Subject|2|||
161320625|NCT00262002|582558950|FG005|Overall Study|Withdrawal by Subject|2|||
161320626|NCT00262002|582558951|FG006|Overall Study|Withdrawal by Subject|2|||
161320627|NCT00262002|582558945|FG000|Overall Study|Lost to Follow-up|2|||
161320628|NCT00262002|582558946|FG001|Overall Study|Lost to Follow-up|0|||
161320629|NCT00262002|582558947|FG002|Overall Study|Lost to Follow-up|0|||
161320630|NCT00262002|582558948|FG003|Overall Study|Lost to Follow-up|2|||
161320631|NCT00262002|582558949|FG004|Overall Study|Lost to Follow-up|0|||
161320632|NCT00262002|582558950|FG005|Overall Study|Lost to Follow-up|1|||
161320633|NCT00262002|582558951|FG006|Overall Study|Lost to Follow-up|0|||
161320634|NCT00262002|582558945|FG000|Overall Study|Inapropriate enrollment|0|||
161320635|NCT00262002|582558946|FG001|Overall Study|Inapropriate enrollment|1|||
161320636|NCT00262002|582558947|FG002|Overall Study|Inapropriate enrollment|0|||
161320637|NCT00262002|582558948|FG003|Overall Study|Inapropriate enrollment|0|||
161320638|NCT00262002|582558949|FG004|Overall Study|Inapropriate enrollment|0|||
161320639|NCT00262002|582558950|FG005|Overall Study|Inapropriate enrollment|0|||
161320640|NCT00262002|582558951|FG006|Overall Study|Inapropriate enrollment|0|||
161320641|NCT00262002|582558945|FG000|Overall Study|Protocol Violation|3|||
161320642|NCT00262002|582558946|FG001|Overall Study|Protocol Violation|2|||
161320643|NCT00262002|582558947|FG002|Overall Study|Protocol Violation|0|||
161320644|NCT00262002|582558948|FG003|Overall Study|Protocol Violation|2|||
161320645|NCT00262002|582558949|FG004|Overall Study|Protocol Violation|5|||
161320646|NCT00262002|582558950|FG005|Overall Study|Protocol Violation|3|||
161320647|NCT00262002|582558951|FG006|Overall Study|Protocol Violation|2|||
161320648|NCT00262002|582558945|FG000|Overall Study|Unable to classify|0|||
161320649|NCT00262002|582558946|FG001|Overall Study|Unable to classify|0|||
161320650|NCT00262002|582558947|FG002|Overall Study|Unable to classify|0|||
161320651|NCT00262002|582558948|FG003|Overall Study|Unable to classify|0|||
161320652|NCT00262002|582558949|FG004|Overall Study|Unable to classify|0|||
161320653|NCT00262002|582558950|FG005|Overall Study|Unable to classify|0|||
161320654|NCT00262002|582558951|FG006|Overall Study|Unable to classify|2|||
161320655|NCT01451554|582558952|FG000|Overall Study|Withdrawal by Subject|14|||
161320656|NCT01451554|582558953|FG001|Overall Study|Withdrawal by Subject|9|||
161320657|NCT00958412|582558954|FG000|Overall Study|Study prematurely terminated|18|||
161320658|NCT02552888|582558957|FG000|Overall Study|Lost to Follow-up|1|||
161320659|NCT02552888|582558958|FG001|Overall Study|Lost to Follow-up|1|||
161320660|NCT01048944|582560878|FG000|Overall Study|Protocol Violation|8|||
161320661|NCT01048944|582560879|FG001|Overall Study|Protocol Violation|10|||
161320662|NCT01048944|582560880|FG002|Overall Study|Protocol Violation|10|||
161320663|NCT01048944|582560881|FG003|Overall Study|Protocol Violation|2|||
161320664|NCT01962948|582560882|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
161320665|NCT01962948|582560883|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
161320666|NCT01962948|582560884|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
161320667|NCT01962948|582560885|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
161320668|NCT00376532|582560886|FG000|Overall Study|Lack sufficient blood sample|6|||
161320669|NCT00376532|582560887|FG001|Overall Study|Lack sufficient blood sample|6|||
161320670|NCT01133704|582560888|FG000|Overall Study|Death|44|||
161320671|NCT01133704|582560889|FG001|Overall Study|Death|26|||
161320672|NCT01133704|582560888|FG000|Overall Study|Patient refused to continue|4|||
161320673|NCT01133704|582560889|FG001|Overall Study|Patient refused to continue|0|||
161320674|NCT01133704|582560888|FG000|Overall Study|Study Closure|1|||
161320675|NCT01133704|582560889|FG001|Overall Study|Study Closure|0|||
161320676|NCT02849704|582560890|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
161320677|NCT02849704|582560891|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
161320678|NCT02849704|582560890|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
161320679|NCT02849704|582560891|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
161320680|NCT02849704|582560890|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
161320681|NCT02849704|582560891|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
161320682|NCT02362425|582560897|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
161320683|NCT02362425|582560898|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161320684|NCT02362425|582560899|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161320685|NCT02362425|582560900|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
161320686|NCT02362425|582560897|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
161320687|NCT02362425|582560898|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161320688|NCT02362425|582560899|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161320689|NCT02362425|582560900|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
161320690|NCT02362425|582560897|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
161320691|NCT02362425|582560898|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
161320692|NCT02362425|582560899|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
161320693|NCT02362425|582560900|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
161320694|NCT02362425|582560897|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
161320695|NCT02362425|582560898|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161320696|NCT02362425|582560899|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161320697|NCT02362425|582560900|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
161320698|NCT02362425|582560897|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
161320699|NCT02362425|582560898|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
161320700|NCT02362425|582560899|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
161320701|NCT02362425|582560900|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
161320702|NCT02362425|582560897|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161320703|NCT02362425|582560898|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161320704|NCT02362425|582560899|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
161320705|NCT02362425|582560900|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
161320706|NCT02362425|582560897|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161320707|NCT02362425|582560898|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161320708|NCT02362425|582560899|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
161320709|NCT02362425|582560900|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
161320710|NCT02362425|582560897|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161320711|NCT02362425|582560898|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161320712|NCT02362425|582560899|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
161320713|NCT02362425|582560900|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
161320714|NCT00314808|582560908|FG000|Overall Study|Disease Progression without AE|4|||
161320715|NCT00314808|582560908|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
161320716|NCT02688764|582560915|FG000|Overall Study|Adverse Event|3|||
161320717|NCT02688764|582560916|FG001|Overall Study|Adverse Event|3|||
161320718|NCT02688764|582560915|FG000|Overall Study|AE/Kidney transplant|1|||
161320719|NCT02688764|582560916|FG001|Overall Study|AE/Kidney transplant|0|||
161320720|NCT02688764|582560915|FG000|Overall Study|AE/Lack of efficacy|1|||
161320721|NCT02688764|582560916|FG001|Overall Study|AE/Lack of efficacy|0|||
161320722|NCT02688764|582560915|FG000|Overall Study|AE/Non-compl.|1|||
161320723|NCT02688764|582560916|FG001|Overall Study|AE/Non-compl.|0|||
161320724|NCT02688764|582560915|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
161320725|NCT02688764|582560916|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
161320726|NCT02688764|582560915|FG000|Overall Study|AE/Other|0|||
161320727|NCT02688764|582560916|FG001|Overall Study|AE/Other|1|||
161320728|NCT02688764|582560915|FG000|Overall Study|AE/Physician decision|1|||
161320729|NCT02688764|582560916|FG001|Overall Study|AE/Physician decision|0|||
161320730|NCT02688764|582560915|FG000|Overall Study|AE/Withd. parent|3|||
161320731|NCT02688764|582560916|FG001|Overall Study|AE/Withd. parent|0|||
161320732|NCT02688764|582560915|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
161320733|NCT02688764|582560916|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
161320734|NCT02688764|582560915|FG000|Overall Study|AE/Withd. subject|1|||
161320735|NCT02688764|582560916|FG001|Overall Study|AE/Withd. subject|0|||
161320736|NCT02688764|582560915|FG000|Overall Study|Kidney transplant|10|||
161320737|NCT02688764|582560916|FG001|Overall Study|Kidney transplant|4|||
161320738|NCT02688764|582560915|FG000|Overall Study|Lack of Efficacy|3|||
161320739|NCT02688764|582560916|FG001|Overall Study|Lack of Efficacy|2|||
161320740|NCT02688764|582560915|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
161320741|NCT02688764|582560916|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
161320742|NCT02688764|582560915|FG000|Overall Study|Non-compliance with study drug|4|||
161320743|NCT02688764|582560916|FG001|Overall Study|Non-compliance with study drug|0|||
161320744|NCT02688764|582560915|FG000|Overall Study|Non-compl./Physician decision|2|||
161320745|NCT02688764|582560916|FG001|Overall Study|Non-compl./Physician decision|0|||
161320746|NCT02688764|582560915|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
161320747|NCT02688764|582560916|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
161320748|NCT02688764|582560915|FG000|Overall Study|Non-compl./Withd. subject|0|||
161320749|NCT02688764|582560916|FG001|Overall Study|Non-compl./Withd. subject|2|||
161320750|NCT02688764|582560915|FG000|Overall Study|Phosphorus level outside safe range|0|||
161320751|NCT02688764|582560916|FG001|Overall Study|Phosphorus level outside safe range|1|||
161320752|NCT02688764|582560915|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
161320753|NCT02688764|582560916|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
161320754|NCT02688764|582560915|FG000|Overall Study|Study drug taste/Withd. parent|1|||
161320755|NCT02688764|582560916|FG001|Overall Study|Study drug taste/Withd. parent|0|||
161320756|NCT02688764|582560915|FG000|Overall Study|Subject moving out|2|||
161320757|NCT02688764|582560916|FG001|Overall Study|Subject moving out|0|||
161320758|NCT02688764|582560915|FG000|Overall Study|Subject taken off dialysis|1|||
161320759|NCT02688764|582560916|FG001|Overall Study|Subject taken off dialysis|0|||
161320760|NCT02688764|582560915|FG000|Overall Study|Withdrawal by parent|3|||
161320761|NCT02688764|582560916|FG001|Overall Study|Withdrawal by parent|0|||
161320762|NCT02579382|582560917|FG000|Main Study Phase|Lost to Follow-up|0|||
161320763|NCT02579382|582560918|FG001|Main Study Phase|Lost to Follow-up|0|||
161320764|NCT02579382|582560919|FG002|Main Study Phase|Lost to Follow-up|2|||
161320765|NCT02579382|582560920|FG003|Main Study Phase|Lost to Follow-up|0|||
161320766|NCT02579382|582560917|FG000|Main Study Phase|Withdrew Consent|0|||
161320767|NCT02579382|582560918|FG001|Main Study Phase|Withdrew Consent|0|||
161320768|NCT02579382|582560919|FG002|Main Study Phase|Withdrew Consent|0|||
161320769|NCT02579382|582560920|FG003|Main Study Phase|Withdrew Consent|2|||
161320770|NCT02579382|582560917|FG000|Main Study Phase|Lack of Efficacy|0|||
161320771|NCT02579382|582560918|FG001|Main Study Phase|Lack of Efficacy|0|||
161320772|NCT02579382|582560919|FG002|Main Study Phase|Lack of Efficacy|0|||
161320773|NCT02579382|582560920|FG003|Main Study Phase|Lack of Efficacy|1|||
161320774|NCT02579382|582560917|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
161320775|NCT02579382|582560918|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
161320776|NCT02579382|582560919|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
161320777|NCT02579382|582560920|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
161320778|NCT02579382|582560917|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
161320779|NCT02579382|582560918|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
161320780|NCT02579382|582560919|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
161320781|NCT02579382|582560920|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
161320782|NCT02579382|582560917|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
161320783|NCT02579382|582560918|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161320784|NCT02579382|582560919|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161320785|NCT02579382|582560920|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
161320786|NCT02579382|582560917|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161320787|NCT02579382|582560918|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
161320788|NCT02579382|582560919|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161320789|NCT02579382|582560920|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
161320790|NCT02579382|582560917|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161320791|NCT02579382|582560918|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
161320792|NCT02579382|582560919|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161320793|NCT02579382|582560920|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
161320794|NCT02579382|582560917|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161320795|NCT02579382|582560918|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
161320796|NCT02579382|582560919|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161320797|NCT02579382|582560920|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
161320798|NCT01775787|582560921|FG000|First 7-10 Days|Adverse Event|0|||
161320799|NCT01775787|582560922|FG001|First 7-10 Days|Adverse Event|1|||
161320800|NCT01775787|582560921|FG000|First 7-10 Days|family emergency|0|||
161320801|NCT01775787|582560922|FG001|First 7-10 Days|family emergency|1|||
161320802|NCT01775787|582560921|FG000|First 7-10 Days|time commitment|0|||
161320803|NCT01775787|582560922|FG001|First 7-10 Days|time commitment|2|||
161320804|NCT01775787|582560921|FG000|First 7-10 Days|concerns with using IV|1|||
161320805|NCT01775787|582560922|FG001|First 7-10 Days|concerns with using IV|2|||
161320806|NCT01775787|582560921|FG000|Second 7-10 Days|time commitment|0|||
161320807|NCT01775787|582560922|FG001|Second 7-10 Days|time commitment|1|||
161320808|NCT01775787|582560921|FG000|Second 7-10 Days|concerns with using IV|0|||
161320809|NCT01775787|582560922|FG001|Second 7-10 Days|concerns with using IV|1|||
161320810|NCT03026283|582560923|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
161320811|NCT03026283|582560924|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
161320812|NCT03026283|582560925|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
161320813|NCT03026283|582560926|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
161320814|NCT03026283|582560927|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
161320815|NCT03026283|582560928|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
161320816|NCT03026283|582560929|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
161320817|NCT03026283|582560930|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
161320818|NCT03026283|582560923|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
161320819|NCT03026283|582560924|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
161320820|NCT03026283|582560925|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
161320821|NCT03026283|582560926|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
161320822|NCT03026283|582560927|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
161320823|NCT03026283|582560928|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
161320824|NCT03026283|582560929|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
161320825|NCT03026283|582560930|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
161320826|NCT03026283|582560923|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320827|NCT03026283|582560924|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
161320828|NCT03026283|582560925|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320829|NCT03026283|582560926|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320830|NCT03026283|582560927|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320831|NCT03026283|582560928|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320832|NCT03026283|582560929|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320833|NCT03026283|582560930|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
161320834|NCT03026283|582560923|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320835|NCT03026283|582560924|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320836|NCT03026283|582560925|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
161320837|NCT03026283|582560926|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320838|NCT03026283|582560927|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320839|NCT03026283|582560928|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320840|NCT03026283|582560929|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320841|NCT03026283|582560930|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
161320842|NCT03026283|582560923|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161320843|NCT03026283|582560924|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161320844|NCT03026283|582560925|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161320845|NCT03026283|582560926|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
161320846|NCT03026283|582560927|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
161320847|NCT03026283|582560928|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161320848|NCT03026283|582560929|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161320849|NCT03026283|582560930|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
161320850|NCT03026283|582560923|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161320851|NCT03026283|582560924|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161320852|NCT03026283|582560925|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161320853|NCT03026283|582560926|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
161320854|NCT03026283|582560927|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
161320855|NCT03026283|582560928|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
161320856|NCT03026283|582560929|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161320857|NCT03026283|582560930|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
161320858|NCT03026283|582560923|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161320859|NCT03026283|582560924|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161320860|NCT03026283|582560925|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161320861|NCT03026283|582560926|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
161320862|NCT03026283|582560927|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161320863|NCT03026283|582560928|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
161320864|NCT03026283|582560929|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161320865|NCT03026283|582560930|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
161320866|NCT03026283|582560923|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320867|NCT03026283|582560924|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320868|NCT03026283|582560925|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320869|NCT03026283|582560926|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
161320870|NCT03026283|582560927|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320871|NCT03026283|582560928|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320872|NCT03026283|582560929|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320873|NCT03026283|582560930|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
161320874|NCT03026283|582560923|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161320875|NCT03026283|582560924|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161320876|NCT03026283|582560925|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161320877|NCT03026283|582560926|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161320878|NCT03026283|582560927|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
161320879|NCT03026283|582560928|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
161320880|NCT03026283|582560929|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161320881|NCT03026283|582560930|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
161320882|NCT00824655|582560931|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
161320883|NCT00824655|582560932|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
161320884|NCT00824655|582560931|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
161320885|NCT00824655|582560932|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
161320886|NCT01826981|582560935|FG000|Overall Study|Lack of Efficacy|0|||
161320887|NCT01826981|582560936|FG001|Overall Study|Lack of Efficacy|1|||
161320888|NCT01826981|582560937|FG002|Overall Study|Lack of Efficacy|0|||
161320889|NCT01826981|582560938|FG003|Overall Study|Lack of Efficacy|0|||
161320890|NCT01826981|582560939|FG004|Overall Study|Lack of Efficacy|5|||
161320891|NCT01826981|582560940|FG005|Overall Study|Lack of Efficacy|0|||
161320892|NCT01826981|582560941|FG006|Overall Study|Lack of Efficacy|0|||
161320893|NCT01826981|582560942|FG007|Overall Study|Lack of Efficacy|8|||
161320894|NCT01826981|582560943|FG008|Overall Study|Lack of Efficacy|7|||
161320895|NCT01826981|582560944|FG009|Overall Study|Lack of Efficacy|0|||
161320896|NCT01826981|582560945|FG010|Overall Study|Lack of Efficacy|1|||
161320897|NCT01826981|582560946|FG011|Overall Study|Lack of Efficacy|0|||
161320898|NCT01826981|582560947|FG012|Overall Study|Lack of Efficacy|0|||
161320899|NCT01826981|582560948|FG013|Overall Study|Lack of Efficacy|3|||
161320900|NCT01826981|582560949|FG014|Overall Study|Lack of Efficacy|0|||
161320901|NCT01826981|582560935|FG000|Overall Study|Lost to Follow-up|0|||
161320902|NCT01826981|582560936|FG001|Overall Study|Lost to Follow-up|0|||
161320903|NCT01826981|582560937|FG002|Overall Study|Lost to Follow-up|0|||
161320904|NCT01826981|582560938|FG003|Overall Study|Lost to Follow-up|0|||
161320905|NCT01826981|582560939|FG004|Overall Study|Lost to Follow-up|1|||
161320906|NCT01826981|582560940|FG005|Overall Study|Lost to Follow-up|1|||
161320907|NCT01826981|582560941|FG006|Overall Study|Lost to Follow-up|0|||
161320908|NCT01826981|582560942|FG007|Overall Study|Lost to Follow-up|1|||
161320909|NCT01826981|582560943|FG008|Overall Study|Lost to Follow-up|0|||
161320910|NCT01826981|582560944|FG009|Overall Study|Lost to Follow-up|1|||
161320911|NCT01826981|582560945|FG010|Overall Study|Lost to Follow-up|1|||
161320912|NCT01826981|582560946|FG011|Overall Study|Lost to Follow-up|1|||
161320913|NCT01826981|582560947|FG012|Overall Study|Lost to Follow-up|1|||
161320914|NCT01826981|582560948|FG013|Overall Study|Lost to Follow-up|0|||
161320915|NCT01826981|582560949|FG014|Overall Study|Lost to Follow-up|0|||
161320916|NCT01826981|582560935|FG000|Overall Study|Withdrew Consent|0|||
161320917|NCT01826981|582560936|FG001|Overall Study|Withdrew Consent|0|||
161320918|NCT01826981|582560937|FG002|Overall Study|Withdrew Consent|0|||
161320919|NCT01826981|582560938|FG003|Overall Study|Withdrew Consent|0|||
161320920|NCT01826981|582560939|FG004|Overall Study|Withdrew Consent|0|||
161320921|NCT01826981|582560940|FG005|Overall Study|Withdrew Consent|0|||
161320922|NCT01826981|582560941|FG006|Overall Study|Withdrew Consent|1|||
161320923|NCT01826981|582560942|FG007|Overall Study|Withdrew Consent|1|||
161320924|NCT01826981|582560943|FG008|Overall Study|Withdrew Consent|0|||
161320925|NCT01826981|582560944|FG009|Overall Study|Withdrew Consent|0|||
161320926|NCT01826981|582560945|FG010|Overall Study|Withdrew Consent|0|||
161320927|NCT01826981|582560946|FG011|Overall Study|Withdrew Consent|1|||
161320928|NCT01826981|582560947|FG012|Overall Study|Withdrew Consent|0|||
161320929|NCT01826981|582560948|FG013|Overall Study|Withdrew Consent|1|||
161320930|NCT01826981|582560949|FG014|Overall Study|Withdrew Consent|0|||
161320931|NCT01826981|582560935|FG000|Overall Study|Adverse Event|0|||
161320932|NCT01826981|582560936|FG001|Overall Study|Adverse Event|0|||
161320933|NCT01826981|582560937|FG002|Overall Study|Adverse Event|0|||
161320934|NCT01826981|582560938|FG003|Overall Study|Adverse Event|0|||
161320935|NCT01826981|582560939|FG004|Overall Study|Adverse Event|1|||
161320936|NCT01826981|582560940|FG005|Overall Study|Adverse Event|0|||
161320937|NCT01826981|582560941|FG006|Overall Study|Adverse Event|0|||
161320938|NCT01826981|582560942|FG007|Overall Study|Adverse Event|0|||
161320939|NCT01826981|582560943|FG008|Overall Study|Adverse Event|0|||
161320940|NCT01826981|582560944|FG009|Overall Study|Adverse Event|0|||
161320941|NCT01826981|582560945|FG010|Overall Study|Adverse Event|0|||
161320942|NCT01826981|582560946|FG011|Overall Study|Adverse Event|0|||
161320943|NCT01826981|582560947|FG012|Overall Study|Adverse Event|0|||
161320944|NCT01826981|582560948|FG013|Overall Study|Adverse Event|0|||
161320945|NCT01826981|582560949|FG014|Overall Study|Adverse Event|0|||
161320946|NCT01826981|582560935|FG000|Overall Study|Upper G-I Haemorrhage|0|||
161320947|NCT01826981|582560936|FG001|Overall Study|Upper G-I Haemorrhage|0|||
161320948|NCT01826981|582560937|FG002|Overall Study|Upper G-I Haemorrhage|0|||
161320949|NCT01826981|582560938|FG003|Overall Study|Upper G-I Haemorrhage|0|||
161320950|NCT01826981|582560939|FG004|Overall Study|Upper G-I Haemorrhage|0|||
161320951|NCT01826981|582560940|FG005|Overall Study|Upper G-I Haemorrhage|0|||
161320952|NCT01826981|582560941|FG006|Overall Study|Upper G-I Haemorrhage|0|||
161320953|NCT01826981|582560942|FG007|Overall Study|Upper G-I Haemorrhage|0|||
161320954|NCT01826981|582560943|FG008|Overall Study|Upper G-I Haemorrhage|0|||
161320955|NCT01826981|582560944|FG009|Overall Study|Upper G-I Haemorrhage|0|||
161320956|NCT01826981|582560945|FG010|Overall Study|Upper G-I Haemorrhage|0|||
161320957|NCT01826981|582560946|FG011|Overall Study|Upper G-I Haemorrhage|0|||
161320958|NCT01826981|582560947|FG012|Overall Study|Upper G-I Haemorrhage|0|||
161320959|NCT01826981|582560948|FG013|Overall Study|Upper G-I Haemorrhage|1|||
161320960|NCT01826981|582560949|FG014|Overall Study|Upper G-I Haemorrhage|0|||
161320961|NCT01826981|582560935|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320962|NCT01826981|582560936|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320963|NCT01826981|582560937|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320964|NCT01826981|582560938|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320965|NCT01826981|582560939|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320966|NCT01826981|582560940|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320967|NCT01826981|582560941|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320968|NCT01826981|582560942|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
161320969|NCT01826981|582560943|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320970|NCT01826981|582560944|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320971|NCT01826981|582560945|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320972|NCT01826981|582560946|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320973|NCT01826981|582560947|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320974|NCT01826981|582560948|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320975|NCT01826981|582560949|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
161320976|NCT03746405|582560954|FG000|Overall Study|Withdrawal by Subject|3|||
161320977|NCT03746405|582560955|FG001|Overall Study|Withdrawal by Subject|0|||
161320978|NCT03746405|582560954|FG000|Overall Study|technical difficulties|0|||
161320979|NCT03746405|582560955|FG001|Overall Study|technical difficulties|2|||
161320980|NCT03479008|582560956|FG000|Overall Study|Withdrawal by Subject|3|||
161320981|NCT00412932|582560957|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
161320982|NCT00412932|582560957|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
161320983|NCT00412932|582560957|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
161320984|NCT00412932|582560957|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
161320985|NCT00412932|582560957|FG000|Olmesartan (Olm) 20 mg|Other|1|||
161320986|NCT00412932|582560957|FG000|Olmesartan 40 mg|Adverse Event|4|||
161320987|NCT00412932|582560957|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
161320988|NCT00412932|582560957|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
161320989|NCT00412932|582560957|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
161320990|NCT00412932|582560957|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
161320991|NCT00412932|582560957|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
161320992|NCT00412932|582560957|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
161320993|NCT02630563|582560958|FG000|Overall Study|Administrative|1|||
161320994|NCT00667563|582560959|FG000|Overall Study|Protocol Violation|24|||
161320995|NCT02384538|582560974|FG000|Overall Study|Adverse Event|1|||
161320996|NCT02384538|582560975|FG001|Overall Study|Adverse Event|4|||
161320997|NCT02384538|582560974|FG000|Overall Study|Lack of Efficacy|4|||
161320998|NCT02384538|582560975|FG001|Overall Study|Lack of Efficacy|4|||
161320999|NCT02384538|582560974|FG000|Overall Study|Withdrew Consent|0|||
161321000|NCT02384538|582560975|FG001|Overall Study|Withdrew Consent|4|||
161321001|NCT02384538|582560974|FG000|Overall Study|Other|1|||
161321002|NCT02384538|582560975|FG001|Overall Study|Other|3|||
161321003|NCT01301079|582560976|FG000|Overall Study|Lost to Follow-up|2|||
161321004|NCT01301079|582560977|FG001|Overall Study|Lost to Follow-up|2|||
161321005|NCT00313586|582560978|FG000|Overall Study|Disease progression|14|||
161321006|NCT00313586|582560979|FG001|Overall Study|Disease progression|19|||
161321007|NCT00313586|582560980|FG002|Overall Study|Disease progression|10|||
161321008|NCT00313586|582560981|FG003|Overall Study|Disease progression|3|||
161321009|NCT00313586|582560978|FG000|Overall Study|Adverse Event|12|||
161321010|NCT00313586|582560979|FG001|Overall Study|Adverse Event|18|||
161321011|NCT00313586|582560980|FG002|Overall Study|Adverse Event|3|||
161321012|NCT00313586|582560981|FG003|Overall Study|Adverse Event|10|||
161321013|NCT00313586|582560978|FG000|Overall Study|Death|11|||
161321014|NCT00313586|582560979|FG001|Overall Study|Death|8|||
161321015|NCT00313586|582560980|FG002|Overall Study|Death|1|||
161321016|NCT00313586|582560981|FG003|Overall Study|Death|7|||
161321017|NCT00313586|582560978|FG000|Overall Study|Withdrawal by Subject|13|||
161321018|NCT00313586|582560979|FG001|Overall Study|Withdrawal by Subject|6|||
161321019|NCT00313586|582560980|FG002|Overall Study|Withdrawal by Subject|6|||
161321020|NCT00313586|582560981|FG003|Overall Study|Withdrawal by Subject|2|||
161321021|NCT00313586|582560978|FG000|Overall Study|Alternative therapy|3|||
161321022|NCT00313586|582560979|FG001|Overall Study|Alternative therapy|6|||
161321023|NCT00313586|582560980|FG002|Overall Study|Alternative therapy|2|||
161321024|NCT00313586|582560981|FG003|Overall Study|Alternative therapy|0|||
161321025|NCT00313586|582560978|FG000|Overall Study|Other complicating disease|2|||
161321026|NCT00313586|582560979|FG001|Overall Study|Other complicating disease|2|||
161321027|NCT00313586|582560980|FG002|Overall Study|Other complicating disease|0|||
161321028|NCT00313586|582560981|FG003|Overall Study|Other complicating disease|0|||
161321029|NCT00313586|582560978|FG000|Overall Study|Did not achieve HI-major/better response|10|||
161321030|NCT00313586|582560979|FG001|Overall Study|Did not achieve HI-major/better response|7|||
161321031|NCT00313586|582560980|FG002|Overall Study|Did not achieve HI-major/better response|2|||
161321032|NCT00313586|582560981|FG003|Overall Study|Did not achieve HI-major/better response|1|||
161321033|NCT00313586|582560978|FG000|Overall Study|Physician Decision|2|||
161321034|NCT00313586|582560979|FG001|Overall Study|Physician Decision|1|||
161321035|NCT00313586|582560980|FG002|Overall Study|Physician Decision|0|||
161321036|NCT00313586|582560981|FG003|Overall Study|Physician Decision|0|||
161321037|NCT00313586|582560978|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
161321038|NCT00313586|582560979|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
161321039|NCT00313586|582560980|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
161321040|NCT00313586|582560981|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
161321041|NCT00313586|582560978|FG000|Overall Study|Lost insurance|0|||
161321042|NCT00313586|582560979|FG001|Overall Study|Lost insurance|1|||
161321043|NCT00313586|582560980|FG002|Overall Study|Lost insurance|0|||
161321044|NCT00313586|582560981|FG003|Overall Study|Lost insurance|0|||
161321045|NCT00313586|582560978|FG000|Overall Study|Moved|0|||
161321046|NCT00313586|582560979|FG001|Overall Study|Moved|1|||
161321047|NCT00313586|582560980|FG002|Overall Study|Moved|0|||
161321048|NCT00313586|582560981|FG003|Overall Study|Moved|0|||
161321049|NCT00313586|582560978|FG000|Overall Study|Death before starting treatment|1|||
161321050|NCT00313586|582560979|FG001|Overall Study|Death before starting treatment|0|||
161321051|NCT00313586|582560980|FG002|Overall Study|Death before starting treatment|0|||
161321052|NCT00313586|582560981|FG003|Overall Study|Death before starting treatment|0|||
161321053|NCT00264290|582560982|FG000|Intervention (8 Weeks)|Adverse Event|1|||
161321054|NCT00264290|582560983|FG001|Intervention (8 Weeks)|Adverse Event|0|||
161321055|NCT04472494|582560984|FG000|Pre-treatment|Other reasons|2|||
161321056|NCT04472494|582560985|FG001|Pre-treatment|Other reasons|0|||
161321057|NCT04472494|582560984|FG000|Treatment|Death|5|||
161321058|NCT04472494|582560985|FG001|Treatment|Death|2|||
161321059|NCT04472494|582560984|FG000|Treatment|Hospital discharge|1|||
161321060|NCT04472494|582560985|FG001|Treatment|Hospital discharge|1|||
161321061|NCT03519919|582560986|FG000|Overall Study|Withdrawal by Subject|1|||
161321062|NCT03519919|582560986|FG000|Overall Study|Lack of Efficacy|1|||
161321063|NCT03519919|582560986|FG000|Overall Study|Screen Failure|1|||
161321064|NCT00587795|582560991|FG000|Overall Study|Withdrawal by Subject|1|||
161321065|NCT00587795|582560992|FG001|Overall Study|Withdrawal by Subject|0|||
161321066|NCT02144077|582560993|FG000|Overall Study|Withdrawal by Subject|3|||
161321067|NCT02144077|582560994|FG001|Overall Study|Withdrawal by Subject|3|||
161321068|NCT02144077|582560993|FG000|Overall Study|Adverse Event|2|||
161321069|NCT02144077|582560994|FG001|Overall Study|Adverse Event|3|||
161321070|NCT02144077|582560993|FG000|Overall Study|Lost to Follow-up|2|||
161321071|NCT02144077|582560994|FG001|Overall Study|Lost to Follow-up|2|||
161321072|NCT02144077|582560993|FG000|Overall Study|Protocol Violation|1|||
161321073|NCT02144077|582560994|FG001|Overall Study|Protocol Violation|2|||
161321074|NCT02144077|582560993|FG000|Overall Study|Death|0|||
161321075|NCT02144077|582560994|FG001|Overall Study|Death|1|||
161321076|NCT02144077|582560993|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
161321077|NCT02144077|582560994|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
161321078|NCT01869777|582560995|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
161321079|NCT01951573|582560996|FG000|Washout Period|Adverse Event|0|||
161321080|NCT01951573|582560997|FG001|Washout Period|Adverse Event|1|||
161321081|NCT00943592|582560998|FG000|Overall Study|Death|3|||
161321082|NCT01909973|582560999|FG000|Overall Study|Lost to Follow-up|1|||
161321083|NCT01909973|582561000|FG001|Overall Study|Lost to Follow-up|0|||
161321084|NCT02982863|582561005|FG000|Overall Study|Not eligible patients|809|||
161321085|NCT02982863|582561006|FG001|Overall Study|Not eligible patients|4261|||
161321086|NCT02982863|582561007|FG002|Overall Study|Not eligible patients|1852|||
161321087|NCT02982863|582561008|FG003|Overall Study|Not eligible patients|1400|||
161321088|NCT02982863|582561009|FG004|Overall Study|Not eligible patients|492|||
161321089|NCT03739710|582561010|FG000|Overall Study|Screen Failed|81|||
161321090|NCT04313400|582561011|FG000|Overall Study|Withdrawal by Subject|0|||
161321091|NCT04313400|582561012|FG001|Overall Study|Withdrawal by Subject|0|||
161321092|NCT04313400|582561013|FG002|Overall Study|Withdrawal by Subject|0|||
161321093|NCT04313400|582561014|FG003|Overall Study|Withdrawal by Subject|0|||
161321094|NCT04313400|582561015|FG004|Overall Study|Withdrawal by Subject|0|||
161321095|NCT04313400|582561016|FG005|Overall Study|Withdrawal by Subject|4|||
161321096|NCT04313400|582561017|FG006|Overall Study|Withdrawal by Subject|1|||
161321097|NCT04313400|582561011|FG000|Overall Study|Adverse Event|0|||
161321098|NCT04313400|582561012|FG001|Overall Study|Adverse Event|0|||
161321099|NCT04313400|582561013|FG002|Overall Study|Adverse Event|0|||
161321100|NCT04313400|582561014|FG003|Overall Study|Adverse Event|0|||
161321101|NCT04313400|582561015|FG004|Overall Study|Adverse Event|0|||
161321102|NCT04313400|582561016|FG005|Overall Study|Adverse Event|1|||
161321103|NCT04313400|582561017|FG006|Overall Study|Adverse Event|0|||
161321104|NCT04313400|582561011|FG000|Overall Study|Lost to Follow-up|0|||
161321105|NCT04313400|582561012|FG001|Overall Study|Lost to Follow-up|0|||
161321106|NCT04313400|582561013|FG002|Overall Study|Lost to Follow-up|0|||
161321107|NCT04313400|582561014|FG003|Overall Study|Lost to Follow-up|0|||
161321108|NCT04313400|582561015|FG004|Overall Study|Lost to Follow-up|0|||
161321109|NCT04313400|582561016|FG005|Overall Study|Lost to Follow-up|1|||
161321110|NCT04313400|582561017|FG006|Overall Study|Lost to Follow-up|0|||
161321111|NCT02091414|582561018|FG000|Overall Study|Withdrawal by Subject|2|||
161321112|NCT02091414|582561018|FG000|Overall Study|Death|2|||
161321113|NCT00073008|582561019|FG000|Overall Study|Missing|6|||
161321114|NCT00073008|582561020|FG001|Overall Study|Missing|6|||
161321115|NCT00073008|582561019|FG000|Overall Study|Withdrawal by Subject|2|||
161321116|NCT00073008|582561020|FG001|Overall Study|Withdrawal by Subject|2|||
161321117|NCT00073008|582561019|FG000|Overall Study|Lost to Follow-up|1|||
161321118|NCT00073008|582561020|FG001|Overall Study|Lost to Follow-up|3|||
161321119|NCT00073008|582561019|FG000|Overall Study|Death|46|||
161321120|NCT00073008|582561020|FG001|Overall Study|Death|47|||
161321121|NCT00073008|582561019|FG000|Overall Study|"Other selected on Case Report Form"|7|||
161321122|NCT00073008|582561020|FG001|Overall Study|"Other selected on Case Report Form"|5|||
161321123|NCT01778751|582561030|FG000|Overall Study|Lost to Follow-up|1|||
161321124|NCT01778751|582561031|FG001|Overall Study|Lost to Follow-up|0|||
161321125|NCT01778751|582561030|FG000|Overall Study|Withdrawal by Subject|0|||
161321126|NCT01778751|582561031|FG001|Overall Study|Withdrawal by Subject|2|||
161321127|NCT01778751|582561030|FG000|Overall Study|Transfered care|1|||
161321128|NCT01778751|582561031|FG001|Overall Study|Transfered care|0|||
161321129|NCT03337048|582561032|FG000|Overall Study|Withdrawal by Subject|2|||
161321130|NCT03337048|582561033|FG001|Overall Study|Withdrawal by Subject|0|||
161321131|NCT03337048|582561034|FG002|Overall Study|Withdrawal by Subject|0|||
161321132|NCT02669667|582561035|FG000|Overall Study|Lost to Follow-up|0|||
161321133|NCT02669667|582561036|FG001|Overall Study|Lost to Follow-up|0|||
161321134|NCT02669667|582561037|FG002|Overall Study|Lost to Follow-up|0|||
161321135|NCT02669667|582561038|FG003|Overall Study|Lost to Follow-up|0|||
161321136|NCT02669667|582561039|FG004|Overall Study|Lost to Follow-up|0|||
161321137|NCT02669667|582561040|FG005|Overall Study|Lost to Follow-up|1|||
161321138|NCT02669667|582561041|FG006|Overall Study|Lost to Follow-up|0|||
161321139|NCT00636961|582561055|FG000|Period 1|Administrative problems|1|||
161321140|NCT00636961|582561056|FG001|Period 1|Administrative problems|1|||
161321141|NCT00636961|582561055|FG000|Period 2|Adverse Event|1|||
161321142|NCT00636961|582561056|FG001|Period 2|Adverse Event|0|||
161321143|NCT01428115|582561060|FG000|Overall Study|Lack of Efficacy|3|||
161321144|NCT01428115|582561060|FG000|Overall Study|Lost to Follow-up|10|||
161321145|NCT01428115|582561060|FG000|Overall Study|Pregnancy|1|||
161321146|NCT01428115|582561060|FG000|Overall Study|Protocol Violation|3|||
161321147|NCT01428115|582561060|FG000|Overall Study|Withdrawal by Subject|4|||
161321148|NCT03755518|582561061|FG000|Overall Study|Lack of Efficacy|10|||
161321149|NCT03755518|582561061|FG000|Overall Study|Adverse Event|7|||
161321150|NCT03755518|582561061|FG000|Overall Study|Study Terminated by Sponsor|5|||
161321151|NCT03755518|582561061|FG000|Overall Study|Death|1|||
161321152|NCT03755518|582561061|FG000|Overall Study|Withdrawal by Subject|3|||
161321153|NCT03755518|582561061|FG000|Overall Study|Progressive Disease|4|||
161321154|NCT03755518|582561061|FG000|Overall Study|Bone Marrow Transplant|4|||
161321155|NCT03755518|582561061|FG000|Overall Study|Physicians Decision|1|||
161321156|NCT03755518|582561061|FG000|Overall Study|Relapse|1|||
161321157|NCT03755518|582561061|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
161321158|NCT03755518|582561061|FG000|Overall Study|Withdrawal by PI|1|||
161321159|NCT01714609|582561062|FG000|Overall Study|Protocol Violation|1|||
161321160|NCT01714609|582561063|FG001|Overall Study|Protocol Violation|0|||
161321161|NCT03403621|582561064|FG000|Overall Study|Withdrawal by Subject|2|||
161321162|NCT03403621|582561065|FG001|Overall Study|Withdrawal by Subject|2|||
161321163|NCT00395642|582561066|FG000|Overall Study|Death|4|||
161321164|NCT00395642|582561066|FG000|Overall Study|Lost to Follow-up|1|||
161321165|NCT00395642|582561066|FG000|Overall Study|Physician Decision|7|||
161321166|NCT00395642|582561066|FG000|Overall Study|Withdrawal by Subject|1|||
161321167|NCT02749799|582561071|FG000|Overall Study|Adverse Event|2|||
161321168|NCT02749799|582561071|FG000|Overall Study|Lost to Follow-up|4|||
161321169|NCT02749799|582561071|FG000|Overall Study|Protocol Violation|1|||
161321170|NCT02749799|582561071|FG000|Overall Study|Withdrawal by Subject|1|||
161321171|NCT02070978|582561072|FG000|Overall Study|Adverse Event|6|||
161321172|NCT02070978|582561073|FG001|Overall Study|Adverse Event|2|||
161321173|NCT02070978|582561074|FG002|Overall Study|Adverse Event|0|||
161321174|NCT02070978|582561072|FG000|Overall Study|Lost to Follow-up|1|||
161321175|NCT02070978|582561073|FG001|Overall Study|Lost to Follow-up|3|||
161321176|NCT02070978|582561074|FG002|Overall Study|Lost to Follow-up|4|||
161321177|NCT02070978|582561072|FG000|Overall Study|Withdrawal by Subject|3|||
161321178|NCT02070978|582561073|FG001|Overall Study|Withdrawal by Subject|5|||
161321179|NCT02070978|582561074|FG002|Overall Study|Withdrawal by Subject|3|||
161321180|NCT02070978|582561072|FG000|Overall Study|Protocol Violation|1|||
161321181|NCT02070978|582561073|FG001|Overall Study|Protocol Violation|0|||
161321182|NCT02070978|582561074|FG002|Overall Study|Protocol Violation|3|||
161321183|NCT02070978|582561072|FG000|Overall Study|Lack of Efficacy|0|||
161321184|NCT02070978|582561073|FG001|Overall Study|Lack of Efficacy|1|||
161321185|NCT02070978|582561074|FG002|Overall Study|Lack of Efficacy|0|||
161321186|NCT02070978|582561072|FG000|Overall Study|Death|0|||
161321187|NCT02070978|582561073|FG001|Overall Study|Death|0|||
161321188|NCT02070978|582561074|FG002|Overall Study|Death|2|||
161321189|NCT02070978|582561072|FG000|Overall Study|Un-specified|3|||
161321190|NCT02070978|582561073|FG001|Overall Study|Un-specified|2|||
161321191|NCT02070978|582561074|FG002|Overall Study|Un-specified|2|||
161321192|NCT02070978|582561072|FG000|Overall Study|Terminated by Sponsor|33|||
161321193|NCT02070978|582561073|FG001|Overall Study|Terminated by Sponsor|40|||
161321194|NCT02070978|582561074|FG002|Overall Study|Terminated by Sponsor|39|||
161321195|NCT03951753|582561075|FG000|Overall Study|Adverse Event|1|||
161321196|NCT03951753|582561076|FG001|Overall Study|Adverse Event|0|||
161321197|NCT03951753|582561077|FG002|Overall Study|Adverse Event|3|||
161321198|NCT03951753|582561075|FG000|Overall Study|Withdrawal by Subject|3|||
161321199|NCT03951753|582561076|FG001|Overall Study|Withdrawal by Subject|1|||
161321200|NCT03951753|582561077|FG002|Overall Study|Withdrawal by Subject|0|||
161321201|NCT03951753|582561075|FG000|Overall Study|Lost to Follow-up|0|||
161321202|NCT03951753|582561076|FG001|Overall Study|Lost to Follow-up|0|||
161321203|NCT03951753|582561077|FG002|Overall Study|Lost to Follow-up|1|||
161321204|NCT01905592|582561080|FG000|Overall Study|Disease Progression|51|||
161321205|NCT01905592|582561081|FG001|Overall Study|Disease Progression|110|||
161321206|NCT01905592|582561080|FG000|Overall Study|Toxicity|1|||
161321207|NCT01905592|582561081|FG001|Overall Study|Toxicity|16|||
161321208|NCT01905592|582561080|FG000|Overall Study|Physician Decision|0|||
161321209|NCT01905592|582561081|FG001|Overall Study|Physician Decision|2|||
161321210|NCT01905592|582561080|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
161321211|NCT01905592|582561081|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
161321212|NCT01905592|582561080|FG000|Overall Study|Protocol Violation|0|||
161321213|NCT01905592|582561081|FG001|Overall Study|Protocol Violation|1|||
161321214|NCT01905592|582561080|FG000|Overall Study|Sponsor's decision|1|||
161321215|NCT01905592|582561081|FG001|Overall Study|Sponsor's decision|1|||
161321216|NCT01905592|582561080|FG000|Overall Study|Not treated|7|||
161321217|NCT01905592|582561081|FG001|Overall Study|Not treated|3|||
161321218|NCT01905592|582561080|FG000|Overall Study|Withdrawal by Subject|10|||
161321219|NCT01905592|582561081|FG001|Overall Study|Withdrawal by Subject|2|||
161321220|NCT02669043|582561082|FG000|Overall Study|Didn't meet I/E criteria|4|||
161321221|NCT01483599|582561084|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
161321222|NCT01483599|582561085|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321223|NCT01483599|582561086|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321224|NCT01483599|582561087|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
161321225|NCT01483599|582561088|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
161321226|NCT01483599|582561089|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
161321227|NCT01483599|582561090|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
161321228|NCT01483599|582561091|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321229|NCT01483599|582561092|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321230|NCT01483599|582561093|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321231|NCT01483599|582561094|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321232|NCT01483599|582561095|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321233|NCT01483599|582561096|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321234|NCT01483599|582561097|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
161321235|NCT01483599|582561084|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321236|NCT01483599|582561085|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161321237|NCT01483599|582561086|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321238|NCT01483599|582561087|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161321239|NCT01483599|582561088|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321240|NCT01483599|582561089|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321241|NCT01483599|582561090|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
161321242|NCT01483599|582561091|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321243|NCT01483599|582561092|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321244|NCT01483599|582561093|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321245|NCT01483599|582561094|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321246|NCT01483599|582561095|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321247|NCT01483599|582561096|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321248|NCT01483599|582561097|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
161321249|NCT01483599|582561084|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
161321250|NCT01483599|582561085|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321251|NCT01483599|582561086|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321252|NCT01483599|582561087|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321253|NCT01483599|582561088|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321254|NCT01483599|582561089|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321255|NCT01483599|582561090|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321256|NCT01483599|582561091|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321257|NCT01483599|582561092|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321258|NCT01483599|582561093|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321259|NCT01483599|582561094|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321260|NCT01483599|582561095|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321261|NCT01483599|582561096|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321262|NCT01483599|582561097|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
161321263|NCT01483599|582561084|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
161321264|NCT01483599|582561085|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
161321265|NCT01483599|582561086|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
161321266|NCT01483599|582561087|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
161321267|NCT01483599|582561088|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
161321268|NCT01483599|582561089|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
161321269|NCT01483599|582561090|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
161321270|NCT01483599|582561091|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
161321271|NCT01483599|582561092|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
161321272|NCT01483599|582561093|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
161321273|NCT01483599|582561094|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
161321274|NCT01483599|582561095|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
161321275|NCT01483599|582561096|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
161321276|NCT01483599|582561097|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
161321277|NCT01483599|582561084|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
161321278|NCT01483599|582561085|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
161321279|NCT01483599|582561086|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
161321280|NCT01483599|582561087|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
161321281|NCT01483599|582561088|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
161321282|NCT01483599|582561089|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
161321283|NCT01483599|582561090|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
161321284|NCT01483599|582561091|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
161321285|NCT01483599|582561092|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
161321286|NCT01483599|582561093|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
161321287|NCT01483599|582561094|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
161321288|NCT01483599|582561095|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
161321289|NCT01483599|582561096|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
161321290|NCT01483599|582561097|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
161321291|NCT01483599|582561084|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321292|NCT01483599|582561085|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321293|NCT01483599|582561086|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321294|NCT01483599|582561087|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321295|NCT01483599|582561088|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321296|NCT01483599|582561089|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321297|NCT01483599|582561090|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321298|NCT01483599|582561091|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161321299|NCT01483599|582561092|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161321300|NCT01483599|582561093|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321301|NCT01483599|582561094|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321302|NCT01483599|582561095|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
161321303|NCT01483599|582561096|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161321304|NCT01483599|582561097|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
161321305|NCT01483599|582561084|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321306|NCT01483599|582561085|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321307|NCT01483599|582561086|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321308|NCT01483599|582561087|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321309|NCT01483599|582561088|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321310|NCT01483599|582561089|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321311|NCT01483599|582561090|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321312|NCT01483599|582561091|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321313|NCT01483599|582561092|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161321314|NCT01483599|582561093|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321315|NCT01483599|582561094|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321316|NCT01483599|582561095|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161321317|NCT01483599|582561096|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
161321318|NCT01483599|582561097|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
161321319|NCT01483599|582561084|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321320|NCT01483599|582561085|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321321|NCT01483599|582561086|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321322|NCT01483599|582561087|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321323|NCT01483599|582561088|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321324|NCT01483599|582561089|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321325|NCT01483599|582561090|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321326|NCT01483599|582561091|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321327|NCT01483599|582561092|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
161321328|NCT01483599|582561093|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321329|NCT01483599|582561094|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
161321330|NCT01483599|582561095|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321331|NCT01483599|582561096|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
161321332|NCT01483599|582561097|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
161321333|NCT01483599|582561084|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321334|NCT01483599|582561085|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321335|NCT01483599|582561086|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321336|NCT01483599|582561087|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321337|NCT01483599|582561088|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321338|NCT01483599|582561089|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321339|NCT01483599|582561090|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321340|NCT01483599|582561091|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321341|NCT01483599|582561092|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
161321342|NCT01483599|582561093|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321343|NCT01483599|582561094|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321344|NCT01483599|582561095|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
161321345|NCT01483599|582561096|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
161321346|NCT01483599|582561097|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
161321347|NCT01483599|582561084|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
161321348|NCT01483599|582561085|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
161321349|NCT01483599|582561086|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
161321350|NCT01483599|582561087|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
161321351|NCT01483599|582561088|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
161321352|NCT01483599|582561089|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
161321353|NCT01483599|582561090|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
161321354|NCT01483599|582561091|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
161321355|NCT01483599|582561092|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
161321356|NCT01483599|582561093|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
161321357|NCT01483599|582561094|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
161321358|NCT01483599|582561095|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
161321359|NCT01483599|582561096|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
161321360|NCT01483599|582561097|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
161321361|NCT02109445|582561098|FG000|Overall Study|Symptomatic deterioration|2|||
161321362|NCT02109445|582561098|FG000|Overall Study|Adverse Event|1|||
161321363|NCT00966355|582561103|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
161321364|NCT00966355|582561104|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
161321365|NCT00966355|582561105|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
161321366|NCT00966355|582561103|FG000|Overall Study|newly diagnosed advanced HCC|11|||
161321367|NCT00966355|582561104|FG001|Overall Study|newly diagnosed advanced HCC|12|||
161321368|NCT00966355|582561105|FG002|Overall Study|newly diagnosed advanced HCC|10|||
161321369|NCT00966355|582561103|FG000|Overall Study|Lost to Follow-up|5|||
161321370|NCT00966355|582561104|FG001|Overall Study|Lost to Follow-up|4|||
161321371|NCT00966355|582561105|FG002|Overall Study|Lost to Follow-up|3|||
